id|nct_id|result_group_id|ctgov_group_code|period|reason|count
1066858|NCT03670537|3447557|P1|Overall Study|Protocol Violation|1
1066859|NCT03648983|3447565|P1|Overall Study|Study was terminated due to PI departure|95
1066860|NCT03585504|3447633|P2|Overall Study|Lost to Follow-up|29
1066861|NCT03585504|3447634|P1|Overall Study|Lost to Follow-up|26
1066862|NCT03582943|3447646|P2|Analyzed|Protocol Violation|1
1066863|NCT03582943|3447647|P1|Analyzed|Protocol Violation|4
1066864|NCT03582943|3447646|P2|Intervention and Follow up|Withdrawal by Subject|2
1066865|NCT03582943|3447647|P1|Intervention and Follow up|Withdrawal by Subject|4
1066866|NCT03582943|3447646|P2|Allocated to Groups|Withdrawal by Subject|1
1066867|NCT03582943|3447647|P1|Allocated to Groups|Withdrawal by Subject|1
1066868|NCT03578146|3447659|P6|Overall Study|Lost to Follow-up|1
1066869|NCT03578146|3447660|P5|Overall Study|Lost to Follow-up|0
1066870|NCT03578146|3447661|P4|Overall Study|Lost to Follow-up|0
1066871|NCT03578146|3447662|P3|Overall Study|Lost to Follow-up|1
1066872|NCT03578146|3447663|P2|Overall Study|Lost to Follow-up|1
1066873|NCT03578146|3447664|P1|Overall Study|Lost to Follow-up|0
1066874|NCT03578146|3447659|P6|Overall Study|Did Not Receive Treatment|2
1066875|NCT03578146|3447660|P5|Overall Study|Did Not Receive Treatment|0
1066876|NCT03578146|3447661|P4|Overall Study|Did Not Receive Treatment|0
1066877|NCT03578146|3447662|P3|Overall Study|Did Not Receive Treatment|0
1066878|NCT03578146|3447663|P2|Overall Study|Did Not Receive Treatment|0
1066879|NCT03578146|3447664|P1|Overall Study|Did Not Receive Treatment|1
1066880|NCT03551743|3447730|P4|Overall Study|Withdrawal by Subject|0
1066881|NCT03551743|3447731|P3|Overall Study|Withdrawal by Subject|0
1066882|NCT03551743|3447732|P2|Overall Study|Withdrawal by Subject|0
1066883|NCT03551743|3447733|P1|Overall Study|Withdrawal by Subject|1
1066884|NCT03551743|3447730|P4|Overall Study|Adverse Event|0
1066885|NCT03551743|3447731|P3|Overall Study|Adverse Event|0
1066886|NCT03551743|3447732|P2|Overall Study|Adverse Event|0
1066887|NCT03551743|3447733|P1|Overall Study|Adverse Event|1
1066888|NCT03551730|3447779|P4|Overall Study|Adverse Event|0
1066889|NCT03551730|3447780|P3|Overall Study|Adverse Event|0
1066890|NCT03551730|3447781|P2|Overall Study|Adverse Event|0
1066891|NCT03551730|3447782|P1|Overall Study|Adverse Event|1
1066892|NCT03549130|3447822|P2|Overall Study|Lost to Follow-up|1
1066893|NCT03549130|3447823|P1|Overall Study|Lost to Follow-up|0
1066894|NCT03549130|3447822|P2|Overall Study|Adverse Event|1
1066895|NCT03549130|3447823|P1|Overall Study|Adverse Event|0
1066896|NCT03549117|3447841|P2|Overall Study|Withdrawal by Subject|0
1066897|NCT03549117|3447842|P1|Overall Study|Withdrawal by Subject|1
1066898|NCT03494985|3447979|P4|Overall Study|Other (Not specified)|0
1066899|NCT03494985|3447980|P3|Overall Study|Other (Not specified)|1
1066900|NCT03494985|3447981|P2|Overall Study|Other (Not specified)|1
1066901|NCT03494985|3447982|P1|Overall Study|Other (Not specified)|0
1066902|NCT03494985|3447979|P4|Overall Study|Other (Withdrawal of consent)|5
1066903|NCT03494985|3447980|P3|Overall Study|Other (Withdrawal of consent)|2
1066904|NCT03494985|3447981|P2|Overall Study|Other (Withdrawal of consent)|3
1066905|NCT03494985|3447982|P1|Overall Study|Other (Withdrawal of consent)|2
1066906|NCT03494985|3447979|P4|Overall Study|Adverse Event|0
1066907|NCT03494985|3447980|P3|Overall Study|Adverse Event|3
1066908|NCT03494985|3447981|P2|Overall Study|Adverse Event|2
1066909|NCT03494985|3447982|P1|Overall Study|Adverse Event|3
1066910|NCT03489551|3448035|P1|Overall Study|Withdrawal by Subject|2
1066911|NCT03489304|3448039|P1|Overall Study|Lost to Follow-up|4
1066912|NCT03479216|3448047|P2|Overall Study|Physician Decision|3
1066913|NCT03479216|3448048|P1|Overall Study|Physician Decision|2
1066914|NCT03479216|3448047|P2|Overall Study|Withdrawal by Subject|2
1066915|NCT03479216|3448048|P1|Overall Study|Withdrawal by Subject|3
1066916|NCT03478891|3448069|P3|Overall Study|Lost to Follow-up|0
1066917|NCT03478891|3448070|P2|Overall Study|Lost to Follow-up|0
1066918|NCT03478891|3448071|P1|Overall Study|Lost to Follow-up|1
1066919|NCT03478891|3448069|P3|Overall Study|Moved from area|1
1066920|NCT03478891|3448070|P2|Overall Study|Moved from area|0
1066921|NCT03478891|3448071|P1|Overall Study|Moved from area|0
1066922|NCT03478891|3448069|P3|Overall Study|Still Active in Study|9
1066923|NCT03478891|3448070|P2|Overall Study|Still Active in Study|5
1066924|NCT03478891|3448071|P1|Overall Study|Still Active in Study|2
1066925|NCT03478891|3448069|P3|Overall Study|Enrolled, but product never administered|1
1066926|NCT03478891|3448070|P2|Overall Study|Enrolled, but product never administered|0
1066927|NCT03478891|3448071|P1|Overall Study|Enrolled, but product never administered|0
1066928|NCT03478644|3448087|P2|Phase 2|Lost to Follow-up|0
1066929|NCT03478644|3448088|P1|Phase 2|Lost to Follow-up|1
1066930|NCT03478644|3448087|P2|Phase 2|Withdrawal by Subject|1
1066931|NCT03478644|3448088|P1|Phase 2|Withdrawal by Subject|2
1066932|NCT03447821|3448103|P3|Overall Study|Lost to Follow-up|1
1066933|NCT03447821|3448104|P2|Overall Study|Lost to Follow-up|0
1066934|NCT03447821|3448105|P1|Overall Study|Lost to Follow-up|0
1066935|NCT03447821|3448103|P3|Overall Study|Withdrawal by Subject|0
1066936|NCT03447821|3448104|P2|Overall Study|Withdrawal by Subject|1
1066937|NCT03447821|3448105|P1|Overall Study|Withdrawal by Subject|1
1066938|NCT03447353|3448128|P1|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1
1066939|NCT03447353|3448128|P1|Overall Study|Scheduling Conflicts|3
1066940|NCT03447353|3448128|P1|Overall Study|Lost to Follow-up|4
1066941|NCT03447353|3448128|P1|Overall Study|Failure at Screening Visit|2
1066942|NCT03407430|3448176|P2|Washout|Protocol Violation|0
1066943|NCT03407430|3448177|P1|Washout|Protocol Violation|1
1066944|NCT03405818|3448209|P1|Overall Study|Lost to Follow-up|4
1066945|NCT03405818|3448209|P1|Overall Study|Withdrawal by Subject|4
1066946|NCT03365011|3448295|P2|Overall Study|Withdrawal by Subject|2
1066947|NCT03365011|3448296|P1|Overall Study|Withdrawal by Subject|1
1066948|NCT03364335|3448311|P5|Overall Study|Lost to Follow-up|11
1066949|NCT03364335|3448312|P4|Overall Study|Lost to Follow-up|11
1066950|NCT03364335|3448313|P3|Overall Study|Lost to Follow-up|10
1066951|NCT03364335|3448314|P2|Overall Study|Lost to Follow-up|7
1066952|NCT03364335|3448315|P1|Overall Study|Lost to Follow-up|7
1066953|NCT03364335|3448311|P5|Overall Study|Adverse Event|0
1066954|NCT03364335|3448312|P4|Overall Study|Adverse Event|2
1066955|NCT03364335|3448313|P3|Overall Study|Adverse Event|1
1066956|NCT03364335|3448314|P2|Overall Study|Adverse Event|4
1066957|NCT03364335|3448315|P1|Overall Study|Adverse Event|3
1066958|NCT03349099|3448454|P2|Overall Study|Stone migrated from the kidney|0
1066959|NCT03349099|3448455|P1|Overall Study|Stone migrated from the kidney|1
1066960|NCT03349099|3448454|P2|Overall Study|Physician Decision|4
1066961|NCT03349099|3448455|P1|Overall Study|Physician Decision|3
1066962|NCT03346759|3448476|P2|Second Menstrual Cycle|Lost to Follow-up|0
1066963|NCT03346759|3448477|P1|Second Menstrual Cycle|Lost to Follow-up|1
1066964|NCT03346759|3448476|P2|First Menstrual Cycle|Withdrawal by Subject|0
1066965|NCT03346759|3448477|P1|First Menstrual Cycle|Withdrawal by Subject|1
1066966|NCT03346759|3448476|P2|Enrollment to Baseline Data Collected|Lost to Follow-up|3
1066967|NCT03346759|3448477|P1|Enrollment to Baseline Data Collected|Lost to Follow-up|2
1066968|NCT03335566|3448513|P2|Overall Study|Other than specified above|2
1066969|NCT03335566|3448514|P1|Overall Study|Other than specified above|1
1066970|NCT03335566|3448513|P2|Overall Study|Protocol Violation|0
1066971|NCT03335566|3448514|P1|Overall Study|Protocol Violation|1
1066972|NCT03335566|3448513|P2|Overall Study|Technical Problems|0
1066973|NCT03335566|3448514|P1|Overall Study|Technical Problems|1
1066974|NCT03335566|3448513|P2|Overall Study|Lost to Follow-up|0
1066975|NCT03335566|3448514|P1|Overall Study|Lost to Follow-up|1
1066976|NCT03335566|3448513|P2|Overall Study|Adverse Event|1
1066977|NCT03335566|3448514|P1|Overall Study|Adverse Event|0
1066978|NCT03331315|3448528|P2|Overall Study|Physician Decision|14
1066979|NCT03331315|3448529|P1|Overall Study|Physician Decision|18
1066980|NCT03308825|3448596|P4|Overall Study|Protocol Violation|0
1066981|NCT03308825|3448597|P3|Overall Study|Protocol Violation|0
1066982|NCT03308825|3448598|P2|Overall Study|Protocol Violation|2
1066983|NCT03308825|3448599|P1|Overall Study|Protocol Violation|0
1066984|NCT03308825|3448596|P4|Overall Study|Lost to Follow-up|0
1066985|NCT03308825|3448597|P3|Overall Study|Lost to Follow-up|1
1066986|NCT03308825|3448598|P2|Overall Study|Lost to Follow-up|2
1066987|NCT03308825|3448599|P1|Overall Study|Lost to Follow-up|2
1066988|NCT03295201|3448627|P2|Overall Study|Hospital admission|1
1066989|NCT03295201|3448628|P1|Overall Study|Hospital admission|0
1066990|NCT03295201|3448627|P2|Overall Study|Lost to Follow-up|1
1066991|NCT03295201|3448628|P1|Overall Study|Lost to Follow-up|1
1066992|NCT03274453|3448748|P4|Overall Study|Surgery Cancelled|0
1066993|NCT03274453|3448749|P3|Overall Study|Surgery Cancelled|0
1066994|NCT03274453|3448750|P2|Overall Study|Surgery Cancelled|1
1066995|NCT03274453|3448751|P1|Overall Study|Surgery Cancelled|0
1066996|NCT03274453|3448748|P4|Overall Study|Physician Decision|3
1066997|NCT03274453|3448749|P3|Overall Study|Physician Decision|0
1066998|NCT03274453|3448750|P2|Overall Study|Physician Decision|0
1066999|NCT03274453|3448751|P1|Overall Study|Physician Decision|2
1067000|NCT03274453|3448748|P4|Overall Study|Lost to Follow-up|1
1067001|NCT03274453|3448749|P3|Overall Study|Lost to Follow-up|4
1067002|NCT03274453|3448750|P2|Overall Study|Lost to Follow-up|5
1067003|NCT03274453|3448751|P1|Overall Study|Lost to Follow-up|2
1067004|NCT03263806|3448778|P2|Overall Study|Study Termination|6
1067005|NCT03263806|3448779|P1|Overall Study|Study Termination|5
1067006|NCT03263806|3448778|P2|Overall Study|Withdrawal by Subject|1
1067007|NCT03263806|3448779|P1|Overall Study|Withdrawal by Subject|0
1067008|NCT03263806|3448778|P2|Overall Study|Elevated Troponin (failed screen)|0
1067009|NCT03263806|3448779|P1|Overall Study|Elevated Troponin (failed screen)|1
1067010|NCT03256552|3448791|P1|Overall Study|Withdrawal by Subject|2
1067011|NCT03256552|3448791|P1|Overall Study|Adverse Event|1
1067012|NCT03256552|3448791|P1|Overall Study|Physician Decision|1
1067013|NCT03256552|3448791|P1|Overall Study|Protocol Violation|1
1067014|NCT03255733|3448813|P1|Overall Study|Lost to Follow-up|4
1067015|NCT03255655|3448820|P2|Overall Study|Lost to Follow-up|4
1067016|NCT03255655|3448821|P1|Overall Study|Lost to Follow-up|7
1067017|NCT03254602|3448829|P1|Overall Study|Lost to Follow-up|4
1067018|NCT03254459|3448837|P2|Overall Study|Miscellaneous|1
1067019|NCT03254459|3448838|P1|Overall Study|Miscellaneous|0
1067020|NCT03254459|3448837|P2|Overall Study|Lost to Follow-up|1
1067021|NCT03254459|3448838|P1|Overall Study|Lost to Follow-up|0
1067022|NCT03254459|3448837|P2|Overall Study|Withdrawal by Subject Consent|1
1067023|NCT03254459|3448838|P1|Overall Study|Withdrawal by Subject Consent|3
1067024|NCT03254459|3448837|P2|Overall Study|Adverse Event|20
1067025|NCT03254459|3448838|P1|Overall Study|Adverse Event|7
1067026|NCT03243084|3448875|P2|Washout (1-3 Weeks)|Lost to Follow-up|0
1067027|NCT03243084|3448876|P1|Washout (1-3 Weeks)|Lost to Follow-up|1
1067028|NCT03238924|3448888|P2|Overall Study|Withdrawal by Subject|2
1067029|NCT03238924|3448889|P1|Overall Study|Withdrawal by Subject|2
1067030|NCT03238352|3448902|P3|Overall Study|Withdrawal by Subject|0
1067031|NCT03238352|3448903|P2|Overall Study|Withdrawal by Subject|1
1067032|NCT03238352|3448904|P1|Overall Study|Withdrawal by Subject|0
1067033|NCT03238352|3448902|P3|Overall Study|Lost to Follow-up|1
1067034|NCT03238352|3448903|P2|Overall Study|Lost to Follow-up|2
1067035|NCT03238352|3448904|P1|Overall Study|Lost to Follow-up|0
1067036|NCT03238001|3448915|P1|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4
1067037|NCT03238001|3448915|P1|Visit 2 (Secondary Endpoint Cohort)|Study completion|1
1067038|NCT03238001|3448915|P1|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3
1067039|NCT03238001|3448915|P1|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3
1067040|NCT03238001|3448915|P1|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2
1067041|NCT03238001|3448915|P1|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16
1067042|NCT03238001|3448915|P1|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2
1067043|NCT03238001|3448915|P1|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2
1067044|NCT03235115|3448960|P6|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1
1067045|NCT03235115|3448961|P5|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
1067046|NCT03235115|3448962|P4|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
1067047|NCT03235115|3448963|P3|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
1067048|NCT03235115|3448964|P2|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
1067049|NCT03235115|3448965|P1|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
1067050|NCT03233009|3448985|P1|Overall Study|Lost to Follow-up|1
1067051|NCT03231371|3449028|P1|Overall Study|chose or were ineligible to have MRI|12
1067052|NCT03231371|3449028|P1|Overall Study|Withdrawal by Subject|1
1067053|NCT03228212|3449033|P2|Period 2|Lost to Follow-up|0
1067054|NCT03228212|3449034|P1|Period 2|Lost to Follow-up|1
1067055|NCT03228212|3449033|P2|Period 1|no longer meets eligibility criteria|1
1067056|NCT03228212|3449034|P1|Period 1|no longer meets eligibility criteria|0
1067057|NCT03228212|3449033|P2|Period 1|Adverse Event|0
1067058|NCT03228212|3449034|P1|Period 1|Adverse Event|1
1067059|NCT03223662|3449055|P1|Overall Study|Study closure|1
1067060|NCT03223662|3449055|P1|Overall Study|Physician Decision|1
1067061|NCT03222141|3449065|P1|Overall Study|Lost to Follow-up|3
1067062|NCT03222141|3449065|P1|Overall Study|Death|15
1067063|NCT03218163|3449085|P1|Overall Study|Study termination|1
1067064|NCT03217968|3449089|P1|Overall Study|Protocol Violation|6
1067065|NCT03217968|3449089|P1|Overall Study|Lost to Follow-up|1
1067066|NCT03217968|3449089|P1|Overall Study|Withdrawal by Subject|4
1067067|NCT03206216|3449100|P2|Overall Study|Withdrawal by Subject|1
1067068|NCT03206216|3449101|P1|Overall Study|Withdrawal by Subject|0
1067069|NCT03198767|3449116|P7|Overall Study|Protocol Violation|0
1067070|NCT03198767|3449117|P6|Overall Study|Protocol Violation|0
1067071|NCT03198767|3449118|P5|Overall Study|Protocol Violation|0
1067072|NCT03198767|3449119|P4|Overall Study|Protocol Violation|6
1067073|NCT03198767|3449120|P3|Overall Study|Protocol Violation|0
1067074|NCT03198767|3449121|P2|Overall Study|Protocol Violation|0
1067075|NCT03198767|3449122|P1|Overall Study|Protocol Violation|0
1067076|NCT03196635|3449267|P1|Overall Study|Withdrawal by Subject|1
1067077|NCT03192306|3449287|P2|Overall Study|Protocol Violation|1
1067078|NCT03192306|3449288|P1|Overall Study|Protocol Violation|1
1067079|NCT03192306|3449287|P2|Overall Study|Lost to Follow-up|0
1067080|NCT03192306|3449288|P1|Overall Study|Lost to Follow-up|1
1067081|NCT03192306|3449287|P2|Overall Study|Withdrawal by Subject|1
1067082|NCT03192306|3449288|P1|Overall Study|Withdrawal by Subject|1
1067083|NCT03192306|3449287|P2|Overall Study|Did not treat cold sore during study|143
1067084|NCT03192306|3449288|P1|Overall Study|Did not treat cold sore during study|149
1067085|NCT03191552|3449309|P3|Overall Study|Undergone surgery (Progressive hip dyspl|0
1067086|NCT03191552|3449310|P2|Overall Study|Undergone surgery (Progressive hip dyspl|1
1067087|NCT03191552|3449311|P1|Overall Study|Undergone surgery (Progressive hip dyspl|0
1067088|NCT03191552|3449309|P3|Overall Study|Lost to Follow-up|0
1067089|NCT03191552|3449310|P2|Overall Study|Lost to Follow-up|0
1067090|NCT03191552|3449311|P1|Overall Study|Lost to Follow-up|1
1067091|NCT03184441|3449362|P1|Overall Study|Withdrawal by Subject|1
1067092|NCT03184077|3449372|P2|Overall Study|Lost to Follow-up|21
1067093|NCT03184077|3449373|P1|Overall Study|Lost to Follow-up|21
1067094|NCT03180138|3449402|P3|Overall Study|Found to be >24 mon after randomization|3
1067095|NCT03180138|3449403|P2|Overall Study|Found to be >24 mon after randomization|0
1067096|NCT03180138|3449404|P1|Overall Study|Found to be >24 mon after randomization|3
1067097|NCT03180138|3449402|P3|Overall Study|No prior immunization records|6
1067098|NCT03180138|3449403|P2|Overall Study|No prior immunization records|0
1067099|NCT03180138|3449404|P1|Overall Study|No prior immunization records|17
1067100|NCT03180138|3449402|P3|Overall Study|Mobile-phone could not be verified|15
1067101|NCT03180138|3449403|P2|Overall Study|Mobile-phone could not be verified|13
1067102|NCT03180138|3449404|P1|Overall Study|Mobile-phone could not be verified|2
1067103|NCT03166618|3449449|P2|Overall Study|Study was Terminated|1
1067104|NCT03166618|3449450|P1|Overall Study|Study was Terminated|0
1067105|NCT03154047|3449514|P1|Overall Study|Withdrawal by Subject|3
1067106|NCT03154047|3449514|P1|Overall Study|Study terminated by sponsor|76
1067107|NCT03154047|3449514|P1|Overall Study|Death|1
1067108|NCT03151226|3449518|P1|Overall Study|not wear device correctly|1
1067109|NCT03151226|3449518|P1|Overall Study|Withdrawal by Subject|2
1067110|NCT03150485|3449522|P6|Overall Study|Unsatisfactory Lens Fitting|0
1067111|NCT03150485|3449523|P5|Overall Study|Unsatisfactory Lens Fitting|0
1067112|NCT03150485|3449524|P4|Overall Study|Unsatisfactory Lens Fitting|0
1067113|NCT03150485|3449525|P3|Overall Study|Unsatisfactory Lens Fitting|0
1067114|NCT03150485|3449526|P2|Overall Study|Unsatisfactory Lens Fitting|1
1067115|NCT03150485|3449527|P1|Overall Study|Unsatisfactory Lens Fitting|0
1067116|NCT03150082|3449542|P2|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0
1067117|NCT03150082|3449543|P1|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1
1067118|NCT03148756|3449599|P2|Overall Study|Study Terminated|1
1067119|NCT03148756|3449600|P1|Overall Study|Study Terminated|0
1067120|NCT03143101|3449642|P3|Overall Study|Lost to Follow-up|0
1067121|NCT03143101|3449643|P2|Overall Study|Lost to Follow-up|2
1067122|NCT03143101|3449644|P1|Overall Study|Lost to Follow-up|2
1067123|NCT03143101|3449642|P3|Overall Study|Withdrawal by Subject|0
1067124|NCT03143101|3449643|P2|Overall Study|Withdrawal by Subject|1
1067125|NCT03143101|3449644|P1|Overall Study|Withdrawal by Subject|0
1067126|NCT03142932|3449699|P2|Overall Study|Lost to Follow-up|11
1067127|NCT03142932|3449700|P1|Overall Study|Lost to Follow-up|2
1067128|NCT03139552|3449783|P1|Overall Study|unable to attend tasting due to schedule|3
1067129|NCT03134183|3449892|P2|Overall Study|Withdrawal by Subject|1
1067130|NCT03134183|3449893|P1|Overall Study|Withdrawal by Subject|1
1067131|NCT03133767|3449903|P2|Overall Study|Protocol Violation|1
1067132|NCT03133767|3449904|P1|Overall Study|Protocol Violation|0
1067133|NCT03133767|3449903|P2|Overall Study|Lost to Follow-up|24
1067134|NCT03133767|3449904|P1|Overall Study|Lost to Follow-up|38
1067135|NCT03128723|3449943|P1|Overall Study|Withdrawal by Subject|2
1067136|NCT03128307|3449962|P1|Overall Study|Withdrawal by Subject|5
1067137|NCT03128307|3449962|P1|Overall Study|Lost to Follow-up|29
1067138|NCT03124784|3450009|P1|Overall Study|Computer/Equip Malfunction|1
1067139|NCT03124784|3450009|P1|Overall Study|Adverse Event|1
1067140|NCT03124381|3450027|P2|Overall Study|Non-Compliance with Study Treatment|0
1067141|NCT03124381|3450028|P1|Overall Study|Non-Compliance with Study Treatment|1
1067142|NCT03124381|3450027|P2|Overall Study|Adverse Event|1
1067143|NCT03124381|3450028|P1|Overall Study|Adverse Event|1
1067144|NCT03124381|3450027|P2|Overall Study|Protocol Violation|1
1067145|NCT03124381|3450028|P1|Overall Study|Protocol Violation|0
1067146|NCT03124381|3450027|P2|Overall Study|Withdrawal by Subject|3
1067147|NCT03124381|3450028|P1|Overall Study|Withdrawal by Subject|6
1067148|NCT03124381|3450027|P2|Overall Study|Lost to Follow-up|1
1067149|NCT03124381|3450028|P1|Overall Study|Lost to Follow-up|1
1067150|NCT03124199|3450118|P1|Overall Study|Lost to Follow-up|4
1067151|NCT03123354|3450146|P1|Overall Study|Physician Decision|6
1067152|NCT03118934|3450238|P6|Overall Study|Discontinued prior to exposure|0
1067153|NCT03118934|3450239|P5|Overall Study|Discontinued prior to exposure|2
1067154|NCT03118934|3450240|P4|Overall Study|Discontinued prior to exposure|1
1067155|NCT03118934|3450241|P3|Overall Study|Discontinued prior to exposure|1
1067156|NCT03118934|3450242|P2|Overall Study|Discontinued prior to exposure|1
1067157|NCT03118934|3450243|P1|Overall Study|Discontinued prior to exposure|0
1067158|NCT03118934|3450238|P6|Overall Study|Physician Decision|1
1067159|NCT03118934|3450239|P5|Overall Study|Physician Decision|0
1067160|NCT03118934|3450240|P4|Overall Study|Physician Decision|0
1067161|NCT03118934|3450241|P3|Overall Study|Physician Decision|0
1067162|NCT03118934|3450242|P2|Overall Study|Physician Decision|0
1067163|NCT03118934|3450243|P1|Overall Study|Physician Decision|0
1067164|NCT03118934|3450238|P6|Overall Study|Adverse Event|1
1067165|NCT03118934|3450239|P5|Overall Study|Adverse Event|0
1067166|NCT03118934|3450240|P4|Overall Study|Adverse Event|0
1067167|NCT03118934|3450241|P3|Overall Study|Adverse Event|0
1067168|NCT03118934|3450242|P2|Overall Study|Adverse Event|0
1067169|NCT03118934|3450243|P1|Overall Study|Adverse Event|0
1067170|NCT03118297|3450255|P2|Overall Study|Lost to Follow-up|2
1067171|NCT03118297|3450256|P1|Overall Study|Lost to Follow-up|0
1067172|NCT03110900|3450388|P2|Overall Study|Sponsor withdrew|1
1067173|NCT03110900|3450389|P1|Overall Study|Sponsor withdrew|1
1067174|NCT03101150|3450493|P2|Overall Study|Miscarriage|6
1067175|NCT03101150|3450494|P1|Overall Study|Miscarriage|3
1067176|NCT03101150|3450493|P2|Overall Study|Lost to Follow-up|4
1067177|NCT03101150|3450494|P1|Overall Study|Lost to Follow-up|2
1067178|NCT03099096|3450527|P1|Overall Study|Physician Decision|1
1067179|NCT03099096|3450527|P1|Overall Study|Adverse Event|1
1067180|NCT03097614|3450540|P1|Overall Study|Adverse Event|3
1067181|NCT03097289|3450544|P1|Overall Study|Collected platelet product unusable|3
1067182|NCT03097289|3450544|P1|Overall Study|Equipment failure|2
1067183|NCT03097289|3450544|P1|Overall Study|Adverse Event|1
1067184|NCT03091439|3450780|P2|Overall Study|Study Terminated by the Sponsor|0
1067185|NCT03091439|3450781|P1|Overall Study|Study Terminated by the Sponsor|1
1067186|NCT03086447|3450830|P2|Overall Study|Lens Discomfort|1
1067187|NCT03086447|3450831|P1|Overall Study|Lens Discomfort|2
1067188|NCT03086447|3450830|P2|Overall Study|Adverse Event|0
1067189|NCT03086447|3450831|P1|Overall Study|Adverse Event|3
1067190|NCT03086447|3450830|P2|Overall Study|Lost to Follow-up|1
1067191|NCT03086447|3450831|P1|Overall Study|Lost to Follow-up|0
1067192|NCT03086447|3450830|P2|Overall Study|Protocol Violation|4
1067193|NCT03086447|3450831|P1|Overall Study|Protocol Violation|2
1067194|NCT03086447|3450830|P2|Overall Study|Test Article No Longer Available|0
1067195|NCT03086447|3450831|P1|Overall Study|Test Article No Longer Available|1
1067196|NCT03086447|3450830|P2|Overall Study|Unsatisfactory Lens Fitting|1
1067197|NCT03086447|3450831|P1|Overall Study|Unsatisfactory Lens Fitting|0
1067198|NCT03086447|3450830|P2|Overall Study|Lens Damage|6
1067199|NCT03086447|3450831|P1|Overall Study|Lens Damage|1
1067200|NCT03086447|3450830|P2|Overall Study|Product quality complaint|1
1067201|NCT03086447|3450831|P1|Overall Study|Product quality complaint|0
1067202|NCT03086447|3450830|P2|Overall Study|Lost Lens|5
1067203|NCT03086447|3450831|P1|Overall Study|Lost Lens|2
1067204|NCT03086447|3450830|P2|Overall Study|No Longer Meets Eligibility Criteria|1
1067205|NCT03086447|3450831|P1|Overall Study|No Longer Meets Eligibility Criteria|0
1067206|NCT03083483|3450854|P3|Overall Study|technological issues|1
1067207|NCT03083483|3450855|P2|Overall Study|technological issues|0
1067208|NCT03083483|3450856|P1|Overall Study|technological issues|1
1067209|NCT03083483|3450854|P3|Overall Study|Lost to Follow-up|1
1067210|NCT03083483|3450855|P2|Overall Study|Lost to Follow-up|1
1067211|NCT03083483|3450856|P1|Overall Study|Lost to Follow-up|2
1067212|NCT03083483|3450854|P3|Overall Study|Adverse Event|1
1067213|NCT03083483|3450855|P2|Overall Study|Adverse Event|1
1067214|NCT03083483|3450856|P1|Overall Study|Adverse Event|1
1067215|NCT03073798|3450879|P1|Overall Study|Withdrawal by Subject|1
1067216|NCT03073798|3450879|P1|Overall Study|Adverse Event|1
1067217|NCT03072875|3450890|P1|Overall Study|Lost to Follow-up|1
1067218|NCT03072719|3450897|P2|Overall Study|Adverse Event|1
1067219|NCT03072719|3450898|P1|Overall Study|Adverse Event|1
1067220|NCT03070002|3451080|P1|Follow up for 2 Years|Death|1
1067221|NCT03069313|3451086|P1|Overall Study|Adverse Event|5
1067222|NCT03065933|3451098|P1|Overall Study|study terminated|5
1067223|NCT03061331|3451120|P2|Washout Period (8 Weeks)|Adverse Event|1
1067224|NCT03061331|3451121|P1|Washout Period (8 Weeks)|Adverse Event|2
1067225|NCT03060512|3451129|P2|Overall Study|Non-compliance with study medication|2
1067226|NCT03060512|3451130|P1|Overall Study|Non-compliance with study medication|1
1067227|NCT03060512|3451129|P2|Overall Study|Withdrawal by Subject|0
1067228|NCT03060512|3451130|P1|Overall Study|Withdrawal by Subject|1
1067229|NCT03060512|3451129|P2|Overall Study|Lost to Follow-up|1
1067230|NCT03060512|3451130|P1|Overall Study|Lost to Follow-up|1
1067231|NCT03060512|3451129|P2|Overall Study|Adverse Event|6
1067232|NCT03060512|3451130|P1|Overall Study|Adverse Event|4
1067233|NCT03056352|3451173|P1|Overall Study|Lost to Follow-up|1
1067234|NCT03056300|3451179|P1|Overall Study|Surgical reason per study protocol|3
1067235|NCT03055338|3451187|P3|Overall Study|Withdrawal by Subject|7
1067236|NCT03055338|3451188|P2|Overall Study|Withdrawal by Subject|8
1067237|NCT03055338|3451189|P1|Overall Study|Withdrawal by Subject|9
1067238|NCT03055338|3451187|P3|Overall Study|Physician Decision|2
1067239|NCT03055338|3451188|P2|Overall Study|Physician Decision|0
1067240|NCT03055338|3451189|P1|Overall Study|Physician Decision|0
1067241|NCT03055338|3451187|P3|Overall Study|No Post-treatment Protocol Contact|0
1067242|NCT03055338|3451188|P2|Overall Study|No Post-treatment Protocol Contact|1
1067243|NCT03055338|3451189|P1|Overall Study|No Post-treatment Protocol Contact|0
1067244|NCT03055338|3451187|P3|Overall Study|Lost to Follow-up|3
1067245|NCT03055338|3451188|P2|Overall Study|Lost to Follow-up|2
1067246|NCT03055338|3451189|P1|Overall Study|Lost to Follow-up|9
1067247|NCT03055221|3451206|P1|Overall Study|Study terminated by Sponsor|3
1067248|NCT03055221|3451206|P1|Overall Study|Physician Decision|1
1067249|NCT03055221|3451206|P1|Overall Study|Death|6
1067250|NCT03055221|3451206|P1|Overall Study|Withdrawal by Subject|4
1067251|NCT03055221|3451206|P1|Overall Study|Adverse Event|2
1067252|NCT03055195|3451213|P2|Overall Study|Physician Decision|0
1067253|NCT03055195|3451214|P1|Overall Study|Physician Decision|1
1067254|NCT03055195|3451213|P2|Overall Study|Protocol Violation|1
1067255|NCT03055195|3451214|P1|Overall Study|Protocol Violation|2
1067256|NCT03055195|3451213|P2|Overall Study|Study Terminated by Sponsor|6
1067257|NCT03055195|3451214|P1|Overall Study|Study Terminated by Sponsor|2
1067258|NCT03055195|3451213|P2|Overall Study|Withdrawal by Subject|7
1067259|NCT03055195|3451214|P1|Overall Study|Withdrawal by Subject|6
1067260|NCT03055195|3451213|P2|Overall Study|Lack of Efficacy|0
1067261|NCT03055195|3451214|P1|Overall Study|Lack of Efficacy|1
1067262|NCT03051165|3451349|P1|Overall Study|Early termination of study|12
1067263|NCT03051165|3451349|P1|Overall Study|Withdrawal by Subject|1
1067264|NCT03048058|3451478|P2|Overall Study|Withdrawal by Subject|4
1067265|NCT03048058|3451479|P1|Overall Study|Withdrawal by Subject|0
1067266|NCT03048058|3451478|P2|Overall Study|Lost to Follow-up|0
1067267|NCT03048058|3451479|P1|Overall Study|Lost to Follow-up|4
1067268|NCT03044431|3451554|P1|Overall Study|Lost to Follow-up|59
1067269|NCT03037307|3451717|P6|Period 1|Did Not Meet Study Criteria|0
1067270|NCT03037307|3451718|P5|Period 1|Did Not Meet Study Criteria|0
1067271|NCT03037307|3451719|P4|Period 1|Did Not Meet Study Criteria|1
1067272|NCT03037307|3451720|P3|Period 1|Did Not Meet Study Criteria|0
1067273|NCT03037307|3451721|P2|Period 1|Did Not Meet Study Criteria|0
1067274|NCT03037307|3451722|P1|Period 1|Did Not Meet Study Criteria|0
1067275|NCT03035916|3451761|P3|Overall Study|Puncture failed|0
1067276|NCT03035916|3451762|P2|Overall Study|Puncture failed|2
1067277|NCT03035916|3451763|P1|Overall Study|Puncture failed|0
1067278|NCT03034954|3451812|P2|Overall Study|Machine malfunction; did not reach 3 mA|0
1067279|NCT03034954|3451813|P1|Overall Study|Machine malfunction; did not reach 3 mA|1
1067280|NCT03031899|3451907|P1|Overall Study|lesion disappeared after stopping habit|1
1067281|NCT03031899|3451907|P1|Overall Study|Protocol Violation|1
1067282|NCT03031496|3451924|P2|Period 1|Withdrawal by Subject|2
1067283|NCT03031496|3451925|P1|Period 1|Withdrawal by Subject|0
1067284|NCT03031496|3451924|P2|Period 1|Adverse Event|0
1067285|NCT03031496|3451925|P1|Period 1|Adverse Event|2
1067286|NCT03029819|3451982|P2|Overall Study|Removed due to disruptive behavior|1
1067287|NCT03029819|3451983|P1|Overall Study|Removed due to disruptive behavior|0
1067288|NCT03029819|3451982|P2|Overall Study|Lost to Follow-up|5
1067289|NCT03029819|3451983|P1|Overall Study|Lost to Follow-up|3
1067290|NCT03029780|3451997|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
1067291|NCT03029780|3451998|P1|Overall Study|Adverse Event Unrelated to Study Drug|0
1067292|NCT03029780|3451997|P2|Overall Study|Study Drug Toxicity|5
1067293|NCT03029780|3451998|P1|Overall Study|Study Drug Toxicity|5
1067294|NCT03029780|3451997|P2|Overall Study|Disease Progression|3
1067295|NCT03029780|3451998|P1|Overall Study|Disease Progression|1
1067296|NCT03029650|3452010|P2|Washout (1 Week)|Physician Decision|1
1067297|NCT03029650|3452011|P1|Washout (1 Week)|Physician Decision|0
1067298|NCT03029650|3452010|P2|Washout (1 Week)|Withdrawal by Subject|1
1067299|NCT03029650|3452011|P1|Washout (1 Week)|Withdrawal by Subject|1
1067300|NCT03028870|3452089|P4|Overall Study|Administrative|4
1067301|NCT03028870|3452090|P3|Overall Study|Administrative|12
1067302|NCT03028870|3452091|P2|Overall Study|Administrative|5
1067303|NCT03028870|3452092|P1|Overall Study|Administrative|5
1067304|NCT03028870|3452089|P4|Overall Study|Lack of Efficacy|0
1067305|NCT03028870|3452090|P3|Overall Study|Lack of Efficacy|0
1067306|NCT03028870|3452091|P2|Overall Study|Lack of Efficacy|0
1067307|NCT03028870|3452092|P1|Overall Study|Lack of Efficacy|3
1067308|NCT03028870|3452089|P4|Overall Study|Lost to Follow-up|0
1067309|NCT03028870|3452090|P3|Overall Study|Lost to Follow-up|0
1067310|NCT03028870|3452091|P2|Overall Study|Lost to Follow-up|0
1067311|NCT03028870|3452092|P1|Overall Study|Lost to Follow-up|1
1067312|NCT03028870|3452089|P4|Overall Study|Withdrawal by Subject|2
1067313|NCT03028870|3452090|P3|Overall Study|Withdrawal by Subject|1
1067314|NCT03028870|3452091|P2|Overall Study|Withdrawal by Subject|1
1067315|NCT03028870|3452092|P1|Overall Study|Withdrawal by Subject|1
1067316|NCT03028870|3452089|P4|Overall Study|Adverse Event|3
1067317|NCT03028870|3452090|P3|Overall Study|Adverse Event|3
1067318|NCT03028870|3452091|P2|Overall Study|Adverse Event|4
1067319|NCT03028870|3452092|P1|Overall Study|Adverse Event|7
1067320|NCT03026530|3452198|P2|Overall Study|Protocol Violation|5
1067321|NCT03026530|3452199|P1|Overall Study|Protocol Violation|2
1067322|NCT03026530|3452198|P2|Overall Study|Lost to Follow-up|24
1067323|NCT03026530|3452199|P1|Overall Study|Lost to Follow-up|19
1067324|NCT03026257|3452213|P6|Overall Study|Withdrawal by Subject|0
1067325|NCT03026257|3452214|P5|Overall Study|Withdrawal by Subject|0
1067326|NCT03026257|3452215|P4|Overall Study|Withdrawal by Subject|0
1067327|NCT03026257|3452216|P3|Overall Study|Withdrawal by Subject|0
1067328|NCT03026257|3452217|P2|Overall Study|Withdrawal by Subject|1
1067329|NCT03026257|3452218|P1|Overall Study|Withdrawal by Subject|1
1067330|NCT03026257|3452213|P6|Overall Study|Protocol Violation|0
1067331|NCT03026257|3452214|P5|Overall Study|Protocol Violation|1
1067332|NCT03026257|3452215|P4|Overall Study|Protocol Violation|1
1067333|NCT03026257|3452216|P3|Overall Study|Protocol Violation|0
1067334|NCT03026257|3452217|P2|Overall Study|Protocol Violation|0
1067335|NCT03026257|3452218|P1|Overall Study|Protocol Violation|1
1067336|NCT03026257|3452213|P6|Overall Study|Lost to Follow-up|0
1067337|NCT03026257|3452214|P5|Overall Study|Lost to Follow-up|0
1067338|NCT03026257|3452215|P4|Overall Study|Lost to Follow-up|0
1067339|NCT03026257|3452216|P3|Overall Study|Lost to Follow-up|0
1067340|NCT03026257|3452217|P2|Overall Study|Lost to Follow-up|0
1067341|NCT03026257|3452218|P1|Overall Study|Lost to Follow-up|1
1067342|NCT03026257|3452213|P6|Overall Study|Adverse Event|0
1067343|NCT03026257|3452214|P5|Overall Study|Adverse Event|0
1067344|NCT03026257|3452215|P4|Overall Study|Adverse Event|0
1067345|NCT03026257|3452216|P3|Overall Study|Adverse Event|0
1067346|NCT03026257|3452217|P2|Overall Study|Adverse Event|0
1067347|NCT03026257|3452218|P1|Overall Study|Adverse Event|3
1067348|NCT03024606|3452243|P2|Overall Study|Withdrawal by Subject|10
1067349|NCT03024606|3452244|P1|Overall Study|Withdrawal by Subject|9
1067350|NCT03023137|3452318|P2|Overall Study|Lost the baby in a car accident|0
1067351|NCT03023137|3452319|P1|Overall Study|Lost the baby in a car accident|1
1067352|NCT03023137|3452318|P2|Overall Study|Protocol Violation|4
1067353|NCT03023137|3452319|P1|Overall Study|Protocol Violation|0
1067354|NCT03023137|3452318|P2|Overall Study|Lost to Follow-up|1
1067355|NCT03023137|3452319|P1|Overall Study|Lost to Follow-up|1
1067356|NCT03023137|3452318|P2|Overall Study|Multiple pregnancy|4
1067357|NCT03023137|3452319|P1|Overall Study|Multiple pregnancy|2
1067358|NCT03022422|3452377|P6|Overall Study|3 subjects consented but not vaccinated|0
1067359|NCT03022422|3452378|P5|Overall Study|3 subjects consented but not vaccinated|0
1067360|NCT03022422|3452379|P4|Overall Study|3 subjects consented but not vaccinated|0
1067361|NCT03022422|3452380|P3|Overall Study|3 subjects consented but not vaccinated|3
1067362|NCT03022422|3452381|P2|Overall Study|3 subjects consented but not vaccinated|0
1067363|NCT03022422|3452382|P1|Overall Study|3 subjects consented but not vaccinated|0
1067364|NCT03021304|3452444|P1|Overall Study|Lack of Efficacy|1
1067365|NCT03020576|3452451|P2|Overall Study|Withdrawal by Subject|2
1067366|NCT03020576|3452452|P1|Overall Study|Withdrawal by Subject|1
1067367|NCT03020160|3452507|P2|Overall Study|Continuing to receive emicizumab|41
1067368|NCT03020160|3452508|P1|Overall Study|Continuing to receive emicizumab|7
1067369|NCT03018106|3452595|P2|Overall Study|Lost to Follow-up|1
1067370|NCT03018106|3452596|P1|Overall Study|Lost to Follow-up|0
1067371|NCT03017612|3452604|P1|Overall Study|Adverse Event|2
1067372|NCT03017235|3452614|P2|Overall Study|Cancer, emergency, allergy, active UTI|2
1067373|NCT03017235|3452615|P1|Overall Study|Cancer, emergency, allergy, active UTI|4
1067374|NCT03017235|3452614|P2|Overall Study|Protocol Violation|1
1067375|NCT03017235|3452615|P1|Overall Study|Protocol Violation|2
1067376|NCT03017235|3452614|P2|Overall Study|Adverse Event|1
1067377|NCT03017235|3452615|P1|Overall Study|Adverse Event|0
1067378|NCT03017235|3452614|P2|Overall Study|Lost to Follow-up|7
1067379|NCT03017235|3452615|P1|Overall Study|Lost to Follow-up|2
1067380|NCT03017235|3452614|P2|Overall Study|Withdrawal by Subject|3
1067381|NCT03017235|3452615|P1|Overall Study|Withdrawal by Subject|4
1067382|NCT03016078|3452676|P1|Overall Study|Protocol Violation|1
1067383|NCT03016078|3452676|P1|Overall Study|Protocol Violation|1
1067384|NCT03014674|3452690|P3|Overall Study|Withdrawal by Subject|0
1067385|NCT03014674|3452691|P2|Overall Study|Withdrawal by Subject|0
1067386|NCT03014674|3452692|P1|Overall Study|Withdrawal by Subject|1
1067387|NCT03011099|3452756|P2|Overall Study|Withdrawal by Subject|2
1067388|NCT03011099|3452757|P1|Overall Study|Withdrawal by Subject|0
1067389|NCT03005067|3452792|P2|Overall Study|Protocol Violation|1
1067390|NCT03005067|3452793|P1|Overall Study|Protocol Violation|0
1067391|NCT03005067|3452792|P2|Overall Study|Other (reason not specified)|1
1067392|NCT03005067|3452793|P1|Overall Study|Other (reason not specified)|3
1067393|NCT03005067|3452792|P2|Overall Study|Adverse Event|3
1067394|NCT03005067|3452793|P1|Overall Study|Adverse Event|4
1067395|NCT03005067|3452792|P2|Overall Study|Withdrawal by Subject|2
1067396|NCT03005067|3452793|P1|Overall Study|Withdrawal by Subject|3
1067397|NCT03002623|3452937|P2|Overall Study|Physician Decision|1
1067398|NCT03002623|3452938|P1|Overall Study|Physician Decision|1
1067399|NCT03002623|3452937|P2|Overall Study|Lost to Follow-up|0
1067400|NCT03002623|3452938|P1|Overall Study|Lost to Follow-up|1
1067401|NCT03000452|3453005|P1|Follow-Up Period|Withdrawal by Subject|3
1067402|NCT03000452|3453005|P1|Follow-Up Period|Death|3
1067403|NCT03000452|3453005|P1|Follow-Up Period|Study Terminated by Sponsor|1
1067404|NCT03000452|3453005|P1|Treatment Period|Miscellaneous|2
1067405|NCT03000452|3453005|P1|Treatment Period|Physician Decision|1
1067406|NCT03000452|3453005|P1|Treatment Period|Progressive Disease (PD)|14
1067407|NCT03000452|3453005|P1|Treatment Period|Death|1
1067408|NCT02992691|3453065|P1|Overall Study|Withdrawal by Subject|1
1067409|NCT02992691|3453065|P1|Overall Study|Adverse Event|2
1067410|NCT02990910|3453095|P2|Overall Study|Lack of Efficacy|10
1067411|NCT02990910|3453096|P1|Overall Study|Lack of Efficacy|6
1067412|NCT02988622|3453117|P1|Overall Study|Lost to Follow-up|17
1067413|NCT02988219|3453152|P2|Overall Study|Withdrawal by Subject|2
1067414|NCT02988219|3453153|P1|Overall Study|Withdrawal by Subject|0
1067415|NCT02988219|3453152|P2|Overall Study|Lack of Efficacy|1
1067416|NCT02988219|3453153|P1|Overall Study|Lack of Efficacy|1
1067417|NCT02987205|3453173|P1|Overall Study|Withdrawal by Subject|3
1067418|NCT02987205|3453173|P1|Overall Study|Adverse Event|1
1067419|NCT02986854|3453207|P3|Overall Study|Lost to Follow-up|2
1067420|NCT02986854|3453208|P2|Overall Study|Lost to Follow-up|11
1067421|NCT02986854|3453209|P1|Overall Study|Lost to Follow-up|3
1067422|NCT02986854|3453207|P3|Overall Study|Withdrawal by Subject|1
1067423|NCT02986854|3453208|P2|Overall Study|Withdrawal by Subject|1
1067424|NCT02986854|3453209|P1|Overall Study|Withdrawal by Subject|0
1067425|NCT02986139|3453300|P2|Overall Study|Lost to Follow-up|1
1067426|NCT02986139|3453301|P1|Overall Study|Lost to Follow-up|0
1067427|NCT02986139|3453300|P2|Overall Study|Withdrawal by Subject|1
1067428|NCT02986139|3453301|P1|Overall Study|Withdrawal by Subject|0
1067429|NCT02986139|3453300|P2|Overall Study|Sponsor Decision|2
1067430|NCT02986139|3453301|P1|Overall Study|Sponsor Decision|1
1067431|NCT02984267|3453350|P2|Overall Study|Withdrawal by Subject|1
1067432|NCT02984267|3453351|P1|Overall Study|Withdrawal by Subject|0
1067433|NCT02984267|3453350|P2|Overall Study|Protocol Violation|0
1067434|NCT02984267|3453351|P1|Overall Study|Protocol Violation|1
1067435|NCT02982863|3453387|P5|Overall Study|Not eligible patients|492
1067436|NCT02982863|3453388|P4|Overall Study|Not eligible patients|1400
1067437|NCT02982863|3453389|P3|Overall Study|Not eligible patients|1852
1067438|NCT02982863|3453390|P2|Overall Study|Not eligible patients|4261
1067439|NCT02982863|3453391|P1|Overall Study|Not eligible patients|809
1067440|NCT02982018|3453450|P2|Overall Study|Withdrawal by Subject|1
1067441|NCT02982018|3453451|P1|Overall Study|Withdrawal by Subject|0
1067442|NCT02982018|3453450|P2|Overall Study|Lens Discomfort|0
1067443|NCT02982018|3453451|P1|Overall Study|Lens Discomfort|2
1067444|NCT02982018|3453450|P2|Overall Study|Adverse Event|1
1067445|NCT02982018|3453451|P1|Overall Study|Adverse Event|1
1067446|NCT02982018|3453450|P2|Overall Study|Protocol Violation|1
1067447|NCT02982018|3453451|P1|Overall Study|Protocol Violation|1
1067448|NCT02982018|3453450|P2|Overall Study|Incorrect Lens Dispensed|0
1067449|NCT02982018|3453451|P1|Overall Study|Incorrect Lens Dispensed|1
1067450|NCT02978833|3453483|P2|Overall Study|Study terminated|1
1067451|NCT02978833|3453484|P1|Overall Study|Study terminated|1
1067452|NCT02977572|3453502|P2|Overall Study|Exclusion criterion|2
1067453|NCT02977572|3453503|P1|Overall Study|Exclusion criterion|2
1067454|NCT02977507|3453525|P2|Overall Study|Lost to Follow-up|0
1067455|NCT02977507|3453526|P1|Overall Study|Lost to Follow-up|1
1067456|NCT02977507|3453525|P2|Overall Study|Protocol Deviation|0
1067457|NCT02977507|3453526|P1|Overall Study|Protocol Deviation|1
1067458|NCT02974543|3453551|P2|Overall Study|Withdrawal by Subject|0
1067459|NCT02974543|3453552|P1|Overall Study|Withdrawal by Subject|1
1067460|NCT02974140|3453572|P1|Overall Study|Study Terminated by Sponsor|36
1067461|NCT02974140|3453572|P1|Overall Study|Lost to Follow-up|1
1067462|NCT02974140|3453572|P1|Overall Study|Adverse Event|2
1067463|NCT02974114|3453588|P3|Overall Study|Other (Not specified)|2
1067464|NCT02974114|3453589|P2|Overall Study|Other (Not specified)|1
1067465|NCT02974114|3453590|P1|Overall Study|Other (Not specified)|0
1067466|NCT02973100|3453635|P4|Overall Study|Failed to attend Safety followup period|0
1067467|NCT02973100|3453636|P3|Overall Study|Failed to attend Safety followup period|1
1067468|NCT02973100|3453637|P2|Overall Study|Failed to attend Safety followup period|0
1067469|NCT02973100|3453638|P1|Overall Study|Failed to attend Safety followup period|0
1067470|NCT02973100|3453635|P4|Overall Study|Notification of change in address|1
1067471|NCT02973100|3453636|P3|Overall Study|Notification of change in address|0
1067472|NCT02973100|3453637|P2|Overall Study|Notification of change in address|0
1067473|NCT02973100|3453638|P1|Overall Study|Notification of change in address|0
1067474|NCT02973100|3453635|P4|Overall Study|Withdrawal by Subject|4
1067475|NCT02973100|3453636|P3|Overall Study|Withdrawal by Subject|1
1067476|NCT02973100|3453637|P2|Overall Study|Withdrawal by Subject|5
1067477|NCT02973100|3453638|P1|Overall Study|Withdrawal by Subject|3
1067478|NCT02973100|3453635|P4|Overall Study|Lost to Follow-up|0
1067479|NCT02973100|3453636|P3|Overall Study|Lost to Follow-up|1
1067480|NCT02973100|3453637|P2|Overall Study|Lost to Follow-up|1
1067481|NCT02973100|3453638|P1|Overall Study|Lost to Follow-up|3
1067482|NCT02973100|3453635|P4|Overall Study|Adverse Event|2
1067483|NCT02973100|3453636|P3|Overall Study|Adverse Event|1
1067484|NCT02973100|3453637|P2|Overall Study|Adverse Event|2
1067485|NCT02973100|3453638|P1|Overall Study|Adverse Event|1
1067486|NCT02972515|3453693|P1|Overall Study|Lost to Follow-up|78
1067487|NCT02972502|3453702|P2|Overall Study|Withdrawal by Subject|1
1067488|NCT02972502|3453703|P1|Overall Study|Withdrawal by Subject|1
1067489|NCT02972502|3453702|P2|Overall Study|Lost to Follow-up|1
1067490|NCT02972502|3453703|P1|Overall Study|Lost to Follow-up|3
1067491|NCT02971670|3453717|P4|Overall Study|Withdrawal by Subject|2
1067492|NCT02971670|3453718|P3|Overall Study|Withdrawal by Subject|1
1067493|NCT02971670|3453719|P2|Overall Study|Withdrawal by Subject|1
1067494|NCT02971670|3453720|P1|Overall Study|Withdrawal by Subject|4
1067495|NCT02971007|3453741|P3|Overall Study|Patient discontinued study drug|0
1067496|NCT02971007|3453742|P2|Overall Study|Patient discontinued study drug|1
1067497|NCT02971007|3453743|P1|Overall Study|Patient discontinued study drug|0
1067498|NCT02971007|3453741|P3|Overall Study|Patient had yeast at Day 5 visit|0
1067499|NCT02971007|3453742|P2|Overall Study|Patient had yeast at Day 5 visit|0
1067500|NCT02971007|3453743|P1|Overall Study|Patient had yeast at Day 5 visit|1
1067501|NCT02971007|3453741|P3|Overall Study|Withdrawal by Subject|0
1067502|NCT02971007|3453742|P2|Overall Study|Withdrawal by Subject|1
1067503|NCT02971007|3453743|P1|Overall Study|Withdrawal by Subject|0
1067504|NCT02971007|3453741|P3|Overall Study|Lost to Follow-up|1
1067505|NCT02971007|3453742|P2|Overall Study|Lost to Follow-up|1
1067506|NCT02971007|3453743|P1|Overall Study|Lost to Follow-up|0
1067507|NCT02971007|3453741|P3|Overall Study|Adverse Event|0
1067508|NCT02971007|3453742|P2|Overall Study|Adverse Event|0
1067509|NCT02971007|3453743|P1|Overall Study|Adverse Event|1
1067510|NCT02969863|3453784|P6|Overall Study|Physician Decision|0
1067511|NCT02969863|3453785|P5|Overall Study|Physician Decision|0
1067512|NCT02969863|3453786|P4|Overall Study|Physician Decision|0
1067513|NCT02969863|3453787|P3|Overall Study|Physician Decision|0
1067514|NCT02969863|3453788|P2|Overall Study|Physician Decision|0
1067515|NCT02969863|3453789|P1|Overall Study|Physician Decision|1
1067516|NCT02969044|3453805|P2|Overall Study|Adverse Event|0
1067517|NCT02969044|3453806|P1|Overall Study|Adverse Event|3
1067518|NCT02969044|3453805|P2|Overall Study|Withdrawal by Subject|6
1067519|NCT02969044|3453806|P1|Overall Study|Withdrawal by Subject|2
1067520|NCT02968173|3453846|P1|Overall Study|Withdrawal by Subject|1
1067521|NCT02966509|3453934|P2|End of Life Utilization and Cost 15month|Patient Still Alive|48
1067522|NCT02966509|3453935|P1|End of Life Utilization and Cost 15month|Patient Still Alive|45
1067523|NCT02966509|3453934|P2|End of Life Utilization and Cost 6 Month|Patient Still Alive|75
1067524|NCT02966509|3453935|P1|End of Life Utilization and Cost 6 Month|Patient Still Alive|69
1067525|NCT02966509|3453934|P2|6 Month Satisfaction Survey|Refused to Answer|11
1067526|NCT02966509|3453935|P1|6 Month Satisfaction Survey|Refused to Answer|8
1067527|NCT02966509|3453934|P2|6 Month Satisfaction Survey|Lost to Follow-up|1
1067528|NCT02966509|3453935|P1|6 Month Satisfaction Survey|Lost to Follow-up|1
1067529|NCT02966509|3453934|P2|6 Month Satisfaction Survey|Withdrawal by Subject|3
1067530|NCT02966509|3453935|P1|6 Month Satisfaction Survey|Withdrawal by Subject|2
1067531|NCT02966509|3453934|P2|6 Month Satisfaction Survey|Death|33
1067532|NCT02966509|3453935|P1|6 Month Satisfaction Survey|Death|36
1067533|NCT02966509|3453934|P2|6 Month Satisfaction Decision Survey|Refused to Answer|2
1067534|NCT02966509|3453935|P1|6 Month Satisfaction Decision Survey|Refused to Answer|0
1067535|NCT02966509|3453934|P2|6 Month Satisfaction Decision Survey|Lost to Follow-up|1
1067536|NCT02966509|3453935|P1|6 Month Satisfaction Decision Survey|Lost to Follow-up|1
1067537|NCT02966509|3453934|P2|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3
1067538|NCT02966509|3453935|P1|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2
1067539|NCT02966509|3453934|P2|6 Month Satisfaction Decision Survey|Death|25
1067540|NCT02966509|3453935|P1|6 Month Satisfaction Decision Survey|Death|22
1067541|NCT02966509|3453934|P2|Baseline Satisfaction Survey|Refused to Answer|2
1067542|NCT02966509|3453935|P1|Baseline Satisfaction Survey|Refused to Answer|1
1067543|NCT02966509|3453934|P2|Baseline Satisfaction Survey|Lost to Follow-up|1
1067544|NCT02966509|3453935|P1|Baseline Satisfaction Survey|Lost to Follow-up|1
1067545|NCT02966509|3453934|P2|Baseline Satisfaction Survey|Death|1
1067546|NCT02966509|3453935|P1|Baseline Satisfaction Survey|Death|0
1067547|NCT02966509|3453934|P2|Baseline Satisfaction Survey|Withdrawal by Subject|3
1067548|NCT02966509|3453935|P1|Baseline Satisfaction Survey|Withdrawal by Subject|2
1067549|NCT02966015|3453996|P2|Inclusion Visit|did not answer questionnaire|3
1067550|NCT02966015|3453997|P1|Inclusion Visit|did not answer questionnaire|8
1067551|NCT02966002|3454003|P1|Overall Study|Lost to Follow-up|1
1067552|NCT02966002|3454003|P1|Overall Study|Adverse Event|1
1067553|NCT02966002|3454003|P1|Overall Study|Withdrawal by Subject|2
1067554|NCT02965846|3454013|P3|Overall Study|Participants not randomized|33
1067555|NCT02965846|3454014|P2|Overall Study|Participants not randomized|0
1067556|NCT02965846|3454015|P1|Overall Study|Participants not randomized|0
1067557|NCT02965846|3454013|P3|Overall Study|Study Terminated By Sponsor|0
1067558|NCT02965846|3454014|P2|Overall Study|Study Terminated By Sponsor|4
1067559|NCT02965846|3454015|P1|Overall Study|Study Terminated By Sponsor|4
1067560|NCT02965846|3454013|P3|Overall Study|Withdrawal by Subject|0
1067561|NCT02965846|3454014|P2|Overall Study|Withdrawal by Subject|1
1067562|NCT02965846|3454015|P1|Overall Study|Withdrawal by Subject|0
1067563|NCT02965846|3454013|P3|Overall Study|Lost to Follow-up|0
1067564|NCT02965846|3454014|P2|Overall Study|Lost to Follow-up|0
1067565|NCT02965846|3454015|P1|Overall Study|Lost to Follow-up|1
1067566|NCT02965833|3454023|P2|Period 2, Second 30 Days of Wear|Protocol Violation|0
1067567|NCT02965833|3454024|P1|Period 2, Second 30 Days of Wear|Protocol Violation|2
1067568|NCT02965833|3454023|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
1067569|NCT02965833|3454024|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
1067570|NCT02965833|3454023|P2|Period 1, First 30 Days of Wear|Protocol Violation|0
1067571|NCT02965833|3454024|P1|Period 1, First 30 Days of Wear|Protocol Violation|1
1067572|NCT02965833|3454023|P2|Period 1, First 30 Days of Wear|Lost to Follow-up|1
1067573|NCT02965833|3454024|P1|Period 1, First 30 Days of Wear|Lost to Follow-up|1
1067574|NCT02965833|3454023|P2|Period 1, First 30 Days of Wear|Adverse Event|1
1067575|NCT02965833|3454024|P1|Period 1, First 30 Days of Wear|Adverse Event|0
1067576|NCT02965820|3454030|P2|Period 2, Second 30 Days|Adverse Event|1
1067577|NCT02965820|3454031|P1|Period 2, Second 30 Days|Adverse Event|1
1067578|NCT02963701|3454049|P2|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0
1067579|NCT02963701|3454050|P1|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1
1067580|NCT02962882|3454080|P1|Overall Study|Transfer from ICU|32
1067581|NCT02962882|3454080|P1|Overall Study|Withdrawal by Subject|2
1067582|NCT02962882|3454080|P1|Overall Study|Adverse Event|2
1067583|NCT02961244|3454091|P2|Overall Study|İnadequate data|2
1067584|NCT02961244|3454092|P1|Overall Study|İnadequate data|0
1067585|NCT02961244|3454091|P2|Overall Study|Lost to Follow-up|2
1067586|NCT02961244|3454092|P1|Overall Study|Lost to Follow-up|0
1067587|NCT02961244|3454091|P2|Overall Study|Surgery plan change after study approval|2
1067588|NCT02961244|3454092|P1|Overall Study|Surgery plan change after study approval|0
1067589|NCT02961244|3454091|P2|Overall Study|Withdrawal by Subject|2
1067590|NCT02961244|3454092|P1|Overall Study|Withdrawal by Subject|1
1067591|NCT02961244|3454091|P2|Overall Study|Protocol Violation|1
1067592|NCT02961244|3454092|P1|Overall Study|Protocol Violation|0
1067593|NCT02956837|3454217|P4|Overall Study|Lost to Follow-up|0
1067594|NCT02956837|3454218|P3|Overall Study|Lost to Follow-up|2
1067595|NCT02956837|3454219|P2|Overall Study|Lost to Follow-up|1
1067596|NCT02956837|3454220|P1|Overall Study|Lost to Follow-up|0
1067597|NCT02956837|3454217|P4|Overall Study|Withdrawal by Subject|3
1067598|NCT02956837|3454218|P3|Overall Study|Withdrawal by Subject|0
1067599|NCT02956837|3454219|P2|Overall Study|Withdrawal by Subject|1
1067600|NCT02956837|3454220|P1|Overall Study|Withdrawal by Subject|0
1067601|NCT02956837|3454217|P4|Overall Study|Serious Adverse Events|0
1067602|NCT02956837|3454218|P3|Overall Study|Serious Adverse Events|0
1067603|NCT02956837|3454219|P2|Overall Study|Serious Adverse Events|1
1067604|NCT02956837|3454220|P1|Overall Study|Serious Adverse Events|0
1067605|NCT02956629|3454316|P6|Overall Study|Withdrawal by Subject|0
1067606|NCT02956629|3454317|P5|Overall Study|Withdrawal by Subject|0
1067607|NCT02956629|3454318|P4|Overall Study|Withdrawal by Subject|0
1067608|NCT02956629|3454319|P3|Overall Study|Withdrawal by Subject|0
1067609|NCT02956629|3454320|P2|Overall Study|Withdrawal by Subject|1
1067610|NCT02956629|3454321|P1|Overall Study|Withdrawal by Subject|3
1067611|NCT02956629|3454316|P6|Overall Study|Lost to Follow-up|1
1067612|NCT02956629|3454317|P5|Overall Study|Lost to Follow-up|0
1067613|NCT02956629|3454318|P4|Overall Study|Lost to Follow-up|1
1067614|NCT02956629|3454319|P3|Overall Study|Lost to Follow-up|3
1067615|NCT02956629|3454320|P2|Overall Study|Lost to Follow-up|5
1067616|NCT02956629|3454321|P1|Overall Study|Lost to Follow-up|2
1067617|NCT02956629|3454316|P6|Overall Study|Adverse Event|0
1067618|NCT02956629|3454317|P5|Overall Study|Adverse Event|0
1067619|NCT02956629|3454318|P4|Overall Study|Adverse Event|0
1067620|NCT02956629|3454319|P3|Overall Study|Adverse Event|1
1067621|NCT02956629|3454320|P2|Overall Study|Adverse Event|0
1067622|NCT02956629|3454321|P1|Overall Study|Adverse Event|0
1067623|NCT02956460|3454385|P2|Lens 1|Lost to Follow-up|0
1067624|NCT02956460|3454386|P1|Lens 1|Lost to Follow-up|1
1067625|NCT02954601|3454416|P4|First Intervention (Five Days)|Withdrawal by Subject|0
1067626|NCT02954601|3454417|P3|First Intervention (Five Days)|Withdrawal by Subject|1
1067627|NCT02954601|3454418|P2|First Intervention (Five Days)|Withdrawal by Subject|0
1067628|NCT02954601|3454419|P1|First Intervention (Five Days)|Withdrawal by Subject|0
1067629|NCT02954354|3454444|P3|Overall Study|Miscellaneous|1
1067630|NCT02954354|3454445|P2|Overall Study|Miscellaneous|2
1067631|NCT02954354|3454446|P1|Overall Study|Miscellaneous|2
1067632|NCT02954354|3454444|P3|Overall Study|Lost to Follow-up|0
1067633|NCT02954354|3454445|P2|Overall Study|Lost to Follow-up|5
1067634|NCT02954354|3454446|P1|Overall Study|Lost to Follow-up|12
1067635|NCT02954354|3454444|P3|Overall Study|Withdrawal by Subject|11
1067636|NCT02954354|3454445|P2|Overall Study|Withdrawal by Subject|9
1067637|NCT02954354|3454446|P1|Overall Study|Withdrawal by Subject|17
1067638|NCT02954354|3454444|P3|Overall Study|Lack of Efficacy|0
1067639|NCT02954354|3454445|P2|Overall Study|Lack of Efficacy|2
1067640|NCT02954354|3454446|P1|Overall Study|Lack of Efficacy|0
1067641|NCT02954354|3454444|P3|Overall Study|Failure to Meet Eligibility Criteria|0
1067642|NCT02954354|3454445|P2|Overall Study|Failure to Meet Eligibility Criteria|0
1067643|NCT02954354|3454446|P1|Overall Study|Failure to Meet Eligibility Criteria|1
1067644|NCT02954354|3454444|P3|Overall Study|Adverse Event|4
1067645|NCT02954354|3454445|P2|Overall Study|Adverse Event|2
1067646|NCT02954354|3454446|P1|Overall Study|Adverse Event|2
1067647|NCT02952261|3454538|P2|Overall Study|Protocol Violation|0
1067648|NCT02952261|3454539|P1|Overall Study|Protocol Violation|1
1067649|NCT02952261|3454538|P2|Overall Study|Withdrawal by Subject|5
1067650|NCT02952261|3454539|P1|Overall Study|Withdrawal by Subject|4
1067651|NCT02951767|3454567|P1|Overall Study|Lost to Follow-up|1
1067652|NCT02951767|3454567|P1|Overall Study|Death|59
1067653|NCT02951767|3454567|P1|Overall Study|Withdrawal by Subject|5
1067654|NCT02951767|3454567|P1|Overall Study|Ongoing at data cutoff 04 July 2016|54
1067655|NCT02948582|3454759|P6|Washout Period 4|Adverse Event|0
1067656|NCT02948582|3454760|P5|Washout Period 4|Adverse Event|0
1067657|NCT02948582|3454761|P4|Washout Period 4|Adverse Event|0
1067658|NCT02948582|3454762|P3|Washout Period 4|Adverse Event|1
1067659|NCT02948582|3454763|P2|Washout Period 4|Adverse Event|0
1067660|NCT02948582|3454764|P1|Washout Period 4|Adverse Event|1
1067661|NCT02948582|3454759|P6|Washout Period 2|personal reasons|0
1067662|NCT02948582|3454760|P5|Washout Period 2|personal reasons|0
1067663|NCT02948582|3454761|P4|Washout Period 2|personal reasons|1
1067664|NCT02948582|3454762|P3|Washout Period 2|personal reasons|0
1067665|NCT02948582|3454763|P2|Washout Period 2|personal reasons|0
1067666|NCT02948582|3454764|P1|Washout Period 2|personal reasons|0
1067667|NCT02948582|3454759|P6|Washout Period 2|Adverse Event|0
1067668|NCT02948582|3454760|P5|Washout Period 2|Adverse Event|0
1067669|NCT02948582|3454761|P4|Washout Period 2|Adverse Event|0
1067670|NCT02948582|3454762|P3|Washout Period 2|Adverse Event|0
1067671|NCT02948582|3454763|P2|Washout Period 2|Adverse Event|1
1067672|NCT02948582|3454764|P1|Washout Period 2|Adverse Event|0
1067673|NCT02948582|3454759|P6|Washout Period 1|Protocol Violation|1
1067674|NCT02948582|3454760|P5|Washout Period 1|Protocol Violation|0
1067675|NCT02948582|3454761|P4|Washout Period 1|Protocol Violation|0
1067676|NCT02948582|3454762|P3|Washout Period 1|Protocol Violation|0
1067677|NCT02948582|3454763|P2|Washout Period 1|Protocol Violation|0
1067678|NCT02948582|3454764|P1|Washout Period 1|Protocol Violation|0
1067679|NCT02948582|3454759|P6|Washout Period 1|Adverse Event|0
1067680|NCT02948582|3454760|P5|Washout Period 1|Adverse Event|0
1067681|NCT02948582|3454761|P4|Washout Period 1|Adverse Event|0
1067682|NCT02948582|3454762|P3|Washout Period 1|Adverse Event|0
1067683|NCT02948582|3454763|P2|Washout Period 1|Adverse Event|2
1067684|NCT02948582|3454764|P1|Washout Period 1|Adverse Event|0
1067685|NCT02947022|3454872|P1|Overall Study|Study Stopped|1
1067686|NCT02945657|3454895|P1|Overall Study|Withdrawal by Parent/Guardian|3
1067687|NCT02945657|3454895|P1|Overall Study|Adverse Event|1
1067688|NCT02945254|3454914|P2|Overall Study|Withdrawal by Subject|0
1067689|NCT02945254|3454915|P1|Overall Study|Withdrawal by Subject|1
1067690|NCT02945254|3454914|P2|Overall Study|Lost to Follow-up|0
1067691|NCT02945254|3454915|P1|Overall Study|Lost to Follow-up|1
1067692|NCT02940522|3455020|P2|Overall Study|Withdrawal by Subject|0
1067693|NCT02940522|3455021|P1|Overall Study|Withdrawal by Subject|1
1067694|NCT02940522|3455020|P2|Overall Study|Lost to Follow-up|2
1067695|NCT02940522|3455021|P1|Overall Study|Lost to Follow-up|1
1067696|NCT02937870|3455070|P1|Overall Study|Protocol Deviation|2
1067697|NCT02937870|3455070|P1|Overall Study|Adverse Event|1
1067698|NCT02935894|3455127|P1|Overall Study|Subject dismissed|1
1067699|NCT02933528|3455220|P1|Overall Study|Lost to Follow-up|2
1067700|NCT02932904|3455239|P4|Overall Study|Randomized But Not Treated|2
1067701|NCT02932904|3455240|P3|Overall Study|Randomized But Not Treated|0
1067702|NCT02932904|3455241|P2|Overall Study|Randomized But Not Treated|1
1067703|NCT02932904|3455242|P1|Overall Study|Randomized But Not Treated|1
1067704|NCT02932904|3455239|P4|Overall Study|Pretreatment Event/Adverse Event|3
1067705|NCT02932904|3455240|P3|Overall Study|Pretreatment Event/Adverse Event|1
1067706|NCT02932904|3455241|P2|Overall Study|Pretreatment Event/Adverse Event|5
1067707|NCT02932904|3455242|P1|Overall Study|Pretreatment Event/Adverse Event|3
1067708|NCT02932904|3455239|P4|Overall Study|Significant Protocol Deviation|1
1067709|NCT02932904|3455240|P3|Overall Study|Significant Protocol Deviation|6
1067710|NCT02932904|3455241|P2|Overall Study|Significant Protocol Deviation|3
1067711|NCT02932904|3455242|P1|Overall Study|Significant Protocol Deviation|2
1067712|NCT02932904|3455239|P4|Overall Study|Lost to Follow-up|0
1067713|NCT02932904|3455240|P3|Overall Study|Lost to Follow-up|6
1067714|NCT02932904|3455241|P2|Overall Study|Lost to Follow-up|3
1067715|NCT02932904|3455242|P1|Overall Study|Lost to Follow-up|5
1067716|NCT02932904|3455239|P4|Overall Study|Voluntary Withdrawal|2
1067717|NCT02932904|3455240|P3|Overall Study|Voluntary Withdrawal|4
1067718|NCT02932904|3455241|P2|Overall Study|Voluntary Withdrawal|1
1067719|NCT02932904|3455242|P1|Overall Study|Voluntary Withdrawal|2
1067720|NCT02932904|3455239|P4|Overall Study|Study Termination|0
1067721|NCT02932904|3455240|P3|Overall Study|Study Termination|0
1067722|NCT02932904|3455241|P2|Overall Study|Study Termination|1
1067723|NCT02932904|3455242|P1|Overall Study|Study Termination|0
1067724|NCT02932904|3455239|P4|Overall Study|Pregnancy|0
1067725|NCT02932904|3455240|P3|Overall Study|Pregnancy|1
1067726|NCT02932904|3455241|P2|Overall Study|Pregnancy|1
1067727|NCT02932904|3455242|P1|Overall Study|Pregnancy|0
1067728|NCT02932904|3455239|P4|Overall Study|Noncompliance with Study Drug|4
1067729|NCT02932904|3455240|P3|Overall Study|Noncompliance with Study Drug|3
1067730|NCT02932904|3455241|P2|Overall Study|Noncompliance with Study Drug|3
1067731|NCT02932904|3455242|P1|Overall Study|Noncompliance with Study Drug|2
1067732|NCT02932904|3455239|P4|Overall Study|Reason not Specified|2
1067733|NCT02932904|3455240|P3|Overall Study|Reason not Specified|2
1067734|NCT02932904|3455241|P2|Overall Study|Reason not Specified|0
1067735|NCT02932904|3455242|P1|Overall Study|Reason not Specified|1
1067736|NCT02932891|3455277|P1|Overall Study|HPA Suppress|2
1067737|NCT02932891|3455277|P1|Overall Study|Lost to Follow-up|2
1067738|NCT02932878|3455283|P2|Overall Study|Due to Lab Results|1
1067739|NCT02932878|3455284|P1|Overall Study|Due to Lab Results|2
1067740|NCT02932462|3455292|P2|Overall Study|Progressive Disease|0
1067741|NCT02932462|3455293|P1|Overall Study|Progressive Disease|1
1067742|NCT02932462|3455292|P2|Overall Study|Non-Compliance With Study Drug|1
1067743|NCT02932462|3455293|P1|Overall Study|Non-Compliance With Study Drug|0
1067744|NCT02932462|3455292|P2|Overall Study|Withdrawal by Subject|4
1067745|NCT02932462|3455293|P1|Overall Study|Withdrawal by Subject|1
1067746|NCT02932462|3455292|P2|Overall Study|Protocol Violation|5
1067747|NCT02932462|3455293|P1|Overall Study|Protocol Violation|0
1067748|NCT02932462|3455292|P2|Overall Study|Lost to Follow-up|1
1067749|NCT02932462|3455293|P1|Overall Study|Lost to Follow-up|4
1067750|NCT02932462|3455292|P2|Overall Study|Adverse Event|2
1067751|NCT02932462|3455293|P1|Overall Study|Adverse Event|1
1067752|NCT02927431|3455624|P3|Overall Study|Withdrawal by Subject|1
1067753|NCT02927431|3455625|P2|Overall Study|Withdrawal by Subject|0
1067754|NCT02927431|3455626|P1|Overall Study|Withdrawal by Subject|0
1067755|NCT02926573|3455719|P2|Overall Study|Delirium|1
1067756|NCT02926573|3455720|P1|Overall Study|Delirium|0
1067757|NCT02926573|3455719|P2|Overall Study|Return to operating room|2
1067758|NCT02926573|3455720|P1|Overall Study|Return to operating room|0
1067759|NCT02926573|3455719|P2|Overall Study|Withdrawal by Subject|2
1067760|NCT02926573|3455720|P1|Overall Study|Withdrawal by Subject|0
1067761|NCT02926573|3455719|P2|Overall Study|Change to outpatient status|1
1067762|NCT02926573|3455720|P1|Overall Study|Change to outpatient status|5
1067763|NCT02926573|3455719|P2|Overall Study|Change in surgery plan|1
1067764|NCT02926573|3455720|P1|Overall Study|Change in surgery plan|3
1067765|NCT02926573|3455719|P2|Overall Study|Remain intubated|2
1067766|NCT02926573|3455720|P1|Overall Study|Remain intubated|2
1067767|NCT02926573|3455719|P2|Overall Study|Nausea|0
1067768|NCT02926573|3455720|P1|Overall Study|Nausea|1
1067769|NCT02923245|3455768|P2|Overall Study|ultrasound order was cancelled|1
1067770|NCT02923245|3455769|P1|Overall Study|ultrasound order was cancelled|2
1067771|NCT02921425|3455820|P1|Overall Study|Protocol Violation|9
1067772|NCT02920957|3455890|P2|Second Intervention: 1 Month|Lost to Follow-up|1
1067773|NCT02920957|3455891|P1|Second Intervention: 1 Month|Lost to Follow-up|0
1067774|NCT02920957|3455890|P2|First Intervention : 1 Month|Adverse Event|0
1067775|NCT02920957|3455891|P1|First Intervention : 1 Month|Adverse Event|1
1067776|NCT02920957|3455890|P2|First Intervention : 1 Month|Lost to Follow-up|0
1067777|NCT02920957|3455891|P1|First Intervention : 1 Month|Lost to Follow-up|1
1067778|NCT02920957|3455890|P2|First Intervention : 1 Month|Withdrawal by Subject|0
1067779|NCT02920957|3455891|P1|First Intervention : 1 Month|Withdrawal by Subject|2
1067780|NCT02918071|3456083|P1|Overall Study|Lost to Follow-up|1
1067781|NCT02918071|3456083|P1|Overall Study|Withdrawal by Subject|2
1067782|NCT02915978|3456107|P3|Overall Study|Adverse Event|0
1067783|NCT02915978|3456108|P2|Overall Study|Adverse Event|1
1067784|NCT02915978|3456109|P1|Overall Study|Adverse Event|2
1067785|NCT02915302|3456161|P2|Overall Study|Other|0
1067786|NCT02915302|3456162|P1|Overall Study|Other|1
1067787|NCT02915302|3456161|P2|Overall Study|Withdrawal by Subject|29
1067788|NCT02915302|3456162|P1|Overall Study|Withdrawal by Subject|22
1067789|NCT02915302|3456161|P2|Overall Study|Lost to Follow-up|22
1067790|NCT02915302|3456162|P1|Overall Study|Lost to Follow-up|19
1067791|NCT02915302|3456161|P2|Overall Study|Protocol Violation|27
1067792|NCT02915302|3456162|P1|Overall Study|Protocol Violation|20
1067793|NCT02915302|3456161|P2|Overall Study|Adverse Event|0
1067794|NCT02915302|3456162|P1|Overall Study|Adverse Event|3
1067795|NCT02914236|3456172|P1|Overall Study|Lost to Follow-up|1
1067796|NCT02912650|3456184|P4|Overall Study|Adverse Event|0
1067797|NCT02912650|3456185|P3|Overall Study|Adverse Event|1
1067798|NCT02912650|3456186|P2|Overall Study|Adverse Event|0
1067799|NCT02912650|3456187|P1|Overall Study|Adverse Event|0
1067800|NCT02912650|3456184|P4|Overall Study|Withdrawal by Subject|5
1067801|NCT02912650|3456185|P3|Overall Study|Withdrawal by Subject|1
1067802|NCT02912650|3456186|P2|Overall Study|Withdrawal by Subject|0
1067803|NCT02912650|3456187|P1|Overall Study|Withdrawal by Subject|1
1067804|NCT02910739|3456284|P4|Overall Study|Adverse Event|0
1067805|NCT02910739|3456285|P3|Overall Study|Adverse Event|0
1067806|NCT02910739|3456286|P2|Overall Study|Adverse Event|0
1067807|NCT02910739|3456287|P1|Overall Study|Adverse Event|1
1067808|NCT02907892|3456343|P2|Overall Study|Lost to Follow-up|40
1067809|NCT02907892|3456344|P1|Overall Study|Lost to Follow-up|27
1067810|NCT02906917|3456362|P2|Intensification Period (Week 26-38)|Withdrawal by Subject|2
1067811|NCT02906917|3456363|P1|Intensification Period (Week 26-38)|Withdrawal by Subject|3
1067812|NCT02906917|3456362|P2|Intensification Period (Week 26-38)|Lost to Follow-up|1
1067813|NCT02906917|3456363|P1|Intensification Period (Week 26-38)|Lost to Follow-up|3
1067814|NCT02906917|3456362|P2|Intensification Period (Week 26-38)|Adverse Event|2
1067815|NCT02906917|3456363|P1|Intensification Period (Week 26-38)|Adverse Event|0
1067816|NCT02906917|3456362|P2|Intensification Period (Week 26-38)|Unclassified|2
1067817|NCT02906917|3456363|P1|Intensification Period (Week 26-38)|Unclassified|3
1067818|NCT02906917|3456362|P2|Initiation Period (Week 0-26)|Withdrawal by Subject|4
1067819|NCT02906917|3456363|P1|Initiation Period (Week 0-26)|Withdrawal by Subject|3
1067820|NCT02906917|3456362|P2|Initiation Period (Week 0-26)|Lost to Follow-up|4
1067821|NCT02906917|3456363|P1|Initiation Period (Week 0-26)|Lost to Follow-up|1
1067822|NCT02906917|3456362|P2|Initiation Period (Week 0-26)|Adverse Event|0
1067823|NCT02906917|3456363|P1|Initiation Period (Week 0-26)|Adverse Event|1
1067824|NCT02906917|3456362|P2|Initiation Period (Week 0-26)|Unclassified|3
1067825|NCT02906917|3456363|P1|Initiation Period (Week 0-26)|Unclassified|1
1067826|NCT02906358|3456424|P2|Overall Study|Lost to Follow-up|15
1067827|NCT02906358|3456425|P1|Overall Study|Lost to Follow-up|12
1067828|NCT02906358|3456424|P2|Overall Study|Withdrawal by Subject|7
1067829|NCT02906358|3456425|P1|Overall Study|Withdrawal by Subject|10
1067830|NCT02905825|3456453|P1|Overall Study|Device Malfunction|1
1067831|NCT02905825|3456453|P1|Overall Study|Protocol Violation|11
1067832|NCT02905331|3456461|P3|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0
1067833|NCT02905331|3456462|P2|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2
1067834|NCT02905331|3456463|P1|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0
1067835|NCT02905331|3456461|P3|Active Treatment and Follow up (wk16-40)|Other|0
1067836|NCT02905331|3456462|P2|Active Treatment and Follow up (wk16-40)|Other|6
1067837|NCT02905331|3456463|P1|Active Treatment and Follow up (wk16-40)|Other|0
1067838|NCT02905331|3456461|P3|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0
1067839|NCT02905331|3456462|P2|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1
1067840|NCT02905331|3456463|P1|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0
1067841|NCT02905331|3456461|P3|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0
1067842|NCT02905331|3456462|P2|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0
1067843|NCT02905331|3456463|P1|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2
1067844|NCT02905331|3456461|P3|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0
1067845|NCT02905331|3456462|P2|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0
1067846|NCT02905331|3456463|P1|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1
1067847|NCT02903238|3456515|P1|Overall Study|Lost to Follow-up|4
1067848|NCT02901054|3456546|P1|Overall Study|Withdrawal by Subject|3
1067849|NCT02901054|3456546|P1|Overall Study|Physician Decision|1
1067850|NCT02899338|3456552|P2|Overall Study|Withdrawal by Subject|0
1067851|NCT02899338|3456553|P1|Overall Study|Withdrawal by Subject|2
1067852|NCT02899338|3456552|P2|Overall Study|Adverse Event|2
1067853|NCT02899338|3456553|P1|Overall Study|Adverse Event|1
1067854|NCT02898116|3456565|P1|Overall Study|Progressive disease|1
1067855|NCT02898116|3456565|P1|Overall Study|Adverse Event|1
1067856|NCT02896296|3456581|P1|Overall Study|Relocation|1
1067857|NCT02896296|3456581|P1|Overall Study|Incarceration|1
1067858|NCT02896296|3456581|P1|Overall Study|Site closing|7
1067859|NCT02896296|3456581|P1|Overall Study|Withdrawal by Subject|10
1067860|NCT02896296|3456581|P1|Overall Study|Physician Decision|2
1067861|NCT02896296|3456581|P1|Overall Study|Pregnancy|1
1067862|NCT02896296|3456581|P1|Overall Study|Lost to Follow-up|19
1067863|NCT02896296|3456581|P1|Overall Study|Adverse Event|1
1067864|NCT02895347|3456589|P2|Overall Study|Withdrawal by Subject|1
1067865|NCT02895347|3456590|P1|Overall Study|Withdrawal by Subject|3
1067866|NCT02894840|3456603|P4|Overall Study|Lost to Follow-up|0
1067867|NCT02894840|3456604|P3|Overall Study|Lost to Follow-up|3
1067868|NCT02894840|3456605|P2|Overall Study|Lost to Follow-up|0
1067869|NCT02894840|3456606|P1|Overall Study|Lost to Follow-up|1
1067870|NCT02887989|3456677|P2|Overall Study|Death|0
1067871|NCT02887989|3456678|P1|Overall Study|Death|1
1067872|NCT02887989|3456677|P2|Overall Study|Withdrawal by Subject|11
1067873|NCT02887989|3456678|P1|Overall Study|Withdrawal by Subject|8
1067874|NCT02886715|3456691|P3|Overall Study|missing|2
1067875|NCT02886715|3456692|P2|Overall Study|missing|2
1067876|NCT02886715|3456693|P1|Overall Study|missing|7
1067877|NCT02886715|3456691|P3|Overall Study|Withdrawal by Subject|5
1067878|NCT02886715|3456692|P2|Overall Study|Withdrawal by Subject|18
1067879|NCT02886715|3456693|P1|Overall Study|Withdrawal by Subject|20
1067880|NCT02886715|3456691|P3|Overall Study|Protocol Violation|1
1067881|NCT02886715|3456692|P2|Overall Study|Protocol Violation|2
1067882|NCT02886715|3456693|P1|Overall Study|Protocol Violation|3
1067883|NCT02886715|3456691|P3|Overall Study|Pregnancy|1
1067884|NCT02886715|3456692|P2|Overall Study|Pregnancy|1
1067885|NCT02886715|3456693|P1|Overall Study|Pregnancy|1
1067886|NCT02886715|3456691|P3|Overall Study|Lost to Follow-up|10
1067887|NCT02886715|3456692|P2|Overall Study|Lost to Follow-up|26
1067888|NCT02886715|3456693|P1|Overall Study|Lost to Follow-up|29
1067889|NCT02886715|3456691|P3|Overall Study|Lack of Efficacy|1
1067890|NCT02886715|3456692|P2|Overall Study|Lack of Efficacy|2
1067891|NCT02886715|3456693|P1|Overall Study|Lack of Efficacy|0
1067892|NCT02886715|3456691|P3|Overall Study|Adverse Event|0
1067893|NCT02886715|3456692|P2|Overall Study|Adverse Event|2
1067894|NCT02886715|3456693|P1|Overall Study|Adverse Event|4
1067895|NCT02886715|3456691|P3|Overall Study|Non-Compliance With Study Drug|0
1067896|NCT02886715|3456692|P2|Overall Study|Non-Compliance With Study Drug|2
1067897|NCT02886715|3456693|P1|Overall Study|Non-Compliance With Study Drug|0
1067898|NCT02886702|3456710|P3|Overall Study|Administrative Reasons|1
1067899|NCT02886702|3456711|P2|Overall Study|Administrative Reasons|0
1067900|NCT02886702|3456712|P1|Overall Study|Administrative Reasons|0
1067901|NCT02886702|3456710|P3|Overall Study|Adverse Event|3
1067902|NCT02886702|3456711|P2|Overall Study|Adverse Event|9
1067903|NCT02886702|3456712|P1|Overall Study|Adverse Event|4
1067904|NCT02886702|3456710|P3|Overall Study|Lack of Efficacy|5
1067905|NCT02886702|3456711|P2|Overall Study|Lack of Efficacy|4
1067906|NCT02886702|3456712|P1|Overall Study|Lack of Efficacy|3
1067907|NCT02886702|3456710|P3|Overall Study|Lost to Follow-up|8
1067908|NCT02886702|3456711|P2|Overall Study|Lost to Follow-up|13
1067909|NCT02886702|3456712|P1|Overall Study|Lost to Follow-up|11
1067910|NCT02886702|3456710|P3|Overall Study|Non-Compliance With Study Drug|4
1067911|NCT02886702|3456711|P2|Overall Study|Non-Compliance With Study Drug|1
1067912|NCT02886702|3456712|P1|Overall Study|Non-Compliance With Study Drug|0
1067913|NCT02886702|3456710|P3|Overall Study|Protocol Violation|1
1067914|NCT02886702|3456711|P2|Overall Study|Protocol Violation|2
1067915|NCT02886702|3456712|P1|Overall Study|Protocol Violation|2
1067916|NCT02886702|3456710|P3|Overall Study|Significant Worsening of Condition|0
1067917|NCT02886702|3456711|P2|Overall Study|Significant Worsening of Condition|1
1067918|NCT02886702|3456712|P1|Overall Study|Significant Worsening of Condition|0
1067919|NCT02886702|3456710|P3|Overall Study|Withdrawal by Subject|22
1067920|NCT02886702|3456711|P2|Overall Study|Withdrawal by Subject|18
1067921|NCT02886702|3456712|P1|Overall Study|Withdrawal by Subject|24
1067922|NCT02886702|3456710|P3|Overall Study|Not Specified|9
1067923|NCT02886702|3456711|P2|Overall Study|Not Specified|3
1067924|NCT02886702|3456712|P1|Overall Study|Not Specified|4
1067925|NCT02886338|3456726|P1|Overall Study|Withdrawal by Subject|1
1067926|NCT02885181|3456734|P4|Overall Study|Withdrawal by Subject|1
1067927|NCT02885181|3456735|P3|Overall Study|Withdrawal by Subject|0
1067928|NCT02885181|3456736|P2|Overall Study|Withdrawal by Subject|0
1067929|NCT02885181|3456737|P1|Overall Study|Withdrawal by Subject|0
1067930|NCT02885181|3456734|P4|Overall Study|Adverse Event|1
1067931|NCT02885181|3456735|P3|Overall Study|Adverse Event|0
1067932|NCT02885181|3456736|P2|Overall Study|Adverse Event|0
1067933|NCT02885181|3456737|P1|Overall Study|Adverse Event|0
1067934|NCT02885181|3456734|P4|Overall Study|Investigator's Discretion|1
1067935|NCT02885181|3456735|P3|Overall Study|Investigator's Discretion|0
1067936|NCT02885181|3456736|P2|Overall Study|Investigator's Discretion|1
1067937|NCT02885181|3456737|P1|Overall Study|Investigator's Discretion|0
1067938|NCT02884089|3456791|P4|Follow-up Visit|Withdrawal by Subject|1
1067939|NCT02884089|3456792|P3|Follow-up Visit|Withdrawal by Subject|0
1067940|NCT02884089|3456793|P2|Follow-up Visit|Withdrawal by Subject|0
1067941|NCT02884089|3456794|P1|Follow-up Visit|Withdrawal by Subject|1
1067942|NCT02884089|3456791|P4|Period 4|Lost to Follow-up|0
1067943|NCT02884089|3456792|P3|Period 4|Lost to Follow-up|0
1067944|NCT02884089|3456793|P2|Period 4|Lost to Follow-up|0
1067945|NCT02884089|3456794|P1|Period 4|Lost to Follow-up|1
1067946|NCT02884089|3456791|P4|Period 4|Withdrawal by Subject|0
1067947|NCT02884089|3456792|P3|Period 4|Withdrawal by Subject|0
1067948|NCT02884089|3456793|P2|Period 4|Withdrawal by Subject|1
1067949|NCT02884089|3456794|P1|Period 4|Withdrawal by Subject|0
1067950|NCT02884089|3456791|P4|Washout Period 3|Lost to Follow-up|1
1067951|NCT02884089|3456792|P3|Washout Period 3|Lost to Follow-up|0
1067952|NCT02884089|3456793|P2|Washout Period 3|Lost to Follow-up|0
1067953|NCT02884089|3456794|P1|Washout Period 3|Lost to Follow-up|0
1067954|NCT02884089|3456791|P4|Washout Period 3|Withdrawal by Subject|0
1067955|NCT02884089|3456792|P3|Washout Period 3|Withdrawal by Subject|1
1067956|NCT02884089|3456793|P2|Washout Period 3|Withdrawal by Subject|0
1067957|NCT02884089|3456794|P1|Washout Period 3|Withdrawal by Subject|0
1067958|NCT02884089|3456791|P4|Period 3|Withdrawal by Subject|0
1067959|NCT02884089|3456792|P3|Period 3|Withdrawal by Subject|1
1067960|NCT02884089|3456793|P2|Period 3|Withdrawal by Subject|0
1067961|NCT02884089|3456794|P1|Period 3|Withdrawal by Subject|0
1067962|NCT02884089|3456791|P4|Period 2|Adverse Event|0
1067963|NCT02884089|3456792|P3|Period 2|Adverse Event|0
1067964|NCT02884089|3456793|P2|Period 2|Adverse Event|0
1067965|NCT02884089|3456794|P1|Period 2|Adverse Event|1
1067966|NCT02884089|3456791|P4|Washout Period 1|Withdrawal by Subject|0
1067967|NCT02884089|3456792|P3|Washout Period 1|Withdrawal by Subject|0
1067968|NCT02884089|3456793|P2|Washout Period 1|Withdrawal by Subject|1
1067969|NCT02884089|3456794|P1|Washout Period 1|Withdrawal by Subject|0
1067970|NCT02884089|3456791|P4|Washout Period 1|Lost to Follow-up|1
1067971|NCT02884089|3456792|P3|Washout Period 1|Lost to Follow-up|0
1067972|NCT02884089|3456793|P2|Washout Period 1|Lost to Follow-up|1
1067973|NCT02884089|3456794|P1|Washout Period 1|Lost to Follow-up|0
1067974|NCT02884089|3456791|P4|Period 1|Dosing error|0
1067975|NCT02884089|3456792|P3|Period 1|Dosing error|0
1067976|NCT02884089|3456793|P2|Period 1|Dosing error|2
1067977|NCT02884089|3456794|P1|Period 1|Dosing error|2
1067978|NCT02883244|3456810|P2|Overall Study|Lost to Follow-up|1
1067979|NCT02883244|3456811|P1|Overall Study|Lost to Follow-up|0
1067980|NCT02882152|3456829|P2|Overall Study|Lost to Follow-up|0
1067981|NCT02882152|3456830|P1|Overall Study|Lost to Follow-up|1
1067982|NCT02878590|3456953|P1|Overall Study|Withdrawal by Subject|2
1067983|NCT02877927|3456959|P2|Overall Study|Missed EOT/PTE Visit|6
1067984|NCT02877927|3456960|P1|Overall Study|Missed EOT/PTE Visit|5
1067985|NCT02877927|3456959|P2|Overall Study|Physician Decision|1
1067986|NCT02877927|3456960|P1|Overall Study|Physician Decision|0
1067987|NCT02877927|3456959|P2|Overall Study|Withdrawal by Subject|12
1067988|NCT02877927|3456960|P1|Overall Study|Withdrawal by Subject|11
1067989|NCT02877927|3456959|P2|Overall Study|Lost to Follow-up|38
1067990|NCT02877927|3456960|P1|Overall Study|Lost to Follow-up|37
1067991|NCT02877927|3456959|P2|Overall Study|Adverse Event|0
1067992|NCT02877927|3456960|P1|Overall Study|Adverse Event|1
1067993|NCT02877082|3456989|P1|Overall Study|Trial was closed early|5
1067994|NCT02875977|3457031|P2|Overall Study|Lost to Follow-up|29
1067995|NCT02875977|3457032|P1|Overall Study|Lost to Follow-up|42
1067996|NCT02875340|3457046|P1|Overall Study|Adverse Event|1
1067997|NCT02875340|3457046|P1|Overall Study|Physician Decision|3
1067998|NCT02875340|3457046|P1|Overall Study|Withdrawal by Subject|2
1067999|NCT02875340|3457046|P1|Overall Study|Death|2
1068000|NCT02874924|3457071|P3|Overall Study|Withdrawal by Subject|0
1068001|NCT02874924|3457072|P2|Overall Study|Withdrawal by Subject|0
1068002|NCT02874924|3457073|P1|Overall Study|Withdrawal by Subject|1
1068003|NCT02874924|3457071|P3|Overall Study|Adverse Event|0
1068004|NCT02874924|3457072|P2|Overall Study|Adverse Event|0
1068005|NCT02874924|3457073|P1|Overall Study|Adverse Event|2
1068006|NCT02873754|3457104|P1|Overall Study|Couldn't complete study procedures|1
1068007|NCT02873754|3457104|P1|Overall Study|Lost to Follow-up|5
1068008|NCT02873429|3457139|P2|16 Weeks|Lost to Follow-up|0
1068009|NCT02873429|3457140|P1|16 Weeks|Lost to Follow-up|3
1068010|NCT02873429|3457139|P2|16 Weeks|Completed 6-8 week, missed 16 week|2
1068011|NCT02873429|3457140|P1|16 Weeks|Completed 6-8 week, missed 16 week|2
1068012|NCT02873429|3457139|P2|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1
1068013|NCT02873429|3457140|P1|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10
1068014|NCT02871375|3457196|P2|Period 1, First 14 Days of Wear|Inclusion criteria not met|1
1068015|NCT02871375|3457197|P1|Period 1, First 14 Days of Wear|Inclusion criteria not met|0
1068016|NCT02868892|3457245|P1|Overall Study|Investigator left site and no follow-up|6
1068017|NCT02865083|3457283|P2|Overall Study|Early Termination|1
1068018|NCT02865083|3457284|P1|Overall Study|Early Termination|3
1068019|NCT02864342|3457322|P2|Overall Study|Adverse Event|0
1068020|NCT02864342|3457323|P1|Overall Study|Adverse Event|1
1068021|NCT02864342|3457322|P2|Overall Study|Lost Device|0
1068022|NCT02864342|3457323|P1|Overall Study|Lost Device|1
1068023|NCT02864342|3457322|P2|Overall Study|Lost to Follow-up|5
1068024|NCT02864342|3457323|P1|Overall Study|Lost to Follow-up|1
1068025|NCT02864342|3457322|P2|Overall Study|Did Not Start Treatment with Symbicort|1
1068026|NCT02864342|3457323|P1|Overall Study|Did Not Start Treatment with Symbicort|0
1068027|NCT02864342|3457322|P2|Overall Study|Death|1
1068028|NCT02864342|3457323|P1|Overall Study|Death|0
1068029|NCT02864342|3457322|P2|Overall Study|Device Technology Issue|7
1068030|NCT02864342|3457323|P1|Overall Study|Device Technology Issue|6
1068031|NCT02864342|3457322|P2|Overall Study|Withdrawal by Subject|2
1068032|NCT02864342|3457323|P1|Overall Study|Withdrawal by Subject|4
1068033|NCT02864342|3457322|P2|Overall Study|Eligibility Criteria Deviation|3
1068034|NCT02864342|3457323|P1|Overall Study|Eligibility Criteria Deviation|2
1068035|NCT02862730|3457357|P7|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
1068036|NCT02862730|3457358|P6|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
1068037|NCT02862730|3457359|P5|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
1068038|NCT02862730|3457360|P4|Third Intervention (84 Hours)|diagnosis of gastroparesis|1
1068039|NCT02862730|3457361|P3|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
1068040|NCT02862730|3457362|P2|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
1068041|NCT02862730|3457363|P1|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
1068042|NCT02862730|3457357|P7|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
1068043|NCT02862730|3457358|P6|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
1068044|NCT02862730|3457359|P5|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
1068045|NCT02862730|3457360|P4|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
1068046|NCT02862730|3457361|P3|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
1068047|NCT02862730|3457362|P2|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
1068048|NCT02862730|3457363|P1|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
1068049|NCT02862730|3457357|P7|Second Intervention (84 Hours)|Withdrawal by Subject|0
1068050|NCT02862730|3457358|P6|Second Intervention (84 Hours)|Withdrawal by Subject|0
1068051|NCT02862730|3457359|P5|Second Intervention (84 Hours)|Withdrawal by Subject|0
1068052|NCT02862730|3457360|P4|Second Intervention (84 Hours)|Withdrawal by Subject|0
1068053|NCT02862730|3457361|P3|Second Intervention (84 Hours)|Withdrawal by Subject|0
1068054|NCT02862730|3457362|P2|Second Intervention (84 Hours)|Withdrawal by Subject|0
1068055|NCT02862730|3457363|P1|Second Intervention (84 Hours)|Withdrawal by Subject|1
1068056|NCT02862730|3457357|P7|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
1068057|NCT02862730|3457358|P6|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
1068058|NCT02862730|3457359|P5|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
1068059|NCT02862730|3457360|P4|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
1068060|NCT02862730|3457361|P3|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1
1068061|NCT02862730|3457362|P2|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
1068062|NCT02862730|3457363|P1|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
1068063|NCT02862600|3457418|P1|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7
1068064|NCT02862600|3457418|P1|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1
1068065|NCT02862600|3457418|P1|Period 1--Perhexiline-low Target Range|Protocol Violation|3
1068066|NCT02862600|3457418|P1|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9
1068067|NCT02862574|3457428|P3|Open-Label Treatment Period|Study Terminated by Sponsor|1
1068068|NCT02862574|3457429|P2|Open-Label Treatment Period|Study Terminated by Sponsor|3
1068069|NCT02862574|3457430|P1|Open-Label Treatment Period|Study Terminated by Sponsor|2
1068070|NCT02862574|3457428|P3|Double-Blind Treatment Period|Study Terminated by Sponsor|4
1068071|NCT02862574|3457429|P2|Double-Blind Treatment Period|Study Terminated by Sponsor|1
1068072|NCT02862574|3457430|P1|Double-Blind Treatment Period|Study Terminated by Sponsor|3
1068073|NCT02862574|3457428|P3|Double-Blind Treatment Period|Adverse Event|0
1068074|NCT02862574|3457429|P2|Double-Blind Treatment Period|Adverse Event|1
1068075|NCT02862574|3457430|P1|Double-Blind Treatment Period|Adverse Event|0
1068076|NCT02862106|3457454|P2|Overall Study|Subjects moved to other city|0
1068077|NCT02862106|3457455|P1|Overall Study|Subjects moved to other city|1
1068078|NCT02862106|3457454|P2|Overall Study|Withdrawal by Subject|0
1068079|NCT02862106|3457455|P1|Overall Study|Withdrawal by Subject|2
1068080|NCT02862106|3457454|P2|Overall Study|Lost to Follow-up|5
1068081|NCT02862106|3457455|P1|Overall Study|Lost to Follow-up|15
1068082|NCT02862106|3457454|P2|Overall Study|Protocol Violation|1
1068083|NCT02862106|3457455|P1|Overall Study|Protocol Violation|16
1068084|NCT02862106|3457454|P2|Overall Study|Adverse Event|0
1068085|NCT02862106|3457455|P1|Overall Study|Adverse Event|4
1068086|NCT02861664|3457515|P2|Overall Study|Withdrawal of Consent|1
1068087|NCT02861664|3457516|P1|Overall Study|Withdrawal of Consent|0
1068088|NCT02857816|3457535|P1|Overall Study|Lost to Follow-up|1
1068089|NCT02857816|3457535|P1|Overall Study|Withdrawal by Subject|4
1068090|NCT02857816|3457535|P1|Overall Study|Screen Failure|33
1068091|NCT02856880|3457541|P1|Overall Study|Withdrawal of consent|1
1068092|NCT02855541|3457565|P1|Overall Study|Withdrawal by Subject|2
1068093|NCT02855541|3457565|P1|Overall Study|Change in health status|2
1068094|NCT02855411|3457576|P1|Overall Study|Does not meet entrance criteria|14
1068095|NCT02855411|3457576|P1|Overall Study|Study terminated by sponsor|21
1068096|NCT02854527|3457617|P10|Overall Study|Lost to Follow-up|0
1068097|NCT02854527|3457618|P9|Overall Study|Lost to Follow-up|0
1068098|NCT02854527|3457619|P8|Overall Study|Lost to Follow-up|0
1068099|NCT02854527|3457620|P7|Overall Study|Lost to Follow-up|0
1068100|NCT02854527|3457621|P6|Overall Study|Lost to Follow-up|0
1068101|NCT02854527|3457622|P5|Overall Study|Lost to Follow-up|0
1068102|NCT02854527|3457623|P4|Overall Study|Lost to Follow-up|1
1068103|NCT02854527|3457624|P3|Overall Study|Lost to Follow-up|0
1068104|NCT02854527|3457625|P2|Overall Study|Lost to Follow-up|0
1068105|NCT02854527|3457626|P1|Overall Study|Lost to Follow-up|0
1068106|NCT02854527|3457617|P10|Overall Study|Adverse Event|0
1068107|NCT02854527|3457618|P9|Overall Study|Adverse Event|0
1068108|NCT02854527|3457619|P8|Overall Study|Adverse Event|0
1068109|NCT02854527|3457620|P7|Overall Study|Adverse Event|0
1068110|NCT02854527|3457621|P6|Overall Study|Adverse Event|0
1068111|NCT02854527|3457622|P5|Overall Study|Adverse Event|1
1068112|NCT02854527|3457623|P4|Overall Study|Adverse Event|0
1068113|NCT02854527|3457624|P3|Overall Study|Adverse Event|0
1068114|NCT02854527|3457625|P2|Overall Study|Adverse Event|0
1068115|NCT02854527|3457626|P1|Overall Study|Adverse Event|0
1068116|NCT02853435|3457660|P6|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
1068117|NCT02853435|3457661|P5|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1
1068118|NCT02853435|3457662|P4|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
1068119|NCT02853435|3457663|P3|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
1068120|NCT02853435|3457664|P2|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
1068121|NCT02853435|3457665|P1|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
1068122|NCT02852434|3457975|P2|Overall Study|Unsuccessful Dilator Procedure|0
1068123|NCT02852434|3457976|P1|Overall Study|Unsuccessful Dilator Procedure|2
1068124|NCT02852434|3457975|P2|Overall Study|Withdrawal by Subject|1
1068125|NCT02852434|3457976|P1|Overall Study|Withdrawal by Subject|0
1068126|NCT02852265|3457992|P2|3-month Follow-up|Lost to Follow-up|1
1068127|NCT02852265|3457993|P1|3-month Follow-up|Lost to Follow-up|1
1068128|NCT02849678|3458028|P2|Overall Study|Protocol Violation|6
1068129|NCT02849678|3458029|P1|Overall Study|Protocol Violation|3
1068130|NCT02848326|3458053|P6|Safety Follow-up Period|Lost to Follow-up|3
1068131|NCT02848326|3458054|P5|Safety Follow-up Period|Lost to Follow-up|1
1068132|NCT02848326|3458055|P4|Safety Follow-up Period|Lost to Follow-up|0
1068133|NCT02848326|3458056|P3|Safety Follow-up Period|Lost to Follow-up|2
1068134|NCT02848326|3458057|P2|Safety Follow-up Period|Lost to Follow-up|0
1068135|NCT02848326|3458058|P1|Safety Follow-up Period|Lost to Follow-up|4
1068136|NCT02848326|3458053|P6|Safety Follow-up Period|Withdrawal of Consent|2
1068137|NCT02848326|3458054|P5|Safety Follow-up Period|Withdrawal of Consent|0
1068138|NCT02848326|3458055|P4|Safety Follow-up Period|Withdrawal of Consent|0
1068139|NCT02848326|3458056|P3|Safety Follow-up Period|Withdrawal of Consent|1
1068140|NCT02848326|3458057|P2|Safety Follow-up Period|Withdrawal of Consent|1
1068141|NCT02848326|3458058|P1|Safety Follow-up Period|Withdrawal of Consent|0
1068142|NCT02848326|3458053|P6|Treatment Period|Non-compliance with Study Drug|0
1068143|NCT02848326|3458054|P5|Treatment Period|Non-compliance with Study Drug|0
1068144|NCT02848326|3458055|P4|Treatment Period|Non-compliance with Study Drug|1
1068145|NCT02848326|3458056|P3|Treatment Period|Non-compliance with Study Drug|0
1068146|NCT02848326|3458057|P2|Treatment Period|Non-compliance with Study Drug|0
1068147|NCT02848326|3458058|P1|Treatment Period|Non-compliance with Study Drug|4
1068148|NCT02848326|3458053|P6|Treatment Period|Protocol Violation|3
1068149|NCT02848326|3458054|P5|Treatment Period|Protocol Violation|3
1068150|NCT02848326|3458055|P4|Treatment Period|Protocol Violation|2
1068151|NCT02848326|3458056|P3|Treatment Period|Protocol Violation|4
1068152|NCT02848326|3458057|P2|Treatment Period|Protocol Violation|3
1068153|NCT02848326|3458058|P1|Treatment Period|Protocol Violation|4
1068154|NCT02848326|3458053|P6|Treatment Period|Pregnancy|1
1068155|NCT02848326|3458054|P5|Treatment Period|Pregnancy|0
1068156|NCT02848326|3458055|P4|Treatment Period|Pregnancy|1
1068157|NCT02848326|3458056|P3|Treatment Period|Pregnancy|1
1068158|NCT02848326|3458057|P2|Treatment Period|Pregnancy|0
1068159|NCT02848326|3458058|P1|Treatment Period|Pregnancy|0
1068160|NCT02848326|3458053|P6|Treatment Period|Lost to Follow-up|3
1068161|NCT02848326|3458054|P5|Treatment Period|Lost to Follow-up|2
1068162|NCT02848326|3458055|P4|Treatment Period|Lost to Follow-up|7
1068163|NCT02848326|3458056|P3|Treatment Period|Lost to Follow-up|11
1068164|NCT02848326|3458057|P2|Treatment Period|Lost to Follow-up|1
1068165|NCT02848326|3458058|P1|Treatment Period|Lost to Follow-up|5
1068166|NCT02848326|3458053|P6|Treatment Period|Withdrawal of Consent|6
1068167|NCT02848326|3458054|P5|Treatment Period|Withdrawal of Consent|9
1068168|NCT02848326|3458055|P4|Treatment Period|Withdrawal of Consent|6
1068169|NCT02848326|3458056|P3|Treatment Period|Withdrawal of Consent|9
1068170|NCT02848326|3458057|P2|Treatment Period|Withdrawal of Consent|6
1068171|NCT02848326|3458058|P1|Treatment Period|Withdrawal of Consent|20
1068172|NCT02848326|3458053|P6|Treatment Period|Adverse Event|7
1068173|NCT02848326|3458054|P5|Treatment Period|Adverse Event|5
1068174|NCT02848326|3458055|P4|Treatment Period|Adverse Event|6
1068175|NCT02848326|3458056|P3|Treatment Period|Adverse Event|11
1068176|NCT02848326|3458057|P2|Treatment Period|Adverse Event|4
1068177|NCT02848326|3458058|P1|Treatment Period|Adverse Event|5
1068178|NCT02847637|3458107|P4|Overall Study|First emicizumab dose delayed|0
1068179|NCT02847637|3458108|P3|Overall Study|First emicizumab dose delayed|0
1068180|NCT02847637|3458109|P2|Overall Study|First emicizumab dose delayed|0
1068181|NCT02847637|3458110|P1|Overall Study|First emicizumab dose delayed|1
1068182|NCT02847637|3458107|P4|Overall Study|Ongoing treatment with emicizumab|63
1068183|NCT02847637|3458108|P3|Overall Study|Ongoing treatment with emicizumab|34
1068184|NCT02847637|3458109|P2|Overall Study|Ongoing treatment with emicizumab|35
1068185|NCT02847637|3458110|P1|Overall Study|Ongoing treatment with emicizumab|16
1068186|NCT02847637|3458107|P4|Overall Study|Withdrew from treatment due to AE|0
1068187|NCT02847637|3458108|P3|Overall Study|Withdrew from treatment due to AE|1
1068188|NCT02847637|3458109|P2|Overall Study|Withdrew from treatment due to AE|0
1068189|NCT02847637|3458110|P1|Overall Study|Withdrew from treatment due to AE|0
1068190|NCT02847260|3458222|P1|Overall Study|Physician Decision|1
1068191|NCT02847260|3458222|P1|Overall Study|Clinical Deterioration|1
1068192|NCT02847260|3458222|P1|Overall Study|Withdrawal by Subject|2
1068193|NCT02847260|3458222|P1|Overall Study|Adverse Event|3
1068194|NCT02846558|3458273|P4|Overall Study|Lost to Follow-up|0
1068195|NCT02846558|3458274|P3|Overall Study|Lost to Follow-up|0
1068196|NCT02846558|3458275|P2|Overall Study|Lost to Follow-up|0
1068197|NCT02846558|3458276|P1|Overall Study|Lost to Follow-up|2
1068198|NCT02846558|3458273|P4|Overall Study|Withdrawal by Subject|2
1068199|NCT02846558|3458274|P3|Overall Study|Withdrawal by Subject|2
1068200|NCT02846558|3458275|P2|Overall Study|Withdrawal by Subject|4
1068201|NCT02846558|3458276|P1|Overall Study|Withdrawal by Subject|5
1068202|NCT02846558|3458273|P4|Overall Study|Adverse Event|0
1068203|NCT02846558|3458274|P3|Overall Study|Adverse Event|0
1068204|NCT02846558|3458275|P2|Overall Study|Adverse Event|0
1068205|NCT02846558|3458276|P1|Overall Study|Adverse Event|1
1068206|NCT02844543|3458337|P1|Overall Study|Did not meet eligibility criteria|1
1068207|NCT02844543|3458337|P1|Overall Study|Withdrawal by Subject|4
1068208|NCT02843659|3458347|P3|Overall Study|Adverse Event|0
1068209|NCT02843659|3458348|P2|Overall Study|Adverse Event|1
1068210|NCT02843659|3458349|P1|Overall Study|Adverse Event|0
1068211|NCT02843659|3458347|P3|Overall Study|Administrative Reason by Sponsor|4
1068212|NCT02843659|3458348|P2|Overall Study|Administrative Reason by Sponsor|5
1068213|NCT02843659|3458349|P1|Overall Study|Administrative Reason by Sponsor|4
1068214|NCT02843659|3458347|P3|Overall Study|Subject Withdrew Consent|1
1068215|NCT02843659|3458348|P2|Overall Study|Subject Withdrew Consent|0
1068216|NCT02843659|3458349|P1|Overall Study|Subject Withdrew Consent|0
1068217|NCT02842073|3458414|P1|Overall Study|Withdrawal by Subject|1
1068218|NCT02841787|3458425|P3|Overall Study|Withdrawal by Subject|0
1068219|NCT02841787|3458426|P2|Overall Study|Withdrawal by Subject|4
1068220|NCT02841787|3458427|P1|Overall Study|Withdrawal by Subject|1
1068221|NCT02841787|3458425|P3|Overall Study|Symptoms dropped below threshold|0
1068222|NCT02841787|3458426|P2|Overall Study|Symptoms dropped below threshold|0
1068223|NCT02841787|3458427|P1|Overall Study|Symptoms dropped below threshold|1
1068224|NCT02841787|3458425|P3|Overall Study|Lost to Follow-up|0
1068225|NCT02841787|3458426|P2|Overall Study|Lost to Follow-up|0
1068226|NCT02841787|3458427|P1|Overall Study|Lost to Follow-up|1
1068227|NCT02840253|3458454|P1|Overall Study|Unsuccessful block|4
1068228|NCT02838901|3458501|P2|Overall Study|Lost to Follow-up|1
1068229|NCT02838901|3458502|P1|Overall Study|Lost to Follow-up|1
1068230|NCT02838901|3458501|P2|Overall Study|Withdrawal by Subject|1
1068231|NCT02838901|3458502|P1|Overall Study|Withdrawal by Subject|1
1068232|NCT02837952|3458532|P2|Overall Study|Medication Error|0
1068233|NCT02837952|3458533|P1|Overall Study|Medication Error|1
1068234|NCT02837952|3458532|P2|Overall Study|Withdrawal by Subject|5
1068235|NCT02837952|3458533|P1|Overall Study|Withdrawal by Subject|4
1068236|NCT02837952|3458532|P2|Overall Study|Adverse Event|1
1068237|NCT02837952|3458533|P1|Overall Study|Adverse Event|0
1068238|NCT02836249|3458558|P2|Overall Study|Still on Study|55
1068239|NCT02836249|3458559|P1|Overall Study|Still on Study|121
1068240|NCT02836249|3458558|P2|Overall Study|Lost to Follow-up|1
1068241|NCT02836249|3458559|P1|Overall Study|Lost to Follow-up|0
1068242|NCT02836249|3458558|P2|Overall Study|Withdrew Consent|1
1068243|NCT02836249|3458559|P1|Overall Study|Withdrew Consent|0
1068244|NCT02836249|3458558|P2|Overall Study|Pregnancy|0
1068245|NCT02836249|3458559|P1|Overall Study|Pregnancy|2
1068246|NCT02836249|3458558|P2|Overall Study|Randomized but Never Treated|1
1068247|NCT02836249|3458559|P1|Overall Study|Randomized but Never Treated|0
1068248|NCT02836236|3458577|P2|Overall Study|Still on Study|49
1068249|NCT02836236|3458578|P1|Overall Study|Still on Study|101
1068250|NCT02836236|3458577|P2|Overall Study|Investigator's Discretion|0
1068251|NCT02836236|3458578|P1|Overall Study|Investigator's Discretion|1
1068252|NCT02836236|3458577|P2|Overall Study|Adverse Event|1
1068253|NCT02836236|3458578|P1|Overall Study|Adverse Event|0
1068254|NCT02836236|3458577|P2|Overall Study|Withdrew Consent|0
1068255|NCT02836236|3458578|P1|Overall Study|Withdrew Consent|2
1068256|NCT02836236|3458577|P2|Overall Study|Randomized but Never Treated|0
1068257|NCT02836236|3458578|P1|Overall Study|Randomized but Never Treated|1
1068258|NCT02832375|3458616|P2|Overall Study|Withdrawal of Consent|0
1068259|NCT02832375|3458617|P1|Overall Study|Withdrawal of Consent|1
1068260|NCT02832375|3458616|P2|Overall Study|Lost to Follow-up|0
1068261|NCT02832375|3458617|P1|Overall Study|Lost to Follow-up|1
1068262|NCT02831387|3458646|P2|Overall Study|Discontinued due to stock recovery|1
1068263|NCT02831387|3458647|P1|Overall Study|Discontinued due to stock recovery|0
1068264|NCT02831387|3458646|P2|Overall Study|Withdrawal by Subject|1
1068265|NCT02831387|3458647|P1|Overall Study|Withdrawal by Subject|1
1068266|NCT02830087|3458671|P6|Overall Study|No study staff to follow-up patients|3
1068267|NCT02830087|3458672|P5|Overall Study|No study staff to follow-up patients|3
1068268|NCT02830087|3458673|P4|Overall Study|No study staff to follow-up patients|3
1068269|NCT02830087|3458674|P3|Overall Study|No study staff to follow-up patients|4
1068270|NCT02830087|3458675|P2|Overall Study|No study staff to follow-up patients|4
1068271|NCT02830087|3458676|P1|Overall Study|No study staff to follow-up patients|4
1068272|NCT02829996|3458743|P5|Overall Study|Withdrawal by Subject|0
1068273|NCT02829996|3458744|P4|Overall Study|Withdrawal by Subject|0
1068274|NCT02829996|3458745|P3|Overall Study|Withdrawal by Subject|0
1068275|NCT02829996|3458746|P2|Overall Study|Withdrawal by Subject|0
1068276|NCT02829996|3458747|P1|Overall Study|Withdrawal by Subject|1
1068277|NCT02829775|3458770|P1|Overall Study|Disease remission|1
1068278|NCT02829775|3458770|P1|Overall Study|Withdrawal by Subject|3
1068279|NCT02829775|3458770|P1|Overall Study|Death|1
1068280|NCT02829138|3458846|P2|Overall Study|Withdrawal by Subject|0
1068281|NCT02829138|3458847|P1|Overall Study|Withdrawal by Subject|1
1068282|NCT02826421|3458885|P4|Overall Study|Reason not given|0
1068283|NCT02826421|3458886|P3|Overall Study|Reason not given|1
1068284|NCT02826421|3458887|P2|Overall Study|Reason not given|0
1068285|NCT02826421|3458888|P1|Overall Study|Reason not given|1
1068286|NCT02826421|3458885|P4|Overall Study|Withdrawal by Subject|1
1068287|NCT02826421|3458886|P3|Overall Study|Withdrawal by Subject|1
1068288|NCT02826421|3458887|P2|Overall Study|Withdrawal by Subject|3
1068289|NCT02826421|3458888|P1|Overall Study|Withdrawal by Subject|1
1068290|NCT02826421|3458885|P4|Overall Study|Adverse Event|1
1068291|NCT02826421|3458886|P3|Overall Study|Adverse Event|0
1068292|NCT02826421|3458887|P2|Overall Study|Adverse Event|0
1068293|NCT02826421|3458888|P1|Overall Study|Adverse Event|1
1068294|NCT02825550|3458900|P1|Overall Study|Physician Decision|1
1068295|NCT02825251|3458908|P2|Overall Study|Unclassified|0
1068296|NCT02825251|3458909|P1|Overall Study|Unclassified|2
1068297|NCT02825251|3458908|P2|Overall Study|Withdrawal by Subject|4
1068298|NCT02825251|3458909|P1|Overall Study|Withdrawal by Subject|1
1068299|NCT02825251|3458908|P2|Overall Study|Lost to Follow-up|1
1068300|NCT02825251|3458909|P1|Overall Study|Lost to Follow-up|0
1068301|NCT02825251|3458908|P2|Overall Study|Adverse Event|1
1068302|NCT02825251|3458909|P1|Overall Study|Adverse Event|0
1068303|NCT02824562|3459112|P2|Overall Study|Death|1
1068304|NCT02824562|3459113|P1|Overall Study|Death|0
1068305|NCT02824562|3459112|P2|Overall Study|Lost to Follow-up|4
1068306|NCT02824562|3459113|P1|Overall Study|Lost to Follow-up|3
1068307|NCT02823964|3459120|P1|Overall Study|Withdrawal by Subject|1
1068308|NCT02823964|3459120|P1|Overall Study|Lack of Efficacy|1
1068309|NCT02823964|3459120|P1|Overall Study|Physician Decision|1
1068310|NCT02823964|3459120|P1|Overall Study|Adverse Event|2
1068311|NCT02823470|3459134|P2|Overall Study|Study terminated by sponsor|15
1068312|NCT02823470|3459135|P1|Overall Study|Study terminated by sponsor|8
1068313|NCT02823470|3459134|P2|Overall Study|Adverse Event|0
1068314|NCT02823470|3459135|P1|Overall Study|Adverse Event|1
1068315|NCT02822794|3459195|P2|Overall Study|Withdrew Consent|0
1068316|NCT02822794|3459196|P1|Overall Study|Withdrew Consent|1
1068317|NCT02816138|3459318|P1|Overall Study|Adverse Event|1
1068318|NCT02815735|3459364|P2|Second Intervention (4 Weeks)|Protocol Violation|0
1068319|NCT02815735|3459365|P1|Second Intervention (4 Weeks)|Protocol Violation|1
1068320|NCT02815735|3459364|P2|First Intervention (4 Weeks)|Poor fitting characteristics|1
1068321|NCT02815735|3459365|P1|First Intervention (4 Weeks)|Poor fitting characteristics|0
1068322|NCT02815735|3459364|P2|First Intervention (4 Weeks)|Lost to Follow-up|0
1068323|NCT02815735|3459365|P1|First Intervention (4 Weeks)|Lost to Follow-up|1
1068324|NCT02815735|3459364|P2|First Intervention (4 Weeks)|Discomfort|0
1068325|NCT02815735|3459365|P1|First Intervention (4 Weeks)|Discomfort|1
1068326|NCT02815397|3459401|P1|Overall Study|Physician Decision|2
1068327|NCT02814643|3459410|P2|Overall Study|Withdrawal by Subject|2
1068328|NCT02814643|3459411|P1|Overall Study|Withdrawal by Subject|1
1068329|NCT02814643|3459410|P2|Overall Study|Lost to Follow-up|1
1068330|NCT02814643|3459411|P1|Overall Study|Lost to Follow-up|0
1068331|NCT02809833|3459541|P1|Overall Study|Missing Information|52
1068332|NCT02809833|3459541|P1|Overall Study|Not Specified|5
1068333|NCT02809833|3459541|P1|Overall Study|Adverse Event (AE)|24
1068334|NCT02809833|3459541|P1|Overall Study|Lost to Follow-up|35
1068335|NCT02809833|3459541|P1|Overall Study|Withdrawal by Subject|34
1068336|NCT02809833|3459541|P1|Overall Study|Noncompliance|1
1068337|NCT02809833|3459541|P1|Overall Study|Remission/Treatment No Longer Needed|3
1068338|NCT02809833|3459541|P1|Overall Study|Lack of Efficacy|89
1068339|NCT02809833|3459541|P1|Overall Study|Intolerance|54
1068340|NCT02809833|3459541|P1|Overall Study|Death|3
1068341|NCT02807376|3459667|P2|Overall Study|Lost to Follow-up|1
1068342|NCT02807376|3459668|P1|Overall Study|Lost to Follow-up|0
1068343|NCT02807376|3459667|P2|Overall Study|Intra-operative exclusion criteria|0
1068344|NCT02807376|3459668|P1|Overall Study|Intra-operative exclusion criteria|3
1068345|NCT02806505|3459700|P2|Overall Study|Insufficient therapeutic response|4
1068346|NCT02806505|3459701|P1|Overall Study|Insufficient therapeutic response|2
1068347|NCT02806505|3459700|P2|Overall Study|Failure to return|1
1068348|NCT02806505|3459701|P1|Overall Study|Failure to return|0
1068349|NCT02806505|3459700|P2|Overall Study|Did not cooperate/refused treatment|3
1068350|NCT02806505|3459701|P1|Overall Study|Did not cooperate/refused treatment|3
1068351|NCT02806505|3459700|P2|Overall Study|Death|0
1068352|NCT02806505|3459701|P1|Overall Study|Death|4
1068353|NCT02806505|3459700|P2|Overall Study|Adverse event/intercurrent illness|3
1068354|NCT02806505|3459701|P1|Overall Study|Adverse event/intercurrent illness|1
1068355|NCT02805907|3459713|P2|Overall Study|Lost to Follow-up|3
1068356|NCT02805907|3459714|P1|Overall Study|Lost to Follow-up|3
1068357|NCT02802878|3459728|P2|Overall Study|Protocol Violation|0
1068358|NCT02802878|3459729|P1|Overall Study|Protocol Violation|1
1068359|NCT02802878|3459728|P2|Overall Study|Withdrawal by Subject|3
1068360|NCT02802878|3459729|P1|Overall Study|Withdrawal by Subject|3
1068361|NCT02802592|3459743|P1|Overall Study|Study terminated due to loss of funding|4
1068362|NCT02801396|3459771|P6|Period 1|Withdrawal by Subject|0
1068363|NCT02801396|3459772|P5|Period 1|Withdrawal by Subject|1
1068364|NCT02801396|3459773|P4|Period 1|Withdrawal by Subject|0
1068365|NCT02801396|3459774|P3|Period 1|Withdrawal by Subject|0
1068366|NCT02801396|3459775|P2|Period 1|Withdrawal by Subject|0
1068367|NCT02801396|3459776|P1|Period 1|Withdrawal by Subject|0
1068368|NCT02799784|3459819|P2|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1
1068369|NCT02799784|3459820|P1|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0
1068370|NCT02799784|3459819|P2|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1
1068371|NCT02799784|3459820|P1|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0
1068372|NCT02799784|3459819|P2|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0
1068373|NCT02799784|3459820|P1|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1
1068374|NCT02799784|3459819|P2|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1
1068375|NCT02799784|3459820|P1|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0
1068376|NCT02799784|3459819|P2|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0
1068377|NCT02799784|3459820|P1|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5
1068378|NCT02799784|3459819|P2|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1
1068379|NCT02799784|3459820|P1|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1
1068380|NCT02799472|3459828|P2|Overall Study|Lost to Follow-up|1
1068381|NCT02799472|3459829|P1|Overall Study|Lost to Follow-up|0
1068382|NCT02799472|3459828|P2|Overall Study|Lack of Efficacy|0
1068383|NCT02799472|3459829|P1|Overall Study|Lack of Efficacy|2
1068384|NCT02799472|3459828|P2|Overall Study|Withdrawal by Subject|4
1068385|NCT02799472|3459829|P1|Overall Study|Withdrawal by Subject|2
1068386|NCT02799082|3459889|P2|Overall Study|Protocol Violation|1
1068387|NCT02799082|3459890|P1|Overall Study|Protocol Violation|0
1068388|NCT02799082|3459889|P2|Overall Study|Refused second PDT or withdraw consent|3
1068389|NCT02799082|3459890|P1|Overall Study|Refused second PDT or withdraw consent|4
1068390|NCT02799069|3459927|P3|Overall Study|Protocol Violation|2
1068391|NCT02799069|3459928|P2|Overall Study|Protocol Violation|0
1068392|NCT02799069|3459929|P1|Overall Study|Protocol Violation|1
1068393|NCT02799069|3459927|P3|Overall Study|Withdrawal by Subject|3
1068394|NCT02799069|3459928|P2|Overall Study|Withdrawal by Subject|4
1068395|NCT02799069|3459929|P1|Overall Study|Withdrawal by Subject|4
1068396|NCT02799069|3459927|P3|Overall Study|Lost to Follow-up|0
1068397|NCT02799069|3459928|P2|Overall Study|Lost to Follow-up|1
1068398|NCT02799069|3459929|P1|Overall Study|Lost to Follow-up|1
1068399|NCT02799069|3459927|P3|Overall Study|Lack of Efficacy|0
1068400|NCT02799069|3459928|P2|Overall Study|Lack of Efficacy|0
1068401|NCT02799069|3459929|P1|Overall Study|Lack of Efficacy|2
1068402|NCT02799069|3459927|P3|Overall Study|Adverse Event|2
1068403|NCT02799069|3459928|P2|Overall Study|Adverse Event|2
1068404|NCT02799069|3459929|P1|Overall Study|Adverse Event|0
1068405|NCT02798315|3460039|P1|Overall Study|Failure to return|1
1068406|NCT02797522|3460084|P11|Overall Study|Study Terminated by Sponsor|1
1068407|NCT02797522|3460085|P10|Overall Study|Study Terminated by Sponsor|4
1068408|NCT02797522|3460086|P9|Overall Study|Study Terminated by Sponsor|2
1068409|NCT02797522|3460087|P8|Overall Study|Study Terminated by Sponsor|4
1068410|NCT02797522|3460088|P7|Overall Study|Study Terminated by Sponsor|0
1068411|NCT02797522|3460089|P6|Overall Study|Study Terminated by Sponsor|0
1068412|NCT02797522|3460090|P5|Overall Study|Study Terminated by Sponsor|0
1068413|NCT02797522|3460091|P4|Overall Study|Study Terminated by Sponsor|0
1068414|NCT02797522|3460092|P3|Overall Study|Study Terminated by Sponsor|0
1068415|NCT02797522|3460093|P2|Overall Study|Study Terminated by Sponsor|0
1068416|NCT02797522|3460094|P1|Overall Study|Study Terminated by Sponsor|0
1068417|NCT02797132|3460200|P1|Part B (24 Weeks)|Adverse Event|3
1068418|NCT02797132|3460200|P1|Part A (15 Days)|Adverse Event|1
1068419|NCT02797080|3460252|P1|Overall Study|Withdrawal by Subject|1
1068420|NCT02797080|3460252|P1|Overall Study|Lost to Follow-up|1
1068421|NCT02796963|3460294|P4|Overall Study|Lost to Follow-up|72
1068422|NCT02796963|3460295|P3|Overall Study|Lost to Follow-up|69
1068423|NCT02796963|3460296|P2|Overall Study|Lost to Follow-up|76
1068424|NCT02796963|3460297|P1|Overall Study|Lost to Follow-up|89
1068425|NCT02796677|3460363|P4|Overall Study|Reason not mentioned|5
1068426|NCT02796677|3460364|P3|Overall Study|Reason not mentioned|0
1068427|NCT02796677|3460365|P2|Overall Study|Reason not mentioned|3
1068428|NCT02796677|3460366|P1|Overall Study|Reason not mentioned|2
1068429|NCT02796677|3460363|P4|Overall Study|Progressive disease|18
1068430|NCT02796677|3460364|P3|Overall Study|Progressive disease|13
1068431|NCT02796677|3460365|P2|Overall Study|Progressive disease|15
1068432|NCT02796677|3460366|P1|Overall Study|Progressive disease|6
1068433|NCT02796677|3460363|P4|Overall Study|Withdrawal by Subject|7
1068434|NCT02796677|3460364|P3|Overall Study|Withdrawal by Subject|6
1068435|NCT02796677|3460365|P2|Overall Study|Withdrawal by Subject|14
1068436|NCT02796677|3460366|P1|Overall Study|Withdrawal by Subject|4
1068437|NCT02796677|3460363|P4|Overall Study|Lack of Efficacy|20
1068438|NCT02796677|3460364|P3|Overall Study|Lack of Efficacy|14
1068439|NCT02796677|3460365|P2|Overall Study|Lack of Efficacy|9
1068440|NCT02796677|3460366|P1|Overall Study|Lack of Efficacy|7
1068441|NCT02796677|3460363|P4|Overall Study|Lost to Follow-up|2
1068442|NCT02796677|3460364|P3|Overall Study|Lost to Follow-up|2
1068443|NCT02796677|3460365|P2|Overall Study|Lost to Follow-up|5
1068444|NCT02796677|3460366|P1|Overall Study|Lost to Follow-up|1
1068445|NCT02796677|3460363|P4|Overall Study|Protocol Violation|8
1068446|NCT02796677|3460364|P3|Overall Study|Protocol Violation|4
1068447|NCT02796677|3460365|P2|Overall Study|Protocol Violation|5
1068448|NCT02796677|3460366|P1|Overall Study|Protocol Violation|7
1068449|NCT02796677|3460363|P4|Overall Study|Adverse Event|14
1068450|NCT02796677|3460364|P3|Overall Study|Adverse Event|14
1068451|NCT02796677|3460365|P2|Overall Study|Adverse Event|22
1068452|NCT02796677|3460366|P1|Overall Study|Adverse Event|11
1068453|NCT02796651|3460390|P1|Overall Study|Not specified|10
1068454|NCT02796651|3460390|P1|Overall Study|Lack of Efficacy|1
1068455|NCT02796651|3460390|P1|Overall Study|Protocol Violation|4
1068456|NCT02796651|3460390|P1|Overall Study|Withdrawal by Subject|4
1068457|NCT02796651|3460390|P1|Overall Study|Lost to Follow-up|1
1068458|NCT02796651|3460390|P1|Overall Study|Adverse Event|6
1068459|NCT02794974|3460463|P2|Overall Study|Physician Decision|1
1068460|NCT02794974|3460464|P1|Overall Study|Physician Decision|0
1068461|NCT02794870|3460480|P2|Overall Study|Withdrawal by Subject|0
1068462|NCT02794870|3460481|P1|Overall Study|Withdrawal by Subject|2
1068463|NCT02794480|3460517|P4|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
1068464|NCT02794480|3460518|P3|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1068465|NCT02794480|3460519|P2|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1068466|NCT02794480|3460520|P1|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
1068467|NCT02794480|3460517|P4|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1
1068468|NCT02794480|3460518|P3|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1068469|NCT02794480|3460519|P2|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2
1068470|NCT02794480|3460520|P1|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1068471|NCT02794480|3460517|P4|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2
1068472|NCT02794480|3460518|P3|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
1068473|NCT02794480|3460519|P2|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
1068474|NCT02794480|3460520|P1|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
1068475|NCT02794480|3460517|P4|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
1068476|NCT02794480|3460518|P3|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1
1068477|NCT02794480|3460519|P2|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
1068478|NCT02794480|3460520|P1|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
1068479|NCT02794480|3460517|P4|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
1068480|NCT02794480|3460518|P3|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1
1068646|NCT02773368|3461902|P1|Overall Study|Withdrawal by Subject|5
1068481|NCT02794480|3460519|P2|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
1068482|NCT02794480|3460520|P1|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
1068483|NCT02793947|3460540|P2|Overall Study|Physician Decision|5
1068484|NCT02793947|3460541|P1|Overall Study|Physician Decision|1
1068485|NCT02793947|3460540|P2|Overall Study|Death|0
1068486|NCT02793947|3460541|P1|Overall Study|Death|1
1068487|NCT02793232|3460575|P9|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
1068488|NCT02793232|3460576|P8|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
1068489|NCT02793232|3460577|P7|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1
1068490|NCT02793232|3460578|P6|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
1068491|NCT02793232|3460579|P5|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1
1068492|NCT02793232|3460580|P4|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
1068493|NCT02793232|3460581|P3|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
1068494|NCT02793232|3460582|P2|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
1068495|NCT02793232|3460583|P1|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
1068496|NCT02792517|3460836|P1|Overall Study|Lost to Follow-up|3
1068497|NCT02792517|3460836|P1|Overall Study|Decision by Sponsor|7
1068498|NCT02792517|3460836|P1|Overall Study|Withdrawal by Subject|10
1068499|NCT02792062|3460856|P6|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
1068500|NCT02792062|3460857|P5|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
1068501|NCT02792062|3460858|P4|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
1068502|NCT02792062|3460859|P3|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
1068503|NCT02792062|3460860|P2|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
1068504|NCT02792062|3460861|P1|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1
1068505|NCT02791659|3460912|P2|Overall Study|Protocol Violation|1
1068506|NCT02791659|3460913|P1|Overall Study|Protocol Violation|0
1068507|NCT02791269|3460921|P2|Overall Study|Lost to Follow-up|1
1068508|NCT02791269|3460922|P1|Overall Study|Lost to Follow-up|0
1068509|NCT02788357|3460955|P2|Overall Study|Lost to Follow-up|0
1068510|NCT02788357|3460956|P1|Overall Study|Lost to Follow-up|3
1068511|NCT02786927|3461025|P1|Overall Study|Protocol Violation|4
1068512|NCT02786927|3461025|P1|Overall Study|Adverse Event|1
1068513|NCT02786004|3461055|P2|Overall Study|Withdrawal by Subject|1
1068514|NCT02786004|3461056|P1|Overall Study|Withdrawal by Subject|0
1068515|NCT02785900|3461066|P2|Overall Study|Physician Decision|2
1068516|NCT02785900|3461067|P1|Overall Study|Physician Decision|3
1068517|NCT02785900|3461066|P2|Overall Study|Withdrawal by Subject|8
1068518|NCT02785900|3461067|P1|Overall Study|Withdrawal by Subject|4
1068519|NCT02785900|3461066|P2|Overall Study|Death|32
1068520|NCT02785900|3461067|P1|Overall Study|Death|46
1068521|NCT02785900|3461066|P2|Overall Study|Study Termination by Sponsor|81
1068522|NCT02785900|3461067|P1|Overall Study|Study Termination by Sponsor|64
1068523|NCT02785770|3461091|P4|Intervention Period 3 (1 Day)|Adverse Event|1
1068524|NCT02785770|3461092|P3|Intervention Period 3 (1 Day)|Adverse Event|0
1068525|NCT02785770|3461093|P2|Intervention Period 3 (1 Day)|Adverse Event|0
1068526|NCT02785770|3461094|P1|Intervention Period 3 (1 Day)|Adverse Event|0
1068527|NCT02785770|3461091|P4|Intervention Period 2 (1 Day)|Family related obligations|0
1068528|NCT02785770|3461092|P3|Intervention Period 2 (1 Day)|Family related obligations|1
1068529|NCT02785770|3461093|P2|Intervention Period 2 (1 Day)|Family related obligations|0
1068530|NCT02785770|3461094|P1|Intervention Period 2 (1 Day)|Family related obligations|0
1068531|NCT02785770|3461091|P4|Intervention Period 2 (1 Day)|Adverse Event|0
1068532|NCT02785770|3461092|P3|Intervention Period 2 (1 Day)|Adverse Event|0
1068533|NCT02785770|3461093|P2|Intervention Period 2 (1 Day)|Adverse Event|1
1068534|NCT02785770|3461094|P1|Intervention Period 2 (1 Day)|Adverse Event|0
1068535|NCT02784106|3461250|P4|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
1068536|NCT02784106|3461251|P3|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
1068537|NCT02784106|3461252|P2|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
1068538|NCT02784106|3461253|P1|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
1068539|NCT02784106|3461250|P4|Open-Label Extension Period (26 Weeks)|Adverse Event|1
1068540|NCT02784106|3461251|P3|Open-Label Extension Period (26 Weeks)|Adverse Event|2
1068541|NCT02784106|3461252|P2|Open-Label Extension Period (26 Weeks)|Adverse Event|0
1068542|NCT02784106|3461253|P1|Open-Label Extension Period (26 Weeks)|Adverse Event|0
1068543|NCT02784106|3461250|P4|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
1068544|NCT02784106|3461251|P3|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
1068545|NCT02784106|3461252|P2|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
1068546|NCT02784106|3461253|P1|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1
1068547|NCT02784106|3461250|P4|Double-Blind Treatment Period (12 Weeks)|Not specified|0
1068548|NCT02784106|3461251|P3|Double-Blind Treatment Period (12 Weeks)|Not specified|0
1068549|NCT02784106|3461252|P2|Double-Blind Treatment Period (12 Weeks)|Not specified|0
1068550|NCT02784106|3461253|P1|Double-Blind Treatment Period (12 Weeks)|Not specified|2
1068551|NCT02784106|3461250|P4|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
1068552|NCT02784106|3461251|P3|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
1068553|NCT02784106|3461252|P2|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1
1068554|NCT02784106|3461253|P1|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2
1068555|NCT02784106|3461250|P4|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
1068556|NCT02784106|3461251|P3|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
1068557|NCT02784106|3461252|P2|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5
1068558|NCT02784106|3461253|P1|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3
1068559|NCT02782676|3461314|P2|Overall Study|Lost to Follow-up|1
1068560|NCT02782676|3461315|P1|Overall Study|Lost to Follow-up|0
1068561|NCT02782169|3461345|P2|Overall Study|Lost to Follow-up|2
1068562|NCT02782169|3461346|P1|Overall Study|Lost to Follow-up|1
1068563|NCT02781818|3461363|P3|Overall Study|Lost to Follow-up|1
1068564|NCT02781818|3461364|P2|Overall Study|Lost to Follow-up|2
1068565|NCT02781818|3461365|P1|Overall Study|Lost to Follow-up|4
1068566|NCT02781558|3461431|P2|Overall Study|Adverse Event|0
1068567|NCT02781558|3461432|P1|Overall Study|Adverse Event|1
1068568|NCT02781558|3461431|P2|Overall Study|Lost to Follow-up|2
1068569|NCT02781558|3461432|P1|Overall Study|Lost to Follow-up|2
1068570|NCT02780700|3461492|P1|Overall Study|Progressive disease|1
1068571|NCT02780167|3461565|P5|Overall Study|Other|2
1068572|NCT02780167|3461566|P4|Overall Study|Other|1
1068573|NCT02780167|3461567|P3|Overall Study|Other|3
1068574|NCT02780167|3461568|P2|Overall Study|Other|0
1068575|NCT02780167|3461569|P1|Overall Study|Other|0
1068576|NCT02780167|3461565|P5|Overall Study|Withdrawal by Subject|4
1068577|NCT02780167|3461566|P4|Overall Study|Withdrawal by Subject|3
1068578|NCT02780167|3461567|P3|Overall Study|Withdrawal by Subject|4
1068579|NCT02780167|3461568|P2|Overall Study|Withdrawal by Subject|4
1068580|NCT02780167|3461569|P1|Overall Study|Withdrawal by Subject|6
1068581|NCT02780167|3461565|P5|Overall Study|Protocol Violation|2
1068582|NCT02780167|3461566|P4|Overall Study|Protocol Violation|1
1068583|NCT02780167|3461567|P3|Overall Study|Protocol Violation|1
1068584|NCT02780167|3461568|P2|Overall Study|Protocol Violation|5
1068585|NCT02780167|3461569|P1|Overall Study|Protocol Violation|5
1068586|NCT02780167|3461565|P5|Overall Study|No longer meets eligibility criteria|1
1068587|NCT02780167|3461566|P4|Overall Study|No longer meets eligibility criteria|1
1068588|NCT02780167|3461567|P3|Overall Study|No longer meets eligibility criteria|0
1068589|NCT02780167|3461568|P2|Overall Study|No longer meets eligibility criteria|0
1068590|NCT02780167|3461569|P1|Overall Study|No longer meets eligibility criteria|0
1068591|NCT02780167|3461565|P5|Overall Study|Does not meet entrance criteria|0
1068592|NCT02780167|3461566|P4|Overall Study|Does not meet entrance criteria|0
1068593|NCT02780167|3461567|P3|Overall Study|Does not meet entrance criteria|1
1068594|NCT02780167|3461568|P2|Overall Study|Does not meet entrance criteria|0
1068595|NCT02780167|3461569|P1|Overall Study|Does not meet entrance criteria|0
1068596|NCT02780167|3461565|P5|Overall Study|Lost to Follow-up|0
1068597|NCT02780167|3461566|P4|Overall Study|Lost to Follow-up|0
1068598|NCT02780167|3461567|P3|Overall Study|Lost to Follow-up|1
1068599|NCT02780167|3461568|P2|Overall Study|Lost to Follow-up|0
1068600|NCT02780167|3461569|P1|Overall Study|Lost to Follow-up|2
1068601|NCT02780167|3461565|P5|Overall Study|Lack of Efficacy|0
1068602|NCT02780167|3461566|P4|Overall Study|Lack of Efficacy|1
1068603|NCT02780167|3461567|P3|Overall Study|Lack of Efficacy|6
1068604|NCT02780167|3461568|P2|Overall Study|Lack of Efficacy|5
1068605|NCT02780167|3461569|P1|Overall Study|Lack of Efficacy|6
1068606|NCT02780167|3461565|P5|Overall Study|Adverse Event|8
1068607|NCT02780167|3461566|P4|Overall Study|Adverse Event|12
1068608|NCT02780167|3461567|P3|Overall Study|Adverse Event|8
1068609|NCT02780167|3461568|P2|Overall Study|Adverse Event|8
1068610|NCT02780167|3461569|P1|Overall Study|Adverse Event|9
1068611|NCT02777242|3461738|P1|Overall Study|Withdrawal by Subject|1
1068612|NCT02777242|3461738|P1|Overall Study|Sponsor's request|1
1068613|NCT02777242|3461738|P1|Overall Study|Multiple|1
1068614|NCT02777242|3461738|P1|Overall Study|Lost to Follow-up|1
1068615|NCT02777242|3461738|P1|Overall Study|Other|2
1068616|NCT02777125|3461744|P2|Overall Study|Protocol Violation|12
1068617|NCT02777125|3461745|P1|Overall Study|Protocol Violation|8
1068618|NCT02777125|3461744|P2|Overall Study|Assent form violation|23
1068619|NCT02777125|3461745|P1|Overall Study|Assent form violation|21
1068620|NCT02777125|3461744|P2|Overall Study|Consent form violation|12
1068621|NCT02777125|3461745|P1|Overall Study|Consent form violation|14
1068622|NCT02774278|3461798|P1|Overall Study|Protocol Violation|2
1068623|NCT02774278|3461798|P1|Overall Study|Withdrawal by Subject|3
1068624|NCT02774278|3461798|P1|Overall Study|Administrative reasons|6
1068625|NCT02774278|3461798|P1|Overall Study|Refused treatment/did not cooperate|9
1068626|NCT02774278|3461798|P1|Overall Study|Adverse event/intercurrent illness|16
1068627|NCT02774278|3461798|P1|Overall Study|Death|29
1068628|NCT02774278|3461798|P1|Overall Study|Lack of Efficacy|199
1068629|NCT02773446|3461855|P6|First Admission|Lost to Follow-up|0
1068630|NCT02773446|3461856|P5|First Admission|Lost to Follow-up|0
1068631|NCT02773446|3461857|P4|First Admission|Lost to Follow-up|0
1068632|NCT02773446|3461858|P3|First Admission|Lost to Follow-up|0
1068633|NCT02773446|3461859|P2|First Admission|Lost to Follow-up|0
1068634|NCT02773446|3461860|P1|First Admission|Lost to Follow-up|1
1068635|NCT02773446|3461855|P6|First Admission|Withdrawal by Subject|0
1068636|NCT02773446|3461856|P5|First Admission|Withdrawal by Subject|0
1068637|NCT02773446|3461857|P4|First Admission|Withdrawal by Subject|1
1068638|NCT02773446|3461858|P3|First Admission|Withdrawal by Subject|0
1068639|NCT02773446|3461859|P2|First Admission|Withdrawal by Subject|0
1068640|NCT02773446|3461860|P1|First Admission|Withdrawal by Subject|0
1068641|NCT02773368|3461901|P2|Overall Study|Missing|1
1068642|NCT02773368|3461902|P1|Overall Study|Missing|0
1068643|NCT02773368|3461901|P2|Overall Study|Unclassified|1
1068644|NCT02773368|3461902|P1|Overall Study|Unclassified|1
1068645|NCT02773368|3461901|P2|Overall Study|Withdrawal by Subject|1
1068647|NCT02773368|3461901|P2|Overall Study|Lost to Follow-up|1
1068648|NCT02773368|3461902|P1|Overall Study|Lost to Follow-up|4
1068649|NCT02771145|3461977|P1|Overall Study|Lost to Follow-up|1
1068650|NCT02771145|3461977|P1|Overall Study|Adverse Event|3
1068651|NCT02770248|3462086|P2|Overall Study|Randomized in error, prior to treatment|1
1068652|NCT02770248|3462087|P1|Overall Study|Randomized in error, prior to treatment|0
1068653|NCT02770248|3462086|P2|Overall Study|Adverse Event|1
1068654|NCT02770248|3462087|P1|Overall Study|Adverse Event|0
1068655|NCT02769858|3462099|P1|Overall Study|Withdrawal by Subject|2
1068656|NCT02769247|3462125|P4|Overall Study|Physician Decision|0
1068657|NCT02769247|3462126|P3|Overall Study|Physician Decision|0
1068658|NCT02769247|3462127|P2|Overall Study|Physician Decision|0
1068659|NCT02769247|3462128|P1|Overall Study|Physician Decision|1
1068660|NCT02769247|3462125|P4|Overall Study|Protocol Violation|0
1068661|NCT02769247|3462126|P3|Overall Study|Protocol Violation|1
1068662|NCT02769247|3462127|P2|Overall Study|Protocol Violation|0
1068663|NCT02769247|3462128|P1|Overall Study|Protocol Violation|0
1068664|NCT02769247|3462125|P4|Overall Study|Withdrawal by Subject|1
1068665|NCT02769247|3462126|P3|Overall Study|Withdrawal by Subject|0
1068666|NCT02769247|3462127|P2|Overall Study|Withdrawal by Subject|0
1068667|NCT02769247|3462128|P1|Overall Study|Withdrawal by Subject|1
1068668|NCT02768194|3462166|P6|Period 3|Other (Reason not specified)|0
1068669|NCT02768194|3462167|P5|Period 3|Other (Reason not specified)|0
1068670|NCT02768194|3462168|P4|Period 3|Other (Reason not specified)|0
1068671|NCT02768194|3462169|P3|Period 3|Other (Reason not specified)|0
1068672|NCT02768194|3462170|P2|Period 3|Other (Reason not specified)|1
1068673|NCT02768194|3462171|P1|Period 3|Other (Reason not specified)|0
1068674|NCT02768194|3462166|P6|Period 2|Other (Reason not specified)|0
1068675|NCT02768194|3462167|P5|Period 2|Other (Reason not specified)|0
1068676|NCT02768194|3462168|P4|Period 2|Other (Reason not specified)|0
1068677|NCT02768194|3462169|P3|Period 2|Other (Reason not specified)|0
1068678|NCT02768194|3462170|P2|Period 2|Other (Reason not specified)|0
1068679|NCT02768194|3462171|P1|Period 2|Other (Reason not specified)|1
1068680|NCT02768194|3462166|P6|Period 1|Adverse Event|0
1068681|NCT02768194|3462167|P5|Period 1|Adverse Event|0
1068682|NCT02768194|3462168|P4|Period 1|Adverse Event|1
1068683|NCT02768194|3462169|P3|Period 1|Adverse Event|0
1068684|NCT02768194|3462170|P2|Period 1|Adverse Event|0
1068685|NCT02768194|3462171|P1|Period 1|Adverse Event|0
1068686|NCT02767765|3462188|P1|Overall Study|Withdrawal by Subject|1
1068687|NCT02767765|3462188|P1|Overall Study|Non-Compliance|1
1068688|NCT02767765|3462188|P1|Overall Study|Investigator decision|1
1068689|NCT02767765|3462188|P1|Overall Study|Lost to Follow-up|2
1068690|NCT02767765|3462188|P1|Overall Study|Insufficient response|1
1068691|NCT02767765|3462188|P1|Overall Study|Death|1
1068692|NCT02767765|3462188|P1|Overall Study|Adverse Event|4
1068693|NCT02766400|3462199|P2|Overall Study|Withdrawal by Subject|0
1068694|NCT02766400|3462200|P1|Overall Study|Withdrawal by Subject|1
1068695|NCT02766400|3462199|P2|Overall Study|Death|2
1068696|NCT02766400|3462200|P1|Overall Study|Death|1
1068697|NCT02766283|3462206|P1|Overall Study|Lost to Follow-up|27
1068698|NCT02764697|3462269|P1|Overall Study|Lack of Efficacy|3
1068699|NCT02763189|3462276|P2|Overall Study|Device failure|2
1068700|NCT02763189|3462277|P1|Overall Study|Device failure|0
1068701|NCT02762578|3462364|P2|Overall Study|Unclassified|0
1068702|NCT02762578|3462365|P1|Overall Study|Unclassified|6
1068703|NCT02762578|3462364|P2|Overall Study|Withdrawal by Subject|2
1068704|NCT02762578|3462365|P1|Overall Study|Withdrawal by Subject|4
1068705|NCT02762578|3462364|P2|Overall Study|Protocol Violation|2
1068706|NCT02762578|3462365|P1|Overall Study|Protocol Violation|4
1068707|NCT02762578|3462364|P2|Overall Study|Adverse Event|6
1068708|NCT02762578|3462365|P1|Overall Study|Adverse Event|1
1068709|NCT02762370|3462467|P2|Overall Study|Protocol Violation|0
1068710|NCT02762370|3462468|P1|Overall Study|Protocol Violation|1
1068711|NCT02761980|3462490|P4|Overall Study|Other|0
1068712|NCT02761980|3462491|P3|Overall Study|Other|1
1068713|NCT02761980|3462492|P2|Overall Study|Other|0
1068714|NCT02761980|3462493|P1|Overall Study|Other|0
1068715|NCT02761980|3462490|P4|Overall Study|Withdrawal by Subject|0
1068716|NCT02761980|3462491|P3|Overall Study|Withdrawal by Subject|0
1068717|NCT02761980|3462492|P2|Overall Study|Withdrawal by Subject|1
1068718|NCT02761980|3462493|P1|Overall Study|Withdrawal by Subject|0
1068719|NCT02761980|3462490|P4|Overall Study|Adverse Event|6
1068720|NCT02761980|3462491|P3|Overall Study|Adverse Event|5
1068721|NCT02761980|3462492|P2|Overall Study|Adverse Event|6
1068722|NCT02761980|3462493|P1|Overall Study|Adverse Event|4
1068723|NCT02761733|3462527|P4|Overall Study|Cognitive Impairment|0
1068724|NCT02761733|3462528|P3|Overall Study|Cognitive Impairment|1
1068725|NCT02761733|3462529|P2|Overall Study|Cognitive Impairment|0
1068726|NCT02761733|3462530|P1|Overall Study|Cognitive Impairment|5
1068727|NCT02761733|3462527|P4|Overall Study|Discharged from Study Site|11
1068728|NCT02761733|3462528|P3|Overall Study|Discharged from Study Site|25
1068729|NCT02761733|3462529|P2|Overall Study|Discharged from Study Site|9
1068730|NCT02761733|3462530|P1|Overall Study|Discharged from Study Site|10
1068731|NCT02761733|3462527|P4|Overall Study|Withdrawal by Subject|0
1068732|NCT02761733|3462528|P3|Overall Study|Withdrawal by Subject|0
1068733|NCT02761733|3462529|P2|Overall Study|Withdrawal by Subject|0
1068734|NCT02761733|3462530|P1|Overall Study|Withdrawal by Subject|2
1068735|NCT02761733|3462527|P4|Overall Study|Physician Decision|0
1068736|NCT02761733|3462528|P3|Overall Study|Physician Decision|0
1068737|NCT02761733|3462529|P2|Overall Study|Physician Decision|0
1068738|NCT02761733|3462530|P1|Overall Study|Physician Decision|4
1068739|NCT02761733|3462527|P4|Overall Study|Lost to Follow-up|3
1068740|NCT02761733|3462528|P3|Overall Study|Lost to Follow-up|0
1068741|NCT02761733|3462529|P2|Overall Study|Lost to Follow-up|7
1068742|NCT02761733|3462530|P1|Overall Study|Lost to Follow-up|6
1068743|NCT02761733|3462527|P4|Overall Study|Death|1
1068744|NCT02761733|3462528|P3|Overall Study|Death|1
1068745|NCT02761733|3462529|P2|Overall Study|Death|5
1068746|NCT02761733|3462530|P1|Overall Study|Death|3
1068747|NCT02761642|3462560|P1|Overall Study|Reason Unspecified|21
1068748|NCT02761642|3462560|P1|Overall Study|Physician Decision|1
1068749|NCT02761642|3462560|P1|Overall Study|Lack of Efficacy|20
1068750|NCT02761642|3462560|P1|Overall Study|Death|3
1068751|NCT02761642|3462560|P1|Overall Study|Non-compliant|7
1068752|NCT02761642|3462560|P1|Overall Study|Withdrawal by Subject|2
1068753|NCT02761642|3462560|P1|Overall Study|Adverse Event|13
1068754|NCT02761642|3462560|P1|Overall Study|Did not Receive Study Treatment|3
1068755|NCT02761629|3462573|P2|Overall Study|Randomized But Not Treated|4
1068756|NCT02761629|3462574|P1|Overall Study|Randomized But Not Treated|8
1068757|NCT02761629|3462573|P2|Overall Study|Lost to Follow-up|1
1068758|NCT02761629|3462574|P1|Overall Study|Lost to Follow-up|4
1068759|NCT02761629|3462573|P2|Overall Study|Other|2
1068760|NCT02761629|3462574|P1|Overall Study|Other|0
1068761|NCT02761629|3462573|P2|Overall Study|Withdrawal by Subject|3
1068762|NCT02761629|3462574|P1|Overall Study|Withdrawal by Subject|0
1068763|NCT02761629|3462573|P2|Overall Study|Protocol Violation|2
1068764|NCT02761629|3462574|P1|Overall Study|Protocol Violation|2
1068765|NCT02761629|3462573|P2|Overall Study|Did not Cooperate/Refused Treatment|4
1068766|NCT02761629|3462574|P1|Overall Study|Did not Cooperate/Refused Treatment|2
1068767|NCT02761629|3462573|P2|Overall Study|Failure to Return|4
1068768|NCT02761629|3462574|P1|Overall Study|Failure to Return|2
1068769|NCT02761629|3462573|P2|Overall Study|Insufficient Therapeutic Response|7
1068770|NCT02761629|3462574|P1|Overall Study|Insufficient Therapeutic Response|2
1068771|NCT02761629|3462573|P2|Overall Study|Adverse Event/Intercurrent Illness|5
1068772|NCT02761629|3462574|P1|Overall Study|Adverse Event/Intercurrent Illness|7
1068773|NCT02760927|3462594|P1|Overall Study|Tube Slippage from Device|1
1068774|NCT02760810|3462602|P1|Overall Study|Protocol Violation|1
1068775|NCT02760654|3462610|P2|Overall Study|Withdrawal by Subject|3
1068776|NCT02760654|3462611|P1|Overall Study|Withdrawal by Subject|4
1068777|NCT02760654|3462610|P2|Overall Study|Lost to Follow-up|3
1068778|NCT02760654|3462611|P1|Overall Study|Lost to Follow-up|3
1068779|NCT02760602|3462637|P2|Overall Study|Terminated by sponsor|13
1068780|NCT02760602|3462638|P1|Overall Study|Terminated by sponsor|12
1068781|NCT02760602|3462637|P2|Overall Study|Withdrawal by Subject|0
1068782|NCT02760602|3462638|P1|Overall Study|Withdrawal by Subject|1
1068783|NCT02759692|3462687|P2|Period 2|Test article no longer available|1
1068784|NCT02759692|3462688|P1|Period 2|Test article no longer available|0
1068785|NCT02759692|3462687|P2|Period 2|Lost to Follow-up|0
1068786|NCT02759692|3462688|P1|Period 2|Lost to Follow-up|1
1068787|NCT02759692|3462687|P2|Period 1|Miss-Randomized|1
1068788|NCT02759692|3462688|P1|Period 1|Miss-Randomized|1
1068789|NCT02759692|3462687|P2|Period 1|No longer meets eligibility criteria.|0
1068790|NCT02759692|3462688|P1|Period 1|No longer meets eligibility criteria.|1
1068791|NCT02759692|3462687|P2|Period 1|Test article no longer available|1
1068792|NCT02759692|3462688|P1|Period 1|Test article no longer available|1
1068793|NCT02759562|3462706|P2|Open-Label Treatment Period|Study Terminated by Sponsor|2
1068794|NCT02759562|3462707|P1|Open-Label Treatment Period|Study Terminated by Sponsor|1
1068795|NCT02759562|3462706|P2|Open-Label Treatment Period|Withdrew Consent|0
1068796|NCT02759562|3462707|P1|Open-Label Treatment Period|Withdrew Consent|1
1068797|NCT02759471|3462720|P1|Overall Study|discomfort|2
1068798|NCT02759315|3462735|P5|Overall Study|Study terminated prior to completion|1
1068799|NCT02759315|3462736|P4|Overall Study|Study terminated prior to completion|0
1068800|NCT02759315|3462737|P3|Overall Study|Study terminated prior to completion|5
1068801|NCT02759315|3462738|P2|Overall Study|Study terminated prior to completion|0
1068802|NCT02759315|3462739|P1|Overall Study|Study terminated prior to completion|2
1068803|NCT02759315|3462735|P5|Overall Study|Protocol Violation|0
1068804|NCT02759315|3462736|P4|Overall Study|Protocol Violation|0
1068805|NCT02759315|3462737|P3|Overall Study|Protocol Violation|0
1068806|NCT02759315|3462738|P2|Overall Study|Protocol Violation|1
1068807|NCT02759315|3462739|P1|Overall Study|Protocol Violation|0
1068808|NCT02759315|3462735|P5|Overall Study|Lost to Follow-up|0
1068809|NCT02759315|3462736|P4|Overall Study|Lost to Follow-up|0
1068810|NCT02759315|3462737|P3|Overall Study|Lost to Follow-up|4
1068811|NCT02759315|3462738|P2|Overall Study|Lost to Follow-up|0
1068812|NCT02759315|3462739|P1|Overall Study|Lost to Follow-up|2
1068813|NCT02759315|3462735|P5|Overall Study|Death|0
1068814|NCT02759315|3462736|P4|Overall Study|Death|0
1068815|NCT02759315|3462737|P3|Overall Study|Death|1
1068816|NCT02759315|3462738|P2|Overall Study|Death|0
1068817|NCT02759315|3462739|P1|Overall Study|Death|0
1068818|NCT02759315|3462735|P5|Overall Study|Adverse Event|0
1068819|NCT02759315|3462736|P4|Overall Study|Adverse Event|1
1068820|NCT02759315|3462737|P3|Overall Study|Adverse Event|0
1068821|NCT02759315|3462738|P2|Overall Study|Adverse Event|0
1068822|NCT02759315|3462739|P1|Overall Study|Adverse Event|0
1068823|NCT02758613|3462787|P4|Treatment|Withdrawal by Subject|0
1068824|NCT02758613|3462788|P3|Treatment|Withdrawal by Subject|1
1068825|NCT02758613|3462789|P2|Treatment|Withdrawal by Subject|0
1068826|NCT02758613|3462790|P1|Treatment|Withdrawal by Subject|1
1068827|NCT02758613|3462787|P4|Treatment|Physician and Sponsor Decision|0
1068828|NCT02758613|3462788|P3|Treatment|Physician and Sponsor Decision|0
1068829|NCT02758613|3462789|P2|Treatment|Physician and Sponsor Decision|0
1068830|NCT02758613|3462790|P1|Treatment|Physician and Sponsor Decision|1
1068831|NCT02758171|3462817|P2|Wash-out|Other reason|0
1068832|NCT02758171|3462818|P1|Wash-out|Other reason|1
1068833|NCT02758171|3462817|P2|Wash-out|Withdrawal by Subject|0
1068834|NCT02758171|3462818|P1|Wash-out|Withdrawal by Subject|1
1068835|NCT02757625|3462838|P4|Overall Study|Adverse Event|0
1068836|NCT02757625|3462839|P3|Overall Study|Adverse Event|1
1068837|NCT02757625|3462840|P2|Overall Study|Adverse Event|0
1068838|NCT02757625|3462841|P1|Overall Study|Adverse Event|0
1068839|NCT02757625|3462838|P4|Overall Study|Investigator’s discretion|0
1068840|NCT02757625|3462839|P3|Overall Study|Investigator’s discretion|1
1068841|NCT02757625|3462840|P2|Overall Study|Investigator’s discretion|0
1068842|NCT02757625|3462841|P1|Overall Study|Investigator’s discretion|0
1068843|NCT02756637|3463033|P2|Overall Study|Did not complete curative therapy|0
1068844|NCT02756637|3463034|P1|Overall Study|Did not complete curative therapy|33
1068845|NCT02756637|3463033|P2|Overall Study|No available NLR value|44
1068846|NCT02756637|3463034|P1|Overall Study|No available NLR value|44
1068847|NCT02756637|3463033|P2|Overall Study|Not eligible for initial SWOG study|10
1068848|NCT02756637|3463034|P1|Overall Study|Not eligible for initial SWOG study|10
1068849|NCT02756338|3463066|P1|Overall Study|Device Replaced with Pacemaker|4
1068850|NCT02756338|3463066|P1|Overall Study|Withdrawn by Investigator|1
1068851|NCT02756078|3463075|P2|Period 2|Withdrawal by Subject|1
1068852|NCT02756078|3463076|P1|Period 2|Withdrawal by Subject|3
1068853|NCT02756078|3463075|P2|Period 2|Unsatisfactory Lens Fitting|1
1068854|NCT02756078|3463076|P1|Period 2|Unsatisfactory Lens Fitting|0
1068855|NCT02756078|3463075|P2|Period 2|Adverse Event|5
1068856|NCT02756078|3463076|P1|Period 2|Adverse Event|3
1068857|NCT02756078|3463075|P2|Period 1|Lens Discomfort|2
1068858|NCT02756078|3463076|P1|Period 1|Lens Discomfort|2
1068859|NCT02756078|3463075|P2|Period 1|Withdrawal by Subject|6
1068860|NCT02756078|3463076|P1|Period 1|Withdrawal by Subject|6
1068861|NCT02756078|3463075|P2|Period 1|Adverse Event|10
1068862|NCT02756078|3463076|P1|Period 1|Adverse Event|1
1068863|NCT02756078|3463075|P2|Period 1|Protocol Violation|1
1068864|NCT02756078|3463076|P1|Period 1|Protocol Violation|0
1068865|NCT02756078|3463075|P2|Period 1|Lost to Follow-up|2
1068866|NCT02756078|3463076|P1|Period 1|Lost to Follow-up|0
1068867|NCT02756078|3463075|P2|Period 1|Unsatisfactory Lens Fitting|1
1068868|NCT02756078|3463076|P1|Period 1|Unsatisfactory Lens Fitting|0
1068869|NCT02755805|3463101|P2|Overall Study|Withdrawal by Subject|2
1068870|NCT02755805|3463102|P1|Overall Study|Withdrawal by Subject|0
1068871|NCT02755805|3463101|P2|Overall Study|Refused assessments|0
1068872|NCT02755805|3463102|P1|Overall Study|Refused assessments|1
1068873|NCT02755805|3463101|P2|Overall Study|Lost to Follow-up|2
1068874|NCT02755805|3463102|P1|Overall Study|Lost to Follow-up|1
1068875|NCT02755090|3463116|P2|Overall Study|equipment malfunction|0
1068876|NCT02755090|3463117|P1|Overall Study|equipment malfunction|1
1068877|NCT02754492|3463129|P4|Overall Study|Venous access issues not resulting in AE|4
1068878|NCT02754492|3463130|P3|Overall Study|Venous access issues not resulting in AE|0
1068879|NCT02754492|3463131|P2|Overall Study|Venous access issues not resulting in AE|0
1068880|NCT02754492|3463132|P1|Overall Study|Venous access issues not resulting in AE|0
1068881|NCT02754492|3463129|P4|Overall Study|Adverse Event|13
1068882|NCT02754492|3463130|P3|Overall Study|Adverse Event|0
1068883|NCT02754492|3463131|P2|Overall Study|Adverse Event|0
1068884|NCT02754492|3463132|P1|Overall Study|Adverse Event|0
1068885|NCT02754492|3463129|P4|Overall Study|Equipment malfuntion|5
1068886|NCT02754492|3463130|P3|Overall Study|Equipment malfuntion|2
1068887|NCT02754492|3463131|P2|Overall Study|Equipment malfuntion|0
1068888|NCT02754492|3463132|P1|Overall Study|Equipment malfuntion|0
1068889|NCT02754492|3463129|P4|Overall Study|Withdrawal by Subject|0
1068890|NCT02754492|3463130|P3|Overall Study|Withdrawal by Subject|0
1068891|NCT02754492|3463131|P2|Overall Study|Withdrawal by Subject|0
1068892|NCT02754492|3463132|P1|Overall Study|Withdrawal by Subject|2
1068893|NCT02754492|3463129|P4|Overall Study|Protocol Violation|1
1068894|NCT02754492|3463130|P3|Overall Study|Protocol Violation|0
1068895|NCT02754492|3463131|P2|Overall Study|Protocol Violation|2
1068896|NCT02754492|3463132|P1|Overall Study|Protocol Violation|2
1068897|NCT02754440|3463148|P4|Overall Study|Subject issues not resulting in AE|12
1068898|NCT02754440|3463149|P3|Overall Study|Subject issues not resulting in AE|0
1068899|NCT02754440|3463150|P2|Overall Study|Subject issues not resulting in AE|0
1068900|NCT02754440|3463151|P1|Overall Study|Subject issues not resulting in AE|0
1068901|NCT02754440|3463148|P4|Overall Study|Equipment failure|7
1068902|NCT02754440|3463149|P3|Overall Study|Equipment failure|5
1068903|NCT02754440|3463150|P2|Overall Study|Equipment failure|5
1068904|NCT02754440|3463151|P1|Overall Study|Equipment failure|0
1068905|NCT02754440|3463148|P4|Overall Study|Withdrawal by Subject|1
1068906|NCT02754440|3463149|P3|Overall Study|Withdrawal by Subject|0
1068907|NCT02754440|3463150|P2|Overall Study|Withdrawal by Subject|0
1068908|NCT02754440|3463151|P1|Overall Study|Withdrawal by Subject|0
1068909|NCT02754440|3463148|P4|Overall Study|Adverse Event|9
1068910|NCT02754440|3463149|P3|Overall Study|Adverse Event|0
1068911|NCT02754440|3463150|P2|Overall Study|Adverse Event|1
1068912|NCT02754440|3463151|P1|Overall Study|Adverse Event|3
1068913|NCT02754440|3463148|P4|Overall Study|Protocol Violation|6
1068914|NCT02754440|3463149|P3|Overall Study|Protocol Violation|2
1068915|NCT02754440|3463150|P2|Overall Study|Protocol Violation|2
1068916|NCT02754440|3463151|P1|Overall Study|Protocol Violation|3
1068917|NCT02753946|3463165|P2|Overall Study|Physician Decision|2
1068918|NCT02753946|3463166|P1|Overall Study|Physician Decision|0
1068919|NCT02753946|3463165|P2|Overall Study|Lack of Efficacy|0
1068920|NCT02753946|3463166|P1|Overall Study|Lack of Efficacy|1
1068921|NCT02753946|3463165|P2|Overall Study|Withdrawal by Subject|1
1068922|NCT02753946|3463166|P1|Overall Study|Withdrawal by Subject|6
1068923|NCT02753946|3463165|P2|Overall Study|Adverse Event|6
1068924|NCT02753946|3463166|P1|Overall Study|Adverse Event|7
1068925|NCT02753075|3463246|P3|Overall Study|Physician Decision|0
1068926|NCT02753075|3463247|P2|Overall Study|Physician Decision|1
1068927|NCT02753075|3463248|P1|Overall Study|Physician Decision|3
1068928|NCT02753075|3463246|P3|Overall Study|Withdrawal of Consent|3
1068929|NCT02753075|3463247|P2|Overall Study|Withdrawal of Consent|1
1068930|NCT02753075|3463248|P1|Overall Study|Withdrawal of Consent|1
1068931|NCT02753075|3463246|P3|Overall Study|Lost to Follow-up|0
1068932|NCT02753075|3463247|P2|Overall Study|Lost to Follow-up|0
1068933|NCT02753075|3463248|P1|Overall Study|Lost to Follow-up|2
1068934|NCT02753075|3463246|P3|Overall Study|Adverse Event|0
1068935|NCT02753075|3463247|P2|Overall Study|Adverse Event|1
1068936|NCT02753075|3463248|P1|Overall Study|Adverse Event|2
1068937|NCT02752958|3463273|P1|Overall Study|Other (Reason not specified)|2
1068938|NCT02752958|3463273|P1|Overall Study|Withdrawal by Subject|2
1068939|NCT02752958|3463273|P1|Overall Study|Protocol Violation|1
1068940|NCT02752958|3463273|P1|Overall Study|Lost to Follow-up|1
1068941|NCT02752958|3463273|P1|Overall Study|Adverse Event|3
1068942|NCT02752802|3463344|P2|Overall Study|Contrast Volume Not Collected|0
1068943|NCT02752802|3463345|P1|Overall Study|Contrast Volume Not Collected|1
1068944|NCT02752633|3463354|P1|Overall Study|Withdrawal by Subject|1
1068945|NCT02751450|3463383|P2|Overall Study|Adverse Event|0
1068946|NCT02751450|3463384|P1|Overall Study|Adverse Event|1
1068947|NCT02751424|3463405|P9|Part 2|Adverse Event|0
1068948|NCT02751424|3463406|P8|Part 2|Adverse Event|5
1068949|NCT02751424|3463407|P7|Part 2|Adverse Event|0
1068950|NCT02751424|3463408|P6|Part 2|Adverse Event|0
1068951|NCT02751424|3463409|P5|Part 2|Adverse Event|0
1068952|NCT02751424|3463410|P4|Part 2|Adverse Event|0
1068953|NCT02751424|3463411|P3|Part 2|Adverse Event|0
1068954|NCT02751424|3463412|P2|Part 2|Adverse Event|0
1068955|NCT02751424|3463413|P1|Part 2|Adverse Event|0
1068956|NCT02751320|3463556|P1|Overall Study|Withdrawal by Subject|1
1068957|NCT02751320|3463556|P1|Overall Study|Adverse Event|2
1068958|NCT02750943|3463594|P2|Overall Study|Withdrawal by Subject|7
1068959|NCT02750943|3463595|P1|Overall Study|Withdrawal by Subject|5
1068960|NCT02750943|3463594|P2|Overall Study|Lost to Follow-up|2
1068961|NCT02750943|3463595|P1|Overall Study|Lost to Follow-up|1
1068962|NCT02750930|3463609|P1|Overall Study|Study closed/terminated|8
1068963|NCT02750813|3463621|P2|Period 1, First 14 Days of Wear|Reason not given|1
1068964|NCT02750813|3463622|P1|Period 1, First 14 Days of Wear|Reason not given|0
1068965|NCT02750813|3463621|P2|Period 1, First 14 Days of Wear|Withdrawal by Subject|0
1068966|NCT02750813|3463622|P1|Period 1, First 14 Days of Wear|Withdrawal by Subject|1
1068967|NCT02750709|3463631|P6|Treatment Period 1|Adverse Event|1
1068968|NCT02750709|3463632|P5|Treatment Period 1|Adverse Event|0
1068969|NCT02750709|3463633|P4|Treatment Period 1|Adverse Event|0
1068970|NCT02750709|3463634|P3|Treatment Period 1|Adverse Event|0
1068971|NCT02750709|3463635|P2|Treatment Period 1|Adverse Event|0
1068972|NCT02750709|3463636|P1|Treatment Period 1|Adverse Event|0
1068973|NCT02750501|3463678|P1|Overall Study|Non-compliant use of PERT|1
1068974|NCT02750501|3463678|P1|Overall Study|G-tube came out|1
1068975|NCT02750501|3463678|P1|Overall Study|Protocol Violation|1
1068976|NCT02750501|3463678|P1|Overall Study|Physician Decision|1
1068977|NCT02750501|3463678|P1|Overall Study|Adverse Event|4
1068978|NCT02750345|3463690|P6|Intervention 1|Adverse Event|0
1068979|NCT02750345|3463691|P5|Intervention 1|Adverse Event|1
1068980|NCT02750345|3463692|P4|Intervention 1|Adverse Event|0
1068981|NCT02750345|3463693|P3|Intervention 1|Adverse Event|0
1068982|NCT02750345|3463694|P2|Intervention 1|Adverse Event|0
1068983|NCT02750345|3463695|P1|Intervention 1|Adverse Event|0
1068984|NCT02750332|3463721|P2|Treatment Period 1|Withdrawal by Subject|1
1068985|NCT02750332|3463722|P1|Treatment Period 1|Withdrawal by Subject|0
1068986|NCT02749370|3463781|P1|Overall Study|Lost to Follow-up|3
1068987|NCT02749370|3463781|P1|Overall Study|Withdrawal by Subject|11
1068988|NCT02748213|3463870|P2|Overall Study|Not Specified|29
1068989|NCT02748213|3463871|P1|Overall Study|Not Specified|30
1068990|NCT02748213|3463870|P2|Overall Study|Failure to Return|0
1068991|NCT02748213|3463871|P1|Overall Study|Failure to Return|1
1068992|NCT02748213|3463870|P2|Overall Study|Refused Treatment*|6
1068993|NCT02748213|3463871|P1|Overall Study|Refused Treatment*|6
1068994|NCT02748213|3463870|P2|Overall Study|Protocol Violation|4
1068995|NCT02748213|3463871|P1|Overall Study|Protocol Violation|6
1068996|NCT02748213|3463870|P2|Overall Study|Violation of Selection Criteria|0
1068997|NCT02748213|3463871|P1|Overall Study|Violation of Selection Criteria|2
1068998|NCT02748213|3463870|P2|Overall Study|Insufficient Therapeutic Response|57
1068999|NCT02748213|3463871|P1|Overall Study|Insufficient Therapeutic Response|56
1069000|NCT02748213|3463870|P2|Overall Study|Death|3
1069001|NCT02748213|3463871|P1|Overall Study|Death|5
1069002|NCT02748213|3463870|P2|Overall Study|Adverse Event or Intercurrent Illness|11
1069003|NCT02748213|3463871|P1|Overall Study|Adverse Event or Intercurrent Illness|5
1069004|NCT02748213|3463870|P2|Overall Study|Abnormal Laboratory Test|0
1069005|NCT02748213|3463871|P1|Overall Study|Abnormal Laboratory Test|1
1069006|NCT02748213|3463870|P2|Overall Study|Withdrawal Prior to Treatment|2
1069007|NCT02748213|3463871|P1|Overall Study|Withdrawal Prior to Treatment|1
1069008|NCT02748057|3463889|P2|Overall Study|Withdrawal by Subject|0
1069009|NCT02748057|3463890|P1|Overall Study|Withdrawal by Subject|1
1069010|NCT02748057|3463889|P2|Overall Study|Participant Moved|0
1069011|NCT02748057|3463890|P1|Overall Study|Participant Moved|1
1069012|NCT02748057|3463889|P2|Overall Study|Protocol Violation|1
1069013|NCT02748057|3463890|P1|Overall Study|Protocol Violation|2
1069014|NCT02748057|3463889|P2|Overall Study|Physician Decision|1
1069015|NCT02748057|3463890|P1|Overall Study|Physician Decision|0
1069016|NCT02748057|3463889|P2|Overall Study|Adverse Event|0
1069017|NCT02748057|3463890|P1|Overall Study|Adverse Event|1
1069018|NCT02746679|3463929|P2|Overall Study|Lost to Follow-up|6
1069019|NCT02746679|3463930|P1|Overall Study|Lost to Follow-up|4
1069020|NCT02745392|3464014|P4|Overall Study|Lost to Follow-up|0
1069021|NCT02745392|3464015|P3|Overall Study|Lost to Follow-up|0
1069022|NCT02745392|3464016|P2|Overall Study|Lost to Follow-up|1
1069023|NCT02745392|3464017|P1|Overall Study|Lost to Follow-up|0
1069024|NCT02744755|3464033|P2|Study Period 2|Lack of Efficacy|2
1069025|NCT02744755|3464034|P1|Study Period 2|Lack of Efficacy|3
1069026|NCT02744755|3464033|P2|Study Period 2|Withdrawal by Subject|2
1069027|NCT02744755|3464034|P1|Study Period 2|Withdrawal by Subject|2
1069028|NCT02744755|3464033|P2|Study Period 2|Lost to Follow-up|2
1069029|NCT02744755|3464034|P1|Study Period 2|Lost to Follow-up|0
1069030|NCT02744755|3464033|P2|Study Period 2|not defined|2
1069031|NCT02744755|3464034|P1|Study Period 2|not defined|3
1069032|NCT02744755|3464033|P2|Study Period 2|Protocol Violation|0
1069033|NCT02744755|3464034|P1|Study Period 2|Protocol Violation|1
1069034|NCT02744755|3464033|P2|Study Period 2|Adverse Event|0
1069035|NCT02744755|3464034|P1|Study Period 2|Adverse Event|5
1069036|NCT02744755|3464033|P2|Study Period 1|Withdrawal by Subject|4
1069037|NCT02744755|3464034|P1|Study Period 1|Withdrawal by Subject|8
1069038|NCT02744755|3464033|P2|Study Period 1|Lack of Efficacy|0
1069039|NCT02744755|3464034|P1|Study Period 1|Lack of Efficacy|1
1069040|NCT02744755|3464033|P2|Study Period 1|Lost to Follow-up|1
1069041|NCT02744755|3464034|P1|Study Period 1|Lost to Follow-up|1
1069042|NCT02744755|3464033|P2|Study Period 1|Adverse Event|1
1069043|NCT02744755|3464034|P1|Study Period 1|Adverse Event|1
1069044|NCT02744755|3464033|P2|Study Period 1|Pregnancy|0
1069045|NCT02744755|3464034|P1|Study Period 1|Pregnancy|1
1069046|NCT02744755|3464033|P2|Study Period 1|not defined|1
1069047|NCT02744755|3464034|P1|Study Period 1|not defined|0
1069048|NCT02744755|3464033|P2|Study Period 1|Protocol Violation|1
1069049|NCT02744755|3464034|P1|Study Period 1|Protocol Violation|2
1069050|NCT02744066|3464090|P2|Overall Study|Discharged from NICU prior to completion|4
1069051|NCT02744066|3464091|P1|Overall Study|Discharged from NICU prior to completion|0
1069052|NCT02744066|3464090|P2|Overall Study|Withdrawal by parent|1
1069053|NCT02744066|3464091|P1|Overall Study|Withdrawal by parent|0
1069054|NCT02743962|3464101|P2|Overall Study|Atrophic vaginitis diagnosed|0
1069055|NCT02743962|3464102|P1|Overall Study|Atrophic vaginitis diagnosed|1
1069056|NCT02743780|3464137|P5|Part 3 (7 Days)|Adverse Event|0
1069057|NCT02743780|3464138|P4|Part 3 (7 Days)|Adverse Event|0
1069058|NCT02743780|3464139|P3|Part 3 (7 Days)|Adverse Event|1
1069059|NCT02743780|3464140|P2|Part 3 (7 Days)|Adverse Event|0
1069060|NCT02743780|3464141|P1|Part 3 (7 Days)|Adverse Event|0
1069061|NCT02743117|3464231|P2|Overall Study|Other|0
1069062|NCT02743117|3464232|P1|Overall Study|Other|1
1069063|NCT02743117|3464231|P2|Overall Study|Lost to Follow-up|1
1069064|NCT02743117|3464232|P1|Overall Study|Lost to Follow-up|0
1069065|NCT02742818|3464257|P2|Overall Study|Protocol Violation|1
1069066|NCT02742818|3464258|P1|Overall Study|Protocol Violation|0
1069067|NCT02742818|3464257|P2|Overall Study|Adverse Event|1
1069068|NCT02742818|3464258|P1|Overall Study|Adverse Event|0
1069069|NCT02742649|3464275|P5|Open-Label Period|Lost to Follow-up|1
1069070|NCT02742649|3464276|P4|Open-Label Period|Lost to Follow-up|0
1069071|NCT02742649|3464277|P3|Open-Label Period|Lost to Follow-up|0
1069072|NCT02742649|3464278|P2|Open-Label Period|Lost to Follow-up|0
1069073|NCT02742649|3464279|P1|Open-Label Period|Lost to Follow-up|0
1069074|NCT02742649|3464275|P5|Double-Blind Treatment Period|Adverse Event|0
1069075|NCT02742649|3464276|P4|Double-Blind Treatment Period|Adverse Event|0
1069076|NCT02742649|3464277|P3|Double-Blind Treatment Period|Adverse Event|0
1069077|NCT02742649|3464278|P2|Double-Blind Treatment Period|Adverse Event|1
1069078|NCT02742649|3464279|P1|Double-Blind Treatment Period|Adverse Event|0
1069079|NCT02742649|3464275|P5|Pre-Randomization Washout Period|Washout/Randomization Failure|0
1069080|NCT02742649|3464276|P4|Pre-Randomization Washout Period|Washout/Randomization Failure|0
1069081|NCT02742649|3464277|P3|Pre-Randomization Washout Period|Washout/Randomization Failure|0
1069082|NCT02742649|3464278|P2|Pre-Randomization Washout Period|Washout/Randomization Failure|0
1069083|NCT02742649|3464279|P1|Pre-Randomization Washout Period|Washout/Randomization Failure|5
1069084|NCT02742519|3464307|P3|Part 2 Open Label Period (32 Weeks)|Other|1
1069085|NCT02742519|3464308|P2|Part 2 Open Label Period (32 Weeks)|Other|0
1069086|NCT02742519|3464309|P1|Part 2 Open Label Period (32 Weeks)|Other|0
1069087|NCT02742519|3464307|P3|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9
1069088|NCT02742519|3464308|P2|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0
1069089|NCT02742519|3464309|P1|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0
1069090|NCT02742519|3464307|P3|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0
1069091|NCT02742519|3464308|P2|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1
1069092|NCT02742519|3464309|P1|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1
1069093|NCT02742441|3464329|P2|Overall Study|Adverse Event|2
1069094|NCT02742441|3464330|P1|Overall Study|Adverse Event|0
1069095|NCT02742441|3464329|P2|Overall Study|Withdrawal by Subject|2
1069096|NCT02742441|3464330|P1|Overall Study|Withdrawal by Subject|2
1069097|NCT02742441|3464329|P2|Overall Study|Lost to Follow-up|4
1069098|NCT02742441|3464330|P1|Overall Study|Lost to Follow-up|4
1069099|NCT02741713|3464348|P2|Overall Study|Surgery type changed intra-operatively|1
1069100|NCT02741713|3464349|P1|Overall Study|Surgery type changed intra-operatively|2
1069101|NCT02741245|3464413|P5|Overall Study|Withdrawal by Subject|0
1069102|NCT02741245|3464414|P4|Overall Study|Withdrawal by Subject|1
1069103|NCT02741245|3464415|P3|Overall Study|Withdrawal by Subject|0
1069104|NCT02741245|3464416|P2|Overall Study|Withdrawal by Subject|0
1069105|NCT02741245|3464417|P1|Overall Study|Withdrawal by Subject|0
1069106|NCT02741245|3464413|P5|Overall Study|Protocol Violation|0
1069107|NCT02741245|3464414|P4|Overall Study|Protocol Violation|1
1069108|NCT02741245|3464415|P3|Overall Study|Protocol Violation|0
1069109|NCT02741245|3464416|P2|Overall Study|Protocol Violation|1
1069110|NCT02741245|3464417|P1|Overall Study|Protocol Violation|0
1069111|NCT02741245|3464413|P5|Overall Study|Adverse Event|2
1069112|NCT02741245|3464414|P4|Overall Study|Adverse Event|2
1069113|NCT02741245|3464415|P3|Overall Study|Adverse Event|0
1069114|NCT02741245|3464416|P2|Overall Study|Adverse Event|0
1069115|NCT02741245|3464417|P1|Overall Study|Adverse Event|0
1069116|NCT02739997|3464519|P1|Overall Study|Withdrawal by Subject|1
1069117|NCT02739997|3464519|P1|Overall Study|Death|1
1069118|NCT02739984|3464533|P2|Overall Study|Lost to Follow-up|0
1069119|NCT02739984|3464534|P1|Overall Study|Lost to Follow-up|3
1069120|NCT02739984|3464533|P2|Overall Study|Death|1
1069121|NCT02739984|3464534|P1|Overall Study|Death|0
1069122|NCT02739984|3464533|P2|Overall Study|Withdrawal by Subject|1
1069123|NCT02739984|3464534|P1|Overall Study|Withdrawal by Subject|1
1069124|NCT02739984|3464533|P2|Overall Study|Sponsor Decision|0
1069125|NCT02739984|3464534|P1|Overall Study|Sponsor Decision|1
1069126|NCT02739594|3464593|P2|Overall Study|Not Specified|2
1069127|NCT02739594|3464594|P1|Overall Study|Not Specified|6
1069128|NCT02739594|3464593|P2|Overall Study|Elevated Serum Creatinine|1
1069129|NCT02739594|3464594|P1|Overall Study|Elevated Serum Creatinine|0
1069130|NCT02739594|3464593|P2|Overall Study|Lost to Follow-up|1
1069131|NCT02739594|3464594|P1|Overall Study|Lost to Follow-up|0
1069132|NCT02739594|3464593|P2|Overall Study|Withdrawal by Subject|1
1069133|NCT02739594|3464594|P1|Overall Study|Withdrawal by Subject|1
1069134|NCT02739594|3464593|P2|Overall Study|Administrative Reasons|3
1069135|NCT02739594|3464594|P1|Overall Study|Administrative Reasons|1
1069136|NCT02739594|3464593|P2|Overall Study|Renal Insufficiency|6
1069137|NCT02739594|3464594|P1|Overall Study|Renal Insufficiency|4
1069138|NCT02739594|3464593|P2|Overall Study|Death|2
1069139|NCT02739594|3464594|P1|Overall Study|Death|4
1069140|NCT02739594|3464593|P2|Overall Study|Protocol Violation|6
1069141|NCT02739594|3464594|P1|Overall Study|Protocol Violation|5
1069142|NCT02739594|3464593|P2|Overall Study|Violation of Eligibility Criteria|2
1069143|NCT02739594|3464594|P1|Overall Study|Violation of Eligibility Criteria|1
1069144|NCT02739594|3464593|P2|Overall Study|Undesired Event|4
1069145|NCT02739594|3464594|P1|Overall Study|Undesired Event|3
1069146|NCT02739321|3464626|P2|Overall Study|Withdrawal by Subject|2
1069147|NCT02739321|3464627|P1|Overall Study|Withdrawal by Subject|1
1069148|NCT02739321|3464626|P2|Overall Study|Lost to Follow-up|1
1069149|NCT02739321|3464627|P1|Overall Study|Lost to Follow-up|1
1069150|NCT02739321|3464626|P2|Overall Study|Lack of Efficacy|1
1069151|NCT02739321|3464627|P1|Overall Study|Lack of Efficacy|1
1069152|NCT02738333|3464690|P3|Overall Study|Lost to Follow-up|0
1069153|NCT02738333|3464691|P2|Overall Study|Lost to Follow-up|0
1069154|NCT02738333|3464692|P1|Overall Study|Lost to Follow-up|1
1069155|NCT02738333|3464690|P3|Overall Study|Death|0
1069156|NCT02738333|3464691|P2|Overall Study|Death|0
1069157|NCT02738333|3464692|P1|Overall Study|Death|1
1069158|NCT02738203|3464781|P2|Overall Study|Protocol Violation|1
1069159|NCT02738203|3464782|P1|Overall Study|Protocol Violation|0
1069160|NCT02738203|3464781|P2|Overall Study|Failed IUD Insertion|2
1069161|NCT02738203|3464782|P1|Overall Study|Failed IUD Insertion|2
1069162|NCT02738151|3464798|P2|Overall Study|Other than specified above|21
1069163|NCT02738151|3464799|P1|Overall Study|Other than specified above|11
1069164|NCT02738151|3464798|P2|Overall Study|Poor Compliance to Protocol|3
1069165|NCT02738151|3464799|P1|Overall Study|Poor Compliance to Protocol|4
1069166|NCT02738151|3464798|P2|Overall Study|Hypoglycemia|1
1069167|NCT02738151|3464799|P1|Overall Study|Hypoglycemia|0
1069168|NCT02738151|3464798|P2|Overall Study|Adverse Event|5
1069169|NCT02738151|3464799|P1|Overall Study|Adverse Event|4
1069170|NCT02738151|3464798|P2|Overall Study|Randomized but not treated|1
1069171|NCT02738151|3464799|P1|Overall Study|Randomized but not treated|4
1069172|NCT02738138|3464843|P2|Overall Study|Other - not further specified|0
1069173|NCT02738138|3464844|P1|Overall Study|Other - not further specified|1
1069174|NCT02738138|3464843|P2|Overall Study|Lost to Follow-up|0
1069175|NCT02738138|3464844|P1|Overall Study|Lost to Follow-up|2
1069176|NCT02738138|3464843|P2|Overall Study|Adverse Event|1
1069177|NCT02738138|3464844|P1|Overall Study|Adverse Event|0
1069178|NCT02737852|3464851|P1|Overall Study|Withdrawal by Subject|2
1069179|NCT02737618|3464861|P1|Overall Study|Withdrawal by Subject|9
1069180|NCT02737592|3464866|P1|Overall Study|Withdrawal by Subject|1
1069181|NCT02736721|3464904|P1|Overall Study|Other|5
1069182|NCT02736721|3464904|P1|Overall Study|Lost to Follow-up|3
1069183|NCT02736721|3464904|P1|Overall Study|Adverse Event|8
1069184|NCT02735200|3464926|P2|Overall Study|Withdrawal by Subject|0
1069185|NCT02735200|3464927|P1|Overall Study|Withdrawal by Subject|8
1069186|NCT02735200|3464926|P2|Overall Study|Lost to Follow-up|5
1069187|NCT02735200|3464927|P1|Overall Study|Lost to Follow-up|0
1069188|NCT02734810|3464975|P2|Overall Study|Lack of Efficacy|0
1069189|NCT02734810|3464976|P1|Overall Study|Lack of Efficacy|1
1069190|NCT02734810|3464975|P2|Overall Study|Adverse Event|0
1069191|NCT02734810|3464976|P1|Overall Study|Adverse Event|1
1069192|NCT02734212|3465017|P2|Overall Study|Lost to Follow-up|10
1069193|NCT02734212|3465018|P1|Overall Study|Lost to Follow-up|5
1069194|NCT02732639|3465061|P1|Overall Study|Lost to Follow-up|1
1069195|NCT02732561|3465074|P2|Overall Study|Withdrawal by Subject|0
1069196|NCT02732561|3465075|P1|Overall Study|Withdrawal by Subject|1
1069197|NCT02732561|3465074|P2|Overall Study|Lost to Follow-up|1
1069198|NCT02732561|3465075|P1|Overall Study|Lost to Follow-up|1
1069199|NCT02732327|3465085|P2|Overall Study|Protocol Violation|1
1069200|NCT02732327|3465086|P1|Overall Study|Protocol Violation|0
1069201|NCT02732210|3465094|P2|Overall Study|Missing|8
1069202|NCT02732210|3465095|P1|Overall Study|Missing|0
1069203|NCT02732210|3465094|P2|Overall Study|Other|103
1069204|NCT02732210|3465095|P1|Overall Study|Other|35
1069205|NCT02732210|3465094|P2|Overall Study|Death|15
1069206|NCT02732210|3465095|P1|Overall Study|Death|4
1069207|NCT02732210|3465094|P2|Overall Study|Lost to Follow-up|57
1069208|NCT02732210|3465095|P1|Overall Study|Lost to Follow-up|5
1069209|NCT02732210|3465094|P2|Overall Study|Withdrawal by Subject|87
1069210|NCT02732210|3465095|P1|Overall Study|Withdrawal by Subject|28
1069211|NCT02732210|3465094|P2|Overall Study|Study Ended|13
1069212|NCT02732210|3465095|P1|Overall Study|Study Ended|13
1069213|NCT02732210|3465094|P2|Overall Study|Site Closed|11
1069214|NCT02732210|3465095|P1|Overall Study|Site Closed|0
1069215|NCT02731131|3465147|P2|Overall Study|Refused Therapy|1
1069216|NCT02731131|3465148|P1|Overall Study|Refused Therapy|0
1069217|NCT02731131|3465147|P2|Overall Study|Psychiatric Disorder|1
1069218|NCT02731131|3465148|P1|Overall Study|Psychiatric Disorder|0
1069219|NCT02730819|3465164|P1|Overall Study|Lost to Follow-up|9
1069220|NCT02730728|3465173|P3|Overall Study|Lack of Efficacy|1
1069221|NCT02730728|3465174|P2|Overall Study|Lack of Efficacy|1
1069222|NCT02730728|3465175|P1|Overall Study|Lack of Efficacy|0
1069223|NCT02730728|3465173|P3|Overall Study|Withdrawal by Subject|0
1069224|NCT02730728|3465174|P2|Overall Study|Withdrawal by Subject|1
1069225|NCT02730728|3465175|P1|Overall Study|Withdrawal by Subject|0
1069226|NCT02730598|3465194|P2|Overall Study|Unrelated Injury affecting outcomes.|0
1069227|NCT02730598|3465195|P1|Overall Study|Unrelated Injury affecting outcomes.|1
1069228|NCT02730598|3465194|P2|Overall Study|Protocol Violation|1
1069229|NCT02730598|3465195|P1|Overall Study|Protocol Violation|0
1069230|NCT02730598|3465194|P2|Overall Study|Withdrawal by Subject|3
1069231|NCT02730598|3465195|P1|Overall Study|Withdrawal by Subject|3
1069232|NCT02730351|3465215|P2|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0
1069233|NCT02730351|3465216|P1|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1
1069234|NCT02730351|3465215|P2|Treatment Period 2 (2 Weeks)|Adverse Event|0
1069235|NCT02730351|3465216|P1|Treatment Period 2 (2 Weeks)|Adverse Event|1
1069236|NCT02730351|3465215|P2|Wash-out Period (2 Weeks)|Withdrawal by Subject|0
1069237|NCT02730351|3465216|P1|Wash-out Period (2 Weeks)|Withdrawal by Subject|1
1069238|NCT02730351|3465215|P2|Wash-out Period (2 Weeks)|Protocol Violation|1
1069239|NCT02730351|3465216|P1|Wash-out Period (2 Weeks)|Protocol Violation|0
1069240|NCT02730351|3465215|P2|Treatment Period 1 (2 Weeks)|Adverse Event|0
1069241|NCT02730351|3465216|P1|Treatment Period 1 (2 Weeks)|Adverse Event|1
1069242|NCT02729753|3465239|P2|Overall Study|Device Malfunction. No units in stock.|1
1069243|NCT02729753|3465240|P1|Overall Study|Device Malfunction. No units in stock.|0
1069244|NCT02728089|3465378|P1|Overall Study|Withdrawal by Subject|1
1069245|NCT02728089|3465378|P1|Overall Study|Physician Decision|2
1069246|NCT02726022|3465468|P1|Overall Study|Treatment Failure and Poor Compliance|1
1069247|NCT02726022|3465468|P1|Overall Study|Poor Compliance|13
1069248|NCT02726022|3465468|P1|Overall Study|Treatment Failure|8
1069249|NCT02726022|3465468|P1|Overall Study|Adverse Event|14
1069250|NCT02725788|3465479|P2|Overall Study|Protocol Violation|1
1069251|NCT02725788|3465480|P1|Overall Study|Protocol Violation|0
1069252|NCT02725788|3465479|P2|Overall Study|Lost to Follow-up|1
1069253|NCT02725788|3465480|P1|Overall Study|Lost to Follow-up|1
1069254|NCT02725476|3465488|P2|Overall Study|Adverse Event|1
1069255|NCT02725476|3465489|P1|Overall Study|Adverse Event|1
1069256|NCT02725476|3465488|P2|Overall Study|Physician Decision|0
1069257|NCT02725476|3465489|P1|Overall Study|Physician Decision|2
1069258|NCT02724644|3465499|P2|Overall Study|Administrative|0
1069259|NCT02724644|3465500|P1|Overall Study|Administrative|1
1069260|NCT02724644|3465499|P2|Overall Study|Withdrawal by Subject|1
1069261|NCT02724644|3465500|P1|Overall Study|Withdrawal by Subject|7
1069262|NCT02724644|3465499|P2|Overall Study|Lost to Follow-up|2
1069263|NCT02724644|3465500|P1|Overall Study|Lost to Follow-up|6
1069264|NCT02724644|3465499|P2|Overall Study|Adverse Event|1
1069265|NCT02724644|3465500|P1|Overall Study|Adverse Event|7
1069266|NCT02724111|3465534|P2|Overall Study|Protocol Violation|5
1069267|NCT02724111|3465535|P1|Overall Study|Protocol Violation|2
1069268|NCT02723201|3465558|P3|Second Intervention Period|Adverse Event|0
1069269|NCT02723201|3465559|P2|Second Intervention Period|Adverse Event|0
1069270|NCT02723201|3465560|P1|Second Intervention Period|Adverse Event|1
1069271|NCT02723201|3465558|P3|Second Intervention Period|Protocol Violation|0
1069272|NCT02723201|3465559|P2|Second Intervention Period|Protocol Violation|0
1069273|NCT02723201|3465560|P1|Second Intervention Period|Protocol Violation|1
1069274|NCT02723188|3465619|P3|Overall Study|Withdrawal by Subject|0
1069275|NCT02723188|3465620|P2|Overall Study|Withdrawal by Subject|0
1069276|NCT02723188|3465621|P1|Overall Study|Withdrawal by Subject|1
1069277|NCT02723175|3465634|P2|Overall Study|Lost to 3 Month Follow Up|1
1069278|NCT02723175|3465635|P1|Overall Study|Lost to 3 Month Follow Up|1
1069279|NCT02723175|3465634|P2|Overall Study|Lost to 1 Month Follow Up|2
1069280|NCT02723175|3465635|P1|Overall Study|Lost to 1 Month Follow Up|3
1069281|NCT02722967|3465678|P3|Overall Study|Non-adherence of the patch to the skin|2
1069282|NCT02722967|3465679|P2|Overall Study|Non-adherence of the patch to the skin|0
1069283|NCT02722967|3465680|P1|Overall Study|Non-adherence of the patch to the skin|0
1069284|NCT02722967|3465678|P3|Overall Study|Physician Decision|0
1069285|NCT02722967|3465679|P2|Overall Study|Physician Decision|0
1069286|NCT02722967|3465680|P1|Overall Study|Physician Decision|1
1069287|NCT02722967|3465678|P3|Overall Study|Withdrawal by Subject|1
1069288|NCT02722967|3465679|P2|Overall Study|Withdrawal by Subject|0
1069289|NCT02722967|3465680|P1|Overall Study|Withdrawal by Subject|1
1069290|NCT02722967|3465678|P3|Overall Study|Non-compliance with patch wearing|1
1069291|NCT02722967|3465679|P2|Overall Study|Non-compliance with patch wearing|1
1069292|NCT02722967|3465680|P1|Overall Study|Non-compliance with patch wearing|2
1069293|NCT02722967|3465678|P3|Overall Study|Lost to Follow-up|0
1069294|NCT02722967|3465679|P2|Overall Study|Lost to Follow-up|1
1069295|NCT02722967|3465680|P1|Overall Study|Lost to Follow-up|0
1069296|NCT02722967|3465678|P3|Overall Study|Adverse Event|0
1069297|NCT02722967|3465679|P2|Overall Study|Adverse Event|0
1069298|NCT02722967|3465680|P1|Overall Study|Adverse Event|1
1069299|NCT02722278|3465712|P2|Overall Study|Site closure not study related|1
1069300|NCT02722278|3465713|P1|Overall Study|Site closure not study related|0
1069301|NCT02722278|3465712|P2|Overall Study|Subject declined after tx assignment|1
1069302|NCT02722278|3465713|P1|Overall Study|Subject declined after tx assignment|0
1069303|NCT02722278|3465712|P2|Overall Study|High PSA pre-study/ not eligible|1
1069304|NCT02722278|3465713|P1|Overall Study|High PSA pre-study/ not eligible|0
1069305|NCT02722278|3465712|P2|Overall Study|Protocol Violation|0
1069306|NCT02722278|3465713|P1|Overall Study|Protocol Violation|1
1069307|NCT02722278|3465712|P2|Overall Study|Lost to Follow-up|0
1069308|NCT02722278|3465713|P1|Overall Study|Lost to Follow-up|2
1069309|NCT02722278|3465712|P2|Overall Study|Adverse Event|1
1069310|NCT02722278|3465713|P1|Overall Study|Adverse Event|4
1069311|NCT02722278|3465712|P2|Overall Study|Withdrawal by Subject|3
1069312|NCT02722278|3465713|P1|Overall Study|Withdrawal by Subject|5
1069313|NCT02722044|3465737|P1|Overall Study|Did Not Meet Criteria at Week 14|1
1069314|NCT02722044|3465737|P1|Overall Study|Withdrawal by Subject|1
1069315|NCT02722044|3465737|P1|Overall Study|Physician Decision|1
1069316|NCT02722044|3465737|P1|Overall Study|Adverse Event|2
1069317|NCT02721875|3465766|P2|Overall Study|Progressive disease/relapse|0
1069318|NCT02721875|3465767|P1|Overall Study|Progressive disease/relapse|1
1069319|NCT02721147|3465818|P3|Overall Study|Lost to Follow-up|0
1069320|NCT02721147|3465819|P2|Overall Study|Lost to Follow-up|0
1069321|NCT02721147|3465820|P1|Overall Study|Lost to Follow-up|2
1069322|NCT02720510|3465866|P2|Overall Study|Physician Decision|2
1069323|NCT02720510|3465867|P1|Overall Study|Physician Decision|1
1069324|NCT02720510|3465866|P2|Overall Study|Adverse Event|1
1069325|NCT02720510|3465867|P1|Overall Study|Adverse Event|0
1069326|NCT02720510|3465866|P2|Overall Study|Study Terminated by the sponsor|0
1069327|NCT02720510|3465867|P1|Overall Study|Study Terminated by the sponsor|2
1069328|NCT02720081|3465909|P2|Overall Study|Protocol Violation|1
1069329|NCT02720081|3465910|P1|Overall Study|Protocol Violation|4
1069330|NCT02720081|3465909|P2|Overall Study|Adverse Event|3
1069331|NCT02720081|3465910|P1|Overall Study|Adverse Event|0
1069332|NCT02718898|3465968|P2|Overall Study|Lost to Follow-up|0
1069333|NCT02718898|3465969|P1|Overall Study|Lost to Follow-up|2
1069334|NCT02718898|3465968|P2|Overall Study|Lack of Efficacy|0
1069335|NCT02718898|3465969|P1|Overall Study|Lack of Efficacy|1
1069336|NCT02718898|3465968|P2|Overall Study|Physician Decision|0
1069337|NCT02718898|3465969|P1|Overall Study|Physician Decision|1
1069338|NCT02718898|3465968|P2|Overall Study|Adverse Event|1
1069339|NCT02718898|3465969|P1|Overall Study|Adverse Event|5
1069340|NCT02717754|3466076|P6|Overall Study|Incorrect Infusion Duration|20
1069341|NCT02717754|3466077|P5|Overall Study|Incorrect Infusion Duration|20
1069342|NCT02717754|3466078|P4|Overall Study|Incorrect Infusion Duration|10
1069343|NCT02717754|3466079|P3|Overall Study|Incorrect Infusion Duration|0
1069344|NCT02717754|3466080|P2|Overall Study|Incorrect Infusion Duration|0
1069345|NCT02717754|3466081|P1|Overall Study|Incorrect Infusion Duration|0
1069346|NCT02716779|3466133|P3|Combination Therapy|Adverse Event|1
1069347|NCT02716779|3466134|P2|Combination Therapy|Adverse Event|2
1069348|NCT02716779|3466135|P1|Combination Therapy|Adverse Event|0
1069349|NCT02716779|3466133|P3|Monotherapy|Adverse Event|1
1069350|NCT02716779|3466134|P2|Monotherapy|Adverse Event|1
1069351|NCT02716779|3466135|P1|Monotherapy|Adverse Event|0
1069352|NCT02716298|3466208|P2|First Intervention (1 Month)|Lens discomfort|1
1069353|NCT02716298|3466209|P1|First Intervention (1 Month)|Lens discomfort|1
1069354|NCT02716194|3466227|P3|Period 1 - ADVATE|Withdrawal by Subject|0
1069355|NCT02716194|3466228|P2|Period 1 - ADVATE|Withdrawal by Subject|1
1069356|NCT02716194|3466229|P1|Period 1 - ADVATE|Withdrawal by Subject|1
1069357|NCT02714062|3466319|P3|Overall Study|Protocol Violation|0
1069358|NCT02714062|3466320|P2|Overall Study|Protocol Violation|1
1069359|NCT02714062|3466321|P1|Overall Study|Protocol Violation|0
1069360|NCT02714062|3466319|P3|Overall Study|Withdrawal by Subject|1
1069361|NCT02714062|3466320|P2|Overall Study|Withdrawal by Subject|0
1069362|NCT02714062|3466321|P1|Overall Study|Withdrawal by Subject|1
1069363|NCT02714062|3466319|P3|Overall Study|Adverse Event|2
1069364|NCT02714062|3466320|P2|Overall Study|Adverse Event|0
1069365|NCT02714062|3466321|P1|Overall Study|Adverse Event|0
1069366|NCT02713594|3466380|P2|Overall Study|Lost to Follow-up|374
1069367|NCT02713594|3466381|P1|Overall Study|Lost to Follow-up|358
1069368|NCT02713594|3466380|P2|Overall Study|Withdrawal by Subject|22
1069369|NCT02713594|3466381|P1|Overall Study|Withdrawal by Subject|32
1069370|NCT02712333|3466399|P2|First Period|Withdrawal by Subject|2
1069371|NCT02712333|3466400|P1|First Period|Withdrawal by Subject|3
1069372|NCT02712320|3466418|P1|Overall Study|Treating with the prohibited medications|2
1069373|NCT02712320|3466418|P1|Overall Study|Transferred to another facility|1
1069374|NCT02712320|3466418|P1|Overall Study|Withdrawal by Subject|1
1069375|NCT02712320|3466418|P1|Overall Study|Lost to Follow-up|1
1069376|NCT02712008|3466461|P8|From Week 12 up to Week 36|Withdrawal by Subject|2
1069377|NCT02712008|3466462|P7|From Week 12 up to Week 36|Withdrawal by Subject|3
1069378|NCT02712008|3466463|P6|From Week 12 up to Week 36|Withdrawal by Subject|0
1069379|NCT02712008|3466464|P5|From Week 12 up to Week 36|Withdrawal by Subject|0
1069380|NCT02712008|3466465|P4|From Week 12 up to Week 36|Withdrawal by Subject|0
1069381|NCT02712008|3466466|P3|From Week 12 up to Week 36|Withdrawal by Subject|0
1069382|NCT02712008|3466467|P2|From Week 12 up to Week 36|Withdrawal by Subject|0
1069383|NCT02712008|3466468|P1|From Week 12 up to Week 36|Withdrawal by Subject|0
1069384|NCT02712008|3466461|P8|From Week 12 up to Week 36|Physician Decision|0
1069385|NCT02712008|3466462|P7|From Week 12 up to Week 36|Physician Decision|0
1069386|NCT02712008|3466463|P6|From Week 12 up to Week 36|Physician Decision|0
1069387|NCT02712008|3466464|P5|From Week 12 up to Week 36|Physician Decision|1
1069388|NCT02712008|3466465|P4|From Week 12 up to Week 36|Physician Decision|1
1069389|NCT02712008|3466466|P3|From Week 12 up to Week 36|Physician Decision|0
1069390|NCT02712008|3466467|P2|From Week 12 up to Week 36|Physician Decision|0
1069391|NCT02712008|3466468|P1|From Week 12 up to Week 36|Physician Decision|0
1069392|NCT02712008|3466461|P8|From Week 12 up to Week 36|Lost to Follow-up|0
1069393|NCT02712008|3466462|P7|From Week 12 up to Week 36|Lost to Follow-up|1
1069394|NCT02712008|3466463|P6|From Week 12 up to Week 36|Lost to Follow-up|0
1069395|NCT02712008|3466464|P5|From Week 12 up to Week 36|Lost to Follow-up|0
1069396|NCT02712008|3466465|P4|From Week 12 up to Week 36|Lost to Follow-up|1
1069397|NCT02712008|3466466|P3|From Week 12 up to Week 36|Lost to Follow-up|0
1069398|NCT02712008|3466467|P2|From Week 12 up to Week 36|Lost to Follow-up|0
1069399|NCT02712008|3466468|P1|From Week 12 up to Week 36|Lost to Follow-up|0
1069400|NCT02712008|3466461|P8|From Week 12 up to Week 36|Death|0
1069401|NCT02712008|3466462|P7|From Week 12 up to Week 36|Death|1
1069402|NCT02712008|3466463|P6|From Week 12 up to Week 36|Death|0
1069403|NCT02712008|3466464|P5|From Week 12 up to Week 36|Death|0
1069404|NCT02712008|3466465|P4|From Week 12 up to Week 36|Death|0
1069405|NCT02712008|3466466|P3|From Week 12 up to Week 36|Death|0
1069406|NCT02712008|3466467|P2|From Week 12 up to Week 36|Death|0
1069407|NCT02712008|3466468|P1|From Week 12 up to Week 36|Death|1
1069408|NCT02712008|3466461|P8|From Week 12 up to Week 36|Adverse Event|2
1069409|NCT02712008|3466462|P7|From Week 12 up to Week 36|Adverse Event|0
1069410|NCT02712008|3466463|P6|From Week 12 up to Week 36|Adverse Event|0
1069411|NCT02712008|3466464|P5|From Week 12 up to Week 36|Adverse Event|1
1069412|NCT02712008|3466465|P4|From Week 12 up to Week 36|Adverse Event|0
1069413|NCT02712008|3466466|P3|From Week 12 up to Week 36|Adverse Event|0
1069414|NCT02712008|3466467|P2|From Week 12 up to Week 36|Adverse Event|0
1069415|NCT02712008|3466468|P1|From Week 12 up to Week 36|Adverse Event|0
1069416|NCT02712008|3466461|P8|Baseline (Day 1) up to Week 12|Other Unspecified|0
1069417|NCT02712008|3466462|P7|Baseline (Day 1) up to Week 12|Other Unspecified|0
1069418|NCT02712008|3466463|P6|Baseline (Day 1) up to Week 12|Other Unspecified|0
1069419|NCT02712008|3466464|P5|Baseline (Day 1) up to Week 12|Other Unspecified|0
1069420|NCT02712008|3466465|P4|Baseline (Day 1) up to Week 12|Other Unspecified|0
1069421|NCT02712008|3466466|P3|Baseline (Day 1) up to Week 12|Other Unspecified|0
1069422|NCT02712008|3466467|P2|Baseline (Day 1) up to Week 12|Other Unspecified|1
1069423|NCT02712008|3466468|P1|Baseline (Day 1) up to Week 12|Other Unspecified|0
1069424|NCT02712008|3466461|P8|Baseline (Day 1) up to Week 12|Protocol Violation|0
1069425|NCT02712008|3466462|P7|Baseline (Day 1) up to Week 12|Protocol Violation|0
1069426|NCT02712008|3466463|P6|Baseline (Day 1) up to Week 12|Protocol Violation|0
1069427|NCT02712008|3466464|P5|Baseline (Day 1) up to Week 12|Protocol Violation|0
1069428|NCT02712008|3466465|P4|Baseline (Day 1) up to Week 12|Protocol Violation|0
1069429|NCT02712008|3466466|P3|Baseline (Day 1) up to Week 12|Protocol Violation|1
1069430|NCT02712008|3466467|P2|Baseline (Day 1) up to Week 12|Protocol Violation|0
1069431|NCT02712008|3466468|P1|Baseline (Day 1) up to Week 12|Protocol Violation|0
1069432|NCT02712008|3466461|P8|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
1069433|NCT02712008|3466462|P7|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
1069434|NCT02712008|3466463|P6|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
1069435|NCT02712008|3466464|P5|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
1069436|NCT02712008|3466465|P4|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
1069437|NCT02712008|3466466|P3|Baseline (Day 1) up to Week 12|Lost to Follow-up|2
1069438|NCT02712008|3466467|P2|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
1069439|NCT02712008|3466468|P1|Baseline (Day 1) up to Week 12|Lost to Follow-up|1
1069440|NCT02712008|3466461|P8|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
1069441|NCT02712008|3466462|P7|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
1069442|NCT02712008|3466463|P6|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
1069443|NCT02712008|3466464|P5|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
1069444|NCT02712008|3466465|P4|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
1069445|NCT02712008|3466466|P3|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1
1069446|NCT02712008|3466467|P2|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2
1069447|NCT02712008|3466468|P1|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
1069448|NCT02712008|3466461|P8|Baseline (Day 1) up to Week 12|Death|0
1069449|NCT02712008|3466462|P7|Baseline (Day 1) up to Week 12|Death|0
1069450|NCT02712008|3466463|P6|Baseline (Day 1) up to Week 12|Death|0
1069451|NCT02712008|3466464|P5|Baseline (Day 1) up to Week 12|Death|0
1069452|NCT02712008|3466465|P4|Baseline (Day 1) up to Week 12|Death|0
1069453|NCT02712008|3466466|P3|Baseline (Day 1) up to Week 12|Death|0
1069454|NCT02712008|3466467|P2|Baseline (Day 1) up to Week 12|Death|0
1069455|NCT02712008|3466468|P1|Baseline (Day 1) up to Week 12|Death|3
1069456|NCT02711995|3466500|P1|Washout (90 Days)|Conflicting medication|1
1069457|NCT02710292|3466575|P2|Period 1, First 10 Days of Wear|Withdrawal by Subject|2
1069458|NCT02710292|3466576|P1|Period 1, First 10 Days of Wear|Withdrawal by Subject|1
1069459|NCT02710292|3466575|P2|Period 1, First 10 Days of Wear|Adverse Event|1
1069460|NCT02710292|3466576|P1|Period 1, First 10 Days of Wear|Adverse Event|0
1069461|NCT02710136|3466585|P2|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0
1069462|NCT02710136|3466586|P1|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1
1069463|NCT02709785|3466612|P3|Overall Study|Withdrawal by Subject|1
1069464|NCT02709785|3466613|P2|Overall Study|Withdrawal by Subject|2
1069465|NCT02709785|3466614|P1|Overall Study|Withdrawal by Subject|1
1069466|NCT02709577|3466636|P4|Overall Study|Withdrawal by Subject|0
1069467|NCT02709577|3466637|P3|Overall Study|Withdrawal by Subject|2
1069468|NCT02709577|3466638|P2|Overall Study|Withdrawal by Subject|3
1069469|NCT02709577|3466639|P1|Overall Study|Withdrawal by Subject|2
1069470|NCT02709577|3466636|P4|Overall Study|procedural complication|0
1069471|NCT02709577|3466637|P3|Overall Study|procedural complication|0
1069472|NCT02709577|3466638|P2|Overall Study|procedural complication|1
1069473|NCT02709577|3466639|P1|Overall Study|procedural complication|0
1069474|NCT02709577|3466636|P4|Overall Study|non-accommodating anatomy|0
1069475|NCT02709577|3466637|P3|Overall Study|non-accommodating anatomy|0
1069476|NCT02709577|3466638|P2|Overall Study|non-accommodating anatomy|1
1069477|NCT02709577|3466639|P1|Overall Study|non-accommodating anatomy|0
1069478|NCT02709538|3466654|P3|Overall Study|Other|5
1069479|NCT02709538|3466655|P2|Overall Study|Other|7
1069480|NCT02709538|3466656|P1|Overall Study|Other|16
1069481|NCT02709538|3466654|P3|Overall Study|Withdrawal by Parent or Legal Guardian|0
1069482|NCT02709538|3466655|P2|Overall Study|Withdrawal by Parent or Legal Guardian|0
1069483|NCT02709538|3466656|P1|Overall Study|Withdrawal by Parent or Legal Guardian|1
1069484|NCT02709538|3466654|P3|Overall Study|Protocol deviation|4
1069485|NCT02709538|3466655|P2|Overall Study|Protocol deviation|4
1069486|NCT02709538|3466656|P1|Overall Study|Protocol deviation|10
1069487|NCT02709538|3466654|P3|Overall Study|Non-compliance with study drug|0
1069488|NCT02709538|3466655|P2|Overall Study|Non-compliance with study drug|0
1069489|NCT02709538|3466656|P1|Overall Study|Non-compliance with study drug|2
1069490|NCT02709538|3466654|P3|Overall Study|Non-compliance with study procedures|0
1069491|NCT02709538|3466655|P2|Overall Study|Non-compliance with study procedures|0
1069492|NCT02709538|3466656|P1|Overall Study|Non-compliance with study procedures|5
1069493|NCT02709538|3466654|P3|Overall Study|Withdrawal by Subject|4
1069494|NCT02709538|3466655|P2|Overall Study|Withdrawal by Subject|7
1069495|NCT02709538|3466656|P1|Overall Study|Withdrawal by Subject|40
1069496|NCT02709538|3466654|P3|Overall Study|Physician Decision|0
1069497|NCT02709538|3466655|P2|Overall Study|Physician Decision|0
1069498|NCT02709538|3466656|P1|Overall Study|Physician Decision|1
1069499|NCT02709538|3466654|P3|Overall Study|Lost to Follow-up|4
1069500|NCT02709538|3466655|P2|Overall Study|Lost to Follow-up|8
1069501|NCT02709538|3466656|P1|Overall Study|Lost to Follow-up|24
1069502|NCT02709538|3466654|P3|Overall Study|Lack of Efficacy|0
1069503|NCT02709538|3466655|P2|Overall Study|Lack of Efficacy|0
1069504|NCT02709538|3466656|P1|Overall Study|Lack of Efficacy|1
1069505|NCT02709538|3466654|P3|Overall Study|Adverse Event|3
1069506|NCT02709538|3466655|P2|Overall Study|Adverse Event|2
1069507|NCT02709538|3466656|P1|Overall Study|Adverse Event|13
1069508|NCT02709330|3466664|P2|Overall Study|Withdrawal by Subject|0
1069509|NCT02709330|3466665|P1|Overall Study|Withdrawal by Subject|4
1069510|NCT02709330|3466664|P2|Overall Study|Physician Decision|0
1069511|NCT02709330|3466665|P1|Overall Study|Physician Decision|2
1069512|NCT02709330|3466664|P2|Overall Study|Lost to Follow-up|0
1069513|NCT02709330|3466665|P1|Overall Study|Lost to Follow-up|2
1069514|NCT02709330|3466664|P2|Overall Study|Death|0
1069515|NCT02709330|3466665|P1|Overall Study|Death|5
1069516|NCT02709096|3466679|P2|Overall Study|non-compliance|1
1069517|NCT02709096|3466680|P1|Overall Study|non-compliance|1
1069518|NCT02709083|3466686|P1|Overall Study|Original PI left institution|7
1069519|NCT02709005|3466699|P2|Overall Study|Withdrawal by Subject|0
1069520|NCT02709005|3466700|P1|Overall Study|Withdrawal by Subject|3
1069521|NCT02709005|3466699|P2|Overall Study|Lost to Follow-up|1
1069522|NCT02709005|3466700|P1|Overall Study|Lost to Follow-up|1
1069523|NCT02708524|3466732|P4|Overall Study|Subject lost study lens|0
1069524|NCT02708524|3466733|P3|Overall Study|Subject lost study lens|0
1069525|NCT02708524|3466734|P2|Overall Study|Subject lost study lens|0
1069526|NCT02708524|3466735|P1|Overall Study|Subject lost study lens|1
1069527|NCT02708524|3466732|P4|Overall Study|Did not wear lens at final visit|0
1069528|NCT02708524|3466733|P3|Overall Study|Did not wear lens at final visit|0
1069529|NCT02708524|3466734|P2|Overall Study|Did not wear lens at final visit|1
1069530|NCT02708524|3466735|P1|Overall Study|Did not wear lens at final visit|0
1069531|NCT02708524|3466732|P4|Overall Study|Dispensed incorrect study lens|0
1069532|NCT02708524|3466733|P3|Overall Study|Dispensed incorrect study lens|1
1069533|NCT02708524|3466734|P2|Overall Study|Dispensed incorrect study lens|1
1069534|NCT02708524|3466735|P1|Overall Study|Dispensed incorrect study lens|0
1069535|NCT02708524|3466732|P4|Overall Study|Withdrawal by Subject|0
1069536|NCT02708524|3466733|P3|Overall Study|Withdrawal by Subject|0
1069537|NCT02708524|3466734|P2|Overall Study|Withdrawal by Subject|1
1069538|NCT02708524|3466735|P1|Overall Study|Withdrawal by Subject|1
1069539|NCT02708524|3466732|P4|Overall Study|Protocol Violation|0
1069540|NCT02708524|3466733|P3|Overall Study|Protocol Violation|0
1069541|NCT02708524|3466734|P2|Overall Study|Protocol Violation|1
1069542|NCT02708524|3466735|P1|Overall Study|Protocol Violation|0
1069543|NCT02708524|3466732|P4|Overall Study|Lost to Follow-up|0
1069544|NCT02708524|3466733|P3|Overall Study|Lost to Follow-up|1
1069545|NCT02708524|3466734|P2|Overall Study|Lost to Follow-up|1
1069546|NCT02708524|3466735|P1|Overall Study|Lost to Follow-up|1
1069547|NCT02708524|3466732|P4|Overall Study|Lens Discomfort|0
1069548|NCT02708524|3466733|P3|Overall Study|Lens Discomfort|1
1069549|NCT02708524|3466734|P2|Overall Study|Lens Discomfort|0
1069550|NCT02708524|3466735|P1|Overall Study|Lens Discomfort|1
1069551|NCT02708524|3466732|P4|Overall Study|Adverse Event|0
1069552|NCT02708524|3466733|P3|Overall Study|Adverse Event|0
1069553|NCT02708524|3466734|P2|Overall Study|Adverse Event|1
1069554|NCT02708524|3466735|P1|Overall Study|Adverse Event|0
1069555|NCT02708485|3466783|P2|Overall Study|Withdrawal by Subject|2
1069556|NCT02708485|3466784|P1|Overall Study|Withdrawal by Subject|3
1069557|NCT02708355|3466804|P3|Overall Study|Adverse Event|0
1069558|NCT02708355|3466805|P2|Overall Study|Adverse Event|0
1069559|NCT02708355|3466806|P1|Overall Study|Adverse Event|1
1069560|NCT02708277|3466819|P2|Overall Study|Lost to Follow-up|4
1069561|NCT02708277|3466820|P1|Overall Study|Lost to Follow-up|7
1069562|NCT02708095|3466864|P3|Overall Study|Withdrawal by Subject|4
1069563|NCT02708095|3466865|P2|Overall Study|Withdrawal by Subject|3
1069564|NCT02708095|3466866|P1|Overall Study|Withdrawal by Subject|5
1069565|NCT02708095|3466864|P3|Overall Study|Protocol Violation|1
1069566|NCT02708095|3466865|P2|Overall Study|Protocol Violation|0
1069567|NCT02708095|3466866|P1|Overall Study|Protocol Violation|0
1069568|NCT02708095|3466864|P3|Overall Study|Physician Decision|2
1069569|NCT02708095|3466865|P2|Overall Study|Physician Decision|3
1069570|NCT02708095|3466866|P1|Overall Study|Physician Decision|2
1069571|NCT02708095|3466864|P3|Overall Study|Lost to Follow-up|0
1069572|NCT02708095|3466865|P2|Overall Study|Lost to Follow-up|0
1069573|NCT02708095|3466866|P1|Overall Study|Lost to Follow-up|2
1069574|NCT02708095|3466864|P3|Overall Study|Lack of Efficacy|0
1069575|NCT02708095|3466865|P2|Overall Study|Lack of Efficacy|3
1069576|NCT02708095|3466866|P1|Overall Study|Lack of Efficacy|9
1069577|NCT02708095|3466864|P3|Overall Study|Adverse Event|11
1069578|NCT02708095|3466865|P2|Overall Study|Adverse Event|10
1069579|NCT02708095|3466866|P1|Overall Study|Adverse Event|4
1069580|NCT02707952|3466891|P4|Overall Study|Withdrawal by Subject|0
1069581|NCT02707952|3466892|P3|Overall Study|Withdrawal by Subject|2
1069582|NCT02707952|3466893|P2|Overall Study|Withdrawal by Subject|1
1069583|NCT02707952|3466894|P1|Overall Study|Withdrawal by Subject|0
1069584|NCT02707952|3466891|P4|Overall Study|Lost to Follow-up|0
1069585|NCT02707952|3466892|P3|Overall Study|Lost to Follow-up|0
1069586|NCT02707952|3466893|P2|Overall Study|Lost to Follow-up|0
1069587|NCT02707952|3466894|P1|Overall Study|Lost to Follow-up|1
1069588|NCT02707952|3466891|P4|Overall Study|Adverse Event|0
1069589|NCT02707952|3466892|P3|Overall Study|Adverse Event|0
1069590|NCT02707952|3466893|P2|Overall Study|Adverse Event|0
1069591|NCT02707952|3466894|P1|Overall Study|Adverse Event|1
1069592|NCT02707640|3466915|P2|Overall Study|Sponsor Discretion|0
1069593|NCT02707640|3466916|P1|Overall Study|Sponsor Discretion|1
1069594|NCT02707640|3466915|P2|Overall Study|Participant's Personal Decision|2
1069595|NCT02707640|3466916|P1|Overall Study|Participant's Personal Decision|1
1069596|NCT02707640|3466915|P2|Overall Study|Withdrawal by Subject|1
1069597|NCT02707640|3466916|P1|Overall Study|Withdrawal by Subject|0
1069598|NCT02707640|3466915|P2|Overall Study|Physician Decision|0
1069599|NCT02707640|3466916|P1|Overall Study|Physician Decision|2
1069600|NCT02707640|3466915|P2|Overall Study|Death|2
1069601|NCT02707640|3466916|P1|Overall Study|Death|1
1069602|NCT02707640|3466915|P2|Overall Study|Adverse Event|2
1069603|NCT02707640|3466916|P1|Overall Study|Adverse Event|4
1069604|NCT02707601|3466936|P2|Overall Study|Participants Randomized but Not Treated|0
1069605|NCT02707601|3466937|P1|Overall Study|Participants Randomized but Not Treated|2
1069606|NCT02707601|3466936|P2|Overall Study|Lost to Follow-up|1
1069607|NCT02707601|3466937|P1|Overall Study|Lost to Follow-up|1
1069608|NCT02707601|3466936|P2|Overall Study|Withdrew Consent|1
1069609|NCT02707601|3466937|P1|Overall Study|Withdrew Consent|0
1069610|NCT02707601|3466936|P2|Overall Study|Investigator's Discretion|0
1069611|NCT02707601|3466937|P1|Overall Study|Investigator's Discretion|1
1069612|NCT02707601|3466936|P2|Overall Study|Lack of Efficacy|1
1069613|NCT02707601|3466937|P1|Overall Study|Lack of Efficacy|0
1069614|NCT02707601|3466936|P2|Overall Study|Death|1
1069615|NCT02707601|3466937|P1|Overall Study|Death|0
1069616|NCT02706899|3466958|P2|Overall Study|Study Termination by Sponsor|6
1069617|NCT02706899|3466959|P1|Overall Study|Study Termination by Sponsor|4
1069618|NCT02706899|3466958|P2|Overall Study|Death|0
1069619|NCT02706899|3466959|P1|Overall Study|Death|8
1069620|NCT02706899|3466958|P2|Overall Study|Withdrawal by Subject|0
1069621|NCT02706899|3466959|P1|Overall Study|Withdrawal by Subject|1
1069622|NCT02706834|3466978|P11|Overall Study|Other Reason Not Specified|0
1069623|NCT02706834|3466979|P10|Overall Study|Other Reason Not Specified|0
1069624|NCT02706834|3466980|P9|Overall Study|Other Reason Not Specified|0
1069625|NCT02706834|3466981|P8|Overall Study|Other Reason Not Specified|0
1069626|NCT02706834|3466982|P7|Overall Study|Other Reason Not Specified|0
1069627|NCT02706834|3466983|P6|Overall Study|Other Reason Not Specified|0
1069628|NCT02706834|3466984|P5|Overall Study|Other Reason Not Specified|1
1069629|NCT02706834|3466985|P4|Overall Study|Other Reason Not Specified|0
1069630|NCT02706834|3466986|P3|Overall Study|Other Reason Not Specified|0
1069631|NCT02706834|3466987|P2|Overall Study|Other Reason Not Specified|0
1069632|NCT02706834|3466988|P1|Overall Study|Other Reason Not Specified|1
1069633|NCT02706834|3466978|P11|Overall Study|Voluntary Withdrawal|0
1069634|NCT02706834|3466979|P10|Overall Study|Voluntary Withdrawal|1
1069635|NCT02706834|3466980|P9|Overall Study|Voluntary Withdrawal|0
1069636|NCT02706834|3466981|P8|Overall Study|Voluntary Withdrawal|0
1069637|NCT02706834|3466982|P7|Overall Study|Voluntary Withdrawal|0
1069638|NCT02706834|3466983|P6|Overall Study|Voluntary Withdrawal|0
1069639|NCT02706834|3466984|P5|Overall Study|Voluntary Withdrawal|0
1069640|NCT02706834|3466985|P4|Overall Study|Voluntary Withdrawal|0
1069641|NCT02706834|3466986|P3|Overall Study|Voluntary Withdrawal|0
1069642|NCT02706834|3466987|P2|Overall Study|Voluntary Withdrawal|0
1069643|NCT02706834|3466988|P1|Overall Study|Voluntary Withdrawal|1
1069644|NCT02706834|3466978|P11|Overall Study|Lost to Follow-up|0
1069645|NCT02706834|3466979|P10|Overall Study|Lost to Follow-up|0
1069646|NCT02706834|3466980|P9|Overall Study|Lost to Follow-up|0
1069647|NCT02706834|3466981|P8|Overall Study|Lost to Follow-up|0
1069648|NCT02706834|3466982|P7|Overall Study|Lost to Follow-up|0
1069649|NCT02706834|3466983|P6|Overall Study|Lost to Follow-up|0
1069650|NCT02706834|3466984|P5|Overall Study|Lost to Follow-up|0
1069651|NCT02706834|3466985|P4|Overall Study|Lost to Follow-up|0
1069652|NCT02706834|3466986|P3|Overall Study|Lost to Follow-up|1
1069653|NCT02706834|3466987|P2|Overall Study|Lost to Follow-up|0
1069654|NCT02706834|3466988|P1|Overall Study|Lost to Follow-up|0
1069655|NCT02706834|3466978|P11|Overall Study|Pretreatment Event/Adverse Event|1
1069656|NCT02706834|3466979|P10|Overall Study|Pretreatment Event/Adverse Event|0
1069657|NCT02706834|3466980|P9|Overall Study|Pretreatment Event/Adverse Event|0
1069658|NCT02706834|3466981|P8|Overall Study|Pretreatment Event/Adverse Event|0
1069659|NCT02706834|3466982|P7|Overall Study|Pretreatment Event/Adverse Event|0
1069660|NCT02706834|3466983|P6|Overall Study|Pretreatment Event/Adverse Event|0
1069661|NCT02706834|3466984|P5|Overall Study|Pretreatment Event/Adverse Event|0
1069662|NCT02706834|3466985|P4|Overall Study|Pretreatment Event/Adverse Event|0
1069663|NCT02706834|3466986|P3|Overall Study|Pretreatment Event/Adverse Event|0
1069664|NCT02706834|3466987|P2|Overall Study|Pretreatment Event/Adverse Event|1
1069665|NCT02706834|3466988|P1|Overall Study|Pretreatment Event/Adverse Event|0
1069666|NCT02706717|3467132|P2|Overall Study|Death|1
1069667|NCT02706717|3467133|P1|Overall Study|Death|0
1069668|NCT02706717|3467132|P2|Overall Study|Physician Decision|1
1069669|NCT02706717|3467133|P1|Overall Study|Physician Decision|0
1069670|NCT02706717|3467132|P2|Overall Study|Lost to Follow-up|1
1069671|NCT02706717|3467133|P1|Overall Study|Lost to Follow-up|0
1069672|NCT02706717|3467132|P2|Overall Study|Withdrawal by Subject|8
1069673|NCT02706717|3467133|P1|Overall Study|Withdrawal by Subject|1
1069674|NCT02706327|3467154|P3|Overall Study|Lost to Follow-up|2
1069675|NCT02706327|3467155|P2|Overall Study|Lost to Follow-up|1
1069676|NCT02706327|3467156|P1|Overall Study|Lost to Follow-up|1
1069677|NCT02705716|3467208|P2|Overall Study|Withdrawal of Consent|1
1069678|NCT02705716|3467209|P1|Overall Study|Withdrawal of Consent|1
1069679|NCT02705716|3467208|P2|Overall Study|Protocol Violation|0
1069680|NCT02705716|3467209|P1|Overall Study|Protocol Violation|3
1069681|NCT02705716|3467208|P2|Overall Study|Adverse Event|1
1069682|NCT02705716|3467209|P1|Overall Study|Adverse Event|0
1069683|NCT02704689|3467273|P1|Overall Study|Study device not implanted|2
1069684|NCT02704689|3467273|P1|Overall Study|Physician Decision|1
1069685|NCT02702193|3467363|P2|12 Month Follow up|Lost to Follow-up|18
1069686|NCT02702193|3467364|P1|12 Month Follow up|Lost to Follow-up|16
1069687|NCT02702193|3467363|P2|12 Month Follow up|Withdrawal by Subject|0
1069688|NCT02702193|3467364|P1|12 Month Follow up|Withdrawal by Subject|1
1069689|NCT02702193|3467363|P2|8 Month Follow up|Lost to Follow-up|18
1069690|NCT02702193|3467364|P1|8 Month Follow up|Lost to Follow-up|14
1069691|NCT02702193|3467363|P2|8 Month Follow up|Withdrawal by Subject|0
1069692|NCT02702193|3467364|P1|8 Month Follow up|Withdrawal by Subject|1
1069693|NCT02702193|3467363|P2|4 Month Follow up|Lost to Follow-up|18
1069694|NCT02702193|3467364|P1|4 Month Follow up|Lost to Follow-up|17
1069695|NCT02702193|3467363|P2|4 Month Follow up|Withdrawal by Subject|0
1069696|NCT02702193|3467364|P1|4 Month Follow up|Withdrawal by Subject|1
1069697|NCT02702193|3467363|P2|Baseline Assessment/Randomization|Withdrawal by Subject|0
1069698|NCT02702193|3467364|P1|Baseline Assessment/Randomization|Withdrawal by Subject|1
1069699|NCT02702011|3467392|P4|Overall Study|Withdrawal by Subject|0
1069700|NCT02702011|3467393|P3|Overall Study|Withdrawal by Subject|0
1069701|NCT02702011|3467394|P2|Overall Study|Withdrawal by Subject|1
1069702|NCT02702011|3467395|P1|Overall Study|Withdrawal by Subject|0
1069703|NCT02701985|3467407|P2|Overall Study|Adverse Event|5
1069704|NCT02701985|3467408|P1|Overall Study|Adverse Event|0
1069705|NCT02701985|3467407|P2|Overall Study|Death|0
1069706|NCT02701985|3467408|P1|Overall Study|Death|1
1069707|NCT02701985|3467407|P2|Overall Study|Lost to Follow-up|0
1069708|NCT02701985|3467408|P1|Overall Study|Lost to Follow-up|1
1069709|NCT02701985|3467407|P2|Overall Study|Withdrawal by Subject|1
1069710|NCT02701985|3467408|P1|Overall Study|Withdrawal by Subject|1
1069711|NCT02701634|3467451|P2|Overall Study|Randomized but not treated|0
1069712|NCT02701634|3467452|P1|Overall Study|Randomized but not treated|1
1069713|NCT02701634|3467451|P2|Overall Study|Withdrew Consent|7
1069714|NCT02701634|3467452|P1|Overall Study|Withdrew Consent|6
1069715|NCT02701634|3467451|P2|Overall Study|Study terminated by Sponsor|17
1069716|NCT02701634|3467452|P1|Overall Study|Study terminated by Sponsor|15
1069717|NCT02701634|3467451|P2|Overall Study|Investigator's Discretion|4
1069718|NCT02701634|3467452|P1|Overall Study|Investigator's Discretion|7
1069719|NCT02701634|3467451|P2|Overall Study|Death|0
1069720|NCT02701634|3467452|P1|Overall Study|Death|1
1069721|NCT02701634|3467451|P2|Overall Study|Adverse Event|3
1069722|NCT02701634|3467452|P1|Overall Study|Adverse Event|2
1069723|NCT02701361|3467497|P3|Overall Study|incarceration|1
1069724|NCT02701361|3467498|P2|Overall Study|incarceration|0
1069725|NCT02701361|3467499|P1|Overall Study|incarceration|0
1069726|NCT02701361|3467497|P3|Overall Study|timed out in rehab center|0
1069727|NCT02701361|3467498|P2|Overall Study|timed out in rehab center|1
1069728|NCT02701361|3467499|P1|Overall Study|timed out in rehab center|0
1069729|NCT02701361|3467497|P3|Overall Study|Withdrawal by Subject|0
1069730|NCT02701361|3467498|P2|Overall Study|Withdrawal by Subject|0
1069731|NCT02701361|3467499|P1|Overall Study|Withdrawal by Subject|4
1069732|NCT02701361|3467497|P3|Overall Study|Lost to Follow-up|1
1069733|NCT02701361|3467498|P2|Overall Study|Lost to Follow-up|2
1069734|NCT02701361|3467499|P1|Overall Study|Lost to Follow-up|5
1069735|NCT02701296|3467540|P2|Overall Study|Incomplete Data|2
1069736|NCT02701296|3467541|P1|Overall Study|Incomplete Data|0
1069737|NCT02700997|3467591|P1|Overall Study|No CT measurement - pelvic calcification|1
1069738|NCT02700997|3467591|P1|Overall Study|Did not undergo CT imaging|1
1069739|NCT02699892|3467595|P1|Overall Study|Other|36
1069740|NCT02699684|3467600|P2|Period 2, Second 30 Days of Wear|Adverse Event|0
1069741|NCT02699684|3467601|P1|Period 2, Second 30 Days of Wear|Adverse Event|1
1069742|NCT02699593|3467618|P2|Period 2|Torn Contact Lens|0
1069743|NCT02699593|3467619|P1|Period 2|Torn Contact Lens|1
1069744|NCT02699593|3467618|P2|Period 2|Lost Contact Lens|1
1069745|NCT02699593|3467619|P1|Period 2|Lost Contact Lens|0
1069746|NCT02699593|3467618|P2|Period 2|Adverse Event|1
1069747|NCT02699593|3467619|P1|Period 2|Adverse Event|1
1069748|NCT02699593|3467618|P2|Period 1|Adverse Event|1
1069749|NCT02699593|3467619|P1|Period 1|Adverse Event|1
1069750|NCT02699593|3467618|P2|Period 1|Withdrawal by Subject|1
1069751|NCT02699593|3467619|P1|Period 1|Withdrawal by Subject|0
1069752|NCT02699593|3467618|P2|Period 1|Protocol Violation|1
1069753|NCT02699593|3467619|P1|Period 1|Protocol Violation|0
1069754|NCT02699593|3467618|P2|Period 1|Torn Contact Len|3
1069755|NCT02699593|3467619|P1|Period 1|Torn Contact Len|4
1069756|NCT02699593|3467618|P2|Period 1|Unsatisfactory Visual Response|1
1069757|NCT02699593|3467619|P1|Period 1|Unsatisfactory Visual Response|0
1069758|NCT02698436|3467636|P2|Overall Study|Non-compliance with study regimen|0
1069759|NCT02698436|3467637|P1|Overall Study|Non-compliance with study regimen|1
1069760|NCT02698436|3467636|P2|Overall Study|Lost to Follow-up|4
1069761|NCT02698436|3467637|P1|Overall Study|Lost to Follow-up|2
1069762|NCT02698436|3467636|P2|Overall Study|Withdrawal by Subject|3
1069763|NCT02698436|3467637|P1|Overall Study|Withdrawal by Subject|3
1069764|NCT02698436|3467636|P2|Overall Study|Adverse Event|0
1069765|NCT02698436|3467637|P1|Overall Study|Adverse Event|1
1069766|NCT02698423|3467677|P2|Overall Study|Lost to Follow-up|24
1069767|NCT02698423|3467678|P1|Overall Study|Lost to Follow-up|19
1069768|NCT02698176|3467689|P4|Overall Study|Clinical progression|0
1069769|NCT02698176|3467690|P3|Overall Study|Clinical progression|0
1069770|NCT02698176|3467691|P2|Overall Study|Clinical progression|0
1069771|NCT02698176|3467692|P1|Overall Study|Clinical progression|3
1069772|NCT02698176|3467689|P4|Overall Study|Adverse Event|0
1069773|NCT02698176|3467690|P3|Overall Study|Adverse Event|0
1069774|NCT02698176|3467691|P2|Overall Study|Adverse Event|0
1069775|NCT02698176|3467692|P1|Overall Study|Adverse Event|2
1069776|NCT02698176|3467689|P4|Overall Study|Progressive disease|0
1069777|NCT02698176|3467690|P3|Overall Study|Progressive disease|1
1069778|NCT02698176|3467691|P2|Overall Study|Progressive disease|3
1069779|NCT02698176|3467692|P1|Overall Study|Progressive disease|4
1069780|NCT02696317|3467751|P2|Period 2, 10 Days of Wear|Withdrawal by Subject|0
1069781|NCT02696317|3467752|P1|Period 2, 10 Days of Wear|Withdrawal by Subject|1
1069782|NCT02696317|3467751|P2|Habitual, 10 Days of Wear|Withdrawal by Subject|4
1069783|NCT02696317|3467752|P1|Habitual, 10 Days of Wear|Withdrawal by Subject|2
1069784|NCT02696226|3467796|P4|Overall Study|Study terminated - lack of enrollment|0
1069785|NCT02696226|3467797|P3|Overall Study|Study terminated - lack of enrollment|2
1069786|NCT02696226|3467798|P2|Overall Study|Study terminated - lack of enrollment|0
1069787|NCT02696226|3467799|P1|Overall Study|Study terminated - lack of enrollment|1
1069788|NCT02695719|3467829|P2|Overall Study|Voluntary Withdrawal|0
1069789|NCT02695719|3467830|P1|Overall Study|Voluntary Withdrawal|1
1069790|NCT02695719|3467829|P2|Overall Study|Significant Protocol Deviation|1
1069791|NCT02695719|3467830|P1|Overall Study|Significant Protocol Deviation|0
1069792|NCT02695719|3467829|P2|Overall Study|Pretreatment Event/Adverse Event|9
1069793|NCT02695719|3467830|P1|Overall Study|Pretreatment Event/Adverse Event|2
1069794|NCT02694978|3467861|P2|Overall Study|Other-Withdrew prior to dosing|8
1069795|NCT02694978|3467862|P1|Overall Study|Other-Withdrew prior to dosing|9
1069796|NCT02694978|3467861|P2|Overall Study|Other-Personal reasons|3
1069797|NCT02694978|3467862|P1|Overall Study|Other-Personal reasons|3
1069798|NCT02694978|3467861|P2|Overall Study|Other-Protocol noncompliant|1
1069799|NCT02694978|3467862|P1|Overall Study|Other-Protocol noncompliant|2
1069800|NCT02694978|3467861|P2|Overall Study|Other-Unable to be reached|1
1069801|NCT02694978|3467862|P1|Overall Study|Other-Unable to be reached|0
1069802|NCT02694978|3467861|P2|Overall Study|Other-Investigator’s decision|0
1069803|NCT02694978|3467862|P1|Overall Study|Other-Investigator’s decision|1
1069804|NCT02694978|3467861|P2|Overall Study|Other-Decision of Participant|1
1069805|NCT02694978|3467862|P1|Overall Study|Other-Decision of Participant|6
1069806|NCT02694978|3467861|P2|Overall Study|Death|1
1069807|NCT02694978|3467862|P1|Overall Study|Death|4
1069808|NCT02694978|3467861|P2|Overall Study|Lost to Follow-up|17
1069809|NCT02694978|3467862|P1|Overall Study|Lost to Follow-up|14
1069810|NCT02694978|3467861|P2|Overall Study|Withdrawal by Subject|19
1069811|NCT02694978|3467862|P1|Overall Study|Withdrawal by Subject|22
1069812|NCT02694978|3467861|P2|Overall Study|Adverse Event|9
1069813|NCT02694978|3467862|P1|Overall Study|Adverse Event|10
1069814|NCT02694744|3467876|P2|Overall Study|Taking potassium supplement: exclusion 6|1
1069815|NCT02694744|3467877|P1|Overall Study|Taking potassium supplement: exclusion 6|0
1069816|NCT02694744|3467876|P2|Overall Study|Lost to Follow-up|0
1069817|NCT02694744|3467877|P1|Overall Study|Lost to Follow-up|1
1069818|NCT02694744|3467876|P2|Overall Study|Physician Decision|2
1069819|NCT02694744|3467877|P1|Overall Study|Physician Decision|1
1069820|NCT02694744|3467876|P2|Overall Study|Withdrawal by Subject|1
1069821|NCT02694744|3467877|P1|Overall Study|Withdrawal by Subject|2
1069822|NCT02694744|3467876|P2|Overall Study|Adverse Event|1
1069823|NCT02694744|3467877|P1|Overall Study|Adverse Event|2
1069824|NCT02694718|3467885|P1|Overall Study|Withdrawal by Subject|1
1069825|NCT02694718|3467885|P1|Overall Study|Death|1
1069826|NCT02694549|3467915|P1|Overall Study|screen failures|2
1069827|NCT02694536|3467921|P1|Overall Study|Not Specified|22
1069828|NCT02694536|3467921|P1|Overall Study|Death|8
1069829|NCT02694536|3467921|P1|Overall Study|Withdrawal by Subject|8
1069830|NCT02694536|3467921|P1|Overall Study|Study Drug-Related Adverse Event|1
1069831|NCT02694536|3467921|P1|Overall Study|Lost to Follow-up|1
1069832|NCT02694536|3467921|P1|Overall Study|Progressive Disease|40
1069833|NCT02693002|3467992|P2|Overall Study|Withdrawal by Subject|0
1069834|NCT02693002|3467993|P1|Overall Study|Withdrawal by Subject|1
1069835|NCT02692703|3468014|P1|Overall Study|Not Specified|1
1069836|NCT02692703|3468014|P1|Overall Study|Lost to Follow-up|1
1069837|NCT02692560|3468022|P2|Overall Study|Withdrawal by Subject|6
1069838|NCT02692560|3468023|P1|Overall Study|Withdrawal by Subject|0
1069839|NCT02691702|3468072|P11|Overall Study|Protocol Violation|0
1069840|NCT02691702|3468073|P10|Overall Study|Protocol Violation|2
1069841|NCT02691702|3468074|P9|Overall Study|Protocol Violation|0
1069842|NCT02691702|3468075|P8|Overall Study|Protocol Violation|0
1069843|NCT02691702|3468076|P7|Overall Study|Protocol Violation|0
1069844|NCT02691702|3468077|P6|Overall Study|Protocol Violation|0
1069845|NCT02691702|3468078|P5|Overall Study|Protocol Violation|0
1069846|NCT02691702|3468079|P4|Overall Study|Protocol Violation|0
1069847|NCT02691702|3468080|P3|Overall Study|Protocol Violation|0
1069848|NCT02691702|3468081|P2|Overall Study|Protocol Violation|0
1069849|NCT02691702|3468082|P1|Overall Study|Protocol Violation|0
1069850|NCT02691702|3468072|P11|Overall Study|not specified|0
1069851|NCT02691702|3468073|P10|Overall Study|not specified|0
1069852|NCT02691702|3468074|P9|Overall Study|not specified|1
1069853|NCT02691702|3468075|P8|Overall Study|not specified|0
1069854|NCT02691702|3468076|P7|Overall Study|not specified|1
1069855|NCT02691702|3468077|P6|Overall Study|not specified|0
1069856|NCT02691702|3468078|P5|Overall Study|not specified|0
1069857|NCT02691702|3468079|P4|Overall Study|not specified|0
1069858|NCT02691702|3468080|P3|Overall Study|not specified|0
1069859|NCT02691702|3468081|P2|Overall Study|not specified|0
1069860|NCT02691702|3468082|P1|Overall Study|not specified|0
1069861|NCT02691702|3468072|P11|Overall Study|Withdrawal by Subject|0
1069862|NCT02691702|3468073|P10|Overall Study|Withdrawal by Subject|0
1069863|NCT02691702|3468074|P9|Overall Study|Withdrawal by Subject|0
1069864|NCT02691702|3468075|P8|Overall Study|Withdrawal by Subject|0
1069865|NCT02691702|3468076|P7|Overall Study|Withdrawal by Subject|2
1069866|NCT02691702|3468077|P6|Overall Study|Withdrawal by Subject|1
1069867|NCT02691702|3468078|P5|Overall Study|Withdrawal by Subject|0
1069868|NCT02691702|3468079|P4|Overall Study|Withdrawal by Subject|0
1069869|NCT02691702|3468080|P3|Overall Study|Withdrawal by Subject|0
1069870|NCT02691702|3468081|P2|Overall Study|Withdrawal by Subject|1
1069871|NCT02691702|3468082|P1|Overall Study|Withdrawal by Subject|1
1069872|NCT02691702|3468072|P11|Overall Study|Lost to Follow-up|1
1069873|NCT02691702|3468073|P10|Overall Study|Lost to Follow-up|0
1069874|NCT02691702|3468074|P9|Overall Study|Lost to Follow-up|0
1069875|NCT02691702|3468075|P8|Overall Study|Lost to Follow-up|0
1069876|NCT02691702|3468076|P7|Overall Study|Lost to Follow-up|0
1069877|NCT02691702|3468077|P6|Overall Study|Lost to Follow-up|2
1069878|NCT02691702|3468078|P5|Overall Study|Lost to Follow-up|0
1069879|NCT02691702|3468079|P4|Overall Study|Lost to Follow-up|0
1069880|NCT02691702|3468080|P3|Overall Study|Lost to Follow-up|1
1069881|NCT02691702|3468081|P2|Overall Study|Lost to Follow-up|0
1069882|NCT02691702|3468082|P1|Overall Study|Lost to Follow-up|0
1069883|NCT02691702|3468072|P11|Overall Study|Adverse Event|1
1069884|NCT02691702|3468073|P10|Overall Study|Adverse Event|0
1069885|NCT02691702|3468074|P9|Overall Study|Adverse Event|1
1069886|NCT02691702|3468075|P8|Overall Study|Adverse Event|0
1069887|NCT02691702|3468076|P7|Overall Study|Adverse Event|0
1069888|NCT02691702|3468077|P6|Overall Study|Adverse Event|0
1069889|NCT02691702|3468078|P5|Overall Study|Adverse Event|0
1069890|NCT02691702|3468079|P4|Overall Study|Adverse Event|0
1069891|NCT02691702|3468080|P3|Overall Study|Adverse Event|0
1069892|NCT02691702|3468081|P2|Overall Study|Adverse Event|0
1069893|NCT02691702|3468082|P1|Overall Study|Adverse Event|1
1069894|NCT02691572|3468368|P2|Overall Study|Protocol Violation|1
1069895|NCT02691572|3468369|P1|Overall Study|Protocol Violation|0
1069896|NCT02691572|3468368|P2|Overall Study|Withdrawal by Subject|0
1069897|NCT02691572|3468369|P1|Overall Study|Withdrawal by Subject|1
1069898|NCT02691507|3468377|P2|Overall Study|Missed Visit 3|1
1069899|NCT02691507|3468378|P1|Overall Study|Missed Visit 3|0
1069900|NCT02690727|3468553|P2|Overall Study|Adverse Event|2
1069901|NCT02690727|3468554|P1|Overall Study|Adverse Event|2
1069902|NCT02690194|3468567|P3|Overall Study|Withdrawal by Subject|0
1069903|NCT02690194|3468568|P2|Overall Study|Withdrawal by Subject|4
1069904|NCT02690194|3468569|P1|Overall Study|Withdrawal by Subject|1
1069905|NCT02689804|3468710|P2|Overall Study|Withdrawal by Subject|0
1069906|NCT02689804|3468711|P1|Overall Study|Withdrawal by Subject|2
1069907|NCT02689206|3468742|P5|Overall Study|Withdrawal by Subject|0
1069908|NCT02689206|3468743|P4|Overall Study|Withdrawal by Subject|0
1069909|NCT02689206|3468744|P3|Overall Study|Withdrawal by Subject|1
1069910|NCT02689206|3468745|P2|Overall Study|Withdrawal by Subject|0
1069911|NCT02689206|3468746|P1|Overall Study|Withdrawal by Subject|1
1069912|NCT02689206|3468742|P5|Overall Study|Physician Decision|0
1069913|NCT02689206|3468743|P4|Overall Study|Physician Decision|0
1069914|NCT02689206|3468744|P3|Overall Study|Physician Decision|0
1069915|NCT02689206|3468745|P2|Overall Study|Physician Decision|0
1069916|NCT02689206|3468746|P1|Overall Study|Physician Decision|1
1069917|NCT02689206|3468742|P5|Overall Study|Other: Reached stopping criteria|4
1069918|NCT02689206|3468743|P4|Overall Study|Other: Reached stopping criteria|3
1069919|NCT02689206|3468744|P3|Overall Study|Other: Reached stopping criteria|2
1069920|NCT02689206|3468745|P2|Overall Study|Other: Reached stopping criteria|1
1069921|NCT02689206|3468746|P1|Overall Study|Other: Reached stopping criteria|0
1069922|NCT02689206|3468742|P5|Overall Study|Protocol Violation|2
1069923|NCT02689206|3468743|P4|Overall Study|Protocol Violation|1
1069924|NCT02689206|3468744|P3|Overall Study|Protocol Violation|0
1069925|NCT02689206|3468745|P2|Overall Study|Protocol Violation|0
1069926|NCT02689206|3468746|P1|Overall Study|Protocol Violation|1
1069927|NCT02689206|3468742|P5|Overall Study|Adverse Event|2
1069928|NCT02689206|3468743|P4|Overall Study|Adverse Event|0
1069929|NCT02689206|3468744|P3|Overall Study|Adverse Event|1
1069930|NCT02689206|3468745|P2|Overall Study|Adverse Event|0
1069931|NCT02689206|3468746|P1|Overall Study|Adverse Event|0
1069932|NCT02688933|3468952|P2|Overall Study|Lost to Follow-up|5
1069933|NCT02688933|3468953|P1|Overall Study|Lost to Follow-up|1
1069934|NCT02688933|3468952|P2|Overall Study|Other than Specified|25
1069935|NCT02688933|3468953|P1|Overall Study|Other than Specified|14
1069936|NCT02688933|3468952|P2|Overall Study|Hypoglycemia|0
1069937|NCT02688933|3468953|P1|Overall Study|Hypoglycemia|2
1069938|NCT02688933|3468952|P2|Overall Study|Poor compliance to protocol|4
1069939|NCT02688933|3468953|P1|Overall Study|Poor compliance to protocol|7
1069940|NCT02688933|3468952|P2|Overall Study|Lack of Efficacy|2
1069941|NCT02688933|3468953|P1|Overall Study|Lack of Efficacy|2
1069942|NCT02688933|3468952|P2|Overall Study|Adverse Event|1
1069943|NCT02688933|3468953|P1|Overall Study|Adverse Event|3
1069944|NCT02688153|3468975|P2|Overall Study|Conversion to Commercial Valve|0
1069945|NCT02688153|3468976|P1|Overall Study|Conversion to Commercial Valve|3
1069946|NCT02688153|3468975|P2|Overall Study|Valve Explant|0
1069947|NCT02688153|3468976|P1|Overall Study|Valve Explant|1
1069948|NCT02688153|3468975|P2|Overall Study|Withdrawal by Subject|2
1069949|NCT02688153|3468976|P1|Overall Study|Withdrawal by Subject|4
1069950|NCT02688153|3468975|P2|Overall Study|Death|5
1069951|NCT02688153|3468976|P1|Overall Study|Death|7
1069952|NCT02687542|3469039|P5|Overall Study|Withdrawal by Subject|4
1069953|NCT02687542|3469040|P4|Overall Study|Withdrawal by Subject|2
1069954|NCT02687542|3469041|P3|Overall Study|Withdrawal by Subject|1
1069955|NCT02687542|3469042|P2|Overall Study|Withdrawal by Subject|1
1069956|NCT02687542|3469043|P1|Overall Study|Withdrawal by Subject|0
1069957|NCT02687542|3469039|P5|Overall Study|Adverse Event|9
1069958|NCT02687542|3469040|P4|Overall Study|Adverse Event|2
1069959|NCT02687542|3469041|P3|Overall Study|Adverse Event|3
1069960|NCT02687542|3469042|P2|Overall Study|Adverse Event|1
1069961|NCT02687542|3469043|P1|Overall Study|Adverse Event|3
1069962|NCT02687542|3469039|P5|Overall Study|Other|5
1069963|NCT02687542|3469040|P4|Overall Study|Other|6
1069964|NCT02687542|3469041|P3|Overall Study|Other|10
1069965|NCT02687542|3469042|P2|Overall Study|Other|9
1069966|NCT02687542|3469043|P1|Overall Study|Other|5
1069967|NCT02687542|3469039|P5|Overall Study|Protocol Violation|0
1069968|NCT02687542|3469040|P4|Overall Study|Protocol Violation|0
1069969|NCT02687542|3469041|P3|Overall Study|Protocol Violation|0
1069970|NCT02687542|3469042|P2|Overall Study|Protocol Violation|1
1069971|NCT02687542|3469043|P1|Overall Study|Protocol Violation|0
1069972|NCT02687542|3469039|P5|Overall Study|Lost to Follow-up|1
1069973|NCT02687542|3469040|P4|Overall Study|Lost to Follow-up|0
1069974|NCT02687542|3469041|P3|Overall Study|Lost to Follow-up|0
1069975|NCT02687542|3469042|P2|Overall Study|Lost to Follow-up|0
1069976|NCT02687542|3469043|P1|Overall Study|Lost to Follow-up|0
1069977|NCT02687542|3469039|P5|Overall Study|Medication error without associated AEs|1
1069978|NCT02687542|3469040|P4|Overall Study|Medication error without associated AEs|0
1069979|NCT02687542|3469041|P3|Overall Study|Medication error without associated AEs|0
1069980|NCT02687542|3469042|P2|Overall Study|Medication error without associated AEs|0
1069981|NCT02687542|3469043|P1|Overall Study|Medication error without associated AEs|0
1069982|NCT02685488|3469148|P2|Overall Study|Withdrawal by Subject|1
1069983|NCT02685488|3469149|P1|Overall Study|Withdrawal by Subject|0
1069984|NCT02685202|3469163|P1|Overall Study|Lost to Follow-up|9
1069985|NCT02683785|3469309|P2|Overall Study|Adverse Event|2
1069986|NCT02683785|3469310|P1|Overall Study|Adverse Event|0
1069987|NCT02683785|3469309|P2|Overall Study|Lost to Follow-up|1
1069988|NCT02683785|3469310|P1|Overall Study|Lost to Follow-up|0
1069989|NCT02683785|3469309|P2|Overall Study|Withdrawal by Subject|1
1069990|NCT02683785|3469310|P1|Overall Study|Withdrawal by Subject|1
1069991|NCT02683746|3469349|P2|Overall Study|Physician Decision|1
1069992|NCT02683746|3469350|P1|Overall Study|Physician Decision|2
1069993|NCT02683746|3469349|P2|Overall Study|Withdrawal by Subject|5
1069994|NCT02683746|3469350|P1|Overall Study|Withdrawal by Subject|6
1069995|NCT02683746|3469349|P2|Overall Study|Lost to Follow-up|6
1069996|NCT02683746|3469350|P1|Overall Study|Lost to Follow-up|5
1069997|NCT02683746|3469349|P2|Overall Study|Adverse Event|2
1069998|NCT02683746|3469350|P1|Overall Study|Adverse Event|3
1069999|NCT02683109|3469450|P2|Overall Study|Adverse Event|0
1070000|NCT02683109|3469451|P1|Overall Study|Adverse Event|1
1070001|NCT02681510|3469549|P1|Overall Study|Lost to Follow-up|9
1070002|NCT02681510|3469549|P1|Overall Study|Withdrawal by Subject|1
1070003|NCT02681094|3469579|P3|2 - Enrolled Participants Set|No treatment given|1
1070004|NCT02681094|3469580|P2|2 - Enrolled Participants Set|No treatment given|1
1070005|NCT02681094|3469581|P1|2 - Enrolled Participants Set|No treatment given|0
1070006|NCT02681094|3469579|P3|2 - Enrolled Participants Set|Not specified|7
1070007|NCT02681094|3469580|P2|2 - Enrolled Participants Set|Not specified|6
1070008|NCT02681094|3469581|P1|2 - Enrolled Participants Set|Not specified|6
1070009|NCT02681094|3469579|P3|2 - Enrolled Participants Set|Study specific discontinuation criteria|21
1070010|NCT02681094|3469580|P2|2 - Enrolled Participants Set|Study specific discontinuation criteria|15
1070011|NCT02681094|3469581|P1|2 - Enrolled Participants Set|Study specific discontinuation criteria|14
1070012|NCT02681094|3469579|P3|2 - Enrolled Participants Set|Lack of therapeutic response|14
1070013|NCT02681094|3469580|P2|2 - Enrolled Participants Set|Lack of therapeutic response|5
1070014|NCT02681094|3469581|P1|2 - Enrolled Participants Set|Lack of therapeutic response|1
1070015|NCT02681094|3469579|P3|2 - Enrolled Participants Set|Severe non-compliance to protocol|1
1070016|NCT02681094|3469580|P2|2 - Enrolled Participants Set|Severe non-compliance to protocol|0
1070017|NCT02681094|3469581|P1|2 - Enrolled Participants Set|Severe non-compliance to protocol|2
1070018|NCT02681094|3469579|P3|2 - Enrolled Participants Set|Adverse Event|1
1070019|NCT02681094|3469580|P2|2 - Enrolled Participants Set|Adverse Event|4
1070020|NCT02681094|3469581|P1|2 - Enrolled Participants Set|Adverse Event|10
1070021|NCT02681094|3469579|P3|2 - Enrolled Participants Set|Participant decision|9
1070022|NCT02681094|3469580|P2|2 - Enrolled Participants Set|Participant decision|10
1070023|NCT02681094|3469581|P1|2 - Enrolled Participants Set|Participant decision|7
1070024|NCT02681094|3469579|P3|1 -Modified Enrolled Participants Set|No treatment given|1
1070025|NCT02681094|3469580|P2|1 -Modified Enrolled Participants Set|No treatment given|1
1070026|NCT02681094|3469581|P1|1 -Modified Enrolled Participants Set|No treatment given|0
1070027|NCT02681094|3469579|P3|1 -Modified Enrolled Participants Set|Not specified|7
1070028|NCT02681094|3469580|P2|1 -Modified Enrolled Participants Set|Not specified|6
1070029|NCT02681094|3469581|P1|1 -Modified Enrolled Participants Set|Not specified|6
1070030|NCT02681094|3469579|P3|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20
1070112|NCT02675907|3469940|P1|Study Overall|Lost to Follow-up|0
1070031|NCT02681094|3469580|P2|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13
1070032|NCT02681094|3469581|P1|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11
1070033|NCT02681094|3469579|P3|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14
1070034|NCT02681094|3469580|P2|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5
1070035|NCT02681094|3469581|P1|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1
1070036|NCT02681094|3469579|P3|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1
1070037|NCT02681094|3469580|P2|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0
1070038|NCT02681094|3469581|P1|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2
1070039|NCT02681094|3469579|P3|1 -Modified Enrolled Participants Set|Adverse Event|1
1070040|NCT02681094|3469580|P2|1 -Modified Enrolled Participants Set|Adverse Event|4
1070041|NCT02681094|3469581|P1|1 -Modified Enrolled Participants Set|Adverse Event|10
1070042|NCT02681094|3469579|P3|1 -Modified Enrolled Participants Set|Participant decision|9
1070043|NCT02681094|3469580|P2|1 -Modified Enrolled Participants Set|Participant decision|10
1070044|NCT02681094|3469581|P1|1 -Modified Enrolled Participants Set|Participant decision|7
1070045|NCT02680847|3469600|P3|Overall Study|Adverse Event|1
1070046|NCT02680847|3469601|P2|Overall Study|Adverse Event|0
1070047|NCT02680847|3469602|P1|Overall Study|Adverse Event|0
1070048|NCT02680847|3469600|P3|Overall Study|Lack of Efficacy|2
1070049|NCT02680847|3469601|P2|Overall Study|Lack of Efficacy|0
1070050|NCT02680847|3469602|P1|Overall Study|Lack of Efficacy|0
1070051|NCT02680847|3469600|P3|Overall Study|Unwilling to participate in study|0
1070052|NCT02680847|3469601|P2|Overall Study|Unwilling to participate in study|1
1070053|NCT02680847|3469602|P1|Overall Study|Unwilling to participate in study|1
1070054|NCT02680847|3469600|P3|Overall Study|No longer met eligibility criteria|0
1070055|NCT02680847|3469601|P2|Overall Study|No longer met eligibility criteria|2
1070056|NCT02680847|3469602|P1|Overall Study|No longer met eligibility criteria|2
1070057|NCT02680847|3469600|P3|Overall Study|Other|0
1070058|NCT02680847|3469601|P2|Overall Study|Other|0
1070059|NCT02680847|3469602|P1|Overall Study|Other|2
1070060|NCT02679729|3469672|P9|Overall Study|Participant decision|0
1070061|NCT02679729|3469673|P8|Overall Study|Participant decision|0
1070062|NCT02679729|3469674|P7|Overall Study|Participant decision|1
1070063|NCT02679729|3469675|P6|Overall Study|Participant decision|0
1070064|NCT02679729|3469676|P5|Overall Study|Participant decision|0
1070065|NCT02679729|3469677|P4|Overall Study|Participant decision|0
1070066|NCT02679729|3469678|P3|Overall Study|Participant decision|0
1070067|NCT02679729|3469679|P2|Overall Study|Participant decision|1
1070068|NCT02679729|3469680|P1|Overall Study|Participant decision|0
1070069|NCT02679729|3469672|P9|Overall Study|Lost to Follow-up|0
1070070|NCT02679729|3469673|P8|Overall Study|Lost to Follow-up|0
1070071|NCT02679729|3469674|P7|Overall Study|Lost to Follow-up|0
1070072|NCT02679729|3469675|P6|Overall Study|Lost to Follow-up|0
1070073|NCT02679729|3469676|P5|Overall Study|Lost to Follow-up|1
1070074|NCT02679729|3469677|P4|Overall Study|Lost to Follow-up|0
1070075|NCT02679729|3469678|P3|Overall Study|Lost to Follow-up|0
1070076|NCT02679729|3469679|P2|Overall Study|Lost to Follow-up|1
1070077|NCT02679729|3469680|P1|Overall Study|Lost to Follow-up|0
1070078|NCT02678923|3469792|P2|Overall Study|Did Not Return for Study Visits|0
1070079|NCT02678923|3469793|P1|Overall Study|Did Not Return for Study Visits|1
1070080|NCT02678923|3469792|P2|Overall Study|Lost to Follow-up|0
1070081|NCT02678923|3469793|P1|Overall Study|Lost to Follow-up|1
1070082|NCT02678923|3469792|P2|Overall Study|Withdrawal by Subject|2
1070083|NCT02678923|3469793|P1|Overall Study|Withdrawal by Subject|3
1070084|NCT02678923|3469792|P2|Overall Study|Protocol Deviation (Not Dosed)|3
1070085|NCT02678923|3469793|P1|Overall Study|Protocol Deviation (Not Dosed)|1
1070086|NCT02678676|3469809|P2|Overall Study|Unconfirmed for lost to follow-up|67
1070087|NCT02678676|3469810|P1|Overall Study|Unconfirmed for lost to follow-up|85
1070088|NCT02678676|3469809|P2|Overall Study|Lost to Follow-up|151
1070089|NCT02678676|3469810|P1|Overall Study|Lost to Follow-up|171
1070090|NCT02678676|3469809|P2|Overall Study|Withdrawal by Subject|5
1070091|NCT02678676|3469810|P1|Overall Study|Withdrawal by Subject|13
1070092|NCT02678676|3469809|P2|Overall Study|Death|649
1070093|NCT02678676|3469810|P1|Overall Study|Death|619
1070094|NCT02678286|3469820|P2|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
1070095|NCT02678286|3469821|P1|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
1070096|NCT02678286|3469820|P2|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2
1070097|NCT02678286|3469821|P1|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3
1070098|NCT02678286|3469820|P2|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0
1070099|NCT02678286|3469821|P1|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1
1070100|NCT02678286|3469820|P2|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1
1070101|NCT02678286|3469821|P1|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0
1070102|NCT02678286|3469820|P2|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1
1070103|NCT02678286|3469821|P1|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2
1070104|NCT02677844|3469870|P7|Period 3|Withdrawal by Subject|0
1070105|NCT02677844|3469871|P6|Period 3|Withdrawal by Subject|0
1070106|NCT02677844|3469872|P5|Period 3|Withdrawal by Subject|0
1070107|NCT02677844|3469873|P4|Period 3|Withdrawal by Subject|1
1070108|NCT02677844|3469874|P3|Period 3|Withdrawal by Subject|0
1070109|NCT02677844|3469875|P2|Period 3|Withdrawal by Subject|0
1070110|NCT02677844|3469876|P1|Period 3|Withdrawal by Subject|0
1070111|NCT02675907|3469939|P2|Study Overall|Lost to Follow-up|2
1070113|NCT02675907|3469939|P2|Study Overall|Withdrawal by Subject|2
1070114|NCT02675907|3469940|P1|Study Overall|Withdrawal by Subject|2
1070115|NCT02675907|3469939|P2|Study Overall|Lack of Efficacy|0
1070116|NCT02675907|3469940|P1|Study Overall|Lack of Efficacy|1
1070117|NCT02675907|3469939|P2|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
1070118|NCT02675907|3469940|P1|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
1070119|NCT02675907|3469939|P2|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
1070120|NCT02675907|3469940|P1|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
1070121|NCT02675634|3469985|P6|Test Period 2|Adverse Event|1
1070122|NCT02675634|3469986|P5|Test Period 2|Adverse Event|0
1070123|NCT02675634|3469987|P4|Test Period 2|Adverse Event|0
1070124|NCT02675634|3469988|P3|Test Period 2|Adverse Event|0
1070125|NCT02675634|3469989|P2|Test Period 2|Adverse Event|0
1070126|NCT02675634|3469990|P1|Test Period 2|Adverse Event|0
1070127|NCT02675634|3469985|P6|Test Period 2|Lack of Efficacy|0
1070128|NCT02675634|3469986|P5|Test Period 2|Lack of Efficacy|0
1070129|NCT02675634|3469987|P4|Test Period 2|Lack of Efficacy|0
1070130|NCT02675634|3469988|P3|Test Period 2|Lack of Efficacy|0
1070131|NCT02675634|3469989|P2|Test Period 2|Lack of Efficacy|0
1070132|NCT02675634|3469990|P1|Test Period 2|Lack of Efficacy|1
1070133|NCT02675634|3469985|P6|Test Period 1|Device deficiency that did not lead to A|0
1070134|NCT02675634|3469986|P5|Test Period 1|Device deficiency that did not lead to A|0
1070135|NCT02675634|3469987|P4|Test Period 1|Device deficiency that did not lead to A|0
1070136|NCT02675634|3469988|P3|Test Period 1|Device deficiency that did not lead to A|1
1070137|NCT02675634|3469989|P2|Test Period 1|Device deficiency that did not lead to A|0
1070138|NCT02675634|3469990|P1|Test Period 1|Device deficiency that did not lead to A|0
1070139|NCT02675634|3469985|P6|Test Period 1|Adverse Event|0
1070140|NCT02675634|3469986|P5|Test Period 1|Adverse Event|0
1070141|NCT02675634|3469987|P4|Test Period 1|Adverse Event|1
1070142|NCT02675634|3469988|P3|Test Period 1|Adverse Event|0
1070143|NCT02675634|3469989|P2|Test Period 1|Adverse Event|1
1070144|NCT02675634|3469990|P1|Test Period 1|Adverse Event|0
1070145|NCT02675517|3470007|P1|Overall Study|Evaluable PF-10 questionnaire at visit1|151
1070146|NCT02675517|3470007|P1|Overall Study|No evaluable PF-10 questionnaire at all|8
1070147|NCT02674334|3470029|P2|Overall Study|NIRS not recording|0
1070148|NCT02674334|3470030|P1|Overall Study|NIRS not recording|1
1070149|NCT02674334|3470029|P2|Overall Study|participant difficulty breathing|0
1070150|NCT02674334|3470030|P1|Overall Study|participant difficulty breathing|1
1070151|NCT02674334|3470029|P2|Overall Study|Lost to Follow-up|3
1070152|NCT02674334|3470030|P1|Overall Study|Lost to Follow-up|5
1070153|NCT02673619|3470047|P4|Overall Study|Lack of Efficacy|0
1070154|NCT02673619|3470048|P3|Overall Study|Lack of Efficacy|1
1070155|NCT02673619|3470049|P2|Overall Study|Lack of Efficacy|0
1070156|NCT02673619|3470050|P1|Overall Study|Lack of Efficacy|0
1070157|NCT02673619|3470047|P4|Overall Study|Adverse Event|0
1070158|NCT02673619|3470048|P3|Overall Study|Adverse Event|1
1070159|NCT02673619|3470049|P2|Overall Study|Adverse Event|0
1070160|NCT02673619|3470050|P1|Overall Study|Adverse Event|0
1070161|NCT02673619|3470047|P4|Overall Study|Withdrawal by Subject|0
1070162|NCT02673619|3470048|P3|Overall Study|Withdrawal by Subject|1
1070163|NCT02673619|3470049|P2|Overall Study|Withdrawal by Subject|1
1070164|NCT02673619|3470050|P1|Overall Study|Withdrawal by Subject|1
1070165|NCT02673619|3470047|P4|Overall Study|Lost to Follow-up|0
1070166|NCT02673619|3470048|P3|Overall Study|Lost to Follow-up|0
1070167|NCT02673619|3470049|P2|Overall Study|Lost to Follow-up|0
1070168|NCT02673619|3470050|P1|Overall Study|Lost to Follow-up|1
1070169|NCT02673489|3470142|P2|Follow Up Period|Unable to return for follow-up|1
1070170|NCT02673489|3470143|P1|Follow Up Period|Unable to return for follow-up|0
1070171|NCT02673489|3470142|P2|Follow Up Period|Unable to return for week 24 follow-up|1
1070172|NCT02673489|3470143|P1|Follow Up Period|Unable to return for week 24 follow-up|0
1070173|NCT02673489|3470142|P2|Treatment Period|Adverse Event|1
1070174|NCT02673489|3470143|P1|Treatment Period|Adverse Event|0
1070175|NCT02673489|3470142|P2|Treatment Period|Participant was incarcerated|1
1070176|NCT02673489|3470143|P1|Treatment Period|Participant was incarcerated|0
1070177|NCT02673489|3470142|P2|Treatment Period|Participant moved to another province|0
1070178|NCT02673489|3470143|P1|Treatment Period|Participant moved to another province|1
1070179|NCT02673489|3470142|P2|Treatment Period|Participant request to discontinue|1
1070180|NCT02673489|3470143|P1|Treatment Period|Participant request to discontinue|1
1070181|NCT02673489|3470142|P2|Treatment Period|Lost to Follow-up|0
1070182|NCT02673489|3470143|P1|Treatment Period|Lost to Follow-up|3
1070183|NCT02672423|3470180|P10|Period 3|Physician Decision|0
1070184|NCT02672423|3470181|P9|Period 3|Physician Decision|0
1070185|NCT02672423|3470182|P8|Period 3|Physician Decision|0
1070186|NCT02672423|3470183|P7|Period 3|Physician Decision|0
1070187|NCT02672423|3470184|P6|Period 3|Physician Decision|1
1070188|NCT02672423|3470185|P5|Period 3|Physician Decision|0
1070189|NCT02672423|3470186|P4|Period 3|Physician Decision|0
1070190|NCT02672423|3470187|P3|Period 3|Physician Decision|0
1070191|NCT02672423|3470188|P2|Period 3|Physician Decision|0
1070192|NCT02672423|3470189|P1|Period 3|Physician Decision|0
1070193|NCT02672423|3470180|P10|Period 3|Withdrawal by Subject|0
1070194|NCT02672423|3470181|P9|Period 3|Withdrawal by Subject|0
1070195|NCT02672423|3470182|P8|Period 3|Withdrawal by Subject|1
1070196|NCT02672423|3470183|P7|Period 3|Withdrawal by Subject|0
1070197|NCT02672423|3470184|P6|Period 3|Withdrawal by Subject|0
1070198|NCT02672423|3470185|P5|Period 3|Withdrawal by Subject|0
1070199|NCT02672423|3470186|P4|Period 3|Withdrawal by Subject|0
1070200|NCT02672423|3470187|P3|Period 3|Withdrawal by Subject|0
1070201|NCT02672423|3470188|P2|Period 3|Withdrawal by Subject|0
1070202|NCT02672423|3470189|P1|Period 3|Withdrawal by Subject|0
1070203|NCT02672423|3470180|P10|Period 2|Withdrawal by Subject|0
1070204|NCT02672423|3470181|P9|Period 2|Withdrawal by Subject|0
1070205|NCT02672423|3470182|P8|Period 2|Withdrawal by Subject|0
1070206|NCT02672423|3470183|P7|Period 2|Withdrawal by Subject|0
1070207|NCT02672423|3470184|P6|Period 2|Withdrawal by Subject|0
1070208|NCT02672423|3470185|P5|Period 2|Withdrawal by Subject|0
1070209|NCT02672423|3470186|P4|Period 2|Withdrawal by Subject|0
1070210|NCT02672423|3470187|P3|Period 2|Withdrawal by Subject|1
1070211|NCT02672423|3470188|P2|Period 2|Withdrawal by Subject|0
1070212|NCT02672423|3470189|P1|Period 2|Withdrawal by Subject|0
1070213|NCT02672423|3470180|P10|Period 1|Adverse Event|0
1070214|NCT02672423|3470181|P9|Period 1|Adverse Event|0
1070215|NCT02672423|3470182|P8|Period 1|Adverse Event|0
1070216|NCT02672423|3470183|P7|Period 1|Adverse Event|0
1070217|NCT02672423|3470184|P6|Period 1|Adverse Event|0
1070218|NCT02672423|3470185|P5|Period 1|Adverse Event|1
1070219|NCT02672423|3470186|P4|Period 1|Adverse Event|0
1070220|NCT02672423|3470187|P3|Period 1|Adverse Event|0
1070221|NCT02672423|3470188|P2|Period 1|Adverse Event|0
1070222|NCT02672423|3470189|P1|Period 1|Adverse Event|0
1070223|NCT02671760|3470212|P3|Overall Study|Lost to Follow-up|0
1070224|NCT02671760|3470213|P2|Overall Study|Lost to Follow-up|1
1070225|NCT02671760|3470214|P1|Overall Study|Lost to Follow-up|0
1070226|NCT02671461|3470243|P3|Follow-up|Administrative Reason by Sponsor|0
1070227|NCT02671461|3470244|P2|Follow-up|Administrative Reason by Sponsor|1
1070228|NCT02671461|3470245|P1|Follow-up|Administrative Reason by Sponsor|0
1070229|NCT02671461|3470243|P3|Follow-up|Lost to Follow-up|1
1070230|NCT02671461|3470244|P2|Follow-up|Lost to Follow-up|0
1070231|NCT02671461|3470245|P1|Follow-up|Lost to Follow-up|0
1070232|NCT02671461|3470243|P3|Follow-up|Withdrawal by Subject|0
1070233|NCT02671461|3470244|P2|Follow-up|Withdrawal by Subject|0
1070234|NCT02671461|3470245|P1|Follow-up|Withdrawal by Subject|1
1070235|NCT02671461|3470243|P3|Treatment|Randomized, not treated|0
1070236|NCT02671461|3470244|P2|Treatment|Randomized, not treated|0
1070237|NCT02671461|3470245|P1|Treatment|Randomized, not treated|1
1070238|NCT02671461|3470243|P3|Treatment|Administrative Reason by Sponsor|4
1070239|NCT02671461|3470244|P2|Treatment|Administrative Reason by Sponsor|3
1070240|NCT02671461|3470245|P1|Treatment|Administrative Reason by Sponsor|1
1070241|NCT02671461|3470243|P3|Treatment|Adverse Event|1
1070242|NCT02671461|3470244|P2|Treatment|Adverse Event|0
1070243|NCT02671461|3470245|P1|Treatment|Adverse Event|0
1070244|NCT02671266|3470270|P2|Overall Study|Withdrawal by Subject|1
1070245|NCT02671266|3470271|P1|Overall Study|Withdrawal by Subject|1
1070246|NCT02670473|3470302|P1|Overall Study|Withdrawal by Subject|1
1070247|NCT02669940|3470361|P2|Overall Study|Insufficient follow-up data|0
1070248|NCT02669940|3470362|P1|Overall Study|Insufficient follow-up data|1
1070249|NCT02669940|3470361|P2|Overall Study|Failure to return|3
1070250|NCT02669940|3470362|P1|Overall Study|Failure to return|0
1070251|NCT02669862|3470464|P3|Overall Study|Protocol Violation|1
1070252|NCT02669862|3470465|P2|Overall Study|Protocol Violation|0
1070253|NCT02669862|3470466|P1|Overall Study|Protocol Violation|0
1070254|NCT02669862|3470464|P3|Overall Study|moved|0
1070255|NCT02669862|3470465|P2|Overall Study|moved|1
1070256|NCT02669862|3470466|P1|Overall Study|moved|0
1070257|NCT02669862|3470464|P3|Overall Study|Withdrawal by Subject|3
1070258|NCT02669862|3470465|P2|Overall Study|Withdrawal by Subject|2
1070259|NCT02669862|3470466|P1|Overall Study|Withdrawal by Subject|2
1070260|NCT02669862|3470464|P3|Overall Study|Lost to Follow-up|1
1070261|NCT02669862|3470465|P2|Overall Study|Lost to Follow-up|2
1070262|NCT02669862|3470466|P1|Overall Study|Lost to Follow-up|0
1070263|NCT02669095|3470487|P2|Overall Study|Visit 5 assessments not completed|1
1070264|NCT02669095|3470488|P1|Overall Study|Visit 5 assessments not completed|0
1070265|NCT02669095|3470487|P2|Overall Study|Torn Lens|1
1070266|NCT02669095|3470488|P1|Overall Study|Torn Lens|0
1070267|NCT02669095|3470487|P2|Overall Study|Unsatisfactory Lens Fitting|1
1070268|NCT02669095|3470488|P1|Overall Study|Unsatisfactory Lens Fitting|0
1070269|NCT02669095|3470487|P2|Overall Study|Adverse Event|0
1070270|NCT02669095|3470488|P1|Overall Study|Adverse Event|1
1070271|NCT02669043|3470496|P1|Overall Study|Didn't meet I/E criteria|4
1070272|NCT02668822|3470523|P2|Overall Study|Study Terminated by Sponsor|9
1070273|NCT02668822|3470524|P1|Overall Study|Study Terminated by Sponsor|7
1070274|NCT02668822|3470523|P2|Overall Study|Protocol Violation|0
1070275|NCT02668822|3470524|P1|Overall Study|Protocol Violation|2
1070276|NCT02668783|3470546|P2|Overall Study|Withdrawal by Subject|0
1070277|NCT02668783|3470547|P1|Overall Study|Withdrawal by Subject|1
1070278|NCT02668783|3470546|P2|Overall Study|Subject moved|0
1070279|NCT02668783|3470547|P1|Overall Study|Subject moved|1
1070280|NCT02668783|3470546|P2|Overall Study|Study terminated by sponsor|10
1070281|NCT02668783|3470547|P1|Overall Study|Study terminated by sponsor|9
1070282|NCT02668783|3470546|P2|Overall Study|Protocol Violation|1
1070283|NCT02668783|3470547|P1|Overall Study|Protocol Violation|2
1070284|NCT02668783|3470546|P2|Overall Study|Pregnancy|1
1070285|NCT02668783|3470547|P1|Overall Study|Pregnancy|0
1070286|NCT02668302|3470569|P2|Overall Study|Withdrawal by Subject|0
1070287|NCT02668302|3470570|P1|Overall Study|Withdrawal by Subject|1
1070288|NCT02667288|3470593|P1|Overall Study|Withdrawal by Subject|5
1070289|NCT02667288|3470593|P1|Overall Study|Lost to Follow-up|3
1070290|NCT02667288|3470593|P1|Overall Study|Protocol Violation|5
1070291|NCT02667275|3470600|P2|Overall Study|Discontinued early without completing|1
1070292|NCT02667275|3470601|P1|Overall Study|Discontinued early without completing|0
1070293|NCT02667275|3470600|P2|Overall Study|Withdrawal by Subject|5
1070294|NCT02667275|3470601|P1|Overall Study|Withdrawal by Subject|0
1070295|NCT02667275|3470600|P2|Overall Study|Lost to Follow-up|2
1070296|NCT02667275|3470601|P1|Overall Study|Lost to Follow-up|0
1070297|NCT02667275|3470600|P2|Overall Study|Protocol Violation|7
1070298|NCT02667275|3470601|P1|Overall Study|Protocol Violation|11
1070299|NCT02667236|3470611|P2|Overall Study|Withdrawal by Subject|0
1070300|NCT02667236|3470612|P1|Overall Study|Withdrawal by Subject|2
1070301|NCT02667236|3470611|P2|Overall Study|Adverse Event|1
1070302|NCT02667236|3470612|P1|Overall Study|Adverse Event|1
1070303|NCT02666222|3470746|P1|Overall Study|Death|2
1070304|NCT02665455|3470754|P1|Overall Study|Protocol Violation|1
1070305|NCT02665455|3470754|P1|Overall Study|Adverse Event|1
1070306|NCT02665455|3470754|P1|Overall Study|Lost to Follow-up|1
1070307|NCT02665455|3470754|P1|Overall Study|Withdrawal by Subject|6
1070308|NCT02665286|3470761|P3|Overall Study|Lost to Follow-up|1
1070309|NCT02665286|3470762|P2|Overall Study|Lost to Follow-up|2
1070310|NCT02665286|3470763|P1|Overall Study|Lost to Follow-up|3
1070311|NCT02664415|3470853|P2|Overall Study|Adverse Event|0
1070312|NCT02664415|3470854|P1|Overall Study|Adverse Event|1
1070313|NCT02663687|3470909|P5|Overall Study|Other|0
1070314|NCT02663687|3470910|P4|Overall Study|Other|0
1070315|NCT02663687|3470911|P3|Overall Study|Other|1
1070316|NCT02663687|3470912|P2|Overall Study|Other|0
1070317|NCT02663687|3470913|P1|Overall Study|Other|1
1070318|NCT02663687|3470909|P5|Overall Study|Adverse Event|0
1070319|NCT02663687|3470910|P4|Overall Study|Adverse Event|0
1070320|NCT02663687|3470911|P3|Overall Study|Adverse Event|0
1070321|NCT02663687|3470912|P2|Overall Study|Adverse Event|0
1070322|NCT02663687|3470913|P1|Overall Study|Adverse Event|1
1070323|NCT02663453|3470967|P2|Overall Study|Withdrawal by Subject|0
1070324|NCT02663453|3470968|P1|Overall Study|Withdrawal by Subject|1
1070325|NCT02663453|3470967|P2|Overall Study|Death|4
1070326|NCT02663453|3470968|P1|Overall Study|Death|4
1070327|NCT02662764|3471011|P1|Overall Study|Patient discharged prior to 24 hrs|5
1070328|NCT02662764|3471011|P1|Overall Study|Patient changed treatment|1
1070329|NCT02662764|3471011|P1|Overall Study|Device failure|4
1070330|NCT02662764|3471011|P1|Overall Study|Withdrawal by Subject|5
1070331|NCT02662764|3471011|P1|Overall Study|Protocol Violation|1
1070332|NCT02662764|3471011|P1|Overall Study|Lack of Efficacy|8
1070333|NCT02662764|3471011|P1|Overall Study|Adverse Event|6
1070334|NCT02662556|3471075|P1|Overall Study|Lack of Efficacy|4
1070335|NCT02662556|3471075|P1|Overall Study|Adverse Event|4
1070336|NCT02661594|3471107|P4|Overall Study|Protocol Violation|0
1070337|NCT02661594|3471108|P3|Overall Study|Protocol Violation|1
1070338|NCT02661594|3471109|P2|Overall Study|Protocol Violation|0
1070339|NCT02661594|3471110|P1|Overall Study|Protocol Violation|1
1070340|NCT02660242|3471211|P1|Glucagon Injection|Lost to Follow-up|1
1070341|NCT02660242|3471211|P1|Glucose Tabs|Lost to Follow-up|1
1070342|NCT02660229|3471267|P2|Overall Study|Withdrawal by Subject|1
1070343|NCT02660229|3471268|P1|Overall Study|Withdrawal by Subject|0
1070344|NCT02660229|3471267|P2|Overall Study|Adverse Event|0
1070345|NCT02660229|3471268|P1|Overall Study|Adverse Event|2
1070346|NCT02658149|3471328|P2|Overall Study|Physician Decision|0
1070347|NCT02658149|3471329|P1|Overall Study|Physician Decision|1
1070348|NCT02657031|3471374|P2|Overall Study|Adverse Event|2
1070349|NCT02657031|3471375|P1|Overall Study|Adverse Event|1
1070350|NCT02656173|3471417|P2|Overall Study|Miscellaneous|0
1070351|NCT02656173|3471418|P1|Overall Study|Miscellaneous|2
1070352|NCT02656173|3471417|P2|Overall Study|Protocol Violation|1
1070353|NCT02656173|3471418|P1|Overall Study|Protocol Violation|0
1070354|NCT02656173|3471417|P2|Overall Study|Withdrawal by Subject|3
1070355|NCT02656173|3471418|P1|Overall Study|Withdrawal by Subject|1
1070356|NCT02656173|3471417|P2|Overall Study|Adverse Event|5
1070357|NCT02656173|3471418|P1|Overall Study|Adverse Event|7
1070358|NCT02656173|3471417|P2|Overall Study|Deviation from the Eligible Criteria|2
1070359|NCT02656173|3471418|P1|Overall Study|Deviation from the Eligible Criteria|3
1070360|NCT02655666|3471490|P1|Overall Study|Sponsor stopped this clinical research.|12
1070361|NCT02654145|3471507|P1|Overall Study|Withdrawal by Subject|5
1070362|NCT02654145|3471507|P1|Overall Study|Protocol Violation|1
1070363|NCT02654145|3471507|P1|Overall Study|Lack of Efficacy|1
1070364|NCT02653625|3471549|P1|Overall Study|Suspected Drug Induced Liver Injury|1
1070365|NCT02653625|3471549|P1|Overall Study|Protocol Violation|1
1070366|NCT02653625|3471549|P1|Overall Study|Non-compliance with Study Drug|1
1070367|NCT02653625|3471549|P1|Overall Study|Adverse Event|1
1070368|NCT02653495|3471573|P2|Overall Study|Screening Failure|0
1070369|NCT02653495|3471574|P1|Overall Study|Screening Failure|10
1070370|NCT02653495|3471573|P2|Overall Study|Lost to Follow-up|0
1070371|NCT02653495|3471574|P1|Overall Study|Lost to Follow-up|2
1070372|NCT02652624|3471597|P2|Extension Phase|Lost to Follow-up|1
1070373|NCT02652624|3471598|P1|Extension Phase|Lost to Follow-up|0
1070374|NCT02652624|3471597|P2|Extension Phase|Still in Extension Phase of Study|227
1070375|NCT02652624|3471598|P1|Extension Phase|Still in Extension Phase of Study|230
1070376|NCT02652624|3471597|P2|Randomized Phase|Still in Randomized Phase of Study|3
1070377|NCT02652624|3471598|P1|Randomized Phase|Still in Randomized Phase of Study|1
1070378|NCT02652624|3471597|P2|Randomized Phase|Lost to Follow-up|1
1070379|NCT02652624|3471598|P1|Randomized Phase|Lost to Follow-up|0
1070380|NCT02652624|3471597|P2|Randomized Phase|Investigator's Discretion|2
1070381|NCT02652624|3471598|P1|Randomized Phase|Investigator's Discretion|0
1070382|NCT02652624|3471597|P2|Randomized Phase|Pregnancy|1
1070383|NCT02652624|3471598|P1|Randomized Phase|Pregnancy|3
1070384|NCT02652624|3471597|P2|Randomized Phase|Death|1
1070385|NCT02652624|3471598|P1|Randomized Phase|Death|0
1070386|NCT02652624|3471597|P2|Randomized Phase|Randomized but Not Treated|1
1070387|NCT02652624|3471598|P1|Randomized Phase|Randomized but Not Treated|1
1070388|NCT02652156|3471658|P3|Overall Study|Physician Decision|0
1070389|NCT02652156|3471659|P2|Overall Study|Physician Decision|0
1070390|NCT02652156|3471660|P1|Overall Study|Physician Decision|1
1070391|NCT02651922|3471686|P1|Overall Study|due to exclusion criteria|2
1070392|NCT02651467|3471706|P3|Overall Study|Other (Not specified)|2
1070393|NCT02651467|3471707|P2|Overall Study|Other (Not specified)|0
1070394|NCT02651467|3471708|P1|Overall Study|Other (Not specified)|1
1070395|NCT02651467|3471706|P3|Overall Study|Withdrawal by Subject|2
1070396|NCT02651467|3471707|P2|Overall Study|Withdrawal by Subject|0
1070397|NCT02651467|3471708|P1|Overall Study|Withdrawal by Subject|0
1070398|NCT02651194|3471727|P1|Overall Study|Not Specified|2
1070399|NCT02651194|3471727|P1|Overall Study|Lost to Follow-up|3
1070400|NCT02651155|3471735|P2|Overall Study|Voluntary Withdrawal|0
1070401|NCT02651155|3471736|P1|Overall Study|Voluntary Withdrawal|5
1070402|NCT02651155|3471735|P2|Overall Study|Pretreatment Event/Adverse Event|2
1070403|NCT02651155|3471736|P1|Overall Study|Pretreatment Event/Adverse Event|1
1070404|NCT02650921|3471756|P1|Overall Study|Due to Medical Condition|1
1070405|NCT02650921|3471756|P1|Overall Study|Adverse Event|1
1070406|NCT02650921|3471756|P1|Overall Study|Lost to Follow-up|2
1070407|NCT02650921|3471756|P1|Overall Study|Withdrawal by Subject|4
1070408|NCT02650128|3471928|P1|Overall Study|Death|2
1070409|NCT02649634|3471937|P2|Overall Study|Lost to Follow-up|1
1070410|NCT02649634|3471938|P1|Overall Study|Lost to Follow-up|0
1070411|NCT02649634|3471937|P2|Overall Study|Withdrawal by Subject|5
1070412|NCT02649634|3471938|P1|Overall Study|Withdrawal by Subject|3
1070413|NCT02648438|3472045|P3|Overall Study|Withdrawal by Subject|0
1070414|NCT02648438|3472046|P2|Overall Study|Withdrawal by Subject|1
1070415|NCT02648438|3472047|P1|Overall Study|Withdrawal by Subject|1
1070416|NCT02648438|3472045|P3|Overall Study|Protocol Violation|0
1070417|NCT02648438|3472046|P2|Overall Study|Protocol Violation|0
1070418|NCT02648438|3472047|P1|Overall Study|Protocol Violation|2
1070419|NCT02648438|3472045|P3|Overall Study|Eligibility criteria not fulfilled|0
1070420|NCT02648438|3472046|P2|Overall Study|Eligibility criteria not fulfilled|2
1070421|NCT02648438|3472047|P1|Overall Study|Eligibility criteria not fulfilled|0
1070422|NCT02648217|3472089|P2|Overall Study|Unclassified|0
1070423|NCT02648217|3472090|P1|Overall Study|Unclassified|5
1070424|NCT02648217|3472089|P2|Overall Study|Withdrawal by Subject|3
1070425|NCT02648217|3472090|P1|Overall Study|Withdrawal by Subject|4
1070426|NCT02648217|3472089|P2|Overall Study|Lost to Follow-up|1
1070427|NCT02648217|3472090|P1|Overall Study|Lost to Follow-up|1
1070428|NCT02648217|3472089|P2|Overall Study|Adverse Event|1
1070429|NCT02648217|3472090|P1|Overall Study|Adverse Event|0
1070430|NCT02648204|3472112|P4|Overall Study|Adverse Event|0
1070431|NCT02648204|3472113|P3|Overall Study|Adverse Event|1
1070432|NCT02648204|3472114|P2|Overall Study|Adverse Event|0
1070433|NCT02648204|3472115|P1|Overall Study|Adverse Event|0
1070434|NCT02648204|3472112|P4|Overall Study|Death|2
1070435|NCT02648204|3472113|P3|Overall Study|Death|2
1070436|NCT02648204|3472114|P2|Overall Study|Death|1
1070437|NCT02648204|3472115|P1|Overall Study|Death|1
1070438|NCT02648204|3472112|P4|Overall Study|Missing follow-up information|2
1070439|NCT02648204|3472113|P3|Overall Study|Missing follow-up information|4
1070440|NCT02648204|3472114|P2|Overall Study|Missing follow-up information|4
1070441|NCT02648204|3472115|P1|Overall Study|Missing follow-up information|4
1070442|NCT02648204|3472112|P4|Overall Study|Lost to Follow-up|6
1070443|NCT02648204|3472113|P3|Overall Study|Lost to Follow-up|4
1070444|NCT02648204|3472114|P2|Overall Study|Lost to Follow-up|8
1070445|NCT02648204|3472115|P1|Overall Study|Lost to Follow-up|5
1070446|NCT02648204|3472112|P4|Overall Study|Withdrawal by Subject|6
1070447|NCT02648204|3472113|P3|Overall Study|Withdrawal by Subject|2
1070448|NCT02648204|3472114|P2|Overall Study|Withdrawal by Subject|8
1070449|NCT02648204|3472115|P1|Overall Study|Withdrawal by Subject|12
1070450|NCT02647944|3472248|P2|Overall Study|Adverse Event|0
1070451|NCT02647944|3472249|P1|Overall Study|Adverse Event|2
1070452|NCT02647944|3472248|P2|Overall Study|Withdrawal by Subject|3
1070453|NCT02647944|3472249|P1|Overall Study|Withdrawal by Subject|0
1070454|NCT02647905|3472273|P1|Overall Study|Withdrawal by Subject|2
1070455|NCT02647905|3472273|P1|Overall Study|Lost to Follow-up|1
1070456|NCT02647645|3472280|P2|Overall Study|Lost to Follow-up|1
1070457|NCT02647645|3472281|P1|Overall Study|Lost to Follow-up|2
1070458|NCT02647320|3472296|P5|Overall Study|Disposition Missing Due to Fire at Site|4
1070459|NCT02647320|3472297|P4|Overall Study|Disposition Missing Due to Fire at Site|3
1070460|NCT02647320|3472298|P3|Overall Study|Disposition Missing Due to Fire at Site|4
1070461|NCT02647320|3472299|P2|Overall Study|Disposition Missing Due to Fire at Site|3
1070462|NCT02647320|3472300|P1|Overall Study|Disposition Missing Due to Fire at Site|2
1070463|NCT02647320|3472296|P5|Overall Study|Lack of Efficacy|0
1070464|NCT02647320|3472297|P4|Overall Study|Lack of Efficacy|1
1070465|NCT02647320|3472298|P3|Overall Study|Lack of Efficacy|0
1070466|NCT02647320|3472299|P2|Overall Study|Lack of Efficacy|0
1070467|NCT02647320|3472300|P1|Overall Study|Lack of Efficacy|0
1070468|NCT02647320|3472296|P5|Overall Study|Develop anemia|0
1070469|NCT02647320|3472297|P4|Overall Study|Develop anemia|0
1070470|NCT02647320|3472298|P3|Overall Study|Develop anemia|0
1070471|NCT02647320|3472299|P2|Overall Study|Develop anemia|0
1070472|NCT02647320|3472300|P1|Overall Study|Develop anemia|1
1070473|NCT02647320|3472296|P5|Overall Study|Lost to Follow-up|0
1070474|NCT02647320|3472297|P4|Overall Study|Lost to Follow-up|0
1070475|NCT02647320|3472298|P3|Overall Study|Lost to Follow-up|0
1070476|NCT02647320|3472299|P2|Overall Study|Lost to Follow-up|1
1070477|NCT02647320|3472300|P1|Overall Study|Lost to Follow-up|1
1070478|NCT02647320|3472296|P5|Overall Study|Reason not provided|2
1070479|NCT02647320|3472297|P4|Overall Study|Reason not provided|0
1070480|NCT02647320|3472298|P3|Overall Study|Reason not provided|1
1070481|NCT02647320|3472299|P2|Overall Study|Reason not provided|0
1070482|NCT02647320|3472300|P1|Overall Study|Reason not provided|0
1070483|NCT02647320|3472296|P5|Overall Study|Study terminated by sponsor|2
1070484|NCT02647320|3472297|P4|Overall Study|Study terminated by sponsor|1
1070485|NCT02647320|3472298|P3|Overall Study|Study terminated by sponsor|1
1070486|NCT02647320|3472299|P2|Overall Study|Study terminated by sponsor|1
1070487|NCT02647320|3472300|P1|Overall Study|Study terminated by sponsor|1
1070488|NCT02647320|3472296|P5|Overall Study|Persistent hyperglycemia|1
1070489|NCT02647320|3472297|P4|Overall Study|Persistent hyperglycemia|1
1070490|NCT02647320|3472298|P3|Overall Study|Persistent hyperglycemia|1
1070491|NCT02647320|3472299|P2|Overall Study|Persistent hyperglycemia|1
1070492|NCT02647320|3472300|P1|Overall Study|Persistent hyperglycemia|0
1070493|NCT02647320|3472296|P5|Overall Study|Withdrawal by Subject|7
1070494|NCT02647320|3472297|P4|Overall Study|Withdrawal by Subject|2
1070495|NCT02647320|3472298|P3|Overall Study|Withdrawal by Subject|2
1070496|NCT02647320|3472299|P2|Overall Study|Withdrawal by Subject|4
1070497|NCT02647320|3472300|P1|Overall Study|Withdrawal by Subject|7
1070498|NCT02647320|3472296|P5|Overall Study|Protocol Violation|0
1070499|NCT02647320|3472297|P4|Overall Study|Protocol Violation|0
1070500|NCT02647320|3472298|P3|Overall Study|Protocol Violation|3
1070501|NCT02647320|3472299|P2|Overall Study|Protocol Violation|0
1070502|NCT02647320|3472300|P1|Overall Study|Protocol Violation|0
1070503|NCT02647320|3472296|P5|Overall Study|Adverse Event|1
1070504|NCT02647320|3472297|P4|Overall Study|Adverse Event|2
1070505|NCT02647320|3472298|P3|Overall Study|Adverse Event|3
1070506|NCT02647320|3472299|P2|Overall Study|Adverse Event|1
1070507|NCT02647320|3472300|P1|Overall Study|Adverse Event|0
1070508|NCT02647281|3472391|P9|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1
1070509|NCT02647281|3472392|P8|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
1070510|NCT02647281|3472393|P7|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
1070511|NCT02647281|3472394|P6|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
1070512|NCT02647281|3472395|P5|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
1070513|NCT02647281|3472396|P4|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
1070514|NCT02647281|3472397|P3|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
1070515|NCT02647281|3472398|P2|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
1070516|NCT02647281|3472399|P1|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
1070517|NCT02646566|3472580|P3|Overall Study|Treatment failure|0
1070518|NCT02646566|3472581|P2|Overall Study|Treatment failure|0
1070519|NCT02646566|3472582|P1|Overall Study|Treatment failure|1
1070520|NCT02646566|3472580|P3|Overall Study|Lost to Follow-up|5
1070521|NCT02646566|3472581|P2|Overall Study|Lost to Follow-up|4
1070522|NCT02646566|3472582|P1|Overall Study|Lost to Follow-up|5
1070523|NCT02646124|3472633|P2|Overall Study|Lost to Follow-up|2
1070524|NCT02646124|3472634|P1|Overall Study|Lost to Follow-up|0
1070525|NCT02644356|3472811|P1|Overall Study|Withdrawal by Subject|2
1070526|NCT02644122|3472821|P1|Overall Study|Withdrawal by Subject|1
1070527|NCT02644109|3472831|P2|Overall Study|Adverse Event|4
1070528|NCT02644109|3472832|P1|Overall Study|Adverse Event|0
1070529|NCT02644096|3472840|P2|Overall Study|Withdrawal by Subject|25
1070530|NCT02644096|3472841|P1|Overall Study|Withdrawal by Subject|28
1070531|NCT02643394|3472875|P2|Overall Study|Protocol Violation|5
1070532|NCT02643394|3472876|P1|Overall Study|Protocol Violation|4
1070533|NCT02643251|3472886|P2|Overall Study|PI Decision to terminate patient|0
1070534|NCT02643251|3472887|P1|Overall Study|PI Decision to terminate patient|1
1070535|NCT02643251|3472886|P2|Overall Study|Protocol Violation|0
1070536|NCT02643251|3472887|P1|Overall Study|Protocol Violation|1
1070537|NCT02643251|3472886|P2|Overall Study|Lost to Follow-up|1
1070538|NCT02643251|3472887|P1|Overall Study|Lost to Follow-up|4
1070539|NCT02643251|3472886|P2|Overall Study|Withdrawal by Subject|0
1070540|NCT02643251|3472887|P1|Overall Study|Withdrawal by Subject|2
1070541|NCT02643251|3472886|P2|Overall Study|Adverse Event|1
1070542|NCT02643251|3472887|P1|Overall Study|Adverse Event|3
1070543|NCT02642679|3472973|P1|Overall Study|Physician Decision|1
1070544|NCT02642679|3472973|P1|Overall Study|Physician Decision|1
1070545|NCT02642679|3472973|P1|Overall Study|Withdrawal by Subject|1
1070546|NCT02642432|3473014|P1|Overall Study|Not Specified|3
1070547|NCT02642432|3473014|P1|Overall Study|Lost to Follow-up|2
1070548|NCT02642432|3473014|P1|Overall Study|Withdrew Consent|1
1070549|NCT02642432|3473014|P1|Overall Study|Adverse Event|2
1070550|NCT02642159|3473022|P2|Overall Study|Other than specified above|3
1070551|NCT02642159|3473023|P1|Overall Study|Other than specified above|10
1070552|NCT02642159|3473022|P2|Overall Study|Poor compliance to study protocol|0
1070553|NCT02642159|3473023|P1|Overall Study|Poor compliance to study protocol|1
1070554|NCT02642159|3473022|P2|Overall Study|Withdrawal by Subject|1
1070555|NCT02642159|3473023|P1|Overall Study|Withdrawal by Subject|9
1070556|NCT02642159|3473022|P2|Overall Study|Adverse Event|4
1070557|NCT02642159|3473023|P1|Overall Study|Adverse Event|10
1070558|NCT02642159|3473022|P2|Overall Study|Randomized but not treated|0
1070559|NCT02642159|3473023|P1|Overall Study|Randomized but not treated|1
1070560|NCT02641379|3473252|P11|Overall Study|PCR positive|0
1070561|NCT02641379|3473253|P10|Overall Study|PCR positive|0
1070562|NCT02641379|3473254|P9|Overall Study|PCR positive|0
1070563|NCT02641379|3473255|P8|Overall Study|PCR positive|0
1070564|NCT02641379|3473256|P7|Overall Study|PCR positive|1
1070565|NCT02641379|3473257|P6|Overall Study|PCR positive|0
1070566|NCT02641379|3473258|P5|Overall Study|PCR positive|0
1070567|NCT02641379|3473259|P4|Overall Study|PCR positive|0
1070568|NCT02641379|3473260|P3|Overall Study|PCR positive|0
1070569|NCT02641379|3473261|P2|Overall Study|PCR positive|0
1070570|NCT02641379|3473262|P1|Overall Study|PCR positive|0
1070571|NCT02641379|3473252|P11|Overall Study|Missing PCR result at Week 8|0
1070572|NCT02641379|3473253|P10|Overall Study|Missing PCR result at Week 8|1
1070573|NCT02641379|3473254|P9|Overall Study|Missing PCR result at Week 8|0
1070574|NCT02641379|3473255|P8|Overall Study|Missing PCR result at Week 8|0
1070575|NCT02641379|3473256|P7|Overall Study|Missing PCR result at Week 8|0
1070576|NCT02641379|3473257|P6|Overall Study|Missing PCR result at Week 8|0
1070577|NCT02641379|3473258|P5|Overall Study|Missing PCR result at Week 8|0
1070578|NCT02641379|3473259|P4|Overall Study|Missing PCR result at Week 8|0
1070579|NCT02641379|3473260|P3|Overall Study|Missing PCR result at Week 8|0
1070580|NCT02641379|3473261|P2|Overall Study|Missing PCR result at Week 8|0
1070581|NCT02641379|3473262|P1|Overall Study|Missing PCR result at Week 8|0
1070582|NCT02641379|3473252|P11|Overall Study|Participant treated after Week 24|0
1070583|NCT02641379|3473253|P10|Overall Study|Participant treated after Week 24|0
1070584|NCT02641379|3473254|P9|Overall Study|Participant treated after Week 24|1
1070585|NCT02641379|3473255|P8|Overall Study|Participant treated after Week 24|0
1070586|NCT02641379|3473256|P7|Overall Study|Participant treated after Week 24|0
1070587|NCT02641379|3473257|P6|Overall Study|Participant treated after Week 24|0
1070588|NCT02641379|3473258|P5|Overall Study|Participant treated after Week 24|0
1070589|NCT02641379|3473259|P4|Overall Study|Participant treated after Week 24|0
1070590|NCT02641379|3473260|P3|Overall Study|Participant treated after Week 24|0
1070591|NCT02641379|3473261|P2|Overall Study|Participant treated after Week 24|0
1070592|NCT02641379|3473262|P1|Overall Study|Participant treated after Week 24|0
1070593|NCT02641379|3473252|P11|Overall Study|Participant’s PCR high|0
1070594|NCT02641379|3473253|P10|Overall Study|Participant’s PCR high|0
1070595|NCT02641379|3473254|P9|Overall Study|Participant’s PCR high|0
1070596|NCT02641379|3473255|P8|Overall Study|Participant’s PCR high|1
1070597|NCT02641379|3473256|P7|Overall Study|Participant’s PCR high|0
1070598|NCT02641379|3473257|P6|Overall Study|Participant’s PCR high|0
1070599|NCT02641379|3473258|P5|Overall Study|Participant’s PCR high|0
1070600|NCT02641379|3473259|P4|Overall Study|Participant’s PCR high|0
1070601|NCT02641379|3473260|P3|Overall Study|Participant’s PCR high|0
1070602|NCT02641379|3473261|P2|Overall Study|Participant’s PCR high|0
1070603|NCT02641379|3473262|P1|Overall Study|Participant’s PCR high|0
1070604|NCT02641379|3473252|P11|Overall Study|Negative PCR result|0
1070605|NCT02641379|3473253|P10|Overall Study|Negative PCR result|1
1070606|NCT02641379|3473254|P9|Overall Study|Negative PCR result|0
1070607|NCT02641379|3473255|P8|Overall Study|Negative PCR result|0
1070608|NCT02641379|3473256|P7|Overall Study|Negative PCR result|0
1070609|NCT02641379|3473257|P6|Overall Study|Negative PCR result|0
1070610|NCT02641379|3473258|P5|Overall Study|Negative PCR result|0
1070611|NCT02641379|3473259|P4|Overall Study|Negative PCR result|0
1070612|NCT02641379|3473260|P3|Overall Study|Negative PCR result|0
1070613|NCT02641379|3473261|P2|Overall Study|Negative PCR result|0
1070614|NCT02641379|3473262|P1|Overall Study|Negative PCR result|0
1070615|NCT02641379|3473252|P11|Overall Study|No 2 Log drop at Week 12|1
1070616|NCT02641379|3473253|P10|Overall Study|No 2 Log drop at Week 12|0
1070617|NCT02641379|3473254|P9|Overall Study|No 2 Log drop at Week 12|0
1070618|NCT02641379|3473255|P8|Overall Study|No 2 Log drop at Week 12|0
1070619|NCT02641379|3473256|P7|Overall Study|No 2 Log drop at Week 12|0
1070620|NCT02641379|3473257|P6|Overall Study|No 2 Log drop at Week 12|0
1070621|NCT02641379|3473258|P5|Overall Study|No 2 Log drop at Week 12|0
1070622|NCT02641379|3473259|P4|Overall Study|No 2 Log drop at Week 12|0
1070623|NCT02641379|3473260|P3|Overall Study|No 2 Log drop at Week 12|0
1070624|NCT02641379|3473261|P2|Overall Study|No 2 Log drop at Week 12|0
1070625|NCT02641379|3473262|P1|Overall Study|No 2 Log drop at Week 12|0
1070626|NCT02641379|3473252|P11|Overall Study|Non-response Week 12|0
1070627|NCT02641379|3473253|P10|Overall Study|Non-response Week 12|0
1070628|NCT02641379|3473254|P9|Overall Study|Non-response Week 12|0
1070629|NCT02641379|3473255|P8|Overall Study|Non-response Week 12|1
1070630|NCT02641379|3473256|P7|Overall Study|Non-response Week 12|0
1070631|NCT02641379|3473257|P6|Overall Study|Non-response Week 12|0
1070632|NCT02641379|3473258|P5|Overall Study|Non-response Week 12|0
1070633|NCT02641379|3473259|P4|Overall Study|Non-response Week 12|0
1070634|NCT02641379|3473260|P3|Overall Study|Non-response Week 12|0
1070635|NCT02641379|3473261|P2|Overall Study|Non-response Week 12|0
1070636|NCT02641379|3473262|P1|Overall Study|Non-response Week 12|0
1070637|NCT02641379|3473252|P11|Overall Study|Participant showed weight reduction|0
1070638|NCT02641379|3473253|P10|Overall Study|Participant showed weight reduction|0
1070639|NCT02641379|3473254|P9|Overall Study|Participant showed weight reduction|0
1070640|NCT02641379|3473255|P8|Overall Study|Participant showed weight reduction|1
1070641|NCT02641379|3473256|P7|Overall Study|Participant showed weight reduction|0
1070642|NCT02641379|3473257|P6|Overall Study|Participant showed weight reduction|0
1070643|NCT02641379|3473258|P5|Overall Study|Participant showed weight reduction|0
1070644|NCT02641379|3473259|P4|Overall Study|Participant showed weight reduction|0
1070645|NCT02641379|3473260|P3|Overall Study|Participant showed weight reduction|0
1070646|NCT02641379|3473261|P2|Overall Study|Participant showed weight reduction|0
1070647|NCT02641379|3473262|P1|Overall Study|Participant showed weight reduction|0
1070648|NCT02641379|3473252|P11|Overall Study|Source data not found|0
1070649|NCT02641379|3473253|P10|Overall Study|Source data not found|0
1070650|NCT02641379|3473254|P9|Overall Study|Source data not found|0
1070651|NCT02641379|3473255|P8|Overall Study|Source data not found|0
1070652|NCT02641379|3473256|P7|Overall Study|Source data not found|0
1070653|NCT02641379|3473257|P6|Overall Study|Source data not found|1
1070654|NCT02641379|3473258|P5|Overall Study|Source data not found|0
1070655|NCT02641379|3473259|P4|Overall Study|Source data not found|0
1070656|NCT02641379|3473260|P3|Overall Study|Source data not found|0
1070657|NCT02641379|3473261|P2|Overall Study|Source data not found|0
1070658|NCT02641379|3473262|P1|Overall Study|Source data not found|0
1070659|NCT02641379|3473252|P11|Overall Study|Lost to Follow-up|0
1070660|NCT02641379|3473253|P10|Overall Study|Lost to Follow-up|0
1070661|NCT02641379|3473254|P9|Overall Study|Lost to Follow-up|1
1070662|NCT02641379|3473255|P8|Overall Study|Lost to Follow-up|0
1070663|NCT02641379|3473256|P7|Overall Study|Lost to Follow-up|0
1070664|NCT02641379|3473257|P6|Overall Study|Lost to Follow-up|0
1070665|NCT02641379|3473258|P5|Overall Study|Lost to Follow-up|0
1070666|NCT02641379|3473259|P4|Overall Study|Lost to Follow-up|0
1070667|NCT02641379|3473260|P3|Overall Study|Lost to Follow-up|0
1070668|NCT02641379|3473261|P2|Overall Study|Lost to Follow-up|0
1070669|NCT02641379|3473262|P1|Overall Study|Lost to Follow-up|0
1070670|NCT02641379|3473252|P11|Overall Study|Participation in sili rescue study|0
1070671|NCT02641379|3473253|P10|Overall Study|Participation in sili rescue study|0
1070672|NCT02641379|3473254|P9|Overall Study|Participation in sili rescue study|0
1070673|NCT02641379|3473255|P8|Overall Study|Participation in sili rescue study|0
1070674|NCT02641379|3473256|P7|Overall Study|Participation in sili rescue study|0
1070675|NCT02641379|3473257|P6|Overall Study|Participation in sili rescue study|1
1070676|NCT02641379|3473258|P5|Overall Study|Participation in sili rescue study|0
1070677|NCT02641379|3473259|P4|Overall Study|Participation in sili rescue study|0
1070678|NCT02641379|3473260|P3|Overall Study|Participation in sili rescue study|0
1070679|NCT02641379|3473261|P2|Overall Study|Participation in sili rescue study|0
1070680|NCT02641379|3473262|P1|Overall Study|Participation in sili rescue study|0
1070681|NCT02641379|3473252|P11|Overall Study|Protocol Violation|0
1070682|NCT02641379|3473253|P10|Overall Study|Protocol Violation|0
1070683|NCT02641379|3473254|P9|Overall Study|Protocol Violation|1
1070684|NCT02641379|3473255|P8|Overall Study|Protocol Violation|0
1070685|NCT02641379|3473256|P7|Overall Study|Protocol Violation|0
1070686|NCT02641379|3473257|P6|Overall Study|Protocol Violation|0
1070687|NCT02641379|3473258|P5|Overall Study|Protocol Violation|2
1070688|NCT02641379|3473259|P4|Overall Study|Protocol Violation|0
1070689|NCT02641379|3473260|P3|Overall Study|Protocol Violation|0
1070690|NCT02641379|3473261|P2|Overall Study|Protocol Violation|0
1070691|NCT02641379|3473262|P1|Overall Study|Protocol Violation|0
1070692|NCT02641379|3473252|P11|Overall Study|Blood could not be drawn|0
1070693|NCT02641379|3473253|P10|Overall Study|Blood could not be drawn|0
1070694|NCT02641379|3473254|P9|Overall Study|Blood could not be drawn|0
1070695|NCT02641379|3473255|P8|Overall Study|Blood could not be drawn|0
1070696|NCT02641379|3473256|P7|Overall Study|Blood could not be drawn|0
1070697|NCT02641379|3473257|P6|Overall Study|Blood could not be drawn|0
1070698|NCT02641379|3473258|P5|Overall Study|Blood could not be drawn|1
1070699|NCT02641379|3473259|P4|Overall Study|Blood could not be drawn|0
1070700|NCT02641379|3473260|P3|Overall Study|Blood could not be drawn|0
1070701|NCT02641379|3473261|P2|Overall Study|Blood could not be drawn|0
1070702|NCT02641379|3473262|P1|Overall Study|Blood could not be drawn|0
1070703|NCT02641379|3473252|P11|Overall Study|Baseline viral load unavailable|0
1070704|NCT02641379|3473253|P10|Overall Study|Baseline viral load unavailable|0
1070705|NCT02641379|3473254|P9|Overall Study|Baseline viral load unavailable|0
1070706|NCT02641379|3473255|P8|Overall Study|Baseline viral load unavailable|0
1070707|NCT02641379|3473256|P7|Overall Study|Baseline viral load unavailable|0
1070708|NCT02641379|3473257|P6|Overall Study|Baseline viral load unavailable|0
1070709|NCT02641379|3473258|P5|Overall Study|Baseline viral load unavailable|0
1070710|NCT02641379|3473259|P4|Overall Study|Baseline viral load unavailable|1
1070711|NCT02641379|3473260|P3|Overall Study|Baseline viral load unavailable|0
1070712|NCT02641379|3473261|P2|Overall Study|Baseline viral load unavailable|0
1070713|NCT02641379|3473262|P1|Overall Study|Baseline viral load unavailable|0
1070795|NCT02641379|3473256|P7|Overall Study|Financial problems|0
1070714|NCT02641379|3473252|P11|Overall Study|Inclusion criteria not fulfilled|0
1070715|NCT02641379|3473253|P10|Overall Study|Inclusion criteria not fulfilled|0
1070716|NCT02641379|3473254|P9|Overall Study|Inclusion criteria not fulfilled|0
1070717|NCT02641379|3473255|P8|Overall Study|Inclusion criteria not fulfilled|0
1070718|NCT02641379|3473256|P7|Overall Study|Inclusion criteria not fulfilled|0
1070719|NCT02641379|3473257|P6|Overall Study|Inclusion criteria not fulfilled|0
1070720|NCT02641379|3473258|P5|Overall Study|Inclusion criteria not fulfilled|0
1070721|NCT02641379|3473259|P4|Overall Study|Inclusion criteria not fulfilled|1
1070722|NCT02641379|3473260|P3|Overall Study|Inclusion criteria not fulfilled|0
1070723|NCT02641379|3473261|P2|Overall Study|Inclusion criteria not fulfilled|0
1070724|NCT02641379|3473262|P1|Overall Study|Inclusion criteria not fulfilled|0
1070725|NCT02641379|3473252|P11|Overall Study|PCR sample for Week 4 not drawn|0
1070726|NCT02641379|3473253|P10|Overall Study|PCR sample for Week 4 not drawn|0
1070727|NCT02641379|3473254|P9|Overall Study|PCR sample for Week 4 not drawn|0
1070728|NCT02641379|3473255|P8|Overall Study|PCR sample for Week 4 not drawn|0
1070729|NCT02641379|3473256|P7|Overall Study|PCR sample for Week 4 not drawn|0
1070730|NCT02641379|3473257|P6|Overall Study|PCR sample for Week 4 not drawn|0
1070731|NCT02641379|3473258|P5|Overall Study|PCR sample for Week 4 not drawn|0
1070732|NCT02641379|3473259|P4|Overall Study|PCR sample for Week 4 not drawn|1
1070733|NCT02641379|3473260|P3|Overall Study|PCR sample for Week 4 not drawn|0
1070734|NCT02641379|3473261|P2|Overall Study|PCR sample for Week 4 not drawn|0
1070735|NCT02641379|3473262|P1|Overall Study|PCR sample for Week 4 not drawn|0
1070736|NCT02641379|3473252|P11|Overall Study|PCR positive at Week 28|0
1070737|NCT02641379|3473253|P10|Overall Study|PCR positive at Week 28|0
1070738|NCT02641379|3473254|P9|Overall Study|PCR positive at Week 28|0
1070739|NCT02641379|3473255|P8|Overall Study|PCR positive at Week 28|0
1070740|NCT02641379|3473256|P7|Overall Study|PCR positive at Week 28|0
1070741|NCT02641379|3473257|P6|Overall Study|PCR positive at Week 28|0
1070742|NCT02641379|3473258|P5|Overall Study|PCR positive at Week 28|0
1070743|NCT02641379|3473259|P4|Overall Study|PCR positive at Week 28|0
1070744|NCT02641379|3473260|P3|Overall Study|PCR positive at Week 28|1
1070745|NCT02641379|3473261|P2|Overall Study|PCR positive at Week 28|0
1070746|NCT02641379|3473262|P1|Overall Study|PCR positive at Week 28|0
1070747|NCT02641379|3473252|P11|Overall Study|No PCR at baseline|0
1070748|NCT02641379|3473253|P10|Overall Study|No PCR at baseline|0
1070749|NCT02641379|3473254|P9|Overall Study|No PCR at baseline|0
1070750|NCT02641379|3473255|P8|Overall Study|No PCR at baseline|0
1070751|NCT02641379|3473256|P7|Overall Study|No PCR at baseline|0
1070752|NCT02641379|3473257|P6|Overall Study|No PCR at baseline|0
1070753|NCT02641379|3473258|P5|Overall Study|No PCR at baseline|0
1070754|NCT02641379|3473259|P4|Overall Study|No PCR at baseline|0
1070755|NCT02641379|3473260|P3|Overall Study|No PCR at baseline|1
1070756|NCT02641379|3473261|P2|Overall Study|No PCR at baseline|0
1070757|NCT02641379|3473262|P1|Overall Study|No PCR at baseline|0
1070758|NCT02641379|3473252|P11|Overall Study|PCR not performed at Week 12|0
1070759|NCT02641379|3473253|P10|Overall Study|PCR not performed at Week 12|0
1070760|NCT02641379|3473254|P9|Overall Study|PCR not performed at Week 12|0
1070761|NCT02641379|3473255|P8|Overall Study|PCR not performed at Week 12|0
1070762|NCT02641379|3473256|P7|Overall Study|PCR not performed at Week 12|0
1070763|NCT02641379|3473257|P6|Overall Study|PCR not performed at Week 12|0
1070764|NCT02641379|3473258|P5|Overall Study|PCR not performed at Week 12|0
1070765|NCT02641379|3473259|P4|Overall Study|PCR not performed at Week 12|0
1070766|NCT02641379|3473260|P3|Overall Study|PCR not performed at Week 12|1
1070767|NCT02641379|3473261|P2|Overall Study|PCR not performed at Week 12|0
1070768|NCT02641379|3473262|P1|Overall Study|PCR not performed at Week 12|0
1070769|NCT02641379|3473252|P11|Overall Study|PCR positive at Week 48|0
1070770|NCT02641379|3473253|P10|Overall Study|PCR positive at Week 48|0
1070771|NCT02641379|3473254|P9|Overall Study|PCR positive at Week 48|0
1070772|NCT02641379|3473255|P8|Overall Study|PCR positive at Week 48|0
1070773|NCT02641379|3473256|P7|Overall Study|PCR positive at Week 48|0
1070774|NCT02641379|3473257|P6|Overall Study|PCR positive at Week 48|0
1070775|NCT02641379|3473258|P5|Overall Study|PCR positive at Week 48|0
1070776|NCT02641379|3473259|P4|Overall Study|PCR positive at Week 48|0
1070777|NCT02641379|3473260|P3|Overall Study|PCR positive at Week 48|0
1070778|NCT02641379|3473261|P2|Overall Study|PCR positive at Week 48|1
1070779|NCT02641379|3473262|P1|Overall Study|PCR positive at Week 48|0
1070780|NCT02641379|3473252|P11|Overall Study|PCR positive at Week 68|0
1070781|NCT02641379|3473253|P10|Overall Study|PCR positive at Week 68|0
1070782|NCT02641379|3473254|P9|Overall Study|PCR positive at Week 68|0
1070783|NCT02641379|3473255|P8|Overall Study|PCR positive at Week 68|0
1070784|NCT02641379|3473256|P7|Overall Study|PCR positive at Week 68|0
1070785|NCT02641379|3473257|P6|Overall Study|PCR positive at Week 68|0
1070786|NCT02641379|3473258|P5|Overall Study|PCR positive at Week 68|0
1070787|NCT02641379|3473259|P4|Overall Study|PCR positive at Week 68|0
1070788|NCT02641379|3473260|P3|Overall Study|PCR positive at Week 68|0
1070789|NCT02641379|3473261|P2|Overall Study|PCR positive at Week 68|1
1070790|NCT02641379|3473262|P1|Overall Study|PCR positive at Week 68|0
1070791|NCT02641379|3473252|P11|Overall Study|Financial problems|0
1070792|NCT02641379|3473253|P10|Overall Study|Financial problems|0
1070793|NCT02641379|3473254|P9|Overall Study|Financial problems|0
1070794|NCT02641379|3473255|P8|Overall Study|Financial problems|0
1070796|NCT02641379|3473257|P6|Overall Study|Financial problems|0
1070797|NCT02641379|3473258|P5|Overall Study|Financial problems|0
1070798|NCT02641379|3473259|P4|Overall Study|Financial problems|0
1070799|NCT02641379|3473260|P3|Overall Study|Financial problems|0
1070800|NCT02641379|3473261|P2|Overall Study|Financial problems|1
1070801|NCT02641379|3473262|P1|Overall Study|Financial problems|0
1070802|NCT02641379|3473252|P11|Overall Study|Therapy stopped due to misunderstanding|0
1070803|NCT02641379|3473253|P10|Overall Study|Therapy stopped due to misunderstanding|0
1070804|NCT02641379|3473254|P9|Overall Study|Therapy stopped due to misunderstanding|0
1070805|NCT02641379|3473255|P8|Overall Study|Therapy stopped due to misunderstanding|0
1070806|NCT02641379|3473256|P7|Overall Study|Therapy stopped due to misunderstanding|0
1070807|NCT02641379|3473257|P6|Overall Study|Therapy stopped due to misunderstanding|0
1070808|NCT02641379|3473258|P5|Overall Study|Therapy stopped due to misunderstanding|0
1070809|NCT02641379|3473259|P4|Overall Study|Therapy stopped due to misunderstanding|0
1070810|NCT02641379|3473260|P3|Overall Study|Therapy stopped due to misunderstanding|0
1070811|NCT02641379|3473261|P2|Overall Study|Therapy stopped due to misunderstanding|0
1070812|NCT02641379|3473262|P1|Overall Study|Therapy stopped due to misunderstanding|1
1070813|NCT02641379|3473252|P11|Overall Study|Participant stopped study/treatment|0
1070814|NCT02641379|3473253|P10|Overall Study|Participant stopped study/treatment|0
1070815|NCT02641379|3473254|P9|Overall Study|Participant stopped study/treatment|1
1070816|NCT02641379|3473255|P8|Overall Study|Participant stopped study/treatment|0
1070817|NCT02641379|3473256|P7|Overall Study|Participant stopped study/treatment|2
1070818|NCT02641379|3473257|P6|Overall Study|Participant stopped study/treatment|1
1070819|NCT02641379|3473258|P5|Overall Study|Participant stopped study/treatment|0
1070820|NCT02641379|3473259|P4|Overall Study|Participant stopped study/treatment|0
1070821|NCT02641379|3473260|P3|Overall Study|Participant stopped study/treatment|1
1070822|NCT02641379|3473261|P2|Overall Study|Participant stopped study/treatment|3
1070823|NCT02641379|3473262|P1|Overall Study|Participant stopped study/treatment|1
1070824|NCT02641379|3473252|P11|Overall Study|Participant showed relapse|0
1070825|NCT02641379|3473253|P10|Overall Study|Participant showed relapse|0
1070826|NCT02641379|3473254|P9|Overall Study|Participant showed relapse|0
1070827|NCT02641379|3473255|P8|Overall Study|Participant showed relapse|0
1070828|NCT02641379|3473256|P7|Overall Study|Participant showed relapse|1
1070829|NCT02641379|3473257|P6|Overall Study|Participant showed relapse|0
1070830|NCT02641379|3473258|P5|Overall Study|Participant showed relapse|0
1070831|NCT02641379|3473259|P4|Overall Study|Participant showed relapse|0
1070832|NCT02641379|3473260|P3|Overall Study|Participant showed relapse|0
1070833|NCT02641379|3473261|P2|Overall Study|Participant showed relapse|0
1070834|NCT02641379|3473262|P1|Overall Study|Participant showed relapse|1
1070835|NCT02641379|3473252|P11|Overall Study|PCR positive at follow up 2|0
1070836|NCT02641379|3473253|P10|Overall Study|PCR positive at follow up 2|0
1070837|NCT02641379|3473254|P9|Overall Study|PCR positive at follow up 2|0
1070838|NCT02641379|3473255|P8|Overall Study|PCR positive at follow up 2|0
1070839|NCT02641379|3473256|P7|Overall Study|PCR positive at follow up 2|0
1070840|NCT02641379|3473257|P6|Overall Study|PCR positive at follow up 2|0
1070841|NCT02641379|3473258|P5|Overall Study|PCR positive at follow up 2|0
1070842|NCT02641379|3473259|P4|Overall Study|PCR positive at follow up 2|0
1070843|NCT02641379|3473260|P3|Overall Study|PCR positive at follow up 2|0
1070844|NCT02641379|3473261|P2|Overall Study|PCR positive at follow up 2|0
1070845|NCT02641379|3473262|P1|Overall Study|PCR positive at follow up 2|1
1070846|NCT02641379|3473252|P11|Overall Study|PCR positive at Week 24|0
1070847|NCT02641379|3473253|P10|Overall Study|PCR positive at Week 24|1
1070848|NCT02641379|3473254|P9|Overall Study|PCR positive at Week 24|0
1070849|NCT02641379|3473255|P8|Overall Study|PCR positive at Week 24|8
1070850|NCT02641379|3473256|P7|Overall Study|PCR positive at Week 24|3
1070851|NCT02641379|3473257|P6|Overall Study|PCR positive at Week 24|6
1070852|NCT02641379|3473258|P5|Overall Study|PCR positive at Week 24|0
1070853|NCT02641379|3473259|P4|Overall Study|PCR positive at Week 24|0
1070854|NCT02641379|3473260|P3|Overall Study|PCR positive at Week 24|62
1070855|NCT02641379|3473261|P2|Overall Study|PCR positive at Week 24|21
1070856|NCT02641379|3473262|P1|Overall Study|PCR positive at Week 24|15
1070857|NCT02641379|3473252|P11|Overall Study|Participant cannot be reached|1
1070858|NCT02641379|3473253|P10|Overall Study|Participant cannot be reached|2
1070859|NCT02641379|3473254|P9|Overall Study|Participant cannot be reached|0
1070860|NCT02641379|3473255|P8|Overall Study|Participant cannot be reached|1
1070861|NCT02641379|3473256|P7|Overall Study|Participant cannot be reached|0
1070862|NCT02641379|3473257|P6|Overall Study|Participant cannot be reached|1
1070863|NCT02641379|3473258|P5|Overall Study|Participant cannot be reached|2
1070864|NCT02641379|3473259|P4|Overall Study|Participant cannot be reached|8
1070865|NCT02641379|3473260|P3|Overall Study|Participant cannot be reached|0
1070866|NCT02641379|3473261|P2|Overall Study|Participant cannot be reached|4
1070867|NCT02641379|3473262|P1|Overall Study|Participant cannot be reached|4
1070868|NCT02641379|3473252|P11|Overall Study|Participant’s compliance|1
1070869|NCT02641379|3473253|P10|Overall Study|Participant’s compliance|1
1070870|NCT02641379|3473254|P9|Overall Study|Participant’s compliance|1
1070871|NCT02641379|3473255|P8|Overall Study|Participant’s compliance|0
1070872|NCT02641379|3473256|P7|Overall Study|Participant’s compliance|0
1070873|NCT02641379|3473257|P6|Overall Study|Participant’s compliance|2
1070874|NCT02641379|3473258|P5|Overall Study|Participant’s compliance|0
1070875|NCT02641379|3473259|P4|Overall Study|Participant’s compliance|1
1070876|NCT02641379|3473260|P3|Overall Study|Participant’s compliance|0
1070877|NCT02641379|3473261|P2|Overall Study|Participant’s compliance|1
1070878|NCT02641379|3473262|P1|Overall Study|Participant’s compliance|0
1070879|NCT02641379|3473252|P11|Overall Study|Participant unable to attend study visit|0
1070880|NCT02641379|3473253|P10|Overall Study|Participant unable to attend study visit|2
1070881|NCT02641379|3473254|P9|Overall Study|Participant unable to attend study visit|0
1070882|NCT02641379|3473255|P8|Overall Study|Participant unable to attend study visit|1
1070883|NCT02641379|3473256|P7|Overall Study|Participant unable to attend study visit|1
1070884|NCT02641379|3473257|P6|Overall Study|Participant unable to attend study visit|1
1070885|NCT02641379|3473258|P5|Overall Study|Participant unable to attend study visit|5
1070886|NCT02641379|3473259|P4|Overall Study|Participant unable to attend study visit|2
1070887|NCT02641379|3473260|P3|Overall Study|Participant unable to attend study visit|1
1070888|NCT02641379|3473261|P2|Overall Study|Participant unable to attend study visit|10
1070889|NCT02641379|3473262|P1|Overall Study|Participant unable to attend study visit|4
1070890|NCT02641379|3473252|P11|Overall Study|Lack of Efficacy|0
1070891|NCT02641379|3473253|P10|Overall Study|Lack of Efficacy|0
1070892|NCT02641379|3473254|P9|Overall Study|Lack of Efficacy|0
1070893|NCT02641379|3473255|P8|Overall Study|Lack of Efficacy|5
1070894|NCT02641379|3473256|P7|Overall Study|Lack of Efficacy|0
1070895|NCT02641379|3473257|P6|Overall Study|Lack of Efficacy|2
1070896|NCT02641379|3473258|P5|Overall Study|Lack of Efficacy|0
1070897|NCT02641379|3473259|P4|Overall Study|Lack of Efficacy|0
1070898|NCT02641379|3473260|P3|Overall Study|Lack of Efficacy|2
1070899|NCT02641379|3473261|P2|Overall Study|Lack of Efficacy|0
1070900|NCT02641379|3473262|P1|Overall Study|Lack of Efficacy|0
1070901|NCT02641379|3473252|P11|Overall Study|Adverse Event|5
1070902|NCT02641379|3473253|P10|Overall Study|Adverse Event|1
1070903|NCT02641379|3473254|P9|Overall Study|Adverse Event|1
1070904|NCT02641379|3473255|P8|Overall Study|Adverse Event|0
1070905|NCT02641379|3473256|P7|Overall Study|Adverse Event|5
1070906|NCT02641379|3473257|P6|Overall Study|Adverse Event|1
1070907|NCT02641379|3473258|P5|Overall Study|Adverse Event|5
1070908|NCT02641379|3473259|P4|Overall Study|Adverse Event|2
1070909|NCT02641379|3473260|P3|Overall Study|Adverse Event|2
1070910|NCT02641379|3473261|P2|Overall Study|Adverse Event|8
1070911|NCT02641379|3473262|P1|Overall Study|Adverse Event|7
1070912|NCT02641379|3473252|P11|Overall Study|Withdrawal of informed consent|0
1070913|NCT02641379|3473253|P10|Overall Study|Withdrawal of informed consent|0
1070914|NCT02641379|3473254|P9|Overall Study|Withdrawal of informed consent|0
1070915|NCT02641379|3473255|P8|Overall Study|Withdrawal of informed consent|1
1070916|NCT02641379|3473256|P7|Overall Study|Withdrawal of informed consent|0
1070917|NCT02641379|3473257|P6|Overall Study|Withdrawal of informed consent|0
1070918|NCT02641379|3473258|P5|Overall Study|Withdrawal of informed consent|0
1070919|NCT02641379|3473259|P4|Overall Study|Withdrawal of informed consent|0
1070920|NCT02641379|3473260|P3|Overall Study|Withdrawal of informed consent|0
1070921|NCT02641379|3473261|P2|Overall Study|Withdrawal of informed consent|1
1070922|NCT02641379|3473262|P1|Overall Study|Withdrawal of informed consent|0
1070923|NCT02641379|3473252|P11|Overall Study|Exclusion criterion during screening|0
1070924|NCT02641379|3473253|P10|Overall Study|Exclusion criterion during screening|0
1070925|NCT02641379|3473254|P9|Overall Study|Exclusion criterion during screening|0
1070926|NCT02641379|3473255|P8|Overall Study|Exclusion criterion during screening|0
1070927|NCT02641379|3473256|P7|Overall Study|Exclusion criterion during screening|0
1070928|NCT02641379|3473257|P6|Overall Study|Exclusion criterion during screening|0
1070929|NCT02641379|3473258|P5|Overall Study|Exclusion criterion during screening|2
1070930|NCT02641379|3473259|P4|Overall Study|Exclusion criterion during screening|1
1070931|NCT02641379|3473260|P3|Overall Study|Exclusion criterion during screening|0
1070932|NCT02641379|3473261|P2|Overall Study|Exclusion criterion during screening|0
1070933|NCT02641379|3473262|P1|Overall Study|Exclusion criterion during screening|1
1070934|NCT02640612|3473339|P3|Overall Study|Lack of Efficacy|0
1070935|NCT02640612|3473340|P2|Overall Study|Lack of Efficacy|1
1070936|NCT02640612|3473341|P1|Overall Study|Lack of Efficacy|1
1070937|NCT02640612|3473339|P3|Overall Study|Protocol Violation|0
1070938|NCT02640612|3473340|P2|Overall Study|Protocol Violation|2
1070939|NCT02640612|3473341|P1|Overall Study|Protocol Violation|0
1070940|NCT02640612|3473339|P3|Overall Study|Lost to Follow-up|1
1070941|NCT02640612|3473340|P2|Overall Study|Lost to Follow-up|1
1070942|NCT02640612|3473341|P1|Overall Study|Lost to Follow-up|4
1070943|NCT02640612|3473339|P3|Overall Study|Withdrawal by Subject|3
1070944|NCT02640612|3473340|P2|Overall Study|Withdrawal by Subject|3
1070945|NCT02640612|3473341|P1|Overall Study|Withdrawal by Subject|10
1070946|NCT02640612|3473339|P3|Overall Study|Death|0
1070947|NCT02640612|3473340|P2|Overall Study|Death|0
1070948|NCT02640612|3473341|P1|Overall Study|Death|1
1070949|NCT02640612|3473339|P3|Overall Study|Adverse Event|2
1070950|NCT02640612|3473340|P2|Overall Study|Adverse Event|7
1070951|NCT02640612|3473341|P1|Overall Study|Adverse Event|6
1070952|NCT02640547|3473361|P1|Overall Study|Miscellaneous|3
1070953|NCT02640547|3473361|P1|Overall Study|Death|6
1070954|NCT02640547|3473361|P1|Overall Study|Withdrawal by Subject|1
1070955|NCT02640547|3473361|P1|Overall Study|Failure to Return|1
1070956|NCT02640482|3473438|P2|Overall Study|Lost to Follow-up|0
1070957|NCT02640482|3473439|P1|Overall Study|Lost to Follow-up|3
1070958|NCT02640404|3473451|P2|Overall Study|Withdrawal by Subject|0
1070959|NCT02640404|3473452|P1|Overall Study|Withdrawal by Subject|1
1070960|NCT02640404|3473451|P2|Overall Study|Protocol Violation|0
1070961|NCT02640404|3473452|P1|Overall Study|Protocol Violation|1
1070962|NCT02640157|3473463|P3|Overall Study|Randomized in error; did not receive Tx|0
1070963|NCT02640157|3473464|P2|Overall Study|Randomized in error; did not receive Tx|1
1070964|NCT02640157|3473465|P1|Overall Study|Randomized in error; did not receive Tx|0
1070965|NCT02640157|3473463|P3|Overall Study|Lost to Follow-up|7
1070966|NCT02640157|3473464|P2|Overall Study|Lost to Follow-up|2
1070967|NCT02640157|3473465|P1|Overall Study|Lost to Follow-up|9
1070968|NCT02640157|3473463|P3|Overall Study|Withdrew consent|2
1070969|NCT02640157|3473464|P2|Overall Study|Withdrew consent|0
1070970|NCT02640157|3473465|P1|Overall Study|Withdrew consent|2
1070971|NCT02640157|3473463|P3|Overall Study|Adverse Event|1
1070972|NCT02640157|3473464|P2|Overall Study|Adverse Event|2
1070973|NCT02640157|3473465|P1|Overall Study|Adverse Event|2
1070974|NCT02640053|3473484|P2|Overall Study|Chemo regimen changed after 1st Rx|1
1070975|NCT02640053|3473485|P1|Overall Study|Chemo regimen changed after 1st Rx|0
1070976|NCT02640053|3473484|P2|Overall Study|Alternative Therapy|1
1070977|NCT02640053|3473485|P1|Overall Study|Alternative Therapy|1
1070978|NCT02640053|3473484|P2|Overall Study|Adverse Event|1
1070979|NCT02640053|3473485|P1|Overall Study|Adverse Event|1
1070980|NCT02640053|3473484|P2|Overall Study|Withdrawal by Subject|1
1070981|NCT02640053|3473485|P1|Overall Study|Withdrawal by Subject|2
1070982|NCT02639338|3473590|P2|Overall Study|Randomized but Not Treated|1
1070983|NCT02639338|3473591|P1|Overall Study|Randomized but Not Treated|0
1070984|NCT02639338|3473590|P2|Overall Study|Death|0
1070985|NCT02639338|3473591|P1|Overall Study|Death|1
1070986|NCT02639338|3473590|P2|Overall Study|Withdrew Consent|2
1070987|NCT02639338|3473591|P1|Overall Study|Withdrew Consent|1
1070988|NCT02639338|3473590|P2|Overall Study|Lost to Follow-up|2
1070989|NCT02639338|3473591|P1|Overall Study|Lost to Follow-up|2
1070990|NCT02639247|3473609|P2|Overall Study|Protocol Violation|0
1070991|NCT02639247|3473610|P1|Overall Study|Protocol Violation|1
1070992|NCT02639247|3473609|P2|Overall Study|Withdrew Consent|1
1070993|NCT02639247|3473610|P1|Overall Study|Withdrew Consent|0
1070994|NCT02639247|3473609|P2|Overall Study|Death|0
1070995|NCT02639247|3473610|P1|Overall Study|Death|2
1070996|NCT02639247|3473609|P2|Overall Study|Lost to Follow-up|1
1070997|NCT02639247|3473610|P1|Overall Study|Lost to Follow-up|2
1070998|NCT02639052|3473626|P1|Overall Study|Lost to Follow-up|1
1070999|NCT02638493|3473643|P3|Overall Study|Inability to provide semen samples|0
1071000|NCT02638493|3473644|P2|Overall Study|Inability to provide semen samples|0
1071001|NCT02638493|3473645|P1|Overall Study|Inability to provide semen samples|2
1071002|NCT02638259|3473676|P2|Treatment Period 2|Withdrawal by Subject|7
1071003|NCT02638259|3473677|P1|Treatment Period 2|Withdrawal by Subject|1
1071004|NCT02638259|3473676|P2|Treatment Period 2|Adverse Event|4
1071005|NCT02638259|3473677|P1|Treatment Period 2|Adverse Event|5
1071006|NCT02638259|3473676|P2|Treatment Period 1|Withdrawn per sponsor decision|2
1071007|NCT02638259|3473677|P1|Treatment Period 1|Withdrawn per sponsor decision|0
1071008|NCT02638259|3473676|P2|Treatment Period 1|Withdrawal by Subject|6
1071009|NCT02638259|3473677|P1|Treatment Period 1|Withdrawal by Subject|4
1071010|NCT02638259|3473676|P2|Treatment Period 1|Protocol Violation|3
1071011|NCT02638259|3473677|P1|Treatment Period 1|Protocol Violation|0
1071012|NCT02638259|3473676|P2|Treatment Period 1|Lack of Efficacy|1
1071013|NCT02638259|3473677|P1|Treatment Period 1|Lack of Efficacy|0
1071014|NCT02638259|3473676|P2|Treatment Period 1|Death|1
1071015|NCT02638259|3473677|P1|Treatment Period 1|Death|0
1071016|NCT02638259|3473676|P2|Treatment Period 1|Adverse Event|5
1071017|NCT02638259|3473677|P1|Treatment Period 1|Adverse Event|1
1071018|NCT02638129|3473753|P2|Overall Study|Study terminated|30
1071019|NCT02638129|3473754|P1|Overall Study|Study terminated|28
1071020|NCT02637323|3473927|P2|Overall Study|Protocol Violation|1
1071021|NCT02637323|3473928|P1|Overall Study|Protocol Violation|0
1071022|NCT02637323|3473927|P2|Overall Study|Lost to Follow-up|0
1071023|NCT02637323|3473928|P1|Overall Study|Lost to Follow-up|2
1071024|NCT02637063|3473939|P3|Overall Study|Withdrawal by Subject|3
1071025|NCT02637063|3473940|P2|Overall Study|Withdrawal by Subject|2
1071026|NCT02637063|3473941|P1|Overall Study|Withdrawal by Subject|2
1071027|NCT02637063|3473939|P3|Overall Study|Lost to Follow-up|3
1071028|NCT02637063|3473940|P2|Overall Study|Lost to Follow-up|2
1071029|NCT02637063|3473941|P1|Overall Study|Lost to Follow-up|3
1071030|NCT02637037|3473969|P2|Overall Study|Adverse Event|0
1071031|NCT02637037|3473970|P1|Overall Study|Adverse Event|1
1071032|NCT02637037|3473969|P2|Overall Study|Withdrawal by Subject|1
1071033|NCT02637037|3473970|P1|Overall Study|Withdrawal by Subject|2
1071034|NCT02637037|3473969|P2|Overall Study|Positive drug screen at admission|0
1071035|NCT02637037|3473970|P1|Overall Study|Positive drug screen at admission|1
1071036|NCT02636907|3474036|P1|Extension Phase|Lack of Efficacy|1
1071037|NCT02636907|3474036|P1|Extension Phase|Lost to Follow-up|2
1071038|NCT02636907|3474036|P1|Extension Phase|Physician Decision|1
1071039|NCT02636907|3474036|P1|Extension Phase|Withdrawal by Subject|4
1071040|NCT02636907|3474036|P1|Extension Phase|Adverse Event|2
1071041|NCT02636907|3474036|P1|Autoinjector Assessment Period|Withdrawal by Subject|2
1071042|NCT02636907|3474036|P1|Autoinjector Assessment Period|Adverse Event|2
1071043|NCT02636595|3474045|P1|Overall Study|Not specified|1
1071044|NCT02636595|3474045|P1|Overall Study|Lost to Follow-up|1
1071045|NCT02635984|3474053|P2|Overall Study|Study Arm Closed|0
1071046|NCT02635984|3474054|P1|Overall Study|Study Arm Closed|1
1071047|NCT02635984|3474053|P2|Overall Study|Lost to Follow-up|4
1071048|NCT02635984|3474054|P1|Overall Study|Lost to Follow-up|2
1071049|NCT02635204|3474123|P2|Overall Study|Lost to Follow-up|1
1071050|NCT02635204|3474124|P1|Overall Study|Lost to Follow-up|1
1071051|NCT02635204|3474123|P2|Overall Study|Adverse Event|0
1071052|NCT02635204|3474124|P1|Overall Study|Adverse Event|1
1071053|NCT02634801|3474137|P3|Follow-up Period|Adverse Event|0
1071054|NCT02634801|3474138|P2|Follow-up Period|Adverse Event|5
1071055|NCT02634801|3474139|P1|Follow-up Period|Adverse Event|1
1071056|NCT02634801|3474137|P3|Follow-up Period|Withdrawal by Subject|5
1071057|NCT02634801|3474138|P2|Follow-up Period|Withdrawal by Subject|2
1071058|NCT02634801|3474139|P1|Follow-up Period|Withdrawal by Subject|1
1071059|NCT02634801|3474137|P3|Follow-up Period|Physician Decision|1
1071060|NCT02634801|3474138|P2|Follow-up Period|Physician Decision|0
1071061|NCT02634801|3474139|P1|Follow-up Period|Physician Decision|0
1071062|NCT02634801|3474137|P3|Follow-up Period|Lost to Follow-up|2
1071063|NCT02634801|3474138|P2|Follow-up Period|Lost to Follow-up|1
1071064|NCT02634801|3474139|P1|Follow-up Period|Lost to Follow-up|3
1071065|NCT02634801|3474137|P3|Extension Period (Weeks 24 to 36)|Missing|0
1071066|NCT02634801|3474138|P2|Extension Period (Weeks 24 to 36)|Missing|0
1071067|NCT02634801|3474139|P1|Extension Period (Weeks 24 to 36)|Missing|1
1071068|NCT02634801|3474137|P3|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
1071069|NCT02634801|3474138|P2|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
1071070|NCT02634801|3474139|P1|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
1071071|NCT02634801|3474137|P3|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0
1071072|NCT02634801|3474138|P2|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0
1071073|NCT02634801|3474139|P1|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1
1071074|NCT02634801|3474137|P3|Extension Period (Weeks 24 to 36)|Adverse Event|1
1071075|NCT02634801|3474138|P2|Extension Period (Weeks 24 to 36)|Adverse Event|0
1071076|NCT02634801|3474139|P1|Extension Period (Weeks 24 to 36)|Adverse Event|0
1071077|NCT02634801|3474137|P3|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3
1071078|NCT02634801|3474138|P2|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8
1071079|NCT02634801|3474139|P1|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0
1071080|NCT02634801|3474137|P3|Treatment Period (Weeks 0 to 24)|Protocol Violation|1
1071081|NCT02634801|3474138|P2|Treatment Period (Weeks 0 to 24)|Protocol Violation|0
1071082|NCT02634801|3474139|P1|Treatment Period (Weeks 0 to 24)|Protocol Violation|0
1071083|NCT02634801|3474137|P3|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1
1071084|NCT02634801|3474138|P2|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1
1071085|NCT02634801|3474139|P1|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2
1071086|NCT02634801|3474137|P3|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0
1071087|NCT02634801|3474138|P2|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2
1071088|NCT02634801|3474139|P1|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0
1071089|NCT02634801|3474137|P3|Treatment Period (Weeks 0 to 24)|Adverse Event|0
1071090|NCT02634801|3474138|P2|Treatment Period (Weeks 0 to 24)|Adverse Event|20
1071091|NCT02634801|3474139|P1|Treatment Period (Weeks 0 to 24)|Adverse Event|2
1071092|NCT02634788|3474239|P4|Overall Study|Withdrawal by Subject|0
1071093|NCT02634788|3474240|P3|Overall Study|Withdrawal by Subject|1
1071094|NCT02634788|3474241|P2|Overall Study|Withdrawal by Subject|1
1071095|NCT02634788|3474242|P1|Overall Study|Withdrawal by Subject|0
1071096|NCT02634788|3474239|P4|Overall Study|Lost to Follow-up|0
1071097|NCT02634788|3474240|P3|Overall Study|Lost to Follow-up|0
1071098|NCT02634788|3474241|P2|Overall Study|Lost to Follow-up|1
1071099|NCT02634788|3474242|P1|Overall Study|Lost to Follow-up|0
1071100|NCT02634788|3474239|P4|Overall Study|Lack of Efficacy|4
1071101|NCT02634788|3474240|P3|Overall Study|Lack of Efficacy|1
1071102|NCT02634788|3474241|P2|Overall Study|Lack of Efficacy|0
1071103|NCT02634788|3474242|P1|Overall Study|Lack of Efficacy|4
1071104|NCT02634788|3474239|P4|Overall Study|Adverse Event|1
1071105|NCT02634788|3474240|P3|Overall Study|Adverse Event|3
1071106|NCT02634788|3474241|P2|Overall Study|Adverse Event|8
1071107|NCT02634788|3474242|P1|Overall Study|Adverse Event|0
1071108|NCT02634580|3474312|P4|Overall Study|Subject Request|1
1071109|NCT02634580|3474313|P3|Overall Study|Subject Request|1
1071110|NCT02634580|3474314|P2|Overall Study|Subject Request|0
1071111|NCT02634580|3474315|P1|Overall Study|Subject Request|1
1071112|NCT02634346|3474372|P3|Overall Study|Protocol Violation|0
1071113|NCT02634346|3474373|P2|Overall Study|Protocol Violation|1
1071114|NCT02634346|3474374|P1|Overall Study|Protocol Violation|0
1071115|NCT02634346|3474372|P3|Overall Study|Lost to Follow-up|0
1071116|NCT02634346|3474373|P2|Overall Study|Lost to Follow-up|0
1071117|NCT02634346|3474374|P1|Overall Study|Lost to Follow-up|1
1071118|NCT02634346|3474372|P3|Overall Study|Lack of Efficacy|8
1071119|NCT02634346|3474373|P2|Overall Study|Lack of Efficacy|2
1071120|NCT02634346|3474374|P1|Overall Study|Lack of Efficacy|1
1071121|NCT02634346|3474372|P3|Overall Study|Adverse Event|7
1071122|NCT02634346|3474373|P2|Overall Study|Adverse Event|2
1071123|NCT02634346|3474374|P1|Overall Study|Adverse Event|2
1071124|NCT02634346|3474372|P3|Overall Study|Withdrawal by Subject|8
1071125|NCT02634346|3474373|P2|Overall Study|Withdrawal by Subject|9
1071126|NCT02634346|3474374|P1|Overall Study|Withdrawal by Subject|8
1071127|NCT02634320|3474388|P1|Overall Study|Lack of Efficacy|2
1071128|NCT02634320|3474388|P1|Overall Study|Withdrawal by Subject|5
1071129|NCT02634320|3474388|P1|Overall Study|Protocol Violation|1
1071130|NCT02634320|3474388|P1|Overall Study|Out of window for study visits|1
1071131|NCT02634320|3474388|P1|Overall Study|Moved out of area|2
1071132|NCT02634320|3474388|P1|Overall Study|Lost to Follow-up|3
1071133|NCT02634320|3474388|P1|Overall Study|Adverse Event|2
1071134|NCT02633787|3474511|P1|Overall Study|Withdrawal by Subject|1
1071135|NCT02633215|3474523|P2|Overall Study|Lost to Follow-up|3
1071136|NCT02633215|3474524|P1|Overall Study|Lost to Follow-up|2
1071137|NCT02632838|3474536|P2|Overall Study|Lost to Follow-up|2
1071138|NCT02632838|3474537|P1|Overall Study|Lost to Follow-up|0
1071139|NCT02632838|3474536|P2|Overall Study|Withdrawal by Subject|0
1071140|NCT02632838|3474537|P1|Overall Study|Withdrawal by Subject|3
1071141|NCT02632110|3474577|P10|Overall Study|Withdrawal by Subject|1
1071142|NCT02632110|3474578|P9|Overall Study|Withdrawal by Subject|1
1071143|NCT02632110|3474579|P8|Overall Study|Withdrawal by Subject|3
1071144|NCT02632110|3474580|P7|Overall Study|Withdrawal by Subject|3
1071145|NCT02632110|3474581|P6|Overall Study|Withdrawal by Subject|1
1071146|NCT02632110|3474582|P5|Overall Study|Withdrawal by Subject|1
1071147|NCT02632110|3474583|P4|Overall Study|Withdrawal by Subject|0
1071148|NCT02632110|3474584|P3|Overall Study|Withdrawal by Subject|0
1071149|NCT02632110|3474585|P2|Overall Study|Withdrawal by Subject|1
1071150|NCT02632110|3474586|P1|Overall Study|Withdrawal by Subject|1
1071151|NCT02631551|3475057|P4|Overall Study|Other, specific reasons not collected|2
1071152|NCT02631551|3475058|P3|Overall Study|Other, specific reasons not collected|2
1071153|NCT02631551|3475059|P2|Overall Study|Other, specific reasons not collected|7
1071154|NCT02631551|3475060|P1|Overall Study|Other, specific reasons not collected|5
1071155|NCT02631551|3475057|P4|Overall Study|Non-compliance with study drug|0
1071156|NCT02631551|3475058|P3|Overall Study|Non-compliance with study drug|0
1071157|NCT02631551|3475059|P2|Overall Study|Non-compliance with study drug|0
1071158|NCT02631551|3475060|P1|Overall Study|Non-compliance with study drug|1
1071159|NCT02631551|3475057|P4|Overall Study|Non-compliance with study procedures|1
1071160|NCT02631551|3475058|P3|Overall Study|Non-compliance with study procedures|1
1071161|NCT02631551|3475059|P2|Overall Study|Non-compliance with study procedures|0
1071162|NCT02631551|3475060|P1|Overall Study|Non-compliance with study procedures|0
1071163|NCT02631551|3475057|P4|Overall Study|Protocol deviation|0
1071164|NCT02631551|3475058|P3|Overall Study|Protocol deviation|3
1071165|NCT02631551|3475059|P2|Overall Study|Protocol deviation|6
1071166|NCT02631551|3475060|P1|Overall Study|Protocol deviation|3
1071167|NCT02631551|3475057|P4|Overall Study|Withdrawal by Subject|5
1071168|NCT02631551|3475058|P3|Overall Study|Withdrawal by Subject|0
1071169|NCT02631551|3475059|P2|Overall Study|Withdrawal by Subject|2
1071170|NCT02631551|3475060|P1|Overall Study|Withdrawal by Subject|2
1071171|NCT02631551|3475057|P4|Overall Study|Lost to Follow-up|3
1071172|NCT02631551|3475058|P3|Overall Study|Lost to Follow-up|0
1071173|NCT02631551|3475059|P2|Overall Study|Lost to Follow-up|2
1071174|NCT02631551|3475060|P1|Overall Study|Lost to Follow-up|1
1071175|NCT02631551|3475057|P4|Overall Study|Lack of Efficacy|0
1071176|NCT02631551|3475058|P3|Overall Study|Lack of Efficacy|1
1071177|NCT02631551|3475059|P2|Overall Study|Lack of Efficacy|0
1071178|NCT02631551|3475060|P1|Overall Study|Lack of Efficacy|0
1071179|NCT02631551|3475057|P4|Overall Study|Adverse Event|0
1071180|NCT02631551|3475058|P3|Overall Study|Adverse Event|4
1071181|NCT02631551|3475059|P2|Overall Study|Adverse Event|2
1071182|NCT02631551|3475060|P1|Overall Study|Adverse Event|1
1071183|NCT02630706|3475099|P3|Overall Study|Withdrawal by Subject|7
1071184|NCT02630706|3475100|P2|Overall Study|Withdrawal by Subject|5
1071185|NCT02630706|3475101|P1|Overall Study|Withdrawal by Subject|4
1071186|NCT02630706|3475099|P3|Overall Study|Pregnancy|0
1071187|NCT02630706|3475100|P2|Overall Study|Pregnancy|1
1071188|NCT02630706|3475101|P1|Overall Study|Pregnancy|0
1071189|NCT02630706|3475099|P3|Overall Study|Physician Decision|0
1071190|NCT02630706|3475100|P2|Overall Study|Physician Decision|1
1071191|NCT02630706|3475101|P1|Overall Study|Physician Decision|1
1071192|NCT02630706|3475099|P3|Overall Study|Lost to Follow-up|2
1071193|NCT02630706|3475100|P2|Overall Study|Lost to Follow-up|1
1071194|NCT02630706|3475101|P1|Overall Study|Lost to Follow-up|0
1071195|NCT02630706|3475099|P3|Overall Study|Adverse Event|1
1071196|NCT02630706|3475100|P2|Overall Study|Adverse Event|1
1071197|NCT02630706|3475101|P1|Overall Study|Adverse Event|2
1071198|NCT02630563|3475208|P1|Overall Study|Administrative|1
1071199|NCT02629861|3475220|P3|Overall Study|Pregnancy|0
1071200|NCT02629861|3475221|P2|Overall Study|Pregnancy|1
1071201|NCT02629861|3475222|P1|Overall Study|Pregnancy|2
1071202|NCT02629861|3475220|P3|Overall Study|Not specified|0
1071203|NCT02629861|3475221|P2|Overall Study|Not specified|1
1071204|NCT02629861|3475222|P1|Overall Study|Not specified|1
1071205|NCT02629861|3475220|P3|Overall Study|Lost to Follow-up|4
1071206|NCT02629861|3475221|P2|Overall Study|Lost to Follow-up|9
1071207|NCT02629861|3475222|P1|Overall Study|Lost to Follow-up|12
1071208|NCT02629861|3475220|P3|Overall Study|Protocol Violation|7
1071209|NCT02629861|3475221|P2|Overall Study|Protocol Violation|3
1071210|NCT02629861|3475222|P1|Overall Study|Protocol Violation|2
1071211|NCT02629861|3475220|P3|Overall Study|Withdrawal by Subject|13
1071212|NCT02629861|3475221|P2|Overall Study|Withdrawal by Subject|8
1071213|NCT02629861|3475222|P1|Overall Study|Withdrawal by Subject|5
1071214|NCT02629861|3475220|P3|Overall Study|Adverse Event|4
1071215|NCT02629861|3475221|P2|Overall Study|Adverse Event|5
1071216|NCT02629861|3475222|P1|Overall Study|Adverse Event|7
1071217|NCT02628938|3475302|P3|Overall Study|Failure to comply with the instructions|3
1071218|NCT02628938|3475303|P2|Overall Study|Failure to comply with the instructions|0
1071219|NCT02628938|3475304|P1|Overall Study|Failure to comply with the instructions|3
1071220|NCT02628938|3475302|P3|Overall Study|Did not attend the follow up recall|1
1071221|NCT02628938|3475303|P2|Overall Study|Did not attend the follow up recall|2
1071222|NCT02628938|3475304|P1|Overall Study|Did not attend the follow up recall|2
1071223|NCT02628418|3475320|P2|Overall Study|Lost to Follow-up|2
1071224|NCT02628418|3475321|P1|Overall Study|Lost to Follow-up|1
1071225|NCT02627144|3475396|P1|Overall Study|Other|17
1071226|NCT02627144|3475396|P1|Overall Study|Enrolled, not treated|6
1071227|NCT02627144|3475396|P1|Overall Study|Lost to Follow-up|8
1071228|NCT02627144|3475396|P1|Overall Study|Administrative reasons|65
1071229|NCT02627144|3475396|P1|Overall Study|Refusal of treatment / poor cooperation|38
1071230|NCT02627144|3475396|P1|Overall Study|Death from other cause|8
1071231|NCT02627144|3475396|P1|Overall Study|Death from cancer|20
1071232|NCT02627144|3475396|P1|Overall Study|Cancer progression|171
1071233|NCT02627144|3475396|P1|Overall Study|Serious adverse event|32
1071234|NCT02626819|3475437|P2|Overall Study|Diagnosed w/ catastrophic illness|1
1071235|NCT02626819|3475438|P1|Overall Study|Diagnosed w/ catastrophic illness|0
1071236|NCT02626819|3475437|P2|Overall Study|Withdrawal by Subject|0
1071237|NCT02626819|3475438|P1|Overall Study|Withdrawal by Subject|1
1071238|NCT02626819|3475437|P2|Overall Study|Lost to Follow-up|2
1071239|NCT02626819|3475438|P1|Overall Study|Lost to Follow-up|3
1071240|NCT02626520|3475486|P2|Overall Study|Study terminated|1
1071241|NCT02626520|3475487|P1|Overall Study|Study terminated|0
1071242|NCT02626520|3475486|P2|Overall Study|Did not start protocol therapy|2
1071243|NCT02626520|3475487|P1|Overall Study|Did not start protocol therapy|0
1071244|NCT02626520|3475486|P2|Overall Study|Lack of Efficacy|2
1071245|NCT02626520|3475487|P1|Overall Study|Lack of Efficacy|0
1071246|NCT02626520|3475486|P2|Overall Study|Adverse Event|4
1071247|NCT02626520|3475487|P1|Overall Study|Adverse Event|0
1071248|NCT02626520|3475486|P2|Overall Study|Physician Decision|1
1071249|NCT02626520|3475487|P1|Overall Study|Physician Decision|1
1071250|NCT02625922|3475499|P2|Overall Study|Systolic blood pressure < 125 mmHg|1
1071251|NCT02625922|3475500|P1|Overall Study|Systolic blood pressure < 125 mmHg|1
1071252|NCT02625922|3475499|P2|Overall Study|Non-availability of IMP|1
1071253|NCT02625922|3475500|P1|Overall Study|Non-availability of IMP|1
1071254|NCT02625623|3475519|P2|Overall Study|Off-Treatment, but follow up ongoing|24
1071255|NCT02625623|3475520|P1|Overall Study|Off-Treatment, but follow up ongoing|30
1071256|NCT02625623|3475519|P2|Overall Study|Still on Treatment|10
1071257|NCT02625623|3475520|P1|Overall Study|Still on Treatment|10
1071258|NCT02625623|3475519|P2|Overall Study|Participants randomized but not treated|1
1071259|NCT02625623|3475520|P1|Overall Study|Participants randomized but not treated|9
1071260|NCT02625259|3475569|P5|First Intervention (Day 1)|Withdrawal by Subject|0
1071261|NCT02625259|3475570|P4|First Intervention (Day 1)|Withdrawal by Subject|1
1071262|NCT02625259|3475571|P3|First Intervention (Day 1)|Withdrawal by Subject|0
1071263|NCT02625259|3475572|P2|First Intervention (Day 1)|Withdrawal by Subject|0
1071264|NCT02625259|3475573|P1|First Intervention (Day 1)|Withdrawal by Subject|0
1071265|NCT02625259|3475569|P5|First Intervention (Day 1)|Adverse Event|0
1071266|NCT02625259|3475570|P4|First Intervention (Day 1)|Adverse Event|0
1071267|NCT02625259|3475571|P3|First Intervention (Day 1)|Adverse Event|0
1071268|NCT02625259|3475572|P2|First Intervention (Day 1)|Adverse Event|1
1071269|NCT02625259|3475573|P1|First Intervention (Day 1)|Adverse Event|2
1071270|NCT02625259|3475569|P5|First Intervention (Day 1)|Other|0
1071271|NCT02625259|3475570|P4|First Intervention (Day 1)|Other|0
1071272|NCT02625259|3475571|P3|First Intervention (Day 1)|Other|1
1071273|NCT02625259|3475572|P2|First Intervention (Day 1)|Other|0
1071274|NCT02625259|3475573|P1|First Intervention (Day 1)|Other|0
1071275|NCT02625233|3475610|P2|Overall Study|Adverse Event|0
1071276|NCT02625233|3475611|P1|Overall Study|Adverse Event|2
1071277|NCT02625220|3475619|P1|Overall Study|Study discontinued at site|2
1071278|NCT02625220|3475619|P1|Overall Study|Protocol Violation|1
1071279|NCT02625220|3475619|P1|Overall Study|Lost to Follow-up|2
1071280|NCT02625220|3475619|P1|Overall Study|Adverse Event|2
1071281|NCT02624791|3475719|P6|Overall Study|Withdrawal by Subject|0
1071282|NCT02624791|3475720|P5|Overall Study|Withdrawal by Subject|0
1071283|NCT02624791|3475721|P4|Overall Study|Withdrawal by Subject|0
1071284|NCT02624791|3475722|P3|Overall Study|Withdrawal by Subject|0
1071285|NCT02624791|3475723|P2|Overall Study|Withdrawal by Subject|0
1071286|NCT02624791|3475724|P1|Overall Study|Withdrawal by Subject|2
1071287|NCT02623361|3475731|P2|Overall Study|Withdrawal by Subject|1
1071288|NCT02623361|3475732|P1|Overall Study|Withdrawal by Subject|0
1071289|NCT02623361|3475731|P2|Overall Study|Protocol Violation|1
1071290|NCT02623361|3475732|P1|Overall Study|Protocol Violation|0
1071291|NCT02622568|3475744|P2|Overall Study|Lost to Follow-up|5
1071292|NCT02622568|3475745|P1|Overall Study|Lost to Follow-up|5
1071293|NCT02622321|3475755|P4|Overall Study|Withdrawal by Subject|0
1071294|NCT02622321|3475756|P3|Overall Study|Withdrawal by Subject|0
1071295|NCT02622321|3475757|P2|Overall Study|Withdrawal by Subject|0
1071296|NCT02622321|3475758|P1|Overall Study|Withdrawal by Subject|1
1071297|NCT02622321|3475755|P4|Overall Study|Ongoing treatment with emicizumab|7
1071298|NCT02622321|3475756|P3|Overall Study|Ongoing treatment with emicizumab|49
1071299|NCT02622321|3475757|P2|Overall Study|Ongoing treatment with emicizumab|13
1071300|NCT02622321|3475758|P1|Overall Study|Ongoing treatment with emicizumab|31
1071301|NCT02622321|3475755|P4|Overall Study|Ongoing in safety follow-up|0
1071302|NCT02622321|3475756|P3|Overall Study|Ongoing in safety follow-up|0
1071303|NCT02622321|3475757|P2|Overall Study|Ongoing in safety follow-up|0
1071304|NCT02622321|3475758|P1|Overall Study|Ongoing in safety follow-up|3
1071305|NCT02622321|3475755|P4|Overall Study|Ongoing treatment with no emicizumab|0
1071306|NCT02622321|3475756|P3|Overall Study|Ongoing treatment with no emicizumab|0
1071307|NCT02622321|3475757|P2|Overall Study|Ongoing treatment with no emicizumab|5
1071308|NCT02622321|3475758|P1|Overall Study|Ongoing treatment with no emicizumab|0
1071309|NCT02621931|3475820|P3|Overall Study|Not specified|3
1071310|NCT02621931|3475821|P2|Overall Study|Not specified|1
1071311|NCT02621931|3475822|P1|Overall Study|Not specified|1
1071312|NCT02621931|3475820|P3|Overall Study|Lack of Efficacy|1
1071313|NCT02621931|3475821|P2|Overall Study|Lack of Efficacy|0
1071314|NCT02621931|3475822|P1|Overall Study|Lack of Efficacy|0
1071315|NCT02621931|3475820|P3|Overall Study|Lost to Follow-up|10
1071316|NCT02621931|3475821|P2|Overall Study|Lost to Follow-up|7
1071317|NCT02621931|3475822|P1|Overall Study|Lost to Follow-up|8
1071318|NCT02621931|3475820|P3|Overall Study|Noncompliance to study procedures|2
1071319|NCT02621931|3475821|P2|Overall Study|Noncompliance to study procedures|1
1071320|NCT02621931|3475822|P1|Overall Study|Noncompliance to study procedures|0
1071321|NCT02621931|3475820|P3|Overall Study|Pregnancy|0
1071322|NCT02621931|3475821|P2|Overall Study|Pregnancy|0
1071323|NCT02621931|3475822|P1|Overall Study|Pregnancy|2
1071324|NCT02621931|3475820|P3|Overall Study|Protocol Violation|2
1071325|NCT02621931|3475821|P2|Overall Study|Protocol Violation|2
1071326|NCT02621931|3475822|P1|Overall Study|Protocol Violation|2
1071327|NCT02621931|3475820|P3|Overall Study|Withdrawal by Subject|11
1071328|NCT02621931|3475821|P2|Overall Study|Withdrawal by Subject|10
1071329|NCT02621931|3475822|P1|Overall Study|Withdrawal by Subject|12
1071330|NCT02621931|3475820|P3|Overall Study|Adverse Event|7
1071331|NCT02621931|3475821|P2|Overall Study|Adverse Event|5
1071332|NCT02621931|3475822|P1|Overall Study|Adverse Event|8
1071333|NCT02621931|3475820|P3|Overall Study|Death|0
1071334|NCT02621931|3475821|P2|Overall Study|Death|1
1071335|NCT02621931|3475822|P1|Overall Study|Death|0
1071336|NCT02621047|3475885|P3|Overall Study|Adverse Event|1
1071337|NCT02621047|3475886|P2|Overall Study|Adverse Event|0
1071338|NCT02621047|3475887|P1|Overall Study|Adverse Event|0
1071339|NCT02621034|3476003|P3|Overall Study|Lost to Follow-up|5
1071340|NCT02621034|3476004|P2|Overall Study|Lost to Follow-up|2
1071341|NCT02621034|3476005|P1|Overall Study|Lost to Follow-up|3
1071342|NCT02619812|3476031|P4|Overall Study|Withdrawal by Subject|2
1071343|NCT02619812|3476032|P3|Overall Study|Withdrawal by Subject|1
1071344|NCT02619812|3476033|P2|Overall Study|Withdrawal by Subject|0
1071345|NCT02619812|3476034|P1|Overall Study|Withdrawal by Subject|0
1071346|NCT02618759|3476166|P2|Overall Study|Other Reasons|4
1071347|NCT02618759|3476167|P1|Overall Study|Other Reasons|1
1071348|NCT02618759|3476166|P2|Overall Study|Withdrawal by Subject|0
1071349|NCT02618759|3476167|P1|Overall Study|Withdrawal by Subject|1
1071350|NCT02618759|3476166|P2|Overall Study|Lost to Follow-up|1
1071351|NCT02618759|3476167|P1|Overall Study|Lost to Follow-up|0
1071352|NCT02615990|3476302|P2|Overall Study|study terminated|1
1071353|NCT02615990|3476303|P1|Overall Study|study terminated|1
1071354|NCT02614183|3476459|P3|Post Treatment Follow-up Phase|Withdrawal by Subject|5
1071355|NCT02614183|3476460|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|2
1071356|NCT02614183|3476461|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|7
1071357|NCT02614183|3476459|P3|Post Treatment Follow-up Phase|Protocol Violation|0
1071358|NCT02614183|3476460|P2|Post Treatment Follow-up Phase|Protocol Violation|0
1071359|NCT02614183|3476461|P1|Post Treatment Follow-up Phase|Protocol Violation|1
1071360|NCT02614183|3476459|P3|Post Treatment Follow-up Phase|Physician Decision|2
1071361|NCT02614183|3476460|P2|Post Treatment Follow-up Phase|Physician Decision|1
1071362|NCT02614183|3476461|P1|Post Treatment Follow-up Phase|Physician Decision|5
1071363|NCT02614183|3476459|P3|Post Treatment Follow-up Phase|Lost to Follow-up|5
1071364|NCT02614183|3476460|P2|Post Treatment Follow-up Phase|Lost to Follow-up|3
1071365|NCT02614183|3476461|P1|Post Treatment Follow-up Phase|Lost to Follow-up|5
1071366|NCT02614183|3476459|P3|Double Blind Treatment Phase|Did not receive study drug|2
1071367|NCT02614183|3476460|P2|Double Blind Treatment Phase|Did not receive study drug|1
1071368|NCT02614183|3476461|P1|Double Blind Treatment Phase|Did not receive study drug|1
1071369|NCT02614183|3476459|P3|Double Blind Treatment Phase|Withdrawal by Subject|16
1071370|NCT02614183|3476460|P2|Double Blind Treatment Phase|Withdrawal by Subject|11
1071371|NCT02614183|3476461|P1|Double Blind Treatment Phase|Withdrawal by Subject|33
1071372|NCT02614183|3476459|P3|Double Blind Treatment Phase|Protocol Violation|2
1071373|NCT02614183|3476460|P2|Double Blind Treatment Phase|Protocol Violation|2
1071374|NCT02614183|3476461|P1|Double Blind Treatment Phase|Protocol Violation|2
1071375|NCT02614183|3476459|P3|Double Blind Treatment Phase|Pregnancy|3
1071376|NCT02614183|3476460|P2|Double Blind Treatment Phase|Pregnancy|1
1071377|NCT02614183|3476461|P1|Double Blind Treatment Phase|Pregnancy|2
1071378|NCT02614183|3476459|P3|Double Blind Treatment Phase|Physician Decision|2
1071379|NCT02614183|3476460|P2|Double Blind Treatment Phase|Physician Decision|3
1071380|NCT02614183|3476461|P1|Double Blind Treatment Phase|Physician Decision|7
1071381|NCT02614183|3476459|P3|Double Blind Treatment Phase|Lost to Follow-up|5
1071382|NCT02614183|3476460|P2|Double Blind Treatment Phase|Lost to Follow-up|9
1071383|NCT02614183|3476461|P1|Double Blind Treatment Phase|Lost to Follow-up|18
1071384|NCT02614183|3476459|P3|Double Blind Treatment Phase|Lack of Efficacy|2
1071385|NCT02614183|3476460|P2|Double Blind Treatment Phase|Lack of Efficacy|1
1071386|NCT02614183|3476461|P1|Double Blind Treatment Phase|Lack of Efficacy|10
1071387|NCT02614183|3476459|P3|Double Blind Treatment Phase|Adverse Event|7
1071388|NCT02614183|3476460|P2|Double Blind Treatment Phase|Adverse Event|9
1071389|NCT02614183|3476461|P1|Double Blind Treatment Phase|Adverse Event|10
1071390|NCT02614079|3476498|P1|Overall Study|Withdrawal by Subject|1
1071391|NCT02613910|3476502|P1|Overall Study|Termination of study|1
1071392|NCT02613871|3476551|P1|Overall Study|On Study|111
1071393|NCT02613403|3476570|P5|Overall Study|Withdrawal by Subject|0
1071394|NCT02613403|3476571|P4|Overall Study|Withdrawal by Subject|0
1071395|NCT02613403|3476572|P3|Overall Study|Withdrawal by Subject|0
1071396|NCT02613403|3476573|P2|Overall Study|Withdrawal by Subject|0
1071397|NCT02613403|3476574|P1|Overall Study|Withdrawal by Subject|2
1071398|NCT02613403|3476570|P5|Overall Study|Lost to Follow-up|0
1071399|NCT02613403|3476571|P4|Overall Study|Lost to Follow-up|0
1071400|NCT02613403|3476572|P3|Overall Study|Lost to Follow-up|0
1071401|NCT02613403|3476573|P2|Overall Study|Lost to Follow-up|1
1071402|NCT02613403|3476574|P1|Overall Study|Lost to Follow-up|0
1071403|NCT02612610|3476620|P4|Overall Study|Cough Improvement|0
1071404|NCT02612610|3476621|P3|Overall Study|Cough Improvement|1
1071405|NCT02612610|3476622|P2|Overall Study|Cough Improvement|0
1071406|NCT02612610|3476623|P1|Overall Study|Cough Improvement|0
1071407|NCT02612610|3476620|P4|Overall Study|Noncompliance|0
1071408|NCT02612610|3476621|P3|Overall Study|Noncompliance|0
1071409|NCT02612610|3476622|P2|Overall Study|Noncompliance|0
1071410|NCT02612610|3476623|P1|Overall Study|Noncompliance|1
1071411|NCT02612610|3476620|P4|Overall Study|Physician Decision|0
1071412|NCT02612610|3476621|P3|Overall Study|Physician Decision|0
1071413|NCT02612610|3476622|P2|Overall Study|Physician Decision|1
1071414|NCT02612610|3476623|P1|Overall Study|Physician Decision|0
1071415|NCT02612610|3476620|P4|Overall Study|Lack of Efficacy|1
1071416|NCT02612610|3476621|P3|Overall Study|Lack of Efficacy|0
1071417|NCT02612610|3476622|P2|Overall Study|Lack of Efficacy|2
1071418|NCT02612610|3476623|P1|Overall Study|Lack of Efficacy|1
1071419|NCT02612610|3476620|P4|Overall Study|Protocol Violation|0
1071420|NCT02612610|3476621|P3|Overall Study|Protocol Violation|1
1071421|NCT02612610|3476622|P2|Overall Study|Protocol Violation|1
1071422|NCT02612610|3476623|P1|Overall Study|Protocol Violation|0
1071423|NCT02612610|3476620|P4|Overall Study|Lost to Follow-up|0
1071424|NCT02612610|3476621|P3|Overall Study|Lost to Follow-up|0
1071425|NCT02612610|3476622|P2|Overall Study|Lost to Follow-up|1
1071426|NCT02612610|3476623|P1|Overall Study|Lost to Follow-up|0
1071427|NCT02612610|3476620|P4|Overall Study|Adverse Event|10
1071428|NCT02612610|3476621|P3|Overall Study|Adverse Event|3
1071429|NCT02612610|3476622|P2|Overall Study|Adverse Event|2
1071430|NCT02612610|3476623|P1|Overall Study|Adverse Event|2
1071431|NCT02612610|3476620|P4|Overall Study|Withdrawal by Subject|2
1071432|NCT02612610|3476621|P3|Overall Study|Withdrawal by Subject|0
1071433|NCT02612610|3476622|P2|Overall Study|Withdrawal by Subject|1
1071434|NCT02612610|3476623|P1|Overall Study|Withdrawal by Subject|1
1071435|NCT02612285|3476865|P1|Overall Study|Withdrawal by Subject|1
1071436|NCT02612077|3476869|P1|Overall Study|Unknown reason|2
1071437|NCT02612077|3476869|P1|Overall Study|Disease Progression|3
1071438|NCT02612077|3476869|P1|Overall Study|Enrollment in a Clinical Trial|1
1071439|NCT02612077|3476869|P1|Overall Study|Moved or Changed Medical Team|23
1071440|NCT02612077|3476869|P1|Overall Study|Death|377
1071441|NCT02612077|3476869|P1|Overall Study|Lost to Follow-up|20
1071442|NCT02612077|3476869|P1|Overall Study|Protocol Violation|28
1071443|NCT02612077|3476869|P1|Overall Study|Withdrawal by Subject|9
1071444|NCT02612077|3476869|P1|Overall Study|Adverse Event|3
1071445|NCT02612064|3476881|P2|Overall Study|Not Specified|2
1071446|NCT02612064|3476882|P1|Overall Study|Not Specified|0
1071447|NCT02612064|3476881|P2|Overall Study|Withdrawal by Subject|1
1071448|NCT02612064|3476882|P1|Overall Study|Withdrawal by Subject|1
1071449|NCT02610842|3476920|P1|Overall Study|Lost to Follow-up|5
1071450|NCT02610816|3476929|P4|Phase 2|Pregnancy|1
1071451|NCT02610816|3476930|P3|Phase 2|Pregnancy|0
1071452|NCT02610816|3476931|P2|Phase 2|Pregnancy|0
1071453|NCT02610816|3476932|P1|Phase 2|Pregnancy|0
1071454|NCT02610816|3476929|P4|Phase 2|Physician Decision|2
1071455|NCT02610816|3476930|P3|Phase 2|Physician Decision|0
1071456|NCT02610816|3476931|P2|Phase 2|Physician Decision|0
1071457|NCT02610816|3476932|P1|Phase 2|Physician Decision|0
1071458|NCT02610816|3476929|P4|Phase 2|Lost to Follow-up|0
1071459|NCT02610816|3476930|P3|Phase 2|Lost to Follow-up|2
1071460|NCT02610816|3476931|P2|Phase 2|Lost to Follow-up|0
1071461|NCT02610816|3476932|P1|Phase 2|Lost to Follow-up|0
1071462|NCT02610816|3476929|P4|Phase 2|Withdrawal by Subject|3
1071463|NCT02610816|3476930|P3|Phase 2|Withdrawal by Subject|9
1071464|NCT02610816|3476931|P2|Phase 2|Withdrawal by Subject|0
1071465|NCT02610816|3476932|P1|Phase 2|Withdrawal by Subject|0
1071466|NCT02610816|3476929|P4|Phase 1|Physician Decision|0
1071467|NCT02610816|3476930|P3|Phase 1|Physician Decision|0
1071468|NCT02610816|3476931|P2|Phase 1|Physician Decision|1
1071469|NCT02610816|3476932|P1|Phase 1|Physician Decision|0
1071470|NCT02610816|3476929|P4|Phase 1|Lost to Follow-up|0
1071471|NCT02610816|3476930|P3|Phase 1|Lost to Follow-up|0
1071472|NCT02610816|3476931|P2|Phase 1|Lost to Follow-up|1
1071473|NCT02610816|3476932|P1|Phase 1|Lost to Follow-up|2
1071474|NCT02610816|3476929|P4|Phase 1|Withdrawal by Subject|0
1071475|NCT02610816|3476930|P3|Phase 1|Withdrawal by Subject|0
1071476|NCT02610816|3476931|P2|Phase 1|Withdrawal by Subject|6
1071477|NCT02610816|3476932|P1|Phase 1|Withdrawal by Subject|2
1071478|NCT02609672|3476972|P2|Overall Study|Lost to Follow-up|1
1071479|NCT02609672|3476973|P1|Overall Study|Lost to Follow-up|3
1071480|NCT02609659|3477007|P1|Overall Study|Not Specified|1
1071481|NCT02609659|3477007|P1|Overall Study|Lost to Follow-up|6
1071482|NCT02609659|3477007|P1|Overall Study|Adverse Event|1
1071483|NCT02609633|3477017|P2|Overall Study|Reason not Specified|1
1071484|NCT02609633|3477018|P1|Overall Study|Reason not Specified|2
1071485|NCT02609633|3477017|P2|Overall Study|Non-Compliant with Study Procedures|0
1071486|NCT02609633|3477018|P1|Overall Study|Non-Compliant with Study Procedures|2
1071487|NCT02609633|3477017|P2|Overall Study|Protocol Deviation|0
1071488|NCT02609633|3477018|P1|Overall Study|Protocol Deviation|1
1071489|NCT02609633|3477017|P2|Overall Study|Consent Withdrawn|1
1071490|NCT02609633|3477018|P1|Overall Study|Consent Withdrawn|0
1071491|NCT02609399|3477045|P2|Influenza Season 2016-2017|Found ineligible after randomization|0
1071492|NCT02609399|3477046|P1|Influenza Season 2016-2017|Found ineligible after randomization|1
1071493|NCT02609399|3477045|P2|Influenza Season 2016-2017|Lost to Follow-up|5
1071494|NCT02609399|3477046|P1|Influenza Season 2016-2017|Lost to Follow-up|8
1071495|NCT02609399|3477045|P2|Influenza Season 2015-2016|Lost to Follow-up|2
1071496|NCT02609399|3477046|P1|Influenza Season 2015-2016|Lost to Follow-up|3
1071497|NCT02609178|3477063|P6|First Crown|Withdrawal by Subject|0
1071498|NCT02609178|3477064|P5|First Crown|Withdrawal by Subject|0
1071499|NCT02609178|3477065|P4|First Crown|Withdrawal by Subject|1
1071500|NCT02609178|3477066|P3|First Crown|Withdrawal by Subject|1
1071501|NCT02609178|3477067|P2|First Crown|Withdrawal by Subject|0
1071502|NCT02609178|3477068|P1|First Crown|Withdrawal by Subject|0
1071503|NCT02607956|3477165|P2|Overall Study|Lost to Follow-up|5
1071504|NCT02607956|3477166|P1|Overall Study|Lost to Follow-up|8
1071505|NCT02607956|3477165|P2|Overall Study|Withdrawal by Subject|8
1071506|NCT02607956|3477166|P1|Overall Study|Withdrawal by Subject|7
1071507|NCT02607956|3477165|P2|Overall Study|Protocol Violation|1
1071508|NCT02607956|3477166|P1|Overall Study|Protocol Violation|2
1071509|NCT02607956|3477165|P2|Overall Study|Non-Compliance with Study Drug|1
1071510|NCT02607956|3477166|P1|Overall Study|Non-Compliance with Study Drug|0
1071511|NCT02607956|3477165|P2|Overall Study|Investigator's Decision|0
1071512|NCT02607956|3477166|P1|Overall Study|Investigator's Decision|3
1071513|NCT02607956|3477165|P2|Overall Study|Death|2
1071514|NCT02607956|3477166|P1|Overall Study|Death|1
1071515|NCT02607956|3477165|P2|Overall Study|Adverse Event|1
1071516|NCT02607956|3477166|P1|Overall Study|Adverse Event|3
1071517|NCT02607956|3477165|P2|Overall Study|Still on Study|307
1071518|NCT02607956|3477166|P1|Overall Study|Still on Study|296
1071519|NCT02607956|3477165|P2|Overall Study|Randomized and Never Treated|5
1071520|NCT02607956|3477166|P1|Overall Study|Randomized and Never Treated|7
1071521|NCT02607930|3477180|P2|Overall Study|Lost to Follow-up|6
1071522|NCT02607930|3477181|P1|Overall Study|Lost to Follow-up|9
1071523|NCT02607930|3477180|P2|Overall Study|Withdrawal by Subject|5
1071524|NCT02607930|3477181|P1|Overall Study|Withdrawal by Subject|3
1071525|NCT02607930|3477180|P2|Overall Study|Protocol Violation|0
1071526|NCT02607930|3477181|P1|Overall Study|Protocol Violation|1
1071527|NCT02607930|3477180|P2|Overall Study|Non-Compliance with Study Drug|0
1071528|NCT02607930|3477181|P1|Overall Study|Non-Compliance with Study Drug|2
1071529|NCT02607930|3477180|P2|Overall Study|Physician Decision|0
1071530|NCT02607930|3477181|P1|Overall Study|Physician Decision|3
1071531|NCT02607930|3477180|P2|Overall Study|Adverse Event|3
1071532|NCT02607930|3477181|P1|Overall Study|Adverse Event|0
1071533|NCT02607930|3477180|P2|Overall Study|Still in Study|301
1071534|NCT02607930|3477181|P1|Overall Study|Still in Study|296
1071535|NCT02607930|3477180|P2|Overall Study|Randomized and Never Treated|0
1071536|NCT02607930|3477181|P1|Overall Study|Randomized and Never Treated|2
1071537|NCT02607800|3477203|P2|Overall Study|Randomized/Enrolled but Not Treated|1
1071538|NCT02607800|3477204|P1|Overall Study|Randomized/Enrolled but Not Treated|1
1071539|NCT02607800|3477203|P2|Overall Study|Withdrew Consent|0
1071540|NCT02607800|3477204|P1|Overall Study|Withdrew Consent|2
1071541|NCT02607800|3477203|P2|Overall Study|Lost to Follow-up|10
1071542|NCT02607800|3477204|P1|Overall Study|Lost to Follow-up|7
1071543|NCT02607735|3477222|P3|Deferred Treatment Substudy|Withdrew Consent|1
1071544|NCT02607735|3477223|P2|Deferred Treatment Substudy|Withdrew Consent|0
1071545|NCT02607735|3477224|P1|Deferred Treatment Substudy|Withdrew Consent|0
1071546|NCT02607735|3477222|P3|Deferred Treatment Substudy|Lost to Follow-up|4
1071547|NCT02607735|3477223|P2|Deferred Treatment Substudy|Lost to Follow-up|0
1071548|NCT02607735|3477224|P1|Deferred Treatment Substudy|Lost to Follow-up|0
1071549|NCT02607735|3477222|P3|Primary Study|Withdrew Consent|0
1071550|NCT02607735|3477223|P2|Primary Study|Withdrew Consent|0
1071551|NCT02607735|3477224|P1|Primary Study|Withdrew Consent|2
1071552|NCT02607735|3477222|P3|Primary Study|Lost to Follow-up|0
1071553|NCT02607735|3477223|P2|Primary Study|Lost to Follow-up|0
1071554|NCT02607735|3477224|P1|Primary Study|Lost to Follow-up|4
1071555|NCT02607735|3477222|P3|Primary Study|Randomized but Never Treated|0
1071556|NCT02607735|3477223|P2|Primary Study|Randomized but Never Treated|0
1071557|NCT02607735|3477224|P1|Primary Study|Randomized but Never Treated|1
1071558|NCT02606643|3477306|P2|Overall Study|did not meet inclusion criteria|3
1071559|NCT02606643|3477307|P1|Overall Study|did not meet inclusion criteria|1
1071560|NCT02606279|3477338|P2|Overall Study|Lost to Follow-up|1
1071561|NCT02606279|3477339|P1|Overall Study|Lost to Follow-up|0
1071562|NCT02605954|3477353|P2|Overall Study|Randomized but not treated|1
1071563|NCT02605954|3477354|P1|Overall Study|Randomized but not treated|0
1071564|NCT02605954|3477353|P2|Overall Study|Lost to Follow-up|0
1071565|NCT02605954|3477354|P1|Overall Study|Lost to Follow-up|3
1071566|NCT02605954|3477353|P2|Overall Study|Withdrew Consent|2
1071567|NCT02605954|3477354|P1|Overall Study|Withdrew Consent|2
1071568|NCT02605954|3477353|P2|Overall Study|Non-Compliance with Study Drug|0
1071569|NCT02605954|3477354|P1|Overall Study|Non-Compliance with Study Drug|1
1071570|NCT02605954|3477353|P2|Overall Study|Investigator's Discretion|0
1071571|NCT02605954|3477354|P1|Overall Study|Investigator's Discretion|1
1071572|NCT02605954|3477353|P2|Overall Study|Adverse Event|1
1071573|NCT02605954|3477354|P1|Overall Study|Adverse Event|5
1071574|NCT02605928|3477371|P1|Overall Study|Lack of Efficacy|5
1071575|NCT02605928|3477371|P1|Overall Study|Model tuning phase|28
1071576|NCT02605174|3477489|P7|Overall Study|Randomization Failure|30
1071577|NCT02605174|3477490|P6|Overall Study|Randomization Failure|11
1071578|NCT02605174|3477491|P5|Overall Study|Randomization Failure|16
1071579|NCT02605174|3477492|P4|Overall Study|Randomization Failure|7
1071580|NCT02605174|3477493|P3|Overall Study|Randomization Failure|20
1071581|NCT02605174|3477494|P2|Overall Study|Randomization Failure|6
1071582|NCT02605174|3477495|P1|Overall Study|Randomization Failure|22
1071583|NCT02605174|3477489|P7|Overall Study|Physician Decision|3
1071584|NCT02605174|3477490|P6|Overall Study|Physician Decision|0
1071585|NCT02605174|3477491|P5|Overall Study|Physician Decision|0
1071586|NCT02605174|3477492|P4|Overall Study|Physician Decision|0
1071587|NCT02605174|3477493|P3|Overall Study|Physician Decision|0
1071588|NCT02605174|3477494|P2|Overall Study|Physician Decision|0
1071589|NCT02605174|3477495|P1|Overall Study|Physician Decision|2
1071590|NCT02605174|3477489|P7|Overall Study|Withdrawal by Subject|15
1071591|NCT02605174|3477490|P6|Overall Study|Withdrawal by Subject|4
1071592|NCT02605174|3477491|P5|Overall Study|Withdrawal by Subject|6
1071593|NCT02605174|3477492|P4|Overall Study|Withdrawal by Subject|11
1071594|NCT02605174|3477493|P3|Overall Study|Withdrawal by Subject|14
1071595|NCT02605174|3477494|P2|Overall Study|Withdrawal by Subject|6
1071596|NCT02605174|3477495|P1|Overall Study|Withdrawal by Subject|9
1071597|NCT02605174|3477489|P7|Overall Study|Pregnancy|0
1071598|NCT02605174|3477490|P6|Overall Study|Pregnancy|0
1071599|NCT02605174|3477491|P5|Overall Study|Pregnancy|0
1071600|NCT02605174|3477492|P4|Overall Study|Pregnancy|2
1071601|NCT02605174|3477493|P3|Overall Study|Pregnancy|0
1071602|NCT02605174|3477494|P2|Overall Study|Pregnancy|0
1071603|NCT02605174|3477495|P1|Overall Study|Pregnancy|1
1071604|NCT02605174|3477489|P7|Overall Study|Protocol Violation|12
1071605|NCT02605174|3477490|P6|Overall Study|Protocol Violation|7
1071606|NCT02605174|3477491|P5|Overall Study|Protocol Violation|7
1071607|NCT02605174|3477492|P4|Overall Study|Protocol Violation|6
1071608|NCT02605174|3477493|P3|Overall Study|Protocol Violation|14
1071609|NCT02605174|3477494|P2|Overall Study|Protocol Violation|4
1071610|NCT02605174|3477495|P1|Overall Study|Protocol Violation|10
1071611|NCT02605174|3477489|P7|Overall Study|Lost to Follow-up|29
1071612|NCT02605174|3477490|P6|Overall Study|Lost to Follow-up|10
1071613|NCT02605174|3477491|P5|Overall Study|Lost to Follow-up|20
1071614|NCT02605174|3477492|P4|Overall Study|Lost to Follow-up|10
1071615|NCT02605174|3477493|P3|Overall Study|Lost to Follow-up|27
1071616|NCT02605174|3477494|P2|Overall Study|Lost to Follow-up|7
1071617|NCT02605174|3477495|P1|Overall Study|Lost to Follow-up|20
1071618|NCT02605174|3477489|P7|Overall Study|Adverse Event|0
1071619|NCT02605174|3477490|P6|Overall Study|Adverse Event|0
1071620|NCT02605174|3477491|P5|Overall Study|Adverse Event|4
1071621|NCT02605174|3477492|P4|Overall Study|Adverse Event|0
1071622|NCT02605174|3477493|P3|Overall Study|Adverse Event|1
1071623|NCT02605174|3477494|P2|Overall Study|Adverse Event|0
1071624|NCT02605174|3477495|P1|Overall Study|Adverse Event|0
1071625|NCT02604589|3477558|P3|Overall Study|catheter dislodgement|1
1071626|NCT02604589|3477559|P2|Overall Study|catheter dislodgement|0
1071627|NCT02604589|3477560|P1|Overall Study|catheter dislodgement|0
1071628|NCT02604550|3477588|P2|Overall Study|Incomplete data using paper journal|19
1071629|NCT02604550|3477589|P1|Overall Study|Incomplete data using paper journal|18
1071630|NCT02604550|3477588|P2|Overall Study|Withdrawal by Subject|1
1071631|NCT02604550|3477589|P1|Overall Study|Withdrawal by Subject|0
1071632|NCT02604550|3477588|P2|Overall Study|Lost to Follow-up|6
1071633|NCT02604550|3477589|P1|Overall Study|Lost to Follow-up|7
1071634|NCT02604407|3477616|P3|Overall Study|Other|4
1071635|NCT02604407|3477617|P2|Overall Study|Other|1
1071636|NCT02604407|3477618|P1|Overall Study|Other|3
1071637|NCT02604407|3477616|P3|Overall Study|Lack of Efficacy|0
1071638|NCT02604407|3477617|P2|Overall Study|Lack of Efficacy|0
1071639|NCT02604407|3477618|P1|Overall Study|Lack of Efficacy|1
1071640|NCT02604407|3477616|P3|Overall Study|Lost to Follow-up|2
1071641|NCT02604407|3477617|P2|Overall Study|Lost to Follow-up|1
1071642|NCT02604407|3477618|P1|Overall Study|Lost to Follow-up|2
1071643|NCT02604407|3477616|P3|Overall Study|Withdrawal by Subject|5
1071644|NCT02604407|3477617|P2|Overall Study|Withdrawal by Subject|3
1071645|NCT02604407|3477618|P1|Overall Study|Withdrawal by Subject|3
1071646|NCT02604407|3477616|P3|Overall Study|Protocol Violation|0
1071647|NCT02604407|3477617|P2|Overall Study|Protocol Violation|0
1071648|NCT02604407|3477618|P1|Overall Study|Protocol Violation|2
1071649|NCT02604407|3477616|P3|Overall Study|Adverse Event|5
1071650|NCT02604407|3477617|P2|Overall Study|Adverse Event|7
1071651|NCT02604407|3477618|P1|Overall Study|Adverse Event|0
1071652|NCT02604342|3477631|P2|Overall Study|Ongoing|25
1071653|NCT02604342|3477632|P1|Overall Study|Ongoing|52
1071654|NCT02604342|3477631|P2|Overall Study|Withdrawal by Subject|3
1071655|NCT02604342|3477632|P1|Overall Study|Withdrawal by Subject|3
1071656|NCT02604342|3477631|P2|Overall Study|Progression of disease|0
1071657|NCT02604342|3477632|P1|Overall Study|Progression of disease|1
1071658|NCT02604342|3477631|P2|Overall Study|Death|7
1071659|NCT02604342|3477632|P1|Overall Study|Death|16
1071660|NCT02604264|3477684|P2|Intervention|Didn't use CVC for at least 21 days|242
1071661|NCT02604264|3477685|P1|Intervention|Didn't use CVC for at least 21 days|200
1071662|NCT02604017|3477712|P2|Overall Study|Not Specified|0
1071663|NCT02604017|3477713|P1|Overall Study|Not Specified|1
1071664|NCT02604017|3477712|P2|Overall Study|Lost to Follow-up|6
1071665|NCT02604017|3477713|P1|Overall Study|Lost to Follow-up|5
1071666|NCT02604017|3477712|P2|Overall Study|Withdrew Consent|2
1071667|NCT02604017|3477713|P1|Overall Study|Withdrew Consent|0
1071668|NCT02603952|3477742|P4|Overall Study|Received oseltamivir by error|1
1071669|NCT02603952|3477743|P3|Overall Study|Received oseltamivir by error|0
1071670|NCT02603952|3477744|P2|Overall Study|Received oseltamivir by error|0
1071671|NCT02603952|3477745|P1|Overall Study|Received oseltamivir by error|0
1071672|NCT02603952|3477742|P4|Overall Study|Withdrawal by Subject|0
1071673|NCT02603952|3477743|P3|Overall Study|Withdrawal by Subject|0
1071674|NCT02603952|3477744|P2|Overall Study|Withdrawal by Subject|0
1071675|NCT02603952|3477745|P1|Overall Study|Withdrawal by Subject|1
1071676|NCT02603120|3477799|P2|Overall Study|Lost to Follow-up|2
1071677|NCT02603120|3477800|P1|Overall Study|Lost to Follow-up|2
1071678|NCT02603120|3477799|P2|Overall Study|Withdrew Consent|7
1071679|NCT02603120|3477800|P1|Overall Study|Withdrew Consent|3
1071680|NCT02603120|3477799|P2|Overall Study|Pregnancy|1
1071681|NCT02603120|3477800|P1|Overall Study|Pregnancy|0
1071682|NCT02603120|3477799|P2|Overall Study|Death|0
1071683|NCT02603120|3477800|P1|Overall Study|Death|2
1071684|NCT02603120|3477799|P2|Overall Study|Adverse Event|2
1071685|NCT02603120|3477800|P1|Overall Study|Adverse Event|3
1071686|NCT02603120|3477799|P2|Overall Study|Still in Study|269
1071687|NCT02603120|3477800|P1|Overall Study|Still in Study|272
1071688|NCT02603120|3477799|P2|Overall Study|Randomized but Never Treated|2
1071689|NCT02603120|3477800|P1|Overall Study|Randomized but Never Treated|2
1071690|NCT02603107|3477820|P2|Optional Extension Phase|Still in Study|213
1071691|NCT02603107|3477821|P1|Optional Extension Phase|Still in Study|241
1071692|NCT02603107|3477820|P2|Randomized Phase|Lost to Follow-up|3
1071693|NCT02603107|3477821|P1|Randomized Phase|Lost to Follow-up|0
1071694|NCT02603107|3477820|P2|Randomized Phase|Withdrew Consent|14
1071695|NCT02603107|3477821|P1|Randomized Phase|Withdrew Consent|8
1071696|NCT02603107|3477820|P2|Randomized Phase|Protocol Violation|0
1071697|NCT02603107|3477821|P1|Randomized Phase|Protocol Violation|1
1071698|NCT02603107|3477820|P2|Randomized Phase|Non-Compliance with Study Drug|1
1071699|NCT02603107|3477821|P1|Randomized Phase|Non-Compliance with Study Drug|1
1071700|NCT02603107|3477820|P2|Randomized Phase|Investigator's Discretion|1
1071701|NCT02603107|3477821|P1|Randomized Phase|Investigator's Discretion|0
1071702|NCT02603107|3477820|P2|Randomized Phase|Death|1
1071703|NCT02603107|3477821|P1|Randomized Phase|Death|1
1071704|NCT02603107|3477820|P2|Randomized Phase|Adverse Event|0
1071705|NCT02603107|3477821|P1|Randomized Phase|Adverse Event|2
1071706|NCT02603107|3477820|P2|Randomized Phase|Still in Study|27
1071707|NCT02603107|3477821|P1|Randomized Phase|Still in Study|32
1071708|NCT02603107|3477820|P2|Randomized Phase|Randomized and Never Treated|1
1071709|NCT02603107|3477821|P1|Randomized Phase|Randomized and Never Treated|0
1071710|NCT02601573|3477860|P5|Overall Study|Withdrawal by Subject|0
1071711|NCT02601573|3477861|P4|Overall Study|Withdrawal by Subject|1
1071712|NCT02601573|3477862|P3|Overall Study|Withdrawal by Subject|0
1071713|NCT02601573|3477863|P2|Overall Study|Withdrawal by Subject|1
1071714|NCT02601573|3477864|P1|Overall Study|Withdrawal by Subject|0
1071715|NCT02601573|3477860|P5|Overall Study|Lost to Follow-up|2
1071716|NCT02601573|3477861|P4|Overall Study|Lost to Follow-up|0
1071717|NCT02601573|3477862|P3|Overall Study|Lost to Follow-up|1
1071718|NCT02601573|3477863|P2|Overall Study|Lost to Follow-up|3
1071719|NCT02601573|3477864|P1|Overall Study|Lost to Follow-up|0
1071720|NCT02601560|3477899|P8|Overall Study|Other|0
1071721|NCT02601560|3477900|P7|Overall Study|Other|1
1071722|NCT02601560|3477901|P6|Overall Study|Other|0
1071723|NCT02601560|3477902|P5|Overall Study|Other|0
1071724|NCT02601560|3477903|P4|Overall Study|Other|0
1071725|NCT02601560|3477904|P3|Overall Study|Other|0
1071726|NCT02601560|3477905|P2|Overall Study|Other|0
1071727|NCT02601560|3477906|P1|Overall Study|Other|0
1071728|NCT02601469|3478090|P2|Overall Study|Enrolled in Error|0
1071729|NCT02601469|3478091|P1|Overall Study|Enrolled in Error|1
1071730|NCT02601300|3478097|P1|Extension Phase|Lack of Efficacy|10
1071731|NCT02601300|3478097|P1|Extension Phase|Adverse Event|4
1071732|NCT02601300|3478097|P1|Extension Phase|Withdrawal by Subject|3
1071733|NCT02601300|3478097|P1|Induction Phase|Protocol Violation|1
1071734|NCT02601300|3478097|P1|Induction Phase|Lack of Efficacy|2
1071735|NCT02600871|3478112|P2|Overall Study|Lost to Follow-up|10
1071736|NCT02600871|3478113|P1|Overall Study|Lost to Follow-up|13
1071737|NCT02600845|3478123|P1|Overall Study|Consent Withdrawal|5
1071738|NCT02600845|3478123|P1|Overall Study|Non-compliance with Study Procedures|10
1071739|NCT02600845|3478123|P1|Overall Study|Reason Not Specified|3
1071740|NCT02600819|3478138|P1|Overall Study|Still on Study|45
1071741|NCT02600819|3478138|P1|Overall Study|Withdrew Consent|5
1071742|NCT02600819|3478138|P1|Overall Study|Non-Compliance with Study Drug|1
1071743|NCT02600819|3478138|P1|Overall Study|Investigator's Discretion|2
1071744|NCT02600819|3478138|P1|Overall Study|Adverse Event|2
1071745|NCT02600351|3478227|P4|Overall Study|Randomized but Not Treated|3
1071746|NCT02600351|3478228|P3|Overall Study|Randomized but Not Treated|1
1071747|NCT02600351|3478229|P2|Overall Study|Randomized but Not Treated|0
1071748|NCT02600351|3478230|P1|Overall Study|Randomized but Not Treated|1
1071749|NCT02600351|3478227|P4|Overall Study|Lost to Follow-up|0
1071750|NCT02600351|3478228|P3|Overall Study|Lost to Follow-up|0
1071751|NCT02600351|3478229|P2|Overall Study|Lost to Follow-up|0
1071752|NCT02600351|3478230|P1|Overall Study|Lost to Follow-up|1
1071753|NCT02600351|3478227|P4|Overall Study|Lack of Efficacy|2
1071754|NCT02600351|3478228|P3|Overall Study|Lack of Efficacy|5
1071755|NCT02600351|3478229|P2|Overall Study|Lack of Efficacy|0
1071756|NCT02600351|3478230|P1|Overall Study|Lack of Efficacy|3
1071757|NCT02599129|3478262|P2|Overall Study|Withdrawal by Subject|1
1071758|NCT02599129|3478263|P1|Overall Study|Withdrawal by Subject|2
1071759|NCT02599129|3478262|P2|Overall Study|Lost to Follow-up|0
1071760|NCT02599129|3478263|P1|Overall Study|Lost to Follow-up|1
1071761|NCT02599129|3478262|P2|Overall Study|Lack of Efficacy|2
1071762|NCT02599129|3478263|P1|Overall Study|Lack of Efficacy|2
1071763|NCT02598934|3478279|P2|Overall Study|Protocol Violation|2
1071764|NCT02598934|3478280|P1|Overall Study|Protocol Violation|1
1071765|NCT02598934|3478279|P2|Overall Study|Administrative|1
1071766|NCT02598934|3478280|P1|Overall Study|Administrative|2
1071767|NCT02598934|3478279|P2|Overall Study|Withdrawal by Subject|3
1071768|NCT02598934|3478280|P1|Overall Study|Withdrawal by Subject|2
1071769|NCT02598934|3478279|P2|Overall Study|Failure to Return|3
1071770|NCT02598934|3478280|P1|Overall Study|Failure to Return|3
1071771|NCT02598934|3478279|P2|Overall Study|Adverse Event|13
1071772|NCT02598934|3478280|P1|Overall Study|Adverse Event|11
1071773|NCT02598622|3478292|P2|Overall Study|Physician Decision|0
1071774|NCT02598622|3478293|P1|Overall Study|Physician Decision|3
1071775|NCT02598622|3478292|P2|Overall Study|Withdrawal by Subject|0
1071776|NCT02598622|3478293|P1|Overall Study|Withdrawal by Subject|3
1071777|NCT02598193|3478320|P1|Overall Study|Does not want to take Nintedanib|1
1071778|NCT02598193|3478320|P1|Overall Study|Listed in active lung transplant list|1
1071779|NCT02598193|3478320|P1|Overall Study|Withdrawal by Subject|1
1071780|NCT02598193|3478320|P1|Overall Study|Adverse Event|13
1071781|NCT02598128|3478328|P4|Period A: Days -7 to -1|Adverse Event|0
1071782|NCT02598128|3478329|P3|Period A: Days -7 to -1|Adverse Event|0
1071783|NCT02598128|3478330|P2|Period A: Days -7 to -1|Adverse Event|0
1071784|NCT02598128|3478331|P1|Period A: Days -7 to -1|Adverse Event|1
1071785|NCT02597855|3478354|P2|Overall Study|Lost to Follow-up|1
1071786|NCT02597855|3478355|P1|Overall Study|Lost to Follow-up|2
1071787|NCT02597049|3478404|P3|Overall Study|Noncompliant with Study Visits|0
1071788|NCT02597049|3478405|P2|Overall Study|Noncompliant with Study Visits|0
1071789|NCT02597049|3478406|P1|Overall Study|Noncompliant with Study Visits|1
1071790|NCT02597049|3478404|P3|Overall Study|Death|0
1071791|NCT02597049|3478405|P2|Overall Study|Death|0
1071792|NCT02597049|3478406|P1|Overall Study|Death|2
1071793|NCT02597049|3478404|P3|Overall Study|Adverse Event|0
1071794|NCT02597049|3478405|P2|Overall Study|Adverse Event|0
1071795|NCT02597049|3478406|P1|Overall Study|Adverse Event|2
1071796|NCT02597049|3478404|P3|Overall Study|Withdrawal by Subject|1
1071797|NCT02597049|3478405|P2|Overall Study|Withdrawal by Subject|2
1071798|NCT02597049|3478406|P1|Overall Study|Withdrawal by Subject|2
1071799|NCT02597049|3478404|P3|Overall Study|Lost to Follow-up|2
1071800|NCT02597049|3478405|P2|Overall Study|Lost to Follow-up|3
1071801|NCT02597049|3478406|P1|Overall Study|Lost to Follow-up|0
1071802|NCT02596958|3478444|P1|Overall Study|Excluded Due to Second Line Treatment|9
1071803|NCT02596958|3478444|P1|Overall Study|Missing|32
1071804|NCT02596958|3478444|P1|Overall Study|Lost to Follow-up|33
1071805|NCT02596958|3478444|P1|Overall Study|Administrative Reasons/Other|231
1071806|NCT02596958|3478444|P1|Overall Study|Refusal of Treatment/Poor Cooperation|61
1071807|NCT02596958|3478444|P1|Overall Study|Death From Other Cause|33
1071808|NCT02596958|3478444|P1|Overall Study|Death From Cancer|112
1071809|NCT02596958|3478444|P1|Overall Study|Cancer Progression|441
1071810|NCT02596958|3478444|P1|Overall Study|Serious Adverse Drug Reactions|44
1071811|NCT02596945|3478456|P1|Overall Study|Missing|1
1071812|NCT02596945|3478456|P1|Overall Study|Withdrawal by Subject|1
1071813|NCT02596945|3478456|P1|Overall Study|Other Erythropoietin stimulating agent|4
1071814|NCT02596945|3478456|P1|Overall Study|Change to hemodialysis|15
1071815|NCT02596945|3478456|P1|Overall Study|Other|32
1071816|NCT02596945|3478456|P1|Overall Study|No documentation of study drug dosing|3
1071817|NCT02596854|3478467|P1|Overall Study|Withdrawn|8
1071818|NCT02596620|3478488|P2|Overall Study|Lost to Follow-up|1
1071819|NCT02596620|3478489|P1|Overall Study|Lost to Follow-up|1
1071820|NCT02596009|3478531|P6|Overall Study|Administrative problems|0
1071821|NCT02596009|3478532|P5|Overall Study|Administrative problems|0
1071822|NCT02596009|3478533|P4|Overall Study|Administrative problems|0
1071823|NCT02596009|3478534|P3|Overall Study|Administrative problems|0
1071824|NCT02596009|3478535|P2|Overall Study|Administrative problems|1
1071825|NCT02596009|3478536|P1|Overall Study|Administrative problems|0
1071826|NCT02595502|3478549|P2|Period 3|Received Incorrect Treatment at period 3|1
1071827|NCT02595502|3478550|P1|Period 3|Received Incorrect Treatment at period 3|0
1071828|NCT02595502|3478549|P2|Period 3|Lost to Follow-up|0
1071829|NCT02595502|3478550|P1|Period 3|Lost to Follow-up|1
1071830|NCT02595502|3478549|P2|Period 3|Protocol Violation|1
1071831|NCT02595502|3478550|P1|Period 3|Protocol Violation|0
1071832|NCT02595502|3478549|P2|Period 2|Received incorrect lens at Period 1|1
1071833|NCT02595502|3478550|P1|Period 2|Received incorrect lens at Period 1|0
1071834|NCT02595502|3478549|P2|Period 2|Adverse Event|1
1071835|NCT02595502|3478550|P1|Period 2|Adverse Event|1
1071836|NCT02595502|3478549|P2|Period 1|Lost to Follow-up|1
1071837|NCT02595502|3478550|P1|Period 1|Lost to Follow-up|0
1071838|NCT02595502|3478549|P2|Period 1|Withdrawal by Subject|0
1071839|NCT02595502|3478550|P1|Period 1|Withdrawal by Subject|1
1071840|NCT02595502|3478549|P2|Period 1|Adverse Event|1
1071841|NCT02595502|3478550|P1|Period 1|Adverse Event|0
1071842|NCT02595450|3478556|P1|Overall Study|Enrolled, but not treated|8
1071843|NCT02595450|3478556|P1|Overall Study|Unspecified (only completed 1 cycle)|73
1071844|NCT02595437|3478562|P1|Triferic Via IV|Withdrawal by Subject|1
1071845|NCT02595073|3478582|P2|Overall Study|Protocol Violation|0
1071846|NCT02595073|3478583|P1|Overall Study|Protocol Violation|2
1071847|NCT02595073|3478582|P2|Overall Study|Progressive Disease|1
1071848|NCT02595073|3478583|P1|Overall Study|Progressive Disease|0
1071849|NCT02595008|3478593|P2|Overall Study|Enrolled In Error|0
1071850|NCT02595008|3478594|P1|Overall Study|Enrolled In Error|1
1071851|NCT02594163|3478630|P2|Follow-up Period|Physician Decision|1
1071852|NCT02594163|3478631|P1|Follow-up Period|Physician Decision|0
1071853|NCT02594163|3478630|P2|Follow-up Period|Progressive Disease|0
1071854|NCT02594163|3478631|P1|Follow-up Period|Progressive Disease|2
1071855|NCT02594163|3478630|P2|Follow-up Period|Adverse Event|1
1071856|NCT02594163|3478631|P1|Follow-up Period|Adverse Event|0
1071857|NCT02594163|3478630|P2|Follow-up Period|Death|5
1071858|NCT02594163|3478631|P1|Follow-up Period|Death|2
1071859|NCT02594163|3478630|P2|Follow-up Period|Lost to Follow-up|0
1071860|NCT02594163|3478631|P1|Follow-up Period|Lost to Follow-up|1
1071861|NCT02594163|3478630|P2|Follow-up Period|Study Termination by Sponsor|4
1071862|NCT02594163|3478631|P1|Follow-up Period|Study Termination by Sponsor|6
1071863|NCT02594163|3478630|P2|Follow-up Period|Withdrawal by Subject|1
1071864|NCT02594163|3478631|P1|Follow-up Period|Withdrawal by Subject|0
1071865|NCT02594163|3478630|P2|Treatment Period|Other, Non-AE|0
1071866|NCT02594163|3478631|P1|Treatment Period|Other, Non-AE|1
1071867|NCT02594163|3478630|P2|Treatment Period|Study termination by sponsor|1
1071868|NCT02594163|3478631|P1|Treatment Period|Study termination by sponsor|2
1071869|NCT02594163|3478630|P2|Treatment Period|Physician Decision|3
1071870|NCT02594163|3478631|P1|Treatment Period|Physician Decision|1
1071871|NCT02594163|3478630|P2|Treatment Period|Adverse Event|5
1071872|NCT02594163|3478631|P1|Treatment Period|Adverse Event|1
1071873|NCT02594163|3478630|P2|Treatment Period|Progressive disease|3
1071874|NCT02594163|3478631|P1|Treatment Period|Progressive disease|2
1071875|NCT02593773|3478656|P1|Overall Study|Death|1
1071876|NCT02593773|3478656|P1|Overall Study|Study Terminated by Sponsor|31
1071877|NCT02593773|3478656|P1|Overall Study|Voluntary Withdrawal|3
1071878|NCT02591290|3478728|P1|Overall Study|Withdrawal by Subject|2
1071879|NCT02591238|3478738|P4|Overall Study|personal circumstances|0
1071880|NCT02591238|3478739|P3|Overall Study|personal circumstances|0
1071881|NCT02591238|3478740|P2|Overall Study|personal circumstances|1
1071882|NCT02591238|3478741|P1|Overall Study|personal circumstances|0
1071883|NCT02591238|3478738|P4|Overall Study|personal circumstances|1
1071884|NCT02591238|3478739|P3|Overall Study|personal circumstances|0
1071885|NCT02591238|3478740|P2|Overall Study|personal circumstances|0
1071886|NCT02591238|3478741|P1|Overall Study|personal circumstances|0
1071887|NCT02591238|3478738|P4|Overall Study|influenza|1
1071888|NCT02591238|3478739|P3|Overall Study|influenza|0
1071889|NCT02591238|3478740|P2|Overall Study|influenza|0
1071890|NCT02591238|3478741|P1|Overall Study|influenza|0
1071891|NCT02591238|3478738|P4|Overall Study|Withdrawal by Subject|1
1071892|NCT02591238|3478739|P3|Overall Study|Withdrawal by Subject|0
1071893|NCT02591238|3478740|P2|Overall Study|Withdrawal by Subject|0
1071894|NCT02591238|3478741|P1|Overall Study|Withdrawal by Subject|0
1071895|NCT02591238|3478738|P4|Overall Study|Pregnancy|0
1071896|NCT02591238|3478739|P3|Overall Study|Pregnancy|0
1071897|NCT02591238|3478740|P2|Overall Study|Pregnancy|0
1071898|NCT02591238|3478741|P1|Overall Study|Pregnancy|1
1071899|NCT02590939|3478777|P2|Overall Study|Failed the nociceptive test|1
1071900|NCT02590939|3478778|P1|Overall Study|Failed the nociceptive test|2
1071901|NCT02590939|3478777|P2|Overall Study|Withdrawal by Subject|1
1071902|NCT02590939|3478778|P1|Overall Study|Withdrawal by Subject|3
1071903|NCT02590588|3478798|P1|Overall Study|Adverse Event|1
1071904|NCT02590562|3478806|P1|Overall Study|Did Not Meet the Inclusion Criteria|6
1071905|NCT02590003|3478865|P2|Overall Study|Death|2
1071906|NCT02590003|3478866|P1|Overall Study|Death|1
1071907|NCT02587819|3478913|P1|Overall Study|Lost to Follow-up|1
1071908|NCT02587819|3478913|P1|Overall Study|Adverse Event|1
1071909|NCT02587234|3478922|P2|Overall Study|Lost to Follow-up|2
1071910|NCT02587234|3478923|P1|Overall Study|Lost to Follow-up|0
1071911|NCT02587234|3478922|P2|Overall Study|Withdrawal by Subject|1
1071912|NCT02587234|3478923|P1|Overall Study|Withdrawal by Subject|1
1071913|NCT02586805|3478948|P4|Overall Study|Physician Decision|0
1071914|NCT02586805|3478949|P3|Overall Study|Physician Decision|0
1071915|NCT02586805|3478950|P2|Overall Study|Physician Decision|0
1071916|NCT02586805|3478951|P1|Overall Study|Physician Decision|1
1071917|NCT02586805|3478948|P4|Overall Study|Lost to Follow-up|0
1071918|NCT02586805|3478949|P3|Overall Study|Lost to Follow-up|1
1071919|NCT02586805|3478950|P2|Overall Study|Lost to Follow-up|0
1071920|NCT02586805|3478951|P1|Overall Study|Lost to Follow-up|0
1071921|NCT02586805|3478948|P4|Overall Study|Adverse Event|0
1071922|NCT02586805|3478949|P3|Overall Study|Adverse Event|1
1071923|NCT02586805|3478950|P2|Overall Study|Adverse Event|0
1071924|NCT02586805|3478951|P1|Overall Study|Adverse Event|2
1071925|NCT02586805|3478948|P4|Overall Study|Withdrawal by Subject|2
1071926|NCT02586805|3478949|P3|Overall Study|Withdrawal by Subject|1
1071927|NCT02586805|3478950|P2|Overall Study|Withdrawal by Subject|1
1071928|NCT02586805|3478951|P1|Overall Study|Withdrawal by Subject|3
1071929|NCT02586506|3478973|P1|Overall Study|Other Reason|2
1071930|NCT02586506|3478973|P1|Overall Study|Lost to Follow-up|1
1071931|NCT02586506|3478973|P1|Overall Study|Protocol Violation|6
1071932|NCT02586493|3478979|P1|Overall Study|Withdrawal by Subject|1
1071933|NCT02586493|3478979|P1|Overall Study|Lost to Follow-up|1
1071934|NCT02586493|3478979|P1|Overall Study|Protocol Violation|6
1071935|NCT02586493|3478979|P1|Overall Study|Adverse Event|4
1071936|NCT02586415|3478987|P2|Overall Study|Lost to Follow-up|2
1071937|NCT02586415|3478988|P1|Overall Study|Lost to Follow-up|1
1071938|NCT02586415|3478987|P2|Overall Study|Death|23
1071939|NCT02586415|3478988|P1|Overall Study|Death|13
1071940|NCT02585999|3478996|P1|Overall Study|Protocol Violation|1
1071941|NCT02585999|3478996|P1|Overall Study|Lost to Follow-up|1
1071942|NCT02585934|3479003|P2|Overall Study|Another Reason|5
1071943|NCT02585934|3479004|P1|Overall Study|Another Reason|10
1071944|NCT02585934|3479003|P2|Overall Study|Sponsor Termination|2
1071945|NCT02585934|3479004|P1|Overall Study|Sponsor Termination|1
1071946|NCT02585934|3479003|P2|Overall Study|Caregiver Withdrew Consent|7
1071947|NCT02585934|3479004|P1|Overall Study|Caregiver Withdrew Consent|7
1071948|NCT02585934|3479003|P2|Overall Study|Death|0
1071949|NCT02585934|3479004|P1|Overall Study|Death|2
1071950|NCT02585934|3479003|P2|Overall Study|Lack of Efficacy|1
1071951|NCT02585934|3479004|P1|Overall Study|Lack of Efficacy|2
1071952|NCT02585934|3479003|P2|Overall Study|Withdrawal by Subject|21
1071953|NCT02585934|3479004|P1|Overall Study|Withdrawal by Subject|7
1071954|NCT02585934|3479003|P2|Overall Study|Physician Decision|2
1071955|NCT02585934|3479004|P1|Overall Study|Physician Decision|3
1071956|NCT02585934|3479003|P2|Overall Study|Adverse Event|22
1071957|NCT02585934|3479004|P1|Overall Study|Adverse Event|21
1071958|NCT02585934|3479003|P2|Overall Study|Protocol Violation|11
1071959|NCT02585934|3479004|P1|Overall Study|Protocol Violation|14
1071960|NCT02585934|3479003|P2|Overall Study|Lost to Follow-up|2
1071961|NCT02585934|3479004|P1|Overall Study|Lost to Follow-up|2
1071962|NCT02585778|3479047|P2|Overall Study|Other than specified above|2
1071963|NCT02585778|3479048|P1|Overall Study|Other than specified above|6
1071964|NCT02585778|3479047|P2|Overall Study|Randomized but not treated|2
1071965|NCT02585778|3479048|P1|Overall Study|Randomized but not treated|1
1071966|NCT02585778|3479047|P2|Overall Study|Death|1
1071967|NCT02585778|3479048|P1|Overall Study|Death|0
1071968|NCT02585778|3479047|P2|Overall Study|Poor compliance to study protocol|2
1071969|NCT02585778|3479048|P1|Overall Study|Poor compliance to study protocol|0
1071970|NCT02585778|3479047|P2|Overall Study|Participant did not wish to continue|4
1071971|NCT02585778|3479048|P1|Overall Study|Participant did not wish to continue|9
1071972|NCT02585778|3479047|P2|Overall Study|Adverse Event|4
1071973|NCT02585778|3479048|P1|Overall Study|Adverse Event|17
1071974|NCT02584959|3479186|P3|Period 2|Withdrawn from study|2
1071975|NCT02584959|3479187|P2|Period 2|Withdrawn from study|1
1071976|NCT02584959|3479188|P1|Period 2|Withdrawn from study|6
1071977|NCT02584959|3479186|P3|Period 1|Withdrawn from study|0
1071978|NCT02584959|3479187|P2|Period 1|Withdrawn from study|4
1071979|NCT02584959|3479188|P1|Period 1|Withdrawn from study|3
1071980|NCT02584660|3479295|P2|Overall Study|Other|1
1071981|NCT02584660|3479296|P1|Overall Study|Other|0
1071982|NCT02584660|3479295|P2|Overall Study|Withdrawal by Subject|2
1071983|NCT02584660|3479296|P1|Overall Study|Withdrawal by Subject|0
1071984|NCT02584660|3479295|P2|Overall Study|Protocol Violation|1
1071985|NCT02584660|3479296|P1|Overall Study|Protocol Violation|0
1071986|NCT02584660|3479295|P2|Overall Study|Lost to Follow-up|4
1071987|NCT02584660|3479296|P1|Overall Study|Lost to Follow-up|3
1071988|NCT02584660|3479295|P2|Overall Study|Adverse Event|0
1071989|NCT02584660|3479296|P1|Overall Study|Adverse Event|4
1071990|NCT02584504|3479315|P3|Open-label Treatment|Entered but not treated|1
1071991|NCT02584504|3479316|P2|Open-label Treatment|Entered but not treated|1
1071992|NCT02584504|3479317|P1|Open-label Treatment|Entered but not treated|0
1071993|NCT02584504|3479315|P3|Open-label Treatment|Ongoing in the study|52
1071994|NCT02584504|3479316|P2|Open-label Treatment|Ongoing in the study|49
1071995|NCT02584504|3479317|P1|Open-label Treatment|Ongoing in the study|54
1071996|NCT02584504|3479315|P3|Open-label Treatment|Adverse Event|0
1071997|NCT02584504|3479316|P2|Open-label Treatment|Adverse Event|1
1071998|NCT02584504|3479317|P1|Open-label Treatment|Adverse Event|0
1071999|NCT02584504|3479315|P3|Open-label Treatment|Participant withdrew consent|2
1072000|NCT02584504|3479316|P2|Open-label Treatment|Participant withdrew consent|0
1072001|NCT02584504|3479317|P1|Open-label Treatment|Participant withdrew consent|0
1072002|NCT02584504|3479315|P3|Double-blind Treatment|Family Matter|0
1072003|NCT02584504|3479316|P2|Double-blind Treatment|Family Matter|1
1072004|NCT02584504|3479317|P1|Double-blind Treatment|Family Matter|0
1072005|NCT02584504|3479315|P3|Double-blind Treatment|Adverse Event|0
1072006|NCT02584504|3479316|P2|Double-blind Treatment|Adverse Event|1
1072007|NCT02584504|3479317|P1|Double-blind Treatment|Adverse Event|0
1072008|NCT02584504|3479315|P3|Double-blind Treatment|Participant withdrew consent|1
1072009|NCT02584504|3479316|P2|Double-blind Treatment|Participant withdrew consent|0
1072010|NCT02584504|3479317|P1|Double-blind Treatment|Participant withdrew consent|0
1072011|NCT02583425|3479368|P1|Treatment Period|Adverse Event|1
1072012|NCT02583425|3479368|P1|Baseline|Did not meet continued criteria|5
1072013|NCT02583425|3479368|P1|Screening|Did not meet entry criteria|12
1072014|NCT02582983|3479379|P1|Overall Study|Adverse Event|1
1072015|NCT02582983|3479379|P1|Overall Study|Withdrawal by Subject|2
1072016|NCT02582983|3479379|P1|Overall Study|Death|3
1072017|NCT02582684|3479394|P1|Overall Study|Found to be ineligible after enrollment|2
1072018|NCT02582684|3479394|P1|Overall Study|Subject withdrew consent|1
1072019|NCT02582684|3479394|P1|Overall Study|Subject not able to get to clinic|10
1072020|NCT02582684|3479394|P1|Overall Study|Unable to contact subject/parent|4
1072021|NCT02582632|3479413|P1|Overall Study|Not Specified|1
1072022|NCT02582242|3479428|P2|Overall Study|Unclassified|1
1072023|NCT02582242|3479429|P1|Overall Study|Unclassified|2
1072024|NCT02582242|3479428|P2|Overall Study|Withdrawal by Subject|11
1072025|NCT02582242|3479429|P1|Overall Study|Withdrawal by Subject|11
1072026|NCT02582242|3479428|P2|Overall Study|Lost to Follow-up|1
1072027|NCT02582242|3479429|P1|Overall Study|Lost to Follow-up|0
1072028|NCT02582242|3479428|P2|Overall Study|Protocol Violation|1
1072029|NCT02582242|3479429|P1|Overall Study|Protocol Violation|3
1072030|NCT02582242|3479428|P2|Overall Study|Adverse Event|3
1072031|NCT02582242|3479429|P1|Overall Study|Adverse Event|4
1072032|NCT02581995|3479469|P1|Overall Study|Death|4
1072033|NCT02581995|3479469|P1|Overall Study|Physician Decision|1
1072034|NCT02581995|3479469|P1|Overall Study|Withdrawal by participant|12
1072035|NCT02581995|3479469|P1|Overall Study|Lost to Follow-up|5
1072036|NCT02581995|3479469|P1|Overall Study|Adverse Event|6
1072037|NCT02581995|3479469|P1|Overall Study|Unspecified other|3
1072038|NCT02581488|3479485|P2|Overall Study|Protocol Violation|4
1072039|NCT02581488|3479486|P1|Overall Study|Protocol Violation|0
1072040|NCT02581488|3479485|P2|Overall Study|Non-Compliance|0
1072041|NCT02581488|3479486|P1|Overall Study|Non-Compliance|1
1072042|NCT02581488|3479485|P2|Overall Study|Withdrawal by Subject|0
1072043|NCT02581488|3479486|P1|Overall Study|Withdrawal by Subject|1
1072044|NCT02581488|3479485|P2|Overall Study|Lost to Follow-up|0
1072045|NCT02581488|3479486|P1|Overall Study|Lost to Follow-up|1
1072046|NCT02581488|3479485|P2|Overall Study|Adverse Event|7
1072047|NCT02581488|3479486|P1|Overall Study|Adverse Event|6
1072048|NCT02581410|3479517|P2|End of Study Phase|Other-transfer of subject not completed|1
1072049|NCT02581410|3479518|P1|End of Study Phase|Other-transfer of subject not completed|0
1072050|NCT02581410|3479517|P2|End of Study Phase|Lost to Follow-up|2
1072051|NCT02581410|3479518|P1|End of Study Phase|Lost to Follow-up|0
1072052|NCT02581410|3479517|P2|End of Study Phase|Migrated/moved from study area|3
1072053|NCT02581410|3479518|P1|End of Study Phase|Migrated/moved from study area|0
1072054|NCT02581410|3479517|P2|End of Study Phase|Withdrawal by Subject|2
1072055|NCT02581410|3479518|P1|End of Study Phase|Withdrawal by Subject|1
1072056|NCT02581410|3479517|P2|End of Study Phase|Adverse Event|3
1072057|NCT02581410|3479518|P1|End of Study Phase|Adverse Event|4
1072058|NCT02581410|3479517|P2|Vaccination Phase|Migrated/moved from study area|1
1072059|NCT02581410|3479518|P1|Vaccination Phase|Migrated/moved from study area|0
1072060|NCT02581410|3479517|P2|Vaccination Phase|Withdrawal by Subject|1
1072061|NCT02581410|3479518|P1|Vaccination Phase|Withdrawal by Subject|0
1072062|NCT02581410|3479517|P2|Vaccination Phase|Adverse Event|1
1072063|NCT02581410|3479518|P1|Vaccination Phase|Adverse Event|2
1072064|NCT02581345|3479548|P4|Part 2: Week 17 to Week 47|Unspecified Reason|1
1072065|NCT02581345|3479549|P3|Part 2: Week 17 to Week 47|Unspecified Reason|1
1072066|NCT02581345|3479550|P2|Part 2: Week 17 to Week 47|Unspecified Reason|0
1072067|NCT02581345|3479551|P1|Part 2: Week 17 to Week 47|Unspecified Reason|2
1072068|NCT02581345|3479548|P4|Part 2: Week 17 to Week 47|Lost to Follow-up|1
1072069|NCT02581345|3479549|P3|Part 2: Week 17 to Week 47|Lost to Follow-up|0
1072070|NCT02581345|3479550|P2|Part 2: Week 17 to Week 47|Lost to Follow-up|0
1072071|NCT02581345|3479551|P1|Part 2: Week 17 to Week 47|Lost to Follow-up|2
1072072|NCT02581345|3479548|P4|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2
1072073|NCT02581345|3479549|P3|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3
1072074|NCT02581345|3479550|P2|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0
1072075|NCT02581345|3479551|P1|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8
1072076|NCT02581345|3479548|P4|Part 2: Week 17 to Week 47|Withdrawal by Subject|5
1072077|NCT02581345|3479549|P3|Part 2: Week 17 to Week 47|Withdrawal by Subject|7
1072078|NCT02581345|3479550|P2|Part 2: Week 17 to Week 47|Withdrawal by Subject|0
1072079|NCT02581345|3479551|P1|Part 2: Week 17 to Week 47|Withdrawal by Subject|9
1072080|NCT02581345|3479548|P4|Part 2: Week 17 to Week 47|Physician Decision|1
1072081|NCT02581345|3479549|P3|Part 2: Week 17 to Week 47|Physician Decision|2
1072082|NCT02581345|3479550|P2|Part 2: Week 17 to Week 47|Physician Decision|0
1072083|NCT02581345|3479551|P1|Part 2: Week 17 to Week 47|Physician Decision|3
1072084|NCT02581345|3479548|P4|Part 2: Week 17 to Week 47|Adverse Event|2
1072085|NCT02581345|3479549|P3|Part 2: Week 17 to Week 47|Adverse Event|2
1072086|NCT02581345|3479550|P2|Part 2: Week 17 to Week 47|Adverse Event|0
1072087|NCT02581345|3479551|P1|Part 2: Week 17 to Week 47|Adverse Event|5
1072088|NCT02581345|3479548|P4|Part 1: up to Week 16|Did Not Receive Treatment|0
1072089|NCT02581345|3479549|P3|Part 1: up to Week 16|Did Not Receive Treatment|0
1072090|NCT02581345|3479550|P2|Part 1: up to Week 16|Did Not Receive Treatment|1
1072091|NCT02581345|3479551|P1|Part 1: up to Week 16|Did Not Receive Treatment|1
1072092|NCT02581345|3479548|P4|Part 1: up to Week 16|Unspecified Reason|0
1072093|NCT02581345|3479549|P3|Part 1: up to Week 16|Unspecified Reason|0
1072094|NCT02581345|3479550|P2|Part 1: up to Week 16|Unspecified Reason|3
1072095|NCT02581345|3479551|P1|Part 1: up to Week 16|Unspecified Reason|3
1072096|NCT02581345|3479548|P4|Part 1: up to Week 16|Lost to Follow-up|0
1072097|NCT02581345|3479549|P3|Part 1: up to Week 16|Lost to Follow-up|0
1072098|NCT02581345|3479550|P2|Part 1: up to Week 16|Lost to Follow-up|0
1072099|NCT02581345|3479551|P1|Part 1: up to Week 16|Lost to Follow-up|2
1072100|NCT02581345|3479548|P4|Part 1: up to Week 16|Withdrawal by Subject|0
1072101|NCT02581345|3479549|P3|Part 1: up to Week 16|Withdrawal by Subject|0
1072102|NCT02581345|3479550|P2|Part 1: up to Week 16|Withdrawal by Subject|7
1072103|NCT02581345|3479551|P1|Part 1: up to Week 16|Withdrawal by Subject|4
1072104|NCT02581345|3479548|P4|Part 1: up to Week 16|Physician Decision|0
1072105|NCT02581345|3479549|P3|Part 1: up to Week 16|Physician Decision|0
1072106|NCT02581345|3479550|P2|Part 1: up to Week 16|Physician Decision|4
1072107|NCT02581345|3479551|P1|Part 1: up to Week 16|Physician Decision|2
1072108|NCT02581345|3479548|P4|Part 1: up to Week 16|Adverse Event|0
1072109|NCT02581345|3479549|P3|Part 1: up to Week 16|Adverse Event|0
1072110|NCT02581345|3479550|P2|Part 1: up to Week 16|Adverse Event|8
1072111|NCT02581345|3479551|P1|Part 1: up to Week 16|Adverse Event|3
1072112|NCT02580591|3479692|P4|Overall Study|Other than specified|2
1072113|NCT02580591|3479693|P3|Overall Study|Other than specified|5
1072114|NCT02580591|3479694|P2|Overall Study|Other than specified|2
1072115|NCT02580591|3479695|P1|Overall Study|Other than specified|3
1072116|NCT02580591|3479692|P4|Overall Study|Not treated|0
1072117|NCT02580591|3479693|P3|Overall Study|Not treated|0
1072118|NCT02580591|3479694|P2|Overall Study|Not treated|1
1072119|NCT02580591|3479695|P1|Overall Study|Not treated|1
1072120|NCT02580591|3479692|P4|Overall Study|Withdrawal by Subject|3
1072121|NCT02580591|3479693|P3|Overall Study|Withdrawal by Subject|2
1072122|NCT02580591|3479694|P2|Overall Study|Withdrawal by Subject|1
1072123|NCT02580591|3479695|P1|Overall Study|Withdrawal by Subject|6
1072124|NCT02580591|3479692|P4|Overall Study|Lost to Follow-up|1
1072125|NCT02580591|3479693|P3|Overall Study|Lost to Follow-up|3
1072126|NCT02580591|3479694|P2|Overall Study|Lost to Follow-up|3
1072127|NCT02580591|3479695|P1|Overall Study|Lost to Follow-up|5
1072128|NCT02580591|3479692|P4|Overall Study|Protocol Violation|1
1072129|NCT02580591|3479693|P3|Overall Study|Protocol Violation|1
1072130|NCT02580591|3479694|P2|Overall Study|Protocol Violation|2
1072131|NCT02580591|3479695|P1|Overall Study|Protocol Violation|3
1072132|NCT02580591|3479692|P4|Overall Study|Adverse Event|5
1072133|NCT02580591|3479693|P3|Overall Study|Adverse Event|2
1072134|NCT02580591|3479694|P2|Overall Study|Adverse Event|1
1072135|NCT02580591|3479695|P1|Overall Study|Adverse Event|0
1072136|NCT02580357|3479728|P3|Overall Study|Protocol Violation|0
1072137|NCT02580357|3479729|P2|Overall Study|Protocol Violation|0
1072138|NCT02580357|3479730|P1|Overall Study|Protocol Violation|1
1072139|NCT02580357|3479728|P3|Overall Study|Lost to Follow-up|0
1072140|NCT02580357|3479729|P2|Overall Study|Lost to Follow-up|0
1072141|NCT02580357|3479730|P1|Overall Study|Lost to Follow-up|2
1072142|NCT02580240|3479747|P2|Overall Study|Physician Decision|0
1072143|NCT02580240|3479748|P1|Overall Study|Physician Decision|2
1072144|NCT02579772|3479765|P2|Overall Study|flu-like illness, orthopedic trauma|1
1072145|NCT02579772|3479766|P1|Overall Study|flu-like illness, orthopedic trauma|1
1072146|NCT02579772|3479765|P2|Overall Study|Usage of additional antioxidants|0
1072147|NCT02579772|3479766|P1|Overall Study|Usage of additional antioxidants|1
1072148|NCT02579772|3479765|P2|Overall Study|Withdrawal by Subject|1
1072149|NCT02579772|3479766|P1|Overall Study|Withdrawal by Subject|0
1072150|NCT02579603|3479786|P2|Overall Study|Other than stated|0
1072151|NCT02579603|3479787|P1|Overall Study|Other than stated|1
1072152|NCT02579603|3479786|P2|Overall Study|Adverse Event|2
1072153|NCT02579603|3479787|P1|Overall Study|Adverse Event|2
1072154|NCT02579603|3479786|P2|Overall Study|Not treated|0
1072155|NCT02579603|3479787|P1|Overall Study|Not treated|1
1072156|NCT02578992|3479825|P2|Overall Study|equipment not available or malfunction|3
1072157|NCT02578992|3479826|P1|Overall Study|equipment not available or malfunction|3
1072158|NCT02578862|3479840|P2|Overall Study|Unplanned unilateral procedure|1
1072159|NCT02578862|3479841|P1|Overall Study|Unplanned unilateral procedure|0
1072160|NCT02578862|3479840|P2|Overall Study|Withdrawal by Subject|1
1072161|NCT02578862|3479841|P1|Overall Study|Withdrawal by Subject|0
1072162|NCT02578706|3479860|P3|Overall Study|Physician Decision|0
1072163|NCT02578706|3479861|P2|Overall Study|Physician Decision|1
1072164|NCT02578706|3479862|P1|Overall Study|Physician Decision|0
1072165|NCT02578706|3479860|P3|Overall Study|Lost to Follow-up|0
1072166|NCT02578706|3479861|P2|Overall Study|Lost to Follow-up|4
1072167|NCT02578706|3479862|P1|Overall Study|Lost to Follow-up|0
1072168|NCT02578706|3479860|P3|Overall Study|Withdrawal by Subject|0
1072169|NCT02578706|3479861|P2|Overall Study|Withdrawal by Subject|0
1072170|NCT02578706|3479862|P1|Overall Study|Withdrawal by Subject|1
1072171|NCT02578680|3479941|P2|Overall Study|Ongoing in Study|96
1072172|NCT02578680|3479942|P1|Overall Study|Ongoing in Study|276
1072173|NCT02578680|3479941|P2|Overall Study|Withdrawal by Subject|5
1072174|NCT02578680|3479942|P1|Overall Study|Withdrawal by Subject|8
1072175|NCT02578680|3479941|P2|Overall Study|Withdrawal by Parent/Guardian|0
1072176|NCT02578680|3479942|P1|Overall Study|Withdrawal by Parent/Guardian|1
1072177|NCT02578680|3479941|P2|Overall Study|Protocol Violation|1
1072178|NCT02578680|3479942|P1|Overall Study|Protocol Violation|1
1072179|NCT02578680|3479941|P2|Overall Study|Death|104
1072180|NCT02578680|3479942|P1|Overall Study|Death|124
1072181|NCT02578316|3479958|P1|Extension Phase|Progression of disease|6
1072182|NCT02578186|3479991|P2|Period 1 (First of Crossover)|Withdrawal by Subject|1
1072183|NCT02578186|3479992|P1|Period 1 (First of Crossover)|Withdrawal by Subject|1
1072184|NCT02578186|3479991|P2|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
1072185|NCT02578186|3479992|P1|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
1072186|NCT02577718|3479998|P1|Overall Study|Withdrawal by Subject|2
1072187|NCT02577718|3479998|P1|Overall Study|Death|6
1072188|NCT02577315|3480040|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
1072189|NCT02577315|3480041|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
1072190|NCT02577107|3480059|P2|Overall Study|Protocol deviation|1
1072191|NCT02577107|3480060|P1|Overall Study|Protocol deviation|0
1072192|NCT02577016|3480074|P2|Overall Study|Physician Decision|1
1072193|NCT02577016|3480075|P1|Overall Study|Physician Decision|0
1072194|NCT02577016|3480074|P2|Overall Study|Adverse Event|1
1072195|NCT02577016|3480075|P1|Overall Study|Adverse Event|2
1072196|NCT02577003|3480093|P2|Overall Study|Withdrawal by Subject|1
1072197|NCT02577003|3480094|P1|Overall Study|Withdrawal by Subject|0
1072198|NCT02577003|3480093|P2|Overall Study|Adverse Event|4
1072199|NCT02577003|3480094|P1|Overall Study|Adverse Event|2
1072200|NCT02576938|3480115|P3|Overall Study|Met Exclusion Criteria|0
1072201|NCT02576938|3480116|P2|Overall Study|Met Exclusion Criteria|1
1072202|NCT02576938|3480117|P1|Overall Study|Met Exclusion Criteria|0
1072203|NCT02576938|3480115|P3|Overall Study|Physician Decision|0
1072204|NCT02576938|3480116|P2|Overall Study|Physician Decision|1
1072205|NCT02576938|3480117|P1|Overall Study|Physician Decision|0
1072206|NCT02576938|3480115|P3|Overall Study|Lost to Follow-up|1
1072207|NCT02576938|3480116|P2|Overall Study|Lost to Follow-up|0
1072208|NCT02576938|3480117|P1|Overall Study|Lost to Follow-up|2
1072209|NCT02576938|3480115|P3|Overall Study|Lack of Efficacy|0
1072210|NCT02576938|3480116|P2|Overall Study|Lack of Efficacy|4
1072211|NCT02576938|3480117|P1|Overall Study|Lack of Efficacy|9
1072212|NCT02576938|3480115|P3|Overall Study|Withdrawal by Subject|4
1072213|NCT02576938|3480116|P2|Overall Study|Withdrawal by Subject|2
1072214|NCT02576938|3480117|P1|Overall Study|Withdrawal by Subject|3
1072215|NCT02576938|3480115|P3|Overall Study|Protocol Violation|1
1072216|NCT02576938|3480116|P2|Overall Study|Protocol Violation|1
1072217|NCT02576938|3480117|P1|Overall Study|Protocol Violation|1
1072218|NCT02576938|3480115|P3|Overall Study|Adverse Event|6
1072219|NCT02576938|3480116|P2|Overall Study|Adverse Event|3
1072220|NCT02576938|3480117|P1|Overall Study|Adverse Event|5
1072221|NCT02576678|3480148|P3|Overall Study|Ongoing|10
1072222|NCT02576678|3480149|P2|Overall Study|Ongoing|0
1072223|NCT02576678|3480150|P1|Overall Study|Ongoing|0
1072224|NCT02576678|3480148|P3|Overall Study|Miscellaneous|0
1072225|NCT02576678|3480149|P2|Overall Study|Miscellaneous|0
1072226|NCT02576678|3480150|P1|Overall Study|Miscellaneous|2
1072227|NCT02576678|3480148|P3|Overall Study|Lost to Follow-up|1
1072228|NCT02576678|3480149|P2|Overall Study|Lost to Follow-up|0
1072229|NCT02576678|3480150|P1|Overall Study|Lost to Follow-up|0
1072230|NCT02576678|3480148|P3|Overall Study|Withdrawal by Subject|2
1072231|NCT02576678|3480149|P2|Overall Study|Withdrawal by Subject|1
1072232|NCT02576678|3480150|P1|Overall Study|Withdrawal by Subject|3
1072233|NCT02576678|3480148|P3|Overall Study|Adverse Event|2
1072234|NCT02576678|3480149|P2|Overall Study|Adverse Event|0
1072235|NCT02576678|3480150|P1|Overall Study|Adverse Event|0
1072236|NCT02576639|3480187|P5|Overall Study|Physician Decision|1
1072237|NCT02576639|3480188|P4|Overall Study|Physician Decision|0
1072238|NCT02576639|3480189|P3|Overall Study|Physician Decision|0
1072239|NCT02576639|3480190|P2|Overall Study|Physician Decision|0
1072240|NCT02576639|3480191|P1|Overall Study|Physician Decision|0
1072241|NCT02576639|3480187|P5|Overall Study|Adverse Event|2
1072242|NCT02576639|3480188|P4|Overall Study|Adverse Event|1
1072243|NCT02576639|3480189|P3|Overall Study|Adverse Event|1
1072244|NCT02576639|3480190|P2|Overall Study|Adverse Event|0
1072245|NCT02576639|3480191|P1|Overall Study|Adverse Event|1
1072246|NCT02576639|3480187|P5|Overall Study|Withdrawal by Subject|1
1072247|NCT02576639|3480188|P4|Overall Study|Withdrawal by Subject|0
1072248|NCT02576639|3480189|P3|Overall Study|Withdrawal by Subject|1
1072249|NCT02576639|3480190|P2|Overall Study|Withdrawal by Subject|2
1072250|NCT02576639|3480191|P1|Overall Study|Withdrawal by Subject|1
1072251|NCT02576587|3480250|P2|Follow up Period (Case Only)|Controls not eligible for followup|155
1072252|NCT02576587|3480251|P1|Follow up Period (Case Only)|Controls not eligible for followup|0
1072253|NCT02576587|3480250|P2|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0
1072254|NCT02576587|3480251|P1|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92
1072255|NCT02576587|3480250|P2|Follow up Period (Case Only)|Withdrawal by Subject|0
1072256|NCT02576587|3480251|P1|Follow up Period (Case Only)|Withdrawal by Subject|25
1072257|NCT02576587|3480250|P2|Baseline|Equipment failure|1
1072258|NCT02576587|3480251|P1|Baseline|Equipment failure|0
1072259|NCT02576535|3480269|P1|Overall Study|Withdrawal by Subject|2
1072260|NCT02576145|3480293|P2|Overall Study|Tetanus Titers Decreased|1
1072261|NCT02576145|3480294|P1|Overall Study|Tetanus Titers Decreased|0
1072262|NCT02576145|3480293|P2|Overall Study|Acute rejection|0
1072263|NCT02576145|3480294|P1|Overall Study|Acute rejection|1
1072264|NCT02576145|3480293|P2|Overall Study|Withdrawal by Subject|0
1072265|NCT02576145|3480294|P1|Overall Study|Withdrawal by Subject|1
1072266|NCT02576145|3480293|P2|Overall Study|Adverse Event|0
1072267|NCT02576145|3480294|P1|Overall Study|Adverse Event|1
1072268|NCT02575911|3480336|P1|Overall Study|Lost to Follow-up|1
1072269|NCT02575833|3480356|P2|Overall Study|Lost to Follow-up|0
1072270|NCT02575833|3480357|P1|Overall Study|Lost to Follow-up|1
1072271|NCT02575833|3480356|P2|Overall Study|Withdrawal by Subject|1
1072272|NCT02575833|3480357|P1|Overall Study|Withdrawal by Subject|0
1072273|NCT02574845|3480378|P6|Overall Study|Adverse Event|1
1072274|NCT02574845|3480379|P5|Overall Study|Adverse Event|0
1072275|NCT02574845|3480380|P4|Overall Study|Adverse Event|0
1072276|NCT02574845|3480381|P3|Overall Study|Adverse Event|0
1072277|NCT02574845|3480382|P2|Overall Study|Adverse Event|1
1072278|NCT02574845|3480383|P1|Overall Study|Adverse Event|0
1072279|NCT02574845|3480378|P6|Overall Study|Consent withdrawn further participation|0
1072280|NCT02574845|3480379|P5|Overall Study|Consent withdrawn further participation|1
1072281|NCT02574845|3480380|P4|Overall Study|Consent withdrawn further participation|0
1072282|NCT02574845|3480381|P3|Overall Study|Consent withdrawn further participation|0
1072283|NCT02574845|3480382|P2|Overall Study|Consent withdrawn further participation|0
1072284|NCT02574845|3480383|P1|Overall Study|Consent withdrawn further participation|0
1072285|NCT02574260|3480413|P1|Overall Study|Disease Progression|1
1072286|NCT02574247|3480422|P3|Overall Study|Did not meet inclusion criteria|5
1072287|NCT02574247|3480423|P2|Overall Study|Did not meet inclusion criteria|3
1072288|NCT02574247|3480424|P1|Overall Study|Did not meet inclusion criteria|4
1072289|NCT02574247|3480422|P3|Overall Study|Withdrawal by Subject|0
1072290|NCT02574247|3480423|P2|Overall Study|Withdrawal by Subject|0
1072291|NCT02574247|3480424|P1|Overall Study|Withdrawal by Subject|1
1072292|NCT02573948|3480436|P1|Longitudinal Cohort|Incarcerated|25
1072293|NCT02573948|3480436|P1|Longitudinal Cohort|Lost to Follow-up|22
1072294|NCT02573948|3480436|P1|Longitudinal Cohort|Death|9
1072295|NCT02573870|3480446|P2|Overall Study|Other: Fail to Meet Visit|2
1072296|NCT02573870|3480447|P1|Overall Study|Other: Fail to Meet Visit|0
1072297|NCT02573870|3480446|P2|Overall Study|Lost to Follow-up|1
1072298|NCT02573870|3480447|P1|Overall Study|Lost to Follow-up|0
1072299|NCT02573870|3480446|P2|Overall Study|Other: Reached defined stopping criteria|1
1072300|NCT02573870|3480447|P1|Overall Study|Other: Reached defined stopping criteria|0
1072301|NCT02573870|3480446|P2|Overall Study|Lack of Efficacy|1
1072302|NCT02573870|3480447|P1|Overall Study|Lack of Efficacy|0
1072303|NCT02573870|3480446|P2|Overall Study|Adverse Event|2
1072304|NCT02573870|3480447|P1|Overall Study|Adverse Event|0
1072305|NCT02573467|3480457|P4|Post-treatment Follow up Epoch|Technical problems|0
1072306|NCT02573467|3480458|P3|Post-treatment Follow up Epoch|Technical problems|1
1072307|NCT02573467|3480459|P2|Post-treatment Follow up Epoch|Technical problems|0
1072308|NCT02573467|3480460|P1|Post-treatment Follow up Epoch|Technical problems|0
1072309|NCT02573467|3480457|P4|Post-treatment Follow up Epoch|Withdrawal by Subject|2
1072310|NCT02573467|3480458|P3|Post-treatment Follow up Epoch|Withdrawal by Subject|9
1072311|NCT02573467|3480459|P2|Post-treatment Follow up Epoch|Withdrawal by Subject|4
1072312|NCT02573467|3480460|P1|Post-treatment Follow up Epoch|Withdrawal by Subject|5
1072313|NCT02573467|3480457|P4|Post-treatment Follow up Epoch|Death|1
1072314|NCT02573467|3480458|P3|Post-treatment Follow up Epoch|Death|0
1072315|NCT02573467|3480459|P2|Post-treatment Follow up Epoch|Death|1
1072316|NCT02573467|3480460|P1|Post-treatment Follow up Epoch|Death|1
1072317|NCT02573467|3480457|P4|Double-blind Treatment Epoch|Study Terminated by sponsor|55
1072318|NCT02573467|3480458|P3|Double-blind Treatment Epoch|Study Terminated by sponsor|48
1072319|NCT02573467|3480459|P2|Double-blind Treatment Epoch|Study Terminated by sponsor|51
1072320|NCT02573467|3480460|P1|Double-blind Treatment Epoch|Study Terminated by sponsor|50
1072321|NCT02573467|3480457|P4|Double-blind Treatment Epoch|Withdrawal by Subject|0
1072322|NCT02573467|3480458|P3|Double-blind Treatment Epoch|Withdrawal by Subject|1
1072323|NCT02573467|3480459|P2|Double-blind Treatment Epoch|Withdrawal by Subject|1
1072324|NCT02573467|3480460|P1|Double-blind Treatment Epoch|Withdrawal by Subject|2
1072325|NCT02573467|3480457|P4|Double-blind Treatment Epoch|Adverse Event|0
1072326|NCT02573467|3480458|P3|Double-blind Treatment Epoch|Adverse Event|1
1072327|NCT02573467|3480459|P2|Double-blind Treatment Epoch|Adverse Event|0
1072328|NCT02573467|3480460|P1|Double-blind Treatment Epoch|Adverse Event|1
1072329|NCT02573467|3480457|P4|Double-blind Treatment Epoch|Lack of Efficacy|0
1072330|NCT02573467|3480458|P3|Double-blind Treatment Epoch|Lack of Efficacy|1
1072331|NCT02573467|3480459|P2|Double-blind Treatment Epoch|Lack of Efficacy|0
1072332|NCT02573467|3480460|P1|Double-blind Treatment Epoch|Lack of Efficacy|0
1072333|NCT02573155|3480524|P2|Washout Between Treatment Period 4 and 5|Adverse Event|1
1072334|NCT02573155|3480525|P1|Washout Between Treatment Period 4 and 5|Adverse Event|0
1072335|NCT02573155|3480524|P2|Washout Between Treatment Period 3 and 4|Adverse Event|1
1072336|NCT02573155|3480525|P1|Washout Between Treatment Period 3 and 4|Adverse Event|0
1072337|NCT02573155|3480524|P2|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1
1072338|NCT02573155|3480525|P1|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0
1072339|NCT02573155|3480524|P2|Washout Between Treatment Period 2 and 3|Adverse Event|2
1072340|NCT02573155|3480525|P1|Washout Between Treatment Period 2 and 3|Adverse Event|0
1072341|NCT02573155|3480524|P2|Washout Between Treatment Period 2 and 3|Sponsor's decision|0
1072342|NCT02573155|3480525|P1|Washout Between Treatment Period 2 and 3|Sponsor's decision|1
1072343|NCT02573155|3480524|P2|Washout Between Treatment Period 1 and 2|Adverse Event|3
1072344|NCT02573155|3480525|P1|Washout Between Treatment Period 1 and 2|Adverse Event|0
1072345|NCT02573155|3480524|P2|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1
1072346|NCT02573155|3480525|P1|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0
1072347|NCT02573155|3480524|P2|Washout Between Treatment Period 1 and 2|Physician Decision|1
1072348|NCT02573155|3480525|P1|Washout Between Treatment Period 1 and 2|Physician Decision|0
1072349|NCT02572076|3480711|P1|Overall Study|Protocol Violation|1
1072350|NCT02571244|3480752|P2|Overall Study|Unable to reach out post discharge|0
1072351|NCT02571244|3480753|P1|Overall Study|Unable to reach out post discharge|3
1072352|NCT02571244|3480752|P2|Overall Study|Lost to Follow-up|1
1072353|NCT02571244|3480753|P1|Overall Study|Lost to Follow-up|0
1072354|NCT02571049|3480798|P2|Randomization|No migraine attack|1
1072355|NCT02571049|3480799|P1|Randomization|No migraine attack|0
1072356|NCT02571049|3480798|P2|Screening|Did not meet entry criteria|2
1072357|NCT02571049|3480799|P1|Screening|Did not meet entry criteria|2
1072358|NCT02570750|3480807|P2|Overall Study|Adverse Event|1
1072359|NCT02570750|3480808|P1|Overall Study|Adverse Event|2
1072360|NCT02570750|3480807|P2|Overall Study|Lost to Follow-up|2
1072361|NCT02570750|3480808|P1|Overall Study|Lost to Follow-up|2
1072362|NCT02570750|3480807|P2|Overall Study|Withdrawal by Subject|0
1072363|NCT02570750|3480808|P1|Overall Study|Withdrawal by Subject|5
1072364|NCT02570750|3480807|P2|Overall Study|Protocol deviation|2
1072365|NCT02570750|3480808|P1|Overall Study|Protocol deviation|4
1072366|NCT02570750|3480807|P2|Overall Study|Inclusion/exclusion criteria deviation|0
1072367|NCT02570750|3480808|P1|Overall Study|Inclusion/exclusion criteria deviation|1
1072368|NCT02570165|3480906|P7|Overall Study|Withdrawal Request by GSK|0
1072369|NCT02570165|3480907|P6|Overall Study|Withdrawal Request by GSK|0
1072370|NCT02570165|3480908|P5|Overall Study|Withdrawal Request by GSK|0
1072371|NCT02570165|3480909|P4|Overall Study|Withdrawal Request by GSK|0
1072372|NCT02570165|3480910|P3|Overall Study|Withdrawal Request by GSK|2
1072373|NCT02570165|3480911|P2|Overall Study|Withdrawal Request by GSK|0
1072374|NCT02570165|3480912|P1|Overall Study|Withdrawal Request by GSK|0
1072375|NCT02570165|3480906|P7|Overall Study|Par. did not Meet Continuation Criteria|0
1072376|NCT02570165|3480907|P6|Overall Study|Par. did not Meet Continuation Criteria|1
1072377|NCT02570165|3480908|P5|Overall Study|Par. did not Meet Continuation Criteria|0
1072378|NCT02570165|3480909|P4|Overall Study|Par. did not Meet Continuation Criteria|0
1072379|NCT02570165|3480910|P3|Overall Study|Par. did not Meet Continuation Criteria|0
1072380|NCT02570165|3480911|P2|Overall Study|Par. did not Meet Continuation Criteria|0
1072381|NCT02570165|3480912|P1|Overall Study|Par. did not Meet Continuation Criteria|0
1072382|NCT02570165|3480906|P7|Overall Study|Withdrawal by Subject|0
1072383|NCT02570165|3480907|P6|Overall Study|Withdrawal by Subject|0
1072384|NCT02570165|3480908|P5|Overall Study|Withdrawal by Subject|1
1072385|NCT02570165|3480909|P4|Overall Study|Withdrawal by Subject|2
1072386|NCT02570165|3480910|P3|Overall Study|Withdrawal by Subject|0
1072387|NCT02570165|3480911|P2|Overall Study|Withdrawal by Subject|0
1072388|NCT02570165|3480912|P1|Overall Study|Withdrawal by Subject|0
1072389|NCT02570165|3480906|P7|Overall Study|Physician Decision|0
1072390|NCT02570165|3480907|P6|Overall Study|Physician Decision|0
1072391|NCT02570165|3480908|P5|Overall Study|Physician Decision|0
1072392|NCT02570165|3480909|P4|Overall Study|Physician Decision|0
1072393|NCT02570165|3480910|P3|Overall Study|Physician Decision|0
1072394|NCT02570165|3480911|P2|Overall Study|Physician Decision|1
1072395|NCT02570165|3480912|P1|Overall Study|Physician Decision|0
1072396|NCT02570165|3480906|P7|Overall Study|Lost to Follow-up|0
1072397|NCT02570165|3480907|P6|Overall Study|Lost to Follow-up|0
1072398|NCT02570165|3480908|P5|Overall Study|Lost to Follow-up|0
1072399|NCT02570165|3480909|P4|Overall Study|Lost to Follow-up|1
1072400|NCT02570165|3480910|P3|Overall Study|Lost to Follow-up|1
1072401|NCT02570165|3480911|P2|Overall Study|Lost to Follow-up|0
1072402|NCT02570165|3480912|P1|Overall Study|Lost to Follow-up|0
1072403|NCT02570165|3480906|P7|Overall Study|Par. Reached Stopping Criteria|0
1072404|NCT02570165|3480907|P6|Overall Study|Par. Reached Stopping Criteria|1
1072405|NCT02570165|3480908|P5|Overall Study|Par. Reached Stopping Criteria|1
1072406|NCT02570165|3480909|P4|Overall Study|Par. Reached Stopping Criteria|2
1072407|NCT02570165|3480910|P3|Overall Study|Par. Reached Stopping Criteria|0
1072408|NCT02570165|3480911|P2|Overall Study|Par. Reached Stopping Criteria|1
1072409|NCT02570165|3480912|P1|Overall Study|Par. Reached Stopping Criteria|1
1072410|NCT02570165|3480906|P7|Overall Study|Lack of Efficacy|0
1072411|NCT02570165|3480907|P6|Overall Study|Lack of Efficacy|0
1072412|NCT02570165|3480908|P5|Overall Study|Lack of Efficacy|4
1072413|NCT02570165|3480909|P4|Overall Study|Lack of Efficacy|0
1072414|NCT02570165|3480910|P3|Overall Study|Lack of Efficacy|0
1072415|NCT02570165|3480911|P2|Overall Study|Lack of Efficacy|1
1072416|NCT02570165|3480912|P1|Overall Study|Lack of Efficacy|0
1072417|NCT02570165|3480906|P7|Overall Study|Adverse Event|0
1072418|NCT02570165|3480907|P6|Overall Study|Adverse Event|0
1072419|NCT02570165|3480908|P5|Overall Study|Adverse Event|0
1072420|NCT02570165|3480909|P4|Overall Study|Adverse Event|0
1072421|NCT02570165|3480910|P3|Overall Study|Adverse Event|2
1072422|NCT02570165|3480911|P2|Overall Study|Adverse Event|0
1072423|NCT02570165|3480912|P1|Overall Study|Adverse Event|1
1072424|NCT02570126|3480952|P2|Overall Study|Withdrawal by Subject|7
1072425|NCT02570126|3480953|P1|Overall Study|Withdrawal by Subject|3
1072426|NCT02570126|3480952|P2|Overall Study|Protocol Violation|1
1072427|NCT02570126|3480953|P1|Overall Study|Protocol Violation|0
1072428|NCT02570126|3480952|P2|Overall Study|Violation Of Procedures GSK|1
1072429|NCT02570126|3480953|P1|Overall Study|Violation Of Procedures GSK|0
1072430|NCT02570126|3480952|P2|Overall Study|Unable To Arrange Visit 3|0
1072431|NCT02570126|3480953|P1|Overall Study|Unable To Arrange Visit 3|1
1072432|NCT02570126|3480952|P2|Overall Study|Lost to Follow-up|0
1072433|NCT02570126|3480953|P1|Overall Study|Lost to Follow-up|2
1072434|NCT02569996|3480988|P1|Overall Study|Unknown reason|1
1072435|NCT02569996|3480988|P1|Overall Study|Complete remission|7
1072436|NCT02569996|3480988|P1|Overall Study|Lost to Follow-up|5
1072437|NCT02569996|3480988|P1|Overall Study|Withdrawal by Subject|5
1072438|NCT02569996|3480988|P1|Overall Study|Non-compliance|9
1072439|NCT02569996|3480988|P1|Overall Study|New anti-lymphoma treatment|1
1072440|NCT02569996|3480988|P1|Overall Study|Progression of the disease|18
1072441|NCT02569996|3480988|P1|Overall Study|Physician Decision|3
1072442|NCT02569996|3480988|P1|Overall Study|Adverse Event|6
1072443|NCT02569957|3481000|P2|Overall Study|Withdrawal by Subject|1
1072444|NCT02569957|3481001|P1|Overall Study|Withdrawal by Subject|0
1072445|NCT02569853|3481033|P2|Overall Study|Physician Decision|1
1072446|NCT02569853|3481034|P1|Overall Study|Physician Decision|1
1072447|NCT02569853|3481033|P2|Overall Study|Did not experience migraine attack|7
1072448|NCT02569853|3481034|P1|Overall Study|Did not experience migraine attack|10
1072449|NCT02569853|3481033|P2|Overall Study|Protocol Violation|1
1072450|NCT02569853|3481034|P1|Overall Study|Protocol Violation|1
1072451|NCT02569853|3481033|P2|Overall Study|Lost to Follow-up|3
1072452|NCT02569853|3481034|P1|Overall Study|Lost to Follow-up|3
1072453|NCT02569853|3481033|P2|Overall Study|Withdrawal by Subject|2
1072454|NCT02569853|3481034|P1|Overall Study|Withdrawal by Subject|3
1072455|NCT02569853|3481033|P2|Overall Study|Adverse Event|0
1072456|NCT02569853|3481034|P1|Overall Study|Adverse Event|2
1072457|NCT02569437|3481063|P2|Overall Study|Lost to Follow-up|14
1072458|NCT02569437|3481064|P1|Overall Study|Lost to Follow-up|12
1072459|NCT02568384|3481128|P1|Overall Study|Mobile devices incompatible with App|2
1072460|NCT02568254|3481142|P6|Period 3|Unstatisfactory Lens fitting|0
1072461|NCT02568254|3481143|P5|Period 3|Unstatisfactory Lens fitting|1
1072462|NCT02568254|3481144|P4|Period 3|Unstatisfactory Lens fitting|0
1072463|NCT02568254|3481145|P3|Period 3|Unstatisfactory Lens fitting|0
1072464|NCT02568254|3481146|P2|Period 3|Unstatisfactory Lens fitting|0
1072465|NCT02568254|3481147|P1|Period 3|Unstatisfactory Lens fitting|0
1072466|NCT02568254|3481142|P6|Period 2|Adverse Event|0
1072467|NCT02568254|3481143|P5|Period 2|Adverse Event|0
1072468|NCT02568254|3481144|P4|Period 2|Adverse Event|0
1072469|NCT02568254|3481145|P3|Period 2|Adverse Event|1
1072470|NCT02568254|3481146|P2|Period 2|Adverse Event|0
1072471|NCT02568254|3481147|P1|Period 2|Adverse Event|0
1072472|NCT02567708|3481178|P2|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3
1072473|NCT02567708|3481179|P1|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0
1072474|NCT02567708|3481178|P2|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0
1072475|NCT02567708|3481179|P1|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2
1072476|NCT02567708|3481178|P2|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1
1072477|NCT02567708|3481179|P1|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0
1072478|NCT02567708|3481178|P2|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2
1072479|NCT02567708|3481179|P1|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0
1072480|NCT02567552|3481220|P2|Overall Study|Adverse Event|1
1072481|NCT02567552|3481221|P1|Overall Study|Adverse Event|0
1072482|NCT02567188|3481251|P1|Overall Study|Protocol Violation|5
1072483|NCT02567188|3481251|P1|Overall Study|Started Hemodialysis|2
1072484|NCT02567188|3481251|P1|Overall Study|Moved and Changed Clinic|1
1072485|NCT02567188|3481251|P1|Overall Study|Refused Treatment/ Did not Cooperate|1
1072486|NCT02567188|3481251|P1|Overall Study|Withdrawal by Subject|1
1072487|NCT02567188|3481251|P1|Overall Study|Adverse Event|1
1072488|NCT02567188|3481251|P1|Overall Study|Lost to Follow-up|5
1072489|NCT02567188|3481251|P1|Overall Study|Terminated Mircera Treatment|9
1072490|NCT02567188|3481251|P1|Overall Study|Death|10
1072491|NCT02566785|3481282|P2|Overall Study|Worsening condition|1
1072492|NCT02566785|3481283|P1|Overall Study|Worsening condition|1
1072493|NCT02566785|3481282|P2|Overall Study|Lost to Follow-up|2
1072494|NCT02566785|3481283|P1|Overall Study|Lost to Follow-up|0
1072495|NCT02566759|3481310|P17|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1
1072496|NCT02566759|3481311|P16|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1072497|NCT02566759|3481312|P15|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1072498|NCT02566759|3481313|P14|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1072499|NCT02566759|3481314|P13|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1072500|NCT02566759|3481315|P12|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1072501|NCT02566759|3481316|P11|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1072502|NCT02566759|3481317|P10|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1072503|NCT02566759|3481318|P9|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1072504|NCT02566759|3481319|P8|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1072505|NCT02566759|3481320|P7|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1072506|NCT02566759|3481321|P6|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1072507|NCT02566759|3481322|P5|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1072508|NCT02566759|3481323|P4|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1072509|NCT02566759|3481324|P3|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1072510|NCT02566759|3481325|P2|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1072511|NCT02566759|3481326|P1|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1072512|NCT02566759|3481310|P17|All Parts|Other|0
1072513|NCT02566759|3481311|P16|All Parts|Other|0
1072514|NCT02566759|3481312|P15|All Parts|Other|0
1072515|NCT02566759|3481313|P14|All Parts|Other|2
1072516|NCT02566759|3481314|P13|All Parts|Other|0
1072517|NCT02566759|3481315|P12|All Parts|Other|0
1072518|NCT02566759|3481316|P11|All Parts|Other|0
1072519|NCT02566759|3481317|P10|All Parts|Other|0
1072520|NCT02566759|3481318|P9|All Parts|Other|0
1072521|NCT02566759|3481319|P8|All Parts|Other|0
1072522|NCT02566759|3481320|P7|All Parts|Other|0
1072523|NCT02566759|3481321|P6|All Parts|Other|0
1072524|NCT02566759|3481322|P5|All Parts|Other|0
1072525|NCT02566759|3481323|P4|All Parts|Other|0
1072526|NCT02566759|3481324|P3|All Parts|Other|0
1072527|NCT02566759|3481325|P2|All Parts|Other|0
1072528|NCT02566759|3481326|P1|All Parts|Other|0
1072529|NCT02566759|3481310|P17|All Parts|Adverse Event|0
1072530|NCT02566759|3481311|P16|All Parts|Adverse Event|0
1072531|NCT02566759|3481312|P15|All Parts|Adverse Event|0
1072532|NCT02566759|3481313|P14|All Parts|Adverse Event|3
1072533|NCT02566759|3481314|P13|All Parts|Adverse Event|1
1072534|NCT02566759|3481315|P12|All Parts|Adverse Event|0
1072535|NCT02566759|3481316|P11|All Parts|Adverse Event|0
1072536|NCT02566759|3481317|P10|All Parts|Adverse Event|0
1072537|NCT02566759|3481318|P9|All Parts|Adverse Event|0
1072538|NCT02566759|3481319|P8|All Parts|Adverse Event|0
1072539|NCT02566759|3481320|P7|All Parts|Adverse Event|0
1072540|NCT02566759|3481321|P6|All Parts|Adverse Event|0
1072541|NCT02566759|3481322|P5|All Parts|Adverse Event|0
1072542|NCT02566759|3481323|P4|All Parts|Adverse Event|0
1072543|NCT02566759|3481324|P3|All Parts|Adverse Event|0
1072544|NCT02566759|3481325|P2|All Parts|Adverse Event|0
1072545|NCT02566759|3481326|P1|All Parts|Adverse Event|0
1072546|NCT02566759|3481310|P17|All Parts|Withdrawal by Subject|0
1072547|NCT02566759|3481311|P16|All Parts|Withdrawal by Subject|0
1072548|NCT02566759|3481312|P15|All Parts|Withdrawal by Subject|0
1072549|NCT02566759|3481313|P14|All Parts|Withdrawal by Subject|0
1072550|NCT02566759|3481314|P13|All Parts|Withdrawal by Subject|0
1072551|NCT02566759|3481315|P12|All Parts|Withdrawal by Subject|0
1072552|NCT02566759|3481316|P11|All Parts|Withdrawal by Subject|0
1072553|NCT02566759|3481317|P10|All Parts|Withdrawal by Subject|0
1072554|NCT02566759|3481318|P9|All Parts|Withdrawal by Subject|0
1072555|NCT02566759|3481319|P8|All Parts|Withdrawal by Subject|0
1072556|NCT02566759|3481320|P7|All Parts|Withdrawal by Subject|0
1072557|NCT02566759|3481321|P6|All Parts|Withdrawal by Subject|0
1072558|NCT02566759|3481322|P5|All Parts|Withdrawal by Subject|0
1072559|NCT02566759|3481323|P4|All Parts|Withdrawal by Subject|0
1072560|NCT02566759|3481324|P3|All Parts|Withdrawal by Subject|0
1072561|NCT02566759|3481325|P2|All Parts|Withdrawal by Subject|1
1072562|NCT02566759|3481326|P1|All Parts|Withdrawal by Subject|0
1072563|NCT02566005|3481502|P2|Overall Study|labor after randomization|4
1072564|NCT02566005|3481503|P1|Overall Study|labor after randomization|0
1072565|NCT02566005|3481502|P2|Overall Study|did not receive foley|1
1072566|NCT02566005|3481503|P1|Overall Study|did not receive foley|0
1072567|NCT02566005|3481502|P2|Overall Study|received foley|0
1072568|NCT02566005|3481503|P1|Overall Study|received foley|8
1072569|NCT02566005|3481502|P2|Overall Study|vaginal bleeding|1
1072570|NCT02566005|3481503|P1|Overall Study|vaginal bleeding|0
1072571|NCT02565381|3481580|P3|Overall Study|Lost to Follow-up|1
1072572|NCT02565381|3481581|P2|Overall Study|Lost to Follow-up|0
1072573|NCT02565381|3481582|P1|Overall Study|Lost to Follow-up|1
1072574|NCT02565147|3481622|P2|Overall Study|Death|1
1072575|NCT02565147|3481623|P1|Overall Study|Death|1
1072576|NCT02565147|3481622|P2|Overall Study|Lost to Follow-up|1
1072577|NCT02565147|3481623|P1|Overall Study|Lost to Follow-up|0
1072578|NCT02565147|3481622|P2|Overall Study|Withdrawal by Subject|1
1072579|NCT02565147|3481623|P1|Overall Study|Withdrawal by Subject|5
1072580|NCT02565108|3481647|P2|Overall Study|Withdrew Consent|0
1072581|NCT02565108|3481648|P1|Overall Study|Withdrew Consent|1
1072582|NCT02565108|3481647|P2|Overall Study|Adverse Event|0
1072583|NCT02565108|3481648|P1|Overall Study|Adverse Event|1
1072584|NCT02564952|3481664|P1|Overall Study|Participant Met Withdrawal Criteria|1
1072585|NCT02564952|3481664|P1|Overall Study|Low Efficacy|1
1072586|NCT02564952|3481664|P1|Overall Study|Withdrawal by Subject|1
1072587|NCT02564952|3481664|P1|Overall Study|Participant Withdrawn by Investigator|1
1072588|NCT02564952|3481664|P1|Overall Study|Lost to Follow-up|1
1072589|NCT02564952|3481664|P1|Overall Study|Adverse Event|6
1072590|NCT02564718|3481670|P2|Overall Study|Withdrew from treatment|1
1072591|NCT02564718|3481671|P1|Overall Study|Withdrew from treatment|0
1072592|NCT02564211|3481699|P1|Overall Study|Adverse Event|4
1072593|NCT02564055|3481711|P6|Overall Study|Withdrawal by Subject|10
1072594|NCT02564055|3481712|P5|Overall Study|Withdrawal by Subject|10
1072595|NCT02564055|3481713|P4|Overall Study|Withdrawal by Subject|3
1072596|NCT02564055|3481714|P3|Overall Study|Withdrawal by Subject|3
1072597|NCT02564055|3481715|P2|Overall Study|Withdrawal by Subject|4
1072598|NCT02564055|3481716|P1|Overall Study|Withdrawal by Subject|4
1072599|NCT02564055|3481711|P6|Overall Study|Physician Decision|0
1072600|NCT02564055|3481712|P5|Overall Study|Physician Decision|0
1072601|NCT02564055|3481713|P4|Overall Study|Physician Decision|0
1072602|NCT02564055|3481714|P3|Overall Study|Physician Decision|1
1072603|NCT02564055|3481715|P2|Overall Study|Physician Decision|0
1072604|NCT02564055|3481716|P1|Overall Study|Physician Decision|0
1072605|NCT02564055|3481711|P6|Overall Study|Lost to Follow-up|0
1072606|NCT02564055|3481712|P5|Overall Study|Lost to Follow-up|1
1072607|NCT02564055|3481713|P4|Overall Study|Lost to Follow-up|2
1072608|NCT02564055|3481714|P3|Overall Study|Lost to Follow-up|4
1072609|NCT02564055|3481715|P2|Overall Study|Lost to Follow-up|1
1072610|NCT02564055|3481716|P1|Overall Study|Lost to Follow-up|0
1072611|NCT02564055|3481711|P6|Overall Study|Reached stopping criteria|1
1072612|NCT02564055|3481712|P5|Overall Study|Reached stopping criteria|0
1072613|NCT02564055|3481713|P4|Overall Study|Reached stopping criteria|0
1072614|NCT02564055|3481714|P3|Overall Study|Reached stopping criteria|0
1072615|NCT02564055|3481715|P2|Overall Study|Reached stopping criteria|0
1072616|NCT02564055|3481716|P1|Overall Study|Reached stopping criteria|0
1072617|NCT02564055|3481711|P6|Overall Study|Protocol Violation|0
1072618|NCT02564055|3481712|P5|Overall Study|Protocol Violation|0
1072619|NCT02564055|3481713|P4|Overall Study|Protocol Violation|0
1072620|NCT02564055|3481714|P3|Overall Study|Protocol Violation|0
1072621|NCT02564055|3481715|P2|Overall Study|Protocol Violation|0
1072622|NCT02564055|3481716|P1|Overall Study|Protocol Violation|1
1072623|NCT02564055|3481711|P6|Overall Study|Adverse Event|1
1072624|NCT02564055|3481712|P5|Overall Study|Adverse Event|4
1072625|NCT02564055|3481713|P4|Overall Study|Adverse Event|1
1072626|NCT02564055|3481714|P3|Overall Study|Adverse Event|4
1072627|NCT02564055|3481715|P2|Overall Study|Adverse Event|0
1072628|NCT02564055|3481716|P1|Overall Study|Adverse Event|1
1072629|NCT02564042|3481970|P6|Overall Study|Withdrawal by Subject|12
1072630|NCT02564042|3481971|P5|Overall Study|Withdrawal by Subject|10
1072631|NCT02564042|3481972|P4|Overall Study|Withdrawal by Subject|2
1072632|NCT02564042|3481973|P3|Overall Study|Withdrawal by Subject|2
1072633|NCT02564042|3481974|P2|Overall Study|Withdrawal by Subject|3
1072634|NCT02564042|3481975|P1|Overall Study|Withdrawal by Subject|5
1072635|NCT02564042|3481970|P6|Overall Study|Physician Decision|0
1072636|NCT02564042|3481971|P5|Overall Study|Physician Decision|0
1072637|NCT02564042|3481972|P4|Overall Study|Physician Decision|1
1072638|NCT02564042|3481973|P3|Overall Study|Physician Decision|0
1072639|NCT02564042|3481974|P2|Overall Study|Physician Decision|0
1072640|NCT02564042|3481975|P1|Overall Study|Physician Decision|1
1072641|NCT02564042|3481970|P6|Overall Study|Lost to Follow-up|1
1072642|NCT02564042|3481971|P5|Overall Study|Lost to Follow-up|1
1072643|NCT02564042|3481972|P4|Overall Study|Lost to Follow-up|0
1072644|NCT02564042|3481973|P3|Overall Study|Lost to Follow-up|1
1072645|NCT02564042|3481974|P2|Overall Study|Lost to Follow-up|1
1072646|NCT02564042|3481975|P1|Overall Study|Lost to Follow-up|1
1072647|NCT02564042|3481970|P6|Overall Study|Adverse Event|1
1072648|NCT02564042|3481971|P5|Overall Study|Adverse Event|0
1072649|NCT02564042|3481972|P4|Overall Study|Adverse Event|0
1072650|NCT02564042|3481973|P3|Overall Study|Adverse Event|3
1072651|NCT02564042|3481974|P2|Overall Study|Adverse Event|4
1072652|NCT02564042|3481975|P1|Overall Study|Adverse Event|4
1072653|NCT02563899|3482245|P4|Overall Study|Withdrawal by Subject|0
1072654|NCT02563899|3482246|P3|Overall Study|Withdrawal by Subject|1
1072655|NCT02563899|3482247|P2|Overall Study|Withdrawal by Subject|0
1072656|NCT02563899|3482248|P1|Overall Study|Withdrawal by Subject|0
1072657|NCT02563899|3482245|P4|Overall Study|Protocol Violation|0
1072658|NCT02563899|3482246|P3|Overall Study|Protocol Violation|0
1072659|NCT02563899|3482247|P2|Overall Study|Protocol Violation|0
1072660|NCT02563899|3482248|P1|Overall Study|Protocol Violation|1
1072661|NCT02563106|3482310|P2|Overall Study|Other reason - not specified|1
1072662|NCT02563106|3482311|P1|Overall Study|Other reason - not specified|2
1072663|NCT02563106|3482310|P2|Overall Study|Physician Decision|1
1072664|NCT02563106|3482311|P1|Overall Study|Physician Decision|3
1072665|NCT02563106|3482310|P2|Overall Study|Lost to Follow-up|2
1072666|NCT02563106|3482311|P1|Overall Study|Lost to Follow-up|3
1072667|NCT02563106|3482310|P2|Overall Study|Use of non-permitted concurrent therapy|2
1072668|NCT02563106|3482311|P1|Overall Study|Use of non-permitted concurrent therapy|1
1072669|NCT02563106|3482310|P2|Overall Study|Protocol Violation|0
1072670|NCT02563106|3482311|P1|Overall Study|Protocol Violation|1
1072671|NCT02563106|3482310|P2|Overall Study|Adverse Event|15
1072672|NCT02563106|3482311|P1|Overall Study|Adverse Event|17
1072673|NCT02563106|3482310|P2|Overall Study|Withdrawal by Subject|8
1072674|NCT02563106|3482311|P1|Overall Study|Withdrawal by Subject|7
1072675|NCT02561806|3482397|P2|Post-Treatment Follow-up|Withdrawal by Subject|0
1072676|NCT02561806|3482398|P1|Post-Treatment Follow-up|Withdrawal by Subject|1
1072677|NCT02561806|3482397|P2|Post-Treatment Follow-up|Lost to Follow-up|1
1072678|NCT02561806|3482398|P1|Post-Treatment Follow-up|Lost to Follow-up|1
1072679|NCT02561806|3482397|P2|Maintenance Period|Site staff became unblinded|1
1072680|NCT02561806|3482398|P1|Maintenance Period|Site staff became unblinded|0
1072681|NCT02561806|3482397|P2|Maintenance Period|Withdrawal by Subject|3
1072682|NCT02561806|3482398|P1|Maintenance Period|Withdrawal by Subject|5
1072683|NCT02561806|3482397|P2|Maintenance Period|Protocol Violation|0
1072684|NCT02561806|3482398|P1|Maintenance Period|Protocol Violation|1
1072685|NCT02561806|3482397|P2|Maintenance Period|Lost to Follow-up|2
1072686|NCT02561806|3482398|P1|Maintenance Period|Lost to Follow-up|2
1072687|NCT02561806|3482397|P2|Maintenance Period|Lack of Efficacy|1
1072688|NCT02561806|3482398|P1|Maintenance Period|Lack of Efficacy|3
1072689|NCT02561806|3482397|P2|Maintenance Period|Adverse Event|1
1072690|NCT02561806|3482398|P1|Maintenance Period|Adverse Event|2
1072691|NCT02561806|3482397|P2|Induction Period|Randomized but not treated|1
1072692|NCT02561806|3482398|P1|Induction Period|Randomized but not treated|0
1072693|NCT02561806|3482397|P2|Induction Period|Site staff became unblinded|0
1072694|NCT02561806|3482398|P1|Induction Period|Site staff became unblinded|1
1072695|NCT02561806|3482397|P2|Induction Period|Withdrawal by Subject|2
1072696|NCT02561806|3482398|P1|Induction Period|Withdrawal by Subject|0
1072697|NCT02561806|3482397|P2|Induction Period|Lack of Efficacy|0
1072698|NCT02561806|3482398|P1|Induction Period|Lack of Efficacy|1
1072699|NCT02561806|3482397|P2|Induction Period|Adverse Event|2
1072700|NCT02561806|3482398|P1|Induction Period|Adverse Event|0
1072701|NCT02561572|3482465|P2|Overall Study|Protocol Violation|1
1072702|NCT02561572|3482466|P1|Overall Study|Protocol Violation|0
1072703|NCT02561572|3482465|P2|Overall Study|Inadequate time before surgery|1
1072704|NCT02561572|3482466|P1|Overall Study|Inadequate time before surgery|2
1072705|NCT02561195|3482488|P6|Overall Study|Randomized but not treated|0
1072706|NCT02561195|3482489|P5|Overall Study|Randomized but not treated|0
1072707|NCT02561195|3482490|P4|Overall Study|Randomized but not treated|0
1072708|NCT02561195|3482491|P3|Overall Study|Randomized but not treated|0
1072709|NCT02561195|3482492|P2|Overall Study|Randomized but not treated|0
1072710|NCT02561195|3482493|P1|Overall Study|Randomized but not treated|1
1072711|NCT02561195|3482488|P6|Overall Study|Withdrawal by Subject|0
1072712|NCT02561195|3482489|P5|Overall Study|Withdrawal by Subject|6
1072713|NCT02561195|3482490|P4|Overall Study|Withdrawal by Subject|2
1072714|NCT02561195|3482491|P3|Overall Study|Withdrawal by Subject|4
1072715|NCT02561195|3482492|P2|Overall Study|Withdrawal by Subject|4
1072716|NCT02561195|3482493|P1|Overall Study|Withdrawal by Subject|3
1072717|NCT02561195|3482488|P6|Overall Study|Death|0
1072718|NCT02561195|3482489|P5|Overall Study|Death|0
1072719|NCT02561195|3482490|P4|Overall Study|Death|2
1072720|NCT02561195|3482491|P3|Overall Study|Death|0
1072721|NCT02561195|3482492|P2|Overall Study|Death|1
1072722|NCT02561195|3482493|P1|Overall Study|Death|2
1072723|NCT02561195|3482488|P6|Overall Study|Protocol Violation|2
1072724|NCT02561195|3482489|P5|Overall Study|Protocol Violation|5
1072725|NCT02561195|3482490|P4|Overall Study|Protocol Violation|2
1072726|NCT02561195|3482491|P3|Overall Study|Protocol Violation|1
1072727|NCT02561195|3482492|P2|Overall Study|Protocol Violation|0
1072728|NCT02561195|3482493|P1|Overall Study|Protocol Violation|1
1072729|NCT02561195|3482488|P6|Overall Study|Other|1
1072730|NCT02561195|3482489|P5|Overall Study|Other|5
1072731|NCT02561195|3482490|P4|Overall Study|Other|7
1072732|NCT02561195|3482491|P3|Overall Study|Other|1
1072733|NCT02561195|3482492|P2|Overall Study|Other|3
1072734|NCT02561195|3482493|P1|Overall Study|Other|7
1072735|NCT02561195|3482488|P6|Overall Study|No longer willing to participate|3
1072736|NCT02561195|3482489|P5|Overall Study|No longer willing to participate|1
1072737|NCT02561195|3482490|P4|Overall Study|No longer willing to participate|4
1072738|NCT02561195|3482491|P3|Overall Study|No longer willing to participate|0
1072739|NCT02561195|3482492|P2|Overall Study|No longer willing to participate|4
1072740|NCT02561195|3482493|P1|Overall Study|No longer willing to participate|2
1072741|NCT02561195|3482488|P6|Overall Study|No longer meets eligibility criteria|1
1072742|NCT02561195|3482489|P5|Overall Study|No longer meets eligibility criteria|4
1072743|NCT02561195|3482490|P4|Overall Study|No longer meets eligibility criteria|4
1072744|NCT02561195|3482491|P3|Overall Study|No longer meets eligibility criteria|0
1072745|NCT02561195|3482492|P2|Overall Study|No longer meets eligibility criteria|1
1072746|NCT02561195|3482493|P1|Overall Study|No longer meets eligibility criteria|0
1072747|NCT02561195|3482488|P6|Overall Study|Lost to Follow-up|3
1072748|NCT02561195|3482489|P5|Overall Study|Lost to Follow-up|3
1072749|NCT02561195|3482490|P4|Overall Study|Lost to Follow-up|2
1072750|NCT02561195|3482491|P3|Overall Study|Lost to Follow-up|0
1072751|NCT02561195|3482492|P2|Overall Study|Lost to Follow-up|4
1072752|NCT02561195|3482493|P1|Overall Study|Lost to Follow-up|3
1072753|NCT02561195|3482488|P6|Overall Study|Adverse Event|0
1072754|NCT02561195|3482489|P5|Overall Study|Adverse Event|4
1072755|NCT02561195|3482490|P4|Overall Study|Adverse Event|3
1072756|NCT02561195|3482491|P3|Overall Study|Adverse Event|0
1072757|NCT02561195|3482492|P2|Overall Study|Adverse Event|5
1072758|NCT02561195|3482493|P1|Overall Study|Adverse Event|4
1072759|NCT02560025|3482748|P1|Overall Study|Ineligible after consent/ registration|3
1072760|NCT02560012|3482754|P1|Overall Study|Study Terminated|2
1072761|NCT02559622|3482762|P4|Overall Study|Patient/guardian decision|1
1072762|NCT02559622|3482763|P3|Overall Study|Patient/guardian decision|0
1072763|NCT02559622|3482764|P2|Overall Study|Patient/guardian decision|2
1072764|NCT02559622|3482765|P1|Overall Study|Patient/guardian decision|1
1072765|NCT02559622|3482762|P4|Overall Study|Adverse Event|2
1072766|NCT02559622|3482763|P3|Overall Study|Adverse Event|2
1072767|NCT02559622|3482764|P2|Overall Study|Adverse Event|2
1072768|NCT02559622|3482765|P1|Overall Study|Adverse Event|0
1072769|NCT02559622|3482762|P4|Overall Study|Progressive disease|0
1072770|NCT02559622|3482763|P3|Overall Study|Progressive disease|0
1072771|NCT02559622|3482764|P2|Overall Study|Progressive disease|1
1072772|NCT02559622|3482765|P1|Overall Study|Progressive disease|0
1072773|NCT02559414|3482847|P3|Overall Study|Other|1
1072774|NCT02559414|3482848|P2|Overall Study|Other|1
1072775|NCT02559414|3482849|P1|Overall Study|Other|0
1072776|NCT02559414|3482847|P3|Overall Study|Withdrawal by Subject|1
1072777|NCT02559414|3482848|P2|Overall Study|Withdrawal by Subject|0
1072778|NCT02559414|3482849|P1|Overall Study|Withdrawal by Subject|1
1072779|NCT02559414|3482847|P3|Overall Study|Lost to Follow-up|0
1072780|NCT02559414|3482848|P2|Overall Study|Lost to Follow-up|1
1072781|NCT02559414|3482849|P1|Overall Study|Lost to Follow-up|0
1072782|NCT02558894|3482889|P2|Overall Study|Closure of Part A|1
1072783|NCT02558894|3482890|P1|Overall Study|Closure of Part A|2
1072784|NCT02558894|3482889|P2|Overall Study|Withdrawal by Subject|1
1072785|NCT02558894|3482890|P1|Overall Study|Withdrawal by Subject|2
1072786|NCT02558894|3482889|P2|Overall Study|Death; any cause, entire study duration|31
1072787|NCT02558894|3482890|P1|Overall Study|Death; any cause, entire study duration|28
1072788|NCT02558790|3482951|P1|Overall Study|Screen Fail|3
1072789|NCT02558790|3482951|P1|Overall Study|Withdrawal by Subject|1
1072790|NCT02558790|3482951|P1|Overall Study|Physician Decision|1
1072791|NCT02558790|3482951|P1|Overall Study|Lost to Follow-up|2
1072792|NCT02557646|3483033|P1|Overall Study|Other|14
1072793|NCT02557646|3483033|P1|Overall Study|Lost to Follow-up|17
1072794|NCT02557646|3483033|P1|Overall Study|Withdrawal by Subject|18
1072795|NCT02557646|3483033|P1|Overall Study|Lack of Efficacy|186
1072796|NCT02557646|3483033|P1|Overall Study|Death|1
1072797|NCT02557646|3483033|P1|Overall Study|Adverse Event|40
1072798|NCT02557399|3483058|P2|Overall Study|Withdrawal by Subject|1
1072799|NCT02557399|3483059|P1|Overall Study|Withdrawal by Subject|1
1072800|NCT02557399|3483058|P2|Overall Study|Protocol-defined stopping criteria|1
1072801|NCT02557399|3483059|P1|Overall Study|Protocol-defined stopping criteria|0
1072802|NCT02557399|3483058|P2|Overall Study|Protocol Violation|1
1072803|NCT02557399|3483059|P1|Overall Study|Protocol Violation|0
1072804|NCT02557399|3483058|P2|Overall Study|Adverse Event|5
1072805|NCT02557399|3483059|P1|Overall Study|Adverse Event|6
1072806|NCT02556632|3483119|P3|Overall Study|Treatment or Change Delay|1
1072807|NCT02556632|3483120|P2|Overall Study|Treatment or Change Delay|0
1072808|NCT02556632|3483121|P1|Overall Study|Treatment or Change Delay|0
1072809|NCT02556632|3483119|P3|Overall Study|Disliked Study Procedures|1
1072810|NCT02556632|3483120|P2|Overall Study|Disliked Study Procedures|0
1072811|NCT02556632|3483121|P1|Overall Study|Disliked Study Procedures|0
1072812|NCT02556632|3483119|P3|Overall Study|Ineligible|0
1072813|NCT02556632|3483120|P2|Overall Study|Ineligible|1
1072814|NCT02556632|3483121|P1|Overall Study|Ineligible|0
1072815|NCT02556632|3483119|P3|Overall Study|Did Not Start RT|0
1072816|NCT02556632|3483120|P2|Overall Study|Did Not Start RT|1
1072817|NCT02556632|3483121|P1|Overall Study|Did Not Start RT|0
1072818|NCT02556632|3483119|P3|Overall Study|Possibly Related Adverse Event|1
1072819|NCT02556632|3483120|P2|Overall Study|Possibly Related Adverse Event|0
1072820|NCT02556632|3483121|P1|Overall Study|Possibly Related Adverse Event|0
1072821|NCT02556632|3483119|P3|Overall Study|Related Adverse Event|0
1072822|NCT02556632|3483120|P2|Overall Study|Related Adverse Event|1
1072823|NCT02556632|3483121|P1|Overall Study|Related Adverse Event|0
1072824|NCT02556632|3483119|P3|Overall Study|Unrelated Adverse Event|3
1072825|NCT02556632|3483120|P2|Overall Study|Unrelated Adverse Event|0
1072826|NCT02556632|3483121|P1|Overall Study|Unrelated Adverse Event|1
1072827|NCT02556632|3483119|P3|Overall Study|Withdrew (Unrelated Medical)|0
1072828|NCT02556632|3483120|P2|Overall Study|Withdrew (Unrelated Medical)|0
1072829|NCT02556632|3483121|P1|Overall Study|Withdrew (Unrelated Medical)|1
1072830|NCT02556632|3483119|P3|Overall Study|Changed Mind|0
1072831|NCT02556632|3483120|P2|Overall Study|Changed Mind|1
1072832|NCT02556632|3483121|P1|Overall Study|Changed Mind|0
1072833|NCT02556632|3483119|P3|Overall Study|Personal Issues|1
1072834|NCT02556632|3483120|P2|Overall Study|Personal Issues|1
1072835|NCT02556632|3483121|P1|Overall Study|Personal Issues|0
1072836|NCT02556632|3483119|P3|Overall Study|No Reason|1
1072837|NCT02556632|3483120|P2|Overall Study|No Reason|0
1072838|NCT02556632|3483121|P1|Overall Study|No Reason|1
1072839|NCT02556632|3483119|P3|Overall Study|Disliked Intervention|1
1072840|NCT02556632|3483120|P2|Overall Study|Disliked Intervention|1
1072841|NCT02556632|3483121|P1|Overall Study|Disliked Intervention|1
1072842|NCT02556632|3483119|P3|Overall Study|Lost to Follow-up|0
1072843|NCT02556632|3483120|P2|Overall Study|Lost to Follow-up|0
1072844|NCT02556632|3483121|P1|Overall Study|Lost to Follow-up|1
1072845|NCT02556307|3483139|P1|Overall Study|Enrolled but not treated|2
1072846|NCT02556307|3483139|P1|Overall Study|Change to triple therapy|4
1072847|NCT02556307|3483139|P1|Overall Study|Lost to Follow-up|36
1072848|NCT02556307|3483139|P1|Overall Study|Premature treatment interruption|11
1072849|NCT02556138|3483149|P1|Overall Study|Withdrawal by Subject|1
1072850|NCT02555722|3483157|P2|Month 2|Adverse Event|0
1072851|NCT02555722|3483158|P1|Month 2|Adverse Event|3
1072852|NCT02555722|3483157|P2|Month 1|Withdrawal by Subject|0
1072853|NCT02555722|3483158|P1|Month 1|Withdrawal by Subject|2
1072854|NCT02555722|3483157|P2|Week 2|Lens Discomfort|1
1072855|NCT02555722|3483158|P1|Week 2|Lens Discomfort|0
1072856|NCT02555722|3483157|P2|Week 1|Withdrawal by Subject|0
1072857|NCT02555722|3483158|P1|Week 1|Withdrawal by Subject|1
1072858|NCT02555618|3483325|P2|Overall Study|Sponsor's Circumstances|0
1072859|NCT02555618|3483326|P1|Overall Study|Sponsor's Circumstances|1
1072860|NCT02554981|3483383|P1|Overall Study|Other Miscellaneous Reasons|3
1072861|NCT02554981|3483383|P1|Overall Study|Administrative Reasons|1
1072862|NCT02554981|3483383|P1|Overall Study|Adverse Event|1
1072863|NCT02554877|3483411|P4|Overall Study|No longer willing to participate|0
1072864|NCT02554877|3483412|P3|Overall Study|No longer willing to participate|2
1072865|NCT02554877|3483413|P2|Overall Study|No longer willing to participate|2
1072866|NCT02554877|3483414|P1|Overall Study|No longer willing to participate|0
1072867|NCT02554877|3483411|P4|Overall Study|Insufficient clinical response|0
1072868|NCT02554877|3483412|P3|Overall Study|Insufficient clinical response|0
1072869|NCT02554877|3483413|P2|Overall Study|Insufficient clinical response|0
1072870|NCT02554877|3483414|P1|Overall Study|Insufficient clinical response|4
1072871|NCT02554877|3483411|P4|Overall Study|Other|3
1072872|NCT02554877|3483412|P3|Overall Study|Other|0
1072873|NCT02554877|3483413|P2|Overall Study|Other|3
1072874|NCT02554877|3483414|P1|Overall Study|Other|1
1072875|NCT02554877|3483411|P4|Overall Study|Protocol Violation|0
1072876|NCT02554877|3483412|P3|Overall Study|Protocol Violation|1
1072877|NCT02554877|3483413|P2|Overall Study|Protocol Violation|1
1072878|NCT02554877|3483414|P1|Overall Study|Protocol Violation|3
1072879|NCT02554877|3483411|P4|Overall Study|No longer met eligibility criteria|1
1072880|NCT02554877|3483412|P3|Overall Study|No longer met eligibility criteria|1
1072881|NCT02554877|3483413|P2|Overall Study|No longer met eligibility criteria|0
1072882|NCT02554877|3483414|P1|Overall Study|No longer met eligibility criteria|1
1072883|NCT02554877|3483411|P4|Overall Study|Did not meet entrance criteria|0
1072884|NCT02554877|3483412|P3|Overall Study|Did not meet entrance criteria|1
1072885|NCT02554877|3483413|P2|Overall Study|Did not meet entrance criteria|0
1072886|NCT02554877|3483414|P1|Overall Study|Did not meet entrance criteria|0
1072887|NCT02554877|3483411|P4|Overall Study|Lost to Follow-up|2
1072888|NCT02554877|3483412|P3|Overall Study|Lost to Follow-up|1
1072889|NCT02554877|3483413|P2|Overall Study|Lost to Follow-up|1
1072890|NCT02554877|3483414|P1|Overall Study|Lost to Follow-up|1
1072891|NCT02554877|3483411|P4|Overall Study|Adverse Event|1
1072892|NCT02554877|3483412|P3|Overall Study|Adverse Event|0
1072893|NCT02554877|3483413|P2|Overall Study|Adverse Event|0
1072894|NCT02554877|3483414|P1|Overall Study|Adverse Event|2
1072895|NCT02554279|3483513|P2|Overall Study|Other reason|6
1072896|NCT02554279|3483514|P1|Overall Study|Other reason|19
1072897|NCT02554279|3483513|P2|Overall Study|Protocol Violation|1
1072898|NCT02554279|3483514|P1|Overall Study|Protocol Violation|2
1072899|NCT02554279|3483513|P2|Overall Study|Withdrawal by Subject|4
1072900|NCT02554279|3483514|P1|Overall Study|Withdrawal by Subject|6
1072901|NCT02554279|3483513|P2|Overall Study|Lost to Follow-up|2
1072902|NCT02554279|3483514|P1|Overall Study|Lost to Follow-up|3
1072903|NCT02554279|3483513|P2|Overall Study|Adverse Event|5
1072904|NCT02554279|3483514|P1|Overall Study|Adverse Event|2
1072905|NCT02553772|3483555|P2|Overall Study|Other Miscellaneous Reasons|1
1072906|NCT02553772|3483556|P1|Overall Study|Other Miscellaneous Reasons|0
1072907|NCT02553772|3483555|P2|Overall Study|Lack of Efficacy|0
1072908|NCT02553772|3483556|P1|Overall Study|Lack of Efficacy|1
1072909|NCT02553772|3483555|P2|Overall Study|Withdrawal of Consent|1
1072910|NCT02553772|3483556|P1|Overall Study|Withdrawal of Consent|1
1072911|NCT02553772|3483555|P2|Overall Study|Lost to Follow-up|1
1072912|NCT02553772|3483556|P1|Overall Study|Lost to Follow-up|2
1072913|NCT02553772|3483555|P2|Overall Study|Adverse Event|3
1072914|NCT02553772|3483556|P1|Overall Study|Adverse Event|2
1072915|NCT02553629|3483572|P2|Overall Study|Logistic reasons|6
1072916|NCT02553629|3483573|P1|Overall Study|Logistic reasons|3
1072917|NCT02553538|3483589|P2|Overall Study|Died or Left Network|56
1072918|NCT02553538|3483590|P1|Overall Study|Died or Left Network|54
1072919|NCT02553538|3483589|P2|Overall Study|Could Not Reach by Telephone|0
1072920|NCT02553538|3483590|P1|Overall Study|Could Not Reach by Telephone|133
1072921|NCT02553421|3483612|P2|Overall Study|Improper Device Placement|0
1072922|NCT02553421|3483613|P1|Overall Study|Improper Device Placement|3
1072923|NCT02553421|3483612|P2|Overall Study|Incomplete or Insufficient Data Collecte|0
1072924|NCT02553421|3483613|P1|Overall Study|Incomplete or Insufficient Data Collecte|5
1072925|NCT02553421|3483612|P2|Overall Study|Lost to Follow-up|1
1072926|NCT02553421|3483613|P1|Overall Study|Lost to Follow-up|21
1072927|NCT02552303|3483649|P4|Follow-Up|ineligible|0
1072928|NCT02552303|3483650|P3|Follow-Up|ineligible|0
1072929|NCT02552303|3483651|P2|Follow-Up|ineligible|2
1072930|NCT02552303|3483652|P1|Follow-Up|ineligible|0
1072931|NCT02552303|3483649|P4|Follow-Up|Lost to Follow-up|0
1072932|NCT02552303|3483650|P3|Follow-Up|Lost to Follow-up|1
1072933|NCT02552303|3483651|P2|Follow-Up|Lost to Follow-up|0
1072934|NCT02552303|3483652|P1|Follow-Up|Lost to Follow-up|0
1072935|NCT02552303|3483649|P4|Allocation|ineligible|0
1072936|NCT02552303|3483650|P3|Allocation|ineligible|0
1072937|NCT02552303|3483651|P2|Allocation|ineligible|1
1072938|NCT02552303|3483652|P1|Allocation|ineligible|1
1072939|NCT02552303|3483649|P4|Allocation|Withdrawal by Subject|1
1072940|NCT02552303|3483650|P3|Allocation|Withdrawal by Subject|1
1072941|NCT02552303|3483651|P2|Allocation|Withdrawal by Subject|1
1072942|NCT02552303|3483652|P1|Allocation|Withdrawal by Subject|2
1072943|NCT02551874|3483684|P2|Overall Study|Did not enter long-term study|25
1072944|NCT02551874|3483685|P1|Overall Study|Did not enter long-term study|18
1072945|NCT02551874|3483684|P2|Overall Study|Did not receive randomized treatment|7
1072946|NCT02551874|3483685|P1|Overall Study|Did not receive randomized treatment|0
1072947|NCT02551874|3483684|P2|Overall Study|Reason not reported|4
1072948|NCT02551874|3483685|P1|Overall Study|Reason not reported|10
1072949|NCT02551874|3483684|P2|Overall Study|Pregnancy|1
1072950|NCT02551874|3483685|P1|Overall Study|Pregnancy|0
1072951|NCT02551874|3483684|P2|Overall Study|Lost to Follow-up|2
1072952|NCT02551874|3483685|P1|Overall Study|Lost to Follow-up|0
1072953|NCT02551731|3483714|P1|Overall Study|Withdrawal by Subject|2
1072954|NCT02550873|3483753|P3|Open Label Extension|Study ongoing|111
1072955|NCT02550873|3483754|P2|Open Label Extension|Study ongoing|0
1072956|NCT02550873|3483755|P1|Open Label Extension|Study ongoing|0
1072957|NCT02550873|3483753|P3|Randomized Double Blind|Disease progression|0
1072958|NCT02550873|3483754|P2|Randomized Double Blind|Disease progression|1
1072959|NCT02550873|3483755|P1|Randomized Double Blind|Disease progression|1
1072960|NCT02550873|3483753|P3|Randomized Double Blind|Adverse Event|0
1072961|NCT02550873|3483754|P2|Randomized Double Blind|Adverse Event|1
1072962|NCT02550873|3483755|P1|Randomized Double Blind|Adverse Event|3
1072963|NCT02550288|3483838|P5|Overall Study|Withdrawal by Subject|0
1072964|NCT02550288|3483839|P4|Overall Study|Withdrawal by Subject|1
1072965|NCT02550288|3483840|P3|Overall Study|Withdrawal by Subject|0
1072966|NCT02550288|3483841|P2|Overall Study|Withdrawal by Subject|0
1072967|NCT02550288|3483842|P1|Overall Study|Withdrawal by Subject|0
1072968|NCT02550288|3483838|P5|Overall Study|Participant moved|0
1072969|NCT02550288|3483839|P4|Overall Study|Participant moved|1
1072970|NCT02550288|3483840|P3|Overall Study|Participant moved|0
1072971|NCT02550288|3483841|P2|Overall Study|Participant moved|0
1072972|NCT02550288|3483842|P1|Overall Study|Participant moved|0
1072973|NCT02550288|3483838|P5|Overall Study|Protocol Violation|3
1072974|NCT02550288|3483839|P4|Overall Study|Protocol Violation|0
1072975|NCT02550288|3483840|P3|Overall Study|Protocol Violation|1
1072976|NCT02550288|3483841|P2|Overall Study|Protocol Violation|2
1072977|NCT02550288|3483842|P1|Overall Study|Protocol Violation|2
1072978|NCT02550288|3483838|P5|Overall Study|Physician Decision|0
1072979|NCT02550288|3483839|P4|Overall Study|Physician Decision|1
1072980|NCT02550288|3483840|P3|Overall Study|Physician Decision|0
1072981|NCT02550288|3483841|P2|Overall Study|Physician Decision|0
1072982|NCT02550288|3483842|P1|Overall Study|Physician Decision|0
1072983|NCT02550288|3483838|P5|Overall Study|Adverse Event|0
1072984|NCT02550288|3483839|P4|Overall Study|Adverse Event|0
1072985|NCT02550288|3483840|P3|Overall Study|Adverse Event|0
1072986|NCT02550288|3483841|P2|Overall Study|Adverse Event|1
1072987|NCT02550288|3483842|P1|Overall Study|Adverse Event|0
1072988|NCT02549573|3483997|P2|Overall Study|Protocol Violation|1
1072989|NCT02549573|3483998|P1|Overall Study|Protocol Violation|0
1072990|NCT02549573|3483997|P2|Overall Study|Withdrawal by Subject|2
1072991|NCT02549573|3483998|P1|Overall Study|Withdrawal by Subject|0
1072992|NCT02549352|3484042|P2|12-month Follow-up|Other|3
1072993|NCT02549352|3484043|P1|12-month Follow-up|Other|1
1072994|NCT02549352|3484042|P2|12-month Follow-up|Protocol Violation|1
1072995|NCT02549352|3484043|P1|12-month Follow-up|Protocol Violation|0
1072996|NCT02549352|3484042|P2|12-month Follow-up|Death|1
1072997|NCT02549352|3484043|P1|12-month Follow-up|Death|0
1072998|NCT02549352|3484042|P2|12-month Follow-up|Lost to Follow-up|2
1072999|NCT02549352|3484043|P1|12-month Follow-up|Lost to Follow-up|3
1073000|NCT02549352|3484042|P2|12-month Follow-up|Withdrawal by Subject|5
1073001|NCT02549352|3484043|P1|12-month Follow-up|Withdrawal by Subject|4
1073002|NCT02549352|3484042|P2|3-day Treatment and 8-week Follow-up|Other|2
1073003|NCT02549352|3484043|P1|3-day Treatment and 8-week Follow-up|Other|0
1073004|NCT02549352|3484042|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3
1073005|NCT02549352|3484043|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2
1073006|NCT02549352|3484042|P2|3-day Treatment and 8-week Follow-up|Adverse Event|1
1073007|NCT02549352|3484043|P1|3-day Treatment and 8-week Follow-up|Adverse Event|0
1073008|NCT02549339|3484059|P2|12-month Follow-up|Other|3
1073009|NCT02549339|3484060|P1|12-month Follow-up|Other|0
1073010|NCT02549339|3484059|P2|12-month Follow-up|Lost to Follow-up|3
1073011|NCT02549339|3484060|P1|12-month Follow-up|Lost to Follow-up|1
1073012|NCT02549339|3484059|P2|12-month Follow-up|Withdrawal by Subject|3
1073013|NCT02549339|3484060|P1|12-month Follow-up|Withdrawal by Subject|8
1073014|NCT02549339|3484059|P2|12-month Follow-up|Lack of Efficacy|2
1073015|NCT02549339|3484060|P1|12-month Follow-up|Lack of Efficacy|0
1073016|NCT02549339|3484059|P2|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2
1073017|NCT02549339|3484060|P1|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0
1073018|NCT02549339|3484059|P2|3-day Treatment and 8-week Follow-up|Other|0
1073019|NCT02549339|3484060|P1|3-day Treatment and 8-week Follow-up|Other|1
1073020|NCT02549339|3484059|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3
1073021|NCT02549339|3484060|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1
1073022|NCT02549339|3484059|P2|3-day Treatment and 8-week Follow-up|Protocol Violation|0
1073023|NCT02549339|3484060|P1|3-day Treatment and 8-week Follow-up|Protocol Violation|2
1073024|NCT02549027|3484074|P6|Period 5 - MK-6096 or Placebo|Protocol Violation|0
1073025|NCT02549027|3484075|P5|Period 5 - MK-6096 or Placebo|Protocol Violation|2
1073026|NCT02549027|3484076|P4|Period 5 - MK-6096 or Placebo|Protocol Violation|0
1073027|NCT02549027|3484077|P3|Period 5 - MK-6096 or Placebo|Protocol Violation|0
1073028|NCT02549027|3484078|P2|Period 5 - MK-6096 or Placebo|Protocol Violation|0
1073029|NCT02549027|3484079|P1|Period 5 - MK-6096 or Placebo|Protocol Violation|0
1073030|NCT02549027|3484074|P6|Washout After Period 4|Withdrawal by Subject|0
1073031|NCT02549027|3484075|P5|Washout After Period 4|Withdrawal by Subject|0
1073032|NCT02549027|3484076|P4|Washout After Period 4|Withdrawal by Subject|1
1073033|NCT02549027|3484077|P3|Washout After Period 4|Withdrawal by Subject|1
1073034|NCT02549027|3484078|P2|Washout After Period 4|Withdrawal by Subject|1
1073035|NCT02549027|3484079|P1|Washout After Period 4|Withdrawal by Subject|0
1073036|NCT02548455|3484219|P1|Overall Study|Visit not completed|173
1073037|NCT02548455|3484219|P1|Overall Study|Lost to Follow-up|14
1073038|NCT02548455|3484219|P1|Overall Study|Death|26
1073039|NCT02548455|3484219|P1|Overall Study|Withdrawal by Subject|27
1073040|NCT02548156|3484223|P6|Washout Period 1|Lost to Follow-up|0
1073041|NCT02548156|3484224|P5|Washout Period 1|Lost to Follow-up|1
1073042|NCT02548156|3484225|P4|Washout Period 1|Lost to Follow-up|0
1073043|NCT02548156|3484226|P3|Washout Period 1|Lost to Follow-up|0
1073044|NCT02548156|3484227|P2|Washout Period 1|Lost to Follow-up|0
1073045|NCT02548156|3484228|P1|Washout Period 1|Lost to Follow-up|0
1073046|NCT02548078|3484247|P2|Overall Study|Lost to Follow-up|3
1073047|NCT02548078|3484248|P1|Overall Study|Lost to Follow-up|1
1073048|NCT02548078|3484247|P2|Overall Study|Moved from study area|3
1073049|NCT02548078|3484248|P1|Overall Study|Moved from study area|3
1073050|NCT02548078|3484247|P2|Overall Study|Serious adverse event/Adverse event|0
1073051|NCT02548078|3484248|P1|Overall Study|Serious adverse event/Adverse event|1
1073052|NCT02547974|3484440|P4|Overall Study|Withdrawal by Subject|0
1073053|NCT02547974|3484441|P3|Overall Study|Withdrawal by Subject|0
1073054|NCT02547974|3484442|P2|Overall Study|Withdrawal by Subject|0
1073055|NCT02547974|3484443|P1|Overall Study|Withdrawal by Subject|1
1073056|NCT02547454|3484570|P1|Overall Study|No data|11
1073057|NCT02547454|3484570|P1|Overall Study|Other|39
1073058|NCT02547454|3484570|P1|Overall Study|Lost to Follow-up|26
1073059|NCT02547454|3484570|P1|Overall Study|Death|38
1073060|NCT02547454|3484570|P1|Overall Study|Due to no further need to treat|4
1073061|NCT02547454|3484570|P1|Overall Study|Due to transplantation|1
1073062|NCT02547454|3484570|P1|Overall Study|Due to hemodialysis|53
1073063|NCT02547363|3484600|P2|12-month Follow-up|Other|0
1073064|NCT02547363|3484601|P1|12-month Follow-up|Other|1
1073065|NCT02547363|3484600|P2|12-month Follow-up|Lack of Efficacy|1
1073066|NCT02547363|3484601|P1|12-month Follow-up|Lack of Efficacy|1
1073067|NCT02547363|3484600|P2|12-month Follow-up|Lost to Follow-up|1
1073068|NCT02547363|3484601|P1|12-month Follow-up|Lost to Follow-up|4
1073069|NCT02547363|3484600|P2|12-month Follow-up|Withdrawal by Subject|3
1073070|NCT02547363|3484601|P1|12-month Follow-up|Withdrawal by Subject|4
1073071|NCT02547363|3484600|P2|3-day Treatment and 8-week Follow-up|Other|1
1073072|NCT02547363|3484601|P1|3-day Treatment and 8-week Follow-up|Other|1
1073073|NCT02547363|3484600|P2|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
1073074|NCT02547363|3484601|P1|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
1073075|NCT02547363|3484600|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8
1073076|NCT02547363|3484601|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2
1073077|NCT02547363|3484600|P2|3-day Treatment and 8-week Follow-up|Adverse Event|1
1073078|NCT02547363|3484601|P1|3-day Treatment and 8-week Follow-up|Adverse Event|0
1073079|NCT02547233|3484617|P2|12-month Follow-up|Other|1
1073080|NCT02547233|3484618|P1|12-month Follow-up|Other|0
1073081|NCT02547233|3484617|P2|12-month Follow-up|Protocol Violation|1
1073082|NCT02547233|3484618|P1|12-month Follow-up|Protocol Violation|0
1073083|NCT02547233|3484617|P2|12-month Follow-up|Lack of Efficacy|2
1073084|NCT02547233|3484618|P1|12-month Follow-up|Lack of Efficacy|1
1073085|NCT02547233|3484617|P2|12-month Follow-up|Lost to Follow-up|3
1073086|NCT02547233|3484618|P1|12-month Follow-up|Lost to Follow-up|3
1073087|NCT02547233|3484617|P2|12-month Follow-up|Withdrawal by Subject|10
1073088|NCT02547233|3484618|P1|12-month Follow-up|Withdrawal by Subject|10
1073089|NCT02547233|3484617|P2|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
1073090|NCT02547233|3484618|P1|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0
1073091|NCT02547233|3484617|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9
1073092|NCT02547233|3484618|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0
1073093|NCT02547233|3484617|P2|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0
1073094|NCT02547233|3484618|P1|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1
1073095|NCT02547233|3484617|P2|3-day Treatment and 8-week Follow-up|Adverse Event|0
1073096|NCT02547233|3484618|P1|3-day Treatment and 8-week Follow-up|Adverse Event|1
1073097|NCT02546986|3484663|P2|Survival Follow-Up Phase|Lost to Follow-up|2
1073098|NCT02546986|3484664|P1|Survival Follow-Up Phase|Lost to Follow-up|2
1073099|NCT02546986|3484663|P2|Survival Follow-Up Phase|Alive|16
1073100|NCT02546986|3484664|P1|Survival Follow-Up Phase|Alive|13
1073101|NCT02546986|3484663|P2|Survival Follow-Up Phase|Death|12
1073102|NCT02546986|3484664|P1|Survival Follow-Up Phase|Death|18
1073103|NCT02546986|3484663|P2|Survival Follow-Up Phase|Missing Status|5
1073104|NCT02546986|3484664|P1|Survival Follow-Up Phase|Missing Status|3
1073105|NCT02546986|3484663|P2|Treatment Period|Miscellaneous|9
1073106|NCT02546986|3484664|P1|Treatment Period|Miscellaneous|7
1073107|NCT02546986|3484663|P2|Treatment Period|Study Terminated by Sponsor|1
1073108|NCT02546986|3484664|P1|Treatment Period|Study Terminated by Sponsor|0
1073109|NCT02546986|3484663|P2|Treatment Period|Non-compliance with Study Drug|1
1073110|NCT02546986|3484664|P1|Treatment Period|Non-compliance with Study Drug|0
1073111|NCT02546986|3484663|P2|Treatment Period|Withdrawal by Subject|1
1073112|NCT02546986|3484664|P1|Treatment Period|Withdrawal by Subject|1
1073113|NCT02546986|3484663|P2|Treatment Period|Protocol Violation|0
1073114|NCT02546986|3484664|P1|Treatment Period|Protocol Violation|1
1073115|NCT02546986|3484663|P2|Treatment Period|Physician Decision|2
1073116|NCT02546986|3484664|P1|Treatment Period|Physician Decision|1
1073117|NCT02546986|3484663|P2|Treatment Period|Death|4
1073118|NCT02546986|3484664|P1|Treatment Period|Death|3
1073119|NCT02546986|3484663|P2|Treatment Period|Symptomatic Deterioration|3
1073120|NCT02546986|3484664|P1|Treatment Period|Symptomatic Deterioration|4
1073121|NCT02546986|3484663|P2|Treatment Period|Adverse Event|6
1073122|NCT02546986|3484664|P1|Treatment Period|Adverse Event|14
1073123|NCT02546986|3484663|P2|Treatment Period|Progressive Disease|22
1073124|NCT02546986|3484664|P1|Treatment Period|Progressive Disease|20
1073125|NCT02546609|3484690|P3|Overall Study|travel or work schedule restriction|2
1073126|NCT02546609|3484691|P2|Overall Study|travel or work schedule restriction|0
1073127|NCT02546609|3484692|P1|Overall Study|travel or work schedule restriction|0
1073128|NCT02546609|3484690|P3|Overall Study|Lost to Follow-up|1
1073129|NCT02546609|3484691|P2|Overall Study|Lost to Follow-up|3
1073130|NCT02546609|3484692|P1|Overall Study|Lost to Follow-up|2
1073131|NCT02546609|3484690|P3|Overall Study|Protocol Violation|1
1073132|NCT02546609|3484691|P2|Overall Study|Protocol Violation|1
1073133|NCT02546609|3484692|P1|Overall Study|Protocol Violation|0
1073134|NCT02546609|3484690|P3|Overall Study|Adverse Event|1
1073135|NCT02546609|3484691|P2|Overall Study|Adverse Event|6
1073136|NCT02546609|3484692|P1|Overall Study|Adverse Event|0
1073137|NCT02546609|3484690|P3|Overall Study|Withdrawal by Subject|2
1073138|NCT02546609|3484691|P2|Overall Study|Withdrawal by Subject|1
1073139|NCT02546609|3484692|P1|Overall Study|Withdrawal by Subject|0
1073140|NCT02545868|3484758|P3|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|34
1073141|NCT02545868|3484759|P2|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|35
1073142|NCT02545868|3484760|P1|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|33
1073143|NCT02545543|3484833|P2|Overall Study|Enrolment of subject at >1 study site|1
1073144|NCT02545543|3484834|P1|Overall Study|Enrolment of subject at >1 study site|1
1073145|NCT02545543|3484833|P2|Overall Study|Noncomplaince|0
1073146|NCT02545543|3484834|P1|Overall Study|Noncomplaince|1
1073147|NCT02545543|3484833|P2|Overall Study|Withdrawal by Subject|8
1073148|NCT02545543|3484834|P1|Overall Study|Withdrawal by Subject|9
1073149|NCT02545543|3484833|P2|Overall Study|Physician Decision|0
1073150|NCT02545543|3484834|P1|Overall Study|Physician Decision|3
1073151|NCT02545543|3484833|P2|Overall Study|Lost to Follow-up|25
1073152|NCT02545543|3484834|P1|Overall Study|Lost to Follow-up|67
1073153|NCT02545322|3484858|P1|Overall Study|Withdrawal by Subject|3
1073154|NCT02544074|3484914|P21|Overall Study|Tablet error|0
1073155|NCT02544074|3484915|P20|Overall Study|Tablet error|0
1073156|NCT02544074|3484916|P19|Overall Study|Tablet error|0
1073157|NCT02544074|3484917|P18|Overall Study|Tablet error|0
1073158|NCT02544074|3484918|P17|Overall Study|Tablet error|0
1073159|NCT02544074|3484919|P16|Overall Study|Tablet error|0
1073160|NCT02544074|3484920|P15|Overall Study|Tablet error|0
1073161|NCT02544074|3484921|P14|Overall Study|Tablet error|0
1073162|NCT02544074|3484922|P13|Overall Study|Tablet error|0
1073163|NCT02544074|3484923|P12|Overall Study|Tablet error|0
1073164|NCT02544074|3484924|P11|Overall Study|Tablet error|0
1073165|NCT02544074|3484925|P10|Overall Study|Tablet error|1
1073166|NCT02544074|3484926|P9|Overall Study|Tablet error|0
1073167|NCT02544074|3484927|P8|Overall Study|Tablet error|0
1073168|NCT02544074|3484928|P7|Overall Study|Tablet error|0
1073169|NCT02544074|3484929|P6|Overall Study|Tablet error|1
1073170|NCT02544074|3484930|P5|Overall Study|Tablet error|0
1073171|NCT02544074|3484931|P4|Overall Study|Tablet error|0
1073172|NCT02544074|3484932|P3|Overall Study|Tablet error|0
1073173|NCT02544074|3484933|P2|Overall Study|Tablet error|0
1073174|NCT02544074|3484934|P1|Overall Study|Tablet error|0
1073175|NCT02544074|3484914|P21|Overall Study|Withdrawal by Subject|0
1073176|NCT02544074|3484915|P20|Overall Study|Withdrawal by Subject|0
1073177|NCT02544074|3484916|P19|Overall Study|Withdrawal by Subject|0
1073178|NCT02544074|3484917|P18|Overall Study|Withdrawal by Subject|0
1073179|NCT02544074|3484918|P17|Overall Study|Withdrawal by Subject|0
1073180|NCT02544074|3484919|P16|Overall Study|Withdrawal by Subject|0
1073181|NCT02544074|3484920|P15|Overall Study|Withdrawal by Subject|0
1073182|NCT02544074|3484921|P14|Overall Study|Withdrawal by Subject|0
1073183|NCT02544074|3484922|P13|Overall Study|Withdrawal by Subject|0
1073184|NCT02544074|3484923|P12|Overall Study|Withdrawal by Subject|0
1073185|NCT02544074|3484924|P11|Overall Study|Withdrawal by Subject|0
1073186|NCT02544074|3484925|P10|Overall Study|Withdrawal by Subject|0
1073187|NCT02544074|3484926|P9|Overall Study|Withdrawal by Subject|0
1073188|NCT02544074|3484927|P8|Overall Study|Withdrawal by Subject|0
1073189|NCT02544074|3484928|P7|Overall Study|Withdrawal by Subject|0
1073190|NCT02544074|3484929|P6|Overall Study|Withdrawal by Subject|0
1073191|NCT02544074|3484930|P5|Overall Study|Withdrawal by Subject|0
1073192|NCT02544074|3484931|P4|Overall Study|Withdrawal by Subject|0
1073193|NCT02544074|3484932|P3|Overall Study|Withdrawal by Subject|0
1073194|NCT02544074|3484933|P2|Overall Study|Withdrawal by Subject|1
1073195|NCT02544074|3484934|P1|Overall Study|Withdrawal by Subject|0
1073196|NCT02543918|3484970|P2|Overall Study|Adverse Event|1
1073197|NCT02543918|3484971|P1|Overall Study|Adverse Event|1
1073198|NCT02543918|3484970|P2|Overall Study|Withdrawal by Subject|1
1073199|NCT02543918|3484971|P1|Overall Study|Withdrawal by Subject|1
1073200|NCT02543918|3484970|P2|Overall Study|Lost to Follow-up|1
1073201|NCT02543918|3484971|P1|Overall Study|Lost to Follow-up|1
1073202|NCT02543918|3484970|P2|Overall Study|Never treated|1
1073203|NCT02543918|3484971|P1|Overall Study|Never treated|0
1073204|NCT02543892|3484985|P8|Had Immunology Data|Withdrawal by Subject|0
1073205|NCT02543892|3484986|P7|Had Immunology Data|Withdrawal by Subject|1
1073206|NCT02543892|3484987|P6|Had Immunology Data|Withdrawal by Subject|0
1073207|NCT02543892|3484988|P5|Had Immunology Data|Withdrawal by Subject|0
1073208|NCT02543892|3484989|P4|Had Immunology Data|Withdrawal by Subject|0
1073209|NCT02543892|3484990|P3|Had Immunology Data|Withdrawal by Subject|0
1073210|NCT02543892|3484991|P2|Had Immunology Data|Withdrawal by Subject|0
1073211|NCT02543892|3484992|P1|Had Immunology Data|Withdrawal by Subject|0
1073212|NCT02543892|3484985|P8|Received Vaccination 2|Adverse Event|0
1073213|NCT02543892|3484986|P7|Received Vaccination 2|Adverse Event|0
1073214|NCT02543892|3484987|P6|Received Vaccination 2|Adverse Event|0
1073215|NCT02543892|3484988|P5|Received Vaccination 2|Adverse Event|0
1073216|NCT02543892|3484989|P4|Received Vaccination 2|Adverse Event|0
1073217|NCT02543892|3484990|P3|Received Vaccination 2|Adverse Event|0
1073218|NCT02543892|3484991|P2|Received Vaccination 2|Adverse Event|1
1073219|NCT02543892|3484992|P1|Received Vaccination 2|Adverse Event|0
1073220|NCT02543892|3484985|P8|Received Vaccination 2|Physician Decision|0
1073221|NCT02543892|3484986|P7|Received Vaccination 2|Physician Decision|0
1073222|NCT02543892|3484987|P6|Received Vaccination 2|Physician Decision|1
1073223|NCT02543892|3484988|P5|Received Vaccination 2|Physician Decision|0
1073224|NCT02543892|3484989|P4|Received Vaccination 2|Physician Decision|0
1073225|NCT02543892|3484990|P3|Received Vaccination 2|Physician Decision|0
1073226|NCT02543892|3484991|P2|Received Vaccination 2|Physician Decision|0
1073227|NCT02543892|3484992|P1|Received Vaccination 2|Physician Decision|0
1073228|NCT02543892|3484985|P8|Received Vaccination 2|Withdrawal by Subject|1
1073229|NCT02543892|3484986|P7|Received Vaccination 2|Withdrawal by Subject|0
1073230|NCT02543892|3484987|P6|Received Vaccination 2|Withdrawal by Subject|0
1073231|NCT02543892|3484988|P5|Received Vaccination 2|Withdrawal by Subject|0
1073232|NCT02543892|3484989|P4|Received Vaccination 2|Withdrawal by Subject|0
1073233|NCT02543892|3484990|P3|Received Vaccination 2|Withdrawal by Subject|0
1073234|NCT02543892|3484991|P2|Received Vaccination 2|Withdrawal by Subject|0
1073235|NCT02543892|3484992|P1|Received Vaccination 2|Withdrawal by Subject|1
1073236|NCT02543528|3485049|P5|Extended Wear Period|Withdrawal by Subject|0
1073237|NCT02543528|3485050|P4|Extended Wear Period|Withdrawal by Subject|5
1073238|NCT02543528|3485051|P3|Extended Wear Period|Withdrawal by Subject|10
1073239|NCT02543528|3485052|P2|Extended Wear Period|Withdrawal by Subject|9
1073240|NCT02543528|3485053|P1|Extended Wear Period|Withdrawal by Subject|4
1073241|NCT02543528|3485049|P5|Extended Wear Period|Lost to Follow-up|0
1073242|NCT02543528|3485050|P4|Extended Wear Period|Lost to Follow-up|1
1073243|NCT02543528|3485051|P3|Extended Wear Period|Lost to Follow-up|0
1073244|NCT02543528|3485052|P2|Extended Wear Period|Lost to Follow-up|1
1073245|NCT02543528|3485053|P1|Extended Wear Period|Lost to Follow-up|2
1073246|NCT02543528|3485049|P5|Extended Wear Period|Unsatisfactory Lens Fitting|0
1073247|NCT02543528|3485050|P4|Extended Wear Period|Unsatisfactory Lens Fitting|0
1073248|NCT02543528|3485051|P3|Extended Wear Period|Unsatisfactory Lens Fitting|1
1073249|NCT02543528|3485052|P2|Extended Wear Period|Unsatisfactory Lens Fitting|0
1073250|NCT02543528|3485053|P1|Extended Wear Period|Unsatisfactory Lens Fitting|0
1073251|NCT02543528|3485049|P5|Extended Wear Period|Missed too many scheduled visits|0
1073252|NCT02543528|3485050|P4|Extended Wear Period|Missed too many scheduled visits|3
1073253|NCT02543528|3485051|P3|Extended Wear Period|Missed too many scheduled visits|0
1073254|NCT02543528|3485052|P2|Extended Wear Period|Missed too many scheduled visits|0
1073255|NCT02543528|3485053|P1|Extended Wear Period|Missed too many scheduled visits|1
1073256|NCT02543528|3485049|P5|Extended Wear Period|Adverse Event|0
1073257|NCT02543528|3485050|P4|Extended Wear Period|Adverse Event|3
1073258|NCT02543528|3485051|P3|Extended Wear Period|Adverse Event|17
1073259|NCT02543528|3485052|P2|Extended Wear Period|Adverse Event|11
1073260|NCT02543528|3485053|P1|Extended Wear Period|Adverse Event|16
1073261|NCT02543528|3485049|P5|Adaptation Period|Adverse Event|2
1073262|NCT02543528|3485050|P4|Adaptation Period|Adverse Event|0
1073263|NCT02543528|3485051|P3|Adaptation Period|Adverse Event|0
1073264|NCT02543528|3485052|P2|Adaptation Period|Adverse Event|0
1073265|NCT02543528|3485053|P1|Adaptation Period|Adverse Event|0
1073266|NCT02543528|3485049|P5|Adaptation Period|Lost to Follow-up|14
1073267|NCT02543528|3485050|P4|Adaptation Period|Lost to Follow-up|0
1073268|NCT02543528|3485051|P3|Adaptation Period|Lost to Follow-up|0
1073269|NCT02543528|3485052|P2|Adaptation Period|Lost to Follow-up|0
1073270|NCT02543528|3485053|P1|Adaptation Period|Lost to Follow-up|0
1073271|NCT02543528|3485049|P5|Adaptation Period|Lens Handling Difficultes|8
1073272|NCT02543528|3485050|P4|Adaptation Period|Lens Handling Difficultes|0
1073273|NCT02543528|3485051|P3|Adaptation Period|Lens Handling Difficultes|0
1073274|NCT02543528|3485052|P2|Adaptation Period|Lens Handling Difficultes|0
1073275|NCT02543528|3485053|P1|Adaptation Period|Lens Handling Difficultes|0
1073276|NCT02543528|3485049|P5|Adaptation Period|Unsatisfactory Lens Fitting|2
1073277|NCT02543528|3485050|P4|Adaptation Period|Unsatisfactory Lens Fitting|0
1073278|NCT02543528|3485051|P3|Adaptation Period|Unsatisfactory Lens Fitting|0
1073279|NCT02543528|3485052|P2|Adaptation Period|Unsatisfactory Lens Fitting|0
1073280|NCT02543528|3485053|P1|Adaptation Period|Unsatisfactory Lens Fitting|0
1073281|NCT02542943|3485089|P3|Overall Study|Withdrawal by Subject|0
1073282|NCT02542943|3485090|P2|Overall Study|Withdrawal by Subject|1
1073283|NCT02542943|3485091|P1|Overall Study|Withdrawal by Subject|0
1073284|NCT02542943|3485089|P3|Overall Study|Lost to Follow-up|0
1073285|NCT02542943|3485090|P2|Overall Study|Lost to Follow-up|0
1073286|NCT02542943|3485091|P1|Overall Study|Lost to Follow-up|1
1073287|NCT02542631|3485135|P2|Overall Study|Used Prohibited Medication|1
1073288|NCT02542631|3485136|P1|Overall Study|Used Prohibited Medication|2
1073289|NCT02542631|3485135|P2|Overall Study|Other|1
1073290|NCT02542631|3485136|P1|Overall Study|Other|2
1073291|NCT02542631|3485135|P2|Overall Study|Death|2
1073292|NCT02542631|3485136|P1|Overall Study|Death|1
1073293|NCT02542631|3485135|P2|Overall Study|Lost to Follow-up|5
1073294|NCT02542631|3485136|P1|Overall Study|Lost to Follow-up|6
1073295|NCT02542631|3485135|P2|Overall Study|Physician Decision|4
1073296|NCT02542631|3485136|P1|Overall Study|Physician Decision|6
1073297|NCT02542631|3485135|P2|Overall Study|Protocol Violation|1
1073298|NCT02542631|3485136|P1|Overall Study|Protocol Violation|1
1073299|NCT02542631|3485135|P2|Overall Study|Withdrawal by Subject|16
1073300|NCT02542631|3485136|P1|Overall Study|Withdrawal by Subject|11
1073301|NCT02542631|3485135|P2|Overall Study|Sponsor Termination|0
1073302|NCT02542631|3485136|P1|Overall Study|Sponsor Termination|1
1073303|NCT02542631|3485135|P2|Overall Study|Adverse Event|1
1073304|NCT02542631|3485136|P1|Overall Study|Adverse Event|1
1073305|NCT02542072|3485190|P2|Second Intervention (1 Month)|Lens discomfort|0
1073306|NCT02542072|3485191|P1|Second Intervention (1 Month)|Lens discomfort|1
1073307|NCT02542072|3485190|P2|Second Intervention (1 Month)|Lost to Follow-up|0
1073308|NCT02542072|3485191|P1|Second Intervention (1 Month)|Lost to Follow-up|1
1073309|NCT02542072|3485190|P2|First Intervention (1 Month)|Protocol Violation|0
1073310|NCT02542072|3485191|P1|First Intervention (1 Month)|Protocol Violation|1
1073311|NCT02542072|3485190|P2|First Intervention (1 Month)|Lens discomfort|2
1073312|NCT02542072|3485191|P1|First Intervention (1 Month)|Lens discomfort|1
1073313|NCT02542072|3485190|P2|First Intervention (1 Month)|Lost to Follow-up|0
1073314|NCT02542072|3485191|P1|First Intervention (1 Month)|Lost to Follow-up|2
1073315|NCT02542072|3485190|P2|First Intervention (1 Month)|Adverse Event|1
1073316|NCT02542072|3485191|P1|First Intervention (1 Month)|Adverse Event|1
1073317|NCT02540850|3485310|P3|Overall Study|Lost to Follow-up|34
1073318|NCT02540850|3485311|P2|Overall Study|Lost to Follow-up|66
1073319|NCT02540850|3485312|P1|Overall Study|Lost to Follow-up|69
1073320|NCT02540538|3485356|P3|Overall Study|Pregnancy|0
1073321|NCT02540538|3485357|P2|Overall Study|Pregnancy|1
1073322|NCT02540538|3485358|P1|Overall Study|Pregnancy|0
1073323|NCT02540356|3485402|P2|Overall Study|Terminated due to disease progression|0
1073324|NCT02540356|3485403|P1|Overall Study|Terminated due to disease progression|1
1073325|NCT02540265|3485437|P3|Overall Study|Lost to Follow-up|1
1073326|NCT02540265|3485438|P2|Overall Study|Lost to Follow-up|0
1073327|NCT02540265|3485439|P1|Overall Study|Lost to Follow-up|0
1073328|NCT02540213|3485459|P1|Overall Study|Enrolled but not treated|2
1073329|NCT02540213|3485459|P1|Overall Study|Consent withdrawn|7
1073330|NCT02540213|3485459|P1|Overall Study|Lack of Efficacy|6
1073331|NCT02540213|3485459|P1|Overall Study|Kidney transplant|3
1073332|NCT02540213|3485459|P1|Overall Study|Administrative reasons|3
1073333|NCT02540213|3485459|P1|Overall Study|Death/adverse event|18
1073334|NCT02539797|3485511|P3|Overall Study|Lost to Follow-up|0
1073335|NCT02539797|3485512|P2|Overall Study|Lost to Follow-up|1
1073336|NCT02539797|3485513|P1|Overall Study|Lost to Follow-up|0
1073337|NCT02539134|3485540|P6|Overall Study|Lost to Follow-up|0
1073338|NCT02539134|3485541|P5|Overall Study|Lost to Follow-up|0
1073339|NCT02539134|3485542|P4|Overall Study|Lost to Follow-up|0
1073340|NCT02539134|3485543|P3|Overall Study|Lost to Follow-up|0
1073341|NCT02539134|3485544|P2|Overall Study|Lost to Follow-up|0
1073342|NCT02539134|3485545|P1|Overall Study|Lost to Follow-up|1
1073343|NCT02538965|3485614|P1|Follow-Up Period|Withdrawal by Parent|4
1073344|NCT02538965|3485614|P1|Follow-Up Period|Other = Death due to disease progression|11
1073345|NCT02538965|3485614|P1|Treatment Period|Physician Decision|2
1073346|NCT02538965|3485614|P1|Treatment Period|Disease Progression|1
1073347|NCT02538965|3485614|P1|Treatment Period|Treatment Failure|9
1073348|NCT02538965|3485614|P1|Treatment Period|Withdrawal by Parent/Guardian|2
1073349|NCT02538965|3485614|P1|Treatment Period|Adverse Event|2
1073350|NCT02538965|3485614|P1|Treatment Period|Other = Death due to disease progression|1
1073351|NCT02538107|3485646|P1|Overall Study|Not recorded|7
1073352|NCT02538107|3485646|P1|Overall Study|Other|7
1073353|NCT02538107|3485646|P1|Overall Study|Surgery|1
1073354|NCT02538107|3485646|P1|Overall Study|Adverse Event|4
1073355|NCT02538107|3485646|P1|Overall Study|Administrative reason|5
1073356|NCT02538107|3485646|P1|Overall Study|Death|4
1073357|NCT02538107|3485646|P1|Overall Study|Withdrawal by Subject|17
1073358|NCT02538107|3485646|P1|Overall Study|No further treatment necessary|18
1073359|NCT02538107|3485646|P1|Overall Study|Administration of other ESA|11
1073360|NCT02538107|3485646|P1|Overall Study|Necessity of dialysis|20
1073361|NCT02538107|3485646|P1|Overall Study|Missing|5
1073362|NCT02538107|3485646|P1|Overall Study|Did not receive any Mircera dose|11
1073363|NCT02537522|3485698|P4|Phase II - Period 1 Bilateral|Adverse Event|1
1073364|NCT02537522|3485699|P3|Phase II - Period 1 Bilateral|Adverse Event|0
1073365|NCT02537522|3485700|P2|Phase II - Period 1 Bilateral|Adverse Event|0
1073366|NCT02537522|3485701|P1|Phase II - Period 1 Bilateral|Adverse Event|0
1073367|NCT02537522|3485698|P4|Phase I - Contralateral|unsatisfactory lens fitting|0
1073368|NCT02537522|3485699|P3|Phase I - Contralateral|unsatisfactory lens fitting|0
1073369|NCT02537522|3485700|P2|Phase I - Contralateral|unsatisfactory lens fitting|1
1073370|NCT02537522|3485701|P1|Phase I - Contralateral|unsatisfactory lens fitting|0
1073371|NCT02537522|3485698|P4|Phase I - Contralateral|incorrect randomization|0
1073372|NCT02537522|3485699|P3|Phase I - Contralateral|incorrect randomization|0
1073373|NCT02537522|3485700|P2|Phase I - Contralateral|incorrect randomization|1
1073374|NCT02537522|3485701|P1|Phase I - Contralateral|incorrect randomization|0
1073375|NCT02537522|3485698|P4|Phase I - Contralateral|Withdrawal by Subject|0
1073376|NCT02537522|3485699|P3|Phase I - Contralateral|Withdrawal by Subject|0
1073377|NCT02537522|3485700|P2|Phase I - Contralateral|Withdrawal by Subject|1
1073378|NCT02537522|3485701|P1|Phase I - Contralateral|Withdrawal by Subject|0
1073379|NCT02537522|3485698|P4|Phase I - Contralateral|Subject no longer eligible|0
1073380|NCT02537522|3485699|P3|Phase I - Contralateral|Subject no longer eligible|0
1073381|NCT02537522|3485700|P2|Phase I - Contralateral|Subject no longer eligible|7
1073382|NCT02537522|3485701|P1|Phase I - Contralateral|Subject no longer eligible|15
1073383|NCT02537431|3485709|P1|Overall Study|Withdrawal by Subject|1
1073384|NCT02536781|3485740|P2|Overall Study|Lost to Follow-up|0
1073385|NCT02536781|3485741|P1|Overall Study|Lost to Follow-up|2
1073386|NCT02536664|3485751|P2|Overall Study|Missing|20
1073387|NCT02536664|3485752|P1|Overall Study|Missing|53
1073388|NCT02536664|3485751|P2|Overall Study|Other|24
1073389|NCT02536664|3485752|P1|Overall Study|Other|18
1073390|NCT02536664|3485751|P2|Overall Study|Withdrawal by Subject|5
1073391|NCT02536664|3485752|P1|Overall Study|Withdrawal by Subject|8
1073392|NCT02536664|3485751|P2|Overall Study|Intolerability|6
1073393|NCT02536664|3485752|P1|Overall Study|Intolerability|8
1073394|NCT02536664|3485751|P2|Overall Study|Death due to other reason|2
1073395|NCT02536664|3485752|P1|Overall Study|Death due to other reason|3
1073396|NCT02536664|3485751|P2|Overall Study|Death due to lymphoma|1
1073397|NCT02536664|3485752|P1|Overall Study|Death due to lymphoma|2
1073398|NCT02536664|3485751|P2|Overall Study|Progression|18
1073399|NCT02536664|3485752|P1|Overall Study|Progression|13
1073400|NCT02536664|3485751|P2|Overall Study|Inadequate completion of documentation|4
1073401|NCT02536664|3485752|P1|Overall Study|Inadequate completion of documentation|2
1073402|NCT02536313|3485772|P2|Overall Study|Lack of Efficacy|1
1073403|NCT02536313|3485773|P1|Overall Study|Lack of Efficacy|0
1073404|NCT02535741|3485789|P1|Overall Study|Missing data|6
1073405|NCT02535741|3485789|P1|Overall Study|Exclusion criteria: Bilateral implant|4
1073406|NCT02535741|3485789|P1|Overall Study|Lost to Follow-up|10
1073407|NCT02535741|3485789|P1|Overall Study|Withdrawal by Subject|9
1073408|NCT02535741|3485789|P1|Overall Study|Adverse Event|3
1073409|NCT02535416|3485806|P9|Overall Study|Family bereavement overseas|0
1073410|NCT02535416|3485807|P8|Overall Study|Family bereavement overseas|0
1073411|NCT02535416|3485808|P7|Overall Study|Family bereavement overseas|0
1073412|NCT02535416|3485809|P6|Overall Study|Family bereavement overseas|0
1073413|NCT02535416|3485810|P5|Overall Study|Family bereavement overseas|0
1073414|NCT02535416|3485811|P4|Overall Study|Family bereavement overseas|0
1073415|NCT02535416|3485812|P3|Overall Study|Family bereavement overseas|0
1073416|NCT02535416|3485813|P2|Overall Study|Family bereavement overseas|0
1073417|NCT02535416|3485814|P1|Overall Study|Family bereavement overseas|1
1073418|NCT02535364|3485866|P1|12-Month Follow-up Period|Subject transferred to hospice|1
1073419|NCT02535364|3485866|P1|12-Month Follow-up Period|Subject received alternative therapy|2
1073420|NCT02535364|3485866|P1|12-Month Follow-up Period|Underwent stem cell transplant|5
1073421|NCT02535364|3485866|P1|12-Month Follow-up Period|Death|5
1073422|NCT02535364|3485866|P1|12-Month Follow-up Period|Disease progression|22
1073423|NCT02535364|3485866|P1|Study Treatment|Study placed on clinical hold by FDA|1
1073424|NCT02535364|3485866|P1|Study Treatment|Death|1
1073425|NCT02535364|3485866|P1|Part B Screening|Change in diagnosis, no longer eligible|2
1073426|NCT02535364|3485866|P1|Part B Screening|Adverse Event|1
1073427|NCT02535364|3485866|P1|Part B Screening|Withdrawal by Subject|1
1073428|NCT02535364|3485866|P1|Part B Screening|Physician Decision|1
1073429|NCT02535364|3485866|P1|Part B Screening|Death|2
1073430|NCT02535364|3485866|P1|Part B Screening|Unable to manufacture JCAR015|3
1073431|NCT02535364|3485866|P1|Part B Screening|Study placed on clinical hold by FDA|7
1073432|NCT02535364|3485866|P1|Part A Screening Through Leukapheresis|Disease progression|1
1073433|NCT02535364|3485866|P1|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2
1073434|NCT02535364|3485866|P1|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22
1073435|NCT02534935|3485951|P3|Overall Study|Lost to Follow-up|1
1073436|NCT02534935|3485952|P2|Overall Study|Lost to Follow-up|1
1073437|NCT02534935|3485953|P1|Overall Study|Lost to Follow-up|0
1073438|NCT02534935|3485951|P3|Overall Study|Adverse Event|0
1073439|NCT02534935|3485952|P2|Overall Study|Adverse Event|2
1073440|NCT02534935|3485953|P1|Overall Study|Adverse Event|0
1073441|NCT02534935|3485951|P3|Overall Study|No longer meets the eligibility criteria|0
1073442|NCT02534935|3485952|P2|Overall Study|No longer meets the eligibility criteria|3
1073443|NCT02534935|3485953|P1|Overall Study|No longer meets the eligibility criteria|0
1073444|NCT02534935|3485951|P3|Overall Study|Withdrawal by Subject|3
1073445|NCT02534935|3485952|P2|Overall Study|Withdrawal by Subject|3
1073446|NCT02534935|3485953|P1|Overall Study|Withdrawal by Subject|0
1073447|NCT02534935|3485951|P3|Overall Study|No longer willing to participate|1
1073448|NCT02534935|3485952|P2|Overall Study|No longer willing to participate|1
1073449|NCT02534935|3485953|P1|Overall Study|No longer willing to participate|0
1073450|NCT02534883|3486113|P2|Overall Study|Early Termination|3
1073451|NCT02534883|3486114|P1|Overall Study|Early Termination|8
1073452|NCT02534493|3486130|P1|Overall Study|Withdrawal by Subject|1
1073453|NCT02534493|3486130|P1|Overall Study|Lost to Follow-up|1
1073454|NCT02534350|3486141|P2|Overall Study|Withdrew Consent|0
1073455|NCT02534350|3486142|P1|Overall Study|Withdrew Consent|2
1073456|NCT02534350|3486141|P2|Overall Study|Protocol Violation|0
1073457|NCT02534350|3486142|P1|Overall Study|Protocol Violation|1
1073458|NCT02534350|3486141|P2|Overall Study|Randomized But Not Treated|0
1073459|NCT02534350|3486142|P1|Overall Study|Randomized But Not Treated|1
1073460|NCT02534324|3486156|P2|Overall Study|Adverse Event|0
1073461|NCT02534324|3486157|P1|Overall Study|Adverse Event|1
1073462|NCT02534324|3486156|P2|Overall Study|Lost to Follow-up|7
1073463|NCT02534324|3486157|P1|Overall Study|Lost to Follow-up|20
1073464|NCT02534324|3486156|P2|Overall Study|Protocol Violation|1
1073465|NCT02534324|3486157|P1|Overall Study|Protocol Violation|4
1073466|NCT02533999|3486176|P2|Overall Study|Randomized but intervention not received|1
1073467|NCT02533999|3486177|P1|Overall Study|Randomized but intervention not received|0
1073468|NCT02533999|3486176|P2|Overall Study|Adverse Event|1
1073469|NCT02533999|3486177|P1|Overall Study|Adverse Event|0
1073470|NCT02533999|3486176|P2|Overall Study|Protocol Violation|0
1073471|NCT02533999|3486177|P1|Overall Study|Protocol Violation|3
1073472|NCT02533999|3486176|P2|Overall Study|Lost to Follow-up|5
1073473|NCT02533999|3486177|P1|Overall Study|Lost to Follow-up|3
1073474|NCT02533570|3486209|P3|Overall Study|Adverse Event|1
1073475|NCT02533570|3486210|P2|Overall Study|Adverse Event|1
1073476|NCT02533570|3486211|P1|Overall Study|Adverse Event|0
1073477|NCT02533531|3486222|P1|Overall Study|Device did not turn on|1
1073478|NCT02533401|3486285|P1|Overall Study|Violation of Selection Criteria|1
1073479|NCT02533401|3486285|P1|Overall Study|Lost to Follow-up|1
1073480|NCT02533401|3486285|P1|Overall Study|Insufficient Response/Progressed Disease|1
1073481|NCT02533401|3486285|P1|Overall Study|Death|5
1073482|NCT02533401|3486285|P1|Overall Study|Adverse Event/Intercurrent Disease|3
1073483|NCT02533258|3486293|P1|Overall Study|Lack of Efficacy|2
1073484|NCT02533258|3486293|P1|Overall Study|Progression of pleural effusion|1
1073485|NCT02533258|3486293|P1|Overall Study|Economic factor|1
1073486|NCT02533258|3486293|P1|Overall Study|Other|1
1073487|NCT02533258|3486293|P1|Overall Study|Death|2
1073488|NCT02533258|3486293|P1|Overall Study|Adverse Event|1
1073489|NCT02532855|3486398|P2|Overall Study|Withdrawal by Subject|8
1073490|NCT02532855|3486399|P1|Overall Study|Withdrawal by Subject|4
1073491|NCT02532855|3486398|P2|Overall Study|Lost to Follow-up|3
1073492|NCT02532855|3486399|P1|Overall Study|Lost to Follow-up|4
1073493|NCT02532374|3486423|P1|Overall Study|Physician Decision|1
1073494|NCT02532374|3486423|P1|Overall Study|Withdrawal by Subject|1
1073495|NCT02532179|3486447|P1|Overall Study|Subject received depot steroid injection|1
1073496|NCT02532179|3486447|P1|Overall Study|Pregnancy|1
1073497|NCT02532179|3486447|P1|Overall Study|Lost to Follow-up|1
1073498|NCT02531802|3486502|P21|Received Vaccination 2|Withdrawal by Subject|0
1073499|NCT02531802|3486503|P20|Received Vaccination 2|Withdrawal by Subject|1
1073500|NCT02531802|3486504|P19|Received Vaccination 2|Withdrawal by Subject|1
1073501|NCT02531802|3486505|P18|Received Vaccination 2|Withdrawal by Subject|1
1073502|NCT02531802|3486506|P17|Received Vaccination 2|Withdrawal by Subject|0
1073503|NCT02531802|3486507|P16|Received Vaccination 2|Withdrawal by Subject|0
1073504|NCT02531802|3486508|P15|Received Vaccination 2|Withdrawal by Subject|1
1073505|NCT02531802|3486509|P14|Received Vaccination 2|Withdrawal by Subject|1
1073506|NCT02531802|3486510|P13|Received Vaccination 2|Withdrawal by Subject|1
1073507|NCT02531802|3486511|P12|Received Vaccination 2|Withdrawal by Subject|0
1073508|NCT02531802|3486512|P11|Received Vaccination 2|Withdrawal by Subject|1
1073509|NCT02531802|3486513|P10|Received Vaccination 2|Withdrawal by Subject|0
1073510|NCT02531802|3486514|P9|Received Vaccination 2|Withdrawal by Subject|0
1073511|NCT02531802|3486515|P8|Received Vaccination 2|Withdrawal by Subject|0
1073512|NCT02531802|3486516|P7|Received Vaccination 2|Withdrawal by Subject|0
1073513|NCT02531802|3486517|P6|Received Vaccination 2|Withdrawal by Subject|0
1073514|NCT02531802|3486518|P5|Received Vaccination 2|Withdrawal by Subject|0
1073515|NCT02531802|3486519|P4|Received Vaccination 2|Withdrawal by Subject|0
1073516|NCT02531802|3486520|P3|Received Vaccination 2|Withdrawal by Subject|0
1073517|NCT02531802|3486521|P2|Received Vaccination 2|Withdrawal by Subject|0
1073518|NCT02531802|3486522|P1|Received Vaccination 2|Withdrawal by Subject|0
1073519|NCT02531802|3486502|P21|Received Vaccination 2|Adverse Event|1
1073520|NCT02531802|3486503|P20|Received Vaccination 2|Adverse Event|0
1073521|NCT02531802|3486504|P19|Received Vaccination 2|Adverse Event|1
1073522|NCT02531802|3486505|P18|Received Vaccination 2|Adverse Event|2
1073523|NCT02531802|3486506|P17|Received Vaccination 2|Adverse Event|0
1073524|NCT02531802|3486507|P16|Received Vaccination 2|Adverse Event|0
1073525|NCT02531802|3486508|P15|Received Vaccination 2|Adverse Event|0
1073526|NCT02531802|3486509|P14|Received Vaccination 2|Adverse Event|0
1073527|NCT02531802|3486510|P13|Received Vaccination 2|Adverse Event|0
1073528|NCT02531802|3486511|P12|Received Vaccination 2|Adverse Event|0
1073529|NCT02531802|3486512|P11|Received Vaccination 2|Adverse Event|0
1073530|NCT02531802|3486513|P10|Received Vaccination 2|Adverse Event|0
1073531|NCT02531802|3486514|P9|Received Vaccination 2|Adverse Event|0
1073532|NCT02531802|3486515|P8|Received Vaccination 2|Adverse Event|0
1073533|NCT02531802|3486516|P7|Received Vaccination 2|Adverse Event|0
1073534|NCT02531802|3486517|P6|Received Vaccination 2|Adverse Event|2
1073535|NCT02531802|3486518|P5|Received Vaccination 2|Adverse Event|0
1073536|NCT02531802|3486519|P4|Received Vaccination 2|Adverse Event|0
1073537|NCT02531802|3486520|P3|Received Vaccination 2|Adverse Event|0
1073538|NCT02531802|3486521|P2|Received Vaccination 2|Adverse Event|0
1073539|NCT02531802|3486522|P1|Received Vaccination 2|Adverse Event|0
1073540|NCT02531802|3486502|P21|Received Vaccination 2|Physician Decision|0
1073541|NCT02531802|3486503|P20|Received Vaccination 2|Physician Decision|0
1073542|NCT02531802|3486504|P19|Received Vaccination 2|Physician Decision|0
1073543|NCT02531802|3486505|P18|Received Vaccination 2|Physician Decision|1
1073544|NCT02531802|3486506|P17|Received Vaccination 2|Physician Decision|0
1073545|NCT02531802|3486507|P16|Received Vaccination 2|Physician Decision|0
1073546|NCT02531802|3486508|P15|Received Vaccination 2|Physician Decision|0
1073547|NCT02531802|3486509|P14|Received Vaccination 2|Physician Decision|1
1073548|NCT02531802|3486510|P13|Received Vaccination 2|Physician Decision|0
1073549|NCT02531802|3486511|P12|Received Vaccination 2|Physician Decision|0
1073550|NCT02531802|3486512|P11|Received Vaccination 2|Physician Decision|0
1073551|NCT02531802|3486513|P10|Received Vaccination 2|Physician Decision|2
1073552|NCT02531802|3486514|P9|Received Vaccination 2|Physician Decision|0
1073553|NCT02531802|3486515|P8|Received Vaccination 2|Physician Decision|0
1073554|NCT02531802|3486516|P7|Received Vaccination 2|Physician Decision|0
1073555|NCT02531802|3486517|P6|Received Vaccination 2|Physician Decision|1
1073556|NCT02531802|3486518|P5|Received Vaccination 2|Physician Decision|0
1073557|NCT02531802|3486519|P4|Received Vaccination 2|Physician Decision|0
1073558|NCT02531802|3486520|P3|Received Vaccination 2|Physician Decision|0
1073559|NCT02531802|3486521|P2|Received Vaccination 2|Physician Decision|0
1073560|NCT02531802|3486522|P1|Received Vaccination 2|Physician Decision|0
1073561|NCT02531802|3486502|P21|Received Vaccination 2|Medication interfering with study taken|0
1073562|NCT02531802|3486503|P20|Received Vaccination 2|Medication interfering with study taken|0
1073563|NCT02531802|3486504|P19|Received Vaccination 2|Medication interfering with study taken|1
1073564|NCT02531802|3486505|P18|Received Vaccination 2|Medication interfering with study taken|0
1073565|NCT02531802|3486506|P17|Received Vaccination 2|Medication interfering with study taken|0
1073566|NCT02531802|3486507|P16|Received Vaccination 2|Medication interfering with study taken|0
1073567|NCT02531802|3486508|P15|Received Vaccination 2|Medication interfering with study taken|0
1073568|NCT02531802|3486509|P14|Received Vaccination 2|Medication interfering with study taken|0
1073569|NCT02531802|3486510|P13|Received Vaccination 2|Medication interfering with study taken|1
1073570|NCT02531802|3486511|P12|Received Vaccination 2|Medication interfering with study taken|0
1073571|NCT02531802|3486512|P11|Received Vaccination 2|Medication interfering with study taken|1
1073572|NCT02531802|3486513|P10|Received Vaccination 2|Medication interfering with study taken|1
1073573|NCT02531802|3486514|P9|Received Vaccination 2|Medication interfering with study taken|0
1073574|NCT02531802|3486515|P8|Received Vaccination 2|Medication interfering with study taken|0
1073575|NCT02531802|3486516|P7|Received Vaccination 2|Medication interfering with study taken|0
1073576|NCT02531802|3486517|P6|Received Vaccination 2|Medication interfering with study taken|0
1073577|NCT02531802|3486518|P5|Received Vaccination 2|Medication interfering with study taken|0
1073578|NCT02531802|3486519|P4|Received Vaccination 2|Medication interfering with study taken|0
1073579|NCT02531802|3486520|P3|Received Vaccination 2|Medication interfering with study taken|1
1073580|NCT02531802|3486521|P2|Received Vaccination 2|Medication interfering with study taken|0
1073581|NCT02531802|3486522|P1|Received Vaccination 2|Medication interfering with study taken|0
1073582|NCT02531698|3486954|P2|Overall Study|Lost to Follow-up|0
1073583|NCT02531698|3486955|P1|Overall Study|Lost to Follow-up|1
1073584|NCT02531698|3486954|P2|Overall Study|Protocol Violation|0
1073585|NCT02531698|3486955|P1|Overall Study|Protocol Violation|2
1073586|NCT02531698|3486954|P2|Overall Study|Withdrawal by Subject|1
1073587|NCT02531698|3486955|P1|Overall Study|Withdrawal by Subject|6
1073588|NCT02531698|3486954|P2|Overall Study|Adverse Event|1
1073589|NCT02531698|3486955|P1|Overall Study|Adverse Event|2
1073590|NCT02531646|3487202|P3|Overall Study|equip. image processing issue|0
1073591|NCT02531646|3487203|P2|Overall Study|equip. image processing issue|1
1073592|NCT02531646|3487204|P1|Overall Study|equip. image processing issue|5
1073593|NCT02531438|3487220|P2|Overall Study|Randomized with Exclusion Criteria|0
1073594|NCT02531438|3487221|P1|Overall Study|Randomized with Exclusion Criteria|1
1073595|NCT02531438|3487220|P2|Overall Study|Missed EOT/PTE Visit|2
1073596|NCT02531438|3487221|P1|Overall Study|Missed EOT/PTE Visit|5
1073597|NCT02531438|3487220|P2|Overall Study|Randomized, but Not Treated|0
1073598|NCT02531438|3487221|P1|Overall Study|Randomized, but Not Treated|4
1073599|NCT02531438|3487220|P2|Overall Study|Death|3
1073600|NCT02531438|3487221|P1|Overall Study|Death|6
1073601|NCT02531438|3487220|P2|Overall Study|Physician Decision|1
1073602|NCT02531438|3487221|P1|Overall Study|Physician Decision|0
1073603|NCT02531438|3487220|P2|Overall Study|Withdrawal by Subject|8
1073604|NCT02531438|3487221|P1|Overall Study|Withdrawal by Subject|7
1073605|NCT02531438|3487220|P2|Overall Study|Lost to Follow-up|3
1073606|NCT02531438|3487221|P1|Overall Study|Lost to Follow-up|0
1073607|NCT02531438|3487220|P2|Overall Study|Adverse Event|9
1073608|NCT02531438|3487221|P1|Overall Study|Adverse Event|7
1073609|NCT02531373|3487240|P9|Overall Study|Withdrawal by Subject|0
1073610|NCT02531373|3487241|P8|Overall Study|Withdrawal by Subject|0
1073611|NCT02531373|3487242|P7|Overall Study|Withdrawal by Subject|0
1073612|NCT02531373|3487243|P6|Overall Study|Withdrawal by Subject|0
1073613|NCT02531373|3487244|P5|Overall Study|Withdrawal by Subject|3
1073614|NCT02531373|3487245|P4|Overall Study|Withdrawal by Subject|0
1073615|NCT02531373|3487246|P3|Overall Study|Withdrawal by Subject|0
1073616|NCT02531373|3487247|P2|Overall Study|Withdrawal by Subject|0
1073617|NCT02531373|3487248|P1|Overall Study|Withdrawal by Subject|0
1073618|NCT02531373|3487240|P9|Overall Study|Withdrawal by Parent/Guardian|3
1073619|NCT02531373|3487241|P8|Overall Study|Withdrawal by Parent/Guardian|1
1073620|NCT02531373|3487242|P7|Overall Study|Withdrawal by Parent/Guardian|4
1073621|NCT02531373|3487243|P6|Overall Study|Withdrawal by Parent/Guardian|3
1073622|NCT02531373|3487244|P5|Overall Study|Withdrawal by Parent/Guardian|0
1073623|NCT02531373|3487245|P4|Overall Study|Withdrawal by Parent/Guardian|0
1073624|NCT02531373|3487246|P3|Overall Study|Withdrawal by Parent/Guardian|0
1073625|NCT02531373|3487247|P2|Overall Study|Withdrawal by Parent/Guardian|0
1073626|NCT02531373|3487248|P1|Overall Study|Withdrawal by Parent/Guardian|0
1073627|NCT02531373|3487240|P9|Overall Study|Protocol Violation|1
1073628|NCT02531373|3487241|P8|Overall Study|Protocol Violation|0
1073629|NCT02531373|3487242|P7|Overall Study|Protocol Violation|1
1073630|NCT02531373|3487243|P6|Overall Study|Protocol Violation|1
1073631|NCT02531373|3487244|P5|Overall Study|Protocol Violation|0
1073632|NCT02531373|3487245|P4|Overall Study|Protocol Violation|0
1073633|NCT02531373|3487246|P3|Overall Study|Protocol Violation|0
1073634|NCT02531373|3487247|P2|Overall Study|Protocol Violation|0
1073635|NCT02531373|3487248|P1|Overall Study|Protocol Violation|0
1073636|NCT02531373|3487240|P9|Overall Study|Physician Decision|0
1073637|NCT02531373|3487241|P8|Overall Study|Physician Decision|0
1073638|NCT02531373|3487242|P7|Overall Study|Physician Decision|0
1073639|NCT02531373|3487243|P6|Overall Study|Physician Decision|1
1073640|NCT02531373|3487244|P5|Overall Study|Physician Decision|2
1073641|NCT02531373|3487245|P4|Overall Study|Physician Decision|0
1073642|NCT02531373|3487246|P3|Overall Study|Physician Decision|0
1073643|NCT02531373|3487247|P2|Overall Study|Physician Decision|0
1073644|NCT02531373|3487248|P1|Overall Study|Physician Decision|0
1073645|NCT02531373|3487240|P9|Overall Study|Lost to Follow-up|0
1073646|NCT02531373|3487241|P8|Overall Study|Lost to Follow-up|0
1073647|NCT02531373|3487242|P7|Overall Study|Lost to Follow-up|2
1073648|NCT02531373|3487243|P6|Overall Study|Lost to Follow-up|2
1073649|NCT02531373|3487244|P5|Overall Study|Lost to Follow-up|0
1073650|NCT02531373|3487245|P4|Overall Study|Lost to Follow-up|0
1073651|NCT02531373|3487246|P3|Overall Study|Lost to Follow-up|0
1073652|NCT02531373|3487247|P2|Overall Study|Lost to Follow-up|0
1073653|NCT02531373|3487248|P1|Overall Study|Lost to Follow-up|0
1073654|NCT02531373|3487240|P9|Overall Study|Lack of Efficacy|5
1073655|NCT02531373|3487241|P8|Overall Study|Lack of Efficacy|8
1073656|NCT02531373|3487242|P7|Overall Study|Lack of Efficacy|4
1073657|NCT02531373|3487243|P6|Overall Study|Lack of Efficacy|2
1073658|NCT02531373|3487244|P5|Overall Study|Lack of Efficacy|3
1073659|NCT02531373|3487245|P4|Overall Study|Lack of Efficacy|0
1073660|NCT02531373|3487246|P3|Overall Study|Lack of Efficacy|0
1073661|NCT02531373|3487247|P2|Overall Study|Lack of Efficacy|0
1073662|NCT02531373|3487248|P1|Overall Study|Lack of Efficacy|0
1073663|NCT02530671|3487311|P2|Overall Study|Withdrawal by Subject|0
1073664|NCT02530671|3487312|P1|Overall Study|Withdrawal by Subject|1
1073665|NCT02530671|3487311|P2|Overall Study|Lost to Follow-up|0
1073666|NCT02530671|3487312|P1|Overall Study|Lost to Follow-up|2
1073667|NCT02530125|3487373|P1|Followed for Survival for 2 Years|Early termination of study|3
1073668|NCT02530125|3487373|P1|Completed Treatment|Early termination of study|1
1073669|NCT02529995|3487387|P2|Part B|Discontinued Study|5
1073670|NCT02529995|3487388|P1|Part B|Discontinued Study|6
1073671|NCT02529995|3487387|P2|Part B|Ongoing Study at Data Cut-off|7
1073672|NCT02529995|3487388|P1|Part B|Ongoing Study at Data Cut-off|0
1073673|NCT02529995|3487387|P2|Part A|Discontinued Study|0
1073674|NCT02529995|3487388|P1|Part A|Discontinued Study|1
1073675|NCT02529995|3487387|P2|Part A|Ongoing Study at Data Cut-off|16
1073676|NCT02529995|3487388|P1|Part A|Ongoing Study at Data Cut-off|14
1073677|NCT02529488|3487422|P1|Overall Study|Death|3
1073678|NCT02529488|3487422|P1|Overall Study|Adverse Event|1
1073679|NCT02528643|3487449|P2|Overall Study|No End of Study Information Available|0
1073680|NCT02528643|3487450|P1|Overall Study|No End of Study Information Available|1
1073681|NCT02528643|3487449|P2|Overall Study|Miscellaneous|1
1073682|NCT02528643|3487450|P1|Overall Study|Miscellaneous|0
1073683|NCT02528643|3487449|P2|Overall Study|Withdrawal by Subject|7
1073684|NCT02528643|3487450|P1|Overall Study|Withdrawal by Subject|0
1073685|NCT02528643|3487449|P2|Overall Study|Lost to Follow-up|1
1073686|NCT02528643|3487450|P1|Overall Study|Lost to Follow-up|0
1073687|NCT02528643|3487449|P2|Overall Study|Death|76
1073688|NCT02528643|3487450|P1|Overall Study|Death|38
1073689|NCT02528331|3487467|P1|Overall Study|Withdrawal by Subject|2
1073690|NCT02528305|3487474|P1|Overall Study|Physician Decision|1
1073691|NCT02528305|3487474|P1|Overall Study|Adverse Event|1
1073692|NCT02528305|3487474|P1|Overall Study|Withdrawal by Subject|1
1073693|NCT02528214|3487518|P2|Overall Study|Other than specified above|1
1073694|NCT02528214|3487519|P1|Overall Study|Other than specified above|0
1073695|NCT02528214|3487518|P2|Overall Study|Adverse Event|1
1073696|NCT02528214|3487519|P1|Overall Study|Adverse Event|0
1073697|NCT02528214|3487518|P2|Overall Study|Protocol Violation|1
1073698|NCT02528214|3487519|P1|Overall Study|Protocol Violation|0
1073699|NCT02527161|3487571|P1|Overall Study|Consent violation|4
1073700|NCT02527161|3487571|P1|Overall Study|MRI contraindication|2
1073701|NCT02527161|3487571|P1|Overall Study|Delay in or unfit for surgery|5
1073702|NCT02527161|3487571|P1|Overall Study|Exclusion RA diagnosis|1
1073703|NCT02527161|3487571|P1|Overall Study|Exclusion for excessive deformity|1
1073704|NCT02527161|3487571|P1|Overall Study|Exclusion for BMI|2
1073705|NCT02527161|3487571|P1|Overall Study|Shape Match not used in surgery|2
1073706|NCT02527161|3487571|P1|Overall Study|Withdrawal by Subject|6
1073707|NCT02527161|3487571|P1|Overall Study|Failed MRI|39
1073708|NCT02527148|3487590|P2|Overall Study|Did not receive study intervention|0
1073709|NCT02527148|3487591|P1|Overall Study|Did not receive study intervention|1
1073710|NCT02526550|3487616|P1|Overall Study|Lost to Follow-up|1
1073711|NCT02526524|3487628|P6|Overall Study|Sponsor Decision|0
1073712|NCT02526524|3487629|P5|Overall Study|Sponsor Decision|0
1073713|NCT02526524|3487630|P4|Overall Study|Sponsor Decision|0
1073714|NCT02526524|3487631|P3|Overall Study|Sponsor Decision|0
1073715|NCT02526524|3487632|P2|Overall Study|Sponsor Decision|0
1073716|NCT02526524|3487633|P1|Overall Study|Sponsor Decision|1
1073717|NCT02526524|3487628|P6|Overall Study|Physician Decision|0
1073718|NCT02526524|3487629|P5|Overall Study|Physician Decision|1
1073719|NCT02526524|3487630|P4|Overall Study|Physician Decision|0
1073720|NCT02526524|3487631|P3|Overall Study|Physician Decision|0
1073721|NCT02526524|3487632|P2|Overall Study|Physician Decision|0
1073722|NCT02526524|3487633|P1|Overall Study|Physician Decision|0
1073723|NCT02526524|3487628|P6|Overall Study|Loss of Glucose Control|0
1073724|NCT02526524|3487629|P5|Overall Study|Loss of Glucose Control|2
1073725|NCT02526524|3487630|P4|Overall Study|Loss of Glucose Control|0
1073726|NCT02526524|3487631|P3|Overall Study|Loss of Glucose Control|3
1073727|NCT02526524|3487632|P2|Overall Study|Loss of Glucose Control|0
1073728|NCT02526524|3487633|P1|Overall Study|Loss of Glucose Control|0
1073729|NCT02526524|3487628|P6|Overall Study|Protocol Violation|3
1073730|NCT02526524|3487629|P5|Overall Study|Protocol Violation|4
1073731|NCT02526524|3487630|P4|Overall Study|Protocol Violation|3
1073732|NCT02526524|3487631|P3|Overall Study|Protocol Violation|5
1073733|NCT02526524|3487632|P2|Overall Study|Protocol Violation|1
1073734|NCT02526524|3487633|P1|Overall Study|Protocol Violation|3
1073735|NCT02526524|3487628|P6|Overall Study|Lost to Follow-up|5
1073736|NCT02526524|3487629|P5|Overall Study|Lost to Follow-up|2
1073737|NCT02526524|3487630|P4|Overall Study|Lost to Follow-up|1
1073738|NCT02526524|3487631|P3|Overall Study|Lost to Follow-up|8
1073739|NCT02526524|3487632|P2|Overall Study|Lost to Follow-up|3
1073740|NCT02526524|3487633|P1|Overall Study|Lost to Follow-up|2
1073741|NCT02526524|3487628|P6|Overall Study|Adverse Event|8
1073742|NCT02526524|3487629|P5|Overall Study|Adverse Event|6
1073743|NCT02526524|3487630|P4|Overall Study|Adverse Event|2
1073744|NCT02526524|3487631|P3|Overall Study|Adverse Event|4
1073745|NCT02526524|3487632|P2|Overall Study|Adverse Event|2
1073746|NCT02526524|3487633|P1|Overall Study|Adverse Event|3
1073747|NCT02526524|3487628|P6|Overall Study|Withdrawal by Subject|5
1073748|NCT02526524|3487629|P5|Overall Study|Withdrawal by Subject|9
1073749|NCT02526524|3487630|P4|Overall Study|Withdrawal by Subject|1
1073750|NCT02526524|3487631|P3|Overall Study|Withdrawal by Subject|6
1073751|NCT02526524|3487632|P2|Overall Study|Withdrawal by Subject|3
1073752|NCT02526524|3487633|P1|Overall Study|Withdrawal by Subject|3
1073753|NCT02526290|3487647|P1|Overall Study|Physician Decision|1
1073754|NCT02526290|3487647|P1|Overall Study|Withdrawal by Subject|4
1073755|NCT02526290|3487647|P1|Overall Study|Adverse Event|3
1073756|NCT02525094|3487732|P2|Overall Study|Not Treated|1
1073757|NCT02525094|3487733|P1|Overall Study|Not Treated|1
1073758|NCT02525094|3487732|P2|Overall Study|Withdrawal by Subject|6
1073759|NCT02525094|3487733|P1|Overall Study|Withdrawal by Subject|5
1073760|NCT02525094|3487732|P2|Overall Study|Lost to Follow-up|1
1073761|NCT02525094|3487733|P1|Overall Study|Lost to Follow-up|2
1073762|NCT02524665|3487771|P1|Overall Study|Lost to Follow-up|1
1073763|NCT02524288|3487822|P1|Overall Study|Physician Decision|2
1073764|NCT02524288|3487822|P1|Overall Study|Pregnancy|22
1073765|NCT02524288|3487822|P1|Overall Study|Withdrawal by Subject|76
1073766|NCT02524288|3487822|P1|Overall Study|Subject Moved|32
1073767|NCT02524288|3487822|P1|Overall Study|Study Terminated By Sponsor|1417
1073768|NCT02524288|3487822|P1|Overall Study|Site Discontinued Study Participation|1
1073769|NCT02524288|3487822|P1|Overall Study|Screen Failure|2
1073770|NCT02524288|3487822|P1|Overall Study|Protocol Violation|6
1073771|NCT02524288|3487822|P1|Overall Study|Pregnancy Wish|6
1073772|NCT02524288|3487822|P1|Overall Study|Non-Compliance With Study Drug|14
1073773|NCT02524288|3487822|P1|Overall Study|Non-Compliance With Protocol|32
1073774|NCT02524288|3487822|P1|Overall Study|Lost to Follow-up|216
1073775|NCT02524288|3487822|P1|Overall Study|Adverse Event|115
1073776|NCT02524158|3487832|P2|6-month Assessment|Lost to Follow-up|20
1073777|NCT02524158|3487833|P1|6-month Assessment|Lost to Follow-up|21
1073778|NCT02524158|3487832|P2|6-month Assessment|Withdrawal by Subject|1
1073779|NCT02524158|3487833|P1|6-month Assessment|Withdrawal by Subject|1
1073780|NCT02524158|3487832|P2|12-weeks Assessment|Lost to Follow-up|12
1073781|NCT02524158|3487833|P1|12-weeks Assessment|Lost to Follow-up|18
1073782|NCT02524158|3487832|P2|12-weeks Assessment|Withdrawal by Subject|1
1073783|NCT02524158|3487833|P1|12-weeks Assessment|Withdrawal by Subject|1
1073784|NCT02522624|3487900|P2|Overall Study|Technical failure|0
1073785|NCT02522624|3487901|P1|Overall Study|Technical failure|1
1073786|NCT02522403|3487919|P2|Overall Study|Withdrawal by Subject|4
1073787|NCT02522403|3487920|P1|Overall Study|Withdrawal by Subject|2
1073788|NCT02522403|3487919|P2|Overall Study|Lost to Follow-up|2
1073789|NCT02522403|3487920|P1|Overall Study|Lost to Follow-up|2
1073790|NCT02522286|3487934|P4|Overall Study|Withdrawal by Subject|3
1073791|NCT02522286|3487935|P3|Overall Study|Withdrawal by Subject|0
1073792|NCT02522286|3487936|P2|Overall Study|Withdrawal by Subject|0
1073793|NCT02522286|3487937|P1|Overall Study|Withdrawal by Subject|3
1073794|NCT02521948|3487963|P1|Overall Study|Did not attend one or both follow-ups|6
1073795|NCT02521948|3487963|P1|Overall Study|Lost to Follow-up|1
1073796|NCT02521948|3487963|P1|Overall Study|Death|4
1073797|NCT02521948|3487963|P1|Overall Study|Adverse Event|2
1073798|NCT02520726|3487974|P2|Overall Study|Lost to Follow-up|2
1073799|NCT02520726|3487975|P1|Overall Study|Lost to Follow-up|3
1073800|NCT02520388|3488054|P2|Overall Study|Other (reason not defined)|4
1073801|NCT02520388|3488055|P1|Overall Study|Other (reason not defined)|4
1073802|NCT02520388|3488054|P2|Overall Study|Lost to Follow-up|2
1073803|NCT02520388|3488055|P1|Overall Study|Lost to Follow-up|3
1073804|NCT02520388|3488054|P2|Overall Study|Adverse Event|4
1073805|NCT02520388|3488055|P1|Overall Study|Adverse Event|1
1073806|NCT02520388|3488054|P2|Overall Study|Subject or parent/guardian request|6
1073807|NCT02520388|3488055|P1|Overall Study|Subject or parent/guardian request|0
1073808|NCT02520388|3488054|P2|Overall Study|Physician Decision|0
1073809|NCT02520388|3488055|P1|Overall Study|Physician Decision|1
1073810|NCT02520089|3488065|P2|Overall Study|Lost to Follow-up|4
1073811|NCT02520089|3488066|P1|Overall Study|Lost to Follow-up|3
1073812|NCT02519855|3488076|P2|Overall Study|Lost to Follow-up|3
1073813|NCT02519855|3488077|P1|Overall Study|Lost to Follow-up|3
1073814|NCT02519855|3488076|P2|Overall Study|Adverse Event|1
1073815|NCT02519855|3488077|P1|Overall Study|Adverse Event|0
1073816|NCT02519842|3488095|P3|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2
1073817|NCT02519842|3488096|P2|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
1073818|NCT02519842|3488097|P1|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
1073819|NCT02519842|3488095|P3|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1
1073820|NCT02519842|3488096|P2|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
1073821|NCT02519842|3488097|P1|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
1073822|NCT02519842|3488095|P3|Optional Extension: Cycles 2-6|Completed Chemotherapy|13
1073823|NCT02519842|3488096|P2|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
1073824|NCT02519842|3488097|P1|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
1073825|NCT02519842|3488095|P3|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2
1073826|NCT02519842|3488096|P2|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
1073827|NCT02519842|3488097|P1|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
1073828|NCT02519842|3488095|P3|Optional Extension: Cycles 2-6|Death|1
1073829|NCT02519842|3488096|P2|Optional Extension: Cycles 2-6|Death|0
1073830|NCT02519842|3488097|P1|Optional Extension: Cycles 2-6|Death|0
1073831|NCT02519842|3488095|P3|Optional Extension: Cycles 2-6|Withdrawal by Subject|1
1073832|NCT02519842|3488096|P2|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
1073833|NCT02519842|3488097|P1|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
1073834|NCT02519842|3488095|P3|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3
1073835|NCT02519842|3488096|P2|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
1073836|NCT02519842|3488097|P1|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
1073837|NCT02519842|3488095|P3|Optional Extension: Cycles 2-6|Adverse Event|1
1073838|NCT02519842|3488096|P2|Optional Extension: Cycles 2-6|Adverse Event|0
1073839|NCT02519842|3488097|P1|Optional Extension: Cycles 2-6|Adverse Event|0
1073840|NCT02519842|3488095|P3|Optional Extension: Cycles 2-6|Physician Decision|5
1073841|NCT02519842|3488096|P2|Optional Extension: Cycles 2-6|Physician Decision|0
1073842|NCT02519842|3488097|P1|Optional Extension: Cycles 2-6|Physician Decision|0
1073843|NCT02519842|3488095|P3|Base Study: Cycle 1|Non-compliance with Study Drug|0
1073844|NCT02519842|3488096|P2|Base Study: Cycle 1|Non-compliance with Study Drug|1
1073845|NCT02519842|3488097|P1|Base Study: Cycle 1|Non-compliance with Study Drug|0
1073846|NCT02519842|3488095|P3|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
1073847|NCT02519842|3488096|P2|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1
1073848|NCT02519842|3488097|P1|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
1073849|NCT02519842|3488095|P3|Base Study: Cycle 1|Adverse Event|0
1073850|NCT02519842|3488096|P2|Base Study: Cycle 1|Adverse Event|0
1073851|NCT02519842|3488097|P1|Base Study: Cycle 1|Adverse Event|1
1073852|NCT02519842|3488095|P3|Base Study: Cycle 1|Screening Failure|0
1073853|NCT02519842|3488096|P2|Base Study: Cycle 1|Screening Failure|1
1073854|NCT02519842|3488097|P1|Base Study: Cycle 1|Screening Failure|1
1073855|NCT02519712|3488116|P1|Overall Study|Accruals are donors|2
1073856|NCT02519712|3488116|P1|Overall Study|Disease Progression|1
1073857|NCT02519712|3488116|P1|Overall Study|Disease Relapse|1
1073858|NCT02519595|3488123|P3|Overall Study|Protocol Violation|16
1073859|NCT02519595|3488124|P2|Overall Study|Protocol Violation|22
1073860|NCT02519595|3488125|P1|Overall Study|Protocol Violation|8
1073861|NCT02518919|3488194|P3|Overall Study|Protocol Violation|2
1073862|NCT02518919|3488195|P2|Overall Study|Protocol Violation|1
1073863|NCT02518919|3488196|P1|Overall Study|Protocol Violation|1
1073864|NCT02518048|3488229|P1|Overall Study|Withdrawal by Subject|1
1073865|NCT02517541|3488256|P1|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2
1073866|NCT02517541|3488256|P1|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4
1073867|NCT02517541|3488256|P1|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1
1073868|NCT02517541|3488256|P1|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2
1073869|NCT02517541|3488256|P1|Test Period (SenSura Mio Convex Soft)|Adverse Event|3
1073870|NCT02517541|3488256|P1|Baseline Period (Own Product)|Protocol Violation|1
1073871|NCT02517528|3488262|P1|Overall Study|Withdrawal by Subject|1
1073872|NCT02517515|3488272|P2|Overall Study|Not Specified|0
1073873|NCT02517515|3488273|P1|Overall Study|Not Specified|1
1073874|NCT02517515|3488272|P2|Overall Study|Lost to Follow-up|0
1073875|NCT02517515|3488273|P1|Overall Study|Lost to Follow-up|1
1073876|NCT02517515|3488272|P2|Overall Study|Withdrew Consent|1
1073877|NCT02517515|3488273|P1|Overall Study|Withdrew Consent|0
1073878|NCT02517515|3488272|P2|Overall Study|Adverse Event|1
1073879|NCT02517515|3488273|P1|Overall Study|Adverse Event|0
1073880|NCT02517463|3488290|P2|Overall Study|Lost to Follow-up|2
1073881|NCT02517463|3488291|P1|Overall Study|Lost to Follow-up|5
1073882|NCT02516410|3488337|P2|Overall Study|Withdrawal by Subject|1
1073883|NCT02516410|3488338|P1|Overall Study|Withdrawal by Subject|0
1073884|NCT02516410|3488337|P2|Overall Study|Adverse Event|1
1073885|NCT02516410|3488338|P1|Overall Study|Adverse Event|0
1073886|NCT02516306|3488367|P2|Period 2: Day 8 - 91|Protocol Violation|2
1073887|NCT02516306|3488368|P1|Period 2: Day 8 - 91|Protocol Violation|1
1073888|NCT02516202|3488377|P3|Overall Study|Stopped Follow-up|1
1073889|NCT02516202|3488378|P2|Overall Study|Stopped Follow-up|0
1073890|NCT02516202|3488379|P1|Overall Study|Stopped Follow-up|0
1073891|NCT02516202|3488377|P3|Overall Study|Lost to Follow-up|1
1073892|NCT02516202|3488378|P2|Overall Study|Lost to Follow-up|1
1073893|NCT02516202|3488379|P1|Overall Study|Lost to Follow-up|1
1073894|NCT02516202|3488377|P3|Overall Study|Withdrawal by Subject|1
1073895|NCT02516202|3488378|P2|Overall Study|Withdrawal by Subject|0
1073896|NCT02516202|3488379|P1|Overall Study|Withdrawal by Subject|1
1073897|NCT02516163|3488405|P1|Overall Study|MRI contraindication exclusion|6
1073898|NCT02516163|3488405|P1|Overall Study|Data not recorded|2
1073899|NCT02516163|3488405|P1|Overall Study|Use of incorrect measurement technique|5
1073900|NCT02516163|3488405|P1|Overall Study|Unfit/delay in surgery|3
1073901|NCT02516163|3488405|P1|Overall Study|Failed MRI/incorrect MRI protocol|11
1073902|NCT02516163|3488405|P1|Overall Study|Withdrawal by Subject|1
1073903|NCT02516098|3488419|P2|Period 2|Withdrawal by Subject|1
1073904|NCT02516098|3488420|P1|Period 2|Withdrawal by Subject|0
1073905|NCT02516098|3488419|P2|Washout After Period 1|Adverse Event|1
1073906|NCT02516098|3488420|P1|Washout After Period 1|Adverse Event|0
1073907|NCT02516098|3488419|P2|Period 1|Protocol Violation|0
1073908|NCT02516098|3488420|P1|Period 1|Protocol Violation|1
1073909|NCT02515994|3488434|P2|Overall Study|Withdrawal by Subject|0
1073910|NCT02515994|3488435|P1|Overall Study|Withdrawal by Subject|2
1073911|NCT02515994|3488434|P2|Overall Study|Adverse Event|1
1073912|NCT02515994|3488435|P1|Overall Study|Adverse Event|3
1073913|NCT02515994|3488434|P2|Overall Study|No Longer Meets Eligibility Criteria|1
1073914|NCT02515994|3488435|P1|Overall Study|No Longer Meets Eligibility Criteria|2
1073915|NCT02515994|3488434|P2|Overall Study|Protocol Violation|5
1073916|NCT02515994|3488435|P1|Overall Study|Protocol Violation|3
1073917|NCT02515942|3488450|P3|Overall Study|Withdrawal by Subject|2
1073918|NCT02515942|3488451|P2|Overall Study|Withdrawal by Subject|3
1073919|NCT02515942|3488452|P1|Overall Study|Withdrawal by Subject|0
1073920|NCT02515942|3488450|P3|Overall Study|Lost to Follow-up|0
1073921|NCT02515942|3488451|P2|Overall Study|Lost to Follow-up|0
1073922|NCT02515942|3488452|P1|Overall Study|Lost to Follow-up|2
1073923|NCT02515942|3488450|P3|Overall Study|Lack of Efficacy|1
1073924|NCT02515942|3488451|P2|Overall Study|Lack of Efficacy|0
1073925|NCT02515942|3488452|P1|Overall Study|Lack of Efficacy|0
1073926|NCT02515942|3488450|P3|Overall Study|Death|1
1073927|NCT02515942|3488451|P2|Overall Study|Death|0
1073928|NCT02515942|3488452|P1|Overall Study|Death|0
1073929|NCT02515942|3488450|P3|Overall Study|Adverse Event|0
1073930|NCT02515942|3488451|P2|Overall Study|Adverse Event|0
1073931|NCT02515942|3488452|P1|Overall Study|Adverse Event|5
1073932|NCT02515331|3488511|P3|Overall Study|Adverse Event|0
1073933|NCT02515331|3488512|P2|Overall Study|Adverse Event|0
1073934|NCT02515331|3488513|P1|Overall Study|Adverse Event|2
1073935|NCT02515331|3488511|P3|Overall Study|Protocol deviation|3
1073936|NCT02515331|3488512|P2|Overall Study|Protocol deviation|0
1073937|NCT02515331|3488513|P1|Overall Study|Protocol deviation|0
1073938|NCT02515331|3488511|P3|Overall Study|Withdrawal by Subject|1
1073939|NCT02515331|3488512|P2|Overall Study|Withdrawal by Subject|0
1073940|NCT02515331|3488513|P1|Overall Study|Withdrawal by Subject|0
1073941|NCT02515279|3488534|P1|Overall Study|Other|22
1073942|NCT02515279|3488534|P1|Overall Study|End-of-treatment visit not attended|17
1073943|NCT02515279|3488534|P1|Overall Study|Withdrawal by Subject|18
1073944|NCT02515279|3488534|P1|Overall Study|Lost to Follow-up|9
1073945|NCT02515279|3488534|P1|Overall Study|Lack of Efficacy|31
1073946|NCT02515279|3488534|P1|Overall Study|Adverse Event|7
1073947|NCT02515045|3488553|P3|Overall Study|Lost to Follow-up|1
1073948|NCT02515045|3488554|P2|Overall Study|Lost to Follow-up|1
1073949|NCT02515045|3488555|P1|Overall Study|Lost to Follow-up|0
1073950|NCT02515045|3488553|P3|Overall Study|Adverse Event|3
1073951|NCT02515045|3488554|P2|Overall Study|Adverse Event|3
1073952|NCT02515045|3488555|P1|Overall Study|Adverse Event|0
1073953|NCT02514772|3488592|P2|Overall Study|Withdrawal by Subject|1
1073954|NCT02514772|3488593|P1|Overall Study|Withdrawal by Subject|2
1073955|NCT02514772|3488592|P2|Overall Study|Death|1
1073956|NCT02514772|3488593|P1|Overall Study|Death|0
1073957|NCT02514772|3488592|P2|Overall Study|Adverse Event|0
1073958|NCT02514772|3488593|P1|Overall Study|Adverse Event|1
1073959|NCT02514551|3488607|P2|Overall Study|On Treatment|6
1073960|NCT02514551|3488608|P1|Overall Study|On Treatment|5
1073961|NCT02514551|3488607|P2|Overall Study|Participant Never Treated|2
1073962|NCT02514551|3488608|P1|Overall Study|Participant Never Treated|0
1073963|NCT02514551|3488607|P2|Overall Study|Lost to Follow-up|1
1073964|NCT02514551|3488608|P1|Overall Study|Lost to Follow-up|0
1073965|NCT02514473|3488625|P2|Overall Study|Other|1
1073966|NCT02514473|3488626|P1|Overall Study|Other|1
1073967|NCT02514473|3488625|P2|Overall Study|Lost to Follow-up|1
1073968|NCT02514473|3488626|P1|Overall Study|Lost to Follow-up|0
1073969|NCT02514473|3488625|P2|Overall Study|Withdrawal by Subject|1
1073970|NCT02514473|3488626|P1|Overall Study|Withdrawal by Subject|2
1073971|NCT02514473|3488625|P2|Overall Study|Adverse Event|2
1073972|NCT02514473|3488626|P1|Overall Study|Adverse Event|0
1073973|NCT02514122|3488669|P2|Overall Study|Withdrawal by Subject|0
1073974|NCT02514122|3488670|P1|Overall Study|Withdrawal by Subject|2
1073975|NCT02513771|3488694|P2|Overall Study|Not being able to get to clinic|0
1073976|NCT02513771|3488695|P1|Overall Study|Not being able to get to clinic|1
1073977|NCT02513771|3488694|P2|Overall Study|Lost to Follow-up|1
1073978|NCT02513771|3488695|P1|Overall Study|Lost to Follow-up|1
1073979|NCT02513550|3488737|P6|Post-Treatment Follow-up Period|Labor Reasons|0
1073980|NCT02513550|3488738|P5|Post-Treatment Follow-up Period|Labor Reasons|0
1073981|NCT02513550|3488739|P4|Post-Treatment Follow-up Period|Labor Reasons|0
1073982|NCT02513550|3488740|P3|Post-Treatment Follow-up Period|Labor Reasons|1
1073983|NCT02513550|3488741|P2|Post-Treatment Follow-up Period|Labor Reasons|0
1073984|NCT02513550|3488742|P1|Post-Treatment Follow-up Period|Labor Reasons|0
1073985|NCT02513550|3488737|P6|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
1073986|NCT02513550|3488738|P5|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
1073987|NCT02513550|3488739|P4|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
1073988|NCT02513550|3488740|P3|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3
1073989|NCT02513550|3488741|P2|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
1073990|NCT02513550|3488742|P1|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
1073991|NCT02513550|3488737|P6|Post-Treatment Follow-up Period|Subject move out of town|0
1073992|NCT02513550|3488738|P5|Post-Treatment Follow-up Period|Subject move out of town|0
1073993|NCT02513550|3488739|P4|Post-Treatment Follow-up Period|Subject move out of town|0
1073994|NCT02513550|3488740|P3|Post-Treatment Follow-up Period|Subject move out of town|1
1073995|NCT02513550|3488741|P2|Post-Treatment Follow-up Period|Subject move out of town|0
1073996|NCT02513550|3488742|P1|Post-Treatment Follow-up Period|Subject move out of town|0
1073997|NCT02513550|3488737|P6|Post-Treatment Follow-up Period|Death|0
1073998|NCT02513550|3488738|P5|Post-Treatment Follow-up Period|Death|0
1073999|NCT02513550|3488739|P4|Post-Treatment Follow-up Period|Death|0
1074000|NCT02513550|3488740|P3|Post-Treatment Follow-up Period|Death|1
1074001|NCT02513550|3488741|P2|Post-Treatment Follow-up Period|Death|0
1074002|NCT02513550|3488742|P1|Post-Treatment Follow-up Period|Death|0
1074003|NCT02513550|3488737|P6|Post-Treatment Follow-up Period|Physician Decision|0
1074004|NCT02513550|3488738|P5|Post-Treatment Follow-up Period|Physician Decision|0
1074005|NCT02513550|3488739|P4|Post-Treatment Follow-up Period|Physician Decision|0
1074006|NCT02513550|3488740|P3|Post-Treatment Follow-up Period|Physician Decision|0
1074007|NCT02513550|3488741|P2|Post-Treatment Follow-up Period|Physician Decision|0
1074008|NCT02513550|3488742|P1|Post-Treatment Follow-up Period|Physician Decision|2
1074009|NCT02513550|3488737|P6|Post-Treatment Follow-up Period|Adverse Event|0
1074010|NCT02513550|3488738|P5|Post-Treatment Follow-up Period|Adverse Event|0
1074011|NCT02513550|3488739|P4|Post-Treatment Follow-up Period|Adverse Event|0
1074012|NCT02513550|3488740|P3|Post-Treatment Follow-up Period|Adverse Event|4
1074013|NCT02513550|3488741|P2|Post-Treatment Follow-up Period|Adverse Event|1
1074014|NCT02513550|3488742|P1|Post-Treatment Follow-up Period|Adverse Event|1
1074015|NCT02513550|3488737|P6|Post-Treatment Follow-up Period|Lost to Follow-up|0
1074016|NCT02513550|3488738|P5|Post-Treatment Follow-up Period|Lost to Follow-up|0
1074017|NCT02513550|3488739|P4|Post-Treatment Follow-up Period|Lost to Follow-up|0
1074018|NCT02513550|3488740|P3|Post-Treatment Follow-up Period|Lost to Follow-up|7
1074019|NCT02513550|3488741|P2|Post-Treatment Follow-up Period|Lost to Follow-up|2
1074020|NCT02513550|3488742|P1|Post-Treatment Follow-up Period|Lost to Follow-up|4
1074021|NCT02513550|3488737|P6|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
1074022|NCT02513550|3488738|P5|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
1074023|NCT02513550|3488739|P4|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
1074024|NCT02513550|3488740|P3|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20
1074025|NCT02513550|3488741|P2|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16
1074026|NCT02513550|3488742|P1|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12
1074027|NCT02513550|3488737|P6|Post-Treatment Follow-up Period|Withdrawal by Subject|0
1074028|NCT02513550|3488738|P5|Post-Treatment Follow-up Period|Withdrawal by Subject|0
1074029|NCT02513550|3488739|P4|Post-Treatment Follow-up Period|Withdrawal by Subject|0
1074030|NCT02513550|3488740|P3|Post-Treatment Follow-up Period|Withdrawal by Subject|26
1074031|NCT02513550|3488741|P2|Post-Treatment Follow-up Period|Withdrawal by Subject|20
1074032|NCT02513550|3488742|P1|Post-Treatment Follow-up Period|Withdrawal by Subject|12
1074033|NCT02513550|3488737|P6|Double Blind Treatment Period|Death|0
1074034|NCT02513550|3488738|P5|Double Blind Treatment Period|Death|0
1074035|NCT02513550|3488739|P4|Double Blind Treatment Period|Death|0
1074036|NCT02513550|3488740|P3|Double Blind Treatment Period|Death|2
1074037|NCT02513550|3488741|P2|Double Blind Treatment Period|Death|0
1074038|NCT02513550|3488742|P1|Double Blind Treatment Period|Death|1
1074039|NCT02513550|3488737|P6|Double Blind Treatment Period|Due to personal business|0
1074040|NCT02513550|3488738|P5|Double Blind Treatment Period|Due to personal business|0
1074041|NCT02513550|3488739|P4|Double Blind Treatment Period|Due to personal business|0
1074042|NCT02513550|3488740|P3|Double Blind Treatment Period|Due to personal business|1
1074043|NCT02513550|3488741|P2|Double Blind Treatment Period|Due to personal business|0
1074044|NCT02513550|3488742|P1|Double Blind Treatment Period|Due to personal business|2
1074045|NCT02513550|3488737|P6|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
1074046|NCT02513550|3488738|P5|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
1074047|NCT02513550|3488739|P4|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
1074048|NCT02513550|3488740|P3|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1
1074049|NCT02513550|3488741|P2|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
1074050|NCT02513550|3488742|P1|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
1074051|NCT02513550|3488737|P6|Double Blind Treatment Period|Site terminated by sponsor|0
1074052|NCT02513550|3488738|P5|Double Blind Treatment Period|Site terminated by sponsor|0
1074053|NCT02513550|3488739|P4|Double Blind Treatment Period|Site terminated by sponsor|0
1074054|NCT02513550|3488740|P3|Double Blind Treatment Period|Site terminated by sponsor|3
1074055|NCT02513550|3488741|P2|Double Blind Treatment Period|Site terminated by sponsor|1
1074056|NCT02513550|3488742|P1|Double Blind Treatment Period|Site terminated by sponsor|1
1074057|NCT02513550|3488737|P6|Double Blind Treatment Period|Physician Decision|0
1074058|NCT02513550|3488738|P5|Double Blind Treatment Period|Physician Decision|0
1074059|NCT02513550|3488739|P4|Double Blind Treatment Period|Physician Decision|0
1074060|NCT02513550|3488740|P3|Double Blind Treatment Period|Physician Decision|4
1074061|NCT02513550|3488741|P2|Double Blind Treatment Period|Physician Decision|0
1074062|NCT02513550|3488742|P1|Double Blind Treatment Period|Physician Decision|2
1074063|NCT02513550|3488737|P6|Double Blind Treatment Period|Protocol Violation|0
1074064|NCT02513550|3488738|P5|Double Blind Treatment Period|Protocol Violation|0
1074065|NCT02513550|3488739|P4|Double Blind Treatment Period|Protocol Violation|0
1074066|NCT02513550|3488740|P3|Double Blind Treatment Period|Protocol Violation|4
1074067|NCT02513550|3488741|P2|Double Blind Treatment Period|Protocol Violation|1
1074068|NCT02513550|3488742|P1|Double Blind Treatment Period|Protocol Violation|1
1074069|NCT02513550|3488737|P6|Double Blind Treatment Period|Lack of Efficacy|0
1074070|NCT02513550|3488738|P5|Double Blind Treatment Period|Lack of Efficacy|0
1074071|NCT02513550|3488739|P4|Double Blind Treatment Period|Lack of Efficacy|0
1074072|NCT02513550|3488740|P3|Double Blind Treatment Period|Lack of Efficacy|6
1074073|NCT02513550|3488741|P2|Double Blind Treatment Period|Lack of Efficacy|5
1074074|NCT02513550|3488742|P1|Double Blind Treatment Period|Lack of Efficacy|4
1074075|NCT02513550|3488737|P6|Double Blind Treatment Period|Lost to Follow-up|1
1074076|NCT02513550|3488738|P5|Double Blind Treatment Period|Lost to Follow-up|0
1074077|NCT02513550|3488739|P4|Double Blind Treatment Period|Lost to Follow-up|0
1074078|NCT02513550|3488740|P3|Double Blind Treatment Period|Lost to Follow-up|11
1074079|NCT02513550|3488741|P2|Double Blind Treatment Period|Lost to Follow-up|7
1074080|NCT02513550|3488742|P1|Double Blind Treatment Period|Lost to Follow-up|9
1074081|NCT02513550|3488737|P6|Double Blind Treatment Period|Adverse Event|0
1074082|NCT02513550|3488738|P5|Double Blind Treatment Period|Adverse Event|1
1074083|NCT02513550|3488739|P4|Double Blind Treatment Period|Adverse Event|0
1074084|NCT02513550|3488740|P3|Double Blind Treatment Period|Adverse Event|17
1074085|NCT02513550|3488741|P2|Double Blind Treatment Period|Adverse Event|13
1074086|NCT02513550|3488742|P1|Double Blind Treatment Period|Adverse Event|5
1074087|NCT02513550|3488737|P6|Double Blind Treatment Period|Withdrawal by Subject|0
1074088|NCT02513550|3488738|P5|Double Blind Treatment Period|Withdrawal by Subject|0
1074089|NCT02513550|3488739|P4|Double Blind Treatment Period|Withdrawal by Subject|0
1074090|NCT02513550|3488740|P3|Double Blind Treatment Period|Withdrawal by Subject|25
1074091|NCT02513550|3488741|P2|Double Blind Treatment Period|Withdrawal by Subject|11
1074092|NCT02513550|3488742|P1|Double Blind Treatment Period|Withdrawal by Subject|11
1074093|NCT02513160|3488818|P4|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
1074094|NCT02513160|3488819|P3|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
1074095|NCT02513160|3488820|P2|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1
1074096|NCT02513160|3488821|P1|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
1074097|NCT02513160|3488818|P4|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
1074098|NCT02513160|3488819|P3|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
1074099|NCT02513160|3488820|P2|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
1074100|NCT02513160|3488821|P1|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1
1074101|NCT02513160|3488818|P4|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
1074102|NCT02513160|3488819|P3|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
1074103|NCT02513160|3488820|P2|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
1074104|NCT02513160|3488821|P1|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2
1074105|NCT02513160|3488818|P4|Treatment Period (Day 0 to Week 6)|Noncompliance|0
1074106|NCT02513160|3488819|P3|Treatment Period (Day 0 to Week 6)|Noncompliance|0
1074107|NCT02513160|3488820|P2|Treatment Period (Day 0 to Week 6)|Noncompliance|0
1074108|NCT02513160|3488821|P1|Treatment Period (Day 0 to Week 6)|Noncompliance|1
1074109|NCT02513160|3488818|P4|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1
1074110|NCT02513160|3488819|P3|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0
1074111|NCT02513160|3488820|P2|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
1074112|NCT02513160|3488821|P1|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
1074113|NCT02513160|3488818|P4|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
1074114|NCT02513160|3488819|P3|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
1074115|NCT02513160|3488820|P2|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
1074116|NCT02513160|3488821|P1|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10
1074117|NCT02513160|3488818|P4|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
1074118|NCT02513160|3488819|P3|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
1074119|NCT02513160|3488820|P2|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
1074120|NCT02513160|3488821|P1|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1
1074121|NCT02513160|3488818|P4|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
1074122|NCT02513160|3488819|P3|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
1074123|NCT02513160|3488820|P2|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
1074124|NCT02513160|3488821|P1|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20
1074125|NCT02513160|3488818|P4|Run-In Period (Days -14 to Day -1)|Adverse Event|0
1074126|NCT02513160|3488819|P3|Run-In Period (Days -14 to Day -1)|Adverse Event|0
1074127|NCT02513160|3488820|P2|Run-In Period (Days -14 to Day -1)|Adverse Event|0
1074128|NCT02513160|3488821|P1|Run-In Period (Days -14 to Day -1)|Adverse Event|4
1074129|NCT02513160|3488818|P4|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
1074130|NCT02513160|3488819|P3|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
1074131|NCT02513160|3488820|P2|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
1074132|NCT02513160|3488821|P1|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6
1074133|NCT02513160|3488818|P4|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
1074134|NCT02513160|3488819|P3|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
1074135|NCT02513160|3488820|P2|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
1074136|NCT02513160|3488821|P1|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214
1074137|NCT02513160|3488818|P4|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
1074138|NCT02513160|3488819|P3|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
1074139|NCT02513160|3488820|P2|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
1074140|NCT02513160|3488821|P1|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33
1074141|NCT02513095|3488858|P2|Overall Study|Stampede resulted in transfers out of ER|16
1074142|NCT02513095|3488859|P1|Overall Study|Stampede resulted in transfers out of ER|14
1074143|NCT02512861|3488905|P2|Overall Study|Withdrawal by Subject|1
1074144|NCT02512861|3488906|P1|Overall Study|Withdrawal by Subject|0
1074145|NCT02512861|3488905|P2|Overall Study|Physician Decision|1
1074146|NCT02512861|3488906|P1|Overall Study|Physician Decision|3
1074147|NCT02512861|3488905|P2|Overall Study|Protocol Violation|7
1074148|NCT02512861|3488906|P1|Overall Study|Protocol Violation|3
1074149|NCT02512302|3489173|P10|Period 4|Adverse Event|0
1074150|NCT02512302|3489174|P9|Period 4|Adverse Event|0
1074151|NCT02512302|3489175|P8|Period 4|Adverse Event|0
1074152|NCT02512302|3489176|P7|Period 4|Adverse Event|1
1074153|NCT02512302|3489177|P6|Period 4|Adverse Event|0
1074154|NCT02512302|3489178|P5|Period 4|Adverse Event|0
1074155|NCT02512302|3489179|P4|Period 4|Adverse Event|0
1074156|NCT02512302|3489180|P3|Period 4|Adverse Event|0
1074157|NCT02512302|3489181|P2|Period 4|Adverse Event|0
1074158|NCT02512302|3489182|P1|Period 4|Adverse Event|0
1074159|NCT02512302|3489173|P10|Period 3|Lost to Follow-up|0
1074160|NCT02512302|3489174|P9|Period 3|Lost to Follow-up|0
1074161|NCT02512302|3489175|P8|Period 3|Lost to Follow-up|0
1074162|NCT02512302|3489176|P7|Period 3|Lost to Follow-up|0
1074163|NCT02512302|3489177|P6|Period 3|Lost to Follow-up|0
1074164|NCT02512302|3489178|P5|Period 3|Lost to Follow-up|0
1074165|NCT02512302|3489179|P4|Period 3|Lost to Follow-up|0
1074166|NCT02512302|3489180|P3|Period 3|Lost to Follow-up|1
1074167|NCT02512302|3489181|P2|Period 3|Lost to Follow-up|0
1074168|NCT02512302|3489182|P1|Period 3|Lost to Follow-up|0
1074169|NCT02512302|3489173|P10|Period 2|Adverse Event|1
1074170|NCT02512302|3489174|P9|Period 2|Adverse Event|0
1074171|NCT02512302|3489175|P8|Period 2|Adverse Event|0
1074172|NCT02512302|3489176|P7|Period 2|Adverse Event|0
1074173|NCT02512302|3489177|P6|Period 2|Adverse Event|0
1074174|NCT02512302|3489178|P5|Period 2|Adverse Event|0
1074175|NCT02512302|3489179|P4|Period 2|Adverse Event|0
1074176|NCT02512302|3489180|P3|Period 2|Adverse Event|0
1074177|NCT02512302|3489181|P2|Period 2|Adverse Event|0
1074178|NCT02512302|3489182|P1|Period 2|Adverse Event|0
1074179|NCT02512302|3489173|P10|Period 1|Adverse Event|0
1074180|NCT02512302|3489174|P9|Period 1|Adverse Event|0
1074181|NCT02512302|3489175|P8|Period 1|Adverse Event|0
1074182|NCT02512302|3489176|P7|Period 1|Adverse Event|0
1074183|NCT02512302|3489177|P6|Period 1|Adverse Event|0
1074184|NCT02512302|3489178|P5|Period 1|Adverse Event|0
1074185|NCT02512302|3489179|P4|Period 1|Adverse Event|0
1074186|NCT02512302|3489180|P3|Period 1|Adverse Event|0
1074187|NCT02512302|3489181|P2|Period 1|Adverse Event|1
1074188|NCT02512302|3489182|P1|Period 1|Adverse Event|0
1074189|NCT02511782|3489280|P3|Overall Study|Withdrawal by Subject|0
1074190|NCT02511782|3489281|P2|Overall Study|Withdrawal by Subject|0
1074191|NCT02511782|3489282|P1|Overall Study|Withdrawal by Subject|1
1074192|NCT02511431|3489311|P6|Treatment|Lost to Follow-up|1
1074193|NCT02511431|3489312|P5|Treatment|Lost to Follow-up|0
1074194|NCT02511431|3489313|P4|Treatment|Lost to Follow-up|0
1074195|NCT02511431|3489314|P3|Treatment|Lost to Follow-up|1
1074196|NCT02511431|3489315|P2|Treatment|Lost to Follow-up|0
1074197|NCT02511431|3489316|P1|Treatment|Lost to Follow-up|0
1074198|NCT02510820|3489341|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|0
1074199|NCT02510820|3489342|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
1074200|NCT02510820|3489341|P2|First Intervention (4 Weeks)|Withdrawal by Subject|1
1074201|NCT02510820|3489342|P1|First Intervention (4 Weeks)|Withdrawal by Subject|0
1074202|NCT02510014|3489382|P2|Treatment Period|Incarceration, pregnancy, misc|5
1074203|NCT02510014|3489383|P1|Treatment Period|Incarceration, pregnancy, misc|29
1074204|NCT02510014|3489382|P2|Treatment Period|Protocol Violation|4
1074205|NCT02510014|3489383|P1|Treatment Period|Protocol Violation|4
1074206|NCT02510014|3489382|P2|Treatment Period|Withdrawn by the investigator|1
1074207|NCT02510014|3489383|P1|Treatment Period|Withdrawn by the investigator|7
1074208|NCT02510014|3489382|P2|Treatment Period|Withdrawal by Subject|24
1074209|NCT02510014|3489383|P1|Treatment Period|Withdrawal by Subject|67
1074210|NCT02510014|3489382|P2|Treatment Period|Physician Decision|0
1074211|NCT02510014|3489383|P1|Treatment Period|Physician Decision|5
1074212|NCT02510014|3489382|P2|Treatment Period|Lost to Follow-up|19
1074213|NCT02510014|3489383|P1|Treatment Period|Lost to Follow-up|80
1074214|NCT02510014|3489382|P2|Treatment Period|Withdrawal symptoms|0
1074215|NCT02510014|3489383|P1|Treatment Period|Withdrawal symptoms|3
1074216|NCT02510014|3489382|P2|Treatment Period|Adverse Event|4
1074217|NCT02510014|3489383|P1|Treatment Period|Adverse Event|11
1074218|NCT02510014|3489382|P2|Run-In Period (Days -14 to Day -1)|Not specified|1
1074219|NCT02510014|3489383|P1|Run-In Period (Days -14 to Day -1)|Not specified|19
1074220|NCT02510014|3489382|P2|Run-In Period (Days -14 to Day -1)|Protocol Violation|0
1074221|NCT02510014|3489383|P1|Run-In Period (Days -14 to Day -1)|Protocol Violation|2
1074222|NCT02510014|3489382|P2|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1
1074223|NCT02510014|3489383|P1|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7
1074224|NCT02510014|3489382|P2|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3
1074225|NCT02510014|3489383|P1|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22
1074226|NCT02510014|3489382|P2|Run-In Period (Days -14 to Day -1)|Physician Decision|1
1074227|NCT02510014|3489383|P1|Run-In Period (Days -14 to Day -1)|Physician Decision|0
1074228|NCT02510014|3489382|P2|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3
1074229|NCT02510014|3489383|P1|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44
1074230|NCT02510014|3489382|P2|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0
1074231|NCT02510014|3489383|P1|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1
1074232|NCT02510014|3489382|P2|Run-In Period (Days -14 to Day -1)|Adverse Event|1
1074233|NCT02510014|3489383|P1|Run-In Period (Days -14 to Day -1)|Adverse Event|1
1074234|NCT02509117|3489413|P10|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1
1074235|NCT02509117|3489414|P9|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
1074236|NCT02509117|3489415|P8|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
1074237|NCT02509117|3489416|P7|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
1074238|NCT02509117|3489417|P6|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
1074239|NCT02509117|3489418|P5|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
1074240|NCT02509117|3489419|P4|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
1074241|NCT02509117|3489420|P3|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
1074242|NCT02509117|3489421|P2|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
1074243|NCT02509117|3489422|P1|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
1074244|NCT02509117|3489413|P10|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1
1074245|NCT02509117|3489414|P9|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
1074246|NCT02509117|3489415|P8|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
1074247|NCT02509117|3489416|P7|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
1074248|NCT02509117|3489417|P6|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
1074249|NCT02509117|3489418|P5|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
1074250|NCT02509117|3489419|P4|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
1074251|NCT02509117|3489420|P3|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
1074252|NCT02509117|3489421|P2|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
1074253|NCT02509117|3489422|P1|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
1074254|NCT02509117|3489413|P10|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
1074255|NCT02509117|3489414|P9|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
1074256|NCT02509117|3489415|P8|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
1074257|NCT02509117|3489416|P7|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
1074258|NCT02509117|3489417|P6|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
1074259|NCT02509117|3489418|P5|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
1074260|NCT02509117|3489419|P4|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
1074261|NCT02509117|3489420|P3|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
1074431|NCT02503202|3490392|P5|Extension: Month 6 to 24|Physician Decision|0
1074262|NCT02509117|3489421|P2|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1
1074263|NCT02509117|3489422|P1|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
1074264|NCT02508701|3489742|P4|Overall Study|Lost to Follow-up|3
1074265|NCT02508701|3489743|P3|Overall Study|Lost to Follow-up|5
1074266|NCT02508701|3489744|P2|Overall Study|Lost to Follow-up|5
1074267|NCT02508701|3489745|P1|Overall Study|Lost to Follow-up|9
1074268|NCT02508194|3489786|P2|Overall Study|Principal Investigator Decision|2
1074269|NCT02508194|3489787|P1|Overall Study|Principal Investigator Decision|1
1074270|NCT02508194|3489786|P2|Overall Study|Error in Randomization|3
1074271|NCT02508194|3489787|P1|Overall Study|Error in Randomization|1
1074272|NCT02508194|3489786|P2|Overall Study|Withdrawal by Subject|18
1074273|NCT02508194|3489787|P1|Overall Study|Withdrawal by Subject|20
1074274|NCT02508194|3489786|P2|Overall Study|Lost to Follow-up|18
1074275|NCT02508194|3489787|P1|Overall Study|Lost to Follow-up|25
1074276|NCT02508194|3489786|P2|Overall Study|Death|3
1074277|NCT02508194|3489787|P1|Overall Study|Death|5
1074278|NCT02508116|3489827|P2|Overall Study|Physician Decision|0
1074279|NCT02508116|3489828|P1|Overall Study|Physician Decision|2
1074280|NCT02508116|3489827|P2|Overall Study|Protocol Violation|2
1074281|NCT02508116|3489828|P1|Overall Study|Protocol Violation|1
1074282|NCT02508116|3489827|P2|Overall Study|Withdrawal by Subject|2
1074283|NCT02508116|3489828|P1|Overall Study|Withdrawal by Subject|3
1074284|NCT02508116|3489827|P2|Overall Study|Lost to Follow-up|3
1074285|NCT02508116|3489828|P1|Overall Study|Lost to Follow-up|2
1074286|NCT02507752|3489855|P1|Overall Study|Participant didn't perform visit Week 24|1
1074287|NCT02507752|3489855|P1|Overall Study|Participant didn't perform visit Week 12|1
1074288|NCT02507752|3489855|P1|Overall Study|Infusion reaction at first infusion|1
1074289|NCT02507752|3489855|P1|Overall Study|Lost to Follow-up|7
1074290|NCT02507752|3489855|P1|Overall Study|Protocol Violation|6
1074291|NCT02507752|3489855|P1|Overall Study|Adverse Event|1
1074292|NCT02507375|3489899|P2|Overall Study|Adverse Event|1
1074293|NCT02507375|3489900|P1|Overall Study|Adverse Event|0
1074294|NCT02507375|3489899|P2|Overall Study|Refused treatment|1
1074295|NCT02507375|3489900|P1|Overall Study|Refused treatment|0
1074296|NCT02507375|3489899|P2|Overall Study|Death|1
1074297|NCT02507375|3489900|P1|Overall Study|Death|0
1074298|NCT02507375|3489899|P2|Overall Study|Progressive Disease|5
1074299|NCT02507375|3489900|P1|Overall Study|Progressive Disease|4
1074300|NCT02507219|3489917|P6|Overall Study|Withdrawal by Subject|0
1074301|NCT02507219|3489918|P5|Overall Study|Withdrawal by Subject|1
1074302|NCT02507219|3489919|P4|Overall Study|Withdrawal by Subject|0
1074303|NCT02507219|3489920|P3|Overall Study|Withdrawal by Subject|0
1074304|NCT02507219|3489921|P2|Overall Study|Withdrawal by Subject|0
1074305|NCT02507219|3489922|P1|Overall Study|Withdrawal by Subject|0
1074306|NCT02507219|3489917|P6|Overall Study|Physician Decision|0
1074307|NCT02507219|3489918|P5|Overall Study|Physician Decision|0
1074308|NCT02507219|3489919|P4|Overall Study|Physician Decision|0
1074309|NCT02507219|3489920|P3|Overall Study|Physician Decision|0
1074310|NCT02507219|3489921|P2|Overall Study|Physician Decision|0
1074311|NCT02507219|3489922|P1|Overall Study|Physician Decision|1
1074312|NCT02506881|3489951|P4|First Intervention (Day 1)|Violation of blood storage conditions|12
1074313|NCT02506881|3489952|P3|First Intervention (Day 1)|Violation of blood storage conditions|12
1074314|NCT02506881|3489953|P2|First Intervention (Day 1)|Violation of blood storage conditions|0
1074315|NCT02506881|3489954|P1|First Intervention (Day 1)|Violation of blood storage conditions|0
1074316|NCT02506881|3489951|P4|First Intervention (Day 1)|Withdrawal by Subject|0
1074317|NCT02506881|3489952|P3|First Intervention (Day 1)|Withdrawal by Subject|0
1074318|NCT02506881|3489953|P2|First Intervention (Day 1)|Withdrawal by Subject|0
1074319|NCT02506881|3489954|P1|First Intervention (Day 1)|Withdrawal by Subject|1
1074320|NCT02506881|3489951|P4|First Intervention (Day 1)|Protocol Violation|0
1074321|NCT02506881|3489952|P3|First Intervention (Day 1)|Protocol Violation|1
1074322|NCT02506881|3489953|P2|First Intervention (Day 1)|Protocol Violation|0
1074323|NCT02506881|3489954|P1|First Intervention (Day 1)|Protocol Violation|0
1074324|NCT02506257|3490028|P4|Overall Study|Protocol Violation|0
1074325|NCT02506257|3490029|P3|Overall Study|Protocol Violation|1
1074326|NCT02506257|3490030|P2|Overall Study|Protocol Violation|0
1074327|NCT02506257|3490031|P1|Overall Study|Protocol Violation|0
1074328|NCT02506257|3490028|P4|Overall Study|Adverse Event|0
1074329|NCT02506257|3490029|P3|Overall Study|Adverse Event|3
1074330|NCT02506257|3490030|P2|Overall Study|Adverse Event|2
1074331|NCT02506257|3490031|P1|Overall Study|Adverse Event|0
1074332|NCT02506101|3490063|P2|Overall Study|No enrollment and staff unavailability|0
1074333|NCT02506101|3490064|P1|Overall Study|No enrollment and staff unavailability|1
1074334|NCT02506101|3490063|P2|Overall Study|Transportation issues|0
1074335|NCT02506101|3490064|P1|Overall Study|Transportation issues|1
1074336|NCT02505945|3490080|P2|Overall Study|Lost to Follow-up|1
1074337|NCT02505945|3490081|P1|Overall Study|Lost to Follow-up|6
1074338|NCT02505945|3490080|P2|Overall Study|Physician Decision|1
1074339|NCT02505945|3490081|P1|Overall Study|Physician Decision|2
1074340|NCT02505945|3490080|P2|Overall Study|Adverse Event|0
1074341|NCT02505945|3490081|P1|Overall Study|Adverse Event|1
1074342|NCT02505945|3490080|P2|Overall Study|Withdrawal by Subject|2
1074343|NCT02505945|3490081|P1|Overall Study|Withdrawal by Subject|13
1074344|NCT02505334|3490091|P2|Extension Treatment Period|Unclassified|0
1074345|NCT02505334|3490092|P1|Extension Treatment Period|Unclassified|3
1074346|NCT02505334|3490091|P2|Extension Treatment Period|Withdrawal by Subject|0
1074347|NCT02505334|3490092|P1|Extension Treatment Period|Withdrawal by Subject|6
1074348|NCT02505334|3490091|P2|Extension Treatment Period|Lack of Efficacy|0
1074349|NCT02505334|3490092|P1|Extension Treatment Period|Lack of Efficacy|4
1074350|NCT02505334|3490091|P2|Extension Treatment Period|Adverse Event|0
1074351|NCT02505334|3490092|P1|Extension Treatment Period|Adverse Event|5
1074352|NCT02505334|3490091|P2|Main Treatment Period|Unclassified|10
1074353|NCT02505334|3490092|P1|Main Treatment Period|Unclassified|4
1074354|NCT02505334|3490091|P2|Main Treatment Period|Withdrawal by Subject|8
1074355|NCT02505334|3490092|P1|Main Treatment Period|Withdrawal by Subject|1
1074356|NCT02505334|3490091|P2|Main Treatment Period|Protocol Violation|1
1074357|NCT02505334|3490092|P1|Main Treatment Period|Protocol Violation|0
1074358|NCT02505334|3490091|P2|Main Treatment Period|Lack of Efficacy|17
1074359|NCT02505334|3490092|P1|Main Treatment Period|Lack of Efficacy|7
1074360|NCT02505334|3490091|P2|Main Treatment Period|Adverse Event|3
1074361|NCT02505334|3490092|P1|Main Treatment Period|Adverse Event|3
1074362|NCT02504827|3490228|P1|Overall Study|Could not produce sputum|1
1074363|NCT02504541|3490261|P1|Overall Study|Multiple|5
1074364|NCT02504541|3490261|P1|Overall Study|Other|2
1074365|NCT02504541|3490261|P1|Overall Study|Termination by Sponsor|1
1074366|NCT02504541|3490261|P1|Overall Study|Protocol Violation|2
1074367|NCT02504541|3490261|P1|Overall Study|Met Stopping Criteria|1
1074368|NCT02504541|3490261|P1|Overall Study|Lost to Follow-up|1
1074369|NCT02504541|3490261|P1|Overall Study|Withdrawal by Subject|4
1074370|NCT02504541|3490261|P1|Overall Study|Adverse Event|4
1074371|NCT02504502|3490267|P2|Crossover to Enhanced Report|Lost to Follow-up|0
1074372|NCT02504502|3490268|P1|Crossover to Enhanced Report|Lost to Follow-up|5
1074373|NCT02504502|3490267|P2|Routine Care vs. Enhanced Report|Lost to Follow-up|7
1074374|NCT02504502|3490268|P1|Routine Care vs. Enhanced Report|Lost to Follow-up|4
1074375|NCT02504424|3490274|P1|Overall Study|Withdrawal by Subject|2
1074376|NCT02504320|3490283|P4|Treatment Period 3|Adverse Event|0
1074377|NCT02504320|3490284|P3|Treatment Period 3|Adverse Event|1
1074378|NCT02504320|3490285|P2|Treatment Period 3|Adverse Event|0
1074379|NCT02504320|3490286|P1|Treatment Period 3|Adverse Event|0
1074380|NCT02504320|3490283|P4|Treatment Period 3|Positive Drug Screen|1
1074381|NCT02504320|3490284|P3|Treatment Period 3|Positive Drug Screen|0
1074382|NCT02504320|3490285|P2|Treatment Period 3|Positive Drug Screen|0
1074383|NCT02504320|3490286|P1|Treatment Period 3|Positive Drug Screen|0
1074384|NCT02504320|3490283|P4|Treatment Period 2|Positive Drug Screen|0
1074385|NCT02504320|3490284|P3|Treatment Period 2|Positive Drug Screen|0
1074386|NCT02504320|3490285|P2|Treatment Period 2|Positive Drug Screen|1
1074387|NCT02504320|3490286|P1|Treatment Period 2|Positive Drug Screen|0
1074388|NCT02504320|3490283|P4|Treatment Period 1|Positive Drug Screen|0
1074389|NCT02504320|3490284|P3|Treatment Period 1|Positive Drug Screen|1
1074390|NCT02504320|3490285|P2|Treatment Period 1|Positive Drug Screen|0
1074391|NCT02504320|3490286|P1|Treatment Period 1|Positive Drug Screen|0
1074392|NCT02504294|3490306|P2|Overall Study|Lost to Follow-up|7
1074393|NCT02504294|3490307|P1|Overall Study|Lost to Follow-up|6
1074394|NCT02504294|3490306|P2|Overall Study|Physician Decision|2
1074395|NCT02504294|3490307|P1|Overall Study|Physician Decision|1
1074396|NCT02504294|3490306|P2|Overall Study|Protocol Violation|26
1074397|NCT02504294|3490307|P1|Overall Study|Protocol Violation|27
1074398|NCT02504294|3490306|P2|Overall Study|Withdrawal by Subject|1
1074399|NCT02504294|3490307|P1|Overall Study|Withdrawal by Subject|7
1074400|NCT02504294|3490306|P2|Overall Study|Adverse Event|12
1074401|NCT02504294|3490307|P1|Overall Study|Adverse Event|15
1074402|NCT02503865|3490336|P3|Overall Study|Refused treatment|2
1074403|NCT02503865|3490337|P2|Overall Study|Refused treatment|39
1074404|NCT02503865|3490338|P1|Overall Study|Refused treatment|4
1074405|NCT02503865|3490336|P3|Overall Study|Moved out of area|0
1074406|NCT02503865|3490337|P2|Overall Study|Moved out of area|8
1074407|NCT02503865|3490338|P1|Overall Study|Moved out of area|1
1074408|NCT02503787|3490358|P1|Implant to 3 Month Endpoint|Withdrawal by Subject|1
1074409|NCT02503787|3490358|P1|Implant to 3 Month Endpoint|Adverse Event|2
1074410|NCT02503787|3490358|P1|Successful Trial (≥50% Pain Relief)|Physician Decision|2
1074411|NCT02503787|3490358|P1|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3
1074412|NCT02503787|3490358|P1|Device Trial (HD Programming Trial)|Withdrawal by Subject|1
1074413|NCT02503787|3490358|P1|Device Trial (HD Programming Trial)|Lack of Efficacy|6
1074414|NCT02503787|3490358|P1|Enrollment|Unable to be programmed|1
1074415|NCT02503787|3490358|P1|Enrollment|Inability to implant system|1
1074416|NCT02503787|3490358|P1|Enrollment|Protocol Violation|1
1074417|NCT02503787|3490358|P1|Enrollment|Adverse Event|1
1074418|NCT02503787|3490358|P1|Enrollment|Study closure|1
1074419|NCT02503787|3490358|P1|Enrollment|Lost to Follow-up|1
1074420|NCT02503787|3490358|P1|Enrollment|Insurance issue|2
1074421|NCT02503787|3490358|P1|Enrollment|Physician Decision|2
1074422|NCT02503787|3490358|P1|Enrollment|Inclusion/exclusion criteria not met|4
1074423|NCT02503787|3490358|P1|Enrollment|Withdrawal by Subject|6
1074424|NCT02503215|3490381|P1|Overall Study|Unable to use positive airway pressure|2
1074425|NCT02503215|3490381|P1|Overall Study|Unable to wear compression stockings|1
1074426|NCT02503202|3490392|P5|Extension: Month 6 to 24|Withdrawal by Subject|0
1074427|NCT02503202|3490393|P4|Extension: Month 6 to 24|Withdrawal by Subject|4
1074428|NCT02503202|3490394|P3|Extension: Month 6 to 24|Withdrawal by Subject|2
1074429|NCT02503202|3490395|P2|Extension: Month 6 to 24|Withdrawal by Subject|8
1074430|NCT02503202|3490396|P1|Extension: Month 6 to 24|Withdrawal by Subject|5
1074432|NCT02503202|3490393|P4|Extension: Month 6 to 24|Physician Decision|3
1074433|NCT02503202|3490394|P3|Extension: Month 6 to 24|Physician Decision|1
1074434|NCT02503202|3490395|P2|Extension: Month 6 to 24|Physician Decision|0
1074435|NCT02503202|3490396|P1|Extension: Month 6 to 24|Physician Decision|1
1074436|NCT02503202|3490392|P5|Extension: Month 6 to 24|Lost to Follow-up|1
1074437|NCT02503202|3490393|P4|Extension: Month 6 to 24|Lost to Follow-up|10
1074438|NCT02503202|3490394|P3|Extension: Month 6 to 24|Lost to Follow-up|6
1074439|NCT02503202|3490395|P2|Extension: Month 6 to 24|Lost to Follow-up|8
1074440|NCT02503202|3490396|P1|Extension: Month 6 to 24|Lost to Follow-up|4
1074441|NCT02503202|3490392|P5|Extension: Month 6 to 24|Death|0
1074442|NCT02503202|3490393|P4|Extension: Month 6 to 24|Death|0
1074443|NCT02503202|3490394|P3|Extension: Month 6 to 24|Death|0
1074444|NCT02503202|3490395|P2|Extension: Month 6 to 24|Death|0
1074445|NCT02503202|3490396|P1|Extension: Month 6 to 24|Death|1
1074446|NCT02503202|3490392|P5|Extension: Month 6 to 24|Protocol Violation|0
1074447|NCT02503202|3490393|P4|Extension: Month 6 to 24|Protocol Violation|1
1074448|NCT02503202|3490394|P3|Extension: Month 6 to 24|Protocol Violation|0
1074449|NCT02503202|3490395|P2|Extension: Month 6 to 24|Protocol Violation|0
1074450|NCT02503202|3490396|P1|Extension: Month 6 to 24|Protocol Violation|0
1074451|NCT02503202|3490392|P5|Base Study: Up to Month 6|Randomized not vaccinated|0
1074452|NCT02503202|3490393|P4|Base Study: Up to Month 6|Randomized not vaccinated|2
1074453|NCT02503202|3490394|P3|Base Study: Up to Month 6|Randomized not vaccinated|1
1074454|NCT02503202|3490395|P2|Base Study: Up to Month 6|Randomized not vaccinated|0
1074455|NCT02503202|3490396|P1|Base Study: Up to Month 6|Randomized not vaccinated|0
1074456|NCT02503202|3490392|P5|Base Study: Up to Month 6|Withdrawal by Subject|1
1074457|NCT02503202|3490393|P4|Base Study: Up to Month 6|Withdrawal by Subject|4
1074458|NCT02503202|3490394|P3|Base Study: Up to Month 6|Withdrawal by Subject|4
1074459|NCT02503202|3490395|P2|Base Study: Up to Month 6|Withdrawal by Subject|3
1074460|NCT02503202|3490396|P1|Base Study: Up to Month 6|Withdrawal by Subject|6
1074461|NCT02503202|3490392|P5|Base Study: Up to Month 6|Physician Decision|1
1074462|NCT02503202|3490393|P4|Base Study: Up to Month 6|Physician Decision|0
1074463|NCT02503202|3490394|P3|Base Study: Up to Month 6|Physician Decision|0
1074464|NCT02503202|3490395|P2|Base Study: Up to Month 6|Physician Decision|0
1074465|NCT02503202|3490396|P1|Base Study: Up to Month 6|Physician Decision|0
1074466|NCT02503202|3490392|P5|Base Study: Up to Month 6|Lost to Follow-up|1
1074467|NCT02503202|3490393|P4|Base Study: Up to Month 6|Lost to Follow-up|5
1074468|NCT02503202|3490394|P3|Base Study: Up to Month 6|Lost to Follow-up|10
1074469|NCT02503202|3490395|P2|Base Study: Up to Month 6|Lost to Follow-up|8
1074470|NCT02503202|3490396|P1|Base Study: Up to Month 6|Lost to Follow-up|11
1074471|NCT02503202|3490392|P5|Base Study: Up to Month 6|Death|0
1074472|NCT02503202|3490393|P4|Base Study: Up to Month 6|Death|0
1074473|NCT02503202|3490394|P3|Base Study: Up to Month 6|Death|0
1074474|NCT02503202|3490395|P2|Base Study: Up to Month 6|Death|1
1074475|NCT02503202|3490396|P1|Base Study: Up to Month 6|Death|1
1074476|NCT02503085|3490438|P4|Period 2: Washout (3 to 7 Days)|Adverse Event|0
1074477|NCT02503085|3490439|P3|Period 2: Washout (3 to 7 Days)|Adverse Event|1
1074478|NCT02503085|3490440|P2|Period 2: Washout (3 to 7 Days)|Adverse Event|0
1074479|NCT02503085|3490441|P1|Period 2: Washout (3 to 7 Days)|Adverse Event|1
1074480|NCT02502864|3490480|P1|Overall Study|Withdrawal by Subject|1
1074481|NCT02502734|3490489|P2|Washout Period|Adverse Event|0
1074482|NCT02502734|3490490|P1|Washout Period|Adverse Event|1
1074483|NCT02502734|3490489|P2|Double-blind Treatment Period 1|Adverse Event|0
1074484|NCT02502734|3490490|P1|Double-blind Treatment Period 1|Adverse Event|1
1074485|NCT02502526|3490501|P3|Overall Study|Enrollment suspension|1
1074486|NCT02502526|3490502|P2|Overall Study|Enrollment suspension|1
1074487|NCT02502526|3490503|P1|Overall Study|Enrollment suspension|4
1074488|NCT02502526|3490501|P3|Overall Study|Disqualified due to cataract grading|1
1074489|NCT02502526|3490502|P2|Overall Study|Disqualified due to cataract grading|0
1074490|NCT02502526|3490503|P1|Overall Study|Disqualified due to cataract grading|0
1074491|NCT02502526|3490501|P3|Overall Study|Withdrawal by Subject|1
1074492|NCT02502526|3490502|P2|Overall Study|Withdrawal by Subject|1
1074493|NCT02502526|3490503|P1|Overall Study|Withdrawal by Subject|0
1074494|NCT02502526|3490501|P3|Overall Study|Lost to Follow-up|3
1074495|NCT02502526|3490502|P2|Overall Study|Lost to Follow-up|2
1074496|NCT02502526|3490503|P1|Overall Study|Lost to Follow-up|2
1074497|NCT02502149|3490589|P5|Intermediate|Discontinued prematurely|0
1074498|NCT02502149|3490590|P4|Intermediate|Discontinued prematurely|0
1074499|NCT02502149|3490591|P3|Intermediate|Discontinued prematurely|0
1074500|NCT02502149|3490592|P2|Intermediate|Discontinued prematurely|0
1074501|NCT02502149|3490593|P1|Intermediate|Discontinued prematurely|1
1074502|NCT02501629|3490719|P2|Overall Study|Subject did not return to site|1
1074503|NCT02501629|3490720|P1|Overall Study|Subject did not return to site|0
1074504|NCT02501629|3490719|P2|Overall Study|Withdrawal by Subject|5
1074505|NCT02501629|3490720|P1|Overall Study|Withdrawal by Subject|3
1074506|NCT02501629|3490719|P2|Overall Study|Early termination by sponsor|0
1074507|NCT02501629|3490720|P1|Overall Study|Early termination by sponsor|1
1074508|NCT02501629|3490719|P2|Overall Study|Withdrawn from study by sponsor|0
1074509|NCT02501629|3490720|P1|Overall Study|Withdrawn from study by sponsor|1
1074510|NCT02501629|3490719|P2|Overall Study|Death|1
1074511|NCT02501629|3490720|P1|Overall Study|Death|0
1074512|NCT02500979|3490753|P2|Period 2|Change in risk|0
1074513|NCT02500979|3490754|P1|Period 2|Change in risk|1
1074514|NCT02500979|3490753|P2|Period 1|Subject decision|0
1074515|NCT02500979|3490754|P1|Period 1|Subject decision|2
1074516|NCT02500979|3490753|P2|Period 1|Adverse Event|0
1074517|NCT02500979|3490754|P1|Period 1|Adverse Event|1
1074518|NCT02500979|3490753|P2|Period 1|Severe non-compliance to protocol|1
1074519|NCT02500979|3490754|P1|Period 1|Severe non-compliance to protocol|0
1074520|NCT02500979|3490753|P2|Period 1|Hyperglycemia|0
1074521|NCT02500979|3490754|P1|Period 1|Hyperglycemia|1
1074522|NCT02500758|3490804|P2|Second Intervention (2 Minutes)|Protocol Violation|1
1074523|NCT02500758|3490805|P1|Second Intervention (2 Minutes)|Protocol Violation|1
1074524|NCT02500758|3490804|P2|Second Intervention (2 Minutes)|Lost to Follow-up|1
1074525|NCT02500758|3490805|P1|Second Intervention (2 Minutes)|Lost to Follow-up|0
1074526|NCT02500758|3490804|P2|Second Intervention (2 Minutes)|Withdrawal by Subject|0
1074527|NCT02500758|3490805|P1|Second Intervention (2 Minutes)|Withdrawal by Subject|2
1074528|NCT02500758|3490804|P2|Washout (1 Week)|Lost to Follow-up|2
1074529|NCT02500758|3490805|P1|Washout (1 Week)|Lost to Follow-up|2
1074530|NCT02500758|3490804|P2|First Intervention (2 Minutes)|Withdrawal by Subject|1
1074531|NCT02500758|3490805|P1|First Intervention (2 Minutes)|Withdrawal by Subject|0
1074532|NCT02500706|3490816|P3|Overall Study|Unclassified|1
1074533|NCT02500706|3490817|P2|Overall Study|Unclassified|0
1074534|NCT02500706|3490818|P1|Overall Study|Unclassified|0
1074535|NCT02500706|3490816|P3|Overall Study|Withdrawal by Subject|4
1074536|NCT02500706|3490817|P2|Overall Study|Withdrawal by Subject|6
1074537|NCT02500706|3490818|P1|Overall Study|Withdrawal by Subject|4
1074538|NCT02500706|3490816|P3|Overall Study|Lost to Follow-up|1
1074539|NCT02500706|3490817|P2|Overall Study|Lost to Follow-up|1
1074540|NCT02500706|3490818|P1|Overall Study|Lost to Follow-up|0
1074541|NCT02500706|3490816|P3|Overall Study|Adverse Event|1
1074542|NCT02500706|3490817|P2|Overall Study|Adverse Event|0
1074543|NCT02500706|3490818|P1|Overall Study|Adverse Event|0
1074544|NCT02500537|3490985|P2|Overall Study|Withdrawal by Subject|0
1074545|NCT02500537|3490986|P1|Overall Study|Withdrawal by Subject|1
1074546|NCT02500537|3490985|P2|Overall Study|Lost to Follow-up|1
1074547|NCT02500537|3490986|P1|Overall Study|Lost to Follow-up|0
1074548|NCT02500537|3490985|P2|Overall Study|Death|0
1074549|NCT02500537|3490986|P1|Overall Study|Death|2
1074550|NCT02500056|3491055|P2|Overall Study|Death|1
1074551|NCT02500056|3491056|P1|Overall Study|Death|3
1074552|NCT02500056|3491055|P2|Overall Study|Recurrence|0
1074553|NCT02500056|3491056|P1|Overall Study|Recurrence|1
1074554|NCT02500056|3491055|P2|Overall Study|Lost to Follow-up|7
1074555|NCT02500056|3491056|P1|Overall Study|Lost to Follow-up|3
1074556|NCT02499952|3491066|P1|Overall Study|Death|9
1074557|NCT02499952|3491066|P1|Overall Study|Lost to Follow-up|1
1074558|NCT02499900|3491075|P2|Extension Study Period|Not specified|2
1074559|NCT02499900|3491076|P1|Extension Study Period|Not specified|0
1074560|NCT02499900|3491075|P2|Extension Study Period|Lost to Follow-up|5
1074561|NCT02499900|3491076|P1|Extension Study Period|Lost to Follow-up|2
1074562|NCT02499900|3491075|P2|Extension Study Period|Pregnancy|2
1074563|NCT02499900|3491076|P1|Extension Study Period|Pregnancy|1
1074564|NCT02499900|3491075|P2|Extension Study Period|Physician Decision|5
1074565|NCT02499900|3491076|P1|Extension Study Period|Physician Decision|2
1074566|NCT02499900|3491075|P2|Extension Study Period|Withdrawal by Subject|2
1074567|NCT02499900|3491076|P1|Extension Study Period|Withdrawal by Subject|5
1074568|NCT02499900|3491075|P2|Extension Study Period|Adverse Event|4
1074569|NCT02499900|3491076|P1|Extension Study Period|Adverse Event|2
1074570|NCT02499900|3491075|P2|Completed Core, Continued Into Extension|Personal motivation|0
1074571|NCT02499900|3491076|P1|Completed Core, Continued Into Extension|Personal motivation|1
1074572|NCT02499900|3491075|P2|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0
1074573|NCT02499900|3491076|P1|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1
1074574|NCT02499900|3491075|P2|Completed Core, Continued Into Extension|Withdrawal by Subject|2
1074575|NCT02499900|3491076|P1|Completed Core, Continued Into Extension|Withdrawal by Subject|0
1074576|NCT02499900|3491075|P2|Completed Core, Continued Into Extension|Physician Decision|0
1074577|NCT02499900|3491076|P1|Completed Core, Continued Into Extension|Physician Decision|1
1074578|NCT02499900|3491075|P2|Core Study Period|Death|1
1074579|NCT02499900|3491076|P1|Core Study Period|Death|0
1074580|NCT02499900|3491075|P2|Core Study Period|Adverse Event|14
1074581|NCT02499900|3491076|P1|Core Study Period|Adverse Event|18
1074582|NCT02499900|3491075|P2|Core Study Period|Withdrawal by Subject|10
1074583|NCT02499900|3491076|P1|Core Study Period|Withdrawal by Subject|11
1074584|NCT02499900|3491075|P2|Core Study Period|Protocol Violation|0
1074585|NCT02499900|3491076|P1|Core Study Period|Protocol Violation|3
1074586|NCT02499900|3491075|P2|Core Study Period|Pregnancy|0
1074587|NCT02499900|3491076|P1|Core Study Period|Pregnancy|1
1074588|NCT02499900|3491075|P2|Core Study Period|Per sponsor request|1
1074589|NCT02499900|3491076|P1|Core Study Period|Per sponsor request|0
1074590|NCT02499900|3491075|P2|Core Study Period|Lost to Follow-up|2
1074591|NCT02499900|3491076|P1|Core Study Period|Lost to Follow-up|1
1074592|NCT02499900|3491075|P2|Core Study Period|Not specified|4
1074593|NCT02499900|3491076|P1|Core Study Period|Not specified|1
1074594|NCT02499575|3491107|P2|Overall Study|Protocol Violation|1
1074595|NCT02499575|3491108|P1|Overall Study|Protocol Violation|0
1074596|NCT02499029|3491120|P2|Overall Study|Death|0
1074597|NCT02499029|3491121|P1|Overall Study|Death|1
1074598|NCT02499029|3491120|P2|Overall Study|Physician Decision|1
1074599|NCT02499029|3491121|P1|Overall Study|Physician Decision|2
1074600|NCT02499029|3491120|P2|Overall Study|Lost to Follow-up|2
1074601|NCT02499029|3491121|P1|Overall Study|Lost to Follow-up|2
1074602|NCT02498821|3491135|P2|Overall Study|Screen failure|5
1074603|NCT02498821|3491136|P1|Overall Study|Screen failure|3
1074604|NCT02498678|3491180|P2|Overall Study|interference from the surgical team|2
1074605|NCT02498678|3491181|P1|Overall Study|interference from the surgical team|0
1074606|NCT02498652|3491197|P2|Overall Study|Protocol Violation|1
1074607|NCT02498652|3491198|P1|Overall Study|Protocol Violation|0
1074608|NCT02497976|3491308|P2|Overall Study|Moved out of area|1
1074609|NCT02497976|3491309|P1|Overall Study|Moved out of area|0
1074610|NCT02497976|3491308|P2|Overall Study|Withdrawal by Subject|0
1074611|NCT02497976|3491309|P1|Overall Study|Withdrawal by Subject|2
1074612|NCT02497781|3491404|P2|Overall Study|Lost to Follow-up|1
1074613|NCT02497781|3491405|P1|Overall Study|Lost to Follow-up|1
1074614|NCT02497781|3491404|P2|Overall Study|Randomised but not treated|1
1074615|NCT02497781|3491405|P1|Overall Study|Randomised but not treated|1
1074616|NCT02497781|3491404|P2|Overall Study|Lack of Efficacy|1
1074617|NCT02497781|3491405|P1|Overall Study|Lack of Efficacy|0
1074618|NCT02497781|3491404|P2|Overall Study|Withdrawal by Subject|0
1074619|NCT02497781|3491405|P1|Overall Study|Withdrawal by Subject|2
1074620|NCT02497755|3491468|P2|Overall Study|Protocol Violation|0
1074621|NCT02497755|3491469|P1|Overall Study|Protocol Violation|1
1074622|NCT02497391|3491482|P6|Period 3 (14 Days)|Withdrawal by Subject|0
1074623|NCT02497391|3491483|P5|Period 3 (14 Days)|Withdrawal by Subject|0
1074624|NCT02497391|3491484|P4|Period 3 (14 Days)|Withdrawal by Subject|0
1074625|NCT02497391|3491485|P3|Period 3 (14 Days)|Withdrawal by Subject|1
1074626|NCT02497391|3491486|P2|Period 3 (14 Days)|Withdrawal by Subject|0
1074627|NCT02497391|3491487|P1|Period 3 (14 Days)|Withdrawal by Subject|0
1074628|NCT02497391|3491482|P6|Period 3 (14 Days)|Sponsor Decision|0
1074629|NCT02497391|3491483|P5|Period 3 (14 Days)|Sponsor Decision|1
1074630|NCT02497391|3491484|P4|Period 3 (14 Days)|Sponsor Decision|0
1074631|NCT02497391|3491485|P3|Period 3 (14 Days)|Sponsor Decision|0
1074632|NCT02497391|3491486|P2|Period 3 (14 Days)|Sponsor Decision|0
1074633|NCT02497391|3491487|P1|Period 3 (14 Days)|Sponsor Decision|0
1074634|NCT02497391|3491482|P6|Period 3 (14 Days)|Adverse Event|0
1074635|NCT02497391|3491483|P5|Period 3 (14 Days)|Adverse Event|0
1074636|NCT02497391|3491484|P4|Period 3 (14 Days)|Adverse Event|0
1074637|NCT02497391|3491485|P3|Period 3 (14 Days)|Adverse Event|0
1074638|NCT02497391|3491486|P2|Period 3 (14 Days)|Adverse Event|1
1074639|NCT02497391|3491487|P1|Period 3 (14 Days)|Adverse Event|0
1074640|NCT02497391|3491482|P6|Period 2 (14 Days)|Sponsor Decision|3
1074641|NCT02497391|3491483|P5|Period 2 (14 Days)|Sponsor Decision|2
1074642|NCT02497391|3491484|P4|Period 2 (14 Days)|Sponsor Decision|3
1074643|NCT02497391|3491485|P3|Period 2 (14 Days)|Sponsor Decision|2
1074644|NCT02497391|3491486|P2|Period 2 (14 Days)|Sponsor Decision|1
1074645|NCT02497391|3491487|P1|Period 2 (14 Days)|Sponsor Decision|3
1074646|NCT02497391|3491482|P6|Period 2 (14 Days)|Withdrawal by Subject|0
1074647|NCT02497391|3491483|P5|Period 2 (14 Days)|Withdrawal by Subject|0
1074648|NCT02497391|3491484|P4|Period 2 (14 Days)|Withdrawal by Subject|0
1074649|NCT02497391|3491485|P3|Period 2 (14 Days)|Withdrawal by Subject|1
1074650|NCT02497391|3491486|P2|Period 2 (14 Days)|Withdrawal by Subject|0
1074651|NCT02497391|3491487|P1|Period 2 (14 Days)|Withdrawal by Subject|1
1074652|NCT02496702|3491552|P2|Overall Study|Only partially tested|2
1074653|NCT02496702|3491553|P1|Overall Study|Only partially tested|0
1074654|NCT02496702|3491552|P2|Overall Study|Lost to Follow-up|6
1074655|NCT02496702|3491553|P1|Overall Study|Lost to Follow-up|8
1074656|NCT02496533|3491575|P2|Overall Study|Late for radiologic testing|2
1074657|NCT02496533|3491576|P1|Overall Study|Late for radiologic testing|0
1074658|NCT02496533|3491575|P2|Overall Study|Patient did not complete all measures|4
1074659|NCT02496533|3491576|P1|Overall Study|Patient did not complete all measures|0
1074660|NCT02496533|3491575|P2|Overall Study|Lack of data on outcome|0
1074661|NCT02496533|3491576|P1|Overall Study|Lack of data on outcome|3
1074662|NCT02496221|3491588|P2|Treatment Period 2 - 4 Days|Physician Decision|0
1074663|NCT02496221|3491589|P1|Treatment Period 2 - 4 Days|Physician Decision|1
1074664|NCT02496221|3491588|P2|Treatment Period 2 - 4 Days|Protocol Violation|0
1074665|NCT02496221|3491589|P1|Treatment Period 2 - 4 Days|Protocol Violation|1
1074666|NCT02496221|3491588|P2|Treatment Period 2 - 4 Days|Adverse Event|1
1074667|NCT02496221|3491589|P1|Treatment Period 2 - 4 Days|Adverse Event|0
1074668|NCT02496039|3491623|P1|Overall Study|Protocol Violation|1
1074669|NCT02496039|3491623|P1|Overall Study|Adverse Event|3
1074670|NCT02496000|3491638|P3|Overall Study|undetermined|0
1074671|NCT02496000|3491639|P2|Overall Study|undetermined|1
1074672|NCT02496000|3491640|P1|Overall Study|undetermined|0
1074673|NCT02496000|3491638|P3|Overall Study|Non-compliance or lack of cooperation|0
1074674|NCT02496000|3491639|P2|Overall Study|Non-compliance or lack of cooperation|2
1074675|NCT02496000|3491640|P1|Overall Study|Non-compliance or lack of cooperation|0
1074676|NCT02496000|3491638|P3|Overall Study|Protocol Violation|1
1074677|NCT02496000|3491639|P2|Overall Study|Protocol Violation|0
1074678|NCT02496000|3491640|P1|Overall Study|Protocol Violation|0
1074679|NCT02496000|3491638|P3|Overall Study|Lost to Follow-up|1
1074680|NCT02496000|3491639|P2|Overall Study|Lost to Follow-up|0
1074681|NCT02496000|3491640|P1|Overall Study|Lost to Follow-up|1
1074682|NCT02496000|3491638|P3|Overall Study|Withdrawal by Subject|0
1074683|NCT02496000|3491639|P2|Overall Study|Withdrawal by Subject|2
1074684|NCT02496000|3491640|P1|Overall Study|Withdrawal by Subject|1
1074685|NCT02495948|3491649|P2|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
1074686|NCT02495948|3491650|P1|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
1074687|NCT02495948|3491649|P2|Period 1, First 30 Days of Wear|Adverse Event|1
1074688|NCT02495948|3491650|P1|Period 1, First 30 Days of Wear|Adverse Event|0
1074689|NCT02494596|3491770|P3|Overall Study|Refused Treatment|0
1074690|NCT02494596|3491771|P2|Overall Study|Refused Treatment|1
1074691|NCT02494596|3491772|P1|Overall Study|Refused Treatment|0
1074692|NCT02494596|3491770|P3|Overall Study|Adverse Event|0
1074693|NCT02494596|3491771|P2|Overall Study|Adverse Event|1
1074694|NCT02494596|3491772|P1|Overall Study|Adverse Event|0
1074695|NCT02494596|3491770|P3|Overall Study|Insufficient Therapeutic Response|1
1074696|NCT02494596|3491771|P2|Overall Study|Insufficient Therapeutic Response|3
1074697|NCT02494596|3491772|P1|Overall Study|Insufficient Therapeutic Response|3
1074698|NCT02494206|3491808|P1|Overall Study|Disease Progression|1
1074699|NCT02494206|3491808|P1|Overall Study|Adverse Event|1
1074700|NCT02493855|3491828|P3|Overall Study|Withdrawal by Subject|0
1074701|NCT02493855|3491829|P2|Overall Study|Withdrawal by Subject|0
1074702|NCT02493855|3491830|P1|Overall Study|Withdrawal by Subject|1
1074703|NCT02493855|3491828|P3|Overall Study|Adverse Event|0
1074704|NCT02493855|3491829|P2|Overall Study|Adverse Event|1
1074705|NCT02493855|3491830|P1|Overall Study|Adverse Event|0
1074706|NCT02493855|3491828|P3|Overall Study|Non-compliance|0
1074707|NCT02493855|3491829|P2|Overall Study|Non-compliance|0
1074708|NCT02493855|3491830|P1|Overall Study|Non-compliance|1
1074709|NCT02493777|3491840|P2|Overall Study|Lost to Follow-up|1
1074710|NCT02493777|3491841|P1|Overall Study|Lost to Follow-up|0
1074711|NCT02493517|3491851|P2|Overall Study|Missed study visit|1
1074712|NCT02493517|3491852|P1|Overall Study|Missed study visit|0
1074713|NCT02493517|3491851|P2|Overall Study|Adverse Event|2
1074714|NCT02493517|3491852|P1|Overall Study|Adverse Event|0
1074715|NCT02493517|3491851|P2|Overall Study|Withdrawal by Subject|2
1074716|NCT02493517|3491852|P1|Overall Study|Withdrawal by Subject|1
1074717|NCT02493517|3491851|P2|Overall Study|Protocol Violation|2
1074718|NCT02493517|3491852|P1|Overall Study|Protocol Violation|1
1074719|NCT02493127|3491876|P2|Overall Study|Lost to Follow-up|1
1074720|NCT02493127|3491877|P1|Overall Study|Lost to Follow-up|1
1074721|NCT02492984|3491910|P2|Overall Study|Withdrawal by Subject|0
1074722|NCT02492984|3491911|P1|Overall Study|Withdrawal by Subject|1
1074723|NCT02492984|3491910|P2|Overall Study|Protocol Violation|0
1074724|NCT02492984|3491911|P1|Overall Study|Protocol Violation|1
1074725|NCT02492984|3491910|P2|Overall Study|Adverse Event|0
1074726|NCT02492984|3491911|P1|Overall Study|Adverse Event|1
1074727|NCT02492958|3491935|P4|Overall Study|Adverse Event|0
1074728|NCT02492958|3491936|P3|Overall Study|Adverse Event|1
1074729|NCT02492958|3491937|P2|Overall Study|Adverse Event|0
1074730|NCT02492958|3491938|P1|Overall Study|Adverse Event|1
1074731|NCT02492958|3491935|P4|Overall Study|Withdrawal by Subject|0
1074732|NCT02492958|3491936|P3|Overall Study|Withdrawal by Subject|1
1074733|NCT02492958|3491937|P2|Overall Study|Withdrawal by Subject|0
1074734|NCT02492958|3491938|P1|Overall Study|Withdrawal by Subject|0
1074735|NCT02492880|3492024|P1|Overall Study|Protocol Violation|1
1074736|NCT02492880|3492024|P1|Overall Study|Lost to Follow-up|1
1074737|NCT02492841|3492031|P3|Overall Study|Lost to Follow-up|35
1074738|NCT02492841|3492032|P2|Overall Study|Lost to Follow-up|31
1074739|NCT02492841|3492033|P1|Overall Study|Lost to Follow-up|34
1074740|NCT02492763|3492048|P4|Overall Study|Study Terminated by Sponsor|10
1074741|NCT02492763|3492049|P3|Overall Study|Study Terminated by Sponsor|6
1074742|NCT02492763|3492050|P2|Overall Study|Study Terminated by Sponsor|10
1074743|NCT02492763|3492051|P1|Overall Study|Study Terminated by Sponsor|13
1074744|NCT02492763|3492048|P4|Overall Study|Screen Failure|1
1074745|NCT02492763|3492049|P3|Overall Study|Screen Failure|0
1074746|NCT02492763|3492050|P2|Overall Study|Screen Failure|0
1074747|NCT02492763|3492051|P1|Overall Study|Screen Failure|0
1074748|NCT02492763|3492048|P4|Overall Study|Non-Compliance With Study Drug|0
1074749|NCT02492763|3492049|P3|Overall Study|Non-Compliance With Study Drug|0
1074750|NCT02492763|3492050|P2|Overall Study|Non-Compliance With Study Drug|1
1074751|NCT02492763|3492051|P1|Overall Study|Non-Compliance With Study Drug|0
1074752|NCT02492763|3492048|P4|Overall Study|Lost to Follow-up|0
1074753|NCT02492763|3492049|P3|Overall Study|Lost to Follow-up|1
1074754|NCT02492763|3492050|P2|Overall Study|Lost to Follow-up|0
1074755|NCT02492763|3492051|P1|Overall Study|Lost to Follow-up|0
1074756|NCT02492763|3492048|P4|Overall Study|Hyperglycemia Discontinuation Criteria|0
1074757|NCT02492763|3492049|P3|Overall Study|Hyperglycemia Discontinuation Criteria|0
1074758|NCT02492763|3492050|P2|Overall Study|Hyperglycemia Discontinuation Criteria|1
1074759|NCT02492763|3492051|P1|Overall Study|Hyperglycemia Discontinuation Criteria|0
1074760|NCT02492763|3492048|P4|Overall Study|Death|0
1074761|NCT02492763|3492049|P3|Overall Study|Death|1
1074762|NCT02492763|3492050|P2|Overall Study|Death|0
1074763|NCT02492763|3492051|P1|Overall Study|Death|0
1074764|NCT02492763|3492048|P4|Overall Study|Adverse Event|2
1074765|NCT02492763|3492049|P3|Overall Study|Adverse Event|1
1074766|NCT02492763|3492050|P2|Overall Study|Adverse Event|1
1074767|NCT02492763|3492051|P1|Overall Study|Adverse Event|3
1074768|NCT02492763|3492048|P4|Overall Study|Withdrawal by Subject|0
1074769|NCT02492763|3492049|P3|Overall Study|Withdrawal by Subject|1
1074770|NCT02492763|3492050|P2|Overall Study|Withdrawal by Subject|2
1074771|NCT02492763|3492051|P1|Overall Study|Withdrawal by Subject|0
1074772|NCT02492165|3492122|P4|Overall Study|Withdrawal by Subject|0
1074773|NCT02492165|3492123|P3|Overall Study|Withdrawal by Subject|0
1074774|NCT02492165|3492124|P2|Overall Study|Withdrawal by Subject|1
1074775|NCT02492165|3492125|P1|Overall Study|Withdrawal by Subject|0
1074776|NCT02491892|3492169|P2|Overall Study|Lost to Follow-up|0
1074777|NCT02491892|3492170|P1|Overall Study|Lost to Follow-up|1
1074778|NCT02491892|3492169|P2|Overall Study|Refused Treatment|0
1074779|NCT02491892|3492170|P1|Overall Study|Refused Treatment|1
1074780|NCT02491892|3492169|P2|Overall Study|Lack of Efficacy|36
1074781|NCT02491892|3492170|P1|Overall Study|Lack of Efficacy|37
1074782|NCT02491892|3492169|P2|Overall Study|Death|1
1074783|NCT02491892|3492170|P1|Overall Study|Death|1
1074784|NCT02491892|3492169|P2|Overall Study|Adverse Event|1
1074785|NCT02491892|3492170|P1|Overall Study|Adverse Event|1
1074786|NCT02491463|3492218|P4|Overall Study|Lost to Follow-up|0
1074787|NCT02491463|3492219|P3|Overall Study|Lost to Follow-up|3
1074788|NCT02491463|3492220|P2|Overall Study|Lost to Follow-up|3
1074789|NCT02491463|3492221|P1|Overall Study|Lost to Follow-up|0
1074790|NCT02491463|3492218|P4|Overall Study|Migrated/moved from study area|1
1074791|NCT02491463|3492219|P3|Overall Study|Migrated/moved from study area|1
1074792|NCT02491463|3492220|P2|Overall Study|Migrated/moved from study area|5
1074793|NCT02491463|3492221|P1|Overall Study|Migrated/moved from study area|1
1074794|NCT02491463|3492218|P4|Overall Study|Withdrawal by Subject|0
1074795|NCT02491463|3492219|P3|Overall Study|Withdrawal by Subject|0
1074796|NCT02491463|3492220|P2|Overall Study|Withdrawal by Subject|2
1074797|NCT02491463|3492221|P1|Overall Study|Withdrawal by Subject|1
1074798|NCT02491411|3492307|P1|Overall Study|Physician Decision|4
1074799|NCT02491073|3492319|P2|Overall Study|screen failure|0
1074800|NCT02491073|3492320|P1|Overall Study|screen failure|1
1074801|NCT02490475|3492361|P4|Period 2: Extension Phase|Adverse Event|0
1074802|NCT02490475|3492362|P3|Period 2: Extension Phase|Adverse Event|1
1074803|NCT02490475|3492363|P2|Period 2: Extension Phase|Adverse Event|0
1074804|NCT02490475|3492364|P1|Period 2: Extension Phase|Adverse Event|0
1074805|NCT02490475|3492361|P4|Period 2: Extension Phase|Refused Treatment|1
1074806|NCT02490475|3492362|P3|Period 2: Extension Phase|Refused Treatment|0
1074807|NCT02490475|3492363|P2|Period 2: Extension Phase|Refused Treatment|0
1074808|NCT02490475|3492364|P1|Period 2: Extension Phase|Refused Treatment|0
1074809|NCT02490475|3492361|P4|Period 2: Extension Phase|Insufficient Therapeutic Response|0
1074810|NCT02490475|3492362|P3|Period 2: Extension Phase|Insufficient Therapeutic Response|2
1074811|NCT02490475|3492363|P2|Period 2: Extension Phase|Insufficient Therapeutic Response|0
1074812|NCT02490475|3492364|P1|Period 2: Extension Phase|Insufficient Therapeutic Response|1
1074813|NCT02490475|3492361|P4|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2
1074814|NCT02490475|3492362|P3|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4
1074815|NCT02490475|3492363|P2|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
1074816|NCT02490475|3492364|P1|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
1074817|NCT02490475|3492361|P4|Period 1: First 6 Cycles|Refused Treatment|0
1074818|NCT02490475|3492362|P3|Period 1: First 6 Cycles|Refused Treatment|0
1074819|NCT02490475|3492363|P2|Period 1: First 6 Cycles|Refused Treatment|0
1074820|NCT02490475|3492364|P1|Period 1: First 6 Cycles|Refused Treatment|1
1074821|NCT02490475|3492361|P4|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
1074822|NCT02490475|3492362|P3|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
1074823|NCT02490475|3492363|P2|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0
1074824|NCT02490475|3492364|P1|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
1074825|NCT02490475|3492361|P4|Period 1: First 6 Cycles|Adverse Event|1
1074826|NCT02490475|3492362|P3|Period 1: First 6 Cycles|Adverse Event|0
1074827|NCT02490475|3492363|P2|Period 1: First 6 Cycles|Adverse Event|1
1074828|NCT02490475|3492364|P1|Period 1: First 6 Cycles|Adverse Event|2
1074829|NCT02489968|3492453|P6|Double-blind Treatment Period|Other than specified above|0
1074830|NCT02489968|3492454|P5|Double-blind Treatment Period|Other than specified above|1
1074831|NCT02489968|3492455|P4|Double-blind Treatment Period|Other than specified above|0
1074832|NCT02489968|3492456|P3|Double-blind Treatment Period|Other than specified above|0
1074833|NCT02489968|3492457|P2|Double-blind Treatment Period|Other than specified above|0
1074834|NCT02489968|3492458|P1|Double-blind Treatment Period|Other than specified above|0
1074835|NCT02489968|3492453|P6|Double-blind Treatment Period|Withdrawal by Subject|2
1074836|NCT02489968|3492454|P5|Double-blind Treatment Period|Withdrawal by Subject|0
1074837|NCT02489968|3492455|P4|Double-blind Treatment Period|Withdrawal by Subject|2
1074838|NCT02489968|3492456|P3|Double-blind Treatment Period|Withdrawal by Subject|0
1074839|NCT02489968|3492457|P2|Double-blind Treatment Period|Withdrawal by Subject|0
1074840|NCT02489968|3492458|P1|Double-blind Treatment Period|Withdrawal by Subject|0
1074841|NCT02489968|3492453|P6|Double-blind Treatment Period|Protocol Violation|1
1074842|NCT02489968|3492454|P5|Double-blind Treatment Period|Protocol Violation|1
1074843|NCT02489968|3492455|P4|Double-blind Treatment Period|Protocol Violation|0
1074844|NCT02489968|3492456|P3|Double-blind Treatment Period|Protocol Violation|0
1074845|NCT02489968|3492457|P2|Double-blind Treatment Period|Protocol Violation|0
1074846|NCT02489968|3492458|P1|Double-blind Treatment Period|Protocol Violation|0
1074847|NCT02489968|3492453|P6|Double-blind Treatment Period|Adverse Event|5
1074848|NCT02489968|3492454|P5|Double-blind Treatment Period|Adverse Event|4
1074849|NCT02489968|3492455|P4|Double-blind Treatment Period|Adverse Event|6
1074850|NCT02489968|3492456|P3|Double-blind Treatment Period|Adverse Event|2
1074851|NCT02489968|3492457|P2|Double-blind Treatment Period|Adverse Event|0
1074852|NCT02489968|3492458|P1|Double-blind Treatment Period|Adverse Event|0
1074853|NCT02489968|3492453|P6|Open-label Treatment Period|Other than specified above|0
1074937|NCT02487498|3492757|P2|Period: Period 1|Adverse Event|4
1074854|NCT02489968|3492454|P5|Open-label Treatment Period|Other than specified above|0
1074855|NCT02489968|3492455|P4|Open-label Treatment Period|Other than specified above|0
1074856|NCT02489968|3492456|P3|Open-label Treatment Period|Other than specified above|0
1074857|NCT02489968|3492457|P2|Open-label Treatment Period|Other than specified above|189
1074858|NCT02489968|3492458|P1|Open-label Treatment Period|Other than specified above|204
1074859|NCT02489968|3492453|P6|Open-label Treatment Period|Withdrawal by Subject|0
1074860|NCT02489968|3492454|P5|Open-label Treatment Period|Withdrawal by Subject|0
1074861|NCT02489968|3492455|P4|Open-label Treatment Period|Withdrawal by Subject|0
1074862|NCT02489968|3492456|P3|Open-label Treatment Period|Withdrawal by Subject|0
1074863|NCT02489968|3492457|P2|Open-label Treatment Period|Withdrawal by Subject|7
1074864|NCT02489968|3492458|P1|Open-label Treatment Period|Withdrawal by Subject|4
1074865|NCT02489968|3492453|P6|Open-label Treatment Period|Lost to Follow-up|0
1074866|NCT02489968|3492454|P5|Open-label Treatment Period|Lost to Follow-up|0
1074867|NCT02489968|3492455|P4|Open-label Treatment Period|Lost to Follow-up|0
1074868|NCT02489968|3492456|P3|Open-label Treatment Period|Lost to Follow-up|0
1074869|NCT02489968|3492457|P2|Open-label Treatment Period|Lost to Follow-up|3
1074870|NCT02489968|3492458|P1|Open-label Treatment Period|Lost to Follow-up|0
1074871|NCT02489968|3492453|P6|Open-label Treatment Period|Protocol Violation|0
1074872|NCT02489968|3492454|P5|Open-label Treatment Period|Protocol Violation|0
1074873|NCT02489968|3492455|P4|Open-label Treatment Period|Protocol Violation|0
1074874|NCT02489968|3492456|P3|Open-label Treatment Period|Protocol Violation|0
1074875|NCT02489968|3492457|P2|Open-label Treatment Period|Protocol Violation|2
1074876|NCT02489968|3492458|P1|Open-label Treatment Period|Protocol Violation|2
1074877|NCT02489968|3492453|P6|Open-label Treatment Period|Adverse Event|0
1074878|NCT02489968|3492454|P5|Open-label Treatment Period|Adverse Event|0
1074879|NCT02489968|3492455|P4|Open-label Treatment Period|Adverse Event|0
1074880|NCT02489968|3492456|P3|Open-label Treatment Period|Adverse Event|0
1074881|NCT02489968|3492457|P2|Open-label Treatment Period|Adverse Event|7
1074882|NCT02489968|3492458|P1|Open-label Treatment Period|Adverse Event|14
1074883|NCT02489799|3492472|P2|Overall Study|Death|1
1074884|NCT02489799|3492473|P1|Overall Study|Death|0
1074885|NCT02489799|3492472|P2|Overall Study|Withdrawal by Subject|1
1074886|NCT02489799|3492473|P1|Overall Study|Withdrawal by Subject|1
1074887|NCT02489799|3492472|P2|Overall Study|Failure to Maintain Eligibility|6
1074888|NCT02489799|3492473|P1|Overall Study|Failure to Maintain Eligibility|4
1074889|NCT02489799|3492472|P2|Overall Study|Lost to Follow-up|1
1074890|NCT02489799|3492473|P1|Overall Study|Lost to Follow-up|4
1074891|NCT02489500|3492499|P2|Overall Study|Death|1
1074892|NCT02489500|3492500|P1|Overall Study|Death|1
1074893|NCT02488980|3492526|P3|Overall Study|Protocol Violation|2
1074894|NCT02488980|3492527|P2|Overall Study|Protocol Violation|2
1074895|NCT02488980|3492528|P1|Overall Study|Protocol Violation|2
1074896|NCT02488915|3492545|P1|Overall Study|Withdrawal by Subject|1
1074897|NCT02488915|3492545|P1|Overall Study|Lost to Follow-up|4
1074898|NCT02488915|3492545|P1|Overall Study|Death|21
1074899|NCT02488681|3492561|P1|Overall Study|Implant unsuccessful|7
1074900|NCT02487979|3492594|P1|Overall Study|Progressive Disease|17
1074901|NCT02487979|3492594|P1|Overall Study|Withdrawal by Subject|2
1074902|NCT02487979|3492594|P1|Overall Study|Physician Decision|2
1074903|NCT02487771|3492606|P2|Overall Study|Withdrawal by Subject|5
1074904|NCT02487771|3492607|P1|Overall Study|Withdrawal by Subject|3
1074905|NCT02487771|3492606|P2|Overall Study|Moved out of area|6
1074906|NCT02487771|3492607|P1|Overall Study|Moved out of area|5
1074907|NCT02487771|3492606|P2|Overall Study|Lost to Follow-up|3
1074908|NCT02487771|3492607|P1|Overall Study|Lost to Follow-up|2
1074909|NCT02487498|3492757|P2|Period: Period 2|Physician Decision|0
1074910|NCT02487498|3492758|P1|Period: Period 2|Physician Decision|1
1074911|NCT02487498|3492757|P2|Period: Period 2|Death|1
1074912|NCT02487498|3492758|P1|Period: Period 2|Death|0
1074913|NCT02487498|3492757|P2|Period: Period 2|Lost to Follow-up|1
1074914|NCT02487498|3492758|P1|Period: Period 2|Lost to Follow-up|1
1074915|NCT02487498|3492757|P2|Period: Period 2|Subject/guardian decision|1
1074916|NCT02487498|3492758|P1|Period: Period 2|Subject/guardian decision|2
1074917|NCT02487498|3492757|P2|Period: Period 2|Adverse Event|2
1074918|NCT02487498|3492758|P1|Period: Period 2|Adverse Event|2
1074919|NCT02487498|3492757|P2|Period: Washout|Non-compliance with study treatment|1
1074920|NCT02487498|3492758|P1|Period: Washout|Non-compliance with study treatment|0
1074921|NCT02487498|3492757|P2|Period: Washout|Physician Decision|0
1074922|NCT02487498|3492758|P1|Period: Washout|Physician Decision|1
1074923|NCT02487498|3492757|P2|Period: Washout|Lack of Efficacy|1
1074924|NCT02487498|3492758|P1|Period: Washout|Lack of Efficacy|1
1074925|NCT02487498|3492757|P2|Period: Washout|Subject/guardian decision|5
1074926|NCT02487498|3492758|P1|Period: Washout|Subject/guardian decision|0
1074927|NCT02487498|3492757|P2|Period: Period 1|Protocol deviation|0
1074928|NCT02487498|3492758|P1|Period: Period 1|Protocol deviation|1
1074929|NCT02487498|3492757|P2|Period: Period 1|Physician Decision|1
1074930|NCT02487498|3492758|P1|Period: Period 1|Physician Decision|0
1074931|NCT02487498|3492757|P2|Period: Period 1|Lack of Efficacy|0
1074932|NCT02487498|3492758|P1|Period: Period 1|Lack of Efficacy|1
1074933|NCT02487498|3492757|P2|Period: Period 1|Lost to Follow-up|2
1074934|NCT02487498|3492758|P1|Period: Period 1|Lost to Follow-up|0
1074935|NCT02487498|3492757|P2|Period: Period 1|Subject/guardian decision|4
1074936|NCT02487498|3492758|P1|Period: Period 1|Subject/guardian decision|2
1074938|NCT02487498|3492758|P1|Period: Period 1|Adverse Event|2
1074939|NCT02487446|3492781|P2|Period 2|Adverse Event|2
1074940|NCT02487446|3492782|P1|Period 2|Adverse Event|6
1074941|NCT02487446|3492781|P2|Period 2|Withdrawal by Subject|1
1074942|NCT02487446|3492782|P1|Period 2|Withdrawal by Subject|1
1074943|NCT02487446|3492781|P2|Period 2|Lost to Follow-up|1
1074944|NCT02487446|3492782|P1|Period 2|Lost to Follow-up|1
1074945|NCT02487446|3492781|P2|Period 2|Protocol deviation|1
1074946|NCT02487446|3492782|P1|Period 2|Protocol deviation|0
1074947|NCT02487446|3492781|P2|Washout|Adverse Event|2
1074948|NCT02487446|3492782|P1|Washout|Adverse Event|2
1074949|NCT02487446|3492781|P2|Washout|Withdrawal by Subject|4
1074950|NCT02487446|3492782|P1|Washout|Withdrawal by Subject|1
1074951|NCT02487446|3492781|P2|Washout|Lost to Follow-up|2
1074952|NCT02487446|3492782|P1|Washout|Lost to Follow-up|0
1074953|NCT02487446|3492781|P2|Period 1|Adverse Event|5
1074954|NCT02487446|3492782|P1|Period 1|Adverse Event|5
1074955|NCT02487446|3492781|P2|Period 1|Withdrawal by Subject|0
1074956|NCT02487446|3492782|P1|Period 1|Withdrawal by Subject|2
1074957|NCT02487446|3492781|P2|Period 1|Lost to Follow-up|0
1074958|NCT02487446|3492782|P1|Period 1|Lost to Follow-up|2
1074959|NCT02487446|3492781|P2|Period 1|Protocol deviation|2
1074960|NCT02487446|3492782|P1|Period 1|Protocol deviation|3
1074961|NCT02487446|3492781|P2|Period 1|Lack of Efficacy|0
1074962|NCT02487446|3492782|P1|Period 1|Lack of Efficacy|1
1074963|NCT02487446|3492781|P2|Period 1|Physician Decision|1
1074964|NCT02487446|3492782|P1|Period 1|Physician Decision|0
1074965|NCT02487199|3492829|P2|Overall Study|Withdrew Consent|1
1074966|NCT02487199|3492830|P1|Overall Study|Withdrew Consent|0
1074967|NCT02487030|3492849|P7|Overall Study|Death|0
1074968|NCT02487030|3492850|P6|Overall Study|Death|0
1074969|NCT02487030|3492851|P5|Overall Study|Death|1
1074970|NCT02487030|3492852|P4|Overall Study|Death|0
1074971|NCT02487030|3492853|P3|Overall Study|Death|0
1074972|NCT02487030|3492854|P2|Overall Study|Death|0
1074973|NCT02487030|3492855|P1|Overall Study|Death|0
1074974|NCT02487030|3492849|P7|Overall Study|Adverse Event|0
1074975|NCT02487030|3492850|P6|Overall Study|Adverse Event|0
1074976|NCT02487030|3492851|P5|Overall Study|Adverse Event|0
1074977|NCT02487030|3492852|P4|Overall Study|Adverse Event|1
1074978|NCT02487030|3492853|P3|Overall Study|Adverse Event|0
1074979|NCT02487030|3492854|P2|Overall Study|Adverse Event|0
1074980|NCT02487030|3492855|P1|Overall Study|Adverse Event|0
1074981|NCT02487030|3492849|P7|Overall Study|Lost to Follow-up|0
1074982|NCT02487030|3492850|P6|Overall Study|Lost to Follow-up|1
1074983|NCT02487030|3492851|P5|Overall Study|Lost to Follow-up|0
1074984|NCT02487030|3492852|P4|Overall Study|Lost to Follow-up|1
1074985|NCT02487030|3492853|P3|Overall Study|Lost to Follow-up|1
1074986|NCT02487030|3492854|P2|Overall Study|Lost to Follow-up|0
1074987|NCT02487030|3492855|P1|Overall Study|Lost to Follow-up|0
1074988|NCT02487030|3492849|P7|Overall Study|Lack of Efficacy|0
1074989|NCT02487030|3492850|P6|Overall Study|Lack of Efficacy|0
1074990|NCT02487030|3492851|P5|Overall Study|Lack of Efficacy|1
1074991|NCT02487030|3492852|P4|Overall Study|Lack of Efficacy|0
1074992|NCT02487030|3492853|P3|Overall Study|Lack of Efficacy|1
1074993|NCT02487030|3492854|P2|Overall Study|Lack of Efficacy|4
1074994|NCT02487030|3492855|P1|Overall Study|Lack of Efficacy|2
1074995|NCT02486952|3492886|P1|Overall Study|Other|2
1074996|NCT02486952|3492886|P1|Overall Study|Lost to Follow-up|26
1074997|NCT02486952|3492886|P1|Overall Study|Lack of Efficacy|3
1074998|NCT02486952|3492886|P1|Overall Study|Death|15
1074999|NCT02486952|3492886|P1|Overall Study|Adverse Event|1
1075000|NCT02486952|3492886|P1|Overall Study|Not Started Induction Therapy|3
1075001|NCT02486796|3492904|P2|Overall Study|Physician Decision|0
1075002|NCT02486796|3492905|P1|Overall Study|Physician Decision|1
1075003|NCT02486796|3492904|P2|Overall Study|Withdrawal by Subject|1
1075004|NCT02486796|3492905|P1|Overall Study|Withdrawal by Subject|1
1075005|NCT02486757|3492917|P1|Overall Study|Lost to Follow-up|1
1075006|NCT02486627|3492923|P2|Overall Study|Lost to Follow-up|3
1075007|NCT02486627|3492924|P1|Overall Study|Lost to Follow-up|1
1075008|NCT02486627|3492923|P2|Overall Study|Significant Participant Noncompliance|1
1075009|NCT02486627|3492924|P1|Overall Study|Significant Participant Noncompliance|1
1075010|NCT02486627|3492923|P2|Overall Study|Consent Withdrawn by Participant|3
1075011|NCT02486627|3492924|P1|Overall Study|Consent Withdrawn by Participant|4
1075012|NCT02486627|3492923|P2|Overall Study|Other Unspecified|2
1075013|NCT02486627|3492924|P1|Overall Study|Other Unspecified|0
1075014|NCT02486627|3492923|P2|Overall Study|Death|0
1075015|NCT02486627|3492924|P1|Overall Study|Death|1
1075016|NCT02485925|3492941|P1|Overall Study|Lost to Follow-up|11
1075017|NCT02485925|3492941|P1|Overall Study|Death|1
1075018|NCT02485925|3492941|P1|Overall Study|Withdrawal by Subject|3
1075019|NCT02485483|3492991|P2|Overall Study|Discontinued after baseline|0
1075020|NCT02485483|3492992|P1|Overall Study|Discontinued after baseline|39
1075021|NCT02485483|3492991|P2|Overall Study|Depression at baseline|0
1075022|NCT02485483|3492992|P1|Overall Study|Depression at baseline|15
1075023|NCT02485353|3493007|P1|Overall Study|Disease Progression|1
1075024|NCT02485353|3493007|P1|Overall Study|Death|1
1075025|NCT02485301|3493014|P2|Overall Study|Other|4
1075026|NCT02485301|3493015|P1|Overall Study|Other|3
1075027|NCT02485301|3493014|P2|Overall Study|Lost to Follow-up|17
1075028|NCT02485301|3493015|P1|Overall Study|Lost to Follow-up|17
1075029|NCT02485301|3493014|P2|Overall Study|Migrated/moved from study area|19
1076490|NCT02430311|3501377|P1|Part B|Death|1
1075030|NCT02485301|3493015|P1|Overall Study|Migrated/moved from study area|10
1075031|NCT02485301|3493014|P2|Overall Study|Withdrawal by Subject|7
1075032|NCT02485301|3493015|P1|Overall Study|Withdrawal by Subject|6
1075033|NCT02485301|3493014|P2|Overall Study|Protocol Violation|1
1075034|NCT02485301|3493015|P1|Overall Study|Protocol Violation|0
1075035|NCT02485301|3493014|P2|Overall Study|Serious Adverse Events|1
1075036|NCT02485301|3493015|P1|Overall Study|Serious Adverse Events|2
1075037|NCT02485158|3493065|P1|Overall Study|expected drug side effect|1
1075038|NCT02485158|3493065|P1|Overall Study|Withdrawal by Subject|3
1075039|NCT02484911|3493154|P2|Overall Study|Protocol Violation|1
1075040|NCT02484911|3493155|P1|Overall Study|Protocol Violation|2
1075041|NCT02484911|3493154|P2|Overall Study|Withdrawal by Subject|1
1075042|NCT02484911|3493155|P1|Overall Study|Withdrawal by Subject|2
1075043|NCT02484729|3493197|P10|Overall Study|Failure of IntelliCap Error|1
1075044|NCT02484729|3493198|P9|Overall Study|Failure of IntelliCap Error|0
1075045|NCT02484729|3493199|P8|Overall Study|Failure of IntelliCap Error|0
1075046|NCT02484729|3493200|P7|Overall Study|Failure of IntelliCap Error|0
1075047|NCT02484729|3493201|P6|Overall Study|Failure of IntelliCap Error|0
1075048|NCT02484729|3493202|P5|Overall Study|Failure of IntelliCap Error|0
1075049|NCT02484729|3493203|P4|Overall Study|Failure of IntelliCap Error|0
1075050|NCT02484729|3493204|P3|Overall Study|Failure of IntelliCap Error|0
1075051|NCT02484729|3493205|P2|Overall Study|Failure of IntelliCap Error|0
1075052|NCT02484729|3493206|P1|Overall Study|Failure of IntelliCap Error|0
1075053|NCT02483975|3493404|P2|Overall Study|Physician Decision|0
1075054|NCT02483975|3493405|P1|Overall Study|Physician Decision|2
1075055|NCT02483975|3493404|P2|Overall Study|Lost to Follow-up|1
1075056|NCT02483975|3493405|P1|Overall Study|Lost to Follow-up|0
1075057|NCT02483975|3493404|P2|Overall Study|Adverse Event|1
1075058|NCT02483975|3493405|P1|Overall Study|Adverse Event|0
1075059|NCT02483611|3493422|P3|Overall Study|Protocol Violation|1
1075060|NCT02483611|3493423|P2|Overall Study|Protocol Violation|0
1075061|NCT02483611|3493424|P1|Overall Study|Protocol Violation|0
1075062|NCT02483585|3493521|P2|Open-label Treatment Phase|Lost to Follow-up|5
1075063|NCT02483585|3493522|P1|Open-label Treatment Phase|Lost to Follow-up|3
1075064|NCT02483585|3493521|P2|Open-label Treatment Phase|Withdrawal by Subject|14
1075065|NCT02483585|3493522|P1|Open-label Treatment Phase|Withdrawal by Subject|18
1075066|NCT02483585|3493521|P2|Open-label Treatment Phase|Decision by Sponsor|1
1075067|NCT02483585|3493522|P1|Open-label Treatment Phase|Decision by Sponsor|0
1075068|NCT02483585|3493521|P2|Open-label Treatment Phase|Protocol-specified Criteria|5
1075069|NCT02483585|3493522|P1|Open-label Treatment Phase|Protocol-specified Criteria|6
1075070|NCT02483585|3493521|P2|Double-blind Treatment Phase|Lost to Follow-up|2
1075071|NCT02483585|3493522|P1|Double-blind Treatment Phase|Lost to Follow-up|3
1075072|NCT02483585|3493521|P2|Double-blind Treatment Phase|Withdrawal by Subject|12
1075073|NCT02483585|3493522|P1|Double-blind Treatment Phase|Withdrawal by Subject|12
1075074|NCT02483585|3493521|P2|Double-blind Treatment Phase|Decision by Sponsor|1
1075075|NCT02483585|3493522|P1|Double-blind Treatment Phase|Decision by Sponsor|1
1075076|NCT02482935|3493542|P2|Period 1|Withdrawal by Subject|0
1075077|NCT02482935|3493543|P1|Period 1|Withdrawal by Subject|1
1075078|NCT02482805|3493571|P3|Overall Study|Lost to Follow-up|0
1075079|NCT02482805|3493572|P2|Overall Study|Lost to Follow-up|4
1075080|NCT02482805|3493573|P1|Overall Study|Lost to Follow-up|4
1075081|NCT02482571|3493587|P1|Overall Study|Withdrawal by Subject|4
1075082|NCT02482571|3493587|P1|Overall Study|Scanner or Respiract failure|3
1075083|NCT02482571|3493587|P1|Overall Study|Adverse Event|1
1075084|NCT02482428|3493599|P5|Overall Study|subject/guardian decision|2
1075085|NCT02482428|3493600|P4|Overall Study|subject/guardian decision|0
1075086|NCT02482428|3493601|P3|Overall Study|subject/guardian decision|0
1075087|NCT02482428|3493602|P2|Overall Study|subject/guardian decision|2
1075088|NCT02482428|3493603|P1|Overall Study|subject/guardian decision|4
1075089|NCT02482428|3493599|P5|Overall Study|protocol deviation|0
1075090|NCT02482428|3493600|P4|Overall Study|protocol deviation|0
1075091|NCT02482428|3493601|P3|Overall Study|protocol deviation|0
1075092|NCT02482428|3493602|P2|Overall Study|protocol deviation|1
1075093|NCT02482428|3493603|P1|Overall Study|protocol deviation|1
1075094|NCT02482428|3493599|P5|Overall Study|Physician Decision|1
1075095|NCT02482428|3493600|P4|Overall Study|Physician Decision|0
1075096|NCT02482428|3493601|P3|Overall Study|Physician Decision|0
1075097|NCT02482428|3493602|P2|Overall Study|Physician Decision|0
1075098|NCT02482428|3493603|P1|Overall Study|Physician Decision|0
1075099|NCT02482428|3493599|P5|Overall Study|Lost to Follow-up|4
1075100|NCT02482428|3493600|P4|Overall Study|Lost to Follow-up|2
1075101|NCT02482428|3493601|P3|Overall Study|Lost to Follow-up|1
1075102|NCT02482428|3493602|P2|Overall Study|Lost to Follow-up|9
1075103|NCT02482428|3493603|P1|Overall Study|Lost to Follow-up|4
1075104|NCT02482298|3493626|P3|Overall Study|Lost to Follow-up|0
1075105|NCT02482298|3493627|P2|Overall Study|Lost to Follow-up|1
1075106|NCT02482298|3493628|P1|Overall Study|Lost to Follow-up|0
1075107|NCT02482298|3493626|P3|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1
1075108|NCT02482298|3493627|P2|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
1075109|NCT02482298|3493628|P1|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
1075110|NCT02482298|3493626|P3|Overall Study|Did Not Fulfill Randomization Criteria|0
1075111|NCT02482298|3493627|P2|Overall Study|Did Not Fulfill Randomization Criteria|1
1075112|NCT02482298|3493628|P1|Overall Study|Did Not Fulfill Randomization Criteria|0
1075113|NCT02482298|3493626|P3|Overall Study|Withdrawal by Subject|2
1075114|NCT02482298|3493627|P2|Overall Study|Withdrawal by Subject|1
1075115|NCT02482298|3493628|P1|Overall Study|Withdrawal by Subject|2
1075116|NCT02482129|3493650|P2|Overall Study|Criteria not met|0
1075117|NCT02482129|3493651|P1|Overall Study|Criteria not met|1
1075118|NCT02482129|3493650|P2|Overall Study|Withdrawal by Subject|0
1075119|NCT02482129|3493651|P1|Overall Study|Withdrawal by Subject|2
1075120|NCT02482129|3493650|P2|Overall Study|Adverse Event|0
1075121|NCT02482129|3493651|P1|Overall Study|Adverse Event|1
1075122|NCT02482129|3493650|P2|Overall Study|Criteria not met-prior to treatment|0
1075123|NCT02482129|3493651|P1|Overall Study|Criteria not met-prior to treatment|1
1075124|NCT02482129|3493650|P2|Overall Study|Unable to draw blood-prior to treatment|0
1075125|NCT02482129|3493651|P1|Overall Study|Unable to draw blood-prior to treatment|1
1075126|NCT02482129|3493650|P2|Overall Study|Withdrawal by subject-prior to treatment|1
1075127|NCT02482129|3493651|P1|Overall Study|Withdrawal by subject-prior to treatment|0
1075128|NCT02482129|3493650|P2|Overall Study|Adverse Event-prior to treatment|1
1075129|NCT02482129|3493651|P1|Overall Study|Adverse Event-prior to treatment|0
1075130|NCT02481934|3493678|P1|Overall Study|Death|2
1075131|NCT02481050|3493774|P1|Overall Study|Other|3
1075132|NCT02481050|3493774|P1|Overall Study|Withdrawal by Subject|7
1075133|NCT02481050|3493774|P1|Overall Study|Disease Progression|47
1075134|NCT02481050|3493774|P1|Overall Study|Adverse Event|1
1075135|NCT02480712|3493794|P1|Overall Study|Lack of Efficacy|1
1075136|NCT02480712|3493794|P1|Overall Study|Death|1
1075137|NCT02480712|3493794|P1|Overall Study|Withdrew Consent|3
1075138|NCT02480712|3493794|P1|Overall Study|Lost to Follow-up|5
1075139|NCT02480712|3493794|P1|Overall Study|Enrolled but Never Treated|1
1075140|NCT02480621|3493813|P2|Follow Up|Lost to Follow-up|2
1075141|NCT02480621|3493814|P1|Follow Up|Lost to Follow-up|4
1075142|NCT02480621|3493813|P2|Randomization|Surgeon did not give intervention|1
1075143|NCT02480621|3493814|P1|Randomization|Surgeon did not give intervention|0
1075144|NCT02480621|3493813|P2|Randomization|Withdrawal by Subject|0
1075145|NCT02480621|3493814|P1|Randomization|Withdrawal by Subject|1
1075146|NCT02480153|3493891|P2|Overall Study|Randomized but not treated|1
1075147|NCT02480153|3493892|P1|Overall Study|Randomized but not treated|0
1075148|NCT02480153|3493891|P2|Overall Study|Withdrew treatment; continued in study|14
1075149|NCT02480153|3493892|P1|Overall Study|Withdrew treatment; continued in study|6
1075150|NCT02480153|3493891|P2|Overall Study|Discontinued from treatment and study|12
1075151|NCT02480153|3493892|P1|Overall Study|Discontinued from treatment and study|5
1075152|NCT02480010|3493900|P2|Overall Study|Refused Treatment|3
1075153|NCT02480010|3493901|P1|Overall Study|Refused Treatment|0
1075154|NCT02480010|3493900|P2|Overall Study|Insufficient therapeutic response|29
1075155|NCT02480010|3493901|P1|Overall Study|Insufficient therapeutic response|31
1075156|NCT02480010|3493900|P2|Overall Study|Death|0
1075157|NCT02480010|3493901|P1|Overall Study|Death|1
1075158|NCT02480010|3493900|P2|Overall Study|Adverse Event|1
1075159|NCT02480010|3493901|P1|Overall Study|Adverse Event|3
1075160|NCT02479412|3493963|P9|Overall Study|Randomization to wrong PK sampling group|0
1075161|NCT02479412|3493964|P8|Overall Study|Randomization to wrong PK sampling group|0
1075162|NCT02479412|3493965|P7|Overall Study|Randomization to wrong PK sampling group|0
1075163|NCT02479412|3493966|P6|Overall Study|Randomization to wrong PK sampling group|0
1075164|NCT02479412|3493967|P5|Overall Study|Randomization to wrong PK sampling group|1
1075165|NCT02479412|3493968|P4|Overall Study|Randomization to wrong PK sampling group|0
1075166|NCT02479412|3493969|P3|Overall Study|Randomization to wrong PK sampling group|0
1075167|NCT02479412|3493970|P2|Overall Study|Randomization to wrong PK sampling group|0
1075168|NCT02479412|3493971|P1|Overall Study|Randomization to wrong PK sampling group|0
1075169|NCT02479412|3493963|P9|Overall Study|Study-specific withdrawal criteria|1
1075170|NCT02479412|3493964|P8|Overall Study|Study-specific withdrawal criteria|1
1075171|NCT02479412|3493965|P7|Overall Study|Study-specific withdrawal criteria|0
1075172|NCT02479412|3493966|P6|Overall Study|Study-specific withdrawal criteria|0
1075173|NCT02479412|3493967|P5|Overall Study|Study-specific withdrawal criteria|0
1075174|NCT02479412|3493968|P4|Overall Study|Study-specific withdrawal criteria|1
1075175|NCT02479412|3493969|P3|Overall Study|Study-specific withdrawal criteria|1
1075176|NCT02479412|3493970|P2|Overall Study|Study-specific withdrawal criteria|0
1075177|NCT02479412|3493971|P1|Overall Study|Study-specific withdrawal criteria|0
1075178|NCT02479412|3493963|P9|Overall Study|Adverse Event|0
1075179|NCT02479412|3493964|P8|Overall Study|Adverse Event|0
1075180|NCT02479412|3493965|P7|Overall Study|Adverse Event|0
1075181|NCT02479412|3493966|P6|Overall Study|Adverse Event|0
1075182|NCT02479412|3493967|P5|Overall Study|Adverse Event|0
1075183|NCT02479412|3493968|P4|Overall Study|Adverse Event|0
1075184|NCT02479412|3493969|P3|Overall Study|Adverse Event|1
1075185|NCT02479412|3493970|P2|Overall Study|Adverse Event|0
1075186|NCT02479412|3493971|P1|Overall Study|Adverse Event|0
1075187|NCT02479139|3494048|P6|Overall Study|Other Miscellaneous Reasons|0
1075188|NCT02479139|3494049|P5|Overall Study|Other Miscellaneous Reasons|1
1075189|NCT02479139|3494050|P4|Overall Study|Other Miscellaneous Reasons|1
1075190|NCT02479139|3494051|P3|Overall Study|Other Miscellaneous Reasons|1
1075191|NCT02479139|3494052|P2|Overall Study|Other Miscellaneous Reasons|0
1075192|NCT02479139|3494053|P1|Overall Study|Other Miscellaneous Reasons|1
1075193|NCT02479139|3494048|P6|Overall Study|Treatment Failure/Lack of Efficacy|0
1075194|NCT02479139|3494049|P5|Overall Study|Treatment Failure/Lack of Efficacy|0
1075195|NCT02479139|3494050|P4|Overall Study|Treatment Failure/Lack of Efficacy|0
1075196|NCT02479139|3494051|P3|Overall Study|Treatment Failure/Lack of Efficacy|1
1075197|NCT02479139|3494052|P2|Overall Study|Treatment Failure/Lack of Efficacy|0
1075198|NCT02479139|3494053|P1|Overall Study|Treatment Failure/Lack of Efficacy|0
1075199|NCT02479139|3494048|P6|Overall Study|Withdrew Consent|1
1075200|NCT02479139|3494049|P5|Overall Study|Withdrew Consent|1
1075201|NCT02479139|3494050|P4|Overall Study|Withdrew Consent|4
1075202|NCT02479139|3494051|P3|Overall Study|Withdrew Consent|1
1075203|NCT02479139|3494052|P2|Overall Study|Withdrew Consent|6
1075204|NCT02479139|3494053|P1|Overall Study|Withdrew Consent|5
1075205|NCT02479139|3494048|P6|Overall Study|Lost to Follow-up|5
1075206|NCT02479139|3494049|P5|Overall Study|Lost to Follow-up|3
1075207|NCT02479139|3494050|P4|Overall Study|Lost to Follow-up|2
1075208|NCT02479139|3494051|P3|Overall Study|Lost to Follow-up|4
1075209|NCT02479139|3494052|P2|Overall Study|Lost to Follow-up|4
1075210|NCT02479139|3494053|P1|Overall Study|Lost to Follow-up|2
1075211|NCT02478632|3494086|P2|Overall Study|Other (Withdrawal from parent study)|5
1075212|NCT02478632|3494087|P1|Overall Study|Other (Withdrawal from parent study)|4
1075213|NCT02478372|3494114|P2|Overall Study|Death|2
1075214|NCT02478372|3494115|P1|Overall Study|Death|0
1075215|NCT02478372|3494114|P2|Overall Study|Lost to Follow-up|4
1075216|NCT02478372|3494115|P1|Overall Study|Lost to Follow-up|1
1075217|NCT02478372|3494114|P2|Overall Study|Protocol Violation|8
1075218|NCT02478372|3494115|P1|Overall Study|Protocol Violation|12
1075219|NCT02478164|3494137|P1|Overall Study|Withdrawal by Subject|1
1075220|NCT02478164|3494137|P1|Overall Study|Adverse Event|1
1075221|NCT02478164|3494137|P1|Overall Study|Lack of Efficacy|13
1075222|NCT02477605|3494150|P2|Overall Study|Administered gas during surgery|1
1075223|NCT02477605|3494151|P1|Overall Study|Administered gas during surgery|0
1075224|NCT02477605|3494150|P2|Overall Study|Withdrawal by Subject|1
1075225|NCT02477605|3494151|P1|Overall Study|Withdrawal by Subject|0
1075226|NCT02477605|3494150|P2|Overall Study|Lost to Follow-up|2
1075227|NCT02477605|3494151|P1|Overall Study|Lost to Follow-up|0
1075228|NCT02477605|3494150|P2|Overall Study|Discontinued prior to treatment|0
1075229|NCT02477605|3494151|P1|Overall Study|Discontinued prior to treatment|1
1075230|NCT02477527|3494165|P1|Overall Study|Screen Failure|3
1075231|NCT02477527|3494165|P1|Overall Study|Withdrawal by Subject|1
1075232|NCT02477527|3494165|P1|Overall Study|Lost to Follow-up|2
1075233|NCT02477332|3494179|P6|Overall Study|Withdrawal by Subject|0
1075234|NCT02477332|3494180|P5|Overall Study|Withdrawal by Subject|1
1075235|NCT02477332|3494181|P4|Overall Study|Withdrawal by Subject|2
1075236|NCT02477332|3494182|P3|Overall Study|Withdrawal by Subject|1
1075237|NCT02477332|3494183|P2|Overall Study|Withdrawal by Subject|3
1075238|NCT02477332|3494184|P1|Overall Study|Withdrawal by Subject|0
1075239|NCT02477332|3494179|P6|Overall Study|Physician Decision|1
1075240|NCT02477332|3494180|P5|Overall Study|Physician Decision|0
1075241|NCT02477332|3494181|P4|Overall Study|Physician Decision|3
1075242|NCT02477332|3494182|P3|Overall Study|Physician Decision|1
1075243|NCT02477332|3494183|P2|Overall Study|Physician Decision|0
1075244|NCT02477332|3494184|P1|Overall Study|Physician Decision|0
1075245|NCT02477332|3494179|P6|Overall Study|Lost to Follow-up|0
1075246|NCT02477332|3494180|P5|Overall Study|Lost to Follow-up|0
1075247|NCT02477332|3494181|P4|Overall Study|Lost to Follow-up|0
1075248|NCT02477332|3494182|P3|Overall Study|Lost to Follow-up|2
1075249|NCT02477332|3494183|P2|Overall Study|Lost to Follow-up|0
1075250|NCT02477332|3494184|P1|Overall Study|Lost to Follow-up|0
1075251|NCT02477332|3494179|P6|Overall Study|Technical problems|0
1075252|NCT02477332|3494180|P5|Overall Study|Technical problems|0
1075253|NCT02477332|3494181|P4|Overall Study|Technical problems|0
1075254|NCT02477332|3494182|P3|Overall Study|Technical problems|1
1075255|NCT02477332|3494183|P2|Overall Study|Technical problems|0
1075256|NCT02477332|3494184|P1|Overall Study|Technical problems|0
1075257|NCT02477332|3494179|P6|Overall Study|Protocol Violation|1
1075258|NCT02477332|3494180|P5|Overall Study|Protocol Violation|1
1075259|NCT02477332|3494181|P4|Overall Study|Protocol Violation|3
1075260|NCT02477332|3494182|P3|Overall Study|Protocol Violation|3
1075261|NCT02477332|3494183|P2|Overall Study|Protocol Violation|0
1075262|NCT02477332|3494184|P1|Overall Study|Protocol Violation|2
1075263|NCT02477332|3494179|P6|Overall Study|Pregnancy|0
1075264|NCT02477332|3494180|P5|Overall Study|Pregnancy|0
1075265|NCT02477332|3494181|P4|Overall Study|Pregnancy|1
1075266|NCT02477332|3494182|P3|Overall Study|Pregnancy|0
1075267|NCT02477332|3494183|P2|Overall Study|Pregnancy|0
1075268|NCT02477332|3494184|P1|Overall Study|Pregnancy|0
1075269|NCT02477332|3494179|P6|Overall Study|Non-compliance with study treatment|0
1075270|NCT02477332|3494180|P5|Overall Study|Non-compliance with study treatment|0
1075271|NCT02477332|3494181|P4|Overall Study|Non-compliance with study treatment|0
1075272|NCT02477332|3494182|P3|Overall Study|Non-compliance with study treatment|2
1075273|NCT02477332|3494183|P2|Overall Study|Non-compliance with study treatment|1
1075274|NCT02477332|3494184|P1|Overall Study|Non-compliance with study treatment|0
1075275|NCT02477332|3494179|P6|Overall Study|Lack of Efficacy|1
1075276|NCT02477332|3494180|P5|Overall Study|Lack of Efficacy|1
1075277|NCT02477332|3494181|P4|Overall Study|Lack of Efficacy|2
1075278|NCT02477332|3494182|P3|Overall Study|Lack of Efficacy|1
1075279|NCT02477332|3494183|P2|Overall Study|Lack of Efficacy|2
1075280|NCT02477332|3494184|P1|Overall Study|Lack of Efficacy|1
1075281|NCT02477332|3494179|P6|Overall Study|Adverse Event|2
1075282|NCT02477332|3494180|P5|Overall Study|Adverse Event|1
1075283|NCT02477332|3494181|P4|Overall Study|Adverse Event|2
1075284|NCT02477332|3494182|P3|Overall Study|Adverse Event|1
1075285|NCT02477332|3494183|P2|Overall Study|Adverse Event|1
1075286|NCT02477332|3494184|P1|Overall Study|Adverse Event|0
1075287|NCT02477020|3494260|P2|Overall Study|Lack of Efficacy|5
1075288|NCT02477020|3494261|P1|Overall Study|Lack of Efficacy|14
1075289|NCT02477020|3494260|P2|Overall Study|Reason not Specified|1
1075290|NCT02477020|3494261|P1|Overall Study|Reason not Specified|3
1075291|NCT02477020|3494260|P2|Overall Study|Voluntary Withdrawal|16
1075292|NCT02477020|3494261|P1|Overall Study|Voluntary Withdrawal|7
1075293|NCT02477020|3494260|P2|Overall Study|Pretreatment Event/Adverse Event|6
1075294|NCT02477020|3494261|P1|Overall Study|Pretreatment Event/Adverse Event|6
1075295|NCT02476994|3494291|P2|Overall Study|Based on feedback from FDA|0
1075296|NCT02476994|3494292|P1|Overall Study|Based on feedback from FDA|1
1075297|NCT02476617|3494361|P1|Overall Study|Lost to Follow-up|1
1075298|NCT02476617|3494361|P1|Overall Study|Adverse Event|1
1075299|NCT02476422|3494390|P2|Overall Study|Subject/guardian decision|1
1075300|NCT02476422|3494391|P1|Overall Study|Subject/guardian decision|0
1075301|NCT02476175|3494421|P1|Overall Study|Adverse Event|2
1075302|NCT02475980|3494445|P1|Overall Study|Withdrawal by Subject|1
1075303|NCT02475980|3494445|P1|Overall Study|Lost to Follow-up|4
1075304|NCT02475733|3494456|P2|Overall Study|Physician Decision|0
1075305|NCT02475733|3494457|P1|Overall Study|Physician Decision|1
1075306|NCT02475733|3494456|P2|Overall Study|Withdrawal by Subject|0
1075307|NCT02475733|3494457|P1|Overall Study|Withdrawal by Subject|1
1075308|NCT02475564|3494514|P2|Overall Study|Intense Menstrual bleeding|0
1075309|NCT02475564|3494515|P1|Overall Study|Intense Menstrual bleeding|1
1075310|NCT02475564|3494514|P2|Overall Study|Lost to Follow-up|1
1075311|NCT02475564|3494515|P1|Overall Study|Lost to Follow-up|2
1075312|NCT02475564|3494514|P2|Overall Study|Withdrawal by Subject|0
1075313|NCT02475564|3494515|P1|Overall Study|Withdrawal by Subject|1
1075314|NCT02475395|3494527|P2|Overall Study|Protocol Violation|3
1075315|NCT02475395|3494528|P1|Overall Study|Protocol Violation|30
1075316|NCT02475278|3494538|P1|Overall Study|Reason Not Specified|1
1075317|NCT02475278|3494538|P1|Overall Study|Lost to Follow-up|1
1075318|NCT02474589|3494585|P2|Overall Study|Inability to complete study procedures|1
1075319|NCT02474589|3494586|P1|Overall Study|Inability to complete study procedures|5
1075320|NCT02474589|3494585|P2|Overall Study|Withdrawal by Subject|0
1075321|NCT02474589|3494586|P1|Overall Study|Withdrawal by Subject|4
1075322|NCT02474589|3494585|P2|Overall Study|Protocol Violation|1
1075323|NCT02474589|3494586|P1|Overall Study|Protocol Violation|4
1075324|NCT02474589|3494585|P2|Overall Study|Lost to Follow-up|1
1075325|NCT02474589|3494586|P1|Overall Study|Lost to Follow-up|6
1075326|NCT02474589|3494585|P2|Overall Study|Adverse Event|2
1075327|NCT02474589|3494586|P1|Overall Study|Adverse Event|6
1075328|NCT02474082|3494645|P2|Overall Study|Protocol deviation|1
1075329|NCT02474082|3494646|P1|Overall Study|Protocol deviation|0
1075330|NCT02474082|3494645|P2|Overall Study|Non-compliance with study treatment|2
1075331|NCT02474082|3494646|P1|Overall Study|Non-compliance with study treatment|0
1075332|NCT02474082|3494645|P2|Overall Study|Participant/guardian decision|2
1075333|NCT02474082|3494646|P1|Overall Study|Participant/guardian decision|1
1075334|NCT02474082|3494645|P2|Overall Study|Dose tapering not achieved|4
1075335|NCT02474082|3494646|P1|Overall Study|Dose tapering not achieved|0
1075336|NCT02474082|3494645|P2|Overall Study|Lost to Follow-up|2
1075337|NCT02474082|3494646|P1|Overall Study|Lost to Follow-up|2
1075338|NCT02474082|3494645|P2|Overall Study|Withdrawal of informed consent|11
1075339|NCT02474082|3494646|P1|Overall Study|Withdrawal of informed consent|1
1075340|NCT02474082|3494645|P2|Overall Study|Adverse Event|32
1075341|NCT02474082|3494646|P1|Overall Study|Adverse Event|2
1075342|NCT02473640|3494720|P1|Treatment Period 1|Adverse Event|1
1075343|NCT02473523|3494729|P1|Overall Study|Lost to Follow-up|1
1075344|NCT02473523|3494729|P1|Overall Study|Death|1
1075345|NCT02473510|3494750|P2|Overall Study|Lost to Follow-up|2
1075346|NCT02473510|3494751|P1|Overall Study|Lost to Follow-up|1
1075347|NCT02473471|3494765|P1|Overall Study|Lost to Follow-up|1
1075348|NCT02473471|3494765|P1|Overall Study|poor oral hygiene|2
1075349|NCT02473445|3494796|P1|Overall Study|Sponsor Decision|20
1075350|NCT02473445|3494796|P1|Overall Study|Withdrawal by Subject|2
1075351|NCT02473367|3494802|P1|Period 4|Lost to Follow-up|1
1075352|NCT02473367|3494802|P1|Wait 1|Withdrawal by Subject|1
1075353|NCT02472977|3494823|P3|Overall Study|Subject request to discontinue treatment|0
1075354|NCT02472977|3494824|P2|Overall Study|Subject request to discontinue treatment|1
1075355|NCT02472977|3494825|P1|Overall Study|Subject request to discontinue treatment|0
1075356|NCT02472977|3494823|P3|Overall Study|Study drug toxicity|2
1075357|NCT02472977|3494824|P2|Overall Study|Study drug toxicity|0
1075358|NCT02472977|3494825|P1|Overall Study|Study drug toxicity|2
1075359|NCT02472977|3494823|P3|Overall Study|Withdrawal by Subject|0
1075360|NCT02472977|3494824|P2|Overall Study|Withdrawal by Subject|1
1075361|NCT02472977|3494825|P1|Overall Study|Withdrawal by Subject|0
1075362|NCT02472977|3494823|P3|Overall Study|Disease progression|6
1075363|NCT02472977|3494824|P2|Overall Study|Disease progression|25
1075364|NCT02472977|3494825|P1|Overall Study|Disease progression|4
1075365|NCT02472964|3494850|P2|Part 2 (Week 24-week 48)|Protocol Violation|1
1075366|NCT02472964|3494851|P1|Part 2 (Week 24-week 48)|Protocol Violation|3
1075367|NCT02472964|3494850|P2|Part 2 (Week 24-week 48)|Withdrawal by Subject|1
1075368|NCT02472964|3494851|P1|Part 2 (Week 24-week 48)|Withdrawal by Subject|3
1075369|NCT02472964|3494850|P2|Part 2 (Week 24-week 48)|Lost to Follow-up|1
1075370|NCT02472964|3494851|P1|Part 2 (Week 24-week 48)|Lost to Follow-up|2
1075371|NCT02472964|3494850|P2|Part 2 (Week 24-week 48)|Physician Decision|1
1075372|NCT02472964|3494851|P1|Part 2 (Week 24-week 48)|Physician Decision|1
1075373|NCT02472964|3494850|P2|Part 2 (Week 24-week 48)|Death|1
1075374|NCT02472964|3494851|P1|Part 2 (Week 24-week 48)|Death|0
1075375|NCT02472964|3494850|P2|Part 2 (Week 24-week 48)|Disease Progression|56
1075376|NCT02472964|3494851|P1|Part 2 (Week 24-week 48)|Disease Progression|52
1075377|NCT02472964|3494850|P2|Part 2 (Week 24-week 48)|Adverse Event|2
1075378|NCT02472964|3494851|P1|Part 2 (Week 24-week 48)|Adverse Event|4
1075379|NCT02472964|3494850|P2|Part 1 (up to Week 24)|Other|1
1075380|NCT02472964|3494851|P1|Part 1 (up to Week 24)|Other|2
1075381|NCT02472964|3494850|P2|Part 1 (up to Week 24)|Withdrawal by Subject|2
1075382|NCT02472964|3494851|P1|Part 1 (up to Week 24)|Withdrawal by Subject|7
1075383|NCT02472964|3494850|P2|Part 1 (up to Week 24)|Lost to Follow-up|1
1075384|NCT02472964|3494851|P1|Part 1 (up to Week 24)|Lost to Follow-up|0
1075385|NCT02472964|3494850|P2|Part 1 (up to Week 24)|Physician Decision|1
1075386|NCT02472964|3494851|P1|Part 1 (up to Week 24)|Physician Decision|3
1075387|NCT02472964|3494850|P2|Part 1 (up to Week 24)|Death|6
1075388|NCT02472964|3494851|P1|Part 1 (up to Week 24)|Death|3
1075389|NCT02472964|3494850|P2|Part 1 (up to Week 24)|disease progression|47
1075390|NCT02472964|3494851|P1|Part 1 (up to Week 24)|disease progression|58
1075391|NCT02472964|3494850|P2|Part 1 (up to Week 24)|Adverse Event|4
1075392|NCT02472964|3494851|P1|Part 1 (up to Week 24)|Adverse Event|2
1075393|NCT02472886|3494860|P3|Overall Study|Lack of Efficacy|1
1075394|NCT02472886|3494861|P2|Overall Study|Lack of Efficacy|2
1075395|NCT02472886|3494862|P1|Overall Study|Lack of Efficacy|0
1075396|NCT02472847|3494890|P2|Overall Study|Withdrawal by Subject|5
1075397|NCT02472847|3494891|P1|Overall Study|Withdrawal by Subject|1
1075398|NCT02472756|3494897|P1|Maintenance (Approximately 2 Years)|Adverse Event|1
1075399|NCT02472756|3494897|P1|Maintenance (Approximately 2 Years)|Progression Disease|2
1075400|NCT02472756|3494897|P1|Maintenance (Approximately 2 Years)|Lack of Drug|7
1075401|NCT02472756|3494897|P1|Induction (Approximately 6 Months)|Enrolled But Not Treated|1
1075402|NCT02472756|3494897|P1|Induction (Approximately 6 Months)|Adverse Event|1
1075403|NCT02472639|3494905|P2|Overall Study|Physician Decision|3
1075404|NCT02472639|3494906|P1|Overall Study|Physician Decision|4
1075405|NCT02472405|3494953|P1|Overall Study|Adverse Event|1
1075406|NCT02472405|3494953|P1|Overall Study|Lost to Follow-up|9
1075407|NCT02472366|3494961|P2|Overall Study|Lost to Follow-up|0
1075408|NCT02472366|3494962|P1|Overall Study|Lost to Follow-up|1
1075409|NCT02471755|3494978|P2|Overall Study|Lost to Follow-up|1
1075410|NCT02471755|3494979|P1|Overall Study|Lost to Follow-up|0
1075411|NCT02471755|3494978|P2|Overall Study|Withdrawal by Subject|0
1075412|NCT02471755|3494979|P1|Overall Study|Withdrawal by Subject|1
1075413|NCT02471612|3494995|P1|Overall Study|Lost to Follow-up|2
1075414|NCT02471183|3495017|P1|Extended Treatment Period|Lack of Efficacy|1
1075415|NCT02471183|3495017|P1|Main Treatment Period|Withdrawal by Subject|1
1075416|NCT02471183|3495017|P1|Main Treatment Period|Adverse Event|1
1075417|NCT02470429|3495053|P2|Overall Study|Withdrawal by Subject|0
1075418|NCT02470429|3495054|P1|Overall Study|Withdrawal by Subject|1
1075419|NCT02470429|3495053|P2|Overall Study|Adverse Event|0
1075420|NCT02470429|3495054|P1|Overall Study|Adverse Event|1
1075421|NCT02470403|3495072|P5|Overall Study|Subject/guardian decision|0
1075422|NCT02470403|3495073|P4|Overall Study|Subject/guardian decision|4
1075423|NCT02470403|3495074|P3|Overall Study|Subject/guardian decision|0
1075424|NCT02470403|3495075|P2|Overall Study|Subject/guardian decision|0
1075425|NCT02470403|3495076|P1|Overall Study|Subject/guardian decision|1
1075426|NCT02470403|3495072|P5|Overall Study|Lost to Follow-up|0
1075427|NCT02470403|3495073|P4|Overall Study|Lost to Follow-up|0
1075428|NCT02470403|3495074|P3|Overall Study|Lost to Follow-up|0
1075429|NCT02470403|3495075|P2|Overall Study|Lost to Follow-up|1
1075430|NCT02470403|3495076|P1|Overall Study|Lost to Follow-up|0
1075431|NCT02470403|3495072|P5|Overall Study|Adverse Event|0
1075432|NCT02470403|3495073|P4|Overall Study|Adverse Event|0
1075433|NCT02470403|3495074|P3|Overall Study|Adverse Event|0
1075434|NCT02470403|3495075|P2|Overall Study|Adverse Event|0
1075435|NCT02470403|3495076|P1|Overall Study|Adverse Event|1
1075436|NCT02469961|3495145|P2|Overall Study|Physician Decision|1
1075437|NCT02469961|3495146|P1|Overall Study|Physician Decision|4
1075438|NCT02469415|3495181|P1|Overall Study|Investigational agent placed on hold|2
1075439|NCT02469415|3495181|P1|Overall Study|Withdrawal by Subject|1
1075440|NCT02469298|3495189|P4|Overall Study|Withdrawal by Subject|1
1075441|NCT02469298|3495190|P3|Overall Study|Withdrawal by Subject|0
1075442|NCT02469298|3495191|P2|Overall Study|Withdrawal by Subject|0
1075443|NCT02469298|3495192|P1|Overall Study|Withdrawal by Subject|0
1075444|NCT02469298|3495189|P4|Overall Study|Physician Decision|1
1075445|NCT02469298|3495190|P3|Overall Study|Physician Decision|0
1075446|NCT02469298|3495191|P2|Overall Study|Physician Decision|0
1075447|NCT02469298|3495192|P1|Overall Study|Physician Decision|0
1075448|NCT02469298|3495189|P4|Overall Study|Lost to Follow-up|0
1075449|NCT02469298|3495190|P3|Overall Study|Lost to Follow-up|1
1075450|NCT02469298|3495191|P2|Overall Study|Lost to Follow-up|0
1075451|NCT02469298|3495192|P1|Overall Study|Lost to Follow-up|1
1075452|NCT02469298|3495189|P4|Overall Study|Protocol Violation|0
1075453|NCT02469298|3495190|P3|Overall Study|Protocol Violation|1
1075454|NCT02469298|3495191|P2|Overall Study|Protocol Violation|1
1075455|NCT02469298|3495192|P1|Overall Study|Protocol Violation|0
1075456|NCT02469246|3495332|P2|Overall Study|Lost to Follow-up|0
1075457|NCT02469246|3495333|P1|Overall Study|Lost to Follow-up|3
1075458|NCT02469246|3495332|P2|Overall Study|Withdrew Consent|6
1075459|NCT02469246|3495333|P1|Overall Study|Withdrew Consent|9
1075460|NCT02469246|3495332|P2|Overall Study|Protocol Violation|1
1075461|NCT02469246|3495333|P1|Overall Study|Protocol Violation|0
1075462|NCT02469246|3495332|P2|Overall Study|Non-Compliance with Study Drug|0
1075463|NCT02469246|3495333|P1|Overall Study|Non-Compliance with Study Drug|1
1075464|NCT02469246|3495332|P2|Overall Study|Investigator's Discretion|0
1075465|NCT02469246|3495333|P1|Overall Study|Investigator's Discretion|1
1075466|NCT02469246|3495332|P2|Overall Study|Lack of Efficacy|0
1075467|NCT02469246|3495333|P1|Overall Study|Lack of Efficacy|1
1075468|NCT02469246|3495332|P2|Overall Study|Death|0
1075469|NCT02469246|3495333|P1|Overall Study|Death|1
1075470|NCT02469246|3495332|P2|Overall Study|Adverse Event|5
1075471|NCT02469246|3495333|P1|Overall Study|Adverse Event|6
1075472|NCT02469246|3495332|P2|Overall Study|Still in Study up to the Data Cut Date|264
1075473|NCT02469246|3495333|P1|Overall Study|Still in Study up to the Data Cut Date|258
1075474|NCT02469246|3495332|P2|Overall Study|Randomized and Never Treated|6
1075475|NCT02469246|3495333|P1|Overall Study|Randomized and Never Treated|5
1075476|NCT02469168|3495351|P2|Overall Study|Trial closed|0
1075477|NCT02469168|3495352|P1|Overall Study|Trial closed|1
1075478|NCT02469064|3495372|P2|Overall Study|Request not to receive intervention.|3
1075479|NCT02469064|3495373|P1|Overall Study|Request not to receive intervention.|1
1075480|NCT02468934|3495381|P1|Overall Study|Screen Failure|3
1075481|NCT02468934|3495381|P1|Overall Study|Withdrawal by Subject|4
1075482|NCT02468414|3495464|P2|Overall Study|Screen Failure|0
1075483|NCT02468414|3495465|P1|Overall Study|Screen Failure|1
1075484|NCT02468414|3495464|P2|Overall Study|Poor in-vitro secreting TARGTs|0
1075485|NCT02468414|3495465|P1|Overall Study|Poor in-vitro secreting TARGTs|1
1075486|NCT02468414|3495464|P2|Overall Study|Early Study Termination by Sponsor|0
1075487|NCT02468414|3495465|P1|Overall Study|Early Study Termination by Sponsor|1
1075488|NCT02466659|3495525|P2|Overall Study|Lost to Follow-up|2
1075489|NCT02466659|3495526|P1|Overall Study|Lost to Follow-up|5
1075490|NCT02466425|3495536|P2|Overall Study|Withdrawal by Parent/Guardian|0
1075491|NCT02466425|3495537|P1|Overall Study|Withdrawal by Parent/Guardian|2
1075492|NCT02466425|3495536|P2|Overall Study|Other|3
1075493|NCT02466425|3495537|P1|Overall Study|Other|1
1075494|NCT02466425|3495536|P2|Overall Study|Withdrawal by Subject|1
1075495|NCT02466425|3495537|P1|Overall Study|Withdrawal by Subject|0
1075496|NCT02466425|3495536|P2|Overall Study|Protocol Violation|0
1075497|NCT02466425|3495537|P1|Overall Study|Protocol Violation|1
1075498|NCT02466425|3495536|P2|Overall Study|Lost to Follow-up|0
1075499|NCT02466425|3495537|P1|Overall Study|Lost to Follow-up|3
1075500|NCT02466425|3495536|P2|Overall Study|Lack of Efficacy|1
1075501|NCT02466425|3495537|P1|Overall Study|Lack of Efficacy|4
1075502|NCT02466425|3495536|P2|Overall Study|Adverse Event|11
1075503|NCT02466425|3495537|P1|Overall Study|Adverse Event|3
1075504|NCT02465931|3495564|P2|Overall Study|Withdrawal by Subject|0
1075505|NCT02465931|3495565|P1|Overall Study|Withdrawal by Subject|1
1075506|NCT02465931|3495564|P2|Overall Study|Protocol Violation|0
1075507|NCT02465931|3495565|P1|Overall Study|Protocol Violation|1
1075508|NCT02465931|3495564|P2|Overall Study|Lost to Follow-up|11
1075509|NCT02465931|3495565|P1|Overall Study|Lost to Follow-up|9
1075510|NCT02465866|3495571|P4|Period 3|Withdrawal by Subject|0
1075511|NCT02465866|3495572|P3|Period 3|Withdrawal by Subject|0
1075512|NCT02465866|3495573|P2|Period 3|Withdrawal by Subject|1
1075513|NCT02465866|3495574|P1|Period 3|Withdrawal by Subject|0
1075514|NCT02465489|3495660|P1|Overall Study|Adverse Event|5
1075515|NCT02465463|3495689|P2|Overall Study|Protocol Violation|0
1075516|NCT02465463|3495690|P1|Overall Study|Protocol Violation|1
1075517|NCT02465463|3495689|P2|Overall Study|Death|0
1075518|NCT02465463|3495690|P1|Overall Study|Death|1
1075519|NCT02465463|3495689|P2|Overall Study|Lost to Follow-up|1
1075520|NCT02465463|3495690|P1|Overall Study|Lost to Follow-up|2
1075521|NCT02465437|3495738|P4|Overall Study|Adverse Event|0
1075522|NCT02465437|3495739|P3|Overall Study|Adverse Event|0
1075523|NCT02465437|3495740|P2|Overall Study|Adverse Event|1
1075524|NCT02465437|3495741|P1|Overall Study|Adverse Event|0
1075525|NCT02465437|3495738|P4|Overall Study|Withdrawal by Subject|1
1075526|NCT02465437|3495739|P3|Overall Study|Withdrawal by Subject|0
1075527|NCT02465437|3495740|P2|Overall Study|Withdrawal by Subject|0
1075528|NCT02465437|3495741|P1|Overall Study|Withdrawal by Subject|1
1075529|NCT02465437|3495738|P4|Overall Study|Physician Decision|0
1075530|NCT02465437|3495739|P3|Overall Study|Physician Decision|1
1075531|NCT02465437|3495740|P2|Overall Study|Physician Decision|0
1075532|NCT02465437|3495741|P1|Overall Study|Physician Decision|0
1075533|NCT02465203|3495796|P3|Overall Study|Patient/guardian decision|1
1075534|NCT02465203|3495797|P2|Overall Study|Patient/guardian decision|1
1075535|NCT02465203|3495798|P1|Overall Study|Patient/guardian decision|1
1075536|NCT02465203|3495796|P3|Overall Study|New therapy for study indication|0
1075537|NCT02465203|3495797|P2|Overall Study|New therapy for study indication|0
1075538|NCT02465203|3495798|P1|Overall Study|New therapy for study indication|4
1075539|NCT02465203|3495796|P3|Overall Study|Study terminated by sponsor|11
1075540|NCT02465203|3495797|P2|Overall Study|Study terminated by sponsor|34
1075541|NCT02465203|3495798|P1|Overall Study|Study terminated by sponsor|50
1075542|NCT02465203|3495796|P3|Overall Study|Protocol Violation|1
1075543|NCT02465203|3495797|P2|Overall Study|Protocol Violation|1
1075544|NCT02465203|3495798|P1|Overall Study|Protocol Violation|1
1075545|NCT02463409|3495893|P1|Overall Study|Screen failure|1
1075546|NCT02463409|3495893|P1|Overall Study|Withdrawal by Subject|1
1075547|NCT02463331|3495901|P2|Overall Study|Physician Decision|0
1075548|NCT02463331|3495902|P1|Overall Study|Physician Decision|3
1075549|NCT02463331|3495901|P2|Overall Study|Lack of Efficacy|0
1075550|NCT02463331|3495902|P1|Overall Study|Lack of Efficacy|6
1075551|NCT02463331|3495901|P2|Overall Study|Pregnancy|3
1075552|NCT02463331|3495902|P1|Overall Study|Pregnancy|2
1075553|NCT02463331|3495901|P2|Overall Study|Lost to Follow-up|1
1075554|NCT02463331|3495902|P1|Overall Study|Lost to Follow-up|1
1075555|NCT02463331|3495901|P2|Overall Study|Adverse Event|2
1075556|NCT02463331|3495902|P1|Overall Study|Adverse Event|4
1075557|NCT02463097|3495918|P1|Overall Study|Withdrawal by Subject|1
1075558|NCT02463071|3495927|P3|Overall Study|Lost to Follow-up|1
1075559|NCT02463071|3495928|P2|Overall Study|Lost to Follow-up|0
1075560|NCT02463071|3495929|P1|Overall Study|Lost to Follow-up|0
1075561|NCT02463071|3495927|P3|Overall Study|Protocol Violation|0
1075562|NCT02463071|3495928|P2|Overall Study|Protocol Violation|2
1075563|NCT02463071|3495929|P1|Overall Study|Protocol Violation|0
1075564|NCT02463071|3495927|P3|Overall Study|Reason not specified|4
1075565|NCT02463071|3495928|P2|Overall Study|Reason not specified|9
1075566|NCT02463071|3495929|P1|Overall Study|Reason not specified|7
1075567|NCT02463071|3495927|P3|Overall Study|Eligibility criteria not fulfilled|0
1075568|NCT02463071|3495928|P2|Overall Study|Eligibility criteria not fulfilled|0
1075569|NCT02463071|3495929|P1|Overall Study|Eligibility criteria not fulfilled|1
1075570|NCT02463071|3495927|P3|Overall Study|Death|0
1075571|NCT02463071|3495928|P2|Overall Study|Death|0
1075572|NCT02463071|3495929|P1|Overall Study|Death|1
1075573|NCT02463071|3495927|P3|Overall Study|Adverse Event|1
1075574|NCT02463071|3495928|P2|Overall Study|Adverse Event|5
1075575|NCT02463071|3495929|P1|Overall Study|Adverse Event|3
1075576|NCT02462720|3495955|P2|Part 2|Protocol Violation|1
1075577|NCT02462720|3495956|P1|Part 2|Protocol Violation|0
1075578|NCT02462720|3495955|P2|Part 2|Withdrawal by Subject|0
1075579|NCT02462720|3495956|P1|Part 2|Withdrawal by Subject|1
1075580|NCT02462473|3495966|P1|Overall Study|Other|3
1075581|NCT02462473|3495966|P1|Overall Study|Death|1
1075582|NCT02462057|3496051|P5|Overall Study|Joined HealthyFood Before Intervention|17
1075583|NCT02462057|3496052|P4|Overall Study|Joined HealthyFood Before Intervention|16
1075584|NCT02462057|3496053|P3|Overall Study|Joined HealthyFood Before Intervention|23
1075585|NCT02462057|3496054|P2|Overall Study|Joined HealthyFood Before Intervention|13
1075586|NCT02462057|3496055|P1|Overall Study|Joined HealthyFood Before Intervention|22
1075587|NCT02462057|3496051|P5|Overall Study|Left Vitality|33
1075588|NCT02462057|3496052|P4|Overall Study|Left Vitality|35
1075589|NCT02462057|3496053|P3|Overall Study|Left Vitality|23
1075590|NCT02462057|3496054|P2|Overall Study|Left Vitality|27
1075591|NCT02462057|3496055|P1|Overall Study|Left Vitality|32
1075592|NCT02461589|3496122|P10|Overall Study|Withdrawal from trial before exposure|1
1075593|NCT02461589|3496123|P9|Overall Study|Withdrawal from trial before exposure|0
1075594|NCT02461589|3496124|P8|Overall Study|Withdrawal from trial before exposure|0
1075595|NCT02461589|3496125|P7|Overall Study|Withdrawal from trial before exposure|0
1075596|NCT02461589|3496126|P6|Overall Study|Withdrawal from trial before exposure|0
1075597|NCT02461589|3496127|P5|Overall Study|Withdrawal from trial before exposure|0
1075598|NCT02461589|3496128|P4|Overall Study|Withdrawal from trial before exposure|0
1075599|NCT02461589|3496129|P3|Overall Study|Withdrawal from trial before exposure|0
1075600|NCT02461589|3496130|P2|Overall Study|Withdrawal from trial before exposure|0
1075601|NCT02461589|3496131|P1|Overall Study|Withdrawal from trial before exposure|0
1075602|NCT02461589|3496122|P10|Overall Study|Missing follow-up information|0
1075603|NCT02461589|3496123|P9|Overall Study|Missing follow-up information|0
1075604|NCT02461589|3496124|P8|Overall Study|Missing follow-up information|0
1075605|NCT02461589|3496125|P7|Overall Study|Missing follow-up information|1
1075606|NCT02461589|3496126|P6|Overall Study|Missing follow-up information|0
1075607|NCT02461589|3496127|P5|Overall Study|Missing follow-up information|0
1075608|NCT02461589|3496128|P4|Overall Study|Missing follow-up information|0
1075609|NCT02461589|3496129|P3|Overall Study|Missing follow-up information|0
1075610|NCT02461589|3496130|P2|Overall Study|Missing follow-up information|1
1075611|NCT02461589|3496131|P1|Overall Study|Missing follow-up information|1
1075612|NCT02461589|3496122|P10|Overall Study|Unclassified|2
1075613|NCT02461589|3496123|P9|Overall Study|Unclassified|0
1075614|NCT02461589|3496124|P8|Overall Study|Unclassified|0
1075615|NCT02461589|3496125|P7|Overall Study|Unclassified|1
1075616|NCT02461589|3496126|P6|Overall Study|Unclassified|0
1075617|NCT02461589|3496127|P5|Overall Study|Unclassified|0
1075618|NCT02461589|3496128|P4|Overall Study|Unclassified|0
1075619|NCT02461589|3496129|P3|Overall Study|Unclassified|0
1075620|NCT02461589|3496130|P2|Overall Study|Unclassified|0
1075621|NCT02461589|3496131|P1|Overall Study|Unclassified|0
1075622|NCT02461589|3496122|P10|Overall Study|Death|0
1075623|NCT02461589|3496123|P9|Overall Study|Death|0
1075624|NCT02461589|3496124|P8|Overall Study|Death|1
1075625|NCT02461589|3496125|P7|Overall Study|Death|0
1075626|NCT02461589|3496126|P6|Overall Study|Death|0
1075627|NCT02461589|3496127|P5|Overall Study|Death|0
1075628|NCT02461589|3496128|P4|Overall Study|Death|0
1075629|NCT02461589|3496129|P3|Overall Study|Death|0
1075630|NCT02461589|3496130|P2|Overall Study|Death|0
1075631|NCT02461589|3496131|P1|Overall Study|Death|0
1075632|NCT02461589|3496122|P10|Overall Study|Lost to Follow-up|1
1075633|NCT02461589|3496123|P9|Overall Study|Lost to Follow-up|3
1075634|NCT02461589|3496124|P8|Overall Study|Lost to Follow-up|1
1075635|NCT02461589|3496125|P7|Overall Study|Lost to Follow-up|3
1075636|NCT02461589|3496126|P6|Overall Study|Lost to Follow-up|1
1075637|NCT02461589|3496127|P5|Overall Study|Lost to Follow-up|1
1075638|NCT02461589|3496128|P4|Overall Study|Lost to Follow-up|3
1075639|NCT02461589|3496129|P3|Overall Study|Lost to Follow-up|2
1075640|NCT02461589|3496130|P2|Overall Study|Lost to Follow-up|0
1075641|NCT02461589|3496131|P1|Overall Study|Lost to Follow-up|0
1075642|NCT02461589|3496122|P10|Overall Study|Withdrawal by Subject|1
1075643|NCT02461589|3496123|P9|Overall Study|Withdrawal by Subject|3
1075644|NCT02461589|3496124|P8|Overall Study|Withdrawal by Subject|3
1075645|NCT02461589|3496125|P7|Overall Study|Withdrawal by Subject|1
1075646|NCT02461589|3496126|P6|Overall Study|Withdrawal by Subject|2
1075647|NCT02461589|3496127|P5|Overall Study|Withdrawal by Subject|1
1075648|NCT02461589|3496128|P4|Overall Study|Withdrawal by Subject|2
1075649|NCT02461589|3496129|P3|Overall Study|Withdrawal by Subject|3
1075650|NCT02461589|3496130|P2|Overall Study|Withdrawal by Subject|1
1075651|NCT02461589|3496131|P1|Overall Study|Withdrawal by Subject|5
1075652|NCT02461290|3496257|P1|Overall Study|Lost to Follow-up|3
1075653|NCT02461290|3496257|P1|Overall Study|Withdrawn for Inadequate Clinical Stage|7
1075654|NCT02461134|3496264|P1|Overall Study|Adverse Event|1
1075655|NCT02460991|3496272|P2|Overall Study|Withdrawal by Subject|2
1075656|NCT02460991|3496273|P1|Overall Study|Withdrawal by Subject|0
1075657|NCT02460978|3496290|P3|Overall Study|Pregnancy|2
1075658|NCT02460978|3496291|P2|Overall Study|Pregnancy|0
1075659|NCT02460978|3496292|P1|Overall Study|Pregnancy|0
1075660|NCT02460978|3496290|P3|Overall Study|Discontinued due to DKA/hypoglycemia|4
1075661|NCT02460978|3496291|P2|Overall Study|Discontinued due to DKA/hypoglycemia|5
1075662|NCT02460978|3496292|P1|Overall Study|Discontinued due to DKA/hypoglycemia|2
1075663|NCT02460978|3496290|P3|Overall Study|Protocol Violation|1
1075664|NCT02460978|3496291|P2|Overall Study|Protocol Violation|1
1075665|NCT02460978|3496292|P1|Overall Study|Protocol Violation|1
1075666|NCT02460978|3496290|P3|Overall Study|Lost to Follow-up|1
1075667|NCT02460978|3496291|P2|Overall Study|Lost to Follow-up|3
1075668|NCT02460978|3496292|P1|Overall Study|Lost to Follow-up|2
1075669|NCT02460978|3496290|P3|Overall Study|Withdrawal by Subject|14
1075670|NCT02460978|3496291|P2|Overall Study|Withdrawal by Subject|5
1075671|NCT02460978|3496292|P1|Overall Study|Withdrawal by Subject|5
1075672|NCT02460978|3496290|P3|Overall Study|Adverse Event|11
1075673|NCT02460978|3496291|P2|Overall Study|Adverse Event|11
1075674|NCT02460978|3496292|P1|Overall Study|Adverse Event|17
1075675|NCT02460822|3496318|P1|Overall Study|Withdrawal by Subject|1
1075676|NCT02460380|3496335|P2|Overall Study|Withdrawal by Subject|5
1075677|NCT02460380|3496336|P1|Overall Study|Withdrawal by Subject|10
1075678|NCT02460159|3496358|P2|Overall Study|Withdrawal by Subject|0
1075679|NCT02460159|3496359|P1|Overall Study|Withdrawal by Subject|2
1075680|NCT02460159|3496358|P2|Overall Study|Adverse Event|1
1075681|NCT02460159|3496359|P1|Overall Study|Adverse Event|4
1075682|NCT02459418|3496389|P2|Overall Study|Abnormal Transvaginal Ultrasound|0
1075683|NCT02459418|3496390|P1|Overall Study|Abnormal Transvaginal Ultrasound|1
1075684|NCT02459418|3496389|P2|Overall Study|Elevated Creatine Kinase|0
1075685|NCT02459418|3496390|P1|Overall Study|Elevated Creatine Kinase|1
1075686|NCT02459418|3496389|P2|Overall Study|Withdrawal by Subject|1
1075687|NCT02459418|3496390|P1|Overall Study|Withdrawal by Subject|1
1075688|NCT02459418|3496389|P2|Overall Study|Adverse Event|1
1075689|NCT02459418|3496390|P1|Overall Study|Adverse Event|0
1075690|NCT02459418|3496389|P2|Overall Study|Endometrial thickness of >5 mm|0
1075691|NCT02459418|3496390|P1|Overall Study|Endometrial thickness of >5 mm|1
1075692|NCT02459418|3496389|P2|Overall Study|Physician Decision|2
1075693|NCT02459418|3496390|P1|Overall Study|Physician Decision|0
1075694|NCT02459418|3496389|P2|Overall Study|Protocol Violation|2
1075695|NCT02459418|3496390|P1|Overall Study|Protocol Violation|0
1075696|NCT02459418|3496389|P2|Overall Study|Exclusion Criteria|0
1075697|NCT02459418|3496390|P1|Overall Study|Exclusion Criteria|4
1075698|NCT02459093|3496412|P2|Overall Study|Lost to Follow-up|7
1075699|NCT02459093|3496413|P1|Overall Study|Lost to Follow-up|6
1075700|NCT02459093|3496412|P2|Overall Study|Protocol Violation|11
1075701|NCT02459093|3496413|P1|Overall Study|Protocol Violation|6
1075702|NCT02458287|3496485|P4|Overall Study|Relocated Out of State|1
1075703|NCT02458287|3496486|P3|Overall Study|Relocated Out of State|0
1075704|NCT02458287|3496487|P2|Overall Study|Relocated Out of State|0
1075705|NCT02458287|3496488|P1|Overall Study|Relocated Out of State|0
1075706|NCT02458287|3496485|P4|Overall Study|Withdrawal by Subject|1
1075707|NCT02458287|3496486|P3|Overall Study|Withdrawal by Subject|2
1075708|NCT02458287|3496487|P2|Overall Study|Withdrawal by Subject|2
1075709|NCT02458287|3496488|P1|Overall Study|Withdrawal by Subject|0
1075710|NCT02458287|3496485|P4|Overall Study|Protocol Violation|0
1075711|NCT02458287|3496486|P3|Overall Study|Protocol Violation|0
1075712|NCT02458287|3496487|P2|Overall Study|Protocol Violation|1
1075713|NCT02458287|3496488|P1|Overall Study|Protocol Violation|0
1075714|NCT02458287|3496485|P4|Overall Study|Lost to Follow-up|0
1075715|NCT02458287|3496486|P3|Overall Study|Lost to Follow-up|1
1075716|NCT02458287|3496487|P2|Overall Study|Lost to Follow-up|1
1075717|NCT02458287|3496488|P1|Overall Study|Lost to Follow-up|0
1075718|NCT02458287|3496485|P4|Overall Study|Adverse Event|1
1075719|NCT02458287|3496486|P3|Overall Study|Adverse Event|0
1075720|NCT02458287|3496487|P2|Overall Study|Adverse Event|0
1075721|NCT02458287|3496488|P1|Overall Study|Adverse Event|0
1075722|NCT02457793|3496539|P6|Overall Study|Physician Decision|3
1075723|NCT02457793|3496540|P5|Overall Study|Physician Decision|1
1075724|NCT02457793|3496541|P4|Overall Study|Physician Decision|1
1075725|NCT02457793|3496542|P3|Overall Study|Physician Decision|1
1075726|NCT02457793|3496543|P2|Overall Study|Physician Decision|0
1075727|NCT02457793|3496544|P1|Overall Study|Physician Decision|1
1075728|NCT02457793|3496539|P6|Overall Study|Adverse Event|0
1075729|NCT02457793|3496540|P5|Overall Study|Adverse Event|0
1075730|NCT02457793|3496541|P4|Overall Study|Adverse Event|1
1075731|NCT02457793|3496542|P3|Overall Study|Adverse Event|0
1075732|NCT02457793|3496543|P2|Overall Study|Adverse Event|0
1075733|NCT02457793|3496544|P1|Overall Study|Adverse Event|0
1075734|NCT02457793|3496539|P6|Overall Study|Withdrawal by Subject|2
1075735|NCT02457793|3496540|P5|Overall Study|Withdrawal by Subject|2
1075736|NCT02457793|3496541|P4|Overall Study|Withdrawal by Subject|2
1075737|NCT02457793|3496542|P3|Overall Study|Withdrawal by Subject|2
1075738|NCT02457793|3496543|P2|Overall Study|Withdrawal by Subject|4
1075739|NCT02457793|3496544|P1|Overall Study|Withdrawal by Subject|0
1075740|NCT02457793|3496539|P6|Overall Study|Reason not specified|1
1075741|NCT02457793|3496540|P5|Overall Study|Reason not specified|1
1075742|NCT02457793|3496541|P4|Overall Study|Reason not specified|1
1075743|NCT02457793|3496542|P3|Overall Study|Reason not specified|0
1075744|NCT02457793|3496543|P2|Overall Study|Reason not specified|0
1075745|NCT02457793|3496544|P1|Overall Study|Reason not specified|0
1075746|NCT02457611|3496688|P1|Overall Study|Lost to Follow-up|3
1075747|NCT02457546|3496702|P2|Overall Study|Adverse Event|1
1075748|NCT02457546|3496703|P1|Overall Study|Adverse Event|0
1075749|NCT02457546|3496702|P2|Overall Study|Lost to Follow-up|1
1075750|NCT02457546|3496703|P1|Overall Study|Lost to Follow-up|4
1075751|NCT02457546|3496702|P2|Overall Study|Refused to complete study/procedures|1
1075752|NCT02457546|3496703|P1|Overall Study|Refused to complete study/procedures|1
1075753|NCT02457546|3496702|P2|Overall Study|Other reasons|1
1075754|NCT02457546|3496703|P1|Overall Study|Other reasons|4
1075755|NCT02457247|3496758|P4|Period 2|Voluntary Withdrawal|0
1075756|NCT02457247|3496759|P3|Period 2|Voluntary Withdrawal|0
1075757|NCT02457247|3496760|P2|Period 2|Voluntary Withdrawal|1
1075758|NCT02457247|3496761|P1|Period 2|Voluntary Withdrawal|1
1075759|NCT02457247|3496758|P4|Period 2|Lost to Follow-up|0
1075760|NCT02457247|3496759|P3|Period 2|Lost to Follow-up|0
1075761|NCT02457247|3496760|P2|Period 2|Lost to Follow-up|1
1075762|NCT02457247|3496761|P1|Period 2|Lost to Follow-up|0
1075763|NCT02457247|3496758|P4|Period 2|Significant Protocol Deviation|0
1075764|NCT02457247|3496759|P3|Period 2|Significant Protocol Deviation|0
1075765|NCT02457247|3496760|P2|Period 2|Significant Protocol Deviation|0
1075766|NCT02457247|3496761|P1|Period 2|Significant Protocol Deviation|1
1075767|NCT02457247|3496758|P4|Period 2|Pretreatment Event/Adverse Event|0
1075768|NCT02457247|3496759|P3|Period 2|Pretreatment Event/Adverse Event|0
1075769|NCT02457247|3496760|P2|Period 2|Pretreatment Event/Adverse Event|1
1075770|NCT02457247|3496761|P1|Period 2|Pretreatment Event/Adverse Event|0
1075771|NCT02457247|3496758|P4|Period 1|Voluntary Withdrawal|0
1075772|NCT02457247|3496759|P3|Period 1|Voluntary Withdrawal|0
1075773|NCT02457247|3496760|P2|Period 1|Voluntary Withdrawal|0
1075774|NCT02457247|3496761|P1|Period 1|Voluntary Withdrawal|1
1075775|NCT02457247|3496758|P4|Period 1|Significant Protocol Deviation|0
1075776|NCT02457247|3496759|P3|Period 1|Significant Protocol Deviation|0
1075777|NCT02457247|3496760|P2|Period 1|Significant Protocol Deviation|1
1075778|NCT02457247|3496761|P1|Period 1|Significant Protocol Deviation|1
1075779|NCT02457247|3496758|P4|Period 1|Pretreatment Event/Adverse Event|0
1075780|NCT02457247|3496759|P3|Period 1|Pretreatment Event/Adverse Event|0
1075781|NCT02457247|3496760|P2|Period 1|Pretreatment Event/Adverse Event|1
1075782|NCT02457247|3496761|P1|Period 1|Pretreatment Event/Adverse Event|0
1075783|NCT02457182|3496783|P2|Overall Study|Lost to Follow-up|0
1075784|NCT02457182|3496784|P1|Overall Study|Lost to Follow-up|1
1075785|NCT02457065|3496802|P2|Overall Study|Lost to Follow-up|11
1075786|NCT02457065|3496803|P1|Overall Study|Lost to Follow-up|9
1075787|NCT02456740|3496814|P9|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4
1075788|NCT02456740|3496815|P8|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3
1075789|NCT02456740|3496816|P7|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
1075790|NCT02456740|3496817|P6|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4
1075791|NCT02456740|3496818|P5|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2
1075792|NCT02456740|3496819|P4|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3
1075793|NCT02456740|3496820|P3|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
1075794|NCT02456740|3496821|P2|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
1075795|NCT02456740|3496822|P1|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
1075796|NCT02456740|3496814|P9|Active Treatment Phase (Weeks 24 - 52)|Death|0
1075797|NCT02456740|3496815|P8|Active Treatment Phase (Weeks 24 - 52)|Death|1
1075798|NCT02456740|3496816|P7|Active Treatment Phase (Weeks 24 - 52)|Death|0
1075799|NCT02456740|3496817|P6|Active Treatment Phase (Weeks 24 - 52)|Death|0
1075800|NCT02456740|3496818|P5|Active Treatment Phase (Weeks 24 - 52)|Death|0
1075801|NCT02456740|3496819|P4|Active Treatment Phase (Weeks 24 - 52)|Death|0
1075802|NCT02456740|3496820|P3|Active Treatment Phase (Weeks 24 - 52)|Death|0
1075803|NCT02456740|3496821|P2|Active Treatment Phase (Weeks 24 - 52)|Death|0
1075804|NCT02456740|3496822|P1|Active Treatment Phase (Weeks 24 - 52)|Death|0
1075805|NCT02456740|3496814|P9|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9
1075806|NCT02456740|3496815|P8|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8
1075807|NCT02456740|3496816|P7|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8
1075808|NCT02456740|3496817|P6|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9
1075809|NCT02456740|3496818|P5|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11
1075810|NCT02456740|3496819|P4|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10
1075811|NCT02456740|3496820|P3|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
1075812|NCT02456740|3496821|P2|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
1075813|NCT02456740|3496822|P1|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
1075814|NCT02456740|3496814|P9|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5
1075815|NCT02456740|3496815|P8|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
1075816|NCT02456740|3496816|P7|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
1075817|NCT02456740|3496817|P6|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
1075818|NCT02456740|3496818|P5|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4
1075819|NCT02456740|3496819|P4|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1
1075820|NCT02456740|3496820|P3|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
1075821|NCT02456740|3496821|P2|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
1075822|NCT02456740|3496822|P1|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
1075823|NCT02456740|3496814|P9|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
1075824|NCT02456740|3496815|P8|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
1075825|NCT02456740|3496816|P7|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
1075826|NCT02456740|3496817|P6|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
1075827|NCT02456740|3496818|P5|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
1075828|NCT02456740|3496819|P4|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
1075829|NCT02456740|3496820|P3|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5
1075830|NCT02456740|3496821|P2|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4
1075831|NCT02456740|3496822|P1|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9
1075832|NCT02456740|3496814|P9|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
1075833|NCT02456740|3496815|P8|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
1075834|NCT02456740|3496816|P7|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
1075835|NCT02456740|3496817|P6|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
1075836|NCT02456740|3496818|P5|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
1075837|NCT02456740|3496819|P4|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
1075838|NCT02456740|3496820|P3|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21
1075839|NCT02456740|3496821|P2|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28
1075840|NCT02456740|3496822|P1|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27
1075841|NCT02456740|3496814|P9|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
1075842|NCT02456740|3496815|P8|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
1075843|NCT02456740|3496816|P7|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
1075844|NCT02456740|3496817|P6|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
1075845|NCT02456740|3496818|P5|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
1075846|NCT02456740|3496819|P4|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
1075847|NCT02456740|3496820|P3|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
1075848|NCT02456740|3496821|P2|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
1075849|NCT02456740|3496822|P1|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
1075850|NCT02455518|3496848|P4|Overall Study|Protocol Violation|3
1075851|NCT02455518|3496849|P3|Overall Study|Protocol Violation|1
1075852|NCT02455518|3496850|P2|Overall Study|Protocol Violation|1
1075853|NCT02455518|3496851|P1|Overall Study|Protocol Violation|0
1075854|NCT02455388|3496867|P3|Overall Study|Withdrawal by Subject|7
1075855|NCT02455388|3496868|P2|Overall Study|Withdrawal by Subject|0
1075856|NCT02455388|3496869|P1|Overall Study|Withdrawal by Subject|0
1075857|NCT02455388|3496867|P3|Overall Study|Protocol Violation|4
1075858|NCT02455388|3496868|P2|Overall Study|Protocol Violation|0
1075859|NCT02455388|3496869|P1|Overall Study|Protocol Violation|1
1075860|NCT02455050|3496880|P4|Treatment Period 2|Lost to Follow-up|1
1075861|NCT02455050|3496881|P3|Treatment Period 2|Lost to Follow-up|2
1075862|NCT02455050|3496882|P2|Treatment Period 2|Lost to Follow-up|0
1075863|NCT02455050|3496883|P1|Treatment Period 2|Lost to Follow-up|1
1075864|NCT02455050|3496880|P4|Treatment Period 1|Lost to Follow-up|2
1075865|NCT02455050|3496881|P3|Treatment Period 1|Lost to Follow-up|1
1075866|NCT02455050|3496882|P2|Treatment Period 1|Lost to Follow-up|1
1075867|NCT02455050|3496883|P1|Treatment Period 1|Lost to Follow-up|1
1075868|NCT02454959|3496947|P1|Overall Study|Adverse Event|2
1075869|NCT02454959|3496947|P1|Overall Study|Withdrawal by Subject|3
1075870|NCT02454959|3496947|P1|Overall Study|Physician Decision|1
1075871|NCT02454959|3496947|P1|Overall Study|Protocol-Specified Criteria|3
1075872|NCT02454933|3496967|P2|Overall Study|Withdrawal by Subject|2
1075873|NCT02454933|3496968|P1|Overall Study|Withdrawal by Subject|0
1075874|NCT02454933|3496967|P2|Overall Study|Adverse Event|1
1075875|NCT02454933|3496968|P1|Overall Study|Adverse Event|1
1075876|NCT02454933|3496967|P2|Overall Study|Progressive disease|5
1075877|NCT02454933|3496968|P1|Overall Study|Progressive disease|7
1075878|NCT02454608|3496976|P3|Open Label Period|Withdrawal by Subject|8
1075879|NCT02454608|3496977|P2|Open Label Period|Withdrawal by Subject|0
1075880|NCT02454608|3496978|P1|Open Label Period|Withdrawal by Subject|0
1075881|NCT02454608|3496976|P3|Open Label Period|Lost to Follow-up|11
1075882|NCT02454608|3496977|P2|Open Label Period|Lost to Follow-up|0
1075883|NCT02454608|3496978|P1|Open Label Period|Lost to Follow-up|0
1075884|NCT02454608|3496976|P3|Double-Blind Period|Lack of Efficacy|0
1075885|NCT02454608|3496977|P2|Double-Blind Period|Lack of Efficacy|2
1075886|NCT02454608|3496978|P1|Double-Blind Period|Lack of Efficacy|0
1075887|NCT02454101|3497070|P2|Overall Study|Lost to Follow-up|4
1075888|NCT02454101|3497071|P1|Overall Study|Lost to Follow-up|3
1075889|NCT02454101|3497070|P2|Overall Study|Adverse Event|3
1075890|NCT02454101|3497071|P1|Overall Study|Adverse Event|2
1075891|NCT02453841|3497093|P1|Overall Study|Unable to obtain blood samples|2
1075892|NCT02453841|3497093|P1|Overall Study|Protocol Violation|1
1075893|NCT02453321|3497138|P3|Overall Study|Deep Venous Thrombosis|0
1075894|NCT02453321|3497139|P2|Overall Study|Deep Venous Thrombosis|1
1075895|NCT02453321|3497140|P1|Overall Study|Deep Venous Thrombosis|0
1075896|NCT02453321|3497138|P3|Overall Study|Weakness|2
1075897|NCT02453321|3497139|P2|Overall Study|Weakness|1
1075898|NCT02453321|3497140|P1|Overall Study|Weakness|1
1075899|NCT02452892|3497172|P4|Follow-up|Subject left town on Day 42|0
1075900|NCT02452892|3497173|P3|Follow-up|Subject left town on Day 42|0
1075901|NCT02452892|3497174|P2|Follow-up|Subject left town on Day 42|0
1075902|NCT02452892|3497175|P1|Follow-up|Subject left town on Day 42|1
1075903|NCT02452892|3497172|P4|Follow-up|Withdrawal by Subject|1
1075904|NCT02452892|3497173|P3|Follow-up|Withdrawal by Subject|0
1075905|NCT02452892|3497174|P2|Follow-up|Withdrawal by Subject|0
1075906|NCT02452892|3497175|P1|Follow-up|Withdrawal by Subject|0
1075907|NCT02452892|3497172|P4|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
1075908|NCT02452892|3497173|P3|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
1075909|NCT02452892|3497174|P2|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
1075910|NCT02452892|3497175|P1|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2
1075911|NCT02452892|3497172|P4|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2
1075912|NCT02452892|3497173|P3|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
1075913|NCT02452892|3497174|P2|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
1075914|NCT02452892|3497175|P1|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
1075915|NCT02452892|3497172|P4|Week 1 Initial Randommization|Lost to Follow-up|0
1075916|NCT02452892|3497173|P3|Week 1 Initial Randommization|Lost to Follow-up|1
1075917|NCT02452892|3497174|P2|Week 1 Initial Randommization|Lost to Follow-up|0
1075918|NCT02452892|3497175|P1|Week 1 Initial Randommization|Lost to Follow-up|0
1075919|NCT02452892|3497172|P4|Week 1 Initial Randommization|Adverse Event|0
1075920|NCT02452892|3497173|P3|Week 1 Initial Randommization|Adverse Event|0
1075921|NCT02452892|3497174|P2|Week 1 Initial Randommization|Adverse Event|0
1075922|NCT02452892|3497175|P1|Week 1 Initial Randommization|Adverse Event|1
1075923|NCT02452320|3497247|P2|Overall Study|Adverse Event|1
1075924|NCT02452320|3497248|P1|Overall Study|Adverse Event|0
1075925|NCT02452047|3497261|P3|Overall Study|Withdrawal by Subject|0
1075926|NCT02452047|3497262|P2|Overall Study|Withdrawal by Subject|0
1075927|NCT02452047|3497263|P1|Overall Study|Withdrawal by Subject|1
1075928|NCT02452047|3497261|P3|Overall Study|Lost to Follow-up|0
1075929|NCT02452047|3497262|P2|Overall Study|Lost to Follow-up|1
1075930|NCT02452047|3497263|P1|Overall Study|Lost to Follow-up|1
1075931|NCT02452047|3497261|P3|Overall Study|Physician Decision|0
1075932|NCT02452047|3497262|P2|Overall Study|Physician Decision|0
1075933|NCT02452047|3497263|P1|Overall Study|Physician Decision|1
1075934|NCT02452047|3497261|P3|Overall Study|Death|1
1075935|NCT02452047|3497262|P2|Overall Study|Death|3
1075936|NCT02452047|3497263|P1|Overall Study|Death|1
1075937|NCT02452047|3497261|P3|Overall Study|Adverse Event|1
1075938|NCT02452047|3497262|P2|Overall Study|Adverse Event|1
1075939|NCT02452047|3497263|P1|Overall Study|Adverse Event|0
1075940|NCT02451917|3497324|P2|First Intervention (24 Weeks)|Adverse Event|2
1075941|NCT02451917|3497325|P1|First Intervention (24 Weeks)|Adverse Event|0
1075942|NCT02451917|3497324|P2|First Intervention (24 Weeks)|Death|1
1075943|NCT02451917|3497325|P1|First Intervention (24 Weeks)|Death|0
1075944|NCT02451917|3497324|P2|First Intervention (24 Weeks)|Lost to Follow-up|0
1075945|NCT02451917|3497325|P1|First Intervention (24 Weeks)|Lost to Follow-up|2
1075946|NCT02451358|3497347|P4|Overall Study|Protocol Violation|0
1075947|NCT02451358|3497348|P3|Overall Study|Protocol Violation|1
1075948|NCT02451358|3497349|P2|Overall Study|Protocol Violation|1
1075949|NCT02451358|3497350|P1|Overall Study|Protocol Violation|0
1075950|NCT02451358|3497347|P4|Overall Study|Withdrawal by Subject|0
1075951|NCT02451358|3497348|P3|Overall Study|Withdrawal by Subject|0
1075952|NCT02451358|3497349|P2|Overall Study|Withdrawal by Subject|1
1075953|NCT02451358|3497350|P1|Overall Study|Withdrawal by Subject|1
1075954|NCT02450539|3497456|P2|Overall Study|On study treatment/follow up|25
1075955|NCT02450539|3497457|P1|Overall Study|On study treatment/follow up|27
1075956|NCT02450539|3497456|P2|Overall Study|Lost to Follow-up|1
1075957|NCT02450539|3497457|P1|Overall Study|Lost to Follow-up|4
1075958|NCT02450539|3497456|P2|Overall Study|Withdrawal by Subject|7
1075959|NCT02450539|3497457|P1|Overall Study|Withdrawal by Subject|19
1075960|NCT02449915|3497494|P2|Overall Study|Abnormal preop lab|1
1075961|NCT02449915|3497495|P1|Overall Study|Abnormal preop lab|0
1075962|NCT02449915|3497494|P2|Overall Study|Intraoperative surgical findings|1
1075963|NCT02449915|3497495|P1|Overall Study|Intraoperative surgical findings|1
1075964|NCT02449915|3497494|P2|Overall Study|Withdrawal by Subject|2
1075965|NCT02449915|3497495|P1|Overall Study|Withdrawal by Subject|0
1075966|NCT02449915|3497494|P2|Overall Study|Exclusion criteria - drug use|0
1075967|NCT02449915|3497495|P1|Overall Study|Exclusion criteria - drug use|1
1075968|NCT02449902|3497503|P2|Overall Study|Withdrawal by Subject|1
1075969|NCT02449902|3497504|P1|Overall Study|Withdrawal by Subject|0
1075970|NCT02449902|3497503|P2|Overall Study|Adverse Event|1
1075971|NCT02449902|3497504|P1|Overall Study|Adverse Event|0
1075972|NCT02449044|3497599|P1|Overall Study|Sponsor Discontinued Trial|3
1075973|NCT02449044|3497599|P1|Overall Study|Physician Decision|9
1075974|NCT02449044|3497599|P1|Overall Study|Met Withdrawal Criteria|7
1075975|NCT02449044|3497599|P1|Overall Study|Adverse Event|30
1075976|NCT02449044|3497599|P1|Overall Study|Withdrawal by Subject|13
1075977|NCT02449044|3497599|P1|Overall Study|Lost to Follow-up|2
1075978|NCT02449018|3497620|P2|Overall Study|Patient decision|0
1075979|NCT02449018|3497621|P1|Overall Study|Patient decision|2
1075980|NCT02449018|3497620|P2|Overall Study|Protocol deviation|0
1075981|NCT02449018|3497621|P1|Overall Study|Protocol deviation|4
1075982|NCT02449018|3497620|P2|Overall Study|Adverse Event|1
1075983|NCT02449018|3497621|P1|Overall Study|Adverse Event|5
1075984|NCT02449018|3497620|P2|Overall Study|Administrative problems|0
1075985|NCT02449018|3497621|P1|Overall Study|Administrative problems|1
1075986|NCT02449018|3497620|P2|Overall Study|Abnormal laboratory value|1
1075987|NCT02449018|3497621|P1|Overall Study|Abnormal laboratory value|0
1075988|NCT02448810|3497690|P8|Overall Study|Other (unspecified)|0
1075989|NCT02448810|3497691|P7|Overall Study|Other (unspecified)|2
1075990|NCT02448810|3497692|P6|Overall Study|Other (unspecified)|0
1075991|NCT02448810|3497693|P5|Overall Study|Other (unspecified)|0
1075992|NCT02448810|3497694|P4|Overall Study|Other (unspecified)|0
1075993|NCT02448810|3497695|P3|Overall Study|Other (unspecified)|0
1075994|NCT02448810|3497696|P2|Overall Study|Other (unspecified)|0
1075995|NCT02448810|3497697|P1|Overall Study|Other (unspecified)|0
1075996|NCT02448810|3497690|P8|Overall Study|Lost to Follow-up|0
1075997|NCT02448810|3497691|P7|Overall Study|Lost to Follow-up|0
1075998|NCT02448810|3497692|P6|Overall Study|Lost to Follow-up|0
1075999|NCT02448810|3497693|P5|Overall Study|Lost to Follow-up|0
1076000|NCT02448810|3497694|P4|Overall Study|Lost to Follow-up|0
1076001|NCT02448810|3497695|P3|Overall Study|Lost to Follow-up|0
1076002|NCT02448810|3497696|P2|Overall Study|Lost to Follow-up|1
1076003|NCT02448810|3497697|P1|Overall Study|Lost to Follow-up|0
1076004|NCT02448810|3497690|P8|Overall Study|Other (Progressive disease)|5
1076005|NCT02448810|3497691|P7|Overall Study|Other (Progressive disease)|14
1076006|NCT02448810|3497692|P6|Overall Study|Other (Progressive disease)|9
1076007|NCT02448810|3497693|P5|Overall Study|Other (Progressive disease)|23
1076008|NCT02448810|3497694|P4|Overall Study|Other (Progressive disease)|3
1076009|NCT02448810|3497695|P3|Overall Study|Other (Progressive disease)|0
1076010|NCT02448810|3497696|P2|Overall Study|Other (Progressive disease)|2
1076011|NCT02448810|3497697|P1|Overall Study|Other (Progressive disease)|2
1076012|NCT02448810|3497690|P8|Overall Study|Death|0
1076013|NCT02448810|3497691|P7|Overall Study|Death|0
1076014|NCT02448810|3497692|P6|Overall Study|Death|0
1076015|NCT02448810|3497693|P5|Overall Study|Death|1
1076016|NCT02448810|3497694|P4|Overall Study|Death|0
1076017|NCT02448810|3497695|P3|Overall Study|Death|1
1076018|NCT02448810|3497696|P2|Overall Study|Death|0
1076019|NCT02448810|3497697|P1|Overall Study|Death|1
1076020|NCT02448810|3497690|P8|Overall Study|Other (study terminated by sponsor)|1
1076021|NCT02448810|3497691|P7|Overall Study|Other (study terminated by sponsor)|2
1076022|NCT02448810|3497692|P6|Overall Study|Other (study terminated by sponsor)|2
1076023|NCT02448810|3497693|P5|Overall Study|Other (study terminated by sponsor)|4
1076024|NCT02448810|3497694|P4|Overall Study|Other (study terminated by sponsor)|0
1076025|NCT02448810|3497695|P3|Overall Study|Other (study terminated by sponsor)|0
1076026|NCT02448810|3497696|P2|Overall Study|Other (study terminated by sponsor)|0
1076027|NCT02448810|3497697|P1|Overall Study|Other (study terminated by sponsor)|0
1076028|NCT02448810|3497690|P8|Overall Study|Withdrawal by Subject|2
1076029|NCT02448810|3497691|P7|Overall Study|Withdrawal by Subject|0
1076030|NCT02448810|3497692|P6|Overall Study|Withdrawal by Subject|5
1076031|NCT02448810|3497693|P5|Overall Study|Withdrawal by Subject|3
1076032|NCT02448810|3497694|P4|Overall Study|Withdrawal by Subject|0
1076033|NCT02448810|3497695|P3|Overall Study|Withdrawal by Subject|1
1076034|NCT02448810|3497696|P2|Overall Study|Withdrawal by Subject|0
1076035|NCT02448810|3497697|P1|Overall Study|Withdrawal by Subject|0
1076036|NCT02448810|3497690|P8|Overall Study|Adverse Event|0
1076037|NCT02448810|3497691|P7|Overall Study|Adverse Event|0
1076038|NCT02448810|3497692|P6|Overall Study|Adverse Event|0
1076039|NCT02448810|3497693|P5|Overall Study|Adverse Event|0
1076040|NCT02448810|3497694|P4|Overall Study|Adverse Event|0
1076041|NCT02448810|3497695|P3|Overall Study|Adverse Event|1
1076042|NCT02448810|3497696|P2|Overall Study|Adverse Event|0
1076043|NCT02448810|3497697|P1|Overall Study|Adverse Event|0
1076044|NCT02448563|3497767|P2|Overall Study|Withdrawal by Subject|1
1076045|NCT02448563|3497768|P1|Overall Study|Withdrawal by Subject|0
1076046|NCT02448563|3497767|P2|Overall Study|Lost to Follow-up|10
1076047|NCT02448563|3497768|P1|Overall Study|Lost to Follow-up|16
1076048|NCT02448537|3497790|P3|Overall Study|Withdrawal by Subject|1
1076049|NCT02448537|3497791|P2|Overall Study|Withdrawal by Subject|1
1076050|NCT02448537|3497792|P1|Overall Study|Withdrawal by Subject|1
1076051|NCT02447952|3497895|P1|Overall Study|Withdrawal by Subject|4
1076052|NCT02447952|3497895|P1|Overall Study|Physician Decision|1
1076053|NCT02447952|3497895|P1|Overall Study|Adverse Event|2
1076054|NCT02447848|3497947|P1|Overall Study|Withdrawal by Subject|4
1076055|NCT02447848|3497947|P1|Overall Study|Lack of Efficacy|4
1076056|NCT02447848|3497947|P1|Overall Study|Patient discharged|3
1076057|NCT02447458|3497959|P6|Overall Study|Other|0
1076058|NCT02447458|3497960|P5|Overall Study|Other|0
1076059|NCT02447458|3497961|P4|Overall Study|Other|0
1076060|NCT02447458|3497962|P3|Overall Study|Other|1
1076061|NCT02447458|3497963|P2|Overall Study|Other|0
1076062|NCT02447458|3497964|P1|Overall Study|Other|0
1076063|NCT02447432|3498062|P2|Epoch 001|Lost to Follow-up|3
1076064|NCT02447432|3498063|P1|Epoch 001|Lost to Follow-up|1
1076065|NCT02447432|3498062|P2|Epoch 001|Migrated/moved from study area|5
1076066|NCT02447432|3498063|P1|Epoch 001|Migrated/moved from study area|3
1076067|NCT02447432|3498062|P2|Epoch 001|Withdrawal by Subject|4
1076068|NCT02447432|3498063|P1|Epoch 001|Withdrawal by Subject|0
1076069|NCT02447432|3498062|P2|Epoch 001|Adverse Event|1
1076070|NCT02447432|3498063|P1|Epoch 001|Adverse Event|1
1076071|NCT02447328|3498095|P1|Overall Study|Withdrawal by Subject|1
1076072|NCT02447029|3498107|P2|Overall Study|Withdrawal by Subject|2
1076073|NCT02447029|3498108|P1|Overall Study|Withdrawal by Subject|3
1076074|NCT02446990|3498128|P2|Overall Study|Withdrawal by Subject|199
1076075|NCT02446990|3498129|P1|Overall Study|Withdrawal by Subject|231
1076076|NCT02446990|3498128|P2|Overall Study|Physician Decision|0
1076077|NCT02446990|3498129|P1|Overall Study|Physician Decision|1
1076078|NCT02446990|3498128|P2|Overall Study|Lost to Follow-up|1
1076079|NCT02446990|3498129|P1|Overall Study|Lost to Follow-up|3
1076080|NCT02446990|3498128|P2|Overall Study|Death|458
1076081|NCT02446990|3498129|P1|Overall Study|Death|485
1076082|NCT02446743|3498163|P2|Overall Study|Other|3
1076083|NCT02446743|3498164|P1|Overall Study|Other|2
1076084|NCT02446743|3498163|P2|Overall Study|Adverse Event|1
1076085|NCT02446743|3498164|P1|Overall Study|Adverse Event|1
1076086|NCT02446743|3498163|P2|Overall Study|Lost to Follow-up|0
1076087|NCT02446743|3498164|P1|Overall Study|Lost to Follow-up|1
1076088|NCT02446743|3498163|P2|Overall Study|Withdrawal by Subject|1
1076089|NCT02446743|3498164|P1|Overall Study|Withdrawal by Subject|1
1076090|NCT02446717|3498319|P5|Overall Study|Withdrew consent|0
1076091|NCT02446717|3498320|P4|Overall Study|Withdrew consent|1
1076092|NCT02446717|3498321|P3|Overall Study|Withdrew consent|0
1076093|NCT02446717|3498322|P2|Overall Study|Withdrew consent|0
1076094|NCT02446717|3498323|P1|Overall Study|Withdrew consent|0
1076095|NCT02446717|3498319|P5|Overall Study|Lost to Follow-up|1
1076096|NCT02446717|3498320|P4|Overall Study|Lost to Follow-up|0
1076097|NCT02446717|3498321|P3|Overall Study|Lost to Follow-up|1
1076098|NCT02446717|3498322|P2|Overall Study|Lost to Follow-up|1
1076099|NCT02446717|3498323|P1|Overall Study|Lost to Follow-up|0
1076100|NCT02446717|3498319|P5|Overall Study|Adverse Event|0
1076101|NCT02446717|3498320|P4|Overall Study|Adverse Event|0
1076102|NCT02446717|3498321|P3|Overall Study|Adverse Event|1
1076103|NCT02446717|3498322|P2|Overall Study|Adverse Event|0
1076104|NCT02446717|3498323|P1|Overall Study|Adverse Event|0
1076105|NCT02446171|3498404|P4|Overall Study|Withdrawal by Subject|0
1076106|NCT02446171|3498405|P3|Overall Study|Withdrawal by Subject|2
1076107|NCT02446171|3498406|P2|Overall Study|Withdrawal by Subject|0
1076108|NCT02446171|3498407|P1|Overall Study|Withdrawal by Subject|0
1076109|NCT02446015|3498478|P2|Overall Study|Withdrawal by Subject|0
1076110|NCT02446015|3498479|P1|Overall Study|Withdrawal by Subject|1
1076111|NCT02446015|3498478|P2|Overall Study|Adverse Event|1
1076112|NCT02446015|3498479|P1|Overall Study|Adverse Event|0
1076113|NCT02445755|3498503|P1|Overall Study|Screen Failure|5
1076114|NCT02445755|3498503|P1|Overall Study|Protocol Violation|6
1076115|NCT02445755|3498503|P1|Overall Study|Withdrawal by Subject|2
1076116|NCT02445573|3498512|P2|Overall Study|Lost to Follow-up|1
1076117|NCT02445573|3498513|P1|Overall Study|Lost to Follow-up|0
1076118|NCT02445573|3498512|P2|Overall Study|Withdrawal by Subject|1
1076119|NCT02445573|3498513|P1|Overall Study|Withdrawal by Subject|1
1076120|NCT02444533|3498621|P2|Overall Study|Only gave post-procedure complications|2
1076121|NCT02444533|3498622|P1|Overall Study|Only gave post-procedure complications|2
1076122|NCT02444533|3498621|P2|Overall Study|Not able to complete forms|2
1076123|NCT02444533|3498622|P1|Overall Study|Not able to complete forms|0
1076124|NCT02444182|3498638|P2|Overall Study|Lost to Follow-up|4
1076125|NCT02444182|3498639|P1|Overall Study|Lost to Follow-up|0
1076126|NCT02444182|3498638|P2|Overall Study|non-compliance|1
1076127|NCT02444182|3498639|P1|Overall Study|non-compliance|2
1076128|NCT02443883|3498662|P4|Overall Study|Randomized, but never treated|1
1076129|NCT02443883|3498663|P3|Overall Study|Randomized, but never treated|1
1076130|NCT02443883|3498664|P2|Overall Study|Randomized, but never treated|0
1076131|NCT02443883|3498665|P1|Overall Study|Randomized, but never treated|2
1076132|NCT02443883|3498662|P4|Overall Study|Withdrawal by Subject|1
1076133|NCT02443883|3498663|P3|Overall Study|Withdrawal by Subject|2
1076134|NCT02443883|3498664|P2|Overall Study|Withdrawal by Subject|0
1076135|NCT02443883|3498665|P1|Overall Study|Withdrawal by Subject|1
1076136|NCT02443883|3498662|P4|Overall Study|Physician Decision|3
1076137|NCT02443883|3498663|P3|Overall Study|Physician Decision|0
1076138|NCT02443883|3498664|P2|Overall Study|Physician Decision|1
1076139|NCT02443883|3498665|P1|Overall Study|Physician Decision|2
1076140|NCT02443883|3498662|P4|Overall Study|Lost to Follow-up|0
1076141|NCT02443883|3498663|P3|Overall Study|Lost to Follow-up|0
1076142|NCT02443883|3498664|P2|Overall Study|Lost to Follow-up|2
1076143|NCT02443883|3498665|P1|Overall Study|Lost to Follow-up|1
1076144|NCT02443883|3498662|P4|Overall Study|Adverse Event|2
1076145|NCT02443883|3498663|P3|Overall Study|Adverse Event|1
1076146|NCT02443883|3498664|P2|Overall Study|Adverse Event|2
1076147|NCT02443883|3498665|P1|Overall Study|Adverse Event|0
1076148|NCT02443740|3498704|P11|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1076149|NCT02443740|3498705|P10|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1076150|NCT02443740|3498706|P9|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1076151|NCT02443740|3498707|P8|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1076152|NCT02443740|3498708|P7|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1076153|NCT02443740|3498709|P6|Intervention Period 1 (3 Days)|Withdrawal by Subject|1
1076154|NCT02443740|3498710|P5|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1076155|NCT02443740|3498711|P4|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1076156|NCT02443740|3498712|P3|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1076157|NCT02443740|3498713|P2|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1076158|NCT02443740|3498714|P1|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1076159|NCT02443740|3498704|P11|Intervention Period 1 (3 Days)|Protocol Violation|0
1076160|NCT02443740|3498705|P10|Intervention Period 1 (3 Days)|Protocol Violation|0
1076161|NCT02443740|3498706|P9|Intervention Period 1 (3 Days)|Protocol Violation|0
1076162|NCT02443740|3498707|P8|Intervention Period 1 (3 Days)|Protocol Violation|0
1076163|NCT02443740|3498708|P7|Intervention Period 1 (3 Days)|Protocol Violation|1
1076164|NCT02443740|3498709|P6|Intervention Period 1 (3 Days)|Protocol Violation|0
1076165|NCT02443740|3498710|P5|Intervention Period 1 (3 Days)|Protocol Violation|0
1076166|NCT02443740|3498711|P4|Intervention Period 1 (3 Days)|Protocol Violation|0
1076167|NCT02443740|3498712|P3|Intervention Period 1 (3 Days)|Protocol Violation|0
1076168|NCT02443740|3498713|P2|Intervention Period 1 (3 Days)|Protocol Violation|0
1076169|NCT02443740|3498714|P1|Intervention Period 1 (3 Days)|Protocol Violation|1
1076170|NCT02443740|3498704|P11|Intervention Period 1 (3 Days)|Adverse Event|0
1076171|NCT02443740|3498705|P10|Intervention Period 1 (3 Days)|Adverse Event|0
1076172|NCT02443740|3498706|P9|Intervention Period 1 (3 Days)|Adverse Event|0
1076173|NCT02443740|3498707|P8|Intervention Period 1 (3 Days)|Adverse Event|0
1076174|NCT02443740|3498708|P7|Intervention Period 1 (3 Days)|Adverse Event|0
1076175|NCT02443740|3498709|P6|Intervention Period 1 (3 Days)|Adverse Event|1
1076176|NCT02443740|3498710|P5|Intervention Period 1 (3 Days)|Adverse Event|0
1076177|NCT02443740|3498711|P4|Intervention Period 1 (3 Days)|Adverse Event|0
1076178|NCT02443740|3498712|P3|Intervention Period 1 (3 Days)|Adverse Event|0
1076179|NCT02443740|3498713|P2|Intervention Period 1 (3 Days)|Adverse Event|0
1076180|NCT02443740|3498714|P1|Intervention Period 1 (3 Days)|Adverse Event|0
1076181|NCT02443402|3498910|P2|Overall Study|Screen Failure|2
1076182|NCT02443402|3498911|P1|Overall Study|Screen Failure|1
1076183|NCT02443402|3498910|P2|Overall Study|Withdrawal by Subject|1
1076184|NCT02443402|3498911|P1|Overall Study|Withdrawal by Subject|3
1076185|NCT02443103|3498971|P1|Overall Study|Noncompliance|1
1076186|NCT02443103|3498971|P1|Overall Study|Adverse Event|2
1076187|NCT02442830|3498978|P2|Overall Study|Technical Failure|1
1076188|NCT02442830|3498979|P1|Overall Study|Technical Failure|0
1076189|NCT02442804|3498989|P2|Overall Study|Adverse Event|0
1076190|NCT02442804|3498990|P1|Overall Study|Adverse Event|1
1076191|NCT02442804|3498989|P2|Overall Study|Withdrawal by Subject|1
1076192|NCT02442804|3498990|P1|Overall Study|Withdrawal by Subject|0
1076193|NCT02442349|3499029|P1|Overall Study|On-going Study at Data Cut-off|149
1076194|NCT02442349|3499029|P1|Overall Study|Withdrawal by Subject|8
1076195|NCT02442349|3499029|P1|Overall Study|Death|14
1076196|NCT02442310|3499034|P1|Overall Study|Withdrawal by Subject|1
1076197|NCT02442310|3499034|P1|Overall Study|Adverse Event|2
1076198|NCT02442284|3499056|P1|Overall Study|Not Specified|1
1076199|NCT02442284|3499056|P1|Overall Study|Lost to Follow-up|3
1076200|NCT02442284|3499056|P1|Overall Study|Withdrew Consent|2
1076201|NCT02442284|3499056|P1|Overall Study|Adverse Event|1
1076202|NCT02442271|3499063|P1|Overall Study|Not Specified|1
1076203|NCT02442271|3499063|P1|Overall Study|Lost to Follow-up|1
1076204|NCT02442271|3499063|P1|Overall Study|Withdrew Consent|1
1076205|NCT02442271|3499063|P1|Overall Study|Adverse Event|1
1076206|NCT02442206|3499089|P2|Period 2|Adverse Event|0
1076207|NCT02442206|3499090|P1|Period 2|Adverse Event|1
1076208|NCT02442206|3499089|P2|Period 1|COPD exacerbation|1
1076209|NCT02442206|3499090|P1|Period 1|COPD exacerbation|0
1076210|NCT02442206|3499089|P2|Period 1|withdrew consent|1
1076211|NCT02442206|3499090|P1|Period 1|withdrew consent|0
1076212|NCT02442206|3499089|P2|Period 1|Adverse Event|1
1076213|NCT02442206|3499090|P1|Period 1|Adverse Event|1
1076214|NCT02441946|3499122|P3|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
1076215|NCT02441946|3499123|P2|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
1076216|NCT02441946|3499124|P1|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9
1076217|NCT02441946|3499122|P3|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
1076218|NCT02441946|3499123|P2|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
1076219|NCT02441946|3499124|P1|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1
1076220|NCT02441946|3499122|P3|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
1076221|NCT02441946|3499123|P2|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
1076222|NCT02441946|3499124|P1|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1
1076223|NCT02441946|3499122|P3|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
1076224|NCT02441946|3499123|P2|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
1076225|NCT02441946|3499124|P1|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1
1076226|NCT02441946|3499122|P3|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
1076227|NCT02441946|3499123|P2|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
1076228|NCT02441946|3499124|P1|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15
1076229|NCT02441946|3499122|P3|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
1076230|NCT02441946|3499123|P2|Cycle 1 Period 1 (2 Weeks)|Never Treated|1
1076231|NCT02441946|3499124|P1|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
1076232|NCT02441946|3499122|P3|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
1076233|NCT02441946|3499123|P2|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3
1076234|NCT02441946|3499124|P1|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
1076235|NCT02441946|3499122|P3|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
1076236|NCT02441946|3499123|P2|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
1076237|NCT02441946|3499124|P1|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1
1076238|NCT02441946|3499122|P3|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0
1076239|NCT02441946|3499123|P2|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
1076240|NCT02441946|3499124|P1|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
1076241|NCT02441517|3499136|P1|Overall Study|Study Terminated by Sponsor|1
1076242|NCT02441517|3499136|P1|Overall Study|Withdrawal by Subject|2
1076243|NCT02441517|3499136|P1|Overall Study|Lost to Follow-up|1
1076244|NCT02441218|3499148|P2|Overall Study|Lost to Follow-up|1
1076245|NCT02441218|3499149|P1|Overall Study|Lost to Follow-up|2
1076246|NCT02441218|3499148|P2|Overall Study|Withdrawal by Subject|58
1076247|NCT02441218|3499149|P1|Overall Study|Withdrawal by Subject|73
1076248|NCT02441218|3499148|P2|Overall Study|Death|553
1076249|NCT02441218|3499149|P1|Overall Study|Death|503
1076250|NCT02441179|3499175|P2|Overall Study|Withdrawal by Subject|1
1076251|NCT02441179|3499176|P1|Overall Study|Withdrawal by Subject|1
1076252|NCT02441114|3499194|P1|Washout2|Withdrawal by Subject|4
1076253|NCT02439138|3499261|P1|Overall Study|PI decision to terminate the study|2
1076254|NCT02439138|3499261|P1|Overall Study|Adverse Event|1
1076255|NCT02438813|3499272|P1|Overall Study|Patients Not Treated/No EOT Visit|249
1076256|NCT02438813|3499272|P1|Overall Study|Study Ended by Sponsor|80
1076257|NCT02438813|3499272|P1|Overall Study|Patient Lost to Follow-Up|137
1076258|NCT02438813|3499272|P1|Overall Study|Patient Decision|59
1076259|NCT02438787|3499324|P3|Overall Study|Site terminated by sponsor|1
1076260|NCT02438787|3499325|P2|Overall Study|Site terminated by sponsor|0
1076261|NCT02438787|3499326|P1|Overall Study|Site terminated by sponsor|0
1076262|NCT02438787|3499324|P3|Overall Study|Other|0
1076263|NCT02438787|3499325|P2|Overall Study|Other|1
1076264|NCT02438787|3499326|P1|Overall Study|Other|0
1076265|NCT02438787|3499324|P3|Overall Study|Study discontinued by sponsor|69
1076266|NCT02438787|3499325|P2|Overall Study|Study discontinued by sponsor|72
1076267|NCT02438787|3499326|P1|Overall Study|Study discontinued by sponsor|64
1076268|NCT02438787|3499324|P3|Overall Study|Withdrawal by Subject|10
1076269|NCT02438787|3499325|P2|Overall Study|Withdrawal by Subject|7
1076270|NCT02438787|3499326|P1|Overall Study|Withdrawal by Subject|15
1076271|NCT02438787|3499324|P3|Overall Study|Protocol Violation|1
1076272|NCT02438787|3499325|P2|Overall Study|Protocol Violation|0
1076273|NCT02438787|3499326|P1|Overall Study|Protocol Violation|0
1076274|NCT02438787|3499324|P3|Overall Study|Lost to Follow-up|0
1076275|NCT02438787|3499325|P2|Overall Study|Lost to Follow-up|1
1076276|NCT02438787|3499326|P1|Overall Study|Lost to Follow-up|0
1076277|NCT02438787|3499324|P3|Overall Study|Lack of Efficacy|0
1076278|NCT02438787|3499325|P2|Overall Study|Lack of Efficacy|2
1076279|NCT02438787|3499326|P1|Overall Study|Lack of Efficacy|1
1076280|NCT02438787|3499324|P3|Overall Study|Adverse Event|2
1076281|NCT02438787|3499325|P2|Overall Study|Adverse Event|0
1076282|NCT02438787|3499326|P1|Overall Study|Adverse Event|1
1076283|NCT02438280|3499414|P2|Overall Study|Physician Decision|0
1076284|NCT02438280|3499415|P1|Overall Study|Physician Decision|1
1076285|NCT02438137|3499425|P2|Overall Study|Physician Decision|1
1076286|NCT02438137|3499426|P1|Overall Study|Physician Decision|0
1076287|NCT02438137|3499425|P2|Overall Study|Withdrawal by Subject|3
1076288|NCT02438137|3499426|P1|Overall Study|Withdrawal by Subject|4
1076289|NCT02438137|3499425|P2|Overall Study|Adverse Event|0
1076290|NCT02438137|3499426|P1|Overall Study|Adverse Event|1
1076291|NCT02438137|3499425|P2|Overall Study|Lost to Follow-up|2
1076292|NCT02438137|3499426|P1|Overall Study|Lost to Follow-up|3
1076293|NCT02437903|3499434|P1|Overall Study|Lost to Follow-up|3
1076294|NCT02437903|3499434|P1|Overall Study|Withdrawal by Subject|1
1076295|NCT02437903|3499434|P1|Overall Study|Adverse Event|1
1076296|NCT02437864|3499444|P2|Overall Study|Protocol Violation|0
1076297|NCT02437864|3499445|P1|Overall Study|Protocol Violation|4
1076298|NCT02437513|3499459|P1|Overall Study|Withdrawal by Subject|2
1076299|NCT02437409|3499484|P1|Overall Study|Screening failure|12
1076300|NCT02437409|3499484|P1|Overall Study|Withdrawal by Subject|3
1076301|NCT02437305|3499499|P2|Overall Study|Lost to Follow-up|12
1076302|NCT02437305|3499500|P1|Overall Study|Lost to Follow-up|18
1076303|NCT02437162|3499528|P3|Overall Study|Other|1
1076304|NCT02437162|3499529|P2|Overall Study|Other|0
1076305|NCT02437162|3499530|P1|Overall Study|Other|0
1076306|NCT02437162|3499528|P3|Overall Study|Death|0
1076307|NCT02437162|3499529|P2|Overall Study|Death|1
1076308|NCT02437162|3499530|P1|Overall Study|Death|0
1076309|NCT02437162|3499528|P3|Overall Study|Lost to Follow-up|1
1076310|NCT02437162|3499529|P2|Overall Study|Lost to Follow-up|0
1076311|NCT02437162|3499530|P1|Overall Study|Lost to Follow-up|1
1076312|NCT02437162|3499528|P3|Overall Study|Adverse Event|0
1076313|NCT02437162|3499529|P2|Overall Study|Adverse Event|1
1076314|NCT02437162|3499530|P1|Overall Study|Adverse Event|0
1076315|NCT02437162|3499528|P3|Overall Study|Withdrawal by Subject|9
1076316|NCT02437162|3499529|P2|Overall Study|Withdrawal by Subject|7
1076317|NCT02437162|3499530|P1|Overall Study|Withdrawal by Subject|13
1076318|NCT02437162|3499528|P3|Overall Study|Study discontinued by Sponsor|97
1076319|NCT02437162|3499529|P2|Overall Study|Study discontinued by Sponsor|98
1076320|NCT02437162|3499530|P1|Overall Study|Study discontinued by Sponsor|93
1076321|NCT02437162|3499528|P3|Overall Study|Randomized but not treated|1
1076322|NCT02437162|3499529|P2|Overall Study|Randomized but not treated|0
1076323|NCT02437162|3499530|P1|Overall Study|Randomized but not treated|0
1076324|NCT02437162|3499528|P3|Overall Study|Protocol Violation|0
1076325|NCT02437162|3499529|P2|Overall Study|Protocol Violation|1
1076326|NCT02437162|3499530|P1|Overall Study|Protocol Violation|0
1076327|NCT02436811|3499651|P3|Overall Study|Lost to Follow-up|7
1076328|NCT02436811|3499652|P2|Overall Study|Lost to Follow-up|9
1076329|NCT02436811|3499653|P1|Overall Study|Lost to Follow-up|2
1076330|NCT02436577|3499667|P6|Overall Study|Protocol Deviation|0
1076331|NCT02436577|3499668|P5|Overall Study|Protocol Deviation|0
1076332|NCT02436577|3499669|P4|Overall Study|Protocol Deviation|0
1076333|NCT02436577|3499670|P3|Overall Study|Protocol Deviation|0
1076334|NCT02436577|3499671|P2|Overall Study|Protocol Deviation|1
1076335|NCT02436577|3499672|P1|Overall Study|Protocol Deviation|0
1076336|NCT02436330|3499727|P2|Cohort 6|Withdrawal by Subject|1
1076337|NCT02436330|3499728|P1|Cohort 6|Withdrawal by Subject|1
1076338|NCT02436330|3499727|P2|Cohort 6|Lost to Follow-up|0
1076339|NCT02436330|3499728|P1|Cohort 6|Lost to Follow-up|2
1076340|NCT02436330|3499727|P2|Cohort 5|Withdrawal by Subject|2
1076341|NCT02436330|3499728|P1|Cohort 5|Withdrawal by Subject|3
1076342|NCT02436330|3499727|P2|Cohort 5|Lost to Follow-up|2
1076343|NCT02436330|3499728|P1|Cohort 5|Lost to Follow-up|3
1076344|NCT02436330|3499727|P2|Cohort 4|Withdrawal by Subject|0
1076345|NCT02436330|3499728|P1|Cohort 4|Withdrawal by Subject|1
1076346|NCT02436330|3499727|P2|Cohort 4|Lost to Follow-up|0
1076347|NCT02436330|3499728|P1|Cohort 4|Lost to Follow-up|1
1076348|NCT02436330|3499727|P2|Cohort 3|Withdrawal by Subject|0
1076349|NCT02436330|3499728|P1|Cohort 3|Withdrawal by Subject|4
1076350|NCT02436330|3499727|P2|Cohort 3|Lost to Follow-up|0
1076351|NCT02436330|3499728|P1|Cohort 3|Lost to Follow-up|1
1076352|NCT02436330|3499727|P2|Cohort 2|Withdrawal by Subject|3
1076353|NCT02436330|3499728|P1|Cohort 2|Withdrawal by Subject|2
1076354|NCT02436330|3499727|P2|Cohort 2|Lost to Follow-up|0
1076355|NCT02436330|3499728|P1|Cohort 2|Lost to Follow-up|2
1076356|NCT02436330|3499727|P2|Cohort 1|Withdrawal by Subject|1
1076357|NCT02436330|3499728|P1|Cohort 1|Withdrawal by Subject|0
1076358|NCT02436330|3499727|P2|Cohort 1|Lost to Follow-up|2
1076359|NCT02436330|3499728|P1|Cohort 1|Lost to Follow-up|5
1076360|NCT02436304|3499773|P3|Overall Study|Randomized in error didn’t meet I/E crit|1
1076361|NCT02436304|3499774|P2|Overall Study|Randomized in error didn’t meet I/E crit|0
1076362|NCT02436304|3499775|P1|Overall Study|Randomized in error didn’t meet I/E crit|0
1076363|NCT02436304|3499773|P3|Overall Study|Withdrawal by Subject|0
1076364|NCT02436304|3499774|P2|Overall Study|Withdrawal by Subject|1
1076365|NCT02436304|3499775|P1|Overall Study|Withdrawal by Subject|0
1076366|NCT02436304|3499773|P3|Overall Study|Lost to Follow-up|0
1076367|NCT02436304|3499774|P2|Overall Study|Lost to Follow-up|1
1076368|NCT02436304|3499775|P1|Overall Study|Lost to Follow-up|0
1076369|NCT02435966|3499804|P3|Overall Study|Withdrawal by Subject|0
1076370|NCT02435966|3499805|P2|Overall Study|Withdrawal by Subject|1
1076371|NCT02435966|3499806|P1|Overall Study|Withdrawal by Subject|0
1076372|NCT02435836|3499814|P1|Overall Study|AE of Worsening Schizophrenia|96
1076373|NCT02435836|3499814|P1|Overall Study|Met Withdrawal Criteria|7
1076374|NCT02435836|3499814|P1|Overall Study|Protocol Violation|6
1076375|NCT02435836|3499814|P1|Overall Study|Noncompliance|27
1076376|NCT02435836|3499814|P1|Overall Study|Sponsor discontinued trial|167
1076377|NCT02435836|3499814|P1|Overall Study|Adverse Event|44
1076378|NCT02435836|3499814|P1|Overall Study|Insufficient Clinical Response|26
1076379|NCT02435836|3499814|P1|Overall Study|Withdrawal by Subject|236
1076380|NCT02435836|3499814|P1|Overall Study|Lack of Efficacy|1
1076381|NCT02435836|3499814|P1|Overall Study|Lost to Follow-up|21
1076382|NCT02435277|3499845|P4|Overall Study|Withdrawal by Subject|0
1076383|NCT02435277|3499846|P3|Overall Study|Withdrawal by Subject|0
1076384|NCT02435277|3499847|P2|Overall Study|Withdrawal by Subject|0
1076385|NCT02435277|3499848|P1|Overall Study|Withdrawal by Subject|1
1076386|NCT02435277|3499845|P4|Overall Study|Adverse Event|0
1076387|NCT02435277|3499846|P3|Overall Study|Adverse Event|0
1076388|NCT02435277|3499847|P2|Overall Study|Adverse Event|1
1076389|NCT02435277|3499848|P1|Overall Study|Adverse Event|1
1076390|NCT02435147|3499862|P1|Overall Study|non-evaluable DXA scan|11
1076391|NCT02434939|3499869|P2|Overall Study|Adverse Event|1
1076392|NCT02434939|3499870|P1|Overall Study|Adverse Event|0
1076393|NCT02434939|3499869|P2|Overall Study|Withdrawal by Subject|0
1076394|NCT02434939|3499870|P1|Overall Study|Withdrawal by Subject|3
1076395|NCT02434939|3499869|P2|Overall Study|Lack of Efficacy|48
1076396|NCT02434939|3499870|P1|Overall Study|Lack of Efficacy|34
1076397|NCT02434471|3499997|P1|Overall Study|Physician Decision|9
1076398|NCT02433834|3500016|P1|Overall Study|Physician Decision|1
1076399|NCT02433834|3500016|P1|Overall Study|Adverse Event|6
1076400|NCT02433834|3500016|P1|Overall Study|Withdrawal by Subject|14
1076401|NCT02433834|3500016|P1|Overall Study|Lost to Follow-up|6
1076402|NCT02433834|3500016|P1|Overall Study|Protocol Violation|3
1076403|NCT02433834|3500016|P1|Overall Study|Protocol-specified criteria|7
1076404|NCT02433483|3500109|P1|Overall Study|Other antineoplastic therapy/HSCT|1
1076405|NCT02433483|3500109|P1|Overall Study|Unacceptable toxicity|1
1076406|NCT02433340|3500136|P4|Overall Study|Not Specified|0
1076407|NCT02433340|3500137|P3|Overall Study|Not Specified|0
1076408|NCT02433340|3500138|P2|Overall Study|Not Specified|1
1076409|NCT02433340|3500139|P1|Overall Study|Not Specified|0
1076410|NCT02433340|3500136|P4|Overall Study|Required Alternative/Prohibited Therapy|0
1076411|NCT02433340|3500137|P3|Overall Study|Required Alternative/Prohibited Therapy|0
1076412|NCT02433340|3500138|P2|Overall Study|Required Alternative/Prohibited Therapy|0
1076413|NCT02433340|3500139|P1|Overall Study|Required Alternative/Prohibited Therapy|1
1076414|NCT02433340|3500136|P4|Overall Study|Lost to Follow-up|0
1076415|NCT02433340|3500137|P3|Overall Study|Lost to Follow-up|0
1076416|NCT02433340|3500138|P2|Overall Study|Lost to Follow-up|1
1076417|NCT02433340|3500139|P1|Overall Study|Lost to Follow-up|0
1076418|NCT02433340|3500136|P4|Overall Study|Withdrawal by Subject|2
1076419|NCT02433340|3500137|P3|Overall Study|Withdrawal by Subject|1
1076420|NCT02433340|3500138|P2|Overall Study|Withdrawal by Subject|0
1076421|NCT02433340|3500139|P1|Overall Study|Withdrawal by Subject|1
1076422|NCT02433340|3500136|P4|Overall Study|Adverse Event|0
1076423|NCT02433340|3500137|P3|Overall Study|Adverse Event|1
1076424|NCT02433340|3500138|P2|Overall Study|Adverse Event|0
1076425|NCT02433340|3500139|P1|Overall Study|Adverse Event|0
1076426|NCT02432105|3501052|P3|Overall Study|Randomized in error|2
1076427|NCT02432105|3501053|P2|Overall Study|Randomized in error|0
1076428|NCT02432105|3501054|P1|Overall Study|Randomized in error|0
1076429|NCT02432105|3501052|P3|Overall Study|Culture positive for yeast|0
1076430|NCT02432105|3501053|P2|Overall Study|Culture positive for yeast|1
1076431|NCT02432105|3501054|P1|Overall Study|Culture positive for yeast|0
1076432|NCT02432105|3501052|P3|Overall Study|Withdrawal by Subject|1
1076433|NCT02432105|3501053|P2|Overall Study|Withdrawal by Subject|0
1076434|NCT02432105|3501054|P1|Overall Study|Withdrawal by Subject|1
1076435|NCT02432105|3501052|P3|Overall Study|Lost to Follow-up|0
1076436|NCT02432105|3501053|P2|Overall Study|Lost to Follow-up|1
1076437|NCT02432105|3501054|P1|Overall Study|Lost to Follow-up|1
1076438|NCT02432040|3501071|P2|Overall Study|Physician Decision|1
1076439|NCT02432040|3501072|P1|Overall Study|Physician Decision|1
1076440|NCT02432040|3501071|P2|Overall Study|Lost to Follow-up|5
1076441|NCT02432040|3501072|P1|Overall Study|Lost to Follow-up|4
1076442|NCT02432040|3501071|P2|Overall Study|Lack of Efficacy|0
1076443|NCT02432040|3501072|P1|Overall Study|Lack of Efficacy|3
1076444|NCT02431468|3501149|P3|Overall Study|noncompliance, investigator termination,|2
1076445|NCT02431468|3501150|P2|Overall Study|noncompliance, investigator termination,|2
1076446|NCT02431468|3501151|P1|Overall Study|noncompliance, investigator termination,|2
1076447|NCT02431468|3501149|P3|Overall Study|Withdrawal by Subject|2
1076448|NCT02431468|3501150|P2|Overall Study|Withdrawal by Subject|12
1076449|NCT02431468|3501151|P1|Overall Study|Withdrawal by Subject|4
1076450|NCT02431468|3501149|P3|Overall Study|Adverse Event|5
1076451|NCT02431468|3501150|P2|Overall Study|Adverse Event|4
1076452|NCT02431468|3501151|P1|Overall Study|Adverse Event|2
1076453|NCT02431247|3501204|P2|Overall Study|Non-compliance with study drug|0
1076454|NCT02431247|3501205|P1|Overall Study|Non-compliance with study drug|1
1076455|NCT02431247|3501204|P2|Overall Study|Ongoing|336
1076456|NCT02431247|3501205|P1|Overall Study|Ongoing|339
1076457|NCT02431247|3501204|P2|Overall Study|Other|1
1076458|NCT02431247|3501205|P1|Overall Study|Other|2
1076459|NCT02431247|3501204|P2|Overall Study|Withdrawal by Subject|6
1076460|NCT02431247|3501205|P1|Overall Study|Withdrawal by Subject|4
1076461|NCT02431247|3501204|P2|Overall Study|Physician Decision|0
1076462|NCT02431247|3501205|P1|Overall Study|Physician Decision|3
1076463|NCT02431247|3501204|P2|Overall Study|Adverse Event|15
1076464|NCT02431247|3501205|P1|Overall Study|Adverse Event|8
1076465|NCT02431247|3501204|P2|Overall Study|Lost to Follow-up|5
1076466|NCT02431247|3501205|P1|Overall Study|Lost to Follow-up|5
1076467|NCT02430870|3501267|P8|Part 2|Other Reason Not Specified|1
1076468|NCT02430870|3501268|P7|Part 2|Other Reason Not Specified|0
1076469|NCT02430870|3501269|P6|Part 2|Other Reason Not Specified|0
1076470|NCT02430870|3501270|P5|Part 2|Other Reason Not Specified|0
1076471|NCT02430870|3501271|P4|Part 2|Other Reason Not Specified|0
1076472|NCT02430870|3501272|P3|Part 2|Other Reason Not Specified|0
1076473|NCT02430870|3501273|P2|Part 2|Other Reason Not Specified|0
1076474|NCT02430870|3501274|P1|Part 2|Other Reason Not Specified|0
1076475|NCT02430870|3501267|P8|Part 2|Voluntary Withdrawal|0
1076476|NCT02430870|3501268|P7|Part 2|Voluntary Withdrawal|1
1076477|NCT02430870|3501269|P6|Part 2|Voluntary Withdrawal|0
1076478|NCT02430870|3501270|P5|Part 2|Voluntary Withdrawal|0
1076479|NCT02430870|3501271|P4|Part 2|Voluntary Withdrawal|0
1076480|NCT02430870|3501272|P3|Part 2|Voluntary Withdrawal|0
1076481|NCT02430870|3501273|P2|Part 2|Voluntary Withdrawal|0
1076482|NCT02430870|3501274|P1|Part 2|Voluntary Withdrawal|0
1076483|NCT02430532|3501348|P2|Overall Study|Adverse Event|1
1076484|NCT02430532|3501349|P1|Overall Study|Adverse Event|0
1076485|NCT02430532|3501348|P2|Overall Study|Consent Withdrawn|2
1076486|NCT02430532|3501349|P1|Overall Study|Consent Withdrawn|0
1076487|NCT02430532|3501348|P2|Overall Study|Sponsor Decision to Stop Study Early|25
1076488|NCT02430532|3501349|P1|Overall Study|Sponsor Decision to Stop Study Early|30
1076489|NCT02430311|3501376|P2|Part B|Death|0
1076491|NCT02430311|3501376|P2|Part B|Adverse Event|0
1076492|NCT02430311|3501377|P1|Part B|Adverse Event|1
1076493|NCT02430311|3501376|P2|Part B|Withdrawal by Subject|2
1076494|NCT02430311|3501377|P1|Part B|Withdrawal by Subject|2
1076495|NCT02430311|3501376|P2|Part B|Meet study-specific withdrawal criteria|6
1076496|NCT02430311|3501377|P1|Part B|Meet study-specific withdrawal criteria|6
1076497|NCT02430311|3501376|P2|Part A|Withdrawal by Subject|0
1076498|NCT02430311|3501377|P1|Part A|Withdrawal by Subject|1
1076499|NCT02430311|3501376|P2|Part A|Adverse Event|1
1076500|NCT02430311|3501377|P1|Part A|Adverse Event|0
1076501|NCT02429791|3501425|P2|Overall Study|Withdrawal by Subject|7
1076502|NCT02429791|3501426|P1|Overall Study|Withdrawal by Subject|3
1076503|NCT02429791|3501425|P2|Overall Study|Protocol Violation|4
1076504|NCT02429791|3501426|P1|Overall Study|Protocol Violation|1
1076505|NCT02429791|3501425|P2|Overall Study|Lost to Follow-up|2
1076506|NCT02429791|3501426|P1|Overall Study|Lost to Follow-up|1
1076507|NCT02429791|3501425|P2|Overall Study|Lack of Efficacy|1
1076508|NCT02429791|3501426|P1|Overall Study|Lack of Efficacy|2
1076509|NCT02429791|3501425|P2|Overall Study|Physician Decision|2
1076510|NCT02429791|3501426|P1|Overall Study|Physician Decision|0
1076511|NCT02429791|3501425|P2|Overall Study|Adverse Event|2
1076512|NCT02429791|3501426|P1|Overall Study|Adverse Event|6
1076513|NCT02429258|3501498|P2|Overall Study|Protocol Violation|1
1076514|NCT02429258|3501499|P1|Overall Study|Protocol Violation|0
1076515|NCT02429258|3501498|P2|Overall Study|Withdrawal by Subject|0
1076516|NCT02429258|3501499|P1|Overall Study|Withdrawal by Subject|2
1076517|NCT02428699|3501525|P2|Washout Period 1|Screen Failure|2
1076518|NCT02428699|3501526|P1|Washout Period 1|Screen Failure|1
1076519|NCT02428413|3501565|P2|Overall Study|Nurse Refusal|0
1076520|NCT02428413|3501566|P1|Overall Study|Nurse Refusal|1
1076521|NCT02428413|3501565|P2|Overall Study|Missed Cases|2
1076522|NCT02428413|3501566|P1|Overall Study|Missed Cases|1
1076523|NCT02428413|3501565|P2|Overall Study|Case Cancelled|0
1076524|NCT02428413|3501566|P1|Overall Study|Case Cancelled|2
1076525|NCT02428413|3501565|P2|Overall Study|Protocol Violation|2
1076526|NCT02428413|3501566|P1|Overall Study|Protocol Violation|1
1076527|NCT02428413|3501565|P2|Overall Study|Device to measure WAG malfunctioned|5
1076528|NCT02428413|3501566|P1|Overall Study|Device to measure WAG malfunctioned|3
1076529|NCT02428231|3501580|P2|Overall Study|Adverse Event|0
1076530|NCT02428231|3501581|P1|Overall Study|Adverse Event|3
1076531|NCT02428231|3501580|P2|Overall Study|Required Symptomatic Therapy|1
1076532|NCT02428231|3501581|P1|Overall Study|Required Symptomatic Therapy|0
1076533|NCT02428231|3501580|P2|Overall Study|Not Specified|16
1076534|NCT02428231|3501581|P1|Overall Study|Not Specified|10
1076535|NCT02427984|3501598|P3|Overall Study|Lost to Follow-up|18
1076536|NCT02427984|3501599|P2|Overall Study|Lost to Follow-up|5
1076537|NCT02427984|3501600|P1|Overall Study|Lost to Follow-up|13
1076538|NCT02427607|3501640|P1|Overall Study|Withdrawal by Subject|1
1076539|NCT02427477|3501646|P2|Period 1|Adverse Event|0
1076540|NCT02427477|3501647|P1|Period 1|Adverse Event|1
1076541|NCT02427399|3501660|P5|Overall Study|Protocol Violation|15
1076542|NCT02427399|3501661|P4|Overall Study|Protocol Violation|18
1076543|NCT02427399|3501662|P3|Overall Study|Protocol Violation|12
1076544|NCT02427399|3501663|P2|Overall Study|Protocol Violation|16
1076545|NCT02427399|3501664|P1|Overall Study|Protocol Violation|14
1076546|NCT02426541|3501688|P2|Overall Study|Protocol Violation|0
1076547|NCT02426541|3501689|P1|Overall Study|Protocol Violation|1
1076548|NCT02425826|3501706|P3|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1
1076549|NCT02425826|3501707|P2|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
1076550|NCT02425826|3501708|P1|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
1076551|NCT02425826|3501706|P3|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1
1076552|NCT02425826|3501707|P2|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0
1076553|NCT02425826|3501708|P1|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8
1076554|NCT02425826|3501706|P3|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4
1076555|NCT02425826|3501707|P2|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0
1076556|NCT02425826|3501708|P1|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12
1076557|NCT02425826|3501706|P3|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6
1076558|NCT02425826|3501707|P2|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0
1076559|NCT02425826|3501708|P1|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8
1076560|NCT02425826|3501706|P3|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2
1076561|NCT02425826|3501707|P2|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0
1076562|NCT02425826|3501708|P1|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7
1076563|NCT02425826|3501706|P3|Placebo-controlled Phase (Week 0 - 16)|Other|0
1076564|NCT02425826|3501707|P2|Placebo-controlled Phase (Week 0 - 16)|Other|1
1076565|NCT02425826|3501708|P1|Placebo-controlled Phase (Week 0 - 16)|Other|3
1076566|NCT02425826|3501706|P3|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0
1076567|NCT02425826|3501707|P2|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4
1076568|NCT02425826|3501708|P1|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10
1076569|NCT02425826|3501706|P3|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0
1076570|NCT02425826|3501707|P2|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1
1076571|NCT02425826|3501708|P1|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9
1076572|NCT02425826|3501706|P3|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
1076573|NCT02425826|3501707|P2|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1
1076574|NCT02425826|3501708|P1|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
1076575|NCT02425826|3501706|P3|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0
1076576|NCT02425826|3501707|P2|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2
1076577|NCT02425826|3501708|P1|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5
1076578|NCT02425111|3501762|P1|Part B: Treatment Extension Period|Lack of Efficacy|7
1076579|NCT02425111|3501762|P1|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3
1076580|NCT02425111|3501762|P1|Part A: Treatment Period|Lost to Follow-up|2
1076581|NCT02425111|3501762|P1|Part A: Treatment Period|Voluntary Withdrawal|4
1076582|NCT02425111|3501762|P1|Part A: Treatment Period|Lack of Efficacy|15
1076583|NCT02425111|3501762|P1|Part A: Treatment Period|Pretreatment Event/Adverse Event|2
1076584|NCT02424734|3501784|P3|Overall Study|Treatment stopped to be discharged home|0
1076585|NCT02424734|3501785|P2|Overall Study|Treatment stopped to be discharged home|2
1076586|NCT02424734|3501786|P1|Overall Study|Treatment stopped to be discharged home|2
1076587|NCT02424591|3501805|P2|Overall Study|Protocol Violation|3
1076588|NCT02424591|3501806|P1|Overall Study|Protocol Violation|2
1076589|NCT02424578|3501818|P2|Overall Study|Withdrawal by Subject|1
1076590|NCT02424578|3501819|P1|Overall Study|Withdrawal by Subject|0
1076591|NCT02424565|3501825|P2|Period 1 (D0)|Protocol Violation|1
1076592|NCT02424565|3501826|P1|Period 1 (D0)|Protocol Violation|0
1076593|NCT02424344|3501845|P2|Overall Study|Adverse Event|8
1076594|NCT02424344|3501846|P1|Overall Study|Adverse Event|4
1076595|NCT02424344|3501845|P2|Overall Study|Lost to Follow-up|0
1076596|NCT02424344|3501846|P1|Overall Study|Lost to Follow-up|1
1076597|NCT02424344|3501845|P2|Overall Study|Withdrawal by Subject|1
1076598|NCT02424344|3501846|P1|Overall Study|Withdrawal by Subject|2
1076599|NCT02424344|3501845|P2|Overall Study|Lack of Efficacy|1
1076600|NCT02424344|3501846|P1|Overall Study|Lack of Efficacy|0
1076601|NCT02424149|3501858|P2|Overall Study|Withdrawal by Subject|1
1076602|NCT02424149|3501859|P1|Overall Study|Withdrawal by Subject|0
1076603|NCT02424149|3501858|P2|Overall Study|surgery cancelled|0
1076604|NCT02424149|3501859|P1|Overall Study|surgery cancelled|2
1076605|NCT02424097|3501875|P2|Overall Study|Lost to Follow-up|2
1076606|NCT02424097|3501876|P1|Overall Study|Lost to Follow-up|1
1076607|NCT02423798|3501931|P1|Overall Study|Withdrawal by Subject|3
1076608|NCT02423291|3501997|P1|Overall Study|Adverse Event|1
1076609|NCT02423291|3501997|P1|Overall Study|Lack of Efficacy|14
1076610|NCT02423109|3502012|P2|Lens 1|Adverse Event|0
1076611|NCT02423109|3502013|P1|Lens 1|Adverse Event|1
1076612|NCT02422797|3502046|P2|Overall Study|Withdrawal by Subject|7
1076613|NCT02422797|3502047|P1|Overall Study|Withdrawal by Subject|2
1076614|NCT02422797|3502046|P2|Overall Study|Other; Reached stopping criteria|1
1076615|NCT02422797|3502047|P1|Overall Study|Other; Reached stopping criteria|1
1076616|NCT02422797|3502046|P2|Overall Study|Protocol Violation|3
1076617|NCT02422797|3502047|P1|Overall Study|Protocol Violation|0
1076618|NCT02422797|3502046|P2|Overall Study|Lost to Follow-up|1
1076619|NCT02422797|3502047|P1|Overall Study|Lost to Follow-up|1
1076620|NCT02422797|3502046|P2|Overall Study|Lack of Efficacy|2
1076621|NCT02422797|3502047|P1|Overall Study|Lack of Efficacy|1
1076622|NCT02422797|3502046|P2|Overall Study|Physician Decision|1
1076623|NCT02422797|3502047|P1|Overall Study|Physician Decision|0
1076624|NCT02422797|3502046|P2|Overall Study|Adverse Event|1
1076625|NCT02422797|3502047|P1|Overall Study|Adverse Event|11
1076626|NCT02422615|3502119|P2|Overall Study|Technical problems|1
1076627|NCT02422615|3502120|P1|Overall Study|Technical problems|0
1076628|NCT02422615|3502119|P2|Overall Study|Protocol Violation|1
1076629|NCT02422615|3502120|P1|Overall Study|Protocol Violation|1
1076630|NCT02422615|3502119|P2|Overall Study|Death|0
1076631|NCT02422615|3502120|P1|Overall Study|Death|2
1076632|NCT02422615|3502119|P2|Overall Study|Subject/guardian decision|5
1076633|NCT02422615|3502120|P1|Overall Study|Subject/guardian decision|21
1076634|NCT02422615|3502119|P2|Overall Study|Physician Decision|7
1076635|NCT02422615|3502120|P1|Overall Study|Physician Decision|22
1076636|NCT02422615|3502119|P2|Overall Study|Adverse Event|10
1076637|NCT02422615|3502120|P1|Overall Study|Adverse Event|41
1076638|NCT02422615|3502119|P2|Overall Study|Progressive disease|142
1076639|NCT02422615|3502120|P1|Overall Study|Progressive disease|193
1076640|NCT02422303|3502137|P2|Overall Study|Lost to Follow-up|1
1076641|NCT02422303|3502138|P1|Overall Study|Lost to Follow-up|1
1076642|NCT02421419|3502147|P3|Overall Study|Physician Decision|1
1076643|NCT02421419|3502148|P2|Overall Study|Physician Decision|0
1076644|NCT02421419|3502149|P1|Overall Study|Physician Decision|0
1076645|NCT02421120|3502234|P1|Overall Study|Adverse Event|1
1076646|NCT02420821|3502276|P2|Overall Study|Death|116
1076647|NCT02420821|3502277|P1|Overall Study|Death|129
1076648|NCT02420821|3502276|P2|Overall Study|Withdrawal by Subject|17
1076649|NCT02420821|3502277|P1|Overall Study|Withdrawal by Subject|31
1076650|NCT02420821|3502276|P2|Overall Study|Physician Decision|2
1076651|NCT02420821|3502277|P1|Overall Study|Physician Decision|5
1076652|NCT02420821|3502276|P2|Overall Study|Non-compliance|2
1076653|NCT02420821|3502277|P1|Overall Study|Non-compliance|1
1076654|NCT02420821|3502276|P2|Overall Study|Lost to Follow-up|0
1076655|NCT02420821|3502277|P1|Overall Study|Lost to Follow-up|2
1076656|NCT02420327|3502345|P1|Overall Study|Protocol Violation|1
1076657|NCT02420327|3502345|P1|Overall Study|Lost to Follow-up|1
1076658|NCT02420327|3502345|P1|Overall Study|Withdrawal by Subject|6
1076659|NCT02420327|3502345|P1|Overall Study|Pregnancy|1
1076660|NCT02420327|3502345|P1|Overall Study|Adverse Event|7
1076661|NCT02420262|3502381|P2|Overall Study|Unclassified|1
1076662|NCT02420262|3502382|P1|Overall Study|Unclassified|0
1076663|NCT02420262|3502381|P2|Overall Study|Withdrawal by Subject|4
1076664|NCT02420262|3502382|P1|Overall Study|Withdrawal by Subject|1
1076665|NCT02420262|3502381|P2|Overall Study|Adverse Event|0
1076666|NCT02420262|3502382|P1|Overall Study|Adverse Event|1
1076667|NCT02420093|3502408|P2|Overall Study|Withdrawal by Subject|1
1076668|NCT02420093|3502409|P1|Overall Study|Withdrawal by Subject|1
1076669|NCT02419937|3502452|P2|Overall Study|Lost to Follow-up|0
1076670|NCT02419937|3502453|P1|Overall Study|Lost to Follow-up|1
1076671|NCT02419755|3502461|P2|Overall Study|Withdrawal by Subject|0
1076672|NCT02419755|3502462|P1|Overall Study|Withdrawal by Subject|1
1076673|NCT02419755|3502461|P2|Overall Study|Ineligible|0
1076674|NCT02419755|3502462|P1|Overall Study|Ineligible|1
1076675|NCT02419755|3502461|P2|Overall Study|Relapse|1
1076676|NCT02419755|3502462|P1|Overall Study|Relapse|0
1076677|NCT02419755|3502461|P2|Overall Study|Death|3
1076678|NCT02419755|3502462|P1|Overall Study|Death|1
1076679|NCT02419612|3502488|P2|Overall Study|Subject moved out of state|1
1076680|NCT02419612|3502489|P1|Overall Study|Subject moved out of state|0
1076681|NCT02419612|3502488|P2|Overall Study|Worsening of liver function|1
1076682|NCT02419612|3502489|P1|Overall Study|Worsening of liver function|0
1076683|NCT02419612|3502488|P2|Overall Study|Noncompliance With Study Drug|2
1076684|NCT02419612|3502489|P1|Overall Study|Noncompliance With Study Drug|0
1076685|NCT02419612|3502488|P2|Overall Study|Subject Request To Discontinue Treatment|1
1076686|NCT02419612|3502489|P1|Overall Study|Subject Request To Discontinue Treatment|1
1076687|NCT02419612|3502488|P2|Overall Study|Withdrawal by Subject|9
1076688|NCT02419612|3502489|P1|Overall Study|Withdrawal by Subject|9
1076689|NCT02419612|3502488|P2|Overall Study|Lost to Follow-up|6
1076690|NCT02419612|3502489|P1|Overall Study|Lost to Follow-up|6
1076691|NCT02419612|3502488|P2|Overall Study|Death|2
1076692|NCT02419612|3502489|P1|Overall Study|Death|0
1076693|NCT02419612|3502488|P2|Overall Study|Adverse Event|1
1076694|NCT02419612|3502489|P1|Overall Study|Adverse Event|1
1076695|NCT02419573|3502505|P2|Overall Study|Withdrawal by Subject|0
1076696|NCT02419573|3502506|P1|Overall Study|Withdrawal by Subject|1
1076697|NCT02419573|3502505|P2|Overall Study|Lost to Follow-up|0
1076698|NCT02419573|3502506|P1|Overall Study|Lost to Follow-up|3
1076699|NCT02419508|3502532|P2|Overall Study|Other - Reason not specified|1
1076700|NCT02419508|3502533|P1|Overall Study|Other - Reason not specified|0
1076701|NCT02419508|3502532|P2|Overall Study|Withdrawal by Subject|0
1076702|NCT02419508|3502533|P1|Overall Study|Withdrawal by Subject|1
1076703|NCT02419508|3502532|P2|Overall Study|Adverse Event|3
1076704|NCT02419508|3502533|P1|Overall Study|Adverse Event|9
1076705|NCT02419469|3502551|P1|Overall Study|Withdrawal by Subject|1
1076706|NCT02419313|3502555|P2|Second Intervention|Lost to Follow-up|0
1076707|NCT02419313|3502556|P1|Second Intervention|Lost to Follow-up|1
1076708|NCT02419313|3502555|P2|First Intervention|Lost to Follow-up|0
1076709|NCT02419313|3502556|P1|First Intervention|Lost to Follow-up|2
1076710|NCT02419001|3502568|P2|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0
1076711|NCT02419001|3502569|P1|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1
1076712|NCT02418468|3502597|P2|Overall Study|Withdrawal of informed consent|1
1076713|NCT02418468|3502598|P1|Overall Study|Withdrawal of informed consent|1
1076714|NCT02418468|3502597|P2|Overall Study|Adverse Event|0
1076715|NCT02418468|3502598|P1|Overall Study|Adverse Event|1
1076716|NCT02417961|3502648|P1|Overall Study|Withdrawal by Subject|2
1076717|NCT02417961|3502648|P1|Overall Study|Lost to Follow-up|1
1076718|NCT02417961|3502648|P1|Overall Study|Adverse Event|1
1076719|NCT02417935|3502660|P2|Treatment Period|Physician Decision|1
1076720|NCT02417935|3502661|P1|Treatment Period|Physician Decision|3
1076721|NCT02417935|3502660|P2|Treatment Period|Withdrawal by Subject|3
1076722|NCT02417935|3502661|P1|Treatment Period|Withdrawal by Subject|3
1076723|NCT02417935|3502660|P2|Treatment Period|Protocol Violation|1
1076724|NCT02417935|3502661|P1|Treatment Period|Protocol Violation|2
1076725|NCT02417935|3502660|P2|Treatment Period|Entry Criteria not met|1
1076726|NCT02417935|3502661|P1|Treatment Period|Entry Criteria not met|0
1076727|NCT02417935|3502660|P2|Treatment Period|Lost to Follow-up|0
1076728|NCT02417935|3502661|P1|Treatment Period|Lost to Follow-up|1
1076729|NCT02417935|3502660|P2|Treatment Period|Adverse Event|10
1076730|NCT02417935|3502661|P1|Treatment Period|Adverse Event|12
1076731|NCT02417753|3502685|P1|Overall Study|Death|1
1076732|NCT02417532|3502695|P1|Overall Study|unable to complete exercises|4
1076733|NCT02417233|3502756|P3|Overall Study|Mentally unstable|0
1076734|NCT02417233|3502757|P2|Overall Study|Mentally unstable|1
1076735|NCT02417233|3502758|P1|Overall Study|Mentally unstable|0
1076736|NCT02417233|3502756|P3|Overall Study|Relocation out of study area|1
1076737|NCT02417233|3502757|P2|Overall Study|Relocation out of study area|0
1076738|NCT02417233|3502758|P1|Overall Study|Relocation out of study area|1
1076739|NCT02417233|3502756|P3|Overall Study|Withdrawal by Subject|8
1076740|NCT02417233|3502757|P2|Overall Study|Withdrawal by Subject|1
1076741|NCT02417233|3502758|P1|Overall Study|Withdrawal by Subject|2
1076742|NCT02417233|3502756|P3|Overall Study|Protocol Violation|2
1076743|NCT02417233|3502757|P2|Overall Study|Protocol Violation|0
1076744|NCT02417233|3502758|P1|Overall Study|Protocol Violation|2
1076745|NCT02417233|3502756|P3|Overall Study|Lost to Follow-up|34
1076746|NCT02417233|3502757|P2|Overall Study|Lost to Follow-up|39
1076747|NCT02417233|3502758|P1|Overall Study|Lost to Follow-up|27
1076748|NCT02417233|3502756|P3|Overall Study|Death|14
1076749|NCT02417233|3502757|P2|Overall Study|Death|10
1076750|NCT02417233|3502758|P1|Overall Study|Death|4
1076751|NCT02416934|3502807|P2|Overall Study|re-operation|0
1076752|NCT02416934|3502808|P1|Overall Study|re-operation|1
1076753|NCT02416934|3502807|P2|Overall Study|surgery started late|1
1076754|NCT02416934|3502808|P1|Overall Study|surgery started late|0
1076755|NCT02416934|3502807|P2|Overall Study|Protocol Violation|1
1076756|NCT02416934|3502808|P1|Overall Study|Protocol Violation|0
1076757|NCT02416934|3502807|P2|Overall Study|recruited during continuing renewal proc|1
1076758|NCT02416934|3502808|P1|Overall Study|recruited during continuing renewal proc|0
1076759|NCT02416934|3502807|P2|Overall Study|Withdrawal by Subject|0
1076760|NCT02416934|3502808|P1|Overall Study|Withdrawal by Subject|1
1076761|NCT02416934|3502807|P2|Overall Study|Lost to Follow-up|2
1076762|NCT02416934|3502808|P1|Overall Study|Lost to Follow-up|0
1076763|NCT02416934|3502807|P2|Overall Study|given steroids|2
1076764|NCT02416934|3502808|P1|Overall Study|given steroids|1
1076765|NCT02416180|3502818|P1|Overall Study|Withdrawal by Subject|1
1076766|NCT02415959|3502830|P5|Overall Study|Protocol Violation|0
1076767|NCT02415959|3502831|P4|Overall Study|Protocol Violation|1
1076768|NCT02415959|3502832|P3|Overall Study|Protocol Violation|0
1076769|NCT02415959|3502833|P2|Overall Study|Protocol Violation|0
1076770|NCT02415959|3502834|P1|Overall Study|Protocol Violation|0
1076771|NCT02415959|3502830|P5|Overall Study|Adverse Event|0
1076772|NCT02415959|3502831|P4|Overall Study|Adverse Event|0
1076773|NCT02415959|3502832|P3|Overall Study|Adverse Event|0
1076774|NCT02415959|3502833|P2|Overall Study|Adverse Event|1
1076775|NCT02415959|3502834|P1|Overall Study|Adverse Event|0
1076776|NCT02415595|3502899|P4|Overall Study|Other|0
1076777|NCT02415595|3502900|P3|Overall Study|Other|1
1076778|NCT02415595|3502901|P2|Overall Study|Other|1
1076779|NCT02415595|3502902|P1|Overall Study|Other|0
1076780|NCT02415595|3502899|P4|Overall Study|Withdrawal by Subject|3
1076781|NCT02415595|3502900|P3|Overall Study|Withdrawal by Subject|1
1076782|NCT02415595|3502901|P2|Overall Study|Withdrawal by Subject|0
1076783|NCT02415595|3502902|P1|Overall Study|Withdrawal by Subject|4
1076784|NCT02415595|3502899|P4|Overall Study|Reached stopping criteria|0
1076785|NCT02415595|3502900|P3|Overall Study|Reached stopping criteria|1
1076786|NCT02415595|3502901|P2|Overall Study|Reached stopping criteria|1
1076787|NCT02415595|3502902|P1|Overall Study|Reached stopping criteria|0
1076788|NCT02415595|3502899|P4|Overall Study|Poor/Non-compliance|0
1076789|NCT02415595|3502900|P3|Overall Study|Poor/Non-compliance|1
1076790|NCT02415595|3502901|P2|Overall Study|Poor/Non-compliance|0
1076791|NCT02415595|3502902|P1|Overall Study|Poor/Non-compliance|1
1076792|NCT02415595|3502899|P4|Overall Study|Lost to Follow-up|1
1076793|NCT02415595|3502900|P3|Overall Study|Lost to Follow-up|1
1076794|NCT02415595|3502901|P2|Overall Study|Lost to Follow-up|3
1076795|NCT02415595|3502902|P1|Overall Study|Lost to Follow-up|1
1076796|NCT02415595|3502899|P4|Overall Study|Lack of Efficacy|0
1076797|NCT02415595|3502900|P3|Overall Study|Lack of Efficacy|0
1076798|NCT02415595|3502901|P2|Overall Study|Lack of Efficacy|4
1076799|NCT02415595|3502902|P1|Overall Study|Lack of Efficacy|4
1076800|NCT02415595|3502899|P4|Overall Study|Adverse Event|10
1076801|NCT02415595|3502900|P3|Overall Study|Adverse Event|5
1076802|NCT02415595|3502901|P2|Overall Study|Adverse Event|3
1076803|NCT02415595|3502902|P1|Overall Study|Adverse Event|1
1076804|NCT02415595|3502899|P4|Overall Study|Administrative reason by sponsor|39
1076805|NCT02415595|3502900|P3|Overall Study|Administrative reason by sponsor|41
1076806|NCT02415595|3502901|P2|Overall Study|Administrative reason by sponsor|40
1076807|NCT02415595|3502902|P1|Overall Study|Administrative reason by sponsor|39
1076808|NCT02415127|3503075|P2|Overall Study|Adverse Event|0
1076809|NCT02415127|3503076|P1|Overall Study|Adverse Event|1
1076810|NCT02414958|3503093|P3|Overall Study|Other than specified|5
1076811|NCT02414958|3503094|P2|Overall Study|Other than specified|4
1076812|NCT02414958|3503095|P1|Overall Study|Other than specified|4
1076813|NCT02414958|3503093|P3|Overall Study|Withdrawal by Subject|5
1076814|NCT02414958|3503094|P2|Overall Study|Withdrawal by Subject|3
1076815|NCT02414958|3503095|P1|Overall Study|Withdrawal by Subject|5
1076816|NCT02414958|3503093|P3|Overall Study|Lost to Follow-up|0
1076817|NCT02414958|3503094|P2|Overall Study|Lost to Follow-up|4
1076818|NCT02414958|3503095|P1|Overall Study|Lost to Follow-up|7
1076819|NCT02414958|3503093|P3|Overall Study|Protocol Violation|1
1076820|NCT02414958|3503094|P2|Overall Study|Protocol Violation|3
1076821|NCT02414958|3503095|P1|Overall Study|Protocol Violation|10
1076822|NCT02414958|3503093|P3|Overall Study|Adverse Event|3
1076823|NCT02414958|3503094|P2|Overall Study|Adverse Event|6
1076824|NCT02414958|3503095|P1|Overall Study|Adverse Event|6
1076825|NCT02414854|3503128|P4|Overall Study|Other than specified above|37
1076826|NCT02414854|3503129|P3|Overall Study|Other than specified above|17
1076827|NCT02414854|3503130|P2|Overall Study|Other than specified above|37
1076828|NCT02414854|3503131|P1|Overall Study|Other than specified above|12
1076829|NCT02414854|3503128|P4|Overall Study|Poor compliance to protocol|2
1076830|NCT02414854|3503129|P3|Overall Study|Poor compliance to protocol|2
1076831|NCT02414854|3503130|P2|Overall Study|Poor compliance to protocol|1
1076832|NCT02414854|3503131|P1|Overall Study|Poor compliance to protocol|1
1076833|NCT02414854|3503128|P4|Overall Study|Adverse Event|12
1076834|NCT02414854|3503129|P3|Overall Study|Adverse Event|1
1076835|NCT02414854|3503130|P2|Overall Study|Adverse Event|7
1076836|NCT02414854|3503131|P1|Overall Study|Adverse Event|9
1076837|NCT02414828|3503297|P4|Overall Study|Lost to Follow-up|2
1076838|NCT02414828|3503298|P3|Overall Study|Lost to Follow-up|1
1076839|NCT02414828|3503299|P2|Overall Study|Lost to Follow-up|1
1076840|NCT02414828|3503300|P1|Overall Study|Lost to Follow-up|0
1076841|NCT02414152|3503370|P1|Overall Study|Lack of Efficacy|1
1076842|NCT02414152|3503370|P1|Overall Study|Withdrawal by Subject|1
1076843|NCT02413593|3503397|P1|Overall Study|Adverse Event|1
1076844|NCT02413593|3503397|P1|Overall Study|Lost to Follow-up|3
1076845|NCT02413489|3503409|P3|Overall Study|Study Terminated By Sponsor|1
1076846|NCT02413489|3503410|P2|Overall Study|Study Terminated By Sponsor|13
1076847|NCT02413489|3503411|P1|Overall Study|Study Terminated By Sponsor|2
1076848|NCT02413489|3503409|P3|Overall Study|Withdrawal by Subject|0
1076849|NCT02413489|3503410|P2|Overall Study|Withdrawal by Subject|0
1076850|NCT02413489|3503411|P1|Overall Study|Withdrawal by Subject|2
1076851|NCT02413489|3503409|P3|Overall Study|Death|4
1076852|NCT02413489|3503410|P2|Overall Study|Death|3
1076853|NCT02413489|3503411|P1|Overall Study|Death|11
1076854|NCT02413398|3503433|P2|Overall Study|Other Eligibility criteria|2
1076855|NCT02413398|3503434|P1|Overall Study|Other Eligibility criteria|1
1076856|NCT02413398|3503433|P2|Overall Study|Withdrawal by Subject|1
1076857|NCT02413398|3503434|P1|Overall Study|Withdrawal by Subject|1
1076858|NCT02413398|3503433|P2|Overall Study|Lost to Follow-up|4
1076859|NCT02413398|3503434|P1|Overall Study|Lost to Follow-up|2
1076860|NCT02413346|3503448|P2|Overall Study|Other Miscellaneous Reasons|3
1076861|NCT02413346|3503449|P1|Overall Study|Other Miscellaneous Reasons|4
1076862|NCT02413346|3503448|P2|Overall Study|Protocol Violation|0
1076863|NCT02413346|3503449|P1|Overall Study|Protocol Violation|2
1076864|NCT02413346|3503448|P2|Overall Study|Lost to Follow-up|21
1076865|NCT02413346|3503449|P1|Overall Study|Lost to Follow-up|17
1076866|NCT02413346|3503448|P2|Overall Study|Withdrawal by Subject|40
1076867|NCT02413346|3503449|P1|Overall Study|Withdrawal by Subject|30
1076868|NCT02413346|3503448|P2|Overall Study|Adverse Event|6
1076869|NCT02413346|3503449|P1|Overall Study|Adverse Event|6
1076870|NCT02413333|3503459|P2|Period 2|Protocol Deviation|0
1076871|NCT02413333|3503460|P1|Period 2|Protocol Deviation|1
1076872|NCT02413333|3503459|P2|Period 1|Reason Not Specified|1
1076873|NCT02413333|3503460|P1|Period 1|Reason Not Specified|0
1076874|NCT02413333|3503459|P2|Period 1|Adverse Event|0
1076875|NCT02413333|3503460|P1|Period 1|Adverse Event|1
1076876|NCT02413294|3503468|P1|Overall Study|Withdrawal by Subject|1
1076877|NCT02413229|3503494|P8|Overall Study|Progressive Disease|1
1076878|NCT02413229|3503495|P7|Overall Study|Progressive Disease|0
1076879|NCT02413229|3503496|P6|Overall Study|Progressive Disease|0
1076880|NCT02413229|3503497|P5|Overall Study|Progressive Disease|0
1076881|NCT02413229|3503498|P4|Overall Study|Progressive Disease|0
1076882|NCT02413229|3503499|P3|Overall Study|Progressive Disease|0
1076883|NCT02413229|3503500|P2|Overall Study|Progressive Disease|0
1076884|NCT02413229|3503501|P1|Overall Study|Progressive Disease|0
1076885|NCT02413229|3503494|P8|Overall Study|Withdrawal by Subject|2
1076886|NCT02413229|3503495|P7|Overall Study|Withdrawal by Subject|0
1076887|NCT02413229|3503496|P6|Overall Study|Withdrawal by Subject|0
1076888|NCT02413229|3503497|P5|Overall Study|Withdrawal by Subject|1
1076889|NCT02413229|3503498|P4|Overall Study|Withdrawal by Subject|0
1076890|NCT02413229|3503499|P3|Overall Study|Withdrawal by Subject|0
1076891|NCT02413229|3503500|P2|Overall Study|Withdrawal by Subject|1
1076892|NCT02413229|3503501|P1|Overall Study|Withdrawal by Subject|1
1076893|NCT02413229|3503494|P8|Overall Study|Lost to Follow-up|0
1076894|NCT02413229|3503495|P7|Overall Study|Lost to Follow-up|0
1076895|NCT02413229|3503496|P6|Overall Study|Lost to Follow-up|0
1076896|NCT02413229|3503497|P5|Overall Study|Lost to Follow-up|2
1076897|NCT02413229|3503498|P4|Overall Study|Lost to Follow-up|0
1076898|NCT02413229|3503499|P3|Overall Study|Lost to Follow-up|1
1076899|NCT02413229|3503500|P2|Overall Study|Lost to Follow-up|0
1076900|NCT02413229|3503501|P1|Overall Study|Lost to Follow-up|0
1076901|NCT02413229|3503494|P8|Overall Study|Adverse Event|1
1076902|NCT02413229|3503495|P7|Overall Study|Adverse Event|0
1076903|NCT02413229|3503496|P6|Overall Study|Adverse Event|0
1076904|NCT02413229|3503497|P5|Overall Study|Adverse Event|0
1076905|NCT02413229|3503498|P4|Overall Study|Adverse Event|1
1076906|NCT02413229|3503499|P3|Overall Study|Adverse Event|0
1076907|NCT02413229|3503500|P2|Overall Study|Adverse Event|0
1076908|NCT02413229|3503501|P1|Overall Study|Adverse Event|0
1076909|NCT02412878|3503555|P2|Overall Study|Missing|1
1076910|NCT02412878|3503556|P1|Overall Study|Missing|0
1076911|NCT02412878|3503555|P2|Overall Study|Continuing Study|176
1076912|NCT02412878|3503556|P1|Overall Study|Continuing Study|156
1076913|NCT02412878|3503555|P2|Overall Study|Withdrawal by Subject|6
1076914|NCT02412878|3503556|P1|Overall Study|Withdrawal by Subject|18
1076915|NCT02412761|3503570|P6|First Intervention (2 Weeks)|Withdrawal by Subject|1
1076916|NCT02412761|3503571|P5|First Intervention (2 Weeks)|Withdrawal by Subject|0
1076917|NCT02412761|3503572|P4|First Intervention (2 Weeks)|Withdrawal by Subject|0
1076918|NCT02412761|3503573|P3|First Intervention (2 Weeks)|Withdrawal by Subject|1
1076919|NCT02412761|3503574|P2|First Intervention (2 Weeks)|Withdrawal by Subject|1
1076920|NCT02412761|3503575|P1|First Intervention (2 Weeks)|Withdrawal by Subject|0
1076921|NCT02412657|3503586|P3|Overall Study|Protocol Violation|3
1076922|NCT02412657|3503587|P2|Overall Study|Protocol Violation|2
1076923|NCT02412657|3503588|P1|Overall Study|Protocol Violation|0
1076924|NCT02412657|3503586|P3|Overall Study|Lost to Follow-up|0
1076925|NCT02412657|3503587|P2|Overall Study|Lost to Follow-up|0
1076926|NCT02412657|3503588|P1|Overall Study|Lost to Follow-up|1
1076927|NCT02412436|3503605|P1|Overall Study|Not Willing to Adhere to Requirements|1
1076928|NCT02412436|3503605|P1|Overall Study|Death|1
1076929|NCT02412436|3503605|P1|Overall Study|Unable to get to clinic|3
1076930|NCT02412436|3503605|P1|Overall Study|Lost to Follow-up|6
1076931|NCT02412436|3503605|P1|Overall Study|Protocol-mandated Discontinuation|7
1076932|NCT02411747|3503649|P2|Overall Study|Protocol Violation|4
1076933|NCT02411747|3503650|P1|Overall Study|Protocol Violation|2
1076934|NCT02411747|3503649|P2|Overall Study|Withdrawal by Subject|0
1076935|NCT02411747|3503650|P1|Overall Study|Withdrawal by Subject|1
1076936|NCT02411578|3503665|P2|Crossover Trial Phase|Pregnancy|1
1076937|NCT02411578|3503666|P1|Crossover Trial Phase|Pregnancy|0
1076938|NCT02411539|3503708|P2|Overall Study|Confounding medical condition|1
1076939|NCT02411539|3503709|P1|Overall Study|Confounding medical condition|0
1076940|NCT02411539|3503708|P2|Overall Study|Lost to Follow-up|0
1076941|NCT02411539|3503709|P1|Overall Study|Lost to Follow-up|2
1076942|NCT02411292|3503797|P1|Overall Study|Lost to Follow-up|3
1076943|NCT02411292|3503797|P1|Overall Study|Death|2
1076944|NCT02411292|3503797|P1|Overall Study|Discharged before 3rd enoxaparin dose|16
1076945|NCT02411201|3503803|P1|Overall Study|Age group completed|2
1076946|NCT02411201|3503803|P1|Overall Study|Withdrawal by Subject|2
1076947|NCT02411201|3503803|P1|Overall Study|Adverse Event|2
1076948|NCT02411110|3503816|P2|Treatment Period 2|Personal Reasons|2
1076949|NCT02411110|3503817|P1|Treatment Period 2|Personal Reasons|0
1076950|NCT02411110|3503816|P2|Treatment Period 2|Lost to Follow-up|2
1076951|NCT02411110|3503817|P1|Treatment Period 2|Lost to Follow-up|0
1076952|NCT02411110|3503816|P2|Treatment Period 2|Adverse Event|0
1076953|NCT02411110|3503817|P1|Treatment Period 2|Adverse Event|1
1076954|NCT02411110|3503816|P2|Treatment Period 1|Other Miscellaneous Reasons|0
1076955|NCT02411110|3503817|P1|Treatment Period 1|Other Miscellaneous Reasons|2
1076956|NCT02411110|3503816|P2|Treatment Period 1|Personal Reasons|5
1076957|NCT02411110|3503817|P1|Treatment Period 1|Personal Reasons|2
1076958|NCT02411110|3503816|P2|Treatment Period 1|Lost to Follow-up|0
1076959|NCT02411110|3503817|P1|Treatment Period 1|Lost to Follow-up|1
1076960|NCT02411110|3503816|P2|Treatment Period 1|Adverse Event|2
1076961|NCT02411110|3503817|P1|Treatment Period 1|Adverse Event|4
1076962|NCT02410824|3503844|P2|First Intervention (One Week)|Headache|1
1076963|NCT02410824|3503845|P1|First Intervention (One Week)|Headache|0
1076964|NCT02410551|3503877|P1|Overall Study|FDA Clinical hold-patients taken off|2
1076965|NCT02410551|3503877|P1|Overall Study|Withdrawal by Subject|1
1076966|NCT02410551|3503877|P1|Overall Study|Adverse Event|1
1076967|NCT02410343|3503884|P2|Extension Period (12 Months)|Early termination of study by sponsor|1
1076968|NCT02410343|3503885|P1|Extension Period (12 Months)|Early termination of study by sponsor|0
1076969|NCT02410343|3503884|P2|Extension Period (12 Months)|Adverse Event|0
1076970|NCT02410343|3503885|P1|Extension Period (12 Months)|Adverse Event|1
1076971|NCT02410343|3503884|P2|Core Period (24 Weeks)|Early termination of study by sponsor|7
1076972|NCT02410343|3503885|P1|Core Period (24 Weeks)|Early termination of study by sponsor|4
1076973|NCT02410343|3503884|P2|Core Period (24 Weeks)|Adverse Event|0
1076974|NCT02410343|3503885|P1|Core Period (24 Weeks)|Adverse Event|1
1076975|NCT02410278|3503931|P3|Study Treatment Period|GSRS Threshold Not Met|0
1076976|NCT02410278|3503932|P2|Study Treatment Period|GSRS Threshold Not Met|1
1076977|NCT02410278|3503933|P1|Study Treatment Period|GSRS Threshold Not Met|0
1076978|NCT02410278|3503931|P3|Study Treatment Period|Other|0
1076979|NCT02410278|3503932|P2|Study Treatment Period|Other|3
1076980|NCT02410278|3503933|P1|Study Treatment Period|Other|0
1076981|NCT02410278|3503931|P3|Study Treatment Period|Withdrawal by Subject|0
1076982|NCT02410278|3503932|P2|Study Treatment Period|Withdrawal by Subject|1
1076983|NCT02410278|3503933|P1|Study Treatment Period|Withdrawal by Subject|0
1076984|NCT02410278|3503931|P3|Study Treatment Period|Physician Decision|1
1076985|NCT02410278|3503932|P2|Study Treatment Period|Physician Decision|0
1076986|NCT02410278|3503933|P1|Study Treatment Period|Physician Decision|0
1076987|NCT02410278|3503931|P3|Study Treatment Period|Adverse Event|3
1076988|NCT02410278|3503932|P2|Study Treatment Period|Adverse Event|6
1076989|NCT02410278|3503933|P1|Study Treatment Period|Adverse Event|0
1076990|NCT02410278|3503931|P3|Run-in Period|Pregnancy|0
1076991|NCT02410278|3503932|P2|Run-in Period|Pregnancy|0
1076992|NCT02410278|3503933|P1|Run-in Period|Pregnancy|1
1076993|NCT02410278|3503931|P3|Run-in Period|Withdrawal by Subject|0
1076994|NCT02410278|3503932|P2|Run-in Period|Withdrawal by Subject|0
1076995|NCT02410278|3503933|P1|Run-in Period|Withdrawal by Subject|1
1076996|NCT02410278|3503931|P3|Run-in Period|Lost to Follow-up|0
1076997|NCT02410278|3503932|P2|Run-in Period|Lost to Follow-up|0
1076998|NCT02410278|3503933|P1|Run-in Period|Lost to Follow-up|1
1076999|NCT02410278|3503931|P3|Run-in Period|GSRS Threshold Not Met|0
1077000|NCT02410278|3503932|P2|Run-in Period|GSRS Threshold Not Met|0
1077001|NCT02410278|3503933|P1|Run-in Period|GSRS Threshold Not Met|30
1077002|NCT02410278|3503931|P3|Run-in Period|Adverse Event|0
1077003|NCT02410278|3503932|P2|Run-in Period|Adverse Event|0
1077004|NCT02410278|3503933|P1|Run-in Period|Adverse Event|5
1077005|NCT02410252|3503958|P1|Overall Study|Physician Decision|2
1077006|NCT02410252|3503958|P1|Overall Study|Withdrawal by Subject|4
1077007|NCT02410200|3503971|P1|Overall Study|Adverse Event|2
1077008|NCT02409732|3504021|P1|Overall Study|Lost to Follow-up|2
1077009|NCT02409732|3504021|P1|Overall Study|Withdrawal by Subject|4
1077010|NCT02409355|3504052|P2|Overall Study|Study terminated by Sponsor|3
1077011|NCT02409355|3504053|P1|Overall Study|Study terminated by Sponsor|2
1077012|NCT02409355|3504052|P2|Overall Study|Death|1
1077013|NCT02409355|3504053|P1|Overall Study|Death|1
1077014|NCT02409355|3504052|P2|Overall Study|Withdrawal by Subject|0
1077015|NCT02409355|3504053|P1|Overall Study|Withdrawal by Subject|1
1077016|NCT02408068|3504082|P6|Treatment 3 (1.5 Days)|Adverse Event|0
1077017|NCT02408068|3504083|P5|Treatment 3 (1.5 Days)|Adverse Event|0
1077018|NCT02408068|3504084|P4|Treatment 3 (1.5 Days)|Adverse Event|0
1077019|NCT02408068|3504085|P3|Treatment 3 (1.5 Days)|Adverse Event|1
1077020|NCT02408068|3504086|P2|Treatment 3 (1.5 Days)|Adverse Event|0
1077021|NCT02408068|3504087|P1|Treatment 3 (1.5 Days)|Adverse Event|0
1077022|NCT02407704|3504114|P4|Overall Study|Withdrawal by Subject|0
1077023|NCT02407704|3504115|P3|Overall Study|Withdrawal by Subject|1
1077024|NCT02407704|3504116|P2|Overall Study|Withdrawal by Subject|0
1077025|NCT02407704|3504117|P1|Overall Study|Withdrawal by Subject|0
1077026|NCT02407704|3504114|P4|Overall Study|Protocol Violation|1
1077027|NCT02407704|3504115|P3|Overall Study|Protocol Violation|0
1077028|NCT02407704|3504116|P2|Overall Study|Protocol Violation|0
1077029|NCT02407704|3504117|P1|Overall Study|Protocol Violation|0
1077030|NCT02407704|3504114|P4|Overall Study|Lost to Follow-up|2
1077031|NCT02407704|3504115|P3|Overall Study|Lost to Follow-up|0
1077032|NCT02407704|3504116|P2|Overall Study|Lost to Follow-up|0
1077033|NCT02407704|3504117|P1|Overall Study|Lost to Follow-up|0
1077034|NCT02406612|3504214|P2|Overall Study|Guidewire Failure|1
1077035|NCT02406612|3504215|P1|Overall Study|Guidewire Failure|0
1077036|NCT02406612|3504214|P2|Overall Study|Intra-procedural Exclusion|3
1077037|NCT02406612|3504215|P1|Overall Study|Intra-procedural Exclusion|1
1077038|NCT02406612|3504214|P2|Overall Study|Screening Failure|0
1077039|NCT02406612|3504215|P1|Overall Study|Screening Failure|3
1077040|NCT02406586|3504230|P3|Overall Study|Withdrawal by Subject|0
1077041|NCT02406586|3504231|P2|Overall Study|Withdrawal by Subject|0
1077042|NCT02406586|3504232|P1|Overall Study|Withdrawal by Subject|1
1077043|NCT02406586|3504230|P3|Overall Study|Lost to Follow-up|2
1077044|NCT02406586|3504231|P2|Overall Study|Lost to Follow-up|4
1077045|NCT02406586|3504232|P1|Overall Study|Lost to Follow-up|0
1077046|NCT02406248|3504345|P1|Overall Study|Withdrawal by Subject|2
1077047|NCT02406248|3504345|P1|Overall Study|Death|7
1077048|NCT02405091|3504375|P3|Overall Study|Physician Decision|0
1077049|NCT02405091|3504376|P2|Overall Study|Physician Decision|2
1077050|NCT02405091|3504377|P1|Overall Study|Physician Decision|2
1077051|NCT02405091|3504375|P3|Overall Study|Lost to Follow-up|0
1077052|NCT02405091|3504376|P2|Overall Study|Lost to Follow-up|6
1077053|NCT02405091|3504377|P1|Overall Study|Lost to Follow-up|5
1077054|NCT02405091|3504375|P3|Overall Study|Death|0
1077055|NCT02405091|3504376|P2|Overall Study|Death|1
1077056|NCT02405091|3504377|P1|Overall Study|Death|0
1077057|NCT02405091|3504375|P3|Overall Study|Withdrawal by Subject|0
1077058|NCT02405091|3504376|P2|Overall Study|Withdrawal by Subject|8
1077059|NCT02405091|3504377|P1|Overall Study|Withdrawal by Subject|4
1077060|NCT02405091|3504375|P3|Overall Study|Noncompliance|2
1077061|NCT02405091|3504376|P2|Overall Study|Noncompliance|6
1077062|NCT02405091|3504377|P1|Overall Study|Noncompliance|1
1077063|NCT02405091|3504375|P3|Overall Study|Protocol Violation|0
1077064|NCT02405091|3504376|P2|Overall Study|Protocol Violation|0
1077065|NCT02405091|3504377|P1|Overall Study|Protocol Violation|1
1077066|NCT02405091|3504375|P3|Overall Study|Adverse Event|0
1077067|NCT02405091|3504376|P2|Overall Study|Adverse Event|10
1077068|NCT02405091|3504377|P1|Overall Study|Adverse Event|16
1077069|NCT02404649|3504400|P2|Overall Study|Adverse Event|2
1077070|NCT02404649|3504401|P1|Overall Study|Adverse Event|1
1077071|NCT02404545|3504409|P2|Overall Study|Sponsor Termination|6
1077072|NCT02404545|3504410|P1|Overall Study|Sponsor Termination|6
1077073|NCT02404493|3504429|P2|Overall Study|Adverse Event|1
1077074|NCT02404493|3504430|P1|Overall Study|Adverse Event|1
1077075|NCT02404389|3504675|P5|Overall Study|Subject/guardian decision|1
1077076|NCT02404389|3504676|P4|Overall Study|Subject/guardian decision|1
1077077|NCT02404389|3504677|P3|Overall Study|Subject/guardian decision|0
1077078|NCT02404389|3504678|P2|Overall Study|Subject/guardian decision|0
1077079|NCT02404389|3504679|P1|Overall Study|Subject/guardian decision|1
1077080|NCT02404389|3504675|P5|Overall Study|Adverse Event|2
1077081|NCT02404389|3504676|P4|Overall Study|Adverse Event|0
1077082|NCT02404389|3504677|P3|Overall Study|Adverse Event|1
1077083|NCT02404389|3504678|P2|Overall Study|Adverse Event|0
1077084|NCT02404389|3504679|P1|Overall Study|Adverse Event|1
1077085|NCT02404103|3504717|P2|Overall Study|Lost to Follow-up|3
1077086|NCT02404103|3504718|P1|Overall Study|Lost to Follow-up|3
1077087|NCT02404103|3504717|P2|Overall Study|Adverse Event|0
1077088|NCT02404103|3504718|P1|Overall Study|Adverse Event|1
1077089|NCT02403674|3504780|P2|Overall Study|Protocol Violation|2
1077090|NCT02403674|3504781|P1|Overall Study|Protocol Violation|4
1077091|NCT02403674|3504780|P2|Overall Study|Pregnancy|1
1077092|NCT02403674|3504781|P1|Overall Study|Pregnancy|1
1077093|NCT02403674|3504780|P2|Overall Study|Not treated with study drug|2
1077094|NCT02403674|3504781|P1|Overall Study|Not treated with study drug|4
1077095|NCT02403674|3504780|P2|Overall Study|Physician Decision|2
1077096|NCT02403674|3504781|P1|Overall Study|Physician Decision|2
1077097|NCT02403674|3504780|P2|Overall Study|Withdrawal by Subject|11
1077098|NCT02403674|3504781|P1|Overall Study|Withdrawal by Subject|8
1077099|NCT02403674|3504780|P2|Overall Study|Noncompliance with study drug|2
1077100|NCT02403674|3504781|P1|Overall Study|Noncompliance with study drug|1
1077101|NCT02403674|3504780|P2|Overall Study|Lost to Follow-up|7
1077102|NCT02403674|3504781|P1|Overall Study|Lost to Follow-up|6
1077103|NCT02403674|3504780|P2|Overall Study|Lack of Efficacy|10
1077104|NCT02403674|3504781|P1|Overall Study|Lack of Efficacy|18
1077105|NCT02403674|3504780|P2|Overall Study|Death|3
1077106|NCT02403674|3504781|P1|Overall Study|Death|1
1077107|NCT02403674|3504780|P2|Overall Study|Adverse Event|23
1077108|NCT02403674|3504781|P1|Overall Study|Adverse Event|10
1077109|NCT02403206|3504822|P2|Overall Study|Reason not given|4
1077110|NCT02403206|3504823|P1|Overall Study|Reason not given|2
1077111|NCT02403206|3504822|P2|Overall Study|Withdrawal by Subject|3
1077112|NCT02403206|3504823|P1|Overall Study|Withdrawal by Subject|3
1077113|NCT02403206|3504822|P2|Overall Study|Physician Decision|0
1077114|NCT02403206|3504823|P1|Overall Study|Physician Decision|2
1077115|NCT02403206|3504822|P2|Overall Study|Lost to Follow-up|3
1077116|NCT02403206|3504823|P1|Overall Study|Lost to Follow-up|4
1077117|NCT02403180|3504834|P2|Period 2 (5 Days)|Withdrawal by Subject|1
1077118|NCT02403180|3504835|P1|Period 2 (5 Days)|Withdrawal by Subject|0
1077119|NCT02403180|3504834|P2|Pre-Treatment Period|Withdrawal by subject prior to treatment|1
1077120|NCT02403180|3504835|P1|Pre-Treatment Period|Withdrawal by subject prior to treatment|0
1077121|NCT02402933|3504864|P1|Overall Study|Discontinued; Site Termination|10
1077122|NCT02402933|3504864|P1|Overall Study|Withdrawal by Subject|4
1077123|NCT02402322|3504882|P3|Follow-up|Withdrawal by Subject|24
1077124|NCT02402322|3504883|P2|Follow-up|Withdrawal by Subject|3
1077125|NCT02402322|3504884|P1|Follow-up|Withdrawal by Subject|6
1077126|NCT02402322|3504882|P3|Pretreatment|Withdrawal by Subject|1
1077127|NCT02402322|3504883|P2|Pretreatment|Withdrawal by Subject|1
1077128|NCT02402322|3504884|P1|Pretreatment|Withdrawal by Subject|3
1077129|NCT02402166|3504931|P1|Overall Study|Lost to Follow-up|1
1077130|NCT02402166|3504931|P1|Overall Study|Withdrawal by Subject|2
1077131|NCT02402166|3504931|P1|Overall Study|Adverse Event|2
1077132|NCT02401867|3504984|P1|Analysis|Cervical assay could not be conducted|9
1077133|NCT02401867|3504984|P1|Specimen Collection|Didn't receive 1 or more tests|10
1077134|NCT02401529|3505004|P2|Overall Study|Protocol Violation|0
1077135|NCT02401529|3505005|P1|Overall Study|Protocol Violation|5
1077136|NCT02401529|3505004|P2|Overall Study|Physician Decision|6
1077137|NCT02401529|3505005|P1|Overall Study|Physician Decision|2
1077138|NCT02401529|3505004|P2|Overall Study|Lost to Follow-up|1
1077139|NCT02401529|3505005|P1|Overall Study|Lost to Follow-up|2
1077140|NCT02401412|3505072|P2|Overall Study|Improper Enrollment per In/Ex Criteria|6
1077141|NCT02401412|3505073|P1|Overall Study|Improper Enrollment per In/Ex Criteria|10
1077142|NCT02401412|3505072|P2|Overall Study|Subject withdrawal prior to intervention|1
1077143|NCT02401412|3505073|P1|Overall Study|Subject withdrawal prior to intervention|0
1077144|NCT02401412|3505072|P2|Overall Study|Withdrawal by Subject|4
1077145|NCT02401412|3505073|P1|Overall Study|Withdrawal by Subject|4
1077146|NCT02401412|3505072|P2|Overall Study|Discontinued Intervention|21
1077147|NCT02401412|3505073|P1|Overall Study|Discontinued Intervention|15
1077148|NCT02401412|3505072|P2|Overall Study|Lost to Follow-up|0
1077149|NCT02401412|3505073|P1|Overall Study|Lost to Follow-up|1
1077150|NCT02401256|3505081|P1|Overall Study|Withdrawal by Subject|12
1077151|NCT02401256|3505081|P1|Overall Study|Adverse Event|5
1077152|NCT02401230|3505090|P3|Overall Study|Lost to Follow-up|3
1077153|NCT02401230|3505091|P2|Overall Study|Lost to Follow-up|3
1077154|NCT02401230|3505092|P1|Overall Study|Lost to Follow-up|1
1077155|NCT02401230|3505090|P3|Overall Study|Withdrawal by Subject|1
1077156|NCT02401230|3505091|P2|Overall Study|Withdrawal by Subject|1
1077157|NCT02401230|3505092|P1|Overall Study|Withdrawal by Subject|2
1077158|NCT02401230|3505090|P3|Overall Study|Adverse Event|0
1077159|NCT02401230|3505091|P2|Overall Study|Adverse Event|2
1077160|NCT02401230|3505092|P1|Overall Study|Adverse Event|3
1077161|NCT02400749|3505140|P2|Week 17 - 32|Adverse Event|1
1077162|NCT02400749|3505141|P1|Week 17 - 32|Adverse Event|2
1077163|NCT02400749|3505140|P2|Week 17 - 32|Withdrawal by Subject|2
1077164|NCT02400749|3505141|P1|Week 17 - 32|Withdrawal by Subject|3
1077165|NCT02400749|3505140|P2|Week 0 -16|Protocol Violation|0
1077166|NCT02400749|3505141|P1|Week 0 -16|Protocol Violation|1
1077167|NCT02400749|3505140|P2|Week 0 -16|Lost to Follow-up|0
1077168|NCT02400749|3505141|P1|Week 0 -16|Lost to Follow-up|2
1077169|NCT02400749|3505140|P2|Week 0 -16|Adverse Event|1
1077170|NCT02400749|3505141|P1|Week 0 -16|Adverse Event|3
1077171|NCT02400749|3505140|P2|Week 0 -16|Withdrawal by Subject|5
1077172|NCT02400749|3505141|P1|Week 0 -16|Withdrawal by Subject|5
1077173|NCT02400580|3505168|P2|Overall Study|Adverse Event|0
1077174|NCT02400580|3505169|P1|Overall Study|Adverse Event|1
1077175|NCT02400580|3505168|P2|Overall Study|Withdrawal by Subject|1
1077176|NCT02400580|3505169|P1|Overall Study|Withdrawal by Subject|1
1077177|NCT02400346|3505185|P1|Overall Study|Lost to Follow-up|1
1077178|NCT02400346|3505185|P1|Overall Study|Administrative or other reason(s)|2
1077179|NCT02400346|3505185|P1|Overall Study|Withdrawal by Subject|7
1077180|NCT02400346|3505185|P1|Overall Study|Non-compliance with IMP|1
1077181|NCT02400346|3505185|P1|Overall Study|Lack of Efficacy|9
1077182|NCT02400346|3505185|P1|Overall Study|Adverse Event|24
1077183|NCT02400333|3505193|P4|Overall Study|Protocol Violation|1
1077184|NCT02400333|3505194|P3|Overall Study|Protocol Violation|2
1077185|NCT02400333|3505195|P2|Overall Study|Protocol Violation|0
1077186|NCT02400333|3505196|P1|Overall Study|Protocol Violation|1
1077187|NCT02400333|3505193|P4|Overall Study|Withdrawal by Subject|1
1077188|NCT02400333|3505194|P3|Overall Study|Withdrawal by Subject|0
1077189|NCT02400333|3505195|P2|Overall Study|Withdrawal by Subject|1
1077190|NCT02400333|3505196|P1|Overall Study|Withdrawal by Subject|0
1077191|NCT02399163|3505260|P1|Overall Study|Withdrawal by Participant|5
1077192|NCT02399163|3505260|P1|Overall Study|Protocol Deviation|2
1077193|NCT02399163|3505260|P1|Overall Study|Adverse Event|2
1077194|NCT02398227|3505307|P2|Overall Study|Removed from treatment and dropped out|0
1077195|NCT02398227|3505308|P1|Overall Study|Removed from treatment and dropped out|1
1077196|NCT02398227|3505307|P2|Overall Study|Withdrawal by Subject|6
1077197|NCT02398227|3505308|P1|Overall Study|Withdrawal by Subject|5
1077198|NCT02398227|3505307|P2|Overall Study|Lost to Follow-up|12
1077199|NCT02398227|3505308|P1|Overall Study|Lost to Follow-up|21
1077200|NCT02397915|3505316|P4|Period 1|Physician Decision|0
1077201|NCT02397915|3505317|P3|Period 1|Physician Decision|0
1077202|NCT02397915|3505318|P2|Period 1|Physician Decision|0
1077203|NCT02397915|3505319|P1|Period 1|Physician Decision|1
1077204|NCT02397915|3505316|P4|Period 1|Protocol Violation|0
1077205|NCT02397915|3505317|P3|Period 1|Protocol Violation|0
1077206|NCT02397915|3505318|P2|Period 1|Protocol Violation|1
1077207|NCT02397915|3505319|P1|Period 1|Protocol Violation|0
1077208|NCT02397694|3505418|P2|Open Label Extension Phase|Withdrawal by Subject|0
1077209|NCT02397694|3505419|P1|Open Label Extension Phase|Withdrawal by Subject|1
1077210|NCT02397694|3505418|P2|Open Label Extension Phase|Still on Study Drug|30
1077211|NCT02397694|3505419|P1|Open Label Extension Phase|Still on Study Drug|61
1077212|NCT02397694|3505418|P2|Double-Blinded Phase|Lost to Follow-up|1
1077213|NCT02397694|3505419|P1|Double-Blinded Phase|Lost to Follow-up|1
1077214|NCT02397694|3505418|P2|Double-Blinded Phase|Withdrawal by Subject|0
1077215|NCT02397694|3505419|P1|Double-Blinded Phase|Withdrawal by Subject|1
1077216|NCT02397694|3505418|P2|Double-Blinded Phase|Non-compliance with study drug|2
1077217|NCT02397694|3505419|P1|Double-Blinded Phase|Non-compliance with study drug|0
1077218|NCT02397694|3505418|P2|Double-Blinded Phase|Adverse Event|0
1077219|NCT02397694|3505419|P1|Double-Blinded Phase|Adverse Event|1
1077220|NCT02397655|3505457|P1|Overall Study|data not completed|1301
1077221|NCT02396537|3505487|P2|Overall Study|Protocol Violation|1
1077222|NCT02396537|3505488|P1|Overall Study|Protocol Violation|0
1077223|NCT02396420|3505494|P1|Overall Study|Death|1
1077224|NCT02396316|3505516|P2|Overall Study|Treatment unblinded|1
1077225|NCT02396316|3505517|P1|Overall Study|Treatment unblinded|0
1077226|NCT02396316|3505516|P2|Overall Study|Protocol Violation|1
1077227|NCT02396316|3505517|P1|Overall Study|Protocol Violation|0
1077228|NCT02396316|3505516|P2|Overall Study|Progressive disease|3
1077229|NCT02396316|3505517|P1|Overall Study|Progressive disease|6
1077230|NCT02396316|3505516|P2|Overall Study|Physician Decision|0
1077231|NCT02396316|3505517|P1|Overall Study|Physician Decision|1
1077232|NCT02395822|3505615|P1|Overall Study|Death|1
1077233|NCT02395822|3505615|P1|Overall Study|Withdrawal by Subject|1
1077234|NCT02395653|3505623|P1|Overall Study|Lost to Follow-up|1
1077235|NCT02395653|3505623|P1|Overall Study|Withdrawal by Subject|1
1077236|NCT02395653|3505623|P1|Overall Study|Inclusion Criteria Not Met at Screening|3
1077237|NCT02395653|3505623|P1|Overall Study|Investigator Decision at Screening|1
1077238|NCT02395653|3505623|P1|Overall Study|SSEC Application But With 0 Dose|1
1077239|NCT02395653|3505623|P1|Overall Study|Consent Withdrawn at Screening|1
1077240|NCT02395653|3505623|P1|Overall Study|Exclusion Criteria Met at Screening|4
1077241|NCT02395536|3505632|P2|Overall Study|Insurance issue|1
1077242|NCT02395536|3505633|P1|Overall Study|Insurance issue|0
1077243|NCT02395536|3505632|P2|Overall Study|Inclusion/Excusion Criteria Violation|2
1077244|NCT02395536|3505633|P1|Overall Study|Inclusion/Excusion Criteria Violation|1
1077245|NCT02395536|3505632|P2|Overall Study|Withdrawal by Subject|17
1077246|NCT02395536|3505633|P1|Overall Study|Withdrawal by Subject|9
1077247|NCT02395536|3505632|P2|Overall Study|Physician Decision|6
1077248|NCT02395536|3505633|P1|Overall Study|Physician Decision|4
1077249|NCT02395536|3505632|P2|Overall Study|Death|0
1077250|NCT02395536|3505633|P1|Overall Study|Death|2
1077251|NCT02395536|3505632|P2|Overall Study|Lost to Follow-up|4
1077252|NCT02395536|3505633|P1|Overall Study|Lost to Follow-up|4
1077253|NCT02395302|3505639|P1|Overall Study|Physician Decision|2
1077254|NCT02395302|3505639|P1|Overall Study|Withdrawal by Subject|2
1077255|NCT02395302|3505639|P1|Overall Study|Run In Failure|7
1077256|NCT02395302|3505639|P1|Overall Study|Screen Failure|3
1077257|NCT02395172|3505659|P2|Overall Study|Treatment ongoing|5
1077258|NCT02395172|3505660|P1|Overall Study|Treatment ongoing|49
1077259|NCT02395172|3505659|P2|Overall Study|Participants randomized but not treated|31
1077260|NCT02395172|3505660|P1|Overall Study|Participants randomized but not treated|3
1077261|NCT02395133|3505699|P4|Overall Study|Other than specified above|4
1077262|NCT02395133|3505700|P3|Overall Study|Other than specified above|2
1077263|NCT02395133|3505701|P2|Overall Study|Other than specified above|2
1077264|NCT02395133|3505702|P1|Overall Study|Other than specified above|5
1077265|NCT02395133|3505699|P4|Overall Study|Sponsor decision|1
1077266|NCT02395133|3505700|P3|Overall Study|Sponsor decision|0
1077267|NCT02395133|3505701|P2|Overall Study|Sponsor decision|0
1077268|NCT02395133|3505702|P1|Overall Study|Sponsor decision|2
1077269|NCT02395133|3505699|P4|Overall Study|Consent withdrawn with personal reason|3
1077270|NCT02395133|3505700|P3|Overall Study|Consent withdrawn with personal reason|0
1077271|NCT02395133|3505701|P2|Overall Study|Consent withdrawn with personal reason|1
1077272|NCT02395133|3505702|P1|Overall Study|Consent withdrawn with personal reason|0
1077273|NCT02395133|3505699|P4|Overall Study|Consent withdrawn with no reason given|2
1077274|NCT02395133|3505700|P3|Overall Study|Consent withdrawn with no reason given|0
1077275|NCT02395133|3505701|P2|Overall Study|Consent withdrawn with no reason given|3
1077276|NCT02395133|3505702|P1|Overall Study|Consent withdrawn with no reason given|1
1077277|NCT02395133|3505699|P4|Overall Study|Pregnancy|0
1077278|NCT02395133|3505700|P3|Overall Study|Pregnancy|3
1077279|NCT02395133|3505701|P2|Overall Study|Pregnancy|0
1077280|NCT02395133|3505702|P1|Overall Study|Pregnancy|0
1077281|NCT02395133|3505699|P4|Overall Study|Lost to Follow-up|0
1077282|NCT02395133|3505700|P3|Overall Study|Lost to Follow-up|1
1077283|NCT02395133|3505701|P2|Overall Study|Lost to Follow-up|1
1077284|NCT02395133|3505702|P1|Overall Study|Lost to Follow-up|0
1077285|NCT02395133|3505699|P4|Overall Study|Protocol Violation|3
1077286|NCT02395133|3505700|P3|Overall Study|Protocol Violation|0
1077287|NCT02395133|3505701|P2|Overall Study|Protocol Violation|1
1077288|NCT02395133|3505702|P1|Overall Study|Protocol Violation|1
1077289|NCT02395133|3505699|P4|Overall Study|Lack of Efficacy|1
1077290|NCT02395133|3505700|P3|Overall Study|Lack of Efficacy|1
1077291|NCT02395133|3505701|P2|Overall Study|Lack of Efficacy|0
1077292|NCT02395133|3505702|P1|Overall Study|Lack of Efficacy|1
1077293|NCT02395133|3505699|P4|Overall Study|Adverse Event|0
1077294|NCT02395133|3505700|P3|Overall Study|Adverse Event|3
1077295|NCT02395133|3505701|P2|Overall Study|Adverse Event|1
1077296|NCT02395133|3505702|P1|Overall Study|Adverse Event|4
1077297|NCT02395055|3505790|P2|Overall Study|Withdrawal by Subject|3
1077298|NCT02395055|3505791|P1|Overall Study|Withdrawal by Subject|7
1077299|NCT02395042|3505804|P3|Treatment 2 Period|Lack of Efficacy|0
1077300|NCT02395042|3505805|P2|Treatment 2 Period|Lack of Efficacy|1
1077301|NCT02395042|3505806|P1|Treatment 2 Period|Lack of Efficacy|1
1077302|NCT02395042|3505804|P3|Treatment 1 Period|Other Miscellaneous Reasons|1
1077303|NCT02395042|3505805|P2|Treatment 1 Period|Other Miscellaneous Reasons|2
1077304|NCT02395042|3505806|P1|Treatment 1 Period|Other Miscellaneous Reasons|0
1077305|NCT02395042|3505804|P3|Treatment 1 Period|Lost to Follow-up|0
1077306|NCT02395042|3505805|P2|Treatment 1 Period|Lost to Follow-up|0
1077307|NCT02395042|3505806|P1|Treatment 1 Period|Lost to Follow-up|1
1077308|NCT02395042|3505804|P3|Treatment 1 Period|Lack of Efficacy|0
1077309|NCT02395042|3505805|P2|Treatment 1 Period|Lack of Efficacy|1
1077310|NCT02395042|3505806|P1|Treatment 1 Period|Lack of Efficacy|1
1077311|NCT02395042|3505804|P3|Treatment 1 Period|Adverse Event|1
1077312|NCT02395042|3505805|P2|Treatment 1 Period|Adverse Event|3
1077313|NCT02395042|3505806|P1|Treatment 1 Period|Adverse Event|1
1077314|NCT02394925|3505823|P1|Overall Study|Unsatisfactory Visual Response|5
1077315|NCT02394925|3505823|P1|Overall Study|No longer meet eligibility criteria|1
1077316|NCT02394925|3505823|P1|Overall Study|Protocol Violation|5
1077317|NCT02394925|3505823|P1|Overall Study|Lost to Follow-up|9
1077318|NCT02394925|3505823|P1|Overall Study|Lens handling difficulities|5
1077319|NCT02394925|3505823|P1|Overall Study|Lens Discomfort|3
1077320|NCT02394925|3505823|P1|Overall Study|Adverse Event|1
1077321|NCT02394808|3505831|P2|Period 2|Lost to Follow-up|0
1077322|NCT02394808|3505832|P1|Period 2|Lost to Follow-up|1
1077323|NCT02394808|3505831|P2|Period 1|Unsatisfactory lens fitting|1
1077324|NCT02394808|3505832|P1|Period 1|Unsatisfactory lens fitting|0
1077325|NCT02394756|3505840|P6|Period 2|Unsatisfactory Visual Response|0
1077326|NCT02394756|3505841|P5|Period 2|Unsatisfactory Visual Response|1
1077327|NCT02394756|3505842|P4|Period 2|Unsatisfactory Visual Response|0
1077328|NCT02394756|3505843|P3|Period 2|Unsatisfactory Visual Response|0
1077329|NCT02394756|3505844|P2|Period 2|Unsatisfactory Visual Response|0
1077330|NCT02394756|3505845|P1|Period 2|Unsatisfactory Visual Response|0
1077331|NCT02394756|3505840|P6|Period 1|Withdrawal by Subject|0
1077332|NCT02394756|3505841|P5|Period 1|Withdrawal by Subject|0
1077333|NCT02394756|3505842|P4|Period 1|Withdrawal by Subject|1
1077334|NCT02394756|3505843|P3|Period 1|Withdrawal by Subject|1
1077335|NCT02394756|3505844|P2|Period 1|Withdrawal by Subject|1
1077336|NCT02394756|3505845|P1|Period 1|Withdrawal by Subject|0
1077337|NCT02394756|3505840|P6|Period 1|Lens Discomfort|1
1077338|NCT02394756|3505841|P5|Period 1|Lens Discomfort|0
1077339|NCT02394756|3505842|P4|Period 1|Lens Discomfort|0
1077340|NCT02394756|3505843|P3|Period 1|Lens Discomfort|0
1077341|NCT02394756|3505844|P2|Period 1|Lens Discomfort|0
1077342|NCT02394756|3505845|P1|Period 1|Lens Discomfort|0
1077343|NCT02394665|3505859|P3|Overall Study|Physician Decision|0
1077344|NCT02394665|3505860|P2|Overall Study|Physician Decision|0
1077345|NCT02394665|3505861|P1|Overall Study|Physician Decision|1
1077346|NCT02394600|3505883|P2|Overall Study|Protocol Violation|0
1077347|NCT02394600|3505884|P1|Overall Study|Protocol Violation|1
1077348|NCT02394600|3505883|P2|Overall Study|Withdrawal by Subject|1
1077349|NCT02394600|3505884|P1|Overall Study|Withdrawal by Subject|0
1077350|NCT02394600|3505883|P2|Overall Study|Lost to Follow-up|1
1077351|NCT02394600|3505884|P1|Overall Study|Lost to Follow-up|0
1077352|NCT02394600|3505883|P2|Overall Study|Adverse Event|0
1077353|NCT02394600|3505884|P1|Overall Study|Adverse Event|3
1077354|NCT02393950|3505913|P2|Overall Study|Withdrawal by Subject|1
1077355|NCT02393950|3505914|P1|Overall Study|Withdrawal by Subject|0
1077356|NCT02393950|3505913|P2|Overall Study|Adverse Event|0
1077357|NCT02393950|3505914|P1|Overall Study|Adverse Event|1
1077358|NCT02393547|3505988|P1|Overall Study|Lost to Follow-up|1
1077359|NCT02393547|3505988|P1|Overall Study|Withdrawal by Subject|3
1077360|NCT02393547|3505988|P1|Overall Study|Adverse Event|2
1077361|NCT02393209|3505997|P4|Overall Study|Lost to Follow-up|0
1077362|NCT02393209|3505998|P3|Overall Study|Lost to Follow-up|0
1077363|NCT02393209|3505999|P2|Overall Study|Lost to Follow-up|1
1077364|NCT02393209|3506000|P1|Overall Study|Lost to Follow-up|0
1077365|NCT02393209|3505997|P4|Overall Study|Patient Seen by Another Oncologist|0
1077366|NCT02393209|3505998|P3|Overall Study|Patient Seen by Another Oncologist|0
1077367|NCT02393209|3505999|P2|Overall Study|Patient Seen by Another Oncologist|1
1077368|NCT02393209|3506000|P1|Overall Study|Patient Seen by Another Oncologist|0
1077369|NCT02393209|3505997|P4|Overall Study|Death from Legionella Infection|0
1077370|NCT02393209|3505998|P3|Overall Study|Death from Legionella Infection|0
1077371|NCT02393209|3505999|P2|Overall Study|Death from Legionella Infection|1
1077372|NCT02393209|3506000|P1|Overall Study|Death from Legionella Infection|0
1077373|NCT02393209|3505997|P4|Overall Study|Death due to Disease Progression|0
1077374|NCT02393209|3505998|P3|Overall Study|Death due to Disease Progression|0
1077375|NCT02393209|3505999|P2|Overall Study|Death due to Disease Progression|2
1077376|NCT02393209|3506000|P1|Overall Study|Death due to Disease Progression|2
1077377|NCT02393209|3505997|P4|Overall Study|Death|0
1077378|NCT02393209|3505998|P3|Overall Study|Death|0
1077379|NCT02393209|3505999|P2|Overall Study|Death|2
1077380|NCT02393209|3506000|P1|Overall Study|Death|2
1077381|NCT02393209|3505997|P4|Overall Study|Withdrawal by Patient|0
1077382|NCT02393209|3505998|P3|Overall Study|Withdrawal by Patient|0
1077383|NCT02393209|3505999|P2|Overall Study|Withdrawal by Patient|0
1077384|NCT02393209|3506000|P1|Overall Study|Withdrawal by Patient|1
1077385|NCT02393209|3505997|P4|Overall Study|Study Terminated by Sponsor|0
1077386|NCT02393209|3505998|P3|Overall Study|Study Terminated by Sponsor|0
1077387|NCT02393209|3505999|P2|Overall Study|Study Terminated by Sponsor|1
1077388|NCT02393209|3506000|P1|Overall Study|Study Terminated by Sponsor|1
1077389|NCT02392624|3506089|P3|Overall Study|Other|1
1077390|NCT02392624|3506090|P2|Overall Study|Other|1
1077391|NCT02392624|3506091|P1|Overall Study|Other|49
1077392|NCT02392624|3506089|P3|Overall Study|Sponsor/Investigator Decision|0
1077393|NCT02392624|3506090|P2|Overall Study|Sponsor/Investigator Decision|1
1077394|NCT02392624|3506091|P1|Overall Study|Sponsor/Investigator Decision|2
1077395|NCT02392624|3506089|P3|Overall Study|Protocol Violation|1
1077396|NCT02392624|3506090|P2|Overall Study|Protocol Violation|0
1077397|NCT02392624|3506091|P1|Overall Study|Protocol Violation|0
1077398|NCT02392624|3506089|P3|Overall Study|Pregnancy|0
1077399|NCT02392624|3506090|P2|Overall Study|Pregnancy|0
1077400|NCT02392624|3506091|P1|Overall Study|Pregnancy|1
1077401|NCT02392624|3506089|P3|Overall Study|Adverse Event|2
1077402|NCT02392624|3506090|P2|Overall Study|Adverse Event|1
1077403|NCT02392624|3506091|P1|Overall Study|Adverse Event|4
1077404|NCT02392624|3506089|P3|Overall Study|Withdrawal by Subject|9
1077405|NCT02392624|3506090|P2|Overall Study|Withdrawal by Subject|12
1077406|NCT02392624|3506091|P1|Overall Study|Withdrawal by Subject|15
1077407|NCT02392481|3506128|P4|Overall Study|Withdrawal by Subject|0
1077408|NCT02392481|3506129|P3|Overall Study|Withdrawal by Subject|1
1077409|NCT02392481|3506130|P2|Overall Study|Withdrawal by Subject|0
1077410|NCT02392481|3506131|P1|Overall Study|Withdrawal by Subject|0
1077411|NCT02392481|3506128|P4|Overall Study|Adverse Event|2
1077412|NCT02392481|3506129|P3|Overall Study|Adverse Event|1
1077413|NCT02392481|3506130|P2|Overall Study|Adverse Event|0
1077414|NCT02392481|3506131|P1|Overall Study|Adverse Event|0
1077415|NCT02392403|3506153|P1|Overall Study|Withdrawal by Subject|1
1077416|NCT02392403|3506153|P1|Overall Study|Death|1
1077417|NCT02392403|3506153|P1|Overall Study|Adverse Event|1
1077418|NCT02392377|3506167|P2|Overall Study|Withdrawal by Subject|1
1077419|NCT02392377|3506168|P1|Overall Study|Withdrawal by Subject|0
1077420|NCT02392247|3506192|P1|Overall Study|Surgery cancelled; no data|1
1077421|NCT02392247|3506192|P1|Overall Study|Withdrawal by Subject|1
1077422|NCT02392234|3506203|P6|Treatment Period 2 (8 Weeks)|Adverse Event|0
1077423|NCT02392234|3506204|P5|Treatment Period 2 (8 Weeks)|Adverse Event|0
1077424|NCT02392234|3506205|P4|Treatment Period 2 (8 Weeks)|Adverse Event|0
1077425|NCT02392234|3506206|P3|Treatment Period 2 (8 Weeks)|Adverse Event|0
1077426|NCT02392234|3506207|P2|Treatment Period 2 (8 Weeks)|Adverse Event|0
1077427|NCT02392234|3506208|P1|Treatment Period 2 (8 Weeks)|Adverse Event|1
1077428|NCT02392234|3506203|P6|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
1077429|NCT02392234|3506204|P5|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
1077430|NCT02392234|3506205|P4|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
1077431|NCT02392234|3506206|P3|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
1077432|NCT02392234|3506207|P2|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
1077433|NCT02392234|3506208|P1|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
1077434|NCT02392234|3506203|P6|Treatment Period 1 (8 Weeks)|Other|0
1077435|NCT02392234|3506204|P5|Treatment Period 1 (8 Weeks)|Other|0
1077436|NCT02392234|3506205|P4|Treatment Period 1 (8 Weeks)|Other|0
1077437|NCT02392234|3506206|P3|Treatment Period 1 (8 Weeks)|Other|0
1077438|NCT02392234|3506207|P2|Treatment Period 1 (8 Weeks)|Other|0
1077439|NCT02392234|3506208|P1|Treatment Period 1 (8 Weeks)|Other|1
1077440|NCT02392234|3506203|P6|Treatment Period 1 (8 Weeks)|Noncompliance|1
1077441|NCT02392234|3506204|P5|Treatment Period 1 (8 Weeks)|Noncompliance|0
1077442|NCT02392234|3506205|P4|Treatment Period 1 (8 Weeks)|Noncompliance|0
1077443|NCT02392234|3506206|P3|Treatment Period 1 (8 Weeks)|Noncompliance|0
1077444|NCT02392234|3506207|P2|Treatment Period 1 (8 Weeks)|Noncompliance|0
1077445|NCT02392234|3506208|P1|Treatment Period 1 (8 Weeks)|Noncompliance|0
1077446|NCT02392234|3506203|P6|Treatment Period 1 (8 Weeks)|Pregnancy|0
1077447|NCT02392234|3506204|P5|Treatment Period 1 (8 Weeks)|Pregnancy|0
1077448|NCT02392234|3506205|P4|Treatment Period 1 (8 Weeks)|Pregnancy|1
1077449|NCT02392234|3506206|P3|Treatment Period 1 (8 Weeks)|Pregnancy|0
1077450|NCT02392234|3506207|P2|Treatment Period 1 (8 Weeks)|Pregnancy|0
1077451|NCT02392234|3506208|P1|Treatment Period 1 (8 Weeks)|Pregnancy|1
1077452|NCT02392234|3506203|P6|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
1077453|NCT02392234|3506204|P5|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
1077454|NCT02392234|3506205|P4|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
1077455|NCT02392234|3506206|P3|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
1077456|NCT02392234|3506207|P2|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
1077457|NCT02392234|3506208|P1|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
1077458|NCT02392234|3506203|P6|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
1077459|NCT02392234|3506204|P5|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2
1077460|NCT02392234|3506205|P4|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
1077461|NCT02392234|3506206|P3|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
1077462|NCT02392234|3506207|P2|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
1077463|NCT02392234|3506208|P1|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
1077464|NCT02392234|3506203|P6|Treatment Period 1 (8 Weeks)|Adverse Event|1
1077465|NCT02392234|3506204|P5|Treatment Period 1 (8 Weeks)|Adverse Event|1
1077466|NCT02392234|3506205|P4|Treatment Period 1 (8 Weeks)|Adverse Event|0
1077467|NCT02392234|3506206|P3|Treatment Period 1 (8 Weeks)|Adverse Event|1
1077468|NCT02392234|3506207|P2|Treatment Period 1 (8 Weeks)|Adverse Event|0
1077469|NCT02392234|3506208|P1|Treatment Period 1 (8 Weeks)|Adverse Event|1
1077470|NCT02392000|3506240|P1|Overall Study|Lost to Follow-up|8
1077471|NCT02392000|3506240|P1|Overall Study|Withdrawal by Subject|1
1077472|NCT02392000|3506240|P1|Overall Study|Greater than mild sleep apnea exclusion|18
1077473|NCT02391584|3506263|P2|12 Month (End of Study)|Lost to Follow-up|0
1077474|NCT02391584|3506264|P1|12 Month (End of Study)|Lost to Follow-up|2
1077475|NCT02391584|3506263|P2|6 Month|Withdrawal by Subject|0
1077476|NCT02391584|3506264|P1|6 Month|Withdrawal by Subject|1
1077477|NCT02391584|3506263|P2|3 Month|Lost to Follow-up|0
1077478|NCT02391584|3506264|P1|3 Month|Lost to Follow-up|1
1077479|NCT02391584|3506263|P2|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0
1077480|NCT02391584|3506264|P1|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1
1077481|NCT02391584|3506263|P2|Primary Endpoint (6-weeks)|Lost to Follow-up|2
1077482|NCT02391584|3506264|P1|Primary Endpoint (6-weeks)|Lost to Follow-up|1
1077483|NCT02391311|3506281|P2|Overall Study|deemed ineligible after baseline|1
1077484|NCT02391311|3506282|P1|Overall Study|deemed ineligible after baseline|1
1077485|NCT02391311|3506281|P2|Overall Study|Lost to Follow-up|1
1077486|NCT02391311|3506282|P1|Overall Study|Lost to Follow-up|2
1077487|NCT02391116|3506290|P1|Survival Follow-up|Ongoing with Survival Follow-up|12
1077488|NCT02391116|3506290|P1|Survival Follow-up|Withdrawal by Subject|2
1077489|NCT02391116|3506290|P1|Active Follow-up|Switching to Other Therapy|2
1077490|NCT02391116|3506290|P1|Active Follow-up|Withdrawal by Subject|1
1077491|NCT02391116|3506290|P1|Safety Follow-up|Deterioration of General Conditions|3
1077492|NCT02391116|3506290|P1|Safety Follow-up|No Follow Up|1
1077493|NCT02391116|3506290|P1|Safety Follow-up|Switching to Other Therapy|4
1077494|NCT02391116|3506290|P1|Safety Follow-up|Withdrawal by Subject|4
1077495|NCT02391116|3506290|P1|Safety Follow-up|Adverse Event|1
1077496|NCT02391116|3506290|P1|Treatment|Ongoing with Treatment|1
1077497|NCT02391116|3506290|P1|Treatment|AE with Clinical PD|3
1077498|NCT02391116|3506290|P1|Treatment|Adverse Event (AE) Without Clinical PD|9
1077499|NCT02391116|3506290|P1|Treatment|Protocol Violation|1
1077500|NCT02391116|3506290|P1|Treatment|Withdrawal by Subject|1
1077501|NCT02391038|3506343|P3|Overall Study|Progressive disease|6
1077502|NCT02391038|3506344|P2|Overall Study|Progressive disease|3
1077503|NCT02391038|3506345|P1|Overall Study|Progressive disease|3
1077504|NCT02390557|3506462|P3|Wave 2|Survey non-respondent|23
1077505|NCT02390557|3506463|P2|Wave 2|Survey non-respondent|41
1077506|NCT02390557|3506464|P1|Wave 2|Survey non-respondent|72
1077507|NCT02390219|3506472|P1|Overall Study|Other|2
1077508|NCT02390219|3506472|P1|Overall Study|Lost to Follow-up|2
1077509|NCT02390219|3506472|P1|Overall Study|Withdrawal by Subject|1
1077510|NCT02390219|3506472|P1|Overall Study|Adverse Event|6
1077511|NCT02390219|3506472|P1|Overall Study|Physician Decision|1
1077512|NCT02390219|3506472|P1|Overall Study|Death|1
1077513|NCT02390167|3506482|P1|Overall Study|Lost to Follow-up|1
1077514|NCT02389829|3506565|P2|Overall Study|Lost to Follow-up|1
1077515|NCT02389829|3506566|P1|Overall Study|Lost to Follow-up|0
1077516|NCT02389621|3506584|P2|Posttreatment Period|Other - Miscellaneous|0
1077517|NCT02389621|3506585|P1|Posttreatment Period|Other - Miscellaneous|2
1077518|NCT02389621|3506584|P2|Posttreatment Period|Lost to Follow-up|1
1077519|NCT02389621|3506585|P1|Posttreatment Period|Lost to Follow-up|1
1077520|NCT02389621|3506584|P2|Posttreatment Period|Withdrawal by Subject|2
1077521|NCT02389621|3506585|P1|Posttreatment Period|Withdrawal by Subject|3
1077522|NCT02389621|3506584|P2|Posttreatment Period|Adverse Event|1
1077523|NCT02389621|3506585|P1|Posttreatment Period|Adverse Event|3
1077524|NCT02389621|3506584|P2|Treatment Period|Withdrawal by Subject|1
1077525|NCT02389621|3506585|P1|Treatment Period|Withdrawal by Subject|1
1077526|NCT02389452|3506615|P1|Overall Study|Enrolled but Not Eligible for Study|6
1077527|NCT02389452|3506615|P1|Overall Study|Withdrawal by Subject|5
1077528|NCT02389452|3506615|P1|Overall Study|Adverse Event|1
1077529|NCT02389452|3506615|P1|Overall Study|Lost to Follow-up|13
1077530|NCT02388997|3506723|P2|Overall Study|Tested positive for virus during run-in|1
1077531|NCT02388997|3506724|P1|Overall Study|Tested positive for virus during run-in|0
1077532|NCT02388997|3506723|P2|Overall Study|Lung function exclusion criteria|2
1077533|NCT02388997|3506724|P1|Overall Study|Lung function exclusion criteria|0
1077534|NCT02388997|3506723|P2|Overall Study|Withdrawal by Subject|1
1077535|NCT02388997|3506724|P1|Overall Study|Withdrawal by Subject|2
1077536|NCT02388997|3506723|P2|Overall Study|Adverse Event|2
1077537|NCT02388997|3506724|P1|Overall Study|Adverse Event|1
1077538|NCT02388932|3506742|P1|Overall Study|Death|1
1077539|NCT02388776|3506755|P1|Overall Study|Lost to Follow-up|1
1077540|NCT02388776|3506755|P1|Overall Study|Death|1
1077541|NCT02388763|3506760|P2|Period 1, 10 Days of Wear|Withdrawal by Subject|1
1077542|NCT02388763|3506761|P1|Period 1, 10 Days of Wear|Withdrawal by Subject|1
1077543|NCT02388763|3506760|P2|Habitual, 10 Days of Wear|Withdrawal by Subject|1
1077544|NCT02388763|3506761|P1|Habitual, 10 Days of Wear|Withdrawal by Subject|1
1077545|NCT02388347|3506796|P5|Overall Study|Withdrawal by Subject|0
1077546|NCT02388347|3506797|P4|Overall Study|Withdrawal by Subject|0
1077547|NCT02388347|3506798|P3|Overall Study|Withdrawal by Subject|1
1077548|NCT02388347|3506799|P2|Overall Study|Withdrawal by Subject|0
1077549|NCT02388347|3506800|P1|Overall Study|Withdrawal by Subject|0
1077550|NCT02388295|3506879|P3|Treatment Weeks 3 to 12|Adverse Event|0
1077551|NCT02388295|3506880|P2|Treatment Weeks 3 to 12|Adverse Event|1
1077552|NCT02388295|3506881|P1|Treatment Weeks 3 to 12|Adverse Event|1
1077553|NCT02388295|3506879|P3|Dose Escalation Week 2|Determined not eligible|1
1077554|NCT02388295|3506880|P2|Dose Escalation Week 2|Determined not eligible|1
1077555|NCT02388295|3506881|P1|Dose Escalation Week 2|Determined not eligible|1
1077556|NCT02388295|3506879|P3|Dose Escalation Week 2|Protocol Violation|0
1077557|NCT02388295|3506880|P2|Dose Escalation Week 2|Protocol Violation|1
1077558|NCT02388295|3506881|P1|Dose Escalation Week 2|Protocol Violation|0
1077559|NCT02388295|3506879|P3|Dose Escalation Week 1|Determined not eligible|1
1077560|NCT02388295|3506880|P2|Dose Escalation Week 1|Determined not eligible|1
1077561|NCT02388295|3506881|P1|Dose Escalation Week 1|Determined not eligible|1
1077562|NCT02388295|3506879|P3|Dose Escalation Week 1|Adverse Event|1
1077563|NCT02388295|3506880|P2|Dose Escalation Week 1|Adverse Event|2
1077564|NCT02388295|3506881|P1|Dose Escalation Week 1|Adverse Event|1
1077565|NCT02388269|3506899|P3|Overall Study|Screen Failure|10
1077566|NCT02388269|3506900|P2|Overall Study|Screen Failure|0
1077567|NCT02388269|3506901|P1|Overall Study|Screen Failure|0
1077568|NCT02388269|3506899|P3|Overall Study|Protocol Violation|0
1077569|NCT02388269|3506900|P2|Overall Study|Protocol Violation|0
1077570|NCT02388269|3506901|P1|Overall Study|Protocol Violation|2
1077571|NCT02388269|3506899|P3|Overall Study|no diary data|0
1077572|NCT02388269|3506900|P2|Overall Study|no diary data|0
1077573|NCT02388269|3506901|P1|Overall Study|no diary data|3
1077574|NCT02388269|3506899|P3|Overall Study|less than 50% stimulations|0
1077575|NCT02388269|3506900|P2|Overall Study|less than 50% stimulations|0
1077576|NCT02388269|3506901|P1|Overall Study|less than 50% stimulations|1
1077577|NCT02388269|3506899|P3|Overall Study|Withdrawal by Subject|0
1077578|NCT02388269|3506900|P2|Overall Study|Withdrawal by Subject|2
1077579|NCT02388269|3506901|P1|Overall Study|Withdrawal by Subject|1
1077580|NCT02388269|3506899|P3|Overall Study|Adverse Event|0
1077581|NCT02388269|3506900|P2|Overall Study|Adverse Event|0
1077582|NCT02388269|3506901|P1|Overall Study|Adverse Event|2
1077583|NCT02388191|3506933|P2|Overall Study|Patient did not receive IUD|0
1077584|NCT02388191|3506934|P1|Overall Study|Patient did not receive IUD|1
1077585|NCT02388074|3506948|P1|Overall Study|Sample Not Returned|1
1077586|NCT02388074|3506948|P1|Overall Study|Lost in Transit|2
1077587|NCT02387996|3506952|P1|Overall Study|Poor/Non-Compliance|1
1077588|NCT02387996|3506952|P1|Overall Study|Lost to Follow-up|1
1077589|NCT02387996|3506952|P1|Overall Study|Subject Withdrew Consent|1
1077590|NCT02387996|3506952|P1|Overall Study|Subject Request to Discontinue Treatment|9
1077591|NCT02387996|3506952|P1|Overall Study|Adverse Event Unrelated to Study Drug|34
1077592|NCT02387996|3506952|P1|Overall Study|Study Drug Toxicity|14
1077593|NCT02387996|3506952|P1|Overall Study|Disease Progression|144
1077594|NCT02387983|3506963|P1|Overall Study|Withdrawal by Subject|2
1077595|NCT02387983|3506963|P1|Overall Study|Protocol Violation|1
1077596|NCT02387983|3506963|P1|Overall Study|Adverse Event|4
1077597|NCT02387580|3507022|P6|Overall Study|Withdrawal by Subject|0
1077598|NCT02387580|3507023|P5|Overall Study|Withdrawal by Subject|0
1077599|NCT02387580|3507024|P4|Overall Study|Withdrawal by Subject|1
1077600|NCT02387580|3507025|P3|Overall Study|Withdrawal by Subject|0
1077601|NCT02387580|3507026|P2|Overall Study|Withdrawal by Subject|0
1077602|NCT02387580|3507027|P1|Overall Study|Withdrawal by Subject|0
1077603|NCT02386098|3507128|P5|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
1077604|NCT02386098|3507129|P4|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
1077605|NCT02386098|3507130|P3|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
1077606|NCT02386098|3507131|P2|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8
1077607|NCT02386098|3507132|P1|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5
1077608|NCT02386098|3507128|P5|Stage 1 (96 Weeks)|Other|0
1077609|NCT02386098|3507129|P4|Stage 1 (96 Weeks)|Other|0
1077610|NCT02386098|3507130|P3|Stage 1 (96 Weeks)|Other|0
1077611|NCT02386098|3507131|P2|Stage 1 (96 Weeks)|Other|0
1077612|NCT02386098|3507132|P1|Stage 1 (96 Weeks)|Other|1
1077613|NCT02386098|3507128|P5|Stage 1 (96 Weeks)|Withdrawal by Subject|0
1077614|NCT02386098|3507129|P4|Stage 1 (96 Weeks)|Withdrawal by Subject|0
1077615|NCT02386098|3507130|P3|Stage 1 (96 Weeks)|Withdrawal by Subject|0
1077616|NCT02386098|3507131|P2|Stage 1 (96 Weeks)|Withdrawal by Subject|1
1077617|NCT02386098|3507132|P1|Stage 1 (96 Weeks)|Withdrawal by Subject|3
1077618|NCT02386098|3507128|P5|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
1077619|NCT02386098|3507129|P4|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
1077620|NCT02386098|3507130|P3|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
1077621|NCT02386098|3507131|P2|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2
1077622|NCT02386098|3507132|P1|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
1077623|NCT02386098|3507128|P5|Stage 1 (96 Weeks)|Lost to Follow-up|0
1077624|NCT02386098|3507129|P4|Stage 1 (96 Weeks)|Lost to Follow-up|0
1077625|NCT02386098|3507130|P3|Stage 1 (96 Weeks)|Lost to Follow-up|0
1077626|NCT02386098|3507131|P2|Stage 1 (96 Weeks)|Lost to Follow-up|2
1077627|NCT02386098|3507132|P1|Stage 1 (96 Weeks)|Lost to Follow-up|2
1077628|NCT02386098|3507128|P5|Stage 1 (96 Weeks)|Adverse Event|0
1077629|NCT02386098|3507129|P4|Stage 1 (96 Weeks)|Adverse Event|0
1077630|NCT02386098|3507130|P3|Stage 1 (96 Weeks)|Adverse Event|0
1077631|NCT02386098|3507131|P2|Stage 1 (96 Weeks)|Adverse Event|1
1077632|NCT02386098|3507132|P1|Stage 1 (96 Weeks)|Adverse Event|2
1077633|NCT02386098|3507128|P5|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
1077634|NCT02386098|3507129|P4|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
1077635|NCT02386098|3507130|P3|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
1077636|NCT02386098|3507131|P2|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29
1077637|NCT02386098|3507132|P1|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30
1077638|NCT02385526|3507212|P3|Overall Study|Protocol Violation|0
1077639|NCT02385526|3507213|P2|Overall Study|Protocol Violation|0
1077640|NCT02385526|3507214|P1|Overall Study|Protocol Violation|1
1077641|NCT02385526|3507212|P3|Overall Study|Physician Decision|0
1077642|NCT02385526|3507213|P2|Overall Study|Physician Decision|0
1077643|NCT02385526|3507214|P1|Overall Study|Physician Decision|1
1077644|NCT02385526|3507212|P3|Overall Study|Lost to Follow-up|0
1077645|NCT02385526|3507213|P2|Overall Study|Lost to Follow-up|1
1077646|NCT02385526|3507214|P1|Overall Study|Lost to Follow-up|0
1077647|NCT02385526|3507212|P3|Overall Study|Withdrawal by Subject|0
1077648|NCT02385526|3507213|P2|Overall Study|Withdrawal by Subject|2
1077649|NCT02385526|3507214|P1|Overall Study|Withdrawal by Subject|0
1077650|NCT02385084|3507222|P6|Period 2|Protocol Violation|0
1077651|NCT02385084|3507223|P5|Period 2|Protocol Violation|0
1077652|NCT02385084|3507224|P4|Period 2|Protocol Violation|0
1077653|NCT02385084|3507225|P3|Period 2|Protocol Violation|1
1077654|NCT02385084|3507226|P2|Period 2|Protocol Violation|0
1077655|NCT02385084|3507227|P1|Period 2|Protocol Violation|0
1077656|NCT02384538|3507240|P2|Overall Study|Not Specified|3
1077657|NCT02384538|3507241|P1|Overall Study|Not Specified|1
1077658|NCT02384538|3507240|P2|Overall Study|Withdrew Consent|4
1077659|NCT02384538|3507241|P1|Overall Study|Withdrew Consent|0
1077660|NCT02384538|3507240|P2|Overall Study|Lack of Efficacy|4
1077661|NCT02384538|3507241|P1|Overall Study|Lack of Efficacy|4
1077662|NCT02384538|3507240|P2|Overall Study|Adverse Event|4
1077663|NCT02384538|3507241|P1|Overall Study|Adverse Event|1
1077664|NCT02384460|3507261|P2|Overall Study|Non-compliance|0
1077665|NCT02384460|3507262|P1|Overall Study|Non-compliance|1
1077666|NCT02384460|3507261|P2|Overall Study|Elective medical treatment|0
1077667|NCT02384460|3507262|P1|Overall Study|Elective medical treatment|1
1077668|NCT02384460|3507261|P2|Overall Study|Withdrawal by Subject|3
1077669|NCT02384460|3507262|P1|Overall Study|Withdrawal by Subject|0
1077670|NCT02384460|3507261|P2|Overall Study|Adverse Event|2
1077671|NCT02384460|3507262|P1|Overall Study|Adverse Event|5
1077672|NCT02384460|3507261|P2|Overall Study|Returned to previous therapeutic regimen|1
1077673|NCT02384460|3507262|P1|Overall Study|Returned to previous therapeutic regimen|0
1077674|NCT02384460|3507261|P2|Overall Study|Protocol Violation|1
1077675|NCT02384460|3507262|P1|Overall Study|Protocol Violation|0
1077676|NCT02383862|3507309|P2|3 Month Follow up|Lost to Follow-up|21
1077677|NCT02383862|3507310|P1|3 Month Follow up|Lost to Follow-up|23
1077678|NCT02383758|3507343|P2|Overall Study|Withdrawal by Subject|2
1077679|NCT02383758|3507344|P1|Overall Study|Withdrawal by Subject|0
1077680|NCT02383576|3507362|P2|Overall Study|Administrative/Other|4
1077681|NCT02383576|3507363|P1|Overall Study|Administrative/Other|2
1077682|NCT02383576|3507362|P2|Overall Study|Investigator's Decision|1
1077683|NCT02383576|3507363|P1|Overall Study|Investigator's Decision|0
1077684|NCT02383576|3507362|P2|Overall Study|Withdrew Consent|6
1077685|NCT02383576|3507363|P1|Overall Study|Withdrew Consent|1
1077686|NCT02383576|3507362|P2|Overall Study|Lost to Follow-up|1
1077687|NCT02383576|3507363|P1|Overall Study|Lost to Follow-up|7
1077688|NCT02383576|3507362|P2|Overall Study|Death|33
1077689|NCT02383576|3507363|P1|Overall Study|Death|53
1077690|NCT02383472|3507379|P2|Overall Study|Withdrawal by Subject|1
1077691|NCT02383472|3507380|P1|Overall Study|Withdrawal by Subject|1
1077692|NCT02382640|3507500|P4|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
1077693|NCT02382640|3507501|P3|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
1077694|NCT02382640|3507502|P2|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
1077695|NCT02382640|3507503|P1|Intervention Period 4 (3 Days)|Laboratory Abnormality|1
1077696|NCT02382133|3507541|P1|Overall Study|pressure injury both sites|1
1077697|NCT02382133|3507541|P1|Overall Study|arterial catheter loss|4
1077698|NCT02382133|3507541|P1|Overall Study|Physician Decision|2
1077699|NCT02382133|3507541|P1|Overall Study|transfer out of ICU|4
1077700|NCT02382133|3507541|P1|Overall Study|Death|22
1077701|NCT02382016|3507548|P2|Overall Study|Withdrawal by Subject|1
1077702|NCT02382016|3507549|P1|Overall Study|Withdrawal by Subject|0
1077703|NCT02382016|3507548|P2|Overall Study|Lack of Efficacy|0
1077704|NCT02382016|3507549|P1|Overall Study|Lack of Efficacy|1
1077705|NCT02382016|3507548|P2|Overall Study|Physician Decision|0
1077706|NCT02382016|3507549|P1|Overall Study|Physician Decision|3
1077707|NCT02381795|3507571|P1|Overall Study|Study Terminated|2
1077708|NCT02381795|3507571|P1|Overall Study|Withdrawal by Subject|1
1077709|NCT02380742|3507642|P2|Overall Study|Withdrawal by Subject|0
1077710|NCT02380742|3507643|P1|Overall Study|Withdrawal by Subject|1
1077711|NCT02380287|3507663|P8|Overall Study|Adverse Event|0
1077712|NCT02380287|3507664|P7|Overall Study|Adverse Event|0
1077713|NCT02380287|3507665|P6|Overall Study|Adverse Event|0
1077714|NCT02380287|3507666|P5|Overall Study|Adverse Event|0
1077715|NCT02380287|3507667|P4|Overall Study|Adverse Event|0
1077716|NCT02380287|3507668|P3|Overall Study|Adverse Event|1
1077717|NCT02380287|3507669|P2|Overall Study|Adverse Event|0
1077718|NCT02380287|3507670|P1|Overall Study|Adverse Event|0
1077719|NCT02380248|3507686|P1|Overall Study|Withdrawal by Subject|3
1077720|NCT02380248|3507686|P1|Overall Study|Lost to Follow-up|11
1077721|NCT02379923|3507691|P1|Overall Study|Death|5
1077722|NCT02379637|3507707|P2|Overall Study|Withdrawal by Subject|0
1077723|NCT02379637|3507708|P1|Overall Study|Withdrawal by Subject|1
1077724|NCT02379637|3507707|P2|Overall Study|Adverse Event|0
1077725|NCT02379637|3507708|P1|Overall Study|Adverse Event|1
1077726|NCT02379637|3507707|P2|Overall Study|Protocol Violation|1
1077727|NCT02379637|3507708|P1|Overall Study|Protocol Violation|0
1077728|NCT02379221|3507741|P1|Overall Study|Lost to Follow-up|1
1077729|NCT02379091|3507760|P4|Overall Study|Lack of Efficacy|0
1077730|NCT02379091|3507761|P3|Overall Study|Lack of Efficacy|0
1077731|NCT02379091|3507762|P2|Overall Study|Lack of Efficacy|0
1077732|NCT02379091|3507763|P1|Overall Study|Lack of Efficacy|3
1077733|NCT02379091|3507760|P4|Overall Study|Study Termination|8
1077734|NCT02379091|3507761|P3|Overall Study|Study Termination|5
1077735|NCT02379091|3507762|P2|Overall Study|Study Termination|2
1077736|NCT02379091|3507763|P1|Overall Study|Study Termination|7
1077737|NCT02379091|3507760|P4|Overall Study|Voluntary Withdrawal|4
1077738|NCT02379091|3507761|P3|Overall Study|Voluntary Withdrawal|2
1077739|NCT02379091|3507762|P2|Overall Study|Voluntary Withdrawal|5
1077740|NCT02379091|3507763|P1|Overall Study|Voluntary Withdrawal|2
1077741|NCT02379091|3507760|P4|Overall Study|Lost to Follow-up|1
1077742|NCT02379091|3507761|P3|Overall Study|Lost to Follow-up|0
1077743|NCT02379091|3507762|P2|Overall Study|Lost to Follow-up|0
1077744|NCT02379091|3507763|P1|Overall Study|Lost to Follow-up|0
1077745|NCT02379091|3507760|P4|Overall Study|Principal Investigator Discretion|0
1077746|NCT02379091|3507761|P3|Overall Study|Principal Investigator Discretion|0
1077747|NCT02379091|3507762|P2|Overall Study|Principal Investigator Discretion|1
1077748|NCT02379091|3507763|P1|Overall Study|Principal Investigator Discretion|0
1077749|NCT02379091|3507760|P4|Overall Study|Pretreatment Event/Adverse Event|1
1077750|NCT02379091|3507761|P3|Overall Study|Pretreatment Event/Adverse Event|0
1077751|NCT02379091|3507762|P2|Overall Study|Pretreatment Event/Adverse Event|2
1077752|NCT02379091|3507763|P1|Overall Study|Pretreatment Event/Adverse Event|0
1077753|NCT02378961|3507803|P4|Overall Study|Death|0
1077754|NCT02378961|3507804|P3|Overall Study|Death|1
1077755|NCT02378961|3507805|P2|Overall Study|Death|0
1077756|NCT02378961|3507806|P1|Overall Study|Death|0
1077757|NCT02378961|3507803|P4|Overall Study|Lack of Efficacy|1
1077758|NCT02378961|3507804|P3|Overall Study|Lack of Efficacy|0
1077759|NCT02378961|3507805|P2|Overall Study|Lack of Efficacy|2
1077760|NCT02378961|3507806|P1|Overall Study|Lack of Efficacy|4
1077761|NCT02378935|3507843|P7|Overall Study|Death|0
1077762|NCT02378935|3507844|P6|Overall Study|Death|0
1077763|NCT02378935|3507845|P5|Overall Study|Death|0
1077764|NCT02378935|3507846|P4|Overall Study|Death|0
1077765|NCT02378935|3507847|P3|Overall Study|Death|1
1077766|NCT02378935|3507848|P2|Overall Study|Death|0
1077767|NCT02378935|3507849|P1|Overall Study|Death|0
1077768|NCT02378935|3507843|P7|Overall Study|Lack of Efficacy|0
1077769|NCT02378935|3507844|P6|Overall Study|Lack of Efficacy|0
1077770|NCT02378935|3507845|P5|Overall Study|Lack of Efficacy|0
1077771|NCT02378935|3507846|P4|Overall Study|Lack of Efficacy|6
1077772|NCT02378935|3507847|P3|Overall Study|Lack of Efficacy|2
1077773|NCT02378935|3507848|P2|Overall Study|Lack of Efficacy|0
1077774|NCT02378935|3507849|P1|Overall Study|Lack of Efficacy|10
1077775|NCT02378662|3507923|P2|Overall Study|Early Discontinuation|0
1077776|NCT02378662|3507924|P1|Overall Study|Early Discontinuation|2
1077777|NCT02378506|3507930|P1|Overall Study|Randomized But Not Treated|1
1077778|NCT02378506|3507930|P1|Overall Study|Adverse Event|14
1077779|NCT02378506|3507930|P1|Overall Study|Death|1
1077780|NCT02378506|3507930|P1|Overall Study|Protocol Violation|2
1077781|NCT02378506|3507930|P1|Overall Study|Withdrawal by Subject|4
1077782|NCT02378506|3507930|P1|Overall Study|Lack of Efficacy|3
1077783|NCT02378220|3507949|P2|Overall Study|Death|1
1077784|NCT02378220|3507950|P1|Overall Study|Death|6
1077785|NCT02377921|3507982|P2|Overall Study|Subject non-compliance|1
1077786|NCT02377921|3507983|P1|Overall Study|Subject non-compliance|1
1077787|NCT02377466|3508007|P2|Overall Study|Other: Randomized and not treated|2
1077788|NCT02377466|3508008|P1|Overall Study|Other: Randomized and not treated|0
1077789|NCT02377427|3508126|P5|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
1077790|NCT02377427|3508127|P4|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
1077791|NCT02377427|3508128|P3|Part B (From Week 20 and up to Week 80)|Protocol Violation|1
1077792|NCT02377427|3508129|P2|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
1077793|NCT02377427|3508130|P1|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
1077794|NCT02377427|3508126|P5|Part A (Up to Week 20)|Withdrawal by Subject|0
1077795|NCT02377427|3508127|P4|Part A (Up to Week 20)|Withdrawal by Subject|0
1077796|NCT02377427|3508128|P3|Part A (Up to Week 20)|Withdrawal by Subject|0
1077797|NCT02377427|3508129|P2|Part A (Up to Week 20)|Withdrawal by Subject|0
1077798|NCT02377427|3508130|P1|Part A (Up to Week 20)|Withdrawal by Subject|2
1077799|NCT02377427|3508126|P5|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
1077800|NCT02377427|3508127|P4|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
1077801|NCT02377427|3508128|P3|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
1077802|NCT02377427|3508129|P2|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
1077803|NCT02377427|3508130|P1|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1
1077804|NCT02377427|3508126|P5|Part A (Up to Week 20)|Physician Decision|0
1077805|NCT02377427|3508127|P4|Part A (Up to Week 20)|Physician Decision|0
1077806|NCT02377427|3508128|P3|Part A (Up to Week 20)|Physician Decision|0
1077807|NCT02377427|3508129|P2|Part A (Up to Week 20)|Physician Decision|0
1077808|NCT02377427|3508130|P1|Part A (Up to Week 20)|Physician Decision|1
1077809|NCT02376166|3508252|P1|Overall Study|Discontinued metformin early|2
1077810|NCT02376166|3508252|P1|Overall Study|Adverse Event|1
1077811|NCT02375971|3508280|P3|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0
1077812|NCT02375971|3508281|P2|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1
1077813|NCT02375971|3508282|P1|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1
1077814|NCT02375971|3508280|P3|Follow-Up Phase (up to Day 169)|Death|4
1077815|NCT02375971|3508281|P2|Follow-Up Phase (up to Day 169)|Death|4
1077816|NCT02375971|3508282|P1|Follow-Up Phase (up to Day 169)|Death|4
1077817|NCT02375971|3508280|P3|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1
1077818|NCT02375971|3508281|P2|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0
1077819|NCT02375971|3508282|P1|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1
1077820|NCT02375971|3508280|P3|Follow-Up Phase (up to Day 169)|Adverse Event|0
1077821|NCT02375971|3508281|P2|Follow-Up Phase (up to Day 169)|Adverse Event|0
1077822|NCT02375971|3508282|P1|Follow-Up Phase (up to Day 169)|Adverse Event|1
1077823|NCT02375971|3508280|P3|Treatment (Day 1 - Baseline)|Adverse Event|1
1077824|NCT02375971|3508281|P2|Treatment (Day 1 - Baseline)|Adverse Event|0
1077825|NCT02375971|3508282|P1|Treatment (Day 1 - Baseline)|Adverse Event|0
1077826|NCT02375971|3508280|P3|Treatment (Day 1 - Baseline)|Lost to Follow-up|1
1077827|NCT02375971|3508281|P2|Treatment (Day 1 - Baseline)|Lost to Follow-up|0
1077828|NCT02375971|3508282|P1|Treatment (Day 1 - Baseline)|Lost to Follow-up|0
1077829|NCT02375971|3508280|P3|Treatment (Day 1 - Baseline)|Physician Decision|1
1077830|NCT02375971|3508281|P2|Treatment (Day 1 - Baseline)|Physician Decision|1
1077831|NCT02375971|3508282|P1|Treatment (Day 1 - Baseline)|Physician Decision|1
1077832|NCT02375971|3508280|P3|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2
1077833|NCT02375971|3508281|P2|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0
1077834|NCT02375971|3508282|P1|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0
1077835|NCT02375724|3508324|P2|Overall Study|Adverse Event|4
1077836|NCT02375724|3508325|P1|Overall Study|Adverse Event|2
1077837|NCT02375724|3508324|P2|Overall Study|Protocol Violation|0
1077838|NCT02375724|3508325|P1|Overall Study|Protocol Violation|1
1077839|NCT02375724|3508324|P2|Overall Study|Lost to Follow-up|0
1077840|NCT02375724|3508325|P1|Overall Study|Lost to Follow-up|1
1077841|NCT02375724|3508324|P2|Overall Study|Withdrawal by Subject|1
1077842|NCT02375724|3508325|P1|Overall Study|Withdrawal by Subject|1
1077843|NCT02375724|3508324|P2|Overall Study|Lack of Efficacy|1
1077844|NCT02375724|3508325|P1|Overall Study|Lack of Efficacy|1
1077845|NCT02375373|3508335|P1|Overall Study|Withdrawal by Subject|11
1077846|NCT02375347|3508339|P1|Overall Study|Protocol Violation|1
1077847|NCT02374957|3508345|P2|Overall Study|Patient did not complete forms correctly|0
1077848|NCT02374957|3508346|P1|Overall Study|Patient did not complete forms correctly|1
1077849|NCT02374593|3508374|P2|Overall Study|non-compliant|0
1077850|NCT02374593|3508375|P1|Overall Study|non-compliant|2
1077851|NCT02374346|3508418|P1|Overall Study|operated or discharged during weekend|48
1077852|NCT02374099|3508448|P2|Overall Study|Study Terminated by Sponsor|4
1077853|NCT02374099|3508449|P1|Overall Study|Study Terminated by Sponsor|3
1077854|NCT02374099|3508448|P2|Overall Study|Randomized, but not treated|1
1077855|NCT02374099|3508449|P1|Overall Study|Randomized, but not treated|2
1077856|NCT02374099|3508448|P2|Overall Study|Miscellaneous|3
1077857|NCT02374099|3508449|P1|Overall Study|Miscellaneous|2
1077858|NCT02374099|3508448|P2|Overall Study|Withdrawal by Subject|1
1077859|NCT02374099|3508449|P1|Overall Study|Withdrawal by Subject|5
1077860|NCT02374099|3508448|P2|Overall Study|Progressive Disease|40
1077861|NCT02374099|3508449|P1|Overall Study|Progressive Disease|35
1077862|NCT02374099|3508448|P2|Overall Study|Adverse Event|0
1077863|NCT02374099|3508449|P1|Overall Study|Adverse Event|1
1077864|NCT02373202|3508524|P4|Overall Study|Not specified|0
1077865|NCT02373202|3508525|P3|Overall Study|Not specified|0
1077866|NCT02373202|3508526|P2|Overall Study|Not specified|1
1077867|NCT02373202|3508527|P1|Overall Study|Not specified|0
1077868|NCT02373202|3508524|P4|Overall Study|Lack of Efficacy|0
1077869|NCT02373202|3508525|P3|Overall Study|Lack of Efficacy|1
1077870|NCT02373202|3508526|P2|Overall Study|Lack of Efficacy|0
1077871|NCT02373202|3508527|P1|Overall Study|Lack of Efficacy|0
1077872|NCT02373202|3508524|P4|Overall Study|Adverse Event|1
1077873|NCT02373202|3508525|P3|Overall Study|Adverse Event|2
1077874|NCT02373202|3508526|P2|Overall Study|Adverse Event|5
1077875|NCT02373202|3508527|P1|Overall Study|Adverse Event|2
1077876|NCT02372396|3508579|P2|Overall Study|Lost to Follow-up|9
1077877|NCT02372396|3508580|P1|Overall Study|Lost to Follow-up|7
1077878|NCT02372071|3508631|P1|Overall Study|Protocol Violation|18
1077879|NCT02372058|3508636|P1|Overall Study|Withdrawal by Subject|3
1077880|NCT02371759|3508665|P8|Overall Study|Withdrawal by Subject|1
1077881|NCT02371759|3508666|P7|Overall Study|Withdrawal by Subject|0
1077882|NCT02371759|3508667|P6|Overall Study|Withdrawal by Subject|0
1077883|NCT02371759|3508668|P5|Overall Study|Withdrawal by Subject|0
1077884|NCT02371759|3508669|P4|Overall Study|Withdrawal by Subject|0
1077885|NCT02371759|3508670|P3|Overall Study|Withdrawal by Subject|0
1077886|NCT02371759|3508671|P2|Overall Study|Withdrawal by Subject|0
1077887|NCT02371759|3508672|P1|Overall Study|Withdrawal by Subject|0
1077888|NCT02371759|3508665|P8|Overall Study|Protocol Violation|3
1077889|NCT02371759|3508666|P7|Overall Study|Protocol Violation|0
1077890|NCT02371759|3508667|P6|Overall Study|Protocol Violation|1
1077891|NCT02371759|3508668|P5|Overall Study|Protocol Violation|3
1077892|NCT02371759|3508669|P4|Overall Study|Protocol Violation|0
1077893|NCT02371759|3508670|P3|Overall Study|Protocol Violation|1
1077894|NCT02371759|3508671|P2|Overall Study|Protocol Violation|1
1077895|NCT02371759|3508672|P1|Overall Study|Protocol Violation|3
1077896|NCT02371616|3508884|P2|Overall Study|Other (Not specified)|5
1077897|NCT02371616|3508885|P1|Overall Study|Other (Not specified)|1
1077898|NCT02371616|3508884|P2|Overall Study|Withdrawal of Consent|0
1077899|NCT02371616|3508885|P1|Overall Study|Withdrawal of Consent|1
1077900|NCT02371616|3508884|P2|Overall Study|Adverse Event|1
1077901|NCT02371616|3508885|P1|Overall Study|Adverse Event|0
1077902|NCT02371616|3508884|P2|Overall Study|Protocol Violation|1
1077903|NCT02371616|3508885|P1|Overall Study|Protocol Violation|2
1077904|NCT02370914|3508901|P1|Overall Study|Protocol Violation|2
1077905|NCT02370667|3508908|P3|Overall Study|Lost to Follow-up|0
1077906|NCT02370667|3508909|P2|Overall Study|Lost to Follow-up|1
1077907|NCT02370667|3508910|P1|Overall Study|Lost to Follow-up|0
1077908|NCT02370615|3508974|P2|Overall Study|Adverse Event|0
1077909|NCT02370615|3508975|P1|Overall Study|Adverse Event|1
1077910|NCT02370602|3509018|P6|Overall Study|Pretreatment Event/Adverse Event|0
1077911|NCT02370602|3509019|P5|Overall Study|Pretreatment Event/Adverse Event|0
1077912|NCT02370602|3509020|P4|Overall Study|Pretreatment Event/Adverse Event|0
1077913|NCT02370602|3509021|P3|Overall Study|Pretreatment Event/Adverse Event|0
1077914|NCT02370602|3509022|P2|Overall Study|Pretreatment Event/Adverse Event|0
1077915|NCT02370602|3509023|P1|Overall Study|Pretreatment Event/Adverse Event|1
1077916|NCT02370537|3509117|P3|Part B|Withdrawal by Subject|0
1077917|NCT02370537|3509118|P2|Part B|Withdrawal by Subject|1
1077918|NCT02370537|3509119|P1|Part B|Withdrawal by Subject|0
1077919|NCT02370537|3509117|P3|Part B|Not randomised to receive treatment|259
1077920|NCT02370537|3509118|P2|Part B|Not randomised to receive treatment|2
1077921|NCT02370537|3509119|P1|Part B|Not randomised to receive treatment|1
1077922|NCT02370537|3509117|P3|Part A (Open-label Recruitment)|Adverse Event|1
1077923|NCT02370537|3509118|P2|Part A (Open-label Recruitment)|Adverse Event|0
1077924|NCT02370537|3509119|P1|Part A (Open-label Recruitment)|Adverse Event|0
1077925|NCT02370537|3509117|P3|Part A (Open-label Recruitment)|Withdrawal by Subject|0
1077926|NCT02370537|3509118|P2|Part A (Open-label Recruitment)|Withdrawal by Subject|1
1077927|NCT02370537|3509119|P1|Part A (Open-label Recruitment)|Withdrawal by Subject|0
1077928|NCT02370498|3509168|P2|Overall Study|Ongoing In Trial|33
1077929|NCT02370498|3509169|P1|Overall Study|Ongoing In Trial|56
1077930|NCT02370498|3509168|P2|Overall Study|Withdrawal by Subject|11
1077931|NCT02370498|3509169|P1|Overall Study|Withdrawal by Subject|6
1077932|NCT02370498|3509168|P2|Overall Study|Protocol Violation|2
1077933|NCT02370498|3509169|P1|Overall Study|Protocol Violation|1
1077934|NCT02370498|3509168|P2|Overall Study|Lost to Follow-up|0
1077935|NCT02370498|3509169|P1|Overall Study|Lost to Follow-up|1
1077936|NCT02370498|3509168|P2|Overall Study|Death|242
1077937|NCT02370498|3509169|P1|Overall Study|Death|222
1077938|NCT02370498|3509168|P2|Overall Study|Adverse Event|8
1077939|NCT02370498|3509169|P1|Overall Study|Adverse Event|10
1077940|NCT02370420|3509223|P2|Overall Study|Lost to Follow-up|9
1077941|NCT02370420|3509224|P1|Overall Study|Lost to Follow-up|11
1077942|NCT02370420|3509223|P2|Overall Study|Physician Decision|3
1077943|NCT02370420|3509224|P1|Overall Study|Physician Decision|3
1077944|NCT02370394|3509261|P2|Overall Study|Withdrawal by Subject|1
1077945|NCT02370394|3509262|P1|Overall Study|Withdrawal by Subject|0
1077946|NCT02370394|3509261|P2|Overall Study|Lost to Follow-up|1
1077947|NCT02370394|3509262|P1|Overall Study|Lost to Follow-up|2
1077948|NCT02370121|3509278|P2|Overall Study|Lost to Follow-up|1
1077949|NCT02370121|3509279|P1|Overall Study|Lost to Follow-up|1
1077950|NCT02369848|3509317|P1|Overall Study|Lost to Follow-up|1
1077951|NCT02369848|3509317|P1|Overall Study|Withdrawal by Subject|2
1077952|NCT02369848|3509317|P1|Overall Study|Death|1
1077953|NCT02369510|3509382|P3|Overall Study|Epidural Activation|5
1077954|NCT02369510|3509383|P2|Overall Study|Epidural Activation|1
1077955|NCT02369510|3509384|P1|Overall Study|Epidural Activation|1
1077956|NCT02369510|3509382|P3|Overall Study|Spilled Medication|1
1077957|NCT02369510|3509383|P2|Overall Study|Spilled Medication|2
1077958|NCT02369510|3509384|P1|Overall Study|Spilled Medication|1
1077959|NCT02369341|3509415|P2|Overall Study|Migrated/moved from study area|0
1077960|NCT02369341|3509416|P1|Overall Study|Migrated/moved from study area|1
1077961|NCT02368314|3509483|P2|Overall Study|Adverse Event|2
1077962|NCT02368314|3509484|P1|Overall Study|Adverse Event|1
1077963|NCT02368314|3509483|P2|Overall Study|Withdrawal by Subject|1
1077964|NCT02368314|3509484|P1|Overall Study|Withdrawal by Subject|2
1077965|NCT02368210|3509496|P2|Overall Study|Adverse Event|1
1077966|NCT02368210|3509497|P1|Overall Study|Adverse Event|0
1077967|NCT02368210|3509496|P2|Overall Study|Withdrawal by Subject|0
1077968|NCT02368210|3509497|P1|Overall Study|Withdrawal by Subject|1
1077969|NCT02367911|3509524|P2|Overall Study|Lost to Follow-up|2
1077970|NCT02367911|3509525|P1|Overall Study|Lost to Follow-up|2
1077971|NCT02367911|3509524|P2|Overall Study|Withdrawal by Subject|2
1077972|NCT02367911|3509525|P1|Overall Study|Withdrawal by Subject|3
1077973|NCT02367885|3509536|P3|Overall Study|Withdrawal by Subject|0
1077974|NCT02367885|3509537|P2|Overall Study|Withdrawal by Subject|0
1077975|NCT02367885|3509538|P1|Overall Study|Withdrawal by Subject|1
1077976|NCT02367885|3509536|P3|Overall Study|Lost to Follow-up|0
1077977|NCT02367885|3509537|P2|Overall Study|Lost to Follow-up|0
1077978|NCT02367885|3509538|P1|Overall Study|Lost to Follow-up|1
1077979|NCT02367729|3509773|P2|Overall Study|Withdrawal by Subject|5
1077980|NCT02367729|3509774|P1|Overall Study|Withdrawal by Subject|0
1077981|NCT02367729|3509773|P2|Overall Study|Adverse Event|2
1077982|NCT02367729|3509774|P1|Overall Study|Adverse Event|1
1077983|NCT02367729|3509773|P2|Overall Study|Organic disorder diagnosed|1
1077984|NCT02367729|3509774|P1|Overall Study|Organic disorder diagnosed|2
1077985|NCT02367521|3509792|P2|Overall Study|unable to find transportation|0
1077986|NCT02367521|3509793|P1|Overall Study|unable to find transportation|2
1077987|NCT02367521|3509792|P2|Overall Study|severe headache after intervention|0
1077988|NCT02367521|3509793|P1|Overall Study|severe headache after intervention|2
1077989|NCT02367131|3509879|P1|Overall Study|Other than stated above|20
1077990|NCT02367131|3509879|P1|Overall Study|No change/progressive disease|78
1077991|NCT02367131|3509879|P1|Overall Study|Improvement/remission|2
1077992|NCT02367131|3509879|P1|Overall Study|Request by patient|54
1077993|NCT02367131|3509879|P1|Overall Study|No visit since the first visit|4
1077994|NCT02367131|3509879|P1|Overall Study|Adverse Event|64
1077995|NCT02366936|3509946|P1|Overall Study|Physician Decision|2
1077996|NCT02366936|3509946|P1|Overall Study|Lost to Follow-up|4
1077997|NCT02366936|3509946|P1|Overall Study|Withdrawal by Subject|2
1077998|NCT02366923|3509951|P1|Overall Study|High Astigmatism|3
1077999|NCT02366923|3509951|P1|Overall Study|Positive Slit Lamp Findings|2
1078000|NCT02366923|3509951|P1|Overall Study|Withdrawal by Subject|1
1078001|NCT02366910|3509964|P1|Overall Study|Screen Failure|3
1078002|NCT02366910|3509964|P1|Overall Study|Withdrawal by Subject|2
1078003|NCT02366767|3509978|P2|Overall Study|left for home after 1 day at camp|0
1078004|NCT02366767|3509979|P1|Overall Study|left for home after 1 day at camp|1
1078005|NCT02366689|3509992|P3|Overall Study|Pregnancy|1
1078006|NCT02366689|3509993|P2|Overall Study|Pregnancy|1
1078007|NCT02366689|3509994|P1|Overall Study|Pregnancy|0
1078008|NCT02366689|3509992|P3|Overall Study|Lost to Follow-up|0
1078009|NCT02366689|3509993|P2|Overall Study|Lost to Follow-up|2
1078010|NCT02366689|3509994|P1|Overall Study|Lost to Follow-up|3
1078011|NCT02366689|3509992|P3|Overall Study|Withdrawal by Subject|1
1078012|NCT02366689|3509993|P2|Overall Study|Withdrawal by Subject|0
1078013|NCT02366689|3509994|P1|Overall Study|Withdrawal by Subject|1
1078014|NCT02366637|3510046|P2|Second Intervention Period|Study Terminated by Sponsor|1
1078015|NCT02366637|3510047|P1|Second Intervention Period|Study Terminated by Sponsor|1
1078016|NCT02366637|3510046|P2|First Intervention Period|Study Terminated by Sponsor|4
1078017|NCT02366637|3510047|P1|First Intervention Period|Study Terminated by Sponsor|6
1078018|NCT02366637|3510046|P2|First Intervention Period|Adverse Event|1
1078019|NCT02366637|3510047|P1|First Intervention Period|Adverse Event|0
1078020|NCT02366195|3510084|P1|Overall Study|Death|26
1078021|NCT02366195|3510084|P1|Overall Study|Lost to Follow-up|1
1078022|NCT02366195|3510084|P1|Overall Study|Withdrawal by Subject|6
1078023|NCT02366195|3510084|P1|Overall Study|Continuing Study|79
1078024|NCT02365636|3510115|P3|Overall Study|Not specified|0
1078025|NCT02365636|3510116|P2|Overall Study|Not specified|0
1078026|NCT02365636|3510117|P1|Overall Study|Not specified|2
1078027|NCT02365636|3510115|P3|Overall Study|Lost to Follow-up|1
1078028|NCT02365636|3510116|P2|Overall Study|Lost to Follow-up|0
1078029|NCT02365636|3510117|P1|Overall Study|Lost to Follow-up|0
1078030|NCT02365636|3510115|P3|Overall Study|Protocol Violation|0
1078031|NCT02365636|3510116|P2|Overall Study|Protocol Violation|4
1078032|NCT02365636|3510117|P1|Overall Study|Protocol Violation|1
1078033|NCT02365636|3510115|P3|Overall Study|Adverse Event|2
1078034|NCT02365636|3510116|P2|Overall Study|Adverse Event|3
1078035|NCT02365636|3510117|P1|Overall Study|Adverse Event|3
1078036|NCT02365558|3510161|P2|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1
1078037|NCT02365558|3510162|P1|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0
1078038|NCT02365558|3510161|P2|Period 1 (Day 1 Through Day 7)|Adverse Event|0
1078039|NCT02365558|3510162|P1|Period 1 (Day 1 Through Day 7)|Adverse Event|1
1078040|NCT02365519|3510175|P3|Randomized and Treated|Withdrawal by Subject|1
1078041|NCT02365519|3510176|P2|Randomized and Treated|Withdrawal by Subject|1
1078042|NCT02365519|3510177|P1|Randomized and Treated|Withdrawal by Subject|0
1078043|NCT02365519|3510175|P3|Randomized and Treated|Adverse Event|0
1078044|NCT02365519|3510176|P2|Randomized and Treated|Adverse Event|1
1078045|NCT02365519|3510177|P1|Randomized and Treated|Adverse Event|0
1078046|NCT02365298|3510198|P2|Period 2|Protocol Violation|1
1078047|NCT02365298|3510199|P1|Period 2|Protocol Violation|0
1078048|NCT02365298|3510198|P2|Period 2|Test Article longer available|1
1078049|NCT02365298|3510199|P1|Period 2|Test Article longer available|0
1078050|NCT02365298|3510198|P2|Period 2|Discontinued at request of Sponsor|0
1078051|NCT02365298|3510199|P1|Period 2|Discontinued at request of Sponsor|1
1078052|NCT02365298|3510198|P2|Period 2|incorrect Rx dispensed|0
1078053|NCT02365298|3510199|P1|Period 2|incorrect Rx dispensed|1
1078054|NCT02365233|3510218|P3|Overall Study|IRB withheld the data|2
1078055|NCT02365233|3510219|P2|Overall Study|IRB withheld the data|2
1078056|NCT02365233|3510220|P1|Overall Study|IRB withheld the data|1
1078057|NCT02364999|3510230|P2|Overall Study|Randomized but did not receive treatment|3
1078058|NCT02364999|3510231|P1|Overall Study|Randomized but did not receive treatment|2
1078059|NCT02364999|3510230|P2|Overall Study|Other|1
1078060|NCT02364999|3510231|P1|Overall Study|Other|0
1078061|NCT02364999|3510230|P2|Overall Study|Withdrawal by Subject|14
1078062|NCT02364999|3510231|P1|Overall Study|Withdrawal by Subject|14
1078063|NCT02364999|3510230|P2|Overall Study|Protocol Violation|2
1078064|NCT02364999|3510231|P1|Overall Study|Protocol Violation|3
1078065|NCT02364999|3510230|P2|Overall Study|Lost to Follow-up|15
1078066|NCT02364999|3510231|P1|Overall Study|Lost to Follow-up|10
1078067|NCT02364999|3510230|P2|Overall Study|Death|138
1078068|NCT02364999|3510231|P1|Overall Study|Death|136
1078069|NCT02364180|3510277|P1|Overall Study|Screen Fail|1
1078070|NCT02364037|3510283|P2|Overall Study|Lost to Follow-up|49
1078071|NCT02364037|3510284|P1|Overall Study|Lost to Follow-up|37
1078072|NCT02364037|3510283|P2|Overall Study|Withdrawal by Subject|4
1078073|NCT02364037|3510284|P1|Overall Study|Withdrawal by Subject|7
1078074|NCT02363946|3510309|P13|Overall Study|Lost to Follow-up|0
1078075|NCT02363946|3510310|P12|Overall Study|Lost to Follow-up|0
1078076|NCT02363946|3510311|P11|Overall Study|Lost to Follow-up|0
1078077|NCT02363946|3510312|P10|Overall Study|Lost to Follow-up|0
1078078|NCT02363946|3510313|P9|Overall Study|Lost to Follow-up|0
1078079|NCT02363946|3510314|P8|Overall Study|Lost to Follow-up|1
1078080|NCT02363946|3510315|P7|Overall Study|Lost to Follow-up|0
1078081|NCT02363946|3510316|P6|Overall Study|Lost to Follow-up|0
1078082|NCT02363946|3510317|P5|Overall Study|Lost to Follow-up|0
1078083|NCT02363946|3510318|P4|Overall Study|Lost to Follow-up|0
1078084|NCT02363946|3510319|P3|Overall Study|Lost to Follow-up|0
1078085|NCT02363946|3510320|P2|Overall Study|Lost to Follow-up|0
1078086|NCT02363946|3510321|P1|Overall Study|Lost to Follow-up|0
1078087|NCT02363478|3510516|P1|Overall Study|Adverse Event|4
1078088|NCT02363478|3510516|P1|Overall Study|Lost to Follow-up|4
1078089|NCT02363439|3510523|P1|Overall Study|Lack of Efficacy|4
1078090|NCT02362789|3510538|P3|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2
1078091|NCT02362789|3510539|P2|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1
1078092|NCT02362789|3510540|P1|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0
1078093|NCT02362789|3510538|P3|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4
1078094|NCT02362789|3510539|P2|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1
1078095|NCT02362789|3510540|P1|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0
1078096|NCT02362789|3510538|P3|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6
1078097|NCT02362789|3510539|P2|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2
1078098|NCT02362789|3510540|P1|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0
1078099|NCT02362789|3510538|P3|Run-in Phase (Week 0 to 16)|Adverse Event|0
1078100|NCT02362789|3510539|P2|Run-in Phase (Week 0 to 16)|Adverse Event|0
1078101|NCT02362789|3510540|P1|Run-in Phase (Week 0 to 16)|Adverse Event|1
1078102|NCT02362789|3510538|P3|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0
1078103|NCT02362789|3510539|P2|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0
1078104|NCT02362789|3510540|P1|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1
1078105|NCT02362503|3510550|P3|Open Label Period-Up to Atleast 96 Weeks|Ongoing at the time of analysis|67
1078106|NCT02362503|3510551|P2|Open Label Period-Up to Atleast 96 Weeks|Ongoing at the time of analysis|160
1078107|NCT02362503|3510552|P1|Open Label Period-Up to Atleast 96 Weeks|Ongoing at the time of analysis|55
1078108|NCT02362503|3510550|P3|Open Label Period-Up to Atleast 96 Weeks|Progression of disease|0
1078109|NCT02362503|3510551|P2|Open Label Period-Up to Atleast 96 Weeks|Progression of disease|1
1078110|NCT02362503|3510552|P1|Open Label Period-Up to Atleast 96 Weeks|Progression of disease|0
1078111|NCT02362503|3510550|P3|Open Label Period-Up to Atleast 96 Weeks|No longer meets study criteria|2
1078112|NCT02362503|3510551|P2|Open Label Period-Up to Atleast 96 Weeks|No longer meets study criteria|2
1078113|NCT02362503|3510552|P1|Open Label Period-Up to Atleast 96 Weeks|No longer meets study criteria|0
1078114|NCT02362503|3510550|P3|Open Label Period-Up to Atleast 96 Weeks|Pregnancy|0
1078115|NCT02362503|3510551|P2|Open Label Period-Up to Atleast 96 Weeks|Pregnancy|1
1078116|NCT02362503|3510552|P1|Open Label Period-Up to Atleast 96 Weeks|Pregnancy|0
1078117|NCT02362503|3510550|P3|Open Label Period-Up to Atleast 96 Weeks|Non-compliance with study drug|5
1078118|NCT02362503|3510551|P2|Open Label Period-Up to Atleast 96 Weeks|Non-compliance with study drug|8
1078119|NCT02362503|3510552|P1|Open Label Period-Up to Atleast 96 Weeks|Non-compliance with study drug|3
1078120|NCT02362503|3510550|P3|Open Label Period-Up to Atleast 96 Weeks|Lost to Follow-up|1
1078121|NCT02362503|3510551|P2|Open Label Period-Up to Atleast 96 Weeks|Lost to Follow-up|3
1078122|NCT02362503|3510552|P1|Open Label Period-Up to Atleast 96 Weeks|Lost to Follow-up|3
1078123|NCT02362503|3510550|P3|Open Label Period-Up to Atleast 96 Weeks|Withdrawal by Subject|1
1078124|NCT02362503|3510551|P2|Open Label Period-Up to Atleast 96 Weeks|Withdrawal by Subject|5
1078125|NCT02362503|3510552|P1|Open Label Period-Up to Atleast 96 Weeks|Withdrawal by Subject|0
1078126|NCT02362503|3510550|P3|Open Label Period-Up to Atleast 96 Weeks|Death|12
1078127|NCT02362503|3510551|P2|Open Label Period-Up to Atleast 96 Weeks|Death|5
1078128|NCT02362503|3510552|P1|Open Label Period-Up to Atleast 96 Weeks|Death|1
1078129|NCT02362503|3510550|P3|Open Label Period-Up to Atleast 96 Weeks|Adverse Event|5
1078130|NCT02362503|3510551|P2|Open Label Period-Up to Atleast 96 Weeks|Adverse Event|4
1078131|NCT02362503|3510552|P1|Open Label Period-Up to Atleast 96 Weeks|Adverse Event|3
1078132|NCT02362503|3510550|P3|Open Label Period-Up to Atleast 96 Weeks|Lack of Efficacy|6
1078133|NCT02362503|3510551|P2|Open Label Period-Up to Atleast 96 Weeks|Lack of Efficacy|9
1078134|NCT02362503|3510552|P1|Open Label Period-Up to Atleast 96 Weeks|Lack of Efficacy|3
1078135|NCT02362503|3510550|P3|Double-blind Period-Up to 8 Days|No longer meets study criteria|0
1078136|NCT02362503|3510551|P2|Double-blind Period-Up to 8 Days|No longer meets study criteria|1
1078137|NCT02362503|3510552|P1|Double-blind Period-Up to 8 Days|No longer meets study criteria|0
1078138|NCT02362503|3510550|P3|Double-blind Period-Up to 8 Days|Lost to Follow-up|0
1078139|NCT02362503|3510551|P2|Double-blind Period-Up to 8 Days|Lost to Follow-up|1
1078140|NCT02362503|3510552|P1|Double-blind Period-Up to 8 Days|Lost to Follow-up|0
1078141|NCT02362503|3510550|P3|Double-blind Period-Up to 8 Days|Death|0
1078142|NCT02362503|3510551|P2|Double-blind Period-Up to 8 Days|Death|1
1078143|NCT02362503|3510552|P1|Double-blind Period-Up to 8 Days|Death|1
1078144|NCT02362503|3510550|P3|Double-blind Period-Up to 8 Days|Adverse Event|0
1078145|NCT02362503|3510551|P2|Double-blind Period-Up to 8 Days|Adverse Event|2
1078146|NCT02362503|3510552|P1|Double-blind Period-Up to 8 Days|Adverse Event|0
1078147|NCT02362412|3510577|P2|Treatment Period III|Lost to Follow-up|1
1078148|NCT02362412|3510578|P1|Treatment Period III|Lost to Follow-up|0
1078149|NCT02362360|3510612|P2|Period 1|Withdrawal by Subject|1
1078150|NCT02362360|3510613|P1|Period 1|Withdrawal by Subject|2
1078151|NCT02362360|3510612|P2|Period 1|Lack of Efficacy|0
1078152|NCT02362360|3510613|P1|Period 1|Lack of Efficacy|1
1078153|NCT02361580|3510651|P2|Overall Study|Lost to Follow-up|3
1078154|NCT02361580|3510652|P1|Overall Study|Lost to Follow-up|6
1078155|NCT02361216|3510664|P2|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2
1078156|NCT02361216|3510665|P1|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0
1078157|NCT02361216|3510664|P2|3 Day Treatment and 8 Week Follow/up|Trial site closed|3
1078158|NCT02361216|3510665|P1|3 Day Treatment and 8 Week Follow/up|Trial site closed|3
1078159|NCT02361216|3510664|P2|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11
1078160|NCT02361216|3510665|P1|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6
1078161|NCT02361216|3510664|P2|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0
1078162|NCT02361216|3510665|P1|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1
1078163|NCT02361216|3510664|P2|3 Day Treatment and 8 Week Follow/up|Adverse Event|2
1078164|NCT02361216|3510665|P1|3 Day Treatment and 8 Week Follow/up|Adverse Event|1
1078165|NCT02361216|3510664|P2|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1
1078166|NCT02361216|3510665|P1|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0
1078167|NCT02360995|3510680|P3|Overall Study|Withdrawal by Subject|0
1078168|NCT02360995|3510681|P2|Overall Study|Withdrawal by Subject|1
1078169|NCT02360995|3510682|P1|Overall Study|Withdrawal by Subject|0
1078170|NCT02360995|3510680|P3|Overall Study|Lost to Follow-up|2
1078171|NCT02360995|3510681|P2|Overall Study|Lost to Follow-up|0
1078172|NCT02360995|3510682|P1|Overall Study|Lost to Follow-up|2
1078173|NCT02360475|3510724|P4|Overall Study|Migrated/moved from study area|1
1078174|NCT02360475|3510725|P3|Overall Study|Migrated/moved from study area|0
1078175|NCT02360475|3510726|P2|Overall Study|Migrated/moved from study area|0
1078176|NCT02360475|3510727|P1|Overall Study|Migrated/moved from study area|0
1078177|NCT02360475|3510724|P4|Overall Study|Withdrawal by Subject|0
1078178|NCT02360475|3510725|P3|Overall Study|Withdrawal by Subject|2
1078179|NCT02360475|3510726|P2|Overall Study|Withdrawal by Subject|1
1078180|NCT02360475|3510727|P1|Overall Study|Withdrawal by Subject|0
1078181|NCT02360475|3510724|P4|Overall Study|Lost to Follow-up|4
1078182|NCT02360475|3510725|P3|Overall Study|Lost to Follow-up|6
1078183|NCT02360475|3510726|P2|Overall Study|Lost to Follow-up|12
1078184|NCT02360475|3510727|P1|Overall Study|Lost to Follow-up|4
1078185|NCT02360228|3510788|P3|Overall Study|Unstable symptoms during screening|1
1078186|NCT02360228|3510789|P2|Overall Study|Unstable symptoms during screening|0
1078187|NCT02360228|3510790|P1|Overall Study|Unstable symptoms during screening|0
1078188|NCT02360228|3510788|P3|Overall Study|Self-discontinued medication|0
1078189|NCT02360228|3510789|P2|Overall Study|Self-discontinued medication|1
1078190|NCT02360228|3510790|P1|Overall Study|Self-discontinued medication|0
1078191|NCT02360228|3510788|P3|Overall Study|Withdrawal by Subject|0
1078192|NCT02360228|3510789|P2|Overall Study|Withdrawal by Subject|0
1078193|NCT02360228|3510790|P1|Overall Study|Withdrawal by Subject|1
1078194|NCT02360111|3510832|P1|Overall Study|Death|2
1078195|NCT02359903|3510903|P2|Overall Study|Adverse Event|2
1078196|NCT02359903|3510904|P1|Overall Study|Adverse Event|0
1078197|NCT02359890|3510912|P1|Overall Study|Never treated with study catheter|6
1078198|NCT02359890|3510912|P1|Overall Study|Not meeting eligibility|4
1078199|NCT02359877|3510923|P4|Overall Study|Adverse Event|1
1078200|NCT02359877|3510924|P3|Overall Study|Adverse Event|0
1078201|NCT02359877|3510925|P2|Overall Study|Adverse Event|0
1078202|NCT02359877|3510926|P1|Overall Study|Adverse Event|0
1078203|NCT02359877|3510923|P4|Overall Study|Withdrawal by Subject|2
1078204|NCT02359877|3510924|P3|Overall Study|Withdrawal by Subject|0
1078205|NCT02359877|3510925|P2|Overall Study|Withdrawal by Subject|0
1078206|NCT02359877|3510926|P1|Overall Study|Withdrawal by Subject|1
1078207|NCT02359851|3510976|P1|Overall Study|Disease progression|1
1078208|NCT02359851|3510976|P1|Overall Study|Death|1
1078209|NCT02359435|3510986|P2|Overall Study|Lost to Follow-up|4
1078210|NCT02359435|3510987|P1|Overall Study|Lost to Follow-up|4
1078211|NCT02359045|3511047|P2|Overall Study|Adverse Event|1
1078212|NCT02359045|3511048|P1|Overall Study|Adverse Event|0
1078213|NCT02359045|3511047|P2|Overall Study|Lost to Follow-up|1
1078214|NCT02359045|3511048|P1|Overall Study|Lost to Follow-up|1
1078215|NCT02359045|3511047|P2|Overall Study|Eligibility criteria not fulfilled|1
1078216|NCT02359045|3511048|P1|Overall Study|Eligibility criteria not fulfilled|3
1078217|NCT02358863|3511285|P1|Overall Study|Physician Decision|3
1078218|NCT02358668|3511292|P3|Overall Study|Withdrawal by Subject|0
1078219|NCT02358668|3511293|P2|Overall Study|Withdrawal by Subject|1
1078220|NCT02358668|3511294|P1|Overall Study|Withdrawal by Subject|0
1078221|NCT02358668|3511292|P3|Overall Study|Adverse Event|0
1078222|NCT02358668|3511293|P2|Overall Study|Adverse Event|0
1078223|NCT02358668|3511294|P1|Overall Study|Adverse Event|2
1078224|NCT02358473|3511434|P1|Overall Study|Physician Decision|2
1078225|NCT02358473|3511434|P1|Overall Study|Withdrawal by Subject|2
1078226|NCT02358473|3511434|P1|Overall Study|Adverse Event|3
1078227|NCT02358473|3511434|P1|Overall Study|Disease Progession|6
1078228|NCT02358044|3511445|P2|Overall Study|Withdrawal by Subject|4
1078229|NCT02358044|3511446|P1|Overall Study|Withdrawal by Subject|0
1078230|NCT02358044|3511445|P2|Overall Study|Physician Decision|1
1078231|NCT02358044|3511446|P1|Overall Study|Physician Decision|0
1078232|NCT02358044|3511445|P2|Overall Study|Lost to Follow-up|1
1078233|NCT02358044|3511446|P1|Overall Study|Lost to Follow-up|2
1078234|NCT02358044|3511445|P2|Overall Study|Adverse Event|1
1078235|NCT02358044|3511446|P1|Overall Study|Adverse Event|0
1078236|NCT02357940|3511464|P2|Overall Study|Investigator's judgement|1
1078237|NCT02357940|3511465|P1|Overall Study|Investigator's judgement|0
1078238|NCT02357940|3511464|P2|Overall Study|Adverse Event|1
1078239|NCT02357940|3511465|P1|Overall Study|Adverse Event|0
1078240|NCT02357901|3511592|P4|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7
1078241|NCT02357901|3511593|P3|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6
1078242|NCT02357901|3511594|P2|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17
1078243|NCT02357901|3511595|P1|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0
1078244|NCT02357901|3511592|P4|Treatment Period (Day 1 to Week 24)|Physician Decision|1
1078245|NCT02357901|3511593|P3|Treatment Period (Day 1 to Week 24)|Physician Decision|1
1078246|NCT02357901|3511594|P2|Treatment Period (Day 1 to Week 24)|Physician Decision|0
1078247|NCT02357901|3511595|P1|Treatment Period (Day 1 to Week 24)|Physician Decision|0
1078248|NCT02357901|3511592|P4|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3
1078249|NCT02357901|3511593|P3|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
1078250|NCT02357901|3511594|P2|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1
1078251|NCT02357901|3511595|P1|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
1078252|NCT02357901|3511592|P4|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
1078253|NCT02357901|3511593|P3|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
1078254|NCT02357901|3511594|P2|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
1078255|NCT02357901|3511595|P1|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
1078256|NCT02357901|3511592|P4|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3
1078257|NCT02357901|3511593|P3|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
1078258|NCT02357901|3511594|P2|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
1078259|NCT02357901|3511595|P1|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0
1078260|NCT02357901|3511592|P4|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
1078261|NCT02357901|3511593|P3|Treatment Period (Day 1 to Week 24)|Protocol Violation|5
1078262|NCT02357901|3511594|P2|Treatment Period (Day 1 to Week 24)|Protocol Violation|2
1078263|NCT02357901|3511595|P1|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
1078264|NCT02357901|3511592|P4|Treatment Period (Day 1 to Week 24)|Adverse Event|2
1078265|NCT02357901|3511593|P3|Treatment Period (Day 1 to Week 24)|Adverse Event|10
1078266|NCT02357901|3511594|P2|Treatment Period (Day 1 to Week 24)|Adverse Event|6
1078267|NCT02357901|3511595|P1|Treatment Period (Day 1 to Week 24)|Adverse Event|0
1078268|NCT02357901|3511592|P4|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18
1078269|NCT02357901|3511593|P3|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5
1078270|NCT02357901|3511594|P2|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3
1078271|NCT02357901|3511595|P1|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0
1078272|NCT02357901|3511592|P4|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18
1078273|NCT02357901|3511593|P3|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21
1078274|NCT02357901|3511594|P2|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20
1078275|NCT02357901|3511595|P1|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0
1078276|NCT02357901|3511592|P4|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12
1078277|NCT02357901|3511593|P3|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23
1078278|NCT02357901|3511594|P2|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26
1078453|NCT02351817|3512285|P2|Period 1|Lack of Efficacy|1
1078279|NCT02357901|3511595|P1|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0
1078280|NCT02357901|3511592|P4|Run-In Period (Days -14 to Day -1)|Run-In failures|0
1078281|NCT02357901|3511593|P3|Run-In Period (Days -14 to Day -1)|Run-In failures|0
1078282|NCT02357901|3511594|P2|Run-In Period (Days -14 to Day -1)|Run-In failures|0
1078283|NCT02357901|3511595|P1|Run-In Period (Days -14 to Day -1)|Run-In failures|161
1078284|NCT02357459|3511656|P3|Overall Study|Job Commitments|1
1078285|NCT02357459|3511657|P2|Overall Study|Job Commitments|0
1078286|NCT02357459|3511658|P1|Overall Study|Job Commitments|0
1078287|NCT02357459|3511656|P3|Overall Study|Pre-planned Knee surgery|2
1078288|NCT02357459|3511657|P2|Overall Study|Pre-planned Knee surgery|0
1078289|NCT02357459|3511658|P1|Overall Study|Pre-planned Knee surgery|0
1078290|NCT02357459|3511656|P3|Overall Study|Incarceration|1
1078291|NCT02357459|3511657|P2|Overall Study|Incarceration|0
1078292|NCT02357459|3511658|P1|Overall Study|Incarceration|0
1078293|NCT02357459|3511656|P3|Overall Study|Instruction from PCP|0
1078294|NCT02357459|3511657|P2|Overall Study|Instruction from PCP|0
1078295|NCT02357459|3511658|P1|Overall Study|Instruction from PCP|1
1078296|NCT02357459|3511656|P3|Overall Study|Patient Relocated|0
1078297|NCT02357459|3511657|P2|Overall Study|Patient Relocated|0
1078298|NCT02357459|3511658|P1|Overall Study|Patient Relocated|2
1078299|NCT02357459|3511656|P3|Overall Study|Lack of Efficacy|4
1078300|NCT02357459|3511657|P2|Overall Study|Lack of Efficacy|4
1078301|NCT02357459|3511658|P1|Overall Study|Lack of Efficacy|7
1078302|NCT02357459|3511656|P3|Overall Study|Lost to Follow-up|0
1078303|NCT02357459|3511657|P2|Overall Study|Lost to Follow-up|3
1078304|NCT02357459|3511658|P1|Overall Study|Lost to Follow-up|1
1078305|NCT02357459|3511656|P3|Overall Study|Protocol Violation|0
1078306|NCT02357459|3511657|P2|Overall Study|Protocol Violation|1
1078307|NCT02357459|3511658|P1|Overall Study|Protocol Violation|1
1078308|NCT02357459|3511656|P3|Overall Study|Physician Decision|0
1078309|NCT02357459|3511657|P2|Overall Study|Physician Decision|2
1078310|NCT02357459|3511658|P1|Overall Study|Physician Decision|0
1078311|NCT02357459|3511656|P3|Overall Study|Withdrawal by Subject|3
1078312|NCT02357459|3511657|P2|Overall Study|Withdrawal by Subject|3
1078313|NCT02357459|3511658|P1|Overall Study|Withdrawal by Subject|5
1078314|NCT02357459|3511656|P3|Overall Study|Adverse Event|1
1078315|NCT02357459|3511657|P2|Overall Study|Adverse Event|1
1078316|NCT02357459|3511658|P1|Overall Study|Adverse Event|0
1078317|NCT02357342|3511702|P2|First 6 Months|Death|0
1078318|NCT02357342|3511703|P1|First 6 Months|Death|2
1078319|NCT02356783|3511767|P2|Overall Study|Lost to Follow-up|3
1078320|NCT02356783|3511768|P1|Overall Study|Lost to Follow-up|1
1078321|NCT02356588|3511778|P2|Overall Study|Protocol Violation|1
1078322|NCT02356588|3511779|P1|Overall Study|Protocol Violation|0
1078323|NCT02356588|3511778|P2|Overall Study|Withdrawal by Subject|0
1078324|NCT02356588|3511779|P1|Overall Study|Withdrawal by Subject|1
1078325|NCT02356588|3511778|P2|Overall Study|Adverse Event|2
1078326|NCT02356588|3511779|P1|Overall Study|Adverse Event|0
1078327|NCT02356588|3511778|P2|Overall Study|Lack of Efficacy|10
1078328|NCT02356588|3511779|P1|Overall Study|Lack of Efficacy|4
1078329|NCT02356562|3511813|P2|Overall Study|site closure|0
1078330|NCT02356562|3511814|P1|Overall Study|site closure|1
1078331|NCT02356562|3511813|P2|Overall Study|Re-entered treatment in a previous study|0
1078332|NCT02356562|3511814|P1|Overall Study|Re-entered treatment in a previous study|1
1078333|NCT02356562|3511813|P2|Overall Study|Withdrawal by Subject|1
1078334|NCT02356562|3511814|P1|Overall Study|Withdrawal by Subject|0
1078335|NCT02355743|3511860|P1|Overall Study|Lost to Follow-up|1
1078336|NCT02355743|3511860|P1|Overall Study|Withdrawal by Subject|1
1078337|NCT02355691|3511868|P2|Overall Study|Loss of Research Personnel|9
1078338|NCT02355691|3511869|P1|Overall Study|Loss of Research Personnel|7
1078339|NCT02355028|3511888|P2|Overall Study|Deemed ineligible after randomization|4
1078340|NCT02355028|3511889|P1|Overall Study|Deemed ineligible after randomization|8
1078341|NCT02355028|3511888|P2|Overall Study|Withdrawal by Subject|1
1078342|NCT02355028|3511889|P1|Overall Study|Withdrawal by Subject|1
1078343|NCT02355028|3511888|P2|Overall Study|Adverse Event|0
1078344|NCT02355028|3511889|P1|Overall Study|Adverse Event|2
1078345|NCT02354976|3511925|P3|Overall Study|Adverse Event|2
1078346|NCT02354976|3511926|P2|Overall Study|Adverse Event|0
1078347|NCT02354976|3511927|P1|Overall Study|Adverse Event|1
1078348|NCT02354976|3511925|P3|Overall Study|Study-specifc withdrawal criteria|0
1078349|NCT02354976|3511926|P2|Overall Study|Study-specifc withdrawal criteria|1
1078350|NCT02354976|3511927|P1|Overall Study|Study-specifc withdrawal criteria|0
1078351|NCT02354976|3511925|P3|Overall Study|Other - reason not specified|1
1078352|NCT02354976|3511926|P2|Overall Study|Other - reason not specified|0
1078353|NCT02354976|3511927|P1|Overall Study|Other - reason not specified|1
1078354|NCT02354599|3511970|P6|Overall Study|Withdrawal by Subject|0
1078355|NCT02354599|3511971|P5|Overall Study|Withdrawal by Subject|0
1078356|NCT02354599|3511972|P4|Overall Study|Withdrawal by Subject|0
1078357|NCT02354599|3511973|P3|Overall Study|Withdrawal by Subject|0
1078358|NCT02354599|3511974|P2|Overall Study|Withdrawal by Subject|1
1078359|NCT02354599|3511975|P1|Overall Study|Withdrawal by Subject|1
1078360|NCT02354599|3511970|P6|Overall Study|Pretreatment Event/Adverse Event|1
1078361|NCT02354599|3511971|P5|Overall Study|Pretreatment Event/Adverse Event|0
1078362|NCT02354599|3511972|P4|Overall Study|Pretreatment Event/Adverse Event|0
1078363|NCT02354599|3511973|P3|Overall Study|Pretreatment Event/Adverse Event|0
1078364|NCT02354599|3511974|P2|Overall Study|Pretreatment Event/Adverse Event|0
1078365|NCT02354599|3511975|P1|Overall Study|Pretreatment Event/Adverse Event|0
1078366|NCT02354417|3512049|P1|Overall Study|Physician Decision|1
1078367|NCT02354235|3512055|P2|Overall Study|Conflict with the stopping criteria|1
1078368|NCT02354235|3512056|P1|Overall Study|Conflict with the stopping criteria|0
1078369|NCT02354235|3512055|P2|Overall Study|Withdrawal by Subject|3
1078370|NCT02354235|3512056|P1|Overall Study|Withdrawal by Subject|1
1078371|NCT02354235|3512055|P2|Overall Study|Physician Decision|1
1078372|NCT02354235|3512056|P1|Overall Study|Physician Decision|0
1078373|NCT02354235|3512055|P2|Overall Study|Adverse Event|2
1078374|NCT02354235|3512056|P1|Overall Study|Adverse Event|2
1078375|NCT02354222|3512072|P2|Overall Study|Conflict with the stopping criteria|4
1078376|NCT02354222|3512073|P1|Overall Study|Conflict with the stopping criteria|0
1078377|NCT02354222|3512072|P2|Overall Study|Withdrawal by Subject|3
1078378|NCT02354222|3512073|P1|Overall Study|Withdrawal by Subject|2
1078379|NCT02354222|3512072|P2|Overall Study|Pregnancy|0
1078380|NCT02354222|3512073|P1|Overall Study|Pregnancy|1
1078381|NCT02354222|3512072|P2|Overall Study|Physician Decision|1
1078382|NCT02354222|3512073|P1|Overall Study|Physician Decision|1
1078383|NCT02354222|3512072|P2|Overall Study|Adverse Event|3
1078384|NCT02354222|3512073|P1|Overall Study|Adverse Event|0
1078385|NCT02353871|3512089|P2|Overall Study|Lost to Follow-up|0
1078386|NCT02353871|3512090|P1|Overall Study|Lost to Follow-up|2
1078387|NCT02353871|3512089|P2|Overall Study|Consent withdrawn|8
1078388|NCT02353871|3512090|P1|Overall Study|Consent withdrawn|1
1078389|NCT02353871|3512089|P2|Overall Study|Protocol deviation|1
1078390|NCT02353871|3512090|P1|Overall Study|Protocol deviation|0
1078391|NCT02353572|3512123|P1|Overall Study|Study terminated|2
1078392|NCT02353572|3512123|P1|Overall Study|Withdrawal by Subject|1
1078393|NCT02353468|3512127|P1|Overall Study|Study terminated|3
1078394|NCT02353442|3512133|P2|Overall Study|Withdrawal by Subject|4
1078395|NCT02353442|3512134|P1|Overall Study|Withdrawal by Subject|3
1078396|NCT02352779|3512214|P3|Overall Study|No Reason|1
1078397|NCT02352779|3512215|P2|Overall Study|No Reason|0
1078398|NCT02352779|3512216|P1|Overall Study|No Reason|0
1078399|NCT02352779|3512214|P3|Overall Study|Other Medical Reason|1
1078400|NCT02352779|3512215|P2|Overall Study|Other Medical Reason|0
1078401|NCT02352779|3512216|P1|Overall Study|Other Medical Reason|0
1078402|NCT02352779|3512214|P3|Overall Study|Absence of Symptoms|0
1078403|NCT02352779|3512215|P2|Overall Study|Absence of Symptoms|0
1078404|NCT02352779|3512216|P1|Overall Study|Absence of Symptoms|1
1078405|NCT02352779|3512214|P3|Overall Study|Study Related Symptoms|0
1078406|NCT02352779|3512215|P2|Overall Study|Study Related Symptoms|0
1078407|NCT02352779|3512216|P1|Overall Study|Study Related Symptoms|1
1078408|NCT02352779|3512214|P3|Overall Study|Changed Mind|0
1078409|NCT02352779|3512215|P2|Overall Study|Changed Mind|0
1078410|NCT02352779|3512216|P1|Overall Study|Changed Mind|1
1078411|NCT02352779|3512214|P3|Overall Study|Disliked Intervention|0
1078412|NCT02352779|3512215|P2|Overall Study|Disliked Intervention|0
1078413|NCT02352779|3512216|P1|Overall Study|Disliked Intervention|1
1078414|NCT02352779|3512214|P3|Overall Study|Feeling Overwhelmed|0
1078415|NCT02352779|3512215|P2|Overall Study|Feeling Overwhelmed|0
1078416|NCT02352779|3512216|P1|Overall Study|Feeling Overwhelmed|1
1078417|NCT02352779|3512214|P3|Overall Study|Too Many Forms|0
1078418|NCT02352779|3512215|P2|Overall Study|Too Many Forms|0
1078419|NCT02352779|3512216|P1|Overall Study|Too Many Forms|2
1078420|NCT02352779|3512214|P3|Overall Study|Personal Issues|0
1078421|NCT02352779|3512215|P2|Overall Study|Personal Issues|1
1078422|NCT02352779|3512216|P1|Overall Study|Personal Issues|1
1078423|NCT02351960|3512246|P2|Overall Study|Significant Protocol Deviation|5
1078424|NCT02351960|3512247|P1|Overall Study|Significant Protocol Deviation|0
1078425|NCT02351960|3512246|P2|Overall Study|Voluntary Withdrawal|4
1078426|NCT02351960|3512247|P1|Overall Study|Voluntary Withdrawal|5
1078427|NCT02351960|3512246|P2|Overall Study|Pretreatment Event/Adverse Event|3
1078428|NCT02351960|3512247|P1|Overall Study|Pretreatment Event/Adverse Event|6
1078429|NCT02351934|3512268|P2|Follow-Up|2 ERAS Components Noncompliant|4
1078430|NCT02351934|3512269|P1|Follow-Up|2 ERAS Components Noncompliant|0
1078431|NCT02351934|3512268|P2|Follow-Up|1 ERAS Component Noncompliant|6
1078432|NCT02351934|3512269|P1|Follow-Up|1 ERAS Component Noncompliant|0
1078433|NCT02351934|3512268|P2|Follow-Up|No documentation|0
1078434|NCT02351934|3512269|P1|Follow-Up|No documentation|2
1078435|NCT02351934|3512268|P2|Follow-Up|Hypotension|0
1078436|NCT02351934|3512269|P1|Follow-Up|Hypotension|3
1078437|NCT02351934|3512268|P2|Follow-Up|Early dismissal|0
1078438|NCT02351934|3512269|P1|Follow-Up|Early dismissal|3
1078439|NCT02351934|3512268|P2|Follow-Up|Acute Kidney Injury|0
1078440|NCT02351934|3512269|P1|Follow-Up|Acute Kidney Injury|1
1078441|NCT02351934|3512268|P2|Follow-Up|POD weight<pre-op weight|0
1078442|NCT02351934|3512269|P1|Follow-Up|POD weight<pre-op weight|3
1078443|NCT02351934|3512268|P2|Allocation|Acute Kidney Injury on Post Op Day 1|0
1078444|NCT02351934|3512269|P1|Allocation|Acute Kidney Injury on Post Op Day 1|1
1078445|NCT02351934|3512268|P2|Allocation|Hypotension preventing administration|0
1078446|NCT02351934|3512269|P1|Allocation|Hypotension preventing administration|2
1078447|NCT02351934|3512268|P2|Allocation|POD weight<pre-op weight|0
1078448|NCT02351934|3512269|P1|Allocation|POD weight<pre-op weight|3
1078449|NCT02351817|3512285|P2|Period 2|Protocol Violation|0
1078450|NCT02351817|3512286|P1|Period 2|Protocol Violation|1
1078451|NCT02351817|3512285|P2|Period 2|Adverse Event|2
1078452|NCT02351817|3512286|P1|Period 2|Adverse Event|0
1078454|NCT02351817|3512286|P1|Period 1|Lack of Efficacy|0
1078455|NCT02351817|3512285|P2|Period 1|Adverse Event|2
1078456|NCT02351817|3512286|P1|Period 1|Adverse Event|1
1078457|NCT02349711|3512366|P2|Overall Study|Lost to Follow-up|1
1078458|NCT02349711|3512367|P1|Overall Study|Lost to Follow-up|1
1078459|NCT02349711|3512366|P2|Overall Study|Withdrawal by Subject|1
1078460|NCT02349711|3512367|P1|Overall Study|Withdrawal by Subject|2
1078461|NCT02349542|3512400|P1|Overall Study|Withdrawal by Subject|5
1078462|NCT02349451|3512409|P4|Overall Study|Withdrawal by Subject|1
1078463|NCT02349451|3512410|P3|Overall Study|Withdrawal by Subject|2
1078464|NCT02349451|3512411|P2|Overall Study|Withdrawal by Subject|1
1078465|NCT02349451|3512412|P1|Overall Study|Withdrawal by Subject|0
1078466|NCT02349360|3512461|P2|Overall Study|Withdrawal by Subject|1
1078467|NCT02349360|3512462|P1|Overall Study|Withdrawal by Subject|0
1078468|NCT02349295|3512473|P5|IR (Week 16-24)|Lack of Efficacy|1
1078469|NCT02349295|3512474|P4|IR (Week 16-24)|Lack of Efficacy|0
1078470|NCT02349295|3512475|P3|IR (Week 16-24)|Lack of Efficacy|0
1078471|NCT02349295|3512476|P2|IR (Week 16-24)|Lack of Efficacy|0
1078472|NCT02349295|3512477|P1|IR (Week 16-24)|Lack of Efficacy|0
1078473|NCT02349295|3512473|P5|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
1078474|NCT02349295|3512474|P4|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
1078475|NCT02349295|3512475|P3|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
1078476|NCT02349295|3512476|P2|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
1078477|NCT02349295|3512477|P1|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
1078478|NCT02349295|3512473|P5|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
1078479|NCT02349295|3512474|P4|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
1078480|NCT02349295|3512475|P3|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
1078481|NCT02349295|3512476|P2|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
1078482|NCT02349295|3512477|P1|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2
1078483|NCT02349295|3512473|P5|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
1078484|NCT02349295|3512474|P4|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
1078485|NCT02349295|3512475|P3|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
1078486|NCT02349295|3512476|P2|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
1078487|NCT02349295|3512477|P1|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7
1078488|NCT02349295|3512473|P5|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
1078489|NCT02349295|3512474|P4|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
1078490|NCT02349295|3512475|P3|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4
1078491|NCT02349295|3512476|P2|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2
1078492|NCT02349295|3512477|P1|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9
1078493|NCT02349295|3512473|P5|Double Blind Treatment (Week 0-24)|Adverse Event|0
1078494|NCT02349295|3512474|P4|Double Blind Treatment (Week 0-24)|Adverse Event|0
1078495|NCT02349295|3512475|P3|Double Blind Treatment (Week 0-24)|Adverse Event|7
1078496|NCT02349295|3512476|P2|Double Blind Treatment (Week 0-24)|Adverse Event|5
1078497|NCT02349295|3512477|P1|Double Blind Treatment (Week 0-24)|Adverse Event|5
1078498|NCT02349061|3512580|P2|Overall Study|Other|1
1078499|NCT02349061|3512581|P1|Overall Study|Other|3
1078500|NCT02349061|3512580|P2|Overall Study|Physician Decision|0
1078501|NCT02349061|3512581|P1|Overall Study|Physician Decision|1
1078502|NCT02349061|3512580|P2|Overall Study|Lack of Efficacy|0
1078503|NCT02349061|3512581|P1|Overall Study|Lack of Efficacy|1
1078504|NCT02349061|3512580|P2|Overall Study|Adverse Event|3
1078505|NCT02349061|3512581|P1|Overall Study|Adverse Event|4
1078506|NCT02349048|3512589|P2|Overall Study|Lost to Follow-up|0
1078507|NCT02349048|3512590|P1|Overall Study|Lost to Follow-up|1
1078508|NCT02349048|3512589|P2|Overall Study|Withdrawal by Subject|0
1078509|NCT02349048|3512590|P1|Overall Study|Withdrawal by Subject|4
1078510|NCT02348723|3512649|P2|Overall Study|Adverse Event|1
1078511|NCT02348723|3512650|P1|Overall Study|Adverse Event|3
1078512|NCT02348723|3512649|P2|Overall Study|Reason other than specified|1
1078513|NCT02348723|3512650|P1|Overall Study|Reason other than specified|1
1078514|NCT02348723|3512649|P2|Overall Study|Consent withdrawn|3
1078515|NCT02348723|3512650|P1|Overall Study|Consent withdrawn|1
1078516|NCT02348723|3512649|P2|Overall Study|Lost to Follow-up|1
1078517|NCT02348723|3512650|P1|Overall Study|Lost to Follow-up|1
1078518|NCT02348723|3512649|P2|Overall Study|Non-compliant with Protocol|0
1078519|NCT02348723|3512650|P1|Overall Study|Non-compliant with Protocol|1
1078520|NCT02348723|3512649|P2|Overall Study|No ablation|20
1078521|NCT02348723|3512650|P1|Overall Study|No ablation|21
1078522|NCT02347774|3512717|P3|On Study Treatment|ranomized in error|1
1078523|NCT02347774|3512718|P2|On Study Treatment|ranomized in error|0
1078524|NCT02347774|3512719|P1|On Study Treatment|ranomized in error|0
1078525|NCT02347774|3512717|P3|On Study Treatment|Met Prolonged QT criteria|0
1078526|NCT02347774|3512718|P2|On Study Treatment|Met Prolonged QT criteria|0
1078527|NCT02347774|3512719|P1|On Study Treatment|Met Prolonged QT criteria|1
1078528|NCT02347774|3512717|P3|On Study Treatment|Lost to Follow-up|1
1078529|NCT02347774|3512718|P2|On Study Treatment|Lost to Follow-up|6
1078530|NCT02347774|3512719|P1|On Study Treatment|Lost to Follow-up|2
1078531|NCT02347774|3512717|P3|On Study Treatment|withdrew consent|12
1078532|NCT02347774|3512718|P2|On Study Treatment|withdrew consent|8
1078533|NCT02347774|3512719|P1|On Study Treatment|withdrew consent|9
1078534|NCT02347774|3512717|P3|On Study Treatment|Protocol Violation|1
1078535|NCT02347774|3512718|P2|On Study Treatment|Protocol Violation|0
1078536|NCT02347774|3512719|P1|On Study Treatment|Protocol Violation|0
1078537|NCT02347774|3512717|P3|On Study Treatment|non-complicance with study medication|0
1078538|NCT02347774|3512718|P2|On Study Treatment|non-complicance with study medication|2
1078539|NCT02347774|3512719|P1|On Study Treatment|non-complicance with study medication|0
1078540|NCT02347774|3512717|P3|On Study Treatment|Lack of Efficacy|2
1078541|NCT02347774|3512718|P2|On Study Treatment|Lack of Efficacy|0
1078542|NCT02347774|3512719|P1|On Study Treatment|Lack of Efficacy|3
1078543|NCT02347774|3512717|P3|On Study Treatment|Adverse Event|19
1078544|NCT02347774|3512718|P2|On Study Treatment|Adverse Event|15
1078545|NCT02347774|3512719|P1|On Study Treatment|Adverse Event|9
1078546|NCT02347774|3512717|P3|Study Participation|randomized in error|1
1078547|NCT02347774|3512718|P2|Study Participation|randomized in error|0
1078548|NCT02347774|3512719|P1|Study Participation|randomized in error|0
1078549|NCT02347774|3512717|P3|Study Participation|incarceration|0
1078550|NCT02347774|3512718|P2|Study Participation|incarceration|0
1078551|NCT02347774|3512719|P1|Study Participation|incarceration|1
1078552|NCT02347774|3512717|P3|Study Participation|non-compliance with study drug|0
1078553|NCT02347774|3512718|P2|Study Participation|non-compliance with study drug|1
1078554|NCT02347774|3512719|P1|Study Participation|non-compliance with study drug|0
1078555|NCT02347774|3512717|P3|Study Participation|Met Prolonged QT criteria|0
1078556|NCT02347774|3512718|P2|Study Participation|Met Prolonged QT criteria|0
1078557|NCT02347774|3512719|P1|Study Participation|Met Prolonged QT criteria|1
1078558|NCT02347774|3512717|P3|Study Participation|withdrew consent|1
1078559|NCT02347774|3512718|P2|Study Participation|withdrew consent|1
1078560|NCT02347774|3512719|P1|Study Participation|withdrew consent|1
1078561|NCT02347774|3512717|P3|Study Participation|Adverse Event|6
1078562|NCT02347774|3512718|P2|Study Participation|Adverse Event|4
1078563|NCT02347774|3512719|P1|Study Participation|Adverse Event|1
1078564|NCT02347774|3512717|P3|Study Participation|Withdrawal by Subject|15
1078565|NCT02347774|3512718|P2|Study Participation|Withdrawal by Subject|9
1078566|NCT02347774|3512719|P1|Study Participation|Withdrawal by Subject|8
1078567|NCT02347774|3512717|P3|Study Participation|Lost to Follow-up|2
1078568|NCT02347774|3512718|P2|Study Participation|Lost to Follow-up|6
1078569|NCT02347774|3512719|P1|Study Participation|Lost to Follow-up|3
1078570|NCT02347761|3512775|P3|On Study Treatment|Adverse Event|20
1078571|NCT02347761|3512776|P2|On Study Treatment|Adverse Event|8
1078572|NCT02347761|3512777|P1|On Study Treatment|Adverse Event|10
1078573|NCT02347761|3512775|P3|On Study Treatment|durg not working|1
1078574|NCT02347761|3512776|P2|On Study Treatment|durg not working|1
1078575|NCT02347761|3512777|P1|On Study Treatment|durg not working|0
1078576|NCT02347761|3512775|P3|On Study Treatment|investigator discretion|0
1078577|NCT02347761|3512776|P2|On Study Treatment|investigator discretion|0
1078578|NCT02347761|3512777|P1|On Study Treatment|investigator discretion|2
1078579|NCT02347761|3512775|P3|On Study Treatment|Lost to Follow-up|1
1078580|NCT02347761|3512776|P2|On Study Treatment|Lost to Follow-up|1
1078581|NCT02347761|3512777|P1|On Study Treatment|Lost to Follow-up|2
1078582|NCT02347761|3512775|P3|On Study Treatment|dissastisfaction with device|4
1078583|NCT02347761|3512776|P2|On Study Treatment|dissastisfaction with device|1
1078584|NCT02347761|3512777|P1|On Study Treatment|dissastisfaction with device|2
1078585|NCT02347761|3512775|P3|On Study Treatment|move/travel|5
1078586|NCT02347761|3512776|P2|On Study Treatment|move/travel|6
1078587|NCT02347761|3512777|P1|On Study Treatment|move/travel|2
1078588|NCT02347761|3512775|P3|On Study Treatment|Withdrawal by Subject|5
1078589|NCT02347761|3512776|P2|On Study Treatment|Withdrawal by Subject|3
1078590|NCT02347761|3512777|P1|On Study Treatment|Withdrawal by Subject|7
1078591|NCT02347761|3512775|P3|On Study Treatment|non-compliance with study medication|2
1078592|NCT02347761|3512776|P2|On Study Treatment|non-compliance with study medication|0
1078593|NCT02347761|3512777|P1|On Study Treatment|non-compliance with study medication|0
1078594|NCT02347761|3512775|P3|On Study Treatment|Lack of Efficacy|4
1078595|NCT02347761|3512776|P2|On Study Treatment|Lack of Efficacy|3
1078596|NCT02347761|3512777|P1|On Study Treatment|Lack of Efficacy|2
1078597|NCT02347761|3512775|P3|All Collected|moved/travel|0
1078598|NCT02347761|3512776|P2|All Collected|moved/travel|1
1078599|NCT02347761|3512777|P1|All Collected|moved/travel|0
1078600|NCT02347761|3512775|P3|All Collected|exacerbation of COPD|1
1078601|NCT02347761|3512776|P2|All Collected|exacerbation of COPD|0
1078602|NCT02347761|3512777|P1|All Collected|exacerbation of COPD|0
1078603|NCT02347761|3512775|P3|All Collected|instillation site pain|1
1078604|NCT02347761|3512776|P2|All Collected|instillation site pain|0
1078605|NCT02347761|3512777|P1|All Collected|instillation site pain|0
1078606|NCT02347761|3512775|P3|All Collected|invetigator disretion|0
1078607|NCT02347761|3512776|P2|All Collected|invetigator disretion|0
1078608|NCT02347761|3512777|P1|All Collected|invetigator disretion|2
1078609|NCT02347761|3512775|P3|All Collected|Withdrawal by Subject|22
1078610|NCT02347761|3512776|P2|All Collected|Withdrawal by Subject|11
1078611|NCT02347761|3512777|P1|All Collected|Withdrawal by Subject|11
1078612|NCT02347761|3512775|P3|All Collected|Lost to Follow-up|3
1078613|NCT02347761|3512776|P2|All Collected|Lost to Follow-up|2
1078614|NCT02347761|3512777|P1|All Collected|Lost to Follow-up|3
1078615|NCT02347761|3512775|P3|All Collected|Death|0
1078616|NCT02347761|3512776|P2|All Collected|Death|0
1078617|NCT02347761|3512777|P1|All Collected|Death|1
1078618|NCT02347657|3512838|P2|Overall Study|Other|3
1078619|NCT02347657|3512839|P1|Overall Study|Other|3
1078620|NCT02347657|3512838|P2|Overall Study|Randomized but not treated|0
1078621|NCT02347657|3512839|P1|Overall Study|Randomized but not treated|1
1078622|NCT02347657|3512838|P2|Overall Study|Withdrawal by Subject|7
1078623|NCT02347657|3512839|P1|Overall Study|Withdrawal by Subject|6
1078624|NCT02347657|3512838|P2|Overall Study|Adverse Event|4
1078625|NCT02347657|3512839|P1|Overall Study|Adverse Event|8
1078626|NCT02347657|3512838|P2|Overall Study|Physician Decision|1
1078627|NCT02347657|3512839|P1|Overall Study|Physician Decision|0
1078628|NCT02347189|3512896|P1|Overall Study|No primary outcome data available|2
1078629|NCT02347189|3512896|P1|Overall Study|No implant attempted of study device|9
1078630|NCT02347176|3512904|P4|Overall Study|Other|0
1078631|NCT02347176|3512905|P3|Overall Study|Other|2
1078632|NCT02347176|3512906|P2|Overall Study|Other|2
1078633|NCT02347176|3512907|P1|Overall Study|Other|1
1078634|NCT02347176|3512904|P4|Overall Study|Withdrawal by Subject|3
1078635|NCT02347176|3512905|P3|Overall Study|Withdrawal by Subject|5
1078636|NCT02347176|3512906|P2|Overall Study|Withdrawal by Subject|5
1078637|NCT02347176|3512907|P1|Overall Study|Withdrawal by Subject|9
1078638|NCT02347176|3512904|P4|Overall Study|Lost to Follow-up|1
1078639|NCT02347176|3512905|P3|Overall Study|Lost to Follow-up|1
1078640|NCT02347176|3512906|P2|Overall Study|Lost to Follow-up|3
1078641|NCT02347176|3512907|P1|Overall Study|Lost to Follow-up|2
1078642|NCT02347085|3512990|P1|Overall Study|Protocol Criteria|2
1078643|NCT02347085|3512990|P1|Overall Study|Lost to Follow-up|1
1078644|NCT02347085|3512990|P1|Overall Study|Withdrawal by Subject|4
1078645|NCT02347085|3512990|P1|Overall Study|Lack of Efficacy|1
1078646|NCT02347085|3512990|P1|Overall Study|Adverse Event|2
1078647|NCT02347072|3513012|P1|Overall Study|Disc due to Protocol-specified Criteria|6
1078648|NCT02347072|3513012|P1|Overall Study|Protocol Violation|1
1078649|NCT02347072|3513012|P1|Overall Study|Lost to Follow-up|2
1078650|NCT02347072|3513012|P1|Overall Study|Physician Decision|1
1078651|NCT02347072|3513012|P1|Overall Study|Withdrawal by Subject|6
1078652|NCT02347072|3513012|P1|Overall Study|Adverse Event|2
1078653|NCT02346877|3513046|P2|Overall Study|Missing|0
1078654|NCT02346877|3513047|P1|Overall Study|Missing|5
1078655|NCT02346877|3513046|P2|Overall Study|Sponsor Decision|0
1078656|NCT02346877|3513047|P1|Overall Study|Sponsor Decision|12
1078657|NCT02346877|3513046|P2|Overall Study|Administrative Decision|0
1078658|NCT02346877|3513047|P1|Overall Study|Administrative Decision|1
1078659|NCT02346877|3513046|P2|Overall Study|Adverse Event|0
1078660|NCT02346877|3513047|P1|Overall Study|Adverse Event|1
1078661|NCT02346721|3513057|P1|Overall Study|Lack of Efficacy|1
1078662|NCT02346721|3513057|P1|Overall Study|Withdrew Consent|3
1078663|NCT02346240|3513075|P17|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1078664|NCT02346240|3513076|P16|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1078665|NCT02346240|3513077|P15|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|1
1078666|NCT02346240|3513078|P14|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1078667|NCT02346240|3513079|P13|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1078668|NCT02346240|3513080|P12|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1078669|NCT02346240|3513081|P11|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1078670|NCT02346240|3513082|P10|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1078671|NCT02346240|3513083|P9|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1078672|NCT02346240|3513084|P8|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1078673|NCT02346240|3513085|P7|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1078674|NCT02346240|3513086|P6|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1078675|NCT02346240|3513087|P5|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1078676|NCT02346240|3513088|P4|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1078677|NCT02346240|3513089|P3|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1078678|NCT02346240|3513090|P2|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1078679|NCT02346240|3513091|P1|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1078680|NCT02346240|3513075|P17|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1078681|NCT02346240|3513076|P16|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1078682|NCT02346240|3513077|P15|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1078683|NCT02346240|3513078|P14|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1078684|NCT02346240|3513079|P13|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1078685|NCT02346240|3513080|P12|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1078686|NCT02346240|3513081|P11|Finished Wk16 Entered Maintenance Period|Patient’s decisions|1
1078687|NCT02346240|3513082|P10|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1078688|NCT02346240|3513083|P9|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1078689|NCT02346240|3513084|P8|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1078690|NCT02346240|3513085|P7|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1078691|NCT02346240|3513086|P6|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1078692|NCT02346240|3513087|P5|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1078693|NCT02346240|3513088|P4|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1078694|NCT02346240|3513089|P3|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1078695|NCT02346240|3513090|P2|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1078696|NCT02346240|3513091|P1|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1078697|NCT02346240|3513075|P17|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1078698|NCT02346240|3513076|P16|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1078699|NCT02346240|3513077|P15|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1078700|NCT02346240|3513078|P14|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1078701|NCT02346240|3513079|P13|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1078702|NCT02346240|3513080|P12|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1078703|NCT02346240|3513081|P11|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1078704|NCT02346240|3513082|P10|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|1
1078705|NCT02346240|3513083|P9|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1078706|NCT02346240|3513084|P8|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1078707|NCT02346240|3513085|P7|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1078708|NCT02346240|3513086|P6|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1078709|NCT02346240|3513087|P5|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1078710|NCT02346240|3513088|P4|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1078711|NCT02346240|3513089|P3|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1078712|NCT02346240|3513090|P2|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1078713|NCT02346240|3513091|P1|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1078714|NCT02346240|3513075|P17|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1078715|NCT02346240|3513076|P16|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1078716|NCT02346240|3513077|P15|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|1
1078717|NCT02346240|3513078|P14|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|1
1078718|NCT02346240|3513079|P13|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1078719|NCT02346240|3513080|P12|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|1
1078720|NCT02346240|3513081|P11|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1078721|NCT02346240|3513082|P10|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1078722|NCT02346240|3513083|P9|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|1
1078723|NCT02346240|3513084|P8|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1078724|NCT02346240|3513085|P7|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1078725|NCT02346240|3513086|P6|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1078726|NCT02346240|3513087|P5|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1078727|NCT02346240|3513088|P4|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1078728|NCT02346240|3513089|P3|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1078729|NCT02346240|3513090|P2|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1078730|NCT02346240|3513091|P1|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1078731|NCT02346240|3513075|P17|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1078732|NCT02346240|3513076|P16|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1078733|NCT02346240|3513077|P15|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1078734|NCT02346240|3513078|P14|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1078735|NCT02346240|3513079|P13|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1078736|NCT02346240|3513080|P12|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1078737|NCT02346240|3513081|P11|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1078738|NCT02346240|3513082|P10|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1078739|NCT02346240|3513083|P9|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1078740|NCT02346240|3513084|P8|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1078741|NCT02346240|3513085|P7|Finished Wk16 Entered Maintenance Period|Moved out of state|1
1078742|NCT02346240|3513086|P6|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1078743|NCT02346240|3513087|P5|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1078744|NCT02346240|3513088|P4|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1078745|NCT02346240|3513089|P3|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1078746|NCT02346240|3513090|P2|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1078747|NCT02346240|3513091|P1|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1078748|NCT02346240|3513075|P17|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|4
1078749|NCT02346240|3513076|P16|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|8
1078750|NCT02346240|3513077|P15|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|3
1078751|NCT02346240|3513078|P14|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|3
1078752|NCT02346240|3513079|P13|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1078753|NCT02346240|3513080|P12|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1078754|NCT02346240|3513081|P11|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1078755|NCT02346240|3513082|P10|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1078756|NCT02346240|3513083|P9|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1078757|NCT02346240|3513084|P8|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1078758|NCT02346240|3513085|P7|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1078759|NCT02346240|3513086|P6|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1078760|NCT02346240|3513087|P5|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1078761|NCT02346240|3513088|P4|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1078762|NCT02346240|3513089|P3|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1078763|NCT02346240|3513090|P2|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1078764|NCT02346240|3513091|P1|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1078765|NCT02346240|3513075|P17|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
1078766|NCT02346240|3513076|P16|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|1
1078767|NCT02346240|3513077|P15|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|4
1078768|NCT02346240|3513078|P14|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|2
1078769|NCT02346240|3513079|P13|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
1078770|NCT02346240|3513080|P12|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|2
1078771|NCT02346240|3513081|P11|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|1
1078772|NCT02346240|3513082|P10|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
1078773|NCT02346240|3513083|P9|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|1
1078774|NCT02346240|3513084|P8|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|1
1078775|NCT02346240|3513085|P7|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|1
1078776|NCT02346240|3513086|P6|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|1
1078777|NCT02346240|3513087|P5|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
1078778|NCT02346240|3513088|P4|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
1078779|NCT02346240|3513089|P3|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
1078780|NCT02346240|3513090|P2|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
1078781|NCT02346240|3513091|P1|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
1078782|NCT02346240|3513075|P17|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1078783|NCT02346240|3513076|P16|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1078784|NCT02346240|3513077|P15|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|1
1078785|NCT02346240|3513078|P14|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1078786|NCT02346240|3513079|P13|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1078787|NCT02346240|3513080|P12|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1078788|NCT02346240|3513081|P11|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1078789|NCT02346240|3513082|P10|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1078790|NCT02346240|3513083|P9|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1078791|NCT02346240|3513084|P8|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1078792|NCT02346240|3513085|P7|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1078793|NCT02346240|3513086|P6|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1078794|NCT02346240|3513087|P5|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1078795|NCT02346240|3513088|P4|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1078796|NCT02346240|3513089|P3|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1078797|NCT02346240|3513090|P2|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1078798|NCT02346240|3513091|P1|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1078799|NCT02346240|3513075|P17|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1078800|NCT02346240|3513076|P16|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|3
1078801|NCT02346240|3513077|P15|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1078802|NCT02346240|3513078|P14|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1078803|NCT02346240|3513079|P13|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1078804|NCT02346240|3513080|P12|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1078805|NCT02346240|3513081|P11|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1078806|NCT02346240|3513082|P10|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1078807|NCT02346240|3513083|P9|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1078808|NCT02346240|3513084|P8|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1078809|NCT02346240|3513085|P7|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1078810|NCT02346240|3513086|P6|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1078811|NCT02346240|3513087|P5|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1078812|NCT02346240|3513088|P4|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1078813|NCT02346240|3513089|P3|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1078814|NCT02346240|3513090|P2|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1078815|NCT02346240|3513091|P1|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1078816|NCT02346240|3513075|P17|Finished Wk16 Entered Maintenance Period|Adverse Event|2
1078817|NCT02346240|3513076|P16|Finished Wk16 Entered Maintenance Period|Adverse Event|1
1078818|NCT02346240|3513077|P15|Finished Wk16 Entered Maintenance Period|Adverse Event|4
1078819|NCT02346240|3513078|P14|Finished Wk16 Entered Maintenance Period|Adverse Event|1
1078820|NCT02346240|3513079|P13|Finished Wk16 Entered Maintenance Period|Adverse Event|0
1078821|NCT02346240|3513080|P12|Finished Wk16 Entered Maintenance Period|Adverse Event|0
1078822|NCT02346240|3513081|P11|Finished Wk16 Entered Maintenance Period|Adverse Event|0
1078823|NCT02346240|3513082|P10|Finished Wk16 Entered Maintenance Period|Adverse Event|0
1078824|NCT02346240|3513083|P9|Finished Wk16 Entered Maintenance Period|Adverse Event|2
1078825|NCT02346240|3513084|P8|Finished Wk16 Entered Maintenance Period|Adverse Event|1
1078826|NCT02346240|3513085|P7|Finished Wk16 Entered Maintenance Period|Adverse Event|0
1078827|NCT02346240|3513086|P6|Finished Wk16 Entered Maintenance Period|Adverse Event|0
1078974|NCT02345226|3513199|P2|Overall Study|Lost to Follow-up|6
1078828|NCT02346240|3513087|P5|Finished Wk16 Entered Maintenance Period|Adverse Event|0
1078829|NCT02346240|3513088|P4|Finished Wk16 Entered Maintenance Period|Adverse Event|0
1078830|NCT02346240|3513089|P3|Finished Wk16 Entered Maintenance Period|Adverse Event|0
1078831|NCT02346240|3513090|P2|Finished Wk16 Entered Maintenance Period|Adverse Event|0
1078832|NCT02346240|3513091|P1|Finished Wk16 Entered Maintenance Period|Adverse Event|0
1078833|NCT02346240|3513075|P17|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1078834|NCT02346240|3513076|P16|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1078835|NCT02346240|3513077|P15|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1078836|NCT02346240|3513078|P14|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1078837|NCT02346240|3513079|P13|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1078838|NCT02346240|3513080|P12|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1078839|NCT02346240|3513081|P11|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1078840|NCT02346240|3513082|P10|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1078841|NCT02346240|3513083|P9|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1078842|NCT02346240|3513084|P8|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1078843|NCT02346240|3513085|P7|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1078844|NCT02346240|3513086|P6|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1078845|NCT02346240|3513087|P5|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1078846|NCT02346240|3513088|P4|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1078847|NCT02346240|3513089|P3|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1
1078848|NCT02346240|3513090|P2|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1078849|NCT02346240|3513091|P1|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1078850|NCT02346240|3513075|P17|Initial Period (Baseline to Week 16)|Non-compliance|0
1078851|NCT02346240|3513076|P16|Initial Period (Baseline to Week 16)|Non-compliance|0
1078852|NCT02346240|3513077|P15|Initial Period (Baseline to Week 16)|Non-compliance|0
1078853|NCT02346240|3513078|P14|Initial Period (Baseline to Week 16)|Non-compliance|0
1078854|NCT02346240|3513079|P13|Initial Period (Baseline to Week 16)|Non-compliance|0
1078855|NCT02346240|3513080|P12|Initial Period (Baseline to Week 16)|Non-compliance|0
1078856|NCT02346240|3513081|P11|Initial Period (Baseline to Week 16)|Non-compliance|0
1078857|NCT02346240|3513082|P10|Initial Period (Baseline to Week 16)|Non-compliance|0
1078858|NCT02346240|3513083|P9|Initial Period (Baseline to Week 16)|Non-compliance|0
1078859|NCT02346240|3513084|P8|Initial Period (Baseline to Week 16)|Non-compliance|0
1078860|NCT02346240|3513085|P7|Initial Period (Baseline to Week 16)|Non-compliance|0
1078861|NCT02346240|3513086|P6|Initial Period (Baseline to Week 16)|Non-compliance|0
1078862|NCT02346240|3513087|P5|Initial Period (Baseline to Week 16)|Non-compliance|0
1078863|NCT02346240|3513088|P4|Initial Period (Baseline to Week 16)|Non-compliance|1
1078864|NCT02346240|3513089|P3|Initial Period (Baseline to Week 16)|Non-compliance|0
1078865|NCT02346240|3513090|P2|Initial Period (Baseline to Week 16)|Non-compliance|1
1078866|NCT02346240|3513091|P1|Initial Period (Baseline to Week 16)|Non-compliance|0
1078867|NCT02346240|3513075|P17|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1078868|NCT02346240|3513076|P16|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1078869|NCT02346240|3513077|P15|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1078870|NCT02346240|3513078|P14|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1078871|NCT02346240|3513079|P13|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1078872|NCT02346240|3513080|P12|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1078873|NCT02346240|3513081|P11|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1078874|NCT02346240|3513082|P10|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1078875|NCT02346240|3513083|P9|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1078876|NCT02346240|3513084|P8|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1078877|NCT02346240|3513085|P7|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1078878|NCT02346240|3513086|P6|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1078879|NCT02346240|3513087|P5|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1078880|NCT02346240|3513088|P4|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2
1078881|NCT02346240|3513089|P3|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3
1078882|NCT02346240|3513090|P2|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2
1078883|NCT02346240|3513091|P1|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1
1078884|NCT02346240|3513075|P17|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1078885|NCT02346240|3513076|P16|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1078886|NCT02346240|3513077|P15|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1078887|NCT02346240|3513078|P14|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1078888|NCT02346240|3513079|P13|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1078889|NCT02346240|3513080|P12|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1078890|NCT02346240|3513081|P11|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1078891|NCT02346240|3513082|P10|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1078892|NCT02346240|3513083|P9|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1078893|NCT02346240|3513084|P8|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1078894|NCT02346240|3513085|P7|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1078895|NCT02346240|3513086|P6|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1078896|NCT02346240|3513087|P5|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1078897|NCT02346240|3513088|P4|Initial Period (Baseline to Week 16)|Lost to Follow-up|3
1078898|NCT02346240|3513089|P3|Initial Period (Baseline to Week 16)|Lost to Follow-up|1
1078899|NCT02346240|3513090|P2|Initial Period (Baseline to Week 16)|Lost to Follow-up|2
1078900|NCT02346240|3513091|P1|Initial Period (Baseline to Week 16)|Lost to Follow-up|1
1078901|NCT02346240|3513075|P17|Initial Period (Baseline to Week 16)|Protocol Violation|0
1078902|NCT02346240|3513076|P16|Initial Period (Baseline to Week 16)|Protocol Violation|0
1078903|NCT02346240|3513077|P15|Initial Period (Baseline to Week 16)|Protocol Violation|0
1078904|NCT02346240|3513078|P14|Initial Period (Baseline to Week 16)|Protocol Violation|0
1078905|NCT02346240|3513079|P13|Initial Period (Baseline to Week 16)|Protocol Violation|0
1078906|NCT02346240|3513080|P12|Initial Period (Baseline to Week 16)|Protocol Violation|0
1078907|NCT02346240|3513081|P11|Initial Period (Baseline to Week 16)|Protocol Violation|0
1078908|NCT02346240|3513082|P10|Initial Period (Baseline to Week 16)|Protocol Violation|0
1078909|NCT02346240|3513083|P9|Initial Period (Baseline to Week 16)|Protocol Violation|0
1078910|NCT02346240|3513084|P8|Initial Period (Baseline to Week 16)|Protocol Violation|0
1078911|NCT02346240|3513085|P7|Initial Period (Baseline to Week 16)|Protocol Violation|0
1078912|NCT02346240|3513086|P6|Initial Period (Baseline to Week 16)|Protocol Violation|0
1078913|NCT02346240|3513087|P5|Initial Period (Baseline to Week 16)|Protocol Violation|0
1078914|NCT02346240|3513088|P4|Initial Period (Baseline to Week 16)|Protocol Violation|0
1078915|NCT02346240|3513089|P3|Initial Period (Baseline to Week 16)|Protocol Violation|0
1078916|NCT02346240|3513090|P2|Initial Period (Baseline to Week 16)|Protocol Violation|1
1078917|NCT02346240|3513091|P1|Initial Period (Baseline to Week 16)|Protocol Violation|0
1078918|NCT02346240|3513075|P17|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1078919|NCT02346240|3513076|P16|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1078920|NCT02346240|3513077|P15|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1078921|NCT02346240|3513078|P14|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1078922|NCT02346240|3513079|P13|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1078923|NCT02346240|3513080|P12|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1078924|NCT02346240|3513081|P11|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1078925|NCT02346240|3513082|P10|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1078926|NCT02346240|3513083|P9|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1078927|NCT02346240|3513084|P8|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1078928|NCT02346240|3513085|P7|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1078929|NCT02346240|3513086|P6|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1078930|NCT02346240|3513087|P5|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1078931|NCT02346240|3513088|P4|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1078932|NCT02346240|3513089|P3|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1078933|NCT02346240|3513090|P2|Initial Period (Baseline to Week 16)|Lack of Efficacy|1
1078934|NCT02346240|3513091|P1|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1078935|NCT02346240|3513075|P17|Initial Period (Baseline to Week 16)|Adverse Event|0
1078936|NCT02346240|3513076|P16|Initial Period (Baseline to Week 16)|Adverse Event|0
1078937|NCT02346240|3513077|P15|Initial Period (Baseline to Week 16)|Adverse Event|0
1078938|NCT02346240|3513078|P14|Initial Period (Baseline to Week 16)|Adverse Event|0
1078939|NCT02346240|3513079|P13|Initial Period (Baseline to Week 16)|Adverse Event|0
1078940|NCT02346240|3513080|P12|Initial Period (Baseline to Week 16)|Adverse Event|0
1078941|NCT02346240|3513081|P11|Initial Period (Baseline to Week 16)|Adverse Event|0
1078942|NCT02346240|3513082|P10|Initial Period (Baseline to Week 16)|Adverse Event|0
1078943|NCT02346240|3513083|P9|Initial Period (Baseline to Week 16)|Adverse Event|0
1078944|NCT02346240|3513084|P8|Initial Period (Baseline to Week 16)|Adverse Event|0
1078945|NCT02346240|3513085|P7|Initial Period (Baseline to Week 16)|Adverse Event|0
1078946|NCT02346240|3513086|P6|Initial Period (Baseline to Week 16)|Adverse Event|0
1078947|NCT02346240|3513087|P5|Initial Period (Baseline to Week 16)|Adverse Event|0
1078948|NCT02346240|3513088|P4|Initial Period (Baseline to Week 16)|Adverse Event|1
1078949|NCT02346240|3513089|P3|Initial Period (Baseline to Week 16)|Adverse Event|1
1078950|NCT02346240|3513090|P2|Initial Period (Baseline to Week 16)|Adverse Event|4
1078951|NCT02346240|3513091|P1|Initial Period (Baseline to Week 16)|Adverse Event|0
1078952|NCT02345330|3513170|P1|Overall Study|Progressive Disease|2
1078953|NCT02345330|3513170|P1|Overall Study|Death|1
1078954|NCT02345252|3513182|P2|Overall Study|Still in Study up to the Data Cut Date|300
1078955|NCT02345252|3513183|P1|Overall Study|Still in Study up to the Data Cut Date|304
1078956|NCT02345252|3513182|P2|Overall Study|Randomized but Never Treated|2
1078957|NCT02345252|3513183|P1|Overall Study|Randomized but Never Treated|0
1078958|NCT02345252|3513182|P2|Overall Study|Lost to Follow-up|3
1078959|NCT02345252|3513183|P1|Overall Study|Lost to Follow-up|2
1078960|NCT02345252|3513182|P2|Overall Study|Withdrew Consent|9
1078961|NCT02345252|3513183|P1|Overall Study|Withdrew Consent|7
1078962|NCT02345252|3513182|P2|Overall Study|Protocol Violation|0
1078963|NCT02345252|3513183|P1|Overall Study|Protocol Violation|1
1078964|NCT02345252|3513182|P2|Overall Study|Investigator's Discretion|1
1078965|NCT02345252|3513183|P1|Overall Study|Investigator's Discretion|0
1078966|NCT02345252|3513182|P2|Overall Study|Death|1
1078967|NCT02345252|3513183|P1|Overall Study|Death|1
1078968|NCT02345252|3513182|P2|Overall Study|Adverse Event|0
1078969|NCT02345252|3513183|P1|Overall Study|Adverse Event|1
1078970|NCT02345226|3513199|P2|Overall Study|Still in Study up to the Data Cut Date|409
1078971|NCT02345226|3513200|P1|Overall Study|Still in Study up to the Data Cut Date|405
1078972|NCT02345226|3513199|P2|Overall Study|Randomized but Never Treated|4
1078973|NCT02345226|3513200|P1|Overall Study|Randomized but Never Treated|2
1078975|NCT02345226|3513200|P1|Overall Study|Lost to Follow-up|7
1078976|NCT02345226|3513199|P2|Overall Study|Withdrew Consent|16
1078977|NCT02345226|3513200|P1|Overall Study|Withdrew Consent|18
1078978|NCT02345226|3513199|P2|Overall Study|Non-Compliance with Study Drug|0
1078979|NCT02345226|3513200|P1|Overall Study|Non-Compliance with Study Drug|1
1078980|NCT02345226|3513199|P2|Overall Study|Investigator's Discretion|1
1078981|NCT02345226|3513200|P1|Overall Study|Investigator's Discretion|3
1078982|NCT02345226|3513199|P2|Overall Study|Lack of Efficacy|0
1078983|NCT02345226|3513200|P1|Overall Study|Lack of Efficacy|1
1078984|NCT02345226|3513199|P2|Overall Study|Pregnancy|1
1078985|NCT02345226|3513200|P1|Overall Study|Pregnancy|0
1078986|NCT02345226|3513199|P2|Overall Study|Death|0
1078987|NCT02345226|3513200|P1|Overall Study|Death|1
1078988|NCT02345226|3513199|P2|Overall Study|Adverse Event|4
1078989|NCT02345226|3513200|P1|Overall Study|Adverse Event|2
1078990|NCT02345161|3513218|P2|Overall Study|Lost to Follow-up|1
1078991|NCT02345161|3513219|P1|Overall Study|Lost to Follow-up|0
1078992|NCT02345161|3513218|P2|Overall Study|Physician Decision|4
1078993|NCT02345161|3513219|P1|Overall Study|Physician Decision|4
1078994|NCT02345161|3513218|P2|Overall Study|Adverse Event|19
1078995|NCT02345161|3513219|P1|Overall Study|Adverse Event|16
1078996|NCT02345161|3513218|P2|Overall Study|Withdrawal by Subject|33
1078997|NCT02345161|3513219|P1|Overall Study|Withdrawal by Subject|25
1078998|NCT02344745|3513340|P2|Overall Study|Data collection sheets were lost|0
1078999|NCT02344745|3513341|P1|Overall Study|Data collection sheets were lost|2
1079000|NCT02344342|3513386|P4|Overall Study|Industry partner dropped out|10
1079001|NCT02344342|3513387|P3|Overall Study|Industry partner dropped out|14
1079002|NCT02344342|3513388|P2|Overall Study|Industry partner dropped out|9
1079003|NCT02344342|3513389|P1|Overall Study|Industry partner dropped out|11
1079004|NCT02344004|3513438|P2|Overall Study|Ongoing|26
1079005|NCT02344004|3513439|P1|Overall Study|Ongoing|110
1079006|NCT02344004|3513438|P2|Overall Study|Other|0
1079007|NCT02344004|3513439|P1|Overall Study|Other|6
1079008|NCT02344004|3513438|P2|Overall Study|Rescue Medication|0
1079009|NCT02344004|3513439|P1|Overall Study|Rescue Medication|1
1079010|NCT02344004|3513438|P2|Overall Study|Withdrawal by Subject|4
1079011|NCT02344004|3513439|P1|Overall Study|Withdrawal by Subject|19
1079012|NCT02344004|3513438|P2|Overall Study|Physician Decision|1
1079013|NCT02344004|3513439|P1|Overall Study|Physician Decision|3
1079014|NCT02344004|3513438|P2|Overall Study|Death|4
1079015|NCT02344004|3513439|P1|Overall Study|Death|7
1079016|NCT02344004|3513438|P2|Overall Study|Adverse Event|1
1079017|NCT02344004|3513439|P1|Overall Study|Adverse Event|8
1079018|NCT02343263|3513482|P3|Overall Study|Physician Decision|1
1079019|NCT02343263|3513483|P2|Overall Study|Physician Decision|3
1079020|NCT02343263|3513484|P1|Overall Study|Physician Decision|5
1079021|NCT02343159|3513513|P3|Overall Study|Enrollment Error|0
1079022|NCT02343159|3513514|P2|Overall Study|Enrollment Error|0
1079023|NCT02343159|3513515|P1|Overall Study|Enrollment Error|1
1079024|NCT02343159|3513513|P3|Overall Study|Sponsor Decision|0
1079025|NCT02343159|3513514|P2|Overall Study|Sponsor Decision|1
1079026|NCT02343159|3513515|P1|Overall Study|Sponsor Decision|0
1079027|NCT02343159|3513513|P3|Overall Study|Adverse Event|2
1079028|NCT02343159|3513514|P2|Overall Study|Adverse Event|4
1079029|NCT02343159|3513515|P1|Overall Study|Adverse Event|4
1079030|NCT02343159|3513513|P3|Overall Study|Lost to Follow-up|2
1079031|NCT02343159|3513514|P2|Overall Study|Lost to Follow-up|2
1079032|NCT02343159|3513515|P1|Overall Study|Lost to Follow-up|0
1079033|NCT02343159|3513513|P3|Overall Study|Withdrawal by Subject|2
1079034|NCT02343159|3513514|P2|Overall Study|Withdrawal by Subject|0
1079035|NCT02343159|3513515|P1|Overall Study|Withdrawal by Subject|3
1079036|NCT02343159|3513513|P3|Overall Study|Physician Decision|1
1079037|NCT02343159|3513514|P2|Overall Study|Physician Decision|0
1079038|NCT02343159|3513515|P1|Overall Study|Physician Decision|2
1079039|NCT02343159|3513513|P3|Overall Study|Early Study Termination|23
1079040|NCT02343159|3513514|P2|Overall Study|Early Study Termination|19
1079041|NCT02343159|3513515|P1|Overall Study|Early Study Termination|16
1079042|NCT02343003|3513559|P2|Overall Study|terminated by sponsor|0
1079043|NCT02343003|3513560|P1|Overall Study|terminated by sponsor|2
1079044|NCT02343003|3513559|P2|Overall Study|exclusion criteria met|1
1079045|NCT02343003|3513560|P1|Overall Study|exclusion criteria met|1
1079046|NCT02343003|3513559|P2|Overall Study|Death|1
1079047|NCT02343003|3513560|P1|Overall Study|Death|0
1079048|NCT02343003|3513559|P2|Overall Study|Protocol Violation|0
1079049|NCT02343003|3513560|P1|Overall Study|Protocol Violation|1
1079050|NCT02343003|3513559|P2|Overall Study|Lost to Follow-up|1
1079051|NCT02343003|3513560|P1|Overall Study|Lost to Follow-up|5
1079052|NCT02343003|3513559|P2|Overall Study|Withdrawal by Subject|4
1079053|NCT02343003|3513560|P1|Overall Study|Withdrawal by Subject|9
1079054|NCT02342743|3513576|P1|Treatment Period|Change in prophylactic medication|1
1079055|NCT02342743|3513576|P1|Treatment Period|Lost to Follow-up|8
1079056|NCT02342743|3513576|P1|Treatment Period|Withdrawal by Subject|2
1079057|NCT02342743|3513576|P1|Run-in Period|Change in prophylactic medication|3
1079058|NCT02342743|3513576|P1|Run-in Period|Lost to Follow-up|2
1079059|NCT02342743|3513576|P1|Run-in Period|Withdrawal by Subject|3
1079060|NCT02342704|3513589|P2|Overall Study|Adverse Event|3
1079061|NCT02342704|3513590|P1|Overall Study|Adverse Event|1
1079062|NCT02342704|3513589|P2|Overall Study|Lost to Follow-up|1
1079063|NCT02342704|3513590|P1|Overall Study|Lost to Follow-up|2
1079064|NCT02342704|3513589|P2|Overall Study|Withdrawal by Subject|0
1079065|NCT02342704|3513590|P1|Overall Study|Withdrawal by Subject|1
1079066|NCT02342704|3513589|P2|Overall Study|Not Specified|1
1079067|NCT02342704|3513590|P1|Overall Study|Not Specified|0
1079068|NCT02342704|3513589|P2|Overall Study|Sponsor Termination|43
1079069|NCT02342704|3513590|P1|Overall Study|Sponsor Termination|49
1079070|NCT02342704|3513589|P2|Overall Study|Physician Decision|3
1079071|NCT02342704|3513590|P1|Overall Study|Physician Decision|0
1079072|NCT02342678|3513618|P2|Overall Study|Illness/medical reason|1
1079073|NCT02342678|3513619|P1|Overall Study|Illness/medical reason|1
1079074|NCT02342678|3513618|P2|Overall Study|Family illness/emergency|1
1079075|NCT02342678|3513619|P1|Overall Study|Family illness/emergency|0
1079076|NCT02342678|3513618|P2|Overall Study|Too busy to complete study|2
1079077|NCT02342678|3513619|P1|Overall Study|Too busy to complete study|0
1079078|NCT02342678|3513618|P2|Overall Study|Lost to Follow-up|1
1079079|NCT02342678|3513619|P1|Overall Study|Lost to Follow-up|0
1079080|NCT02342548|3513650|P3|Overall Study|Other|1
1079081|NCT02342548|3513651|P2|Overall Study|Other|1
1079082|NCT02342548|3513652|P1|Overall Study|Other|1
1079083|NCT02342548|3513650|P3|Overall Study|Withdrawal by Subject|4
1079084|NCT02342548|3513651|P2|Overall Study|Withdrawal by Subject|3
1079085|NCT02342548|3513652|P1|Overall Study|Withdrawal by Subject|1
1079086|NCT02342548|3513650|P3|Overall Study|Protocol Violation|0
1079087|NCT02342548|3513651|P2|Overall Study|Protocol Violation|1
1079088|NCT02342548|3513652|P1|Overall Study|Protocol Violation|0
1079089|NCT02342548|3513650|P3|Overall Study|Study terminated by sponsor|25
1079090|NCT02342548|3513651|P2|Overall Study|Study terminated by sponsor|39
1079091|NCT02342548|3513652|P1|Overall Study|Study terminated by sponsor|20
1079092|NCT02342548|3513650|P3|Overall Study|Lost to Follow-up|0
1079093|NCT02342548|3513651|P2|Overall Study|Lost to Follow-up|1
1079094|NCT02342548|3513652|P1|Overall Study|Lost to Follow-up|0
1079095|NCT02342548|3513650|P3|Overall Study|Adverse Event|13
1079096|NCT02342548|3513651|P2|Overall Study|Adverse Event|17
1079097|NCT02342548|3513652|P1|Overall Study|Adverse Event|12
1079098|NCT02342418|3513696|P2|Overall Study|Adverse Event|1
1079099|NCT02342418|3513697|P1|Overall Study|Adverse Event|0
1079100|NCT02342288|3513707|P2|Overall Study|coordinator not available|2
1079101|NCT02342288|3513708|P1|Overall Study|coordinator not available|0
1079102|NCT02342288|3513707|P2|Overall Study|subject cannot tolerate numbing drops|1
1079103|NCT02342288|3513708|P1|Overall Study|subject cannot tolerate numbing drops|0
1079104|NCT02342288|3513707|P2|Overall Study|coordinator contaminated with blood|1
1079105|NCT02342288|3513708|P1|Overall Study|coordinator contaminated with blood|0
1079106|NCT02342288|3513707|P2|Overall Study|Withdrawal by Subject|0
1079107|NCT02342288|3513708|P1|Overall Study|Withdrawal by Subject|1
1079108|NCT02342288|3513707|P2|Overall Study|anesthesia leak in system|0
1079109|NCT02342288|3513708|P1|Overall Study|anesthesia leak in system|1
1079110|NCT02342288|3513707|P2|Overall Study|no protocol anesthesiologist available|2
1079111|NCT02342288|3513708|P1|Overall Study|no protocol anesthesiologist available|3
1079112|NCT02342223|3513714|P1|Overall Study|Lost to Follow-up|1
1079113|NCT02341482|3513886|P1|Overall Study|Adverse Event|1
1079114|NCT02341417|3513915|P3|Overall Study|Death|1
1079115|NCT02341417|3513916|P2|Overall Study|Death|0
1079116|NCT02341417|3513917|P1|Overall Study|Death|0
1079117|NCT02341417|3513915|P3|Overall Study|Decision by sponsor|0
1079118|NCT02341417|3513916|P2|Overall Study|Decision by sponsor|0
1079119|NCT02341417|3513917|P1|Overall Study|Decision by sponsor|2
1079120|NCT02341417|3513915|P3|Overall Study|Withdrawal by Subject|0
1079121|NCT02341417|3513916|P2|Overall Study|Withdrawal by Subject|2
1079122|NCT02341417|3513917|P1|Overall Study|Withdrawal by Subject|0
1079123|NCT02340962|3513978|P2|Overall Study|Lost to Follow-up|0
1079124|NCT02340962|3513979|P1|Overall Study|Lost to Follow-up|1
1079125|NCT02340663|3514016|P2|Overall Study|Withdrawal by Subject|1
1079126|NCT02340663|3514017|P1|Overall Study|Withdrawal by Subject|3
1079127|NCT02340663|3514016|P2|Overall Study|Protocol Violation|0
1079128|NCT02340663|3514017|P1|Overall Study|Protocol Violation|1
1079129|NCT02340663|3514016|P2|Overall Study|Lost to Follow-up|0
1079130|NCT02340663|3514017|P1|Overall Study|Lost to Follow-up|1
1079131|NCT02340520|3514073|P1|Overall Study|Withdrawal by Subject|1
1079132|NCT02340520|3514073|P1|Overall Study|Patient did not take drug as specified|1
1079133|NCT02340520|3514073|P1|Overall Study|Lost to Follow-up|1
1079134|NCT02340000|3514121|P2|Time Period 2|Lost to Follow-up|8
1079135|NCT02340000|3514122|P1|Time Period 2|Lost to Follow-up|10
1079136|NCT02340000|3514121|P2|Time Period 2|Withdrawal by Subject|7
1079137|NCT02340000|3514122|P1|Time Period 2|Withdrawal by Subject|9
1079138|NCT02340000|3514121|P2|Time Period 1|Lost to Follow-up|7
1079139|NCT02340000|3514122|P1|Time Period 1|Lost to Follow-up|6
1079140|NCT02340000|3514121|P2|Time Period 1|Withdrawal by Subject|8
1079141|NCT02340000|3514122|P1|Time Period 1|Withdrawal by Subject|6
1079142|NCT02339909|3514152|P3|Overall Study|Became ineligible after randomisation|71
1079143|NCT02339909|3514153|P2|Overall Study|Became ineligible after randomisation|63
1079144|NCT02339909|3514154|P1|Overall Study|Became ineligible after randomisation|89
1079145|NCT02339584|3514192|P2|Overall Study|Withdrawal by Subject|4
1079146|NCT02339584|3514193|P1|Overall Study|Withdrawal by Subject|2
1079147|NCT02339584|3514192|P2|Overall Study|Protocol Violation|1
1079148|NCT02339584|3514193|P1|Overall Study|Protocol Violation|1
1079149|NCT02339584|3514192|P2|Overall Study|Physician Decision|2
1079150|NCT02339584|3514193|P1|Overall Study|Physician Decision|1
1079151|NCT02339584|3514192|P2|Overall Study|Lack of Efficacy|1
1079152|NCT02339584|3514193|P1|Overall Study|Lack of Efficacy|0
1079153|NCT02339584|3514192|P2|Overall Study|Adverse Event|7
1079154|NCT02339584|3514193|P1|Overall Study|Adverse Event|11
1079155|NCT02339506|3514199|P2|Washout (Period 2)|Withdrawal by Subject|0
1079156|NCT02339506|3514200|P1|Washout (Period 2)|Withdrawal by Subject|2
1079157|NCT02339506|3514199|P2|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1
1079158|NCT02339506|3514200|P1|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0
1079159|NCT02339285|3514214|P3|Overall Study|Protocol Deviation|0
1079160|NCT02339285|3514215|P2|Overall Study|Protocol Deviation|1
1079161|NCT02339285|3514216|P1|Overall Study|Protocol Deviation|0
1079162|NCT02339285|3514214|P3|Overall Study|Lost to Follow-up|1
1079163|NCT02339285|3514215|P2|Overall Study|Lost to Follow-up|1
1079164|NCT02339285|3514216|P1|Overall Study|Lost to Follow-up|1
1079165|NCT02339285|3514214|P3|Overall Study|Withdrawal by Subject|1
1079166|NCT02339285|3514215|P2|Overall Study|Withdrawal by Subject|1
1079167|NCT02339285|3514216|P1|Overall Study|Withdrawal by Subject|0
1079168|NCT02339155|3514262|P2|Overall Study|Withdrawal by Subject|4
1079169|NCT02339155|3514263|P1|Overall Study|Withdrawal by Subject|4
1079170|NCT02339155|3514262|P2|Overall Study|Physician Decision|1
1079171|NCT02339155|3514263|P1|Overall Study|Physician Decision|2
1079172|NCT02339155|3514262|P2|Overall Study|Lost to Follow-up|9
1079173|NCT02339155|3514263|P1|Overall Study|Lost to Follow-up|8
1079174|NCT02339155|3514262|P2|Overall Study|Death|1
1079175|NCT02339155|3514263|P1|Overall Study|Death|1
1079176|NCT02339155|3514262|P2|Overall Study|Adverse Event|6
1079177|NCT02339155|3514263|P1|Overall Study|Adverse Event|0
1079178|NCT02338843|3514295|P2|Overall Study|Discontinued prior to randomizat|0
1079179|NCT02338843|3514296|P1|Overall Study|Discontinued prior to randomizat|1
1079180|NCT02338843|3514295|P2|Overall Study|Subject Recovered|2
1079181|NCT02338843|3514296|P1|Overall Study|Subject Recovered|0
1079182|NCT02338843|3514295|P2|Overall Study|Withdrawal by Subject|2
1079183|NCT02338843|3514296|P1|Overall Study|Withdrawal by Subject|0
1079184|NCT02338843|3514295|P2|Overall Study|Physician Decision|0
1079185|NCT02338843|3514296|P1|Overall Study|Physician Decision|1
1079186|NCT02338843|3514295|P2|Overall Study|Death|53
1079187|NCT02338843|3514296|P1|Overall Study|Death|40
1079188|NCT02338843|3514295|P2|Overall Study|Adverse Event|1
1079189|NCT02338843|3514296|P1|Overall Study|Adverse Event|2
1079190|NCT02338492|3514324|P1|Overall Study|Reason not captured above|6
1079191|NCT02338492|3514324|P1|Overall Study|Lost to Follow-up|4
1079192|NCT02338492|3514324|P1|Overall Study|Adverse Event|3
1079193|NCT02338492|3514324|P1|Overall Study|Death|32
1079194|NCT02337907|3514385|P6|Overall Study|Adverse Event|0
1079195|NCT02337907|3514386|P5|Overall Study|Adverse Event|4
1079196|NCT02337907|3514387|P4|Overall Study|Adverse Event|1
1079197|NCT02337907|3514388|P3|Overall Study|Adverse Event|1
1079198|NCT02337907|3514389|P2|Overall Study|Adverse Event|1
1079199|NCT02337907|3514390|P1|Overall Study|Adverse Event|1
1079200|NCT02337907|3514385|P6|Overall Study|Lost to Follow-up|1
1079201|NCT02337907|3514386|P5|Overall Study|Lost to Follow-up|0
1079202|NCT02337907|3514387|P4|Overall Study|Lost to Follow-up|0
1079203|NCT02337907|3514388|P3|Overall Study|Lost to Follow-up|0
1079204|NCT02337907|3514389|P2|Overall Study|Lost to Follow-up|0
1079205|NCT02337907|3514390|P1|Overall Study|Lost to Follow-up|0
1079206|NCT02337907|3514385|P6|Overall Study|Withdrawal by Subject|0
1079207|NCT02337907|3514386|P5|Overall Study|Withdrawal by Subject|5
1079208|NCT02337907|3514387|P4|Overall Study|Withdrawal by Subject|2
1079209|NCT02337907|3514388|P3|Overall Study|Withdrawal by Subject|0
1079210|NCT02337907|3514389|P2|Overall Study|Withdrawal by Subject|3
1079211|NCT02337907|3514390|P1|Overall Study|Withdrawal by Subject|2
1079212|NCT02337907|3514385|P6|Overall Study|Other than listed|0
1079213|NCT02337907|3514386|P5|Overall Study|Other than listed|1
1079214|NCT02337907|3514387|P4|Overall Study|Other than listed|1
1079215|NCT02337907|3514388|P3|Overall Study|Other than listed|0
1079216|NCT02337907|3514389|P2|Overall Study|Other than listed|0
1079217|NCT02337907|3514390|P1|Overall Study|Other than listed|1
1079218|NCT02337725|3514427|P2|Overall Study|Lack of Efficacy|0
1079219|NCT02337725|3514428|P1|Overall Study|Lack of Efficacy|4
1079220|NCT02337725|3514427|P2|Overall Study|Voluntary Withdrawal|3
1079221|NCT02337725|3514428|P1|Overall Study|Voluntary Withdrawal|14
1079222|NCT02337725|3514427|P2|Overall Study|Major Protocol Deviation|1
1079223|NCT02337725|3514428|P1|Overall Study|Major Protocol Deviation|0
1079224|NCT02337725|3514427|P2|Overall Study|Pretreatment Event/AE in Treatment|3
1079225|NCT02337725|3514428|P1|Overall Study|Pretreatment Event/AE in Treatment|8
1079226|NCT02337725|3514427|P2|Overall Study|Pretreatment Event/AE before Treatment|1
1079227|NCT02337725|3514428|P1|Overall Study|Pretreatment Event/AE before Treatment|0
1079228|NCT02337491|3514452|P2|Overall Study|On Treatment|0
1079229|NCT02337491|3514453|P1|Overall Study|On Treatment|2
1079230|NCT02337491|3514452|P2|Overall Study|Progressive Disease|28
1079231|NCT02337491|3514453|P1|Overall Study|Progressive Disease|44
1079232|NCT02337491|3514452|P2|Overall Study|Withdrawal by Subject|0
1079233|NCT02337491|3514453|P1|Overall Study|Withdrawal by Subject|3
1079234|NCT02337491|3514452|P2|Overall Study|Adverse Event|1
1079235|NCT02337491|3514453|P1|Overall Study|Adverse Event|0
1079236|NCT02337491|3514452|P2|Overall Study|Death|1
1079237|NCT02337491|3514453|P1|Overall Study|Death|1
1079238|NCT02336607|3514501|P4|Overall Study|Withdrawal by Subject|20
1079239|NCT02336607|3514502|P3|Overall Study|Withdrawal by Subject|0
1079240|NCT02336607|3514503|P2|Overall Study|Withdrawal by Subject|2
1079241|NCT02336607|3514504|P1|Overall Study|Withdrawal by Subject|0
1079242|NCT02336607|3514501|P4|Overall Study|Adverse Event|26
1079243|NCT02336607|3514502|P3|Overall Study|Adverse Event|2
1079244|NCT02336607|3514503|P2|Overall Study|Adverse Event|2
1079245|NCT02336607|3514504|P1|Overall Study|Adverse Event|0
1079246|NCT02336607|3514501|P4|Overall Study|Protocol Violation|3
1079247|NCT02336607|3514502|P3|Overall Study|Protocol Violation|1
1079248|NCT02336607|3514503|P2|Overall Study|Protocol Violation|1
1079249|NCT02336607|3514504|P1|Overall Study|Protocol Violation|0
1079250|NCT02336607|3514501|P4|Overall Study|Lost to Follow-up|21
1079251|NCT02336607|3514502|P3|Overall Study|Lost to Follow-up|0
1079252|NCT02336607|3514503|P2|Overall Study|Lost to Follow-up|1
1079253|NCT02336607|3514504|P1|Overall Study|Lost to Follow-up|2
1079254|NCT02336607|3514501|P4|Overall Study|Lack of Efficacy|2
1079255|NCT02336607|3514502|P3|Overall Study|Lack of Efficacy|0
1079256|NCT02336607|3514503|P2|Overall Study|Lack of Efficacy|0
1079257|NCT02336607|3514504|P1|Overall Study|Lack of Efficacy|1
1079258|NCT02336607|3514501|P4|Overall Study|Physician Decision|15
1079259|NCT02336607|3514502|P3|Overall Study|Physician Decision|3
1079260|NCT02336607|3514503|P2|Overall Study|Physician Decision|4
1079261|NCT02336607|3514504|P1|Overall Study|Physician Decision|1
1079262|NCT02336425|3514618|P4|Overall Study|Study terminated.|3
1079263|NCT02336425|3514619|P3|Overall Study|Study terminated.|3
1079264|NCT02336425|3514620|P2|Overall Study|Study terminated.|2
1079265|NCT02336425|3514621|P1|Overall Study|Study terminated.|2
1079266|NCT02336282|3514671|P1|Overall Study|Not enough time to complete sessions|2
1079267|NCT02336282|3514671|P1|Overall Study|Lost to Follow-up|1
1079268|NCT02336282|3514671|P1|Overall Study|Uncomfortable with technology|1
1079269|NCT02336282|3514671|P1|Overall Study|Unrelated illness|1
1079270|NCT02336178|3514695|P1|Overall Study|Other|1
1079271|NCT02336178|3514695|P1|Overall Study|Withdrawal by Subject|1
1079272|NCT02336178|3514695|P1|Overall Study|Protocol Violation|1
1079273|NCT02336178|3514695|P1|Overall Study|Lost to Follow-up|1
1079274|NCT02335489|3514809|P1|Overall Study|Lack of Efficacy|1
1079275|NCT02335489|3514809|P1|Overall Study|Physician Decision|2
1079276|NCT02335489|3514809|P1|Overall Study|Withdrawal by Subject|2
1079277|NCT02335489|3514809|P1|Overall Study|Lost to Follow-up|1
1079278|NCT02335489|3514809|P1|Overall Study|Sponsor terminated study|4
1079279|NCT02335346|3514813|P1|Overall Study|Withdrawal by Subject|1
1079280|NCT02335346|3514813|P1|Overall Study|Adverse Event|11
1079281|NCT02334384|3515093|P2|Overall Study|Lost to Follow-up|1
1079282|NCT02334384|3515094|P1|Overall Study|Lost to Follow-up|1
1079283|NCT02332889|3515133|P1|Overall Study|Physician Decision|1
1079284|NCT02332876|3515139|P2|Overall Study|Lost to Follow-up|1
1079285|NCT02332876|3515140|P1|Overall Study|Lost to Follow-up|1
1079286|NCT02332824|3515152|P6|Overall Study|Transfer|0
1079287|NCT02332824|3515153|P5|Overall Study|Transfer|0
1079288|NCT02332824|3515154|P4|Overall Study|Transfer|1
1079289|NCT02332824|3515155|P3|Overall Study|Transfer|1
1079290|NCT02332824|3515156|P2|Overall Study|Transfer|0
1079291|NCT02332824|3515157|P1|Overall Study|Transfer|0
1079292|NCT02332824|3515152|P6|Overall Study|Inconvenient schedule|0
1079293|NCT02332824|3515153|P5|Overall Study|Inconvenient schedule|0
1079294|NCT02332824|3515154|P4|Overall Study|Inconvenient schedule|0
1079295|NCT02332824|3515155|P3|Overall Study|Inconvenient schedule|0
1079296|NCT02332824|3515156|P2|Overall Study|Inconvenient schedule|1
1079297|NCT02332824|3515157|P1|Overall Study|Inconvenient schedule|1
1079298|NCT02332824|3515152|P6|Overall Study|Voluntary Withdrawal|0
1079299|NCT02332824|3515153|P5|Overall Study|Voluntary Withdrawal|0
1079300|NCT02332824|3515154|P4|Overall Study|Voluntary Withdrawal|0
1079301|NCT02332824|3515155|P3|Overall Study|Voluntary Withdrawal|0
1079302|NCT02332824|3515156|P2|Overall Study|Voluntary Withdrawal|0
1079303|NCT02332824|3515157|P1|Overall Study|Voluntary Withdrawal|1
1079304|NCT02332824|3515152|P6|Overall Study|Pretreatment Event/Adverse Event|1
1079305|NCT02332824|3515153|P5|Overall Study|Pretreatment Event/Adverse Event|4
1079306|NCT02332824|3515154|P4|Overall Study|Pretreatment Event/Adverse Event|1
1079307|NCT02332824|3515155|P3|Overall Study|Pretreatment Event/Adverse Event|1
1079308|NCT02332824|3515156|P2|Overall Study|Pretreatment Event/Adverse Event|0
1079309|NCT02332824|3515157|P1|Overall Study|Pretreatment Event/Adverse Event|4
1079310|NCT02332798|3515198|P3|Overall Study|Abnormal laboratory findings|0
1079311|NCT02332798|3515199|P2|Overall Study|Abnormal laboratory findings|0
1079312|NCT02332798|3515200|P1|Overall Study|Abnormal laboratory findings|1
1079313|NCT02332798|3515198|P3|Overall Study|Positive urine drug test|0
1079314|NCT02332798|3515199|P2|Overall Study|Positive urine drug test|1
1079315|NCT02332798|3515200|P1|Overall Study|Positive urine drug test|0
1079316|NCT02332798|3515198|P3|Overall Study|Unwilling to participate in study|1
1079317|NCT02332798|3515199|P2|Overall Study|Unwilling to participate in study|1
1079318|NCT02332798|3515200|P1|Overall Study|Unwilling to participate in study|0
1079319|NCT02332720|3515273|P23|Part A and Part B|Withdrawal by Subject|0
1079320|NCT02332720|3515274|P22|Part A and Part B|Withdrawal by Subject|0
1079321|NCT02332720|3515275|P21|Part A and Part B|Withdrawal by Subject|0
1079322|NCT02332720|3515276|P20|Part A and Part B|Withdrawal by Subject|1
1079323|NCT02332720|3515277|P19|Part A and Part B|Withdrawal by Subject|0
1079324|NCT02332720|3515278|P18|Part A and Part B|Withdrawal by Subject|0
1079325|NCT02332720|3515279|P17|Part A and Part B|Withdrawal by Subject|0
1079326|NCT02332720|3515280|P16|Part A and Part B|Withdrawal by Subject|0
1079327|NCT02332720|3515281|P15|Part A and Part B|Withdrawal by Subject|0
1079328|NCT02332720|3515282|P14|Part A and Part B|Withdrawal by Subject|0
1079329|NCT02332720|3515283|P13|Part A and Part B|Withdrawal by Subject|0
1079330|NCT02332720|3515284|P12|Part A and Part B|Withdrawal by Subject|0
1079331|NCT02332720|3515285|P11|Part A and Part B|Withdrawal by Subject|0
1079332|NCT02332720|3515286|P10|Part A and Part B|Withdrawal by Subject|0
1079333|NCT02332720|3515287|P9|Part A and Part B|Withdrawal by Subject|0
1079334|NCT02332720|3515288|P8|Part A and Part B|Withdrawal by Subject|0
1079335|NCT02332720|3515289|P7|Part A and Part B|Withdrawal by Subject|0
1079336|NCT02332720|3515290|P6|Part A and Part B|Withdrawal by Subject|1
1079337|NCT02332720|3515291|P5|Part A and Part B|Withdrawal by Subject|0
1079338|NCT02332720|3515292|P4|Part A and Part B|Withdrawal by Subject|0
1079339|NCT02332720|3515293|P3|Part A and Part B|Withdrawal by Subject|0
1079340|NCT02332720|3515294|P2|Part A and Part B|Withdrawal by Subject|0
1079341|NCT02332720|3515295|P1|Part A and Part B|Withdrawal by Subject|0
1079342|NCT02332720|3515273|P23|Part A and Part B|Physician Decision|0
1079343|NCT02332720|3515274|P22|Part A and Part B|Physician Decision|0
1079344|NCT02332720|3515275|P21|Part A and Part B|Physician Decision|0
1079345|NCT02332720|3515276|P20|Part A and Part B|Physician Decision|0
1079346|NCT02332720|3515277|P19|Part A and Part B|Physician Decision|1
1079347|NCT02332720|3515278|P18|Part A and Part B|Physician Decision|0
1079348|NCT02332720|3515279|P17|Part A and Part B|Physician Decision|0
1079349|NCT02332720|3515280|P16|Part A and Part B|Physician Decision|0
1079350|NCT02332720|3515281|P15|Part A and Part B|Physician Decision|0
1079351|NCT02332720|3515282|P14|Part A and Part B|Physician Decision|0
1079352|NCT02332720|3515283|P13|Part A and Part B|Physician Decision|0
1079353|NCT02332720|3515284|P12|Part A and Part B|Physician Decision|0
1079354|NCT02332720|3515285|P11|Part A and Part B|Physician Decision|0
1079355|NCT02332720|3515286|P10|Part A and Part B|Physician Decision|0
1079356|NCT02332720|3515287|P9|Part A and Part B|Physician Decision|0
1079357|NCT02332720|3515288|P8|Part A and Part B|Physician Decision|0
1079358|NCT02332720|3515289|P7|Part A and Part B|Physician Decision|0
1079359|NCT02332720|3515290|P6|Part A and Part B|Physician Decision|0
1079360|NCT02332720|3515291|P5|Part A and Part B|Physician Decision|0
1079361|NCT02332720|3515292|P4|Part A and Part B|Physician Decision|0
1079362|NCT02332720|3515293|P3|Part A and Part B|Physician Decision|0
1079363|NCT02332720|3515294|P2|Part A and Part B|Physician Decision|0
1079364|NCT02332720|3515295|P1|Part A and Part B|Physician Decision|0
1079365|NCT02332720|3515273|P23|Part A and Part B|Adverse Event|0
1079366|NCT02332720|3515274|P22|Part A and Part B|Adverse Event|0
1079367|NCT02332720|3515275|P21|Part A and Part B|Adverse Event|0
1079368|NCT02332720|3515276|P20|Part A and Part B|Adverse Event|0
1079369|NCT02332720|3515277|P19|Part A and Part B|Adverse Event|0
1079370|NCT02332720|3515278|P18|Part A and Part B|Adverse Event|1
1079371|NCT02332720|3515279|P17|Part A and Part B|Adverse Event|0
1079372|NCT02332720|3515280|P16|Part A and Part B|Adverse Event|0
1079373|NCT02332720|3515281|P15|Part A and Part B|Adverse Event|0
1079374|NCT02332720|3515282|P14|Part A and Part B|Adverse Event|0
1079375|NCT02332720|3515283|P13|Part A and Part B|Adverse Event|0
1079376|NCT02332720|3515284|P12|Part A and Part B|Adverse Event|0
1079377|NCT02332720|3515285|P11|Part A and Part B|Adverse Event|0
1079378|NCT02332720|3515286|P10|Part A and Part B|Adverse Event|0
1079379|NCT02332720|3515287|P9|Part A and Part B|Adverse Event|0
1079380|NCT02332720|3515288|P8|Part A and Part B|Adverse Event|0
1079381|NCT02332720|3515289|P7|Part A and Part B|Adverse Event|0
1079382|NCT02332720|3515290|P6|Part A and Part B|Adverse Event|0
1079383|NCT02332720|3515291|P5|Part A and Part B|Adverse Event|0
1079384|NCT02332720|3515292|P4|Part A and Part B|Adverse Event|0
1079385|NCT02332720|3515293|P3|Part A and Part B|Adverse Event|0
1079386|NCT02332720|3515294|P2|Part A and Part B|Adverse Event|0
1079387|NCT02332720|3515295|P1|Part A and Part B|Adverse Event|0
1079388|NCT02332720|3515273|P23|Part A and Part B|Lost to Follow-up|0
1079389|NCT02332720|3515274|P22|Part A and Part B|Lost to Follow-up|0
1079390|NCT02332720|3515275|P21|Part A and Part B|Lost to Follow-up|0
1079391|NCT02332720|3515276|P20|Part A and Part B|Lost to Follow-up|0
1079392|NCT02332720|3515277|P19|Part A and Part B|Lost to Follow-up|0
1079393|NCT02332720|3515278|P18|Part A and Part B|Lost to Follow-up|0
1079394|NCT02332720|3515279|P17|Part A and Part B|Lost to Follow-up|0
1079395|NCT02332720|3515280|P16|Part A and Part B|Lost to Follow-up|1
1079396|NCT02332720|3515281|P15|Part A and Part B|Lost to Follow-up|0
1079397|NCT02332720|3515282|P14|Part A and Part B|Lost to Follow-up|0
1079398|NCT02332720|3515283|P13|Part A and Part B|Lost to Follow-up|0
1079399|NCT02332720|3515284|P12|Part A and Part B|Lost to Follow-up|0
1079400|NCT02332720|3515285|P11|Part A and Part B|Lost to Follow-up|0
1079401|NCT02332720|3515286|P10|Part A and Part B|Lost to Follow-up|0
1079402|NCT02332720|3515287|P9|Part A and Part B|Lost to Follow-up|0
1079403|NCT02332720|3515288|P8|Part A and Part B|Lost to Follow-up|1
1079404|NCT02332720|3515289|P7|Part A and Part B|Lost to Follow-up|1
1079405|NCT02332720|3515290|P6|Part A and Part B|Lost to Follow-up|2
1079406|NCT02332720|3515291|P5|Part A and Part B|Lost to Follow-up|0
1079407|NCT02332720|3515292|P4|Part A and Part B|Lost to Follow-up|0
1079408|NCT02332720|3515293|P3|Part A and Part B|Lost to Follow-up|0
1079409|NCT02332720|3515294|P2|Part A and Part B|Lost to Follow-up|0
1079410|NCT02332720|3515295|P1|Part A and Part B|Lost to Follow-up|1
1079411|NCT02332707|3515431|P18|Overall Study|Withdrawal by Subject|0
1079412|NCT02332707|3515432|P17|Overall Study|Withdrawal by Subject|0
1079413|NCT02332707|3515433|P16|Overall Study|Withdrawal by Subject|0
1079414|NCT02332707|3515434|P15|Overall Study|Withdrawal by Subject|0
1079415|NCT02332707|3515435|P14|Overall Study|Withdrawal by Subject|0
1079416|NCT02332707|3515436|P13|Overall Study|Withdrawal by Subject|0
1079417|NCT02332707|3515437|P12|Overall Study|Withdrawal by Subject|0
1079418|NCT02332707|3515438|P11|Overall Study|Withdrawal by Subject|0
1079419|NCT02332707|3515439|P10|Overall Study|Withdrawal by Subject|3
1079420|NCT02332707|3515440|P9|Overall Study|Withdrawal by Subject|0
1079421|NCT02332707|3515441|P8|Overall Study|Withdrawal by Subject|0
1079422|NCT02332707|3515442|P7|Overall Study|Withdrawal by Subject|0
1079423|NCT02332707|3515443|P6|Overall Study|Withdrawal by Subject|0
1079424|NCT02332707|3515444|P5|Overall Study|Withdrawal by Subject|0
1079425|NCT02332707|3515445|P4|Overall Study|Withdrawal by Subject|0
1079426|NCT02332707|3515446|P3|Overall Study|Withdrawal by Subject|1
1079427|NCT02332707|3515447|P2|Overall Study|Withdrawal by Subject|0
1079428|NCT02332707|3515448|P1|Overall Study|Withdrawal by Subject|0
1079429|NCT02332707|3515431|P18|Overall Study|Physician Decision|0
1079430|NCT02332707|3515432|P17|Overall Study|Physician Decision|0
1079431|NCT02332707|3515433|P16|Overall Study|Physician Decision|0
1079432|NCT02332707|3515434|P15|Overall Study|Physician Decision|0
1079433|NCT02332707|3515435|P14|Overall Study|Physician Decision|0
1079434|NCT02332707|3515436|P13|Overall Study|Physician Decision|1
1079435|NCT02332707|3515437|P12|Overall Study|Physician Decision|0
1079436|NCT02332707|3515438|P11|Overall Study|Physician Decision|0
1079437|NCT02332707|3515439|P10|Overall Study|Physician Decision|0
1079438|NCT02332707|3515440|P9|Overall Study|Physician Decision|0
1079439|NCT02332707|3515441|P8|Overall Study|Physician Decision|0
1079440|NCT02332707|3515442|P7|Overall Study|Physician Decision|0
1079441|NCT02332707|3515443|P6|Overall Study|Physician Decision|0
1079442|NCT02332707|3515444|P5|Overall Study|Physician Decision|0
1079443|NCT02332707|3515445|P4|Overall Study|Physician Decision|1
1079444|NCT02332707|3515446|P3|Overall Study|Physician Decision|0
1079445|NCT02332707|3515447|P2|Overall Study|Physician Decision|0
1079446|NCT02332707|3515448|P1|Overall Study|Physician Decision|0
1079447|NCT02332707|3515431|P18|Overall Study|Lost to Follow-up|0
1079448|NCT02332707|3515432|P17|Overall Study|Lost to Follow-up|0
1079449|NCT02332707|3515433|P16|Overall Study|Lost to Follow-up|0
1079450|NCT02332707|3515434|P15|Overall Study|Lost to Follow-up|0
1079451|NCT02332707|3515435|P14|Overall Study|Lost to Follow-up|0
1079452|NCT02332707|3515436|P13|Overall Study|Lost to Follow-up|3
1079453|NCT02332707|3515437|P12|Overall Study|Lost to Follow-up|0
1079454|NCT02332707|3515438|P11|Overall Study|Lost to Follow-up|2
1079455|NCT02332707|3515439|P10|Overall Study|Lost to Follow-up|0
1079456|NCT02332707|3515440|P9|Overall Study|Lost to Follow-up|0
1079457|NCT02332707|3515441|P8|Overall Study|Lost to Follow-up|0
1079458|NCT02332707|3515442|P7|Overall Study|Lost to Follow-up|0
1079459|NCT02332707|3515443|P6|Overall Study|Lost to Follow-up|1
1079460|NCT02332707|3515444|P5|Overall Study|Lost to Follow-up|0
1079461|NCT02332707|3515445|P4|Overall Study|Lost to Follow-up|0
1079462|NCT02332707|3515446|P3|Overall Study|Lost to Follow-up|0
1079463|NCT02332707|3515447|P2|Overall Study|Lost to Follow-up|0
1079464|NCT02332707|3515448|P1|Overall Study|Lost to Follow-up|0
1079465|NCT02332707|3515431|P18|Overall Study|Adverse Event|0
1079466|NCT02332707|3515432|P17|Overall Study|Adverse Event|0
1079467|NCT02332707|3515433|P16|Overall Study|Adverse Event|0
1079468|NCT02332707|3515434|P15|Overall Study|Adverse Event|0
1079469|NCT02332707|3515435|P14|Overall Study|Adverse Event|0
1079470|NCT02332707|3515436|P13|Overall Study|Adverse Event|1
1079471|NCT02332707|3515437|P12|Overall Study|Adverse Event|0
1079472|NCT02332707|3515438|P11|Overall Study|Adverse Event|0
1079473|NCT02332707|3515439|P10|Overall Study|Adverse Event|0
1079474|NCT02332707|3515440|P9|Overall Study|Adverse Event|0
1079475|NCT02332707|3515441|P8|Overall Study|Adverse Event|0
1079476|NCT02332707|3515442|P7|Overall Study|Adverse Event|0
1079477|NCT02332707|3515443|P6|Overall Study|Adverse Event|0
1079478|NCT02332707|3515444|P5|Overall Study|Adverse Event|0
1079479|NCT02332707|3515445|P4|Overall Study|Adverse Event|0
1079480|NCT02332707|3515446|P3|Overall Study|Adverse Event|0
1079481|NCT02332707|3515447|P2|Overall Study|Adverse Event|0
1079482|NCT02332707|3515448|P1|Overall Study|Adverse Event|0
1079483|NCT02332590|3515542|P2|Overall Study|Other than specified above|5
1079484|NCT02332590|3515543|P1|Overall Study|Other than specified above|6
1079485|NCT02332590|3515542|P2|Overall Study|Randomized but not treated|0
1079486|NCT02332590|3515543|P1|Overall Study|Randomized but not treated|1
1079487|NCT02332590|3515542|P2|Overall Study|Poor compliance to protocol|1
1079488|NCT02332590|3515543|P1|Overall Study|Poor compliance to protocol|3
1079489|NCT02332590|3515542|P2|Overall Study|Lack of Efficacy|2
1079490|NCT02332590|3515543|P1|Overall Study|Lack of Efficacy|4
1079491|NCT02332590|3515542|P2|Overall Study|Adverse Event|11
1079492|NCT02332590|3515543|P1|Overall Study|Adverse Event|15
1079493|NCT02332239|3515607|P2|Overall Study|Lost to Follow-up|6
1079494|NCT02332239|3515608|P1|Overall Study|Lost to Follow-up|4
1079495|NCT02331446|3515660|P4|Overall Study|Lost before baseline analysis|0
1079496|NCT02331446|3515661|P3|Overall Study|Lost before baseline analysis|1
1079497|NCT02331446|3515662|P2|Overall Study|Lost before baseline analysis|1
1079498|NCT02331446|3515663|P1|Overall Study|Lost before baseline analysis|0
1079499|NCT02331446|3515660|P4|Overall Study|Physician Decision|1
1079500|NCT02331446|3515661|P3|Overall Study|Physician Decision|0
1079501|NCT02331446|3515662|P2|Overall Study|Physician Decision|1
1079502|NCT02331446|3515663|P1|Overall Study|Physician Decision|0
1079503|NCT02331446|3515660|P4|Overall Study|Disease|1
1079504|NCT02331446|3515661|P3|Overall Study|Disease|2
1079505|NCT02331446|3515662|P2|Overall Study|Disease|2
1079506|NCT02331446|3515663|P1|Overall Study|Disease|0
1079507|NCT02331446|3515660|P4|Overall Study|Personal Problem|0
1079508|NCT02331446|3515661|P3|Overall Study|Personal Problem|0
1079509|NCT02331446|3515662|P2|Overall Study|Personal Problem|0
1079510|NCT02331446|3515663|P1|Overall Study|Personal Problem|2
1079511|NCT02331446|3515660|P4|Overall Study|Lost to Follow-up|1
1079512|NCT02331446|3515661|P3|Overall Study|Lost to Follow-up|0
1079513|NCT02331446|3515662|P2|Overall Study|Lost to Follow-up|1
1079514|NCT02331446|3515663|P1|Overall Study|Lost to Follow-up|2
1079515|NCT02331368|3515733|P1|Overall Study|Withdrawal by Subject|3
1079516|NCT02330055|3515857|P2|Overall Study|participant did not sleep|1
1079517|NCT02330055|3515858|P1|Overall Study|participant did not sleep|0
1079518|NCT02330055|3515857|P2|Overall Study|data for less than 60 minutes|3
1079519|NCT02330055|3515858|P1|Overall Study|data for less than 60 minutes|3
1079520|NCT02330055|3515857|P2|Overall Study|participant forgot to wear device|5
1079521|NCT02330055|3515858|P1|Overall Study|participant forgot to wear device|5
1079522|NCT02330055|3515857|P2|Overall Study|technical issues|0
1079523|NCT02330055|3515858|P1|Overall Study|technical issues|2
1079524|NCT02329730|3515905|P12|Overall Study|Withdrawal by Subject|0
1079525|NCT02329730|3515906|P11|Overall Study|Withdrawal by Subject|0
1079526|NCT02329730|3515907|P10|Overall Study|Withdrawal by Subject|1
1079527|NCT02329730|3515908|P9|Overall Study|Withdrawal by Subject|1
1079528|NCT02329730|3515909|P8|Overall Study|Withdrawal by Subject|1
1079529|NCT02329730|3515910|P7|Overall Study|Withdrawal by Subject|1
1079530|NCT02329730|3515911|P6|Overall Study|Withdrawal by Subject|0
1079531|NCT02329730|3515912|P5|Overall Study|Withdrawal by Subject|1
1079532|NCT02329730|3515913|P4|Overall Study|Withdrawal by Subject|0
1079533|NCT02329730|3515914|P3|Overall Study|Withdrawal by Subject|0
1079534|NCT02329730|3515915|P2|Overall Study|Withdrawal by Subject|0
1079535|NCT02329730|3515916|P1|Overall Study|Withdrawal by Subject|0
1079536|NCT02329730|3515905|P12|Overall Study|Protocol Violation|0
1079537|NCT02329730|3515906|P11|Overall Study|Protocol Violation|0
1079538|NCT02329730|3515907|P10|Overall Study|Protocol Violation|0
1079539|NCT02329730|3515908|P9|Overall Study|Protocol Violation|0
1079540|NCT02329730|3515909|P8|Overall Study|Protocol Violation|0
1079541|NCT02329730|3515910|P7|Overall Study|Protocol Violation|0
1079542|NCT02329730|3515911|P6|Overall Study|Protocol Violation|2
1079543|NCT02329730|3515912|P5|Overall Study|Protocol Violation|2
1079544|NCT02329730|3515913|P4|Overall Study|Protocol Violation|0
1079545|NCT02329730|3515914|P3|Overall Study|Protocol Violation|0
1079546|NCT02329730|3515915|P2|Overall Study|Protocol Violation|0
1079547|NCT02329730|3515916|P1|Overall Study|Protocol Violation|0
1079548|NCT02329431|3516027|P2|Overall Study|Lost to Follow-up|13
1079549|NCT02329431|3516028|P1|Overall Study|Lost to Follow-up|20
1079550|NCT02329223|3516047|P3|Overall Study|Adverse Event|0
1079551|NCT02329223|3516048|P2|Overall Study|Adverse Event|1
1079552|NCT02329223|3516049|P1|Overall Study|Adverse Event|0
1079553|NCT02329223|3516047|P3|Overall Study|Physician Decision|1
1079554|NCT02329223|3516048|P2|Overall Study|Physician Decision|0
1079555|NCT02329223|3516049|P1|Overall Study|Physician Decision|0
1079556|NCT02329223|3516047|P3|Overall Study|Withdrawal by Subject|5
1079557|NCT02329223|3516048|P2|Overall Study|Withdrawal by Subject|2
1079558|NCT02329223|3516049|P1|Overall Study|Withdrawal by Subject|1
1079559|NCT02328937|3516099|P6|Period 2|Adverse Event|0
1079560|NCT02328937|3516100|P5|Period 2|Adverse Event|0
1079561|NCT02328937|3516101|P4|Period 2|Adverse Event|0
1079562|NCT02328937|3516102|P3|Period 2|Adverse Event|1
1079563|NCT02328937|3516103|P2|Period 2|Adverse Event|0
1079564|NCT02328937|3516104|P1|Period 2|Adverse Event|0
1079565|NCT02328937|3516099|P6|Period 1|Lost to Follow-up|0
1079566|NCT02328937|3516100|P5|Period 1|Lost to Follow-up|0
1079567|NCT02328937|3516101|P4|Period 1|Lost to Follow-up|1
1079568|NCT02328937|3516102|P3|Period 1|Lost to Follow-up|0
1079569|NCT02328937|3516103|P2|Period 1|Lost to Follow-up|0
1079570|NCT02328937|3516104|P1|Period 1|Lost to Follow-up|0
1079571|NCT02328105|3516152|P1|Overall Study|Still On Study in Follow-Up|4
1079572|NCT02328105|3516152|P1|Overall Study|Withdrawal by Subject|1
1079573|NCT02328105|3516152|P1|Overall Study|Death|6
1079574|NCT02328040|3516157|P2|First Intervention (2 Days)|Withdrawal by Subject|1
1079575|NCT02328040|3516158|P1|First Intervention (2 Days)|Withdrawal by Subject|1
1079576|NCT02327325|3516189|P3|Overall Study|Excluded by Study Team|1
1079577|NCT02327325|3516190|P2|Overall Study|Excluded by Study Team|0
1079578|NCT02327325|3516191|P1|Overall Study|Excluded by Study Team|0
1079579|NCT02327325|3516189|P3|Overall Study|Withdrawal by Subject|4
1079580|NCT02327325|3516190|P2|Overall Study|Withdrawal by Subject|4
1079581|NCT02327325|3516191|P1|Overall Study|Withdrawal by Subject|1
1079582|NCT02327013|3516232|P5|Overall Study|Withdrawal before treatment|0
1079583|NCT02327013|3516233|P4|Overall Study|Withdrawal before treatment|0
1079584|NCT02327013|3516234|P3|Overall Study|Withdrawal before treatment|5
1079585|NCT02327013|3516235|P2|Overall Study|Withdrawal before treatment|1
1079586|NCT02327013|3516236|P1|Overall Study|Withdrawal before treatment|2
1079587|NCT02327013|3516232|P5|Overall Study|Protocol Violation|1
1079588|NCT02327013|3516233|P4|Overall Study|Protocol Violation|0
1079589|NCT02327013|3516234|P3|Overall Study|Protocol Violation|3
1079590|NCT02327013|3516235|P2|Overall Study|Protocol Violation|0
1079591|NCT02327013|3516236|P1|Overall Study|Protocol Violation|0
1079592|NCT02327013|3516232|P5|Overall Study|Administrative or other reason(s)|1
1079593|NCT02327013|3516233|P4|Overall Study|Administrative or other reason(s)|1
1079594|NCT02327013|3516234|P3|Overall Study|Administrative or other reason(s)|11
1079595|NCT02327013|3516235|P2|Overall Study|Administrative or other reason(s)|5
1079596|NCT02327013|3516236|P1|Overall Study|Administrative or other reason(s)|1
1079597|NCT02327013|3516232|P5|Overall Study|Lost to Follow-up|0
1079598|NCT02327013|3516233|P4|Overall Study|Lost to Follow-up|0
1079599|NCT02327013|3516234|P3|Overall Study|Lost to Follow-up|5
1079600|NCT02327013|3516235|P2|Overall Study|Lost to Follow-up|4
1079601|NCT02327013|3516236|P1|Overall Study|Lost to Follow-up|2
1079602|NCT02327013|3516232|P5|Overall Study|Withdrawal of Consent|0
1079603|NCT02327013|3516233|P4|Overall Study|Withdrawal of Consent|0
1079604|NCT02327013|3516234|P3|Overall Study|Withdrawal of Consent|3
1079605|NCT02327013|3516235|P2|Overall Study|Withdrawal of Consent|0
1079606|NCT02327013|3516236|P1|Overall Study|Withdrawal of Consent|1
1079607|NCT02327013|3516232|P5|Overall Study|Non-compliance with IMP|0
1079608|NCT02327013|3516233|P4|Overall Study|Non-compliance with IMP|0
1079609|NCT02327013|3516234|P3|Overall Study|Non-compliance with IMP|7
1079610|NCT02327013|3516235|P2|Overall Study|Non-compliance with IMP|2
1079611|NCT02327013|3516236|P1|Overall Study|Non-compliance with IMP|1
1079612|NCT02327013|3516232|P5|Overall Study|Lack of Efficacy|1
1079613|NCT02327013|3516233|P4|Overall Study|Lack of Efficacy|0
1079614|NCT02327013|3516234|P3|Overall Study|Lack of Efficacy|5
1079615|NCT02327013|3516235|P2|Overall Study|Lack of Efficacy|0
1079616|NCT02327013|3516236|P1|Overall Study|Lack of Efficacy|2
1079617|NCT02327013|3516232|P5|Overall Study|Adverse Event|1
1079618|NCT02327013|3516233|P4|Overall Study|Adverse Event|0
1079619|NCT02327013|3516234|P3|Overall Study|Adverse Event|3
1079620|NCT02327013|3516235|P2|Overall Study|Adverse Event|4
1079621|NCT02327013|3516236|P1|Overall Study|Adverse Event|4
1079622|NCT02326597|3516422|P2|Overall Study|Lost to Follow-up|32
1079623|NCT02326597|3516423|P1|Overall Study|Lost to Follow-up|42
1079624|NCT02326298|3516444|P10|Maintenance Period (Week 16 - Week 48)|Adverse Event|0
1079625|NCT02326298|3516445|P9|Maintenance Period (Week 16 - Week 48)|Adverse Event|0
1079626|NCT02326298|3516446|P8|Maintenance Period (Week 16 - Week 48)|Adverse Event|1
1079627|NCT02326298|3516447|P7|Maintenance Period (Week 16 - Week 48)|Adverse Event|0
1079628|NCT02326298|3516448|P6|Maintenance Period (Week 16 - Week 48)|Adverse Event|0
1079629|NCT02326298|3516449|P5|Maintenance Period (Week 16 - Week 48)|Adverse Event|0
1079630|NCT02326298|3516450|P4|Maintenance Period (Week 16 - Week 48)|Adverse Event|0
1079631|NCT02326298|3516451|P3|Maintenance Period (Week 16 - Week 48)|Adverse Event|0
1079632|NCT02326298|3516452|P2|Maintenance Period (Week 16 - Week 48)|Adverse Event|0
1079633|NCT02326298|3516453|P1|Maintenance Period (Week 16 - Week 48)|Adverse Event|0
1079634|NCT02326298|3516444|P10|Maintenance Period (Week 16 - Week 48)|Lost to Follow-up|0
1079635|NCT02326298|3516445|P9|Maintenance Period (Week 16 - Week 48)|Lost to Follow-up|0
1079636|NCT02326298|3516446|P8|Maintenance Period (Week 16 - Week 48)|Lost to Follow-up|2
1079637|NCT02326298|3516447|P7|Maintenance Period (Week 16 - Week 48)|Lost to Follow-up|1
1079638|NCT02326298|3516448|P6|Maintenance Period (Week 16 - Week 48)|Lost to Follow-up|0
1079639|NCT02326298|3516449|P5|Maintenance Period (Week 16 - Week 48)|Lost to Follow-up|0
1079640|NCT02326298|3516450|P4|Maintenance Period (Week 16 - Week 48)|Lost to Follow-up|0
1079641|NCT02326298|3516451|P3|Maintenance Period (Week 16 - Week 48)|Lost to Follow-up|0
1079642|NCT02326298|3516452|P2|Maintenance Period (Week 16 - Week 48)|Lost to Follow-up|0
1079643|NCT02326298|3516453|P1|Maintenance Period (Week 16 - Week 48)|Lost to Follow-up|0
1079644|NCT02326298|3516444|P10|Maintenance Period (Week 16 - Week 48)|No valid reason stated by patient|0
1079645|NCT02326298|3516445|P9|Maintenance Period (Week 16 - Week 48)|No valid reason stated by patient|0
1079646|NCT02326298|3516446|P8|Maintenance Period (Week 16 - Week 48)|No valid reason stated by patient|1
1079647|NCT02326298|3516447|P7|Maintenance Period (Week 16 - Week 48)|No valid reason stated by patient|0
1079648|NCT02326298|3516448|P6|Maintenance Period (Week 16 - Week 48)|No valid reason stated by patient|0
1079649|NCT02326298|3516449|P5|Maintenance Period (Week 16 - Week 48)|No valid reason stated by patient|0
1079650|NCT02326298|3516450|P4|Maintenance Period (Week 16 - Week 48)|No valid reason stated by patient|0
1079651|NCT02326298|3516451|P3|Maintenance Period (Week 16 - Week 48)|No valid reason stated by patient|0
1079652|NCT02326298|3516452|P2|Maintenance Period (Week 16 - Week 48)|No valid reason stated by patient|0
1079653|NCT02326298|3516453|P1|Maintenance Period (Week 16 - Week 48)|No valid reason stated by patient|0
1079654|NCT02326298|3516444|P10|Maintenance Period (Week 16 - Week 48)|Pregnancy|0
1079655|NCT02326298|3516445|P9|Maintenance Period (Week 16 - Week 48)|Pregnancy|0
1079656|NCT02326298|3516446|P8|Maintenance Period (Week 16 - Week 48)|Pregnancy|0
1079657|NCT02326298|3516447|P7|Maintenance Period (Week 16 - Week 48)|Pregnancy|1
1079658|NCT02326298|3516448|P6|Maintenance Period (Week 16 - Week 48)|Pregnancy|0
1079659|NCT02326298|3516449|P5|Maintenance Period (Week 16 - Week 48)|Pregnancy|0
1079660|NCT02326298|3516450|P4|Maintenance Period (Week 16 - Week 48)|Pregnancy|0
1079661|NCT02326298|3516451|P3|Maintenance Period (Week 16 - Week 48)|Pregnancy|0
1079662|NCT02326298|3516452|P2|Maintenance Period (Week 16 - Week 48)|Pregnancy|0
1079663|NCT02326298|3516453|P1|Maintenance Period (Week 16 - Week 48)|Pregnancy|0
1079664|NCT02326298|3516444|P10|Maintenance Period (Week 16 - Week 48)|Patient cannot attend visits|0
1079665|NCT02326298|3516445|P9|Maintenance Period (Week 16 - Week 48)|Patient cannot attend visits|0
1079666|NCT02326298|3516446|P8|Maintenance Period (Week 16 - Week 48)|Patient cannot attend visits|0
1079667|NCT02326298|3516447|P7|Maintenance Period (Week 16 - Week 48)|Patient cannot attend visits|0
1079668|NCT02326298|3516448|P6|Maintenance Period (Week 16 - Week 48)|Patient cannot attend visits|0
1079669|NCT02326298|3516449|P5|Maintenance Period (Week 16 - Week 48)|Patient cannot attend visits|1
1079670|NCT02326298|3516450|P4|Maintenance Period (Week 16 - Week 48)|Patient cannot attend visits|0
1079671|NCT02326298|3516451|P3|Maintenance Period (Week 16 - Week 48)|Patient cannot attend visits|0
1079672|NCT02326298|3516452|P2|Maintenance Period (Week 16 - Week 48)|Patient cannot attend visits|0
1079673|NCT02326298|3516453|P1|Maintenance Period (Week 16 - Week 48)|Patient cannot attend visits|0
1079674|NCT02326298|3516444|P10|Maintenance Period (Week 16 - Week 48)|Patient did not achieve PASI50 response|0
1079675|NCT02326298|3516445|P9|Maintenance Period (Week 16 - Week 48)|Patient did not achieve PASI50 response|4
1079676|NCT02326298|3516446|P8|Maintenance Period (Week 16 - Week 48)|Patient did not achieve PASI50 response|0
1079677|NCT02326298|3516447|P7|Maintenance Period (Week 16 - Week 48)|Patient did not achieve PASI50 response|2
1079678|NCT02326298|3516448|P6|Maintenance Period (Week 16 - Week 48)|Patient did not achieve PASI50 response|0
1079679|NCT02326298|3516449|P5|Maintenance Period (Week 16 - Week 48)|Patient did not achieve PASI50 response|1
1079680|NCT02326298|3516450|P4|Maintenance Period (Week 16 - Week 48)|Patient did not achieve PASI50 response|0
1079681|NCT02326298|3516451|P3|Maintenance Period (Week 16 - Week 48)|Patient did not achieve PASI50 response|0
1079682|NCT02326298|3516452|P2|Maintenance Period (Week 16 - Week 48)|Patient did not achieve PASI50 response|0
1079683|NCT02326298|3516453|P1|Maintenance Period (Week 16 - Week 48)|Patient did not achieve PASI50 response|0
1079684|NCT02326298|3516444|P10|Maintenance Period (Week 16 - Week 48)|Withdrawal by Subject|1
1079685|NCT02326298|3516445|P9|Maintenance Period (Week 16 - Week 48)|Withdrawal by Subject|1
1079686|NCT02326298|3516446|P8|Maintenance Period (Week 16 - Week 48)|Withdrawal by Subject|1
1079687|NCT02326298|3516447|P7|Maintenance Period (Week 16 - Week 48)|Withdrawal by Subject|3
1079688|NCT02326298|3516448|P6|Maintenance Period (Week 16 - Week 48)|Withdrawal by Subject|0
1079689|NCT02326298|3516449|P5|Maintenance Period (Week 16 - Week 48)|Withdrawal by Subject|1
1079690|NCT02326298|3516450|P4|Maintenance Period (Week 16 - Week 48)|Withdrawal by Subject|0
1079691|NCT02326298|3516451|P3|Maintenance Period (Week 16 - Week 48)|Withdrawal by Subject|0
1079692|NCT02326298|3516452|P2|Maintenance Period (Week 16 - Week 48)|Withdrawal by Subject|0
1079693|NCT02326298|3516453|P1|Maintenance Period (Week 16 - Week 48)|Withdrawal by Subject|0
1079694|NCT02326298|3516444|P10|Initial Period (Week 0/Baseline - Wk 16)|Withdrawal by Subject|0
1079695|NCT02326298|3516445|P9|Initial Period (Week 0/Baseline - Wk 16)|Withdrawal by Subject|0
1079696|NCT02326298|3516446|P8|Initial Period (Week 0/Baseline - Wk 16)|Withdrawal by Subject|0
1079697|NCT02326298|3516447|P7|Initial Period (Week 0/Baseline - Wk 16)|Withdrawal by Subject|0
1079698|NCT02326298|3516448|P6|Initial Period (Week 0/Baseline - Wk 16)|Withdrawal by Subject|0
1079699|NCT02326298|3516449|P5|Initial Period (Week 0/Baseline - Wk 16)|Withdrawal by Subject|0
1079700|NCT02326298|3516450|P4|Initial Period (Week 0/Baseline - Wk 16)|Withdrawal by Subject|0
1079701|NCT02326298|3516451|P3|Initial Period (Week 0/Baseline - Wk 16)|Withdrawal by Subject|0
1079702|NCT02326298|3516452|P2|Initial Period (Week 0/Baseline - Wk 16)|Withdrawal by Subject|2
1079703|NCT02326298|3516453|P1|Initial Period (Week 0/Baseline - Wk 16)|Withdrawal by Subject|3
1079704|NCT02326298|3516444|P10|Initial Period (Week 0/Baseline - Wk 16)|Lost to Follow-up|0
1079705|NCT02326298|3516445|P9|Initial Period (Week 0/Baseline - Wk 16)|Lost to Follow-up|0
1079706|NCT02326298|3516446|P8|Initial Period (Week 0/Baseline - Wk 16)|Lost to Follow-up|0
1079707|NCT02326298|3516447|P7|Initial Period (Week 0/Baseline - Wk 16)|Lost to Follow-up|0
1079708|NCT02326298|3516448|P6|Initial Period (Week 0/Baseline - Wk 16)|Lost to Follow-up|0
1079709|NCT02326298|3516449|P5|Initial Period (Week 0/Baseline - Wk 16)|Lost to Follow-up|0
1079710|NCT02326298|3516450|P4|Initial Period (Week 0/Baseline - Wk 16)|Lost to Follow-up|0
1079711|NCT02326298|3516451|P3|Initial Period (Week 0/Baseline - Wk 16)|Lost to Follow-up|0
1079712|NCT02326298|3516452|P2|Initial Period (Week 0/Baseline - Wk 16)|Lost to Follow-up|1
1079713|NCT02326298|3516453|P1|Initial Period (Week 0/Baseline - Wk 16)|Lost to Follow-up|1
1079714|NCT02326298|3516444|P10|Initial Period (Week 0/Baseline - Wk 16)|Lack of Efficacy|0
1079715|NCT02326298|3516445|P9|Initial Period (Week 0/Baseline - Wk 16)|Lack of Efficacy|0
1079716|NCT02326298|3516446|P8|Initial Period (Week 0/Baseline - Wk 16)|Lack of Efficacy|0
1079717|NCT02326298|3516447|P7|Initial Period (Week 0/Baseline - Wk 16)|Lack of Efficacy|0
1079718|NCT02326298|3516448|P6|Initial Period (Week 0/Baseline - Wk 16)|Lack of Efficacy|0
1079719|NCT02326298|3516449|P5|Initial Period (Week 0/Baseline - Wk 16)|Lack of Efficacy|0
1079720|NCT02326298|3516450|P4|Initial Period (Week 0/Baseline - Wk 16)|Lack of Efficacy|0
1079721|NCT02326298|3516451|P3|Initial Period (Week 0/Baseline - Wk 16)|Lack of Efficacy|0
1079722|NCT02326298|3516452|P2|Initial Period (Week 0/Baseline - Wk 16)|Lack of Efficacy|0
1079723|NCT02326298|3516453|P1|Initial Period (Week 0/Baseline - Wk 16)|Lack of Efficacy|1
1079724|NCT02326298|3516444|P10|Initial Period (Week 0/Baseline - Wk 16)|Adverse Event|0
1079725|NCT02326298|3516445|P9|Initial Period (Week 0/Baseline - Wk 16)|Adverse Event|0
1079726|NCT02326298|3516446|P8|Initial Period (Week 0/Baseline - Wk 16)|Adverse Event|0
1079727|NCT02326298|3516447|P7|Initial Period (Week 0/Baseline - Wk 16)|Adverse Event|0
1079728|NCT02326298|3516448|P6|Initial Period (Week 0/Baseline - Wk 16)|Adverse Event|0
1079729|NCT02326298|3516449|P5|Initial Period (Week 0/Baseline - Wk 16)|Adverse Event|0
1079730|NCT02326298|3516450|P4|Initial Period (Week 0/Baseline - Wk 16)|Adverse Event|0
1079731|NCT02326298|3516451|P3|Initial Period (Week 0/Baseline - Wk 16)|Adverse Event|3
1079732|NCT02326298|3516452|P2|Initial Period (Week 0/Baseline - Wk 16)|Adverse Event|0
1079733|NCT02326298|3516453|P1|Initial Period (Week 0/Baseline - Wk 16)|Adverse Event|0
1079734|NCT02326272|3516476|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1079735|NCT02326272|3516477|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2
1079736|NCT02326272|3516478|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1
1079737|NCT02326272|3516479|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1
1079738|NCT02326272|3516480|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2
1079739|NCT02326272|3516481|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1079740|NCT02326272|3516482|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1079741|NCT02326272|3516483|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1079742|NCT02326272|3516484|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1079743|NCT02326272|3516485|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1079744|NCT02326272|3516476|P10|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1079745|NCT02326272|3516477|P9|Maintenance Period (Week 16 to Week 48)|Non-compliance|1
1079746|NCT02326272|3516478|P8|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1079747|NCT02326272|3516479|P7|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1079748|NCT02326272|3516480|P6|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1079749|NCT02326272|3516481|P5|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1079750|NCT02326272|3516482|P4|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1079751|NCT02326272|3516483|P3|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1079752|NCT02326272|3516484|P2|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1079753|NCT02326272|3516485|P1|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1079754|NCT02326272|3516476|P10|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1079755|NCT02326272|3516477|P9|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1079756|NCT02326272|3516478|P8|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1079757|NCT02326272|3516479|P7|Maintenance Period (Week 16 to Week 48)|Pregnancy|1
1079758|NCT02326272|3516480|P6|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1079759|NCT02326272|3516481|P5|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1079760|NCT02326272|3516482|P4|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1079761|NCT02326272|3516483|P3|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1079762|NCT02326272|3516484|P2|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1079763|NCT02326272|3516485|P1|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1079764|NCT02326272|3516476|P10|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1079765|NCT02326272|3516477|P9|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1079766|NCT02326272|3516478|P8|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1
1079767|NCT02326272|3516479|P7|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1079768|NCT02326272|3516480|P6|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1079769|NCT02326272|3516481|P5|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1079770|NCT02326272|3516482|P4|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1079771|NCT02326272|3516483|P3|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1079772|NCT02326272|3516484|P2|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1079773|NCT02326272|3516485|P1|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1079774|NCT02326272|3516476|P10|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
1079775|NCT02326272|3516477|P9|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1079776|NCT02326272|3516478|P8|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
1079777|NCT02326272|3516479|P7|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
1079778|NCT02326272|3516480|P6|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3
1079779|NCT02326272|3516481|P5|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1079780|NCT02326272|3516482|P4|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
1079781|NCT02326272|3516483|P3|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1079782|NCT02326272|3516484|P2|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1079783|NCT02326272|3516485|P1|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1079784|NCT02326272|3516476|P10|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1079785|NCT02326272|3516477|P9|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1079786|NCT02326272|3516478|P8|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
1079787|NCT02326272|3516479|P7|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1079788|NCT02326272|3516480|P6|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
1079789|NCT02326272|3516481|P5|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1079790|NCT02326272|3516482|P4|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1079791|NCT02326272|3516483|P3|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1079792|NCT02326272|3516484|P2|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1079793|NCT02326272|3516485|P1|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1079794|NCT02326272|3516476|P10|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
1079795|NCT02326272|3516477|P9|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
1079796|NCT02326272|3516478|P8|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1079797|NCT02326272|3516479|P7|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
1079798|NCT02326272|3516480|P6|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2
1079799|NCT02326272|3516481|P5|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1079800|NCT02326272|3516482|P4|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1079801|NCT02326272|3516483|P3|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1079802|NCT02326272|3516484|P2|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1079803|NCT02326272|3516485|P1|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1079804|NCT02326272|3516476|P10|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1079805|NCT02326272|3516477|P9|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
1079806|NCT02326272|3516478|P8|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
1079807|NCT02326272|3516479|P7|Maintenance Period (Week 16 to Week 48)|Adverse Event|4
1079808|NCT02326272|3516480|P6|Maintenance Period (Week 16 to Week 48)|Adverse Event|3
1079809|NCT02326272|3516481|P5|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
1079810|NCT02326272|3516482|P4|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1079811|NCT02326272|3516483|P3|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1079812|NCT02326272|3516484|P2|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1079813|NCT02326272|3516485|P1|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1079814|NCT02326272|3516476|P10|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1079815|NCT02326272|3516477|P9|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1079816|NCT02326272|3516478|P8|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1079817|NCT02326272|3516479|P7|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1079818|NCT02326272|3516480|P6|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1079819|NCT02326272|3516481|P5|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1079820|NCT02326272|3516482|P4|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1079821|NCT02326272|3516483|P3|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1
1079822|NCT02326272|3516484|P2|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1079823|NCT02326272|3516485|P1|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1079824|NCT02326272|3516476|P10|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1079825|NCT02326272|3516477|P9|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1079826|NCT02326272|3516478|P8|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1079827|NCT02326272|3516479|P7|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1079828|NCT02326272|3516480|P6|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1079829|NCT02326272|3516481|P5|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1079830|NCT02326272|3516482|P4|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1079831|NCT02326272|3516483|P3|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1
1079832|NCT02326272|3516484|P2|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1079833|NCT02326272|3516485|P1|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1079834|NCT02326272|3516476|P10|Initial Period (Week 0 to Week 16)|Missed two doses|0
1079835|NCT02326272|3516477|P9|Initial Period (Week 0 to Week 16)|Missed two doses|0
1079836|NCT02326272|3516478|P8|Initial Period (Week 0 to Week 16)|Missed two doses|0
1079837|NCT02326272|3516479|P7|Initial Period (Week 0 to Week 16)|Missed two doses|0
1079838|NCT02326272|3516480|P6|Initial Period (Week 0 to Week 16)|Missed two doses|0
1079839|NCT02326272|3516481|P5|Initial Period (Week 0 to Week 16)|Missed two doses|0
1079840|NCT02326272|3516482|P4|Initial Period (Week 0 to Week 16)|Missed two doses|0
1079841|NCT02326272|3516483|P3|Initial Period (Week 0 to Week 16)|Missed two doses|1
1079842|NCT02326272|3516484|P2|Initial Period (Week 0 to Week 16)|Missed two doses|0
1079843|NCT02326272|3516485|P1|Initial Period (Week 0 to Week 16)|Missed two doses|0
1079844|NCT02326272|3516476|P10|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1079845|NCT02326272|3516477|P9|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1079846|NCT02326272|3516478|P8|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1079847|NCT02326272|3516479|P7|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1079848|NCT02326272|3516480|P6|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1079849|NCT02326272|3516481|P5|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1079850|NCT02326272|3516482|P4|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1079851|NCT02326272|3516483|P3|Initial Period (Week 0 to Week 16)|Moved from the study area|1
1079852|NCT02326272|3516484|P2|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1079853|NCT02326272|3516485|P1|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1079854|NCT02326272|3516476|P10|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1079855|NCT02326272|3516477|P9|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1079856|NCT02326272|3516478|P8|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1079857|NCT02326272|3516479|P7|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1079858|NCT02326272|3516480|P6|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1079859|NCT02326272|3516481|P5|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1079860|NCT02326272|3516482|P4|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1079861|NCT02326272|3516483|P3|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
1079862|NCT02326272|3516484|P2|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2
1079863|NCT02326272|3516485|P1|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3
1079864|NCT02326272|3516476|P10|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1079865|NCT02326272|3516477|P9|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1079866|NCT02326272|3516478|P8|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1079867|NCT02326272|3516479|P7|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1079868|NCT02326272|3516480|P6|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1079869|NCT02326272|3516481|P5|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1079870|NCT02326272|3516482|P4|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1079871|NCT02326272|3516483|P3|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1079872|NCT02326272|3516484|P2|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2
1079873|NCT02326272|3516485|P1|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
1079874|NCT02326272|3516476|P10|Initial Period (Week 0 to Week 16)|Adverse Event|0
1079875|NCT02326272|3516477|P9|Initial Period (Week 0 to Week 16)|Adverse Event|0
1079876|NCT02326272|3516478|P8|Initial Period (Week 0 to Week 16)|Adverse Event|0
1079877|NCT02326272|3516479|P7|Initial Period (Week 0 to Week 16)|Adverse Event|0
1079878|NCT02326272|3516480|P6|Initial Period (Week 0 to Week 16)|Adverse Event|0
1079879|NCT02326272|3516481|P5|Initial Period (Week 0 to Week 16)|Adverse Event|0
1079880|NCT02326272|3516482|P4|Initial Period (Week 0 to Week 16)|Adverse Event|0
1079881|NCT02326272|3516483|P3|Initial Period (Week 0 to Week 16)|Adverse Event|1
1079882|NCT02326272|3516484|P2|Initial Period (Week 0 to Week 16)|Adverse Event|3
1079883|NCT02326272|3516485|P1|Initial Period (Week 0 to Week 16)|Adverse Event|0
1079884|NCT02325791|3516520|P4|Overall Study|Withdrawal by Subject|16
1079885|NCT02325791|3516521|P3|Overall Study|Withdrawal by Subject|8
1079886|NCT02325791|3516522|P2|Overall Study|Withdrawal by Subject|5
1079887|NCT02325791|3516523|P1|Overall Study|Withdrawal by Subject|0
1079888|NCT02325791|3516520|P4|Overall Study|Protocol Violation|0
1079889|NCT02325791|3516521|P3|Overall Study|Protocol Violation|1
1079890|NCT02325791|3516522|P2|Overall Study|Protocol Violation|0
1079891|NCT02325791|3516523|P1|Overall Study|Protocol Violation|0
1079892|NCT02325791|3516520|P4|Overall Study|Physician Decision|0
1079893|NCT02325791|3516521|P3|Overall Study|Physician Decision|1
1079894|NCT02325791|3516522|P2|Overall Study|Physician Decision|1
1079895|NCT02325791|3516523|P1|Overall Study|Physician Decision|0
1079896|NCT02325791|3516520|P4|Overall Study|Lost to Follow-up|9
1079897|NCT02325791|3516521|P3|Overall Study|Lost to Follow-up|14
1079898|NCT02325791|3516522|P2|Overall Study|Lost to Follow-up|15
1079899|NCT02325791|3516523|P1|Overall Study|Lost to Follow-up|0
1079900|NCT02325791|3516520|P4|Overall Study|Death|1
1079901|NCT02325791|3516521|P3|Overall Study|Death|0
1079902|NCT02325791|3516522|P2|Overall Study|Death|3
1079903|NCT02325791|3516523|P1|Overall Study|Death|0
1079904|NCT02325791|3516520|P4|Overall Study|Adverse Event|0
1079905|NCT02325791|3516521|P3|Overall Study|Adverse Event|1
1079906|NCT02325791|3516522|P2|Overall Study|Adverse Event|1
1079907|NCT02325791|3516523|P1|Overall Study|Adverse Event|0
1079908|NCT02325713|3516558|P16|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1079909|NCT02325713|3516559|P15|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1079910|NCT02325713|3516560|P14|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1079911|NCT02325713|3516561|P13|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1079912|NCT02325713|3516562|P12|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1079913|NCT02325713|3516563|P11|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1079914|NCT02325713|3516564|P10|Intervention Period 3 (2 Days)|Withdrawal by Subject|1
1079915|NCT02325713|3516565|P9|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1079916|NCT02325713|3516566|P8|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1079917|NCT02325713|3516567|P7|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1079918|NCT02325713|3516568|P6|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1079919|NCT02325713|3516569|P5|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1079920|NCT02325713|3516570|P4|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1079921|NCT02325713|3516571|P3|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1079922|NCT02325713|3516572|P2|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1079923|NCT02325713|3516573|P1|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1079924|NCT02325713|3516558|P16|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1079925|NCT02325713|3516559|P15|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1079926|NCT02325713|3516560|P14|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1079927|NCT02325713|3516561|P13|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1079928|NCT02325713|3516562|P12|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1079929|NCT02325713|3516563|P11|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1079930|NCT02325713|3516564|P10|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1079931|NCT02325713|3516565|P9|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1079932|NCT02325713|3516566|P8|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1079933|NCT02325713|3516567|P7|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1079934|NCT02325713|3516568|P6|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1079935|NCT02325713|3516569|P5|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1079936|NCT02325713|3516570|P4|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1079937|NCT02325713|3516571|P3|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1079938|NCT02325713|3516572|P2|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1079939|NCT02325713|3516573|P1|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1
1079940|NCT02325713|3516558|P16|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1079941|NCT02325713|3516559|P15|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1079942|NCT02325713|3516560|P14|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1079943|NCT02325713|3516561|P13|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1079944|NCT02325713|3516562|P12|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1079945|NCT02325713|3516563|P11|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1
1079946|NCT02325713|3516564|P10|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1079947|NCT02325713|3516565|P9|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1079948|NCT02325713|3516566|P8|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1079949|NCT02325713|3516567|P7|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1079950|NCT02325713|3516568|P6|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1079951|NCT02325713|3516569|P5|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1079952|NCT02325713|3516570|P4|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1079953|NCT02325713|3516571|P3|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1079954|NCT02325713|3516572|P2|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1079955|NCT02325713|3516573|P1|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1079956|NCT02325518|3516668|P2|Overall Study|Withdrawal by Subject|1
1079957|NCT02325518|3516669|P1|Overall Study|Withdrawal by Subject|0
1079958|NCT02325518|3516668|P2|Overall Study|Physician Decision|1
1079959|NCT02325518|3516669|P1|Overall Study|Physician Decision|0
1079960|NCT02325518|3516668|P2|Overall Study|Adverse Event|1
1079961|NCT02325518|3516669|P1|Overall Study|Adverse Event|4
1079962|NCT02324049|3516813|P1|Part C|Study terminated|11
1079963|NCT02322892|3516846|P2|Overall Study|Protocol Violation|0
1079964|NCT02322892|3516847|P1|Overall Study|Protocol Violation|1
1079965|NCT02322892|3516846|P2|Overall Study|Met exclusion criteria|1
1079966|NCT02322892|3516847|P1|Overall Study|Met exclusion criteria|0
1079967|NCT02322892|3516846|P2|Overall Study|Surgery cancelled|2
1079968|NCT02322892|3516847|P1|Overall Study|Surgery cancelled|1
1079969|NCT02322879|3516863|P2|First Intervention|Physician Decision|0
1079970|NCT02322879|3516864|P1|First Intervention|Physician Decision|1
1079971|NCT02322866|3516872|P2|Overall Study|Other Miscellaneous Reasons|6
1079972|NCT02322866|3516873|P1|Overall Study|Other Miscellaneous Reasons|6
1079973|NCT02322866|3516872|P2|Overall Study|Lack of Efficacy|1
1079974|NCT02322866|3516873|P1|Overall Study|Lack of Efficacy|3
1079975|NCT02322866|3516872|P2|Overall Study|Noncompliance with Treatment|4
1079976|NCT02322866|3516873|P1|Overall Study|Noncompliance with Treatment|3
1079977|NCT02322866|3516872|P2|Overall Study|Protocol Violation|0
1079978|NCT02322866|3516873|P1|Overall Study|Protocol Violation|1
1079979|NCT02322866|3516872|P2|Overall Study|Lost to Follow-up|39
1079980|NCT02322866|3516873|P1|Overall Study|Lost to Follow-up|36
1079981|NCT02322866|3516872|P2|Overall Study|Withdrawal of Consent|25
1079982|NCT02322866|3516873|P1|Overall Study|Withdrawal of Consent|16
1079983|NCT02322866|3516872|P2|Overall Study|Adverse Event|11
1079984|NCT02322866|3516873|P1|Overall Study|Adverse Event|6
1079985|NCT02322775|3516910|P2|Overall Study|Not willing to perform all FU visits|1
1079986|NCT02322775|3516911|P1|Overall Study|Not willing to perform all FU visits|0
1079987|NCT02322775|3516910|P2|Overall Study|Withdrawal by Subject|4
1079988|NCT02322775|3516911|P1|Overall Study|Withdrawal by Subject|3
1079989|NCT02322775|3516910|P2|Overall Study|Protocol Violation|0
1079990|NCT02322775|3516911|P1|Overall Study|Protocol Violation|1
1079991|NCT02322775|3516910|P2|Overall Study|Lost to Follow-up|1
1079992|NCT02322775|3516911|P1|Overall Study|Lost to Follow-up|0
1079993|NCT02322775|3516910|P2|Overall Study|Adverse Event|0
1079994|NCT02322775|3516911|P1|Overall Study|Adverse Event|1
1079995|NCT02322749|3516937|P6|Period 3|Withdrawal by Subject|0
1079996|NCT02322749|3516938|P5|Period 3|Withdrawal by Subject|0
1079997|NCT02322749|3516939|P4|Period 3|Withdrawal by Subject|0
1079998|NCT02322749|3516940|P3|Period 3|Withdrawal by Subject|1
1079999|NCT02322749|3516941|P2|Period 3|Withdrawal by Subject|0
1080000|NCT02322749|3516942|P1|Period 3|Withdrawal by Subject|0
1080001|NCT02322749|3516937|P6|Period 2|Withdrawal by Subject|0
1080002|NCT02322749|3516938|P5|Period 2|Withdrawal by Subject|0
1080003|NCT02322749|3516939|P4|Period 2|Withdrawal by Subject|1
1080004|NCT02322749|3516940|P3|Period 2|Withdrawal by Subject|0
1080005|NCT02322749|3516941|P2|Period 2|Withdrawal by Subject|0
1080006|NCT02322749|3516942|P1|Period 2|Withdrawal by Subject|0
1080007|NCT02322749|3516937|P6|Period 2|Adverse Event|0
1080008|NCT02322749|3516938|P5|Period 2|Adverse Event|0
1080009|NCT02322749|3516939|P4|Period 2|Adverse Event|1
1080010|NCT02322749|3516940|P3|Period 2|Adverse Event|0
1080011|NCT02322749|3516941|P2|Period 2|Adverse Event|0
1080012|NCT02322749|3516942|P1|Period 2|Adverse Event|0
1080013|NCT02322229|3516970|P1|Overall Study|Physician Decision|2
1080014|NCT02322216|3516982|P2|Overall Study|Withdrawal by Subject|4
1080015|NCT02322216|3516983|P1|Overall Study|Withdrawal by Subject|1
1080016|NCT02322216|3516982|P2|Overall Study|Adverse Event|0
1080017|NCT02322216|3516983|P1|Overall Study|Adverse Event|1
1080018|NCT02321436|3516996|P2|Overall Study|Lost to Follow-up|1
1080019|NCT02321436|3516997|P1|Overall Study|Lost to Follow-up|0
1080020|NCT02321436|3516996|P2|Overall Study|Withdrawal by Subject|0
1080021|NCT02321436|3516997|P1|Overall Study|Withdrawal by Subject|1
1080022|NCT02321098|3517016|P3|Additional 15 Months Treatment|Withdrawal by Subject|1
1080023|NCT02321098|3517017|P2|Additional 15 Months Treatment|Withdrawal by Subject|0
1080024|NCT02321098|3517018|P1|Additional 15 Months Treatment|Withdrawal by Subject|0
1080025|NCT02321098|3517016|P3|Additional 15 Months Treatment|Lost to Follow-up|1
1080026|NCT02321098|3517017|P2|Additional 15 Months Treatment|Lost to Follow-up|0
1080027|NCT02321098|3517018|P1|Additional 15 Months Treatment|Lost to Follow-up|0
1080028|NCT02321098|3517016|P3|Additional 15 Months Treatment|Lack of Efficacy|6
1080029|NCT02321098|3517017|P2|Additional 15 Months Treatment|Lack of Efficacy|0
1080030|NCT02321098|3517018|P1|Additional 15 Months Treatment|Lack of Efficacy|0
1080031|NCT02321098|3517016|P3|12 Weeks Treament|Lost to Follow-up|0
1080032|NCT02321098|3517017|P2|12 Weeks Treament|Lost to Follow-up|1
1080033|NCT02321098|3517018|P1|12 Weeks Treament|Lost to Follow-up|1
1080034|NCT02320903|3517030|P3|Overall Study|Lost to Follow-up|5
1080035|NCT02320903|3517031|P2|Overall Study|Lost to Follow-up|5
1080036|NCT02320903|3517032|P1|Overall Study|Lost to Follow-up|0
1080037|NCT02320903|3517030|P3|Overall Study|Exited therapy; no longer eligible|2
1080038|NCT02320903|3517031|P2|Overall Study|Exited therapy; no longer eligible|2
1080039|NCT02320903|3517032|P1|Overall Study|Exited therapy; no longer eligible|8
1080040|NCT02320903|3517030|P3|Overall Study|Withdrawal by Subject|9
1080041|NCT02320903|3517031|P2|Overall Study|Withdrawal by Subject|9
1080042|NCT02320903|3517032|P1|Overall Study|Withdrawal by Subject|0
1080043|NCT02320721|3517136|P2|Overall Study|Other than specified above|20
1080044|NCT02320721|3517137|P1|Overall Study|Other than specified above|15
1080045|NCT02320721|3517136|P2|Overall Study|Hypoglycemia|0
1080046|NCT02320721|3517137|P1|Overall Study|Hypoglycemia|1
1080047|NCT02320721|3517136|P2|Overall Study|Randomized but not treated|1
1080048|NCT02320721|3517137|P1|Overall Study|Randomized but not treated|0
1080049|NCT02320721|3517136|P2|Overall Study|Poor compliance to protocol|7
1080050|NCT02320721|3517137|P1|Overall Study|Poor compliance to protocol|3
1080051|NCT02320721|3517136|P2|Overall Study|Lack of Efficacy|0
1080052|NCT02320721|3517137|P1|Overall Study|Lack of Efficacy|2
1080053|NCT02320721|3517136|P2|Overall Study|Adverse Event|6
1080054|NCT02320721|3517137|P1|Overall Study|Adverse Event|6
1080055|NCT02320487|3517192|P1|Overall Study|Adverse Event|11
1080056|NCT02320487|3517192|P1|Overall Study|Death|3
1080057|NCT02320487|3517192|P1|Overall Study|Withdrawal by Subject|1
1080058|NCT02320487|3517192|P1|Overall Study|Physician Decision|5
1080059|NCT02320487|3517192|P1|Overall Study|Reason not Specified|1
1080060|NCT02320396|3517212|P2|Overall Study|Withdrawal by Subject|0
1080061|NCT02320396|3517213|P1|Overall Study|Withdrawal by Subject|2
1080062|NCT02320396|3517212|P2|Overall Study|Protocol Violation|1
1080063|NCT02320396|3517213|P1|Overall Study|Protocol Violation|0
1080064|NCT02320396|3517212|P2|Overall Study|Pregnancy|1
1080065|NCT02320396|3517213|P1|Overall Study|Pregnancy|0
1080066|NCT02320396|3517212|P2|Overall Study|Adverse Event|2
1080067|NCT02320396|3517213|P1|Overall Study|Adverse Event|2
1080068|NCT02320149|3517255|P2|Overall Study|Other Miscellaneous Reasons|3
1080069|NCT02320149|3517256|P1|Overall Study|Other Miscellaneous Reasons|2
1080070|NCT02320149|3517255|P2|Overall Study|Lack of Efficacy|1
1080071|NCT02320149|3517256|P1|Overall Study|Lack of Efficacy|0
1080072|NCT02320149|3517255|P2|Overall Study|Noncompliance with Study Treatment|2
1080073|NCT02320149|3517256|P1|Overall Study|Noncompliance with Study Treatment|7
1080074|NCT02320149|3517255|P2|Overall Study|Protocol Violation|1
1080075|NCT02320149|3517256|P1|Overall Study|Protocol Violation|2
1080076|NCT02320149|3517255|P2|Overall Study|Lost to Follow-up|34
1080077|NCT02320149|3517256|P1|Overall Study|Lost to Follow-up|21
1080078|NCT02320149|3517255|P2|Overall Study|Withdrawal of Consent|32
1080079|NCT02320149|3517256|P1|Overall Study|Withdrawal of Consent|28
1080080|NCT02320149|3517255|P2|Overall Study|Adverse Event|7
1080081|NCT02320149|3517256|P1|Overall Study|Adverse Event|3
1080082|NCT02319668|3517302|P2|Overall Study|Other (Not specified)|2
1080083|NCT02319668|3517303|P1|Overall Study|Other (Not specified)|0
1080084|NCT02319642|3517317|P2|Overall Study|Withdrawal by Subject|1
1080085|NCT02319642|3517318|P1|Overall Study|Withdrawal by Subject|1
1080086|NCT02319642|3517317|P2|Overall Study|Lack of Efficacy|1
1080087|NCT02319642|3517318|P1|Overall Study|Lack of Efficacy|1
1080088|NCT02319642|3517317|P2|Overall Study|Adverse Event|4
1080089|NCT02319642|3517318|P1|Overall Study|Adverse Event|2
1080090|NCT02319525|3517338|P2|Overall Study|Withdrawal by Subject|1
1080091|NCT02319525|3517339|P1|Overall Study|Withdrawal by Subject|2
1080092|NCT02319148|3517381|P4|Second Intervention Period|Other|1
1080093|NCT02319148|3517382|P3|Second Intervention Period|Other|0
1080094|NCT02319148|3517383|P2|Second Intervention Period|Other|0
1080095|NCT02319148|3517384|P1|Second Intervention Period|Other|0
1080096|NCT02319148|3517381|P4|Second Intervention Period|No longer willing to participate|0
1080097|NCT02319148|3517382|P3|Second Intervention Period|No longer willing to participate|0
1080098|NCT02319148|3517383|P2|Second Intervention Period|No longer willing to participate|1
1080099|NCT02319148|3517384|P1|Second Intervention Period|No longer willing to participate|0
1080100|NCT02319148|3517381|P4|Second Intervention Period|Adverse event (AE) related to study drug|1
1080101|NCT02319148|3517382|P3|Second Intervention Period|Adverse event (AE) related to study drug|1
1080102|NCT02319148|3517383|P2|Second Intervention Period|Adverse event (AE) related to study drug|0
1080103|NCT02319148|3517384|P1|Second Intervention Period|Adverse event (AE) related to study drug|0
1080104|NCT02319044|3517447|P3|Overall Study|Not treated|2
1080105|NCT02319044|3517448|P2|Overall Study|Not treated|2
1080106|NCT02319044|3517449|P1|Overall Study|Not treated|0
1080107|NCT02319044|3517447|P3|Overall Study|Study specific discontinuation criteria|1
1080108|NCT02319044|3517448|P2|Overall Study|Study specific discontinuation criteria|2
1080109|NCT02319044|3517449|P1|Overall Study|Study specific discontinuation criteria|2
1080110|NCT02319044|3517447|P3|Overall Study|Adverse Event|8
1080111|NCT02319044|3517448|P2|Overall Study|Adverse Event|2
1080112|NCT02319044|3517449|P1|Overall Study|Adverse Event|17
1080113|NCT02319044|3517447|P3|Overall Study|Condition under investigation worsened|46
1080114|NCT02319044|3517448|P2|Overall Study|Condition under investigation worsened|50
1080115|NCT02319044|3517449|P1|Overall Study|Condition under investigation worsened|100
1080116|NCT02319044|3517447|P3|Overall Study|Withdrawal by Subject|6
1080117|NCT02319044|3517448|P2|Overall Study|Withdrawal by Subject|3
1080118|NCT02319044|3517449|P1|Overall Study|Withdrawal by Subject|3
1080119|NCT02319044|3517447|P3|Overall Study|Death, PI/sponsor decision, med history|4
1080120|NCT02319044|3517448|P2|Overall Study|Death, PI/sponsor decision, med history|1
1080121|NCT02319044|3517449|P1|Overall Study|Death, PI/sponsor decision, med history|0
1080122|NCT02319031|3517505|P2|Treatment Period|Death|0
1080123|NCT02319031|3517506|P1|Treatment Period|Death|1
1080124|NCT02318940|3517541|P2|Overall Study|lost the record|0
1080125|NCT02318940|3517542|P1|Overall Study|lost the record|1
1080126|NCT02318797|3517569|P2|Overall Study|Lost to Follow-up|96
1080127|NCT02318797|3517570|P1|Overall Study|Lost to Follow-up|85
1080128|NCT02318797|3517569|P2|Overall Study|Death|6
1080129|NCT02318797|3517570|P1|Overall Study|Death|3
1080130|NCT02318693|3517610|P2|Overall Study|Protocol Violation|1
1080131|NCT02318693|3517611|P1|Overall Study|Protocol Violation|0
1080132|NCT02318667|3517625|P1|Overall Study|Protocol Violation|2
1080133|NCT02318667|3517625|P1|Overall Study|Lack of Efficacy|6
1080134|NCT02318667|3517625|P1|Overall Study|Adverse Event|1
1080135|NCT02318602|3517644|P3|Overall Study|Guardian decision to withdraw|1
1080136|NCT02318602|3517645|P2|Overall Study|Guardian decision to withdraw|0
1080137|NCT02318602|3517646|P1|Overall Study|Guardian decision to withdraw|0
1080138|NCT02318602|3517644|P3|Overall Study|Death|0
1080139|NCT02318602|3517645|P2|Overall Study|Death|0
1080140|NCT02318602|3517646|P1|Overall Study|Death|1
1080141|NCT02318602|3517644|P3|Overall Study|Withdrawal by Subject|0
1080142|NCT02318602|3517645|P2|Overall Study|Withdrawal by Subject|3
1080143|NCT02318602|3517646|P1|Overall Study|Withdrawal by Subject|0
1080144|NCT02318602|3517644|P3|Overall Study|Adverse Event|1
1080145|NCT02318602|3517645|P2|Overall Study|Adverse Event|1
1080146|NCT02318602|3517646|P1|Overall Study|Adverse Event|0
1080147|NCT02317809|3517706|P2|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0
1080148|NCT02317809|3517707|P1|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1
1080149|NCT02317809|3517706|P2|First Intervention Period (8 Days)|Protocol Non-Compliance|0
1080150|NCT02317809|3517707|P1|First Intervention Period (8 Days)|Protocol Non-Compliance|2
1080151|NCT02317614|3517795|P2|Overall Study|Death|1
1080152|NCT02317614|3517796|P1|Overall Study|Death|1
1080153|NCT02317614|3517795|P2|Overall Study|Withdrawal by Subject|0
1080154|NCT02317614|3517796|P1|Overall Study|Withdrawal by Subject|1
1080155|NCT02317614|3517795|P2|Overall Study|Lost to Follow-up|1
1080156|NCT02317614|3517796|P1|Overall Study|Lost to Follow-up|1
1080157|NCT02317510|3517823|P2|Overall Study|Adverse Event|1
1080158|NCT02317510|3517824|P1|Overall Study|Adverse Event|0
1080159|NCT02317016|3517852|P1|Part B: Day 35 to End Part B (AZD9291)|Death|5
1080160|NCT02317016|3517852|P1|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2
1080161|NCT02317016|3517852|P1|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1
1080162|NCT02317016|3517852|P1|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23
1080163|NCT02317016|3517852|P1|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1
1080164|NCT02317016|3517852|P1|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1
1080165|NCT02317016|3517852|P1|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1
1080166|NCT02316847|3517880|P2|Overall Study|Withdrawn due to termination by Sponsor|67
1080167|NCT02316847|3517881|P1|Overall Study|Withdrawn due to termination by Sponsor|7
1080168|NCT02316847|3517880|P2|Overall Study|Noncompliance with study drug|3
1080169|NCT02316847|3517881|P1|Overall Study|Noncompliance with study drug|0
1080170|NCT02316847|3517880|P2|Overall Study|Withdrawal by Subject|9
1080171|NCT02316847|3517881|P1|Overall Study|Withdrawal by Subject|2
1080172|NCT02316847|3517880|P2|Overall Study|Pregnancy|1
1080173|NCT02316847|3517881|P1|Overall Study|Pregnancy|0
1080174|NCT02316847|3517880|P2|Overall Study|Physician Decision|1
1080175|NCT02316847|3517881|P1|Overall Study|Physician Decision|0
1080176|NCT02316847|3517880|P2|Overall Study|Lost to Follow-up|2
1080177|NCT02316847|3517881|P1|Overall Study|Lost to Follow-up|0
1080178|NCT02316847|3517880|P2|Overall Study|Adverse Event|3
1080179|NCT02316847|3517881|P1|Overall Study|Adverse Event|0
1080180|NCT02316769|3517892|P2|Overall Study|Withdrawal by Subject|0
1080181|NCT02316769|3517893|P1|Overall Study|Withdrawal by Subject|1
1080182|NCT02316769|3517892|P2|Overall Study|Physician Decision|0
1080183|NCT02316769|3517893|P1|Overall Study|Physician Decision|1
1080184|NCT02316613|3517910|P1|Overall Study|Did not met selection criteria|14
1080185|NCT02316613|3517910|P1|Overall Study|No data and duplicate cases|5
1080186|NCT02316613|3517910|P1|Overall Study|Participant moved/changed medical team|11
1080187|NCT02316613|3517910|P1|Overall Study|Lymphoma transformation|2
1080188|NCT02316613|3517910|P1|Overall Study|Lost to Follow-up|9
1080189|NCT02316613|3517910|P1|Overall Study|Death|63
1080190|NCT02316548|3517949|P2|Overall Study|Protocol Violation|1
1080191|NCT02316548|3517950|P1|Overall Study|Protocol Violation|0
1080192|NCT02316353|3518080|P2|Overall Study|Withdrawal by Subject|2
1080193|NCT02316353|3518081|P1|Overall Study|Withdrawal by Subject|6
1080194|NCT02316353|3518080|P2|Overall Study|Adverse Event|3
1080195|NCT02316353|3518081|P1|Overall Study|Adverse Event|1
1080196|NCT02316353|3518080|P2|Overall Study|Pregnancy|3
1080197|NCT02316353|3518081|P1|Overall Study|Pregnancy|1
1080198|NCT02315560|3518107|P1|Overall Study|noncompliance by subjects|3
1080199|NCT02314637|3518354|P2|Overall Study|Other Reason|0
1080200|NCT02314637|3518355|P1|Overall Study|Other Reason|1
1080201|NCT02314637|3518354|P2|Overall Study|Withdrawal by Subject|4
1080202|NCT02314637|3518355|P1|Overall Study|Withdrawal by Subject|5
1080203|NCT02314637|3518354|P2|Overall Study|Physician Decision|2
1080204|NCT02314637|3518355|P1|Overall Study|Physician Decision|5
1080205|NCT02314637|3518354|P2|Overall Study|Lack of Efficacy|0
1080206|NCT02314637|3518355|P1|Overall Study|Lack of Efficacy|1
1080207|NCT02314637|3518354|P2|Overall Study|Adverse Event|8
1080208|NCT02314637|3518355|P1|Overall Study|Adverse Event|4
1080209|NCT02314247|3518420|P3|Overall Study|Progression of Disease|0
1080210|NCT02314247|3518421|P2|Overall Study|Progression of Disease|2
1080211|NCT02314247|3518422|P1|Overall Study|Progression of Disease|6
1080212|NCT02314247|3518420|P3|Overall Study|Withdrawal by Subject|1
1080213|NCT02314247|3518421|P2|Overall Study|Withdrawal by Subject|3
1080214|NCT02314247|3518422|P1|Overall Study|Withdrawal by Subject|1
1080215|NCT02314247|3518420|P3|Overall Study|Adverse Event|0
1080216|NCT02314247|3518421|P2|Overall Study|Adverse Event|1
1080217|NCT02314247|3518422|P1|Overall Study|Adverse Event|2
1080218|NCT02314117|3518446|P2|Overall Study|No post-discontinuation follow-up|19
1080219|NCT02314117|3518447|P1|Overall Study|No post-discontinuation follow-up|21
1080220|NCT02314117|3518446|P2|Overall Study|Withdrawal by Subject|2
1080221|NCT02314117|3518447|P1|Overall Study|Withdrawal by Subject|2
1080222|NCT02314117|3518446|P2|Overall Study|On Treatment|6
1080223|NCT02314117|3518447|P1|Overall Study|On Treatment|10
1080224|NCT02314117|3518446|P2|Overall Study|Lost to Follow-up|11
1080225|NCT02314117|3518447|P1|Overall Study|Lost to Follow-up|8
1080226|NCT02314052|3518500|P6|Cycle One|Adverse Event|0
1080227|NCT02314052|3518501|P5|Cycle One|Adverse Event|0
1080228|NCT02314052|3518502|P4|Cycle One|Adverse Event|1
1080229|NCT02314052|3518503|P3|Cycle One|Adverse Event|0
1080230|NCT02314052|3518504|P2|Cycle One|Adverse Event|0
1080231|NCT02314052|3518505|P1|Cycle One|Adverse Event|0
1080232|NCT02313766|3518576|P3|Overall Study|Adverse Event|0
1080233|NCT02313766|3518577|P2|Overall Study|Adverse Event|1
1080234|NCT02313766|3518578|P1|Overall Study|Adverse Event|0
1080235|NCT02313766|3518576|P3|Overall Study|Lost to Follow-up|0
1080236|NCT02313766|3518577|P2|Overall Study|Lost to Follow-up|2
1080237|NCT02313766|3518578|P1|Overall Study|Lost to Follow-up|0
1080238|NCT02313766|3518576|P3|Overall Study|surgery cancelled|0
1080239|NCT02313766|3518577|P2|Overall Study|surgery cancelled|0
1080240|NCT02313766|3518578|P1|Overall Study|surgery cancelled|1
1080241|NCT02313558|3518615|P2|Overall Study|Lost to Follow-up|4
1080242|NCT02313558|3518616|P1|Overall Study|Lost to Follow-up|4
1080243|NCT02313558|3518615|P2|Overall Study|Withdrawal by Subject|0
1080244|NCT02313558|3518616|P1|Overall Study|Withdrawal by Subject|2
1080245|NCT02313233|3518630|P2|Overall Study|Administrative reason|1
1080246|NCT02313233|3518631|P1|Overall Study|Administrative reason|1
1080247|NCT02313233|3518630|P2|Overall Study|Withdrawal by Subject|2
1080248|NCT02313233|3518631|P1|Overall Study|Withdrawal by Subject|1
1080249|NCT02313155|3518653|P2|Overall Study|Lost to Follow-up|1
1080250|NCT02313155|3518654|P1|Overall Study|Lost to Follow-up|0
1080251|NCT02311894|3518846|P1|Overall Study|Withdrawal by Subject|1
1080252|NCT02311894|3518846|P1|Overall Study|Adverse Event|1
1080253|NCT02311894|3518846|P1|Overall Study|Lost to Follow-up|1
1080254|NCT02311894|3518846|P1|Overall Study|Discontinued in error|1
1080255|NCT02311881|3518858|P3|Overall Study|Serious Adverse Event|0
1080256|NCT02311881|3518859|P2|Overall Study|Serious Adverse Event|1
1080257|NCT02311881|3518860|P1|Overall Study|Serious Adverse Event|0
1080258|NCT02311881|3518858|P3|Overall Study|Participant taking another medication|1
1080259|NCT02311881|3518859|P2|Overall Study|Participant taking another medication|0
1080260|NCT02311881|3518860|P1|Overall Study|Participant taking another medication|0
1080261|NCT02311881|3518858|P3|Overall Study|Medical Monitor Discretion|1
1080262|NCT02311881|3518859|P2|Overall Study|Medical Monitor Discretion|0
1080263|NCT02311881|3518860|P1|Overall Study|Medical Monitor Discretion|0
1080264|NCT02311881|3518858|P3|Overall Study|Physician Decision|1
1080265|NCT02311881|3518859|P2|Overall Study|Physician Decision|0
1080266|NCT02311881|3518860|P1|Overall Study|Physician Decision|0
1080267|NCT02311881|3518858|P3|Overall Study|Non-Compliance|2
1080268|NCT02311881|3518859|P2|Overall Study|Non-Compliance|0
1080269|NCT02311881|3518860|P1|Overall Study|Non-Compliance|1
1080270|NCT02311881|3518858|P3|Overall Study|Protocol Deviation|0
1080271|NCT02311881|3518859|P2|Overall Study|Protocol Deviation|0
1080272|NCT02311881|3518860|P1|Overall Study|Protocol Deviation|1
1080273|NCT02311881|3518858|P3|Overall Study|Sponsor Decision|1
1080274|NCT02311881|3518859|P2|Overall Study|Sponsor Decision|1
1080275|NCT02311881|3518860|P1|Overall Study|Sponsor Decision|1
1080276|NCT02311881|3518858|P3|Overall Study|Withdrawal by Subject|4
1080277|NCT02311881|3518859|P2|Overall Study|Withdrawal by Subject|1
1080278|NCT02311881|3518860|P1|Overall Study|Withdrawal by Subject|3
1080279|NCT02311881|3518858|P3|Overall Study|Subject has border line pregnancy test|0
1080280|NCT02311881|3518859|P2|Overall Study|Subject has border line pregnancy test|0
1080281|NCT02311881|3518860|P1|Overall Study|Subject has border line pregnancy test|1
1080282|NCT02311881|3518858|P3|Overall Study|Lack of Efficacy|0
1080283|NCT02311881|3518859|P2|Overall Study|Lack of Efficacy|2
1080284|NCT02311881|3518860|P1|Overall Study|Lack of Efficacy|1
1080285|NCT02311881|3518858|P3|Overall Study|Not Specified|1
1080286|NCT02311881|3518859|P2|Overall Study|Not Specified|0
1080287|NCT02311881|3518860|P1|Overall Study|Not Specified|0
1080288|NCT02311881|3518858|P3|Overall Study|Withdrawal of consent|17
1080289|NCT02311881|3518859|P2|Overall Study|Withdrawal of consent|16
1080290|NCT02311881|3518860|P1|Overall Study|Withdrawal of consent|14
1080291|NCT02311881|3518858|P3|Overall Study|Protocol Violation|3
1080292|NCT02311881|3518859|P2|Overall Study|Protocol Violation|2
1080293|NCT02311881|3518860|P1|Overall Study|Protocol Violation|1
1080294|NCT02311881|3518858|P3|Overall Study|Lost to Follow-up|2
1080295|NCT02311881|3518859|P2|Overall Study|Lost to Follow-up|3
1080296|NCT02311881|3518860|P1|Overall Study|Lost to Follow-up|3
1080297|NCT02311881|3518858|P3|Overall Study|Adverse Event|8
1080298|NCT02311881|3518859|P2|Overall Study|Adverse Event|15
1080299|NCT02311881|3518860|P1|Overall Study|Adverse Event|7
1080300|NCT02311881|3518858|P3|Overall Study|Did not meet the study criteria|0
1080301|NCT02311881|3518859|P2|Overall Study|Did not meet the study criteria|2
1080302|NCT02311881|3518860|P1|Overall Study|Did not meet the study criteria|2
1080303|NCT02311153|3518913|P2|Overall Study|Lost to Follow-up|7
1080304|NCT02311153|3518914|P1|Overall Study|Lost to Follow-up|5
1080305|NCT02310789|3518930|P1|Overall Study|Adverse Event|1
1080306|NCT02310750|3518950|P16|HP Washout 2|Lost to Follow-up|0
1080307|NCT02310750|3518951|P15|HP Washout 2|Lost to Follow-up|0
1080308|NCT02310750|3518952|P14|HP Washout 2|Lost to Follow-up|0
1080309|NCT02310750|3518953|P13|HP Washout 2|Lost to Follow-up|0
1080310|NCT02310750|3518954|P12|HP Washout 2|Lost to Follow-up|0
1080311|NCT02310750|3518955|P11|HP Washout 2|Lost to Follow-up|0
1080312|NCT02310750|3518956|P10|HP Washout 2|Lost to Follow-up|0
1080313|NCT02310750|3518957|P9|HP Washout 2|Lost to Follow-up|0
1080314|NCT02310750|3518958|P8|HP Washout 2|Lost to Follow-up|0
1080315|NCT02310750|3518959|P7|HP Washout 2|Lost to Follow-up|7
1080316|NCT02310750|3518960|P6|HP Washout 2|Lost to Follow-up|0
1080317|NCT02310750|3518961|P5|HP Washout 2|Lost to Follow-up|1
1080318|NCT02310750|3518962|P4|HP Washout 2|Lost to Follow-up|0
1080319|NCT02310750|3518963|P3|HP Washout 2|Lost to Follow-up|0
1080320|NCT02310750|3518964|P2|HP Washout 2|Lost to Follow-up|0
1080321|NCT02310750|3518965|P1|HP Washout 2|Lost to Follow-up|0
1080322|NCT02310750|3518950|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1080323|NCT02310750|3518951|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1080324|NCT02310750|3518952|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1080325|NCT02310750|3518953|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1080326|NCT02310750|3518954|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1080327|NCT02310750|3518955|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1080328|NCT02310750|3518956|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1080329|NCT02310750|3518957|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
1080330|NCT02310750|3518958|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
1080331|NCT02310750|3518959|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1080332|NCT02310750|3518960|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1080333|NCT02310750|3518961|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1080334|NCT02310750|3518962|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1080335|NCT02310750|3518963|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1080336|NCT02310750|3518964|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1080337|NCT02310750|3518965|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1080338|NCT02310750|3518950|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1080339|NCT02310750|3518951|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1080340|NCT02310750|3518952|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1080341|NCT02310750|3518953|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1080342|NCT02310750|3518954|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1080343|NCT02310750|3518955|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1080344|NCT02310750|3518956|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
1080345|NCT02310750|3518957|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
1080346|NCT02310750|3518958|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
1080347|NCT02310750|3518959|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1080348|NCT02310750|3518960|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1080349|NCT02310750|3518961|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1080350|NCT02310750|3518962|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1080351|NCT02310750|3518963|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1080352|NCT02310750|3518964|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1080353|NCT02310750|3518965|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1080354|NCT02310750|3518950|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1080355|NCT02310750|3518951|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1080356|NCT02310750|3518952|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1080357|NCT02310750|3518953|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1080358|NCT02310750|3518954|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1080359|NCT02310750|3518955|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1080360|NCT02310750|3518956|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1
1080361|NCT02310750|3518957|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1080362|NCT02310750|3518958|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1080363|NCT02310750|3518959|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1080364|NCT02310750|3518960|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1080365|NCT02310750|3518961|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1080366|NCT02310750|3518962|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1080367|NCT02310750|3518963|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1080368|NCT02310750|3518964|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1080369|NCT02310750|3518965|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1080370|NCT02310750|3518950|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1080371|NCT02310750|3518951|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1080372|NCT02310750|3518952|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1080373|NCT02310750|3518953|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1080374|NCT02310750|3518954|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1080375|NCT02310750|3518955|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1080376|NCT02310750|3518956|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
1080377|NCT02310750|3518957|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6
1080378|NCT02310750|3518958|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1080379|NCT02310750|3518959|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1080380|NCT02310750|3518960|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2
1080381|NCT02310750|3518961|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1080382|NCT02310750|3518962|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
1080383|NCT02310750|3518963|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1080384|NCT02310750|3518964|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1080385|NCT02310750|3518965|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1080386|NCT02310750|3518950|P16|HP Washout 1|Lost to Follow-up|0
1080387|NCT02310750|3518951|P15|HP Washout 1|Lost to Follow-up|0
1080388|NCT02310750|3518952|P14|HP Washout 1|Lost to Follow-up|0
1080389|NCT02310750|3518953|P13|HP Washout 1|Lost to Follow-up|0
1080390|NCT02310750|3518954|P12|HP Washout 1|Lost to Follow-up|0
1080391|NCT02310750|3518955|P11|HP Washout 1|Lost to Follow-up|0
1080392|NCT02310750|3518956|P10|HP Washout 1|Lost to Follow-up|0
1080393|NCT02310750|3518957|P9|HP Washout 1|Lost to Follow-up|0
1080394|NCT02310750|3518958|P8|HP Washout 1|Lost to Follow-up|0
1080395|NCT02310750|3518959|P7|HP Washout 1|Lost to Follow-up|3
1080396|NCT02310750|3518960|P6|HP Washout 1|Lost to Follow-up|2
1080397|NCT02310750|3518961|P5|HP Washout 1|Lost to Follow-up|2
1080398|NCT02310750|3518962|P4|HP Washout 1|Lost to Follow-up|1
1080399|NCT02310750|3518963|P3|HP Washout 1|Lost to Follow-up|1
1080400|NCT02310750|3518964|P2|HP Washout 1|Lost to Follow-up|0
1080401|NCT02310750|3518965|P1|HP Washout 1|Lost to Follow-up|0
1080402|NCT02310750|3518950|P16|HP Period 1|Withdrawal by Subject|0
1080403|NCT02310750|3518951|P15|HP Period 1|Withdrawal by Subject|0
1080404|NCT02310750|3518952|P14|HP Period 1|Withdrawal by Subject|0
1080405|NCT02310750|3518953|P13|HP Period 1|Withdrawal by Subject|0
1080406|NCT02310750|3518954|P12|HP Period 1|Withdrawal by Subject|0
1080407|NCT02310750|3518955|P11|HP Period 1|Withdrawal by Subject|0
1080408|NCT02310750|3518956|P10|HP Period 1|Withdrawal by Subject|0
1080409|NCT02310750|3518957|P9|HP Period 1|Withdrawal by Subject|0
1080410|NCT02310750|3518958|P8|HP Period 1|Withdrawal by Subject|0
1080411|NCT02310750|3518959|P7|HP Period 1|Withdrawal by Subject|0
1080412|NCT02310750|3518960|P6|HP Period 1|Withdrawal by Subject|0
1080413|NCT02310750|3518961|P5|HP Period 1|Withdrawal by Subject|0
1080414|NCT02310750|3518962|P4|HP Period 1|Withdrawal by Subject|1
1080415|NCT02310750|3518963|P3|HP Period 1|Withdrawal by Subject|0
1080416|NCT02310750|3518964|P2|HP Period 1|Withdrawal by Subject|0
1080417|NCT02310750|3518965|P1|HP Period 1|Withdrawal by Subject|1
1080418|NCT02310750|3518950|P16|HP Period 1|Lost to Follow-up|0
1080419|NCT02310750|3518951|P15|HP Period 1|Lost to Follow-up|0
1080420|NCT02310750|3518952|P14|HP Period 1|Lost to Follow-up|0
1080421|NCT02310750|3518953|P13|HP Period 1|Lost to Follow-up|0
1080422|NCT02310750|3518954|P12|HP Period 1|Lost to Follow-up|0
1080423|NCT02310750|3518955|P11|HP Period 1|Lost to Follow-up|0
1080424|NCT02310750|3518956|P10|HP Period 1|Lost to Follow-up|0
1080425|NCT02310750|3518957|P9|HP Period 1|Lost to Follow-up|0
1080426|NCT02310750|3518958|P8|HP Period 1|Lost to Follow-up|0
1080427|NCT02310750|3518959|P7|HP Period 1|Lost to Follow-up|1
1080428|NCT02310750|3518960|P6|HP Period 1|Lost to Follow-up|0
1080429|NCT02310750|3518961|P5|HP Period 1|Lost to Follow-up|0
1080430|NCT02310750|3518962|P4|HP Period 1|Lost to Follow-up|0
1080431|NCT02310750|3518963|P3|HP Period 1|Lost to Follow-up|0
1080432|NCT02310750|3518964|P2|HP Period 1|Lost to Follow-up|0
1080433|NCT02310750|3518965|P1|HP Period 1|Lost to Follow-up|0
1080434|NCT02310646|3519406|P2|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0
1080435|NCT02310646|3519407|P1|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1
1080436|NCT02310646|3519406|P2|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0
1080437|NCT02310646|3519407|P1|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1
1080438|NCT02310581|3519435|P4|Overall Study|Withdrawal by Subject|1
1080439|NCT02310581|3519436|P3|Overall Study|Withdrawal by Subject|0
1080440|NCT02310581|3519437|P2|Overall Study|Withdrawal by Subject|1
1080441|NCT02310581|3519438|P1|Overall Study|Withdrawal by Subject|2
1080442|NCT02310581|3519435|P4|Overall Study|Adverse Event|0
1080443|NCT02310581|3519436|P3|Overall Study|Adverse Event|1
1080444|NCT02310581|3519437|P2|Overall Study|Adverse Event|1
1080445|NCT02310581|3519438|P1|Overall Study|Adverse Event|1
1080446|NCT02310568|3519477|P5|Stage 2 (4 Weeks)|Lost to Follow-up|0
1080447|NCT02310568|3519478|P4|Stage 2 (4 Weeks)|Lost to Follow-up|2
1080448|NCT02310568|3519479|P3|Stage 2 (4 Weeks)|Lost to Follow-up|0
1080449|NCT02310568|3519480|P2|Stage 2 (4 Weeks)|Lost to Follow-up|0
1080450|NCT02310568|3519481|P1|Stage 2 (4 Weeks)|Lost to Follow-up|0
1080451|NCT02310568|3519477|P5|Stage 2 (4 Weeks)|Protocol Violation|0
1080452|NCT02310568|3519478|P4|Stage 2 (4 Weeks)|Protocol Violation|1
1080453|NCT02310568|3519479|P3|Stage 2 (4 Weeks)|Protocol Violation|0
1080454|NCT02310568|3519480|P2|Stage 2 (4 Weeks)|Protocol Violation|0
1080455|NCT02310568|3519481|P1|Stage 2 (4 Weeks)|Protocol Violation|0
1080456|NCT02310568|3519477|P5|Stage 2 (4 Weeks)|Adverse Event|1
1080457|NCT02310568|3519478|P4|Stage 2 (4 Weeks)|Adverse Event|1
1080458|NCT02310568|3519479|P3|Stage 2 (4 Weeks)|Adverse Event|0
1080459|NCT02310568|3519480|P2|Stage 2 (4 Weeks)|Adverse Event|0
1080460|NCT02310568|3519481|P1|Stage 2 (4 Weeks)|Adverse Event|0
1080461|NCT02310568|3519477|P5|Stage 2 (4 Weeks)|Other|0
1080462|NCT02310568|3519478|P4|Stage 2 (4 Weeks)|Other|0
1080463|NCT02310568|3519479|P3|Stage 2 (4 Weeks)|Other|1
1080464|NCT02310568|3519480|P2|Stage 2 (4 Weeks)|Other|1
1080465|NCT02310568|3519481|P1|Stage 2 (4 Weeks)|Other|0
1080466|NCT02310568|3519477|P5|Stage 2 (4 Weeks)|Withdrawal by Participants|0
1080467|NCT02310568|3519478|P4|Stage 2 (4 Weeks)|Withdrawal by Participants|1
1080468|NCT02310568|3519479|P3|Stage 2 (4 Weeks)|Withdrawal by Participants|0
1080469|NCT02310568|3519480|P2|Stage 2 (4 Weeks)|Withdrawal by Participants|0
1080470|NCT02310568|3519481|P1|Stage 2 (4 Weeks)|Withdrawal by Participants|1
1080471|NCT02310568|3519477|P5|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
1080472|NCT02310568|3519478|P4|Stage 1 ( 4 Weeks)|Lost to Follow-up|1
1080473|NCT02310568|3519479|P3|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
1080474|NCT02310568|3519480|P2|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
1080475|NCT02310568|3519481|P1|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
1080476|NCT02310568|3519477|P5|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
1080477|NCT02310568|3519478|P4|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1
1080478|NCT02310568|3519479|P3|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
1080479|NCT02310568|3519480|P2|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
1080480|NCT02310568|3519481|P1|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
1080481|NCT02310568|3519477|P5|Stage 1 ( 4 Weeks)|Adverse Event|0
1080482|NCT02310568|3519478|P4|Stage 1 ( 4 Weeks)|Adverse Event|0
1080483|NCT02310568|3519479|P3|Stage 1 ( 4 Weeks)|Adverse Event|1
1080484|NCT02310568|3519480|P2|Stage 1 ( 4 Weeks)|Adverse Event|1
1080485|NCT02310568|3519481|P1|Stage 1 ( 4 Weeks)|Adverse Event|1
1080486|NCT02310568|3519477|P5|Stage 1 ( 4 Weeks)|Other|0
1080487|NCT02310568|3519478|P4|Stage 1 ( 4 Weeks)|Other|0
1080488|NCT02310568|3519479|P3|Stage 1 ( 4 Weeks)|Other|0
1080489|NCT02310568|3519480|P2|Stage 1 ( 4 Weeks)|Other|1
1080490|NCT02310568|3519481|P1|Stage 1 ( 4 Weeks)|Other|1
1080491|NCT02310568|3519477|P5|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
1080492|NCT02310568|3519478|P4|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
1080493|NCT02310568|3519479|P3|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
1080494|NCT02310568|3519480|P2|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
1080495|NCT02310568|3519481|P1|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1
1080496|NCT02310568|3519477|P5|Stage 1 ( 4 Weeks)|Lack of Efficacy|1
1080497|NCT02310568|3519478|P4|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
1080498|NCT02310568|3519479|P3|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
1080499|NCT02310568|3519480|P2|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
1080500|NCT02310568|3519481|P1|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
1080501|NCT02310126|3519561|P2|Period 1 (15 Minutes)|Protocol Violation|1
1080502|NCT02310126|3519562|P1|Period 1 (15 Minutes)|Protocol Violation|0
1080503|NCT02310126|3519561|P2|Period 1 (15 Minutes)|Lost to Follow-up|1
1080504|NCT02310126|3519562|P1|Period 1 (15 Minutes)|Lost to Follow-up|0
1080505|NCT02309723|3519571|P3|Overall Study|Withdrawal by Subject|24
1080506|NCT02309723|3519572|P2|Overall Study|Withdrawal by Subject|23
1080507|NCT02309723|3519573|P1|Overall Study|Withdrawal by Subject|24
1080508|NCT02309411|3519590|P3|Overall Study|Withdrawal by Subject|0
1080509|NCT02309411|3519591|P2|Overall Study|Withdrawal by Subject|1
1080510|NCT02309411|3519592|P1|Overall Study|Withdrawal by Subject|1
1080511|NCT02309411|3519590|P3|Overall Study|Physician Decision|0
1080512|NCT02309411|3519591|P2|Overall Study|Physician Decision|0
1080513|NCT02309411|3519592|P1|Overall Study|Physician Decision|1
1080514|NCT02309294|3519611|P1|Overall Study|Withdrawal by Subject|2
1080515|NCT02309112|3519618|P3|Overall Study|Lost to Follow-up|0
1080516|NCT02309112|3519619|P2|Overall Study|Lost to Follow-up|1
1080517|NCT02309112|3519620|P1|Overall Study|Lost to Follow-up|0
1080518|NCT02309112|3519618|P3|Overall Study|Withdrawal by Subject|1
1080519|NCT02309112|3519619|P2|Overall Study|Withdrawal by Subject|0
1080520|NCT02309112|3519620|P1|Overall Study|Withdrawal by Subject|1
1080521|NCT02309099|3519643|P2|Overall Study|Adverse Event|0
1080522|NCT02309099|3519644|P1|Overall Study|Adverse Event|2
1080523|NCT02308748|3519705|P10|Period 5|Adverse Event|0
1080524|NCT02308748|3519706|P9|Period 5|Adverse Event|1
1080525|NCT02308748|3519707|P8|Period 5|Adverse Event|0
1080526|NCT02308748|3519708|P7|Period 5|Adverse Event|0
1080527|NCT02308748|3519709|P6|Period 5|Adverse Event|0
1080528|NCT02308748|3519710|P5|Period 5|Adverse Event|0
1080529|NCT02308748|3519711|P4|Period 5|Adverse Event|0
1080530|NCT02308748|3519712|P3|Period 5|Adverse Event|0
1080531|NCT02308748|3519713|P2|Period 5|Adverse Event|0
1080532|NCT02308748|3519714|P1|Period 5|Adverse Event|1
1080533|NCT02308748|3519705|P10|Period 3|Protocol Violation|1
1080534|NCT02308748|3519706|P9|Period 3|Protocol Violation|0
1080535|NCT02308748|3519707|P8|Period 3|Protocol Violation|0
1080536|NCT02308748|3519708|P7|Period 3|Protocol Violation|0
1080537|NCT02308748|3519709|P6|Period 3|Protocol Violation|0
1080538|NCT02308748|3519710|P5|Period 3|Protocol Violation|0
1080539|NCT02308748|3519711|P4|Period 3|Protocol Violation|0
1080540|NCT02308748|3519712|P3|Period 3|Protocol Violation|0
1080541|NCT02308748|3519713|P2|Period 3|Protocol Violation|0
1080542|NCT02308748|3519714|P1|Period 3|Protocol Violation|0
1080543|NCT02308748|3519705|P10|Period 2|Adverse Event|0
1080544|NCT02308748|3519706|P9|Period 2|Adverse Event|0
1080545|NCT02308748|3519707|P8|Period 2|Adverse Event|1
1080546|NCT02308748|3519708|P7|Period 2|Adverse Event|0
1080547|NCT02308748|3519709|P6|Period 2|Adverse Event|0
1080548|NCT02308748|3519710|P5|Period 2|Adverse Event|0
1080549|NCT02308748|3519711|P4|Period 2|Adverse Event|0
1080550|NCT02308748|3519712|P3|Period 2|Adverse Event|0
1080551|NCT02308748|3519713|P2|Period 2|Adverse Event|0
1080552|NCT02308748|3519714|P1|Period 2|Adverse Event|0
1080553|NCT02308748|3519705|P10|Period 1|Withdrawal by Subject|0
1080554|NCT02308748|3519706|P9|Period 1|Withdrawal by Subject|0
1080555|NCT02308748|3519707|P8|Period 1|Withdrawal by Subject|0
1080556|NCT02308748|3519708|P7|Period 1|Withdrawal by Subject|0
1080557|NCT02308748|3519709|P6|Period 1|Withdrawal by Subject|0
1080558|NCT02308748|3519710|P5|Period 1|Withdrawal by Subject|0
1080559|NCT02308748|3519711|P4|Period 1|Withdrawal by Subject|0
1080560|NCT02308748|3519712|P3|Period 1|Withdrawal by Subject|1
1080561|NCT02308748|3519713|P2|Period 1|Withdrawal by Subject|0
1080562|NCT02308748|3519714|P1|Period 1|Withdrawal by Subject|0
1080563|NCT02308124|3519765|P3|Overall Study|Adverse Event|2
1080564|NCT02308124|3519766|P2|Overall Study|Adverse Event|2
1080565|NCT02308124|3519767|P1|Overall Study|Adverse Event|0
1080566|NCT02308124|3519765|P3|Overall Study|Lost to Follow-up|6
1080567|NCT02308124|3519766|P2|Overall Study|Lost to Follow-up|6
1080568|NCT02308124|3519767|P1|Overall Study|Lost to Follow-up|6
1080569|NCT02307266|3519859|P3|Overall Study|Lost to Follow-up|0
1080570|NCT02307266|3519860|P2|Overall Study|Lost to Follow-up|0
1080571|NCT02307266|3519861|P1|Overall Study|Lost to Follow-up|3
1080572|NCT02307266|3519859|P3|Overall Study|Withdrawal by Subject|1
1080573|NCT02307266|3519860|P2|Overall Study|Withdrawal by Subject|0
1080574|NCT02307266|3519861|P1|Overall Study|Withdrawal by Subject|2
1080575|NCT02307266|3519859|P3|Overall Study|Adverse Event|5
1080576|NCT02307266|3519860|P2|Overall Study|Adverse Event|1
1080577|NCT02307266|3519861|P1|Overall Study|Adverse Event|3
1080578|NCT02305797|3519905|P2|Overall Study|Reason not collected|1
1080579|NCT02305797|3519906|P1|Overall Study|Reason not collected|0
1080580|NCT02305797|3519905|P2|Overall Study|Noncompliance|12
1080581|NCT02305797|3519906|P1|Overall Study|Noncompliance|14
1080582|NCT02305797|3519905|P2|Overall Study|Pregnancy|2
1080583|NCT02305797|3519906|P1|Overall Study|Pregnancy|0
1080584|NCT02305797|3519905|P2|Overall Study|Lost to Follow-up|11
1080585|NCT02305797|3519906|P1|Overall Study|Lost to Follow-up|5
1080586|NCT02305797|3519905|P2|Overall Study|Lack of Efficacy|0
1080587|NCT02305797|3519906|P1|Overall Study|Lack of Efficacy|6
1080588|NCT02305797|3519905|P2|Overall Study|Withdrawal by Subject|10
1080589|NCT02305797|3519906|P1|Overall Study|Withdrawal by Subject|9
1080590|NCT02305797|3519905|P2|Overall Study|Adverse Event|2
1080591|NCT02305797|3519906|P1|Overall Study|Adverse Event|11
1080592|NCT02305758|3519916|P2|Overall Study|Other, not specified|1
1080593|NCT02305758|3519917|P1|Overall Study|Other, not specified|2
1080594|NCT02305758|3519916|P2|Overall Study|Study Terminated by Sponsor|34
1080595|NCT02305758|3519917|P1|Overall Study|Study Terminated by Sponsor|21
1080596|NCT02305758|3519916|P2|Overall Study|Lost to Follow-up|1
1080597|NCT02305758|3519917|P1|Overall Study|Lost to Follow-up|6
1080598|NCT02305758|3519916|P2|Overall Study|Withdrew consent|2
1080599|NCT02305758|3519917|P1|Overall Study|Withdrew consent|9
1080600|NCT02305758|3519916|P2|Overall Study|Death|27
1080601|NCT02305758|3519917|P1|Overall Study|Death|27
1080602|NCT02305446|3519935|P1|Overall Study|Adverse Event|1
1080603|NCT02305381|3519943|P3|Overall Study|Unclassified|7
1080604|NCT02305381|3519944|P2|Overall Study|Unclassified|5
1080605|NCT02305381|3519945|P1|Overall Study|Unclassified|5
1080606|NCT02305238|3520058|P3|Overall Study|Randomized failure|8
1080607|NCT02305238|3520059|P2|Overall Study|Randomized failure|0
1080608|NCT02305238|3520060|P1|Overall Study|Randomized failure|0
1080609|NCT02305238|3520058|P3|Overall Study|Withdrawal by Subject|0
1080610|NCT02305238|3520059|P2|Overall Study|Withdrawal by Subject|2
1080611|NCT02305238|3520060|P1|Overall Study|Withdrawal by Subject|2
1080612|NCT02305238|3520058|P3|Overall Study|Adverse Event|0
1080613|NCT02305238|3520059|P2|Overall Study|Adverse Event|1
1080614|NCT02305238|3520060|P1|Overall Study|Adverse Event|3
1080615|NCT02305238|3520058|P3|Overall Study|Physician Decision|0
1080616|NCT02305238|3520059|P2|Overall Study|Physician Decision|0
1080617|NCT02305238|3520060|P1|Overall Study|Physician Decision|1
1080618|NCT02305238|3520058|P3|Overall Study|Protocol Violation|0
1080619|NCT02305238|3520059|P2|Overall Study|Protocol Violation|1
1080620|NCT02305238|3520060|P1|Overall Study|Protocol Violation|0
1080621|NCT02305238|3520058|P3|Overall Study|Logistical difficulties|0
1080622|NCT02305238|3520059|P2|Overall Study|Logistical difficulties|1
1080623|NCT02305238|3520060|P1|Overall Study|Logistical difficulties|1
1080624|NCT02305238|3520058|P3|Overall Study|Progressive disease|0
1080625|NCT02305238|3520059|P2|Overall Study|Progressive disease|2
1080626|NCT02305238|3520060|P1|Overall Study|Progressive disease|4
1080627|NCT02305238|3520058|P3|Overall Study|Death|0
1080628|NCT02305238|3520059|P2|Overall Study|Death|0
1080629|NCT02305238|3520060|P1|Overall Study|Death|2
1080630|NCT02304926|3520092|P2|Overall Study|Lost to Follow-up|1
1080631|NCT02304926|3520093|P1|Overall Study|Lost to Follow-up|2
1080632|NCT02303704|3520185|P2|Overall Study|Protocol Violation|9
1080633|NCT02303704|3520186|P1|Overall Study|Protocol Violation|5
1080634|NCT02303574|3520214|P10|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
1080635|NCT02303574|3520215|P9|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
1080636|NCT02303574|3520216|P8|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1
1080637|NCT02303574|3520217|P7|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
1080638|NCT02303574|3520218|P6|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
1080639|NCT02303574|3520219|P5|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
1080640|NCT02303574|3520220|P4|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
1080641|NCT02303574|3520221|P3|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
1080642|NCT02303574|3520222|P2|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
1080643|NCT02303574|3520223|P1|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
1080644|NCT02303574|3520214|P10|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
1080645|NCT02303574|3520215|P9|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
1080646|NCT02303574|3520216|P8|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
1080647|NCT02303574|3520217|P7|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
1080648|NCT02303574|3520218|P6|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
1080649|NCT02303574|3520219|P5|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
1080650|NCT02303574|3520220|P4|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
1080651|NCT02303574|3520221|P3|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1
1080652|NCT02303574|3520222|P2|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
1080653|NCT02303574|3520223|P1|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
1080654|NCT02302846|3520435|P1|Overall Study|Withdrawal by Subject|1
1080655|NCT02302807|3520441|P2|Overall Study|Death|322
1080656|NCT02302807|3520442|P1|Overall Study|Death|345
1080657|NCT02302807|3520441|P2|Overall Study|Lost to Follow-up|3
1080658|NCT02302807|3520442|P1|Overall Study|Lost to Follow-up|3
1080659|NCT02302807|3520441|P2|Overall Study|Withdrawal by Subject|9
1080660|NCT02302807|3520442|P1|Overall Study|Withdrawal by Subject|27
1080661|NCT02302716|3520489|P2|Overall Study|Protocol Violation|1
1080662|NCT02302716|3520490|P1|Overall Study|Protocol Violation|0
1080663|NCT02302716|3520489|P2|Overall Study|Withdrawal by Subject|7
1080664|NCT02302716|3520490|P1|Overall Study|Withdrawal by Subject|13
1080665|NCT02302716|3520489|P2|Overall Study|Physician Decision|4
1080666|NCT02302716|3520490|P1|Overall Study|Physician Decision|3
1080667|NCT02302716|3520489|P2|Overall Study|Lost to Follow-up|4
1080668|NCT02302716|3520490|P1|Overall Study|Lost to Follow-up|2
1080669|NCT02302716|3520489|P2|Overall Study|Lack of Efficacy|1
1080670|NCT02302716|3520490|P1|Overall Study|Lack of Efficacy|0
1080671|NCT02302716|3520489|P2|Overall Study|Death|1
1080672|NCT02302716|3520490|P1|Overall Study|Death|0
1080673|NCT02302716|3520489|P2|Overall Study|Adverse Event|1
1080674|NCT02302716|3520490|P1|Overall Study|Adverse Event|1
1080675|NCT02302222|3520536|P2|Overall Study|Withdrawn prior to any treatment|1
1080676|NCT02302222|3520537|P1|Overall Study|Withdrawn prior to any treatment|0
1080677|NCT02302222|3520536|P2|Overall Study|Treatment discontinued before day 5|1
1080678|NCT02302222|3520537|P1|Overall Study|Treatment discontinued before day 5|0
1080679|NCT02302222|3520536|P2|Overall Study|Lost to Follow-up|0
1080680|NCT02302222|3520537|P1|Overall Study|Lost to Follow-up|1
1080681|NCT02302222|3520536|P2|Overall Study|Physician Decision|4
1080682|NCT02302222|3520537|P1|Overall Study|Physician Decision|0
1080683|NCT02301988|3520574|P2|Overall Study|Adverse Event|1
1080684|NCT02301988|3520575|P1|Overall Study|Adverse Event|1
1080685|NCT02301988|3520574|P2|Overall Study|Death|0
1080686|NCT02301988|3520575|P1|Overall Study|Death|1
1080687|NCT02301988|3520574|P2|Overall Study|Lack of Efficacy|2
1080688|NCT02301988|3520575|P1|Overall Study|Lack of Efficacy|3
1080689|NCT02301988|3520574|P2|Overall Study|Unknown Reason|3
1080690|NCT02301988|3520575|P1|Overall Study|Unknown Reason|1
1080691|NCT02301988|3520574|P2|Overall Study|Physician Decision|2
1080692|NCT02301988|3520575|P1|Overall Study|Physician Decision|2
1080693|NCT02301988|3520574|P2|Overall Study|Withdrawal by Subject|1
1080694|NCT02301988|3520575|P1|Overall Study|Withdrawal by Subject|2
1080695|NCT02301975|3520608|P3|Overall Study|Withdrawal by Subject|11
1080696|NCT02301975|3520609|P2|Overall Study|Withdrawal by Subject|12
1080697|NCT02301975|3520610|P1|Overall Study|Withdrawal by Subject|15
1080698|NCT02301975|3520608|P3|Overall Study|Physician Decision|3
1080699|NCT02301975|3520609|P2|Overall Study|Physician Decision|2
1080700|NCT02301975|3520610|P1|Overall Study|Physician Decision|4
1080701|NCT02301975|3520608|P3|Overall Study|Lost to Follow-up|2
1080702|NCT02301975|3520609|P2|Overall Study|Lost to Follow-up|2
1080703|NCT02301975|3520610|P1|Overall Study|Lost to Follow-up|0
1080704|NCT02301975|3520608|P3|Overall Study|Protocol Violation|3
1080705|NCT02301975|3520609|P2|Overall Study|Protocol Violation|5
1080706|NCT02301975|3520610|P1|Overall Study|Protocol Violation|3
1080707|NCT02301975|3520608|P3|Overall Study|Lack of Efficacy|1
1080708|NCT02301975|3520609|P2|Overall Study|Lack of Efficacy|1
1080709|NCT02301975|3520610|P1|Overall Study|Lack of Efficacy|1
1080710|NCT02301975|3520608|P3|Overall Study|Adverse Event|2
1080711|NCT02301975|3520609|P2|Overall Study|Adverse Event|3
1080712|NCT02301975|3520610|P1|Overall Study|Adverse Event|8
1080713|NCT02301936|3520638|P2|Overall Study|Lost to Follow-up|0
1080714|NCT02301936|3520639|P1|Overall Study|Lost to Follow-up|1
1080715|NCT02301429|3520661|P1|Overall Study|not acceptable vascular anatomy|3
1080716|NCT02301169|3520687|P2|Overall Study|Adverse Event|0
1080717|NCT02301169|3520688|P1|Overall Study|Adverse Event|1
1080718|NCT02300558|3520702|P1|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29
1080719|NCT02300558|3520702|P1|Open-Label (OL) Extension Phase|Withdrew Consent|1
1080720|NCT02300558|3520702|P1|Open-Label (OL) Extension Phase|Lack of Efficacy|2
1080721|NCT02300558|3520702|P1|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6
1080722|NCT02300311|3520715|P2|Overall Study|Refused to continue taking medication|0
1080723|NCT02300311|3520716|P1|Overall Study|Refused to continue taking medication|18
1080724|NCT02300311|3520715|P2|Overall Study|Other than the reason specified|0
1080725|NCT02300311|3520716|P1|Overall Study|Other than the reason specified|1
1080726|NCT02300298|3520728|P2|Disposition for Docetaxel|other adverse event|4
1080727|NCT02300298|3520729|P1|Disposition for Docetaxel|other adverse event|0
1080728|NCT02300298|3520728|P2|Disposition for Docetaxel|Progressive disease|6
1080729|NCT02300298|3520729|P1|Disposition for Docetaxel|Progressive disease|0
1080730|NCT02300298|3520728|P2|Disposition for Nintedanib|Progressive disease|0
1080731|NCT02300298|3520729|P1|Disposition for Nintedanib|Progressive disease|10
1080732|NCT02300129|3520739|P4|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
1080733|NCT02300129|3520740|P3|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
1080734|NCT02300129|3520741|P2|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
1080735|NCT02300129|3520742|P1|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1
1080736|NCT02300129|3520739|P4|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1
1080737|NCT02300129|3520740|P3|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
1080738|NCT02300129|3520741|P2|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
1080739|NCT02300129|3520742|P1|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
1080740|NCT02300129|3520739|P4|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
1080741|NCT02300129|3520740|P3|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
1080742|NCT02300129|3520741|P2|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1
1080743|NCT02300129|3520742|P1|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
1080744|NCT02300103|3520752|P1|Overall Study|Withdrew Consent|2
1080745|NCT02300103|3520752|P1|Overall Study|Protocol Violation|1
1080746|NCT02300103|3520752|P1|Overall Study|Lack of Efficacy|3
1080747|NCT02299635|3520849|P1|Overall Study|Other|3
1080748|NCT02299635|3520849|P1|Overall Study|Withdrawal by Subject|2
1080749|NCT02299635|3520849|P1|Overall Study|Objective progression or relapse|10
1080750|NCT02299635|3520849|P1|Overall Study|Global deterioration of health status|1
1080751|NCT02299635|3520849|P1|Overall Study|Death|1
1080752|NCT02299635|3520849|P1|Overall Study|Adverse Event|2
1080753|NCT02299427|3520889|P2|Overall Study|not adherent to dog website use|0
1080754|NCT02299427|3520890|P1|Overall Study|not adherent to dog website use|21
1080755|NCT02299427|3520889|P2|Overall Study|Lost to Follow-up|3
1080756|NCT02299427|3520890|P1|Overall Study|Lost to Follow-up|1
1080757|NCT02299427|3520889|P2|Overall Study|Withdrawal by Subject|0
1080758|NCT02299427|3520890|P1|Overall Study|Withdrawal by Subject|1
1080759|NCT02299375|3520900|P2|Overall Study|Withdrawal by Subject|4
1080760|NCT02299375|3520901|P1|Overall Study|Withdrawal by Subject|1
1080761|NCT02299375|3520900|P2|Overall Study|Physician Decision|1
1080762|NCT02299375|3520901|P1|Overall Study|Physician Decision|1
1080763|NCT02299375|3520900|P2|Overall Study|Lost to Follow-up|2
1080764|NCT02299375|3520901|P1|Overall Study|Lost to Follow-up|0
1080765|NCT02299375|3520900|P2|Overall Study|Other: Study closed/terminated|55
1080766|NCT02299375|3520901|P1|Overall Study|Other: Study closed/terminated|66
1080767|NCT02299375|3520900|P2|Overall Study|Other: Met stopping criteria|0
1080768|NCT02299375|3520901|P1|Overall Study|Other: Met stopping criteria|1
1080769|NCT02299375|3520900|P2|Overall Study|Protocol Violation|3
1080770|NCT02299375|3520901|P1|Overall Study|Protocol Violation|1
1080771|NCT02299375|3520900|P2|Overall Study|Lack of Efficacy|3
1080772|NCT02299375|3520901|P1|Overall Study|Lack of Efficacy|1
1080773|NCT02299375|3520900|P2|Overall Study|Adverse Event, non-fatal|9
1080774|NCT02299375|3520901|P1|Overall Study|Adverse Event, non-fatal|8
1080775|NCT02299375|3520900|P2|Overall Study|Adverse Event, serious fatal|3
1080776|NCT02299375|3520901|P1|Overall Study|Adverse Event, serious fatal|1
1080777|NCT02299336|3520960|P1|Overall Study|Lost to Follow-up|1
1080778|NCT02299336|3520960|P1|Overall Study|Death|1
1080779|NCT02299336|3520960|P1|Overall Study|Adverse Event|1
1080780|NCT02299336|3520960|P1|Overall Study|Withdrawal by Subject|11
1080781|NCT02299206|3520984|P1|Overall Study|Withdrawal by Subject|1
1080782|NCT02299206|3520984|P1|Overall Study|Lost to Follow-up|1
1080783|NCT02299076|3521045|P2|Overall Study|Fraudulent Entries|14
1080784|NCT02299076|3521046|P1|Overall Study|Fraudulent Entries|20
1080785|NCT02298868|3521054|P1|Overall Study|Patient underwent transplant|1
1080786|NCT02298868|3521054|P1|Overall Study|Death|1
1080787|NCT02298868|3521054|P1|Overall Study|Adverse Event|1
1080788|NCT02298192|3521125|P2|Overall Study|Adverse Event|2
1080789|NCT02298192|3521126|P1|Overall Study|Adverse Event|6
1080790|NCT02298192|3521125|P2|Overall Study|Lost to Follow-up|1
1080791|NCT02298192|3521126|P1|Overall Study|Lost to Follow-up|2
1080792|NCT02298192|3521125|P2|Overall Study|Withdrawal by Subject|1
1080793|NCT02298192|3521126|P1|Overall Study|Withdrawal by Subject|6
1080794|NCT02298192|3521125|P2|Overall Study|Withdrawal criteria|0
1080795|NCT02298192|3521126|P1|Overall Study|Withdrawal criteria|2
1080796|NCT02298192|3521125|P2|Overall Study|Unclassified|2
1080797|NCT02298192|3521126|P1|Overall Study|Unclassified|3
1080798|NCT02298179|3521150|P12|Overall Study|Lost to Follow-up|0
1080799|NCT02298179|3521151|P11|Overall Study|Lost to Follow-up|0
1080800|NCT02298179|3521152|P10|Overall Study|Lost to Follow-up|0
1080801|NCT02298179|3521153|P9|Overall Study|Lost to Follow-up|0
1080802|NCT02298179|3521154|P8|Overall Study|Lost to Follow-up|1
1080803|NCT02298179|3521155|P7|Overall Study|Lost to Follow-up|0
1080804|NCT02298179|3521156|P6|Overall Study|Lost to Follow-up|0
1080805|NCT02298179|3521157|P5|Overall Study|Lost to Follow-up|0
1080806|NCT02298179|3521158|P4|Overall Study|Lost to Follow-up|0
1080807|NCT02298179|3521159|P3|Overall Study|Lost to Follow-up|1
1080808|NCT02298179|3521160|P2|Overall Study|Lost to Follow-up|0
1080809|NCT02298179|3521161|P1|Overall Study|Lost to Follow-up|0
1080810|NCT02297841|3521403|P1|Overall Study|Protocol Violation|7
1080811|NCT02297841|3521403|P1|Overall Study|Withdrawal by Subject|1
1080812|NCT02297815|3521409|P2|Overall Study|Lost to Follow-up|140
1080813|NCT02297815|3521410|P1|Overall Study|Lost to Follow-up|236
1080814|NCT02297412|3521426|P2|Overall Study|Canceled|1
1080815|NCT02297412|3521427|P1|Overall Study|Canceled|1
1080816|NCT02296931|3521488|P2|Overall Study|Protocol Violation|2
1080817|NCT02296931|3521489|P1|Overall Study|Protocol Violation|0
1080818|NCT02296840|3521497|P2|Overall Study|Lost to Follow-up|17
1080819|NCT02296840|3521498|P1|Overall Study|Lost to Follow-up|6
1080820|NCT02296840|3521497|P2|Overall Study|Protocol Violation|1
1080821|NCT02296840|3521498|P1|Overall Study|Protocol Violation|2
1080822|NCT02296840|3521497|P2|Overall Study|Adverse Event|1
1080823|NCT02296840|3521498|P1|Overall Study|Adverse Event|1
1080824|NCT02296476|3521513|P3|Overall Study|Disease Progression|2
1080825|NCT02296476|3521514|P2|Overall Study|Disease Progression|4
1080826|NCT02296476|3521515|P1|Overall Study|Disease Progression|6
1080827|NCT02296242|3521573|P5|Overall Study|Lack of Efficacy|3
1080828|NCT02296242|3521574|P4|Overall Study|Lack of Efficacy|0
1080829|NCT02296242|3521575|P3|Overall Study|Lack of Efficacy|0
1080830|NCT02296242|3521576|P2|Overall Study|Lack of Efficacy|0
1080831|NCT02296242|3521577|P1|Overall Study|Lack of Efficacy|0
1080832|NCT02296242|3521573|P5|Overall Study|Adverse Event|0
1080833|NCT02296242|3521574|P4|Overall Study|Adverse Event|1
1080834|NCT02296242|3521575|P3|Overall Study|Adverse Event|0
1080835|NCT02296242|3521576|P2|Overall Study|Adverse Event|0
1080836|NCT02296242|3521577|P1|Overall Study|Adverse Event|0
1080837|NCT02296242|3521573|P5|Overall Study|Alternative Treatment|0
1080838|NCT02296242|3521574|P4|Overall Study|Alternative Treatment|1
1080839|NCT02296242|3521575|P3|Overall Study|Alternative Treatment|0
1080840|NCT02296242|3521576|P2|Overall Study|Alternative Treatment|0
1080841|NCT02296242|3521577|P1|Overall Study|Alternative Treatment|0
1080842|NCT02296242|3521573|P5|Overall Study|Physician Decision|0
1080843|NCT02296242|3521574|P4|Overall Study|Physician Decision|1
1080844|NCT02296242|3521575|P3|Overall Study|Physician Decision|0
1080845|NCT02296242|3521576|P2|Overall Study|Physician Decision|1
1080846|NCT02296242|3521577|P1|Overall Study|Physician Decision|0
1080847|NCT02296242|3521573|P5|Overall Study|Screened for Other Protocol|0
1080848|NCT02296242|3521574|P4|Overall Study|Screened for Other Protocol|0
1080849|NCT02296242|3521575|P3|Overall Study|Screened for Other Protocol|0
1080850|NCT02296242|3521576|P2|Overall Study|Screened for Other Protocol|1
1080851|NCT02296242|3521577|P1|Overall Study|Screened for Other Protocol|0
1080852|NCT02296242|3521573|P5|Overall Study|Need for Hydroxyurea|0
1080853|NCT02296242|3521574|P4|Overall Study|Need for Hydroxyurea|0
1080854|NCT02296242|3521575|P3|Overall Study|Need for Hydroxyurea|0
1080855|NCT02296242|3521576|P2|Overall Study|Need for Hydroxyurea|0
1080856|NCT02296242|3521577|P1|Overall Study|Need for Hydroxyurea|2
1080857|NCT02296242|3521573|P5|Overall Study|Lost to Follow-up|0
1080858|NCT02296242|3521574|P4|Overall Study|Lost to Follow-up|0
1080859|NCT02296242|3521575|P3|Overall Study|Lost to Follow-up|0
1080860|NCT02296242|3521576|P2|Overall Study|Lost to Follow-up|0
1080861|NCT02296242|3521577|P1|Overall Study|Lost to Follow-up|1
1080862|NCT02296242|3521573|P5|Overall Study|At Least 3 Drug Interruptions|1
1080863|NCT02296242|3521574|P4|Overall Study|At Least 3 Drug Interruptions|1
1080864|NCT02296242|3521575|P3|Overall Study|At Least 3 Drug Interruptions|1
1080865|NCT02296242|3521576|P2|Overall Study|At Least 3 Drug Interruptions|0
1080866|NCT02296242|3521577|P1|Overall Study|At Least 3 Drug Interruptions|0
1080867|NCT02296242|3521573|P5|Overall Study|Patient Condition Changed|1
1080868|NCT02296242|3521574|P4|Overall Study|Patient Condition Changed|0
1080869|NCT02296242|3521575|P3|Overall Study|Patient Condition Changed|2
1080870|NCT02296242|3521576|P2|Overall Study|Patient Condition Changed|0
1080871|NCT02296242|3521577|P1|Overall Study|Patient Condition Changed|0
1080872|NCT02296242|3521573|P5|Overall Study|Unacceptable Toxicity|1
1080873|NCT02296242|3521574|P4|Overall Study|Unacceptable Toxicity|0
1080874|NCT02296242|3521575|P3|Overall Study|Unacceptable Toxicity|0
1080875|NCT02296242|3521576|P2|Overall Study|Unacceptable Toxicity|0
1080876|NCT02296242|3521577|P1|Overall Study|Unacceptable Toxicity|0
1080877|NCT02296242|3521573|P5|Overall Study|Disease Progression|11
1080878|NCT02296242|3521574|P4|Overall Study|Disease Progression|8
1080879|NCT02296242|3521575|P3|Overall Study|Disease Progression|2
1080880|NCT02296242|3521576|P2|Overall Study|Disease Progression|3
1080881|NCT02296242|3521577|P1|Overall Study|Disease Progression|1
1080882|NCT02296242|3521573|P5|Overall Study|Withdrawal by Subject|3
1080883|NCT02296242|3521574|P4|Overall Study|Withdrawal by Subject|1
1080884|NCT02296242|3521575|P3|Overall Study|Withdrawal by Subject|1
1080885|NCT02296242|3521576|P2|Overall Study|Withdrawal by Subject|0
1080886|NCT02296242|3521577|P1|Overall Study|Withdrawal by Subject|0
1080887|NCT02296242|3521573|P5|Overall Study|Death|1
1080888|NCT02296242|3521574|P4|Overall Study|Death|1
1080889|NCT02296242|3521575|P3|Overall Study|Death|1
1080890|NCT02296242|3521576|P2|Overall Study|Death|1
1080891|NCT02296242|3521577|P1|Overall Study|Death|1
1080892|NCT02296138|3521601|P2|Overall Study|Other than specified|13
1080893|NCT02296138|3521602|P1|Overall Study|Other than specified|15
1080894|NCT02296138|3521601|P2|Overall Study|Patients with data irregularities|11
1080895|NCT02296138|3521602|P1|Overall Study|Patients with data irregularities|10
1080896|NCT02296138|3521601|P2|Overall Study|Not Treated|1
1080897|NCT02296138|3521602|P1|Overall Study|Not Treated|1
1080898|NCT02296138|3521601|P2|Overall Study|Withdrawal by Subject|131
1080899|NCT02296138|3521602|P1|Overall Study|Withdrawal by Subject|184
1080900|NCT02296138|3521601|P2|Overall Study|Lost to Follow-up|12
1080901|NCT02296138|3521602|P1|Overall Study|Lost to Follow-up|9
1080902|NCT02296138|3521601|P2|Overall Study|Protocol Violation|36
1080903|NCT02296138|3521602|P1|Overall Study|Protocol Violation|35
1080904|NCT02296138|3521601|P2|Overall Study|Lack of Efficacy|37
1080905|NCT02296138|3521602|P1|Overall Study|Lack of Efficacy|59
1080906|NCT02296138|3521601|P2|Overall Study|Adverse Event|259
1080907|NCT02296138|3521602|P1|Overall Study|Adverse Event|348
1080908|NCT02296125|3521618|P2|Overall Study|Any reason not specifically recorded|3
1080909|NCT02296125|3521619|P1|Overall Study|Any reason not specifically recorded|3
1080910|NCT02296125|3521618|P2|Overall Study|Condition under investigation worsened|151
1080911|NCT02296125|3521619|P1|Overall Study|Condition under investigation worsened|87
1080912|NCT02296125|3521618|P2|Overall Study|Severe non-compliance to protocol|1
1080913|NCT02296125|3521619|P1|Overall Study|Severe non-compliance to protocol|0
1080914|NCT02296125|3521618|P2|Overall Study|Adverse Event|50
1080915|NCT02296125|3521619|P1|Overall Study|Adverse Event|36
1080916|NCT02296125|3521618|P2|Overall Study|Withdrawal by Subject|8
1080917|NCT02296125|3521619|P1|Overall Study|Withdrawal by Subject|12
1080918|NCT02295774|3521673|P1|Overall Study|Withdrawal by Subject|2
1080919|NCT02295774|3521673|P1|Overall Study|Physician Decision|1
1080920|NCT02295644|3521682|P4|Overall Study|Did not meet inclusion criterion|2
1080921|NCT02295644|3521683|P3|Overall Study|Did not meet inclusion criterion|1
1080922|NCT02295644|3521684|P2|Overall Study|Did not meet inclusion criterion|0
1080923|NCT02295644|3521685|P1|Overall Study|Did not meet inclusion criterion|0
1080924|NCT02295280|3521705|P2|Overall Study|Adverse Event|1
1080925|NCT02295280|3521706|P1|Overall Study|Adverse Event|0
1080926|NCT02295020|3521714|P2|Overall Study|Withdrawal by Subject|2
1080927|NCT02295020|3521715|P1|Overall Study|Withdrawal by Subject|3
1080928|NCT02295020|3521714|P2|Overall Study|Adverse Event|1
1080929|NCT02295020|3521715|P1|Overall Study|Adverse Event|0
1080930|NCT02294773|3521747|P2|Overall Study|Withdrawal by Subject|2
1080931|NCT02294773|3521748|P1|Overall Study|Withdrawal by Subject|0
1080932|NCT02294734|3521764|P2|Overall Study|Withdrawal by Subject|2
1080933|NCT02294734|3521765|P1|Overall Study|Withdrawal by Subject|4
1080934|NCT02294734|3521764|P2|Overall Study|Physician Decision|1
1080935|NCT02294734|3521765|P1|Overall Study|Physician Decision|2
1080936|NCT02294734|3521764|P2|Overall Study|Lost to Follow-up|0
1080937|NCT02294734|3521765|P1|Overall Study|Lost to Follow-up|2
1080938|NCT02294734|3521764|P2|Overall Study|Met Protocol Defined Stopping Criteria|0
1080939|NCT02294734|3521765|P1|Overall Study|Met Protocol Defined Stopping Criteria|1
1080940|NCT02294734|3521764|P2|Overall Study|Adverse Event|5
1080941|NCT02294734|3521765|P1|Overall Study|Adverse Event|5
1080942|NCT02294682|3521817|P2|Overall Study|Could not swallow pills|0
1080943|NCT02294682|3521818|P1|Overall Study|Could not swallow pills|1
1080944|NCT02294604|3521861|P3|Overall Study|Culture contamination|0
1080945|NCT02294604|3521862|P2|Overall Study|Culture contamination|2
1080946|NCT02294604|3521863|P1|Overall Study|Culture contamination|1
1080947|NCT02294604|3521861|P3|Overall Study|Did not provide samples for culture|0
1080948|NCT02294604|3521862|P2|Overall Study|Did not provide samples for culture|1
1080949|NCT02294604|3521863|P1|Overall Study|Did not provide samples for culture|0
1080950|NCT02294474|3521882|P2|Overall Study|Other than specified above|12
1080951|NCT02294474|3521883|P1|Overall Study|Other than specified above|12
1080952|NCT02294474|3521882|P2|Overall Study|Protocol Violation|2
1080953|NCT02294474|3521883|P1|Overall Study|Protocol Violation|4
1080954|NCT02294474|3521882|P2|Overall Study|Lack of Efficacy|1
1080955|NCT02294474|3521883|P1|Overall Study|Lack of Efficacy|2
1080956|NCT02294474|3521882|P2|Overall Study|Adverse Event|7
1080957|NCT02294474|3521883|P1|Overall Study|Adverse Event|7
1080958|NCT02294461|3521907|P2|Overall Study|Miscellaneous|32
1080959|NCT02294461|3521908|P1|Overall Study|Miscellaneous|11
1080960|NCT02294461|3521907|P2|Overall Study|Adverse Event|10
1080961|NCT02294461|3521908|P1|Overall Study|Adverse Event|11
1080962|NCT02294461|3521907|P2|Overall Study|Disease Progression|39
1080963|NCT02294461|3521908|P1|Overall Study|Disease Progression|23
1080964|NCT02294461|3521907|P2|Overall Study|Withdrawal by Subject|45
1080965|NCT02294461|3521908|P1|Overall Study|Withdrawal by Subject|14
1080966|NCT02294461|3521907|P2|Overall Study|Protocol Violation|2
1080967|NCT02294461|3521908|P1|Overall Study|Protocol Violation|0
1080968|NCT02294461|3521907|P2|Overall Study|Death|3
1080969|NCT02294461|3521908|P1|Overall Study|Death|3
1080970|NCT02294396|3521964|P4|Overall Study|Miscellaneous|2
1080971|NCT02294396|3521965|P3|Overall Study|Miscellaneous|5
1080972|NCT02294396|3521966|P2|Overall Study|Miscellaneous|0
1080973|NCT02294396|3521967|P1|Overall Study|Miscellaneous|2
1080974|NCT02294396|3521964|P4|Overall Study|Protocol Deviation|1
1080975|NCT02294396|3521965|P3|Overall Study|Protocol Deviation|2
1080976|NCT02294396|3521966|P2|Overall Study|Protocol Deviation|2
1080977|NCT02294396|3521967|P1|Overall Study|Protocol Deviation|3
1080978|NCT02294396|3521964|P4|Overall Study|Lost to Follow-up|1
1080979|NCT02294396|3521965|P3|Overall Study|Lost to Follow-up|1
1080980|NCT02294396|3521966|P2|Overall Study|Lost to Follow-up|0
1080981|NCT02294396|3521967|P1|Overall Study|Lost to Follow-up|0
1080982|NCT02294396|3521964|P4|Overall Study|Withdrawal by Subject|8
1080983|NCT02294396|3521965|P3|Overall Study|Withdrawal by Subject|6
1080984|NCT02294396|3521966|P2|Overall Study|Withdrawal by Subject|6
1080985|NCT02294396|3521967|P1|Overall Study|Withdrawal by Subject|8
1080986|NCT02294396|3521964|P4|Overall Study|Electrocardiogram adviser's judgment|1
1080987|NCT02294396|3521965|P3|Overall Study|Electrocardiogram adviser's judgment|0
1080988|NCT02294396|3521966|P2|Overall Study|Electrocardiogram adviser's judgment|0
1080989|NCT02294396|3521967|P1|Overall Study|Electrocardiogram adviser's judgment|1
1080990|NCT02294396|3521964|P4|Overall Study|Adverse Event|24
1080991|NCT02294396|3521965|P3|Overall Study|Adverse Event|21
1080992|NCT02294396|3521966|P2|Overall Study|Adverse Event|25
1080993|NCT02294396|3521967|P1|Overall Study|Adverse Event|26
1080994|NCT02294019|3522037|P1|Overall Study|Withdrawal by Subject|1
1080995|NCT02294019|3522037|P1|Overall Study|Other|1
1080996|NCT02294019|3522037|P1|Overall Study|Lost to Follow-up|31
1080997|NCT02294019|3522037|P1|Overall Study|Protocol Violation|68
1080998|NCT02294019|3522037|P1|Overall Study|Adverse Event|2
1080999|NCT02293902|3522045|P5|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
1081000|NCT02293902|3522046|P4|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
1081001|NCT02293902|3522047|P3|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
1081002|NCT02293902|3522048|P2|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
1081003|NCT02293902|3522049|P1|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
1081004|NCT02293902|3522045|P5|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6
1081005|NCT02293902|3522046|P4|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
1081006|NCT02293902|3522047|P3|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
1081007|NCT02293902|3522048|P2|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7
1081008|NCT02293902|3522049|P1|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0
1081009|NCT02293902|3522045|P5|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
1081010|NCT02293902|3522046|P4|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
1081011|NCT02293902|3522047|P3|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
1081012|NCT02293902|3522048|P2|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
1081013|NCT02293902|3522049|P1|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1
1081014|NCT02293902|3522045|P5|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
1081015|NCT02293902|3522046|P4|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
1081016|NCT02293902|3522047|P3|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2
1081017|NCT02293902|3522048|P2|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1
1081018|NCT02293902|3522049|P1|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5
1081019|NCT02293902|3522045|P5|Double-Blind Period (Up to Week 24)|Adverse Event|0
1081020|NCT02293902|3522046|P4|Double-Blind Period (Up to Week 24)|Adverse Event|0
1081021|NCT02293902|3522047|P3|Double-Blind Period (Up to Week 24)|Adverse Event|8
1081022|NCT02293902|3522048|P2|Double-Blind Period (Up to Week 24)|Adverse Event|6
1081023|NCT02293902|3522049|P1|Double-Blind Period (Up to Week 24)|Adverse Event|5
1081024|NCT02293863|3522111|P3|Overall Study|Reason Not Specified|2
1081025|NCT02293863|3522112|P2|Overall Study|Reason Not Specified|2
1081026|NCT02293863|3522113|P1|Overall Study|Reason Not Specified|0
1081027|NCT02293863|3522111|P3|Overall Study|Withdrawal by Subject|1
1081028|NCT02293863|3522112|P2|Overall Study|Withdrawal by Subject|3
1081029|NCT02293863|3522113|P1|Overall Study|Withdrawal by Subject|3
1081030|NCT02293863|3522111|P3|Overall Study|Lost to Follow-up|2
1081031|NCT02293863|3522112|P2|Overall Study|Lost to Follow-up|2
1081032|NCT02293863|3522113|P1|Overall Study|Lost to Follow-up|2
1081033|NCT02293863|3522111|P3|Overall Study|Death|4
1081034|NCT02293863|3522112|P2|Overall Study|Death|6
1081035|NCT02293863|3522113|P1|Overall Study|Death|4
1081036|NCT02293538|3522178|P2|Overall Study|Withdrawal by Subject|1
1081037|NCT02293538|3522179|P1|Overall Study|Withdrawal by Subject|0
1081038|NCT02293538|3522178|P2|Overall Study|Lost to Follow-up|0
1081039|NCT02293538|3522179|P1|Overall Study|Lost to Follow-up|1
1081040|NCT02293538|3522178|P2|Overall Study|Adverse Event|1
1081041|NCT02293538|3522179|P1|Overall Study|Adverse Event|0
1081042|NCT02293395|3522211|P2|Overall Study|Withdrawal by Subject|7
1081043|NCT02293395|3522212|P1|Overall Study|Withdrawal by Subject|8
1081044|NCT02293395|3522211|P2|Overall Study|Lost to Follow-up|0
1081045|NCT02293395|3522212|P1|Overall Study|Lost to Follow-up|1
1081046|NCT02292849|3522221|P3|Overall Study|Physician Decision|0
1081047|NCT02292849|3522222|P2|Overall Study|Physician Decision|0
1081048|NCT02292849|3522223|P1|Overall Study|Physician Decision|4
1081049|NCT02292849|3522221|P3|Overall Study|Lost to Follow-up|2
1081050|NCT02292849|3522222|P2|Overall Study|Lost to Follow-up|2
1081051|NCT02292849|3522223|P1|Overall Study|Lost to Follow-up|0
1081052|NCT02292771|3522233|P2|Overall Study|Lost to Follow-up|1
1081053|NCT02292771|3522234|P1|Overall Study|Lost to Follow-up|2
1081054|NCT02292771|3522233|P2|Overall Study|Withdrawal by Subject|1
1081055|NCT02292771|3522234|P1|Overall Study|Withdrawal by Subject|2
1081056|NCT02292719|3522330|P6|Overall Study|Subject enrolled in new study.|0
1081057|NCT02292719|3522331|P5|Overall Study|Subject enrolled in new study.|0
1081058|NCT02292719|3522332|P4|Overall Study|Subject enrolled in new study.|0
1081059|NCT02292719|3522333|P3|Overall Study|Subject enrolled in new study.|1
1081060|NCT02292719|3522334|P2|Overall Study|Subject enrolled in new study.|0
1081061|NCT02292719|3522335|P1|Overall Study|Subject enrolled in new study.|0
1081062|NCT02292719|3522330|P6|Overall Study|Withdrawal by Subject|0
1081063|NCT02292719|3522331|P5|Overall Study|Withdrawal by Subject|1
1081064|NCT02292719|3522332|P4|Overall Study|Withdrawal by Subject|1
1081065|NCT02292719|3522333|P3|Overall Study|Withdrawal by Subject|0
1081066|NCT02292719|3522334|P2|Overall Study|Withdrawal by Subject|0
1081067|NCT02292719|3522335|P1|Overall Study|Withdrawal by Subject|0
1081068|NCT02292212|3522474|P1|ViE Phase|Protocol Violation|2
1081069|NCT02292212|3522474|P1|ViE Phase|Withdrawal by Subject|1
1081070|NCT02291861|3522518|P4|Overall Study|Not specified|1
1081071|NCT02291861|3522519|P3|Overall Study|Not specified|0
1081072|NCT02291861|3522520|P2|Overall Study|Not specified|0
1081073|NCT02291861|3522521|P1|Overall Study|Not specified|0
1081074|NCT02291861|3522518|P4|Overall Study|Lost to Follow-up|0
1081075|NCT02291861|3522519|P3|Overall Study|Lost to Follow-up|4
1081076|NCT02291861|3522520|P2|Overall Study|Lost to Follow-up|1
1081077|NCT02291861|3522521|P1|Overall Study|Lost to Follow-up|2
1081078|NCT02291861|3522518|P4|Overall Study|Noncompliance|1
1081079|NCT02291861|3522519|P3|Overall Study|Noncompliance|2
1081080|NCT02291861|3522520|P2|Overall Study|Noncompliance|1
1081081|NCT02291861|3522521|P1|Overall Study|Noncompliance|1
1081082|NCT02291861|3522518|P4|Overall Study|Withdrawal by Subject|4
1081083|NCT02291861|3522519|P3|Overall Study|Withdrawal by Subject|1
1081084|NCT02291861|3522520|P2|Overall Study|Withdrawal by Subject|2
1081085|NCT02291861|3522521|P1|Overall Study|Withdrawal by Subject|1
1081086|NCT02291861|3522518|P4|Overall Study|Protocol Violation|1
1081087|NCT02291861|3522519|P3|Overall Study|Protocol Violation|0
1081088|NCT02291861|3522520|P2|Overall Study|Protocol Violation|0
1081089|NCT02291861|3522521|P1|Overall Study|Protocol Violation|1
1081090|NCT02291861|3522518|P4|Overall Study|Death|1
1081091|NCT02291861|3522519|P3|Overall Study|Death|1
1081092|NCT02291861|3522520|P2|Overall Study|Death|0
1081093|NCT02291861|3522521|P1|Overall Study|Death|0
1081094|NCT02291861|3522518|P4|Overall Study|Adverse Event|2
1081095|NCT02291861|3522519|P3|Overall Study|Adverse Event|1
1081096|NCT02291861|3522520|P2|Overall Study|Adverse Event|4
1081097|NCT02291861|3522521|P1|Overall Study|Adverse Event|2
1081098|NCT02291679|3522584|P3|Overall Study|Not Specified|2
1081099|NCT02291679|3522585|P2|Overall Study|Not Specified|4
1081100|NCT02291679|3522586|P1|Overall Study|Not Specified|2
1081101|NCT02291679|3522584|P3|Overall Study|Insufficient Therapeutic Response|7
1081102|NCT02291679|3522585|P2|Overall Study|Insufficient Therapeutic Response|5
1081103|NCT02291679|3522586|P1|Overall Study|Insufficient Therapeutic Response|5
1081104|NCT02291679|3522584|P3|Overall Study|Lost to Follow-up|9
1081105|NCT02291679|3522585|P2|Overall Study|Lost to Follow-up|10
1081106|NCT02291679|3522586|P1|Overall Study|Lost to Follow-up|12
1081107|NCT02291679|3522584|P3|Overall Study|Withdrew Consent|15
1081108|NCT02291679|3522585|P2|Overall Study|Withdrew Consent|10
1081109|NCT02291679|3522586|P1|Overall Study|Withdrew Consent|18
1081110|NCT02291679|3522584|P3|Overall Study|Protocol Violation|7
1081111|NCT02291679|3522585|P2|Overall Study|Protocol Violation|1
1081112|NCT02291679|3522586|P1|Overall Study|Protocol Violation|5
1081113|NCT02291679|3522584|P3|Overall Study|Adverse Event|19
1081114|NCT02291679|3522585|P2|Overall Study|Adverse Event|12
1081115|NCT02291679|3522586|P1|Overall Study|Adverse Event|2
1081116|NCT02291549|3522617|P2|Overall Study|Withdrawal by Subject|1
1081117|NCT02291549|3522618|P1|Overall Study|Withdrawal by Subject|0
1081118|NCT02291549|3522617|P2|Overall Study|Lost to Follow-up|0
1081119|NCT02291549|3522618|P1|Overall Study|Lost to Follow-up|1
1081120|NCT02291510|3522640|P4|Overall Study|Adverse Event|1
1081121|NCT02291510|3522641|P3|Overall Study|Adverse Event|0
1081122|NCT02291510|3522642|P2|Overall Study|Adverse Event|0
1081123|NCT02291510|3522643|P1|Overall Study|Adverse Event|0
1081124|NCT02291419|3522659|P2|Overall Study|Early study termination|5
1081125|NCT02291419|3522660|P1|Overall Study|Early study termination|1
1081126|NCT02291237|3522678|P2|Overall Study|Subject Required Prohibited Medication|0
1081127|NCT02291237|3522679|P1|Overall Study|Subject Required Prohibited Medication|2
1081128|NCT02291237|3522678|P2|Overall Study|Lost to Follow-up|2
1081129|NCT02291237|3522679|P1|Overall Study|Lost to Follow-up|0
1081130|NCT02291237|3522678|P2|Overall Study|Withdrew Consent|11
1081131|NCT02291237|3522679|P1|Overall Study|Withdrew Consent|11
1081132|NCT02291237|3522678|P2|Overall Study|Investigator's Discretion|3
1081133|NCT02291237|3522679|P1|Overall Study|Investigator's Discretion|0
1081134|NCT02291237|3522678|P2|Overall Study|Adverse Event|3
1081135|NCT02291237|3522679|P1|Overall Study|Adverse Event|1
1081136|NCT02291237|3522678|P2|Overall Study|Study Terminated by Sponsor|67
1081137|NCT02291237|3522679|P1|Overall Study|Study Terminated by Sponsor|72
1081138|NCT02290873|3522698|P3|Overall Study|Protocol Violation|1
1081139|NCT02290873|3522699|P2|Overall Study|Protocol Violation|0
1081140|NCT02290873|3522700|P1|Overall Study|Protocol Violation|0
1081141|NCT02290873|3522698|P3|Overall Study|Esophagogastroduodenoscopy was added|0
1081142|NCT02290873|3522699|P2|Overall Study|Esophagogastroduodenoscopy was added|0
1081143|NCT02290873|3522700|P1|Overall Study|Esophagogastroduodenoscopy was added|1
1081144|NCT02290873|3522698|P3|Overall Study|Nellcor device error|0
1081145|NCT02290873|3522699|P2|Overall Study|Nellcor device error|0
1081146|NCT02290873|3522700|P1|Overall Study|Nellcor device error|1
1081147|NCT02290873|3522698|P3|Overall Study|Withdrawal by Subject|1
1081148|NCT02290873|3522699|P2|Overall Study|Withdrawal by Subject|1
1081149|NCT02290873|3522700|P1|Overall Study|Withdrawal by Subject|0
1081150|NCT02290821|3522719|P2|Overall Study|Lost to Follow-up|2
1081151|NCT02290821|3522720|P1|Overall Study|Lost to Follow-up|3
1081152|NCT02290821|3522719|P2|Overall Study|Unable or unwilling to cooperate with|0
1081153|NCT02290821|3522720|P1|Overall Study|Unable or unwilling to cooperate with|2
1081154|NCT02290821|3522719|P2|Overall Study|Withdrawal by Subject|1
1081155|NCT02290821|3522720|P1|Overall Study|Withdrawal by Subject|1
1081156|NCT02290691|3522728|P2|Overall Study|Lost to Follow-up|7
1081157|NCT02290691|3522729|P1|Overall Study|Lost to Follow-up|7
1081158|NCT02290691|3522728|P2|Overall Study|Withdrawal by Subject|1
1081159|NCT02290691|3522729|P1|Overall Study|Withdrawal by Subject|1
1081160|NCT02290691|3522728|P2|Overall Study|Noncompliance|1
1081161|NCT02290691|3522729|P1|Overall Study|Noncompliance|0
1081162|NCT02290340|3522762|P4|Overall Study|Other|1
1081163|NCT02290340|3522763|P3|Overall Study|Other|0
1081164|NCT02290340|3522764|P2|Overall Study|Other|0
1081165|NCT02290340|3522765|P1|Overall Study|Other|1
1081166|NCT02290340|3522762|P4|Overall Study|Withdrawal by Subject|0
1081167|NCT02290340|3522763|P3|Overall Study|Withdrawal by Subject|0
1081168|NCT02290340|3522764|P2|Overall Study|Withdrawal by Subject|0
1081169|NCT02290340|3522765|P1|Overall Study|Withdrawal by Subject|1
1081170|NCT02290340|3522762|P4|Overall Study|Lost to Follow-up|1
1081171|NCT02290340|3522763|P3|Overall Study|Lost to Follow-up|0
1081172|NCT02290340|3522764|P2|Overall Study|Lost to Follow-up|0
1081173|NCT02290340|3522765|P1|Overall Study|Lost to Follow-up|0
1081174|NCT02289963|3522829|P2|Overall Study|Other than specified above|2
1081175|NCT02289963|3522830|P1|Overall Study|Other than specified above|0
1081176|NCT02289963|3522829|P2|Overall Study|End treatment visit outside visit window|4
1081177|NCT02289963|3522830|P1|Overall Study|End treatment visit outside visit window|0
1081178|NCT02289963|3522829|P2|Overall Study|Last injection missed|2
1081179|NCT02289963|3522830|P1|Overall Study|Last injection missed|2
1081180|NCT02289963|3522829|P2|Overall Study|Withdrawal by Subject|0
1081181|NCT02289963|3522830|P1|Overall Study|Withdrawal by Subject|1
1081182|NCT02289963|3522829|P2|Overall Study|Poor compliance to protocol|0
1081183|NCT02289963|3522830|P1|Overall Study|Poor compliance to protocol|1
1081184|NCT02289963|3522829|P2|Overall Study|Adverse Event|2
1081185|NCT02289963|3522830|P1|Overall Study|Adverse Event|1
1081186|NCT02289898|3522881|P3|Overall Study|Not specified|10
1081187|NCT02289898|3522882|P2|Overall Study|Not specified|7
1081188|NCT02289898|3522883|P1|Overall Study|Not specified|8
1081189|NCT02289898|3522881|P3|Overall Study|Use of another anticancer therapy|1
1081190|NCT02289898|3522882|P2|Overall Study|Use of another anticancer therapy|0
1081191|NCT02289898|3522883|P1|Overall Study|Use of another anticancer therapy|0
1081192|NCT02289898|3522881|P3|Overall Study|Disease progression|34
1081193|NCT02289898|3522882|P2|Overall Study|Disease progression|28
1081194|NCT02289898|3522883|P1|Overall Study|Disease progression|34
1081195|NCT02289898|3522881|P3|Overall Study|Adverse Event|5
1081196|NCT02289898|3522882|P2|Overall Study|Adverse Event|5
1081197|NCT02289898|3522883|P1|Overall Study|Adverse Event|3
1081198|NCT02289898|3522881|P3|Overall Study|Withdrawal by Subject|1
1081199|NCT02289898|3522882|P2|Overall Study|Withdrawal by Subject|4
1081200|NCT02289898|3522883|P1|Overall Study|Withdrawal by Subject|0
1081201|NCT02289898|3522881|P3|Overall Study|Physician Decision|2
1081202|NCT02289898|3522882|P2|Overall Study|Physician Decision|5
1081203|NCT02289898|3522883|P1|Overall Study|Physician Decision|2
1081204|NCT02289898|3522881|P3|Overall Study|Death|3
1081205|NCT02289898|3522882|P2|Overall Study|Death|4
1081206|NCT02289898|3522883|P1|Overall Study|Death|5
1081207|NCT02289833|3522892|P2|Overall Study|Death|8
1081208|NCT02289833|3522893|P1|Overall Study|Death|15
1081209|NCT02289833|3522892|P2|Overall Study|Lost to Follow-up|0
1081210|NCT02289833|3522893|P1|Overall Study|Lost to Follow-up|2
1081211|NCT02289833|3522892|P2|Overall Study|Disease Progression|3
1081212|NCT02289833|3522893|P1|Overall Study|Disease Progression|0
1081213|NCT02289833|3522892|P2|Overall Study|Clinical Progression|1
1081214|NCT02289833|3522893|P1|Overall Study|Clinical Progression|0
1081215|NCT02289833|3522892|P2|Overall Study|Continued Participation in Study|8
1081216|NCT02289833|3522893|P1|Overall Study|Continued Participation in Study|12
1081217|NCT02289820|3522931|P7|Overall Study|withdrawal of consent|0
1081218|NCT02289820|3522932|P6|Overall Study|withdrawal of consent|0
1081219|NCT02289820|3522933|P5|Overall Study|withdrawal of consent|0
1081220|NCT02289820|3522934|P4|Overall Study|withdrawal of consent|0
1081221|NCT02289820|3522935|P3|Overall Study|withdrawal of consent|0
1081222|NCT02289820|3522936|P2|Overall Study|withdrawal of consent|1
1081223|NCT02289820|3522937|P1|Overall Study|withdrawal of consent|0
1081224|NCT02289820|3522931|P7|Overall Study|Lost to Follow-up|1
1081225|NCT02289820|3522932|P6|Overall Study|Lost to Follow-up|1
1081226|NCT02289820|3522933|P5|Overall Study|Lost to Follow-up|0
1081227|NCT02289820|3522934|P4|Overall Study|Lost to Follow-up|1
1081228|NCT02289820|3522935|P3|Overall Study|Lost to Follow-up|3
1081229|NCT02289820|3522936|P2|Overall Study|Lost to Follow-up|0
1081230|NCT02289820|3522937|P1|Overall Study|Lost to Follow-up|0
1081231|NCT02289820|3522931|P7|Overall Study|Death|0
1081232|NCT02289820|3522932|P6|Overall Study|Death|0
1081233|NCT02289820|3522933|P5|Overall Study|Death|0
1081234|NCT02289820|3522934|P4|Overall Study|Death|0
1081235|NCT02289820|3522935|P3|Overall Study|Death|1
1081236|NCT02289820|3522936|P2|Overall Study|Death|0
1081237|NCT02289820|3522937|P1|Overall Study|Death|0
1081238|NCT02289820|3522931|P7|Overall Study|Withdrawal by Subject|1
1081239|NCT02289820|3522932|P6|Overall Study|Withdrawal by Subject|0
1081240|NCT02289820|3522933|P5|Overall Study|Withdrawal by Subject|0
1081241|NCT02289820|3522934|P4|Overall Study|Withdrawal by Subject|1
1081242|NCT02289820|3522935|P3|Overall Study|Withdrawal by Subject|2
1081243|NCT02289820|3522936|P2|Overall Study|Withdrawal by Subject|1
1081244|NCT02289820|3522937|P1|Overall Study|Withdrawal by Subject|2
1081245|NCT02289742|3523055|P4|Third Wear Period|Reason not given|1
1081246|NCT02289742|3523056|P3|Third Wear Period|Reason not given|0
1081247|NCT02289742|3523057|P2|Third Wear Period|Reason not given|0
1081248|NCT02289742|3523058|P1|Third Wear Period|Reason not given|0
1081249|NCT02289742|3523055|P4|Third Wear Period|Adverse Event|0
1081250|NCT02289742|3523056|P3|Third Wear Period|Adverse Event|0
1081251|NCT02289742|3523057|P2|Third Wear Period|Adverse Event|1
1081252|NCT02289742|3523058|P1|Third Wear Period|Adverse Event|0
1081253|NCT02289742|3523055|P4|First Wear Period|Other prior to treatment|1
1081254|NCT02289742|3523056|P3|First Wear Period|Other prior to treatment|0
1081255|NCT02289742|3523057|P2|First Wear Period|Other prior to treatment|0
1081256|NCT02289742|3523058|P1|First Wear Period|Other prior to treatment|0
1081257|NCT02289742|3523055|P4|First Wear Period|Adverse Event|0
1081258|NCT02289742|3523056|P3|First Wear Period|Adverse Event|1
1081259|NCT02289742|3523057|P2|First Wear Period|Adverse Event|0
1081260|NCT02289742|3523058|P1|First Wear Period|Adverse Event|0
1081261|NCT02289742|3523055|P4|First Wear Period|Adverse event prior to treatment|0
1081262|NCT02289742|3523056|P3|First Wear Period|Adverse event prior to treatment|0
1081263|NCT02289742|3523057|P2|First Wear Period|Adverse event prior to treatment|1
1081264|NCT02289742|3523058|P1|First Wear Period|Adverse event prior to treatment|0
1081265|NCT02289469|3523077|P2|Overall Study|Unable to match a control|0
1081266|NCT02289469|3523078|P1|Overall Study|Unable to match a control|6
1081267|NCT02289456|3523086|P1|Monotherapy Period|Miscellaneous|1
1081268|NCT02289456|3523086|P1|Monotherapy Period|Study Terminated by Sponsor|2
1081269|NCT02289456|3523086|P1|Monotherapy Period|Withdrawal by Subject|2
1081270|NCT02289456|3523086|P1|Monotherapy Period|Symptomatic Deterioration|1
1081271|NCT02289456|3523086|P1|Monotherapy Period|Progressive Disease (PD)|8
1081272|NCT02289456|3523086|P1|Monotherapy Period|Adverse Event|1
1081273|NCT02289456|3523086|P1|Monotherapy Period|Death|1
1081274|NCT02289456|3523086|P1|Induction Period|Miscellaneous|1
1081275|NCT02289456|3523086|P1|Induction Period|Withdrawal by Subject|2
1081276|NCT02289456|3523086|P1|Induction Period|Symptomatic Deterioration|4
1081277|NCT02289456|3523086|P1|Induction Period|Progressive Disease (PD)|4
1081278|NCT02289456|3523086|P1|Induction Period|Adverse Event|11
1081279|NCT02289456|3523086|P1|Induction Period|Death|2
1081280|NCT02289417|3523109|P3|Overall Study|Lack of Efficacy|0
1081281|NCT02289417|3523110|P2|Overall Study|Lack of Efficacy|0
1081282|NCT02289417|3523111|P1|Overall Study|Lack of Efficacy|3
1081283|NCT02289417|3523109|P3|Overall Study|Lost to Follow-up|1
1081284|NCT02289417|3523110|P2|Overall Study|Lost to Follow-up|1
1081285|NCT02289417|3523111|P1|Overall Study|Lost to Follow-up|0
1081286|NCT02289417|3523109|P3|Overall Study|Withdrawal by Subject|0
1081287|NCT02289417|3523110|P2|Overall Study|Withdrawal by Subject|3
1081288|NCT02289417|3523111|P1|Overall Study|Withdrawal by Subject|1
1081289|NCT02289417|3523109|P3|Overall Study|Adverse Event|2
1081290|NCT02289417|3523110|P2|Overall Study|Adverse Event|0
1081291|NCT02289417|3523111|P1|Overall Study|Adverse Event|3
1081292|NCT02289079|3523205|P2|Overall Study|Lost to Follow-up|1
1081293|NCT02289079|3523206|P1|Overall Study|Lost to Follow-up|0
1081294|NCT02289079|3523205|P2|Overall Study|Physician Decision|0
1081295|NCT02289079|3523206|P1|Overall Study|Physician Decision|2
1081296|NCT02288325|3523245|P3|Double-blind Treatment Period|Multiple Reasons|2
1081297|NCT02288325|3523246|P2|Double-blind Treatment Period|Multiple Reasons|8
1081298|NCT02288325|3523247|P1|Double-blind Treatment Period|Multiple Reasons|0
1081299|NCT02288325|3523245|P3|Double-blind Treatment Period|Non-Compliance With Study Drug|4
1081300|NCT02288325|3523246|P2|Double-blind Treatment Period|Non-Compliance With Study Drug|1
1081301|NCT02288325|3523247|P1|Double-blind Treatment Period|Non-Compliance With Study Drug|0
1081302|NCT02288325|3523245|P3|Double-blind Treatment Period|Protocol Violation|2
1081303|NCT02288325|3523246|P2|Double-blind Treatment Period|Protocol Violation|1
1081304|NCT02288325|3523247|P1|Double-blind Treatment Period|Protocol Violation|0
1081305|NCT02288325|3523245|P3|Double-blind Treatment Period|Lost to Follow-up|5
1081306|NCT02288325|3523246|P2|Double-blind Treatment Period|Lost to Follow-up|4
1081307|NCT02288325|3523247|P1|Double-blind Treatment Period|Lost to Follow-up|0
1081308|NCT02288325|3523245|P3|Double-blind Treatment Period|Withdrawal of Consent|8
1081309|NCT02288325|3523246|P2|Double-blind Treatment Period|Withdrawal of Consent|8
1081310|NCT02288325|3523247|P1|Double-blind Treatment Period|Withdrawal of Consent|0
1081311|NCT02288325|3523245|P3|Double-blind Treatment Period|Adverse Event|5
1081312|NCT02288325|3523246|P2|Double-blind Treatment Period|Adverse Event|2
1081313|NCT02288325|3523247|P1|Double-blind Treatment Period|Adverse Event|0
1081314|NCT02288325|3523245|P3|Stabilization Period|Reason not Specified|0
1081315|NCT02288325|3523246|P2|Stabilization Period|Reason not Specified|0
1081316|NCT02288325|3523247|P1|Stabilization Period|Reason not Specified|15
1081317|NCT02288325|3523245|P3|Stabilization Period|Non-Compliance With Study Drug|0
1081318|NCT02288325|3523246|P2|Stabilization Period|Non-Compliance With Study Drug|0
1081319|NCT02288325|3523247|P1|Stabilization Period|Non-Compliance With Study Drug|5
1081320|NCT02288325|3523245|P3|Stabilization Period|Protocol Violation|0
1081321|NCT02288325|3523246|P2|Stabilization Period|Protocol Violation|0
1081322|NCT02288325|3523247|P1|Stabilization Period|Protocol Violation|8
1081323|NCT02288325|3523245|P3|Stabilization Period|Lost to Follow-up|0
1081324|NCT02288325|3523246|P2|Stabilization Period|Lost to Follow-up|0
1081325|NCT02288325|3523247|P1|Stabilization Period|Lost to Follow-up|12
1081326|NCT02288325|3523245|P3|Stabilization Period|Withdrawal of Consent|0
1081327|NCT02288325|3523246|P2|Stabilization Period|Withdrawal of Consent|0
1081328|NCT02288325|3523247|P1|Stabilization Period|Withdrawal of Consent|23
1081329|NCT02288325|3523245|P3|Stabilization Period|Lack of Efficacy|0
1081330|NCT02288325|3523246|P2|Stabilization Period|Lack of Efficacy|0
1081331|NCT02288325|3523247|P1|Stabilization Period|Lack of Efficacy|22
1081332|NCT02288325|3523245|P3|Stabilization Period|Adverse Event|0
1081333|NCT02288325|3523246|P2|Stabilization Period|Adverse Event|0
1081334|NCT02288325|3523247|P1|Stabilization Period|Adverse Event|13
1081335|NCT02288325|3523245|P3|Run-in Period|Reason not Specified|0
1081336|NCT02288325|3523246|P2|Run-in Period|Reason not Specified|0
1081337|NCT02288325|3523247|P1|Run-in Period|Reason not Specified|8
1081338|NCT02288325|3523245|P3|Run-in Period|Non-Compliance With Study Drug|0
1081339|NCT02288325|3523246|P2|Run-in Period|Non-Compliance With Study Drug|0
1081340|NCT02288325|3523247|P1|Run-in Period|Non-Compliance With Study Drug|3
1081341|NCT02288325|3523245|P3|Run-in Period|Protocol Violation|0
1081342|NCT02288325|3523246|P2|Run-in Period|Protocol Violation|0
1081343|NCT02288325|3523247|P1|Run-in Period|Protocol Violation|17
1081344|NCT02288325|3523245|P3|Run-in Period|Lost to Follow-up|0
1081345|NCT02288325|3523246|P2|Run-in Period|Lost to Follow-up|0
1081346|NCT02288325|3523247|P1|Run-in Period|Lost to Follow-up|25
1081347|NCT02288325|3523245|P3|Run-in Period|Withdrawal of Consent|0
1081348|NCT02288325|3523246|P2|Run-in Period|Withdrawal of Consent|0
1081349|NCT02288325|3523247|P1|Run-in Period|Withdrawal of Consent|28
1081350|NCT02288325|3523245|P3|Run-in Period|Lack of Efficacy|0
1081351|NCT02288325|3523246|P2|Run-in Period|Lack of Efficacy|0
1081352|NCT02288325|3523247|P1|Run-in Period|Lack of Efficacy|16
1081353|NCT02288325|3523245|P3|Run-in Period|Adverse Event|0
1081354|NCT02288325|3523246|P2|Run-in Period|Adverse Event|0
1081355|NCT02288325|3523247|P1|Run-in Period|Adverse Event|48
1081356|NCT02288312|3523257|P3|Overall Study|Pregnancy|0
1081357|NCT02288312|3523258|P2|Overall Study|Pregnancy|0
1081358|NCT02288312|3523259|P1|Overall Study|Pregnancy|1
1081359|NCT02288091|3523297|P1|Overall Study|Screen fail|7
1081360|NCT02288091|3523297|P1|Overall Study|Lost to Follow-up|1
1081361|NCT02287883|3523307|P2|Overall Study|Non-response to survey|237
1081362|NCT02287883|3523308|P1|Overall Study|Non-response to survey|229
1081363|NCT02287883|3523307|P2|Overall Study|No longer eligible|182
1081364|NCT02287883|3523308|P1|Overall Study|No longer eligible|222
1081365|NCT02287883|3523307|P2|Overall Study|Death|7
1081366|NCT02287883|3523308|P1|Overall Study|Death|8
1081367|NCT02287623|3523473|P2|Overall Study|Protocol Violation|1
1081368|NCT02287623|3523474|P1|Overall Study|Protocol Violation|0
1081369|NCT02287610|3523490|P1|Overall Study|Excluded-investigator non-responsiveness|5
1081370|NCT02287610|3523490|P1|Overall Study|Withdrawal by Subject|8
1081371|NCT02287610|3523490|P1|Overall Study|Lost to Follow-up|3
1081372|NCT02287402|3523529|P1|Follow-up|Voluntary Withdrawal|2
1081373|NCT02287402|3523529|P1|Follow-up|Lost to Follow-up|1
1081374|NCT02287402|3523529|P1|Treatment Period|Voluntary Withdrawal|10
1081375|NCT02287402|3523529|P1|Treatment Period|Adverse Event|17
1081376|NCT02287025|3523634|P2|Overall Study|Screening failed|1
1081377|NCT02287025|3523635|P1|Overall Study|Screening failed|1
1081378|NCT02287025|3523634|P2|Overall Study|Withdrawal by Subject|2
1081379|NCT02287025|3523635|P1|Overall Study|Withdrawal by Subject|2
1081380|NCT02287025|3523634|P2|Overall Study|Adverse Event|4
1081381|NCT02287025|3523635|P1|Overall Study|Adverse Event|2
1081382|NCT02287025|3523634|P2|Overall Study|Progression of disease|2
1081383|NCT02287025|3523635|P1|Overall Study|Progression of disease|3
1081384|NCT02287025|3523634|P2|Overall Study|Not treated|0
1081385|NCT02287025|3523635|P1|Overall Study|Not treated|2
1081386|NCT02286895|3523646|P2|Assessed for Measles Seroconversion|Baseline measure non-negative|32
1081387|NCT02286895|3523647|P1|Assessed for Measles Seroconversion|Baseline measure non-negative|41
1081388|NCT02286895|3523646|P2|Assessed for Measles Seroconversion|Missing measurement|3
1081389|NCT02286895|3523647|P1|Assessed for Measles Seroconversion|Missing measurement|6
1081390|NCT02286895|3523646|P2|Assessed for Measles Seroconversion|Protocol Violation|4
1081391|NCT02286895|3523647|P1|Assessed for Measles Seroconversion|Protocol Violation|1
1081392|NCT02286466|3523858|P2|Overall Study|Declined Clinician Assessment|1
1081393|NCT02286466|3523859|P1|Overall Study|Declined Clinician Assessment|0
1081394|NCT02286466|3523858|P2|Overall Study|Lost to Follow-up|4
1081395|NCT02286466|3523859|P1|Overall Study|Lost to Follow-up|1
1081396|NCT02286466|3523858|P2|Overall Study|Withdrawal by Subject|2
1081397|NCT02286466|3523859|P1|Overall Study|Withdrawal by Subject|5
1081398|NCT02286466|3523858|P2|Overall Study|Death|3
1081399|NCT02286466|3523859|P1|Overall Study|Death|1
1081400|NCT02286193|3523871|P1|Overall Study|Referred: Declined service|38
1081401|NCT02286193|3523871|P1|Overall Study|Referred: unable to reach/resource sent|104
1081402|NCT02286193|3523871|P1|Overall Study|Referred: CRS unable to make contact|62
1081403|NCT02286102|3523878|P2|Overall Study|Screen Failure|1
1081404|NCT02286102|3523879|P1|Overall Study|Screen Failure|1
1081405|NCT02285998|3523891|P2|Overall Study|Other Reasons|10
1081406|NCT02285998|3523892|P1|Overall Study|Other Reasons|7
1081407|NCT02285998|3523891|P2|Overall Study|Withdrawal by Subject|61
1081408|NCT02285998|3523892|P1|Overall Study|Withdrawal by Subject|53
1081409|NCT02285998|3523891|P2|Overall Study|Lost to Follow-up|172
1081410|NCT02285998|3523892|P1|Overall Study|Lost to Follow-up|176
1081411|NCT02285998|3523891|P2|Overall Study|Physician Decision|2
1081412|NCT02285998|3523892|P1|Overall Study|Physician Decision|1
1081413|NCT02285998|3523891|P2|Overall Study|Adverse Event|8
1081414|NCT02285998|3523892|P1|Overall Study|Adverse Event|9
1081415|NCT02285777|3523944|P2|Overall Study|Lost to Follow-up|2
1081416|NCT02285777|3523945|P1|Overall Study|Lost to Follow-up|4
1081417|NCT02285777|3523944|P2|Overall Study|Withdrawal by Subject|1
1081418|NCT02285777|3523945|P1|Overall Study|Withdrawal by Subject|1
1081419|NCT02285270|3524026|P1|Overall Study|Determined to be ineligible|1
1081420|NCT02285270|3524026|P1|Overall Study|Physician Decision|3
1081421|NCT02285270|3524026|P1|Overall Study|Lost to Follow-up|1
1081422|NCT02284893|3524034|P2|52 Week (Long Term)|Non-Compliance|3
1081423|NCT02284893|3524035|P1|52 Week (Long Term)|Non-Compliance|2
1081424|NCT02284893|3524034|P2|52 Week (Long Term)|Lost to Follow-up|2
1081425|NCT02284893|3524035|P1|52 Week (Long Term)|Lost to Follow-up|2
1081426|NCT02284893|3524034|P2|52 Week (Long Term)|Withrawal of the consent by the subject|6
1081427|NCT02284893|3524035|P1|52 Week (Long Term)|Withrawal of the consent by the subject|4
1081428|NCT02284893|3524034|P2|52 Week (Long Term)|Subject no longer meets study criteria|1
1081429|NCT02284893|3524035|P1|52 Week (Long Term)|Subject no longer meets study criteria|0
1081430|NCT02284893|3524034|P2|52 Week (Long Term)|Adverse Event|1
1081431|NCT02284893|3524035|P1|52 Week (Long Term)|Adverse Event|3
1081432|NCT02284893|3524034|P2|26 Week (Short Term)|Other|1
1081433|NCT02284893|3524035|P1|26 Week (Short Term)|Other|1
1081434|NCT02284893|3524034|P2|26 Week (Short Term)|Subject no longer meets study criteria|8
1081435|NCT02284893|3524035|P1|26 Week (Short Term)|Subject no longer meets study criteria|5
1081436|NCT02284893|3524034|P2|26 Week (Short Term)|Lost to Follow-up|1
1081437|NCT02284893|3524035|P1|26 Week (Short Term)|Lost to Follow-up|3
1081438|NCT02284893|3524034|P2|26 Week (Short Term)|Withrawal of the consent by the subject|10
1081439|NCT02284893|3524035|P1|26 Week (Short Term)|Withrawal of the consent by the subject|7
1081440|NCT02284893|3524034|P2|26 Week (Short Term)|Discontinuation by the subject|2
1081441|NCT02284893|3524035|P1|26 Week (Short Term)|Discontinuation by the subject|2
1081442|NCT02284893|3524034|P2|26 Week (Short Term)|Adverse Event|9
1081443|NCT02284893|3524035|P1|26 Week (Short Term)|Adverse Event|1
1081444|NCT02284568|3524112|P3|Overall Study|Withdrew before taking study drug|0
1081445|NCT02284568|3524113|P2|Overall Study|Withdrew before taking study drug|1
1081446|NCT02284568|3524114|P1|Overall Study|Withdrew before taking study drug|0
1081447|NCT02284568|3524112|P3|Overall Study|Not specified|0
1081448|NCT02284568|3524113|P2|Overall Study|Not specified|2
1081449|NCT02284568|3524114|P1|Overall Study|Not specified|1
1081450|NCT02284568|3524112|P3|Overall Study|Lack of Efficacy|0
1081451|NCT02284568|3524113|P2|Overall Study|Lack of Efficacy|7
1081452|NCT02284568|3524114|P1|Overall Study|Lack of Efficacy|4
1081453|NCT02284568|3524112|P3|Overall Study|Lost to Follow-up|0
1081454|NCT02284568|3524113|P2|Overall Study|Lost to Follow-up|3
1081455|NCT02284568|3524114|P1|Overall Study|Lost to Follow-up|0
1081456|NCT02284568|3524112|P3|Overall Study|Sponsor requested patient stop treatment|90
1081457|NCT02284568|3524113|P2|Overall Study|Sponsor requested patient stop treatment|0
1081458|NCT02284568|3524114|P1|Overall Study|Sponsor requested patient stop treatment|0
1081459|NCT02284568|3524112|P3|Overall Study|Protocol Violation|0
1081460|NCT02284568|3524113|P2|Overall Study|Protocol Violation|1
1081461|NCT02284568|3524114|P1|Overall Study|Protocol Violation|0
1081462|NCT02284568|3524112|P3|Overall Study|Noncompliance|0
1081463|NCT02284568|3524113|P2|Overall Study|Noncompliance|0
1081464|NCT02284568|3524114|P1|Overall Study|Noncompliance|1
1081465|NCT02284568|3524112|P3|Overall Study|Noncompliance with study drug admin|0
1081466|NCT02284568|3524113|P2|Overall Study|Noncompliance with study drug admin|2
1081467|NCT02284568|3524114|P1|Overall Study|Noncompliance with study drug admin|1
1081468|NCT02284568|3524112|P3|Overall Study|Withdrawal by Subject|1
1081469|NCT02284568|3524113|P2|Overall Study|Withdrawal by Subject|21
1081470|NCT02284568|3524114|P1|Overall Study|Withdrawal by Subject|22
1081471|NCT02284568|3524112|P3|Overall Study|Adverse Event|4
1081472|NCT02284568|3524113|P2|Overall Study|Adverse Event|9
1081473|NCT02284568|3524114|P1|Overall Study|Adverse Event|2
1081474|NCT02284347|3524165|P1|Overall Study|Withdrawn prior to treatment|1
1081475|NCT02284347|3524165|P1|Overall Study|Lost to Follow-up|2
1081476|NCT02284243|3524173|P2|Overall Study|Adverse Event|0
1081477|NCT02284243|3524174|P1|Overall Study|Adverse Event|1
1081478|NCT02284243|3524173|P2|Overall Study|Lack of Efficacy|3
1081479|NCT02284243|3524174|P1|Overall Study|Lack of Efficacy|3
1081480|NCT02283788|3524270|P4|Overall Study|Withdrawal by Subject|1
1081481|NCT02283788|3524271|P3|Overall Study|Withdrawal by Subject|0
1081482|NCT02283788|3524272|P2|Overall Study|Withdrawal by Subject|1
1081483|NCT02283788|3524273|P1|Overall Study|Withdrawal by Subject|0
1081484|NCT02283788|3524270|P4|Overall Study|Adverse Event|1
1081485|NCT02283788|3524271|P3|Overall Study|Adverse Event|5
1081486|NCT02283788|3524272|P2|Overall Study|Adverse Event|3
1081487|NCT02283788|3524273|P1|Overall Study|Adverse Event|1
1081488|NCT02283411|3524289|P1|Overall Study|Screen Failed|28
1081489|NCT02283411|3524289|P1|Overall Study|Withdrawal by Subject|3
1081490|NCT02283268|3524297|P1|Overall Study|Withdrawal by Subject|1
1081491|NCT02282982|3524358|P1|Overall Study|Other, not specified|18
1081492|NCT02282982|3524358|P1|Overall Study|Palivizumab is ended|11
1081493|NCT02282982|3524358|P1|Overall Study|Lack of product|156
1081494|NCT02282982|3524358|P1|Overall Study|Death|4
1081495|NCT02282982|3524358|P1|Overall Study|Withdrew consent|2
1081496|NCT02282982|3524358|P1|Overall Study|Lost to Follow-up|15
1081497|NCT02282813|3524376|P3|Overall Study|Administrative reasons|0
1081498|NCT02282813|3524377|P2|Overall Study|Administrative reasons|1
1081499|NCT02282813|3524378|P1|Overall Study|Administrative reasons|0
1081500|NCT02282813|3524376|P3|Overall Study|Lack of Efficacy|0
1081501|NCT02282813|3524377|P2|Overall Study|Lack of Efficacy|0
1081502|NCT02282813|3524378|P1|Overall Study|Lack of Efficacy|1
1081503|NCT02282813|3524376|P3|Overall Study|Serum Ca >/=11.0mg/dL|0
1081504|NCT02282813|3524377|P2|Overall Study|Serum Ca >/=11.0mg/dL|0
1081505|NCT02282813|3524378|P1|Overall Study|Serum Ca >/=11.0mg/dL|1
1081506|NCT02282813|3524376|P3|Overall Study|Lost to Follow-up|1
1081507|NCT02282813|3524377|P2|Overall Study|Lost to Follow-up|0
1081508|NCT02282813|3524378|P1|Overall Study|Lost to Follow-up|2
1081509|NCT02282813|3524376|P3|Overall Study|Physician Decision|1
1081510|NCT02282813|3524377|P2|Overall Study|Physician Decision|3
1081511|NCT02282813|3524378|P1|Overall Study|Physician Decision|0
1081512|NCT02282813|3524376|P3|Overall Study|Subject non-compliance|0
1081513|NCT02282813|3524377|P2|Overall Study|Subject non-compliance|4
1081514|NCT02282813|3524378|P1|Overall Study|Subject non-compliance|1
1081515|NCT02282813|3524376|P3|Overall Study|Adverse Event|1
1081516|NCT02282813|3524377|P2|Overall Study|Adverse Event|10
1081517|NCT02282813|3524378|P1|Overall Study|Adverse Event|3
1081518|NCT02282813|3524376|P3|Overall Study|Withdrawal by Subject|0
1081519|NCT02282813|3524377|P2|Overall Study|Withdrawal by Subject|5
1081520|NCT02282813|3524378|P1|Overall Study|Withdrawal by Subject|4
1081521|NCT02282631|3524424|P2|Overall Study|Lost to Follow-up|0
1081522|NCT02282631|3524425|P1|Overall Study|Lost to Follow-up|2
1081523|NCT02282605|3524466|P3|Overall Study|negative SA result on Day -1|0
1081524|NCT02282605|3524467|P2|Overall Study|negative SA result on Day -1|0
1081525|NCT02282605|3524468|P1|Overall Study|negative SA result on Day -1|3
1081526|NCT02282527|3524490|P2|Overall Study|Lack of home health aid|0
1081527|NCT02282527|3524491|P1|Overall Study|Lack of home health aid|1
1081528|NCT02282527|3524490|P2|Overall Study|Lost to Follow-up|1
1081529|NCT02282527|3524491|P1|Overall Study|Lost to Follow-up|0
1081530|NCT02281773|3524523|P5|Overall Study|Other Reason|1
1081531|NCT02281773|3524524|P4|Overall Study|Other Reason|3
1081532|NCT02281773|3524525|P3|Overall Study|Other Reason|2
1081533|NCT02281773|3524526|P2|Overall Study|Other Reason|4
1081534|NCT02281773|3524527|P1|Overall Study|Other Reason|0
1081535|NCT02281773|3524523|P5|Overall Study|Withdrawal by Subject|8
1081536|NCT02281773|3524524|P4|Overall Study|Withdrawal by Subject|6
1081537|NCT02281773|3524525|P3|Overall Study|Withdrawal by Subject|6
1081538|NCT02281773|3524526|P2|Overall Study|Withdrawal by Subject|8
1081539|NCT02281773|3524527|P1|Overall Study|Withdrawal by Subject|2
1081540|NCT02281773|3524523|P5|Overall Study|Lost to Follow-up|10
1081541|NCT02281773|3524524|P4|Overall Study|Lost to Follow-up|2
1081542|NCT02281773|3524525|P3|Overall Study|Lost to Follow-up|6
1081543|NCT02281773|3524526|P2|Overall Study|Lost to Follow-up|2
1081544|NCT02281773|3524527|P1|Overall Study|Lost to Follow-up|2
1081545|NCT02281773|3524523|P5|Overall Study|Protocol Violation|2
1081546|NCT02281773|3524524|P4|Overall Study|Protocol Violation|2
1081547|NCT02281773|3524525|P3|Overall Study|Protocol Violation|0
1081548|NCT02281773|3524526|P2|Overall Study|Protocol Violation|0
1081549|NCT02281773|3524527|P1|Overall Study|Protocol Violation|1
1081550|NCT02281773|3524523|P5|Overall Study|Adverse Event|9
1081551|NCT02281773|3524524|P4|Overall Study|Adverse Event|8
1081552|NCT02281773|3524525|P3|Overall Study|Adverse Event|4
1081553|NCT02281773|3524526|P2|Overall Study|Adverse Event|1
1081554|NCT02281773|3524527|P1|Overall Study|Adverse Event|6
1081555|NCT02281552|3524615|P2|Overall Study|Adverse Event|9
1081556|NCT02281552|3524616|P1|Overall Study|Adverse Event|3
1081557|NCT02281552|3524615|P2|Overall Study|Insufficient clinical response|1
1081558|NCT02281552|3524616|P1|Overall Study|Insufficient clinical response|0
1081559|NCT02281552|3524615|P2|Overall Study|Medication error|0
1081560|NCT02281552|3524616|P1|Overall Study|Medication error|1
1081561|NCT02281357|3524709|P2|Overall Study|Withdrawal by Subject|3
1081562|NCT02281357|3524710|P1|Overall Study|Withdrawal by Subject|4
1081563|NCT02281357|3524709|P2|Overall Study|Lost to Follow-up|0
1081564|NCT02281357|3524710|P1|Overall Study|Lost to Follow-up|1
1081565|NCT02281357|3524709|P2|Overall Study|Adverse Event|1
1081566|NCT02281357|3524710|P1|Overall Study|Adverse Event|2
1081567|NCT02281318|3524724|P2|Overall Study|Withdrawal by Subject|2
1081568|NCT02281318|3524725|P1|Overall Study|Withdrawal by Subject|6
1081569|NCT02281318|3524724|P2|Overall Study|Physician Decision|0
1081570|NCT02281318|3524725|P1|Overall Study|Physician Decision|2
1081571|NCT02281318|3524724|P2|Overall Study|Lost to Follow-up|1
1081572|NCT02281318|3524725|P1|Overall Study|Lost to Follow-up|2
1081573|NCT02281318|3524724|P2|Overall Study|Lack of Efficacy|0
1081574|NCT02281318|3524725|P1|Overall Study|Lack of Efficacy|2
1081575|NCT02281318|3524724|P2|Overall Study|Adverse Event|2
1081576|NCT02281318|3524725|P1|Overall Study|Adverse Event|2
1081577|NCT02280863|3524771|P2|Integrated Platform|Met stopping criteria|1
1081578|NCT02280863|3524772|P1|Integrated Platform|Met stopping criteria|0
1081579|NCT02280499|3524856|P1|Overall Study|Adverse Event|5
1081580|NCT02280499|3524856|P1|Overall Study|Lost to Follow-up|42
1081581|NCT02280499|3524856|P1|Overall Study|Death|14
1081582|NCT02280473|3524864|P2|Overall Study|Lost to Follow-up|1
1081583|NCT02280473|3524865|P1|Overall Study|Lost to Follow-up|0
1081584|NCT02280473|3524864|P2|Overall Study|Lack of Efficacy|1
1081585|NCT02280473|3524865|P1|Overall Study|Lack of Efficacy|0
1081586|NCT02280473|3524864|P2|Overall Study|Adverse Event|1
1081587|NCT02280473|3524865|P1|Overall Study|Adverse Event|1
1081588|NCT02280187|3524884|P1|Overall Study|Lost to Follow-up|218
1081589|NCT02280044|3524912|P2|Overall Study|Planned alternate|2
1081590|NCT02280044|3524913|P1|Overall Study|Planned alternate|0
1081591|NCT02279862|3524923|P2|Overall Study|Withdrawal by Subject|0
1081592|NCT02279862|3524924|P1|Overall Study|Withdrawal by Subject|1
1081593|NCT02279862|3524923|P2|Overall Study|Other|2
1081594|NCT02279862|3524924|P1|Overall Study|Other|1
1081595|NCT02279862|3524923|P2|Overall Study|Study closed by sponsor|13
1081596|NCT02279862|3524924|P1|Overall Study|Study closed by sponsor|16
1081597|NCT02279862|3524923|P2|Overall Study|Disease progression|2
1081598|NCT02279862|3524924|P1|Overall Study|Disease progression|5
1081599|NCT02279862|3524923|P2|Overall Study|Administrative reason by sponsor|1
1081600|NCT02279862|3524924|P1|Overall Study|Administrative reason by sponsor|0
1081601|NCT02279862|3524923|P2|Overall Study|No longer meets criteria|1
1081602|NCT02279862|3524924|P1|Overall Study|No longer meets criteria|0
1081603|NCT02279862|3524923|P2|Overall Study|Study drug toxicity|6
1081604|NCT02279862|3524924|P1|Overall Study|Study drug toxicity|3
1081605|NCT02279498|3525022|P2|Overall Study|Undefined|1
1081606|NCT02279498|3525023|P1|Overall Study|Undefined|2
1081607|NCT02279498|3525022|P2|Overall Study|Withdrawal by Subject|2
1081608|NCT02279498|3525023|P1|Overall Study|Withdrawal by Subject|9
1081609|NCT02279498|3525022|P2|Overall Study|Lost to Follow-up|1
1081610|NCT02279498|3525023|P1|Overall Study|Lost to Follow-up|0
1081611|NCT02279498|3525022|P2|Overall Study|Lack of Efficacy|0
1081612|NCT02279498|3525023|P1|Overall Study|Lack of Efficacy|4
1081613|NCT02279498|3525022|P2|Overall Study|Adverse Event|0
1081614|NCT02279498|3525023|P1|Overall Study|Adverse Event|3
1081615|NCT02279420|3525032|P1|Overall Study|Lost to Follow-up|23
1081616|NCT02279407|3525040|P4|Overall Study|Adverse Event|0
1081617|NCT02279407|3525041|P3|Overall Study|Adverse Event|2
1081618|NCT02279407|3525042|P2|Overall Study|Adverse Event|1
1081619|NCT02279407|3525043|P1|Overall Study|Adverse Event|1
1081620|NCT02279407|3525040|P4|Overall Study|Withdrawal by Subject|1
1081621|NCT02279407|3525041|P3|Overall Study|Withdrawal by Subject|1
1081622|NCT02279407|3525042|P2|Overall Study|Withdrawal by Subject|0
1081623|NCT02279407|3525043|P1|Overall Study|Withdrawal by Subject|1
1081624|NCT02279407|3525040|P4|Overall Study|Couldn't swallow IP; noncompliance|0
1081625|NCT02279407|3525041|P3|Overall Study|Couldn't swallow IP; noncompliance|2
1081626|NCT02279407|3525042|P2|Overall Study|Couldn't swallow IP; noncompliance|0
1081627|NCT02279407|3525043|P1|Overall Study|Couldn't swallow IP; noncompliance|0
1081628|NCT02278939|3525085|P2|Overall Study|family emergency unable to commit|0
1081629|NCT02278939|3525086|P1|Overall Study|family emergency unable to commit|2
1081630|NCT02278939|3525085|P2|Overall Study|death in family|0
1081631|NCT02278939|3525086|P1|Overall Study|death in family|1
1081632|NCT02278939|3525085|P2|Overall Study|Lost to Follow-up|1
1081633|NCT02278939|3525086|P1|Overall Study|Lost to Follow-up|1
1081634|NCT02278939|3525085|P2|Overall Study|lack of time|0
1081635|NCT02278939|3525086|P1|Overall Study|lack of time|1
1081636|NCT02278614|3525114|P2|Overall Study|left eye was not eligible|0
1081637|NCT02278614|3525115|P1|Overall Study|left eye was not eligible|1
1081638|NCT02278614|3525114|P2|Overall Study|Adverse Event|0
1081639|NCT02278614|3525115|P1|Overall Study|Adverse Event|1
1081640|NCT02278614|3525114|P2|Overall Study|Withdrawal by Subject|5
1081641|NCT02278614|3525115|P1|Overall Study|Withdrawal by Subject|3
1081642|NCT02278003|3525162|P2|Overall Study|Recognition task improperly completed|0
1081643|NCT02278003|3525163|P1|Overall Study|Recognition task improperly completed|7
1081644|NCT02278003|3525162|P2|Overall Study|Not Treated|0
1081645|NCT02278003|3525163|P1|Overall Study|Not Treated|1
1081646|NCT02278003|3525162|P2|Overall Study|Withdrawal by Subject|0
1081647|NCT02278003|3525163|P1|Overall Study|Withdrawal by Subject|11
1081648|NCT02277769|3525174|P3|Overall Study|Other than specified above|5
1081649|NCT02277769|3525175|P2|Overall Study|Other than specified above|8
1081650|NCT02277769|3525176|P1|Overall Study|Other than specified above|12
1081651|NCT02277769|3525174|P3|Overall Study|Adverse Event|4
1081652|NCT02277769|3525175|P2|Overall Study|Adverse Event|2
1081653|NCT02277769|3525176|P1|Overall Study|Adverse Event|14
1081654|NCT02277769|3525174|P3|Overall Study|Lack of Efficacy|4
1081655|NCT02277769|3525175|P2|Overall Study|Lack of Efficacy|0
1081656|NCT02277769|3525176|P1|Overall Study|Lack of Efficacy|17
1081657|NCT02277769|3525174|P3|Overall Study|Protocol Violation|5
1081658|NCT02277769|3525175|P2|Overall Study|Protocol Violation|3
1081659|NCT02277769|3525176|P1|Overall Study|Protocol Violation|3
1081660|NCT02277743|3525247|P3|Overall Study|Other than specified above|16
1081661|NCT02277743|3525248|P2|Overall Study|Other than specified above|5
1081662|NCT02277743|3525249|P1|Overall Study|Other than specified above|18
1081663|NCT02277743|3525247|P3|Overall Study|Lack of Efficacy|3
1081664|NCT02277743|3525248|P2|Overall Study|Lack of Efficacy|4
1081665|NCT02277743|3525249|P1|Overall Study|Lack of Efficacy|11
1081666|NCT02277743|3525247|P3|Overall Study|Adverse Event|6
1081667|NCT02277743|3525248|P2|Overall Study|Adverse Event|6
1081668|NCT02277743|3525249|P1|Overall Study|Adverse Event|10
1081669|NCT02277743|3525247|P3|Overall Study|Protocol Violation|1
1081670|NCT02277743|3525248|P2|Overall Study|Protocol Violation|1
1081671|NCT02277743|3525249|P1|Overall Study|Protocol Violation|1
1081672|NCT02277691|3525317|P1|Overall Study|Used Other Antihypertensive Drug|1
1081673|NCT02277691|3525317|P1|Overall Study|Lack of Efficacy|5
1081674|NCT02277691|3525317|P1|Overall Study|Voluntary Withdrawal|7
1081675|NCT02277691|3525317|P1|Overall Study|Pretreatment Event/Adverse Event|33
1081676|NCT02277119|3525363|P3|Overall Study|Protocol Violation|7
1081677|NCT02277119|3525364|P2|Overall Study|Protocol Violation|3
1081678|NCT02277119|3525365|P1|Overall Study|Protocol Violation|2
1081679|NCT02277119|3525363|P3|Overall Study|Lack of Efficacy|1
1081680|NCT02277119|3525364|P2|Overall Study|Lack of Efficacy|1
1081681|NCT02277119|3525365|P1|Overall Study|Lack of Efficacy|1
1081682|NCT02276612|3525398|P2|Overall Study|Lost to Follow-up|0
1081683|NCT02276612|3525399|P1|Overall Study|Lost to Follow-up|1
1081684|NCT02276612|3525398|P2|Overall Study|Withdrew Consent|0
1081685|NCT02276612|3525399|P1|Overall Study|Withdrew Consent|1
1081686|NCT02276612|3525398|P2|Overall Study|Pregnancy|0
1081687|NCT02276612|3525399|P1|Overall Study|Pregnancy|1
1081688|NCT02276612|3525398|P2|Overall Study|Death|0
1081689|NCT02276612|3525399|P1|Overall Study|Death|1
1081690|NCT02276560|3525422|P3|Overall Study|Adverse Event|0
1081691|NCT02276560|3525423|P2|Overall Study|Adverse Event|0
1081692|NCT02276560|3525424|P1|Overall Study|Adverse Event|1
1081693|NCT02276222|3525545|P2|Overall Study|subject withdrew after randomization|0
1081694|NCT02276222|3525546|P1|Overall Study|subject withdrew after randomization|1
1081695|NCT02276222|3525545|P2|Overall Study|sheduling conflict|0
1081696|NCT02276222|3525546|P1|Overall Study|sheduling conflict|1
1081697|NCT02276222|3525545|P2|Overall Study|Physician Decision|1
1081698|NCT02276222|3525546|P1|Overall Study|Physician Decision|2
1081699|NCT02276222|3525545|P2|Overall Study|Lost to Follow-up|5
1081700|NCT02276222|3525546|P1|Overall Study|Lost to Follow-up|15
1081701|NCT02276222|3525545|P2|Overall Study|sponsor decision|3
1081702|NCT02276222|3525546|P1|Overall Study|sponsor decision|0
1081703|NCT02276222|3525545|P2|Overall Study|non compliance with study medication|2
1081704|NCT02276222|3525546|P1|Overall Study|non compliance with study medication|6
1081705|NCT02276222|3525545|P2|Overall Study|Withdrawal by Subject|33
1081706|NCT02276222|3525546|P1|Overall Study|Withdrawal by Subject|79
1081707|NCT02276222|3525545|P2|Overall Study|Protocol Violation|2
1081708|NCT02276222|3525546|P1|Overall Study|Protocol Violation|3
1081709|NCT02276222|3525545|P2|Overall Study|Lack of Efficacy|3
1081710|NCT02276222|3525546|P1|Overall Study|Lack of Efficacy|13
1081711|NCT02276222|3525545|P2|Overall Study|Death|4
1081712|NCT02276222|3525546|P1|Overall Study|Death|3
1081713|NCT02276222|3525545|P2|Overall Study|Adverse Event|11
1081714|NCT02276222|3525546|P1|Overall Study|Adverse Event|62
1081715|NCT02276040|3525570|P1|Overall Study|Physician Decision|15
1081716|NCT02275780|3525576|P2|Extension Study: up to 192 Weeks|Ongoing|233
1081717|NCT02275780|3525577|P1|Extension Study: up to 192 Weeks|Ongoing|260
1081718|NCT02275780|3525576|P2|Base Study: 96 Weeks|Randomized not treated|1
1081719|NCT02275780|3525577|P1|Base Study: 96 Weeks|Randomized not treated|2
1081720|NCT02275780|3525576|P2|Base Study: 96 Weeks|Pregnancy|1
1081721|NCT02275780|3525577|P1|Base Study: 96 Weeks|Pregnancy|2
1081722|NCT02275780|3525576|P2|Base Study: 96 Weeks|Physician Decision|4
1081723|NCT02275780|3525577|P1|Base Study: 96 Weeks|Physician Decision|2
1081724|NCT02275780|3525576|P2|Base Study: 96 Weeks|Noncompliance with drug|6
1081725|NCT02275780|3525577|P1|Base Study: 96 Weeks|Noncompliance with drug|9
1081726|NCT02275780|3525576|P2|Base Study: 96 Weeks|Withdrawal by Subject|22
1081727|NCT02275780|3525577|P1|Base Study: 96 Weeks|Withdrawal by Subject|19
1081728|NCT02275780|3525576|P2|Base Study: 96 Weeks|Protocol Violation|6
1081729|NCT02275780|3525577|P1|Base Study: 96 Weeks|Protocol Violation|1
1081730|NCT02275780|3525576|P2|Base Study: 96 Weeks|Lost to Follow-up|24
1081731|NCT02275780|3525577|P1|Base Study: 96 Weeks|Lost to Follow-up|28
1081732|NCT02275780|3525576|P2|Base Study: 96 Weeks|Lack of Efficacy|32
1081733|NCT02275780|3525577|P1|Base Study: 96 Weeks|Lack of Efficacy|21
1081734|NCT02275780|3525576|P2|Base Study: 96 Weeks|Death|1
1081735|NCT02275780|3525577|P1|Base Study: 96 Weeks|Death|3
1081736|NCT02275780|3525576|P2|Base Study: 96 Weeks|Adverse Event|14
1081737|NCT02275780|3525577|P1|Base Study: 96 Weeks|Adverse Event|6
1081738|NCT02275611|3525633|P4|Inpatient Withdrawal|Withdrawal by Subject|0
1081739|NCT02275611|3525634|P3|Inpatient Withdrawal|Withdrawal by Subject|0
1081740|NCT02275611|3525635|P2|Inpatient Withdrawal|Withdrawal by Subject|0
1081741|NCT02275611|3525636|P1|Inpatient Withdrawal|Withdrawal by Subject|1
1081742|NCT02275546|3525648|P2|Treatment Period 2|Protocol Violation|1
1081743|NCT02275546|3525649|P1|Treatment Period 2|Protocol Violation|0
1081744|NCT02275546|3525648|P2|Treatment Period 2|Withdrawal by Subject|1
1081745|NCT02275546|3525649|P1|Treatment Period 2|Withdrawal by Subject|2
1081746|NCT02275481|3525659|P2|Overall Study|Physician Decision|1
1081747|NCT02275481|3525660|P1|Overall Study|Physician Decision|0
1081748|NCT02275481|3525659|P2|Overall Study|all other reasons combined|1
1081749|NCT02275481|3525660|P1|Overall Study|all other reasons combined|2
1081750|NCT02275481|3525659|P2|Overall Study|Withdrawal by Subject|0
1081751|NCT02275481|3525660|P1|Overall Study|Withdrawal by Subject|3
1081752|NCT02275481|3525659|P2|Overall Study|Lost to Follow-up|0
1081753|NCT02275481|3525660|P1|Overall Study|Lost to Follow-up|2
1081754|NCT02275481|3525659|P2|Overall Study|Death|1
1081755|NCT02275481|3525660|P1|Overall Study|Death|2
1081756|NCT02275364|3525666|P2|Period 1|Other reason|0
1081757|NCT02275364|3525667|P1|Period 1|Other reason|1
1081758|NCT02275364|3525666|P2|Period 1|Withdrawal by Subject|0
1081759|NCT02275364|3525667|P1|Period 1|Withdrawal by Subject|1
1081760|NCT02275052|3525728|P4|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2
1081761|NCT02275052|3525729|P3|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
1081762|NCT02275052|3525730|P2|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
1081763|NCT02275052|3525731|P1|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
1081764|NCT02275052|3525728|P4|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6
1081765|NCT02275052|3525729|P3|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
1081766|NCT02275052|3525730|P2|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
1081767|NCT02275052|3525731|P1|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
1081768|NCT02275052|3525728|P4|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4
1081769|NCT02275052|3525729|P3|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
1081770|NCT02275052|3525730|P2|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
1081771|NCT02275052|3525731|P1|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
1081772|NCT02275052|3525728|P4|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2
1081773|NCT02275052|3525729|P3|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3
1081774|NCT02275052|3525730|P2|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
1081775|NCT02275052|3525731|P1|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
1081776|NCT02275052|3525728|P4|Washout Period (12-17 Days)|Lack of Efficacy|0
1081777|NCT02275052|3525729|P3|Washout Period (12-17 Days)|Lack of Efficacy|0
1081778|NCT02275052|3525730|P2|Washout Period (12-17 Days)|Lack of Efficacy|0
1081779|NCT02275052|3525731|P1|Washout Period (12-17 Days)|Lack of Efficacy|1
1081780|NCT02275052|3525728|P4|Washout Period (12-17 Days)|Withdrawal by Subject|0
1081781|NCT02275052|3525729|P3|Washout Period (12-17 Days)|Withdrawal by Subject|0
1081782|NCT02275052|3525730|P2|Washout Period (12-17 Days)|Withdrawal by Subject|0
1081783|NCT02275052|3525731|P1|Washout Period (12-17 Days)|Withdrawal by Subject|3
1081784|NCT02275052|3525728|P4|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
1081785|NCT02275052|3525729|P3|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
1081786|NCT02275052|3525730|P2|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
1081787|NCT02275052|3525731|P1|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2
1081788|NCT02275052|3525728|P4|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
1081789|NCT02275052|3525729|P3|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
1081790|NCT02275052|3525730|P2|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
1081791|NCT02275052|3525731|P1|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1
1081792|NCT02275052|3525728|P4|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
1081793|NCT02275052|3525729|P3|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
1081794|NCT02275052|3525730|P2|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4
1081795|NCT02275052|3525731|P1|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6
1081796|NCT02275052|3525728|P4|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
1081797|NCT02275052|3525729|P3|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
1081798|NCT02275052|3525730|P2|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1
1081799|NCT02275052|3525731|P1|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
1081800|NCT02275052|3525728|P4|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1081801|NCT02275052|3525729|P3|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1081802|NCT02275052|3525730|P2|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
1081803|NCT02275052|3525731|P1|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1081804|NCT02274948|3525745|P2|Overall Study|Left the area|3
1081805|NCT02274948|3525746|P1|Overall Study|Left the area|4
1081806|NCT02274948|3525745|P2|Overall Study|Stopped on family Practitioner advice|5
1081807|NCT02274948|3525746|P1|Overall Study|Stopped on family Practitioner advice|2
1081808|NCT02274948|3525745|P2|Overall Study|Withdrawal by Subject|58
1081809|NCT02274948|3525746|P1|Overall Study|Withdrawal by Subject|64
1081810|NCT02274948|3525745|P2|Overall Study|Lost to Follow-up|25
1081811|NCT02274948|3525746|P1|Overall Study|Lost to Follow-up|28
1081812|NCT02274792|3525787|P1|Overall Study|Sponsor Decision|2
1081813|NCT02274792|3525787|P1|Overall Study|Protocol Specified Criteria|2
1081814|NCT02274792|3525787|P1|Overall Study|Lost to Follow-up|8
1081815|NCT02274792|3525787|P1|Overall Study|Withdrawal by Subject|13
1081816|NCT02274766|3525797|P2|Overall Study|Adverse Event|1
1081817|NCT02274766|3525798|P1|Overall Study|Adverse Event|0
1081818|NCT02274766|3525797|P2|Overall Study|Subject Unwilling to Proceed|1
1081819|NCT02274766|3525798|P1|Overall Study|Subject Unwilling to Proceed|0
1081820|NCT02274766|3525797|P2|Overall Study|Did Not Receive Study Drug|1
1081821|NCT02274766|3525798|P1|Overall Study|Did Not Receive Study Drug|1
1081822|NCT02274766|3525797|P2|Overall Study|Withdrawal by Subject|6
1081823|NCT02274766|3525798|P1|Overall Study|Withdrawal by Subject|3
1081824|NCT02274558|3525844|P3|Overall Study|Physician Decision|1
1081825|NCT02274558|3525845|P2|Overall Study|Physician Decision|2
1081826|NCT02274558|3525846|P1|Overall Study|Physician Decision|0
1081827|NCT02274558|3525844|P3|Overall Study|Lost to Follow-up|1
1081828|NCT02274558|3525845|P2|Overall Study|Lost to Follow-up|1
1081829|NCT02274558|3525846|P1|Overall Study|Lost to Follow-up|2
1081830|NCT02274558|3525844|P3|Overall Study|Death|1
1081831|NCT02274558|3525845|P2|Overall Study|Death|0
1081832|NCT02274558|3525846|P1|Overall Study|Death|0
1081833|NCT02274558|3525844|P3|Overall Study|Withdrawal by Subject|4
1081834|NCT02274558|3525845|P2|Overall Study|Withdrawal by Subject|5
1081835|NCT02274558|3525846|P1|Overall Study|Withdrawal by Subject|1
1081836|NCT02274558|3525844|P3|Overall Study|Non-compliance|0
1081837|NCT02274558|3525845|P2|Overall Study|Non-compliance|1
1081838|NCT02274558|3525846|P1|Overall Study|Non-compliance|2
1081839|NCT02274558|3525844|P3|Overall Study|Adverse Event|2
1081840|NCT02274558|3525845|P2|Overall Study|Adverse Event|4
1081841|NCT02274558|3525846|P1|Overall Study|Adverse Event|2
1081842|NCT02273973|3525862|P2|Overall Study|Reason not specified|1
1081843|NCT02273973|3525863|P1|Overall Study|Reason not specified|0
1081844|NCT02273973|3525862|P2|Overall Study|Physician Decision|1
1081845|NCT02273973|3525863|P1|Overall Study|Physician Decision|0
1081846|NCT02273973|3525862|P2|Overall Study|Lost to Follow-up|1
1081847|NCT02273973|3525863|P1|Overall Study|Lost to Follow-up|0
1081848|NCT02273973|3525862|P2|Overall Study|Progression of disease|2
1081849|NCT02273973|3525863|P1|Overall Study|Progression of disease|0
1081850|NCT02273973|3525862|P2|Overall Study|Protocol Violation|0
1081851|NCT02273973|3525863|P1|Overall Study|Protocol Violation|1
1081852|NCT02273973|3525862|P2|Overall Study|Non-compliance|0
1081853|NCT02273973|3525863|P1|Overall Study|Non-compliance|1
1081854|NCT02273973|3525862|P2|Overall Study|Death|0
1081855|NCT02273973|3525863|P1|Overall Study|Death|1
1081856|NCT02273973|3525862|P2|Overall Study|Withdrawal by Subject|3
1081857|NCT02273973|3525863|P1|Overall Study|Withdrawal by Subject|2
1081858|NCT02273973|3525862|P2|Overall Study|Adverse Event|0
1081859|NCT02273973|3525863|P1|Overall Study|Adverse Event|4
1081860|NCT02273908|3525905|P2|Overall Study|Withdrawal by Subject|2
1081861|NCT02273908|3525906|P1|Overall Study|Withdrawal by Subject|4
1081862|NCT02273908|3525905|P2|Overall Study|Did not meet entrance criteria|2
1081863|NCT02273908|3525906|P1|Overall Study|Did not meet entrance criteria|3
1081864|NCT02273908|3525905|P2|Overall Study|Lost to Follow-up|1
1081865|NCT02273908|3525906|P1|Overall Study|Lost to Follow-up|10
1081866|NCT02273908|3525905|P2|Overall Study|Adverse Event|0
1081867|NCT02273908|3525906|P1|Overall Study|Adverse Event|16
1081868|NCT02273752|3525928|P1|Overall Study|Trial was terminated early|2
1081869|NCT02273180|3525972|P2|Overall Study|Other than specified above|10
1081870|NCT02273180|3525973|P1|Overall Study|Other than specified above|21
1081871|NCT02273180|3525972|P2|Overall Study|Hypoglycemia(not reported as serious AE)|0
1081872|NCT02273180|3525973|P1|Overall Study|Hypoglycemia(not reported as serious AE)|1
1081873|NCT02273180|3525972|P2|Overall Study|Randomized but not treated|0
1081874|NCT02273180|3525973|P1|Overall Study|Randomized but not treated|1
1081875|NCT02273180|3525972|P2|Overall Study|Protocol Violation|7
1081876|NCT02273180|3525973|P1|Overall Study|Protocol Violation|1
1081877|NCT02273180|3525972|P2|Overall Study|Lack of Efficacy|0
1081878|NCT02273180|3525973|P1|Overall Study|Lack of Efficacy|1
1081879|NCT02273180|3525972|P2|Overall Study|Adverse Event|2
1081880|NCT02273180|3525973|P1|Overall Study|Adverse Event|2
1081881|NCT02273167|3525998|P3|Overall Study|Various|8
1081882|NCT02273167|3525999|P2|Overall Study|Various|9
1081883|NCT02273167|3526000|P1|Overall Study|Various|10
1081884|NCT02273167|3525998|P3|Overall Study|Withdrawal by Subject|11
1081885|NCT02273167|3525999|P2|Overall Study|Withdrawal by Subject|12
1081886|NCT02273167|3526000|P1|Overall Study|Withdrawal by Subject|10
1081887|NCT02273167|3525998|P3|Overall Study|Lost to Follow-up|1
1081888|NCT02273167|3525999|P2|Overall Study|Lost to Follow-up|1
1081889|NCT02273167|3526000|P1|Overall Study|Lost to Follow-up|0
1081890|NCT02273167|3525998|P3|Overall Study|Protocol Violation|1
1081891|NCT02273167|3525999|P2|Overall Study|Protocol Violation|1
1081892|NCT02273167|3526000|P1|Overall Study|Protocol Violation|3
1081893|NCT02273167|3525998|P3|Overall Study|Adverse Event|0
1081894|NCT02273167|3525999|P2|Overall Study|Adverse Event|0
1081895|NCT02273167|3526000|P1|Overall Study|Adverse Event|1
1081896|NCT02273141|3526025|P2|Overall Study|Various|6
1081897|NCT02273141|3526026|P1|Overall Study|Various|6
1081898|NCT02273141|3526025|P2|Overall Study|Withdrawal by Subject|15
1081899|NCT02273141|3526026|P1|Overall Study|Withdrawal by Subject|10
1081900|NCT02273141|3526025|P2|Overall Study|Lost to Follow-up|3
1081901|NCT02273141|3526026|P1|Overall Study|Lost to Follow-up|1
1081902|NCT02273141|3526025|P2|Overall Study|Adverse Event|1
1081903|NCT02273141|3526026|P1|Overall Study|Adverse Event|0
1081904|NCT02273050|3526099|P3|Overall Study|Protocol Violation|4
1081905|NCT02273050|3526100|P2|Overall Study|Protocol Violation|1
1081906|NCT02273050|3526101|P1|Overall Study|Protocol Violation|3
1081907|NCT02273050|3526099|P3|Overall Study|Lost to Follow-up|3
1081908|NCT02273050|3526100|P2|Overall Study|Lost to Follow-up|2
1081909|NCT02273050|3526101|P1|Overall Study|Lost to Follow-up|0
1081910|NCT02273050|3526099|P3|Overall Study|Withdrawal by Subject|16
1081911|NCT02273050|3526100|P2|Overall Study|Withdrawal by Subject|14
1081912|NCT02273050|3526101|P1|Overall Study|Withdrawal by Subject|17
1081913|NCT02273050|3526099|P3|Overall Study|Lack of Efficacy|1
1081914|NCT02273050|3526100|P2|Overall Study|Lack of Efficacy|1
1081915|NCT02273050|3526101|P1|Overall Study|Lack of Efficacy|0
1081916|NCT02273050|3526099|P3|Overall Study|Dev. of study spec. withdrawal criteria|1
1081917|NCT02273050|3526100|P2|Overall Study|Dev. of study spec. withdrawal criteria|1
1081918|NCT02273050|3526101|P1|Overall Study|Dev. of study spec. withdrawal criteria|0
1081919|NCT02273050|3526099|P3|Overall Study|Death|1
1081920|NCT02273050|3526100|P2|Overall Study|Death|0
1081921|NCT02273050|3526101|P1|Overall Study|Death|0
1081922|NCT02273050|3526099|P3|Overall Study|Adverse Event|3
1081923|NCT02273050|3526100|P2|Overall Study|Adverse Event|3
1081924|NCT02273050|3526101|P1|Overall Study|Adverse Event|4
1081925|NCT02273037|3526129|P2|Overall Study|Other complication|0
1081926|NCT02273037|3526130|P1|Overall Study|Other complication|2
1081927|NCT02273037|3526129|P2|Overall Study|Multiple delivery|2
1081928|NCT02273037|3526130|P1|Overall Study|Multiple delivery|2
1081929|NCT02273037|3526129|P2|Overall Study|Breech delivery|3
1081930|NCT02273037|3526130|P1|Overall Study|Breech delivery|2
1081931|NCT02273037|3526129|P2|Overall Study|Delivered before monitoring initiated|3
1081932|NCT02273037|3526130|P1|Overall Study|Delivered before monitoring initiated|1
1081933|NCT02273037|3526129|P2|Overall Study|Lost to Follow-up|0
1081934|NCT02273037|3526130|P1|Overall Study|Lost to Follow-up|1
1081935|NCT02272803|3526142|P2|Overall Study|Withdrawal by Subject|0
1081936|NCT02272803|3526143|P1|Overall Study|Withdrawal by Subject|1
1081937|NCT02272803|3526142|P2|Overall Study|Poor/non-compliance|1
1081938|NCT02272803|3526143|P1|Overall Study|Poor/non-compliance|0
1081939|NCT02272803|3526142|P2|Overall Study|Subject moved to care facility|1
1081940|NCT02272803|3526143|P1|Overall Study|Subject moved to care facility|0
1081941|NCT02272803|3526142|P2|Overall Study|Maximum clinical benefit|1
1081942|NCT02272803|3526143|P1|Overall Study|Maximum clinical benefit|1
1081943|NCT02272803|3526142|P2|Overall Study|Subj request to discontinue study trt|4
1081944|NCT02272803|3526143|P1|Overall Study|Subj request to discontinue study trt|1
1081945|NCT02272803|3526142|P2|Overall Study|Study drug toxicity|4
1081946|NCT02272803|3526143|P1|Overall Study|Study drug toxicity|1
1081947|NCT02272803|3526142|P2|Overall Study|Adverse Event unrelated to study drug|4
1081948|NCT02272803|3526143|P1|Overall Study|Adverse Event unrelated to study drug|1
1081949|NCT02272803|3526142|P2|Overall Study|Disease progression|2
1081950|NCT02272803|3526143|P1|Overall Study|Disease progression|4
1081951|NCT02272725|3526156|P2|Overall Study|equipment malfunction|0
1081952|NCT02272725|3526157|P1|Overall Study|equipment malfunction|2
1081953|NCT02271984|3526172|P12|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1081954|NCT02271984|3526173|P11|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1081955|NCT02271984|3526174|P10|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1081956|NCT02271984|3526175|P9|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1081957|NCT02271984|3526176|P8|Washout Period 4 (7 Days)|Withdrawal by Subject|1
1081958|NCT02271984|3526177|P7|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1081959|NCT02271984|3526178|P6|Washout Period 4 (7 Days)|Withdrawal by Subject|1
1081960|NCT02271984|3526179|P5|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1081961|NCT02271984|3526180|P4|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1081962|NCT02271984|3526181|P3|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1081963|NCT02271984|3526182|P2|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1081964|NCT02271984|3526183|P1|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1081965|NCT02271945|3526272|P2|Overall Study|Other|1
1081966|NCT02271945|3526273|P1|Overall Study|Other|1
1081967|NCT02271945|3526272|P2|Overall Study|Withdrawal by Subject|1
1081968|NCT02271945|3526273|P1|Overall Study|Withdrawal by Subject|1
1081969|NCT02271945|3526272|P2|Overall Study|Death|3
1081970|NCT02271945|3526273|P1|Overall Study|Death|3
1081971|NCT02271880|3526311|P2|Overall Study|Premature discontinuation of study|4
1081972|NCT02271880|3526312|P1|Overall Study|Premature discontinuation of study|3
1081973|NCT02271854|3526318|P1|Overall Study|Lost to Follow-up|1
1081974|NCT02271854|3526318|P1|Overall Study|Unable or unwilling to cooperate with st|1
1081975|NCT02271854|3526318|P1|Overall Study|Withdrawal by Subject|2
1081976|NCT02271529|3526358|P1|Overall Study|Withdrawal by Subject|1
1081977|NCT02270944|3526395|P2|Overall Study|Withdrawal by Subject|1
1081978|NCT02270944|3526396|P1|Overall Study|Withdrawal by Subject|2
1081979|NCT02270944|3526395|P2|Overall Study|Lost to Follow-up|4
1081980|NCT02270944|3526396|P1|Overall Study|Lost to Follow-up|9
1081981|NCT02270684|3526412|P2|Overall Study|Study terminated|0
1081982|NCT02270684|3526413|P1|Overall Study|Study terminated|1
1081983|NCT02270684|3526412|P2|Overall Study|Lost to Follow-up|3
1081984|NCT02270684|3526413|P1|Overall Study|Lost to Follow-up|0
1081985|NCT02270671|3526421|P2|Overall Study|Lost to Follow-up|1
1081986|NCT02270671|3526422|P1|Overall Study|Lost to Follow-up|2
1081987|NCT02270671|3526421|P2|Overall Study|Missed Post-intervention Data Collection|2
1081988|NCT02270671|3526422|P1|Overall Study|Missed Post-intervention Data Collection|2
1081989|NCT02270671|3526421|P2|Overall Study|Protocol Violation|1
1081990|NCT02270671|3526422|P1|Overall Study|Protocol Violation|0
1081991|NCT02270671|3526421|P2|Overall Study|Withdrawal by Subject|1
1081992|NCT02270671|3526422|P1|Overall Study|Withdrawal by Subject|1
1081993|NCT02270515|3526447|P1|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16
1081994|NCT02270515|3526447|P1|Intervention Period 3: 12-18 Months|Death|3
1081995|NCT02270515|3526447|P1|Intervention Period 3: 12-18 Months|Received transplant|2
1081996|NCT02270515|3526447|P1|Intervention Period 3: 12-18 Months|No longer patient at study site|2
1081997|NCT02270515|3526447|P1|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1
1081998|NCT02270515|3526447|P1|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17
1081999|NCT02270515|3526447|P1|Intervention Period 2: 6-12 Months|Death|5
1082000|NCT02270515|3526447|P1|Intervention Period 2: 6-12 Months|Received transplant|1
1082001|NCT02270515|3526447|P1|Intervention Period 2: 6-12 Months|No longer patient at study site|7
1082002|NCT02270515|3526447|P1|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2
1082003|NCT02270515|3526447|P1|Intervention Period 1: 0-6 Months|Death|7
1082004|NCT02270515|3526447|P1|Intervention Period 1: 0-6 Months|Received transplant|3
1082005|NCT02270515|3526447|P1|Intervention Period 1: 0-6 Months|No longer patient at study site|5
1082006|NCT02270515|3526447|P1|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1
1082007|NCT02269943|3526464|P2|Follow-Up Survival Period|Alive|8
1082008|NCT02269943|3526465|P1|Follow-Up Survival Period|Alive|2
1082009|NCT02269943|3526464|P2|Follow-Up Survival Period|Lost to Follow-up|2
1082010|NCT02269943|3526465|P1|Follow-Up Survival Period|Lost to Follow-up|0
1082011|NCT02269943|3526464|P2|Follow-Up Survival Period|Death|16
1082012|NCT02269943|3526465|P1|Follow-Up Survival Period|Death|3
1082013|NCT02269943|3526464|P2|Treatment Period|Symptomatic Deterioration|2
1082014|NCT02269943|3526465|P1|Treatment Period|Symptomatic Deterioration|0
1082015|NCT02269943|3526464|P2|Treatment Period|Progressive Disease|17
1082016|NCT02269943|3526465|P1|Treatment Period|Progressive Disease|5
1082017|NCT02269943|3526464|P2|Treatment Period|Adverse Event|10
1082018|NCT02269943|3526465|P1|Treatment Period|Adverse Event|1
1082019|NCT02269943|3526464|P2|Treatment Period|Death|1
1082020|NCT02269943|3526465|P1|Treatment Period|Death|0
1082021|NCT02269917|3526495|P2|Overall Study|Randomized but not treated|5
1082022|NCT02269917|3526496|P1|Overall Study|Randomized but not treated|3
1082023|NCT02269917|3526495|P2|Overall Study|Non-compliance with study drug|0
1082024|NCT02269917|3526496|P1|Overall Study|Non-compliance with study drug|2
1082025|NCT02269917|3526495|P2|Overall Study|Adverse Event|4
1082026|NCT02269917|3526496|P1|Overall Study|Adverse Event|11
1082027|NCT02269917|3526495|P2|Overall Study|Withdrawal by Subject|8
1082028|NCT02269917|3526496|P1|Overall Study|Withdrawal by Subject|9
1082029|NCT02269917|3526495|P2|Overall Study|Other|3
1082030|NCT02269917|3526496|P1|Overall Study|Other|6
1082031|NCT02269917|3526495|P2|Overall Study|Ongoing|360
1082032|NCT02269917|3526496|P1|Overall Study|Ongoing|731
1082033|NCT02269917|3526495|P2|Overall Study|Lost to Follow-up|3
1082034|NCT02269917|3526496|P1|Overall Study|Lost to Follow-up|4
1082035|NCT02269709|3526547|P1|Six Month Follow-up|Lost to Follow-up|12
1082036|NCT02269709|3526547|P1|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1
1082037|NCT02269709|3526547|P1|Time of Enrollment|Withdrawal by Subject|3
1082038|NCT02269657|3526552|P1|Overall Study|Protocol Violation|3
1082039|NCT02269475|3526572|P2|Overall Study|Withdrawal by Subject|1
1082040|NCT02269475|3526573|P1|Overall Study|Withdrawal by Subject|0
1082041|NCT02269475|3526572|P2|Overall Study|Meet Exclusion Criteria No. 17|0
1082042|NCT02269475|3526573|P1|Overall Study|Meet Exclusion Criteria No. 17|3
1082043|NCT02269098|3526586|P2|Overall Study|Lost to Follow-up|9
1082044|NCT02269098|3526587|P1|Overall Study|Lost to Follow-up|14
1082045|NCT02268864|3526634|P3|Overall Study|Death|0
1082046|NCT02268864|3526635|P2|Overall Study|Death|1
1082047|NCT02268864|3526636|P1|Overall Study|Death|0
1082048|NCT02268864|3526634|P3|Overall Study|Withdrawal by Subject|0
1082049|NCT02268864|3526635|P2|Overall Study|Withdrawal by Subject|0
1082050|NCT02268864|3526636|P1|Overall Study|Withdrawal by Subject|2
1082051|NCT02268812|3526662|P4|Overall Study|Not specified|3
1082052|NCT02268812|3526663|P3|Overall Study|Not specified|1
1082053|NCT02268812|3526664|P2|Overall Study|Not specified|4
1082054|NCT02268812|3526665|P1|Overall Study|Not specified|5
1082055|NCT02268812|3526662|P4|Overall Study|Physician Decision|1
1082056|NCT02268812|3526663|P3|Overall Study|Physician Decision|0
1082057|NCT02268812|3526664|P2|Overall Study|Physician Decision|1
1082058|NCT02268812|3526665|P1|Overall Study|Physician Decision|3
1082059|NCT02268812|3526662|P4|Overall Study|Withdrawal by Subject|0
1082060|NCT02268812|3526663|P3|Overall Study|Withdrawal by Subject|0
1082061|NCT02268812|3526664|P2|Overall Study|Withdrawal by Subject|1
1082062|NCT02268812|3526665|P1|Overall Study|Withdrawal by Subject|0
1082063|NCT02268812|3526662|P4|Overall Study|Protocol deviation|0
1082064|NCT02268812|3526663|P3|Overall Study|Protocol deviation|1
1082065|NCT02268812|3526664|P2|Overall Study|Protocol deviation|0
1082066|NCT02268812|3526665|P1|Overall Study|Protocol deviation|0
1082067|NCT02268812|3526662|P4|Overall Study|Adverse Event|10
1082068|NCT02268812|3526663|P3|Overall Study|Adverse Event|7
1082069|NCT02268812|3526664|P2|Overall Study|Adverse Event|26
1082070|NCT02268812|3526665|P1|Overall Study|Adverse Event|8
1082071|NCT02268526|3526698|P3|Overall Study|Subject/guardian decision|3
1082072|NCT02268526|3526699|P2|Overall Study|Subject/guardian decision|7
1082073|NCT02268526|3526700|P1|Overall Study|Subject/guardian decision|0
1082074|NCT02268526|3526698|P3|Overall Study|Physician Decision|1
1082075|NCT02268526|3526699|P2|Overall Study|Physician Decision|0
1082076|NCT02268526|3526700|P1|Overall Study|Physician Decision|0
1082077|NCT02268526|3526698|P3|Overall Study|protocol deviation|0
1082078|NCT02268526|3526699|P2|Overall Study|protocol deviation|1
1082079|NCT02268526|3526700|P1|Overall Study|protocol deviation|0
1082080|NCT02268526|3526698|P3|Overall Study|Death|0
1082081|NCT02268526|3526699|P2|Overall Study|Death|11
1082082|NCT02268526|3526700|P1|Overall Study|Death|1
1082083|NCT02268526|3526698|P3|Overall Study|Adverse Event|1
1082084|NCT02268526|3526699|P2|Overall Study|Adverse Event|2
1082085|NCT02268526|3526700|P1|Overall Study|Adverse Event|0
1082086|NCT02268396|3526721|P1|Overall Study|2 Subjects no Day 29 Assessment|2
1082087|NCT02268396|3526721|P1|Overall Study|Protocol-Specified Criteria|2
1082088|NCT02268396|3526721|P1|Overall Study|Lost to Follow-up|2
1082089|NCT02268396|3526721|P1|Overall Study|Withdrawal by Subject|1
1082090|NCT02268396|3526721|P1|Overall Study|Administrative|2
1082091|NCT02268396|3526721|P1|Overall Study|Adverse Event|3
1082092|NCT02268214|3526733|P3|Overall Study|Not entering long-term period|5
1082093|NCT02268214|3526734|P2|Overall Study|Not entering long-term period|3
1082094|NCT02268214|3526735|P1|Overall Study|Not entering long-term period|2
1082095|NCT02268214|3526733|P3|Overall Study|Other reasons|3
1082096|NCT02268214|3526734|P2|Overall Study|Other reasons|3
1082097|NCT02268214|3526735|P1|Overall Study|Other reasons|7
1082098|NCT02268214|3526733|P3|Overall Study|Poor/non-compliance|2
1082099|NCT02268214|3526734|P2|Overall Study|Poor/non-compliance|1
1082100|NCT02268214|3526735|P1|Overall Study|Poor/non-compliance|2
1082101|NCT02268214|3526733|P3|Overall Study|Subject request to discontinue treatment|6
1082102|NCT02268214|3526734|P2|Overall Study|Subject request to discontinue treatment|8
1082103|NCT02268214|3526735|P1|Overall Study|Subject request to discontinue treatment|10
1082104|NCT02268214|3526733|P3|Overall Study|Withdrawal by Subject|10
1082105|NCT02268214|3526734|P2|Overall Study|Withdrawal by Subject|5
1082106|NCT02268214|3526735|P1|Overall Study|Withdrawal by Subject|4
1082107|NCT02268214|3526733|P3|Overall Study|Adverse Event|9
1082108|NCT02268214|3526734|P2|Overall Study|Adverse Event|14
1082109|NCT02268214|3526735|P1|Overall Study|Adverse Event|11
1082110|NCT02268214|3526733|P3|Overall Study|Lack of Efficacy|2
1082111|NCT02268214|3526734|P2|Overall Study|Lack of Efficacy|0
1082112|NCT02268214|3526735|P1|Overall Study|Lack of Efficacy|1
1082113|NCT02268214|3526733|P3|Overall Study|Lost to Follow-up|4
1082114|NCT02268214|3526734|P2|Overall Study|Lost to Follow-up|3
1082115|NCT02268214|3526735|P1|Overall Study|Lost to Follow-up|3
1082116|NCT02268214|3526733|P3|Overall Study|Pregnancy|1
1082117|NCT02268214|3526734|P2|Overall Study|Pregnancy|2
1082118|NCT02268214|3526735|P1|Overall Study|Pregnancy|2
1082119|NCT02268214|3526733|P3|Overall Study|Subject no longer meets study criteria|0
1082120|NCT02268214|3526734|P2|Overall Study|Subject no longer meets study criteria|2
1082121|NCT02268214|3526735|P1|Overall Study|Subject no longer meets study criteria|0
1082122|NCT02268058|3526765|P4|Overall Study|Protocol Violation|0
1082123|NCT02268058|3526766|P3|Overall Study|Protocol Violation|0
1082124|NCT02268058|3526767|P2|Overall Study|Protocol Violation|0
1082125|NCT02268058|3526768|P1|Overall Study|Protocol Violation|1
1082126|NCT02267824|3526810|P2|Overall Study|Did Not Meet Initial Dental Criteria|0
1082127|NCT02267824|3526811|P1|Overall Study|Did Not Meet Initial Dental Criteria|2
1082128|NCT02267824|3526810|P2|Overall Study|Protocol Violation|0
1082129|NCT02267824|3526811|P1|Overall Study|Protocol Violation|3
1082130|NCT02267824|3526810|P2|Overall Study|Lost to Follow-up|0
1082131|NCT02267824|3526811|P1|Overall Study|Lost to Follow-up|4
1082132|NCT02267824|3526810|P2|Overall Study|Pregnancy|1
1082133|NCT02267824|3526811|P1|Overall Study|Pregnancy|1
1082134|NCT02267187|3526854|P1|Overall Study|Screen fail|3
1082135|NCT02267187|3526854|P1|Overall Study|Physician Decision|2
1082136|NCT02267135|3526862|P2|Period 2 (Randomized Set)|Withdrawal by Subject|0
1082137|NCT02267135|3526863|P1|Period 2 (Randomized Set)|Withdrawal by Subject|1
1082138|NCT02267135|3526862|P2|Period 2 (Randomized Set)|Adverse Event|0
1082139|NCT02267135|3526863|P1|Period 2 (Randomized Set)|Adverse Event|2
1082140|NCT02267135|3526862|P2|Period 2 (Randomized Set)|Lost to Follow-up|1
1082141|NCT02267135|3526863|P1|Period 2 (Randomized Set)|Lost to Follow-up|1
1082142|NCT02267135|3526862|P2|Period 1 (Randomized Set)|Lost to Follow-up|1
1082143|NCT02267135|3526863|P1|Period 1 (Randomized Set)|Lost to Follow-up|0
1082144|NCT02267135|3526862|P2|Period 1 (Randomized Set)|Withdrawal by Subject|3
1082145|NCT02267135|3526863|P1|Period 1 (Randomized Set)|Withdrawal by Subject|1
1082146|NCT02266875|3526903|P2|Overall Study|Lost to Follow-up|0
1082147|NCT02266875|3526904|P1|Overall Study|Lost to Follow-up|2
1082148|NCT02266875|3526903|P2|Overall Study|Withdrawal by Subject|0
1082149|NCT02266875|3526904|P1|Overall Study|Withdrawal by Subject|9
1082150|NCT02266381|3526982|P3|Overall Study|Physician Decision|4
1082151|NCT02266381|3526983|P2|Overall Study|Physician Decision|5
1082152|NCT02266381|3526984|P1|Overall Study|Physician Decision|3
1082153|NCT02265796|3527051|P2|Overall Study|Withdrawal by Subject|1
1082154|NCT02265796|3527052|P1|Overall Study|Withdrawal by Subject|1
1082155|NCT02265796|3527051|P2|Overall Study|started on excluded medication|0
1082156|NCT02265796|3527052|P1|Overall Study|started on excluded medication|1
1082157|NCT02265796|3527051|P2|Overall Study|Death|0
1082158|NCT02265796|3527052|P1|Overall Study|Death|1
1082159|NCT02265237|3527070|P4|As Treated (Overall Study)|Other|1
1082160|NCT02265237|3527071|P3|As Treated (Overall Study)|Other|3
1082161|NCT02265237|3527072|P2|As Treated (Overall Study)|Other|0
1082162|NCT02265237|3527073|P1|As Treated (Overall Study)|Other|2
1082163|NCT02265237|3527070|P4|As Treated (Overall Study)|Lost to Follow-up|0
1082164|NCT02265237|3527071|P3|As Treated (Overall Study)|Lost to Follow-up|6
1082165|NCT02265237|3527072|P2|As Treated (Overall Study)|Lost to Follow-up|2
1082166|NCT02265237|3527073|P1|As Treated (Overall Study)|Lost to Follow-up|1
1082167|NCT02265237|3527070|P4|As Treated (Overall Study)|Withdrawal by Subject|0
1082168|NCT02265237|3527071|P3|As Treated (Overall Study)|Withdrawal by Subject|1
1082169|NCT02265237|3527072|P2|As Treated (Overall Study)|Withdrawal by Subject|0
1082170|NCT02265237|3527073|P1|As Treated (Overall Study)|Withdrawal by Subject|1
1082171|NCT02265237|3527070|P4|As Treated (Overall Study)|Adverse Event|0
1082172|NCT02265237|3527071|P3|As Treated (Overall Study)|Adverse Event|0
1082173|NCT02265237|3527072|P2|As Treated (Overall Study)|Adverse Event|1
1082174|NCT02265237|3527073|P1|As Treated (Overall Study)|Adverse Event|1
1082175|NCT02264821|3527103|P3|Overall Study|Protocol Violation|6
1082176|NCT02264821|3527104|P2|Overall Study|Protocol Violation|3
1082177|NCT02264821|3527105|P1|Overall Study|Protocol Violation|1
1082178|NCT02263365|3527167|P2|Overall Study|Physician Decision|18
1082179|NCT02263365|3527168|P1|Overall Study|Physician Decision|22
1082180|NCT02263326|3527182|P2|Overall Study|Lost to Follow-up|1
1082181|NCT02263326|3527183|P1|Overall Study|Lost to Follow-up|1
1082182|NCT02262754|3527244|P3|Overall Study|Other|2
1082183|NCT02262754|3527245|P2|Overall Study|Other|0
1082184|NCT02262754|3527246|P1|Overall Study|Other|4
1082185|NCT02262754|3527244|P3|Overall Study|Withdrawal by Subject|1
1082186|NCT02262754|3527245|P2|Overall Study|Withdrawal by Subject|0
1082187|NCT02262754|3527246|P1|Overall Study|Withdrawal by Subject|1
1082188|NCT02262754|3527244|P3|Overall Study|Protocol Violation|0
1082189|NCT02262754|3527245|P2|Overall Study|Protocol Violation|0
1082190|NCT02262754|3527246|P1|Overall Study|Protocol Violation|1
1082191|NCT02262754|3527244|P3|Overall Study|Study terminated by sponsor|4
1082192|NCT02262754|3527245|P2|Overall Study|Study terminated by sponsor|4
1082193|NCT02262754|3527246|P1|Overall Study|Study terminated by sponsor|5
1082194|NCT02262754|3527244|P3|Overall Study|No longer meets eligibility criteria|0
1082195|NCT02262754|3527245|P2|Overall Study|No longer meets eligibility criteria|1
1082196|NCT02262754|3527246|P1|Overall Study|No longer meets eligibility criteria|0
1082197|NCT02262754|3527244|P3|Overall Study|Lost to Follow-up|1
1082198|NCT02262754|3527245|P2|Overall Study|Lost to Follow-up|0
1082199|NCT02262754|3527246|P1|Overall Study|Lost to Follow-up|0
1082200|NCT02262754|3527244|P3|Overall Study|Lack of Efficacy|1
1082201|NCT02262754|3527245|P2|Overall Study|Lack of Efficacy|0
1082202|NCT02262754|3527246|P1|Overall Study|Lack of Efficacy|2
1082203|NCT02262754|3527244|P3|Overall Study|Adverse Event|0
1082204|NCT02262754|3527245|P2|Overall Study|Adverse Event|4
1082205|NCT02262754|3527246|P1|Overall Study|Adverse Event|3
1082206|NCT02261974|3527390|P2|Overall Study|Adverse Event|0
1082207|NCT02261974|3527391|P1|Overall Study|Adverse Event|1
1082208|NCT02261974|3527390|P2|Overall Study|Lost to Follow-up|0
1082209|NCT02261974|3527391|P1|Overall Study|Lost to Follow-up|2
1082210|NCT02261974|3527390|P2|Overall Study|Received partial treatment; FU to 1 mo|1
1082211|NCT02261974|3527391|P1|Overall Study|Received partial treatment; FU to 1 mo|3
1082212|NCT02261974|3527390|P2|Overall Study|Missed treatment cut-off date|3
1082213|NCT02261974|3527391|P1|Overall Study|Missed treatment cut-off date|6
1082214|NCT02261974|3527390|P2|Overall Study|Pregnancy|1
1082215|NCT02261974|3527391|P1|Overall Study|Pregnancy|0
1082216|NCT02261974|3527390|P2|Overall Study|Withdrawal by Subject|2
1082217|NCT02261974|3527391|P1|Overall Study|Withdrawal by Subject|3
1082218|NCT02261493|3527435|P3|Overall Study|Adverse Event|0
1082219|NCT02261493|3527436|P2|Overall Study|Adverse Event|1
1082220|NCT02261493|3527437|P1|Overall Study|Adverse Event|0
1082221|NCT02261493|3527435|P3|Overall Study|Lack of Efficacy|0
1082222|NCT02261493|3527436|P2|Overall Study|Lack of Efficacy|1
1082223|NCT02261493|3527437|P1|Overall Study|Lack of Efficacy|0
1082224|NCT02261493|3527435|P3|Overall Study|Pregnancy|0
1082225|NCT02261493|3527436|P2|Overall Study|Pregnancy|2
1082226|NCT02261493|3527437|P1|Overall Study|Pregnancy|1
1082227|NCT02261493|3527435|P3|Overall Study|Lost to Follow-up|8
1082228|NCT02261493|3527436|P2|Overall Study|Lost to Follow-up|27
1082229|NCT02261493|3527437|P1|Overall Study|Lost to Follow-up|14
1082230|NCT02261493|3527435|P3|Overall Study|Personal Reasons|16
1082231|NCT02261493|3527436|P2|Overall Study|Personal Reasons|14
1082232|NCT02261493|3527437|P1|Overall Study|Personal Reasons|14
1082233|NCT02261493|3527435|P3|Overall Study|Protocol Violation|0
1082234|NCT02261493|3527436|P2|Overall Study|Protocol Violation|0
1082235|NCT02261493|3527437|P1|Overall Study|Protocol Violation|1
1082236|NCT02261493|3527435|P3|Overall Study|Undisclosed alcohol abuse|0
1082237|NCT02261493|3527436|P2|Overall Study|Undisclosed alcohol abuse|1
1082238|NCT02261493|3527437|P1|Overall Study|Undisclosed alcohol abuse|0
1082239|NCT02261493|3527435|P3|Overall Study|Physician Decision|0
1082240|NCT02261493|3527436|P2|Overall Study|Physician Decision|1
1082241|NCT02261493|3527437|P1|Overall Study|Physician Decision|0
1082242|NCT02261493|3527435|P3|Overall Study|Noncompliance|2
1082243|NCT02261493|3527436|P2|Overall Study|Noncompliance|0
1082244|NCT02261493|3527437|P1|Overall Study|Noncompliance|0
1082245|NCT02261467|3527465|P2|Overall Study|Adverse Event|1
1082246|NCT02261467|3527466|P1|Overall Study|Adverse Event|1
1082247|NCT02261467|3527465|P2|Overall Study|Lost to Follow-up|13
1082248|NCT02261467|3527466|P1|Overall Study|Lost to Follow-up|2
1082249|NCT02261467|3527465|P2|Overall Study|Personal Reasons|22
1082250|NCT02261467|3527466|P1|Overall Study|Personal Reasons|17
1082251|NCT02261467|3527465|P2|Overall Study|Protocol Violation|1
1082252|NCT02261467|3527466|P1|Overall Study|Protocol Violation|0
1082253|NCT02261467|3527465|P2|Overall Study|Enrolled in Error|0
1082254|NCT02261467|3527466|P1|Overall Study|Enrolled in Error|1
1082255|NCT02260986|3527508|P3|Overall Study|Pregnancy|0
1082256|NCT02260986|3527509|P2|Overall Study|Pregnancy|0
1082257|NCT02260986|3527510|P1|Overall Study|Pregnancy|2
1082258|NCT02260986|3527508|P3|Overall Study|Lost to Follow-up|3
1082259|NCT02260986|3527509|P2|Overall Study|Lost to Follow-up|0
1082260|NCT02260986|3527510|P1|Overall Study|Lost to Follow-up|4
1082261|NCT02260986|3527508|P3|Overall Study|Lack of investigation product supply|1
1082262|NCT02260986|3527509|P2|Overall Study|Lack of investigation product supply|0
1082263|NCT02260986|3527510|P1|Overall Study|Lack of investigation product supply|2
1082264|NCT02260986|3527508|P3|Overall Study|Incorrect randomization|0
1082265|NCT02260986|3527509|P2|Overall Study|Incorrect randomization|1
1082266|NCT02260986|3527510|P1|Overall Study|Incorrect randomization|0
1082267|NCT02260986|3527508|P3|Overall Study|Withdrawal by Subject|9
1082268|NCT02260986|3527509|P2|Overall Study|Withdrawal by Subject|4
1082269|NCT02260986|3527510|P1|Overall Study|Withdrawal by Subject|17
1082270|NCT02260986|3527508|P3|Overall Study|Car accident|1
1082271|NCT02260986|3527509|P2|Overall Study|Car accident|0
1082272|NCT02260986|3527510|P1|Overall Study|Car accident|0
1082273|NCT02260986|3527508|P3|Overall Study|Protocol Violation|16
1082274|NCT02260986|3527509|P2|Overall Study|Protocol Violation|5
1082275|NCT02260986|3527510|P1|Overall Study|Protocol Violation|14
1082276|NCT02260986|3527508|P3|Overall Study|Lack of Efficacy|0
1082277|NCT02260986|3527509|P2|Overall Study|Lack of Efficacy|3
1082278|NCT02260986|3527510|P1|Overall Study|Lack of Efficacy|27
1082279|NCT02260986|3527508|P3|Overall Study|Adverse Event|11
1082280|NCT02260986|3527509|P2|Overall Study|Adverse Event|0
1082281|NCT02260986|3527510|P1|Overall Study|Adverse Event|24
1082282|NCT02260882|3527628|P2|Overall Study|Protocol Violation|1
1082283|NCT02260882|3527629|P1|Overall Study|Protocol Violation|0
1082284|NCT02260791|3527653|P2|Overall Study|Protocol deviation|3
1082285|NCT02260791|3527654|P1|Overall Study|Protocol deviation|2
1082286|NCT02260791|3527653|P2|Overall Study|Screen failure|1
1082287|NCT02260791|3527654|P1|Overall Study|Screen failure|0
1082288|NCT02260791|3527653|P2|Overall Study|Withdrawal by Subject|16
1082289|NCT02260791|3527654|P1|Overall Study|Withdrawal by Subject|11
1082290|NCT02260791|3527653|P2|Overall Study|Death|0
1082291|NCT02260791|3527654|P1|Overall Study|Death|1
1082292|NCT02260791|3527653|P2|Overall Study|Adverse Event|9
1082293|NCT02260791|3527654|P1|Overall Study|Adverse Event|13
1082294|NCT02260791|3527653|P2|Overall Study|Lack of Efficacy|1
1082295|NCT02260791|3527654|P1|Overall Study|Lack of Efficacy|2
1082296|NCT02260791|3527653|P2|Overall Study|Lost to Follow-up|4
1082297|NCT02260791|3527654|P1|Overall Study|Lost to Follow-up|4
1082298|NCT02260648|3527693|P3|Overall Study|Discontinue Due to Study Termination|7
1082299|NCT02260648|3527694|P2|Overall Study|Discontinue Due to Study Termination|12
1082300|NCT02260648|3527695|P1|Overall Study|Discontinue Due to Study Termination|13
1082301|NCT02260648|3527693|P3|Overall Study|Protocol Violation|0
1082302|NCT02260648|3527694|P2|Overall Study|Protocol Violation|0
1082303|NCT02260648|3527695|P1|Overall Study|Protocol Violation|1
1082304|NCT02260648|3527693|P3|Overall Study|Withdrawal by Subject|0
1082305|NCT02260648|3527694|P2|Overall Study|Withdrawal by Subject|1
1082306|NCT02260648|3527695|P1|Overall Study|Withdrawal by Subject|1
1082307|NCT02260648|3527693|P3|Overall Study|Adverse Event|1
1082308|NCT02260648|3527694|P2|Overall Study|Adverse Event|0
1082309|NCT02260648|3527695|P1|Overall Study|Adverse Event|3
1082310|NCT02260635|3527723|P2|Open-Label Extension|Withdrawal by Subject|0
1082311|NCT02260635|3527724|P1|Open-Label Extension|Withdrawal by Subject|1
1082312|NCT02260635|3527723|P2|Open-Label Extension|Study Termination|25
1082313|NCT02260635|3527724|P1|Open-Label Extension|Study Termination|25
1082314|NCT02260635|3527723|P2|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2
1082315|NCT02260635|3527724|P1|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1
1082316|NCT02260492|3527747|P3|Overall Study|Withdrawal by Subject|2
1082317|NCT02260492|3527748|P2|Overall Study|Withdrawal by Subject|2
1082318|NCT02260492|3527749|P1|Overall Study|Withdrawal by Subject|3
1082319|NCT02260492|3527747|P3|Overall Study|Physician Decision|1
1082320|NCT02260492|3527748|P2|Overall Study|Physician Decision|0
1082321|NCT02260492|3527749|P1|Overall Study|Physician Decision|2
1082322|NCT02260492|3527747|P3|Overall Study|Lost to Follow-up|0
1082323|NCT02260492|3527748|P2|Overall Study|Lost to Follow-up|9
1082324|NCT02260492|3527749|P1|Overall Study|Lost to Follow-up|12
1082325|NCT02260492|3527747|P3|Overall Study|Death|0
1082326|NCT02260492|3527748|P2|Overall Study|Death|1
1082327|NCT02260492|3527749|P1|Overall Study|Death|0
1082328|NCT02260492|3527747|P3|Overall Study|Adverse Event|2
1082329|NCT02260492|3527748|P2|Overall Study|Adverse Event|1
1082330|NCT02260492|3527749|P1|Overall Study|Adverse Event|6
1082331|NCT02260388|3527782|P4|Overall Study|Lost to Follow-up|4
1082332|NCT02260388|3527783|P3|Overall Study|Lost to Follow-up|3
1082333|NCT02260388|3527784|P2|Overall Study|Lost to Follow-up|8
1082334|NCT02260388|3527785|P1|Overall Study|Lost to Follow-up|2
1082335|NCT02260180|3527814|P3|Overall Study|Adverse Event|1
1082336|NCT02260180|3527815|P2|Overall Study|Adverse Event|0
1082337|NCT02260180|3527816|P1|Overall Study|Adverse Event|2
1082338|NCT02259582|3527835|P3|Overall Study|Lack of Subject Adherence to Protocol|1
1082339|NCT02259582|3527836|P2|Overall Study|Lack of Subject Adherence to Protocol|1
1082340|NCT02259582|3527837|P1|Overall Study|Lack of Subject Adherence to Protocol|1
1082341|NCT02259582|3527835|P3|Overall Study|Disease progression|17
1082342|NCT02259582|3527836|P2|Overall Study|Disease progression|15
1082343|NCT02259582|3527837|P1|Overall Study|Disease progression|14
1082344|NCT02259582|3527835|P3|Overall Study|Withdrawal by Subject|1
1082345|NCT02259582|3527836|P2|Overall Study|Withdrawal by Subject|0
1082346|NCT02259582|3527837|P1|Overall Study|Withdrawal by Subject|0
1082347|NCT02259582|3527835|P3|Overall Study|Adverse Event|1
1082348|NCT02259582|3527836|P2|Overall Study|Adverse Event|0
1082349|NCT02259582|3527837|P1|Overall Study|Adverse Event|1
1082350|NCT02259582|3527835|P3|Overall Study|Death|1
1082351|NCT02259582|3527836|P2|Overall Study|Death|0
1082352|NCT02259582|3527837|P1|Overall Study|Death|0
1082353|NCT02259582|3527835|P3|Overall Study|Physician Decision|0
1082354|NCT02259582|3527836|P2|Overall Study|Physician Decision|1
1082355|NCT02259582|3527837|P1|Overall Study|Physician Decision|0
1082356|NCT02259400|3527847|P2|Overall Study|Death|2
1082357|NCT02259400|3527848|P1|Overall Study|Death|0
1082358|NCT02259348|3527880|P1|Overall Study|Death|4
1082359|NCT02259348|3527880|P1|Overall Study|Donors|6
1082360|NCT02259114|3527897|P5|Overall Study|Not Treated|0
1082361|NCT02259114|3527898|P4|Overall Study|Not Treated|0
1082362|NCT02259114|3527899|P3|Overall Study|Not Treated|0
1082363|NCT02259114|3527900|P2|Overall Study|Not Treated|0
1082364|NCT02259114|3527901|P1|Overall Study|Not Treated|1
1082365|NCT02259114|3527897|P5|Overall Study|Treatment Delay >2 wks: Toxicity|0
1082366|NCT02259114|3527898|P4|Overall Study|Treatment Delay >2 wks: Toxicity|0
1082367|NCT02259114|3527899|P3|Overall Study|Treatment Delay >2 wks: Toxicity|0
1082368|NCT02259114|3527900|P2|Overall Study|Treatment Delay >2 wks: Toxicity|1
1082369|NCT02259114|3527901|P1|Overall Study|Treatment Delay >2 wks: Toxicity|1
1082370|NCT02259114|3527897|P5|Overall Study|Withdrawal by Subject|0
1082371|NCT02259114|3527898|P4|Overall Study|Withdrawal by Subject|1
1082372|NCT02259114|3527899|P3|Overall Study|Withdrawal by Subject|1
1082373|NCT02259114|3527900|P2|Overall Study|Withdrawal by Subject|0
1082374|NCT02259114|3527901|P1|Overall Study|Withdrawal by Subject|0
1082375|NCT02259114|3527897|P5|Overall Study|Treatment Delay >2 wks: Adverse Event|0
1082376|NCT02259114|3527898|P4|Overall Study|Treatment Delay >2 wks: Adverse Event|0
1082377|NCT02259114|3527899|P3|Overall Study|Treatment Delay >2 wks: Adverse Event|1
1082378|NCT02259114|3527900|P2|Overall Study|Treatment Delay >2 wks: Adverse Event|0
1082379|NCT02259114|3527901|P1|Overall Study|Treatment Delay >2 wks: Adverse Event|0
1082380|NCT02259114|3527897|P5|Overall Study|Death|0
1082381|NCT02259114|3527898|P4|Overall Study|Death|0
1082382|NCT02259114|3527899|P3|Overall Study|Death|1
1082383|NCT02259114|3527900|P2|Overall Study|Death|0
1082384|NCT02259114|3527901|P1|Overall Study|Death|3
1082385|NCT02259114|3527897|P5|Overall Study|Adverse Event|1
1082386|NCT02259114|3527898|P4|Overall Study|Adverse Event|0
1082387|NCT02259114|3527899|P3|Overall Study|Adverse Event|0
1082388|NCT02259114|3527900|P2|Overall Study|Adverse Event|1
1082389|NCT02259114|3527901|P1|Overall Study|Adverse Event|2
1082390|NCT02259114|3527897|P5|Overall Study|Progressive Disease|5
1082391|NCT02259114|3527898|P4|Overall Study|Progressive Disease|2
1082392|NCT02259114|3527899|P3|Overall Study|Progressive Disease|10
1082393|NCT02259114|3527900|P2|Overall Study|Progressive Disease|2
1082394|NCT02259114|3527901|P1|Overall Study|Progressive Disease|14
1082395|NCT02258529|3527958|P1|Overall Study|Adverse Event|1
1082396|NCT02258529|3527958|P1|Overall Study|Study Terminated by Sponsor|9
1082397|NCT02258334|3528047|P4|Overall Study|Adverse Event|0
1082398|NCT02258334|3528048|P3|Overall Study|Adverse Event|0
1082399|NCT02258334|3528049|P2|Overall Study|Adverse Event|0
1082400|NCT02258334|3528050|P1|Overall Study|Adverse Event|1
1082401|NCT02257918|3528113|P3|Overall Study|Pregnancy|1
1082402|NCT02257918|3528114|P2|Overall Study|Pregnancy|0
1082403|NCT02257918|3528115|P1|Overall Study|Pregnancy|0
1082404|NCT02257918|3528113|P3|Overall Study|Withdrawal by Subject|1
1082405|NCT02257918|3528114|P2|Overall Study|Withdrawal by Subject|0
1082406|NCT02257918|3528115|P1|Overall Study|Withdrawal by Subject|0
1082407|NCT02257918|3528113|P3|Overall Study|Lost to Follow-up|0
1082408|NCT02257918|3528114|P2|Overall Study|Lost to Follow-up|1
1082409|NCT02257918|3528115|P1|Overall Study|Lost to Follow-up|4
1082410|NCT02257684|3528165|P1|Overall Study|Sponsor's Decision|1
1082411|NCT02257684|3528165|P1|Overall Study|Lack of Efficacy|1
1082412|NCT02257684|3528165|P1|Overall Study|Adverse Event|2
1082413|NCT02257385|3528175|P2|Overall Study|Withdrawal by Subject|4
1082414|NCT02257385|3528176|P1|Overall Study|Withdrawal by Subject|4
1082415|NCT02257385|3528175|P2|Overall Study|Lost to Follow-up|1
1082416|NCT02257385|3528176|P1|Overall Study|Lost to Follow-up|0
1082417|NCT02257385|3528175|P2|Overall Study|Protocol Violation|7
1082418|NCT02257385|3528176|P1|Overall Study|Protocol Violation|5
1082419|NCT02257385|3528175|P2|Overall Study|Lack of Efficacy|2
1082420|NCT02257385|3528176|P1|Overall Study|Lack of Efficacy|1
1082421|NCT02257385|3528175|P2|Overall Study|Adverse Event|8
1082422|NCT02257385|3528176|P1|Overall Study|Adverse Event|12
1082423|NCT02257372|3528186|P2|Overall Study|Withdrew consent|0
1082424|NCT02257372|3528187|P1|Overall Study|Withdrew consent|1
1082425|NCT02257372|3528186|P2|Overall Study|Lost to Follow-up|1
1082426|NCT02257372|3528187|P1|Overall Study|Lost to Follow-up|0
1082427|NCT02257372|3528186|P2|Overall Study|Protocol Violation|1
1082428|NCT02257372|3528187|P1|Overall Study|Protocol Violation|1
1082429|NCT02257372|3528186|P2|Overall Study|Lack of Efficacy|1
1082430|NCT02257372|3528187|P1|Overall Study|Lack of Efficacy|2
1082431|NCT02257372|3528186|P2|Overall Study|Adverse Event|7
1082432|NCT02257372|3528187|P1|Overall Study|Adverse Event|3
1082433|NCT02256982|3528197|P2|Overall Study|Disease Progression|1
1082434|NCT02256982|3528198|P1|Overall Study|Disease Progression|0
1082435|NCT02256969|3528207|P3|Overall Study|Screenfailed or withdrew|1
1082436|NCT02256969|3528208|P2|Overall Study|Screenfailed or withdrew|1
1082437|NCT02256969|3528209|P1|Overall Study|Screenfailed or withdrew|2
1082438|NCT02256891|3528228|P2|Overall Study|Equipment Malfunction|1
1082439|NCT02256891|3528229|P1|Overall Study|Equipment Malfunction|0
1082440|NCT02256891|3528228|P2|Overall Study|Screen Fail|4
1082441|NCT02256891|3528229|P1|Overall Study|Screen Fail|5
1082442|NCT02256891|3528228|P2|Overall Study|Physician Decision|3
1082443|NCT02256891|3528229|P1|Overall Study|Physician Decision|7
1082444|NCT02256891|3528228|P2|Overall Study|Lost to Follow-up|3
1082445|NCT02256891|3528229|P1|Overall Study|Lost to Follow-up|0
1082446|NCT02256891|3528228|P2|Overall Study|Death|2
1082447|NCT02256891|3528229|P1|Overall Study|Death|0
1082448|NCT02256553|3528253|P1|Period III|Adverse Event|3
1082449|NCT02256553|3528253|P1|Period II|Subject Moved|1
1082450|NCT02256553|3528253|P1|Period II|Adverse Event|1
1082451|NCT02256553|3528253|P1|Period I|Protocol Violation|1
1082452|NCT02256553|3528253|P1|Period I|Adverse Event|5
1082453|NCT02256488|3528266|P4|Overall Study|Withdrawal by Subject|2
1082454|NCT02256488|3528267|P3|Overall Study|Withdrawal by Subject|0
1082455|NCT02256488|3528268|P2|Overall Study|Withdrawal by Subject|0
1082456|NCT02256488|3528269|P1|Overall Study|Withdrawal by Subject|1
1082457|NCT02256488|3528266|P4|Overall Study|OTHER|1
1082458|NCT02256488|3528267|P3|Overall Study|OTHER|1
1082459|NCT02256488|3528268|P2|Overall Study|OTHER|0
1082460|NCT02256488|3528269|P1|Overall Study|OTHER|1
1082461|NCT02256488|3528266|P4|Overall Study|Lost to Follow-up|3
1082462|NCT02256488|3528267|P3|Overall Study|Lost to Follow-up|9
1082463|NCT02256488|3528268|P2|Overall Study|Lost to Follow-up|6
1082464|NCT02256488|3528269|P1|Overall Study|Lost to Follow-up|6
1082465|NCT02256436|3528285|P2|Overall Study|Ongoing in Study|67
1082466|NCT02256436|3528286|P1|Overall Study|Ongoing in Study|108
1082467|NCT02256436|3528285|P2|Overall Study|Withdrawal by Subject|30
1082468|NCT02256436|3528286|P1|Overall Study|Withdrawal by Subject|7
1082469|NCT02256436|3528285|P2|Overall Study|Protocol Violation|0
1082470|NCT02256436|3528286|P1|Overall Study|Protocol Violation|1
1082471|NCT02256436|3528285|P2|Overall Study|Physician Decision|3
1082472|NCT02256436|3528286|P1|Overall Study|Physician Decision|1
1082473|NCT02256436|3528285|P2|Overall Study|Lost to Follow-up|1
1082474|NCT02256436|3528286|P1|Overall Study|Lost to Follow-up|1
1082475|NCT02256436|3528285|P2|Overall Study|Death|158
1082476|NCT02256436|3528286|P1|Overall Study|Death|137
1082477|NCT02256436|3528285|P2|Overall Study|Adverse Event|13
1082478|NCT02256436|3528286|P1|Overall Study|Adverse Event|15
1082479|NCT02256267|3528346|P1|Period 2 (Day 7 to Day 14)|Adverse Event|1
1082480|NCT02256267|3528346|P1|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1
1082481|NCT02255760|3528377|P5|Overall Study|Lost to Follow-up|0
1082482|NCT02255760|3528378|P4|Overall Study|Lost to Follow-up|0
1082483|NCT02255760|3528379|P3|Overall Study|Lost to Follow-up|0
1082484|NCT02255760|3528380|P2|Overall Study|Lost to Follow-up|1
1082485|NCT02255760|3528381|P1|Overall Study|Lost to Follow-up|0
1082486|NCT02255565|3528436|P3|Overall Study|Withdrawal by Subject|0
1082487|NCT02255565|3528437|P2|Overall Study|Withdrawal by Subject|1
1082488|NCT02255565|3528438|P1|Overall Study|Withdrawal by Subject|0
1082489|NCT02255279|3528499|P2|Overall Study|Withdrawal by Subject|6
1082490|NCT02255279|3528500|P1|Overall Study|Withdrawal by Subject|3
1082491|NCT02255279|3528499|P2|Overall Study|Protocol Violation|1
1082492|NCT02255279|3528500|P1|Overall Study|Protocol Violation|0
1082493|NCT02255279|3528499|P2|Overall Study|Lost to Follow-up|2
1082494|NCT02255279|3528500|P1|Overall Study|Lost to Follow-up|2
1082495|NCT02255149|3528526|P1|Overall Study|Implant Failure|1
1082496|NCT02255149|3528526|P1|Overall Study|Withdrawal by PI|1
1082497|NCT02255149|3528526|P1|Overall Study|Withdrawal by Subject|1
1082498|NCT02255149|3528526|P1|Overall Study|Lost to Follow-up|2
1082499|NCT02255097|3528542|P1|Overall Study|Treatment Ongoing|36
1082500|NCT02255097|3528542|P1|Overall Study|Allocated but not treated|1
1082501|NCT02255097|3528542|P1|Overall Study|Withdrawal by Subject|2
1082502|NCT02255097|3528542|P1|Overall Study|Progressive Disease|80
1082503|NCT02255097|3528542|P1|Overall Study|Physician Decision|1
1082504|NCT02255097|3528542|P1|Overall Study|Lost to Follow-up|1
1082505|NCT02255097|3528542|P1|Overall Study|Death|2
1082506|NCT02255097|3528542|P1|Overall Study|Excluded Medication|1
1082507|NCT02255097|3528542|P1|Overall Study|Complete Response|1
1082508|NCT02255097|3528542|P1|Overall Study|Clinical Progression|23
1082509|NCT02255097|3528542|P1|Overall Study|Adverse Event|24
1082510|NCT02254772|3528563|P1|Overall Study|Withdrawal by Subject|1
1082511|NCT02254772|3528563|P1|Overall Study|Ineligible|1
1082512|NCT02254681|3528569|P1|Overall Study|Lack of Efficacy|6
1082513|NCT02254551|3528579|P1|Dose Escalation|Dose-limiting toxicity|2
1082514|NCT02254551|3528579|P1|Dose Escalation|Physician Decision|1
1082515|NCT02254486|3528589|P2|Overall Study|Various|12
1082516|NCT02254486|3528590|P1|Overall Study|Various|12
1082517|NCT02254486|3528589|P2|Overall Study|GFR<60mL/min|21
1082518|NCT02254486|3528590|P1|Overall Study|GFR<60mL/min|16
1082519|NCT02254486|3528589|P2|Overall Study|Withdrawal by Subject|15
1082520|NCT02254486|3528590|P1|Overall Study|Withdrawal by Subject|17
1082521|NCT02254486|3528589|P2|Overall Study|Protocol Violation|2
1082522|NCT02254486|3528590|P1|Overall Study|Protocol Violation|1
1082523|NCT02254486|3528589|P2|Overall Study|Lost to Follow-up|4
1082524|NCT02254486|3528590|P1|Overall Study|Lost to Follow-up|2
1082525|NCT02254486|3528589|P2|Overall Study|Lack of Efficacy|0
1082526|NCT02254486|3528590|P1|Overall Study|Lack of Efficacy|1
1082527|NCT02254486|3528589|P2|Overall Study|Adverse Event|1
1082528|NCT02254486|3528590|P1|Overall Study|Adverse Event|1
1082529|NCT02254460|3528606|P2|Overall Study|Adverse Event|0
1082530|NCT02254460|3528607|P1|Overall Study|Adverse Event|1
1082531|NCT02254421|3528615|P2|Overall Study|Withdrew Consent|1
1082532|NCT02254421|3528616|P1|Overall Study|Withdrew Consent|1
1082533|NCT02254421|3528615|P2|Overall Study|Death|2
1082534|NCT02254421|3528616|P1|Overall Study|Death|0
1082535|NCT02254421|3528615|P2|Overall Study|Randomized but Not Treated|0
1082536|NCT02254421|3528616|P1|Overall Study|Randomized but Not Treated|1
1082537|NCT02254408|3528630|P2|Overall Study|Lost to Follow-up|0
1082538|NCT02254408|3528631|P1|Overall Study|Lost to Follow-up|1
1082539|NCT02254408|3528630|P2|Overall Study|Withdrawal by Subject|3
1082540|NCT02254408|3528631|P1|Overall Study|Withdrawal by Subject|3
1082541|NCT02254408|3528630|P2|Overall Study|Investigator's Discretion|1
1082542|NCT02254408|3528631|P1|Overall Study|Investigator's Discretion|0
1082543|NCT02254408|3528630|P2|Overall Study|Death|3
1082544|NCT02254408|3528631|P1|Overall Study|Death|2
1082545|NCT02254408|3528630|P2|Overall Study|Adverse Event|0
1082546|NCT02254408|3528631|P1|Overall Study|Adverse Event|1
1082547|NCT02254408|3528630|P2|Overall Study|Randomized But Not Treated|3
1082548|NCT02254408|3528631|P1|Overall Study|Randomized But Not Treated|1
1082549|NCT02254304|3528643|P2|Overall Study|Personal decision|0
1082550|NCT02254304|3528644|P1|Overall Study|Personal decision|1
1082551|NCT02254304|3528643|P2|Overall Study|Personal causes|1
1082552|NCT02254304|3528644|P1|Overall Study|Personal causes|4
1082553|NCT02254304|3528643|P2|Overall Study|Injection site pain and Injection fear|0
1082554|NCT02254304|3528644|P1|Overall Study|Injection site pain and Injection fear|1
1082555|NCT02254304|3528643|P2|Overall Study|Withdrawal by Subject|0
1082556|NCT02254304|3528644|P1|Overall Study|Withdrawal by Subject|3
1082557|NCT02254304|3528643|P2|Overall Study|Protocol Violation|0
1082558|NCT02254304|3528644|P1|Overall Study|Protocol Violation|1
1082559|NCT02254304|3528643|P2|Overall Study|Lost to Follow-up|2
1082560|NCT02254304|3528644|P1|Overall Study|Lost to Follow-up|2
1082561|NCT02254304|3528643|P2|Overall Study|Adverse Event|1
1082562|NCT02254304|3528644|P1|Overall Study|Adverse Event|2
1082563|NCT02254291|3528704|P3|Overall Study|Missing follow-up information|1
1082564|NCT02254291|3528705|P2|Overall Study|Missing follow-up information|0
1082565|NCT02254291|3528706|P1|Overall Study|Missing follow-up information|0
1082566|NCT02254291|3528704|P3|Overall Study|Withdrawal by Subject|1
1082567|NCT02254291|3528705|P2|Overall Study|Withdrawal by Subject|3
1082568|NCT02254291|3528706|P1|Overall Study|Withdrawal by Subject|0
1082569|NCT02253654|3528763|P2|Overall Study|Did Not Receive Study Treatment|1
1082570|NCT02253654|3528764|P1|Overall Study|Did Not Receive Study Treatment|4
1082571|NCT02253654|3528763|P2|Overall Study|Death|7
1082572|NCT02253654|3528764|P1|Overall Study|Death|4
1082573|NCT02253654|3528763|P2|Overall Study|Lost to Follow-up|5
1082574|NCT02253654|3528764|P1|Overall Study|Lost to Follow-up|2
1082575|NCT02253654|3528763|P2|Overall Study|Decision by Sponsor|1
1082576|NCT02253654|3528764|P1|Overall Study|Decision by Sponsor|1
1082577|NCT02253654|3528763|P2|Overall Study|Withdrawal by Subject|4
1082578|NCT02253654|3528764|P1|Overall Study|Withdrawal by Subject|12
1082579|NCT02253433|3528786|P2|Overall Study|Medical or Other Concerns|2
1082580|NCT02253433|3528787|P1|Overall Study|Medical or Other Concerns|1
1082581|NCT02253433|3528786|P2|Overall Study|Too Busy|4
1082582|NCT02253433|3528787|P1|Overall Study|Too Busy|0
1082583|NCT02253433|3528786|P2|Overall Study|Unstable Housing/Homeless|7
1082584|NCT02253433|3528787|P1|Overall Study|Unstable Housing/Homeless|0
1082585|NCT02253433|3528786|P2|Overall Study|Uncomfortable with home visitors|3
1082586|NCT02253433|3528787|P1|Overall Study|Uncomfortable with home visitors|0
1082587|NCT02253433|3528786|P2|Overall Study|Out of Study Area|7
1082588|NCT02253433|3528787|P1|Overall Study|Out of Study Area|2
1082589|NCT02253433|3528786|P2|Overall Study|No Longer Interested|15
1082590|NCT02253433|3528787|P1|Overall Study|No Longer Interested|3
1082591|NCT02253433|3528786|P2|Overall Study|Death|1
1082592|NCT02253433|3528787|P1|Overall Study|Death|1
1082593|NCT02253433|3528786|P2|Overall Study|Unable to Contact|16
1082594|NCT02253433|3528787|P1|Overall Study|Unable to Contact|9
1082595|NCT02253147|3529039|P1|Overall Study|Withdrawal by Subject|1
1082596|NCT02253147|3529039|P1|Overall Study|Lost to Follow-up|2
1082597|NCT02253147|3529039|P1|Overall Study|Conditional re-treatment at W52|5
1082598|NCT02253147|3529039|P1|Overall Study|Did not consent to study extension|9
1082599|NCT02253147|3529039|P1|Overall Study|Protocol Violation|30
1082600|NCT02252965|3529073|P2|Overall Study|Other|5
1082601|NCT02252965|3529074|P1|Overall Study|Other|4
1082602|NCT02252965|3529073|P2|Overall Study|Withdrawal by Subject|9
1082603|NCT02252965|3529074|P1|Overall Study|Withdrawal by Subject|7
1082604|NCT02252965|3529073|P2|Overall Study|Lack of Efficacy|2
1082605|NCT02252965|3529074|P1|Overall Study|Lack of Efficacy|0
1082606|NCT02252965|3529073|P2|Overall Study|Protocol Violation|5
1082607|NCT02252965|3529074|P1|Overall Study|Protocol Violation|4
1082608|NCT02252965|3529073|P2|Overall Study|Lost to Follow-up|8
1082609|NCT02252965|3529074|P1|Overall Study|Lost to Follow-up|16
1082610|NCT02252965|3529073|P2|Overall Study|Adverse Event|14
1082611|NCT02252965|3529074|P1|Overall Study|Adverse Event|9
1082612|NCT02252939|3529101|P1|Overall Study|Lost to Follow-up|3
1082613|NCT02252536|3529120|P2|Overall Study|Lost to Follow-up|3
1082614|NCT02252536|3529121|P1|Overall Study|Lost to Follow-up|5
1082615|NCT02252146|3529228|P1|Overall Study|Inability to travel to study site|1
1082616|NCT02252146|3529228|P1|Overall Study|Entered hospice care|1
1082617|NCT02252146|3529228|P1|Overall Study|Lack of Efficacy|4
1082618|NCT02252042|3529241|P2|Overall Study|Ongoing in study|35
1082619|NCT02252042|3529242|P1|Overall Study|Ongoing in study|64
1082620|NCT02252042|3529241|P2|Overall Study|Withdrawal by Subject|20
1082621|NCT02252042|3529242|P1|Overall Study|Withdrawal by Subject|13
1082622|NCT02252042|3529241|P2|Overall Study|Physician Decision|1
1082623|NCT02252042|3529242|P1|Overall Study|Physician Decision|0
1082624|NCT02252042|3529241|P2|Overall Study|Death|192
1082625|NCT02252042|3529242|P1|Overall Study|Death|170
1082626|NCT02252016|3529282|P2|Overall Study|Withdrawal by Subject|2
1082627|NCT02252016|3529283|P1|Overall Study|Withdrawal by Subject|0
1082628|NCT02252016|3529282|P2|Overall Study|Physician Decision|0
1082629|NCT02252016|3529283|P1|Overall Study|Physician Decision|1
1082630|NCT02252016|3529282|P2|Overall Study|Lost to Follow-up|1
1082631|NCT02252016|3529283|P1|Overall Study|Lost to Follow-up|2
1082632|NCT02251990|3529297|P2|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2
1082633|NCT02251990|3529298|P1|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0
1082634|NCT02251990|3529297|P2|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1
1082635|NCT02251990|3529298|P1|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0
1082636|NCT02251990|3529297|P2|Period 1 (Double-blind [DB])|Not Treated|0
1082637|NCT02251990|3529298|P1|Period 1 (Double-blind [DB])|Not Treated|1
1082638|NCT02251990|3529297|P2|Period 1 (Double-blind [DB])|Withdrawal by Subject|0
1082639|NCT02251990|3529298|P1|Period 1 (Double-blind [DB])|Withdrawal by Subject|1
1082640|NCT02251990|3529297|P2|Period 1 (Double-blind [DB])|Lack of Efficacy|0
1082641|NCT02251990|3529298|P1|Period 1 (Double-blind [DB])|Lack of Efficacy|5
1082642|NCT02251990|3529297|P2|Period 1 (Double-blind [DB])|Adverse Event|1
1082643|NCT02251990|3529298|P1|Period 1 (Double-blind [DB])|Adverse Event|1
1082644|NCT02251912|3529315|P2|Overall Study|Adverse Event|2
1082645|NCT02251912|3529316|P1|Overall Study|Adverse Event|0
1082646|NCT02251912|3529315|P2|Overall Study|Withdrawal by Subject|3
1082647|NCT02251912|3529316|P1|Overall Study|Withdrawal by Subject|2
1082648|NCT02251717|3529345|P2|Overall Study|Withdrew Consent|0
1082649|NCT02251717|3529346|P1|Overall Study|Withdrew Consent|1
1082650|NCT02251717|3529345|P2|Overall Study|Adverse Event|1
1082651|NCT02251717|3529346|P1|Overall Study|Adverse Event|0
1082652|NCT02251652|3529358|P1|Overall Study|Withdrawal by Subject|1
1082653|NCT02250443|3529423|P1|Overall Study|Adverse Event|3
1082654|NCT02250443|3529423|P1|Overall Study|Administrative problems|7
1082655|NCT02250326|3529452|P3|Follow-Up Period|Lost to Follow-up|3
1082656|NCT02250326|3529453|P2|Follow-Up Period|Lost to Follow-up|1
1082657|NCT02250326|3529454|P1|Follow-Up Period|Lost to Follow-up|1
1082658|NCT02250326|3529452|P3|Follow-Up Period|Unknown or Missing|3
1082659|NCT02250326|3529453|P2|Follow-Up Period|Unknown or Missing|3
1082660|NCT02250326|3529454|P1|Follow-Up Period|Unknown or Missing|2
1082661|NCT02250326|3529452|P3|Follow-Up Period|Death|32
1082662|NCT02250326|3529453|P2|Follow-Up Period|Death|26
1082663|NCT02250326|3529454|P1|Follow-Up Period|Death|46
1082664|NCT02250326|3529452|P3|Treatment Period|Randomized or assigned; not treated|1
1082665|NCT02250326|3529453|P2|Treatment Period|Randomized or assigned; not treated|1
1082666|NCT02250326|3529454|P1|Treatment Period|Randomized or assigned; not treated|2
1082667|NCT02250326|3529452|P3|Treatment Period|Miscellaneous|7
1082668|NCT02250326|3529453|P2|Treatment Period|Miscellaneous|2
1082669|NCT02250326|3529454|P1|Treatment Period|Miscellaneous|8
1082670|NCT02250326|3529452|P3|Treatment Period|Withdrawal by Subject|4
1082671|NCT02250326|3529453|P2|Treatment Period|Withdrawal by Subject|5
1082672|NCT02250326|3529454|P1|Treatment Period|Withdrawal by Subject|11
1082673|NCT02250326|3529452|P3|Treatment Period|Symptomatic Deterioration|10
1082674|NCT02250326|3529453|P2|Treatment Period|Symptomatic Deterioration|4
1082675|NCT02250326|3529454|P1|Treatment Period|Symptomatic Deterioration|9
1082676|NCT02250326|3529452|P3|Treatment Period|Progressive Disease|45
1082677|NCT02250326|3529453|P2|Treatment Period|Progressive Disease|36
1082678|NCT02250326|3529454|P1|Treatment Period|Progressive Disease|42
1082679|NCT02250326|3529452|P3|Treatment Period|Adverse Event|8
1082680|NCT02250326|3529453|P2|Treatment Period|Adverse Event|4
1082681|NCT02250326|3529454|P1|Treatment Period|Adverse Event|8
1082682|NCT02250326|3529452|P3|Treatment Period|Death|2
1082683|NCT02250326|3529453|P2|Treatment Period|Death|12
1082684|NCT02250326|3529454|P1|Treatment Period|Death|1
1082685|NCT02250274|3529487|P2|Overall Study|Insufficient blood draw amount|6
1082686|NCT02250274|3529488|P1|Overall Study|Insufficient blood draw amount|7
1082687|NCT02248818|3529613|P9|Randomised Study|Administrative - randomization error|0
1082688|NCT02248818|3529614|P8|Randomised Study|Administrative - randomization error|0
1082689|NCT02248818|3529615|P7|Randomised Study|Administrative - randomization error|0
1082690|NCT02248818|3529616|P6|Randomised Study|Administrative - randomization error|8
1082691|NCT02248818|3529617|P5|Randomised Study|Administrative - randomization error|0
1082692|NCT02248818|3529618|P4|Randomised Study|Administrative - randomization error|0
1082693|NCT02248818|3529619|P3|Randomised Study|Administrative - randomization error|0
1082694|NCT02248818|3529620|P2|Randomised Study|Administrative - randomization error|0
1082695|NCT02248818|3529621|P1|Randomised Study|Administrative - randomization error|0
1082696|NCT02248818|3529613|P9|Screening|Lost to Follow-up|7
1082697|NCT02248818|3529614|P8|Screening|Lost to Follow-up|0
1082698|NCT02248818|3529615|P7|Screening|Lost to Follow-up|0
1082699|NCT02248818|3529616|P6|Screening|Lost to Follow-up|0
1082700|NCT02248818|3529617|P5|Screening|Lost to Follow-up|0
1082701|NCT02248818|3529618|P4|Screening|Lost to Follow-up|0
1082702|NCT02248818|3529619|P3|Screening|Lost to Follow-up|0
1082703|NCT02248818|3529620|P2|Screening|Lost to Follow-up|0
1082704|NCT02248818|3529621|P1|Screening|Lost to Follow-up|0
1082705|NCT02248818|3529613|P9|Screening|Withdrawal by Subject|6
1082706|NCT02248818|3529614|P8|Screening|Withdrawal by Subject|0
1082707|NCT02248818|3529615|P7|Screening|Withdrawal by Subject|0
1082708|NCT02248818|3529616|P6|Screening|Withdrawal by Subject|0
1082709|NCT02248818|3529617|P5|Screening|Withdrawal by Subject|0
1082710|NCT02248818|3529618|P4|Screening|Withdrawal by Subject|0
1082711|NCT02248818|3529619|P3|Screening|Withdrawal by Subject|0
1082712|NCT02248818|3529620|P2|Screening|Withdrawal by Subject|0
1082713|NCT02248818|3529621|P1|Screening|Withdrawal by Subject|0
1082714|NCT02248818|3529613|P9|Screening|Physician Decision|73
1082715|NCT02248818|3529614|P8|Screening|Physician Decision|0
1082716|NCT02248818|3529615|P7|Screening|Physician Decision|0
1082717|NCT02248818|3529616|P6|Screening|Physician Decision|0
1082718|NCT02248818|3529617|P5|Screening|Physician Decision|0
1082719|NCT02248818|3529618|P4|Screening|Physician Decision|0
1082720|NCT02248818|3529619|P3|Screening|Physician Decision|0
1082721|NCT02248818|3529620|P2|Screening|Physician Decision|0
1082722|NCT02248818|3529621|P1|Screening|Physician Decision|0
1082723|NCT02248818|3529613|P9|Screening|Study fully enrolled|14
1082724|NCT02248818|3529614|P8|Screening|Study fully enrolled|0
1082725|NCT02248818|3529615|P7|Screening|Study fully enrolled|0
1082726|NCT02248818|3529616|P6|Screening|Study fully enrolled|0
1082727|NCT02248818|3529617|P5|Screening|Study fully enrolled|0
1082728|NCT02248818|3529618|P4|Screening|Study fully enrolled|0
1082729|NCT02248818|3529619|P3|Screening|Study fully enrolled|0
1082730|NCT02248818|3529620|P2|Screening|Study fully enrolled|0
1082731|NCT02248818|3529621|P1|Screening|Study fully enrolled|0
1082732|NCT02248818|3529613|P9|Screening|Protocol Violation|7
1082733|NCT02248818|3529614|P8|Screening|Protocol Violation|0
1082734|NCT02248818|3529615|P7|Screening|Protocol Violation|0
1082735|NCT02248818|3529616|P6|Screening|Protocol Violation|0
1082736|NCT02248818|3529617|P5|Screening|Protocol Violation|0
1082737|NCT02248818|3529618|P4|Screening|Protocol Violation|0
1082738|NCT02248818|3529619|P3|Screening|Protocol Violation|0
1082739|NCT02248818|3529620|P2|Screening|Protocol Violation|0
1082740|NCT02248818|3529621|P1|Screening|Protocol Violation|0
1082741|NCT02248675|3529784|P2|Overall Study|Lost to Follow-up|1
1082742|NCT02248675|3529785|P1|Overall Study|Lost to Follow-up|3
1082743|NCT02248480|3529812|P2|Overall Study|Other:Physician Decision|1
1082744|NCT02248480|3529813|P1|Overall Study|Other:Physician Decision|0
1082745|NCT02248480|3529812|P2|Overall Study|Entry Criteria Not Met|1
1082746|NCT02248480|3529813|P1|Overall Study|Entry Criteria Not Met|0
1082747|NCT02248480|3529812|P2|Overall Study|Withdrawal by Subject|4
1082748|NCT02248480|3529813|P1|Overall Study|Withdrawal by Subject|2
1082749|NCT02248480|3529812|P2|Overall Study|Adverse Event|2
1082750|NCT02248480|3529813|P1|Overall Study|Adverse Event|11
1082751|NCT02248480|3529812|P2|Overall Study|Lack of Efficacy|6
1082752|NCT02248480|3529813|P1|Overall Study|Lack of Efficacy|4
1082753|NCT02247960|3529880|P2|Catheter Removed|Lost to Follow-up|10
1082754|NCT02247960|3529881|P1|Catheter Removed|Lost to Follow-up|7
1082755|NCT02247960|3529880|P2|Patient Consent and Randomization|Withdrawal by Subject|4
1082756|NCT02247960|3529881|P1|Patient Consent and Randomization|Withdrawal by Subject|0
1082757|NCT02247960|3529880|P2|Patient Consent and Randomization|Physician Decision|2
1082758|NCT02247960|3529881|P1|Patient Consent and Randomization|Physician Decision|2
1082759|NCT02247401|3529920|P3|Overall Study|Lost to Follow-up|1
1082760|NCT02247401|3529921|P2|Overall Study|Lost to Follow-up|1
1082761|NCT02247401|3529922|P1|Overall Study|Lost to Follow-up|1
1082762|NCT02247401|3529920|P3|Overall Study|Withdrawal by Subject|1
1082763|NCT02247401|3529921|P2|Overall Study|Withdrawal by Subject|1
1082764|NCT02247401|3529922|P1|Overall Study|Withdrawal by Subject|4
1082765|NCT02247401|3529920|P3|Overall Study|Adverse Event|0
1082766|NCT02247401|3529921|P2|Overall Study|Adverse Event|0
1082767|NCT02247401|3529922|P1|Overall Study|Adverse Event|1
1082768|NCT02247011|3529952|P1|Overall Study|Poor quality of radiological results|125
1082769|NCT02246998|3529973|P4|Overall Study|Randomized but Never Dosed|1
1082770|NCT02246998|3529974|P3|Overall Study|Randomized but Never Dosed|2
1082771|NCT02246998|3529975|P2|Overall Study|Randomized but Never Dosed|2
1082772|NCT02246998|3529976|P1|Overall Study|Randomized but Never Dosed|1
1082773|NCT02246998|3529973|P4|Overall Study|Lost to Follow-up|1
1082774|NCT02246998|3529974|P3|Overall Study|Lost to Follow-up|0
1082775|NCT02246998|3529975|P2|Overall Study|Lost to Follow-up|0
1082776|NCT02246998|3529976|P1|Overall Study|Lost to Follow-up|1
1082777|NCT02246998|3529973|P4|Overall Study|Adverse Event|0
1082778|NCT02246998|3529974|P3|Overall Study|Adverse Event|1
1082779|NCT02246998|3529975|P2|Overall Study|Adverse Event|1
1082780|NCT02246998|3529976|P1|Overall Study|Adverse Event|0
1082781|NCT02246777|3530086|P1|Overall Study|Change of residence|1
1082782|NCT02246777|3530086|P1|Overall Study|Adverse Event|2
1082783|NCT02246764|3530102|P3|Overall Study|Protocol Violation|1
1082784|NCT02246764|3530103|P2|Overall Study|Protocol Violation|1
1082785|NCT02246764|3530104|P1|Overall Study|Protocol Violation|2
1082786|NCT02246764|3530102|P3|Overall Study|Physician Decision|1
1082787|NCT02246764|3530103|P2|Overall Study|Physician Decision|2
1082788|NCT02246764|3530104|P1|Overall Study|Physician Decision|0
1082789|NCT02246764|3530102|P3|Overall Study|Disallowed Concomitant Medication|0
1082790|NCT02246764|3530103|P2|Overall Study|Disallowed Concomitant Medication|0
1082791|NCT02246764|3530104|P1|Overall Study|Disallowed Concomitant Medication|1
1082792|NCT02246764|3530102|P3|Overall Study|Withdrawal by Subject|1
1082793|NCT02246764|3530103|P2|Overall Study|Withdrawal by Subject|0
1082794|NCT02246764|3530104|P1|Overall Study|Withdrawal by Subject|0
1082795|NCT02246764|3530102|P3|Overall Study|Adverse Event|1
1082796|NCT02246764|3530103|P2|Overall Study|Adverse Event|29
1082797|NCT02246764|3530104|P1|Overall Study|Adverse Event|15
1082798|NCT02246673|3530117|P5|Overall Study|Protocol Violation|0
1082799|NCT02246673|3530118|P4|Overall Study|Protocol Violation|1
1082800|NCT02246673|3530119|P3|Overall Study|Protocol Violation|0
1082801|NCT02246673|3530120|P2|Overall Study|Protocol Violation|0
1082802|NCT02246673|3530121|P1|Overall Study|Protocol Violation|0
1082803|NCT02246673|3530117|P5|Overall Study|Lost to Follow-up|0
1082804|NCT02246673|3530118|P4|Overall Study|Lost to Follow-up|1
1082805|NCT02246673|3530119|P3|Overall Study|Lost to Follow-up|0
1082806|NCT02246673|3530120|P2|Overall Study|Lost to Follow-up|0
1082807|NCT02246673|3530121|P1|Overall Study|Lost to Follow-up|0
1082808|NCT02246673|3530117|P5|Overall Study|Withdrawal by Subject|1
1082809|NCT02246673|3530118|P4|Overall Study|Withdrawal by Subject|0
1082810|NCT02246673|3530119|P3|Overall Study|Withdrawal by Subject|0
1082811|NCT02246673|3530120|P2|Overall Study|Withdrawal by Subject|0
1082812|NCT02246673|3530121|P1|Overall Study|Withdrawal by Subject|0
1082813|NCT02246673|3530117|P5|Overall Study|Sponsor Decision|0
1082814|NCT02246673|3530118|P4|Overall Study|Sponsor Decision|0
1082815|NCT02246673|3530119|P3|Overall Study|Sponsor Decision|0
1082816|NCT02246673|3530120|P2|Overall Study|Sponsor Decision|0
1082817|NCT02246673|3530121|P1|Overall Study|Sponsor Decision|1
1082818|NCT02246660|3530229|P3|Overall Study|Death|1
1082819|NCT02246660|3530230|P2|Overall Study|Death|0
1082820|NCT02246660|3530231|P1|Overall Study|Death|0
1082821|NCT02246660|3530229|P3|Overall Study|Withdrawal by Subject|0
1082822|NCT02246660|3530230|P2|Overall Study|Withdrawal by Subject|1
1082823|NCT02246660|3530231|P1|Overall Study|Withdrawal by Subject|0
1082824|NCT02246621|3530241|P2|Overall Study|On Study Treatment/ Follow Up|133
1082825|NCT02246621|3530242|P1|Overall Study|On Study Treatment/ Follow Up|257
1082826|NCT02246621|3530241|P2|Overall Study|Lost to Follow-up|1
1082827|NCT02246621|3530242|P1|Overall Study|Lost to Follow-up|3
1082828|NCT02246621|3530241|P2|Overall Study|Withdrawal by Subject|14
1082829|NCT02246621|3530242|P1|Overall Study|Withdrawal by Subject|36
1082830|NCT02246582|3530279|P2|Overall Study|Withdrawal by Subject|4
1082831|NCT02246582|3530280|P1|Overall Study|Withdrawal by Subject|3
1082832|NCT02246166|3530301|P2|Overall Study|Protocol Violation|0
1082833|NCT02246166|3530302|P1|Overall Study|Protocol Violation|1
1082834|NCT02246114|3530338|P2|Overall Study|miscarriage|0
1082835|NCT02246114|3530339|P1|Overall Study|miscarriage|1
1082836|NCT02245412|3530373|P3|Overall Study|Other|0
1082837|NCT02245412|3530374|P2|Overall Study|Other|0
1082838|NCT02245412|3530375|P1|Overall Study|Other|1
1082839|NCT02245412|3530373|P3|Overall Study|Biopsy did not confirm GI GVHD|0
1082840|NCT02245412|3530374|P2|Overall Study|Biopsy did not confirm GI GVHD|0
1082841|NCT02245412|3530375|P1|Overall Study|Biopsy did not confirm GI GVHD|1
1082842|NCT02245412|3530373|P3|Overall Study|Withdrawal by Subject|0
1082843|NCT02245412|3530374|P2|Overall Study|Withdrawal by Subject|1
1082844|NCT02245412|3530375|P1|Overall Study|Withdrawal by Subject|1
1082845|NCT02245412|3530373|P3|Overall Study|Physician Decision|0
1082846|NCT02245412|3530374|P2|Overall Study|Physician Decision|1
1082847|NCT02245412|3530375|P1|Overall Study|Physician Decision|1
1082848|NCT02245412|3530373|P3|Overall Study|Death|0
1082849|NCT02245412|3530374|P2|Overall Study|Death|1
1082850|NCT02245412|3530375|P1|Overall Study|Death|1
1082851|NCT02244944|3530409|P1|Overall Study|Study Terminated|1
1082852|NCT02244944|3530409|P1|Overall Study|Withdrawal by Subject|1
1082853|NCT02244619|3530421|P2|Overall Study|Did not receive study intervention|21
1082854|NCT02244619|3530422|P1|Overall Study|Did not receive study intervention|8
1082855|NCT02244580|3530440|P1|Overall Study|No cancer tissues available|241
1082856|NCT02243293|3530478|P22|Overall Study|Randomized but did'nt receive study drug|0
1082857|NCT02243293|3530479|P21|Overall Study|Randomized but did'nt receive study drug|0
1082858|NCT02243293|3530480|P20|Overall Study|Randomized but did'nt receive study drug|1
1082859|NCT02243293|3530481|P19|Overall Study|Randomized but did'nt receive study drug|0
1082860|NCT02243293|3530482|P18|Overall Study|Randomized but did'nt receive study drug|0
1082861|NCT02243293|3530483|P17|Overall Study|Randomized but did'nt receive study drug|0
1082862|NCT02243293|3530484|P16|Overall Study|Randomized but did'nt receive study drug|0
1082863|NCT02243293|3530485|P15|Overall Study|Randomized but did'nt receive study drug|0
1082864|NCT02243293|3530486|P14|Overall Study|Randomized but did'nt receive study drug|0
1082865|NCT02243293|3530487|P13|Overall Study|Randomized but did'nt receive study drug|0
1082866|NCT02243293|3530488|P12|Overall Study|Randomized but did'nt receive study drug|0
1082867|NCT02243293|3530489|P11|Overall Study|Randomized but did'nt receive study drug|0
1082868|NCT02243293|3530490|P10|Overall Study|Randomized but did'nt receive study drug|1
1082869|NCT02243293|3530491|P9|Overall Study|Randomized but did'nt receive study drug|0
1082870|NCT02243293|3530492|P8|Overall Study|Randomized but did'nt receive study drug|0
1082871|NCT02243293|3530493|P7|Overall Study|Randomized but did'nt receive study drug|0
1082872|NCT02243293|3530494|P6|Overall Study|Randomized but did'nt receive study drug|0
1082873|NCT02243293|3530495|P5|Overall Study|Randomized but did'nt receive study drug|1
1082874|NCT02243293|3530496|P4|Overall Study|Randomized but did'nt receive study drug|0
1082875|NCT02243293|3530497|P3|Overall Study|Randomized but did'nt receive study drug|0
1082876|NCT02243293|3530498|P2|Overall Study|Randomized but did'nt receive study drug|0
1082877|NCT02243293|3530499|P1|Overall Study|Randomized but did'nt receive study drug|0
1082878|NCT02243293|3530478|P22|Overall Study|Enrolled into a Re-treatment Study|0
1082879|NCT02243293|3530479|P21|Overall Study|Enrolled into a Re-treatment Study|0
1082880|NCT02243293|3530480|P20|Overall Study|Enrolled into a Re-treatment Study|0
1082881|NCT02243293|3530481|P19|Overall Study|Enrolled into a Re-treatment Study|0
1082882|NCT02243293|3530482|P18|Overall Study|Enrolled into a Re-treatment Study|0
1082883|NCT02243293|3530483|P17|Overall Study|Enrolled into a Re-treatment Study|0
1082884|NCT02243293|3530484|P16|Overall Study|Enrolled into a Re-treatment Study|0
1082885|NCT02243293|3530485|P15|Overall Study|Enrolled into a Re-treatment Study|1
1082886|NCT02243293|3530486|P14|Overall Study|Enrolled into a Re-treatment Study|0
1082887|NCT02243293|3530487|P13|Overall Study|Enrolled into a Re-treatment Study|0
1082888|NCT02243293|3530488|P12|Overall Study|Enrolled into a Re-treatment Study|0
1082889|NCT02243293|3530489|P11|Overall Study|Enrolled into a Re-treatment Study|0
1082890|NCT02243293|3530490|P10|Overall Study|Enrolled into a Re-treatment Study|0
1082891|NCT02243293|3530491|P9|Overall Study|Enrolled into a Re-treatment Study|0
1082892|NCT02243293|3530492|P8|Overall Study|Enrolled into a Re-treatment Study|0
1082893|NCT02243293|3530493|P7|Overall Study|Enrolled into a Re-treatment Study|0
1082894|NCT02243293|3530494|P6|Overall Study|Enrolled into a Re-treatment Study|0
1082895|NCT02243293|3530495|P5|Overall Study|Enrolled into a Re-treatment Study|0
1082896|NCT02243293|3530496|P4|Overall Study|Enrolled into a Re-treatment Study|0
1082897|NCT02243293|3530497|P3|Overall Study|Enrolled into a Re-treatment Study|0
1082898|NCT02243293|3530498|P2|Overall Study|Enrolled into a Re-treatment Study|0
1082899|NCT02243293|3530499|P1|Overall Study|Enrolled into a Re-treatment Study|0
1082900|NCT02243293|3530478|P22|Overall Study|Lost to Follow-up|2
1082901|NCT02243293|3530479|P21|Overall Study|Lost to Follow-up|1
1082902|NCT02243293|3530480|P20|Overall Study|Lost to Follow-up|0
1082903|NCT02243293|3530481|P19|Overall Study|Lost to Follow-up|0
1082904|NCT02243293|3530482|P18|Overall Study|Lost to Follow-up|1
1082905|NCT02243293|3530483|P17|Overall Study|Lost to Follow-up|3
1082906|NCT02243293|3530484|P16|Overall Study|Lost to Follow-up|0
1082907|NCT02243293|3530485|P15|Overall Study|Lost to Follow-up|0
1082908|NCT02243293|3530486|P14|Overall Study|Lost to Follow-up|0
1082909|NCT02243293|3530487|P13|Overall Study|Lost to Follow-up|0
1082910|NCT02243293|3530488|P12|Overall Study|Lost to Follow-up|2
1082911|NCT02243293|3530489|P11|Overall Study|Lost to Follow-up|0
1082912|NCT02243293|3530490|P10|Overall Study|Lost to Follow-up|0
1082913|NCT02243293|3530491|P9|Overall Study|Lost to Follow-up|0
1082914|NCT02243293|3530492|P8|Overall Study|Lost to Follow-up|0
1082915|NCT02243293|3530493|P7|Overall Study|Lost to Follow-up|3
1082916|NCT02243293|3530494|P6|Overall Study|Lost to Follow-up|0
1082917|NCT02243293|3530495|P5|Overall Study|Lost to Follow-up|0
1082918|NCT02243293|3530496|P4|Overall Study|Lost to Follow-up|1
1082919|NCT02243293|3530497|P3|Overall Study|Lost to Follow-up|1
1082920|NCT02243293|3530498|P2|Overall Study|Lost to Follow-up|1
1082921|NCT02243293|3530499|P1|Overall Study|Lost to Follow-up|0
1082922|NCT02243293|3530478|P22|Overall Study|Withdrawal by Subject|1
1082923|NCT02243293|3530479|P21|Overall Study|Withdrawal by Subject|0
1082924|NCT02243293|3530480|P20|Overall Study|Withdrawal by Subject|0
1082925|NCT02243293|3530481|P19|Overall Study|Withdrawal by Subject|0
1082926|NCT02243293|3530482|P18|Overall Study|Withdrawal by Subject|0
1082927|NCT02243293|3530483|P17|Overall Study|Withdrawal by Subject|0
1082928|NCT02243293|3530484|P16|Overall Study|Withdrawal by Subject|0
1082929|NCT02243293|3530485|P15|Overall Study|Withdrawal by Subject|0
1082930|NCT02243293|3530486|P14|Overall Study|Withdrawal by Subject|0
1082931|NCT02243293|3530487|P13|Overall Study|Withdrawal by Subject|0
1082932|NCT02243293|3530488|P12|Overall Study|Withdrawal by Subject|1
1082933|NCT02243293|3530489|P11|Overall Study|Withdrawal by Subject|0
1082934|NCT02243293|3530490|P10|Overall Study|Withdrawal by Subject|1
1082935|NCT02243293|3530491|P9|Overall Study|Withdrawal by Subject|0
1082936|NCT02243293|3530492|P8|Overall Study|Withdrawal by Subject|0
1082937|NCT02243293|3530493|P7|Overall Study|Withdrawal by Subject|0
1082938|NCT02243293|3530494|P6|Overall Study|Withdrawal by Subject|0
1082939|NCT02243293|3530495|P5|Overall Study|Withdrawal by Subject|0
1082940|NCT02243293|3530496|P4|Overall Study|Withdrawal by Subject|0
1082941|NCT02243293|3530497|P3|Overall Study|Withdrawal by Subject|0
1082942|NCT02243293|3530498|P2|Overall Study|Withdrawal by Subject|0
1082943|NCT02243293|3530499|P1|Overall Study|Withdrawal by Subject|1
1082944|NCT02243293|3530478|P22|Overall Study|Adverse Event|0
1082945|NCT02243293|3530479|P21|Overall Study|Adverse Event|1
1082946|NCT02243293|3530480|P20|Overall Study|Adverse Event|0
1082947|NCT02243293|3530481|P19|Overall Study|Adverse Event|0
1082948|NCT02243293|3530482|P18|Overall Study|Adverse Event|0
1082949|NCT02243293|3530483|P17|Overall Study|Adverse Event|0
1082950|NCT02243293|3530484|P16|Overall Study|Adverse Event|1
1082951|NCT02243293|3530485|P15|Overall Study|Adverse Event|0
1082952|NCT02243293|3530486|P14|Overall Study|Adverse Event|0
1082953|NCT02243293|3530487|P13|Overall Study|Adverse Event|0
1082954|NCT02243293|3530488|P12|Overall Study|Adverse Event|0
1082955|NCT02243293|3530489|P11|Overall Study|Adverse Event|0
1082956|NCT02243293|3530490|P10|Overall Study|Adverse Event|0
1082957|NCT02243293|3530491|P9|Overall Study|Adverse Event|0
1082958|NCT02243293|3530492|P8|Overall Study|Adverse Event|0
1082959|NCT02243293|3530493|P7|Overall Study|Adverse Event|0
1082960|NCT02243293|3530494|P6|Overall Study|Adverse Event|0
1082961|NCT02243293|3530495|P5|Overall Study|Adverse Event|0
1082962|NCT02243293|3530496|P4|Overall Study|Adverse Event|0
1082963|NCT02243293|3530497|P3|Overall Study|Adverse Event|0
1082964|NCT02243293|3530498|P2|Overall Study|Adverse Event|0
1082965|NCT02243293|3530499|P1|Overall Study|Adverse Event|1
1082966|NCT02243280|3530598|P11|Treated|Lost to Follow-up|2
1082967|NCT02243280|3530599|P10|Treated|Lost to Follow-up|0
1082968|NCT02243280|3530600|P9|Treated|Lost to Follow-up|1
1082969|NCT02243280|3530601|P8|Treated|Lost to Follow-up|0
1082970|NCT02243280|3530602|P7|Treated|Lost to Follow-up|0
1082971|NCT02243280|3530603|P6|Treated|Lost to Follow-up|0
1082972|NCT02243280|3530604|P5|Treated|Lost to Follow-up|0
1082973|NCT02243280|3530605|P4|Treated|Lost to Follow-up|0
1082974|NCT02243280|3530606|P3|Treated|Lost to Follow-up|0
1082975|NCT02243280|3530607|P2|Treated|Lost to Follow-up|0
1082976|NCT02243280|3530608|P1|Treated|Lost to Follow-up|0
1082977|NCT02243280|3530598|P11|Treated|Adverse Event|1
1082978|NCT02243280|3530599|P10|Treated|Adverse Event|0
1082979|NCT02243280|3530600|P9|Treated|Adverse Event|0
1082980|NCT02243280|3530601|P8|Treated|Adverse Event|0
1082981|NCT02243280|3530602|P7|Treated|Adverse Event|0
1082982|NCT02243280|3530603|P6|Treated|Adverse Event|0
1082983|NCT02243280|3530604|P5|Treated|Adverse Event|0
1082984|NCT02243280|3530605|P4|Treated|Adverse Event|0
1082985|NCT02243280|3530606|P3|Treated|Adverse Event|0
1082986|NCT02243280|3530607|P2|Treated|Adverse Event|0
1082987|NCT02243280|3530608|P1|Treated|Adverse Event|1
1082988|NCT02243202|3530663|P4|Overall Study|Randomized but not received treatment|1
1082989|NCT02243202|3530664|P3|Overall Study|Randomized but not received treatment|0
1082990|NCT02243202|3530665|P2|Overall Study|Randomized but not received treatment|0
1082991|NCT02243202|3530666|P1|Overall Study|Randomized but not received treatment|0
1082992|NCT02243202|3530663|P4|Overall Study|Other|2
1082993|NCT02243202|3530664|P3|Overall Study|Other|1
1082994|NCT02243202|3530665|P2|Overall Study|Other|3
1082995|NCT02243202|3530666|P1|Overall Study|Other|1
1082996|NCT02243202|3530663|P4|Overall Study|Withdrawal by Subject|4
1082997|NCT02243202|3530664|P3|Overall Study|Withdrawal by Subject|4
1082998|NCT02243202|3530665|P2|Overall Study|Withdrawal by Subject|6
1082999|NCT02243202|3530666|P1|Overall Study|Withdrawal by Subject|7
1083000|NCT02243202|3530663|P4|Overall Study|Protocol Violation|1
1083001|NCT02243202|3530664|P3|Overall Study|Protocol Violation|2
1083002|NCT02243202|3530665|P2|Overall Study|Protocol Violation|1
1083003|NCT02243202|3530666|P1|Overall Study|Protocol Violation|3
1083004|NCT02243202|3530663|P4|Overall Study|Lost to Follow-up|11
1083005|NCT02243202|3530664|P3|Overall Study|Lost to Follow-up|14
1083006|NCT02243202|3530665|P2|Overall Study|Lost to Follow-up|9
1083007|NCT02243202|3530666|P1|Overall Study|Lost to Follow-up|9
1083008|NCT02243202|3530663|P4|Overall Study|Adverse Event|4
1083009|NCT02243202|3530664|P3|Overall Study|Adverse Event|10
1083010|NCT02243202|3530665|P2|Overall Study|Adverse Event|6
1083011|NCT02243202|3530666|P1|Overall Study|Adverse Event|5
1083012|NCT02243176|3530702|P2|Overall Study|Adverse Event|2
1083013|NCT02243176|3530703|P1|Overall Study|Adverse Event|2
1083014|NCT02243176|3530702|P2|Overall Study|Withdrawal by Subject|7
1083015|NCT02243176|3530703|P1|Overall Study|Withdrawal by Subject|8
1083016|NCT02243176|3530702|P2|Overall Study|Protocol Violation|1
1083017|NCT02243176|3530703|P1|Overall Study|Protocol Violation|2
1083018|NCT02243176|3530702|P2|Overall Study|protocol specified withdrawal critera|3
1083019|NCT02243176|3530703|P1|Overall Study|protocol specified withdrawal critera|1
1083020|NCT02243176|3530702|P2|Overall Study|Other reason|2
1083021|NCT02243176|3530703|P1|Overall Study|Other reason|1
1083022|NCT02243046|3530728|P3|Overall Study|Lost to Follow-up|4
1083023|NCT02243046|3530729|P2|Overall Study|Lost to Follow-up|1
1083024|NCT02243046|3530730|P1|Overall Study|Lost to Follow-up|1
1083025|NCT02242903|3530790|P7|Overall Study|Withdrawal by Subject|0
1083026|NCT02242903|3530791|P6|Overall Study|Withdrawal by Subject|0
1083027|NCT02242903|3530792|P5|Overall Study|Withdrawal by Subject|0
1083028|NCT02242903|3530793|P4|Overall Study|Withdrawal by Subject|0
1083029|NCT02242903|3530794|P3|Overall Study|Withdrawal by Subject|0
1083030|NCT02242903|3530795|P2|Overall Study|Withdrawal by Subject|0
1083031|NCT02242903|3530796|P1|Overall Study|Withdrawal by Subject|1
1083032|NCT02242643|3530826|P2|Overall Study|Withdrawal by subject at Visit 2|1
1083033|NCT02242643|3530827|P1|Overall Study|Withdrawal by subject at Visit 2|0
1083034|NCT02242643|3530826|P2|Overall Study|Language barrier|0
1083035|NCT02242643|3530827|P1|Overall Study|Language barrier|1
1083036|NCT02242643|3530826|P2|Overall Study|Protocol requirements not followed|0
1083037|NCT02242643|3530827|P1|Overall Study|Protocol requirements not followed|1
1083038|NCT02242643|3530826|P2|Overall Study|Consent withdrawal by parent|0
1083039|NCT02242643|3530827|P1|Overall Study|Consent withdrawal by parent|1
1083040|NCT02242643|3530826|P2|Overall Study|Non-compliance|0
1083041|NCT02242643|3530827|P1|Overall Study|Non-compliance|1
1083042|NCT02242643|3530826|P2|Overall Study|Child placed in foster care by family|1
1083043|NCT02242643|3530827|P1|Overall Study|Child placed in foster care by family|0
1083044|NCT02242643|3530826|P2|Overall Study|Lost to Follow-up|61
1083045|NCT02242643|3530827|P1|Overall Study|Lost to Follow-up|54
1083046|NCT02242643|3530826|P2|Overall Study|Migrated/moved from study area|3
1083047|NCT02242643|3530827|P1|Overall Study|Migrated/moved from study area|1
1083048|NCT02242643|3530826|P2|Overall Study|Withdrawal by Subject|10
1083049|NCT02242643|3530827|P1|Overall Study|Withdrawal by Subject|15
1083050|NCT02242643|3530826|P2|Overall Study|Protocol Violation|2
1083051|NCT02242643|3530827|P1|Overall Study|Protocol Violation|1
1083052|NCT02242305|3530882|P2|Overall Study|Lost to Follow-up|0
1083053|NCT02242305|3530883|P1|Overall Study|Lost to Follow-up|2
1083054|NCT02242305|3530882|P2|Overall Study|Subject withdraws inform consent|4
1083055|NCT02242305|3530883|P1|Overall Study|Subject withdraws inform consent|0
1083056|NCT02242305|3530882|P2|Overall Study|Non-compliance dosing regimen or visit|2
1083057|NCT02242305|3530883|P1|Overall Study|Non-compliance dosing regimen or visit|2
1083058|NCT02242305|3530882|P2|Overall Study|Adverse Event|0
1083059|NCT02242305|3530883|P1|Overall Study|Adverse Event|1
1083060|NCT02242305|3530882|P2|Overall Study|Without spasm-like pain during 3 weeks|4
1083061|NCT02242305|3530883|P1|Overall Study|Without spasm-like pain during 3 weeks|1
1083062|NCT02242201|3530904|P3|Overall Study|preoperative opioid consumption|0
1083063|NCT02242201|3530905|P2|Overall Study|preoperative opioid consumption|1
1083064|NCT02242201|3530906|P1|Overall Study|preoperative opioid consumption|0
1083065|NCT02242201|3530904|P3|Overall Study|postponed surgery|1
1083066|NCT02242201|3530905|P2|Overall Study|postponed surgery|0
1083067|NCT02242201|3530906|P1|Overall Study|postponed surgery|0
1083068|NCT02242201|3530904|P3|Overall Study|changed surgical procedure|0
1083069|NCT02242201|3530905|P2|Overall Study|changed surgical procedure|0
1083070|NCT02242201|3530906|P1|Overall Study|changed surgical procedure|1
1083071|NCT02242201|3530904|P3|Overall Study|planned post-op anticoagulation|0
1083072|NCT02242201|3530905|P2|Overall Study|planned post-op anticoagulation|0
1083073|NCT02242201|3530906|P1|Overall Study|planned post-op anticoagulation|1
1083074|NCT02242201|3530904|P3|Overall Study|preoperative identified neuropathy|0
1083075|NCT02242201|3530905|P2|Overall Study|preoperative identified neuropathy|0
1083076|NCT02242201|3530906|P1|Overall Study|preoperative identified neuropathy|2
1083077|NCT02241889|3530944|P6|Overall Study|Withdrawal by Subject|1
1083078|NCT02241889|3530945|P5|Overall Study|Withdrawal by Subject|0
1083079|NCT02241889|3530946|P4|Overall Study|Withdrawal by Subject|0
1083080|NCT02241889|3530947|P3|Overall Study|Withdrawal by Subject|0
1083081|NCT02241889|3530948|P2|Overall Study|Withdrawal by Subject|0
1083082|NCT02241889|3530949|P1|Overall Study|Withdrawal by Subject|0
1083083|NCT02241889|3530944|P6|Overall Study|device issues|0
1083084|NCT02241889|3530945|P5|Overall Study|device issues|0
1083085|NCT02241889|3530946|P4|Overall Study|device issues|0
1083086|NCT02241889|3530947|P3|Overall Study|device issues|1
1083087|NCT02241889|3530948|P2|Overall Study|device issues|0
1083088|NCT02241889|3530949|P1|Overall Study|device issues|0
1083089|NCT02241785|3530984|P1|Overall Study|Adverse Event|1
1083090|NCT02241785|3530984|P1|Overall Study|Lost to Follow-up|2
1083091|NCT02241785|3530984|P1|Overall Study|Withdrawal by Subject|1
1083092|NCT02241785|3530984|P1|Overall Study|Sponsor Termination|43
1083093|NCT02241551|3530998|P2|Overall Study|Adverse Event|0
1083094|NCT02241551|3530999|P1|Overall Study|Adverse Event|1
1083095|NCT02241187|3531023|P1|Overall Study|Protocol closed due to lack of accrual.|2
1083096|NCT02240693|3531033|P5|Overall Study|Other than specified|0
1083097|NCT02240693|3531034|P4|Overall Study|Other than specified|0
1083098|NCT02240693|3531035|P3|Overall Study|Other than specified|2
1083099|NCT02240693|3531036|P2|Overall Study|Other than specified|0
1083100|NCT02240693|3531037|P1|Overall Study|Other than specified|0
1083101|NCT02240693|3531033|P5|Overall Study|Withdrawal by Subject|0
1083102|NCT02240693|3531034|P4|Overall Study|Withdrawal by Subject|1
1083103|NCT02240693|3531035|P3|Overall Study|Withdrawal by Subject|2
1083104|NCT02240693|3531036|P2|Overall Study|Withdrawal by Subject|0
1083105|NCT02240693|3531037|P1|Overall Study|Withdrawal by Subject|0
1083106|NCT02240693|3531033|P5|Overall Study|Adverse Event|1
1083107|NCT02240693|3531034|P4|Overall Study|Adverse Event|0
1083108|NCT02240693|3531035|P3|Overall Study|Adverse Event|0
1083109|NCT02240693|3531036|P2|Overall Study|Adverse Event|0
1083110|NCT02240693|3531037|P1|Overall Study|Adverse Event|0
1083111|NCT02240680|3531073|P4|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
1083112|NCT02240680|3531074|P3|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1
1083113|NCT02240680|3531075|P2|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
1083114|NCT02240680|3531076|P1|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
1083115|NCT02240680|3531073|P4|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
1083116|NCT02240680|3531074|P3|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1
1083117|NCT02240680|3531075|P2|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
1083118|NCT02240680|3531076|P1|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
1083119|NCT02240680|3531073|P4|Japanese Patients (Up to 52 Weeks)|Adverse Event|7
1083120|NCT02240680|3531074|P3|Japanese Patients (Up to 52 Weeks)|Adverse Event|6
1083121|NCT02240680|3531075|P2|Japanese Patients (Up to 52 Weeks)|Adverse Event|0
1083122|NCT02240680|3531076|P1|Japanese Patients (Up to 52 Weeks)|Adverse Event|0
1083123|NCT02240680|3531073|P4|Overall Study (Up to 24 Weeks)|Other than specified|0
1083124|NCT02240680|3531074|P3|Overall Study (Up to 24 Weeks)|Other than specified|0
1083125|NCT02240680|3531075|P2|Overall Study (Up to 24 Weeks)|Other than specified|0
1083126|NCT02240680|3531076|P1|Overall Study (Up to 24 Weeks)|Other than specified|1
1083127|NCT02240680|3531073|P4|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0
1083128|NCT02240680|3531074|P3|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0
1083129|NCT02240680|3531075|P2|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1
1083130|NCT02240680|3531076|P1|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3
1083131|NCT02240680|3531073|P4|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
1083132|NCT02240680|3531074|P3|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
1083133|NCT02240680|3531075|P2|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
1083134|NCT02240680|3531076|P1|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1
1083135|NCT02240680|3531073|P4|Overall Study (Up to 24 Weeks)|Protocol Violation|0
1083136|NCT02240680|3531074|P3|Overall Study (Up to 24 Weeks)|Protocol Violation|0
1083137|NCT02240680|3531075|P2|Overall Study (Up to 24 Weeks)|Protocol Violation|1
1083138|NCT02240680|3531076|P1|Overall Study (Up to 24 Weeks)|Protocol Violation|4
1083139|NCT02240680|3531073|P4|Overall Study (Up to 24 Weeks)|Adverse Event|0
1083140|NCT02240680|3531074|P3|Overall Study (Up to 24 Weeks)|Adverse Event|0
1083141|NCT02240680|3531075|P2|Overall Study (Up to 24 Weeks)|Adverse Event|6
1083142|NCT02240680|3531076|P1|Overall Study (Up to 24 Weeks)|Adverse Event|6
1083143|NCT02240628|3531117|P2|Overall Study|Physician Decision|5
1083144|NCT02240628|3531118|P1|Overall Study|Physician Decision|6
1083145|NCT02240368|3531152|P3|Overall Study|Entropy failed to detect more than 50%|1
1083146|NCT02240368|3531153|P2|Overall Study|Entropy failed to detect more than 50%|0
1083147|NCT02240368|3531154|P1|Overall Study|Entropy failed to detect more than 50%|0
1083148|NCT02240368|3531152|P3|Overall Study|Surgery lasted less then 20 minutes|0
1083149|NCT02240368|3531153|P2|Overall Study|Surgery lasted less then 20 minutes|0
1083150|NCT02240368|3531154|P1|Overall Study|Surgery lasted less then 20 minutes|1
1083151|NCT02239978|3531213|P2|Overall Study|Withdrawal by Subject|0
1083152|NCT02239978|3531214|P1|Overall Study|Withdrawal by Subject|2
1083153|NCT02239939|3531231|P2|Overall Study|Lost to Follow-up|1
1083154|NCT02239939|3531232|P1|Overall Study|Lost to Follow-up|0
1083155|NCT02239939|3531231|P2|Overall Study|Withdrawal by Subject|1
1083156|NCT02239939|3531232|P1|Overall Study|Withdrawal by Subject|1
1083157|NCT02239939|3531231|P2|Overall Study|Adverse Event|0
1083158|NCT02239939|3531232|P1|Overall Study|Adverse Event|1
1083159|NCT02239926|3531248|P2|Overall Study|Withdrawal by Subject|1
1083160|NCT02239926|3531249|P1|Overall Study|Withdrawal by Subject|0
1083161|NCT02239692|3531311|P2|Overall Study|Other reason|0
1083162|NCT02239692|3531312|P1|Overall Study|Other reason|1
1083163|NCT02239692|3531311|P2|Overall Study|Withdrawal by Subject|5
1083164|NCT02239692|3531312|P1|Overall Study|Withdrawal by Subject|3
1083165|NCT02239692|3531311|P2|Overall Study|Lost to Follow-up|4
1083166|NCT02239692|3531312|P1|Overall Study|Lost to Follow-up|1
1083167|NCT02239692|3531311|P2|Overall Study|Physician Decision|1
1083168|NCT02239692|3531312|P1|Overall Study|Physician Decision|0
1083169|NCT02239692|3531311|P2|Overall Study|Adverse Event|1
1083170|NCT02239692|3531312|P1|Overall Study|Adverse Event|0
1083171|NCT02239692|3531311|P2|Overall Study|Incomplete colonoscopy|2
1083172|NCT02239692|3531312|P1|Overall Study|Incomplete colonoscopy|1
1083173|NCT02239679|3531331|P3|Overall Study|Withdrawal by Subject|1
1083174|NCT02239679|3531332|P2|Overall Study|Withdrawal by Subject|3
1083175|NCT02239679|3531333|P1|Overall Study|Withdrawal by Subject|2
1083176|NCT02239679|3531331|P3|Overall Study|Lost to Follow-up|0
1083177|NCT02239679|3531332|P2|Overall Study|Lost to Follow-up|0
1083178|NCT02239679|3531333|P1|Overall Study|Lost to Follow-up|1
1083179|NCT02239328|3531545|P1|Overall Study|Equipment or website malfunction|2
1083180|NCT02239328|3531545|P1|Overall Study|Benign disease noted at time of surgery|6
1083181|NCT02239094|3531568|P1|Overall Study|Remitted before started|1
1083182|NCT02239094|3531568|P1|Overall Study|Withdrawal by Subject|1
1083183|NCT02238483|3531596|P2|Overall Study|Illness in family member|0
1083184|NCT02238483|3531597|P1|Overall Study|Illness in family member|1
1083185|NCT02238483|3531596|P2|Overall Study|Completion status not recorded|1
1083186|NCT02238483|3531597|P1|Overall Study|Completion status not recorded|1
1083187|NCT02238483|3531596|P2|Overall Study|Withdrawn due to physician decision|0
1083188|NCT02238483|3531597|P1|Overall Study|Withdrawn due to physician decision|1
1083189|NCT02238483|3531596|P2|Overall Study|Adverse Event|3
1083190|NCT02238483|3531597|P1|Overall Study|Adverse Event|7
1083191|NCT02238483|3531596|P2|Overall Study|Death|0
1083192|NCT02238483|3531597|P1|Overall Study|Death|1
1083193|NCT02238483|3531596|P2|Overall Study|Protocol Violation|2
1083194|NCT02238483|3531597|P1|Overall Study|Protocol Violation|1
1083195|NCT02238483|3531596|P2|Overall Study|Lost to Follow-up|1
1083196|NCT02238483|3531597|P1|Overall Study|Lost to Follow-up|1
1083197|NCT02238483|3531596|P2|Overall Study|Withdrawal by Subject|7
1083198|NCT02238483|3531597|P1|Overall Study|Withdrawal by Subject|2
1083199|NCT02238379|3531635|P2|Overall Study|Lost to Follow-up|0
1083200|NCT02238379|3531636|P1|Overall Study|Lost to Follow-up|1
1083201|NCT02238080|3531662|P1|Overall Study|Other|4
1083202|NCT02238080|3531662|P1|Overall Study|Withdrawal by Subject|2
1083203|NCT02238080|3531662|P1|Overall Study|Treatment interrupted|6
1083204|NCT02238080|3531662|P1|Overall Study|Death|13
1083205|NCT02238067|3531676|P1|Overall Study|Not completed survey at Month 6|45
1083206|NCT02237118|3531721|P2|Overall Study|consent withdrawn|0
1083207|NCT02237118|3531722|P1|Overall Study|consent withdrawn|1
1083208|NCT02237118|3531721|P2|Overall Study|Protocol Violation|1
1083209|NCT02237118|3531722|P1|Overall Study|Protocol Violation|0
1083210|NCT02236611|3531759|P2|Overall Study|Withdrew consent|4
1083211|NCT02236611|3531760|P1|Overall Study|Withdrew consent|9
1083212|NCT02236611|3531759|P2|Overall Study|Protocol deviation|5
1083213|NCT02236611|3531760|P1|Overall Study|Protocol deviation|3
1083214|NCT02236611|3531759|P2|Overall Study|Lost to Follow-up|2
1083215|NCT02236611|3531760|P1|Overall Study|Lost to Follow-up|0
1083216|NCT02236611|3531759|P2|Overall Study|Lack of Efficacy|7
1083217|NCT02236611|3531760|P1|Overall Study|Lack of Efficacy|4
1083218|NCT02236611|3531759|P2|Overall Study|Adverse Event|16
1083219|NCT02236611|3531760|P1|Overall Study|Adverse Event|10
1083220|NCT02236598|3531768|P2|Overall Study|Withdrawal by Subject|1
1083221|NCT02236598|3531769|P1|Overall Study|Withdrawal by Subject|0
1083222|NCT02236598|3531768|P2|Overall Study|Adverse Event|1
1083223|NCT02236598|3531769|P1|Overall Study|Adverse Event|0
1083224|NCT02236130|3531805|P2|Overall Study|Lost to Follow-up|12
1083225|NCT02236130|3531806|P1|Overall Study|Lost to Follow-up|7
1083226|NCT02235454|3531856|P1|Overall Study|Withdrawal by Subject|2
1083227|NCT02235311|3531862|P2|Overall Study|Protocol Violation|1
1083228|NCT02235311|3531863|P1|Overall Study|Protocol Violation|0
1083229|NCT02235311|3531862|P2|Overall Study|Lost to Follow-up|1
1083230|NCT02235311|3531863|P1|Overall Study|Lost to Follow-up|0
1083231|NCT02235077|3531881|P2|Overall Study|Physician Decision|1
1083232|NCT02235077|3531882|P1|Overall Study|Physician Decision|0
1083233|NCT02235077|3531881|P2|Overall Study|Withdrawal by Subject|5
1083234|NCT02235077|3531882|P1|Overall Study|Withdrawal by Subject|8
1083235|NCT02235077|3531881|P2|Overall Study|Lost to Follow-up|6
1083236|NCT02235077|3531882|P1|Overall Study|Lost to Follow-up|5
1083237|NCT02235077|3531881|P2|Overall Study|Death|7
1083238|NCT02235077|3531882|P1|Overall Study|Death|5
1083239|NCT02234479|3531963|P2|Overall Study|Withdrawal by Subject|3
1083240|NCT02234479|3531964|P1|Overall Study|Withdrawal by Subject|1
1083241|NCT02234362|3531974|P1|Overall Study|Withdrawal by Subject|3
1083242|NCT02234362|3531974|P1|Overall Study|Lost to Follow-up|6
1083243|NCT02234362|3531974|P1|Overall Study|Not eligible after first screening visit|17
1083244|NCT02233803|3532062|P2|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2
1083245|NCT02233803|3532063|P1|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1
1083246|NCT02233803|3532062|P2|Treatment Period 2 (4-Wks)|Lost to Follow-up|0
1083247|NCT02233803|3532063|P1|Treatment Period 2 (4-Wks)|Lost to Follow-up|1
1083248|NCT02233803|3532062|P2|Washout Period (4-Wks)|Withdrawal by Subject|1
1083249|NCT02233803|3532063|P1|Washout Period (4-Wks)|Withdrawal by Subject|1
1083250|NCT02233803|3532062|P2|Washout Period (4-Wks)|Physician Decision|0
1083251|NCT02233803|3532063|P1|Washout Period (4-Wks)|Physician Decision|1
1083252|NCT02233803|3532062|P2|Washout Period (4-Wks)|Lost to Follow-up|1
1083253|NCT02233803|3532063|P1|Washout Period (4-Wks)|Lost to Follow-up|0
1083254|NCT02233803|3532062|P2|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1
1083255|NCT02233803|3532063|P1|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0
1083256|NCT02233803|3532062|P2|Treatment Period 1 (4-Wks)|Protocol Violation|2
1083257|NCT02233803|3532063|P1|Treatment Period 1 (4-Wks)|Protocol Violation|2
1083258|NCT02233803|3532062|P2|Treatment Period 1 (4-Wks)|Adverse Event|1
1083259|NCT02233803|3532063|P1|Treatment Period 1 (4-Wks)|Adverse Event|0
1083260|NCT02233803|3532062|P2|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0
1083261|NCT02233803|3532063|P1|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1
1083262|NCT02233647|3532073|P1|Overall Study|Adverse Event|1
1083263|NCT02233543|3532102|P2|Period 2|COPD exacerbation|0
1083264|NCT02233543|3532103|P1|Period 2|COPD exacerbation|1
1083265|NCT02233543|3532102|P2|Period 2|Participant required other treatment.|1
1083266|NCT02233543|3532103|P1|Period 2|Participant required other treatment.|0
1083267|NCT02233543|3532102|P2|Period 2|Adverse Event|0
1083268|NCT02233543|3532103|P1|Period 2|Adverse Event|1
1083269|NCT02233543|3532102|P2|Period 1|Participants required other treatment.|3
1083270|NCT02233543|3532103|P1|Period 1|Participants required other treatment.|2
1083271|NCT02233543|3532102|P2|Period 1|Withdrawal by Subject|0
1083272|NCT02233543|3532103|P1|Period 1|Withdrawal by Subject|1
1083273|NCT02233309|3532111|P1|Overall Study|Physician Decision|5
1083274|NCT02232880|3532145|P1|Overall Study|study stopped prior to randomization|1
1083275|NCT02232698|3532154|P2|Overall Study|Withdrawal by Subject|11
1083276|NCT02232698|3532155|P1|Overall Study|Withdrawal by Subject|0
1083277|NCT02232698|3532154|P2|Overall Study|Allocated to control group|3
1083278|NCT02232698|3532155|P1|Overall Study|Allocated to control group|0
1083279|NCT02232698|3532154|P2|Overall Study|Non-compliance with study device|4
1083280|NCT02232698|3532155|P1|Overall Study|Non-compliance with study device|1
1083281|NCT02232698|3532154|P2|Overall Study|Had device-associated symptoms|0
1083282|NCT02232698|3532155|P1|Overall Study|Had device-associated symptoms|7
1083283|NCT02232698|3532154|P2|Overall Study|Met exclusion criteria|1
1083284|NCT02232698|3532155|P1|Overall Study|Met exclusion criteria|1
1083285|NCT02232698|3532154|P2|Overall Study|Pregnancy|1
1083286|NCT02232698|3532155|P1|Overall Study|Pregnancy|1
1083287|NCT02232178|3532179|P3|Overall Study|surgical complication|0
1083288|NCT02232178|3532180|P2|Overall Study|surgical complication|0
1083289|NCT02232178|3532181|P1|Overall Study|surgical complication|1
1083290|NCT02232178|3532179|P3|Overall Study|ineligibility|1
1083291|NCT02232178|3532180|P2|Overall Study|ineligibility|0
1083292|NCT02232178|3532181|P1|Overall Study|ineligibility|0
1083293|NCT02232178|3532179|P3|Overall Study|Lost to Follow-up|0
1083294|NCT02232178|3532180|P2|Overall Study|Lost to Follow-up|1
1083295|NCT02232178|3532181|P1|Overall Study|Lost to Follow-up|0
1083296|NCT02231918|3532212|P3|Overall Study|Adverse Event|1
1083297|NCT02231918|3532213|P2|Overall Study|Adverse Event|0
1083298|NCT02231918|3532214|P1|Overall Study|Adverse Event|0
1083299|NCT02231918|3532212|P3|Overall Study|Withdrawal by Subject|0
1083300|NCT02231918|3532213|P2|Overall Study|Withdrawal by Subject|1
1083301|NCT02231918|3532214|P1|Overall Study|Withdrawal by Subject|0
1083302|NCT02231749|3532278|P2|Overall Study|No longer meets Study Criteria|0
1083303|NCT02231749|3532279|P1|Overall Study|No longer meets Study Criteria|1
1083304|NCT02231749|3532278|P2|Overall Study|other|8
1083305|NCT02231749|3532279|P1|Overall Study|other|0
1083306|NCT02231749|3532278|P2|Overall Study|Pregnancy|0
1083307|NCT02231749|3532279|P1|Overall Study|Pregnancy|1
1083308|NCT02231749|3532278|P2|Overall Study|Poor/Non-Compliance|3
1083309|NCT02231749|3532279|P1|Overall Study|Poor/Non-Compliance|0
1083310|NCT02231749|3532278|P2|Overall Study|Maximum Clinical Benefit|8
1083311|NCT02231749|3532279|P1|Overall Study|Maximum Clinical Benefit|5
1083312|NCT02231749|3532278|P2|Overall Study|Lost to Follow-up|2
1083313|NCT02231749|3532279|P1|Overall Study|Lost to Follow-up|1
1083314|NCT02231749|3532278|P2|Overall Study|Participant withdrew Consent|15
1083315|NCT02231749|3532279|P1|Overall Study|Participant withdrew Consent|8
1083316|NCT02231749|3532278|P2|Overall Study|Participant's request to discontinue|21
1083317|NCT02231749|3532279|P1|Overall Study|Participant's request to discontinue|10
1083318|NCT02231749|3532278|P2|Overall Study|AE unrelated to Study drug|31
1083319|NCT02231749|3532279|P1|Overall Study|AE unrelated to Study drug|32
1083320|NCT02231749|3532278|P2|Overall Study|Death|1
1083321|NCT02231749|3532279|P1|Overall Study|Death|1
1083322|NCT02231749|3532278|P2|Overall Study|Study Drug Toxicity|63
1083323|NCT02231749|3532279|P1|Overall Study|Study Drug Toxicity|134
1083324|NCT02231749|3532278|P2|Overall Study|Disease progression|297
1083325|NCT02231749|3532279|P1|Overall Study|Disease progression|229
1083326|NCT02231580|3532297|P2|Overall Study|Adverse Event|0
1083327|NCT02231580|3532298|P1|Overall Study|Adverse Event|5
1083328|NCT02231164|3532415|P2|Overall Study|Withdrawal by Subject|2
1083329|NCT02231164|3532416|P1|Overall Study|Withdrawal by Subject|1
1083330|NCT02231164|3532415|P2|Overall Study|Lack of Efficacy|3
1083331|NCT02231164|3532416|P1|Overall Study|Lack of Efficacy|4
1083332|NCT02231164|3532415|P2|Overall Study|Adverse Event|1
1083333|NCT02231164|3532416|P1|Overall Study|Adverse Event|1
1083334|NCT02230956|3532444|P3|Overall Study|Other Miscellaneous Reason|2
1083335|NCT02230956|3532445|P2|Overall Study|Other Miscellaneous Reason|1
1083336|NCT02230956|3532446|P1|Overall Study|Other Miscellaneous Reason|0
1083337|NCT02230956|3532444|P3|Overall Study|Protocol Violation|1
1083338|NCT02230956|3532445|P2|Overall Study|Protocol Violation|1
1083339|NCT02230956|3532446|P1|Overall Study|Protocol Violation|0
1083340|NCT02230956|3532444|P3|Overall Study|Personal Reasons|1
1083341|NCT02230956|3532445|P2|Overall Study|Personal Reasons|1
1083342|NCT02230956|3532446|P1|Overall Study|Personal Reasons|2
1083343|NCT02230956|3532444|P3|Overall Study|Lost to Follow-up|2
1083344|NCT02230956|3532445|P2|Overall Study|Lost to Follow-up|1
1083345|NCT02230956|3532446|P1|Overall Study|Lost to Follow-up|1
1083346|NCT02230956|3532444|P3|Overall Study|Lack of Efficacy|1
1083347|NCT02230956|3532445|P2|Overall Study|Lack of Efficacy|1
1083348|NCT02230956|3532446|P1|Overall Study|Lack of Efficacy|1
1083349|NCT02230956|3532444|P3|Overall Study|Adverse Event|0
1083350|NCT02230956|3532445|P2|Overall Study|Adverse Event|1
1083351|NCT02230956|3532446|P1|Overall Study|Adverse Event|1
1083352|NCT02230904|3532468|P2|Overall Study|Safety follow up could not take place|1
1083353|NCT02230904|3532469|P1|Overall Study|Safety follow up could not take place|0
1083354|NCT02230683|3532502|P1|Overall Study|Adverse Event|1
1083355|NCT02230670|3532519|P2|Overall Study|Progression to Child-Pugh C|2
1083356|NCT02230670|3532520|P1|Overall Study|Progression to Child-Pugh C|1
1083357|NCT02230670|3532519|P2|Overall Study|Protocol Violation|1
1083358|NCT02230670|3532520|P1|Overall Study|Protocol Violation|0
1083359|NCT02230670|3532519|P2|Overall Study|Physician Decision|1
1083360|NCT02230670|3532520|P1|Overall Study|Physician Decision|0
1083361|NCT02230670|3532519|P2|Overall Study|Withdrawal by Subject|2
1083362|NCT02230670|3532520|P1|Overall Study|Withdrawal by Subject|2
1083363|NCT02230670|3532519|P2|Overall Study|Adverse Event|2
1083364|NCT02230670|3532520|P1|Overall Study|Adverse Event|1
1083365|NCT02230384|3532606|P2|Phase 2 - Switch|Adverse Event|0
1083366|NCT02230384|3532607|P1|Phase 2 - Switch|Adverse Event|2
1083367|NCT02230384|3532606|P2|Phase 2 - Switch|Lost to Follow-up|0
1083368|NCT02230384|3532607|P1|Phase 2 - Switch|Lost to Follow-up|1
1083369|NCT02230384|3532606|P2|Phase 2 - Switch|Withdrawal by Subject|1
1083370|NCT02230384|3532607|P1|Phase 2 - Switch|Withdrawal by Subject|0
1083371|NCT02230384|3532606|P2|Phase 1|Physician Decision|1
1083372|NCT02230384|3532607|P1|Phase 1|Physician Decision|0
1083373|NCT02230384|3532606|P2|Phase 1|Lost to Follow-up|0
1083374|NCT02230384|3532607|P1|Phase 1|Lost to Follow-up|1
1083375|NCT02230332|3532615|P2|Overall Study|Protocol Violation|0
1083376|NCT02230332|3532616|P1|Overall Study|Protocol Violation|1
1083377|NCT02230332|3532615|P2|Overall Study|Lost to Follow-up|0
1083378|NCT02230332|3532616|P1|Overall Study|Lost to Follow-up|1
1083379|NCT02230332|3532615|P2|Overall Study|Adverse Event|1
1083380|NCT02230332|3532616|P1|Overall Study|Adverse Event|2
1083381|NCT02230306|3532632|P1|Overall Study|Did not receive study treatment|1
1083382|NCT02230085|3532643|P1|Overall Study|Withdrawal by Subject|3
1083383|NCT02230085|3532643|P1|Overall Study|Physician Decision|1
1083384|NCT02229864|3532647|P1|3 - Year Visit|Death|2
1083385|NCT02229864|3532647|P1|2 - Year Visit|Missed Visits|1
1083386|NCT02229539|3532702|P3|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0
1083387|NCT02229539|3532703|P2|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1
1083388|NCT02229539|3532704|P1|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2
1083389|NCT02229539|3532702|P3|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3
1083390|NCT02229539|3532703|P2|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
1083391|NCT02229539|3532704|P1|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
1083392|NCT02229539|3532702|P3|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
1083393|NCT02229539|3532703|P2|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
1083394|NCT02229539|3532704|P1|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0
1083395|NCT02229539|3532702|P3|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
1083396|NCT02229539|3532703|P2|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
1083397|NCT02229539|3532704|P1|Cycle 2 (Optional Continuation Phase)|Adverse Event|2
1083398|NCT02229539|3532702|P3|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6
1083399|NCT02229539|3532703|P2|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
1083400|NCT02229539|3532704|P1|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
1083401|NCT02229539|3532702|P3|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1
1083402|NCT02229539|3532703|P2|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4
1083403|NCT02229539|3532704|P1|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3
1083404|NCT02229539|3532702|P3|Cycle 1 (Treatment Per Protocol)|Medical Problems|1
1083405|NCT02229539|3532703|P2|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
1083406|NCT02229539|3532704|P1|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
1083407|NCT02229539|3532702|P3|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1
1083408|NCT02229539|3532703|P2|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
1083409|NCT02229539|3532704|P1|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
1083410|NCT02229539|3532702|P3|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
1083411|NCT02229539|3532703|P2|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1
1083412|NCT02229539|3532704|P1|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
1083413|NCT02229396|3532835|P3|Overall Study|Withdrew; No Record on Termination Page|1
1083414|NCT02229396|3532836|P2|Overall Study|Withdrew; No Record on Termination Page|0
1083415|NCT02229396|3532837|P1|Overall Study|Withdrew; No Record on Termination Page|2
1083416|NCT02229396|3532835|P3|Overall Study|Study-Specific Withdrawal Criteria|3
1083417|NCT02229396|3532836|P2|Overall Study|Study-Specific Withdrawal Criteria|1
1083418|NCT02229396|3532837|P1|Overall Study|Study-Specific Withdrawal Criteria|0
1083419|NCT02229396|3532835|P3|Overall Study|Withdrawal by Subject|41
1083420|NCT02229396|3532836|P2|Overall Study|Withdrawal by Subject|28
1083421|NCT02229396|3532837|P1|Overall Study|Withdrawal by Subject|42
1083422|NCT02229396|3532835|P3|Overall Study|Other|15
1083423|NCT02229396|3532836|P2|Overall Study|Other|18
1083424|NCT02229396|3532837|P1|Overall Study|Other|10
1083425|NCT02229396|3532835|P3|Overall Study|Patient Incorrectly Randomized|1
1083426|NCT02229396|3532836|P2|Overall Study|Patient Incorrectly Randomized|0
1083427|NCT02229396|3532837|P1|Overall Study|Patient Incorrectly Randomized|0
1083428|NCT02229396|3532835|P3|Overall Study|Protocol Violation|0
1083429|NCT02229396|3532836|P2|Overall Study|Protocol Violation|1
1083430|NCT02229396|3532837|P1|Overall Study|Protocol Violation|2
1083431|NCT02229396|3532835|P3|Overall Study|Lost to Follow-up|21
1083432|NCT02229396|3532836|P2|Overall Study|Lost to Follow-up|14
1083433|NCT02229396|3532837|P1|Overall Study|Lost to Follow-up|14
1083434|NCT02229396|3532835|P3|Overall Study|Death|1
1083435|NCT02229396|3532836|P2|Overall Study|Death|3
1083436|NCT02229396|3532837|P1|Overall Study|Death|2
1083437|NCT02229396|3532835|P3|Overall Study|Adverse Event|12
1083438|NCT02229396|3532836|P2|Overall Study|Adverse Event|12
1083439|NCT02229396|3532837|P1|Overall Study|Adverse Event|6
1083440|NCT02229383|3532868|P2|Overall Study|Randomized in error|0
1083441|NCT02229383|3532869|P1|Overall Study|Randomized in error|1
1083442|NCT02229383|3532868|P2|Overall Study|Investigator decision|4
1083443|NCT02229383|3532869|P1|Overall Study|Investigator decision|1
1083444|NCT02229383|3532868|P2|Overall Study|Death|1
1083445|NCT02229383|3532869|P1|Overall Study|Death|0
1083446|NCT02229383|3532868|P2|Overall Study|Fire at the study center|4
1083447|NCT02229383|3532869|P1|Overall Study|Fire at the study center|2
1083448|NCT02229383|3532868|P2|Overall Study|Withdrawal by Subject|9
1083449|NCT02229383|3532869|P1|Overall Study|Withdrawal by Subject|5
1083450|NCT02229383|3532868|P2|Overall Study|Lost to Follow-up|2
1083451|NCT02229383|3532869|P1|Overall Study|Lost to Follow-up|4
1083452|NCT02229383|3532868|P2|Overall Study|Adverse Event|4
1083453|NCT02229383|3532869|P1|Overall Study|Adverse Event|9
1083454|NCT02229227|3532894|P2|Overall Study|Physician Decision|12
1083455|NCT02229227|3532895|P1|Overall Study|Physician Decision|5
1083456|NCT02229227|3532894|P2|Overall Study|Other|1
1083457|NCT02229227|3532895|P1|Overall Study|Other|0
1083458|NCT02229227|3532894|P2|Overall Study|Withdrawal by Subject|12
1083459|NCT02229227|3532895|P1|Overall Study|Withdrawal by Subject|8
1083460|NCT02229227|3532894|P2|Overall Study|Study terminated by sponsor|11
1083461|NCT02229227|3532895|P1|Overall Study|Study terminated by sponsor|11
1083462|NCT02229227|3532894|P2|Overall Study|Lost to Follow-up|3
1083463|NCT02229227|3532895|P1|Overall Study|Lost to Follow-up|3
1083464|NCT02229227|3532894|P2|Overall Study|Protocol defined stopping criteria|3
1083465|NCT02229227|3532895|P1|Overall Study|Protocol defined stopping criteria|1
1083466|NCT02229227|3532894|P2|Overall Study|Protocol Violation|8
1083467|NCT02229227|3532895|P1|Overall Study|Protocol Violation|6
1083468|NCT02229227|3532894|P2|Overall Study|Lack of Efficacy|3
1083469|NCT02229227|3532895|P1|Overall Study|Lack of Efficacy|3
1083470|NCT02229227|3532894|P2|Overall Study|Adverse Event|9
1083471|NCT02229227|3532895|P1|Overall Study|Adverse Event|14
1083472|NCT02229214|3532980|P2|Overall Study|Withdrawal by Subject|0
1083473|NCT02229214|3532981|P1|Overall Study|Withdrawal by Subject|4
1083474|NCT02229214|3532980|P2|Overall Study|Adverse Event|0
1083475|NCT02229214|3532981|P1|Overall Study|Adverse Event|2
1083476|NCT02228980|3533005|P4|Overall Study|Withdrawal by Subject|3
1083477|NCT02228980|3533006|P3|Overall Study|Withdrawal by Subject|2
1083478|NCT02228980|3533007|P2|Overall Study|Withdrawal by Subject|3
1083479|NCT02228980|3533008|P1|Overall Study|Withdrawal by Subject|3
1083480|NCT02228980|3533005|P4|Overall Study|Protocol Violation|0
1083481|NCT02228980|3533006|P3|Overall Study|Protocol Violation|0
1083482|NCT02228980|3533007|P2|Overall Study|Protocol Violation|0
1083483|NCT02228980|3533008|P1|Overall Study|Protocol Violation|7
1083484|NCT02228980|3533005|P4|Overall Study|Adverse Event|0
1083485|NCT02228980|3533006|P3|Overall Study|Adverse Event|0
1083486|NCT02228980|3533007|P2|Overall Study|Adverse Event|0
1083487|NCT02228980|3533008|P1|Overall Study|Adverse Event|14
1083488|NCT02228720|3533047|P1|Open Label - Day 30|Lost to Follow-up|1
1083489|NCT02228395|3533055|P3|First Intervention Period|Unable to comply with study dates|1
1083490|NCT02228395|3533056|P2|First Intervention Period|Unable to comply with study dates|1
1083491|NCT02228395|3533057|P1|First Intervention Period|Unable to comply with study dates|0
1083492|NCT02228395|3533055|P3|First Intervention Period|No longer willing to participate|0
1083493|NCT02228395|3533056|P2|First Intervention Period|No longer willing to participate|0
1083494|NCT02228395|3533057|P1|First Intervention Period|No longer willing to participate|1
1083495|NCT02227784|3533140|P5|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3
1083496|NCT02227784|3533141|P4|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
1083497|NCT02227784|3533142|P3|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
1083498|NCT02227784|3533143|P2|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
1083499|NCT02227784|3533144|P1|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
1083500|NCT02227784|3533140|P5|Open-Label Extension Phase (OLE)|Sponsor Decision|243
1083501|NCT02227784|3533141|P4|Open-Label Extension Phase (OLE)|Sponsor Decision|0
1083502|NCT02227784|3533142|P3|Open-Label Extension Phase (OLE)|Sponsor Decision|0
1083503|NCT02227784|3533143|P2|Open-Label Extension Phase (OLE)|Sponsor Decision|0
1083504|NCT02227784|3533144|P1|Open-Label Extension Phase (OLE)|Sponsor Decision|0
1083505|NCT02227784|3533140|P5|Open-Label Extension Phase (OLE)|Death|1
1083506|NCT02227784|3533141|P4|Open-Label Extension Phase (OLE)|Death|0
1083507|NCT02227784|3533142|P3|Open-Label Extension Phase (OLE)|Death|0
1083508|NCT02227784|3533143|P2|Open-Label Extension Phase (OLE)|Death|0
1083509|NCT02227784|3533144|P1|Open-Label Extension Phase (OLE)|Death|0
1083510|NCT02227784|3533140|P5|Open-Label Extension Phase (OLE)|Adverse Event|1
1083511|NCT02227784|3533141|P4|Open-Label Extension Phase (OLE)|Adverse Event|0
1083512|NCT02227784|3533142|P3|Open-Label Extension Phase (OLE)|Adverse Event|0
1083513|NCT02227784|3533143|P2|Open-Label Extension Phase (OLE)|Adverse Event|0
1083514|NCT02227784|3533144|P1|Open-Label Extension Phase (OLE)|Adverse Event|0
1083515|NCT02227784|3533140|P5|Double-Blind Phase|Withdrawal by Subject|0
1083516|NCT02227784|3533141|P4|Double-Blind Phase|Withdrawal by Subject|2
1083517|NCT02227784|3533142|P3|Double-Blind Phase|Withdrawal by Subject|5
1083518|NCT02227784|3533143|P2|Double-Blind Phase|Withdrawal by Subject|1
1083519|NCT02227784|3533144|P1|Double-Blind Phase|Withdrawal by Subject|2
1083520|NCT02227784|3533140|P5|Double-Blind Phase|Sponsor Decision|0
1083521|NCT02227784|3533141|P4|Double-Blind Phase|Sponsor Decision|32
1083522|NCT02227784|3533142|P3|Double-Blind Phase|Sponsor Decision|14
1083523|NCT02227784|3533143|P2|Double-Blind Phase|Sponsor Decision|15
1083524|NCT02227784|3533144|P1|Double-Blind Phase|Sponsor Decision|34
1083525|NCT02227784|3533140|P5|Double-Blind Phase|Protocol Violation|0
1083526|NCT02227784|3533141|P4|Double-Blind Phase|Protocol Violation|1
1083527|NCT02227784|3533142|P3|Double-Blind Phase|Protocol Violation|1
1083528|NCT02227784|3533143|P2|Double-Blind Phase|Protocol Violation|0
1083529|NCT02227784|3533144|P1|Double-Blind Phase|Protocol Violation|0
1083530|NCT02227784|3533140|P5|Double-Blind Phase|Physician Decision|0
1083531|NCT02227784|3533141|P4|Double-Blind Phase|Physician Decision|1
1083532|NCT02227784|3533142|P3|Double-Blind Phase|Physician Decision|0
1083533|NCT02227784|3533143|P2|Double-Blind Phase|Physician Decision|0
1083534|NCT02227784|3533144|P1|Double-Blind Phase|Physician Decision|1
1083535|NCT02227784|3533140|P5|Double-Blind Phase|Adverse Event|0
1083536|NCT02227784|3533141|P4|Double-Blind Phase|Adverse Event|3
1083537|NCT02227784|3533142|P3|Double-Blind Phase|Adverse Event|1
1083538|NCT02227784|3533143|P2|Double-Blind Phase|Adverse Event|2
1083539|NCT02227784|3533144|P1|Double-Blind Phase|Adverse Event|3
1083540|NCT02227368|3533212|P2|Overall Study|Adverse Event|0
1083541|NCT02227368|3533213|P1|Overall Study|Adverse Event|1
1083542|NCT02227368|3533212|P2|Overall Study|Lost to Follow-up|0
1083543|NCT02227368|3533213|P1|Overall Study|Lost to Follow-up|1
1083544|NCT02227368|3533212|P2|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4
1083545|NCT02227368|3533213|P1|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0
1083546|NCT02227108|3533271|P1|Overall Study|Adverse Event|6
1083547|NCT02227108|3533271|P1|Overall Study|Investigator discretion|1
1083548|NCT02227108|3533271|P1|Overall Study|Initiation of alternative therapy|2
1083549|NCT02227108|3533271|P1|Overall Study|Progressive disease|17
1083550|NCT02227108|3533271|P1|Overall Study|Other|3
1083551|NCT02227108|3533271|P1|Overall Study|Did not receive treatment|2
1083552|NCT02226653|3533300|P2|Treatment Period 5 Fed State|Adverse Event|1
1083553|NCT02226653|3533301|P1|Treatment Period 5 Fed State|Adverse Event|0
1083554|NCT02226653|3533300|P2|Treatment Period 2 Fasted State|Lost to Follow-up|0
1083555|NCT02226653|3533301|P1|Treatment Period 2 Fasted State|Lost to Follow-up|1
1083556|NCT02226562|3533325|P2|Overall Study|Lost to Follow-up|1
1083557|NCT02226562|3533326|P1|Overall Study|Lost to Follow-up|0
1083558|NCT02226549|3533344|P2|Overall Study|Lost to Follow-up|1
1083559|NCT02226549|3533345|P1|Overall Study|Lost to Follow-up|0
1083560|NCT02226549|3533344|P2|Overall Study|Randomized but Never Treated|0
1083561|NCT02226549|3533345|P1|Overall Study|Randomized but Never Treated|1
1083562|NCT02226198|3533355|P3|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
1083563|NCT02226198|3533356|P2|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1
1083564|NCT02226198|3533357|P1|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
1083565|NCT02226198|3533355|P3|Lead-in Phase|Protocol Violation|0
1083566|NCT02226198|3533356|P2|Lead-in Phase|Protocol Violation|0
1083567|NCT02226198|3533357|P1|Lead-in Phase|Protocol Violation|1
1083568|NCT02226172|3533430|P1|Overall Study|Ongoing in study|3
1083569|NCT02226172|3533430|P1|Overall Study|Death|1
1083570|NCT02226172|3533430|P1|Overall Study|Other|4
1083571|NCT02226172|3533430|P1|Overall Study|Subject refused further follow-up|5
1083572|NCT02226003|3533452|P3|Overall Study|Withdrawal by Subject|3
1083573|NCT02226003|3533453|P2|Overall Study|Withdrawal by Subject|0
1083574|NCT02226003|3533454|P1|Overall Study|Withdrawal by Subject|0
1083575|NCT02226003|3533452|P3|Overall Study|Lost to Follow-up|3
1083576|NCT02226003|3533453|P2|Overall Study|Lost to Follow-up|1
1083577|NCT02226003|3533454|P1|Overall Study|Lost to Follow-up|2
1083578|NCT02225353|3533502|P3|Overall Study|Protocol Violation|12
1083579|NCT02225353|3533503|P2|Overall Study|Protocol Violation|5
1083580|NCT02225353|3533504|P1|Overall Study|Protocol Violation|4
1083581|NCT02225353|3533502|P3|Overall Study|Lost to Follow-up|3
1083582|NCT02225353|3533503|P2|Overall Study|Lost to Follow-up|1
1083583|NCT02225353|3533504|P1|Overall Study|Lost to Follow-up|0
1083584|NCT02224846|3533536|P2|Period 2 (Month 12 to Month 24)|Sponsor Decision|1
1083585|NCT02224846|3533537|P1|Period 2 (Month 12 to Month 24)|Sponsor Decision|2
1083586|NCT02224846|3533536|P2|Period 2 (Month 12 to Month 24)|Physician Decision|2
1083587|NCT02224846|3533537|P1|Period 2 (Month 12 to Month 24)|Physician Decision|0
1083588|NCT02224846|3533536|P2|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43
1083589|NCT02224846|3533537|P1|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25
1083590|NCT02224846|3533536|P2|Period 2 (Month 12 to Month 24)|Protocol Violation|11
1083591|NCT02224846|3533537|P1|Period 2 (Month 12 to Month 24)|Protocol Violation|4
1083592|NCT02224846|3533536|P2|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13
1083593|NCT02224846|3533537|P1|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7
1083594|NCT02224846|3533536|P2|Period 2 (Month 12 to Month 24)|Death|0
1083595|NCT02224846|3533537|P1|Period 2 (Month 12 to Month 24)|Death|1
1083596|NCT02224846|3533536|P2|Period 2 (Month 12 to Month 24)|Adverse Event|4
1083597|NCT02224846|3533537|P1|Period 2 (Month 12 to Month 24)|Adverse Event|3
1083598|NCT02224846|3533536|P2|Period 2 (Month 3 to Month 12)|Physician Decision|2
1083599|NCT02224846|3533537|P1|Period 2 (Month 3 to Month 12)|Physician Decision|0
1083600|NCT02224846|3533536|P2|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19
1083601|NCT02224846|3533537|P1|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15
1083602|NCT02224846|3533536|P2|Period 2 (Month 3 to Month 12)|Protocol Violation|3
1083603|NCT02224846|3533537|P1|Period 2 (Month 3 to Month 12)|Protocol Violation|0
1083604|NCT02224846|3533536|P2|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5
1083605|NCT02224846|3533537|P1|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3
1083606|NCT02224846|3533536|P2|Period 2 (Month 3 to Month 12)|Adverse Event|2
1083607|NCT02224846|3533537|P1|Period 2 (Month 3 to Month 12)|Adverse Event|1
1083608|NCT02224846|3533536|P2|Period 1 (Month 3)|Sponsor Decision|1
1083609|NCT02224846|3533537|P1|Period 1 (Month 3)|Sponsor Decision|2
1083610|NCT02224846|3533536|P2|Period 1 (Month 3)|Withdrawal by Subject|18
1083611|NCT02224846|3533537|P1|Period 1 (Month 3)|Withdrawal by Subject|8
1083612|NCT02224846|3533536|P2|Period 1 (Month 3)|Protocol Violation|8
1083613|NCT02224846|3533537|P1|Period 1 (Month 3)|Protocol Violation|4
1083614|NCT02224846|3533536|P2|Period 1 (Month 3)|Lost to Follow-up|8
1083615|NCT02224846|3533537|P1|Period 1 (Month 3)|Lost to Follow-up|3
1083616|NCT02224846|3533536|P2|Period 1 (Month 3)|Adverse Event|1
1083617|NCT02224846|3533537|P1|Period 1 (Month 3)|Adverse Event|2
1083618|NCT02224690|3533575|P2|Overall Study|Did not meet eligibility criteria|0
1083619|NCT02224690|3533576|P1|Overall Study|Did not meet eligibility criteria|1
1083620|NCT02224690|3533575|P2|Overall Study|Use of G-tube|0
1083621|NCT02224690|3533576|P1|Overall Study|Use of G-tube|1
1083622|NCT02224690|3533575|P2|Overall Study|Met Withdrawal Criteria|0
1083623|NCT02224690|3533576|P1|Overall Study|Met Withdrawal Criteria|4
1083624|NCT02224690|3533575|P2|Overall Study|Adverse Event|1
1083625|NCT02224690|3533576|P1|Overall Study|Adverse Event|8
1083626|NCT02224664|3533588|P5|Dose Escalation Period (21 Days)|Withdrawal by Subject|4
1083627|NCT02224664|3533589|P4|Dose Escalation Period (21 Days)|Withdrawal by Subject|1
1083628|NCT02224664|3533590|P3|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
1083629|NCT02224664|3533591|P2|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
1083630|NCT02224664|3533592|P1|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
1083631|NCT02224664|3533588|P5|Dose Escalation Period (21 Days)|Adverse Event|7
1083632|NCT02224664|3533589|P4|Dose Escalation Period (21 Days)|Adverse Event|2
1083633|NCT02224664|3533590|P3|Dose Escalation Period (21 Days)|Adverse Event|2
1083634|NCT02224664|3533591|P2|Dose Escalation Period (21 Days)|Adverse Event|0
1083635|NCT02224664|3533592|P1|Dose Escalation Period (21 Days)|Adverse Event|0
1083636|NCT02224664|3533588|P5|Lead-in Period (3 Days)|Does not meet entrance criteria|0
1083637|NCT02224664|3533589|P4|Lead-in Period (3 Days)|Does not meet entrance criteria|0
1083638|NCT02224664|3533590|P3|Lead-in Period (3 Days)|Does not meet entrance criteria|0
1083639|NCT02224664|3533591|P2|Lead-in Period (3 Days)|Does not meet entrance criteria|0
1083640|NCT02224664|3533592|P1|Lead-in Period (3 Days)|Does not meet entrance criteria|5
1083641|NCT02224638|3533674|P2|Overall Study|Adverse Event|1
1083642|NCT02224638|3533675|P1|Overall Study|Adverse Event|1
1083643|NCT02224625|3533683|P1|Sensitization|Adverse Event|55
1083644|NCT02224625|3533683|P1|Irritation|Adverse Event|6
1083645|NCT02224560|3533698|P3|Overall Study|Withdrawn by Investigator|0
1083646|NCT02224560|3533699|P2|Overall Study|Withdrawn by Investigator|1
1083647|NCT02224560|3533700|P1|Overall Study|Withdrawn by Investigator|1
1083648|NCT02224560|3533698|P3|Overall Study|Adverse Event|1
1083649|NCT02224560|3533699|P2|Overall Study|Adverse Event|1
1083650|NCT02224560|3533700|P1|Overall Study|Adverse Event|4
1083651|NCT02224560|3533698|P3|Overall Study|Met Withdrawal Criteria|0
1083652|NCT02224560|3533699|P2|Overall Study|Met Withdrawal Criteria|0
1083653|NCT02224560|3533700|P1|Overall Study|Met Withdrawal Criteria|1
1083654|NCT02224560|3533698|P3|Overall Study|Withdrawal by Subject|1
1083655|NCT02224560|3533699|P2|Overall Study|Withdrawal by Subject|0
1083656|NCT02224560|3533700|P1|Overall Study|Withdrawal by Subject|2
1083657|NCT02224560|3533698|P3|Overall Study|Protocol Deviation|0
1083658|NCT02224560|3533699|P2|Overall Study|Protocol Deviation|0
1083659|NCT02224560|3533700|P1|Overall Study|Protocol Deviation|1
1083660|NCT02224053|3533735|P1|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2
1083661|NCT02224053|3533735|P1|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1
1083662|NCT02224053|3533735|P1|AZD9291 and Omeprazole Co-administration|Adverse Event|3
1083663|NCT02224053|3533735|P1|AZD9291 and Omeprazole Co-administration|Protocol Violation|4
1083664|NCT02224053|3533735|P1|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11
1083665|NCT02223754|3533781|P2|Period 2|Test Article No Longer Available|1
1083666|NCT02223754|3533782|P1|Period 2|Test Article No Longer Available|0
1083667|NCT02223754|3533781|P2|Period 2|Lost to Follow-up|0
1083668|NCT02223754|3533782|P1|Period 2|Lost to Follow-up|1
1083669|NCT02223754|3533781|P2|Period 2|Lens Discomfort|1
1083670|NCT02223754|3533782|P1|Period 2|Lens Discomfort|1
1083671|NCT02223754|3533781|P2|Period 2|Protocol Violation|0
1083672|NCT02223754|3533782|P1|Period 2|Protocol Violation|1
1083673|NCT02223754|3533781|P2|Period 2|Adverse Event|1
1083674|NCT02223754|3533782|P1|Period 2|Adverse Event|0
1083675|NCT02223754|3533781|P2|Period 1|Unsatisfactory Visual Response|1
1083676|NCT02223754|3533782|P1|Period 1|Unsatisfactory Visual Response|0
1083677|NCT02223754|3533781|P2|Period 1|Test Article No Longer Available|5
1083678|NCT02223754|3533782|P1|Period 1|Test Article No Longer Available|1
1083679|NCT02223754|3533781|P2|Period 1|Withdrawal by Subject|4
1083680|NCT02223754|3533782|P1|Period 1|Withdrawal by Subject|0
1083681|NCT02223754|3533781|P2|Period 1|Protocol Violation|4
1083682|NCT02223754|3533782|P1|Period 1|Protocol Violation|2
1083683|NCT02223754|3533781|P2|Period 1|Lost to Follow-up|1
1083684|NCT02223754|3533782|P1|Period 1|Lost to Follow-up|0
1083685|NCT02223754|3533781|P2|Period 1|Adverse Event|0
1083686|NCT02223754|3533782|P1|Period 1|Adverse Event|1
1083687|NCT02223715|3533802|P1|Overall Study|Lost to Follow-up|73
1083688|NCT02223715|3533802|P1|Overall Study|Death|31
1083689|NCT02223390|3533890|P2|Overall Study|Lost to Follow-up|4
1083690|NCT02223390|3533891|P1|Overall Study|Lost to Follow-up|9
1083691|NCT02223364|3533902|P3|Overall Study|Physician Decision|0
1083692|NCT02223364|3533903|P2|Overall Study|Physician Decision|0
1083693|NCT02223364|3533904|P1|Overall Study|Physician Decision|1
1083694|NCT02223364|3533902|P3|Overall Study|subject expired before surgery|0
1083695|NCT02223364|3533903|P2|Overall Study|subject expired before surgery|0
1083696|NCT02223364|3533904|P1|Overall Study|subject expired before surgery|1
1083697|NCT02223364|3533902|P3|Overall Study|Protocol Violation|3
1083698|NCT02223364|3533903|P2|Overall Study|Protocol Violation|0
1083699|NCT02223364|3533904|P1|Overall Study|Protocol Violation|3
1083700|NCT02222818|3534019|P2|Period 1|Eligibility criteria not met|3
1083701|NCT02222818|3534020|P1|Period 1|Eligibility criteria not met|0
1083702|NCT02222714|3534032|P5|Overall Study|Withdrawal by Subject|1
1083703|NCT02222714|3534033|P4|Overall Study|Withdrawal by Subject|0
1083704|NCT02222714|3534034|P3|Overall Study|Withdrawal by Subject|1
1083705|NCT02222714|3534035|P2|Overall Study|Withdrawal by Subject|0
1083706|NCT02222714|3534036|P1|Overall Study|Withdrawal by Subject|0
1083707|NCT02222714|3534032|P5|Overall Study|Death|6
1083708|NCT02222714|3534033|P4|Overall Study|Death|4
1083709|NCT02222714|3534034|P3|Overall Study|Death|3
1083710|NCT02222714|3534035|P2|Overall Study|Death|2
1083711|NCT02222714|3534036|P1|Overall Study|Death|0
1083712|NCT02222558|3534075|P6|Period 3|Withdrawal by Subject|1
1083713|NCT02222558|3534076|P5|Period 3|Withdrawal by Subject|0
1083714|NCT02222558|3534077|P4|Period 3|Withdrawal by Subject|0
1083715|NCT02222558|3534078|P3|Period 3|Withdrawal by Subject|0
1083716|NCT02222558|3534079|P2|Period 3|Withdrawal by Subject|0
1083717|NCT02222558|3534080|P1|Period 3|Withdrawal by Subject|0
1083718|NCT02222558|3534075|P6|Period 1: Single Dose|Withdrawal by Subject|0
1083719|NCT02222558|3534076|P5|Period 1: Single Dose|Withdrawal by Subject|0
1083720|NCT02222558|3534077|P4|Period 1: Single Dose|Withdrawal by Subject|0
1083721|NCT02222558|3534078|P3|Period 1: Single Dose|Withdrawal by Subject|0
1083722|NCT02222558|3534079|P2|Period 1: Single Dose|Withdrawal by Subject|0
1083723|NCT02222558|3534080|P1|Period 1: Single Dose|Withdrawal by Subject|4
1083724|NCT02222493|3534096|P2|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0
1083725|NCT02222493|3534097|P1|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9
1083726|NCT02222493|3534096|P2|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0
1083727|NCT02222493|3534097|P1|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1
1083728|NCT02222493|3534096|P2|Period 3: Week 54 Dosing-Week 78 Visit|Other|0
1083729|NCT02222493|3534097|P1|Period 3: Week 54 Dosing-Week 78 Visit|Other|4
1083730|NCT02222493|3534096|P2|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0
1083731|NCT02222493|3534097|P1|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14
1083732|NCT02222493|3534096|P2|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0
1083733|NCT02222493|3534097|P1|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3
1083734|NCT02222493|3534096|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3
1083735|NCT02222493|3534097|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9
1083736|NCT02222493|3534096|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
1083737|NCT02222493|3534097|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
1083738|NCT02222493|3534096|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4
1083739|NCT02222493|3534097|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6
1083740|NCT02222493|3534096|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0
1083741|NCT02222493|3534097|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1
1083742|NCT02222493|3534096|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0
1083743|NCT02222493|3534097|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3
1083744|NCT02222493|3534096|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9
1083745|NCT02222493|3534097|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22
1083746|NCT02222493|3534096|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0
1083747|NCT02222493|3534097|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1
1083748|NCT02222493|3534096|P2|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0
1083749|NCT02222493|3534097|P1|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1
1083750|NCT02222493|3534096|P2|Period 1: First Dose-Week 30 (Pre-dose)|Other|0
1083751|NCT02222493|3534097|P1|Period 1: First Dose-Week 30 (Pre-dose)|Other|4
1083752|NCT02222493|3534096|P2|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20
1083753|NCT02222493|3534097|P1|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18
1083754|NCT02222493|3534096|P2|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0
1083755|NCT02222493|3534097|P1|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2
1083756|NCT02222493|3534096|P2|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0
1083757|NCT02222493|3534097|P1|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1
1083758|NCT02222493|3534096|P2|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7
1083759|NCT02222493|3534097|P1|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0
1083760|NCT02222493|3534096|P2|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1
1083761|NCT02222493|3534097|P1|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5
1083762|NCT02222493|3534096|P2|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9
1083763|NCT02222493|3534097|P1|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11
1083764|NCT02222493|3534096|P2|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1
1083765|NCT02222493|3534097|P1|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0
1083766|NCT02222493|3534096|P2|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
1083767|NCT02222493|3534097|P1|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
1083768|NCT02222246|3534215|P2|Overall Study|Physician Decision|1
1083769|NCT02222246|3534216|P1|Overall Study|Physician Decision|0
1083770|NCT02222246|3534215|P2|Overall Study|No Emergency Department Visits|26
1083771|NCT02222246|3534216|P1|Overall Study|No Emergency Department Visits|27
1083772|NCT02222207|3534244|P1|Overall Study|Adverse Event|1
1083773|NCT02222207|3534244|P1|Overall Study|Other reasons|2
1083774|NCT02222207|3534244|P1|Overall Study|Death|1
1083775|NCT02221674|3534288|P3|Overall Study|Lost to Follow-up|0
1083776|NCT02221674|3534289|P2|Overall Study|Lost to Follow-up|0
1083777|NCT02221674|3534290|P1|Overall Study|Lost to Follow-up|1
1083778|NCT02221648|3534306|P2|Overall Study|Withdrawal by Subject|3
1083779|NCT02221648|3534307|P1|Overall Study|Withdrawal by Subject|3
1083780|NCT02220998|3534323|P2|Overall Study|Lost to Follow-up|4
1083781|NCT02220998|3534324|P1|Overall Study|Lost to Follow-up|4
1083782|NCT02220998|3534323|P2|Overall Study|Lack of Efficacy|5
1083783|NCT02220998|3534324|P1|Overall Study|Lack of Efficacy|0
1083784|NCT02220998|3534323|P2|Overall Study|Death|0
1083785|NCT02220998|3534324|P1|Overall Study|Death|2
1083786|NCT02220998|3534323|P2|Overall Study|Randomized but Never Treated|2
1083787|NCT02220998|3534324|P1|Overall Study|Randomized but Never Treated|1
1083788|NCT02220920|3534342|P2|Overall Study|Conflict with the stopping criteria|2
1083789|NCT02220920|3534343|P1|Overall Study|Conflict with the stopping criteria|1
1083790|NCT02220920|3534342|P2|Overall Study|Withdrawal by Subject|0
1083791|NCT02220920|3534343|P1|Overall Study|Withdrawal by Subject|1
1083792|NCT02220920|3534342|P2|Overall Study|Lack of Efficacy|1
1083793|NCT02220920|3534343|P1|Overall Study|Lack of Efficacy|0
1083794|NCT02220920|3534342|P2|Overall Study|Adverse Event|0
1083795|NCT02220920|3534343|P1|Overall Study|Adverse Event|1
1083796|NCT02220907|3534357|P1|Overall Study|Conflict with the stopping criteria|1
1083797|NCT02220907|3534357|P1|Overall Study|Withdrawal by Subject|2
1083798|NCT02220907|3534357|P1|Overall Study|Physician Decision|1
1083799|NCT02220907|3534357|P1|Overall Study|Adverse Event|7
1083800|NCT02220855|3534364|P1|Overall Study|Withdrawal by Subject|1
1083801|NCT02220855|3534364|P1|Overall Study|Disease Progression|5
1083802|NCT02220855|3534364|P1|Overall Study|Adverse Event|8
1083803|NCT02220764|3534374|P2|Overall Study|Death|0
1083804|NCT02220764|3534375|P1|Overall Study|Death|1
1083805|NCT02220764|3534374|P2|Overall Study|Lost to Follow-up|1
1083806|NCT02220764|3534375|P1|Overall Study|Lost to Follow-up|3
1083807|NCT02220725|3534389|P4|Overall Study|Withdrawal by Subject|1
1083808|NCT02220725|3534390|P3|Overall Study|Withdrawal by Subject|0
1083809|NCT02220725|3534391|P2|Overall Study|Withdrawal by Subject|0
1083810|NCT02220725|3534392|P1|Overall Study|Withdrawal by Subject|0
1083811|NCT02220725|3534389|P4|Overall Study|Lost to Follow-up|1
1083812|NCT02220725|3534390|P3|Overall Study|Lost to Follow-up|0
1083813|NCT02220725|3534391|P2|Overall Study|Lost to Follow-up|0
1083814|NCT02220725|3534392|P1|Overall Study|Lost to Follow-up|0
1083815|NCT02220205|3534422|P2|Overall Study|Withdrawal by Subject|0
1083816|NCT02220205|3534423|P1|Overall Study|Withdrawal by Subject|1
1083817|NCT02219932|3534448|P2|Overall Study|Adverse Event|21
1083818|NCT02219932|3534449|P1|Overall Study|Adverse Event|23
1083819|NCT02219932|3534448|P2|Overall Study|Lost to Follow-up|2
1083820|NCT02219932|3534449|P1|Overall Study|Lost to Follow-up|4
1083821|NCT02219932|3534448|P2|Overall Study|Pregnancy|0
1083822|NCT02219932|3534449|P1|Overall Study|Pregnancy|1
1083823|NCT02219932|3534448|P2|Overall Study|Protocol Violation|6
1083824|NCT02219932|3534449|P1|Overall Study|Protocol Violation|10
1083825|NCT02219932|3534448|P2|Overall Study|Lack of Efficacy (Subject Perception)|2
1083826|NCT02219932|3534449|P1|Overall Study|Lack of Efficacy (Subject Perception)|10
1083827|NCT02219932|3534448|P2|Overall Study|Consent Withdrawn|7
1083828|NCT02219932|3534449|P1|Overall Study|Consent Withdrawn|11
1083829|NCT02219932|3534448|P2|Overall Study|Investigator Decision|1
1083830|NCT02219932|3534449|P1|Overall Study|Investigator Decision|0
1083831|NCT02219932|3534448|P2|Overall Study|Death|1
1083832|NCT02219932|3534449|P1|Overall Study|Death|1
1083833|NCT02219932|3534448|P2|Overall Study|Not Specified|11
1083834|NCT02219932|3534449|P1|Overall Study|Not Specified|5
1083835|NCT02219685|3534465|P2|Blinded Treatment Phase|Withdrew Consent|0
1083836|NCT02219685|3534466|P1|Blinded Treatment Phase|Withdrew Consent|1
1083837|NCT02219685|3534465|P2|Blinded Treatment Phase|Lost to Follow-up|0
1083838|NCT02219685|3534466|P1|Blinded Treatment Phase|Lost to Follow-up|1
1083839|NCT02219477|3534572|P3|Overall Study|Withdrawal by Subject|0
1083840|NCT02219477|3534573|P2|Overall Study|Withdrawal by Subject|1
1083841|NCT02219477|3534574|P1|Overall Study|Withdrawal by Subject|0
1083842|NCT02219477|3534572|P3|Overall Study|Adverse Event|1
1083843|NCT02219477|3534573|P2|Overall Study|Adverse Event|1
1083844|NCT02219477|3534574|P1|Overall Study|Adverse Event|0
1083845|NCT02219464|3534602|P2|Overall Study|catheter malfunction|0
1083846|NCT02219464|3534603|P1|Overall Study|catheter malfunction|1
1083847|NCT02219464|3534602|P2|Overall Study|case cancelled|0
1083848|NCT02219464|3534603|P1|Overall Study|case cancelled|1
1083849|NCT02219464|3534602|P2|Overall Study|Withdrawal by Subject|0
1083850|NCT02219464|3534603|P1|Overall Study|Withdrawal by Subject|1
1083851|NCT02219087|3534763|P2|Overall Study|Randomization envelope pulled out of seq|1
1083852|NCT02219087|3534764|P1|Overall Study|Randomization envelope pulled out of seq|0
1083853|NCT02219009|3534784|P2|Overall Study|Physician Decision|1
1083854|NCT02219009|3534785|P1|Overall Study|Physician Decision|0
1083855|NCT02219009|3534784|P2|Overall Study|Protocol deviation|0
1083856|NCT02219009|3534785|P1|Overall Study|Protocol deviation|1
1083857|NCT02219009|3534784|P2|Overall Study|Lost to Follow-up|2
1083858|NCT02219009|3534785|P1|Overall Study|Lost to Follow-up|2
1083859|NCT02219009|3534784|P2|Overall Study|Adverse Event|4
1083860|NCT02219009|3534785|P1|Overall Study|Adverse Event|2
1083861|NCT02219009|3534784|P2|Overall Study|Withdrawal by Subject|1
1083862|NCT02219009|3534785|P1|Overall Study|Withdrawal by Subject|5
1083863|NCT02218697|3534797|P2|Overall Study|Withdrawal by Subject|3
1083864|NCT02218697|3534798|P1|Overall Study|Withdrawal by Subject|2
1083865|NCT02218697|3534797|P2|Overall Study|Unwilling to be vaccinated in left arm|1
1083866|NCT02218697|3534798|P1|Overall Study|Unwilling to be vaccinated in left arm|0
1083867|NCT02218697|3534797|P2|Overall Study|Adverse Event|2
1083868|NCT02218697|3534798|P1|Overall Study|Adverse Event|0
1083869|NCT02218541|3534838|P2|Overall Study|Implant Failure|1
1083870|NCT02218541|3534839|P1|Overall Study|Implant Failure|4
1083871|NCT02218541|3534838|P2|Overall Study|Lost to Follow-up|1
1083872|NCT02218541|3534839|P1|Overall Study|Lost to Follow-up|2
1083873|NCT02218372|3534874|P2|Overall Study|Withdrawal by Parent/Guardian|1
1083874|NCT02218372|3534875|P1|Overall Study|Withdrawal by Parent/Guardian|0
1083875|NCT02218372|3534874|P2|Overall Study|Randomized but did not receive treatment|3
1083876|NCT02218372|3534875|P1|Overall Study|Randomized but did not receive treatment|2
1083877|NCT02218372|3534874|P2|Overall Study|Miscellaneous|1
1083878|NCT02218372|3534875|P1|Overall Study|Miscellaneous|2
1083879|NCT02218372|3534874|P2|Overall Study|Adverse Event|1
1083880|NCT02218372|3534875|P1|Overall Study|Adverse Event|1
1083881|NCT02218268|3534955|P2|24 Hour Washout|Physician Decision|9
1083882|NCT02218268|3534956|P1|24 Hour Washout|Physician Decision|11
1083883|NCT02218216|3534968|P3|Overall Study|Study terminated before completed|0
1083884|NCT02218216|3534969|P2|Overall Study|Study terminated before completed|0
1083885|NCT02218216|3534970|P1|Overall Study|Study terminated before completed|6
1083886|NCT02217982|3535009|P2|Overall Study|Adverse Event|1
1083887|NCT02217982|3535010|P1|Overall Study|Adverse Event|0
1083888|NCT02217982|3535009|P2|Overall Study|Trial discontinued|0
1083889|NCT02217982|3535010|P1|Overall Study|Trial discontinued|1
1083890|NCT02217878|3535093|P2|Overall Study|initial diagnosis of STEMI not confirmed|0
1083979|NCT02214186|3535733|P1|Overall Study|Lost to Follow-up|1
1083891|NCT02217878|3535094|P1|Overall Study|initial diagnosis of STEMI not confirmed|1
1083892|NCT02217878|3535093|P2|Overall Study|required morphine due to chest pain|2
1083893|NCT02217878|3535094|P1|Overall Study|required morphine due to chest pain|1
1083894|NCT02217527|3535194|P2|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1
1083895|NCT02217527|3535195|P1|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0
1083896|NCT02217527|3535194|P2|Drug Condition 1: First Study Phase|Withdrawal by Subject|3
1083897|NCT02217527|3535195|P1|Drug Condition 1: First Study Phase|Withdrawal by Subject|1
1083898|NCT02217410|3535208|P3|Overall Study|Physician Decision|0
1083899|NCT02217410|3535209|P2|Overall Study|Physician Decision|3
1083900|NCT02217410|3535210|P1|Overall Study|Physician Decision|1
1083901|NCT02217410|3535208|P3|Overall Study|Lack of Efficacy|0
1083902|NCT02217410|3535209|P2|Overall Study|Lack of Efficacy|1
1083903|NCT02217410|3535210|P1|Overall Study|Lack of Efficacy|0
1083904|NCT02217410|3535208|P3|Overall Study|Lost to Follow-up|1
1083905|NCT02217410|3535209|P2|Overall Study|Lost to Follow-up|0
1083906|NCT02217410|3535210|P1|Overall Study|Lost to Follow-up|0
1083907|NCT02217410|3535208|P3|Overall Study|Withdrawal by Subject|2
1083908|NCT02217410|3535209|P2|Overall Study|Withdrawal by Subject|0
1083909|NCT02217410|3535210|P1|Overall Study|Withdrawal by Subject|0
1083910|NCT02217410|3535208|P3|Overall Study|Graft Loss|2
1083911|NCT02217410|3535209|P2|Overall Study|Graft Loss|0
1083912|NCT02217410|3535210|P1|Overall Study|Graft Loss|0
1083913|NCT02217280|3535233|P1|Overall Study|Post-consent sceen fail|2
1083914|NCT02217280|3535233|P1|Overall Study|Withdrawal by Subject|2
1083915|NCT02216812|3535240|P2|Overall Study|Lost to Follow-up|5
1083916|NCT02216812|3535241|P1|Overall Study|Lost to Follow-up|10
1083917|NCT02216591|3535266|P2|Overall Study|Lost to Follow-up|1
1083918|NCT02216591|3535267|P1|Overall Study|Lost to Follow-up|0
1083919|NCT02216526|3535280|P3|Overall Study|Hospitalization|3
1083920|NCT02216526|3535281|P2|Overall Study|Hospitalization|1
1083921|NCT02216526|3535282|P1|Overall Study|Hospitalization|2
1083922|NCT02216526|3535280|P3|Overall Study|Protocol Violation|2
1083923|NCT02216526|3535281|P2|Overall Study|Protocol Violation|0
1083924|NCT02216526|3535282|P1|Overall Study|Protocol Violation|2
1083925|NCT02216526|3535280|P3|Overall Study|Death|3
1083926|NCT02216526|3535281|P2|Overall Study|Death|1
1083927|NCT02216526|3535282|P1|Overall Study|Death|0
1083928|NCT02216526|3535280|P3|Overall Study|Adverse Event|0
1083929|NCT02216526|3535281|P2|Overall Study|Adverse Event|1
1083930|NCT02216526|3535282|P1|Overall Study|Adverse Event|1
1083931|NCT02216357|3535400|P2|Overall Study|Inclusion or exclusion criteria not met|1
1083932|NCT02216357|3535401|P1|Overall Study|Inclusion or exclusion criteria not met|2
1083933|NCT02216123|3535427|P2|Overall Study|Withdrawal by Subject|0
1083934|NCT02216123|3535428|P1|Overall Study|Withdrawal by Subject|2
1083935|NCT02216123|3535427|P2|Overall Study|Lost to Follow-up|2
1083936|NCT02216123|3535428|P1|Overall Study|Lost to Follow-up|4
1083937|NCT02215954|3535520|P3|Overall Study|Not exposed|3
1083938|NCT02215954|3535521|P2|Overall Study|Not exposed|1
1083939|NCT02215954|3535522|P1|Overall Study|Not exposed|1
1083940|NCT02215954|3535520|P3|Overall Study|Withdrawal by Subject|2
1083941|NCT02215954|3535521|P2|Overall Study|Withdrawal by Subject|0
1083942|NCT02215954|3535522|P1|Overall Study|Withdrawal by Subject|0
1083943|NCT02215954|3535520|P3|Overall Study|Adverse Event|1
1083944|NCT02215954|3535521|P2|Overall Study|Adverse Event|0
1083945|NCT02215954|3535522|P1|Overall Study|Adverse Event|0
1083946|NCT02215252|3535545|P3|Overall Study|Other|1
1083947|NCT02215252|3535546|P2|Overall Study|Other|1
1083948|NCT02215252|3535547|P1|Overall Study|Other|0
1083949|NCT02215252|3535545|P3|Overall Study|Withdrawal by Subject|0
1083950|NCT02215252|3535546|P2|Overall Study|Withdrawal by Subject|0
1083951|NCT02215252|3535547|P1|Overall Study|Withdrawal by Subject|1
1083952|NCT02215252|3535545|P3|Overall Study|Protocol Violation|0
1083953|NCT02215252|3535546|P2|Overall Study|Protocol Violation|1
1083954|NCT02215252|3535547|P1|Overall Study|Protocol Violation|0
1083955|NCT02215252|3535545|P3|Overall Study|Does not Meet Entrance Criteria|0
1083956|NCT02215252|3535546|P2|Overall Study|Does not Meet Entrance Criteria|1
1083957|NCT02215252|3535547|P1|Overall Study|Does not Meet Entrance Criteria|0
1083958|NCT02215252|3535545|P3|Overall Study|Lost to Follow-up|1
1083959|NCT02215252|3535546|P2|Overall Study|Lost to Follow-up|0
1083960|NCT02215252|3535547|P1|Overall Study|Lost to Follow-up|0
1083961|NCT02215252|3535545|P3|Overall Study|Adverse Event|2
1083962|NCT02215252|3535546|P2|Overall Study|Adverse Event|5
1083963|NCT02215252|3535547|P1|Overall Study|Adverse Event|1
1083964|NCT02214225|3535671|P3|Overall Study|randomized in error, not vaccinated|1
1083965|NCT02214225|3535672|P2|Overall Study|randomized in error, not vaccinated|1
1083966|NCT02214225|3535673|P1|Overall Study|randomized in error, not vaccinated|2
1083967|NCT02214225|3535671|P3|Overall Study|Death|1
1083968|NCT02214225|3535672|P2|Overall Study|Death|0
1083969|NCT02214225|3535673|P1|Overall Study|Death|5
1083970|NCT02214225|3535671|P3|Overall Study|Withdrawal by Subject|2
1083971|NCT02214225|3535672|P2|Overall Study|Withdrawal by Subject|0
1083972|NCT02214225|3535673|P1|Overall Study|Withdrawal by Subject|2
1083973|NCT02214225|3535671|P3|Overall Study|Lost to Follow-up|18
1083974|NCT02214225|3535672|P2|Overall Study|Lost to Follow-up|18
1083975|NCT02214225|3535673|P1|Overall Study|Lost to Follow-up|46
1083976|NCT02214186|3535732|P2|Overall Study|Protocol Violation|1
1083977|NCT02214186|3535733|P1|Overall Study|Protocol Violation|1
1083978|NCT02214186|3535732|P2|Overall Study|Lost to Follow-up|1
1083980|NCT02214121|3535801|P3|Part B|Lost to Follow-up|1
1083981|NCT02214121|3535802|P2|Part B|Lost to Follow-up|0
1083982|NCT02214121|3535803|P1|Part B|Lost to Follow-up|0
1083983|NCT02214121|3535801|P3|Part B|Dev. of study-specific withdrawal crit.|0
1083984|NCT02214121|3535802|P2|Part B|Dev. of study-specific withdrawal crit.|2
1083985|NCT02214121|3535803|P1|Part B|Dev. of study-specific withdrawal crit.|0
1083986|NCT02214121|3535801|P3|Part B|Patient decision|0
1083987|NCT02214121|3535802|P2|Part B|Patient decision|1
1083988|NCT02214121|3535803|P1|Part B|Patient decision|0
1083989|NCT02214121|3535801|P3|Part A|Other|0
1083990|NCT02214121|3535802|P2|Part A|Other|0
1083991|NCT02214121|3535803|P1|Part A|Other|1
1083992|NCT02214121|3535801|P3|Part A|Dev. of study-specific withdrawal crit.|0
1083993|NCT02214121|3535802|P2|Part A|Dev. of study-specific withdrawal crit.|0
1083994|NCT02214121|3535803|P1|Part A|Dev. of study-specific withdrawal crit.|4
1083995|NCT02214121|3535801|P3|Part A|Patient decision|0
1083996|NCT02214121|3535802|P2|Part A|Patient decision|0
1083997|NCT02214121|3535803|P1|Part A|Patient decision|2
1083998|NCT02213666|3535912|P1|Overall Study|Withdrawal by Subject|1
1083999|NCT02213510|3535918|P2|Overall Study|Lost to Follow-up|0
1084000|NCT02213510|3535919|P1|Overall Study|Lost to Follow-up|1
1084001|NCT02213510|3535918|P2|Overall Study|Death|1
1084002|NCT02213510|3535919|P1|Overall Study|Death|0
1084003|NCT02213263|3535947|P2|Overall Study|Ongoing in study|43
1084004|NCT02213263|3535948|P1|Overall Study|Ongoing in study|39
1084005|NCT02213263|3535947|P2|Overall Study|Adverse Event|2
1084006|NCT02213263|3535948|P1|Overall Study|Adverse Event|1
1084007|NCT02213263|3535947|P2|Overall Study|Progressive disease|13
1084008|NCT02213263|3535948|P1|Overall Study|Progressive disease|20
1084009|NCT02213263|3535947|P2|Overall Study|No longer willing to participate|3
1084010|NCT02213263|3535948|P1|Overall Study|No longer willing to participate|2
1084011|NCT02213263|3535947|P2|Overall Study|Lost to Follow-up|1
1084012|NCT02213263|3535948|P1|Overall Study|Lost to Follow-up|0
1084013|NCT02213263|3535947|P2|Overall Study|Insufficient clinical response|3
1084014|NCT02213263|3535948|P1|Overall Study|Insufficient clinical response|4
1084015|NCT02213198|3536016|P2|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7
1084016|NCT02213198|3536017|P1|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23
1084017|NCT02213198|3536016|P2|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10
1084018|NCT02213198|3536017|P1|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17
1084019|NCT02213198|3536016|P2|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25
1084020|NCT02213198|3536017|P1|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68
1084021|NCT02213198|3536016|P2|Follow up 1 3 Mos Post BL End of TCC tx|Death|0
1084022|NCT02213198|3536017|P1|Follow up 1 3 Mos Post BL End of TCC tx|Death|1
1084023|NCT02213198|3536016|P2|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2
1084024|NCT02213198|3536017|P1|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3
1084025|NCT02213198|3536016|P2|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
1084026|NCT02213198|3536017|P1|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
1084027|NCT02213198|3536016|P2|Baseline|incarcerated,violent|1
1084028|NCT02213198|3536017|P1|Baseline|incarcerated,violent|0
1084029|NCT02213198|3536016|P2|Baseline|Lost to Follow-up|21
1084030|NCT02213198|3536017|P1|Baseline|Lost to Follow-up|40
1084031|NCT02213198|3536016|P2|Baseline|transferred out of clinic|9
1084032|NCT02213198|3536017|P1|Baseline|transferred out of clinic|7
1084033|NCT02213198|3536016|P2|Baseline|Withdrawal by Subject|11
1084034|NCT02213198|3536017|P1|Baseline|Withdrawal by Subject|34
1084035|NCT02213198|3536016|P2|Baseline|No show for intake|9
1084036|NCT02213198|3536017|P1|Baseline|No show for intake|7
1084037|NCT02213094|3536027|P2|Overall Study|Adverse Event|0
1084038|NCT02213094|3536028|P1|Overall Study|Adverse Event|1
1084039|NCT02213055|3536036|P2|Overall Study|Did not Return to School|0
1084040|NCT02213055|3536037|P1|Overall Study|Did not Return to School|5
1084041|NCT02213055|3536036|P2|Overall Study|Did not meet Inclusion Criteria|0
1084042|NCT02213055|3536037|P1|Overall Study|Did not meet Inclusion Criteria|6
1084043|NCT02213055|3536036|P2|Overall Study|Had another Treatment during the Study|0
1084044|NCT02213055|3536037|P1|Overall Study|Had another Treatment during the Study|3
1084045|NCT02213055|3536036|P2|Overall Study|Did not have Live Lice|0
1084046|NCT02213055|3536037|P1|Overall Study|Did not have Live Lice|8
1084047|NCT02213055|3536036|P2|Overall Study|Documentation Issue during Study|0
1084048|NCT02213055|3536037|P1|Overall Study|Documentation Issue during Study|10
1084049|NCT02213055|3536036|P2|Overall Study|Documentation Issue at Enrollment|0
1084050|NCT02213055|3536037|P1|Overall Study|Documentation Issue at Enrollment|1
1084051|NCT02213055|3536036|P2|Overall Study|Protocol was not Followed during Study|0
1084052|NCT02213055|3536037|P1|Overall Study|Protocol was not Followed during Study|1
1084053|NCT02213055|3536036|P2|Overall Study|Protocol was not Followed at Enrollment|0
1084054|NCT02213055|3536037|P1|Overall Study|Protocol was not Followed at Enrollment|5
1084055|NCT02212457|3536075|P6|Overall Study|Other|1
1084056|NCT02212457|3536076|P5|Overall Study|Other|0
1084057|NCT02212457|3536077|P4|Overall Study|Other|1
1084058|NCT02212457|3536078|P3|Overall Study|Other|2
1084059|NCT02212457|3536079|P2|Overall Study|Other|1
1084060|NCT02212457|3536080|P1|Overall Study|Other|2
1084061|NCT02212457|3536075|P6|Overall Study|Protocol Violation|3
1084062|NCT02212457|3536076|P5|Overall Study|Protocol Violation|2
1084063|NCT02212457|3536077|P4|Overall Study|Protocol Violation|1
1084064|NCT02212457|3536078|P3|Overall Study|Protocol Violation|0
1084065|NCT02212457|3536079|P2|Overall Study|Protocol Violation|1
1084066|NCT02212457|3536080|P1|Overall Study|Protocol Violation|2
1084067|NCT02212457|3536075|P6|Overall Study|Lost to Follow-up|4
1084068|NCT02212457|3536076|P5|Overall Study|Lost to Follow-up|8
1084069|NCT02212457|3536077|P4|Overall Study|Lost to Follow-up|1
1084070|NCT02212457|3536078|P3|Overall Study|Lost to Follow-up|4
1084071|NCT02212457|3536079|P2|Overall Study|Lost to Follow-up|7
1084072|NCT02212457|3536080|P1|Overall Study|Lost to Follow-up|6
1084073|NCT02212457|3536075|P6|Overall Study|Withdrawal by Subject|4
1084074|NCT02212457|3536076|P5|Overall Study|Withdrawal by Subject|5
1084075|NCT02212457|3536077|P4|Overall Study|Withdrawal by Subject|6
1084076|NCT02212457|3536078|P3|Overall Study|Withdrawal by Subject|8
1084077|NCT02212457|3536079|P2|Overall Study|Withdrawal by Subject|10
1084078|NCT02212457|3536080|P1|Overall Study|Withdrawal by Subject|8
1084079|NCT02212457|3536075|P6|Overall Study|Adverse Event|1
1084080|NCT02212457|3536076|P5|Overall Study|Adverse Event|0
1084081|NCT02212457|3536077|P4|Overall Study|Adverse Event|2
1084082|NCT02212457|3536078|P3|Overall Study|Adverse Event|2
1084083|NCT02212457|3536079|P2|Overall Study|Adverse Event|2
1084084|NCT02212457|3536080|P1|Overall Study|Adverse Event|1
1084085|NCT02212301|3536118|P2|Period 1|Lost to Follow-up|1
1084086|NCT02212301|3536119|P1|Period 1|Lost to Follow-up|0
1084087|NCT02212197|3536130|P3|Overall Study|Need for radiotherapy|0
1084088|NCT02212197|3536131|P2|Overall Study|Need for radiotherapy|0
1084089|NCT02212197|3536132|P1|Overall Study|Need for radiotherapy|1
1084090|NCT02211638|3536185|P1|Overall Study|Protocol Violation|692
1084091|NCT02211638|3536185|P1|Overall Study|Case Report Forms Uncollected|291
1084092|NCT02211261|3536228|P11|Overall Study|Lost to Follow-up|0
1084093|NCT02211261|3536229|P10|Overall Study|Lost to Follow-up|0
1084094|NCT02211261|3536230|P9|Overall Study|Lost to Follow-up|0
1084095|NCT02211261|3536231|P8|Overall Study|Lost to Follow-up|1
1084096|NCT02211261|3536232|P7|Overall Study|Lost to Follow-up|0
1084097|NCT02211261|3536233|P6|Overall Study|Lost to Follow-up|0
1084098|NCT02211261|3536234|P5|Overall Study|Lost to Follow-up|0
1084099|NCT02211261|3536235|P4|Overall Study|Lost to Follow-up|0
1084100|NCT02211261|3536236|P3|Overall Study|Lost to Follow-up|0
1084101|NCT02211261|3536237|P2|Overall Study|Lost to Follow-up|0
1084102|NCT02211261|3536238|P1|Overall Study|Lost to Follow-up|0
1084103|NCT02211261|3536228|P11|Overall Study|Other|0
1084104|NCT02211261|3536229|P10|Overall Study|Other|2
1084105|NCT02211261|3536230|P9|Overall Study|Other|0
1084106|NCT02211261|3536231|P8|Overall Study|Other|0
1084107|NCT02211261|3536232|P7|Overall Study|Other|0
1084108|NCT02211261|3536233|P6|Overall Study|Other|1
1084109|NCT02211261|3536234|P5|Overall Study|Other|0
1084110|NCT02211261|3536235|P4|Overall Study|Other|0
1084111|NCT02211261|3536236|P3|Overall Study|Other|0
1084112|NCT02211261|3536237|P2|Overall Study|Other|0
1084113|NCT02211261|3536238|P1|Overall Study|Other|0
1084114|NCT02211261|3536228|P11|Overall Study|Withdrawal by Subject|0
1084115|NCT02211261|3536229|P10|Overall Study|Withdrawal by Subject|0
1084116|NCT02211261|3536230|P9|Overall Study|Withdrawal by Subject|0
1084117|NCT02211261|3536231|P8|Overall Study|Withdrawal by Subject|0
1084118|NCT02211261|3536232|P7|Overall Study|Withdrawal by Subject|0
1084119|NCT02211261|3536233|P6|Overall Study|Withdrawal by Subject|0
1084120|NCT02211261|3536234|P5|Overall Study|Withdrawal by Subject|2
1084121|NCT02211261|3536235|P4|Overall Study|Withdrawal by Subject|0
1084122|NCT02211261|3536236|P3|Overall Study|Withdrawal by Subject|1
1084123|NCT02211261|3536237|P2|Overall Study|Withdrawal by Subject|0
1084124|NCT02211261|3536238|P1|Overall Study|Withdrawal by Subject|0
1084125|NCT02210208|3536359|P1|Period B (Donor Site)|7 subjects healed at or before Day 14|7
1084126|NCT02210208|3536359|P1|Period A (Graft Site)|Physician decided not to graft at OR|1
1084127|NCT02210208|3536359|P1|Period A (Graft Site)|Withdrawal by Subject|1
1084128|NCT02210091|3536379|P2|Overall Study|Withdrawal by Sponsor|1
1084129|NCT02210091|3536380|P1|Overall Study|Withdrawal by Sponsor|0
1084130|NCT02210091|3536379|P2|Overall Study|Physician Decision|1
1084131|NCT02210091|3536380|P1|Overall Study|Physician Decision|0
1084132|NCT02210000|3536462|P2|Overall Study|Physician Decision|1
1084133|NCT02210000|3536463|P1|Overall Study|Physician Decision|0
1084134|NCT02210000|3536462|P2|Overall Study|Lost to Follow-up|2
1084135|NCT02210000|3536463|P1|Overall Study|Lost to Follow-up|0
1084136|NCT02210000|3536462|P2|Overall Study|Adverse Event|5
1084137|NCT02210000|3536463|P1|Overall Study|Adverse Event|1
1084138|NCT02210000|3536462|P2|Overall Study|Withdrawal by Subject|1
1084139|NCT02210000|3536463|P1|Overall Study|Withdrawal by Subject|7
1084140|NCT02210000|3536462|P2|Overall Study|Study Terminated|12
1084141|NCT02210000|3536463|P1|Overall Study|Study Terminated|11
1084142|NCT02209766|3536489|P5|Overall Study|Withdrawal by Subject|0
1084143|NCT02209766|3536490|P4|Overall Study|Withdrawal by Subject|1
1084144|NCT02209766|3536491|P3|Overall Study|Withdrawal by Subject|0
1084145|NCT02209766|3536492|P2|Overall Study|Withdrawal by Subject|0
1084146|NCT02209766|3536493|P1|Overall Study|Withdrawal by Subject|0
1084147|NCT02209506|3536544|P5|Overall Study|Withdrawal by Subject|1
1084148|NCT02209506|3536545|P4|Overall Study|Withdrawal by Subject|0
1084149|NCT02209506|3536546|P3|Overall Study|Withdrawal by Subject|0
1084150|NCT02209506|3536547|P2|Overall Study|Withdrawal by Subject|0
1084151|NCT02209506|3536548|P1|Overall Study|Withdrawal by Subject|0
1084152|NCT02209454|3536623|P2|Second Period|Adverse Event|0
1084153|NCT02209454|3536624|P1|Second Period|Adverse Event|1
1084154|NCT02209181|3536661|P4|Overall Study|Withdrawal by Subject|0
1084155|NCT02209181|3536662|P3|Overall Study|Withdrawal by Subject|0
1084156|NCT02209181|3536663|P2|Overall Study|Withdrawal by Subject|1
1084157|NCT02209181|3536664|P1|Overall Study|Withdrawal by Subject|0
1084158|NCT02209181|3536661|P4|Overall Study|Adverse Event|0
1084159|NCT02209181|3536662|P3|Overall Study|Adverse Event|1
1084160|NCT02209181|3536663|P2|Overall Study|Adverse Event|0
1084161|NCT02209181|3536664|P1|Overall Study|Adverse Event|1
1084162|NCT02208843|3536833|P1|Overall Study|Switched to commercial afatinib|20
1084163|NCT02208843|3536833|P1|Overall Study|Withdrawal by Subject|1
1084164|NCT02208843|3536833|P1|Overall Study|Protocol Violation|1
1084165|NCT02208843|3536833|P1|Overall Study|Adverse Event|12
1084166|NCT02208843|3536833|P1|Overall Study|Progression disease according to RECIST|24
1084167|NCT02208843|3536833|P1|Overall Study|Clinical symptoms of progression|2
1084168|NCT02207907|3536898|P2|Overall Study|Pregnancy|1
1084169|NCT02207907|3536899|P1|Overall Study|Pregnancy|0
1084170|NCT02207907|3536898|P2|Overall Study|Did not meet study criteria|0
1084171|NCT02207907|3536899|P1|Overall Study|Did not meet study criteria|3
1084172|NCT02207907|3536898|P2|Overall Study|Withdrawal by Subject|6
1084173|NCT02207907|3536899|P1|Overall Study|Withdrawal by Subject|5
1084174|NCT02207907|3536898|P2|Overall Study|Lost to Follow-up|1
1084175|NCT02207907|3536899|P1|Overall Study|Lost to Follow-up|3
1084176|NCT02207829|3536917|P2|Overall Study|Withdrew consent|14
1084177|NCT02207829|3536918|P1|Overall Study|Withdrew consent|18
1084178|NCT02207829|3536917|P2|Overall Study|Protocol deviation|4
1084179|NCT02207829|3536918|P1|Overall Study|Protocol deviation|5
1084180|NCT02207829|3536917|P2|Overall Study|Lost to Follow-up|2
1084181|NCT02207829|3536918|P1|Overall Study|Lost to Follow-up|2
1084182|NCT02207829|3536917|P2|Overall Study|Lack of Efficacy|5
1084183|NCT02207829|3536918|P1|Overall Study|Lack of Efficacy|7
1084184|NCT02207829|3536917|P2|Overall Study|Adverse Event|9
1084185|NCT02207829|3536918|P1|Overall Study|Adverse Event|10
1084186|NCT02207725|3536939|P4|Overall Study|Did Not Receive Treatment|1
1084187|NCT02207725|3536940|P3|Overall Study|Did Not Receive Treatment|1
1084188|NCT02207725|3536941|P2|Overall Study|Did Not Receive Treatment|1
1084189|NCT02207725|3536942|P1|Overall Study|Did Not Receive Treatment|0
1084190|NCT02207634|3536972|P2|Overall Study|Lost to Follow-up|0
1084191|NCT02207634|3536973|P1|Overall Study|Lost to Follow-up|1
1084192|NCT02207634|3536972|P2|Overall Study|Withdrawal by Subject|31
1084193|NCT02207634|3536973|P1|Overall Study|Withdrawal by Subject|21
1084194|NCT02207621|3536988|P3|Overall Study|Other(Site,Sponsor and Subject request)|5
1084195|NCT02207621|3536989|P2|Overall Study|Other(Site,Sponsor and Subject request)|1
1084196|NCT02207621|3536990|P1|Overall Study|Other(Site,Sponsor and Subject request)|2
1084197|NCT02207621|3536988|P3|Overall Study|Death|0
1084198|NCT02207621|3536989|P2|Overall Study|Death|0
1084199|NCT02207621|3536990|P1|Overall Study|Death|2
1084200|NCT02207621|3536988|P3|Overall Study|Protocol Violation|6
1084201|NCT02207621|3536989|P2|Overall Study|Protocol Violation|10
1084202|NCT02207621|3536990|P1|Overall Study|Protocol Violation|4
1084203|NCT02207621|3536988|P3|Overall Study|Physician Decision|2
1084204|NCT02207621|3536989|P2|Overall Study|Physician Decision|2
1084205|NCT02207621|3536990|P1|Overall Study|Physician Decision|1
1084206|NCT02207621|3536988|P3|Overall Study|Disallowed Concurrent Medication|2
1084207|NCT02207621|3536989|P2|Overall Study|Disallowed Concurrent Medication|5
1084208|NCT02207621|3536990|P1|Overall Study|Disallowed Concurrent Medication|2
1084209|NCT02207621|3536988|P3|Overall Study|Lack of Efficacy|4
1084210|NCT02207621|3536989|P2|Overall Study|Lack of Efficacy|2
1084211|NCT02207621|3536990|P1|Overall Study|Lack of Efficacy|10
1084212|NCT02207621|3536988|P3|Overall Study|Lost to Follow-up|3
1084213|NCT02207621|3536989|P2|Overall Study|Lost to Follow-up|0
1084214|NCT02207621|3536990|P1|Overall Study|Lost to Follow-up|1
1084215|NCT02207621|3536988|P3|Overall Study|Non-Compliant|1
1084216|NCT02207621|3536989|P2|Overall Study|Non-Compliant|3
1084217|NCT02207621|3536990|P1|Overall Study|Non-Compliant|3
1084218|NCT02207621|3536988|P3|Overall Study|Withdrawal by Subject|13
1084219|NCT02207621|3536989|P2|Overall Study|Withdrawal by Subject|9
1084220|NCT02207621|3536990|P1|Overall Study|Withdrawal by Subject|9
1084221|NCT02207621|3536988|P3|Overall Study|Adverse Event|132
1084222|NCT02207621|3536989|P2|Overall Study|Adverse Event|15
1084223|NCT02207621|3536990|P1|Overall Study|Adverse Event|71
1084224|NCT02207608|3537003|P2|Overall Study|Adverse Event|0
1084225|NCT02207608|3537004|P1|Overall Study|Adverse Event|1
1084226|NCT02207530|3537028|P1|Overall Study|Adverse Event|8
1084227|NCT02207530|3537028|P1|Overall Study|Patient decision to stop study treatment|5
1084228|NCT02207530|3537028|P1|Overall Study|Worsening condition under investigation|78
1084229|NCT02207491|3537042|P2|Overall Study|Protocol Violation|5
1084230|NCT02207491|3537043|P1|Overall Study|Protocol Violation|3
1084231|NCT02207491|3537042|P2|Overall Study|Physician Decision|0
1084232|NCT02207491|3537043|P1|Overall Study|Physician Decision|2
1084233|NCT02207491|3537042|P2|Overall Study|Lack of Efficacy|0
1084234|NCT02207491|3537043|P1|Overall Study|Lack of Efficacy|3
1084235|NCT02207491|3537042|P2|Overall Study|Lost to Follow-up|1
1084236|NCT02207491|3537043|P1|Overall Study|Lost to Follow-up|0
1084237|NCT02207491|3537042|P2|Overall Study|Non-compliant|1
1084238|NCT02207491|3537043|P1|Overall Study|Non-compliant|0
1084239|NCT02207491|3537042|P2|Overall Study|Withdrawal by Subject|2
1084240|NCT02207491|3537043|P1|Overall Study|Withdrawal by Subject|3
1084241|NCT02207491|3537042|P2|Overall Study|Adverse Event|4
1084242|NCT02207491|3537043|P1|Overall Study|Adverse Event|20
1084243|NCT02207413|3537068|P6|Overall Study|Migrated/moved from study area|0
1084244|NCT02207413|3537069|P5|Overall Study|Migrated/moved from study area|1
1084245|NCT02207413|3537070|P4|Overall Study|Migrated/moved from study area|0
1084246|NCT02207413|3537071|P3|Overall Study|Migrated/moved from study area|0
1084247|NCT02207413|3537072|P2|Overall Study|Migrated/moved from study area|0
1084248|NCT02207413|3537073|P1|Overall Study|Migrated/moved from study area|0
1084249|NCT02207413|3537068|P6|Overall Study|Adverse Event|1
1084250|NCT02207413|3537069|P5|Overall Study|Adverse Event|2
1084251|NCT02207413|3537070|P4|Overall Study|Adverse Event|0
1084252|NCT02207413|3537071|P3|Overall Study|Adverse Event|0
1084253|NCT02207413|3537072|P2|Overall Study|Adverse Event|0
1084254|NCT02207413|3537073|P1|Overall Study|Adverse Event|0
1084255|NCT02207413|3537068|P6|Overall Study|Lost to Follow-up|5
1084256|NCT02207413|3537069|P5|Overall Study|Lost to Follow-up|1
1084257|NCT02207413|3537070|P4|Overall Study|Lost to Follow-up|1
1084258|NCT02207413|3537071|P3|Overall Study|Lost to Follow-up|0
1084259|NCT02207413|3537072|P2|Overall Study|Lost to Follow-up|0
1084260|NCT02207413|3537073|P1|Overall Study|Lost to Follow-up|0
1084261|NCT02207413|3537068|P6|Overall Study|Withdrawal by Subject|7
1084262|NCT02207413|3537069|P5|Overall Study|Withdrawal by Subject|3
1084263|NCT02207413|3537070|P4|Overall Study|Withdrawal by Subject|0
1084264|NCT02207413|3537071|P3|Overall Study|Withdrawal by Subject|0
1084265|NCT02207413|3537072|P2|Overall Study|Withdrawal by Subject|0
1084266|NCT02207413|3537073|P1|Overall Study|Withdrawal by Subject|1
1084267|NCT02207400|3537169|P2|Overall Study|Positive Urine Pregnancy Test|1
1084268|NCT02207400|3537170|P1|Overall Study|Positive Urine Pregnancy Test|0
1084269|NCT02207400|3537169|P2|Overall Study|Withdrawal by Subject|4
1084270|NCT02207400|3537170|P1|Overall Study|Withdrawal by Subject|8
1084271|NCT02207400|3537169|P2|Overall Study|Protocol Violation|1
1084272|NCT02207400|3537170|P1|Overall Study|Protocol Violation|1
1084273|NCT02207400|3537169|P2|Overall Study|Lost to Follow-up|7
1084274|NCT02207400|3537170|P1|Overall Study|Lost to Follow-up|6
1084275|NCT02207400|3537169|P2|Overall Study|Adverse Event|1
1084276|NCT02207400|3537170|P1|Overall Study|Adverse Event|1
1084277|NCT02207244|3537191|P9|Withdrawal, Retreatment Period:Week28-48|Other|0
1084278|NCT02207244|3537192|P8|Withdrawal, Retreatment Period:Week28-48|Other|1
1084279|NCT02207244|3537193|P7|Withdrawal, Retreatment Period:Week28-48|Other|0
1084280|NCT02207244|3537194|P6|Withdrawal, Retreatment Period:Week28-48|Other|0
1084281|NCT02207244|3537195|P5|Withdrawal, Retreatment Period:Week28-48|Other|0
1084282|NCT02207244|3537196|P4|Withdrawal, Retreatment Period:Week28-48|Other|0
1084283|NCT02207244|3537197|P3|Withdrawal, Retreatment Period:Week28-48|Other|0
1084284|NCT02207244|3537198|P2|Withdrawal, Retreatment Period:Week28-48|Other|0
1084285|NCT02207244|3537199|P1|Withdrawal, Retreatment Period:Week28-48|Other|0
1084286|NCT02207244|3537191|P9|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
1084287|NCT02207244|3537192|P8|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
1084288|NCT02207244|3537193|P7|Withdrawal, Retreatment Period:Week28-48|Non-compliance|1
1084289|NCT02207244|3537194|P6|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
1084290|NCT02207244|3537195|P5|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
1084291|NCT02207244|3537196|P4|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
1084292|NCT02207244|3537197|P3|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
1084293|NCT02207244|3537198|P2|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
1084294|NCT02207244|3537199|P1|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
1084295|NCT02207244|3537191|P9|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
1084296|NCT02207244|3537192|P8|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
1084297|NCT02207244|3537193|P7|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|1
1084298|NCT02207244|3537194|P6|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
1084299|NCT02207244|3537195|P5|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
1084300|NCT02207244|3537196|P4|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
1084301|NCT02207244|3537197|P3|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
1084302|NCT02207244|3537198|P2|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
1084303|NCT02207244|3537199|P1|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
1084304|NCT02207244|3537191|P9|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|1
1084305|NCT02207244|3537192|P8|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|2
1084306|NCT02207244|3537193|P7|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|1
1084307|NCT02207244|3537194|P6|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
1084308|NCT02207244|3537195|P5|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
1084309|NCT02207244|3537196|P4|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
1084310|NCT02207244|3537197|P3|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
1084311|NCT02207244|3537198|P2|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
1084312|NCT02207244|3537199|P1|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
1084313|NCT02207244|3537191|P9|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|2
1084314|NCT02207244|3537192|P8|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|5
1084315|NCT02207244|3537193|P7|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|2
1084316|NCT02207244|3537194|P6|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
1084317|NCT02207244|3537195|P5|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
1084318|NCT02207244|3537196|P4|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
1084319|NCT02207244|3537197|P3|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
1084320|NCT02207244|3537198|P2|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
1084321|NCT02207244|3537199|P1|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
1084322|NCT02207244|3537191|P9|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|2
1084323|NCT02207244|3537192|P8|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|2
1084324|NCT02207244|3537193|P7|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
1084325|NCT02207244|3537194|P6|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
1084326|NCT02207244|3537195|P5|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
1084327|NCT02207244|3537196|P4|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
1084328|NCT02207244|3537197|P3|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
1084329|NCT02207244|3537198|P2|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
1084330|NCT02207244|3537199|P1|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
1084331|NCT02207244|3537191|P9|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
1084332|NCT02207244|3537192|P8|Withdrawal, Retreatment Period:Week28-48|Pregnancy|2
1084333|NCT02207244|3537193|P7|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
1084334|NCT02207244|3537194|P6|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
1084335|NCT02207244|3537195|P5|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
1084336|NCT02207244|3537196|P4|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
1084337|NCT02207244|3537197|P3|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
1084338|NCT02207244|3537198|P2|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
1084339|NCT02207244|3537199|P1|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
1084340|NCT02207244|3537191|P9|Withdrawal, Retreatment Period:Week28-48|Adverse Event|3
1084341|NCT02207244|3537192|P8|Withdrawal, Retreatment Period:Week28-48|Adverse Event|1
1084342|NCT02207244|3537193|P7|Withdrawal, Retreatment Period:Week28-48|Adverse Event|3
1084343|NCT02207244|3537194|P6|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
1084344|NCT02207244|3537195|P5|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
1084345|NCT02207244|3537196|P4|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
1084346|NCT02207244|3537197|P3|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
1084347|NCT02207244|3537198|P2|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
1084348|NCT02207244|3537199|P1|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
1084349|NCT02207244|3537191|P9|Placebo Crossover and ACP: Week 16 - 28|Other|0
1084350|NCT02207244|3537192|P8|Placebo Crossover and ACP: Week 16 - 28|Other|0
1084351|NCT02207244|3537193|P7|Placebo Crossover and ACP: Week 16 - 28|Other|0
1084352|NCT02207244|3537194|P6|Placebo Crossover and ACP: Week 16 - 28|Other|0
1084353|NCT02207244|3537195|P5|Placebo Crossover and ACP: Week 16 - 28|Other|0
1084354|NCT02207244|3537196|P4|Placebo Crossover and ACP: Week 16 - 28|Other|1
1084355|NCT02207244|3537197|P3|Placebo Crossover and ACP: Week 16 - 28|Other|0
1084356|NCT02207244|3537198|P2|Placebo Crossover and ACP: Week 16 - 28|Other|0
1084357|NCT02207244|3537199|P1|Placebo Crossover and ACP: Week 16 - 28|Other|0
1084358|NCT02207244|3537191|P9|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
1084359|NCT02207244|3537192|P8|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
1084360|NCT02207244|3537193|P7|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
1084361|NCT02207244|3537194|P6|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|1
1084362|NCT02207244|3537195|P5|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
1084363|NCT02207244|3537196|P4|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|1
1084364|NCT02207244|3537197|P3|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
1084365|NCT02207244|3537198|P2|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
1084366|NCT02207244|3537199|P1|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
1084367|NCT02207244|3537191|P9|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
1084368|NCT02207244|3537192|P8|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
1084369|NCT02207244|3537193|P7|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
1084370|NCT02207244|3537194|P6|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|2
1084371|NCT02207244|3537195|P5|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|3
1084372|NCT02207244|3537196|P4|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|3
1084373|NCT02207244|3537197|P3|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
1084374|NCT02207244|3537198|P2|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
1084375|NCT02207244|3537199|P1|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
1084376|NCT02207244|3537191|P9|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
1084377|NCT02207244|3537192|P8|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
1084378|NCT02207244|3537193|P7|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
1084379|NCT02207244|3537194|P6|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|2
1084380|NCT02207244|3537195|P5|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|2
1084381|NCT02207244|3537196|P4|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|1
1084382|NCT02207244|3537197|P3|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
1084383|NCT02207244|3537198|P2|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
1084384|NCT02207244|3537199|P1|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
1084385|NCT02207244|3537191|P9|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
1084386|NCT02207244|3537192|P8|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
1084387|NCT02207244|3537193|P7|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
1084388|NCT02207244|3537194|P6|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|2
1084389|NCT02207244|3537195|P5|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
1084390|NCT02207244|3537196|P4|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
1084391|NCT02207244|3537197|P3|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
1084392|NCT02207244|3537198|P2|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
1084393|NCT02207244|3537199|P1|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
1084394|NCT02207244|3537191|P9|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
1084395|NCT02207244|3537192|P8|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
1084396|NCT02207244|3537193|P7|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
1084397|NCT02207244|3537194|P6|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|2
1084398|NCT02207244|3537195|P5|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|3
1084399|NCT02207244|3537196|P4|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
1084400|NCT02207244|3537197|P3|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
1084401|NCT02207244|3537198|P2|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
1084402|NCT02207244|3537199|P1|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
1084403|NCT02207244|3537191|P9|Placebo Controlled Period: Week 0 - 16|Other|0
1084404|NCT02207244|3537192|P8|Placebo Controlled Period: Week 0 - 16|Other|0
1084405|NCT02207244|3537193|P7|Placebo Controlled Period: Week 0 - 16|Other|0
1084406|NCT02207244|3537194|P6|Placebo Controlled Period: Week 0 - 16|Other|0
1084407|NCT02207244|3537195|P5|Placebo Controlled Period: Week 0 - 16|Other|0
1084408|NCT02207244|3537196|P4|Placebo Controlled Period: Week 0 - 16|Other|0
1084409|NCT02207244|3537197|P3|Placebo Controlled Period: Week 0 - 16|Other|0
1084410|NCT02207244|3537198|P2|Placebo Controlled Period: Week 0 - 16|Other|1
1084411|NCT02207244|3537199|P1|Placebo Controlled Period: Week 0 - 16|Other|0
1084412|NCT02207244|3537191|P9|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
1084413|NCT02207244|3537192|P8|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
1084414|NCT02207244|3537193|P7|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
1084415|NCT02207244|3537194|P6|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
1084416|NCT02207244|3537195|P5|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
1084417|NCT02207244|3537196|P4|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
1084418|NCT02207244|3537197|P3|Placebo Controlled Period: Week 0 - 16|Non-Compliance|2
1084419|NCT02207244|3537198|P2|Placebo Controlled Period: Week 0 - 16|Non-Compliance|1
1084420|NCT02207244|3537199|P1|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
1084421|NCT02207244|3537191|P9|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
1084422|NCT02207244|3537192|P8|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
1084423|NCT02207244|3537193|P7|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
1084424|NCT02207244|3537194|P6|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
1084425|NCT02207244|3537195|P5|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
1084426|NCT02207244|3537196|P4|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
1084427|NCT02207244|3537197|P3|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
1084428|NCT02207244|3537198|P2|Placebo Controlled Period: Week 0 - 16|Protocol Violation|3
1084429|NCT02207244|3537199|P1|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
1084430|NCT02207244|3537191|P9|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
1084431|NCT02207244|3537192|P8|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
1084432|NCT02207244|3537193|P7|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
1084433|NCT02207244|3537194|P6|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
1084434|NCT02207244|3537195|P5|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
1084435|NCT02207244|3537196|P4|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
1084436|NCT02207244|3537197|P3|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
1084437|NCT02207244|3537198|P2|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|1
1084438|NCT02207244|3537199|P1|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|7
1084439|NCT02207244|3537191|P9|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
1084440|NCT02207244|3537192|P8|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
1084441|NCT02207244|3537193|P7|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
1084442|NCT02207244|3537194|P6|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
1084443|NCT02207244|3537195|P5|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
1084444|NCT02207244|3537196|P4|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
1084445|NCT02207244|3537197|P3|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|2
1084446|NCT02207244|3537198|P2|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|3
1084447|NCT02207244|3537199|P1|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
1084448|NCT02207244|3537191|P9|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
1084449|NCT02207244|3537192|P8|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
1084450|NCT02207244|3537193|P7|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
1084451|NCT02207244|3537194|P6|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
1084452|NCT02207244|3537195|P5|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
1084453|NCT02207244|3537196|P4|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
1084454|NCT02207244|3537197|P3|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2
1084455|NCT02207244|3537198|P2|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
1084456|NCT02207244|3537199|P1|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|4
1084457|NCT02207244|3537191|P9|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
1084458|NCT02207244|3537192|P8|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
1084459|NCT02207244|3537193|P7|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
1084460|NCT02207244|3537194|P6|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
1084461|NCT02207244|3537195|P5|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
1084462|NCT02207244|3537196|P4|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
1084463|NCT02207244|3537197|P3|Placebo Controlled Period: Week 0 - 16|Adverse Event|4
1084464|NCT02207244|3537198|P2|Placebo Controlled Period: Week 0 - 16|Adverse Event|9
1084465|NCT02207244|3537199|P1|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
1084466|NCT02207231|3537240|P3|Active Controlled Period: Week 16 - 48|Non-compliance|3
1084467|NCT02207231|3537241|P2|Active Controlled Period: Week 16 - 48|Non-compliance|3
1084468|NCT02207231|3537242|P1|Active Controlled Period: Week 16 - 48|Non-compliance|0
1084469|NCT02207231|3537240|P3|Active Controlled Period: Week 16 - 48|Other|3
1084470|NCT02207231|3537241|P2|Active Controlled Period: Week 16 - 48|Other|2
1084471|NCT02207231|3537242|P1|Active Controlled Period: Week 16 - 48|Other|0
1084472|NCT02207231|3537240|P3|Active Controlled Period: Week 16 - 48|Protocol Violation|0
1084473|NCT02207231|3537241|P2|Active Controlled Period: Week 16 - 48|Protocol Violation|1
1084474|NCT02207231|3537242|P1|Active Controlled Period: Week 16 - 48|Protocol Violation|0
1084475|NCT02207231|3537240|P3|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10
1084476|NCT02207231|3537241|P2|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4
1084477|NCT02207231|3537242|P1|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1
1084478|NCT02207231|3537240|P3|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5
1084479|NCT02207231|3537241|P2|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2
1084480|NCT02207231|3537242|P1|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1
1084481|NCT02207231|3537240|P3|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11
1084482|NCT02207231|3537241|P2|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3
1084483|NCT02207231|3537242|P1|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0
1084484|NCT02207231|3537240|P3|Active Controlled Period: Week 16 - 48|Pregnancy|1
1084485|NCT02207231|3537241|P2|Active Controlled Period: Week 16 - 48|Pregnancy|0
1084486|NCT02207231|3537242|P1|Active Controlled Period: Week 16 - 48|Pregnancy|0
1084487|NCT02207231|3537240|P3|Active Controlled Period: Week 16 - 48|Adverse Event|9
1084488|NCT02207231|3537241|P2|Active Controlled Period: Week 16 - 48|Adverse Event|6
1084489|NCT02207231|3537242|P1|Active Controlled Period: Week 16 - 48|Adverse Event|1
1084490|NCT02207231|3537240|P3|Placebo Controlled Period: Week 0 - 16|Noncompliance|1
1084491|NCT02207231|3537241|P2|Placebo Controlled Period: Week 0 - 16|Noncompliance|2
1084492|NCT02207231|3537242|P1|Placebo Controlled Period: Week 0 - 16|Noncompliance|0
1084493|NCT02207231|3537240|P3|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
1084494|NCT02207231|3537241|P2|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
1084495|NCT02207231|3537242|P1|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
1084496|NCT02207231|3537240|P3|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4
1084497|NCT02207231|3537241|P2|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
1084498|NCT02207231|3537242|P1|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2
1084499|NCT02207231|3537240|P3|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
1084500|NCT02207231|3537241|P2|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
1084501|NCT02207231|3537242|P1|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
1084502|NCT02207231|3537240|P3|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1
1084503|NCT02207231|3537241|P2|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
1084504|NCT02207231|3537242|P1|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2
1084505|NCT02207231|3537240|P3|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
1084506|NCT02207231|3537241|P2|Placebo Controlled Period: Week 0 - 16|Adverse Event|4
1084507|NCT02207231|3537242|P1|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
1084508|NCT02207088|3537274|P1|Overall Study|Adverse Event|2
1084509|NCT02206607|3537289|P5|Second Intervention Period|Insufficient Clinical Response|0
1084510|NCT02206607|3537290|P4|Second Intervention Period|Insufficient Clinical Response|1
1084511|NCT02206607|3537291|P3|Second Intervention Period|Insufficient Clinical Response|0
1084512|NCT02206607|3537292|P2|Second Intervention Period|Insufficient Clinical Response|0
1084513|NCT02206607|3537293|P1|Second Intervention Period|Insufficient Clinical Response|0
1084514|NCT02206607|3537289|P5|Open-Label Run-In|Withdrawal by Subject|0
1084515|NCT02206607|3537290|P4|Open-Label Run-In|Withdrawal by Subject|0
1084516|NCT02206607|3537291|P3|Open-Label Run-In|Withdrawal by Subject|0
1084517|NCT02206607|3537292|P2|Open-Label Run-In|Withdrawal by Subject|0
1084518|NCT02206607|3537293|P1|Open-Label Run-In|Withdrawal by Subject|3
1084519|NCT02205814|3537366|P4|Overall Study|not compliant with study procedures|0
1084520|NCT02205814|3537367|P3|Overall Study|not compliant with study procedures|1
1084521|NCT02205814|3537368|P2|Overall Study|not compliant with study procedures|0
1084522|NCT02205814|3537369|P1|Overall Study|not compliant with study procedures|0
1084523|NCT02205814|3537366|P4|Overall Study|Withdrawal by Subject|1
1084524|NCT02205814|3537367|P3|Overall Study|Withdrawal by Subject|2
1084525|NCT02205814|3537368|P2|Overall Study|Withdrawal by Subject|1
1084526|NCT02205814|3537369|P1|Overall Study|Withdrawal by Subject|0
1084527|NCT02205814|3537366|P4|Overall Study|Protocol Violation|1
1084528|NCT02205814|3537367|P3|Overall Study|Protocol Violation|0
1084529|NCT02205814|3537368|P2|Overall Study|Protocol Violation|0
1084530|NCT02205814|3537369|P1|Overall Study|Protocol Violation|1
1084531|NCT02205814|3537366|P4|Overall Study|Physician Decision|0
1084532|NCT02205814|3537367|P3|Overall Study|Physician Decision|1
1084533|NCT02205814|3537368|P2|Overall Study|Physician Decision|0
1084534|NCT02205814|3537369|P1|Overall Study|Physician Decision|0
1084535|NCT02205814|3537366|P4|Overall Study|Lack of Efficacy|1
1084536|NCT02205814|3537367|P3|Overall Study|Lack of Efficacy|1
1084537|NCT02205814|3537368|P2|Overall Study|Lack of Efficacy|0
1084538|NCT02205814|3537369|P1|Overall Study|Lack of Efficacy|1
1084539|NCT02205814|3537366|P4|Overall Study|Lost to Follow-up|1
1084540|NCT02205814|3537367|P3|Overall Study|Lost to Follow-up|0
1084541|NCT02205814|3537368|P2|Overall Study|Lost to Follow-up|0
1084542|NCT02205814|3537369|P1|Overall Study|Lost to Follow-up|0
1084543|NCT02205476|3537422|P2|Overall Study|Study termination by Sponsor|3
1084544|NCT02205476|3537423|P1|Overall Study|Study termination by Sponsor|7
1084545|NCT02205333|3537462|P9|Overall Study|Withdrawal by Subject|0
1084546|NCT02205333|3537463|P8|Overall Study|Withdrawal by Subject|0
1084547|NCT02205333|3537464|P7|Overall Study|Withdrawal by Subject|2
1084548|NCT02205333|3537465|P6|Overall Study|Withdrawal by Subject|0
1084549|NCT02205333|3537466|P5|Overall Study|Withdrawal by Subject|0
1084550|NCT02205333|3537467|P4|Overall Study|Withdrawal by Subject|1
1084551|NCT02205333|3537468|P3|Overall Study|Withdrawal by Subject|0
1084552|NCT02205333|3537469|P2|Overall Study|Withdrawal by Subject|0
1084553|NCT02205333|3537470|P1|Overall Study|Withdrawal by Subject|1
1084554|NCT02205333|3537462|P9|Overall Study|Death|0
1084555|NCT02205333|3537463|P8|Overall Study|Death|2
1084556|NCT02205333|3537464|P7|Overall Study|Death|3
1084557|NCT02205333|3537465|P6|Overall Study|Death|3
1084558|NCT02205333|3537466|P5|Overall Study|Death|5
1084559|NCT02205333|3537467|P4|Overall Study|Death|6
1084560|NCT02205333|3537468|P3|Overall Study|Death|2
1084561|NCT02205333|3537469|P2|Overall Study|Death|6
1084562|NCT02205333|3537470|P1|Overall Study|Death|5
1084563|NCT02204917|3537643|P1|Overall Study|Protocol Violation|1
1084564|NCT02204579|3537680|P1|Overall Study|Screen failures|2
1084565|NCT02204449|3537734|P2|Overall Study|Withdrawal by Subject|1
1084566|NCT02204449|3537735|P1|Overall Study|Withdrawal by Subject|0
1084567|NCT02204449|3537734|P2|Overall Study|Death|1
1084568|NCT02204449|3537735|P1|Overall Study|Death|0
1084569|NCT02204449|3537734|P2|Overall Study|Lost to Follow-up|9
1084570|NCT02204449|3537735|P1|Overall Study|Lost to Follow-up|7
1084571|NCT02204410|3537745|P1|Overall Study|Withdrawal by Subject|3
1084572|NCT02204410|3537745|P1|Overall Study|Protocol Violation|1
1084573|NCT02204410|3537745|P1|Overall Study|Physician Decision|2
1084574|NCT02204410|3537745|P1|Overall Study|Lost to Follow-up|5
1084575|NCT02204371|3537750|P1|Overall Study|Adverse Event|1
1084576|NCT02204319|3537773|P1|Overall Study|Withdrawal by Subject|2
1084577|NCT02204319|3537773|P1|Overall Study|Pregnancy|1
1084578|NCT02204007|3537802|P2|Overall Study|Surgery Canceled|1
1084579|NCT02204007|3537803|P1|Overall Study|Surgery Canceled|1
1084580|NCT02203916|3537814|P3|Overall Study|Reason Not Specified|1
1084581|NCT02203916|3537815|P2|Overall Study|Reason Not Specified|2
1084582|NCT02203916|3537816|P1|Overall Study|Reason Not Specified|0
1084583|NCT02203916|3537814|P3|Overall Study|Lack of Efficacy|0
1084584|NCT02203916|3537815|P2|Overall Study|Lack of Efficacy|0
1084585|NCT02203916|3537816|P1|Overall Study|Lack of Efficacy|3
1084586|NCT02203916|3537814|P3|Overall Study|Voluntary Withdrawal|8
1084587|NCT02203916|3537815|P2|Overall Study|Voluntary Withdrawal|3
1084588|NCT02203916|3537816|P1|Overall Study|Voluntary Withdrawal|3
1084589|NCT02203916|3537814|P3|Overall Study|Lost to Follow-up|0
1084590|NCT02203916|3537815|P2|Overall Study|Lost to Follow-up|1
1084591|NCT02203916|3537816|P1|Overall Study|Lost to Follow-up|0
1084592|NCT02203916|3537814|P3|Overall Study|Major Protocol Deviation|0
1084593|NCT02203916|3537815|P2|Overall Study|Major Protocol Deviation|1
1084594|NCT02203916|3537816|P1|Overall Study|Major Protocol Deviation|1
1084595|NCT02203916|3537814|P3|Overall Study|Pretreatment Event/Adverse Event|2
1084596|NCT02203916|3537815|P2|Overall Study|Pretreatment Event/Adverse Event|3
1084597|NCT02203916|3537816|P1|Overall Study|Pretreatment Event/Adverse Event|1
1084598|NCT02203838|3537840|P4|Overall Study|Other|0
1084599|NCT02203838|3537841|P3|Overall Study|Other|0
1084600|NCT02203838|3537842|P2|Overall Study|Other|0
1084601|NCT02203838|3537843|P1|Overall Study|Other|1
1084602|NCT02203838|3537840|P4|Overall Study|Physician Decision|3
1084603|NCT02203838|3537841|P3|Overall Study|Physician Decision|2
1084604|NCT02203838|3537842|P2|Overall Study|Physician Decision|0
1084605|NCT02203838|3537843|P1|Overall Study|Physician Decision|27
1084606|NCT02203838|3537840|P4|Overall Study|Withdrawal by Subject|11
1084607|NCT02203838|3537841|P3|Overall Study|Withdrawal by Subject|8
1084608|NCT02203838|3537842|P2|Overall Study|Withdrawal by Subject|10
1084609|NCT02203838|3537843|P1|Overall Study|Withdrawal by Subject|83
1084610|NCT02203838|3537840|P4|Overall Study|Protocol Violation|0
1084611|NCT02203838|3537841|P3|Overall Study|Protocol Violation|0
1084612|NCT02203838|3537842|P2|Overall Study|Protocol Violation|3
1084613|NCT02203838|3537843|P1|Overall Study|Protocol Violation|7
1084614|NCT02203838|3537840|P4|Overall Study|Lost to Follow-up|1
1084615|NCT02203838|3537841|P3|Overall Study|Lost to Follow-up|2
1084616|NCT02203838|3537842|P2|Overall Study|Lost to Follow-up|3
1084617|NCT02203838|3537843|P1|Overall Study|Lost to Follow-up|39
1084618|NCT02203838|3537840|P4|Overall Study|Adverse Event|2
1084619|NCT02203838|3537841|P3|Overall Study|Adverse Event|3
1084620|NCT02203838|3537842|P2|Overall Study|Adverse Event|6
1084621|NCT02203838|3537843|P1|Overall Study|Adverse Event|46
1084622|NCT02203838|3537840|P4|Overall Study|Lack of Efficacy|1
1084623|NCT02203838|3537841|P3|Overall Study|Lack of Efficacy|1
1084624|NCT02203838|3537842|P2|Overall Study|Lack of Efficacy|0
1084625|NCT02203838|3537843|P1|Overall Study|Lack of Efficacy|7
1084626|NCT02203721|3537923|P2|Overall Study|Illness|1
1084627|NCT02203721|3537924|P1|Overall Study|Illness|0
1084628|NCT02203721|3537923|P2|Overall Study|Death|2
1084629|NCT02203721|3537924|P1|Overall Study|Death|0
1084630|NCT02203721|3537923|P2|Overall Study|Lost to Follow-up|0
1084631|NCT02203721|3537924|P1|Overall Study|Lost to Follow-up|1
1084632|NCT02203331|3538027|P6|Overall Study|Lost to Follow-up|0
1084633|NCT02203331|3538028|P5|Overall Study|Lost to Follow-up|1
1084634|NCT02203331|3538029|P4|Overall Study|Lost to Follow-up|0
1084635|NCT02203331|3538030|P3|Overall Study|Lost to Follow-up|0
1084636|NCT02203331|3538031|P2|Overall Study|Lost to Follow-up|0
1084637|NCT02203331|3538032|P1|Overall Study|Lost to Follow-up|0
1084638|NCT02203331|3538027|P6|Overall Study|Protocol Violation|0
1084639|NCT02203331|3538028|P5|Overall Study|Protocol Violation|1
1084640|NCT02203331|3538029|P4|Overall Study|Protocol Violation|1
1084641|NCT02203331|3538030|P3|Overall Study|Protocol Violation|0
1084642|NCT02203331|3538031|P2|Overall Study|Protocol Violation|2
1084643|NCT02203331|3538032|P1|Overall Study|Protocol Violation|0
1084644|NCT02203331|3538027|P6|Overall Study|Lack of Efficacy|1
1084645|NCT02203331|3538028|P5|Overall Study|Lack of Efficacy|0
1084646|NCT02203331|3538029|P4|Overall Study|Lack of Efficacy|0
1084647|NCT02203331|3538030|P3|Overall Study|Lack of Efficacy|1
1084648|NCT02203331|3538031|P2|Overall Study|Lack of Efficacy|2
1084649|NCT02203331|3538032|P1|Overall Study|Lack of Efficacy|0
1084650|NCT02203331|3538027|P6|Overall Study|Other Reasons|0
1084651|NCT02203331|3538028|P5|Overall Study|Other Reasons|0
1084652|NCT02203331|3538029|P4|Overall Study|Other Reasons|2
1084653|NCT02203331|3538030|P3|Overall Study|Other Reasons|0
1084654|NCT02203331|3538031|P2|Overall Study|Other Reasons|2
1084655|NCT02203331|3538032|P1|Overall Study|Other Reasons|1
1084656|NCT02203331|3538027|P6|Overall Study|Adverse Event|3
1084657|NCT02203331|3538028|P5|Overall Study|Adverse Event|3
1084658|NCT02203331|3538029|P4|Overall Study|Adverse Event|4
1084659|NCT02203331|3538030|P3|Overall Study|Adverse Event|3
1084660|NCT02203331|3538031|P2|Overall Study|Adverse Event|8
1084661|NCT02203331|3538032|P1|Overall Study|Adverse Event|4
1084662|NCT02203331|3538027|P6|Overall Study|Withdrawal by Subject|3
1084663|NCT02203331|3538028|P5|Overall Study|Withdrawal by Subject|0
1084664|NCT02203331|3538029|P4|Overall Study|Withdrawal by Subject|0
1084665|NCT02203331|3538030|P3|Overall Study|Withdrawal by Subject|1
1084666|NCT02203331|3538031|P2|Overall Study|Withdrawal by Subject|0
1084667|NCT02203331|3538032|P1|Overall Study|Withdrawal by Subject|1
1084668|NCT02203331|3538027|P6|Overall Study|Pregnancy|0
1084669|NCT02203331|3538028|P5|Overall Study|Pregnancy|2
1084670|NCT02203331|3538029|P4|Overall Study|Pregnancy|0
1084671|NCT02203331|3538030|P3|Overall Study|Pregnancy|0
1084672|NCT02203331|3538031|P2|Overall Study|Pregnancy|0
1084673|NCT02203331|3538032|P1|Overall Study|Pregnancy|1
1084674|NCT02203149|3538091|P5|Part 2|Adverse Event|1
1084675|NCT02203149|3538092|P4|Part 2|Adverse Event|1
1084676|NCT02203149|3538093|P3|Part 2|Adverse Event|0
1084677|NCT02203149|3538094|P2|Part 2|Adverse Event|0
1084678|NCT02203149|3538095|P1|Part 2|Adverse Event|0
1084679|NCT02203149|3538091|P5|Part 2|Withdrawal by Subject|0
1084680|NCT02203149|3538092|P4|Part 2|Withdrawal by Subject|1
1084681|NCT02203149|3538093|P3|Part 2|Withdrawal by Subject|0
1084682|NCT02203149|3538094|P2|Part 2|Withdrawal by Subject|0
1084683|NCT02203149|3538095|P1|Part 2|Withdrawal by Subject|0
1084684|NCT02203149|3538091|P5|Part 2|Death|0
1084685|NCT02203149|3538092|P4|Part 2|Death|1
1084686|NCT02203149|3538093|P3|Part 2|Death|1
1084687|NCT02203149|3538094|P2|Part 2|Death|0
1084688|NCT02203149|3538095|P1|Part 2|Death|0
1084689|NCT02203149|3538091|P5|Part 1|Adverse Event|0
1084690|NCT02203149|3538092|P4|Part 1|Adverse Event|0
1084691|NCT02203149|3538093|P3|Part 1|Adverse Event|0
1084692|NCT02203149|3538094|P2|Part 1|Adverse Event|1
1084693|NCT02203149|3538095|P1|Part 1|Adverse Event|0
1084694|NCT02203032|3538128|P4|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2
1084695|NCT02203032|3538129|P3|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3
1084696|NCT02203032|3538130|P2|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1
1084697|NCT02203032|3538131|P1|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0
1084698|NCT02203032|3538128|P4|Blinded Phase (Week 16 to Week 44)|Death|1
1084699|NCT02203032|3538129|P3|Blinded Phase (Week 16 to Week 44)|Death|0
1084700|NCT02203032|3538130|P2|Blinded Phase (Week 16 to Week 44)|Death|0
1084701|NCT02203032|3538131|P1|Blinded Phase (Week 16 to Week 44)|Death|0
1084702|NCT02203032|3538128|P4|Blinded Phase (Week 16 to Week 44)|Other|15
1084703|NCT02203032|3538129|P3|Blinded Phase (Week 16 to Week 44)|Other|1
1084704|NCT02203032|3538130|P2|Blinded Phase (Week 16 to Week 44)|Other|4
1084705|NCT02203032|3538131|P1|Blinded Phase (Week 16 to Week 44)|Other|0
1084706|NCT02203032|3538128|P4|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20
1084707|NCT02203032|3538129|P3|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19
1084708|NCT02203032|3538130|P2|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8
1084709|NCT02203032|3538131|P1|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0
1084710|NCT02203032|3538128|P4|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8
1084711|NCT02203032|3538129|P3|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3
1084712|NCT02203032|3538130|P2|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2
1084713|NCT02203032|3538131|P1|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0
1084714|NCT02203032|3538128|P4|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
1084715|NCT02203032|3538129|P3|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
1084716|NCT02203032|3538130|P2|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
1084717|NCT02203032|3538131|P1|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1
1084718|NCT02203032|3538128|P4|Open Label Run-in (Week 0 to Week 16)|Other|0
1084719|NCT02203032|3538129|P3|Open Label Run-in (Week 0 to Week 16)|Other|0
1084720|NCT02203032|3538130|P2|Open Label Run-in (Week 0 to Week 16)|Other|0
1084721|NCT02203032|3538131|P1|Open Label Run-in (Week 0 to Week 16)|Other|2
1084722|NCT02203032|3538128|P4|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
1084723|NCT02203032|3538129|P3|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
1084724|NCT02203032|3538130|P2|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
1084725|NCT02203032|3538131|P1|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4
1084726|NCT02203032|3538128|P4|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
1084727|NCT02203032|3538129|P3|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
1084728|NCT02203032|3538130|P2|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
1084729|NCT02203032|3538131|P1|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6
1084730|NCT02203032|3538128|P4|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
1084731|NCT02203032|3538129|P3|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
1084732|NCT02203032|3538130|P2|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
1084733|NCT02203032|3538131|P1|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3
1084734|NCT02203032|3538128|P4|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
1084735|NCT02203032|3538129|P3|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
1084736|NCT02203032|3538130|P2|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
1084737|NCT02203032|3538131|P1|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1
1084738|NCT02203032|3538128|P4|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
1084739|NCT02203032|3538129|P3|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
1084740|NCT02203032|3538130|P2|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
1084741|NCT02203032|3538131|P1|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2
1084742|NCT02202980|3538159|P14|Overall Study|Withdrew Consent|0
1084743|NCT02202980|3538160|P13|Overall Study|Withdrew Consent|0
1084744|NCT02202980|3538161|P12|Overall Study|Withdrew Consent|0
1084745|NCT02202980|3538162|P11|Overall Study|Withdrew Consent|0
1084746|NCT02202980|3538163|P10|Overall Study|Withdrew Consent|0
1084747|NCT02202980|3538164|P9|Overall Study|Withdrew Consent|1
1084748|NCT02202980|3538165|P8|Overall Study|Withdrew Consent|0
1084749|NCT02202980|3538166|P7|Overall Study|Withdrew Consent|0
1084750|NCT02202980|3538167|P6|Overall Study|Withdrew Consent|0
1084751|NCT02202980|3538168|P5|Overall Study|Withdrew Consent|0
1084752|NCT02202980|3538169|P4|Overall Study|Withdrew Consent|0
1084753|NCT02202980|3538170|P3|Overall Study|Withdrew Consent|2
1084754|NCT02202980|3538171|P2|Overall Study|Withdrew Consent|1
1084755|NCT02202980|3538172|P1|Overall Study|Withdrew Consent|0
1084756|NCT02202980|3538159|P14|Overall Study|Lost to Follow-up|0
1084757|NCT02202980|3538160|P13|Overall Study|Lost to Follow-up|1
1084758|NCT02202980|3538161|P12|Overall Study|Lost to Follow-up|0
1084759|NCT02202980|3538162|P11|Overall Study|Lost to Follow-up|0
1084760|NCT02202980|3538163|P10|Overall Study|Lost to Follow-up|0
1084761|NCT02202980|3538164|P9|Overall Study|Lost to Follow-up|1
1084762|NCT02202980|3538165|P8|Overall Study|Lost to Follow-up|1
1084763|NCT02202980|3538166|P7|Overall Study|Lost to Follow-up|0
1084764|NCT02202980|3538167|P6|Overall Study|Lost to Follow-up|0
1084765|NCT02202980|3538168|P5|Overall Study|Lost to Follow-up|0
1084766|NCT02202980|3538169|P4|Overall Study|Lost to Follow-up|1
1084767|NCT02202980|3538170|P3|Overall Study|Lost to Follow-up|1
1084768|NCT02202980|3538171|P2|Overall Study|Lost to Follow-up|1
1084769|NCT02202980|3538172|P1|Overall Study|Lost to Follow-up|0
1084770|NCT02202980|3538159|P14|Overall Study|Protocol Violation|0
1084771|NCT02202980|3538160|P13|Overall Study|Protocol Violation|0
1084772|NCT02202980|3538161|P12|Overall Study|Protocol Violation|0
1084773|NCT02202980|3538162|P11|Overall Study|Protocol Violation|0
1084774|NCT02202980|3538163|P10|Overall Study|Protocol Violation|0
1084775|NCT02202980|3538164|P9|Overall Study|Protocol Violation|0
1084776|NCT02202980|3538165|P8|Overall Study|Protocol Violation|0
1084777|NCT02202980|3538166|P7|Overall Study|Protocol Violation|0
1084778|NCT02202980|3538167|P6|Overall Study|Protocol Violation|0
1084779|NCT02202980|3538168|P5|Overall Study|Protocol Violation|3
1084780|NCT02202980|3538169|P4|Overall Study|Protocol Violation|3
1084781|NCT02202980|3538170|P3|Overall Study|Protocol Violation|0
1084782|NCT02202980|3538171|P2|Overall Study|Protocol Violation|0
1084783|NCT02202980|3538172|P1|Overall Study|Protocol Violation|0
1084784|NCT02202980|3538159|P14|Overall Study|Lack of Efficacy|0
1084785|NCT02202980|3538160|P13|Overall Study|Lack of Efficacy|10
1084786|NCT02202980|3538161|P12|Overall Study|Lack of Efficacy|3
1084787|NCT02202980|3538162|P11|Overall Study|Lack of Efficacy|0
1084788|NCT02202980|3538163|P10|Overall Study|Lack of Efficacy|0
1084789|NCT02202980|3538164|P9|Overall Study|Lack of Efficacy|2
1084790|NCT02202980|3538165|P8|Overall Study|Lack of Efficacy|2
1084791|NCT02202980|3538166|P7|Overall Study|Lack of Efficacy|11
1084792|NCT02202980|3538167|P6|Overall Study|Lack of Efficacy|1
1084793|NCT02202980|3538168|P5|Overall Study|Lack of Efficacy|3
1084794|NCT02202980|3538169|P4|Overall Study|Lack of Efficacy|0
1084795|NCT02202980|3538170|P3|Overall Study|Lack of Efficacy|7
1084796|NCT02202980|3538171|P2|Overall Study|Lack of Efficacy|0
1084797|NCT02202980|3538172|P1|Overall Study|Lack of Efficacy|1
1084798|NCT02202850|3538260|P2|Overall Study|Lost to Follow-up|1
1084799|NCT02202850|3538261|P1|Overall Study|Lost to Follow-up|7
1084800|NCT02202850|3538260|P2|Overall Study|Enbrel treatment discontinued|3
1084801|NCT02202850|3538261|P1|Overall Study|Enbrel treatment discontinued|15
1084802|NCT02202850|3538260|P2|Overall Study|Other|2
1084803|NCT02202850|3538261|P1|Overall Study|Other|2
1084804|NCT02202837|3538313|P2|Overall Study|Lost to Follow-up|1
1084805|NCT02202837|3538314|P1|Overall Study|Lost to Follow-up|7
1084806|NCT02202837|3538313|P2|Overall Study|Other|0
1084807|NCT02202837|3538314|P1|Overall Study|Other|10
1084808|NCT02202837|3538313|P2|Overall Study|Enbrel treatment discontinued|4
1084809|NCT02202837|3538314|P1|Overall Study|Enbrel treatment discontinued|36
1084810|NCT02202785|3538365|P3|Overall Study|Reason not Specified|13
1084811|NCT02202785|3538366|P2|Overall Study|Reason not Specified|7
1084812|NCT02202785|3538367|P1|Overall Study|Reason not Specified|10
1084813|NCT02202785|3538365|P3|Overall Study|Lost to Follow-up|0
1084814|NCT02202785|3538366|P2|Overall Study|Lost to Follow-up|1
1084815|NCT02202785|3538367|P1|Overall Study|Lost to Follow-up|0
1084816|NCT02202785|3538365|P3|Overall Study|Withdrawal by Subject|0
1084817|NCT02202785|3538366|P2|Overall Study|Withdrawal by Subject|1
1084818|NCT02202785|3538367|P1|Overall Study|Withdrawal by Subject|0
1084819|NCT02202785|3538365|P3|Overall Study|Study Terminated by Sponsor|4
1084820|NCT02202785|3538366|P2|Overall Study|Study Terminated by Sponsor|6
1084821|NCT02202785|3538367|P1|Overall Study|Study Terminated by Sponsor|1
1084822|NCT02202759|3538404|P3|Overall Study|Reason not Specified|10
1084823|NCT02202759|3538405|P2|Overall Study|Reason not Specified|11
1084824|NCT02202759|3538406|P1|Overall Study|Reason not Specified|4
1084825|NCT02202759|3538404|P3|Overall Study|Withdrawal by Subject|1
1084826|NCT02202759|3538405|P2|Overall Study|Withdrawal by Subject|1
1084827|NCT02202759|3538406|P1|Overall Study|Withdrawal by Subject|2
1084828|NCT02202759|3538404|P3|Overall Study|Study Terminated by Sponsor|3
1084829|NCT02202759|3538405|P2|Overall Study|Study Terminated by Sponsor|3
1084830|NCT02202759|3538406|P1|Overall Study|Study Terminated by Sponsor|3
1084831|NCT02202538|3538440|P1|Overall Study|Investigator Decision|1
1084832|NCT02202538|3538440|P1|Overall Study|Did not meet all inclusion criteria|2
1084833|NCT02202538|3538440|P1|Overall Study|Withdrawal by Subject|5
1084834|NCT02202317|3538451|P1|Overall Study|Lost to Follow-up|1
1084835|NCT02202161|3538478|P8|Overall Study|Withdrawal by Subject|0
1084836|NCT02202161|3538479|P7|Overall Study|Withdrawal by Subject|0
1084837|NCT02202161|3538480|P6|Overall Study|Withdrawal by Subject|0
1084838|NCT02202161|3538481|P5|Overall Study|Withdrawal by Subject|1
1084839|NCT02202161|3538482|P4|Overall Study|Withdrawal by Subject|0
1084840|NCT02202161|3538483|P3|Overall Study|Withdrawal by Subject|0
1084841|NCT02202161|3538484|P2|Overall Study|Withdrawal by Subject|0
1084842|NCT02202161|3538485|P1|Overall Study|Withdrawal by Subject|0
1084843|NCT02202161|3538478|P8|Overall Study|Physician Decision|3
1084844|NCT02202161|3538479|P7|Overall Study|Physician Decision|0
1084845|NCT02202161|3538480|P6|Overall Study|Physician Decision|0
1084846|NCT02202161|3538481|P5|Overall Study|Physician Decision|0
1084847|NCT02202161|3538482|P4|Overall Study|Physician Decision|0
1084848|NCT02202161|3538483|P3|Overall Study|Physician Decision|0
1084849|NCT02202161|3538484|P2|Overall Study|Physician Decision|0
1084850|NCT02202161|3538485|P1|Overall Study|Physician Decision|0
1084851|NCT02202161|3538478|P8|Overall Study|Did not meet continuation criteria|3
1084852|NCT02202161|3538479|P7|Overall Study|Did not meet continuation criteria|0
1084853|NCT02202161|3538480|P6|Overall Study|Did not meet continuation criteria|0
1084854|NCT02202161|3538481|P5|Overall Study|Did not meet continuation criteria|0
1084855|NCT02202161|3538482|P4|Overall Study|Did not meet continuation criteria|0
1084856|NCT02202161|3538483|P3|Overall Study|Did not meet continuation criteria|0
1084857|NCT02202161|3538484|P2|Overall Study|Did not meet continuation criteria|0
1084858|NCT02202161|3538485|P1|Overall Study|Did not meet continuation criteria|0
1084859|NCT02202161|3538478|P8|Overall Study|Adverse Event|0
1084860|NCT02202161|3538479|P7|Overall Study|Adverse Event|0
1084861|NCT02202161|3538480|P6|Overall Study|Adverse Event|1
1084862|NCT02202161|3538481|P5|Overall Study|Adverse Event|0
1084863|NCT02202161|3538482|P4|Overall Study|Adverse Event|0
1084864|NCT02202161|3538483|P3|Overall Study|Adverse Event|0
1084865|NCT02202161|3538484|P2|Overall Study|Adverse Event|1
1084866|NCT02202161|3538485|P1|Overall Study|Adverse Event|1
1084867|NCT02202109|3538645|P2|Overall Study|Withdrawal by Subject|0
1084868|NCT02202109|3538646|P1|Overall Study|Withdrawal by Subject|2
1084869|NCT02202109|3538645|P2|Overall Study|Lost to Follow-up|87
1084870|NCT02202109|3538646|P1|Overall Study|Lost to Follow-up|88
1084871|NCT02201953|3538658|P2|Overall Study|Death|3
1084872|NCT02201953|3538659|P1|Overall Study|Death|0
1084873|NCT02201953|3538658|P2|Overall Study|Adverse Event|5
1084874|NCT02201953|3538659|P1|Overall Study|Adverse Event|0
1084875|NCT02201953|3538658|P2|Overall Study|Withdrew Consent|5
1084876|NCT02201953|3538659|P1|Overall Study|Withdrew Consent|2
1084877|NCT02201953|3538658|P2|Overall Study|Lost to Follow-up|8
1084878|NCT02201953|3538659|P1|Overall Study|Lost to Follow-up|8
1084879|NCT02201953|3538658|P2|Overall Study|Lack of Efficacy|30
1084880|NCT02201953|3538659|P1|Overall Study|Lack of Efficacy|9
1084881|NCT02201953|3538658|P2|Overall Study|Randomized but Never Treated|5
1084882|NCT02201953|3538659|P1|Overall Study|Randomized but Never Treated|1
1084883|NCT02201940|3538677|P2|Overall Study|Adverse Event|1
1084884|NCT02201940|3538678|P1|Overall Study|Adverse Event|0
1084885|NCT02201940|3538677|P2|Overall Study|Death|0
1084886|NCT02201940|3538678|P1|Overall Study|Death|1
1084887|NCT02201940|3538677|P2|Overall Study|Investigator's Discretion|1
1084888|NCT02201940|3538678|P1|Overall Study|Investigator's Discretion|1
1084889|NCT02201940|3538677|P2|Overall Study|Withdrew Consent|1
1084890|NCT02201940|3538678|P1|Overall Study|Withdrew Consent|2
1084891|NCT02201940|3538677|P2|Overall Study|Lost to Follow-up|0
1084892|NCT02201940|3538678|P1|Overall Study|Lost to Follow-up|5
1084893|NCT02201940|3538677|P2|Overall Study|Lack of Efficacy|113
1084894|NCT02201940|3538678|P1|Overall Study|Lack of Efficacy|2
1084895|NCT02201940|3538677|P2|Overall Study|Randomized/Enrolled but Never Treated|0
1084896|NCT02201940|3538678|P1|Overall Study|Randomized/Enrolled but Never Treated|1
1084897|NCT02201901|3538697|P3|Overall Study|Adverse Event|0
1084898|NCT02201901|3538698|P2|Overall Study|Adverse Event|1
1084899|NCT02201901|3538699|P1|Overall Study|Adverse Event|1
1084900|NCT02201901|3538697|P3|Overall Study|Withdrew Consent|2
1084901|NCT02201901|3538698|P2|Overall Study|Withdrew Consent|0
1084902|NCT02201901|3538699|P1|Overall Study|Withdrew Consent|2
1084903|NCT02201901|3538697|P3|Overall Study|Lost to Follow-up|2
1084904|NCT02201901|3538698|P2|Overall Study|Lost to Follow-up|3
1084905|NCT02201901|3538699|P1|Overall Study|Lost to Follow-up|2
1084906|NCT02201901|3538697|P3|Overall Study|Death|3
1084907|NCT02201901|3538698|P2|Overall Study|Death|3
1084908|NCT02201901|3538699|P1|Overall Study|Death|3
1084909|NCT02201901|3538697|P3|Overall Study|Lack of Efficacy|6
1084910|NCT02201901|3538698|P2|Overall Study|Lack of Efficacy|1
1084911|NCT02201901|3538699|P1|Overall Study|Lack of Efficacy|7
1084912|NCT02201901|3538697|P3|Overall Study|Randomized but never treated|0
1084913|NCT02201901|3538698|P2|Overall Study|Randomized but never treated|1
1084914|NCT02201901|3538699|P1|Overall Study|Randomized but never treated|0
1084915|NCT02201784|3538730|P2|Overall Study|Failure to achieve adequate block|0
1084916|NCT02201784|3538731|P1|Overall Study|Failure to achieve adequate block|2
1084917|NCT02201524|3538749|P4|Overall Study|Other|0
1084918|NCT02201524|3538750|P3|Overall Study|Other|0
1084919|NCT02201524|3538751|P2|Overall Study|Other|1
1084920|NCT02201524|3538752|P1|Overall Study|Other|1
1084921|NCT02201524|3538749|P4|Overall Study|Withdrawal by Subject|1
1084922|NCT02201524|3538750|P3|Overall Study|Withdrawal by Subject|1
1084923|NCT02201524|3538751|P2|Overall Study|Withdrawal by Subject|0
1084924|NCT02201524|3538752|P1|Overall Study|Withdrawal by Subject|0
1084925|NCT02201524|3538749|P4|Overall Study|Protocol Violation|1
1084926|NCT02201524|3538750|P3|Overall Study|Protocol Violation|0
1084927|NCT02201524|3538751|P2|Overall Study|Protocol Violation|0
1084928|NCT02201524|3538752|P1|Overall Study|Protocol Violation|0
1084929|NCT02201524|3538749|P4|Overall Study|No longer meets eligibility criteria|2
1084930|NCT02201524|3538750|P3|Overall Study|No longer meets eligibility criteria|0
1084931|NCT02201524|3538751|P2|Overall Study|No longer meets eligibility criteria|0
1084932|NCT02201524|3538752|P1|Overall Study|No longer meets eligibility criteria|0
1084933|NCT02201524|3538749|P4|Overall Study|Lost to Follow-up|0
1084934|NCT02201524|3538750|P3|Overall Study|Lost to Follow-up|2
1084935|NCT02201524|3538751|P2|Overall Study|Lost to Follow-up|0
1084936|NCT02201524|3538752|P1|Overall Study|Lost to Follow-up|0
1084937|NCT02201524|3538749|P4|Overall Study|Insufficient clinical response|0
1084938|NCT02201524|3538750|P3|Overall Study|Insufficient clinical response|0
1084939|NCT02201524|3538751|P2|Overall Study|Insufficient clinical response|0
1084940|NCT02201524|3538752|P1|Overall Study|Insufficient clinical response|1
1084941|NCT02201524|3538749|P4|Overall Study|Adverse Event|0
1084942|NCT02201524|3538750|P3|Overall Study|Adverse Event|1
1084943|NCT02201524|3538751|P2|Overall Study|Adverse Event|2
1084944|NCT02201524|3538752|P1|Overall Study|Adverse Event|0
1084945|NCT02201329|3538877|P1|Overall Study|Withdrawal by Subject|2
1084946|NCT02201329|3538877|P1|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3
1084947|NCT02200510|3538971|P2|Overall Study|potential COI - joined study team|0
1084948|NCT02200510|3538972|P1|Overall Study|potential COI - joined study team|1
1084949|NCT02200510|3538971|P2|Overall Study|Lost to Follow-up|1
1084950|NCT02200510|3538972|P1|Overall Study|Lost to Follow-up|7
1084951|NCT02200510|3538971|P2|Overall Study|Protocol Violation|1
1084952|NCT02200510|3538972|P1|Overall Study|Protocol Violation|0
1084953|NCT02200510|3538971|P2|Overall Study|Death|1
1084954|NCT02200510|3538972|P1|Overall Study|Death|1
1084955|NCT02200211|3538997|P4|Overall Study|Withdrawal by Subject|0
1084956|NCT02200211|3538998|P3|Overall Study|Withdrawal by Subject|0
1084957|NCT02200211|3538999|P2|Overall Study|Withdrawal by Subject|0
1084958|NCT02200211|3539000|P1|Overall Study|Withdrawal by Subject|1
1084959|NCT02200211|3538997|P4|Overall Study|Lost to Follow-up|2
1084960|NCT02200211|3538998|P3|Overall Study|Lost to Follow-up|1
1084961|NCT02200211|3538999|P2|Overall Study|Lost to Follow-up|7
1084962|NCT02200211|3539000|P1|Overall Study|Lost to Follow-up|7
1084963|NCT02199795|3539113|P2|Overall Study|withdrew due to shoulder pain|0
1084964|NCT02199795|3539114|P1|Overall Study|withdrew due to shoulder pain|1
1084965|NCT02199795|3539113|P2|Overall Study|no longer met inclusion criteria|0
1084966|NCT02199795|3539114|P1|Overall Study|no longer met inclusion criteria|1
1084967|NCT02199509|3539155|P2|Overall Study|Misunderstood titration schedule|0
1084968|NCT02199509|3539156|P1|Overall Study|Misunderstood titration schedule|1
1084969|NCT02199509|3539155|P2|Overall Study|Suicidal Ideation|1
1084970|NCT02199509|3539156|P1|Overall Study|Suicidal Ideation|0
1084971|NCT02198963|3539181|P1|Overall Study|Withdrawal by Subject|6
1084972|NCT02198963|3539181|P1|Overall Study|Adverse Event|1
1084973|NCT02198235|3539223|P3|Overall Study|Lost to Follow-up|2
1084974|NCT02198235|3539224|P2|Overall Study|Lost to Follow-up|2
1084975|NCT02198235|3539225|P1|Overall Study|Lost to Follow-up|3
1084976|NCT02198040|3539245|P3|Overall Study|Withdrawal by Subject|1
1084977|NCT02198040|3539246|P2|Overall Study|Withdrawal by Subject|0
1084978|NCT02198040|3539247|P1|Overall Study|Withdrawal by Subject|0
1084979|NCT02198040|3539245|P3|Overall Study|Work reasons|0
1084980|NCT02198040|3539246|P2|Overall Study|Work reasons|1
1084981|NCT02198040|3539247|P1|Overall Study|Work reasons|0
1084982|NCT02197806|3539277|P4|Overall Study|Adverse Event|1
1084983|NCT02197806|3539278|P3|Overall Study|Adverse Event|0
1084984|NCT02197806|3539279|P2|Overall Study|Adverse Event|1
1084985|NCT02197806|3539280|P1|Overall Study|Adverse Event|0
1084986|NCT02197520|3539290|P2|Period 2|Withdrawal by Subject|0
1084987|NCT02197520|3539291|P1|Period 2|Withdrawal by Subject|1
1084988|NCT02197520|3539290|P2|Period 2|Adverse Event|2
1084989|NCT02197520|3539291|P1|Period 2|Adverse Event|0
1084990|NCT02197520|3539290|P2|Period 1|Withdrawal by Subject|0
1084991|NCT02197520|3539291|P1|Period 1|Withdrawal by Subject|1
1084992|NCT02197377|3539337|P2|Overall Study|Insertion Failure|3
1084993|NCT02197377|3539338|P1|Overall Study|Insertion Failure|0
1084994|NCT02197247|3539359|P1|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9
1084995|NCT02197247|3539359|P1|Part B: Day 78 to End Part B (AZD9291)|Death|1
1084996|NCT02197247|3539359|P1|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1
1084997|NCT02197247|3539359|P1|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2
1084998|NCT02197247|3539359|P1|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2
1084999|NCT02197247|3539359|P1|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5
1085000|NCT02197247|3539359|P1|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2
1085001|NCT02197247|3539359|P1|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2
1085002|NCT02197234|3539404|P1|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22
1085003|NCT02197234|3539404|P1|Part B: Day 33 to End Part B (AZD9291)|Death|6
1085004|NCT02197234|3539404|P1|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1
1085005|NCT02197234|3539404|P1|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1
1085006|NCT02197234|3539404|P1|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1
1085007|NCT02197234|3539404|P1|Part A: Day 3-30 (AZD9291 Alone)|Adverse Event|1
1085008|NCT02197234|3539404|P1|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1
1085009|NCT02197130|3539426|P3|Overall Study|Other|3
1085010|NCT02197130|3539427|P2|Overall Study|Other|0
1085011|NCT02197130|3539428|P1|Overall Study|Other|1
1085012|NCT02197130|3539426|P3|Overall Study|Withdrawal by Subject|4
1085013|NCT02197130|3539427|P2|Overall Study|Withdrawal by Subject|3
1085014|NCT02197130|3539428|P1|Overall Study|Withdrawal by Subject|0
1085015|NCT02197130|3539426|P3|Overall Study|Does not meet entrance criteria|1
1085016|NCT02197130|3539427|P2|Overall Study|Does not meet entrance criteria|0
1085017|NCT02197130|3539428|P1|Overall Study|Does not meet entrance criteria|0
1085018|NCT02197130|3539426|P3|Overall Study|Lost to Follow-up|1
1085019|NCT02197130|3539427|P2|Overall Study|Lost to Follow-up|0
1085020|NCT02197130|3539428|P1|Overall Study|Lost to Follow-up|2
1085021|NCT02197130|3539426|P3|Overall Study|Death|0
1085022|NCT02197130|3539427|P2|Overall Study|Death|1
1085023|NCT02197130|3539428|P1|Overall Study|Death|0
1085024|NCT02197130|3539426|P3|Overall Study|Adverse Event|23
1085025|NCT02197130|3539427|P2|Overall Study|Adverse Event|4
1085026|NCT02197130|3539428|P1|Overall Study|Adverse Event|13
1085027|NCT02196714|3539520|P4|Overall Study|Protocol Violation|0
1085028|NCT02196714|3539521|P3|Overall Study|Protocol Violation|1
1085029|NCT02196714|3539522|P2|Overall Study|Protocol Violation|0
1085030|NCT02196714|3539523|P1|Overall Study|Protocol Violation|0
1085031|NCT02196701|3539645|P1|Overall Study|Non-adherence to Protocol|1
1085032|NCT02196701|3539645|P1|Overall Study|Lost to Follow-up|1
1085033|NCT02196701|3539645|P1|Overall Study|Adverse Event|1
1085034|NCT02196675|3539704|P3|Overall Study|Death|1
1085035|NCT02196675|3539705|P2|Overall Study|Death|0
1085036|NCT02196675|3539706|P1|Overall Study|Death|0
1085037|NCT02196675|3539704|P3|Overall Study|Protocol Violation|0
1085038|NCT02196675|3539705|P2|Overall Study|Protocol Violation|1
1085039|NCT02196675|3539706|P1|Overall Study|Protocol Violation|0
1085040|NCT02196675|3539704|P3|Overall Study|Intra-operative surgical exclusion|0
1085041|NCT02196675|3539705|P2|Overall Study|Intra-operative surgical exclusion|1
1085042|NCT02196675|3539706|P1|Overall Study|Intra-operative surgical exclusion|1
1085043|NCT02196675|3539704|P3|Overall Study|Withdrawal by Subject|0
1085044|NCT02196675|3539705|P2|Overall Study|Withdrawal by Subject|0
1085045|NCT02196675|3539706|P1|Overall Study|Withdrawal by Subject|1
1085046|NCT02196506|3539728|P4|Phase A+|Participant withdrawn by investigator|1
1085047|NCT02196506|3539729|P3|Phase A+|Participant withdrawn by investigator|0
1085048|NCT02196506|3539730|P2|Phase A+|Participant withdrawn by investigator|0
1085049|NCT02196506|3539731|P1|Phase A+|Participant withdrawn by investigator|0
1085050|NCT02196506|3539728|P4|Phase A+|Lost to Follow-up|6
1085051|NCT02196506|3539729|P3|Phase A+|Lost to Follow-up|0
1085052|NCT02196506|3539730|P2|Phase A+|Lost to Follow-up|0
1085053|NCT02196506|3539731|P1|Phase A+|Lost to Follow-up|0
1085054|NCT02196506|3539728|P4|Phase A+|Adverse Event|1
1085055|NCT02196506|3539729|P3|Phase A+|Adverse Event|0
1085056|NCT02196506|3539730|P2|Phase A+|Adverse Event|0
1085057|NCT02196506|3539731|P1|Phase A+|Adverse Event|0
1085058|NCT02196506|3539728|P4|Phase A+|Withdrawal by Participant|5
1085059|NCT02196506|3539729|P3|Phase A+|Withdrawal by Participant|0
1085060|NCT02196506|3539730|P2|Phase A+|Withdrawal by Participant|0
1085061|NCT02196506|3539731|P1|Phase A+|Withdrawal by Participant|0
1085062|NCT02196506|3539728|P4|Phase A+|Participant Met Withdrawal Criteria|1
1085063|NCT02196506|3539729|P3|Phase A+|Participant Met Withdrawal Criteria|0
1085064|NCT02196506|3539730|P2|Phase A+|Participant Met Withdrawal Criteria|0
1085065|NCT02196506|3539731|P1|Phase A+|Participant Met Withdrawal Criteria|0
1085066|NCT02196506|3539728|P4|Phase B|Lost to Follow-up|0
1085067|NCT02196506|3539729|P3|Phase B|Lost to Follow-up|1
1085068|NCT02196506|3539730|P2|Phase B|Lost to Follow-up|2
1085069|NCT02196506|3539731|P1|Phase B|Lost to Follow-up|0
1085070|NCT02196506|3539728|P4|Phase B|Adverse Event|0
1085071|NCT02196506|3539729|P3|Phase B|Adverse Event|1
1085072|NCT02196506|3539730|P2|Phase B|Adverse Event|4
1085073|NCT02196506|3539731|P1|Phase B|Adverse Event|0
1085074|NCT02196506|3539728|P4|Phase B|Withdrawal by Participant|0
1085075|NCT02196506|3539729|P3|Phase B|Withdrawal by Participant|1
1085076|NCT02196506|3539730|P2|Phase B|Withdrawal by Participant|8
1085077|NCT02196506|3539731|P1|Phase B|Withdrawal by Participant|0
1085078|NCT02196506|3539728|P4|Phase B|Lack of Efficacy|0
1085079|NCT02196506|3539729|P3|Phase B|Lack of Efficacy|2
1085080|NCT02196506|3539730|P2|Phase B|Lack of Efficacy|1
1085081|NCT02196506|3539731|P1|Phase B|Lack of Efficacy|0
1085082|NCT02196506|3539728|P4|Phase B|Participant Met Withdrawal Criteria|0
1085083|NCT02196506|3539729|P3|Phase B|Participant Met Withdrawal Criteria|1
1085084|NCT02196506|3539730|P2|Phase B|Participant Met Withdrawal Criteria|0
1085085|NCT02196506|3539731|P1|Phase B|Participant Met Withdrawal Criteria|0
1085086|NCT02196506|3539728|P4|Phase A|Participant withdrawn by investigator|0
1085087|NCT02196506|3539729|P3|Phase A|Participant withdrawn by investigator|0
1085088|NCT02196506|3539730|P2|Phase A|Participant withdrawn by investigator|0
1085089|NCT02196506|3539731|P1|Phase A|Participant withdrawn by investigator|10
1085090|NCT02196506|3539728|P4|Phase A|Protocol deviation|0
1085091|NCT02196506|3539729|P3|Phase A|Protocol deviation|0
1085092|NCT02196506|3539730|P2|Phase A|Protocol deviation|0
1085093|NCT02196506|3539731|P1|Phase A|Protocol deviation|12
1085094|NCT02196506|3539728|P4|Phase A|Lost to Follow-up|0
1085095|NCT02196506|3539729|P3|Phase A|Lost to Follow-up|0
1085096|NCT02196506|3539730|P2|Phase A|Lost to Follow-up|0
1085097|NCT02196506|3539731|P1|Phase A|Lost to Follow-up|9
1085098|NCT02196506|3539728|P4|Phase A|Adverse Event|0
1085099|NCT02196506|3539729|P3|Phase A|Adverse Event|0
1085100|NCT02196506|3539730|P2|Phase A|Adverse Event|0
1085101|NCT02196506|3539731|P1|Phase A|Adverse Event|22
1085102|NCT02196506|3539728|P4|Phase A|Withdrawal by Subject|0
1085103|NCT02196506|3539729|P3|Phase A|Withdrawal by Subject|0
1085104|NCT02196506|3539730|P2|Phase A|Withdrawal by Subject|0
1085105|NCT02196506|3539731|P1|Phase A|Withdrawal by Subject|34
1085106|NCT02196506|3539728|P4|Phase A|Participant Met Withdrawal Criteria|0
1085107|NCT02196506|3539729|P3|Phase A|Participant Met Withdrawal Criteria|0
1085108|NCT02196506|3539730|P2|Phase A|Participant Met Withdrawal Criteria|0
1085109|NCT02196506|3539731|P1|Phase A|Participant Met Withdrawal Criteria|34
1085110|NCT02196259|3539746|P3|Overall Study|Partial data analysis|0
1085111|NCT02196259|3539747|P2|Overall Study|Partial data analysis|3
1085112|NCT02196259|3539748|P1|Overall Study|Partial data analysis|0
1085113|NCT02196259|3539746|P3|Overall Study|Researcher choice|1
1085114|NCT02196259|3539747|P2|Overall Study|Researcher choice|0
1085115|NCT02196259|3539748|P1|Overall Study|Researcher choice|0
1085116|NCT02196077|3539776|P1|Overall Study|Protocol Violation|24
1085117|NCT02196077|3539776|P1|Overall Study|Lost to Follow-up|3
1085118|NCT02196077|3539776|P1|Overall Study|Physician Decision|1
1085119|NCT02196077|3539776|P1|Overall Study|Withdrawal by Subject|14
1085120|NCT02196077|3539776|P1|Overall Study|Lack of Efficacy|1
1085121|NCT02196077|3539776|P1|Overall Study|Adverse Event|4
1085122|NCT02195986|3539826|P3|Overall Study|Non-compliance|0
1085123|NCT02195986|3539827|P2|Overall Study|Non-compliance|1
1085124|NCT02195986|3539828|P1|Overall Study|Non-compliance|0
1085125|NCT02195986|3539826|P3|Overall Study|Protocol Violation|1
1085126|NCT02195986|3539827|P2|Overall Study|Protocol Violation|1
1085127|NCT02195986|3539828|P1|Overall Study|Protocol Violation|0
1085128|NCT02195986|3539826|P3|Overall Study|Family Emergency|1
1085129|NCT02195986|3539827|P2|Overall Study|Family Emergency|0
1085130|NCT02195986|3539828|P1|Overall Study|Family Emergency|0
1085131|NCT02195986|3539826|P3|Overall Study|Withdrawal by Subject|0
1085132|NCT02195986|3539827|P2|Overall Study|Withdrawal by Subject|3
1085133|NCT02195986|3539828|P1|Overall Study|Withdrawal by Subject|0
1085134|NCT02195986|3539826|P3|Overall Study|Adverse Event|0
1085135|NCT02195986|3539827|P2|Overall Study|Adverse Event|0
1085136|NCT02195986|3539828|P1|Overall Study|Adverse Event|3
1085137|NCT02195700|3539862|P2|Overall Study|Lost to Follow-up|1
1085138|NCT02195700|3539863|P1|Overall Study|Lost to Follow-up|1
1085139|NCT02195700|3539862|P2|Overall Study|Withdrawal by Subject|2
1085140|NCT02195700|3539863|P1|Overall Study|Withdrawal by Subject|3
1085141|NCT02195700|3539862|P2|Overall Study|Adverse Event|2
1085142|NCT02195700|3539863|P1|Overall Study|Adverse Event|1
1085143|NCT02195700|3539862|P2|Overall Study|Noncompliance|0
1085144|NCT02195700|3539863|P1|Overall Study|Noncompliance|1
1085145|NCT02195700|3539862|P2|Overall Study|Protocol Violation|2
1085146|NCT02195700|3539863|P1|Overall Study|Protocol Violation|0
1085147|NCT02195687|3539885|P2|Overall Study|Lost to Follow-up|1
1085148|NCT02195687|3539886|P1|Overall Study|Lost to Follow-up|4
1085149|NCT02195687|3539885|P2|Overall Study|Personal Reasons|1
1085150|NCT02195687|3539886|P1|Overall Study|Personal Reasons|1
1085151|NCT02195583|3539902|P1|Overall Study|Other Reason|2
1085152|NCT02195583|3539902|P1|Overall Study|Adverse Event|2
1085153|NCT02195583|3539902|P1|Overall Study|Withdrawal by Subject|4
1085154|NCT02195583|3539902|P1|Overall Study|Lost to Follow-up|1
1085155|NCT02195479|3539936|P2|Overall Study|Ongoing|297
1085156|NCT02195479|3539937|P1|Overall Study|Ongoing|291
1085157|NCT02195479|3539936|P2|Overall Study|Other|2
1085158|NCT02195479|3539937|P1|Overall Study|Other|2
1085159|NCT02195479|3539936|P2|Overall Study|Withdrawal by Subject|6
1085160|NCT02195479|3539937|P1|Overall Study|Withdrawal by Subject|11
1085161|NCT02195479|3539936|P2|Overall Study|Physician Decision|0
1085162|NCT02195479|3539937|P1|Overall Study|Physician Decision|1
1085163|NCT02195479|3539936|P2|Overall Study|Death|45
1085164|NCT02195479|3539937|P1|Overall Study|Death|48
1085165|NCT02195479|3539936|P2|Overall Study|Lost to Follow-up|0
1085166|NCT02195479|3539937|P1|Overall Study|Lost to Follow-up|3
1085167|NCT02195427|3539975|P2|Overall Study|Conditional re-treatment at W52|1
1085168|NCT02195427|3539976|P1|Overall Study|Conditional re-treatment at W52|2
1085169|NCT02195427|3539975|P2|Overall Study|Protocol Violation|14
1085170|NCT02195427|3539976|P1|Overall Study|Protocol Violation|7
1085171|NCT02195427|3539975|P2|Overall Study|Lost to Follow-up|1
1085172|NCT02195427|3539976|P1|Overall Study|Lost to Follow-up|0
1085173|NCT02195427|3539975|P2|Overall Study|Withdrawal by Subject|2
1085174|NCT02195427|3539976|P1|Overall Study|Withdrawal by Subject|4
1085175|NCT02195427|3539975|P2|Overall Study|Did not consent to study extension|9
1085176|NCT02195427|3539976|P1|Overall Study|Did not consent to study extension|13
1085177|NCT02195011|3540047|P2|Overall Study|Withdrawal by Subject|0
1085178|NCT02195011|3540048|P1|Overall Study|Withdrawal by Subject|3
1085179|NCT02195011|3540047|P2|Overall Study|Progressive Disease|1
1085180|NCT02195011|3540048|P1|Overall Study|Progressive Disease|18
1085181|NCT02195011|3540047|P2|Overall Study|Adverse Event|0
1085182|NCT02195011|3540048|P1|Overall Study|Adverse Event|4
1085183|NCT02194933|3540062|P2|Overall Study|Lack of Efficacy|2
1085184|NCT02194933|3540063|P1|Overall Study|Lack of Efficacy|1
1085185|NCT02194933|3540062|P2|Overall Study|Withdrawal by Subject|2
1085186|NCT02194933|3540063|P1|Overall Study|Withdrawal by Subject|0
1085187|NCT02194933|3540062|P2|Overall Study|Participant met withdrawal criteria|3
1085188|NCT02194933|3540063|P1|Overall Study|Participant met withdrawal criteria|1
1085189|NCT02194933|3540062|P2|Overall Study|Lost to Follow-up|2
1085190|NCT02194933|3540063|P1|Overall Study|Lost to Follow-up|1
1085191|NCT02194699|3540117|P2|With Potential to Receive 52 Weeks of IP|Other|16
1085192|NCT02194699|3540118|P1|With Potential to Receive 52 Weeks of IP|Other|24
1085193|NCT02194699|3540117|P2|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20
1085194|NCT02194699|3540118|P1|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14
1085195|NCT02194699|3540117|P2|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
1085196|NCT02194699|3540118|P1|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
1085197|NCT02194699|3540117|P2|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8
1085198|NCT02194699|3540118|P1|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5
1085199|NCT02194699|3540117|P2|With Potential to Receive 52 Weeks of IP|Death|3
1085200|NCT02194699|3540118|P1|With Potential to Receive 52 Weeks of IP|Death|1
1085201|NCT02194699|3540117|P2|With Potential to Receive 52 Weeks of IP|Adverse Event|3
1085202|NCT02194699|3540118|P1|With Potential to Receive 52 Weeks of IP|Adverse Event|4
1085203|NCT02194699|3540117|P2|Randomised|Duplicate patient|1
1085204|NCT02194699|3540118|P1|Randomised|Duplicate patient|2
1085205|NCT02194699|3540117|P2|Randomised|Without potential for 52 weeks of IP|5
1085206|NCT02194699|3540118|P1|Randomised|Without potential for 52 weeks of IP|5
1085207|NCT02194699|3540117|P2|Randomised|Did not receive treatment|5
1085208|NCT02194699|3540118|P1|Randomised|Did not receive treatment|1
1085209|NCT02194621|3540226|P3|Overall Study|Withdrawal by Subject|7
1085210|NCT02194621|3540227|P2|Overall Study|Withdrawal by Subject|4
1085211|NCT02194621|3540228|P1|Overall Study|Withdrawal by Subject|4
1085212|NCT02194621|3540226|P3|Overall Study|6 withdrew prior to randomization|2
1085213|NCT02194621|3540227|P2|Overall Study|6 withdrew prior to randomization|2
1085214|NCT02194621|3540228|P1|Overall Study|6 withdrew prior to randomization|2
1085215|NCT02194062|3540261|P3|Overall Study|Lost to Follow-up|5
1085216|NCT02194062|3540262|P2|Overall Study|Lost to Follow-up|2
1085217|NCT02194062|3540263|P1|Overall Study|Lost to Follow-up|2
1085218|NCT02193828|3540278|P4|Overall Study|Withdrawal by Subject|1
1085219|NCT02193828|3540279|P3|Overall Study|Withdrawal by Subject|1
1085220|NCT02193828|3540280|P2|Overall Study|Withdrawal by Subject|0
1085221|NCT02193828|3540281|P1|Overall Study|Withdrawal by Subject|0
1085222|NCT02193178|3540354|P1|Overall Study|Dry eyes|1
1085223|NCT02193178|3540354|P1|Overall Study|Lost to Follow-up|1
1085224|NCT02193165|3540404|P3|6 Week Product Use|Lost to Follow-up|0
1085225|NCT02193165|3540405|P2|6 Week Product Use|Lost to Follow-up|1
1085226|NCT02193165|3540406|P1|6 Week Product Use|Lost to Follow-up|0
1085227|NCT02193165|3540404|P3|4 Week Product Use|Lost to Follow-up|1
1085228|NCT02193165|3540405|P2|4 Week Product Use|Lost to Follow-up|1
1085229|NCT02193165|3540406|P1|4 Week Product Use|Lost to Follow-up|1
1085230|NCT02193087|3540433|P4|Overall Study|Did Not Receive Any Vaccination|1
1085231|NCT02193087|3540434|P3|Overall Study|Did Not Receive Any Vaccination|0
1085232|NCT02193087|3540435|P2|Overall Study|Did Not Receive Any Vaccination|3
1085233|NCT02193087|3540436|P1|Overall Study|Did Not Receive Any Vaccination|2
1085234|NCT02193087|3540433|P4|Overall Study|Other Reason Not Specified|9
1085235|NCT02193087|3540434|P3|Overall Study|Other Reason Not Specified|1
1085236|NCT02193087|3540435|P2|Overall Study|Other Reason Not Specified|2
1085237|NCT02193087|3540436|P1|Overall Study|Other Reason Not Specified|7
1085238|NCT02193087|3540433|P4|Overall Study|Withdrawal by Subject|19
1085239|NCT02193087|3540434|P3|Overall Study|Withdrawal by Subject|1
1085240|NCT02193087|3540435|P2|Overall Study|Withdrawal by Subject|3
1085241|NCT02193087|3540436|P1|Overall Study|Withdrawal by Subject|10
1085242|NCT02193087|3540433|P4|Overall Study|Protocol Violation|2
1085243|NCT02193087|3540434|P3|Overall Study|Protocol Violation|1
1085244|NCT02193087|3540435|P2|Overall Study|Protocol Violation|0
1085245|NCT02193087|3540436|P1|Overall Study|Protocol Violation|2
1085246|NCT02193087|3540433|P4|Overall Study|Lost to Follow-up|37
1085247|NCT02193087|3540434|P3|Overall Study|Lost to Follow-up|4
1085248|NCT02193087|3540435|P2|Overall Study|Lost to Follow-up|6
1085249|NCT02193087|3540436|P1|Overall Study|Lost to Follow-up|14
1085250|NCT02193087|3540433|P4|Overall Study|Adverse Event|11
1085251|NCT02193087|3540434|P3|Overall Study|Adverse Event|0
1085252|NCT02193087|3540435|P2|Overall Study|Adverse Event|0
1085253|NCT02193087|3540436|P1|Overall Study|Adverse Event|2
1085254|NCT02193074|3540481|P2|Overall Study|Adverse Event|13
1085255|NCT02193074|3540482|P1|Overall Study|Adverse Event|16
1085256|NCT02193074|3540481|P2|Overall Study|Withdrawal by Subject|2
1085257|NCT02193074|3540482|P1|Overall Study|Withdrawal by Subject|1
1085258|NCT02192905|3540514|P1|Overall Study|Lost to Follow-up|1
1085259|NCT02192606|3540578|P2|Overall Study|3D equipment rep unable to join|1
1085260|NCT02192606|3540579|P1|Overall Study|3D equipment rep unable to join|0
1085261|NCT02192606|3540578|P2|Overall Study|Physician Decision|2
1085262|NCT02192606|3540579|P1|Overall Study|Physician Decision|1
1085263|NCT02192606|3540578|P2|Overall Study|surgery type was changed|1
1085264|NCT02192606|3540579|P1|Overall Study|surgery type was changed|1
1085265|NCT02192190|3540616|P6|Overall Study|Inadequate Pain Relief|0
1085266|NCT02192190|3540617|P5|Overall Study|Inadequate Pain Relief|0
1085267|NCT02192190|3540618|P4|Overall Study|Inadequate Pain Relief|0
1085268|NCT02192190|3540619|P3|Overall Study|Inadequate Pain Relief|1
1085269|NCT02192190|3540620|P2|Overall Study|Inadequate Pain Relief|1
1085270|NCT02192190|3540621|P1|Overall Study|Inadequate Pain Relief|0
1085271|NCT02192190|3540616|P6|Overall Study|Positive Drug Screen|0
1085272|NCT02192190|3540617|P5|Overall Study|Positive Drug Screen|0
1085273|NCT02192190|3540618|P4|Overall Study|Positive Drug Screen|1
1085274|NCT02192190|3540619|P3|Overall Study|Positive Drug Screen|0
1085275|NCT02192190|3540620|P2|Overall Study|Positive Drug Screen|0
1085276|NCT02192190|3540621|P1|Overall Study|Positive Drug Screen|0
1085277|NCT02192190|3540616|P6|Overall Study|Could not Keep Visit Schedule|0
1085278|NCT02192190|3540617|P5|Overall Study|Could not Keep Visit Schedule|0
1085279|NCT02192190|3540618|P4|Overall Study|Could not Keep Visit Schedule|0
1085280|NCT02192190|3540619|P3|Overall Study|Could not Keep Visit Schedule|0
1085281|NCT02192190|3540620|P2|Overall Study|Could not Keep Visit Schedule|0
1085282|NCT02192190|3540621|P1|Overall Study|Could not Keep Visit Schedule|1
1085283|NCT02192190|3540616|P6|Overall Study|Withdrawal by Subject|3
1085284|NCT02192190|3540617|P5|Overall Study|Withdrawal by Subject|5
1085285|NCT02192190|3540618|P4|Overall Study|Withdrawal by Subject|1
1085286|NCT02192190|3540619|P3|Overall Study|Withdrawal by Subject|2
1085287|NCT02192190|3540620|P2|Overall Study|Withdrawal by Subject|1
1085288|NCT02192190|3540621|P1|Overall Study|Withdrawal by Subject|4
1085289|NCT02192190|3540616|P6|Overall Study|Terminated by Sponsor|23
1085290|NCT02192190|3540617|P5|Overall Study|Terminated by Sponsor|21
1085291|NCT02192190|3540618|P4|Overall Study|Terminated by Sponsor|23
1085292|NCT02192190|3540619|P3|Overall Study|Terminated by Sponsor|20
1085293|NCT02192190|3540620|P2|Overall Study|Terminated by Sponsor|23
1085294|NCT02192190|3540621|P1|Overall Study|Terminated by Sponsor|43
1085295|NCT02192190|3540616|P6|Overall Study|Physician Decision|0
1085296|NCT02192190|3540617|P5|Overall Study|Physician Decision|0
1085297|NCT02192190|3540618|P4|Overall Study|Physician Decision|0
1085298|NCT02192190|3540619|P3|Overall Study|Physician Decision|0
1085299|NCT02192190|3540620|P2|Overall Study|Physician Decision|0
1085300|NCT02192190|3540621|P1|Overall Study|Physician Decision|2
1085301|NCT02192190|3540616|P6|Overall Study|Lost to Follow-up|3
1085302|NCT02192190|3540617|P5|Overall Study|Lost to Follow-up|4
1085303|NCT02192190|3540618|P4|Overall Study|Lost to Follow-up|1
1085304|NCT02192190|3540619|P3|Overall Study|Lost to Follow-up|2
1085305|NCT02192190|3540620|P2|Overall Study|Lost to Follow-up|3
1085306|NCT02192190|3540621|P1|Overall Study|Lost to Follow-up|3
1085307|NCT02192190|3540616|P6|Overall Study|Adverse Event|0
1085308|NCT02192190|3540617|P5|Overall Study|Adverse Event|0
1085309|NCT02192190|3540618|P4|Overall Study|Adverse Event|0
1085310|NCT02192190|3540619|P3|Overall Study|Adverse Event|0
1085311|NCT02192190|3540620|P2|Overall Study|Adverse Event|1
1085312|NCT02192190|3540621|P1|Overall Study|Adverse Event|1
1085313|NCT02192164|3540665|P1|Overall Study|Did not meet the exclusion criteria|1
1085314|NCT02192164|3540665|P1|Overall Study|Physician Decision|4
1085315|NCT02192164|3540665|P1|Overall Study|Withdrawal by Subject|1
1085316|NCT02192164|3540665|P1|Overall Study|Other|8
1085317|NCT02191605|3540711|P5|Overall Study|Lost to Follow-up|4
1085318|NCT02191605|3540712|P4|Overall Study|Lost to Follow-up|3
1085319|NCT02191605|3540713|P3|Overall Study|Lost to Follow-up|7
1085320|NCT02191605|3540714|P2|Overall Study|Lost to Follow-up|4
1085321|NCT02191605|3540715|P1|Overall Study|Lost to Follow-up|9
1085322|NCT02191579|3540734|P2|Treatment 2|Multiple Reasons Specified|25
1085323|NCT02191579|3540735|P1|Treatment 2|Multiple Reasons Specified|0
1085324|NCT02191579|3540734|P2|Treatment 1|Multiple Reasons Specified|58
1085325|NCT02191579|3540735|P1|Treatment 1|Multiple Reasons Specified|27
1085326|NCT02191267|3540750|P3|Overall Study|Withdrawal by Subject|0
1085327|NCT02191267|3540751|P2|Overall Study|Withdrawal by Subject|0
1085328|NCT02191267|3540752|P1|Overall Study|Withdrawal by Subject|1
1085329|NCT02191137|3540763|P1|Follow-up|Adverse Event|1
1085330|NCT02191137|3540763|P1|Follow-up|Ongoing/unknown|2
1085331|NCT02191137|3540763|P1|Follow-up|Lost to Follow-up|2
1085332|NCT02191137|3540763|P1|Treatment|Other|1
1085333|NCT02191137|3540763|P1|Treatment|Adverse Event|2
1085334|NCT02191137|3540763|P1|Treatment|Withdrawal by Subject|3
1085335|NCT02191137|3540763|P1|Treatment|Death|4
1085336|NCT02191046|3540793|P2|Overall Study|low compliance|1
1085337|NCT02191046|3540794|P1|Overall Study|low compliance|5
1085338|NCT02190721|3540825|P3|Overall Study|Patient was out of the city|0
1085339|NCT02190721|3540826|P2|Overall Study|Patient was out of the city|1
1085340|NCT02190721|3540827|P1|Overall Study|Patient was out of the city|0
1085341|NCT02190604|3540950|P19|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1085342|NCT02190604|3540951|P18|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1085343|NCT02190604|3540952|P17|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1085344|NCT02190604|3540953|P16|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1085345|NCT02190604|3540954|P15|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1085346|NCT02190604|3540955|P14|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1
1085347|NCT02190604|3540956|P13|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1085348|NCT02190604|3540957|P12|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1085349|NCT02190604|3540958|P11|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1085350|NCT02190604|3540959|P10|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1085351|NCT02190604|3540960|P9|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1085352|NCT02190604|3540961|P8|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1085353|NCT02190604|3540962|P7|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1085354|NCT02190604|3540963|P6|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1085355|NCT02190604|3540964|P5|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1085356|NCT02190604|3540965|P4|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1085357|NCT02190604|3540966|P3|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1085358|NCT02190604|3540967|P2|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1085359|NCT02190604|3540968|P1|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1085360|NCT02190604|3540950|P19|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1085361|NCT02190604|3540951|P18|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1085362|NCT02190604|3540952|P17|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1085363|NCT02190604|3540953|P16|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1085364|NCT02190604|3540954|P15|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2
1085365|NCT02190604|3540955|P14|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1085366|NCT02190604|3540956|P13|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1085367|NCT02190604|3540957|P12|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1085368|NCT02190604|3540958|P11|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1085369|NCT02190604|3540959|P10|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1085370|NCT02190604|3540960|P9|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1085371|NCT02190604|3540961|P8|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1085372|NCT02190604|3540962|P7|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1085373|NCT02190604|3540963|P6|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1085374|NCT02190604|3540964|P5|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1085375|NCT02190604|3540965|P4|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1085376|NCT02190604|3540966|P3|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1085377|NCT02190604|3540967|P2|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1085378|NCT02190604|3540968|P1|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1085379|NCT02190591|3541159|P2|Overall Study|face presentation so she was ineligible|1
1085380|NCT02190591|3541160|P1|Overall Study|face presentation so she was ineligible|0
1085381|NCT02190591|3541159|P2|Overall Study|did not use peanut ball as instructed|2
1085382|NCT02190591|3541160|P1|Overall Study|did not use peanut ball as instructed|0
1085383|NCT02190591|3541159|P2|Overall Study|Protocol Violation|0
1085384|NCT02190591|3541160|P1|Overall Study|Protocol Violation|1
1085385|NCT02190591|3541159|P2|Overall Study|Withdrawal by Subject|8
1085386|NCT02190591|3541160|P1|Overall Study|Withdrawal by Subject|1
1085387|NCT02190435|3541172|P2|Overall Study|3 consented screen fails|0
1085388|NCT02190435|3541173|P1|Overall Study|3 consented screen fails|3
1085389|NCT02190435|3541172|P2|Overall Study|First 12 patients were lead-ins|0
1085390|NCT02190435|3541173|P1|Overall Study|First 12 patients were lead-ins|12
1085391|NCT02189941|3541201|P3|Overall Study|Non-compliance|1
1085392|NCT02189941|3541202|P2|Overall Study|Non-compliance|0
1085393|NCT02189941|3541203|P1|Overall Study|Non-compliance|0
1085394|NCT02189863|3541231|P2|First 2 Weeks|Motion Sickness|2
1085395|NCT02189863|3541232|P1|First 2 Weeks|Motion Sickness|4
1085396|NCT02189837|3541247|P4|Overall Study|Sponsor Decision|1
1085397|NCT02189837|3541248|P3|Overall Study|Sponsor Decision|0
1085398|NCT02189837|3541249|P2|Overall Study|Sponsor Decision|0
1085399|NCT02189837|3541250|P1|Overall Study|Sponsor Decision|0
1085400|NCT02189837|3541247|P4|Overall Study|Withdrawal by Subject|1
1085401|NCT02189837|3541248|P3|Overall Study|Withdrawal by Subject|3
1085402|NCT02189837|3541249|P2|Overall Study|Withdrawal by Subject|1
1085403|NCT02189837|3541250|P1|Overall Study|Withdrawal by Subject|2
1085404|NCT02189759|3541280|P4|Overall Study|Lost to Follow-up|5
1085405|NCT02189759|3541281|P3|Overall Study|Lost to Follow-up|2
1085406|NCT02189759|3541282|P2|Overall Study|Lost to Follow-up|0
1085407|NCT02189759|3541283|P1|Overall Study|Lost to Follow-up|0
1085408|NCT02189252|3541340|P4|Period 1 (Visit 4b, Week 4)|Adverse Event|0
1085409|NCT02189252|3541341|P3|Period 1 (Visit 4b, Week 4)|Adverse Event|0
1085410|NCT02189252|3541342|P2|Period 1 (Visit 4b, Week 4)|Adverse Event|1
1085411|NCT02189252|3541343|P1|Period 1 (Visit 4b, Week 4)|Adverse Event|0
1085412|NCT02189252|3541340|P4|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
1085413|NCT02189252|3541341|P3|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
1085414|NCT02189252|3541342|P2|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1
1085415|NCT02189252|3541343|P1|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
1085416|NCT02188849|3541402|P2|Overall Study|Lost to Follow-up|8
1085417|NCT02188849|3541403|P1|Overall Study|Lost to Follow-up|3
1085418|NCT02188784|3541417|P2|Overall Study|Physician Decision|3
1085419|NCT02188784|3541418|P1|Overall Study|Physician Decision|2
1085420|NCT02188784|3541417|P2|Overall Study|Withdrawal by Subject|9
1085421|NCT02188784|3541418|P1|Overall Study|Withdrawal by Subject|3
1085422|NCT02188784|3541417|P2|Overall Study|Lost to Follow-up|0
1085423|NCT02188784|3541418|P1|Overall Study|Lost to Follow-up|1
1085424|NCT02188784|3541417|P2|Overall Study|Death|1
1085425|NCT02188784|3541418|P1|Overall Study|Death|3
1085426|NCT02187861|3541454|P4|Overall Study|Alive in Study Follow-Up|31
1085427|NCT02187861|3541455|P3|Overall Study|Alive in Study Follow-Up|26
1085428|NCT02187861|3541456|P2|Overall Study|Alive in Study Follow-Up|10
1085429|NCT02187861|3541457|P1|Overall Study|Alive in Study Follow-Up|4
1085430|NCT02187861|3541454|P4|Overall Study|Other|1
1085431|NCT02187861|3541455|P3|Overall Study|Other|6
1085432|NCT02187861|3541456|P2|Overall Study|Other|2
1085433|NCT02187861|3541457|P1|Overall Study|Other|0
1085434|NCT02187861|3541454|P4|Overall Study|Withdrawal by Subject|3
1085435|NCT02187861|3541455|P3|Overall Study|Withdrawal by Subject|2
1085436|NCT02187861|3541456|P2|Overall Study|Withdrawal by Subject|0
1085437|NCT02187861|3541457|P1|Overall Study|Withdrawal by Subject|0
1085438|NCT02187861|3541454|P4|Overall Study|Progressive Disease|11
1085439|NCT02187861|3541455|P3|Overall Study|Progressive Disease|13
1085440|NCT02187861|3541456|P2|Overall Study|Progressive Disease|35
1085441|NCT02187861|3541457|P1|Overall Study|Progressive Disease|3
1085442|NCT02187861|3541454|P4|Overall Study|Physician Decision|3
1085443|NCT02187861|3541455|P3|Overall Study|Physician Decision|0
1085444|NCT02187861|3541456|P2|Overall Study|Physician Decision|1
1085445|NCT02187861|3541457|P1|Overall Study|Physician Decision|0
1085446|NCT02187861|3541454|P4|Overall Study|Lack of Efficacy|0
1085447|NCT02187861|3541455|P3|Overall Study|Lack of Efficacy|0
1085448|NCT02187861|3541456|P2|Overall Study|Lack of Efficacy|1
1085449|NCT02187861|3541457|P1|Overall Study|Lack of Efficacy|0
1085450|NCT02187861|3541454|P4|Overall Study|Death|2
1085451|NCT02187861|3541455|P3|Overall Study|Death|1
1085452|NCT02187861|3541456|P2|Overall Study|Death|3
1085453|NCT02187861|3541457|P1|Overall Study|Death|0
1085454|NCT02187861|3541454|P4|Overall Study|Adverse Event|0
1085455|NCT02187861|3541455|P3|Overall Study|Adverse Event|3
1085456|NCT02187861|3541456|P2|Overall Study|Adverse Event|1
1085457|NCT02187861|3541457|P1|Overall Study|Adverse Event|2
1085458|NCT02187809|3541553|P1|Overall Study|The study was terminated|3
1085459|NCT02187744|3541565|P2|Treatment|Participant refused continued treatment|1
1085460|NCT02187744|3541566|P1|Treatment|Participant refused continued treatment|1
1085461|NCT02187744|3541565|P2|Treatment|Not specified|0
1085462|NCT02187744|3541566|P1|Treatment|Not specified|2
1085463|NCT02187744|3541565|P2|Treatment|Lost to Follow-up|1
1085464|NCT02187744|3541566|P1|Treatment|Lost to Follow-up|0
1085465|NCT02187744|3541565|P2|Treatment|Related adverse event, not serious|2
1085466|NCT02187744|3541566|P1|Treatment|Related adverse event, not serious|0
1085467|NCT02187744|3541565|P2|Treatment|Related adverse event, serious non-fatal|1
1085468|NCT02187744|3541566|P1|Treatment|Related adverse event, serious non-fatal|0
1085469|NCT02187744|3541565|P2|Treatment|Death|0
1085470|NCT02187744|3541566|P1|Treatment|Death|1
1085471|NCT02187744|3541565|P2|Study|Related adverse event, serious non-fatal|1
1085472|NCT02187744|3541566|P1|Study|Related adverse event, serious non-fatal|0
1085473|NCT02187744|3541565|P2|Study|Death|0
1085474|NCT02187744|3541566|P1|Study|Death|1
1085475|NCT02187744|3541565|P2|Study|Related adverse event, not serious|2
1085476|NCT02187744|3541566|P1|Study|Related adverse event, not serious|0
1085477|NCT02187744|3541565|P2|Study|Lost to Follow-up|2
1085478|NCT02187744|3541566|P1|Study|Lost to Follow-up|0
1085479|NCT02187744|3541565|P2|Study|Not specified|1
1085480|NCT02187744|3541566|P1|Study|Not specified|2
1085481|NCT02187744|3541565|P2|Study|Participant refused further follow-up|0
1085482|NCT02187744|3541566|P1|Study|Participant refused further follow-up|1
1085483|NCT02187055|3541585|P3|Overall Study|Death|0
1085484|NCT02187055|3541586|P2|Overall Study|Death|0
1085485|NCT02187055|3541587|P1|Overall Study|Death|2
1085486|NCT02187055|3541585|P3|Overall Study|Adverse Event|36
1085487|NCT02187055|3541586|P2|Overall Study|Adverse Event|26
1085488|NCT02187055|3541587|P1|Overall Study|Adverse Event|21
1085489|NCT02187055|3541585|P3|Overall Study|Withdrawal by Subject|11
1085490|NCT02187055|3541586|P2|Overall Study|Withdrawal by Subject|11
1085491|NCT02187055|3541587|P1|Overall Study|Withdrawal by Subject|11
1085492|NCT02187055|3541585|P3|Overall Study|Pregnancy|0
1085493|NCT02187055|3541586|P2|Overall Study|Pregnancy|1
1085494|NCT02187055|3541587|P1|Overall Study|Pregnancy|3
1085495|NCT02187055|3541585|P3|Overall Study|Protocol Violation|4
1085496|NCT02187055|3541586|P2|Overall Study|Protocol Violation|9
1085497|NCT02187055|3541587|P1|Overall Study|Protocol Violation|9
1085498|NCT02187055|3541585|P3|Overall Study|Other|3
1085499|NCT02187055|3541586|P2|Overall Study|Other|6
1085500|NCT02187055|3541587|P1|Overall Study|Other|5
1085501|NCT02187055|3541585|P3|Overall Study|No longer willing to participate|10
1085502|NCT02187055|3541586|P2|Overall Study|No longer willing to participate|8
1085503|NCT02187055|3541587|P1|Overall Study|No longer willing to participate|6
1085504|NCT02187055|3541585|P3|Overall Study|No longer meets eligibility criteria|0
1085505|NCT02187055|3541586|P2|Overall Study|No longer meets eligibility criteria|2
1085506|NCT02187055|3541587|P1|Overall Study|No longer meets eligibility criteria|0
1085507|NCT02187055|3541585|P3|Overall Study|Lost to Follow-up|3
1085508|NCT02187055|3541586|P2|Overall Study|Lost to Follow-up|7
1085509|NCT02187055|3541587|P1|Overall Study|Lost to Follow-up|2
1085510|NCT02187055|3541585|P3|Overall Study|Lack of Efficacy|7
1085511|NCT02187055|3541586|P2|Overall Study|Lack of Efficacy|3
1085512|NCT02187055|3541587|P1|Overall Study|Lack of Efficacy|10
1085513|NCT02187029|3541689|P4|Overall Study|Withdrawal by Subject|0
1085514|NCT02187029|3541690|P3|Overall Study|Withdrawal by Subject|0
1085515|NCT02187029|3541691|P2|Overall Study|Withdrawal by Subject|0
1085516|NCT02187029|3541692|P1|Overall Study|Withdrawal by Subject|1
1085517|NCT02187029|3541689|P4|Overall Study|Study Terminated by Sponsor|3
1085518|NCT02187029|3541690|P3|Overall Study|Study Terminated by Sponsor|10
1085519|NCT02187029|3541691|P2|Overall Study|Study Terminated by Sponsor|0
1085520|NCT02187029|3541692|P1|Overall Study|Study Terminated by Sponsor|0
1085521|NCT02187029|3541689|P4|Overall Study|Adverse Event|0
1085522|NCT02187029|3541690|P3|Overall Study|Adverse Event|1
1085523|NCT02187029|3541691|P2|Overall Study|Adverse Event|1
1085524|NCT02187029|3541692|P1|Overall Study|Adverse Event|0
1085525|NCT02186873|3541814|P2|Overall Study|Withdrawal by Subject|2
1085526|NCT02186873|3541815|P1|Overall Study|Withdrawal by Subject|7
1085527|NCT02186873|3541814|P2|Overall Study|Lost to Follow-up|2
1085528|NCT02186873|3541815|P1|Overall Study|Lost to Follow-up|1
1085529|NCT02186873|3541814|P2|Overall Study|Lack of Efficacy|1
1085530|NCT02186873|3541815|P1|Overall Study|Lack of Efficacy|0
1085531|NCT02186873|3541814|P2|Overall Study|Adverse Event|3
1085532|NCT02186873|3541815|P1|Overall Study|Adverse Event|1
1085533|NCT02186223|3541860|P1|Overall Study|Device in place less than 48 hours|9
1085534|NCT02186223|3541860|P1|Overall Study|Death|3
1085535|NCT02186223|3541860|P1|Overall Study|Unable to obtain femoral access|3
1085536|NCT02186223|3541860|P1|Overall Study|Not eligible for device placement|6
1085537|NCT02185534|3541901|P6|First Washout Period|Protocol Violation|1
1085538|NCT02185534|3541902|P5|First Washout Period|Protocol Violation|0
1085539|NCT02185534|3541903|P4|First Washout Period|Protocol Violation|0
1085540|NCT02185534|3541904|P3|First Washout Period|Protocol Violation|0
1085541|NCT02185534|3541905|P2|First Washout Period|Protocol Violation|0
1085542|NCT02185534|3541906|P1|First Washout Period|Protocol Violation|0
1085543|NCT02185534|3541901|P6|First Washout Period|Withdrawal by Subject|0
1085544|NCT02185534|3541902|P5|First Washout Period|Withdrawal by Subject|1
1085545|NCT02185534|3541903|P4|First Washout Period|Withdrawal by Subject|0
1085546|NCT02185534|3541904|P3|First Washout Period|Withdrawal by Subject|0
1085547|NCT02185534|3541905|P2|First Washout Period|Withdrawal by Subject|0
1085548|NCT02185534|3541906|P1|First Washout Period|Withdrawal by Subject|1
1085549|NCT02185534|3541901|P6|First Period|Withdrawal by Subject|0
1085550|NCT02185534|3541902|P5|First Period|Withdrawal by Subject|0
1085551|NCT02185534|3541903|P4|First Period|Withdrawal by Subject|1
1085552|NCT02185534|3541904|P3|First Period|Withdrawal by Subject|0
1085553|NCT02185534|3541905|P2|First Period|Withdrawal by Subject|0
1085554|NCT02185534|3541906|P1|First Period|Withdrawal by Subject|0
1085555|NCT02185014|3542004|P1|Overall Study|Not Specified|4
1085556|NCT02185014|3542004|P1|Overall Study|Subject Noncompliance|1
1085557|NCT02185014|3542004|P1|Overall Study|Requires Alternative/Prohibited Therapy|5
1085558|NCT02185014|3542004|P1|Overall Study|Lack of Efficacy|14
1085559|NCT02185014|3542004|P1|Overall Study|Lost to Follow-up|4
1085560|NCT02185014|3542004|P1|Overall Study|Withdrew Consent|8
1085561|NCT02185014|3542004|P1|Overall Study|Adverse Event|18
1085562|NCT02184572|3542061|P2|Overall Study|Withdrawal by Subject|9
1085563|NCT02184572|3542062|P1|Overall Study|Withdrawal by Subject|14
1085564|NCT02184572|3542061|P2|Overall Study|Traveling Outside The Country|0
1085565|NCT02184572|3542062|P1|Overall Study|Traveling Outside The Country|1
1085566|NCT02184572|3542061|P2|Overall Study|2nd blooddraw & diary card incomplete|0
1085567|NCT02184572|3542062|P1|Overall Study|2nd blooddraw & diary card incomplete|1
1085568|NCT02184572|3542061|P2|Overall Study|Loss Of Kaiser Insurance|0
1085569|NCT02184572|3542062|P1|Overall Study|Loss Of Kaiser Insurance|1
1085570|NCT02184572|3542061|P2|Overall Study|Family Out Of Country Until 9/29/2015|0
1085571|NCT02184572|3542062|P1|Overall Study|Family Out Of Country Until 9/29/2015|1
1085572|NCT02184572|3542061|P2|Overall Study|Lost to Follow-up|21
1085573|NCT02184572|3542062|P1|Overall Study|Lost to Follow-up|29
1085574|NCT02184442|3542125|P2|Overall Study|Withdrawal by Subject|11
1085575|NCT02184442|3542126|P1|Overall Study|Withdrawal by Subject|3
1085576|NCT02184442|3542125|P2|Overall Study|Death|65
1085577|NCT02184442|3542126|P1|Overall Study|Death|61
1085578|NCT02183675|3542150|P6|Treatment Period 2 (10 Days)|Adverse Event|2
1085579|NCT02183675|3542151|P5|Treatment Period 2 (10 Days)|Adverse Event|0
1085580|NCT02183675|3542152|P4|Treatment Period 2 (10 Days)|Adverse Event|0
1085581|NCT02183675|3542153|P3|Treatment Period 2 (10 Days)|Adverse Event|0
1085582|NCT02183675|3542154|P2|Treatment Period 2 (10 Days)|Adverse Event|0
1085583|NCT02183675|3542155|P1|Treatment Period 2 (10 Days)|Adverse Event|0
1085584|NCT02183519|3542179|P2|Overall Study|Did not respond to cough inducter|3
1085585|NCT02183519|3542180|P1|Overall Study|Did not respond to cough inducter|0
1085586|NCT02183519|3542179|P2|Overall Study|computer error|0
1085587|NCT02183519|3542180|P1|Overall Study|computer error|3
1085588|NCT02182999|3542188|P2|Overall Study|Physician Decision|0
1085589|NCT02182999|3542189|P1|Overall Study|Physician Decision|1
1085590|NCT02182999|3542188|P2|Overall Study|Adverse Event|3
1085591|NCT02182999|3542189|P1|Overall Study|Adverse Event|4
1085592|NCT02182895|3542205|P2|Overall Study|Discharged from hospital within 24 hours|4
1085593|NCT02182895|3542206|P1|Overall Study|Discharged from hospital within 24 hours|2
1085594|NCT02182830|3542228|P2|Overall Study|Lost to Follow-up|3
1085595|NCT02182830|3542229|P1|Overall Study|Lost to Follow-up|3
1085596|NCT02182830|3542228|P2|Overall Study|Consent withdrawn|8
1085597|NCT02182830|3542229|P1|Overall Study|Consent withdrawn|8
1085598|NCT02182830|3542228|P2|Overall Study|Trial stopped, reason missing|3
1085599|NCT02182830|3542229|P1|Overall Study|Trial stopped, reason missing|3
1085600|NCT02182830|3542228|P2|Overall Study|Not Treated|1
1085601|NCT02182830|3542229|P1|Overall Study|Not Treated|1
1085602|NCT02181790|3542277|P2|Overall Study|study terminated|0
1085603|NCT02181790|3542278|P1|Overall Study|study terminated|2
1085604|NCT02181738|3542290|P4|Overall Study|Patient Return to Home Country|0
1085605|NCT02181738|3542291|P3|Overall Study|Patient Return to Home Country|0
1085606|NCT02181738|3542292|P2|Overall Study|Patient Return to Home Country|1
1085607|NCT02181738|3542293|P1|Overall Study|Patient Return to Home Country|0
1085608|NCT02181738|3542290|P4|Overall Study|Lost to Follow-up|0
1085609|NCT02181738|3542291|P3|Overall Study|Lost to Follow-up|2
1085610|NCT02181738|3542292|P2|Overall Study|Lost to Follow-up|4
1085611|NCT02181738|3542293|P1|Overall Study|Lost to Follow-up|0
1085612|NCT02181738|3542290|P4|Overall Study|Subject Withdrew Consent|1
1085613|NCT02181738|3542291|P3|Overall Study|Subject Withdrew Consent|2
1085614|NCT02181738|3542292|P2|Overall Study|Subject Withdrew Consent|3
1085615|NCT02181738|3542293|P1|Overall Study|Subject Withdrew Consent|1
1085616|NCT02181738|3542290|P4|Overall Study|Death|1
1085617|NCT02181738|3542291|P3|Overall Study|Death|6
1085618|NCT02181738|3542292|P2|Overall Study|Death|1
1085619|NCT02181738|3542293|P1|Overall Study|Death|1
1085620|NCT02181673|3542334|P3|Week 24-Week 60|Physician Decision|1
1085621|NCT02181673|3542335|P2|Week 24-Week 60|Physician Decision|0
1085622|NCT02181673|3542336|P1|Week 24-Week 60|Physician Decision|0
1085623|NCT02181673|3542334|P3|Week 24-Week 60|Lost to Follow-up|1
1085624|NCT02181673|3542335|P2|Week 24-Week 60|Lost to Follow-up|0
1085625|NCT02181673|3542336|P1|Week 24-Week 60|Lost to Follow-up|0
1085626|NCT02181673|3542334|P3|Week 24-Week 60|Lack of Efficacy|1
1085627|NCT02181673|3542335|P2|Week 24-Week 60|Lack of Efficacy|0
1085628|NCT02181673|3542336|P1|Week 24-Week 60|Lack of Efficacy|0
1085629|NCT02181673|3542334|P3|Week 24-Week 60|Pregnancy|1
1085630|NCT02181673|3542335|P2|Week 24-Week 60|Pregnancy|0
1085631|NCT02181673|3542336|P1|Week 24-Week 60|Pregnancy|0
1085632|NCT02181673|3542334|P3|Week 24-Week 60|Withdrawal by Subject|2
1085633|NCT02181673|3542335|P2|Week 24-Week 60|Withdrawal by Subject|2
1085634|NCT02181673|3542336|P1|Week 24-Week 60|Withdrawal by Subject|0
1085635|NCT02181673|3542334|P3|Week 24-Week 60|Other|1
1085636|NCT02181673|3542335|P2|Week 24-Week 60|Other|2
1085637|NCT02181673|3542336|P1|Week 24-Week 60|Other|0
1085638|NCT02181673|3542334|P3|Week 24-Week 60|Adverse Event|10
1085639|NCT02181673|3542335|P2|Week 24-Week 60|Adverse Event|4
1085640|NCT02181673|3542336|P1|Week 24-Week 60|Adverse Event|0
1085641|NCT02181673|3542334|P3|Up to Week 24|Randomized not Treated|1
1085642|NCT02181673|3542335|P2|Up to Week 24|Randomized not Treated|0
1085643|NCT02181673|3542336|P1|Up to Week 24|Randomized not Treated|0
1085644|NCT02181673|3542334|P3|Up to Week 24|Other|3
1085645|NCT02181673|3542335|P2|Up to Week 24|Other|0
1085646|NCT02181673|3542336|P1|Up to Week 24|Other|2
1085647|NCT02181673|3542334|P3|Up to Week 24|Withdrawal by Subject|1
1085648|NCT02181673|3542335|P2|Up to Week 24|Withdrawal by Subject|0
1085649|NCT02181673|3542336|P1|Up to Week 24|Withdrawal by Subject|10
1085650|NCT02181673|3542334|P3|Up to Week 24|Physician Decision|3
1085651|NCT02181673|3542335|P2|Up to Week 24|Physician Decision|0
1085652|NCT02181673|3542336|P1|Up to Week 24|Physician Decision|0
1085653|NCT02181673|3542334|P3|Up to Week 24|Lost to Follow-up|0
1085654|NCT02181673|3542335|P2|Up to Week 24|Lost to Follow-up|0
1085655|NCT02181673|3542336|P1|Up to Week 24|Lost to Follow-up|1
1085656|NCT02181673|3542334|P3|Up to Week 24|Lack of Efficacy|0
1085657|NCT02181673|3542335|P2|Up to Week 24|Lack of Efficacy|0
1085658|NCT02181673|3542336|P1|Up to Week 24|Lack of Efficacy|1
1085659|NCT02181673|3542334|P3|Up to Week 24|Death|0
1085660|NCT02181673|3542335|P2|Up to Week 24|Death|0
1085661|NCT02181673|3542336|P1|Up to Week 24|Death|1
1085662|NCT02181673|3542334|P3|Up to Week 24|Adverse Event|3
1085663|NCT02181673|3542335|P2|Up to Week 24|Adverse Event|0
1085664|NCT02181673|3542336|P1|Up to Week 24|Adverse Event|2
1085665|NCT02181634|3542363|P1|Overall Study|Patient opted to proceed to surgery|1
1085666|NCT02181634|3542363|P1|Overall Study|Symptomatic progression|1
1085667|NCT02181634|3542363|P1|Overall Study|Max number of dose reduction|1
1085668|NCT02181634|3542363|P1|Overall Study|Ineligible|1
1085669|NCT02181634|3542363|P1|Overall Study|Treatment delayed greater than 4 weeks|3
1085670|NCT02181634|3542363|P1|Overall Study|Death|2
1085671|NCT02181634|3542363|P1|Overall Study|Withdrawal by Subject|5
1085672|NCT02181634|3542363|P1|Overall Study|Physician Decision|8
1085673|NCT02181634|3542363|P1|Overall Study|Adverse Event|17
1085674|NCT02181634|3542363|P1|Overall Study|Lack of Efficacy|33
1085675|NCT02181504|3542412|P3|Overall Study|Adverse Event|1
1085676|NCT02181504|3542413|P2|Overall Study|Adverse Event|1
1085677|NCT02181504|3542414|P1|Overall Study|Adverse Event|1
1085678|NCT02181296|3542462|P2|Overall Study|Lost to Follow-up|6
1085679|NCT02181296|3542463|P1|Overall Study|Lost to Follow-up|7
1085680|NCT02180659|3542528|P2|Overall Study|AT REQUEST OF THE SPONSOR|1
1085681|NCT02180659|3542529|P1|Overall Study|AT REQUEST OF THE SPONSOR|0
1085682|NCT02180659|3542528|P2|Overall Study|Withdrawal by Subject|2
1085683|NCT02180659|3542529|P1|Overall Study|Withdrawal by Subject|0
1085684|NCT02180659|3542528|P2|Overall Study|Subject incarcerated during conduct|0
1085685|NCT02180659|3542529|P1|Overall Study|Subject incarcerated during conduct|1
1085686|NCT02180659|3542528|P2|Overall Study|Lost to Follow-up|2
1085687|NCT02180659|3542529|P1|Overall Study|Lost to Follow-up|4
1085688|NCT02180659|3542528|P2|Overall Study|Adverse Event|0
1085689|NCT02180659|3542529|P1|Overall Study|Adverse Event|1
1085690|NCT02180438|3542562|P1|Overall Study|Lost to Follow-up|1
1085691|NCT02180061|3542584|P2|Overall Study|Physician Decision|0
1085692|NCT02180061|3542585|P1|Overall Study|Physician Decision|1
1085693|NCT02180061|3542584|P2|Overall Study|Progressive Disease|5
1085694|NCT02180061|3542585|P1|Overall Study|Progressive Disease|15
1085695|NCT02180061|3542584|P2|Overall Study|Clinical Progression|1
1085696|NCT02180061|3542585|P1|Overall Study|Clinical Progression|5
1085697|NCT02180061|3542584|P2|Overall Study|Adverse Event|2
1085698|NCT02180061|3542585|P1|Overall Study|Adverse Event|4
1085699|NCT02179918|3542604|P5|Overall Study|Subject refused further follow-up|1
1085700|NCT02179918|3542605|P4|Overall Study|Subject refused further follow-up|0
1085701|NCT02179918|3542606|P3|Overall Study|Subject refused further follow-up|0
1085702|NCT02179918|3542607|P2|Overall Study|Subject refused further follow-up|1
1085703|NCT02179918|3542608|P1|Overall Study|Subject refused further follow-up|0
1085704|NCT02179918|3542604|P5|Overall Study|Other|1
1085705|NCT02179918|3542605|P4|Overall Study|Other|0
1085706|NCT02179918|3542606|P3|Overall Study|Other|0
1085707|NCT02179918|3542607|P2|Overall Study|Other|1
1085708|NCT02179918|3542608|P1|Overall Study|Other|0
1085709|NCT02179918|3542604|P5|Overall Study|Progressive Disease|6
1085710|NCT02179918|3542605|P4|Overall Study|Progressive Disease|2
1085711|NCT02179918|3542606|P3|Overall Study|Progressive Disease|1
1085712|NCT02179918|3542607|P2|Overall Study|Progressive Disease|1
1085713|NCT02179918|3542608|P1|Overall Study|Progressive Disease|4
1085714|NCT02179918|3542604|P5|Overall Study|Lost to Follow-up|0
1085715|NCT02179918|3542605|P4|Overall Study|Lost to Follow-up|0
1085716|NCT02179918|3542606|P3|Overall Study|Lost to Follow-up|1
1085717|NCT02179918|3542607|P2|Overall Study|Lost to Follow-up|0
1085718|NCT02179918|3542608|P1|Overall Study|Lost to Follow-up|0
1085719|NCT02179918|3542604|P5|Overall Study|Death|0
1085720|NCT02179918|3542605|P4|Overall Study|Death|1
1085721|NCT02179918|3542606|P3|Overall Study|Death|0
1085722|NCT02179918|3542607|P2|Overall Study|Death|0
1085723|NCT02179918|3542608|P1|Overall Study|Death|0
1085724|NCT02179398|3542771|P2|Overall Study|Lost to Follow-up|1
1085725|NCT02179398|3542772|P1|Overall Study|Lost to Follow-up|0
1085726|NCT02179398|3542771|P2|Overall Study|Lack of obligatory data|3
1085727|NCT02179398|3542772|P1|Overall Study|Lack of obligatory data|3
1085728|NCT02179190|3542790|P1|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1
1085729|NCT02179190|3542790|P1|Follow-Up Post Barrel VRD Implanted|Physician Decision|2
1085730|NCT02179190|3542790|P1|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3
1085731|NCT02179190|3542790|P1|Follow-Up Post Barrel VRD Implanted|Death|3
1085732|NCT02179190|3542790|P1|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7
1085733|NCT02179190|3542790|P1|Enrollment|Exit Prior to Device Attempt|11
1085734|NCT02178995|3542803|P9|Open Label|Adverse Event|0
1085735|NCT02178995|3542804|P8|Open Label|Adverse Event|0
1085736|NCT02178995|3542805|P7|Open Label|Adverse Event|0
1085737|NCT02178995|3542806|P6|Open Label|Adverse Event|0
1085738|NCT02178995|3542807|P5|Open Label|Adverse Event|0
1085739|NCT02178995|3542808|P4|Open Label|Adverse Event|0
1085740|NCT02178995|3542809|P3|Open Label|Adverse Event|0
1085741|NCT02178995|3542810|P2|Open Label|Adverse Event|0
1085742|NCT02178995|3542811|P1|Open Label|Adverse Event|2
1085743|NCT02178995|3542803|P9|Double Blind|Lost to Follow-up|0
1085744|NCT02178995|3542804|P8|Double Blind|Lost to Follow-up|1
1085745|NCT02178995|3542805|P7|Double Blind|Lost to Follow-up|0
1085746|NCT02178995|3542806|P6|Double Blind|Lost to Follow-up|0
1085747|NCT02178995|3542807|P5|Double Blind|Lost to Follow-up|0
1085748|NCT02178995|3542808|P4|Double Blind|Lost to Follow-up|0
1085749|NCT02178995|3542809|P3|Double Blind|Lost to Follow-up|0
1085750|NCT02178995|3542810|P2|Double Blind|Lost to Follow-up|1
1085751|NCT02178995|3542811|P1|Double Blind|Lost to Follow-up|0
1085752|NCT02178995|3542803|P9|Double Blind|Adverse Event|1
1085753|NCT02178995|3542804|P8|Double Blind|Adverse Event|1
1085754|NCT02178995|3542805|P7|Double Blind|Adverse Event|0
1085755|NCT02178995|3542806|P6|Double Blind|Adverse Event|1
1085756|NCT02178995|3542807|P5|Double Blind|Adverse Event|0
1085757|NCT02178995|3542808|P4|Double Blind|Adverse Event|0
1085758|NCT02178995|3542809|P3|Double Blind|Adverse Event|0
1085759|NCT02178995|3542810|P2|Double Blind|Adverse Event|0
1085760|NCT02178995|3542811|P1|Double Blind|Adverse Event|0
1085761|NCT02178787|3542893|P2|Overall Study|Physician Decision|0
1085762|NCT02178787|3542894|P1|Overall Study|Physician Decision|1
1085763|NCT02178787|3542893|P2|Overall Study|No TCD window|7
1085764|NCT02178787|3542894|P1|Overall Study|No TCD window|3
1085765|NCT02178787|3542893|P2|Overall Study|Withdrawal by Subject|2
1085766|NCT02178787|3542894|P1|Overall Study|Withdrawal by Subject|0
1085767|NCT02178787|3542893|P2|Overall Study|Lost to Follow-up|0
1085768|NCT02178787|3542894|P1|Overall Study|Lost to Follow-up|1
1085769|NCT02178475|3542923|P1|Overall Study|Protocol-specified Criteria|99
1085770|NCT02178475|3542923|P1|Overall Study|Death|13
1085771|NCT02178475|3542923|P1|Overall Study|Lost to Follow-up|10
1085772|NCT02178475|3542923|P1|Overall Study|Withdrawal by Subject|7
1085773|NCT02178059|3542943|P2|Washout|Physician Decision|0
1085774|NCT02178059|3542944|P1|Washout|Physician Decision|1
1085775|NCT02177266|3542962|P2|Overall Study|Withdrawal by Subject|0
1085776|NCT02177266|3542963|P1|Overall Study|Withdrawal by Subject|1
1085777|NCT02177266|3542962|P2|Overall Study|Adverse Event|1
1085778|NCT02177266|3542963|P1|Overall Study|Adverse Event|0
1085779|NCT02177136|3542985|P3|Overall Study|Protocol Violation|1
1085780|NCT02177136|3542986|P2|Overall Study|Protocol Violation|0
1085781|NCT02177136|3542987|P1|Overall Study|Protocol Violation|0
1085782|NCT02177136|3542985|P3|Overall Study|Adverse Event|3
1085783|NCT02177136|3542986|P2|Overall Study|Adverse Event|2
1085784|NCT02177136|3542987|P1|Overall Study|Adverse Event|3
1085785|NCT02177136|3542985|P3|Overall Study|Discontinued due to pruritus|0
1085786|NCT02177136|3542986|P2|Overall Study|Discontinued due to pruritus|3
1085787|NCT02177136|3542987|P1|Overall Study|Discontinued due to pruritus|1
1085788|NCT02177136|3542985|P3|Overall Study|Withdrawal by Subject|0
1085789|NCT02177136|3542986|P2|Overall Study|Withdrawal by Subject|0
1085790|NCT02177136|3542987|P1|Overall Study|Withdrawal by Subject|2
1085791|NCT02177032|3543020|P4|Overall Study|Withdrawal by Subject|0
1085792|NCT02177032|3543021|P3|Overall Study|Withdrawal by Subject|1
1085793|NCT02177032|3543022|P2|Overall Study|Withdrawal by Subject|0
1085794|NCT02177032|3543023|P1|Overall Study|Withdrawal by Subject|1
1085795|NCT02177032|3543020|P4|Overall Study|OTHER|0
1085796|NCT02177032|3543021|P3|Overall Study|OTHER|1
1085797|NCT02177032|3543022|P2|Overall Study|OTHER|0
1085798|NCT02177032|3543023|P1|Overall Study|OTHER|2
1085799|NCT02177032|3543020|P4|Overall Study|Lost to Follow-up|0
1085800|NCT02177032|3543021|P3|Overall Study|Lost to Follow-up|0
1085801|NCT02177032|3543022|P2|Overall Study|Lost to Follow-up|2
1085802|NCT02177032|3543023|P1|Overall Study|Lost to Follow-up|0
1085803|NCT02177032|3543020|P4|Overall Study|ADMINISTRATIVE REASON|0
1085804|NCT02177032|3543021|P3|Overall Study|ADMINISTRATIVE REASON|1
1085805|NCT02177032|3543022|P2|Overall Study|ADMINISTRATIVE REASON|0
1085806|NCT02177032|3543023|P1|Overall Study|ADMINISTRATIVE REASON|2
1085807|NCT02176655|3543061|P1|Overall Study|Subjects did not treat|6
1085808|NCT02176642|3543084|P2|Overall Study|Withdrawal by Subject|1
1085809|NCT02176642|3543085|P1|Overall Study|Withdrawal by Subject|0
1085810|NCT02176525|3543115|P8|Overall Study|not treated|0
1085811|NCT02176525|3543116|P7|Overall Study|not treated|0
1085812|NCT02176525|3543117|P6|Overall Study|not treated|1
1085813|NCT02176525|3543118|P5|Overall Study|not treated|0
1085814|NCT02176525|3543119|P4|Overall Study|not treated|0
1085815|NCT02176525|3543120|P3|Overall Study|not treated|0
1085816|NCT02176525|3543121|P2|Overall Study|not treated|0
1085817|NCT02176525|3543122|P1|Overall Study|not treated|1
1085818|NCT02176525|3543115|P8|Overall Study|Adverse Event|0
1085819|NCT02176525|3543116|P7|Overall Study|Adverse Event|1
1085820|NCT02176525|3543117|P6|Overall Study|Adverse Event|0
1085821|NCT02176525|3543118|P5|Overall Study|Adverse Event|1
1085822|NCT02176525|3543119|P4|Overall Study|Adverse Event|1
1085823|NCT02176525|3543120|P3|Overall Study|Adverse Event|0
1085824|NCT02176525|3543121|P2|Overall Study|Adverse Event|0
1085825|NCT02176525|3543122|P1|Overall Study|Adverse Event|0
1085826|NCT02176421|3543299|P1|Overall Study|Adverse Event|1
1085827|NCT02176421|3543299|P1|Overall Study|Lost to Follow-up|4
1085828|NCT02176356|3543308|P1|Overall Study|Other Miscellaneous Reasons|2
1085829|NCT02176356|3543308|P1|Overall Study|Personal Reasons|3
1085830|NCT02176356|3543308|P1|Overall Study|Lost to Follow-up|4
1085831|NCT02176356|3543308|P1|Overall Study|Screen Failure|14
1085832|NCT02176291|3543338|P2|Overall Study|Withdrawal by Subject|0
1085833|NCT02176291|3543339|P1|Overall Study|Withdrawal by Subject|2
1085834|NCT02176291|3543338|P2|Overall Study|non compliance with protocol|0
1085835|NCT02176291|3543339|P1|Overall Study|non compliance with protocol|2
1085836|NCT02176291|3543338|P2|Overall Study|Death|0
1085837|NCT02176291|3543339|P1|Overall Study|Death|1
1085838|NCT02176226|3543347|P1|Overall Study|Withdrew prior to treatment|6
1085839|NCT02176226|3543347|P1|Overall Study|Lost to Follow-up|3
1085840|NCT02176018|3543355|P2|Overall Study|Withdrawal by Subject|2
1085841|NCT02176018|3543356|P1|Overall Study|Withdrawal by Subject|1
1085842|NCT02176018|3543355|P2|Overall Study|Protocol Violation|1
1085843|NCT02176018|3543356|P1|Overall Study|Protocol Violation|1
1085844|NCT02176018|3543355|P2|Overall Study|Lost to Follow-up|1
1085845|NCT02176018|3543356|P1|Overall Study|Lost to Follow-up|3
1085846|NCT02176018|3543355|P2|Overall Study|Adverse Event|2
1085847|NCT02176018|3543356|P1|Overall Study|Adverse Event|0
1085848|NCT02175771|3543388|P9|Treatment Period|Not specified|0
1085849|NCT02175771|3543389|P8|Treatment Period|Not specified|2
1085850|NCT02175771|3543390|P7|Treatment Period|Not specified|0
1085851|NCT02175771|3543391|P6|Treatment Period|Not specified|0
1085852|NCT02175771|3543392|P5|Treatment Period|Not specified|1
1085853|NCT02175771|3543393|P4|Treatment Period|Not specified|3
1085854|NCT02175771|3543394|P3|Treatment Period|Not specified|0
1085855|NCT02175771|3543395|P2|Treatment Period|Not specified|1
1085856|NCT02175771|3543396|P1|Treatment Period|Not specified|0
1085857|NCT02175771|3543388|P9|Treatment Period|Lack of Efficacy|0
1085858|NCT02175771|3543389|P8|Treatment Period|Lack of Efficacy|1
1085859|NCT02175771|3543390|P7|Treatment Period|Lack of Efficacy|0
1085860|NCT02175771|3543391|P6|Treatment Period|Lack of Efficacy|1
1085861|NCT02175771|3543392|P5|Treatment Period|Lack of Efficacy|0
1085862|NCT02175771|3543393|P4|Treatment Period|Lack of Efficacy|0
1085863|NCT02175771|3543394|P3|Treatment Period|Lack of Efficacy|0
1085864|NCT02175771|3543395|P2|Treatment Period|Lack of Efficacy|0
1085865|NCT02175771|3543396|P1|Treatment Period|Lack of Efficacy|0
1085866|NCT02175771|3543388|P9|Treatment Period|Lost to Follow-up|2
1085867|NCT02175771|3543389|P8|Treatment Period|Lost to Follow-up|2
1085868|NCT02175771|3543390|P7|Treatment Period|Lost to Follow-up|1
1085869|NCT02175771|3543391|P6|Treatment Period|Lost to Follow-up|2
1085870|NCT02175771|3543392|P5|Treatment Period|Lost to Follow-up|1
1085871|NCT02175771|3543393|P4|Treatment Period|Lost to Follow-up|3
1085872|NCT02175771|3543394|P3|Treatment Period|Lost to Follow-up|1
1085873|NCT02175771|3543395|P2|Treatment Period|Lost to Follow-up|3
1085874|NCT02175771|3543396|P1|Treatment Period|Lost to Follow-up|0
1085875|NCT02175771|3543388|P9|Treatment Period|Disease progression|0
1085876|NCT02175771|3543389|P8|Treatment Period|Disease progression|2
1085877|NCT02175771|3543390|P7|Treatment Period|Disease progression|0
1085878|NCT02175771|3543391|P6|Treatment Period|Disease progression|0
1085879|NCT02175771|3543392|P5|Treatment Period|Disease progression|0
1085880|NCT02175771|3543393|P4|Treatment Period|Disease progression|0
1085881|NCT02175771|3543394|P3|Treatment Period|Disease progression|0
1085882|NCT02175771|3543395|P2|Treatment Period|Disease progression|0
1085883|NCT02175771|3543396|P1|Treatment Period|Disease progression|0
1085884|NCT02175771|3543388|P9|Treatment Period|Protocol Violation|0
1085885|NCT02175771|3543389|P8|Treatment Period|Protocol Violation|1
1085886|NCT02175771|3543390|P7|Treatment Period|Protocol Violation|0
1085887|NCT02175771|3543391|P6|Treatment Period|Protocol Violation|0
1085888|NCT02175771|3543392|P5|Treatment Period|Protocol Violation|0
1085889|NCT02175771|3543393|P4|Treatment Period|Protocol Violation|0
1085890|NCT02175771|3543394|P3|Treatment Period|Protocol Violation|0
1085891|NCT02175771|3543395|P2|Treatment Period|Protocol Violation|0
1085892|NCT02175771|3543396|P1|Treatment Period|Protocol Violation|0
1085893|NCT02175771|3543388|P9|Treatment Period|Noncompliance|1
1085894|NCT02175771|3543389|P8|Treatment Period|Noncompliance|0
1085895|NCT02175771|3543390|P7|Treatment Period|Noncompliance|0
1085896|NCT02175771|3543391|P6|Treatment Period|Noncompliance|0
1085897|NCT02175771|3543392|P5|Treatment Period|Noncompliance|0
1085898|NCT02175771|3543393|P4|Treatment Period|Noncompliance|0
1085899|NCT02175771|3543394|P3|Treatment Period|Noncompliance|2
1085900|NCT02175771|3543395|P2|Treatment Period|Noncompliance|1
1085901|NCT02175771|3543396|P1|Treatment Period|Noncompliance|0
1085902|NCT02175771|3543388|P9|Treatment Period|Withdrawal by Subject|2
1085903|NCT02175771|3543389|P8|Treatment Period|Withdrawal by Subject|9
1085904|NCT02175771|3543390|P7|Treatment Period|Withdrawal by Subject|2
1085905|NCT02175771|3543391|P6|Treatment Period|Withdrawal by Subject|4
1085906|NCT02175771|3543392|P5|Treatment Period|Withdrawal by Subject|2
1085907|NCT02175771|3543393|P4|Treatment Period|Withdrawal by Subject|6
1085908|NCT02175771|3543394|P3|Treatment Period|Withdrawal by Subject|3
1085909|NCT02175771|3543395|P2|Treatment Period|Withdrawal by Subject|9
1085910|NCT02175771|3543396|P1|Treatment Period|Withdrawal by Subject|0
1085911|NCT02175771|3543388|P9|Treatment Period|Adverse Event|1
1085912|NCT02175771|3543389|P8|Treatment Period|Adverse Event|0
1085913|NCT02175771|3543390|P7|Treatment Period|Adverse Event|2
1085914|NCT02175771|3543391|P6|Treatment Period|Adverse Event|3
1085915|NCT02175771|3543392|P5|Treatment Period|Adverse Event|1
1085916|NCT02175771|3543393|P4|Treatment Period|Adverse Event|1
1085917|NCT02175771|3543394|P3|Treatment Period|Adverse Event|1
1085918|NCT02175771|3543395|P2|Treatment Period|Adverse Event|2
1085919|NCT02175771|3543396|P1|Treatment Period|Adverse Event|0
1085920|NCT02175771|3543388|P9|Run-In Period (Pre-assignment)|Not specified|0
1085921|NCT02175771|3543389|P8|Run-In Period (Pre-assignment)|Not specified|0
1085922|NCT02175771|3543390|P7|Run-In Period (Pre-assignment)|Not specified|0
1085923|NCT02175771|3543391|P6|Run-In Period (Pre-assignment)|Not specified|0
1085924|NCT02175771|3543392|P5|Run-In Period (Pre-assignment)|Not specified|0
1085925|NCT02175771|3543393|P4|Run-In Period (Pre-assignment)|Not specified|0
1085926|NCT02175771|3543394|P3|Run-In Period (Pre-assignment)|Not specified|0
1085927|NCT02175771|3543395|P2|Run-In Period (Pre-assignment)|Not specified|0
1085928|NCT02175771|3543396|P1|Run-In Period (Pre-assignment)|Not specified|8
1085929|NCT02175771|3543388|P9|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1085930|NCT02175771|3543389|P8|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1085931|NCT02175771|3543390|P7|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1085932|NCT02175771|3543391|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1085933|NCT02175771|3543392|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1085934|NCT02175771|3543393|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1085935|NCT02175771|3543394|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1085936|NCT02175771|3543395|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1085937|NCT02175771|3543396|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|6
1085938|NCT02175771|3543388|P9|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1085939|NCT02175771|3543389|P8|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1085940|NCT02175771|3543390|P7|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1085941|NCT02175771|3543391|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1085942|NCT02175771|3543392|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1085943|NCT02175771|3543393|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1085944|NCT02175771|3543394|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1085945|NCT02175771|3543395|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1085946|NCT02175771|3543396|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|7
1085947|NCT02175771|3543388|P9|Run-In Period (Pre-assignment)|Adverse Event|0
1085948|NCT02175771|3543389|P8|Run-In Period (Pre-assignment)|Adverse Event|0
1085949|NCT02175771|3543390|P7|Run-In Period (Pre-assignment)|Adverse Event|0
1085950|NCT02175771|3543391|P6|Run-In Period (Pre-assignment)|Adverse Event|0
1085951|NCT02175771|3543392|P5|Run-In Period (Pre-assignment)|Adverse Event|0
1085952|NCT02175771|3543393|P4|Run-In Period (Pre-assignment)|Adverse Event|0
1085953|NCT02175771|3543394|P3|Run-In Period (Pre-assignment)|Adverse Event|0
1085954|NCT02175771|3543395|P2|Run-In Period (Pre-assignment)|Adverse Event|0
1085955|NCT02175771|3543396|P1|Run-In Period (Pre-assignment)|Adverse Event|9
1085956|NCT02175771|3543388|P9|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1085957|NCT02175771|3543389|P8|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1085958|NCT02175771|3543390|P7|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1085959|NCT02175771|3543391|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1085960|NCT02175771|3543392|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1085961|NCT02175771|3543393|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1085962|NCT02175771|3543394|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1085963|NCT02175771|3543395|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1085964|NCT02175771|3543396|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|11
1085965|NCT02175771|3543388|P9|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1085966|NCT02175771|3543389|P8|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1085967|NCT02175771|3543390|P7|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1085968|NCT02175771|3543391|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1085969|NCT02175771|3543392|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1085970|NCT02175771|3543393|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1085971|NCT02175771|3543394|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1085972|NCT02175771|3543395|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1085973|NCT02175771|3543396|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|20
1085974|NCT02175771|3543388|P9|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1085975|NCT02175771|3543389|P8|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1085976|NCT02175771|3543390|P7|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1085977|NCT02175771|3543391|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1085978|NCT02175771|3543392|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1085979|NCT02175771|3543393|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1085980|NCT02175771|3543394|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1085981|NCT02175771|3543395|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1085982|NCT02175771|3543396|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|23
1085983|NCT02175745|3543454|P1|Overall Study|Not Eligible|1
1085984|NCT02175368|3543476|P1|Overall Study|Lost to Follow-up|1
1085985|NCT02175277|3543480|P1|Overall Study|Protocol-specified Criteria|1
1085986|NCT02175199|3543503|P2|Overall Study|Sponsor Decision|0
1085987|NCT02175199|3543504|P1|Overall Study|Sponsor Decision|1
1085988|NCT02175199|3543503|P2|Overall Study|Randomized in Error|0
1085989|NCT02175199|3543504|P1|Overall Study|Randomized in Error|1
1085990|NCT02175199|3543503|P2|Overall Study|Withdrawal by Subject|5
1085991|NCT02175199|3543504|P1|Overall Study|Withdrawal by Subject|1
1085992|NCT02175121|3543518|P5|Overall Study|Time issues|0
1085993|NCT02175121|3543519|P4|Overall Study|Time issues|0
1085994|NCT02175121|3543520|P3|Overall Study|Time issues|1
1085995|NCT02175121|3543521|P2|Overall Study|Time issues|0
1085996|NCT02175121|3543522|P1|Overall Study|Time issues|0
1085997|NCT02175121|3543518|P5|Overall Study|Schedule conflict|0
1085998|NCT02175121|3543519|P4|Overall Study|Schedule conflict|0
1085999|NCT02175121|3543520|P3|Overall Study|Schedule conflict|1
1086000|NCT02175121|3543521|P2|Overall Study|Schedule conflict|0
1086001|NCT02175121|3543522|P1|Overall Study|Schedule conflict|0
1086002|NCT02175121|3543518|P5|Overall Study|Personal emergency|1
1086003|NCT02175121|3543519|P4|Overall Study|Personal emergency|0
1086004|NCT02175121|3543520|P3|Overall Study|Personal emergency|0
1086005|NCT02175121|3543521|P2|Overall Study|Personal emergency|0
1086006|NCT02175121|3543522|P1|Overall Study|Personal emergency|0
1086007|NCT02175121|3543518|P5|Overall Study|Lost to Follow-up|0
1086008|NCT02175121|3543519|P4|Overall Study|Lost to Follow-up|1
1086009|NCT02175121|3543520|P3|Overall Study|Lost to Follow-up|0
1086010|NCT02175121|3543521|P2|Overall Study|Lost to Follow-up|1
1086011|NCT02175121|3543522|P1|Overall Study|Lost to Follow-up|0
1086012|NCT02175121|3543518|P5|Overall Study|Lack of Efficacy|0
1086013|NCT02175121|3543519|P4|Overall Study|Lack of Efficacy|0
1086014|NCT02175121|3543520|P3|Overall Study|Lack of Efficacy|0
1086015|NCT02175121|3543521|P2|Overall Study|Lack of Efficacy|0
1086016|NCT02175121|3543522|P1|Overall Study|Lack of Efficacy|1
1086017|NCT02174861|3543649|P1|Overall Study|Lost to Follow-up|26
1086018|NCT02174861|3543649|P1|Overall Study|Withdrawal by Subject|124
1086019|NCT02174861|3543649|P1|Overall Study|Decision by sponsor|8
1086020|NCT02173769|3543661|P1|Overall Study|Protocol Violation|4
1086021|NCT02173704|3543674|P2|Overall Study|Withdrawal by Subject|4
1086022|NCT02173704|3543675|P1|Overall Study|Withdrawal by Subject|9
1086023|NCT02173704|3543674|P2|Overall Study|Protocol Violation|0
1086024|NCT02173704|3543675|P1|Overall Study|Protocol Violation|1
1086025|NCT02173704|3543674|P2|Overall Study|Other|0
1086026|NCT02173704|3543675|P1|Overall Study|Other|1
1086027|NCT02173704|3543674|P2|Overall Study|Lost to Follow-up|0
1086028|NCT02173704|3543675|P1|Overall Study|Lost to Follow-up|1
1086029|NCT02173704|3543674|P2|Overall Study|Adverse Event|0
1086030|NCT02173704|3543675|P1|Overall Study|Adverse Event|1
1086031|NCT02173548|3543701|P2|Overall Study|Withdrawal by Subject|0
1086032|NCT02173548|3543702|P1|Overall Study|Withdrawal by Subject|1
1086033|NCT02173548|3543701|P2|Overall Study|Lost to Follow-up|2
1086034|NCT02173548|3543702|P1|Overall Study|Lost to Follow-up|0
1086035|NCT02173379|3543813|P2|Overall Study|Withdrawn by the physician|1
1086036|NCT02173379|3543814|P1|Overall Study|Withdrawn by the physician|0
1086037|NCT02173379|3543813|P2|Overall Study|Death|1
1086038|NCT02173379|3543814|P1|Overall Study|Death|1
1086039|NCT02173379|3543813|P2|Overall Study|Physician Decision|1
1086040|NCT02173379|3543814|P1|Overall Study|Physician Decision|4
1086041|NCT02173379|3543813|P2|Overall Study|Withdrawal by Subject|4
1086042|NCT02173379|3543814|P1|Overall Study|Withdrawal by Subject|1
1086043|NCT02173379|3543813|P2|Overall Study|Lost to Follow-up|0
1086044|NCT02173379|3543814|P1|Overall Study|Lost to Follow-up|3
1086045|NCT02173158|3543880|P1|Efficacy Phase|Adverse Event|1
1086046|NCT02173054|3543897|P3|Overall Study|Withdrawal by Subject|1
1086047|NCT02173054|3543898|P2|Overall Study|Withdrawal by Subject|0
1086048|NCT02173054|3543899|P1|Overall Study|Withdrawal by Subject|0
1086049|NCT02173054|3543897|P3|Overall Study|lack of compliance|0
1086050|NCT02173054|3543898|P2|Overall Study|lack of compliance|0
1086051|NCT02173054|3543899|P1|Overall Study|lack of compliance|1
1086052|NCT02172625|3543944|P2|Overall Study|car accident|1
1086053|NCT02172625|3543945|P1|Overall Study|car accident|0
1086054|NCT02172625|3543944|P2|Overall Study|Pregnancy|1
1086055|NCT02172625|3543945|P1|Overall Study|Pregnancy|0
1086056|NCT02172625|3543944|P2|Overall Study|Adverse Event|1
1086057|NCT02172625|3543945|P1|Overall Study|Adverse Event|0
1086058|NCT02172040|3543967|P4|Overall Study|Family emergency abroad|1
1086059|NCT02172040|3543968|P3|Overall Study|Family emergency abroad|0
1086060|NCT02172040|3543969|P2|Overall Study|Family emergency abroad|0
1086061|NCT02172040|3543970|P1|Overall Study|Family emergency abroad|0
1086062|NCT02172040|3543967|P4|Overall Study|Not available for Day 13 & 14 visits|0
1086063|NCT02172040|3543968|P3|Overall Study|Not available for Day 13 & 14 visits|1
1086064|NCT02172040|3543969|P2|Overall Study|Not available for Day 13 & 14 visits|0
1086065|NCT02172040|3543970|P1|Overall Study|Not available for Day 13 & 14 visits|0
1086066|NCT02172040|3543967|P4|Overall Study|Withdrawal by Subject|0
1086067|NCT02172040|3543968|P3|Overall Study|Withdrawal by Subject|1
1086068|NCT02172040|3543969|P2|Overall Study|Withdrawal by Subject|0
1086069|NCT02172040|3543970|P1|Overall Study|Withdrawal by Subject|0
1086070|NCT02172040|3543967|P4|Overall Study|Protocol Violation|0
1086071|NCT02172040|3543968|P3|Overall Study|Protocol Violation|0
1086072|NCT02172040|3543969|P2|Overall Study|Protocol Violation|1
1086073|NCT02172040|3543970|P1|Overall Study|Protocol Violation|0
1086074|NCT02172040|3543967|P4|Overall Study|Adverse Event|0
1086075|NCT02172040|3543968|P3|Overall Study|Adverse Event|0
1086076|NCT02172040|3543969|P2|Overall Study|Adverse Event|2
1086077|NCT02172040|3543970|P1|Overall Study|Adverse Event|0
1086078|NCT02171260|3544093|P4|Overall Study|Evidence of progressive disease|4
1086079|NCT02171260|3544094|P3|Overall Study|Evidence of progressive disease|4
1086080|NCT02171260|3544095|P2|Overall Study|Evidence of progressive disease|6
1086081|NCT02171260|3544096|P1|Overall Study|Evidence of progressive disease|4
1086082|NCT02171260|3544093|P4|Overall Study|Withdrawal by Subject|0
1086083|NCT02171260|3544094|P3|Overall Study|Withdrawal by Subject|0
1086084|NCT02171260|3544095|P2|Overall Study|Withdrawal by Subject|0
1086085|NCT02171260|3544096|P1|Overall Study|Withdrawal by Subject|1
1086086|NCT02171260|3544093|P4|Overall Study|Physician Decision|0
1086087|NCT02171260|3544094|P3|Overall Study|Physician Decision|1
1086088|NCT02171260|3544095|P2|Overall Study|Physician Decision|0
1086089|NCT02171260|3544096|P1|Overall Study|Physician Decision|1
1086090|NCT02171260|3544093|P4|Overall Study|Death|1
1086091|NCT02171260|3544094|P3|Overall Study|Death|0
1086092|NCT02171260|3544095|P2|Overall Study|Death|0
1086093|NCT02171260|3544096|P1|Overall Study|Death|0
1086094|NCT02170779|3544234|P2|Overall Study|Lost to Follow-up|1
1086095|NCT02170779|3544235|P1|Overall Study|Lost to Follow-up|0
1086096|NCT02170779|3544234|P2|Overall Study|Withdrawal by Subject|0
1086097|NCT02170779|3544235|P1|Overall Study|Withdrawal by Subject|1
1086098|NCT02170688|3544262|P5|Overall Study|Physician Decision|0
1086099|NCT02170688|3544263|P4|Overall Study|Physician Decision|0
1086100|NCT02170688|3544264|P3|Overall Study|Physician Decision|1
1086101|NCT02170688|3544265|P2|Overall Study|Physician Decision|0
1086102|NCT02170688|3544266|P1|Overall Study|Physician Decision|0
1086103|NCT02170688|3544262|P5|Overall Study|Full dose not received|0
1086104|NCT02170688|3544263|P4|Overall Study|Full dose not received|0
1086105|NCT02170688|3544264|P3|Overall Study|Full dose not received|0
1086106|NCT02170688|3544265|P2|Overall Study|Full dose not received|1
1086107|NCT02170688|3544266|P1|Overall Study|Full dose not received|0
1086108|NCT02170688|3544262|P5|Overall Study|Exclusion Criteria: Fatty Liver|0
1086109|NCT02170688|3544263|P4|Overall Study|Exclusion Criteria: Fatty Liver|2
1086110|NCT02170688|3544264|P3|Overall Study|Exclusion Criteria: Fatty Liver|3
1086111|NCT02170688|3544265|P2|Overall Study|Exclusion Criteria: Fatty Liver|2
1086112|NCT02170688|3544266|P1|Overall Study|Exclusion Criteria: Fatty Liver|4
1086113|NCT02170207|3544439|P1|Overall Study|Case report forms unavailable|5
1086114|NCT02170077|3544450|P3|Overall Study|Exacerbation of seizures|1
1086115|NCT02170077|3544451|P2|Overall Study|Exacerbation of seizures|2
1086116|NCT02170077|3544452|P1|Overall Study|Exacerbation of seizures|0
1086117|NCT02170077|3544450|P3|Overall Study|Exclusion criteria|5
1086118|NCT02170077|3544451|P2|Overall Study|Exclusion criteria|2
1086119|NCT02170077|3544452|P1|Overall Study|Exclusion criteria|2
1086120|NCT02170077|3544450|P3|Overall Study|Lost to Follow-up|0
1086121|NCT02170077|3544451|P2|Overall Study|Lost to Follow-up|1
1086122|NCT02170077|3544452|P1|Overall Study|Lost to Follow-up|0
1086123|NCT02170077|3544450|P3|Overall Study|Adverse Event|4
1086124|NCT02170077|3544451|P2|Overall Study|Adverse Event|4
1086125|NCT02170077|3544452|P1|Overall Study|Adverse Event|4
1086126|NCT02170077|3544450|P3|Overall Study|Withdrawal by Subject|2
1086127|NCT02170077|3544451|P2|Overall Study|Withdrawal by Subject|4
1086128|NCT02170077|3544452|P1|Overall Study|Withdrawal by Subject|3
1086129|NCT02170064|3544463|P3|Overall Study|Physician Decision|0
1086130|NCT02170064|3544464|P2|Overall Study|Physician Decision|1
1086131|NCT02170064|3544465|P1|Overall Study|Physician Decision|1
1086132|NCT02170064|3544463|P3|Overall Study|Withdrawal by Subject|1
1086133|NCT02170064|3544464|P2|Overall Study|Withdrawal by Subject|1
1086134|NCT02170064|3544465|P1|Overall Study|Withdrawal by Subject|5
1086135|NCT02170025|3544481|P2|Overall Study|Adverse Event|0
1086136|NCT02170025|3544482|P1|Overall Study|Adverse Event|2
1086137|NCT02169414|3544632|P4|Overall Study|Adverse Event|0
1086138|NCT02169414|3544633|P3|Overall Study|Adverse Event|0
1086139|NCT02169414|3544634|P2|Overall Study|Adverse Event|1
1086140|NCT02169414|3544635|P1|Overall Study|Adverse Event|0
1086141|NCT02169414|3544632|P4|Overall Study|Withdrawal by Subject|0
1086142|NCT02169414|3544633|P3|Overall Study|Withdrawal by Subject|0
1086143|NCT02169414|3544634|P2|Overall Study|Withdrawal by Subject|0
1086144|NCT02169414|3544635|P1|Overall Study|Withdrawal by Subject|1
1086145|NCT02169336|3544676|P3|Overall Study|Subject declined to continue dosing|1
1086146|NCT02169336|3544677|P2|Overall Study|Subject declined to continue dosing|0
1086147|NCT02169336|3544678|P1|Overall Study|Subject declined to continue dosing|0
1086148|NCT02169336|3544676|P3|Overall Study|Physician Decision|1
1086149|NCT02169336|3544677|P2|Overall Study|Physician Decision|0
1086150|NCT02169336|3544678|P1|Overall Study|Physician Decision|0
1086151|NCT02169336|3544676|P3|Overall Study|Withdrawal by Subject|0
1086152|NCT02169336|3544677|P2|Overall Study|Withdrawal by Subject|0
1086153|NCT02169336|3544678|P1|Overall Study|Withdrawal by Subject|1
1086154|NCT02169336|3544676|P3|Overall Study|Adverse Event|1
1086155|NCT02169336|3544677|P2|Overall Study|Adverse Event|3
1086156|NCT02169336|3544678|P1|Overall Study|Adverse Event|2
1086157|NCT02169336|3544676|P3|Overall Study|Lack of Efficacy|0
1086158|NCT02169336|3544677|P2|Overall Study|Lack of Efficacy|1
1086159|NCT02169336|3544678|P1|Overall Study|Lack of Efficacy|1
1086160|NCT02169219|3544686|P1|Overall Study|Lack of Efficacy|6
1086161|NCT02168946|3544712|P2|Overall Study|Subject unable to come back for visits|0
1086162|NCT02168946|3544713|P1|Overall Study|Subject unable to come back for visits|1
1086163|NCT02168946|3544712|P2|Overall Study|Lost to Follow-up|0
1086164|NCT02168946|3544713|P1|Overall Study|Lost to Follow-up|3
1086165|NCT02168946|3544712|P2|Overall Study|Adverse Event|5
1086166|NCT02168946|3544713|P1|Overall Study|Adverse Event|8
1086167|NCT02168816|3544751|P2|Overall Study|Lost to Follow-up|2
1086168|NCT02168816|3544752|P1|Overall Study|Lost to Follow-up|2
1086169|NCT02168803|3544763|P3|Overall Study|Sponsor Decision|1
1086170|NCT02168803|3544764|P2|Overall Study|Sponsor Decision|0
1086171|NCT02168803|3544765|P1|Overall Study|Sponsor Decision|0
1086172|NCT02168803|3544763|P3|Overall Study|Death|1
1086173|NCT02168803|3544764|P2|Overall Study|Death|0
1086174|NCT02168803|3544765|P1|Overall Study|Death|0
1086175|NCT02168803|3544763|P3|Overall Study|Adverse Event|1
1086176|NCT02168803|3544764|P2|Overall Study|Adverse Event|1
1086177|NCT02168803|3544765|P1|Overall Study|Adverse Event|0
1086178|NCT02168803|3544763|P3|Overall Study|Physician Decision|0
1086179|NCT02168803|3544764|P2|Overall Study|Physician Decision|1
1086180|NCT02168803|3544765|P1|Overall Study|Physician Decision|0
1086181|NCT02168803|3544763|P3|Overall Study|Withdrawal by Subject|2
1086182|NCT02168803|3544764|P2|Overall Study|Withdrawal by Subject|1
1086183|NCT02168803|3544765|P1|Overall Study|Withdrawal by Subject|1
1086184|NCT02168803|3544763|P3|Overall Study|Lost to Follow-up|1
1086185|NCT02168803|3544764|P2|Overall Study|Lost to Follow-up|0
1086186|NCT02168803|3544765|P1|Overall Study|Lost to Follow-up|1
1086187|NCT02168777|3544795|P3|Overall Study|Other reason|0
1086188|NCT02168777|3544796|P2|Overall Study|Other reason|1
1086189|NCT02168777|3544797|P1|Overall Study|Other reason|0
1086190|NCT02168777|3544795|P3|Overall Study|Clinical disease progression|2
1086191|NCT02168777|3544796|P2|Overall Study|Clinical disease progression|1
1086192|NCT02168777|3544797|P1|Overall Study|Clinical disease progression|0
1086193|NCT02168777|3544795|P3|Overall Study|Radiological disease progression|5
1086194|NCT02168777|3544796|P2|Overall Study|Radiological disease progression|5
1086195|NCT02168777|3544797|P1|Overall Study|Radiological disease progression|0
1086196|NCT02168777|3544795|P3|Overall Study|Disease recurrence|1
1086197|NCT02168777|3544796|P2|Overall Study|Disease recurrence|0
1086198|NCT02168777|3544797|P1|Overall Study|Disease recurrence|0
1086199|NCT02168777|3544795|P3|Overall Study|Adverse Event|1
1086200|NCT02168777|3544796|P2|Overall Study|Adverse Event|0
1086201|NCT02168777|3544797|P1|Overall Study|Adverse Event|1
1086202|NCT02168777|3544795|P3|Overall Study|Withdrawal by Subject|2
1086203|NCT02168777|3544796|P2|Overall Study|Withdrawal by Subject|0
1086204|NCT02168777|3544797|P1|Overall Study|Withdrawal by Subject|1
1086205|NCT02168491|3544874|P1|Overall Study|Withdrawal by Subject|1
1086206|NCT02168478|3544880|P1|Overall Study|Did Not Meet Exclusionary Criteria|1
1086207|NCT02168478|3544880|P1|Overall Study|Did Not Consent to Participation|2
1086208|NCT02168478|3544880|P1|Overall Study|Withdrawal by Subject|1
1086209|NCT02168439|3544886|P2|Overall Study|Protocol Violation|2
1086210|NCT02168439|3544887|P1|Overall Study|Protocol Violation|0
1086211|NCT02168387|3544905|P2|Overall Study|Death|0
1086212|NCT02168387|3544906|P1|Overall Study|Death|1
1086213|NCT02168387|3544905|P2|Overall Study|Planned exubation|3
1086214|NCT02168387|3544906|P1|Overall Study|Planned exubation|6
1086215|NCT02168270|3544938|P1|Overall Study|Lack of Efficacy|4
1086216|NCT02167893|3544945|P1|Overall Study|Case report forms not collected|68
1086217|NCT02167893|3544945|P1|Overall Study|Investigator health reasons|10
1086218|NCT02167893|3544945|P1|Overall Study|Investigator transferred|85
1086219|NCT02167139|3544983|P4|Transition-extension|Lost to Follow-up|0
1086220|NCT02167139|3544984|P3|Transition-extension|Lost to Follow-up|0
1086221|NCT02167139|3544985|P2|Transition-extension|Lost to Follow-up|0
1086222|NCT02167139|3544986|P1|Transition-extension|Lost to Follow-up|1
1086223|NCT02167139|3544983|P4|Transition-extension|Other|0
1086224|NCT02167139|3544984|P3|Transition-extension|Other|1
1086225|NCT02167139|3544985|P2|Transition-extension|Other|0
1086226|NCT02167139|3544986|P1|Transition-extension|Other|1
1086227|NCT02167139|3544983|P4|Transition-extension|Lack of Efficacy|1
1086228|NCT02167139|3544984|P3|Transition-extension|Lack of Efficacy|1
1086229|NCT02167139|3544985|P2|Transition-extension|Lack of Efficacy|0
1086230|NCT02167139|3544986|P1|Transition-extension|Lack of Efficacy|0
1086231|NCT02167139|3544983|P4|Transition-extension|Withdrawal by Subject|1
1086232|NCT02167139|3544984|P3|Transition-extension|Withdrawal by Subject|4
1086233|NCT02167139|3544985|P2|Transition-extension|Withdrawal by Subject|0
1086234|NCT02167139|3544986|P1|Transition-extension|Withdrawal by Subject|2
1086235|NCT02167139|3544983|P4|Transition-extension|Adverse Event|3
1086236|NCT02167139|3544984|P3|Transition-extension|Adverse Event|2
1086237|NCT02167139|3544985|P2|Transition-extension|Adverse Event|0
1086238|NCT02167139|3544986|P1|Transition-extension|Adverse Event|2
1086239|NCT02167139|3544983|P4|Randomised, Double-blind|Other|0
1086240|NCT02167139|3544984|P3|Randomised, Double-blind|Other|0
1086241|NCT02167139|3544985|P2|Randomised, Double-blind|Other|0
1086242|NCT02167139|3544986|P1|Randomised, Double-blind|Other|3
1086243|NCT02167139|3544983|P4|Randomised, Double-blind|Lack of Efficacy|0
1086244|NCT02167139|3544984|P3|Randomised, Double-blind|Lack of Efficacy|0
1086245|NCT02167139|3544985|P2|Randomised, Double-blind|Lack of Efficacy|2
1086246|NCT02167139|3544986|P1|Randomised, Double-blind|Lack of Efficacy|1
1086247|NCT02167139|3544983|P4|Randomised, Double-blind|Adverse Event|0
1086248|NCT02167139|3544984|P3|Randomised, Double-blind|Adverse Event|0
1086249|NCT02167139|3544985|P2|Randomised, Double-blind|Adverse Event|9
1086250|NCT02167139|3544986|P1|Randomised, Double-blind|Adverse Event|2
1086251|NCT02167139|3544983|P4|Randomised, Double-blind|Withdrawal by Subject|0
1086252|NCT02167139|3544984|P3|Randomised, Double-blind|Withdrawal by Subject|0
1086253|NCT02167139|3544985|P2|Randomised, Double-blind|Withdrawal by Subject|8
1086254|NCT02167139|3544986|P1|Randomised, Double-blind|Withdrawal by Subject|11
1086255|NCT02167035|3545002|P2|Overall Study|Randomized to incorrect Study Medication|1
1086256|NCT02167035|3545003|P1|Overall Study|Randomized to incorrect Study Medication|0
1086257|NCT02167035|3545002|P2|Overall Study|Lost to Follow-up|3
1086258|NCT02167035|3545003|P1|Overall Study|Lost to Follow-up|3
1086259|NCT02167035|3545002|P2|Overall Study|Adverse Event|2
1086260|NCT02167035|3545003|P1|Overall Study|Adverse Event|2
1086261|NCT02166697|3545011|P1|Overall Study|Protocol Violation|347
1086262|NCT02166476|3545022|P2|Overall Study|Unable to Come for Visit|3
1086263|NCT02166476|3545023|P1|Overall Study|Unable to Come for Visit|0
1086264|NCT02166476|3545022|P2|Overall Study|Physician Decision|0
1086265|NCT02166476|3545023|P1|Overall Study|Physician Decision|1
1086266|NCT02166476|3545022|P2|Overall Study|Lost to Follow-up|10
1086267|NCT02166476|3545023|P1|Overall Study|Lost to Follow-up|5
1086268|NCT02166476|3545022|P2|Overall Study|Adverse Event|3
1086269|NCT02166476|3545023|P1|Overall Study|Adverse Event|3
1086270|NCT02166476|3545022|P2|Overall Study|Withdrawal by Subject|7
1086271|NCT02166476|3545023|P1|Overall Study|Withdrawal by Subject|5
1086272|NCT02165826|3545068|P3|Down-Titration Period|Reason Not Specified|2
1086273|NCT02165826|3545069|P2|Down-Titration Period|Reason Not Specified|0
1086274|NCT02165826|3545070|P1|Down-Titration Period|Reason Not Specified|1
1086275|NCT02165826|3545068|P3|Down-Titration Period|Voluntary Withdrawal|2
1086276|NCT02165826|3545069|P2|Down-Titration Period|Voluntary Withdrawal|1
1086277|NCT02165826|3545070|P1|Down-Titration Period|Voluntary Withdrawal|2
1086278|NCT02165826|3545068|P3|Down-Titration Period|Pre-treatment Event/Adverse Event|3
1086279|NCT02165826|3545069|P2|Down-Titration Period|Pre-treatment Event/Adverse Event|10
1086280|NCT02165826|3545070|P1|Down-Titration Period|Pre-treatment Event/Adverse Event|4
1086281|NCT02165826|3545068|P3|Main Treatment Period|Did Not Receive Study Drug|0
1086282|NCT02165826|3545069|P2|Main Treatment Period|Did Not Receive Study Drug|2
1086283|NCT02165826|3545070|P1|Main Treatment Period|Did Not Receive Study Drug|0
1086284|NCT02165826|3545068|P3|Main Treatment Period|Reason Not Specified|16
1086285|NCT02165826|3545069|P2|Main Treatment Period|Reason Not Specified|5
1086286|NCT02165826|3545070|P1|Main Treatment Period|Reason Not Specified|8
1086287|NCT02165826|3545068|P3|Main Treatment Period|Lack of Efficacy|0
1086288|NCT02165826|3545069|P2|Main Treatment Period|Lack of Efficacy|0
1086289|NCT02165826|3545070|P1|Main Treatment Period|Lack of Efficacy|2
1086290|NCT02165826|3545068|P3|Main Treatment Period|Voluntary Withdrawal|21
1086291|NCT02165826|3545069|P2|Main Treatment Period|Voluntary Withdrawal|23
1086292|NCT02165826|3545070|P1|Main Treatment Period|Voluntary Withdrawal|23
1086293|NCT02165826|3545068|P3|Main Treatment Period|Lost to Follow-up|1
1086294|NCT02165826|3545069|P2|Main Treatment Period|Lost to Follow-up|2
1086295|NCT02165826|3545070|P1|Main Treatment Period|Lost to Follow-up|4
1086296|NCT02165826|3545068|P3|Main Treatment Period|Major/Significant Protocol Deviation|3
1086297|NCT02165826|3545069|P2|Main Treatment Period|Major/Significant Protocol Deviation|1
1086298|NCT02165826|3545070|P1|Main Treatment Period|Major/Significant Protocol Deviation|0
1086299|NCT02165826|3545068|P3|Main Treatment Period|Pre-treatment Event/Adverse Event|68
1086300|NCT02165826|3545069|P2|Main Treatment Period|Pre-treatment Event/Adverse Event|57
1086301|NCT02165826|3545070|P1|Main Treatment Period|Pre-treatment Event/Adverse Event|44
1086302|NCT02165735|3545138|P2|Overall Study|Protocol Violation|1
1086303|NCT02165735|3545139|P1|Overall Study|Protocol Violation|0
1086304|NCT02165735|3545138|P2|Overall Study|Participant indicated lack of time|3
1086305|NCT02165735|3545139|P1|Overall Study|Participant indicated lack of time|1
1086306|NCT02165735|3545138|P2|Overall Study|Withdrawal by Subject|0
1086307|NCT02165735|3545139|P1|Overall Study|Withdrawal by Subject|3
1086308|NCT02165735|3545138|P2|Overall Study|Lost to Follow-up|10
1086309|NCT02165735|3545139|P1|Overall Study|Lost to Follow-up|12
1086310|NCT02165202|3545199|P2|Injection Phase|Participant unwilling to comply|0
1086311|NCT02165202|3545200|P1|Injection Phase|Participant unwilling to comply|1
1086312|NCT02165202|3545199|P2|Injection Phase|No longer interested|1
1086313|NCT02165202|3545200|P1|Injection Phase|No longer interested|0
1086314|NCT02165202|3545199|P2|Injection Phase|Study Product related Toxicity|0
1086315|NCT02165202|3545200|P1|Injection Phase|Study Product related Toxicity|1
1086316|NCT02165202|3545199|P2|Injection Phase|End of Study|1
1086317|NCT02165202|3545200|P1|Injection Phase|End of Study|2
1086318|NCT02165202|3545199|P2|Injection Phase|QTcF>500 ms or increase of>60 ms|1
1086319|NCT02165202|3545200|P1|Injection Phase|QTcF>500 ms or increase of>60 ms|0
1086320|NCT02165202|3545199|P2|Injection Phase|Unable to attend within Visit Window|0
1086321|NCT02165202|3545200|P1|Injection Phase|Unable to attend within Visit Window|1
1086322|NCT02165202|3545199|P2|Injection Phase|Reactive HIV or HIV Suspected|2
1086323|NCT02165202|3545200|P1|Injection Phase|Reactive HIV or HIV Suspected|0
1086324|NCT02165202|3545199|P2|Injection Phase|Abnormal Lab Value|1
1086325|NCT02165202|3545200|P1|Injection Phase|Abnormal Lab Value|5
1086326|NCT02165202|3545199|P2|Oral Phase|Abnormal EKG|1
1086327|NCT02165202|3545200|P1|Oral Phase|Abnormal EKG|0
1086328|NCT02165202|3545199|P2|Oral Phase|Relocated, no follow-up planned|0
1086329|NCT02165202|3545200|P1|Oral Phase|Relocated, no follow-up planned|1
1086330|NCT02165202|3545199|P2|Oral Phase|CMC advised termination|0
1086331|NCT02165202|3545200|P1|Oral Phase|CMC advised termination|1
1086332|NCT02165202|3545199|P2|Oral Phase|QTcF>500 ms or increase of>60 ms|0
1086333|NCT02165202|3545200|P1|Oral Phase|QTcF>500 ms or increase of>60 ms|1
1086334|NCT02165202|3545199|P2|Oral Phase|Clinical reasons|0
1086335|NCT02165202|3545200|P1|Oral Phase|Clinical reasons|1
1086336|NCT02165202|3545199|P2|Oral Phase|Unable to contact Participant|1
1086337|NCT02165202|3545200|P1|Oral Phase|Unable to contact Participant|1
1086338|NCT02165202|3545199|P2|Oral Phase|Study product Related Toxicity|0
1086339|NCT02165202|3545200|P1|Oral Phase|Study product Related Toxicity|1
1086340|NCT02165202|3545199|P2|Oral Phase|Refused further participation|1
1086341|NCT02165202|3545200|P1|Oral Phase|Refused further participation|5
1086342|NCT02164981|3545237|P3|Phase 2 (Day 14 - Day 28)|Protocol Violation|0
1086343|NCT02164981|3545238|P2|Phase 2 (Day 14 - Day 28)|Protocol Violation|1
1086344|NCT02164981|3545239|P1|Phase 2 (Day 14 - Day 28)|Protocol Violation|0
1086345|NCT02164981|3545237|P3|Phase 2 (Day 14 - Day 28)|Adverse Event|0
1086346|NCT02164981|3545238|P2|Phase 2 (Day 14 - Day 28)|Adverse Event|1
1086347|NCT02164981|3545239|P1|Phase 2 (Day 14 - Day 28)|Adverse Event|2
1086348|NCT02164981|3545237|P3|Phase 1 (Day 0 - Day 14)|Adverse Event|0
1086349|NCT02164981|3545238|P2|Phase 1 (Day 0 - Day 14)|Adverse Event|2
1086350|NCT02164981|3545239|P1|Phase 1 (Day 0 - Day 14)|Adverse Event|0
1086351|NCT02164981|3545237|P3|Started|Adverse Event|0
1086352|NCT02164981|3545238|P2|Started|Adverse Event|2
1086353|NCT02164981|3545239|P1|Started|Adverse Event|1
1086354|NCT02164981|3545237|P3|Started|Protocol Violation|0
1086355|NCT02164981|3545238|P2|Started|Protocol Violation|0
1086356|NCT02164981|3545239|P1|Started|Protocol Violation|2
1086357|NCT02164981|3545237|P3|Started|Withdrawal by Subject|0
1086358|NCT02164981|3545238|P2|Started|Withdrawal by Subject|1
1086359|NCT02164981|3545239|P1|Started|Withdrawal by Subject|2
1086360|NCT02164929|3545312|P4|Overall Study|Failed regional block|0
1086361|NCT02164929|3545313|P3|Overall Study|Failed regional block|1
1086362|NCT02164929|3545314|P2|Overall Study|Failed regional block|0
1086363|NCT02164929|3545315|P1|Overall Study|Failed regional block|0
1086364|NCT02164929|3545312|P4|Overall Study|Converted to open procedure|2
1086365|NCT02164929|3545313|P3|Overall Study|Converted to open procedure|0
1086366|NCT02164929|3545314|P2|Overall Study|Converted to open procedure|0
1086367|NCT02164929|3545315|P1|Overall Study|Converted to open procedure|1
1086368|NCT02164916|3545359|P2|Overall Study|Not eligible|5
1086369|NCT02164916|3545360|P1|Overall Study|Not eligible|2
1086370|NCT02164916|3545359|P2|Overall Study|Reason under review|6
1086371|NCT02164916|3545360|P1|Overall Study|Reason under review|1
1086372|NCT02164916|3545359|P2|Overall Study|Not protocol specified|1
1086373|NCT02164916|3545360|P1|Overall Study|Not protocol specified|5
1086374|NCT02164916|3545359|P2|Overall Study|Progression|26
1086375|NCT02164916|3545360|P1|Overall Study|Progression|37
1086376|NCT02164916|3545359|P2|Overall Study|Refusal unrelated to adverse event|7
1086377|NCT02164916|3545360|P1|Overall Study|Refusal unrelated to adverse event|3
1086378|NCT02164916|3545359|P2|Overall Study|Death|1
1086379|NCT02164916|3545360|P1|Overall Study|Death|1
1086380|NCT02164916|3545359|P2|Overall Study|Adverse Event|8
1086381|NCT02164916|3545360|P1|Overall Study|Adverse Event|3
1086382|NCT02164864|3545380|P3|Overall Study|Other than stated|14
1086383|NCT02164864|3545381|P2|Overall Study|Other than stated|4
1086384|NCT02164864|3545382|P1|Overall Study|Other than stated|3
1086385|NCT02164864|3545380|P3|Overall Study|Consent withdrawn, not due to AE|56
1086386|NCT02164864|3545381|P2|Overall Study|Consent withdrawn, not due to AE|8
1086387|NCT02164864|3545382|P1|Overall Study|Consent withdrawn, not due to AE|21
1086388|NCT02164864|3545380|P3|Overall Study|Lost to Follow-up|2
1086389|NCT02164864|3545381|P2|Overall Study|Lost to Follow-up|3
1086390|NCT02164864|3545382|P1|Overall Study|Lost to Follow-up|4
1086391|NCT02164864|3545380|P3|Overall Study|Protocol Violation|1
1086392|NCT02164864|3545381|P2|Overall Study|Protocol Violation|4
1086393|NCT02164864|3545382|P1|Overall Study|Protocol Violation|2
1086394|NCT02164864|3545380|P3|Overall Study|Other Adverse Event (AE)|49
1086395|NCT02164864|3545381|P2|Overall Study|Other Adverse Event (AE)|32
1086396|NCT02164864|3545382|P1|Overall Study|Other Adverse Event (AE)|52
1086397|NCT02164864|3545380|P3|Overall Study|Other pre-existing disease worsening|9
1086398|NCT02164864|3545381|P2|Overall Study|Other pre-existing disease worsening|4
1086399|NCT02164864|3545382|P1|Overall Study|Other pre-existing disease worsening|6
1086400|NCT02164864|3545380|P3|Overall Study|Trial disease worsening|1
1086401|NCT02164864|3545381|P2|Overall Study|Trial disease worsening|5
1086402|NCT02164864|3545382|P1|Overall Study|Trial disease worsening|7
1086403|NCT02164539|3545447|P7|Treatment Phase C (1 Week)|Physician Decision|1
1086404|NCT02164539|3545448|P6|Treatment Phase C (1 Week)|Physician Decision|0
1086405|NCT02164539|3545449|P5|Treatment Phase C (1 Week)|Physician Decision|0
1086406|NCT02164539|3545450|P4|Treatment Phase C (1 Week)|Physician Decision|0
1086407|NCT02164539|3545451|P3|Treatment Phase C (1 Week)|Physician Decision|0
1086408|NCT02164539|3545452|P2|Treatment Phase C (1 Week)|Physician Decision|0
1086409|NCT02164539|3545453|P1|Treatment Phase C (1 Week)|Physician Decision|0
1086410|NCT02164539|3545447|P7|Treatment Phase C (1 Week)|Adverse Event|1
1086411|NCT02164539|3545448|P6|Treatment Phase C (1 Week)|Adverse Event|0
1086412|NCT02164539|3545449|P5|Treatment Phase C (1 Week)|Adverse Event|0
1086413|NCT02164539|3545450|P4|Treatment Phase C (1 Week)|Adverse Event|0
1086414|NCT02164539|3545451|P3|Treatment Phase C (1 Week)|Adverse Event|0
1086415|NCT02164539|3545452|P2|Treatment Phase C (1 Week)|Adverse Event|0
1086416|NCT02164539|3545453|P1|Treatment Phase C (1 Week)|Adverse Event|0
1086417|NCT02164539|3545447|P7|Treatment Phase C (1 Week)|Withdrawal by Subject|0
1086418|NCT02164539|3545448|P6|Treatment Phase C (1 Week)|Withdrawal by Subject|0
1086419|NCT02164539|3545449|P5|Treatment Phase C (1 Week)|Withdrawal by Subject|0
1086420|NCT02164539|3545450|P4|Treatment Phase C (1 Week)|Withdrawal by Subject|0
1086421|NCT02164539|3545451|P3|Treatment Phase C (1 Week)|Withdrawal by Subject|0
1086422|NCT02164539|3545452|P2|Treatment Phase C (1 Week)|Withdrawal by Subject|0
1086423|NCT02164539|3545453|P1|Treatment Phase C (1 Week)|Withdrawal by Subject|1
1086424|NCT02164539|3545447|P7|Treatment Phase B (1 Week)|Physician Decision|1
1086425|NCT02164539|3545448|P6|Treatment Phase B (1 Week)|Physician Decision|0
1086426|NCT02164539|3545449|P5|Treatment Phase B (1 Week)|Physician Decision|1
1086427|NCT02164539|3545450|P4|Treatment Phase B (1 Week)|Physician Decision|0
1086428|NCT02164539|3545451|P3|Treatment Phase B (1 Week)|Physician Decision|0
1086429|NCT02164539|3545452|P2|Treatment Phase B (1 Week)|Physician Decision|0
1086430|NCT02164539|3545453|P1|Treatment Phase B (1 Week)|Physician Decision|0
1086431|NCT02164539|3545447|P7|Treatment Phase B (1 Week)|Adverse Event|0
1086432|NCT02164539|3545448|P6|Treatment Phase B (1 Week)|Adverse Event|0
1086433|NCT02164539|3545449|P5|Treatment Phase B (1 Week)|Adverse Event|2
1086434|NCT02164539|3545450|P4|Treatment Phase B (1 Week)|Adverse Event|0
1086435|NCT02164539|3545451|P3|Treatment Phase B (1 Week)|Adverse Event|0
1086436|NCT02164539|3545452|P2|Treatment Phase B (1 Week)|Adverse Event|0
1086437|NCT02164539|3545453|P1|Treatment Phase B (1 Week)|Adverse Event|0
1086438|NCT02164539|3545447|P7|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
1086439|NCT02164539|3545448|P6|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
1086440|NCT02164539|3545449|P5|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3
1086441|NCT02164539|3545450|P4|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
1086442|NCT02164539|3545451|P3|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
1086443|NCT02164539|3545452|P2|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
1086444|NCT02164539|3545453|P1|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
1086445|NCT02164513|3545501|P3|Overall Study|Other: Reason not provided by site|0
1086446|NCT02164513|3545502|P2|Overall Study|Other: Reason not provided by site|0
1086447|NCT02164513|3545503|P1|Overall Study|Other: Reason not provided by site|1
1086448|NCT02164513|3545501|P3|Overall Study|Withdrawal by Subject|130
1086449|NCT02164513|3545502|P2|Overall Study|Withdrawal by Subject|261
1086450|NCT02164513|3545503|P1|Overall Study|Withdrawal by Subject|192
1086451|NCT02164513|3545501|P3|Overall Study|Physician Decision|28
1086452|NCT02164513|3545502|P2|Overall Study|Physician Decision|57
1086453|NCT02164513|3545503|P1|Overall Study|Physician Decision|47
1086454|NCT02164513|3545501|P3|Overall Study|Lost to Follow-up|22
1086455|NCT02164513|3545502|P2|Overall Study|Lost to Follow-up|36
1086456|NCT02164513|3545503|P1|Overall Study|Lost to Follow-up|30
1086457|NCT02164513|3545501|P3|Overall Study|Other: Study Closed or terminated|4
1086458|NCT02164513|3545502|P2|Overall Study|Other: Study Closed or terminated|2
1086459|NCT02164513|3545503|P1|Overall Study|Other: Study Closed or terminated|5
1086460|NCT02164513|3545501|P3|Overall Study|Adverse Event|111
1086461|NCT02164513|3545502|P2|Overall Study|Adverse Event|180
1086462|NCT02164513|3545503|P1|Overall Study|Adverse Event|162
1086463|NCT02164318|3545542|P4|Overall Study|Withdrawal by Subject|1
1086464|NCT02164318|3545543|P3|Overall Study|Withdrawal by Subject|0
1086465|NCT02164318|3545544|P2|Overall Study|Withdrawal by Subject|1
1086466|NCT02164318|3545545|P1|Overall Study|Withdrawal by Subject|0
1086467|NCT02163993|3545568|P5|Post-treatment Period|Withdrawal by Subject|2
1086468|NCT02163993|3545569|P4|Post-treatment Period|Withdrawal by Subject|1
1086469|NCT02163993|3545570|P3|Post-treatment Period|Withdrawal by Subject|0
1086470|NCT02163993|3545571|P2|Post-treatment Period|Withdrawal by Subject|4
1086471|NCT02163993|3545572|P1|Post-treatment Period|Withdrawal by Subject|2
1086472|NCT02163993|3545568|P5|Post-treatment Period|Protocol Violation|1
1086473|NCT02163993|3545569|P4|Post-treatment Period|Protocol Violation|0
1086474|NCT02163993|3545570|P3|Post-treatment Period|Protocol Violation|0
1086475|NCT02163993|3545571|P2|Post-treatment Period|Protocol Violation|0
1086476|NCT02163993|3545572|P1|Post-treatment Period|Protocol Violation|0
1086477|NCT02163993|3545568|P5|Post-treatment Period|Lost to Follow-up|0
1086478|NCT02163993|3545569|P4|Post-treatment Period|Lost to Follow-up|1
1086479|NCT02163993|3545570|P3|Post-treatment Period|Lost to Follow-up|3
1086480|NCT02163993|3545571|P2|Post-treatment Period|Lost to Follow-up|2
1086481|NCT02163993|3545572|P1|Post-treatment Period|Lost to Follow-up|2
1086482|NCT02163993|3545568|P5|Post-treatment Period|Adverse Event|0
1086483|NCT02163993|3545569|P4|Post-treatment Period|Adverse Event|0
1086484|NCT02163993|3545570|P3|Post-treatment Period|Adverse Event|1
1086485|NCT02163993|3545571|P2|Post-treatment Period|Adverse Event|0
1086486|NCT02163993|3545572|P1|Post-treatment Period|Adverse Event|0
1086487|NCT02163993|3545568|P5|Treatment Period|Not treated|2
1086488|NCT02163993|3545569|P4|Treatment Period|Not treated|1
1086489|NCT02163993|3545570|P3|Treatment Period|Not treated|0
1086490|NCT02163993|3545571|P2|Treatment Period|Not treated|0
1086491|NCT02163993|3545572|P1|Treatment Period|Not treated|1
1086492|NCT02163993|3545568|P5|Treatment Period|Withdrawal by Subject|1
1086493|NCT02163993|3545569|P4|Treatment Period|Withdrawal by Subject|4
1086494|NCT02163993|3545570|P3|Treatment Period|Withdrawal by Subject|1
1086495|NCT02163993|3545571|P2|Treatment Period|Withdrawal by Subject|4
1086496|NCT02163993|3545572|P1|Treatment Period|Withdrawal by Subject|6
1086497|NCT02163993|3545568|P5|Treatment Period|Protocol Violation|2
1086498|NCT02163993|3545569|P4|Treatment Period|Protocol Violation|1
1086499|NCT02163993|3545570|P3|Treatment Period|Protocol Violation|0
1086500|NCT02163993|3545571|P2|Treatment Period|Protocol Violation|1
1086501|NCT02163993|3545572|P1|Treatment Period|Protocol Violation|2
1086502|NCT02163993|3545568|P5|Treatment Period|Physician Decision|0
1086503|NCT02163993|3545569|P4|Treatment Period|Physician Decision|0
1086504|NCT02163993|3545570|P3|Treatment Period|Physician Decision|0
1086505|NCT02163993|3545571|P2|Treatment Period|Physician Decision|0
1086506|NCT02163993|3545572|P1|Treatment Period|Physician Decision|1
1086507|NCT02163993|3545568|P5|Treatment Period|Lost to Follow-up|1
1086508|NCT02163993|3545569|P4|Treatment Period|Lost to Follow-up|3
1086509|NCT02163993|3545570|P3|Treatment Period|Lost to Follow-up|1
1086510|NCT02163993|3545571|P2|Treatment Period|Lost to Follow-up|3
1086511|NCT02163993|3545572|P1|Treatment Period|Lost to Follow-up|2
1086512|NCT02163993|3545568|P5|Treatment Period|Adverse Event|1
1086513|NCT02163993|3545569|P4|Treatment Period|Adverse Event|0
1086514|NCT02163993|3545570|P3|Treatment Period|Adverse Event|0
1086515|NCT02163993|3545571|P2|Treatment Period|Adverse Event|1
1086516|NCT02163993|3545572|P1|Treatment Period|Adverse Event|0
1086517|NCT02163915|3545653|P5|Overall Study|Physician Decision|0
1086518|NCT02163915|3545654|P4|Overall Study|Physician Decision|1
1086519|NCT02163915|3545655|P3|Overall Study|Physician Decision|0
1086520|NCT02163915|3545656|P2|Overall Study|Physician Decision|0
1086521|NCT02163915|3545657|P1|Overall Study|Physician Decision|0
1086522|NCT02163915|3545653|P5|Overall Study|Study termination|2
1086523|NCT02163915|3545654|P4|Overall Study|Study termination|0
1086524|NCT02163915|3545655|P3|Overall Study|Study termination|0
1086525|NCT02163915|3545656|P2|Overall Study|Study termination|0
1086526|NCT02163915|3545657|P1|Overall Study|Study termination|1
1086527|NCT02163915|3545653|P5|Overall Study|Withdrawal by Subject|2
1086528|NCT02163915|3545654|P4|Overall Study|Withdrawal by Subject|2
1086529|NCT02163915|3545655|P3|Overall Study|Withdrawal by Subject|2
1086530|NCT02163915|3545656|P2|Overall Study|Withdrawal by Subject|0
1086531|NCT02163915|3545657|P1|Overall Study|Withdrawal by Subject|2
1086532|NCT02163733|3545712|P3|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19
1086533|NCT02163733|3545713|P2|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
1086534|NCT02163733|3545714|P1|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
1086535|NCT02163733|3545712|P3|Part B: Day 15 to End Part B (AZD9291)|Death|5
1086536|NCT02163733|3545713|P2|Part B: Day 15 to End Part B (AZD9291)|Death|0
1086537|NCT02163733|3545714|P1|Part B: Day 15 to End Part B (AZD9291)|Death|0
1086538|NCT02163538|3545751|P2|Overall Study|Physician Decision|1
1086539|NCT02163538|3545752|P1|Overall Study|Physician Decision|0
1086540|NCT02163538|3545751|P2|Overall Study|Protocol Violation|0
1086541|NCT02163538|3545752|P1|Overall Study|Protocol Violation|1
1086542|NCT02163499|3545768|P1|Extended Dosing Phase: ZS|Various reasons|16
1086543|NCT02163499|3545768|P1|Extended Dosing Phase: ZS|Hyperkalemia|5
1086544|NCT02163499|3545768|P1|Extended Dosing Phase: ZS|Subject Compliance|17
1086545|NCT02163499|3545768|P1|Extended Dosing Phase: ZS|Death|8
1086546|NCT02163499|3545768|P1|Extended Dosing Phase: ZS|Protocol Violation|2
1086547|NCT02163499|3545768|P1|Extended Dosing Phase: ZS|Lost to Follow-up|31
1086548|NCT02163499|3545768|P1|Extended Dosing Phase: ZS|Physician Decision|8
1086549|NCT02163499|3545768|P1|Extended Dosing Phase: ZS|Withdrawal by Subject|81
1086550|NCT02163499|3545768|P1|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7
1086551|NCT02163499|3545768|P1|Extended Dosing Phase: ZS|Sponsor's Decision|5
1086552|NCT02163499|3545768|P1|Extended Dosing Phase: ZS|Hypokalemia|9
1086553|NCT02163499|3545768|P1|Extended Dosing Phase: ZS|Expected Progression of CKD|40
1086554|NCT02163499|3545768|P1|Extended Dosing Phase: ZS|Adverse Event|51
1086555|NCT02163499|3545768|P1|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1
1086556|NCT02163499|3545768|P1|Acute Phase: ZS 10 g TID|Physician Decision|1
1086557|NCT02163499|3545768|P1|Acute Phase: ZS 10 g TID|Protocol Violation|1
1086558|NCT02163499|3545768|P1|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1
1086559|NCT02163499|3545768|P1|Acute Phase: ZS 10 g TID|Participant's Compliance|1
1086560|NCT02163447|3545796|P3|Overall Study|Became HIV infected at time of delivery|0
1086561|NCT02163447|3545797|P2|Overall Study|Became HIV infected at time of delivery|0
1086562|NCT02163447|3545798|P1|Overall Study|Became HIV infected at time of delivery|1
1086563|NCT02163447|3545796|P3|Overall Study|Moved out of study area|2
1086564|NCT02163447|3545797|P2|Overall Study|Moved out of study area|3
1086565|NCT02163447|3545798|P1|Overall Study|Moved out of study area|2
1086566|NCT02163447|3545796|P3|Overall Study|Lost to Follow-up|0
1086567|NCT02163447|3545797|P2|Overall Study|Lost to Follow-up|3
1086568|NCT02163447|3545798|P1|Overall Study|Lost to Follow-up|1
1086569|NCT02163447|3545796|P3|Overall Study|Withdrawal by Subject|1
1086570|NCT02163447|3545797|P2|Overall Study|Withdrawal by Subject|0
1086571|NCT02163447|3545798|P1|Overall Study|Withdrawal by Subject|2
1086572|NCT02163395|3545838|P1|Overall Study|Adverse Event|1
1086573|NCT02163395|3545838|P1|Overall Study|Lost to Follow-up|3
1086574|NCT02163395|3545838|P1|Overall Study|Withdrawal by Subject|1
1086575|NCT02163187|3545847|P2|Overall Study|Progressive disease|0
1086576|NCT02163187|3545848|P1|Overall Study|Progressive disease|1
1086577|NCT02163187|3545847|P2|Overall Study|Device removed|0
1086578|NCT02163187|3545848|P1|Overall Study|Device removed|1
1086579|NCT02162862|3545872|P3|Overall Study|Subject did not feel the med was needed|4
1086580|NCT02162862|3545873|P2|Overall Study|Subject did not feel the med was needed|0
1086581|NCT02162862|3545874|P1|Overall Study|Subject did not feel the med was needed|0
1086582|NCT02162862|3545872|P3|Overall Study|Lost to Follow-up|0
1086583|NCT02162862|3545873|P2|Overall Study|Lost to Follow-up|11
1086584|NCT02162862|3545874|P1|Overall Study|Lost to Follow-up|0
1086585|NCT02162758|3545887|P2|Overall Study|Study termination|1
1086586|NCT02162758|3545888|P1|Overall Study|Study termination|0
1086587|NCT02161757|3545922|P3|Treatment Through Study Completion|Death|1
1086588|NCT02161757|3545923|P2|Treatment Through Study Completion|Death|1
1086589|NCT02161757|3545924|P1|Treatment Through Study Completion|Death|2
1086590|NCT02161757|3545922|P3|Treatment Through Study Completion|Other|12
1086591|NCT02161757|3545923|P2|Treatment Through Study Completion|Other|19
1086592|NCT02161757|3545924|P1|Treatment Through Study Completion|Other|20
1086593|NCT02161757|3545922|P3|Treatment Through Study Completion|Lost to Follow-up|4
1086594|NCT02161757|3545923|P2|Treatment Through Study Completion|Lost to Follow-up|2
1086595|NCT02161757|3545924|P1|Treatment Through Study Completion|Lost to Follow-up|7
1086596|NCT02161757|3545922|P3|Treatment Through Study Completion|Withdrawal by Subject|20
1086597|NCT02161757|3545923|P2|Treatment Through Study Completion|Withdrawal by Subject|19
1086598|NCT02161757|3545924|P1|Treatment Through Study Completion|Withdrawal by Subject|27
1086599|NCT02161757|3545922|P3|Treatment Through Study Completion|Protocol Violation|2
1086600|NCT02161757|3545923|P2|Treatment Through Study Completion|Protocol Violation|1
1086601|NCT02161757|3545924|P1|Treatment Through Study Completion|Protocol Violation|0
1086602|NCT02161757|3545922|P3|Treatment Through Study Completion|Adverse Event|0
1086603|NCT02161757|3545923|P2|Treatment Through Study Completion|Adverse Event|1
1086604|NCT02161757|3545924|P1|Treatment Through Study Completion|Adverse Event|1
1086605|NCT02161757|3545922|P3|Randomised Through Start Treatment|Did not receive treatment|0
1086606|NCT02161757|3545923|P2|Randomised Through Start Treatment|Did not receive treatment|2
1086607|NCT02161757|3545924|P1|Randomised Through Start Treatment|Did not receive treatment|3
1086608|NCT02161731|3545982|P2|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1
1086609|NCT02161731|3545983|P1|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0
1086610|NCT02161731|3545982|P2|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1
1086611|NCT02161731|3545983|P1|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0
1086612|NCT02161562|3546002|P2|Overall Study|Participant moved out of province|0
1086613|NCT02161562|3546003|P1|Overall Study|Participant moved out of province|1
1086614|NCT02161562|3546002|P2|Overall Study|Withdrew due to being out of the country|0
1086615|NCT02161562|3546003|P1|Overall Study|Withdrew due to being out of the country|1
1086616|NCT02161562|3546002|P2|Overall Study|Participant moved back to home country|0
1086617|NCT02161562|3546003|P1|Overall Study|Participant moved back to home country|1
1086618|NCT02161562|3546002|P2|Overall Study|Adverse Event|1
1086619|NCT02161562|3546003|P1|Overall Study|Adverse Event|1
1086620|NCT02161562|3546002|P2|Overall Study|Lack of Efficacy|1
1086621|NCT02161562|3546003|P1|Overall Study|Lack of Efficacy|4
1086622|NCT02161562|3546002|P2|Overall Study|Lost to Follow-up|1
1086623|NCT02161562|3546003|P1|Overall Study|Lost to Follow-up|3
1086624|NCT02161562|3546002|P2|Overall Study|Pregnancy|2
1086625|NCT02161562|3546003|P1|Overall Study|Pregnancy|1
1086626|NCT02161562|3546002|P2|Overall Study|Protocol Violation|4
1086627|NCT02161562|3546003|P1|Overall Study|Protocol Violation|9
1086628|NCT02161562|3546002|P2|Overall Study|Withdrawal by Subject|8
1086629|NCT02161562|3546003|P1|Overall Study|Withdrawal by Subject|5
1086630|NCT02161549|3546031|P2|Overall Study|Physician Decision|2
1086631|NCT02161549|3546032|P1|Overall Study|Physician Decision|6
1086632|NCT02161146|3546081|P5|Overall Study|Other Miscellaneous Reasons|0
1086633|NCT02161146|3546082|P4|Overall Study|Other Miscellaneous Reasons|0
1086634|NCT02161146|3546083|P3|Overall Study|Other Miscellaneous Reasons|0
1086635|NCT02161146|3546084|P2|Overall Study|Other Miscellaneous Reasons|1
1086636|NCT02161146|3546085|P1|Overall Study|Other Miscellaneous Reasons|0
1086637|NCT02161146|3546081|P5|Overall Study|Personal Reasons|1
1086638|NCT02161146|3546082|P4|Overall Study|Personal Reasons|2
1086639|NCT02161146|3546083|P3|Overall Study|Personal Reasons|0
1086640|NCT02161146|3546084|P2|Overall Study|Personal Reasons|1
1086641|NCT02161146|3546085|P1|Overall Study|Personal Reasons|0
1086642|NCT02161146|3546081|P5|Overall Study|Lost to Follow-up|0
1086643|NCT02161146|3546082|P4|Overall Study|Lost to Follow-up|0
1086644|NCT02161146|3546083|P3|Overall Study|Lost to Follow-up|0
1086645|NCT02161146|3546084|P2|Overall Study|Lost to Follow-up|1
1086646|NCT02161146|3546085|P1|Overall Study|Lost to Follow-up|0
1086647|NCT02161146|3546081|P5|Overall Study|Adverse Event|0
1086648|NCT02161146|3546082|P4|Overall Study|Adverse Event|1
1086649|NCT02161146|3546083|P3|Overall Study|Adverse Event|0
1086650|NCT02161146|3546084|P2|Overall Study|Adverse Event|1
1086651|NCT02161146|3546085|P1|Overall Study|Adverse Event|1
1086652|NCT02161016|3546098|P1|Overall Study|withdrawn by IRB|1
1086653|NCT02160977|3546129|P2|Six Months After Surgery|Lost to Follow-up|1
1086654|NCT02160977|3546130|P1|Six Months After Surgery|Lost to Follow-up|2
1086655|NCT02160977|3546129|P2|Three Months After Surgery|Lost to Follow-up|2
1086656|NCT02160977|3546130|P1|Three Months After Surgery|Lost to Follow-up|0
1086657|NCT02160977|3546129|P2|Six Weeks After Surgery|Lost to Follow-up|0
1086658|NCT02160977|3546130|P1|Six Weeks After Surgery|Lost to Follow-up|1
1086659|NCT02160626|3546169|P3|Overall Study|Withdrawal by Subject|0
1086660|NCT02160626|3546170|P2|Overall Study|Withdrawal by Subject|1
1086661|NCT02160626|3546171|P1|Overall Study|Withdrawal by Subject|0
1086662|NCT02160626|3546169|P3|Overall Study|Schedule not conducive to study visits|1
1086663|NCT02160626|3546170|P2|Overall Study|Schedule not conducive to study visits|0
1086664|NCT02160626|3546171|P1|Overall Study|Schedule not conducive to study visits|0
1086665|NCT02160626|3546169|P3|Overall Study|Adverse Event|0
1086666|NCT02160626|3546170|P2|Overall Study|Adverse Event|0
1086667|NCT02160626|3546171|P1|Overall Study|Adverse Event|1
1086668|NCT02160314|3546194|P2|Overall Study|Lost to Follow-up|1
1086669|NCT02160314|3546195|P1|Overall Study|Lost to Follow-up|0
1086670|NCT02160314|3546194|P2|Overall Study|Withdrawal by Subject|2
1086671|NCT02160314|3546195|P1|Overall Study|Withdrawal by Subject|1
1086672|NCT02160314|3546194|P2|Overall Study|Protocol Violation|4
1086673|NCT02160314|3546195|P1|Overall Study|Protocol Violation|0
1086674|NCT02160314|3546194|P2|Overall Study|Adverse Event|6
1086675|NCT02160314|3546195|P1|Overall Study|Adverse Event|0
1086676|NCT02160145|3546203|P3|Randomized Double-blind Period|Physician Decision|5
1086677|NCT02160145|3546204|P2|Randomized Double-blind Period|Physician Decision|7
1086678|NCT02160145|3546205|P1|Randomized Double-blind Period|Physician Decision|0
1086679|NCT02160145|3546203|P3|Randomized Double-blind Period|Lost to Follow-up|3
1086680|NCT02160145|3546204|P2|Randomized Double-blind Period|Lost to Follow-up|1
1086681|NCT02160145|3546205|P1|Randomized Double-blind Period|Lost to Follow-up|0
1086682|NCT02160145|3546203|P3|Randomized Double-blind Period|Subject decision|20
1086683|NCT02160145|3546204|P2|Randomized Double-blind Period|Subject decision|21
1086684|NCT02160145|3546205|P1|Randomized Double-blind Period|Subject decision|0
1086685|NCT02160145|3546203|P3|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0
1086686|NCT02160145|3546204|P2|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0
1086864|NCT02153736|3547318|P1|Overall Study|Death|0
1086687|NCT02160145|3546205|P1|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126
1086688|NCT02160145|3546203|P3|Prerandomization Single-blind Period|Placebo run-in failure|0
1086689|NCT02160145|3546204|P2|Prerandomization Single-blind Period|Placebo run-in failure|0
1086690|NCT02160145|3546205|P1|Prerandomization Single-blind Period|Placebo run-in failure|23
1086691|NCT02160002|3546220|P2|Overall Study|Withdrawal by Subject|1
1086692|NCT02160002|3546221|P1|Overall Study|Withdrawal by Subject|2
1086693|NCT02159950|3546253|P2|Overall Study|Progression|1
1086694|NCT02159950|3546254|P1|Overall Study|Progression|0
1086695|NCT02159950|3546253|P2|Overall Study|Adverse Event|1
1086696|NCT02159950|3546254|P1|Overall Study|Adverse Event|0
1086697|NCT02159482|3546326|P1|Overall Study|Physician Decision|3
1086698|NCT02159482|3546326|P1|Overall Study|Withdrawal by Subject|2
1086699|NCT02159469|3546331|P1|Overall Study|Multiple|29
1086700|NCT02159469|3546331|P1|Overall Study|Other|1
1086701|NCT02159469|3546331|P1|Overall Study|Met Stopping Criteria|3
1086702|NCT02159469|3546331|P1|Overall Study|Sponsor's request|2
1086703|NCT02159469|3546331|P1|Overall Study|Lost to Follow-up|1
1086704|NCT02159469|3546331|P1|Overall Study|Withdrawal by Subject|9
1086705|NCT02159469|3546331|P1|Overall Study|Non-compliance|2
1086706|NCT02159469|3546331|P1|Overall Study|Adverse Event|5
1086707|NCT02159469|3546331|P1|Overall Study|Missing Completion status|1
1086708|NCT02159365|3546336|P1|Overall Study|Other|1
1086709|NCT02159365|3546336|P1|Overall Study|Subject Withdrew Consent|1
1086710|NCT02159365|3546336|P1|Overall Study|Subject Request to Discontinue Treatment|1
1086711|NCT02159365|3546336|P1|Overall Study|Study Drug Toxicity|1
1086712|NCT02159365|3546336|P1|Overall Study|Lost to Follow-up|1
1086713|NCT02159365|3546336|P1|Overall Study|Adverse Event Unrelated to Study Drug|6
1086714|NCT02159365|3546336|P1|Overall Study|Disease Progression|11
1086715|NCT02159352|3546342|P2|Overall Study|Withdrawal by Subject|1
1086716|NCT02159352|3546343|P1|Overall Study|Withdrawal by Subject|0
1086717|NCT02159352|3546342|P2|Overall Study|Adverse Event|1
1086718|NCT02159352|3546343|P1|Overall Study|Adverse Event|3
1086719|NCT02159040|3546418|P1|Overall Study|Death|1
1086720|NCT02158975|3546431|P1|Overall Study|Did not complete 1 cycle nor > 1dose|1
1086721|NCT02158936|3546441|P2|Overall Study|Lost to Follow-up|1
1086722|NCT02158936|3546442|P1|Overall Study|Lost to Follow-up|0
1086723|NCT02158936|3546441|P2|Overall Study|Physician Decision|13
1086724|NCT02158936|3546442|P1|Overall Study|Physician Decision|15
1086725|NCT02158936|3546441|P2|Overall Study|Withdrawal by Subject|16
1086726|NCT02158936|3546442|P1|Overall Study|Withdrawal by Subject|15
1086727|NCT02158936|3546441|P2|Overall Study|Adverse Event|24
1086728|NCT02158936|3546442|P1|Overall Study|Adverse Event|39
1086729|NCT02158936|3546441|P2|Overall Study|Azacitidine tx discontinued|46
1086730|NCT02158936|3546442|P1|Overall Study|Azacitidine tx discontinued|53
1086731|NCT02158936|3546441|P2|Overall Study|Study closed/ terminated|77
1086732|NCT02158936|3546442|P1|Overall Study|Study closed/ terminated|57
1086733|NCT02158728|3546484|P1|Overall Study|no qualified dataset|24
1086734|NCT02158728|3546484|P1|Overall Study|no procedure according to CIP done|3
1086735|NCT02158442|3546501|P2|Overall Study|Perfusion staff not available|0
1086736|NCT02158442|3546502|P1|Overall Study|Perfusion staff not available|1
1086737|NCT02158442|3546501|P2|Overall Study|Withdrawal by Subject|0
1086738|NCT02158442|3546502|P1|Overall Study|Withdrawal by Subject|1
1086739|NCT02158364|3546508|P1|Overall Study|Protocol Deviation|50
1086740|NCT02158364|3546508|P1|Overall Study|Case report forms uncollected|10
1086741|NCT02158247|3546526|P1|Overall Study|Invisible vocal cords|5
1086742|NCT02158091|3546545|P3|Overall Study|DLT|0
1086743|NCT02158091|3546546|P2|Overall Study|DLT|1
1086744|NCT02158091|3546547|P1|Overall Study|DLT|2
1086745|NCT02158039|3546555|P1|Overall Study|Screen Failure|9
1086746|NCT02158039|3546555|P1|Overall Study|Withdrawal by Subject|1
1086747|NCT02157948|3546562|P2|Overall Study|Decision by Sponsor|1
1086748|NCT02157948|3546563|P1|Overall Study|Decision by Sponsor|0
1086749|NCT02157948|3546562|P2|Overall Study|Protocol Specified Criteria|1
1086750|NCT02157948|3546563|P1|Overall Study|Protocol Specified Criteria|2
1086751|NCT02157948|3546562|P2|Overall Study|Lost to Follow-up|2
1086752|NCT02157948|3546563|P1|Overall Study|Lost to Follow-up|3
1086753|NCT02157948|3546562|P2|Overall Study|Withdrawal by Subject|5
1086754|NCT02157948|3546563|P1|Overall Study|Withdrawal by Subject|4
1086755|NCT02157935|3546575|P2|Overall Study|Adverse Event|5
1086756|NCT02157935|3546576|P1|Overall Study|Adverse Event|3
1086757|NCT02157935|3546575|P2|Overall Study|Death|4
1086758|NCT02157935|3546576|P1|Overall Study|Death|4
1086759|NCT02157935|3546575|P2|Overall Study|Lack of Efficacy|1
1086760|NCT02157935|3546576|P1|Overall Study|Lack of Efficacy|0
1086761|NCT02157935|3546575|P2|Overall Study|Other|12
1086762|NCT02157935|3546576|P1|Overall Study|Other|5
1086763|NCT02157935|3546575|P2|Overall Study|Progressive disease|2
1086764|NCT02157935|3546576|P1|Overall Study|Progressive disease|0
1086765|NCT02157935|3546575|P2|Overall Study|Protocol Violation|0
1086766|NCT02157935|3546576|P1|Overall Study|Protocol Violation|1
1086767|NCT02157935|3546575|P2|Overall Study|Screen failure|2
1086768|NCT02157935|3546576|P1|Overall Study|Screen failure|1
1086769|NCT02157935|3546575|P2|Overall Study|Withdrawal by Subject|39
1086770|NCT02157935|3546576|P1|Overall Study|Withdrawal by Subject|25
1086771|NCT02157883|3546602|P1|Part B: Day 19 to End Part B (AZD9291)|Death|3
1086772|NCT02157883|3546602|P1|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1
1086773|NCT02157883|3546602|P1|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15
1086774|NCT02157883|3546602|P1|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3
1086775|NCT02157883|3546602|P1|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1
1086776|NCT02157623|3546633|P2|Overall Study|Physician Decision|3
1086777|NCT02157623|3546634|P1|Overall Study|Physician Decision|4
1086778|NCT02157519|3546642|P2|Overall Study|Lost to Follow-up|0
1086779|NCT02157519|3546643|P1|Overall Study|Lost to Follow-up|1
1086780|NCT02157519|3546642|P2|Overall Study|Withdrawal by Subject|0
1086781|NCT02157519|3546643|P1|Overall Study|Withdrawal by Subject|7
1086782|NCT02157519|3546642|P2|Overall Study|Death|1
1086783|NCT02157519|3546643|P1|Overall Study|Death|3
1086784|NCT02157376|3546663|P2|Overall Study|Investigator's misjudgement|2
1086785|NCT02157376|3546664|P1|Overall Study|Investigator's misjudgement|1
1086786|NCT02157376|3546663|P2|Overall Study|Not treated|3
1086787|NCT02157376|3546664|P1|Overall Study|Not treated|8
1086788|NCT02157376|3546663|P2|Overall Study|Withdrawal by Subject|8
1086789|NCT02157376|3546664|P1|Overall Study|Withdrawal by Subject|3
1086790|NCT02157376|3546663|P2|Overall Study|Eligibility criteria not fulfilled|1
1086791|NCT02157376|3546664|P1|Overall Study|Eligibility criteria not fulfilled|0
1086792|NCT02157376|3546663|P2|Overall Study|Death|4
1086793|NCT02157376|3546664|P1|Overall Study|Death|10
1086794|NCT02157298|3546674|P2|Overall Study|Withdrawal by Subject|0
1086795|NCT02157298|3546675|P1|Overall Study|Withdrawal by Subject|1
1086796|NCT02157298|3546674|P2|Overall Study|Poor/Non-compliance|0
1086797|NCT02157298|3546675|P1|Overall Study|Poor/Non-compliance|1
1086798|NCT02157298|3546674|P2|Overall Study|Subject no longer meets study criteria|2
1086799|NCT02157298|3546675|P1|Overall Study|Subject no longer meets study criteria|1
1086800|NCT02157298|3546674|P2|Overall Study|Adverse Event|0
1086801|NCT02157298|3546675|P1|Overall Study|Adverse Event|1
1086802|NCT02157116|3546714|P1|Overall Study|Failed Screening|2
1086803|NCT02157116|3546714|P1|Overall Study|Physician Decision|3
1086804|NCT02157116|3546714|P1|Overall Study|Withdrawal by Subject|4
1086805|NCT02156492|3546732|P3|Period 3|Adverse Event|0
1086806|NCT02156492|3546733|P2|Period 3|Adverse Event|1
1086807|NCT02156492|3546734|P1|Period 3|Adverse Event|0
1086808|NCT02156492|3546732|P3|Period 1|No Reason Given|0
1086809|NCT02156492|3546733|P2|Period 1|No Reason Given|1
1086810|NCT02156492|3546734|P1|Period 1|No Reason Given|0
1086811|NCT02156466|3546760|P5|Overall Study|Quantiferon Positivity|0
1086812|NCT02156466|3546761|P4|Overall Study|Quantiferon Positivity|1
1086813|NCT02156466|3546762|P3|Overall Study|Quantiferon Positivity|0
1086814|NCT02156466|3546763|P2|Overall Study|Quantiferon Positivity|0
1086815|NCT02156466|3546764|P1|Overall Study|Quantiferon Positivity|0
1086816|NCT02156466|3546760|P5|Overall Study|Adverse Event|0
1086817|NCT02156466|3546761|P4|Overall Study|Adverse Event|1
1086818|NCT02156466|3546762|P3|Overall Study|Adverse Event|1
1086819|NCT02156466|3546763|P2|Overall Study|Adverse Event|0
1086820|NCT02156466|3546764|P1|Overall Study|Adverse Event|0
1086821|NCT02156271|3546945|P2|Overall Study|Physician Decision|3
1086822|NCT02156271|3546946|P1|Overall Study|Physician Decision|4
1086823|NCT02155985|3546985|P3|Overall Study|Lost to Follow-up|0
1086824|NCT02155985|3546986|P2|Overall Study|Lost to Follow-up|0
1086825|NCT02155985|3546987|P1|Overall Study|Lost to Follow-up|1
1086826|NCT02155985|3546985|P3|Overall Study|Withdrawal by Subject|1
1086827|NCT02155985|3546986|P2|Overall Study|Withdrawal by Subject|0
1086828|NCT02155985|3546987|P1|Overall Study|Withdrawal by Subject|0
1086829|NCT02155881|3547054|P2|Overall Study|Inappropriately randomized|2
1086830|NCT02155881|3547055|P1|Overall Study|Inappropriately randomized|2
1086831|NCT02155881|3547054|P2|Overall Study|Withdrawal by Subject|2
1086832|NCT02155881|3547055|P1|Overall Study|Withdrawal by Subject|0
1086833|NCT02155738|3547079|P4|Overall Study|Missing critical information|1
1086834|NCT02155738|3547080|P3|Overall Study|Missing critical information|0
1086835|NCT02155738|3547081|P2|Overall Study|Missing critical information|0
1086836|NCT02155738|3547082|P1|Overall Study|Missing critical information|1
1086837|NCT02155322|3547132|P1|Overall Study|Withdrawal by Subject|4
1086838|NCT02155322|3547132|P1|Overall Study|Relapse/Recurrence|8
1086839|NCT02155322|3547132|P1|Overall Study|Physician Decision|1
1086840|NCT02155322|3547132|P1|Overall Study|Adverse Event|1
1086841|NCT02155309|3547139|P3|Overall Study|Protocol Violation|1
1086842|NCT02155309|3547140|P2|Overall Study|Protocol Violation|0
1086843|NCT02155309|3547141|P1|Overall Study|Protocol Violation|0
1086844|NCT02155283|3547148|P1|Overall Study|Protocol Violation|3
1086845|NCT02155283|3547148|P1|Overall Study|Withdrawal by Subject|1
1086846|NCT02155283|3547148|P1|Overall Study|Lost to Follow-up|3
1086847|NCT02154425|3547175|P1|Screening Period|Adverse Event|1
1086848|NCT02154139|3547234|P1|Overall Study|Investigator transferred|3
1086849|NCT02154139|3547234|P1|Overall Study|Other|2
1086850|NCT02154139|3547234|P1|Overall Study|Injection not administered|2
1086851|NCT02154087|3547242|P1|Overall Study|Study Termination|1
1086852|NCT02154061|3547248|P2|Overall Study|enrolled but not vaccinated|0
1086853|NCT02154061|3547249|P1|Overall Study|enrolled but not vaccinated|1
1086854|NCT02154061|3547248|P2|Overall Study|Pregnancy|0
1086855|NCT02154061|3547249|P1|Overall Study|Pregnancy|1
1086856|NCT02153918|3547268|P1|Overall Study|Refused further treatment|1
1086857|NCT02153827|3547279|P2|Overall Study|Lost to Follow-up|9
1086858|NCT02153827|3547280|P1|Overall Study|Lost to Follow-up|3
1086859|NCT02153788|3547296|P2|Overall Study|Physician Decision|1
1086860|NCT02153788|3547297|P1|Overall Study|Physician Decision|2
1086861|NCT02153736|3547317|P2|Overall Study|Withdrawal by Subject|1
1086862|NCT02153736|3547318|P1|Overall Study|Withdrawal by Subject|0
1086863|NCT02153736|3547317|P2|Overall Study|Death|1
1086865|NCT02153736|3547317|P2|Overall Study|Medical status change made ineligible|0
1086866|NCT02153736|3547318|P1|Overall Study|Medical status change made ineligible|1
1086867|NCT02153736|3547317|P2|Overall Study|Lost to Follow-up|0
1086868|NCT02153736|3547318|P1|Overall Study|Lost to Follow-up|1
1086869|NCT02153398|3547396|P5|Overall Study|Adverse Event|0
1086870|NCT02153398|3547397|P4|Overall Study|Adverse Event|1
1086871|NCT02153398|3547398|P3|Overall Study|Adverse Event|1
1086872|NCT02153398|3547399|P2|Overall Study|Adverse Event|0
1086873|NCT02153398|3547400|P1|Overall Study|Adverse Event|0
1086874|NCT02153398|3547396|P5|Overall Study|Withdrawal by Subject|0
1086875|NCT02153398|3547397|P4|Overall Study|Withdrawal by Subject|0
1086876|NCT02153398|3547398|P3|Overall Study|Withdrawal by Subject|0
1086877|NCT02153398|3547399|P2|Overall Study|Withdrawal by Subject|0
1086878|NCT02153398|3547400|P1|Overall Study|Withdrawal by Subject|1
1086879|NCT02153346|3547522|P1|Overall Study|Lost to Follow-up|11
1086880|NCT02153086|3547596|P1|Overall Study|Other|2
1086881|NCT02153086|3547596|P1|Overall Study|Not enrolled >=28 days and <=56 days|2
1086882|NCT02152631|3547612|P2|Overall Study|On Treatment|3
1086883|NCT02152631|3547613|P1|Overall Study|On Treatment|19
1086884|NCT02152631|3547612|P2|Overall Study|Lost to Follow-up|1
1086885|NCT02152631|3547613|P1|Overall Study|Lost to Follow-up|0
1086886|NCT02152631|3547612|P2|Overall Study|Physician Decision|2
1086887|NCT02152631|3547613|P1|Overall Study|Physician Decision|1
1086888|NCT02152631|3547612|P2|Overall Study|Noncompliance with study drug|0
1086889|NCT02152631|3547613|P1|Overall Study|Noncompliance with study drug|1
1086890|NCT02152631|3547612|P2|Overall Study|Withdrawal by Subject|16
1086891|NCT02152631|3547613|P1|Overall Study|Withdrawal by Subject|13
1086892|NCT02152631|3547612|P2|Overall Study|Adverse Event|4
1086893|NCT02152631|3547613|P1|Overall Study|Adverse Event|32
1086894|NCT02152605|3547632|P2|Overall Study|Withdrew consent|2
1086895|NCT02152605|3547633|P1|Overall Study|Withdrew consent|4
1086896|NCT02152605|3547632|P2|Overall Study|Lost to Follow-up|0
1086897|NCT02152605|3547633|P1|Overall Study|Lost to Follow-up|1
1086898|NCT02152605|3547632|P2|Overall Study|Protocol deviation|4
1086899|NCT02152605|3547633|P1|Overall Study|Protocol deviation|1
1086900|NCT02152605|3547632|P2|Overall Study|Lack of Efficacy|4
1086901|NCT02152605|3547633|P1|Overall Study|Lack of Efficacy|7
1086902|NCT02152605|3547632|P2|Overall Study|Adverse Event|8
1086903|NCT02152605|3547633|P1|Overall Study|Adverse Event|6
1086904|NCT02152566|3547643|P1|Overall Study|Withdrawal by Subject|2
1086905|NCT02152566|3547643|P1|Overall Study|Lost to Follow-up|1
1086906|NCT02152371|3547649|P2|Overall Study|Reason Not Given|1
1086907|NCT02152371|3547650|P1|Overall Study|Reason Not Given|0
1086908|NCT02152371|3547649|P2|Overall Study|Physician Decision|2
1086909|NCT02152371|3547650|P1|Overall Study|Physician Decision|0
1086910|NCT02152371|3547649|P2|Overall Study|Lack of Efficacy|1
1086911|NCT02152371|3547650|P1|Overall Study|Lack of Efficacy|0
1086912|NCT02152371|3547649|P2|Overall Study|Lost to Follow-up|0
1086913|NCT02152371|3547650|P1|Overall Study|Lost to Follow-up|1
1086914|NCT02152371|3547649|P2|Overall Study|Protocol Violation|3
1086915|NCT02152371|3547650|P1|Overall Study|Protocol Violation|2
1086916|NCT02152371|3547649|P2|Overall Study|Withdrawal by Subject|7
1086917|NCT02152371|3547650|P1|Overall Study|Withdrawal by Subject|3
1086918|NCT02152371|3547649|P2|Overall Study|Adverse Event|2
1086919|NCT02152371|3547650|P1|Overall Study|Adverse Event|6
1086920|NCT02152007|3547686|P1|Overall Study|Withdrawal by Subject|1
1086921|NCT02151981|3547747|P2|Overall Study|Eligibility criteria not fulfilled|1
1086922|NCT02151981|3547748|P1|Overall Study|Eligibility criteria not fulfilled|0
1086923|NCT02151981|3547747|P2|Overall Study|Ongoing Study at Data Cut-off|95
1086924|NCT02151981|3547748|P1|Overall Study|Ongoing Study at Data Cut-off|224
1086925|NCT02151981|3547747|P2|Overall Study|Withdrawal by Subject|18
1086926|NCT02151981|3547748|P1|Overall Study|Withdrawal by Subject|19
1086927|NCT02151981|3547747|P2|Overall Study|Lost to Follow-up|0
1086928|NCT02151981|3547748|P1|Overall Study|Lost to Follow-up|1
1086929|NCT02151981|3547747|P2|Overall Study|Death|26
1086930|NCT02151981|3547748|P1|Overall Study|Death|35
1086931|NCT02151851|3547766|P2|Overall Study|Adverse Event|28
1086932|NCT02151851|3547767|P1|Overall Study|Adverse Event|6
1086933|NCT02151851|3547766|P2|Overall Study|Subject entered into study in error|1
1086934|NCT02151851|3547767|P1|Overall Study|Subject entered into study in error|0
1086935|NCT02151851|3547766|P2|Overall Study|Low compliance to study visits|1
1086936|NCT02151851|3547767|P1|Overall Study|Low compliance to study visits|0
1086937|NCT02151851|3547766|P2|Overall Study|Medical impairment|0
1086938|NCT02151851|3547767|P1|Overall Study|Medical impairment|1
1086939|NCT02151851|3547766|P2|Overall Study|Withdrawal by Subject|5
1086940|NCT02151851|3547767|P1|Overall Study|Withdrawal by Subject|2
1086941|NCT02151851|3547766|P2|Overall Study|Protocol Violation|1
1086942|NCT02151851|3547767|P1|Overall Study|Protocol Violation|0
1086943|NCT02151851|3547766|P2|Overall Study|Lack of Efficacy|94
1086944|NCT02151851|3547767|P1|Overall Study|Lack of Efficacy|67
1086945|NCT02151786|3547779|P1|Overall Study|Unavailability of Information|8
1086946|NCT02151786|3547779|P1|Overall Study|Randomized, not Treated|1
1086947|NCT02151786|3547779|P1|Overall Study|Outside the Contract Period|1
1086948|NCT02151786|3547779|P1|Overall Study|Unavailability of Case Report Form|26
1086949|NCT02151773|3547790|P1|Overall Study|Protocol Deviation|64
1086950|NCT02151643|3547800|P5|Overall Study|High Ferritin levels|1
1086951|NCT02151643|3547801|P4|Overall Study|High Ferritin levels|2
1086952|NCT02151643|3547802|P3|Overall Study|High Ferritin levels|2
1086953|NCT02151643|3547803|P2|Overall Study|High Ferritin levels|3
1086954|NCT02151643|3547804|P1|Overall Study|High Ferritin levels|3
1086955|NCT02151643|3547800|P5|Overall Study|Hyperphosphataemia|1
1086956|NCT02151643|3547801|P4|Overall Study|Hyperphosphataemia|0
1086957|NCT02151643|3547802|P3|Overall Study|Hyperphosphataemia|0
1086958|NCT02151643|3547803|P2|Overall Study|Hyperphosphataemia|0
1086959|NCT02151643|3547804|P1|Overall Study|Hyperphosphataemia|1
1086960|NCT02151643|3547800|P5|Overall Study|Withdrawal by Subject|1
1086961|NCT02151643|3547801|P4|Overall Study|Withdrawal by Subject|1
1086962|NCT02151643|3547802|P3|Overall Study|Withdrawal by Subject|1
1086963|NCT02151643|3547803|P2|Overall Study|Withdrawal by Subject|1
1086964|NCT02151643|3547804|P1|Overall Study|Withdrawal by Subject|0
1086965|NCT02151643|3547800|P5|Overall Study|Adverse Event|0
1086966|NCT02151643|3547801|P4|Overall Study|Adverse Event|4
1086967|NCT02151643|3547802|P3|Overall Study|Adverse Event|1
1086968|NCT02151643|3547803|P2|Overall Study|Adverse Event|0
1086969|NCT02151643|3547804|P1|Overall Study|Adverse Event|2
1086970|NCT02151461|3547845|P4|Overall Study|Treatment discontinuation|0
1086971|NCT02151461|3547846|P3|Overall Study|Treatment discontinuation|1
1086972|NCT02151461|3547847|P2|Overall Study|Treatment discontinuation|0
1086973|NCT02151461|3547848|P1|Overall Study|Treatment discontinuation|0
1086974|NCT02151461|3547845|P4|Overall Study|Withdrawal by Subject|1
1086975|NCT02151461|3547846|P3|Overall Study|Withdrawal by Subject|1
1086976|NCT02151461|3547847|P2|Overall Study|Withdrawal by Subject|0
1086977|NCT02151461|3547848|P1|Overall Study|Withdrawal by Subject|1
1086978|NCT02151461|3547845|P4|Overall Study|Lost to Follow-up|1
1086979|NCT02151461|3547846|P3|Overall Study|Lost to Follow-up|1
1086980|NCT02151461|3547847|P2|Overall Study|Lost to Follow-up|0
1086981|NCT02151461|3547848|P1|Overall Study|Lost to Follow-up|0
1086982|NCT02151461|3547845|P4|Overall Study|Adverse Event|2
1086983|NCT02151461|3547846|P3|Overall Study|Adverse Event|0
1086984|NCT02151461|3547847|P2|Overall Study|Adverse Event|1
1086985|NCT02151461|3547848|P1|Overall Study|Adverse Event|5
1086986|NCT02151149|3547918|P2|Follow-Up Period|Death|34
1086987|NCT02151149|3547919|P1|Follow-Up Period|Death|37
1086988|NCT02151149|3547918|P2|Follow-Up Period|Lost to Follow-up|3
1086989|NCT02151149|3547919|P1|Follow-Up Period|Lost to Follow-up|2
1086990|NCT02151149|3547918|P2|Treatment Period|Participants randomized but not treated|2
1086991|NCT02151149|3547919|P1|Treatment Period|Participants randomized but not treated|3
1086992|NCT02151149|3547918|P2|Treatment Period|Miscellaneous|7
1086993|NCT02151149|3547919|P1|Treatment Period|Miscellaneous|8
1086994|NCT02151149|3547918|P2|Treatment Period|Withdrawal by Subject|11
1086995|NCT02151149|3547919|P1|Treatment Period|Withdrawal by Subject|13
1086996|NCT02151149|3547918|P2|Treatment Period|Symptomatic Deterioration|10
1086997|NCT02151149|3547919|P1|Treatment Period|Symptomatic Deterioration|2
1086998|NCT02151149|3547918|P2|Treatment Period|Progressive Disease|24
1086999|NCT02151149|3547919|P1|Treatment Period|Progressive Disease|25
1087000|NCT02151149|3547918|P2|Treatment Period|Adverse Event|14
1087001|NCT02151149|3547919|P1|Treatment Period|Adverse Event|17
1087002|NCT02151149|3547918|P2|Treatment Period|Death|3
1087003|NCT02151149|3547919|P1|Treatment Period|Death|2
1087004|NCT02151058|3547946|P3|Overall Study|Lost to Follow-up|2
1087005|NCT02151058|3547947|P2|Overall Study|Lost to Follow-up|0
1087006|NCT02151058|3547948|P1|Overall Study|Lost to Follow-up|1
1087007|NCT02151058|3547946|P3|Overall Study|Withdrawal by Subject|3
1087008|NCT02151058|3547947|P2|Overall Study|Withdrawal by Subject|1
1087009|NCT02151058|3547948|P1|Overall Study|Withdrawal by Subject|1
1087010|NCT02150954|3547982|P2|Overall Study|Protocol Violation|0
1087011|NCT02150954|3547983|P1|Overall Study|Protocol Violation|1
1087012|NCT02150343|3548059|P4|Overall Study|Not specified|2
1087013|NCT02150343|3548060|P3|Overall Study|Not specified|0
1087014|NCT02150343|3548061|P2|Overall Study|Not specified|6
1087015|NCT02150343|3548062|P1|Overall Study|Not specified|2
1087016|NCT02150343|3548059|P4|Overall Study|Lost to Follow-up|3
1087017|NCT02150343|3548060|P3|Overall Study|Lost to Follow-up|2
1087018|NCT02150343|3548061|P2|Overall Study|Lost to Follow-up|4
1087019|NCT02150343|3548062|P1|Overall Study|Lost to Follow-up|4
1087020|NCT02150343|3548059|P4|Overall Study|Withdrawal by Subject|4
1087021|NCT02150343|3548060|P3|Overall Study|Withdrawal by Subject|9
1087022|NCT02150343|3548061|P2|Overall Study|Withdrawal by Subject|10
1087023|NCT02150343|3548062|P1|Overall Study|Withdrawal by Subject|13
1087024|NCT02150343|3548059|P4|Overall Study|Adverse Event|1
1087025|NCT02150343|3548060|P3|Overall Study|Adverse Event|1
1087026|NCT02150343|3548061|P2|Overall Study|Adverse Event|0
1087027|NCT02150343|3548062|P1|Overall Study|Adverse Event|2
1087028|NCT02150213|3548100|P1|Overall Study|Withdrawal by Subject|1
1087029|NCT02150213|3548100|P1|Overall Study|Lost to Follow-up|1
1087030|NCT02149875|3548126|P3|Overall Study|Physician Decision|2
1087031|NCT02149875|3548127|P2|Overall Study|Physician Decision|2
1087032|NCT02149875|3548128|P1|Overall Study|Physician Decision|1
1087033|NCT02149875|3548126|P3|Overall Study|Withdrawal by Subject|2
1087034|NCT02149875|3548127|P2|Overall Study|Withdrawal by Subject|2
1087035|NCT02149875|3548128|P1|Overall Study|Withdrawal by Subject|3
1087036|NCT02149875|3548126|P3|Overall Study|Lost to Follow-up|5
1087037|NCT02149875|3548127|P2|Overall Study|Lost to Follow-up|4
1087038|NCT02149875|3548128|P1|Overall Study|Lost to Follow-up|3
1087039|NCT02149264|3548174|P1|Overall Study|Protocol Violation|1
1087040|NCT02149264|3548174|P1|Overall Study|Physician Decision|3
1087041|NCT02149264|3548174|P1|Overall Study|Adverse Event|7
1087042|NCT02149264|3548174|P1|Overall Study|Withdrawal by Subject|9
1087043|NCT02149108|3548189|P2|Overall Study|Lost to Follow-up|0
1087044|NCT02149108|3548190|P1|Overall Study|Lost to Follow-up|1
1087045|NCT02149108|3548189|P2|Overall Study|Refusal to continue trial medication|11
1087046|NCT02149108|3548190|P1|Overall Study|Refusal to continue trial medication|15
1087047|NCT02149108|3548189|P2|Overall Study|Other not defined above|2
1087048|NCT02149108|3548190|P1|Overall Study|Other not defined above|0
1087049|NCT02149108|3548189|P2|Overall Study|Other Adverse Event (AE)|18
1087050|NCT02149108|3548190|P1|Overall Study|Other Adverse Event (AE)|8
1087051|NCT02149108|3548189|P2|Overall Study|Worsening/adverse event cancer disease|32
1087052|NCT02149108|3548190|P1|Overall Study|Worsening/adverse event cancer disease|31
1087053|NCT02149108|3548189|P2|Overall Study|Progressive Disease (PD)|318
1087054|NCT02149108|3548190|P1|Overall Study|Progressive Disease (PD)|324
1087055|NCT02149108|3548189|P2|Overall Study|Not treated|2
1087056|NCT02149108|3548190|P1|Overall Study|Not treated|1
1087057|NCT02148718|3548216|P1|Overall Study|Discontinued Study Prematurely|5
1087058|NCT02148718|3548216|P1|Overall Study|Protocol Violation|26
1087059|NCT02148445|3548264|P2|Overall Study|Death|3
1087060|NCT02148445|3548265|P1|Overall Study|Death|1
1087061|NCT02147691|3548340|P2|Overall Study|Lost to Follow-up|1
1087062|NCT02147691|3548341|P1|Overall Study|Lost to Follow-up|0
1087063|NCT02147691|3548340|P2|Overall Study|Adverse Event|0
1087064|NCT02147691|3548341|P1|Overall Study|Adverse Event|2
1087065|NCT02147691|3548340|P2|Overall Study|Withdrawal by Subject|0
1087066|NCT02147691|3548341|P1|Overall Study|Withdrawal by Subject|2
1087067|NCT02147587|3548387|P2|Overall Study|Lack of Efficacy|1
1087068|NCT02147587|3548388|P1|Overall Study|Lack of Efficacy|2
1087069|NCT02147587|3548387|P2|Overall Study|Adverse Event|4
1087070|NCT02147587|3548388|P1|Overall Study|Adverse Event|9
1087071|NCT02147561|3548408|P1|Overall Study|Subjects who didn’t receive BOTOX|1
1087072|NCT02147561|3548408|P1|Overall Study|Lost to Follow-up|3
1087073|NCT02147288|3548429|P10|Overall Study|complications from concurrent hernia rep|0
1087074|NCT02147288|3548430|P9|Overall Study|complications from concurrent hernia rep|0
1087075|NCT02147288|3548431|P8|Overall Study|complications from concurrent hernia rep|0
1087076|NCT02147288|3548432|P7|Overall Study|complications from concurrent hernia rep|0
1087077|NCT02147288|3548433|P6|Overall Study|complications from concurrent hernia rep|0
1087078|NCT02147288|3548434|P5|Overall Study|complications from concurrent hernia rep|0
1087079|NCT02147288|3548435|P4|Overall Study|complications from concurrent hernia rep|0
1087080|NCT02147288|3548436|P3|Overall Study|complications from concurrent hernia rep|0
1087081|NCT02147288|3548437|P2|Overall Study|complications from concurrent hernia rep|1
1087082|NCT02147288|3548438|P1|Overall Study|complications from concurrent hernia rep|0
1087083|NCT02147288|3548429|P10|Overall Study|post-operative hematoma|0
1087084|NCT02147288|3548430|P9|Overall Study|post-operative hematoma|0
1087085|NCT02147288|3548431|P8|Overall Study|post-operative hematoma|0
1087086|NCT02147288|3548432|P7|Overall Study|post-operative hematoma|0
1087087|NCT02147288|3548433|P6|Overall Study|post-operative hematoma|0
1087088|NCT02147288|3548434|P5|Overall Study|post-operative hematoma|0
1087089|NCT02147288|3548435|P4|Overall Study|post-operative hematoma|0
1087090|NCT02147288|3548436|P3|Overall Study|post-operative hematoma|0
1087091|NCT02147288|3548437|P2|Overall Study|post-operative hematoma|1
1087092|NCT02147288|3548438|P1|Overall Study|post-operative hematoma|1
1087093|NCT02147184|3548446|P2|Overall Study|Other|0
1087094|NCT02147184|3548447|P1|Overall Study|Other|1
1087095|NCT02147184|3548446|P2|Overall Study|Physician Decision|2
1087096|NCT02147184|3548447|P1|Overall Study|Physician Decision|0
1087097|NCT02147184|3548446|P2|Overall Study|Moved out of state|3
1087098|NCT02147184|3548447|P1|Overall Study|Moved out of state|3
1087099|NCT02147184|3548446|P2|Overall Study|Pregnancy|0
1087100|NCT02147184|3548447|P1|Overall Study|Pregnancy|6
1087101|NCT02147184|3548446|P2|Overall Study|Study Burden|7
1087102|NCT02147184|3548447|P1|Overall Study|Study Burden|11
1087103|NCT02147184|3548446|P2|Overall Study|Lost to Follow-up|15
1087104|NCT02147184|3548447|P1|Overall Study|Lost to Follow-up|28
1087105|NCT02147132|3548465|P4|Overall Study|Lost to Follow-up|0
1087106|NCT02147132|3548466|P3|Overall Study|Lost to Follow-up|0
1087107|NCT02147132|3548467|P2|Overall Study|Lost to Follow-up|0
1087108|NCT02147132|3548468|P1|Overall Study|Lost to Follow-up|1
1087109|NCT02147093|3548488|P2|Period 2|Protocol Violation|0
1087110|NCT02147093|3548489|P1|Period 2|Protocol Violation|2
1087111|NCT02147093|3548488|P2|Period 1|Lost to Follow-up|1
1087112|NCT02147093|3548489|P1|Period 1|Lost to Follow-up|0
1087113|NCT02146599|3548497|P1|Overall Study|Failed to meet inclusion criteria|5
1087114|NCT02146352|3548510|P1|Overall Study|Patient entered hospice care|1
1087115|NCT02146352|3548510|P1|Overall Study|Death|1
1087116|NCT02146326|3548528|P4|Overall Study|Unable to complete interview|6
1087117|NCT02146326|3548529|P3|Overall Study|Unable to complete interview|10
1087118|NCT02146326|3548530|P2|Overall Study|Unable to complete interview|0
1087119|NCT02146326|3548531|P1|Overall Study|Unable to complete interview|0
1087120|NCT02146326|3548528|P4|Overall Study|Death|4
1087121|NCT02146326|3548529|P3|Overall Study|Death|4
1087122|NCT02146326|3548530|P2|Overall Study|Death|0
1087123|NCT02146326|3548531|P1|Overall Study|Death|0
1087124|NCT02146326|3548528|P4|Overall Study|Incarcerated|8
1087125|NCT02146326|3548529|P3|Overall Study|Incarcerated|3
1087126|NCT02146326|3548530|P2|Overall Study|Incarcerated|0
1087127|NCT02146326|3548531|P1|Overall Study|Incarcerated|0
1087128|NCT02146326|3548528|P4|Overall Study|Separated from mental health center|0
1087129|NCT02146326|3548529|P3|Overall Study|Separated from mental health center|0
1087130|NCT02146326|3548530|P2|Overall Study|Separated from mental health center|33
1087131|NCT02146326|3548531|P1|Overall Study|Separated from mental health center|23
1087132|NCT02146326|3548528|P4|Overall Study|Withdrawal by Subject|11
1087133|NCT02146326|3548529|P3|Overall Study|Withdrawal by Subject|15
1087134|NCT02146326|3548530|P2|Overall Study|Withdrawal by Subject|1
1087135|NCT02146326|3548531|P1|Overall Study|Withdrawal by Subject|2
1087136|NCT02146326|3548528|P4|Overall Study|Lost to Follow-up|19
1087137|NCT02146326|3548529|P3|Overall Study|Lost to Follow-up|11
1087138|NCT02146326|3548530|P2|Overall Study|Lost to Follow-up|3
1087139|NCT02146326|3548531|P1|Overall Study|Lost to Follow-up|3
1087140|NCT02146248|3548693|P1|Overall Study|Withdrawal by Subject|2
1087141|NCT02146131|3548703|P2|Overall Study|Physician Decision|56
1087142|NCT02146131|3548704|P1|Overall Study|Physician Decision|61
1087143|NCT02146105|3548710|P1|Overall Study|Withdrawal by Subject|5
1087144|NCT02146105|3548710|P1|Overall Study|Adverse Event|1
1087145|NCT02145468|3548761|P2|Overall Study|Withdrawal by Subject|8
1087146|NCT02145468|3548762|P1|Overall Study|Withdrawal by Subject|5
1087147|NCT02145390|3548818|P1|Overall Study|Withdrawal by Subject|1
1087148|NCT02145182|3548858|P2|Overall Study|Withdrawal by Subject|4
1087149|NCT02145182|3548859|P1|Overall Study|Withdrawal by Subject|5
1087150|NCT02145182|3548858|P2|Overall Study|Pre-transplant Withdrawal|2
1087151|NCT02145182|3548859|P1|Overall Study|Pre-transplant Withdrawal|0
1087152|NCT02145182|3548858|P2|Overall Study|Lost to Follow-up|2
1087153|NCT02145182|3548859|P1|Overall Study|Lost to Follow-up|2
1087154|NCT02145182|3548858|P2|Overall Study|Death|7
1087155|NCT02145182|3548859|P1|Overall Study|Death|7
1087156|NCT02145182|3548858|P2|Overall Study|Adverse Event|1
1087157|NCT02145182|3548859|P1|Overall Study|Adverse Event|4
1087158|NCT02145156|3548876|P3|Overall Study|No match to vaccination records|41
1087159|NCT02145156|3548877|P2|Overall Study|No match to vaccination records|52
1087160|NCT02145156|3548878|P1|Overall Study|No match to vaccination records|60
1087161|NCT02144701|3548943|P2|Overall Study|development of relapse, GVHD or death|3
1087162|NCT02144701|3548944|P1|Overall Study|development of relapse, GVHD or death|9
1087163|NCT02144337|3548982|P2|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0
1087164|NCT02144337|3548983|P1|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1
1087165|NCT02144337|3548982|P2|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0
1087166|NCT02144337|3548983|P1|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2
1087167|NCT02144337|3548982|P2|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0
1087168|NCT02144337|3548983|P1|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1
1087169|NCT02144337|3548982|P2|T2 Follow-up (Post-intervention)|Lost to Follow-up|0
1087170|NCT02144337|3548983|P1|T2 Follow-up (Post-intervention)|Lost to Follow-up|2
1087171|NCT02144337|3548982|P2|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
1087172|NCT02144337|3548983|P1|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
1087173|NCT02144220|3549012|P1|Overall Study|Protocol Violation|1
1087174|NCT02144220|3549012|P1|Overall Study|Withdrawal by Subject|2
1087175|NCT02144220|3549012|P1|Overall Study|Physician Decision|3
1087176|NCT02144220|3549012|P1|Overall Study|Lack of Efficacy|4
1087177|NCT02144220|3549012|P1|Overall Study|technology incompatibility|9
1087178|NCT02144012|3549022|P2|Overall Study|Other|0
1087179|NCT02144012|3549023|P1|Overall Study|Other|3
1087180|NCT02144012|3549022|P2|Overall Study|Study Terminated by Sponsor|12
1087181|NCT02144012|3549023|P1|Overall Study|Study Terminated by Sponsor|18
1087182|NCT02144012|3549022|P2|Overall Study|Withdrawal by Subject|3
1087183|NCT02144012|3549023|P1|Overall Study|Withdrawal by Subject|11
1087184|NCT02144012|3549022|P2|Overall Study|Death|0
1087185|NCT02144012|3549023|P1|Overall Study|Death|1
1087186|NCT02144012|3549022|P2|Overall Study|Adverse Event|0
1087187|NCT02144012|3549023|P1|Overall Study|Adverse Event|1
1087188|NCT02143947|3549060|P2|Overall Study|Lost to Follow-up|2
1087189|NCT02143947|3549061|P1|Overall Study|Lost to Follow-up|4
1087190|NCT02143713|3549077|P4|Post-treatment Follow-up (12 Months)|Other|7
1087191|NCT02143713|3549078|P3|Post-treatment Follow-up (12 Months)|Other|7
1087192|NCT02143713|3549079|P2|Post-treatment Follow-up (12 Months)|Other|4
1087193|NCT02143713|3549080|P1|Post-treatment Follow-up (12 Months)|Other|3
1087194|NCT02143713|3549077|P4|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1
1087195|NCT02143713|3549078|P3|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0
1087196|NCT02143713|3549079|P2|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1
1087197|NCT02143713|3549080|P1|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0
1087198|NCT02143713|3549077|P4|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1
1087199|NCT02143713|3549078|P3|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4
1087200|NCT02143713|3549079|P2|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4
1087201|NCT02143713|3549080|P1|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2
1087202|NCT02143713|3549077|P4|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8
1087203|NCT02143713|3549078|P3|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11
1087204|NCT02143713|3549079|P2|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8
1087205|NCT02143713|3549080|P1|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3
1087206|NCT02143713|3549077|P4|Post-treatment Follow-up (12 Months)|Adverse Event|0
1087207|NCT02143713|3549078|P3|Post-treatment Follow-up (12 Months)|Adverse Event|1
1087208|NCT02143713|3549079|P2|Post-treatment Follow-up (12 Months)|Adverse Event|0
1087209|NCT02143713|3549080|P1|Post-treatment Follow-up (12 Months)|Adverse Event|0
1087210|NCT02143713|3549077|P4|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10
1087211|NCT02143713|3549078|P3|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
1087212|NCT02143713|3549079|P2|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7
1087213|NCT02143713|3549080|P1|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4
1087214|NCT02143713|3549077|P4|Treatment Period (6 Months)|Lack of Efficacy|1
1087215|NCT02143713|3549078|P3|Treatment Period (6 Months)|Lack of Efficacy|0
1087216|NCT02143713|3549079|P2|Treatment Period (6 Months)|Lack of Efficacy|0
1087217|NCT02143713|3549080|P1|Treatment Period (6 Months)|Lack of Efficacy|1
1087218|NCT02143713|3549077|P4|Treatment Period (6 Months)|Exclusionary Medication|0
1087219|NCT02143713|3549078|P3|Treatment Period (6 Months)|Exclusionary Medication|0
1087220|NCT02143713|3549079|P2|Treatment Period (6 Months)|Exclusionary Medication|0
1087221|NCT02143713|3549080|P1|Treatment Period (6 Months)|Exclusionary Medication|2
1087222|NCT02143713|3549077|P4|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4
1087223|NCT02143713|3549078|P3|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
1087224|NCT02143713|3549079|P2|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
1087225|NCT02143713|3549080|P1|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
1087226|NCT02143713|3549077|P4|Treatment Period (6 Months)|Other|2
1087227|NCT02143713|3549078|P3|Treatment Period (6 Months)|Other|3
1087228|NCT02143713|3549079|P2|Treatment Period (6 Months)|Other|0
1087229|NCT02143713|3549080|P1|Treatment Period (6 Months)|Other|3
1087230|NCT02143713|3549077|P4|Treatment Period (6 Months)|Non-compliance|3
1087231|NCT02143713|3549078|P3|Treatment Period (6 Months)|Non-compliance|0
1087232|NCT02143713|3549079|P2|Treatment Period (6 Months)|Non-compliance|0
1087233|NCT02143713|3549080|P1|Treatment Period (6 Months)|Non-compliance|1
1087234|NCT02143713|3549077|P4|Treatment Period (6 Months)|Pregnancy|0
1087235|NCT02143713|3549078|P3|Treatment Period (6 Months)|Pregnancy|2
1087236|NCT02143713|3549079|P2|Treatment Period (6 Months)|Pregnancy|2
1087237|NCT02143713|3549080|P1|Treatment Period (6 Months)|Pregnancy|0
1087238|NCT02143713|3549077|P4|Treatment Period (6 Months)|Surgery or Invasive Intervention|2
1087239|NCT02143713|3549078|P3|Treatment Period (6 Months)|Surgery or Invasive Intervention|0
1087240|NCT02143713|3549079|P2|Treatment Period (6 Months)|Surgery or Invasive Intervention|0
1087241|NCT02143713|3549080|P1|Treatment Period (6 Months)|Surgery or Invasive Intervention|2
1087242|NCT02143713|3549077|P4|Treatment Period (6 Months)|Lost to Follow-up|3
1087243|NCT02143713|3549078|P3|Treatment Period (6 Months)|Lost to Follow-up|4
1087244|NCT02143713|3549079|P2|Treatment Period (6 Months)|Lost to Follow-up|0
1087245|NCT02143713|3549080|P1|Treatment Period (6 Months)|Lost to Follow-up|3
1087246|NCT02143713|3549077|P4|Treatment Period (6 Months)|Adverse Event|9
1087247|NCT02143713|3549078|P3|Treatment Period (6 Months)|Adverse Event|8
1087248|NCT02143713|3549079|P2|Treatment Period (6 Months)|Adverse Event|8
1087249|NCT02143713|3549080|P1|Treatment Period (6 Months)|Adverse Event|7
1087250|NCT02143713|3549077|P4|Treatment Period (6 Months)|Withdrawal by Subject|4
1087251|NCT02143713|3549078|P3|Treatment Period (6 Months)|Withdrawal by Subject|5
1087252|NCT02143713|3549079|P2|Treatment Period (6 Months)|Withdrawal by Subject|2
1087253|NCT02143713|3549080|P1|Treatment Period (6 Months)|Withdrawal by Subject|1
1087254|NCT02143583|3549161|P3|Overall Study|husband illness|1
1087255|NCT02143583|3549162|P2|Overall Study|husband illness|0
1087256|NCT02143583|3549163|P1|Overall Study|husband illness|0
1087257|NCT02143583|3549161|P3|Overall Study|Withdrawal by Subject|1
1087258|NCT02143583|3549162|P2|Overall Study|Withdrawal by Subject|0
1087259|NCT02143583|3549163|P1|Overall Study|Withdrawal by Subject|1
1087260|NCT02143141|3549176|P2|Overall Study|pain scores at 24 hours not collected|0
1087261|NCT02143141|3549177|P1|Overall Study|pain scores at 24 hours not collected|1
1087262|NCT02143102|3549189|P2|Overall Study|Lost to Follow-up|0
1087263|NCT02143102|3549190|P1|Overall Study|Lost to Follow-up|11
1087264|NCT02142738|3549200|P2|Overall Study|Ongoing in Study|82
1087265|NCT02142738|3549201|P1|Overall Study|Ongoing in Study|107
1087266|NCT02142738|3549200|P2|Overall Study|Withdrawal by Subject|5
1087267|NCT02142738|3549201|P1|Overall Study|Withdrawal by Subject|5
1087268|NCT02142738|3549200|P2|Overall Study|Progressive Disease|1
1087269|NCT02142738|3549201|P1|Overall Study|Progressive Disease|0
1087270|NCT02142738|3549200|P2|Overall Study|Death|55
1087271|NCT02142738|3549201|P1|Overall Study|Death|33
1087272|NCT02142738|3549200|P2|Overall Study|Adverse Event|8
1087273|NCT02142738|3549201|P1|Overall Study|Adverse Event|9
1087274|NCT02142712|3549214|P4|Overall Study|Lost to Follow-up|0
1087275|NCT02142712|3549215|P3|Overall Study|Lost to Follow-up|1
1087276|NCT02142712|3549216|P2|Overall Study|Lost to Follow-up|1
1087277|NCT02142712|3549217|P1|Overall Study|Lost to Follow-up|1
1087278|NCT02142504|3549240|P3|Overall Study|Reason Not Specified|4
1087279|NCT02142504|3549241|P2|Overall Study|Reason Not Specified|5
1087280|NCT02142504|3549242|P1|Overall Study|Reason Not Specified|4
1087281|NCT02142504|3549240|P3|Overall Study|Physician Decision|3
1087282|NCT02142504|3549241|P2|Overall Study|Physician Decision|1
1087283|NCT02142504|3549242|P1|Overall Study|Physician Decision|0
1087284|NCT02142504|3549240|P3|Overall Study|Pregnancy|2
1087285|NCT02142504|3549241|P2|Overall Study|Pregnancy|4
1087286|NCT02142504|3549242|P1|Overall Study|Pregnancy|4
1087287|NCT02142504|3549240|P3|Overall Study|Withdrawal by Subject|11
1087288|NCT02142504|3549241|P2|Overall Study|Withdrawal by Subject|9
1087289|NCT02142504|3549242|P1|Overall Study|Withdrawal by Subject|7
1087290|NCT02142504|3549240|P3|Overall Study|Lost to Follow-up|17
1087291|NCT02142504|3549241|P2|Overall Study|Lost to Follow-up|19
1087292|NCT02142504|3549242|P1|Overall Study|Lost to Follow-up|12
1087293|NCT02142504|3549240|P3|Overall Study|Adverse Event|4
1087294|NCT02142504|3549241|P2|Overall Study|Adverse Event|3
1087295|NCT02142504|3549242|P1|Overall Study|Adverse Event|2
1087296|NCT02142504|3549240|P3|Overall Study|Protocol Violation|2
1087297|NCT02142504|3549241|P2|Overall Study|Protocol Violation|1
1087298|NCT02142504|3549242|P1|Overall Study|Protocol Violation|2
1087299|NCT02142283|3549431|P2|Overall Study|Withdrawal by Subject|3
1087300|NCT02142283|3549432|P1|Overall Study|Withdrawal by Subject|1
1087301|NCT02142283|3549431|P2|Overall Study|Death|18
1087302|NCT02142283|3549432|P1|Overall Study|Death|20
1087303|NCT02141997|3549507|P4|Overall Study|Not specified|0
1087304|NCT02141997|3549508|P3|Overall Study|Not specified|0
1087305|NCT02141997|3549509|P2|Overall Study|Not specified|4
1087306|NCT02141997|3549510|P1|Overall Study|Not specified|1
1087307|NCT02141997|3549507|P4|Overall Study|Withdrew consent|0
1087308|NCT02141997|3549508|P3|Overall Study|Withdrew consent|3
1087309|NCT02141997|3549509|P2|Overall Study|Withdrew consent|0
1087310|NCT02141997|3549510|P1|Overall Study|Withdrew consent|1
1087311|NCT02141997|3549507|P4|Overall Study|Participant noncompliance|0
1087312|NCT02141997|3549508|P3|Overall Study|Participant noncompliance|0
1087313|NCT02141997|3549509|P2|Overall Study|Participant noncompliance|0
1087314|NCT02141997|3549510|P1|Overall Study|Participant noncompliance|1
1087315|NCT02141997|3549507|P4|Overall Study|Adverse Event|1
1087316|NCT02141997|3549508|P3|Overall Study|Adverse Event|0
1087317|NCT02141997|3549509|P2|Overall Study|Adverse Event|2
1087318|NCT02141997|3549510|P1|Overall Study|Adverse Event|0
1087319|NCT02141984|3549548|P1|Overall Study|Lack of Efficacy|2
1087320|NCT02141854|3549567|P6|Treatment Period|Lost to Follow-up|1
1087321|NCT02141854|3549568|P5|Treatment Period|Lost to Follow-up|0
1087322|NCT02141854|3549569|P4|Treatment Period|Lost to Follow-up|1
1087323|NCT02141854|3549570|P3|Treatment Period|Lost to Follow-up|1
1087324|NCT02141854|3549571|P2|Treatment Period|Lost to Follow-up|1
1087325|NCT02141854|3549572|P1|Treatment Period|Lost to Follow-up|0
1087326|NCT02141854|3549567|P6|Treatment Period|Disease progression|18
1087327|NCT02141854|3549568|P5|Treatment Period|Disease progression|0
1087328|NCT02141854|3549569|P4|Treatment Period|Disease progression|3
1087329|NCT02141854|3549570|P3|Treatment Period|Disease progression|1
1087330|NCT02141854|3549571|P2|Treatment Period|Disease progression|2
1087331|NCT02141854|3549572|P1|Treatment Period|Disease progression|0
1087332|NCT02141854|3549567|P6|Treatment Period|Withdrawal by Subject|7
1087333|NCT02141854|3549568|P5|Treatment Period|Withdrawal by Subject|4
1087334|NCT02141854|3549569|P4|Treatment Period|Withdrawal by Subject|3
1087335|NCT02141854|3549570|P3|Treatment Period|Withdrawal by Subject|3
1087336|NCT02141854|3549571|P2|Treatment Period|Withdrawal by Subject|2
1087337|NCT02141854|3549572|P1|Treatment Period|Withdrawal by Subject|0
1087338|NCT02141854|3549567|P6|Treatment Period|Adverse Event|2
1087339|NCT02141854|3549568|P5|Treatment Period|Adverse Event|2
1087340|NCT02141854|3549569|P4|Treatment Period|Adverse Event|0
1087341|NCT02141854|3549570|P3|Treatment Period|Adverse Event|2
1087342|NCT02141854|3549571|P2|Treatment Period|Adverse Event|2
1087343|NCT02141854|3549572|P1|Treatment Period|Adverse Event|0
1087344|NCT02141854|3549567|P6|Treatment Period|Not specified|2
1087345|NCT02141854|3549568|P5|Treatment Period|Not specified|1
1087346|NCT02141854|3549569|P4|Treatment Period|Not specified|0
1087347|NCT02141854|3549570|P3|Treatment Period|Not specified|2
1087348|NCT02141854|3549571|P2|Treatment Period|Not specified|1
1087349|NCT02141854|3549572|P1|Treatment Period|Not specified|0
1087350|NCT02141854|3549567|P6|Treatment Period|Pregnancy|0
1087351|NCT02141854|3549568|P5|Treatment Period|Pregnancy|0
1087352|NCT02141854|3549569|P4|Treatment Period|Pregnancy|0
1087353|NCT02141854|3549570|P3|Treatment Period|Pregnancy|0
1087354|NCT02141854|3549571|P2|Treatment Period|Pregnancy|1
1087355|NCT02141854|3549572|P1|Treatment Period|Pregnancy|0
1087356|NCT02141854|3549567|P6|Treatment Period|Lack of Efficacy|7
1087357|NCT02141854|3549568|P5|Treatment Period|Lack of Efficacy|1
1087358|NCT02141854|3549569|P4|Treatment Period|Lack of Efficacy|1
1087359|NCT02141854|3549570|P3|Treatment Period|Lack of Efficacy|0
1087360|NCT02141854|3549571|P2|Treatment Period|Lack of Efficacy|0
1087361|NCT02141854|3549572|P1|Treatment Period|Lack of Efficacy|0
1087362|NCT02141854|3549567|P6|Treatment Period|Noncompliance|0
1087363|NCT02141854|3549568|P5|Treatment Period|Noncompliance|0
1087364|NCT02141854|3549569|P4|Treatment Period|Noncompliance|1
1087365|NCT02141854|3549570|P3|Treatment Period|Noncompliance|0
1087366|NCT02141854|3549571|P2|Treatment Period|Noncompliance|0
1087367|NCT02141854|3549572|P1|Treatment Period|Noncompliance|0
1087368|NCT02141854|3549567|P6|Treatment Period|Protocol Violation|1
1087369|NCT02141854|3549568|P5|Treatment Period|Protocol Violation|2
1087370|NCT02141854|3549569|P4|Treatment Period|Protocol Violation|2
1087371|NCT02141854|3549570|P3|Treatment Period|Protocol Violation|0
1087372|NCT02141854|3549571|P2|Treatment Period|Protocol Violation|1
1087373|NCT02141854|3549572|P1|Treatment Period|Protocol Violation|0
1087374|NCT02141854|3549567|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1087375|NCT02141854|3549568|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1087376|NCT02141854|3549569|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1087377|NCT02141854|3549570|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1087378|NCT02141854|3549571|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1087379|NCT02141854|3549572|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|6
1087380|NCT02141854|3549567|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1087381|NCT02141854|3549568|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1087382|NCT02141854|3549569|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1087383|NCT02141854|3549570|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1087384|NCT02141854|3549571|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1087385|NCT02141854|3549572|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|9
1087386|NCT02141854|3549567|P6|Run-In Period (Pre-assignment)|Adverse Event|0
1087387|NCT02141854|3549568|P5|Run-In Period (Pre-assignment)|Adverse Event|0
1087388|NCT02141854|3549569|P4|Run-In Period (Pre-assignment)|Adverse Event|0
1087389|NCT02141854|3549570|P3|Run-In Period (Pre-assignment)|Adverse Event|0
1087390|NCT02141854|3549571|P2|Run-In Period (Pre-assignment)|Adverse Event|0
1087391|NCT02141854|3549572|P1|Run-In Period (Pre-assignment)|Adverse Event|10
1087392|NCT02141854|3549567|P6|Run-In Period (Pre-assignment)|Not specified|0
1087393|NCT02141854|3549568|P5|Run-In Period (Pre-assignment)|Not specified|0
1087394|NCT02141854|3549569|P4|Run-In Period (Pre-assignment)|Not specified|0
1087395|NCT02141854|3549570|P3|Run-In Period (Pre-assignment)|Not specified|0
1087396|NCT02141854|3549571|P2|Run-In Period (Pre-assignment)|Not specified|0
1087397|NCT02141854|3549572|P1|Run-In Period (Pre-assignment)|Not specified|14
1087398|NCT02141854|3549567|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1087399|NCT02141854|3549568|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1087400|NCT02141854|3549569|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1087401|NCT02141854|3549570|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1087402|NCT02141854|3549571|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1087403|NCT02141854|3549572|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|14
1087404|NCT02141854|3549567|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1087405|NCT02141854|3549568|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1087406|NCT02141854|3549569|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1087407|NCT02141854|3549570|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1087408|NCT02141854|3549571|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1087409|NCT02141854|3549572|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|76
1087410|NCT02141854|3549567|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1087411|NCT02141854|3549568|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1087412|NCT02141854|3549569|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1087413|NCT02141854|3549570|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1087414|NCT02141854|3549571|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1087415|NCT02141854|3549572|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|25
1087416|NCT02141659|3549630|P6|Overall Study|Pretreatment Event/ Adverse Event|1
1087417|NCT02141659|3549631|P5|Overall Study|Pretreatment Event/ Adverse Event|2
1087418|NCT02141659|3549632|P4|Overall Study|Pretreatment Event/ Adverse Event|0
1087419|NCT02141659|3549633|P3|Overall Study|Pretreatment Event/ Adverse Event|0
1087420|NCT02141659|3549634|P2|Overall Study|Pretreatment Event/ Adverse Event|0
1087421|NCT02141659|3549635|P1|Overall Study|Pretreatment Event/ Adverse Event|0
1087422|NCT02141659|3549630|P6|Overall Study|Lack of Efficacy|1
1087423|NCT02141659|3549631|P5|Overall Study|Lack of Efficacy|0
1087424|NCT02141659|3549632|P4|Overall Study|Lack of Efficacy|0
1087425|NCT02141659|3549633|P3|Overall Study|Lack of Efficacy|0
1087426|NCT02141659|3549634|P2|Overall Study|Lack of Efficacy|0
1087427|NCT02141659|3549635|P1|Overall Study|Lack of Efficacy|0
1087428|NCT02141659|3549630|P6|Overall Study|Major Protocol Deviation|0
1087429|NCT02141659|3549631|P5|Overall Study|Major Protocol Deviation|0
1087430|NCT02141659|3549632|P4|Overall Study|Major Protocol Deviation|0
1087431|NCT02141659|3549633|P3|Overall Study|Major Protocol Deviation|0
1087432|NCT02141659|3549634|P2|Overall Study|Major Protocol Deviation|1
1087433|NCT02141659|3549635|P1|Overall Study|Major Protocol Deviation|0
1087434|NCT02141633|3549691|P2|Overall Study|Physician Decision|0
1087435|NCT02141633|3549692|P1|Overall Study|Physician Decision|1
1087436|NCT02141620|3549700|P2|Treatment Condition 1 (7 Days)|Adverse Event|0
1087437|NCT02141620|3549701|P1|Treatment Condition 1 (7 Days)|Adverse Event|1
1087438|NCT02141516|3549778|P3|Overall Study|Other|0
1087439|NCT02141516|3549779|P2|Overall Study|Other|3
1087440|NCT02141516|3549780|P1|Overall Study|Other|0
1087441|NCT02141516|3549778|P3|Overall Study|Lost to Follow-up|0
1087442|NCT02141516|3549779|P2|Overall Study|Lost to Follow-up|1
1087443|NCT02141516|3549780|P1|Overall Study|Lost to Follow-up|0
1087444|NCT02141516|3549778|P3|Overall Study|Adverse Event|0
1087445|NCT02141516|3549779|P2|Overall Study|Adverse Event|1
1087446|NCT02141516|3549780|P1|Overall Study|Adverse Event|0
1087447|NCT02141399|3549828|P1|Overall Study|Failure to meet eligibility criteria|14
1087448|NCT02141399|3549828|P1|Overall Study|Withdrawal by Subject|238
1087449|NCT02141399|3549828|P1|Overall Study|Protocol Violation|38
1087450|NCT02141399|3549828|P1|Overall Study|Pregnancy|3
1087451|NCT02141399|3549828|P1|Overall Study|Physician Decision|17
1087452|NCT02141399|3549828|P1|Overall Study|Not specified|45
1087453|NCT02141399|3549828|P1|Overall Study|Non-compliance with study drug|18
1087454|NCT02141399|3549828|P1|Overall Study|Lost to Follow-up|151
1087455|NCT02141399|3549828|P1|Overall Study|Lack of Efficacy|62
1087456|NCT02141399|3549828|P1|Overall Study|Adverse Event|158
1087457|NCT02141360|3549834|P3|Overall Study|Study Terminated before Visit|0
1087458|NCT02141360|3549835|P2|Overall Study|Study Terminated before Visit|0
1087459|NCT02141360|3549836|P1|Overall Study|Study Terminated before Visit|1
1087460|NCT02141360|3549834|P3|Overall Study|Withdrawal by Subject|0
1087461|NCT02141360|3549835|P2|Overall Study|Withdrawal by Subject|0
1087462|NCT02141360|3549836|P1|Overall Study|Withdrawal by Subject|6
1087463|NCT02141217|3549846|P2|Overall Study|Surgical Intervention|1
1087464|NCT02141217|3549847|P1|Overall Study|Surgical Intervention|1
1087465|NCT02141217|3549846|P2|Overall Study|Physician Decision|0
1087466|NCT02141217|3549847|P1|Overall Study|Physician Decision|1
1087467|NCT02141217|3549846|P2|Overall Study|Lost to Follow-up|1
1087468|NCT02141217|3549847|P1|Overall Study|Lost to Follow-up|1
1087469|NCT02141217|3549846|P2|Overall Study|Withdrawal by Subject|0
1087470|NCT02141217|3549847|P1|Overall Study|Withdrawal by Subject|6
1087471|NCT02141217|3549846|P2|Overall Study|Protocol Violation|4
1087472|NCT02141217|3549847|P1|Overall Study|Protocol Violation|1
1087473|NCT02141217|3549846|P2|Overall Study|Adverse Event|2
1087474|NCT02141217|3549847|P1|Overall Study|Adverse Event|1
1087475|NCT02140762|3549909|P2|Overall Study|Other|1
1087476|NCT02140762|3549910|P1|Overall Study|Other|0
1087477|NCT02140762|3549909|P2|Overall Study|Withdrawal by Subject|4
1087478|NCT02140762|3549910|P1|Overall Study|Withdrawal by Subject|6
1087479|NCT02140762|3549909|P2|Overall Study|Protocol Violation|1
1087480|NCT02140762|3549910|P1|Overall Study|Protocol Violation|1
1087481|NCT02140762|3549909|P2|Overall Study|Lost to Follow-up|5
1087482|NCT02140762|3549910|P1|Overall Study|Lost to Follow-up|9
1087483|NCT02140762|3549909|P2|Overall Study|Adverse Event|1
1087484|NCT02140762|3549910|P1|Overall Study|Adverse Event|1
1087485|NCT02140645|3549976|P6|Overall Study|Not linked|70896
1087486|NCT02140645|3549977|P5|Overall Study|Not linked|3286
1087487|NCT02140645|3549978|P4|Overall Study|Not linked|13833
1087488|NCT02140645|3549979|P3|Overall Study|Not linked|4236
1087489|NCT02140645|3549980|P2|Overall Study|Not linked|61654
1087490|NCT02140645|3549981|P1|Overall Study|Not linked|5489
1087491|NCT02140567|3550079|P1|Overall Study|Problems with recording equipment|6
1087492|NCT02140164|3550095|P1|Overall Study|Cystoid Macular Edema (CME) resolved|2
1087493|NCT02140060|3550116|P6|Overall Study|Lack of Efficacy|0
1087494|NCT02140060|3550117|P5|Overall Study|Lack of Efficacy|0
1087495|NCT02140060|3550118|P4|Overall Study|Lack of Efficacy|1
1087496|NCT02140060|3550119|P3|Overall Study|Lack of Efficacy|0
1087497|NCT02140060|3550120|P2|Overall Study|Lack of Efficacy|0
1087498|NCT02140060|3550121|P1|Overall Study|Lack of Efficacy|0
1087499|NCT02140060|3550116|P6|Overall Study|Adverse Event|1
1087500|NCT02140060|3550117|P5|Overall Study|Adverse Event|1
1087501|NCT02140060|3550118|P4|Overall Study|Adverse Event|1
1087502|NCT02140060|3550119|P3|Overall Study|Adverse Event|0
1087503|NCT02140060|3550120|P2|Overall Study|Adverse Event|0
1087504|NCT02140060|3550121|P1|Overall Study|Adverse Event|0
1087505|NCT02139982|3550146|P10|Overall Study|Lack of Efficacy|0
1087506|NCT02139982|3550147|P9|Overall Study|Lack of Efficacy|0
1087507|NCT02139982|3550148|P8|Overall Study|Lack of Efficacy|0
1087508|NCT02139982|3550149|P7|Overall Study|Lack of Efficacy|0
1087509|NCT02139982|3550150|P6|Overall Study|Lack of Efficacy|0
1087510|NCT02139982|3550151|P5|Overall Study|Lack of Efficacy|0
1087511|NCT02139982|3550152|P4|Overall Study|Lack of Efficacy|1
1087512|NCT02139982|3550153|P3|Overall Study|Lack of Efficacy|0
1087513|NCT02139982|3550154|P2|Overall Study|Lack of Efficacy|1
1087514|NCT02139982|3550155|P1|Overall Study|Lack of Efficacy|0
1087515|NCT02139943|3550200|P3|Overall Study|eGFR Withdrawal Criteria|1
1087516|NCT02139943|3550201|P2|Overall Study|eGFR Withdrawal Criteria|0
1087517|NCT02139943|3550202|P1|Overall Study|eGFR Withdrawal Criteria|0
1087518|NCT02139943|3550200|P3|Overall Study|Participant in Poor Compliance|1
1087519|NCT02139943|3550201|P2|Overall Study|Participant in Poor Compliance|0
1087520|NCT02139943|3550202|P1|Overall Study|Participant in Poor Compliance|1
1087521|NCT02139943|3550200|P3|Overall Study|Participant wishes to discontinue|0
1087522|NCT02139943|3550201|P2|Overall Study|Participant wishes to discontinue|0
1087523|NCT02139943|3550202|P1|Overall Study|Participant wishes to discontinue|2
1087524|NCT02139943|3550200|P3|Overall Study|Other|1
1087525|NCT02139943|3550201|P2|Overall Study|Other|0
1087526|NCT02139943|3550202|P1|Overall Study|Other|0
1087527|NCT02139943|3550200|P3|Overall Study|Withdrawal by Subject|0
1087528|NCT02139943|3550201|P2|Overall Study|Withdrawal by Subject|3
1087529|NCT02139943|3550202|P1|Overall Study|Withdrawal by Subject|4
1087530|NCT02139943|3550200|P3|Overall Study|Lost to Follow-up|2
1087531|NCT02139943|3550201|P2|Overall Study|Lost to Follow-up|2
1087532|NCT02139943|3550202|P1|Overall Study|Lost to Follow-up|3
1087533|NCT02139943|3550200|P3|Overall Study|Adverse Event|2
1087534|NCT02139943|3550201|P2|Overall Study|Adverse Event|1
1087535|NCT02139943|3550202|P1|Overall Study|Adverse Event|0
1087536|NCT02139644|3550227|P6|Treatment Period|Not specified|1
1087537|NCT02139644|3550228|P5|Treatment Period|Not specified|0
1087538|NCT02139644|3550229|P4|Treatment Period|Not specified|1
1087539|NCT02139644|3550230|P3|Treatment Period|Not specified|1
1087540|NCT02139644|3550231|P2|Treatment Period|Not specified|3
1087541|NCT02139644|3550232|P1|Treatment Period|Not specified|0
1087542|NCT02139644|3550227|P6|Treatment Period|Lack of Efficacy|4
1087543|NCT02139644|3550228|P5|Treatment Period|Lack of Efficacy|1
1087544|NCT02139644|3550229|P4|Treatment Period|Lack of Efficacy|0
1087545|NCT02139644|3550230|P3|Treatment Period|Lack of Efficacy|1
1087546|NCT02139644|3550231|P2|Treatment Period|Lack of Efficacy|0
1087547|NCT02139644|3550232|P1|Treatment Period|Lack of Efficacy|0
1087548|NCT02139644|3550227|P6|Treatment Period|Lost to Follow-up|1
1087549|NCT02139644|3550228|P5|Treatment Period|Lost to Follow-up|1
1087550|NCT02139644|3550229|P4|Treatment Period|Lost to Follow-up|1
1087551|NCT02139644|3550230|P3|Treatment Period|Lost to Follow-up|1
1087552|NCT02139644|3550231|P2|Treatment Period|Lost to Follow-up|0
1087553|NCT02139644|3550232|P1|Treatment Period|Lost to Follow-up|0
1087554|NCT02139644|3550227|P6|Treatment Period|Disease progression|2
1087555|NCT02139644|3550228|P5|Treatment Period|Disease progression|1
1087556|NCT02139644|3550229|P4|Treatment Period|Disease progression|1
1087557|NCT02139644|3550230|P3|Treatment Period|Disease progression|0
1087558|NCT02139644|3550231|P2|Treatment Period|Disease progression|0
1087559|NCT02139644|3550232|P1|Treatment Period|Disease progression|0
1087560|NCT02139644|3550227|P6|Treatment Period|Protocol Violation|1
1087561|NCT02139644|3550228|P5|Treatment Period|Protocol Violation|1
1087562|NCT02139644|3550229|P4|Treatment Period|Protocol Violation|1
1087563|NCT02139644|3550230|P3|Treatment Period|Protocol Violation|0
1087564|NCT02139644|3550231|P2|Treatment Period|Protocol Violation|0
1087565|NCT02139644|3550232|P1|Treatment Period|Protocol Violation|0
1087566|NCT02139644|3550227|P6|Treatment Period|Non-compliance|0
1087567|NCT02139644|3550228|P5|Treatment Period|Non-compliance|0
1087568|NCT02139644|3550229|P4|Treatment Period|Non-compliance|1
1087569|NCT02139644|3550230|P3|Treatment Period|Non-compliance|0
1087570|NCT02139644|3550231|P2|Treatment Period|Non-compliance|0
1087571|NCT02139644|3550232|P1|Treatment Period|Non-compliance|0
1087572|NCT02139644|3550227|P6|Treatment Period|Withdrawal by Subject|2
1087573|NCT02139644|3550228|P5|Treatment Period|Withdrawal by Subject|3
1087574|NCT02139644|3550229|P4|Treatment Period|Withdrawal by Subject|2
1087575|NCT02139644|3550230|P3|Treatment Period|Withdrawal by Subject|2
1087576|NCT02139644|3550231|P2|Treatment Period|Withdrawal by Subject|0
1087577|NCT02139644|3550232|P1|Treatment Period|Withdrawal by Subject|0
1087578|NCT02139644|3550227|P6|Treatment Period|Adverse Event|6
1087579|NCT02139644|3550228|P5|Treatment Period|Adverse Event|1
1087580|NCT02139644|3550229|P4|Treatment Period|Adverse Event|2
1087581|NCT02139644|3550230|P3|Treatment Period|Adverse Event|3
1087582|NCT02139644|3550231|P2|Treatment Period|Adverse Event|0
1087583|NCT02139644|3550232|P1|Treatment Period|Adverse Event|0
1087584|NCT02139644|3550227|P6|Run-In Period (Pre-assignment)|Not specified|0
1087585|NCT02139644|3550228|P5|Run-In Period (Pre-assignment)|Not specified|0
1087586|NCT02139644|3550229|P4|Run-In Period (Pre-assignment)|Not specified|0
1087587|NCT02139644|3550230|P3|Run-In Period (Pre-assignment)|Not specified|0
1087588|NCT02139644|3550231|P2|Run-In Period (Pre-assignment)|Not specified|0
1087589|NCT02139644|3550232|P1|Run-In Period (Pre-assignment)|Not specified|6
1087590|NCT02139644|3550227|P6|Run-In Period (Pre-assignment)|Adverse Event|0
1087591|NCT02139644|3550228|P5|Run-In Period (Pre-assignment)|Adverse Event|0
1087592|NCT02139644|3550229|P4|Run-In Period (Pre-assignment)|Adverse Event|0
1087593|NCT02139644|3550230|P3|Run-In Period (Pre-assignment)|Adverse Event|0
1087594|NCT02139644|3550231|P2|Run-In Period (Pre-assignment)|Adverse Event|0
1087595|NCT02139644|3550232|P1|Run-In Period (Pre-assignment)|Adverse Event|3
1087596|NCT02139644|3550227|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1087597|NCT02139644|3550228|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1087598|NCT02139644|3550229|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1087599|NCT02139644|3550230|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1087600|NCT02139644|3550231|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1087601|NCT02139644|3550232|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|8
1087602|NCT02139644|3550227|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1087603|NCT02139644|3550228|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1087604|NCT02139644|3550229|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1087605|NCT02139644|3550230|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1087606|NCT02139644|3550231|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1087607|NCT02139644|3550232|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|11
1087608|NCT02139644|3550227|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1087609|NCT02139644|3550228|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1087610|NCT02139644|3550229|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1087611|NCT02139644|3550230|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1087612|NCT02139644|3550231|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1087613|NCT02139644|3550232|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|12
1087614|NCT02139644|3550227|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1087615|NCT02139644|3550228|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1087616|NCT02139644|3550229|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1087617|NCT02139644|3550230|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1087618|NCT02139644|3550231|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1087619|NCT02139644|3550232|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|30
1087620|NCT02139644|3550227|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1087621|NCT02139644|3550228|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1087622|NCT02139644|3550229|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1087623|NCT02139644|3550230|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1087624|NCT02139644|3550231|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1087625|NCT02139644|3550232|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|70
1087626|NCT02139046|3550337|P5|Overall Study|Other Miscellaneous Reasons|12
1087627|NCT02139046|3550338|P4|Overall Study|Other Miscellaneous Reasons|9
1087628|NCT02139046|3550339|P3|Overall Study|Other Miscellaneous Reasons|4
1087629|NCT02139046|3550340|P2|Overall Study|Other Miscellaneous Reasons|9
1087630|NCT02139046|3550341|P1|Overall Study|Other Miscellaneous Reasons|10
1087631|NCT02139046|3550337|P5|Overall Study|Withdrawal due to a Gout Flare|1
1087632|NCT02139046|3550338|P4|Overall Study|Withdrawal due to a Gout Flare|0
1087633|NCT02139046|3550339|P3|Overall Study|Withdrawal due to a Gout Flare|1
1087634|NCT02139046|3550340|P2|Overall Study|Withdrawal due to a Gout Flare|1
1087635|NCT02139046|3550341|P1|Overall Study|Withdrawal due to a Gout Flare|1
1087636|NCT02139046|3550337|P5|Overall Study|Lack of Efficacy|2
1087637|NCT02139046|3550338|P4|Overall Study|Lack of Efficacy|1
1087638|NCT02139046|3550339|P3|Overall Study|Lack of Efficacy|2
1087639|NCT02139046|3550340|P2|Overall Study|Lack of Efficacy|1
1087640|NCT02139046|3550341|P1|Overall Study|Lack of Efficacy|0
1087641|NCT02139046|3550337|P5|Overall Study|Voluntary Withdrawal|16
1087642|NCT02139046|3550338|P4|Overall Study|Voluntary Withdrawal|15
1087643|NCT02139046|3550339|P3|Overall Study|Voluntary Withdrawal|10
1087644|NCT02139046|3550340|P2|Overall Study|Voluntary Withdrawal|8
1087645|NCT02139046|3550341|P1|Overall Study|Voluntary Withdrawal|20
1087646|NCT02139046|3550337|P5|Overall Study|Lost to Follow-up|13
1087647|NCT02139046|3550338|P4|Overall Study|Lost to Follow-up|18
1087648|NCT02139046|3550339|P3|Overall Study|Lost to Follow-up|16
1087649|NCT02139046|3550340|P2|Overall Study|Lost to Follow-up|16
1087650|NCT02139046|3550341|P1|Overall Study|Lost to Follow-up|13
1087651|NCT02139046|3550337|P5|Overall Study|Major Protocol Deviation|6
1087652|NCT02139046|3550338|P4|Overall Study|Major Protocol Deviation|12
1087653|NCT02139046|3550339|P3|Overall Study|Major Protocol Deviation|16
1087654|NCT02139046|3550340|P2|Overall Study|Major Protocol Deviation|10
1087655|NCT02139046|3550341|P1|Overall Study|Major Protocol Deviation|9
1087656|NCT02139046|3550337|P5|Overall Study|Pretreatment Event/Adverse Event|7
1087657|NCT02139046|3550338|P4|Overall Study|Pretreatment Event/Adverse Event|13
1087658|NCT02139046|3550339|P3|Overall Study|Pretreatment Event/Adverse Event|10
1087659|NCT02139046|3550340|P2|Overall Study|Pretreatment Event/Adverse Event|9
1087660|NCT02139046|3550341|P1|Overall Study|Pretreatment Event/Adverse Event|9
1087661|NCT02138838|3550381|P2|Overall Study|Withdrawal by Subject|5
1087662|NCT02138838|3550382|P1|Overall Study|Withdrawal by Subject|1
1087663|NCT02138838|3550381|P2|Overall Study|Study Closure|6
1087664|NCT02138838|3550382|P1|Overall Study|Study Closure|7
1087665|NCT02138825|3550400|P2|Safety Follow-up|withdrawn due to lung transplant|1
1087666|NCT02138825|3550401|P1|Safety Follow-up|withdrawn due to lung transplant|0
1087667|NCT02138825|3550400|P2|Safety Follow-up|treatment unblinded|1
1087668|NCT02138825|3550401|P1|Safety Follow-up|treatment unblinded|0
1087669|NCT02138825|3550400|P2|Safety Follow-up|too unwell to attend the visit|1
1087670|NCT02138825|3550401|P1|Safety Follow-up|too unwell to attend the visit|0
1087671|NCT02138825|3550400|P2|Safety Follow-up|progressive disease|2
1087672|NCT02138825|3550401|P1|Safety Follow-up|progressive disease|0
1087673|NCT02138825|3550400|P2|Safety Follow-up|logistical difficulties|1
1087674|NCT02138825|3550401|P1|Safety Follow-up|logistical difficulties|0
1087675|NCT02138825|3550400|P2|Safety Follow-up|withdrawal by PI|0
1087676|NCT02138825|3550401|P1|Safety Follow-up|withdrawal by PI|1
1087677|NCT02138825|3550400|P2|Safety Follow-up|clinic worsening|0
1087678|NCT02138825|3550401|P1|Safety Follow-up|clinic worsening|1
1087679|NCT02138825|3550400|P2|Safety Follow-up|Withdrawal by Subject|3
1087680|NCT02138825|3550401|P1|Safety Follow-up|Withdrawal by Subject|5
1087681|NCT02138825|3550400|P2|Safety Follow-up|Death|5
1087682|NCT02138825|3550401|P1|Safety Follow-up|Death|11
1087683|NCT02138825|3550400|P2|Safety Follow-up|Adverse Event|3
1087684|NCT02138825|3550401|P1|Safety Follow-up|Adverse Event|4
1087685|NCT02138825|3550400|P2|Long-term Extension|Study termination by sponsor|38
1087686|NCT02138825|3550401|P1|Long-term Extension|Study termination by sponsor|32
1087687|NCT02138825|3550400|P2|Main Study Treatment|Medical decision|0
1087688|NCT02138825|3550401|P1|Main Study Treatment|Medical decision|1
1087689|NCT02138825|3550400|P2|Main Study Treatment|Withdrawal by Subject|1
1087690|NCT02138825|3550401|P1|Main Study Treatment|Withdrawal by Subject|3
1087691|NCT02138825|3550400|P2|Main Study Treatment|Study terminated by sponsor|9
1087692|NCT02138825|3550401|P1|Main Study Treatment|Study terminated by sponsor|10
1087693|NCT02138825|3550400|P2|Main Study Treatment|Sponsor decision|18
1087694|NCT02138825|3550401|P1|Main Study Treatment|Sponsor decision|12
1087695|NCT02138825|3550400|P2|Main Study Treatment|Protocol Violation|2
1087696|NCT02138825|3550401|P1|Main Study Treatment|Protocol Violation|2
1087697|NCT02138825|3550400|P2|Main Study Treatment|Death|2
1087698|NCT02138825|3550401|P1|Main Study Treatment|Death|1
1087699|NCT02138825|3550400|P2|Main Study Treatment|Adverse Event|3
1087700|NCT02138825|3550401|P1|Main Study Treatment|Adverse Event|11
1087701|NCT02138747|3550419|P4|Treatment Period 2|Other - Miscellaneous|0
1087702|NCT02138747|3550420|P3|Treatment Period 2|Other - Miscellaneous|0
1087703|NCT02138747|3550421|P2|Treatment Period 2|Other - Miscellaneous|0
1087704|NCT02138747|3550422|P1|Treatment Period 2|Other - Miscellaneous|3
1087705|NCT02138747|3550419|P4|Treatment Period 2|Withdrawal by Subject|2
1087706|NCT02138747|3550420|P3|Treatment Period 2|Withdrawal by Subject|1
1087707|NCT02138747|3550421|P2|Treatment Period 2|Withdrawal by Subject|4
1087708|NCT02138747|3550422|P1|Treatment Period 2|Withdrawal by Subject|5
1087709|NCT02138747|3550419|P4|Treatment Period 2|Protocol Violation|0
1087710|NCT02138747|3550420|P3|Treatment Period 2|Protocol Violation|0
1087711|NCT02138747|3550421|P2|Treatment Period 2|Protocol Violation|0
1087712|NCT02138747|3550422|P1|Treatment Period 2|Protocol Violation|1
1087713|NCT02138747|3550419|P4|Treatment Period 2|Lost to Follow-up|0
1087714|NCT02138747|3550420|P3|Treatment Period 2|Lost to Follow-up|0
1087715|NCT02138747|3550421|P2|Treatment Period 2|Lost to Follow-up|0
1087716|NCT02138747|3550422|P1|Treatment Period 2|Lost to Follow-up|2
1087717|NCT02138747|3550419|P4|Treatment Period 2|Adverse Event|1
1087718|NCT02138747|3550420|P3|Treatment Period 2|Adverse Event|1
1087719|NCT02138747|3550421|P2|Treatment Period 2|Adverse Event|3
1087720|NCT02138747|3550422|P1|Treatment Period 2|Adverse Event|6
1087721|NCT02138747|3550419|P4|Treatment Period 1|Other - Miscellaneous|0
1087722|NCT02138747|3550420|P3|Treatment Period 1|Other - Miscellaneous|0
1087723|NCT02138747|3550421|P2|Treatment Period 1|Other - Miscellaneous|4
1087724|NCT02138747|3550422|P1|Treatment Period 1|Other - Miscellaneous|2
1087725|NCT02138747|3550419|P4|Treatment Period 1|Withdrawal by Subject|3
1087726|NCT02138747|3550420|P3|Treatment Period 1|Withdrawal by Subject|1
1087727|NCT02138747|3550421|P2|Treatment Period 1|Withdrawal by Subject|4
1087728|NCT02138747|3550422|P1|Treatment Period 1|Withdrawal by Subject|8
1087729|NCT02138747|3550419|P4|Treatment Period 1|Protocol Violation|0
1087730|NCT02138747|3550420|P3|Treatment Period 1|Protocol Violation|0
1087731|NCT02138747|3550421|P2|Treatment Period 1|Protocol Violation|2
1087732|NCT02138747|3550422|P1|Treatment Period 1|Protocol Violation|0
1087733|NCT02138747|3550419|P4|Treatment Period 1|Lost to Follow-up|0
1087734|NCT02138747|3550420|P3|Treatment Period 1|Lost to Follow-up|1
1087735|NCT02138747|3550421|P2|Treatment Period 1|Lost to Follow-up|1
1087736|NCT02138747|3550422|P1|Treatment Period 1|Lost to Follow-up|0
1087737|NCT02138747|3550419|P4|Treatment Period 1|Adverse Event|1
1087738|NCT02138747|3550420|P3|Treatment Period 1|Adverse Event|2
1087739|NCT02138747|3550421|P2|Treatment Period 1|Adverse Event|14
1087740|NCT02138747|3550422|P1|Treatment Period 1|Adverse Event|10
1087741|NCT02138110|3550528|P1|6-month Post-implantation Follow-up|Death|3
1087742|NCT02138110|3550528|P1|Enrolled for Scaffold Implantation|Physician Decision|1
1087743|NCT02138110|3550528|P1|Enrolled in Study|Failed Eligibility|5
1087744|NCT02137785|3550760|P2|Overall Study|subject moved out of state|0
1087745|NCT02137785|3550761|P1|Overall Study|subject moved out of state|1
1087746|NCT02137785|3550760|P2|Overall Study|Withdrawal by Subject|4
1087747|NCT02137785|3550761|P1|Overall Study|Withdrawal by Subject|1
1087748|NCT02137785|3550760|P2|Overall Study|Lost to Follow-up|0
1087749|NCT02137785|3550761|P1|Overall Study|Lost to Follow-up|1
1087750|NCT02137772|3550869|P2|Overall Study|Not treated|2
1087751|NCT02137772|3550870|P1|Overall Study|Not treated|3
1087752|NCT02137772|3550869|P2|Overall Study|Non-compliance with study drug|0
1087753|NCT02137772|3550870|P1|Overall Study|Non-compliance with study drug|1
1087754|NCT02137772|3550869|P2|Overall Study|Withdrawal by Subject|17
1087755|NCT02137772|3550870|P1|Overall Study|Withdrawal by Subject|28
1087756|NCT02137772|3550869|P2|Overall Study|Physician Decision|5
1087757|NCT02137772|3550870|P1|Overall Study|Physician Decision|15
1087758|NCT02137772|3550869|P2|Overall Study|Lost to Follow-up|4
1087759|NCT02137772|3550870|P1|Overall Study|Lost to Follow-up|8
1087760|NCT02137772|3550869|P2|Overall Study|Death|44
1087761|NCT02137772|3550870|P1|Overall Study|Death|71
1087762|NCT02137772|3550869|P2|Overall Study|Adverse Event|3
1087763|NCT02137772|3550870|P1|Overall Study|Adverse Event|6
1087764|NCT02137226|3551084|P5|Period 2 (Re - Randomization)|Other Reason|1
1087765|NCT02137226|3551085|P4|Period 2 (Re - Randomization)|Other Reason|1
1087766|NCT02137226|3551086|P3|Period 2 (Re - Randomization)|Other Reason|1
1087767|NCT02137226|3551087|P2|Period 2 (Re - Randomization)|Other Reason|0
1087768|NCT02137226|3551088|P1|Period 2 (Re - Randomization)|Other Reason|0
1087769|NCT02137226|3551084|P5|Period 2 (Re - Randomization)|Lack of Efficacy|0
1087770|NCT02137226|3551085|P4|Period 2 (Re - Randomization)|Lack of Efficacy|0
1087771|NCT02137226|3551086|P3|Period 2 (Re - Randomization)|Lack of Efficacy|2
1087772|NCT02137226|3551087|P2|Period 2 (Re - Randomization)|Lack of Efficacy|0
1087773|NCT02137226|3551088|P1|Period 2 (Re - Randomization)|Lack of Efficacy|0
1087774|NCT02137226|3551084|P5|Period 2 (Re - Randomization)|Lost to Follow-up|0
1087775|NCT02137226|3551085|P4|Period 2 (Re - Randomization)|Lost to Follow-up|0
1087776|NCT02137226|3551086|P3|Period 2 (Re - Randomization)|Lost to Follow-up|3
1087777|NCT02137226|3551087|P2|Period 2 (Re - Randomization)|Lost to Follow-up|0
1087778|NCT02137226|3551088|P1|Period 2 (Re - Randomization)|Lost to Follow-up|0
1087779|NCT02137226|3551084|P5|Period 2 (Re - Randomization)|Physician Decision|0
1087780|NCT02137226|3551085|P4|Period 2 (Re - Randomization)|Physician Decision|1
1087781|NCT02137226|3551086|P3|Period 2 (Re - Randomization)|Physician Decision|0
1087782|NCT02137226|3551087|P2|Period 2 (Re - Randomization)|Physician Decision|0
1087783|NCT02137226|3551088|P1|Period 2 (Re - Randomization)|Physician Decision|0
1087784|NCT02137226|3551084|P5|Period 2 (Re - Randomization)|Withdrawal by Subject|4
1087785|NCT02137226|3551085|P4|Period 2 (Re - Randomization)|Withdrawal by Subject|5
1087786|NCT02137226|3551086|P3|Period 2 (Re - Randomization)|Withdrawal by Subject|8
1087787|NCT02137226|3551087|P2|Period 2 (Re - Randomization)|Withdrawal by Subject|0
1087788|NCT02137226|3551088|P1|Period 2 (Re - Randomization)|Withdrawal by Subject|0
1087789|NCT02137226|3551084|P5|Period 2 (Re - Randomization)|Adverse Event|4
1087790|NCT02137226|3551085|P4|Period 2 (Re - Randomization)|Adverse Event|1
1087791|NCT02137226|3551086|P3|Period 2 (Re - Randomization)|Adverse Event|3
1087792|NCT02137226|3551087|P2|Period 2 (Re - Randomization)|Adverse Event|0
1087793|NCT02137226|3551088|P1|Period 2 (Re - Randomization)|Adverse Event|0
1087794|NCT02137226|3551084|P5|Period 1 (Initial Randomization)|Other Reason|0
1087795|NCT02137226|3551085|P4|Period 1 (Initial Randomization)|Other Reason|0
1087796|NCT02137226|3551086|P3|Period 1 (Initial Randomization)|Other Reason|0
1087797|NCT02137226|3551087|P2|Period 1 (Initial Randomization)|Other Reason|3
1087798|NCT02137226|3551088|P1|Period 1 (Initial Randomization)|Other Reason|1
1087799|NCT02137226|3551084|P5|Period 1 (Initial Randomization)|Lack of Efficacy|0
1087800|NCT02137226|3551085|P4|Period 1 (Initial Randomization)|Lack of Efficacy|0
1087801|NCT02137226|3551086|P3|Period 1 (Initial Randomization)|Lack of Efficacy|0
1087802|NCT02137226|3551087|P2|Period 1 (Initial Randomization)|Lack of Efficacy|0
1087803|NCT02137226|3551088|P1|Period 1 (Initial Randomization)|Lack of Efficacy|1
1087804|NCT02137226|3551084|P5|Period 1 (Initial Randomization)|Lost to Follow-up|0
1087805|NCT02137226|3551085|P4|Period 1 (Initial Randomization)|Lost to Follow-up|0
1087806|NCT02137226|3551086|P3|Period 1 (Initial Randomization)|Lost to Follow-up|0
1087807|NCT02137226|3551087|P2|Period 1 (Initial Randomization)|Lost to Follow-up|2
1087808|NCT02137226|3551088|P1|Period 1 (Initial Randomization)|Lost to Follow-up|3
1087809|NCT02137226|3551084|P5|Period 1 (Initial Randomization)|Physician Decision|0
1087810|NCT02137226|3551085|P4|Period 1 (Initial Randomization)|Physician Decision|0
1087811|NCT02137226|3551086|P3|Period 1 (Initial Randomization)|Physician Decision|0
1087812|NCT02137226|3551087|P2|Period 1 (Initial Randomization)|Physician Decision|3
1087813|NCT02137226|3551088|P1|Period 1 (Initial Randomization)|Physician Decision|1
1087814|NCT02137226|3551084|P5|Period 1 (Initial Randomization)|Withdrawal by Subject|0
1087815|NCT02137226|3551085|P4|Period 1 (Initial Randomization)|Withdrawal by Subject|0
1087816|NCT02137226|3551086|P3|Period 1 (Initial Randomization)|Withdrawal by Subject|0
1087817|NCT02137226|3551087|P2|Period 1 (Initial Randomization)|Withdrawal by Subject|5
1087818|NCT02137226|3551088|P1|Period 1 (Initial Randomization)|Withdrawal by Subject|11
1087819|NCT02137226|3551084|P5|Period 1 (Initial Randomization)|Adverse Event|0
1087820|NCT02137226|3551085|P4|Period 1 (Initial Randomization)|Adverse Event|0
1087821|NCT02137226|3551086|P3|Period 1 (Initial Randomization)|Adverse Event|0
1087822|NCT02137226|3551087|P2|Period 1 (Initial Randomization)|Adverse Event|3
1087823|NCT02137226|3551088|P1|Period 1 (Initial Randomization)|Adverse Event|3
1087824|NCT02136914|3551102|P2|Overall Study|Death|1
1087825|NCT02136914|3551103|P1|Overall Study|Death|0
1087826|NCT02136914|3551102|P2|Overall Study|Lack of Efficacy|0
1087827|NCT02136914|3551103|P1|Overall Study|Lack of Efficacy|1
1087828|NCT02136914|3551102|P2|Overall Study|Did Not Receive Study Drug|0
1087829|NCT02136914|3551103|P1|Overall Study|Did Not Receive Study Drug|2
1087830|NCT02136914|3551102|P2|Overall Study|Lost to Follow-up|1
1087831|NCT02136914|3551103|P1|Overall Study|Lost to Follow-up|1
1087832|NCT02136914|3551102|P2|Overall Study|Subject Unwilling to Proceed|2
1087833|NCT02136914|3551103|P1|Overall Study|Subject Unwilling to Proceed|7
1087834|NCT02136914|3551102|P2|Overall Study|Withdrawal by Subject|10
1087835|NCT02136914|3551103|P1|Overall Study|Withdrawal by Subject|3
1087836|NCT02136914|3551102|P2|Overall Study|Sponsor's Decision to Stop the Study|7
1087837|NCT02136914|3551103|P1|Overall Study|Sponsor's Decision to Stop the Study|7
1087838|NCT02136134|3551182|P2|Overall Study|Subjects randomized but not treated|8
1087839|NCT02136134|3551183|P1|Overall Study|Subjects randomized but not treated|10
1087840|NCT02136134|3551182|P2|Overall Study|Ongoing|207
1087841|NCT02136134|3551183|P1|Overall Study|Ongoing|185
1087842|NCT02136134|3551182|P2|Overall Study|Other|3
1087843|NCT02136134|3551183|P1|Overall Study|Other|3
1087844|NCT02136134|3551182|P2|Overall Study|Withdrawal by Subject|4
1087845|NCT02136134|3551183|P1|Overall Study|Withdrawal by Subject|14
1087846|NCT02136134|3551182|P2|Overall Study|Death|29
1087847|NCT02136134|3551183|P1|Overall Study|Death|35
1087848|NCT02135848|3551221|P2|Overall Study|Withdrawal by Subject|1
1087849|NCT02135848|3551222|P1|Overall Study|Withdrawal by Subject|1
1087850|NCT02135848|3551221|P2|Overall Study|Adverse Event|0
1087851|NCT02135848|3551222|P1|Overall Study|Adverse Event|2
1087852|NCT02135692|3551280|P1|Overall Study|Withdrawal by Subject|15
1087853|NCT02135692|3551280|P1|Overall Study|Lost to Follow-up|4
1087854|NCT02135692|3551280|P1|Overall Study|Study closed/terminated|153
1087855|NCT02135692|3551280|P1|Overall Study|Product commercially available|159
1087856|NCT02135692|3551280|P1|Overall Study|Subject met Liver Stopping Criteria|1
1087857|NCT02135692|3551280|P1|Overall Study|Protocol Violation|2
1087858|NCT02135692|3551280|P1|Overall Study|Lack of Efficacy|2
1087859|NCT02135692|3551280|P1|Overall Study|Adverse Event|3
1087860|NCT02135614|3551299|P2|Overall Study|Lost to Follow-up|0
1087861|NCT02135614|3551300|P1|Overall Study|Lost to Follow-up|3
1087862|NCT02135614|3551299|P2|Overall Study|Withdrew Consent|2
1087863|NCT02135614|3551300|P1|Overall Study|Withdrew Consent|2
1087864|NCT02135614|3551299|P2|Overall Study|Investigator's Discretion|1
1087865|NCT02135614|3551300|P1|Overall Study|Investigator's Discretion|0
1087866|NCT02135614|3551299|P2|Overall Study|Death|0
1087867|NCT02135614|3551300|P1|Overall Study|Death|1
1087868|NCT02135614|3551299|P2|Overall Study|Adverse Event|1
1087869|NCT02135614|3551300|P1|Overall Study|Adverse Event|0
1087870|NCT02135614|3551299|P2|Overall Study|Randomized but Not Treated|1
1087871|NCT02135614|3551300|P1|Overall Study|Randomized but Not Treated|2
1087872|NCT02135445|3551314|P2|Overall Study|Withdrawal by Subject|0
1087873|NCT02135445|3551315|P1|Overall Study|Withdrawal by Subject|1
1087874|NCT02135445|3551314|P2|Overall Study|Lost to Follow-up|0
1087875|NCT02135445|3551315|P1|Overall Study|Lost to Follow-up|1
1087876|NCT02135107|3551381|P4|Maintenance Therapy Period|Not specified|8
1087877|NCT02135107|3551382|P3|Maintenance Therapy Period|Not specified|7
1087878|NCT02135107|3551383|P2|Maintenance Therapy Period|Not specified|0
1087879|NCT02135107|3551384|P1|Maintenance Therapy Period|Not specified|0
1087880|NCT02135107|3551381|P4|Maintenance Therapy Period|Pregnancy|1
1087881|NCT02135107|3551382|P3|Maintenance Therapy Period|Pregnancy|0
1087882|NCT02135107|3551383|P2|Maintenance Therapy Period|Pregnancy|0
1087883|NCT02135107|3551384|P1|Maintenance Therapy Period|Pregnancy|0
1087884|NCT02135107|3551381|P4|Maintenance Therapy Period|Withdrawal by Subject|4
1087885|NCT02135107|3551382|P3|Maintenance Therapy Period|Withdrawal by Subject|5
1087886|NCT02135107|3551383|P2|Maintenance Therapy Period|Withdrawal by Subject|0
1087887|NCT02135107|3551384|P1|Maintenance Therapy Period|Withdrawal by Subject|0
1087888|NCT02135107|3551381|P4|Maintenance Therapy Period|Adverse Event|7
1087889|NCT02135107|3551382|P3|Maintenance Therapy Period|Adverse Event|3
1087890|NCT02135107|3551383|P2|Maintenance Therapy Period|Adverse Event|0
1087891|NCT02135107|3551384|P1|Maintenance Therapy Period|Adverse Event|0
1087892|NCT02135107|3551381|P4|Treatment Period|Not specified|0
1087893|NCT02135107|3551382|P3|Treatment Period|Not specified|0
1087894|NCT02135107|3551383|P2|Treatment Period|Not specified|24
1087895|NCT02135107|3551384|P1|Treatment Period|Not specified|115
1087896|NCT02135107|3551381|P4|Treatment Period|Pregnancy|0
1087897|NCT02135107|3551382|P3|Treatment Period|Pregnancy|0
1087898|NCT02135107|3551383|P2|Treatment Period|Pregnancy|0
1087899|NCT02135107|3551384|P1|Treatment Period|Pregnancy|1
1087900|NCT02135107|3551381|P4|Treatment Period|Adverse Event|0
1087901|NCT02135107|3551382|P3|Treatment Period|Adverse Event|0
1087902|NCT02135107|3551383|P2|Treatment Period|Adverse Event|2
1087903|NCT02135107|3551384|P1|Treatment Period|Adverse Event|5
1087904|NCT02135107|3551381|P4|Treatment Period|Withdrawal by Subject|0
1087905|NCT02135107|3551382|P3|Treatment Period|Withdrawal by Subject|0
1087906|NCT02135107|3551383|P2|Treatment Period|Withdrawal by Subject|0
1087907|NCT02135107|3551384|P1|Treatment Period|Withdrawal by Subject|11
1087908|NCT02135029|3551430|P3|Overall Study|Death|0
1087909|NCT02135029|3551431|P2|Overall Study|Death|1
1087910|NCT02135029|3551432|P1|Overall Study|Death|0
1087911|NCT02135029|3551430|P3|Overall Study|Other|0
1087912|NCT02135029|3551431|P2|Overall Study|Other|1
1087913|NCT02135029|3551432|P1|Overall Study|Other|0
1087914|NCT02135029|3551430|P3|Overall Study|Withdrawal by Subject|1
1087915|NCT02135029|3551431|P2|Overall Study|Withdrawal by Subject|0
1087916|NCT02135029|3551432|P1|Overall Study|Withdrawal by Subject|2
1087917|NCT02135029|3551430|P3|Overall Study|Lost to Follow-up|0
1087918|NCT02135029|3551431|P2|Overall Study|Lost to Follow-up|1
1087919|NCT02135029|3551432|P1|Overall Study|Lost to Follow-up|0
1087920|NCT02135029|3551430|P3|Overall Study|Adverse Event|2
1087921|NCT02135029|3551431|P2|Overall Study|Adverse Event|2
1087922|NCT02135029|3551432|P1|Overall Study|Adverse Event|2
1087923|NCT02134977|3551537|P1|Overall Study|Protocol Deviation|102
1087924|NCT02134925|3551571|P2|Overall Study|Cancel|6
1087925|NCT02134925|3551572|P1|Overall Study|Cancel|1
1087926|NCT02134925|3551571|P2|Overall Study|Withdrawal by Subject|0
1087927|NCT02134925|3551572|P1|Overall Study|Withdrawal by Subject|1
1087928|NCT02134587|3551586|P1|Overall Study|Did not completed all meetings|30
1087929|NCT02134015|3551692|P2|Overall Study|Withdrawal by Subject|7
1087930|NCT02134015|3551693|P1|Overall Study|Withdrawal by Subject|3
1087931|NCT02134015|3551692|P2|Overall Study|Adverse Event|10
1087932|NCT02134015|3551693|P1|Overall Study|Adverse Event|9
1087933|NCT02134015|3551692|P2|Overall Study|Study terminated by sponsor|3
1087934|NCT02134015|3551693|P1|Overall Study|Study terminated by sponsor|2
1087935|NCT02134015|3551692|P2|Overall Study|Progressive disease (per RECIST 1.1)|43
1087936|NCT02134015|3551693|P1|Overall Study|Progressive disease (per RECIST 1.1)|40
1087937|NCT02134015|3551692|P2|Overall Study|Clinical progression|7
1087938|NCT02134015|3551693|P1|Overall Study|Clinical progression|14
1087939|NCT02134015|3551692|P2|Overall Study|Reason not provided|2
1087940|NCT02134015|3551693|P1|Overall Study|Reason not provided|1
1087941|NCT02134015|3551692|P2|Overall Study|Death|1
1087942|NCT02134015|3551693|P1|Overall Study|Death|2
1087943|NCT02134015|3551692|P2|Overall Study|Protocol Violation|1
1087944|NCT02134015|3551693|P1|Overall Study|Protocol Violation|0
1087945|NCT02133664|3551731|P2|Overall Study|Adverse Event|6
1087946|NCT02133664|3551732|P1|Overall Study|Adverse Event|3
1087947|NCT02133664|3551731|P2|Overall Study|Lost to Follow-up|1
1087948|NCT02133664|3551732|P1|Overall Study|Lost to Follow-up|2
1087949|NCT02133508|3551748|P1|Overall Study|Lost to Follow-up|2
1087950|NCT02133508|3551748|P1|Overall Study|Death|12
1087951|NCT02133508|3551748|P1|Overall Study|Decision of Investigator or Sponsor|1
1087952|NCT02133352|3551756|P1|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6
1087953|NCT02133131|3551787|P7|Overall Study|Protocol Violation|1
1087954|NCT02133131|3551788|P6|Overall Study|Protocol Violation|0
1087955|NCT02133131|3551789|P5|Overall Study|Protocol Violation|0
1087956|NCT02133131|3551790|P4|Overall Study|Protocol Violation|0
1087957|NCT02133131|3551791|P3|Overall Study|Protocol Violation|0
1087958|NCT02133131|3551792|P2|Overall Study|Protocol Violation|0
1087959|NCT02133131|3551793|P1|Overall Study|Protocol Violation|0
1087960|NCT02133131|3551787|P7|Overall Study|Ongoing in study|11
1087961|NCT02133131|3551788|P6|Overall Study|Ongoing in study|14
1087962|NCT02133131|3551789|P5|Overall Study|Ongoing in study|15
1087963|NCT02133131|3551790|P4|Overall Study|Ongoing in study|0
1087964|NCT02133131|3551791|P3|Overall Study|Ongoing in study|0
1087965|NCT02133131|3551792|P2|Overall Study|Ongoing in study|0
1087966|NCT02133131|3551793|P1|Overall Study|Ongoing in study|0
1087967|NCT02133131|3551787|P7|Overall Study|Status not recorded|0
1087968|NCT02133131|3551788|P6|Overall Study|Status not recorded|0
1087969|NCT02133131|3551789|P5|Overall Study|Status not recorded|0
1087970|NCT02133131|3551790|P4|Overall Study|Status not recorded|4
1087971|NCT02133131|3551791|P3|Overall Study|Status not recorded|1
1087972|NCT02133131|3551792|P2|Overall Study|Status not recorded|5
1087973|NCT02133131|3551793|P1|Overall Study|Status not recorded|4
1087974|NCT02133131|3551787|P7|Overall Study|Lost to Follow-up|0
1087975|NCT02133131|3551788|P6|Overall Study|Lost to Follow-up|0
1087976|NCT02133131|3551789|P5|Overall Study|Lost to Follow-up|0
1087977|NCT02133131|3551790|P4|Overall Study|Lost to Follow-up|1
1087978|NCT02133131|3551791|P3|Overall Study|Lost to Follow-up|0
1087979|NCT02133131|3551792|P2|Overall Study|Lost to Follow-up|0
1087980|NCT02133131|3551793|P1|Overall Study|Lost to Follow-up|1
1087981|NCT02133131|3551787|P7|Overall Study|Adverse Event|0
1087982|NCT02133131|3551788|P6|Overall Study|Adverse Event|0
1087983|NCT02133131|3551789|P5|Overall Study|Adverse Event|0
1087984|NCT02133131|3551790|P4|Overall Study|Adverse Event|1
1087985|NCT02133131|3551791|P3|Overall Study|Adverse Event|0
1087986|NCT02133131|3551792|P2|Overall Study|Adverse Event|0
1087987|NCT02133131|3551793|P1|Overall Study|Adverse Event|0
1087988|NCT02132949|3551847|P2|Adjuvant Treatment Period|Ongoing in Adjuvant Treatment|157
1087989|NCT02132949|3551848|P1|Adjuvant Treatment Period|Ongoing in Adjuvant Treatment|142
1087990|NCT02132949|3551847|P2|Adjuvant Treatment Period|Protocol Deviation|0
1087991|NCT02132949|3551848|P1|Adjuvant Treatment Period|Protocol Deviation|1
1087992|NCT02132949|3551847|P2|Adjuvant Treatment Period|Withdrawal by Subject|1
1087993|NCT02132949|3551848|P1|Adjuvant Treatment Period|Withdrawal by Subject|1
1087994|NCT02132949|3551847|P2|Adjuvant Treatment Period|Physician Decision|0
1087995|NCT02132949|3551848|P1|Adjuvant Treatment Period|Physician Decision|1
1087996|NCT02132949|3551847|P2|Adjuvant Treatment Period|Disease Relapse|1
1087997|NCT02132949|3551848|P1|Adjuvant Treatment Period|Disease Relapse|0
1087998|NCT02132949|3551847|P2|Adjuvant Treatment Period|Disease Progression|1
1087999|NCT02132949|3551848|P1|Adjuvant Treatment Period|Disease Progression|0
1088000|NCT02132949|3551847|P2|Adjuvant Treatment Period|Reason unspecified|1
1088001|NCT02132949|3551848|P1|Adjuvant Treatment Period|Reason unspecified|0
1088002|NCT02132949|3551847|P2|Adjuvant Treatment Period|Adverse Event|6
1088003|NCT02132949|3551848|P1|Adjuvant Treatment Period|Adverse Event|4
1088004|NCT02132949|3551847|P2|Neoadjuvant Treatment Period|Withdrew prior to treatment|3
1088005|NCT02132949|3551848|P1|Neoadjuvant Treatment Period|Withdrew prior to treatment|0
1088006|NCT02132949|3551847|P2|Neoadjuvant Treatment Period|Adverse Event|3
1088007|NCT02132949|3551848|P1|Neoadjuvant Treatment Period|Adverse Event|6
1088008|NCT02132949|3551847|P2|Neoadjuvant Treatment Period|Disease Progression|1
1088009|NCT02132949|3551848|P1|Neoadjuvant Treatment Period|Disease Progression|1
1088010|NCT02132949|3551847|P2|Neoadjuvant Treatment Period|Withdrawal by Subject|0
1088011|NCT02132949|3551848|P1|Neoadjuvant Treatment Period|Withdrawal by Subject|1
1088012|NCT02132949|3551847|P2|Neoadjuvant Treatment Period|Physician Decision|0
1088013|NCT02132949|3551848|P1|Neoadjuvant Treatment Period|Physician Decision|2
1088014|NCT02132949|3551847|P2|Neoadjuvant Treatment Period|Lack of Efficacy|1
1088015|NCT02132949|3551848|P1|Neoadjuvant Treatment Period|Lack of Efficacy|0
1088016|NCT02132949|3551847|P2|Neoadjuvant Treatment Period|Reason unspecified|1
1088017|NCT02132949|3551848|P1|Neoadjuvant Treatment Period|Reason unspecified|3
1088018|NCT02132949|3551847|P2|Neoadjuvant Treatment Period|Early surgery|3
1088019|NCT02132949|3551848|P1|Neoadjuvant Treatment Period|Early surgery|4
1088020|NCT02132767|3551941|P2|Overall Study|Lost to Follow-up|4
1088021|NCT02132767|3551942|P1|Overall Study|Lost to Follow-up|4
1088022|NCT02132767|3551941|P2|Overall Study|Withdrawal by Subject|9
1088023|NCT02132767|3551942|P1|Overall Study|Withdrawal by Subject|10
1088024|NCT02132767|3551941|P2|Overall Study|Death|2
1088025|NCT02132767|3551942|P1|Overall Study|Death|3
1088026|NCT02132637|3551964|P2|Study Period 2 (Crossover)|Physician Decision|0
1088027|NCT02132637|3551965|P1|Study Period 2 (Crossover)|Physician Decision|2
1088028|NCT02132637|3551964|P2|Study Period 2 (Crossover)|Adverse Event|1
1088029|NCT02132637|3551965|P1|Study Period 2 (Crossover)|Adverse Event|0
1088030|NCT02132637|3551964|P2|Study Period 1|Physician Decision|0
1088031|NCT02132637|3551965|P1|Study Period 1|Physician Decision|1
1088032|NCT02132637|3551964|P2|Study Period 1|Withdrawal by Subject|4
1088033|NCT02132637|3551965|P1|Study Period 1|Withdrawal by Subject|0
1088034|NCT02132611|3551989|P1|Overall Study|Death|2
1088035|NCT02132247|3552007|P2|Overall Study|Protocol Violation|0
1088036|NCT02132247|3552008|P1|Overall Study|Protocol Violation|1
1088037|NCT02132117|3552037|P2|Overall Study|Other Miscellaneous Reasons|0
1088038|NCT02132117|3552038|P1|Overall Study|Other Miscellaneous Reasons|2
1088039|NCT02132117|3552037|P2|Overall Study|Personal Reasons|2
1088040|NCT02132117|3552038|P1|Overall Study|Personal Reasons|1
1088041|NCT02132117|3552037|P2|Overall Study|Lost to Follow-up|2
1088042|NCT02132117|3552038|P1|Overall Study|Lost to Follow-up|2
1088043|NCT02132117|3552037|P2|Overall Study|Adverse Event|1
1088044|NCT02132117|3552038|P1|Overall Study|Adverse Event|6
1088045|NCT02131662|3552059|P5|Overall Study|Not treated|3
1088046|NCT02131662|3552060|P4|Overall Study|Not treated|2
1088047|NCT02131662|3552061|P3|Overall Study|Not treated|2
1088048|NCT02131662|3552062|P2|Overall Study|Not treated|0
1088049|NCT02131662|3552063|P1|Overall Study|Not treated|2
1088050|NCT02131662|3552059|P5|Overall Study|Lost to Follow-up|0
1088051|NCT02131662|3552060|P4|Overall Study|Lost to Follow-up|9
1088052|NCT02131662|3552061|P3|Overall Study|Lost to Follow-up|0
1088053|NCT02131662|3552062|P2|Overall Study|Lost to Follow-up|3
1088054|NCT02131662|3552063|P1|Overall Study|Lost to Follow-up|1
1088055|NCT02131662|3552059|P5|Overall Study|Withdrawal by Subject|6
1088056|NCT02131662|3552060|P4|Overall Study|Withdrawal by Subject|5
1088057|NCT02131662|3552061|P3|Overall Study|Withdrawal by Subject|1
1088058|NCT02131662|3552062|P2|Overall Study|Withdrawal by Subject|5
1088059|NCT02131662|3552063|P1|Overall Study|Withdrawal by Subject|1
1088060|NCT02131662|3552059|P5|Overall Study|Lack of Efficacy|1
1088061|NCT02131662|3552060|P4|Overall Study|Lack of Efficacy|0
1088062|NCT02131662|3552061|P3|Overall Study|Lack of Efficacy|0
1088063|NCT02131662|3552062|P2|Overall Study|Lack of Efficacy|0
1088064|NCT02131662|3552063|P1|Overall Study|Lack of Efficacy|1
1088065|NCT02131662|3552059|P5|Overall Study|Wish for pregnancy|1
1088066|NCT02131662|3552060|P4|Overall Study|Wish for pregnancy|0
1088067|NCT02131662|3552061|P3|Overall Study|Wish for pregnancy|0
1088068|NCT02131662|3552062|P2|Overall Study|Wish for pregnancy|0
1088069|NCT02131662|3552063|P1|Overall Study|Wish for pregnancy|0
1088070|NCT02131662|3552059|P5|Overall Study|Pregnancy|0
1088071|NCT02131662|3552060|P4|Overall Study|Pregnancy|1
1088072|NCT02131662|3552061|P3|Overall Study|Pregnancy|0
1088073|NCT02131662|3552062|P2|Overall Study|Pregnancy|1
1088074|NCT02131662|3552063|P1|Overall Study|Pregnancy|0
1088075|NCT02131662|3552059|P5|Overall Study|Adverse Event|3
1088076|NCT02131662|3552060|P4|Overall Study|Adverse Event|1
1088077|NCT02131662|3552061|P3|Overall Study|Adverse Event|1
1088078|NCT02131662|3552062|P2|Overall Study|Adverse Event|1
1088079|NCT02131662|3552063|P1|Overall Study|Adverse Event|0
1088080|NCT02131662|3552059|P5|Overall Study|Other|4
1088081|NCT02131662|3552060|P4|Overall Study|Other|3
1088082|NCT02131662|3552061|P3|Overall Study|Other|3
1088083|NCT02131662|3552062|P2|Overall Study|Other|4
1088084|NCT02131662|3552063|P1|Overall Study|Other|2
1088085|NCT02131662|3552059|P5|Overall Study|Protocol Violation|0
1088086|NCT02131662|3552060|P4|Overall Study|Protocol Violation|0
1088087|NCT02131662|3552061|P3|Overall Study|Protocol Violation|0
1088088|NCT02131662|3552062|P2|Overall Study|Protocol Violation|0
1088089|NCT02131662|3552063|P1|Overall Study|Protocol Violation|1
1088090|NCT02131636|3552109|P2|Overall Study|Adverse Event|1
1088091|NCT02131636|3552110|P1|Overall Study|Adverse Event|4
1088092|NCT02131636|3552109|P2|Overall Study|Lost to Follow-up|0
1088093|NCT02131636|3552110|P1|Overall Study|Lost to Follow-up|4
1088094|NCT02131636|3552109|P2|Overall Study|Personal Reasons|4
1088095|NCT02131636|3552110|P1|Overall Study|Personal Reasons|4
1088096|NCT02131532|3552126|P1|Overall Study|Other health conditions|2
1088097|NCT02131532|3552126|P1|Overall Study|Physician Decision|1
1088098|NCT02131532|3552126|P1|Overall Study|Withdrawal by Subject|1
1088099|NCT02131324|3552218|P2|Overall Study|Lost to Follow-up|1
1088100|NCT02131324|3552219|P1|Overall Study|Lost to Follow-up|1
1088101|NCT02131324|3552218|P2|Overall Study|Withdrawal by Subject|2
1088102|NCT02131324|3552219|P1|Overall Study|Withdrawal by Subject|1
1088103|NCT02131311|3552225|P1|Overall Study|Lost to Follow-up|1
1088104|NCT02131311|3552225|P1|Overall Study|Protocol Violation|1
1088105|NCT02131311|3552225|P1|Overall Study|Adverse Event|2
1088106|NCT02131272|3552237|P2|Overall Study|Withdrawal Criteria|0
1088107|NCT02131272|3552238|P1|Overall Study|Withdrawal Criteria|1
1088108|NCT02131272|3552237|P2|Overall Study|Withdrawal by Subject|1
1088109|NCT02131272|3552238|P1|Overall Study|Withdrawal by Subject|0
1088110|NCT02131272|3552237|P2|Overall Study|Withdrawal by parent|1
1088111|NCT02131272|3552238|P1|Overall Study|Withdrawal by parent|0
1088112|NCT02131259|3552256|P1|Overall Study|Missing|3
1088113|NCT02131259|3552256|P1|Overall Study|Progressive disease/AE/other|1
1088114|NCT02131259|3552256|P1|Overall Study|AE/other|1
1088115|NCT02131259|3552256|P1|Overall Study|AE/lost to follow-up|1
1088116|NCT02131259|3552256|P1|Overall Study|Progressive disease/other|2
1088117|NCT02131259|3552256|P1|Overall Study|Progressive disease/relocation|1
1088118|NCT02131259|3552256|P1|Overall Study|Progressive disease/Adverse Event (AE)|22
1088119|NCT02131259|3552256|P1|Overall Study|Not specified|63
1088120|NCT02131259|3552256|P1|Overall Study|Relocation|32
1088121|NCT02131259|3552256|P1|Overall Study|Lost to Follow-up|7
1088122|NCT02131259|3552256|P1|Overall Study|Adverse Event|341
1088123|NCT02131259|3552256|P1|Overall Study|Progressive disease|751
1088124|NCT02131233|3552263|P2|Overall Study|Withdrawal by Subject|11
1088125|NCT02131233|3552264|P1|Overall Study|Withdrawal by Subject|18
1088126|NCT02131233|3552263|P2|Overall Study|Pregnancy|0
1088127|NCT02131233|3552264|P1|Overall Study|Pregnancy|4
1088128|NCT02131233|3552263|P2|Overall Study|Physician Decision|0
1088129|NCT02131233|3552264|P1|Overall Study|Physician Decision|7
1088130|NCT02131233|3552263|P2|Overall Study|Non-Compliance With Study Drug|5
1088131|NCT02131233|3552264|P1|Overall Study|Non-Compliance With Study Drug|8
1088132|NCT02131233|3552263|P2|Overall Study|Lost to Follow-up|13
1088133|NCT02131233|3552264|P1|Overall Study|Lost to Follow-up|14
1088134|NCT02131233|3552263|P2|Overall Study|Lack of Efficacy|3
1088135|NCT02131233|3552264|P1|Overall Study|Lack of Efficacy|6
1088136|NCT02131233|3552263|P2|Overall Study|Death|1
1088137|NCT02131233|3552264|P1|Overall Study|Death|0
1088138|NCT02131233|3552263|P2|Overall Study|Adverse Event|6
1088139|NCT02131233|3552264|P1|Overall Study|Adverse Event|7
1088140|NCT02131233|3552263|P2|Overall Study|Not Treated|3
1088141|NCT02131233|3552264|P1|Overall Study|Not Treated|2
1088142|NCT02131064|3552298|P2|Overall Study|Other|0
1088143|NCT02131064|3552299|P1|Overall Study|Other|1
1088144|NCT02131064|3552298|P2|Overall Study|Ongoing|207
1088145|NCT02131064|3552299|P1|Overall Study|Ongoing|214
1088146|NCT02131064|3552298|P2|Overall Study|Withdrawal by Subject|14
1088147|NCT02131064|3552299|P1|Overall Study|Withdrawal by Subject|6
1088148|NCT02131064|3552298|P2|Overall Study|Lost to Follow-up|1
1088149|NCT02131064|3552299|P1|Overall Study|Lost to Follow-up|0
1088150|NCT02131064|3552298|P2|Overall Study|Death|1
1088151|NCT02131064|3552299|P1|Overall Study|Death|0
1088152|NCT02130765|3552362|P4|Overall Study|Did not receive treatment|0
1088153|NCT02130765|3552363|P3|Overall Study|Did not receive treatment|0
1088154|NCT02130765|3552364|P2|Overall Study|Did not receive treatment|0
1088155|NCT02130765|3552365|P1|Overall Study|Did not receive treatment|4
1088156|NCT02130557|3552590|P2|Overall Study|Ongoing|255
1088157|NCT02130557|3552591|P1|Overall Study|Ongoing|260
1088158|NCT02130557|3552590|P2|Overall Study|Deceased|6
1088159|NCT02130557|3552591|P1|Overall Study|Deceased|1
1088160|NCT02130557|3552590|P2|Overall Study|Lost to Follow-up|2
1088161|NCT02130557|3552591|P1|Overall Study|Lost to Follow-up|2
1088162|NCT02130557|3552590|P2|Overall Study|Withdrawal by Subject|2
1088163|NCT02130557|3552591|P1|Overall Study|Withdrawal by Subject|5
1088164|NCT02130557|3552590|P2|Overall Study|Randomized, not treated|3
1088165|NCT02130557|3552591|P1|Overall Study|Randomized, not treated|0
1088166|NCT02130284|3552623|P1|Overall Study|Screen Failure|1
1088167|NCT02130284|3552623|P1|Overall Study|Subject was screened as backup for study|3
1088168|NCT02130284|3552623|P1|Overall Study|Subject's sensor failed at Visit 2, Day|1
1088169|NCT02130284|3552623|P1|Overall Study|Subject Withdrew Consent|1
1088170|NCT02130284|3552623|P1|Overall Study|Withdrawal by Subject|3
1088171|NCT02130193|3552649|P3|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
1088172|NCT02130193|3552650|P2|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
1088173|NCT02130193|3552651|P1|Part B: 52-week Double-blind Period|Withdrawal by Subject|0
1088174|NCT02130193|3552649|P3|Part B: 52-week Double-blind Period|Physician Decision|1
1088175|NCT02130193|3552650|P2|Part B: 52-week Double-blind Period|Physician Decision|0
1088176|NCT02130193|3552651|P1|Part B: 52-week Double-blind Period|Physician Decision|0
1088177|NCT02130193|3552649|P3|Part B: 52-week Double-blind Period|Protocol Violation|1
1088178|NCT02130193|3552650|P2|Part B: 52-week Double-blind Period|Protocol Violation|2
1088179|NCT02130193|3552651|P1|Part B: 52-week Double-blind Period|Protocol Violation|0
1088180|NCT02130193|3552649|P3|Part B: 52-week Double-blind Period|Adverse Event|3
1088181|NCT02130193|3552650|P2|Part B: 52-week Double-blind Period|Adverse Event|5
1088182|NCT02130193|3552651|P1|Part B: 52-week Double-blind Period|Adverse Event|0
1088183|NCT02129777|3552735|P7|Open-Label Period|Study Termination|39
1088184|NCT02129777|3552736|P6|Open-Label Period|Study Termination|10
1088185|NCT02129777|3552737|P5|Open-Label Period|Study Termination|0
1088186|NCT02129777|3552738|P4|Open-Label Period|Study Termination|0
1088187|NCT02129777|3552739|P3|Open-Label Period|Study Termination|0
1088188|NCT02129777|3552740|P2|Open-Label Period|Study Termination|0
1088189|NCT02129777|3552741|P1|Open-Label Period|Study Termination|0
1088190|NCT02129777|3552735|P7|Open-Label Period|Withdrawal by Subject|3
1088191|NCT02129777|3552736|P6|Open-Label Period|Withdrawal by Subject|1
1088192|NCT02129777|3552737|P5|Open-Label Period|Withdrawal by Subject|0
1088193|NCT02129777|3552738|P4|Open-Label Period|Withdrawal by Subject|0
1088194|NCT02129777|3552739|P3|Open-Label Period|Withdrawal by Subject|0
1088195|NCT02129777|3552740|P2|Open-Label Period|Withdrawal by Subject|0
1088196|NCT02129777|3552741|P1|Open-Label Period|Withdrawal by Subject|0
1088197|NCT02129777|3552735|P7|Open-Label Period|Lost to Follow-up|1
1088198|NCT02129777|3552736|P6|Open-Label Period|Lost to Follow-up|1
1088199|NCT02129777|3552737|P5|Open-Label Period|Lost to Follow-up|0
1088200|NCT02129777|3552738|P4|Open-Label Period|Lost to Follow-up|0
1088201|NCT02129777|3552739|P3|Open-Label Period|Lost to Follow-up|0
1088202|NCT02129777|3552740|P2|Open-Label Period|Lost to Follow-up|0
1088203|NCT02129777|3552741|P1|Open-Label Period|Lost to Follow-up|0
1088204|NCT02129777|3552735|P7|Open-Label Period|Lack of Efficacy|5
1088205|NCT02129777|3552736|P6|Open-Label Period|Lack of Efficacy|0
1088206|NCT02129777|3552737|P5|Open-Label Period|Lack of Efficacy|0
1088207|NCT02129777|3552738|P4|Open-Label Period|Lack of Efficacy|0
1088208|NCT02129777|3552739|P3|Open-Label Period|Lack of Efficacy|0
1088209|NCT02129777|3552740|P2|Open-Label Period|Lack of Efficacy|0
1088210|NCT02129777|3552741|P1|Open-Label Period|Lack of Efficacy|0
1088211|NCT02129777|3552735|P7|Double-Blind Period|Other|0
1088212|NCT02129777|3552736|P6|Double-Blind Period|Other|0
1088213|NCT02129777|3552737|P5|Double-Blind Period|Other|0
1088214|NCT02129777|3552738|P4|Double-Blind Period|Other|0
1088215|NCT02129777|3552739|P3|Double-Blind Period|Other|0
1088216|NCT02129777|3552740|P2|Double-Blind Period|Other|2
1088217|NCT02129777|3552741|P1|Double-Blind Period|Other|1
1088218|NCT02129777|3552735|P7|Double-Blind Period|Lack of Efficacy|0
1088219|NCT02129777|3552736|P6|Double-Blind Period|Lack of Efficacy|0
1088220|NCT02129777|3552737|P5|Double-Blind Period|Lack of Efficacy|2
1088221|NCT02129777|3552738|P4|Double-Blind Period|Lack of Efficacy|3
1088222|NCT02129777|3552739|P3|Double-Blind Period|Lack of Efficacy|0
1088223|NCT02129777|3552740|P2|Double-Blind Period|Lack of Efficacy|1
1088224|NCT02129777|3552741|P1|Double-Blind Period|Lack of Efficacy|3
1088225|NCT02129777|3552735|P7|Double-Blind Period|Pregnancy|0
1088226|NCT02129777|3552736|P6|Double-Blind Period|Pregnancy|0
1088227|NCT02129777|3552737|P5|Double-Blind Period|Pregnancy|1
1088228|NCT02129777|3552738|P4|Double-Blind Period|Pregnancy|0
1088229|NCT02129777|3552739|P3|Double-Blind Period|Pregnancy|0
1088230|NCT02129777|3552740|P2|Double-Blind Period|Pregnancy|0
1088231|NCT02129777|3552741|P1|Double-Blind Period|Pregnancy|0
1088232|NCT02129777|3552735|P7|Double-Blind Period|Withdrawal by Subject|0
1088233|NCT02129777|3552736|P6|Double-Blind Period|Withdrawal by Subject|0
1088234|NCT02129777|3552737|P5|Double-Blind Period|Withdrawal by Subject|3
1088235|NCT02129777|3552738|P4|Double-Blind Period|Withdrawal by Subject|2
1088236|NCT02129777|3552739|P3|Double-Blind Period|Withdrawal by Subject|3
1088237|NCT02129777|3552740|P2|Double-Blind Period|Withdrawal by Subject|4
1088238|NCT02129777|3552741|P1|Double-Blind Period|Withdrawal by Subject|2
1088239|NCT02129777|3552735|P7|Double-Blind Period|Lost to Follow-up|0
1088240|NCT02129777|3552736|P6|Double-Blind Period|Lost to Follow-up|0
1088241|NCT02129777|3552737|P5|Double-Blind Period|Lost to Follow-up|0
1088242|NCT02129777|3552738|P4|Double-Blind Period|Lost to Follow-up|2
1088243|NCT02129777|3552739|P3|Double-Blind Period|Lost to Follow-up|1
1088244|NCT02129777|3552740|P2|Double-Blind Period|Lost to Follow-up|1
1088245|NCT02129777|3552741|P1|Double-Blind Period|Lost to Follow-up|1
1088246|NCT02129777|3552735|P7|Double-Blind Period|Adverse Event|0
1088247|NCT02129777|3552736|P6|Double-Blind Period|Adverse Event|0
1088248|NCT02129777|3552737|P5|Double-Blind Period|Adverse Event|1
1088249|NCT02129777|3552738|P4|Double-Blind Period|Adverse Event|0
1088250|NCT02129777|3552739|P3|Double-Blind Period|Adverse Event|0
1088251|NCT02129777|3552740|P2|Double-Blind Period|Adverse Event|0
1088252|NCT02129777|3552741|P1|Double-Blind Period|Adverse Event|0
1088253|NCT02129608|3552908|P3|Overall Study|Withdrawal by Subject|2
1088254|NCT02129608|3552909|P2|Overall Study|Withdrawal by Subject|0
1088255|NCT02129608|3552910|P1|Overall Study|Withdrawal by Subject|0
1088256|NCT02129608|3552908|P3|Overall Study|Lost to Follow-up|1
1088257|NCT02129608|3552909|P2|Overall Study|Lost to Follow-up|1
1088258|NCT02129608|3552910|P1|Overall Study|Lost to Follow-up|0
1088259|NCT02129192|3552923|P2|Period 1 Including Washout Period|Withdrawal by Subject|1
1088260|NCT02129192|3552924|P1|Period 1 Including Washout Period|Withdrawal by Subject|0
1088261|NCT02129062|3552941|P1|Overall Study|Disease Progression|2
1088262|NCT02129062|3552941|P1|Overall Study|Death|1
1088263|NCT02128997|3552948|P2|Overall Study|Lost to Follow-up|11
1088264|NCT02128997|3552949|P1|Overall Study|Lost to Follow-up|6
1088265|NCT02128932|3552964|P3|Overall Study|No reason for withdrawal|7
1088266|NCT02128932|3552965|P2|Overall Study|No reason for withdrawal|11
1088267|NCT02128932|3552966|P1|Overall Study|No reason for withdrawal|12
1088268|NCT02128932|3552964|P3|Overall Study|Lost to Follow-up|1
1088269|NCT02128932|3552965|P2|Overall Study|Lost to Follow-up|1
1088270|NCT02128932|3552966|P1|Overall Study|Lost to Follow-up|2
1088271|NCT02128932|3552964|P3|Overall Study|Death|2
1088272|NCT02128932|3552965|P2|Overall Study|Death|0
1088273|NCT02128932|3552966|P1|Overall Study|Death|2
1088274|NCT02128932|3552964|P3|Overall Study|Withdrawal by Subject|8
1088275|NCT02128932|3552965|P2|Overall Study|Withdrawal by Subject|7
1088276|NCT02128932|3552966|P1|Overall Study|Withdrawal by Subject|11
1088277|NCT02128542|3553023|P2|Overall Study|Withdrew Consent|0
1088278|NCT02128542|3553024|P1|Overall Study|Withdrew Consent|1
1088279|NCT02128542|3553023|P2|Overall Study|Lost to Follow-up|0
1088280|NCT02128542|3553024|P1|Overall Study|Lost to Follow-up|3
1088281|NCT02128490|3553042|P5|Overall Study|Other Miscellaneous Reasons|1
1088282|NCT02128490|3553043|P4|Overall Study|Other Miscellaneous Reasons|1
1088283|NCT02128490|3553044|P3|Overall Study|Other Miscellaneous Reasons|2
1088284|NCT02128490|3553045|P2|Overall Study|Other Miscellaneous Reasons|0
1088285|NCT02128490|3553046|P1|Overall Study|Other Miscellaneous Reasons|0
1088286|NCT02128490|3553042|P5|Overall Study|Withdraw from Study Drug, Gout Flare|1
1088287|NCT02128490|3553043|P4|Overall Study|Withdraw from Study Drug, Gout Flare|0
1088288|NCT02128490|3553044|P3|Overall Study|Withdraw from Study Drug, Gout Flare|0
1088289|NCT02128490|3553045|P2|Overall Study|Withdraw from Study Drug, Gout Flare|0
1088290|NCT02128490|3553046|P1|Overall Study|Withdraw from Study Drug, Gout Flare|0
1088291|NCT02128490|3553042|P5|Overall Study|Lack of Efficacy|0
1088292|NCT02128490|3553043|P4|Overall Study|Lack of Efficacy|0
1088293|NCT02128490|3553044|P3|Overall Study|Lack of Efficacy|0
1088294|NCT02128490|3553045|P2|Overall Study|Lack of Efficacy|1
1088295|NCT02128490|3553046|P1|Overall Study|Lack of Efficacy|0
1088296|NCT02128490|3553042|P5|Overall Study|Voluntary Withdrawal|2
1088297|NCT02128490|3553043|P4|Overall Study|Voluntary Withdrawal|1
1088298|NCT02128490|3553044|P3|Overall Study|Voluntary Withdrawal|1
1088299|NCT02128490|3553045|P2|Overall Study|Voluntary Withdrawal|3
1088300|NCT02128490|3553046|P1|Overall Study|Voluntary Withdrawal|3
1088301|NCT02128490|3553042|P5|Overall Study|Lost to Follow-up|1
1088302|NCT02128490|3553043|P4|Overall Study|Lost to Follow-up|1
1088303|NCT02128490|3553044|P3|Overall Study|Lost to Follow-up|1
1088304|NCT02128490|3553045|P2|Overall Study|Lost to Follow-up|0
1088305|NCT02128490|3553046|P1|Overall Study|Lost to Follow-up|0
1088306|NCT02128490|3553042|P5|Overall Study|Major Protocol Deviation|2
1088307|NCT02128490|3553043|P4|Overall Study|Major Protocol Deviation|2
1088308|NCT02128490|3553044|P3|Overall Study|Major Protocol Deviation|0
1088309|NCT02128490|3553045|P2|Overall Study|Major Protocol Deviation|2
1088310|NCT02128490|3553046|P1|Overall Study|Major Protocol Deviation|1
1088311|NCT02128490|3553042|P5|Overall Study|Pretreatment Event/Adverse Event|0
1088312|NCT02128490|3553043|P4|Overall Study|Pretreatment Event/Adverse Event|1
1088313|NCT02128490|3553044|P3|Overall Study|Pretreatment Event/Adverse Event|1
1088314|NCT02128490|3553045|P2|Overall Study|Pretreatment Event/Adverse Event|0
1088315|NCT02128490|3553046|P1|Overall Study|Pretreatment Event/Adverse Event|1
1088316|NCT02128269|3553068|P1|Treatment Period|Physician Decision|1
1088317|NCT02128269|3553068|P1|Treatment Period|Adverse Event|1
1088318|NCT02128217|3553074|P2|Overall Study|Lost to Follow-up|1
1088319|NCT02128217|3553075|P1|Overall Study|Lost to Follow-up|0
1088320|NCT02127970|3553123|P2|Overall Study|Subject Withdrew Consent|3
1088321|NCT02127970|3553124|P1|Overall Study|Subject Withdrew Consent|5
1088322|NCT02127970|3553123|P2|Overall Study|Pregnancy|1
1088323|NCT02127970|3553124|P1|Overall Study|Pregnancy|0
1088324|NCT02127970|3553123|P2|Overall Study|Reason not Specified|7
1088325|NCT02127970|3553124|P1|Overall Study|Reason not Specified|4
1088326|NCT02127970|3553123|P2|Overall Study|Lost to Follow-up|14
1088327|NCT02127970|3553124|P1|Overall Study|Lost to Follow-up|14
1088328|NCT02127970|3553123|P2|Overall Study|Death|1
1088329|NCT02127970|3553124|P1|Overall Study|Death|1
1088330|NCT02127970|3553123|P2|Overall Study|Adverse Event|1
1088331|NCT02127970|3553124|P1|Overall Study|Adverse Event|2
1088332|NCT02127372|3553259|P2|Overall Study|Withdrawal by Subject|0
1088333|NCT02127372|3553260|P1|Overall Study|Withdrawal by Subject|1
1088334|NCT02127307|3553270|P1|Overall Study|Other than specified above|169
1088335|NCT02127307|3553270|P1|Overall Study|Death|101
1088336|NCT02127307|3553270|P1|Overall Study|Lost to Follow-up|2
1088337|NCT02127307|3553270|P1|Overall Study|Protocol Violation|36
1088338|NCT02127281|3553276|P2|Overall Study|Lost to Follow-up|0
1088339|NCT02127281|3553277|P1|Overall Study|Lost to Follow-up|1
1088340|NCT02126839|3553305|P2|Overall Study|Not specified|5
1088341|NCT02126839|3553306|P1|Overall Study|Not specified|5
1088342|NCT02126839|3553305|P2|Overall Study|Lost to Follow-up|4
1088343|NCT02126839|3553306|P1|Overall Study|Lost to Follow-up|1
1088344|NCT02126839|3553305|P2|Overall Study|Sponsor request|1
1088345|NCT02126839|3553306|P1|Overall Study|Sponsor request|0
1088346|NCT02126839|3553305|P2|Overall Study|Protocol Violation|3
1088347|NCT02126839|3553306|P1|Overall Study|Protocol Violation|2
1088348|NCT02126839|3553305|P2|Overall Study|Withdrawal by parent/guardian|0
1088349|NCT02126839|3553306|P1|Overall Study|Withdrawal by parent/guardian|1
1088350|NCT02126839|3553305|P2|Overall Study|Withdrawal by Subject|0
1088351|NCT02126839|3553306|P1|Overall Study|Withdrawal by Subject|1
1088352|NCT02126839|3553305|P2|Overall Study|Adverse Event|1
1088353|NCT02126839|3553306|P1|Overall Study|Adverse Event|0
1088354|NCT02126670|3553333|P4|Overall Study|Withdrawal by Subject|1
1088355|NCT02126670|3553334|P3|Overall Study|Withdrawal by Subject|0
1088356|NCT02126670|3553335|P2|Overall Study|Withdrawal by Subject|0
1088357|NCT02126670|3553336|P1|Overall Study|Withdrawal by Subject|1
1088358|NCT02125877|3553388|P2|Overall Study|Adverse Event|4
1088359|NCT02125877|3553389|P1|Overall Study|Adverse Event|6
1088360|NCT02125877|3553388|P2|Overall Study|Protocol deviation|1
1088361|NCT02125877|3553389|P1|Overall Study|Protocol deviation|4
1088362|NCT02125877|3553388|P2|Overall Study|Withdrawal by Subject|1
1088363|NCT02125877|3553389|P1|Overall Study|Withdrawal by Subject|2
1088364|NCT02125877|3553388|P2|Overall Study|Participant/guardian decision|2
1088365|NCT02125877|3553389|P1|Overall Study|Participant/guardian decision|0
1088366|NCT02125877|3553388|P2|Overall Study|Administrative problems|1
1088367|NCT02125877|3553389|P1|Overall Study|Administrative problems|0
1088368|NCT02125877|3553388|P2|Overall Study|Death|1
1088369|NCT02125877|3553389|P1|Overall Study|Death|0
1088370|NCT02125877|3553388|P2|Overall Study|Physician Decision|0
1088371|NCT02125877|3553389|P1|Overall Study|Physician Decision|1
1088372|NCT02125838|3553419|P2|Overall Study|Lost to Follow-up|4
1088373|NCT02125838|3553420|P1|Overall Study|Lost to Follow-up|4
1088374|NCT02125734|3553438|P2|Period 2|Adverse Event|1
1088375|NCT02125734|3553439|P1|Period 2|Adverse Event|0
1088376|NCT02125604|3553449|P1|Overall Study|Adverse Event|20
1088377|NCT02125604|3553449|P1|Overall Study|Consent Withdrawn|4
1088378|NCT02125604|3553449|P1|Overall Study|Lost to Follow-up|2
1088379|NCT02125604|3553449|P1|Overall Study|Investigator Decision|1
1088380|NCT02125604|3553449|P1|Overall Study|Not Specified|4
1088381|NCT02124811|3553497|P2|Overall Study|Withdrawal by Subject|0
1088382|NCT02124811|3553498|P1|Overall Study|Withdrawal by Subject|1
1088383|NCT02124811|3553497|P2|Overall Study|Early termination|2
1088384|NCT02124811|3553498|P1|Overall Study|Early termination|2
1088385|NCT02124798|3553514|P1|Overall Study|Lost to Follow-up|1
1088386|NCT02124798|3553514|P1|Overall Study|Adverse Event|3
1088387|NCT02124161|3553572|P2|Overall Study|Lost to Follow-up|4
1088388|NCT02124161|3553573|P1|Overall Study|Lost to Follow-up|3
1088389|NCT02124161|3553572|P2|Overall Study|No longer meets eligibility criteria|4
1088390|NCT02124161|3553573|P1|Overall Study|No longer meets eligibility criteria|5
1088391|NCT02124161|3553572|P2|Overall Study|Does not meet entrance criteria|3
1088392|NCT02124161|3553573|P1|Overall Study|Does not meet entrance criteria|2
1088393|NCT02124161|3553572|P2|Overall Study|Adverse Event|0
1088394|NCT02124161|3553573|P1|Overall Study|Adverse Event|2
1088395|NCT02124161|3553572|P2|Overall Study|Withdrawal by Subject|2
1088396|NCT02124161|3553573|P1|Overall Study|Withdrawal by Subject|1
1088397|NCT02124161|3553572|P2|Overall Study|Protocol Violation|1
1088398|NCT02124161|3553573|P1|Overall Study|Protocol Violation|2
1088399|NCT02124161|3553572|P2|Overall Study|Death|0
1088400|NCT02124161|3553573|P1|Overall Study|Death|1
1088401|NCT02124161|3553572|P2|Overall Study|Other unspecified|1
1088402|NCT02124161|3553573|P1|Overall Study|Other unspecified|0
1088403|NCT02123966|3553632|P1|Overall Study|Intercurrent Illness|1
1088404|NCT02123472|3553672|P2|Period 2 (7 Days)|Withdrawal by Subject|1
1088405|NCT02123472|3553673|P1|Period 2 (7 Days)|Withdrawal by Subject|0
1088406|NCT02123459|3553683|P2|Washout Period (1 Day)|Adverse Event|0
1088407|NCT02123459|3553684|P1|Washout Period (1 Day)|Adverse Event|1
1088408|NCT02123446|3553694|P2|Washout Period (1 Day)|Physician Decision|0
1088409|NCT02123446|3553695|P1|Washout Period (1 Day)|Physician Decision|1
1088410|NCT02122146|3553793|P8|Part 1: Dose Escalation|Other|2
1088411|NCT02122146|3553794|P7|Part 1: Dose Escalation|Other|1
1088412|NCT02122146|3553795|P6|Part 1: Dose Escalation|Other|1
1088413|NCT02122146|3553796|P5|Part 1: Dose Escalation|Other|0
1088414|NCT02122146|3553797|P4|Part 1: Dose Escalation|Other|0
1088415|NCT02122146|3553798|P3|Part 1: Dose Escalation|Other|0
1088416|NCT02122146|3553799|P2|Part 1: Dose Escalation|Other|0
1088417|NCT02122146|3553800|P1|Part 1: Dose Escalation|Other|1
1088418|NCT02122146|3553793|P8|Part 1: Dose Escalation|Withdrawal by Subject|0
1088419|NCT02122146|3553794|P7|Part 1: Dose Escalation|Withdrawal by Subject|0
1088420|NCT02122146|3553795|P6|Part 1: Dose Escalation|Withdrawal by Subject|0
1088421|NCT02122146|3553796|P5|Part 1: Dose Escalation|Withdrawal by Subject|0
1088422|NCT02122146|3553797|P4|Part 1: Dose Escalation|Withdrawal by Subject|1
1088423|NCT02122146|3553798|P3|Part 1: Dose Escalation|Withdrawal by Subject|0
1088424|NCT02122146|3553799|P2|Part 1: Dose Escalation|Withdrawal by Subject|0
1088425|NCT02122146|3553800|P1|Part 1: Dose Escalation|Withdrawal by Subject|0
1088426|NCT02122146|3553793|P8|Part 1: Dose Escalation|Lost to Follow-up|0
1088427|NCT02122146|3553794|P7|Part 1: Dose Escalation|Lost to Follow-up|0
1088428|NCT02122146|3553795|P6|Part 1: Dose Escalation|Lost to Follow-up|0
1088429|NCT02122146|3553796|P5|Part 1: Dose Escalation|Lost to Follow-up|1
1088430|NCT02122146|3553797|P4|Part 1: Dose Escalation|Lost to Follow-up|0
1088431|NCT02122146|3553798|P3|Part 1: Dose Escalation|Lost to Follow-up|1
1088432|NCT02122146|3553799|P2|Part 1: Dose Escalation|Lost to Follow-up|0
1088433|NCT02122146|3553800|P1|Part 1: Dose Escalation|Lost to Follow-up|0
1088434|NCT02122146|3553793|P8|Part 1: Dose Escalation|Death|0
1088435|NCT02122146|3553794|P7|Part 1: Dose Escalation|Death|0
1088436|NCT02122146|3553795|P6|Part 1: Dose Escalation|Death|0
1088437|NCT02122146|3553796|P5|Part 1: Dose Escalation|Death|0
1088438|NCT02122146|3553797|P4|Part 1: Dose Escalation|Death|0
1088439|NCT02122146|3553798|P3|Part 1: Dose Escalation|Death|1
1088440|NCT02122146|3553799|P2|Part 1: Dose Escalation|Death|1
1088441|NCT02122146|3553800|P1|Part 1: Dose Escalation|Death|0
1088442|NCT02121847|3554061|P1|Overall Study|Adverse Event|2
1088443|NCT02121847|3554061|P1|Overall Study|Administrative Reasons|1
1088444|NCT02121834|3554087|P7|Overall Study|Lost to Follow-up|0
1088445|NCT02121834|3554088|P6|Overall Study|Lost to Follow-up|0
1088446|NCT02121834|3554089|P5|Overall Study|Lost to Follow-up|0
1088447|NCT02121834|3554090|P4|Overall Study|Lost to Follow-up|0
1088448|NCT02121834|3554091|P3|Overall Study|Lost to Follow-up|1
1088449|NCT02121834|3554092|P2|Overall Study|Lost to Follow-up|0
1088450|NCT02121834|3554093|P1|Overall Study|Lost to Follow-up|0
1088451|NCT02121834|3554087|P7|Overall Study|Withdrawal by Subject|0
1088452|NCT02121834|3554088|P6|Overall Study|Withdrawal by Subject|0
1088453|NCT02121834|3554089|P5|Overall Study|Withdrawal by Subject|0
1088454|NCT02121834|3554090|P4|Overall Study|Withdrawal by Subject|0
1088455|NCT02121834|3554091|P3|Overall Study|Withdrawal by Subject|1
1088456|NCT02121834|3554092|P2|Overall Study|Withdrawal by Subject|1
1088457|NCT02121834|3554093|P1|Overall Study|Withdrawal by Subject|0
1088458|NCT02121834|3554087|P7|Overall Study|Protocol Violation|0
1088459|NCT02121834|3554088|P6|Overall Study|Protocol Violation|0
1088460|NCT02121834|3554089|P5|Overall Study|Protocol Violation|0
1088461|NCT02121834|3554090|P4|Overall Study|Protocol Violation|0
1088462|NCT02121834|3554091|P3|Overall Study|Protocol Violation|0
1088463|NCT02121834|3554092|P2|Overall Study|Protocol Violation|1
1088464|NCT02121834|3554093|P1|Overall Study|Protocol Violation|0
1088465|NCT02121808|3554119|P1|Overall Study|Technical problem|3
1088466|NCT02121795|3554130|P2|Overall Study|Still in Study up to the Data Cut Date|316
1088467|NCT02121795|3554131|P1|Overall Study|Still in Study up to the Data Cut Date|315
1088468|NCT02121795|3554130|P2|Overall Study|Lost to Follow-up|1
1088469|NCT02121795|3554131|P1|Overall Study|Lost to Follow-up|2
1088470|NCT02121795|3554130|P2|Overall Study|Withdrew Consent|10
1088471|NCT02121795|3554131|P1|Overall Study|Withdrew Consent|10
1088472|NCT02121795|3554130|P2|Overall Study|Protocol Violation|2
1088473|NCT02121795|3554131|P1|Overall Study|Protocol Violation|0
1088474|NCT02121795|3554130|P2|Overall Study|Non-Compliance with Study Drug|1
1088475|NCT02121795|3554131|P1|Overall Study|Non-Compliance with Study Drug|1
1088476|NCT02121795|3554130|P2|Overall Study|Investigator's Discretion|0
1088477|NCT02121795|3554131|P1|Overall Study|Investigator's Discretion|1
1088478|NCT02121795|3554130|P2|Overall Study|Adverse Event|0
1088479|NCT02121795|3554131|P1|Overall Study|Adverse Event|4
1088480|NCT02121795|3554130|P2|Overall Study|Randomized but Never Treated|4
1088481|NCT02121795|3554131|P1|Overall Study|Randomized but Never Treated|1
1088482|NCT02121535|3554147|P2|Period 3 (8 Trial Days)|Withdrawal by Subject|0
1088483|NCT02121535|3554148|P1|Period 3 (8 Trial Days)|Withdrawal by Subject|1
1088484|NCT02121535|3554147|P2|Period 1 (8 Trial Days)|Withdrawal by Subject|1
1088485|NCT02121535|3554148|P1|Period 1 (8 Trial Days)|Withdrawal by Subject|0
1088486|NCT02121522|3554171|P1|Overall Study|Adverse Event|1
1088487|NCT02121509|3554178|P4|Washout Period (35 Days)|elevated AST and ALT levels|0
1088488|NCT02121509|3554179|P3|Washout Period (35 Days)|elevated AST and ALT levels|0
1088489|NCT02121509|3554180|P2|Washout Period (35 Days)|elevated AST and ALT levels|0
1088490|NCT02121509|3554181|P1|Washout Period (35 Days)|elevated AST and ALT levels|1
1088491|NCT02121509|3554178|P4|Washout Period (35 Days)|Withdrawal by Subject|0
1088492|NCT02121509|3554179|P3|Washout Period (35 Days)|Withdrawal by Subject|0
1088493|NCT02121509|3554180|P2|Washout Period (35 Days)|Withdrawal by Subject|3
1088494|NCT02121509|3554181|P1|Washout Period (35 Days)|Withdrawal by Subject|0
1088495|NCT02121509|3554178|P4|Washout Period (35 Days)|Adverse Event|0
1088496|NCT02121509|3554179|P3|Washout Period (35 Days)|Adverse Event|0
1088497|NCT02121509|3554180|P2|Washout Period (35 Days)|Adverse Event|1
1088498|NCT02121509|3554181|P1|Washout Period (35 Days)|Adverse Event|1
1088499|NCT02121210|3554252|P2|Overall Study|Other than specified above|2
1088500|NCT02121210|3554253|P1|Overall Study|Other than specified above|0
1088501|NCT02121210|3554252|P2|Overall Study|Lack of Efficacy|0
1088502|NCT02121210|3554253|P1|Overall Study|Lack of Efficacy|2
1088503|NCT02121210|3554252|P2|Overall Study|Adverse Event|7
1088504|NCT02121210|3554253|P1|Overall Study|Adverse Event|5
1088505|NCT02120833|3554278|P2|Overall Study|Lost to Follow-up|1
1088506|NCT02120833|3554279|P1|Overall Study|Lost to Follow-up|1
1088507|NCT02120833|3554278|P2|Overall Study|Withdrawal by Subject|0
1088508|NCT02120833|3554279|P1|Overall Study|Withdrawal by Subject|2
1088509|NCT02120833|3554278|P2|Overall Study|Adverse Event|0
1088510|NCT02120833|3554279|P1|Overall Study|Adverse Event|1
1088511|NCT02120794|3554433|P1|Overall Study|Due to insurance coverage|1
1088512|NCT02120794|3554433|P1|Overall Study|Physician Decision|4
1088513|NCT02120794|3554433|P1|Overall Study|Adverse Event|10
1088514|NCT02120794|3554433|P1|Overall Study|Withdrawal by Subject|43
1088515|NCT02120664|3554457|P5|Overall Study|Withdrawal by Subject|0
1088516|NCT02120664|3554458|P4|Overall Study|Withdrawal by Subject|1
1088517|NCT02120664|3554459|P3|Overall Study|Withdrawal by Subject|0
1088518|NCT02120664|3554460|P2|Overall Study|Withdrawal by Subject|0
1088519|NCT02120664|3554461|P1|Overall Study|Withdrawal by Subject|0
1088520|NCT02120625|3554479|P1|Overall Study|Physician Decision|2
1088521|NCT02120417|3554494|P2|Overall Study|Other unspecified|4
1088522|NCT02120417|3554495|P1|Overall Study|Other unspecified|5
1088523|NCT02120417|3554494|P2|Overall Study|Physician Decision|3
1088524|NCT02120417|3554495|P1|Overall Study|Physician Decision|2
1088525|NCT02120417|3554494|P2|Overall Study|Noncompliance with study treatment|2
1088526|NCT02120417|3554495|P1|Overall Study|Noncompliance with study treatment|0
1088527|NCT02120417|3554494|P2|Overall Study|Disease progression|45
1088528|NCT02120417|3554495|P1|Overall Study|Disease progression|41
1088529|NCT02120417|3554494|P2|Overall Study|Participant decision|4
1088530|NCT02120417|3554495|P1|Overall Study|Participant decision|4
1088531|NCT02120417|3554494|P2|Overall Study|Adverse Event|9
1088532|NCT02120417|3554495|P1|Overall Study|Adverse Event|3
1088533|NCT02120417|3554494|P2|Overall Study|Death|1
1088534|NCT02120417|3554495|P1|Overall Study|Death|5
1088535|NCT02120300|3554517|P4|Overall Study|Lost to Follow-up|0
1088536|NCT02120300|3554518|P3|Overall Study|Lost to Follow-up|0
1088537|NCT02120300|3554519|P2|Overall Study|Lost to Follow-up|0
1088538|NCT02120300|3554520|P1|Overall Study|Lost to Follow-up|1
1088539|NCT02120300|3554517|P4|Overall Study|Lack of Efficacy|1
1088540|NCT02120300|3554518|P3|Overall Study|Lack of Efficacy|0
1088541|NCT02120300|3554519|P2|Overall Study|Lack of Efficacy|0
1088542|NCT02120300|3554520|P1|Overall Study|Lack of Efficacy|0
1088543|NCT02120300|3554517|P4|Overall Study|Enrolled but Never Treated|0
1088544|NCT02120300|3554518|P3|Overall Study|Enrolled but Never Treated|0
1088545|NCT02120300|3554519|P2|Overall Study|Enrolled but Never Treated|0
1088546|NCT02120300|3554520|P1|Overall Study|Enrolled but Never Treated|2
1088547|NCT02120027|3554558|P2|Overall Study|Withdrawal by Subject|25
1088548|NCT02120027|3554559|P1|Overall Study|Withdrawal by Subject|33
1088549|NCT02120027|3554558|P2|Overall Study|Study terminated by Sponsor|47
1088550|NCT02120027|3554559|P1|Overall Study|Study terminated by Sponsor|45
1088551|NCT02120027|3554558|P2|Overall Study|Protocol Violation|21
1088552|NCT02120027|3554559|P1|Overall Study|Protocol Violation|18
1088553|NCT02120027|3554558|P2|Overall Study|Physician Decision|3
1088554|NCT02120027|3554559|P1|Overall Study|Physician Decision|4
1088555|NCT02120027|3554558|P2|Overall Study|Other|0
1088556|NCT02120027|3554559|P1|Overall Study|Other|4
1088557|NCT02120027|3554558|P2|Overall Study|Lost to Follow-up|13
1088558|NCT02120027|3554559|P1|Overall Study|Lost to Follow-up|5
1088559|NCT02120027|3554558|P2|Overall Study|Lack of Efficacy|5
1088560|NCT02120027|3554559|P1|Overall Study|Lack of Efficacy|3
1088561|NCT02120027|3554558|P2|Overall Study|Adverse Event|5
1088562|NCT02120027|3554559|P1|Overall Study|Adverse Event|4
1088563|NCT02119936|3554584|P1|Overall Study|Lost to Follow-up|10
1088564|NCT02119676|3554618|P4|Overall Study|Did not receive study med|5
1088565|NCT02119676|3554619|P3|Overall Study|Did not receive study med|4
1088566|NCT02119676|3554620|P2|Overall Study|Did not receive study med|2
1088567|NCT02119676|3554621|P1|Overall Study|Did not receive study med|2
1088568|NCT02119676|3554618|P4|Overall Study|Other, unspecified|4
1088569|NCT02119676|3554619|P3|Overall Study|Other, unspecified|3
1088570|NCT02119676|3554620|P2|Overall Study|Other, unspecified|1
1088571|NCT02119676|3554621|P1|Overall Study|Other, unspecified|2
1088572|NCT02119676|3554618|P4|Overall Study|Protocol deviation|0
1088573|NCT02119676|3554619|P3|Overall Study|Protocol deviation|1
1088574|NCT02119676|3554620|P2|Overall Study|Protocol deviation|0
1088575|NCT02119676|3554621|P1|Overall Study|Protocol deviation|0
1088576|NCT02119676|3554618|P4|Overall Study|Lost to Follow-up|0
1088577|NCT02119676|3554619|P3|Overall Study|Lost to Follow-up|1
1088578|NCT02119676|3554620|P2|Overall Study|Lost to Follow-up|0
1088579|NCT02119676|3554621|P1|Overall Study|Lost to Follow-up|0
1088580|NCT02119676|3554618|P4|Overall Study|Noncompliance|0
1088581|NCT02119676|3554619|P3|Overall Study|Noncompliance|0
1088582|NCT02119676|3554620|P2|Overall Study|Noncompliance|1
1088583|NCT02119676|3554621|P1|Overall Study|Noncompliance|0
1088584|NCT02119676|3554618|P4|Overall Study|Death|1
1088585|NCT02119676|3554619|P3|Overall Study|Death|2
1088586|NCT02119676|3554620|P2|Overall Study|Death|3
1088587|NCT02119676|3554621|P1|Overall Study|Death|9
1088588|NCT02119676|3554618|P4|Overall Study|Physician Decision|2
1088589|NCT02119676|3554619|P3|Overall Study|Physician Decision|3
1088590|NCT02119676|3554620|P2|Overall Study|Physician Decision|2
1088591|NCT02119676|3554621|P1|Overall Study|Physician Decision|4
1088592|NCT02119676|3554618|P4|Overall Study|Patient decision, inc. consent withdrawn|6
1088593|NCT02119676|3554619|P3|Overall Study|Patient decision, inc. consent withdrawn|5
1088594|NCT02119676|3554620|P2|Overall Study|Patient decision, inc. consent withdrawn|5
1088595|NCT02119676|3554621|P1|Overall Study|Patient decision, inc. consent withdrawn|4
1088596|NCT02119676|3554618|P4|Overall Study|Disease progression|73
1088597|NCT02119676|3554619|P3|Overall Study|Disease progression|68
1088598|NCT02119676|3554620|P2|Overall Study|Disease progression|55
1088599|NCT02119676|3554621|P1|Overall Study|Disease progression|53
1088600|NCT02119676|3554618|P4|Overall Study|Adverse Event|10
1088601|NCT02119676|3554619|P3|Overall Study|Adverse Event|10
1088602|NCT02119676|3554620|P2|Overall Study|Adverse Event|17
1088603|NCT02119676|3554621|P1|Overall Study|Adverse Event|9
1088604|NCT02119663|3554653|P2|Overall Study|Study Terminated by the Sponsor|4
1088605|NCT02119663|3554654|P1|Overall Study|Study Terminated by the Sponsor|3
1088606|NCT02119663|3554653|P2|Overall Study|Subject decision|1
1088607|NCT02119663|3554654|P1|Overall Study|Subject decision|0
1088608|NCT02119663|3554653|P2|Overall Study|Other unspecified|0
1088609|NCT02119663|3554654|P1|Overall Study|Other unspecified|2
1088610|NCT02119663|3554653|P2|Overall Study|Physician Decision|2
1088611|NCT02119663|3554654|P1|Overall Study|Physician Decision|1
1088612|NCT02119663|3554653|P2|Overall Study|Death|2
1088613|NCT02119663|3554654|P1|Overall Study|Death|3
1088614|NCT02119663|3554653|P2|Overall Study|Adverse Event|5
1088615|NCT02119663|3554654|P1|Overall Study|Adverse Event|5
1088616|NCT02119663|3554653|P2|Overall Study|Disease progression|27
1088617|NCT02119663|3554654|P1|Overall Study|Disease progression|26
1088618|NCT02119650|3554672|P2|Overall Study|Multiple reasons for termination|1
1088619|NCT02119650|3554673|P1|Overall Study|Multiple reasons for termination|2
1088620|NCT02119650|3554672|P2|Overall Study|Physician Decision|2
1088621|NCT02119650|3554673|P1|Overall Study|Physician Decision|0
1088622|NCT02119650|3554672|P2|Overall Study|Study terminated by the sponsor|0
1088623|NCT02119650|3554673|P1|Overall Study|Study terminated by the sponsor|1
1088624|NCT02119650|3554672|P2|Overall Study|Noncompliance with study treatment|1
1088625|NCT02119650|3554673|P1|Overall Study|Noncompliance with study treatment|1
1088626|NCT02119650|3554672|P2|Overall Study|Death|1
1088627|NCT02119650|3554673|P1|Overall Study|Death|5
1088628|NCT02119650|3554672|P2|Overall Study|Disease progression|14
1088629|NCT02119650|3554673|P1|Overall Study|Disease progression|11
1088630|NCT02119650|3554672|P2|Overall Study|Subject decision|3
1088631|NCT02119650|3554673|P1|Overall Study|Subject decision|2
1088632|NCT02119650|3554672|P2|Overall Study|Adverse Event|4
1088633|NCT02119650|3554673|P1|Overall Study|Adverse Event|3
1088634|NCT02119325|3554687|P2|Washout Period 1|Adverse Event|1
1088635|NCT02119325|3554688|P1|Washout Period 1|Adverse Event|0
1088636|NCT02119299|3554732|P1|Overall Study|Pregnancy|1
1088637|NCT02119299|3554732|P1|Overall Study|Lack of Efficacy|1
1088638|NCT02119299|3554732|P1|Overall Study|Withdrawal by Subject|7
1088639|NCT02119286|3554746|P3|Overall Study|Withdrawal by Subject|0
1088640|NCT02119286|3554747|P2|Overall Study|Withdrawal by Subject|1
1088641|NCT02119286|3554748|P1|Overall Study|Withdrawal by Subject|4
1088642|NCT02119286|3554746|P3|Overall Study|Lost to Follow-up|1
1088643|NCT02119286|3554747|P2|Overall Study|Lost to Follow-up|0
1088644|NCT02119286|3554748|P1|Overall Study|Lost to Follow-up|2
1088645|NCT02119286|3554746|P3|Overall Study|Lack of Efficacy|4
1088646|NCT02119286|3554747|P2|Overall Study|Lack of Efficacy|3
1088647|NCT02119286|3554748|P1|Overall Study|Lack of Efficacy|11
1088648|NCT02119286|3554746|P3|Overall Study|Adverse Event|2
1088649|NCT02119286|3554747|P2|Overall Study|Adverse Event|7
1088650|NCT02119286|3554748|P1|Overall Study|Adverse Event|9
1088651|NCT02119260|3554766|P7|Overall Study|Withdrew consent|0
1088652|NCT02119260|3554767|P6|Overall Study|Withdrew consent|0
1088653|NCT02119260|3554768|P5|Overall Study|Withdrew consent|0
1088654|NCT02119260|3554769|P4|Overall Study|Withdrew consent|0
1088655|NCT02119260|3554770|P3|Overall Study|Withdrew consent|1
1088656|NCT02119260|3554771|P2|Overall Study|Withdrew consent|1
1088657|NCT02119260|3554772|P1|Overall Study|Withdrew consent|0
1088658|NCT02119260|3554766|P7|Overall Study|Adverse Event|0
1088659|NCT02119260|3554767|P6|Overall Study|Adverse Event|0
1088660|NCT02119260|3554768|P5|Overall Study|Adverse Event|0
1088661|NCT02119260|3554769|P4|Overall Study|Adverse Event|0
1088662|NCT02119260|3554770|P3|Overall Study|Adverse Event|0
1088663|NCT02119260|3554771|P2|Overall Study|Adverse Event|0
1088664|NCT02119260|3554772|P1|Overall Study|Adverse Event|1
1088665|NCT02119104|3554842|P1|Overall Study|Protocol Violation|16
1088666|NCT02118961|3554848|P2|Overall Study|Withdrawal by Subject|0
1088667|NCT02118961|3554849|P1|Overall Study|Withdrawal by Subject|1
1088668|NCT02118896|3554877|P10|Overall Study|Miscellaneous|0
1088669|NCT02118896|3554878|P9|Overall Study|Miscellaneous|0
1088670|NCT02118896|3554879|P8|Overall Study|Miscellaneous|0
1088671|NCT02118896|3554880|P7|Overall Study|Miscellaneous|0
1088672|NCT02118896|3554881|P6|Overall Study|Miscellaneous|4
1088673|NCT02118896|3554882|P5|Overall Study|Miscellaneous|0
1088674|NCT02118896|3554883|P4|Overall Study|Miscellaneous|2
1088675|NCT02118896|3554884|P3|Overall Study|Miscellaneous|0
1088676|NCT02118896|3554885|P2|Overall Study|Miscellaneous|2
1088677|NCT02118896|3554886|P1|Overall Study|Miscellaneous|1
1088678|NCT02118896|3554877|P10|Overall Study|Prohibited medication|0
1088679|NCT02118896|3554878|P9|Overall Study|Prohibited medication|0
1088680|NCT02118896|3554879|P8|Overall Study|Prohibited medication|0
1088681|NCT02118896|3554880|P7|Overall Study|Prohibited medication|0
1088682|NCT02118896|3554881|P6|Overall Study|Prohibited medication|3
1088683|NCT02118896|3554882|P5|Overall Study|Prohibited medication|1
1088684|NCT02118896|3554883|P4|Overall Study|Prohibited medication|0
1088685|NCT02118896|3554884|P3|Overall Study|Prohibited medication|0
1088686|NCT02118896|3554885|P2|Overall Study|Prohibited medication|0
1088687|NCT02118896|3554886|P1|Overall Study|Prohibited medication|0
1088688|NCT02118896|3554877|P10|Overall Study|Immunosuppressive regimen (not MR4)|2
1088689|NCT02118896|3554878|P9|Overall Study|Immunosuppressive regimen (not MR4)|0
1088690|NCT02118896|3554879|P8|Overall Study|Immunosuppressive regimen (not MR4)|0
1088691|NCT02118896|3554880|P7|Overall Study|Immunosuppressive regimen (not MR4)|0
1088692|NCT02118896|3554881|P6|Overall Study|Immunosuppressive regimen (not MR4)|2
1088693|NCT02118896|3554882|P5|Overall Study|Immunosuppressive regimen (not MR4)|4
1088694|NCT02118896|3554883|P4|Overall Study|Immunosuppressive regimen (not MR4)|2
1088695|NCT02118896|3554884|P3|Overall Study|Immunosuppressive regimen (not MR4)|1
1088696|NCT02118896|3554885|P2|Overall Study|Immunosuppressive regimen (not MR4)|5
1088697|NCT02118896|3554886|P1|Overall Study|Immunosuppressive regimen (not MR4)|1
1088698|NCT02118896|3554877|P10|Overall Study|Lost to Follow-up|0
1088699|NCT02118896|3554878|P9|Overall Study|Lost to Follow-up|0
1088700|NCT02118896|3554879|P8|Overall Study|Lost to Follow-up|0
1088701|NCT02118896|3554880|P7|Overall Study|Lost to Follow-up|0
1088702|NCT02118896|3554881|P6|Overall Study|Lost to Follow-up|1
1088703|NCT02118896|3554882|P5|Overall Study|Lost to Follow-up|2
1088704|NCT02118896|3554883|P4|Overall Study|Lost to Follow-up|0
1088705|NCT02118896|3554884|P3|Overall Study|Lost to Follow-up|1
1088706|NCT02118896|3554885|P2|Overall Study|Lost to Follow-up|2
1088707|NCT02118896|3554886|P1|Overall Study|Lost to Follow-up|1
1088708|NCT02118896|3554877|P10|Overall Study|Pregnancy|0
1088709|NCT02118896|3554878|P9|Overall Study|Pregnancy|0
1088710|NCT02118896|3554879|P8|Overall Study|Pregnancy|0
1088711|NCT02118896|3554880|P7|Overall Study|Pregnancy|1
1088712|NCT02118896|3554881|P6|Overall Study|Pregnancy|3
1088713|NCT02118896|3554882|P5|Overall Study|Pregnancy|1
1088714|NCT02118896|3554883|P4|Overall Study|Pregnancy|0
1088715|NCT02118896|3554884|P3|Overall Study|Pregnancy|0
1088716|NCT02118896|3554885|P2|Overall Study|Pregnancy|1
1088717|NCT02118896|3554886|P1|Overall Study|Pregnancy|1
1088718|NCT02118896|3554877|P10|Overall Study|Non-compliance|0
1088719|NCT02118896|3554878|P9|Overall Study|Non-compliance|0
1088720|NCT02118896|3554879|P8|Overall Study|Non-compliance|1
1088721|NCT02118896|3554880|P7|Overall Study|Non-compliance|0
1088722|NCT02118896|3554881|P6|Overall Study|Non-compliance|1
1088723|NCT02118896|3554882|P5|Overall Study|Non-compliance|0
1088724|NCT02118896|3554883|P4|Overall Study|Non-compliance|5
1088725|NCT02118896|3554884|P3|Overall Study|Non-compliance|1
1088726|NCT02118896|3554885|P2|Overall Study|Non-compliance|1
1088727|NCT02118896|3554886|P1|Overall Study|Non-compliance|2
1088728|NCT02118896|3554877|P10|Overall Study|Consent withdrawn|0
1088729|NCT02118896|3554878|P9|Overall Study|Consent withdrawn|0
1088730|NCT02118896|3554879|P8|Overall Study|Consent withdrawn|0
1088731|NCT02118896|3554880|P7|Overall Study|Consent withdrawn|0
1088732|NCT02118896|3554881|P6|Overall Study|Consent withdrawn|4
1088733|NCT02118896|3554882|P5|Overall Study|Consent withdrawn|1
1088734|NCT02118896|3554883|P4|Overall Study|Consent withdrawn|4
1088735|NCT02118896|3554884|P3|Overall Study|Consent withdrawn|3
1088736|NCT02118896|3554885|P2|Overall Study|Consent withdrawn|0
1088737|NCT02118896|3554886|P1|Overall Study|Consent withdrawn|2
1088738|NCT02118896|3554877|P10|Overall Study|Adverse Event|0
1088739|NCT02118896|3554878|P9|Overall Study|Adverse Event|4
1088740|NCT02118896|3554879|P8|Overall Study|Adverse Event|1
1088741|NCT02118896|3554880|P7|Overall Study|Adverse Event|1
1088742|NCT02118896|3554881|P6|Overall Study|Adverse Event|9
1088743|NCT02118896|3554882|P5|Overall Study|Adverse Event|5
1088744|NCT02118896|3554883|P4|Overall Study|Adverse Event|5
1088745|NCT02118896|3554884|P3|Overall Study|Adverse Event|4
1088746|NCT02118896|3554885|P2|Overall Study|Adverse Event|4
1088747|NCT02118896|3554886|P1|Overall Study|Adverse Event|5
1088748|NCT02118896|3554877|P10|Overall Study|Death|0
1088749|NCT02118896|3554878|P9|Overall Study|Death|0
1088750|NCT02118896|3554879|P8|Overall Study|Death|0
1088751|NCT02118896|3554880|P7|Overall Study|Death|0
1088752|NCT02118896|3554881|P6|Overall Study|Death|1
1088753|NCT02118896|3554882|P5|Overall Study|Death|3
1088754|NCT02118896|3554883|P4|Overall Study|Death|6
1088755|NCT02118896|3554884|P3|Overall Study|Death|4
1088756|NCT02118896|3554885|P2|Overall Study|Death|0
1088757|NCT02118896|3554886|P1|Overall Study|Death|4
1088758|NCT02118792|3554976|P2|Overall Study|Randomised but not treated|0
1088759|NCT02118792|3554977|P1|Overall Study|Randomised but not treated|1
1088760|NCT02118792|3554976|P2|Overall Study|Other|6
1088761|NCT02118792|3554977|P1|Overall Study|Other|1
1088762|NCT02118792|3554976|P2|Overall Study|Withdrawal by parent/guardian|20
1088763|NCT02118792|3554977|P1|Overall Study|Withdrawal by parent/guardian|14
1088764|NCT02118792|3554976|P2|Overall Study|Adverse Event|4
1088765|NCT02118792|3554977|P1|Overall Study|Adverse Event|5
1088766|NCT02118792|3554976|P2|Overall Study|Lost to Follow-up|4
1088767|NCT02118792|3554977|P1|Overall Study|Lost to Follow-up|4
1088768|NCT02118792|3554976|P2|Overall Study|Withdrawal by Subject|3
1088769|NCT02118792|3554977|P1|Overall Study|Withdrawal by Subject|6
1088770|NCT02118766|3555019|P2|Overall Study|Other|1
1088771|NCT02118766|3555020|P1|Overall Study|Other|3
1088772|NCT02118766|3555019|P2|Overall Study|Withdrawal by parent/guardian|18
1088773|NCT02118766|3555020|P1|Overall Study|Withdrawal by parent/guardian|12
1088774|NCT02118766|3555019|P2|Overall Study|Lost to Follow-up|4
1088775|NCT02118766|3555020|P1|Overall Study|Lost to Follow-up|5
1088776|NCT02118766|3555019|P2|Overall Study|Withdrawal by Subject|6
1088777|NCT02118766|3555020|P1|Overall Study|Withdrawal by Subject|3
1088778|NCT02118766|3555019|P2|Overall Study|Adverse Event|2
1088779|NCT02118766|3555020|P1|Overall Study|Adverse Event|7
1088780|NCT02118597|3555042|P1|Overall Study|Investigator's decision|1
1088781|NCT02118597|3555042|P1|Overall Study|Serious Adverse Event|1
1088782|NCT02118597|3555042|P1|Overall Study|Sponsor terminated the study|14
1088783|NCT02117687|3555084|P2|Overall Study|Other Reasons|1
1088784|NCT02117687|3555085|P1|Overall Study|Other Reasons|1
1088785|NCT02117687|3555084|P2|Overall Study|Adverse Event|2
1088786|NCT02117687|3555085|P1|Overall Study|Adverse Event|0
1088787|NCT02117687|3555084|P2|Overall Study|Lost to Follow-up|1
1088788|NCT02117687|3555085|P1|Overall Study|Lost to Follow-up|0
1088789|NCT02117648|3555117|P1|Abemaciclib Safety-Extension Phase|Adverse Event|2
1088790|NCT02117648|3555117|P1|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2
1088791|NCT02117648|3555117|P1|Abemaciclib Safety-Extension Phase|Death|3
1088792|NCT02117648|3555117|P1|Abemaciclib Safety-Extension Phase|Physician Decision|1
1088793|NCT02117648|3555117|P1|Abemaciclib Safety-Extension Phase|Progressive Disease|12
1088794|NCT02117648|3555117|P1|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1
1088795|NCT02117648|3555117|P1|Abemaciclib + Clarithromycin Period 2|Adverse Event|1
1088796|NCT02117648|3555117|P1|Abemaciclib + Clarithromycin Period 2|Death|1
1088797|NCT02117648|3555117|P1|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1
1088798|NCT02117648|3555117|P1|Abemaciclib Alone Period 1|Adverse Event|1
1088799|NCT02117648|3555117|P1|Abemaciclib Alone Period 1|Withdrawal by Subject|1
1088800|NCT02117570|3555130|P3|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
1088801|NCT02117570|3555131|P2|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1
1088802|NCT02117570|3555132|P1|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
1088803|NCT02117570|3555130|P3|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
1088804|NCT02117570|3555131|P2|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
1088805|NCT02117570|3555132|P1|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1
1088806|NCT02117570|3555130|P3|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1
1088807|NCT02117570|3555131|P2|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
1088808|NCT02117570|3555132|P1|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
1088809|NCT02117570|3555130|P3|Stage 2 Participants Aged 65 to 85 Years|Death|1
1088810|NCT02117570|3555131|P2|Stage 2 Participants Aged 65 to 85 Years|Death|0
1088811|NCT02117570|3555132|P1|Stage 2 Participants Aged 65 to 85 Years|Death|0
1088812|NCT02117570|3555130|P3|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2
1088813|NCT02117570|3555131|P2|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
1088814|NCT02117570|3555132|P1|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
1088815|NCT02117570|3555130|P3|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0
1088816|NCT02117570|3555131|P2|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
1088817|NCT02117570|3555132|P1|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
1088818|NCT02117570|3555130|P3|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1
1088819|NCT02117570|3555131|P2|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2
1088820|NCT02117570|3555132|P1|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0
1088821|NCT02117544|3555182|P2|Period 1|Lost to follow-up (prior to treatment)|0
1088822|NCT02117544|3555183|P1|Period 1|Lost to follow-up (prior to treatment)|2
1088823|NCT02117479|3555198|P2|Overall Study|Other unspecified|7
1088824|NCT02117479|3555199|P1|Overall Study|Other unspecified|11
1088825|NCT02117479|3555198|P2|Overall Study|Physician Decision|2
1088826|NCT02117479|3555199|P1|Overall Study|Physician Decision|7
1088827|NCT02117479|3555198|P2|Overall Study|Study terminated by the sponsor|6
1088828|NCT02117479|3555199|P1|Overall Study|Study terminated by the sponsor|4
1088829|NCT02117479|3555198|P2|Overall Study|Noncompliance with study treatment|0
1088830|NCT02117479|3555199|P1|Overall Study|Noncompliance with study treatment|1
1088831|NCT02117479|3555198|P2|Overall Study|Disease progression|108
1088832|NCT02117479|3555199|P1|Overall Study|Disease progression|104
1088833|NCT02117479|3555198|P2|Overall Study|Subject decision|9
1088834|NCT02117479|3555199|P1|Overall Study|Subject decision|8
1088835|NCT02117479|3555198|P2|Overall Study|Adverse Event|16
1088836|NCT02117479|3555199|P1|Overall Study|Adverse Event|8
1088837|NCT02117479|3555198|P2|Overall Study|Death|8
1088838|NCT02117479|3555199|P1|Overall Study|Death|13
1088839|NCT02117427|3555218|P3|Overall Study|Death|0
1088840|NCT02117427|3555219|P2|Overall Study|Death|1
1088841|NCT02117427|3555220|P1|Overall Study|Death|0
1088842|NCT02117427|3555218|P3|Overall Study|No longer meets inclusion criteria|0
1088843|NCT02117427|3555219|P2|Overall Study|No longer meets inclusion criteria|1
1088844|NCT02117427|3555220|P1|Overall Study|No longer meets inclusion criteria|0
1088845|NCT02117427|3555218|P3|Overall Study|Physician Decision|0
1088846|NCT02117427|3555219|P2|Overall Study|Physician Decision|2
1088847|NCT02117427|3555220|P1|Overall Study|Physician Decision|0
1088848|NCT02117427|3555218|P3|Overall Study|Permanent need for exogenous ESA Tx|0
1088849|NCT02117427|3555219|P2|Overall Study|Permanent need for exogenous ESA Tx|1
1088850|NCT02117427|3555220|P1|Overall Study|Permanent need for exogenous ESA Tx|3
1088851|NCT02117427|3555218|P3|Overall Study|Permanent need for exogenous EPO Tx|0
1088852|NCT02117427|3555219|P2|Overall Study|Permanent need for exogenous EPO Tx|0
1088853|NCT02117427|3555220|P1|Overall Study|Permanent need for exogenous EPO Tx|2
1088854|NCT02117414|3555230|P2|Overall Study|Withdrawal by Subject|4
1088855|NCT02117414|3555231|P1|Overall Study|Withdrawal by Subject|10
1088856|NCT02117414|3555230|P2|Overall Study|Death|2
1088857|NCT02117414|3555231|P1|Overall Study|Death|5
1088858|NCT02117050|3555275|P1|Overall Study|Subject Enrolled but not Dosed|1
1088859|NCT02116972|3555290|P3|Overall Study|scheduling conflicts and relocation|6
1088860|NCT02116972|3555291|P2|Overall Study|scheduling conflicts and relocation|3
1088861|NCT02116972|3555292|P1|Overall Study|scheduling conflicts and relocation|3
1088862|NCT02116972|3555290|P3|Overall Study|Lack of Efficacy|5
1088863|NCT02116972|3555291|P2|Overall Study|Lack of Efficacy|6
1088864|NCT02116972|3555292|P1|Overall Study|Lack of Efficacy|6
1088865|NCT02116972|3555290|P3|Overall Study|Lost to Follow-up|1
1088866|NCT02116972|3555291|P2|Overall Study|Lost to Follow-up|3
1088867|NCT02116972|3555292|P1|Overall Study|Lost to Follow-up|4
1088868|NCT02116972|3555290|P3|Overall Study|Protocol Violation|1
1088869|NCT02116972|3555291|P2|Overall Study|Protocol Violation|0
1088870|NCT02116972|3555292|P1|Overall Study|Protocol Violation|1
1088871|NCT02116972|3555290|P3|Overall Study|Withdrawal by Subject|5
1088872|NCT02116972|3555291|P2|Overall Study|Withdrawal by Subject|1
1088873|NCT02116972|3555292|P1|Overall Study|Withdrawal by Subject|1
1088874|NCT02116972|3555290|P3|Overall Study|Adverse Event|1
1088875|NCT02116972|3555291|P2|Overall Study|Adverse Event|4
1088876|NCT02116972|3555292|P1|Overall Study|Adverse Event|4
1088877|NCT02116803|3555324|P2|Overall Study|Death|0
1088878|NCT02116803|3555325|P1|Overall Study|Death|1
1088879|NCT02116803|3555324|P2|Overall Study|Study terminated by sponsor|1
1088880|NCT02116803|3555325|P1|Overall Study|Study terminated by sponsor|2
1088881|NCT02116803|3555324|P2|Overall Study|Progressive disease|0
1088882|NCT02116803|3555325|P1|Overall Study|Progressive disease|4
1088883|NCT02116803|3555324|P2|Overall Study|Physician Decision|0
1088884|NCT02116803|3555325|P1|Overall Study|Physician Decision|1
1088885|NCT02116803|3555324|P2|Overall Study|Adverse Event|1
1088886|NCT02116803|3555325|P1|Overall Study|Adverse Event|2
1088887|NCT02116621|3555333|P2|Twelve Month Follow-up|Enrolled within 12 months of study end|8
1088888|NCT02116621|3555334|P1|Twelve Month Follow-up|Enrolled within 12 months of study end|14
1088889|NCT02116621|3555333|P2|Twelve Month Follow-up|Did not complete follow-up survey|3
1088890|NCT02116621|3555334|P1|Twelve Month Follow-up|Did not complete follow-up survey|1
1088891|NCT02116621|3555333|P2|Twelve Month Follow-up|Lost to Follow-up|1
1088892|NCT02116621|3555334|P1|Twelve Month Follow-up|Lost to Follow-up|0
1088893|NCT02116621|3555333|P2|Twelve Month Follow-up|Withdrawal by Subject|0
1088894|NCT02116621|3555334|P1|Twelve Month Follow-up|Withdrawal by Subject|1
1088895|NCT02116621|3555333|P2|Six Month Follow-up|Did not complete follow-up survey|1
1088896|NCT02116621|3555334|P1|Six Month Follow-up|Did not complete follow-up survey|1
1088897|NCT02116621|3555333|P2|Six Month Follow-up|Lost to Follow-up|1
1088898|NCT02116621|3555334|P1|Six Month Follow-up|Lost to Follow-up|2
1088899|NCT02116621|3555333|P2|Six Month Follow-up|Withdrawal by Subject|1
1088900|NCT02116621|3555334|P1|Six Month Follow-up|Withdrawal by Subject|1
1088901|NCT02116621|3555333|P2|Three Month Follow-up|Did not complete follow-up survey|4
1088902|NCT02116621|3555334|P1|Three Month Follow-up|Did not complete follow-up survey|14
1088903|NCT02116621|3555333|P2|Three Month Follow-up|Lost to Follow-up|1
1088904|NCT02116621|3555334|P1|Three Month Follow-up|Lost to Follow-up|0
1088905|NCT02116621|3555333|P2|Three Month Follow-up|Withdrawal by Subject|1
1088906|NCT02116621|3555334|P1|Three Month Follow-up|Withdrawal by Subject|4
1088907|NCT02116621|3555333|P2|Three Month Follow-up|Death|1
1088908|NCT02116621|3555334|P1|Three Month Follow-up|Death|1
1088909|NCT02116621|3555333|P2|Baseline|Withdrawal by Subject|4
1088910|NCT02116621|3555334|P1|Baseline|Withdrawal by Subject|0
1088911|NCT02116582|3555422|P1|Overall Study|Other: Transitioned to 9785-CL-0123|12
1088912|NCT02116582|3555422|P1|Overall Study|Lost to Follow-up|1
1088913|NCT02116582|3555422|P1|Overall Study|Other: Miscellaneous|11
1088914|NCT02116582|3555422|P1|Overall Study|Withdrawal by Subject|8
1088915|NCT02116582|3555422|P1|Overall Study|Protocol Violation|3
1088916|NCT02116582|3555422|P1|Overall Study|Progressive Disease|148
1088917|NCT02116582|3555422|P1|Overall Study|Death|9
1088918|NCT02116582|3555422|P1|Overall Study|Adverse Event|22
1088919|NCT02116582|3555422|P1|Overall Study|Enrolled but Never Received Study Drug|1
1088920|NCT02116530|3555432|P2|Overall Study|Other Medical Problems|2
1088921|NCT02116530|3555433|P1|Overall Study|Other Medical Problems|2
1088922|NCT02116530|3555432|P2|Overall Study|Lost to Follow-up|0
1088923|NCT02116530|3555433|P1|Overall Study|Lost to Follow-up|1
1088924|NCT02116530|3555432|P2|Overall Study|Physician Decision|0
1088925|NCT02116530|3555433|P1|Overall Study|Physician Decision|1
1088926|NCT02116530|3555432|P2|Overall Study|Adverse Event|0
1088927|NCT02116530|3555433|P1|Overall Study|Adverse Event|4
1088928|NCT02116530|3555432|P2|Overall Study|Withdrawal by Subject|2
1088929|NCT02116530|3555433|P1|Overall Study|Withdrawal by Subject|1
1088930|NCT02116361|3555451|P4|Overall Study|Investigator Decision - Relapse|5
1088931|NCT02116361|3555452|P3|Overall Study|Investigator Decision - Relapse|8
1088932|NCT02116361|3555453|P2|Overall Study|Investigator Decision - Relapse|7
1088933|NCT02116361|3555454|P1|Overall Study|Investigator Decision - Relapse|9
1088934|NCT02116361|3555451|P4|Overall Study|Personal Reasons|9
1088935|NCT02116361|3555452|P3|Overall Study|Personal Reasons|4
1088936|NCT02116361|3555453|P2|Overall Study|Personal Reasons|6
1088937|NCT02116361|3555454|P1|Overall Study|Personal Reasons|6
1088938|NCT02116361|3555451|P4|Overall Study|Lost to Follow-up|5
1088939|NCT02116361|3555452|P3|Overall Study|Lost to Follow-up|7
1088940|NCT02116361|3555453|P2|Overall Study|Lost to Follow-up|5
1088941|NCT02116361|3555454|P1|Overall Study|Lost to Follow-up|4
1088942|NCT02116361|3555451|P4|Overall Study|Lack of Efficacy|3
1088943|NCT02116361|3555452|P3|Overall Study|Lack of Efficacy|4
1088944|NCT02116361|3555453|P2|Overall Study|Lack of Efficacy|7
1088945|NCT02116361|3555454|P1|Overall Study|Lack of Efficacy|5
1088946|NCT02116361|3555451|P4|Overall Study|Other Reasons|3
1088947|NCT02116361|3555452|P3|Overall Study|Other Reasons|3
1088948|NCT02116361|3555453|P2|Overall Study|Other Reasons|3
1088949|NCT02116361|3555454|P1|Overall Study|Other Reasons|3
1088950|NCT02116361|3555451|P4|Overall Study|Adverse Event|3
1088951|NCT02116361|3555452|P3|Overall Study|Adverse Event|0
1088952|NCT02116361|3555453|P2|Overall Study|Adverse Event|0
1088953|NCT02116361|3555454|P1|Overall Study|Adverse Event|1
1088954|NCT02116361|3555451|P4|Overall Study|Physician Decision|0
1088955|NCT02116361|3555452|P3|Overall Study|Physician Decision|0
1088956|NCT02116361|3555453|P2|Overall Study|Physician Decision|3
1088957|NCT02116361|3555454|P1|Overall Study|Physician Decision|2
1088958|NCT02116361|3555451|P4|Overall Study|Protocol Violation|2
1088959|NCT02116361|3555452|P3|Overall Study|Protocol Violation|0
1088960|NCT02116361|3555453|P2|Overall Study|Protocol Violation|0
1088961|NCT02116361|3555454|P1|Overall Study|Protocol Violation|1
1088962|NCT02116361|3555451|P4|Overall Study|Pregnancy|1
1088963|NCT02116361|3555452|P3|Overall Study|Pregnancy|0
1088964|NCT02116361|3555453|P2|Overall Study|Pregnancy|0
1088965|NCT02116361|3555454|P1|Overall Study|Pregnancy|0
1088966|NCT02116309|3555491|P2|Overall Study|Lost to Follow-up|1
1088967|NCT02116309|3555492|P1|Overall Study|Lost to Follow-up|0
1088968|NCT02115815|3555524|P7|Overall Study|Missed appointment, randomized in error|0
1088969|NCT02115815|3555525|P6|Overall Study|Missed appointment, randomized in error|1
1088970|NCT02115815|3555526|P5|Overall Study|Missed appointment, randomized in error|0
1088971|NCT02115815|3555527|P4|Overall Study|Missed appointment, randomized in error|0
1088972|NCT02115815|3555528|P3|Overall Study|Missed appointment, randomized in error|0
1088973|NCT02115815|3555529|P2|Overall Study|Missed appointment, randomized in error|0
1088974|NCT02115815|3555530|P1|Overall Study|Missed appointment, randomized in error|0
1088975|NCT02115815|3555524|P7|Overall Study|Not enough drug to dose participant|0
1088976|NCT02115815|3555525|P6|Overall Study|Not enough drug to dose participant|1
1088977|NCT02115815|3555526|P5|Overall Study|Not enough drug to dose participant|0
1088978|NCT02115815|3555527|P4|Overall Study|Not enough drug to dose participant|0
1088979|NCT02115815|3555528|P3|Overall Study|Not enough drug to dose participant|0
1088980|NCT02115815|3555529|P2|Overall Study|Not enough drug to dose participant|0
1088981|NCT02115815|3555530|P1|Overall Study|Not enough drug to dose participant|0
1088982|NCT02115815|3555524|P7|Overall Study|Withdrawal by Subject|0
1088983|NCT02115815|3555525|P6|Overall Study|Withdrawal by Subject|0
1088984|NCT02115815|3555526|P5|Overall Study|Withdrawal by Subject|0
1088985|NCT02115815|3555527|P4|Overall Study|Withdrawal by Subject|0
1088986|NCT02115815|3555528|P3|Overall Study|Withdrawal by Subject|0
1088987|NCT02115815|3555529|P2|Overall Study|Withdrawal by Subject|0
1088988|NCT02115815|3555530|P1|Overall Study|Withdrawal by Subject|2
1088989|NCT02115321|3555688|P2|Overall Study|Death|0
1088990|NCT02115321|3555689|P1|Overall Study|Death|1
1088991|NCT02115308|3555711|P2|Overall Study|Safety Screening|2
1088992|NCT02115308|3555712|P1|Overall Study|Safety Screening|2
1088993|NCT02115269|3555728|P1|Overall Study|Didn't take study drug|2
1088994|NCT02115269|3555728|P1|Overall Study|Withdrawal by Subject|2
1088995|NCT02115269|3555728|P1|Overall Study|Moved to another city|7
1088996|NCT02115269|3555728|P1|Overall Study|Did not complete patient diary|3
1088997|NCT02115269|3555728|P1|Overall Study|Lost to Follow-up|43
1088998|NCT02115256|3555748|P2|Overall Study|Withdrawal by Subject|1
1088999|NCT02115256|3555749|P1|Overall Study|Withdrawal by Subject|0
1089000|NCT02114931|3555763|P2|Overall Study|Other|1
1089001|NCT02114931|3555764|P1|Overall Study|Other|2
1089002|NCT02114931|3555763|P2|Overall Study|Physician Decision|2
1089003|NCT02114931|3555764|P1|Overall Study|Physician Decision|1
1089004|NCT02114931|3555763|P2|Overall Study|Lost to Follow-up|3
1089005|NCT02114931|3555764|P1|Overall Study|Lost to Follow-up|3
1089006|NCT02114931|3555763|P2|Overall Study|Adverse Event|6
1089007|NCT02114931|3555764|P1|Overall Study|Adverse Event|4
1089008|NCT02114931|3555763|P2|Overall Study|Withdrawal by Subject|18
1089009|NCT02114931|3555764|P1|Overall Study|Withdrawal by Subject|15
1089010|NCT02114892|3555780|P2|Overall Study|Lost to Follow-up|2
1089011|NCT02114892|3555781|P1|Overall Study|Lost to Follow-up|1
1089012|NCT02114697|3555817|P2|Overall Study|Study terminated|4
1089013|NCT02114697|3555818|P1|Overall Study|Study terminated|5
1089014|NCT02114385|3555826|P2|Overall Study|Lost to Follow-up|6
1089015|NCT02114385|3555827|P1|Overall Study|Lost to Follow-up|0
1089016|NCT02114385|3555826|P2|Overall Study|Withdrawal by Subject|2
1089017|NCT02114385|3555827|P1|Overall Study|Withdrawal by Subject|3
1089018|NCT02114268|3555855|P6|Overall Study|Withdrawn by site due to noncompliance|0
1089019|NCT02114268|3555856|P5|Overall Study|Withdrawn by site due to noncompliance|0
1089020|NCT02114268|3555857|P4|Overall Study|Withdrawn by site due to noncompliance|0
1089021|NCT02114268|3555858|P3|Overall Study|Withdrawn by site due to noncompliance|0
1089022|NCT02114268|3555859|P2|Overall Study|Withdrawn by site due to noncompliance|0
1089023|NCT02114268|3555860|P1|Overall Study|Withdrawn by site due to noncompliance|1
1089024|NCT02114268|3555855|P6|Overall Study|Withdrawal by Subject|1
1089025|NCT02114268|3555856|P5|Overall Study|Withdrawal by Subject|0
1089026|NCT02114268|3555857|P4|Overall Study|Withdrawal by Subject|0
1089027|NCT02114268|3555858|P3|Overall Study|Withdrawal by Subject|0
1089028|NCT02114268|3555859|P2|Overall Study|Withdrawal by Subject|0
1089029|NCT02114268|3555860|P1|Overall Study|Withdrawal by Subject|1
1089030|NCT02114268|3555855|P6|Overall Study|Lost to Follow-up|2
1089031|NCT02114268|3555856|P5|Overall Study|Lost to Follow-up|0
1089032|NCT02114268|3555857|P4|Overall Study|Lost to Follow-up|0
1089033|NCT02114268|3555858|P3|Overall Study|Lost to Follow-up|1
1089034|NCT02114268|3555859|P2|Overall Study|Lost to Follow-up|1
1089035|NCT02114268|3555860|P1|Overall Study|Lost to Follow-up|4
1089036|NCT02114203|3555929|P3|Overall Study|Withdrawal by Subject|0
1089037|NCT02114203|3555930|P2|Overall Study|Withdrawal by Subject|1
1089038|NCT02114203|3555931|P1|Overall Study|Withdrawal by Subject|0
1089039|NCT02114203|3555929|P3|Overall Study|Adverse Event|0
1089040|NCT02114203|3555930|P2|Overall Study|Adverse Event|1
1089041|NCT02114203|3555931|P1|Overall Study|Adverse Event|0
1089042|NCT02114177|3555965|P2|Overall Study|Other|1
1089043|NCT02114177|3555966|P1|Overall Study|Other|2
1089044|NCT02114177|3555965|P2|Overall Study|Withdrawal by Subject|1
1089045|NCT02114177|3555966|P1|Overall Study|Withdrawal by Subject|6
1089046|NCT02114177|3555965|P2|Overall Study|Lost to Follow-up|2
1089047|NCT02114177|3555966|P1|Overall Study|Lost to Follow-up|1
1089048|NCT02114151|3555990|P1|Overall Study|Withdrawal by Subject|5
1089049|NCT02114151|3555990|P1|Overall Study|Lost to Follow-up|1
1089050|NCT02114151|3555990|P1|Overall Study|Death|1
1089051|NCT02113579|3556007|P2|Overall Study|Lost to Follow-up|2
1089052|NCT02113579|3556008|P1|Overall Study|Lost to Follow-up|6
1089053|NCT02113579|3556007|P2|Overall Study|Withdrawal by Subject|2
1089054|NCT02113579|3556008|P1|Overall Study|Withdrawal by Subject|3
1089055|NCT02113579|3556007|P2|Overall Study|Adverse Event|0
1089056|NCT02113579|3556008|P1|Overall Study|Adverse Event|1
1089057|NCT02113449|3556032|P1|Overall Study|Adverse Event|4
1089058|NCT02113436|3556048|P4|Period 2: 16 Weeks|Withdrawal by Subject|1
1089059|NCT02113436|3556049|P3|Period 2: 16 Weeks|Withdrawal by Subject|1
1089060|NCT02113436|3556050|P2|Period 2: 16 Weeks|Withdrawal by Subject|0
1089061|NCT02113436|3556051|P1|Period 2: 16 Weeks|Withdrawal by Subject|0
1089062|NCT02113436|3556048|P4|Period 2: 16 Weeks|Physician Decision|0
1089063|NCT02113436|3556049|P3|Period 2: 16 Weeks|Physician Decision|2
1089064|NCT02113436|3556050|P2|Period 2: 16 Weeks|Physician Decision|0
1089065|NCT02113436|3556051|P1|Period 2: 16 Weeks|Physician Decision|0
1089066|NCT02113436|3556048|P4|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5
1089067|NCT02113436|3556049|P3|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2
1089068|NCT02113436|3556050|P2|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
1089069|NCT02113436|3556051|P1|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
1089070|NCT02113436|3556048|P4|Period 2: 16 Weeks|Adverse Event|5
1089071|NCT02113436|3556049|P3|Period 2: 16 Weeks|Adverse Event|4
1089072|NCT02113436|3556050|P2|Period 2: 16 Weeks|Adverse Event|0
1089073|NCT02113436|3556051|P1|Period 2: 16 Weeks|Adverse Event|0
1089074|NCT02113436|3556048|P4|Period 1: 8 Weeks|Withdrawal by Subject|0
1089075|NCT02113436|3556049|P3|Period 1: 8 Weeks|Withdrawal by Subject|0
1089076|NCT02113436|3556050|P2|Period 1: 8 Weeks|Withdrawal by Subject|0
1089077|NCT02113436|3556051|P1|Period 1: 8 Weeks|Withdrawal by Subject|1
1089078|NCT02113436|3556048|P4|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
1089079|NCT02113436|3556049|P3|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
1089080|NCT02113436|3556050|P2|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2
1089081|NCT02113436|3556051|P1|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5
1089082|NCT02113436|3556048|P4|Period 1: 8 Weeks|Protocol Violation|0
1089083|NCT02113436|3556049|P3|Period 1: 8 Weeks|Protocol Violation|0
1089084|NCT02113436|3556050|P2|Period 1: 8 Weeks|Protocol Violation|0
1089085|NCT02113436|3556051|P1|Period 1: 8 Weeks|Protocol Violation|1
1089086|NCT02113436|3556048|P4|Period 1: 8 Weeks|Adverse Event|0
1089087|NCT02113436|3556049|P3|Period 1: 8 Weeks|Adverse Event|0
1089088|NCT02113436|3556050|P2|Period 1: 8 Weeks|Adverse Event|0
1089089|NCT02113436|3556051|P1|Period 1: 8 Weeks|Adverse Event|1
1089090|NCT02113124|3556074|P2|Overall Study|Unable to retrieve blood sample|1
1089091|NCT02113124|3556075|P1|Overall Study|Unable to retrieve blood sample|1
1089092|NCT02113007|3556081|P1|Overall Study|Progressive disease|2
1089093|NCT02112448|3556089|P2|Overall Study|required heparin so could not use ketoro|0
1089094|NCT02112448|3556090|P1|Overall Study|required heparin so could not use ketoro|1
1089095|NCT02112448|3556089|P2|Overall Study|Physician Decision|6
1089096|NCT02112448|3556090|P1|Overall Study|Physician Decision|4
1089097|NCT02112448|3556089|P2|Overall Study|Protocol Violation|2
1089098|NCT02112448|3556090|P1|Overall Study|Protocol Violation|1
1089099|NCT02112448|3556089|P2|Overall Study|lab values precluding use of ketorolac|2
1089100|NCT02112448|3556090|P1|Overall Study|lab values precluding use of ketorolac|2
1089101|NCT02111785|3556131|P4|Overall Study|Death|0
1089102|NCT02111785|3556132|P3|Overall Study|Death|0
1089103|NCT02111785|3556133|P2|Overall Study|Death|1
1089104|NCT02111785|3556134|P1|Overall Study|Death|0
1089105|NCT02111603|3556196|P1|Overall Study|Withdrawal by Subject|1
1089106|NCT02111369|3556205|P1|Overall Study|Withdrawal by Subject|1
1089107|NCT02111369|3556205|P1|Overall Study|Lost to Follow-up|2
1089108|NCT02111174|3556250|P2|Secondary Outcomes (2 and 3 Month f/u)|Death|1
1089109|NCT02111174|3556251|P1|Secondary Outcomes (2 and 3 Month f/u)|Death|0
1089110|NCT02111174|3556250|P2|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6
1089111|NCT02111174|3556251|P1|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8
1089112|NCT02111174|3556250|P2|Treatment and Primary Outcome|Withdrawal by Subject|2
1089113|NCT02111174|3556251|P1|Treatment and Primary Outcome|Withdrawal by Subject|2
1089114|NCT02111174|3556250|P2|Treatment and Primary Outcome|Ineligible (not used in analysis)|0
1089115|NCT02111174|3556251|P1|Treatment and Primary Outcome|Ineligible (not used in analysis)|1
1089116|NCT02111096|3556280|P3|Overall Study|Withdrawal by Subject|8
1089117|NCT02111096|3556281|P2|Overall Study|Withdrawal by Subject|2
1089118|NCT02111096|3556282|P1|Overall Study|Withdrawal by Subject|4
1089119|NCT02111096|3556280|P3|Overall Study|Terminated by Sponsor|54
1089120|NCT02111096|3556281|P2|Overall Study|Terminated by Sponsor|35
1089121|NCT02111096|3556282|P1|Overall Study|Terminated by Sponsor|53
1089122|NCT02111096|3556280|P3|Overall Study|Protocol Violation|1
1089123|NCT02111096|3556281|P2|Overall Study|Protocol Violation|0
1089124|NCT02111096|3556282|P1|Overall Study|Protocol Violation|1
1089125|NCT02111096|3556280|P3|Overall Study|Physician Decision|0
1089126|NCT02111096|3556281|P2|Overall Study|Physician Decision|1
1089127|NCT02111096|3556282|P1|Overall Study|Physician Decision|0
1089128|NCT02111096|3556280|P3|Overall Study|Lost to Follow Up|1
1089129|NCT02111096|3556281|P2|Overall Study|Lost to Follow Up|1
1089130|NCT02111096|3556282|P1|Overall Study|Lost to Follow Up|1
1089131|NCT02111096|3556280|P3|Overall Study|Non-Compliance with Study Drug|0
1089132|NCT02111096|3556281|P2|Overall Study|Non-Compliance with Study Drug|1
1089133|NCT02111096|3556282|P1|Overall Study|Non-Compliance with Study Drug|1
1089134|NCT02111096|3556280|P3|Overall Study|Adverse Event|2
1089135|NCT02111096|3556281|P2|Overall Study|Adverse Event|1
1089136|NCT02111096|3556282|P1|Overall Study|Adverse Event|4
1089137|NCT02111083|3556330|P2|Interval Between Dosing (7-8 Days)|Adverse Event|1
1089138|NCT02111083|3556331|P1|Interval Between Dosing (7-8 Days)|Adverse Event|1
1089139|NCT02110706|3556351|P2|Overall Study|Patients who didn't receive 2nd infusion|1
1089140|NCT02110706|3556352|P1|Overall Study|Patients who didn't receive 2nd infusion|3
1089141|NCT02110706|3556351|P2|Overall Study|Adverse Event|3
1089142|NCT02110706|3556352|P1|Overall Study|Adverse Event|2
1089143|NCT02110693|3556364|P2|Overall Study|Other|0
1089144|NCT02110693|3556365|P1|Overall Study|Other|1
1089145|NCT02110693|3556364|P2|Overall Study|technical difficulties|4
1089146|NCT02110693|3556365|P1|Overall Study|technical difficulties|6
1089147|NCT02110693|3556364|P2|Overall Study|skipped assessment|18
1089148|NCT02110693|3556365|P1|Overall Study|skipped assessment|15
1089149|NCT02110693|3556364|P2|Overall Study|Withdrawal by Subject|7
1089150|NCT02110693|3556365|P1|Overall Study|Withdrawal by Subject|6
1089151|NCT02110238|3556411|P2|14 Week Blinded Extension Phase|Withdrawal by Subject|3
1089152|NCT02110238|3556412|P1|14 Week Blinded Extension Phase|Withdrawal by Subject|4
1089153|NCT02110238|3556411|P2|14 Week Blinded Extension Phase|Protocol Violation|3
1089154|NCT02110238|3556412|P1|14 Week Blinded Extension Phase|Protocol Violation|2
1089155|NCT02110238|3556411|P2|14 Week Blinded Extension Phase|Lost to Follow-up|1
1089156|NCT02110238|3556412|P1|14 Week Blinded Extension Phase|Lost to Follow-up|3
1089157|NCT02110238|3556411|P2|14 Week Blinded Extension Phase|Lack of Efficacy|4
1089158|NCT02110238|3556412|P1|14 Week Blinded Extension Phase|Lack of Efficacy|2
1089159|NCT02110238|3556411|P2|14 Week Blinded Extension Phase|Adverse Event|1
1089160|NCT02110238|3556412|P1|14 Week Blinded Extension Phase|Adverse Event|1
1089161|NCT02110238|3556411|P2|12 Week Pivotal Phase|Withdrawal by Subject|3
1089162|NCT02110238|3556412|P1|12 Week Pivotal Phase|Withdrawal by Subject|3
1089163|NCT02110238|3556411|P2|12 Week Pivotal Phase|Protocol Violation|1
1089164|NCT02110238|3556412|P1|12 Week Pivotal Phase|Protocol Violation|0
1089165|NCT02110238|3556411|P2|12 Week Pivotal Phase|Physician Decision|2
1089166|NCT02110238|3556412|P1|12 Week Pivotal Phase|Physician Decision|0
1089167|NCT02110238|3556411|P2|12 Week Pivotal Phase|Lost to Follow-up|0
1089168|NCT02110238|3556412|P1|12 Week Pivotal Phase|Lost to Follow-up|2
1089169|NCT02110238|3556411|P2|12 Week Pivotal Phase|Lack of Efficacy|3
1089170|NCT02110238|3556412|P1|12 Week Pivotal Phase|Lack of Efficacy|2
1089171|NCT02110238|3556411|P2|12 Week Pivotal Phase|Adverse Event|0
1089172|NCT02110238|3556412|P1|12 Week Pivotal Phase|Adverse Event|3
1089173|NCT02109562|3556450|P3|Overall Study|Physician Decision|5
1089174|NCT02109562|3556451|P2|Overall Study|Physician Decision|4
1089175|NCT02109562|3556452|P1|Overall Study|Physician Decision|3
1089176|NCT02109562|3556450|P3|Overall Study|Withdrawal by Subject|21
1089177|NCT02109562|3556451|P2|Overall Study|Withdrawal by Subject|25
1089178|NCT02109562|3556452|P1|Overall Study|Withdrawal by Subject|20
1089179|NCT02109562|3556450|P3|Overall Study|Protocol Violation|1
1089180|NCT02109562|3556451|P2|Overall Study|Protocol Violation|3
1089181|NCT02109562|3556452|P1|Overall Study|Protocol Violation|0
1089182|NCT02109562|3556450|P3|Overall Study|Lost to Follow-up|1
1089183|NCT02109562|3556451|P2|Overall Study|Lost to Follow-up|0
1089184|NCT02109562|3556452|P1|Overall Study|Lost to Follow-up|1
1089185|NCT02109562|3556450|P3|Overall Study|Adverse Event|3
1089186|NCT02109562|3556451|P2|Overall Study|Adverse Event|2
1089187|NCT02109562|3556452|P1|Overall Study|Adverse Event|0
1089188|NCT02109562|3556450|P3|Overall Study|Insufficient clinical response|4
1089189|NCT02109562|3556451|P2|Overall Study|Insufficient clinical response|0
1089190|NCT02109562|3556452|P1|Overall Study|Insufficient clinical response|2
1089191|NCT02109484|3556479|P8|Overall Study|Moved away from study area|1
1089192|NCT02109484|3556480|P7|Overall Study|Moved away from study area|1
1089193|NCT02109484|3556481|P6|Overall Study|Moved away from study area|0
1089194|NCT02109484|3556482|P5|Overall Study|Moved away from study area|0
1089195|NCT02109484|3556483|P4|Overall Study|Moved away from study area|0
1089196|NCT02109484|3556484|P3|Overall Study|Moved away from study area|0
1089197|NCT02109484|3556485|P2|Overall Study|Moved away from study area|0
1089198|NCT02109484|3556486|P1|Overall Study|Moved away from study area|0
1089199|NCT02109484|3556479|P8|Overall Study|Death|2
1089200|NCT02109484|3556480|P7|Overall Study|Death|0
1089201|NCT02109484|3556481|P6|Overall Study|Death|0
1089202|NCT02109484|3556482|P5|Overall Study|Death|0
1089203|NCT02109484|3556483|P4|Overall Study|Death|0
1089204|NCT02109484|3556484|P3|Overall Study|Death|0
1089205|NCT02109484|3556485|P2|Overall Study|Death|0
1089206|NCT02109484|3556486|P1|Overall Study|Death|0
1089207|NCT02109484|3556479|P8|Overall Study|Physician Decision|0
1089208|NCT02109484|3556480|P7|Overall Study|Physician Decision|0
1089209|NCT02109484|3556481|P6|Overall Study|Physician Decision|0
1089210|NCT02109484|3556482|P5|Overall Study|Physician Decision|2
1089211|NCT02109484|3556483|P4|Overall Study|Physician Decision|0
1089212|NCT02109484|3556484|P3|Overall Study|Physician Decision|0
1089213|NCT02109484|3556485|P2|Overall Study|Physician Decision|0
1089214|NCT02109484|3556486|P1|Overall Study|Physician Decision|0
1089215|NCT02109484|3556479|P8|Overall Study|Withdrawal by Subject|0
1089216|NCT02109484|3556480|P7|Overall Study|Withdrawal by Subject|1
1089217|NCT02109484|3556481|P6|Overall Study|Withdrawal by Subject|1
1089218|NCT02109484|3556482|P5|Overall Study|Withdrawal by Subject|1
1089219|NCT02109484|3556483|P4|Overall Study|Withdrawal by Subject|0
1089220|NCT02109484|3556484|P3|Overall Study|Withdrawal by Subject|0
1089221|NCT02109484|3556485|P2|Overall Study|Withdrawal by Subject|0
1089222|NCT02109484|3556486|P1|Overall Study|Withdrawal by Subject|0
1089223|NCT02109484|3556479|P8|Overall Study|Lost to Follow-up|0
1089224|NCT02109484|3556480|P7|Overall Study|Lost to Follow-up|1
1089225|NCT02109484|3556481|P6|Overall Study|Lost to Follow-up|0
1089226|NCT02109484|3556482|P5|Overall Study|Lost to Follow-up|1
1089227|NCT02109484|3556483|P4|Overall Study|Lost to Follow-up|1
1089228|NCT02109484|3556484|P3|Overall Study|Lost to Follow-up|0
1089229|NCT02109484|3556485|P2|Overall Study|Lost to Follow-up|0
1089230|NCT02109484|3556486|P1|Overall Study|Lost to Follow-up|0
1089231|NCT02109445|3556542|P1|Overall Study|Adverse Event|1
1089232|NCT02109445|3556542|P1|Overall Study|Symptomatic deterioration|2
1089233|NCT02109172|3556575|P6|Overall Study|Death|0
1089234|NCT02109172|3556576|P5|Overall Study|Death|1
1089235|NCT02109172|3556577|P4|Overall Study|Death|0
1089236|NCT02109172|3556578|P3|Overall Study|Death|0
1089237|NCT02109172|3556579|P2|Overall Study|Death|0
1089238|NCT02109172|3556580|P1|Overall Study|Death|0
1089239|NCT02109172|3556575|P6|Overall Study|Adverse Event|1
1089240|NCT02109172|3556576|P5|Overall Study|Adverse Event|0
1089241|NCT02109172|3556577|P4|Overall Study|Adverse Event|0
1089242|NCT02109172|3556578|P3|Overall Study|Adverse Event|1
1089243|NCT02109172|3556579|P2|Overall Study|Adverse Event|0
1089244|NCT02109172|3556580|P1|Overall Study|Adverse Event|0
1089245|NCT02109172|3556575|P6|Overall Study|Withdrawal by Subject|0
1089246|NCT02109172|3556576|P5|Overall Study|Withdrawal by Subject|0
1089247|NCT02109172|3556577|P4|Overall Study|Withdrawal by Subject|1
1089248|NCT02109172|3556578|P3|Overall Study|Withdrawal by Subject|0
1089249|NCT02109172|3556579|P2|Overall Study|Withdrawal by Subject|0
1089250|NCT02109172|3556580|P1|Overall Study|Withdrawal by Subject|1
1089251|NCT02109133|3556601|P2|Overall Study|Lost to Follow-up|0
1089252|NCT02109133|3556602|P1|Overall Study|Lost to Follow-up|1
1089253|NCT02109107|3556614|P1|Overall Study|Lost to Follow-up|2
1089254|NCT02109042|3556621|P1|Overall Study|Sponsor Decision|15
1089255|NCT02108951|3556642|P1|Overall Study|Study Terminated by Sponsor|14
1089256|NCT02108951|3556642|P1|Overall Study|Patient's/guardian's decision|1
1089257|NCT02108951|3556642|P1|Overall Study|Lost to Follow-up|1
1089258|NCT02108652|3556680|P1|Overall Study|Ongoing at data cutoff 04 July 2016|74
1089259|NCT02108652|3556680|P1|Overall Study|Withdrawal by Subject|8
1089260|NCT02108652|3556680|P1|Overall Study|Lost to Follow-up|2
1089261|NCT02108652|3556680|P1|Overall Study|Death|226
1089262|NCT02107898|3556849|P2|Overall Study|Randomized but not treated|1
1089263|NCT02107898|3556850|P1|Overall Study|Randomized but not treated|0
1089264|NCT02107898|3556849|P2|Overall Study|Consent withdrawn by participant|1
1089265|NCT02107898|3556850|P1|Overall Study|Consent withdrawn by participant|2
1089266|NCT02107898|3556849|P2|Overall Study|Participant moved|2
1089267|NCT02107898|3556850|P1|Overall Study|Participant moved|0
1089268|NCT02107898|3556849|P2|Overall Study|Poor compliance to protocol|1
1089269|NCT02107898|3556850|P1|Overall Study|Poor compliance to protocol|0
1089270|NCT02107898|3556849|P2|Overall Study|Adverse Event|7
1089271|NCT02107898|3556850|P1|Overall Study|Adverse Event|4
1089272|NCT02107703|3556904|P2|Overall Study|On study treatment/follow up|152
1089273|NCT02107703|3556905|P1|Overall Study|On study treatment/follow up|319
1089274|NCT02107703|3556904|P2|Overall Study|Lost to Follow-up|4
1089275|NCT02107703|3556905|P1|Overall Study|Lost to Follow-up|6
1089276|NCT02107703|3556904|P2|Overall Study|Withdrawal by Subject|19
1089277|NCT02107703|3556905|P1|Overall Study|Withdrawal by Subject|36
1089278|NCT02107482|3556937|P1|Overall Study|Lack of Efficacy|1
1089279|NCT02107482|3556937|P1|Overall Study|Lost to Follow-up|1
1089280|NCT02107482|3556937|P1|Overall Study|inconveinence|2
1089281|NCT02107443|3556945|P2|Overall Study|Withdrawal: Personal Issues|3
1089282|NCT02107443|3556946|P1|Overall Study|Withdrawal: Personal Issues|0
1089283|NCT02107443|3556945|P2|Overall Study|Withdrawal: Disease Progression|2
1089284|NCT02107443|3556946|P1|Overall Study|Withdrawal: Disease Progression|4
1089285|NCT02107443|3556945|P2|Overall Study|Withdrawal: Other Medical|5
1089286|NCT02107443|3556946|P1|Overall Study|Withdrawal: Other Medical|9
1089287|NCT02107443|3556945|P2|Overall Study|Withdrawal: Feeling Overwhelmed|1
1089288|NCT02107443|3556946|P1|Overall Study|Withdrawal: Feeling Overwhelmed|2
1089289|NCT02107443|3556945|P2|Overall Study|Withdrawal: Too Time Consuming|6
1089290|NCT02107443|3556946|P1|Overall Study|Withdrawal: Too Time Consuming|3
1089291|NCT02107443|3556945|P2|Overall Study|Withdrawal: Too Many Forms|1
1089292|NCT02107443|3556946|P1|Overall Study|Withdrawal: Too Many Forms|3
1089293|NCT02107443|3556945|P2|Overall Study|Withdrawal: Changed MD/Facility|3
1089294|NCT02107443|3556946|P1|Overall Study|Withdrawal: Changed MD/Facility|1
1089295|NCT02107443|3556945|P2|Overall Study|Withdrawal: Changed Mind|0
1089296|NCT02107443|3556946|P1|Overall Study|Withdrawal: Changed Mind|2
1089297|NCT02107443|3556945|P2|Overall Study|Withdrawal: Disliked Study Procedures|2
1089298|NCT02107443|3556946|P1|Overall Study|Withdrawal: Disliked Study Procedures|1
1089299|NCT02107443|3556945|P2|Overall Study|Withdrawal: Hospitalization/Hospice|28
1089300|NCT02107443|3556946|P1|Overall Study|Withdrawal: Hospitalization/Hospice|28
1089301|NCT02107443|3556945|P2|Overall Study|Registered but Not Eligible|1
1089302|NCT02107443|3556946|P1|Overall Study|Registered but Not Eligible|0
1089303|NCT02107443|3556945|P2|Overall Study|Study Protocol Violation|1
1089304|NCT02107443|3556946|P1|Overall Study|Study Protocol Violation|3
1089305|NCT02107443|3556945|P2|Overall Study|Death|30
1089306|NCT02107443|3556946|P1|Overall Study|Death|42
1089307|NCT02107313|3556985|P2|Overall Study|One participant did not do the FED cohor|1
1089308|NCT02107313|3556986|P1|Overall Study|One participant did not do the FED cohor|0
1089309|NCT02107274|3557007|P2|Control Phase|Adverse Event|1
1089310|NCT02107274|3557008|P1|Control Phase|Adverse Event|0
1089311|NCT02107274|3557007|P2|Control Phase|Death|0
1089312|NCT02107274|3557008|P1|Control Phase|Death|2
1089313|NCT02107274|3557007|P2|Control Phase|Lost to Follow-up|1
1089314|NCT02107274|3557008|P1|Control Phase|Lost to Follow-up|1
1089315|NCT02107274|3557007|P2|Treatment vs. Placebo|Lost to Follow-up|2
1089316|NCT02107274|3557008|P1|Treatment vs. Placebo|Lost to Follow-up|0
1089317|NCT02107274|3557007|P2|Treatment vs. Placebo|Adverse Event|0
1089318|NCT02107274|3557008|P1|Treatment vs. Placebo|Adverse Event|3
1089319|NCT02107196|3557022|P2|4-week Randomized Withdrawal (RW) Period|Reason Missing|5
1089320|NCT02107196|3557023|P1|4-week Randomized Withdrawal (RW) Period|Reason Missing|18
1089321|NCT02107196|3557022|P2|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0
1089322|NCT02107196|3557023|P1|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2
1089323|NCT02107196|3557022|P2|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
1089324|NCT02107196|3557023|P1|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1
1089325|NCT02107196|3557022|P2|4-week Randomized Withdrawal (RW) Period|Adverse Event|0
1089326|NCT02107196|3557023|P1|4-week Randomized Withdrawal (RW) Period|Adverse Event|2
1089327|NCT02107196|3557022|P2|12-week Treatment Period|Reason Missing|8
1089328|NCT02107196|3557023|P1|12-week Treatment Period|Reason Missing|11
1089329|NCT02107196|3557022|P2|12-week Treatment Period|Protocol Violation|8
1089330|NCT02107196|3557023|P1|12-week Treatment Period|Protocol Violation|7
1089331|NCT02107196|3557022|P2|12-week Treatment Period|Withdrawal by Subject|12
1089332|NCT02107196|3557023|P1|12-week Treatment Period|Withdrawal by Subject|15
1089333|NCT02107196|3557022|P2|12-week Treatment Period|Physician Decision|1
1089334|NCT02107196|3557023|P1|12-week Treatment Period|Physician Decision|0
1089335|NCT02107196|3557022|P2|12-week Treatment Period|Lost to Follow-up|6
1089336|NCT02107196|3557023|P1|12-week Treatment Period|Lost to Follow-up|3
1089337|NCT02107196|3557022|P2|12-week Treatment Period|Lack of Efficacy|1
1089338|NCT02107196|3557023|P1|12-week Treatment Period|Lack of Efficacy|2
1089339|NCT02107196|3557022|P2|12-week Treatment Period|Adverse Event|3
1089340|NCT02107196|3557023|P1|12-week Treatment Period|Adverse Event|6
1089341|NCT02107131|3557038|P2|Overall Study|Protocol Violation|4
1089342|NCT02107131|3557039|P1|Overall Study|Protocol Violation|0
1089343|NCT02107131|3557038|P2|Overall Study|Death|1
1089344|NCT02107131|3557039|P1|Overall Study|Death|0
1089345|NCT02107131|3557038|P2|Overall Study|mental instability|0
1089346|NCT02107131|3557039|P1|Overall Study|mental instability|1
1089347|NCT02107131|3557038|P2|Overall Study|Withdrawal by Subject|0
1089348|NCT02107131|3557039|P1|Overall Study|Withdrawal by Subject|2
1089349|NCT02107131|3557038|P2|Overall Study|Physician Decision|0
1089350|NCT02107131|3557039|P1|Overall Study|Physician Decision|1
1089351|NCT02107131|3557038|P2|Overall Study|Lost to Follow-up|4
1089352|NCT02107131|3557039|P1|Overall Study|Lost to Follow-up|4
1089353|NCT02107092|3557051|P1|Overall Study|Expected progression of CKD|12
1089354|NCT02107092|3557051|P1|Overall Study|Adverse Event|7
1089355|NCT02107092|3557051|P1|Overall Study|Withdrawal by Subject|9
1089356|NCT02107092|3557051|P1|Overall Study|Lost to Follow-up|2
1089357|NCT02107092|3557051|P1|Overall Study|Physician Decision|3
1089358|NCT02107092|3557051|P1|Overall Study|Met ECG withdrawal criteria|3
1089359|NCT02107092|3557051|P1|Overall Study|Hypo-or hyperkalemia|2
1089360|NCT02107092|3557051|P1|Overall Study|Subject compliance|3
1089361|NCT02107092|3557051|P1|Overall Study|Miscellaneous|3
1089362|NCT02107014|3557056|P1|Overall Study|Withdrew before drug: moving interstate|1
1089363|NCT02106923|3557138|P6|Overall Study|Protocol Violation|1
1089364|NCT02106923|3557139|P5|Overall Study|Protocol Violation|0
1089365|NCT02106923|3557140|P4|Overall Study|Protocol Violation|0
1089366|NCT02106923|3557141|P3|Overall Study|Protocol Violation|0
1089367|NCT02106923|3557142|P2|Overall Study|Protocol Violation|0
1089368|NCT02106923|3557143|P1|Overall Study|Protocol Violation|0
1089369|NCT02106832|3557191|P4|Overall Study|Technical problems|0
1089370|NCT02106832|3557192|P3|Overall Study|Technical problems|0
1089371|NCT02106832|3557193|P2|Overall Study|Technical problems|1
1089372|NCT02106832|3557194|P1|Overall Study|Technical problems|0
1089373|NCT02106832|3557191|P4|Overall Study|Withdrawal by Subject|7
1089374|NCT02106832|3557192|P3|Overall Study|Withdrawal by Subject|10
1089375|NCT02106832|3557193|P2|Overall Study|Withdrawal by Subject|17
1089376|NCT02106832|3557194|P1|Overall Study|Withdrawal by Subject|17
1089377|NCT02106832|3557191|P4|Overall Study|Protocol Violation|1
1089378|NCT02106832|3557192|P3|Overall Study|Protocol Violation|0
1089379|NCT02106832|3557193|P2|Overall Study|Protocol Violation|0
1089380|NCT02106832|3557194|P1|Overall Study|Protocol Violation|0
1089381|NCT02106832|3557191|P4|Overall Study|Physician Decision|0
1089382|NCT02106832|3557192|P3|Overall Study|Physician Decision|0
1089383|NCT02106832|3557193|P2|Overall Study|Physician Decision|0
1089384|NCT02106832|3557194|P1|Overall Study|Physician Decision|1
1089385|NCT02106832|3557191|P4|Overall Study|Lost to Follow-up|3
1089386|NCT02106832|3557192|P3|Overall Study|Lost to Follow-up|1
1089387|NCT02106832|3557193|P2|Overall Study|Lost to Follow-up|1
1089388|NCT02106832|3557194|P1|Overall Study|Lost to Follow-up|0
1089389|NCT02106832|3557191|P4|Overall Study|Deterioration of general conditions|0
1089390|NCT02106832|3557192|P3|Overall Study|Deterioration of general conditions|1
1089391|NCT02106832|3557193|P2|Overall Study|Deterioration of general conditions|0
1089392|NCT02106832|3557194|P1|Overall Study|Deterioration of general conditions|0
1089393|NCT02106832|3557191|P4|Overall Study|Death|4
1089394|NCT02106832|3557192|P3|Overall Study|Death|1
1089395|NCT02106832|3557193|P2|Overall Study|Death|4
1089396|NCT02106832|3557194|P1|Overall Study|Death|4
1089397|NCT02106832|3557191|P4|Overall Study|Adverse Event|0
1089398|NCT02106832|3557192|P3|Overall Study|Adverse Event|3
1089399|NCT02106832|3557193|P2|Overall Study|Adverse Event|2
1089400|NCT02106832|3557194|P1|Overall Study|Adverse Event|1
1089401|NCT02106403|3557261|P6|Follow-Up Visit 3|Other Reason|1
1089402|NCT02106403|3557262|P5|Follow-Up Visit 3|Other Reason|0
1089403|NCT02106403|3557263|P4|Follow-Up Visit 3|Other Reason|0
1089404|NCT02106403|3557264|P3|Follow-Up Visit 3|Other Reason|0
1089405|NCT02106403|3557265|P2|Follow-Up Visit 3|Other Reason|0
1089406|NCT02106403|3557266|P1|Follow-Up Visit 3|Other Reason|0
1089407|NCT02106390|3557289|P3|Overall Study|Protocol Violation|0
1089408|NCT02106390|3557290|P2|Overall Study|Protocol Violation|1
1089409|NCT02106390|3557291|P1|Overall Study|Protocol Violation|0
1089410|NCT02106390|3557289|P3|Overall Study|Adverse Event|1
1089411|NCT02106390|3557290|P2|Overall Study|Adverse Event|2
1089412|NCT02106390|3557291|P1|Overall Study|Adverse Event|0
1089413|NCT02106390|3557289|P3|Overall Study|Other: Unspecified|2
1089414|NCT02106390|3557290|P2|Overall Study|Other: Unspecified|4
1089415|NCT02106390|3557291|P1|Overall Study|Other: Unspecified|1
1089416|NCT02106390|3557289|P3|Overall Study|Other: Administrative Reason|12
1089417|NCT02106390|3557290|P2|Overall Study|Other: Administrative Reason|5
1089418|NCT02106390|3557291|P1|Overall Study|Other: Administrative Reason|8
1089419|NCT02106390|3557289|P3|Overall Study|Lost to Follow-up|13
1089420|NCT02106390|3557290|P2|Overall Study|Lost to Follow-up|20
1089421|NCT02106390|3557291|P1|Overall Study|Lost to Follow-up|25
1089422|NCT02106390|3557289|P3|Overall Study|Withdrawal by Subject|15
1089423|NCT02106390|3557290|P2|Overall Study|Withdrawal by Subject|16
1089424|NCT02106390|3557291|P1|Overall Study|Withdrawal by Subject|15
1089425|NCT02106325|3557367|P2|Phase 3|Lost to Follow-up|1
1089426|NCT02106325|3557368|P1|Phase 3|Lost to Follow-up|2
1089427|NCT02106325|3557367|P2|Phase 2|Lost to Follow-up|3
1089428|NCT02106325|3557368|P1|Phase 2|Lost to Follow-up|2
1089429|NCT02106325|3557367|P2|Phase 1|Lost to Follow-up|2
1089430|NCT02106325|3557368|P1|Phase 1|Lost to Follow-up|2
1089431|NCT02106156|3557393|P3|Overall Study|Relocation/Change of Physician|0
1089432|NCT02106156|3557394|P2|Overall Study|Relocation/Change of Physician|1
1089433|NCT02106156|3557395|P1|Overall Study|Relocation/Change of Physician|40
1089434|NCT02106156|3557393|P3|Overall Study|Hospitalization/Surgical Intervention|0
1089435|NCT02106156|3557394|P2|Overall Study|Hospitalization/Surgical Intervention|0
1089436|NCT02106156|3557395|P1|Overall Study|Hospitalization/Surgical Intervention|6
1089437|NCT02106156|3557393|P3|Overall Study|Change of Laboratory Parameter|0
1089438|NCT02106156|3557394|P2|Overall Study|Change of Laboratory Parameter|0
1089439|NCT02106156|3557395|P1|Overall Study|Change of Laboratory Parameter|10
1089440|NCT02106156|3557393|P3|Overall Study|Unplanned Event|0
1089441|NCT02106156|3557394|P2|Overall Study|Unplanned Event|2
1089442|NCT02106156|3557395|P1|Overall Study|Unplanned Event|82
1089443|NCT02106156|3557393|P3|Overall Study|Lost to Follow-up|0
1089444|NCT02106156|3557394|P2|Overall Study|Lost to Follow-up|8
1089445|NCT02106156|3557395|P1|Overall Study|Lost to Follow-up|451
1089446|NCT02106156|3557393|P3|Overall Study|Patients Request|0
1089447|NCT02106156|3557394|P2|Overall Study|Patients Request|9
1089448|NCT02106156|3557395|P1|Overall Study|Patients Request|307
1089449|NCT02106156|3557393|P3|Overall Study|Lack of Compliance|0
1089450|NCT02106156|3557394|P2|Overall Study|Lack of Compliance|7
1089451|NCT02106156|3557395|P1|Overall Study|Lack of Compliance|211
1089452|NCT02106156|3557393|P3|Overall Study|Concomitant Disease|0
1089453|NCT02106156|3557394|P2|Overall Study|Concomitant Disease|2
1089454|NCT02106156|3557395|P1|Overall Study|Concomitant Disease|74
1089455|NCT02106156|3557393|P3|Overall Study|Lack of Virological Response|0
1089456|NCT02106156|3557394|P2|Overall Study|Lack of Virological Response|8
1089457|NCT02106156|3557395|P1|Overall Study|Lack of Virological Response|1044
1089458|NCT02106156|3557393|P3|Overall Study|Lack of Tolerability|0
1089459|NCT02106156|3557394|P2|Overall Study|Lack of Tolerability|3
1089460|NCT02106156|3557395|P1|Overall Study|Lack of Tolerability|305
1089461|NCT02106156|3557393|P3|Overall Study|Patient Died|0
1089462|NCT02106156|3557394|P2|Overall Study|Patient Died|0
1089463|NCT02106156|3557395|P1|Overall Study|Patient Died|19
1089464|NCT02105987|3557419|P6|Continuation Phase|Protocol Violation|0
1089465|NCT02105987|3557420|P5|Continuation Phase|Protocol Violation|1
1089466|NCT02105987|3557421|P4|Continuation Phase|Protocol Violation|0
1089467|NCT02105987|3557422|P3|Continuation Phase|Protocol Violation|0
1089468|NCT02105987|3557423|P2|Continuation Phase|Protocol Violation|0
1089469|NCT02105987|3557424|P1|Continuation Phase|Protocol Violation|0
1089470|NCT02105987|3557419|P6|Late Switch Phase (24 Weeks)|Per sponsor request|0
1089471|NCT02105987|3557420|P5|Late Switch Phase (24 Weeks)|Per sponsor request|0
1089472|NCT02105987|3557421|P4|Late Switch Phase (24 Weeks)|Per sponsor request|0
1089473|NCT02105987|3557422|P3|Late Switch Phase (24 Weeks)|Per sponsor request|1
1089474|NCT02105987|3557423|P2|Late Switch Phase (24 Weeks)|Per sponsor request|0
1089475|NCT02105987|3557424|P1|Late Switch Phase (24 Weeks)|Per sponsor request|0
1089476|NCT02105987|3557419|P6|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
1089477|NCT02105987|3557420|P5|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
1089478|NCT02105987|3557421|P4|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1
1089479|NCT02105987|3557422|P3|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
1089480|NCT02105987|3557423|P2|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
1089481|NCT02105987|3557424|P1|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
1089482|NCT02105987|3557419|P6|Late Switch Phase (24 Weeks)|Physician Decision|0
1089483|NCT02105987|3557420|P5|Late Switch Phase (24 Weeks)|Physician Decision|0
1089484|NCT02105987|3557421|P4|Late Switch Phase (24 Weeks)|Physician Decision|0
1089485|NCT02105987|3557422|P3|Late Switch Phase (24 Weeks)|Physician Decision|5
1089486|NCT02105987|3557423|P2|Late Switch Phase (24 Weeks)|Physician Decision|0
1089487|NCT02105987|3557424|P1|Late Switch Phase (24 Weeks)|Physician Decision|0
1089488|NCT02105987|3557419|P6|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
1089489|NCT02105987|3557420|P5|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
1089490|NCT02105987|3557421|P4|Late Switch Phase (24 Weeks)|Lost to Follow-up|3
1089491|NCT02105987|3557422|P3|Late Switch Phase (24 Weeks)|Lost to Follow-up|8
1089492|NCT02105987|3557423|P2|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
1089493|NCT02105987|3557424|P1|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
1089494|NCT02105987|3557419|P6|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
1089495|NCT02105987|3557420|P5|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
1089496|NCT02105987|3557421|P4|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5
1089497|NCT02105987|3557422|P3|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6
1089498|NCT02105987|3557423|P2|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
1089499|NCT02105987|3557424|P1|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
1089500|NCT02105987|3557419|P6|Late Switch Phase (24 Weeks)|Protocol Violation|0
1089501|NCT02105987|3557420|P5|Late Switch Phase (24 Weeks)|Protocol Violation|0
1089502|NCT02105987|3557421|P4|Late Switch Phase (24 Weeks)|Protocol Violation|1
1089503|NCT02105987|3557422|P3|Late Switch Phase (24 Weeks)|Protocol Violation|15
1089504|NCT02105987|3557423|P2|Late Switch Phase (24 Weeks)|Protocol Violation|0
1089505|NCT02105987|3557424|P1|Late Switch Phase (24 Weeks)|Protocol Violation|0
1089506|NCT02105987|3557419|P6|Late Switch Phase (24 Weeks)|Adverse Event|0
1089507|NCT02105987|3557420|P5|Late Switch Phase (24 Weeks)|Adverse Event|0
1089508|NCT02105987|3557421|P4|Late Switch Phase (24 Weeks)|Adverse Event|4
1089509|NCT02105987|3557422|P3|Late Switch Phase (24 Weeks)|Adverse Event|10
1089510|NCT02105987|3557423|P2|Late Switch Phase (24 Weeks)|Adverse Event|0
1089511|NCT02105987|3557424|P1|Late Switch Phase (24 Weeks)|Adverse Event|0
1089512|NCT02105987|3557419|P6|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
1089513|NCT02105987|3557420|P5|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
1089514|NCT02105987|3557421|P4|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
1089515|NCT02105987|3557422|P3|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
1089516|NCT02105987|3557423|P2|Early Switch Phase (24 Weeks)|Missing Disposition Data|1
1089517|NCT02105987|3557424|P1|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
1089518|NCT02105987|3557419|P6|Early Switch Phase (24 Weeks)|Physician Decision|0
1089519|NCT02105987|3557420|P5|Early Switch Phase (24 Weeks)|Physician Decision|0
1089520|NCT02105987|3557421|P4|Early Switch Phase (24 Weeks)|Physician Decision|0
1089521|NCT02105987|3557422|P3|Early Switch Phase (24 Weeks)|Physician Decision|0
1089522|NCT02105987|3557423|P2|Early Switch Phase (24 Weeks)|Physician Decision|3
1089523|NCT02105987|3557424|P1|Early Switch Phase (24 Weeks)|Physician Decision|4
1089524|NCT02105987|3557419|P6|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
1089525|NCT02105987|3557420|P5|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
1089526|NCT02105987|3557421|P4|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
1089527|NCT02105987|3557422|P3|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
1089528|NCT02105987|3557423|P2|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
1089529|NCT02105987|3557424|P1|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
1089530|NCT02105987|3557419|P6|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
1089531|NCT02105987|3557420|P5|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
1089532|NCT02105987|3557421|P4|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
1089533|NCT02105987|3557422|P3|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
1089534|NCT02105987|3557423|P2|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10
1089535|NCT02105987|3557424|P1|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4
1089536|NCT02105987|3557419|P6|Early Switch Phase (24 Weeks)|Protocol Violation|0
1089537|NCT02105987|3557420|P5|Early Switch Phase (24 Weeks)|Protocol Violation|0
1089538|NCT02105987|3557421|P4|Early Switch Phase (24 Weeks)|Protocol Violation|0
1089539|NCT02105987|3557422|P3|Early Switch Phase (24 Weeks)|Protocol Violation|0
1089540|NCT02105987|3557423|P2|Early Switch Phase (24 Weeks)|Protocol Violation|17
1089541|NCT02105987|3557424|P1|Early Switch Phase (24 Weeks)|Protocol Violation|15
1089542|NCT02105987|3557419|P6|Early Switch Phase (24 Weeks)|Adverse Event|0
1089543|NCT02105987|3557420|P5|Early Switch Phase (24 Weeks)|Adverse Event|0
1089544|NCT02105987|3557421|P4|Early Switch Phase (24 Weeks)|Adverse Event|0
1089545|NCT02105987|3557422|P3|Early Switch Phase (24 Weeks)|Adverse Event|0
1089546|NCT02105987|3557423|P2|Early Switch Phase (24 Weeks)|Adverse Event|0
1089547|NCT02105987|3557424|P1|Early Switch Phase (24 Weeks)|Adverse Event|10
1089548|NCT02105974|3557478|P3|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18
1089549|NCT02105974|3557479|P2|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12
1089550|NCT02105974|3557480|P1|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0
1089551|NCT02105974|3557478|P3|12 Week (Wk) Treatment Period (TP)|Physician Decision|4
1089552|NCT02105974|3557479|P2|12 Week (Wk) Treatment Period (TP)|Physician Decision|7
1089553|NCT02105974|3557480|P1|12 Week (Wk) Treatment Period (TP)|Physician Decision|0
1089554|NCT02105974|3557478|P3|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1
1089555|NCT02105974|3557479|P2|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
1089556|NCT02105974|3557480|P1|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
1089557|NCT02105974|3557478|P3|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2
1089558|NCT02105974|3557479|P2|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1
1089559|NCT02105974|3557480|P1|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0
1089560|NCT02105974|3557478|P3|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6
1089561|NCT02105974|3557479|P2|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2
1089562|NCT02105974|3557480|P1|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0
1089563|NCT02105974|3557478|P3|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9
1089564|NCT02105974|3557479|P2|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6
1089565|NCT02105974|3557480|P1|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0
1089566|NCT02105974|3557478|P3|12 Week (Wk) Treatment Period (TP)|Adverse Event|18
1089567|NCT02105974|3557479|P2|12 Week (Wk) Treatment Period (TP)|Adverse Event|14
1089568|NCT02105974|3557480|P1|12 Week (Wk) Treatment Period (TP)|Adverse Event|0
1089569|NCT02105974|3557478|P3|2 Week Run-in Period|Investigator discretion|0
1089570|NCT02105974|3557479|P2|2 Week Run-in Period|Investigator discretion|0
1089571|NCT02105974|3557480|P1|2 Week Run-in Period|Investigator discretion|8
1089572|NCT02105974|3557478|P3|2 Week Run-in Period|Withdrew consent|0
1089573|NCT02105974|3557479|P2|2 Week Run-in Period|Withdrew consent|0
1089574|NCT02105974|3557480|P1|2 Week Run-in Period|Withdrew consent|23
1089575|NCT02105974|3557478|P3|2 Week Run-in Period|Lost to Follow-up|0
1089576|NCT02105974|3557479|P2|2 Week Run-in Period|Lost to Follow-up|0
1089577|NCT02105974|3557480|P1|2 Week Run-in Period|Lost to Follow-up|2
1089578|NCT02105974|3557478|P3|2 Week Run-in Period|Study closed/terminated|0
1089579|NCT02105974|3557479|P2|2 Week Run-in Period|Study closed/terminated|0
1089580|NCT02105974|3557480|P1|2 Week Run-in Period|Study closed/terminated|1
1089581|NCT02105974|3557478|P3|2 Week Run-in Period|Adverse Event|0
1089582|NCT02105974|3557479|P2|2 Week Run-in Period|Adverse Event|0
1089583|NCT02105974|3557480|P1|2 Week Run-in Period|Adverse Event|6
1089584|NCT02105974|3557478|P3|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
1089585|NCT02105974|3557479|P2|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
1089586|NCT02105974|3557480|P1|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603
1089587|NCT02105974|3557478|P3|2 Week Run-in Period|Withdrew during pre-screen period|0
1089588|NCT02105974|3557479|P2|2 Week Run-in Period|Withdrew during pre-screen period|0
1089589|NCT02105974|3557480|P1|2 Week Run-in Period|Withdrew during pre-screen period|158
1089590|NCT02105961|3557493|P3|Overall Study|Withdrawal by Subject|11
1089591|NCT02105961|3557494|P2|Overall Study|Withdrawal by Subject|7
1089592|NCT02105961|3557495|P1|Overall Study|Withdrawal by Subject|15
1089593|NCT02105961|3557493|P3|Overall Study|Physician Decision|2
1089594|NCT02105961|3557494|P2|Overall Study|Physician Decision|3
1089595|NCT02105961|3557495|P1|Overall Study|Physician Decision|3
1089596|NCT02105961|3557493|P3|Overall Study|Lost to Follow-up|1
1089597|NCT02105961|3557494|P2|Overall Study|Lost to Follow-up|0
1089598|NCT02105961|3557495|P1|Overall Study|Lost to Follow-up|2
1089599|NCT02105961|3557493|P3|Overall Study|Lack of Efficacy|3
1089600|NCT02105961|3557494|P2|Overall Study|Lack of Efficacy|0
1089601|NCT02105961|3557495|P1|Overall Study|Lack of Efficacy|3
1089602|NCT02105961|3557493|P3|Overall Study|Adverse Event|13
1089603|NCT02105961|3557494|P2|Overall Study|Adverse Event|7
1089604|NCT02105961|3557495|P1|Overall Study|Adverse Event|18
1089605|NCT02105948|3557519|P4|Overall Study|Withdrawal by Subject|11
1089606|NCT02105948|3557520|P3|Overall Study|Withdrawal by Subject|10
1089607|NCT02105948|3557521|P2|Overall Study|Withdrawal by Subject|10
1089608|NCT02105948|3557522|P1|Overall Study|Withdrawal by Subject|15
1089609|NCT02105948|3557519|P4|Overall Study|Physician Decision|2
1089610|NCT02105948|3557520|P3|Overall Study|Physician Decision|2
1089611|NCT02105948|3557521|P2|Overall Study|Physician Decision|2
1089612|NCT02105948|3557522|P1|Overall Study|Physician Decision|2
1089613|NCT02105948|3557519|P4|Overall Study|Lost to Follow-up|1
1089614|NCT02105948|3557520|P3|Overall Study|Lost to Follow-up|2
1089615|NCT02105948|3557521|P2|Overall Study|Lost to Follow-up|0
1089616|NCT02105948|3557522|P1|Overall Study|Lost to Follow-up|0
1089617|NCT02105948|3557519|P4|Overall Study|Lack of Efficacy|2
1089618|NCT02105948|3557520|P3|Overall Study|Lack of Efficacy|3
1089619|NCT02105948|3557521|P2|Overall Study|Lack of Efficacy|1
1089620|NCT02105948|3557522|P1|Overall Study|Lack of Efficacy|0
1089621|NCT02105948|3557519|P4|Overall Study|Adverse Event|11
1089622|NCT02105948|3557520|P3|Overall Study|Adverse Event|11
1089623|NCT02105948|3557521|P2|Overall Study|Adverse Event|7
1089624|NCT02105948|3557522|P1|Overall Study|Adverse Event|10
1089625|NCT02105701|3557563|P4|Overall Study|Death|0
1089626|NCT02105701|3557564|P3|Overall Study|Death|0
1089627|NCT02105701|3557565|P2|Overall Study|Death|0
1089628|NCT02105701|3557566|P1|Overall Study|Death|1
1089629|NCT02105701|3557563|P4|Overall Study|Withdrawal by Subject|1
1089630|NCT02105701|3557564|P3|Overall Study|Withdrawal by Subject|0
1089631|NCT02105701|3557565|P2|Overall Study|Withdrawal by Subject|1
1089632|NCT02105701|3557566|P1|Overall Study|Withdrawal by Subject|2
1089633|NCT02105701|3557563|P4|Overall Study|Protocol Violation|0
1089634|NCT02105701|3557564|P3|Overall Study|Protocol Violation|1
1089635|NCT02105701|3557565|P2|Overall Study|Protocol Violation|0
1089636|NCT02105701|3557566|P1|Overall Study|Protocol Violation|0
1089637|NCT02105701|3557563|P4|Overall Study|Lost to Follow-up|1
1089638|NCT02105701|3557564|P3|Overall Study|Lost to Follow-up|2
1089639|NCT02105701|3557565|P2|Overall Study|Lost to Follow-up|0
1089640|NCT02105701|3557566|P1|Overall Study|Lost to Follow-up|1
1089641|NCT02105688|3557590|P2|Overall Study|Withdrawal by Subject|2
1089642|NCT02105688|3557591|P1|Overall Study|Withdrawal by Subject|4
1089643|NCT02105688|3557590|P2|Overall Study|Protocol Violation|1
1089644|NCT02105688|3557591|P1|Overall Study|Protocol Violation|0
1089645|NCT02105688|3557590|P2|Overall Study|Physician Decision|1
1089646|NCT02105688|3557591|P1|Overall Study|Physician Decision|0
1089647|NCT02105688|3557590|P2|Overall Study|Lost to Follow-up|4
1089648|NCT02105688|3557591|P1|Overall Study|Lost to Follow-up|9
1089649|NCT02105688|3557590|P2|Overall Study|Adverse Event|1
1089650|NCT02105688|3557591|P1|Overall Study|Adverse Event|1
1089651|NCT02105688|3557590|P2|Overall Study|Ongoing|90
1089652|NCT02105688|3557591|P1|Overall Study|Ongoing|12
1089653|NCT02105662|3557601|P1|Overall Study|Withdrawal by Subject|1
1089654|NCT02105662|3557601|P1|Overall Study|Lost to Follow-up|5
1089655|NCT02105636|3557610|P2|Overall Study|Not Reported|0
1089656|NCT02105636|3557611|P1|Overall Study|Not Reported|3
1089657|NCT02105636|3557610|P2|Overall Study|Reason Not Specified|2
1089658|NCT02105636|3557611|P1|Overall Study|Reason Not Specified|0
1089659|NCT02105636|3557610|P2|Overall Study|Poor/Non-compliance|1
1089660|NCT02105636|3557611|P1|Overall Study|Poor/Non-compliance|0
1089661|NCT02105636|3557610|P2|Overall Study|Maximum Clinical Benefit|1
1089662|NCT02105636|3557611|P1|Overall Study|Maximum Clinical Benefit|1
1089663|NCT02105636|3557610|P2|Overall Study|Subject Withdrew Consent|1
1089664|NCT02105636|3557611|P1|Overall Study|Subject Withdrew Consent|4
1089665|NCT02105636|3557610|P2|Overall Study|Subject Request to Discontinue Treatment|6
1089666|NCT02105636|3557611|P1|Overall Study|Subject Request to Discontinue Treatment|4
1089667|NCT02105636|3557610|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
1089668|NCT02105636|3557611|P1|Overall Study|Adverse Event Unrelated to Study Drug|12
1089669|NCT02105636|3557610|P2|Overall Study|Study Drug Toxicity|11
1089670|NCT02105636|3557611|P1|Overall Study|Study Drug Toxicity|9
1089671|NCT02105636|3557610|P2|Overall Study|Disease Progression|83
1089672|NCT02105636|3557611|P1|Overall Study|Disease Progression|162
1089673|NCT02105467|3557654|P2|Period 3|Lost to Follow-up|1
1089674|NCT02105467|3557655|P1|Period 3|Lost to Follow-up|0
1089675|NCT02105467|3557654|P2|Period 2|Withdrawal by Subject|2
1089676|NCT02105467|3557655|P1|Period 2|Withdrawal by Subject|0
1089677|NCT02105467|3557654|P2|Period 2|Death|0
1089678|NCT02105467|3557655|P1|Period 2|Death|1
1089679|NCT02105467|3557654|P2|Period 2|Lost to Follow-up|0
1089680|NCT02105467|3557655|P1|Period 2|Lost to Follow-up|1
1089681|NCT02105467|3557654|P2|Period 1|Death|0
1089682|NCT02105467|3557655|P1|Period 1|Death|1
1089683|NCT02105467|3557654|P2|Period 1|Lost to Follow-up|0
1089684|NCT02105467|3557655|P1|Period 1|Lost to Follow-up|1
1089685|NCT02105454|3557667|P1|Overall Study|Withdrawal by Subject|1
1089686|NCT02105285|3557754|P3|Overall Study|Withdrawal by Subject|0
1089687|NCT02105285|3557755|P2|Overall Study|Withdrawal by Subject|0
1089688|NCT02105285|3557756|P1|Overall Study|Withdrawal by Subject|1
1089689|NCT02105285|3557754|P3|Overall Study|Protocol Violation|0
1089690|NCT02105285|3557755|P2|Overall Study|Protocol Violation|1
1089691|NCT02105285|3557756|P1|Overall Study|Protocol Violation|0
1089692|NCT02105285|3557754|P3|Overall Study|Adverse Event|0
1089693|NCT02105285|3557755|P2|Overall Study|Adverse Event|1
1089694|NCT02105285|3557756|P1|Overall Study|Adverse Event|1
1089695|NCT02105272|3557775|P2|Overall Study|Withdrawal by Subject|0
1089696|NCT02105272|3557776|P1|Overall Study|Withdrawal by Subject|2
1089697|NCT02105272|3557775|P2|Overall Study|Protocol Violation|0
1089698|NCT02105272|3557776|P1|Overall Study|Protocol Violation|2
1089699|NCT02105272|3557775|P2|Overall Study|Physician Decision|1
1089700|NCT02105272|3557776|P1|Overall Study|Physician Decision|0
1089701|NCT02105272|3557775|P2|Overall Study|Adverse Event|2
1089702|NCT02105272|3557776|P1|Overall Study|Adverse Event|1
1089703|NCT02105116|3557792|P1|Overall Study|Death|1
1089704|NCT02105116|3557792|P1|Overall Study|not eligible for step 2 of trial|5
1089705|NCT02105012|3557799|P1|Overall Study|Lack of Efficacy|1
1089706|NCT02105012|3557799|P1|Overall Study|Adverse Event|1
1089707|NCT02105012|3557799|P1|Overall Study|Physician Decision|3
1089708|NCT02105012|3557799|P1|Overall Study|Protocol Violation|4
1089709|NCT02105012|3557799|P1|Overall Study|Lost to Follow-up|4
1089710|NCT02105012|3557799|P1|Overall Study|Protocol Specified Criteria|9
1089711|NCT02105012|3557799|P1|Overall Study|Withdrawal by Subject|11
1089712|NCT02104947|3557833|P2|Overall Study|Other than stated above|3
1089713|NCT02104947|3557834|P1|Overall Study|Other than stated above|2
1089714|NCT02104947|3557833|P2|Overall Study|Adverse Event|38
1089715|NCT02104947|3557834|P1|Overall Study|Adverse Event|57
1089716|NCT02104947|3557833|P2|Overall Study|Protocol Violation|8
1089717|NCT02104947|3557834|P1|Overall Study|Protocol Violation|6
1089718|NCT02104947|3557833|P2|Overall Study|Lost to Follow-up|4
1089719|NCT02104947|3557834|P1|Overall Study|Lost to Follow-up|4
1089720|NCT02104947|3557833|P2|Overall Study|Withdrawal by Subject|3
1089721|NCT02104947|3557834|P1|Overall Study|Withdrawal by Subject|10
1089722|NCT02104895|3557852|P2|Overall Study|Withdrawal by Subject|14
1089723|NCT02104895|3557853|P1|Overall Study|Withdrawal by Subject|0
1089724|NCT02104804|3557893|P2|Overall Study|Withdrawal by Subject|12
1089725|NCT02104804|3557894|P1|Overall Study|Withdrawal by Subject|4
1089726|NCT02104804|3557893|P2|Overall Study|Adverse Event|3
1089727|NCT02104804|3557894|P1|Overall Study|Adverse Event|4
1089728|NCT02104804|3557893|P2|Overall Study|Protocol Violation|1
1089729|NCT02104804|3557894|P1|Overall Study|Protocol Violation|0
1089730|NCT02104804|3557893|P2|Overall Study|Other listed|1
1089731|NCT02104804|3557894|P1|Overall Study|Other listed|2
1089732|NCT02104804|3557893|P2|Overall Study|Study specific discontinuation criteria|1
1089733|NCT02104804|3557894|P1|Overall Study|Study specific discontinuation criteria|6
1089734|NCT02104804|3557893|P2|Overall Study|Did not take study medication|1
1089735|NCT02104804|3557894|P1|Overall Study|Did not take study medication|0
1089736|NCT02104505|3557976|P2|Second Intervention (14 Days)|Adverse Event|0
1089737|NCT02104505|3557977|P1|Second Intervention (14 Days)|Adverse Event|2
1089738|NCT02104505|3557976|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
1089739|NCT02104505|3557977|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
1089740|NCT02104505|3557976|P2|First Intervention (14 Days)|exclusionary condition|1
1089741|NCT02104505|3557977|P1|First Intervention (14 Days)|exclusionary condition|0
1089742|NCT02104505|3557976|P2|First Intervention (14 Days)|Lost to Follow-up|1
1089743|NCT02104505|3557977|P1|First Intervention (14 Days)|Lost to Follow-up|0
1089744|NCT02104505|3557976|P2|First Intervention (14 Days)|Withdrawal by Subject|1
1089745|NCT02104505|3557977|P1|First Intervention (14 Days)|Withdrawal by Subject|0
1089746|NCT02104505|3557976|P2|First Intervention (14 Days)|Adverse Event|0
1089747|NCT02104505|3557977|P1|First Intervention (14 Days)|Adverse Event|2
1089748|NCT02103439|3558061|P2|Overall Study|Withdrawal by Subject|1
1089749|NCT02103439|3558062|P1|Overall Study|Withdrawal by Subject|3
1089750|NCT02103439|3558061|P2|Overall Study|Adverse Event|2
1089751|NCT02103439|3558062|P1|Overall Study|Adverse Event|0
1089752|NCT02103062|3558154|P2|Overall Study|Death|1
1089753|NCT02103062|3558155|P1|Overall Study|Death|0
1089754|NCT02103062|3558154|P2|Overall Study|Progressive Disease|20
1089755|NCT02103062|3558155|P1|Overall Study|Progressive Disease|17
1089756|NCT02103062|3558154|P2|Overall Study|Adverse Event|2
1089757|NCT02103062|3558155|P1|Overall Study|Adverse Event|1
1089758|NCT02102490|3558246|P1|Overall Study|Lost to Follow-up|1
1089759|NCT02102490|3558246|P1|Overall Study|Death|5
1089760|NCT02102490|3558246|P1|Overall Study|Adverse Event|3
1089761|NCT02102464|3558260|P3|Randomized Study|Withdrawal by Subject|0
1089762|NCT02102464|3558261|P2|Randomized Study|Withdrawal by Subject|1
1089763|NCT02102464|3558262|P1|Randomized Study|Withdrawal by Subject|0
1089764|NCT02102399|3558281|P2|Overall Study|Withdrawal by Subject|4
1089765|NCT02102399|3558282|P1|Overall Study|Withdrawal by Subject|6
1089766|NCT02102204|3558330|P1|Overall Study|Ongoing|5
1089767|NCT02102204|3558330|P1|Overall Study|Sponsor Decision|5
1089768|NCT02102204|3558330|P1|Overall Study|Lost to Follow-up|65
1089769|NCT02102204|3558330|P1|Overall Study|Death|92
1089770|NCT02102204|3558330|P1|Overall Study|Withdrawal by Subject|137
1089771|NCT02101983|3558341|P2|Overall Study|Physician Decision|0
1089772|NCT02101983|3558342|P1|Overall Study|Physician Decision|1
1089773|NCT02101359|3558395|P2|Overall Study|Protocol Violation|2
1089774|NCT02101359|3558396|P1|Overall Study|Protocol Violation|0
1089775|NCT02101359|3558395|P2|Overall Study|Lost to Follow-up|0
1089776|NCT02101359|3558396|P1|Overall Study|Lost to Follow-up|1
1089777|NCT02101359|3558395|P2|Overall Study|Withdrawal by Subject|4
1089778|NCT02101359|3558396|P1|Overall Study|Withdrawal by Subject|5
1089779|NCT02101359|3558395|P2|Overall Study|Not included|13
1089780|NCT02101359|3558396|P1|Overall Study|Not included|23
1089781|NCT02101294|3558402|P1|Overall Study|Lost to Follow-up|6
1089782|NCT02101294|3558402|P1|Overall Study|Withdrawal by Subject|5
1089783|NCT02101112|3558422|P6|Overall Study|Withdrawal by Subject|0
1089784|NCT02101112|3558423|P5|Overall Study|Withdrawal by Subject|1
1089785|NCT02101112|3558424|P4|Overall Study|Withdrawal by Subject|0
1089786|NCT02101112|3558425|P3|Overall Study|Withdrawal by Subject|0
1089787|NCT02101112|3558426|P2|Overall Study|Withdrawal by Subject|0
1089788|NCT02101112|3558427|P1|Overall Study|Withdrawal by Subject|0
1089789|NCT02101112|3558422|P6|Overall Study|Adverse Event|0
1089790|NCT02101112|3558423|P5|Overall Study|Adverse Event|0
1089791|NCT02101112|3558424|P4|Overall Study|Adverse Event|0
1089792|NCT02101112|3558425|P3|Overall Study|Adverse Event|1
1089793|NCT02101112|3558426|P2|Overall Study|Adverse Event|0
1089794|NCT02101112|3558427|P1|Overall Study|Adverse Event|0
1089795|NCT02101021|3558457|P5|Overall Study|Study Terminated by Sponsor|1
1089796|NCT02101021|3558458|P4|Overall Study|Study Terminated by Sponsor|1
1089797|NCT02101021|3558459|P3|Overall Study|Study Terminated by Sponsor|1
1089798|NCT02101021|3558460|P2|Overall Study|Study Terminated by Sponsor|0
1089799|NCT02101021|3558461|P1|Overall Study|Study Terminated by Sponsor|1
1089800|NCT02101021|3558457|P5|Overall Study|Lost to Follow-up|0
1089801|NCT02101021|3558458|P4|Overall Study|Lost to Follow-up|0
1089802|NCT02101021|3558459|P3|Overall Study|Lost to Follow-up|0
1089803|NCT02101021|3558460|P2|Overall Study|Lost to Follow-up|0
1089804|NCT02101021|3558461|P1|Overall Study|Lost to Follow-up|1
1089805|NCT02101021|3558457|P5|Overall Study|Withdrew Consent from study|0
1089806|NCT02101021|3558458|P4|Overall Study|Withdrew Consent from study|2
1089807|NCT02101021|3558459|P3|Overall Study|Withdrew Consent from study|0
1089808|NCT02101021|3558460|P2|Overall Study|Withdrew Consent from study|1
1089809|NCT02101021|3558461|P1|Overall Study|Withdrew Consent from study|1
1089810|NCT02101021|3558457|P5|Overall Study|Death|3
1089811|NCT02101021|3558458|P4|Overall Study|Death|0
1089812|NCT02101021|3558459|P3|Overall Study|Death|6
1089813|NCT02101021|3558460|P2|Overall Study|Death|3
1089814|NCT02101021|3558461|P1|Overall Study|Death|4
1089815|NCT02100839|3558510|P2|Multiple Ascending Dose|Withdrawal by Subject|0
1089816|NCT02100839|3558511|P1|Multiple Ascending Dose|Withdrawal by Subject|2
1089817|NCT02100839|3558510|P2|Multiple Ascending Dose|Adverse Event|0
1089818|NCT02100839|3558511|P1|Multiple Ascending Dose|Adverse Event|2
1089819|NCT02100670|3558538|P4|Overall Study|Withdrawal by Subject|0
1089820|NCT02100670|3558539|P3|Overall Study|Withdrawal by Subject|0
1089821|NCT02100670|3558540|P2|Overall Study|Withdrawal by Subject|0
1089822|NCT02100670|3558541|P1|Overall Study|Withdrawal by Subject|1
1089823|NCT02100670|3558538|P4|Overall Study|Physician Decision|0
1089824|NCT02100670|3558539|P3|Overall Study|Physician Decision|0
1089825|NCT02100670|3558540|P2|Overall Study|Physician Decision|1
1089826|NCT02100670|3558541|P1|Overall Study|Physician Decision|0
1089827|NCT02100670|3558538|P4|Overall Study|Poor Efficacy|0
1089828|NCT02100670|3558539|P3|Overall Study|Poor Efficacy|0
1089829|NCT02100670|3558540|P2|Overall Study|Poor Efficacy|1
1089830|NCT02100670|3558541|P1|Overall Study|Poor Efficacy|0
1089831|NCT02100670|3558538|P4|Overall Study|No swelling no pain|0
1089832|NCT02100670|3558539|P3|Overall Study|No swelling no pain|0
1089833|NCT02100670|3558540|P2|Overall Study|No swelling no pain|0
1089834|NCT02100670|3558541|P1|Overall Study|No swelling no pain|1
1089835|NCT02100670|3558538|P4|Overall Study|Withdrawal of Consent|0
1089836|NCT02100670|3558539|P3|Overall Study|Withdrawal of Consent|1
1089837|NCT02100670|3558540|P2|Overall Study|Withdrawal of Consent|1
1089838|NCT02100670|3558541|P1|Overall Study|Withdrawal of Consent|0
1089839|NCT02100670|3558538|P4|Overall Study|Protocol Violation|1
1089840|NCT02100670|3558539|P3|Overall Study|Protocol Violation|0
1089841|NCT02100670|3558540|P2|Overall Study|Protocol Violation|1
1089842|NCT02100670|3558541|P1|Overall Study|Protocol Violation|0
1089843|NCT02100670|3558538|P4|Overall Study|Lost to Follow-up|0
1089844|NCT02100670|3558539|P3|Overall Study|Lost to Follow-up|0
1089845|NCT02100670|3558540|P2|Overall Study|Lost to Follow-up|0
1089846|NCT02100670|3558541|P1|Overall Study|Lost to Follow-up|1
1089847|NCT02100670|3558538|P4|Overall Study|Adverse Event|0
1089848|NCT02100670|3558539|P3|Overall Study|Adverse Event|3
1089849|NCT02100670|3558540|P2|Overall Study|Adverse Event|3
1089850|NCT02100670|3558541|P1|Overall Study|Adverse Event|10
1089851|NCT02100644|3558601|P3|LTG Escalation Phase|Withdrawal by Subject|0
1089852|NCT02100644|3558602|P2|LTG Escalation Phase|Withdrawal by Subject|0
1089853|NCT02100644|3558603|P1|LTG Escalation Phase|Withdrawal by Subject|3
1089854|NCT02100644|3558601|P3|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
1089855|NCT02100644|3558602|P2|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
1089856|NCT02100644|3558603|P1|LTG Escalation Phase|Protocol-defined Stopping Criteria|1
1089857|NCT02100644|3558601|P3|LTG Escalation Phase|Adverse Event|0
1089858|NCT02100644|3558602|P2|LTG Escalation Phase|Adverse Event|0
1089859|NCT02100644|3558603|P1|LTG Escalation Phase|Adverse Event|9
1089860|NCT02100514|3558628|P5|Extension Period|Withdrew consent|0
1089861|NCT02100514|3558629|P4|Extension Period|Withdrew consent|0
1089862|NCT02100514|3558630|P3|Extension Period|Withdrew consent|2
1089863|NCT02100514|3558631|P2|Extension Period|Withdrew consent|0
1089864|NCT02100514|3558632|P1|Extension Period|Withdrew consent|0
1089865|NCT02100514|3558628|P5|Treatment Period|Other|0
1089866|NCT02100514|3558629|P4|Treatment Period|Other|0
1089867|NCT02100514|3558630|P3|Treatment Period|Other|0
1089868|NCT02100514|3558631|P2|Treatment Period|Other|11
1089869|NCT02100514|3558632|P1|Treatment Period|Other|9
1089870|NCT02100514|3558628|P5|Treatment Period|Withdrawal by Subject|0
1089871|NCT02100514|3558629|P4|Treatment Period|Withdrawal by Subject|0
1089872|NCT02100514|3558630|P3|Treatment Period|Withdrawal by Subject|0
1089873|NCT02100514|3558631|P2|Treatment Period|Withdrawal by Subject|37
1089874|NCT02100514|3558632|P1|Treatment Period|Withdrawal by Subject|12
1089875|NCT02100514|3558628|P5|Treatment Period|Protocol Violation|0
1089876|NCT02100514|3558629|P4|Treatment Period|Protocol Violation|0
1089877|NCT02100514|3558630|P3|Treatment Period|Protocol Violation|0
1089878|NCT02100514|3558631|P2|Treatment Period|Protocol Violation|1
1089879|NCT02100514|3558632|P1|Treatment Period|Protocol Violation|1
1089880|NCT02100514|3558628|P5|Treatment Period|Did Not Meet Entrance Criteria|0
1089881|NCT02100514|3558629|P4|Treatment Period|Did Not Meet Entrance Criteria|0
1089882|NCT02100514|3558630|P3|Treatment Period|Did Not Meet Entrance Criteria|0
1089883|NCT02100514|3558631|P2|Treatment Period|Did Not Meet Entrance Criteria|1
1089884|NCT02100514|3558632|P1|Treatment Period|Did Not Meet Entrance Criteria|0
1089885|NCT02100514|3558628|P5|Treatment Period|Lost to Follow-up|0
1089886|NCT02100514|3558629|P4|Treatment Period|Lost to Follow-up|0
1089887|NCT02100514|3558630|P3|Treatment Period|Lost to Follow-up|0
1089888|NCT02100514|3558631|P2|Treatment Period|Lost to Follow-up|17
1089889|NCT02100514|3558632|P1|Treatment Period|Lost to Follow-up|5
1089890|NCT02100514|3558628|P5|Treatment Period|Death|0
1089891|NCT02100514|3558629|P4|Treatment Period|Death|0
1089892|NCT02100514|3558630|P3|Treatment Period|Death|0
1089893|NCT02100514|3558631|P2|Treatment Period|Death|2
1089894|NCT02100514|3558632|P1|Treatment Period|Death|2
1089895|NCT02100514|3558628|P5|Treatment Period|Adverse Event|0
1089896|NCT02100514|3558629|P4|Treatment Period|Adverse Event|0
1089897|NCT02100514|3558630|P3|Treatment Period|Adverse Event|0
1089898|NCT02100514|3558631|P2|Treatment Period|Adverse Event|5
1089899|NCT02100514|3558632|P1|Treatment Period|Adverse Event|0
1089900|NCT02100475|3558700|P2|Overall Study|Withdrawal criteria|0
1089901|NCT02100475|3558701|P1|Overall Study|Withdrawal criteria|1
1089902|NCT02100475|3558700|P2|Overall Study|Unclassified|2
1089903|NCT02100475|3558701|P1|Overall Study|Unclassified|1
1089904|NCT02100228|3558751|P2|Overall Study|Death|1
1089905|NCT02100228|3558752|P1|Overall Study|Death|1
1089906|NCT02100228|3558751|P2|Overall Study|Adverse Event|12
1089907|NCT02100228|3558752|P1|Overall Study|Adverse Event|16
1089908|NCT02100228|3558751|P2|Overall Study|Withdrawal by Subject|37
1089909|NCT02100228|3558752|P1|Overall Study|Withdrawal by Subject|27
1089910|NCT02100228|3558751|P2|Overall Study|Lost to Follow-up|1
1089911|NCT02100228|3558752|P1|Overall Study|Lost to Follow-up|0
1089912|NCT02100228|3558751|P2|Overall Study|Non-compliance|3
1089913|NCT02100228|3558752|P1|Overall Study|Non-compliance|0
1089914|NCT02100228|3558751|P2|Overall Study|Inclusion/Exclusion criteria not met|16
1089915|NCT02100228|3558752|P1|Overall Study|Inclusion/Exclusion criteria not met|12
1089916|NCT02100228|3558751|P2|Overall Study|Administrative reason|1
1089917|NCT02100228|3558752|P1|Overall Study|Administrative reason|0
1089918|NCT02100228|3558751|P2|Overall Study|Other|19
1089919|NCT02100228|3558752|P1|Overall Study|Other|19
1089920|NCT02100124|3558788|P3|Overall Study|Withdrawal by Subject|0
1089921|NCT02100124|3558789|P2|Overall Study|Withdrawal by Subject|0
1089922|NCT02100124|3558790|P1|Overall Study|Withdrawal by Subject|1
1089923|NCT02100124|3558788|P3|Overall Study|Lost to Follow-up|3
1089924|NCT02100124|3558789|P2|Overall Study|Lost to Follow-up|11
1089925|NCT02100124|3558790|P1|Overall Study|Lost to Follow-up|5
1089926|NCT02099838|3558820|P2|Overall Study|Withdrawal by Subject|1
1089927|NCT02099838|3558821|P1|Overall Study|Withdrawal by Subject|0
1089928|NCT02099838|3558820|P2|Overall Study|Lost to Follow-up|1
1089929|NCT02099838|3558821|P1|Overall Study|Lost to Follow-up|3
1089930|NCT02099838|3558820|P2|Overall Study|Death|0
1089931|NCT02099838|3558821|P1|Overall Study|Death|1
1089932|NCT02099708|3558851|P1|Overall Study|Other|29
1089933|NCT02099708|3558851|P1|Overall Study|Lost to Follow-up|141
1089934|NCT02099708|3558851|P1|Overall Study|Data Not Available|30
1089935|NCT02099682|3558862|P1|Overall Study|Other|29
1089936|NCT02099682|3558862|P1|Overall Study|Lost to Follow-up|31
1089937|NCT02099682|3558862|P1|Overall Study|Data Not Available|51
1089938|NCT02099344|3558888|P2|Overall Study|Physician Decision|0
1089939|NCT02099344|3558889|P1|Overall Study|Physician Decision|1
1089940|NCT02099110|3558926|P5|Overall Study|Physician Decision|1
1089941|NCT02099110|3558927|P4|Overall Study|Physician Decision|2
1089942|NCT02099110|3558928|P3|Overall Study|Physician Decision|1
1089943|NCT02099110|3558929|P2|Overall Study|Physician Decision|0
1089944|NCT02099110|3558930|P1|Overall Study|Physician Decision|3
1089945|NCT02099110|3558926|P5|Overall Study|Non-compliance with study drug|1
1089946|NCT02099110|3558927|P4|Overall Study|Non-compliance with study drug|0
1089947|NCT02099110|3558928|P3|Overall Study|Non-compliance with study drug|0
1089948|NCT02099110|3558929|P2|Overall Study|Non-compliance with study drug|0
1089949|NCT02099110|3558930|P1|Overall Study|Non-compliance with study drug|2
1089950|NCT02099110|3558926|P5|Overall Study|Screen failure|1
1089951|NCT02099110|3558927|P4|Overall Study|Screen failure|0
1089952|NCT02099110|3558928|P3|Overall Study|Screen failure|0
1089953|NCT02099110|3558929|P2|Overall Study|Screen failure|0
1089954|NCT02099110|3558930|P1|Overall Study|Screen failure|0
1089955|NCT02099110|3558926|P5|Overall Study|Death|0
1089956|NCT02099110|3558927|P4|Overall Study|Death|0
1089957|NCT02099110|3558928|P3|Overall Study|Death|0
1089958|NCT02099110|3558929|P2|Overall Study|Death|1
1089959|NCT02099110|3558930|P1|Overall Study|Death|0
1089960|NCT02099110|3558926|P5|Overall Study|Lost to Follow-up|6
1089961|NCT02099110|3558927|P4|Overall Study|Lost to Follow-up|5
1089962|NCT02099110|3558928|P3|Overall Study|Lost to Follow-up|11
1089963|NCT02099110|3558929|P2|Overall Study|Lost to Follow-up|12
1089964|NCT02099110|3558930|P1|Overall Study|Lost to Follow-up|6
1089965|NCT02099110|3558926|P5|Overall Study|Adverse Event|2
1089966|NCT02099110|3558927|P4|Overall Study|Adverse Event|3
1089967|NCT02099110|3558928|P3|Overall Study|Adverse Event|2
1089968|NCT02099110|3558929|P2|Overall Study|Adverse Event|5
1089969|NCT02099110|3558930|P1|Overall Study|Adverse Event|3
1089970|NCT02099110|3558926|P5|Overall Study|Withdrawal by Subject|13
1089971|NCT02099110|3558927|P4|Overall Study|Withdrawal by Subject|9
1089972|NCT02099110|3558928|P3|Overall Study|Withdrawal by Subject|13
1089973|NCT02099110|3558929|P2|Overall Study|Withdrawal by Subject|11
1089974|NCT02099110|3558930|P1|Overall Study|Withdrawal by Subject|7
1089975|NCT02099110|3558926|P5|Overall Study|Participant moved|2
1089976|NCT02099110|3558927|P4|Overall Study|Participant moved|0
1089977|NCT02099110|3558928|P3|Overall Study|Participant moved|1
1089978|NCT02099110|3558929|P2|Overall Study|Participant moved|1
1089979|NCT02099110|3558930|P1|Overall Study|Participant moved|1
1089980|NCT02099110|3558926|P5|Overall Study|Protocol Violation|1
1089981|NCT02099110|3558927|P4|Overall Study|Protocol Violation|3
1089982|NCT02099110|3558928|P3|Overall Study|Protocol Violation|0
1089983|NCT02099110|3558929|P2|Overall Study|Protocol Violation|1
1089984|NCT02099110|3558930|P1|Overall Study|Protocol Violation|2
1089985|NCT02098746|3559004|P1|Overall Study|Data Not Available After Treatment|1
1089986|NCT02098746|3559004|P1|Overall Study|Enrolled 15 Days After the First Dose|1
1089987|NCT02098746|3559004|P1|Overall Study|Other Miscellaneous Reasons|1
1089988|NCT02098746|3559004|P1|Overall Study|Changes of Investigator|2
1089989|NCT02098733|3559012|P1|Overall Study|Lost to Follow-up|5
1089990|NCT02098733|3559012|P1|Overall Study|Data Not Available|5
1089991|NCT02098395|3559026|P4|Overall Study|Unclassified|2
1089992|NCT02098395|3559027|P3|Overall Study|Unclassified|3
1089993|NCT02098395|3559028|P2|Overall Study|Unclassified|0
1089994|NCT02098395|3559029|P1|Overall Study|Unclassified|0
1089995|NCT02098395|3559026|P4|Overall Study|Lost to Follow-up|3
1089996|NCT02098395|3559027|P3|Overall Study|Lost to Follow-up|0
1089997|NCT02098395|3559028|P2|Overall Study|Lost to Follow-up|1
1089998|NCT02098395|3559029|P1|Overall Study|Lost to Follow-up|2
1089999|NCT02098395|3559026|P4|Overall Study|Adverse Event|2
1090000|NCT02098395|3559027|P3|Overall Study|Adverse Event|34
1090001|NCT02098395|3559028|P2|Overall Study|Adverse Event|19
1090002|NCT02098395|3559029|P1|Overall Study|Adverse Event|12
1090003|NCT02098395|3559026|P4|Overall Study|Withdrawal by Subject|13
1090004|NCT02098395|3559027|P3|Overall Study|Withdrawal by Subject|5
1090005|NCT02098395|3559028|P2|Overall Study|Withdrawal by Subject|10
1090006|NCT02098395|3559029|P1|Overall Study|Withdrawal by Subject|10
1090007|NCT02098395|3559026|P4|Overall Study|Protocol Violation|7
1090008|NCT02098395|3559027|P3|Overall Study|Protocol Violation|0
1090009|NCT02098395|3559028|P2|Overall Study|Protocol Violation|2
1090010|NCT02098395|3559029|P1|Overall Study|Protocol Violation|2
1090011|NCT02098369|3559050|P3|Overall Study|Other|1
1090012|NCT02098369|3559051|P2|Overall Study|Other|2
1090013|NCT02098369|3559052|P1|Overall Study|Other|0
1090014|NCT02098369|3559050|P3|Overall Study|Death|1
1090015|NCT02098369|3559051|P2|Overall Study|Death|1
1090016|NCT02098369|3559052|P1|Overall Study|Death|1
1090017|NCT02098369|3559050|P3|Overall Study|Lost to Follow-up|3
1090018|NCT02098369|3559051|P2|Overall Study|Lost to Follow-up|1
1090019|NCT02098369|3559052|P1|Overall Study|Lost to Follow-up|5
1090020|NCT02098369|3559050|P3|Overall Study|Withdrawal by Subject|0
1090021|NCT02098369|3559051|P2|Overall Study|Withdrawal by Subject|5
1090022|NCT02098369|3559052|P1|Overall Study|Withdrawal by Subject|1
1090023|NCT02098109|3559090|P2|Overall Study|Protocol Violation|0
1090024|NCT02098109|3559091|P1|Overall Study|Protocol Violation|3
1090025|NCT02097823|3559169|P2|Overall Study|Withdrawal by Subject|1
1090026|NCT02097823|3559170|P1|Overall Study|Withdrawal by Subject|1
1090027|NCT02097745|3559185|P1|Overall Study|Reason Not Specified|96
1090028|NCT02097745|3559185|P1|Overall Study|Administrative/Other|27
1090029|NCT02097745|3559185|P1|Overall Study|Failure to Return|14
1090030|NCT02097745|3559185|P1|Overall Study|Death|16
1090031|NCT02097745|3559185|P1|Overall Study|Adverse Event|25
1090032|NCT02097719|3559221|P2|Overall Study|Adverse Event|0
1090033|NCT02097719|3559222|P1|Overall Study|Adverse Event|2
1090034|NCT02097719|3559221|P2|Overall Study|Lost to Follow-up|1
1090035|NCT02097719|3559222|P1|Overall Study|Lost to Follow-up|0
1090036|NCT02097719|3559221|P2|Overall Study|Subject Withdrew Consent|0
1090037|NCT02097719|3559222|P1|Overall Study|Subject Withdrew Consent|1
1090038|NCT02097472|3559242|P8|Received Vaccination 2|Adverse Event|0
1090039|NCT02097472|3559243|P7|Received Vaccination 2|Adverse Event|1
1090040|NCT02097472|3559244|P6|Received Vaccination 2|Adverse Event|0
1090041|NCT02097472|3559245|P5|Received Vaccination 2|Adverse Event|0
1090042|NCT02097472|3559246|P4|Received Vaccination 2|Adverse Event|0
1090043|NCT02097472|3559247|P3|Received Vaccination 2|Adverse Event|0
1090044|NCT02097472|3559248|P2|Received Vaccination 2|Adverse Event|0
1090045|NCT02097472|3559249|P1|Received Vaccination 2|Adverse Event|0
1090046|NCT02097290|3559680|P1|Overall Study|Attempt|8
1090047|NCT02097290|3559680|P1|Overall Study|Total Withdrawals|3
1090048|NCT02097290|3559680|P1|Overall Study|Death|6
1090049|NCT02097238|3559690|P1|Overall Study|Progressive Disease|17
1090050|NCT02097238|3559690|P1|Overall Study|Physician Decision|1
1090051|NCT02097238|3559690|P1|Overall Study|Death|1
1090052|NCT02097134|3559696|P1|Overall Study|Refusal of Further Protocol Therapy|1
1090053|NCT02097134|3559696|P1|Overall Study|Progressive Disease|3
1090054|NCT02097134|3559696|P1|Overall Study|Non-Protocol Therapy|1
1090055|NCT02097134|3559696|P1|Overall Study|Physician Decision|4
1090056|NCT02097108|3559700|P1|Overall Study|patient was abroad for 6 months|1
1090057|NCT02097108|3559700|P1|Overall Study|Adverse Event|1
1090058|NCT02097056|3559707|P1|Overall Study|Not specified|2
1090059|NCT02097056|3559707|P1|Overall Study|Adverse Event|37
1090060|NCT02097056|3559707|P1|Overall Study|Lost to Follow-up|2
1090061|NCT02097056|3559707|P1|Overall Study|Withdrawal by Subject|15
1090062|NCT02097056|3559707|P1|Overall Study|Protocol Violation|2
1090063|NCT02097030|3559715|P2|First Intervention (3 Days)|Visual Acuity|1
1090064|NCT02097030|3559716|P1|First Intervention (3 Days)|Visual Acuity|0
1090065|NCT02097030|3559715|P2|First Intervention (3 Days)|Lost to Follow-up|0
1090066|NCT02097030|3559716|P1|First Intervention (3 Days)|Lost to Follow-up|1
1090067|NCT02096952|3559777|P1|Overall Study|Adverse Event|1
1090068|NCT02096900|3559783|P2|Overall Study|Surgery cancelled- medication received|1
1090069|NCT02096900|3559784|P1|Overall Study|Surgery cancelled- medication received|1
1090070|NCT02096900|3559783|P2|Overall Study|Did not receive medication|1
1090071|NCT02096900|3559784|P1|Overall Study|Did not receive medication|3
1090072|NCT02096835|3559836|P3|Overall Study|Lost to Follow-up|1
1090073|NCT02096835|3559837|P2|Overall Study|Lost to Follow-up|0
1090074|NCT02096835|3559838|P1|Overall Study|Lost to Follow-up|1
1090075|NCT02096835|3559836|P3|Overall Study|converted to open procedures|0
1090076|NCT02096835|3559837|P2|Overall Study|converted to open procedures|0
1090077|NCT02096835|3559838|P1|Overall Study|converted to open procedures|1
1090078|NCT02096835|3559836|P3|Overall Study|Withdrawal by Subject|0
1090079|NCT02096835|3559837|P2|Overall Study|Withdrawal by Subject|0
1090080|NCT02096835|3559838|P1|Overall Study|Withdrawal by Subject|1
1090081|NCT02096744|3559855|P2|Treatment Period 3 (7 Days)|Withdrawal by Subject|1
1090082|NCT02096744|3559856|P1|Treatment Period 3 (7 Days)|Withdrawal by Subject|0
1090083|NCT02096744|3559855|P2|Treatment Period 1(7 Days)|Non compliance with the site rule|0
1090084|NCT02096744|3559856|P1|Treatment Period 1(7 Days)|Non compliance with the site rule|1
1090085|NCT02096744|3559855|P2|Treatment Period 1(7 Days)|Accidental early removal of the patch|1
1090086|NCT02096744|3559856|P1|Treatment Period 1(7 Days)|Accidental early removal of the patch|0
1090087|NCT02096705|3559910|P2|Follow-up|Subjects not reporting status|2
1090088|NCT02096705|3559911|P1|Follow-up|Subjects not reporting status|1
1090089|NCT02096705|3559910|P2|Follow-up|Adverse Event|2
1090090|NCT02096705|3559911|P1|Follow-up|Adverse Event|2
1090091|NCT02096705|3559910|P2|Follow-up|Withdrawal by Subject|0
1090092|NCT02096705|3559911|P1|Follow-up|Withdrawal by Subject|1
1090093|NCT02096705|3559910|P2|Treatment|Other|1
1090094|NCT02096705|3559911|P1|Treatment|Other|1
1090095|NCT02096705|3559910|P2|Treatment|Withdrawal by Subject|0
1090096|NCT02096705|3559911|P1|Treatment|Withdrawal by Subject|1
1090097|NCT02096705|3559910|P2|Treatment|Subject request to discontinue treatment|1
1090098|NCT02096705|3559911|P1|Treatment|Subject request to discontinue treatment|1
1090099|NCT02096705|3559910|P2|Treatment|Adverse Event|3
1090100|NCT02096705|3559911|P1|Treatment|Adverse Event|6
1090101|NCT02096263|3559977|P3|Overall Study|Withdrawal by Subject|8
1090102|NCT02096263|3559978|P2|Overall Study|Withdrawal by Subject|7
1090103|NCT02096263|3559979|P1|Overall Study|Withdrawal by Subject|5
1090104|NCT02096263|3559977|P3|Overall Study|Protocol Violation|8
1090105|NCT02096263|3559978|P2|Overall Study|Protocol Violation|2
1090106|NCT02096263|3559979|P1|Overall Study|Protocol Violation|7
1090107|NCT02096263|3559977|P3|Overall Study|Sponsor study termination|1
1090108|NCT02096263|3559978|P2|Overall Study|Sponsor study termination|0
1090109|NCT02096263|3559979|P1|Overall Study|Sponsor study termination|0
1090110|NCT02096263|3559977|P3|Overall Study|Other|6
1090111|NCT02096263|3559978|P2|Overall Study|Other|9
1090112|NCT02096263|3559979|P1|Overall Study|Other|7
1090113|NCT02096263|3559977|P3|Overall Study|Lost to Follow-up|15
1090114|NCT02096263|3559978|P2|Overall Study|Lost to Follow-up|18
1090115|NCT02096263|3559979|P1|Overall Study|Lost to Follow-up|14
1090116|NCT02096263|3559977|P3|Overall Study|Adverse Event|1
1090117|NCT02096263|3559978|P2|Overall Study|Adverse Event|0
1090118|NCT02096263|3559979|P1|Overall Study|Adverse Event|1
1090119|NCT02096042|3560167|P3|Overall Study|Disease Progression|0
1090120|NCT02096042|3560168|P2|Overall Study|Disease Progression|0
1090121|NCT02096042|3560169|P1|Overall Study|Disease Progression|1
1090122|NCT02095951|3560178|P2|Overall Study|NO POSITIVE BLOOD CULTURE|6
1090123|NCT02095951|3560179|P1|Overall Study|NO POSITIVE BLOOD CULTURE|9
1090124|NCT02095873|3560199|P2|Second Intervention (8 Weeks)|Protocol Violation|0
1090125|NCT02095873|3560200|P1|Second Intervention (8 Weeks)|Protocol Violation|1
1090126|NCT02095873|3560199|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|0
1090127|NCT02095873|3560200|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|1
1090128|NCT02095873|3560199|P2|First Intervention (8 Weeks)|Withdrawal by Subject|0
1090129|NCT02095873|3560200|P1|First Intervention (8 Weeks)|Withdrawal by Subject|1
1090130|NCT02095691|3560212|P1|Overall Study|Physician Decision|1
1090131|NCT02095535|3560244|P1|Recruitment|Protocol Violation|2
1090132|NCT02095223|3560250|P2|Overall Study|Withdrawal by Subject|0
1090133|NCT02095223|3560251|P1|Overall Study|Withdrawal by Subject|1
1090134|NCT02095197|3560261|P2|Overall Study|Lost to Follow-up|3
1090135|NCT02095197|3560262|P1|Overall Study|Lost to Follow-up|0
1090136|NCT02095158|3560274|P1|Overall Study|Other Miscellaneous Reasons|1
1090137|NCT02095158|3560274|P1|Overall Study|Protocol Violation|1
1090138|NCT02095158|3560274|P1|Overall Study|Personal Reasons|35
1090139|NCT02095158|3560274|P1|Overall Study|Lost to Follow-up|20
1090140|NCT02095158|3560274|P1|Overall Study|Pregnancy|1
1090141|NCT02095158|3560274|P1|Overall Study|Lack of Efficacy|3
1090142|NCT02095158|3560274|P1|Overall Study|Adverse Event|14
1090143|NCT02095106|3560281|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
1090144|NCT02095106|3560282|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
1090145|NCT02094937|3560298|P4|12 Weeks in Period 2|Randomized incorrectly|0
1090146|NCT02094937|3560299|P3|12 Weeks in Period 2|Randomized incorrectly|0
1090147|NCT02094937|3560300|P2|12 Weeks in Period 2|Randomized incorrectly|1
1090148|NCT02094937|3560301|P1|12 Weeks in Period 2|Randomized incorrectly|0
1090149|NCT02094937|3560298|P4|12 Weeks in Period 2|Withdrawal by Subject|0
1090150|NCT02094937|3560299|P3|12 Weeks in Period 2|Withdrawal by Subject|2
1090151|NCT02094937|3560300|P2|12 Weeks in Period 2|Withdrawal by Subject|2
1090152|NCT02094937|3560301|P1|12 Weeks in Period 2|Withdrawal by Subject|0
1090153|NCT02094937|3560298|P4|12 Weeks in Period 2|Protocol defined stopping criteria|11
1090154|NCT02094937|3560299|P3|12 Weeks in Period 2|Protocol defined stopping criteria|6
1090155|NCT02094937|3560300|P2|12 Weeks in Period 2|Protocol defined stopping criteria|5
1090156|NCT02094937|3560301|P1|12 Weeks in Period 2|Protocol defined stopping criteria|0
1090157|NCT02094937|3560298|P4|12 Weeks in Period 2|Lack of Efficacy|0
1090158|NCT02094937|3560299|P3|12 Weeks in Period 2|Lack of Efficacy|0
1090159|NCT02094937|3560300|P2|12 Weeks in Period 2|Lack of Efficacy|1
1090160|NCT02094937|3560301|P1|12 Weeks in Period 2|Lack of Efficacy|0
1090161|NCT02094937|3560298|P4|12 Weeks in Period 2|Adverse Event|1
1090162|NCT02094937|3560299|P3|12 Weeks in Period 2|Adverse Event|4
1090163|NCT02094937|3560300|P2|12 Weeks in Period 2|Adverse Event|2
1090164|NCT02094937|3560301|P1|12 Weeks in Period 2|Adverse Event|0
1090165|NCT02094937|3560298|P4|8 Weeks in Period 1|Withdrawal by Subject|0
1090166|NCT02094937|3560299|P3|8 Weeks in Period 1|Withdrawal by Subject|0
1090167|NCT02094937|3560300|P2|8 Weeks in Period 1|Withdrawal by Subject|0
1090168|NCT02094937|3560301|P1|8 Weeks in Period 1|Withdrawal by Subject|4
1090169|NCT02094937|3560298|P4|8 Weeks in Period 1|Physician Decision|0
1090170|NCT02094937|3560299|P3|8 Weeks in Period 1|Physician Decision|0
1090171|NCT02094937|3560300|P2|8 Weeks in Period 1|Physician Decision|0
1090172|NCT02094937|3560301|P1|8 Weeks in Period 1|Physician Decision|1
1090173|NCT02094937|3560298|P4|8 Weeks in Period 1|Protocol defined stopping criteria|0
1090174|NCT02094937|3560299|P3|8 Weeks in Period 1|Protocol defined stopping criteria|0
1090175|NCT02094937|3560300|P2|8 Weeks in Period 1|Protocol defined stopping criteria|0
1090176|NCT02094937|3560301|P1|8 Weeks in Period 1|Protocol defined stopping criteria|41
1090177|NCT02094937|3560298|P4|8 Weeks in Period 1|Protocol Violation|0
1090178|NCT02094937|3560299|P3|8 Weeks in Period 1|Protocol Violation|0
1090179|NCT02094937|3560300|P2|8 Weeks in Period 1|Protocol Violation|0
1090180|NCT02094937|3560301|P1|8 Weeks in Period 1|Protocol Violation|2
1090181|NCT02094937|3560298|P4|8 Weeks in Period 1|Lack of Efficacy|0
1090182|NCT02094937|3560299|P3|8 Weeks in Period 1|Lack of Efficacy|0
1090183|NCT02094937|3560300|P2|8 Weeks in Period 1|Lack of Efficacy|0
1090184|NCT02094937|3560301|P1|8 Weeks in Period 1|Lack of Efficacy|3
1090185|NCT02094937|3560298|P4|8 Weeks in Period 1|Adverse Event|0
1090186|NCT02094937|3560299|P3|8 Weeks in Period 1|Adverse Event|0
1090187|NCT02094937|3560300|P2|8 Weeks in Period 1|Adverse Event|0
1090188|NCT02094937|3560301|P1|8 Weeks in Period 1|Adverse Event|9
1090189|NCT02094898|3560331|P1|Overall Study|Lack of Efficacy|1
1090190|NCT02094898|3560331|P1|Overall Study|Adverse Event|2
1090191|NCT02094898|3560331|P1|Overall Study|Clinical Worsening|2
1090192|NCT02094885|3560378|P2|Overall Study|Withdrawn due to age|0
1090193|NCT02094885|3560379|P1|Overall Study|Withdrawn due to age|1
1090194|NCT02094885|3560378|P2|Overall Study|Death|5
1090195|NCT02094885|3560379|P1|Overall Study|Death|1
1090196|NCT02094677|3560393|P2|Overall Study|Screening|1
1090197|NCT02094677|3560394|P1|Overall Study|Screening|3
1090198|NCT02094612|3560473|P2|Overall Study|Never started ADHD medication|23
1090199|NCT02094612|3560474|P1|Overall Study|Never started ADHD medication|32
1090200|NCT02094612|3560473|P2|Overall Study|Lost to Follow-up|47
1090201|NCT02094612|3560474|P1|Overall Study|Lost to Follow-up|47
1090202|NCT02094573|3560494|P2|Overall Study|Ongoing|76
1090203|NCT02094573|3560495|P1|Overall Study|Ongoing|64
1090204|NCT02094573|3560494|P2|Overall Study|Randomized but not treated|0
1090205|NCT02094573|3560495|P1|Overall Study|Randomized but not treated|3
1090206|NCT02094573|3560494|P2|Overall Study|Withdrawal by Subject|4
1090207|NCT02094573|3560495|P1|Overall Study|Withdrawal by Subject|2
1090208|NCT02094573|3560494|P2|Overall Study|Non-compliance with study drug|1
1090209|NCT02094573|3560495|P1|Overall Study|Non-compliance with study drug|0
1090210|NCT02094573|3560494|P2|Overall Study|Death|1
1090211|NCT02094573|3560495|P1|Overall Study|Death|7
1090212|NCT02094573|3560494|P2|Overall Study|Adverse Event|9
1090213|NCT02094573|3560495|P1|Overall Study|Adverse Event|3
1090214|NCT02094573|3560494|P2|Overall Study|Clinical Progressive Disease|3
1090215|NCT02094573|3560495|P1|Overall Study|Clinical Progressive Disease|4
1090216|NCT02094573|3560494|P2|Overall Study|Documented Progressive Disease|16
1090217|NCT02094573|3560495|P1|Overall Study|Documented Progressive Disease|29
1090218|NCT02094300|3560577|P1|Overall Study|Still be eligible for follow-up|3
1090219|NCT02094300|3560577|P1|Overall Study|Lost to Follow-up|10
1090220|NCT02094300|3560577|P1|Overall Study|Death|7
1090221|NCT02094261|3560581|P1|Overall Study|Ongoing Study at Data Cut-off|181
1090222|NCT02094261|3560581|P1|Overall Study|Withdrawal by Subject|4
1090223|NCT02094261|3560581|P1|Overall Study|Lost to Follow-up|1
1090224|NCT02094261|3560581|P1|Overall Study|Death|24
1090225|NCT02093923|3560623|P5|Overall Study|Screen failure after randomization|0
1090226|NCT02093923|3560624|P4|Overall Study|Screen failure after randomization|1
1090227|NCT02093923|3560625|P3|Overall Study|Screen failure after randomization|0
1090228|NCT02093923|3560626|P2|Overall Study|Screen failure after randomization|0
1090229|NCT02093923|3560627|P1|Overall Study|Screen failure after randomization|0
1090230|NCT02093923|3560623|P5|Overall Study|Lost to Follow-up|0
1090231|NCT02093923|3560624|P4|Overall Study|Lost to Follow-up|1
1090232|NCT02093923|3560625|P3|Overall Study|Lost to Follow-up|0
1090233|NCT02093923|3560626|P2|Overall Study|Lost to Follow-up|0
1090234|NCT02093923|3560627|P1|Overall Study|Lost to Follow-up|0
1090235|NCT02093897|3560682|P1|Overall Study|Adverse event, non-fatal|1
1090236|NCT02093897|3560682|P1|Overall Study|Planned age group closure - no's reached|17
1090237|NCT02093897|3560682|P1|Overall Study|Physician Decision|1
1090238|NCT02093689|3560785|P3|Overall Study|Physician Decision|0
1090239|NCT02093689|3560786|P2|Overall Study|Physician Decision|0
1090240|NCT02093689|3560787|P1|Overall Study|Physician Decision|4
1090241|NCT02093520|3560795|P2|Overall Study|Not treated|22
1090242|NCT02093520|3560796|P1|Overall Study|Not treated|6
1090243|NCT02093390|3560808|P2|Overall Study|Withdrawal by Subject|1
1090244|NCT02093390|3560809|P1|Overall Study|Withdrawal by Subject|0
1090245|NCT02093351|3560848|P3|Overall Study|Death|0
1090246|NCT02093351|3560849|P2|Overall Study|Death|1
1090247|NCT02093351|3560850|P1|Overall Study|Death|0
1090248|NCT02093351|3560848|P3|Overall Study|Condition under investigation worsened|2
1090249|NCT02093351|3560849|P2|Overall Study|Condition under investigation worsened|0
1090250|NCT02093351|3560850|P1|Overall Study|Condition under investigation worsened|2
1090251|NCT02093351|3560848|P3|Overall Study|Adverse Event|1
1090252|NCT02093351|3560849|P2|Overall Study|Adverse Event|1
1090253|NCT02093351|3560850|P1|Overall Study|Adverse Event|0
1090254|NCT02093221|3560906|P5|Overall Study|Study termination|7
1090255|NCT02093221|3560907|P4|Overall Study|Study termination|6
1090256|NCT02093221|3560908|P3|Overall Study|Study termination|4
1090257|NCT02093221|3560909|P2|Overall Study|Study termination|5
1090258|NCT02093221|3560910|P1|Overall Study|Study termination|6
1090259|NCT02093221|3560906|P5|Overall Study|Protocol Violation|0
1090260|NCT02093221|3560907|P4|Overall Study|Protocol Violation|0
1090261|NCT02093221|3560908|P3|Overall Study|Protocol Violation|0
1090262|NCT02093221|3560909|P2|Overall Study|Protocol Violation|1
1090263|NCT02093221|3560910|P1|Overall Study|Protocol Violation|0
1090264|NCT02093221|3560906|P5|Overall Study|Death|0
1090265|NCT02093221|3560907|P4|Overall Study|Death|0
1090266|NCT02093221|3560908|P3|Overall Study|Death|0
1090267|NCT02093221|3560909|P2|Overall Study|Death|1
1090268|NCT02093221|3560910|P1|Overall Study|Death|0
1090269|NCT02093221|3560906|P5|Overall Study|Lost to Follow-up|0
1090270|NCT02093221|3560907|P4|Overall Study|Lost to Follow-up|1
1090271|NCT02093221|3560908|P3|Overall Study|Lost to Follow-up|1
1090272|NCT02093221|3560909|P2|Overall Study|Lost to Follow-up|0
1090273|NCT02093221|3560910|P1|Overall Study|Lost to Follow-up|2
1090274|NCT02093221|3560906|P5|Overall Study|Withdrawal by Subject|1
1090275|NCT02093221|3560907|P4|Overall Study|Withdrawal by Subject|1
1090276|NCT02093221|3560908|P3|Overall Study|Withdrawal by Subject|4
1090277|NCT02093221|3560909|P2|Overall Study|Withdrawal by Subject|1
1090278|NCT02093221|3560910|P1|Overall Study|Withdrawal by Subject|1
1090279|NCT02093221|3560906|P5|Overall Study|Adverse Event|0
1090280|NCT02093221|3560907|P4|Overall Study|Adverse Event|0
1090281|NCT02093221|3560908|P3|Overall Study|Adverse Event|0
1090282|NCT02093221|3560909|P2|Overall Study|Adverse Event|0
1090283|NCT02093221|3560910|P1|Overall Study|Adverse Event|1
1090284|NCT02093026|3560947|P1|Overall Study|Other|157
1090285|NCT02093026|3560947|P1|Overall Study|Death|10
1090286|NCT02093026|3560947|P1|Overall Study|Adverse Event|26
1090287|NCT02092961|3560969|P3|Overall Study|Adverse Event|0
1090288|NCT02092961|3560970|P2|Overall Study|Adverse Event|4
1090289|NCT02092961|3560971|P1|Overall Study|Adverse Event|2
1090290|NCT02092961|3560969|P3|Overall Study|Dev. of study specific discont. criteria|0
1090291|NCT02092961|3560970|P2|Overall Study|Dev. of study specific discont. criteria|0
1090292|NCT02092961|3560971|P1|Overall Study|Dev. of study specific discont. criteria|3
1090293|NCT02092961|3560969|P3|Overall Study|Lack of therapeutic response|3
1090294|NCT02092961|3560970|P2|Overall Study|Lack of therapeutic response|1
1090295|NCT02092961|3560971|P1|Overall Study|Lack of therapeutic response|2
1090296|NCT02092961|3560969|P3|Overall Study|Study stopped|12
1090297|NCT02092961|3560970|P2|Overall Study|Study stopped|9
1090298|NCT02092961|3560971|P1|Overall Study|Study stopped|13
1090299|NCT02092961|3560969|P3|Overall Study|Not reported|1
1090300|NCT02092961|3560970|P2|Overall Study|Not reported|0
1090301|NCT02092961|3560971|P1|Overall Study|Not reported|1
1090302|NCT02092662|3561007|P2|Overall Study|Lost to Follow-up|0
1090303|NCT02092662|3561008|P1|Overall Study|Lost to Follow-up|13
1090304|NCT02092389|3561067|P1|Overall Study|Not specified|5
1090305|NCT02092389|3561067|P1|Overall Study|Adverse Event|1
1090306|NCT02092350|3561079|P2|Overall Study|Withdrawal by Subject|2
1090307|NCT02092350|3561080|P1|Overall Study|Withdrawal by Subject|2
1090308|NCT02092350|3561079|P2|Overall Study|Screen Failure|0
1090309|NCT02092350|3561080|P1|Overall Study|Screen Failure|1
1090310|NCT02092350|3561079|P2|Overall Study|Physician Decision|1
1090311|NCT02092350|3561080|P1|Overall Study|Physician Decision|1
1090312|NCT02092350|3561079|P2|Overall Study|Protocol Violation|0
1090313|NCT02092350|3561080|P1|Overall Study|Protocol Violation|1
1090314|NCT02092350|3561079|P2|Overall Study|Lost to Follow-up|1
1090315|NCT02092350|3561080|P1|Overall Study|Lost to Follow-up|3
1090316|NCT02092350|3561079|P2|Overall Study|Death|5
1090317|NCT02092350|3561080|P1|Overall Study|Death|2
1090318|NCT02092350|3561079|P2|Overall Study|Adverse Event|3
1090319|NCT02092350|3561080|P1|Overall Study|Adverse Event|0
1090320|NCT02092285|3561108|P1|Maintenance Phase & Follow-up|Lack of Efficacy|23
1090321|NCT02092285|3561108|P1|Maintenance Phase & Follow-up|Withdrawal by Subject|11
1090322|NCT02092285|3561108|P1|Maintenance Phase & Follow-up|Relapse/recurrence|29
1090323|NCT02092285|3561108|P1|Maintenance Phase & Follow-up|Protocol Violation|11
1090324|NCT02092285|3561108|P1|Maintenance Phase & Follow-up|Pregnancy|1
1090325|NCT02092285|3561108|P1|Maintenance Phase & Follow-up|Physician Decision|10
1090326|NCT02092285|3561108|P1|Maintenance Phase & Follow-up|Non-compliance with study drug|2
1090327|NCT02092285|3561108|P1|Maintenance Phase & Follow-up|Lost to Follow-up|1
1090328|NCT02092285|3561108|P1|Maintenance Phase & Follow-up|Adverse Event|22
1090329|NCT02092285|3561108|P1|Induction Phase|Lack of Efficacy|14
1090330|NCT02092285|3561108|P1|Induction Phase|Withdrawal by Subject|2
1090331|NCT02092285|3561108|P1|Induction Phase|Relapse/Recurrence|7
1090332|NCT02092285|3561108|P1|Induction Phase|Pregnancy|1
1090333|NCT02092285|3561108|P1|Induction Phase|Physician Decision|4
1090334|NCT02092285|3561108|P1|Induction Phase|Adverse Event|7
1090335|NCT02092220|3561112|P2|Period 2|Nausea, Anxiety, Inconvenience|1
1090336|NCT02092220|3561113|P1|Period 2|Nausea, Anxiety, Inconvenience|0
1090337|NCT02092220|3561112|P2|Period 2|Severe Hypoglycaemia|0
1090338|NCT02092220|3561113|P1|Period 2|Severe Hypoglycaemia|1
1090339|NCT02092220|3561112|P2|Period 1|Unrelated Illness|2
1090340|NCT02092220|3561113|P1|Period 1|Unrelated Illness|0
1090341|NCT02092116|3561186|P2|Overall Study|Adverse Event|1
1090342|NCT02092116|3561187|P1|Overall Study|Adverse Event|0
1090343|NCT02092116|3561186|P2|Overall Study|Withdrawal by Subject|3
1090344|NCT02092116|3561187|P1|Overall Study|Withdrawal by Subject|0
1090345|NCT02091986|3561199|P3|Overall Study|Adverse Event|2
1090346|NCT02091986|3561200|P2|Overall Study|Adverse Event|0
1090347|NCT02091986|3561201|P1|Overall Study|Adverse Event|0
1090348|NCT02091986|3561199|P3|Overall Study|Withdrawal by Subject|3
1090349|NCT02091986|3561200|P2|Overall Study|Withdrawal by Subject|8
1090350|NCT02091986|3561201|P1|Overall Study|Withdrawal by Subject|4
1090351|NCT02091986|3561199|P3|Overall Study|Lost to Follow-up|0
1090352|NCT02091986|3561200|P2|Overall Study|Lost to Follow-up|0
1090353|NCT02091986|3561201|P1|Overall Study|Lost to Follow-up|1
1090354|NCT02091986|3561199|P3|Overall Study|7 rand in error 1 patient decision|3
1090355|NCT02091986|3561200|P2|Overall Study|7 rand in error 1 patient decision|3
1090356|NCT02091986|3561201|P1|Overall Study|7 rand in error 1 patient decision|2
1090357|NCT02091960|3561248|P1|Overall Study|On Study at Data Cut-off|12
1090358|NCT02091960|3561248|P1|Overall Study|Miscellaneous Reasons|31
1090359|NCT02091960|3561248|P1|Overall Study|Withdrawal by Subject|1
1090360|NCT02091960|3561248|P1|Overall Study|Death|7
1090361|NCT02091869|3561261|P2|Overall Study|Withdrawal by Subject|3
1090362|NCT02091869|3561262|P1|Overall Study|Withdrawal by Subject|0
1090363|NCT02091752|3561303|P1|Overall Study|Adverse Event|1
1090364|NCT02091752|3561303|P1|Overall Study|Study terminated by Sponsor|2
1090365|NCT02091739|3561317|P5|EP: 48 Weeks|Withdrawal by Subject|6
1090366|NCT02091739|3561318|P4|EP: 48 Weeks|Withdrawal by Subject|2
1090367|NCT02091739|3561319|P3|EP: 48 Weeks|Withdrawal by Subject|0
1090368|NCT02091739|3561320|P2|EP: 48 Weeks|Withdrawal by Subject|0
1090369|NCT02091739|3561321|P1|EP: 48 Weeks|Withdrawal by Subject|0
1090370|NCT02091739|3561317|P5|EP: 48 Weeks|Adverse Event|6
1090371|NCT02091739|3561318|P4|EP: 48 Weeks|Adverse Event|2
1090372|NCT02091739|3561319|P3|EP: 48 Weeks|Adverse Event|0
1090373|NCT02091739|3561320|P2|EP: 48 Weeks|Adverse Event|0
1090374|NCT02091739|3561321|P1|EP: 48 Weeks|Adverse Event|0
1090375|NCT02091739|3561317|P5|EP: 48 Weeks|Death|2
1090376|NCT02091739|3561318|P4|EP: 48 Weeks|Death|3
1090377|NCT02091739|3561319|P3|EP: 48 Weeks|Death|0
1090378|NCT02091739|3561320|P2|EP: 48 Weeks|Death|0
1090379|NCT02091739|3561321|P1|EP: 48 Weeks|Death|0
1090380|NCT02091739|3561317|P5|EP: 48 Weeks|Other|0
1090381|NCT02091739|3561318|P4|EP: 48 Weeks|Other|1
1090382|NCT02091739|3561319|P3|EP: 48 Weeks|Other|0
1090383|NCT02091739|3561320|P2|EP: 48 Weeks|Other|0
1090384|NCT02091739|3561321|P1|EP: 48 Weeks|Other|0
1090385|NCT02091739|3561317|P5|MP: 16 Weeks|Lost to Follow-up|0
1090386|NCT02091739|3561318|P4|MP: 16 Weeks|Lost to Follow-up|0
1090387|NCT02091739|3561319|P3|MP: 16 Weeks|Lost to Follow-up|1
1090388|NCT02091739|3561320|P2|MP: 16 Weeks|Lost to Follow-up|0
1090389|NCT02091739|3561321|P1|MP: 16 Weeks|Lost to Follow-up|0
1090390|NCT02091739|3561317|P5|MP: 16 Weeks|Withdrawal by Subject|0
1090391|NCT02091739|3561318|P4|MP: 16 Weeks|Withdrawal by Subject|0
1090392|NCT02091739|3561319|P3|MP: 16 Weeks|Withdrawal by Subject|0
1090393|NCT02091739|3561320|P2|MP: 16 Weeks|Withdrawal by Subject|4
1090394|NCT02091739|3561321|P1|MP: 16 Weeks|Withdrawal by Subject|3
1090395|NCT02091739|3561317|P5|MP: 16 Weeks|Adverse Event|0
1090396|NCT02091739|3561318|P4|MP: 16 Weeks|Adverse Event|0
1090397|NCT02091739|3561319|P3|MP: 16 Weeks|Adverse Event|1
1090398|NCT02091739|3561320|P2|MP: 16 Weeks|Adverse Event|1
1090399|NCT02091739|3561321|P1|MP: 16 Weeks|Adverse Event|1
1090400|NCT02091726|3561340|P1|Overall Study|Lost to Follow-up|6
1090401|NCT02091414|3561357|P1|Overall Study|Death|2
1090402|NCT02091414|3561357|P1|Overall Study|Withdrawal by Subject|2
1090403|NCT02091375|3561371|P2|Overall Study|Withdrawn by the investigator|0
1090404|NCT02091375|3561372|P1|Overall Study|Withdrawn by the investigator|1
1090405|NCT02091375|3561371|P2|Overall Study|Withdrawal by Subject|1
1090406|NCT02091375|3561372|P1|Overall Study|Withdrawal by Subject|0
1090407|NCT02091375|3561371|P2|Overall Study|Lost to Follow-up|1
1090408|NCT02091375|3561372|P1|Overall Study|Lost to Follow-up|0
1090409|NCT02091375|3561371|P2|Overall Study|Adverse Event|1
1090410|NCT02091375|3561372|P1|Overall Study|Adverse Event|8
1090411|NCT02091362|3561402|P2|Period 2|Withdrawal by Subject|1
1090412|NCT02091362|3561403|P1|Period 2|Withdrawal by Subject|1
1090413|NCT02091362|3561402|P2|Period 2|Lost to Follow-up|1
1090414|NCT02091362|3561403|P1|Period 2|Lost to Follow-up|0
1090415|NCT02091362|3561402|P2|Period 2|Adverse Event|0
1090416|NCT02091362|3561403|P1|Period 2|Adverse Event|1
1090417|NCT02091362|3561402|P2|Wash-out|Withdrawal by Subject|2
1090418|NCT02091362|3561403|P1|Wash-out|Withdrawal by Subject|0
1090419|NCT02091362|3561402|P2|Wash-out|Lost to Follow-up|1
1090420|NCT02091362|3561403|P1|Wash-out|Lost to Follow-up|1
1090421|NCT02091362|3561402|P2|Period 1|Adverse Event|0
1090422|NCT02091362|3561403|P1|Period 1|Adverse Event|2
1090423|NCT02091362|3561402|P2|Period 1|Lost to Follow-up|1
1090424|NCT02091362|3561403|P1|Period 1|Lost to Follow-up|0
1090425|NCT02091362|3561402|P2|Period 1|Withdrawal by Subject|3
1090426|NCT02091362|3561403|P1|Period 1|Withdrawal by Subject|2
1090427|NCT02091362|3561402|P2|Period 1|Protocol Violation|0
1090428|NCT02091362|3561403|P1|Period 1|Protocol Violation|1
1090429|NCT02091206|3561427|P4|Taper Period|Lost to Follow-up|1
1090430|NCT02091206|3561428|P3|Taper Period|Lost to Follow-up|0
1090431|NCT02091206|3561429|P2|Taper Period|Lost to Follow-up|0
1090432|NCT02091206|3561430|P1|Taper Period|Lost to Follow-up|0
1090433|NCT02091206|3561427|P4|Taper Period|Participant refused study drug|1
1090434|NCT02091206|3561428|P3|Taper Period|Participant refused study drug|0
1090435|NCT02091206|3561429|P2|Taper Period|Participant refused study drug|0
1090436|NCT02091206|3561430|P1|Taper Period|Participant refused study drug|1
1090437|NCT02091206|3561427|P4|Treatment Period|Met withdrawal criteria|0
1090438|NCT02091206|3561428|P3|Treatment Period|Met withdrawal criteria|1
1090439|NCT02091206|3561429|P2|Treatment Period|Met withdrawal criteria|0
1090440|NCT02091206|3561430|P1|Treatment Period|Met withdrawal criteria|0
1090441|NCT02091206|3561427|P4|Treatment Period|Adverse Event|0
1090442|NCT02091206|3561428|P3|Treatment Period|Adverse Event|0
1090443|NCT02091206|3561429|P2|Treatment Period|Adverse Event|1
1090444|NCT02091206|3561430|P1|Treatment Period|Adverse Event|0
1090445|NCT02090855|3561452|P1|Overall Study|no evaluable Standard of Truth results|2
1090446|NCT02090764|3561465|P2|Overall Study|Lost to Follow-up|2
1090447|NCT02090764|3561466|P1|Overall Study|Lost to Follow-up|2
1090448|NCT02090764|3561465|P2|Overall Study|Intercurrent illness and other|1
1090449|NCT02090764|3561466|P1|Overall Study|Intercurrent illness and other|1
1090450|NCT02090764|3561465|P2|Overall Study|Withdrawal by Subject|1
1090451|NCT02090764|3561466|P1|Overall Study|Withdrawal by Subject|2
1090452|NCT02090764|3561465|P2|Overall Study|Lack of Efficacy|13
1090453|NCT02090764|3561466|P1|Overall Study|Lack of Efficacy|0
1090454|NCT02090764|3561465|P2|Overall Study|Adverse Event|3
1090455|NCT02090764|3561466|P1|Overall Study|Adverse Event|1
1090456|NCT02090413|3561475|P3|Overall Study|Lost to Follow-up|0
1090457|NCT02090413|3561476|P2|Overall Study|Lost to Follow-up|1
1090458|NCT02090413|3561477|P1|Overall Study|Lost to Follow-up|1
1090459|NCT02090413|3561475|P3|Overall Study|Not Specified|0
1090460|NCT02090413|3561476|P2|Overall Study|Not Specified|1
1090461|NCT02090413|3561477|P1|Overall Study|Not Specified|2
1090462|NCT02090413|3561475|P3|Overall Study|Investigator Decision|0
1090463|NCT02090413|3561476|P2|Overall Study|Investigator Decision|1
1090464|NCT02090413|3561477|P1|Overall Study|Investigator Decision|1
1090465|NCT02090413|3561475|P3|Overall Study|Withdrawal by Subject|2
1090466|NCT02090413|3561476|P2|Overall Study|Withdrawal by Subject|2
1090467|NCT02090413|3561477|P1|Overall Study|Withdrawal by Subject|2
1090468|NCT02090413|3561475|P3|Overall Study|Flushing event|1
1090469|NCT02090413|3561476|P2|Overall Study|Flushing event|0
1090470|NCT02090413|3561477|P1|Overall Study|Flushing event|2
1090471|NCT02090413|3561475|P3|Overall Study|Adverse Event|20
1090472|NCT02090413|3561476|P2|Overall Study|Adverse Event|15
1090473|NCT02090413|3561477|P1|Overall Study|Adverse Event|11
1090474|NCT02089997|3561563|P1|Overall Study|Protocol Violation|147
1090475|NCT02089997|3561563|P1|Overall Study|Case report forms uncollected|99
1090476|NCT02089737|3561578|P1|Overall Study|Not treated|1
1090477|NCT02089737|3561578|P1|Overall Study|Survey form not completed|5
1090478|NCT02089347|3561603|P2|Overall Study|Protocol Violation|0
1090479|NCT02089347|3561604|P1|Overall Study|Protocol Violation|1
1090480|NCT02088957|3561644|P2|Overall Study|Lack of Efficacy|0
1090481|NCT02088957|3561645|P1|Overall Study|Lack of Efficacy|1
1090482|NCT02088177|3561672|P1|Overall Study|Lost to Follow-up|3
1090483|NCT02088073|3561682|P5|Maintanance Phase|Subject compliance|0
1090484|NCT02088073|3561683|P4|Maintanance Phase|Subject compliance|0
1090485|NCT02088073|3561684|P3|Maintanance Phase|Subject compliance|0
1090486|NCT02088073|3561685|P2|Maintanance Phase|Subject compliance|1
1090487|NCT02088073|3561686|P1|Maintanance Phase|Subject compliance|0
1090488|NCT02088073|3561682|P5|Maintanance Phase|Met ECG withdrawal criteria|2
1090489|NCT02088073|3561683|P4|Maintanance Phase|Met ECG withdrawal criteria|0
1090490|NCT02088073|3561684|P3|Maintanance Phase|Met ECG withdrawal criteria|1
1090491|NCT02088073|3561685|P2|Maintanance Phase|Met ECG withdrawal criteria|0
1090492|NCT02088073|3561686|P1|Maintanance Phase|Met ECG withdrawal criteria|0
1090493|NCT02088073|3561682|P5|Maintanance Phase|Miscellaneous|1
1090494|NCT02088073|3561683|P4|Maintanance Phase|Miscellaneous|2
1090495|NCT02088073|3561684|P3|Maintanance Phase|Miscellaneous|1
1090496|NCT02088073|3561685|P2|Maintanance Phase|Miscellaneous|2
1090497|NCT02088073|3561686|P1|Maintanance Phase|Miscellaneous|0
1090498|NCT02088073|3561682|P5|Maintanance Phase|Hypo- or hyperkalemia|1
1090499|NCT02088073|3561683|P4|Maintanance Phase|Hypo- or hyperkalemia|3
1090500|NCT02088073|3561684|P3|Maintanance Phase|Hypo- or hyperkalemia|0
1090501|NCT02088073|3561685|P2|Maintanance Phase|Hypo- or hyperkalemia|3
1090502|NCT02088073|3561686|P1|Maintanance Phase|Hypo- or hyperkalemia|0
1090503|NCT02088073|3561682|P5|Maintanance Phase|Sponsor's decision|1
1090504|NCT02088073|3561683|P4|Maintanance Phase|Sponsor's decision|2
1090505|NCT02088073|3561684|P3|Maintanance Phase|Sponsor's decision|0
1090506|NCT02088073|3561685|P2|Maintanance Phase|Sponsor's decision|2
1090507|NCT02088073|3561686|P1|Maintanance Phase|Sponsor's decision|0
1090508|NCT02088073|3561682|P5|Maintanance Phase|Physician Decision|1
1090509|NCT02088073|3561683|P4|Maintanance Phase|Physician Decision|0
1090510|NCT02088073|3561684|P3|Maintanance Phase|Physician Decision|0
1090511|NCT02088073|3561685|P2|Maintanance Phase|Physician Decision|0
1090512|NCT02088073|3561686|P1|Maintanance Phase|Physician Decision|0
1090513|NCT02088073|3561682|P5|Maintanance Phase|Adverse Event|1
1090514|NCT02088073|3561683|P4|Maintanance Phase|Adverse Event|0
1090515|NCT02088073|3561684|P3|Maintanance Phase|Adverse Event|3
1090516|NCT02088073|3561685|P2|Maintanance Phase|Adverse Event|0
1090517|NCT02088073|3561686|P1|Maintanance Phase|Adverse Event|0
1090518|NCT02088073|3561682|P5|Maintanance Phase|Withdrawal by Subject|0
1090519|NCT02088073|3561683|P4|Maintanance Phase|Withdrawal by Subject|0
1090520|NCT02088073|3561684|P3|Maintanance Phase|Withdrawal by Subject|0
1090521|NCT02088073|3561685|P2|Maintanance Phase|Withdrawal by Subject|2
1090522|NCT02088073|3561686|P1|Maintanance Phase|Withdrawal by Subject|0
1090523|NCT02088073|3561682|P5|Acute Phase|Hyperkalemia|0
1090524|NCT02088073|3561683|P4|Acute Phase|Hyperkalemia|0
1090525|NCT02088073|3561684|P3|Acute Phase|Hyperkalemia|0
1090526|NCT02088073|3561685|P2|Acute Phase|Hyperkalemia|0
1090527|NCT02088073|3561686|P1|Acute Phase|Hyperkalemia|2
1090528|NCT02088073|3561682|P5|Acute Phase|Withdrawal by Subject|0
1090529|NCT02088073|3561683|P4|Acute Phase|Withdrawal by Subject|0
1090530|NCT02088073|3561684|P3|Acute Phase|Withdrawal by Subject|0
1090531|NCT02088073|3561685|P2|Acute Phase|Withdrawal by Subject|0
1090532|NCT02088073|3561686|P1|Acute Phase|Withdrawal by Subject|5
1090533|NCT02087943|3561745|P5|Active Treatment Phase Week 12-24|Other-Unspecified|0
1090534|NCT02087943|3561746|P4|Active Treatment Phase Week 12-24|Other-Unspecified|1
1090535|NCT02087943|3561747|P3|Active Treatment Phase Week 12-24|Other-Unspecified|1
1090536|NCT02087943|3561748|P2|Active Treatment Phase Week 12-24|Other-Unspecified|0
1090537|NCT02087943|3561749|P1|Active Treatment Phase Week 12-24|Other-Unspecified|0
1090538|NCT02087943|3561745|P5|Active Treatment Phase Week 12-24|Lost to Follow-up|1
1090539|NCT02087943|3561746|P4|Active Treatment Phase Week 12-24|Lost to Follow-up|0
1090540|NCT02087943|3561747|P3|Active Treatment Phase Week 12-24|Lost to Follow-up|0
1090541|NCT02087943|3561748|P2|Active Treatment Phase Week 12-24|Lost to Follow-up|0
1090542|NCT02087943|3561749|P1|Active Treatment Phase Week 12-24|Lost to Follow-up|0
1090543|NCT02087943|3561745|P5|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
1090544|NCT02087943|3561746|P4|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
1090545|NCT02087943|3561747|P3|Active Treatment Phase Week 12-24|Withdrawal by Subject|1
1090546|NCT02087943|3561748|P2|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
1090547|NCT02087943|3561749|P1|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
1090548|NCT02087943|3561745|P5|Active Treatment Phase Week 12-24|Lack of Efficacy|0
1090549|NCT02087943|3561746|P4|Active Treatment Phase Week 12-24|Lack of Efficacy|1
1090550|NCT02087943|3561747|P3|Active Treatment Phase Week 12-24|Lack of Efficacy|1
1090551|NCT02087943|3561748|P2|Active Treatment Phase Week 12-24|Lack of Efficacy|3
1090552|NCT02087943|3561749|P1|Active Treatment Phase Week 12-24|Lack of Efficacy|0
1090553|NCT02087943|3561745|P5|Active Treatment Phase Week 12-24|Adverse Event|1
1090554|NCT02087943|3561746|P4|Active Treatment Phase Week 12-24|Adverse Event|0
1090555|NCT02087943|3561747|P3|Active Treatment Phase Week 12-24|Adverse Event|2
1090556|NCT02087943|3561748|P2|Active Treatment Phase Week 12-24|Adverse Event|1
1090557|NCT02087943|3561749|P1|Active Treatment Phase Week 12-24|Adverse Event|0
1090558|NCT02087943|3561745|P5|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
1090559|NCT02087943|3561746|P4|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
1090560|NCT02087943|3561747|P3|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
1090561|NCT02087943|3561748|P2|Placebo-Controlled Phase Week 0-12|Protocol Violation|1
1090562|NCT02087943|3561749|P1|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
1090563|NCT02087943|3561745|P5|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
1090564|NCT02087943|3561746|P4|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
1090565|NCT02087943|3561747|P3|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
1090566|NCT02087943|3561748|P2|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
1090567|NCT02087943|3561749|P1|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
1090568|NCT02087943|3561745|P5|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
1090569|NCT02087943|3561746|P4|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
1090570|NCT02087943|3561747|P3|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
1090571|NCT02087943|3561748|P2|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
1090572|NCT02087943|3561749|P1|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4
1090573|NCT02087943|3561745|P5|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
1090574|NCT02087943|3561746|P4|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
1090575|NCT02087943|3561747|P3|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4
1090576|NCT02087943|3561748|P2|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7
1090577|NCT02087943|3561749|P1|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8
1090578|NCT02087943|3561745|P5|Placebo-Controlled Phase Week 0-12|Adverse Event|0
1090579|NCT02087943|3561746|P4|Placebo-Controlled Phase Week 0-12|Adverse Event|0
1090580|NCT02087943|3561747|P3|Placebo-Controlled Phase Week 0-12|Adverse Event|6
1090581|NCT02087943|3561748|P2|Placebo-Controlled Phase Week 0-12|Adverse Event|2
1090582|NCT02087943|3561749|P1|Placebo-Controlled Phase Week 0-12|Adverse Event|1
1090583|NCT02087774|3561775|P2|Overall Study|Were absent day of data collection|20
1090584|NCT02087774|3561776|P1|Overall Study|Were absent day of data collection|8
1090585|NCT02087670|3561796|P2|Overall Study|Withdrawal by Subject|2
1090586|NCT02087670|3561797|P1|Overall Study|Withdrawal by Subject|3
1090587|NCT02087423|3561833|P3|Overall Study|Terminated from study at final DCO|25
1090588|NCT02087423|3561834|P2|Overall Study|Terminated from study at final DCO|36
1090589|NCT02087423|3561835|P1|Overall Study|Terminated from study at final DCO|23
1090590|NCT02087423|3561833|P3|Overall Study|Lost to Follow-up|0
1090591|NCT02087423|3561834|P2|Overall Study|Lost to Follow-up|2
1090592|NCT02087423|3561835|P1|Overall Study|Lost to Follow-up|0
1090593|NCT02087423|3561833|P3|Overall Study|Death|40
1090594|NCT02087423|3561834|P2|Overall Study|Death|207
1090595|NCT02087423|3561835|P1|Overall Study|Death|68
1090596|NCT02087423|3561833|P3|Overall Study|Withdrawal by Subject|3
1090597|NCT02087423|3561834|P2|Overall Study|Withdrawal by Subject|20
1090598|NCT02087423|3561835|P1|Overall Study|Withdrawal by Subject|20
1090599|NCT02087241|3561864|P4|Overall Study|Study Terminated by Sponsor|4
1090600|NCT02087241|3561865|P3|Overall Study|Study Terminated by Sponsor|0
1090601|NCT02087241|3561866|P2|Overall Study|Study Terminated by Sponsor|2
1090602|NCT02087241|3561867|P1|Overall Study|Study Terminated by Sponsor|0
1090603|NCT02087241|3561864|P4|Overall Study|Progressive Disease|1
1090604|NCT02087241|3561865|P3|Overall Study|Progressive Disease|0
1090605|NCT02087241|3561866|P2|Overall Study|Progressive Disease|0
1090606|NCT02087241|3561867|P1|Overall Study|Progressive Disease|0
1090607|NCT02087241|3561864|P4|Overall Study|Withdrawal by Subject|1
1090608|NCT02087241|3561865|P3|Overall Study|Withdrawal by Subject|0
1090609|NCT02087241|3561866|P2|Overall Study|Withdrawal by Subject|0
1090610|NCT02087241|3561867|P1|Overall Study|Withdrawal by Subject|1
1090611|NCT02087241|3561864|P4|Overall Study|Death|1
1090612|NCT02087241|3561865|P3|Overall Study|Death|1
1090613|NCT02087241|3561866|P2|Overall Study|Death|1
1090614|NCT02087241|3561867|P1|Overall Study|Death|2
1090615|NCT02087176|3561893|P1|Overall Study|Study Terminated by Sponsor|2
1090616|NCT02087176|3561893|P1|Overall Study|Censored|19
1090617|NCT02087176|3561893|P1|Overall Study|Death|10
1090618|NCT02087176|3561893|P1|Overall Study|Withdrawal by Subject|1
1090619|NCT02087059|3561898|P1|Overall Study|Lost to Follow-up|1
1090620|NCT02087059|3561898|P1|Overall Study|Adverse Event|5
1090621|NCT02087059|3561898|P1|Overall Study|Disease Progression|1
1090622|NCT02086591|3561945|P1|Overall Study|protocol terminated|3
1090623|NCT02086591|3561945|P1|Overall Study|Withdrawal by Subject|1
1090624|NCT02086591|3561945|P1|Overall Study|Adverse Event|1
1090625|NCT02086162|3561953|P2|Overall Study|Death|0
1090626|NCT02086162|3561954|P1|Overall Study|Death|1
1090627|NCT02086162|3561953|P2|Overall Study|Lost to Follow-up|2
1090628|NCT02086162|3561954|P1|Overall Study|Lost to Follow-up|4
1090629|NCT02086162|3561953|P2|Overall Study|moved|1
1090630|NCT02086162|3561954|P1|Overall Study|moved|1
1090631|NCT02086162|3561953|P2|Overall Study|Withdrawal by Subject|4
1090632|NCT02086162|3561954|P1|Overall Study|Withdrawal by Subject|4
1090633|NCT02085785|3561966|P2|Overall Study|Lost to Follow-up|1
1090634|NCT02085785|3561967|P1|Overall Study|Lost to Follow-up|0
1090635|NCT02085785|3561966|P2|Overall Study|Withdrawal by Subject|1
1090636|NCT02085785|3561967|P1|Overall Study|Withdrawal by Subject|2
1090637|NCT02085161|3562060|P4|Overall Study|Other Reason|1
1090638|NCT02085161|3562061|P3|Overall Study|Other Reason|1
1090639|NCT02085161|3562062|P2|Overall Study|Other Reason|0
1090640|NCT02085161|3562063|P1|Overall Study|Other Reason|1
1090641|NCT02085161|3562060|P4|Overall Study|Withdrawal by Subject|3
1090642|NCT02085161|3562061|P3|Overall Study|Withdrawal by Subject|0
1090643|NCT02085161|3562062|P2|Overall Study|Withdrawal by Subject|4
1090644|NCT02085161|3562063|P1|Overall Study|Withdrawal by Subject|2
1090645|NCT02085161|3562060|P4|Overall Study|Protocol Violation|1
1090646|NCT02085161|3562061|P3|Overall Study|Protocol Violation|0
1090647|NCT02085161|3562062|P2|Overall Study|Protocol Violation|1
1090648|NCT02085161|3562063|P1|Overall Study|Protocol Violation|0
1090649|NCT02085161|3562060|P4|Overall Study|Adverse Event|5
1090650|NCT02085161|3562061|P3|Overall Study|Adverse Event|4
1090651|NCT02085161|3562062|P2|Overall Study|Adverse Event|5
1090652|NCT02085161|3562063|P1|Overall Study|Adverse Event|8
1090653|NCT02085161|3562060|P4|Overall Study|Not Treated|0
1090654|NCT02085161|3562061|P3|Overall Study|Not Treated|0
1090655|NCT02085161|3562062|P2|Overall Study|Not Treated|0
1090656|NCT02085161|3562063|P1|Overall Study|Not Treated|1
1090657|NCT02084238|3562131|P1|Overall Study|Lost to Follow-up|2
1090658|NCT02084134|3562144|P2|Overall Study|Death|1
1090659|NCT02084134|3562145|P1|Overall Study|Death|0
1090660|NCT02084134|3562144|P2|Overall Study|Protocol Violation|2
1090661|NCT02084134|3562145|P1|Overall Study|Protocol Violation|4
1090662|NCT02084082|3562155|P4|Washout Period 1 (35 Days)|Withdrawal by Subject|1
1090663|NCT02084082|3562156|P3|Washout Period 1 (35 Days)|Withdrawal by Subject|0
1090664|NCT02084082|3562157|P2|Washout Period 1 (35 Days)|Withdrawal by Subject|0
1090665|NCT02084082|3562158|P1|Washout Period 1 (35 Days)|Withdrawal by Subject|0
1090666|NCT02084082|3562155|P4|Washout Period 1 (35 Days)|Adverse Event|1
1090667|NCT02084082|3562156|P3|Washout Period 1 (35 Days)|Adverse Event|1
1090668|NCT02084082|3562157|P2|Washout Period 1 (35 Days)|Adverse Event|0
1090669|NCT02084082|3562158|P1|Washout Period 1 (35 Days)|Adverse Event|0
1090670|NCT02084056|3562199|P4|Washout Period 1 (35 Days)|Withdrawal by Subject|0
1090671|NCT02084056|3562200|P3|Washout Period 1 (35 Days)|Withdrawal by Subject|0
1090672|NCT02084056|3562201|P2|Washout Period 1 (35 Days)|Withdrawal by Subject|0
1090673|NCT02084056|3562202|P1|Washout Period 1 (35 Days)|Withdrawal by Subject|1
1090674|NCT02084056|3562199|P4|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
1090675|NCT02084056|3562200|P3|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
1090676|NCT02084056|3562201|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
1090677|NCT02084056|3562202|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
1090678|NCT02083965|3562234|P2|Treatment Period|Not Specified|0
1090679|NCT02083965|3562235|P1|Treatment Period|Not Specified|1
1090680|NCT02083653|3562330|P3|Overall Study|Reason Missing|4
1090681|NCT02083653|3562331|P2|Overall Study|Reason Missing|0
1090682|NCT02083653|3562332|P1|Overall Study|Reason Missing|0
1090683|NCT02083653|3562330|P3|Overall Study|Other Events|2
1090684|NCT02083653|3562331|P2|Overall Study|Other Events|2
1090685|NCT02083653|3562332|P1|Overall Study|Other Events|0
1090686|NCT02083653|3562330|P3|Overall Study|Withdrawal by Subject|2
1090687|NCT02083653|3562331|P2|Overall Study|Withdrawal by Subject|1
1090688|NCT02083653|3562332|P1|Overall Study|Withdrawal by Subject|2
1090689|NCT02083653|3562330|P3|Overall Study|Progressive Disease|63
1090690|NCT02083653|3562331|P2|Overall Study|Progressive Disease|73
1090691|NCT02083653|3562332|P1|Overall Study|Progressive Disease|65
1090692|NCT02083653|3562330|P3|Overall Study|Death|2
1090693|NCT02083653|3562331|P2|Overall Study|Death|2
1090694|NCT02083653|3562332|P1|Overall Study|Death|2
1090695|NCT02083653|3562330|P3|Overall Study|Lost to Follow-up|0
1090696|NCT02083653|3562331|P2|Overall Study|Lost to Follow-up|0
1090697|NCT02083653|3562332|P1|Overall Study|Lost to Follow-up|1
1090698|NCT02083653|3562330|P3|Overall Study|Adverse Event|4
1090699|NCT02083653|3562331|P2|Overall Study|Adverse Event|5
1090700|NCT02083653|3562332|P1|Overall Study|Adverse Event|12
1090701|NCT02083653|3562330|P3|Overall Study|Randomized but not Treated|7
1090702|NCT02083653|3562331|P2|Overall Study|Randomized but not Treated|2
1090703|NCT02083653|3562332|P1|Overall Study|Randomized but not Treated|0
1090704|NCT02083380|3562400|P3|Overall Study|Other|6
1090705|NCT02083380|3562401|P2|Overall Study|Other|4
1090706|NCT02083380|3562402|P1|Overall Study|Other|8
1090707|NCT02083380|3562400|P3|Overall Study|Lost to Follow-up|3
1090708|NCT02083380|3562401|P2|Overall Study|Lost to Follow-up|3
1090709|NCT02083380|3562402|P1|Overall Study|Lost to Follow-up|5
1090710|NCT02083380|3562400|P3|Overall Study|Adverse Event|1
1090711|NCT02083380|3562401|P2|Overall Study|Adverse Event|0
1090712|NCT02083380|3562402|P1|Overall Study|Adverse Event|0
1090713|NCT02083380|3562400|P3|Overall Study|Physician Decision|3
1090714|NCT02083380|3562401|P2|Overall Study|Physician Decision|6
1090715|NCT02083380|3562402|P1|Overall Study|Physician Decision|1
1090716|NCT02083380|3562400|P3|Overall Study|Withdrawal by Subject|7
1090717|NCT02083380|3562401|P2|Overall Study|Withdrawal by Subject|3
1090718|NCT02083380|3562402|P1|Overall Study|Withdrawal by Subject|9
1090719|NCT02083380|3562400|P3|Overall Study|Lack of Efficacy|64
1090720|NCT02083380|3562401|P2|Overall Study|Lack of Efficacy|79
1090721|NCT02083380|3562402|P1|Overall Study|Lack of Efficacy|68
1090722|NCT02083185|3562507|P3|Overall Study|Did not Receive Study Drug|0
1090723|NCT02083185|3562508|P2|Overall Study|Did not Receive Study Drug|2
1090724|NCT02083185|3562509|P1|Overall Study|Did not Receive Study Drug|0
1090725|NCT02083185|3562507|P3|Overall Study|Study Terminated by Sponsor|0
1090726|NCT02083185|3562508|P2|Overall Study|Study Terminated by Sponsor|1
1090727|NCT02083185|3562509|P1|Overall Study|Study Terminated by Sponsor|0
1090728|NCT02083185|3562507|P3|Overall Study|Reason not Specified|5
1090729|NCT02083185|3562508|P2|Overall Study|Reason not Specified|6
1090730|NCT02083185|3562509|P1|Overall Study|Reason not Specified|9
1090731|NCT02083185|3562507|P3|Overall Study|Death|1
1090732|NCT02083185|3562508|P2|Overall Study|Death|2
1090733|NCT02083185|3562509|P1|Overall Study|Death|2
1090734|NCT02083185|3562507|P3|Overall Study|Withdrawal by Subject|1
1090735|NCT02083185|3562508|P2|Overall Study|Withdrawal by Subject|15
1090736|NCT02083185|3562509|P1|Overall Study|Withdrawal by Subject|9
1090737|NCT02083185|3562507|P3|Overall Study|Lost to Follow-up|0
1090738|NCT02083185|3562508|P2|Overall Study|Lost to Follow-up|3
1090739|NCT02083185|3562509|P1|Overall Study|Lost to Follow-up|0
1090740|NCT02082912|3562606|P2|Overall Study|Physician Decision|1
1090741|NCT02082912|3562607|P1|Overall Study|Physician Decision|0
1090742|NCT02082262|3562679|P1|Overall Study|Adverse Event|48
1090743|NCT02082262|3562679|P1|Overall Study|Withdrawal by Subject|3
1090744|NCT02082184|3562685|P2|Overall Study|Subject non-compliance|1
1090745|NCT02082184|3562686|P1|Overall Study|Subject non-compliance|0
1090746|NCT02082184|3562685|P2|Overall Study|Lost to Follow-up|2
1090747|NCT02082184|3562686|P1|Overall Study|Lost to Follow-up|0
1090748|NCT02082184|3562685|P2|Overall Study|Protocol Violation|6
1090749|NCT02082184|3562686|P1|Overall Study|Protocol Violation|0
1090750|NCT02082184|3562685|P2|Overall Study|Withdrawal by Subject|2
1090751|NCT02082184|3562686|P1|Overall Study|Withdrawal by Subject|3
1090752|NCT02082184|3562685|P2|Overall Study|Device associated symptoms|0
1090753|NCT02082184|3562686|P1|Overall Study|Device associated symptoms|5
1090754|NCT02082184|3562685|P2|Overall Study|Medical diagnosis|2
1090755|NCT02082184|3562686|P1|Overall Study|Medical diagnosis|1
1090756|NCT02082184|3562685|P2|Overall Study|Adverse Event|0
1090757|NCT02082184|3562686|P1|Overall Study|Adverse Event|1
1090758|NCT02082158|3562711|P6|Overall Study|Failed Fit-testing|7
1090759|NCT02082158|3562712|P5|Overall Study|Failed Fit-testing|3
1090760|NCT02082158|3562713|P4|Overall Study|Failed Fit-testing|4
1090761|NCT02082158|3562714|P3|Overall Study|Failed Fit-testing|14
1090762|NCT02082158|3562715|P2|Overall Study|Failed Fit-testing|8
1090763|NCT02082158|3562716|P1|Overall Study|Failed Fit-testing|8
1090764|NCT02082158|3562711|P6|Overall Study|Withdrawal by Subject|0
1090765|NCT02082158|3562712|P5|Overall Study|Withdrawal by Subject|1
1090766|NCT02082158|3562713|P4|Overall Study|Withdrawal by Subject|0
1090767|NCT02082158|3562714|P3|Overall Study|Withdrawal by Subject|0
1090768|NCT02082158|3562715|P2|Overall Study|Withdrawal by Subject|0
1090769|NCT02082158|3562716|P1|Overall Study|Withdrawal by Subject|0
1090770|NCT02081859|3562738|P2|Overall Study|Other reasons|0
1090771|NCT02081859|3562739|P1|Overall Study|Other reasons|2
1090772|NCT02081859|3562738|P2|Overall Study|< 4 embryos|23
1090773|NCT02081859|3562739|P1|Overall Study|< 4 embryos|27
1090774|NCT02081859|3562738|P2|Overall Study|Unanticipated freeze all cycle|6
1090775|NCT02081859|3562739|P1|Overall Study|Unanticipated freeze all cycle|2
1090776|NCT02081859|3562738|P2|Overall Study|No sperm|0
1090777|NCT02081859|3562739|P1|Overall Study|No sperm|1
1090778|NCT02081859|3562738|P2|Overall Study|No fertilization|2
1090779|NCT02081859|3562739|P1|Overall Study|No fertilization|2
1090780|NCT02081690|3562747|P1|Overall Study|Withdrawal by Subject|1
1090781|NCT02081690|3562747|P1|Overall Study|Physician Decision|3
1090782|NCT02081690|3562747|P1|Overall Study|Death|3
1090783|NCT02081677|3562758|P4|Overall Study|Unsatisfactory Lens Fitting|0
1090784|NCT02081677|3562759|P3|Overall Study|Unsatisfactory Lens Fitting|0
1090785|NCT02081677|3562760|P2|Overall Study|Unsatisfactory Lens Fitting|1
1090786|NCT02081677|3562761|P1|Overall Study|Unsatisfactory Lens Fitting|0
1090787|NCT02081677|3562758|P4|Overall Study|Not comfortable with lens care system|0
1090788|NCT02081677|3562759|P3|Overall Study|Not comfortable with lens care system|0
1090789|NCT02081677|3562760|P2|Overall Study|Not comfortable with lens care system|0
1090790|NCT02081677|3562761|P1|Overall Study|Not comfortable with lens care system|1
1090791|NCT02081677|3562758|P4|Overall Study|No Longer Meets Eligibility Criteria|0
1090792|NCT02081677|3562759|P3|Overall Study|No Longer Meets Eligibility Criteria|1
1090793|NCT02081677|3562760|P2|Overall Study|No Longer Meets Eligibility Criteria|0
1090794|NCT02081677|3562761|P1|Overall Study|No Longer Meets Eligibility Criteria|0
1090795|NCT02081677|3562758|P4|Overall Study|Adverse Event|0
1090796|NCT02081677|3562759|P3|Overall Study|Adverse Event|1
1090797|NCT02081677|3562760|P2|Overall Study|Adverse Event|0
1090798|NCT02081677|3562761|P1|Overall Study|Adverse Event|0
1090799|NCT02081599|3562853|P2|Period 2：Open-label Period|Withdrawal by Subject|0
1090800|NCT02081599|3562854|P1|Period 2：Open-label Period|Withdrawal by Subject|2
1090801|NCT02081599|3562853|P2|Period 2：Open-label Period|Physician Decision|0
1090802|NCT02081599|3562854|P1|Period 2：Open-label Period|Physician Decision|1
1090803|NCT02081599|3562853|P2|Period 2：Open-label Period|Lack of Efficacy|4
1090804|NCT02081599|3562854|P1|Period 2：Open-label Period|Lack of Efficacy|2
1090805|NCT02081599|3562853|P2|Period 2：Open-label Period|Adverse Event|0
1090806|NCT02081599|3562854|P1|Period 2：Open-label Period|Adverse Event|1
1090807|NCT02081599|3562853|P2|Period 1：Double-blind Period|stopping criteria|0
1090808|NCT02081599|3562854|P1|Period 1：Double-blind Period|stopping criteria|1
1090809|NCT02081599|3562853|P2|Period 1：Double-blind Period|Withdrawal by Subject|0
1090810|NCT02081599|3562854|P1|Period 1：Double-blind Period|Withdrawal by Subject|1
1090811|NCT02081599|3562853|P2|Period 1：Double-blind Period|Protocol Violation|1
1090812|NCT02081599|3562854|P1|Period 1：Double-blind Period|Protocol Violation|0
1090813|NCT02081599|3562853|P2|Period 1：Double-blind Period|Physician Decision|0
1090814|NCT02081599|3562854|P1|Period 1：Double-blind Period|Physician Decision|1
1090815|NCT02081599|3562853|P2|Period 1：Double-blind Period|Lack of Efficacy|1
1090816|NCT02081599|3562854|P1|Period 1：Double-blind Period|Lack of Efficacy|2
1090817|NCT02081599|3562853|P2|Period 1：Double-blind Period|Adverse Event|0
1090818|NCT02081599|3562854|P1|Period 1：Double-blind Period|Adverse Event|3
1090819|NCT02081586|3562872|P4|Overall Study|Head injury not related to study|0
1090820|NCT02081586|3562873|P3|Overall Study|Head injury not related to study|1
1090821|NCT02081586|3562874|P2|Overall Study|Head injury not related to study|0
1090822|NCT02081586|3562875|P1|Overall Study|Head injury not related to study|0
1090823|NCT02081586|3562872|P4|Overall Study|Lost to Follow-up|1
1090824|NCT02081586|3562873|P3|Overall Study|Lost to Follow-up|0
1090825|NCT02081586|3562874|P2|Overall Study|Lost to Follow-up|1
1090826|NCT02081586|3562875|P1|Overall Study|Lost to Follow-up|0
1090827|NCT02081183|3562981|P2|Overall Study|Not specified|3
1090828|NCT02081183|3562982|P1|Overall Study|Not specified|3
1090829|NCT02081183|3562981|P2|Overall Study|Protocol Violation|0
1090830|NCT02081183|3562982|P1|Overall Study|Protocol Violation|1
1090831|NCT02081183|3562981|P2|Overall Study|Lost to Follow-up|1
1090832|NCT02081183|3562982|P1|Overall Study|Lost to Follow-up|0
1090833|NCT02081079|3562998|P2|Overall Study|Lost to Follow-up|0
1090834|NCT02081079|3562999|P1|Overall Study|Lost to Follow-up|1
1090835|NCT02081079|3562998|P2|Overall Study|Lack of Efficacy|2
1090836|NCT02081079|3562999|P1|Overall Study|Lack of Efficacy|3
1090837|NCT02081001|3563072|P12|Overall Study|Adverse Event|0
1090838|NCT02081001|3563073|P11|Overall Study|Adverse Event|0
1090839|NCT02081001|3563074|P10|Overall Study|Adverse Event|0
1090840|NCT02081001|3563075|P9|Overall Study|Adverse Event|0
1090841|NCT02081001|3563076|P8|Overall Study|Adverse Event|0
1090842|NCT02081001|3563077|P7|Overall Study|Adverse Event|0
1090843|NCT02081001|3563078|P6|Overall Study|Adverse Event|0
1090844|NCT02081001|3563079|P5|Overall Study|Adverse Event|1
1090845|NCT02081001|3563080|P4|Overall Study|Adverse Event|0
1090846|NCT02081001|3563081|P3|Overall Study|Adverse Event|0
1090847|NCT02081001|3563082|P2|Overall Study|Adverse Event|0
1090848|NCT02081001|3563083|P1|Overall Study|Adverse Event|0
1090849|NCT02080871|3563147|P1|Overall Study|Lost to Follow-up|1
1090850|NCT02080871|3563147|P1|Overall Study|Death|1
1090851|NCT02080832|3563192|P3|Overall Study|Lost to Follow-up|2
1090852|NCT02080832|3563193|P2|Overall Study|Lost to Follow-up|2
1090853|NCT02080832|3563194|P1|Overall Study|Lost to Follow-up|0
1090854|NCT02080832|3563192|P3|Overall Study|Excluded from analysis by MRI|14
1090855|NCT02080832|3563193|P2|Overall Study|Excluded from analysis by MRI|10
1090856|NCT02080832|3563194|P1|Overall Study|Excluded from analysis by MRI|9
1090857|NCT02080481|3563252|P2|Overall Study|Never received a block.|0
1090858|NCT02080481|3563253|P1|Overall Study|Never received a block.|1
1090859|NCT02080091|3563280|P1|Overall Study|Other|1
1090860|NCT02080091|3563280|P1|Overall Study|Withdrawal by Subject|1
1090861|NCT02080091|3563280|P1|Overall Study|Death|1
1090862|NCT02080091|3563280|P1|Overall Study|Study Terminated|22
1090863|NCT02079909|3563289|P3|Overall Study|Relocation etc.|3
1090864|NCT02079909|3563290|P2|Overall Study|Relocation etc.|2
1090865|NCT02079909|3563291|P1|Overall Study|Relocation etc.|2
1090866|NCT02079909|3563289|P3|Overall Study|Physician Decision|1
1090867|NCT02079909|3563290|P2|Overall Study|Physician Decision|1
1090868|NCT02079909|3563291|P1|Overall Study|Physician Decision|0
1090869|NCT02079909|3563289|P3|Overall Study|Protocol Violation|1
1090870|NCT02079909|3563290|P2|Overall Study|Protocol Violation|1
1090871|NCT02079909|3563291|P1|Overall Study|Protocol Violation|0
1090872|NCT02079909|3563289|P3|Overall Study|Lack of Efficacy|1
1090873|NCT02079909|3563290|P2|Overall Study|Lack of Efficacy|0
1090874|NCT02079909|3563291|P1|Overall Study|Lack of Efficacy|0
1090875|NCT02079909|3563289|P3|Overall Study|Death|0
1090876|NCT02079909|3563290|P2|Overall Study|Death|2
1090877|NCT02079909|3563291|P1|Overall Study|Death|2
1090878|NCT02079909|3563289|P3|Overall Study|Lost to Follow-up|1
1090879|NCT02079909|3563290|P2|Overall Study|Lost to Follow-up|3
1090880|NCT02079909|3563291|P1|Overall Study|Lost to Follow-up|2
1090881|NCT02079909|3563289|P3|Overall Study|Withdrawal by Subject|4
1090882|NCT02079909|3563290|P2|Overall Study|Withdrawal by Subject|17
1090883|NCT02079909|3563291|P1|Overall Study|Withdrawal by Subject|9
1090884|NCT02079909|3563289|P3|Overall Study|Adverse Event|7
1090885|NCT02079909|3563290|P2|Overall Study|Adverse Event|23
1090886|NCT02079909|3563291|P1|Overall Study|Adverse Event|23
1090887|NCT02079844|3563308|P3|Treatment Period 2|Voluntary Withdrawal|0
1090888|NCT02079844|3563309|P2|Treatment Period 2|Voluntary Withdrawal|1
1090889|NCT02079844|3563310|P1|Treatment Period 2|Voluntary Withdrawal|0
1090890|NCT02079844|3563308|P3|Treatment Period 1|Voluntary Withdrawal|2
1090891|NCT02079844|3563309|P2|Treatment Period 1|Voluntary Withdrawal|0
1090892|NCT02079844|3563310|P1|Treatment Period 1|Voluntary Withdrawal|0
1090893|NCT02079805|3563368|P2|Overall Study|Voluntary Withdrawal|1
1090894|NCT02079805|3563369|P1|Overall Study|Voluntary Withdrawal|0
1090895|NCT02079805|3563368|P2|Overall Study|Pretreatment Event/Adverse Event|1
1090896|NCT02079805|3563369|P1|Overall Study|Pretreatment Event/Adverse Event|0
1090897|NCT02079649|3563391|P4|Overall Study|Randomization error (prior to treatment)|0
1090898|NCT02079649|3563392|P3|Overall Study|Randomization error (prior to treatment)|1
1090899|NCT02079649|3563393|P2|Overall Study|Randomization error (prior to treatment)|0
1090900|NCT02079649|3563394|P1|Overall Study|Randomization error (prior to treatment)|1
1090901|NCT02079649|3563391|P4|Overall Study|Withdrawal by Subject|1
1090902|NCT02079649|3563392|P3|Overall Study|Withdrawal by Subject|0
1090903|NCT02079649|3563393|P2|Overall Study|Withdrawal by Subject|0
1090904|NCT02079649|3563394|P1|Overall Study|Withdrawal by Subject|0
1090905|NCT02079649|3563391|P4|Overall Study|Lost to Follow-up|1
1090906|NCT02079649|3563392|P3|Overall Study|Lost to Follow-up|0
1090907|NCT02079649|3563393|P2|Overall Study|Lost to Follow-up|0
1090908|NCT02079649|3563394|P1|Overall Study|Lost to Follow-up|0
1090909|NCT02079610|3563411|P2|Overall Study|Withdrawal by Subject|1
1090910|NCT02079610|3563412|P1|Overall Study|Withdrawal by Subject|1
1090911|NCT02079532|3563422|P1|Overall Study|Not specified|3
1090912|NCT02079532|3563422|P1|Overall Study|Inclusion into ReFIRST|3
1090913|NCT02079532|3563422|P1|Overall Study|Administrative problems|1
1090914|NCT02079532|3563422|P1|Overall Study|Withdrawal by Subject|1
1090915|NCT02079532|3563422|P1|Overall Study|Protocol Violation|3
1090916|NCT02079532|3563422|P1|Overall Study|Lack of Efficacy|9
1090917|NCT02079532|3563422|P1|Overall Study|Additional or changed therapy|2
1090918|NCT02079532|3563422|P1|Overall Study|Adverse Event|7
1090919|NCT02079519|3563444|P1|Overall Study|Adverse Event|1
1090920|NCT02079519|3563444|P1|Overall Study|Disease Progression|9
1090921|NCT02079246|3563457|P2|OLEX-MEM|Other: Moved to nursing home|3
1090922|NCT02079246|3563458|P1|OLEX-MEM|Other: Moved to nursing home|0
1090923|NCT02079246|3563457|P2|OLEX-MEM|Lost to Follow-up|1
1090924|NCT02079246|3563458|P1|OLEX-MEM|Lost to Follow-up|0
1090925|NCT02079246|3563457|P2|OLEX-MEM|Protocol Violation|2
1090926|NCT02079246|3563458|P1|OLEX-MEM|Protocol Violation|0
1090927|NCT02079246|3563457|P2|OLEX-MEM|Withdrawal by Subject|7
1090928|NCT02079246|3563458|P1|OLEX-MEM|Withdrawal by Subject|0
1090929|NCT02079246|3563457|P2|OLEX-MEM|Adverse Event|6
1090930|NCT02079246|3563458|P1|OLEX-MEM|Adverse Event|0
1090931|NCT02079246|3563457|P2|OLEX|Other: Withdrawal of caregiver consent|0
1090932|NCT02079246|3563458|P1|OLEX|Other: Withdrawal of caregiver consent|1
1090933|NCT02079246|3563457|P2|OLEX|Other: Moved to nursing home|0
1090934|NCT02079246|3563458|P1|OLEX|Other: Moved to nursing home|1
1090935|NCT02079246|3563457|P2|OLEX|Other: Worsening of condition|0
1090936|NCT02079246|3563458|P1|OLEX|Other: Worsening of condition|1
1090937|NCT02079246|3563457|P2|OLEX|Other: Coordinator decision|0
1090938|NCT02079246|3563458|P1|OLEX|Other: Coordinator decision|1
1090939|NCT02079246|3563457|P2|OLEX|Other: Caregiver unavailable|0
1090940|NCT02079246|3563458|P1|OLEX|Other: Caregiver unavailable|3
1090941|NCT02079246|3563457|P2|OLEX|Other: Insufficient compliance|0
1090942|NCT02079246|3563458|P1|OLEX|Other: Insufficient compliance|2
1090943|NCT02079246|3563457|P2|OLEX|Other: Disallowed medication|0
1090944|NCT02079246|3563458|P1|OLEX|Other: Disallowed medication|8
1090945|NCT02079246|3563457|P2|OLEX|Results of the lead-in studies|0
1090946|NCT02079246|3563458|P1|OLEX|Results of the lead-in studies|58
1090947|NCT02079246|3563457|P2|OLEX|Lack of Efficacy|0
1090948|NCT02079246|3563458|P1|OLEX|Lack of Efficacy|3
1090949|NCT02079246|3563457|P2|OLEX|Protocol Violation|0
1090950|NCT02079246|3563458|P1|OLEX|Protocol Violation|6
1090951|NCT02079246|3563457|P2|OLEX|Lost to Follow-up|0
1090952|NCT02079246|3563458|P1|OLEX|Lost to Follow-up|6
1090953|NCT02079246|3563457|P2|OLEX|Withdrawal by Subject|0
1090954|NCT02079246|3563458|P1|OLEX|Withdrawal by Subject|60
1090955|NCT02079246|3563457|P2|OLEX|Adverse Event|0
1090956|NCT02079246|3563458|P1|OLEX|Adverse Event|66
1090957|NCT02079246|3563457|P2|OLEX|Death|0
1090958|NCT02079246|3563458|P1|OLEX|Death|11
1090959|NCT02079246|3563457|P2|OLEX|Withdrawal before treatment|0
1090960|NCT02079246|3563458|P1|OLEX|Withdrawal before treatment|1
1090961|NCT02078713|3563479|P4|Overall Study|Enrolled twice|0
1090962|NCT02078713|3563480|P3|Overall Study|Enrolled twice|0
1090963|NCT02078713|3563481|P2|Overall Study|Enrolled twice|1
1090964|NCT02078713|3563482|P1|Overall Study|Enrolled twice|0
1090965|NCT02078713|3563479|P4|Overall Study|Pregnant at baseline|0
1090966|NCT02078713|3563480|P3|Overall Study|Pregnant at baseline|0
1090967|NCT02078713|3563481|P2|Overall Study|Pregnant at baseline|5
1090968|NCT02078713|3563482|P1|Overall Study|Pregnant at baseline|3
1090969|NCT02078713|3563479|P4|Overall Study|Lost to Follow-up|0
1090970|NCT02078713|3563480|P3|Overall Study|Lost to Follow-up|0
1090971|NCT02078713|3563481|P2|Overall Study|Lost to Follow-up|55
1090972|NCT02078713|3563482|P1|Overall Study|Lost to Follow-up|49
1090973|NCT02077374|3563585|P2|Overall Study|Protocol Violation|1
1090974|NCT02077374|3563586|P1|Overall Study|Protocol Violation|0
1090975|NCT02077374|3563585|P2|Overall Study|Withdrawal by Subject|1
1090976|NCT02077374|3563586|P1|Overall Study|Withdrawal by Subject|0
1090977|NCT02077140|3563607|P5|Overall Study|Withdrawal by Subject|2
1090978|NCT02077140|3563608|P4|Overall Study|Withdrawal by Subject|2
1090979|NCT02077140|3563609|P3|Overall Study|Withdrawal by Subject|0
1090980|NCT02077140|3563610|P2|Overall Study|Withdrawal by Subject|1
1090981|NCT02077140|3563611|P1|Overall Study|Withdrawal by Subject|0
1090982|NCT02077140|3563607|P5|Overall Study|Lost to Follow-up|3
1090983|NCT02077140|3563608|P4|Overall Study|Lost to Follow-up|2
1090984|NCT02077140|3563609|P3|Overall Study|Lost to Follow-up|2
1090985|NCT02077140|3563610|P2|Overall Study|Lost to Follow-up|1
1090986|NCT02077140|3563611|P1|Overall Study|Lost to Follow-up|4
1090987|NCT02076334|3563834|P4|Overall Study|muscle soreness|1
1090988|NCT02076334|3563835|P3|Overall Study|muscle soreness|0
1090989|NCT02076334|3563836|P2|Overall Study|muscle soreness|0
1090990|NCT02076334|3563837|P1|Overall Study|muscle soreness|0
1090991|NCT02076334|3563834|P4|Overall Study|Lost to Follow-up|0
1090992|NCT02076334|3563835|P3|Overall Study|Lost to Follow-up|1
1090993|NCT02076334|3563836|P2|Overall Study|Lost to Follow-up|1
1090994|NCT02076334|3563837|P1|Overall Study|Lost to Follow-up|0
1090995|NCT02076334|3563834|P4|Overall Study|Protocol Violation|0
1090996|NCT02076334|3563835|P3|Overall Study|Protocol Violation|0
1090997|NCT02076334|3563836|P2|Overall Study|Protocol Violation|0
1090998|NCT02076334|3563837|P1|Overall Study|Protocol Violation|1
1090999|NCT02076178|3563870|P2|Injection Phase|Lost to Follow-up|1
1091000|NCT02076178|3563871|P1|Injection Phase|Lost to Follow-up|0
1091001|NCT02076178|3563870|P2|Injection Phase|Physician Decision|3
1091002|NCT02076178|3563871|P1|Injection Phase|Physician Decision|0
1091003|NCT02076178|3563870|P2|Injection Phase|Withdrawal by Subject|3
1091004|NCT02076178|3563871|P1|Injection Phase|Withdrawal by Subject|0
1091005|NCT02076178|3563870|P2|Injection Phase|Protocol defined stopping criteria|0
1091006|NCT02076178|3563871|P1|Injection Phase|Protocol defined stopping criteria|1
1091007|NCT02076178|3563870|P2|Oral Phase|Physician Decision|1
1091008|NCT02076178|3563871|P1|Oral Phase|Physician Decision|0
1091009|NCT02076178|3563870|P2|Oral Phase|Withdrawal by Subject|4
1091010|NCT02076178|3563871|P1|Oral Phase|Withdrawal by Subject|0
1091011|NCT02076178|3563870|P2|Oral Phase|Adverse Event|7
1091012|NCT02076178|3563871|P1|Oral Phase|Adverse Event|0
1091013|NCT02076009|3563949|P2|Overall Study|Subjects randomized but not treated|3
1091014|NCT02076009|3563950|P1|Overall Study|Subjects randomized but not treated|2
1091015|NCT02076009|3563949|P2|Overall Study|Ongoing|249
1091016|NCT02076009|3563950|P1|Overall Study|Ongoing|226
1091017|NCT02076009|3563949|P2|Overall Study|Progressive disease|0
1091018|NCT02076009|3563950|P1|Overall Study|Progressive disease|1
1091019|NCT02076009|3563949|P2|Overall Study|Lost to Follow-up|1
1091020|NCT02076009|3563950|P1|Overall Study|Lost to Follow-up|1
1091021|NCT02076009|3563949|P2|Overall Study|Withdrawal by Subject|3
1091022|NCT02076009|3563950|P1|Overall Study|Withdrawal by Subject|9
1091023|NCT02076009|3563949|P2|Overall Study|Death|30
1091024|NCT02076009|3563950|P1|Overall Study|Death|44
1091025|NCT02075840|3563972|P2|Overall Study|Ongoing at CCOD|82
1091026|NCT02075840|3563973|P1|Overall Study|Ongoing at CCOD|99
1091027|NCT02075840|3563972|P2|Overall Study|Physician Decision|3
1091028|NCT02075840|3563973|P1|Overall Study|Physician Decision|1
1091029|NCT02075840|3563972|P2|Overall Study|Lost to Follow-up|2
1091030|NCT02075840|3563973|P1|Overall Study|Lost to Follow-up|3
1091031|NCT02075840|3563972|P2|Overall Study|Death|40
1091032|NCT02075840|3563973|P1|Overall Study|Death|35
1091033|NCT02075840|3563972|P2|Overall Study|Adverse Event|2
1091034|NCT02075840|3563973|P1|Overall Study|Adverse Event|0
1091035|NCT02075840|3563972|P2|Overall Study|Reason not specified|0
1091036|NCT02075840|3563973|P1|Overall Study|Reason not specified|1
1091037|NCT02075840|3563972|P2|Overall Study|Withdrawal by Subject|22
1091038|NCT02075840|3563973|P1|Overall Study|Withdrawal by Subject|13
1091039|NCT02075658|3564029|P2|Overall Study|Physician Decision|2
1091040|NCT02075658|3564030|P1|Overall Study|Physician Decision|2
1091041|NCT02075632|3564040|P2|Overall Study|Withdrawal by Subject|1
1091042|NCT02075632|3564041|P1|Overall Study|Withdrawal by Subject|0
1091043|NCT02075632|3564040|P2|Overall Study|Lost to Follow-up|3
1091044|NCT02075632|3564041|P1|Overall Study|Lost to Follow-up|0
1091045|NCT02075632|3564040|P2|Overall Study|Adverse Event|1
1091046|NCT02075632|3564041|P1|Overall Study|Adverse Event|1
1091047|NCT02075541|3564053|P2|Overall Study|Other- unable to perform study procedure|0
1091048|NCT02075541|3564054|P1|Overall Study|Other- unable to perform study procedure|1
1091049|NCT02075541|3564053|P2|Overall Study|Sponsor study termination|1
1091050|NCT02075541|3564054|P1|Overall Study|Sponsor study termination|0
1091051|NCT02075541|3564053|P2|Overall Study|Withdrawal by Subject|3
1091052|NCT02075541|3564054|P1|Overall Study|Withdrawal by Subject|1
1091053|NCT02075541|3564053|P2|Overall Study|Protocol Violation|0
1091054|NCT02075541|3564054|P1|Overall Study|Protocol Violation|1
1091055|NCT02075541|3564053|P2|Overall Study|Serious Adverse Event|4
1091056|NCT02075541|3564054|P1|Overall Study|Serious Adverse Event|1
1091057|NCT02075515|3564103|P3|Overall Study|Lost to Follow-up|6
1091058|NCT02075515|3564104|P2|Overall Study|Lost to Follow-up|3
1091059|NCT02075515|3564105|P1|Overall Study|Lost to Follow-up|1
1091060|NCT02075515|3564103|P3|Overall Study|Withdrawal by Subject|1
1091061|NCT02075515|3564104|P2|Overall Study|Withdrawal by Subject|0
1091062|NCT02075515|3564105|P1|Overall Study|Withdrawal by Subject|2
1091063|NCT02075515|3564103|P3|Overall Study|Non-Serious Adverse Event|0
1091064|NCT02075515|3564104|P2|Overall Study|Non-Serious Adverse Event|1
1091065|NCT02075515|3564105|P1|Overall Study|Non-Serious Adverse Event|0
1091066|NCT02075515|3564103|P3|Overall Study|Serious Adverse Event|1
1091067|NCT02075515|3564104|P2|Overall Study|Serious Adverse Event|1
1091068|NCT02075515|3564105|P1|Overall Study|Serious Adverse Event|1
1091069|NCT02075463|3564140|P1|Overall Study|Withdrawal by Subject|1
1091070|NCT02075463|3564140|P1|Overall Study|Par. reached stopping criteria|4
1091071|NCT02075463|3564140|P1|Overall Study|Adverse Event|3
1091072|NCT02075320|3564190|P1|Overall Study|Withdrawal by Subject|2
1091073|NCT02075255|3564200|P3|Overall Study|Death|0
1091074|NCT02075255|3564201|P2|Overall Study|Death|2
1091075|NCT02075255|3564202|P1|Overall Study|Death|0
1091076|NCT02075255|3564200|P3|Overall Study|Adverse Event|1
1091077|NCT02075255|3564201|P2|Overall Study|Adverse Event|0
1091078|NCT02075255|3564202|P1|Overall Study|Adverse Event|0
1091079|NCT02075255|3564200|P3|Overall Study|Lost to Follow-up|1
1091080|NCT02075255|3564201|P2|Overall Study|Lost to Follow-up|0
1091081|NCT02075255|3564202|P1|Overall Study|Lost to Follow-up|0
1091082|NCT02075255|3564200|P3|Overall Study|Withdrawal by Subject|0
1091083|NCT02075255|3564201|P2|Overall Study|Withdrawal by Subject|1
1091084|NCT02075255|3564202|P1|Overall Study|Withdrawal by Subject|4
1091085|NCT02075255|3564200|P3|Overall Study|Study specific withdrawal criteria|1
1091086|NCT02075255|3564201|P2|Overall Study|Study specific withdrawal criteria|1
1091087|NCT02075255|3564202|P1|Overall Study|Study specific withdrawal criteria|0
1091088|NCT02075073|3564333|P3|Overall Study|Withdrawal by Subject|0
1091089|NCT02075073|3564334|P2|Overall Study|Withdrawal by Subject|1
1091090|NCT02075073|3564335|P1|Overall Study|Withdrawal by Subject|0
1091091|NCT02075008|3564357|P1|Overall Study|Study terminated by Sponsor|159
1091092|NCT02075008|3564357|P1|Overall Study|Withdrawal by Subject|6
1091093|NCT02075008|3564357|P1|Overall Study|Adverse Event|5
1091094|NCT02075008|3564357|P1|Overall Study|Death|1
1091095|NCT02075008|3564357|P1|Overall Study|Lack of Efficacy|1
1091096|NCT02075008|3564357|P1|Overall Study|Lost to Follow-up|1
1091097|NCT02075008|3564357|P1|Overall Study|Physician Decision|1
1091098|NCT02075008|3564357|P1|Overall Study|Pregnancy|1
1091099|NCT02075008|3564357|P1|Overall Study|Technical problems|1
1091100|NCT02074982|3564380|P2|Overall Study|Death|2
1091101|NCT02074982|3564381|P1|Overall Study|Death|0
1091102|NCT02074982|3564380|P2|Overall Study|Subject/guardian decision|24
1091103|NCT02074982|3564381|P1|Overall Study|Subject/guardian decision|15
1091104|NCT02074982|3564380|P2|Overall Study|Technical problems|2
1091105|NCT02074982|3564381|P1|Overall Study|Technical problems|0
1091106|NCT02074982|3564380|P2|Overall Study|Protocol deviation|3
1091107|NCT02074982|3564381|P1|Overall Study|Protocol deviation|4
1091108|NCT02074982|3564380|P2|Overall Study|Pregnancy|2
1091109|NCT02074982|3564381|P1|Overall Study|Pregnancy|1
1091110|NCT02074982|3564380|P2|Overall Study|Physician Decision|1
1091111|NCT02074982|3564381|P1|Overall Study|Physician Decision|1
1091112|NCT02074982|3564380|P2|Overall Study|Non-compliance with study treatment|2
1091113|NCT02074982|3564381|P1|Overall Study|Non-compliance with study treatment|0
1091114|NCT02074982|3564380|P2|Overall Study|Lost to Follow-up|10
1091115|NCT02074982|3564381|P1|Overall Study|Lost to Follow-up|9
1091116|NCT02074982|3564380|P2|Overall Study|Lack of Efficacy|1
1091117|NCT02074982|3564381|P1|Overall Study|Lack of Efficacy|6
1091118|NCT02074982|3564380|P2|Overall Study|Adverse Event|7
1091119|NCT02074982|3564381|P1|Overall Study|Adverse Event|15
1091120|NCT02074553|3564428|P8|Washout Period 3|Physician Decision|1
1091121|NCT02074553|3564429|P7|Washout Period 3|Physician Decision|0
1091122|NCT02074553|3564430|P6|Washout Period 3|Physician Decision|0
1091123|NCT02074553|3564431|P5|Washout Period 3|Physician Decision|0
1091124|NCT02074553|3564432|P4|Washout Period 3|Physician Decision|0
1091125|NCT02074553|3564433|P3|Washout Period 3|Physician Decision|0
1091126|NCT02074553|3564434|P2|Washout Period 3|Physician Decision|0
1091127|NCT02074553|3564435|P1|Washout Period 3|Physician Decision|0
1091128|NCT02074553|3564428|P8|Washout Period 2|Lost to Follow-up|0
1091129|NCT02074553|3564429|P7|Washout Period 2|Lost to Follow-up|0
1091130|NCT02074553|3564430|P6|Washout Period 2|Lost to Follow-up|0
1091131|NCT02074553|3564431|P5|Washout Period 2|Lost to Follow-up|0
1091132|NCT02074553|3564432|P4|Washout Period 2|Lost to Follow-up|0
1091133|NCT02074553|3564433|P3|Washout Period 2|Lost to Follow-up|1
1091134|NCT02074553|3564434|P2|Washout Period 2|Lost to Follow-up|0
1091135|NCT02074553|3564435|P1|Washout Period 2|Lost to Follow-up|0
1091136|NCT02074553|3564428|P8|Washout Period 2|Physician Decision|0
1091137|NCT02074553|3564429|P7|Washout Period 2|Physician Decision|0
1091138|NCT02074553|3564430|P6|Washout Period 2|Physician Decision|1
1091139|NCT02074553|3564431|P5|Washout Period 2|Physician Decision|0
1091140|NCT02074553|3564432|P4|Washout Period 2|Physician Decision|0
1091141|NCT02074553|3564433|P3|Washout Period 2|Physician Decision|0
1091142|NCT02074553|3564434|P2|Washout Period 2|Physician Decision|0
1091143|NCT02074553|3564435|P1|Washout Period 2|Physician Decision|0
1091144|NCT02074553|3564428|P8|Washout Period 2|Adverse Event|0
1091145|NCT02074553|3564429|P7|Washout Period 2|Adverse Event|1
1091146|NCT02074553|3564430|P6|Washout Period 2|Adverse Event|0
1091147|NCT02074553|3564431|P5|Washout Period 2|Adverse Event|0
1091148|NCT02074553|3564432|P4|Washout Period 2|Adverse Event|0
1091149|NCT02074553|3564433|P3|Washout Period 2|Adverse Event|0
1091150|NCT02074553|3564434|P2|Washout Period 2|Adverse Event|0
1091151|NCT02074553|3564435|P1|Washout Period 2|Adverse Event|0
1091152|NCT02074553|3564428|P8|Washout Period 1|Other|0
1091153|NCT02074553|3564429|P7|Washout Period 1|Other|0
1091154|NCT02074553|3564430|P6|Washout Period 1|Other|1
1091155|NCT02074553|3564431|P5|Washout Period 1|Other|0
1091156|NCT02074553|3564432|P4|Washout Period 1|Other|0
1091157|NCT02074553|3564433|P3|Washout Period 1|Other|0
1091158|NCT02074553|3564434|P2|Washout Period 1|Other|0
1091159|NCT02074553|3564435|P1|Washout Period 1|Other|0
1091160|NCT02074553|3564428|P8|Washout Period 1|Physician Decision|0
1091161|NCT02074553|3564429|P7|Washout Period 1|Physician Decision|0
1091162|NCT02074553|3564430|P6|Washout Period 1|Physician Decision|0
1091163|NCT02074553|3564431|P5|Washout Period 1|Physician Decision|0
1091164|NCT02074553|3564432|P4|Washout Period 1|Physician Decision|1
1091165|NCT02074553|3564433|P3|Washout Period 1|Physician Decision|0
1091166|NCT02074553|3564434|P2|Washout Period 1|Physician Decision|0
1091167|NCT02074553|3564435|P1|Washout Period 1|Physician Decision|0
1091168|NCT02074553|3564428|P8|Washout Period 1|Adverse Event|0
1091169|NCT02074553|3564429|P7|Washout Period 1|Adverse Event|0
1091170|NCT02074553|3564430|P6|Washout Period 1|Adverse Event|0
1091171|NCT02074553|3564431|P5|Washout Period 1|Adverse Event|0
1091172|NCT02074553|3564432|P4|Washout Period 1|Adverse Event|0
1091173|NCT02074553|3564433|P3|Washout Period 1|Adverse Event|0
1091174|NCT02074553|3564434|P2|Washout Period 1|Adverse Event|0
1091175|NCT02074553|3564435|P1|Washout Period 1|Adverse Event|1
1091176|NCT02074553|3564428|P8|Intervention Period 1|Family Emergency|0
1091177|NCT02074553|3564429|P7|Intervention Period 1|Family Emergency|0
1091178|NCT02074553|3564430|P6|Intervention Period 1|Family Emergency|0
1091179|NCT02074553|3564431|P5|Intervention Period 1|Family Emergency|0
1091180|NCT02074553|3564432|P4|Intervention Period 1|Family Emergency|1
1091181|NCT02074553|3564433|P3|Intervention Period 1|Family Emergency|0
1091182|NCT02074553|3564434|P2|Intervention Period 1|Family Emergency|0
1091183|NCT02074553|3564435|P1|Intervention Period 1|Family Emergency|0
1091184|NCT02074514|3564617|P2|Overall Study|Withdrew Consent|1
1091185|NCT02074514|3564618|P1|Overall Study|Withdrew Consent|0
1091186|NCT02074514|3564617|P2|Overall Study|Lost to Follow-up|1
1091187|NCT02074514|3564618|P1|Overall Study|Lost to Follow-up|0
1091188|NCT02074514|3564617|P2|Overall Study|Lack of Efficacy|2
1091189|NCT02074514|3564618|P1|Overall Study|Lack of Efficacy|3
1091190|NCT02074059|3564759|P6|Overall Study|Death|1
1091191|NCT02074059|3564760|P5|Overall Study|Death|1
1091192|NCT02074059|3564761|P4|Overall Study|Death|0
1091193|NCT02074059|3564762|P3|Overall Study|Death|0
1091194|NCT02074059|3564763|P2|Overall Study|Death|0
1091195|NCT02074059|3564764|P1|Overall Study|Death|0
1091196|NCT02073682|3564813|P2|Overall Study|ID: Benefit/Risk Judgment|46
1091197|NCT02073682|3564814|P1|Overall Study|ID: Benefit/Risk Judgment|32
1091198|NCT02073682|3564813|P2|Overall Study|Lost to Follow-up|1
1091199|NCT02073682|3564814|P1|Overall Study|Lost to Follow-up|1
1091200|NCT02073682|3564813|P2|Overall Study|PD: Inconvenience of Dosing|78
1091201|NCT02073682|3564814|P1|Overall Study|PD: Inconvenience of Dosing|21
1091202|NCT02073682|3564813|P2|Overall Study|No reason provided|9
1091203|NCT02073682|3564814|P1|Overall Study|No reason provided|11
1091204|NCT02073682|3564813|P2|Overall Study|Adverse Event|62
1091205|NCT02073682|3564814|P1|Overall Study|Adverse Event|79
1091206|NCT02073682|3564813|P2|Overall Study|Protocol Violation|0
1091207|NCT02073682|3564814|P1|Overall Study|Protocol Violation|1
1091208|NCT02073682|3564813|P2|Overall Study|Cancer Progression|33
1091209|NCT02073682|3564814|P1|Overall Study|Cancer Progression|53
1091210|NCT02073682|3564813|P2|Overall Study|Start of New Chemotherapy Regimen|3
1091211|NCT02073682|3564814|P1|Overall Study|Start of New Chemotherapy Regimen|6
1091212|NCT02073682|3564813|P2|Overall Study|Withdrawal by Subject|8
1091213|NCT02073682|3564814|P1|Overall Study|Withdrawal by Subject|6
1091214|NCT02073682|3564813|P2|Overall Study|Surgery/Medical Procedure|1
1091215|NCT02073682|3564814|P1|Overall Study|Surgery/Medical Procedure|3
1091216|NCT02073682|3564813|P2|Overall Study|Platelet Count <50,000/mL|2
1091217|NCT02073682|3564814|P1|Overall Study|Platelet Count <50,000/mL|1
1091218|NCT02073682|3564813|P2|Overall Study|Prohibited Concomitant Medication Use|1
1091219|NCT02073682|3564814|P1|Overall Study|Prohibited Concomitant Medication Use|0
1091220|NCT02073682|3564813|P2|Overall Study|ID: Palliative Treatment Only|7
1091221|NCT02073682|3564814|P1|Overall Study|ID: Palliative Treatment Only|10
1091222|NCT02073682|3564813|P2|Overall Study|ID: Patient Noncompliance|2
1091223|NCT02073682|3564814|P1|Overall Study|ID: Patient Noncompliance|1
1091224|NCT02073682|3564813|P2|Overall Study|Cancer Cured|15
1091225|NCT02073682|3564814|P1|Overall Study|Cancer Cured|10
1091226|NCT02073682|3564813|P2|Overall Study|Death|100
1091227|NCT02073682|3564814|P1|Overall Study|Death|86
1091228|NCT02073682|3564813|P2|Overall Study|Low Creatinine Clearance|2
1091229|NCT02073682|3564814|P1|Overall Study|Low Creatinine Clearance|1
1091230|NCT02073656|3564832|P1|Primary Study|Withdrew Consent|1
1091231|NCT02073656|3564832|P1|Primary Study|Death|1
1091232|NCT02073656|3564832|P1|Primary Study|Lost to Follow-up|6
1091233|NCT02073565|3564850|P2|Cohort C|Lost to Follow-up|2
1091234|NCT02073565|3564851|P1|Cohort C|Lost to Follow-up|0
1091235|NCT02073565|3564850|P2|Cohort C|Withdrawal by Subject|2
1091236|NCT02073565|3564851|P1|Cohort C|Withdrawal by Subject|0
1091237|NCT02073565|3564850|P2|Cohort B|Withdrawal by Subject|2
1091238|NCT02073565|3564851|P1|Cohort B|Withdrawal by Subject|1
1091239|NCT02073565|3564850|P2|Cohort A|Withdrawal by Subject|0
1091240|NCT02073565|3564851|P1|Cohort A|Withdrawal by Subject|1
1091241|NCT02072980|3564936|P2|Period 2, Second Wear|Adverse Event|1
1091242|NCT02072980|3564937|P1|Period 2, Second Wear|Adverse Event|0
1091243|NCT02072824|3564950|P3|Overall Study|Adverse Event|1
1091244|NCT02072824|3564951|P2|Overall Study|Adverse Event|0
1091245|NCT02072824|3564952|P1|Overall Study|Adverse Event|0
1091246|NCT02072824|3564950|P3|Overall Study|Medication error|0
1091247|NCT02072824|3564951|P2|Overall Study|Medication error|1
1091248|NCT02072824|3564952|P1|Overall Study|Medication error|0
1091249|NCT02072824|3564950|P3|Overall Study|No longer willing to participate|1
1091250|NCT02072824|3564951|P2|Overall Study|No longer willing to participate|0
1091251|NCT02072824|3564952|P1|Overall Study|No longer willing to participate|1
1091252|NCT02072824|3564950|P3|Overall Study|Insufficient clinical response|1
1091253|NCT02072824|3564951|P2|Overall Study|Insufficient clinical response|0
1091254|NCT02072824|3564952|P1|Overall Study|Insufficient clinical response|1
1091255|NCT02072226|3564997|P2|Overall Study|Patient Withdrawal of Consent|0
1091256|NCT02072226|3564998|P1|Overall Study|Patient Withdrawal of Consent|1
1091257|NCT02072226|3564997|P2|Overall Study|Death|0
1091258|NCT02072226|3564998|P1|Overall Study|Death|1
1091259|NCT02072226|3564997|P2|Overall Study|Patient Non-compliance|3
1091260|NCT02072226|3564998|P1|Overall Study|Patient Non-compliance|2
1091261|NCT02072226|3564997|P2|Overall Study|Lost to Follow-up|7
1091262|NCT02072226|3564998|P1|Overall Study|Lost to Follow-up|11
1091263|NCT02072096|3565028|P2|Overall Study|Lost to Follow-up|0
1091264|NCT02072096|3565029|P1|Overall Study|Lost to Follow-up|1
1091265|NCT02072096|3565028|P2|Overall Study|Study Terminated by Sponsor|30
1091266|NCT02072096|3565029|P1|Overall Study|Study Terminated by Sponsor|43
1091267|NCT02072096|3565028|P2|Overall Study|Physician Decision|1
1091268|NCT02072096|3565029|P1|Overall Study|Physician Decision|0
1091269|NCT02072096|3565028|P2|Overall Study|Death|0
1091270|NCT02072096|3565029|P1|Overall Study|Death|2
1091271|NCT02072096|3565028|P2|Overall Study|No Reason Provided|2
1091272|NCT02072096|3565029|P1|Overall Study|No Reason Provided|4
1091273|NCT02072096|3565028|P2|Overall Study|Adverse Event|2
1091274|NCT02072096|3565029|P1|Overall Study|Adverse Event|5
1091275|NCT02072096|3565028|P2|Overall Study|Withdrawal by Subject|7
1091276|NCT02072096|3565029|P1|Overall Study|Withdrawal by Subject|5
1091277|NCT02072096|3565028|P2|Overall Study|Protocol Violation|7
1091278|NCT02072096|3565029|P1|Overall Study|Protocol Violation|7
1091279|NCT02072096|3565028|P2|Overall Study|Lack of Efficacy|29
1091280|NCT02072096|3565029|P1|Overall Study|Lack of Efficacy|18
1091281|NCT02071849|3565051|P1|2-year Extended Follow-up|Adverse Event|1
1091282|NCT02071849|3565051|P1|6-month Primary Endpoint|Adverse Event|1
1091283|NCT02071849|3565051|P1|6-month Primary Endpoint|Did not receive device|4
1091284|NCT02071771|3565117|P2|Period 1: First 10 Days|Unavailable lens power|0
1091285|NCT02071771|3565118|P1|Period 1: First 10 Days|Unavailable lens power|1
1091286|NCT02071771|3565117|P2|Period 1: First 10 Days|Unacceptable lens fit|0
1091287|NCT02071771|3565118|P1|Period 1: First 10 Days|Unacceptable lens fit|1
1091288|NCT02071082|3565173|P2|Overall Study|Lost to Follow-up|1
1091289|NCT02071082|3565174|P1|Overall Study|Lost to Follow-up|1
1091290|NCT02071082|3565173|P2|Overall Study|Withdrew Consent|4
1091291|NCT02071082|3565174|P1|Overall Study|Withdrew Consent|0
1091292|NCT02071082|3565173|P2|Overall Study|Adverse Event|1
1091293|NCT02071082|3565174|P1|Overall Study|Adverse Event|0
1091294|NCT02071082|3565173|P2|Overall Study|Enrolled and Never Treated|1
1091295|NCT02071082|3565174|P1|Overall Study|Enrolled and Never Treated|1
1091296|NCT02070965|3565205|P3|Overall Study|Subject moved|0
1091297|NCT02070965|3565206|P2|Overall Study|Subject moved|0
1091298|NCT02070965|3565207|P1|Overall Study|Subject moved|1
1091299|NCT02070965|3565205|P3|Overall Study|Withdrawal by Subject|1
1091300|NCT02070965|3565206|P2|Overall Study|Withdrawal by Subject|1
1091301|NCT02070965|3565207|P1|Overall Study|Withdrawal by Subject|1
1091302|NCT02070965|3565205|P3|Overall Study|Lost to Follow-up|0
1091303|NCT02070965|3565206|P2|Overall Study|Lost to Follow-up|1
1091304|NCT02070965|3565207|P1|Overall Study|Lost to Follow-up|0
1091305|NCT02070744|3565219|P5|OLE Phase (48 Weeks)|Other|1
1091306|NCT02070744|3565220|P4|OLE Phase (48 Weeks)|Other|0
1091307|NCT02070744|3565221|P3|OLE Phase (48 Weeks)|Other|0
1091308|NCT02070744|3565222|P2|OLE Phase (48 Weeks)|Other|0
1091309|NCT02070744|3565223|P1|OLE Phase (48 Weeks)|Other|0
1091310|NCT02070744|3565219|P5|OLE Phase (48 Weeks)|Withdrawal by Subject|2
1091311|NCT02070744|3565220|P4|OLE Phase (48 Weeks)|Withdrawal by Subject|0
1091312|NCT02070744|3565221|P3|OLE Phase (48 Weeks)|Withdrawal by Subject|0
1091313|NCT02070744|3565222|P2|OLE Phase (48 Weeks)|Withdrawal by Subject|0
1091314|NCT02070744|3565223|P1|OLE Phase (48 Weeks)|Withdrawal by Subject|0
1091315|NCT02070744|3565219|P5|PC Phase (12 Weeks)|Randomized, but not treated|0
1091316|NCT02070744|3565220|P4|PC Phase (12 Weeks)|Randomized, but not treated|1
1091317|NCT02070744|3565221|P3|PC Phase (12 Weeks)|Randomized, but not treated|0
1091318|NCT02070744|3565222|P2|PC Phase (12 Weeks)|Randomized, but not treated|0
1091319|NCT02070744|3565223|P1|PC Phase (12 Weeks)|Randomized, but not treated|0
1091320|NCT02070588|3565306|P3|Overall Study|Adverse Event|0
1091321|NCT02070588|3565307|P2|Overall Study|Adverse Event|0
1091322|NCT02070588|3565308|P1|Overall Study|Adverse Event|1
1091323|NCT02070588|3565306|P3|Overall Study|Writhdrawal due to early termination|0
1091324|NCT02070588|3565307|P2|Overall Study|Writhdrawal due to early termination|0
1091325|NCT02070588|3565308|P1|Overall Study|Writhdrawal due to early termination|9
1091326|NCT02070588|3565306|P3|Overall Study|Withdrawal by Subject|0
1091327|NCT02070588|3565307|P2|Overall Study|Withdrawal by Subject|1
1091328|NCT02070588|3565308|P1|Overall Study|Withdrawal by Subject|29
1091329|NCT02070484|3565324|P2|Overall Study|Withdrawal by Subject|0
1091330|NCT02070484|3565325|P1|Overall Study|Withdrawal by Subject|1
1091331|NCT02070380|3565347|P4|Second Injection|Protocol Violation|5
1091332|NCT02070380|3565348|P3|Second Injection|Protocol Violation|1
1091333|NCT02070380|3565349|P2|Second Injection|Protocol Violation|1
1091334|NCT02070380|3565350|P1|Second Injection|Protocol Violation|0
1091335|NCT02070380|3565347|P4|Second Injection|Image sets missing or technically inadeq|0
1091336|NCT02070380|3565348|P3|Second Injection|Image sets missing or technically inadeq|0
1091337|NCT02070380|3565349|P2|Second Injection|Image sets missing or technically inadeq|1
1091338|NCT02070380|3565350|P1|Second Injection|Image sets missing or technically inadeq|0
1091339|NCT02070380|3565347|P4|Washout (no Second Injection/MRI)|Withdrawal by Subject|3
1091340|NCT02070380|3565348|P3|Washout (no Second Injection/MRI)|Withdrawal by Subject|2
1091341|NCT02070380|3565349|P2|Washout (no Second Injection/MRI)|Withdrawal by Subject|5
1091342|NCT02070380|3565350|P1|Washout (no Second Injection/MRI)|Withdrawal by Subject|0
1091343|NCT02069379|3565430|P4|Second Treatment Arm|Lost to Follow-up|0
1091344|NCT02069379|3565431|P3|Second Treatment Arm|Lost to Follow-up|1
1091345|NCT02069379|3565432|P2|Second Treatment Arm|Lost to Follow-up|0
1091346|NCT02069379|3565433|P1|Second Treatment Arm|Lost to Follow-up|0
1091347|NCT02069379|3565430|P4|Washout Period (4 Weeks)|Unrelated event|0
1091348|NCT02069379|3565431|P3|Washout Period (4 Weeks)|Unrelated event|0
1091349|NCT02069379|3565432|P2|Washout Period (4 Weeks)|Unrelated event|1
1091350|NCT02069379|3565433|P1|Washout Period (4 Weeks)|Unrelated event|0
1091351|NCT02069379|3565430|P4|Washout Period (4 Weeks)|Lost to Follow-up|0
1091352|NCT02069379|3565431|P3|Washout Period (4 Weeks)|Lost to Follow-up|0
1091353|NCT02069379|3565432|P2|Washout Period (4 Weeks)|Lost to Follow-up|1
1091354|NCT02069379|3565433|P1|Washout Period (4 Weeks)|Lost to Follow-up|0
1091355|NCT02069379|3565430|P4|First Treatment Arm|Lost to Follow-up|0
1091356|NCT02069379|3565431|P3|First Treatment Arm|Lost to Follow-up|1
1091357|NCT02069379|3565432|P2|First Treatment Arm|Lost to Follow-up|1
1091358|NCT02069379|3565433|P1|First Treatment Arm|Lost to Follow-up|0
1091359|NCT02069379|3565430|P4|Baseline Measurements|Ineligible based on initial assessments|2
1091360|NCT02069379|3565431|P3|Baseline Measurements|Ineligible based on initial assessments|0
1091361|NCT02069379|3565432|P2|Baseline Measurements|Ineligible based on initial assessments|0
1091362|NCT02069379|3565433|P1|Baseline Measurements|Ineligible based on initial assessments|2
1091363|NCT02069379|3565430|P4|Baseline Measurements|Lost to Follow-up|0
1091364|NCT02069379|3565431|P3|Baseline Measurements|Lost to Follow-up|0
1091365|NCT02069379|3565432|P2|Baseline Measurements|Lost to Follow-up|0
1091366|NCT02069379|3565433|P1|Baseline Measurements|Lost to Follow-up|1
1091367|NCT02069093|3565490|P1|Overall Study|Adverse Event|10
1091368|NCT02069093|3565490|P1|Overall Study|Abnormal laboratory values|1
1091369|NCT02069093|3565490|P1|Overall Study|Withdrawal by Subject|2
1091370|NCT02069093|3565490|P1|Overall Study|Administrative problems|1
1091371|NCT02069093|3565490|P1|Overall Study|Death|1
1091372|NCT02069093|3565490|P1|Overall Study|New cancer therapy|1
1091373|NCT02069093|3565490|P1|Overall Study|Disease progression|14
1091374|NCT02068599|3565510|P3|Overall Study|Noncompliance|1
1091375|NCT02068599|3565511|P2|Overall Study|Noncompliance|0
1091376|NCT02068599|3565512|P1|Overall Study|Noncompliance|0
1091377|NCT02068599|3565510|P3|Overall Study|Lack of Efficacy|3
1091378|NCT02068599|3565511|P2|Overall Study|Lack of Efficacy|0
1091379|NCT02068599|3565512|P1|Overall Study|Lack of Efficacy|0
1091380|NCT02068599|3565510|P3|Overall Study|Lost to Follow-up|0
1091381|NCT02068599|3565511|P2|Overall Study|Lost to Follow-up|0
1091382|NCT02068599|3565512|P1|Overall Study|Lost to Follow-up|1
1091383|NCT02068599|3565510|P3|Overall Study|Protocol Violation|3
1091384|NCT02068599|3565511|P2|Overall Study|Protocol Violation|2
1091385|NCT02068599|3565512|P1|Overall Study|Protocol Violation|4
1091386|NCT02068599|3565510|P3|Overall Study|Withdrawal by Subject|5
1091387|NCT02068599|3565511|P2|Overall Study|Withdrawal by Subject|7
1091388|NCT02068599|3565512|P1|Overall Study|Withdrawal by Subject|2
1091389|NCT02068599|3565510|P3|Overall Study|Adverse Event|1
1091390|NCT02068599|3565511|P2|Overall Study|Adverse Event|1
1091391|NCT02068599|3565512|P1|Overall Study|Adverse Event|4
1091392|NCT02068547|3565552|P2|Overall Study|Physician Decision|0
1091393|NCT02068547|3565553|P1|Overall Study|Physician Decision|1
1091394|NCT02068547|3565552|P2|Overall Study|Lost to Follow-up|3
1091395|NCT02068547|3565553|P1|Overall Study|Lost to Follow-up|3
1091396|NCT02068495|3565563|P1|Overall Study|Protocol Deviation|49
1091397|NCT02068495|3565563|P1|Overall Study|Case Report Forms Uncollected|60
1091398|NCT02068443|3565575|P3|Overall Study|Other Reason Not Specified|0
1091399|NCT02068443|3565576|P2|Overall Study|Other Reason Not Specified|0
1091400|NCT02068443|3565577|P1|Overall Study|Other Reason Not Specified|1
1091401|NCT02068443|3565575|P3|Overall Study|Lack of Efficacy|0
1091402|NCT02068443|3565576|P2|Overall Study|Lack of Efficacy|1
1091403|NCT02068443|3565577|P1|Overall Study|Lack of Efficacy|2
1091404|NCT02068443|3565575|P3|Overall Study|Voluntary Withdrawal|1
1091405|NCT02068443|3565576|P2|Overall Study|Voluntary Withdrawal|0
1091406|NCT02068443|3565577|P1|Overall Study|Voluntary Withdrawal|4
1091407|NCT02068443|3565575|P3|Overall Study|Pretreatment Event/Adverse Event|2
1091408|NCT02068443|3565576|P2|Overall Study|Pretreatment Event/Adverse Event|5
1091409|NCT02068443|3565577|P1|Overall Study|Pretreatment Event/Adverse Event|0
1091410|NCT02068222|3565612|P1|Overall Study|Lost to Follow-up|1
1091411|NCT02067728|3565643|P2|6 Month Measurements|Unable to attend|97
1091412|NCT02067728|3565644|P1|6 Month Measurements|Unable to attend|114
1091413|NCT02067728|3565643|P2|6 Month Follow up Survey|Lost to Follow-up|60
1091414|NCT02067728|3565644|P1|6 Month Follow up Survey|Lost to Follow-up|48
1091415|NCT02067728|3565643|P2|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28
1091416|NCT02067728|3565644|P1|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7
1091417|NCT02067676|3565678|P6|Overall Study|Withdrawal by Subject|0
1091418|NCT02067676|3565679|P5|Overall Study|Withdrawal by Subject|0
1091419|NCT02067676|3565680|P4|Overall Study|Withdrawal by Subject|0
1091420|NCT02067676|3565681|P3|Overall Study|Withdrawal by Subject|0
1091421|NCT02067676|3565682|P2|Overall Study|Withdrawal by Subject|0
1091422|NCT02067676|3565683|P1|Overall Study|Withdrawal by Subject|1
1091423|NCT02067533|3565800|P2|Overall Study|Lost to Follow-up|2
1091424|NCT02067533|3565801|P1|Overall Study|Lost to Follow-up|4
1091425|NCT02066922|3565816|P1|Overall Study|Adverse Event|1
1091426|NCT02066415|3565871|P3|Overall Study|Lost to Follow-up|2
1091427|NCT02066415|3565872|P2|Overall Study|Lost to Follow-up|2
1091428|NCT02066415|3565873|P1|Overall Study|Lost to Follow-up|7
1091429|NCT02066415|3565871|P3|Overall Study|Withdrawal by Subject|4
1091430|NCT02066415|3565872|P2|Overall Study|Withdrawal by Subject|1
1091431|NCT02066415|3565873|P1|Overall Study|Withdrawal by Subject|9
1091432|NCT02066415|3565871|P3|Overall Study|Decision by Sponsor|2
1091433|NCT02066415|3565872|P2|Overall Study|Decision by Sponsor|4
1091434|NCT02066415|3565873|P1|Overall Study|Decision by Sponsor|5
1091435|NCT02066402|3565898|P2|Overall Study|Protocol driven decision point|1
1091436|NCT02066402|3565899|P1|Overall Study|Protocol driven decision point|0
1091437|NCT02066402|3565898|P2|Overall Study|Progressive disease-clinical progression|1
1091438|NCT02066402|3565899|P1|Overall Study|Progressive disease-clinical progression|0
1091439|NCT02066402|3565898|P2|Overall Study|Withdrawal by Subject|11
1091440|NCT02066402|3565899|P1|Overall Study|Withdrawal by Subject|14
1091441|NCT02066402|3565898|P2|Overall Study|Lost to Follow-up|8
1091442|NCT02066402|3565899|P1|Overall Study|Lost to Follow-up|11
1091443|NCT02066402|3565898|P2|Overall Study|Adverse Event|2
1091444|NCT02066402|3565899|P1|Overall Study|Adverse Event|1
1091445|NCT02066233|3565927|P2|EG Scan II (Day 1)|difficulty intubating subject|6
1091446|NCT02066233|3565928|P1|EG Scan II (Day 1)|difficulty intubating subject|6
1091447|NCT02066129|3565938|P2|Overall Study|Physician Decision|1
1091448|NCT02066129|3565939|P1|Overall Study|Physician Decision|1
1091449|NCT02066129|3565938|P2|Overall Study|Lack of Efficacy|10
1091450|NCT02066129|3565939|P1|Overall Study|Lack of Efficacy|8
1091451|NCT02066129|3565938|P2|Overall Study|Withdrawal by Subject|10
1091452|NCT02066129|3565939|P1|Overall Study|Withdrawal by Subject|7
1091453|NCT02066129|3565938|P2|Overall Study|Lost to Follow-up|12
1091454|NCT02066129|3565939|P1|Overall Study|Lost to Follow-up|13
1091455|NCT02066051|3565953|P1|Overall Study|Subject developed active GVHD|1
1091456|NCT02065895|3565958|P6|Overall Study|Scheduling conflicts|0
1091457|NCT02065895|3565959|P5|Overall Study|Scheduling conflicts|0
1091458|NCT02065895|3565960|P4|Overall Study|Scheduling conflicts|0
1091459|NCT02065895|3565961|P3|Overall Study|Scheduling conflicts|0
1091460|NCT02065895|3565962|P2|Overall Study|Scheduling conflicts|1
1091461|NCT02065895|3565963|P1|Overall Study|Scheduling conflicts|0
1091462|NCT02065895|3565958|P6|Overall Study|Protocol Violation|0
1091463|NCT02065895|3565959|P5|Overall Study|Protocol Violation|0
1091464|NCT02065895|3565960|P4|Overall Study|Protocol Violation|1
1091465|NCT02065895|3565961|P3|Overall Study|Protocol Violation|0
1091466|NCT02065895|3565962|P2|Overall Study|Protocol Violation|0
1091467|NCT02065895|3565963|P1|Overall Study|Protocol Violation|1
1091468|NCT02064920|3566156|P2|Overall Study|Withdrawal by Subject|3
1091469|NCT02064920|3566157|P1|Overall Study|Withdrawal by Subject|1
1091470|NCT02064920|3566156|P2|Overall Study|Technical Problems|1
1091471|NCT02064920|3566157|P1|Overall Study|Technical Problems|0
1091472|NCT02064920|3566156|P2|Overall Study|Physician Decision|1
1091473|NCT02064920|3566157|P1|Overall Study|Physician Decision|0
1091474|NCT02064920|3566156|P2|Overall Study|Adverse Event|4
1091475|NCT02064920|3566157|P1|Overall Study|Adverse Event|0
1091476|NCT02064894|3566187|P3|Overall Study|Withdrawal by Subject|115
1091477|NCT02064894|3566188|P2|Overall Study|Withdrawal by Subject|102
1091478|NCT02064894|3566189|P1|Overall Study|Withdrawal by Subject|43
1091479|NCT02064816|3566202|P2|Overall Study|Other|3
1091480|NCT02064816|3566203|P1|Overall Study|Other|1
1091481|NCT02064816|3566202|P2|Overall Study|Therapeutic failure|1
1091482|NCT02064816|3566203|P1|Overall Study|Therapeutic failure|0
1091483|NCT02064816|3566202|P2|Overall Study|Lost to Follow-up|1
1091484|NCT02064816|3566203|P1|Overall Study|Lost to Follow-up|2
1091485|NCT02064816|3566202|P2|Overall Study|Withdrawal by Subject|1
1091486|NCT02064816|3566203|P1|Overall Study|Withdrawal by Subject|2
1091487|NCT02064816|3566202|P2|Overall Study|Adverse Event|2
1091488|NCT02064816|3566203|P1|Overall Study|Adverse Event|3
1091489|NCT02064439|3566244|P3|Overall Study|Other|7
1091490|NCT02064439|3566245|P2|Overall Study|Other|2
1091491|NCT02064439|3566246|P1|Overall Study|Other|2
1091492|NCT02064439|3566244|P3|Overall Study|Safety outcome reached|10
1091493|NCT02064439|3566245|P2|Overall Study|Safety outcome reached|20
1091494|NCT02064439|3566246|P1|Overall Study|Safety outcome reached|12
1091495|NCT02064439|3566244|P3|Overall Study|Efficacy outcome reached|57
1091496|NCT02064439|3566245|P2|Overall Study|Efficacy outcome reached|16
1091497|NCT02064439|3566246|P1|Overall Study|Efficacy outcome reached|18
1091498|NCT02064439|3566244|P3|Overall Study|Logistical difficulties|2
1091499|NCT02064439|3566245|P2|Overall Study|Logistical difficulties|5
1091500|NCT02064439|3566246|P1|Overall Study|Logistical difficulties|6
1091501|NCT02064439|3566244|P3|Overall Study|Physician Decision|1
1091502|NCT02064439|3566245|P2|Overall Study|Physician Decision|1
1091503|NCT02064439|3566246|P1|Overall Study|Physician Decision|0
1091504|NCT02064439|3566244|P3|Overall Study|Non-compliance with study medication|23
1091505|NCT02064439|3566245|P2|Overall Study|Non-compliance with study medication|19
1091506|NCT02064439|3566246|P1|Overall Study|Non-compliance with study medication|21
1091507|NCT02064439|3566244|P3|Overall Study|Lost to Follow-up|4
1091508|NCT02064439|3566245|P2|Overall Study|Lost to Follow-up|3
1091509|NCT02064439|3566246|P1|Overall Study|Lost to Follow-up|1
1091510|NCT02064439|3566244|P3|Overall Study|Protocol Violation|3
1091511|NCT02064439|3566245|P2|Overall Study|Protocol Violation|5
1091512|NCT02064439|3566246|P1|Overall Study|Protocol Violation|3
1091513|NCT02064439|3566244|P3|Overall Study|Withdrawal by Subject|26
1091514|NCT02064439|3566245|P2|Overall Study|Withdrawal by Subject|18
1091515|NCT02064439|3566246|P1|Overall Study|Withdrawal by Subject|29
1091516|NCT02064439|3566244|P3|Overall Study|Death|3
1091517|NCT02064439|3566245|P2|Overall Study|Death|2
1091518|NCT02064439|3566246|P1|Overall Study|Death|0
1091519|NCT02064439|3566244|P3|Overall Study|Adverse Event|46
1091520|NCT02064439|3566245|P2|Overall Study|Adverse Event|47
1091521|NCT02064439|3566246|P1|Overall Study|Adverse Event|51
1091522|NCT02064231|3566281|P4|Second Test Period (Test B or Test D)|Lack of Efficacy|0
1091523|NCT02064231|3566282|P3|Second Test Period (Test B or Test D)|Lack of Efficacy|0
1091524|NCT02064231|3566283|P2|Second Test Period (Test B or Test D)|Lack of Efficacy|1
1091525|NCT02064231|3566284|P1|Second Test Period (Test B or Test D)|Lack of Efficacy|1
1091526|NCT02064231|3566281|P4|First Test Period (Test A or Test C)|Adverse Event|0
1091527|NCT02064231|3566282|P3|First Test Period (Test A or Test C)|Adverse Event|1
1091528|NCT02064231|3566283|P2|First Test Period (Test A or Test C)|Adverse Event|0
1091529|NCT02064231|3566284|P1|First Test Period (Test A or Test C)|Adverse Event|1
1091530|NCT02064231|3566281|P4|First Test Period (Test A or Test C)|Withdrawal by Subject|0
1091531|NCT02064231|3566282|P3|First Test Period (Test A or Test C)|Withdrawal by Subject|0
1091532|NCT02064231|3566283|P2|First Test Period (Test A or Test C)|Withdrawal by Subject|1
1091533|NCT02064231|3566284|P1|First Test Period (Test A or Test C)|Withdrawal by Subject|1
1091534|NCT02064231|3566281|P4|First Test Period (Test A or Test C)|Lack of Efficacy|0
1091535|NCT02064231|3566282|P3|First Test Period (Test A or Test C)|Lack of Efficacy|0
1091536|NCT02064231|3566283|P2|First Test Period (Test A or Test C)|Lack of Efficacy|3
1091537|NCT02064231|3566284|P1|First Test Period (Test A or Test C)|Lack of Efficacy|5
1091538|NCT02064205|3566296|P1|Overall Study|Withdrawal by Subject|1
1091539|NCT02064166|3566314|P2|Overall Study|Adverse Event|0
1091540|NCT02064166|3566315|P1|Overall Study|Adverse Event|1
1091541|NCT02063880|3566345|P2|Overall Study|Ineligible|2
1091542|NCT02063880|3566346|P1|Overall Study|Ineligible|0
1091543|NCT02063880|3566345|P2|Overall Study|Lost to Follow-up|7
1091544|NCT02063880|3566346|P1|Overall Study|Lost to Follow-up|7
1091545|NCT02063880|3566345|P2|Overall Study|Death|18
1091546|NCT02063880|3566346|P1|Overall Study|Death|21
1091547|NCT02063854|3566363|P7|Overall Study|Did Not Receive Study Drug|0
1091548|NCT02063854|3566364|P6|Overall Study|Did Not Receive Study Drug|1
1091549|NCT02063854|3566365|P5|Overall Study|Did Not Receive Study Drug|0
1091550|NCT02063854|3566366|P4|Overall Study|Did Not Receive Study Drug|0
1091551|NCT02063854|3566367|P3|Overall Study|Did Not Receive Study Drug|0
1091552|NCT02063854|3566368|P2|Overall Study|Did Not Receive Study Drug|0
1091553|NCT02063854|3566369|P1|Overall Study|Did Not Receive Study Drug|0
1091554|NCT02063854|3566363|P7|Overall Study|Reason Not Specified|0
1091555|NCT02063854|3566364|P6|Overall Study|Reason Not Specified|0
1091556|NCT02063854|3566365|P5|Overall Study|Reason Not Specified|0
1091557|NCT02063854|3566366|P4|Overall Study|Reason Not Specified|0
1091558|NCT02063854|3566367|P3|Overall Study|Reason Not Specified|0
1091559|NCT02063854|3566368|P2|Overall Study|Reason Not Specified|0
1091560|NCT02063854|3566369|P1|Overall Study|Reason Not Specified|1
1091561|NCT02063854|3566363|P7|Overall Study|Surgical Dental Work Performed/Planned|1
1091562|NCT02063854|3566364|P6|Overall Study|Surgical Dental Work Performed/Planned|6
1091563|NCT02063854|3566365|P5|Overall Study|Surgical Dental Work Performed/Planned|1
1091564|NCT02063854|3566366|P4|Overall Study|Surgical Dental Work Performed/Planned|1
1091565|NCT02063854|3566367|P3|Overall Study|Surgical Dental Work Performed/Planned|6
1091566|NCT02063854|3566368|P2|Overall Study|Surgical Dental Work Performed/Planned|2
1091567|NCT02063854|3566369|P1|Overall Study|Surgical Dental Work Performed/Planned|5
1091568|NCT02063854|3566363|P7|Overall Study|Voluntary Withdrawal|1
1091569|NCT02063854|3566364|P6|Overall Study|Voluntary Withdrawal|6
1091570|NCT02063854|3566365|P5|Overall Study|Voluntary Withdrawal|3
1091571|NCT02063854|3566366|P4|Overall Study|Voluntary Withdrawal|1
1091572|NCT02063854|3566367|P3|Overall Study|Voluntary Withdrawal|8
1091573|NCT02063854|3566368|P2|Overall Study|Voluntary Withdrawal|0
1091574|NCT02063854|3566369|P1|Overall Study|Voluntary Withdrawal|2
1091575|NCT02063854|3566363|P7|Overall Study|Major Protocol Deviation|0
1091576|NCT02063854|3566364|P6|Overall Study|Major Protocol Deviation|0
1091577|NCT02063854|3566365|P5|Overall Study|Major Protocol Deviation|0
1091578|NCT02063854|3566366|P4|Overall Study|Major Protocol Deviation|0
1091579|NCT02063854|3566367|P3|Overall Study|Major Protocol Deviation|3
1091580|NCT02063854|3566368|P2|Overall Study|Major Protocol Deviation|0
1091581|NCT02063854|3566369|P1|Overall Study|Major Protocol Deviation|0
1091582|NCT02063854|3566363|P7|Overall Study|Pretreatment Event/Adverse Event|4
1091583|NCT02063854|3566364|P6|Overall Study|Pretreatment Event/Adverse Event|18
1091584|NCT02063854|3566365|P5|Overall Study|Pretreatment Event/Adverse Event|7
1091585|NCT02063854|3566366|P4|Overall Study|Pretreatment Event/Adverse Event|8
1091586|NCT02063854|3566367|P3|Overall Study|Pretreatment Event/Adverse Event|13
1091587|NCT02063854|3566368|P2|Overall Study|Pretreatment Event/Adverse Event|10
1091588|NCT02063854|3566369|P1|Overall Study|Pretreatment Event/Adverse Event|13
1091589|NCT02063737|3566453|P2|Overall Study|Lost to Follow-up|4
1091590|NCT02063737|3566454|P1|Overall Study|Lost to Follow-up|11
1091591|NCT02063672|3566488|P2|Overall Study|Withdrawal by Subject|2
1091592|NCT02063672|3566489|P1|Overall Study|Withdrawal by Subject|2
1091593|NCT02063672|3566488|P2|Overall Study|Lost to Follow-up|3
1091594|NCT02063672|3566489|P1|Overall Study|Lost to Follow-up|1
1091595|NCT02063672|3566488|P2|Overall Study|Death|3
1091596|NCT02063672|3566489|P1|Overall Study|Death|5
1091597|NCT02063672|3566488|P2|Overall Study|Ongoing Follow-up|14
1091598|NCT02063672|3566489|P1|Overall Study|Ongoing Follow-up|27
1091599|NCT02063659|3566536|P4|Open-Label Extension Period (OLE)|Reason not Specified|2
1091600|NCT02063659|3566537|P3|Open-Label Extension Period (OLE)|Reason not Specified|0
1091601|NCT02063659|3566538|P2|Open-Label Extension Period (OLE)|Reason not Specified|0
1091602|NCT02063659|3566539|P1|Open-Label Extension Period (OLE)|Reason not Specified|0
1091603|NCT02063659|3566536|P4|Open-Label Extension Period (OLE)|Adverse Event|7
1091604|NCT02063659|3566537|P3|Open-Label Extension Period (OLE)|Adverse Event|0
1091605|NCT02063659|3566538|P2|Open-Label Extension Period (OLE)|Adverse Event|0
1091606|NCT02063659|3566539|P1|Open-Label Extension Period (OLE)|Adverse Event|0
1091607|NCT02063659|3566536|P4|Open-Label Extension Period (OLE)|Lack of Efficacy|1
1091608|NCT02063659|3566537|P3|Open-Label Extension Period (OLE)|Lack of Efficacy|0
1091609|NCT02063659|3566538|P2|Open-Label Extension Period (OLE)|Lack of Efficacy|0
1091610|NCT02063659|3566539|P1|Open-Label Extension Period (OLE)|Lack of Efficacy|0
1091611|NCT02063659|3566536|P4|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
1091612|NCT02063659|3566537|P3|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
1091613|NCT02063659|3566538|P2|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
1091614|NCT02063659|3566539|P1|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
1091615|NCT02063659|3566536|P4|Open-Label Extension Period (OLE)|Physician Decision|1
1091616|NCT02063659|3566537|P3|Open-Label Extension Period (OLE)|Physician Decision|0
1091617|NCT02063659|3566538|P2|Open-Label Extension Period (OLE)|Physician Decision|0
1091618|NCT02063659|3566539|P1|Open-Label Extension Period (OLE)|Physician Decision|0
1091619|NCT02063659|3566536|P4|Double-Blind Treatment Period|Withdrawal of consent|0
1091620|NCT02063659|3566537|P3|Double-Blind Treatment Period|Withdrawal of consent|3
1091621|NCT02063659|3566538|P2|Double-Blind Treatment Period|Withdrawal of consent|1
1091622|NCT02063659|3566539|P1|Double-Blind Treatment Period|Withdrawal of consent|0
1091623|NCT02063659|3566536|P4|Double-Blind Treatment Period|Physician Decision|0
1091624|NCT02063659|3566537|P3|Double-Blind Treatment Period|Physician Decision|0
1091625|NCT02063659|3566538|P2|Double-Blind Treatment Period|Physician Decision|0
1091626|NCT02063659|3566539|P1|Double-Blind Treatment Period|Physician Decision|1
1091627|NCT02063659|3566536|P4|Double-Blind Treatment Period|Adverse Event|0
1091628|NCT02063659|3566537|P3|Double-Blind Treatment Period|Adverse Event|0
1091629|NCT02063659|3566538|P2|Double-Blind Treatment Period|Adverse Event|2
1091630|NCT02063659|3566539|P1|Double-Blind Treatment Period|Adverse Event|1
1091631|NCT02063217|3566622|P3|Overall Study|Withdrawal by Subject|0
1091632|NCT02063217|3566623|P2|Overall Study|Withdrawal by Subject|0
1091633|NCT02063217|3566624|P1|Overall Study|Withdrawal by Subject|1
1091634|NCT02062879|3566660|P2|Overall Study|Withdrawal by Subject|1
1091635|NCT02062879|3566661|P1|Overall Study|Withdrawal by Subject|4
1091636|NCT02062658|3566697|P1|Overall Study|Lack of Efficacy|1
1091637|NCT02062658|3566697|P1|Overall Study|Withdrawal by Subject|1
1091638|NCT02062645|3566701|P1|Overall Study|Lost to Follow-up|5
1091639|NCT02062645|3566701|P1|Overall Study|Protocol Violation|8
1091640|NCT02062645|3566701|P1|Overall Study|Adverse Event|2
1091641|NCT02062450|3566743|P1|Overall Study|No follow-up visit|124
1091642|NCT02062437|3566757|P1|Overall Study|Pt. couldn't come due to med. condition|1
1091643|NCT02062437|3566757|P1|Overall Study|Death|2
1091644|NCT02062437|3566757|P1|Overall Study|Patient not available for the 2y visit|18
1091645|NCT02062437|3566757|P1|Overall Study|Pt. didn't want to come for the 2y visit|31
1091646|NCT02062385|3566770|P4|Overall Study|Lost to Follow-up|0
1091647|NCT02062385|3566771|P3|Overall Study|Lost to Follow-up|1
1091648|NCT02062385|3566772|P2|Overall Study|Lost to Follow-up|0
1091649|NCT02062385|3566773|P1|Overall Study|Lost to Follow-up|0
1091650|NCT02062385|3566770|P4|Overall Study|Death|1
1091651|NCT02062385|3566771|P3|Overall Study|Death|0
1091652|NCT02062385|3566772|P2|Overall Study|Death|0
1091653|NCT02062385|3566773|P1|Overall Study|Death|0
1091654|NCT02062385|3566770|P4|Overall Study|Withdrawn by parent/guardian|8
1091655|NCT02062385|3566771|P3|Overall Study|Withdrawn by parent/guardian|9
1091656|NCT02062385|3566772|P2|Overall Study|Withdrawn by parent/guardian|41
1091657|NCT02062385|3566773|P1|Overall Study|Withdrawn by parent/guardian|46
1091658|NCT02062385|3566770|P4|Overall Study|Moved|0
1091659|NCT02062385|3566771|P3|Overall Study|Moved|1
1091660|NCT02062385|3566772|P2|Overall Study|Moved|11
1091661|NCT02062385|3566773|P1|Overall Study|Moved|10
1091662|NCT02062385|3566770|P4|Overall Study|Incomplete EPI by database lock|0
1091663|NCT02062385|3566771|P3|Overall Study|Incomplete EPI by database lock|0
1091664|NCT02062385|3566772|P2|Overall Study|Incomplete EPI by database lock|0
1091665|NCT02062385|3566773|P1|Overall Study|Incomplete EPI by database lock|2
1091666|NCT02062385|3566770|P4|Overall Study|Protocol Violation|0
1091667|NCT02062385|3566771|P3|Overall Study|Protocol Violation|0
1091668|NCT02062385|3566772|P2|Overall Study|Protocol Violation|0
1091669|NCT02062385|3566773|P1|Overall Study|Protocol Violation|1
1091670|NCT02062385|3566770|P4|Overall Study|Adverse Event|0
1091671|NCT02062385|3566771|P3|Overall Study|Adverse Event|1
1091672|NCT02062385|3566772|P2|Overall Study|Adverse Event|13
1091673|NCT02062385|3566773|P1|Overall Study|Adverse Event|19
1091674|NCT02061592|3566957|P2|Period 2|Lost to Follow-up|1
1091675|NCT02061592|3566958|P1|Period 2|Lost to Follow-up|0
1091676|NCT02061592|3566957|P2|Period 1|Protocol Violation|0
1091677|NCT02061592|3566958|P1|Period 1|Protocol Violation|1
1091678|NCT02061592|3566957|P2|Period 1|Withdrawal by Subject|0
1091679|NCT02061592|3566958|P1|Period 1|Withdrawal by Subject|1
1091680|NCT02061540|3566970|P1|Overall Study|Withdrawal by Subject|2
1091681|NCT02061540|3566970|P1|Overall Study|Adverse Event|2
1091682|NCT02061280|3567138|P2|Overall Study|Lost to Follow-up|1
1091683|NCT02061280|3567139|P1|Overall Study|Lost to Follow-up|5
1091684|NCT02061280|3567138|P2|Overall Study|Withdrawal by Subject|2
1091685|NCT02061280|3567139|P1|Overall Study|Withdrawal by Subject|1
1091686|NCT02061280|3567138|P2|Overall Study|moved out of state|1
1091687|NCT02061280|3567139|P1|Overall Study|moved out of state|0
1091688|NCT02061280|3567138|P2|Overall Study|Protocol Violation|8
1091689|NCT02061280|3567139|P1|Overall Study|Protocol Violation|12
1091690|NCT02059980|3567309|P2|Overall Study|Lost to Follow-up|1
1091691|NCT02059980|3567310|P1|Overall Study|Lost to Follow-up|2
1091692|NCT02059395|3567348|P2|Overall Study|Lost to Follow-up|4
1091693|NCT02059395|3567349|P1|Overall Study|Lost to Follow-up|2
1091694|NCT02059291|3567364|P25|Epoch 4|Lack of Efficacy|0
1091695|NCT02059291|3567365|P24|Epoch 4|Lack of Efficacy|1
1091696|NCT02059291|3567366|P23|Epoch 4|Lack of Efficacy|0
1091697|NCT02059291|3567367|P22|Epoch 4|Lack of Efficacy|0
1091698|NCT02059291|3567368|P21|Epoch 4|Lack of Efficacy|0
1091699|NCT02059291|3567369|P20|Epoch 4|Lack of Efficacy|0
1091700|NCT02059291|3567370|P19|Epoch 4|Lack of Efficacy|0
1091701|NCT02059291|3567371|P18|Epoch 4|Lack of Efficacy|0
1091702|NCT02059291|3567372|P17|Epoch 4|Lack of Efficacy|0
1091703|NCT02059291|3567373|P16|Epoch 4|Lack of Efficacy|0
1091704|NCT02059291|3567374|P15|Epoch 4|Lack of Efficacy|0
1091705|NCT02059291|3567375|P14|Epoch 4|Lack of Efficacy|0
1091706|NCT02059291|3567376|P13|Epoch 4|Lack of Efficacy|0
1091707|NCT02059291|3567377|P12|Epoch 4|Lack of Efficacy|0
1091708|NCT02059291|3567378|P11|Epoch 4|Lack of Efficacy|0
1091709|NCT02059291|3567379|P10|Epoch 4|Lack of Efficacy|0
1091710|NCT02059291|3567380|P9|Epoch 4|Lack of Efficacy|0
1091711|NCT02059291|3567381|P8|Epoch 4|Lack of Efficacy|0
1091712|NCT02059291|3567382|P7|Epoch 4|Lack of Efficacy|0
1091713|NCT02059291|3567383|P6|Epoch 4|Lack of Efficacy|0
1091714|NCT02059291|3567384|P5|Epoch 4|Lack of Efficacy|0
1091715|NCT02059291|3567385|P4|Epoch 4|Lack of Efficacy|0
1091716|NCT02059291|3567386|P3|Epoch 4|Lack of Efficacy|0
1091717|NCT02059291|3567387|P2|Epoch 4|Lack of Efficacy|0
1091718|NCT02059291|3567388|P1|Epoch 4|Lack of Efficacy|0
1091719|NCT02059291|3567364|P25|Epoch 4|Withdrawal by Subject|0
1091720|NCT02059291|3567365|P24|Epoch 4|Withdrawal by Subject|0
1091721|NCT02059291|3567366|P23|Epoch 4|Withdrawal by Subject|0
1091722|NCT02059291|3567367|P22|Epoch 4|Withdrawal by Subject|0
1091723|NCT02059291|3567368|P21|Epoch 4|Withdrawal by Subject|1
1091724|NCT02059291|3567369|P20|Epoch 4|Withdrawal by Subject|0
1091725|NCT02059291|3567370|P19|Epoch 4|Withdrawal by Subject|0
1091726|NCT02059291|3567371|P18|Epoch 4|Withdrawal by Subject|0
1091727|NCT02059291|3567372|P17|Epoch 4|Withdrawal by Subject|0
1091728|NCT02059291|3567373|P16|Epoch 4|Withdrawal by Subject|0
1091729|NCT02059291|3567374|P15|Epoch 4|Withdrawal by Subject|0
1091730|NCT02059291|3567375|P14|Epoch 4|Withdrawal by Subject|0
1091731|NCT02059291|3567376|P13|Epoch 4|Withdrawal by Subject|0
1091732|NCT02059291|3567377|P12|Epoch 4|Withdrawal by Subject|0
1091733|NCT02059291|3567378|P11|Epoch 4|Withdrawal by Subject|0
1091734|NCT02059291|3567379|P10|Epoch 4|Withdrawal by Subject|0
1091735|NCT02059291|3567380|P9|Epoch 4|Withdrawal by Subject|0
1091736|NCT02059291|3567381|P8|Epoch 4|Withdrawal by Subject|0
1091737|NCT02059291|3567382|P7|Epoch 4|Withdrawal by Subject|0
1091738|NCT02059291|3567383|P6|Epoch 4|Withdrawal by Subject|0
1091739|NCT02059291|3567384|P5|Epoch 4|Withdrawal by Subject|0
1091740|NCT02059291|3567385|P4|Epoch 4|Withdrawal by Subject|0
1091741|NCT02059291|3567386|P3|Epoch 4|Withdrawal by Subject|0
1091742|NCT02059291|3567387|P2|Epoch 4|Withdrawal by Subject|0
1091743|NCT02059291|3567388|P1|Epoch 4|Withdrawal by Subject|0
1091744|NCT02059291|3567364|P25|Epoch 4|Pregnancy|0
1091745|NCT02059291|3567365|P24|Epoch 4|Pregnancy|0
1091746|NCT02059291|3567366|P23|Epoch 4|Pregnancy|0
1091747|NCT02059291|3567367|P22|Epoch 4|Pregnancy|0
1091748|NCT02059291|3567368|P21|Epoch 4|Pregnancy|0
1091749|NCT02059291|3567369|P20|Epoch 4|Pregnancy|0
1091750|NCT02059291|3567370|P19|Epoch 4|Pregnancy|0
1091751|NCT02059291|3567371|P18|Epoch 4|Pregnancy|0
1091752|NCT02059291|3567372|P17|Epoch 4|Pregnancy|1
1091753|NCT02059291|3567373|P16|Epoch 4|Pregnancy|0
1091754|NCT02059291|3567374|P15|Epoch 4|Pregnancy|0
1091755|NCT02059291|3567375|P14|Epoch 4|Pregnancy|0
1091756|NCT02059291|3567376|P13|Epoch 4|Pregnancy|0
1091757|NCT02059291|3567377|P12|Epoch 4|Pregnancy|0
1091758|NCT02059291|3567378|P11|Epoch 4|Pregnancy|0
1091759|NCT02059291|3567379|P10|Epoch 4|Pregnancy|0
1091760|NCT02059291|3567380|P9|Epoch 4|Pregnancy|0
1091761|NCT02059291|3567381|P8|Epoch 4|Pregnancy|0
1091762|NCT02059291|3567382|P7|Epoch 4|Pregnancy|0
1091763|NCT02059291|3567383|P6|Epoch 4|Pregnancy|0
1091764|NCT02059291|3567384|P5|Epoch 4|Pregnancy|0
1091765|NCT02059291|3567385|P4|Epoch 4|Pregnancy|0
1091766|NCT02059291|3567386|P3|Epoch 4|Pregnancy|0
1091767|NCT02059291|3567387|P2|Epoch 4|Pregnancy|0
1091768|NCT02059291|3567388|P1|Epoch 4|Pregnancy|0
1091769|NCT02059291|3567364|P25|Epoch 4|Adverse Event|0
1091770|NCT02059291|3567365|P24|Epoch 4|Adverse Event|0
1091771|NCT02059291|3567366|P23|Epoch 4|Adverse Event|1
1091772|NCT02059291|3567367|P22|Epoch 4|Adverse Event|0
1091773|NCT02059291|3567368|P21|Epoch 4|Adverse Event|0
1091774|NCT02059291|3567369|P20|Epoch 4|Adverse Event|0
1091775|NCT02059291|3567370|P19|Epoch 4|Adverse Event|0
1091776|NCT02059291|3567371|P18|Epoch 4|Adverse Event|0
1091777|NCT02059291|3567372|P17|Epoch 4|Adverse Event|1
1091778|NCT02059291|3567373|P16|Epoch 4|Adverse Event|0
1091779|NCT02059291|3567374|P15|Epoch 4|Adverse Event|0
1091780|NCT02059291|3567375|P14|Epoch 4|Adverse Event|0
1091781|NCT02059291|3567376|P13|Epoch 4|Adverse Event|0
1091782|NCT02059291|3567377|P12|Epoch 4|Adverse Event|0
1091783|NCT02059291|3567378|P11|Epoch 4|Adverse Event|0
1091784|NCT02059291|3567379|P10|Epoch 4|Adverse Event|0
1091785|NCT02059291|3567380|P9|Epoch 4|Adverse Event|0
1091786|NCT02059291|3567381|P8|Epoch 4|Adverse Event|0
1091787|NCT02059291|3567382|P7|Epoch 4|Adverse Event|0
1091788|NCT02059291|3567383|P6|Epoch 4|Adverse Event|0
1091789|NCT02059291|3567384|P5|Epoch 4|Adverse Event|0
1091790|NCT02059291|3567385|P4|Epoch 4|Adverse Event|0
1091791|NCT02059291|3567386|P3|Epoch 4|Adverse Event|0
1091792|NCT02059291|3567387|P2|Epoch 4|Adverse Event|0
1091793|NCT02059291|3567388|P1|Epoch 4|Adverse Event|0
1091794|NCT02059291|3567364|P25|Epoch 3|Withdrawal by Subject|0
1091795|NCT02059291|3567365|P24|Epoch 3|Withdrawal by Subject|0
1091796|NCT02059291|3567366|P23|Epoch 3|Withdrawal by Subject|0
1091797|NCT02059291|3567367|P22|Epoch 3|Withdrawal by Subject|0
1091798|NCT02059291|3567368|P21|Epoch 3|Withdrawal by Subject|0
1091799|NCT02059291|3567369|P20|Epoch 3|Withdrawal by Subject|0
1091800|NCT02059291|3567370|P19|Epoch 3|Withdrawal by Subject|0
1091801|NCT02059291|3567371|P18|Epoch 3|Withdrawal by Subject|0
1091802|NCT02059291|3567372|P17|Epoch 3|Withdrawal by Subject|0
1091803|NCT02059291|3567373|P16|Epoch 3|Withdrawal by Subject|1
1091804|NCT02059291|3567374|P15|Epoch 3|Withdrawal by Subject|0
1091805|NCT02059291|3567375|P14|Epoch 3|Withdrawal by Subject|0
1091806|NCT02059291|3567376|P13|Epoch 3|Withdrawal by Subject|0
1091807|NCT02059291|3567377|P12|Epoch 3|Withdrawal by Subject|0
1091808|NCT02059291|3567378|P11|Epoch 3|Withdrawal by Subject|0
1091809|NCT02059291|3567379|P10|Epoch 3|Withdrawal by Subject|0
1091810|NCT02059291|3567380|P9|Epoch 3|Withdrawal by Subject|0
1091811|NCT02059291|3567381|P8|Epoch 3|Withdrawal by Subject|0
1091812|NCT02059291|3567382|P7|Epoch 3|Withdrawal by Subject|0
1091813|NCT02059291|3567383|P6|Epoch 3|Withdrawal by Subject|0
1091814|NCT02059291|3567384|P5|Epoch 3|Withdrawal by Subject|0
1091815|NCT02059291|3567385|P4|Epoch 3|Withdrawal by Subject|0
1091816|NCT02059291|3567386|P3|Epoch 3|Withdrawal by Subject|0
1091817|NCT02059291|3567387|P2|Epoch 3|Withdrawal by Subject|0
1091818|NCT02059291|3567388|P1|Epoch 3|Withdrawal by Subject|0
1091819|NCT02059291|3567364|P25|Epoch 3|Lack of Efficacy|0
1091820|NCT02059291|3567365|P24|Epoch 3|Lack of Efficacy|0
1091821|NCT02059291|3567366|P23|Epoch 3|Lack of Efficacy|0
1091822|NCT02059291|3567367|P22|Epoch 3|Lack of Efficacy|0
1091823|NCT02059291|3567368|P21|Epoch 3|Lack of Efficacy|0
1091824|NCT02059291|3567369|P20|Epoch 3|Lack of Efficacy|0
1091825|NCT02059291|3567370|P19|Epoch 3|Lack of Efficacy|0
1091826|NCT02059291|3567371|P18|Epoch 3|Lack of Efficacy|0
1091827|NCT02059291|3567372|P17|Epoch 3|Lack of Efficacy|0
1091828|NCT02059291|3567373|P16|Epoch 3|Lack of Efficacy|3
1091829|NCT02059291|3567374|P15|Epoch 3|Lack of Efficacy|0
1091830|NCT02059291|3567375|P14|Epoch 3|Lack of Efficacy|0
1091831|NCT02059291|3567376|P13|Epoch 3|Lack of Efficacy|0
1091832|NCT02059291|3567377|P12|Epoch 3|Lack of Efficacy|0
1091833|NCT02059291|3567378|P11|Epoch 3|Lack of Efficacy|0
1091834|NCT02059291|3567379|P10|Epoch 3|Lack of Efficacy|0
1091835|NCT02059291|3567380|P9|Epoch 3|Lack of Efficacy|0
1091836|NCT02059291|3567381|P8|Epoch 3|Lack of Efficacy|0
1091837|NCT02059291|3567382|P7|Epoch 3|Lack of Efficacy|0
1091838|NCT02059291|3567383|P6|Epoch 3|Lack of Efficacy|0
1091839|NCT02059291|3567384|P5|Epoch 3|Lack of Efficacy|0
1091840|NCT02059291|3567385|P4|Epoch 3|Lack of Efficacy|0
1091841|NCT02059291|3567386|P3|Epoch 3|Lack of Efficacy|0
1091842|NCT02059291|3567387|P2|Epoch 3|Lack of Efficacy|0
1091843|NCT02059291|3567388|P1|Epoch 3|Lack of Efficacy|0
1091844|NCT02059291|3567364|P25|Epoch 3|Adverse Event|0
1091845|NCT02059291|3567365|P24|Epoch 3|Adverse Event|0
1091846|NCT02059291|3567366|P23|Epoch 3|Adverse Event|0
1091847|NCT02059291|3567367|P22|Epoch 3|Adverse Event|0
1091848|NCT02059291|3567368|P21|Epoch 3|Adverse Event|0
1091849|NCT02059291|3567369|P20|Epoch 3|Adverse Event|0
1091850|NCT02059291|3567370|P19|Epoch 3|Adverse Event|0
1091851|NCT02059291|3567371|P18|Epoch 3|Adverse Event|0
1091852|NCT02059291|3567372|P17|Epoch 3|Adverse Event|0
1091853|NCT02059291|3567373|P16|Epoch 3|Adverse Event|1
1091854|NCT02059291|3567374|P15|Epoch 3|Adverse Event|0
1091855|NCT02059291|3567375|P14|Epoch 3|Adverse Event|0
1091856|NCT02059291|3567376|P13|Epoch 3|Adverse Event|0
1091857|NCT02059291|3567377|P12|Epoch 3|Adverse Event|0
1091858|NCT02059291|3567378|P11|Epoch 3|Adverse Event|0
1091859|NCT02059291|3567379|P10|Epoch 3|Adverse Event|0
1091860|NCT02059291|3567380|P9|Epoch 3|Adverse Event|0
1091861|NCT02059291|3567381|P8|Epoch 3|Adverse Event|0
1091862|NCT02059291|3567382|P7|Epoch 3|Adverse Event|0
1091863|NCT02059291|3567383|P6|Epoch 3|Adverse Event|0
1091864|NCT02059291|3567384|P5|Epoch 3|Adverse Event|0
1091865|NCT02059291|3567385|P4|Epoch 3|Adverse Event|0
1091866|NCT02059291|3567386|P3|Epoch 3|Adverse Event|0
1091867|NCT02059291|3567387|P2|Epoch 3|Adverse Event|0
1091868|NCT02059291|3567388|P1|Epoch 3|Adverse Event|0
1091869|NCT02059291|3567364|P25|Epoch 3|Physician Decision|0
1091870|NCT02059291|3567365|P24|Epoch 3|Physician Decision|0
1091871|NCT02059291|3567366|P23|Epoch 3|Physician Decision|0
1091872|NCT02059291|3567367|P22|Epoch 3|Physician Decision|0
1091873|NCT02059291|3567368|P21|Epoch 3|Physician Decision|0
1091874|NCT02059291|3567369|P20|Epoch 3|Physician Decision|0
1091875|NCT02059291|3567370|P19|Epoch 3|Physician Decision|0
1091876|NCT02059291|3567371|P18|Epoch 3|Physician Decision|0
1091877|NCT02059291|3567372|P17|Epoch 3|Physician Decision|0
1091878|NCT02059291|3567373|P16|Epoch 3|Physician Decision|1
1091879|NCT02059291|3567374|P15|Epoch 3|Physician Decision|0
1091880|NCT02059291|3567375|P14|Epoch 3|Physician Decision|1
1091881|NCT02059291|3567376|P13|Epoch 3|Physician Decision|0
1091882|NCT02059291|3567377|P12|Epoch 3|Physician Decision|0
1091883|NCT02059291|3567378|P11|Epoch 3|Physician Decision|0
1091884|NCT02059291|3567379|P10|Epoch 3|Physician Decision|0
1091885|NCT02059291|3567380|P9|Epoch 3|Physician Decision|0
1091886|NCT02059291|3567381|P8|Epoch 3|Physician Decision|0
1091887|NCT02059291|3567382|P7|Epoch 3|Physician Decision|0
1091888|NCT02059291|3567383|P6|Epoch 3|Physician Decision|0
1091889|NCT02059291|3567384|P5|Epoch 3|Physician Decision|0
1091890|NCT02059291|3567385|P4|Epoch 3|Physician Decision|0
1091891|NCT02059291|3567386|P3|Epoch 3|Physician Decision|0
1091892|NCT02059291|3567387|P2|Epoch 3|Physician Decision|0
1091893|NCT02059291|3567388|P1|Epoch 3|Physician Decision|0
1091894|NCT02059291|3567364|P25|Epoch 2|Withdrawal by Subject|0
1091895|NCT02059291|3567365|P24|Epoch 2|Withdrawal by Subject|0
1091896|NCT02059291|3567366|P23|Epoch 2|Withdrawal by Subject|0
1091897|NCT02059291|3567367|P22|Epoch 2|Withdrawal by Subject|0
1091898|NCT02059291|3567368|P21|Epoch 2|Withdrawal by Subject|0
1091899|NCT02059291|3567369|P20|Epoch 2|Withdrawal by Subject|0
1091900|NCT02059291|3567370|P19|Epoch 2|Withdrawal by Subject|0
1091901|NCT02059291|3567371|P18|Epoch 2|Withdrawal by Subject|0
1091902|NCT02059291|3567372|P17|Epoch 2|Withdrawal by Subject|0
1091903|NCT02059291|3567373|P16|Epoch 2|Withdrawal by Subject|0
1091904|NCT02059291|3567374|P15|Epoch 2|Withdrawal by Subject|0
1091905|NCT02059291|3567375|P14|Epoch 2|Withdrawal by Subject|0
1091906|NCT02059291|3567376|P13|Epoch 2|Withdrawal by Subject|0
1091907|NCT02059291|3567377|P12|Epoch 2|Withdrawal by Subject|0
1091908|NCT02059291|3567378|P11|Epoch 2|Withdrawal by Subject|0
1091909|NCT02059291|3567379|P10|Epoch 2|Withdrawal by Subject|0
1091910|NCT02059291|3567380|P9|Epoch 2|Withdrawal by Subject|1
1091911|NCT02059291|3567381|P8|Epoch 2|Withdrawal by Subject|0
1091912|NCT02059291|3567382|P7|Epoch 2|Withdrawal by Subject|0
1091913|NCT02059291|3567383|P6|Epoch 2|Withdrawal by Subject|1
1091914|NCT02059291|3567384|P5|Epoch 2|Withdrawal by Subject|0
1091915|NCT02059291|3567385|P4|Epoch 2|Withdrawal by Subject|0
1091916|NCT02059291|3567386|P3|Epoch 2|Withdrawal by Subject|0
1091917|NCT02059291|3567387|P2|Epoch 2|Withdrawal by Subject|1
1091918|NCT02059291|3567388|P1|Epoch 2|Withdrawal by Subject|0
1091919|NCT02059291|3567364|P25|Epoch 2|Adverse Event|0
1091920|NCT02059291|3567365|P24|Epoch 2|Adverse Event|0
1091921|NCT02059291|3567366|P23|Epoch 2|Adverse Event|0
1091922|NCT02059291|3567367|P22|Epoch 2|Adverse Event|0
1091923|NCT02059291|3567368|P21|Epoch 2|Adverse Event|0
1091924|NCT02059291|3567369|P20|Epoch 2|Adverse Event|0
1091925|NCT02059291|3567370|P19|Epoch 2|Adverse Event|0
1091926|NCT02059291|3567371|P18|Epoch 2|Adverse Event|0
1091927|NCT02059291|3567372|P17|Epoch 2|Adverse Event|0
1091928|NCT02059291|3567373|P16|Epoch 2|Adverse Event|0
1091929|NCT02059291|3567374|P15|Epoch 2|Adverse Event|0
1091930|NCT02059291|3567375|P14|Epoch 2|Adverse Event|0
1091931|NCT02059291|3567376|P13|Epoch 2|Adverse Event|0
1091932|NCT02059291|3567377|P12|Epoch 2|Adverse Event|0
1091933|NCT02059291|3567378|P11|Epoch 2|Adverse Event|0
1091934|NCT02059291|3567379|P10|Epoch 2|Adverse Event|0
1091935|NCT02059291|3567380|P9|Epoch 2|Adverse Event|1
1091936|NCT02059291|3567381|P8|Epoch 2|Adverse Event|1
1091937|NCT02059291|3567382|P7|Epoch 2|Adverse Event|0
1091938|NCT02059291|3567383|P6|Epoch 2|Adverse Event|0
1091939|NCT02059291|3567384|P5|Epoch 2|Adverse Event|0
1091940|NCT02059291|3567385|P4|Epoch 2|Adverse Event|1
1091941|NCT02059291|3567386|P3|Epoch 2|Adverse Event|1
1091942|NCT02059291|3567387|P2|Epoch 2|Adverse Event|0
1091943|NCT02059291|3567388|P1|Epoch 2|Adverse Event|0
1091944|NCT02059291|3567364|P25|Epoch 2|Lack of Efficacy|0
1091945|NCT02059291|3567365|P24|Epoch 2|Lack of Efficacy|0
1091946|NCT02059291|3567366|P23|Epoch 2|Lack of Efficacy|0
1091947|NCT02059291|3567367|P22|Epoch 2|Lack of Efficacy|0
1091948|NCT02059291|3567368|P21|Epoch 2|Lack of Efficacy|0
1091949|NCT02059291|3567369|P20|Epoch 2|Lack of Efficacy|0
1091950|NCT02059291|3567370|P19|Epoch 2|Lack of Efficacy|0
1091951|NCT02059291|3567371|P18|Epoch 2|Lack of Efficacy|0
1091952|NCT02059291|3567372|P17|Epoch 2|Lack of Efficacy|0
1091953|NCT02059291|3567373|P16|Epoch 2|Lack of Efficacy|0
1091954|NCT02059291|3567374|P15|Epoch 2|Lack of Efficacy|0
1091955|NCT02059291|3567375|P14|Epoch 2|Lack of Efficacy|0
1091956|NCT02059291|3567376|P13|Epoch 2|Lack of Efficacy|0
1091957|NCT02059291|3567377|P12|Epoch 2|Lack of Efficacy|0
1091958|NCT02059291|3567378|P11|Epoch 2|Lack of Efficacy|0
1091959|NCT02059291|3567379|P10|Epoch 2|Lack of Efficacy|0
1091960|NCT02059291|3567380|P9|Epoch 2|Lack of Efficacy|0
1091961|NCT02059291|3567381|P8|Epoch 2|Lack of Efficacy|0
1091962|NCT02059291|3567382|P7|Epoch 2|Lack of Efficacy|0
1091963|NCT02059291|3567383|P6|Epoch 2|Lack of Efficacy|1
1091964|NCT02059291|3567384|P5|Epoch 2|Lack of Efficacy|0
1091965|NCT02059291|3567385|P4|Epoch 2|Lack of Efficacy|1
1091966|NCT02059291|3567386|P3|Epoch 2|Lack of Efficacy|0
1091967|NCT02059291|3567387|P2|Epoch 2|Lack of Efficacy|0
1091968|NCT02059291|3567388|P1|Epoch 2|Lack of Efficacy|0
1091969|NCT02059278|3567442|P2|Overall Study|Ran out of IP and decided to discontinue|0
1091970|NCT02059278|3567443|P1|Overall Study|Ran out of IP and decided to discontinue|1
1091971|NCT02059278|3567442|P2|Overall Study|Withdrawal by Subject|3
1091972|NCT02059278|3567443|P1|Overall Study|Withdrawal by Subject|0
1091973|NCT02059278|3567442|P2|Overall Study|Lost to Follow-up|0
1091974|NCT02059278|3567443|P1|Overall Study|Lost to Follow-up|1
1091975|NCT02059278|3567442|P2|Overall Study|Adverse Event|1
1091976|NCT02059278|3567443|P1|Overall Study|Adverse Event|1
1091977|NCT02059187|3567459|P2|Overall Study|Withdrawal by Subject|8
1091978|NCT02059187|3567460|P1|Overall Study|Withdrawal by Subject|12
1091979|NCT02059187|3567459|P2|Overall Study|Protocol Violation|0
1091980|NCT02059187|3567460|P1|Overall Study|Protocol Violation|1
1091981|NCT02059187|3567459|P2|Overall Study|Physician Decision|2
1091982|NCT02059187|3567460|P1|Overall Study|Physician Decision|1
1091983|NCT02059187|3567459|P2|Overall Study|Non-compliance with study drug|0
1091984|NCT02059187|3567460|P1|Overall Study|Non-compliance with study drug|1
1091985|NCT02059187|3567459|P2|Overall Study|Lost to Follow-up|8
1091986|NCT02059187|3567460|P1|Overall Study|Lost to Follow-up|9
1091987|NCT02059187|3567459|P2|Overall Study|Death|1
1091988|NCT02059187|3567460|P1|Overall Study|Death|1
1091989|NCT02059187|3567459|P2|Overall Study|Adverse Event|3
1091990|NCT02059187|3567460|P1|Overall Study|Adverse Event|0
1091991|NCT02059174|3567486|P2|Period 3|Physician Decision|0
1091992|NCT02059174|3567487|P1|Period 3|Physician Decision|1
1091993|NCT02059174|3567486|P2|Period 2|Protocol Violation|0
1091994|NCT02059174|3567487|P1|Period 2|Protocol Violation|1
1091995|NCT02059174|3567486|P2|Period 2|Withdrawal by Subject|2
1091996|NCT02059174|3567487|P1|Period 2|Withdrawal by Subject|0
1091997|NCT02059174|3567486|P2|Period 1|Withdrawal by Subject|2
1091998|NCT02059174|3567487|P1|Period 1|Withdrawal by Subject|0
1091999|NCT02059161|3567511|P2|Overall Study|Non-compliance with study drug|2
1092000|NCT02059161|3567512|P1|Overall Study|Non-compliance with study drug|6
1092001|NCT02059161|3567511|P2|Overall Study|Randomized in error, no study drug|1
1092002|NCT02059161|3567512|P1|Overall Study|Randomized in error, no study drug|0
1092003|NCT02059161|3567511|P2|Overall Study|Withdrawal by Subject|13
1092004|NCT02059161|3567512|P1|Overall Study|Withdrawal by Subject|16
1092005|NCT02059161|3567511|P2|Overall Study|Protocol Violation|1
1092006|NCT02059161|3567512|P1|Overall Study|Protocol Violation|1
1092007|NCT02059161|3567511|P2|Overall Study|Physician Decision|4
1092008|NCT02059161|3567512|P1|Overall Study|Physician Decision|4
1092009|NCT02059161|3567511|P2|Overall Study|Lost to Follow-up|12
1092010|NCT02059161|3567512|P1|Overall Study|Lost to Follow-up|20
1092011|NCT02059161|3567511|P2|Overall Study|Adverse Event|6
1092012|NCT02059161|3567512|P1|Overall Study|Adverse Event|2
1092013|NCT02059161|3567511|P2|Overall Study|Pregnancy|2
1092014|NCT02059161|3567512|P1|Overall Study|Pregnancy|0
1092015|NCT02059148|3567572|P6|Treatment 1|Protocol Violation|1
1092016|NCT02059148|3567573|P5|Treatment 1|Protocol Violation|0
1092017|NCT02059148|3567574|P4|Treatment 1|Protocol Violation|0
1092018|NCT02059148|3567575|P3|Treatment 1|Protocol Violation|0
1092019|NCT02059148|3567576|P2|Treatment 1|Protocol Violation|0
1092020|NCT02059148|3567577|P1|Treatment 1|Protocol Violation|0
1092021|NCT02059135|3567596|P2|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1
1092022|NCT02059135|3567597|P1|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0
1092023|NCT02059135|3567596|P2|Neonatal Follow-up (Safety Population)|delivered at another hospital|1
1092024|NCT02059135|3567597|P1|Neonatal Follow-up (Safety Population)|delivered at another hospital|0
1092025|NCT02059135|3567596|P2|Neonatal Follow-up (Safety Population)|Death|2
1092026|NCT02059135|3567597|P1|Neonatal Follow-up (Safety Population)|Death|3
1092027|NCT02059135|3567596|P2|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0
1092028|NCT02059135|3567597|P1|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1
1092029|NCT02059135|3567596|P2|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1
1092030|NCT02059135|3567597|P1|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0
1092031|NCT02059135|3567596|P2|Maternal Follow-up (ITT Population)|declined to see site staff|1
1092032|NCT02059135|3567597|P1|Maternal Follow-up (ITT Population)|declined to see site staff|0
1092033|NCT02059135|3567596|P2|Maternal Follow-up (ITT Population)|Lost to Follow-up|3
1092034|NCT02059135|3567597|P1|Maternal Follow-up (ITT Population)|Lost to Follow-up|0
1092035|NCT02059135|3567596|P2|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2
1092036|NCT02059135|3567597|P1|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3
1092037|NCT02059005|3567633|P2|Overall Study|Inpatient|1
1092038|NCT02059005|3567634|P1|Overall Study|Inpatient|0
1092039|NCT02059005|3567633|P2|Overall Study|Incarceration|1
1092040|NCT02059005|3567634|P1|Overall Study|Incarceration|0
1092041|NCT02059005|3567633|P2|Overall Study|Lost to Follow-up|19
1092042|NCT02059005|3567634|P1|Overall Study|Lost to Follow-up|19
1092043|NCT02059005|3567633|P2|Overall Study|Death|3
1092044|NCT02059005|3567634|P1|Overall Study|Death|1
1092045|NCT02058992|3567644|P1|Overall Study|CRF Uncollected|20
1092046|NCT02058992|3567644|P1|Overall Study|Protocol Violation|92
1092047|NCT02058992|3567644|P1|Overall Study|Lost to Follow-up|4
1092048|NCT02058940|3567653|P1|Overall Study|Discharged from Critical Care Unit|1
1092049|NCT02058836|3567677|P2|Overall Study|Withdrawal by Subject|1
1092050|NCT02058836|3567678|P1|Overall Study|Withdrawal by Subject|1
1092051|NCT02058628|3567708|P2|Overall Study|Non compliance|0
1092052|NCT02058628|3567709|P1|Overall Study|Non compliance|1
1092053|NCT02058628|3567708|P2|Overall Study|A lot of time for study for participant|0
1092054|NCT02058628|3567709|P1|Overall Study|A lot of time for study for participant|1
1092055|NCT02058628|3567708|P2|Overall Study|The visit date was not in timeline|1
1092056|NCT02058628|3567709|P1|Overall Study|The visit date was not in timeline|0
1092057|NCT02058628|3567708|P2|Overall Study|Not in time schedule|1
1092058|NCT02058628|3567709|P1|Overall Study|Not in time schedule|0
1092059|NCT02058628|3567708|P2|Overall Study|Lost to Follow-up|4
1092060|NCT02058628|3567709|P1|Overall Study|Lost to Follow-up|2
1092061|NCT02058628|3567708|P2|Overall Study|Withdrawal by Subject|2
1092062|NCT02058628|3567709|P1|Overall Study|Withdrawal by Subject|2
1092063|NCT02058628|3567708|P2|Overall Study|Adverse Event|0
1092064|NCT02058628|3567709|P1|Overall Study|Adverse Event|1
1092065|NCT02058589|3567741|P2|Overall Study|Withdrawal by Subject|1
1092066|NCT02058589|3567742|P1|Overall Study|Withdrawal by Subject|0
1092067|NCT02058589|3567741|P2|Overall Study|Non-Serious Adverse Event|0
1092068|NCT02058589|3567742|P1|Overall Study|Non-Serious Adverse Event|1
1092069|NCT02058589|3567741|P2|Overall Study|Serious Adverse Event|1
1092070|NCT02058589|3567742|P1|Overall Study|Serious Adverse Event|1
1092071|NCT02058563|3567784|P2|Overall Study|Other (patient incarcerated)|1
1092072|NCT02058563|3567785|P1|Overall Study|Other (patient incarcerated)|0
1092073|NCT02058563|3567784|P2|Overall Study|Consent Withdrawal|1
1092074|NCT02058563|3567785|P1|Overall Study|Consent Withdrawal|1
1092075|NCT02058563|3567784|P2|Overall Study|Other (vaccinated later as new subject)|0
1092076|NCT02058563|3567785|P1|Overall Study|Other (vaccinated later as new subject)|1
1092077|NCT02058563|3567784|P2|Overall Study|Lost to Follow-up|22
1092078|NCT02058563|3567785|P1|Overall Study|Lost to Follow-up|26
1092079|NCT02058537|3567821|P1|Overall Study|Withdrawal by Subject|1
1092080|NCT02058498|3567827|P1|Overall Study|Withdrawal by Subject|4
1092081|NCT02058290|3567835|P2|Overall Study|Withdrawal by Subject|1
1092082|NCT02058290|3567836|P1|Overall Study|Withdrawal by Subject|0
1092083|NCT02058290|3567835|P2|Overall Study|Didn't meet intraoperative criteria|7
1092084|NCT02058290|3567836|P1|Overall Study|Didn't meet intraoperative criteria|8
1092085|NCT02058290|3567835|P2|Overall Study|Physician Decision|0
1092086|NCT02058290|3567836|P1|Overall Study|Physician Decision|1
1092087|NCT02058290|3567835|P2|Overall Study|Protocol Violation|1
1092088|NCT02058290|3567836|P1|Overall Study|Protocol Violation|2
1092089|NCT02058160|3567852|P2|Overall Study|Other than specified above|6
1092090|NCT02058160|3567853|P1|Overall Study|Other than specified above|12
1092091|NCT02058160|3567852|P2|Overall Study|Lost to Follow-up|0
1092092|NCT02058160|3567853|P1|Overall Study|Lost to Follow-up|1
1092093|NCT02058160|3567852|P2|Overall Study|Adverse Event|3
1092094|NCT02058160|3567853|P1|Overall Study|Adverse Event|12
1092095|NCT02058160|3567852|P2|Overall Study|Poor compliance to protocol|1
1092096|NCT02058160|3567853|P1|Overall Study|Poor compliance to protocol|4
1092097|NCT02058160|3567852|P2|Overall Study|Randomized but not treated|4
1092098|NCT02058160|3567853|P1|Overall Study|Randomized but not treated|2
1092099|NCT02058147|3567890|P3|Overall Study|Other than specified|0
1092100|NCT02058147|3567891|P2|Overall Study|Other than specified|9
1092101|NCT02058147|3567892|P1|Overall Study|Other than specified|8
1092102|NCT02058147|3567890|P3|Overall Study|Poor compliance to protocol|4
1092103|NCT02058147|3567891|P2|Overall Study|Poor compliance to protocol|9
1092104|NCT02058147|3567892|P1|Overall Study|Poor compliance to protocol|8
1092105|NCT02058147|3567890|P3|Overall Study|Lack of Efficacy|3
1092106|NCT02058147|3567891|P2|Overall Study|Lack of Efficacy|0
1092107|NCT02058147|3567892|P1|Overall Study|Lack of Efficacy|1
1092108|NCT02058147|3567890|P3|Overall Study|Adverse Event|21
1092109|NCT02058147|3567891|P2|Overall Study|Adverse Event|9
1092110|NCT02058147|3567892|P1|Overall Study|Adverse Event|12
1092111|NCT02058147|3567890|P3|Overall Study|Randomized but not treated|1
1092112|NCT02058147|3567891|P2|Overall Study|Randomized but not treated|0
1092113|NCT02058147|3567892|P1|Overall Study|Randomized but not treated|0
1092114|NCT02058069|3567941|P1|Overall Study|Withdrawal by Subject|6
1092115|NCT02058069|3567941|P1|Overall Study|Exclusion due to implant size|5
1092116|NCT02057874|3567990|P1|Overall Study|participant did not return for scan|1
1092117|NCT02057835|3568008|P10|Overall Study|Withdrawal by Subject|0
1092118|NCT02057835|3568009|P9|Overall Study|Withdrawal by Subject|0
1092119|NCT02057835|3568010|P8|Overall Study|Withdrawal by Subject|0
1092120|NCT02057835|3568011|P7|Overall Study|Withdrawal by Subject|0
1092121|NCT02057835|3568012|P6|Overall Study|Withdrawal by Subject|0
1092122|NCT02057835|3568013|P5|Overall Study|Withdrawal by Subject|0
1092123|NCT02057835|3568014|P4|Overall Study|Withdrawal by Subject|0
1092124|NCT02057835|3568015|P3|Overall Study|Withdrawal by Subject|0
1092125|NCT02057835|3568016|P2|Overall Study|Withdrawal by Subject|2
1092126|NCT02057835|3568017|P1|Overall Study|Withdrawal by Subject|0
1092127|NCT02057757|3568096|P2|Overall Study|Non-compliance|0
1092128|NCT02057757|3568097|P1|Overall Study|Non-compliance|1
1092129|NCT02057757|3568096|P2|Overall Study|Lost to Follow-up|3
1092130|NCT02057757|3568097|P1|Overall Study|Lost to Follow-up|8
1092131|NCT02057757|3568096|P2|Overall Study|Death|0
1092132|NCT02057757|3568097|P1|Overall Study|Death|2
1092133|NCT02057757|3568096|P2|Overall Study|Withdrawal by Subject|5
1092134|NCT02057757|3568097|P1|Overall Study|Withdrawal by Subject|3
1092135|NCT02057692|3568151|P4|Overall Study|Lost to Follow-up|1
1092136|NCT02057692|3568152|P3|Overall Study|Lost to Follow-up|0
1092137|NCT02057692|3568153|P2|Overall Study|Lost to Follow-up|0
1092138|NCT02057692|3568154|P1|Overall Study|Lost to Follow-up|0
1092139|NCT02057692|3568151|P4|Overall Study|Adverse Event|0
1092140|NCT02057692|3568152|P3|Overall Study|Adverse Event|0
1092141|NCT02057692|3568153|P2|Overall Study|Adverse Event|0
1092142|NCT02057692|3568154|P1|Overall Study|Adverse Event|1
1092143|NCT02057549|3568184|P2|Overall Study|Withdrawal by Subject|0
1092144|NCT02057549|3568185|P1|Overall Study|Withdrawal by Subject|1
1092145|NCT02057549|3568184|P2|Overall Study|Physician Decision|0
1092146|NCT02057549|3568185|P1|Overall Study|Physician Decision|1
1092147|NCT02057549|3568184|P2|Overall Study|Lost to Follow-up|0
1092148|NCT02057549|3568185|P1|Overall Study|Lost to Follow-up|1
1092149|NCT02057406|3568208|P3|Overall Study|Patient transportation issues|1
1092150|NCT02057406|3568209|P2|Overall Study|Patient transportation issues|0
1092151|NCT02057406|3568210|P1|Overall Study|Patient transportation issues|0
1092152|NCT02057406|3568208|P3|Overall Study|Protocol Violation|0
1092153|NCT02057406|3568209|P2|Overall Study|Protocol Violation|1
1092154|NCT02057406|3568210|P1|Overall Study|Protocol Violation|0
1092155|NCT02057406|3568208|P3|Overall Study|Death|0
1092156|NCT02057406|3568209|P2|Overall Study|Death|0
1092157|NCT02057406|3568210|P1|Overall Study|Death|1
1092158|NCT02057406|3568208|P3|Overall Study|Lost to Follow-up|1
1092159|NCT02057406|3568209|P2|Overall Study|Lost to Follow-up|0
1092160|NCT02057406|3568210|P1|Overall Study|Lost to Follow-up|0
1092161|NCT02057406|3568208|P3|Overall Study|Withdrawal by Subject|0
1092162|NCT02057406|3568209|P2|Overall Study|Withdrawal by Subject|2
1092163|NCT02057406|3568210|P1|Overall Study|Withdrawal by Subject|0
1092164|NCT02057406|3568208|P3|Overall Study|Physician Decision|2
1092165|NCT02057406|3568209|P2|Overall Study|Physician Decision|0
1092166|NCT02057406|3568210|P1|Overall Study|Physician Decision|0
1092167|NCT02057393|3568221|P1|Overall Study|Patient did not meet criteria|1
1092168|NCT02057393|3568221|P1|Overall Study|Withdrawal by Subject|1
1092169|NCT02057250|3568242|P5|Extension Phase|Other than specified above|7
1092170|NCT02057250|3568243|P4|Extension Phase|Other than specified above|0
1092171|NCT02057250|3568244|P3|Extension Phase|Other than specified above|0
1092172|NCT02057250|3568245|P2|Extension Phase|Other than specified above|0
1092173|NCT02057250|3568246|P1|Extension Phase|Other than specified above|0
1092174|NCT02057250|3568242|P5|Extension Phase|Entered in this period but not treated|4
1092175|NCT02057250|3568243|P4|Extension Phase|Entered in this period but not treated|0
1092176|NCT02057250|3568244|P3|Extension Phase|Entered in this period but not treated|0
1092177|NCT02057250|3568245|P2|Extension Phase|Entered in this period but not treated|0
1092178|NCT02057250|3568246|P1|Extension Phase|Entered in this period but not treated|0
1092179|NCT02057250|3568242|P5|Extension Phase|Lack of Efficacy|10
1092180|NCT02057250|3568243|P4|Extension Phase|Lack of Efficacy|0
1092181|NCT02057250|3568244|P3|Extension Phase|Lack of Efficacy|0
1092182|NCT02057250|3568245|P2|Extension Phase|Lack of Efficacy|0
1092183|NCT02057250|3568246|P1|Extension Phase|Lack of Efficacy|0
1092184|NCT02057250|3568242|P5|Extension Phase|Adverse Event|15
1092185|NCT02057250|3568243|P4|Extension Phase|Adverse Event|0
1092186|NCT02057250|3568244|P3|Extension Phase|Adverse Event|0
1092187|NCT02057250|3568245|P2|Extension Phase|Adverse Event|0
1092188|NCT02057250|3568246|P1|Extension Phase|Adverse Event|0
1092189|NCT02057250|3568242|P5|AID Assessment Phase|Other than specified above|0
1092190|NCT02057250|3568243|P4|AID Assessment Phase|Other than specified above|1
1092191|NCT02057250|3568244|P3|AID Assessment Phase|Other than specified above|1
1092192|NCT02057250|3568245|P2|AID Assessment Phase|Other than specified above|1
1092193|NCT02057250|3568246|P1|AID Assessment Phase|Other than specified above|1
1092194|NCT02057250|3568242|P5|AID Assessment Phase|Adverse Event|0
1092195|NCT02057250|3568243|P4|AID Assessment Phase|Adverse Event|1
1092196|NCT02057250|3568244|P3|AID Assessment Phase|Adverse Event|6
1092197|NCT02057250|3568245|P2|AID Assessment Phase|Adverse Event|2
1092198|NCT02057250|3568246|P1|AID Assessment Phase|Adverse Event|3
1092199|NCT02057068|3568266|P2|Overall Study|Lost to Follow-up|2
1092200|NCT02057068|3568267|P1|Overall Study|Lost to Follow-up|2
1092201|NCT02057068|3568266|P2|Overall Study|Carepartner (CP) Health|2
1092202|NCT02057068|3568267|P1|Overall Study|Carepartner (CP) Health|4
1092203|NCT02057068|3568266|P2|Overall Study|Caregiver (CG) Health|2
1092204|NCT02057068|3568267|P1|Overall Study|Caregiver (CG) Health|0
1092205|NCT02057068|3568266|P2|Overall Study|Withdrawal by Subject|2
1092206|NCT02057068|3568267|P1|Overall Study|Withdrawal by Subject|2
1092207|NCT02056834|3568277|P1|Overall Study|Lost to Follow-up|7
1092208|NCT02056652|3568298|P2|Overall Study|Lost to Follow-up|3
1092209|NCT02056652|3568299|P1|Overall Study|Lost to Follow-up|0
1092210|NCT02056652|3568298|P2|Overall Study|Withdrawal by Subject|0
1092211|NCT02056652|3568299|P1|Overall Study|Withdrawal by Subject|1
1092212|NCT02056392|3568349|P6|Overall Study|Withdrawal by Subject|0
1092213|NCT02056392|3568350|P5|Overall Study|Withdrawal by Subject|1
1092214|NCT02056392|3568351|P4|Overall Study|Withdrawal by Subject|0
1092215|NCT02056392|3568352|P3|Overall Study|Withdrawal by Subject|0
1092216|NCT02056392|3568353|P2|Overall Study|Withdrawal by Subject|0
1092217|NCT02056392|3568354|P1|Overall Study|Withdrawal by Subject|1
1092218|NCT02056392|3568349|P6|Overall Study|Protocol Violation|0
1092219|NCT02056392|3568350|P5|Overall Study|Protocol Violation|0
1092220|NCT02056392|3568351|P4|Overall Study|Protocol Violation|0
1092221|NCT02056392|3568352|P3|Overall Study|Protocol Violation|1
1092222|NCT02056392|3568353|P2|Overall Study|Protocol Violation|0
1092223|NCT02056392|3568354|P1|Overall Study|Protocol Violation|1
1092224|NCT02056392|3568349|P6|Overall Study|Lost to Follow-up|0
1092225|NCT02056392|3568350|P5|Overall Study|Lost to Follow-up|0
1092226|NCT02056392|3568351|P4|Overall Study|Lost to Follow-up|0
1092227|NCT02056392|3568352|P3|Overall Study|Lost to Follow-up|2
1092228|NCT02056392|3568353|P2|Overall Study|Lost to Follow-up|1
1092229|NCT02056392|3568354|P1|Overall Study|Lost to Follow-up|0
1092230|NCT02055820|3568412|P10|Phase II: Expansion|Death|0
1092231|NCT02055820|3568413|P9|Phase II: Expansion|Death|0
1092232|NCT02055820|3568414|P8|Phase II: Expansion|Death|0
1092233|NCT02055820|3568415|P7|Phase II: Expansion|Death|0
1092234|NCT02055820|3568416|P6|Phase II: Expansion|Death|0
1092235|NCT02055820|3568417|P5|Phase II: Expansion|Death|15
1092236|NCT02055820|3568418|P4|Phase II: Expansion|Death|0
1092237|NCT02055820|3568419|P3|Phase II: Expansion|Death|0
1092238|NCT02055820|3568420|P2|Phase II: Expansion|Death|0
1092239|NCT02055820|3568421|P1|Phase II: Expansion|Death|0
1092240|NCT02055820|3568412|P10|Phase II: Expansion|Withdrawal by Subject|0
1092241|NCT02055820|3568413|P9|Phase II: Expansion|Withdrawal by Subject|0
1092242|NCT02055820|3568414|P8|Phase II: Expansion|Withdrawal by Subject|0
1092243|NCT02055820|3568415|P7|Phase II: Expansion|Withdrawal by Subject|0
1092244|NCT02055820|3568416|P6|Phase II: Expansion|Withdrawal by Subject|0
1092245|NCT02055820|3568417|P5|Phase II: Expansion|Withdrawal by Subject|10
1092246|NCT02055820|3568418|P4|Phase II: Expansion|Withdrawal by Subject|0
1092247|NCT02055820|3568419|P3|Phase II: Expansion|Withdrawal by Subject|0
1092248|NCT02055820|3568420|P2|Phase II: Expansion|Withdrawal by Subject|0
1092249|NCT02055820|3568421|P1|Phase II: Expansion|Withdrawal by Subject|0
1092250|NCT02055820|3568412|P10|Phase II: Expansion|Lost to Follow-up|0
1092251|NCT02055820|3568413|P9|Phase II: Expansion|Lost to Follow-up|0
1092252|NCT02055820|3568414|P8|Phase II: Expansion|Lost to Follow-up|0
1092253|NCT02055820|3568415|P7|Phase II: Expansion|Lost to Follow-up|0
1092254|NCT02055820|3568416|P6|Phase II: Expansion|Lost to Follow-up|0
1092255|NCT02055820|3568417|P5|Phase II: Expansion|Lost to Follow-up|3
1092256|NCT02055820|3568418|P4|Phase II: Expansion|Lost to Follow-up|0
1092257|NCT02055820|3568419|P3|Phase II: Expansion|Lost to Follow-up|0
1092258|NCT02055820|3568420|P2|Phase II: Expansion|Lost to Follow-up|0
1092259|NCT02055820|3568421|P1|Phase II: Expansion|Lost to Follow-up|0
1092260|NCT02055820|3568412|P10|Phase II: Expansion|Participants still in study|0
1092261|NCT02055820|3568413|P9|Phase II: Expansion|Participants still in study|0
1092262|NCT02055820|3568414|P8|Phase II: Expansion|Participants still in study|0
1092263|NCT02055820|3568415|P7|Phase II: Expansion|Participants still in study|0
1092264|NCT02055820|3568416|P6|Phase II: Expansion|Participants still in study|0
1092265|NCT02055820|3568417|P5|Phase II: Expansion|Participants still in study|177
1092266|NCT02055820|3568418|P4|Phase II: Expansion|Participants still in study|0
1092267|NCT02055820|3568419|P3|Phase II: Expansion|Participants still in study|0
1092268|NCT02055820|3568420|P2|Phase II: Expansion|Participants still in study|0
1092269|NCT02055820|3568421|P1|Phase II: Expansion|Participants still in study|0
1092270|NCT02055820|3568412|P10|Phase II: Expansion|Unspecified Reason|0
1092271|NCT02055820|3568413|P9|Phase II: Expansion|Unspecified Reason|0
1092272|NCT02055820|3568414|P8|Phase II: Expansion|Unspecified Reason|0
1092273|NCT02055820|3568415|P7|Phase II: Expansion|Unspecified Reason|0
1092274|NCT02055820|3568416|P6|Phase II: Expansion|Unspecified Reason|0
1092275|NCT02055820|3568417|P5|Phase II: Expansion|Unspecified Reason|3
1092276|NCT02055820|3568418|P4|Phase II: Expansion|Unspecified Reason|0
1092277|NCT02055820|3568419|P3|Phase II: Expansion|Unspecified Reason|0
1092278|NCT02055820|3568420|P2|Phase II: Expansion|Unspecified Reason|0
1092279|NCT02055820|3568421|P1|Phase II: Expansion|Unspecified Reason|0
1092280|NCT02055820|3568412|P10|Phase I: Dose-Finding|Participants still in study|6
1092281|NCT02055820|3568413|P9|Phase I: Dose-Finding|Participants still in study|6
1092282|NCT02055820|3568414|P8|Phase I: Dose-Finding|Participants still in study|6
1092283|NCT02055820|3568415|P7|Phase I: Dose-Finding|Participants still in study|7
1092284|NCT02055820|3568416|P6|Phase I: Dose-Finding|Participants still in study|6
1092285|NCT02055820|3568417|P5|Phase I: Dose-Finding|Participants still in study|0
1092286|NCT02055820|3568418|P4|Phase I: Dose-Finding|Participants still in study|4
1092287|NCT02055820|3568419|P3|Phase I: Dose-Finding|Participants still in study|7
1092288|NCT02055820|3568420|P2|Phase I: Dose-Finding|Participants still in study|3
1092289|NCT02055820|3568421|P1|Phase I: Dose-Finding|Participants still in study|6
1092290|NCT02055820|3568412|P10|Phase I: Dose-Finding|Death|0
1092291|NCT02055820|3568413|P9|Phase I: Dose-Finding|Death|0
1092292|NCT02055820|3568414|P8|Phase I: Dose-Finding|Death|0
1092293|NCT02055820|3568415|P7|Phase I: Dose-Finding|Death|0
1092294|NCT02055820|3568416|P6|Phase I: Dose-Finding|Death|0
1092295|NCT02055820|3568417|P5|Phase I: Dose-Finding|Death|0
1092296|NCT02055820|3568418|P4|Phase I: Dose-Finding|Death|2
1092297|NCT02055820|3568419|P3|Phase I: Dose-Finding|Death|1
1092298|NCT02055820|3568420|P2|Phase I: Dose-Finding|Death|0
1092299|NCT02055820|3568421|P1|Phase I: Dose-Finding|Death|1
1092300|NCT02055820|3568412|P10|Phase I: Dose-Finding|Withdrawal by Subject|0
1092301|NCT02055820|3568413|P9|Phase I: Dose-Finding|Withdrawal by Subject|0
1092302|NCT02055820|3568414|P8|Phase I: Dose-Finding|Withdrawal by Subject|0
1092303|NCT02055820|3568415|P7|Phase I: Dose-Finding|Withdrawal by Subject|0
1092304|NCT02055820|3568416|P6|Phase I: Dose-Finding|Withdrawal by Subject|1
1092305|NCT02055820|3568417|P5|Phase I: Dose-Finding|Withdrawal by Subject|0
1092306|NCT02055820|3568418|P4|Phase I: Dose-Finding|Withdrawal by Subject|0
1092307|NCT02055820|3568419|P3|Phase I: Dose-Finding|Withdrawal by Subject|0
1092308|NCT02055820|3568420|P2|Phase I: Dose-Finding|Withdrawal by Subject|0
1092309|NCT02055820|3568421|P1|Phase I: Dose-Finding|Withdrawal by Subject|0
1092310|NCT02055365|3568545|P1|Overall Study|Prematurely Withdrawn|1
1092311|NCT02055352|3568558|P2|Overall Study|Reason unknown|5
1092312|NCT02055352|3568559|P1|Overall Study|Reason unknown|1
1092313|NCT02055352|3568558|P2|Overall Study|Withdrawal of informed consent|0
1092314|NCT02055352|3568559|P1|Overall Study|Withdrawal of informed consent|1
1092315|NCT02055352|3568558|P2|Overall Study|AE, study drug would be detrimental|3
1092316|NCT02055352|3568559|P1|Overall Study|AE, study drug would be detrimental|1
1092317|NCT02055352|3568558|P2|Overall Study|Use of prohibited treatment|3
1092318|NCT02055352|3568559|P1|Overall Study|Use of prohibited treatment|0
1092319|NCT02055352|3568558|P2|Overall Study|Patient decision|1
1092320|NCT02055352|3568559|P1|Overall Study|Patient decision|1
1092321|NCT02055352|3568558|P2|Overall Study|Death|2
1092322|NCT02055352|3568559|P1|Overall Study|Death|1
1092323|NCT02055352|3568558|P2|Overall Study|Poor compliance|1
1092324|NCT02055352|3568559|P1|Overall Study|Poor compliance|1
1092325|NCT02055352|3568558|P2|Overall Study|Non-eligible|1
1092326|NCT02055352|3568559|P1|Overall Study|Non-eligible|0
1092327|NCT02055352|3568558|P2|Overall Study|Adverse Event|1
1092328|NCT02055352|3568559|P1|Overall Study|Adverse Event|0
1092329|NCT02055118|3568576|P3|Overall Study|Withdrawal by Subject|0
1092330|NCT02055118|3568577|P2|Overall Study|Withdrawal by Subject|2
1092331|NCT02055118|3568578|P1|Overall Study|Withdrawal by Subject|0
1092332|NCT02054910|3568637|P2|Overall Study|Lost to Follow-up|1
1092333|NCT02054910|3568638|P1|Overall Study|Lost to Follow-up|4
1092334|NCT02054897|3568657|P3|Overall Study|Randomized but not exposed|0
1092335|NCT02054897|3568658|P2|Overall Study|Randomized but not exposed|0
1092336|NCT02054897|3568659|P1|Overall Study|Randomized but not exposed|1
1092337|NCT02054897|3568657|P3|Overall Study|Lost to Follow-up|7
1092338|NCT02054897|3568658|P2|Overall Study|Lost to Follow-up|2
1092339|NCT02054897|3568659|P1|Overall Study|Lost to Follow-up|4
1092340|NCT02054897|3568657|P3|Overall Study|Missing follow-up information|3
1092341|NCT02054897|3568658|P2|Overall Study|Missing follow-up information|5
1092342|NCT02054897|3568659|P1|Overall Study|Missing follow-up information|3
1092343|NCT02054897|3568657|P3|Overall Study|Withdrawal by Subject|2
1092344|NCT02054897|3568658|P2|Overall Study|Withdrawal by Subject|0
1092345|NCT02054897|3568659|P1|Overall Study|Withdrawal by Subject|2
1092346|NCT02054715|3568706|P2|Follow-up 2|Treatment Change or Delay|0
1092347|NCT02054715|3568707|P1|Follow-up 2|Treatment Change or Delay|1
1092348|NCT02054715|3568706|P2|Follow-up 2|No Reason|0
1092349|NCT02054715|3568707|P1|Follow-up 2|No Reason|2
1092350|NCT02054715|3568706|P2|Follow-up 2|Changed Mind|1
1092351|NCT02054715|3568707|P1|Follow-up 2|Changed Mind|0
1092352|NCT02054715|3568706|P2|Follow-up 2|Changed MD/Facility|1
1092353|NCT02054715|3568707|P1|Follow-up 2|Changed MD/Facility|0
1092354|NCT02054715|3568706|P2|Follow-up 2|Hospitalization|2
1092355|NCT02054715|3568707|P1|Follow-up 2|Hospitalization|0
1092356|NCT02054715|3568706|P2|Follow-up 2|Death|3
1092357|NCT02054715|3568707|P1|Follow-up 2|Death|3
1092358|NCT02054715|3568706|P2|Follow-up 2|Ineligible|5
1092359|NCT02054715|3568707|P1|Follow-up 2|Ineligible|4
1092360|NCT02054715|3568706|P2|Follow-up 2|Followup Not Completed|4
1092361|NCT02054715|3568707|P1|Follow-up 2|Followup Not Completed|3
1092362|NCT02054715|3568706|P2|Follow-up 2|Refused|2
1092363|NCT02054715|3568707|P1|Follow-up 2|Refused|3
1092364|NCT02054715|3568706|P2|Follow-up 2|Lost to Followup|1
1092365|NCT02054715|3568707|P1|Follow-up 2|Lost to Followup|3
1092366|NCT02054715|3568706|P2|Baseline/Follow-up 1|Changed Mind|0
1092367|NCT02054715|3568707|P1|Baseline/Follow-up 1|Changed Mind|1
1092368|NCT02054715|3568706|P2|Baseline/Follow-up 1|Hospitalization|0
1092369|NCT02054715|3568707|P1|Baseline/Follow-up 1|Hospitalization|1
1092370|NCT02054715|3568706|P2|Baseline/Follow-up 1|Ineligible|0
1092371|NCT02054715|3568707|P1|Baseline/Follow-up 1|Ineligible|3
1092372|NCT02054715|3568706|P2|Baseline/Follow-up 1|Overwhelmed|0
1092373|NCT02054715|3568707|P1|Baseline/Follow-up 1|Overwhelmed|2
1092374|NCT02054715|3568706|P2|Baseline/Follow-up 1|No Reason|1
1092375|NCT02054715|3568707|P1|Baseline/Follow-up 1|No Reason|0
1092376|NCT02054715|3568706|P2|Baseline/Follow-up 1|Disliked Procedure|1
1092377|NCT02054715|3568707|P1|Baseline/Follow-up 1|Disliked Procedure|0
1092378|NCT02054715|3568706|P2|Baseline/Follow-up 1|Changed MD/Facility|1
1092379|NCT02054715|3568707|P1|Baseline/Follow-up 1|Changed MD/Facility|0
1092380|NCT02054715|3568706|P2|Baseline/Follow-up 1|Medical|1
1092381|NCT02054715|3568707|P1|Baseline/Follow-up 1|Medical|0
1092382|NCT02054715|3568706|P2|Baseline/Follow-up 1|Refused|3
1092383|NCT02054715|3568707|P1|Baseline/Follow-up 1|Refused|1
1092384|NCT02054702|3568721|P2|Overall Study|Withdrawal by Subject|4
1092385|NCT02054702|3568722|P1|Overall Study|Withdrawal by Subject|14
1092386|NCT02054702|3568721|P2|Overall Study|Physician Decision|1
1092387|NCT02054702|3568722|P1|Overall Study|Physician Decision|0
1092388|NCT02054702|3568721|P2|Overall Study|Met Withdrawal Criteria|1
1092389|NCT02054702|3568722|P1|Overall Study|Met Withdrawal Criteria|4
1092390|NCT02054702|3568721|P2|Overall Study|Adverse Event|1
1092391|NCT02054702|3568722|P1|Overall Study|Adverse Event|3
1092392|NCT02054702|3568721|P2|Overall Study|Lost to Follow-up|5
1092393|NCT02054702|3568722|P1|Overall Study|Lost to Follow-up|3
1092394|NCT02054481|3568777|P4|Overall Study|Other reason|0
1092395|NCT02054481|3568778|P3|Overall Study|Other reason|2
1092396|NCT02054481|3568779|P2|Overall Study|Other reason|1
1092397|NCT02054481|3568780|P1|Overall Study|Other reason|2
1092398|NCT02054481|3568777|P4|Overall Study|Lost to Follow-up|0
1092399|NCT02054481|3568778|P3|Overall Study|Lost to Follow-up|0
1092400|NCT02054481|3568779|P2|Overall Study|Lost to Follow-up|0
1092401|NCT02054481|3568780|P1|Overall Study|Lost to Follow-up|1
1092402|NCT02054481|3568777|P4|Overall Study|Adverse Event|1
1092403|NCT02054481|3568778|P3|Overall Study|Adverse Event|0
1092404|NCT02054481|3568779|P2|Overall Study|Adverse Event|1
1092405|NCT02054481|3568780|P1|Overall Study|Adverse Event|1
1092406|NCT02054325|3568828|P2|Overall Study|Lost to Follow-up|5
1092407|NCT02054325|3568829|P1|Overall Study|Lost to Follow-up|8
1092408|NCT02054130|3568841|P4|Overall Study|Missed dose|10
1092409|NCT02054130|3568842|P3|Overall Study|Missed dose|7
1092410|NCT02054130|3568843|P2|Overall Study|Missed dose|6
1092411|NCT02054130|3568844|P1|Overall Study|Missed dose|4
1092412|NCT02054130|3568841|P4|Overall Study|Lost to Follow-up|2
1092413|NCT02054130|3568842|P3|Overall Study|Lost to Follow-up|1
1092414|NCT02054130|3568843|P2|Overall Study|Lost to Follow-up|0
1092415|NCT02054130|3568844|P1|Overall Study|Lost to Follow-up|0
1092416|NCT02054130|3568841|P4|Overall Study|Death|0
1092417|NCT02054130|3568842|P3|Overall Study|Death|0
1092418|NCT02054130|3568843|P2|Overall Study|Death|1
1092419|NCT02054130|3568844|P1|Overall Study|Death|0
1092420|NCT02054130|3568841|P4|Overall Study|Withdrawal by Subject|10
1092421|NCT02054130|3568842|P3|Overall Study|Withdrawal by Subject|7
1092422|NCT02054130|3568843|P2|Overall Study|Withdrawal by Subject|4
1092423|NCT02054130|3568844|P1|Overall Study|Withdrawal by Subject|4
1092424|NCT02053753|3568938|P2|Overall Study|Lost to Follow-up|3
1092425|NCT02053753|3568939|P1|Overall Study|Lost to Follow-up|4
1092426|NCT02053753|3568938|P2|Overall Study|Decision by Sponsor|1
1092427|NCT02053753|3568939|P1|Overall Study|Decision by Sponsor|1
1092428|NCT02053753|3568938|P2|Overall Study|Withdrawal by Subject|4
1092429|NCT02053753|3568939|P1|Overall Study|Withdrawal by Subject|2
1092430|NCT02053610|3568963|P2|Overall Study|Violation of Selection Criteria|0
1092431|NCT02053610|3568964|P1|Overall Study|Violation of Selection Criteria|1
1092432|NCT02053610|3568963|P2|Overall Study|Insufficient Therapeutic Response|1
1092433|NCT02053610|3568964|P1|Overall Study|Insufficient Therapeutic Response|1
1092434|NCT02053610|3568963|P2|Overall Study|Did not Receive Treatment|2
1092435|NCT02053610|3568964|P1|Overall Study|Did not Receive Treatment|4
1092436|NCT02053610|3568963|P2|Overall Study|Refused treatment/Did not cooperate|3
1092437|NCT02053610|3568964|P1|Overall Study|Refused treatment/Did not cooperate|1
1092438|NCT02053610|3568963|P2|Overall Study|Disease Progression|3
1092439|NCT02053610|3568964|P1|Overall Study|Disease Progression|2
1092440|NCT02053610|3568963|P2|Overall Study|Administrative/Other|1
1092441|NCT02053610|3568964|P1|Overall Study|Administrative/Other|1
1092442|NCT02053610|3568963|P2|Overall Study|Death|5
1092443|NCT02053610|3568964|P1|Overall Study|Death|5
1092444|NCT02053610|3568963|P2|Overall Study|Withdrew Consent|9
1092445|NCT02053610|3568964|P1|Overall Study|Withdrew Consent|2
1092446|NCT02053610|3568963|P2|Overall Study|Adverse Event/Intercurrent Illness|43
1092447|NCT02053610|3568964|P1|Overall Study|Adverse Event/Intercurrent Illness|25
1092448|NCT02053493|3568996|P2|Overall Study|Withdrawal by Subject|1
1092449|NCT02053493|3568997|P1|Overall Study|Withdrawal by Subject|1
1092450|NCT02053168|3569035|P1|Overall Study|Lost to Follow-up|1
1092451|NCT02053168|3569035|P1|Overall Study|Physician Decision|1
1092452|NCT02053168|3569035|P1|Overall Study|Withdrawal by Subject|1
1092453|NCT02052596|3569114|P2|Safety Phase|Lost due to Crohn`s disease|1
1092454|NCT02052596|3569115|P1|Safety Phase|Lost due to Crohn`s disease|0
1092455|NCT02052596|3569114|P2|Safety Phase|Enrolled in error|0
1092456|NCT02052596|3569115|P1|Safety Phase|Enrolled in error|1
1092457|NCT02052596|3569114|P2|Safety Phase|Withdrawal by Subject|11
1092458|NCT02052596|3569115|P1|Safety Phase|Withdrawal by Subject|8
1092459|NCT02052596|3569114|P2|Safety Phase|Protocol Violation|2
1092460|NCT02052596|3569115|P1|Safety Phase|Protocol Violation|1
1092461|NCT02052596|3569114|P2|Safety Phase|Lost to Follow-up|18
1092462|NCT02052596|3569115|P1|Safety Phase|Lost to Follow-up|11
1092463|NCT02052596|3569114|P2|Safety Phase|Adverse Event|3
1092464|NCT02052596|3569115|P1|Safety Phase|Adverse Event|6
1092465|NCT02052596|3569114|P2|Active Phase|Lost due to Crohn`s disease|1
1092466|NCT02052596|3569115|P1|Active Phase|Lost due to Crohn`s disease|0
1092467|NCT02052596|3569114|P2|Active Phase|Enrolled in error|0
1092468|NCT02052596|3569115|P1|Active Phase|Enrolled in error|1
1092469|NCT02052596|3569114|P2|Active Phase|Withdrawal by Subject|4
1092470|NCT02052596|3569115|P1|Active Phase|Withdrawal by Subject|3
1092471|NCT02052596|3569114|P2|Active Phase|Protocol Violation|2
1092472|NCT02052596|3569115|P1|Active Phase|Protocol Violation|1
1092473|NCT02052596|3569114|P2|Active Phase|Lost to Follow-up|11
1092474|NCT02052596|3569115|P1|Active Phase|Lost to Follow-up|8
1092475|NCT02052596|3569114|P2|Active Phase|Adverse Event|2
1092476|NCT02052596|3569115|P1|Active Phase|Adverse Event|3
1092477|NCT02052466|3569145|P1|Overall Study|Acromial fracture|1
1092478|NCT02052466|3569145|P1|Overall Study|Withdrawal by Subject|1
1092479|NCT02052440|3569162|P2|Overall Study|Withdrawal by Subject|1
1092480|NCT02052440|3569163|P1|Overall Study|Withdrawal by Subject|0
1092481|NCT02052414|3569175|P1|Overall Study|Withdrawal by Subject|3
1092482|NCT02052414|3569175|P1|Overall Study|Lack of Efficacy|2
1092483|NCT02052414|3569175|P1|Overall Study|Adverse Event|12
1092484|NCT02052011|3569210|P2|Overall Study|Withdrawal by Subject|2
1092485|NCT02052011|3569211|P1|Overall Study|Withdrawal by Subject|1
1092486|NCT02052011|3569210|P2|Overall Study|Lost to Follow-up|0
1092487|NCT02052011|3569211|P1|Overall Study|Lost to Follow-up|3
1092488|NCT02051296|3569353|P2|Overall Study|withdraw prior to treatment|7
1092489|NCT02051296|3569354|P1|Overall Study|withdraw prior to treatment|7
1092490|NCT02051296|3569353|P2|Overall Study|Lost to Follow-up|2
1092491|NCT02051296|3569354|P1|Overall Study|Lost to Follow-up|1
1092492|NCT02050321|3569371|P1|Overall Study|Adverse Event|1
1092493|NCT02050321|3569371|P1|Overall Study|Withdrawal by Subject|1
1092494|NCT02050048|3569378|P2|Overall Study|Ineligible after ERCP|1
1092495|NCT02050048|3569379|P1|Overall Study|Ineligible after ERCP|4
1092496|NCT02050048|3569378|P2|Overall Study|Death|0
1092497|NCT02050048|3569379|P1|Overall Study|Death|1
1092498|NCT02050048|3569378|P2|Overall Study|Lost to Follow-up|1
1092499|NCT02050048|3569379|P1|Overall Study|Lost to Follow-up|0
1092500|NCT02049450|3569410|P1|Overall Study|Patients/guardian decision|1
1092501|NCT02049450|3569410|P1|Overall Study|Withdrawal by Subject|1
1092502|NCT02049450|3569410|P1|Overall Study|Adverse Event|2
1092503|NCT02048904|3569448|P1|Overall Study|Physician Decision|70
1092504|NCT02048904|3569448|P1|Overall Study|Withdrawal by Subject|7
1092505|NCT02048241|3569463|P2|Overall Study|Withdrawal by Subject|1
1092506|NCT02048241|3569464|P1|Overall Study|Withdrawal by Subject|0
1092507|NCT02048072|3569470|P1|Overall Study|Lost to Follow-up|1
1092508|NCT02048072|3569470|P1|Overall Study|Adverse Event|3
1092509|NCT02047253|3569483|P1|Overall Study|Lost to Follow-up|8
1092510|NCT02047227|3569493|P2|Overall Study|Other|9
1092511|NCT02047227|3569494|P1|Overall Study|Other|10
1092512|NCT02047227|3569493|P2|Overall Study|All embryos discarded|11
1092513|NCT02047227|3569494|P1|Overall Study|All embryos discarded|12
1092514|NCT02047227|3569493|P2|Overall Study|Intention to freeze all embryos|0
1092515|NCT02047227|3569494|P1|Overall Study|Intention to freeze all embryos|1
1092516|NCT02047227|3569493|P2|Overall Study|No fertilization|51
1092517|NCT02047227|3569494|P1|Overall Study|No fertilization|61
1092518|NCT02047227|3569493|P2|Overall Study|No oocytes retrieved|20
1092519|NCT02047227|3569494|P1|Overall Study|No oocytes retrieved|21
1092520|NCT02047227|3569493|P2|Overall Study|Lack of ovarian response to stimulation|32
1092521|NCT02047227|3569494|P1|Overall Study|Lack of ovarian response to stimulation|35
1092522|NCT02047227|3569493|P2|Overall Study|Spontaneous pregnancy|0
1092523|NCT02047227|3569494|P1|Overall Study|Spontaneous pregnancy|1
1092524|NCT02047227|3569493|P2|Overall Study|Protocol Violation|0
1092525|NCT02047227|3569494|P1|Overall Study|Protocol Violation|1
1092526|NCT02047227|3569493|P2|Overall Study|Lost to Follow-up|3
1092527|NCT02047227|3569494|P1|Overall Study|Lost to Follow-up|0
1092528|NCT02047227|3569493|P2|Overall Study|Adverse Event|4
1092529|NCT02047227|3569494|P1|Overall Study|Adverse Event|2
1092530|NCT02046993|3569512|P2|Overall Study|Lost to Follow-up|1
1092531|NCT02046993|3569513|P1|Overall Study|Lost to Follow-up|1
1092532|NCT02046993|3569512|P2|Overall Study|Withdrawal by Subject|10
1092533|NCT02046993|3569513|P1|Overall Study|Withdrawal by Subject|2
1092534|NCT02046616|3569563|P1|8-Week FU Period|Lost to Follow-up|1
1092535|NCT02046616|3569563|P1|24-Week Treatment Period|Not Specified|1
1092536|NCT02046616|3569563|P1|24-Week Treatment Period|Physician Decision|3
1092537|NCT02046616|3569563|P1|24-Week Treatment Period|Insufficient Therapeutic Response|1
1092538|NCT02046616|3569563|P1|24-Week Treatment Period|Any Other Adverse Event|13
1092539|NCT02046616|3569563|P1|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1
1092540|NCT02046603|3569585|P2|Overall Study|Adverse Event|1
1092541|NCT02046603|3569586|P1|Overall Study|Adverse Event|0
1092542|NCT02046603|3569585|P2|Overall Study|Death|1
1092543|NCT02046603|3569586|P1|Overall Study|Death|0
1092544|NCT02046603|3569585|P2|Overall Study|Lost to Follow-up|2
1092545|NCT02046603|3569586|P1|Overall Study|Lost to Follow-up|1
1092546|NCT02046603|3569585|P2|Overall Study|Physician Decision|1
1092547|NCT02046603|3569586|P1|Overall Study|Physician Decision|2
1092548|NCT02046603|3569585|P2|Overall Study|Participant/legal guardian decision|3
1092549|NCT02046603|3569586|P1|Overall Study|Participant/legal guardian decision|1
1092550|NCT02046603|3569585|P2|Overall Study|Protocol Violation|1
1092551|NCT02046603|3569586|P1|Overall Study|Protocol Violation|0
1092552|NCT02046603|3569585|P2|Overall Study|Other|66
1092553|NCT02046603|3569586|P1|Overall Study|Other|11
1092554|NCT02046564|3569665|P2|Overall Study|Subject met withdrawal criteria|5
1092555|NCT02046564|3569666|P1|Overall Study|Subject met withdrawal criteria|2
1092556|NCT02046564|3569665|P2|Overall Study|Withdrawal by Subject|10
1092557|NCT02046564|3569666|P1|Overall Study|Withdrawal by Subject|4
1092558|NCT02046564|3569665|P2|Overall Study|Protocol Violation|1
1092559|NCT02046564|3569666|P1|Overall Study|Protocol Violation|3
1092560|NCT02046564|3569665|P2|Overall Study|Physician Decision|1
1092561|NCT02046564|3569666|P1|Overall Study|Physician Decision|0
1092562|NCT02046564|3569665|P2|Overall Study|Adverse Event|3
1092563|NCT02046564|3569666|P1|Overall Study|Adverse Event|6
1092564|NCT02046369|3569705|P2|Overall Study|non compliance|0
1092565|NCT02046369|3569706|P1|Overall Study|non compliance|1
1092566|NCT02046369|3569705|P2|Overall Study|never received study drug|1
1092567|NCT02046369|3569706|P1|Overall Study|never received study drug|0
1092568|NCT02046369|3569705|P2|Overall Study|Withdrawal by Subject|6
1092569|NCT02046369|3569706|P1|Overall Study|Withdrawal by Subject|3
1092570|NCT02046369|3569705|P2|Overall Study|Protocol Violation|2
1092571|NCT02046369|3569706|P1|Overall Study|Protocol Violation|1
1092572|NCT02046369|3569705|P2|Overall Study|Lost to Follow-up|3
1092573|NCT02046369|3569706|P1|Overall Study|Lost to Follow-up|3
1092574|NCT02046369|3569705|P2|Overall Study|Lack of Efficacy|3
1092575|NCT02046369|3569706|P1|Overall Study|Lack of Efficacy|3
1092576|NCT02046369|3569705|P2|Overall Study|Adverse Event|3
1092577|NCT02046369|3569706|P1|Overall Study|Adverse Event|3
1092578|NCT02046226|3569750|P1|Overall Study|Lost to Follow-up|7
1092579|NCT02046148|3569798|P2|Overall Study|Withdrawal by Subject|2
1092580|NCT02046148|3569799|P1|Overall Study|Withdrawal by Subject|0
1092581|NCT02046148|3569798|P2|Overall Study|Lost to Follow-up|1
1092582|NCT02046148|3569799|P1|Overall Study|Lost to Follow-up|1
1092583|NCT02046122|3569843|P1|Overall Study|Withdrawal by Subject|1
1092584|NCT02046122|3569843|P1|Overall Study|Physician Decision|8
1092585|NCT02045979|3569865|P3|Overall Study|not specified above|0
1092586|NCT02045979|3569866|P2|Overall Study|not specified above|1
1092587|NCT02045979|3569867|P1|Overall Study|not specified above|0
1092588|NCT02045979|3569865|P3|Overall Study|Informed Consent Withdrawn|1
1092589|NCT02045979|3569866|P2|Overall Study|Informed Consent Withdrawn|0
1092590|NCT02045979|3569867|P1|Overall Study|Informed Consent Withdrawn|2
1092591|NCT02045875|3569904|P2|Overall Study|Withdrawal by Subject|3
1092592|NCT02045875|3569905|P1|Overall Study|Withdrawal by Subject|4
1092593|NCT02045875|3569904|P2|Overall Study|Lost to Follow-up|0
1092594|NCT02045875|3569905|P1|Overall Study|Lost to Follow-up|3
1092595|NCT02045862|3569916|P3|Overall Study|Lost to Follow-up|6
1092596|NCT02045862|3569917|P2|Overall Study|Lost to Follow-up|2
1092597|NCT02045862|3569918|P1|Overall Study|Lost to Follow-up|1
1092598|NCT02045862|3569916|P3|Overall Study|Adverse Event|27
1092599|NCT02045862|3569917|P2|Overall Study|Adverse Event|5
1092600|NCT02045862|3569918|P1|Overall Study|Adverse Event|7
1092601|NCT02045862|3569916|P3|Overall Study|Randomized but not Received Study Drug|8
1092602|NCT02045862|3569917|P2|Overall Study|Randomized but not Received Study Drug|2
1092603|NCT02045862|3569918|P1|Overall Study|Randomized but not Received Study Drug|0
1092604|NCT02045862|3569916|P3|Overall Study|Lack of Efficacy|13
1092605|NCT02045862|3569917|P2|Overall Study|Lack of Efficacy|4
1092606|NCT02045862|3569918|P1|Overall Study|Lack of Efficacy|8
1092607|NCT02045862|3569916|P3|Overall Study|Protocol Violation|6
1092608|NCT02045862|3569917|P2|Overall Study|Protocol Violation|0
1092609|NCT02045862|3569918|P1|Overall Study|Protocol Violation|0
1092610|NCT02045862|3569916|P3|Overall Study|Withdrawal by Patient|57
1092611|NCT02045862|3569917|P2|Overall Study|Withdrawal by Patient|27
1092612|NCT02045862|3569918|P1|Overall Study|Withdrawal by Patient|18
1092613|NCT02045862|3569916|P3|Overall Study|Miscellaneous|8
1092614|NCT02045862|3569917|P2|Overall Study|Miscellaneous|0
1092615|NCT02045862|3569918|P1|Overall Study|Miscellaneous|5
1092616|NCT02045862|3569916|P3|Overall Study|Death|1
1092617|NCT02045862|3569917|P2|Overall Study|Death|0
1092618|NCT02045862|3569918|P1|Overall Study|Death|0
1092619|NCT02045836|3570099|P2|Overall Study|Migrated from study area|2
1092620|NCT02045836|3570100|P1|Overall Study|Migrated from study area|0
1092621|NCT02045836|3570099|P2|Overall Study|Lost to Follow-up|7
1092622|NCT02045836|3570100|P1|Overall Study|Lost to Follow-up|4
1092623|NCT02045836|3570099|P2|Overall Study|Withdrawal by Subject|1
1092624|NCT02045836|3570100|P1|Overall Study|Withdrawal by Subject|1
1092625|NCT02045836|3570099|P2|Overall Study|Adverse Event|4
1092626|NCT02045836|3570100|P1|Overall Study|Adverse Event|4
1092627|NCT02045797|3570132|P3|Overall Study|Withdrawal by Subject|0
1092628|NCT02045797|3570133|P2|Overall Study|Withdrawal by Subject|2
1092629|NCT02045797|3570134|P1|Overall Study|Withdrawal by Subject|1
1092630|NCT02045797|3570132|P3|Overall Study|Physician Decision|0
1092631|NCT02045797|3570133|P2|Overall Study|Physician Decision|1
1092632|NCT02045797|3570134|P1|Overall Study|Physician Decision|0
1092633|NCT02045797|3570132|P3|Overall Study|Lost to Follow-up|1
1092634|NCT02045797|3570133|P2|Overall Study|Lost to Follow-up|3
1092635|NCT02045797|3570134|P1|Overall Study|Lost to Follow-up|2
1092636|NCT02045797|3570132|P3|Overall Study|Lack of Efficacy|0
1092637|NCT02045797|3570133|P2|Overall Study|Lack of Efficacy|0
1092638|NCT02045797|3570134|P1|Overall Study|Lack of Efficacy|1
1092639|NCT02045797|3570132|P3|Overall Study|Adverse Event|0
1092640|NCT02045797|3570133|P2|Overall Study|Adverse Event|1
1092641|NCT02045797|3570134|P1|Overall Study|Adverse Event|3
1092642|NCT02045732|3570279|P2|Overall Study|At the discretion of the investigator|1
1092643|NCT02045732|3570280|P1|Overall Study|At the discretion of the investigator|1
1092644|NCT02044848|3570411|P2|Overall Study|Administrative Problems|3
1092645|NCT02044848|3570412|P1|Overall Study|Administrative Problems|2
1092646|NCT02044822|3570418|P1|Overall Study|Lost to Follow-up|1
1092647|NCT02044822|3570418|P1|Overall Study|Initiation of Anti-Neoplastic Therapy|2
1092648|NCT02044822|3570418|P1|Overall Study|Withdrew Consent|3
1092649|NCT02044822|3570418|P1|Overall Study|Investigator's Discretion|10
1092650|NCT02044822|3570418|P1|Overall Study|Study Terminated by Sponsor|77
1092651|NCT02044458|3570430|P2|Overall Study|Protocol Violation|8
1092652|NCT02044458|3570431|P1|Overall Study|Protocol Violation|3
1092653|NCT02044302|3570517|P2|Overall Study|study terminated|0
1092654|NCT02044302|3570518|P1|Overall Study|study terminated|2
1092655|NCT02044094|3570524|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1
1092656|NCT02044094|3570524|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1
1092657|NCT02044094|3570524|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2
1092658|NCT02044094|3570524|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5
1092659|NCT02044094|3570524|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4
1092660|NCT02044094|3570524|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3
1092661|NCT02044094|3570524|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3
1092662|NCT02044094|3570524|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3
1092663|NCT02043938|3570581|P1|Overall Study|Investigator decision|1
1092664|NCT02043938|3570581|P1|Overall Study|No show by subject|1
1092665|NCT02043938|3570581|P1|Overall Study|Unable to place EEG sensors on patient|1
1092666|NCT02043938|3570581|P1|Overall Study|Withdrawal by Subject|7
1092667|NCT02043782|3570632|P6|Period 1|Adverse Event|0
1092668|NCT02043782|3570633|P5|Period 1|Adverse Event|0
1092669|NCT02043782|3570634|P4|Period 1|Adverse Event|0
1092670|NCT02043782|3570635|P3|Period 1|Adverse Event|1
1092671|NCT02043782|3570636|P2|Period 1|Adverse Event|0
1092672|NCT02043782|3570637|P1|Period 1|Adverse Event|0
1092673|NCT02043366|3570748|P6|Overall Study|Lost to Follow-up|2
1092674|NCT02043366|3570749|P5|Overall Study|Lost to Follow-up|2
1092675|NCT02043366|3570750|P4|Overall Study|Lost to Follow-up|2
1092676|NCT02043366|3570751|P3|Overall Study|Lost to Follow-up|2
1092677|NCT02043366|3570752|P2|Overall Study|Lost to Follow-up|2
1092678|NCT02043366|3570753|P1|Overall Study|Lost to Follow-up|2
1092679|NCT02043132|3570812|P2|Overall Study|screen failures|8
1092680|NCT02043132|3570813|P1|Overall Study|screen failures|4
1092681|NCT02043132|3570812|P2|Overall Study|Lost to Follow-up|1
1092682|NCT02043132|3570813|P1|Overall Study|Lost to Follow-up|1
1092683|NCT02043015|3570833|P1|Overall Study|Incarceration|1
1092684|NCT02043015|3570833|P1|Overall Study|Participant moved away from study city|4
1092685|NCT02043015|3570833|P1|Overall Study|Removed once target enrollment reached|15
1092686|NCT02043015|3570833|P1|Overall Study|Withdrawal by Subject|4
1092687|NCT02043015|3570833|P1|Overall Study|Lost to Follow-up|4
1092688|NCT02042924|3570846|P1|Overall Study|Early Death|1
1092689|NCT02042443|3570894|P2|Overall Study|Not eligible/not analyzable|6
1092690|NCT02042443|3570895|P1|Overall Study|Not eligible/not analyzable|3
1092691|NCT02042443|3570894|P2|Overall Study|not protocol specified|1
1092692|NCT02042443|3570895|P1|Overall Study|not protocol specified|1
1092693|NCT02042443|3570894|P2|Overall Study|Progression|17
1092694|NCT02042443|3570895|P1|Overall Study|Progression|21
1092695|NCT02042443|3570894|P2|Overall Study|Withdrawal by Subject|1
1092696|NCT02042443|3570895|P1|Overall Study|Withdrawal by Subject|0
1092697|NCT02042443|3570894|P2|Overall Study|Adverse Event|1
1092698|NCT02042443|3570895|P1|Overall Study|Adverse Event|2
1092699|NCT02042404|3570907|P2|Overall Study|Inability to meet time requirements|0
1092700|NCT02042404|3570908|P1|Overall Study|Inability to meet time requirements|1
1092701|NCT02042404|3570907|P2|Overall Study|Unrelated Adverse Event|0
1092702|NCT02042404|3570908|P1|Overall Study|Unrelated Adverse Event|3
1092703|NCT02042404|3570907|P2|Overall Study|Death|0
1092704|NCT02042404|3570908|P1|Overall Study|Death|1
1092705|NCT02041533|3570948|P2|Overall Study|Randomized, not treated|7
1092706|NCT02041533|3570949|P1|Overall Study|Randomized, not treated|4
1092707|NCT02041533|3570948|P2|Overall Study|Completed max number of chemo cycles|29
1092708|NCT02041533|3570949|P1|Overall Study|Completed max number of chemo cycles|0
1092709|NCT02041533|3570948|P2|Overall Study|Other reasons|1
1092710|NCT02041533|3570949|P1|Overall Study|Other reasons|0
1092711|NCT02041533|3570948|P2|Overall Study|Poor/non-compliance|0
1092712|NCT02041533|3570949|P1|Overall Study|Poor/non-compliance|1
1092713|NCT02041533|3570948|P2|Overall Study|Maximum clinical benefit|18
1092714|NCT02041533|3570949|P1|Overall Study|Maximum clinical benefit|0
1092715|NCT02041533|3570948|P2|Overall Study|Withdrawal by Subject|1
1092716|NCT02041533|3570949|P1|Overall Study|Withdrawal by Subject|2
1092717|NCT02041533|3570948|P2|Overall Study|Subject request to discontinue treatment|9
1092718|NCT02041533|3570949|P1|Overall Study|Subject request to discontinue treatment|5
1092719|NCT02041533|3570948|P2|Overall Study|Adverse Event unrelated to study drug|21
1092720|NCT02041533|3570949|P1|Overall Study|Adverse Event unrelated to study drug|20
1092721|NCT02041533|3570948|P2|Overall Study|Death|0
1092722|NCT02041533|3570949|P1|Overall Study|Death|1
1092723|NCT02041533|3570948|P2|Overall Study|Study drug toxicity|30
1092724|NCT02041533|3570949|P1|Overall Study|Study drug toxicity|27
1092725|NCT02041533|3570948|P2|Overall Study|Disease Progression|142
1092726|NCT02041533|3570949|P1|Overall Study|Disease Progression|168
1092727|NCT02041520|3570971|P2|Overall Study|Hypothiroidism identified during follow-|1
1092728|NCT02041520|3570972|P1|Overall Study|Hypothiroidism identified during follow-|0
1092729|NCT02041520|3570971|P2|Overall Study|Lost to Follow-up|1
1092730|NCT02041520|3570972|P1|Overall Study|Lost to Follow-up|0
1092731|NCT02041520|3570971|P2|Overall Study|Protocol Violation|0
1092732|NCT02041520|3570972|P1|Overall Study|Protocol Violation|1
1092733|NCT02041520|3570971|P2|Overall Study|Withdrawal by Subject|4
1092734|NCT02041520|3570972|P1|Overall Study|Withdrawal by Subject|3
1092735|NCT02041520|3570971|P2|Overall Study|Adverse Event|1
1092736|NCT02041520|3570972|P1|Overall Study|Adverse Event|2
1092737|NCT02041286|3571015|P1|Overall Study|Adverse Event|1
1092738|NCT02041091|3571050|P2|Optional Safety Extension Period|Lost to Follow-up|3
1092739|NCT02041091|3571051|P1|Optional Safety Extension Period|Lost to Follow-up|2
1092740|NCT02041091|3571050|P2|Optional Safety Extension Period|Sponsor Decision|74
1092741|NCT02041091|3571051|P1|Optional Safety Extension Period|Sponsor Decision|70
1092742|NCT02041091|3571050|P2|Optional Safety Extension Period|Physician Decision|1
1092743|NCT02041091|3571051|P1|Optional Safety Extension Period|Physician Decision|2
1092744|NCT02041091|3571050|P2|Optional Safety Extension Period|Protocol Violation|0
1092745|NCT02041091|3571051|P1|Optional Safety Extension Period|Protocol Violation|2
1092746|NCT02041091|3571050|P2|Optional Safety Extension Period|Withdrawal by Subject|2
1092747|NCT02041091|3571051|P1|Optional Safety Extension Period|Withdrawal by Subject|5
1092748|NCT02041091|3571050|P2|Optional Safety Extension Period|Adverse Event|2
1092749|NCT02041091|3571051|P1|Optional Safety Extension Period|Adverse Event|4
1092750|NCT02041091|3571050|P2|Treatment|Lost to Follow-up|0
1092751|NCT02041091|3571051|P1|Treatment|Lost to Follow-up|1
1092752|NCT02041091|3571050|P2|Treatment|Sponsor Decision|16
1092753|NCT02041091|3571051|P1|Treatment|Sponsor Decision|15
1092754|NCT02041091|3571050|P2|Treatment|Physician Decision|0
1092755|NCT02041091|3571051|P1|Treatment|Physician Decision|1
1092756|NCT02041091|3571050|P2|Treatment|Withdrawal by Subject|4
1092757|NCT02041091|3571051|P1|Treatment|Withdrawal by Subject|2
1092758|NCT02041091|3571050|P2|Treatment|Adverse Event|3
1092759|NCT02041091|3571051|P1|Treatment|Adverse Event|3
1092760|NCT02040844|3571076|P3|Overall Study|Concomitant medication|1
1092761|NCT02040844|3571077|P2|Overall Study|Concomitant medication|3
1092762|NCT02040844|3571078|P1|Overall Study|Concomitant medication|1
1092763|NCT02040844|3571076|P3|Overall Study|Non-specified|5
1092764|NCT02040844|3571077|P2|Overall Study|Non-specified|2
1092765|NCT02040844|3571078|P1|Overall Study|Non-specified|8
1092766|NCT02040844|3571076|P3|Overall Study|Missing|2
1092767|NCT02040844|3571077|P2|Overall Study|Missing|3
1092768|NCT02040844|3571078|P1|Overall Study|Missing|13
1092769|NCT02040844|3571076|P3|Overall Study|Lost to Follow-up|13
1092770|NCT02040844|3571077|P2|Overall Study|Lost to Follow-up|9
1092771|NCT02040844|3571078|P1|Overall Study|Lost to Follow-up|12
1092772|NCT02040844|3571076|P3|Overall Study|Withdrawal by Subject|25
1092773|NCT02040844|3571077|P2|Overall Study|Withdrawal by Subject|22
1092774|NCT02040844|3571078|P1|Overall Study|Withdrawal by Subject|16
1092775|NCT02040844|3571076|P3|Overall Study|Adverse Event|1
1092776|NCT02040844|3571077|P2|Overall Study|Adverse Event|0
1092777|NCT02040844|3571078|P1|Overall Study|Adverse Event|0
1092778|NCT02040779|3571125|P3|Overall Study|Lack of Efficacy|0
1092779|NCT02040779|3571126|P2|Overall Study|Lack of Efficacy|2
1092780|NCT02040779|3571127|P1|Overall Study|Lack of Efficacy|4
1092781|NCT02040779|3571125|P3|Overall Study|Lost to Follow-up|1
1092782|NCT02040779|3571126|P2|Overall Study|Lost to Follow-up|2
1092783|NCT02040779|3571127|P1|Overall Study|Lost to Follow-up|1
1092784|NCT02040779|3571125|P3|Overall Study|Protocol Violation|0
1092785|NCT02040779|3571126|P2|Overall Study|Protocol Violation|1
1092786|NCT02040779|3571127|P1|Overall Study|Protocol Violation|2
1092787|NCT02040779|3571125|P3|Overall Study|Non-compliance|0
1092788|NCT02040779|3571126|P2|Overall Study|Non-compliance|1
1092789|NCT02040779|3571127|P1|Overall Study|Non-compliance|0
1092790|NCT02040779|3571125|P3|Overall Study|Withdrawal by Subject|3
1092791|NCT02040779|3571126|P2|Overall Study|Withdrawal by Subject|1
1092792|NCT02040779|3571127|P1|Overall Study|Withdrawal by Subject|4
1092793|NCT02040779|3571125|P3|Overall Study|Adverse Event|0
1092794|NCT02040779|3571126|P2|Overall Study|Adverse Event|0
1092795|NCT02040779|3571127|P1|Overall Study|Adverse Event|1
1092796|NCT02040766|3571167|P5|Overall Study|Lack of Efficacy|5
1092797|NCT02040766|3571168|P4|Overall Study|Lack of Efficacy|6
1092798|NCT02040766|3571169|P3|Overall Study|Lack of Efficacy|4
1092799|NCT02040766|3571170|P2|Overall Study|Lack of Efficacy|3
1092800|NCT02040766|3571171|P1|Overall Study|Lack of Efficacy|6
1092801|NCT02040766|3571167|P5|Overall Study|Not reported|0
1092802|NCT02040766|3571168|P4|Overall Study|Not reported|0
1092803|NCT02040766|3571169|P3|Overall Study|Not reported|0
1092804|NCT02040766|3571170|P2|Overall Study|Not reported|0
1092805|NCT02040766|3571171|P1|Overall Study|Not reported|1
1092806|NCT02040766|3571167|P5|Overall Study|Lost to Follow-up|4
1092807|NCT02040766|3571168|P4|Overall Study|Lost to Follow-up|1
1092808|NCT02040766|3571169|P3|Overall Study|Lost to Follow-up|3
1092809|NCT02040766|3571170|P2|Overall Study|Lost to Follow-up|1
1092810|NCT02040766|3571171|P1|Overall Study|Lost to Follow-up|4
1092811|NCT02040766|3571167|P5|Overall Study|Protocol Violation|0
1092812|NCT02040766|3571168|P4|Overall Study|Protocol Violation|3
1092813|NCT02040766|3571169|P3|Overall Study|Protocol Violation|2
1092814|NCT02040766|3571170|P2|Overall Study|Protocol Violation|1
1092815|NCT02040766|3571171|P1|Overall Study|Protocol Violation|2
1092816|NCT02040766|3571167|P5|Overall Study|Non-compliance|0
1092817|NCT02040766|3571168|P4|Overall Study|Non-compliance|0
1092818|NCT02040766|3571169|P3|Overall Study|Non-compliance|0
1092819|NCT02040766|3571170|P2|Overall Study|Non-compliance|1
1092820|NCT02040766|3571171|P1|Overall Study|Non-compliance|0
1092821|NCT02040766|3571167|P5|Overall Study|Withdrawal by Subject|2
1092822|NCT02040766|3571168|P4|Overall Study|Withdrawal by Subject|3
1092823|NCT02040766|3571169|P3|Overall Study|Withdrawal by Subject|2
1092824|NCT02040766|3571170|P2|Overall Study|Withdrawal by Subject|3
1092825|NCT02040766|3571171|P1|Overall Study|Withdrawal by Subject|4
1092826|NCT02040766|3571167|P5|Overall Study|Adverse Event|2
1092827|NCT02040766|3571168|P4|Overall Study|Adverse Event|0
1092828|NCT02040766|3571169|P3|Overall Study|Adverse Event|1
1092829|NCT02040766|3571170|P2|Overall Study|Adverse Event|1
1092830|NCT02040766|3571171|P1|Overall Study|Adverse Event|1
1092831|NCT02040532|3571222|P1|Overall Study|Withdrawal by Subject|3
1092832|NCT02040532|3571222|P1|Overall Study|Adverse Event|4
1092833|NCT02040532|3571222|P1|Overall Study|Physician Decision|4
1092834|NCT02040532|3571222|P1|Overall Study|Lost to Follow-up|1
1092835|NCT02040428|3571235|P2|Overall Study|Withdrawal by Subject|1
1092836|NCT02040428|3571236|P1|Overall Study|Withdrawal by Subject|1
1092837|NCT02040428|3571235|P2|Overall Study|Death|3
1092838|NCT02040428|3571236|P1|Overall Study|Death|4
1092839|NCT02039778|3571284|P1|Overall Study|Never started the protocol treatment|1
1092840|NCT02039778|3571284|P1|Overall Study|Withdrawal by Subject|1
1092841|NCT02039778|3571284|P1|Overall Study|Death|2
1092842|NCT02039687|3571296|P4|Overall Study|treatment assignment could not be confir|0
1092843|NCT02039687|3571297|P3|Overall Study|treatment assignment could not be confir|2
1092844|NCT02039687|3571298|P2|Overall Study|treatment assignment could not be confir|0
1092845|NCT02039687|3571299|P1|Overall Study|treatment assignment could not be confir|0
1092846|NCT02039687|3571296|P4|Overall Study|Withdrawal by Subject|0
1092847|NCT02039687|3571297|P3|Overall Study|Withdrawal by Subject|0
1092848|NCT02039687|3571298|P2|Overall Study|Withdrawal by Subject|1
1092849|NCT02039687|3571299|P1|Overall Study|Withdrawal by Subject|0
1092850|NCT02039687|3571296|P4|Overall Study|Adverse Event|0
1092851|NCT02039687|3571297|P3|Overall Study|Adverse Event|1
1092852|NCT02039687|3571298|P2|Overall Study|Adverse Event|0
1092853|NCT02039687|3571299|P1|Overall Study|Adverse Event|0
1092854|NCT02039674|3571334|P9|Overall Study|Ongoing in Study|4
1092855|NCT02039674|3571335|P8|Overall Study|Ongoing in Study|33
1092856|NCT02039674|3571336|P7|Overall Study|Ongoing in Study|34
1092857|NCT02039674|3571337|P6|Overall Study|Ongoing in Study|1
1092858|NCT02039674|3571338|P5|Overall Study|Ongoing in Study|6
1092859|NCT02039674|3571339|P4|Overall Study|Ongoing in Study|2
1092860|NCT02039674|3571340|P3|Overall Study|Ongoing in Study|5
1092861|NCT02039674|3571341|P2|Overall Study|Ongoing in Study|5
1092862|NCT02039674|3571342|P1|Overall Study|Ongoing in Study|7
1092863|NCT02039674|3571334|P9|Overall Study|Withdrawal by Subject|2
1092864|NCT02039674|3571335|P8|Overall Study|Withdrawal by Subject|5
1092865|NCT02039674|3571336|P7|Overall Study|Withdrawal by Subject|3
1092866|NCT02039674|3571337|P6|Overall Study|Withdrawal by Subject|1
1092867|NCT02039674|3571338|P5|Overall Study|Withdrawal by Subject|2
1092868|NCT02039674|3571339|P4|Overall Study|Withdrawal by Subject|0
1092869|NCT02039674|3571340|P3|Overall Study|Withdrawal by Subject|1
1092870|NCT02039674|3571341|P2|Overall Study|Withdrawal by Subject|1
1092871|NCT02039674|3571342|P1|Overall Study|Withdrawal by Subject|2
1092872|NCT02039674|3571334|P9|Overall Study|Progressive Disease|23
1092873|NCT02039674|3571335|P8|Overall Study|Progressive Disease|18
1092874|NCT02039674|3571336|P7|Overall Study|Progressive Disease|17
1092875|NCT02039674|3571337|P6|Overall Study|Progressive Disease|0
1092876|NCT02039674|3571338|P5|Overall Study|Progressive Disease|2
1092877|NCT02039674|3571339|P4|Overall Study|Progressive Disease|4
1092878|NCT02039674|3571340|P3|Overall Study|Progressive Disease|15
1092879|NCT02039674|3571341|P2|Overall Study|Progressive Disease|13
1092880|NCT02039674|3571342|P1|Overall Study|Progressive Disease|13
1092881|NCT02039674|3571334|P9|Overall Study|Physician Decision|0
1092882|NCT02039674|3571335|P8|Overall Study|Physician Decision|0
1092883|NCT02039674|3571336|P7|Overall Study|Physician Decision|1
1092884|NCT02039674|3571337|P6|Overall Study|Physician Decision|0
1092885|NCT02039674|3571338|P5|Overall Study|Physician Decision|0
1092886|NCT02039674|3571339|P4|Overall Study|Physician Decision|0
1092887|NCT02039674|3571340|P3|Overall Study|Physician Decision|0
1092888|NCT02039674|3571341|P2|Overall Study|Physician Decision|0
1092889|NCT02039674|3571342|P1|Overall Study|Physician Decision|0
1092890|NCT02039674|3571334|P9|Overall Study|Lost to Follow-up|0
1092891|NCT02039674|3571335|P8|Overall Study|Lost to Follow-up|1
1092892|NCT02039674|3571336|P7|Overall Study|Lost to Follow-up|0
1092893|NCT02039674|3571337|P6|Overall Study|Lost to Follow-up|0
1092894|NCT02039674|3571338|P5|Overall Study|Lost to Follow-up|0
1092895|NCT02039674|3571339|P4|Overall Study|Lost to Follow-up|0
1092896|NCT02039674|3571340|P3|Overall Study|Lost to Follow-up|0
1092897|NCT02039674|3571341|P2|Overall Study|Lost to Follow-up|0
1092898|NCT02039674|3571342|P1|Overall Study|Lost to Follow-up|0
1092899|NCT02039674|3571334|P9|Overall Study|Excluded Medication|5
1092900|NCT02039674|3571335|P8|Overall Study|Excluded Medication|4
1092901|NCT02039674|3571336|P7|Overall Study|Excluded Medication|2
1092902|NCT02039674|3571337|P6|Overall Study|Excluded Medication|4
1092903|NCT02039674|3571338|P5|Overall Study|Excluded Medication|2
1092904|NCT02039674|3571339|P4|Overall Study|Excluded Medication|0
1092905|NCT02039674|3571340|P3|Overall Study|Excluded Medication|2
1092906|NCT02039674|3571341|P2|Overall Study|Excluded Medication|1
1092907|NCT02039674|3571342|P1|Overall Study|Excluded Medication|2
1092908|NCT02039674|3571334|P9|Overall Study|Death|8
1092909|NCT02039674|3571335|P8|Overall Study|Death|0
1092910|NCT02039674|3571336|P7|Overall Study|Death|1
1092911|NCT02039674|3571337|P6|Overall Study|Death|1
1092912|NCT02039674|3571338|P5|Overall Study|Death|0
1092913|NCT02039674|3571339|P4|Overall Study|Death|0
1092914|NCT02039674|3571340|P3|Overall Study|Death|0
1092915|NCT02039674|3571341|P2|Overall Study|Death|3
1092916|NCT02039674|3571342|P1|Overall Study|Death|0
1092917|NCT02039674|3571334|P9|Overall Study|Adverse Event|3
1092918|NCT02039674|3571335|P8|Overall Study|Adverse Event|2
1092919|NCT02039674|3571336|P7|Overall Study|Adverse Event|2
1092920|NCT02039674|3571337|P6|Overall Study|Adverse Event|0
1092921|NCT02039674|3571338|P5|Overall Study|Adverse Event|0
1092922|NCT02039674|3571339|P4|Overall Study|Adverse Event|0
1092923|NCT02039674|3571340|P3|Overall Study|Adverse Event|1
1092924|NCT02039674|3571341|P2|Overall Study|Adverse Event|2
1092925|NCT02039674|3571342|P1|Overall Study|Adverse Event|0
1092926|NCT02039427|3571378|P4|Overall Study|Steroid Use|0
1092927|NCT02039427|3571379|P3|Overall Study|Steroid Use|0
1092928|NCT02039427|3571380|P2|Overall Study|Steroid Use|0
1092929|NCT02039427|3571381|P1|Overall Study|Steroid Use|1
1092930|NCT02039427|3571378|P4|Overall Study|Loss of follow - up|4
1092931|NCT02039427|3571379|P3|Overall Study|Loss of follow - up|2
1092932|NCT02039427|3571380|P2|Overall Study|Loss of follow - up|0
1092933|NCT02039427|3571381|P1|Overall Study|Loss of follow - up|1
1092934|NCT02039427|3571378|P4|Overall Study|Cancellation of surgery|0
1092935|NCT02039427|3571379|P3|Overall Study|Cancellation of surgery|1
1092936|NCT02039427|3571380|P2|Overall Study|Cancellation of surgery|0
1092937|NCT02039427|3571381|P1|Overall Study|Cancellation of surgery|0
1092938|NCT02039427|3571378|P4|Overall Study|Withdrawal on concent|1
1092939|NCT02039427|3571379|P3|Overall Study|Withdrawal on concent|0
1092940|NCT02039427|3571380|P2|Overall Study|Withdrawal on concent|0
1092941|NCT02039427|3571381|P1|Overall Study|Withdrawal on concent|0
1092942|NCT02039427|3571378|P4|Overall Study|Duration of surgery > 3h|0
1092943|NCT02039427|3571379|P3|Overall Study|Duration of surgery > 3h|0
1092944|NCT02039427|3571380|P2|Overall Study|Duration of surgery > 3h|1
1092945|NCT02039427|3571381|P1|Overall Study|Duration of surgery > 3h|1
1092946|NCT02039414|3571401|P2|Overall Study|Protocol Violation|1
1092947|NCT02039414|3571402|P1|Overall Study|Protocol Violation|3
1092948|NCT02039414|3571401|P2|Overall Study|Lost to Follow-up|0
1092949|NCT02039414|3571402|P1|Overall Study|Lost to Follow-up|2
1092950|NCT02039414|3571401|P2|Overall Study|Delivered|1
1092951|NCT02039414|3571402|P1|Overall Study|Delivered|1
1092952|NCT02038959|3571425|P2|Overall Study|Withdrawal by Subject|8
1092953|NCT02038959|3571426|P1|Overall Study|Withdrawal by Subject|6
1092954|NCT02038946|3571452|P1|Overall Study|Other reasons|1
1092955|NCT02038946|3571452|P1|Overall Study|Lost to Follow-up|2
1092956|NCT02038946|3571452|P1|Overall Study|Withdrawal by Subject|3
1092957|NCT02038946|3571452|P1|Overall Study|Death|5
1092958|NCT02038933|3571463|P1|Follow-up|Disease Progression|2
1092959|NCT02038933|3571463|P1|Follow-up|Withdrawal by Subject|1
1092960|NCT02038933|3571463|P1|Follow-up|Lost to Follow-up|1
1092961|NCT02038933|3571463|P1|Follow-up|Adverse event unrelated to study drug|4
1092962|NCT02038933|3571463|P1|Follow-up|Death|11
1092963|NCT02038933|3571463|P1|Treatment|Withdrawal by Subject|1
1092964|NCT02038933|3571463|P1|Treatment|Disease Progression|101
1092965|NCT02038933|3571463|P1|Treatment|Study Drug Toxicity|4
1092966|NCT02038933|3571463|P1|Treatment|Adverse Event Unrelated to Study Drug|6
1092967|NCT02038933|3571463|P1|Treatment|Lost to Follow-up|1
1092968|NCT02038933|3571463|P1|Treatment|No longer meets study criteria|1
1092969|NCT02038907|3571496|P14|Overall Study|Withdrawal by Subject|0
1092970|NCT02038907|3571497|P13|Overall Study|Withdrawal by Subject|0
1092971|NCT02038907|3571498|P12|Overall Study|Withdrawal by Subject|0
1092972|NCT02038907|3571499|P11|Overall Study|Withdrawal by Subject|1
1092973|NCT02038907|3571500|P10|Overall Study|Withdrawal by Subject|0
1092974|NCT02038907|3571501|P9|Overall Study|Withdrawal by Subject|0
1092975|NCT02038907|3571502|P8|Overall Study|Withdrawal by Subject|0
1092976|NCT02038907|3571503|P7|Overall Study|Withdrawal by Subject|0
1092977|NCT02038907|3571504|P6|Overall Study|Withdrawal by Subject|0
1092978|NCT02038907|3571505|P5|Overall Study|Withdrawal by Subject|0
1092979|NCT02038907|3571506|P4|Overall Study|Withdrawal by Subject|0
1092980|NCT02038907|3571507|P3|Overall Study|Withdrawal by Subject|0
1092981|NCT02038907|3571508|P2|Overall Study|Withdrawal by Subject|0
1092982|NCT02038907|3571509|P1|Overall Study|Withdrawal by Subject|0
1092983|NCT02038907|3571496|P14|Overall Study|Protocol Violation|0
1092984|NCT02038907|3571497|P13|Overall Study|Protocol Violation|0
1092985|NCT02038907|3571498|P12|Overall Study|Protocol Violation|0
1092986|NCT02038907|3571499|P11|Overall Study|Protocol Violation|1
1092987|NCT02038907|3571500|P10|Overall Study|Protocol Violation|0
1092988|NCT02038907|3571501|P9|Overall Study|Protocol Violation|0
1092989|NCT02038907|3571502|P8|Overall Study|Protocol Violation|0
1092990|NCT02038907|3571503|P7|Overall Study|Protocol Violation|0
1092991|NCT02038907|3571504|P6|Overall Study|Protocol Violation|0
1092992|NCT02038907|3571505|P5|Overall Study|Protocol Violation|0
1092993|NCT02038907|3571506|P4|Overall Study|Protocol Violation|0
1092994|NCT02038907|3571507|P3|Overall Study|Protocol Violation|0
1092995|NCT02038907|3571508|P2|Overall Study|Protocol Violation|0
1092996|NCT02038907|3571509|P1|Overall Study|Protocol Violation|0
1092997|NCT02038829|3572037|P12|Treatment Period 6|Adverse Event|0
1092998|NCT02038829|3572038|P11|Treatment Period 6|Adverse Event|0
1092999|NCT02038829|3572039|P10|Treatment Period 6|Adverse Event|0
1093000|NCT02038829|3572040|P9|Treatment Period 6|Adverse Event|0
1093001|NCT02038829|3572041|P8|Treatment Period 6|Adverse Event|0
1093002|NCT02038829|3572042|P7|Treatment Period 6|Adverse Event|0
1093003|NCT02038829|3572043|P6|Treatment Period 6|Adverse Event|0
1093004|NCT02038829|3572044|P5|Treatment Period 6|Adverse Event|0
1093005|NCT02038829|3572045|P4|Treatment Period 6|Adverse Event|0
1093006|NCT02038829|3572046|P3|Treatment Period 6|Adverse Event|1
1093007|NCT02038829|3572047|P2|Treatment Period 6|Adverse Event|0
1093008|NCT02038829|3572048|P1|Treatment Period 6|Adverse Event|0
1093009|NCT02038829|3572037|P12|Washout Period 4|Adverse Event|0
1093010|NCT02038829|3572038|P11|Washout Period 4|Adverse Event|0
1093011|NCT02038829|3572039|P10|Washout Period 4|Adverse Event|0
1093012|NCT02038829|3572040|P9|Washout Period 4|Adverse Event|0
1093013|NCT02038829|3572041|P8|Washout Period 4|Adverse Event|0
1093014|NCT02038829|3572042|P7|Washout Period 4|Adverse Event|1
1093015|NCT02038829|3572043|P6|Washout Period 4|Adverse Event|0
1093016|NCT02038829|3572044|P5|Washout Period 4|Adverse Event|0
1093017|NCT02038829|3572045|P4|Washout Period 4|Adverse Event|0
1093018|NCT02038829|3572046|P3|Washout Period 4|Adverse Event|0
1093019|NCT02038829|3572047|P2|Washout Period 4|Adverse Event|0
1093020|NCT02038829|3572048|P1|Washout Period 4|Adverse Event|0
1093021|NCT02038829|3572037|P12|Treatment Period 4|Adverse Event|0
1093022|NCT02038829|3572038|P11|Treatment Period 4|Adverse Event|0
1093023|NCT02038829|3572039|P10|Treatment Period 4|Adverse Event|0
1093024|NCT02038829|3572040|P9|Treatment Period 4|Adverse Event|0
1093025|NCT02038829|3572041|P8|Treatment Period 4|Adverse Event|0
1093026|NCT02038829|3572042|P7|Treatment Period 4|Adverse Event|0
1093027|NCT02038829|3572043|P6|Treatment Period 4|Adverse Event|0
1093028|NCT02038829|3572044|P5|Treatment Period 4|Adverse Event|0
1093029|NCT02038829|3572045|P4|Treatment Period 4|Adverse Event|0
1093030|NCT02038829|3572046|P3|Treatment Period 4|Adverse Event|0
1093031|NCT02038829|3572047|P2|Treatment Period 4|Adverse Event|1
1093032|NCT02038829|3572048|P1|Treatment Period 4|Adverse Event|0
1093033|NCT02038829|3572037|P12|Washout Period 2|Withdrawal by Subject|0
1093034|NCT02038829|3572038|P11|Washout Period 2|Withdrawal by Subject|0
1093035|NCT02038829|3572039|P10|Washout Period 2|Withdrawal by Subject|0
1093036|NCT02038829|3572040|P9|Washout Period 2|Withdrawal by Subject|0
1093037|NCT02038829|3572041|P8|Washout Period 2|Withdrawal by Subject|0
1093038|NCT02038829|3572042|P7|Washout Period 2|Withdrawal by Subject|0
1093039|NCT02038829|3572043|P6|Washout Period 2|Withdrawal by Subject|1
1093040|NCT02038829|3572044|P5|Washout Period 2|Withdrawal by Subject|0
1093041|NCT02038829|3572045|P4|Washout Period 2|Withdrawal by Subject|0
1093042|NCT02038829|3572046|P3|Washout Period 2|Withdrawal by Subject|0
1093043|NCT02038829|3572047|P2|Washout Period 2|Withdrawal by Subject|0
1093044|NCT02038829|3572048|P1|Washout Period 2|Withdrawal by Subject|0
1093045|NCT02038829|3572037|P12|Washout Period 2|Adverse Event|0
1093046|NCT02038829|3572038|P11|Washout Period 2|Adverse Event|0
1093047|NCT02038829|3572039|P10|Washout Period 2|Adverse Event|0
1093048|NCT02038829|3572040|P9|Washout Period 2|Adverse Event|1
1093049|NCT02038829|3572041|P8|Washout Period 2|Adverse Event|0
1093050|NCT02038829|3572042|P7|Washout Period 2|Adverse Event|0
1093051|NCT02038829|3572043|P6|Washout Period 2|Adverse Event|0
1093052|NCT02038829|3572044|P5|Washout Period 2|Adverse Event|0
1093053|NCT02038829|3572045|P4|Washout Period 2|Adverse Event|0
1093054|NCT02038829|3572046|P3|Washout Period 2|Adverse Event|0
1093055|NCT02038829|3572047|P2|Washout Period 2|Adverse Event|0
1093056|NCT02038829|3572048|P1|Washout Period 2|Adverse Event|0
1093057|NCT02038829|3572037|P12|Treatment Period 2|Withdrawal by Subject|0
1093058|NCT02038829|3572038|P11|Treatment Period 2|Withdrawal by Subject|0
1093059|NCT02038829|3572039|P10|Treatment Period 2|Withdrawal by Subject|0
1093060|NCT02038829|3572040|P9|Treatment Period 2|Withdrawal by Subject|0
1093061|NCT02038829|3572041|P8|Treatment Period 2|Withdrawal by Subject|0
1093062|NCT02038829|3572042|P7|Treatment Period 2|Withdrawal by Subject|0
1093063|NCT02038829|3572043|P6|Treatment Period 2|Withdrawal by Subject|0
1093064|NCT02038829|3572044|P5|Treatment Period 2|Withdrawal by Subject|0
1093065|NCT02038829|3572045|P4|Treatment Period 2|Withdrawal by Subject|0
1093066|NCT02038829|3572046|P3|Treatment Period 2|Withdrawal by Subject|0
1093067|NCT02038829|3572047|P2|Treatment Period 2|Withdrawal by Subject|0
1093068|NCT02038829|3572048|P1|Treatment Period 2|Withdrawal by Subject|1
1093069|NCT02038829|3572037|P12|Treatment Period 2|Adverse Event|0
1093070|NCT02038829|3572038|P11|Treatment Period 2|Adverse Event|1
1093071|NCT02038829|3572039|P10|Treatment Period 2|Adverse Event|0
1093072|NCT02038829|3572040|P9|Treatment Period 2|Adverse Event|0
1093073|NCT02038829|3572041|P8|Treatment Period 2|Adverse Event|0
1093074|NCT02038829|3572042|P7|Treatment Period 2|Adverse Event|0
1093075|NCT02038829|3572043|P6|Treatment Period 2|Adverse Event|0
1093076|NCT02038829|3572044|P5|Treatment Period 2|Adverse Event|0
1093077|NCT02038829|3572045|P4|Treatment Period 2|Adverse Event|0
1093078|NCT02038829|3572046|P3|Treatment Period 2|Adverse Event|0
1093079|NCT02038829|3572047|P2|Treatment Period 2|Adverse Event|0
1093080|NCT02038829|3572048|P1|Treatment Period 2|Adverse Event|0
1093081|NCT02038829|3572037|P12|Washout Period 1|Death|0
1093082|NCT02038829|3572038|P11|Washout Period 1|Death|0
1093083|NCT02038829|3572039|P10|Washout Period 1|Death|0
1093084|NCT02038829|3572040|P9|Washout Period 1|Death|0
1093085|NCT02038829|3572041|P8|Washout Period 1|Death|0
1093086|NCT02038829|3572042|P7|Washout Period 1|Death|0
1093087|NCT02038829|3572043|P6|Washout Period 1|Death|0
1093088|NCT02038829|3572044|P5|Washout Period 1|Death|1
1093089|NCT02038829|3572045|P4|Washout Period 1|Death|0
1093090|NCT02038829|3572046|P3|Washout Period 1|Death|0
1093091|NCT02038829|3572047|P2|Washout Period 1|Death|0
1093092|NCT02038829|3572048|P1|Washout Period 1|Death|0
1093093|NCT02038790|3572082|P2|Day 0 - First Treatment|Withdrawal by Subject|1
1093094|NCT02038790|3572083|P1|Day 0 - First Treatment|Withdrawal by Subject|1
1093095|NCT02038764|3572119|P5|Overall Study|Other|0
1093096|NCT02038764|3572120|P4|Overall Study|Other|0
1093097|NCT02038764|3572121|P3|Overall Study|Other|1
1093098|NCT02038764|3572122|P2|Overall Study|Other|0
1093099|NCT02038764|3572123|P1|Overall Study|Other|1
1093100|NCT02038764|3572119|P5|Overall Study|Withdrawal by Subject|1
1093101|NCT02038764|3572120|P4|Overall Study|Withdrawal by Subject|0
1093102|NCT02038764|3572121|P3|Overall Study|Withdrawal by Subject|0
1093103|NCT02038764|3572122|P2|Overall Study|Withdrawal by Subject|0
1093104|NCT02038764|3572123|P1|Overall Study|Withdrawal by Subject|0
1093105|NCT02038764|3572119|P5|Overall Study|Lost to Follow-up|0
1093106|NCT02038764|3572120|P4|Overall Study|Lost to Follow-up|0
1093107|NCT02038764|3572121|P3|Overall Study|Lost to Follow-up|0
1093108|NCT02038764|3572122|P2|Overall Study|Lost to Follow-up|1
1093109|NCT02038764|3572123|P1|Overall Study|Lost to Follow-up|0
1093110|NCT02038764|3572119|P5|Overall Study|Adverse Event|0
1093111|NCT02038764|3572120|P4|Overall Study|Adverse Event|0
1093112|NCT02038764|3572121|P3|Overall Study|Adverse Event|1
1093113|NCT02038764|3572122|P2|Overall Study|Adverse Event|0
1093114|NCT02038764|3572123|P1|Overall Study|Adverse Event|0
1093115|NCT02038647|3572225|P2|Overall Study|Ongoing at Datacut|10
1093116|NCT02038647|3572226|P1|Overall Study|Ongoing at Datacut|9
1093117|NCT02038647|3572225|P2|Overall Study|Not Reported|1
1093118|NCT02038647|3572226|P1|Overall Study|Not Reported|0
1093119|NCT02038647|3572225|P2|Overall Study|Withdrawal by Subject|2
1093120|NCT02038647|3572226|P1|Overall Study|Withdrawal by Subject|5
1093121|NCT02038647|3572225|P2|Overall Study|Symptomatic Deterioration|7
1093122|NCT02038647|3572226|P1|Overall Study|Symptomatic Deterioration|7
1093123|NCT02038647|3572225|P2|Overall Study|Adverse Event|10
1093124|NCT02038647|3572226|P1|Overall Study|Adverse Event|18
1093125|NCT02038647|3572225|P2|Overall Study|Progressive Disease|59
1093126|NCT02038647|3572226|P1|Overall Study|Progressive Disease|50
1093127|NCT02038543|3572289|P4|Overall Study|Withdrawal by Subject|1
1093128|NCT02038543|3572290|P3|Overall Study|Withdrawal by Subject|0
1093129|NCT02038543|3572291|P2|Overall Study|Withdrawal by Subject|0
1093130|NCT02038543|3572292|P1|Overall Study|Withdrawal by Subject|0
1093131|NCT02038543|3572289|P4|Overall Study|Screen Failure|1
1093132|NCT02038543|3572290|P3|Overall Study|Screen Failure|0
1093133|NCT02038543|3572291|P2|Overall Study|Screen Failure|0
1093134|NCT02038543|3572292|P1|Overall Study|Screen Failure|0
1093135|NCT02038075|3572308|P2|Overall Study|Withdrawal by Subject|0
1093136|NCT02038075|3572309|P1|Overall Study|Withdrawal by Subject|3
1093137|NCT02037568|3572404|P2|Overall Study|Patient did not receive transplant|1
1093138|NCT02037568|3572405|P1|Overall Study|Patient did not receive transplant|0
1093139|NCT02037568|3572404|P2|Overall Study|Screen Failure|1
1093140|NCT02037568|3572405|P1|Overall Study|Screen Failure|3
1093141|NCT02037568|3572404|P2|Overall Study|Lost to Follow-up|13
1093142|NCT02037568|3572405|P1|Overall Study|Lost to Follow-up|16
1093143|NCT02037568|3572404|P2|Overall Study|Withdrawal by Subject|24
1093144|NCT02037568|3572405|P1|Overall Study|Withdrawal by Subject|17
1093145|NCT02037477|3572431|P4|Treatment Period 1|Pre-treatment Event/Adverse Event|0
1093146|NCT02037477|3572432|P3|Treatment Period 1|Pre-treatment Event/Adverse Event|1
1093147|NCT02037477|3572433|P2|Treatment Period 1|Pre-treatment Event/Adverse Event|0
1093148|NCT02037477|3572434|P1|Treatment Period 1|Pre-treatment Event/Adverse Event|0
1093149|NCT02036775|3572512|P6|Treatment Period 2 (6 Days)|Withdrawal by Subject|1
1093150|NCT02036775|3572513|P5|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
1093151|NCT02036775|3572514|P4|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
1093152|NCT02036775|3572515|P3|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
1093153|NCT02036775|3572516|P2|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
1093154|NCT02036775|3572517|P1|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
1093155|NCT02036580|3572558|P3|Overall Study|Adverse Event|0
1093156|NCT02036580|3572559|P2|Overall Study|Adverse Event|0
1093157|NCT02036580|3572560|P1|Overall Study|Adverse Event|1
1093158|NCT02036580|3572558|P3|Overall Study|Withdrawal by Subject|0
1093159|NCT02036580|3572559|P2|Overall Study|Withdrawal by Subject|1
1093160|NCT02036580|3572560|P1|Overall Study|Withdrawal by Subject|0
1093161|NCT02036515|3572581|P3|Overall Study|Hyperglycemia|1
1093162|NCT02036515|3572582|P2|Overall Study|Hyperglycemia|0
1093163|NCT02036515|3572583|P1|Overall Study|Hyperglycemia|0
1093164|NCT02036515|3572581|P3|Overall Study|Withdrawal by Subject|9
1093165|NCT02036515|3572582|P2|Overall Study|Withdrawal by Subject|7
1093166|NCT02036515|3572583|P1|Overall Study|Withdrawal by Subject|4
1093167|NCT02036515|3572581|P3|Overall Study|Screen failure|0
1093168|NCT02036515|3572582|P2|Overall Study|Screen failure|2
1093169|NCT02036515|3572583|P1|Overall Study|Screen failure|0
1093170|NCT02036515|3572581|P3|Overall Study|Non-compliance with study drug|2
1093171|NCT02036515|3572582|P2|Overall Study|Non-compliance with study drug|0
1093172|NCT02036515|3572583|P1|Overall Study|Non-compliance with study drug|0
1093173|NCT02036515|3572581|P3|Overall Study|Lost to Follow-up|0
1093174|NCT02036515|3572582|P2|Overall Study|Lost to Follow-up|2
1093175|NCT02036515|3572583|P1|Overall Study|Lost to Follow-up|0
1093176|NCT02036515|3572581|P3|Overall Study|Adverse Event|2
1093177|NCT02036515|3572582|P2|Overall Study|Adverse Event|1
1093178|NCT02036515|3572583|P1|Overall Study|Adverse Event|1
1093179|NCT02035748|3572682|P1|Overall Study|Progressive Disease|1
1093180|NCT02035748|3572682|P1|Overall Study|Withdrawal by Subject|6
1093181|NCT02035748|3572682|P1|Overall Study|Physician Decision|3
1093182|NCT02035748|3572682|P1|Overall Study|Lost to Follow-up|2
1093183|NCT02035748|3572682|P1|Overall Study|Death|3
1093184|NCT02035748|3572682|P1|Overall Study|Adverse Event|5
1093185|NCT02035696|3572696|P4|Overall Study|Withdrawal by Subject|1
1093186|NCT02035696|3572697|P3|Overall Study|Withdrawal by Subject|2
1093187|NCT02035696|3572698|P2|Overall Study|Withdrawal by Subject|0
1093188|NCT02035696|3572699|P1|Overall Study|Withdrawal by Subject|3
1093189|NCT02035696|3572696|P4|Overall Study|Lost to Follow-up|2
1093190|NCT02035696|3572697|P3|Overall Study|Lost to Follow-up|1
1093191|NCT02035696|3572698|P2|Overall Study|Lost to Follow-up|3
1093192|NCT02035696|3572699|P1|Overall Study|Lost to Follow-up|0
1093193|NCT02035553|3572755|P2|Overall Study|Other Reason|4
1093194|NCT02035553|3572756|P1|Overall Study|Other Reason|0
1093195|NCT02035553|3572755|P2|Overall Study|Lost to Follow-up|1
1093196|NCT02035553|3572756|P1|Overall Study|Lost to Follow-up|0
1093197|NCT02035553|3572755|P2|Overall Study|Non-compliance with Study Drug|1
1093198|NCT02035553|3572756|P1|Overall Study|Non-compliance with Study Drug|0
1093199|NCT02035553|3572755|P2|Overall Study|Withdrawal by Subject|7
1093200|NCT02035553|3572756|P1|Overall Study|Withdrawal by Subject|4
1093201|NCT02035553|3572755|P2|Overall Study|Lack of Efficacy|1
1093202|NCT02035553|3572756|P1|Overall Study|Lack of Efficacy|1
1093203|NCT02035553|3572755|P2|Overall Study|Physician Decision|2
1093204|NCT02035553|3572756|P1|Overall Study|Physician Decision|3
1093205|NCT02035553|3572755|P2|Overall Study|Adverse Event|6
1093206|NCT02035553|3572756|P1|Overall Study|Adverse Event|10
1093207|NCT02035553|3572755|P2|Overall Study|Death (See All-Cause Mortality Table)|1
1093208|NCT02035553|3572756|P1|Overall Study|Death (See All-Cause Mortality Table)|0
1093209|NCT02035475|3572762|P1|Overall Study|Equipment Error|1
1093210|NCT02035475|3572762|P1|Overall Study|Physician Decision|1
1093211|NCT02035475|3572762|P1|Overall Study|Withdrawal by Subject|4
1093212|NCT02035332|3572773|P1|Overall Study|Procedure Aborted due to Uterine Width|1
1093213|NCT02034916|3572781|P2|Overall Study|Ongoing as of data cutoff (01 Sep 2016)|20
1093214|NCT02034916|3572782|P1|Overall Study|Ongoing as of data cutoff (01 Sep 2016)|15
1093215|NCT02034916|3572781|P2|Overall Study|Lost to Follow-up|1
1093216|NCT02034916|3572782|P1|Overall Study|Lost to Follow-up|1
1093217|NCT02034916|3572781|P2|Overall Study|Withdrawal by Subject|1
1093218|NCT02034916|3572782|P1|Overall Study|Withdrawal by Subject|1
1093219|NCT02034916|3572781|P2|Overall Study|Death|13
1093220|NCT02034916|3572782|P1|Overall Study|Death|32
1093221|NCT02034877|3572817|P2|Overall Study|No Longer Willing to Participate|3
1093222|NCT02034877|3572818|P1|Overall Study|No Longer Willing to Participate|0
1093223|NCT02034877|3572817|P2|Overall Study|Lost to Follow-up|3
1093224|NCT02034877|3572818|P1|Overall Study|Lost to Follow-up|0
1093225|NCT02034799|3572836|P2|Overall Study|Death|1
1093226|NCT02034799|3572837|P1|Overall Study|Death|2
1093227|NCT02034799|3572836|P2|Overall Study|Lost to Follow-up|1
1093228|NCT02034799|3572837|P1|Overall Study|Lost to Follow-up|0
1093229|NCT02034799|3572836|P2|Overall Study|Withdrawal by Subject|2
1093230|NCT02034799|3572837|P1|Overall Study|Withdrawal by Subject|0
1093231|NCT02034708|3572851|P2|Wash-out (From 2 Days up to 14 Days)|other reason|2
1093232|NCT02034708|3572852|P1|Wash-out (From 2 Days up to 14 Days)|other reason|3
1093233|NCT02034708|3572851|P2|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
1093234|NCT02034708|3572852|P1|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
1093235|NCT02034708|3572851|P2|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0
1093236|NCT02034708|3572852|P1|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1
1093237|NCT02034708|3572851|P2|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5
1093238|NCT02034708|3572852|P1|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2
1093239|NCT02034591|3572863|P6|Overall Study|Withdrawal by Subject|0
1093240|NCT02034591|3572864|P5|Overall Study|Withdrawal by Subject|1
1093241|NCT02034591|3572865|P4|Overall Study|Withdrawal by Subject|0
1093242|NCT02034591|3572866|P3|Overall Study|Withdrawal by Subject|0
1093243|NCT02034591|3572867|P2|Overall Study|Withdrawal by Subject|0
1093244|NCT02034591|3572868|P1|Overall Study|Withdrawal by Subject|0
1093245|NCT02034565|3572923|P2|Overall Study|Adverse Event|0
1093246|NCT02034565|3572924|P1|Overall Study|Adverse Event|1
1093247|NCT02034552|3572941|P3|Overall Study|Non-compliance with study drug|1
1093248|NCT02034552|3572942|P2|Overall Study|Non-compliance with study drug|0
1093249|NCT02034552|3572943|P1|Overall Study|Non-compliance with study drug|0
1093250|NCT02034552|3572941|P3|Overall Study|Withdrawal by Subject|1
1093251|NCT02034552|3572942|P2|Overall Study|Withdrawal by Subject|0
1093252|NCT02034552|3572943|P1|Overall Study|Withdrawal by Subject|2
1093253|NCT02034552|3572941|P3|Overall Study|AE associated with disease progression|0
1093254|NCT02034552|3572942|P2|Overall Study|AE associated with disease progression|1
1093255|NCT02034552|3572943|P1|Overall Study|AE associated with disease progression|0
1093256|NCT02034552|3572941|P3|Overall Study|AE not assoc. with disease progression|2
1093257|NCT02034552|3572942|P2|Overall Study|AE not assoc. with disease progression|3
1093258|NCT02034552|3572943|P1|Overall Study|AE not assoc. with disease progression|1
1093259|NCT02034552|3572941|P3|Overall Study|Ongoing with treatment|11
1093260|NCT02034552|3572942|P2|Overall Study|Ongoing with treatment|11
1093261|NCT02034552|3572943|P1|Overall Study|Ongoing with treatment|0
1093262|NCT02034552|3572941|P3|Overall Study|Never treated|0
1093263|NCT02034552|3572942|P2|Overall Study|Never treated|2
1093264|NCT02034552|3572943|P1|Overall Study|Never treated|3
1093265|NCT02034513|3572968|P2|Overall Study|Unclassified|1
1093266|NCT02034513|3572969|P1|Overall Study|Unclassified|0
1093267|NCT02034513|3572968|P2|Overall Study|Withdrawal by Subject|25
1093268|NCT02034513|3572969|P1|Overall Study|Withdrawal by Subject|25
1093269|NCT02034513|3572968|P2|Overall Study|Protocol Violation|10
1093270|NCT02034513|3572969|P1|Overall Study|Protocol Violation|7
1093271|NCT02034513|3572968|P2|Overall Study|Pregnancy|3
1093272|NCT02034513|3572969|P1|Overall Study|Pregnancy|0
1093273|NCT02034513|3572968|P2|Overall Study|Lost to Follow-up|7
1093274|NCT02034513|3572969|P1|Overall Study|Lost to Follow-up|6
1093275|NCT02034513|3572968|P2|Overall Study|Lack of Efficacy|1
1093276|NCT02034513|3572969|P1|Overall Study|Lack of Efficacy|0
1093277|NCT02034513|3572968|P2|Overall Study|Adverse Event|10
1093278|NCT02034513|3572969|P1|Overall Study|Adverse Event|11
1093279|NCT02034474|3572987|P2|Overall Study|Withdrawal by Subject|2
1093280|NCT02034474|3572988|P1|Overall Study|Withdrawal by Subject|1
1093281|NCT02034474|3572987|P2|Overall Study|Adverse Event|2
1093282|NCT02034474|3572988|P1|Overall Study|Adverse Event|3
1093283|NCT02034162|3573000|P3|Double-blind|Withdrawal by Subject|0
1093284|NCT02034162|3573001|P2|Double-blind|Withdrawal by Subject|7
1093285|NCT02034162|3573002|P1|Double-blind|Withdrawal by Subject|5
1093286|NCT02034162|3573000|P3|Double-blind|Protocol Violation|0
1093287|NCT02034162|3573001|P2|Double-blind|Protocol Violation|1
1093288|NCT02034162|3573002|P1|Double-blind|Protocol Violation|0
1093289|NCT02034162|3573000|P3|Double-blind|Physician Decision|0
1093290|NCT02034162|3573001|P2|Double-blind|Physician Decision|0
1093291|NCT02034162|3573002|P1|Double-blind|Physician Decision|1
1093292|NCT02034162|3573000|P3|Double-blind|Lost to Follow-up|0
1093293|NCT02034162|3573001|P2|Double-blind|Lost to Follow-up|0
1093294|NCT02034162|3573002|P1|Double-blind|Lost to Follow-up|3
1093295|NCT02033889|3573033|P3|Overall Study|Withdrawal by Subject|13
1093296|NCT02033889|3573034|P2|Overall Study|Withdrawal by Subject|10
1093297|NCT02033889|3573035|P1|Overall Study|Withdrawal by Subject|18
1093298|NCT02033889|3573033|P3|Overall Study|Participant moved|0
1093299|NCT02033889|3573034|P2|Overall Study|Participant moved|1
1093300|NCT02033889|3573035|P1|Overall Study|Participant moved|0
1093301|NCT02033889|3573033|P3|Overall Study|Physician Decision|1
1093302|NCT02033889|3573034|P2|Overall Study|Physician Decision|1
1093303|NCT02033889|3573035|P1|Overall Study|Physician Decision|0
1093304|NCT02033889|3573033|P3|Overall Study|Non-Compliance With Study Drug|0
1093305|NCT02033889|3573034|P2|Overall Study|Non-Compliance With Study Drug|0
1093306|NCT02033889|3573035|P1|Overall Study|Non-Compliance With Study Drug|1
1093307|NCT02033889|3573033|P3|Overall Study|Lost to Follow-up|6
1093308|NCT02033889|3573034|P2|Overall Study|Lost to Follow-up|5
1093309|NCT02033889|3573035|P1|Overall Study|Lost to Follow-up|8
1093310|NCT02033889|3573033|P3|Overall Study|Excluded Medication|0
1093311|NCT02033889|3573034|P2|Overall Study|Excluded Medication|1
1093312|NCT02033889|3573035|P1|Overall Study|Excluded Medication|1
1093313|NCT02033889|3573033|P3|Overall Study|Death|2
1093314|NCT02033889|3573034|P2|Overall Study|Death|1
1093315|NCT02033889|3573035|P1|Overall Study|Death|3
1093316|NCT02033889|3573033|P3|Overall Study|Adverse Event|3
1093317|NCT02033889|3573034|P2|Overall Study|Adverse Event|1
1093318|NCT02033889|3573035|P1|Overall Study|Adverse Event|3
1093319|NCT02033369|3573232|P2|Overall Study|Protocol Violation|0
1093320|NCT02033369|3573233|P1|Overall Study|Protocol Violation|2
1093321|NCT02033369|3573232|P2|Overall Study|Lost to Follow-up|0
1093322|NCT02033369|3573233|P1|Overall Study|Lost to Follow-up|1
1093323|NCT02033369|3573232|P2|Overall Study|Withdrawal by Subject|1
1093324|NCT02033369|3573233|P1|Overall Study|Withdrawal by Subject|1
1093325|NCT02033369|3573232|P2|Overall Study|Not a good demographic match|2
1093326|NCT02033369|3573233|P1|Overall Study|Not a good demographic match|0
1093327|NCT02033369|3573232|P2|Overall Study|Physician Decision|2
1093328|NCT02033369|3573233|P1|Overall Study|Physician Decision|1
1093329|NCT02032901|3573308|P2|Follow-Up Period (24 Weeks)|Lost to Follow-up|1
1093330|NCT02032901|3573309|P1|Follow-Up Period (24 Weeks)|Lost to Follow-up|0
1093331|NCT02032901|3573308|P2|Treatment Period (12 Weeks)|Pregnancy|0
1093332|NCT02032901|3573309|P1|Treatment Period (12 Weeks)|Pregnancy|1
1093333|NCT02032888|3573333|P3|Follow-up Period|Not specified|0
1093334|NCT02032888|3573334|P2|Follow-up Period|Not specified|0
1093335|NCT02032888|3573335|P1|Follow-up Period|Not specified|1
1093336|NCT02032888|3573333|P3|Follow-up Period|Death|0
1093337|NCT02032888|3573334|P2|Follow-up Period|Death|1
1093338|NCT02032888|3573335|P1|Follow-up Period|Death|1
1093339|NCT02032888|3573333|P3|Follow-up Period|Lost to Follow-up|0
1093340|NCT02032888|3573334|P2|Follow-up Period|Lost to Follow-up|1
1093341|NCT02032888|3573335|P1|Follow-up Period|Lost to Follow-up|1
1093342|NCT02032888|3573333|P3|Treatment Period|Not specified|0
1093343|NCT02032888|3573334|P2|Treatment Period|Not specified|1
1093344|NCT02032888|3573335|P1|Treatment Period|Not specified|1
1093345|NCT02032888|3573333|P3|Treatment Period|Poor compliance/noncompliance|0
1093346|NCT02032888|3573334|P2|Treatment Period|Poor compliance/noncompliance|1
1093347|NCT02032888|3573335|P1|Treatment Period|Poor compliance/noncompliance|1
1093348|NCT02032875|3573366|P2|Follow-up Period|Virologic Relapse|10
1093349|NCT02032875|3573367|P1|Follow-up Period|Virologic Relapse|3
1093350|NCT02032875|3573366|P2|Follow-up Period|Death|1
1093351|NCT02032875|3573367|P1|Follow-up Period|Death|0
1093352|NCT02032875|3573366|P2|Treatment Period|Liver transplant, Treatment extension|3
1093353|NCT02032875|3573367|P1|Treatment Period|Liver transplant, Treatment extension|0
1093354|NCT02032875|3573366|P2|Treatment Period|Liver transplant, No extension needed|1
1093355|NCT02032875|3573367|P1|Treatment Period|Liver transplant, No extension needed|0
1093356|NCT02032875|3573366|P2|Treatment Period|Adverse Event|0
1093357|NCT02032875|3573367|P1|Treatment Period|Adverse Event|1
1093358|NCT02032706|3573396|P1|Overall Study|Protocol Violation|1
1093359|NCT02032706|3573396|P1|Overall Study|Did not qualify|5
1093360|NCT02032407|3573453|P1|Overall Study|Other Miscellaneous Reasons|2
1093361|NCT02032407|3573453|P1|Overall Study|Pregnancy|1
1093362|NCT02032407|3573453|P1|Overall Study|Lost to Follow-up|2
1093363|NCT02032238|3573466|P2|Overall Study|Lost to Follow-up|0
1093364|NCT02032238|3573467|P1|Overall Study|Lost to Follow-up|2
1093365|NCT02031679|3573508|P2|Overall Study|Lack of Efficacy|1
1093366|NCT02031679|3573509|P1|Overall Study|Lack of Efficacy|0
1093367|NCT02031679|3573508|P2|Overall Study|Protocol Violation|1
1093368|NCT02031679|3573509|P1|Overall Study|Protocol Violation|0
1093369|NCT02031640|3573524|P6|Double-blind Treatment Period|Lost to Follow-up|0
1093370|NCT02031640|3573525|P5|Double-blind Treatment Period|Lost to Follow-up|1
1093371|NCT02031640|3573526|P4|Double-blind Treatment Period|Lost to Follow-up|0
1093372|NCT02031640|3573527|P3|Double-blind Treatment Period|Lost to Follow-up|0
1093373|NCT02031640|3573528|P2|Double-blind Treatment Period|Lost to Follow-up|3
1093374|NCT02031640|3573529|P1|Double-blind Treatment Period|Lost to Follow-up|0
1093375|NCT02031640|3573524|P6|Double-blind Treatment Period|Withdrawal by Subject|1
1093376|NCT02031640|3573525|P5|Double-blind Treatment Period|Withdrawal by Subject|1
1093377|NCT02031640|3573526|P4|Double-blind Treatment Period|Withdrawal by Subject|1
1093378|NCT02031640|3573527|P3|Double-blind Treatment Period|Withdrawal by Subject|3
1093379|NCT02031640|3573528|P2|Double-blind Treatment Period|Withdrawal by Subject|2
1093380|NCT02031640|3573529|P1|Double-blind Treatment Period|Withdrawal by Subject|0
1093381|NCT02031640|3573524|P6|Double-blind Treatment Period|Adverse Event|0
1093382|NCT02031640|3573525|P5|Double-blind Treatment Period|Adverse Event|0
1093383|NCT02031640|3573526|P4|Double-blind Treatment Period|Adverse Event|2
1093384|NCT02031640|3573527|P3|Double-blind Treatment Period|Adverse Event|0
1093385|NCT02031640|3573528|P2|Double-blind Treatment Period|Adverse Event|0
1093386|NCT02031640|3573529|P1|Double-blind Treatment Period|Adverse Event|0
1093387|NCT02031640|3573524|P6|Double-blind Treatment Period|Non-compliance|0
1093388|NCT02031640|3573525|P5|Double-blind Treatment Period|Non-compliance|1
1093389|NCT02031640|3573526|P4|Double-blind Treatment Period|Non-compliance|1
1093390|NCT02031640|3573527|P3|Double-blind Treatment Period|Non-compliance|0
1093391|NCT02031640|3573528|P2|Double-blind Treatment Period|Non-compliance|1
1093392|NCT02031640|3573529|P1|Double-blind Treatment Period|Non-compliance|0
1093393|NCT02031640|3573524|P6|Double-blind Treatment Period|Lack of Efficacy|1
1093394|NCT02031640|3573525|P5|Double-blind Treatment Period|Lack of Efficacy|5
1093395|NCT02031640|3573526|P4|Double-blind Treatment Period|Lack of Efficacy|2
1093396|NCT02031640|3573527|P3|Double-blind Treatment Period|Lack of Efficacy|3
1093397|NCT02031640|3573528|P2|Double-blind Treatment Period|Lack of Efficacy|14
1093398|NCT02031640|3573529|P1|Double-blind Treatment Period|Lack of Efficacy|0
1093399|NCT02031640|3573524|P6|Double-blind Treatment Period|Protocol deviation|1
1093400|NCT02031640|3573525|P5|Double-blind Treatment Period|Protocol deviation|3
1093401|NCT02031640|3573526|P4|Double-blind Treatment Period|Protocol deviation|1
1093402|NCT02031640|3573527|P3|Double-blind Treatment Period|Protocol deviation|0
1093403|NCT02031640|3573528|P2|Double-blind Treatment Period|Protocol deviation|2
1093404|NCT02031640|3573529|P1|Double-blind Treatment Period|Protocol deviation|0
1093405|NCT02031640|3573524|P6|Run-In Period|Various administrative reasons|0
1093406|NCT02031640|3573525|P5|Run-In Period|Various administrative reasons|0
1093407|NCT02031640|3573526|P4|Run-In Period|Various administrative reasons|0
1093408|NCT02031640|3573527|P3|Run-In Period|Various administrative reasons|0
1093409|NCT02031640|3573528|P2|Run-In Period|Various administrative reasons|0
1093410|NCT02031640|3573529|P1|Run-In Period|Various administrative reasons|17
1093411|NCT02031640|3573524|P6|Run-In Period|Randomization criteria not met|0
1093412|NCT02031640|3573525|P5|Run-In Period|Randomization criteria not met|0
1093413|NCT02031640|3573526|P4|Run-In Period|Randomization criteria not met|0
1093414|NCT02031640|3573527|P3|Run-In Period|Randomization criteria not met|0
1093415|NCT02031640|3573528|P2|Run-In Period|Randomization criteria not met|0
1093416|NCT02031640|3573529|P1|Run-In Period|Randomization criteria not met|85
1093417|NCT02031640|3573524|P6|Run-In Period|Exclusion criteria met|0
1093418|NCT02031640|3573525|P5|Run-In Period|Exclusion criteria met|0
1093419|NCT02031640|3573526|P4|Run-In Period|Exclusion criteria met|0
1093420|NCT02031640|3573527|P3|Run-In Period|Exclusion criteria met|0
1093421|NCT02031640|3573528|P2|Run-In Period|Exclusion criteria met|0
1093422|NCT02031640|3573529|P1|Run-In Period|Exclusion criteria met|8
1093423|NCT02031640|3573524|P6|Run-In Period|Inclusion criteria not met|0
1093424|NCT02031640|3573525|P5|Run-In Period|Inclusion criteria not met|0
1093425|NCT02031640|3573526|P4|Run-In Period|Inclusion criteria not met|0
1093426|NCT02031640|3573527|P3|Run-In Period|Inclusion criteria not met|0
1093427|NCT02031640|3573528|P2|Run-In Period|Inclusion criteria not met|0
1093428|NCT02031640|3573529|P1|Run-In Period|Inclusion criteria not met|38
1093429|NCT02031640|3573524|P6|Run-In Period|Withdrawal by Subject|0
1093430|NCT02031640|3573525|P5|Run-In Period|Withdrawal by Subject|0
1093431|NCT02031640|3573526|P4|Run-In Period|Withdrawal by Subject|0
1093432|NCT02031640|3573527|P3|Run-In Period|Withdrawal by Subject|0
1093433|NCT02031640|3573528|P2|Run-In Period|Withdrawal by Subject|0
1093434|NCT02031640|3573529|P1|Run-In Period|Withdrawal by Subject|17
1093435|NCT02031640|3573524|P6|Run-In Period|Adverse Event|0
1093436|NCT02031640|3573525|P5|Run-In Period|Adverse Event|0
1093437|NCT02031640|3573526|P4|Run-In Period|Adverse Event|0
1093438|NCT02031640|3573527|P3|Run-In Period|Adverse Event|0
1093439|NCT02031640|3573528|P2|Run-In Period|Adverse Event|0
1093440|NCT02031640|3573529|P1|Run-In Period|Adverse Event|4
1093441|NCT02031640|3573524|P6|Screening Period|Enrollment closed|0
1093442|NCT02031640|3573525|P5|Screening Period|Enrollment closed|0
1093443|NCT02031640|3573526|P4|Screening Period|Enrollment closed|0
1093444|NCT02031640|3573527|P3|Screening Period|Enrollment closed|0
1093445|NCT02031640|3573528|P2|Screening Period|Enrollment closed|0
1093446|NCT02031640|3573529|P1|Screening Period|Enrollment closed|26
1093447|NCT02031640|3573524|P6|Screening Period|Lost to Follow-up|0
1093448|NCT02031640|3573525|P5|Screening Period|Lost to Follow-up|0
1093449|NCT02031640|3573526|P4|Screening Period|Lost to Follow-up|0
1093450|NCT02031640|3573527|P3|Screening Period|Lost to Follow-up|0
1093451|NCT02031640|3573528|P2|Screening Period|Lost to Follow-up|0
1093452|NCT02031640|3573529|P1|Screening Period|Lost to Follow-up|14
1093453|NCT02031640|3573524|P6|Screening Period|Exclusion criteria met|0
1093454|NCT02031640|3573525|P5|Screening Period|Exclusion criteria met|0
1093455|NCT02031640|3573526|P4|Screening Period|Exclusion criteria met|0
1093456|NCT02031640|3573527|P3|Screening Period|Exclusion criteria met|0
1093457|NCT02031640|3573528|P2|Screening Period|Exclusion criteria met|0
1093458|NCT02031640|3573529|P1|Screening Period|Exclusion criteria met|30
1093459|NCT02031640|3573524|P6|Screening Period|Inclusion criteria not met|0
1093460|NCT02031640|3573525|P5|Screening Period|Inclusion criteria not met|0
1093461|NCT02031640|3573526|P4|Screening Period|Inclusion criteria not met|0
1093462|NCT02031640|3573527|P3|Screening Period|Inclusion criteria not met|0
1093463|NCT02031640|3573528|P2|Screening Period|Inclusion criteria not met|0
1093464|NCT02031640|3573529|P1|Screening Period|Inclusion criteria not met|312
1093465|NCT02031640|3573524|P6|Screening Period|Withdrawal by Subject|0
1093466|NCT02031640|3573525|P5|Screening Period|Withdrawal by Subject|0
1093467|NCT02031640|3573526|P4|Screening Period|Withdrawal by Subject|0
1093468|NCT02031640|3573527|P3|Screening Period|Withdrawal by Subject|0
1093469|NCT02031640|3573528|P2|Screening Period|Withdrawal by Subject|0
1093470|NCT02031640|3573529|P1|Screening Period|Withdrawal by Subject|29
1093471|NCT02031640|3573524|P6|Screening Period|Adverse Event|0
1093472|NCT02031640|3573525|P5|Screening Period|Adverse Event|0
1093473|NCT02031640|3573526|P4|Screening Period|Adverse Event|0
1093474|NCT02031640|3573527|P3|Screening Period|Adverse Event|0
1093475|NCT02031640|3573528|P2|Screening Period|Adverse Event|0
1093476|NCT02031640|3573529|P1|Screening Period|Adverse Event|1
1093477|NCT02031471|3573572|P1|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1
1093478|NCT02031471|3573572|P1|Long Term Extension (LTE) Period|Adverse Event|1
1093479|NCT02031471|3573572|P1|24 Week Treatment Period|Hypersensitivity Reaction|1
1093480|NCT02031471|3573572|P1|24 Week Treatment Period|Insufficient Therapeutic Response|1
1093481|NCT02031471|3573572|P1|24 Week Treatment Period|Protocol Violation|1
1093482|NCT02031471|3573572|P1|24 Week Treatment Period|Participant Decision to Withdraw|2
1093483|NCT02031471|3573572|P1|24 Week Treatment Period|Adverse Event|6
1093484|NCT02031458|3573605|P3|Overall Study|Lost to Follow-up|2
1093485|NCT02031458|3573606|P2|Overall Study|Lost to Follow-up|1
1093486|NCT02031458|3573607|P1|Overall Study|Lost to Follow-up|1
1093487|NCT02031458|3573605|P3|Overall Study|On Treatment|73
1093488|NCT02031458|3573606|P2|Overall Study|On Treatment|81
1093489|NCT02031458|3573607|P1|Overall Study|On Treatment|43
1093490|NCT02031458|3573605|P3|Overall Study|On Survival Follow-Up|73
1093491|NCT02031458|3573606|P2|Overall Study|On Survival Follow-Up|83
1093492|NCT02031458|3573607|P1|Overall Study|On Survival Follow-Up|46
1093493|NCT02031458|3573605|P3|Overall Study|Withdrawal by Subject|3
1093494|NCT02031458|3573606|P2|Overall Study|Withdrawal by Subject|9
1093495|NCT02031458|3573607|P1|Overall Study|Withdrawal by Subject|6
1093496|NCT02031458|3573605|P3|Overall Study|Unknown Reason|2
1093497|NCT02031458|3573606|P2|Overall Study|Unknown Reason|1
1093498|NCT02031458|3573607|P1|Overall Study|Unknown Reason|0
1093499|NCT02031458|3573605|P3|Overall Study|Physician Decision|0
1093500|NCT02031458|3573606|P2|Overall Study|Physician Decision|1
1093501|NCT02031458|3573607|P1|Overall Study|Physician Decision|0
1093502|NCT02031458|3573605|P3|Overall Study|Protocol Violation|0
1093503|NCT02031458|3573606|P2|Overall Study|Protocol Violation|4
1093504|NCT02031458|3573607|P1|Overall Study|Protocol Violation|7
1093505|NCT02031458|3573605|P3|Overall Study|Death|100
1093506|NCT02031458|3573606|P2|Overall Study|Death|87
1093507|NCT02031458|3573607|P1|Overall Study|Death|36
1093508|NCT02031276|3573704|P3|Period 3 Open-label Risankizumab SC|Not Specified|1
1093509|NCT02031276|3573705|P2|Period 3 Open-label Risankizumab SC|Not Specified|0
1093510|NCT02031276|3573706|P1|Period 3 Open-label Risankizumab SC|Not Specified|0
1093511|NCT02031276|3573704|P3|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
1093512|NCT02031276|3573705|P2|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
1093513|NCT02031276|3573706|P1|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
1093514|NCT02031276|3573704|P3|Period 3 Open-label Risankizumab SC|Protocol Violation|0
1093515|NCT02031276|3573705|P2|Period 3 Open-label Risankizumab SC|Protocol Violation|0
1093516|NCT02031276|3573706|P1|Period 3 Open-label Risankizumab SC|Protocol Violation|2
1093517|NCT02031276|3573704|P3|Period 3 Open-label Risankizumab SC|Adverse Event|0
1093518|NCT02031276|3573705|P2|Period 3 Open-label Risankizumab SC|Adverse Event|2
1093519|NCT02031276|3573706|P1|Period 3 Open-label Risankizumab SC|Adverse Event|0
1093520|NCT02031276|3573704|P3|Period 2 Open-label Risankizumab IV|Not Specified|1
1093521|NCT02031276|3573705|P2|Period 2 Open-label Risankizumab IV|Not Specified|2
1093522|NCT02031276|3573706|P1|Period 2 Open-label Risankizumab IV|Not Specified|0
1093523|NCT02031276|3573704|P3|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0
1093524|NCT02031276|3573705|P2|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0
1093525|NCT02031276|3573706|P1|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3
1093526|NCT02031276|3573704|P3|Period 2 Open-label Risankizumab IV|Adverse Event|0
1093527|NCT02031276|3573705|P2|Period 2 Open-label Risankizumab IV|Adverse Event|0
1093528|NCT02031276|3573706|P1|Period 2 Open-label Risankizumab IV|Adverse Event|1
1093529|NCT02031276|3573704|P3|Period 1 Double-blind IV|Not specified|0
1093530|NCT02031276|3573705|P2|Period 1 Double-blind IV|Not specified|1
1093531|NCT02031276|3573706|P1|Period 1 Double-blind IV|Not specified|0
1093532|NCT02031276|3573704|P3|Period 1 Double-blind IV|Adverse Event|1
1093533|NCT02031276|3573705|P2|Period 1 Double-blind IV|Adverse Event|5
1093534|NCT02031276|3573706|P1|Period 1 Double-blind IV|Adverse Event|6
1093535|NCT02030821|3573742|P4|Overall Study|Physician Decision|2
1093536|NCT02030821|3573743|P3|Overall Study|Physician Decision|5
1093537|NCT02030821|3573744|P2|Overall Study|Physician Decision|2
1093538|NCT02030821|3573745|P1|Overall Study|Physician Decision|2
1093539|NCT02030600|3573773|P2|Treatment Period 2|Unclassified|0
1093540|NCT02030600|3573774|P1|Treatment Period 2|Unclassified|1
1093541|NCT02030600|3573773|P2|Treatment Period 2|Withdrawal by Subject|9
1093542|NCT02030600|3573774|P1|Treatment Period 2|Withdrawal by Subject|13
1093543|NCT02030600|3573773|P2|Treatment Period 2|Protocol Violation|2
1093544|NCT02030600|3573774|P1|Treatment Period 2|Protocol Violation|1
1093545|NCT02030600|3573773|P2|Treatment Period 2|Lost to Follow-up|2
1093546|NCT02030600|3573774|P1|Treatment Period 2|Lost to Follow-up|4
1093547|NCT02030600|3573773|P2|Treatment Period 2|Lack of Efficacy|1
1093548|NCT02030600|3573774|P1|Treatment Period 2|Lack of Efficacy|2
1093549|NCT02030600|3573773|P2|Treatment Period 2|Adverse Event|4
1093550|NCT02030600|3573774|P1|Treatment Period 2|Adverse Event|4
1093551|NCT02030600|3573773|P2|Treatment Period 1|Unclassified|0
1093552|NCT02030600|3573774|P1|Treatment Period 1|Unclassified|1
1093553|NCT02030600|3573773|P2|Treatment Period 1|Casebook Unsigned|0
1093554|NCT02030600|3573774|P1|Treatment Period 1|Casebook Unsigned|1
1093555|NCT02030600|3573773|P2|Treatment Period 1|Withdrawal by Subject|17
1093556|NCT02030600|3573774|P1|Treatment Period 1|Withdrawal by Subject|13
1093557|NCT02030600|3573773|P2|Treatment Period 1|Protocol Violation|17
1093558|NCT02030600|3573774|P1|Treatment Period 1|Protocol Violation|22
1093559|NCT02030600|3573773|P2|Treatment Period 1|Lost to Follow-up|3
1093560|NCT02030600|3573774|P1|Treatment Period 1|Lost to Follow-up|11
1093561|NCT02030600|3573773|P2|Treatment Period 1|Lack of Efficacy|1
1093562|NCT02030600|3573774|P1|Treatment Period 1|Lack of Efficacy|0
1093563|NCT02030600|3573773|P2|Treatment Period 1|Adverse Event|7
1093564|NCT02030600|3573774|P1|Treatment Period 1|Adverse Event|5
1093565|NCT02030535|3573795|P1|Washout Period 1 (21 Days)|Adverse Event|1
1093566|NCT02030405|3573863|P1|Overall Study|Lost to Follow-up|1
1093567|NCT02030405|3573863|P1|Overall Study|Withdrawal by Subject|1
1093568|NCT02030119|3573872|P4|Overall Study|Ineligible (see Pre-assignment Details)|0
1093569|NCT02030119|3573873|P3|Overall Study|Ineligible (see Pre-assignment Details)|1
1093570|NCT02030119|3573874|P2|Overall Study|Ineligible (see Pre-assignment Details)|1
1093571|NCT02030119|3573875|P1|Overall Study|Ineligible (see Pre-assignment Details)|0
1093572|NCT02030119|3573872|P4|Overall Study|Withdrawal by Subject|3
1093573|NCT02030119|3573873|P3|Overall Study|Withdrawal by Subject|5
1093574|NCT02030119|3573874|P2|Overall Study|Withdrawal by Subject|1
1093575|NCT02030119|3573875|P1|Overall Study|Withdrawal by Subject|3
1093576|NCT02030041|3573913|P3|Overall Study|Withdrawal by Subject|1
1093577|NCT02030041|3573914|P2|Overall Study|Withdrawal by Subject|2
1093578|NCT02030041|3573915|P1|Overall Study|Withdrawal by Subject|2
1093579|NCT02029989|3573928|P2|Overall Study|Protocol Violation|0
1093580|NCT02029989|3573929|P1|Overall Study|Protocol Violation|1
1093581|NCT02029989|3573928|P2|Overall Study|Death|1
1093582|NCT02029989|3573929|P1|Overall Study|Death|0
1093583|NCT02029989|3573928|P2|Overall Study|Lost to Follow-up|7
1093584|NCT02029989|3573929|P1|Overall Study|Lost to Follow-up|9
1093585|NCT02029989|3573928|P2|Overall Study|Physician Decision|0
1093586|NCT02029989|3573929|P1|Overall Study|Physician Decision|2
1093587|NCT02029989|3573928|P2|Overall Study|Change of location|3
1093588|NCT02029989|3573929|P1|Overall Study|Change of location|2
1093589|NCT02029989|3573928|P2|Overall Study|Withdrawal: Fear of needles|0
1093590|NCT02029989|3573929|P1|Overall Study|Withdrawal: Fear of needles|1
1093591|NCT02029989|3573928|P2|Overall Study|Withdrawal by Subject|0
1093592|NCT02029989|3573929|P1|Overall Study|Withdrawal by Subject|1
1093593|NCT02029846|3573952|P2|Overall Study|n=1 each arm|1
1093594|NCT02029846|3573953|P1|Overall Study|n=1 each arm|1
1093595|NCT02029638|3573991|P3|Overall Study|Decision by Study Sponsor or Regulatory|0
1093596|NCT02029638|3573992|P2|Overall Study|Decision by Study Sponsor or Regulatory|0
1093597|NCT02029638|3573993|P1|Overall Study|Decision by Study Sponsor or Regulatory|2
1093598|NCT02029638|3573991|P3|Overall Study|Death|1
1093599|NCT02029638|3573992|P2|Overall Study|Death|0
1093600|NCT02029638|3573993|P1|Overall Study|Death|0
1093601|NCT02029521|3574022|P2|Overall Study|Withdrawal by Subject|1
1093602|NCT02029521|3574023|P1|Overall Study|Withdrawal by Subject|1
1093603|NCT02029521|3574022|P2|Overall Study|Protocol Violation|0
1093604|NCT02029521|3574023|P1|Overall Study|Protocol Violation|1
1093605|NCT02029417|3574121|P1|Overall Study|Adverse Event|1
1093606|NCT02029417|3574121|P1|Overall Study|Death|1
1093607|NCT02029235|3574128|P2|Overall Study|Non-compliance with study meds or diary|1
1093608|NCT02029235|3574129|P1|Overall Study|Non-compliance with study meds or diary|4
1093609|NCT02028871|3574150|P2|Overall Study|Current Illness|0
1093610|NCT02028871|3574151|P1|Overall Study|Current Illness|1
1093611|NCT02028871|3574150|P2|Overall Study|IV placement difficulty|0
1093612|NCT02028871|3574151|P1|Overall Study|IV placement difficulty|1
1093613|NCT02028871|3574150|P2|Overall Study|Withdrawal by Subject|2
1093614|NCT02028871|3574151|P1|Overall Study|Withdrawal by Subject|1
1093615|NCT02028871|3574150|P2|Overall Study|Positive urine drug screen|1
1093616|NCT02028871|3574151|P1|Overall Study|Positive urine drug screen|1
1093617|NCT02028767|3574248|P2|Treatment Period 2|Reason other than those specified above|0
1093618|NCT02028767|3574249|P1|Treatment Period 2|Reason other than those specified above|1
1093619|NCT02028767|3574248|P2|Treatment Period 2|Non compliant with protocol|0
1093620|NCT02028767|3574249|P1|Treatment Period 2|Non compliant with protocol|1
1093621|NCT02028715|3574282|P2|Overall Study|Did not complete satisfaction surveys|2
1093622|NCT02028715|3574283|P1|Overall Study|Did not complete satisfaction surveys|2
1093623|NCT02028715|3574282|P2|Overall Study|Physician Decision|0
1093624|NCT02028715|3574283|P1|Overall Study|Physician Decision|1
1093625|NCT02028715|3574282|P2|Overall Study|Adverse Event|2
1093626|NCT02028715|3574283|P1|Overall Study|Adverse Event|2
1093627|NCT02028169|3574495|P1|Overall Study|Concomitant Medication Usage|1
1093628|NCT02028169|3574495|P1|Overall Study|Cessation of Drug|1
1093629|NCT02028169|3574495|P1|Overall Study|Adverse Event|1
1093630|NCT02028169|3574495|P1|Overall Study|Withdrawal by Subject|2
1093631|NCT02028169|3574495|P1|Overall Study|Lack of Efficacy|2
1093632|NCT02028169|3574495|P1|Overall Study|Lost to Follow-up|21
1093633|NCT02028065|3574521|P3|Treatment Through Study Completion|Adverse Event|5
1093634|NCT02028065|3574522|P2|Treatment Through Study Completion|Adverse Event|3
1093635|NCT02028065|3574523|P1|Treatment Through Study Completion|Adverse Event|3
1093636|NCT02028065|3574521|P3|Treatment Through Study Completion|Withdrawal by Subject|3
1093637|NCT02028065|3574522|P2|Treatment Through Study Completion|Withdrawal by Subject|4
1093638|NCT02028065|3574523|P1|Treatment Through Study Completion|Withdrawal by Subject|5
1093639|NCT02028065|3574521|P3|Treatment Through Study Completion|Protocol Violation|0
1093640|NCT02028065|3574522|P2|Treatment Through Study Completion|Protocol Violation|4
1093641|NCT02028065|3574523|P1|Treatment Through Study Completion|Protocol Violation|1
1093642|NCT02028065|3574521|P3|Treatment Through Study Completion|Physician Decision|0
1093643|NCT02028065|3574522|P2|Treatment Through Study Completion|Physician Decision|0
1093644|NCT02028065|3574523|P1|Treatment Through Study Completion|Physician Decision|1
1093645|NCT02028065|3574521|P3|Treatment Through Study Completion|Lost to Follow-up|6
1093646|NCT02028065|3574522|P2|Treatment Through Study Completion|Lost to Follow-up|4
1093647|NCT02028065|3574523|P1|Treatment Through Study Completion|Lost to Follow-up|2
1093648|NCT02028065|3574521|P3|Randomization Through Start Treatment|Not treated|3
1093649|NCT02028065|3574522|P2|Randomization Through Start Treatment|Not treated|3
1093650|NCT02028065|3574523|P1|Randomization Through Start Treatment|Not treated|1
1093651|NCT02027844|3574550|P3|Overall Study|Incomlete data|0
1093652|NCT02027844|3574551|P2|Overall Study|Incomlete data|0
1093653|NCT02027844|3574552|P1|Overall Study|Incomlete data|2
1093654|NCT02027844|3574550|P3|Overall Study|Protocol Violation|0
1093655|NCT02027844|3574551|P2|Overall Study|Protocol Violation|2
1093656|NCT02027844|3574552|P1|Overall Study|Protocol Violation|0
1093657|NCT02027844|3574550|P3|Overall Study|Lost to Follow-up|1
1093658|NCT02027844|3574551|P2|Overall Study|Lost to Follow-up|2
1093659|NCT02027844|3574552|P1|Overall Study|Lost to Follow-up|0
1093660|NCT02027844|3574550|P3|Overall Study|Withdrawal by Subject|1
1093661|NCT02027844|3574551|P2|Overall Study|Withdrawal by Subject|2
1093662|NCT02027844|3574552|P1|Overall Study|Withdrawal by Subject|3
1093663|NCT02027701|3574569|P1|Overall Study|Withdrawal by Subject|3
1093664|NCT02027701|3574569|P1|Overall Study|Physician Decision|2
1093665|NCT02027701|3574569|P1|Overall Study|Lack of Efficacy|8
1093666|NCT02027701|3574569|P1|Overall Study|Adverse Event|3
1093667|NCT02027428|3574587|P3|Survival Follow-up|Lost to Follow-up|0
1093668|NCT02027428|3574588|P2|Survival Follow-up|Lost to Follow-up|1
1093669|NCT02027428|3574589|P1|Survival Follow-up|Lost to Follow-up|0
1093670|NCT02027428|3574587|P3|Survival Follow-up|Death|30
1093671|NCT02027428|3574588|P2|Survival Follow-up|Death|47
1093672|NCT02027428|3574589|P1|Survival Follow-up|Death|0
1093673|NCT02027428|3574587|P3|Maintenance|Not specified|3
1093674|NCT02027428|3574588|P2|Maintenance|Not specified|6
1093675|NCT02027428|3574589|P1|Maintenance|Not specified|0
1093676|NCT02027428|3574587|P3|Maintenance|Protocol Violation|1
1093677|NCT02027428|3574588|P2|Maintenance|Protocol Violation|0
1093678|NCT02027428|3574589|P1|Maintenance|Protocol Violation|0
1093679|NCT02027428|3574587|P3|Maintenance|Withdrawal by Subject|5
1093680|NCT02027428|3574588|P2|Maintenance|Withdrawal by Subject|6
1093681|NCT02027428|3574589|P1|Maintenance|Withdrawal by Subject|0
1093682|NCT02027428|3574587|P3|Maintenance|Symptomatic deterioration|1
1093683|NCT02027428|3574588|P2|Maintenance|Symptomatic deterioration|4
1093684|NCT02027428|3574589|P1|Maintenance|Symptomatic deterioration|0
1093685|NCT02027428|3574587|P3|Maintenance|Progressive disease|47
1093686|NCT02027428|3574588|P2|Maintenance|Progressive disease|84
1093687|NCT02027428|3574589|P1|Maintenance|Progressive disease|0
1093688|NCT02027428|3574587|P3|Maintenance|Adverse Event|1
1093689|NCT02027428|3574588|P2|Maintenance|Adverse Event|21
1093690|NCT02027428|3574589|P1|Maintenance|Adverse Event|0
1093691|NCT02027428|3574587|P3|Maintenance|Death|2
1093692|NCT02027428|3574588|P2|Maintenance|Death|3
1093693|NCT02027428|3574589|P1|Maintenance|Death|0
1093694|NCT02027428|3574587|P3|Induction|Induction treatment ongoing|0
1093695|NCT02027428|3574588|P2|Induction|Induction treatment ongoing|0
1093696|NCT02027428|3574589|P1|Induction|Induction treatment ongoing|4
1093697|NCT02027428|3574587|P3|Induction|Protocol Violation|0
1093698|NCT02027428|3574588|P2|Induction|Protocol Violation|0
1093699|NCT02027428|3574589|P1|Induction|Protocol Violation|1
1093700|NCT02027428|3574587|P3|Induction|Study terminated by sponsor|0
1093701|NCT02027428|3574588|P2|Induction|Study terminated by sponsor|0
1093702|NCT02027428|3574589|P1|Induction|Study terminated by sponsor|12
1093703|NCT02027428|3574587|P3|Induction|Not specified|0
1093704|NCT02027428|3574588|P2|Induction|Not specified|0
1093705|NCT02027428|3574589|P1|Induction|Not specified|14
1093706|NCT02027428|3574587|P3|Induction|Symptomatic deterioration|0
1093707|NCT02027428|3574588|P2|Induction|Symptomatic deterioration|0
1093708|NCT02027428|3574589|P1|Induction|Symptomatic deterioration|16
1093709|NCT02027428|3574587|P3|Induction|Death|0
1093710|NCT02027428|3574588|P2|Induction|Death|0
1093711|NCT02027428|3574589|P1|Induction|Death|21
1093712|NCT02027428|3574587|P3|Induction|Withdrawal by Subject|0
1093713|NCT02027428|3574588|P2|Induction|Withdrawal by Subject|0
1093714|NCT02027428|3574589|P1|Induction|Withdrawal by Subject|22
1093715|NCT02027428|3574587|P3|Induction|Adverse Event|0
1093716|NCT02027428|3574588|P2|Induction|Adverse Event|0
1093717|NCT02027428|3574589|P1|Induction|Adverse Event|51
1093718|NCT02027428|3574587|P3|Induction|Progressive disease|0
1093719|NCT02027428|3574588|P2|Induction|Progressive disease|0
1093720|NCT02027428|3574589|P1|Induction|Progressive disease|77
1093721|NCT02027428|3574587|P3|Induction|Never treated|0
1093722|NCT02027428|3574588|P2|Induction|Never treated|0
1093723|NCT02027428|3574589|P1|Induction|Never treated|7
1093724|NCT02027402|3574627|P2|Overall Study|Withdrawal by Subject|1
1093725|NCT02027402|3574628|P1|Overall Study|Withdrawal by Subject|4
1093726|NCT02027376|3574640|P3|Overall Study|Death|0
1093727|NCT02027376|3574641|P2|Overall Study|Death|0
1093728|NCT02027376|3574642|P1|Overall Study|Death|1
1093729|NCT02027311|3574668|P2|Overall Study|Protocol Violation|2
1093730|NCT02027311|3574669|P1|Overall Study|Protocol Violation|3
1093731|NCT02026258|3574704|P2|Recieved Allocated Intervention|Lost to Follow-up|1
1093732|NCT02026258|3574705|P1|Recieved Allocated Intervention|Lost to Follow-up|0
1093733|NCT02026258|3574704|P2|Recieved Allocated Intervention|Withdrawal by Subject|1
1093734|NCT02026258|3574705|P1|Recieved Allocated Intervention|Withdrawal by Subject|1
1093735|NCT02026258|3574704|P2|Randomized|Presence of periodontal disease|1
1093736|NCT02026258|3574705|P1|Randomized|Presence of periodontal disease|1
1093737|NCT02026258|3574704|P2|Randomized|Change in treatment plan|0
1093738|NCT02026258|3574705|P1|Randomized|Change in treatment plan|1
1093739|NCT02026258|3574704|P2|Randomized|Did not start treatment|1
1093740|NCT02026258|3574705|P1|Randomized|Did not start treatment|2
1093741|NCT02026141|3574739|P2|Overall Study|Protocol Violation|1
1093742|NCT02026141|3574740|P1|Overall Study|Protocol Violation|0
1093743|NCT02025907|3574748|P2|Overall Study|Potential misconduct,GCPcompliance issue|1
1093744|NCT02025907|3574749|P1|Overall Study|Potential misconduct,GCPcompliance issue|2
1093745|NCT02025907|3574748|P2|Overall Study|Adverse Event|1
1093746|NCT02025907|3574749|P1|Overall Study|Adverse Event|3
1093747|NCT02025907|3574748|P2|Overall Study|Lost to Follow-up|2
1093748|NCT02025907|3574749|P1|Overall Study|Lost to Follow-up|2
1093749|NCT02025907|3574748|P2|Overall Study|Physician Decision|0
1093750|NCT02025907|3574749|P1|Overall Study|Physician Decision|2
1093751|NCT02025907|3574748|P2|Overall Study|Protocol Violation|0
1093752|NCT02025907|3574749|P1|Overall Study|Protocol Violation|2
1093753|NCT02025907|3574748|P2|Overall Study|Withdrawal by Subject|8
1093754|NCT02025907|3574749|P1|Overall Study|Withdrawal by Subject|15
1093755|NCT02025907|3574748|P2|Overall Study|Lack of Efficacy|0
1093756|NCT02025907|3574749|P1|Overall Study|Lack of Efficacy|1
1093757|NCT02025621|3574806|P2|Overall Study|Surgery initiated before infusion|3
1093758|NCT02025621|3574807|P1|Overall Study|Surgery initiated before infusion|3
1093759|NCT02025621|3574806|P2|Overall Study|No longer eligible|15
1093760|NCT02025621|3574807|P1|Overall Study|No longer eligible|10
1093761|NCT02025621|3574806|P2|Overall Study|Death|1
1093762|NCT02025621|3574807|P1|Overall Study|Death|0
1093763|NCT02025621|3574806|P2|Overall Study|Withdrawal by Subject|0
1093764|NCT02025621|3574807|P1|Overall Study|Withdrawal by Subject|1
1093765|NCT02025179|3574828|P3|Overall Study|Lost to Follow-up|1
1093766|NCT02025179|3574829|P2|Overall Study|Lost to Follow-up|0
1093767|NCT02025179|3574830|P1|Overall Study|Lost to Follow-up|0
1093768|NCT02024971|3574880|P1|Overall Study|Lost to Follow-up|6
1093769|NCT02024971|3574880|P1|Overall Study|Data Not Available|30
1093770|NCT02024932|3574893|P6|Overall Study|Abnormal laboratory value|0
1093771|NCT02024932|3574894|P5|Overall Study|Abnormal laboratory value|0
1093772|NCT02024932|3574895|P4|Overall Study|Abnormal laboratory value|2
1093773|NCT02024932|3574896|P3|Overall Study|Abnormal laboratory value|0
1093774|NCT02024932|3574897|P2|Overall Study|Abnormal laboratory value|0
1093775|NCT02024932|3574898|P1|Overall Study|Abnormal laboratory value|0
1093776|NCT02024932|3574893|P6|Overall Study|Adverse Event|0
1093777|NCT02024932|3574894|P5|Overall Study|Adverse Event|2
1093778|NCT02024932|3574895|P4|Overall Study|Adverse Event|0
1093779|NCT02024932|3574896|P3|Overall Study|Adverse Event|0
1093780|NCT02024932|3574897|P2|Overall Study|Adverse Event|3
1093781|NCT02024932|3574898|P1|Overall Study|Adverse Event|2
1093782|NCT02024867|3574957|P2|Overall Study|Lost to Follow-up|4
1093783|NCT02024867|3574958|P1|Overall Study|Lost to Follow-up|6
1093784|NCT02024867|3574957|P2|Overall Study|Protocol Violation|3
1093785|NCT02024867|3574958|P1|Overall Study|Protocol Violation|3
1093786|NCT02024698|3574983|P2|First Intervention (7 Days)|Withdrawal by Subject|1
1093787|NCT02024698|3574984|P1|First Intervention (7 Days)|Withdrawal by Subject|0
1093788|NCT02023879|3575062|P3|Extension Open Label Treatment|Other than specified above|2
1093789|NCT02023879|3575063|P2|Extension Open Label Treatment|Other than specified above|7
1093790|NCT02023879|3575064|P1|Extension Open Label Treatment|Other than specified above|2
1093791|NCT02023879|3575062|P3|Extension Open Label Treatment|Participant moved|0
1093792|NCT02023879|3575063|P2|Extension Open Label Treatment|Participant moved|2
1093793|NCT02023879|3575064|P1|Extension Open Label Treatment|Participant moved|1
1093794|NCT02023879|3575062|P3|Extension Open Label Treatment|Poor compliance to protocol|0
1093795|NCT02023879|3575063|P2|Extension Open Label Treatment|Poor compliance to protocol|1
1093796|NCT02023879|3575064|P1|Extension Open Label Treatment|Poor compliance to protocol|1
1093797|NCT02023879|3575062|P3|Extension Open Label Treatment|Adverse Event|3
1093798|NCT02023879|3575063|P2|Extension Open Label Treatment|Adverse Event|7
1093799|NCT02023879|3575064|P1|Extension Open Label Treatment|Adverse Event|1
1093800|NCT02023879|3575062|P3|Period 1: 24-Week Double-blind Treatment|Other than specified above|1
1093801|NCT02023879|3575063|P2|Period 1: 24-Week Double-blind Treatment|Other than specified above|3
1093802|NCT02023879|3575064|P1|Period 1: 24-Week Double-blind Treatment|Other than specified above|1
1093803|NCT02023879|3575062|P3|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1
1093804|NCT02023879|3575063|P2|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1
1093805|NCT02023879|3575064|P1|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0
1093806|NCT02023879|3575062|P3|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1
1093807|NCT02023879|3575063|P2|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0
1093808|NCT02023879|3575064|P1|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1
1093809|NCT02023879|3575062|P3|Period 1: 24-Week Double-blind Treatment|Physician Decision|0
1093810|NCT02023879|3575063|P2|Period 1: 24-Week Double-blind Treatment|Physician Decision|1
1093811|NCT02023879|3575064|P1|Period 1: 24-Week Double-blind Treatment|Physician Decision|0
1093812|NCT02023879|3575062|P3|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1
1093813|NCT02023879|3575063|P2|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2
1093814|NCT02023879|3575064|P1|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0
1093815|NCT02023879|3575062|P3|Period 1: 24-Week Double-blind Treatment|Adverse Event|5
1093816|NCT02023879|3575063|P2|Period 1: 24-Week Double-blind Treatment|Adverse Event|2
1093817|NCT02023879|3575064|P1|Period 1: 24-Week Double-blind Treatment|Adverse Event|2
1093818|NCT02023866|3575153|P1|Overall Study|Withdrawal by Subject|1
1093819|NCT02023866|3575153|P1|Overall Study|Adverse Event|3
1093820|NCT02023866|3575153|P1|Overall Study|Non-compliance|2
1093821|NCT02023697|3575175|P3|Active Follow-up Period|PD - radiological progression|1
1093822|NCT02023697|3575176|P2|Active Follow-up Period|PD - radiological progression|0
1093823|NCT02023697|3575177|P1|Active Follow-up Period|PD - radiological progression|0
1093824|NCT02023697|3575175|P3|Active Follow-up Period|Progressive disease-clinical progression|1
1093825|NCT02023697|3575176|P2|Active Follow-up Period|Progressive disease-clinical progression|2
1093826|NCT02023697|3575177|P1|Active Follow-up Period|Progressive disease-clinical progression|0
1093827|NCT02023697|3575175|P3|Active Follow-up Period|Other unspecified|2
1093828|NCT02023697|3575176|P2|Active Follow-up Period|Other unspecified|0
1093829|NCT02023697|3575177|P1|Active Follow-up Period|Other unspecified|3
1093830|NCT02023697|3575175|P3|Active Follow-up Period|Lost to Follow-up|0
1093831|NCT02023697|3575176|P2|Active Follow-up Period|Lost to Follow-up|1
1093832|NCT02023697|3575177|P1|Active Follow-up Period|Lost to Follow-up|0
1093833|NCT02023697|3575175|P3|Active Follow-up Period|Death|75
1093834|NCT02023697|3575176|P2|Active Follow-up Period|Death|73
1093835|NCT02023697|3575177|P1|Active Follow-up Period|Death|76
1093836|NCT02023697|3575175|P3|Active Follow-up Period|Withdrawal by Subject|6
1093837|NCT02023697|3575176|P2|Active Follow-up Period|Withdrawal by Subject|12
1093838|NCT02023697|3575177|P1|Active Follow-up Period|Withdrawal by Subject|3
1093839|NCT02023697|3575175|P3|Active Follow-up Period|Ongoing active follow-up|31
1093840|NCT02023697|3575176|P2|Active Follow-up Period|Ongoing active follow-up|31
1093841|NCT02023697|3575177|P1|Active Follow-up Period|Ongoing active follow-up|35
1093842|NCT02023697|3575175|P3|Treatment Period|Withdrawal by Subject|10
1093843|NCT02023697|3575176|P2|Treatment Period|Withdrawal by Subject|4
1093844|NCT02023697|3575177|P1|Treatment Period|Withdrawal by Subject|4
1093845|NCT02023697|3575175|P3|Treatment Period|Progressive disease-clinical progression|28
1093846|NCT02023697|3575176|P2|Treatment Period|Progressive disease-clinical progression|8
1093847|NCT02023697|3575177|P1|Treatment Period|Progressive disease-clinical progression|10
1093848|NCT02023697|3575175|P3|Treatment Period|Other unspecified|5
1093849|NCT02023697|3575176|P2|Treatment Period|Other unspecified|3
1093850|NCT02023697|3575177|P1|Treatment Period|Other unspecified|1
1093851|NCT02023697|3575175|P3|Treatment Period|Adverse Event|23
1093852|NCT02023697|3575176|P2|Treatment Period|Adverse Event|25
1093853|NCT02023697|3575177|P1|Treatment Period|Adverse Event|13
1093854|NCT02023697|3575175|P3|Treatment Period|Never Treated|10
1093855|NCT02023697|3575176|P2|Treatment Period|Never Treated|6
1093856|NCT02023697|3575177|P1|Treatment Period|Never Treated|5
1093857|NCT02023697|3575175|P3|Treatment Period|PD - radiological progression|26
1093858|NCT02023697|3575176|P2|Treatment Period|PD - radiological progression|17
1093859|NCT02023697|3575177|P1|Treatment Period|PD - radiological progression|13
1093860|NCT02023268|3575290|P2|Overall Study|Withdrawal by Subject|1
1093861|NCT02023268|3575291|P1|Overall Study|Withdrawal by Subject|0
1093862|NCT02023268|3575290|P2|Overall Study|Adverse Event|2
1093863|NCT02023268|3575291|P1|Overall Study|Adverse Event|0
1093864|NCT02023268|3575290|P2|Overall Study|Lack of Efficacy|1
1093865|NCT02023268|3575291|P1|Overall Study|Lack of Efficacy|0
1093866|NCT02023151|3575297|P1|Overall Study|Lost to Follow-up|4
1093867|NCT02023112|3575367|P2|Overall Study|Withdrawal by Subject|1
1093868|NCT02023112|3575368|P1|Overall Study|Withdrawal by Subject|2
1093869|NCT02023099|3575389|P3|Overall Study|Non-treatment-emergent Fatal AE|1
1093870|NCT02023099|3575390|P2|Overall Study|Non-treatment-emergent Fatal AE|0
1093871|NCT02023099|3575391|P1|Overall Study|Non-treatment-emergent Fatal AE|0
1093872|NCT02023099|3575389|P3|Overall Study|Withdrawn Consent|1
1093873|NCT02023099|3575390|P2|Overall Study|Withdrawn Consent|0
1093874|NCT02023099|3575391|P1|Overall Study|Withdrawn Consent|3
1093875|NCT02023099|3575389|P3|Overall Study|Non-fatal Adverse Event (AE)|1
1093876|NCT02023099|3575390|P2|Overall Study|Non-fatal Adverse Event (AE)|0
1093877|NCT02023099|3575391|P1|Overall Study|Non-fatal Adverse Event (AE)|0
1093878|NCT02022748|3575414|P3|Overall Study|Withdrawal by Subject|0
1093879|NCT02022748|3575415|P2|Overall Study|Withdrawal by Subject|1
1093880|NCT02022748|3575416|P1|Overall Study|Withdrawal by Subject|0
1093881|NCT02022748|3575414|P3|Overall Study|Adverse Event|0
1093882|NCT02022748|3575415|P2|Overall Study|Adverse Event|1
1093883|NCT02022748|3575416|P1|Overall Study|Adverse Event|1
1093884|NCT02022670|3575442|P3|Overall Study|Adverse Event|1
1093885|NCT02022670|3575443|P2|Overall Study|Adverse Event|0
1093886|NCT02022670|3575444|P1|Overall Study|Adverse Event|1
1093887|NCT02022007|3575493|P3|Overall Study|Noncompliant|1
1093888|NCT02022007|3575494|P2|Overall Study|Noncompliant|0
1093889|NCT02022007|3575495|P1|Overall Study|Noncompliant|0
1093890|NCT02022007|3575493|P3|Overall Study|Withdrawal by Subject|1
1093891|NCT02022007|3575494|P2|Overall Study|Withdrawal by Subject|1
1093892|NCT02022007|3575495|P1|Overall Study|Withdrawal by Subject|1
1093893|NCT02021656|3575554|P1|Overall Study|Withdrew Consent|2
1093894|NCT02021656|3575554|P1|Overall Study|Lost to Follow-up|1
1093895|NCT02021656|3575554|P1|Overall Study|Lack of Efficacy|2
1093896|NCT02021656|3575554|P1|Overall Study|Adverse Event|1
1093897|NCT02021643|3575574|P4|Overall Study|Withdrew Consent|0
1093898|NCT02021643|3575575|P3|Overall Study|Withdrew Consent|0
1093899|NCT02021643|3575576|P2|Overall Study|Withdrew Consent|1
1093900|NCT02021643|3575577|P1|Overall Study|Withdrew Consent|0
1093901|NCT02021643|3575574|P4|Overall Study|Lost to Follow-up|0
1093902|NCT02021643|3575575|P3|Overall Study|Lost to Follow-up|0
1093903|NCT02021643|3575576|P2|Overall Study|Lost to Follow-up|1
1093904|NCT02021643|3575577|P1|Overall Study|Lost to Follow-up|0
1093905|NCT02021643|3575574|P4|Overall Study|Lack of Efficacy|12
1093906|NCT02021643|3575575|P3|Overall Study|Lack of Efficacy|0
1093907|NCT02021643|3575576|P2|Overall Study|Lack of Efficacy|6
1093908|NCT02021643|3575577|P1|Overall Study|Lack of Efficacy|7
1093909|NCT02021643|3575574|P4|Overall Study|Investigator's Discretion|0
1093910|NCT02021643|3575575|P3|Overall Study|Investigator's Discretion|0
1093911|NCT02021643|3575576|P2|Overall Study|Investigator's Discretion|0
1093912|NCT02021643|3575577|P1|Overall Study|Investigator's Discretion|1
1093913|NCT02021643|3575574|P4|Overall Study|Death|0
1093914|NCT02021643|3575575|P3|Overall Study|Death|0
1093915|NCT02021643|3575576|P2|Overall Study|Death|1
1093916|NCT02021643|3575577|P1|Overall Study|Death|0
1093917|NCT02021643|3575574|P4|Overall Study|Adverse Event|0
1093918|NCT02021643|3575575|P3|Overall Study|Adverse Event|0
1093919|NCT02021643|3575576|P2|Overall Study|Adverse Event|1
1093920|NCT02021643|3575577|P1|Overall Study|Adverse Event|0
1093921|NCT02021643|3575574|P4|Overall Study|Enrolled but Never Treated|0
1093922|NCT02021643|3575575|P3|Overall Study|Enrolled but Never Treated|0
1093923|NCT02021643|3575576|P2|Overall Study|Enrolled but Never Treated|0
1093924|NCT02021643|3575577|P1|Overall Study|Enrolled but Never Treated|1
1093925|NCT02021565|3575619|P2|3-month Follow-up|Protocol Violation|2
1093926|NCT02021565|3575620|P1|3-month Follow-up|Protocol Violation|3
1093927|NCT02021565|3575619|P2|3-month Follow-up|Withdrawal by Subject|0
1093928|NCT02021565|3575620|P1|3-month Follow-up|Withdrawal by Subject|4
1093929|NCT02021565|3575619|P2|3-month Follow-up|Death|0
1093930|NCT02021565|3575620|P1|3-month Follow-up|Death|3
1093931|NCT02021565|3575619|P2|Baseline Through Intervention|Lost to Follow-up|2
1093932|NCT02021565|3575620|P1|Baseline Through Intervention|Lost to Follow-up|4
1093933|NCT02021565|3575619|P2|Baseline Through Intervention|Protocol Violation|7
1093934|NCT02021565|3575620|P1|Baseline Through Intervention|Protocol Violation|0
1093935|NCT02021565|3575619|P2|Baseline Through Intervention|Withdrawal by Subject|8
1093936|NCT02021565|3575620|P1|Baseline Through Intervention|Withdrawal by Subject|8
1093937|NCT02021565|3575619|P2|Baseline Through Intervention|Death|1
1093938|NCT02021565|3575620|P1|Baseline Through Intervention|Death|0
1093939|NCT02021331|3575640|P2|Overall Study|Adverse Event|2
1093940|NCT02021331|3575641|P1|Overall Study|Adverse Event|0
1093941|NCT02021292|3575653|P2|Overall Study|Death|1
1093942|NCT02021292|3575654|P1|Overall Study|Death|0
1093943|NCT02021292|3575653|P2|Overall Study|Lost to Follow-up|1
1093944|NCT02021292|3575654|P1|Overall Study|Lost to Follow-up|0
1093945|NCT02021292|3575653|P2|Overall Study|Physician Decision|1
1093946|NCT02021292|3575654|P1|Overall Study|Physician Decision|0
1093947|NCT02020941|3575680|P1|Overall Study|Disease Progression|4
1093948|NCT02020941|3575680|P1|Overall Study|Withdrawal by Subject|1
1093949|NCT02020941|3575680|P1|Overall Study|Physician Decision|2
1093950|NCT02020941|3575680|P1|Overall Study|Adverse Event|1
1093951|NCT02020889|3575691|P2|Overall Study|Withdrawal by Subject|2
1093952|NCT02020889|3575692|P1|Overall Study|Withdrawal by Subject|3
1093953|NCT02020889|3575691|P2|Overall Study|Physician Decision|0
1093954|NCT02020889|3575692|P1|Overall Study|Physician Decision|2
1093955|NCT02020889|3575691|P2|Overall Study|Lost to Follow-up|0
1093956|NCT02020889|3575692|P1|Overall Study|Lost to Follow-up|1
1093957|NCT02020889|3575691|P2|Overall Study|Lack of Efficacy|0
1093958|NCT02020889|3575692|P1|Overall Study|Lack of Efficacy|1
1093959|NCT02020889|3575691|P2|Overall Study|Adverse Event|1
1093960|NCT02020889|3575692|P1|Overall Study|Adverse Event|0
1093961|NCT02020863|3575746|P1|Overall Study|Team chose not to place an a line|1
1093962|NCT02020863|3575746|P1|Overall Study|Discovery of Metastatic disease|4
1093963|NCT02020616|3575761|P7|Overall Study|Lack of Efficacy|0
1093964|NCT02020616|3575762|P6|Overall Study|Lack of Efficacy|0
1093965|NCT02020616|3575763|P5|Overall Study|Lack of Efficacy|1
1093966|NCT02020616|3575764|P4|Overall Study|Lack of Efficacy|0
1093967|NCT02020616|3575765|P3|Overall Study|Lack of Efficacy|0
1093968|NCT02020616|3575766|P2|Overall Study|Lack of Efficacy|0
1093969|NCT02020616|3575767|P1|Overall Study|Lack of Efficacy|0
1093970|NCT02020616|3575761|P7|Overall Study|Randomized in Error|0
1093971|NCT02020616|3575762|P6|Overall Study|Randomized in Error|0
1093972|NCT02020616|3575763|P5|Overall Study|Randomized in Error|0
1093973|NCT02020616|3575764|P4|Overall Study|Randomized in Error|1
1093974|NCT02020616|3575765|P3|Overall Study|Randomized in Error|0
1093975|NCT02020616|3575766|P2|Overall Study|Randomized in Error|0
1093976|NCT02020616|3575767|P1|Overall Study|Randomized in Error|0
1093977|NCT02020616|3575761|P7|Overall Study|Early Termination Criteria Met|0
1093978|NCT02020616|3575762|P6|Overall Study|Early Termination Criteria Met|1
1093979|NCT02020616|3575763|P5|Overall Study|Early Termination Criteria Met|0
1093980|NCT02020616|3575764|P4|Overall Study|Early Termination Criteria Met|0
1093981|NCT02020616|3575765|P3|Overall Study|Early Termination Criteria Met|1
1093982|NCT02020616|3575766|P2|Overall Study|Early Termination Criteria Met|0
1093983|NCT02020616|3575767|P1|Overall Study|Early Termination Criteria Met|0
1093984|NCT02020616|3575761|P7|Overall Study|Lost to Follow-up|0
1093985|NCT02020616|3575762|P6|Overall Study|Lost to Follow-up|1
1093986|NCT02020616|3575763|P5|Overall Study|Lost to Follow-up|1
1093987|NCT02020616|3575764|P4|Overall Study|Lost to Follow-up|1
1093988|NCT02020616|3575765|P3|Overall Study|Lost to Follow-up|0
1093989|NCT02020616|3575766|P2|Overall Study|Lost to Follow-up|1
1093990|NCT02020616|3575767|P1|Overall Study|Lost to Follow-up|0
1093991|NCT02020616|3575761|P7|Overall Study|Withdrawal by Subject|1
1093992|NCT02020616|3575762|P6|Overall Study|Withdrawal by Subject|1
1093993|NCT02020616|3575763|P5|Overall Study|Withdrawal by Subject|0
1093994|NCT02020616|3575764|P4|Overall Study|Withdrawal by Subject|0
1093995|NCT02020616|3575765|P3|Overall Study|Withdrawal by Subject|1
1093996|NCT02020616|3575766|P2|Overall Study|Withdrawal by Subject|0
1093997|NCT02020616|3575767|P1|Overall Study|Withdrawal by Subject|0
1093998|NCT02020616|3575761|P7|Overall Study|Physician Decision|2
1093999|NCT02020616|3575762|P6|Overall Study|Physician Decision|1
1094000|NCT02020616|3575763|P5|Overall Study|Physician Decision|0
1094001|NCT02020616|3575764|P4|Overall Study|Physician Decision|0
1094002|NCT02020616|3575765|P3|Overall Study|Physician Decision|0
1094003|NCT02020616|3575766|P2|Overall Study|Physician Decision|0
1094004|NCT02020616|3575767|P1|Overall Study|Physician Decision|0
1094005|NCT02020616|3575761|P7|Overall Study|Adverse Event|1
1094006|NCT02020616|3575762|P6|Overall Study|Adverse Event|1
1094007|NCT02020616|3575763|P5|Overall Study|Adverse Event|0
1094008|NCT02020616|3575764|P4|Overall Study|Adverse Event|0
1094009|NCT02020616|3575765|P3|Overall Study|Adverse Event|0
1094010|NCT02020616|3575766|P2|Overall Study|Adverse Event|0
1094011|NCT02020616|3575767|P1|Overall Study|Adverse Event|0
1094012|NCT02020577|3575860|P2|Overall Study|Other than stated above|1
1094013|NCT02020577|3575861|P1|Overall Study|Other than stated above|0
1094014|NCT02020577|3575860|P2|Overall Study|Withdrawal by Subject|1
1094015|NCT02020577|3575861|P1|Overall Study|Withdrawal by Subject|0
1094016|NCT02020577|3575860|P2|Overall Study|Other AE or clinical progression|15
1094017|NCT02020577|3575861|P1|Overall Study|Other AE or clinical progression|0
1094018|NCT02020577|3575860|P2|Overall Study|Progressive disease|38
1094019|NCT02020577|3575861|P1|Overall Study|Progressive disease|3
1094020|NCT02020512|3575888|P1|Overall Study|Protocol Violation|4
1094021|NCT02020512|3575888|P1|Overall Study|Lost to Follow-up|3
1094022|NCT02020512|3575888|P1|Overall Study|Adverse Event|1
1094023|NCT02020031|3575940|P2|Overall Study|Physician Decision|1
1094024|NCT02020031|3575941|P1|Overall Study|Physician Decision|1
1094025|NCT02019979|3575949|P1|Overall Study|study terminated|14
1094026|NCT02019719|3575960|P5|Overall Study|Physician Decision|0
1094027|NCT02019719|3575961|P4|Overall Study|Physician Decision|0
1094028|NCT02019719|3575962|P3|Overall Study|Physician Decision|0
1094029|NCT02019719|3575963|P2|Overall Study|Physician Decision|0
1094030|NCT02019719|3575964|P1|Overall Study|Physician Decision|2
1094031|NCT02019719|3575960|P5|Overall Study|Protocol defined stopping criteria|1
1094032|NCT02019719|3575961|P4|Overall Study|Protocol defined stopping criteria|1
1094033|NCT02019719|3575962|P3|Overall Study|Protocol defined stopping criteria|0
1094034|NCT02019719|3575963|P2|Overall Study|Protocol defined stopping criteria|0
1094035|NCT02019719|3575964|P1|Overall Study|Protocol defined stopping criteria|2
1094036|NCT02019719|3575960|P5|Overall Study|Protocol Violation|0
1094037|NCT02019719|3575961|P4|Overall Study|Protocol Violation|0
1094038|NCT02019719|3575962|P3|Overall Study|Protocol Violation|0
1094039|NCT02019719|3575963|P2|Overall Study|Protocol Violation|1
1094040|NCT02019719|3575964|P1|Overall Study|Protocol Violation|1
1094041|NCT02019719|3575960|P5|Overall Study|Adverse Event|1
1094042|NCT02019719|3575961|P4|Overall Study|Adverse Event|1
1094043|NCT02019719|3575962|P3|Overall Study|Adverse Event|0
1094044|NCT02019719|3575963|P2|Overall Study|Adverse Event|0
1094045|NCT02019719|3575964|P1|Overall Study|Adverse Event|1
1094046|NCT02019550|3576080|P2|Treatment Period 1 (4 Weeks)|Adverse Event|1
1094047|NCT02019550|3576081|P1|Treatment Period 1 (4 Weeks)|Adverse Event|0
1094048|NCT02019472|3576122|P3|Overall Study|Other|6
1094049|NCT02019472|3576123|P2|Overall Study|Other|8
1094050|NCT02019472|3576124|P1|Overall Study|Other|3
1094051|NCT02019472|3576122|P3|Overall Study|Withdrawal by Subject|11
1094052|NCT02019472|3576123|P2|Overall Study|Withdrawal by Subject|10
1094053|NCT02019472|3576124|P1|Overall Study|Withdrawal by Subject|11
1094054|NCT02019472|3576122|P3|Overall Study|Pregnancy|2
1094055|NCT02019472|3576123|P2|Overall Study|Pregnancy|2
1094056|NCT02019472|3576124|P1|Overall Study|Pregnancy|1
1094057|NCT02019472|3576122|P3|Overall Study|Physician Decision|0
1094058|NCT02019472|3576123|P2|Overall Study|Physician Decision|2
1094059|NCT02019472|3576124|P1|Overall Study|Physician Decision|1
1094060|NCT02019472|3576122|P3|Overall Study|Lost to Follow-up|1
1094061|NCT02019472|3576123|P2|Overall Study|Lost to Follow-up|2
1094062|NCT02019472|3576124|P1|Overall Study|Lost to Follow-up|0
1094063|NCT02019472|3576122|P3|Overall Study|Lack of Efficacy|4
1094064|NCT02019472|3576123|P2|Overall Study|Lack of Efficacy|4
1094065|NCT02019472|3576124|P1|Overall Study|Lack of Efficacy|7
1094066|NCT02019472|3576122|P3|Overall Study|Death|1
1094067|NCT02019472|3576123|P2|Overall Study|Death|1
1094068|NCT02019472|3576124|P1|Overall Study|Death|0
1094069|NCT02019472|3576122|P3|Overall Study|Adverse Event|17
1094070|NCT02019472|3576123|P2|Overall Study|Adverse Event|23
1094071|NCT02019472|3576124|P1|Overall Study|Adverse Event|14
1094072|NCT02019277|3576145|P1|Overall Study|Adverse Event|1
1094073|NCT02019277|3576145|P1|Overall Study|Did no Cooperate|1
1094074|NCT02019277|3576145|P1|Overall Study|Death|7
1094075|NCT02019277|3576145|P1|Overall Study|Withdrawal by Subject|3
1094076|NCT02018822|3576164|P3|Overall Study|Lost to Follow-up|5
1094077|NCT02018822|3576165|P2|Overall Study|Lost to Follow-up|6
1094078|NCT02018822|3576166|P1|Overall Study|Lost to Follow-up|6
1094079|NCT02018822|3576164|P3|Overall Study|Physician Decision|1
1094080|NCT02018822|3576165|P2|Overall Study|Physician Decision|1
1094081|NCT02018822|3576166|P1|Overall Study|Physician Decision|0
1094082|NCT02018822|3576164|P3|Overall Study|filling replaced by crown|0
1094083|NCT02018822|3576165|P2|Overall Study|filling replaced by crown|1
1094084|NCT02018822|3576166|P1|Overall Study|filling replaced by crown|0
1094085|NCT02018562|3576221|P2|Overall Study|Discharged prior to study completion|0
1094086|NCT02018562|3576222|P1|Overall Study|Discharged prior to study completion|1
1094087|NCT02018562|3576221|P2|Overall Study|Withdrawal by Subject|0
1094088|NCT02018562|3576222|P1|Overall Study|Withdrawal by Subject|2
1094089|NCT02017522|3576251|P1|Overall Study|Withdrawal by Subject|1
1094090|NCT02017015|3576267|P1|Overall Study|Physician Decision|2
1094091|NCT02017015|3576267|P1|Overall Study|Non-compliance with study drug|2
1094092|NCT02017015|3576267|P1|Overall Study|Progressive Disease|31
1094093|NCT02017015|3576267|P1|Overall Study|Death|4
1094094|NCT02017015|3576267|P1|Overall Study|Withdrawal by Subject|21
1094095|NCT02017015|3576267|P1|Overall Study|Adverse Event|9
1094096|NCT02016898|3576292|P2|Overall Study|Lost to Follow-up|4
1094097|NCT02016898|3576293|P1|Overall Study|Lost to Follow-up|4
1094098|NCT02016898|3576292|P2|Overall Study|Death|1
1094099|NCT02016898|3576293|P1|Overall Study|Death|1
1094100|NCT02016716|3576350|P3|Overall Study|Lost to Follow-up|1
1094101|NCT02016716|3576351|P2|Overall Study|Lost to Follow-up|2
1094102|NCT02016716|3576352|P1|Overall Study|Lost to Follow-up|1
1094103|NCT02016716|3576350|P3|Overall Study|Protocol-specified Criteria|0
1094104|NCT02016716|3576351|P2|Overall Study|Protocol-specified Criteria|1
1094105|NCT02016716|3576352|P1|Overall Study|Protocol-specified Criteria|0
1094106|NCT02016716|3576350|P3|Overall Study|Withdrawal by Subject|5
1094107|NCT02016716|3576351|P2|Overall Study|Withdrawal by Subject|5
1094108|NCT02016716|3576352|P1|Overall Study|Withdrawal by Subject|5
1094109|NCT02016690|3576373|P1|Overall Study|Hospitalized for RSV at study start|3
1094110|NCT02016690|3576373|P1|Overall Study|Did not meet inclusion criteria|13
1094111|NCT02016690|3576373|P1|Overall Study|Excluded from SAS: Ineligible for study|2
1094112|NCT02016690|3576373|P1|Overall Study|Excluded from SAS: Early treatment|2
1094113|NCT02016690|3576373|P1|Overall Study|Excluded from SAS: Duplication|2
1094114|NCT02016690|3576373|P1|Overall Study|Excluded from SAS: Enrollment violation|2
1094115|NCT02016625|3576386|P2|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0
1094116|NCT02016625|3576387|P1|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2
1094117|NCT02016625|3576386|P2|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0
1094118|NCT02016625|3576387|P1|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1
1094119|NCT02016625|3576386|P2|Cyclo or Tac (Single Dose, Day 1)|not treated|1
1094120|NCT02016625|3576387|P1|Cyclo or Tac (Single Dose, Day 1)|not treated|0
1094121|NCT02016482|3576442|P2|Period B|Required Alternative/Prohibited Therapy|2
1094122|NCT02016482|3576443|P1|Period B|Required Alternative/Prohibited Therapy|0
1094123|NCT02016482|3576442|P2|Period B|Not Specified|0
1094124|NCT02016482|3576443|P1|Period B|Not Specified|4
1094125|NCT02016482|3576442|P2|Period B|Lack of Efficacy|4
1094126|NCT02016482|3576443|P1|Period B|Lack of Efficacy|6
1094127|NCT02016482|3576442|P2|Period B|Lost to Follow-up|0
1094128|NCT02016482|3576443|P1|Period B|Lost to Follow-up|2
1094129|NCT02016482|3576442|P2|Period B|Withdrawal by Subject|1
1094130|NCT02016482|3576443|P1|Period B|Withdrawal by Subject|1
1094131|NCT02016482|3576442|P2|Period A|Required Alternative/Prohibited Therapy|1
1094132|NCT02016482|3576443|P1|Period A|Required Alternative/Prohibited Therapy|0
1094133|NCT02016482|3576442|P2|Period A|Protocol Violation|1
1094134|NCT02016482|3576443|P1|Period A|Protocol Violation|0
1094135|NCT02016482|3576442|P2|Period A|Not Specified|0
1094136|NCT02016482|3576443|P1|Period A|Not Specified|3
1094137|NCT02016482|3576442|P2|Period A|Lack of Efficacy|1
1094138|NCT02016482|3576443|P1|Period A|Lack of Efficacy|2
1094139|NCT02016482|3576442|P2|Period A|Lost to Follow-up|3
1094140|NCT02016482|3576443|P1|Period A|Lost to Follow-up|3
1094141|NCT02016482|3576442|P2|Period A|Withdrawal by Subject|4
1094142|NCT02016482|3576443|P1|Period A|Withdrawal by Subject|3
1094143|NCT02016482|3576442|P2|Period A|Adverse Event|5
1094144|NCT02016482|3576443|P1|Period A|Adverse Event|3
1094145|NCT02016183|3576531|P1|Overall Study|Protocol Violation|52
1094146|NCT02016183|3576531|P1|Overall Study|Case Report Forms Uncollected|13
1094147|NCT02016170|3576541|P3|Overall Study|Protocol Violation|0
1094148|NCT02016170|3576542|P2|Overall Study|Protocol Violation|0
1094149|NCT02016170|3576543|P1|Overall Study|Protocol Violation|1
1094150|NCT02016170|3576541|P3|Overall Study|Adverse Event|0
1094151|NCT02016170|3576542|P2|Overall Study|Adverse Event|1
1094152|NCT02016170|3576543|P1|Overall Study|Adverse Event|1
1094153|NCT02016105|3576554|P6|EXTENSION PERIOD|Lost to Follow-up|2
1094154|NCT02016105|3576555|P5|EXTENSION PERIOD|Lost to Follow-up|0
1094155|NCT02016105|3576556|P4|EXTENSION PERIOD|Lost to Follow-up|0
1094156|NCT02016105|3576557|P3|EXTENSION PERIOD|Lost to Follow-up|0
1094157|NCT02016105|3576558|P2|EXTENSION PERIOD|Lost to Follow-up|0
1094158|NCT02016105|3576559|P1|EXTENSION PERIOD|Lost to Follow-up|0
1094159|NCT02016105|3576554|P6|EXTENSION PERIOD|Non-compliance with study indication|0
1094160|NCT02016105|3576555|P5|EXTENSION PERIOD|Non-compliance with study indication|1
1094161|NCT02016105|3576556|P4|EXTENSION PERIOD|Non-compliance with study indication|0
1094162|NCT02016105|3576557|P3|EXTENSION PERIOD|Non-compliance with study indication|0
1094163|NCT02016105|3576558|P2|EXTENSION PERIOD|Non-compliance with study indication|0
1094164|NCT02016105|3576559|P1|EXTENSION PERIOD|Non-compliance with study indication|0
1094165|NCT02016105|3576554|P6|EXTENSION PERIOD|Withdrawal by Subject|2
1094166|NCT02016105|3576555|P5|EXTENSION PERIOD|Withdrawal by Subject|2
1094167|NCT02016105|3576556|P4|EXTENSION PERIOD|Withdrawal by Subject|2
1094168|NCT02016105|3576557|P3|EXTENSION PERIOD|Withdrawal by Subject|2
1094169|NCT02016105|3576558|P2|EXTENSION PERIOD|Withdrawal by Subject|0
1094170|NCT02016105|3576559|P1|EXTENSION PERIOD|Withdrawal by Subject|0
1094171|NCT02016105|3576554|P6|EXTENSION PERIOD|Adverse Event|0
1094172|NCT02016105|3576555|P5|EXTENSION PERIOD|Adverse Event|1
1094173|NCT02016105|3576556|P4|EXTENSION PERIOD|Adverse Event|0
1094174|NCT02016105|3576557|P3|EXTENSION PERIOD|Adverse Event|2
1094175|NCT02016105|3576558|P2|EXTENSION PERIOD|Adverse Event|0
1094176|NCT02016105|3576559|P1|EXTENSION PERIOD|Adverse Event|0
1094177|NCT02016105|3576554|P6|EXTENSION PERIOD|Lack of Efficacy|1
1094178|NCT02016105|3576555|P5|EXTENSION PERIOD|Lack of Efficacy|1
1094179|NCT02016105|3576556|P4|EXTENSION PERIOD|Lack of Efficacy|3
1094180|NCT02016105|3576557|P3|EXTENSION PERIOD|Lack of Efficacy|1
1094181|NCT02016105|3576558|P2|EXTENSION PERIOD|Lack of Efficacy|0
1094182|NCT02016105|3576559|P1|EXTENSION PERIOD|Lack of Efficacy|0
1094183|NCT02016105|3576554|P6|EXTENSION PERIOD|New therapy for study indication|1
1094184|NCT02016105|3576555|P5|EXTENSION PERIOD|New therapy for study indication|1
1094185|NCT02016105|3576556|P4|EXTENSION PERIOD|New therapy for study indication|0
1094186|NCT02016105|3576557|P3|EXTENSION PERIOD|New therapy for study indication|0
1094187|NCT02016105|3576558|P2|EXTENSION PERIOD|New therapy for study indication|0
1094188|NCT02016105|3576559|P1|EXTENSION PERIOD|New therapy for study indication|0
1094189|NCT02016105|3576554|P6|TREATMENT PERIOD 2|Lost to Follow-up|1
1094190|NCT02016105|3576555|P5|TREATMENT PERIOD 2|Lost to Follow-up|0
1094191|NCT02016105|3576556|P4|TREATMENT PERIOD 2|Lost to Follow-up|0
1094192|NCT02016105|3576557|P3|TREATMENT PERIOD 2|Lost to Follow-up|1
1094193|NCT02016105|3576558|P2|TREATMENT PERIOD 2|Lost to Follow-up|0
1094194|NCT02016105|3576559|P1|TREATMENT PERIOD 2|Lost to Follow-up|0
1094195|NCT02016105|3576554|P6|TREATMENT PERIOD 2|Withdrawal by Subject|7
1094196|NCT02016105|3576555|P5|TREATMENT PERIOD 2|Withdrawal by Subject|1
1094197|NCT02016105|3576556|P4|TREATMENT PERIOD 2|Withdrawal by Subject|1
1094198|NCT02016105|3576557|P3|TREATMENT PERIOD 2|Withdrawal by Subject|3
1094199|NCT02016105|3576558|P2|TREATMENT PERIOD 2|Withdrawal by Subject|0
1094200|NCT02016105|3576559|P1|TREATMENT PERIOD 2|Withdrawal by Subject|0
1094201|NCT02016105|3576554|P6|TREATMENT PERIOD 2|Adverse Event|1
1094202|NCT02016105|3576555|P5|TREATMENT PERIOD 2|Adverse Event|0
1094203|NCT02016105|3576556|P4|TREATMENT PERIOD 2|Adverse Event|4
1094204|NCT02016105|3576557|P3|TREATMENT PERIOD 2|Adverse Event|0
1094205|NCT02016105|3576558|P2|TREATMENT PERIOD 2|Adverse Event|0
1094206|NCT02016105|3576559|P1|TREATMENT PERIOD 2|Adverse Event|0
1094207|NCT02016105|3576554|P6|TREATMENT PERIOD 2|Death|1
1094208|NCT02016105|3576555|P5|TREATMENT PERIOD 2|Death|0
1094209|NCT02016105|3576556|P4|TREATMENT PERIOD 2|Death|0
1094210|NCT02016105|3576557|P3|TREATMENT PERIOD 2|Death|0
1094211|NCT02016105|3576558|P2|TREATMENT PERIOD 2|Death|0
1094212|NCT02016105|3576559|P1|TREATMENT PERIOD 2|Death|0
1094213|NCT02016105|3576554|P6|TREATMENT PERIOD 2|Pregnancy|1
1094214|NCT02016105|3576555|P5|TREATMENT PERIOD 2|Pregnancy|0
1094215|NCT02016105|3576556|P4|TREATMENT PERIOD 2|Pregnancy|0
1094216|NCT02016105|3576557|P3|TREATMENT PERIOD 2|Pregnancy|0
1094217|NCT02016105|3576558|P2|TREATMENT PERIOD 2|Pregnancy|0
1094218|NCT02016105|3576559|P1|TREATMENT PERIOD 2|Pregnancy|0
1094219|NCT02016105|3576554|P6|TREATMENT PERIOD 2|Lack of Efficacy|2
1094220|NCT02016105|3576555|P5|TREATMENT PERIOD 2|Lack of Efficacy|3
1094221|NCT02016105|3576556|P4|TREATMENT PERIOD 2|Lack of Efficacy|6
1094222|NCT02016105|3576557|P3|TREATMENT PERIOD 2|Lack of Efficacy|2
1094223|NCT02016105|3576558|P2|TREATMENT PERIOD 2|Lack of Efficacy|0
1094224|NCT02016105|3576559|P1|TREATMENT PERIOD 2|Lack of Efficacy|0
1094225|NCT02016105|3576554|P6|TREATMENT PERIOD 2|Non compliance study medication|1
1094226|NCT02016105|3576555|P5|TREATMENT PERIOD 2|Non compliance study medication|0
1094227|NCT02016105|3576556|P4|TREATMENT PERIOD 2|Non compliance study medication|0
1094228|NCT02016105|3576557|P3|TREATMENT PERIOD 2|Non compliance study medication|0
1094229|NCT02016105|3576558|P2|TREATMENT PERIOD 2|Non compliance study medication|0
1094230|NCT02016105|3576559|P1|TREATMENT PERIOD 2|Non compliance study medication|0
1094231|NCT02016105|3576554|P6|TREATMENT PERIOD 1|Lost to Follow-up|0
1094232|NCT02016105|3576555|P5|TREATMENT PERIOD 1|Lost to Follow-up|0
1094233|NCT02016105|3576556|P4|TREATMENT PERIOD 1|Lost to Follow-up|0
1094234|NCT02016105|3576557|P3|TREATMENT PERIOD 1|Lost to Follow-up|0
1094235|NCT02016105|3576558|P2|TREATMENT PERIOD 1|Lost to Follow-up|4
1094236|NCT02016105|3576559|P1|TREATMENT PERIOD 1|Lost to Follow-up|6
1094237|NCT02016105|3576554|P6|TREATMENT PERIOD 1|Withdrawal by Subject|0
1094238|NCT02016105|3576555|P5|TREATMENT PERIOD 1|Withdrawal by Subject|0
1094239|NCT02016105|3576556|P4|TREATMENT PERIOD 1|Withdrawal by Subject|0
1094240|NCT02016105|3576557|P3|TREATMENT PERIOD 1|Withdrawal by Subject|0
1094241|NCT02016105|3576558|P2|TREATMENT PERIOD 1|Withdrawal by Subject|11
1094242|NCT02016105|3576559|P1|TREATMENT PERIOD 1|Withdrawal by Subject|15
1094243|NCT02016105|3576554|P6|TREATMENT PERIOD 1|Adverse Event|0
1094244|NCT02016105|3576555|P5|TREATMENT PERIOD 1|Adverse Event|0
1094245|NCT02016105|3576556|P4|TREATMENT PERIOD 1|Adverse Event|0
1094246|NCT02016105|3576557|P3|TREATMENT PERIOD 1|Adverse Event|0
1094247|NCT02016105|3576558|P2|TREATMENT PERIOD 1|Adverse Event|5
1094248|NCT02016105|3576559|P1|TREATMENT PERIOD 1|Adverse Event|3
1094249|NCT02016105|3576554|P6|TREATMENT PERIOD 1|Pregnancy|0
1094250|NCT02016105|3576555|P5|TREATMENT PERIOD 1|Pregnancy|0
1094251|NCT02016105|3576556|P4|TREATMENT PERIOD 1|Pregnancy|0
1094252|NCT02016105|3576557|P3|TREATMENT PERIOD 1|Pregnancy|0
1094253|NCT02016105|3576558|P2|TREATMENT PERIOD 1|Pregnancy|1
1094254|NCT02016105|3576559|P1|TREATMENT PERIOD 1|Pregnancy|0
1094255|NCT02016105|3576554|P6|TREATMENT PERIOD 1|Lack of Efficacy|0
1094256|NCT02016105|3576555|P5|TREATMENT PERIOD 1|Lack of Efficacy|0
1094257|NCT02016105|3576556|P4|TREATMENT PERIOD 1|Lack of Efficacy|0
1094258|NCT02016105|3576557|P3|TREATMENT PERIOD 1|Lack of Efficacy|0
1094259|NCT02016105|3576558|P2|TREATMENT PERIOD 1|Lack of Efficacy|2
1094260|NCT02016105|3576559|P1|TREATMENT PERIOD 1|Lack of Efficacy|4
1094261|NCT02016105|3576554|P6|TREATMENT PERIOD 1|Physician Decision|0
1094262|NCT02016105|3576555|P5|TREATMENT PERIOD 1|Physician Decision|0
1094263|NCT02016105|3576556|P4|TREATMENT PERIOD 1|Physician Decision|0
1094264|NCT02016105|3576557|P3|TREATMENT PERIOD 1|Physician Decision|0
1094265|NCT02016105|3576558|P2|TREATMENT PERIOD 1|Physician Decision|2
1094266|NCT02016105|3576559|P1|TREATMENT PERIOD 1|Physician Decision|0
1094267|NCT02016105|3576554|P6|TREATMENT PERIOD 1|Protocol Violation|0
1094268|NCT02016105|3576555|P5|TREATMENT PERIOD 1|Protocol Violation|0
1094269|NCT02016105|3576556|P4|TREATMENT PERIOD 1|Protocol Violation|0
1094270|NCT02016105|3576557|P3|TREATMENT PERIOD 1|Protocol Violation|0
1094271|NCT02016105|3576558|P2|TREATMENT PERIOD 1|Protocol Violation|8
1094272|NCT02016105|3576559|P1|TREATMENT PERIOD 1|Protocol Violation|2
1094273|NCT02015793|3576618|P2|Overall Study|Withdrawal by Subject|1
1094274|NCT02015793|3576619|P1|Overall Study|Withdrawal by Subject|1
1094275|NCT02015793|3576618|P2|Overall Study|Adverse Event|3
1094276|NCT02015793|3576619|P1|Overall Study|Adverse Event|3
1094277|NCT02015754|3576649|P1|Overall Study|Lost to Follow-up|1
1094278|NCT02015754|3576649|P1|Overall Study|Change in treatment modality|5
1094279|NCT02015754|3576649|P1|Overall Study|Disease progression|5
1094280|NCT02015676|3576669|P3|Overall Study|Disease progression|1
1094281|NCT02015676|3576670|P2|Overall Study|Disease progression|1
1094282|NCT02015676|3576671|P1|Overall Study|Disease progression|3
1094283|NCT02015676|3576669|P3|Overall Study|Death|0
1094284|NCT02015676|3576670|P2|Overall Study|Death|1
1094285|NCT02015676|3576671|P1|Overall Study|Death|0
1094286|NCT02015676|3576669|P3|Overall Study|Administrative reasons|1
1094287|NCT02015676|3576670|P2|Overall Study|Administrative reasons|3
1094288|NCT02015676|3576671|P1|Overall Study|Administrative reasons|0
1094289|NCT02015676|3576669|P3|Overall Study|Withdrawal by Subject|1
1094290|NCT02015676|3576670|P2|Overall Study|Withdrawal by Subject|7
1094291|NCT02015676|3576671|P1|Overall Study|Withdrawal by Subject|1
1094292|NCT02015676|3576669|P3|Overall Study|Protocol Violation|0
1094293|NCT02015676|3576670|P2|Overall Study|Protocol Violation|0
1094294|NCT02015676|3576671|P1|Overall Study|Protocol Violation|1
1094295|NCT02015676|3576669|P3|Overall Study|Lack of Efficacy|0
1094296|NCT02015676|3576670|P2|Overall Study|Lack of Efficacy|4
1094297|NCT02015676|3576671|P1|Overall Study|Lack of Efficacy|2
1094298|NCT02015676|3576669|P3|Overall Study|Adverse Event|0
1094299|NCT02015676|3576670|P2|Overall Study|Adverse Event|18
1094300|NCT02015676|3576671|P1|Overall Study|Adverse Event|2
1094301|NCT02015663|3576687|P2|Overall Study|Administrative problems|11
1094302|NCT02015663|3576688|P1|Overall Study|Administrative problems|10
1094303|NCT02015663|3576687|P2|Overall Study|Adverse Event|0
1094304|NCT02015663|3576688|P1|Overall Study|Adverse Event|3
1094305|NCT02015663|3576687|P2|Overall Study|Protocol Violation|1
1094306|NCT02015663|3576688|P1|Overall Study|Protocol Violation|0
1094307|NCT02015663|3576687|P2|Overall Study|Withdrawal by Subject|0
1094308|NCT02015663|3576688|P1|Overall Study|Withdrawal by Subject|1
1094309|NCT02015663|3576687|P2|Overall Study|unsatisfactory therapeutic effect|0
1094310|NCT02015663|3576688|P1|Overall Study|unsatisfactory therapeutic effect|1
1094311|NCT02015637|3576719|P2|Overall Study|Did not take study drug|0
1094312|NCT02015637|3576720|P1|Overall Study|Did not take study drug|2
1094313|NCT02015637|3576719|P2|Overall Study|Adverse Event|0
1094314|NCT02015637|3576720|P1|Overall Study|Adverse Event|3
1094315|NCT02015637|3576719|P2|Overall Study|Lost to Follow-up|5
1094316|NCT02015637|3576720|P1|Overall Study|Lost to Follow-up|3
1094317|NCT02015546|3576731|P3|Overall Study|Screem Failure|3
1094318|NCT02015546|3576732|P2|Overall Study|Screem Failure|1
1094319|NCT02015546|3576733|P1|Overall Study|Screem Failure|2
1094320|NCT02015546|3576731|P3|Overall Study|Withdrawal by Subject|1
1094321|NCT02015546|3576732|P2|Overall Study|Withdrawal by Subject|1
1094322|NCT02015546|3576733|P1|Overall Study|Withdrawal by Subject|1
1094323|NCT02015481|3576765|P1|Overall Study|Death|1
1094324|NCT02015221|3576789|P2|Overall Study|Lost to Follow-up|0
1094325|NCT02015221|3576790|P1|Overall Study|Lost to Follow-up|1
1094326|NCT02015221|3576789|P2|Overall Study|Withdrawal by Subject|6
1094327|NCT02015221|3576790|P1|Overall Study|Withdrawal by Subject|8
1094328|NCT02015195|3576803|P7|Overall Study|Adverse Event|0
1094329|NCT02015195|3576804|P6|Overall Study|Adverse Event|0
1094330|NCT02015195|3576805|P5|Overall Study|Adverse Event|0
1094331|NCT02015195|3576806|P4|Overall Study|Adverse Event|1
1094332|NCT02015195|3576807|P3|Overall Study|Adverse Event|0
1094333|NCT02015195|3576808|P2|Overall Study|Adverse Event|0
1094334|NCT02015195|3576809|P1|Overall Study|Adverse Event|0
1094335|NCT02015039|3576832|P2|Overall Study|Not eligible|1
1094336|NCT02015039|3576833|P1|Overall Study|Not eligible|0
1094337|NCT02014740|3576853|P2|Overall Study|Withdrawal by Subject|1
1094338|NCT02014740|3576854|P1|Overall Study|Withdrawal by Subject|2
1094339|NCT02014740|3576853|P2|Overall Study|Lost to Follow-up|4
1094340|NCT02014740|3576854|P1|Overall Study|Lost to Follow-up|4
1094341|NCT02014584|3576862|P6|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
1094342|NCT02014584|3576863|P5|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1
1094343|NCT02014584|3576864|P4|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
1094344|NCT02014584|3576865|P3|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
1094345|NCT02014584|3576866|P2|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
1094346|NCT02014584|3576867|P1|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
1094347|NCT02014584|3576862|P6|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
1094348|NCT02014584|3576863|P5|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
1094349|NCT02014584|3576864|P4|Open-Label Period (24 Weeks)|Withdrawal by Subject|1
1094350|NCT02014584|3576865|P3|Open-Label Period (24 Weeks)|Withdrawal by Subject|3
1094351|NCT02014584|3576866|P2|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
1094352|NCT02014584|3576867|P1|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
1094353|NCT02014584|3576862|P6|Open-Label Period (24 Weeks)|Lost to Follow-up|0
1094354|NCT02014584|3576863|P5|Open-Label Period (24 Weeks)|Lost to Follow-up|0
1094355|NCT02014584|3576864|P4|Open-Label Period (24 Weeks)|Lost to Follow-up|0
1094356|NCT02014584|3576865|P3|Open-Label Period (24 Weeks)|Lost to Follow-up|2
1094357|NCT02014584|3576866|P2|Open-Label Period (24 Weeks)|Lost to Follow-up|0
1094358|NCT02014584|3576867|P1|Open-Label Period (24 Weeks)|Lost to Follow-up|0
1094359|NCT02014584|3576862|P6|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
1094360|NCT02014584|3576863|P5|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
1094361|NCT02014584|3576864|P4|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
1094362|NCT02014584|3576865|P3|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
1094363|NCT02014584|3576866|P2|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5
1094364|NCT02014584|3576867|P1|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2
1094365|NCT02014584|3576862|P6|Double-Blind Period (24 Weeks)|Protocol Violation|0
1094366|NCT02014584|3576863|P5|Double-Blind Period (24 Weeks)|Protocol Violation|0
1094367|NCT02014584|3576864|P4|Double-Blind Period (24 Weeks)|Protocol Violation|0
1094368|NCT02014584|3576865|P3|Double-Blind Period (24 Weeks)|Protocol Violation|0
1094369|NCT02014584|3576866|P2|Double-Blind Period (24 Weeks)|Protocol Violation|1
1094370|NCT02014584|3576867|P1|Double-Blind Period (24 Weeks)|Protocol Violation|0
1094371|NCT02014480|3577041|P6|Treatment Period 3 (14 Days)|Lack of Efficacy|1
1094372|NCT02014480|3577042|P5|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1094373|NCT02014480|3577043|P4|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1094374|NCT02014480|3577044|P3|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1094375|NCT02014480|3577045|P2|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1094376|NCT02014480|3577046|P1|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1094377|NCT02014480|3577041|P6|Treatment Period 3 (14 Days)|Adverse Event|1
1094378|NCT02014480|3577042|P5|Treatment Period 3 (14 Days)|Adverse Event|0
1094379|NCT02014480|3577043|P4|Treatment Period 3 (14 Days)|Adverse Event|0
1094380|NCT02014480|3577044|P3|Treatment Period 3 (14 Days)|Adverse Event|1
1094381|NCT02014480|3577045|P2|Treatment Period 3 (14 Days)|Adverse Event|0
1094382|NCT02014480|3577046|P1|Treatment Period 3 (14 Days)|Adverse Event|0
1094383|NCT02014480|3577041|P6|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1094384|NCT02014480|3577042|P5|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1094385|NCT02014480|3577043|P4|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1094386|NCT02014480|3577044|P3|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1094387|NCT02014480|3577045|P2|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
1094388|NCT02014480|3577046|P1|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1094389|NCT02014480|3577041|P6|Treatment Period 2 (14 Days)|Protocol Violation|0
1094390|NCT02014480|3577042|P5|Treatment Period 2 (14 Days)|Protocol Violation|0
1094391|NCT02014480|3577043|P4|Treatment Period 2 (14 Days)|Protocol Violation|1
1094392|NCT02014480|3577044|P3|Treatment Period 2 (14 Days)|Protocol Violation|2
1094393|NCT02014480|3577045|P2|Treatment Period 2 (14 Days)|Protocol Violation|1
1094394|NCT02014480|3577046|P1|Treatment Period 2 (14 Days)|Protocol Violation|1
1094395|NCT02014480|3577041|P6|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1094396|NCT02014480|3577042|P5|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1094397|NCT02014480|3577043|P4|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1094398|NCT02014480|3577044|P3|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
1094399|NCT02014480|3577045|P2|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1094400|NCT02014480|3577046|P1|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1094401|NCT02014480|3577041|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1094402|NCT02014480|3577042|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
1094403|NCT02014480|3577043|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|2
1094404|NCT02014480|3577044|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1094405|NCT02014480|3577045|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
1094406|NCT02014480|3577046|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1094407|NCT02014480|3577041|P6|Treatment Period 1 (14 Days)|Lack of Efficacy|0
1094408|NCT02014480|3577042|P5|Treatment Period 1 (14 Days)|Lack of Efficacy|0
1094409|NCT02014480|3577043|P4|Treatment Period 1 (14 Days)|Lack of Efficacy|0
1094410|NCT02014480|3577044|P3|Treatment Period 1 (14 Days)|Lack of Efficacy|1
1094411|NCT02014480|3577045|P2|Treatment Period 1 (14 Days)|Lack of Efficacy|0
1094412|NCT02014480|3577046|P1|Treatment Period 1 (14 Days)|Lack of Efficacy|0
1094413|NCT02014467|3577065|P2|Overall Study|Withdrawal by Subject|4
1094414|NCT02014467|3577066|P1|Overall Study|Withdrawal by Subject|16
1094415|NCT02014467|3577065|P2|Overall Study|Physician Decision|3
1094416|NCT02014467|3577066|P1|Overall Study|Physician Decision|2
1094417|NCT02014467|3577065|P2|Overall Study|Protocol Violation|0
1094418|NCT02014467|3577066|P1|Overall Study|Protocol Violation|3
1094419|NCT02014467|3577065|P2|Overall Study|Adverse Event|0
1094420|NCT02014467|3577066|P1|Overall Study|Adverse Event|4
1094421|NCT02014441|3577126|P1|Overall Study|Continuing in Study|21
1094422|NCT02014441|3577126|P1|Overall Study|Withdrawal by Subject|9
1094423|NCT02014402|3577222|P4|Overall Study|Lost to Follow-up|2
1094424|NCT02014402|3577223|P3|Overall Study|Lost to Follow-up|1
1094425|NCT02014402|3577224|P2|Overall Study|Lost to Follow-up|0
1094426|NCT02014402|3577225|P1|Overall Study|Lost to Follow-up|0
1094427|NCT02014402|3577222|P4|Overall Study|Subject did not have transportation|0
1094428|NCT02014402|3577223|P3|Overall Study|Subject did not have transportation|0
1094429|NCT02014402|3577224|P2|Overall Study|Subject did not have transportation|1
1094430|NCT02014402|3577225|P1|Overall Study|Subject did not have transportation|0
1094431|NCT02014402|3577222|P4|Overall Study|Withdrawal by Subject|1
1094432|NCT02014402|3577223|P3|Overall Study|Withdrawal by Subject|2
1094433|NCT02014402|3577224|P2|Overall Study|Withdrawal by Subject|2
1094434|NCT02014402|3577225|P1|Overall Study|Withdrawal by Subject|1
1094435|NCT02014402|3577222|P4|Overall Study|Adverse Event|0
1094436|NCT02014402|3577223|P3|Overall Study|Adverse Event|0
1094437|NCT02014402|3577224|P2|Overall Study|Adverse Event|0
1094438|NCT02014402|3577225|P1|Overall Study|Adverse Event|1
1094439|NCT02014272|3577265|P2|Intervention Period 1|Adverse Event|1
1094440|NCT02014272|3577266|P1|Intervention Period 1|Adverse Event|0
1094441|NCT02014272|3577265|P2|Intervention Period 1|Withdrawal by Subject|0
1094442|NCT02014272|3577266|P1|Intervention Period 1|Withdrawal by Subject|1
1094443|NCT02013830|3577298|P1|Overall Study|Refused treatment|1
1094444|NCT02013830|3577298|P1|Overall Study|Insufficient therapeutic response|25
1094445|NCT02013830|3577298|P1|Overall Study|Death|1
1094446|NCT02013830|3577298|P1|Overall Study|Adverse Event|3
1094447|NCT02013817|3577309|P1|Overall Study|Not specified|9
1094448|NCT02013817|3577309|P1|Overall Study|Death|2
1094449|NCT02013817|3577309|P1|Overall Study|Withdrawal by Subject|4
1094450|NCT02013817|3577309|P1|Overall Study|Adverse Event|12
1094451|NCT02013791|3577327|P9|Period 1|Other Miscellaneous Reasons|0
1094452|NCT02013791|3577328|P8|Period 1|Other Miscellaneous Reasons|0
1094453|NCT02013791|3577329|P7|Period 1|Other Miscellaneous Reasons|0
1094454|NCT02013791|3577330|P6|Period 1|Other Miscellaneous Reasons|0
1094455|NCT02013791|3577331|P5|Period 1|Other Miscellaneous Reasons|0
1094456|NCT02013791|3577332|P4|Period 1|Other Miscellaneous Reasons|0
1094457|NCT02013791|3577333|P3|Period 1|Other Miscellaneous Reasons|0
1094458|NCT02013791|3577334|P2|Period 1|Other Miscellaneous Reasons|2
1094459|NCT02013791|3577335|P1|Period 1|Other Miscellaneous Reasons|0
1094460|NCT02013791|3577327|P9|Period 1|Lost to Follow-up|0
1094461|NCT02013791|3577328|P8|Period 1|Lost to Follow-up|1
1094462|NCT02013791|3577329|P7|Period 1|Lost to Follow-up|1
1094463|NCT02013791|3577330|P6|Period 1|Lost to Follow-up|0
1094464|NCT02013791|3577331|P5|Period 1|Lost to Follow-up|0
1094465|NCT02013791|3577332|P4|Period 1|Lost to Follow-up|1
1094466|NCT02013791|3577333|P3|Period 1|Lost to Follow-up|0
1094467|NCT02013791|3577334|P2|Period 1|Lost to Follow-up|0
1094468|NCT02013791|3577335|P1|Period 1|Lost to Follow-up|0
1094469|NCT02013765|3577356|P1|Overall Study|Trial was terminated by sponsor|1
1094470|NCT02013687|3577370|P4|Overall Study|Missed visits due to patient travel|0
1094471|NCT02013687|3577371|P3|Overall Study|Missed visits due to patient travel|1
1094472|NCT02013687|3577372|P2|Overall Study|Missed visits due to patient travel|0
1094473|NCT02013687|3577373|P1|Overall Study|Missed visits due to patient travel|0
1094474|NCT02013687|3577370|P4|Overall Study|Withdrawal by Subject|1
1094475|NCT02013687|3577371|P3|Overall Study|Withdrawal by Subject|0
1094476|NCT02013687|3577372|P2|Overall Study|Withdrawal by Subject|0
1094477|NCT02013687|3577373|P1|Overall Study|Withdrawal by Subject|0
1094478|NCT02013687|3577370|P4|Overall Study|Protocol Violation|1
1094479|NCT02013687|3577371|P3|Overall Study|Protocol Violation|0
1094480|NCT02013687|3577372|P2|Overall Study|Protocol Violation|0
1094481|NCT02013687|3577373|P1|Overall Study|Protocol Violation|0
1094482|NCT02013687|3577370|P4|Overall Study|Lost to Follow-up|0
1094483|NCT02013687|3577371|P3|Overall Study|Lost to Follow-up|1
1094484|NCT02013687|3577372|P2|Overall Study|Lost to Follow-up|0
1094485|NCT02013687|3577373|P1|Overall Study|Lost to Follow-up|0
1094486|NCT02013622|3577403|P1|Overall Study|Lack of Efficacy|1
1094487|NCT02013622|3577403|P1|Overall Study|Protocol Deviation|1
1094488|NCT02013622|3577403|P1|Overall Study|Withdrawal by Subject|6
1094489|NCT02013622|3577403|P1|Overall Study|Met Withdrawal Criteria|3
1094490|NCT02013622|3577403|P1|Overall Study|Adverse Event|3
1094491|NCT02013622|3577403|P1|Overall Study|Lost to Follow-up|10
1094492|NCT02013609|3577423|P1|Overall Study|Met Withdrawal Criteria|3
1094493|NCT02013609|3577423|P1|Overall Study|Adverse Event|3
1094494|NCT02013609|3577423|P1|Overall Study|Lost to Follow-up|3
1094495|NCT02013609|3577423|P1|Overall Study|Withdrawal by Subject|9
1094496|NCT02013544|3577448|P2|Overall Study|Entry criteria not met/non-compliance|3
1094497|NCT02013544|3577449|P1|Overall Study|Entry criteria not met/non-compliance|2
1094498|NCT02013544|3577448|P2|Overall Study|Physician Decision|1
1094499|NCT02013544|3577449|P1|Overall Study|Physician Decision|0
1094500|NCT02013544|3577448|P2|Overall Study|Withdrawal by Subject|8
1094501|NCT02013544|3577449|P1|Overall Study|Withdrawal by Subject|2
1094502|NCT02013544|3577448|P2|Overall Study|Lost to Follow-up|3
1094503|NCT02013544|3577449|P1|Overall Study|Lost to Follow-up|2
1094504|NCT02013544|3577448|P2|Overall Study|Adverse Event|5
1094505|NCT02013544|3577449|P1|Overall Study|Adverse Event|5
1094506|NCT02013531|3577471|P1|Overall Study|Withdrawal by Subject|1
1094507|NCT02013531|3577471|P1|Overall Study|Met Withdrawal Criteria|1
1094508|NCT02013531|3577471|P1|Overall Study|Lost to Follow-up|3
1094509|NCT02013388|3577501|P8|Overall Study|work emergency|0
1094510|NCT02013388|3577502|P7|Overall Study|work emergency|0
1094511|NCT02013388|3577503|P6|Overall Study|work emergency|0
1094512|NCT02013388|3577504|P5|Overall Study|work emergency|1
1094513|NCT02013388|3577505|P4|Overall Study|work emergency|0
1094514|NCT02013388|3577506|P3|Overall Study|work emergency|0
1094515|NCT02013388|3577507|P2|Overall Study|work emergency|0
1094516|NCT02013388|3577508|P1|Overall Study|work emergency|1
1094517|NCT02013206|3577565|P2|Overall Study|Other reasons off treatment|2
1094518|NCT02013206|3577566|P1|Overall Study|Other reasons off treatment|5
1094519|NCT02013206|3577565|P2|Overall Study|Death|2
1094520|NCT02013206|3577566|P1|Overall Study|Death|1
1094521|NCT02013206|3577565|P2|Overall Study|Patient non-compliance|0
1094522|NCT02013206|3577566|P1|Overall Study|Patient non-compliance|1
1094523|NCT02013206|3577565|P2|Overall Study|Patient refusal|0
1094524|NCT02013206|3577566|P1|Overall Study|Patient refusal|2
1094525|NCT02013206|3577565|P2|Overall Study|Adverse Event|0
1094526|NCT02013206|3577566|P1|Overall Study|Adverse Event|1
1094527|NCT02013206|3577565|P2|Overall Study|Symptomatic deterioration|1
1094528|NCT02013206|3577566|P1|Overall Study|Symptomatic deterioration|3
1094529|NCT02013206|3577565|P2|Overall Study|Progressive disease (PD)|17
1094530|NCT02013206|3577566|P1|Overall Study|Progressive disease (PD)|14
1094531|NCT02013167|3577588|P2|Overall Study|Death|160
1094532|NCT02013167|3577589|P1|Overall Study|Death|85
1094533|NCT02013167|3577588|P2|Overall Study|Lost to Follow-up|1
1094534|NCT02013167|3577589|P1|Overall Study|Lost to Follow-up|0
1094535|NCT02013167|3577588|P2|Overall Study|Sponsor Decision|3
1094536|NCT02013167|3577589|P1|Overall Study|Sponsor Decision|1
1094537|NCT02013167|3577588|P2|Overall Study|Withdrawal by Subject|14
1094538|NCT02013167|3577589|P1|Overall Study|Withdrawal by Subject|15
1094539|NCT02012959|3577665|P5|Treatment Phase A|Adverse Event|0
1094540|NCT02012959|3577666|P4|Treatment Phase A|Adverse Event|0
1094541|NCT02012959|3577667|P3|Treatment Phase A|Adverse Event|0
1094542|NCT02012959|3577668|P2|Treatment Phase A|Adverse Event|0
1094543|NCT02012959|3577669|P1|Treatment Phase A|Adverse Event|2
1094544|NCT02012686|3577682|P2|Overall Study|electrocardiography monitoring noise|1
1094545|NCT02012686|3577683|P1|Overall Study|electrocardiography monitoring noise|0
1094546|NCT02012686|3577682|P2|Overall Study|muscle contraction|1
1094547|NCT02012686|3577683|P1|Overall Study|muscle contraction|0
1094548|NCT02012491|3577730|P2|Overall Study|Withdrawal by Subject|0
1094549|NCT02012491|3577731|P1|Overall Study|Withdrawal by Subject|1
1094550|NCT02012491|3577730|P2|Overall Study|Protocol Violation|1
1094551|NCT02012491|3577731|P1|Overall Study|Protocol Violation|0
1094552|NCT02012491|3577730|P2|Overall Study|Lost to Follow-up|0
1094553|NCT02012491|3577731|P1|Overall Study|Lost to Follow-up|1
1094554|NCT02012452|3577749|P2|Overall Study|Withdrawal by Subject|0
1094555|NCT02012452|3577750|P1|Overall Study|Withdrawal by Subject|4
1094556|NCT02012452|3577749|P2|Overall Study|Lost to Follow-up|1
1094557|NCT02012452|3577750|P1|Overall Study|Lost to Follow-up|2
1094558|NCT02012218|3577763|P5|Overall Study|Protocol Deviation|0
1094559|NCT02012218|3577764|P4|Overall Study|Protocol Deviation|0
1094560|NCT02012218|3577765|P3|Overall Study|Protocol Deviation|0
1094561|NCT02012218|3577766|P2|Overall Study|Protocol Deviation|0
1094562|NCT02012218|3577767|P1|Overall Study|Protocol Deviation|1
1094563|NCT02012218|3577763|P5|Overall Study|Protocol Specified|0
1094564|NCT02012218|3577764|P4|Overall Study|Protocol Specified|0
1094565|NCT02012218|3577765|P3|Overall Study|Protocol Specified|0
1094566|NCT02012218|3577766|P2|Overall Study|Protocol Specified|0
1094567|NCT02012218|3577767|P1|Overall Study|Protocol Specified|1
1094568|NCT02012218|3577763|P5|Overall Study|Lost to Follow-up|0
1094569|NCT02012218|3577764|P4|Overall Study|Lost to Follow-up|0
1094570|NCT02012218|3577765|P3|Overall Study|Lost to Follow-up|1
1094571|NCT02012218|3577766|P2|Overall Study|Lost to Follow-up|1
1094572|NCT02012218|3577767|P1|Overall Study|Lost to Follow-up|0
1094573|NCT02012218|3577763|P5|Overall Study|Adverse Event|0
1094574|NCT02012218|3577764|P4|Overall Study|Adverse Event|1
1094575|NCT02012218|3577765|P3|Overall Study|Adverse Event|0
1094576|NCT02012218|3577766|P2|Overall Study|Adverse Event|0
1094577|NCT02012218|3577767|P1|Overall Study|Adverse Event|1
1094578|NCT02012218|3577763|P5|Overall Study|Withdrawal by Subject|1
1094579|NCT02012218|3577764|P4|Overall Study|Withdrawal by Subject|1
1094580|NCT02012218|3577765|P3|Overall Study|Withdrawal by Subject|1
1094581|NCT02012218|3577766|P2|Overall Study|Withdrawal by Subject|0
1094582|NCT02012218|3577767|P1|Overall Study|Withdrawal by Subject|1
1094583|NCT02011893|3577779|P3|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1
1094584|NCT02011893|3577780|P2|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
1094585|NCT02011893|3577781|P1|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
1094586|NCT02011893|3577779|P3|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2
1094587|NCT02011893|3577780|P2|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
1094588|NCT02011893|3577781|P1|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
1094589|NCT02011893|3577779|P3|Period 1 (Randomization to 12 Weeks)|Physician Decision|1
1094590|NCT02011893|3577780|P2|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
1094591|NCT02011893|3577781|P1|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
1094592|NCT02011893|3577779|P3|Enrollment to Randomization|Insurance/Financial Reasons|0
1094593|NCT02011893|3577780|P2|Enrollment to Randomization|Insurance/Financial Reasons|0
1094594|NCT02011893|3577781|P1|Enrollment to Randomization|Insurance/Financial Reasons|2
1094595|NCT02011893|3577779|P3|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
1094596|NCT02011893|3577780|P2|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
1094597|NCT02011893|3577781|P1|Enrollment to Randomization|Temporary Trial Stimulation Failure|9
1094598|NCT02011893|3577779|P3|Enrollment to Randomization|Screening Failure|0
1094599|NCT02011893|3577780|P2|Enrollment to Randomization|Screening Failure|0
1094600|NCT02011893|3577781|P1|Enrollment to Randomization|Screening Failure|29
1094601|NCT02011893|3577779|P3|Enrollment to Randomization|Withdrawal by Subject|0
1094602|NCT02011893|3577780|P2|Enrollment to Randomization|Withdrawal by Subject|0
1094603|NCT02011893|3577781|P1|Enrollment to Randomization|Withdrawal by Subject|21
1094604|NCT02011893|3577779|P3|Enrollment to Randomization|Physician Decision|0
1094605|NCT02011893|3577780|P2|Enrollment to Randomization|Physician Decision|0
1094606|NCT02011893|3577781|P1|Enrollment to Randomization|Physician Decision|10
1094607|NCT02011893|3577779|P3|Enrollment to Randomization|Adverse Event|0
1094608|NCT02011893|3577780|P2|Enrollment to Randomization|Adverse Event|0
1094609|NCT02011893|3577781|P1|Enrollment to Randomization|Adverse Event|2
1094610|NCT02011542|3577792|P1|Overall Study|Physician Decision|1
1094611|NCT02011113|3577923|P1|Overall Study|Study terminated by sponsor|11
1094612|NCT02011113|3577923|P1|Overall Study|Investigator's judgement- DP|3
1094613|NCT02011113|3577923|P1|Overall Study|Insufficient effect of Pomalidomide|1
1094614|NCT02011113|3577923|P1|Overall Study|Death|1
1094615|NCT02011113|3577923|P1|Overall Study|Disease Progression (DP)|16
1094616|NCT02011113|3577923|P1|Overall Study|Adverse Event|4
1094617|NCT02010684|3577952|P2|Overall Study|Withdrawal by Subject|5
1094618|NCT02010684|3577953|P1|Overall Study|Withdrawal by Subject|4
1094619|NCT02010684|3577952|P2|Overall Study|Lost to Follow-up|18
1094620|NCT02010684|3577953|P1|Overall Study|Lost to Follow-up|8
1094621|NCT02010632|3577971|P2|Second Intervention (7 Days)|Withdrawal by Subject|0
1094622|NCT02010632|3577972|P1|Second Intervention (7 Days)|Withdrawal by Subject|1
1094623|NCT02010567|3577983|P5|Overall Study|Adverse Event|1
1094624|NCT02010567|3577984|P4|Overall Study|Adverse Event|0
1094625|NCT02010567|3577985|P3|Overall Study|Adverse Event|1
1094626|NCT02010567|3577986|P2|Overall Study|Adverse Event|0
1094627|NCT02010567|3577987|P1|Overall Study|Adverse Event|0
1094628|NCT02010255|3578012|P14|Overall Study|Randomized but Not Treated|1
1094629|NCT02010255|3578013|P13|Overall Study|Randomized but Not Treated|0
1094630|NCT02010255|3578014|P12|Overall Study|Randomized but Not Treated|0
1094631|NCT02010255|3578015|P11|Overall Study|Randomized but Not Treated|0
1094632|NCT02010255|3578016|P10|Overall Study|Randomized but Not Treated|0
1094633|NCT02010255|3578017|P9|Overall Study|Randomized but Not Treated|0
1094634|NCT02010255|3578018|P8|Overall Study|Randomized but Not Treated|0
1094635|NCT02010255|3578019|P7|Overall Study|Randomized but Not Treated|0
1094636|NCT02010255|3578020|P6|Overall Study|Randomized but Not Treated|0
1094637|NCT02010255|3578021|P5|Overall Study|Randomized but Not Treated|0
1094638|NCT02010255|3578022|P4|Overall Study|Randomized but Not Treated|0
1094639|NCT02010255|3578023|P3|Overall Study|Randomized but Not Treated|0
1094640|NCT02010255|3578024|P2|Overall Study|Randomized but Not Treated|0
1094641|NCT02010255|3578025|P1|Overall Study|Randomized but Not Treated|0
1094642|NCT02010255|3578012|P14|Overall Study|Lost to Follow-up|0
1094643|NCT02010255|3578013|P13|Overall Study|Lost to Follow-up|0
1094644|NCT02010255|3578014|P12|Overall Study|Lost to Follow-up|0
1094645|NCT02010255|3578015|P11|Overall Study|Lost to Follow-up|0
1094646|NCT02010255|3578016|P10|Overall Study|Lost to Follow-up|0
1094647|NCT02010255|3578017|P9|Overall Study|Lost to Follow-up|0
1094648|NCT02010255|3578018|P8|Overall Study|Lost to Follow-up|0
1094649|NCT02010255|3578019|P7|Overall Study|Lost to Follow-up|0
1094650|NCT02010255|3578020|P6|Overall Study|Lost to Follow-up|0
1094651|NCT02010255|3578021|P5|Overall Study|Lost to Follow-up|1
1094652|NCT02010255|3578022|P4|Overall Study|Lost to Follow-up|0
1094653|NCT02010255|3578023|P3|Overall Study|Lost to Follow-up|1
1094654|NCT02010255|3578024|P2|Overall Study|Lost to Follow-up|0
1094655|NCT02010255|3578025|P1|Overall Study|Lost to Follow-up|0
1094656|NCT02010255|3578012|P14|Overall Study|Adverse Event|0
1094657|NCT02010255|3578013|P13|Overall Study|Adverse Event|0
1094658|NCT02010255|3578014|P12|Overall Study|Adverse Event|0
1094659|NCT02010255|3578015|P11|Overall Study|Adverse Event|0
1094660|NCT02010255|3578016|P10|Overall Study|Adverse Event|0
1094661|NCT02010255|3578017|P9|Overall Study|Adverse Event|0
1094662|NCT02010255|3578018|P8|Overall Study|Adverse Event|0
1094663|NCT02010255|3578019|P7|Overall Study|Adverse Event|0
1094664|NCT02010255|3578020|P6|Overall Study|Adverse Event|0
1094665|NCT02010255|3578021|P5|Overall Study|Adverse Event|0
1094666|NCT02010255|3578022|P4|Overall Study|Adverse Event|0
1094667|NCT02010255|3578023|P3|Overall Study|Adverse Event|0
1094668|NCT02010255|3578024|P2|Overall Study|Adverse Event|0
1094669|NCT02010255|3578025|P1|Overall Study|Adverse Event|1
1094670|NCT02010255|3578012|P14|Overall Study|Withdrew Consent|0
1094671|NCT02010255|3578013|P13|Overall Study|Withdrew Consent|0
1094672|NCT02010255|3578014|P12|Overall Study|Withdrew Consent|0
1094673|NCT02010255|3578015|P11|Overall Study|Withdrew Consent|0
1094674|NCT02010255|3578016|P10|Overall Study|Withdrew Consent|0
1094675|NCT02010255|3578017|P9|Overall Study|Withdrew Consent|0
1094676|NCT02010255|3578018|P8|Overall Study|Withdrew Consent|0
1094677|NCT02010255|3578019|P7|Overall Study|Withdrew Consent|0
1094678|NCT02010255|3578020|P6|Overall Study|Withdrew Consent|0
1094679|NCT02010255|3578021|P5|Overall Study|Withdrew Consent|0
1094680|NCT02010255|3578022|P4|Overall Study|Withdrew Consent|1
1094681|NCT02010255|3578023|P3|Overall Study|Withdrew Consent|0
1094682|NCT02010255|3578024|P2|Overall Study|Withdrew Consent|0
1094683|NCT02010255|3578025|P1|Overall Study|Withdrew Consent|1
1094684|NCT02010255|3578012|P14|Overall Study|Lack of Efficacy|0
1094685|NCT02010255|3578013|P13|Overall Study|Lack of Efficacy|0
1094686|NCT02010255|3578014|P12|Overall Study|Lack of Efficacy|0
1094687|NCT02010255|3578015|P11|Overall Study|Lack of Efficacy|1
1094688|NCT02010255|3578016|P10|Overall Study|Lack of Efficacy|0
1094689|NCT02010255|3578017|P9|Overall Study|Lack of Efficacy|0
1094690|NCT02010255|3578018|P8|Overall Study|Lack of Efficacy|0
1094691|NCT02010255|3578019|P7|Overall Study|Lack of Efficacy|0
1094692|NCT02010255|3578020|P6|Overall Study|Lack of Efficacy|0
1094693|NCT02010255|3578021|P5|Overall Study|Lack of Efficacy|1
1094694|NCT02010255|3578022|P4|Overall Study|Lack of Efficacy|1
1094695|NCT02010255|3578023|P3|Overall Study|Lack of Efficacy|2
1094696|NCT02010255|3578024|P2|Overall Study|Lack of Efficacy|1
1094697|NCT02010255|3578025|P1|Overall Study|Lack of Efficacy|4
1094698|NCT02010255|3578012|P14|Overall Study|Death|0
1094699|NCT02010255|3578013|P13|Overall Study|Death|0
1094700|NCT02010255|3578014|P12|Overall Study|Death|1
1094701|NCT02010255|3578015|P11|Overall Study|Death|1
1094702|NCT02010255|3578016|P10|Overall Study|Death|0
1094703|NCT02010255|3578017|P9|Overall Study|Death|1
1094704|NCT02010255|3578018|P8|Overall Study|Death|1
1094705|NCT02010255|3578019|P7|Overall Study|Death|1
1094706|NCT02010255|3578020|P6|Overall Study|Death|0
1094707|NCT02010255|3578021|P5|Overall Study|Death|2
1094708|NCT02010255|3578022|P4|Overall Study|Death|4
1094709|NCT02010255|3578023|P3|Overall Study|Death|4
1094710|NCT02010255|3578024|P2|Overall Study|Death|1
1094711|NCT02010255|3578025|P1|Overall Study|Death|0
1094712|NCT02009878|3578380|P3|Overall Study|Participant Met Withdrawal Criteria|0
1094713|NCT02009878|3578381|P2|Overall Study|Participant Met Withdrawal Criteria|1
1094714|NCT02009878|3578382|P1|Overall Study|Participant Met Withdrawal Criteria|0
1094715|NCT02009865|3578416|P2|Overall Study|Withdrawal by Subject|1
1094716|NCT02009865|3578417|P1|Overall Study|Withdrawal by Subject|1
1094717|NCT02009865|3578416|P2|Overall Study|Protocol Violation|2
1094718|NCT02009865|3578417|P1|Overall Study|Protocol Violation|0
1094719|NCT02009865|3578416|P2|Overall Study|Adverse Event|2
1094720|NCT02009865|3578417|P1|Overall Study|Adverse Event|0
1094721|NCT02009722|3578433|P2|Overall Study|Did not receive intervention|1
1094722|NCT02009722|3578434|P1|Overall Study|Did not receive intervention|0
1094723|NCT02009722|3578433|P2|Overall Study|Protocol Violation|2
1094724|NCT02009722|3578434|P1|Overall Study|Protocol Violation|1
1094725|NCT02009696|3578458|P1|Overall Study|Withdrawal by Subject|2
1094726|NCT02009163|3578475|P3|Randomized-withdrawal Period|Not specified|5
1094727|NCT02009163|3578476|P2|Randomized-withdrawal Period|Not specified|9
1094728|NCT02009163|3578477|P1|Randomized-withdrawal Period|Not specified|0
1094729|NCT02009163|3578475|P3|Randomized-withdrawal Period|Pregnancy|2
1094730|NCT02009163|3578476|P2|Randomized-withdrawal Period|Pregnancy|0
1094731|NCT02009163|3578477|P1|Randomized-withdrawal Period|Pregnancy|0
1094732|NCT02009163|3578475|P3|Randomized-withdrawal Period|Protocol Violation|2
1094733|NCT02009163|3578476|P2|Randomized-withdrawal Period|Protocol Violation|1
1094734|NCT02009163|3578477|P1|Randomized-withdrawal Period|Protocol Violation|0
1094735|NCT02009163|3578475|P3|Randomized-withdrawal Period|Relapse Criteria Met|5
1094736|NCT02009163|3578476|P2|Randomized-withdrawal Period|Relapse Criteria Met|40
1094737|NCT02009163|3578477|P1|Randomized-withdrawal Period|Relapse Criteria Met|0
1094738|NCT02009163|3578475|P3|Randomized-withdrawal Period|Adverse Event|6
1094739|NCT02009163|3578476|P2|Randomized-withdrawal Period|Adverse Event|0
1094740|NCT02009163|3578477|P1|Randomized-withdrawal Period|Adverse Event|0
1094741|NCT02009163|3578475|P3|Randomized-withdrawal Period|Lost to Follow-up|6
1094742|NCT02009163|3578476|P2|Randomized-withdrawal Period|Lost to Follow-up|13
1094743|NCT02009163|3578477|P1|Randomized-withdrawal Period|Lost to Follow-up|0
1094744|NCT02009163|3578475|P3|Randomized-withdrawal Period|Withdrawal by Subject|9
1094745|NCT02009163|3578476|P2|Randomized-withdrawal Period|Withdrawal by Subject|25
1094746|NCT02009163|3578477|P1|Randomized-withdrawal Period|Withdrawal by Subject|0
1094747|NCT02009163|3578475|P3|Open-label Period (Non-randomized)|Not specified|0
1094748|NCT02009163|3578476|P2|Open-label Period (Non-randomized)|Not specified|0
1094749|NCT02009163|3578477|P1|Open-label Period (Non-randomized)|Not specified|13
1094750|NCT02009163|3578475|P3|Open-label Period (Non-randomized)|Pregnancy|0
1094751|NCT02009163|3578476|P2|Open-label Period (Non-randomized)|Pregnancy|0
1094752|NCT02009163|3578477|P1|Open-label Period (Non-randomized)|Pregnancy|1
1094753|NCT02009163|3578475|P3|Open-label Period (Non-randomized)|Protocol Violation|0
1094754|NCT02009163|3578476|P2|Open-label Period (Non-randomized)|Protocol Violation|0
1094755|NCT02009163|3578477|P1|Open-label Period (Non-randomized)|Protocol Violation|10
1094756|NCT02009163|3578475|P3|Open-label Period (Non-randomized)|Lost to Follow-up|0
1094757|NCT02009163|3578476|P2|Open-label Period (Non-randomized)|Lost to Follow-up|0
1094758|NCT02009163|3578477|P1|Open-label Period (Non-randomized)|Lost to Follow-up|20
1094759|NCT02009163|3578475|P3|Open-label Period (Non-randomized)|Adverse Event|0
1094760|NCT02009163|3578476|P2|Open-label Period (Non-randomized)|Adverse Event|0
1094761|NCT02009163|3578477|P1|Open-label Period (Non-randomized)|Adverse Event|22
1094762|NCT02009163|3578475|P3|Open-label Period (Non-randomized)|Withdrawal by Subject|0
1094763|NCT02009163|3578476|P2|Open-label Period (Non-randomized)|Withdrawal by Subject|0
1094764|NCT02009163|3578477|P1|Open-label Period (Non-randomized)|Withdrawal by Subject|29
1094765|NCT02009163|3578475|P3|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
1094766|NCT02009163|3578476|P2|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
1094767|NCT02009163|3578477|P1|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48
1094768|NCT02009046|3578512|P2|Overall Study|Lost to Follow-up|206
1094769|NCT02009046|3578513|P1|Overall Study|Lost to Follow-up|256
1094770|NCT02008916|3578573|P3|Week 16 - 156|Physician Decision|0
1094771|NCT02008916|3578574|P2|Week 16 - 156|Physician Decision|1
1094772|NCT02008916|3578575|P1|Week 16 - 156|Physician Decision|0
1094773|NCT02008916|3578573|P3|Week 16 - 156|Pregnancy|0
1094774|NCT02008916|3578574|P2|Week 16 - 156|Pregnancy|1
1094775|NCT02008916|3578575|P1|Week 16 - 156|Pregnancy|0
1094776|NCT02008916|3578573|P3|Week 16 - 156|Lack of Efficacy|2
1094777|NCT02008916|3578574|P2|Week 16 - 156|Lack of Efficacy|5
1094778|NCT02008916|3578575|P1|Week 16 - 156|Lack of Efficacy|3
1094779|NCT02008916|3578573|P3|Week 16 - 156|Lost to Follow-up|0
1094780|NCT02008916|3578574|P2|Week 16 - 156|Lost to Follow-up|0
1094781|NCT02008916|3578575|P1|Week 16 - 156|Lost to Follow-up|5
1094782|NCT02008916|3578573|P3|Week 16 - 156|No longer requires treatment|0
1094783|NCT02008916|3578574|P2|Week 16 - 156|No longer requires treatment|1
1094784|NCT02008916|3578575|P1|Week 16 - 156|No longer requires treatment|0
1094785|NCT02008916|3578573|P3|Week 16 - 156|Withdrawal by Subject|5
1094786|NCT02008916|3578574|P2|Week 16 - 156|Withdrawal by Subject|3
1094787|NCT02008916|3578575|P1|Week 16 - 156|Withdrawal by Subject|7
1094788|NCT02008916|3578573|P3|Week 16 - 156|Adverse Event|3
1094789|NCT02008916|3578574|P2|Week 16 - 156|Adverse Event|2
1094790|NCT02008916|3578575|P1|Week 16 - 156|Adverse Event|4
1094791|NCT02008916|3578573|P3|Primary Assessment (up to Week 16)|Withdrawal by Subject|3
1094792|NCT02008916|3578574|P2|Primary Assessment (up to Week 16)|Withdrawal by Subject|1
1094793|NCT02008916|3578575|P1|Primary Assessment (up to Week 16)|Withdrawal by Subject|0
1094794|NCT02008565|3578646|P4|Overall Study|Protocol Violation|0
1094795|NCT02008565|3578647|P3|Overall Study|Protocol Violation|2
1094796|NCT02008565|3578648|P2|Overall Study|Protocol Violation|1
1094797|NCT02008565|3578649|P1|Overall Study|Protocol Violation|1
1094798|NCT02008526|3578710|P3|Overall Study|Lost to Follow-up|6
1094799|NCT02008526|3578711|P2|Overall Study|Lost to Follow-up|9
1094800|NCT02008526|3578712|P1|Overall Study|Lost to Follow-up|5
1094801|NCT02008526|3578710|P3|Overall Study|Withdrawal by Subject|2
1094802|NCT02008526|3578711|P2|Overall Study|Withdrawal by Subject|3
1094803|NCT02008526|3578712|P1|Overall Study|Withdrawal by Subject|3
1094804|NCT02008526|3578710|P3|Overall Study|Death|1
1094805|NCT02008526|3578711|P2|Overall Study|Death|2
1094806|NCT02008526|3578712|P1|Overall Study|Death|0
1094807|NCT02008227|3578725|P2|Overall Study|Ongoing Survival Follow-up|106
1094808|NCT02008227|3578726|P1|Overall Study|Ongoing Survival Follow-up|135
1094809|NCT02008227|3578725|P2|Overall Study|Ongoing on Study Treatment|85
1094810|NCT02008227|3578726|P1|Overall Study|Ongoing on Study Treatment|4
1094811|NCT02008227|3578725|P2|Overall Study|Withdrawal by Subject|34
1094812|NCT02008227|3578726|P1|Overall Study|Withdrawal by Subject|63
1094813|NCT02008227|3578725|P2|Overall Study|Death|383
1094814|NCT02008227|3578726|P1|Overall Study|Death|407
1094815|NCT02008227|3578725|P2|Overall Study|Lost to Follow-up|5
1094816|NCT02008227|3578726|P1|Overall Study|Lost to Follow-up|3
1094817|NCT02007954|3578787|P1|Overall Study|Death|1
1094818|NCT02007954|3578787|P1|Overall Study|Disease progression and unrelated AE|1
1094819|NCT02007954|3578787|P1|Overall Study|Switch in treatment modality|2
1094820|NCT02007954|3578787|P1|Overall Study|Received liver transplant|3
1094821|NCT02007577|3578806|P2|Overall Study|Withdrawal by Subject|1
1094822|NCT02007577|3578807|P1|Overall Study|Withdrawal by Subject|0
1094823|NCT02007577|3578806|P2|Overall Study|Adverse Event|0
1094824|NCT02007577|3578807|P1|Overall Study|Adverse Event|1
1094825|NCT02007512|3578819|P4|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
1094826|NCT02007512|3578820|P3|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
1094827|NCT02007512|3578821|P2|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3
1094828|NCT02007512|3578822|P1|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
1094829|NCT02007512|3578819|P4|Open Label Treatment Period|Disease progression|11
1094830|NCT02007512|3578820|P3|Open Label Treatment Period|Disease progression|0
1094831|NCT02007512|3578821|P2|Open Label Treatment Period|Disease progression|17
1094832|NCT02007512|3578822|P1|Open Label Treatment Period|Disease progression|0
1094833|NCT02007512|3578819|P4|Open Label Treatment Period|Other|1
1094834|NCT02007512|3578820|P3|Open Label Treatment Period|Other|0
1094835|NCT02007512|3578821|P2|Open Label Treatment Period|Other|0
1094836|NCT02007512|3578822|P1|Open Label Treatment Period|Other|0
1094837|NCT02007512|3578819|P4|Open Label Treatment Period|Adverse Event|0
1094838|NCT02007512|3578820|P3|Open Label Treatment Period|Adverse Event|0
1094839|NCT02007512|3578821|P2|Open Label Treatment Period|Adverse Event|1
1094840|NCT02007512|3578822|P1|Open Label Treatment Period|Adverse Event|0
1094841|NCT02007512|3578819|P4|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1
1094842|NCT02007512|3578820|P3|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5
1094843|NCT02007512|3578821|P2|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11
1094844|NCT02007512|3578822|P1|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10
1094845|NCT02007512|3578819|P4|Double Blind Treatment Period|Other|2
1094846|NCT02007512|3578820|P3|Double Blind Treatment Period|Other|1
1094847|NCT02007512|3578821|P2|Double Blind Treatment Period|Other|0
1094848|NCT02007512|3578822|P1|Double Blind Treatment Period|Other|0
1094849|NCT02007512|3578819|P4|Double Blind Treatment Period|Protocol Violation|1
1094850|NCT02007512|3578820|P3|Double Blind Treatment Period|Protocol Violation|0
1094851|NCT02007512|3578821|P2|Double Blind Treatment Period|Protocol Violation|0
1094852|NCT02007512|3578822|P1|Double Blind Treatment Period|Protocol Violation|0
1094853|NCT02007512|3578819|P4|Double Blind Treatment Period|Withdrawal by Subject|3
1094854|NCT02007512|3578820|P3|Double Blind Treatment Period|Withdrawal by Subject|3
1094855|NCT02007512|3578821|P2|Double Blind Treatment Period|Withdrawal by Subject|2
1094856|NCT02007512|3578822|P1|Double Blind Treatment Period|Withdrawal by Subject|4
1094857|NCT02007512|3578819|P4|Double Blind Treatment Period|Disease progression|51
1094858|NCT02007512|3578820|P3|Double Blind Treatment Period|Disease progression|45
1094859|NCT02007512|3578821|P2|Double Blind Treatment Period|Disease progression|49
1094860|NCT02007512|3578822|P1|Double Blind Treatment Period|Disease progression|44
1094861|NCT02007512|3578819|P4|Double Blind Treatment Period|Death|0
1094862|NCT02007512|3578820|P3|Double Blind Treatment Period|Death|0
1094863|NCT02007512|3578821|P2|Double Blind Treatment Period|Death|0
1094864|NCT02007512|3578822|P1|Double Blind Treatment Period|Death|1
1094865|NCT02007512|3578819|P4|Double Blind Treatment Period|Adverse Event|2
1094866|NCT02007512|3578820|P3|Double Blind Treatment Period|Adverse Event|6
1094867|NCT02007512|3578821|P2|Double Blind Treatment Period|Adverse Event|2
1094868|NCT02007512|3578822|P1|Double Blind Treatment Period|Adverse Event|4
1094869|NCT02007434|3578900|P8|Overall Study|Non-compliance|0
1094870|NCT02007434|3578901|P7|Overall Study|Non-compliance|0
1094871|NCT02007434|3578902|P6|Overall Study|Non-compliance|0
1094872|NCT02007434|3578903|P5|Overall Study|Non-compliance|0
1094873|NCT02007434|3578904|P4|Overall Study|Non-compliance|0
1094874|NCT02007434|3578905|P3|Overall Study|Non-compliance|1
1094875|NCT02007434|3578906|P2|Overall Study|Non-compliance|0
1094876|NCT02007434|3578907|P1|Overall Study|Non-compliance|1
1094877|NCT02007434|3578900|P8|Overall Study|Lost to Follow-up|0
1094878|NCT02007434|3578901|P7|Overall Study|Lost to Follow-up|0
1094879|NCT02007434|3578902|P6|Overall Study|Lost to Follow-up|0
1094880|NCT02007434|3578903|P5|Overall Study|Lost to Follow-up|0
1094881|NCT02007434|3578904|P4|Overall Study|Lost to Follow-up|0
1094882|NCT02007434|3578905|P3|Overall Study|Lost to Follow-up|0
1094883|NCT02007434|3578906|P2|Overall Study|Lost to Follow-up|1
1094884|NCT02007434|3578907|P1|Overall Study|Lost to Follow-up|0
1094885|NCT02007278|3579038|P2|Overall Study|Mis-randomization|1
1094886|NCT02007278|3579039|P1|Overall Study|Mis-randomization|1
1094887|NCT02007278|3579038|P2|Overall Study|Incorrect medication administration|0
1094888|NCT02007278|3579039|P1|Overall Study|Incorrect medication administration|1
1094889|NCT02007278|3579038|P2|Overall Study|Ingestion of drugs not allowed in study|1
1094890|NCT02007278|3579039|P1|Overall Study|Ingestion of drugs not allowed in study|0
1094891|NCT02007278|3579038|P2|Overall Study|Failure to comply with an eligibility|1
1094892|NCT02007278|3579039|P1|Overall Study|Failure to comply with an eligibility|0
1094893|NCT02007252|3579061|P2|Overall Study|Adverse Event|4
1094894|NCT02007252|3579062|P1|Overall Study|Adverse Event|7
1094895|NCT02007252|3579061|P2|Overall Study|Abnormal laboratory value(s)|0
1094896|NCT02007252|3579062|P1|Overall Study|Abnormal laboratory value(s)|1
1094897|NCT02007252|3579061|P2|Overall Study|Administrative problems|7
1094898|NCT02007252|3579062|P1|Overall Study|Administrative problems|3
1094899|NCT02007096|3579077|P2|Overall Study|no mesh placed|1
1094900|NCT02007096|3579078|P1|Overall Study|no mesh placed|0
1094901|NCT02007096|3579077|P2|Overall Study|converted to open surgery|1
1094902|NCT02007096|3579078|P1|Overall Study|converted to open surgery|1
1094903|NCT02007096|3579077|P2|Overall Study|did not follow postoperative protocol|11
1094904|NCT02007096|3579078|P1|Overall Study|did not follow postoperative protocol|8
1094905|NCT02007096|3579077|P2|Overall Study|did not inject saline|3
1094906|NCT02007096|3579078|P1|Overall Study|did not inject saline|0
1094907|NCT02007096|3579077|P2|Overall Study|medication not available|0
1094908|NCT02007096|3579078|P1|Overall Study|medication not available|2
1094909|NCT02007070|3579090|P1|Overall Study|Progressive Disease|21
1094910|NCT02007070|3579090|P1|Overall Study|Physician Decision|1
1094911|NCT02007070|3579090|P1|Overall Study|Protocol Violation|2
1094912|NCT02007070|3579090|P1|Overall Study|Death|1
1094913|NCT02007070|3579090|P1|Overall Study|Clinical Progression|4
1094914|NCT02007070|3579090|P1|Overall Study|Adverse Event|4
1094915|NCT02006732|3579147|P4|Overall Study|Withdrawal by Subject|1
1094916|NCT02006732|3579148|P3|Overall Study|Withdrawal by Subject|4
1094917|NCT02006732|3579149|P2|Overall Study|Withdrawal by Subject|0
1094918|NCT02006732|3579150|P1|Overall Study|Withdrawal by Subject|3
1094919|NCT02006732|3579147|P4|Overall Study|Lost to Follow-up|0
1094920|NCT02006732|3579148|P3|Overall Study|Lost to Follow-up|0
1094921|NCT02006732|3579149|P2|Overall Study|Lost to Follow-up|1
1094922|NCT02006732|3579150|P1|Overall Study|Lost to Follow-up|0
1094923|NCT02006732|3579147|P4|Overall Study|Protocol Violation|0
1094924|NCT02006732|3579148|P3|Overall Study|Protocol Violation|0
1094925|NCT02006732|3579149|P2|Overall Study|Protocol Violation|1
1094926|NCT02006732|3579150|P1|Overall Study|Protocol Violation|1
1094927|NCT02006732|3579147|P4|Overall Study|Lack of Efficacy|1
1094928|NCT02006732|3579148|P3|Overall Study|Lack of Efficacy|1
1094929|NCT02006732|3579149|P2|Overall Study|Lack of Efficacy|3
1094930|NCT02006732|3579150|P1|Overall Study|Lack of Efficacy|6
1094931|NCT02006732|3579147|P4|Overall Study|Adverse Event|2
1094932|NCT02006732|3579148|P3|Overall Study|Adverse Event|4
1094933|NCT02006732|3579149|P2|Overall Study|Adverse Event|7
1094934|NCT02006732|3579150|P1|Overall Study|Adverse Event|10
1094935|NCT02006719|3579190|P2|Overall Study|Other/Unknown|1
1094936|NCT02006719|3579191|P1|Overall Study|Other/Unknown|0
1094937|NCT02006719|3579190|P2|Overall Study|Adverse Event|1
1094938|NCT02006719|3579191|P1|Overall Study|Adverse Event|1
1094939|NCT02006719|3579190|P2|Overall Study|Protocol Violation|0
1094940|NCT02006719|3579191|P1|Overall Study|Protocol Violation|2
1094941|NCT02006719|3579190|P2|Overall Study|Lost to Follow-up|1
1094942|NCT02006719|3579191|P1|Overall Study|Lost to Follow-up|5
1094943|NCT02006719|3579190|P2|Overall Study|Withdrawal by Subject|2
1094944|NCT02006719|3579191|P1|Overall Study|Withdrawal by Subject|10
1094945|NCT02006706|3579221|P1|Overall Study|Lost to Follow-up|1
1094946|NCT02006667|3579226|P1|Overall Study|Withdrawal by Subject|1
1094947|NCT02006667|3579226|P1|Overall Study|Death|2
1094948|NCT02006667|3579226|P1|Overall Study|Adverse Event|3
1094949|NCT02006654|3579238|P2|Overall Study|moving out of state|1
1094950|NCT02006654|3579239|P1|Overall Study|moving out of state|0
1094951|NCT02006654|3579238|P2|Overall Study|disallowed medication|0
1094952|NCT02006654|3579239|P1|Overall Study|disallowed medication|1
1094953|NCT02006654|3579238|P2|Overall Study|mood disorder|1
1094954|NCT02006654|3579239|P1|Overall Study|mood disorder|0
1094955|NCT02006654|3579238|P2|Overall Study|faecal incontinence|1
1094956|NCT02006654|3579239|P1|Overall Study|faecal incontinence|0
1094957|NCT02006654|3579238|P2|Overall Study|worsening cognitive condition|1
1094958|NCT02006654|3579239|P1|Overall Study|worsening cognitive condition|0
1094959|NCT02006654|3579238|P2|Overall Study|insufficient compliance|0
1094960|NCT02006654|3579239|P1|Overall Study|insufficient compliance|1
1094961|NCT02006654|3579238|P2|Overall Study|patient's will|1
1094962|NCT02006654|3579239|P1|Overall Study|patient's will|2
1094963|NCT02006654|3579238|P2|Overall Study|Lost to Follow-up|0
1094964|NCT02006654|3579239|P1|Overall Study|Lost to Follow-up|1
1094965|NCT02006654|3579238|P2|Overall Study|Protocol Violation|8
1094966|NCT02006654|3579239|P1|Overall Study|Protocol Violation|5
1094967|NCT02006654|3579238|P2|Overall Study|Withdrawal by Subject|12
1094968|NCT02006654|3579239|P1|Overall Study|Withdrawal by Subject|14
1094969|NCT02006654|3579238|P2|Overall Study|Death|0
1094970|NCT02006654|3579239|P1|Overall Study|Death|1
1094971|NCT02006654|3579238|P2|Overall Study|Adverse Event|17
1094972|NCT02006654|3579239|P1|Overall Study|Adverse Event|16
1094973|NCT02006654|3579238|P2|Overall Study|Withdrawal before treatment|2
1094974|NCT02006654|3579239|P1|Overall Study|Withdrawal before treatment|4
1094975|NCT02006641|3579268|P3|Overall Study|Other reason: protocol non-compliance|1
1094976|NCT02006641|3579269|P2|Overall Study|Other reason: protocol non-compliance|0
1094977|NCT02006641|3579270|P1|Overall Study|Other reason: protocol non-compliance|0
1094978|NCT02006641|3579268|P3|Overall Study|Other reason: caregiver impossibility|1
1094979|NCT02006641|3579269|P2|Overall Study|Other reason: caregiver impossibility|0
1094980|NCT02006641|3579270|P1|Overall Study|Other reason: caregiver impossibility|0
1094981|NCT02006641|3579268|P3|Overall Study|Other reason: hospitalisation|0
1094982|NCT02006641|3579269|P2|Overall Study|Other reason: hospitalisation|1
1094983|NCT02006641|3579270|P1|Overall Study|Other reason: hospitalisation|0
1094984|NCT02006641|3579268|P3|Overall Study|Other reason: patient's wife has died|1
1094985|NCT02006641|3579269|P2|Overall Study|Other reason: patient's wife has died|0
1094986|NCT02006641|3579270|P1|Overall Study|Other reason: patient's wife has died|0
1094987|NCT02006641|3579268|P3|Overall Study|Other reason: caregiver in hospital|0
1094988|NCT02006641|3579269|P2|Overall Study|Other reason: caregiver in hospital|1
1094989|NCT02006641|3579270|P1|Overall Study|Other reason: caregiver in hospital|0
1094990|NCT02006641|3579268|P3|Overall Study|Other reason: patient has moved|1
1094991|NCT02006641|3579269|P2|Overall Study|Other reason: patient has moved|0
1094992|NCT02006641|3579270|P1|Overall Study|Other reason: patient has moved|1
1094993|NCT02006641|3579268|P3|Overall Study|Other reason:patient didn't want to come|1
1094994|NCT02006641|3579269|P2|Overall Study|Other reason:patient didn't want to come|0
1094995|NCT02006641|3579270|P1|Overall Study|Other reason:patient didn't want to come|0
1094996|NCT02006641|3579268|P3|Overall Study|Other reason: patient didn't show up|0
1094997|NCT02006641|3579269|P2|Overall Study|Other reason: patient didn't show up|0
1094998|NCT02006641|3579270|P1|Overall Study|Other reason: patient didn't show up|1
1094999|NCT02006641|3579268|P3|Overall Study|Withdrawal by Subject|11
1095000|NCT02006641|3579269|P2|Overall Study|Withdrawal by Subject|12
1095001|NCT02006641|3579270|P1|Overall Study|Withdrawal by Subject|7
1095002|NCT02006641|3579268|P3|Overall Study|Lost to Follow-up|0
1095003|NCT02006641|3579269|P2|Overall Study|Lost to Follow-up|1
1095004|NCT02006641|3579270|P1|Overall Study|Lost to Follow-up|0
1095005|NCT02006641|3579268|P3|Overall Study|Protocol Violation|2
1095006|NCT02006641|3579269|P2|Overall Study|Protocol Violation|2
1095007|NCT02006641|3579270|P1|Overall Study|Protocol Violation|0
1095008|NCT02006641|3579268|P3|Overall Study|Adverse Event|15
1095009|NCT02006641|3579269|P2|Overall Study|Adverse Event|11
1095010|NCT02006641|3579270|P1|Overall Study|Adverse Event|15
1095011|NCT02006641|3579268|P3|Overall Study|Withdrawal before treatment|3
1095012|NCT02006641|3579269|P2|Overall Study|Withdrawal before treatment|5
1095013|NCT02006641|3579270|P1|Overall Study|Withdrawal before treatment|2
1095014|NCT02005692|3579369|P1|Overall Study|Discharged earlier than anticipated|5
1095015|NCT02005692|3579369|P1|Overall Study|Withdrawal by Subject|1
1095016|NCT02005692|3579369|P1|Overall Study|Protocol Violation|1
1095017|NCT02005562|3579389|P2|Overall Study|Physician Decision|1
1095018|NCT02005562|3579390|P1|Overall Study|Physician Decision|0
1095019|NCT02005562|3579389|P2|Overall Study|No transplant|4
1095020|NCT02005562|3579390|P1|Overall Study|No transplant|1
1095021|NCT02005562|3579389|P2|Overall Study|Withdrawal by Subject|2
1095022|NCT02005562|3579390|P1|Overall Study|Withdrawal by Subject|2
1095023|NCT02005562|3579389|P2|Overall Study|Graft loss|6
1095024|NCT02005562|3579390|P1|Overall Study|Graft loss|7
1095025|NCT02005562|3579389|P2|Overall Study|Death|2
1095026|NCT02005562|3579390|P1|Overall Study|Death|2
1095027|NCT02005484|3579432|P1|Overall Study|Sponsor decision|1
1095028|NCT02005484|3579432|P1|Overall Study|Changed to a Different Study|1
1095029|NCT02005484|3579432|P1|Overall Study|Disease progression|1
1095030|NCT02005484|3579432|P1|Overall Study|Death|1
1095031|NCT02005471|3579444|P2|Overall Study|Withdrawal by Subject|7
1095032|NCT02005471|3579445|P1|Overall Study|Withdrawal by Subject|18
1095033|NCT02005471|3579444|P2|Overall Study|Progressive Disease|0
1095034|NCT02005471|3579445|P1|Overall Study|Progressive Disease|3
1095035|NCT02005471|3579444|P2|Overall Study|Physician Decision|1
1095036|NCT02005471|3579445|P1|Overall Study|Physician Decision|2
1095037|NCT02005471|3579444|P2|Overall Study|Lost to Follow-up|0
1095038|NCT02005471|3579445|P1|Overall Study|Lost to Follow-up|1
1095039|NCT02005471|3579444|P2|Overall Study|Death|15
1095040|NCT02005471|3579445|P1|Overall Study|Death|26
1095041|NCT02005471|3579444|P2|Overall Study|Adverse Event|0
1095042|NCT02005471|3579445|P1|Overall Study|Adverse Event|1
1095043|NCT02005471|3579444|P2|Overall Study|Ongoing in Study|171
1095044|NCT02005471|3579445|P1|Overall Study|Ongoing in Study|144
1095045|NCT02005211|3579509|P7|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
1095046|NCT02005211|3579510|P6|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
1095047|NCT02005211|3579511|P5|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1
1095048|NCT02005211|3579512|P4|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
1095049|NCT02005211|3579513|P3|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
1095050|NCT02005211|3579514|P2|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
1095051|NCT02005211|3579515|P1|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
1095052|NCT02005029|3579550|P2|First Intervention (1 Day)|participant withdrawn for noncompliance|0
1095053|NCT02005029|3579551|P1|First Intervention (1 Day)|participant withdrawn for noncompliance|1
1095054|NCT02004886|3579603|P4|Overall Study|Unable to attend future visits|0
1095055|NCT02004886|3579604|P3|Overall Study|Unable to attend future visits|0
1095056|NCT02004886|3579605|P2|Overall Study|Unable to attend future visits|0
1095057|NCT02004886|3579606|P1|Overall Study|Unable to attend future visits|1
1095058|NCT02004886|3579603|P4|Overall Study|Adverse Event|0
1095059|NCT02004886|3579604|P3|Overall Study|Adverse Event|0
1095060|NCT02004886|3579605|P2|Overall Study|Adverse Event|1
1095061|NCT02004886|3579606|P1|Overall Study|Adverse Event|0
1095062|NCT02004873|3579656|P1|Overall Study|Withdrawal by Subject|1
1095063|NCT02004873|3579656|P1|Overall Study|Death|23
1095064|NCT02004873|3579656|P1|Overall Study|Missed 6-month visit|4
1095065|NCT02004873|3579656|P1|Overall Study|Awaiting 6-month visit|390
1095066|NCT02004873|3579656|P1|Overall Study|Implant unsuccessful|6
1095067|NCT02004847|3579665|P2|Overall Study|Protocol Violation|1
1095068|NCT02004847|3579666|P1|Overall Study|Protocol Violation|1
1095069|NCT02004262|3579812|P6|Overall Study|Study Terminated by Sponsor|5
1095070|NCT02004262|3579813|P5|Overall Study|Study Terminated by Sponsor|1
1095071|NCT02004262|3579814|P4|Overall Study|Study Terminated by Sponsor|1
1095072|NCT02004262|3579815|P3|Overall Study|Study Terminated by Sponsor|2
1095073|NCT02004262|3579816|P2|Overall Study|Study Terminated by Sponsor|3
1095074|NCT02004262|3579817|P1|Overall Study|Study Terminated by Sponsor|4
1095075|NCT02004262|3579812|P6|Overall Study|Lost to Follow-up|0
1095076|NCT02004262|3579813|P5|Overall Study|Lost to Follow-up|0
1095077|NCT02004262|3579814|P4|Overall Study|Lost to Follow-up|0
1095078|NCT02004262|3579815|P3|Overall Study|Lost to Follow-up|0
1095079|NCT02004262|3579816|P2|Overall Study|Lost to Follow-up|1
1095080|NCT02004262|3579817|P1|Overall Study|Lost to Follow-up|1
1095081|NCT02004262|3579812|P6|Overall Study|Withdrawal by Subject|3
1095082|NCT02004262|3579813|P5|Overall Study|Withdrawal by Subject|1
1095083|NCT02004262|3579814|P4|Overall Study|Withdrawal by Subject|0
1095084|NCT02004262|3579815|P3|Overall Study|Withdrawal by Subject|4
1095085|NCT02004262|3579816|P2|Overall Study|Withdrawal by Subject|0
1095086|NCT02004262|3579817|P1|Overall Study|Withdrawal by Subject|1
1095087|NCT02004262|3579812|P6|Overall Study|Death|22
1095088|NCT02004262|3579813|P5|Overall Study|Death|29
1095089|NCT02004262|3579814|P4|Overall Study|Death|28
1095090|NCT02004262|3579815|P3|Overall Study|Death|66
1095091|NCT02004262|3579816|P2|Overall Study|Death|64
1095092|NCT02004262|3579817|P1|Overall Study|Death|67
1095093|NCT02004236|3579837|P3|Overall Study|Lack of Efficacy|16
1095094|NCT02004236|3579838|P2|Overall Study|Lack of Efficacy|0
1095095|NCT02004236|3579839|P1|Overall Study|Lack of Efficacy|0
1095096|NCT02004093|3579899|P2|Overall Study|Not specified|1
1095097|NCT02004093|3579900|P1|Overall Study|Not specified|3
1095098|NCT02004093|3579899|P2|Overall Study|Withdrawal by Subject|7
1095099|NCT02004093|3579900|P1|Overall Study|Withdrawal by Subject|3
1095100|NCT02004093|3579899|P2|Overall Study|Lost to Follow-up|1
1095101|NCT02004093|3579900|P1|Overall Study|Lost to Follow-up|0
1095102|NCT02004093|3579899|P2|Overall Study|Protocol Violation|1
1095103|NCT02004093|3579900|P1|Overall Study|Protocol Violation|0
1095104|NCT02004093|3579899|P2|Overall Study|Lack of Efficacy|62
1095105|NCT02004093|3579900|P1|Overall Study|Lack of Efficacy|66
1095106|NCT02004093|3579899|P2|Overall Study|Death|1
1095107|NCT02004093|3579900|P1|Overall Study|Death|2
1095108|NCT02003963|3579932|P2|Overall Study|Lost to Follow-up|1
1095109|NCT02003963|3579933|P1|Overall Study|Lost to Follow-up|2
1095110|NCT02003924|3579955|P2|Overall Study|Adverse Event|29
1095111|NCT02003924|3579956|P1|Overall Study|Adverse Event|91
1095112|NCT02003924|3579955|P2|Overall Study|Withdrawal by Subject|34
1095113|NCT02003924|3579956|P1|Overall Study|Withdrawal by Subject|49
1095114|NCT02003924|3579955|P2|Overall Study|Other than specified|19
1095115|NCT02003924|3579956|P1|Overall Study|Other than specified|18
1095116|NCT02003924|3579955|P2|Overall Study|Lost to Follow-up|1
1095117|NCT02003924|3579956|P1|Overall Study|Lost to Follow-up|2
1095118|NCT02003924|3579955|P2|Overall Study|Protocol Violation|2
1095119|NCT02003924|3579956|P1|Overall Study|Protocol Violation|1
1095120|NCT02003924|3579955|P2|Overall Study|Disease progression|207
1095121|NCT02003924|3579956|P1|Overall Study|Disease progression|138
1095122|NCT02003924|3579955|P2|Overall Study|Ongoing in study|176
1095123|NCT02003924|3579956|P1|Overall Study|Ongoing in study|634
1095124|NCT02003638|3580056|P2|Overall Study|Withdrawal by Subject|0
1095125|NCT02003638|3580057|P1|Overall Study|Withdrawal by Subject|1
1095126|NCT02003534|3580063|P1|Overall Study|Lost to Follow-up|47
1095127|NCT02003391|3580075|P2|Overall Study|Adverse Event|0
1095128|NCT02003391|3580076|P1|Overall Study|Adverse Event|1
1095129|NCT02003391|3580075|P2|Overall Study|Protocol Violation|1
1095130|NCT02003391|3580076|P1|Overall Study|Protocol Violation|0
1095131|NCT02003391|3580075|P2|Overall Study|Withdrawal by Subject|1
1095132|NCT02003391|3580076|P1|Overall Study|Withdrawal by Subject|2
1095133|NCT02003365|3580089|P3|Overall Study|Lost to Follow-up|1
1095134|NCT02003365|3580090|P2|Overall Study|Lost to Follow-up|0
1095135|NCT02003365|3580091|P1|Overall Study|Lost to Follow-up|0
1095136|NCT02003014|3580115|P1|Overall Study|Investigator's transfer|4
1095137|NCT02003014|3580115|P1|Overall Study|Patient did not visit the study site|5
1095138|NCT02003014|3580115|P1|Overall Study|Treatment started after contract period|1
1095139|NCT02003014|3580115|P1|Overall Study|Case report forms uncollected|9
1095140|NCT02002689|3580197|P1|Overall Study|Adverse Event|3
1095141|NCT02002689|3580197|P1|Overall Study|Disease Progression|7
1095142|NCT02002533|3580216|P2|Overall Study|Lost to Follow-up|1
1095143|NCT02002533|3580217|P1|Overall Study|Lost to Follow-up|0
1095144|NCT02002533|3580216|P2|Overall Study|Adverse Event|3
1095145|NCT02002533|3580217|P1|Overall Study|Adverse Event|0
1095146|NCT02002533|3580216|P2|Overall Study|Protocol Violation|1
1095147|NCT02002533|3580217|P1|Overall Study|Protocol Violation|0
1095148|NCT02002533|3580216|P2|Overall Study|Withdrawal by Subject|13
1095149|NCT02002533|3580217|P1|Overall Study|Withdrawal by Subject|6
1095150|NCT02002221|3580242|P2|Overall Study|Patient withdrew consent|1
1095151|NCT02002221|3580243|P1|Overall Study|Patient withdrew consent|0
1095152|NCT02002221|3580242|P2|Overall Study|Unsatisfactory therapeutic effect|1
1095153|NCT02002221|3580243|P1|Overall Study|Unsatisfactory therapeutic effect|0
1095154|NCT02002221|3580242|P2|Overall Study|Adverse Event|1
1095155|NCT02002221|3580243|P1|Overall Study|Adverse Event|2
1095156|NCT02002091|3580270|P2|Screening|Death|2
1095157|NCT02002091|3580271|P1|Screening|Death|3
1095158|NCT02002091|3580270|P2|Screening|Lost to Follow-up|12
1095159|NCT02002091|3580271|P1|Screening|Lost to Follow-up|10
1095160|NCT02001987|3580306|P1|LTE Period (52 Weeks)|Other|3
1095161|NCT02001987|3580306|P1|LTE Period (52 Weeks)|Lack of Efficacy|1
1095162|NCT02001987|3580306|P1|LTE Period (52 Weeks)|Withdrawal by Subject|1
1095163|NCT02001987|3580306|P1|LTE Period (52 Weeks)|Physician Decision|2
1095164|NCT02001987|3580306|P1|LTE Period (52 Weeks)|Lost to Follow-up|2
1095165|NCT02001987|3580306|P1|Core Study Period (24 Weeks)|Lack of Efficacy|3
1095166|NCT02001987|3580306|P1|Core Study Period (24 Weeks)|Protocol Violation|3
1095167|NCT02001987|3580306|P1|Core Study Period (24 Weeks)|Withdrawal by Subject|4
1095168|NCT02001987|3580306|P1|Core Study Period (24 Weeks)|Physician Decision|1
1095169|NCT02001987|3580306|P1|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2
1095170|NCT02001987|3580306|P1|Core Study Period (24 Weeks)|Death|1
1095171|NCT02001987|3580306|P1|Core Study Period (24 Weeks)|Adverse Event|9
1095172|NCT02001558|3580391|P2|Overall Study|Lost to Follow-up|14
1095173|NCT02001558|3580392|P1|Overall Study|Lost to Follow-up|8
1095174|NCT02001181|3580426|P2|Overall Study|Withdrawal by Subject|1
1095175|NCT02001181|3580427|P1|Overall Study|Withdrawal by Subject|0
1095176|NCT02001181|3580426|P2|Overall Study|Lost to Follow-up|0
1095177|NCT02001181|3580427|P1|Overall Study|Lost to Follow-up|1
1095178|NCT02001181|3580426|P2|Overall Study|Adverse Event|2
1095179|NCT02001181|3580427|P1|Overall Study|Adverse Event|0
1095180|NCT02001051|3580443|P2|Overall Study|Deemed not eligible following enrollment|1
1095181|NCT02001051|3580444|P1|Overall Study|Deemed not eligible following enrollment|0
1095182|NCT02000921|3580496|P3|Overall Study|Physician Decision|0
1095183|NCT02000921|3580497|P2|Overall Study|Physician Decision|2
1095184|NCT02000921|3580498|P1|Overall Study|Physician Decision|0
1095185|NCT02000921|3580496|P3|Overall Study|Lost to Follow-up|5
1095186|NCT02000921|3580497|P2|Overall Study|Lost to Follow-up|4
1095187|NCT02000921|3580498|P1|Overall Study|Lost to Follow-up|2
1095188|NCT02000921|3580496|P3|Overall Study|Withdrawal by Subject|5
1095189|NCT02000921|3580497|P2|Overall Study|Withdrawal by Subject|10
1095190|NCT02000921|3580498|P1|Overall Study|Withdrawal by Subject|3
1095191|NCT02000752|3580517|P2|Overall Study|Shift Changes|5
1095192|NCT02000752|3580518|P1|Overall Study|Shift Changes|12
1095193|NCT02000752|3580517|P2|Overall Study|Dystocic delivery|8
1095194|NCT02000752|3580518|P1|Overall Study|Dystocic delivery|19
1095195|NCT02000622|3580532|P2|Overall Study|Withdrawal by Subject|7
1095196|NCT02000622|3580533|P1|Overall Study|Withdrawal by Subject|5
1095197|NCT02000622|3580532|P2|Overall Study|Death|46
1095198|NCT02000622|3580533|P1|Overall Study|Death|94
1095199|NCT02000622|3580532|P2|Overall Study|Lost to Follow-up|0
1095200|NCT02000622|3580533|P1|Overall Study|Lost to Follow-up|1
1095201|NCT02000622|3580532|P2|Overall Study|Withdrawn due to site closure|0
1095202|NCT02000622|3580533|P1|Overall Study|Withdrawn due to site closure|1
1095203|NCT02000531|3580555|P2|Overall Study|Discontinued due to data cut-off|8
1095204|NCT02000531|3580556|P1|Overall Study|Discontinued due to data cut-off|3
1095205|NCT02000531|3580555|P2|Overall Study|Lost to Follow-up|0
1095206|NCT02000531|3580556|P1|Overall Study|Lost to Follow-up|1
1095207|NCT02000440|3580564|P1|Overall Study|Other-Protocol-defined Stopping Criteria|1
1095208|NCT02000440|3580564|P1|Overall Study|Adverse Event|3
1095209|NCT02000427|3580584|P1|Overall Study|Death|22
1095210|NCT01999894|3580641|P1|Overall Study|Inclusion/exclusion criteria not met|1
1095211|NCT01999894|3580641|P1|Overall Study|Other Reason|3
1095212|NCT01999894|3580641|P1|Overall Study|Lost to Follow-up|10
1095213|NCT01999894|3580641|P1|Overall Study|Withdrawal by Subject|7
1095214|NCT01999894|3580641|P1|Overall Study|Protocol Violation|1
1095215|NCT01999894|3580641|P1|Overall Study|Lack of Efficacy|5
1095216|NCT01999894|3580641|P1|Overall Study|Adverse Event|9
1095217|NCT01999868|3580649|P3|Blinded Observation Phase (Week 40 – 88)|Worsening psoriasis|0
1095218|NCT01999868|3580650|P2|Blinded Observation Phase (Week 40 – 88)|Worsening psoriasis|4
1095219|NCT01999868|3580651|P1|Blinded Observation Phase (Week 40 – 88)|Worsening psoriasis|12
1095220|NCT01999868|3580649|P3|Blinded Observation Phase (Week 40 – 88)|Terminated early from study in error|0
1095221|NCT01999868|3580650|P2|Blinded Observation Phase (Week 40 – 88)|Terminated early from study in error|2
1095222|NCT01999868|3580651|P1|Blinded Observation Phase (Week 40 – 88)|Terminated early from study in error|0
1095223|NCT01999868|3580649|P3|Blinded Observation Phase (Week 40 – 88)|Met psoriasis relapse criterion|0
1095224|NCT01999868|3580650|P2|Blinded Observation Phase (Week 40 – 88)|Met psoriasis relapse criterion|19
1095225|NCT01999868|3580651|P1|Blinded Observation Phase (Week 40 – 88)|Met psoriasis relapse criterion|10
1095226|NCT01999868|3580649|P3|Blinded Observation Phase (Week 40 – 88)|Withdrawal by Subject|0
1095227|NCT01999868|3580650|P2|Blinded Observation Phase (Week 40 – 88)|Withdrawal by Subject|2
1095228|NCT01999868|3580651|P1|Blinded Observation Phase (Week 40 – 88)|Withdrawal by Subject|1
1095229|NCT01999868|3580649|P3|Blinded Observation Phase (Week 40 – 88)|Lost to Follow-up|0
1095230|NCT01999868|3580650|P2|Blinded Observation Phase (Week 40 – 88)|Lost to Follow-up|1
1095231|NCT01999868|3580651|P1|Blinded Observation Phase (Week 40 – 88)|Lost to Follow-up|0
1095232|NCT01999868|3580649|P3|Blinded Observation Phase (Week 40 – 88)|Adverse Event|0
1095233|NCT01999868|3580650|P2|Blinded Observation Phase (Week 40 – 88)|Adverse Event|1
1095234|NCT01999868|3580651|P1|Blinded Observation Phase (Week 40 – 88)|Adverse Event|0
1095235|NCT01999868|3580649|P3|Blinded Treatment Phase (Week 12 – 40)|Worsening psoriasis|0
1095236|NCT01999868|3580650|P2|Blinded Treatment Phase (Week 12 – 40)|Worsening psoriasis|0
1095237|NCT01999868|3580651|P1|Blinded Treatment Phase (Week 12 – 40)|Worsening psoriasis|4
1095238|NCT01999868|3580649|P3|Blinded Treatment Phase (Week 12 – 40)|Transportation issues|0
1095239|NCT01999868|3580650|P2|Blinded Treatment Phase (Week 12 – 40)|Transportation issues|0
1095240|NCT01999868|3580651|P1|Blinded Treatment Phase (Week 12 – 40)|Transportation issues|1
1095241|NCT01999868|3580649|P3|Blinded Treatment Phase (Week 12 – 40)|Met psoriasis relapse criterion|0
1095242|NCT01999868|3580650|P2|Blinded Treatment Phase (Week 12 – 40)|Met psoriasis relapse criterion|1
1095243|NCT01999868|3580651|P1|Blinded Treatment Phase (Week 12 – 40)|Met psoriasis relapse criterion|8
1095244|NCT01999868|3580649|P3|Blinded Treatment Phase (Week 12 – 40)|Met study drug Discontinuation Criteria|0
1095245|NCT01999868|3580650|P2|Blinded Treatment Phase (Week 12 – 40)|Met study drug Discontinuation Criteria|2
1095246|NCT01999868|3580651|P1|Blinded Treatment Phase (Week 12 – 40)|Met study drug Discontinuation Criteria|1
1095247|NCT01999868|3580649|P3|Blinded Treatment Phase (Week 12 – 40)|Withdrawal by Subject|0
1095248|NCT01999868|3580650|P2|Blinded Treatment Phase (Week 12 – 40)|Withdrawal by Subject|2
1095249|NCT01999868|3580651|P1|Blinded Treatment Phase (Week 12 – 40)|Withdrawal by Subject|0
1095250|NCT01999868|3580649|P3|Blinded Treatment Phase (Week 12 – 40)|Pregnancy|0
1095251|NCT01999868|3580650|P2|Blinded Treatment Phase (Week 12 – 40)|Pregnancy|1
1095252|NCT01999868|3580651|P1|Blinded Treatment Phase (Week 12 – 40)|Pregnancy|0
1095253|NCT01999868|3580649|P3|Blinded Treatment Phase (Week 12 – 40)|Lost to Follow-up|0
1095254|NCT01999868|3580650|P2|Blinded Treatment Phase (Week 12 – 40)|Lost to Follow-up|4
1095255|NCT01999868|3580651|P1|Blinded Treatment Phase (Week 12 – 40)|Lost to Follow-up|3
1095256|NCT01999868|3580649|P3|Blinded Treatment Phase (Week 12 – 40)|Adverse Event|0
1095257|NCT01999868|3580650|P2|Blinded Treatment Phase (Week 12 – 40)|Adverse Event|1
1095258|NCT01999868|3580651|P1|Blinded Treatment Phase (Week 12 – 40)|Adverse Event|1
1095259|NCT01999868|3580649|P3|Lead-in Phase (Week 0 – 12)|Lost to Follow-up|5
1095260|NCT01999868|3580650|P2|Lead-in Phase (Week 0 – 12)|Lost to Follow-up|0
1095261|NCT01999868|3580651|P1|Lead-in Phase (Week 0 – 12)|Lost to Follow-up|0
1095262|NCT01999465|3580689|P2|Overall Study|Protocol Violation|1
1095263|NCT01999465|3580690|P1|Overall Study|Protocol Violation|0
1095264|NCT01999465|3580689|P2|Overall Study|Lost to Follow-up|2
1095265|NCT01999465|3580690|P1|Overall Study|Lost to Follow-up|0
1095266|NCT01999322|3580735|P2|Overall Study|Adverse Event|0
1095267|NCT01999322|3580736|P1|Overall Study|Adverse Event|1
1095268|NCT01999218|3580788|P3|Overall Study|Treated but excluded at 1 trial site|2
1095269|NCT01999218|3580789|P2|Overall Study|Treated but excluded at 1 trial site|5
1095270|NCT01999218|3580790|P1|Overall Study|Treated but excluded at 1 trial site|3
1095271|NCT01999218|3580788|P3|Overall Study|Adverse Event|7
1095272|NCT01999218|3580789|P2|Overall Study|Adverse Event|7
1095273|NCT01999218|3580790|P1|Overall Study|Adverse Event|9
1095274|NCT01999218|3580788|P3|Overall Study|Excluded Medication|2
1095275|NCT01999218|3580789|P2|Overall Study|Excluded Medication|1
1095276|NCT01999218|3580790|P1|Overall Study|Excluded Medication|1
1095277|NCT01999218|3580788|P3|Overall Study|Death|2
1095278|NCT01999218|3580789|P2|Overall Study|Death|1
1095279|NCT01999218|3580790|P1|Overall Study|Death|7
1095280|NCT01999218|3580788|P3|Overall Study|Creatinine/eGFR|1
1095281|NCT01999218|3580789|P2|Overall Study|Creatinine/eGFR|0
1095282|NCT01999218|3580790|P1|Overall Study|Creatinine/eGFR|0
1095283|NCT01999218|3580788|P3|Overall Study|Withdrawal by Subject|34
1095284|NCT01999218|3580789|P2|Overall Study|Withdrawal by Subject|29
1095285|NCT01999218|3580790|P1|Overall Study|Withdrawal by Subject|28
1095286|NCT01999218|3580788|P3|Overall Study|Participant moves|3
1095287|NCT01999218|3580789|P2|Overall Study|Participant moves|5
1095288|NCT01999218|3580790|P1|Overall Study|Participant moves|2
1095289|NCT01999218|3580788|P3|Overall Study|Study Terminated By Sponsor|12
1095290|NCT01999218|3580789|P2|Overall Study|Study Terminated By Sponsor|5
1095291|NCT01999218|3580790|P1|Overall Study|Study Terminated By Sponsor|7
1095292|NCT01999218|3580788|P3|Overall Study|Screen failure|0
1095293|NCT01999218|3580789|P2|Overall Study|Screen failure|1
1095294|NCT01999218|3580790|P1|Overall Study|Screen failure|0
1095295|NCT01999218|3580788|P3|Overall Study|Protocol Violation|4
1095296|NCT01999218|3580789|P2|Overall Study|Protocol Violation|5
1095297|NCT01999218|3580790|P1|Overall Study|Protocol Violation|4
1095298|NCT01999218|3580788|P3|Overall Study|Physician Decision|6
1095299|NCT01999218|3580789|P2|Overall Study|Physician Decision|4
1095300|NCT01999218|3580790|P1|Overall Study|Physician Decision|1
1095301|NCT01999218|3580788|P3|Overall Study|Non-Compliance With Study Drug|1
1095302|NCT01999218|3580789|P2|Overall Study|Non-Compliance With Study Drug|4
1095303|NCT01999218|3580790|P1|Overall Study|Non-Compliance With Study Drug|6
1095304|NCT01999218|3580788|P3|Overall Study|Lost to Follow-up|18
1095305|NCT01999218|3580789|P2|Overall Study|Lost to Follow-up|17
1095306|NCT01999218|3580790|P1|Overall Study|Lost to Follow-up|22
1095307|NCT01999218|3580788|P3|Overall Study|Lack of Efficacy|1
1095308|NCT01999218|3580789|P2|Overall Study|Lack of Efficacy|0
1095309|NCT01999218|3580790|P1|Overall Study|Lack of Efficacy|1
1095310|NCT01999218|3580788|P3|Overall Study|Hyperglycemia|17
1095311|NCT01999218|3580789|P2|Overall Study|Hyperglycemia|17
1095312|NCT01999218|3580790|P1|Overall Study|Hyperglycemia|18
1095313|NCT01999114|3580835|P5|Overall Study|Administrative|2
1095314|NCT01999114|3580836|P4|Overall Study|Administrative|1
1095315|NCT01999114|3580837|P3|Overall Study|Administrative|1
1095316|NCT01999114|3580838|P2|Overall Study|Administrative|0
1095317|NCT01999114|3580839|P1|Overall Study|Administrative|0
1095318|NCT01999114|3580835|P5|Overall Study|Lost to Follow-up|0
1095319|NCT01999114|3580836|P4|Overall Study|Lost to Follow-up|0
1095320|NCT01999114|3580837|P3|Overall Study|Lost to Follow-up|1
1095321|NCT01999114|3580838|P2|Overall Study|Lost to Follow-up|0
1095322|NCT01999114|3580839|P1|Overall Study|Lost to Follow-up|0
1095323|NCT01999114|3580835|P5|Overall Study|Withdrawal by Subject|1
1095324|NCT01999114|3580836|P4|Overall Study|Withdrawal by Subject|0
1095325|NCT01999114|3580837|P3|Overall Study|Withdrawal by Subject|1
1095326|NCT01999114|3580838|P2|Overall Study|Withdrawal by Subject|0
1095327|NCT01999114|3580839|P1|Overall Study|Withdrawal by Subject|0
1095328|NCT01999114|3580835|P5|Overall Study|Adverse Event|1
1095329|NCT01999114|3580836|P4|Overall Study|Adverse Event|2
1095330|NCT01999114|3580837|P3|Overall Study|Adverse Event|2
1095331|NCT01999114|3580838|P2|Overall Study|Adverse Event|7
1095332|NCT01999114|3580839|P1|Overall Study|Adverse Event|8
1095333|NCT01998984|3580907|P4|Overall Study|Other|1
1095334|NCT01998984|3580908|P3|Overall Study|Other|0
1095335|NCT01998984|3580909|P2|Overall Study|Other|0
1095336|NCT01998984|3580910|P1|Overall Study|Other|0
1095337|NCT01998984|3580907|P4|Overall Study|Withdrawal by Subject|0
1095338|NCT01998984|3580908|P3|Overall Study|Withdrawal by Subject|1
1095339|NCT01998984|3580909|P2|Overall Study|Withdrawal by Subject|0
1095340|NCT01998984|3580910|P1|Overall Study|Withdrawal by Subject|0
1095341|NCT01998984|3580907|P4|Overall Study|Lost to Follow-up|1
1095342|NCT01998984|3580908|P3|Overall Study|Lost to Follow-up|0
1095343|NCT01998984|3580909|P2|Overall Study|Lost to Follow-up|1
1095344|NCT01998984|3580910|P1|Overall Study|Lost to Follow-up|0
1095345|NCT01998984|3580907|P4|Overall Study|Adverse Event|1
1095346|NCT01998984|3580908|P3|Overall Study|Adverse Event|0
1095347|NCT01998984|3580909|P2|Overall Study|Adverse Event|0
1095348|NCT01998984|3580910|P1|Overall Study|Adverse Event|0
1095349|NCT01998919|3580930|P2|Overall Study|Not specified|2
1095350|NCT01998919|3580931|P1|Overall Study|Not specified|5
1095351|NCT01998919|3580930|P2|Overall Study|Lost to Follow-up|0
1095352|NCT01998919|3580931|P1|Overall Study|Lost to Follow-up|2
1095353|NCT01998919|3580930|P2|Overall Study|Withdrawal by Subject|4
1095354|NCT01998919|3580931|P1|Overall Study|Withdrawal by Subject|2
1095355|NCT01998919|3580930|P2|Overall Study|Disease progression|22
1095356|NCT01998919|3580931|P1|Overall Study|Disease progression|31
1095357|NCT01998919|3580930|P2|Overall Study|Adverse Event|5
1095358|NCT01998919|3580931|P1|Overall Study|Adverse Event|0
1095359|NCT01998919|3580930|P2|Overall Study|Death|2
1095360|NCT01998919|3580931|P1|Overall Study|Death|2
1095361|NCT01998906|3580952|P3|Overall Study|Not specified|4
1095362|NCT01998906|3580953|P2|Overall Study|Not specified|8
1095363|NCT01998906|3580954|P1|Overall Study|Not specified|3
1095364|NCT01998906|3580952|P3|Overall Study|Administrative/Other|3
1095365|NCT01998906|3580953|P2|Overall Study|Administrative/Other|1
1095366|NCT01998906|3580954|P1|Overall Study|Administrative/Other|2
1095367|NCT01998906|3580952|P3|Overall Study|Withdrawal by Subject|3
1095368|NCT01998906|3580953|P2|Overall Study|Withdrawal by Subject|4
1095369|NCT01998906|3580954|P1|Overall Study|Withdrawal by Subject|1
1095370|NCT01998906|3580952|P3|Overall Study|Violation of Selection Criteria|1
1095371|NCT01998906|3580953|P2|Overall Study|Violation of Selection Criteria|0
1095372|NCT01998906|3580954|P1|Overall Study|Violation of Selection Criteria|0
1095373|NCT01998906|3580952|P3|Overall Study|Failure to return|4
1095374|NCT01998906|3580953|P2|Overall Study|Failure to return|2
1095375|NCT01998906|3580954|P1|Overall Study|Failure to return|0
1095376|NCT01998906|3580952|P3|Overall Study|Lack of Efficacy|8
1095377|NCT01998906|3580953|P2|Overall Study|Lack of Efficacy|9
1095378|NCT01998906|3580954|P1|Overall Study|Lack of Efficacy|10
1095379|NCT01998906|3580952|P3|Overall Study|Death|17
1095380|NCT01998906|3580953|P2|Overall Study|Death|30
1095381|NCT01998906|3580954|P1|Overall Study|Death|21
1095382|NCT01998906|3580952|P3|Overall Study|Participants ongoing in follow−up|58
1095383|NCT01998906|3580953|P2|Overall Study|Participants ongoing in follow−up|60
1095384|NCT01998906|3580954|P1|Overall Study|Participants ongoing in follow−up|77
1095385|NCT01998893|3580998|P1|Overall Study|Transformation to high-grade lymphoma|1
1095386|NCT01998893|3580998|P1|Overall Study|Withdrawal by Subject|1
1095387|NCT01998893|3580998|P1|Overall Study|Protocol Violation|2
1095388|NCT01998893|3580998|P1|Overall Study|Physician Decision|2
1095389|NCT01998893|3580998|P1|Overall Study|Lost to Follow-up|8
1095390|NCT01998893|3580998|P1|Overall Study|Death|1
1095391|NCT01998893|3580998|P1|Overall Study|Adverse Event|2
1095392|NCT01998880|3581010|P2|Overall Study|Did Not Receive Treatment|2
1095393|NCT01998880|3581011|P1|Overall Study|Did Not Receive Treatment|3
1095394|NCT01998880|3581010|P2|Overall Study|Violation of Selection Criteria at Entry|1
1095395|NCT01998880|3581011|P1|Overall Study|Violation of Selection Criteria at Entry|0
1095396|NCT01998880|3581010|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
1095397|NCT01998880|3581011|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
1095398|NCT01998880|3581010|P2|Overall Study|Administrative/Other|1
1095399|NCT01998880|3581011|P1|Overall Study|Administrative/Other|1
1095400|NCT01998880|3581010|P2|Overall Study|Insufficient Therapeutic Response|5
1095401|NCT01998880|3581011|P1|Overall Study|Insufficient Therapeutic Response|1
1095402|NCT01998880|3581010|P2|Overall Study|Death|6
1095403|NCT01998880|3581011|P1|Overall Study|Death|3
1095404|NCT01998880|3581010|P2|Overall Study|Withdrew Consent|1
1095405|NCT01998880|3581011|P1|Overall Study|Withdrew Consent|2
1095406|NCT01998880|3581010|P2|Overall Study|Disease Progression|8
1095407|NCT01998880|3581011|P1|Overall Study|Disease Progression|1
1095408|NCT01998880|3581010|P2|Overall Study|Adverse Events or Intercurrent Illness|16
1095409|NCT01998880|3581011|P1|Overall Study|Adverse Events or Intercurrent Illness|16
1095410|NCT01998737|3581043|P2|Overall Study|Corrupted database|0
1095411|NCT01998737|3581044|P1|Overall Study|Corrupted database|23
1095412|NCT01998633|3581056|P1|Overall Study|Death|1
1095413|NCT01998581|3581074|P2|Overall Study|Randomized but withdrew before treatment|0
1095414|NCT01998581|3581075|P1|Overall Study|Randomized but withdrew before treatment|1
1095415|NCT01998581|3581074|P2|Overall Study|Other reasons|2
1095416|NCT01998581|3581075|P1|Overall Study|Other reasons|3
1095417|NCT01998581|3581074|P2|Overall Study|Adverse Event|1
1095418|NCT01998581|3581075|P1|Overall Study|Adverse Event|1
1095419|NCT01998581|3581074|P2|Overall Study|Lost to Follow-up|4
1095420|NCT01998581|3581075|P1|Overall Study|Lost to Follow-up|12
1095421|NCT01998581|3581074|P2|Overall Study|Withdrawal by Subject|1
1095422|NCT01998581|3581075|P1|Overall Study|Withdrawal by Subject|8
1095423|NCT01998581|3581074|P2|Overall Study|Protocol Violation|0
1095424|NCT01998581|3581075|P1|Overall Study|Protocol Violation|1
1095425|NCT01998581|3581074|P2|Overall Study|Refused repeat treatment|4
1095426|NCT01998581|3581075|P1|Overall Study|Refused repeat treatment|20
1095427|NCT01998477|3581087|P2|Overall Study|Withdrawal by Subject|0
1095428|NCT01998477|3581088|P1|Overall Study|Withdrawal by Subject|6
1095429|NCT01998477|3581087|P2|Overall Study|Lost to Follow-up|5
1095430|NCT01998477|3581088|P1|Overall Study|Lost to Follow-up|4
1095431|NCT01998399|3581134|P2|Overall Study|Withdrawal by Subject|1
1095432|NCT01998399|3581135|P1|Overall Study|Withdrawal by Subject|0
1095433|NCT01998399|3581134|P2|Overall Study|Study stopped before dosing completed|3
1095434|NCT01998399|3581135|P1|Overall Study|Study stopped before dosing completed|3
1095435|NCT01998399|3581134|P2|Overall Study|Death|2
1095436|NCT01998399|3581135|P1|Overall Study|Death|4
1095437|NCT01998399|3581134|P2|Overall Study|Lost to Follow-up|3
1095438|NCT01998399|3581135|P1|Overall Study|Lost to Follow-up|1
1095439|NCT01997892|3581197|P1|Overall Study|Study completion data not recorded|35
1095440|NCT01997892|3581197|P1|Overall Study|Other|3
1095441|NCT01997892|3581197|P1|Overall Study|Renal transplant|8
1095442|NCT01997892|3581197|P1|Overall Study|Death|14
1095443|NCT01997892|3581197|P1|Overall Study|Lost to Follow-up|6
1095444|NCT01997892|3581197|P1|Overall Study|Physician Decision|2
1095445|NCT01996904|3581376|P2|Overall Study|Lost to Follow-up|27
1095446|NCT01996904|3581377|P1|Overall Study|Lost to Follow-up|38
1095447|NCT01996748|3581396|P2|Overall Study|Lost to Follow-up|1
1095448|NCT01996748|3581397|P1|Overall Study|Lost to Follow-up|4
1095449|NCT01996748|3581396|P2|Overall Study|Withdrawal by Subject|1
1095450|NCT01996748|3581397|P1|Overall Study|Withdrawal by Subject|0
1095451|NCT01996748|3581396|P2|Overall Study|Adverse Event|4
1095452|NCT01996748|3581397|P1|Overall Study|Adverse Event|1
1095453|NCT01996748|3581396|P2|Overall Study|Physician Decision|0
1095454|NCT01996748|3581397|P1|Overall Study|Physician Decision|2
1095455|NCT01996748|3581396|P2|Overall Study|Personal reason|0
1095456|NCT01996748|3581397|P1|Overall Study|Personal reason|1
1095457|NCT01996709|3581411|P2|Overall Study|Failed Inclusion/Exclusion Criteria|1
1095458|NCT01996709|3581412|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
1095459|NCT01996709|3581411|P2|Overall Study|Subject Non-Compliant|0
1095460|NCT01996709|3581412|P1|Overall Study|Subject Non-Compliant|1
1095461|NCT01996709|3581411|P2|Overall Study|Lost to Follow-up|0
1095462|NCT01996709|3581412|P1|Overall Study|Lost to Follow-up|3
1095463|NCT01996709|3581411|P2|Overall Study|Withdrawal by Subject|0
1095464|NCT01996709|3581412|P1|Overall Study|Withdrawal by Subject|1
1095465|NCT01996592|3581459|P1|Overall Study|change in mode of delivery|4
1095466|NCT01996592|3581459|P1|Overall Study|Withdrawal by Subject|5
1095467|NCT01996592|3581459|P1|Overall Study|change in surgical date|4
1095468|NCT01996592|3581459|P1|Overall Study|no response to text/no diary entry|32
1095469|NCT01996332|3581495|P1|Overall Study|Lost to Follow-up|34
1095470|NCT01996332|3581495|P1|Overall Study|Physician Decision|17
1095471|NCT01996332|3581495|P1|Overall Study|Clinical Deterioration|28
1095472|NCT01996332|3581495|P1|Overall Study|Other|20
1095473|NCT01996332|3581495|P1|Overall Study|Withdrawal by Subject|71
1095474|NCT01996332|3581495|P1|Overall Study|Protocol Violation|9
1095475|NCT01996332|3581495|P1|Overall Study|Death|264
1095476|NCT01996332|3581495|P1|Overall Study|Lack of Efficacy|1245
1095477|NCT01996332|3581495|P1|Overall Study|Adverse Event|117
1095478|NCT01996319|3581503|P2|Overall Study|Adverse Event|2
1095479|NCT01996319|3581504|P1|Overall Study|Adverse Event|2
1095480|NCT01996319|3581503|P2|Overall Study|Severe or moderate (COPD) Exacerbation|1
1095481|NCT01996319|3581504|P1|Overall Study|Severe or moderate (COPD) Exacerbation|5
1095482|NCT01996319|3581503|P2|Overall Study|Protocol Violation|0
1095483|NCT01996319|3581504|P1|Overall Study|Protocol Violation|1
1095484|NCT01996033|3581524|P1|Overall Study|Lost to Follow-up|3
1095485|NCT01996033|3581524|P1|Overall Study|Withdrawal by Subject|4
1095486|NCT01996033|3581524|P1|Overall Study|Physician Decision|1
1095487|NCT01996033|3581524|P1|Overall Study|Death|1
1095488|NCT01995539|3581537|P1|Overall Study|Subject missed visit 3,4, came in for V5|1
1095489|NCT01995539|3581537|P1|Overall Study|Lost to Follow-up|5
1095490|NCT01995539|3581537|P1|Overall Study|Withdrawal by Subject|11
1095491|NCT01995539|3581537|P1|Overall Study|Withdrawal by Investigator|15
1095492|NCT01995539|3581537|P1|Overall Study|Screening Failure|1
1095493|NCT01995526|3581542|P1|Overall Study|Physician Decision|1
1095494|NCT01995513|3581550|P3|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|18
1095495|NCT01995513|3581551|P2|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|27
1095496|NCT01995513|3581552|P1|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
1095497|NCT01995513|3581550|P3|Double Blind Treatment Period|Disease Progression|93
1095498|NCT01995513|3581551|P2|Double Blind Treatment Period|Disease Progression|82
1095499|NCT01995513|3581552|P1|Double Blind Treatment Period|Disease Progression|0
1095500|NCT01995513|3581550|P3|Double Blind Treatment Period|Death|1
1095501|NCT01995513|3581551|P2|Double Blind Treatment Period|Death|0
1095502|NCT01995513|3581552|P1|Double Blind Treatment Period|Death|0
1095503|NCT01995513|3581550|P3|Double Blind Treatment Period|Withdrawal by Subject|6
1095504|NCT01995513|3581551|P2|Double Blind Treatment Period|Withdrawal by Subject|4
1095505|NCT01995513|3581552|P1|Double Blind Treatment Period|Withdrawal by Subject|0
1095506|NCT01995513|3581550|P3|Double Blind Treatment Period|Other|2
1095507|NCT01995513|3581551|P2|Double Blind Treatment Period|Other|1
1095508|NCT01995513|3581552|P1|Double Blind Treatment Period|Other|0
1095509|NCT01995513|3581550|P3|Double Blind Treatment Period|Adverse Event|5
1095510|NCT01995513|3581551|P2|Double Blind Treatment Period|Adverse Event|12
1095511|NCT01995513|3581552|P1|Double Blind Treatment Period|Adverse Event|0
1095512|NCT01995513|3581550|P3|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
1095513|NCT01995513|3581551|P2|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
1095514|NCT01995513|3581552|P1|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|84
1095515|NCT01995513|3581550|P3|Open Label Treatment Period|Death|0
1095516|NCT01995513|3581551|P2|Open Label Treatment Period|Death|0
1095517|NCT01995513|3581552|P1|Open Label Treatment Period|Death|8
1095518|NCT01995513|3581550|P3|Open Label Treatment Period|Adverse Event|0
1095519|NCT01995513|3581551|P2|Open Label Treatment Period|Adverse Event|0
1095520|NCT01995513|3581552|P1|Open Label Treatment Period|Adverse Event|35
1095521|NCT01995513|3581550|P3|Open Label Treatment Period|No PSA response at week 13|0
1095522|NCT01995513|3581551|P2|Open Label Treatment Period|No PSA response at week 13|0
1095523|NCT01995513|3581552|P1|Open Label Treatment Period|No PSA response at week 13|43
1095524|NCT01995513|3581550|P3|Open Label Treatment Period|Disease Progression|0
1095525|NCT01995513|3581551|P2|Open Label Treatment Period|Disease Progression|0
1095526|NCT01995513|3581552|P1|Open Label Treatment Period|Disease Progression|64
1095527|NCT01995513|3581550|P3|Open Label Treatment Period|Protocol Violation|0
1095528|NCT01995513|3581551|P2|Open Label Treatment Period|Protocol Violation|0
1095529|NCT01995513|3581552|P1|Open Label Treatment Period|Protocol Violation|1
1095530|NCT01995513|3581550|P3|Open Label Treatment Period|Withdrawal by Subject|0
1095531|NCT01995513|3581551|P2|Open Label Treatment Period|Withdrawal by Subject|0
1095532|NCT01995513|3581552|P1|Open Label Treatment Period|Withdrawal by Subject|14
1095533|NCT01995513|3581550|P3|Open Label Treatment Period|Other|0
1095534|NCT01995513|3581551|P2|Open Label Treatment Period|Other|0
1095535|NCT01995513|3581552|P1|Open Label Treatment Period|Other|9
1095536|NCT01995461|3581595|P1|Overall Study|Withdrawal by Subject|2
1095537|NCT01995461|3581595|P1|Overall Study|Lost to Follow-up|2
1095538|NCT01995461|3581595|P1|Overall Study|Death|1
1095539|NCT01995357|3581601|P6|Period 5|Adverse Event|0
1095540|NCT01995357|3581602|P5|Period 5|Adverse Event|0
1095541|NCT01995357|3581603|P4|Period 5|Adverse Event|0
1095542|NCT01995357|3581604|P3|Period 5|Adverse Event|1
1095543|NCT01995357|3581605|P2|Period 5|Adverse Event|0
1095544|NCT01995357|3581606|P1|Period 5|Adverse Event|1
1095545|NCT01995357|3581601|P6|Period 5|Lack of Efficacy|0
1095546|NCT01995357|3581602|P5|Period 5|Lack of Efficacy|0
1095547|NCT01995357|3581603|P4|Period 5|Lack of Efficacy|0
1095548|NCT01995357|3581604|P3|Period 5|Lack of Efficacy|0
1095549|NCT01995357|3581605|P2|Period 5|Lack of Efficacy|0
1095550|NCT01995357|3581606|P1|Period 5|Lack of Efficacy|1
1095551|NCT01995201|3581624|P7|From Week 24 Until Week 48|Protocol Violation|0
1095552|NCT01995201|3581625|P6|From Week 24 Until Week 48|Protocol Violation|0
1095553|NCT01995201|3581626|P5|From Week 24 Until Week 48|Protocol Violation|2
1095554|NCT01995201|3581627|P4|From Week 24 Until Week 48|Protocol Violation|0
1095555|NCT01995201|3581628|P3|From Week 24 Until Week 48|Protocol Violation|1
1095556|NCT01995201|3581629|P2|From Week 24 Until Week 48|Protocol Violation|0
1095557|NCT01995201|3581630|P1|From Week 24 Until Week 48|Protocol Violation|0
1095558|NCT01995201|3581624|P7|From Week 24 Until Week 48|Physician Decision|0
1095559|NCT01995201|3581625|P6|From Week 24 Until Week 48|Physician Decision|0
1095560|NCT01995201|3581626|P5|From Week 24 Until Week 48|Physician Decision|1
1095561|NCT01995201|3581627|P4|From Week 24 Until Week 48|Physician Decision|0
1095562|NCT01995201|3581628|P3|From Week 24 Until Week 48|Physician Decision|0
1095563|NCT01995201|3581629|P2|From Week 24 Until Week 48|Physician Decision|0
1095564|NCT01995201|3581630|P1|From Week 24 Until Week 48|Physician Decision|0
1095565|NCT01995201|3581624|P7|From Week 24 Until Week 48|Withdrawal by Subject|0
1095566|NCT01995201|3581625|P6|From Week 24 Until Week 48|Withdrawal by Subject|0
1095567|NCT01995201|3581626|P5|From Week 24 Until Week 48|Withdrawal by Subject|1
1095568|NCT01995201|3581627|P4|From Week 24 Until Week 48|Withdrawal by Subject|0
1095569|NCT01995201|3581628|P3|From Week 24 Until Week 48|Withdrawal by Subject|1
1095570|NCT01995201|3581629|P2|From Week 24 Until Week 48|Withdrawal by Subject|0
1095571|NCT01995201|3581630|P1|From Week 24 Until Week 48|Withdrawal by Subject|0
1095572|NCT01995201|3581624|P7|From Week 24 Until Week 48|Lost to Follow-up|0
1095573|NCT01995201|3581625|P6|From Week 24 Until Week 48|Lost to Follow-up|1
1095574|NCT01995201|3581626|P5|From Week 24 Until Week 48|Lost to Follow-up|1
1095575|NCT01995201|3581627|P4|From Week 24 Until Week 48|Lost to Follow-up|0
1095576|NCT01995201|3581628|P3|From Week 24 Until Week 48|Lost to Follow-up|0
1095577|NCT01995201|3581629|P2|From Week 24 Until Week 48|Lost to Follow-up|0
1095578|NCT01995201|3581630|P1|From Week 24 Until Week 48|Lost to Follow-up|0
1095579|NCT01995201|3581624|P7|From Week 24 Until Week 48|Lack of Efficacy|1
1095580|NCT01995201|3581625|P6|From Week 24 Until Week 48|Lack of Efficacy|2
1095581|NCT01995201|3581626|P5|From Week 24 Until Week 48|Lack of Efficacy|0
1095582|NCT01995201|3581627|P4|From Week 24 Until Week 48|Lack of Efficacy|0
1095583|NCT01995201|3581628|P3|From Week 24 Until Week 48|Lack of Efficacy|1
1095584|NCT01995201|3581629|P2|From Week 24 Until Week 48|Lack of Efficacy|0
1095585|NCT01995201|3581630|P1|From Week 24 Until Week 48|Lack of Efficacy|0
1095586|NCT01995201|3581624|P7|From Week 24 Until Week 48|Death|0
1095587|NCT01995201|3581625|P6|From Week 24 Until Week 48|Death|2
1095588|NCT01995201|3581626|P5|From Week 24 Until Week 48|Death|0
1095589|NCT01995201|3581627|P4|From Week 24 Until Week 48|Death|0
1095590|NCT01995201|3581628|P3|From Week 24 Until Week 48|Death|0
1095591|NCT01995201|3581629|P2|From Week 24 Until Week 48|Death|0
1095592|NCT01995201|3581630|P1|From Week 24 Until Week 48|Death|0
1095593|NCT01995201|3581624|P7|From Week 24 Until Week 48|Adverse Event|1
1095594|NCT01995201|3581625|P6|From Week 24 Until Week 48|Adverse Event|3
1095595|NCT01995201|3581626|P5|From Week 24 Until Week 48|Adverse Event|1
1095596|NCT01995201|3581627|P4|From Week 24 Until Week 48|Adverse Event|1
1095597|NCT01995201|3581628|P3|From Week 24 Until Week 48|Adverse Event|2
1095598|NCT01995201|3581629|P2|From Week 24 Until Week 48|Adverse Event|0
1095599|NCT01995201|3581630|P1|From Week 24 Until Week 48|Adverse Event|0
1095600|NCT01995201|3581624|P7|From Baseline Until Week 24|Protocol Violation|0
1095601|NCT01995201|3581625|P6|From Baseline Until Week 24|Protocol Violation|0
1095602|NCT01995201|3581626|P5|From Baseline Until Week 24|Protocol Violation|0
1095603|NCT01995201|3581627|P4|From Baseline Until Week 24|Protocol Violation|0
1095604|NCT01995201|3581628|P3|From Baseline Until Week 24|Protocol Violation|0
1095605|NCT01995201|3581629|P2|From Baseline Until Week 24|Protocol Violation|9
1095606|NCT01995201|3581630|P1|From Baseline Until Week 24|Protocol Violation|0
1095607|NCT01995201|3581624|P7|From Baseline Until Week 24|Physician Decision|0
1095608|NCT01995201|3581625|P6|From Baseline Until Week 24|Physician Decision|0
1095609|NCT01995201|3581626|P5|From Baseline Until Week 24|Physician Decision|0
1095610|NCT01995201|3581627|P4|From Baseline Until Week 24|Physician Decision|0
1095611|NCT01995201|3581628|P3|From Baseline Until Week 24|Physician Decision|0
1095612|NCT01995201|3581629|P2|From Baseline Until Week 24|Physician Decision|2
1095613|NCT01995201|3581630|P1|From Baseline Until Week 24|Physician Decision|0
1095614|NCT01995201|3581624|P7|From Baseline Until Week 24|Withdrawal by Subject|0
1095615|NCT01995201|3581625|P6|From Baseline Until Week 24|Withdrawal by Subject|0
1095616|NCT01995201|3581626|P5|From Baseline Until Week 24|Withdrawal by Subject|0
1095617|NCT01995201|3581627|P4|From Baseline Until Week 24|Withdrawal by Subject|0
1095618|NCT01995201|3581628|P3|From Baseline Until Week 24|Withdrawal by Subject|0
1095619|NCT01995201|3581629|P2|From Baseline Until Week 24|Withdrawal by Subject|8
1095620|NCT01995201|3581630|P1|From Baseline Until Week 24|Withdrawal by Subject|2
1095621|NCT01995201|3581624|P7|From Baseline Until Week 24|Lost to Follow-up|0
1095622|NCT01995201|3581625|P6|From Baseline Until Week 24|Lost to Follow-up|0
1095623|NCT01995201|3581626|P5|From Baseline Until Week 24|Lost to Follow-up|0
1095624|NCT01995201|3581627|P4|From Baseline Until Week 24|Lost to Follow-up|0
1095625|NCT01995201|3581628|P3|From Baseline Until Week 24|Lost to Follow-up|0
1095626|NCT01995201|3581629|P2|From Baseline Until Week 24|Lost to Follow-up|3
1095627|NCT01995201|3581630|P1|From Baseline Until Week 24|Lost to Follow-up|2
1095628|NCT01995201|3581624|P7|From Baseline Until Week 24|Lack of Efficacy|0
1095629|NCT01995201|3581625|P6|From Baseline Until Week 24|Lack of Efficacy|0
1095630|NCT01995201|3581626|P5|From Baseline Until Week 24|Lack of Efficacy|0
1095631|NCT01995201|3581627|P4|From Baseline Until Week 24|Lack of Efficacy|0
1095632|NCT01995201|3581628|P3|From Baseline Until Week 24|Lack of Efficacy|0
1095633|NCT01995201|3581629|P2|From Baseline Until Week 24|Lack of Efficacy|5
1095634|NCT01995201|3581630|P1|From Baseline Until Week 24|Lack of Efficacy|2
1095635|NCT01995201|3581624|P7|From Baseline Until Week 24|Death|0
1095636|NCT01995201|3581625|P6|From Baseline Until Week 24|Death|0
1095637|NCT01995201|3581626|P5|From Baseline Until Week 24|Death|0
1095638|NCT01995201|3581627|P4|From Baseline Until Week 24|Death|0
1095639|NCT01995201|3581628|P3|From Baseline Until Week 24|Death|0
1095640|NCT01995201|3581629|P2|From Baseline Until Week 24|Death|1
1095641|NCT01995201|3581630|P1|From Baseline Until Week 24|Death|0
1095642|NCT01995201|3581624|P7|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
1095643|NCT01995201|3581625|P6|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
1095644|NCT01995201|3581626|P5|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
1095645|NCT01995201|3581627|P4|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
1095646|NCT01995201|3581628|P3|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
1095647|NCT01995201|3581629|P2|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3
1095648|NCT01995201|3581630|P1|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
1095649|NCT01995201|3581624|P7|From Baseline Until Week 24|Adverse Event|0
1095650|NCT01995201|3581625|P6|From Baseline Until Week 24|Adverse Event|0
1095651|NCT01995201|3581626|P5|From Baseline Until Week 24|Adverse Event|0
1095652|NCT01995201|3581627|P4|From Baseline Until Week 24|Adverse Event|0
1095653|NCT01995201|3581628|P3|From Baseline Until Week 24|Adverse Event|0
1095654|NCT01995201|3581629|P2|From Baseline Until Week 24|Adverse Event|15
1095655|NCT01995201|3581630|P1|From Baseline Until Week 24|Adverse Event|4
1095656|NCT01995136|3581739|P1|Overall Study|Change in residence|1
1095657|NCT01995071|3581755|P12|Overall Study|Incarcerated|0
1095658|NCT01995071|3581756|P11|Overall Study|Incarcerated|0
1095659|NCT01995071|3581757|P10|Overall Study|Incarcerated|0
1095660|NCT01995071|3581758|P9|Overall Study|Incarcerated|0
1095661|NCT01995071|3581759|P8|Overall Study|Incarcerated|1
1095662|NCT01995071|3581760|P7|Overall Study|Incarcerated|0
1095663|NCT01995071|3581761|P6|Overall Study|Incarcerated|0
1095664|NCT01995071|3581762|P5|Overall Study|Incarcerated|0
1095665|NCT01995071|3581763|P4|Overall Study|Incarcerated|0
1095666|NCT01995071|3581764|P3|Overall Study|Incarcerated|0
1095667|NCT01995071|3581765|P2|Overall Study|Incarcerated|0
1095668|NCT01995071|3581766|P1|Overall Study|Incarcerated|0
1095669|NCT01995071|3581755|P12|Overall Study|Lost to Follow-up|0
1095670|NCT01995071|3581756|P11|Overall Study|Lost to Follow-up|0
1095671|NCT01995071|3581757|P10|Overall Study|Lost to Follow-up|0
1095672|NCT01995071|3581758|P9|Overall Study|Lost to Follow-up|1
1095673|NCT01995071|3581759|P8|Overall Study|Lost to Follow-up|1
1095674|NCT01995071|3581760|P7|Overall Study|Lost to Follow-up|0
1095675|NCT01995071|3581761|P6|Overall Study|Lost to Follow-up|0
1095676|NCT01995071|3581762|P5|Overall Study|Lost to Follow-up|0
1095677|NCT01995071|3581763|P4|Overall Study|Lost to Follow-up|0
1095678|NCT01995071|3581764|P3|Overall Study|Lost to Follow-up|0
1095679|NCT01995071|3581765|P2|Overall Study|Lost to Follow-up|0
1095680|NCT01995071|3581766|P1|Overall Study|Lost to Follow-up|1
1095681|NCT01995071|3581755|P12|Overall Study|Moved|0
1095682|NCT01995071|3581756|P11|Overall Study|Moved|1
1095683|NCT01995071|3581757|P10|Overall Study|Moved|0
1095684|NCT01995071|3581758|P9|Overall Study|Moved|0
1095685|NCT01995071|3581759|P8|Overall Study|Moved|0
1095686|NCT01995071|3581760|P7|Overall Study|Moved|0
1095687|NCT01995071|3581761|P6|Overall Study|Moved|0
1095688|NCT01995071|3581762|P5|Overall Study|Moved|1
1095689|NCT01995071|3581763|P4|Overall Study|Moved|0
1095690|NCT01995071|3581764|P3|Overall Study|Moved|1
1095691|NCT01995071|3581765|P2|Overall Study|Moved|0
1095692|NCT01995071|3581766|P1|Overall Study|Moved|0
1095693|NCT01995071|3581755|P12|Overall Study|Adverse Event|0
1095694|NCT01995071|3581756|P11|Overall Study|Adverse Event|0
1095695|NCT01995071|3581757|P10|Overall Study|Adverse Event|0
1095696|NCT01995071|3581758|P9|Overall Study|Adverse Event|0
1095697|NCT01995071|3581759|P8|Overall Study|Adverse Event|0
1095698|NCT01995071|3581760|P7|Overall Study|Adverse Event|1
1095699|NCT01995071|3581761|P6|Overall Study|Adverse Event|0
1095700|NCT01995071|3581762|P5|Overall Study|Adverse Event|0
1095701|NCT01995071|3581763|P4|Overall Study|Adverse Event|0
1095702|NCT01995071|3581764|P3|Overall Study|Adverse Event|0
1095703|NCT01995071|3581765|P2|Overall Study|Adverse Event|0
1095704|NCT01995071|3581766|P1|Overall Study|Adverse Event|0
1095705|NCT01994902|3581901|P2|Test Period 2|Other|3
1095706|NCT01994902|3581902|P1|Test Period 2|Other|0
1095707|NCT01994902|3581901|P2|Test Period 2|Lack of Efficacy|1
1095708|NCT01994902|3581902|P1|Test Period 2|Lack of Efficacy|0
1095709|NCT01994902|3581901|P2|Test Period 2|Withdrawal by Subject|2
1095710|NCT01994902|3581902|P1|Test Period 2|Withdrawal by Subject|0
1095711|NCT01994902|3581901|P2|Test Period 1|bag too small|0
1095712|NCT01994902|3581902|P1|Test Period 1|bag too small|1
1095713|NCT01994902|3581901|P2|Test Period 1|Lack of Efficacy|1
1095714|NCT01994902|3581902|P1|Test Period 1|Lack of Efficacy|0
1095715|NCT01994902|3581901|P2|Test Period 1|Adverse Event|1
1095716|NCT01994902|3581902|P1|Test Period 1|Adverse Event|2
1095717|NCT01994902|3581901|P2|Test Period 1|device deficiency with adverse event|1
1095718|NCT01994902|3581902|P1|Test Period 1|device deficiency with adverse event|0
1095719|NCT01994902|3581901|P2|Test Period 1|Withdrawal by Subject|0
1095720|NCT01994902|3581902|P1|Test Period 1|Withdrawal by Subject|3
1095721|NCT01994876|3581908|P2|Test Period 2|Protocol Violation|1
1095722|NCT01994876|3581909|P1|Test Period 2|Protocol Violation|0
1095723|NCT01994876|3581908|P2|Test Period 2|Adverse Event|0
1095724|NCT01994876|3581909|P1|Test Period 2|Adverse Event|1
1095725|NCT01994876|3581908|P2|Test Period 1|Adverse Event|1
1095726|NCT01994876|3581909|P1|Test Period 1|Adverse Event|0
1095727|NCT01994876|3581908|P2|Test Period 1|Withdrawal by Subject|1
1095728|NCT01994876|3581909|P1|Test Period 1|Withdrawal by Subject|0
1095729|NCT01994863|3581917|P2|Period 2|Withdrawal by Subject|1
1095730|NCT01994863|3581918|P1|Period 2|Withdrawal by Subject|1
1095731|NCT01994863|3581917|P2|Period 2|Lack of Efficacy|2
1095732|NCT01994863|3581918|P1|Period 2|Lack of Efficacy|0
1095733|NCT01994863|3581917|P2|Period 2|Adverse Event|1
1095734|NCT01994863|3581918|P1|Period 2|Adverse Event|0
1095735|NCT01994863|3581917|P2|Period 1|Lack of Efficacy|0
1095736|NCT01994863|3581918|P1|Period 1|Lack of Efficacy|1
1095737|NCT01994863|3581917|P2|Period 1|Trial stopped by sponsor|3
1095738|NCT01994863|3581918|P1|Period 1|Trial stopped by sponsor|1
1095739|NCT01994863|3581917|P2|Period 1|Withdrawal by Subject|0
1095740|NCT01994863|3581918|P1|Period 1|Withdrawal by Subject|1
1095741|NCT01994863|3581917|P2|Period 1|Adverse Event|0
1095742|NCT01994863|3581918|P1|Period 1|Adverse Event|4
1095743|NCT01994837|3581924|P1|Overall Study|Removed from study due to no response|1
1095744|NCT01994837|3581924|P1|Overall Study|Proceeded to transplant|1
1095745|NCT01994837|3581924|P1|Overall Study|Chose palliative care|1
1095746|NCT01994837|3581924|P1|Overall Study|Adverse event not related to progression|1
1095747|NCT01994837|3581924|P1|Overall Study|Fatal progressive disease|2
1095748|NCT01994837|3581924|P1|Overall Study|Adv event related to progressive disease|3
1095749|NCT01994837|3581924|P1|Overall Study|Progressive disease per protocol|23
1095750|NCT01994720|3581981|P2|Overall Study|Withdrawal by Subject|56
1095751|NCT01994720|3581982|P1|Overall Study|Withdrawal by Subject|46
1095752|NCT01994629|3582024|P2|Overall Study|Lost to Follow-up|3
1095753|NCT01994629|3582025|P1|Overall Study|Lost to Follow-up|0
1095754|NCT01994629|3582024|P2|Overall Study|Withdrawal by Subject|0
1095755|NCT01994629|3582025|P1|Overall Study|Withdrawal by Subject|1
1095756|NCT01994395|3582060|P2|Overall Study|Withdrawal by Subject|2
1095757|NCT01994395|3582061|P1|Overall Study|Withdrawal by Subject|1
1095758|NCT01994291|3582086|P3|Overall Study|Other|0
1095759|NCT01994291|3582087|P2|Overall Study|Other|2
1095760|NCT01994291|3582088|P1|Overall Study|Other|1
1095761|NCT01994291|3582086|P3|Overall Study|Withdrawal by Subject|5
1095762|NCT01994291|3582087|P2|Overall Study|Withdrawal by Subject|3
1095763|NCT01994291|3582088|P1|Overall Study|Withdrawal by Subject|6
1095764|NCT01994291|3582086|P3|Overall Study|Protocol Violation|0
1095765|NCT01994291|3582087|P2|Overall Study|Protocol Violation|0
1095766|NCT01994291|3582088|P1|Overall Study|Protocol Violation|1
1095767|NCT01994291|3582086|P3|Overall Study|Medication error without associated AE|1
1095768|NCT01994291|3582087|P2|Overall Study|Medication error without associated AE|0
1095769|NCT01994291|3582088|P1|Overall Study|Medication error without associated AE|1
1095770|NCT01994291|3582086|P3|Overall Study|Does not meet entrance criteria|0
1095771|NCT01994291|3582087|P2|Overall Study|Does not meet entrance criteria|0
1095772|NCT01994291|3582088|P1|Overall Study|Does not meet entrance criteria|1
1095773|NCT01994291|3582086|P3|Overall Study|Lost to Follow-up|0
1095774|NCT01994291|3582087|P2|Overall Study|Lost to Follow-up|1
1095775|NCT01994291|3582088|P1|Overall Study|Lost to Follow-up|1
1095776|NCT01994291|3582086|P3|Overall Study|Adverse Event|3
1095777|NCT01994291|3582087|P2|Overall Study|Adverse Event|1
1095778|NCT01994291|3582088|P1|Overall Study|Adverse Event|4
1095779|NCT01994226|3582144|P2|Overall Study|Early Cessation of treatment|11
1095780|NCT01994226|3582145|P1|Overall Study|Early Cessation of treatment|6
1095781|NCT01994226|3582144|P2|Overall Study|Protocol Violation|10
1095782|NCT01994226|3582145|P1|Overall Study|Protocol Violation|13
1095783|NCT01993940|3582153|P2|Overall Study|Other - Miscellaneous|1
1095784|NCT01993940|3582154|P1|Overall Study|Other - Miscellaneous|1
1095785|NCT01993940|3582153|P2|Overall Study|Death|0
1095786|NCT01993940|3582154|P1|Overall Study|Death|1
1095787|NCT01993940|3582153|P2|Overall Study|Protocol Violation|8
1095788|NCT01993940|3582154|P1|Overall Study|Protocol Violation|5
1095789|NCT01993940|3582153|P2|Overall Study|Lost to Follow-up|5
1095790|NCT01993940|3582154|P1|Overall Study|Lost to Follow-up|2
1095791|NCT01993940|3582153|P2|Overall Study|Withdrawal by Subject|19
1095792|NCT01993940|3582154|P1|Overall Study|Withdrawal by Subject|15
1095793|NCT01993940|3582153|P2|Overall Study|Adverse Event|11
1095794|NCT01993940|3582154|P1|Overall Study|Adverse Event|16
1095795|NCT01993927|3582168|P1|Overall Study|Protocol Violation|11
1095796|NCT01993927|3582168|P1|Overall Study|Case Report Forms Uncollected|18
1095797|NCT01993888|3582176|P2|Overall Study|Withdrawal by Subject|1
1095798|NCT01993888|3582177|P1|Overall Study|Withdrawal by Subject|0
1095799|NCT01993888|3582176|P2|Overall Study|Lost to Follow-up|1
1095800|NCT01993888|3582177|P1|Overall Study|Lost to Follow-up|1
1095801|NCT01993888|3582176|P2|Overall Study|Death|1
1095802|NCT01993888|3582177|P1|Overall Study|Death|1
1095803|NCT01993823|3582206|P2|Overall Study|Lost to Follow-up|4
1095804|NCT01993823|3582207|P1|Overall Study|Lost to Follow-up|1
1095805|NCT01993823|3582206|P2|Overall Study|Protocol Violation|1
1095806|NCT01993823|3582207|P1|Overall Study|Protocol Violation|0
1095807|NCT01993823|3582206|P2|Overall Study|Requested by the patient|11
1095808|NCT01993823|3582207|P1|Overall Study|Requested by the patient|6
1095809|NCT01993030|3582254|P2|Overall Study|Adverse Event|4
1095810|NCT01993030|3582255|P1|Overall Study|Adverse Event|0
1095899|NCT01990664|3582965|P2|Overall Study|Lens Discomfort|1
1095811|NCT01992757|3582299|P1|Overall Study|2 patients excluded due to FFP given.|2
1095812|NCT01992536|3582314|P10|Overall Study|Withdrawal by Subject|0
1095813|NCT01992536|3582315|P9|Overall Study|Withdrawal by Subject|0
1095814|NCT01992536|3582316|P8|Overall Study|Withdrawal by Subject|0
1095815|NCT01992536|3582317|P7|Overall Study|Withdrawal by Subject|0
1095816|NCT01992536|3582318|P6|Overall Study|Withdrawal by Subject|0
1095817|NCT01992536|3582319|P5|Overall Study|Withdrawal by Subject|0
1095818|NCT01992536|3582320|P4|Overall Study|Withdrawal by Subject|2
1095819|NCT01992536|3582321|P3|Overall Study|Withdrawal by Subject|0
1095820|NCT01992536|3582322|P2|Overall Study|Withdrawal by Subject|1
1095821|NCT01992536|3582323|P1|Overall Study|Withdrawal by Subject|0
1095822|NCT01992536|3582314|P10|Overall Study|Lost to Follow-up|1
1095823|NCT01992536|3582315|P9|Overall Study|Lost to Follow-up|1
1095824|NCT01992536|3582316|P8|Overall Study|Lost to Follow-up|0
1095825|NCT01992536|3582317|P7|Overall Study|Lost to Follow-up|0
1095826|NCT01992536|3582318|P6|Overall Study|Lost to Follow-up|1
1095827|NCT01992536|3582319|P5|Overall Study|Lost to Follow-up|0
1095828|NCT01992536|3582320|P4|Overall Study|Lost to Follow-up|0
1095829|NCT01992536|3582321|P3|Overall Study|Lost to Follow-up|1
1095830|NCT01992536|3582322|P2|Overall Study|Lost to Follow-up|2
1095831|NCT01992536|3582323|P1|Overall Study|Lost to Follow-up|4
1095832|NCT01992536|3582314|P10|Overall Study|Administrative Reason|0
1095833|NCT01992536|3582315|P9|Overall Study|Administrative Reason|0
1095834|NCT01992536|3582316|P8|Overall Study|Administrative Reason|0
1095835|NCT01992536|3582317|P7|Overall Study|Administrative Reason|7
1095836|NCT01992536|3582318|P6|Overall Study|Administrative Reason|0
1095837|NCT01992536|3582319|P5|Overall Study|Administrative Reason|0
1095838|NCT01992536|3582320|P4|Overall Study|Administrative Reason|0
1095839|NCT01992536|3582321|P3|Overall Study|Administrative Reason|0
1095840|NCT01992536|3582322|P2|Overall Study|Administrative Reason|0
1095841|NCT01992536|3582323|P1|Overall Study|Administrative Reason|0
1095842|NCT01992107|3582574|P3|Overall Study|Withdrawal by Subject|8
1095843|NCT01992107|3582575|P2|Overall Study|Withdrawal by Subject|7
1095844|NCT01992107|3582576|P1|Overall Study|Withdrawal by Subject|13
1095845|NCT01992107|3582574|P3|Overall Study|noncompliance and were unavailable|2
1095846|NCT01992107|3582575|P2|Overall Study|noncompliance and were unavailable|3
1095847|NCT01992107|3582576|P1|Overall Study|noncompliance and were unavailable|7
1095848|NCT01992107|3582574|P3|Overall Study|Lost to Follow-up|26
1095849|NCT01992107|3582575|P2|Overall Study|Lost to Follow-up|22
1095850|NCT01992107|3582576|P1|Overall Study|Lost to Follow-up|46
1095851|NCT01992107|3582574|P3|Overall Study|Adverse Event|0
1095852|NCT01992107|3582575|P2|Overall Study|Adverse Event|1
1095853|NCT01992107|3582576|P1|Overall Study|Adverse Event|0
1095854|NCT01992107|3582574|P3|Overall Study|Administrative reasons|0
1095855|NCT01992107|3582575|P2|Overall Study|Administrative reasons|0
1095856|NCT01992107|3582576|P1|Overall Study|Administrative reasons|2
1095857|NCT01992094|3582632|P3|Overall Study|Withdrawal by Subject|4
1095858|NCT01992094|3582633|P2|Overall Study|Withdrawal by Subject|3
1095859|NCT01992094|3582634|P1|Overall Study|Withdrawal by Subject|7
1095860|NCT01992094|3582632|P3|Overall Study|Protocol Violation|1
1095861|NCT01992094|3582633|P2|Overall Study|Protocol Violation|0
1095862|NCT01992094|3582634|P1|Overall Study|Protocol Violation|1
1095863|NCT01992094|3582632|P3|Overall Study|OTHER|0
1095864|NCT01992094|3582633|P2|Overall Study|OTHER|0
1095865|NCT01992094|3582634|P1|Overall Study|OTHER|4
1095866|NCT01992094|3582632|P3|Overall Study|Lost to Follow-up|13
1095867|NCT01992094|3582633|P2|Overall Study|Lost to Follow-up|9
1095868|NCT01992094|3582634|P1|Overall Study|Lost to Follow-up|26
1095869|NCT01992094|3582632|P3|Overall Study|Death|2
1095870|NCT01992094|3582633|P2|Overall Study|Death|5
1095871|NCT01992094|3582634|P1|Overall Study|Death|5
1095872|NCT01992094|3582632|P3|Overall Study|Adverse Event|0
1095873|NCT01992094|3582633|P2|Overall Study|Adverse Event|0
1095874|NCT01992094|3582634|P1|Overall Study|Adverse Event|1
1095875|NCT01992094|3582632|P3|Overall Study|ADMINISTRATIVE REASON|1
1095876|NCT01992094|3582633|P2|Overall Study|ADMINISTRATIVE REASON|7
1095877|NCT01992094|3582634|P1|Overall Study|ADMINISTRATIVE REASON|6
1095878|NCT01991470|3582766|P1|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1
1095879|NCT01991470|3582766|P1|Enlite 3 Period|Physician Decision|8
1095880|NCT01991470|3582766|P1|Enlite 3 Period|Physician Decision|2
1095881|NCT01991470|3582766|P1|Enlite 3 Period|Lost to Follow-up|1
1095882|NCT01991470|3582766|P1|Enlite 1 Period|Inclusion/Exclusion not met|1
1095883|NCT01991470|3582766|P1|Enlite 1 Period|Adverse Event|1
1095884|NCT01991470|3582766|P1|Enlite 1 Period|Withdrawal by Subject|18
1095885|NCT01991314|3582780|P2|Overall Study|Lost to Follow-up|10
1095886|NCT01991314|3582781|P1|Overall Study|Lost to Follow-up|6
1095887|NCT01991314|3582780|P2|Overall Study|Adverse Event|1
1095888|NCT01991314|3582781|P1|Overall Study|Adverse Event|5
1095889|NCT01990859|3582803|P1|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17
1095890|NCT01990859|3582803|P1|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5
1095891|NCT01990742|3582928|P2|Overall Study|Facility closed|270
1095892|NCT01990742|3582929|P1|Overall Study|Facility closed|0
1095893|NCT01990742|3582928|P2|Overall Study|Withdrawal by facility|1083
1095894|NCT01990742|3582929|P1|Overall Study|Withdrawal by facility|407
1095895|NCT01990664|3582965|P2|Overall Study|Unsatisfactory Visual Response|1
1095896|NCT01990664|3582966|P1|Overall Study|Unsatisfactory Visual Response|0
1095897|NCT01990664|3582965|P2|Overall Study|Lens Handling Difficulties|0
1095898|NCT01990664|3582966|P1|Overall Study|Lens Handling Difficulties|1
1095900|NCT01990664|3582966|P1|Overall Study|Lens Discomfort|1
1095901|NCT01990664|3582965|P2|Overall Study|Protocol Violation|0
1095902|NCT01990664|3582966|P1|Overall Study|Protocol Violation|1
1095903|NCT01990664|3582965|P2|Overall Study|Withdrawal by Subject|3
1095904|NCT01990664|3582966|P1|Overall Study|Withdrawal by Subject|2
1095905|NCT01990664|3582965|P2|Overall Study|Lost to Follow-up|6
1095906|NCT01990664|3582966|P1|Overall Study|Lost to Follow-up|2
1095907|NCT01990560|3582972|P1|Overall Study|Withdrawal by Subject|1
1095908|NCT01990534|3582986|P1|Overall Study|Overall Survival Follow-up|25
1095909|NCT01990534|3582986|P1|Overall Study|Progression Free Survival Follow-up|11
1095910|NCT01990534|3582986|P1|Overall Study|Reason Not Specified|2
1095911|NCT01990534|3582986|P1|Overall Study|Withdrawal by Subject|3
1095912|NCT01990534|3582986|P1|Overall Study|Symptomatic Deterioration|1
1095913|NCT01990534|3582986|P1|Overall Study|Withdrawal of Informed Consent|2
1095914|NCT01990534|3582986|P1|Overall Study|Protocol Violation|1
1095915|NCT01990534|3582986|P1|Overall Study|Progressive disease|3
1095916|NCT01990534|3582986|P1|Overall Study|Death|12
1095917|NCT01990339|3583002|P1|Overall Study|Lost to Follow-up|861
1095918|NCT01990339|3583002|P1|Overall Study|Voluntary Withdrawal|1402
1095919|NCT01990339|3583002|P1|Overall Study|Data Not Available|49
1095920|NCT01990313|3583007|P1|Overall Study|Lost to Follow-up|1
1095921|NCT01990261|3583012|P1|Overall Study|Lost to Follow-up|2
1095922|NCT01990261|3583012|P1|Overall Study|Dossier not Approved|1
1095923|NCT01990261|3583012|P1|Overall Study|PD Before Treatment Start|1
1095924|NCT01990261|3583012|P1|Overall Study|Disease Progression (PD)|8
1095925|NCT01990261|3583012|P1|Overall Study|Death From other Causes|1
1095926|NCT01990261|3583012|P1|Overall Study|Death due to Disease Progression (PD)|10
1095927|NCT01990261|3583012|P1|Overall Study|Death Before Treatment Start|2
1095928|NCT01989754|3583049|P2|Overall Study|Closed Site|1
1095929|NCT01989754|3583050|P1|Overall Study|Closed Site|1
1095930|NCT01989754|3583049|P2|Overall Study|Lost to Follow-up|20
1095931|NCT01989754|3583050|P1|Overall Study|Lost to Follow-up|28
1095932|NCT01989754|3583049|P2|Overall Study|Withdrawal by Subject|14
1095933|NCT01989754|3583050|P1|Overall Study|Withdrawal by Subject|10
1095934|NCT01989689|3583062|P2|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1
1095935|NCT01989689|3583063|P1|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0
1095936|NCT01989689|3583062|P2|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2
1095937|NCT01989689|3583063|P1|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0
1095938|NCT01989676|3583075|P2|Overall Study|Discontinued|68
1095939|NCT01989676|3583076|P1|Overall Study|Discontinued|59
1095940|NCT01989676|3583075|P2|Overall Study|Ongoing at data cutoff|279
1095941|NCT01989676|3583076|P1|Overall Study|Ongoing at data cutoff|279
1095942|NCT01989572|3583102|P6|Overall Study|alternative therapy|3
1095943|NCT01989572|3583103|P5|Overall Study|alternative therapy|1
1095944|NCT01989572|3583104|P4|Overall Study|alternative therapy|0
1095945|NCT01989572|3583105|P3|Overall Study|alternative therapy|0
1095946|NCT01989572|3583106|P2|Overall Study|alternative therapy|0
1095947|NCT01989572|3583107|P1|Overall Study|alternative therapy|3
1095948|NCT01989572|3583102|P6|Overall Study|not start protocol therapy|18
1095949|NCT01989572|3583103|P5|Overall Study|not start protocol therapy|4
1095950|NCT01989572|3583104|P4|Overall Study|not start protocol therapy|3
1095951|NCT01989572|3583105|P3|Overall Study|not start protocol therapy|2
1095952|NCT01989572|3583106|P2|Overall Study|not start protocol therapy|1
1095953|NCT01989572|3583107|P1|Overall Study|not start protocol therapy|5
1095954|NCT01989572|3583102|P6|Overall Study|unknown/not specify|5
1095955|NCT01989572|3583103|P5|Overall Study|unknown/not specify|3
1095956|NCT01989572|3583104|P4|Overall Study|unknown/not specify|3
1095957|NCT01989572|3583105|P3|Overall Study|unknown/not specify|1
1095958|NCT01989572|3583106|P2|Overall Study|unknown/not specify|4
1095959|NCT01989572|3583107|P1|Overall Study|unknown/not specify|3
1095960|NCT01989572|3583102|P6|Overall Study|maximum dose reached|0
1095961|NCT01989572|3583103|P5|Overall Study|maximum dose reached|1
1095962|NCT01989572|3583104|P4|Overall Study|maximum dose reached|0
1095963|NCT01989572|3583105|P3|Overall Study|maximum dose reached|0
1095964|NCT01989572|3583106|P2|Overall Study|maximum dose reached|1
1095965|NCT01989572|3583107|P1|Overall Study|maximum dose reached|0
1095966|NCT01989572|3583102|P6|Overall Study|error|1
1095967|NCT01989572|3583103|P5|Overall Study|error|1
1095968|NCT01989572|3583104|P4|Overall Study|error|1
1095969|NCT01989572|3583105|P3|Overall Study|error|1
1095970|NCT01989572|3583106|P2|Overall Study|error|1
1095971|NCT01989572|3583107|P1|Overall Study|error|2
1095972|NCT01989572|3583102|P6|Overall Study|complicating disease|0
1095973|NCT01989572|3583103|P5|Overall Study|complicating disease|1
1095974|NCT01989572|3583104|P4|Overall Study|complicating disease|0
1095975|NCT01989572|3583105|P3|Overall Study|complicating disease|2
1095976|NCT01989572|3583106|P2|Overall Study|complicating disease|1
1095977|NCT01989572|3583107|P1|Overall Study|complicating disease|1
1095978|NCT01989572|3583102|P6|Overall Study|Withdrawal by Subject|4
1095979|NCT01989572|3583103|P5|Overall Study|Withdrawal by Subject|12
1095980|NCT01989572|3583104|P4|Overall Study|Withdrawal by Subject|1
1095981|NCT01989572|3583105|P3|Overall Study|Withdrawal by Subject|5
1095982|NCT01989572|3583106|P2|Overall Study|Withdrawal by Subject|1
1095983|NCT01989572|3583107|P1|Overall Study|Withdrawal by Subject|4
1095984|NCT01989572|3583102|P6|Overall Study|Death|0
1095985|NCT01989572|3583103|P5|Overall Study|Death|1
1095986|NCT01989572|3583104|P4|Overall Study|Death|0
1095987|NCT01989572|3583105|P3|Overall Study|Death|0
1095988|NCT01989572|3583106|P2|Overall Study|Death|0
1095989|NCT01989572|3583107|P1|Overall Study|Death|0
1095990|NCT01989572|3583102|P6|Overall Study|Adverse Event|0
1095991|NCT01989572|3583103|P5|Overall Study|Adverse Event|3
1095992|NCT01989572|3583104|P4|Overall Study|Adverse Event|0
1095993|NCT01989572|3583105|P3|Overall Study|Adverse Event|3
1095994|NCT01989572|3583106|P2|Overall Study|Adverse Event|1
1095995|NCT01989572|3583107|P1|Overall Study|Adverse Event|2
1095996|NCT01989572|3583102|P6|Overall Study|Lack of Efficacy|79
1095997|NCT01989572|3583103|P5|Overall Study|Lack of Efficacy|71
1095998|NCT01989572|3583104|P4|Overall Study|Lack of Efficacy|43
1095999|NCT01989572|3583105|P3|Overall Study|Lack of Efficacy|48
1096000|NCT01989572|3583106|P2|Overall Study|Lack of Efficacy|48
1096001|NCT01989572|3583107|P1|Overall Study|Lack of Efficacy|35
1096002|NCT01989455|3583140|P5|Overall Study|Technical problems with infusion|1
1096003|NCT01989455|3583141|P4|Overall Study|Technical problems with infusion|0
1096004|NCT01989455|3583142|P3|Overall Study|Technical problems with infusion|1
1096005|NCT01989455|3583143|P2|Overall Study|Technical problems with infusion|0
1096006|NCT01989455|3583144|P1|Overall Study|Technical problems with infusion|0
1096007|NCT01989455|3583140|P5|Overall Study|Withdrawal by Subject|0
1096008|NCT01989455|3583141|P4|Overall Study|Withdrawal by Subject|0
1096009|NCT01989455|3583142|P3|Overall Study|Withdrawal by Subject|0
1096010|NCT01989455|3583143|P2|Overall Study|Withdrawal by Subject|1
1096011|NCT01989455|3583144|P1|Overall Study|Withdrawal by Subject|0
1096012|NCT01989455|3583140|P5|Overall Study|Adverse Event|0
1096013|NCT01989455|3583141|P4|Overall Study|Adverse Event|0
1096014|NCT01989455|3583142|P3|Overall Study|Adverse Event|0
1096015|NCT01989455|3583143|P2|Overall Study|Adverse Event|1
1096016|NCT01989455|3583144|P1|Overall Study|Adverse Event|0
1096017|NCT01989169|3583188|P2|Period 2|Adverse Event|1
1096018|NCT01989169|3583189|P1|Period 2|Adverse Event|0
1096019|NCT01989156|3583202|P3|End of Study (Population at Day 90)|Employment Conflict|0
1096020|NCT01989156|3583203|P2|End of Study (Population at Day 90)|Employment Conflict|1
1096021|NCT01989156|3583204|P1|End of Study (Population at Day 90)|Employment Conflict|0
1096022|NCT01989156|3583202|P3|End of Study (Population at Day 90)|Moved out of state|0
1096023|NCT01989156|3583203|P2|End of Study (Population at Day 90)|Moved out of state|0
1096024|NCT01989156|3583204|P1|End of Study (Population at Day 90)|Moved out of state|1
1096025|NCT01989156|3583202|P3|End of Study (Population at Day 90)|Physician Decision|1
1096026|NCT01989156|3583203|P2|End of Study (Population at Day 90)|Physician Decision|0
1096027|NCT01989156|3583204|P1|End of Study (Population at Day 90)|Physician Decision|1
1096028|NCT01989156|3583202|P3|End of Study (Population at Day 90)|Lost to Follow-up|0
1096029|NCT01989156|3583203|P2|End of Study (Population at Day 90)|Lost to Follow-up|2
1096030|NCT01989156|3583204|P1|End of Study (Population at Day 90)|Lost to Follow-up|3
1096031|NCT01989156|3583202|P3|End of Study (Population at Day 90)|Withdrawal by Subject|2
1096032|NCT01989156|3583203|P2|End of Study (Population at Day 90)|Withdrawal by Subject|2
1096033|NCT01989156|3583204|P1|End of Study (Population at Day 90)|Withdrawal by Subject|2
1096034|NCT01989156|3583202|P3|Confinement Period (Population at Day 5)|Adverse Event|1
1096035|NCT01989156|3583203|P2|Confinement Period (Population at Day 5)|Adverse Event|0
1096036|NCT01989156|3583204|P1|Confinement Period (Population at Day 5)|Adverse Event|0
1096037|NCT01989156|3583202|P3|Confinement Period (Population at Day 5)|Patient Anxiety|1
1096038|NCT01989156|3583203|P2|Confinement Period (Population at Day 5)|Patient Anxiety|0
1096039|NCT01989156|3583204|P1|Confinement Period (Population at Day 5)|Patient Anxiety|0
1096040|NCT01989156|3583202|P3|Confinement Period (Population at Day 5)|Withdrawal by Subject|3
1096041|NCT01989156|3583203|P2|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
1096042|NCT01989156|3583204|P1|Confinement Period (Population at Day 5)|Withdrawal by Subject|0
1096043|NCT01988662|3583264|P2|Overall Study|Adverse Event|1
1096044|NCT01988662|3583265|P1|Overall Study|Adverse Event|3
1096045|NCT01988662|3583264|P2|Overall Study|Subject/guardian decision|1
1096046|NCT01988662|3583265|P1|Overall Study|Subject/guardian decision|1
1096047|NCT01988402|3583292|P2|Overall Study|Withdrawal by Subject|0
1096048|NCT01988402|3583293|P1|Overall Study|Withdrawal by Subject|1
1096049|NCT01988402|3583292|P2|Overall Study|Adverse Event|2
1096050|NCT01988402|3583293|P1|Overall Study|Adverse Event|1
1096051|NCT01988012|3583344|P1|Overall Study|Protocol Violation|1
1096052|NCT01988012|3583344|P1|Overall Study|Physician Decision|1
1096053|NCT01988012|3583344|P1|Overall Study|Lost to Follow-up|1
1096054|NCT01988012|3583344|P1|Overall Study|Patient Withdrawal of Consent|4
1096055|NCT01988012|3583344|P1|Overall Study|Insufficient Therapeutic Response|3
1096056|NCT01988012|3583344|P1|Overall Study|Adverse Event|5
1096057|NCT01987986|3583370|P4|Overall Study|Adverse Event|0
1096058|NCT01987986|3583371|P3|Overall Study|Adverse Event|2
1096059|NCT01987986|3583372|P2|Overall Study|Adverse Event|0
1096060|NCT01987986|3583373|P1|Overall Study|Adverse Event|1
1096061|NCT01987986|3583370|P4|Overall Study|Lost to Follow-up|0
1096062|NCT01987986|3583371|P3|Overall Study|Lost to Follow-up|0
1096063|NCT01987986|3583372|P2|Overall Study|Lost to Follow-up|0
1096064|NCT01987986|3583373|P1|Overall Study|Lost to Follow-up|1
1096065|NCT01987960|3583413|P4|Period 3|Administrative or other reason|43
1096066|NCT01987960|3583414|P3|Period 3|Administrative or other reason|0
1096067|NCT01987960|3583415|P2|Period 3|Administrative or other reason|0
1096068|NCT01987960|3583416|P1|Period 3|Administrative or other reason|0
1096069|NCT01987960|3583413|P4|Period 3|Lost to Follow-up|5
1096070|NCT01987960|3583414|P3|Period 3|Lost to Follow-up|0
1096071|NCT01987960|3583415|P2|Period 3|Lost to Follow-up|0
1096072|NCT01987960|3583416|P1|Period 3|Lost to Follow-up|0
1096073|NCT01987960|3583413|P4|Period 3|Withdrawal by Subject|9
1096074|NCT01987960|3583414|P3|Period 3|Withdrawal by Subject|0
1096075|NCT01987960|3583415|P2|Period 3|Withdrawal by Subject|0
1096076|NCT01987960|3583416|P1|Period 3|Withdrawal by Subject|0
1096077|NCT01987960|3583413|P4|Period 3|Protocol Violation|6
1096078|NCT01987960|3583414|P3|Period 3|Protocol Violation|0
1096079|NCT01987960|3583415|P2|Period 3|Protocol Violation|0
1096080|NCT01987960|3583416|P1|Period 3|Protocol Violation|0
1096081|NCT01987960|3583413|P4|Period 3|Non-compliance with IMP|1
1096082|NCT01987960|3583414|P3|Period 3|Non-compliance with IMP|0
1096083|NCT01987960|3583415|P2|Period 3|Non-compliance with IMP|0
1096084|NCT01987960|3583416|P1|Period 3|Non-compliance with IMP|0
1096085|NCT01987960|3583413|P4|Period 3|Adverse Event|7
1096086|NCT01987960|3583414|P3|Period 3|Adverse Event|0
1096087|NCT01987960|3583415|P2|Period 3|Adverse Event|0
1096088|NCT01987960|3583416|P1|Period 3|Adverse Event|0
1096089|NCT01987960|3583413|P4|Period 2|Administrative or other reason|0
1096090|NCT01987960|3583414|P3|Period 2|Administrative or other reason|7
1096091|NCT01987960|3583415|P2|Period 2|Administrative or other reason|5
1096092|NCT01987960|3583416|P1|Period 2|Administrative or other reason|0
1096093|NCT01987960|3583413|P4|Period 2|Withdrawal by Subject|0
1096094|NCT01987960|3583414|P3|Period 2|Withdrawal by Subject|1
1096095|NCT01987960|3583415|P2|Period 2|Withdrawal by Subject|0
1096096|NCT01987960|3583416|P1|Period 2|Withdrawal by Subject|0
1096097|NCT01987960|3583413|P4|Period 2|Adverse Event|0
1096098|NCT01987960|3583414|P3|Period 2|Adverse Event|1
1096099|NCT01987960|3583415|P2|Period 2|Adverse Event|0
1096100|NCT01987960|3583416|P1|Period 2|Adverse Event|0
1096101|NCT01987960|3583413|P4|Period 1|Withdrawal of consent before treatment|0
1096102|NCT01987960|3583414|P3|Period 1|Withdrawal of consent before treatment|0
1096103|NCT01987960|3583415|P2|Period 1|Withdrawal of consent before treatment|0
1096104|NCT01987960|3583416|P1|Period 1|Withdrawal of consent before treatment|4
1096105|NCT01987960|3583413|P4|Period 1|administrative or other reason|0
1096106|NCT01987960|3583414|P3|Period 1|administrative or other reason|0
1096107|NCT01987960|3583415|P2|Period 1|administrative or other reason|0
1096108|NCT01987960|3583416|P1|Period 1|administrative or other reason|75
1096109|NCT01987960|3583413|P4|Period 1|Lost to Follow-up|0
1096110|NCT01987960|3583414|P3|Period 1|Lost to Follow-up|0
1096111|NCT01987960|3583415|P2|Period 1|Lost to Follow-up|0
1096112|NCT01987960|3583416|P1|Period 1|Lost to Follow-up|40
1096113|NCT01987960|3583413|P4|Period 1|Withdrawal by Subject|0
1096114|NCT01987960|3583414|P3|Period 1|Withdrawal by Subject|0
1096115|NCT01987960|3583415|P2|Period 1|Withdrawal by Subject|0
1096116|NCT01987960|3583416|P1|Period 1|Withdrawal by Subject|21
1096117|NCT01987960|3583413|P4|Period 1|Protocol Violation|0
1096118|NCT01987960|3583414|P3|Period 1|Protocol Violation|0
1096119|NCT01987960|3583415|P2|Period 1|Protocol Violation|0
1096120|NCT01987960|3583416|P1|Period 1|Protocol Violation|12
1096121|NCT01987960|3583413|P4|Period 1|Non-compliance with IMP|0
1096122|NCT01987960|3583414|P3|Period 1|Non-compliance with IMP|0
1096123|NCT01987960|3583415|P2|Period 1|Non-compliance with IMP|0
1096124|NCT01987960|3583416|P1|Period 1|Non-compliance with IMP|6
1096125|NCT01987960|3583413|P4|Period 1|Lack of Efficacy|0
1096126|NCT01987960|3583414|P3|Period 1|Lack of Efficacy|0
1096127|NCT01987960|3583415|P2|Period 1|Lack of Efficacy|0
1096128|NCT01987960|3583416|P1|Period 1|Lack of Efficacy|4
1096129|NCT01987960|3583413|P4|Period 1|Adverse Event|0
1096130|NCT01987960|3583414|P3|Period 1|Adverse Event|0
1096131|NCT01987960|3583415|P2|Period 1|Adverse Event|0
1096132|NCT01987960|3583416|P1|Period 1|Adverse Event|24
1096133|NCT01987908|3583428|P3|Post-Treatment Observation Period|Other: Bad Veins|0
1096134|NCT01987908|3583429|P2|Post-Treatment Observation Period|Other: Bad Veins|1
1096135|NCT01987908|3583430|P1|Post-Treatment Observation Period|Other: Bad Veins|0
1096136|NCT01987908|3583428|P3|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
1096137|NCT01987908|3583429|P2|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2
1096138|NCT01987908|3583430|P1|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
1096139|NCT01987908|3583428|P3|Treatment Period|Adverse Event|1
1096140|NCT01987908|3583429|P2|Treatment Period|Adverse Event|1
1096141|NCT01987908|3583430|P1|Treatment Period|Adverse Event|0
1096142|NCT01987908|3583428|P3|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
1096143|NCT01987908|3583429|P2|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
1096144|NCT01987908|3583430|P1|Placebo Lead-in Period|Other: Study Termination by Sponsor|4
1096145|NCT01987908|3583428|P3|Placebo Lead-in Period|Withdrawal by Subject|0
1096146|NCT01987908|3583429|P2|Placebo Lead-in Period|Withdrawal by Subject|0
1096147|NCT01987908|3583430|P1|Placebo Lead-in Period|Withdrawal by Subject|1
1096148|NCT01987908|3583428|P3|Placebo Lead-in Period|Physician Decision|0
1096149|NCT01987908|3583429|P2|Placebo Lead-in Period|Physician Decision|0
1096150|NCT01987908|3583430|P1|Placebo Lead-in Period|Physician Decision|2
1096151|NCT01987908|3583428|P3|Placebo Lead-in Period|Adverse Event|0
1096152|NCT01987908|3583429|P2|Placebo Lead-in Period|Adverse Event|0
1096153|NCT01987908|3583430|P1|Placebo Lead-in Period|Adverse Event|2
1096154|NCT01987895|3583513|P2|Overall Study|randomized before giving IC|1
1096155|NCT01987895|3583514|P1|Overall Study|randomized before giving IC|0
1096156|NCT01987895|3583513|P2|Overall Study|Lost to Follow-up|5
1096157|NCT01987895|3583514|P1|Overall Study|Lost to Follow-up|3
1096158|NCT01987895|3583513|P2|Overall Study|Death|7
1096159|NCT01987895|3583514|P1|Overall Study|Death|7
1096160|NCT01987895|3583513|P2|Overall Study|Physician Decision|10
1096161|NCT01987895|3583514|P1|Overall Study|Physician Decision|8
1096162|NCT01987895|3583513|P2|Overall Study|Withdrawal by Subject|7
1096163|NCT01987895|3583514|P1|Overall Study|Withdrawal by Subject|12
1096164|NCT01987765|3583538|P1|Overall Study|Lost to Follow-up|37
1096165|NCT01987765|3583538|P1|Overall Study|Protocol Violation|65
1096166|NCT01987557|3583562|P3|Overall Study|Adverse Event|0
1096167|NCT01987557|3583563|P2|Overall Study|Adverse Event|2
1096168|NCT01987557|3583564|P1|Overall Study|Adverse Event|0
1096169|NCT01987557|3583562|P3|Overall Study|Withdrawal by Subject|2
1096170|NCT01987557|3583563|P2|Overall Study|Withdrawal by Subject|1
1096171|NCT01987557|3583564|P1|Overall Study|Withdrawal by Subject|2
1096172|NCT01987557|3583562|P3|Overall Study|Protocol Violation|1
1096173|NCT01987557|3583563|P2|Overall Study|Protocol Violation|0
1096174|NCT01987557|3583564|P1|Overall Study|Protocol Violation|1
1096175|NCT01987505|3583574|P1|Overall Study|Death|4
1096176|NCT01987505|3583574|P1|Overall Study|Investigator Decision|2
1096177|NCT01987505|3583574|P1|Overall Study|Lost to Follow-up|15
1096178|NCT01987505|3583574|P1|Overall Study|Other Reason|2
1096179|NCT01987505|3583574|P1|Overall Study|Withdrawal by Subject|2
1096180|NCT01987505|3583574|P1|Overall Study|Other|9
1096181|NCT01987479|3583604|P1|Overall Study|Adverse Event|7
1096182|NCT01987479|3583604|P1|Overall Study|Lost to Follow-up|1
1096183|NCT01987479|3583604|P1|Overall Study|Other|5
1096184|NCT01987479|3583604|P1|Overall Study|Participant/legal guardian decision|1
1096185|NCT01987479|3583604|P1|Overall Study|Physician Decision|2
1096186|NCT01987479|3583604|P1|Overall Study|Protocol Violation|1
1096187|NCT01987453|3583632|P3|Overall Study|Lack of Efficacy|0
1096188|NCT01987453|3583633|P2|Overall Study|Lack of Efficacy|12
1096189|NCT01987453|3583634|P1|Overall Study|Lack of Efficacy|1
1096190|NCT01987453|3583632|P3|Overall Study|Death|1
1096191|NCT01987453|3583633|P2|Overall Study|Death|0
1096192|NCT01987453|3583634|P1|Overall Study|Death|0
1096193|NCT01987232|3583716|P5|Overall Study|Ongoing in Study|0
1096194|NCT01987232|3583717|P4|Overall Study|Ongoing in Study|1
1096195|NCT01987232|3583718|P3|Overall Study|Ongoing in Study|0
1096196|NCT01987232|3583719|P2|Overall Study|Ongoing in Study|0
1096197|NCT01987232|3583720|P1|Overall Study|Ongoing in Study|0
1096198|NCT01986985|3583807|P1|Overall Study|Scan not completed due to malfunction|3
1096199|NCT01986985|3583807|P1|Overall Study|Withdrawal by Subject|4
1096200|NCT01986920|3583844|P4|Placebo|Withdrawal by Subject|1
1096201|NCT01986920|3583845|P3|Placebo|Withdrawal by Subject|0
1096202|NCT01986920|3583846|P2|Placebo|Withdrawal by Subject|0
1096203|NCT01986920|3583847|P1|Placebo|Withdrawal by Subject|0
1096204|NCT01986920|3583844|P4|A-101 40%|Withdrawal by Subject|0
1096205|NCT01986920|3583845|P3|A-101 40%|Withdrawal by Subject|1
1096206|NCT01986920|3583846|P2|A-101 40%|Withdrawal by Subject|0
1096207|NCT01986920|3583847|P1|A-101 40%|Withdrawal by Subject|0
1096208|NCT01986920|3583844|P4|A-101 32.5%|Withdrawal by Subject|0
1096209|NCT01986920|3583845|P3|A-101 32.5%|Withdrawal by Subject|0
1096210|NCT01986920|3583846|P2|A-101 32.5%|Withdrawal by Subject|1
1096211|NCT01986920|3583847|P1|A-101 32.5%|Withdrawal by Subject|0
1096212|NCT01986920|3583844|P4|A- 101 25%|Withdrawal by Subject|0
1096213|NCT01986920|3583845|P3|A- 101 25%|Withdrawal by Subject|0
1096214|NCT01986920|3583846|P2|A- 101 25%|Withdrawal by Subject|0
1096215|NCT01986920|3583847|P1|A- 101 25%|Withdrawal by Subject|1
1096216|NCT01986855|3583864|P3|Overall Study|Withdrawal by Subject|5
1096217|NCT01986855|3583865|P2|Overall Study|Withdrawal by Subject|8
1096218|NCT01986855|3583866|P1|Overall Study|Withdrawal by Subject|7
1096219|NCT01986855|3583864|P3|Overall Study|Participant Moved|2
1096220|NCT01986855|3583865|P2|Overall Study|Participant Moved|0
1096221|NCT01986855|3583866|P1|Overall Study|Participant Moved|0
1096222|NCT01986855|3583864|P3|Overall Study|Screen Failure|0
1096223|NCT01986855|3583865|P2|Overall Study|Screen Failure|1
1096224|NCT01986855|3583866|P1|Overall Study|Screen Failure|0
1096225|NCT01986855|3583864|P3|Overall Study|Lost to Follow-up|0
1096226|NCT01986855|3583865|P2|Overall Study|Lost to Follow-up|1
1096227|NCT01986855|3583866|P1|Overall Study|Lost to Follow-up|2
1096228|NCT01986855|3583864|P3|Overall Study|Death|4
1096229|NCT01986855|3583865|P2|Overall Study|Death|4
1096230|NCT01986855|3583866|P1|Overall Study|Death|3
1096231|NCT01986855|3583864|P3|Overall Study|Adverse Event|0
1096232|NCT01986855|3583865|P2|Overall Study|Adverse Event|0
1096233|NCT01986855|3583866|P1|Overall Study|Adverse Event|1
1096234|NCT01986829|3583895|P1|Overall Study|Death|1
1096235|NCT01986751|3583943|P2|Overall Study|improperly consented|2
1096236|NCT01986751|3583944|P1|Overall Study|improperly consented|10
1096237|NCT01986231|3583998|P1|Overall Study|Adverse Event|1
1096238|NCT01986140|3584005|P2|Overall Study|progression disease|1
1096239|NCT01986140|3584006|P1|Overall Study|progression disease|0
1096240|NCT01986140|3584005|P2|Overall Study|Adverse Event|1
1096241|NCT01986140|3584006|P1|Overall Study|Adverse Event|0
1096242|NCT01986140|3584005|P2|Overall Study|found not eligible|0
1096243|NCT01986140|3584006|P1|Overall Study|found not eligible|3
1096244|NCT01986140|3584005|P2|Overall Study|alternative treatment|1
1096245|NCT01986140|3584006|P1|Overall Study|alternative treatment|1
1096246|NCT01986140|3584005|P2|Overall Study|Withdrawal by Subject|25
1096247|NCT01986140|3584006|P1|Overall Study|Withdrawal by Subject|31
1096248|NCT01986062|3584014|P2|Overall Study|Lost to Follow-up|1
1096249|NCT01986062|3584015|P1|Overall Study|Lost to Follow-up|1
1096250|NCT01985321|3584088|P2|Overall Study|Subject treated wrong type of sore|0
1096251|NCT01985321|3584089|P1|Overall Study|Subject treated wrong type of sore|1
1096252|NCT01985321|3584088|P2|Overall Study|Lost to Follow-up|2
1096253|NCT01985321|3584089|P1|Overall Study|Lost to Follow-up|5
1096254|NCT01985321|3584088|P2|Overall Study|Withdrawal by Subject|0
1096255|NCT01985321|3584089|P1|Overall Study|Withdrawal by Subject|1
1096256|NCT01985321|3584088|P2|Overall Study|Protocol Violation|3
1096257|NCT01985321|3584089|P1|Overall Study|Protocol Violation|4
1096258|NCT01985126|3584099|P2|Overall Study|Withdrawal by Subject|7
1096259|NCT01985126|3584100|P1|Overall Study|Withdrawal by Subject|2
1096260|NCT01985126|3584099|P2|Overall Study|Study Terminated By Sponsor|22
1096261|NCT01985126|3584100|P1|Overall Study|Study Terminated By Sponsor|1
1096262|NCT01985126|3584099|P2|Overall Study|Lost to Follow-up|8
1096263|NCT01985126|3584100|P1|Overall Study|Lost to Follow-up|0
1096264|NCT01985126|3584099|P2|Overall Study|Death|69
1096265|NCT01985126|3584100|P1|Overall Study|Death|15
1096266|NCT01984892|3584118|P1|Overall Study|Progressive disease|7
1096267|NCT01984697|3584129|P5|Overall Study|Pregnancy|1
1096268|NCT01984697|3584130|P4|Overall Study|Pregnancy|0
1096269|NCT01984697|3584131|P3|Overall Study|Pregnancy|1
1096270|NCT01984697|3584132|P2|Overall Study|Pregnancy|0
1096271|NCT01984697|3584133|P1|Overall Study|Pregnancy|2
1096272|NCT01984697|3584129|P5|Overall Study|Death|0
1096273|NCT01984697|3584130|P4|Overall Study|Death|1
1096274|NCT01984697|3584131|P3|Overall Study|Death|0
1096275|NCT01984697|3584132|P2|Overall Study|Death|0
1096276|NCT01984697|3584133|P1|Overall Study|Death|0
1096277|NCT01984697|3584129|P5|Overall Study|Missed last follow-up visit|0
1096278|NCT01984697|3584130|P4|Overall Study|Missed last follow-up visit|0
1096279|NCT01984697|3584131|P3|Overall Study|Missed last follow-up visit|0
1096280|NCT01984697|3584132|P2|Overall Study|Missed last follow-up visit|0
1096281|NCT01984697|3584133|P1|Overall Study|Missed last follow-up visit|1
1096282|NCT01984697|3584129|P5|Overall Study|Withdrawal by Subject|13
1096283|NCT01984697|3584130|P4|Overall Study|Withdrawal by Subject|11
1096284|NCT01984697|3584131|P3|Overall Study|Withdrawal by Subject|13
1096285|NCT01984697|3584132|P2|Overall Study|Withdrawal by Subject|21
1096286|NCT01984697|3584133|P1|Overall Study|Withdrawal by Subject|15
1096287|NCT01984697|3584129|P5|Overall Study|Protocol Violation|0
1096288|NCT01984697|3584130|P4|Overall Study|Protocol Violation|2
1096289|NCT01984697|3584131|P3|Overall Study|Protocol Violation|3
1096290|NCT01984697|3584132|P2|Overall Study|Protocol Violation|5
1096291|NCT01984697|3584133|P1|Overall Study|Protocol Violation|8
1096292|NCT01984697|3584129|P5|Overall Study|Physician Decision|0
1096293|NCT01984697|3584130|P4|Overall Study|Physician Decision|1
1096294|NCT01984697|3584131|P3|Overall Study|Physician Decision|0
1096295|NCT01984697|3584132|P2|Overall Study|Physician Decision|0
1096296|NCT01984697|3584133|P1|Overall Study|Physician Decision|3
1096297|NCT01984697|3584129|P5|Overall Study|Lost to Follow-up|21
1096298|NCT01984697|3584130|P4|Overall Study|Lost to Follow-up|6
1096299|NCT01984697|3584131|P3|Overall Study|Lost to Follow-up|10
1096300|NCT01984697|3584132|P2|Overall Study|Lost to Follow-up|5
1096301|NCT01984697|3584133|P1|Overall Study|Lost to Follow-up|14
1096302|NCT01984697|3584129|P5|Overall Study|Adverse Event|0
1096303|NCT01984697|3584130|P4|Overall Study|Adverse Event|0
1096304|NCT01984697|3584131|P3|Overall Study|Adverse Event|2
1096305|NCT01984697|3584132|P2|Overall Study|Adverse Event|0
1096306|NCT01984697|3584133|P1|Overall Study|Adverse Event|0
1096307|NCT01984684|3584252|P2|Overall Study|Subject had inadequate IV access|1
1096308|NCT01984684|3584253|P1|Overall Study|Subject had inadequate IV access|0
1096309|NCT01984684|3584252|P2|Overall Study|Study drug not available at site|1
1096310|NCT01984684|3584253|P1|Overall Study|Study drug not available at site|1
1096311|NCT01984684|3584252|P2|Overall Study|Subject incarcerated|0
1096312|NCT01984684|3584253|P1|Overall Study|Subject incarcerated|1
1096313|NCT01984684|3584252|P2|Overall Study|Noncompliance with study drug|1
1096314|NCT01984684|3584253|P1|Overall Study|Noncompliance with study drug|2
1096315|NCT01984684|3584252|P2|Overall Study|Death|1
1096316|NCT01984684|3584253|P1|Overall Study|Death|0
1096317|NCT01984684|3584252|P2|Overall Study|Protocol Violation|2
1096318|NCT01984684|3584253|P1|Overall Study|Protocol Violation|4
1096319|NCT01984684|3584252|P2|Overall Study|Physician Decision|2
1096320|NCT01984684|3584253|P1|Overall Study|Physician Decision|4
1096321|NCT01984684|3584252|P2|Overall Study|Lack of Efficacy|6
1096322|NCT01984684|3584253|P1|Overall Study|Lack of Efficacy|3
1096323|NCT01984684|3584252|P2|Overall Study|Withdrawal by Subject|9
1096324|NCT01984684|3584253|P1|Overall Study|Withdrawal by Subject|9
1096325|NCT01984684|3584252|P2|Overall Study|Adverse Event|12
1096326|NCT01984684|3584253|P1|Overall Study|Adverse Event|8
1096327|NCT01984684|3584252|P2|Overall Study|Lost to Follow-up|24
1096328|NCT01984684|3584253|P1|Overall Study|Lost to Follow-up|25
1096329|NCT01984424|3584271|P2|Overall Study|Lost to Follow-up|1
1096330|NCT01984424|3584272|P1|Overall Study|Lost to Follow-up|0
1096331|NCT01984424|3584271|P2|Overall Study|Sponsor Decision|1
1096332|NCT01984424|3584272|P1|Overall Study|Sponsor Decision|0
1096333|NCT01984424|3584271|P2|Overall Study|Withdrawal by Subject|5
1096334|NCT01984424|3584272|P1|Overall Study|Withdrawal by Subject|3
1096335|NCT01984294|3584327|P3|Overall Study|Adverse Event|0
1096336|NCT01984294|3584328|P2|Overall Study|Adverse Event|1
1096337|NCT01984294|3584329|P1|Overall Study|Adverse Event|0
1096338|NCT01984294|3584327|P3|Overall Study|Lack of Efficacy|6
1096339|NCT01984294|3584328|P2|Overall Study|Lack of Efficacy|2
1096340|NCT01984294|3584329|P1|Overall Study|Lack of Efficacy|4
1096341|NCT01984294|3584327|P3|Overall Study|Randomized but Never Treated|1
1096342|NCT01984294|3584328|P2|Overall Study|Randomized but Never Treated|0
1096343|NCT01984294|3584329|P1|Overall Study|Randomized but Never Treated|0
1096344|NCT01984242|3584352|P3|Overall Study|Ongoing in Study|61
1096345|NCT01984242|3584353|P2|Overall Study|Ongoing in Study|65
1096346|NCT01984242|3584354|P1|Overall Study|Ongoing in Study|60
1096347|NCT01984242|3584352|P3|Overall Study|Randomized, but not treated|1
1096348|NCT01984242|3584353|P2|Overall Study|Randomized, but not treated|0
1096349|NCT01984242|3584354|P1|Overall Study|Randomized, but not treated|0
1096350|NCT01984242|3584352|P3|Overall Study|Other|1
1096351|NCT01984242|3584353|P2|Overall Study|Other|0
1096352|NCT01984242|3584354|P1|Overall Study|Other|1
1096353|NCT01984242|3584352|P3|Overall Study|Lost to Follow-up|1
1096354|NCT01984242|3584353|P2|Overall Study|Lost to Follow-up|0
1096355|NCT01984242|3584354|P1|Overall Study|Lost to Follow-up|0
1096356|NCT01984242|3584352|P3|Overall Study|Physician Decision|2
1096357|NCT01984242|3584353|P2|Overall Study|Physician Decision|0
1096358|NCT01984242|3584354|P1|Overall Study|Physician Decision|1
1096359|NCT01984242|3584352|P3|Overall Study|Withdrawal by Subject|5
1096360|NCT01984242|3584353|P2|Overall Study|Withdrawal by Subject|2
1096361|NCT01984242|3584354|P1|Overall Study|Withdrawal by Subject|2
1096362|NCT01984242|3584352|P3|Overall Study|Death|30
1096363|NCT01984242|3584353|P2|Overall Study|Death|36
1096364|NCT01984242|3584354|P1|Overall Study|Death|37
1096365|NCT01984229|3584504|P2|Safety Follow-up Period|Lost to Follow-up|0
1096366|NCT01984229|3584505|P1|Safety Follow-up Period|Lost to Follow-up|1
1096367|NCT01984229|3584504|P2|Safety Follow-up Period|Adverse Event|1
1096368|NCT01984229|3584505|P1|Safety Follow-up Period|Adverse Event|1
1096369|NCT01983930|3584557|P2|Overall Study|Adverse Event|1
1096370|NCT01983930|3584558|P1|Overall Study|Adverse Event|0
1096371|NCT01983930|3584557|P2|Overall Study|Withdrawal by Subject|8
1096372|NCT01983930|3584558|P1|Overall Study|Withdrawal by Subject|9
1096373|NCT01983683|3584611|P2|Overall Study|Sponsor Decision|1
1096374|NCT01983683|3584612|P1|Overall Study|Sponsor Decision|1
1096375|NCT01983683|3584611|P2|Overall Study|Lost to Follow-up|8
1096376|NCT01983683|3584612|P1|Overall Study|Lost to Follow-up|4
1096377|NCT01983683|3584611|P2|Overall Study|Physician Decision|9
1096378|NCT01983683|3584612|P1|Overall Study|Physician Decision|8
1096379|NCT01983683|3584611|P2|Overall Study|Death|15
1096380|NCT01983683|3584612|P1|Overall Study|Death|11
1096381|NCT01983683|3584611|P2|Overall Study|Withdrawal by Subject|18
1096382|NCT01983683|3584612|P1|Overall Study|Withdrawal by Subject|14
1096383|NCT01983254|3584664|P2|Overall Study|too ill|8
1096384|NCT01983254|3584665|P1|Overall Study|too ill|11
1096385|NCT01983254|3584664|P2|Overall Study|Lost to Follow-up|16
1096386|NCT01983254|3584665|P1|Overall Study|Lost to Follow-up|17
1096387|NCT01983254|3584664|P2|Overall Study|Death|6
1096388|NCT01983254|3584665|P1|Overall Study|Death|6
1096389|NCT01983111|3584677|P2|Overall Study|Protocol Violation|1
1096390|NCT01983111|3584678|P1|Overall Study|Protocol Violation|0
1096391|NCT01983111|3584677|P2|Overall Study|Adverse Event|0
1096392|NCT01983111|3584678|P1|Overall Study|Adverse Event|4
1096393|NCT01983111|3584677|P2|Overall Study|Withdrawal by Subject|6
1096394|NCT01983111|3584678|P1|Overall Study|Withdrawal by Subject|8
1096395|NCT01982812|3584713|P2|Overall Study|Adverse Event|5
1096396|NCT01982812|3584714|P1|Overall Study|Adverse Event|0
1096397|NCT01982812|3584713|P2|Overall Study|Death|5
1096398|NCT01982812|3584714|P1|Overall Study|Death|1
1096399|NCT01982773|3584728|P2|Overall Study|Lost to Follow-up|1
1096400|NCT01982773|3584729|P1|Overall Study|Lost to Follow-up|7
1096401|NCT01982773|3584728|P2|Overall Study|Withdrawal by Subject|3
1096402|NCT01982773|3584729|P1|Overall Study|Withdrawal by Subject|1
1096403|NCT01982682|3584750|P1|Overall Study|Physician Decision|1
1096404|NCT01982435|3584764|P2|Overall Study|Adverse Event|0
1096405|NCT01982435|3584765|P1|Overall Study|Adverse Event|1
1096406|NCT01982292|3584804|P2|Overall Study|Technical Problems|0
1096407|NCT01982292|3584805|P1|Overall Study|Technical Problems|2
1096408|NCT01982292|3584804|P2|Overall Study|Patient/Guardian Decision|1
1096409|NCT01982292|3584805|P1|Overall Study|Patient/Guardian Decision|3
1096410|NCT01982292|3584804|P2|Overall Study|Protocol Deviation|0
1096411|NCT01982292|3584805|P1|Overall Study|Protocol Deviation|1
1096412|NCT01982292|3584804|P2|Overall Study|Non-Compliance With Study Treatment|0
1096413|NCT01982292|3584805|P1|Overall Study|Non-Compliance With Study Treatment|1
1096414|NCT01982292|3584804|P2|Overall Study|Lost to Follow-up|0
1096415|NCT01982292|3584805|P1|Overall Study|Lost to Follow-up|2
1096416|NCT01982292|3584804|P2|Overall Study|Death|0
1096417|NCT01982292|3584805|P1|Overall Study|Death|1
1096418|NCT01982292|3584804|P2|Overall Study|Adverse Event|0
1096419|NCT01982292|3584805|P1|Overall Study|Adverse Event|2
1096420|NCT01982253|3584826|P3|Overall Study|Study terminated by sponsor|4
1096421|NCT01982253|3584827|P2|Overall Study|Study terminated by sponsor|4
1096422|NCT01982253|3584828|P1|Overall Study|Study terminated by sponsor|1
1096423|NCT01982253|3584826|P3|Overall Study|Withdrawal by Subject|0
1096424|NCT01982253|3584827|P2|Overall Study|Withdrawal by Subject|0
1096425|NCT01982253|3584828|P1|Overall Study|Withdrawal by Subject|1
1096426|NCT01981954|3584857|P1|Fixed-Dose Assessment Period|Lack of Efficacy|1
1096427|NCT01981954|3584857|P1|Titration Period|Protocol Deviation|1
1096428|NCT01981616|3584926|P2|Overall Study|Protocol Violation|0
1096429|NCT01981616|3584927|P1|Overall Study|Protocol Violation|1
1096430|NCT01981616|3584926|P2|Overall Study|Adverse Event|1
1096431|NCT01981616|3584927|P1|Overall Study|Adverse Event|0
1096432|NCT01981473|3584953|P3|Overall Study|Received treatment for >24 months|6
1096433|NCT01981473|3584954|P2|Overall Study|Received treatment for >24 months|0
1096434|NCT01981473|3584955|P1|Overall Study|Received treatment for >24 months|2
1096435|NCT01981473|3584953|P3|Overall Study|Received treatment for < 6 months|1
1096436|NCT01981473|3584954|P2|Overall Study|Received treatment for < 6 months|0
1096437|NCT01981473|3584955|P1|Overall Study|Received treatment for < 6 months|0
1096438|NCT01981473|3584953|P3|Overall Study|Incorrect diagnosis of RA|1
1096439|NCT01981473|3584954|P2|Overall Study|Incorrect diagnosis of RA|0
1096440|NCT01981473|3584955|P1|Overall Study|Incorrect diagnosis of RA|0
1096441|NCT01981356|3584996|P2|Overall Study|Protocol Violation|0
1096442|NCT01981356|3584997|P1|Overall Study|Protocol Violation|2
1096443|NCT01981356|3584996|P2|Overall Study|Withdrawal by Subject|1
1096444|NCT01981356|3584997|P1|Overall Study|Withdrawal by Subject|1
1096445|NCT01981356|3584996|P2|Overall Study|Lost to Follow-up|1
1096446|NCT01981356|3584997|P1|Overall Study|Lost to Follow-up|4
1096447|NCT01981122|3585024|P2|Overall Study|Death|15
1096448|NCT01981122|3585025|P1|Overall Study|Death|14
1096449|NCT01981122|3585024|P2|Overall Study|Investigator Or Dendreon Discretion|1
1096450|NCT01981122|3585025|P1|Overall Study|Investigator Or Dendreon Discretion|0
1096451|NCT01981122|3585024|P2|Overall Study|Lost to Follow-up|1
1096452|NCT01981122|3585025|P1|Overall Study|Lost to Follow-up|0
1096453|NCT01981122|3585024|P2|Overall Study|Protocol Violation|1
1096454|NCT01981122|3585025|P1|Overall Study|Protocol Violation|0
1096455|NCT01981122|3585024|P2|Overall Study|Withdrawal by Subject|2
1096456|NCT01981122|3585025|P1|Overall Study|Withdrawal by Subject|0
1096457|NCT01981096|3585033|P2|Overall Study|Lost to Follow-up|0
1096458|NCT01981096|3585034|P1|Overall Study|Lost to Follow-up|2
1096459|NCT01981096|3585033|P2|Overall Study|Withdrawal by Subject|1
1096460|NCT01981096|3585034|P1|Overall Study|Withdrawal by Subject|0
1096461|NCT01981096|3585033|P2|Overall Study|Parent illness|0
1096462|NCT01981096|3585034|P1|Overall Study|Parent illness|1
1096463|NCT01980992|3585055|P2|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1
1096464|NCT01980992|3585056|P1|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0
1096465|NCT01980992|3585055|P2|52 Weeks Open Label Active Wheat OIT|Non-compliance|0
1096466|NCT01980992|3585056|P1|52 Weeks Open Label Active Wheat OIT|Non-compliance|1
1096467|NCT01980992|3585055|P2|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0
1096468|NCT01980992|3585056|P1|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2
1096469|NCT01980992|3585055|P2|52 Weeks Blinded Study Treatment|Non-compliance|0
1096470|NCT01980992|3585056|P1|52 Weeks Blinded Study Treatment|Non-compliance|1
1096471|NCT01980992|3585055|P2|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
1096472|NCT01980992|3585056|P1|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
1096473|NCT01980992|3585055|P2|52 Weeks Blinded Study Treatment|Dosing Symptoms|3
1096474|NCT01980992|3585056|P1|52 Weeks Blinded Study Treatment|Dosing Symptoms|0
1096475|NCT01980940|3585081|P8|Overall Study|Protocol Violation|0
1096476|NCT01980940|3585082|P7|Overall Study|Protocol Violation|0
1096477|NCT01980940|3585083|P6|Overall Study|Protocol Violation|2
1096478|NCT01980940|3585084|P5|Overall Study|Protocol Violation|0
1096479|NCT01980940|3585085|P4|Overall Study|Protocol Violation|0
1096480|NCT01980940|3585086|P3|Overall Study|Protocol Violation|0
1096481|NCT01980940|3585087|P2|Overall Study|Protocol Violation|0
1096482|NCT01980940|3585088|P1|Overall Study|Protocol Violation|0
1096483|NCT01980888|3585142|P2|Overall Study|Non-Compliance with Study Drug|2
1096484|NCT01980888|3585143|P1|Overall Study|Non-Compliance with Study Drug|3
1096485|NCT01980888|3585142|P2|Overall Study|Investigator's Discretion|3
1096486|NCT01980888|3585143|P1|Overall Study|Investigator's Discretion|8
1096487|NCT01980888|3585142|P2|Overall Study|Withdrew Consent|6
1096488|NCT01980888|3585143|P1|Overall Study|Withdrew Consent|17
1096489|NCT01980888|3585142|P2|Overall Study|Study Terminated by Sponsor|122
1096490|NCT01980888|3585143|P1|Overall Study|Study Terminated by Sponsor|116
1096491|NCT01980875|3585162|P3|Overall Study|Lost to Follow-up|1
1096492|NCT01980875|3585163|P2|Overall Study|Lost to Follow-up|0
1096493|NCT01980875|3585164|P1|Overall Study|Lost to Follow-up|0
1096494|NCT01980875|3585162|P3|Overall Study|Study Terminated by Sponsor|22
1096495|NCT01980875|3585163|P2|Overall Study|Study Terminated by Sponsor|24
1096496|NCT01980875|3585164|P1|Overall Study|Study Terminated by Sponsor|7
1096497|NCT01980875|3585162|P3|Overall Study|Withdrew Consent|1
1096498|NCT01980875|3585163|P2|Overall Study|Withdrew Consent|1
1096499|NCT01980875|3585164|P1|Overall Study|Withdrew Consent|1
1096500|NCT01980628|3585196|P1|Overall Study|PD, Subj non-Compliant,Study Terminated|42
1096501|NCT01980628|3585196|P1|Overall Study|Withdrawal by Subject|4
1096502|NCT01980628|3585196|P1|Overall Study|Physician Decision|5
1096503|NCT01980628|3585196|P1|Overall Study|Adverse Event|12
1096504|NCT01980095|3585244|P2|Overall Study|Study drug discontinued|0
1096505|NCT01980095|3585245|P1|Overall Study|Study drug discontinued|1
1096506|NCT01980095|3585244|P2|Overall Study|Safety issue|1
1096507|NCT01980095|3585245|P1|Overall Study|Safety issue|0
1096508|NCT01980095|3585244|P2|Overall Study|Poor compliance|0
1096509|NCT01980095|3585245|P1|Overall Study|Poor compliance|5
1096510|NCT01980095|3585244|P2|Overall Study|Withdrawal by Subject|3
1096511|NCT01980095|3585245|P1|Overall Study|Withdrawal by Subject|2
1096512|NCT01980095|3585244|P2|Overall Study|Lost to Follow-up|7
1096513|NCT01980095|3585245|P1|Overall Study|Lost to Follow-up|6
1096514|NCT01980056|3585256|P3|Overall Study|Death|0
1096515|NCT01980056|3585257|P2|Overall Study|Death|1
1096516|NCT01980056|3585258|P1|Overall Study|Death|1
1096517|NCT01979952|3585272|P2|Overall Study|Other than specified above|0
1096518|NCT01979952|3585273|P1|Overall Study|Other than specified above|1
1096519|NCT01979952|3585272|P2|Overall Study|Withdrawal by Subject|1
1096520|NCT01979952|3585273|P1|Overall Study|Withdrawal by Subject|2
1096521|NCT01979952|3585272|P2|Overall Study|Protocol Violation|0
1096522|NCT01979952|3585273|P1|Overall Study|Protocol Violation|1
1096523|NCT01979952|3585272|P2|Overall Study|Adverse Event|5
1096524|NCT01979952|3585273|P1|Overall Study|Adverse Event|4
1096525|NCT01979185|3585340|P2|Period 2|Not specified|1
1096526|NCT01979185|3585341|P1|Period 2|Not specified|0
1096527|NCT01978938|3585383|P2|Overall Study|Previously scheduled procedure|1
1096528|NCT01978938|3585384|P1|Overall Study|Previously scheduled procedure|0
1096529|NCT01978938|3585383|P2|Overall Study|Did not meet inclusion criteria|1
1096530|NCT01978938|3585384|P1|Overall Study|Did not meet inclusion criteria|0
1096531|NCT01978938|3585383|P2|Overall Study|Participant noncompliance|1
1096532|NCT01978938|3585384|P1|Overall Study|Participant noncompliance|1
1096533|NCT01978938|3585383|P2|Overall Study|Adverse Event, non-fatal|1
1096534|NCT01978938|3585384|P1|Overall Study|Adverse Event, non-fatal|2
1096535|NCT01978938|3585383|P2|Overall Study|Withdrawal by Subject|4
1096536|NCT01978938|3585384|P1|Overall Study|Withdrawal by Subject|8
1096537|NCT01978938|3585383|P2|Overall Study|Lost to Follow-up|6
1096538|NCT01978938|3585384|P1|Overall Study|Lost to Follow-up|12
1096539|NCT01978262|3585519|P1|Overall Study|Lost to Follow-up|2
1096540|NCT01978262|3585519|P1|Overall Study|Withdrawal by Subject|9
1096541|NCT01978236|3585524|P1|Overall Study|Discontinued due to study close|2
1096542|NCT01978145|3585543|P2|Treatment Period 2|Par. reached defined stopping criteria|5
1096543|NCT01978145|3585544|P1|Treatment Period 2|Par. reached defined stopping criteria|8
1096544|NCT01978145|3585543|P2|Treatment Period 2|Withdrawal by Subject|4
1096545|NCT01978145|3585544|P1|Treatment Period 2|Withdrawal by Subject|7
1096546|NCT01978145|3585543|P2|Treatment Period 2|Lost to Follow-up|1
1096547|NCT01978145|3585544|P1|Treatment Period 2|Lost to Follow-up|1
1096548|NCT01978145|3585543|P2|Treatment Period 2|Protocol Violation|1
1096549|NCT01978145|3585544|P1|Treatment Period 2|Protocol Violation|0
1096550|NCT01978145|3585543|P2|Treatment Period 2|Adverse Event|3
1096551|NCT01978145|3585544|P1|Treatment Period 2|Adverse Event|3
1096552|NCT01978145|3585543|P2|Washout Period 1|Par. reached defined stopping criteria|1
1096553|NCT01978145|3585544|P1|Washout Period 1|Par. reached defined stopping criteria|0
1096554|NCT01978145|3585543|P2|Washout Period 1|Withdrawal by Subject|1
1096555|NCT01978145|3585544|P1|Washout Period 1|Withdrawal by Subject|1
1096556|NCT01978145|3585543|P2|Washout Period 1|Adverse Event|1
1096557|NCT01978145|3585544|P1|Washout Period 1|Adverse Event|0
1096558|NCT01978145|3585543|P2|Treatment Period 1|Par. reached defined stopping criteria|3
1096559|NCT01978145|3585544|P1|Treatment Period 1|Par. reached defined stopping criteria|2
1096560|NCT01978145|3585543|P2|Treatment Period 1|Withdrawal by Subject|4
1096561|NCT01978145|3585544|P1|Treatment Period 1|Withdrawal by Subject|5
1096562|NCT01978145|3585543|P2|Treatment Period 1|Physician Decision|0
1096563|NCT01978145|3585544|P1|Treatment Period 1|Physician Decision|1
1096564|NCT01978145|3585543|P2|Treatment Period 1|Adverse Event|9
1096565|NCT01978145|3585544|P1|Treatment Period 1|Adverse Event|1
1096566|NCT01978119|3585560|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
1096567|NCT01978119|3585561|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
1096568|NCT01978119|3585560|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
1096569|NCT01978119|3585561|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
1096570|NCT01978119|3585560|P2|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0
1096571|NCT01978119|3585561|P1|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1
1096572|NCT01978093|3585587|P2|Overall Study|N/A for vaccine administration|1
1096573|NCT01978093|3585588|P1|Overall Study|N/A for vaccine administration|0
1096574|NCT01978093|3585587|P2|Overall Study|Child was in care of grandmother|1
1096575|NCT01978093|3585588|P1|Overall Study|Child was in care of grandmother|0
1096576|NCT01978093|3585587|P2|Overall Study|Mother lost custody of child|1
1096577|NCT01978093|3585588|P1|Overall Study|Mother lost custody of child|0
1096578|NCT01978093|3585587|P2|Overall Study|Lost kaiser health plan unable to contac|0
1096579|NCT01978093|3585588|P1|Overall Study|Lost kaiser health plan unable to contac|1
1096580|NCT01978093|3585587|P2|Overall Study|Loss of kaiser coverage|10
1096581|NCT01978093|3585588|P1|Overall Study|Loss of kaiser coverage|4
1096582|NCT01978093|3585587|P2|Overall Study|Migrated/moved from study area|13
1096583|NCT01978093|3585588|P1|Overall Study|Migrated/moved from study area|11
1096584|NCT01978093|3585587|P2|Overall Study|Lost to Follow-up|15
1096585|NCT01978093|3585588|P1|Overall Study|Lost to Follow-up|11
1096586|NCT01978093|3585587|P2|Overall Study|Withdrawal by Subject|25
1096587|NCT01978093|3585588|P1|Overall Study|Withdrawal by Subject|29
1096588|NCT01978093|3585587|P2|Overall Study|Protocol Violation|2
1096589|NCT01978093|3585588|P1|Overall Study|Protocol Violation|8
1096590|NCT01978093|3585587|P2|Overall Study|Adverse Event|5
1096591|NCT01978093|3585588|P1|Overall Study|Adverse Event|0
1096592|NCT01978093|3585587|P2|Overall Study|Death|0
1096593|NCT01978093|3585588|P1|Overall Study|Death|1
1096594|NCT01977820|3585632|P2|Overall Study|Sponsor terminated the study|1
1096595|NCT01977820|3585633|P1|Overall Study|Sponsor terminated the study|1
1096596|NCT01977794|3585641|P2|Overall Study|Other|1
1096597|NCT01977794|3585642|P1|Overall Study|Other|0
1096598|NCT01977794|3585641|P2|Overall Study|Withdrew consent|1
1096599|NCT01977794|3585642|P1|Overall Study|Withdrew consent|2
1096600|NCT01977794|3585641|P2|Overall Study|Death|1
1096601|NCT01977794|3585642|P1|Overall Study|Death|1
1096602|NCT01977794|3585641|P2|Overall Study|Protocol Violation|0
1096603|NCT01977794|3585642|P1|Overall Study|Protocol Violation|1
1096604|NCT01977794|3585641|P2|Overall Study|Lost to Follow-up|1
1096605|NCT01977794|3585642|P1|Overall Study|Lost to Follow-up|2
1096606|NCT01977794|3585641|P2|Overall Study|Adverse Event|2
1096607|NCT01977794|3585642|P1|Overall Study|Adverse Event|2
1096608|NCT01977729|3585677|P1|Overall Study|Study terminated|1
1096609|NCT01977690|3585689|P2|Overall Study|Withdrawal by Subject|4
1096610|NCT01977690|3585690|P1|Overall Study|Withdrawal by Subject|0
1096611|NCT01977677|3585699|P3|Overall Study|Unrelated Adverse Event|1
1096612|NCT01977677|3585700|P2|Overall Study|Unrelated Adverse Event|0
1096613|NCT01977677|3585701|P1|Overall Study|Unrelated Adverse Event|0
1096614|NCT01977625|3585712|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|0
1096615|NCT01977625|3585713|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
1096616|NCT01977625|3585712|P2|First Intervention (4 Weeks)|Withdrawal by Subject|0
1096617|NCT01977625|3585713|P1|First Intervention (4 Weeks)|Withdrawal by Subject|3
1096618|NCT01977612|3585723|P2|Overall Study|Lost to Follow-up|1
1096619|NCT01977612|3585724|P1|Overall Study|Lost to Follow-up|1
1096620|NCT01977573|3585746|P4|Overall Study|Withdrawal by Subject|1
1096621|NCT01977573|3585747|P3|Overall Study|Withdrawal by Subject|1
1096622|NCT01977573|3585748|P2|Overall Study|Withdrawal by Subject|1
1096623|NCT01977573|3585749|P1|Overall Study|Withdrawal by Subject|6
1096624|NCT01977573|3585746|P4|Overall Study|Reached Defined Stopping Criteria|0
1096625|NCT01977573|3585747|P3|Overall Study|Reached Defined Stopping Criteria|1
1096626|NCT01977573|3585748|P2|Overall Study|Reached Defined Stopping Criteria|1
1096627|NCT01977573|3585749|P1|Overall Study|Reached Defined Stopping Criteria|2
1096628|NCT01977573|3585746|P4|Overall Study|Protocol Violation|0
1096629|NCT01977573|3585747|P3|Overall Study|Protocol Violation|0
1096630|NCT01977573|3585748|P2|Overall Study|Protocol Violation|1
1096631|NCT01977573|3585749|P1|Overall Study|Protocol Violation|3
1096632|NCT01977573|3585746|P4|Overall Study|Physician Decision|0
1096633|NCT01977573|3585747|P3|Overall Study|Physician Decision|0
1096634|NCT01977573|3585748|P2|Overall Study|Physician Decision|0
1096635|NCT01977573|3585749|P1|Overall Study|Physician Decision|1
1096636|NCT01977573|3585746|P4|Overall Study|Lost to Follow-up|1
1096637|NCT01977573|3585747|P3|Overall Study|Lost to Follow-up|0
1096638|NCT01977573|3585748|P2|Overall Study|Lost to Follow-up|0
1096639|NCT01977573|3585749|P1|Overall Study|Lost to Follow-up|1
1096640|NCT01977573|3585746|P4|Overall Study|Adverse Event|1
1096641|NCT01977573|3585747|P3|Overall Study|Adverse Event|2
1096642|NCT01977573|3585748|P2|Overall Study|Adverse Event|0
1096643|NCT01977573|3585749|P1|Overall Study|Adverse Event|7
1096644|NCT01977482|3585863|P6|Overall Study|Withdrawal by Subject|5
1096645|NCT01977482|3585864|P5|Overall Study|Withdrawal by Subject|1
1096646|NCT01977482|3585865|P4|Overall Study|Withdrawal by Subject|3
1096647|NCT01977482|3585866|P3|Overall Study|Withdrawal by Subject|1
1096648|NCT01977482|3585867|P2|Overall Study|Withdrawal by Subject|4
1096649|NCT01977482|3585868|P1|Overall Study|Withdrawal by Subject|2
1096650|NCT01977482|3585863|P6|Overall Study|Other-Protocol-defined Stopping Criteria|0
1096651|NCT01977482|3585864|P5|Overall Study|Other-Protocol-defined Stopping Criteria|0
1096652|NCT01977482|3585865|P4|Overall Study|Other-Protocol-defined Stopping Criteria|1
1096653|NCT01977482|3585866|P3|Overall Study|Other-Protocol-defined Stopping Criteria|2
1096654|NCT01977482|3585867|P2|Overall Study|Other-Protocol-defined Stopping Criteria|3
1096655|NCT01977482|3585868|P1|Overall Study|Other-Protocol-defined Stopping Criteria|0
1096656|NCT01977482|3585863|P6|Overall Study|Protocol Violation|0
1096657|NCT01977482|3585864|P5|Overall Study|Protocol Violation|0
1096658|NCT01977482|3585865|P4|Overall Study|Protocol Violation|0
1096659|NCT01977482|3585866|P3|Overall Study|Protocol Violation|1
1096660|NCT01977482|3585867|P2|Overall Study|Protocol Violation|0
1096661|NCT01977482|3585868|P1|Overall Study|Protocol Violation|0
1096662|NCT01977482|3585863|P6|Overall Study|Physician Decision|0
1096663|NCT01977482|3585864|P5|Overall Study|Physician Decision|0
1096664|NCT01977482|3585865|P4|Overall Study|Physician Decision|0
1096665|NCT01977482|3585866|P3|Overall Study|Physician Decision|0
1096666|NCT01977482|3585867|P2|Overall Study|Physician Decision|1
1096667|NCT01977482|3585868|P1|Overall Study|Physician Decision|0
1096668|NCT01977482|3585863|P6|Overall Study|Lost to Follow-up|0
1096669|NCT01977482|3585864|P5|Overall Study|Lost to Follow-up|0
1096670|NCT01977482|3585865|P4|Overall Study|Lost to Follow-up|0
1096671|NCT01977482|3585866|P3|Overall Study|Lost to Follow-up|0
1096672|NCT01977482|3585867|P2|Overall Study|Lost to Follow-up|0
1096673|NCT01977482|3585868|P1|Overall Study|Lost to Follow-up|1
1096674|NCT01977482|3585863|P6|Overall Study|Adverse Event|0
1096675|NCT01977482|3585864|P5|Overall Study|Adverse Event|2
1096676|NCT01977482|3585865|P4|Overall Study|Adverse Event|0
1096677|NCT01977482|3585866|P3|Overall Study|Adverse Event|1
1096678|NCT01977482|3585867|P2|Overall Study|Adverse Event|1
1096679|NCT01977482|3585868|P1|Overall Study|Adverse Event|0
1096680|NCT01977456|3585983|P1|Overall Study|Death|5
1096681|NCT01977352|3585992|P2|Overall Study|Lost to Follow-up|2
1096682|NCT01977352|3585993|P1|Overall Study|Lost to Follow-up|1
1096683|NCT01977222|3586011|P1|Overall Study|Withdrawal by Subject|1
1096684|NCT01977092|3586024|P2|Overall Study|In prison|11
1096685|NCT01977092|3586025|P1|Overall Study|In prison|3
1096686|NCT01977092|3586024|P2|Overall Study|Withdrawal by Subject|1
1096687|NCT01977092|3586025|P1|Overall Study|Withdrawal by Subject|2
1096688|NCT01977092|3586024|P2|Overall Study|Lost to Follow-up|14
1096689|NCT01977092|3586025|P1|Overall Study|Lost to Follow-up|23
1096690|NCT01977092|3586024|P2|Overall Study|Death|4
1096691|NCT01977092|3586025|P1|Overall Study|Death|3
1096692|NCT01976845|3586066|P3|Overall Study|Physician Decision|3
1096693|NCT01976845|3586067|P2|Overall Study|Physician Decision|8
1096694|NCT01976845|3586068|P1|Overall Study|Physician Decision|8
1096695|NCT01976806|3586093|P2|Overall Study|Withdrawal by Subject|1
1096696|NCT01976806|3586094|P1|Overall Study|Withdrawal by Subject|1
1096697|NCT01976806|3586093|P2|Overall Study|Adverse Event|1
1096698|NCT01976806|3586094|P1|Overall Study|Adverse Event|1
1096699|NCT01976806|3586093|P2|Overall Study|Lost to Follow-up|4
1096700|NCT01976806|3586094|P1|Overall Study|Lost to Follow-up|1
1096701|NCT01976663|3586122|P1|Overall Study|Lost to Follow-up|3
1096702|NCT01976663|3586122|P1|Overall Study|Adverse Event|2
1096703|NCT01976663|3586122|P1|Overall Study|Screen Failure|3
1096704|NCT01976663|3586122|P1|Overall Study|Withdrawal by Subject|4
1096705|NCT01976663|3586122|P1|Overall Study|Personal Reasons|6
1096706|NCT01976663|3586122|P1|Overall Study|Completed 18 mos but no repeat treatment|24
1096707|NCT01976624|3586141|P1|Overall Study|Participants age less than 19 years|12
1096708|NCT01976624|3586141|P1|Overall Study|Participants contraindicated|2
1096709|NCT01976507|3586169|P1|Overall Study|ablation not done, drug not given|1
1096710|NCT01976507|3586169|P1|Overall Study|Adverse Event|6
1096711|NCT01976338|3586202|P2|Overall Study|Adverse Event|1
1096712|NCT01976338|3586203|P1|Overall Study|Adverse Event|5
1096713|NCT01976338|3586202|P2|Overall Study|Withdrawal by Subject|2
1096714|NCT01976338|3586203|P1|Overall Study|Withdrawal by Subject|5
1096715|NCT01976338|3586202|P2|Overall Study|Lost to Follow-up|0
1096716|NCT01976338|3586203|P1|Overall Study|Lost to Follow-up|3
1096717|NCT01976338|3586202|P2|Overall Study|Physician Decision|1
1096718|NCT01976338|3586203|P1|Overall Study|Physician Decision|0
1096719|NCT01976312|3586230|P2|Overall Study|Protocol Violation|0
1096720|NCT01976312|3586231|P1|Overall Study|Protocol Violation|2
1096721|NCT01976312|3586230|P2|Overall Study|Adverse Event|6
1096722|NCT01976312|3586231|P1|Overall Study|Adverse Event|6
1096723|NCT01976312|3586230|P2|Overall Study|Withdrawal by Subject|2
1096724|NCT01976312|3586231|P1|Overall Study|Withdrawal by Subject|7
1096725|NCT01976312|3586230|P2|Overall Study|Lost to Follow-up|0
1096726|NCT01976312|3586231|P1|Overall Study|Lost to Follow-up|2
1096727|NCT01976312|3586230|P2|Overall Study|Pregnancy|1
1096728|NCT01976312|3586231|P1|Overall Study|Pregnancy|0
1096729|NCT01976299|3586252|P2|Overall Study|See clarification above in comments|2
1096730|NCT01976299|3586253|P1|Overall Study|See clarification above in comments|9
1096731|NCT01976299|3586252|P2|Overall Study|Lost to Follow-up|1
1096732|NCT01976299|3586253|P1|Overall Study|Lost to Follow-up|7
1096733|NCT01976299|3586252|P2|Overall Study|Death|2
1096734|NCT01976299|3586253|P1|Overall Study|Death|4
1096735|NCT01976299|3586252|P2|Overall Study|Withdrawal by Subject|1
1096736|NCT01976299|3586253|P1|Overall Study|Withdrawal by Subject|3
1096737|NCT01976104|3586280|P4|Overall Study|Other|0
1096738|NCT01976104|3586281|P3|Overall Study|Other|0
1096739|NCT01976104|3586282|P2|Overall Study|Other|1
1096740|NCT01976104|3586283|P1|Overall Study|Other|0
1096741|NCT01976104|3586280|P4|Overall Study|Withdrawal by Subject|1
1096742|NCT01976104|3586281|P3|Overall Study|Withdrawal by Subject|0
1096743|NCT01976104|3586282|P2|Overall Study|Withdrawal by Subject|0
1096744|NCT01976104|3586283|P1|Overall Study|Withdrawal by Subject|3
1096745|NCT01976104|3586280|P4|Overall Study|Subject Choice|1
1096746|NCT01976104|3586281|P3|Overall Study|Subject Choice|0
1096747|NCT01976104|3586282|P2|Overall Study|Subject Choice|1
1096748|NCT01976104|3586283|P1|Overall Study|Subject Choice|0
1096749|NCT01976104|3586280|P4|Overall Study|Lost to Follow-up|1
1096750|NCT01976104|3586281|P3|Overall Study|Lost to Follow-up|1
1096751|NCT01976104|3586282|P2|Overall Study|Lost to Follow-up|0
1096752|NCT01976104|3586283|P1|Overall Study|Lost to Follow-up|3
1096753|NCT01976104|3586280|P4|Overall Study|Adverse Event|0
1096754|NCT01976104|3586281|P3|Overall Study|Adverse Event|1
1096755|NCT01976104|3586282|P2|Overall Study|Adverse Event|0
1096756|NCT01976104|3586283|P1|Overall Study|Adverse Event|0
1096757|NCT01975948|3586317|P4|Overall Study|Withdrawal by Subject|6
1096758|NCT01975948|3586318|P3|Overall Study|Withdrawal by Subject|7
1096759|NCT01975948|3586319|P2|Overall Study|Withdrawal by Subject|21
1096760|NCT01975948|3586320|P1|Overall Study|Withdrawal by Subject|17
1096761|NCT01975675|3586391|P4|Overall Study|Death|0
1096762|NCT01975675|3586392|P3|Overall Study|Death|0
1096763|NCT01975675|3586393|P2|Overall Study|Death|1
1096764|NCT01975675|3586394|P1|Overall Study|Death|0
1096765|NCT01975389|3586427|P2|Overall Study|Randomized, not treated|5
1096766|NCT01975389|3586428|P1|Overall Study|Randomized, not treated|4
1096767|NCT01975389|3586427|P2|Overall Study|Other|9
1096768|NCT01975389|3586428|P1|Overall Study|Other|6
1096769|NCT01975389|3586427|P2|Overall Study|Withdrawal by Subject|76
1096770|NCT01975389|3586428|P1|Overall Study|Withdrawal by Subject|90
1096771|NCT01975389|3586427|P2|Overall Study|Lost to Follow-up|86
1096772|NCT01975389|3586428|P1|Overall Study|Lost to Follow-up|81
1096773|NCT01975389|3586427|P2|Overall Study|Death|54
1096774|NCT01975389|3586428|P1|Overall Study|Death|61
1096775|NCT01975389|3586427|P2|Overall Study|Adverse Event|6
1096776|NCT01975389|3586428|P1|Overall Study|Adverse Event|10
1096777|NCT01975376|3586488|P2|Overall Study|Randomized, Not Treated|8
1096778|NCT01975376|3586489|P1|Overall Study|Randomized, Not Treated|16
1096779|NCT01975376|3586488|P2|Overall Study|Other|4
1096780|NCT01975376|3586489|P1|Overall Study|Other|2
1096781|NCT01975376|3586488|P2|Overall Study|Withdrew consent|62
1096782|NCT01975376|3586489|P1|Overall Study|Withdrew consent|68
1096783|NCT01975376|3586488|P2|Overall Study|Lost to Follow-up|66
1096784|NCT01975376|3586489|P1|Overall Study|Lost to Follow-up|70
1096785|NCT01975376|3586488|P2|Overall Study|Death|72
1096786|NCT01975376|3586489|P1|Overall Study|Death|65
1096787|NCT01975376|3586488|P2|Overall Study|Adverse Event|5
1096788|NCT01975376|3586489|P1|Overall Study|Adverse Event|5
1096789|NCT01975285|3586549|P2|Overall Study|Failed Block and follow up|2
1096790|NCT01975285|3586550|P1|Overall Study|Failed Block and follow up|2
1096791|NCT01975246|3586566|P2|Overall Study|Other than stated|1
1096792|NCT01975246|3586567|P1|Overall Study|Other than stated|0
1096793|NCT01975246|3586566|P2|Overall Study|Protocol Violation|0
1096794|NCT01975246|3586567|P1|Overall Study|Protocol Violation|1
1096795|NCT01975246|3586566|P2|Overall Study|Lack of Efficacy|0
1096796|NCT01975246|3586567|P1|Overall Study|Lack of Efficacy|1
1096797|NCT01975246|3586566|P2|Overall Study|Adverse Event|1
1096798|NCT01975246|3586567|P1|Overall Study|Adverse Event|2
1096799|NCT01975220|3586580|P6|Test Period 1|Not treated|0
1096800|NCT01975220|3586581|P5|Test Period 1|Not treated|0
1096801|NCT01975220|3586582|P4|Test Period 1|Not treated|0
1096802|NCT01975220|3586583|P3|Test Period 1|Not treated|0
1096803|NCT01975220|3586584|P2|Test Period 1|Not treated|1
1096804|NCT01975220|3586585|P1|Test Period 1|Not treated|0
1096805|NCT01974895|3586641|P2|Overall Study|Other (Reason unknown)|8
1096806|NCT01974895|3586642|P1|Overall Study|Other (Reason unknown)|9
1096807|NCT01974895|3586641|P2|Overall Study|Other (Missed Visit)|0
1096808|NCT01974895|3586642|P1|Overall Study|Other (Missed Visit)|1
1096809|NCT01974895|3586641|P2|Overall Study|Withdrawal by Subject|1
1096810|NCT01974895|3586642|P1|Overall Study|Withdrawal by Subject|0
1096811|NCT01974895|3586641|P2|Overall Study|Lost to Follow-up|6
1096812|NCT01974895|3586642|P1|Overall Study|Lost to Follow-up|4
1096813|NCT01974895|3586641|P2|Overall Study|Protocol Violation|0
1096814|NCT01974895|3586642|P1|Overall Study|Protocol Violation|1
1096815|NCT01974817|3586672|P1|Overall Study|Protocol Violation|2
1096816|NCT01974817|3586672|P1|Overall Study|Lost to Follow-up|2
1096817|NCT01974817|3586672|P1|Overall Study|Death|4
1096818|NCT01974752|3586678|P2|Overall Study|Other Eligibility Criteria|1
1096819|NCT01974752|3586679|P1|Overall Study|Other Eligibility Criteria|0
1096820|NCT01974752|3586678|P2|Overall Study|Withdrawal by Subject|3
1096821|NCT01974752|3586679|P1|Overall Study|Withdrawal by Subject|2
1096822|NCT01974752|3586678|P2|Overall Study|Lost to Follow-up|0
1096823|NCT01974752|3586679|P1|Overall Study|Lost to Follow-up|2
1096824|NCT01974752|3586678|P2|Overall Study|Death|11
1096825|NCT01974752|3586679|P1|Overall Study|Death|33
1096826|NCT01974323|3587102|P2|Overall Study|Adverse Event|2
1096827|NCT01974323|3587103|P1|Overall Study|Adverse Event|2
1096828|NCT01974323|3587102|P2|Overall Study|Lack of Efficacy|1
1096829|NCT01974323|3587103|P1|Overall Study|Lack of Efficacy|1
1096830|NCT01974323|3587102|P2|Overall Study|Pregnancy|1
1096831|NCT01974323|3587103|P1|Overall Study|Pregnancy|2
1096832|NCT01974323|3587102|P2|Overall Study|Lost to Follow-up|40
1096833|NCT01974323|3587103|P1|Overall Study|Lost to Follow-up|45
1096834|NCT01974323|3587102|P2|Overall Study|Personal Reasons|19
1096835|NCT01974323|3587103|P1|Overall Study|Personal Reasons|15
1096836|NCT01974323|3587102|P2|Overall Study|Protocol Violation|2
1096837|NCT01974323|3587103|P1|Overall Study|Protocol Violation|2
1096838|NCT01974323|3587102|P2|Overall Study|Other Reasons|28
1096839|NCT01974323|3587103|P1|Overall Study|Other Reasons|25
1096840|NCT01974141|3587136|P2|Overall Study|Adverse Event|5
1096841|NCT01974141|3587137|P1|Overall Study|Adverse Event|4
1096842|NCT01974141|3587136|P2|Overall Study|Lack of Efficacy|1
1096843|NCT01974141|3587137|P1|Overall Study|Lack of Efficacy|0
1096844|NCT01974141|3587136|P2|Overall Study|Pregnancy|3
1096845|NCT01974141|3587137|P1|Overall Study|Pregnancy|3
1096846|NCT01974141|3587136|P2|Overall Study|Lost to Follow-up|29
1096847|NCT01974141|3587137|P1|Overall Study|Lost to Follow-up|38
1096848|NCT01974141|3587136|P2|Overall Study|Personal Reasons|20
1096849|NCT01974141|3587137|P1|Overall Study|Personal Reasons|21
1096850|NCT01974141|3587136|P2|Overall Study|Protocol Violation|6
1096851|NCT01974141|3587137|P1|Overall Study|Protocol Violation|2
1096852|NCT01974141|3587136|P2|Overall Study|Other Reasons|18
1096853|NCT01974141|3587137|P1|Overall Study|Other Reasons|28
1096854|NCT01973595|3587214|P4|Washout|Withdrawal by Subject|0
1096855|NCT01973595|3587215|P3|Washout|Withdrawal by Subject|1
1096856|NCT01973595|3587216|P2|Washout|Withdrawal by Subject|0
1096857|NCT01973595|3587217|P1|Washout|Withdrawal by Subject|1
1096858|NCT01973491|3587231|P1|Treatment Period (16 Weeks)|Adverse Event|1
1096859|NCT01973491|3587231|P1|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1
1096860|NCT01973491|3587231|P1|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17
1096861|NCT01973439|3587247|P1|Overall Study|PK curve incomplete|2
1096862|NCT01973439|3587247|P1|Overall Study|Vomiting after commencing once daily|1
1096863|NCT01973439|3587247|P1|Overall Study|Lost samples from one PK Day|2
1096864|NCT01973387|3587269|P2|Overall Study|Randomized, not treated|2
1096865|NCT01973387|3587270|P1|Overall Study|Randomized, not treated|2
1096866|NCT01973387|3587269|P2|Overall Study|Death|3
1096867|NCT01973387|3587270|P1|Overall Study|Death|4
1096868|NCT01973387|3587269|P2|Overall Study|Progressive disease or relapse|5
1096869|NCT01973387|3587270|P1|Overall Study|Progressive disease or relapse|16
1096870|NCT01973387|3587269|P2|Overall Study|Study terminated by sponsor|0
1096871|NCT01973387|3587270|P1|Overall Study|Study terminated by sponsor|63
1096872|NCT01973387|3587269|P2|Overall Study|Withdrawal by Subject|4
1096873|NCT01973387|3587270|P1|Overall Study|Withdrawal by Subject|7
1096874|NCT01973387|3587269|P2|Overall Study|Adverse Event|4
1096875|NCT01973387|3587270|P1|Overall Study|Adverse Event|14
1096876|NCT01973231|3587311|P2|Overall Study|Withdrawal by Subject|9
1096877|NCT01973231|3587312|P1|Overall Study|Withdrawal by Subject|7
1096878|NCT01973231|3587311|P2|Overall Study|unclassified|1
1096879|NCT01973231|3587312|P1|Overall Study|unclassified|2
1096880|NCT01973231|3587311|P2|Overall Study|Lost to Follow-up|1
1096881|NCT01973231|3587312|P1|Overall Study|Lost to Follow-up|1
1096882|NCT01973231|3587311|P2|Overall Study|Protocol Violation|1
1096883|NCT01973231|3587312|P1|Overall Study|Protocol Violation|1
1096884|NCT01973218|3587332|P2|Overall Study|Withdrawal by Subject|0
1096885|NCT01973218|3587333|P1|Overall Study|Withdrawal by Subject|1
1096886|NCT01973218|3587332|P2|Overall Study|Adverse Event|0
1096887|NCT01973218|3587333|P1|Overall Study|Adverse Event|1
1096888|NCT01972841|3587426|P6|Overall Study|Did not have end of treatment page|0
1096889|NCT01972841|3587427|P5|Overall Study|Did not have end of treatment page|1
1096890|NCT01972841|3587428|P4|Overall Study|Did not have end of treatment page|0
1096891|NCT01972841|3587429|P3|Overall Study|Did not have end of treatment page|0
1096892|NCT01972841|3587430|P2|Overall Study|Did not have end of treatment page|0
1096893|NCT01972841|3587431|P1|Overall Study|Did not have end of treatment page|0
1096894|NCT01972841|3587426|P6|Overall Study|Miscellaneous|4
1096895|NCT01972841|3587427|P5|Overall Study|Miscellaneous|0
1096896|NCT01972841|3587428|P4|Overall Study|Miscellaneous|1
1096897|NCT01972841|3587429|P3|Overall Study|Miscellaneous|4
1096898|NCT01972841|3587430|P2|Overall Study|Miscellaneous|0
1096899|NCT01972841|3587431|P1|Overall Study|Miscellaneous|0
1096900|NCT01972841|3587426|P6|Overall Study|Withdrawal by participants|34
1096901|NCT01972841|3587427|P5|Overall Study|Withdrawal by participants|33
1096902|NCT01972841|3587428|P4|Overall Study|Withdrawal by participants|16
1096903|NCT01972841|3587429|P3|Overall Study|Withdrawal by participants|23
1096904|NCT01972841|3587430|P2|Overall Study|Withdrawal by participants|27
1096905|NCT01972841|3587431|P1|Overall Study|Withdrawal by participants|21
1096906|NCT01972841|3587426|P6|Overall Study|Protocol Violation|4
1096907|NCT01972841|3587427|P5|Overall Study|Protocol Violation|9
1096908|NCT01972841|3587428|P4|Overall Study|Protocol Violation|5
1096909|NCT01972841|3587429|P3|Overall Study|Protocol Violation|3
1096910|NCT01972841|3587430|P2|Overall Study|Protocol Violation|2
1096911|NCT01972841|3587431|P1|Overall Study|Protocol Violation|2
1096912|NCT01972841|3587426|P6|Overall Study|Lost to Follow-up|3
1096913|NCT01972841|3587427|P5|Overall Study|Lost to Follow-up|9
1096914|NCT01972841|3587428|P4|Overall Study|Lost to Follow-up|2
1096915|NCT01972841|3587429|P3|Overall Study|Lost to Follow-up|4
1096916|NCT01972841|3587430|P2|Overall Study|Lost to Follow-up|2
1096917|NCT01972841|3587431|P1|Overall Study|Lost to Follow-up|4
1096918|NCT01972841|3587426|P6|Overall Study|Lack of Efficacy|1
1096919|NCT01972841|3587427|P5|Overall Study|Lack of Efficacy|4
1096920|NCT01972841|3587428|P4|Overall Study|Lack of Efficacy|2
1096921|NCT01972841|3587429|P3|Overall Study|Lack of Efficacy|0
1096922|NCT01972841|3587430|P2|Overall Study|Lack of Efficacy|0
1096923|NCT01972841|3587431|P1|Overall Study|Lack of Efficacy|1
1096924|NCT01972841|3587426|P6|Overall Study|Adverse Event|26
1096925|NCT01972841|3587427|P5|Overall Study|Adverse Event|21
1096926|NCT01972841|3587428|P4|Overall Study|Adverse Event|9
1096927|NCT01972841|3587429|P3|Overall Study|Adverse Event|12
1096928|NCT01972841|3587430|P2|Overall Study|Adverse Event|8
1096929|NCT01972841|3587431|P1|Overall Study|Adverse Event|13
1096930|NCT01972841|3587426|P6|Overall Study|Randomized but Never Received Treatment|13
1096931|NCT01972841|3587427|P5|Overall Study|Randomized but Never Received Treatment|6
1096932|NCT01972841|3587428|P4|Overall Study|Randomized but Never Received Treatment|2
1096933|NCT01972841|3587429|P3|Overall Study|Randomized but Never Received Treatment|4
1096934|NCT01972841|3587430|P2|Overall Study|Randomized but Never Received Treatment|5
1096935|NCT01972841|3587431|P1|Overall Study|Randomized but Never Received Treatment|2
1096936|NCT01972776|3587865|P6|Part 2|Administrative problems|7
1096937|NCT01972776|3587866|P5|Part 2|Administrative problems|10
1096938|NCT01972776|3587867|P4|Part 2|Administrative problems|0
1096939|NCT01972776|3587868|P3|Part 2|Administrative problems|0
1096940|NCT01972776|3587869|P2|Part 2|Administrative problems|0
1096941|NCT01972776|3587870|P1|Part 2|Administrative problems|0
1096942|NCT01972776|3587865|P6|Part 2|Adverse Event|0
1096943|NCT01972776|3587866|P5|Part 2|Adverse Event|3
1096944|NCT01972776|3587867|P4|Part 2|Adverse Event|0
1096945|NCT01972776|3587868|P3|Part 2|Adverse Event|0
1096946|NCT01972776|3587869|P2|Part 2|Adverse Event|0
1096947|NCT01972776|3587870|P1|Part 2|Adverse Event|0
1096948|NCT01972776|3587865|P6|Part 1|Adverse Event|0
1096949|NCT01972776|3587866|P5|Part 1|Adverse Event|0
1096950|NCT01972776|3587867|P4|Part 1|Adverse Event|1
1096951|NCT01972776|3587868|P3|Part 1|Adverse Event|1
1096952|NCT01972776|3587869|P2|Part 1|Adverse Event|0
1096953|NCT01972776|3587870|P1|Part 1|Adverse Event|0
1096954|NCT01972776|3587865|P6|Part 1|Withdrawal by Subject|0
1096955|NCT01972776|3587866|P5|Part 1|Withdrawal by Subject|0
1096956|NCT01972776|3587867|P4|Part 1|Withdrawal by Subject|0
1096957|NCT01972776|3587868|P3|Part 1|Withdrawal by Subject|1
1096958|NCT01972776|3587869|P2|Part 1|Withdrawal by Subject|0
1096959|NCT01972776|3587870|P1|Part 1|Withdrawal by Subject|0
1096960|NCT01972724|3587941|P3|Open-Label|Significant Protocol Deviation|2
1096961|NCT01972724|3587942|P2|Open-Label|Significant Protocol Deviation|0
1096962|NCT01972724|3587943|P1|Open-Label|Significant Protocol Deviation|0
1096963|NCT01972724|3587941|P3|Open-Label|Withdrew Consent|3
1096964|NCT01972724|3587942|P2|Open-Label|Withdrew Consent|0
1096965|NCT01972724|3587943|P1|Open-Label|Withdrew Consent|0
1096966|NCT01972724|3587941|P3|Double-Blind|Significant Protocol Deviation|0
1096967|NCT01972724|3587942|P2|Double-Blind|Significant Protocol Deviation|8
1096968|NCT01972724|3587943|P1|Double-Blind|Significant Protocol Deviation|5
1096969|NCT01972724|3587941|P3|Double-Blind|Withdrawal of Consent|0
1096970|NCT01972724|3587942|P2|Double-Blind|Withdrawal of Consent|1
1096971|NCT01972724|3587943|P1|Double-Blind|Withdrawal of Consent|2
1096972|NCT01972724|3587941|P3|Double-Blind|Adverse Event|0
1096973|NCT01972724|3587942|P2|Double-Blind|Adverse Event|0
1096974|NCT01972724|3587943|P1|Double-Blind|Adverse Event|1
1096975|NCT01972724|3587941|P3|Double-Blind|Rescue Criteria Met|0
1096976|NCT01972724|3587942|P2|Double-Blind|Rescue Criteria Met|0
1096977|NCT01972724|3587943|P1|Double-Blind|Rescue Criteria Met|1
1096978|NCT01972659|3587956|P2|Overall Study|problems realted to acceleromyograph|1
1096979|NCT01972659|3587957|P1|Overall Study|problems realted to acceleromyograph|2
1096980|NCT01972659|3587956|P2|Overall Study|Protocol Violation|2
1096981|NCT01972659|3587957|P1|Overall Study|Protocol Violation|2
1096982|NCT01972568|3587966|P3|Overall Study|Adverse Event|5
1096983|NCT01972568|3587967|P2|Overall Study|Adverse Event|6
1096984|NCT01972568|3587968|P1|Overall Study|Adverse Event|5
1096985|NCT01972568|3587966|P3|Overall Study|Lost to Follow-up|0
1096986|NCT01972568|3587967|P2|Overall Study|Lost to Follow-up|0
1096987|NCT01972568|3587968|P1|Overall Study|Lost to Follow-up|1
1096988|NCT01972568|3587966|P3|Overall Study|Withdrawal by Subject|7
1096989|NCT01972568|3587967|P2|Overall Study|Withdrawal by Subject|3
1096990|NCT01972568|3587968|P1|Overall Study|Withdrawal by Subject|6
1096991|NCT01972568|3587966|P3|Overall Study|Protocol Violation|2
1096992|NCT01972568|3587967|P2|Overall Study|Protocol Violation|2
1096993|NCT01972568|3587968|P1|Overall Study|Protocol Violation|1
1096994|NCT01972568|3587966|P3|Overall Study|Lack of Efficacy|2
1096995|NCT01972568|3587967|P2|Overall Study|Lack of Efficacy|1
1096996|NCT01972568|3587968|P1|Overall Study|Lack of Efficacy|0
1096997|NCT01972568|3587966|P3|Overall Study|Other events|0
1096998|NCT01972568|3587967|P2|Overall Study|Other events|0
1096999|NCT01972568|3587968|P1|Overall Study|Other events|3
1097000|NCT01972529|3588007|P4|Overall Study|Not treated|1
1097001|NCT01972529|3588008|P3|Overall Study|Not treated|2
1097002|NCT01972529|3588009|P2|Overall Study|Not treated|1
1097003|NCT01972529|3588010|P1|Overall Study|Not treated|0
1097004|NCT01972529|3588007|P4|Overall Study|Not Specified|2
1097005|NCT01972529|3588008|P3|Overall Study|Not Specified|0
1097006|NCT01972529|3588009|P2|Overall Study|Not Specified|0
1097007|NCT01972529|3588010|P1|Overall Study|Not Specified|0
1097008|NCT01972529|3588007|P4|Overall Study|Withdrawl of Consent|1
1097009|NCT01972529|3588008|P3|Overall Study|Withdrawl of Consent|0
1097010|NCT01972529|3588009|P2|Overall Study|Withdrawl of Consent|2
1097011|NCT01972529|3588010|P1|Overall Study|Withdrawl of Consent|1
1097012|NCT01972529|3588007|P4|Overall Study|Participant Choice|0
1097013|NCT01972529|3588008|P3|Overall Study|Participant Choice|0
1097014|NCT01972529|3588009|P2|Overall Study|Participant Choice|1
1097015|NCT01972529|3588010|P1|Overall Study|Participant Choice|0
1097016|NCT01972529|3588007|P4|Overall Study|Lost to Follow-up|0
1097017|NCT01972529|3588008|P3|Overall Study|Lost to Follow-up|0
1097018|NCT01972529|3588009|P2|Overall Study|Lost to Follow-up|0
1097019|NCT01972529|3588010|P1|Overall Study|Lost to Follow-up|1
1097020|NCT01972529|3588007|P4|Overall Study|Adverse Event|0
1097021|NCT01972529|3588008|P3|Overall Study|Adverse Event|0
1097022|NCT01972529|3588009|P2|Overall Study|Adverse Event|1
1097023|NCT01972529|3588010|P1|Overall Study|Adverse Event|0
1097024|NCT01972464|3588055|P2|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
1097025|NCT01972464|3588056|P1|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
1097026|NCT01972464|3588055|P2|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1
1097027|NCT01972464|3588056|P1|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0
1097028|NCT01972464|3588055|P2|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0
1097029|NCT01972464|3588056|P1|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1
1097030|NCT01972464|3588055|P2|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3
1097031|NCT01972464|3588056|P1|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2
1097032|NCT01972438|3588072|P2|Post Month 12 Study Period|Early Study Closure|4
1097033|NCT01972438|3588073|P1|Post Month 12 Study Period|Early Study Closure|3
1097034|NCT01972438|3588072|P2|Months 6-12 Study Period|Early Study Closure|2
1097035|NCT01972438|3588073|P1|Months 6-12 Study Period|Early Study Closure|2
1097036|NCT01972438|3588072|P2|Months 6-12 Study Period|Death|0
1097037|NCT01972438|3588073|P1|Months 6-12 Study Period|Death|1
1097038|NCT01972438|3588072|P2|Months 3-6 Crossover Period|Early Study Closure|1
1097039|NCT01972438|3588073|P1|Months 3-6 Crossover Period|Early Study Closure|0
1097040|NCT01972438|3588072|P2|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2
1097041|NCT01972438|3588073|P1|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1
1097042|NCT01972438|3588072|P2|Baseline-Month 3 Crossover Period|Unable to donate blood|1
1097043|NCT01972438|3588073|P1|Baseline-Month 3 Crossover Period|Unable to donate blood|0
1097044|NCT01972438|3588072|P2|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0
1097045|NCT01972438|3588073|P1|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1
1097046|NCT01972438|3588072|P2|Baseline-Month 3 Crossover Period|Death|0
1097047|NCT01972438|3588073|P1|Baseline-Month 3 Crossover Period|Death|1
1097048|NCT01972308|3588127|P2|Overall Study|Death|1
1097049|NCT01972308|3588128|P1|Overall Study|Death|4
1097050|NCT01972308|3588127|P2|Overall Study|Lost to Follow-up|6
1097051|NCT01972308|3588128|P1|Overall Study|Lost to Follow-up|4
1097052|NCT01972308|3588127|P2|Overall Study|Withdrawal by Subject|1
1097053|NCT01972308|3588128|P1|Overall Study|Withdrawal by Subject|0
1097054|NCT01972217|3588148|P4|Part B Double-blind, Randomised Period|Withdrawal by Subject|1
1097055|NCT01972217|3588149|P3|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
1097056|NCT01972217|3588150|P2|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
1097057|NCT01972217|3588151|P1|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
1097058|NCT01972217|3588148|P4|Part B Double-blind, Randomised Period|Lost to Follow-up|1
1097059|NCT01972217|3588149|P3|Part B Double-blind, Randomised Period|Lost to Follow-up|2
1097060|NCT01972217|3588150|P2|Part B Double-blind, Randomised Period|Lost to Follow-up|0
1097061|NCT01972217|3588151|P1|Part B Double-blind, Randomised Period|Lost to Follow-up|0
1097062|NCT01972217|3588148|P4|Part B Double-blind, Randomised Period|Screen failure|1
1097063|NCT01972217|3588149|P3|Part B Double-blind, Randomised Period|Screen failure|0
1097064|NCT01972217|3588150|P2|Part B Double-blind, Randomised Period|Screen failure|0
1097065|NCT01972217|3588151|P1|Part B Double-blind, Randomised Period|Screen failure|0
1097066|NCT01972217|3588148|P4|Part B Double-blind, Randomised Period|Reason not recorded|0
1097067|NCT01972217|3588149|P3|Part B Double-blind, Randomised Period|Reason not recorded|1
1097068|NCT01972217|3588150|P2|Part B Double-blind, Randomised Period|Reason not recorded|0
1097069|NCT01972217|3588151|P1|Part B Double-blind, Randomised Period|Reason not recorded|0
1097070|NCT01972217|3588148|P4|Part B Double-blind, Randomised Period|Death|44
1097071|NCT01972217|3588149|P3|Part B Double-blind, Randomised Period|Death|43
1097072|NCT01972217|3588150|P2|Part B Double-blind, Randomised Period|Death|0
1097073|NCT01972217|3588151|P1|Part B Double-blind, Randomised Period|Death|0
1097074|NCT01972217|3588148|P4|Part A: Open-label Safety Run-in Period|Death|0
1097075|NCT01972217|3588149|P3|Part A: Open-label Safety Run-in Period|Death|0
1097076|NCT01972217|3588150|P2|Part A: Open-label Safety Run-in Period|Death|1
1097077|NCT01972217|3588151|P1|Part A: Open-label Safety Run-in Period|Death|0
1097078|NCT01972217|3588148|P4|Part A: Open-label Safety Run-in Period|Adverse Event|0
1097079|NCT01972217|3588149|P3|Part A: Open-label Safety Run-in Period|Adverse Event|0
1097080|NCT01972217|3588150|P2|Part A: Open-label Safety Run-in Period|Adverse Event|1
1097081|NCT01972217|3588151|P1|Part A: Open-label Safety Run-in Period|Adverse Event|0
1097082|NCT01972217|3588148|P4|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0
1097083|NCT01972217|3588149|P3|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0
1097084|NCT01972217|3588150|P2|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9
1097085|NCT01972217|3588151|P1|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1
1097086|NCT01972217|3588148|P4|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
1097087|NCT01972217|3588149|P3|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
1097088|NCT01972217|3588150|P2|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1
1097089|NCT01972217|3588151|P1|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
1097090|NCT01972152|3588197|P6|Second Treatment Visit|Protocol Violation|0
1097091|NCT01972152|3588198|P5|Second Treatment Visit|Protocol Violation|0
1097092|NCT01972152|3588199|P4|Second Treatment Visit|Protocol Violation|0
1097093|NCT01972152|3588200|P3|Second Treatment Visit|Protocol Violation|0
1097094|NCT01972152|3588201|P2|Second Treatment Visit|Protocol Violation|1
1097095|NCT01972152|3588202|P1|Second Treatment Visit|Protocol Violation|0
1097096|NCT01972152|3588197|P6|First Treatment Visit|Lost to Follow-up|0
1097097|NCT01972152|3588198|P5|First Treatment Visit|Lost to Follow-up|0
1097098|NCT01972152|3588199|P4|First Treatment Visit|Lost to Follow-up|0
1097099|NCT01972152|3588200|P3|First Treatment Visit|Lost to Follow-up|0
1097100|NCT01972152|3588201|P2|First Treatment Visit|Lost to Follow-up|1
1097101|NCT01972152|3588202|P1|First Treatment Visit|Lost to Follow-up|0
1097102|NCT01971723|3588239|P2|Overall Study|Protocol Violation|2
1097103|NCT01971723|3588240|P1|Overall Study|Protocol Violation|1
1097104|NCT01971723|3588239|P2|Overall Study|Withdrawal by Subject|1
1097105|NCT01971723|3588240|P1|Overall Study|Withdrawal by Subject|1
1097106|NCT01971645|3588273|P3|Overall Study|Protocol Violation|1
1097107|NCT01971645|3588274|P2|Overall Study|Protocol Violation|0
1097108|NCT01971645|3588275|P1|Overall Study|Protocol Violation|0
1097109|NCT01971645|3588273|P3|Overall Study|Lost to Follow-up|1
1097110|NCT01971645|3588274|P2|Overall Study|Lost to Follow-up|0
1097111|NCT01971645|3588275|P1|Overall Study|Lost to Follow-up|1
1097112|NCT01971645|3588273|P3|Overall Study|Adverse Event|0
1097113|NCT01971645|3588274|P2|Overall Study|Adverse Event|0
1097114|NCT01971645|3588275|P1|Overall Study|Adverse Event|1
1097115|NCT01971567|3588309|P2|Overall Study|Lost to Follow-up|0
1097116|NCT01971567|3588310|P1|Overall Study|Lost to Follow-up|1
1097117|NCT01971567|3588309|P2|Overall Study|Withdrawal by Subject|2
1097118|NCT01971567|3588310|P1|Overall Study|Withdrawal by Subject|3
1097119|NCT01971554|3588336|P4|Overall Study|Lost to Follow-up|0
1097120|NCT01971554|3588337|P3|Overall Study|Lost to Follow-up|0
1097121|NCT01971554|3588338|P2|Overall Study|Lost to Follow-up|0
1097122|NCT01971554|3588339|P1|Overall Study|Lost to Follow-up|1
1097123|NCT01971476|3588376|P3|Cohort 2: 12 to <18 Years|Adverse Event|0
1097124|NCT01971476|3588377|P2|Cohort 2: 12 to <18 Years|Adverse Event|1
1097125|NCT01971476|3588378|P1|Cohort 2: 12 to <18 Years|Adverse Event|0
1097126|NCT01971476|3588376|P3|Cohort 2: 12 to <18 Years|Other not defined|0
1097127|NCT01971476|3588377|P2|Cohort 2: 12 to <18 Years|Other not defined|3
1097128|NCT01971476|3588378|P1|Cohort 2: 12 to <18 Years|Other not defined|6
1097129|NCT01971476|3588376|P3|Cohort 1: 2 to <12 Years|Other not defined|6
1097130|NCT01971476|3588377|P2|Cohort 1: 2 to <12 Years|Other not defined|3
1097131|NCT01971476|3588378|P1|Cohort 1: 2 to <12 Years|Other not defined|3
1097132|NCT01971203|3588488|P2|Overall Study|Adverse Event|0
1097133|NCT01971203|3588489|P1|Overall Study|Adverse Event|1
1097134|NCT01971203|3588488|P2|Overall Study|Withdrawal by Subject|6
1097135|NCT01971203|3588489|P1|Overall Study|Withdrawal by Subject|5
1097136|NCT01971203|3588488|P2|Overall Study|Protocol Violation|2
1097137|NCT01971203|3588489|P1|Overall Study|Protocol Violation|3
1097138|NCT01970995|3588516|P3|End of Study (Population at Day 90)|Withdrawal by Subject|1
1097139|NCT01970995|3588517|P2|End of Study (Population at Day 90)|Withdrawal by Subject|0
1097140|NCT01970995|3588518|P1|End of Study (Population at Day 90)|Withdrawal by Subject|1
1097141|NCT01970995|3588516|P3|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
1097142|NCT01970995|3588517|P2|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
1097143|NCT01970995|3588518|P1|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
1097144|NCT01970982|3588541|P3|Overall Study|Withdrawal by Subject|2
1097145|NCT01970982|3588542|P2|Overall Study|Withdrawal by Subject|0
1097146|NCT01970982|3588543|P1|Overall Study|Withdrawal by Subject|0
1097147|NCT01970878|3588565|P4|Overall Study|No Completion Status|0
1097148|NCT01970878|3588566|P3|Overall Study|No Completion Status|0
1097149|NCT01970878|3588567|P2|Overall Study|No Completion Status|1
1097150|NCT01970878|3588568|P1|Overall Study|No Completion Status|0
1097151|NCT01970878|3588565|P4|Overall Study|Physician Decision|0
1097152|NCT01970878|3588566|P3|Overall Study|Physician Decision|1
1097153|NCT01970878|3588567|P2|Overall Study|Physician Decision|1
1097154|NCT01970878|3588568|P1|Overall Study|Physician Decision|0
1097155|NCT01970878|3588565|P4|Overall Study|Protocol Specified Criteria|6
1097156|NCT01970878|3588566|P3|Overall Study|Protocol Specified Criteria|3
1097157|NCT01970878|3588567|P2|Overall Study|Protocol Specified Criteria|4
1097158|NCT01970878|3588568|P1|Overall Study|Protocol Specified Criteria|10
1097159|NCT01970878|3588565|P4|Overall Study|Adverse Event|3
1097160|NCT01970878|3588566|P3|Overall Study|Adverse Event|4
1097161|NCT01970878|3588567|P2|Overall Study|Adverse Event|7
1097162|NCT01970878|3588568|P1|Overall Study|Adverse Event|12
1097163|NCT01970878|3588565|P4|Overall Study|Lack of Efficacy|0
1097164|NCT01970878|3588566|P3|Overall Study|Lack of Efficacy|2
1097165|NCT01970878|3588567|P2|Overall Study|Lack of Efficacy|1
1097166|NCT01970878|3588568|P1|Overall Study|Lack of Efficacy|2
1097167|NCT01970878|3588565|P4|Overall Study|Administrative Reasons|4
1097168|NCT01970878|3588566|P3|Overall Study|Administrative Reasons|0
1097169|NCT01970878|3588567|P2|Overall Study|Administrative Reasons|0
1097170|NCT01970878|3588568|P1|Overall Study|Administrative Reasons|1
1097171|NCT01970878|3588565|P4|Overall Study|Lost to Follow-up|4
1097172|NCT01970878|3588566|P3|Overall Study|Lost to Follow-up|2
1097173|NCT01970878|3588567|P2|Overall Study|Lost to Follow-up|3
1097174|NCT01970878|3588568|P1|Overall Study|Lost to Follow-up|1
1097175|NCT01970878|3588565|P4|Overall Study|Withdrawal by Subject|7
1097176|NCT01970878|3588566|P3|Overall Study|Withdrawal by Subject|14
1097177|NCT01970878|3588567|P2|Overall Study|Withdrawal by Subject|10
1097178|NCT01970878|3588568|P1|Overall Study|Withdrawal by Subject|11
1097179|NCT01970865|3588611|P17|Overall Study|Study ongoing|2
1097180|NCT01970865|3588612|P16|Overall Study|Study ongoing|29
1097181|NCT01970865|3588613|P15|Overall Study|Study ongoing|29
1097182|NCT01970865|3588614|P14|Overall Study|Study ongoing|41
1097183|NCT01970865|3588615|P13|Overall Study|Study ongoing|43
1097184|NCT01970865|3588616|P12|Overall Study|Study ongoing|22
1097185|NCT01970865|3588617|P11|Overall Study|Study ongoing|29
1097186|NCT01970865|3588618|P10|Overall Study|Study ongoing|3
1097187|NCT01970865|3588619|P9|Overall Study|Study ongoing|1
1097188|NCT01970865|3588620|P8|Overall Study|Study ongoing|0
1097189|NCT01970865|3588621|P7|Overall Study|Study ongoing|2
1097190|NCT01970865|3588622|P6|Overall Study|Study ongoing|0
1097191|NCT01970865|3588623|P5|Overall Study|Study ongoing|8
1097192|NCT01970865|3588624|P4|Overall Study|Study ongoing|6
1097193|NCT01970865|3588625|P3|Overall Study|Study ongoing|0
1097194|NCT01970865|3588626|P2|Overall Study|Study ongoing|2
1097195|NCT01970865|3588627|P1|Overall Study|Study ongoing|0
1097196|NCT01970865|3588611|P17|Overall Study|Other|0
1097197|NCT01970865|3588612|P16|Overall Study|Other|1
1097198|NCT01970865|3588613|P15|Overall Study|Other|0
1097199|NCT01970865|3588614|P14|Overall Study|Other|1
1097200|NCT01970865|3588615|P13|Overall Study|Other|0
1097201|NCT01970865|3588616|P12|Overall Study|Other|0
1097202|NCT01970865|3588617|P11|Overall Study|Other|0
1097203|NCT01970865|3588618|P10|Overall Study|Other|0
1097204|NCT01970865|3588619|P9|Overall Study|Other|0
1097205|NCT01970865|3588620|P8|Overall Study|Other|0
1097206|NCT01970865|3588621|P7|Overall Study|Other|0
1097207|NCT01970865|3588622|P6|Overall Study|Other|0
1097208|NCT01970865|3588623|P5|Overall Study|Other|0
1097209|NCT01970865|3588624|P4|Overall Study|Other|1
1097210|NCT01970865|3588625|P3|Overall Study|Other|0
1097211|NCT01970865|3588626|P2|Overall Study|Other|0
1097212|NCT01970865|3588627|P1|Overall Study|Other|0
1097213|NCT01970865|3588611|P17|Overall Study|Withdrawal by Subject|0
1097214|NCT01970865|3588612|P16|Overall Study|Withdrawal by Subject|7
1097215|NCT01970865|3588613|P15|Overall Study|Withdrawal by Subject|2
1097216|NCT01970865|3588614|P14|Overall Study|Withdrawal by Subject|5
1097217|NCT01970865|3588615|P13|Overall Study|Withdrawal by Subject|2
1097218|NCT01970865|3588616|P12|Overall Study|Withdrawal by Subject|1
1097219|NCT01970865|3588617|P11|Overall Study|Withdrawal by Subject|0
1097220|NCT01970865|3588618|P10|Overall Study|Withdrawal by Subject|0
1097221|NCT01970865|3588619|P9|Overall Study|Withdrawal by Subject|0
1097222|NCT01970865|3588620|P8|Overall Study|Withdrawal by Subject|0
1097223|NCT01970865|3588621|P7|Overall Study|Withdrawal by Subject|0
1097224|NCT01970865|3588622|P6|Overall Study|Withdrawal by Subject|0
1097225|NCT01970865|3588623|P5|Overall Study|Withdrawal by Subject|2
1097226|NCT01970865|3588624|P4|Overall Study|Withdrawal by Subject|1
1097227|NCT01970865|3588625|P3|Overall Study|Withdrawal by Subject|0
1097228|NCT01970865|3588626|P2|Overall Study|Withdrawal by Subject|0
1097229|NCT01970865|3588627|P1|Overall Study|Withdrawal by Subject|0
1097230|NCT01970865|3588611|P17|Overall Study|Lost to Follow-up|0
1097231|NCT01970865|3588612|P16|Overall Study|Lost to Follow-up|0
1097232|NCT01970865|3588613|P15|Overall Study|Lost to Follow-up|0
1097233|NCT01970865|3588614|P14|Overall Study|Lost to Follow-up|0
1097234|NCT01970865|3588615|P13|Overall Study|Lost to Follow-up|1
1097235|NCT01970865|3588616|P12|Overall Study|Lost to Follow-up|0
1097236|NCT01970865|3588617|P11|Overall Study|Lost to Follow-up|0
1097237|NCT01970865|3588618|P10|Overall Study|Lost to Follow-up|0
1097238|NCT01970865|3588619|P9|Overall Study|Lost to Follow-up|0
1097239|NCT01970865|3588620|P8|Overall Study|Lost to Follow-up|0
1097240|NCT01970865|3588621|P7|Overall Study|Lost to Follow-up|0
1097241|NCT01970865|3588622|P6|Overall Study|Lost to Follow-up|0
1097242|NCT01970865|3588623|P5|Overall Study|Lost to Follow-up|1
1097243|NCT01970865|3588624|P4|Overall Study|Lost to Follow-up|1
1097244|NCT01970865|3588625|P3|Overall Study|Lost to Follow-up|0
1097245|NCT01970865|3588626|P2|Overall Study|Lost to Follow-up|0
1097246|NCT01970865|3588627|P1|Overall Study|Lost to Follow-up|0
1097247|NCT01970865|3588611|P17|Overall Study|Death|1
1097248|NCT01970865|3588612|P16|Overall Study|Death|10
1097249|NCT01970865|3588613|P15|Overall Study|Death|15
1097250|NCT01970865|3588614|P14|Overall Study|Death|19
1097251|NCT01970865|3588615|P13|Overall Study|Death|14
1097252|NCT01970865|3588616|P12|Overall Study|Death|4
1097253|NCT01970865|3588617|P11|Overall Study|Death|1
1097254|NCT01970865|3588618|P10|Overall Study|Death|1
1097255|NCT01970865|3588619|P9|Overall Study|Death|2
1097256|NCT01970865|3588620|P8|Overall Study|Death|3
1097257|NCT01970865|3588621|P7|Overall Study|Death|1
1097258|NCT01970865|3588622|P6|Overall Study|Death|3
1097259|NCT01970865|3588623|P5|Overall Study|Death|6
1097260|NCT01970865|3588624|P4|Overall Study|Death|4
1097261|NCT01970865|3588625|P3|Overall Study|Death|3
1097262|NCT01970865|3588626|P2|Overall Study|Death|1
1097263|NCT01970865|3588627|P1|Overall Study|Death|3
1097264|NCT01970488|3589061|P5|Part 2: Post Week 16|Lost to Follow-up|2
1097265|NCT01970488|3589062|P4|Part 2: Post Week 16|Lost to Follow-up|1
1097266|NCT01970488|3589063|P3|Part 2: Post Week 16|Lost to Follow-up|1
1097267|NCT01970488|3589064|P2|Part 2: Post Week 16|Lost to Follow-up|0
1097268|NCT01970488|3589065|P1|Part 2: Post Week 16|Lost to Follow-up|0
1097269|NCT01970488|3589061|P5|Part 2: Post Week 16|Withdrawal by Subject|3
1097270|NCT01970488|3589062|P4|Part 2: Post Week 16|Withdrawal by Subject|3
1097271|NCT01970488|3589063|P3|Part 2: Post Week 16|Withdrawal by Subject|8
1097272|NCT01970488|3589064|P2|Part 2: Post Week 16|Withdrawal by Subject|0
1097273|NCT01970488|3589065|P1|Part 2: Post Week 16|Withdrawal by Subject|0
1097274|NCT01970488|3589061|P5|Part 2: Post Week 16|Adverse Event|1
1097275|NCT01970488|3589062|P4|Part 2: Post Week 16|Adverse Event|1
1097276|NCT01970488|3589063|P3|Part 2: Post Week 16|Adverse Event|5
1097277|NCT01970488|3589064|P2|Part 2: Post Week 16|Adverse Event|0
1097278|NCT01970488|3589065|P1|Part 2: Post Week 16|Adverse Event|0
1097279|NCT01970488|3589061|P5|Part 2: Post Week 16|Lack of Efficacy|1
1097280|NCT01970488|3589062|P4|Part 2: Post Week 16|Lack of Efficacy|3
1097281|NCT01970488|3589063|P3|Part 2: Post Week 16|Lack of Efficacy|2
1097282|NCT01970488|3589064|P2|Part 2: Post Week 16|Lack of Efficacy|0
1097283|NCT01970488|3589065|P1|Part 2: Post Week 16|Lack of Efficacy|0
1097284|NCT01970488|3589061|P5|Part 2: Post Week 16|Non-compliance|0
1097285|NCT01970488|3589062|P4|Part 2: Post Week 16|Non-compliance|0
1097286|NCT01970488|3589063|P3|Part 2: Post Week 16|Non-compliance|1
1097287|NCT01970488|3589064|P2|Part 2: Post Week 16|Non-compliance|0
1097288|NCT01970488|3589065|P1|Part 2: Post Week 16|Non-compliance|0
1097289|NCT01970488|3589061|P5|Part 2: Post Week 16|Physician Decision|1
1097290|NCT01970488|3589062|P4|Part 2: Post Week 16|Physician Decision|0
1097291|NCT01970488|3589063|P3|Part 2: Post Week 16|Physician Decision|0
1097292|NCT01970488|3589064|P2|Part 2: Post Week 16|Physician Decision|0
1097293|NCT01970488|3589065|P1|Part 2: Post Week 16|Physician Decision|0
1097294|NCT01970488|3589061|P5|Part 1: Through Week 16|Lost to Follow-up|0
1097295|NCT01970488|3589062|P4|Part 1: Through Week 16|Lost to Follow-up|0
1097296|NCT01970488|3589063|P3|Part 1: Through Week 16|Lost to Follow-up|0
1097297|NCT01970488|3589064|P2|Part 1: Through Week 16|Lost to Follow-up|2
1097298|NCT01970488|3589065|P1|Part 1: Through Week 16|Lost to Follow-up|0
1097299|NCT01970488|3589061|P5|Part 1: Through Week 16|Withdrawal by Subject|0
1097300|NCT01970488|3589062|P4|Part 1: Through Week 16|Withdrawal by Subject|0
1097301|NCT01970488|3589063|P3|Part 1: Through Week 16|Withdrawal by Subject|0
1097302|NCT01970488|3589064|P2|Part 1: Through Week 16|Withdrawal by Subject|2
1097303|NCT01970488|3589065|P1|Part 1: Through Week 16|Withdrawal by Subject|3
1097304|NCT01970488|3589061|P5|Part 1: Through Week 16|Adverse Event|0
1097305|NCT01970488|3589062|P4|Part 1: Through Week 16|Adverse Event|0
1097306|NCT01970488|3589063|P3|Part 1: Through Week 16|Adverse Event|0
1097307|NCT01970488|3589064|P2|Part 1: Through Week 16|Adverse Event|5
1097308|NCT01970488|3589065|P1|Part 1: Through Week 16|Adverse Event|6
1097309|NCT01970488|3589061|P5|Part 1: Through Week 16|Protocol Violation|0
1097310|NCT01970488|3589062|P4|Part 1: Through Week 16|Protocol Violation|0
1097311|NCT01970488|3589063|P3|Part 1: Through Week 16|Protocol Violation|0
1097312|NCT01970488|3589064|P2|Part 1: Through Week 16|Protocol Violation|2
1097313|NCT01970488|3589065|P1|Part 1: Through Week 16|Protocol Violation|1
1097314|NCT01970488|3589061|P5|Part 1: Through Week 16|Protocol-specified Criteria|0
1097315|NCT01970488|3589062|P4|Part 1: Through Week 16|Protocol-specified Criteria|0
1097316|NCT01970488|3589063|P3|Part 1: Through Week 16|Protocol-specified Criteria|0
1097317|NCT01970488|3589064|P2|Part 1: Through Week 16|Protocol-specified Criteria|2
1097318|NCT01970488|3589065|P1|Part 1: Through Week 16|Protocol-specified Criteria|1
1097319|NCT01970475|3589132|P2|Overall Study|Protocol Violation|0
1097320|NCT01970475|3589133|P1|Overall Study|Protocol Violation|1
1097321|NCT01970475|3589132|P2|Overall Study|Lost to Follow-up|2
1097322|NCT01970475|3589133|P1|Overall Study|Lost to Follow-up|2
1097323|NCT01970475|3589132|P2|Overall Study|Adverse Event|3
1097324|NCT01970475|3589133|P1|Overall Study|Adverse Event|7
1097325|NCT01970475|3589132|P2|Overall Study|Withdrawal by Subject|6
1097326|NCT01970475|3589133|P1|Overall Study|Withdrawal by Subject|11
1097327|NCT01970462|3589153|P2|Overall Study|Lost to Follow-up|2
1097328|NCT01970462|3589154|P1|Overall Study|Lost to Follow-up|0
1097329|NCT01970397|3589168|P2|Overall Study|Protocol Violation|1
1097330|NCT01970397|3589169|P1|Overall Study|Protocol Violation|1
1097331|NCT01970397|3589168|P2|Overall Study|Personal Reasons|2
1097332|NCT01970397|3589169|P1|Overall Study|Personal Reasons|1
1097333|NCT01970397|3589168|P2|Overall Study|Lost to Follow-up|1
1097334|NCT01970397|3589169|P1|Overall Study|Lost to Follow-up|0
1097335|NCT01970397|3589168|P2|Overall Study|Adverse Event|1
1097336|NCT01970397|3589169|P1|Overall Study|Adverse Event|0
1097337|NCT01970371|3589182|P3|Overall Study|Lost to Follow-up|1
1097338|NCT01970371|3589183|P2|Overall Study|Lost to Follow-up|0
1097339|NCT01970371|3589184|P1|Overall Study|Lost to Follow-up|0
1097340|NCT01970371|3589182|P3|Overall Study|Death|12
1097341|NCT01970371|3589183|P2|Overall Study|Death|13
1097342|NCT01970371|3589184|P1|Overall Study|Death|8
1097343|NCT01969799|3589209|P2|Overall Study|Physician Decision|0
1097344|NCT01969799|3589210|P1|Overall Study|Physician Decision|1
1097345|NCT01969799|3589209|P2|Overall Study|Lost to Follow-up|2
1097346|NCT01969799|3589210|P1|Overall Study|Lost to Follow-up|0
1097347|NCT01969799|3589209|P2|Overall Study|Death|11
1097348|NCT01969799|3589210|P1|Overall Study|Death|16
1097349|NCT01969799|3589209|P2|Overall Study|Adverse Event|1
1097350|NCT01969799|3589210|P1|Overall Study|Adverse Event|0
1097351|NCT01969721|3589247|P4|Overall Study|Discontinued during washout periods.|2
1097352|NCT01969721|3589248|P3|Overall Study|Discontinued during washout periods.|1
1097353|NCT01969721|3589249|P2|Overall Study|Discontinued during washout periods.|1
1097354|NCT01969721|3589250|P1|Overall Study|Discontinued during washout periods.|0
1097355|NCT01969721|3589247|P4|Overall Study|Other not defined above|0
1097356|NCT01969721|3589248|P3|Overall Study|Other not defined above|0
1097357|NCT01969721|3589249|P2|Overall Study|Other not defined above|2
1097358|NCT01969721|3589250|P1|Overall Study|Other not defined above|0
1097359|NCT01969721|3589247|P4|Overall Study|Non compliant with protocol|2
1097360|NCT01969721|3589248|P3|Overall Study|Non compliant with protocol|0
1097361|NCT01969721|3589249|P2|Overall Study|Non compliant with protocol|1
1097362|NCT01969721|3589250|P1|Overall Study|Non compliant with protocol|1
1097363|NCT01969721|3589247|P4|Overall Study|Lack of Efficacy|0
1097364|NCT01969721|3589248|P3|Overall Study|Lack of Efficacy|1
1097365|NCT01969721|3589249|P2|Overall Study|Lack of Efficacy|0
1097366|NCT01969721|3589250|P1|Overall Study|Lack of Efficacy|0
1097367|NCT01969721|3589247|P4|Overall Study|Adverse Event|2
1097368|NCT01969721|3589248|P3|Overall Study|Adverse Event|3
1097369|NCT01969721|3589249|P2|Overall Study|Adverse Event|8
1097370|NCT01969721|3589250|P1|Overall Study|Adverse Event|3
1097371|NCT01969565|3589295|P1|Overall Study|Withdrawal by Subject|1
1097372|NCT01969084|3589376|P2|Overall Study|Adverse Event|1
1097373|NCT01969084|3589377|P1|Overall Study|Adverse Event|0
1097374|NCT01969058|3589393|P2|Overall Study|Adverse Event|0
1097375|NCT01969058|3589394|P1|Overall Study|Adverse Event|1
1097376|NCT01969058|3589393|P2|Overall Study|Withdrawal by Subject|0
1097377|NCT01969058|3589394|P1|Overall Study|Withdrawal by Subject|2
1097378|NCT01968980|3589430|P2|Overall Study|Other unspecified|2
1097379|NCT01968980|3589431|P1|Overall Study|Other unspecified|1
1097380|NCT01968980|3589430|P2|Overall Study|Withdrawal by Subject|5
1097381|NCT01968980|3589431|P1|Overall Study|Withdrawal by Subject|13
1097382|NCT01968980|3589430|P2|Overall Study|Does not meet entry criteria|3
1097383|NCT01968980|3589431|P1|Overall Study|Does not meet entry criteria|1
1097384|NCT01968980|3589430|P2|Overall Study|Adverse Event|3
1097385|NCT01968980|3589431|P1|Overall Study|Adverse Event|1
1097386|NCT01968980|3589430|P2|Overall Study|Death|1
1097387|NCT01968980|3589431|P1|Overall Study|Death|0
1097388|NCT01968967|3589493|P5|Extension Period|Withdrew Consent|5
1097389|NCT01968967|3589494|P4|Extension Period|Withdrew Consent|0
1097390|NCT01968967|3589495|P3|Extension Period|Withdrew Consent|2
1097391|NCT01968967|3589496|P2|Extension Period|Withdrew Consent|0
1097392|NCT01968967|3589497|P1|Extension Period|Withdrew Consent|0
1097393|NCT01968967|3589493|P5|Treatment Period|Randomized Not Treated|0
1097394|NCT01968967|3589494|P4|Treatment Period|Randomized Not Treated|0
1097395|NCT01968967|3589495|P3|Treatment Period|Randomized Not Treated|0
1097396|NCT01968967|3589496|P2|Treatment Period|Randomized Not Treated|5
1097397|NCT01968967|3589497|P1|Treatment Period|Randomized Not Treated|6
1097398|NCT01968967|3589493|P5|Treatment Period|Death|0
1097399|NCT01968967|3589494|P4|Treatment Period|Death|0
1097400|NCT01968967|3589495|P3|Treatment Period|Death|0
1097401|NCT01968967|3589496|P2|Treatment Period|Death|2
1097402|NCT01968967|3589497|P1|Treatment Period|Death|9
1097403|NCT01968967|3589493|P5|Treatment Period|Adverse Event|0
1097404|NCT01968967|3589494|P4|Treatment Period|Adverse Event|0
1097405|NCT01968967|3589495|P3|Treatment Period|Adverse Event|0
1097406|NCT01968967|3589496|P2|Treatment Period|Adverse Event|8
1097407|NCT01968967|3589497|P1|Treatment Period|Adverse Event|9
1097408|NCT01968967|3589493|P5|Treatment Period|Protocol Violation|0
1097409|NCT01968967|3589494|P4|Treatment Period|Protocol Violation|0
1097410|NCT01968967|3589495|P3|Treatment Period|Protocol Violation|0
1097411|NCT01968967|3589496|P2|Treatment Period|Protocol Violation|2
1097412|NCT01968967|3589497|P1|Treatment Period|Protocol Violation|1
1097413|NCT01968967|3589493|P5|Treatment Period|Lost to Follow-up|0
1097414|NCT01968967|3589494|P4|Treatment Period|Lost to Follow-up|0
1097415|NCT01968967|3589495|P3|Treatment Period|Lost to Follow-up|0
1097416|NCT01968967|3589496|P2|Treatment Period|Lost to Follow-up|31
1097417|NCT01968967|3589497|P1|Treatment Period|Lost to Follow-up|26
1097418|NCT01968967|3589493|P5|Treatment Period|Did Not Meet Entrance Criteria|0
1097419|NCT01968967|3589494|P4|Treatment Period|Did Not Meet Entrance Criteria|0
1097420|NCT01968967|3589495|P3|Treatment Period|Did Not Meet Entrance Criteria|0
1097421|NCT01968967|3589496|P2|Treatment Period|Did Not Meet Entrance Criteria|3
1097422|NCT01968967|3589497|P1|Treatment Period|Did Not Meet Entrance Criteria|2
1097423|NCT01968967|3589493|P5|Treatment Period|Withdrawal by Subject|0
1097424|NCT01968967|3589494|P4|Treatment Period|Withdrawal by Subject|0
1097425|NCT01968967|3589495|P3|Treatment Period|Withdrawal by Subject|0
1097426|NCT01968967|3589496|P2|Treatment Period|Withdrawal by Subject|61
1097427|NCT01968967|3589497|P1|Treatment Period|Withdrawal by Subject|71
1097428|NCT01968967|3589493|P5|Treatment Period|Other|0
1097429|NCT01968967|3589494|P4|Treatment Period|Other|0
1097430|NCT01968967|3589495|P3|Treatment Period|Other|0
1097431|NCT01968967|3589496|P2|Treatment Period|Other|22
1097432|NCT01968967|3589497|P1|Treatment Period|Other|22
1097433|NCT01968954|3589566|P2|Overall Study|Did not met inclusion criteria|2
1097434|NCT01968954|3589567|P1|Overall Study|Did not met inclusion criteria|0
1097435|NCT01968954|3589566|P2|Overall Study|Protocol Violation|1
1097436|NCT01968954|3589567|P1|Overall Study|Protocol Violation|0
1097437|NCT01968954|3589566|P2|Overall Study|Other|8
1097438|NCT01968954|3589567|P1|Overall Study|Other|7
1097439|NCT01968954|3589566|P2|Overall Study|Withdrawal by Subject|23
1097440|NCT01968954|3589567|P1|Overall Study|Withdrawal by Subject|20
1097441|NCT01968954|3589566|P2|Overall Study|Lost to Follow-up|4
1097442|NCT01968954|3589567|P1|Overall Study|Lost to Follow-up|6
1097443|NCT01968954|3589566|P2|Overall Study|Death|2
1097444|NCT01968954|3589567|P1|Overall Study|Death|1
1097445|NCT01968954|3589566|P2|Overall Study|Adverse Event|3
1097446|NCT01968954|3589567|P1|Overall Study|Adverse Event|6
1097447|NCT01968811|3589631|P1|Overall Study|post op.ref. of subject to other hospita|1
1097448|NCT01968811|3589631|P1|Overall Study|Protocol Violation|4
1097449|NCT01968694|3589638|P2|Washout (1 Month)|Lost to Follow-up|1
1097450|NCT01968694|3589639|P1|Washout (1 Month)|Lost to Follow-up|0
1097451|NCT01968551|3589656|P3|Extension Phase|Lost to Follow-up|1
1097452|NCT01968551|3589657|P2|Extension Phase|Lost to Follow-up|0
1097453|NCT01968551|3589658|P1|Extension Phase|Lost to Follow-up|1
1097454|NCT01968551|3589656|P3|Extension Phase|Withdrew Consent|1
1097455|NCT01968551|3589657|P2|Extension Phase|Withdrew Consent|0
1097456|NCT01968551|3589658|P1|Extension Phase|Withdrew Consent|0
1097457|NCT01968551|3589656|P3|Extension Phase|Death|0
1097458|NCT01968551|3589657|P2|Extension Phase|Death|1
1097459|NCT01968551|3589658|P1|Extension Phase|Death|0
1097460|NCT01968551|3589656|P3|Extension Phase|Adverse Event|2
1097461|NCT01968551|3589657|P2|Extension Phase|Adverse Event|0
1097462|NCT01968551|3589658|P1|Extension Phase|Adverse Event|0
1097463|NCT01968551|3589656|P3|Open Label Phase (48 Weeks)|Lost to Follow-up|2
1097464|NCT01968551|3589657|P2|Open Label Phase (48 Weeks)|Lost to Follow-up|0
1097465|NCT01968551|3589658|P1|Open Label Phase (48 Weeks)|Lost to Follow-up|0
1097466|NCT01968551|3589656|P3|Open Label Phase (48 Weeks)|Withdrew Consent|3
1097467|NCT01968551|3589657|P2|Open Label Phase (48 Weeks)|Withdrew Consent|1
1097468|NCT01968551|3589658|P1|Open Label Phase (48 Weeks)|Withdrew Consent|1
1097469|NCT01968551|3589656|P3|Open Label Phase (48 Weeks)|Investigator’s Discretion|0
1097470|NCT01968551|3589657|P2|Open Label Phase (48 Weeks)|Investigator’s Discretion|1
1097471|NCT01968551|3589658|P1|Open Label Phase (48 Weeks)|Investigator’s Discretion|0
1097472|NCT01968551|3589656|P3|Open Label Phase (48 Weeks)|Randomized but Never Treated|0
1097473|NCT01968551|3589657|P2|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
1097474|NCT01968551|3589658|P1|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
1097475|NCT01968434|3589674|P2|Overall Study|Lost to Follow-up|6
1097476|NCT01968434|3589675|P1|Overall Study|Lost to Follow-up|3
1097477|NCT01968226|3589685|P1|Overall Study|[F-18] RDG-K5 was not available|2
1097478|NCT01968213|3589691|P2|Overall Study|Ongoing|9
1097479|NCT01968213|3589692|P1|Overall Study|Ongoing|90
1097480|NCT01967940|3589729|P4|Part 2|Unknown Reason|1
1097481|NCT01967940|3589730|P3|Part 2|Unknown Reason|0
1097482|NCT01967940|3589731|P2|Part 2|Unknown Reason|0
1097483|NCT01967940|3589732|P1|Part 2|Unknown Reason|0
1097484|NCT01967940|3589729|P4|Part 2|Adverse Event|1
1097485|NCT01967940|3589730|P3|Part 2|Adverse Event|0
1097486|NCT01967940|3589731|P2|Part 2|Adverse Event|0
1097487|NCT01967940|3589732|P1|Part 2|Adverse Event|0
1097488|NCT01967940|3589729|P4|Part 2|Enrolled in Part 2 and Never Treated|1
1097489|NCT01967940|3589730|P3|Part 2|Enrolled in Part 2 and Never Treated|0
1097490|NCT01967940|3589731|P2|Part 2|Enrolled in Part 2 and Never Treated|0
1097491|NCT01967940|3589732|P1|Part 2|Enrolled in Part 2 and Never Treated|0
1097492|NCT01967732|3589774|P4|First Intervention (Day 1)|Poor venous access|0
1097493|NCT01967732|3589775|P3|First Intervention (Day 1)|Poor venous access|0
1097494|NCT01967732|3589776|P2|First Intervention (Day 1)|Poor venous access|1
1097495|NCT01967732|3589777|P1|First Intervention (Day 1)|Poor venous access|0
1097496|NCT01967732|3589774|P4|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
1097497|NCT01967732|3589775|P3|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
1097498|NCT01967732|3589776|P2|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1
1097499|NCT01967732|3589777|P1|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
1097500|NCT01967719|3589791|P4|Second Intervention (Day 3)|Withdrawal by Subject|0
1097501|NCT01967719|3589792|P3|Second Intervention (Day 3)|Withdrawal by Subject|0
1097502|NCT01967719|3589793|P2|Second Intervention (Day 3)|Withdrawal by Subject|1
1097503|NCT01967719|3589794|P1|Second Intervention (Day 3)|Withdrawal by Subject|0
1097504|NCT01967719|3589791|P4|First Intervention (Day 1)|Withdrawal by Subject|1
1097505|NCT01967719|3589792|P3|First Intervention (Day 1)|Withdrawal by Subject|0
1097506|NCT01967719|3589793|P2|First Intervention (Day 1)|Withdrawal by Subject|1
1097507|NCT01967719|3589794|P1|First Intervention (Day 1)|Withdrawal by Subject|0
1097508|NCT01967706|3589809|P4|First Intervention (Day 1)|Withdrawal by Subject|0
1097509|NCT01967706|3589810|P3|First Intervention (Day 1)|Withdrawal by Subject|0
1097510|NCT01967706|3589811|P2|First Intervention (Day 1)|Withdrawal by Subject|0
1097511|NCT01967706|3589812|P1|First Intervention (Day 1)|Withdrawal by Subject|1
1097512|NCT01967628|3589833|P2|Overall Study|Low protein concentration in sample|25
1097513|NCT01967628|3589834|P1|Overall Study|Low protein concentration in sample|20
1097514|NCT01967628|3589833|P2|Overall Study|Lost to Follow-up|0
1097515|NCT01967628|3589834|P1|Overall Study|Lost to Follow-up|1
1097516|NCT01967628|3589833|P2|Overall Study|Unable to complete bronchoscopy|6
1097517|NCT01967628|3589834|P1|Overall Study|Unable to complete bronchoscopy|4
1097518|NCT01967628|3589833|P2|Overall Study|Withdrawal by Subject|0
1097519|NCT01967628|3589834|P1|Overall Study|Withdrawal by Subject|2
1097520|NCT01967550|3589842|P2|Overall Study|Non Compliance|1
1097521|NCT01967550|3589843|P1|Overall Study|Non Compliance|0
1097522|NCT01967550|3589842|P2|Overall Study|Protocol Violation|1
1097523|NCT01967550|3589843|P1|Overall Study|Protocol Violation|2
1097524|NCT01967550|3589842|P2|Overall Study|Adverse Event|0
1097525|NCT01967550|3589843|P1|Overall Study|Adverse Event|2
1097526|NCT01967550|3589842|P2|Overall Study|Withdrawal by Subject|0
1097527|NCT01967550|3589843|P1|Overall Study|Withdrawal by Subject|1
1097528|NCT01967277|3589873|P2|Overall Study|Unrelated illness|1
1097529|NCT01967277|3589874|P1|Overall Study|Unrelated illness|0
1097530|NCT01967277|3589873|P2|Overall Study|Lost to Follow-up|2
1097531|NCT01967277|3589874|P1|Overall Study|Lost to Follow-up|1
1097532|NCT01967225|3589886|P2|Overall Study|Protocol Violation|0
1097533|NCT01967225|3589887|P1|Overall Study|Protocol Violation|2
1097534|NCT01967225|3589886|P2|Overall Study|Logistical difficulties|0
1097535|NCT01967225|3589887|P1|Overall Study|Logistical difficulties|1
1097536|NCT01967225|3589886|P2|Overall Study|Protocol driven decision point|0
1097537|NCT01967225|3589887|P1|Overall Study|Protocol driven decision point|1
1097538|NCT01967225|3589886|P2|Overall Study|Switching to other therapy|0
1097539|NCT01967225|3589887|P1|Overall Study|Switching to other therapy|2
1097540|NCT01967225|3589886|P2|Overall Study|Lack of Efficacy|1
1097541|NCT01967225|3589887|P1|Overall Study|Lack of Efficacy|1
1097542|NCT01967225|3589886|P2|Overall Study|Withdrawal by Subject|1
1097543|NCT01967225|3589887|P1|Overall Study|Withdrawal by Subject|2
1097544|NCT01967225|3589886|P2|Overall Study|Adverse Event|1
1097545|NCT01967225|3589887|P1|Overall Study|Adverse Event|3
1097546|NCT01967173|3589919|P8|Overall Study|Withdrawal by Subject|12
1097547|NCT01967173|3589920|P7|Overall Study|Withdrawal by Subject|10
1097548|NCT01967173|3589921|P6|Overall Study|Withdrawal by Subject|9
1097549|NCT01967173|3589922|P5|Overall Study|Withdrawal by Subject|8
1097550|NCT01967173|3589923|P4|Overall Study|Withdrawal by Subject|7
1097551|NCT01967173|3589924|P3|Overall Study|Withdrawal by Subject|10
1097552|NCT01967173|3589925|P2|Overall Study|Withdrawal by Subject|14
1097553|NCT01967173|3589926|P1|Overall Study|Withdrawal by Subject|15
1097554|NCT01967173|3589919|P8|Overall Study|Adverse Event|1
1097555|NCT01967173|3589920|P7|Overall Study|Adverse Event|0
1097556|NCT01967173|3589921|P6|Overall Study|Adverse Event|0
1097557|NCT01967173|3589922|P5|Overall Study|Adverse Event|0
1097558|NCT01967173|3589923|P4|Overall Study|Adverse Event|0
1097559|NCT01967173|3589924|P3|Overall Study|Adverse Event|0
1097560|NCT01967173|3589925|P2|Overall Study|Adverse Event|0
1097561|NCT01967173|3589926|P1|Overall Study|Adverse Event|0
1097562|NCT01967173|3589919|P8|Overall Study|Pregnancy|1
1097563|NCT01967173|3589920|P7|Overall Study|Pregnancy|1
1097564|NCT01967173|3589921|P6|Overall Study|Pregnancy|0
1097565|NCT01967173|3589922|P5|Overall Study|Pregnancy|0
1097566|NCT01967173|3589923|P4|Overall Study|Pregnancy|0
1097567|NCT01967173|3589924|P3|Overall Study|Pregnancy|0
1097568|NCT01967173|3589925|P2|Overall Study|Pregnancy|0
1097569|NCT01967173|3589926|P1|Overall Study|Pregnancy|0
1097570|NCT01967173|3589919|P8|Overall Study|Lack of Efficacy|2
1097571|NCT01967173|3589920|P7|Overall Study|Lack of Efficacy|0
1097572|NCT01967173|3589921|P6|Overall Study|Lack of Efficacy|1
1097573|NCT01967173|3589922|P5|Overall Study|Lack of Efficacy|0
1097574|NCT01967173|3589923|P4|Overall Study|Lack of Efficacy|2
1097575|NCT01967173|3589924|P3|Overall Study|Lack of Efficacy|2
1097576|NCT01967173|3589925|P2|Overall Study|Lack of Efficacy|0
1097577|NCT01967173|3589926|P1|Overall Study|Lack of Efficacy|2
1097578|NCT01967173|3589919|P8|Overall Study|Physician Decision|0
1097579|NCT01967173|3589920|P7|Overall Study|Physician Decision|1
1097580|NCT01967173|3589921|P6|Overall Study|Physician Decision|1
1097581|NCT01967173|3589922|P5|Overall Study|Physician Decision|1
1097582|NCT01967173|3589923|P4|Overall Study|Physician Decision|1
1097583|NCT01967173|3589924|P3|Overall Study|Physician Decision|2
1097584|NCT01967173|3589925|P2|Overall Study|Physician Decision|0
1097585|NCT01967173|3589926|P1|Overall Study|Physician Decision|2
1097586|NCT01967173|3589919|P8|Overall Study|Lost to Follow-up|8
1097587|NCT01967173|3589920|P7|Overall Study|Lost to Follow-up|6
1097588|NCT01967173|3589921|P6|Overall Study|Lost to Follow-up|12
1097589|NCT01967173|3589922|P5|Overall Study|Lost to Follow-up|8
1097590|NCT01967173|3589923|P4|Overall Study|Lost to Follow-up|4
1097591|NCT01967173|3589924|P3|Overall Study|Lost to Follow-up|2
1097592|NCT01967173|3589925|P2|Overall Study|Lost to Follow-up|3
1097593|NCT01967173|3589926|P1|Overall Study|Lost to Follow-up|5
1097594|NCT01967147|3589940|P2|Overall Study|Other|5
1097595|NCT01967147|3589941|P1|Overall Study|Other|4
1097596|NCT01967147|3589940|P2|Overall Study|Non-compliance with Study Drug|3
1097597|NCT01967147|3589941|P1|Overall Study|Non-compliance with Study Drug|0
1097598|NCT01967147|3589940|P2|Overall Study|Withdrawal by Subject|4
1097599|NCT01967147|3589941|P1|Overall Study|Withdrawal by Subject|2
1097600|NCT01967147|3589940|P2|Overall Study|Lost to Follow-up|2
1097601|NCT01967147|3589941|P1|Overall Study|Lost to Follow-up|1
1097602|NCT01967147|3589940|P2|Overall Study|Lack of Efficacy|4
1097603|NCT01967147|3589941|P1|Overall Study|Lack of Efficacy|1
1097604|NCT01967147|3589940|P2|Overall Study|Adverse Event|2
1097605|NCT01967147|3589941|P1|Overall Study|Adverse Event|5
1097606|NCT01967069|3589971|P2|Overall Study|Lack of Efficacy|1
1097607|NCT01967069|3589972|P1|Overall Study|Lack of Efficacy|0
1097608|NCT01967069|3589971|P2|Overall Study|Withdrawal by Subject|3
1097609|NCT01967069|3589972|P1|Overall Study|Withdrawal by Subject|1
1097610|NCT01967069|3589971|P2|Overall Study|Lost to Follow-up|2
1097611|NCT01967069|3589972|P1|Overall Study|Lost to Follow-up|5
1097612|NCT01967069|3589971|P2|Overall Study|Adverse Event|2
1097613|NCT01967069|3589972|P1|Overall Study|Adverse Event|2
1097614|NCT01966432|3590129|P3|Overall Study|SBIRT program ended|20
1097615|NCT01966432|3590130|P2|Overall Study|SBIRT program ended|8
1097616|NCT01966432|3590131|P1|Overall Study|SBIRT program ended|1
1097617|NCT01966432|3590129|P3|Overall Study|Subject Incarcerated|1
1097618|NCT01966432|3590130|P2|Overall Study|Subject Incarcerated|0
1097619|NCT01966432|3590131|P1|Overall Study|Subject Incarcerated|0
1097620|NCT01966432|3590129|P3|Overall Study|Withdrawal by Subject|0
1097621|NCT01966432|3590130|P2|Overall Study|Withdrawal by Subject|3
1097622|NCT01966432|3590131|P1|Overall Study|Withdrawal by Subject|1
1097623|NCT01966432|3590129|P3|Overall Study|Lost to Follow-up|5
1097624|NCT01966432|3590130|P2|Overall Study|Lost to Follow-up|2
1097625|NCT01966432|3590131|P1|Overall Study|Lost to Follow-up|3
1097626|NCT01966120|3590201|P2|Overall Study|Lost to Follow-up|1
1097627|NCT01966120|3590202|P1|Overall Study|Lost to Follow-up|1
1097628|NCT01966120|3590201|P2|Overall Study|Withdrawal by Subject|5
1097629|NCT01966120|3590202|P1|Overall Study|Withdrawal by Subject|0
1097630|NCT01966107|3590226|P2|Overall Study|withdrew from the study|303
1097631|NCT01966107|3590227|P1|Overall Study|withdrew from the study|272
1097632|NCT01966107|3590226|P2|Overall Study|due to study closure|186
1097633|NCT01966107|3590227|P1|Overall Study|due to study closure|164
1097634|NCT01966107|3590226|P2|Overall Study|discontinued treatment|372
1097635|NCT01966107|3590227|P1|Overall Study|discontinued treatment|345
1097636|NCT01966107|3590226|P2|Overall Study|excluded from FAS|20
1097637|NCT01966107|3590227|P1|Overall Study|excluded from FAS|21
1097638|NCT01966068|3590241|P1|Overall Study|Lost to Follow-up|81
1097639|NCT01966068|3590241|P1|Overall Study|Withdrawal by Subject|57
1097640|NCT01966042|3590246|P1|Overall Study|Death|2
1097641|NCT01966003|3590255|P2|Overall Study|Other|1
1097642|NCT01966003|3590256|P1|Overall Study|Other|1
1097643|NCT01966003|3590255|P2|Overall Study|Plan to Receive Commercial Bevacizumab|67
1097644|NCT01966003|3590256|P1|Overall Study|Plan to Receive Commercial Bevacizumab|44
1097645|NCT01966003|3590255|P2|Overall Study|Plan to Receive Other Anticancer Therapy|127
1097646|NCT01966003|3590256|P1|Overall Study|Plan to Receive Other Anticancer Therapy|131
1097647|NCT01966003|3590255|P2|Overall Study|Withdrawal by Subject|19
1097648|NCT01966003|3590256|P1|Overall Study|Withdrawal by Subject|29
1097649|NCT01966003|3590255|P2|Overall Study|Physician Decision|13
1097650|NCT01966003|3590256|P1|Overall Study|Physician Decision|12
1097651|NCT01966003|3590255|P2|Overall Study|Lost to Follow-up|3
1097652|NCT01966003|3590256|P1|Overall Study|Lost to Follow-up|4
1097653|NCT01966003|3590255|P2|Overall Study|Protocol Violation|4
1097654|NCT01966003|3590256|P1|Overall Study|Protocol Violation|6
1097655|NCT01966003|3590255|P2|Overall Study|Death|36
1097656|NCT01966003|3590256|P1|Overall Study|Death|43
1097657|NCT01965938|3590274|P2|Overall Study|Withdrawal by Subject|0
1097658|NCT01965938|3590275|P1|Overall Study|Withdrawal by Subject|1
1097659|NCT01965834|3590306|P1|Overall Study|Lack of Efficacy|4
1097660|NCT01965652|3590347|P2|Overall Study|Pregnancy|1
1097661|NCT01965652|3590348|P1|Overall Study|Pregnancy|0
1097662|NCT01965652|3590347|P2|Overall Study|Other - Miscellaneous|21
1097663|NCT01965652|3590348|P1|Overall Study|Other - Miscellaneous|18
1097664|NCT01965652|3590347|P2|Overall Study|Death|4
1097665|NCT01965652|3590348|P1|Overall Study|Death|3
1097666|NCT01965652|3590347|P2|Overall Study|Protocol Violation|38
1097667|NCT01965652|3590348|P1|Overall Study|Protocol Violation|34
1097668|NCT01965652|3590347|P2|Overall Study|Lost to Follow-up|40
1097669|NCT01965652|3590348|P1|Overall Study|Lost to Follow-up|53
1097670|NCT01965652|3590347|P2|Overall Study|Withdrawal by Subject|69
1097671|NCT01965652|3590348|P1|Overall Study|Withdrawal by Subject|62
1097672|NCT01965652|3590347|P2|Overall Study|Adverse Event|37
1097673|NCT01965652|3590348|P1|Overall Study|Adverse Event|40
1097674|NCT01965600|3590378|P4|Second Intervention|Study terminated by Sponsor|2
1097675|NCT01965600|3590379|P3|Second Intervention|Study terminated by Sponsor|2
1097676|NCT01965600|3590380|P2|Second Intervention|Study terminated by Sponsor|0
1097677|NCT01965600|3590381|P1|Second Intervention|Study terminated by Sponsor|0
1097678|NCT01965600|3590378|P4|Washout Period of Approximately 15 Days|Adverse Event|1
1097679|NCT01965600|3590379|P3|Washout Period of Approximately 15 Days|Adverse Event|0
1097680|NCT01965600|3590380|P2|Washout Period of Approximately 15 Days|Adverse Event|0
1097681|NCT01965600|3590381|P1|Washout Period of Approximately 15 Days|Adverse Event|0
1097682|NCT01965600|3590378|P4|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
1097683|NCT01965600|3590379|P3|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
1097684|NCT01965600|3590380|P2|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
1097685|NCT01965600|3590381|P1|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1
1097686|NCT01965600|3590378|P4|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
1097687|NCT01965600|3590379|P3|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
1097688|NCT01965600|3590380|P2|Washout Period of Approximately 15 Days|Withdrawal by Subject|1
1097689|NCT01965600|3590381|P1|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
1097690|NCT01965600|3590378|P4|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
1097691|NCT01965600|3590379|P3|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2
1097692|NCT01965600|3590380|P2|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3
1097693|NCT01965600|3590381|P1|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
1097694|NCT01965535|3590438|P2|Overall Study|Lack of Efficacy|1
1097695|NCT01965535|3590439|P1|Overall Study|Lack of Efficacy|2
1097696|NCT01965431|3590453|P6|Overall Study|Other than stated above|6
1097697|NCT01965431|3590454|P5|Overall Study|Other than stated above|6
1097698|NCT01965431|3590455|P4|Overall Study|Other than stated above|6
1097699|NCT01965431|3590456|P3|Overall Study|Other than stated above|6
1097700|NCT01965431|3590457|P2|Overall Study|Other than stated above|5
1097701|NCT01965431|3590458|P1|Overall Study|Other than stated above|6
1097702|NCT01965431|3590453|P6|Overall Study|Adverse Event|0
1097703|NCT01965431|3590454|P5|Overall Study|Adverse Event|0
1097704|NCT01965431|3590455|P4|Overall Study|Adverse Event|0
1097705|NCT01965431|3590456|P3|Overall Study|Adverse Event|0
1097706|NCT01965431|3590457|P2|Overall Study|Adverse Event|1
1097707|NCT01965431|3590458|P1|Overall Study|Adverse Event|0
1097708|NCT01965327|3590482|P1|Overall Study|Physician Decision|2
1097709|NCT01965262|3590696|P2|Second Intervention (7 Days)|Poor visual acuity|0
1097710|NCT01965262|3590697|P1|Second Intervention (7 Days)|Poor visual acuity|1
1097711|NCT01965262|3590696|P2|Second Intervention (7 Days)|Poor lens fit|9
1097712|NCT01965262|3590697|P1|Second Intervention (7 Days)|Poor lens fit|0
1097713|NCT01965262|3590696|P2|Second Intervention (7 Days)|Discontinued|1
1097714|NCT01965262|3590697|P1|Second Intervention (7 Days)|Discontinued|0
1097715|NCT01965158|3590761|P2|Overall Study|Other - Miscellaneous|0
1097716|NCT01965158|3590762|P1|Overall Study|Other - Miscellaneous|3
1097717|NCT01965158|3590761|P2|Overall Study|Protocol Violation|1
1097718|NCT01965158|3590762|P1|Overall Study|Protocol Violation|1
1097719|NCT01965158|3590761|P2|Overall Study|Lost to Follow-up|5
1097720|NCT01965158|3590762|P1|Overall Study|Lost to Follow-up|7
1097721|NCT01965158|3590761|P2|Overall Study|Withdrawal by Subject|24
1097722|NCT01965158|3590762|P1|Overall Study|Withdrawal by Subject|16
1097723|NCT01965158|3590761|P2|Overall Study|Adverse Event|5
1097724|NCT01965158|3590762|P1|Overall Study|Adverse Event|14
1097725|NCT01964976|3590803|P1|Overall Study|Protocol Violation|31
1097726|NCT01964950|3590817|P1|Overall Study|Protocol Violation|25
1097727|NCT01964898|3590831|P2|Overall Study|Withdrawal by Subject|0
1097728|NCT01964898|3590832|P1|Overall Study|Withdrawal by Subject|1
1097729|NCT01964898|3590831|P2|Overall Study|Lost to Follow-up|5
1097730|NCT01964898|3590832|P1|Overall Study|Lost to Follow-up|3
1097731|NCT01964898|3590831|P2|Overall Study|did not receive the allocated interventi|1
1097732|NCT01964898|3590832|P1|Overall Study|did not receive the allocated interventi|2
1097733|NCT01964898|3590831|P2|Overall Study|ineligible post-randomization|1
1097734|NCT01964898|3590832|P1|Overall Study|ineligible post-randomization|1
1097735|NCT01964716|3590854|P2|Overall Study|Death|0
1097736|NCT01964716|3590855|P1|Overall Study|Death|1
1097737|NCT01964716|3590854|P2|Overall Study|No longer met eligibility criteria|1
1097738|NCT01964716|3590855|P1|Overall Study|No longer met eligibility criteria|1
1097739|NCT01964716|3590854|P2|Overall Study|Lost to Follow-up|2
1097740|NCT01964716|3590855|P1|Overall Study|Lost to Follow-up|1
1097741|NCT01964716|3590854|P2|Overall Study|Withdrawal by Subject|3
1097742|NCT01964716|3590855|P1|Overall Study|Withdrawal by Subject|2
1097743|NCT01964547|3590893|P2|Overall Study|Withdrawal by Investigator|1
1097744|NCT01964547|3590894|P1|Overall Study|Withdrawal by Investigator|0
1097745|NCT01964547|3590893|P2|Overall Study|Lost to Follow-up|1
1097746|NCT01964547|3590894|P1|Overall Study|Lost to Follow-up|0
1097747|NCT01964547|3590893|P2|Overall Study|Withdrawal by Subject|7
1097748|NCT01964547|3590894|P1|Overall Study|Withdrawal by Subject|4
1097749|NCT01964547|3590893|P2|Overall Study|Adverse Event|2
1097750|NCT01964547|3590894|P1|Overall Study|Adverse Event|8
1097751|NCT01964521|3590918|P1|Overall Study|Lost to Follow-up|4
1097752|NCT01964352|3590927|P4|Overall Study|Other than stated above|2
1097753|NCT01964352|3590928|P3|Overall Study|Other than stated above|1
1097754|NCT01964352|3590929|P2|Overall Study|Other than stated above|2
1097755|NCT01964352|3590930|P1|Overall Study|Other than stated above|0
1097756|NCT01964352|3590927|P4|Overall Study|Withdrawal by Subject|0
1097757|NCT01964352|3590928|P3|Overall Study|Withdrawal by Subject|1
1097758|NCT01964352|3590929|P2|Overall Study|Withdrawal by Subject|2
1097759|NCT01964352|3590930|P1|Overall Study|Withdrawal by Subject|4
1097760|NCT01964352|3590927|P4|Overall Study|Lost to Follow-up|1
1097761|NCT01964352|3590928|P3|Overall Study|Lost to Follow-up|0
1097762|NCT01964352|3590929|P2|Overall Study|Lost to Follow-up|0
1097763|NCT01964352|3590930|P1|Overall Study|Lost to Follow-up|1
1097764|NCT01964352|3590927|P4|Overall Study|Protocol Violation|2
1097765|NCT01964352|3590928|P3|Overall Study|Protocol Violation|0
1097766|NCT01964352|3590929|P2|Overall Study|Protocol Violation|4
1097767|NCT01964352|3590930|P1|Overall Study|Protocol Violation|2
1097768|NCT01964352|3590927|P4|Overall Study|Lack of Efficacy|0
1097769|NCT01964352|3590928|P3|Overall Study|Lack of Efficacy|0
1097770|NCT01964352|3590929|P2|Overall Study|Lack of Efficacy|0
1097771|NCT01964352|3590930|P1|Overall Study|Lack of Efficacy|6
1097772|NCT01964352|3590927|P4|Overall Study|Adverse Event|3
1097773|NCT01964352|3590928|P3|Overall Study|Adverse Event|4
1097774|NCT01964352|3590929|P2|Overall Study|Adverse Event|3
1097775|NCT01964352|3590930|P1|Overall Study|Adverse Event|13
1097776|NCT01964326|3590960|P1|Overall Study|Did not meet eligibility criteria|1
1097777|NCT01964326|3590960|P1|Overall Study|Other|9
1097778|NCT01964326|3590960|P1|Overall Study|Investigator Discretion|1
1097779|NCT01964326|3590960|P1|Overall Study|Physician Decision|55
1097780|NCT01964326|3590960|P1|Overall Study|No Longer Meets Eligibility Criteria|1
1097781|NCT01964326|3590960|P1|Overall Study|Pregnancy|1
1097782|NCT01964326|3590960|P1|Overall Study|Withdrawal by Subject|87
1097783|NCT01964326|3590960|P1|Overall Study|Lost to Follow-up|88
1097784|NCT01964326|3590960|P1|Overall Study|Protocol Violation|4
1097785|NCT01964326|3590960|P1|Overall Study|Death|2
1097786|NCT01964326|3590960|P1|Overall Study|Adverse Event|48
1097787|NCT01964222|3590969|P2|Overall Study|Screening Failure|0
1097788|NCT01964222|3590970|P1|Overall Study|Screening Failure|2
1097789|NCT01964222|3590969|P2|Overall Study|Withdrawal by Subject|6
1097790|NCT01964222|3590970|P1|Overall Study|Withdrawal by Subject|6
1097791|NCT01964222|3590969|P2|Overall Study|Lost to Follow-up|5
1097792|NCT01964222|3590970|P1|Overall Study|Lost to Follow-up|7
1097793|NCT01964105|3590987|P3|Overall Study|Lost to Follow-up|0
1097794|NCT01964105|3590988|P2|Overall Study|Lost to Follow-up|13
1097795|NCT01964105|3590989|P1|Overall Study|Lost to Follow-up|2
1097796|NCT01963767|3591016|P2|Overall Study|Adverse Event|0
1097797|NCT01963767|3591017|P1|Overall Study|Adverse Event|2
1097798|NCT01963767|3591016|P2|Overall Study|Withdrawal by Subject|2
1097799|NCT01963767|3591017|P1|Overall Study|Withdrawal by Subject|4
1097800|NCT01963676|3591027|P2|Overall Study|Withdrawal by Subject|0
1097801|NCT01963676|3591028|P1|Overall Study|Withdrawal by Subject|1
1097802|NCT01963611|3591041|P5|Overall Study|Other|45
1097803|NCT01963611|3591042|P4|Overall Study|Other|45
1097804|NCT01963611|3591043|P3|Overall Study|Other|48
1097805|NCT01963611|3591044|P2|Overall Study|Other|46
1097806|NCT01963611|3591045|P1|Overall Study|Other|47
1097807|NCT01963611|3591041|P5|Overall Study|Withdrawal by Subject|3
1097808|NCT01963611|3591042|P4|Overall Study|Withdrawal by Subject|1
1097809|NCT01963611|3591043|P3|Overall Study|Withdrawal by Subject|1
1097810|NCT01963611|3591044|P2|Overall Study|Withdrawal by Subject|2
1097811|NCT01963611|3591045|P1|Overall Study|Withdrawal by Subject|3
1097812|NCT01963611|3591041|P5|Overall Study|Lack of Efficacy|0
1097813|NCT01963611|3591042|P4|Overall Study|Lack of Efficacy|1
1097814|NCT01963611|3591043|P3|Overall Study|Lack of Efficacy|0
1097815|NCT01963611|3591044|P2|Overall Study|Lack of Efficacy|0
1097816|NCT01963611|3591045|P1|Overall Study|Lack of Efficacy|0
1097817|NCT01963611|3591041|P5|Overall Study|Protocol Violation|0
1097818|NCT01963611|3591042|P4|Overall Study|Protocol Violation|1
1097819|NCT01963611|3591043|P3|Overall Study|Protocol Violation|0
1097820|NCT01963611|3591044|P2|Overall Study|Protocol Violation|0
1097821|NCT01963611|3591045|P1|Overall Study|Protocol Violation|0
1097822|NCT01963611|3591041|P5|Overall Study|Adverse Event|3
1097823|NCT01963611|3591042|P4|Overall Study|Adverse Event|4
1097824|NCT01963611|3591043|P3|Overall Study|Adverse Event|3
1097825|NCT01963611|3591044|P2|Overall Study|Adverse Event|1
1097826|NCT01963611|3591045|P1|Overall Study|Adverse Event|1
1097827|NCT01963403|3591104|P2|Overall Study|Implant removal|1
1097828|NCT01963403|3591105|P1|Overall Study|Implant removal|0
1097829|NCT01963403|3591104|P2|Overall Study|Lost to Follow-up|3
1097830|NCT01963403|3591105|P1|Overall Study|Lost to Follow-up|2
1097831|NCT01963260|3591127|P10|Overall Study|Withdrawal by Subject|0
1097832|NCT01963260|3591128|P9|Overall Study|Withdrawal by Subject|0
1097833|NCT01963260|3591129|P8|Overall Study|Withdrawal by Subject|0
1097834|NCT01963260|3591130|P7|Overall Study|Withdrawal by Subject|0
1097835|NCT01963260|3591131|P6|Overall Study|Withdrawal by Subject|0
1097836|NCT01963260|3591132|P5|Overall Study|Withdrawal by Subject|2
1097837|NCT01963260|3591133|P4|Overall Study|Withdrawal by Subject|1
1097838|NCT01963260|3591134|P3|Overall Study|Withdrawal by Subject|0
1097839|NCT01963260|3591135|P2|Overall Study|Withdrawal by Subject|0
1097840|NCT01963260|3591136|P1|Overall Study|Withdrawal by Subject|2
1097841|NCT01962974|3591261|P1|Overall Study|Study termination|7
1097842|NCT01962922|3591288|P2|Extendion Portion (up to Month 6)|Physician Decision|0
1097843|NCT01962922|3591289|P1|Extendion Portion (up to Month 6)|Physician Decision|1
1097844|NCT01962922|3591288|P2|Extendion Portion (up to Month 6)|no longer wished to participate in study|3
1097845|NCT01962922|3591289|P1|Extendion Portion (up to Month 6)|no longer wished to participate in study|4
1097846|NCT01962922|3591288|P2|PK Portion Day 7|non-compliance|0
1097847|NCT01962922|3591289|P1|PK Portion Day 7|non-compliance|1
1097848|NCT01962922|3591288|P2|PK Portion Day 7|Withdrawal by Subject|0
1097849|NCT01962922|3591289|P1|PK Portion Day 7|Withdrawal by Subject|3
1097850|NCT01962493|3591366|P2|Overall Study|Withdrawal by Subject|2
1097851|NCT01962493|3591367|P1|Overall Study|Withdrawal by Subject|4
1097852|NCT01962493|3591366|P2|Overall Study|Protocol Violation|1
1097853|NCT01962493|3591367|P1|Overall Study|Protocol Violation|0
1097854|NCT01962493|3591366|P2|Overall Study|Adverse Event|2
1097855|NCT01962493|3591367|P1|Overall Study|Adverse Event|1
1097856|NCT01962441|3591390|P3|Retreatment Substudy|Lost to Follow-up|0
1097857|NCT01962441|3591391|P2|Retreatment Substudy|Lost to Follow-up|0
1097858|NCT01962441|3591392|P1|Retreatment Substudy|Lost to Follow-up|1
1097859|NCT01962441|3591390|P3|Retreatment Substudy|Lack of Efficacy|0
1097860|NCT01962441|3591391|P2|Retreatment Substudy|Lack of Efficacy|0
1097861|NCT01962441|3591392|P1|Retreatment Substudy|Lack of Efficacy|1
1097862|NCT01962441|3591390|P3|Randomized Period|Protocol Violation|0
1097863|NCT01962441|3591391|P2|Randomized Period|Protocol Violation|1
1097864|NCT01962441|3591392|P1|Randomized Period|Protocol Violation|0
1097865|NCT01962441|3591390|P3|Randomized Period|Death|2
1097866|NCT01962441|3591391|P2|Randomized Period|Death|0
1097867|NCT01962441|3591392|P1|Randomized Period|Death|0
1097868|NCT01962441|3591390|P3|Randomized Period|Adverse Event|0
1097869|NCT01962441|3591391|P2|Randomized Period|Adverse Event|1
1097870|NCT01962441|3591392|P1|Randomized Period|Adverse Event|1
1097871|NCT01962441|3591390|P3|Randomized Period|Withdrew Consent|2
1097872|NCT01962441|3591391|P2|Randomized Period|Withdrew Consent|3
1097873|NCT01962441|3591392|P1|Randomized Period|Withdrew Consent|3
1097874|NCT01962441|3591390|P3|Randomized Period|Lost to Follow-up|4
1097875|NCT01962441|3591391|P2|Randomized Period|Lost to Follow-up|4
1097876|NCT01962441|3591392|P1|Randomized Period|Lost to Follow-up|2
1097877|NCT01962441|3591390|P3|Randomized Period|Randomized but Never Treated|3
1097878|NCT01962441|3591391|P2|Randomized Period|Randomized but Never Treated|2
1097879|NCT01962441|3591392|P1|Randomized Period|Randomized but Never Treated|4
1097880|NCT01962298|3591436|P5|Overall Study|Physician Decision|1
1097881|NCT01962298|3591437|P4|Overall Study|Physician Decision|0
1097882|NCT01962298|3591438|P3|Overall Study|Physician Decision|0
1097883|NCT01962298|3591439|P2|Overall Study|Physician Decision|1
1097884|NCT01962298|3591440|P1|Overall Study|Physician Decision|0
1097885|NCT01962298|3591436|P5|Overall Study|Incorrect data recorded|0
1097886|NCT01962298|3591437|P4|Overall Study|Incorrect data recorded|0
1097887|NCT01962298|3591438|P3|Overall Study|Incorrect data recorded|0
1097888|NCT01962298|3591439|P2|Overall Study|Incorrect data recorded|1
1097889|NCT01962298|3591440|P1|Overall Study|Incorrect data recorded|0
1097890|NCT01962298|3591436|P5|Overall Study|Insufficient data|1
1097891|NCT01962298|3591437|P4|Overall Study|Insufficient data|0
1097892|NCT01962298|3591438|P3|Overall Study|Insufficient data|1
1097893|NCT01962298|3591439|P2|Overall Study|Insufficient data|2
1097894|NCT01962298|3591440|P1|Overall Study|Insufficient data|0
1097895|NCT01962298|3591436|P5|Overall Study|Data quality insufficient|4
1097896|NCT01962298|3591437|P4|Overall Study|Data quality insufficient|1
1097897|NCT01962298|3591438|P3|Overall Study|Data quality insufficient|3
1097898|NCT01962298|3591439|P2|Overall Study|Data quality insufficient|0
1097899|NCT01962298|3591440|P1|Overall Study|Data quality insufficient|2
1097900|NCT01962298|3591436|P5|Overall Study|Protocol Violation|0
1097901|NCT01962298|3591437|P4|Overall Study|Protocol Violation|1
1097902|NCT01962298|3591438|P3|Overall Study|Protocol Violation|1
1097903|NCT01962298|3591439|P2|Overall Study|Protocol Violation|0
1097904|NCT01962298|3591440|P1|Overall Study|Protocol Violation|1
1097905|NCT01962103|3591466|P9|Phase 2|Symptomatic Deterioration|0
1097906|NCT01962103|3591467|P8|Phase 2|Symptomatic Deterioration|2
1097907|NCT01962103|3591468|P7|Phase 2|Symptomatic Deterioration|2
1097908|NCT01962103|3591469|P6|Phase 2|Symptomatic Deterioration|0
1097909|NCT01962103|3591470|P5|Phase 2|Symptomatic Deterioration|0
1097910|NCT01962103|3591471|P4|Phase 2|Symptomatic Deterioration|0
1097911|NCT01962103|3591472|P3|Phase 2|Symptomatic Deterioration|0
1097912|NCT01962103|3591473|P2|Phase 2|Symptomatic Deterioration|0
1097913|NCT01962103|3591474|P1|Phase 2|Symptomatic Deterioration|0
1097914|NCT01962103|3591466|P9|Phase 2|Progressive Disease|11
1097915|NCT01962103|3591467|P8|Phase 2|Progressive Disease|12
1097916|NCT01962103|3591468|P7|Phase 2|Progressive Disease|11
1097917|NCT01962103|3591469|P6|Phase 2|Progressive Disease|0
1097918|NCT01962103|3591470|P5|Phase 2|Progressive Disease|0
1097919|NCT01962103|3591471|P4|Phase 2|Progressive Disease|0
1097920|NCT01962103|3591472|P3|Phase 2|Progressive Disease|0
1097921|NCT01962103|3591473|P2|Phase 2|Progressive Disease|0
1097922|NCT01962103|3591474|P1|Phase 2|Progressive Disease|0
1097923|NCT01962103|3591466|P9|Phase 2|Adverse Event|3
1097924|NCT01962103|3591467|P8|Phase 2|Adverse Event|0
1097925|NCT01962103|3591468|P7|Phase 2|Adverse Event|1
1097926|NCT01962103|3591469|P6|Phase 2|Adverse Event|0
1097927|NCT01962103|3591470|P5|Phase 2|Adverse Event|0
1097928|NCT01962103|3591471|P4|Phase 2|Adverse Event|0
1097929|NCT01962103|3591472|P3|Phase 2|Adverse Event|0
1097930|NCT01962103|3591473|P2|Phase 2|Adverse Event|0
1097931|NCT01962103|3591474|P1|Phase 2|Adverse Event|0
1097932|NCT01962103|3591466|P9|Phase 1|Miscellaneous|0
1097933|NCT01962103|3591467|P8|Phase 1|Miscellaneous|0
1097934|NCT01962103|3591468|P7|Phase 1|Miscellaneous|0
1097935|NCT01962103|3591469|P6|Phase 1|Miscellaneous|0
1097936|NCT01962103|3591470|P5|Phase 1|Miscellaneous|0
1097937|NCT01962103|3591471|P4|Phase 1|Miscellaneous|0
1097938|NCT01962103|3591472|P3|Phase 1|Miscellaneous|0
1097939|NCT01962103|3591473|P2|Phase 1|Miscellaneous|0
1097940|NCT01962103|3591474|P1|Phase 1|Miscellaneous|1
1097941|NCT01962103|3591466|P9|Phase 1|Symptomatic Deterioration|0
1097942|NCT01962103|3591467|P8|Phase 1|Symptomatic Deterioration|0
1097943|NCT01962103|3591468|P7|Phase 1|Symptomatic Deterioration|0
1097944|NCT01962103|3591469|P6|Phase 1|Symptomatic Deterioration|1
1097945|NCT01962103|3591470|P5|Phase 1|Symptomatic Deterioration|1
1097946|NCT01962103|3591471|P4|Phase 1|Symptomatic Deterioration|2
1097947|NCT01962103|3591472|P3|Phase 1|Symptomatic Deterioration|2
1097948|NCT01962103|3591473|P2|Phase 1|Symptomatic Deterioration|2
1097949|NCT01962103|3591474|P1|Phase 1|Symptomatic Deterioration|3
1097950|NCT01962103|3591466|P9|Phase 1|Physician Decision|0
1097951|NCT01962103|3591467|P8|Phase 1|Physician Decision|0
1097952|NCT01962103|3591468|P7|Phase 1|Physician Decision|0
1097953|NCT01962103|3591469|P6|Phase 1|Physician Decision|0
1097954|NCT01962103|3591470|P5|Phase 1|Physician Decision|0
1097955|NCT01962103|3591471|P4|Phase 1|Physician Decision|1
1097956|NCT01962103|3591472|P3|Phase 1|Physician Decision|0
1097957|NCT01962103|3591473|P2|Phase 1|Physician Decision|0
1097958|NCT01962103|3591474|P1|Phase 1|Physician Decision|0
1097959|NCT01962103|3591466|P9|Phase 1|Withdrawal by Parent/Guardian|0
1097960|NCT01962103|3591467|P8|Phase 1|Withdrawal by Parent/Guardian|0
1097961|NCT01962103|3591468|P7|Phase 1|Withdrawal by Parent/Guardian|0
1097962|NCT01962103|3591469|P6|Phase 1|Withdrawal by Parent/Guardian|0
1097963|NCT01962103|3591470|P5|Phase 1|Withdrawal by Parent/Guardian|0
1097964|NCT01962103|3591471|P4|Phase 1|Withdrawal by Parent/Guardian|1
1097965|NCT01962103|3591472|P3|Phase 1|Withdrawal by Parent/Guardian|2
1097966|NCT01962103|3591473|P2|Phase 1|Withdrawal by Parent/Guardian|0
1097967|NCT01962103|3591474|P1|Phase 1|Withdrawal by Parent/Guardian|0
1097968|NCT01962103|3591466|P9|Phase 1|Withdrawal by Subject|0
1097969|NCT01962103|3591467|P8|Phase 1|Withdrawal by Subject|0
1097970|NCT01962103|3591468|P7|Phase 1|Withdrawal by Subject|0
1097971|NCT01962103|3591469|P6|Phase 1|Withdrawal by Subject|0
1097972|NCT01962103|3591470|P5|Phase 1|Withdrawal by Subject|0
1097973|NCT01962103|3591471|P4|Phase 1|Withdrawal by Subject|2
1097974|NCT01962103|3591472|P3|Phase 1|Withdrawal by Subject|0
1097975|NCT01962103|3591473|P2|Phase 1|Withdrawal by Subject|0
1097976|NCT01962103|3591474|P1|Phase 1|Withdrawal by Subject|0
1097977|NCT01962103|3591466|P9|Phase 1|Progressive Disease|0
1097978|NCT01962103|3591467|P8|Phase 1|Progressive Disease|0
1097979|NCT01962103|3591468|P7|Phase 1|Progressive Disease|0
1097980|NCT01962103|3591469|P6|Phase 1|Progressive Disease|4
1097981|NCT01962103|3591470|P5|Phase 1|Progressive Disease|5
1097982|NCT01962103|3591471|P4|Phase 1|Progressive Disease|4
1097983|NCT01962103|3591472|P3|Phase 1|Progressive Disease|8
1097984|NCT01962103|3591473|P2|Phase 1|Progressive Disease|6
1097985|NCT01962103|3591474|P1|Phase 1|Progressive Disease|8
1097986|NCT01962103|3591466|P9|Phase 1|Adverse Event|0
1097987|NCT01962103|3591467|P8|Phase 1|Adverse Event|0
1097988|NCT01962103|3591468|P7|Phase 1|Adverse Event|0
1097989|NCT01962103|3591469|P6|Phase 1|Adverse Event|2
1097990|NCT01962103|3591470|P5|Phase 1|Adverse Event|2
1097991|NCT01962103|3591471|P4|Phase 1|Adverse Event|1
1097992|NCT01962103|3591472|P3|Phase 1|Adverse Event|2
1097993|NCT01962103|3591473|P2|Phase 1|Adverse Event|0
1097994|NCT01962103|3591474|P1|Phase 1|Adverse Event|4
1097995|NCT01961544|3591584|P1|Overall Study|Aggravation of Steral Pain|1
1097996|NCT01961544|3591584|P1|Overall Study|Poor Tolerance|1
1097997|NCT01961544|3591584|P1|Overall Study|Physician Decision|2
1097998|NCT01961544|3591584|P1|Overall Study|Adverse Event|1
1097999|NCT01961544|3591584|P1|Overall Study|Withdrawal by Subject|7
1098000|NCT01961544|3591584|P1|Overall Study|Protocol Violation|1
1098001|NCT01961349|3591592|P3|Overall Study|registration error, personal reason etc|1
1098002|NCT01961349|3591593|P2|Overall Study|registration error, personal reason etc|2
1098003|NCT01961349|3591594|P1|Overall Study|registration error, personal reason etc|2
1098004|NCT01961349|3591592|P3|Overall Study|Adverse Event|1
1098005|NCT01961349|3591593|P2|Overall Study|Adverse Event|0
1098006|NCT01961349|3591594|P1|Overall Study|Adverse Event|0
1098007|NCT01961349|3591592|P3|Overall Study|Withdrawal by Subject|0
1098008|NCT01961349|3591593|P2|Overall Study|Withdrawal by Subject|4
1098009|NCT01961349|3591594|P1|Overall Study|Withdrawal by Subject|1
1098010|NCT01961323|3591605|P1|Overall Study|screen failure|34
1098011|NCT01961323|3591605|P1|Overall Study|Lost to Follow-up|8
1098012|NCT01961323|3591605|P1|Overall Study|Withdrawal by Subject|7
1098013|NCT01961297|3591613|P2|Overall Study|unconfirmed diagnosis of SD|1
1098014|NCT01961297|3591614|P1|Overall Study|unconfirmed diagnosis of SD|2
1098015|NCT01961115|3591640|P3|Overall Study|Adverse Event|1
1098016|NCT01961115|3591641|P2|Overall Study|Adverse Event|0
1098017|NCT01961115|3591642|P1|Overall Study|Adverse Event|1
1098018|NCT01961115|3591640|P3|Overall Study|Disease Progression|3
1098019|NCT01961115|3591641|P2|Overall Study|Disease Progression|0
1098020|NCT01961115|3591642|P1|Overall Study|Disease Progression|1
1098021|NCT01960907|3591685|P2|Overall Study|Withdrawal by Subject|42
1098022|NCT01960907|3591686|P1|Overall Study|Withdrawal by Subject|32
1098023|NCT01960907|3591685|P2|Overall Study|Death|3
1098024|NCT01960907|3591686|P1|Overall Study|Death|4
1098025|NCT01960855|3591701|P5|Overall Study|Lost to Follow-up|2
1098026|NCT01960855|3591702|P4|Overall Study|Lost to Follow-up|0
1098027|NCT01960855|3591703|P3|Overall Study|Lost to Follow-up|0
1098028|NCT01960855|3591704|P2|Overall Study|Lost to Follow-up|1
1098029|NCT01960855|3591705|P1|Overall Study|Lost to Follow-up|2
1098030|NCT01960855|3591701|P5|Overall Study|Consent withdrawn by subject|1
1098031|NCT01960855|3591702|P4|Overall Study|Consent withdrawn by subject|1
1098032|NCT01960855|3591703|P3|Overall Study|Consent withdrawn by subject|2
1098033|NCT01960855|3591704|P2|Overall Study|Consent withdrawn by subject|1
1098034|NCT01960855|3591705|P1|Overall Study|Consent withdrawn by subject|3
1098035|NCT01960855|3591701|P5|Overall Study|Not specified|0
1098036|NCT01960855|3591702|P4|Overall Study|Not specified|1
1098037|NCT01960855|3591703|P3|Overall Study|Not specified|1
1098038|NCT01960855|3591704|P2|Overall Study|Not specified|1
1098039|NCT01960855|3591705|P1|Overall Study|Not specified|2
1098040|NCT01960855|3591701|P5|Overall Study|Lack of Efficacy|0
1098041|NCT01960855|3591702|P4|Overall Study|Lack of Efficacy|0
1098042|NCT01960855|3591703|P3|Overall Study|Lack of Efficacy|0
1098043|NCT01960855|3591704|P2|Overall Study|Lack of Efficacy|1
1098044|NCT01960855|3591705|P1|Overall Study|Lack of Efficacy|1
1098045|NCT01960855|3591701|P5|Overall Study|Adverse Event|2
1098046|NCT01960855|3591702|P4|Overall Study|Adverse Event|2
1098047|NCT01960855|3591703|P3|Overall Study|Adverse Event|6
1098048|NCT01960855|3591704|P2|Overall Study|Adverse Event|0
1098049|NCT01960855|3591705|P1|Overall Study|Adverse Event|2
1098050|NCT01960855|3591701|P5|Overall Study|Subject noncompliant|0
1098051|NCT01960855|3591702|P4|Overall Study|Subject noncompliant|0
1098052|NCT01960855|3591703|P3|Overall Study|Subject noncompliant|0
1098053|NCT01960855|3591704|P2|Overall Study|Subject noncompliant|0
1098054|NCT01960855|3591705|P1|Overall Study|Subject noncompliant|1
1098055|NCT01960842|3591737|P1|Overall Study|Withdrawal by Subject|2
1098056|NCT01960842|3591737|P1|Overall Study|Adverse Event|1
1098057|NCT01960816|3591760|P1|Overall Study|Lost to Follow-up|1
1098058|NCT01960725|3591768|P2|Overall Study|unable to obtain blood sample|2
1098059|NCT01960725|3591769|P1|Overall Study|unable to obtain blood sample|1
1098060|NCT01960725|3591768|P2|Overall Study|Withdrawal by Subject|0
1098061|NCT01960725|3591769|P1|Overall Study|Withdrawal by Subject|1
1098062|NCT01960725|3591768|P2|Overall Study|Lost to Follow-up|3
1098063|NCT01960725|3591769|P1|Overall Study|Lost to Follow-up|4
1098064|NCT01960348|3591848|P2|Overall Study|Protocol Violation|0
1098065|NCT01960348|3591849|P1|Overall Study|Protocol Violation|1
1098066|NCT01960348|3591848|P2|Overall Study|Physician Decision|1
1098067|NCT01960348|3591849|P1|Overall Study|Physician Decision|0
1098068|NCT01960348|3591848|P2|Overall Study|Withdrawal by Subject|11
1098069|NCT01960348|3591849|P1|Overall Study|Withdrawal by Subject|1
1098070|NCT01960348|3591848|P2|Overall Study|Adverse event, serious non-fatal|3
1098071|NCT01960348|3591849|P1|Overall Study|Adverse event, serious non-fatal|0
1098072|NCT01960348|3591848|P2|Overall Study|Adverse event, serious fatal|5
1098073|NCT01960348|3591849|P1|Overall Study|Adverse event, serious fatal|6
1098074|NCT01960348|3591848|P2|Overall Study|Adverse event, not serious|2
1098075|NCT01960348|3591849|P1|Overall Study|Adverse event, not serious|2
1098076|NCT01960296|3591869|P2|Overall Study|Received different procedure|3
1098077|NCT01960296|3591870|P1|Overall Study|Received different procedure|1
1098078|NCT01960296|3591869|P2|Overall Study|Postponed surgery|0
1098079|NCT01960296|3591870|P1|Overall Study|Postponed surgery|1
1098080|NCT01960140|3591890|P1|Period 2 (Days 3-18)|Adverse Event|2
1098081|NCT01960114|3591901|P2|Overall Study|Could not swallow study medication|1
1098082|NCT01960114|3591902|P1|Overall Study|Could not swallow study medication|0
1098083|NCT01960114|3591901|P2|Overall Study|Adverse Event|0
1098084|NCT01960114|3591902|P1|Overall Study|Adverse Event|1
1098085|NCT01959932|3591948|P3|Overall Study|Withdrawal by Subject|0
1098086|NCT01959932|3591949|P2|Overall Study|Withdrawal by Subject|0
1098087|NCT01959932|3591950|P1|Overall Study|Withdrawal by Subject|1
1098088|NCT01959919|3591968|P1|Overall Study|Did not meet the eligibility criteria|2
1098089|NCT01959880|3591982|P4|Overall Study|Study completed early-FDA approved|152
1098090|NCT01959880|3591983|P3|Overall Study|Study completed early-FDA approved|179
1098091|NCT01959880|3591984|P2|Overall Study|Study completed early-FDA approved|311
1098092|NCT01959880|3591985|P1|Overall Study|Study completed early-FDA approved|1003
1098093|NCT01959880|3591982|P4|Overall Study|Explantation w/o study device reimplant.|12
1098094|NCT01959880|3591983|P3|Overall Study|Explantation w/o study device reimplant.|5
1098095|NCT01959880|3591984|P2|Overall Study|Explantation w/o study device reimplant.|17
1098096|NCT01959880|3591985|P1|Overall Study|Explantation w/o study device reimplant.|22
1098097|NCT01959880|3591982|P4|Overall Study|Lost to Follow-up|8
1098098|NCT01959880|3591983|P3|Overall Study|Lost to Follow-up|15
1098099|NCT01959880|3591984|P2|Overall Study|Lost to Follow-up|18
1098100|NCT01959880|3591985|P1|Overall Study|Lost to Follow-up|95
1098101|NCT01959880|3591982|P4|Overall Study|Death|2
1098102|NCT01959880|3591983|P3|Overall Study|Death|1
1098103|NCT01959880|3591984|P2|Overall Study|Death|10
1098104|NCT01959880|3591985|P1|Overall Study|Death|1
1098105|NCT01959880|3591982|P4|Overall Study|Withdrawal by Subject|7
1098106|NCT01959880|3591983|P3|Overall Study|Withdrawal by Subject|8
1098107|NCT01959880|3591984|P2|Overall Study|Withdrawal by Subject|13
1098108|NCT01959880|3591985|P1|Overall Study|Withdrawal by Subject|11
1098109|NCT01959841|3592010|P3|Overall Study|Platelet count below on day1 or 4|11
1098110|NCT01959841|3592011|P2|Overall Study|Platelet count below on day1 or 4|15
1098111|NCT01959841|3592012|P1|Overall Study|Platelet count below on day1 or 4|11
1098112|NCT01959841|3592010|P3|Overall Study|Clinical laboratory value|6
1098113|NCT01959841|3592011|P2|Overall Study|Clinical laboratory value|6
1098114|NCT01959841|3592012|P1|Overall Study|Clinical laboratory value|2
1098115|NCT01959841|3592010|P3|Overall Study|Withdrawal by Subject|5
1098116|NCT01959841|3592011|P2|Overall Study|Withdrawal by Subject|7
1098117|NCT01959841|3592012|P1|Overall Study|Withdrawal by Subject|7
1098118|NCT01959841|3592010|P3|Overall Study|Protocol Violation|16
1098119|NCT01959841|3592011|P2|Overall Study|Protocol Violation|23
1098120|NCT01959841|3592012|P1|Overall Study|Protocol Violation|16
1098121|NCT01959841|3592010|P3|Overall Study|Physician Decision|3
1098122|NCT01959841|3592011|P2|Overall Study|Physician Decision|2
1098123|NCT01959841|3592012|P1|Overall Study|Physician Decision|0
1098124|NCT01959841|3592010|P3|Overall Study|Lost to Follow-up|0
1098125|NCT01959841|3592011|P2|Overall Study|Lost to Follow-up|1
1098126|NCT01959841|3592012|P1|Overall Study|Lost to Follow-up|1
1098127|NCT01959841|3592010|P3|Overall Study|Lack of Efficacy|0
1098128|NCT01959841|3592011|P2|Overall Study|Lack of Efficacy|0
1098129|NCT01959841|3592012|P1|Overall Study|Lack of Efficacy|5
1098130|NCT01959841|3592010|P3|Overall Study|Adverse Event|2
1098131|NCT01959841|3592011|P2|Overall Study|Adverse Event|3
1098132|NCT01959841|3592012|P1|Overall Study|Adverse Event|1
1098133|NCT01959607|3592042|P4|First Intervention (Day 1)|Withdrawal by Subject|0
1098134|NCT01959607|3592043|P3|First Intervention (Day 1)|Withdrawal by Subject|0
1098135|NCT01959607|3592044|P2|First Intervention (Day 1)|Withdrawal by Subject|1
1098136|NCT01959607|3592045|P1|First Intervention (Day 1)|Withdrawal by Subject|1
1098137|NCT01959581|3592058|P1|Overall Study|Lost to Follow-up|5
1098138|NCT01959529|3592064|P2|Overall Study|Lack of glycaemic control|1
1098139|NCT01959529|3592065|P1|Overall Study|Lack of glycaemic control|1
1098140|NCT01959529|3592064|P2|Overall Study|Hypoglycaemia|1
1098141|NCT01959529|3592065|P1|Overall Study|Hypoglycaemia|1
1098142|NCT01959529|3592064|P2|Overall Study|Other|68
1098143|NCT01959529|3592065|P1|Overall Study|Other|70
1098144|NCT01959529|3592064|P2|Overall Study|Lost to Follow-up|1
1098145|NCT01959529|3592065|P1|Overall Study|Lost to Follow-up|4
1098146|NCT01959529|3592064|P2|Overall Study|Adverse event (not hypoglycaemia)|1
1098147|NCT01959529|3592065|P1|Overall Study|Adverse event (not hypoglycaemia)|0
1098148|NCT01959516|3592077|P2|Epoch 2|Moderate or severe COPD exacerbation|1
1098149|NCT01959516|3592078|P1|Epoch 2|Moderate or severe COPD exacerbation|0
1098150|NCT01959516|3592077|P2|Epoch 2|Subject withdrew consent|0
1098151|NCT01959516|3592078|P1|Epoch 2|Subject withdrew consent|1
1098152|NCT01959516|3592077|P2|Epoch 2|unsatisfactory therapeutic effect|0
1098153|NCT01959516|3592078|P1|Epoch 2|unsatisfactory therapeutic effect|1
1098154|NCT01959516|3592077|P2|Epoch 1|Protocol deviation|1
1098155|NCT01959516|3592078|P1|Epoch 1|Protocol deviation|0
1098156|NCT01959516|3592077|P2|Epoch 1|Moderate or severe COPD exacerbation|1
1098157|NCT01959516|3592078|P1|Epoch 1|Moderate or severe COPD exacerbation|0
1098158|NCT01959516|3592077|P2|Epoch 1|Use of prohibited treatment|0
1098159|NCT01959516|3592078|P1|Epoch 1|Use of prohibited treatment|1
1098160|NCT01959516|3592077|P2|Epoch 1|Administrative problems|0
1098161|NCT01959516|3592078|P1|Epoch 1|Administrative problems|1
1098162|NCT01959516|3592077|P2|Epoch 1|Subject withdrew consent|2
1098163|NCT01959516|3592078|P1|Epoch 1|Subject withdrew consent|3
1098164|NCT01959516|3592077|P2|Epoch 1|unsatisfactory therapeutic effect|0
1098165|NCT01959516|3592078|P1|Epoch 1|unsatisfactory therapeutic effect|1
1098166|NCT01959516|3592077|P2|Epoch 1|Adverse Event|1
1098167|NCT01959516|3592078|P1|Epoch 1|Adverse Event|4
1098168|NCT01959503|3592088|P2|Overall Study|Randomized but not treated|1
1098169|NCT01959503|3592089|P1|Overall Study|Randomized but not treated|1
1098170|NCT01959503|3592088|P2|Overall Study|Death|1
1098171|NCT01959503|3592089|P1|Overall Study|Death|2
1098172|NCT01959412|3592109|P6|Overall Study|Adverse Event|0
1098173|NCT01959412|3592110|P5|Overall Study|Adverse Event|0
1098174|NCT01959412|3592111|P4|Overall Study|Adverse Event|1
1098175|NCT01959412|3592112|P3|Overall Study|Adverse Event|0
1098176|NCT01959412|3592113|P2|Overall Study|Adverse Event|0
1098177|NCT01959412|3592114|P1|Overall Study|Adverse Event|0
1098178|NCT01959412|3592109|P6|Overall Study|Protocol deviation|0
1098179|NCT01959412|3592110|P5|Overall Study|Protocol deviation|3
1098180|NCT01959412|3592111|P4|Overall Study|Protocol deviation|1
1098181|NCT01959412|3592112|P3|Overall Study|Protocol deviation|0
1098182|NCT01959412|3592113|P2|Overall Study|Protocol deviation|1
1098183|NCT01959412|3592114|P1|Overall Study|Protocol deviation|1
1098184|NCT01959035|3592152|P1|Overall Study|Other (no primary reason given)|1
1098185|NCT01959035|3592152|P1|Overall Study|Lost to Follow-up|1
1098186|NCT01959035|3592152|P1|Overall Study|Withdrawal by Subject|4
1098187|NCT01959035|3592152|P1|Overall Study|Adverse Event|5
1098188|NCT01958827|3592178|P1|Overall Study|Concomitant Prohibited Medicine for AE|1
1098189|NCT01958827|3592178|P1|Overall Study|Lack of Efficacy|6
1098190|NCT01958827|3592178|P1|Overall Study|Adverse Event|3
1098191|NCT01958671|3592209|P3|Overall Study|Withdrawal by Subject|13
1098192|NCT01958671|3592210|P2|Overall Study|Withdrawal by Subject|10
1098193|NCT01958671|3592211|P1|Overall Study|Withdrawal by Subject|8
1098194|NCT01958671|3592209|P3|Overall Study|Participant moved|1
1098195|NCT01958671|3592210|P2|Overall Study|Participant moved|0
1098196|NCT01958671|3592211|P1|Overall Study|Participant moved|0
1098197|NCT01958671|3592209|P3|Overall Study|Study site terminated by sponsor|1
1098198|NCT01958671|3592210|P2|Overall Study|Study site terminated by sponsor|0
1098199|NCT01958671|3592211|P1|Overall Study|Study site terminated by sponsor|1
1098200|NCT01958671|3592209|P3|Overall Study|Protocol Violation|0
1098201|NCT01958671|3592210|P2|Overall Study|Protocol Violation|1
1098202|NCT01958671|3592211|P1|Overall Study|Protocol Violation|0
1098203|NCT01958671|3592209|P3|Overall Study|Pregnancy|1
1098204|NCT01958671|3592210|P2|Overall Study|Pregnancy|0
1098205|NCT01958671|3592211|P1|Overall Study|Pregnancy|0
1098206|NCT01958671|3592209|P3|Overall Study|Non-compliance with study drug|1
1098207|NCT01958671|3592210|P2|Overall Study|Non-compliance with study drug|1
1098208|NCT01958671|3592211|P1|Overall Study|Non-compliance with study drug|1
1098209|NCT01958671|3592209|P3|Overall Study|Lost to Follow-up|7
1098210|NCT01958671|3592210|P2|Overall Study|Lost to Follow-up|11
1098211|NCT01958671|3592211|P1|Overall Study|Lost to Follow-up|7
1098212|NCT01958671|3592209|P3|Overall Study|Hyperglycemia|2
1098213|NCT01958671|3592210|P2|Overall Study|Hyperglycemia|0
1098214|NCT01958671|3592211|P1|Overall Study|Hyperglycemia|0
1098215|NCT01958671|3592209|P3|Overall Study|Excluded medication|1
1098216|NCT01958671|3592210|P2|Overall Study|Excluded medication|0
1098217|NCT01958671|3592211|P1|Overall Study|Excluded medication|0
1098218|NCT01958671|3592209|P3|Overall Study|Death|0
1098219|NCT01958671|3592210|P2|Overall Study|Death|0
1098220|NCT01958671|3592211|P1|Overall Study|Death|1
1098221|NCT01958671|3592209|P3|Overall Study|Adverse Event|5
1098222|NCT01958671|3592210|P2|Overall Study|Adverse Event|1
1098223|NCT01958671|3592211|P1|Overall Study|Adverse Event|1
1098224|NCT01958619|3592285|P4|Overall Study|Protocol Violation|0
1098225|NCT01958619|3592286|P3|Overall Study|Protocol Violation|1
1098226|NCT01958619|3592287|P2|Overall Study|Protocol Violation|0
1098227|NCT01958619|3592288|P1|Overall Study|Protocol Violation|2
1098228|NCT01958489|3592349|P2|Period 2|Adverse Event|1
1098229|NCT01958489|3592350|P1|Period 2|Adverse Event|0
1098230|NCT01958437|3592366|P4|Overall Study|Incidental MRI findings|1
1098231|NCT01958437|3592367|P3|Overall Study|Incidental MRI findings|1
1098232|NCT01958437|3592368|P2|Overall Study|Incidental MRI findings|0
1098233|NCT01958437|3592369|P1|Overall Study|Incidental MRI findings|0
1098234|NCT01958281|3592436|P3|Overall Study|Withdrew Consent|0
1098235|NCT01958281|3592437|P2|Overall Study|Withdrew Consent|0
1098236|NCT01958281|3592438|P1|Overall Study|Withdrew Consent|1
1098237|NCT01958281|3592436|P3|Overall Study|Adverse Event|0
1098238|NCT01958281|3592437|P2|Overall Study|Adverse Event|2
1098239|NCT01958281|3592438|P1|Overall Study|Adverse Event|0
1098240|NCT01958281|3592436|P3|Overall Study|Lack of Efficacy|0
1098241|NCT01958281|3592437|P2|Overall Study|Lack of Efficacy|2
1098242|NCT01958281|3592438|P1|Overall Study|Lack of Efficacy|5
1098243|NCT01958164|3592514|P2|Overall Study|Lost to Follow-up|3
1098244|NCT01958164|3592515|P1|Overall Study|Lost to Follow-up|2
1098245|NCT01958164|3592514|P2|Overall Study|Adverse Event|2
1098246|NCT01958164|3592515|P1|Overall Study|Adverse Event|0
1098247|NCT01958060|3592534|P6|Overall Study|Not treated|0
1098248|NCT01958060|3592535|P5|Overall Study|Not treated|1
1098249|NCT01958060|3592536|P4|Overall Study|Not treated|0
1098250|NCT01958060|3592537|P3|Overall Study|Not treated|0
1098251|NCT01958060|3592538|P2|Overall Study|Not treated|0
1098252|NCT01958060|3592539|P1|Overall Study|Not treated|2
1098253|NCT01958021|3592564|P2|Overall Study|Death|0
1098254|NCT01958021|3592565|P1|Overall Study|Death|2
1098255|NCT01958021|3592564|P2|Overall Study|Protocol Violation|1
1098256|NCT01958021|3592565|P1|Overall Study|Protocol Violation|3
1098257|NCT01958021|3592564|P2|Overall Study|Physician Decision|13
1098258|NCT01958021|3592565|P1|Overall Study|Physician Decision|10
1098259|NCT01958021|3592564|P2|Overall Study|Subject/guardian decision|13
1098260|NCT01958021|3592565|P1|Overall Study|Subject/guardian decision|12
1098261|NCT01958021|3592564|P2|Overall Study|Adverse Event|7
1098262|NCT01958021|3592565|P1|Overall Study|Adverse Event|25
1098263|NCT01958021|3592564|P2|Overall Study|Progressive disease|146
1098264|NCT01958021|3592565|P1|Overall Study|Progressive disease|87
1098265|NCT01958008|3592577|P4|Overall Study|Other adverse event|0
1098266|NCT01958008|3592578|P3|Overall Study|Other adverse event|0
1098267|NCT01958008|3592579|P2|Overall Study|Other adverse event|0
1098268|NCT01958008|3592580|P1|Overall Study|Other adverse event|1
1098269|NCT01958008|3592577|P4|Overall Study|Worsening of disease under study|0
1098270|NCT01958008|3592578|P3|Overall Study|Worsening of disease under study|1
1098271|NCT01958008|3592579|P2|Overall Study|Worsening of disease under study|0
1098272|NCT01958008|3592580|P1|Overall Study|Worsening of disease under study|0
1098273|NCT01957865|3592620|P3|Overall Study|Lost to Follow-up|2
1098274|NCT01957865|3592621|P2|Overall Study|Lost to Follow-up|2
1098275|NCT01957865|3592622|P1|Overall Study|Lost to Follow-up|0
1098276|NCT01957865|3592620|P3|Overall Study|Found HIV negative|1
1098277|NCT01957865|3592621|P2|Overall Study|Found HIV negative|0
1098278|NCT01957865|3592622|P1|Overall Study|Found HIV negative|0
1098279|NCT01957579|3592655|P4|Overall Study|Death|0
1098280|NCT01957579|3592656|P3|Overall Study|Death|2
1098281|NCT01957579|3592657|P2|Overall Study|Death|0
1098282|NCT01957579|3592658|P1|Overall Study|Death|0
1098283|NCT01957579|3592655|P4|Overall Study|Withdrawal of concent|0
1098284|NCT01957579|3592656|P3|Overall Study|Withdrawal of concent|0
1098285|NCT01957579|3592657|P2|Overall Study|Withdrawal of concent|1
1098286|NCT01957579|3592658|P1|Overall Study|Withdrawal of concent|0
1098287|NCT01957553|3592725|P2|Test Period 2 (21 +- 1 Days)|Other|0
1098288|NCT01957553|3592726|P1|Test Period 2 (21 +- 1 Days)|Other|1
1098289|NCT01957553|3592725|P2|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1
1098290|NCT01957553|3592726|P1|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0
1098291|NCT01957553|3592725|P2|Test Period 2 (21 +- 1 Days)|completed early by mistake|1
1098292|NCT01957553|3592726|P1|Test Period 2 (21 +- 1 Days)|completed early by mistake|0
1098293|NCT01957553|3592725|P2|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2
1098294|NCT01957553|3592726|P1|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1
1098295|NCT01957553|3592725|P2|Test Period 2 (21 +- 1 Days)|Adverse Event|3
1098296|NCT01957553|3592726|P1|Test Period 2 (21 +- 1 Days)|Adverse Event|1
1098297|NCT01957553|3592725|P2|Test Period 1 (21 +- 1 Days)|screen failure|0
1098298|NCT01957553|3592726|P1|Test Period 1 (21 +- 1 Days)|screen failure|1
1098299|NCT01957553|3592725|P2|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0
1098300|NCT01957553|3592726|P1|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2
1098301|NCT01957553|3592725|P2|Test Period 1 (21 +- 1 Days)|Adverse Event|0
1098302|NCT01957553|3592726|P1|Test Period 1 (21 +- 1 Days)|Adverse Event|2
1098303|NCT01957553|3592725|P2|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3
1098304|NCT01957553|3592726|P1|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2
1098305|NCT01957488|3592732|P6|Test Period 3|Lack of Efficacy|0
1098306|NCT01957488|3592733|P5|Test Period 3|Lack of Efficacy|0
1098307|NCT01957488|3592734|P4|Test Period 3|Lack of Efficacy|0
1098308|NCT01957488|3592735|P3|Test Period 3|Lack of Efficacy|0
1098309|NCT01957488|3592736|P2|Test Period 3|Lack of Efficacy|1
1098310|NCT01957488|3592737|P1|Test Period 3|Lack of Efficacy|0
1098311|NCT01957488|3592732|P6|Test Period 3|Withdrawal by Subject|0
1098312|NCT01957488|3592733|P5|Test Period 3|Withdrawal by Subject|0
1098313|NCT01957488|3592734|P4|Test Period 3|Withdrawal by Subject|0
1098314|NCT01957488|3592735|P3|Test Period 3|Withdrawal by Subject|0
1098315|NCT01957488|3592736|P2|Test Period 3|Withdrawal by Subject|0
1098316|NCT01957488|3592737|P1|Test Period 3|Withdrawal by Subject|1
1098317|NCT01957488|3592732|P6|Test Period 2|Discontinue due to personal problems|1
1098318|NCT01957488|3592733|P5|Test Period 2|Discontinue due to personal problems|0
1098319|NCT01957488|3592734|P4|Test Period 2|Discontinue due to personal problems|0
1098320|NCT01957488|3592735|P3|Test Period 2|Discontinue due to personal problems|0
1098321|NCT01957488|3592736|P2|Test Period 2|Discontinue due to personal problems|0
1098322|NCT01957488|3592737|P1|Test Period 2|Discontinue due to personal problems|0
1098323|NCT01957488|3592732|P6|Test Period 2|Adverse Event|0
1098324|NCT01957488|3592733|P5|Test Period 2|Adverse Event|2
1098325|NCT01957488|3592734|P4|Test Period 2|Adverse Event|0
1098326|NCT01957488|3592735|P3|Test Period 2|Adverse Event|0
1098327|NCT01957488|3592736|P2|Test Period 2|Adverse Event|0
1098328|NCT01957488|3592737|P1|Test Period 2|Adverse Event|0
1098329|NCT01957488|3592732|P6|Test Period 2|Withdrawal by Subject|0
1098330|NCT01957488|3592733|P5|Test Period 2|Withdrawal by Subject|0
1098331|NCT01957488|3592734|P4|Test Period 2|Withdrawal by Subject|0
1098332|NCT01957488|3592735|P3|Test Period 2|Withdrawal by Subject|0
1098333|NCT01957488|3592736|P2|Test Period 2|Withdrawal by Subject|1
1098334|NCT01957488|3592737|P1|Test Period 2|Withdrawal by Subject|0
1098335|NCT01957488|3592732|P6|Test Period 2|Other|0
1098336|NCT01957488|3592733|P5|Test Period 2|Other|0
1098337|NCT01957488|3592734|P4|Test Period 2|Other|0
1098338|NCT01957488|3592735|P3|Test Period 2|Other|0
1098339|NCT01957488|3592736|P2|Test Period 2|Other|0
1098340|NCT01957488|3592737|P1|Test Period 2|Other|1
1098341|NCT01957488|3592732|P6|Test Period 2|Protocol Violation|0
1098342|NCT01957488|3592733|P5|Test Period 2|Protocol Violation|0
1098343|NCT01957488|3592734|P4|Test Period 2|Protocol Violation|1
1098344|NCT01957488|3592735|P3|Test Period 2|Protocol Violation|1
1098345|NCT01957488|3592736|P2|Test Period 2|Protocol Violation|0
1098346|NCT01957488|3592737|P1|Test Period 2|Protocol Violation|2
1098347|NCT01957488|3592732|P6|Test Period 1|screen failure|1
1098348|NCT01957488|3592733|P5|Test Period 1|screen failure|0
1098349|NCT01957488|3592734|P4|Test Period 1|screen failure|0
1098350|NCT01957488|3592735|P3|Test Period 1|screen failure|0
1098351|NCT01957488|3592736|P2|Test Period 1|screen failure|0
1098352|NCT01957488|3592737|P1|Test Period 1|screen failure|0
1098353|NCT01957488|3592732|P6|Test Period 1|subject did not want to wait for cut bag|0
1098354|NCT01957488|3592733|P5|Test Period 1|subject did not want to wait for cut bag|1
1098355|NCT01957488|3592734|P4|Test Period 1|subject did not want to wait for cut bag|0
1098356|NCT01957488|3592735|P3|Test Period 1|subject did not want to wait for cut bag|0
1098357|NCT01957488|3592736|P2|Test Period 1|subject did not want to wait for cut bag|0
1098358|NCT01957488|3592737|P1|Test Period 1|subject did not want to wait for cut bag|0
1098359|NCT01957488|3592732|P6|Test Period 1|Withdrawal by Subject|2
1098360|NCT01957488|3592733|P5|Test Period 1|Withdrawal by Subject|1
1098361|NCT01957488|3592734|P4|Test Period 1|Withdrawal by Subject|1
1098362|NCT01957488|3592735|P3|Test Period 1|Withdrawal by Subject|0
1098363|NCT01957488|3592736|P2|Test Period 1|Withdrawal by Subject|0
1098364|NCT01957488|3592737|P1|Test Period 1|Withdrawal by Subject|0
1098365|NCT01957488|3592732|P6|Test Period 1|Adverse Event|0
1098366|NCT01957488|3592733|P5|Test Period 1|Adverse Event|1
1098367|NCT01957488|3592734|P4|Test Period 1|Adverse Event|0
1098368|NCT01957488|3592735|P3|Test Period 1|Adverse Event|1
1098369|NCT01957488|3592736|P2|Test Period 1|Adverse Event|1
1098370|NCT01957488|3592737|P1|Test Period 1|Adverse Event|0
1098371|NCT01957488|3592732|P6|Test Period 1|Protocol Violation|3
1098372|NCT01957488|3592733|P5|Test Period 1|Protocol Violation|0
1098373|NCT01957488|3592734|P4|Test Period 1|Protocol Violation|1
1098374|NCT01957488|3592735|P3|Test Period 1|Protocol Violation|2
1098375|NCT01957488|3592736|P2|Test Period 1|Protocol Violation|2
1098376|NCT01957488|3592737|P1|Test Period 1|Protocol Violation|1
1098377|NCT01957488|3592732|P6|Test Period 1|Lost to Follow-up|0
1098378|NCT01957488|3592733|P5|Test Period 1|Lost to Follow-up|0
1098379|NCT01957488|3592734|P4|Test Period 1|Lost to Follow-up|1
1098380|NCT01957488|3592735|P3|Test Period 1|Lost to Follow-up|1
1098381|NCT01957488|3592736|P2|Test Period 1|Lost to Follow-up|0
1098382|NCT01957488|3592737|P1|Test Period 1|Lost to Follow-up|2
1098383|NCT01957475|3592745|P2|Test Period 2|Adverse Event|0
1098384|NCT01957475|3592746|P1|Test Period 2|Adverse Event|1
1098385|NCT01957475|3592745|P2|Test Period 1|Lack of Efficacy|1
1098386|NCT01957475|3592746|P1|Test Period 1|Lack of Efficacy|0
1098387|NCT01957475|3592745|P2|Test Period 1|Other|0
1098388|NCT01957475|3592746|P1|Test Period 1|Other|1
1098389|NCT01957475|3592745|P2|Test Period 1|Withdrawal by Subject|0
1098390|NCT01957475|3592746|P1|Test Period 1|Withdrawal by Subject|1
1098391|NCT01957462|3592752|P2|Test Period 1|Adverse Event|0
1098392|NCT01957462|3592753|P1|Test Period 1|Adverse Event|1
1098393|NCT01957462|3592752|P2|Test Period 1|Withdrawal by Subject|0
1098394|NCT01957462|3592753|P1|Test Period 1|Withdrawal by Subject|1
1098395|NCT01957397|3592764|P2|Test Period 3|the adhesive did not work|0
1098396|NCT01957397|3592765|P1|Test Period 3|the adhesive did not work|1
1098397|NCT01957397|3592764|P2|Test Period 3|Adverse Event|2
1098398|NCT01957397|3592765|P1|Test Period 3|Adverse Event|1
1098399|NCT01957397|3592764|P2|Test Period 2|Adverse Event|1
1098400|NCT01957397|3592765|P1|Test Period 2|Adverse Event|0
1098401|NCT01957397|3592764|P2|Test Period 1|Withdrawal by Subject|0
1098402|NCT01957397|3592765|P1|Test Period 1|Withdrawal by Subject|1
1098403|NCT01957397|3592764|P2|Test Period 1|sudden leakage/small bag|1
1098404|NCT01957397|3592765|P1|Test Period 1|sudden leakage/small bag|1
1098405|NCT01957215|3592790|P2|Overall Study|Withdrawal by Subject|5
1098406|NCT01957215|3592791|P1|Overall Study|Withdrawal by Subject|7
1098407|NCT01957215|3592790|P2|Overall Study|Protocol Violation|2
1098408|NCT01957215|3592791|P1|Overall Study|Protocol Violation|1
1098409|NCT01957215|3592790|P2|Overall Study|Lost to Follow-up|3
1098410|NCT01957215|3592791|P1|Overall Study|Lost to Follow-up|3
1098411|NCT01957215|3592790|P2|Overall Study|Adverse Event|2
1098412|NCT01957215|3592791|P1|Overall Study|Adverse Event|2
1098413|NCT01957202|3592819|P18|Treatment Period 3 (8 Days)|Adverse Event|0
1098414|NCT01957202|3592820|P17|Treatment Period 3 (8 Days)|Adverse Event|1
1098415|NCT01957202|3592821|P16|Treatment Period 3 (8 Days)|Adverse Event|0
1098416|NCT01957202|3592822|P15|Treatment Period 3 (8 Days)|Adverse Event|0
1098417|NCT01957202|3592823|P14|Treatment Period 3 (8 Days)|Adverse Event|0
1098418|NCT01957202|3592824|P13|Treatment Period 3 (8 Days)|Adverse Event|0
1098419|NCT01957202|3592825|P12|Treatment Period 3 (8 Days)|Adverse Event|0
1098420|NCT01957202|3592826|P11|Treatment Period 3 (8 Days)|Adverse Event|0
1098421|NCT01957202|3592827|P10|Treatment Period 3 (8 Days)|Adverse Event|0
1098422|NCT01957202|3592828|P9|Treatment Period 3 (8 Days)|Adverse Event|0
1098423|NCT01957202|3592829|P8|Treatment Period 3 (8 Days)|Adverse Event|0
1098424|NCT01957202|3592830|P7|Treatment Period 3 (8 Days)|Adverse Event|0
1098425|NCT01957202|3592831|P6|Treatment Period 3 (8 Days)|Adverse Event|0
1098426|NCT01957202|3592832|P5|Treatment Period 3 (8 Days)|Adverse Event|0
1098427|NCT01957202|3592833|P4|Treatment Period 3 (8 Days)|Adverse Event|0
1098428|NCT01957202|3592834|P3|Treatment Period 3 (8 Days)|Adverse Event|0
1098429|NCT01957202|3592835|P2|Treatment Period 3 (8 Days)|Adverse Event|0
1098430|NCT01957202|3592836|P1|Treatment Period 3 (8 Days)|Adverse Event|0
1098431|NCT01957202|3592819|P18|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1098432|NCT01957202|3592820|P17|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
1098433|NCT01957202|3592821|P16|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1098434|NCT01957202|3592822|P15|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1098435|NCT01957202|3592823|P14|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1098436|NCT01957202|3592824|P13|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1098437|NCT01957202|3592825|P12|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1098438|NCT01957202|3592826|P11|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1098439|NCT01957202|3592827|P10|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1098440|NCT01957202|3592828|P9|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1098441|NCT01957202|3592829|P8|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1098442|NCT01957202|3592830|P7|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1098443|NCT01957202|3592831|P6|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1098444|NCT01957202|3592832|P5|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1098445|NCT01957202|3592833|P4|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1098446|NCT01957202|3592834|P3|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1098447|NCT01957202|3592835|P2|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
1098448|NCT01957202|3592836|P1|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1098449|NCT01957163|3592861|P3|Overall Study|Withdrawal by Subject|4
1098450|NCT01957163|3592862|P2|Overall Study|Withdrawal by Subject|2
1098451|NCT01957163|3592863|P1|Overall Study|Withdrawal by Subject|4
1098452|NCT01957163|3592861|P3|Overall Study|Lost to Follow-up|0
1098453|NCT01957163|3592862|P2|Overall Study|Lost to Follow-up|1
1098454|NCT01957163|3592863|P1|Overall Study|Lost to Follow-up|0
1098455|NCT01957163|3592861|P3|Overall Study|Met Protocol-Defined Stopping Criteria|1
1098456|NCT01957163|3592862|P2|Overall Study|Met Protocol-Defined Stopping Criteria|0
1098457|NCT01957163|3592863|P1|Overall Study|Met Protocol-Defined Stopping Criteria|0
1098458|NCT01957163|3592861|P3|Overall Study|Protocol Violation|0
1098459|NCT01957163|3592862|P2|Overall Study|Protocol Violation|2
1098460|NCT01957163|3592863|P1|Overall Study|Protocol Violation|1
1098461|NCT01957163|3592861|P3|Overall Study|Lack of Efficacy|9
1098462|NCT01957163|3592862|P2|Overall Study|Lack of Efficacy|4
1098463|NCT01957163|3592863|P1|Overall Study|Lack of Efficacy|5
1098464|NCT01957163|3592861|P3|Overall Study|Adverse Event|4
1098465|NCT01957163|3592862|P2|Overall Study|Adverse Event|2
1098466|NCT01957163|3592863|P1|Overall Study|Adverse Event|5
1098467|NCT01957137|3592874|P1|Randomized Portion|Withdrawal by Subject|1
1098468|NCT01957137|3592874|P1|Randomized Portion|Adverse Event|1
1098469|NCT01957111|3592904|P2|Overall Study|Withdrawal by Subject|1
1098470|NCT01957111|3592905|P1|Overall Study|Withdrawal by Subject|1
1098471|NCT01956240|3592923|P2|Overall Study|Adverse Event|4
1098472|NCT01956240|3592924|P1|Overall Study|Adverse Event|17
1098473|NCT01956240|3592923|P2|Overall Study|Lost to Follow-up|20
1098474|NCT01956240|3592924|P1|Overall Study|Lost to Follow-up|6
1098475|NCT01956123|3592934|P4|COS Cycle 3|Withdrawal by Subject|1
1098476|NCT01956123|3592935|P3|COS Cycle 3|Withdrawal by Subject|0
1098477|NCT01956123|3592936|P2|COS Cycle 3|Withdrawal by Subject|0
1098478|NCT01956123|3592937|P1|COS Cycle 3|Withdrawal by Subject|0
1098479|NCT01956123|3592934|P4|COS Cycle 3|Personal Reasons|0
1098480|NCT01956123|3592935|P3|COS Cycle 3|Personal Reasons|1
1098481|NCT01956123|3592936|P2|COS Cycle 3|Personal Reasons|0
1098482|NCT01956123|3592937|P1|COS Cycle 3|Personal Reasons|0
1098483|NCT01956123|3592934|P4|COS Cycle 3|Adverse Event|0
1098484|NCT01956123|3592935|P3|COS Cycle 3|Adverse Event|3
1098485|NCT01956123|3592936|P2|COS Cycle 3|Adverse Event|0
1098486|NCT01956123|3592937|P1|COS Cycle 3|Adverse Event|0
1098487|NCT01956123|3592934|P4|COS Cycle 3|Protocol Violation|1
1098488|NCT01956123|3592935|P3|COS Cycle 3|Protocol Violation|2
1098489|NCT01956123|3592936|P2|COS Cycle 3|Protocol Violation|0
1098490|NCT01956123|3592937|P1|COS Cycle 3|Protocol Violation|0
1098491|NCT01956123|3592934|P4|COS Cycle 2|Withdrawal by Subject|0
1098492|NCT01956123|3592935|P3|COS Cycle 2|Withdrawal by Subject|0
1098493|NCT01956123|3592936|P2|COS Cycle 2|Withdrawal by Subject|0
1098494|NCT01956123|3592937|P1|COS Cycle 2|Withdrawal by Subject|1
1098495|NCT01956123|3592934|P4|COS Cycle 2|Personal Reasons|0
1098496|NCT01956123|3592935|P3|COS Cycle 2|Personal Reasons|0
1098497|NCT01956123|3592936|P2|COS Cycle 2|Personal Reasons|0
1098498|NCT01956123|3592937|P1|COS Cycle 2|Personal Reasons|2
1098499|NCT01956123|3592934|P4|COS Cycle 2|Adverse Event|0
1098500|NCT01956123|3592935|P3|COS Cycle 2|Adverse Event|0
1098501|NCT01956123|3592936|P2|COS Cycle 2|Adverse Event|4
1098502|NCT01956123|3592937|P1|COS Cycle 2|Adverse Event|3
1098503|NCT01956123|3592934|P4|COS Cycle 2|Protocol Violation|0
1098504|NCT01956123|3592935|P3|COS Cycle 2|Protocol Violation|0
1098505|NCT01956123|3592936|P2|COS Cycle 2|Protocol Violation|3
1098506|NCT01956123|3592937|P1|COS Cycle 2|Protocol Violation|8
1098507|NCT01956110|3592989|P2|Overall Study|Personal reasons|1
1098508|NCT01956110|3592990|P1|Overall Study|Personal reasons|1
1098509|NCT01956110|3592989|P2|Overall Study|Adverse Event|10
1098510|NCT01956110|3592990|P1|Overall Study|Adverse Event|9
1098511|NCT01956110|3592989|P2|Overall Study|Protocol Violation|11
1098512|NCT01956110|3592990|P1|Overall Study|Protocol Violation|25
1098513|NCT01955733|3593121|P3|Period 2|Other not defined above|2
1098514|NCT01955733|3593122|P2|Period 2|Other not defined above|2
1098515|NCT01955733|3593123|P1|Period 2|Other not defined above|0
1098516|NCT01955733|3593121|P3|Period 2|Lost to Follow-up|0
1098517|NCT01955733|3593122|P2|Period 2|Lost to Follow-up|0
1098518|NCT01955733|3593123|P1|Period 2|Lost to Follow-up|2
1098519|NCT01955733|3593121|P3|Period 2|Study terminated by sponsor|16
1098520|NCT01955733|3593122|P2|Period 2|Study terminated by sponsor|14
1098521|NCT01955733|3593123|P1|Period 2|Study terminated by sponsor|8
1098522|NCT01955733|3593121|P3|Period 2|Withdrawal by Subject|2
1098523|NCT01955733|3593122|P2|Period 2|Withdrawal by Subject|3
1098524|NCT01955733|3593123|P1|Period 2|Withdrawal by Subject|1
1098525|NCT01955733|3593121|P3|Period 2|Physician Decision|1
1098526|NCT01955733|3593122|P2|Period 2|Physician Decision|0
1098527|NCT01955733|3593123|P1|Period 2|Physician Decision|0
1098528|NCT01955733|3593121|P3|Period 2|Adverse Event|0
1098529|NCT01955733|3593122|P2|Period 2|Adverse Event|0
1098530|NCT01955733|3593123|P1|Period 2|Adverse Event|1
1098531|NCT01955733|3593121|P3|Period 1|Lost to Follow-up|0
1098532|NCT01955733|3593122|P2|Period 1|Lost to Follow-up|0
1098533|NCT01955733|3593123|P1|Period 1|Lost to Follow-up|1
1098534|NCT01955707|3593216|P2|Overall Study|Not Specified|2
1098535|NCT01955707|3593217|P1|Overall Study|Not Specified|4
1098536|NCT01955707|3593216|P2|Overall Study|Death|14
1098537|NCT01955707|3593217|P1|Overall Study|Death|13
1098538|NCT01955707|3593216|P2|Overall Study|Withdrawal by Subject|3
1098539|NCT01955707|3593217|P1|Overall Study|Withdrawal by Subject|0
1098540|NCT01955707|3593216|P2|Overall Study|Lost to Follow-up|1
1098541|NCT01955707|3593217|P1|Overall Study|Lost to Follow-up|2
1098542|NCT01955707|3593216|P2|Overall Study|Adverse Event|2
1098543|NCT01955707|3593217|P1|Overall Study|Adverse Event|1
1098544|NCT01955161|3593485|P3|Overall Study|Other reason: patient's will|1
1098545|NCT01955161|3593486|P2|Overall Study|Other reason: patient's will|0
1098546|NCT01955161|3593487|P1|Overall Study|Other reason: patient's will|0
1098547|NCT01955161|3593485|P3|Overall Study|Other reason: primary biliary cirrhosis|0
1098548|NCT01955161|3593486|P2|Overall Study|Other reason: primary biliary cirrhosis|0
1098549|NCT01955161|3593487|P1|Overall Study|Other reason: primary biliary cirrhosis|1
1098550|NCT01955161|3593485|P3|Overall Study|Other reason: insufficient compliance|1
1098551|NCT01955161|3593486|P2|Overall Study|Other reason: insufficient compliance|0
1098552|NCT01955161|3593487|P1|Overall Study|Other reason: insufficient compliance|0
1098553|NCT01955161|3593485|P3|Overall Study|Other reason: moved to nursing home|0
1098554|NCT01955161|3593486|P2|Overall Study|Other reason: moved to nursing home|1
1098555|NCT01955161|3593487|P1|Overall Study|Other reason: moved to nursing home|0
1098556|NCT01955161|3593485|P3|Overall Study|Other reason: caregiver unavailable|0
1098557|NCT01955161|3593486|P2|Overall Study|Other reason: caregiver unavailable|0
1098558|NCT01955161|3593487|P1|Overall Study|Other reason: caregiver unavailable|1
1098559|NCT01955161|3593485|P3|Overall Study|Other reason: disallowed medication|1
1098560|NCT01955161|3593486|P2|Overall Study|Other reason: disallowed medication|0
1098561|NCT01955161|3593487|P1|Overall Study|Other reason: disallowed medication|1
1098562|NCT01955161|3593485|P3|Overall Study|Other reason: physician decision|1
1098563|NCT01955161|3593486|P2|Overall Study|Other reason: physician decision|1
1098564|NCT01955161|3593487|P1|Overall Study|Other reason: physician decision|0
1098565|NCT01955161|3593485|P3|Overall Study|Protocol Violation|0
1098566|NCT01955161|3593486|P2|Overall Study|Protocol Violation|0
1098567|NCT01955161|3593487|P1|Overall Study|Protocol Violation|2
1098568|NCT01955161|3593485|P3|Overall Study|Withdrawal by Subject|12
1098569|NCT01955161|3593486|P2|Overall Study|Withdrawal by Subject|8
1098570|NCT01955161|3593487|P1|Overall Study|Withdrawal by Subject|9
1098571|NCT01955161|3593485|P3|Overall Study|Death|3
1098572|NCT01955161|3593486|P2|Overall Study|Death|1
1098573|NCT01955161|3593487|P1|Overall Study|Death|1
1098574|NCT01955161|3593485|P3|Overall Study|Adverse Event|15
1098575|NCT01955161|3593486|P2|Overall Study|Adverse Event|14
1098576|NCT01955161|3593487|P1|Overall Study|Adverse Event|10
1098577|NCT01955161|3593485|P3|Overall Study|Withdrawal before treatment|1
1098578|NCT01955161|3593486|P2|Overall Study|Withdrawal before treatment|0
1098579|NCT01955161|3593487|P1|Overall Study|Withdrawal before treatment|2
1098580|NCT01955122|3593527|P2|Overall Study|Physician Decision|5
1098581|NCT01955122|3593528|P1|Overall Study|Physician Decision|5
1098582|NCT01955083|3593548|P2|Overall Study|Lost to Follow-up|1
1098583|NCT01955083|3593549|P1|Overall Study|Lost to Follow-up|1
1098584|NCT01955044|3593582|P3|Overall Study|Death|0
1098585|NCT01955044|3593583|P2|Overall Study|Death|1
1098586|NCT01955044|3593584|P1|Overall Study|Death|1
1098587|NCT01955005|3593597|P2|Overall Study|Withdrawal by Subject|5
1098588|NCT01955005|3593598|P1|Overall Study|Withdrawal by Subject|3
1098589|NCT01954771|3593611|P3|Overall Study|Missing HbA1c and CGMS of end-point|3
1098590|NCT01954771|3593612|P2|Overall Study|Missing HbA1c and CGMS of end-point|1
1098591|NCT01954771|3593613|P1|Overall Study|Missing HbA1c and CGMS of end-point|5
1098592|NCT01954771|3593611|P3|Overall Study|Missing CGMS of end-point|0
1098593|NCT01954771|3593612|P2|Overall Study|Missing CGMS of end-point|1
1098594|NCT01954771|3593613|P1|Overall Study|Missing CGMS of end-point|1
1098595|NCT01954771|3593611|P3|Overall Study|Missing HbA1c of end-point|0
1098596|NCT01954771|3593612|P2|Overall Study|Missing HbA1c of end-point|1
1098597|NCT01954771|3593613|P1|Overall Study|Missing HbA1c of end-point|1
1098598|NCT01954745|3593630|P1|Overall Study|Death|1
1098599|NCT01954745|3593630|P1|Overall Study|Adverse Event|2
1098600|NCT01954745|3593630|P1|Overall Study|Clinical Progression|5
1098601|NCT01954745|3593630|P1|Overall Study|Radiological Progression|11
1098602|NCT01954394|3593661|P2|Overall Study|Other than specified above|21
1098603|NCT01954394|3593662|P1|Overall Study|Other than specified above|10
1098604|NCT01954394|3593661|P2|Overall Study|Related to Study Drug administration|2
1098605|NCT01954394|3593662|P1|Overall Study|Related to Study Drug administration|2
1098606|NCT01954394|3593661|P2|Overall Study|Participant Moved|4
1098607|NCT01954394|3593662|P1|Overall Study|Participant Moved|0
1098608|NCT01954394|3593661|P2|Overall Study|Poor compliance to protocol|7
1098609|NCT01954394|3593662|P1|Overall Study|Poor compliance to protocol|7
1098610|NCT01954394|3593661|P2|Overall Study|Adverse Event|23
1098611|NCT01954394|3593662|P1|Overall Study|Adverse Event|10
1098612|NCT01954394|3593661|P2|Overall Study|Enrolled but not treated|0
1098613|NCT01954394|3593662|P1|Overall Study|Enrolled but not treated|1
1098614|NCT01954251|3593764|P2|Overall Study|Withdrawal by Subject|6
1098615|NCT01954251|3593765|P1|Overall Study|Withdrawal by Subject|2
1098616|NCT01954251|3593764|P2|Overall Study|Lost to Follow-up|6
1098617|NCT01954251|3593765|P1|Overall Study|Lost to Follow-up|6
1098618|NCT01954251|3593764|P2|Overall Study|Adverse Event|7
1098619|NCT01954251|3593765|P1|Overall Study|Adverse Event|5
1098620|NCT01954121|3593862|P2|Overall Study|Subject did not follow instructions|2
1098621|NCT01954121|3593863|P1|Overall Study|Subject did not follow instructions|0
1098622|NCT01954121|3593862|P2|Overall Study|Non-compliant patient|1
1098623|NCT01954121|3593863|P1|Overall Study|Non-compliant patient|1
1098624|NCT01954121|3593862|P2|Overall Study|Non-compliant with study procedures|0
1098625|NCT01954121|3593863|P1|Overall Study|Non-compliant with study procedures|1
1098626|NCT01954121|3593862|P2|Overall Study|SAE, non-fatal|4
1098627|NCT01954121|3593863|P1|Overall Study|SAE, non-fatal|1
1098628|NCT01954121|3593862|P2|Overall Study|AE, non-serious non-fatal|22
1098629|NCT01954121|3593863|P1|Overall Study|AE, non-serious non-fatal|5
1098630|NCT01954121|3593862|P2|Overall Study|AE, serious fatal|0
1098631|NCT01954121|3593863|P1|Overall Study|AE, serious fatal|1
1098632|NCT01954121|3593862|P2|Overall Study|Pregnancy|1
1098633|NCT01954121|3593863|P1|Overall Study|Pregnancy|1
1098634|NCT01954121|3593862|P2|Overall Study|Withdrawal by Subject|12
1098635|NCT01954121|3593863|P1|Overall Study|Withdrawal by Subject|18
1098636|NCT01954121|3593862|P2|Overall Study|Lost to Follow-up|6
1098637|NCT01954121|3593863|P1|Overall Study|Lost to Follow-up|5
1098638|NCT01954121|3593862|P2|Overall Study|Protocol Violation|2
1098639|NCT01954121|3593863|P1|Overall Study|Protocol Violation|0
1098640|NCT01954121|3593862|P2|Overall Study|Lack of Efficacy|41
1098641|NCT01954121|3593863|P1|Overall Study|Lack of Efficacy|94
1098642|NCT01954082|3593879|P2|Overall Study|Randomized not Treated|2
1098643|NCT01954082|3593880|P1|Overall Study|Randomized not Treated|4
1098644|NCT01954082|3593879|P2|Overall Study|Infant Moved|1
1098645|NCT01954082|3593880|P1|Overall Study|Infant Moved|0
1098646|NCT01954082|3593879|P2|Overall Study|Comfort Care|1
1098647|NCT01954082|3593880|P1|Overall Study|Comfort Care|0
1098648|NCT01954082|3593879|P2|Overall Study|Miscalculation of Final Dose Day|3
1098649|NCT01954082|3593880|P1|Overall Study|Miscalculation of Final Dose Day|0
1098650|NCT01954082|3593879|P2|Overall Study|Redirection of Care|2
1098651|NCT01954082|3593880|P1|Overall Study|Redirection of Care|0
1098652|NCT01954082|3593879|P2|Overall Study|Discontinued Early Prior to Transfer|2
1098653|NCT01954082|3593880|P1|Overall Study|Discontinued Early Prior to Transfer|3
1098654|NCT01954082|3593879|P2|Overall Study|Withdrawal by Subject|1
1098655|NCT01954082|3593880|P1|Overall Study|Withdrawal by Subject|0
1098656|NCT01954082|3593879|P2|Overall Study|Parent Decision|0
1098657|NCT01954082|3593880|P1|Overall Study|Parent Decision|1
1098658|NCT01954082|3593879|P2|Overall Study|Physician Decision|0
1098659|NCT01954082|3593880|P1|Overall Study|Physician Decision|2
1098660|NCT01954082|3593879|P2|Overall Study|Non-compliance|4
1098661|NCT01954082|3593880|P1|Overall Study|Non-compliance|6
1098662|NCT01954082|3593879|P2|Overall Study|Intolerance|1
1098663|NCT01954082|3593880|P1|Overall Study|Intolerance|0
1098664|NCT01954082|3593879|P2|Overall Study|Adverse Event|4
1098665|NCT01954082|3593880|P1|Overall Study|Adverse Event|10
1098666|NCT01954082|3593879|P2|Overall Study|Study Suspension|36
1098667|NCT01954082|3593880|P1|Overall Study|Study Suspension|42
1098668|NCT01953354|3593946|P2|Overall Study|Disease Exacerbation|0
1098669|NCT01953354|3593947|P1|Overall Study|Disease Exacerbation|1
1098670|NCT01953354|3593946|P2|Overall Study|Decision of Sponsor|1
1098671|NCT01953354|3593947|P1|Overall Study|Decision of Sponsor|0
1098672|NCT01953354|3593946|P2|Overall Study|Withdrawal by Subject|1
1098673|NCT01953354|3593947|P1|Overall Study|Withdrawal by Subject|0
1098674|NCT01953328|3593975|P8|Overall Study|Lost to Follow-up|0
1098675|NCT01953328|3593976|P7|Overall Study|Lost to Follow-up|0
1098676|NCT01953328|3593977|P6|Overall Study|Lost to Follow-up|0
1098677|NCT01953328|3593978|P5|Overall Study|Lost to Follow-up|1
1098678|NCT01953328|3593979|P4|Overall Study|Lost to Follow-up|0
1098679|NCT01953328|3593980|P3|Overall Study|Lost to Follow-up|0
1098680|NCT01953328|3593981|P2|Overall Study|Lost to Follow-up|0
1098681|NCT01953328|3593982|P1|Overall Study|Lost to Follow-up|0
1098682|NCT01953328|3593975|P8|Overall Study|Withdrawal by Subject|0
1098683|NCT01953328|3593976|P7|Overall Study|Withdrawal by Subject|0
1098684|NCT01953328|3593977|P6|Overall Study|Withdrawal by Subject|0
1098685|NCT01953328|3593978|P5|Overall Study|Withdrawal by Subject|1
1098686|NCT01953328|3593979|P4|Overall Study|Withdrawal by Subject|0
1098687|NCT01953328|3593980|P3|Overall Study|Withdrawal by Subject|0
1098688|NCT01953328|3593981|P2|Overall Study|Withdrawal by Subject|0
1098689|NCT01953328|3593982|P1|Overall Study|Withdrawal by Subject|0
1098690|NCT01953224|3594195|P2|Overall Study|Withdrawal by Subject|2
1098691|NCT01953224|3594196|P1|Overall Study|Withdrawal by Subject|1
1098692|NCT01953224|3594195|P2|Overall Study|Lost to Follow-up|1
1098693|NCT01953224|3594196|P1|Overall Study|Lost to Follow-up|1
1098694|NCT01952834|3594231|P1|Overall Study|Adverse Event|1
1098695|NCT01952691|3594238|P1|Overall Study|Lost to Follow-up|2
1098696|NCT01952665|3594265|P2|Overall Study|Protocol Violation|1
1098697|NCT01952665|3594266|P1|Overall Study|Protocol Violation|0
1098698|NCT01952665|3594265|P2|Overall Study|Adverse Event|1
1098699|NCT01952665|3594266|P1|Overall Study|Adverse Event|2
1098700|NCT01952665|3594265|P2|Overall Study|Lost to Follow-up|2
1098701|NCT01952665|3594266|P1|Overall Study|Lost to Follow-up|1
1098702|NCT01952665|3594265|P2|Overall Study|Physician Decision|2
1098703|NCT01952665|3594266|P1|Overall Study|Physician Decision|3
1098704|NCT01952574|3594421|P4|Overall Study|Lost to Follow-up|0
1098705|NCT01952574|3594422|P3|Overall Study|Lost to Follow-up|1
1098706|NCT01952574|3594423|P2|Overall Study|Lost to Follow-up|0
1098707|NCT01952574|3594424|P1|Overall Study|Lost to Follow-up|2
1098708|NCT01952574|3594421|P4|Overall Study|Sponsor Decision|2
1098709|NCT01952574|3594422|P3|Overall Study|Sponsor Decision|5
1098710|NCT01952574|3594423|P2|Overall Study|Sponsor Decision|0
1098711|NCT01952574|3594424|P1|Overall Study|Sponsor Decision|6
1098712|NCT01952574|3594421|P4|Overall Study|Withdrawal by Subject|4
1098713|NCT01952574|3594422|P3|Overall Study|Withdrawal by Subject|3
1098714|NCT01952574|3594423|P2|Overall Study|Withdrawal by Subject|3
1098715|NCT01952574|3594424|P1|Overall Study|Withdrawal by Subject|9
1098716|NCT01952366|3594457|P1|Overall Study|Withdrawal by Subject|9
1098717|NCT01952366|3594457|P1|Overall Study|Death|22
1098718|NCT01952145|3594472|P2|Overall Study|Unclassified|1
1098719|NCT01952145|3594473|P1|Overall Study|Unclassified|1
1098720|NCT01952145|3594472|P2|Overall Study|Withdrawal Criteria|11
1098721|NCT01952145|3594473|P1|Overall Study|Withdrawal Criteria|16
1098722|NCT01952145|3594472|P2|Overall Study|Adverse Event|0
1098723|NCT01952145|3594473|P1|Overall Study|Adverse Event|9
1098724|NCT01952145|3594472|P2|Overall Study|Death|1
1098725|NCT01952145|3594473|P1|Overall Study|Death|0
1098726|NCT01952145|3594472|P2|Overall Study|Protocol Violation|1
1098727|NCT01952145|3594473|P1|Overall Study|Protocol Violation|2
1098728|NCT01952080|3594487|P4|Overall Study|Protocol Non-compliance|0
1098729|NCT01952080|3594488|P3|Overall Study|Protocol Non-compliance|0
1098730|NCT01952080|3594489|P2|Overall Study|Protocol Non-compliance|1
1098731|NCT01952080|3594490|P1|Overall Study|Protocol Non-compliance|0
1098732|NCT01952080|3594487|P4|Overall Study|Withdrawal by Subject|1
1098733|NCT01952080|3594488|P3|Overall Study|Withdrawal by Subject|0
1098734|NCT01952080|3594489|P2|Overall Study|Withdrawal by Subject|0
1098735|NCT01952080|3594490|P1|Overall Study|Withdrawal by Subject|0
1098736|NCT01951703|3594569|P2|Second Intervention|Unsatisfactory Lens fitting|1
1098737|NCT01951703|3594570|P1|Second Intervention|Unsatisfactory Lens fitting|0
1098738|NCT01951703|3594569|P2|Second Intervention|Protocol Violation|1
1098739|NCT01951703|3594570|P1|Second Intervention|Protocol Violation|0
1098740|NCT01951703|3594569|P2|First Intervention|Physician Decision|0
1098741|NCT01951703|3594570|P1|First Intervention|Physician Decision|1
1098742|NCT01951703|3594569|P2|First Intervention|Subject was not compliant|1
1098743|NCT01951703|3594570|P1|First Intervention|Subject was not compliant|1
1098744|NCT01951703|3594569|P2|First Intervention|Withdrawal by Subject|0
1098745|NCT01951703|3594570|P1|First Intervention|Withdrawal by Subject|1
1098746|NCT01951586|3594595|P2|Overall Study|Withdrawal by Subject|13
1098747|NCT01951586|3594596|P1|Overall Study|Withdrawal by Subject|7
1098748|NCT01951586|3594595|P2|Overall Study|Death|100
1098749|NCT01951586|3594596|P1|Overall Study|Death|52
1098750|NCT01951573|3594620|P2|Washout Period|Adverse Event|1
1098751|NCT01951573|3594621|P1|Washout Period|Adverse Event|0
1098752|NCT01951417|3594631|P1|Overall Study|Lost to Follow-up|6
1098753|NCT01951417|3594631|P1|Overall Study|Protocol Violation|2
1098754|NCT01951417|3594631|P1|Overall Study|Withdrawal by Subject|1
1098755|NCT01951170|3594654|P1|Overall Study|Investigator decision|1
1098756|NCT01951092|3594677|P1|Overall Study|Transfer of Care|1
1098757|NCT01951092|3594677|P1|Overall Study|Incarceration|1
1098758|NCT01951092|3594677|P1|Overall Study|Lost to Follow-up|10
1098759|NCT01950741|3594688|P1|Overall Study|Withdrawal by Subject|1
1098760|NCT01950741|3594688|P1|Overall Study|Death|1
1098761|NCT01950741|3594688|P1|Overall Study|Lost to Follow-up|1
1098762|NCT01950364|3594703|P2|Overall Study|Protocol Violation|1
1098763|NCT01950364|3594704|P1|Overall Study|Protocol Violation|0
1098764|NCT01950364|3594703|P2|Overall Study|Withdrawal by Subject|1
1098765|NCT01950364|3594704|P1|Overall Study|Withdrawal by Subject|0
1098766|NCT01950364|3594703|P2|Overall Study|Disease Progression|2
1098767|NCT01950364|3594704|P1|Overall Study|Disease Progression|5
1098768|NCT01950364|3594703|P2|Overall Study|Stem Cell Transplant|6
1098769|NCT01950364|3594704|P1|Overall Study|Stem Cell Transplant|2
1098770|NCT01950364|3594703|P2|Overall Study|Adverse Event|0
1098771|NCT01950364|3594704|P1|Overall Study|Adverse Event|3
1098772|NCT01950273|3594804|P2|Overall Study|Other not defined above|0
1098773|NCT01950273|3594805|P1|Overall Study|Other not defined above|1
1098774|NCT01950273|3594804|P2|Overall Study|Withdrawal by Subject|0
1098775|NCT01950273|3594805|P1|Overall Study|Withdrawal by Subject|2
1098776|NCT01950273|3594804|P2|Overall Study|Protocol Violation|0
1098777|NCT01950273|3594805|P1|Overall Study|Protocol Violation|1
1098778|NCT01949870|3594836|P1|Overall Study|Eligibility requirements not fulfilled|2
1098779|NCT01949870|3594836|P1|Overall Study|Study termination|1
1098780|NCT01949870|3594836|P1|Overall Study|Adverse Event|1
1098781|NCT01949870|3594836|P1|Overall Study|Lack of Efficacy|2
1098782|NCT01949532|3594999|P2|Overall Study|On-study at the Data Cut-off Date|3
1098783|NCT01949532|3595000|P1|Overall Study|On-study at the Data Cut-off Date|3
1098784|NCT01949155|3595075|P2|Overall Study|Protocol Violation|0
1098785|NCT01949155|3595076|P1|Overall Study|Protocol Violation|1
1098786|NCT01949155|3595075|P2|Overall Study|Lost to Follow-up|0
1098787|NCT01949155|3595076|P1|Overall Study|Lost to Follow-up|1
1098788|NCT01949142|3595088|P2|Overall Study|Parent changed their mind|0
1098789|NCT01949142|3595089|P1|Overall Study|Parent changed their mind|1
1098790|NCT01949142|3595088|P2|Overall Study|Lost to Follow-up|1
1098791|NCT01949142|3595089|P1|Overall Study|Lost to Follow-up|1
1098792|NCT01949142|3595088|P2|Overall Study|Withdrawal of consent|0
1098793|NCT01949142|3595089|P1|Overall Study|Withdrawal of consent|1
1098794|NCT01949116|3595101|P2|Overall Study|Withdrawal by Subject|3
1098795|NCT01949116|3595102|P1|Overall Study|Withdrawal by Subject|5
1098796|NCT01949116|3595101|P2|Overall Study|Lost to Follow-up|3
1098797|NCT01949116|3595102|P1|Overall Study|Lost to Follow-up|1
1098798|NCT01949116|3595101|P2|Overall Study|Death|0
1098799|NCT01949116|3595102|P1|Overall Study|Death|2
1098800|NCT01949090|3595139|P5|Overall Study|Lost to Follow-up|1
1098801|NCT01949090|3595140|P4|Overall Study|Lost to Follow-up|1
1098802|NCT01949090|3595141|P3|Overall Study|Lost to Follow-up|0
1098803|NCT01949090|3595142|P2|Overall Study|Lost to Follow-up|1
1098804|NCT01949090|3595143|P1|Overall Study|Lost to Follow-up|2
1098805|NCT01949090|3595139|P5|Overall Study|Protocol non-compliance|1
1098806|NCT01949090|3595140|P4|Overall Study|Protocol non-compliance|0
1098807|NCT01949090|3595141|P3|Overall Study|Protocol non-compliance|0
1098808|NCT01949090|3595142|P2|Overall Study|Protocol non-compliance|0
1098809|NCT01949090|3595143|P1|Overall Study|Protocol non-compliance|0
1098810|NCT01949090|3595139|P5|Overall Study|Withdrawal by Subject|1
1098811|NCT01949090|3595140|P4|Overall Study|Withdrawal by Subject|0
1098812|NCT01949090|3595141|P3|Overall Study|Withdrawal by Subject|0
1098813|NCT01949090|3595142|P2|Overall Study|Withdrawal by Subject|0
1098814|NCT01949090|3595143|P1|Overall Study|Withdrawal by Subject|2
1098815|NCT01949090|3595139|P5|Overall Study|Serious Adverse Event|1
1098816|NCT01949090|3595140|P4|Overall Study|Serious Adverse Event|0
1098817|NCT01949090|3595141|P3|Overall Study|Serious Adverse Event|2
1098818|NCT01949090|3595142|P2|Overall Study|Serious Adverse Event|1
1098819|NCT01949090|3595143|P1|Overall Study|Serious Adverse Event|0
1098820|NCT01949051|3595320|P6|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
1098821|NCT01949051|3595321|P5|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
1098822|NCT01949051|3595322|P4|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
1098823|NCT01949051|3595323|P3|Treatment Period 2 (7 Days)|Withdrawal by Subject|1
1098824|NCT01949051|3595324|P2|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
1098825|NCT01949051|3595325|P1|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
1098826|NCT01949051|3595320|P6|Treatment Period 2 (7 Days)|Lost to Follow-up|0
1098827|NCT01949051|3595321|P5|Treatment Period 2 (7 Days)|Lost to Follow-up|0
1098828|NCT01949051|3595322|P4|Treatment Period 2 (7 Days)|Lost to Follow-up|0
1098829|NCT01949051|3595323|P3|Treatment Period 2 (7 Days)|Lost to Follow-up|0
1098830|NCT01949051|3595324|P2|Treatment Period 2 (7 Days)|Lost to Follow-up|1
1098831|NCT01949051|3595325|P1|Treatment Period 2 (7 Days)|Lost to Follow-up|0
1098832|NCT01949051|3595320|P6|Treatment Period 2 (7 Days)|Protocol Violation|1
1098833|NCT01949051|3595321|P5|Treatment Period 2 (7 Days)|Protocol Violation|0
1098834|NCT01949051|3595322|P4|Treatment Period 2 (7 Days)|Protocol Violation|0
1098835|NCT01949051|3595323|P3|Treatment Period 2 (7 Days)|Protocol Violation|0
1098836|NCT01949051|3595324|P2|Treatment Period 2 (7 Days)|Protocol Violation|0
1098837|NCT01949051|3595325|P1|Treatment Period 2 (7 Days)|Protocol Violation|0
1098838|NCT01949051|3595320|P6|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1098839|NCT01949051|3595321|P5|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1098840|NCT01949051|3595322|P4|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1098841|NCT01949051|3595323|P3|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1098842|NCT01949051|3595324|P2|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1098843|NCT01949051|3595325|P1|Treatment Period 1 (7 Days)|Lost to Follow-up|1
1098844|NCT01949051|3595320|P6|Treatment Period 1 (7 Days)|Protocol Violation|0
1098845|NCT01949051|3595321|P5|Treatment Period 1 (7 Days)|Protocol Violation|0
1098846|NCT01949051|3595322|P4|Treatment Period 1 (7 Days)|Protocol Violation|1
1098847|NCT01949051|3595323|P3|Treatment Period 1 (7 Days)|Protocol Violation|0
1098848|NCT01949051|3595324|P2|Treatment Period 1 (7 Days)|Protocol Violation|0
1098849|NCT01949051|3595325|P1|Treatment Period 1 (7 Days)|Protocol Violation|1
1098850|NCT01948908|3595354|P3|Overall Study|Protocol Violation|2
1098851|NCT01948908|3595355|P2|Overall Study|Protocol Violation|0
1098852|NCT01948908|3595356|P1|Overall Study|Protocol Violation|1
1098853|NCT01948830|3595372|P2|Overall Study|Death|4
1098854|NCT01948830|3595373|P1|Overall Study|Death|3
1098855|NCT01948830|3595372|P2|Overall Study|Adverse Event|2
1098856|NCT01948830|3595373|P1|Overall Study|Adverse Event|9
1098857|NCT01948830|3595372|P2|Overall Study|Withdrawal by Subject|17
1098858|NCT01948830|3595373|P1|Overall Study|Withdrawal by Subject|14
1098859|NCT01948830|3595372|P2|Overall Study|Lost to Follow-up|4
1098860|NCT01948830|3595373|P1|Overall Study|Lost to Follow-up|5
1098861|NCT01948830|3595372|P2|Overall Study|Protocol deviation|2
1098862|NCT01948830|3595373|P1|Overall Study|Protocol deviation|1
1098863|NCT01948830|3595372|P2|Overall Study|Physician Decision|3
1098864|NCT01948830|3595373|P1|Overall Study|Physician Decision|1
1098865|NCT01948791|3595405|P1|Overall Study|Screening failure|35
1098866|NCT01948791|3595405|P1|Overall Study|Others|7
1098867|NCT01948791|3595405|P1|Overall Study|Management issues|1
1098868|NCT01948791|3595405|P1|Overall Study|Lost to Follow-up|6
1098869|NCT01948791|3595405|P1|Overall Study|Withdrawal by Subject|5
1098870|NCT01948791|3595405|P1|Overall Study|Protocol Violation|2
1098871|NCT01948791|3595405|P1|Overall Study|Lack of Efficacy|3
1098872|NCT01948791|3595405|P1|Overall Study|Adverse Event|12
1098873|NCT01948258|3595448|P1|Overall Study|Removed from statistical analysis|2
1098874|NCT01948258|3595448|P1|Overall Study|Health Care Professional|43
1098875|NCT01948258|3595448|P1|Overall Study|Withdrawal by Subject|6
1098876|NCT01948258|3595448|P1|Overall Study|Withdrawal by SPD|8
1098877|NCT01948258|3595448|P1|Overall Study|Lost to Follow-up|27
1098878|NCT01948258|3595448|P1|Overall Study|Did not complete by cut-off date|35
1098879|NCT01948258|3595448|P1|Overall Study|Pregnancy|41
1098880|NCT01948193|3595454|P1|Overall Study|Lost to Follow-up|7
1098881|NCT01948193|3595454|P1|Overall Study|Serious event|2
1098882|NCT01948076|3595476|P2|Overall Study|Withdrawal by Subject|1
1098883|NCT01948076|3595477|P1|Overall Study|Withdrawal by Subject|0
1098884|NCT01948063|3595487|P2|Overall Study|Blood samples were accidentally thawed|0
1098885|NCT01948063|3595488|P1|Overall Study|Blood samples were accidentally thawed|1
1098886|NCT01948063|3595487|P2|Overall Study|Discovered an enrollment in other study|1
1098887|NCT01948063|3595488|P1|Overall Study|Discovered an enrollment in other study|0
1098888|NCT01948063|3595487|P2|Overall Study|Boston MCI halted research protocol|1
1098889|NCT01948063|3595488|P1|Overall Study|Boston MCI halted research protocol|0
1098890|NCT01948050|3595496|P2|Overall Study|Withdrawal by Subject|1
1098891|NCT01948050|3595497|P1|Overall Study|Withdrawal by Subject|0
1098892|NCT01947855|3595565|P3|Overall Study|Withdrawal by Subject|0
1098893|NCT01947855|3595566|P2|Overall Study|Withdrawal by Subject|0
1098894|NCT01947855|3595567|P1|Overall Study|Withdrawal by Subject|1
1098895|NCT01947582|3595575|P1|Overall Study|Withdrawal by Subject|1
1098896|NCT01947517|3595584|P2|Overall Study|Withdrawal by Subject|1
1098897|NCT01947517|3595585|P1|Overall Study|Withdrawal by Subject|1
1098898|NCT01947491|3595603|P4|Overall Study|Adverse Event|2
1098899|NCT01947491|3595604|P3|Overall Study|Adverse Event|0
1098900|NCT01947491|3595605|P2|Overall Study|Adverse Event|1
1098901|NCT01947491|3595606|P1|Overall Study|Adverse Event|0
1098902|NCT01947491|3595603|P4|Overall Study|Worsening of condition|0
1098903|NCT01947491|3595604|P3|Overall Study|Worsening of condition|0
1098904|NCT01947491|3595605|P2|Overall Study|Worsening of condition|1
1098905|NCT01947491|3595606|P1|Overall Study|Worsening of condition|0
1098906|NCT01947491|3595603|P4|Overall Study|Withdrawal by Subject|0
1098907|NCT01947491|3595604|P3|Overall Study|Withdrawal by Subject|1
1098908|NCT01947491|3595605|P2|Overall Study|Withdrawal by Subject|1
1098909|NCT01947491|3595606|P1|Overall Study|Withdrawal by Subject|1
1098910|NCT01947491|3595603|P4|Overall Study|Protocol Violation|0
1098911|NCT01947491|3595604|P3|Overall Study|Protocol Violation|0
1098912|NCT01947491|3595605|P2|Overall Study|Protocol Violation|0
1098913|NCT01947491|3595606|P1|Overall Study|Protocol Violation|1
1098914|NCT01947491|3595603|P4|Overall Study|Lack of Efficacy|1
1098915|NCT01947491|3595604|P3|Overall Study|Lack of Efficacy|0
1098916|NCT01947491|3595605|P2|Overall Study|Lack of Efficacy|0
1098917|NCT01947491|3595606|P1|Overall Study|Lack of Efficacy|1
1098918|NCT01947491|3595603|P4|Overall Study|Lost to Follow-up|2
1098919|NCT01947491|3595604|P3|Overall Study|Lost to Follow-up|1
1098920|NCT01947491|3595605|P2|Overall Study|Lost to Follow-up|3
1098921|NCT01947491|3595606|P1|Overall Study|Lost to Follow-up|5
1098922|NCT01947127|3595650|P2|Overall Study|Data loss|4
1098923|NCT01947127|3595651|P1|Overall Study|Data loss|4
1098924|NCT01947127|3595650|P2|Overall Study|Withdrawal by Subject|1
1098925|NCT01947127|3595651|P1|Overall Study|Withdrawal by Subject|1
1098926|NCT01947127|3595650|P2|Overall Study|Protocol Violation|38
1098927|NCT01947127|3595651|P1|Overall Study|Protocol Violation|18
1098928|NCT01946529|3595675|P3|Completion of All Therapy|Some pts. still receiving study therapy|6
1098929|NCT01946529|3595676|P2|Completion of All Therapy|Some pts. still receiving study therapy|16
1098930|NCT01946529|3595677|P1|Completion of All Therapy|Some pts. still receiving study therapy|1
1098931|NCT01946529|3595675|P3|End of Window Therapy (2 Courses)|Physician Decision|0
1098932|NCT01946529|3595676|P2|End of Window Therapy (2 Courses)|Physician Decision|1
1098933|NCT01946529|3595677|P1|End of Window Therapy (2 Courses)|Physician Decision|0
1098934|NCT01946438|3595688|P4|Overall Study|Withdrawal by Subject|0
1098935|NCT01946438|3595689|P3|Overall Study|Withdrawal by Subject|0
1098936|NCT01946438|3595690|P2|Overall Study|Withdrawal by Subject|0
1098937|NCT01946438|3595691|P1|Overall Study|Withdrawal by Subject|1
1098938|NCT01946438|3595688|P4|Overall Study|Protocol Violation|0
1098939|NCT01946438|3595689|P3|Overall Study|Protocol Violation|1
1098940|NCT01946438|3595690|P2|Overall Study|Protocol Violation|0
1098941|NCT01946438|3595691|P1|Overall Study|Protocol Violation|0
1098942|NCT01946438|3595688|P4|Overall Study|Serious Adverse event|0
1098943|NCT01946438|3595689|P3|Overall Study|Serious Adverse event|0
1098944|NCT01946438|3595690|P2|Overall Study|Serious Adverse event|0
1098945|NCT01946438|3595691|P1|Overall Study|Serious Adverse event|1
1098946|NCT01946438|3595688|P4|Overall Study|Adverse Event|1
1098947|NCT01946438|3595689|P3|Overall Study|Adverse Event|0
1098948|NCT01946438|3595690|P2|Overall Study|Adverse Event|0
1098949|NCT01946438|3595691|P1|Overall Study|Adverse Event|0
1098950|NCT01946425|3595719|P2|Overall Study|Withdrawal by Subject|0
1098951|NCT01946425|3595720|P1|Overall Study|Withdrawal by Subject|1
1098952|NCT01946425|3595719|P2|Overall Study|Protocol Violation|0
1098953|NCT01946425|3595720|P1|Overall Study|Protocol Violation|1
1098954|NCT01946412|3595734|P1|Overall Study|Difficulty in swallowing|1
1098955|NCT01946412|3595734|P1|Overall Study|Continued with commercial Kalydeco|2
1098956|NCT01946412|3595734|P1|Overall Study|Non-Compliance|1
1098957|NCT01946412|3595734|P1|Overall Study|Adverse Event|1
1098958|NCT01946204|3595779|P2|Overall Study|Other|3
1098959|NCT01946204|3595780|P1|Overall Study|Other|7
1098960|NCT01946204|3595779|P2|Overall Study|Ongoing|687
1098961|NCT01946204|3595780|P1|Overall Study|Ongoing|316
1098962|NCT01946204|3595779|P2|Overall Study|Lost to Follow-up|7
1098963|NCT01946204|3595780|P1|Overall Study|Lost to Follow-up|3
1098964|NCT01946204|3595779|P2|Overall Study|Withdrawal by Subject|50
1098965|NCT01946204|3595780|P1|Overall Study|Withdrawal by Subject|37
1098966|NCT01946204|3595779|P2|Overall Study|Death|59
1098967|NCT01946204|3595780|P1|Overall Study|Death|38
1098968|NCT01946178|3595796|P1|Overall Study|Lost to Follow-up|1
1098969|NCT01946178|3595796|P1|Overall Study|Pregnancy|1
1098970|NCT01945996|3595823|P2|Overall Study|Lost to Follow-up|5
1098971|NCT01945996|3595824|P1|Overall Study|Lost to Follow-up|3
1098972|NCT01945944|3595900|P2|Overall Study|Withdrawal by Subject|1
1098973|NCT01945944|3595901|P1|Overall Study|Withdrawal by Subject|0
1098974|NCT01945944|3595900|P2|Overall Study|Physician Decision|0
1098975|NCT01945944|3595901|P1|Overall Study|Physician Decision|1
1098976|NCT01945944|3595900|P2|Overall Study|Adverse Event|2
1098977|NCT01945944|3595901|P1|Overall Study|Adverse Event|0
1098978|NCT01945866|3595925|P2|Overall Study|Eyes did not complete or were dropped|0
1098979|NCT01945866|3595926|P1|Overall Study|Eyes did not complete or were dropped|2
1098980|NCT01945775|3595947|P2|Overall Study|Lost to Follow-up|6
1098981|NCT01945775|3595948|P1|Overall Study|Lost to Follow-up|7
1098982|NCT01945775|3595947|P2|Overall Study|Withdrawal by Subject|20
1098983|NCT01945775|3595948|P1|Overall Study|Withdrawal by Subject|7
1098984|NCT01945775|3595947|P2|Overall Study|Death|53
1098985|NCT01945775|3595948|P1|Overall Study|Death|107
1098986|NCT01945775|3595947|P2|Overall Study|On going|65
1098987|NCT01945775|3595948|P1|Overall Study|On going|166
1098988|NCT01945489|3595979|P2|Cycle 2|Lost to Follow-up|1
1098989|NCT01945489|3595980|P1|Cycle 2|Lost to Follow-up|0
1098990|NCT01945489|3595979|P2|Cycle 2|Adverse Event|0
1098991|NCT01945489|3595980|P1|Cycle 2|Adverse Event|1
1098992|NCT01945489|3595979|P2|Cycle 1|Other Miscellaneous Reasons|1
1098993|NCT01945489|3595980|P1|Cycle 1|Other Miscellaneous Reasons|3
1098994|NCT01945489|3595979|P2|Cycle 1|Protocol Violation|1
1098995|NCT01945489|3595980|P1|Cycle 1|Protocol Violation|0
1098996|NCT01945489|3595979|P2|Cycle 1|Personal Reasons|2
1098997|NCT01945489|3595980|P1|Cycle 1|Personal Reasons|4
1098998|NCT01945489|3595979|P2|Cycle 1|Lost to Follow-up|0
1098999|NCT01945489|3595980|P1|Cycle 1|Lost to Follow-up|4
1099000|NCT01945489|3595979|P2|Cycle 1|Adverse Event|0
1099001|NCT01945489|3595980|P1|Cycle 1|Adverse Event|2
1099002|NCT01945281|3596034|P2|Overall Study|Technical Problems|0
1099003|NCT01945281|3596035|P1|Overall Study|Technical Problems|1
1099004|NCT01945281|3596034|P2|Overall Study|Physician Decision|1
1099005|NCT01945281|3596035|P1|Overall Study|Physician Decision|1
1099006|NCT01945281|3596034|P2|Overall Study|Death|3
1099007|NCT01945281|3596035|P1|Overall Study|Death|3
1099008|NCT01945281|3596034|P2|Overall Study|Adverse Event|0
1099009|NCT01945281|3596035|P1|Overall Study|Adverse Event|1
1099010|NCT01945242|3596047|P2|Overall Study|Physician Decision|3
1099011|NCT01945242|3596048|P1|Overall Study|Physician Decision|3
1099012|NCT01945216|3596063|P1|Overall Study|Protocol Violation|42
1099013|NCT01945216|3596063|P1|Overall Study|Case report forms uncollected|52
1099014|NCT01945086|3596121|P3|Overall Study|Adverse Event|1
1099015|NCT01945086|3596122|P2|Overall Study|Adverse Event|0
1099016|NCT01945086|3596123|P1|Overall Study|Adverse Event|0
1099017|NCT01945086|3596121|P3|Overall Study|Withdrawal by Subject|1
1099018|NCT01945086|3596122|P2|Overall Study|Withdrawal by Subject|0
1099019|NCT01945086|3596123|P1|Overall Study|Withdrawal by Subject|1
1099020|NCT01945034|3596167|P3|Overall Study|Protocol Violation|1
1099021|NCT01945034|3596168|P2|Overall Study|Protocol Violation|0
1099022|NCT01945034|3596169|P1|Overall Study|Protocol Violation|1
1099023|NCT01945034|3596167|P3|Overall Study|Lost to Follow-up|2
1099024|NCT01945034|3596168|P2|Overall Study|Lost to Follow-up|0
1099025|NCT01945034|3596169|P1|Overall Study|Lost to Follow-up|0
1099026|NCT01945034|3596167|P3|Overall Study|Other|3
1099027|NCT01945034|3596168|P2|Overall Study|Other|1
1099028|NCT01945034|3596169|P1|Overall Study|Other|0
1099029|NCT01945034|3596167|P3|Overall Study|Withdrawal by Subject|1
1099030|NCT01945034|3596168|P2|Overall Study|Withdrawal by Subject|3
1099031|NCT01945034|3596169|P1|Overall Study|Withdrawal by Subject|0
1099032|NCT01945034|3596167|P3|Overall Study|Medication Error|0
1099033|NCT01945034|3596168|P2|Overall Study|Medication Error|1
1099034|NCT01945034|3596169|P1|Overall Study|Medication Error|0
1099035|NCT01945021|3596219|P1|Overall Study|Non-RECIST disease progression|1
1099036|NCT01945021|3596219|P1|Overall Study|Withdrawal of consent|3
1099037|NCT01945021|3596219|P1|Overall Study|Withdrawal by Subject|2
1099038|NCT01945021|3596219|P1|Overall Study|Global deterioration of health-related s|1
1099039|NCT01945021|3596219|P1|Overall Study|Disease progression by RECIST v1.1|30
1099040|NCT01945021|3596219|P1|Overall Study|Pregnancy|1
1099041|NCT01945021|3596219|P1|Overall Study|Death|1
1099042|NCT01945021|3596219|P1|Overall Study|Adverse Event|8
1099043|NCT01944969|3596233|P1|Overall Study|Administrative or other reasons|23
1099044|NCT01944969|3596233|P1|Overall Study|Non-compliance with IMP|1
1099045|NCT01944969|3596233|P1|Overall Study|Lack of Efficacy|1
1099046|NCT01944969|3596233|P1|Overall Study|Adverse Event|1
1099047|NCT01944839|3596257|P2|Overall Study|Subject non-compliance|3
1099048|NCT01944839|3596258|P1|Overall Study|Subject non-compliance|0
1099049|NCT01944839|3596257|P2|Overall Study|Lost to Follow-up|0
1099050|NCT01944839|3596258|P1|Overall Study|Lost to Follow-up|1
1099051|NCT01944839|3596257|P2|Overall Study|Withdrawal by Subject|17
1099052|NCT01944839|3596258|P1|Overall Study|Withdrawal by Subject|9
1099053|NCT01944839|3596257|P2|Overall Study|Adverse Event|5
1099054|NCT01944839|3596258|P1|Overall Study|Adverse Event|10
1099055|NCT01944839|3596257|P2|Overall Study|Protocol Violation|1
1099056|NCT01944839|3596258|P1|Overall Study|Protocol Violation|0
1099057|NCT01944839|3596257|P2|Overall Study|Physician Decision|2
1099058|NCT01944839|3596258|P1|Overall Study|Physician Decision|2
1099059|NCT01944774|3596267|P3|Overall Study|Lost to Follow-up|0
1099060|NCT01944774|3596268|P2|Overall Study|Lost to Follow-up|1
1099061|NCT01944774|3596269|P1|Overall Study|Lost to Follow-up|0
1099062|NCT01944774|3596267|P3|Overall Study|Lack of Efficacy|2
1099063|NCT01944774|3596268|P2|Overall Study|Lack of Efficacy|2
1099064|NCT01944774|3596269|P1|Overall Study|Lack of Efficacy|1
1099065|NCT01944774|3596267|P3|Overall Study|Adverse Event|3
1099066|NCT01944774|3596268|P2|Overall Study|Adverse Event|2
1099067|NCT01944774|3596269|P1|Overall Study|Adverse Event|3
1099068|NCT01944774|3596267|P3|Overall Study|Withdrawal by Subject|3
1099069|NCT01944774|3596268|P2|Overall Study|Withdrawal by Subject|3
1099070|NCT01944774|3596269|P1|Overall Study|Withdrawal by Subject|2
1099071|NCT01944722|3596312|P1|Overall Study|>ASCUS Cytology|1122
1099072|NCT01944722|3596312|P1|Overall Study|Unsatisfactory Cytology Result|63
1099073|NCT01944722|3596312|P1|Overall Study|NILM Subjects <30 years old|8106
1099074|NCT01944722|3596312|P1|Overall Study|Withdrawal by Subject|8
1099075|NCT01944722|3596312|P1|Overall Study|Specimens Mislabeled|2
1099076|NCT01944722|3596312|P1|Overall Study|Missing Specimens|3
1099077|NCT01944722|3596312|P1|Overall Study|Insufficient Volume for Test|1
1099078|NCT01944722|3596312|P1|Overall Study|Improper Storage/Transport|5
1099079|NCT01944722|3596312|P1|Overall Study|Specimen Shipping Issues|34
1099080|NCT01944722|3596312|P1|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171
1099081|NCT01944670|3596346|P1|Overall Study|Lost to Follow-up|2
1099082|NCT01944631|3596368|P2|Overall Study|Withdrawal by Subject|1
1099083|NCT01944631|3596369|P1|Overall Study|Withdrawal by Subject|0
1099084|NCT01944631|3596368|P2|Overall Study|Lost to Follow-up|1
1099085|NCT01944631|3596369|P1|Overall Study|Lost to Follow-up|3
1099086|NCT01944631|3596368|P2|Overall Study|Adverse Event|0
1099087|NCT01944631|3596369|P1|Overall Study|Adverse Event|1
1099088|NCT01944462|3596385|P1|PPPP Educational Program|Lost to Follow-up|60
1099089|NCT01944098|3596415|P2|Overall Study|Physician Decision|0
1099090|NCT01944098|3596416|P1|Overall Study|Physician Decision|1
1099091|NCT01944059|3596428|P1|Overall Study|Adverse Event|2
1099092|NCT01944059|3596428|P1|Overall Study|Withdrawal by Subject|1
1099093|NCT01944059|3596428|P1|Overall Study|Physician Decision|3
1099094|NCT01944059|3596428|P1|Overall Study|Lost to Follow-up|1
1099095|NCT01943552|3596501|P2|Overall Study|Other Reasons|17
1099096|NCT01943552|3596502|P1|Overall Study|Other Reasons|16
1099097|NCT01943552|3596501|P2|Overall Study|Withdrawal by Subject|6
1099098|NCT01943552|3596502|P1|Overall Study|Withdrawal by Subject|6
1099099|NCT01943552|3596501|P2|Overall Study|Adverse Event|2
1099100|NCT01943552|3596502|P1|Overall Study|Adverse Event|3
1099101|NCT01943539|3596518|P2|Overall Study|Non-compliance with at-home intervention|0
1099102|NCT01943539|3596519|P1|Overall Study|Non-compliance with at-home intervention|4
1099103|NCT01943435|3596555|P3|6 Month Follow up|Lost to Follow-up|15
1099104|NCT01943435|3596556|P2|6 Month Follow up|Lost to Follow-up|7
1099105|NCT01943435|3596557|P1|6 Month Follow up|Lost to Follow-up|12
1099106|NCT01943435|3596555|P3|2 Month Follow up|Lost to Follow-up|0
1099107|NCT01943435|3596556|P2|2 Month Follow up|Lost to Follow-up|3
1099108|NCT01943435|3596557|P1|2 Month Follow up|Lost to Follow-up|2
1099109|NCT01943435|3596555|P3|Intervention Period|Withdrawal by Subject|4
1099110|NCT01943435|3596556|P2|Intervention Period|Withdrawal by Subject|3
1099111|NCT01943435|3596557|P1|Intervention Period|Withdrawal by Subject|3
1099112|NCT01943435|3596555|P3|Baseline Eligibility and Randomization|Withdrawal by Subject|3
1099113|NCT01943435|3596556|P2|Baseline Eligibility and Randomization|Withdrawal by Subject|12
1099114|NCT01943435|3596557|P1|Baseline Eligibility and Randomization|Withdrawal by Subject|4
1099115|NCT01943292|3596580|P3|Overall Study|Withdrawal by Subject|0
1099116|NCT01943292|3596581|P2|Overall Study|Withdrawal by Subject|0
1099117|NCT01943292|3596582|P1|Overall Study|Withdrawal by Subject|1
1099118|NCT01942785|3596609|P1|Overall Study|Protocol Violation|1
1099119|NCT01942785|3596609|P1|Overall Study|Withdrawal by Subject|1
1099120|NCT01942785|3596609|P1|Overall Study|Adverse Event|2
1099121|NCT01942733|3596638|P1|Overall Study|Administrative|1
1099122|NCT01942733|3596638|P1|Overall Study|Non-compliance with IMP|1
1099123|NCT01942733|3596638|P1|Overall Study|Lost to Follow-up|1
1099124|NCT01942590|3596690|P2|Overall Study|Adverse Event|0
1099125|NCT01942590|3596691|P1|Overall Study|Adverse Event|1
1099126|NCT01942590|3596690|P2|Overall Study|Withdrawal by Subject|1
1099127|NCT01942590|3596691|P1|Overall Study|Withdrawal by Subject|0
1099128|NCT01942161|3596724|P3|Overall Study|Withdrawal by Subject|1
1099129|NCT01942161|3596725|P2|Overall Study|Withdrawal by Subject|3
1099130|NCT01942161|3596726|P1|Overall Study|Withdrawal by Subject|3
1099131|NCT01942161|3596724|P3|Overall Study|Protocol Violation|0
1099132|NCT01942161|3596725|P2|Overall Study|Protocol Violation|0
1099133|NCT01942161|3596726|P1|Overall Study|Protocol Violation|1
1099134|NCT01942161|3596724|P3|Overall Study|Physician Decision|0
1099135|NCT01942161|3596725|P2|Overall Study|Physician Decision|1
1099136|NCT01942161|3596726|P1|Overall Study|Physician Decision|3
1099137|NCT01942161|3596724|P3|Overall Study|Adverse Event|5
1099138|NCT01942161|3596725|P2|Overall Study|Adverse Event|2
1099139|NCT01942161|3596726|P1|Overall Study|Adverse Event|1
1099140|NCT01942148|3596746|P1|Overall Study|Use of the prohibition medicine|1
1099141|NCT01942148|3596746|P1|Overall Study|Withdrawal by Subject|8
1099142|NCT01942148|3596746|P1|Overall Study|Protocol Violation|1
1099143|NCT01942148|3596746|P1|Overall Study|Physician Decision|11
1099144|NCT01942148|3596746|P1|Overall Study|Lack of Efficacy|2
1099145|NCT01942148|3596746|P1|Overall Study|Adverse Event|4
1099146|NCT01942135|3596754|P2|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|75
1099147|NCT01942135|3596755|P1|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|238
1099148|NCT01942135|3596754|P2|Overall Study|Withdrawal by Subject|2
1099149|NCT01942135|3596755|P1|Overall Study|Withdrawal by Subject|4
1099150|NCT01942135|3596754|P2|Overall Study|Participant Refused toContinue Treatment|1
1099151|NCT01942135|3596755|P1|Overall Study|Participant Refused toContinue Treatment|1
1099152|NCT01942135|3596754|P2|Overall Study|ObjectiveProgression+Progressive Disease|87
1099153|NCT01942135|3596755|P1|Overall Study|ObjectiveProgression+Progressive Disease|85
1099154|NCT01942135|3596754|P2|Overall Study|Death|1
1099155|NCT01942135|3596755|P1|Overall Study|Death|0
1099156|NCT01942135|3596754|P2|Overall Study|Randomized Not Treated|2
1099157|NCT01942135|3596755|P1|Overall Study|Randomized Not Treated|2
1099158|NCT01942135|3596754|P2|Overall Study|Global deterioration of health status|3
1099159|NCT01942135|3596755|P1|Overall Study|Global deterioration of health status|8
1099160|NCT01942135|3596754|P2|Overall Study|Adverse Event|3
1099161|NCT01942135|3596755|P1|Overall Study|Adverse Event|9
1099162|NCT01941940|3596792|P1|Overall Study|Other|1
1099163|NCT01941940|3596792|P1|Overall Study|Other|1
1099164|NCT01941940|3596792|P1|Overall Study|Death|1
1099165|NCT01941940|3596792|P1|Overall Study|Withdrawal by Subject|15
1099166|NCT01941940|3596792|P1|Overall Study|Physician Decision|2
1099167|NCT01941940|3596792|P1|Overall Study|Lost to Follow-up|2
1099168|NCT01941940|3596792|P1|Overall Study|Adverse Event|11
1099169|NCT01941498|3596841|P1|Overall Study|Relocated out of state|1
1099170|NCT01941186|3596959|P2|Follow-up|Lost to Follow-up|0
1099171|NCT01941186|3596960|P1|Follow-up|Lost to Follow-up|1
1099172|NCT01941095|3596986|P1|Overall Study|Lost to Follow-up|10
1099173|NCT01941095|3596986|P1|Overall Study|Withdrawal by Subject|17
1099174|NCT01941095|3596986|P1|Overall Study|Physician Decision|3
1099175|NCT01941095|3596986|P1|Overall Study|Adverse Event|11
1099176|NCT01941095|3596986|P1|Overall Study|Anaphylaxis or serious hypersensitivity|2
1099177|NCT01941095|3596986|P1|Overall Study|Insufficient therapeutic response|13
1099178|NCT01940939|3597011|P2|Overall Study|Withdrawal by Subject|8
1099179|NCT01940939|3597012|P1|Overall Study|Withdrawal by Subject|2
1099180|NCT01940900|3597024|P2|Overall Study|other|0
1099181|NCT01940900|3597025|P1|Overall Study|other|1
1099182|NCT01940900|3597024|P2|Overall Study|subject non-compliance|1
1099183|NCT01940900|3597025|P1|Overall Study|subject non-compliance|1
1099184|NCT01940900|3597024|P2|Overall Study|Sponsor Decision|0
1099185|NCT01940900|3597025|P1|Overall Study|Sponsor Decision|1
1099186|NCT01940900|3597024|P2|Overall Study|Lost to Follow-up|0
1099187|NCT01940900|3597025|P1|Overall Study|Lost to Follow-up|1
1099188|NCT01940900|3597024|P2|Overall Study|Withdrawal by Subject|15
1099189|NCT01940900|3597025|P1|Overall Study|Withdrawal by Subject|11
1099190|NCT01940900|3597024|P2|Overall Study|Adverse Event|15
1099191|NCT01940900|3597025|P1|Overall Study|Adverse Event|10
1099192|NCT01940900|3597024|P2|Overall Study|Physician Decision|0
1099193|NCT01940900|3597025|P1|Overall Study|Physician Decision|4
1099194|NCT01940497|3597075|P2|Overall Study|Ongoing at data cut-off|117
1099195|NCT01940497|3597076|P1|Overall Study|Ongoing at data cut-off|116
1099196|NCT01940497|3597075|P2|Overall Study|Withdrawal by Subject|0
1099197|NCT01940497|3597076|P1|Overall Study|Withdrawal by Subject|2
1099198|NCT01940497|3597075|P2|Overall Study|Protocol Violation|0
1099199|NCT01940497|3597076|P1|Overall Study|Protocol Violation|1
1099200|NCT01940497|3597075|P2|Overall Study|Failure to return|1
1099201|NCT01940497|3597076|P1|Overall Study|Failure to return|0
1099202|NCT01940497|3597075|P2|Overall Study|Adverse event/Intercurrent illness|0
1099203|NCT01940497|3597076|P1|Overall Study|Adverse event/Intercurrent illness|1
1099204|NCT01940484|3597115|P1|Overall Study|Adverse Event|1
1099205|NCT01940484|3597115|P1|Overall Study|Death|2
1099206|NCT01940484|3597115|P1|Overall Study|Underwent transplantation|4
1099207|NCT01940484|3597115|P1|Overall Study|Withdrawal by Subject|3
1099208|NCT01940471|3597135|P2|Open-Label Extension|Still on Open-Label Treatment|8
1099209|NCT01940471|3597136|P1|Open-Label Extension|Still on Open-Label Treatment|14
1099210|NCT01940471|3597135|P2|Double-Blind Phase|Still on Double-Blind Treatment|270
1099211|NCT01940471|3597136|P1|Double-Blind Phase|Still on Double-Blind Treatment|537
1099212|NCT01940471|3597135|P2|Double-Blind Phase|HBsAg Seroconversion|0
1099213|NCT01940471|3597136|P1|Double-Blind Phase|HBsAg Seroconversion|1
1099214|NCT01940471|3597135|P2|Double-Blind Phase|Protocol Violation|1
1099215|NCT01940471|3597136|P1|Double-Blind Phase|Protocol Violation|0
1099216|NCT01940471|3597135|P2|Double-Blind Phase|Lack of Efficacy|0
1099217|NCT01940471|3597136|P1|Double-Blind Phase|Lack of Efficacy|1
1099218|NCT01940471|3597135|P2|Double-Blind Phase|Death|0
1099219|NCT01940471|3597136|P1|Double-Blind Phase|Death|1
1099220|NCT01940471|3597135|P2|Double-Blind Phase|Protocol-Specified Criteria|0
1099221|NCT01940471|3597136|P1|Double-Blind Phase|Protocol-Specified Criteria|2
1099222|NCT01940471|3597135|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
1099223|NCT01940471|3597136|P1|Double-Blind Phase|Non-Compliance with Study Drug|2
1099224|NCT01940471|3597135|P2|Double-Blind Phase|Investigator's Discretion|1
1099225|NCT01940471|3597136|P1|Double-Blind Phase|Investigator's Discretion|2
1099226|NCT01940471|3597135|P2|Double-Blind Phase|Pregnancy|1
1099227|NCT01940471|3597136|P1|Double-Blind Phase|Pregnancy|2
1099228|NCT01940471|3597135|P2|Double-Blind Phase|Lost to Follow-up|2
1099229|NCT01940471|3597136|P1|Double-Blind Phase|Lost to Follow-up|2
1099230|NCT01940471|3597135|P2|Double-Blind Phase|Adverse Event|3
1099231|NCT01940471|3597136|P1|Double-Blind Phase|Adverse Event|6
1099232|NCT01940471|3597135|P2|Double-Blind Phase|Withdrew Consent|5
1099233|NCT01940471|3597136|P1|Double-Blind Phase|Withdrew Consent|11
1099234|NCT01940471|3597135|P2|Double-Blind Phase|Randomized but Never Treated|1
1099235|NCT01940471|3597136|P1|Double-Blind Phase|Randomized but Never Treated|1
1099236|NCT01940354|3597154|P2|Overall Study|Withdrawal by Subject|2
1099237|NCT01940354|3597155|P1|Overall Study|Withdrawal by Subject|4
1099238|NCT01940341|3597167|P2|Open-label Extension Phase|Still on Study|1
1099239|NCT01940341|3597168|P1|Open-label Extension Phase|Still on Study|4
1099240|NCT01940341|3597167|P2|Double-Blind Phase|Still on Double-Blind Treatment|132
1099241|NCT01940341|3597168|P1|Double-Blind Phase|Still on Double-Blind Treatment|269
1099242|NCT01940341|3597167|P2|Double-Blind Phase|Protocol Specified Criteria|0
1099243|NCT01940341|3597168|P1|Double-Blind Phase|Protocol Specified Criteria|1
1099244|NCT01940341|3597167|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
1099245|NCT01940341|3597168|P1|Double-Blind Phase|Non-Compliance with Study Drug|0
1099246|NCT01940341|3597167|P2|Double-Blind Phase|Investigator's Discretion|0
1099247|NCT01940341|3597168|P1|Double-Blind Phase|Investigator's Discretion|1
1099248|NCT01940341|3597167|P2|Double-Blind Phase|Pregnancy|1
1099249|NCT01940341|3597168|P1|Double-Blind Phase|Pregnancy|0
1099250|NCT01940341|3597167|P2|Double-Blind Phase|Lost to Follow-up|1
1099251|NCT01940341|3597168|P1|Double-Blind Phase|Lost to Follow-up|4
1099252|NCT01940341|3597167|P2|Double-Blind Phase|Withdrew Consent|2
1099253|NCT01940341|3597168|P1|Double-Blind Phase|Withdrew Consent|3
1099254|NCT01940341|3597167|P2|Double-Blind Phase|Adverse Event|2
1099255|NCT01940341|3597168|P1|Double-Blind Phase|Adverse Event|3
1099256|NCT01940341|3597167|P2|Double-Blind Phase|Randomized but Never Treated|1
1099257|NCT01940341|3597168|P1|Double-Blind Phase|Randomized but Never Treated|0
1099258|NCT01940120|3597199|P1|Overall Study|Withdrawal by Subject|8
1099259|NCT01940120|3597199|P1|Overall Study|Death|40
1099260|NCT01939977|3597355|P2|Overall Study|Did not receive study medication|1
1099261|NCT01939977|3597356|P1|Overall Study|Did not receive study medication|0
1099262|NCT01939977|3597355|P2|Overall Study|Did not meet inclusion criteria|0
1099263|NCT01939977|3597356|P1|Overall Study|Did not meet inclusion criteria|1
1099264|NCT01939977|3597355|P2|Overall Study|Withdrawal by Subject|2
1099265|NCT01939977|3597356|P1|Overall Study|Withdrawal by Subject|0
1099266|NCT01939977|3597355|P2|Overall Study|Physician Decision|1
1099267|NCT01939977|3597356|P1|Overall Study|Physician Decision|1
1099268|NCT01939977|3597355|P2|Overall Study|Lack of Efficacy|0
1099269|NCT01939977|3597356|P1|Overall Study|Lack of Efficacy|3
1099270|NCT01939977|3597355|P2|Overall Study|Adverse Event|3
1099271|NCT01939977|3597356|P1|Overall Study|Adverse Event|4
1099272|NCT01939548|3597401|P3|Overall Study|Did not complete follow-up|0
1099273|NCT01939548|3597402|P2|Overall Study|Did not complete follow-up|1
1099274|NCT01939548|3597403|P1|Overall Study|Did not complete follow-up|0
1099275|NCT01939548|3597401|P3|Overall Study|Participant withdrew consent|0
1099276|NCT01939548|3597402|P2|Overall Study|Participant withdrew consent|2
1099277|NCT01939548|3597403|P1|Overall Study|Participant withdrew consent|0
1099278|NCT01939548|3597401|P3|Overall Study|Participant unwilling to continue|0
1099279|NCT01939548|3597402|P2|Overall Study|Participant unwilling to continue|1
1099280|NCT01939548|3597403|P1|Overall Study|Participant unwilling to continue|0
1099281|NCT01939548|3597401|P3|Overall Study|Participant dropped|1
1099282|NCT01939548|3597402|P2|Overall Study|Participant dropped|0
1099283|NCT01939548|3597403|P1|Overall Study|Participant dropped|0
1099284|NCT01939548|3597401|P3|Overall Study|Death|1
1099285|NCT01939548|3597402|P2|Overall Study|Death|0
1099286|NCT01939548|3597403|P1|Overall Study|Death|0
1099287|NCT01939548|3597401|P3|Overall Study|Adverse Event|7
1099288|NCT01939548|3597402|P2|Overall Study|Adverse Event|9
1099289|NCT01939548|3597403|P1|Overall Study|Adverse Event|2
1099290|NCT01939548|3597401|P3|Overall Study|Lost to Follow-up|3
1099291|NCT01939548|3597402|P2|Overall Study|Lost to Follow-up|5
1099292|NCT01939548|3597403|P1|Overall Study|Lost to Follow-up|5
1099293|NCT01939548|3597401|P3|Overall Study|Protocol Violation|5
1099294|NCT01939548|3597402|P2|Overall Study|Protocol Violation|6
1099295|NCT01939548|3597403|P1|Overall Study|Protocol Violation|7
1099296|NCT01939548|3597401|P3|Overall Study|Withdrawal by Subject|1
1099297|NCT01939548|3597402|P2|Overall Study|Withdrawal by Subject|4
1099298|NCT01939548|3597403|P1|Overall Study|Withdrawal by Subject|4
1099299|NCT01939548|3597401|P3|Overall Study|Did Not Meet Entrance Criteria|0
1099300|NCT01939548|3597402|P2|Overall Study|Did Not Meet Entrance Criteria|0
1099301|NCT01939548|3597403|P1|Overall Study|Did Not Meet Entrance Criteria|1
1099302|NCT01939548|3597401|P3|Overall Study|Insufficient Clinical Response|0
1099303|NCT01939548|3597402|P2|Overall Study|Insufficient Clinical Response|0
1099304|NCT01939548|3597403|P1|Overall Study|Insufficient Clinical Response|1
1099305|NCT01939548|3597401|P3|Overall Study|Study Terminated by Sponsor|12
1099306|NCT01939548|3597402|P2|Overall Study|Study Terminated by Sponsor|19
1099307|NCT01939548|3597403|P1|Overall Study|Study Terminated by Sponsor|17
1099308|NCT01939548|3597401|P3|Overall Study|Non compliance|0
1099309|NCT01939548|3597402|P2|Overall Study|Non compliance|2
1099310|NCT01939548|3597403|P1|Overall Study|Non compliance|0
1099311|NCT01939496|3597477|P3|Overall Study|Other|1
1099312|NCT01939496|3597478|P2|Overall Study|Other|0
1099313|NCT01939496|3597479|P1|Overall Study|Other|2
1099314|NCT01939496|3597477|P3|Overall Study|Blood Pressure Withdrawal Criteria|0
1099315|NCT01939496|3597478|P2|Overall Study|Blood Pressure Withdrawal Criteria|1
1099316|NCT01939496|3597479|P1|Overall Study|Blood Pressure Withdrawal Criteria|0
1099317|NCT01939496|3597477|P3|Overall Study|Withdrawal by Subject|1
1099318|NCT01939496|3597478|P2|Overall Study|Withdrawal by Subject|1
1099319|NCT01939496|3597479|P1|Overall Study|Withdrawal by Subject|0
1099320|NCT01939496|3597477|P3|Overall Study|Protocol Violation|0
1099321|NCT01939496|3597478|P2|Overall Study|Protocol Violation|0
1099322|NCT01939496|3597479|P1|Overall Study|Protocol Violation|3
1099323|NCT01939496|3597477|P3|Overall Study|Physician Decision|0
1099324|NCT01939496|3597478|P2|Overall Study|Physician Decision|0
1099325|NCT01939496|3597479|P1|Overall Study|Physician Decision|1
1099326|NCT01939496|3597477|P3|Overall Study|Lost to Follow-up|0
1099327|NCT01939496|3597478|P2|Overall Study|Lost to Follow-up|1
1099328|NCT01939496|3597479|P1|Overall Study|Lost to Follow-up|1
1099329|NCT01939496|3597477|P3|Overall Study|Adverse Event|0
1099330|NCT01939496|3597478|P2|Overall Study|Adverse Event|0
1099331|NCT01939496|3597479|P1|Overall Study|Adverse Event|2
1099332|NCT01939314|3597546|P2|Overall Study|Lost to Follow-up|6
1099333|NCT01939314|3597547|P1|Overall Study|Lost to Follow-up|5
1099334|NCT01939314|3597546|P2|Overall Study|Pregnancy|1
1099335|NCT01939314|3597547|P1|Overall Study|Pregnancy|0
1099336|NCT01939314|3597546|P2|Overall Study|Protocol Violation|0
1099337|NCT01939314|3597547|P1|Overall Study|Protocol Violation|1
1099338|NCT01939314|3597546|P2|Overall Study|Withdrawal by Subject|1
1099339|NCT01939314|3597547|P1|Overall Study|Withdrawal by Subject|3
1099340|NCT01939223|3597568|P2|Overall Study|Withdrawal by Subject|0
1099341|NCT01939223|3597569|P1|Overall Study|Withdrawal by Subject|6
1099342|NCT01939223|3597568|P2|Overall Study|Study stopped by Sponsor|7
1099343|NCT01939223|3597569|P1|Overall Study|Study stopped by Sponsor|5
1099344|NCT01939223|3597568|P2|Overall Study|Disease recurrence (radiological)|3
1099345|NCT01939223|3597569|P1|Overall Study|Disease recurrence (radiological)|1
1099346|NCT01939223|3597568|P2|Overall Study|AE not assoc. with disease recurrence|1
1099347|NCT01939223|3597569|P1|Overall Study|AE not assoc. with disease recurrence|1
1099348|NCT01939197|3597584|P7|Overall Study|Lost to Follow-up|2
1099349|NCT01939197|3597585|P6|Overall Study|Lost to Follow-up|1
1099350|NCT01939197|3597586|P5|Overall Study|Lost to Follow-up|3
1099351|NCT01939197|3597587|P4|Overall Study|Lost to Follow-up|1
1099352|NCT01939197|3597588|P3|Overall Study|Lost to Follow-up|0
1099353|NCT01939197|3597589|P2|Overall Study|Lost to Follow-up|1
1099354|NCT01939197|3597590|P1|Overall Study|Lost to Follow-up|0
1099355|NCT01939197|3597584|P7|Overall Study|Withdrawal by Subject|0
1099356|NCT01939197|3597585|P6|Overall Study|Withdrawal by Subject|0
1099357|NCT01939197|3597586|P5|Overall Study|Withdrawal by Subject|1
1099358|NCT01939197|3597587|P4|Overall Study|Withdrawal by Subject|0
1099359|NCT01939197|3597588|P3|Overall Study|Withdrawal by Subject|0
1099360|NCT01939197|3597589|P2|Overall Study|Withdrawal by Subject|0
1099361|NCT01939197|3597590|P1|Overall Study|Withdrawal by Subject|1
1099362|NCT01939002|3597661|P2|Overall Study|Not Specified|2
1099363|NCT01939002|3597662|P1|Overall Study|Not Specified|1
1099364|NCT01939002|3597661|P2|Overall Study|Withdrawal by Subject|3
1099365|NCT01939002|3597662|P1|Overall Study|Withdrawal by Subject|5
1099366|NCT01939002|3597661|P2|Overall Study|Adverse Event|13
1099367|NCT01939002|3597662|P1|Overall Study|Adverse Event|13
1099368|NCT01938625|3597745|P2|Overall Study|Adverse Event|1
1099369|NCT01938625|3597746|P1|Overall Study|Adverse Event|0
1099370|NCT01938625|3597745|P2|Overall Study|Withdrawal by Subject|1
1099371|NCT01938625|3597746|P1|Overall Study|Withdrawal by Subject|0
1099372|NCT01938573|3597766|P2|Overall Study|Operation at other hospital|0
1099373|NCT01938573|3597767|P1|Overall Study|Operation at other hospital|1
1099374|NCT01938573|3597766|P2|Overall Study|Lack of Efficacy|0
1099375|NCT01938573|3597767|P1|Overall Study|Lack of Efficacy|1
1099376|NCT01938430|3597787|P14|Overall Study|Withdrew Consent|0
1099377|NCT01938430|3597788|P13|Overall Study|Withdrew Consent|0
1099378|NCT01938430|3597789|P12|Overall Study|Withdrew Consent|0
1099379|NCT01938430|3597790|P11|Overall Study|Withdrew Consent|0
1099380|NCT01938430|3597791|P10|Overall Study|Withdrew Consent|0
1099381|NCT01938430|3597792|P9|Overall Study|Withdrew Consent|1
1099382|NCT01938430|3597793|P8|Overall Study|Withdrew Consent|0
1099383|NCT01938430|3597794|P7|Overall Study|Withdrew Consent|0
1099384|NCT01938430|3597795|P6|Overall Study|Withdrew Consent|0
1099385|NCT01938430|3597796|P5|Overall Study|Withdrew Consent|0
1099386|NCT01938430|3597797|P4|Overall Study|Withdrew Consent|0
1099387|NCT01938430|3597798|P3|Overall Study|Withdrew Consent|0
1099388|NCT01938430|3597799|P2|Overall Study|Withdrew Consent|0
1099389|NCT01938430|3597800|P1|Overall Study|Withdrew Consent|0
1099390|NCT01938430|3597787|P14|Overall Study|Lost to Follow-up|0
1099391|NCT01938430|3597788|P13|Overall Study|Lost to Follow-up|0
1099392|NCT01938430|3597789|P12|Overall Study|Lost to Follow-up|0
1099393|NCT01938430|3597790|P11|Overall Study|Lost to Follow-up|0
1099394|NCT01938430|3597791|P10|Overall Study|Lost to Follow-up|0
1099395|NCT01938430|3597792|P9|Overall Study|Lost to Follow-up|0
1099396|NCT01938430|3597793|P8|Overall Study|Lost to Follow-up|0
1099397|NCT01938430|3597794|P7|Overall Study|Lost to Follow-up|0
1099398|NCT01938430|3597795|P6|Overall Study|Lost to Follow-up|1
1099399|NCT01938430|3597796|P5|Overall Study|Lost to Follow-up|0
1099400|NCT01938430|3597797|P4|Overall Study|Lost to Follow-up|0
1099401|NCT01938430|3597798|P3|Overall Study|Lost to Follow-up|1
1099402|NCT01938430|3597799|P2|Overall Study|Lost to Follow-up|0
1099403|NCT01938430|3597800|P1|Overall Study|Lost to Follow-up|0
1099404|NCT01938430|3597787|P14|Overall Study|Lack of Efficacy|0
1099405|NCT01938430|3597788|P13|Overall Study|Lack of Efficacy|0
1099406|NCT01938430|3597789|P12|Overall Study|Lack of Efficacy|1
1099407|NCT01938430|3597790|P11|Overall Study|Lack of Efficacy|2
1099408|NCT01938430|3597791|P10|Overall Study|Lack of Efficacy|0
1099409|NCT01938430|3597792|P9|Overall Study|Lack of Efficacy|1
1099410|NCT01938430|3597793|P8|Overall Study|Lack of Efficacy|0
1099411|NCT01938430|3597794|P7|Overall Study|Lack of Efficacy|0
1099412|NCT01938430|3597795|P6|Overall Study|Lack of Efficacy|0
1099413|NCT01938430|3597796|P5|Overall Study|Lack of Efficacy|0
1099414|NCT01938430|3597797|P4|Overall Study|Lack of Efficacy|1
1099415|NCT01938430|3597798|P3|Overall Study|Lack of Efficacy|1
1099416|NCT01938430|3597799|P2|Overall Study|Lack of Efficacy|1
1099417|NCT01938430|3597800|P1|Overall Study|Lack of Efficacy|3
1099418|NCT01938430|3597787|P14|Overall Study|Investigator's Discretion|0
1099419|NCT01938430|3597788|P13|Overall Study|Investigator's Discretion|0
1099420|NCT01938430|3597789|P12|Overall Study|Investigator's Discretion|0
1099421|NCT01938430|3597790|P11|Overall Study|Investigator's Discretion|0
1099422|NCT01938430|3597791|P10|Overall Study|Investigator's Discretion|0
1099423|NCT01938430|3597792|P9|Overall Study|Investigator's Discretion|0
1099424|NCT01938430|3597793|P8|Overall Study|Investigator's Discretion|0
1099425|NCT01938430|3597794|P7|Overall Study|Investigator's Discretion|0
1099426|NCT01938430|3597795|P6|Overall Study|Investigator's Discretion|0
1099427|NCT01938430|3597796|P5|Overall Study|Investigator's Discretion|0
1099428|NCT01938430|3597797|P4|Overall Study|Investigator's Discretion|0
1099429|NCT01938430|3597798|P3|Overall Study|Investigator's Discretion|1
1099430|NCT01938430|3597799|P2|Overall Study|Investigator's Discretion|0
1099431|NCT01938430|3597800|P1|Overall Study|Investigator's Discretion|0
1099432|NCT01938430|3597787|P14|Overall Study|Death|0
1099433|NCT01938430|3597788|P13|Overall Study|Death|0
1099434|NCT01938430|3597789|P12|Overall Study|Death|0
1099435|NCT01938430|3597790|P11|Overall Study|Death|0
1099436|NCT01938430|3597791|P10|Overall Study|Death|3
1099437|NCT01938430|3597792|P9|Overall Study|Death|2
1099438|NCT01938430|3597793|P8|Overall Study|Death|1
1099439|NCT01938430|3597794|P7|Overall Study|Death|1
1099440|NCT01938430|3597795|P6|Overall Study|Death|0
1099441|NCT01938430|3597796|P5|Overall Study|Death|0
1099442|NCT01938430|3597797|P4|Overall Study|Death|1
1099443|NCT01938430|3597798|P3|Overall Study|Death|2
1099444|NCT01938430|3597799|P2|Overall Study|Death|2
1099445|NCT01938430|3597800|P1|Overall Study|Death|1
1099446|NCT01938430|3597787|P14|Overall Study|Adverse Event|0
1099447|NCT01938430|3597788|P13|Overall Study|Adverse Event|0
1099448|NCT01938430|3597789|P12|Overall Study|Adverse Event|0
1099449|NCT01938430|3597790|P11|Overall Study|Adverse Event|0
1099450|NCT01938430|3597791|P10|Overall Study|Adverse Event|0
1099451|NCT01938430|3597792|P9|Overall Study|Adverse Event|0
1099452|NCT01938430|3597793|P8|Overall Study|Adverse Event|0
1099453|NCT01938430|3597794|P7|Overall Study|Adverse Event|1
1099454|NCT01938430|3597795|P6|Overall Study|Adverse Event|0
1099455|NCT01938430|3597796|P5|Overall Study|Adverse Event|0
1099456|NCT01938430|3597797|P4|Overall Study|Adverse Event|0
1099457|NCT01938430|3597798|P3|Overall Study|Adverse Event|0
1099458|NCT01938430|3597799|P2|Overall Study|Adverse Event|0
1099459|NCT01938430|3597800|P1|Overall Study|Adverse Event|0
1099460|NCT01938430|3597787|P14|Overall Study|Randomized but Not Treated|1
1099461|NCT01938430|3597788|P13|Overall Study|Randomized but Not Treated|0
1099462|NCT01938430|3597789|P12|Overall Study|Randomized but Not Treated|0
1099463|NCT01938430|3597790|P11|Overall Study|Randomized but Not Treated|1
1099464|NCT01938430|3597791|P10|Overall Study|Randomized but Not Treated|0
1099465|NCT01938430|3597792|P9|Overall Study|Randomized but Not Treated|0
1099466|NCT01938430|3597793|P8|Overall Study|Randomized but Not Treated|0
1099467|NCT01938430|3597794|P7|Overall Study|Randomized but Not Treated|0
1099468|NCT01938430|3597795|P6|Overall Study|Randomized but Not Treated|0
1099469|NCT01938430|3597796|P5|Overall Study|Randomized but Not Treated|0
1099470|NCT01938430|3597797|P4|Overall Study|Randomized but Not Treated|0
1099471|NCT01938430|3597798|P3|Overall Study|Randomized but Not Treated|0
1099472|NCT01938430|3597799|P2|Overall Study|Randomized but Not Treated|0
1099473|NCT01938430|3597800|P1|Overall Study|Randomized but Not Treated|0
1099474|NCT01938391|3598125|P1|12 Month Follow up|Withdrawal by Subject|1
1099475|NCT01938391|3598125|P1|12 Month Follow up|Physician Decision|1
1099476|NCT01938391|3598125|P1|6 Month Follow up|Withdrawal by Subject|1
1099477|NCT01937871|3598244|P3|Overall Study|Entry Criteria Not Met|1
1099478|NCT01937871|3598245|P2|Overall Study|Entry Criteria Not Met|2
1099479|NCT01937871|3598246|P1|Overall Study|Entry Criteria Not Met|1
1099480|NCT01937871|3598244|P3|Overall Study|Physician Decision|0
1099481|NCT01937871|3598245|P2|Overall Study|Physician Decision|1
1099482|NCT01937871|3598246|P1|Overall Study|Physician Decision|0
1099483|NCT01937871|3598244|P3|Overall Study|Withdrawal by Subject|4
1099484|NCT01937871|3598245|P2|Overall Study|Withdrawal by Subject|6
1099485|NCT01937871|3598246|P1|Overall Study|Withdrawal by Subject|9
1099486|NCT01937871|3598244|P3|Overall Study|Lost to Follow-up|4
1099487|NCT01937871|3598245|P2|Overall Study|Lost to Follow-up|2
1099488|NCT01937871|3598246|P1|Overall Study|Lost to Follow-up|8
1099489|NCT01937871|3598244|P3|Overall Study|Adverse Event|2
1099490|NCT01937871|3598245|P2|Overall Study|Adverse Event|6
1099491|NCT01937871|3598246|P1|Overall Study|Adverse Event|6
1099492|NCT01937715|3598322|P5|Overall Study|Other|0
1099493|NCT01937715|3598323|P4|Overall Study|Other|3
1099494|NCT01937715|3598324|P3|Overall Study|Other|0
1099495|NCT01937715|3598325|P2|Overall Study|Other|0
1099496|NCT01937715|3598326|P1|Overall Study|Other|0
1099497|NCT01937715|3598322|P5|Overall Study|Withdrawal by Subject|2
1099498|NCT01937715|3598323|P4|Overall Study|Withdrawal by Subject|0
1099499|NCT01937715|3598324|P3|Overall Study|Withdrawal by Subject|0
1099500|NCT01937715|3598325|P2|Overall Study|Withdrawal by Subject|1
1099501|NCT01937715|3598326|P1|Overall Study|Withdrawal by Subject|0
1099502|NCT01937715|3598322|P5|Overall Study|Death|0
1099503|NCT01937715|3598323|P4|Overall Study|Death|1
1099504|NCT01937715|3598324|P3|Overall Study|Death|0
1099505|NCT01937715|3598325|P2|Overall Study|Death|0
1099506|NCT01937715|3598326|P1|Overall Study|Death|0
1099507|NCT01937390|3598517|P1|Overall Study|Fail to return|21
1099508|NCT01937390|3598517|P1|Overall Study|Withdrawal by Subject|5
1099509|NCT01937390|3598517|P1|Overall Study|Lost to Follow-up|7
1099510|NCT01937390|3598517|P1|Overall Study|Death|2
1099511|NCT01937364|3598527|P2|Overall Study|Adverse Event|1
1099512|NCT01937364|3598528|P1|Overall Study|Adverse Event|2
1099513|NCT01937351|3598540|P2|Overall Study|Not treated w device, per protocol fail|0
1099514|NCT01937351|3598541|P1|Overall Study|Not treated w device, per protocol fail|4
1099515|NCT01937351|3598540|P2|Overall Study|Death|0
1099516|NCT01937351|3598541|P1|Overall Study|Death|1
1099517|NCT01937351|3598540|P2|Overall Study|Withdrawal by Subject|2
1099518|NCT01937351|3598541|P1|Overall Study|Withdrawal by Subject|4
1099519|NCT01937312|3598549|P2|Overall Study|Withdrawal of subject prior to treatment|1
1099520|NCT01937312|3598550|P1|Overall Study|Withdrawal of subject prior to treatment|1
1099521|NCT01937312|3598549|P2|Overall Study|Lack of Efficacy|1
1099522|NCT01937312|3598550|P1|Overall Study|Lack of Efficacy|0
1099523|NCT01937312|3598549|P2|Overall Study|Adverse Event|1
1099524|NCT01937312|3598550|P1|Overall Study|Adverse Event|10
1099525|NCT01937299|3598565|P2|Overall Study|Withdrawal by Subject|0
1099526|NCT01937299|3598566|P1|Overall Study|Withdrawal by Subject|1
1099527|NCT01937299|3598565|P2|Overall Study|Lack of Efficacy|4
1099528|NCT01937299|3598566|P1|Overall Study|Lack of Efficacy|0
1099529|NCT01937299|3598565|P2|Overall Study|Adverse Event|0
1099530|NCT01937299|3598566|P1|Overall Study|Adverse Event|13
1099531|NCT01937130|3598601|P4|Overall Study|Patient lost to FU due to death|0
1099532|NCT01937130|3598602|P3|Overall Study|Patient lost to FU due to death|0
1099533|NCT01937130|3598603|P2|Overall Study|Patient lost to FU due to death|0
1099534|NCT01937130|3598604|P1|Overall Study|Patient lost to FU due to death|2
1099535|NCT01937130|3598601|P4|Overall Study|Patients unable to swallow|0
1099536|NCT01937130|3598602|P3|Overall Study|Patients unable to swallow|0
1099537|NCT01937130|3598603|P2|Overall Study|Patients unable to swallow|1
1099538|NCT01937130|3598604|P1|Overall Study|Patients unable to swallow|0
1099539|NCT01937130|3598601|P4|Overall Study|Physician Decision|0
1099540|NCT01937130|3598602|P3|Overall Study|Physician Decision|0
1099541|NCT01937130|3598603|P2|Overall Study|Physician Decision|1
1099542|NCT01937130|3598604|P1|Overall Study|Physician Decision|0
1099543|NCT01937130|3598601|P4|Overall Study|Lost to Follow-up|0
1099544|NCT01937130|3598602|P3|Overall Study|Lost to Follow-up|2
1099545|NCT01937130|3598603|P2|Overall Study|Lost to Follow-up|0
1099546|NCT01937130|3598604|P1|Overall Study|Lost to Follow-up|2
1099547|NCT01937130|3598601|P4|Overall Study|Death|0
1099548|NCT01937130|3598602|P3|Overall Study|Death|1
1099549|NCT01937130|3598603|P2|Overall Study|Death|1
1099550|NCT01937130|3598604|P1|Overall Study|Death|1
1099551|NCT01937130|3598601|P4|Overall Study|Adverse Event|1
1099552|NCT01937130|3598602|P3|Overall Study|Adverse Event|0
1099553|NCT01937130|3598603|P2|Overall Study|Adverse Event|1
1099554|NCT01937130|3598604|P1|Overall Study|Adverse Event|0
1099555|NCT01937130|3598601|P4|Overall Study|Withdrawal by Subject|1
1099556|NCT01937130|3598602|P3|Overall Study|Withdrawal by Subject|0
1099557|NCT01937130|3598603|P2|Overall Study|Withdrawal by Subject|0
1099558|NCT01937130|3598604|P1|Overall Study|Withdrawal by Subject|0
1099559|NCT01936974|3598642|P2|Overall Study|Physician Decision|5
1099560|NCT01936974|3598643|P1|Overall Study|Physician Decision|2
1099561|NCT01936870|3598673|P1|Overall Study|No Drug Administration|1
1099562|NCT01936870|3598673|P1|Overall Study|Protocol Violation|12
1099563|NCT01936870|3598673|P1|Overall Study|No Visit After Treatment|176
1099564|NCT01936649|3598710|P1|Overall Study|Other than specified above|5
1099565|NCT01936649|3598710|P1|Overall Study|Protocol Violation|2
1099566|NCT01936649|3598710|P1|Overall Study|Physician Decision|2
1099567|NCT01936649|3598710|P1|Overall Study|Withdrawal by Subject|4
1099568|NCT01936623|3598717|P2|Overall Study|Lost to Follow-up|5
1099569|NCT01936623|3598718|P1|Overall Study|Lost to Follow-up|0
1099570|NCT01936181|3598789|P4|Transition-extension|Withdrawal by Subject|1
1099571|NCT01936181|3598790|P3|Transition-extension|Withdrawal by Subject|2
1099572|NCT01936181|3598791|P2|Transition-extension|Withdrawal by Subject|0
1099573|NCT01936181|3598792|P1|Transition-extension|Withdrawal by Subject|7
1099574|NCT01936181|3598789|P4|Transition-extension|Physician Decision|1
1099575|NCT01936181|3598790|P3|Transition-extension|Physician Decision|0
1099576|NCT01936181|3598791|P2|Transition-extension|Physician Decision|0
1099577|NCT01936181|3598792|P1|Transition-extension|Physician Decision|2
1099578|NCT01936181|3598789|P4|Transition-extension|Lost to Follow-up|2
1099579|NCT01936181|3598790|P3|Transition-extension|Lost to Follow-up|1
1099580|NCT01936181|3598791|P2|Transition-extension|Lost to Follow-up|0
1099581|NCT01936181|3598792|P1|Transition-extension|Lost to Follow-up|3
1099582|NCT01936181|3598789|P4|Transition-extension|Adverse Event|1
1099583|NCT01936181|3598790|P3|Transition-extension|Adverse Event|3
1099584|NCT01936181|3598791|P2|Transition-extension|Adverse Event|0
1099585|NCT01936181|3598792|P1|Transition-extension|Adverse Event|3
1099586|NCT01936181|3598789|P4|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
1099587|NCT01936181|3598790|P3|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
1099588|NCT01936181|3598791|P2|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
1099589|NCT01936181|3598792|P1|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
1099590|NCT01936181|3598789|P4|Randomised, Double-blind|Withdrawal by Subject|0
1099591|NCT01936181|3598790|P3|Randomised, Double-blind|Withdrawal by Subject|0
1099592|NCT01936181|3598791|P2|Randomised, Double-blind|Withdrawal by Subject|26
1099593|NCT01936181|3598792|P1|Randomised, Double-blind|Withdrawal by Subject|23
1099594|NCT01936181|3598789|P4|Randomised, Double-blind|Physician Decision|0
1099595|NCT01936181|3598790|P3|Randomised, Double-blind|Physician Decision|0
1099596|NCT01936181|3598791|P2|Randomised, Double-blind|Physician Decision|4
1099597|NCT01936181|3598792|P1|Randomised, Double-blind|Physician Decision|4
1099598|NCT01936181|3598789|P4|Randomised, Double-blind|Pregnancy|0
1099599|NCT01936181|3598790|P3|Randomised, Double-blind|Pregnancy|0
1099600|NCT01936181|3598791|P2|Randomised, Double-blind|Pregnancy|1
1099601|NCT01936181|3598792|P1|Randomised, Double-blind|Pregnancy|0
1099602|NCT01936181|3598789|P4|Randomised, Double-blind|Lost to Follow-up|0
1099603|NCT01936181|3598790|P3|Randomised, Double-blind|Lost to Follow-up|0
1099604|NCT01936181|3598791|P2|Randomised, Double-blind|Lost to Follow-up|1
1099605|NCT01936181|3598792|P1|Randomised, Double-blind|Lost to Follow-up|0
1099606|NCT01936181|3598789|P4|Randomised, Double-blind|Lack of Efficacy|0
1099607|NCT01936181|3598790|P3|Randomised, Double-blind|Lack of Efficacy|0
1099608|NCT01936181|3598791|P2|Randomised, Double-blind|Lack of Efficacy|6
1099609|NCT01936181|3598792|P1|Randomised, Double-blind|Lack of Efficacy|5
1099610|NCT01936181|3598789|P4|Randomised, Double-blind|Protocol Violation|0
1099611|NCT01936181|3598790|P3|Randomised, Double-blind|Protocol Violation|0
1099612|NCT01936181|3598791|P2|Randomised, Double-blind|Protocol Violation|5
1099613|NCT01936181|3598792|P1|Randomised, Double-blind|Protocol Violation|1
1099614|NCT01936181|3598789|P4|Randomised, Double-blind|Adverse Event|0
1099615|NCT01936181|3598790|P3|Randomised, Double-blind|Adverse Event|0
1099616|NCT01936181|3598791|P2|Randomised, Double-blind|Adverse Event|21
1099617|NCT01936181|3598792|P1|Randomised, Double-blind|Adverse Event|27
1099618|NCT01935947|3598806|P3|Overall Study|Death|0
1099619|NCT01935947|3598807|P2|Overall Study|Death|0
1099620|NCT01935947|3598808|P1|Overall Study|Death|1
1099621|NCT01935947|3598806|P3|Overall Study|Diease Progression|2
1099622|NCT01935947|3598807|P2|Overall Study|Diease Progression|2
1099623|NCT01935947|3598808|P1|Overall Study|Diease Progression|2
1099624|NCT01935947|3598806|P3|Overall Study|Adverse Event|0
1099625|NCT01935947|3598807|P2|Overall Study|Adverse Event|2
1099626|NCT01935947|3598808|P1|Overall Study|Adverse Event|0
1099627|NCT01934894|3598867|P2|Overall Study|Progressive Disease|2
1099628|NCT01934894|3598868|P1|Overall Study|Progressive Disease|3
1099629|NCT01934894|3598867|P2|Overall Study|Withdrawal by Subject|1
1099630|NCT01934894|3598868|P1|Overall Study|Withdrawal by Subject|0
1099631|NCT01934894|3598867|P2|Overall Study|Death|0
1099632|NCT01934894|3598868|P1|Overall Study|Death|2
1099633|NCT01934894|3598867|P2|Overall Study|Adverse Event|2
1099634|NCT01934894|3598868|P1|Overall Study|Adverse Event|1
1099635|NCT01934790|3598883|P1|Active Follow up|Other reason|1
1099636|NCT01934790|3598883|P1|Active Follow up|Progressive disease|1
1099637|NCT01934790|3598883|P1|Active Follow up|Physician Decision|2
1099638|NCT01934790|3598883|P1|Active Follow up|Death|20
1099639|NCT01934790|3598883|P1|Treatment|Study drug never administered|1
1099640|NCT01934790|3598883|P1|Treatment|Withdrawal by Subject|2
1099641|NCT01934790|3598883|P1|Treatment|Radiological progression|4
1099642|NCT01934790|3598883|P1|Treatment|Clinical progression|6
1099643|NCT01934790|3598883|P1|Treatment|Adverse Event|3
1099644|NCT01934504|3598950|P4|Overall Study|Study Terminated by Sponsor|5
1099645|NCT01934504|3598951|P3|Overall Study|Study Terminated by Sponsor|5
1099646|NCT01934504|3598952|P2|Overall Study|Study Terminated by Sponsor|0
1099647|NCT01934504|3598953|P1|Overall Study|Study Terminated by Sponsor|1
1099648|NCT01934504|3598950|P4|Overall Study|Protocol Deviation|2
1099649|NCT01934504|3598951|P3|Overall Study|Protocol Deviation|0
1099650|NCT01934504|3598952|P2|Overall Study|Protocol Deviation|0
1099651|NCT01934504|3598953|P1|Overall Study|Protocol Deviation|0
1099652|NCT01934218|3598986|P2|Open-Label Phase|Failure to Exam Primary Evaluation|1
1099653|NCT01934218|3598987|P1|Open-Label Phase|Failure to Exam Primary Evaluation|0
1099654|NCT01934218|3598986|P2|Open-Label Phase|Noncompliance with Study Protocol|2
1099655|NCT01934218|3598987|P1|Open-Label Phase|Noncompliance with Study Protocol|4
1099656|NCT01934218|3598986|P2|Open-Label Phase|Withdrawal by Subject|11
1099657|NCT01934218|3598987|P1|Open-Label Phase|Withdrawal by Subject|13
1099658|NCT01934218|3598986|P2|Open-Label Phase|Protocol Violation|0
1099659|NCT01934218|3598987|P1|Open-Label Phase|Protocol Violation|1
1099660|NCT01934218|3598986|P2|Open-Label Phase|Physician Decision|0
1099661|NCT01934218|3598987|P1|Open-Label Phase|Physician Decision|1
1099662|NCT01934218|3598986|P2|Open-Label Phase|Lost to Follow-up|2
1099663|NCT01934218|3598987|P1|Open-Label Phase|Lost to Follow-up|4
1099664|NCT01934218|3598986|P2|Open-Label Phase|Lack of Efficacy|4
1099665|NCT01934218|3598987|P1|Open-Label Phase|Lack of Efficacy|1
1099666|NCT01934218|3598986|P2|Open-Label Phase|Adverse Event|4
1099667|NCT01934218|3598987|P1|Open-Label Phase|Adverse Event|2
1099668|NCT01934218|3598986|P2|Double-blind Phase|Protocol Violation of Study Eligibility|2
1099669|NCT01934218|3598987|P1|Double-blind Phase|Protocol Violation of Study Eligibility|1
1099670|NCT01934218|3598986|P2|Double-blind Phase|Noncompliance with Study Protocol|8
1099671|NCT01934218|3598987|P1|Double-blind Phase|Noncompliance with Study Protocol|5
1099672|NCT01934218|3598986|P2|Double-blind Phase|Withdrawal by Subject|13
1099673|NCT01934218|3598987|P1|Double-blind Phase|Withdrawal by Subject|16
1099674|NCT01934218|3598986|P2|Double-blind Phase|Protocol Violation|0
1099675|NCT01934218|3598987|P1|Double-blind Phase|Protocol Violation|4
1099676|NCT01934218|3598986|P2|Double-blind Phase|Physician Decision|2
1099677|NCT01934218|3598987|P1|Double-blind Phase|Physician Decision|1
1099678|NCT01934218|3598986|P2|Double-blind Phase|Lost to Follow-up|14
1099679|NCT01934218|3598987|P1|Double-blind Phase|Lost to Follow-up|7
1099680|NCT01934218|3598986|P2|Double-blind Phase|Lack of Efficacy|7
1099681|NCT01934218|3598987|P1|Double-blind Phase|Lack of Efficacy|6
1099682|NCT01934218|3598986|P2|Double-blind Phase|Adverse Event|8
1099683|NCT01934218|3598987|P1|Double-blind Phase|Adverse Event|8
1099684|NCT01934192|3598998|P4|Overall Study|Physician Decision|0
1099685|NCT01934192|3598999|P3|Overall Study|Physician Decision|0
1099686|NCT01934192|3599000|P2|Overall Study|Physician Decision|2
1099687|NCT01934192|3599001|P1|Overall Study|Physician Decision|3
1099688|NCT01934192|3598998|P4|Overall Study|Other: reached stopping criteria|0
1099689|NCT01934192|3598999|P3|Overall Study|Other: reached stopping criteria|1
1099690|NCT01934192|3599000|P2|Overall Study|Other: reached stopping criteria|5
1099691|NCT01934192|3599001|P1|Overall Study|Other: reached stopping criteria|6
1099692|NCT01934192|3598998|P4|Overall Study|Protocol Violation|1
1099693|NCT01934192|3598999|P3|Overall Study|Protocol Violation|0
1099694|NCT01934192|3599000|P2|Overall Study|Protocol Violation|0
1099695|NCT01934192|3599001|P1|Overall Study|Protocol Violation|0
1099696|NCT01934010|3599138|P3|Overall Study|Lost to Follow-up|0
1099697|NCT01934010|3599139|P2|Overall Study|Lost to Follow-up|4
1099698|NCT01934010|3599140|P1|Overall Study|Lost to Follow-up|7
1099699|NCT01934010|3599138|P3|Overall Study|Withdrawal by Subject|2
1099700|NCT01934010|3599139|P2|Overall Study|Withdrawal by Subject|6
1099701|NCT01934010|3599140|P1|Overall Study|Withdrawal by Subject|15
1099702|NCT01934010|3599138|P3|Overall Study|Adverse Event|0
1099703|NCT01934010|3599139|P2|Overall Study|Adverse Event|1
1099704|NCT01934010|3599140|P1|Overall Study|Adverse Event|1
1099705|NCT01933932|3599159|P2|Overall Study|Eligibility criteria not fulfilled|1
1099706|NCT01933932|3599160|P1|Overall Study|Eligibility criteria not fulfilled|0
1099707|NCT01933932|3599159|P2|Overall Study|Withdrawal by Subject|14
1099708|NCT01933932|3599160|P1|Overall Study|Withdrawal by Subject|11
1099709|NCT01933932|3599159|P2|Overall Study|Death|163
1099710|NCT01933932|3599160|P1|Overall Study|Death|173
1099711|NCT01933919|3599178|P2|Open-label Long-term Phase|Other|2
1099712|NCT01933919|3599179|P1|Open-label Long-term Phase|Other|1
1099713|NCT01933919|3599178|P2|Open-label Long-term Phase|Lost to Follow-up|0
1099714|NCT01933919|3599179|P1|Open-label Long-term Phase|Lost to Follow-up|1
1099715|NCT01933919|3599178|P2|Open-label Long-term Phase|Withdrawal by Subject|4
1099716|NCT01933919|3599179|P1|Open-label Long-term Phase|Withdrawal by Subject|3
1099717|NCT01933919|3599178|P2|Open-label Long-term Phase|Adverse Event|0
1099718|NCT01933919|3599179|P1|Open-label Long-term Phase|Adverse Event|2
1099719|NCT01933919|3599178|P2|Double-blind Placebo-controlled Phase|Lack of Efficacy|2
1099720|NCT01933919|3599179|P1|Double-blind Placebo-controlled Phase|Lack of Efficacy|0
1099721|NCT01933919|3599178|P2|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1
1099722|NCT01933919|3599179|P1|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0
1099723|NCT01933919|3599178|P2|Double-blind Placebo-controlled Phase|Adverse Event|1
1099724|NCT01933919|3599179|P1|Double-blind Placebo-controlled Phase|Adverse Event|0
1099725|NCT01933880|3599215|P2|Overall Study|Protocol Violation|0
1099726|NCT01933880|3599216|P1|Overall Study|Protocol Violation|1
1099727|NCT01933880|3599215|P2|Overall Study|Other|0
1099728|NCT01933880|3599216|P1|Overall Study|Other|4
1099729|NCT01933880|3599215|P2|Overall Study|Followup exceeded 4 days to visit window|0
1099730|NCT01933880|3599216|P1|Overall Study|Followup exceeded 4 days to visit window|19
1099731|NCT01933880|3599215|P2|Overall Study|Concomitant medication Interference|1
1099732|NCT01933880|3599216|P1|Overall Study|Concomitant medication Interference|0
1099733|NCT01933880|3599215|P2|Overall Study|Lack of Efficacy|0
1099734|NCT01933880|3599216|P1|Overall Study|Lack of Efficacy|1
1099735|NCT01933880|3599215|P2|Overall Study|Withdrawal by Subject|0
1099736|NCT01933880|3599216|P1|Overall Study|Withdrawal by Subject|5
1099737|NCT01933672|3599292|P7|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
1099738|NCT01933672|3599293|P6|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
1099739|NCT01933672|3599294|P5|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
1099740|NCT01933672|3599295|P4|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
1099741|NCT01933672|3599296|P3|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
1099742|NCT01933672|3599297|P2|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1
1099743|NCT01933672|3599298|P1|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
1099744|NCT01933672|3599292|P7|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
1099745|NCT01933672|3599293|P6|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
1099746|NCT01933672|3599294|P5|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
1099747|NCT01933672|3599295|P4|Third Intervention Period (12-16 Days)|Lost to Follow-up|1
1099748|NCT01933672|3599296|P3|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
1099749|NCT01933672|3599297|P2|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
1099750|NCT01933672|3599298|P1|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
1099751|NCT01933672|3599292|P7|Second Intervention Period (12-16 Days)|Other|0
1099752|NCT01933672|3599293|P6|Second Intervention Period (12-16 Days)|Other|0
1099753|NCT01933672|3599294|P5|Second Intervention Period (12-16 Days)|Other|0
1099754|NCT01933672|3599295|P4|Second Intervention Period (12-16 Days)|Other|0
1099755|NCT01933672|3599296|P3|Second Intervention Period (12-16 Days)|Other|1
1099756|NCT01933672|3599297|P2|Second Intervention Period (12-16 Days)|Other|1
1099757|NCT01933672|3599298|P1|Second Intervention Period (12-16 Days)|Other|0
1099758|NCT01933672|3599292|P7|First Intervention Period (12-16 Days)|Other|0
1099759|NCT01933672|3599293|P6|First Intervention Period (12-16 Days)|Other|1
1099760|NCT01933672|3599294|P5|First Intervention Period (12-16 Days)|Other|0
1099761|NCT01933672|3599295|P4|First Intervention Period (12-16 Days)|Other|0
1099762|NCT01933672|3599296|P3|First Intervention Period (12-16 Days)|Other|1
1099763|NCT01933672|3599297|P2|First Intervention Period (12-16 Days)|Other|0
1099764|NCT01933672|3599298|P1|First Intervention Period (12-16 Days)|Other|0
1099765|NCT01933672|3599292|P7|First Intervention Period (12-16 Days)|Lost to Follow-up|0
1099766|NCT01933672|3599293|P6|First Intervention Period (12-16 Days)|Lost to Follow-up|0
1099767|NCT01933672|3599294|P5|First Intervention Period (12-16 Days)|Lost to Follow-up|1
1099768|NCT01933672|3599295|P4|First Intervention Period (12-16 Days)|Lost to Follow-up|0
1099769|NCT01933672|3599296|P3|First Intervention Period (12-16 Days)|Lost to Follow-up|0
1099770|NCT01933672|3599297|P2|First Intervention Period (12-16 Days)|Lost to Follow-up|0
1099771|NCT01933672|3599298|P1|First Intervention Period (12-16 Days)|Lost to Follow-up|0
1099772|NCT01933672|3599292|P7|Metformin Run-in Period|Other|0
1099773|NCT01933672|3599293|P6|Metformin Run-in Period|Other|0
1099774|NCT01933672|3599294|P5|Metformin Run-in Period|Other|0
1099775|NCT01933672|3599295|P4|Metformin Run-in Period|Other|0
1099776|NCT01933672|3599296|P3|Metformin Run-in Period|Other|0
1099777|NCT01933672|3599297|P2|Metformin Run-in Period|Other|0
1099778|NCT01933672|3599298|P1|Metformin Run-in Period|Other|5
1099779|NCT01933672|3599292|P7|Metformin Run-in Period|No longer meets eligibility criteria|0
1099780|NCT01933672|3599293|P6|Metformin Run-in Period|No longer meets eligibility criteria|0
1099781|NCT01933672|3599294|P5|Metformin Run-in Period|No longer meets eligibility criteria|0
1099782|NCT01933672|3599295|P4|Metformin Run-in Period|No longer meets eligibility criteria|0
1099783|NCT01933672|3599296|P3|Metformin Run-in Period|No longer meets eligibility criteria|0
1099784|NCT01933672|3599297|P2|Metformin Run-in Period|No longer meets eligibility criteria|0
1099785|NCT01933672|3599298|P1|Metformin Run-in Period|No longer meets eligibility criteria|4
1099786|NCT01933672|3599292|P7|Metformin Run-in Period|Adverse Event|0
1099787|NCT01933672|3599293|P6|Metformin Run-in Period|Adverse Event|0
1099788|NCT01933672|3599294|P5|Metformin Run-in Period|Adverse Event|0
1099789|NCT01933672|3599295|P4|Metformin Run-in Period|Adverse Event|0
1099790|NCT01933672|3599296|P3|Metformin Run-in Period|Adverse Event|0
1099791|NCT01933672|3599297|P2|Metformin Run-in Period|Adverse Event|0
1099792|NCT01933672|3599298|P1|Metformin Run-in Period|Adverse Event|1
1099793|NCT01933334|3599373|P2|Overall Study|Withdrawal by Subject|1
1099794|NCT01933334|3599374|P1|Overall Study|Withdrawal by Subject|0
1099795|NCT01933334|3599373|P2|Overall Study|Adverse Event|1
1099796|NCT01933334|3599374|P1|Overall Study|Adverse Event|5
1099797|NCT01933048|3599403|P2|Overall Study|unknown reasons|1
1099798|NCT01933048|3599404|P1|Overall Study|unknown reasons|1
1099799|NCT01933048|3599403|P2|Overall Study|Physician Decision|0
1099800|NCT01933048|3599404|P1|Overall Study|Physician Decision|1
1099801|NCT01933048|3599403|P2|Overall Study|Protocol Violation|8
1099802|NCT01933048|3599404|P1|Overall Study|Protocol Violation|7
1099803|NCT01933048|3599403|P2|Overall Study|personal reasons|1
1099804|NCT01933048|3599404|P1|Overall Study|personal reasons|1
1099805|NCT01933048|3599403|P2|Overall Study|Lost to Follow-up|18
1099806|NCT01933048|3599404|P1|Overall Study|Lost to Follow-up|15
1099807|NCT01932970|3599417|P1|Overall Study|Protocol Specified Criteria|10
1099808|NCT01932970|3599417|P1|Overall Study|Lost to Follow-up|2
1099809|NCT01932970|3599417|P1|Overall Study|Death|1
1099810|NCT01932970|3599417|P1|Overall Study|Withdrawal by Subject|5
1099811|NCT01932788|3599427|P2|Overall Study|Withdrawal by Subject|5
1099812|NCT01932788|3599428|P1|Overall Study|Withdrawal by Subject|0
1099813|NCT01932788|3599427|P2|Overall Study|Lack of Efficacy|0
1099814|NCT01932788|3599428|P1|Overall Study|Lack of Efficacy|2
1099815|NCT01932788|3599427|P2|Overall Study|Lost to Follow-up|46
1099816|NCT01932788|3599428|P1|Overall Study|Lost to Follow-up|18
1099817|NCT01932788|3599427|P2|Overall Study|Protocol Violation|0
1099818|NCT01932788|3599428|P1|Overall Study|Protocol Violation|18
1099819|NCT01932762|3599438|P4|Overall Study|Physician Decision|0
1099820|NCT01932762|3599439|P3|Overall Study|Physician Decision|0
1099821|NCT01932762|3599440|P2|Overall Study|Physician Decision|0
1099822|NCT01932762|3599441|P1|Overall Study|Physician Decision|1
1099823|NCT01932762|3599438|P4|Overall Study|Lost to Follow-up|1
1099824|NCT01932762|3599439|P3|Overall Study|Lost to Follow-up|0
1099825|NCT01932762|3599440|P2|Overall Study|Lost to Follow-up|0
1099826|NCT01932762|3599441|P1|Overall Study|Lost to Follow-up|4
1099827|NCT01932762|3599438|P4|Overall Study|Withdrawal by Subject|0
1099828|NCT01932762|3599439|P3|Overall Study|Withdrawal by Subject|0
1099829|NCT01932762|3599440|P2|Overall Study|Withdrawal by Subject|2
1099830|NCT01932762|3599441|P1|Overall Study|Withdrawal by Subject|1
1099831|NCT01932294|3599528|P1|Overall Study|Transferred to other hospitals|12
1099832|NCT01932294|3599528|P1|Overall Study|Heart Transplantation|16
1099833|NCT01932294|3599528|P1|Overall Study|VAD Implantation|20
1099834|NCT01932294|3599528|P1|Overall Study|Lost to Follow-up|8
1099835|NCT01932294|3599528|P1|Overall Study|Death|43
1099836|NCT01931956|3599558|P4|Overall Study|Not due|0
1099837|NCT01931956|3599559|P3|Overall Study|Not due|21
1099838|NCT01931956|3599560|P2|Overall Study|Not due|0
1099839|NCT01931956|3599561|P1|Overall Study|Not due|0
1099840|NCT01931956|3599558|P4|Overall Study|Expected|0
1099841|NCT01931956|3599559|P3|Overall Study|Expected|6
1099842|NCT01931956|3599560|P2|Overall Study|Expected|0
1099843|NCT01931956|3599561|P1|Overall Study|Expected|2
1099844|NCT01931956|3599558|P4|Overall Study|Lost to Follow-up|7
1099845|NCT01931956|3599559|P3|Overall Study|Lost to Follow-up|11
1099846|NCT01931956|3599560|P2|Overall Study|Lost to Follow-up|0
1099847|NCT01931956|3599561|P1|Overall Study|Lost to Follow-up|2
1099848|NCT01931956|3599558|P4|Overall Study|Withdrawal by Subject|30
1099849|NCT01931956|3599559|P3|Overall Study|Withdrawal by Subject|70
1099850|NCT01931956|3599560|P2|Overall Study|Withdrawal by Subject|0
1099851|NCT01931956|3599561|P1|Overall Study|Withdrawal by Subject|5
1099852|NCT01931956|3599558|P4|Overall Study|Death|96
1099853|NCT01931956|3599559|P3|Overall Study|Death|379
1099854|NCT01931956|3599560|P2|Overall Study|Death|7
1099855|NCT01931956|3599561|P1|Overall Study|Death|42
1099856|NCT01931865|3599928|P1|Overall Study|Withdrawal by Subject|2
1099857|NCT01931865|3599928|P1|Overall Study|Lost to Follow-up|2
1099858|NCT01931839|3599941|P7|Overall Study|Other|0
1099859|NCT01931839|3599942|P6|Overall Study|Other|0
1099860|NCT01931839|3599943|P5|Overall Study|Other|0
1099861|NCT01931839|3599944|P4|Overall Study|Other|0
1099862|NCT01931839|3599945|P3|Overall Study|Other|6
1099863|NCT01931839|3599946|P2|Overall Study|Other|2
1099864|NCT01931839|3599947|P1|Overall Study|Other|4
1099865|NCT01931839|3599941|P7|Overall Study|Lost to Follow-up|0
1099866|NCT01931839|3599942|P6|Overall Study|Lost to Follow-up|0
1099867|NCT01931839|3599943|P5|Overall Study|Lost to Follow-up|0
1099868|NCT01931839|3599944|P4|Overall Study|Lost to Follow-up|5
1099869|NCT01931839|3599945|P3|Overall Study|Lost to Follow-up|4
1099870|NCT01931839|3599946|P2|Overall Study|Lost to Follow-up|2
1099871|NCT01931839|3599947|P1|Overall Study|Lost to Follow-up|1
1099872|NCT01931839|3599941|P7|Overall Study|Other non-compliance|0
1099873|NCT01931839|3599942|P6|Overall Study|Other non-compliance|3
1099874|NCT01931839|3599943|P5|Overall Study|Other non-compliance|0
1099875|NCT01931839|3599944|P4|Overall Study|Other non-compliance|3
1099876|NCT01931839|3599945|P3|Overall Study|Other non-compliance|12
1099877|NCT01931839|3599946|P2|Overall Study|Other non-compliance|9
1099878|NCT01931839|3599947|P1|Overall Study|Other non-compliance|15
1099879|NCT01931839|3599941|P7|Overall Study|Withdrawal of consent (not due to AE)|2
1099880|NCT01931839|3599942|P6|Overall Study|Withdrawal of consent (not due to AE)|2
1099881|NCT01931839|3599943|P5|Overall Study|Withdrawal of consent (not due to AE)|0
1099882|NCT01931839|3599944|P4|Overall Study|Withdrawal of consent (not due to AE)|3
1099883|NCT01931839|3599945|P3|Overall Study|Withdrawal of consent (not due to AE)|13
1099884|NCT01931839|3599946|P2|Overall Study|Withdrawal of consent (not due to AE)|8
1099885|NCT01931839|3599947|P1|Overall Study|Withdrawal of consent (not due to AE)|11
1099886|NCT01931839|3599941|P7|Overall Study|Adverse Event|1
1099887|NCT01931839|3599942|P6|Overall Study|Adverse Event|0
1099888|NCT01931839|3599943|P5|Overall Study|Adverse Event|0
1099889|NCT01931839|3599944|P4|Overall Study|Adverse Event|3
1099890|NCT01931839|3599945|P3|Overall Study|Adverse Event|1
1099891|NCT01931839|3599946|P2|Overall Study|Adverse Event|4
1099892|NCT01931839|3599947|P1|Overall Study|Adverse Event|9
1099893|NCT01931839|3599941|P7|Overall Study|Withdrawal of consent|0
1099894|NCT01931839|3599942|P6|Overall Study|Withdrawal of consent|0
1099895|NCT01931839|3599943|P5|Overall Study|Withdrawal of consent|1
1099896|NCT01931839|3599944|P4|Overall Study|Withdrawal of consent|0
1099897|NCT01931839|3599945|P3|Overall Study|Withdrawal of consent|0
1099898|NCT01931839|3599946|P2|Overall Study|Withdrawal of consent|0
1099899|NCT01931839|3599947|P1|Overall Study|Withdrawal of consent|0
1099900|NCT01931839|3599941|P7|Overall Study|Physician Decision|1
1099901|NCT01931839|3599942|P6|Overall Study|Physician Decision|0
1099902|NCT01931839|3599943|P5|Overall Study|Physician Decision|0
1099903|NCT01931839|3599944|P4|Overall Study|Physician Decision|0
1099904|NCT01931839|3599945|P3|Overall Study|Physician Decision|1
1099905|NCT01931839|3599946|P2|Overall Study|Physician Decision|0
1099906|NCT01931839|3599947|P1|Overall Study|Physician Decision|1
1099907|NCT01931839|3599941|P7|Overall Study|Death|0
1099908|NCT01931839|3599942|P6|Overall Study|Death|0
1099909|NCT01931839|3599943|P5|Overall Study|Death|0
1099910|NCT01931839|3599944|P4|Overall Study|Death|0
1099911|NCT01931839|3599945|P3|Overall Study|Death|2
1099912|NCT01931839|3599946|P2|Overall Study|Death|1
1099913|NCT01931839|3599947|P1|Overall Study|Death|0
1099914|NCT01931735|3600019|P4|Observational Non-Randomized Phase|Withdrawal by Subject|1
1099915|NCT01931735|3600020|P3|Observational Non-Randomized Phase|Withdrawal by Subject|0
1099916|NCT01931735|3600021|P2|Observational Non-Randomized Phase|Withdrawal by Subject|0
1099917|NCT01931735|3600022|P1|Observational Non-Randomized Phase|Withdrawal by Subject|0
1099918|NCT01931735|3600019|P4|Observational Non-Randomized Phase|Adverse Event|1
1099919|NCT01931735|3600020|P3|Observational Non-Randomized Phase|Adverse Event|0
1099920|NCT01931735|3600021|P2|Observational Non-Randomized Phase|Adverse Event|0
1099921|NCT01931735|3600022|P1|Observational Non-Randomized Phase|Adverse Event|0
1099922|NCT01931735|3600019|P4|Randomized Phase|Lost to Follow-up|0
1099923|NCT01931735|3600020|P3|Randomized Phase|Lost to Follow-up|5
1099924|NCT01931735|3600021|P2|Randomized Phase|Lost to Follow-up|2
1099925|NCT01931735|3600022|P1|Randomized Phase|Lost to Follow-up|2
1099926|NCT01931670|3600069|P3|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2
1099927|NCT01931670|3600070|P2|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0
1099928|NCT01931670|3600071|P1|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0
1099929|NCT01931670|3600069|P3|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13
1099930|NCT01931670|3600070|P2|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3
1099931|NCT01931670|3600071|P1|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6
1099932|NCT01931670|3600069|P3|Post-Treatment Follow-Up (PTFU) Period|Not Specified|3
1099933|NCT01931670|3600070|P2|Post-Treatment Follow-Up (PTFU) Period|Not Specified|3
1099934|NCT01931670|3600071|P1|Post-Treatment Follow-Up (PTFU) Period|Not Specified|6
1099935|NCT01931670|3600069|P3|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2
1099936|NCT01931670|3600070|P2|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4
1099937|NCT01931670|3600071|P1|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4
1099938|NCT01931670|3600069|P3|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1
1099939|NCT01931670|3600070|P2|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2
1099940|NCT01931670|3600071|P1|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0
1099941|NCT01931670|3600069|P3|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0
1099942|NCT01931670|3600070|P2|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0
1099943|NCT01931670|3600071|P1|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3
1099944|NCT01931670|3600069|P3|Treatment Period|Lost to Follow-up|7
1099945|NCT01931670|3600070|P2|Treatment Period|Lost to Follow-up|5
1099946|NCT01931670|3600071|P1|Treatment Period|Lost to Follow-up|19
1099947|NCT01931670|3600069|P3|Treatment Period|Consent Withdrawn by Subject|7
1099948|NCT01931670|3600070|P2|Treatment Period|Consent Withdrawn by Subject|12
1099949|NCT01931670|3600071|P1|Treatment Period|Consent Withdrawn by Subject|17
1099950|NCT01931670|3600069|P3|Treatment Period|Not Specified|2
1099951|NCT01931670|3600070|P2|Treatment Period|Not Specified|7
1099952|NCT01931670|3600071|P1|Treatment Period|Not Specified|8
1099953|NCT01931670|3600069|P3|Treatment Period|Pregnancy|0
1099954|NCT01931670|3600070|P2|Treatment Period|Pregnancy|2
1099955|NCT01931670|3600071|P1|Treatment Period|Pregnancy|7
1099956|NCT01931670|3600069|P3|Treatment Period|Lack of Efficacy|2
1099957|NCT01931670|3600070|P2|Treatment Period|Lack of Efficacy|2
1099958|NCT01931670|3600071|P1|Treatment Period|Lack of Efficacy|11
1099959|NCT01931670|3600069|P3|Treatment Period|Adverse Event|21
1099960|NCT01931670|3600070|P2|Treatment Period|Adverse Event|8
1099961|NCT01931670|3600071|P1|Treatment Period|Adverse Event|19
1099962|NCT01931670|3600069|P3|Treatment Period|Subject Noncompliant|5
1099963|NCT01931670|3600070|P2|Treatment Period|Subject Noncompliant|9
1099964|NCT01931670|3600071|P1|Treatment Period|Subject Noncompliant|4
1099965|NCT01931670|3600069|P3|Treatment Period|Surgery/Invasive Intervention|0
1099966|NCT01931670|3600070|P2|Treatment Period|Surgery/Invasive Intervention|2
1099967|NCT01931670|3600071|P1|Treatment Period|Surgery/Invasive Intervention|4
1099968|NCT01931670|3600069|P3|Treatment Period|Exclusionary Medication Received|1
1099969|NCT01931670|3600070|P2|Treatment Period|Exclusionary Medication Received|1
1099970|NCT01931670|3600071|P1|Treatment Period|Exclusionary Medication Received|1
1099971|NCT01931475|3600194|P2|Period 2: Extension Treatment Phase|Lack of Efficacy|1
1099972|NCT01931475|3600195|P1|Period 2: Extension Treatment Phase|Lack of Efficacy|1
1099973|NCT01931475|3600194|P2|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0
1099974|NCT01931475|3600195|P1|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1
1099975|NCT01931475|3600194|P2|Period 2: Extension Treatment Phase|Physician Decision|1
1099976|NCT01931475|3600195|P1|Period 2: Extension Treatment Phase|Physician Decision|1
1099977|NCT01931475|3600194|P2|Period 2: Extension Treatment Phase|Withdrawal by Subject|9
1099978|NCT01931475|3600195|P1|Period 2: Extension Treatment Phase|Withdrawal by Subject|0
1099979|NCT01931475|3600194|P2|Period 2: Extension Treatment Phase|Protocol Violation|0
1100063|NCT01929707|3600551|P4|Intervention Period 1|Withdrawal by Subject|2
1099980|NCT01931475|3600195|P1|Period 2: Extension Treatment Phase|Protocol Violation|1
1099981|NCT01931475|3600194|P2|Period 2: Extension Treatment Phase|Adverse Event|8
1099982|NCT01931475|3600195|P1|Period 2: Extension Treatment Phase|Adverse Event|0
1099983|NCT01931475|3600194|P2|Period 1: Double-Blind Treatment Phase|Physician Decision|1
1099984|NCT01931475|3600195|P1|Period 1: Double-Blind Treatment Phase|Physician Decision|0
1099985|NCT01931475|3600194|P2|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3
1099986|NCT01931475|3600195|P1|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2
1099987|NCT01931475|3600194|P2|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12
1099988|NCT01931475|3600195|P1|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16
1099989|NCT01931475|3600194|P2|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0
1099990|NCT01931475|3600195|P1|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1
1099991|NCT01931475|3600194|P2|Period 1: Double-Blind Treatment Phase|Adverse Event|10
1099992|NCT01931475|3600195|P1|Period 1: Double-Blind Treatment Phase|Adverse Event|20
1099993|NCT01931462|3600222|P1|Overall Study|Withdrawal by Subject|1
1099994|NCT01931397|3600233|P1|Overall Study|moved out of state|1
1099995|NCT01931397|3600233|P1|Overall Study|Withdrawal by Subject|8
1099996|NCT01931397|3600233|P1|Overall Study|Physician Decision|2
1099997|NCT01931150|3600244|P2|Overall Study|Withdrawal by Subject|2
1099998|NCT01931150|3600245|P1|Overall Study|Withdrawal by Subject|1
1099999|NCT01931059|3600253|P2|Day3|Lost to Follow-up|0
1100000|NCT01931059|3600254|P1|Day3|Lost to Follow-up|1
1100001|NCT01931059|3600253|P2|Day 1|Pregnancy|1
1100002|NCT01931059|3600254|P1|Day 1|Pregnancy|0
1100003|NCT01930890|3600270|P4|Overall Study|Adverse Event|0
1100004|NCT01930890|3600271|P3|Overall Study|Adverse Event|0
1100005|NCT01930890|3600272|P2|Overall Study|Adverse Event|1
1100006|NCT01930890|3600273|P1|Overall Study|Adverse Event|0
1100007|NCT01930890|3600270|P4|Overall Study|Consent Withdrawn|1
1100008|NCT01930890|3600271|P3|Overall Study|Consent Withdrawn|0
1100009|NCT01930890|3600272|P2|Overall Study|Consent Withdrawn|3
1100010|NCT01930890|3600273|P1|Overall Study|Consent Withdrawn|0
1100011|NCT01930890|3600270|P4|Overall Study|Investigator Decision|0
1100012|NCT01930890|3600271|P3|Overall Study|Investigator Decision|0
1100013|NCT01930890|3600272|P2|Overall Study|Investigator Decision|1
1100014|NCT01930890|3600273|P1|Overall Study|Investigator Decision|0
1100015|NCT01930890|3600270|P4|Overall Study|Death|1
1100016|NCT01930890|3600271|P3|Overall Study|Death|0
1100017|NCT01930890|3600272|P2|Overall Study|Death|0
1100018|NCT01930890|3600273|P1|Overall Study|Death|0
1100019|NCT01930890|3600270|P4|Overall Study|Study Termination|25
1100020|NCT01930890|3600271|P3|Overall Study|Study Termination|13
1100021|NCT01930890|3600272|P2|Overall Study|Study Termination|28
1100022|NCT01930890|3600273|P1|Overall Study|Study Termination|14
1100023|NCT01930799|3600287|P1|Overall Study|Lost to Follow-up|5
1100024|NCT01930799|3600287|P1|Overall Study|Withdrawal by Subject|3
1100025|NCT01930162|3600395|P1|Overall Study|Death|1
1100026|NCT01930162|3600395|P1|Overall Study|Abnormal test procedure result(s)|4
1100027|NCT01930045|3600431|P6|Pause (up to 37 Days)|Protocol Violation|1
1100028|NCT01930045|3600432|P5|Pause (up to 37 Days)|Protocol Violation|0
1100029|NCT01930045|3600433|P4|Pause (up to 37 Days)|Protocol Violation|0
1100030|NCT01930045|3600434|P3|Pause (up to 37 Days)|Protocol Violation|0
1100031|NCT01930045|3600435|P2|Pause (up to 37 Days)|Protocol Violation|0
1100032|NCT01930045|3600436|P1|Pause (up to 37 Days)|Protocol Violation|0
1100033|NCT01930045|3600431|P6|Pause (up to 37 Days)|Withdrawal by Subject|1
1100034|NCT01930045|3600432|P5|Pause (up to 37 Days)|Withdrawal by Subject|0
1100035|NCT01930045|3600433|P4|Pause (up to 37 Days)|Withdrawal by Subject|0
1100036|NCT01930045|3600434|P3|Pause (up to 37 Days)|Withdrawal by Subject|0
1100037|NCT01930045|3600435|P2|Pause (up to 37 Days)|Withdrawal by Subject|0
1100038|NCT01930045|3600436|P1|Pause (up to 37 Days)|Withdrawal by Subject|0
1100039|NCT01929993|3600463|P2|Overall Study|Absent CIN, invasion present or artifact|22
1100040|NCT01929993|3600464|P1|Overall Study|Absent CIN, invasion present or artifact|26
1100041|NCT01929993|3600463|P2|Overall Study|Protocol Violation|6
1100042|NCT01929993|3600464|P1|Overall Study|Protocol Violation|4
1100043|NCT01929980|3600470|P1|Overall Study|Physician Decision|1
1100044|NCT01929876|3600478|P1|Period 2|Non-Compliance|1
1100045|NCT01929863|3600491|P2|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1
1100046|NCT01929863|3600492|P1|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0
1100047|NCT01929863|3600491|P2|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1
1100048|NCT01929863|3600492|P1|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0
1100049|NCT01929863|3600491|P2|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0
1100050|NCT01929863|3600492|P1|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1
1100051|NCT01929707|3600547|P8|Intervention Period 2|Withdrawal by Subject|0
1100052|NCT01929707|3600548|P7|Intervention Period 2|Withdrawal by Subject|0
1100053|NCT01929707|3600549|P6|Intervention Period 2|Withdrawal by Subject|2
1100054|NCT01929707|3600550|P5|Intervention Period 2|Withdrawal by Subject|0
1100055|NCT01929707|3600551|P4|Intervention Period 2|Withdrawal by Subject|0
1100056|NCT01929707|3600552|P3|Intervention Period 2|Withdrawal by Subject|0
1100057|NCT01929707|3600553|P2|Intervention Period 2|Withdrawal by Subject|0
1100058|NCT01929707|3600554|P1|Intervention Period 2|Withdrawal by Subject|0
1100059|NCT01929707|3600547|P8|Intervention Period 1|Withdrawal by Subject|0
1100060|NCT01929707|3600548|P7|Intervention Period 1|Withdrawal by Subject|0
1100061|NCT01929707|3600549|P6|Intervention Period 1|Withdrawal by Subject|0
1100062|NCT01929707|3600550|P5|Intervention Period 1|Withdrawal by Subject|0
1100064|NCT01929707|3600552|P3|Intervention Period 1|Withdrawal by Subject|0
1100065|NCT01929707|3600553|P2|Intervention Period 1|Withdrawal by Subject|0
1100066|NCT01929707|3600554|P1|Intervention Period 1|Withdrawal by Subject|0
1100067|NCT01929707|3600547|P8|Intervention Period 1|Lost to Follow-up|0
1100068|NCT01929707|3600548|P7|Intervention Period 1|Lost to Follow-up|0
1100069|NCT01929707|3600549|P6|Intervention Period 1|Lost to Follow-up|0
1100070|NCT01929707|3600550|P5|Intervention Period 1|Lost to Follow-up|0
1100071|NCT01929707|3600551|P4|Intervention Period 1|Lost to Follow-up|1
1100072|NCT01929707|3600552|P3|Intervention Period 1|Lost to Follow-up|0
1100073|NCT01929707|3600553|P2|Intervention Period 1|Lost to Follow-up|0
1100074|NCT01929707|3600554|P1|Intervention Period 1|Lost to Follow-up|0
1100075|NCT01929681|3600586|P2|Overall Study|Physician Decision|1
1100076|NCT01929681|3600587|P1|Overall Study|Physician Decision|1
1100077|NCT01929681|3600586|P2|Overall Study|Withdrawal by Subject|0
1100078|NCT01929681|3600587|P1|Overall Study|Withdrawal by Subject|1
1100079|NCT01929317|3600632|P2|Long-term Phase|Study Closed/Terminated|3
1100080|NCT01929317|3600633|P1|Long-term Phase|Study Closed/Terminated|5
1100081|NCT01929317|3600632|P2|Long-term Phase|Protocol-defined Stopping Criteria|0
1100082|NCT01929317|3600633|P1|Long-term Phase|Protocol-defined Stopping Criteria|1
1100083|NCT01929317|3600632|P2|Long-term Phase|Protocol Violation|0
1100084|NCT01929317|3600633|P1|Long-term Phase|Protocol Violation|1
1100085|NCT01929317|3600632|P2|Long-term Phase|Withdrawal by Subject|0
1100086|NCT01929317|3600633|P1|Long-term Phase|Withdrawal by Subject|4
1100087|NCT01929317|3600632|P2|Long-term Phase|Physician Decision|0
1100088|NCT01929317|3600633|P1|Long-term Phase|Physician Decision|3
1100089|NCT01929317|3600632|P2|Long-term Phase|Adverse Event|1
1100090|NCT01929317|3600633|P1|Long-term Phase|Adverse Event|5
1100091|NCT01929317|3600632|P2|Dose Increase Effect Verification Phase|Withdrawal by Subject|0
1100092|NCT01929317|3600633|P1|Dose Increase Effect Verification Phase|Withdrawal by Subject|3
1100093|NCT01929317|3600632|P2|Dose Increase Effect Verification Phase|Physician Decision|0
1100094|NCT01929317|3600633|P1|Dose Increase Effect Verification Phase|Physician Decision|1
1100095|NCT01929317|3600632|P2|Dose Increase Effect Verification Phase|Adverse Event|1
1100096|NCT01929317|3600633|P1|Dose Increase Effect Verification Phase|Adverse Event|5
1100097|NCT01929135|3600702|P2|Overall Study|Lost to Follow-up|1
1100098|NCT01929135|3600703|P1|Overall Study|Lost to Follow-up|1
1100099|NCT01929109|3600722|P5|Period 1 (All Groups)|Deviation from protocol|0
1100100|NCT01929109|3600723|P4|Period 1 (All Groups)|Deviation from protocol|0
1100101|NCT01929109|3600724|P3|Period 1 (All Groups)|Deviation from protocol|1
1100102|NCT01929109|3600725|P2|Period 1 (All Groups)|Deviation from protocol|0
1100103|NCT01929109|3600726|P1|Period 1 (All Groups)|Deviation from protocol|0
1100104|NCT01929083|3600745|P2|Intervention 2|Adverse Event|1
1100105|NCT01929083|3600746|P1|Intervention 2|Adverse Event|0
1100106|NCT01929083|3600745|P2|Intervention 1|Nonadherent to study medications|0
1100107|NCT01929083|3600746|P1|Intervention 1|Nonadherent to study medications|1
1100108|NCT01929083|3600745|P2|Intervention 1|Lost to Follow-up|0
1100109|NCT01929083|3600746|P1|Intervention 1|Lost to Follow-up|2
1100110|NCT01929044|3600772|P2|Overall Study|Not Treated|3
1100111|NCT01929044|3600773|P1|Overall Study|Not Treated|1
1100112|NCT01929044|3600772|P2|Overall Study|Protocol Violation|14
1100113|NCT01929044|3600773|P1|Overall Study|Protocol Violation|9
1100114|NCT01929044|3600772|P2|Overall Study|Adverse Event|0
1100115|NCT01929044|3600773|P1|Overall Study|Adverse Event|1
1100116|NCT01929031|3600795|P6|Overall Study|Reason other than specified above|0
1100117|NCT01929031|3600796|P5|Overall Study|Reason other than specified above|1
1100118|NCT01929031|3600797|P4|Overall Study|Reason other than specified above|0
1100119|NCT01929031|3600798|P3|Overall Study|Reason other than specified above|0
1100120|NCT01929031|3600799|P2|Overall Study|Reason other than specified above|1
1100121|NCT01929031|3600800|P1|Overall Study|Reason other than specified above|0
1100122|NCT01929031|3600795|P6|Overall Study|Protocol Violation|1
1100123|NCT01929031|3600796|P5|Overall Study|Protocol Violation|0
1100124|NCT01929031|3600797|P4|Overall Study|Protocol Violation|0
1100125|NCT01929031|3600798|P3|Overall Study|Protocol Violation|0
1100126|NCT01929031|3600799|P2|Overall Study|Protocol Violation|0
1100127|NCT01929031|3600800|P1|Overall Study|Protocol Violation|1
1100128|NCT01929031|3600795|P6|Overall Study|Adverse Event|0
1100129|NCT01929031|3600796|P5|Overall Study|Adverse Event|0
1100130|NCT01929031|3600797|P4|Overall Study|Adverse Event|0
1100131|NCT01929031|3600798|P3|Overall Study|Adverse Event|1
1100132|NCT01929031|3600799|P2|Overall Study|Adverse Event|1
1100133|NCT01929031|3600800|P1|Overall Study|Adverse Event|3
1100134|NCT01928940|3600824|P2|Overall Study|Adverse Event|1
1100135|NCT01928940|3600825|P1|Overall Study|Adverse Event|0
1100136|NCT01928927|3600868|P2|Overall Study|Withdrawal by Subject|1
1100137|NCT01928927|3600869|P1|Overall Study|Withdrawal by Subject|1
1100138|NCT01928927|3600868|P2|Overall Study|Lost to Follow-up|0
1100139|NCT01928927|3600869|P1|Overall Study|Lost to Follow-up|1
1100140|NCT01928862|3600996|P5|Overall Study|Lost to Follow-up|1
1100141|NCT01928862|3600997|P4|Overall Study|Lost to Follow-up|0
1100142|NCT01928862|3600998|P3|Overall Study|Lost to Follow-up|0
1100143|NCT01928862|3600999|P2|Overall Study|Lost to Follow-up|0
1100144|NCT01928862|3601000|P1|Overall Study|Lost to Follow-up|1
1100145|NCT01928771|3601074|P3|Overall Study|Severe Non-Compliance to Protocol|2
1100146|NCT01928771|3601075|P2|Overall Study|Severe Non-Compliance to Protocol|2
1100147|NCT01928771|3601076|P1|Overall Study|Severe Non-Compliance to Protocol|4
1100148|NCT01928771|3601074|P3|Overall Study|Other Reasons|14
1100149|NCT01928771|3601075|P2|Overall Study|Other Reasons|9
1100150|NCT01928771|3601076|P1|Overall Study|Other Reasons|9
1100151|NCT01928771|3601074|P3|Overall Study|Study-Specific Withdrawal Criteria|1
1100152|NCT01928771|3601075|P2|Overall Study|Study-Specific Withdrawal Criteria|1
1100153|NCT01928771|3601076|P1|Overall Study|Study-Specific Withdrawal Criteria|0
1100154|NCT01928771|3601074|P3|Overall Study|Withdrawal by Subject|17
1100155|NCT01928771|3601075|P2|Overall Study|Withdrawal by Subject|15
1100156|NCT01928771|3601076|P1|Overall Study|Withdrawal by Subject|20
1100157|NCT01928771|3601074|P3|Overall Study|Lost to Follow-up|3
1100158|NCT01928771|3601075|P2|Overall Study|Lost to Follow-up|6
1100159|NCT01928771|3601076|P1|Overall Study|Lost to Follow-up|5
1100160|NCT01928771|3601074|P3|Overall Study|Death|2
1100161|NCT01928771|3601075|P2|Overall Study|Death|2
1100162|NCT01928771|3601076|P1|Overall Study|Death|2
1100163|NCT01928771|3601074|P3|Overall Study|Adverse Event|1
1100164|NCT01928771|3601075|P2|Overall Study|Adverse Event|5
1100165|NCT01928771|3601076|P1|Overall Study|Adverse Event|6
1100166|NCT01928615|3601188|P1|Overall Study|Study Terminated by Sponsor|2
1100167|NCT01928472|3601207|P4|Overall Study|Unclassified|0
1100168|NCT01928472|3601208|P3|Overall Study|Unclassified|1
1100169|NCT01928472|3601209|P2|Overall Study|Unclassified|0
1100170|NCT01928472|3601210|P1|Overall Study|Unclassified|0
1100171|NCT01928472|3601207|P4|Overall Study|Administrative Reason|0
1100172|NCT01928472|3601208|P3|Overall Study|Administrative Reason|0
1100173|NCT01928472|3601209|P2|Overall Study|Administrative Reason|1
1100174|NCT01928472|3601210|P1|Overall Study|Administrative Reason|2
1100175|NCT01928472|3601207|P4|Overall Study|Lost to Follow-up|0
1100176|NCT01928472|3601208|P3|Overall Study|Lost to Follow-up|4
1100177|NCT01928472|3601209|P2|Overall Study|Lost to Follow-up|3
1100178|NCT01928472|3601210|P1|Overall Study|Lost to Follow-up|2
1100179|NCT01928472|3601207|P4|Overall Study|Withdrawal by Subject|2
1100180|NCT01928472|3601208|P3|Overall Study|Withdrawal by Subject|1
1100181|NCT01928472|3601209|P2|Overall Study|Withdrawal by Subject|4
1100182|NCT01928472|3601210|P1|Overall Study|Withdrawal by Subject|4
1100183|NCT01928472|3601207|P4|Overall Study|Death|0
1100184|NCT01928472|3601208|P3|Overall Study|Death|1
1100185|NCT01928472|3601209|P2|Overall Study|Death|0
1100186|NCT01928472|3601210|P1|Overall Study|Death|0
1100187|NCT01928433|3601280|P3|Overall Study|Other reasons|4
1100188|NCT01928433|3601281|P2|Overall Study|Other reasons|3
1100189|NCT01928433|3601282|P1|Overall Study|Other reasons|3
1100190|NCT01928433|3601280|P3|Overall Study|Lost to Follow-up|3
1100191|NCT01928433|3601281|P2|Overall Study|Lost to Follow-up|2
1100192|NCT01928433|3601282|P1|Overall Study|Lost to Follow-up|0
1100193|NCT01928433|3601280|P3|Overall Study|Negative screening urine culture|10
1100194|NCT01928433|3601281|P2|Overall Study|Negative screening urine culture|6
1100195|NCT01928433|3601282|P1|Overall Study|Negative screening urine culture|7
1100196|NCT01928433|3601280|P3|Overall Study|Withdrawal by Subject|0
1100197|NCT01928433|3601281|P2|Overall Study|Withdrawal by Subject|4
1100198|NCT01928433|3601282|P1|Overall Study|Withdrawal by Subject|0
1100199|NCT01928433|3601280|P3|Overall Study|Lack of Efficacy|4
1100200|NCT01928433|3601281|P2|Overall Study|Lack of Efficacy|4
1100201|NCT01928433|3601282|P1|Overall Study|Lack of Efficacy|5
1100202|NCT01928433|3601280|P3|Overall Study|Protocol Violation|2
1100203|NCT01928433|3601281|P2|Overall Study|Protocol Violation|0
1100204|NCT01928433|3601282|P1|Overall Study|Protocol Violation|0
1100205|NCT01928433|3601280|P3|Overall Study|Adverse Event|5
1100206|NCT01928433|3601281|P2|Overall Study|Adverse Event|2
1100207|NCT01928433|3601282|P1|Overall Study|Adverse Event|5
1100208|NCT01928381|3601305|P7|Part 2 - Post Third Intervention|Protocol Violation|0
1100209|NCT01928381|3601306|P6|Part 2 - Post Third Intervention|Protocol Violation|0
1100210|NCT01928381|3601307|P5|Part 2 - Post Third Intervention|Protocol Violation|0
1100211|NCT01928381|3601308|P4|Part 2 - Post Third Intervention|Protocol Violation|0
1100212|NCT01928381|3601309|P3|Part 2 - Post Third Intervention|Protocol Violation|1
1100213|NCT01928381|3601310|P2|Part 2 - Post Third Intervention|Protocol Violation|0
1100214|NCT01928381|3601311|P1|Part 2 - Post Third Intervention|Protocol Violation|0
1100215|NCT01928381|3601305|P7|Part 2 - Second Intervention|Lost to Follow-up|0
1100216|NCT01928381|3601306|P6|Part 2 - Second Intervention|Lost to Follow-up|0
1100217|NCT01928381|3601307|P5|Part 2 - Second Intervention|Lost to Follow-up|0
1100218|NCT01928381|3601308|P4|Part 2 - Second Intervention|Lost to Follow-up|1
1100219|NCT01928381|3601309|P3|Part 2 - Second Intervention|Lost to Follow-up|0
1100220|NCT01928381|3601310|P2|Part 2 - Second Intervention|Lost to Follow-up|1
1100221|NCT01928381|3601311|P1|Part 2 - Second Intervention|Lost to Follow-up|0
1100222|NCT01928381|3601305|P7|Washout First Intervention|Protocol Violation|0
1100223|NCT01928381|3601306|P6|Washout First Intervention|Protocol Violation|0
1100224|NCT01928381|3601307|P5|Washout First Intervention|Protocol Violation|1
1100225|NCT01928381|3601308|P4|Washout First Intervention|Protocol Violation|0
1100226|NCT01928381|3601309|P3|Washout First Intervention|Protocol Violation|0
1100227|NCT01928381|3601310|P2|Washout First Intervention|Protocol Violation|0
1100228|NCT01928381|3601311|P1|Washout First Intervention|Protocol Violation|0
1100229|NCT01928381|3601305|P7|Part 2 - First Intervention|Lost to Follow-up|0
1100230|NCT01928381|3601306|P6|Part 2 - First Intervention|Lost to Follow-up|0
1100231|NCT01928381|3601307|P5|Part 2 - First Intervention|Lost to Follow-up|0
1100232|NCT01928381|3601308|P4|Part 2 - First Intervention|Lost to Follow-up|1
1100233|NCT01928381|3601309|P3|Part 2 - First Intervention|Lost to Follow-up|0
1100234|NCT01928381|3601310|P2|Part 2 - First Intervention|Lost to Follow-up|0
1100235|NCT01928381|3601311|P1|Part 2 - First Intervention|Lost to Follow-up|0
1100236|NCT01928381|3601305|P7|Part 2 - First Intervention|Eligibility criterion not met|1
1100237|NCT01928381|3601306|P6|Part 2 - First Intervention|Eligibility criterion not met|1
1100238|NCT01928381|3601307|P5|Part 2 - First Intervention|Eligibility criterion not met|0
1100239|NCT01928381|3601308|P4|Part 2 - First Intervention|Eligibility criterion not met|0
1100240|NCT01928381|3601309|P3|Part 2 - First Intervention|Eligibility criterion not met|0
1100241|NCT01928381|3601310|P2|Part 2 - First Intervention|Eligibility criterion not met|0
1100242|NCT01928381|3601311|P1|Part 2 - First Intervention|Eligibility criterion not met|0
1100243|NCT01928381|3601305|P7|Part 2 - First Intervention|Study specific withdrawal criteria|0
1100244|NCT01928381|3601306|P6|Part 2 - First Intervention|Study specific withdrawal criteria|0
1100245|NCT01928381|3601307|P5|Part 2 - First Intervention|Study specific withdrawal criteria|0
1100246|NCT01928381|3601308|P4|Part 2 - First Intervention|Study specific withdrawal criteria|0
1100247|NCT01928381|3601309|P3|Part 2 - First Intervention|Study specific withdrawal criteria|1
1100248|NCT01928381|3601310|P2|Part 2 - First Intervention|Study specific withdrawal criteria|0
1100249|NCT01928381|3601311|P1|Part 2 - First Intervention|Study specific withdrawal criteria|0
1100250|NCT01928381|3601305|P7|Part 2 - First Intervention|Withdrawal by Subject|0
1100251|NCT01928381|3601306|P6|Part 2 - First Intervention|Withdrawal by Subject|0
1100252|NCT01928381|3601307|P5|Part 2 - First Intervention|Withdrawal by Subject|0
1100253|NCT01928381|3601308|P4|Part 2 - First Intervention|Withdrawal by Subject|0
1100254|NCT01928381|3601309|P3|Part 2 - First Intervention|Withdrawal by Subject|1
1100255|NCT01928381|3601310|P2|Part 2 - First Intervention|Withdrawal by Subject|0
1100256|NCT01928381|3601311|P1|Part 2 - First Intervention|Withdrawal by Subject|0
1100257|NCT01928381|3601305|P7|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
1100258|NCT01928381|3601306|P6|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
1100259|NCT01928381|3601307|P5|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
1100260|NCT01928381|3601308|P4|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
1100261|NCT01928381|3601309|P3|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
1100262|NCT01928381|3601310|P2|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
1100263|NCT01928381|3601311|P1|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10
1100264|NCT01928381|3601305|P7|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
1100265|NCT01928381|3601306|P6|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
1100266|NCT01928381|3601307|P5|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
1100267|NCT01928381|3601308|P4|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
1100268|NCT01928381|3601309|P3|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
1100269|NCT01928381|3601310|P2|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
1100270|NCT01928381|3601311|P1|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1
1100271|NCT01928381|3601305|P7|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
1100272|NCT01928381|3601306|P6|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
1100273|NCT01928381|3601307|P5|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
1100274|NCT01928381|3601308|P4|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
1100275|NCT01928381|3601309|P3|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
1100276|NCT01928381|3601310|P2|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
1100277|NCT01928381|3601311|P1|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2
1100278|NCT01928381|3601305|P7|Placebo run-in & Part 2 Eligibility|Adverse Event|0
1100279|NCT01928381|3601306|P6|Placebo run-in & Part 2 Eligibility|Adverse Event|0
1100280|NCT01928381|3601307|P5|Placebo run-in & Part 2 Eligibility|Adverse Event|0
1100281|NCT01928381|3601308|P4|Placebo run-in & Part 2 Eligibility|Adverse Event|0
1100282|NCT01928381|3601309|P3|Placebo run-in & Part 2 Eligibility|Adverse Event|0
1100283|NCT01928381|3601310|P2|Placebo run-in & Part 2 Eligibility|Adverse Event|0
1100284|NCT01928381|3601311|P1|Placebo run-in & Part 2 Eligibility|Adverse Event|1
1100285|NCT01928381|3601305|P7|Part 1 - Pain Training|Protocol Violation|0
1100286|NCT01928381|3601306|P6|Part 1 - Pain Training|Protocol Violation|0
1100287|NCT01928381|3601307|P5|Part 1 - Pain Training|Protocol Violation|0
1100288|NCT01928381|3601308|P4|Part 1 - Pain Training|Protocol Violation|0
1100289|NCT01928381|3601309|P3|Part 1 - Pain Training|Protocol Violation|0
1100290|NCT01928381|3601310|P2|Part 1 - Pain Training|Protocol Violation|0
1100291|NCT01928381|3601311|P1|Part 1 - Pain Training|Protocol Violation|1
1100292|NCT01928381|3601305|P7|Part 1 - Pain Training|Lost to Follow-up|0
1100293|NCT01928381|3601306|P6|Part 1 - Pain Training|Lost to Follow-up|0
1100294|NCT01928381|3601307|P5|Part 1 - Pain Training|Lost to Follow-up|0
1100295|NCT01928381|3601308|P4|Part 1 - Pain Training|Lost to Follow-up|0
1100296|NCT01928381|3601309|P3|Part 1 - Pain Training|Lost to Follow-up|0
1100297|NCT01928381|3601310|P2|Part 1 - Pain Training|Lost to Follow-up|0
1100298|NCT01928381|3601311|P1|Part 1 - Pain Training|Lost to Follow-up|4
1100299|NCT01928381|3601305|P7|Part 1 - Pain Training|Withdrawal by Subject|0
1100300|NCT01928381|3601306|P6|Part 1 - Pain Training|Withdrawal by Subject|0
1100301|NCT01928381|3601307|P5|Part 1 - Pain Training|Withdrawal by Subject|0
1100302|NCT01928381|3601308|P4|Part 1 - Pain Training|Withdrawal by Subject|0
1100303|NCT01928381|3601309|P3|Part 1 - Pain Training|Withdrawal by Subject|0
1100304|NCT01928381|3601310|P2|Part 1 - Pain Training|Withdrawal by Subject|0
1100305|NCT01928381|3601311|P1|Part 1 - Pain Training|Withdrawal by Subject|1
1100306|NCT01928381|3601305|P7|Part 1 - Pain Training|Pain training criteria not met|0
1100307|NCT01928381|3601306|P6|Part 1 - Pain Training|Pain training criteria not met|0
1100308|NCT01928381|3601307|P5|Part 1 - Pain Training|Pain training criteria not met|0
1100309|NCT01928381|3601308|P4|Part 1 - Pain Training|Pain training criteria not met|0
1100310|NCT01928381|3601309|P3|Part 1 - Pain Training|Pain training criteria not met|0
1100311|NCT01928381|3601310|P2|Part 1 - Pain Training|Pain training criteria not met|0
1100312|NCT01928381|3601311|P1|Part 1 - Pain Training|Pain training criteria not met|29
1100313|NCT01928381|3601305|P7|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
1100314|NCT01928381|3601306|P6|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
1100315|NCT01928381|3601307|P5|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
1100316|NCT01928381|3601308|P4|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
1100317|NCT01928381|3601309|P3|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
1100318|NCT01928381|3601310|P2|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
1100319|NCT01928381|3601311|P1|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60
1100320|NCT01928082|3601338|P1|Overall Study|Study terminated.|1
1100321|NCT01927757|3601370|P1|Overall Study|Ethical Reasons|4
1100322|NCT01927757|3601370|P1|Overall Study|Other|1
1100323|NCT01927757|3601370|P1|Overall Study|Decision by Sponsor|2
1100324|NCT01927757|3601370|P1|Overall Study|Lost to Follow-up|2
1100325|NCT01927757|3601370|P1|Overall Study|Withdrawal by Subject|14
1100326|NCT01927419|3601398|P2|Overall Study|Not reported|0
1100327|NCT01927419|3601399|P1|Overall Study|Not reported|1
1100328|NCT01927419|3601398|P2|Overall Study|Not specified|1
1100329|NCT01927419|3601399|P1|Overall Study|Not specified|2
1100330|NCT01927419|3601398|P2|Overall Study|Withdrawal by Subject|1
1100331|NCT01927419|3601399|P1|Overall Study|Withdrawal by Subject|3
1100332|NCT01927419|3601398|P2|Overall Study|Adverse event unrelated to study drug|1
1100333|NCT01927419|3601399|P1|Overall Study|Adverse event unrelated to study drug|6
1100334|NCT01927419|3601398|P2|Overall Study|Death|1
1100335|NCT01927419|3601399|P1|Overall Study|Death|0
1100336|NCT01927419|3601398|P2|Overall Study|Study drug toxicity|7
1100337|NCT01927419|3601399|P1|Overall Study|Study drug toxicity|43
1100338|NCT01927419|3601398|P2|Overall Study|Disease progression|17
1100339|NCT01927419|3601399|P1|Overall Study|Disease progression|15
1100340|NCT01927055|3601433|P3|Double-Blind|Extended Vacation|0
1100341|NCT01927055|3601434|P2|Double-Blind|Extended Vacation|1
1100342|NCT01927055|3601435|P1|Double-Blind|Extended Vacation|0
1100343|NCT01927055|3601433|P3|Double-Blind|Supine Hypertension|1
1100344|NCT01927055|3601434|P2|Double-Blind|Supine Hypertension|0
1100345|NCT01927055|3601435|P1|Double-Blind|Supine Hypertension|0
1100346|NCT01927055|3601433|P3|Double-Blind|Study Stopped|7
1100347|NCT01927055|3601434|P2|Double-Blind|Study Stopped|7
1100348|NCT01927055|3601435|P1|Double-Blind|Study Stopped|0
1100349|NCT01927055|3601433|P3|Double-Blind|Withdrawal by Subject|3
1100350|NCT01927055|3601434|P2|Double-Blind|Withdrawal by Subject|2
1100351|NCT01927055|3601435|P1|Double-Blind|Withdrawal by Subject|0
1100352|NCT01927055|3601433|P3|Double-Blind|Protocol Violation|1
1100353|NCT01927055|3601434|P2|Double-Blind|Protocol Violation|0
1100354|NCT01927055|3601435|P1|Double-Blind|Protocol Violation|0
1100355|NCT01927055|3601433|P3|Double-Blind|Adverse Event|1
1100356|NCT01927055|3601434|P2|Double-Blind|Adverse Event|1
1100357|NCT01927055|3601435|P1|Double-Blind|Adverse Event|0
1100358|NCT01927055|3601433|P3|Open-label|Difficulty attending study visits|0
1100359|NCT01927055|3601434|P2|Open-label|Difficulty attending study visits|0
1100360|NCT01927055|3601435|P1|Open-label|Difficulty attending study visits|1
1100361|NCT01927055|3601433|P3|Open-label|Supine Hypertension|0
1100362|NCT01927055|3601434|P2|Open-label|Supine Hypertension|0
1100363|NCT01927055|3601435|P1|Open-label|Supine Hypertension|4
1100364|NCT01927055|3601433|P3|Open-label|Study Stopped|0
1100365|NCT01927055|3601434|P2|Open-label|Study Stopped|0
1100366|NCT01927055|3601435|P1|Open-label|Study Stopped|4
1100367|NCT01927055|3601433|P3|Open-label|Withdrawal by Subject|0
1100368|NCT01927055|3601434|P2|Open-label|Withdrawal by Subject|0
1100369|NCT01927055|3601435|P1|Open-label|Withdrawal by Subject|1
1100370|NCT01927055|3601433|P3|Open-label|Adverse Event|0
1100371|NCT01927055|3601434|P2|Open-label|Adverse Event|0
1100372|NCT01927055|3601435|P1|Open-label|Adverse Event|6
1100373|NCT01926782|3601459|P6|Overall Study|Related to study drug administration|2
1100374|NCT01926782|3601460|P5|Overall Study|Related to study drug administration|0
1100375|NCT01926782|3601461|P4|Overall Study|Related to study drug administration|0
1100376|NCT01926782|3601462|P3|Overall Study|Related to study drug administration|0
1100377|NCT01926782|3601463|P2|Overall Study|Related to study drug administration|0
1100378|NCT01926782|3601464|P1|Overall Study|Related to study drug administration|0
1100379|NCT01926782|3601459|P6|Overall Study|Withdrawal by Subject|5
1100380|NCT01926782|3601460|P5|Overall Study|Withdrawal by Subject|0
1100381|NCT01926782|3601461|P4|Overall Study|Withdrawal by Subject|1
1100382|NCT01926782|3601462|P3|Overall Study|Withdrawal by Subject|8
1100383|NCT01926782|3601463|P2|Overall Study|Withdrawal by Subject|1
1100384|NCT01926782|3601464|P1|Overall Study|Withdrawal by Subject|6
1100385|NCT01926782|3601459|P6|Overall Study|Randomized and not treated|0
1100386|NCT01926782|3601460|P5|Overall Study|Randomized and not treated|0
1100387|NCT01926782|3601461|P4|Overall Study|Randomized and not treated|1
1100388|NCT01926782|3601462|P3|Overall Study|Randomized and not treated|0
1100389|NCT01926782|3601463|P2|Overall Study|Randomized and not treated|0
1100390|NCT01926782|3601464|P1|Overall Study|Randomized and not treated|0
1100391|NCT01926782|3601459|P6|Overall Study|Poor compliance to protocol|6
1100392|NCT01926782|3601460|P5|Overall Study|Poor compliance to protocol|1
1100393|NCT01926782|3601461|P4|Overall Study|Poor compliance to protocol|0
1100394|NCT01926782|3601462|P3|Overall Study|Poor compliance to protocol|8
1100395|NCT01926782|3601463|P2|Overall Study|Poor compliance to protocol|3
1100396|NCT01926782|3601464|P1|Overall Study|Poor compliance to protocol|5
1100397|NCT01926782|3601459|P6|Overall Study|Adverse Event|14
1100398|NCT01926782|3601460|P5|Overall Study|Adverse Event|3
1100399|NCT01926782|3601461|P4|Overall Study|Adverse Event|4
1100400|NCT01926782|3601462|P3|Overall Study|Adverse Event|17
1100401|NCT01926782|3601463|P2|Overall Study|Adverse Event|4
1100402|NCT01926782|3601464|P1|Overall Study|Adverse Event|13
1100403|NCT01926782|3601459|P6|Overall Study|Other than specified|11
1100404|NCT01926782|3601460|P5|Overall Study|Other than specified|4
1100405|NCT01926782|3601461|P4|Overall Study|Other than specified|12
1100406|NCT01926782|3601462|P3|Overall Study|Other than specified|5
1100407|NCT01926782|3601463|P2|Overall Study|Other than specified|3
1100408|NCT01926782|3601464|P1|Overall Study|Other than specified|2
1100409|NCT01926782|3601459|P6|Overall Study|Physician Decision|0
1100410|NCT01926782|3601460|P5|Overall Study|Physician Decision|0
1100411|NCT01926782|3601461|P4|Overall Study|Physician Decision|1
1100412|NCT01926782|3601462|P3|Overall Study|Physician Decision|1
1100413|NCT01926782|3601463|P2|Overall Study|Physician Decision|2
1100414|NCT01926782|3601464|P1|Overall Study|Physician Decision|0
1100415|NCT01926782|3601459|P6|Overall Study|Participant moved|3
1100416|NCT01926782|3601460|P5|Overall Study|Participant moved|0
1100417|NCT01926782|3601461|P4|Overall Study|Participant moved|1
1100418|NCT01926782|3601462|P3|Overall Study|Participant moved|1
1100419|NCT01926782|3601463|P2|Overall Study|Participant moved|0
1100420|NCT01926782|3601464|P1|Overall Study|Participant moved|2
1100421|NCT01926626|3601613|P1|Overall Study|Lost to Follow-up|7
1100422|NCT01926626|3601613|P1|Overall Study|Withdrawal by Subject|15
1100423|NCT01926509|3601627|P4|Overall Study|vital sign met discontinuation criteria|0
1100424|NCT01926509|3601628|P3|Overall Study|vital sign met discontinuation criteria|0
1100425|NCT01926509|3601629|P2|Overall Study|vital sign met discontinuation criteria|0
1100426|NCT01926509|3601630|P1|Overall Study|vital sign met discontinuation criteria|1
1100427|NCT01926119|3601647|P1|Overall Study|Withdrawal by Subject|1
1100428|NCT01926028|3601660|P3|Overall Study|Non compliance or other reasons|0
1100429|NCT01926028|3601661|P2|Overall Study|Non compliance or other reasons|2
1100430|NCT01926028|3601662|P1|Overall Study|Non compliance or other reasons|4
1100431|NCT01926028|3601660|P3|Overall Study|Withdrawal by Subject|2
1100432|NCT01926028|3601661|P2|Overall Study|Withdrawal by Subject|9
1100433|NCT01926028|3601662|P1|Overall Study|Withdrawal by Subject|9
1100434|NCT01926028|3601660|P3|Overall Study|Physician Decision|0
1100435|NCT01926028|3601661|P2|Overall Study|Physician Decision|5
1100436|NCT01926028|3601662|P1|Overall Study|Physician Decision|1
1100437|NCT01926028|3601660|P3|Overall Study|Lost to Follow-up|0
1100438|NCT01926028|3601661|P2|Overall Study|Lost to Follow-up|6
1100439|NCT01926028|3601662|P1|Overall Study|Lost to Follow-up|7
1100440|NCT01926015|3601698|P2|Overall Study|Randomized not treated|0
1100441|NCT01926015|3601699|P1|Overall Study|Randomized not treated|2
1100442|NCT01926015|3601698|P2|Overall Study|Withdrawal by parent/guardian|1
1100443|NCT01926015|3601699|P1|Overall Study|Withdrawal by parent/guardian|0
1100444|NCT01925950|3601731|P2|Part 2|Withdrawal by Subject|0
1100445|NCT01925950|3601732|P1|Part 2|Withdrawal by Subject|1
1100446|NCT01925768|3601751|P2|Overall Study|Non-compliance with study drug|1
1100447|NCT01925768|3601752|P1|Overall Study|Non-compliance with study drug|0
1100448|NCT01925768|3601751|P2|Overall Study|Withdrawal by Subject|4
1100449|NCT01925768|3601752|P1|Overall Study|Withdrawal by Subject|1
1100450|NCT01925768|3601751|P2|Overall Study|Lack of Efficacy|6
1100451|NCT01925768|3601752|P1|Overall Study|Lack of Efficacy|3
1100452|NCT01925768|3601751|P2|Overall Study|Adverse Event|10
1100453|NCT01925768|3601752|P1|Overall Study|Adverse Event|5
1100454|NCT01925768|3601751|P2|Overall Study|Protocol Violation|2
1100455|NCT01925768|3601752|P1|Overall Study|Protocol Violation|1
1100456|NCT01925768|3601751|P2|Overall Study|Lost to Follow-up|0
1100457|NCT01925768|3601752|P1|Overall Study|Lost to Follow-up|1
1100458|NCT01925703|3601760|P1|Overall Study|Discharge prior to full iron repletion|1
1100459|NCT01925703|3601760|P1|Overall Study|Lost to Follow-up|2
1100460|NCT01925703|3601760|P1|Overall Study|Physician Decision|1
1100461|NCT01925612|3601771|P5|Overall Study|Adverse Event|2
1100462|NCT01925612|3601772|P4|Overall Study|Adverse Event|1
1100463|NCT01925612|3601773|P3|Overall Study|Adverse Event|0
1100464|NCT01925612|3601774|P2|Overall Study|Adverse Event|3
1100465|NCT01925612|3601775|P1|Overall Study|Adverse Event|3
1100466|NCT01925612|3601771|P5|Overall Study|Progressive Disease|0
1100467|NCT01925612|3601772|P4|Overall Study|Progressive Disease|0
1100468|NCT01925612|3601773|P3|Overall Study|Progressive Disease|1
1100469|NCT01925612|3601774|P2|Overall Study|Progressive Disease|1
1100470|NCT01925612|3601775|P1|Overall Study|Progressive Disease|1
1100471|NCT01925417|3601825|P1|Overall Study|Death|1
1100472|NCT01925417|3601825|P1|Overall Study|Withdrawal by Subject|2
1100473|NCT01925274|3601857|P3|Overall Study|Protocol amendment|6
1100474|NCT01925274|3601858|P2|Overall Study|Protocol amendment|3
1100475|NCT01925274|3601859|P1|Overall Study|Protocol amendment|1
1100476|NCT01925274|3601857|P3|Overall Study|Study terminated by sponsor|0
1100477|NCT01925274|3601858|P2|Overall Study|Study terminated by sponsor|0
1100478|NCT01925274|3601859|P1|Overall Study|Study terminated by sponsor|4
1100479|NCT01925274|3601857|P3|Overall Study|Withdrawal by Subject|0
1100480|NCT01925274|3601858|P2|Overall Study|Withdrawal by Subject|2
1100481|NCT01925274|3601859|P1|Overall Study|Withdrawal by Subject|1
1100482|NCT01925274|3601857|P3|Overall Study|Lost to Follow-up|0
1100483|NCT01925274|3601858|P2|Overall Study|Lost to Follow-up|1
1100484|NCT01925274|3601859|P1|Overall Study|Lost to Follow-up|0
1100485|NCT01925274|3601857|P3|Overall Study|Death|0
1100486|NCT01925274|3601858|P2|Overall Study|Death|0
1100487|NCT01925274|3601859|P1|Overall Study|Death|1
1100488|NCT01925209|3601940|P4|Follow-up|Withdrawal by Subject|2
1100489|NCT01925209|3601941|P3|Follow-up|Withdrawal by Subject|0
1100490|NCT01925209|3601942|P2|Follow-up|Withdrawal by Subject|2
1100491|NCT01925209|3601943|P1|Follow-up|Withdrawal by Subject|0
1100492|NCT01925209|3601940|P4|Follow-up|Non-compliance with study treatment|1
1100493|NCT01925209|3601941|P3|Follow-up|Non-compliance with study treatment|0
1100494|NCT01925209|3601942|P2|Follow-up|Non-compliance with study treatment|0
1100495|NCT01925209|3601943|P1|Follow-up|Non-compliance with study treatment|0
1100496|NCT01925209|3601940|P4|Follow-up|Physician Decision|0
1100497|NCT01925209|3601941|P3|Follow-up|Physician Decision|1
1100498|NCT01925209|3601942|P2|Follow-up|Physician Decision|0
1100499|NCT01925209|3601943|P1|Follow-up|Physician Decision|0
1100500|NCT01925209|3601940|P4|Follow-up|Adverse Event|1
1100501|NCT01925209|3601941|P3|Follow-up|Adverse Event|0
1100502|NCT01925209|3601942|P2|Follow-up|Adverse Event|4
1100503|NCT01925209|3601943|P1|Follow-up|Adverse Event|1
1100504|NCT01925209|3601940|P4|Maintenance Treatment Epoch|Adverse Event|0
1100505|NCT01925209|3601941|P3|Maintenance Treatment Epoch|Adverse Event|1
1100506|NCT01925209|3601942|P2|Maintenance Treatment Epoch|Adverse Event|0
1100507|NCT01925209|3601943|P1|Maintenance Treatment Epoch|Adverse Event|0
1100508|NCT01925209|3601940|P4|Maintenance Treatment Epoch|Withdrawal by Subject|2
1100509|NCT01925209|3601941|P3|Maintenance Treatment Epoch|Withdrawal by Subject|1
1100510|NCT01925209|3601942|P2|Maintenance Treatment Epoch|Withdrawal by Subject|1
1100511|NCT01925209|3601943|P1|Maintenance Treatment Epoch|Withdrawal by Subject|0
1100512|NCT01925209|3601940|P4|Treatment Epoch|Adverse Event|1
1100513|NCT01925209|3601941|P3|Treatment Epoch|Adverse Event|3
1100514|NCT01925209|3601942|P2|Treatment Epoch|Adverse Event|5
1100515|NCT01925209|3601943|P1|Treatment Epoch|Adverse Event|3
1100516|NCT01925209|3601940|P4|Treatment Epoch|Withdrawal by Subject|2
1100517|NCT01925209|3601941|P3|Treatment Epoch|Withdrawal by Subject|3
1100518|NCT01925209|3601942|P2|Treatment Epoch|Withdrawal by Subject|3
1100519|NCT01925209|3601943|P1|Treatment Epoch|Withdrawal by Subject|4
1100520|NCT01925209|3601940|P4|Treatment Epoch|Protocol deviation|1
1100521|NCT01925209|3601941|P3|Treatment Epoch|Protocol deviation|1
1100522|NCT01925209|3601942|P2|Treatment Epoch|Protocol deviation|0
1100523|NCT01925209|3601943|P1|Treatment Epoch|Protocol deviation|0
1100524|NCT01925209|3601940|P4|Treatment Epoch|Death|0
1100525|NCT01925209|3601941|P3|Treatment Epoch|Death|0
1100526|NCT01925209|3601942|P2|Treatment Epoch|Death|0
1100527|NCT01925209|3601943|P1|Treatment Epoch|Death|1
1100528|NCT01925209|3601940|P4|Treatment Epoch|Non-compliance with study treatment|1
1100529|NCT01925209|3601941|P3|Treatment Epoch|Non-compliance with study treatment|0
1100530|NCT01925209|3601942|P2|Treatment Epoch|Non-compliance with study treatment|0
1100531|NCT01925209|3601943|P1|Treatment Epoch|Non-compliance with study treatment|0
1100532|NCT01925209|3601940|P4|Treatment Epoch|Physician Decision|0
1100533|NCT01925209|3601941|P3|Treatment Epoch|Physician Decision|0
1100534|NCT01925209|3601942|P2|Treatment Epoch|Physician Decision|0
1100535|NCT01925209|3601943|P1|Treatment Epoch|Physician Decision|1
1100536|NCT01925183|3601975|P2|Overall Study|Adverse Event|0
1100537|NCT01925183|3601976|P1|Overall Study|Adverse Event|1
1100538|NCT01925170|3601984|P1|Overall Study|Unverified cancer status|53
1100539|NCT01924845|3602044|P1|Overall Study|Protocol Violation|1
1100540|NCT01924845|3602044|P1|Overall Study|Withdrawal by Subject|2
1100541|NCT01924845|3602044|P1|Overall Study|Adverse Event|3
1100542|NCT01924767|3602057|P5|Overall Study|Adverse Event|0
1100543|NCT01924767|3602058|P4|Overall Study|Adverse Event|0
1100544|NCT01924767|3602059|P3|Overall Study|Adverse Event|1
1100545|NCT01924767|3602060|P2|Overall Study|Adverse Event|0
1100546|NCT01924767|3602061|P1|Overall Study|Adverse Event|1
1100547|NCT01924533|3602177|P2|Overall Study|Other Eligibility criteria|1
1100548|NCT01924533|3602178|P1|Overall Study|Other Eligibility criteria|1
1100549|NCT01924533|3602177|P2|Overall Study|Withdrawal by Subject|3
1100550|NCT01924533|3602178|P1|Overall Study|Withdrawal by Subject|7
1100551|NCT01924533|3602177|P2|Overall Study|Lost to Follow-up|1
1100552|NCT01924533|3602178|P1|Overall Study|Lost to Follow-up|0
1100553|NCT01924533|3602177|P2|Overall Study|Death|200
1100554|NCT01924533|3602178|P1|Overall Study|Death|181
1100555|NCT01924429|3602208|P2|Washout Period (2 Weeks)|Withdrawal by Subject|2
1100556|NCT01924429|3602209|P1|Washout Period (2 Weeks)|Withdrawal by Subject|3
1100557|NCT01924364|3602252|P1|Overall Study|Physician Decision|3
1100558|NCT01924299|3602269|P2|Period 2|Adverse Event|1
1100559|NCT01924299|3602270|P1|Period 2|Adverse Event|0
1100560|NCT01924299|3602269|P2|Period 2|Withdrawal by Subject|0
1100561|NCT01924299|3602270|P1|Period 2|Withdrawal by Subject|1
1100562|NCT01924182|3602292|P2|Overall Study|Withdrawal by Subject|0
1100563|NCT01924182|3602293|P1|Overall Study|Withdrawal by Subject|1
1100564|NCT01923896|3602312|P2|Overall Study|Adverse Event|0
1100565|NCT01923896|3602313|P1|Overall Study|Adverse Event|1
1100566|NCT01923740|3602336|P2|3 Year Clinical Follow-up|Death|0
1100567|NCT01923740|3602337|P1|3 Year Clinical Follow-up|Death|1
1100568|NCT01923740|3602336|P2|2 Year Clinical Follow-up|ICF withdrawal|0
1100569|NCT01923740|3602337|P1|2 Year Clinical Follow-up|ICF withdrawal|1
1100570|NCT01923740|3602336|P2|2 Year Clinical Follow-up|Lost to Follow-up|2
1100571|NCT01923740|3602337|P1|2 Year Clinical Follow-up|Lost to Follow-up|0
1100572|NCT01923740|3602336|P2|2 Year Clinical Follow-up|Death|1
1100573|NCT01923740|3602337|P1|2 Year Clinical Follow-up|Death|1
1100574|NCT01923740|3602336|P2|1 Year Clinical Follow-up|Lost to Follow-up|0
1100575|NCT01923740|3602337|P1|1 Year Clinical Follow-up|Lost to Follow-up|1
1100576|NCT01923740|3602336|P2|270-day Clinical Follow-up|Death|4
1100577|NCT01923740|3602337|P1|270-day Clinical Follow-up|Death|0
1100578|NCT01923467|3602714|P1|Overall Study|Subject non-interest|479
1100579|NCT01923467|3602714|P1|Overall Study|Lost to Follow-up|62
1100580|NCT01923389|3602720|P2|Overall Study|Protocol Violation|0
1100581|NCT01923389|3602721|P1|Overall Study|Protocol Violation|1
1100582|NCT01923363|3602743|P1|Overall Study|Protocol Violation|1
1100583|NCT01923311|3602752|P2|Overall Study|Study Terminated by Sponsor|0
1100584|NCT01923311|3602753|P1|Overall Study|Study Terminated by Sponsor|12
1100585|NCT01923311|3602752|P2|Overall Study|Withdrew Consent|0
1100586|NCT01923311|3602753|P1|Overall Study|Withdrew Consent|1
1100587|NCT01923311|3602752|P2|Overall Study|Non-Compliance with Study Drug|1
1100588|NCT01923311|3602753|P1|Overall Study|Non-Compliance with Study Drug|2
1100589|NCT01923311|3602752|P2|Overall Study|Investigator's Discretion|0
1100590|NCT01923311|3602753|P1|Overall Study|Investigator's Discretion|1
1100591|NCT01923311|3602752|P2|Overall Study|Pregnancy|0
1100592|NCT01923311|3602753|P1|Overall Study|Pregnancy|1
1100593|NCT01923168|3602799|P3|Overall Study|Death|1
1100594|NCT01923168|3602800|P2|Overall Study|Death|0
1100595|NCT01923168|3602801|P1|Overall Study|Death|0
1100596|NCT01923168|3602799|P3|Overall Study|Progressive disease|7
1100597|NCT01923168|3602800|P2|Overall Study|Progressive disease|3
1100598|NCT01923168|3602801|P1|Overall Study|Progressive disease|4
1100599|NCT01923168|3602799|P3|Overall Study|Physician Decision|5
1100600|NCT01923168|3602800|P2|Overall Study|Physician Decision|9
1100601|NCT01923168|3602801|P1|Overall Study|Physician Decision|6
1100602|NCT01923168|3602799|P3|Overall Study|Adverse Event|0
1100603|NCT01923168|3602800|P2|Overall Study|Adverse Event|12
1100604|NCT01923168|3602801|P1|Overall Study|Adverse Event|12
1100605|NCT01923168|3602799|P3|Overall Study|Subject/guardian decision|4
1100606|NCT01923168|3602800|P2|Overall Study|Subject/guardian decision|14
1100607|NCT01923168|3602801|P1|Overall Study|Subject/guardian decision|14
1100608|NCT01923168|3602799|P3|Overall Study|Protocol Violation|0
1100609|NCT01923168|3602800|P2|Overall Study|Protocol Violation|1
1100610|NCT01923168|3602801|P1|Overall Study|Protocol Violation|1
1100611|NCT01922934|3602873|P2|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284
1100612|NCT01922934|3602874|P1|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21
1100613|NCT01922934|3602873|P2|Visit 0 - Patient Contacted & Consented|No response or could not reach|0
1100614|NCT01922934|3602874|P1|Visit 0 - Patient Contacted & Consented|No response or could not reach|66
1100615|NCT01922934|3602873|P2|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0
1100616|NCT01922934|3602874|P1|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169
1100617|NCT01922934|3602873|P2|Eligible Patients|Did not meet inclusion criteria|81
1100618|NCT01922934|3602874|P1|Eligible Patients|Did not meet inclusion criteria|36
1100619|NCT01922934|3602873|P2|Eligible Patients|Physician Decision|0
1100620|NCT01922934|3602874|P1|Eligible Patients|Physician Decision|17
1100621|NCT01922934|3602873|P2|Eligible Patients|Death|7
1100622|NCT01922934|3602874|P1|Eligible Patients|Death|0
1100623|NCT01922739|3602886|P1|Open-label Treatment Period|Sponsor request - investigator leaving|1
1100624|NCT01922739|3602886|P1|Open-label Treatment Period|Physician Decision|1
1100625|NCT01922739|3602886|P1|Open-label Treatment Period|Lost to Follow-up|2
1100626|NCT01922739|3602886|P1|Open-label Treatment Period|Noncompliance to study procedures|1
1100627|NCT01922739|3602886|P1|Open-label Treatment Period|Pregnancy|1
1100628|NCT01922739|3602886|P1|Open-label Treatment Period|Protocol Violation|5
1100629|NCT01922739|3602886|P1|Open-label Treatment Period|Noncompliance to study medication|3
1100630|NCT01922739|3602886|P1|Open-label Treatment Period|Withdrawal by Subject|14
1100631|NCT01922739|3602886|P1|Open-label Treatment Period|Adverse Event|6
1100632|NCT01922739|3602886|P1|Titration/Adjustment Period|Lack of Efficacy|3
1100633|NCT01922739|3602886|P1|Titration/Adjustment Period|Lost to Follow-up|1
1100634|NCT01922739|3602886|P1|Titration/Adjustment Period|Withdrawal by Subject|5
1100635|NCT01922739|3602886|P1|Titration/Adjustment Period|Adverse Event|3
1100636|NCT01922349|3602915|P4|Multiple Rising Dose (MRD) Period|Adverse Event|1
1100637|NCT01922349|3602916|P3|Multiple Rising Dose (MRD) Period|Adverse Event|0
1100638|NCT01922349|3602917|P2|Multiple Rising Dose (MRD) Period|Adverse Event|0
1100639|NCT01922349|3602918|P1|Multiple Rising Dose (MRD) Period|Adverse Event|0
1100640|NCT01922271|3603025|P2|WASHOUT Period|Withdrawal by Subject|0
1100641|NCT01922271|3603026|P1|WASHOUT Period|Withdrawal by Subject|1
1100642|NCT01922089|3603067|P2|Overall Study|Lost to Follow-up|1
1100643|NCT01922089|3603068|P1|Overall Study|Lost to Follow-up|0
1100644|NCT01922089|3603067|P2|Overall Study|Death|1
1100645|NCT01922089|3603068|P1|Overall Study|Death|2
1100646|NCT01922089|3603067|P2|Overall Study|Physician Decision|3
1100647|NCT01922089|3603068|P1|Overall Study|Physician Decision|2
1100648|NCT01922089|3603067|P2|Overall Study|administrative problems|1
1100649|NCT01922089|3603068|P1|Overall Study|administrative problems|4
1100650|NCT01922089|3603067|P2|Overall Study|Withdrawal by Subject|4
1100651|NCT01922089|3603068|P1|Overall Study|Withdrawal by Subject|3
1100652|NCT01922089|3603067|P2|Overall Study|Protocol Deviation|7
1100653|NCT01922089|3603068|P1|Overall Study|Protocol Deviation|10
1100654|NCT01922089|3603067|P2|Overall Study|Adverse Event|13
1100655|NCT01922089|3603068|P1|Overall Study|Adverse Event|18
1100656|NCT01922037|3603080|P2|Overall Study|Other unspecified|66
1100657|NCT01922037|3603081|P1|Overall Study|Other unspecified|2
1100658|NCT01922037|3603080|P2|Overall Study|Investigator/Sponsor decision|4
1100659|NCT01922037|3603081|P1|Overall Study|Investigator/Sponsor decision|1
1100660|NCT01922037|3603080|P2|Overall Study|Participant non-compliance|46
1100661|NCT01922037|3603081|P1|Overall Study|Participant non-compliance|4
1100662|NCT01922037|3603080|P2|Overall Study|Pregnancy|2
1100663|NCT01922037|3603081|P1|Overall Study|Pregnancy|0
1100664|NCT01922037|3603080|P2|Overall Study|Death|5
1100665|NCT01922037|3603081|P1|Overall Study|Death|0
1100666|NCT01922037|3603080|P2|Overall Study|Adverse Event|7
1100667|NCT01922037|3603081|P1|Overall Study|Adverse Event|1
1100668|NCT01922037|3603080|P2|Overall Study|Withdrawal by Subject|44
1100669|NCT01922037|3603081|P1|Overall Study|Withdrawal by Subject|2
1100670|NCT01922011|3603175|P2|Overall Study|Randomized in error|0
1100671|NCT01922011|3603176|P1|Overall Study|Randomized in error|1
1100672|NCT01922011|3603175|P2|Overall Study|Lack of willing home health agency|0
1100673|NCT01922011|3603176|P1|Overall Study|Lack of willing home health agency|1
1100674|NCT01922011|3603175|P2|Overall Study|Not Treated|0
1100675|NCT01922011|3603176|P1|Overall Study|Not Treated|1
1100676|NCT01922011|3603175|P2|Overall Study|Missed Test-of-Cure Visit|2
1100677|NCT01922011|3603176|P1|Overall Study|Missed Test-of-Cure Visit|0
1100678|NCT01922011|3603175|P2|Overall Study|Lost to Follow-up|1
1100679|NCT01922011|3603176|P1|Overall Study|Lost to Follow-up|0
1100680|NCT01922011|3603175|P2|Overall Study|Parent/Guardian Decision|0
1100681|NCT01922011|3603176|P1|Overall Study|Parent/Guardian Decision|3
1100682|NCT01922011|3603175|P2|Overall Study|Physician Decision|1
1100683|NCT01922011|3603176|P1|Overall Study|Physician Decision|0
1100684|NCT01922011|3603175|P2|Overall Study|Protocol Violation|1
1100685|NCT01922011|3603176|P1|Overall Study|Protocol Violation|0
1100686|NCT01921829|3603243|P2|Overall Study|Withdrawal by Subject|1
1100687|NCT01921829|3603244|P1|Overall Study|Withdrawal by Subject|0
1100688|NCT01921387|3603318|P1|Overall Study|Adverse Event|1
1100689|NCT01921348|3603327|P2|Overall Study|Lost to Follow-up|2
1100690|NCT01921348|3603328|P1|Overall Study|Lost to Follow-up|0
1100691|NCT01921348|3603327|P2|Overall Study|Withdrawal by Subject|0
1100692|NCT01921348|3603328|P1|Overall Study|Withdrawal by Subject|1
1100693|NCT01921270|3603357|P1|Overall Study|Withdrawal by Subject|1
1100694|NCT01921257|3603373|P1|Overall Study|Withdrawal by Subject|1
1100695|NCT01921257|3603373|P1|Overall Study|Protocol Violation|1
1100696|NCT01921257|3603373|P1|Overall Study|Adverse Event|1
1100697|NCT01921205|3603380|P2|Overall Study|Non Compliance Of Child|1
1100698|NCT01921205|3603381|P1|Overall Study|Non Compliance Of Child|0
1100699|NCT01921205|3603380|P2|Overall Study|Non Compliance Of The Parent|1
1100700|NCT01921205|3603381|P1|Overall Study|Non Compliance Of The Parent|0
1100701|NCT01921205|3603380|P2|Overall Study|The Excessive Use Of Rescue Medication|1
1100702|NCT01921205|3603381|P1|Overall Study|The Excessive Use Of Rescue Medication|0
1100703|NCT01921205|3603380|P2|Overall Study|Use Of Prohibited Medication|1
1100704|NCT01921205|3603381|P1|Overall Study|Use Of Prohibited Medication|0
1100705|NCT01921205|3603380|P2|Overall Study|Withdrawal by Subject|5
1100706|NCT01921205|3603381|P1|Overall Study|Withdrawal by Subject|6
1100707|NCT01921205|3603380|P2|Overall Study|Lost to Follow-up|1
1100708|NCT01921205|3603381|P1|Overall Study|Lost to Follow-up|1
1100709|NCT01921205|3603380|P2|Overall Study|Protocol Violation|3
1100710|NCT01921205|3603381|P1|Overall Study|Protocol Violation|1
1100711|NCT01921205|3603380|P2|Overall Study|Lack of Efficacy|0
1100712|NCT01921205|3603381|P1|Overall Study|Lack of Efficacy|1
1100713|NCT01921205|3603380|P2|Overall Study|Adverse Event|7
1100714|NCT01921205|3603381|P1|Overall Study|Adverse Event|12
1100715|NCT01921101|3603422|P2|Overall Study|Death|6
1100716|NCT01921101|3603423|P1|Overall Study|Death|16
1100717|NCT01920958|3603431|P1|Overall Study|Did Not Fulfill Inclusion Criteria|5
1100718|NCT01920893|3603449|P2|Overall Study|Lack of Efficacy|0
1100719|NCT01920893|3603450|P1|Overall Study|Lack of Efficacy|2
1100720|NCT01920893|3603449|P2|Overall Study|Adverse Event|2
1100721|NCT01920893|3603450|P1|Overall Study|Adverse Event|5
1100722|NCT01920854|3603483|P7|Overall Study|Withdrawal by Subject|1
1100723|NCT01920854|3603484|P6|Overall Study|Withdrawal by Subject|0
1100724|NCT01920854|3603485|P5|Overall Study|Withdrawal by Subject|1
1100725|NCT01920854|3603486|P4|Overall Study|Withdrawal by Subject|0
1100726|NCT01920854|3603487|P3|Overall Study|Withdrawal by Subject|0
1100727|NCT01920854|3603488|P2|Overall Study|Withdrawal by Subject|0
1100728|NCT01920854|3603489|P1|Overall Study|Withdrawal by Subject|1
1100729|NCT01920594|3603649|P2|Overall Study|Investigator discretion|1
1100730|NCT01920594|3603650|P1|Overall Study|Investigator discretion|0
1100731|NCT01920594|3603649|P2|Overall Study|Recovery|0
1100732|NCT01920594|3603650|P1|Overall Study|Recovery|2
1100733|NCT01920594|3603649|P2|Overall Study|Lost to Follow-up|0
1100734|NCT01920594|3603650|P1|Overall Study|Lost to Follow-up|1
1100735|NCT01920594|3603649|P2|Overall Study|Adverse Event|2
1100736|NCT01920594|3603650|P1|Overall Study|Adverse Event|4
1100737|NCT01920568|3603700|P2|Overall Study|Death due to disease progression|12
1100738|NCT01920568|3603701|P1|Overall Study|Death due to disease progression|25
1100739|NCT01920568|3603700|P2|Overall Study|Withdrawal by Subject|55
1100740|NCT01920568|3603701|P1|Overall Study|Withdrawal by Subject|79
1100741|NCT01920568|3603700|P2|Overall Study|Physician Decision|4
1100742|NCT01920568|3603701|P1|Overall Study|Physician Decision|13
1100743|NCT01920568|3603700|P2|Overall Study|Lost to Follow-up|2
1100744|NCT01920568|3603701|P1|Overall Study|Lost to Follow-up|2
1100745|NCT01920568|3603700|P2|Overall Study|Protocol Violation|3
1100746|NCT01920568|3603701|P1|Overall Study|Protocol Violation|5
1100747|NCT01920568|3603700|P2|Overall Study|Adverse Event|8
1100748|NCT01920568|3603701|P1|Overall Study|Adverse Event|27
1100749|NCT01920555|3603727|P5|Overall Study|Lost to Follow-up|0
1100750|NCT01920555|3603728|P4|Overall Study|Lost to Follow-up|1
1100751|NCT01920555|3603729|P3|Overall Study|Lost to Follow-up|0
1100752|NCT01920555|3603730|P2|Overall Study|Lost to Follow-up|1
1100753|NCT01920555|3603731|P1|Overall Study|Lost to Follow-up|0
1100754|NCT01920555|3603727|P5|Overall Study|Travel Difficulties|1
1100755|NCT01920555|3603728|P4|Overall Study|Travel Difficulties|0
1100756|NCT01920555|3603729|P3|Overall Study|Travel Difficulties|0
1100757|NCT01920555|3603730|P2|Overall Study|Travel Difficulties|1
1100758|NCT01920555|3603731|P1|Overall Study|Travel Difficulties|1
1100759|NCT01920555|3603727|P5|Overall Study|Lack of Efficacy|0
1100760|NCT01920555|3603728|P4|Overall Study|Lack of Efficacy|0
1100761|NCT01920555|3603729|P3|Overall Study|Lack of Efficacy|0
1100762|NCT01920555|3603730|P2|Overall Study|Lack of Efficacy|0
1100763|NCT01920555|3603731|P1|Overall Study|Lack of Efficacy|2
1100764|NCT01920555|3603727|P5|Overall Study|Physician Decision|0
1100765|NCT01920555|3603728|P4|Overall Study|Physician Decision|2
1100766|NCT01920555|3603729|P3|Overall Study|Physician Decision|1
1100767|NCT01920555|3603730|P2|Overall Study|Physician Decision|2
1100768|NCT01920555|3603731|P1|Overall Study|Physician Decision|1
1100769|NCT01920178|3603806|P2|Overall Study|Lost to Follow-up|1
1100770|NCT01920178|3603807|P1|Overall Study|Lost to Follow-up|2
1100771|NCT01919801|3603825|P2|Overall Study|Other|1
1100772|NCT01919801|3603826|P1|Overall Study|Other|0
1100773|NCT01919801|3603825|P2|Overall Study|Lost to Follow-up|1
1100774|NCT01919801|3603826|P1|Overall Study|Lost to Follow-up|0
1100775|NCT01919801|3603825|P2|Overall Study|Physician Decision|1
1100776|NCT01919801|3603826|P1|Overall Study|Physician Decision|0
1100777|NCT01919801|3603825|P2|Overall Study|Withdrawal by Subject|0
1100778|NCT01919801|3603826|P1|Overall Study|Withdrawal by Subject|1
1100779|NCT01919723|3603851|P2|Overall Study|Blood Samples Hemolyzed|2
1100780|NCT01919723|3603852|P1|Overall Study|Blood Samples Hemolyzed|2
1100781|NCT01919307|3603892|P1|Overall Study|Withdrawal by Subject|9
1100782|NCT01919229|3603902|P3|Overall Study|Subject/guardian decision|1
1100783|NCT01919229|3603903|P2|Overall Study|Subject/guardian decision|0
1100784|NCT01919229|3603904|P1|Overall Study|Subject/guardian decision|0
1100785|NCT01918371|3603969|P2|Overall Study|Missing Data|1
1100786|NCT01918371|3603970|P1|Overall Study|Missing Data|1
1100787|NCT01918332|3604048|P4|Overall Study|lipid result by central lab did not meet|0
1100788|NCT01918332|3604049|P3|Overall Study|lipid result by central lab did not meet|1
1100789|NCT01918332|3604050|P2|Overall Study|lipid result by central lab did not meet|0
1100790|NCT01918332|3604051|P1|Overall Study|lipid result by central lab did not meet|0
1100791|NCT01918332|3604048|P4|Overall Study|Protocol Violation|3
1100792|NCT01918332|3604049|P3|Overall Study|Protocol Violation|6
1100793|NCT01918332|3604050|P2|Overall Study|Protocol Violation|2
1100794|NCT01918332|3604051|P1|Overall Study|Protocol Violation|6
1100795|NCT01918332|3604048|P4|Overall Study|Withdrawal by Subject|3
1100796|NCT01918332|3604049|P3|Overall Study|Withdrawal by Subject|2
1100797|NCT01918332|3604050|P2|Overall Study|Withdrawal by Subject|3
1100798|NCT01918332|3604051|P1|Overall Study|Withdrawal by Subject|2
1100799|NCT01918332|3604048|P4|Overall Study|Adverse Event|1
1100800|NCT01918332|3604049|P3|Overall Study|Adverse Event|0
1100801|NCT01918332|3604050|P2|Overall Study|Adverse Event|0
1100802|NCT01918332|3604051|P1|Overall Study|Adverse Event|0
1100803|NCT01918306|3604063|P4|Overall Study|progress disease, crossover|0
1100804|NCT01918306|3604064|P3|Overall Study|progress disease, crossover|1
1100805|NCT01918306|3604065|P2|Overall Study|progress disease, crossover|0
1100806|NCT01918306|3604066|P1|Overall Study|progress disease, crossover|0
1100807|NCT01918306|3604063|P4|Overall Study|Lack of Efficacy|0
1100808|NCT01918306|3604064|P3|Overall Study|Lack of Efficacy|0
1100809|NCT01918306|3604065|P2|Overall Study|Lack of Efficacy|0
1100810|NCT01918306|3604066|P1|Overall Study|Lack of Efficacy|1
1100811|NCT01918306|3604063|P4|Overall Study|neutropenia|0
1100812|NCT01918306|3604064|P3|Overall Study|neutropenia|0
1100813|NCT01918306|3604065|P2|Overall Study|neutropenia|0
1100814|NCT01918306|3604066|P1|Overall Study|neutropenia|1
1100815|NCT01918306|3604063|P4|Overall Study|Withdrawal by Subject|2
1100816|NCT01918306|3604064|P3|Overall Study|Withdrawal by Subject|0
1100817|NCT01918306|3604065|P2|Overall Study|Withdrawal by Subject|0
1100818|NCT01918306|3604066|P1|Overall Study|Withdrawal by Subject|0
1100819|NCT01918306|3604063|P4|Overall Study|progresive disease|1
1100820|NCT01918306|3604064|P3|Overall Study|progresive disease|1
1100821|NCT01918306|3604065|P2|Overall Study|progresive disease|0
1100822|NCT01918306|3604066|P1|Overall Study|progresive disease|4
1100823|NCT01918085|3604088|P2|Test Period 1: Strata Strip|Adverse Event|1
1100824|NCT01918085|3604089|P1|Test Period 1: Strata Strip|Adverse Event|0
1100825|NCT01918033|3604100|P3|Overall Study|Withdrawal by Subject|0
1100826|NCT01918033|3604101|P2|Overall Study|Withdrawal by Subject|1
1100827|NCT01918033|3604102|P1|Overall Study|Withdrawal by Subject|2
1100828|NCT01918033|3604100|P3|Overall Study|Protocol Violation|1
1100829|NCT01918033|3604101|P2|Overall Study|Protocol Violation|0
1100830|NCT01918033|3604102|P1|Overall Study|Protocol Violation|2
1100831|NCT01918033|3604100|P3|Overall Study|Lost to Follow-up|0
1100832|NCT01918033|3604101|P2|Overall Study|Lost to Follow-up|1
1100833|NCT01918033|3604102|P1|Overall Study|Lost to Follow-up|0
1100834|NCT01918033|3604100|P3|Overall Study|Adverse Event|2
1100835|NCT01918033|3604101|P2|Overall Study|Adverse Event|0
1100836|NCT01918033|3604102|P1|Overall Study|Adverse Event|1
1100837|NCT01917656|3604173|P2|Overall Study|Lost to Follow-up|4
1100838|NCT01917656|3604174|P1|Overall Study|Lost to Follow-up|3
1100839|NCT01917656|3604173|P2|Overall Study|Withdrawal by Subject|3
1100840|NCT01917656|3604174|P1|Overall Study|Withdrawal by Subject|4
1100841|NCT01917656|3604173|P2|Overall Study|Unclassified|3
1100842|NCT01917656|3604174|P1|Overall Study|Unclassified|0
1100843|NCT01917656|3604173|P2|Overall Study|Withdrawal criteria|14
1100844|NCT01917656|3604174|P1|Overall Study|Withdrawal criteria|8
1100845|NCT01917656|3604173|P2|Overall Study|Adverse Event|0
1100846|NCT01917656|3604174|P1|Overall Study|Adverse Event|11
1100847|NCT01917526|3604200|P2|Overall Study|Protocol Violation|1
1100848|NCT01917526|3604201|P1|Overall Study|Protocol Violation|1
1100849|NCT01917344|3604218|P1|Overall Study|Withdrawal by Subject|1
1100850|NCT01917006|3604238|P8|Open-label Period|Lost to Follow-up|1
1100851|NCT01917006|3604239|P7|Open-label Period|Lost to Follow-up|0
1100852|NCT01917006|3604240|P6|Open-label Period|Lost to Follow-up|0
1100853|NCT01917006|3604241|P5|Open-label Period|Lost to Follow-up|0
1100854|NCT01917006|3604242|P4|Open-label Period|Lost to Follow-up|0
1100855|NCT01917006|3604243|P3|Open-label Period|Lost to Follow-up|0
1100856|NCT01917006|3604244|P2|Open-label Period|Lost to Follow-up|0
1100857|NCT01917006|3604245|P1|Open-label Period|Lost to Follow-up|0
1100858|NCT01917006|3604238|P8|Open-label Period|Adverse Event|1
1100859|NCT01917006|3604239|P7|Open-label Period|Adverse Event|0
1100860|NCT01917006|3604240|P6|Open-label Period|Adverse Event|0
1100861|NCT01917006|3604241|P5|Open-label Period|Adverse Event|0
1100862|NCT01917006|3604242|P4|Open-label Period|Adverse Event|0
1100863|NCT01917006|3604243|P3|Open-label Period|Adverse Event|0
1100864|NCT01917006|3604244|P2|Open-label Period|Adverse Event|0
1100865|NCT01917006|3604245|P1|Open-label Period|Adverse Event|0
1100866|NCT01917006|3604238|P8|Randomized-treatment Period|Other Miscellaneous Reasons|0
1100867|NCT01917006|3604239|P7|Randomized-treatment Period|Other Miscellaneous Reasons|1
1100868|NCT01917006|3604240|P6|Randomized-treatment Period|Other Miscellaneous Reasons|0
1100869|NCT01917006|3604241|P5|Randomized-treatment Period|Other Miscellaneous Reasons|0
1100870|NCT01917006|3604242|P4|Randomized-treatment Period|Other Miscellaneous Reasons|0
1100871|NCT01917006|3604243|P3|Randomized-treatment Period|Other Miscellaneous Reasons|0
1100872|NCT01917006|3604244|P2|Randomized-treatment Period|Other Miscellaneous Reasons|0
1100873|NCT01917006|3604245|P1|Randomized-treatment Period|Other Miscellaneous Reasons|0
1100874|NCT01917006|3604238|P8|Randomized-treatment Period|Protocol Violation|0
1100875|NCT01917006|3604239|P7|Randomized-treatment Period|Protocol Violation|0
1100876|NCT01917006|3604240|P6|Randomized-treatment Period|Protocol Violation|0
1100877|NCT01917006|3604241|P5|Randomized-treatment Period|Protocol Violation|0
1100878|NCT01917006|3604242|P4|Randomized-treatment Period|Protocol Violation|0
1100879|NCT01917006|3604243|P3|Randomized-treatment Period|Protocol Violation|0
1100880|NCT01917006|3604244|P2|Randomized-treatment Period|Protocol Violation|0
1100881|NCT01917006|3604245|P1|Randomized-treatment Period|Protocol Violation|1
1100882|NCT01917006|3604238|P8|Randomized-treatment Period|Personal Reasons|0
1100883|NCT01917006|3604239|P7|Randomized-treatment Period|Personal Reasons|0
1100884|NCT01917006|3604240|P6|Randomized-treatment Period|Personal Reasons|1
1100885|NCT01917006|3604241|P5|Randomized-treatment Period|Personal Reasons|0
1100886|NCT01917006|3604242|P4|Randomized-treatment Period|Personal Reasons|0
1100887|NCT01917006|3604243|P3|Randomized-treatment Period|Personal Reasons|0
1100888|NCT01917006|3604244|P2|Randomized-treatment Period|Personal Reasons|0
1100889|NCT01917006|3604245|P1|Randomized-treatment Period|Personal Reasons|0
1100890|NCT01917006|3604238|P8|Randomized-treatment Period|Lost to Follow-up|0
1100891|NCT01917006|3604239|P7|Randomized-treatment Period|Lost to Follow-up|0
1100892|NCT01917006|3604240|P6|Randomized-treatment Period|Lost to Follow-up|0
1100893|NCT01917006|3604241|P5|Randomized-treatment Period|Lost to Follow-up|0
1100894|NCT01917006|3604242|P4|Randomized-treatment Period|Lost to Follow-up|1
1100895|NCT01917006|3604243|P3|Randomized-treatment Period|Lost to Follow-up|0
1100896|NCT01917006|3604244|P2|Randomized-treatment Period|Lost to Follow-up|0
1100897|NCT01917006|3604245|P1|Randomized-treatment Period|Lost to Follow-up|1
1100898|NCT01916980|3604278|P2|Overall Study|Withdrawal by Subject|0
1100899|NCT01916980|3604279|P1|Overall Study|Withdrawal by Subject|1
1100900|NCT01916980|3604278|P2|Overall Study|Lack of Efficacy|2
1100901|NCT01916980|3604279|P1|Overall Study|Lack of Efficacy|2
1100902|NCT01916980|3604278|P2|Overall Study|Adverse Event|2
1100903|NCT01916980|3604279|P1|Overall Study|Adverse Event|4
1100904|NCT01916967|3604298|P3|Overall Study|Protocol Violation|0
1100905|NCT01916967|3604299|P2|Overall Study|Protocol Violation|1
1100906|NCT01916967|3604300|P1|Overall Study|Protocol Violation|0
1100907|NCT01916967|3604298|P3|Overall Study|Physician Decision|1
1100908|NCT01916967|3604299|P2|Overall Study|Physician Decision|0
1100909|NCT01916967|3604300|P1|Overall Study|Physician Decision|0
1100910|NCT01916967|3604298|P3|Overall Study|Lack of Efficacy|6
1100911|NCT01916967|3604299|P2|Overall Study|Lack of Efficacy|0
1100912|NCT01916967|3604300|P1|Overall Study|Lack of Efficacy|0
1100913|NCT01916967|3604298|P3|Overall Study|Adverse Event|2
1100914|NCT01916967|3604299|P2|Overall Study|Adverse Event|0
1100915|NCT01916967|3604300|P1|Overall Study|Adverse Event|0
1100916|NCT01916824|3604356|P2|Overall Study|Withdrawal by Subject|3
1100917|NCT01916824|3604357|P1|Overall Study|Withdrawal by Subject|2
1100918|NCT01916824|3604356|P2|Overall Study|Physician Decision|0
1100919|NCT01916824|3604357|P1|Overall Study|Physician Decision|2
1100920|NCT01916824|3604356|P2|Overall Study|Lost to Follow-up|6
1100921|NCT01916824|3604357|P1|Overall Study|Lost to Follow-up|3
1100922|NCT01916304|3604426|P1|Overall Study|Screening failure|17
1100923|NCT01916226|3604438|P4|Overall Study|Physician Decision|1
1100924|NCT01916226|3604439|P3|Overall Study|Physician Decision|0
1100925|NCT01916226|3604440|P2|Overall Study|Physician Decision|0
1100926|NCT01916226|3604441|P1|Overall Study|Physician Decision|0
1100927|NCT01916226|3604438|P4|Overall Study|Protocol Violation|1
1100928|NCT01916226|3604439|P3|Overall Study|Protocol Violation|0
1100929|NCT01916226|3604440|P2|Overall Study|Protocol Violation|1
1100930|NCT01916226|3604441|P1|Overall Study|Protocol Violation|0
1100931|NCT01916226|3604438|P4|Overall Study|Lack of Efficacy|1
1100932|NCT01916226|3604439|P3|Overall Study|Lack of Efficacy|2
1100933|NCT01916226|3604440|P2|Overall Study|Lack of Efficacy|0
1100934|NCT01916226|3604441|P1|Overall Study|Lack of Efficacy|0
1100935|NCT01916226|3604438|P4|Overall Study|Adverse Event|1
1100936|NCT01916226|3604439|P3|Overall Study|Adverse Event|1
1100937|NCT01916226|3604440|P2|Overall Study|Adverse Event|0
1100938|NCT01916226|3604441|P1|Overall Study|Adverse Event|1
1100939|NCT01916109|3604475|P1|Overall Study|Withdrawal by Subject|1
1100940|NCT01915940|3604481|P3|Treatment Period|Other Miscellaneous Reasons|0
1100941|NCT01915940|3604482|P2|Treatment Period|Other Miscellaneous Reasons|1
1100942|NCT01915940|3604483|P1|Treatment Period|Other Miscellaneous Reasons|0
1100943|NCT01915940|3604481|P3|Treatment Period|Adverse Event|1
1100944|NCT01915940|3604482|P2|Treatment Period|Adverse Event|9
1100945|NCT01915940|3604483|P1|Treatment Period|Adverse Event|0
1100946|NCT01915940|3604481|P3|Treatment Period|Decision of Participant|3
1100947|NCT01915940|3604482|P2|Treatment Period|Decision of Participant|1
1100948|NCT01915940|3604483|P1|Treatment Period|Decision of Participant|0
1100949|NCT01915940|3604481|P3|Pre-randomization Washout Period|Not Qualified for Randomization|0
1100950|NCT01915940|3604482|P2|Pre-randomization Washout Period|Not Qualified for Randomization|0
1100951|NCT01915940|3604483|P1|Pre-randomization Washout Period|Not Qualified for Randomization|39
1100952|NCT01915914|3604499|P4|Follow-up Phase|Physician Decision|1
1100953|NCT01915914|3604500|P3|Follow-up Phase|Physician Decision|0
1100954|NCT01915914|3604501|P2|Follow-up Phase|Physician Decision|0
1100955|NCT01915914|3604502|P1|Follow-up Phase|Physician Decision|0
1100956|NCT01915914|3604499|P4|Follow-up Phase|Withdrawal by Subject|1
1100957|NCT01915914|3604500|P3|Follow-up Phase|Withdrawal by Subject|0
1100958|NCT01915914|3604501|P2|Follow-up Phase|Withdrawal by Subject|0
1100959|NCT01915914|3604502|P1|Follow-up Phase|Withdrawal by Subject|0
1100960|NCT01915914|3604499|P4|Maintenance Phase|Missing|0
1100961|NCT01915914|3604500|P3|Maintenance Phase|Missing|0
1100962|NCT01915914|3604501|P2|Maintenance Phase|Missing|1
1100963|NCT01915914|3604502|P1|Maintenance Phase|Missing|0
1100964|NCT01915914|3604499|P4|Maintenance Phase|Lost to Follow-up|0
1100965|NCT01915914|3604500|P3|Maintenance Phase|Lost to Follow-up|1
1100966|NCT01915914|3604501|P2|Maintenance Phase|Lost to Follow-up|4
1100967|NCT01915914|3604502|P1|Maintenance Phase|Lost to Follow-up|0
1100968|NCT01915914|3604499|P4|Maintenance Phase|Withdrawal by Subject|0
1100969|NCT01915914|3604500|P3|Maintenance Phase|Withdrawal by Subject|1
1100970|NCT01915914|3604501|P2|Maintenance Phase|Withdrawal by Subject|1
1100971|NCT01915914|3604502|P1|Maintenance Phase|Withdrawal by Subject|0
1100972|NCT01915914|3604499|P4|Acute Phase|Missing|0
1100973|NCT01915914|3604500|P3|Acute Phase|Missing|0
1100974|NCT01915914|3604501|P2|Acute Phase|Missing|0
1100975|NCT01915914|3604502|P1|Acute Phase|Missing|1
1100976|NCT01915914|3604499|P4|Acute Phase|"Not Achieved treatment success"|0
1100977|NCT01915914|3604500|P3|Acute Phase|"Not Achieved treatment success"|0
1100978|NCT01915914|3604501|P2|Acute Phase|"Not Achieved treatment success"|0
1100979|NCT01915914|3604502|P1|Acute Phase|"Not Achieved treatment success"|1
1100980|NCT01915914|3604499|P4|Acute Phase|Accepted Other Topic Therapies|0
1100981|NCT01915914|3604500|P3|Acute Phase|Accepted Other Topic Therapies|0
1100982|NCT01915914|3604501|P2|Acute Phase|Accepted Other Topic Therapies|0
1100983|NCT01915914|3604502|P1|Acute Phase|Accepted Other Topic Therapies|1
1100984|NCT01915914|3604499|P4|Acute Phase|Physician Decision|0
1100985|NCT01915914|3604500|P3|Acute Phase|Physician Decision|0
1100986|NCT01915914|3604501|P2|Acute Phase|Physician Decision|0
1100987|NCT01915914|3604502|P1|Acute Phase|Physician Decision|1
1100988|NCT01915914|3604499|P4|Acute Phase|Lost to Follow-up|0
1100989|NCT01915914|3604500|P3|Acute Phase|Lost to Follow-up|0
1100990|NCT01915914|3604501|P2|Acute Phase|Lost to Follow-up|0
1100991|NCT01915914|3604502|P1|Acute Phase|Lost to Follow-up|4
1100992|NCT01915914|3604499|P4|Acute Phase|Withdrawal by Subject|0
1100993|NCT01915914|3604500|P3|Acute Phase|Withdrawal by Subject|0
1100994|NCT01915914|3604501|P2|Acute Phase|Withdrawal by Subject|0
1100995|NCT01915914|3604502|P1|Acute Phase|Withdrawal by Subject|4
1100996|NCT01915849|3604534|P4|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
1100997|NCT01915849|3604535|P3|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
1100998|NCT01915849|3604536|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
1100999|NCT01915849|3604537|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
1101000|NCT01915849|3604534|P4|Treatment Period 1 (4 Days)|Protocol Violation|0
1101001|NCT01915849|3604535|P3|Treatment Period 1 (4 Days)|Protocol Violation|0
1101002|NCT01915849|3604536|P2|Treatment Period 1 (4 Days)|Protocol Violation|0
1101003|NCT01915849|3604537|P1|Treatment Period 1 (4 Days)|Protocol Violation|1
1101004|NCT01915732|3604562|P2|Overall Study|Poor Conscious Effect|1
1101005|NCT01915732|3604563|P1|Overall Study|Poor Conscious Effect|0
1101006|NCT01915732|3604562|P2|Overall Study|Improper Facial Procedure|1
1101007|NCT01915732|3604563|P1|Overall Study|Improper Facial Procedure|0
1101008|NCT01915732|3604562|P2|Overall Study|Job Transfer|1
1101009|NCT01915732|3604563|P1|Overall Study|Job Transfer|0
1101010|NCT01915732|3604562|P2|Overall Study|Par. Refused to Hospital Visits|1
1101011|NCT01915732|3604563|P1|Overall Study|Par. Refused to Hospital Visits|0
1101012|NCT01915732|3604562|P2|Overall Study|Par. not Willing to Continue Treatment|1
1101013|NCT01915732|3604563|P1|Overall Study|Par. not Willing to Continue Treatment|0
1101014|NCT01915732|3604562|P2|Overall Study|Got Well|1
1101015|NCT01915732|3604563|P1|Overall Study|Got Well|0
1101016|NCT01915732|3604562|P2|Overall Study|Par. Unable to Come to the Hospital|1
1101017|NCT01915732|3604563|P1|Overall Study|Par. Unable to Come to the Hospital|0
1101018|NCT01915732|3604562|P2|Overall Study|Poor Perceived Efficacy|0
1101019|NCT01915732|3604563|P1|Overall Study|Poor Perceived Efficacy|1
1101020|NCT01915732|3604562|P2|Overall Study|Pregnancy|0
1101021|NCT01915732|3604563|P1|Overall Study|Pregnancy|1
1101022|NCT01915732|3604562|P2|Overall Study|Recovered|0
1101023|NCT01915732|3604563|P1|Overall Study|Recovered|1
1101024|NCT01915732|3604562|P2|Overall Study|Drug Release Error|0
1101025|NCT01915732|3604563|P1|Overall Study|Drug Release Error|1
1101026|NCT01915732|3604562|P2|Overall Study|Par. Conscious Ineffective Vol Exit|0
1101027|NCT01915732|3604563|P1|Overall Study|Par. Conscious Ineffective Vol Exit|1
1101028|NCT01915732|3604562|P2|Overall Study|Par. Improved, Voluntary (Vol) exit|0
1101029|NCT01915732|3604563|P1|Overall Study|Par. Improved, Voluntary (Vol) exit|1
1101030|NCT01915732|3604562|P2|Overall Study|Lost to Follow-up|26
1101031|NCT01915732|3604563|P1|Overall Study|Lost to Follow-up|22
1101032|NCT01915732|3604562|P2|Overall Study|Lack of Efficacy|11
1101033|NCT01915732|3604563|P1|Overall Study|Lack of Efficacy|6
1101034|NCT01915732|3604562|P2|Overall Study|Protocol Violation|5
1101035|NCT01915732|3604563|P1|Overall Study|Protocol Violation|5
1101036|NCT01915732|3604562|P2|Overall Study|Adverse Event|4
1101037|NCT01915732|3604563|P1|Overall Study|Adverse Event|12
1101038|NCT01915732|3604562|P2|Overall Study|Failure to Meet Randomization Criteria|0
1101039|NCT01915732|3604563|P1|Overall Study|Failure to Meet Randomization Criteria|1
1101040|NCT01915732|3604562|P2|Overall Study|Withdrawal by Subject|18
1101041|NCT01915732|3604563|P1|Overall Study|Withdrawal by Subject|18
1101042|NCT01914926|3604631|P2|Overall Study|uncooperative, agitated and removed|1
1101043|NCT01914926|3604632|P1|Overall Study|uncooperative, agitated and removed|0
1101044|NCT01914926|3604631|P2|Overall Study|Adverse Event|0
1101045|NCT01914926|3604632|P1|Overall Study|Adverse Event|1
1101046|NCT01914757|3604641|P3|Overall Study|Other reasons|4
1101047|NCT01914757|3604642|P2|Overall Study|Other reasons|9
1101048|NCT01914757|3604643|P1|Overall Study|Other reasons|5
1101049|NCT01914757|3604641|P3|Overall Study|Eligibility criteria not fulfilled|2
1101050|NCT01914757|3604642|P2|Overall Study|Eligibility criteria not fulfilled|0
1101051|NCT01914757|3604643|P1|Overall Study|Eligibility criteria not fulfilled|2
1101052|NCT01914757|3604641|P3|Overall Study|Study specific withdrawal criteria|0
1101053|NCT01914757|3604642|P2|Overall Study|Study specific withdrawal criteria|1
1101054|NCT01914757|3604643|P1|Overall Study|Study specific withdrawal criteria|0
1101055|NCT01914757|3604641|P3|Overall Study|Adverse Event|4
1101056|NCT01914757|3604642|P2|Overall Study|Adverse Event|3
1101057|NCT01914757|3604643|P1|Overall Study|Adverse Event|4
1101058|NCT01914757|3604641|P3|Overall Study|Death|1
1101059|NCT01914757|3604642|P2|Overall Study|Death|2
1101060|NCT01914757|3604643|P1|Overall Study|Death|2
1101061|NCT01914757|3604641|P3|Overall Study|Withdrawal by Subject|19
1101062|NCT01914757|3604642|P2|Overall Study|Withdrawal by Subject|27
1101063|NCT01914757|3604643|P1|Overall Study|Withdrawal by Subject|15
1101064|NCT01914757|3604641|P3|Overall Study|Lost to Follow-up|6
1101065|NCT01914757|3604642|P2|Overall Study|Lost to Follow-up|8
1101066|NCT01914757|3604643|P1|Overall Study|Lost to Follow-up|5
1101067|NCT01914757|3604641|P3|Overall Study|Severe non-compliance to protocol|2
1101068|NCT01914757|3604642|P2|Overall Study|Severe non-compliance to protocol|1
1101069|NCT01914757|3604643|P1|Overall Study|Severe non-compliance to protocol|3
1101070|NCT01914679|3604717|P1|Overall Study|Sponsor terminated study|4
1101071|NCT01914679|3604717|P1|Overall Study|Lack of Efficacy|1
1101072|NCT01914666|3604724|P3|Treatment Period|Physician Decision|2
1101073|NCT01914666|3604725|P2|Treatment Period|Physician Decision|0
1101074|NCT01914666|3604726|P1|Treatment Period|Physician Decision|0
1101075|NCT01914666|3604724|P3|Treatment Period|Withdrawal by Subject|2
1101076|NCT01914666|3604725|P2|Treatment Period|Withdrawal by Subject|2
1101077|NCT01914666|3604726|P1|Treatment Period|Withdrawal by Subject|3
1101078|NCT01914666|3604724|P3|Treatment Period|Adverse Event|2
1101079|NCT01914666|3604725|P2|Treatment Period|Adverse Event|4
1101080|NCT01914666|3604726|P1|Treatment Period|Adverse Event|10
1101081|NCT01914666|3604724|P3|Treatment Period|Lack of Efficacy|2
1101082|NCT01914666|3604725|P2|Treatment Period|Lack of Efficacy|0
1101083|NCT01914666|3604726|P1|Treatment Period|Lack of Efficacy|0
1101084|NCT01913483|3604848|P2|Overall Study|Death|17
1101085|NCT01913483|3604849|P1|Overall Study|Death|14
1101086|NCT01913483|3604848|P2|Overall Study|Lost to Follow-up|3
1101087|NCT01913483|3604849|P1|Overall Study|Lost to Follow-up|6
1101088|NCT01913483|3604848|P2|Overall Study|Withdrawal by Subject|2
1101089|NCT01913483|3604849|P1|Overall Study|Withdrawal by Subject|1
1101090|NCT01913470|3604861|P2|Overall Study|Withdrawal by Subject|1
1101091|NCT01913470|3604862|P1|Overall Study|Withdrawal by Subject|0
1101092|NCT01913470|3604861|P2|Overall Study|Physician Decision|1
1101093|NCT01913470|3604862|P1|Overall Study|Physician Decision|0
1101094|NCT01913470|3604861|P2|Overall Study|Lost to Follow-up|1
1101095|NCT01913470|3604862|P1|Overall Study|Lost to Follow-up|0
1101096|NCT01913405|3604880|P1|Overall Study|Adverse Event|1
1101097|NCT01913405|3604880|P1|Overall Study|Withdrawal by Subject|1
1101098|NCT01913041|3604947|P1|Overall Study|Physician Decision|1
1101099|NCT01913041|3604947|P1|Overall Study|Withdrawal by Subject|3
1101100|NCT01913041|3604947|P1|Overall Study|Protocol Violation|35
1101101|NCT01912963|3604954|P3|Overall Study|Sought treatment locally|0
1101102|NCT01912963|3604955|P2|Overall Study|Sought treatment locally|1
1101103|NCT01912963|3604956|P1|Overall Study|Sought treatment locally|0
1101104|NCT01912963|3604954|P3|Overall Study|Withdrawal by Subject|0
1101105|NCT01912963|3604955|P2|Overall Study|Withdrawal by Subject|1
1101106|NCT01912963|3604956|P1|Overall Study|Withdrawal by Subject|0
1101107|NCT01912963|3604954|P3|Overall Study|Adverse Event|1
1101108|NCT01912963|3604955|P2|Overall Study|Adverse Event|1
1101109|NCT01912963|3604956|P1|Overall Study|Adverse Event|0
1101110|NCT01912963|3604954|P3|Overall Study|Disease Progression (not RECIST1.1)|1
1101111|NCT01912963|3604955|P2|Overall Study|Disease Progression (not RECIST1.1)|7
1101112|NCT01912963|3604956|P1|Overall Study|Disease Progression (not RECIST1.1)|0
1101113|NCT01912963|3604954|P3|Overall Study|Disease Progression (RECIST1.1)|5
1101114|NCT01912963|3604955|P2|Overall Study|Disease Progression (RECIST1.1)|9
1101115|NCT01912963|3604956|P1|Overall Study|Disease Progression (RECIST1.1)|6
1101116|NCT01912781|3604977|P2|Overall Study|Withdrawal by Subject|0
1101117|NCT01912781|3604978|P1|Overall Study|Withdrawal by Subject|2
1101118|NCT01912768|3605009|P2|Overall Study|Randomized in error|0
1101119|NCT01912768|3605010|P1|Overall Study|Randomized in error|1
1101120|NCT01912768|3605009|P2|Overall Study|Withdrawal by Subject|3
1101121|NCT01912768|3605010|P1|Overall Study|Withdrawal by Subject|5
1101122|NCT01912768|3605009|P2|Overall Study|Lost to Follow-up|1
1101123|NCT01912768|3605010|P1|Overall Study|Lost to Follow-up|2
1101124|NCT01912768|3605009|P2|Overall Study|Adverse Event|0
1101125|NCT01912768|3605010|P1|Overall Study|Adverse Event|2
1101126|NCT01912729|3605041|P2|Overall Study|Withdrawal by Subject|1
1101127|NCT01912729|3605042|P1|Overall Study|Withdrawal by Subject|0
1101128|NCT01912599|3605054|P2|Overall Study|Withdrawal by Subject|1
1101129|NCT01912599|3605055|P1|Overall Study|Withdrawal by Subject|0
1101130|NCT01912404|3605080|P2|Overall Study|Due to personal reasons|0
1101131|NCT01912404|3605081|P1|Overall Study|Due to personal reasons|1
1101132|NCT01912339|3605094|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46
1101133|NCT01912339|3605095|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0
1101134|NCT01912339|3605096|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120
1101135|NCT01912339|3605094|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1
1101136|NCT01912339|3605095|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
1101137|NCT01912339|3605096|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
1101138|NCT01912339|3605094|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1
1101139|NCT01912339|3605095|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
1101140|NCT01912339|3605096|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
1101141|NCT01912339|3605094|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1
1101142|NCT01912339|3605095|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
1101143|NCT01912339|3605096|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
1101144|NCT01912339|3605094|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1
1101145|NCT01912339|3605095|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
1101146|NCT01912339|3605096|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
1101147|NCT01912339|3605094|P3|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
1101148|NCT01912339|3605095|P2|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
1101149|NCT01912339|3605096|P1|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1
1101150|NCT01912339|3605094|P3|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
1101151|NCT01912339|3605095|P2|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
1101152|NCT01912339|3605096|P1|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1
1101153|NCT01912339|3605094|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3
1101154|NCT01912339|3605095|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0
1101155|NCT01912339|3605096|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1
1101156|NCT01912339|3605094|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
1101157|NCT01912339|3605095|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
1101158|NCT01912339|3605096|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5
1101159|NCT01912339|3605094|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
1101160|NCT01912339|3605095|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
1101161|NCT01912339|3605096|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5
1101162|NCT01912339|3605094|P3|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
1101163|NCT01912339|3605095|P2|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
1101164|NCT01912339|3605096|P1|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1
1101165|NCT01912339|3605094|P3|Blinded (0 to 3 Months)|Open Prostatectomy|0
1101166|NCT01912339|3605095|P2|Blinded (0 to 3 Months)|Open Prostatectomy|0
1101167|NCT01912339|3605096|P1|Blinded (0 to 3 Months)|Open Prostatectomy|1
1101168|NCT01912339|3605094|P3|Blinded (0 to 3 Months)|Declined to participate|0
1101169|NCT01912339|3605095|P2|Blinded (0 to 3 Months)|Declined to participate|0
1101170|NCT01912339|3605096|P1|Blinded (0 to 3 Months)|Declined to participate|1
1101171|NCT01912222|3605113|P3|Part B: Treatment Period|Withdrawal by Subject|2
1101172|NCT01912222|3605114|P2|Part B: Treatment Period|Withdrawal by Subject|1
1101173|NCT01912222|3605115|P1|Part B: Treatment Period|Withdrawal by Subject|2
1101174|NCT01912222|3605113|P3|Part B: Treatment Period|Adverse Event|3
1101175|NCT01912222|3605114|P2|Part B: Treatment Period|Adverse Event|2
1101176|NCT01912222|3605115|P1|Part B: Treatment Period|Adverse Event|1
1101177|NCT01912222|3605113|P3|Part B: Treatment Period|Progressive disease|15
1101178|NCT01912222|3605114|P2|Part B: Treatment Period|Progressive disease|12
1101179|NCT01912222|3605115|P1|Part B: Treatment Period|Progressive disease|10
1101180|NCT01912222|3605113|P3|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
1101181|NCT01912222|3605114|P2|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
1101182|NCT01912222|3605115|P1|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1
1101183|NCT01911845|3605138|P1|Overall Study|Other (not specified)|3
1101184|NCT01911845|3605138|P1|Overall Study|Lost to Follow-up|1
1101185|NCT01911845|3605138|P1|Overall Study|Adverse Event|2
1101186|NCT01911819|3605155|P3|Overall Study|Withdrawal by Subject|0
1101187|NCT01911819|3605156|P2|Overall Study|Withdrawal by Subject|1
1101188|NCT01911819|3605157|P1|Overall Study|Withdrawal by Subject|1
1101189|NCT01911819|3605155|P3|Overall Study|Adverse Event|0
1101190|NCT01911819|3605156|P2|Overall Study|Adverse Event|1
1101191|NCT01911819|3605157|P1|Overall Study|Adverse Event|0
1101192|NCT01911793|3605170|P2|Overall Study|Physician Decision|5
1101193|NCT01911793|3605171|P1|Overall Study|Physician Decision|1
1101194|NCT01911780|3605195|P2|Extension Period (52 Weeks)|Personal reason|1
1101195|NCT01911780|3605196|P1|Extension Period (52 Weeks)|Personal reason|1
1101196|NCT01911780|3605195|P2|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2
1101197|NCT01911780|3605196|P1|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0
1101198|NCT01911780|3605195|P2|Extension Period (52 Weeks)|Adverse Event|0
1101199|NCT01911780|3605196|P1|Extension Period (52 Weeks)|Adverse Event|3
1101200|NCT01911780|3605195|P2|Double-blind Period (8 Weeks)|Personal reason|0
1101201|NCT01911780|3605196|P1|Double-blind Period (8 Weeks)|Personal reason|1
1101202|NCT01911780|3605195|P2|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
1101203|NCT01911780|3605196|P1|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
1101204|NCT01911780|3605195|P2|Double-blind Period (8 Weeks)|Adverse Event|2
1101205|NCT01911780|3605196|P1|Double-blind Period (8 Weeks)|Adverse Event|1
1101206|NCT01911546|3605230|P1|Overall Study|Everolimus was discontinued|5
1101207|NCT01911546|3605230|P1|Overall Study|Lost to Follow-up|1
1101208|NCT01911442|3605240|P3|Overall Study|Mother's Work Schedule|0
1101209|NCT01911442|3605241|P2|Overall Study|Mother's Work Schedule|1
1101210|NCT01911442|3605242|P1|Overall Study|Mother's Work Schedule|0
1101211|NCT01911442|3605240|P3|Overall Study|Withdrawal by Subject|6
1101212|NCT01911442|3605241|P2|Overall Study|Withdrawal by Subject|0
1101213|NCT01911442|3605242|P1|Overall Study|Withdrawal by Subject|1
1101214|NCT01911442|3605240|P3|Overall Study|Lost to Follow-up|1
1101215|NCT01911442|3605241|P2|Overall Study|Lost to Follow-up|0
1101216|NCT01911442|3605242|P1|Overall Study|Lost to Follow-up|2
1101217|NCT01911442|3605240|P3|Overall Study|Lack of Efficacy|1
1101218|NCT01911442|3605241|P2|Overall Study|Lack of Efficacy|1
1101219|NCT01911442|3605242|P1|Overall Study|Lack of Efficacy|1
1101220|NCT01911442|3605240|P3|Overall Study|Adverse Event|4
1101221|NCT01911442|3605241|P2|Overall Study|Adverse Event|2
1101222|NCT01911442|3605242|P1|Overall Study|Adverse Event|2
1101223|NCT01911429|3605271|P3|Overall Study|subject left study|0
1101224|NCT01911429|3605272|P2|Overall Study|subject left study|0
1101225|NCT01911429|3605273|P1|Overall Study|subject left study|1
1101226|NCT01911429|3605271|P3|Overall Study|Accidental randomization|1
1101227|NCT01911429|3605272|P2|Overall Study|Accidental randomization|0
1101228|NCT01911429|3605273|P1|Overall Study|Accidental randomization|0
1101229|NCT01911429|3605271|P3|Overall Study|Withdrawal by Subject|4
1101230|NCT01911429|3605272|P2|Overall Study|Withdrawal by Subject|5
1101231|NCT01911429|3605273|P1|Overall Study|Withdrawal by Subject|5
1101232|NCT01911429|3605271|P3|Overall Study|Protocol Violation|1
1101233|NCT01911429|3605272|P2|Overall Study|Protocol Violation|0
1101234|NCT01911429|3605273|P1|Overall Study|Protocol Violation|0
1101235|NCT01911429|3605271|P3|Overall Study|Lost to Follow-up|1
1101236|NCT01911429|3605272|P2|Overall Study|Lost to Follow-up|0
1101237|NCT01911429|3605273|P1|Overall Study|Lost to Follow-up|0
1101238|NCT01911429|3605271|P3|Overall Study|Lack of Efficacy|4
1101239|NCT01911429|3605272|P2|Overall Study|Lack of Efficacy|2
1101240|NCT01911429|3605273|P1|Overall Study|Lack of Efficacy|1
1101241|NCT01911429|3605271|P3|Overall Study|Adverse Event|9
1101242|NCT01911429|3605272|P2|Overall Study|Adverse Event|3
1101243|NCT01911429|3605273|P1|Overall Study|Adverse Event|5
1101244|NCT01911273|3605365|P2|Overall Study|Withdrawal by Subject|2
1101245|NCT01911273|3605366|P1|Overall Study|Withdrawal by Subject|0
1101246|NCT01911273|3605365|P2|Overall Study|Progression of Disease|0
1101247|NCT01911273|3605366|P1|Overall Study|Progression of Disease|1
1101248|NCT01911260|3605400|P4|Follow-up Period|transference or evasion of school|12
1101249|NCT01911260|3605401|P3|Follow-up Period|transference or evasion of school|15
1101250|NCT01911260|3605402|P2|Follow-up Period|transference or evasion of school|20
1101251|NCT01911260|3605403|P1|Follow-up Period|transference or evasion of school|13
1101252|NCT01911260|3605400|P4|Supplementation Period|less than 12 weeks supplementation|2
1101253|NCT01911260|3605401|P3|Supplementation Period|less than 12 weeks supplementation|1
1101254|NCT01911260|3605402|P2|Supplementation Period|less than 12 weeks supplementation|3
1101255|NCT01911260|3605403|P1|Supplementation Period|less than 12 weeks supplementation|0
1101256|NCT01911260|3605400|P4|Supplementation Period|refused to receive supplement|0
1101257|NCT01911260|3605401|P3|Supplementation Period|refused to receive supplement|1
1101258|NCT01911260|3605402|P2|Supplementation Period|refused to receive supplement|0
1101259|NCT01911260|3605403|P1|Supplementation Period|refused to receive supplement|1
1101260|NCT01911260|3605400|P4|Supplementation Period|Adverse Event|0
1101261|NCT01911260|3605401|P3|Supplementation Period|Adverse Event|1
1101262|NCT01911260|3605402|P2|Supplementation Period|Adverse Event|0
1101263|NCT01911260|3605403|P1|Supplementation Period|Adverse Event|2
1101264|NCT01911260|3605400|P4|Supplementation Period|transference or evasion of school|6
1101265|NCT01911260|3605401|P3|Supplementation Period|transference or evasion of school|7
1101266|NCT01911260|3605402|P2|Supplementation Period|transference or evasion of school|9
1101267|NCT01911260|3605403|P1|Supplementation Period|transference or evasion of school|7
1101268|NCT01910441|3605489|P2|Overall Study|Physician Decision|1
1101269|NCT01910441|3605490|P1|Overall Study|Physician Decision|0
1101270|NCT01910441|3605489|P2|Overall Study|Adverse Event|0
1101271|NCT01910441|3605490|P1|Overall Study|Adverse Event|1
1101272|NCT01910441|3605489|P2|Overall Study|Non-compliance|1
1101273|NCT01910441|3605490|P1|Overall Study|Non-compliance|0
1101274|NCT01910441|3605489|P2|Overall Study|Withdrawal by Subject|1
1101275|NCT01910441|3605490|P1|Overall Study|Withdrawal by Subject|0
1101276|NCT01910441|3605489|P2|Overall Study|Lost to Follow-up|5
1101277|NCT01910441|3605490|P1|Overall Study|Lost to Follow-up|6
1101278|NCT01910441|3605489|P2|Overall Study|Sponsor decision|2
1101279|NCT01910441|3605490|P1|Overall Study|Sponsor decision|0
1101280|NCT01910402|3605498|P2|Continuation Phase|Withdrawal by Subject|0
1101281|NCT01910402|3605499|P1|Continuation Phase|Withdrawal by Subject|2
1101282|NCT01910402|3605498|P2|Continuation Phase|Protocol Violation|0
1101283|NCT01910402|3605499|P1|Continuation Phase|Protocol Violation|3
1101284|NCT01910402|3605498|P2|Continuation Phase|Adverse Event|0
1101285|NCT01910402|3605499|P1|Continuation Phase|Adverse Event|1
1101286|NCT01910402|3605498|P2|Continuation Phase|Ongoing|0
1101287|NCT01910402|3605499|P1|Continuation Phase|Ongoing|84
1101288|NCT01910402|3605498|P2|Randomized Phase|Withdrawal by Subject|7
1101289|NCT01910402|3605499|P1|Randomized Phase|Withdrawal by Subject|5
1101290|NCT01910402|3605498|P2|Randomized Phase|Protocol Violation|13
1101291|NCT01910402|3605499|P1|Randomized Phase|Protocol Violation|10
1101292|NCT01910402|3605498|P2|Randomized Phase|Lost to Follow-up|13
1101293|NCT01910402|3605499|P1|Randomized Phase|Lost to Follow-up|11
1101294|NCT01910402|3605498|P2|Randomized Phase|Lack of Efficacy|4
1101295|NCT01910402|3605499|P1|Randomized Phase|Lack of Efficacy|5
1101296|NCT01910402|3605498|P2|Randomized Phase|Physician Decision|0
1101297|NCT01910402|3605499|P1|Randomized Phase|Physician Decision|1
1101298|NCT01910402|3605498|P2|Randomized Phase|Adverse Event|18
1101299|NCT01910402|3605499|P1|Randomized Phase|Adverse Event|10
1101300|NCT01910389|3605569|P2|Overall Study|Study Closed|8
1101301|NCT01910389|3605570|P1|Overall Study|Study Closed|13
1101302|NCT01910389|3605569|P2|Overall Study|Withdrawal by Subject|0
1101303|NCT01910389|3605570|P1|Overall Study|Withdrawal by Subject|2
1101304|NCT01910181|3605611|P1|Overall Study|Alive in Follow-Up|12
1101305|NCT01910181|3605611|P1|Overall Study|Alive on Treatment|14
1101306|NCT01910181|3605611|P1|Overall Study|Death|20
1101307|NCT01910116|3605638|P2|Overall Study|incomplete data|1
1101308|NCT01910116|3605639|P1|Overall Study|incomplete data|0
1101309|NCT01910116|3605638|P2|Overall Study|uncertain allocation|3
1101310|NCT01910116|3605639|P1|Overall Study|uncertain allocation|1
1101311|NCT01910116|3605638|P2|Overall Study|Withdrawal by Subject|3
1101312|NCT01910116|3605639|P1|Overall Study|Withdrawal by Subject|8
1101313|NCT01910116|3605638|P2|Overall Study|Protocol Violation|2
1101314|NCT01910116|3605639|P1|Overall Study|Protocol Violation|1
1101315|NCT01910116|3605638|P2|Overall Study|Lost to Follow-up|0
1101316|NCT01910116|3605639|P1|Overall Study|Lost to Follow-up|1
1101317|NCT01910116|3605638|P2|Overall Study|Lack of Efficacy|4
1101318|NCT01910116|3605639|P1|Overall Study|Lack of Efficacy|3
1101319|NCT01910116|3605638|P2|Overall Study|Adverse Event|3
1101320|NCT01910116|3605639|P1|Overall Study|Adverse Event|0
1101321|NCT01909804|3605736|P12|Overall Study|Protocol Violation|1
1101322|NCT01909804|3605737|P11|Overall Study|Protocol Violation|0
1101323|NCT01909804|3605738|P10|Overall Study|Protocol Violation|0
1101324|NCT01909804|3605739|P9|Overall Study|Protocol Violation|0
1101325|NCT01909804|3605740|P8|Overall Study|Protocol Violation|0
1101326|NCT01909804|3605741|P7|Overall Study|Protocol Violation|0
1101327|NCT01909804|3605742|P6|Overall Study|Protocol Violation|0
1101328|NCT01909804|3605743|P5|Overall Study|Protocol Violation|0
1101329|NCT01909804|3605744|P4|Overall Study|Protocol Violation|0
1101330|NCT01909804|3605745|P3|Overall Study|Protocol Violation|0
1101331|NCT01909804|3605746|P2|Overall Study|Protocol Violation|0
1101332|NCT01909804|3605747|P1|Overall Study|Protocol Violation|0
1101333|NCT01909804|3605736|P12|Overall Study|Withdrew Consent|0
1101334|NCT01909804|3605737|P11|Overall Study|Withdrew Consent|0
1101335|NCT01909804|3605738|P10|Overall Study|Withdrew Consent|0
1101336|NCT01909804|3605739|P9|Overall Study|Withdrew Consent|0
1101337|NCT01909804|3605740|P8|Overall Study|Withdrew Consent|0
1101338|NCT01909804|3605741|P7|Overall Study|Withdrew Consent|0
1101339|NCT01909804|3605742|P6|Overall Study|Withdrew Consent|1
1101340|NCT01909804|3605743|P5|Overall Study|Withdrew Consent|1
1101341|NCT01909804|3605744|P4|Overall Study|Withdrew Consent|0
1101342|NCT01909804|3605745|P3|Overall Study|Withdrew Consent|0
1101343|NCT01909804|3605746|P2|Overall Study|Withdrew Consent|0
1101344|NCT01909804|3605747|P1|Overall Study|Withdrew Consent|0
1101345|NCT01909804|3605736|P12|Overall Study|Lack of Efficacy|1
1101346|NCT01909804|3605737|P11|Overall Study|Lack of Efficacy|0
1101347|NCT01909804|3605738|P10|Overall Study|Lack of Efficacy|1
1101348|NCT01909804|3605739|P9|Overall Study|Lack of Efficacy|0
1101349|NCT01909804|3605740|P8|Overall Study|Lack of Efficacy|1
1101350|NCT01909804|3605741|P7|Overall Study|Lack of Efficacy|1
1101351|NCT01909804|3605742|P6|Overall Study|Lack of Efficacy|3
1101352|NCT01909804|3605743|P5|Overall Study|Lack of Efficacy|7
1101353|NCT01909804|3605744|P4|Overall Study|Lack of Efficacy|0
1101354|NCT01909804|3605745|P3|Overall Study|Lack of Efficacy|0
1101355|NCT01909804|3605746|P2|Overall Study|Lack of Efficacy|1
1101356|NCT01909804|3605747|P1|Overall Study|Lack of Efficacy|4
1101357|NCT01909804|3605736|P12|Overall Study|Death|0
1101358|NCT01909804|3605737|P11|Overall Study|Death|1
1101359|NCT01909804|3605738|P10|Overall Study|Death|0
1101360|NCT01909804|3605739|P9|Overall Study|Death|0
1101361|NCT01909804|3605740|P8|Overall Study|Death|0
1101362|NCT01909804|3605741|P7|Overall Study|Death|0
1101363|NCT01909804|3605742|P6|Overall Study|Death|0
1101364|NCT01909804|3605743|P5|Overall Study|Death|0
1101365|NCT01909804|3605744|P4|Overall Study|Death|0
1101366|NCT01909804|3605745|P3|Overall Study|Death|0
1101367|NCT01909804|3605746|P2|Overall Study|Death|0
1101368|NCT01909804|3605747|P1|Overall Study|Death|0
1101369|NCT01909804|3605736|P12|Overall Study|Randomized but Never Treated|1
1101370|NCT01909804|3605737|P11|Overall Study|Randomized but Never Treated|0
1101371|NCT01909804|3605738|P10|Overall Study|Randomized but Never Treated|0
1101372|NCT01909804|3605739|P9|Overall Study|Randomized but Never Treated|0
1101373|NCT01909804|3605740|P8|Overall Study|Randomized but Never Treated|0
1101374|NCT01909804|3605741|P7|Overall Study|Randomized but Never Treated|1
1101375|NCT01909804|3605742|P6|Overall Study|Randomized but Never Treated|0
1101376|NCT01909804|3605743|P5|Overall Study|Randomized but Never Treated|0
1101377|NCT01909804|3605744|P4|Overall Study|Randomized but Never Treated|0
1101378|NCT01909804|3605745|P3|Overall Study|Randomized but Never Treated|0
1101379|NCT01909804|3605746|P2|Overall Study|Randomized but Never Treated|0
1101380|NCT01909804|3605747|P1|Overall Study|Randomized but Never Treated|0
1101381|NCT01909778|3605793|P1|Overall Study|failed screening|1
1101382|NCT01909674|3605872|P2|Overall Study|Withdrawal by Subject|2
1101383|NCT01909674|3605873|P1|Overall Study|Withdrawal by Subject|5
1101384|NCT01909466|3605892|P2|Overall Study|Lack of Efficacy|0
1101385|NCT01909466|3605893|P1|Overall Study|Lack of Efficacy|1
1101386|NCT01909466|3605892|P2|Overall Study|Withdrawal by Subject|9
1101387|NCT01909466|3605893|P1|Overall Study|Withdrawal by Subject|11
1101388|NCT01909466|3605892|P2|Overall Study|Physician Decision|0
1101389|NCT01909466|3605893|P1|Overall Study|Physician Decision|2
1101390|NCT01909466|3605892|P2|Overall Study|Met Withdrawal Criteria|3
1101391|NCT01909466|3605893|P1|Overall Study|Met Withdrawal Criteria|0
1101392|NCT01909466|3605892|P2|Overall Study|Adverse Event|4
1101393|NCT01909466|3605893|P1|Overall Study|Adverse Event|3
1101394|NCT01909466|3605892|P2|Overall Study|Lost to Follow-up|7
1101395|NCT01909466|3605893|P1|Overall Study|Lost to Follow-up|5
1101396|NCT01909336|3605916|P3|Overall Study|Physician Decision|1
1101397|NCT01909336|3605917|P2|Overall Study|Physician Decision|1
1101398|NCT01909336|3605918|P1|Overall Study|Physician Decision|0
1101399|NCT01909336|3605916|P3|Overall Study|Lost to Follow-up|2
1101400|NCT01909336|3605917|P2|Overall Study|Lost to Follow-up|2
1101401|NCT01909336|3605918|P1|Overall Study|Lost to Follow-up|4
1101402|NCT01908907|3606007|P2|Overall Study|Protocol Violation|0
1101403|NCT01908907|3606008|P1|Overall Study|Protocol Violation|1
1101404|NCT01908907|3606007|P2|Overall Study|Physician Decision|0
1101405|NCT01908907|3606008|P1|Overall Study|Physician Decision|1
1101406|NCT01908829|3606052|P3|Overall Study|Withdrawal by Subject|22
1101407|NCT01908829|3606053|P2|Overall Study|Withdrawal by Subject|29
1101408|NCT01908829|3606054|P1|Overall Study|Withdrawal by Subject|26
1101409|NCT01908829|3606052|P3|Overall Study|Lack of Efficacy|2
1101410|NCT01908829|3606053|P2|Overall Study|Lack of Efficacy|3
1101411|NCT01908829|3606054|P1|Overall Study|Lack of Efficacy|1
1101412|NCT01908829|3606052|P3|Overall Study|Protocol Violation|0
1101413|NCT01908829|3606053|P2|Overall Study|Protocol Violation|2
1101414|NCT01908829|3606054|P1|Overall Study|Protocol Violation|2
1101415|NCT01908829|3606052|P3|Overall Study|Miscellaneous|0
1101416|NCT01908829|3606053|P2|Overall Study|Miscellaneous|2
1101417|NCT01908829|3606054|P1|Overall Study|Miscellaneous|0
1101418|NCT01908829|3606052|P3|Overall Study|Discontinued (no EoT page)|0
1101419|NCT01908829|3606053|P2|Overall Study|Discontinued (no EoT page)|0
1101420|NCT01908829|3606054|P1|Overall Study|Discontinued (no EoT page)|2
1101421|NCT01908829|3606052|P3|Overall Study|Randomized no double-blind drug received|1
1101422|NCT01908829|3606053|P2|Overall Study|Randomized no double-blind drug received|0
1101423|NCT01908829|3606054|P1|Overall Study|Randomized no double-blind drug received|1
1101424|NCT01908829|3606052|P3|Overall Study|Lost to Follow-up|1
1101425|NCT01908829|3606053|P2|Overall Study|Lost to Follow-up|2
1101426|NCT01908829|3606054|P1|Overall Study|Lost to Follow-up|4
1101427|NCT01908829|3606052|P3|Overall Study|Adverse Event|13
1101428|NCT01908829|3606053|P2|Overall Study|Adverse Event|11
1101429|NCT01908829|3606054|P1|Overall Study|Adverse Event|13
1101430|NCT01908803|3606169|P2|Overall Study|Adverse Event (pre-treatment)|0
1101431|NCT01908803|3606170|P1|Overall Study|Adverse Event (pre-treatment)|1
1101432|NCT01908803|3606169|P2|Overall Study|Randomization Error|0
1101433|NCT01908803|3606170|P1|Overall Study|Randomization Error|1
1101434|NCT01908803|3606169|P2|Overall Study|Withdrawal by Subject|0
1101435|NCT01908803|3606170|P1|Overall Study|Withdrawal by Subject|1
1101436|NCT01908803|3606169|P2|Overall Study|Physician Decision|1
1101437|NCT01908803|3606170|P1|Overall Study|Physician Decision|0
1101438|NCT01908803|3606169|P2|Overall Study|Adverse Event|0
1101439|NCT01908803|3606170|P1|Overall Study|Adverse Event|1
1101440|NCT01908582|3606181|P1|Period 2|Withdrawal by Subject|1
1101441|NCT01908582|3606181|P1|Period 2|Physician Decision|1
1101442|NCT01908140|3606194|P2|Overall Study|Adverse Event|23
1101443|NCT01908140|3606195|P1|Overall Study|Adverse Event|22
1101444|NCT01908140|3606194|P2|Overall Study|Protocol Violation|9
1101445|NCT01908140|3606195|P1|Overall Study|Protocol Violation|8
1101446|NCT01908140|3606194|P2|Overall Study|Lost to Follow-up|6
1101447|NCT01908140|3606195|P1|Overall Study|Lost to Follow-up|1
1101448|NCT01908140|3606194|P2|Overall Study|Withdrawal by Subject|24
1101449|NCT01908140|3606195|P1|Overall Study|Withdrawal by Subject|23
1101450|NCT01908140|3606194|P2|Overall Study|Lack of Efficacy|5
1101451|NCT01908140|3606195|P1|Overall Study|Lack of Efficacy|7
1101452|NCT01908140|3606194|P2|Overall Study|Other or Progressive Disease|12
1101453|NCT01908140|3606195|P1|Overall Study|Other or Progressive Disease|5
1101454|NCT01907906|3606216|P2|Overall Study|Physician Decision|1
1101455|NCT01907906|3606217|P1|Overall Study|Physician Decision|3
1101456|NCT01907906|3606216|P2|Overall Study|Withdrawal by Subject|0
1101457|NCT01907906|3606217|P1|Overall Study|Withdrawal by Subject|1
1101458|NCT01907854|3606297|P2|Overall Study|Unclassified|3
1101459|NCT01907854|3606298|P1|Overall Study|Unclassified|4
1101460|NCT01907854|3606297|P2|Overall Study|Lost to Follow-up|2
1101461|NCT01907854|3606298|P1|Overall Study|Lost to Follow-up|2
1101462|NCT01907854|3606297|P2|Overall Study|Withdrawal by Subject|7
1101463|NCT01907854|3606298|P1|Overall Study|Withdrawal by Subject|9
1101464|NCT01907854|3606297|P2|Overall Study|Protocol Violation|1
1101465|NCT01907854|3606298|P1|Overall Study|Protocol Violation|1
1101466|NCT01907815|3606318|P2|Overall Study|Withdrawal by Subject|0
1101467|NCT01907815|3606319|P1|Overall Study|Withdrawal by Subject|1
1101468|NCT01907516|3606335|P2|First Intervention (3 Weeks)|Developed DKA during study|0
1101469|NCT01907516|3606336|P1|First Intervention (3 Weeks)|Developed DKA during study|1
1101470|NCT01907516|3606335|P2|First Intervention (3 Weeks)|Delivered before second arm|4
1101471|NCT01907516|3606336|P1|First Intervention (3 Weeks)|Delivered before second arm|3
1101472|NCT01907516|3606335|P2|First Intervention (3 Weeks)|Lost to Follow-up|3
1101473|NCT01907516|3606336|P1|First Intervention (3 Weeks)|Lost to Follow-up|1
1101474|NCT01907516|3606335|P2|First Intervention (3 Weeks)|Withdrawal by Subject|9
1101475|NCT01907516|3606336|P1|First Intervention (3 Weeks)|Withdrawal by Subject|5
1101476|NCT01907217|3606377|P2|Overall Study|Withdrawal by Subject|2
1101477|NCT01907217|3606378|P1|Overall Study|Withdrawal by Subject|0
1101478|NCT01907087|3606486|P1|Overall Study|Withdrawal by Subject|1
1101479|NCT01906372|3606547|P1|Overall Study|Withdrawal by Subject|2
1101480|NCT01905943|3606577|P1|Overall Study|Ongoing in study|777
1101481|NCT01905943|3606577|P1|Overall Study|Adverse Event|10
1101482|NCT01905943|3606577|P1|Overall Study|Death|105
1101483|NCT01905943|3606577|P1|Overall Study|Investigator discretion|4
1101484|NCT01905943|3606577|P1|Overall Study|Lost to Follow-up|9
1101485|NCT01905943|3606577|P1|Overall Study|Disease progression|2
1101486|NCT01905943|3606577|P1|Overall Study|Renal cell carcinoma|1
1101487|NCT01905943|3606577|P1|Overall Study|Moved away from site|1
1101488|NCT01905943|3606577|P1|Overall Study|Withdrawal of consent|63
1101489|NCT01905683|3606694|P1|Overall Study|Lost to Follow-up|4
1101490|NCT01905683|3606694|P1|Overall Study|Adverse Event|4
1101491|NCT01905683|3606694|P1|Overall Study|Withdrawal by Subject|20
1101492|NCT01905683|3606694|P1|Overall Study|Lack of Efficacy|8
1101493|NCT01905683|3606694|P1|Overall Study|Physician Decision|1
1101494|NCT01905683|3606694|P1|Overall Study|Re-injection criteria not met; others|13
1101495|NCT01905683|3606694|P1|Overall Study|Protocol Violation|1
1101496|NCT01905657|3606710|P3|Overall Study|Excluded from Efficacy Analysis|0
1101497|NCT01905657|3606711|P2|Overall Study|Excluded from Efficacy Analysis|0
1101498|NCT01905657|3606712|P1|Overall Study|Excluded from Efficacy Analysis|1
1101499|NCT01905657|3606710|P3|Overall Study|Continuing in Study|11
1101500|NCT01905657|3606711|P2|Overall Study|Continuing in Study|74
1101501|NCT01905657|3606712|P1|Overall Study|Continuing in Study|74
1101502|NCT01905657|3606710|P3|Overall Study|Withdrawal by Subject|45
1101503|NCT01905657|3606711|P2|Overall Study|Withdrawal by Subject|10
1101504|NCT01905657|3606712|P1|Overall Study|Withdrawal by Subject|5
1101505|NCT01905657|3606710|P3|Overall Study|Protocol Violation|1
1101506|NCT01905657|3606711|P2|Overall Study|Protocol Violation|1
1101507|NCT01905657|3606712|P1|Overall Study|Protocol Violation|2
1101508|NCT01905657|3606710|P3|Overall Study|Progressive Disease|89
1101509|NCT01905657|3606711|P2|Overall Study|Progressive Disease|126
1101510|NCT01905657|3606712|P1|Overall Study|Progressive Disease|124
1101511|NCT01905657|3606710|P3|Overall Study|Physician Decision|113
1101512|NCT01905657|3606711|P2|Overall Study|Physician Decision|74
1101513|NCT01905657|3606712|P1|Overall Study|Physician Decision|82
1101514|NCT01905657|3606710|P3|Overall Study|Other|1
1101515|NCT01905657|3606711|P2|Overall Study|Other|7
1101516|NCT01905657|3606712|P1|Overall Study|Other|3
1101517|NCT01905657|3606710|P3|Overall Study|Death|21
1101518|NCT01905657|3606711|P2|Overall Study|Death|21
1101519|NCT01905657|3606712|P1|Overall Study|Death|21
1101520|NCT01905657|3606710|P3|Overall Study|Adverse Event|47
1101521|NCT01905657|3606711|P2|Overall Study|Adverse Event|32
1101522|NCT01905657|3606712|P1|Overall Study|Adverse Event|33
1101523|NCT01905657|3606710|P3|Overall Study|Not Treated|0
1101524|NCT01905657|3606711|P2|Overall Study|Not Treated|1
1101525|NCT01905657|3606712|P1|Overall Study|Not Treated|0
1101526|NCT01905553|3606737|P2|Period 2|Adverse Event|0
1101527|NCT01905553|3606738|P1|Period 2|Adverse Event|1
1101528|NCT01905540|3606752|P4|Period 3|Not specified|1
1101529|NCT01905540|3606753|P3|Period 3|Not specified|1
1101530|NCT01905540|3606754|P2|Period 3|Not specified|0
1101531|NCT01905540|3606755|P1|Period 3|Not specified|1
1101532|NCT01905267|3606790|P2|Overall Study|Physician Decision|2
1101533|NCT01905267|3606791|P1|Overall Study|Physician Decision|2
1101534|NCT01904773|3606812|P9|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
1101535|NCT01904773|3606813|P8|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
1101536|NCT01904773|3606814|P7|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
1101537|NCT01904773|3606815|P6|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
1101538|NCT01904773|3606816|P5|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
1101539|NCT01904773|3606817|P4|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
1101540|NCT01904773|3606818|P3|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
1101541|NCT01904773|3606819|P2|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1
1101542|NCT01904773|3606820|P1|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
1101543|NCT01904773|3606812|P9|Fifth Intervention|Adverse Event|0
1101544|NCT01904773|3606813|P8|Fifth Intervention|Adverse Event|1
1101545|NCT01904773|3606814|P7|Fifth Intervention|Adverse Event|0
1101546|NCT01904773|3606815|P6|Fifth Intervention|Adverse Event|0
1101547|NCT01904773|3606816|P5|Fifth Intervention|Adverse Event|0
1101548|NCT01904773|3606817|P4|Fifth Intervention|Adverse Event|0
1101549|NCT01904773|3606818|P3|Fifth Intervention|Adverse Event|0
1101550|NCT01904773|3606819|P2|Fifth Intervention|Adverse Event|0
1101551|NCT01904773|3606820|P1|Fifth Intervention|Adverse Event|0
1101552|NCT01904773|3606812|P9|Placebo Washout First Intervention|Condition worsened|0
1101553|NCT01904773|3606813|P8|Placebo Washout First Intervention|Condition worsened|0
1101554|NCT01904773|3606814|P7|Placebo Washout First Intervention|Condition worsened|0
1101555|NCT01904773|3606815|P6|Placebo Washout First Intervention|Condition worsened|0
1101556|NCT01904773|3606816|P5|Placebo Washout First Intervention|Condition worsened|0
1101557|NCT01904773|3606817|P4|Placebo Washout First Intervention|Condition worsened|0
1101558|NCT01904773|3606818|P3|Placebo Washout First Intervention|Condition worsened|0
1101559|NCT01904773|3606819|P2|Placebo Washout First Intervention|Condition worsened|1
1101560|NCT01904773|3606820|P1|Placebo Washout First Intervention|Condition worsened|0
1101561|NCT01904773|3606812|P9|First Intervention|Adverse Event|0
1101562|NCT01904773|3606813|P8|First Intervention|Adverse Event|0
1101563|NCT01904773|3606814|P7|First Intervention|Adverse Event|1
1101564|NCT01904773|3606815|P6|First Intervention|Adverse Event|0
1101565|NCT01904773|3606816|P5|First Intervention|Adverse Event|0
1101566|NCT01904773|3606817|P4|First Intervention|Adverse Event|0
1101567|NCT01904773|3606818|P3|First Intervention|Adverse Event|0
1101568|NCT01904773|3606819|P2|First Intervention|Adverse Event|0
1101569|NCT01904773|3606820|P1|First Intervention|Adverse Event|0
1101570|NCT01904773|3606812|P9|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
1101571|NCT01904773|3606813|P8|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
1101572|NCT01904773|3606814|P7|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
1101573|NCT01904773|3606815|P6|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
1101574|NCT01904773|3606816|P5|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
1101575|NCT01904773|3606817|P4|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
1101576|NCT01904773|3606818|P3|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
1101577|NCT01904773|3606819|P2|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
1101578|NCT01904773|3606820|P1|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1
1101579|NCT01904773|3606812|P9|Screen|Withdrawal by Subject|0
1101580|NCT01904773|3606813|P8|Screen|Withdrawal by Subject|0
1101581|NCT01904773|3606814|P7|Screen|Withdrawal by Subject|0
1101582|NCT01904773|3606815|P6|Screen|Withdrawal by Subject|0
1101583|NCT01904773|3606816|P5|Screen|Withdrawal by Subject|0
1101584|NCT01904773|3606817|P4|Screen|Withdrawal by Subject|0
1101585|NCT01904773|3606818|P3|Screen|Withdrawal by Subject|0
1101586|NCT01904773|3606819|P2|Screen|Withdrawal by Subject|0
1101587|NCT01904773|3606820|P1|Screen|Withdrawal by Subject|1
1101588|NCT01904773|3606812|P9|Screen|Screen failure|0
1101589|NCT01904773|3606813|P8|Screen|Screen failure|0
1101590|NCT01904773|3606814|P7|Screen|Screen failure|0
1101591|NCT01904773|3606815|P6|Screen|Screen failure|0
1101592|NCT01904773|3606816|P5|Screen|Screen failure|0
1101593|NCT01904773|3606817|P4|Screen|Screen failure|0
1101594|NCT01904773|3606818|P3|Screen|Screen failure|0
1101595|NCT01904773|3606819|P2|Screen|Screen failure|0
1101596|NCT01904773|3606820|P1|Screen|Screen failure|3
1101597|NCT01904760|3606837|P2|Overall Study|Protocol Violation|0
1101598|NCT01904760|3606838|P1|Overall Study|Protocol Violation|1
1101599|NCT01904721|3606853|P7|Overall Study|Adverse Event|0
1101600|NCT01904721|3606854|P6|Overall Study|Adverse Event|1
1101601|NCT01904721|3606855|P5|Overall Study|Adverse Event|3
1101602|NCT01904721|3606856|P4|Overall Study|Adverse Event|0
1101603|NCT01904721|3606857|P3|Overall Study|Adverse Event|0
1101604|NCT01904721|3606858|P2|Overall Study|Adverse Event|0
1101605|NCT01904721|3606859|P1|Overall Study|Adverse Event|0
1101606|NCT01904721|3606853|P7|Overall Study|Lack of Efficacy|1
1101607|NCT01904721|3606854|P6|Overall Study|Lack of Efficacy|0
1101608|NCT01904721|3606855|P5|Overall Study|Lack of Efficacy|0
1101609|NCT01904721|3606856|P4|Overall Study|Lack of Efficacy|0
1101610|NCT01904721|3606857|P3|Overall Study|Lack of Efficacy|0
1101611|NCT01904721|3606858|P2|Overall Study|Lack of Efficacy|0
1101612|NCT01904721|3606859|P1|Overall Study|Lack of Efficacy|0
1101613|NCT01904721|3606853|P7|Overall Study|Lost to Follow-up|1
1101614|NCT01904721|3606854|P6|Overall Study|Lost to Follow-up|3
1101615|NCT01904721|3606855|P5|Overall Study|Lost to Follow-up|1
1101616|NCT01904721|3606856|P4|Overall Study|Lost to Follow-up|0
1101617|NCT01904721|3606857|P3|Overall Study|Lost to Follow-up|0
1101618|NCT01904721|3606858|P2|Overall Study|Lost to Follow-up|0
1101619|NCT01904721|3606859|P1|Overall Study|Lost to Follow-up|0
1101620|NCT01904721|3606853|P7|Overall Study|Personal Reasons|3
1101621|NCT01904721|3606854|P6|Overall Study|Personal Reasons|3
1101622|NCT01904721|3606855|P5|Overall Study|Personal Reasons|2
1101623|NCT01904721|3606856|P4|Overall Study|Personal Reasons|0
1101624|NCT01904721|3606857|P3|Overall Study|Personal Reasons|0
1101625|NCT01904721|3606858|P2|Overall Study|Personal Reasons|0
1101626|NCT01904721|3606859|P1|Overall Study|Personal Reasons|0
1101627|NCT01904721|3606853|P7|Overall Study|Other Reasons|2
1101628|NCT01904721|3606854|P6|Overall Study|Other Reasons|2
1101629|NCT01904721|3606855|P5|Overall Study|Other Reasons|2
1101630|NCT01904721|3606856|P4|Overall Study|Other Reasons|1
1101631|NCT01904721|3606857|P3|Overall Study|Other Reasons|1
1101632|NCT01904721|3606858|P2|Overall Study|Other Reasons|0
1101633|NCT01904721|3606859|P1|Overall Study|Other Reasons|0
1101634|NCT01904604|3606889|P3|Overall Study|Unrelated illness|0
1101635|NCT01904604|3606890|P2|Overall Study|Unrelated illness|1
1101636|NCT01904604|3606891|P1|Overall Study|Unrelated illness|0
1101637|NCT01904604|3606889|P3|Overall Study|Increased syncope|0
1101638|NCT01904604|3606890|P2|Overall Study|Increased syncope|1
1101639|NCT01904604|3606891|P1|Overall Study|Increased syncope|0
1101640|NCT01904604|3606889|P3|Overall Study|Patch site reactions|0
1101641|NCT01904604|3606890|P2|Overall Study|Patch site reactions|1
1101642|NCT01904604|3606891|P1|Overall Study|Patch site reactions|0
1101643|NCT01904604|3606889|P3|Overall Study|Anxiety about OFC/Refused OFC|0
1101644|NCT01904604|3606890|P2|Overall Study|Anxiety about OFC/Refused OFC|0
1101645|NCT01904604|3606891|P1|Overall Study|Anxiety about OFC/Refused OFC|2
1101646|NCT01904604|3606889|P3|Overall Study|Non-compliance|0
1101647|NCT01904604|3606890|P2|Overall Study|Non-compliance|0
1101648|NCT01904604|3606891|P1|Overall Study|Non-compliance|1
1101649|NCT01904604|3606889|P3|Overall Study|Withdrew before receiving dosing|0
1101650|NCT01904604|3606890|P2|Overall Study|Withdrew before receiving dosing|1
1101651|NCT01904604|3606891|P1|Overall Study|Withdrew before receiving dosing|0
1101652|NCT01904279|3606945|P2|Overall Study|Withdrawal by Subject|0
1101653|NCT01904279|3606946|P1|Overall Study|Withdrawal by Subject|1
1101654|NCT01904279|3606945|P2|Overall Study|Lack of Efficacy|3
1101655|NCT01904279|3606946|P1|Overall Study|Lack of Efficacy|2
1101656|NCT01904149|3606972|P6|Overall Study|non compliance with study drug|0
1101657|NCT01904149|3606973|P5|Overall Study|non compliance with study drug|0
1101658|NCT01904149|3606974|P4|Overall Study|non compliance with study drug|0
1101659|NCT01904149|3606975|P3|Overall Study|non compliance with study drug|0
1101660|NCT01904149|3606976|P2|Overall Study|non compliance with study drug|0
1101661|NCT01904149|3606977|P1|Overall Study|non compliance with study drug|1
1101662|NCT01904149|3606972|P6|Overall Study|Protocol Violation|0
1101663|NCT01904149|3606973|P5|Overall Study|Protocol Violation|0
1101664|NCT01904149|3606974|P4|Overall Study|Protocol Violation|0
1101665|NCT01904149|3606975|P3|Overall Study|Protocol Violation|0
1101666|NCT01904149|3606976|P2|Overall Study|Protocol Violation|1
1101667|NCT01904149|3606977|P1|Overall Study|Protocol Violation|0
1101668|NCT01904149|3606972|P6|Overall Study|Withdrawal by Subject|0
1101669|NCT01904149|3606973|P5|Overall Study|Withdrawal by Subject|1
1101670|NCT01904149|3606974|P4|Overall Study|Withdrawal by Subject|0
1101671|NCT01904149|3606975|P3|Overall Study|Withdrawal by Subject|1
1101672|NCT01904149|3606976|P2|Overall Study|Withdrawal by Subject|3
1101673|NCT01904149|3606977|P1|Overall Study|Withdrawal by Subject|1
1101674|NCT01904149|3606972|P6|Overall Study|Lack of Efficacy|1
1101675|NCT01904149|3606973|P5|Overall Study|Lack of Efficacy|3
1101676|NCT01904149|3606974|P4|Overall Study|Lack of Efficacy|3
1101677|NCT01904149|3606975|P3|Overall Study|Lack of Efficacy|1
1101678|NCT01904149|3606976|P2|Overall Study|Lack of Efficacy|3
1101679|NCT01904149|3606977|P1|Overall Study|Lack of Efficacy|0
1101680|NCT01904149|3606972|P6|Overall Study|Adverse Event|2
1101681|NCT01904149|3606973|P5|Overall Study|Adverse Event|1
1101682|NCT01904149|3606974|P4|Overall Study|Adverse Event|1
1101683|NCT01904149|3606975|P3|Overall Study|Adverse Event|0
1101684|NCT01904149|3606976|P2|Overall Study|Adverse Event|4
1101685|NCT01904149|3606977|P1|Overall Study|Adverse Event|3
1101686|NCT01904058|3607028|P4|Overall Study|Pregnancy|1
1101687|NCT01904058|3607029|P3|Overall Study|Pregnancy|0
1101688|NCT01904058|3607030|P2|Overall Study|Pregnancy|0
1101689|NCT01904058|3607031|P1|Overall Study|Pregnancy|0
1101690|NCT01904058|3607028|P4|Overall Study|Withdrawal by Subject|0
1101691|NCT01904058|3607029|P3|Overall Study|Withdrawal by Subject|1
1101692|NCT01904058|3607030|P2|Overall Study|Withdrawal by Subject|0
1101693|NCT01904058|3607031|P1|Overall Study|Withdrawal by Subject|1
1101694|NCT01904058|3607028|P4|Overall Study|Adverse Event|0
1101695|NCT01904058|3607029|P3|Overall Study|Adverse Event|0
1101696|NCT01904058|3607030|P2|Overall Study|Adverse Event|0
1101697|NCT01904058|3607031|P1|Overall Study|Adverse Event|2
1101698|NCT01903993|3607071|P2|Overall Study|Lost to Follow-up|1
1101699|NCT01903993|3607072|P1|Overall Study|Lost to Follow-up|2
1101700|NCT01903993|3607071|P2|Overall Study|Withdrawal by Subject|5
1101701|NCT01903993|3607072|P1|Overall Study|Withdrawal by Subject|13
1101702|NCT01903993|3607071|P2|Overall Study|Death|89
1101703|NCT01903993|3607072|P1|Overall Study|Death|108
1101704|NCT01903876|3607089|P2|Six-Month Follow-up Period|Lost to Follow-up|145
1101705|NCT01903876|3607090|P1|Six-Month Follow-up Period|Lost to Follow-up|91
1101706|NCT01903876|3607089|P2|Baseline to Post-Intervention Period|Lost to Follow-up|108
1101707|NCT01903876|3607090|P1|Baseline to Post-Intervention Period|Lost to Follow-up|184
1101708|NCT01903863|3607100|P2|Overall Study|Physician Decision|0
1101709|NCT01903863|3607101|P1|Overall Study|Physician Decision|2
1101710|NCT01903720|3607142|P1|Overall Study|Treatment with alternative drug|1
1101711|NCT01903720|3607142|P1|Overall Study|Lost to Follow-up|2
1101712|NCT01903720|3607142|P1|Overall Study|Rescinding of informed consent|2
1101713|NCT01903720|3607142|P1|Overall Study|Adverse Event|1
1101714|NCT01903720|3607142|P1|Overall Study|Inclusion / exclusion criteria not met|6
1101715|NCT01903460|3607180|P4|Overall Study|Adverse Event|1
1101716|NCT01903460|3607181|P3|Overall Study|Adverse Event|0
1101717|NCT01903460|3607182|P2|Overall Study|Adverse Event|0
1101718|NCT01903460|3607183|P1|Overall Study|Adverse Event|0
1101719|NCT01903434|3607200|P2|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2
1101720|NCT01903434|3607201|P1|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0
1101721|NCT01903434|3607200|P2|Washout Period 1 (at Least 14 Days)|Adverse Event|0
1101722|NCT01903434|3607201|P1|Washout Period 1 (at Least 14 Days)|Adverse Event|1
1101723|NCT01903356|3607209|P1|Overall Study|Violated the dosage and administration|3
1101724|NCT01903356|3607209|P1|Overall Study|Violated inclusion/exclusion criteria|5
1101725|NCT01903356|3607209|P1|Overall Study|Lost to Follow-up|7
1101726|NCT01903252|3607236|P6|Maintenance, Open-Label|Other|2
1101727|NCT01903252|3607237|P5|Maintenance, Open-Label|Other|6
1101728|NCT01903252|3607238|P4|Maintenance, Open-Label|Other|2
1101729|NCT01903252|3607239|P3|Maintenance, Open-Label|Other|0
1101730|NCT01903252|3607240|P2|Maintenance, Open-Label|Other|0
1101731|NCT01903252|3607241|P1|Maintenance, Open-Label|Other|0
1101732|NCT01903252|3607236|P6|Maintenance, Open-Label|Withdrawal by Subject|2
1101733|NCT01903252|3607237|P5|Maintenance, Open-Label|Withdrawal by Subject|6
1101734|NCT01903252|3607238|P4|Maintenance, Open-Label|Withdrawal by Subject|1
1101735|NCT01903252|3607239|P3|Maintenance, Open-Label|Withdrawal by Subject|0
1101736|NCT01903252|3607240|P2|Maintenance, Open-Label|Withdrawal by Subject|0
1101737|NCT01903252|3607241|P1|Maintenance, Open-Label|Withdrawal by Subject|0
1101738|NCT01903252|3607236|P6|Maintenance, Open-Label|Adverse Event|14
1101739|NCT01903252|3607237|P5|Maintenance, Open-Label|Adverse Event|9
1101740|NCT01903252|3607238|P4|Maintenance, Open-Label|Adverse Event|3
1101741|NCT01903252|3607239|P3|Maintenance, Open-Label|Adverse Event|0
1101742|NCT01903252|3607240|P2|Maintenance, Open-Label|Adverse Event|0
1101743|NCT01903252|3607241|P1|Maintenance, Open-Label|Adverse Event|0
1101744|NCT01903252|3607236|P6|Extended Induction, Open-Label|Physician Decision|0
1101745|NCT01903252|3607237|P5|Extended Induction, Open-Label|Physician Decision|0
1101746|NCT01903252|3607238|P4|Extended Induction, Open-Label|Physician Decision|0
1101747|NCT01903252|3607239|P3|Extended Induction, Open-Label|Physician Decision|1
1101748|NCT01903252|3607240|P2|Extended Induction, Open-Label|Physician Decision|0
1101749|NCT01903252|3607241|P1|Extended Induction, Open-Label|Physician Decision|0
1101750|NCT01903252|3607236|P6|Extended Induction, Open-Label|Withdrawal by Subject|0
1101751|NCT01903252|3607237|P5|Extended Induction, Open-Label|Withdrawal by Subject|0
1101752|NCT01903252|3607238|P4|Extended Induction, Open-Label|Withdrawal by Subject|0
1101753|NCT01903252|3607239|P3|Extended Induction, Open-Label|Withdrawal by Subject|5
1101754|NCT01903252|3607240|P2|Extended Induction, Open-Label|Withdrawal by Subject|0
1101755|NCT01903252|3607241|P1|Extended Induction, Open-Label|Withdrawal by Subject|0
1101756|NCT01903252|3607236|P6|Extended Induction, Open-Label|Adverse Event|0
1101757|NCT01903252|3607237|P5|Extended Induction, Open-Label|Adverse Event|0
1101758|NCT01903252|3607238|P4|Extended Induction, Open-Label|Adverse Event|0
1101759|NCT01903252|3607239|P3|Extended Induction, Open-Label|Adverse Event|17
1101760|NCT01903252|3607240|P2|Extended Induction, Open-Label|Adverse Event|0
1101761|NCT01903252|3607241|P1|Extended Induction, Open-Label|Adverse Event|0
1101762|NCT01903252|3607236|P6|Double-Blind Induction|non-compliance,|0
1101763|NCT01903252|3607237|P5|Double-Blind Induction|non-compliance,|0
1101764|NCT01903252|3607238|P4|Double-Blind Induction|non-compliance,|0
1101765|NCT01903252|3607239|P3|Double-Blind Induction|non-compliance,|0
1101766|NCT01903252|3607240|P2|Double-Blind Induction|non-compliance,|7
1101767|NCT01903252|3607241|P1|Double-Blind Induction|non-compliance,|7
1101768|NCT01903252|3607236|P6|Double-Blind Induction|Physician Decision|0
1101769|NCT01903252|3607237|P5|Double-Blind Induction|Physician Decision|0
1101770|NCT01903252|3607238|P4|Double-Blind Induction|Physician Decision|0
1101771|NCT01903252|3607239|P3|Double-Blind Induction|Physician Decision|0
1101772|NCT01903252|3607240|P2|Double-Blind Induction|Physician Decision|3
1101773|NCT01903252|3607241|P1|Double-Blind Induction|Physician Decision|2
1101774|NCT01903252|3607236|P6|Double-Blind Induction|Withdrawal by Subject|0
1101775|NCT01903252|3607237|P5|Double-Blind Induction|Withdrawal by Subject|0
1101776|NCT01903252|3607238|P4|Double-Blind Induction|Withdrawal by Subject|0
1101777|NCT01903252|3607239|P3|Double-Blind Induction|Withdrawal by Subject|0
1101778|NCT01903252|3607240|P2|Double-Blind Induction|Withdrawal by Subject|13
1101779|NCT01903252|3607241|P1|Double-Blind Induction|Withdrawal by Subject|10
1101780|NCT01903252|3607236|P6|Double-Blind Induction|Adverse Event|0
1101781|NCT01903252|3607237|P5|Double-Blind Induction|Adverse Event|0
1101782|NCT01903252|3607238|P4|Double-Blind Induction|Adverse Event|0
1101783|NCT01903252|3607239|P3|Double-Blind Induction|Adverse Event|0
1101784|NCT01903252|3607240|P2|Double-Blind Induction|Adverse Event|18
1101785|NCT01903252|3607241|P1|Double-Blind Induction|Adverse Event|20
1101786|NCT01903031|3607354|P3|Overall Study|NuvaRing removed prior to Day 21 visit|1
1101787|NCT01903031|3607355|P2|Overall Study|NuvaRing removed prior to Day 21 visit|0
1101788|NCT01903031|3607356|P1|Overall Study|NuvaRing removed prior to Day 21 visit|0
1101789|NCT01903031|3607354|P3|Overall Study|Lost to Follow-up|1
1101790|NCT01903031|3607355|P2|Overall Study|Lost to Follow-up|0
1101791|NCT01903031|3607356|P1|Overall Study|Lost to Follow-up|0
1101792|NCT01903031|3607354|P3|Overall Study|Protocol Violation|2
1101793|NCT01903031|3607355|P2|Overall Study|Protocol Violation|0
1101794|NCT01903031|3607356|P1|Overall Study|Protocol Violation|0
1101795|NCT01903031|3607354|P3|Overall Study|Withdrawal by Subject|1
1101796|NCT01903031|3607355|P2|Overall Study|Withdrawal by Subject|1
1101797|NCT01903031|3607356|P1|Overall Study|Withdrawal by Subject|0
1101798|NCT01903031|3607354|P3|Overall Study|Adverse Event|0
1101799|NCT01903031|3607355|P2|Overall Study|Adverse Event|1
1101800|NCT01903031|3607356|P1|Overall Study|Adverse Event|0
1101801|NCT01903031|3607354|P3|Overall Study|Missed Day 21 Primary Endpoint Visit|0
1101802|NCT01903031|3607355|P2|Overall Study|Missed Day 21 Primary Endpoint Visit|0
1101803|NCT01903031|3607356|P1|Overall Study|Missed Day 21 Primary Endpoint Visit|1
1101804|NCT01903031|3607354|P3|Overall Study|Not Able to Attend Clinic|0
1101805|NCT01903031|3607355|P2|Overall Study|Not Able to Attend Clinic|1
1101806|NCT01903031|3607356|P1|Overall Study|Not Able to Attend Clinic|1
1101807|NCT01902888|3607412|P1|Overall Study|Study Terminated|3
1101808|NCT01902628|3607426|P1|Overall Study|Lost to Follow-up|35
1101809|NCT01902628|3607426|P1|Overall Study|Adverse Event|41
1101810|NCT01902628|3607426|P1|Overall Study|Withdrawal of participant's consent|7
1101811|NCT01902303|3607454|P2|Overall Study|Did not develop a cold sore|19
1101812|NCT01902303|3607455|P1|Overall Study|Did not develop a cold sore|21
1101813|NCT01902303|3607454|P2|Overall Study|subject lost investigational product|1
1101814|NCT01902303|3607455|P1|Overall Study|subject lost investigational product|0
1101815|NCT01902303|3607454|P2|Overall Study|Protocol Violation|2
1101816|NCT01902303|3607455|P1|Overall Study|Protocol Violation|2
1101817|NCT01902303|3607454|P2|Overall Study|Lost to Follow-up|1
1101818|NCT01902303|3607455|P1|Overall Study|Lost to Follow-up|0
1101819|NCT01902303|3607454|P2|Overall Study|Adverse Event|1
1101820|NCT01902303|3607455|P1|Overall Study|Adverse Event|0
1101821|NCT01902134|3607469|P6|Overall Study|not specified|0
1101822|NCT01902134|3607470|P5|Overall Study|not specified|1
1101823|NCT01902134|3607471|P4|Overall Study|not specified|0
1101824|NCT01902134|3607472|P3|Overall Study|not specified|2
1101825|NCT01902134|3607473|P2|Overall Study|not specified|1
1101826|NCT01902134|3607474|P1|Overall Study|not specified|0
1101827|NCT01902134|3607469|P6|Overall Study|no compliance|0
1101828|NCT01902134|3607470|P5|Overall Study|no compliance|0
1101829|NCT01902134|3607471|P4|Overall Study|no compliance|0
1101830|NCT01902134|3607472|P3|Overall Study|no compliance|0
1101831|NCT01902134|3607473|P2|Overall Study|no compliance|0
1101832|NCT01902134|3607474|P1|Overall Study|no compliance|1
1101833|NCT01902134|3607469|P6|Overall Study|Withdrawal by Subject|4
1101834|NCT01902134|3607470|P5|Overall Study|Withdrawal by Subject|5
1101835|NCT01902134|3607471|P4|Overall Study|Withdrawal by Subject|1
1101836|NCT01902134|3607472|P3|Overall Study|Withdrawal by Subject|9
1101837|NCT01902134|3607473|P2|Overall Study|Withdrawal by Subject|8
1101838|NCT01902134|3607474|P1|Overall Study|Withdrawal by Subject|4
1101839|NCT01902134|3607469|P6|Overall Study|Protocol Violation|1
1101840|NCT01902134|3607470|P5|Overall Study|Protocol Violation|0
1101841|NCT01902134|3607471|P4|Overall Study|Protocol Violation|0
1101842|NCT01902134|3607472|P3|Overall Study|Protocol Violation|0
1101843|NCT01902134|3607473|P2|Overall Study|Protocol Violation|0
1101844|NCT01902134|3607474|P1|Overall Study|Protocol Violation|0
1101845|NCT01902134|3607469|P6|Overall Study|Physician Decision|0
1101846|NCT01902134|3607470|P5|Overall Study|Physician Decision|0
1101847|NCT01902134|3607471|P4|Overall Study|Physician Decision|0
1101848|NCT01902134|3607472|P3|Overall Study|Physician Decision|0
1101849|NCT01902134|3607473|P2|Overall Study|Physician Decision|1
1101850|NCT01902134|3607474|P1|Overall Study|Physician Decision|0
1101851|NCT01902134|3607469|P6|Overall Study|Lack of Efficacy|1
1101852|NCT01902134|3607470|P5|Overall Study|Lack of Efficacy|0
1101853|NCT01902134|3607471|P4|Overall Study|Lack of Efficacy|0
1101854|NCT01902134|3607472|P3|Overall Study|Lack of Efficacy|2
1101855|NCT01902134|3607473|P2|Overall Study|Lack of Efficacy|0
1101856|NCT01902134|3607474|P1|Overall Study|Lack of Efficacy|0
1101857|NCT01902134|3607469|P6|Overall Study|Adverse Event|3
1101858|NCT01902134|3607470|P5|Overall Study|Adverse Event|1
1101859|NCT01902134|3607471|P4|Overall Study|Adverse Event|1
1101860|NCT01902134|3607472|P3|Overall Study|Adverse Event|2
1101861|NCT01902134|3607473|P2|Overall Study|Adverse Event|1
1101862|NCT01902134|3607474|P1|Overall Study|Adverse Event|3
1101863|NCT01901848|3607498|P2|Removed From Analyses|CPT practice cases to establish fidelity|0
1101864|NCT01901848|3607499|P1|Removed From Analyses|CPT practice cases to establish fidelity|10
1101865|NCT01901848|3607498|P2|Randomized and Treated|Lost to Follow-up|6
1101866|NCT01901848|3607499|P1|Randomized and Treated|Lost to Follow-up|3
1101867|NCT01901653|3607541|P13|Overall Study|Alive at Study Termination by Sponsor|1
1101868|NCT01901653|3607542|P12|Overall Study|Alive at Study Termination by Sponsor|1
1101869|NCT01901653|3607543|P11|Overall Study|Alive at Study Termination by Sponsor|0
1101870|NCT01901653|3607544|P10|Overall Study|Alive at Study Termination by Sponsor|2
1101871|NCT01901653|3607545|P9|Overall Study|Alive at Study Termination by Sponsor|0
1101872|NCT01901653|3607546|P8|Overall Study|Alive at Study Termination by Sponsor|0
1101873|NCT01901653|3607547|P7|Overall Study|Alive at Study Termination by Sponsor|0
1101874|NCT01901653|3607548|P6|Overall Study|Alive at Study Termination by Sponsor|0
1101875|NCT01901653|3607549|P5|Overall Study|Alive at Study Termination by Sponsor|0
1101876|NCT01901653|3607550|P4|Overall Study|Alive at Study Termination by Sponsor|0
1101877|NCT01901653|3607551|P3|Overall Study|Alive at Study Termination by Sponsor|1
1101878|NCT01901653|3607552|P2|Overall Study|Alive at Study Termination by Sponsor|0
1101879|NCT01901653|3607553|P1|Overall Study|Alive at Study Termination by Sponsor|0
1101880|NCT01901653|3607541|P13|Overall Study|Withdrawal by Subject|0
1101881|NCT01901653|3607542|P12|Overall Study|Withdrawal by Subject|0
1101882|NCT01901653|3607543|P11|Overall Study|Withdrawal by Subject|0
1101883|NCT01901653|3607544|P10|Overall Study|Withdrawal by Subject|0
1101884|NCT01901653|3607545|P9|Overall Study|Withdrawal by Subject|0
1101885|NCT01901653|3607546|P8|Overall Study|Withdrawal by Subject|0
1101886|NCT01901653|3607547|P7|Overall Study|Withdrawal by Subject|1
1101887|NCT01901653|3607548|P6|Overall Study|Withdrawal by Subject|0
1101888|NCT01901653|3607549|P5|Overall Study|Withdrawal by Subject|0
1101889|NCT01901653|3607550|P4|Overall Study|Withdrawal by Subject|0
1101890|NCT01901653|3607551|P3|Overall Study|Withdrawal by Subject|0
1101891|NCT01901653|3607552|P2|Overall Study|Withdrawal by Subject|0
1101892|NCT01901653|3607553|P1|Overall Study|Withdrawal by Subject|0
1101893|NCT01901653|3607541|P13|Overall Study|Lost to Follow-up|0
1101894|NCT01901653|3607542|P12|Overall Study|Lost to Follow-up|0
1101895|NCT01901653|3607543|P11|Overall Study|Lost to Follow-up|0
1101896|NCT01901653|3607544|P10|Overall Study|Lost to Follow-up|0
1101897|NCT01901653|3607545|P9|Overall Study|Lost to Follow-up|0
1101898|NCT01901653|3607546|P8|Overall Study|Lost to Follow-up|1
1101899|NCT01901653|3607547|P7|Overall Study|Lost to Follow-up|0
1101900|NCT01901653|3607548|P6|Overall Study|Lost to Follow-up|1
1101901|NCT01901653|3607549|P5|Overall Study|Lost to Follow-up|0
1101902|NCT01901653|3607550|P4|Overall Study|Lost to Follow-up|0
1101903|NCT01901653|3607551|P3|Overall Study|Lost to Follow-up|2
1101904|NCT01901653|3607552|P2|Overall Study|Lost to Follow-up|0
1101905|NCT01901653|3607553|P1|Overall Study|Lost to Follow-up|1
1101906|NCT01901653|3607541|P13|Overall Study|Death|4
1101907|NCT01901653|3607542|P12|Overall Study|Death|15
1101908|NCT01901653|3607543|P11|Overall Study|Death|2
1101909|NCT01901653|3607544|P10|Overall Study|Death|16
1101910|NCT01901653|3607545|P9|Overall Study|Death|1
1101911|NCT01901653|3607546|P8|Overall Study|Death|9
1101912|NCT01901653|3607547|P7|Overall Study|Death|6
1101913|NCT01901653|3607548|P6|Overall Study|Death|2
1101914|NCT01901653|3607549|P5|Overall Study|Death|2
1101915|NCT01901653|3607550|P4|Overall Study|Death|3
1101916|NCT01901653|3607551|P3|Overall Study|Death|8
1101917|NCT01901653|3607552|P2|Overall Study|Death|1
1101918|NCT01901653|3607553|P1|Overall Study|Death|2
1101919|NCT01901393|3607621|P2|Overall Study|Adverse Event|0
1101920|NCT01901393|3607622|P1|Overall Study|Adverse Event|1
1101921|NCT01901341|3607640|P2|Overall Study|Withdrawal by Subject|1
1101922|NCT01901341|3607641|P1|Overall Study|Withdrawal by Subject|1
1101923|NCT01901341|3607640|P2|Overall Study|Study Terminated by Sponsor|15
1101924|NCT01901341|3607641|P1|Overall Study|Study Terminated by Sponsor|13
1101925|NCT01901341|3607640|P2|Overall Study|Protocol Violation|0
1101926|NCT01901341|3607641|P1|Overall Study|Protocol Violation|2
1101927|NCT01901341|3607640|P2|Overall Study|Lost to Follow-up|1
1101928|NCT01901341|3607641|P1|Overall Study|Lost to Follow-up|0
1101929|NCT01901341|3607640|P2|Overall Study|Lack of Efficacy|2
1101930|NCT01901341|3607641|P1|Overall Study|Lack of Efficacy|0
1101931|NCT01901341|3607640|P2|Overall Study|Adverse Event|2
1101932|NCT01901341|3607641|P1|Overall Study|Adverse Event|4
1101933|NCT01901328|3607655|P2|Overall Study|Lack of Efficacy|1
1101934|NCT01901328|3607656|P1|Overall Study|Lack of Efficacy|0
1101935|NCT01901328|3607655|P2|Overall Study|Withdrawal by Subject|2
1101936|NCT01901328|3607656|P1|Overall Study|Withdrawal by Subject|1
1101937|NCT01901328|3607655|P2|Overall Study|Study Terminated by Sponsor|16
1101938|NCT01901328|3607656|P1|Overall Study|Study Terminated by Sponsor|19
1101939|NCT01901328|3607655|P2|Overall Study|Protocol Violation|1
1101940|NCT01901328|3607656|P1|Overall Study|Protocol Violation|1
1101941|NCT01901328|3607655|P2|Overall Study|Physician Decision|1
1101942|NCT01901328|3607656|P1|Overall Study|Physician Decision|0
1101943|NCT01901328|3607655|P2|Overall Study|Lost to Follow-up|0
1101944|NCT01901328|3607656|P1|Overall Study|Lost to Follow-up|1
1101945|NCT01901302|3607670|P2|Overall Study|Withdrawal by Subject|0
1101946|NCT01901302|3607671|P1|Overall Study|Withdrawal by Subject|2
1101947|NCT01901302|3607670|P2|Overall Study|Study Terminated by Sponsor|20
1101948|NCT01901302|3607671|P1|Overall Study|Study Terminated by Sponsor|23
1101949|NCT01901302|3607670|P2|Overall Study|Lack of Efficacy|2
1101950|NCT01901302|3607671|P1|Overall Study|Lack of Efficacy|0
1101951|NCT01901302|3607670|P2|Overall Study|Adverse Event|1
1101952|NCT01901302|3607671|P1|Overall Study|Adverse Event|2
1101953|NCT01901224|3607696|P1|Overall Study|study was not funded and terminated|2
1101954|NCT01901185|3607731|P1|Overall Study|Withdrawal by Subject|2
1101955|NCT01900665|3607740|P2|Open Label Period|Withdrawal by Subject|28
1101956|NCT01900665|3607741|P1|Open Label Period|Withdrawal by Subject|20
1101957|NCT01900665|3607740|P2|Open Label Period|Sponsor Decision|765
1101958|NCT01900665|3607741|P1|Open Label Period|Sponsor Decision|802
1101959|NCT01900665|3607740|P2|Open Label Period|Protocol Violation|1
1101960|NCT01900665|3607741|P1|Open Label Period|Protocol Violation|0
1101961|NCT01900665|3607740|P2|Open Label Period|Physician Decision|4
1101962|NCT01900665|3607741|P1|Open Label Period|Physician Decision|4
1101963|NCT01900665|3607740|P2|Open Label Period|Parent/Caregiver Decision|34
1101964|NCT01900665|3607741|P1|Open Label Period|Parent/Caregiver Decision|33
1101965|NCT01900665|3607740|P2|Open Label Period|Lost to Follow-up|1
1101966|NCT01900665|3607741|P1|Open Label Period|Lost to Follow-up|1
1101967|NCT01900665|3607740|P2|Open Label Period|Death|6
1101968|NCT01900665|3607741|P1|Open Label Period|Death|5
1101969|NCT01900665|3607740|P2|Open Label Period|Adverse Event|20
1101970|NCT01900665|3607741|P1|Open Label Period|Adverse Event|16
1101971|NCT01900665|3607740|P2|Placebo Controlled Period|Entry Criteria Not Met|9
1101972|NCT01900665|3607741|P1|Placebo Controlled Period|Entry Criteria Not Met|5
1101973|NCT01900665|3607740|P2|Placebo Controlled Period|Caregiver Decision|41
1101974|NCT01900665|3607741|P1|Placebo Controlled Period|Caregiver Decision|33
1101975|NCT01900665|3607740|P2|Placebo Controlled Period|Lost to Follow-up|0
1101976|NCT01900665|3607741|P1|Placebo Controlled Period|Lost to Follow-up|3
1101977|NCT01900665|3607740|P2|Placebo Controlled Period|Physician Decision|7
1101978|NCT01900665|3607741|P1|Placebo Controlled Period|Physician Decision|11
1101979|NCT01900665|3607740|P2|Placebo Controlled Period|Withdrawal by Subject|45
1101980|NCT01900665|3607741|P1|Placebo Controlled Period|Withdrawal by Subject|33
1101981|NCT01900665|3607740|P2|Placebo Controlled Period|Protocol Violation|7
1101982|NCT01900665|3607741|P1|Placebo Controlled Period|Protocol Violation|1
1101983|NCT01900665|3607740|P2|Placebo Controlled Period|Adverse Event|39
1101984|NCT01900665|3607741|P1|Placebo Controlled Period|Adverse Event|48
1101985|NCT01900665|3607740|P2|Placebo Controlled Period|Death|16
1101986|NCT01900665|3607741|P1|Placebo Controlled Period|Death|9
1101987|NCT01900652|3607784|P2|Overall Study|Physician Decision|1
1101988|NCT01900652|3607785|P1|Overall Study|Physician Decision|1
1101989|NCT01900652|3607784|P2|Overall Study|Adverse Event|1
1101990|NCT01900652|3607785|P1|Overall Study|Adverse Event|2
1101991|NCT01900652|3607784|P2|Overall Study|Death|0
1101992|NCT01900652|3607785|P1|Overall Study|Death|3
1101993|NCT01900652|3607784|P2|Overall Study|Consent withdrawn by subject|1
1101994|NCT01900652|3607785|P1|Overall Study|Consent withdrawn by subject|1
1101995|NCT01900652|3607784|P2|Overall Study|Progressive Disease|0
1101996|NCT01900652|3607785|P1|Overall Study|Progressive Disease|1
1101997|NCT01900444|3607819|P1|Overall Study|Lost to Follow-up|1
1101998|NCT01900444|3607819|P1|Overall Study|Protocol Violation|2
1101999|NCT01900431|3607832|P3|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3
1102000|NCT01900431|3607833|P2|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
1102001|NCT01900431|3607834|P1|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
1102002|NCT01900431|3607832|P3|Open-Label Treatment Period (Part C)|Lack of Efficacy|3
1102003|NCT01900431|3607833|P2|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
1102004|NCT01900431|3607834|P1|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
1102005|NCT01900431|3607832|P3|Open-Label Treatment Period (Part C)|Adverse Event|2
1102006|NCT01900431|3607833|P2|Open-Label Treatment Period (Part C)|Adverse Event|0
1102007|NCT01900431|3607834|P1|Open-Label Treatment Period (Part C)|Adverse Event|0
1102008|NCT01900431|3607832|P3|Extended Treatment Period (Part B)|Other than specified above|0
1102009|NCT01900431|3607833|P2|Extended Treatment Period (Part B)|Other than specified above|1
1102010|NCT01900431|3607834|P1|Extended Treatment Period (Part B)|Other than specified above|0
1102011|NCT01900431|3607832|P3|Extended Treatment Period (Part B)|Lack of Efficacy|0
1102012|NCT01900431|3607833|P2|Extended Treatment Period (Part B)|Lack of Efficacy|7
1102013|NCT01900431|3607834|P1|Extended Treatment Period (Part B)|Lack of Efficacy|1
1102014|NCT01900431|3607832|P3|Extended Treatment Period (Part B)|Adverse Event|0
1102015|NCT01900431|3607833|P2|Extended Treatment Period (Part B)|Adverse Event|2
1102016|NCT01900431|3607834|P1|Extended Treatment Period (Part B)|Adverse Event|0
1102017|NCT01900431|3607832|P3|Principal Treatment Period (Part A)|Other than specified above|0
1102018|NCT01900431|3607833|P2|Principal Treatment Period (Part A)|Other than specified above|1
1102019|NCT01900431|3607834|P1|Principal Treatment Period (Part A)|Other than specified above|0
1102020|NCT01900431|3607832|P3|Principal Treatment Period (Part A)|Lack of Efficacy|0
1102021|NCT01900431|3607833|P2|Principal Treatment Period (Part A)|Lack of Efficacy|6
1102022|NCT01900431|3607834|P1|Principal Treatment Period (Part A)|Lack of Efficacy|6
1102023|NCT01900431|3607832|P3|Principal Treatment Period (Part A)|Adverse Event|0
1102024|NCT01900431|3607833|P2|Principal Treatment Period (Part A)|Adverse Event|3
1102025|NCT01900431|3607834|P1|Principal Treatment Period (Part A)|Adverse Event|1
1102026|NCT01900314|3607876|P2|Overall Study|Withdrawal by Subject|3
1102027|NCT01900314|3607877|P1|Overall Study|Withdrawal by Subject|3
1102028|NCT01900314|3607876|P2|Overall Study|Protocol Violation|1
1102029|NCT01900314|3607877|P1|Overall Study|Protocol Violation|0
1102030|NCT01900314|3607876|P2|Overall Study|Lost to Follow-up|0
1102031|NCT01900314|3607877|P1|Overall Study|Lost to Follow-up|1
1102032|NCT01900054|3607907|P1|Overall Study|Withdrawal by Subject|1
1102033|NCT01900054|3607907|P1|Overall Study|Physician Decision|1
1102034|NCT01899768|3607916|P1|Part B|Withdrawal by Subject|1
1102035|NCT01899768|3607916|P1|Part B|Adverse Event|1
1102036|NCT01899768|3607916|P1|Part A|Withdrawal by Subject|1
1102037|NCT01899768|3607916|P1|Part A|Adverse Event|2
1102038|NCT01899742|3607990|P2|Overall Study|Withdrawal by Subject|5
1102039|NCT01899742|3607991|P1|Overall Study|Withdrawal by Subject|9
1102040|NCT01899742|3607990|P2|Overall Study|Protocol Violation|2
1102041|NCT01899742|3607991|P1|Overall Study|Protocol Violation|2
1102042|NCT01899742|3607990|P2|Overall Study|Lack of Efficacy|5
1102043|NCT01899742|3607991|P1|Overall Study|Lack of Efficacy|1
1102044|NCT01899742|3607990|P2|Overall Study|Adverse Event|4
1102045|NCT01899742|3607991|P1|Overall Study|Adverse Event|5
1102046|NCT01899144|3608030|P1|Treatment Period 5|Not specified|1
1102047|NCT01899144|3608030|P1|Treatment Period 3|Not specified|2
1102048|NCT01899144|3608030|P1|Treatment Period 2|Not specified|1
1102049|NCT01898884|3608057|P9|Multiple Dose Period|Randomized Not Treated|1
1102050|NCT01898884|3608058|P8|Multiple Dose Period|Randomized Not Treated|0
1102051|NCT01898884|3608059|P7|Multiple Dose Period|Randomized Not Treated|0
1102052|NCT01898884|3608060|P6|Multiple Dose Period|Randomized Not Treated|0
1102053|NCT01898884|3608061|P5|Multiple Dose Period|Randomized Not Treated|0
1102054|NCT01898884|3608062|P4|Multiple Dose Period|Randomized Not Treated|0
1102055|NCT01898884|3608063|P3|Multiple Dose Period|Randomized Not Treated|0
1102056|NCT01898884|3608064|P2|Multiple Dose Period|Randomized Not Treated|0
1102057|NCT01898884|3608065|P1|Multiple Dose Period|Randomized Not Treated|0
1102058|NCT01898884|3608057|P9|Multiple Dose Period|Adverse Event|0
1102059|NCT01898884|3608058|P8|Multiple Dose Period|Adverse Event|0
1102060|NCT01898884|3608059|P7|Multiple Dose Period|Adverse Event|1
1102061|NCT01898884|3608060|P6|Multiple Dose Period|Adverse Event|0
1102062|NCT01898884|3608061|P5|Multiple Dose Period|Adverse Event|0
1102063|NCT01898884|3608062|P4|Multiple Dose Period|Adverse Event|0
1102064|NCT01898884|3608063|P3|Multiple Dose Period|Adverse Event|0
1102065|NCT01898884|3608064|P2|Multiple Dose Period|Adverse Event|0
1102066|NCT01898884|3608065|P1|Multiple Dose Period|Adverse Event|0
1102067|NCT01898598|3608240|P2|Overall Study|Other|1
1102068|NCT01898598|3608241|P1|Overall Study|Other|0
1102069|NCT01898598|3608240|P2|Overall Study|Lost to Follow-up|1
1102070|NCT01898598|3608241|P1|Overall Study|Lost to Follow-up|0
1102071|NCT01898598|3608240|P2|Overall Study|Withdrawal by Subject|0
1102072|NCT01898598|3608241|P1|Overall Study|Withdrawal by Subject|3
1102073|NCT01898598|3608240|P2|Overall Study|Adverse Event|0
1102074|NCT01898598|3608241|P1|Overall Study|Adverse Event|1
1102075|NCT01898442|3608260|P3|Overall Study|Patient vomited pills|1
1102076|NCT01898442|3608261|P2|Overall Study|Patient vomited pills|0
1102077|NCT01898442|3608262|P1|Overall Study|Patient vomited pills|0
1102078|NCT01898442|3608260|P3|Overall Study|Hemolysis/technical problems|2
1102079|NCT01898442|3608261|P2|Overall Study|Hemolysis/technical problems|2
1102080|NCT01898442|3608262|P1|Overall Study|Hemolysis/technical problems|1
1102081|NCT01898286|3608297|P1|Overall Study|Lost to Follow-up|1
1102082|NCT01898286|3608297|P1|Overall Study|Protocol Violation|1
1102083|NCT01898286|3608297|P1|Overall Study|Withdrawal by Subject|1
1102084|NCT01898208|3608307|P3|Overall Study|Lost to Follow-up|1
1102085|NCT01898208|3608308|P2|Overall Study|Lost to Follow-up|1
1102086|NCT01898208|3608309|P1|Overall Study|Lost to Follow-up|3
1102087|NCT01898208|3608307|P3|Overall Study|System/Technical Error|3
1102088|NCT01898208|3608308|P2|Overall Study|System/Technical Error|2
1102089|NCT01898208|3608309|P1|Overall Study|System/Technical Error|1
1102090|NCT01898208|3608307|P3|Overall Study|Non-Blood Specimens in Bottles|4
1102091|NCT01898208|3608308|P2|Overall Study|Non-Blood Specimens in Bottles|5
1102092|NCT01898208|3608309|P1|Overall Study|Non-Blood Specimens in Bottles|3
1102093|NCT01898208|3608307|P3|Overall Study|Negative Gram Stain|6
1102094|NCT01898208|3608308|P2|Overall Study|Negative Gram Stain|9
1102095|NCT01898208|3608309|P1|Overall Study|Negative Gram Stain|6
1102096|NCT01898208|3608307|P3|Overall Study|Death/comfort care within 24 hours|8
1102097|NCT01898208|3608308|P2|Overall Study|Death/comfort care within 24 hours|9
1102098|NCT01898208|3608309|P1|Overall Study|Death/comfort care within 24 hours|10
1102099|NCT01898208|3608307|P3|Overall Study|Positive blood culture|15
1102100|NCT01898208|3608308|P2|Overall Study|Positive blood culture|23
1102101|NCT01898208|3608309|P1|Overall Study|Positive blood culture|17
1102102|NCT01898195|3608356|P3|Smoking Abstinence|Did not have good measurements|36
1102103|NCT01898195|3608357|P2|Smoking Abstinence|Did not have good measurements|38
1102104|NCT01898195|3608358|P1|Smoking Abstinence|Did not have good measurements|35
1102105|NCT01898091|3608371|P2|Overall Study|Withdrawal by Subject|5
1102106|NCT01898091|3608372|P1|Overall Study|Withdrawal by Subject|1
1102107|NCT01898091|3608371|P2|Overall Study|Lost to Follow-up|1
1102108|NCT01898091|3608372|P1|Overall Study|Lost to Follow-up|1
1102109|NCT01897727|3608426|P2|Overall Study|Exclusion: central sleep apnea|1
1102110|NCT01897727|3608427|P1|Overall Study|Exclusion: central sleep apnea|0
1102111|NCT01897493|3608433|P1|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1
1102112|NCT01897233|3608469|P1|Part B (24 Weeks)|Physician Decision|1
1102113|NCT01897233|3608469|P1|Part B (24 Weeks)|Withdrawal by Subject|2
1102114|NCT01897233|3608469|P1|Part B (24 Weeks)|Adverse Event|1
1102115|NCT01896986|3608521|P2|Overall Study|samples lost|23
1102116|NCT01896986|3608522|P1|Overall Study|samples lost|14
1102117|NCT01896934|3608528|P1|Overall Study|Withdrawal by Subject|1
1102118|NCT01896934|3608528|P1|Overall Study|Adverse Event|1
1102119|NCT01896895|3608537|P4|Double-blind MP|Lost to Follow-up|0
1102120|NCT01896895|3608538|P3|Double-blind MP|Lost to Follow-up|1
1102121|NCT01896895|3608539|P2|Double-blind MP|Lost to Follow-up|0
1102122|NCT01896895|3608540|P1|Double-blind MP|Lost to Follow-up|1
1102123|NCT01896895|3608537|P4|Double-blind MP|Withdrawal by Subject|0
1102124|NCT01896895|3608538|P3|Double-blind MP|Withdrawal by Subject|1
1102125|NCT01896895|3608539|P2|Double-blind MP|Withdrawal by Subject|2
1102126|NCT01896895|3608540|P1|Double-blind MP|Withdrawal by Subject|0
1102127|NCT01896895|3608537|P4|Double-blind MP|Physician Decision|0
1102128|NCT01896895|3608538|P3|Double-blind MP|Physician Decision|1
1102129|NCT01896895|3608539|P2|Double-blind MP|Physician Decision|0
1102130|NCT01896895|3608540|P1|Double-blind MP|Physician Decision|0
1102131|NCT01896726|3608555|P1|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1
1102132|NCT01896726|3608555|P1|Treatment Period 2 (Days 23-31)|Adverse Event|1
1102133|NCT01896700|3608570|P2|Overall Study|Withdrawal by Subject|1
1102134|NCT01896700|3608571|P1|Overall Study|Withdrawal by Subject|0
1102135|NCT01896700|3608570|P2|Overall Study|Adverse Event|5
1102136|NCT01896700|3608571|P1|Overall Study|Adverse Event|4
1102137|NCT01896557|3608602|P2|Clopidogrel + GI Protector|Reading error|3
1102138|NCT01896557|3608603|P1|Clopidogrel + GI Protector|Reading error|1
1102139|NCT01896557|3608602|P2|Clopidogrel + GI Protector|low adherence|1
1102140|NCT01896557|3608603|P1|Clopidogrel + GI Protector|low adherence|1
1102141|NCT01896557|3608602|P2|Clopidogrel Alone|Adverse Event|0
1102142|NCT01896557|3608603|P1|Clopidogrel Alone|Adverse Event|1
1102143|NCT01896297|3608640|P1|Overall Study|Died in post treatment phase|1
1102144|NCT01896232|3608647|P2|Overall Study|Lost to Follow-up|12
1102145|NCT01896232|3608648|P1|Overall Study|Lost to Follow-up|9
1102146|NCT01896232|3608647|P2|Overall Study|Sponsor Decision|0
1102147|NCT01896232|3608648|P1|Overall Study|Sponsor Decision|2
1102148|NCT01896232|3608647|P2|Overall Study|Withdrawal by Subject|31
1102149|NCT01896232|3608648|P1|Overall Study|Withdrawal by Subject|32
1102150|NCT01896232|3608647|P2|Overall Study|Death|10
1102151|NCT01896232|3608648|P1|Overall Study|Death|6
1102152|NCT01896193|3608676|P2|Overall Study|Withdrew Consent|0
1102153|NCT01896193|3608677|P1|Overall Study|Withdrew Consent|1
1102154|NCT01896193|3608676|P2|Overall Study|Protocol Violation|1
1102155|NCT01896193|3608677|P1|Overall Study|Protocol Violation|0
1102156|NCT01896193|3608676|P2|Overall Study|Lack of Efficacy|11
1102157|NCT01896193|3608677|P1|Overall Study|Lack of Efficacy|20
1102158|NCT01896050|3608729|P2|Overall Study|Death|0
1102159|NCT01896050|3608730|P1|Overall Study|Death|1
1102160|NCT01896050|3608729|P2|Overall Study|Adverse Event|2
1102161|NCT01896050|3608730|P1|Overall Study|Adverse Event|37
1102162|NCT01895608|3608778|P4|Overall Study|Withdrawal by Subject|0
1102163|NCT01895608|3608779|P3|Overall Study|Withdrawal by Subject|2
1102164|NCT01895608|3608780|P2|Overall Study|Withdrawal by Subject|0
1102165|NCT01895608|3608781|P1|Overall Study|Withdrawal by Subject|0
1102166|NCT01895608|3608778|P4|Overall Study|change in health status|0
1102167|NCT01895608|3608779|P3|Overall Study|change in health status|1
1102168|NCT01895608|3608780|P2|Overall Study|change in health status|1
1102169|NCT01895608|3608781|P1|Overall Study|change in health status|0
1102170|NCT01895543|3608811|P1|Overall Study|Other (Not fulfilling above criteria)|24
1102171|NCT01895543|3608811|P1|Overall Study|Physician Decision|2
1102172|NCT01895543|3608811|P1|Overall Study|Protocol Violation|1
1102173|NCT01895543|3608811|P1|Overall Study|Subject's substantial non-compliance|6
1102174|NCT01895543|3608811|P1|Overall Study|Adverse Event|28
1102175|NCT01895543|3608811|P1|Overall Study|Lost to Follow-up|25
1102176|NCT01895543|3608811|P1|Overall Study|Withdrawal by Subject|43
1102177|NCT01895452|3608827|P2|Overall Study|Noncompliance with study drug|1
1102178|NCT01895452|3608828|P1|Overall Study|Noncompliance with study drug|0
1102179|NCT01895452|3608827|P2|Overall Study|Underlying disease|3
1102180|NCT01895452|3608828|P1|Overall Study|Underlying disease|0
1102181|NCT01895452|3608827|P2|Overall Study|Withdrawal by Subject|14
1102182|NCT01895452|3608828|P1|Overall Study|Withdrawal by Subject|2
1102183|NCT01895452|3608827|P2|Overall Study|Pregnancy|1
1102184|NCT01895452|3608828|P1|Overall Study|Pregnancy|0
1102185|NCT01895452|3608827|P2|Overall Study|Lost to Follow-up|5
1102186|NCT01895452|3608828|P1|Overall Study|Lost to Follow-up|1
1102187|NCT01895452|3608827|P2|Overall Study|Adverse Event|4
1102188|NCT01895452|3608828|P1|Overall Study|Adverse Event|1
1102189|NCT01895335|3608838|P1|Overall Study|Other than Specified Above|44
1102190|NCT01895335|3608838|P1|Overall Study|Included But Not treated|1
1102191|NCT01895335|3608838|P1|Overall Study|Poor Compliance to Protocol|11
1102192|NCT01895335|3608838|P1|Overall Study|Lack of Efficacy|53
1102193|NCT01895335|3608838|P1|Overall Study|Adverse Event|106
1102194|NCT01895322|3608855|P1|Overall Study|Protocol Violation|10
1102195|NCT01895322|3608855|P1|Overall Study|Withdrawal by Subject|2
1102196|NCT01895322|3608855|P1|Overall Study|Adverse Event|1
1102197|NCT01895309|3608864|P2|Overall Study|Withdrawal by Subject|18
1102198|NCT01895309|3608865|P1|Overall Study|Withdrawal by Subject|9
1102199|NCT01895309|3608864|P2|Overall Study|Physician Decision|10
1102200|NCT01895309|3608865|P1|Overall Study|Physician Decision|15
1102201|NCT01895309|3608864|P2|Overall Study|Lost to Follow-up|3
1102202|NCT01895309|3608865|P1|Overall Study|Lost to Follow-up|1
1102203|NCT01895309|3608864|P2|Overall Study|Lack of Efficacy|3
1102204|NCT01895309|3608865|P1|Overall Study|Lack of Efficacy|1
1102205|NCT01895309|3608864|P2|Overall Study|Protocol Violation|0
1102206|NCT01895309|3608865|P1|Overall Study|Protocol Violation|1
1102207|NCT01895309|3608864|P2|Overall Study|Adverse Event|17
1102208|NCT01895309|3608865|P1|Overall Study|Adverse Event|13
1102209|NCT01895270|3608879|P2|Isradipine Taper (W7-8)|Withdrawal by Subject|1
1102210|NCT01895270|3608880|P1|Isradipine Taper (W7-8)|Withdrawal by Subject|0
1102211|NCT01895270|3608879|P2|Isradipine Taper (W7-8)|Lost to Follow-up|1
1102212|NCT01895270|3608880|P1|Isradipine Taper (W7-8)|Lost to Follow-up|0
1102213|NCT01895270|3608879|P2|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5
1102214|NCT01895270|3608880|P1|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3
1102215|NCT01895270|3608879|P2|Study Medications Induction (W1-4)|Blood pressure issues|1
1102216|NCT01895270|3608880|P1|Study Medications Induction (W1-4)|Blood pressure issues|0
1102217|NCT01895270|3608879|P2|Study Medications Induction (W1-4)|noncompliance- missed medications|1
1102218|NCT01895270|3608880|P1|Study Medications Induction (W1-4)|noncompliance- missed medications|3
1102219|NCT01895270|3608879|P2|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2
1102220|NCT01895270|3608880|P1|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3
1102221|NCT01895270|3608879|P2|Study Medications Induction (W1-4)|Withdrawal by Subject|2
1102222|NCT01895270|3608880|P1|Study Medications Induction (W1-4)|Withdrawal by Subject|0
1102223|NCT01895101|3608899|P3|Overall Study|coagulation disorder|0
1102224|NCT01895101|3608900|P2|Overall Study|coagulation disorder|1
1102225|NCT01895101|3608901|P1|Overall Study|coagulation disorder|0
1102226|NCT01895101|3608899|P3|Overall Study|Death|0
1102227|NCT01895101|3608900|P2|Overall Study|Death|1
1102228|NCT01895101|3608901|P1|Overall Study|Death|0
1102229|NCT01895101|3608899|P3|Overall Study|another study, enrolled in other study|0
1102230|NCT01895101|3608900|P2|Overall Study|another study, enrolled in other study|1
1102231|NCT01895101|3608901|P1|Overall Study|another study, enrolled in other study|0
1102232|NCT01895101|3608899|P3|Overall Study|Withdrawal by Subject|2
1102233|NCT01895101|3608900|P2|Overall Study|Withdrawal by Subject|1
1102234|NCT01895101|3608901|P1|Overall Study|Withdrawal by Subject|0
1102235|NCT01895101|3608899|P3|Overall Study|OPCAB procedure|3
1102236|NCT01895101|3608900|P2|Overall Study|OPCAB procedure|1
1102237|NCT01895101|3608901|P1|Overall Study|OPCAB procedure|1
1102238|NCT01894984|3608936|P2|Overall Study|Other|175
1102239|NCT01894984|3608937|P1|Overall Study|Other|314
1102240|NCT01894919|3608966|P13|Overall Study|Lost to Follow-up|0
1102241|NCT01894919|3608967|P12|Overall Study|Lost to Follow-up|0
1102242|NCT01894919|3608968|P11|Overall Study|Lost to Follow-up|0
1102243|NCT01894919|3608969|P10|Overall Study|Lost to Follow-up|0
1102244|NCT01894919|3608970|P9|Overall Study|Lost to Follow-up|0
1102245|NCT01894919|3608971|P8|Overall Study|Lost to Follow-up|0
1102246|NCT01894919|3608972|P7|Overall Study|Lost to Follow-up|0
1102247|NCT01894919|3608973|P6|Overall Study|Lost to Follow-up|0
1102248|NCT01894919|3608974|P5|Overall Study|Lost to Follow-up|2
1102249|NCT01894919|3608975|P4|Overall Study|Lost to Follow-up|0
1102250|NCT01894919|3608976|P3|Overall Study|Lost to Follow-up|0
1102251|NCT01894919|3608977|P2|Overall Study|Lost to Follow-up|0
1102252|NCT01894919|3608978|P1|Overall Study|Lost to Follow-up|0
1102253|NCT01894919|3608966|P13|Overall Study|Other-Unspecified|0
1102254|NCT01894919|3608967|P12|Overall Study|Other-Unspecified|0
1102255|NCT01894919|3608968|P11|Overall Study|Other-Unspecified|0
1102256|NCT01894919|3608969|P10|Overall Study|Other-Unspecified|0
1102257|NCT01894919|3608970|P9|Overall Study|Other-Unspecified|0
1102258|NCT01894919|3608971|P8|Overall Study|Other-Unspecified|0
1102259|NCT01894919|3608972|P7|Overall Study|Other-Unspecified|0
1102260|NCT01894919|3608973|P6|Overall Study|Other-Unspecified|0
1102261|NCT01894919|3608974|P5|Overall Study|Other-Unspecified|0
1102262|NCT01894919|3608975|P4|Overall Study|Other-Unspecified|0
1102263|NCT01894919|3608976|P3|Overall Study|Other-Unspecified|0
1102264|NCT01894919|3608977|P2|Overall Study|Other-Unspecified|0
1102265|NCT01894919|3608978|P1|Overall Study|Other-Unspecified|1
1102266|NCT01894919|3608966|P13|Overall Study|Adverse Event|0
1102267|NCT01894919|3608967|P12|Overall Study|Adverse Event|0
1102268|NCT01894919|3608968|P11|Overall Study|Adverse Event|1
1102269|NCT01894919|3608969|P10|Overall Study|Adverse Event|0
1102270|NCT01894919|3608970|P9|Overall Study|Adverse Event|0
1102271|NCT01894919|3608971|P8|Overall Study|Adverse Event|0
1102272|NCT01894919|3608972|P7|Overall Study|Adverse Event|0
1102273|NCT01894919|3608973|P6|Overall Study|Adverse Event|0
1102274|NCT01894919|3608974|P5|Overall Study|Adverse Event|0
1102275|NCT01894919|3608975|P4|Overall Study|Adverse Event|0
1102276|NCT01894919|3608976|P3|Overall Study|Adverse Event|0
1102277|NCT01894919|3608977|P2|Overall Study|Adverse Event|0
1102278|NCT01894919|3608978|P1|Overall Study|Adverse Event|0
1102279|NCT01894919|3608966|P13|Overall Study|Withdrawal by Subject|0
1102280|NCT01894919|3608967|P12|Overall Study|Withdrawal by Subject|0
1102281|NCT01894919|3608968|P11|Overall Study|Withdrawal by Subject|1
1102282|NCT01894919|3608969|P10|Overall Study|Withdrawal by Subject|1
1102283|NCT01894919|3608970|P9|Overall Study|Withdrawal by Subject|0
1102284|NCT01894919|3608971|P8|Overall Study|Withdrawal by Subject|0
1102285|NCT01894919|3608972|P7|Overall Study|Withdrawal by Subject|0
1102286|NCT01894919|3608973|P6|Overall Study|Withdrawal by Subject|0
1102287|NCT01894919|3608974|P5|Overall Study|Withdrawal by Subject|1
1102288|NCT01894919|3608975|P4|Overall Study|Withdrawal by Subject|0
1102289|NCT01894919|3608976|P3|Overall Study|Withdrawal by Subject|0
1102290|NCT01894919|3608977|P2|Overall Study|Withdrawal by Subject|0
1102291|NCT01894919|3608978|P1|Overall Study|Withdrawal by Subject|1
1102292|NCT01894620|3609139|P2|Overall Study|Withdrawal by Subject|1
1102293|NCT01894620|3609140|P1|Overall Study|Withdrawal by Subject|0
1102294|NCT01894607|3609148|P1|Overall Study|Ineligible|1
1102295|NCT01894581|3609155|P2|Overall Study|Screen Failure|4
1102296|NCT01894581|3609156|P1|Overall Study|Screen Failure|3
1102297|NCT01894581|3609155|P2|Overall Study|Withdrawal by Subject|3
1102298|NCT01894581|3609156|P1|Overall Study|Withdrawal by Subject|2
1102299|NCT01894477|3609173|P2|Overall Study|protocol changed due SC changed to cord|1
1102300|NCT01894477|3609174|P1|Overall Study|protocol changed due SC changed to cord|0
1102301|NCT01894477|3609173|P2|Overall Study|Protocol Violation|1
1102302|NCT01894477|3609174|P1|Overall Study|Protocol Violation|0
1102303|NCT01894256|3609185|P3|Part B|Lack of Efficacy|13
1102304|NCT01894256|3609186|P2|Part B|Lack of Efficacy|12
1102305|NCT01894256|3609187|P1|Part B|Lack of Efficacy|15
1102306|NCT01894256|3609185|P3|Part B|Withdrawal by Subject|0
1102307|NCT01894256|3609186|P2|Part B|Withdrawal by Subject|1
1102308|NCT01894256|3609187|P1|Part B|Withdrawal by Subject|0
1102309|NCT01894256|3609185|P3|Part B|Death|1
1102310|NCT01894256|3609186|P2|Part B|Death|1
1102311|NCT01894256|3609187|P1|Part B|Death|0
1102312|NCT01894256|3609185|P3|Part A|Adverse Event|0
1102313|NCT01894256|3609186|P2|Part A|Adverse Event|1
1102314|NCT01894256|3609187|P1|Part A|Adverse Event|0
1102315|NCT01894230|3609233|P2|Overall Study|Death|0
1102316|NCT01894230|3609234|P1|Overall Study|Death|1
1102317|NCT01894230|3609233|P2|Overall Study|Non-adherent|1
1102318|NCT01894230|3609234|P1|Overall Study|Non-adherent|0
1102319|NCT01894230|3609233|P2|Overall Study|Withdrawal by Subject|4
1102320|NCT01894230|3609234|P1|Overall Study|Withdrawal by Subject|4
1102321|NCT01894230|3609233|P2|Overall Study|Lost to Follow-up|2
1102322|NCT01894230|3609234|P1|Overall Study|Lost to Follow-up|2
1102323|NCT01894100|3609260|P2|Overall Study|Withdrawal by Subject|0
1102324|NCT01894100|3609261|P1|Overall Study|Withdrawal by Subject|3
1102325|NCT01894100|3609260|P2|Overall Study|Lost to Follow-up|1
1102326|NCT01894100|3609261|P1|Overall Study|Lost to Follow-up|0
1102327|NCT01894022|3609286|P2|Overall Study|Study Closed/terminated|10
1102328|NCT01894022|3609287|P1|Overall Study|Study Closed/terminated|7
1102329|NCT01894022|3609286|P2|Overall Study|Adverse Event, non-fatal|0
1102330|NCT01894022|3609287|P1|Overall Study|Adverse Event, non-fatal|1
1102331|NCT01894022|3609286|P2|Overall Study|Death|0
1102332|NCT01894022|3609287|P1|Overall Study|Death|1
1102333|NCT01893905|3609341|P2|Overall Study|Other reason|3
1102334|NCT01893905|3609342|P1|Overall Study|Other reason|1
1102335|NCT01893905|3609341|P2|Overall Study|Lack of adherence to treatment|0
1102336|NCT01893905|3609342|P1|Overall Study|Lack of adherence to treatment|2
1102337|NCT01893905|3609341|P2|Overall Study|Protocol Violation|1
1102338|NCT01893905|3609342|P1|Overall Study|Protocol Violation|6
1102339|NCT01893905|3609341|P2|Overall Study|Lost to Follow-up|0
1102340|NCT01893905|3609342|P1|Overall Study|Lost to Follow-up|1
1102341|NCT01893905|3609341|P2|Overall Study|Lack of Efficacy|7
1102342|NCT01893905|3609342|P1|Overall Study|Lack of Efficacy|5
1102343|NCT01893905|3609341|P2|Overall Study|Adverse Event|3
1102344|NCT01893905|3609342|P1|Overall Study|Adverse Event|9
1102345|NCT01893905|3609341|P2|Overall Study|Withdrawal by Subject|0
1102346|NCT01893905|3609342|P1|Overall Study|Withdrawal by Subject|1
1102347|NCT01893411|3609373|P3|Overall Study|Lost to Follow-up|1
1102348|NCT01893411|3609374|P2|Overall Study|Lost to Follow-up|0
1102349|NCT01893411|3609375|P1|Overall Study|Lost to Follow-up|2
1102350|NCT01893411|3609373|P3|Overall Study|Withdrawal by Subject|3
1102351|NCT01893411|3609374|P2|Overall Study|Withdrawal by Subject|4
1102352|NCT01893411|3609375|P1|Overall Study|Withdrawal by Subject|7
1102353|NCT01893411|3609373|P3|Overall Study|Adverse Event|0
1102354|NCT01893411|3609374|P2|Overall Study|Adverse Event|0
1102355|NCT01893411|3609375|P1|Overall Study|Adverse Event|1
1102356|NCT01893411|3609373|P3|Overall Study|Not Specified|3
1102357|NCT01893411|3609374|P2|Overall Study|Not Specified|1
1102358|NCT01893411|3609375|P1|Overall Study|Not Specified|3
1102359|NCT01893411|3609373|P3|Overall Study|Lack of Efficacy|0
1102360|NCT01893411|3609374|P2|Overall Study|Lack of Efficacy|1
1102361|NCT01893411|3609375|P1|Overall Study|Lack of Efficacy|2
1102362|NCT01893411|3609373|P3|Overall Study|Physician Decision|2
1102363|NCT01893411|3609374|P2|Overall Study|Physician Decision|1
1102364|NCT01893411|3609375|P1|Overall Study|Physician Decision|1
1102365|NCT01893411|3609373|P3|Overall Study|Protocol Violation|0
1102366|NCT01893411|3609374|P2|Overall Study|Protocol Violation|0
1102367|NCT01893411|3609375|P1|Overall Study|Protocol Violation|1
1102368|NCT01893346|3609457|P4|Overall Study|Withdrawal by Subject|0
1102369|NCT01893346|3609458|P3|Overall Study|Withdrawal by Subject|0
1102370|NCT01893346|3609459|P2|Overall Study|Withdrawal by Subject|0
1102371|NCT01893346|3609460|P1|Overall Study|Withdrawal by Subject|2
1102372|NCT01893346|3609457|P4|Overall Study|Protocol Violation|0
1102373|NCT01893346|3609458|P3|Overall Study|Protocol Violation|0
1102374|NCT01893346|3609459|P2|Overall Study|Protocol Violation|0
1102375|NCT01893346|3609460|P1|Overall Study|Protocol Violation|1
1102376|NCT01893346|3609457|P4|Overall Study|Lost to Follow-up|0
1102377|NCT01893346|3609458|P3|Overall Study|Lost to Follow-up|0
1102378|NCT01893346|3609459|P2|Overall Study|Lost to Follow-up|1
1102379|NCT01893346|3609460|P1|Overall Study|Lost to Follow-up|0
1102380|NCT01893281|3609474|P1|Overall Study|Withdrawal by Subject|1
1102381|NCT01893281|3609474|P1|Overall Study|Protocol Violation|1
1102382|NCT01893281|3609474|P1|Overall Study|Adverse Event|1
1102383|NCT01893203|3609481|P1|Overall Study|Withdrawal by Subject|1
1102384|NCT01892722|3609505|P2|Overall Study|Withdrawal by Subject|5
1102385|NCT01892722|3609506|P1|Overall Study|Withdrawal by Subject|3
1102386|NCT01892722|3609505|P2|Overall Study|Lack of Efficacy|7
1102387|NCT01892722|3609506|P1|Overall Study|Lack of Efficacy|0
1102388|NCT01892722|3609505|P2|Overall Study|Adverse Event|2
1102389|NCT01892722|3609506|P1|Overall Study|Adverse Event|3
1102390|NCT01892722|3609505|P2|Overall Study|Physician Decision|2
1102391|NCT01892722|3609506|P1|Overall Study|Physician Decision|1
1102392|NCT01892722|3609505|P2|Overall Study|Patient/guardian decision|2
1102393|NCT01892722|3609506|P1|Overall Study|Patient/guardian decision|0
1102394|NCT01892722|3609505|P2|Overall Study|Administrative problems|1
1102395|NCT01892722|3609506|P1|Overall Study|Administrative problems|0
1102396|NCT01892722|3609505|P2|Overall Study|Protocol deviation|1
1102397|NCT01892722|3609506|P1|Overall Study|Protocol deviation|0
1102398|NCT01892657|3609522|P1|Overall Study|Protocol Violation|12
1102399|NCT01892657|3609522|P1|Overall Study|Withdrawal by Subject|6
1102400|NCT01892293|3609561|P1|Overall Study|Apheresed but not treated|4
1102401|NCT01892189|3609605|P9|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
1102402|NCT01892189|3609606|P8|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
1102403|NCT01892189|3609607|P7|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
1102404|NCT01892189|3609608|P6|Washout Period 1 (7 Days)|Noncompliance, Irritability|1
1102405|NCT01892189|3609609|P5|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
1102406|NCT01892189|3609610|P4|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
1102407|NCT01892189|3609611|P3|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
1102408|NCT01892189|3609612|P2|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
1102409|NCT01892189|3609613|P1|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
1102410|NCT01892189|3609605|P9|Washout Period 1 (7 Days)|Withdrawal by Subject|1
1102411|NCT01892189|3609606|P8|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1102412|NCT01892189|3609607|P7|Washout Period 1 (7 Days)|Withdrawal by Subject|1
1102413|NCT01892189|3609608|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1102414|NCT01892189|3609609|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1102415|NCT01892189|3609610|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|1
1102416|NCT01892189|3609611|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|2
1102417|NCT01892189|3609612|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1102418|NCT01892189|3609613|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1102419|NCT01892189|3609605|P9|Washout Period 1 (7 Days)|Adverse Event|1
1102420|NCT01892189|3609606|P8|Washout Period 1 (7 Days)|Adverse Event|0
1102421|NCT01892189|3609607|P7|Washout Period 1 (7 Days)|Adverse Event|0
1102422|NCT01892189|3609608|P6|Washout Period 1 (7 Days)|Adverse Event|0
1102423|NCT01892189|3609609|P5|Washout Period 1 (7 Days)|Adverse Event|0
1102424|NCT01892189|3609610|P4|Washout Period 1 (7 Days)|Adverse Event|0
1102425|NCT01892189|3609611|P3|Washout Period 1 (7 Days)|Adverse Event|0
1102426|NCT01892189|3609612|P2|Washout Period 1 (7 Days)|Adverse Event|0
1102427|NCT01892189|3609613|P1|Washout Period 1 (7 Days)|Adverse Event|0
1102428|NCT01892163|3609655|P2|Overall Study|Lost to Follow-up|0
1102429|NCT01892163|3609656|P1|Overall Study|Lost to Follow-up|1
1102430|NCT01892163|3609655|P2|Overall Study|Death|1
1102431|NCT01892163|3609656|P1|Overall Study|Death|1
1102432|NCT01892020|3609668|P2|Period 2|Protocol Violation|0
1102433|NCT01892020|3609669|P1|Period 2|Protocol Violation|1
1102434|NCT01892020|3609668|P2|Period 1|Unclassified|1
1102435|NCT01892020|3609669|P1|Period 1|Unclassified|0
1102436|NCT01892020|3609668|P2|Period 1|Protocol Violation|4
1102437|NCT01892020|3609669|P1|Period 1|Protocol Violation|2
1102438|NCT01892020|3609668|P2|Period 1|Adverse Event|1
1102439|NCT01892020|3609669|P1|Period 1|Adverse Event|1
1102440|NCT01891890|3609698|P3|Overall Study|Study ended before endpoint reached|6
1102441|NCT01891890|3609699|P2|Overall Study|Study ended before endpoint reached|3
1102442|NCT01891890|3609700|P1|Overall Study|Study ended before endpoint reached|7
1102443|NCT01891890|3609698|P3|Overall Study|Lost to Follow-up|1
1102444|NCT01891890|3609699|P2|Overall Study|Lost to Follow-up|0
1102445|NCT01891890|3609700|P1|Overall Study|Lost to Follow-up|0
1102446|NCT01891864|3609743|P6|Extension Period|Lost to Follow-up|0
1102447|NCT01891864|3609744|P5|Extension Period|Lost to Follow-up|0
1102448|NCT01891864|3609745|P4|Extension Period|Lost to Follow-up|0
1102449|NCT01891864|3609746|P3|Extension Period|Lost to Follow-up|2
1102450|NCT01891864|3609747|P2|Extension Period|Lost to Follow-up|0
1102451|NCT01891864|3609748|P1|Extension Period|Lost to Follow-up|0
1102452|NCT01891864|3609743|P6|Extension Period|Withdrawal by Subject|0
1102453|NCT01891864|3609744|P5|Extension Period|Withdrawal by Subject|4
1102454|NCT01891864|3609745|P4|Extension Period|Withdrawal by Subject|2
1102455|NCT01891864|3609746|P3|Extension Period|Withdrawal by Subject|1
1102456|NCT01891864|3609747|P2|Extension Period|Withdrawal by Subject|0
1102457|NCT01891864|3609748|P1|Extension Period|Withdrawal by Subject|0
1102458|NCT01891864|3609743|P6|Extension Period|Adverse Event|0
1102459|NCT01891864|3609744|P5|Extension Period|Adverse Event|2
1102460|NCT01891864|3609745|P4|Extension Period|Adverse Event|2
1102461|NCT01891864|3609746|P3|Extension Period|Adverse Event|4
1102462|NCT01891864|3609747|P2|Extension Period|Adverse Event|0
1102463|NCT01891864|3609748|P1|Extension Period|Adverse Event|0
1102464|NCT01891864|3609743|P6|Extension Period|Pregnancy|0
1102465|NCT01891864|3609744|P5|Extension Period|Pregnancy|0
1102466|NCT01891864|3609745|P4|Extension Period|Pregnancy|0
1102467|NCT01891864|3609746|P3|Extension Period|Pregnancy|1
1102468|NCT01891864|3609747|P2|Extension Period|Pregnancy|0
1102469|NCT01891864|3609748|P1|Extension Period|Pregnancy|0
1102470|NCT01891864|3609743|P6|Extension Period|Lack of Efficacy|0
1102471|NCT01891864|3609744|P5|Extension Period|Lack of Efficacy|1
1102472|NCT01891864|3609745|P4|Extension Period|Lack of Efficacy|1
1102473|NCT01891864|3609746|P3|Extension Period|Lack of Efficacy|0
1102474|NCT01891864|3609747|P2|Extension Period|Lack of Efficacy|0
1102475|NCT01891864|3609748|P1|Extension Period|Lack of Efficacy|0
1102476|NCT01891864|3609743|P6|Treatment Period 2|Withdrawal by Subject|1
1102477|NCT01891864|3609744|P5|Treatment Period 2|Withdrawal by Subject|1
1102478|NCT01891864|3609745|P4|Treatment Period 2|Withdrawal by Subject|4
1102479|NCT01891864|3609746|P3|Treatment Period 2|Withdrawal by Subject|3
1102480|NCT01891864|3609747|P2|Treatment Period 2|Withdrawal by Subject|0
1102481|NCT01891864|3609748|P1|Treatment Period 2|Withdrawal by Subject|0
1102482|NCT01891864|3609743|P6|Treatment Period 2|Termination of Site|0
1102483|NCT01891864|3609744|P5|Treatment Period 2|Termination of Site|2
1102484|NCT01891864|3609745|P4|Treatment Period 2|Termination of Site|0
1102485|NCT01891864|3609746|P3|Treatment Period 2|Termination of Site|0
1102486|NCT01891864|3609747|P2|Treatment Period 2|Termination of Site|0
1102487|NCT01891864|3609748|P1|Treatment Period 2|Termination of Site|0
1102488|NCT01891864|3609743|P6|Treatment Period 2|Adverse Event|4
1102489|NCT01891864|3609744|P5|Treatment Period 2|Adverse Event|0
1102490|NCT01891864|3609745|P4|Treatment Period 2|Adverse Event|2
1102491|NCT01891864|3609746|P3|Treatment Period 2|Adverse Event|1
1102492|NCT01891864|3609747|P2|Treatment Period 2|Adverse Event|0
1102493|NCT01891864|3609748|P1|Treatment Period 2|Adverse Event|0
1102494|NCT01891864|3609743|P6|Treatment Period 2|Lack of Efficacy|0
1102495|NCT01891864|3609744|P5|Treatment Period 2|Lack of Efficacy|1
1102496|NCT01891864|3609745|P4|Treatment Period 2|Lack of Efficacy|0
1102497|NCT01891864|3609746|P3|Treatment Period 2|Lack of Efficacy|1
1102498|NCT01891864|3609747|P2|Treatment Period 2|Lack of Efficacy|0
1102499|NCT01891864|3609748|P1|Treatment Period 2|Lack of Efficacy|0
1102500|NCT01891864|3609743|P6|Treatment Period 2|Site Termination|0
1102501|NCT01891864|3609744|P5|Treatment Period 2|Site Termination|0
1102502|NCT01891864|3609745|P4|Treatment Period 2|Site Termination|2
1102503|NCT01891864|3609746|P3|Treatment Period 2|Site Termination|1
1102504|NCT01891864|3609747|P2|Treatment Period 2|Site Termination|0
1102505|NCT01891864|3609748|P1|Treatment Period 2|Site Termination|0
1102506|NCT01891864|3609743|P6|Treatment Period 2|Physician Decision|0
1102507|NCT01891864|3609744|P5|Treatment Period 2|Physician Decision|0
1102508|NCT01891864|3609745|P4|Treatment Period 2|Physician Decision|0
1102509|NCT01891864|3609746|P3|Treatment Period 2|Physician Decision|1
1102510|NCT01891864|3609747|P2|Treatment Period 2|Physician Decision|0
1102511|NCT01891864|3609748|P1|Treatment Period 2|Physician Decision|0
1102512|NCT01891864|3609743|P6|Treatment Period 2|Protocol Violation|0
1102513|NCT01891864|3609744|P5|Treatment Period 2|Protocol Violation|0
1102514|NCT01891864|3609745|P4|Treatment Period 2|Protocol Violation|1
1102515|NCT01891864|3609746|P3|Treatment Period 2|Protocol Violation|0
1102516|NCT01891864|3609747|P2|Treatment Period 2|Protocol Violation|0
1102517|NCT01891864|3609748|P1|Treatment Period 2|Protocol Violation|0
1102518|NCT01891864|3609743|P6|Treatment Period 1|Lost to Follow-up|0
1102519|NCT01891864|3609744|P5|Treatment Period 1|Lost to Follow-up|0
1102520|NCT01891864|3609745|P4|Treatment Period 1|Lost to Follow-up|0
1102521|NCT01891864|3609746|P3|Treatment Period 1|Lost to Follow-up|0
1102522|NCT01891864|3609747|P2|Treatment Period 1|Lost to Follow-up|0
1102523|NCT01891864|3609748|P1|Treatment Period 1|Lost to Follow-up|1
1102524|NCT01891864|3609743|P6|Treatment Period 1|Withdrawal by Subject|0
1102525|NCT01891864|3609744|P5|Treatment Period 1|Withdrawal by Subject|0
1102526|NCT01891864|3609745|P4|Treatment Period 1|Withdrawal by Subject|0
1102527|NCT01891864|3609746|P3|Treatment Period 1|Withdrawal by Subject|0
1102528|NCT01891864|3609747|P2|Treatment Period 1|Withdrawal by Subject|5
1102529|NCT01891864|3609748|P1|Treatment Period 1|Withdrawal by Subject|2
1102530|NCT01891864|3609743|P6|Treatment Period 1|Adverse Event / Injection Site Reaction|0
1102531|NCT01891864|3609744|P5|Treatment Period 1|Adverse Event / Injection Site Reaction|0
1102532|NCT01891864|3609745|P4|Treatment Period 1|Adverse Event / Injection Site Reaction|0
1102533|NCT01891864|3609746|P3|Treatment Period 1|Adverse Event / Injection Site Reaction|0
1102534|NCT01891864|3609747|P2|Treatment Period 1|Adverse Event / Injection Site Reaction|4
1102535|NCT01891864|3609748|P1|Treatment Period 1|Adverse Event / Injection Site Reaction|4
1102536|NCT01891864|3609743|P6|Treatment Period 1|Adverse Event, Serious, Fatal|0
1102537|NCT01891864|3609744|P5|Treatment Period 1|Adverse Event, Serious, Fatal|0
1102538|NCT01891864|3609745|P4|Treatment Period 1|Adverse Event, Serious, Fatal|0
1102539|NCT01891864|3609746|P3|Treatment Period 1|Adverse Event, Serious, Fatal|0
1102540|NCT01891864|3609747|P2|Treatment Period 1|Adverse Event, Serious, Fatal|1
1102541|NCT01891864|3609748|P1|Treatment Period 1|Adverse Event, Serious, Fatal|0
1102542|NCT01891864|3609743|P6|Treatment Period 1|Physician Decision|0
1102543|NCT01891864|3609744|P5|Treatment Period 1|Physician Decision|0
1102544|NCT01891864|3609745|P4|Treatment Period 1|Physician Decision|0
1102545|NCT01891864|3609746|P3|Treatment Period 1|Physician Decision|0
1102546|NCT01891864|3609747|P2|Treatment Period 1|Physician Decision|1
1102547|NCT01891864|3609748|P1|Treatment Period 1|Physician Decision|0
1102548|NCT01891864|3609743|P6|Treatment Period 1|Protocol Violation / IMP non-compliance|0
1102549|NCT01891864|3609744|P5|Treatment Period 1|Protocol Violation / IMP non-compliance|0
1102550|NCT01891864|3609745|P4|Treatment Period 1|Protocol Violation / IMP non-compliance|0
1102551|NCT01891864|3609746|P3|Treatment Period 1|Protocol Violation / IMP non-compliance|0
1102552|NCT01891864|3609747|P2|Treatment Period 1|Protocol Violation / IMP non-compliance|1
1102553|NCT01891864|3609748|P1|Treatment Period 1|Protocol Violation / IMP non-compliance|1
1102554|NCT01891669|3609791|P10|Overall Study|Other|0
1102555|NCT01891669|3609792|P9|Overall Study|Other|0
1102556|NCT01891669|3609793|P8|Overall Study|Other|1
1102557|NCT01891669|3609794|P7|Overall Study|Other|0
1102558|NCT01891669|3609795|P6|Overall Study|Other|0
1102559|NCT01891669|3609796|P5|Overall Study|Other|0
1102560|NCT01891669|3609797|P4|Overall Study|Other|0
1102561|NCT01891669|3609798|P3|Overall Study|Other|0
1102562|NCT01891669|3609799|P2|Overall Study|Other|0
1102563|NCT01891669|3609800|P1|Overall Study|Other|1
1102564|NCT01891669|3609791|P10|Overall Study|Withdrawal by Subject|1
1102565|NCT01891669|3609792|P9|Overall Study|Withdrawal by Subject|1
1102566|NCT01891669|3609793|P8|Overall Study|Withdrawal by Subject|2
1102567|NCT01891669|3609794|P7|Overall Study|Withdrawal by Subject|1
1102568|NCT01891669|3609795|P6|Overall Study|Withdrawal by Subject|0
1102569|NCT01891669|3609796|P5|Overall Study|Withdrawal by Subject|0
1102570|NCT01891669|3609797|P4|Overall Study|Withdrawal by Subject|0
1102571|NCT01891669|3609798|P3|Overall Study|Withdrawal by Subject|0
1102572|NCT01891669|3609799|P2|Overall Study|Withdrawal by Subject|1
1102573|NCT01891669|3609800|P1|Overall Study|Withdrawal by Subject|1
1102574|NCT01891669|3609791|P10|Overall Study|Death|1
1102575|NCT01891669|3609792|P9|Overall Study|Death|0
1102576|NCT01891669|3609793|P8|Overall Study|Death|1
1102577|NCT01891669|3609794|P7|Overall Study|Death|0
1102578|NCT01891669|3609795|P6|Overall Study|Death|0
1102579|NCT01891669|3609796|P5|Overall Study|Death|0
1102580|NCT01891669|3609797|P4|Overall Study|Death|0
1102581|NCT01891669|3609798|P3|Overall Study|Death|0
1102582|NCT01891669|3609799|P2|Overall Study|Death|0
1102583|NCT01891669|3609800|P1|Overall Study|Death|0
1102584|NCT01890967|3609991|P6|Overall Study|Withdrawal by Subject|1
1102585|NCT01890967|3609992|P5|Overall Study|Withdrawal by Subject|3
1102586|NCT01890967|3609993|P4|Overall Study|Withdrawal by Subject|3
1102587|NCT01890967|3609994|P3|Overall Study|Withdrawal by Subject|2
1102588|NCT01890967|3609995|P2|Overall Study|Withdrawal by Subject|4
1102589|NCT01890967|3609996|P1|Overall Study|Withdrawal by Subject|3
1102590|NCT01890967|3609991|P6|Overall Study|Sponsor Decision|3
1102591|NCT01890967|3609992|P5|Overall Study|Sponsor Decision|2
1102592|NCT01890967|3609993|P4|Overall Study|Sponsor Decision|3
1102593|NCT01890967|3609994|P3|Overall Study|Sponsor Decision|1
1102594|NCT01890967|3609995|P2|Overall Study|Sponsor Decision|0
1102595|NCT01890967|3609996|P1|Overall Study|Sponsor Decision|2
1102596|NCT01890967|3609991|P6|Overall Study|Protocol Violation|1
1102597|NCT01890967|3609992|P5|Overall Study|Protocol Violation|4
1102598|NCT01890967|3609993|P4|Overall Study|Protocol Violation|2
1102599|NCT01890967|3609994|P3|Overall Study|Protocol Violation|3
1102600|NCT01890967|3609995|P2|Overall Study|Protocol Violation|3
1102601|NCT01890967|3609996|P1|Overall Study|Protocol Violation|0
1102602|NCT01890967|3609991|P6|Overall Study|Lost to Follow-up|1
1102603|NCT01890967|3609992|P5|Overall Study|Lost to Follow-up|0
1102604|NCT01890967|3609993|P4|Overall Study|Lost to Follow-up|1
1102605|NCT01890967|3609994|P3|Overall Study|Lost to Follow-up|1
1102606|NCT01890967|3609995|P2|Overall Study|Lost to Follow-up|1
1102607|NCT01890967|3609996|P1|Overall Study|Lost to Follow-up|1
1102608|NCT01890967|3609991|P6|Overall Study|Death|0
1102609|NCT01890967|3609992|P5|Overall Study|Death|0
1102610|NCT01890967|3609993|P4|Overall Study|Death|0
1102611|NCT01890967|3609994|P3|Overall Study|Death|0
1102612|NCT01890967|3609995|P2|Overall Study|Death|0
1102613|NCT01890967|3609996|P1|Overall Study|Death|1
1102614|NCT01890967|3609991|P6|Overall Study|Adverse Event|7
1102615|NCT01890967|3609992|P5|Overall Study|Adverse Event|1
1102616|NCT01890967|3609993|P4|Overall Study|Adverse Event|2
1102617|NCT01890967|3609994|P3|Overall Study|Adverse Event|3
1102618|NCT01890967|3609995|P2|Overall Study|Adverse Event|3
1102619|NCT01890967|3609996|P1|Overall Study|Adverse Event|3
1102620|NCT01890915|3610074|P2|Overall Study|Equipment Malfunction|1
1102621|NCT01890915|3610075|P1|Overall Study|Equipment Malfunction|0
1102622|NCT01890915|3610074|P2|Overall Study|Protocol Violation|0
1102623|NCT01890915|3610075|P1|Overall Study|Protocol Violation|2
1102624|NCT01890915|3610074|P2|Overall Study|Adverse Event|0
1102625|NCT01890915|3610075|P1|Overall Study|Adverse Event|1
1102626|NCT01890785|3610091|P6|Third Intervention|Withdrawal by Subject|0
1102627|NCT01890785|3610092|P5|Third Intervention|Withdrawal by Subject|0
1102628|NCT01890785|3610093|P4|Third Intervention|Withdrawal by Subject|0
1102629|NCT01890785|3610094|P3|Third Intervention|Withdrawal by Subject|0
1102630|NCT01890785|3610095|P2|Third Intervention|Withdrawal by Subject|1
1102631|NCT01890785|3610096|P1|Third Intervention|Withdrawal by Subject|0
1102632|NCT01890759|3610115|P2|Overall Study|Withdrawal by Subject|8
1102633|NCT01890759|3610116|P1|Overall Study|Withdrawal by Subject|2
1102634|NCT01890759|3610115|P2|Overall Study|Lost to Follow-up|2
1102635|NCT01890759|3610116|P1|Overall Study|Lost to Follow-up|0
1102636|NCT01890759|3610115|P2|Overall Study|Protocol Violation|2
1102637|NCT01890759|3610116|P1|Overall Study|Protocol Violation|0
1102638|NCT01890746|3610150|P2|Overall Study|Ongoing|50
1102639|NCT01890746|3610151|P1|Overall Study|Ongoing|44
1102640|NCT01890746|3610150|P2|Overall Study|Death|14
1102641|NCT01890746|3610151|P1|Overall Study|Death|23
1102642|NCT01890746|3610150|P2|Overall Study|Withdrawal by Subject|8
1102643|NCT01890746|3610151|P1|Overall Study|Withdrawal by Subject|4
1102644|NCT01890746|3610150|P2|Overall Study|Physician Decision|2
1102645|NCT01890746|3610151|P1|Overall Study|Physician Decision|2
1102646|NCT01890746|3610150|P2|Overall Study|Adverse Event|0
1102647|NCT01890746|3610151|P1|Overall Study|Adverse Event|1
1102648|NCT01890512|3610248|P1|Overall Study|Protocol Violation|1
1102649|NCT01890512|3610248|P1|Overall Study|Withdrawal by Subject|1
1102650|NCT01890512|3610248|P1|Overall Study|Physician Decision|1
1102651|NCT01890473|3610254|P2|Overall Study|Poor/non-compliance|0
1102652|NCT01890473|3610255|P1|Overall Study|Poor/non-compliance|1
1102653|NCT01890473|3610254|P2|Overall Study|Lost to Follow-up|0
1102654|NCT01890473|3610255|P1|Overall Study|Lost to Follow-up|1
1102655|NCT01890434|3610281|P1|Overall Study|Withdrawal by PI for ICA not performed|2
1102656|NCT01890434|3610281|P1|Overall Study|Unable to contact|1
1102657|NCT01890434|3610281|P1|Overall Study|Moved out of position|1
1102658|NCT01890434|3610281|P1|Overall Study|Uncontactable by phone|1
1102659|NCT01890434|3610281|P1|Overall Study|Participant didn't complete MRI|1
1102660|NCT01890434|3610281|P1|Overall Study|GSPECT at rest was not done|1
1102661|NCT01890434|3610281|P1|Overall Study|Decline to return for GSPECT|1
1102662|NCT01890434|3610281|P1|Overall Study|Could not get whole set of images|1
1102663|NCT01890434|3610281|P1|Overall Study|CRC didn't contact participant for FU|1
1102664|NCT01890434|3610281|P1|Overall Study|Assessment discrepancy|1
1102665|NCT01890434|3610281|P1|Overall Study|PCI at external hospital|1
1102666|NCT01890434|3610281|P1|Overall Study|Adverse Event|8
1102667|NCT01890421|3610311|P1|Overall Study|Other reason|10
1102668|NCT01890421|3610311|P1|Overall Study|Adverse Event|1
1102669|NCT01890148|3610350|P1|Overall Study|Adverse Event|1
1102670|NCT01890122|3610370|P4|Overall Study|Randomized but not Treated|0
1102671|NCT01890122|3610371|P3|Overall Study|Randomized but not Treated|0
1102672|NCT01890122|3610372|P2|Overall Study|Randomized but not Treated|1
1102673|NCT01890122|3610373|P1|Overall Study|Randomized but not Treated|1
1102674|NCT01890122|3610370|P4|Overall Study|Reason not Specified|2
1102675|NCT01890122|3610371|P3|Overall Study|Reason not Specified|1
1102676|NCT01890122|3610372|P2|Overall Study|Reason not Specified|1
1102677|NCT01890122|3610373|P1|Overall Study|Reason not Specified|0
1102678|NCT01890122|3610370|P4|Overall Study|Lack of Efficacy|41
1102679|NCT01890122|3610371|P3|Overall Study|Lack of Efficacy|7
1102680|NCT01890122|3610372|P2|Overall Study|Lack of Efficacy|24
1102681|NCT01890122|3610373|P1|Overall Study|Lack of Efficacy|14
1102682|NCT01890122|3610370|P4|Overall Study|Voluntary Withdrawal|11
1102683|NCT01890122|3610371|P3|Overall Study|Voluntary Withdrawal|2
1102684|NCT01890122|3610372|P2|Overall Study|Voluntary Withdrawal|8
1102685|NCT01890122|3610373|P1|Overall Study|Voluntary Withdrawal|8
1102686|NCT01890122|3610370|P4|Overall Study|Lost to Follow-up|2
1102687|NCT01890122|3610371|P3|Overall Study|Lost to Follow-up|2
1102688|NCT01890122|3610372|P2|Overall Study|Lost to Follow-up|1
1102689|NCT01890122|3610373|P1|Overall Study|Lost to Follow-up|0
1102690|NCT01890122|3610370|P4|Overall Study|Major Protocol Deviation|1
1102691|NCT01890122|3610371|P3|Overall Study|Major Protocol Deviation|0
1102692|NCT01890122|3610372|P2|Overall Study|Major Protocol Deviation|1
1102693|NCT01890122|3610373|P1|Overall Study|Major Protocol Deviation|3
1102694|NCT01890122|3610370|P4|Overall Study|Adverse Event|2
1102695|NCT01890122|3610371|P3|Overall Study|Adverse Event|1
1102696|NCT01890122|3610372|P2|Overall Study|Adverse Event|1
1102697|NCT01890122|3610373|P1|Overall Study|Adverse Event|1
1102698|NCT01889251|3610524|P2|Overall Study|Adverse Event|0
1102699|NCT01889251|3610525|P1|Overall Study|Adverse Event|1
1102700|NCT01889238|3610531|P1|Overall Study|Treatment ongoing|9
1102701|NCT01888965|3610548|P1|Overall Study|Lack of Efficacy|4
1102702|NCT01888965|3610548|P1|Overall Study|Adverse Event|5
1102703|NCT01888900|3610560|P2|Overall Study|failed treatment|2
1102704|NCT01888900|3610561|P1|Overall Study|failed treatment|0
1102705|NCT01888432|3610583|P2|24-month Analysis (FAS)|Death|4
1102706|NCT01888432|3610584|P1|24-month Analysis (FAS)|Death|8
1102707|NCT01888432|3610583|P2|24-month Analysis (FAS)|Withdrawal by Subject|6
1102708|NCT01888432|3610584|P1|24-month Analysis (FAS)|Withdrawal by Subject|7
1102709|NCT01888432|3610583|P2|24-month Analysis (FAS)|Physician Decision|4
1102710|NCT01888432|3610584|P1|24-month Analysis (FAS)|Physician Decision|2
1102711|NCT01888432|3610583|P2|24-month Analysis (FAS)|Lost to Follow-up|2
1102712|NCT01888432|3610584|P1|24-month Analysis (FAS)|Lost to Follow-up|0
1102713|NCT01888432|3610583|P2|24-month Analysis (FAS)|Graft loss|1
1102714|NCT01888432|3610584|P1|24-month Analysis (FAS)|Graft loss|0
1102715|NCT01888432|3610583|P2|12-month Analysis (FAS)|Death|3
1102716|NCT01888432|3610584|P1|12-month Analysis (FAS)|Death|4
1102717|NCT01888432|3610583|P2|12-month Analysis (FAS)|Withdrawal by Subject|3
1102718|NCT01888432|3610584|P1|12-month Analysis (FAS)|Withdrawal by Subject|6
1102719|NCT01888432|3610583|P2|12-month Analysis (FAS)|Physician Decision|1
1102720|NCT01888432|3610584|P1|12-month Analysis (FAS)|Physician Decision|1
1102721|NCT01888432|3610583|P2|12-month Analysis (FAS)|Lost to Follow-up|2
1102722|NCT01888432|3610584|P1|12-month Analysis (FAS)|Lost to Follow-up|0
1102723|NCT01888367|3610619|P3|Overall Study|30-Day Visit Too Early (< 28 Days)|0
1102724|NCT01888367|3610620|P2|Overall Study|30-Day Visit Too Early (< 28 Days)|0
1102725|NCT01888367|3610621|P1|Overall Study|30-Day Visit Too Early (< 28 Days)|1
1102726|NCT01888367|3610619|P3|Overall Study|Protocol Violation|1
1102727|NCT01888367|3610620|P2|Overall Study|Protocol Violation|0
1102728|NCT01888367|3610621|P1|Overall Study|Protocol Violation|0
1102729|NCT01888367|3610619|P3|Overall Study|Lost to Follow-up|0
1102730|NCT01888367|3610620|P2|Overall Study|Lost to Follow-up|1
1102731|NCT01888367|3610621|P1|Overall Study|Lost to Follow-up|1
1102732|NCT01888367|3610619|P3|Overall Study|Withdrawal by Subject|1
1102733|NCT01888367|3610620|P2|Overall Study|Withdrawal by Subject|0
1102734|NCT01888367|3610621|P1|Overall Study|Withdrawal by Subject|1
1102735|NCT01888367|3610619|P3|Overall Study|Death|1
1102736|NCT01888367|3610620|P2|Overall Study|Death|0
1102737|NCT01888367|3610621|P1|Overall Study|Death|2
1102738|NCT01888367|3610619|P3|Overall Study|Physician Decision|2
1102739|NCT01888367|3610620|P2|Overall Study|Physician Decision|4
1102740|NCT01888367|3610621|P1|Overall Study|Physician Decision|3
1102741|NCT01888003|3610641|P3|Overall Study|Study Terminated|40
1102742|NCT01888003|3610642|P2|Overall Study|Study Terminated|6
1102743|NCT01888003|3610643|P1|Overall Study|Study Terminated|5
1102744|NCT01887678|3610683|P2|Overall Study|Specified|2
1102745|NCT01887678|3610684|P1|Overall Study|Specified|1
1102746|NCT01887678|3610683|P2|Overall Study|Non-compliance|3
1102747|NCT01887678|3610684|P1|Overall Study|Non-compliance|0
1102748|NCT01887678|3610683|P2|Overall Study|Lack of Efficacy|2
1102749|NCT01887678|3610684|P1|Overall Study|Lack of Efficacy|1
1102750|NCT01887678|3610683|P2|Overall Study|Deterioration of clinical condition|4
1102751|NCT01887678|3610684|P1|Overall Study|Deterioration of clinical condition|0
1102752|NCT01887678|3610683|P2|Overall Study|Lost to Follow-up|2
1102753|NCT01887678|3610684|P1|Overall Study|Lost to Follow-up|4
1102754|NCT01887678|3610683|P2|Overall Study|Withdrawal of consent|4
1102755|NCT01887678|3610684|P1|Overall Study|Withdrawal of consent|3
1102756|NCT01887678|3610683|P2|Overall Study|Exceeded rescue medication dosage|5
1102757|NCT01887678|3610684|P1|Overall Study|Exceeded rescue medication dosage|4
1102758|NCT01887678|3610683|P2|Overall Study|Adverse Event|6
1102759|NCT01887678|3610684|P1|Overall Study|Adverse Event|4
1102760|NCT01887418|3610752|P3|Overall Study|Travelling difficulties|1
1102761|NCT01887418|3610753|P2|Overall Study|Travelling difficulties|0
1102762|NCT01887418|3610754|P1|Overall Study|Travelling difficulties|0
1102763|NCT01887353|3610773|P2|Overall Study|Study stopped early|3
1102764|NCT01887353|3610774|P1|Overall Study|Study stopped early|4
1102765|NCT01887288|3610780|P1|Overall Study|The study was terminated and the PI has|16
1102766|NCT01887210|3610787|P2|Overall Study|Lost to Follow-up|1
1102767|NCT01887210|3610788|P1|Overall Study|Lost to Follow-up|0
1102768|NCT01887210|3610787|P2|Overall Study|Withdrawal by Subject|3
1102769|NCT01887210|3610788|P1|Overall Study|Withdrawal by Subject|1
1102770|NCT01886833|3610832|P1|Overall Study|IgA not available from both periods|204
1102771|NCT01886781|3610855|P2|Overall Study|Worsening of symptoms|1
1102772|NCT01886781|3610856|P1|Overall Study|Worsening of symptoms|1
1102773|NCT01886781|3610855|P2|Overall Study|Withdrawal by Subject|1
1102774|NCT01886781|3610856|P1|Overall Study|Withdrawal by Subject|2
1102775|NCT01886781|3610855|P2|Overall Study|Lost to Follow-up|0
1102776|NCT01886781|3610856|P1|Overall Study|Lost to Follow-up|5
1102777|NCT01886781|3610855|P2|Overall Study|Adverse Event|0
1102778|NCT01886781|3610856|P1|Overall Study|Adverse Event|1
1102779|NCT01886781|3610855|P2|Overall Study|Protocol Violation|0
1102780|NCT01886781|3610856|P1|Overall Study|Protocol Violation|5
1102781|NCT01886716|3610866|P4|Week 3|Lost to Follow-up|1
1102782|NCT01886716|3610867|P3|Week 3|Lost to Follow-up|0
1102783|NCT01886716|3610868|P2|Week 3|Lost to Follow-up|1
1102784|NCT01886716|3610869|P1|Week 3|Lost to Follow-up|1
1102785|NCT01886716|3610866|P4|Week 2|Lost to Follow-up|3
1102786|NCT01886716|3610867|P3|Week 2|Lost to Follow-up|1
1102787|NCT01886716|3610868|P2|Week 2|Lost to Follow-up|2
1102788|NCT01886716|3610869|P1|Week 2|Lost to Follow-up|3
1102789|NCT01886716|3610866|P4|Week 1|Lost to Follow-up|2
1102790|NCT01886716|3610867|P3|Week 1|Lost to Follow-up|2
1102791|NCT01886716|3610868|P2|Week 1|Lost to Follow-up|0
1102792|NCT01886716|3610869|P1|Week 1|Lost to Follow-up|0
1102793|NCT01886690|3610885|P2|Overall Study|Personal Reasons|1
1102794|NCT01886690|3610886|P1|Overall Study|Personal Reasons|0
1102795|NCT01886690|3610885|P2|Overall Study|Protocol Violation|1
1102796|NCT01886690|3610886|P1|Overall Study|Protocol Violation|0
1102797|NCT01886313|3610902|P2|Overall Study|Adverse Event|1
1102798|NCT01886313|3610903|P1|Overall Study|Adverse Event|1
1102799|NCT01886300|3610909|P1|Overall Study|Trial terminated by sponsor|16
1102800|NCT01886287|3610920|P1|Overall Study|Clinical progression due to disease|1
1102801|NCT01886287|3610920|P1|Overall Study|Radiographic disease progression|1
1102802|NCT01885936|3610938|P2|Overall Study|Withdrawal by Subject|0
1102803|NCT01885936|3610939|P1|Overall Study|Withdrawal by Subject|1
1102804|NCT01885559|3610973|P2|Overall Study|Protocol Violation|1
1102805|NCT01885559|3610974|P1|Overall Study|Protocol Violation|0
1102806|NCT01885559|3610973|P2|Overall Study|Less than full participation|19
1102807|NCT01885559|3610974|P1|Overall Study|Less than full participation|9
1102808|NCT01885559|3610973|P2|Overall Study|Lost to Follow-up|16
1102809|NCT01885559|3610974|P1|Overall Study|Lost to Follow-up|15
1102810|NCT01885208|3610996|P2|Overall Study|Unclassified|38
1102811|NCT01885208|3610997|P1|Overall Study|Unclassified|32
1102812|NCT01885104|3611038|P2|Overall Study|Physician Decision|0
1102813|NCT01885104|3611039|P1|Overall Study|Physician Decision|1
1102814|NCT01885104|3611038|P2|Overall Study|Lost to Follow-up|1
1102815|NCT01885104|3611039|P1|Overall Study|Lost to Follow-up|0
1102816|NCT01885104|3611038|P2|Overall Study|Withdrawal of Consent|0
1102817|NCT01885104|3611039|P1|Overall Study|Withdrawal of Consent|1
1102818|NCT01885000|3611049|P2|Overall Study|Protocol Violation|1
1102819|NCT01885000|3611050|P1|Overall Study|Protocol Violation|0
1102820|NCT01885000|3611049|P2|Overall Study|Withdrawal by Subject|1
1102821|NCT01885000|3611050|P1|Overall Study|Withdrawal by Subject|1
1102822|NCT01885000|3611049|P2|Overall Study|Adverse Event|0
1102823|NCT01885000|3611050|P1|Overall Study|Adverse Event|1
1102824|NCT01884688|3611071|P1|Overall Study|Screen Failure|2
1102825|NCT01884675|3611077|P2|Overall Study|Study closed/terminated|2
1102826|NCT01884675|3611078|P1|Overall Study|Study closed/terminated|3
1102827|NCT01884597|3611121|P3|Overall Study|Death|0
1102828|NCT01884597|3611122|P2|Overall Study|Death|1
1102829|NCT01884597|3611123|P1|Overall Study|Death|0
1102830|NCT01884597|3611121|P3|Overall Study|Lack of Efficacy|0
1102831|NCT01884597|3611122|P2|Overall Study|Lack of Efficacy|0
1102832|NCT01884597|3611123|P1|Overall Study|Lack of Efficacy|1
1102833|NCT01884597|3611121|P3|Overall Study|Adverse Event|1
1102834|NCT01884597|3611122|P2|Overall Study|Adverse Event|0
1102835|NCT01884597|3611123|P1|Overall Study|Adverse Event|0
1102836|NCT01884571|3611152|P1|Overall Study|Disease progression|3
1102837|NCT01884571|3611152|P1|Overall Study|Withdrawal by Subject|2
1102838|NCT01884571|3611152|P1|Overall Study|Death|2
1102839|NCT01884571|3611152|P1|Overall Study|Adverse Event|1
1102840|NCT01884545|3611167|P4|Overall Study|Non-adherence|0
1102841|NCT01884545|3611168|P3|Overall Study|Non-adherence|0
1102842|NCT01884545|3611169|P2|Overall Study|Non-adherence|2
1102843|NCT01884545|3611170|P1|Overall Study|Non-adherence|0
1102844|NCT01884545|3611167|P4|Overall Study|Patient withdrawn|5
1102845|NCT01884545|3611168|P3|Overall Study|Patient withdrawn|5
1102846|NCT01884545|3611169|P2|Overall Study|Patient withdrawn|12
1102847|NCT01884545|3611170|P1|Overall Study|Patient withdrawn|7
1102848|NCT01884545|3611167|P4|Overall Study|Lost to Follow-up|4
1102849|NCT01884545|3611168|P3|Overall Study|Lost to Follow-up|9
1102850|NCT01884545|3611169|P2|Overall Study|Lost to Follow-up|4
1102851|NCT01884545|3611170|P1|Overall Study|Lost to Follow-up|6
1102852|NCT01884311|3611321|P1|Overall Study|Precautionary measure|1
1102853|NCT01884311|3611321|P1|Overall Study|withdrew consent due to AEs|1
1102854|NCT01884311|3611321|P1|Overall Study|Withdrawal by Subject|3
1102855|NCT01884077|3611331|P2|Overall Study|study closed|4
1102856|NCT01884077|3611332|P1|Overall Study|study closed|6
1102857|NCT01884077|3611331|P2|Overall Study|Lost to Follow-up|4
1102858|NCT01884077|3611332|P1|Overall Study|Lost to Follow-up|0
1102859|NCT01884077|3611331|P2|Overall Study|canceled surgery|0
1102860|NCT01884077|3611332|P1|Overall Study|canceled surgery|2
1102861|NCT01884077|3611331|P2|Overall Study|screen fail|2
1102862|NCT01884077|3611332|P1|Overall Study|screen fail|0
1102863|NCT01884025|3611353|P2|Overall Study|Lost to Follow-up|4
1102864|NCT01884025|3611354|P1|Overall Study|Lost to Follow-up|3
1102865|NCT01883895|3611414|P1|Overall Study|Lost to Follow-up|2
1102866|NCT01883635|3611428|P2|Overall Study|Withdrawal by Subject|0
1102867|NCT01883635|3611429|P1|Overall Study|Withdrawal by Subject|4
1102868|NCT01883453|3611443|P2|Overall Study|No episode of common cold|23
1102869|NCT01883453|3611444|P1|Overall Study|No episode of common cold|25
1102870|NCT01882985|3611479|P1|Overall Study|Withdrawal by Subject|1
1102871|NCT01882985|3611479|P1|Overall Study|Lost to Follow-up|1
1102872|NCT01882907|3611488|P2|Overall Study|Withdrawal by Subject|6
1102873|NCT01882907|3611489|P1|Overall Study|Withdrawal by Subject|0
1102874|NCT01882907|3611488|P2|Overall Study|Protocol Violation|14
1102875|NCT01882907|3611489|P1|Overall Study|Protocol Violation|10
1102876|NCT01882907|3611488|P2|Overall Study|Lost to Follow-up|4
1102877|NCT01882907|3611489|P1|Overall Study|Lost to Follow-up|1
1102878|NCT01882907|3611488|P2|Overall Study|Lack of Efficacy|3
1102879|NCT01882907|3611489|P1|Overall Study|Lack of Efficacy|0
1102880|NCT01882907|3611488|P2|Overall Study|Adverse Event|1
1102881|NCT01882907|3611489|P1|Overall Study|Adverse Event|3
1102882|NCT01882829|3611525|P1|Overall Study|Withdrawal by Subject|1
1102883|NCT01882829|3611525|P1|Overall Study|Protocol Violation|1
1102884|NCT01882829|3611525|P1|Overall Study|Adverse Event|4
1102885|NCT01882803|3611539|P1|Overall Study|Withdrawal by Subject|4
1102886|NCT01882803|3611539|P1|Overall Study|Protocol Violation|1
1102887|NCT01882803|3611539|P1|Overall Study|Physician Decision|7
1102888|NCT01882803|3611539|P1|Overall Study|Death|7
1102889|NCT01882803|3611539|P1|Overall Study|Adverse Event|22
1102890|NCT01882803|3611539|P1|Overall Study|Disease Progression|53
1102891|NCT01882647|3611557|P2|Overall Study|Withdrawal by Subject|4
1102892|NCT01882647|3611558|P1|Overall Study|Withdrawal by Subject|0
1102893|NCT01882647|3611557|P2|Overall Study|Lost to Follow-up|2
1102894|NCT01882647|3611558|P1|Overall Study|Lost to Follow-up|2
1102895|NCT01882465|3611598|P7|Period 2|Protocol Violation|0
1102896|NCT01882465|3611599|P6|Period 2|Protocol Violation|0
1102897|NCT01882465|3611600|P5|Period 2|Protocol Violation|1
1102898|NCT01882465|3611601|P4|Period 2|Protocol Violation|0
1102899|NCT01882465|3611602|P3|Period 2|Protocol Violation|0
1102900|NCT01882465|3611603|P2|Period 2|Protocol Violation|0
1102901|NCT01882465|3611604|P1|Period 2|Protocol Violation|0
1102902|NCT01882465|3611598|P7|Period 1|Withdrawal by Subject|1
1102903|NCT01882465|3611599|P6|Period 1|Withdrawal by Subject|0
1102904|NCT01882465|3611600|P5|Period 1|Withdrawal by Subject|0
1102905|NCT01882465|3611601|P4|Period 1|Withdrawal by Subject|0
1102906|NCT01882465|3611602|P3|Period 1|Withdrawal by Subject|0
1102907|NCT01882465|3611603|P2|Period 1|Withdrawal by Subject|0
1102908|NCT01882465|3611604|P1|Period 1|Withdrawal by Subject|0
1102909|NCT01882465|3611598|P7|Period 1|Lens Discomfort|0
1102910|NCT01882465|3611599|P6|Period 1|Lens Discomfort|0
1102911|NCT01882465|3611600|P5|Period 1|Lens Discomfort|0
1102912|NCT01882465|3611601|P4|Period 1|Lens Discomfort|1
1102913|NCT01882465|3611602|P3|Period 1|Lens Discomfort|0
1102914|NCT01882465|3611603|P2|Period 1|Lens Discomfort|0
1102915|NCT01882465|3611604|P1|Period 1|Lens Discomfort|0
1102916|NCT01882439|3611616|P4|Overall Study|Adverse event unrelated to study drug|1
1102917|NCT01882439|3611617|P3|Overall Study|Adverse event unrelated to study drug|1
1102918|NCT01882439|3611618|P2|Overall Study|Adverse event unrelated to study drug|2
1102919|NCT01882439|3611619|P1|Overall Study|Adverse event unrelated to study drug|2
1102920|NCT01882439|3611616|P4|Overall Study|Insufficient clinical response|2
1102921|NCT01882439|3611617|P3|Overall Study|Insufficient clinical response|4
1102922|NCT01882439|3611618|P2|Overall Study|Insufficient clinical response|4
1102923|NCT01882439|3611619|P1|Overall Study|Insufficient clinical response|1
1102924|NCT01882439|3611616|P4|Overall Study|Medication error with no associated AE|0
1102925|NCT01882439|3611617|P3|Overall Study|Medication error with no associated AE|2
1102926|NCT01882439|3611618|P2|Overall Study|Medication error with no associated AE|0
1102927|NCT01882439|3611619|P1|Overall Study|Medication error with no associated AE|0
1102928|NCT01882439|3611616|P4|Overall Study|No longer willing to participate|3
1102929|NCT01882439|3611617|P3|Overall Study|No longer willing to participate|2
1102930|NCT01882439|3611618|P2|Overall Study|No longer willing to participate|4
1102931|NCT01882439|3611619|P1|Overall Study|No longer willing to participate|1
1102932|NCT01882439|3611616|P4|Overall Study|Protocol Violation|1
1102933|NCT01882439|3611617|P3|Overall Study|Protocol Violation|0
1102934|NCT01882439|3611618|P2|Overall Study|Protocol Violation|2
1102935|NCT01882439|3611619|P1|Overall Study|Protocol Violation|2
1102936|NCT01882439|3611616|P4|Overall Study|Pregnancy|0
1102937|NCT01882439|3611617|P3|Overall Study|Pregnancy|0
1102938|NCT01882439|3611618|P2|Overall Study|Pregnancy|1
1102939|NCT01882439|3611619|P1|Overall Study|Pregnancy|0
1102940|NCT01882439|3611616|P4|Overall Study|Adverse event related to study drug|2
1102941|NCT01882439|3611617|P3|Overall Study|Adverse event related to study drug|1
1102942|NCT01882439|3611618|P2|Overall Study|Adverse event related to study drug|8
1102943|NCT01882439|3611619|P1|Overall Study|Adverse event related to study drug|3
1102944|NCT01882257|3611816|P3|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4
1102945|NCT01882257|3611817|P2|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11
1102946|NCT01882257|3611818|P1|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0
1102947|NCT01882257|3611816|P3|Study Origination to Beginning Therapy|Withdrawal by Subject|1
1102948|NCT01882257|3611817|P2|Study Origination to Beginning Therapy|Withdrawal by Subject|2
1102949|NCT01882257|3611818|P1|Study Origination to Beginning Therapy|Withdrawal by Subject|0
1102950|NCT01881776|3611882|P3|Overall Study|Protocol Violation|1
1102951|NCT01881776|3611883|P2|Overall Study|Protocol Violation|2
1102952|NCT01881776|3611884|P1|Overall Study|Protocol Violation|0
1102953|NCT01881776|3611882|P3|Overall Study|Lost to Follow-up|1
1102954|NCT01881776|3611883|P2|Overall Study|Lost to Follow-up|2
1102955|NCT01881776|3611884|P1|Overall Study|Lost to Follow-up|1
1102956|NCT01881737|3611910|P1|Overall Study|Worsening of baseline behavior|1
1102957|NCT01881737|3611910|P1|Overall Study|Withdrawal by Subject|1
1102958|NCT01881737|3611910|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|3
1102959|NCT01881230|3611922|P3|Overall Study|Untreated: Withdrawal Before Study Start|0
1102960|NCT01881230|3611923|P2|Overall Study|Untreated: Withdrawal Before Study Start|0
1102961|NCT01881230|3611924|P1|Overall Study|Untreated: Withdrawal Before Study Start|1
1102962|NCT01881230|3611922|P3|Overall Study|Untreated: Death|1
1102963|NCT01881230|3611923|P2|Overall Study|Untreated: Death|0
1102964|NCT01881230|3611924|P1|Overall Study|Untreated: Death|0
1102965|NCT01881230|3611922|P3|Overall Study|Untreated: Other|1
1102966|NCT01881230|3611923|P2|Overall Study|Untreated: Other|0
1102967|NCT01881230|3611924|P1|Overall Study|Untreated: Other|0
1102968|NCT01881230|3611922|P3|Overall Study|Miscellaneous|0
1102969|NCT01881230|3611923|P2|Overall Study|Miscellaneous|3
1102970|NCT01881230|3611924|P1|Overall Study|Miscellaneous|3
1102971|NCT01881230|3611922|P3|Overall Study|Protocol Violation|0
1102972|NCT01881230|3611923|P2|Overall Study|Protocol Violation|1
1102973|NCT01881230|3611924|P1|Overall Study|Protocol Violation|1
1102974|NCT01881230|3611922|P3|Overall Study|Given Commercially Available Drug|2
1102975|NCT01881230|3611923|P2|Overall Study|Given Commercially Available Drug|0
1102976|NCT01881230|3611924|P1|Overall Study|Given Commercially Available Drug|0
1102977|NCT01881230|3611922|P3|Overall Study|Non-Compliance with Study Drug|0
1102978|NCT01881230|3611923|P2|Overall Study|Non-Compliance with Study Drug|2
1102979|NCT01881230|3611924|P1|Overall Study|Non-Compliance with Study Drug|1
1102980|NCT01881230|3611922|P3|Overall Study|Physician Decision|6
1102981|NCT01881230|3611923|P2|Overall Study|Physician Decision|3
1102982|NCT01881230|3611924|P1|Overall Study|Physician Decision|4
1102983|NCT01881230|3611922|P3|Overall Study|Withdrawal by Subject|6
1102984|NCT01881230|3611923|P2|Overall Study|Withdrawal by Subject|4
1102985|NCT01881230|3611924|P1|Overall Study|Withdrawal by Subject|6
1102986|NCT01881230|3611922|P3|Overall Study|Symptomatic Deterioration|1
1102987|NCT01881230|3611923|P2|Overall Study|Symptomatic Deterioration|3
1102988|NCT01881230|3611924|P1|Overall Study|Symptomatic Deterioration|3
1102989|NCT01881230|3611922|P3|Overall Study|Progressive Disease|36
1102990|NCT01881230|3611923|P2|Overall Study|Progressive Disease|35
1102991|NCT01881230|3611924|P1|Overall Study|Progressive Disease|31
1102992|NCT01881230|3611922|P3|Overall Study|Adverse Event|12
1102993|NCT01881230|3611923|P2|Overall Study|Adverse Event|13
1102994|NCT01881230|3611924|P1|Overall Study|Adverse Event|9
1102995|NCT01881230|3611922|P3|Overall Study|Death|1
1102996|NCT01881230|3611923|P2|Overall Study|Death|0
1102997|NCT01881230|3611924|P1|Overall Study|Death|2
1102998|NCT01881126|3611952|P2|Overall Study|Adverse Event|1
1102999|NCT01881126|3611953|P1|Overall Study|Adverse Event|0
1103000|NCT01881126|3611952|P2|Overall Study|Non-compliance|1
1103001|NCT01881126|3611953|P1|Overall Study|Non-compliance|1
1103002|NCT01880736|3612045|P4|Overall Study|Withdrawal Criteria|5
1103003|NCT01880736|3612046|P3|Overall Study|Withdrawal Criteria|1
1103004|NCT01880736|3612047|P2|Overall Study|Withdrawal Criteria|2
1103005|NCT01880736|3612048|P1|Overall Study|Withdrawal Criteria|1
1103006|NCT01880736|3612045|P4|Overall Study|Adverse Event|1
1103007|NCT01880736|3612046|P3|Overall Study|Adverse Event|0
1103008|NCT01880736|3612047|P2|Overall Study|Adverse Event|0
1103009|NCT01880736|3612048|P1|Overall Study|Adverse Event|0
1103010|NCT01880593|3612132|P2|Overall Study|Withdrawal by Subject|1
1103011|NCT01880593|3612133|P1|Overall Study|Withdrawal by Subject|6
1103012|NCT01880593|3612132|P2|Overall Study|Lack of Efficacy|5
1103013|NCT01880593|3612133|P1|Overall Study|Lack of Efficacy|1
1103014|NCT01880593|3612132|P2|Overall Study|Adverse Event|0
1103015|NCT01880593|3612133|P1|Overall Study|Adverse Event|1
1103016|NCT01880515|3612153|P2|Overall Study|Disease Progression|7
1103017|NCT01880515|3612154|P1|Overall Study|Disease Progression|5
1103018|NCT01880515|3612153|P2|Overall Study|Lost to Follow-up|2
1103019|NCT01880515|3612154|P1|Overall Study|Lost to Follow-up|3
1103020|NCT01880437|3612165|P3|Overall Study|Study terminated by Sponsor|2
1103021|NCT01880437|3612166|P2|Overall Study|Study terminated by Sponsor|0
1103022|NCT01880437|3612167|P1|Overall Study|Study terminated by Sponsor|3
1103023|NCT01880437|3612165|P3|Overall Study|Death|17
1103024|NCT01880437|3612166|P2|Overall Study|Death|4
1103025|NCT01880437|3612167|P1|Overall Study|Death|12
1103026|NCT01880424|3612193|P2|Overall Study|Not specified|0
1103027|NCT01880424|3612194|P1|Overall Study|Not specified|1
1103028|NCT01880424|3612193|P2|Overall Study|Withdrawal by Subject|30
1103029|NCT01880424|3612194|P1|Overall Study|Withdrawal by Subject|10
1103030|NCT01880424|3612193|P2|Overall Study|Protocol Violation|13
1103031|NCT01880424|3612194|P1|Overall Study|Protocol Violation|11
1103032|NCT01880424|3612193|P2|Overall Study|Lost to Follow-up|2
1103033|NCT01880424|3612194|P1|Overall Study|Lost to Follow-up|3
1103034|NCT01880424|3612193|P2|Overall Study|Lack of Efficacy|4
1103035|NCT01880424|3612194|P1|Overall Study|Lack of Efficacy|1
1103036|NCT01880424|3612193|P2|Overall Study|Adverse Event|6
1103037|NCT01880424|3612194|P1|Overall Study|Adverse Event|7
1103038|NCT01880086|3612250|P2|Overall Study|Lost to Follow-up|1
1103039|NCT01880086|3612251|P1|Overall Study|Lost to Follow-up|1
1103040|NCT01879852|3612271|P2|Overall Study|Withdrawal by Subject|0
1103041|NCT01879852|3612272|P1|Overall Study|Withdrawal by Subject|2
1103042|NCT01879722|3612316|P10|Overall Study|Voluntary Withdrawal|0
1103043|NCT01879722|3612317|P9|Overall Study|Voluntary Withdrawal|1
1103044|NCT01879722|3612318|P8|Overall Study|Voluntary Withdrawal|0
1103045|NCT01879722|3612319|P7|Overall Study|Voluntary Withdrawal|0
1103046|NCT01879722|3612320|P6|Overall Study|Voluntary Withdrawal|0
1103047|NCT01879722|3612321|P5|Overall Study|Voluntary Withdrawal|0
1103048|NCT01879722|3612322|P4|Overall Study|Voluntary Withdrawal|0
1103049|NCT01879722|3612323|P3|Overall Study|Voluntary Withdrawal|0
1103050|NCT01879722|3612324|P2|Overall Study|Voluntary Withdrawal|0
1103051|NCT01879722|3612325|P1|Overall Study|Voluntary Withdrawal|0
1103052|NCT01879722|3612316|P10|Overall Study|Pretreatment Event/Adverse Event|0
1103053|NCT01879722|3612317|P9|Overall Study|Pretreatment Event/Adverse Event|1
1103054|NCT01879722|3612318|P8|Overall Study|Pretreatment Event/Adverse Event|1
1103055|NCT01879722|3612319|P7|Overall Study|Pretreatment Event/Adverse Event|0
1103056|NCT01879722|3612320|P6|Overall Study|Pretreatment Event/Adverse Event|0
1103057|NCT01879722|3612321|P5|Overall Study|Pretreatment Event/Adverse Event|1
1103058|NCT01879722|3612322|P4|Overall Study|Pretreatment Event/Adverse Event|1
1103059|NCT01879722|3612323|P3|Overall Study|Pretreatment Event/Adverse Event|0
1103060|NCT01879722|3612324|P2|Overall Study|Pretreatment Event/Adverse Event|1
1103061|NCT01879722|3612325|P1|Overall Study|Pretreatment Event/Adverse Event|0
1103062|NCT01879683|3612473|P1|Overall Study|Did not Complete 4-week Follow-up Visit|1
1103063|NCT01879618|3612480|P1|Overall Study|Adverse Event|5
1103064|NCT01879618|3612480|P1|Overall Study|Protocol Violation|6
1103065|NCT01879618|3612480|P1|Overall Study|Surgery;changed schedule; not available|8
1103066|NCT01879618|3612480|P1|Overall Study|Withdrawal by Subject|1
1103067|NCT01879618|3612480|P1|Overall Study|Does not meet entrance criteria|1
1103068|NCT01879579|3612487|P2|Overall Study|Discontinued insulin - possible allergy|1
1103069|NCT01879579|3612488|P1|Overall Study|Discontinued insulin - possible allergy|0
1103070|NCT01879579|3612487|P2|Overall Study|Phenotypic type 1 diabetes|1
1103071|NCT01879579|3612488|P1|Overall Study|Phenotypic type 1 diabetes|0
1103072|NCT01879579|3612487|P2|Overall Study|Did not initiate insulin treatment|0
1103073|NCT01879579|3612488|P1|Overall Study|Did not initiate insulin treatment|1
1103074|NCT01879579|3612487|P2|Overall Study|Did not enroll in texting platform|0
1103075|NCT01879579|3612488|P1|Overall Study|Did not enroll in texting platform|1
1103076|NCT01879579|3612487|P2|Overall Study|Phone incompatible with texting platform|0
1103077|NCT01879579|3612488|P1|Overall Study|Phone incompatible with texting platform|3
1103078|NCT01879553|3612518|P2|Overall Study|Withdrawal by Subject|0
1103079|NCT01879553|3612519|P1|Overall Study|Withdrawal by Subject|1
1103080|NCT01879410|3612553|P2|Overall Study|Randomised in Error|2
1103081|NCT01879410|3612554|P1|Overall Study|Randomised in Error|1
1103082|NCT01879410|3612553|P2|Overall Study|Withdrawal by Subject|8
1103083|NCT01879410|3612554|P1|Overall Study|Withdrawal by Subject|7
1103084|NCT01879410|3612553|P2|Overall Study|Lost to Follow-up|1
1103085|NCT01879410|3612554|P1|Overall Study|Lost to Follow-up|2
1103086|NCT01879410|3612553|P2|Overall Study|Protocol Violation|7
1103087|NCT01879410|3612554|P1|Overall Study|Protocol Violation|1
1103088|NCT01879410|3612553|P2|Overall Study|Lack of Efficacy|6
1103089|NCT01879410|3612554|P1|Overall Study|Lack of Efficacy|4
1103090|NCT01879410|3612553|P2|Overall Study|Adverse Event|14
1103091|NCT01879410|3612554|P1|Overall Study|Adverse Event|9
1103092|NCT01879319|3612621|P2|Overall Study|Lost to Follow-up|5
1103093|NCT01879319|3612622|P1|Overall Study|Lost to Follow-up|1
1103094|NCT01879319|3612621|P2|Overall Study|Withdrawal by Subject|0
1103095|NCT01879319|3612622|P1|Overall Study|Withdrawal by Subject|1
1103096|NCT01879072|3612639|P1|Overall Study|Not Transplanted|30
1103097|NCT01879072|3612639|P1|Overall Study|Withdrawal by Subject|121
1103098|NCT01878214|3612764|P2|Overall Study|Lost to Follow-up|36
1103099|NCT01878214|3612765|P1|Overall Study|Lost to Follow-up|35
1103100|NCT01878214|3612764|P2|Overall Study|Death|1
1103101|NCT01878214|3612765|P1|Overall Study|Death|0
1103102|NCT01878214|3612764|P2|Overall Study|Withdrawal by Subject|7
1103103|NCT01878214|3612765|P1|Overall Study|Withdrawal by Subject|18
1103104|NCT01878175|3612779|P1|Overall Study|Developed contraindicated health problem|2
1103105|NCT01878149|3612798|P2|Overall Study|Did Not Meet Eligibility Criteria|2
1103106|NCT01878149|3612799|P1|Overall Study|Did Not Meet Eligibility Criteria|2
1103107|NCT01878097|3612807|P2|Implementation Year 4|Surveys not fully completed|3007
1103108|NCT01878097|3612808|P1|Implementation Year 4|Surveys not fully completed|3604
1103109|NCT01878097|3612807|P2|Implementation Year 3|Surveys not fully completed|2980
1103110|NCT01878097|3612808|P1|Implementation Year 3|Surveys not fully completed|3494
1103111|NCT01878097|3612807|P2|Implementation Year 2|Surveys not fully completed|2841
1103112|NCT01878097|3612808|P1|Implementation Year 2|Surveys not fully completed|3281
1103113|NCT01878097|3612807|P2|Implementation Year 1|Surveys not fully completed|2549
1103114|NCT01878097|3612808|P1|Implementation Year 1|Surveys not fully completed|3202
1103115|NCT01878097|3612807|P2|Baseline|Surveys not fully completed|1800
1103116|NCT01878097|3612808|P1|Baseline|Surveys not fully completed|2497
1103117|NCT01877720|3612845|P2|Overall Study|Adverse Event|0
1103118|NCT01877720|3612846|P1|Overall Study|Adverse Event|1
1103119|NCT01877668|3612875|P5|Overall Study|Adverse event unrelated to study drug|1
1103120|NCT01877668|3612876|P4|Overall Study|Adverse event unrelated to study drug|0
1103121|NCT01877668|3612877|P3|Overall Study|Adverse event unrelated to study drug|2
1103122|NCT01877668|3612878|P2|Overall Study|Adverse event unrelated to study drug|1
1103123|NCT01877668|3612879|P1|Overall Study|Adverse event unrelated to study drug|4
1103124|NCT01877668|3612875|P5|Overall Study|Adverse event related to study drug|1
1103125|NCT01877668|3612876|P4|Overall Study|Adverse event related to study drug|2
1103126|NCT01877668|3612877|P3|Overall Study|Adverse event related to study drug|2
1103127|NCT01877668|3612878|P2|Overall Study|Adverse event related to study drug|2
1103128|NCT01877668|3612879|P1|Overall Study|Adverse event related to study drug|2
1103129|NCT01877668|3612875|P5|Overall Study|Protocol Violation|3
1103130|NCT01877668|3612876|P4|Overall Study|Protocol Violation|0
1103131|NCT01877668|3612877|P3|Overall Study|Protocol Violation|0
1103132|NCT01877668|3612878|P2|Overall Study|Protocol Violation|1
1103133|NCT01877668|3612879|P1|Overall Study|Protocol Violation|1
1103134|NCT01877668|3612875|P5|Overall Study|Not specified|3
1103135|NCT01877668|3612876|P4|Overall Study|Not specified|1
1103136|NCT01877668|3612877|P3|Overall Study|Not specified|1
1103137|NCT01877668|3612878|P2|Overall Study|Not specified|1
1103138|NCT01877668|3612879|P1|Overall Study|Not specified|1
1103139|NCT01877668|3612875|P5|Overall Study|Withdrawal by Subject|2
1103140|NCT01877668|3612876|P4|Overall Study|Withdrawal by Subject|2
1103141|NCT01877668|3612877|P3|Overall Study|Withdrawal by Subject|3
1103142|NCT01877668|3612878|P2|Overall Study|Withdrawal by Subject|0
1103143|NCT01877668|3612879|P1|Overall Study|Withdrawal by Subject|2
1103144|NCT01877668|3612875|P5|Overall Study|Lost to Follow-up|0
1103145|NCT01877668|3612876|P4|Overall Study|Lost to Follow-up|0
1103146|NCT01877668|3612877|P3|Overall Study|Lost to Follow-up|1
1103147|NCT01877668|3612878|P2|Overall Study|Lost to Follow-up|2
1103148|NCT01877668|3612879|P1|Overall Study|Lost to Follow-up|0
1103149|NCT01877668|3612875|P5|Overall Study|Insufficient clinical response|0
1103150|NCT01877668|3612876|P4|Overall Study|Insufficient clinical response|2
1103151|NCT01877668|3612877|P3|Overall Study|Insufficient clinical response|2
1103152|NCT01877668|3612878|P2|Overall Study|Insufficient clinical response|1
1103153|NCT01877668|3612879|P1|Overall Study|Insufficient clinical response|0
1103154|NCT01877668|3612875|P5|Overall Study|No longer met study criteria|0
1103155|NCT01877668|3612876|P4|Overall Study|No longer met study criteria|0
1103156|NCT01877668|3612877|P3|Overall Study|No longer met study criteria|1
1103157|NCT01877668|3612878|P2|Overall Study|No longer met study criteria|0
1103158|NCT01877668|3612879|P1|Overall Study|No longer met study criteria|1
1103159|NCT01877668|3612875|P5|Overall Study|Death|0
1103160|NCT01877668|3612876|P4|Overall Study|Death|1
1103161|NCT01877668|3612877|P3|Overall Study|Death|0
1103162|NCT01877668|3612878|P2|Overall Study|Death|0
1103163|NCT01877668|3612879|P1|Overall Study|Death|0
1103164|NCT01877655|3613110|P2|Overall Study|Randomized but Never Received Drug|5
1103165|NCT01877655|3613111|P1|Overall Study|Randomized but Never Received Drug|8
1103166|NCT01877655|3613110|P2|Overall Study|Miscellaneous|4
1103167|NCT01877655|3613111|P1|Overall Study|Miscellaneous|4
1103168|NCT01877655|3613110|P2|Overall Study|Physician Decision|10
1103169|NCT01877655|3613111|P1|Overall Study|Physician Decision|11
1103170|NCT01877655|3613110|P2|Overall Study|Withdrawal by Subject|26
1103171|NCT01877655|3613111|P1|Overall Study|Withdrawal by Subject|18
1103172|NCT01877655|3613110|P2|Overall Study|Death|52
1103173|NCT01877655|3613111|P1|Overall Study|Death|57
1103174|NCT01877421|3613202|P18|Phase 2|Protocol Violation|0
1103175|NCT01877421|3613203|P17|Phase 2|Protocol Violation|0
1103176|NCT01877421|3613204|P16|Phase 2|Protocol Violation|0
1103177|NCT01877421|3613205|P15|Phase 2|Protocol Violation|0
1103178|NCT01877421|3613206|P14|Phase 2|Protocol Violation|0
1103179|NCT01877421|3613207|P13|Phase 2|Protocol Violation|0
1103180|NCT01877421|3613208|P12|Phase 2|Protocol Violation|0
1103181|NCT01877421|3613209|P11|Phase 2|Protocol Violation|1
1103182|NCT01877421|3613210|P10|Phase 2|Protocol Violation|0
1103183|NCT01877421|3613211|P9|Phase 2|Protocol Violation|0
1103184|NCT01877421|3613212|P8|Phase 2|Protocol Violation|0
1103185|NCT01877421|3613213|P7|Phase 2|Protocol Violation|0
1103186|NCT01877421|3613214|P6|Phase 2|Protocol Violation|0
1103187|NCT01877421|3613215|P5|Phase 2|Protocol Violation|0
1103188|NCT01877421|3613216|P4|Phase 2|Protocol Violation|0
1103189|NCT01877421|3613217|P3|Phase 2|Protocol Violation|0
1103190|NCT01877421|3613218|P2|Phase 2|Protocol Violation|0
1103191|NCT01877421|3613219|P1|Phase 2|Protocol Violation|0
1103192|NCT01877421|3613202|P18|Phase 2|Withdrawal by Subject|0
1103193|NCT01877421|3613203|P17|Phase 2|Withdrawal by Subject|0
1103194|NCT01877421|3613204|P16|Phase 2|Withdrawal by Subject|1
1103195|NCT01877421|3613205|P15|Phase 2|Withdrawal by Subject|0
1103196|NCT01877421|3613206|P14|Phase 2|Withdrawal by Subject|0
1103197|NCT01877421|3613207|P13|Phase 2|Withdrawal by Subject|1
1103198|NCT01877421|3613208|P12|Phase 2|Withdrawal by Subject|0
1103199|NCT01877421|3613209|P11|Phase 2|Withdrawal by Subject|1
1103200|NCT01877421|3613210|P10|Phase 2|Withdrawal by Subject|0
1103201|NCT01877421|3613211|P9|Phase 2|Withdrawal by Subject|1
1103202|NCT01877421|3613212|P8|Phase 2|Withdrawal by Subject|0
1103203|NCT01877421|3613213|P7|Phase 2|Withdrawal by Subject|0
1103204|NCT01877421|3613214|P6|Phase 2|Withdrawal by Subject|0
1103205|NCT01877421|3613215|P5|Phase 2|Withdrawal by Subject|0
1103206|NCT01877421|3613216|P4|Phase 2|Withdrawal by Subject|0
1103207|NCT01877421|3613217|P3|Phase 2|Withdrawal by Subject|0
1103208|NCT01877421|3613218|P2|Phase 2|Withdrawal by Subject|0
1103209|NCT01877421|3613219|P1|Phase 2|Withdrawal by Subject|0
1103210|NCT01877421|3613202|P18|Phase 2|Lost to Follow-up|0
1103211|NCT01877421|3613203|P17|Phase 2|Lost to Follow-up|0
1103212|NCT01877421|3613204|P16|Phase 2|Lost to Follow-up|0
1103213|NCT01877421|3613205|P15|Phase 2|Lost to Follow-up|0
1103214|NCT01877421|3613206|P14|Phase 2|Lost to Follow-up|0
1103215|NCT01877421|3613207|P13|Phase 2|Lost to Follow-up|0
1103216|NCT01877421|3613208|P12|Phase 2|Lost to Follow-up|0
1103217|NCT01877421|3613209|P11|Phase 2|Lost to Follow-up|0
1103218|NCT01877421|3613210|P10|Phase 2|Lost to Follow-up|0
1103219|NCT01877421|3613211|P9|Phase 2|Lost to Follow-up|0
1103220|NCT01877421|3613212|P8|Phase 2|Lost to Follow-up|0
1103221|NCT01877421|3613213|P7|Phase 2|Lost to Follow-up|1
1103222|NCT01877421|3613214|P6|Phase 2|Lost to Follow-up|0
1103223|NCT01877421|3613215|P5|Phase 2|Lost to Follow-up|0
1103224|NCT01877421|3613216|P4|Phase 2|Lost to Follow-up|0
1103225|NCT01877421|3613217|P3|Phase 2|Lost to Follow-up|0
1103226|NCT01877421|3613218|P2|Phase 2|Lost to Follow-up|0
1103227|NCT01877421|3613219|P1|Phase 2|Lost to Follow-up|0
1103228|NCT01877408|3613329|P2|Overall Study|Lost to Follow-up|2
1103229|NCT01877408|3613330|P1|Overall Study|Lost to Follow-up|0
1103230|NCT01877278|3613363|P2|Overall Study|Lost to Follow-up|3
1103231|NCT01877278|3613364|P1|Overall Study|Lost to Follow-up|3
1103232|NCT01877265|3613372|P6|Treatment Period 3|Lost to Follow-up|0
1103233|NCT01877265|3613373|P5|Treatment Period 3|Lost to Follow-up|0
1103234|NCT01877265|3613374|P4|Treatment Period 3|Lost to Follow-up|0
1103235|NCT01877265|3613375|P3|Treatment Period 3|Lost to Follow-up|0
1103236|NCT01877265|3613376|P2|Treatment Period 3|Lost to Follow-up|0
1103237|NCT01877265|3613377|P1|Treatment Period 3|Lost to Follow-up|1
1103238|NCT01877265|3613372|P6|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1
1103239|NCT01877265|3613373|P5|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
1103240|NCT01877265|3613374|P4|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
1103241|NCT01877265|3613375|P3|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
1103242|NCT01877265|3613376|P2|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
1103243|NCT01877265|3613377|P1|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
1103244|NCT01877265|3613372|P6|Treatment Period 1|Sponsor Decision|0
1103245|NCT01877265|3613373|P5|Treatment Period 1|Sponsor Decision|0
1103246|NCT01877265|3613374|P4|Treatment Period 1|Sponsor Decision|0
1103247|NCT01877265|3613375|P3|Treatment Period 1|Sponsor Decision|1
1103248|NCT01877265|3613376|P2|Treatment Period 1|Sponsor Decision|0
1103249|NCT01877265|3613377|P1|Treatment Period 1|Sponsor Decision|0
1103250|NCT01877239|3613394|P1|Overall Study|Data not available|35
1103251|NCT01877239|3613394|P1|Overall Study|Lack of Efficacy|4
1103252|NCT01877239|3613394|P1|Overall Study|Other|2
1103253|NCT01877239|3613394|P1|Overall Study|Withdrawal by Subject|4
1103254|NCT01877239|3613394|P1|Overall Study|Disease Remission|1
1103255|NCT01877239|3613394|P1|Overall Study|Adverse Event|4
1103256|NCT01876979|3613440|P2|Overall Study|Physician Decision|3
1103257|NCT01876979|3613441|P1|Overall Study|Physician Decision|2
1103258|NCT01876823|3613447|P1|Overall Study|Patients moved|2
1103259|NCT01876823|3613447|P1|Overall Study|Physician Decision|2
1103260|NCT01876823|3613447|P1|Overall Study|Withdrawal by Subject|5
1103261|NCT01876810|3613460|P2|Overall Study|Physician Decision|1
1103262|NCT01876810|3613461|P1|Overall Study|Physician Decision|0
1103263|NCT01876784|3613473|P2|Overall Study|Ongoing|40
1103264|NCT01876784|3613474|P1|Overall Study|Ongoing|41
1103265|NCT01876784|3613473|P2|Overall Study|Other than specified above|6
1103266|NCT01876784|3613474|P1|Overall Study|Other than specified above|5
1103267|NCT01876784|3613473|P2|Overall Study|Randomized but not treated|1
1103268|NCT01876784|3613474|P1|Overall Study|Randomized but not treated|2
1103269|NCT01876784|3613473|P2|Overall Study|Death|0
1103270|NCT01876784|3613474|P1|Overall Study|Death|1
1103271|NCT01876784|3613473|P2|Overall Study|Lost to Follow-up|1
1103272|NCT01876784|3613474|P1|Overall Study|Lost to Follow-up|0
1103273|NCT01876784|3613473|P2|Overall Study|Disease progression|67
1103274|NCT01876784|3613474|P1|Overall Study|Disease progression|37
1103275|NCT01876784|3613473|P2|Overall Study|Protocol Violation|0
1103276|NCT01876784|3613474|P1|Overall Study|Protocol Violation|1
1103277|NCT01876784|3613473|P2|Overall Study|Adverse Event|2
1103278|NCT01876784|3613474|P1|Overall Study|Adverse Event|15
1103279|NCT01876784|3613473|P2|Overall Study|Withdrawal by Subject|2
1103280|NCT01876784|3613474|P1|Overall Study|Withdrawal by Subject|17
1103281|NCT01876732|3613480|P1|Overall Study|MMA was not over 800mg/dL|75
1103282|NCT01876706|3613485|P1|Overall Study|Lost to Follow-up|2
1103283|NCT01876706|3613485|P1|Overall Study|BPH Intervention|2
1103284|NCT01876420|3613502|P1|Overall Study|Missed 30 day visit|1
1103285|NCT01876381|3613514|P1|Overall Study|Withdrawal by Subject|1
1103286|NCT01876381|3613514|P1|Overall Study|Physician Decision|1
1103287|NCT01876381|3613514|P1|Overall Study|Lack of Efficacy|5
1103288|NCT01876368|3613521|P2|Overall Study|Subject/guardian decision|1
1103289|NCT01876368|3613522|P1|Overall Study|Subject/guardian decision|3
1103290|NCT01876368|3613521|P2|Overall Study|Protocol deviation|3
1103291|NCT01876368|3613522|P1|Overall Study|Protocol deviation|3
1103292|NCT01876368|3613521|P2|Overall Study|Physician Decision|2
1103293|NCT01876368|3613522|P1|Overall Study|Physician Decision|0
1103294|NCT01876368|3613521|P2|Overall Study|Non-compliance with study treatment|1
1103295|NCT01876368|3613522|P1|Overall Study|Non-compliance with study treatment|0
1103296|NCT01876368|3613521|P2|Overall Study|Lost to Follow-up|1
1103297|NCT01876368|3613522|P1|Overall Study|Lost to Follow-up|0
1103298|NCT01876368|3613521|P2|Overall Study|Lack of Efficacy|0
1103299|NCT01876368|3613522|P1|Overall Study|Lack of Efficacy|1
1103300|NCT01876368|3613521|P2|Overall Study|Adverse Event|5
1103301|NCT01876368|3613522|P1|Overall Study|Adverse Event|2
1103302|NCT01875991|3613566|P2|Overall Study|Sponsor Decision|0
1103303|NCT01875991|3613567|P1|Overall Study|Sponsor Decision|1
1103304|NCT01875991|3613566|P2|Overall Study|Withdrawal by Subject|6
1103305|NCT01875991|3613567|P1|Overall Study|Withdrawal by Subject|6
1103306|NCT01875874|3613603|P1|Overall Study|Death|3
1103307|NCT01875848|3613610|P2|Overall Study|Withdrawal by Subject|0
1103308|NCT01875848|3613611|P1|Overall Study|Withdrawal by Subject|2
1103309|NCT01875731|3613628|P2|Overall Study|Fail to obtain lab sample|0
1103310|NCT01875731|3613629|P1|Overall Study|Fail to obtain lab sample|1
1103311|NCT01875471|3613648|P2|Overall Study|Unsatisfactory Lens Fitting|0
1103312|NCT01875471|3613649|P1|Overall Study|Unsatisfactory Lens Fitting|1
1103313|NCT01875471|3613648|P2|Overall Study|Adverse Event|1
1103314|NCT01875471|3613649|P1|Overall Study|Adverse Event|0
1103315|NCT01875445|3613657|P2|Overall Study|Withdrawal by Subject|0
1103316|NCT01875445|3613658|P1|Overall Study|Withdrawal by Subject|2
1103317|NCT01875445|3613657|P2|Overall Study|Lost to Follow-up|0
1103318|NCT01875445|3613658|P1|Overall Study|Lost to Follow-up|5
1103319|NCT01875185|3613668|P2|Overall Study|study was terminated|48
1103320|NCT01875185|3613669|P1|Overall Study|study was terminated|52
1103321|NCT01874665|3613717|P2|Overall Study|Other|0
1103322|NCT01874665|3613718|P1|Overall Study|Other|2
1103323|NCT01874665|3613717|P2|Overall Study|Documented Progressive Disease|7
1103324|NCT01874665|3613718|P1|Overall Study|Documented Progressive Disease|11
1103325|NCT01874665|3613717|P2|Overall Study|Study Terminated by Sponsor|2
1103326|NCT01874665|3613718|P1|Overall Study|Study Terminated by Sponsor|0
1103327|NCT01874665|3613717|P2|Overall Study|Clinical Progressive Disease|3
1103328|NCT01874665|3613718|P1|Overall Study|Clinical Progressive Disease|4
1103329|NCT01874665|3613717|P2|Overall Study|Physician Decision|0
1103330|NCT01874665|3613718|P1|Overall Study|Physician Decision|3
1103331|NCT01874665|3613717|P2|Overall Study|Withdrawal by Subject|1
1103332|NCT01874665|3613718|P1|Overall Study|Withdrawal by Subject|4
1103333|NCT01874665|3613717|P2|Overall Study|Adverse Event|2
1103334|NCT01874665|3613718|P1|Overall Study|Adverse Event|6
1103335|NCT01874535|3613746|P2|Overall Study|incomplete symptom resolution|35
1103336|NCT01874535|3613747|P1|Overall Study|incomplete symptom resolution|45
1103337|NCT01874535|3613746|P2|Overall Study|Lost to Follow-up|9
1103338|NCT01874535|3613747|P1|Overall Study|Lost to Follow-up|10
1103339|NCT01874353|3613755|P2|Overall Study|Withdrawal by Subject|9
1103340|NCT01874353|3613756|P1|Overall Study|Withdrawal by Subject|7
1103341|NCT01874353|3613755|P2|Overall Study|Death|27
1103342|NCT01874353|3613756|P1|Overall Study|Death|45
1103343|NCT01874353|3613755|P2|Overall Study|Lost to Follow-up|1
1103344|NCT01874353|3613756|P1|Overall Study|Lost to Follow-up|1
1103345|NCT01874353|3613755|P2|Overall Study|Other|0
1103346|NCT01874353|3613756|P1|Overall Study|Other|2
1103347|NCT01874340|3613783|P4|Overall Study|Withdrawal by Subject|1
1103348|NCT01874340|3613784|P3|Overall Study|Withdrawal by Subject|0
1103349|NCT01874340|3613785|P2|Overall Study|Withdrawal by Subject|0
1103350|NCT01874340|3613786|P1|Overall Study|Withdrawal by Subject|0
1103351|NCT01874340|3613783|P4|Overall Study|Study terminated by Sponsor|4
1103352|NCT01874340|3613784|P3|Overall Study|Study terminated by Sponsor|8
1103353|NCT01874340|3613785|P2|Overall Study|Study terminated by Sponsor|8
1103354|NCT01874340|3613786|P1|Overall Study|Study terminated by Sponsor|6
1103355|NCT01874275|3613814|P2|Overall Study|Lost to Follow-up|0
1103356|NCT01874275|3613815|P1|Overall Study|Lost to Follow-up|1
1103357|NCT01874145|3613838|P2|Extension Period|Lost to Follow-up|1
1103358|NCT01874145|3613839|P1|Extension Period|Lost to Follow-up|1
1103359|NCT01874145|3613838|P2|Extension Period|Withdrawal by Subject|1
1103360|NCT01874145|3613839|P1|Extension Period|Withdrawal by Subject|2
1103361|NCT01874145|3613838|P2|Extension Period|Adverse Event|2
1103362|NCT01874145|3613839|P1|Extension Period|Adverse Event|3
1103363|NCT01874145|3613838|P2|Core Period|Withdrawal by Subject|4
1103364|NCT01874145|3613839|P1|Core Period|Withdrawal by Subject|0
1103365|NCT01874145|3613838|P2|Core Period|Adverse Event|1
1103366|NCT01874145|3613839|P1|Core Period|Adverse Event|0
1103367|NCT01874145|3613838|P2|Core Period|Physician Decision|1
1103368|NCT01874145|3613839|P1|Core Period|Physician Decision|1
1103369|NCT01874145|3613838|P2|Core Period|Protocol Violation|1
1103370|NCT01874145|3613839|P1|Core Period|Protocol Violation|1
1103371|NCT01874145|3613838|P2|Core Period|Non-compliance|0
1103372|NCT01874145|3613839|P1|Core Period|Non-compliance|1
1103373|NCT01874054|3613898|P1|Follow-up Period|Continuing in Follow-up|48
1103374|NCT01874054|3613898|P1|Follow-up Period|Withdrawal by Subject|1
1103375|NCT01874054|3613898|P1|Treatment Period|Non-AE related|2
1103376|NCT01874054|3613898|P1|Treatment Period|Withdrawal by Subject|6
1103377|NCT01874054|3613898|P1|Treatment Period|Physician Decision|3
1103378|NCT01874054|3613898|P1|Treatment Period|Adverse Event|20
1103379|NCT01874054|3613898|P1|Treatment Period|Progressive Disease|7
1103380|NCT01873950|3613920|P5|Period 5|Withdrawal by Subject|0
1103381|NCT01873950|3613921|P4|Period 5|Withdrawal by Subject|1
1103382|NCT01873950|3613922|P3|Period 5|Withdrawal by Subject|0
1103383|NCT01873950|3613923|P2|Period 5|Withdrawal by Subject|0
1103384|NCT01873950|3613924|P1|Period 5|Withdrawal by Subject|0
1103385|NCT01873859|3613961|P2|Overall Study|Withdrawal by Subject|4
1103386|NCT01873859|3613962|P1|Overall Study|Withdrawal by Subject|0
1103387|NCT01873729|3613970|P1|Overall Study|Withdrawal by Subject|1
1103388|NCT01873417|3613975|P1|Overall Study|Physician Decision|3
1103389|NCT01873417|3613975|P1|Overall Study|Withdrawal by Subject|2
1103390|NCT01873417|3613975|P1|Overall Study|Lost to Follow-up|2
1103391|NCT01873417|3613975|P1|Overall Study|Adverse Event|24
1103392|NCT01873417|3613975|P1|Overall Study|Did Not Receive Any Study Drug|4
1103393|NCT01872910|3613992|P6|Overall Study|Lost to Follow-up|0
1103394|NCT01872910|3613993|P5|Overall Study|Lost to Follow-up|0
1103395|NCT01872910|3613994|P4|Overall Study|Lost to Follow-up|0
1103396|NCT01872910|3613995|P3|Overall Study|Lost to Follow-up|2
1103397|NCT01872910|3613996|P2|Overall Study|Lost to Follow-up|0
1103398|NCT01872910|3613997|P1|Overall Study|Lost to Follow-up|2
1103399|NCT01872715|3614042|P1|Overall Study|Withdrawal by Subject|2
1103400|NCT01872715|3614042|P1|Overall Study|Protocol Violation|1
1103401|NCT01872715|3614042|P1|Overall Study|Adverse Event|1
1103402|NCT01872689|3614061|P4|Open-Label Period (Only For Monotherapy)|Adverse Event|0
1103403|NCT01872689|3614062|P3|Open-Label Period (Only For Monotherapy)|Adverse Event|0
1103404|NCT01872689|3614063|P2|Open-Label Period (Only For Monotherapy)|Adverse Event|1
1103405|NCT01872689|3614064|P1|Open-Label Period (Only For Monotherapy)|Adverse Event|2
1103406|NCT01872689|3614061|P4|Open-Label Period (Only For Monotherapy)|Death|0
1103407|NCT01872689|3614062|P3|Open-Label Period (Only For Monotherapy)|Death|0
1103408|NCT01872689|3614063|P2|Open-Label Period (Only For Monotherapy)|Death|3
1103409|NCT01872689|3614064|P1|Open-Label Period (Only For Monotherapy)|Death|5
1103410|NCT01872689|3614061|P4|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0
1103411|NCT01872689|3614062|P3|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0
1103412|NCT01872689|3614063|P2|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3
1103413|NCT01872689|3614064|P1|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1
1103414|NCT01872689|3614061|P4|Open-Label Period (Only For Monotherapy)|Physician Decision|0
1103415|NCT01872689|3614062|P3|Open-Label Period (Only For Monotherapy)|Physician Decision|0
1103416|NCT01872689|3614063|P2|Open-Label Period (Only For Monotherapy)|Physician Decision|1
1103417|NCT01872689|3614064|P1|Open-Label Period (Only For Monotherapy)|Physician Decision|0
1103418|NCT01872689|3614061|P4|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0
1103419|NCT01872689|3614062|P3|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0
1103420|NCT01872689|3614063|P2|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12
1103421|NCT01872689|3614064|P1|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11
1103422|NCT01872689|3614061|P4|Open-Label Period (Only For Monotherapy)|Other|0
1103423|NCT01872689|3614062|P3|Open-Label Period (Only For Monotherapy)|Other|0
1103424|NCT01872689|3614063|P2|Open-Label Period (Only For Monotherapy)|Other|3
1103425|NCT01872689|3614064|P1|Open-Label Period (Only For Monotherapy)|Other|2
1103426|NCT01872689|3614061|P4|Double-Blind/Placebo-Controlled Period|Adverse Event|7
1103427|NCT01872689|3614062|P3|Double-Blind/Placebo-Controlled Period|Adverse Event|10
1103428|NCT01872689|3614063|P2|Double-Blind/Placebo-Controlled Period|Adverse Event|3
1103429|NCT01872689|3614064|P1|Double-Blind/Placebo-Controlled Period|Adverse Event|6
1103430|NCT01872689|3614061|P4|Double-Blind/Placebo-Controlled Period|Death|9
1103431|NCT01872689|3614062|P3|Double-Blind/Placebo-Controlled Period|Death|14
1103432|NCT01872689|3614063|P2|Double-Blind/Placebo-Controlled Period|Death|4
1103433|NCT01872689|3614064|P1|Double-Blind/Placebo-Controlled Period|Death|3
1103434|NCT01872689|3614061|P4|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1
1103435|NCT01872689|3614062|P3|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0
1103436|NCT01872689|3614063|P2|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0
1103437|NCT01872689|3614064|P1|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1
1103438|NCT01872689|3614061|P4|Double-Blind/Placebo-Controlled Period|Physician Decision|1
1103439|NCT01872689|3614062|P3|Double-Blind/Placebo-Controlled Period|Physician Decision|3
1103440|NCT01872689|3614063|P2|Double-Blind/Placebo-Controlled Period|Physician Decision|3
1103441|NCT01872689|3614064|P1|Double-Blind/Placebo-Controlled Period|Physician Decision|0
1103442|NCT01872689|3614061|P4|Double-Blind/Placebo-Controlled Period|Protocol Violation|1
1103443|NCT01872689|3614062|P3|Double-Blind/Placebo-Controlled Period|Protocol Violation|1
1103444|NCT01872689|3614063|P2|Double-Blind/Placebo-Controlled Period|Protocol Violation|0
1103445|NCT01872689|3614064|P1|Double-Blind/Placebo-Controlled Period|Protocol Violation|0
1103446|NCT01872689|3614061|P4|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16
1103447|NCT01872689|3614062|P3|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14
1103448|NCT01872689|3614063|P2|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8
1103449|NCT01872689|3614064|P1|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9
1103450|NCT01872689|3614061|P4|Double-Blind/Placebo-Controlled Period|Other|3
1103451|NCT01872689|3614062|P3|Double-Blind/Placebo-Controlled Period|Other|6
1103452|NCT01872689|3614063|P2|Double-Blind/Placebo-Controlled Period|Other|1
1103453|NCT01872689|3614064|P1|Double-Blind/Placebo-Controlled Period|Other|1
1103454|NCT01872689|3614061|P4|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
1103455|NCT01872689|3614062|P3|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
1103456|NCT01872689|3614063|P2|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1
1103457|NCT01872689|3614064|P1|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
1103458|NCT01872611|3614140|P2|Overall Study|Reason not provided|6
1103459|NCT01872611|3614141|P1|Overall Study|Reason not provided|6
1103460|NCT01872611|3614140|P2|Overall Study|Withdrawal by Subject|1
1103461|NCT01872611|3614141|P1|Overall Study|Withdrawal by Subject|6
1103462|NCT01872611|3614140|P2|Overall Study|Physician Decision|0
1103463|NCT01872611|3614141|P1|Overall Study|Physician Decision|1
1103464|NCT01872611|3614140|P2|Overall Study|Lost to Follow-up|1
1103465|NCT01872611|3614141|P1|Overall Study|Lost to Follow-up|8
1103466|NCT01872611|3614140|P2|Overall Study|Death, prior to treatment|1
1103467|NCT01872611|3614141|P1|Overall Study|Death, prior to treatment|0
1103468|NCT01872611|3614140|P2|Overall Study|Death|1
1103469|NCT01872611|3614141|P1|Overall Study|Death|0
1103470|NCT01872611|3614140|P2|Overall Study|Adverse Event, prior to treatment|1
1103471|NCT01872611|3614141|P1|Overall Study|Adverse Event, prior to treatment|0
1103472|NCT01872611|3614140|P2|Overall Study|Adverse Event|1
1103473|NCT01872611|3614141|P1|Overall Study|Adverse Event|3
1103474|NCT01872078|3614163|P4|Overall Study|Patient met exclusion criterion 16.|1
1103475|NCT01872078|3614164|P3|Overall Study|Patient met exclusion criterion 16.|0
1103476|NCT01872078|3614165|P2|Overall Study|Patient met exclusion criterion 16.|0
1103477|NCT01872078|3614166|P1|Overall Study|Patient met exclusion criterion 16.|0
1103478|NCT01872078|3614163|P4|Overall Study|Withdrawal by Subject|0
1103479|NCT01872078|3614164|P3|Overall Study|Withdrawal by Subject|1
1103480|NCT01872078|3614165|P2|Overall Study|Withdrawal by Subject|0
1103481|NCT01872078|3614166|P1|Overall Study|Withdrawal by Subject|0
1103482|NCT01872078|3614163|P4|Overall Study|Protocol Violation|0
1103483|NCT01872078|3614164|P3|Overall Study|Protocol Violation|1
1103484|NCT01872078|3614165|P2|Overall Study|Protocol Violation|0
1103485|NCT01872078|3614166|P1|Overall Study|Protocol Violation|0
1103486|NCT01872078|3614163|P4|Overall Study|Dose administration non-compliance|1
1103487|NCT01872078|3614164|P3|Overall Study|Dose administration non-compliance|0
1103488|NCT01872078|3614165|P2|Overall Study|Dose administration non-compliance|0
1103489|NCT01872078|3614166|P1|Overall Study|Dose administration non-compliance|0
1103490|NCT01872078|3614163|P4|Overall Study|Adverse Event|0
1103491|NCT01872078|3614164|P3|Overall Study|Adverse Event|1
1103492|NCT01872078|3614165|P2|Overall Study|Adverse Event|0
1103493|NCT01872078|3614166|P1|Overall Study|Adverse Event|0
1103494|NCT01871870|3614176|P1|Overall Study|hyperglycemia|2
1103495|NCT01871870|3614176|P1|Overall Study|Hardware issues|7
1103496|NCT01871805|3614187|P6|Phase II|Lost to Follow-up|13
1103497|NCT01871805|3614188|P5|Phase II|Lost to Follow-up|0
1103498|NCT01871805|3614189|P4|Phase II|Lost to Follow-up|0
1103499|NCT01871805|3614190|P3|Phase II|Lost to Follow-up|0
1103500|NCT01871805|3614191|P2|Phase II|Lost to Follow-up|0
1103501|NCT01871805|3614192|P1|Phase II|Lost to Follow-up|0
1103502|NCT01871805|3614187|P6|Phase II|Alive in Survival Follow-up|29
1103503|NCT01871805|3614188|P5|Phase II|Alive in Survival Follow-up|0
1103504|NCT01871805|3614189|P4|Phase II|Alive in Survival Follow-up|0
1103505|NCT01871805|3614190|P3|Phase II|Alive in Survival Follow-up|0
1103506|NCT01871805|3614191|P2|Phase II|Alive in Survival Follow-up|0
1103507|NCT01871805|3614192|P1|Phase II|Alive in Survival Follow-up|0
1103508|NCT01871805|3614187|P6|Phase II|Death|45
1103509|NCT01871805|3614188|P5|Phase II|Death|0
1103510|NCT01871805|3614189|P4|Phase II|Death|0
1103511|NCT01871805|3614190|P3|Phase II|Death|0
1103512|NCT01871805|3614191|P2|Phase II|Death|0
1103513|NCT01871805|3614192|P1|Phase II|Death|0
1103514|NCT01871805|3614187|P6|Phase I|Lost to Follow-up|0
1103515|NCT01871805|3614188|P5|Phase I|Lost to Follow-up|0
1103516|NCT01871805|3614189|P4|Phase I|Lost to Follow-up|0
1103517|NCT01871805|3614190|P3|Phase I|Lost to Follow-up|3
1103518|NCT01871805|3614191|P2|Phase I|Lost to Follow-up|1
1103519|NCT01871805|3614192|P1|Phase I|Lost to Follow-up|0
1103520|NCT01871805|3614187|P6|Phase I|Alive in Survival Follow-up|0
1103521|NCT01871805|3614188|P5|Phase I|Alive in Survival Follow-up|4
1103522|NCT01871805|3614189|P4|Phase I|Alive in Survival Follow-up|5
1103523|NCT01871805|3614190|P3|Phase I|Alive in Survival Follow-up|4
1103524|NCT01871805|3614191|P2|Phase I|Alive in Survival Follow-up|2
1103525|NCT01871805|3614192|P1|Phase I|Alive in Survival Follow-up|0
1103526|NCT01871805|3614187|P6|Phase I|Death|0
1103527|NCT01871805|3614188|P5|Phase I|Death|9
1103528|NCT01871805|3614189|P4|Phase I|Death|2
1103529|NCT01871805|3614190|P3|Phase I|Death|6
1103530|NCT01871805|3614191|P2|Phase I|Death|4
1103531|NCT01871805|3614192|P1|Phase I|Death|7
1103532|NCT01871558|3614264|P2|Overall Study|Withdrawal by Subject|0
1103533|NCT01871558|3614265|P1|Overall Study|Withdrawal by Subject|2
1103534|NCT01871558|3614264|P2|Overall Study|antidiabetic drug prematurely stopped|1
1103535|NCT01871558|3614265|P1|Overall Study|antidiabetic drug prematurely stopped|1
1103536|NCT01871558|3614264|P2|Overall Study|Other reason|1
1103537|NCT01871558|3614265|P1|Overall Study|Other reason|0
1103538|NCT01871532|3614285|P2|Overall Study|Withdrawal by Subject|2
1103539|NCT01871532|3614286|P1|Overall Study|Withdrawal by Subject|1
1103540|NCT01871519|3614320|P1|Overall Study|Withdrawal by Subject|49
1103541|NCT01871519|3614320|P1|Overall Study|Lost to Follow-up|15
1103542|NCT01871519|3614320|P1|Overall Study|Death|26
1103543|NCT01871402|3614350|P2|Overall Study|Non-compliance|1
1103544|NCT01871402|3614351|P1|Overall Study|Non-compliance|0
1103545|NCT01871402|3614350|P2|Overall Study|Withdrawal by Subject|2
1103546|NCT01871402|3614351|P1|Overall Study|Withdrawal by Subject|0
1103547|NCT01871402|3614350|P2|Overall Study|Lost to Follow-up|0
1103548|NCT01871402|3614351|P1|Overall Study|Lost to Follow-up|1
1103549|NCT01871285|3614369|P4|First Intervention (1 Day)|Lost to Follow-up|0
1103550|NCT01871285|3614370|P3|First Intervention (1 Day)|Lost to Follow-up|1
1103551|NCT01871285|3614371|P2|First Intervention (1 Day)|Lost to Follow-up|1
1103552|NCT01871285|3614372|P1|First Intervention (1 Day)|Lost to Follow-up|0
1103553|NCT01871285|3614369|P4|First Intervention (1 Day)|Adverse Event|0
1103554|NCT01871285|3614370|P3|First Intervention (1 Day)|Adverse Event|0
1103555|NCT01871285|3614371|P2|First Intervention (1 Day)|Adverse Event|0
1103556|NCT01871285|3614372|P1|First Intervention (1 Day)|Adverse Event|1
1103557|NCT01871142|3614398|P1|Overall Study|Adverse Event|1
1103558|NCT01871090|3614414|P2|Overall Study|Subject Non-Compliance|1
1103559|NCT01871090|3614415|P1|Overall Study|Subject Non-Compliance|0
1103560|NCT01871090|3614414|P2|Overall Study|Interrogation not completed correctly|0
1103561|NCT01871090|3614415|P1|Overall Study|Interrogation not completed correctly|1
1103562|NCT01871090|3614414|P2|Overall Study|Interrogation not done in Emergency Room|22
1103563|NCT01871090|3614415|P1|Overall Study|Interrogation not done in Emergency Room|1
1103564|NCT01870999|3614428|P3|Overall Study|Protocol Violation|1
1103565|NCT01870999|3614429|P2|Overall Study|Protocol Violation|0
1103566|NCT01870999|3614430|P1|Overall Study|Protocol Violation|0
1103567|NCT01870999|3614428|P3|Overall Study|Withdrawal by Subject|5
1103568|NCT01870999|3614429|P2|Overall Study|Withdrawal by Subject|2
1103569|NCT01870999|3614430|P1|Overall Study|Withdrawal by Subject|0
1103570|NCT01870999|3614428|P3|Overall Study|Subject withdrawn by Investigator|0
1103571|NCT01870999|3614429|P2|Overall Study|Subject withdrawn by Investigator|0
1103572|NCT01870999|3614430|P1|Overall Study|Subject withdrawn by Investigator|1
1103573|NCT01870999|3614428|P3|Overall Study|Subject met withdrawal criteria|0
1103574|NCT01870999|3614429|P2|Overall Study|Subject met withdrawal criteria|2
1103575|NCT01870999|3614430|P1|Overall Study|Subject met withdrawal criteria|3
1103576|NCT01870999|3614428|P3|Overall Study|Adverse Event|1
1103577|NCT01870999|3614429|P2|Overall Study|Adverse Event|4
1103578|NCT01870999|3614430|P1|Overall Study|Adverse Event|0
1103579|NCT01870973|3614488|P2|Overall Study|Lost to Follow-up|3
1103580|NCT01870973|3614489|P1|Overall Study|Lost to Follow-up|10
1103581|NCT01870921|3614495|P1|Overall Study|Other|1
1103582|NCT01870921|3614495|P1|Overall Study|Subject Lost to Follow up|2
1103583|NCT01870921|3614495|P1|Overall Study|Severe non-compliance to protocol|7
1103584|NCT01870921|3614495|P1|Overall Study|Subject decision|80
1103585|NCT01870843|3614514|P1|Overall Study|Withdrawal by Subject|18
1103586|NCT01870843|3614514|P1|Overall Study|Death|1
1103587|NCT01870843|3614514|P1|Overall Study|Lost to Follow-up|24
1103588|NCT01870843|3614514|P1|Overall Study|Adverse Event|10
1103589|NCT01870778|3614529|P2|Overall Study|Lost to Follow-up|2
1103590|NCT01870778|3614530|P1|Overall Study|Lost to Follow-up|0
1103591|NCT01870778|3614529|P2|Overall Study|Withdrawal by Subject|7
1103592|NCT01870778|3614530|P1|Overall Study|Withdrawal by Subject|8
1103593|NCT01870739|3614556|P2|Add-on Period (40 Weeks)|Patient withdrew consent|0
1103594|NCT01870739|3614557|P1|Add-on Period (40 Weeks)|Patient withdrew consent|1
1103595|NCT01870739|3614556|P2|Add-on Period (40 Weeks)|Protocol deviation|1
1103596|NCT01870739|3614557|P1|Add-on Period (40 Weeks)|Protocol deviation|1
1103597|NCT01870739|3614556|P2|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0
1103598|NCT01870739|3614557|P1|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1
1103599|NCT01870739|3614556|P2|Add-on Period (40 Weeks)|Adverse Event|1
1103600|NCT01870739|3614557|P1|Add-on Period (40 Weeks)|Adverse Event|0
1103601|NCT01870739|3614556|P2|Single Drug Treatment (12 Weeks)|Administrative problems|2
1103602|NCT01870739|3614557|P1|Single Drug Treatment (12 Weeks)|Administrative problems|3
1103603|NCT01870739|3614556|P2|Single Drug Treatment (12 Weeks)|Adverse Event|1
1103604|NCT01870739|3614557|P1|Single Drug Treatment (12 Weeks)|Adverse Event|0
1103605|NCT01870739|3614556|P2|Single Drug Treatment (12 Weeks)|Protocol deviation|1
1103606|NCT01870739|3614557|P1|Single Drug Treatment (12 Weeks)|Protocol deviation|0
1103607|NCT01870726|3614596|P7|Overall Study|Progressive disease|10
1103608|NCT01870726|3614597|P6|Overall Study|Progressive disease|4
1103609|NCT01870726|3614598|P5|Overall Study|Progressive disease|6
1103610|NCT01870726|3614599|P4|Overall Study|Progressive disease|5
1103611|NCT01870726|3614600|P3|Overall Study|Progressive disease|4
1103612|NCT01870726|3614601|P2|Overall Study|Progressive disease|5
1103613|NCT01870726|3614602|P1|Overall Study|Progressive disease|5
1103614|NCT01870726|3614596|P7|Overall Study|Adverse Event|0
1103615|NCT01870726|3614597|P6|Overall Study|Adverse Event|1
1103616|NCT01870726|3614598|P5|Overall Study|Adverse Event|1
1103617|NCT01870726|3614599|P4|Overall Study|Adverse Event|0
1103618|NCT01870726|3614600|P3|Overall Study|Adverse Event|0
1103619|NCT01870726|3614601|P2|Overall Study|Adverse Event|0
1103620|NCT01870726|3614602|P1|Overall Study|Adverse Event|0
1103621|NCT01870726|3614596|P7|Overall Study|Withdrawal by Subject|0
1103622|NCT01870726|3614597|P6|Overall Study|Withdrawal by Subject|0
1103623|NCT01870726|3614598|P5|Overall Study|Withdrawal by Subject|0
1103624|NCT01870726|3614599|P4|Overall Study|Withdrawal by Subject|0
1103625|NCT01870726|3614600|P3|Overall Study|Withdrawal by Subject|0
1103626|NCT01870726|3614601|P2|Overall Study|Withdrawal by Subject|1
1103627|NCT01870726|3614602|P1|Overall Study|Withdrawal by Subject|0
1103628|NCT01870726|3614596|P7|Overall Study|Withdrawal of informed consent|0
1103629|NCT01870726|3614597|P6|Overall Study|Withdrawal of informed consent|0
1103630|NCT01870726|3614598|P5|Overall Study|Withdrawal of informed consent|0
1103631|NCT01870726|3614599|P4|Overall Study|Withdrawal of informed consent|1
1103632|NCT01870726|3614600|P3|Overall Study|Withdrawal of informed consent|0
1103633|NCT01870726|3614601|P2|Overall Study|Withdrawal of informed consent|0
1103634|NCT01870726|3614602|P1|Overall Study|Withdrawal of informed consent|0
1103635|NCT01870583|3614697|P3|Overall Study|Lost to Follow-up|5
1103636|NCT01870583|3614698|P2|Overall Study|Lost to Follow-up|13
1103637|NCT01870583|3614699|P1|Overall Study|Lost to Follow-up|11
1103638|NCT01870583|3614697|P3|Overall Study|Protocol Violation|3
1103639|NCT01870583|3614698|P2|Overall Study|Protocol Violation|5
1103640|NCT01870583|3614699|P1|Overall Study|Protocol Violation|0
1103641|NCT01870076|3614722|P4|Overall Study|Withdrawal by Subject|0
1103642|NCT01870076|3614723|P3|Overall Study|Withdrawal by Subject|1
1103643|NCT01870076|3614724|P2|Overall Study|Withdrawal by Subject|0
1103644|NCT01870076|3614725|P1|Overall Study|Withdrawal by Subject|1
1103645|NCT01869959|3614743|P5|Treatment Period|Withdrawal by Subject|0
1103646|NCT01869959|3614744|P4|Treatment Period|Withdrawal by Subject|0
1103647|NCT01869959|3614745|P3|Treatment Period|Withdrawal by Subject|0
1103648|NCT01869959|3614746|P2|Treatment Period|Withdrawal by Subject|1
1103649|NCT01869959|3614747|P1|Treatment Period|Withdrawal by Subject|0
1103650|NCT01869959|3614743|P5|Treatment Period|Sponsor decision|0
1103651|NCT01869959|3614744|P4|Treatment Period|Sponsor decision|1
1103652|NCT01869959|3614745|P3|Treatment Period|Sponsor decision|0
1103653|NCT01869959|3614746|P2|Treatment Period|Sponsor decision|1
1103654|NCT01869959|3614747|P1|Treatment Period|Sponsor decision|0
1103655|NCT01869959|3614743|P5|Treatment Period|Adverse Event|0
1103656|NCT01869959|3614744|P4|Treatment Period|Adverse Event|1
1103657|NCT01869959|3614745|P3|Treatment Period|Adverse Event|3
1103658|NCT01869959|3614746|P2|Treatment Period|Adverse Event|0
1103659|NCT01869959|3614747|P1|Treatment Period|Adverse Event|1
1103660|NCT01869959|3614743|P5|Randomization Period|Physician Decision|1
1103661|NCT01869959|3614744|P4|Randomization Period|Physician Decision|0
1103662|NCT01869959|3614745|P3|Randomization Period|Physician Decision|0
1103663|NCT01869959|3614746|P2|Randomization Period|Physician Decision|0
1103664|NCT01869959|3614747|P1|Randomization Period|Physician Decision|0
1103665|NCT01869699|3614817|P2|Overall Study|Withdrawal by Subject|0
1103666|NCT01869699|3614818|P1|Overall Study|Withdrawal by Subject|1
1103667|NCT01869348|3614881|P2|Overall Study|Withdrawal by Subject|1
1103668|NCT01869348|3614882|P1|Overall Study|Withdrawal by Subject|1
1103669|NCT01869192|3614890|P2|Postoperative Chemotherapy|Physician Decision|2
1103670|NCT01869192|3614891|P1|Postoperative Chemotherapy|Physician Decision|0
1103671|NCT01869192|3614890|P2|Preoperative Chemotherapy to Surgery|patient choice|1
1103672|NCT01869192|3614891|P1|Preoperative Chemotherapy to Surgery|patient choice|2
1103673|NCT01868997|3614926|P2|Overall Study|Not Specified|1
1103674|NCT01868997|3614927|P1|Overall Study|Not Specified|3
1103675|NCT01868997|3614926|P2|Overall Study|Lack of Efficacy|0
1103676|NCT01868997|3614927|P1|Overall Study|Lack of Efficacy|2
1103677|NCT01868997|3614926|P2|Overall Study|Adverse Event|5
1103678|NCT01868997|3614927|P1|Overall Study|Adverse Event|2
1103679|NCT01868893|3614943|P1|Overall Study|Neutropenia|1
1103680|NCT01868893|3614943|P1|Overall Study|Commercial availability of study drug|17
1103681|NCT01868893|3614943|P1|Overall Study|Adverse Event|2
1103682|NCT01868542|3614989|P2|Overall Study|Unclassified|1
1103683|NCT01868542|3614990|P1|Overall Study|Unclassified|0
1103684|NCT01868542|3614989|P2|Overall Study|Protocol Violation|1
1103685|NCT01868542|3614990|P1|Overall Study|Protocol Violation|0
1103686|NCT01868503|3615008|P1|Overall Study|Protocol Violation|1
1103687|NCT01868503|3615008|P1|Overall Study|Withdrawal by Subject|1
1103688|NCT01868477|3615018|P2|Overall Study|Withdrawal by Subject|0
1103689|NCT01868477|3615019|P1|Overall Study|Withdrawal by Subject|1
1103690|NCT01868477|3615018|P2|Overall Study|Disease progression|1
1103691|NCT01868477|3615019|P1|Overall Study|Disease progression|1
1103692|NCT01868477|3615018|P2|Overall Study|Adverse Event|4
1103693|NCT01868477|3615019|P1|Overall Study|Adverse Event|2
1103694|NCT01868243|3615090|P2|Overall Study|Death|1
1103695|NCT01868243|3615091|P1|Overall Study|Death|0
1103696|NCT01868074|3615101|P2|Overall Study|Withdrawal by Subject|2
1103697|NCT01868074|3615102|P1|Overall Study|Withdrawal by Subject|4
1103698|NCT01868074|3615101|P2|Overall Study|Lost to Follow-up|2
1103699|NCT01868074|3615102|P1|Overall Study|Lost to Follow-up|3
1103700|NCT01868035|3615112|P1|Overall Study|Non-compliance|1
1103701|NCT01868035|3615112|P1|Overall Study|Progressive Disease|2
1103702|NCT01868035|3615112|P1|Overall Study|Withdrawal by Subject|1
1103703|NCT01868035|3615112|P1|Overall Study|Lost to Follow-up|3
1103704|NCT01868009|3615128|P2|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0
1103705|NCT01868009|3615129|P1|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1
1103706|NCT01868009|3615128|P2|Period 2 (5-9 Days)|Adverse Event|0
1103707|NCT01868009|3615129|P1|Period 2 (5-9 Days)|Adverse Event|1
1103708|NCT01868009|3615128|P2|Period 1 (5-9 Days)|Adverse Event|2
1103709|NCT01868009|3615129|P1|Period 1 (5-9 Days)|Adverse Event|0
1103710|NCT01867710|3615143|P4|Overall Study|Other|0
1103711|NCT01867710|3615144|P3|Overall Study|Other|0
1103712|NCT01867710|3615145|P2|Overall Study|Other|1
1103713|NCT01867710|3615146|P1|Overall Study|Other|0
1103714|NCT01867710|3615143|P4|Overall Study|Eligible Criteria Not Met|0
1103715|NCT01867710|3615144|P3|Overall Study|Eligible Criteria Not Met|1
1103716|NCT01867710|3615145|P2|Overall Study|Eligible Criteria Not Met|0
1103717|NCT01867710|3615146|P1|Overall Study|Eligible Criteria Not Met|0
1103718|NCT01867710|3615143|P4|Overall Study|Withdrawal by Subject|0
1103719|NCT01867710|3615144|P3|Overall Study|Withdrawal by Subject|0
1103720|NCT01867710|3615145|P2|Overall Study|Withdrawal by Subject|1
1103721|NCT01867710|3615146|P1|Overall Study|Withdrawal by Subject|0
1103722|NCT01867710|3615143|P4|Overall Study|Protocol Violation|1
1103723|NCT01867710|3615144|P3|Overall Study|Protocol Violation|0
1103724|NCT01867710|3615145|P2|Overall Study|Protocol Violation|0
1103725|NCT01867710|3615146|P1|Overall Study|Protocol Violation|1
1103726|NCT01867710|3615143|P4|Overall Study|Physician Decision|0
1103727|NCT01867710|3615144|P3|Overall Study|Physician Decision|1
1103728|NCT01867710|3615145|P2|Overall Study|Physician Decision|0
1103729|NCT01867710|3615146|P1|Overall Study|Physician Decision|0
1103730|NCT01867710|3615143|P4|Overall Study|Death|0
1103731|NCT01867710|3615144|P3|Overall Study|Death|1
1103732|NCT01867710|3615145|P2|Overall Study|Death|1
1103733|NCT01867710|3615146|P1|Overall Study|Death|0
1103734|NCT01867710|3615143|P4|Overall Study|Other Adverse Events|3
1103735|NCT01867710|3615144|P3|Overall Study|Other Adverse Events|1
1103736|NCT01867710|3615145|P2|Overall Study|Other Adverse Events|0
1103737|NCT01867710|3615146|P1|Overall Study|Other Adverse Events|1
1103738|NCT01867710|3615143|P4|Overall Study|Palliative Radiation Required|1
1103739|NCT01867710|3615144|P3|Overall Study|Palliative Radiation Required|1
1103740|NCT01867710|3615145|P2|Overall Study|Palliative Radiation Required|0
1103741|NCT01867710|3615146|P1|Overall Study|Palliative Radiation Required|0
1103742|NCT01867710|3615143|P4|Overall Study|Adverse Event Sustained Toxicity>Grade 1|0
1103743|NCT01867710|3615144|P3|Overall Study|Adverse Event Sustained Toxicity>Grade 1|0
1103744|NCT01867710|3615145|P2|Overall Study|Adverse Event Sustained Toxicity>Grade 1|0
1103745|NCT01867710|3615146|P1|Overall Study|Adverse Event Sustained Toxicity>Grade 1|1
1103746|NCT01867710|3615143|P4|Overall Study|Adverse Event Grade 3 or 4 Hypokalemia|0
1103747|NCT01867710|3615144|P3|Overall Study|Adverse Event Grade 3 or 4 Hypokalemia|0
1103748|NCT01867710|3615145|P2|Overall Study|Adverse Event Grade 3 or 4 Hypokalemia|2
1103749|NCT01867710|3615146|P1|Overall Study|Adverse Event Grade 3 or 4 Hypokalemia|0
1103750|NCT01867710|3615143|P4|Overall Study|Disease Progression|2
1103751|NCT01867710|3615144|P3|Overall Study|Disease Progression|4
1103752|NCT01867710|3615145|P2|Overall Study|Disease Progression|2
1103753|NCT01867710|3615146|P1|Overall Study|Disease Progression|5
1103754|NCT01867658|3615160|P1|Overall Study|Subject could not be contacted|1
1103755|NCT01867658|3615160|P1|Overall Study|Death|2
1103756|NCT01867658|3615160|P1|Overall Study|Withdrawal by Subject|6
1103757|NCT01867580|3615184|P2|Overall Study|Wound recurrence|1
1103758|NCT01867580|3615185|P1|Overall Study|Wound recurrence|0
1103759|NCT01867580|3615184|P2|Overall Study|Continuation of therapy|1
1103760|NCT01867580|3615185|P1|Overall Study|Continuation of therapy|0
1103761|NCT01867580|3615184|P2|Overall Study|Osteomyelitis|1
1103762|NCT01867580|3615185|P1|Overall Study|Osteomyelitis|0
1103763|NCT01867580|3615184|P2|Overall Study|Interruption to therapy|0
1103764|NCT01867580|3615185|P1|Overall Study|Interruption to therapy|3
1103765|NCT01867580|3615184|P2|Overall Study|Missed follow-up assessment|1
1103766|NCT01867580|3615185|P1|Overall Study|Missed follow-up assessment|2
1103767|NCT01867580|3615184|P2|Overall Study|Sponsor terminated study|0
1103768|NCT01867580|3615185|P1|Overall Study|Sponsor terminated study|1
1103769|NCT01867580|3615184|P2|Overall Study|Lost to Follow-up|5
1103770|NCT01867580|3615185|P1|Overall Study|Lost to Follow-up|3
1103771|NCT01867580|3615184|P2|Overall Study|Physician Decision|12
1103772|NCT01867580|3615185|P1|Overall Study|Physician Decision|17
1103773|NCT01867580|3615184|P2|Overall Study|Withdrawal by Subject|3
1103774|NCT01867580|3615185|P1|Overall Study|Withdrawal by Subject|2
1103775|NCT01867424|3615210|P2|Overall Study|Patient noncompliance|1
1103776|NCT01867424|3615211|P1|Overall Study|Patient noncompliance|2
1103777|NCT01867307|3615225|P2|Overall Study|Other Adverse Event|3
1103778|NCT01867307|3615226|P1|Overall Study|Other Adverse Event|1
1103779|NCT01867307|3615225|P2|Overall Study|Protocol Violation|0
1103780|NCT01867307|3615226|P1|Overall Study|Protocol Violation|2
1103781|NCT01867216|3615239|P7|Overall Study|Unable to Place Catheter for Blood Draws|0
1103782|NCT01867216|3615240|P6|Overall Study|Unable to Place Catheter for Blood Draws|0
1103783|NCT01867216|3615241|P5|Overall Study|Unable to Place Catheter for Blood Draws|0
1103784|NCT01867216|3615242|P4|Overall Study|Unable to Place Catheter for Blood Draws|0
1103785|NCT01867216|3615243|P3|Overall Study|Unable to Place Catheter for Blood Draws|0
1103786|NCT01867216|3615244|P2|Overall Study|Unable to Place Catheter for Blood Draws|0
1103787|NCT01867216|3615245|P1|Overall Study|Unable to Place Catheter for Blood Draws|1
1103788|NCT01867216|3615239|P7|Overall Study|Physician Decision|0
1103789|NCT01867216|3615240|P6|Overall Study|Physician Decision|0
1103790|NCT01867216|3615241|P5|Overall Study|Physician Decision|0
1103791|NCT01867216|3615242|P4|Overall Study|Physician Decision|0
1103792|NCT01867216|3615243|P3|Overall Study|Physician Decision|0
1103793|NCT01867216|3615244|P2|Overall Study|Physician Decision|0
1103794|NCT01867216|3615245|P1|Overall Study|Physician Decision|1
1103795|NCT01867216|3615239|P7|Overall Study|Withdrawal by Subject|1
1103796|NCT01867216|3615240|P6|Overall Study|Withdrawal by Subject|0
1103797|NCT01867216|3615241|P5|Overall Study|Withdrawal by Subject|1
1103798|NCT01867216|3615242|P4|Overall Study|Withdrawal by Subject|0
1103799|NCT01867216|3615243|P3|Overall Study|Withdrawal by Subject|0
1103800|NCT01867216|3615244|P2|Overall Study|Withdrawal by Subject|0
1103801|NCT01867216|3615245|P1|Overall Study|Withdrawal by Subject|2
1103802|NCT01867086|3615317|P1|Overall Study|Disease Progression|1
1103803|NCT01867047|3615326|P2|Overall Study|surgery not indicated in protocol|2
1103804|NCT01867047|3615327|P1|Overall Study|surgery not indicated in protocol|1
1103805|NCT01867047|3615326|P2|Overall Study|Physician Decision|0
1103806|NCT01867047|3615327|P1|Overall Study|Physician Decision|2
1103807|NCT01867047|3615326|P2|Overall Study|Withdrawal by Subject|0
1103808|NCT01867047|3615327|P1|Overall Study|Withdrawal by Subject|2
1103809|NCT01867047|3615326|P2|Overall Study|Lost to Follow-up|3
1103810|NCT01867047|3615327|P1|Overall Study|Lost to Follow-up|3
1103811|NCT01867021|3615347|P2|Overall Study|Withdrawal by Subject|6
1103812|NCT01867021|3615348|P1|Overall Study|Withdrawal by Subject|1
1103813|NCT01867021|3615347|P2|Overall Study|Lost to Follow-up|2
1103814|NCT01867021|3615348|P1|Overall Study|Lost to Follow-up|0
1103815|NCT01867021|3615347|P2|Overall Study|Death|0
1103816|NCT01867021|3615348|P1|Overall Study|Death|1
1103817|NCT01867021|3615347|P2|Overall Study|Not Eligible|1
1103818|NCT01867021|3615348|P1|Overall Study|Not Eligible|0
1103819|NCT01867021|3615347|P2|Overall Study|Adverse Event|1
1103820|NCT01867021|3615348|P1|Overall Study|Adverse Event|0
1103821|NCT01866709|3615379|P2|Overall Study|Adverse Event|0
1103822|NCT01866709|3615380|P1|Overall Study|Adverse Event|1
1103823|NCT01866423|3615421|P1|Overall Study|Sponsor Decision|1
1103824|NCT01866423|3615421|P1|Overall Study|Lack of Efficacy|3
1103825|NCT01866319|3615434|P3|Overall Study|Remain on study|176
1103826|NCT01866319|3615435|P2|Overall Study|Remain on study|190
1103827|NCT01866319|3615436|P1|Overall Study|Remain on study|131
1103828|NCT01866319|3615434|P3|Overall Study|Withdrawal by Subject|6
1103829|NCT01866319|3615435|P2|Overall Study|Withdrawal by Subject|9
1103830|NCT01866319|3615436|P1|Overall Study|Withdrawal by Subject|31
1103831|NCT01866319|3615434|P3|Overall Study|Physician Decision|0
1103832|NCT01866319|3615435|P2|Overall Study|Physician Decision|0
1103833|NCT01866319|3615436|P1|Overall Study|Physician Decision|1
1103834|NCT01866319|3615434|P3|Overall Study|Lost to Follow-up|6
1103835|NCT01866319|3615435|P2|Overall Study|Lost to Follow-up|0
1103836|NCT01866319|3615436|P1|Overall Study|Lost to Follow-up|3
1103837|NCT01866319|3615434|P3|Overall Study|Death|77
1103838|NCT01866319|3615435|P2|Overall Study|Death|74
1103839|NCT01866319|3615436|P1|Overall Study|Death|97
1103840|NCT01866319|3615434|P3|Overall Study|Clinical progression|0
1103841|NCT01866319|3615435|P2|Overall Study|Clinical progression|0
1103842|NCT01866319|3615436|P1|Overall Study|Clinical progression|1
1103843|NCT01866319|3615434|P3|Overall Study|Adverse Event|12
1103844|NCT01866319|3615435|P2|Overall Study|Adverse Event|6
1103845|NCT01866319|3615436|P1|Overall Study|Adverse Event|13
1103846|NCT01866293|3615535|P1|Overall Study|Adverse Event|2
1103847|NCT01865812|3615577|P1|Overall Study|Adverse Event|2
1103848|NCT01865747|3615585|P2|Primary Intent to Treat (PITT)|Other|1
1103849|NCT01865747|3615586|P1|Primary Intent to Treat (PITT)|Other|0
1103850|NCT01865747|3615585|P2|Primary Intent to Treat (PITT)|Progressive Disease|92
1103851|NCT01865747|3615586|P1|Primary Intent to Treat (PITT)|Progressive Disease|82
1103852|NCT01865747|3615585|P2|Primary Intent to Treat (PITT)|Withdrawal by Subject|7
1103853|NCT01865747|3615586|P1|Primary Intent to Treat (PITT)|Withdrawal by Subject|3
1103854|NCT01865747|3615585|P2|Primary Intent to Treat (PITT)|Physician Decision|2
1103855|NCT01865747|3615586|P1|Primary Intent to Treat (PITT)|Physician Decision|4
1103856|NCT01865747|3615585|P2|Primary Intent to Treat (PITT)|Protocol Violation|1
1103857|NCT01865747|3615586|P1|Primary Intent to Treat (PITT)|Protocol Violation|1
1103858|NCT01865747|3615585|P2|Primary Intent to Treat (PITT)|Lack of Efficacy|0
1103859|NCT01865747|3615586|P1|Primary Intent to Treat (PITT)|Lack of Efficacy|2
1103860|NCT01865747|3615585|P2|Primary Intent to Treat (PITT)|Clinical Deterioration|29
1103861|NCT01865747|3615586|P1|Primary Intent to Treat (PITT)|Clinical Deterioration|18
1103862|NCT01865747|3615585|P2|Primary Intent to Treat (PITT)|Adverse Event|20
1103863|NCT01865747|3615586|P1|Primary Intent to Treat (PITT)|Adverse Event|21
1103864|NCT01865747|3615585|P2|Overall Study (ITT)|Reason Not Provided|1
1103865|NCT01865747|3615586|P1|Overall Study (ITT)|Reason Not Provided|0
1103866|NCT01865747|3615585|P2|Overall Study (ITT)|Progressive Disease|158
1103867|NCT01865747|3615586|P1|Overall Study (ITT)|Progressive Disease|122
1103868|NCT01865747|3615585|P2|Overall Study (ITT)|Sponsor Decision|1
1103869|NCT01865747|3615586|P1|Overall Study (ITT)|Sponsor Decision|0
1103870|NCT01865747|3615585|P2|Overall Study (ITT)|Withdrawal by Subject|11
1103871|NCT01865747|3615586|P1|Overall Study (ITT)|Withdrawal by Subject|6
1103872|NCT01865747|3615585|P2|Overall Study (ITT)|Physician Decision|2
1103873|NCT01865747|3615586|P1|Overall Study (ITT)|Physician Decision|5
1103874|NCT01865747|3615585|P2|Overall Study (ITT)|Protocol Violation|1
1103875|NCT01865747|3615586|P1|Overall Study (ITT)|Protocol Violation|1
1103876|NCT01865747|3615585|P2|Overall Study (ITT)|Lack of Efficacy|0
1103877|NCT01865747|3615586|P1|Overall Study (ITT)|Lack of Efficacy|3
1103878|NCT01865747|3615585|P2|Overall Study (ITT)|Clinical Deterioration|50
1103879|NCT01865747|3615586|P1|Overall Study (ITT)|Clinical Deterioration|29
1103880|NCT01865747|3615585|P2|Overall Study (ITT)|Adverse Event|31
1103881|NCT01865747|3615586|P1|Overall Study (ITT)|Adverse Event|32
1103882|NCT01865084|3615604|P3|Open Label Extension (OLE) Period|Withdrawal by Subject|2
1103883|NCT01865084|3615605|P2|Open Label Extension (OLE) Period|Withdrawal by Subject|2
1103884|NCT01865084|3615606|P1|Open Label Extension (OLE) Period|Withdrawal by Subject|0
1103885|NCT01865084|3615604|P3|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2
1103886|NCT01865084|3615605|P2|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8
1103887|NCT01865084|3615606|P1|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0
1103888|NCT01865084|3615604|P3|Open Label Extension (OLE) Period|Lost to Follow-up|0
1103889|NCT01865084|3615605|P2|Open Label Extension (OLE) Period|Lost to Follow-up|1
1103890|NCT01865084|3615606|P1|Open Label Extension (OLE) Period|Lost to Follow-up|0
1103891|NCT01865084|3615604|P3|Open Label Extension (OLE) Period|Lack of Efficacy|2
1103892|NCT01865084|3615605|P2|Open Label Extension (OLE) Period|Lack of Efficacy|0
1103893|NCT01865084|3615606|P1|Open Label Extension (OLE) Period|Lack of Efficacy|0
1103894|NCT01865084|3615604|P3|Open Label Extension (OLE) Period|Adverse Event|1
1103895|NCT01865084|3615605|P2|Open Label Extension (OLE) Period|Adverse Event|0
1103896|NCT01865084|3615606|P1|Open Label Extension (OLE) Period|Adverse Event|0
1103897|NCT01865084|3615604|P3|Double Blind Period (DB)|Withdrawal by Subject|0
1103898|NCT01865084|3615605|P2|Double Blind Period (DB)|Withdrawal by Subject|0
1103899|NCT01865084|3615606|P1|Double Blind Period (DB)|Withdrawal by Subject|1
1103900|NCT01865084|3615604|P3|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4
1103901|NCT01865084|3615605|P2|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
1103902|NCT01865084|3615606|P1|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
1103903|NCT01865084|3615604|P3|Double Blind Period (DB)|Protocol Violation|1
1103904|NCT01865084|3615605|P2|Double Blind Period (DB)|Protocol Violation|0
1103905|NCT01865084|3615606|P1|Double Blind Period (DB)|Protocol Violation|0
1103906|NCT01865084|3615604|P3|Double Blind Period (DB)|Adverse Event|1
1103907|NCT01865084|3615605|P2|Double Blind Period (DB)|Adverse Event|2
1103908|NCT01865084|3615606|P1|Double Blind Period (DB)|Adverse Event|2
1103909|NCT01864525|3615638|P2|Overall Study|Adverse Event|0
1103910|NCT01864525|3615639|P1|Overall Study|Adverse Event|1
1103911|NCT01864200|3615662|P2|Overall Study|Protocol Violation|0
1103912|NCT01864200|3615663|P1|Overall Study|Protocol Violation|1
1103913|NCT01864200|3615662|P2|Overall Study|Lost to Follow-up|3
1103914|NCT01864200|3615663|P1|Overall Study|Lost to Follow-up|1
1103915|NCT01864174|3615671|P2|Off Treatment Follow-Up|Subject Withdrew Consent|0
1103916|NCT01864174|3615672|P1|Off Treatment Follow-Up|Subject Withdrew Consent|1
1103917|NCT01864174|3615671|P2|Off Treatment Follow-Up|Other|0
1103918|NCT01864174|3615672|P1|Off Treatment Follow-Up|Other|2
1103919|NCT01864174|3615671|P2|Double Blind - Compliant Randomized|Other|10
1103920|NCT01864174|3615672|P1|Double Blind - Compliant Randomized|Other|6
1103921|NCT01864174|3615671|P2|Double Blind - Compliant Randomized|Poor/Non-compliance|0
1103922|NCT01864174|3615672|P1|Double Blind - Compliant Randomized|Poor/Non-compliance|1
1103923|NCT01864174|3615671|P2|Double Blind - Compliant Randomized|Lost to Follow-up|10
1103924|NCT01864174|3615672|P1|Double Blind - Compliant Randomized|Lost to Follow-up|3
1103925|NCT01864174|3615671|P2|Double Blind - Compliant Randomized|Death|0
1103926|NCT01864174|3615672|P1|Double Blind - Compliant Randomized|Death|1
1103927|NCT01864174|3615671|P2|Double Blind - Compliant Randomized|Subject Withdrew Consent|5
1103928|NCT01864174|3615672|P1|Double Blind - Compliant Randomized|Subject Withdrew Consent|4
1103929|NCT01864174|3615671|P2|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0
1103930|NCT01864174|3615672|P1|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2
1103931|NCT01864174|3615671|P2|Double Blind - Compliant Randomized|Adverse Event|1
1103932|NCT01864174|3615672|P1|Double Blind - Compliant Randomized|Adverse Event|6
1103933|NCT01864174|3615671|P2|Double Blind Treatment - All Treated|Removed due to site non-compliance|14
1103934|NCT01864174|3615672|P1|Double Blind Treatment - All Treated|Removed due to site non-compliance|15
1103935|NCT01864148|3615691|P5|Overall Study|Not Dosed|0
1103936|NCT01864148|3615692|P4|Overall Study|Not Dosed|1
1103937|NCT01864148|3615693|P3|Overall Study|Not Dosed|0
1103938|NCT01864148|3615694|P2|Overall Study|Not Dosed|0
1103939|NCT01864148|3615695|P1|Overall Study|Not Dosed|0
1103940|NCT01864148|3615691|P5|Overall Study|Adverse Event|7
1103941|NCT01864148|3615692|P4|Overall Study|Adverse Event|7
1103942|NCT01864148|3615693|P3|Overall Study|Adverse Event|4
1103943|NCT01864148|3615694|P2|Overall Study|Adverse Event|2
1103944|NCT01864148|3615695|P1|Overall Study|Adverse Event|4
1103945|NCT01864148|3615691|P5|Overall Study|Lost to Follow-up|1
1103946|NCT01864148|3615692|P4|Overall Study|Lost to Follow-up|2
1103947|NCT01864148|3615693|P3|Overall Study|Lost to Follow-up|0
1103948|NCT01864148|3615694|P2|Overall Study|Lost to Follow-up|0
1103949|NCT01864148|3615695|P1|Overall Study|Lost to Follow-up|0
1103950|NCT01864148|3615691|P5|Overall Study|Withdrawal by Subject|8
1103951|NCT01864148|3615692|P4|Overall Study|Withdrawal by Subject|8
1103952|NCT01864148|3615693|P3|Overall Study|Withdrawal by Subject|6
1103953|NCT01864148|3615694|P2|Overall Study|Withdrawal by Subject|2
1103954|NCT01864148|3615695|P1|Overall Study|Withdrawal by Subject|9
1103955|NCT01864148|3615691|P5|Overall Study|Investigator Decision|6
1103956|NCT01864148|3615692|P4|Overall Study|Investigator Decision|4
1103957|NCT01864148|3615693|P3|Overall Study|Investigator Decision|0
1103958|NCT01864148|3615694|P2|Overall Study|Investigator Decision|0
1103959|NCT01864148|3615695|P1|Overall Study|Investigator Decision|5
1103960|NCT01864148|3615691|P5|Overall Study|Death|0
1103961|NCT01864148|3615692|P4|Overall Study|Death|1
1103962|NCT01864148|3615693|P3|Overall Study|Death|0
1103963|NCT01864148|3615694|P2|Overall Study|Death|0
1103964|NCT01864148|3615695|P1|Overall Study|Death|0
1103965|NCT01864148|3615691|P5|Overall Study|Not Specified|1
1103966|NCT01864148|3615692|P4|Overall Study|Not Specified|3
1103967|NCT01864148|3615693|P3|Overall Study|Not Specified|1
1103968|NCT01864148|3615694|P2|Overall Study|Not Specified|1
1103969|NCT01864148|3615695|P1|Overall Study|Not Specified|2
1103970|NCT01864005|3615724|P2|Overall Study|Need GP IIb/IIIa|3
1103971|NCT01864005|3615725|P1|Overall Study|Need GP IIb/IIIa|1
1103972|NCT01864005|3615724|P2|Overall Study|Disease need|1
1103973|NCT01864005|3615725|P1|Overall Study|Disease need|1
1103974|NCT01864005|3615724|P2|Overall Study|Incorrect enrolment|0
1103975|NCT01864005|3615725|P1|Overall Study|Incorrect enrolment|1
1103976|NCT01864005|3615724|P2|Overall Study|Withdrawal by Subject|1
1103977|NCT01864005|3615725|P1|Overall Study|Withdrawal by Subject|0
1103978|NCT01864005|3615724|P2|Overall Study|Protocol Violation|1
1103979|NCT01864005|3615725|P1|Overall Study|Protocol Violation|0
1103980|NCT01863953|3615742|P3|Overall Study|Adverse Event|1
1103981|NCT01863953|3615743|P2|Overall Study|Adverse Event|0
1103982|NCT01863953|3615744|P1|Overall Study|Adverse Event|0
1103983|NCT01863771|3615758|P4|Maintenance Phase|Withdrawal by Subject|3
1103984|NCT01863771|3615759|P3|Maintenance Phase|Withdrawal by Subject|2
1103985|NCT01863771|3615760|P2|Maintenance Phase|Withdrawal by Subject|1
1103986|NCT01863771|3615761|P1|Maintenance Phase|Withdrawal by Subject|0
1103987|NCT01863771|3615758|P4|Maintenance Phase|Pregnancy|0
1103988|NCT01863771|3615759|P3|Maintenance Phase|Pregnancy|0
1103989|NCT01863771|3615760|P2|Maintenance Phase|Pregnancy|1
1103990|NCT01863771|3615761|P1|Maintenance Phase|Pregnancy|0
1103991|NCT01863771|3615758|P4|Maintenance Phase|Physician Decision|1
1103992|NCT01863771|3615759|P3|Maintenance Phase|Physician Decision|2
1103993|NCT01863771|3615760|P2|Maintenance Phase|Physician Decision|0
1103994|NCT01863771|3615761|P1|Maintenance Phase|Physician Decision|0
1103995|NCT01863771|3615758|P4|Maintenance Phase|Lack of Efficacy|38
1103996|NCT01863771|3615759|P3|Maintenance Phase|Lack of Efficacy|7
1103997|NCT01863771|3615760|P2|Maintenance Phase|Lack of Efficacy|3
1103998|NCT01863771|3615761|P1|Maintenance Phase|Lack of Efficacy|0
1103999|NCT01863771|3615758|P4|Maintenance Phase|Adverse Event|1
1104000|NCT01863771|3615759|P3|Maintenance Phase|Adverse Event|1
1104001|NCT01863771|3615760|P2|Maintenance Phase|Adverse Event|0
1104002|NCT01863771|3615761|P1|Maintenance Phase|Adverse Event|0
1104003|NCT01863771|3615758|P4|Induction Phase|Withdrawal by Subject|0
1104004|NCT01863771|3615759|P3|Induction Phase|Withdrawal by Subject|0
1104005|NCT01863771|3615760|P2|Induction Phase|Withdrawal by Subject|0
1104006|NCT01863771|3615761|P1|Induction Phase|Withdrawal by Subject|2
1104007|NCT01863771|3615758|P4|Induction Phase|Lack of Efficacy|0
1104008|NCT01863771|3615759|P3|Induction Phase|Lack of Efficacy|0
1104009|NCT01863771|3615760|P2|Induction Phase|Lack of Efficacy|0
1104010|NCT01863771|3615761|P1|Induction Phase|Lack of Efficacy|10
1104011|NCT01863771|3615758|P4|Induction Phase|Adverse Event|0
1104012|NCT01863771|3615759|P3|Induction Phase|Adverse Event|0
1104013|NCT01863771|3615760|P2|Induction Phase|Adverse Event|0
1104014|NCT01863771|3615761|P1|Induction Phase|Adverse Event|9
1104015|NCT01863758|3615773|P1|Prophylactic Treatment-Phase II|Lost to Follow-up|1
1104016|NCT01863758|3615773|P1|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1
1104017|NCT01863680|3615781|P1|Overall Study|Other|6
1104018|NCT01863680|3615781|P1|Overall Study|Did not undergo IVF/ET|14
1104019|NCT01863680|3615781|P1|Overall Study|Withdrawal by Subject|1
1104020|NCT01863680|3615781|P1|Overall Study|Spontaneous pregnancy|2
1104021|NCT01863680|3615781|P1|Overall Study|Risk of OHSS|17
1104022|NCT01863680|3615781|P1|Overall Study|Adverse Event|17
1104023|NCT01863667|3615789|P2|Overall Study|Withdrawal by Subject|2
1104024|NCT01863667|3615790|P1|Overall Study|Withdrawal by Subject|2
1104025|NCT01863667|3615789|P2|Overall Study|Study terminated by Sponsor|30
1104026|NCT01863667|3615790|P1|Overall Study|Study terminated by Sponsor|30
1104027|NCT01863667|3615789|P2|Overall Study|Adverse Event|0
1104028|NCT01863667|3615790|P1|Overall Study|Adverse Event|1
1104029|NCT01863433|3615814|P1|Overall Study|Protocol Violation|1
1104030|NCT01863368|3615824|P2|Phase II, Day 35 to Day 90|Lost to Follow-up|0
1104031|NCT01863368|3615825|P1|Phase II, Day 35 to Day 90|Lost to Follow-up|1
1104032|NCT01863368|3615824|P2|Phase II, Day 35 to Day 90|Adverse Event|0
1104033|NCT01863368|3615825|P1|Phase II, Day 35 to Day 90|Adverse Event|1
1104034|NCT01863368|3615824|P2|Phase I, Day 0 to Day 35|Withdrawal by Subject|2
1104035|NCT01863368|3615825|P1|Phase I, Day 0 to Day 35|Withdrawal by Subject|0
1104036|NCT01863368|3615824|P2|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1
1104037|NCT01863368|3615825|P1|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0
1104038|NCT01863368|3615824|P2|Phase I, Day 0 to Day 35|Lost to Follow-up|0
1104039|NCT01863368|3615825|P1|Phase I, Day 0 to Day 35|Lost to Follow-up|1
1104040|NCT01863368|3615824|P2|Phase I, Day 0 to Day 35|Adverse Event|4
1104041|NCT01863368|3615825|P1|Phase I, Day 0 to Day 35|Adverse Event|2
1104042|NCT01862991|3615850|P3|Overall Study|Protocol Violation|0
1104043|NCT01862991|3615851|P2|Overall Study|Protocol Violation|0
1104044|NCT01862991|3615852|P1|Overall Study|Protocol Violation|1
1104045|NCT01862991|3615850|P3|Overall Study|Lost to Follow-up|1
1104046|NCT01862991|3615851|P2|Overall Study|Lost to Follow-up|1
1104047|NCT01862991|3615852|P1|Overall Study|Lost to Follow-up|2
1104048|NCT01862874|3615865|P2|Overall Study|Death|1
1104049|NCT01862874|3615866|P1|Overall Study|Death|0
1104050|NCT01862874|3615865|P2|Overall Study|Withdrawal by Subject|40
1104051|NCT01862874|3615866|P1|Overall Study|Withdrawal by Subject|46
1104052|NCT01862874|3615865|P2|Overall Study|Withdrawn by parent/guardian|1
1104053|NCT01862874|3615866|P1|Overall Study|Withdrawn by parent/guardian|1
1104054|NCT01862874|3615865|P2|Overall Study|Physician Decision|3
1104055|NCT01862874|3615866|P1|Overall Study|Physician Decision|5
1104056|NCT01862874|3615865|P2|Overall Study|Lost to Follow-up|29
1104057|NCT01862874|3615866|P1|Overall Study|Lost to Follow-up|26
1104058|NCT01862874|3615865|P2|Overall Study|Adverse Event|3
1104059|NCT01862874|3615866|P1|Overall Study|Adverse Event|0
1104060|NCT01862874|3615865|P2|Overall Study|Randomized not treated|0
1104061|NCT01862874|3615866|P1|Overall Study|Randomized not treated|1
1104062|NCT01862484|3615884|P2|Overall Study|Withdrawal by Subject|3
1104063|NCT01862484|3615885|P1|Overall Study|Withdrawal by Subject|0
1104064|NCT01862484|3615884|P2|Overall Study|Protocol Violation|2
1104065|NCT01862484|3615885|P1|Overall Study|Protocol Violation|0
1104066|NCT01862484|3615884|P2|Overall Study|Lost to Follow-up|2
1104067|NCT01862484|3615885|P1|Overall Study|Lost to Follow-up|1
1104068|NCT01862484|3615884|P2|Overall Study|Lack of Efficacy|1
1104069|NCT01862484|3615885|P1|Overall Study|Lack of Efficacy|1
1104070|NCT01862250|3615904|P1|Overall Study|Adverse Event|4
1104071|NCT01862029|3615925|P1|Overall Study|Physician Decision|1
1104072|NCT01861522|3616028|P2|Overall Study|Withdrawal by Subject|0
1104073|NCT01861522|3616029|P1|Overall Study|Withdrawal by Subject|2
1104074|NCT01861522|3616028|P2|Overall Study|Adverse Event|0
1104075|NCT01861522|3616029|P1|Overall Study|Adverse Event|1
1104076|NCT01860989|3616053|P1|Overall Study|Unsatisfactory therapeutic|5
1104077|NCT01860976|3616059|P2|Long Term Extension|Ongoing treatment at time of analysis|100
1104078|NCT01860976|3616060|P1|Long Term Extension|Ongoing treatment at time of analysis|106
1104079|NCT01860976|3616059|P2|Long Term Extension|Withdrawal by Subject|0
1104080|NCT01860976|3616060|P1|Long Term Extension|Withdrawal by Subject|1
1104081|NCT01860976|3616059|P2|Long Term Extension|Subject request to discontinue treatment|0
1104082|NCT01860976|3616060|P1|Long Term Extension|Subject request to discontinue treatment|2
1104083|NCT01860976|3616059|P2|Long Term Extension|Lack of Efficacy|7
1104084|NCT01860976|3616060|P1|Long Term Extension|Lack of Efficacy|3
1104085|NCT01860976|3616059|P2|Long Term Extension|Adverse Event|0
1104086|NCT01860976|3616060|P1|Long Term Extension|Adverse Event|1
1104087|NCT01860976|3616059|P2|Open-Label|Ongoing OL treatment at time of analysis|45
1104088|NCT01860976|3616060|P1|Open-Label|Ongoing OL treatment at time of analysis|46
1104089|NCT01860976|3616059|P2|Open-Label|Other Reasons|1
1104090|NCT01860976|3616060|P1|Open-Label|Other Reasons|1
1104091|NCT01860976|3616059|P2|Open-Label|Withdrawal by Subject|1
1104092|NCT01860976|3616060|P1|Open-Label|Withdrawal by Subject|4
1104093|NCT01860976|3616059|P2|Open-Label|Subject request discontinue treatment|3
1104094|NCT01860976|3616060|P1|Open-Label|Subject request discontinue treatment|4
1104095|NCT01860976|3616059|P2|Open-Label|Lost to Follow-up|2
1104096|NCT01860976|3616060|P1|Open-Label|Lost to Follow-up|1
1104097|NCT01860976|3616059|P2|Open-Label|Lack of Efficacy|8
1104098|NCT01860976|3616060|P1|Open-Label|Lack of Efficacy|16
1104099|NCT01860976|3616059|P2|Open-Label|Adverse Event|4
1104100|NCT01860976|3616060|P1|Open-Label|Adverse Event|2
1104101|NCT01860976|3616059|P2|Blinded Treatment|Early Escape: Transitioned to OL period|89
1104102|NCT01860976|3616060|P1|Blinded Treatment|Early Escape: Transitioned to OL period|76
1104103|NCT01860976|3616059|P2|Blinded Treatment|Entered Open-Label in error|1
1104104|NCT01860976|3616060|P1|Blinded Treatment|Entered Open-Label in error|0
1104105|NCT01860976|3616059|P2|Blinded Treatment|Subject no longer met criteria|0
1104106|NCT01860976|3616060|P1|Blinded Treatment|Subject no longer met criteria|1
1104107|NCT01860976|3616059|P2|Blinded Treatment|Withdrawal by Subject|5
1104108|NCT01860976|3616060|P1|Blinded Treatment|Withdrawal by Subject|3
1104109|NCT01860976|3616059|P2|Blinded Treatment|Subject request to discontinue treatment|3
1104110|NCT01860976|3616060|P1|Blinded Treatment|Subject request to discontinue treatment|2
1104111|NCT01860976|3616059|P2|Blinded Treatment|Lack of Efficacy|12
1104112|NCT01860976|3616060|P1|Blinded Treatment|Lack of Efficacy|5
1104113|NCT01860976|3616059|P2|Blinded Treatment|Adverse Event|3
1104114|NCT01860976|3616060|P1|Blinded Treatment|Adverse Event|1
1104115|NCT01860846|3616114|P1|Overall Study|Lost to Follow-up|33
1104116|NCT01860703|3616125|P4|Overall Study|Personal reason|0
1104117|NCT01860703|3616126|P3|Overall Study|Personal reason|1
1104118|NCT01860703|3616127|P2|Overall Study|Personal reason|0
1104119|NCT01860703|3616128|P1|Overall Study|Personal reason|1
1104120|NCT01860703|3616125|P4|Overall Study|Withdrawal by Subject|0
1104121|NCT01860703|3616126|P3|Overall Study|Withdrawal by Subject|0
1104122|NCT01860703|3616127|P2|Overall Study|Withdrawal by Subject|1
1104123|NCT01860703|3616128|P1|Overall Study|Withdrawal by Subject|0
1104124|NCT01860703|3616125|P4|Overall Study|Adverse Event|2
1104125|NCT01860703|3616126|P3|Overall Study|Adverse Event|0
1104126|NCT01860703|3616127|P2|Overall Study|Adverse Event|4
1104127|NCT01860703|3616128|P1|Overall Study|Adverse Event|1
1104128|NCT01860677|3616160|P2|Second Intervention (1 Day)|Lost to Follow-up|0
1104129|NCT01860677|3616161|P1|Second Intervention (1 Day)|Lost to Follow-up|7
1104130|NCT01860534|3616199|P2|ROP #2|discharged prior to ROP #2|0
1104131|NCT01860534|3616200|P1|ROP #2|discharged prior to ROP #2|1
1104132|NCT01860534|3616199|P2|ROP #1|Needed treatment for ROP|1
1104133|NCT01860534|3616200|P1|ROP #1|Needed treatment for ROP|0
1104134|NCT01860079|3616248|P2|Overall Study|Physician Decision|22
1104135|NCT01860079|3616249|P1|Overall Study|Physician Decision|14
1104136|NCT01860040|3616257|P2|Overall Study|Withdrawal by Subject|0
1104137|NCT01860040|3616258|P1|Overall Study|Withdrawal by Subject|1
1104138|NCT01859988|3616269|P6|Overall Study|Other than specified above|3
1104139|NCT01859988|3616270|P5|Overall Study|Other than specified above|5
1104140|NCT01859988|3616271|P4|Overall Study|Other than specified above|3
1104141|NCT01859988|3616272|P3|Overall Study|Other than specified above|11
1104142|NCT01859988|3616273|P2|Overall Study|Other than specified above|2
1104143|NCT01859988|3616274|P1|Overall Study|Other than specified above|0
1104144|NCT01859988|3616269|P6|Overall Study|Protocol Violation|0
1104145|NCT01859988|3616270|P5|Overall Study|Protocol Violation|0
1104146|NCT01859988|3616271|P4|Overall Study|Protocol Violation|0
1104147|NCT01859988|3616272|P3|Overall Study|Protocol Violation|1
1104148|NCT01859988|3616273|P2|Overall Study|Protocol Violation|0
1104149|NCT01859988|3616274|P1|Overall Study|Protocol Violation|0
1104150|NCT01859988|3616269|P6|Overall Study|Lost to Follow-up|2
1104151|NCT01859988|3616270|P5|Overall Study|Lost to Follow-up|3
1104152|NCT01859988|3616271|P4|Overall Study|Lost to Follow-up|0
1104153|NCT01859988|3616272|P3|Overall Study|Lost to Follow-up|3
1104154|NCT01859988|3616273|P2|Overall Study|Lost to Follow-up|2
1104155|NCT01859988|3616274|P1|Overall Study|Lost to Follow-up|1
1104156|NCT01859988|3616269|P6|Overall Study|Adverse Event|2
1104157|NCT01859988|3616270|P5|Overall Study|Adverse Event|2
1104158|NCT01859988|3616271|P4|Overall Study|Adverse Event|1
1104159|NCT01859988|3616272|P3|Overall Study|Adverse Event|3
1104160|NCT01859988|3616273|P2|Overall Study|Adverse Event|1
1104161|NCT01859988|3616274|P1|Overall Study|Adverse Event|2
1104162|NCT01859988|3616269|P6|Overall Study|Physician Decision|1
1104163|NCT01859988|3616270|P5|Overall Study|Physician Decision|4
1104164|NCT01859988|3616271|P4|Overall Study|Physician Decision|3
1104165|NCT01859988|3616272|P3|Overall Study|Physician Decision|1
1104166|NCT01859988|3616273|P2|Overall Study|Physician Decision|3
1104167|NCT01859988|3616274|P1|Overall Study|Physician Decision|1
1104168|NCT01859988|3616269|P6|Overall Study|Lack of Efficacy|9
1104169|NCT01859988|3616270|P5|Overall Study|Lack of Efficacy|7
1104170|NCT01859988|3616271|P4|Overall Study|Lack of Efficacy|0
1104171|NCT01859988|3616272|P3|Overall Study|Lack of Efficacy|5
1104172|NCT01859988|3616273|P2|Overall Study|Lack of Efficacy|1
1104173|NCT01859988|3616274|P1|Overall Study|Lack of Efficacy|1
1104174|NCT01859988|3616269|P6|Overall Study|Withdrawal by Subject|2
1104175|NCT01859988|3616270|P5|Overall Study|Withdrawal by Subject|2
1104176|NCT01859988|3616271|P4|Overall Study|Withdrawal by Subject|3
1104177|NCT01859988|3616272|P3|Overall Study|Withdrawal by Subject|4
1104178|NCT01859988|3616273|P2|Overall Study|Withdrawal by Subject|3
1104179|NCT01859988|3616274|P1|Overall Study|Withdrawal by Subject|6
1104180|NCT01859949|3616368|P2|Overall Study|Adverse Event|1
1104181|NCT01859949|3616369|P1|Overall Study|Adverse Event|0
1104182|NCT01859949|3616368|P2|Overall Study|Protocol Violation|1
1104183|NCT01859949|3616369|P1|Overall Study|Protocol Violation|1
1104184|NCT01859949|3616368|P2|Overall Study|Withdrawal by Subject|10
1104185|NCT01859949|3616369|P1|Overall Study|Withdrawal by Subject|11
1104186|NCT01859949|3616368|P2|Overall Study|Physician Decision|4
1104187|NCT01859949|3616369|P1|Overall Study|Physician Decision|2
1104188|NCT01859949|3616368|P2|Overall Study|Family Matters|1
1104189|NCT01859949|3616369|P1|Overall Study|Family Matters|0
1104190|NCT01859793|3616387|P2|Washout Period (4 Weeks)|Lost to Follow-up|1
1104191|NCT01859793|3616388|P1|Washout Period (4 Weeks)|Lost to Follow-up|1
1104192|NCT01859793|3616387|P2|First Intervention (8 Weeks)|Withdrawal by Subject|1
1104193|NCT01859793|3616388|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
1104194|NCT01859793|3616387|P2|First Intervention (8 Weeks)|Adverse Event|0
1104195|NCT01859793|3616388|P1|First Intervention (8 Weeks)|Adverse Event|1
1104196|NCT01859793|3616387|P2|First Intervention (8 Weeks)|Protocol Violation|0
1104197|NCT01859793|3616388|P1|First Intervention (8 Weeks)|Protocol Violation|2
1104198|NCT01859715|3616401|P3|Overall Study|No 2nd VAS|23
1104199|NCT01859715|3616402|P2|Overall Study|No 2nd VAS|8
1104200|NCT01859715|3616403|P1|Overall Study|No 2nd VAS|16
1104201|NCT01859702|3616414|P1|Overall Study|Adverse Event|2
1104202|NCT01859702|3616414|P1|Overall Study|Protocol deviation|3
1104203|NCT01859598|3616428|P1|Visit 2 at 3 Months|Lost to Follow-up|1742
1104204|NCT01859507|3616436|P1|Overall Study|left the country|4
1104205|NCT01859494|3616441|P1|Overall Study|Adverse Event|1
1104206|NCT01859390|3616452|P2|Overall Study|Shipment Error|1
1104207|NCT01859390|3616453|P1|Overall Study|Shipment Error|0
1104208|NCT01859390|3616452|P2|Overall Study|Tube Cracked|2
1104209|NCT01859390|3616453|P1|Overall Study|Tube Cracked|0
1104210|NCT01859390|3616452|P2|Overall Study|Sample Missing Collection Date|1
1104211|NCT01859390|3616453|P1|Overall Study|Sample Missing Collection Date|0
1104212|NCT01859390|3616452|P2|Overall Study|Insufficient Sputum Collected|3
1104213|NCT01859390|3616453|P1|Overall Study|Insufficient Sputum Collected|1
1104214|NCT01859143|3616587|P2|Overall Study|Lost to Follow-up|0
1104215|NCT01859143|3616588|P1|Overall Study|Lost to Follow-up|2
1104216|NCT01858766|3616644|P19|Overall Study|Withdrew Consent|0
1104217|NCT01858766|3616645|P18|Overall Study|Withdrew Consent|0
1104218|NCT01858766|3616646|P17|Overall Study|Withdrew Consent|0
1104219|NCT01858766|3616647|P16|Overall Study|Withdrew Consent|0
1104220|NCT01858766|3616648|P15|Overall Study|Withdrew Consent|0
1104221|NCT01858766|3616649|P14|Overall Study|Withdrew Consent|0
1104222|NCT01858766|3616650|P13|Overall Study|Withdrew Consent|0
1104223|NCT01858766|3616651|P12|Overall Study|Withdrew Consent|1
1104224|NCT01858766|3616652|P11|Overall Study|Withdrew Consent|0
1104225|NCT01858766|3616653|P10|Overall Study|Withdrew Consent|0
1104226|NCT01858766|3616654|P9|Overall Study|Withdrew Consent|0
1104227|NCT01858766|3616655|P8|Overall Study|Withdrew Consent|0
1104228|NCT01858766|3616656|P7|Overall Study|Withdrew Consent|0
1104229|NCT01858766|3616657|P6|Overall Study|Withdrew Consent|0
1104230|NCT01858766|3616658|P5|Overall Study|Withdrew Consent|0
1104231|NCT01858766|3616659|P4|Overall Study|Withdrew Consent|0
1104232|NCT01858766|3616660|P3|Overall Study|Withdrew Consent|0
1104233|NCT01858766|3616661|P2|Overall Study|Withdrew Consent|0
1104234|NCT01858766|3616662|P1|Overall Study|Withdrew Consent|0
1104235|NCT01858766|3616644|P19|Overall Study|Lost to Follow-up|1
1104236|NCT01858766|3616645|P18|Overall Study|Lost to Follow-up|0
1104237|NCT01858766|3616646|P17|Overall Study|Lost to Follow-up|1
1104238|NCT01858766|3616647|P16|Overall Study|Lost to Follow-up|1
1104239|NCT01858766|3616648|P15|Overall Study|Lost to Follow-up|3
1104240|NCT01858766|3616649|P14|Overall Study|Lost to Follow-up|0
1104241|NCT01858766|3616650|P13|Overall Study|Lost to Follow-up|0
1104242|NCT01858766|3616651|P12|Overall Study|Lost to Follow-up|1
1104243|NCT01858766|3616652|P11|Overall Study|Lost to Follow-up|0
1104244|NCT01858766|3616653|P10|Overall Study|Lost to Follow-up|0
1104245|NCT01858766|3616654|P9|Overall Study|Lost to Follow-up|0
1104246|NCT01858766|3616655|P8|Overall Study|Lost to Follow-up|2
1104247|NCT01858766|3616656|P7|Overall Study|Lost to Follow-up|0
1104248|NCT01858766|3616657|P6|Overall Study|Lost to Follow-up|1
1104249|NCT01858766|3616658|P5|Overall Study|Lost to Follow-up|0
1104250|NCT01858766|3616659|P4|Overall Study|Lost to Follow-up|0
1104251|NCT01858766|3616660|P3|Overall Study|Lost to Follow-up|0
1104252|NCT01858766|3616661|P2|Overall Study|Lost to Follow-up|0
1104253|NCT01858766|3616662|P1|Overall Study|Lost to Follow-up|0
1104254|NCT01858766|3616644|P19|Overall Study|Lack of Efficacy|3
1104255|NCT01858766|3616645|P18|Overall Study|Lack of Efficacy|3
1104256|NCT01858766|3616646|P17|Overall Study|Lack of Efficacy|2
1104257|NCT01858766|3616647|P16|Overall Study|Lack of Efficacy|5
1104258|NCT01858766|3616648|P15|Overall Study|Lack of Efficacy|5
1104259|NCT01858766|3616649|P14|Overall Study|Lack of Efficacy|3
1104260|NCT01858766|3616650|P13|Overall Study|Lack of Efficacy|5
1104261|NCT01858766|3616651|P12|Overall Study|Lack of Efficacy|3
1104262|NCT01858766|3616652|P11|Overall Study|Lack of Efficacy|0
1104263|NCT01858766|3616653|P10|Overall Study|Lack of Efficacy|0
1104264|NCT01858766|3616654|P9|Overall Study|Lack of Efficacy|0
1104265|NCT01858766|3616655|P8|Overall Study|Lack of Efficacy|0
1104266|NCT01858766|3616656|P7|Overall Study|Lack of Efficacy|0
1104267|NCT01858766|3616657|P6|Overall Study|Lack of Efficacy|2
1104268|NCT01858766|3616658|P5|Overall Study|Lack of Efficacy|1
1104269|NCT01858766|3616659|P4|Overall Study|Lack of Efficacy|0
1104270|NCT01858766|3616660|P3|Overall Study|Lack of Efficacy|0
1104271|NCT01858766|3616661|P2|Overall Study|Lack of Efficacy|0
1104272|NCT01858766|3616662|P1|Overall Study|Lack of Efficacy|1
1104273|NCT01858766|3616644|P19|Overall Study|Death|0
1104274|NCT01858766|3616645|P18|Overall Study|Death|0
1104275|NCT01858766|3616646|P17|Overall Study|Death|0
1104276|NCT01858766|3616647|P16|Overall Study|Death|0
1104277|NCT01858766|3616648|P15|Overall Study|Death|0
1104278|NCT01858766|3616649|P14|Overall Study|Death|0
1104279|NCT01858766|3616650|P13|Overall Study|Death|0
1104280|NCT01858766|3616651|P12|Overall Study|Death|0
1104281|NCT01858766|3616652|P11|Overall Study|Death|0
1104282|NCT01858766|3616653|P10|Overall Study|Death|0
1104283|NCT01858766|3616654|P9|Overall Study|Death|0
1104284|NCT01858766|3616655|P8|Overall Study|Death|0
1104285|NCT01858766|3616656|P7|Overall Study|Death|0
1104286|NCT01858766|3616657|P6|Overall Study|Death|0
1104287|NCT01858766|3616658|P5|Overall Study|Death|0
1104288|NCT01858766|3616659|P4|Overall Study|Death|0
1104289|NCT01858766|3616660|P3|Overall Study|Death|1
1104290|NCT01858766|3616661|P2|Overall Study|Death|0
1104291|NCT01858766|3616662|P1|Overall Study|Death|0
1104292|NCT01858766|3616644|P19|Overall Study|Randomized but Never Treated|0
1104293|NCT01858766|3616645|P18|Overall Study|Randomized but Never Treated|1
1104294|NCT01858766|3616646|P17|Overall Study|Randomized but Never Treated|0
1104295|NCT01858766|3616647|P16|Overall Study|Randomized but Never Treated|0
1104296|NCT01858766|3616648|P15|Overall Study|Randomized but Never Treated|0
1104297|NCT01858766|3616649|P14|Overall Study|Randomized but Never Treated|0
1104298|NCT01858766|3616650|P13|Overall Study|Randomized but Never Treated|0
1104299|NCT01858766|3616651|P12|Overall Study|Randomized but Never Treated|0
1104300|NCT01858766|3616652|P11|Overall Study|Randomized but Never Treated|0
1104301|NCT01858766|3616653|P10|Overall Study|Randomized but Never Treated|0
1104302|NCT01858766|3616654|P9|Overall Study|Randomized but Never Treated|0
1104303|NCT01858766|3616655|P8|Overall Study|Randomized but Never Treated|0
1104304|NCT01858766|3616656|P7|Overall Study|Randomized but Never Treated|0
1104305|NCT01858766|3616657|P6|Overall Study|Randomized but Never Treated|1
1104306|NCT01858766|3616658|P5|Overall Study|Randomized but Never Treated|0
1104307|NCT01858766|3616659|P4|Overall Study|Randomized but Never Treated|0
1104308|NCT01858766|3616660|P3|Overall Study|Randomized but Never Treated|0
1104309|NCT01858766|3616661|P2|Overall Study|Randomized but Never Treated|0
1104310|NCT01858766|3616662|P1|Overall Study|Randomized but Never Treated|0
1104311|NCT01858701|3616733|P2|Period 2, Second 30 Days of Wear|Comfort|1
1104312|NCT01858701|3616734|P1|Period 2, Second 30 Days of Wear|Comfort|0
1104313|NCT01858701|3616733|P2|Washout Period, 1-13 Days|Withdrawal by Subject|2
1104314|NCT01858701|3616734|P1|Washout Period, 1-13 Days|Withdrawal by Subject|1
1104315|NCT01858701|3616733|P2|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0
1104316|NCT01858701|3616734|P1|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1
1104317|NCT01858701|3616733|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
1104318|NCT01858701|3616734|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
1104319|NCT01858636|3616740|P1|Overall Study|Withdrawal by Subject|1
1104320|NCT01858636|3616740|P1|Overall Study|Lost to Follow-up|1
1104321|NCT01858636|3616740|P1|Overall Study|Death|1
1104322|NCT01858636|3616740|P1|Overall Study|Physician Decision|1
1104323|NCT01858636|3616740|P1|Overall Study|No Device Deployment Attempted|24
1104324|NCT01858389|3616793|P2|Overall Study|Did not receive treatment|3
1104325|NCT01858389|3616794|P1|Overall Study|Did not receive treatment|0
1104326|NCT01858389|3616793|P2|Overall Study|Adverse Event|1
1104327|NCT01858389|3616794|P1|Overall Study|Adverse Event|3
1104328|NCT01858389|3616793|P2|Overall Study|Not specified|4
1104329|NCT01858389|3616794|P1|Overall Study|Not specified|2
1104330|NCT01858389|3616793|P2|Overall Study|Progressive disease|11
1104331|NCT01858389|3616794|P1|Overall Study|Progressive disease|10
1104332|NCT01858389|3616793|P2|Overall Study|Withdrawal by Subject|1
1104333|NCT01858389|3616794|P1|Overall Study|Withdrawal by Subject|0
1104334|NCT01858389|3616793|P2|Overall Study|Study terminated by sponsor|2
1104335|NCT01858389|3616794|P1|Overall Study|Study terminated by sponsor|0
1104336|NCT01858389|3616793|P2|Overall Study|Death|3
1104337|NCT01858389|3616794|P1|Overall Study|Death|1
1104338|NCT01858376|3616809|P1|Overall Study|Dropped d/t lab work not fitting criter|4
1104339|NCT01857869|3616848|P10|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
1104340|NCT01857869|3616849|P9|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
1104341|NCT01857869|3616850|P8|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
1104342|NCT01857869|3616851|P7|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
1104343|NCT01857869|3616852|P6|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
1104344|NCT01857869|3616853|P5|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
1104345|NCT01857869|3616854|P4|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1
1104346|NCT01857869|3616855|P3|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
1104347|NCT01857869|3616856|P2|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
1104348|NCT01857869|3616857|P1|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
1104349|NCT01857869|3616848|P10|Booster/Rechallenge Phase|Withdrawal by Subject|0
1104350|NCT01857869|3616849|P9|Booster/Rechallenge Phase|Withdrawal by Subject|0
1104351|NCT01857869|3616850|P8|Booster/Rechallenge Phase|Withdrawal by Subject|0
1104352|NCT01857869|3616851|P7|Booster/Rechallenge Phase|Withdrawal by Subject|0
1104353|NCT01857869|3616852|P6|Booster/Rechallenge Phase|Withdrawal by Subject|0
1104354|NCT01857869|3616853|P5|Booster/Rechallenge Phase|Withdrawal by Subject|0
1104355|NCT01857869|3616854|P4|Booster/Rechallenge Phase|Withdrawal by Subject|1
1104356|NCT01857869|3616855|P3|Booster/Rechallenge Phase|Withdrawal by Subject|0
1104357|NCT01857869|3616856|P2|Booster/Rechallenge Phase|Withdrawal by Subject|0
1104358|NCT01857869|3616857|P1|Booster/Rechallenge Phase|Withdrawal by Subject|0
1104359|NCT01857869|3616848|P10|Primary/Challenge Phase|Not Specified|0
1104360|NCT01857869|3616849|P9|Primary/Challenge Phase|Not Specified|0
1104361|NCT01857869|3616850|P8|Primary/Challenge Phase|Not Specified|0
1104362|NCT01857869|3616851|P7|Primary/Challenge Phase|Not Specified|0
1104363|NCT01857869|3616852|P6|Primary/Challenge Phase|Not Specified|0
1104364|NCT01857869|3616853|P5|Primary/Challenge Phase|Not Specified|0
1104365|NCT01857869|3616854|P4|Primary/Challenge Phase|Not Specified|0
1104366|NCT01857869|3616855|P3|Primary/Challenge Phase|Not Specified|0
1104367|NCT01857869|3616856|P2|Primary/Challenge Phase|Not Specified|1
1104368|NCT01857869|3616857|P1|Primary/Challenge Phase|Not Specified|1
1104369|NCT01857869|3616848|P10|Primary/Challenge Phase|Protocol Violation|0
1104370|NCT01857869|3616849|P9|Primary/Challenge Phase|Protocol Violation|0
1104371|NCT01857869|3616850|P8|Primary/Challenge Phase|Protocol Violation|0
1104372|NCT01857869|3616851|P7|Primary/Challenge Phase|Protocol Violation|0
1104373|NCT01857869|3616852|P6|Primary/Challenge Phase|Protocol Violation|0
1104374|NCT01857869|3616853|P5|Primary/Challenge Phase|Protocol Violation|0
1104375|NCT01857869|3616854|P4|Primary/Challenge Phase|Protocol Violation|0
1104376|NCT01857869|3616855|P3|Primary/Challenge Phase|Protocol Violation|0
1104377|NCT01857869|3616856|P2|Primary/Challenge Phase|Protocol Violation|0
1104378|NCT01857869|3616857|P1|Primary/Challenge Phase|Protocol Violation|1
1104379|NCT01857869|3616848|P10|Primary/Challenge Phase|Pregnancy|0
1104380|NCT01857869|3616849|P9|Primary/Challenge Phase|Pregnancy|0
1104381|NCT01857869|3616850|P8|Primary/Challenge Phase|Pregnancy|0
1104382|NCT01857869|3616851|P7|Primary/Challenge Phase|Pregnancy|0
1104383|NCT01857869|3616852|P6|Primary/Challenge Phase|Pregnancy|0
1104384|NCT01857869|3616853|P5|Primary/Challenge Phase|Pregnancy|0
1104385|NCT01857869|3616854|P4|Primary/Challenge Phase|Pregnancy|0
1104386|NCT01857869|3616855|P3|Primary/Challenge Phase|Pregnancy|0
1104387|NCT01857869|3616856|P2|Primary/Challenge Phase|Pregnancy|0
1104388|NCT01857869|3616857|P1|Primary/Challenge Phase|Pregnancy|1
1104389|NCT01857869|3616848|P10|Primary/Challenge Phase|Lost to Follow-up|0
1104390|NCT01857869|3616849|P9|Primary/Challenge Phase|Lost to Follow-up|0
1104391|NCT01857869|3616850|P8|Primary/Challenge Phase|Lost to Follow-up|0
1104392|NCT01857869|3616851|P7|Primary/Challenge Phase|Lost to Follow-up|0
1104393|NCT01857869|3616852|P6|Primary/Challenge Phase|Lost to Follow-up|0
1104394|NCT01857869|3616853|P5|Primary/Challenge Phase|Lost to Follow-up|0
1104395|NCT01857869|3616854|P4|Primary/Challenge Phase|Lost to Follow-up|0
1104396|NCT01857869|3616855|P3|Primary/Challenge Phase|Lost to Follow-up|0
1104397|NCT01857869|3616856|P2|Primary/Challenge Phase|Lost to Follow-up|0
1104398|NCT01857869|3616857|P1|Primary/Challenge Phase|Lost to Follow-up|2
1104399|NCT01857622|3616947|P3|Overall Study|Withdrawal by Subject|0
1104400|NCT01857622|3616948|P2|Overall Study|Withdrawal by Subject|0
1104401|NCT01857622|3616949|P1|Overall Study|Withdrawal by Subject|1
1104402|NCT01857622|3616947|P3|Overall Study|Protocol Violation|0
1104403|NCT01857622|3616948|P2|Overall Study|Protocol Violation|1
1104404|NCT01857622|3616949|P1|Overall Study|Protocol Violation|4
1104405|NCT01857622|3616947|P3|Overall Study|Physician Decision|0
1104406|NCT01857622|3616948|P2|Overall Study|Physician Decision|0
1104407|NCT01857622|3616949|P1|Overall Study|Physician Decision|1
1104408|NCT01857622|3616947|P3|Overall Study|Adverse Event|2
1104409|NCT01857622|3616948|P2|Overall Study|Adverse Event|0
1104410|NCT01857622|3616949|P1|Overall Study|Adverse Event|5
1104411|NCT01857583|3616961|P4|Overall Study|Withdrawal by Subject|2
1104412|NCT01857583|3616962|P3|Overall Study|Withdrawal by Subject|1
1104413|NCT01857583|3616963|P2|Overall Study|Withdrawal by Subject|0
1104414|NCT01857583|3616964|P1|Overall Study|Withdrawal by Subject|1
1104415|NCT01857583|3616961|P4|Overall Study|Physician Decision|1
1104416|NCT01857583|3616962|P3|Overall Study|Physician Decision|0
1104417|NCT01857583|3616963|P2|Overall Study|Physician Decision|0
1104418|NCT01857583|3616964|P1|Overall Study|Physician Decision|0
1104419|NCT01857583|3616961|P4|Overall Study|Death|0
1104420|NCT01857583|3616962|P3|Overall Study|Death|1
1104421|NCT01857583|3616963|P2|Overall Study|Death|1
1104422|NCT01857583|3616964|P1|Overall Study|Death|0
1104423|NCT01857583|3616961|P4|Overall Study|Adverse Event|1
1104424|NCT01857583|3616962|P3|Overall Study|Adverse Event|1
1104425|NCT01857583|3616963|P2|Overall Study|Adverse Event|0
1104426|NCT01857583|3616964|P1|Overall Study|Adverse Event|0
1104427|NCT01857531|3616974|P1|Overall Study|Withdrawal by Subject|4
1104428|NCT01857323|3616992|P1|Overall Study|Did not complete 180 doses|48
1104429|NCT01857323|3616992|P1|Overall Study|Not specified|4
1104430|NCT01857323|3616992|P1|Overall Study|Lost to Follow-up|1
1104431|NCT01857323|3616992|P1|Overall Study|Protocol Violation|6
1104432|NCT01857323|3616992|P1|Overall Study|Non-compliance|1
1104433|NCT01857323|3616992|P1|Overall Study|Withdrawal by Subject|3
1104434|NCT01857323|3616992|P1|Overall Study|Adverse Event|1
1104435|NCT01857206|3617041|P2|Overall Study|Withdrawal by Subject|0
1104436|NCT01857206|3617042|P1|Overall Study|Withdrawal by Subject|1
1104437|NCT01857206|3617041|P2|Overall Study|Unclassified|3
1104438|NCT01857206|3617042|P1|Overall Study|Unclassified|3
1104439|NCT01857206|3617041|P2|Overall Study|Lost to Follow-up|6
1104440|NCT01857206|3617042|P1|Overall Study|Lost to Follow-up|9
1104441|NCT01857206|3617041|P2|Overall Study|ADMINISTRATIVE REASON|1
1104442|NCT01857206|3617042|P1|Overall Study|ADMINISTRATIVE REASON|0
1104443|NCT01857102|3617060|P2|Period 2|Unsatisfactory Lens Fit|0
1104444|NCT01857102|3617061|P1|Period 2|Unsatisfactory Lens Fit|1
1104445|NCT01857102|3617060|P2|Period 2|Lens Discomfort|0
1104446|NCT01857102|3617061|P1|Period 2|Lens Discomfort|1
1104447|NCT01857102|3617060|P2|Period 1|Physician Decision|0
1104448|NCT01857102|3617061|P1|Period 1|Physician Decision|1
1104449|NCT01857102|3617060|P2|Period 1|Unsatisfactory Visual Response|0
1104450|NCT01857102|3617061|P1|Period 1|Unsatisfactory Visual Response|1
1104451|NCT01857102|3617060|P2|Period 1|Unsatisfactory Lens Fit|0
1104452|NCT01857102|3617061|P1|Period 1|Unsatisfactory Lens Fit|1
1104453|NCT01857102|3617060|P2|Period 1|Lost to Follow-up|3
1104454|NCT01857102|3617061|P1|Period 1|Lost to Follow-up|0
1104455|NCT01857102|3617060|P2|Period 1|No longer meets Eligibility Criteria|2
1104456|NCT01857102|3617061|P1|Period 1|No longer meets Eligibility Criteria|0
1104457|NCT01857063|3617071|P2|Period 2 (7 Days)|Withdrawal by Subject|0
1104458|NCT01857063|3617072|P1|Period 2 (7 Days)|Withdrawal by Subject|1
1104459|NCT01857063|3617071|P2|Period 2 (7 Days)|Physician Decision|1
1104460|NCT01857063|3617072|P1|Period 2 (7 Days)|Physician Decision|1
1104461|NCT01857063|3617071|P2|Period 2 (7 Days)|Adverse Event|1
1104462|NCT01857063|3617072|P1|Period 2 (7 Days)|Adverse Event|2
1104463|NCT01857063|3617071|P2|Period 1 (7 Days)|Withdrawal by Subject|3
1104464|NCT01857063|3617072|P1|Period 1 (7 Days)|Withdrawal by Subject|1
1104465|NCT01857063|3617071|P2|Period 1 (7 Days)|Physician Decision|0
1104466|NCT01857063|3617072|P1|Period 1 (7 Days)|Physician Decision|1
1104467|NCT01857063|3617071|P2|Period 1 (7 Days)|Adverse Event|1
1104468|NCT01857063|3617072|P1|Period 1 (7 Days)|Adverse Event|0
1104469|NCT01856907|3617105|P3|Overall Study|Withdrawal by Subject|0
1104470|NCT01856907|3617106|P2|Overall Study|Withdrawal by Subject|1
1104471|NCT01856907|3617107|P1|Overall Study|Withdrawal by Subject|0
1104472|NCT01856907|3617105|P3|Overall Study|Pregnancy|0
1104473|NCT01856907|3617106|P2|Overall Study|Pregnancy|1
1104474|NCT01856907|3617107|P1|Overall Study|Pregnancy|0
1104475|NCT01856907|3617105|P3|Overall Study|Pregnancy|0
1104476|NCT01856907|3617106|P2|Overall Study|Pregnancy|1
1104477|NCT01856907|3617107|P1|Overall Study|Pregnancy|0
1104478|NCT01856686|3617160|P2|Overall Study|Lost to Follow-up|11
1104479|NCT01856686|3617161|P1|Overall Study|Lost to Follow-up|5
1104480|NCT01856673|3617204|P3|Overall Study|Protocol Violation|1
1104481|NCT01856673|3617205|P2|Overall Study|Protocol Violation|0
1104482|NCT01856673|3617206|P1|Overall Study|Protocol Violation|1
1104483|NCT01856673|3617204|P3|Overall Study|Death|0
1104484|NCT01856673|3617205|P2|Overall Study|Death|1
1104485|NCT01856673|3617206|P1|Overall Study|Death|2
1104486|NCT01856673|3617204|P3|Overall Study|Paperwork errors|0
1104487|NCT01856673|3617205|P2|Overall Study|Paperwork errors|0
1104488|NCT01856673|3617206|P1|Overall Study|Paperwork errors|4
1104489|NCT01856673|3617204|P3|Overall Study|Psychologist decision|0
1104490|NCT01856673|3617205|P2|Overall Study|Psychologist decision|0
1104491|NCT01856673|3617206|P1|Overall Study|Psychologist decision|3
1104492|NCT01856673|3617204|P3|Overall Study|Unknown reasons|0
1104493|NCT01856673|3617205|P2|Overall Study|Unknown reasons|0
1104494|NCT01856673|3617206|P1|Overall Study|Unknown reasons|20
1104495|NCT01856673|3617204|P3|Overall Study|Lost to Follow-up|0
1104496|NCT01856673|3617205|P2|Overall Study|Lost to Follow-up|34
1104497|NCT01856673|3617206|P1|Overall Study|Lost to Follow-up|22
1104498|NCT01856673|3617204|P3|Overall Study|Withdrawal by Subject|33
1104499|NCT01856673|3617205|P2|Overall Study|Withdrawal by Subject|50
1104500|NCT01856673|3617206|P1|Overall Study|Withdrawal by Subject|46
1104501|NCT01856595|3617226|P9|Overall Study|Withdrawal by Subject|0
1104502|NCT01856595|3617227|P8|Overall Study|Withdrawal by Subject|0
1104503|NCT01856595|3617228|P7|Overall Study|Withdrawal by Subject|1
1104504|NCT01856595|3617229|P6|Overall Study|Withdrawal by Subject|0
1104505|NCT01856595|3617230|P5|Overall Study|Withdrawal by Subject|0
1104506|NCT01856595|3617231|P4|Overall Study|Withdrawal by Subject|0
1104507|NCT01856595|3617232|P3|Overall Study|Withdrawal by Subject|0
1104508|NCT01856595|3617233|P2|Overall Study|Withdrawal by Subject|1
1104509|NCT01856595|3617234|P1|Overall Study|Withdrawal by Subject|0
1104510|NCT01856569|3617467|P1|Overall Study|Did not met inclusion criteria|8
1104511|NCT01856569|3617467|P1|Overall Study|Lost to Follow-up|3
1104512|NCT01856569|3617467|P1|Overall Study|Changed Site/Structure|1
1104513|NCT01856569|3617467|P1|Overall Study|Other|1
1104514|NCT01856322|3617522|P3|Overall Study|off study due to lack of accrual|3
1104515|NCT01856322|3617523|P2|Overall Study|off study due to lack of accrual|0
1104516|NCT01856322|3617524|P1|Overall Study|off study due to lack of accrual|0
1104517|NCT01856257|3617557|P4|Overall Study|Donor complication|1
1104518|NCT01856257|3617558|P3|Overall Study|Donor complication|0
1104519|NCT01856257|3617559|P2|Overall Study|Donor complication|0
1104520|NCT01856257|3617560|P1|Overall Study|Donor complication|0
1104521|NCT01856257|3617557|P4|Overall Study|Withdrawal by Subject|0
1104522|NCT01856257|3617558|P3|Overall Study|Withdrawal by Subject|0
1104523|NCT01856257|3617559|P2|Overall Study|Withdrawal by Subject|1
1104524|NCT01856257|3617560|P1|Overall Study|Withdrawal by Subject|1
1104525|NCT01856257|3617557|P4|Overall Study|Physician Decision|1
1104526|NCT01856257|3617558|P3|Overall Study|Physician Decision|0
1104527|NCT01856257|3617559|P2|Overall Study|Physician Decision|0
1104528|NCT01856257|3617560|P1|Overall Study|Physician Decision|0
1104529|NCT01856257|3617557|P4|Overall Study|Death|0
1104530|NCT01856257|3617558|P3|Overall Study|Death|0
1104531|NCT01856257|3617559|P2|Overall Study|Death|0
1104532|NCT01856257|3617560|P1|Overall Study|Death|2
1104533|NCT01855958|3617728|P2|Overall Study|Withdrawal by Subject|0
1104534|NCT01855958|3617729|P1|Overall Study|Withdrawal by Subject|1
1104535|NCT01855945|3617759|P12|Overall Study|Withdrawal by Subject|1
1104536|NCT01855945|3617760|P11|Overall Study|Withdrawal by Subject|4
1104537|NCT01855945|3617761|P10|Overall Study|Withdrawal by Subject|2
1104538|NCT01855945|3617762|P9|Overall Study|Withdrawal by Subject|0
1104539|NCT01855945|3617763|P8|Overall Study|Withdrawal by Subject|0
1104540|NCT01855945|3617764|P7|Overall Study|Withdrawal by Subject|1
1104541|NCT01855945|3617765|P6|Overall Study|Withdrawal by Subject|0
1104542|NCT01855945|3617766|P5|Overall Study|Withdrawal by Subject|1
1104543|NCT01855945|3617767|P4|Overall Study|Withdrawal by Subject|1
1104544|NCT01855945|3617768|P3|Overall Study|Withdrawal by Subject|4
1104545|NCT01855945|3617769|P2|Overall Study|Withdrawal by Subject|0
1104546|NCT01855945|3617770|P1|Overall Study|Withdrawal by Subject|4
1104547|NCT01855945|3617759|P12|Overall Study|Other - Unclassified|0
1104548|NCT01855945|3617760|P11|Overall Study|Other - Unclassified|1
1104549|NCT01855945|3617761|P10|Overall Study|Other - Unclassified|0
1104550|NCT01855945|3617762|P9|Overall Study|Other - Unclassified|0
1104551|NCT01855945|3617763|P8|Overall Study|Other - Unclassified|1
1104552|NCT01855945|3617764|P7|Overall Study|Other - Unclassified|2
1104553|NCT01855945|3617765|P6|Overall Study|Other - Unclassified|0
1104554|NCT01855945|3617766|P5|Overall Study|Other - Unclassified|0
1104555|NCT01855945|3617767|P4|Overall Study|Other - Unclassified|0
1104556|NCT01855945|3617768|P3|Overall Study|Other - Unclassified|1
1104557|NCT01855945|3617769|P2|Overall Study|Other - Unclassified|1
1104558|NCT01855945|3617770|P1|Overall Study|Other - Unclassified|1
1104559|NCT01855945|3617759|P12|Overall Study|Lost to Follow-up|2
1104560|NCT01855945|3617760|P11|Overall Study|Lost to Follow-up|0
1104561|NCT01855945|3617761|P10|Overall Study|Lost to Follow-up|0
1104562|NCT01855945|3617762|P9|Overall Study|Lost to Follow-up|2
1104563|NCT01855945|3617763|P8|Overall Study|Lost to Follow-up|7
1104564|NCT01855945|3617764|P7|Overall Study|Lost to Follow-up|4
1104565|NCT01855945|3617765|P6|Overall Study|Lost to Follow-up|3
1104566|NCT01855945|3617766|P5|Overall Study|Lost to Follow-up|0
1104567|NCT01855945|3617767|P4|Overall Study|Lost to Follow-up|3
1104568|NCT01855945|3617768|P3|Overall Study|Lost to Follow-up|7
1104569|NCT01855945|3617769|P2|Overall Study|Lost to Follow-up|10
1104570|NCT01855945|3617770|P1|Overall Study|Lost to Follow-up|11
1104571|NCT01855945|3617759|P12|Overall Study|Death|0
1104572|NCT01855945|3617760|P11|Overall Study|Death|0
1104573|NCT01855945|3617761|P10|Overall Study|Death|0
1104574|NCT01855945|3617762|P9|Overall Study|Death|0
1104575|NCT01855945|3617763|P8|Overall Study|Death|0
1104576|NCT01855945|3617764|P7|Overall Study|Death|2
1104577|NCT01855945|3617765|P6|Overall Study|Death|0
1104578|NCT01855945|3617766|P5|Overall Study|Death|0
1104579|NCT01855945|3617767|P4|Overall Study|Death|0
1104580|NCT01855945|3617768|P3|Overall Study|Death|0
1104581|NCT01855945|3617769|P2|Overall Study|Death|0
1104582|NCT01855945|3617770|P1|Overall Study|Death|0
1104583|NCT01855945|3617759|P12|Overall Study|Adverse Event|0
1104584|NCT01855945|3617760|P11|Overall Study|Adverse Event|0
1104585|NCT01855945|3617761|P10|Overall Study|Adverse Event|0
1104586|NCT01855945|3617762|P9|Overall Study|Adverse Event|0
1104587|NCT01855945|3617763|P8|Overall Study|Adverse Event|0
1104588|NCT01855945|3617764|P7|Overall Study|Adverse Event|1
1104589|NCT01855945|3617765|P6|Overall Study|Adverse Event|0
1104590|NCT01855945|3617766|P5|Overall Study|Adverse Event|0
1104591|NCT01855945|3617767|P4|Overall Study|Adverse Event|0
1104592|NCT01855945|3617768|P3|Overall Study|Adverse Event|0
1104593|NCT01855945|3617769|P2|Overall Study|Adverse Event|0
1104594|NCT01855945|3617770|P1|Overall Study|Adverse Event|0
1104595|NCT01855919|3617906|P2|Overall Study|Protocol Violation|4
1104596|NCT01855919|3617907|P1|Overall Study|Protocol Violation|1
1104597|NCT01855919|3617906|P2|Overall Study|Entry Criteria Not Met|1
1104598|NCT01855919|3617907|P1|Overall Study|Entry Criteria Not Met|1
1104599|NCT01855919|3617906|P2|Overall Study|Withdrawal by Subject|10
1104600|NCT01855919|3617907|P1|Overall Study|Withdrawal by Subject|4
1104601|NCT01855919|3617906|P2|Overall Study|Lack of Efficacy|3
1104602|NCT01855919|3617907|P1|Overall Study|Lack of Efficacy|1
1104603|NCT01855919|3617906|P2|Overall Study|Adverse Event|8
1104604|NCT01855919|3617907|P1|Overall Study|Adverse Event|16
1104605|NCT01855789|3617939|P4|2) Week 24 up to End of Study|Other|1
1104606|NCT01855789|3617940|P3|2) Week 24 up to End of Study|Other|0
1104607|NCT01855789|3617941|P2|2) Week 24 up to End of Study|Other|0
1104608|NCT01855789|3617942|P1|2) Week 24 up to End of Study|Other|0
1104609|NCT01855789|3617939|P4|2) Week 24 up to End of Study|Sponsor Decision|1
1104610|NCT01855789|3617940|P3|2) Week 24 up to End of Study|Sponsor Decision|0
1104611|NCT01855789|3617941|P2|2) Week 24 up to End of Study|Sponsor Decision|0
1104612|NCT01855789|3617942|P1|2) Week 24 up to End of Study|Sponsor Decision|0
1104613|NCT01855789|3617939|P4|2) Week 24 up to End of Study|Participant Non-compliance|1
1104614|NCT01855789|3617940|P3|2) Week 24 up to End of Study|Participant Non-compliance|0
1104615|NCT01855789|3617941|P2|2) Week 24 up to End of Study|Participant Non-compliance|1
1104616|NCT01855789|3617942|P1|2) Week 24 up to End of Study|Participant Non-compliance|0
1104617|NCT01855789|3617939|P4|2) Week 24 up to End of Study|Physician Decision|4
1104618|NCT01855789|3617940|P3|2) Week 24 up to End of Study|Physician Decision|2
1104619|NCT01855789|3617941|P2|2) Week 24 up to End of Study|Physician Decision|0
1104620|NCT01855789|3617942|P1|2) Week 24 up to End of Study|Physician Decision|0
1104621|NCT01855789|3617939|P4|2) Week 24 up to End of Study|Withdrawal by Subject|8
1104622|NCT01855789|3617940|P3|2) Week 24 up to End of Study|Withdrawal by Subject|5
1104623|NCT01855789|3617941|P2|2) Week 24 up to End of Study|Withdrawal by Subject|7
1104624|NCT01855789|3617942|P1|2) Week 24 up to End of Study|Withdrawal by Subject|0
1104625|NCT01855789|3617939|P4|2) Week 24 up to End of Study|Protocol Violation|1
1104626|NCT01855789|3617940|P3|2) Week 24 up to End of Study|Protocol Violation|0
1104627|NCT01855789|3617941|P2|2) Week 24 up to End of Study|Protocol Violation|0
1104628|NCT01855789|3617942|P1|2) Week 24 up to End of Study|Protocol Violation|0
1104629|NCT01855789|3617939|P4|2) Week 24 up to End of Study|Lost to Follow-up|4
1104630|NCT01855789|3617940|P3|2) Week 24 up to End of Study|Lost to Follow-up|1
1104631|NCT01855789|3617941|P2|2) Week 24 up to End of Study|Lost to Follow-up|1
1104632|NCT01855789|3617942|P1|2) Week 24 up to End of Study|Lost to Follow-up|0
1104633|NCT01855789|3617939|P4|2) Week 24 up to End of Study|Lack of Efficacy|16
1104634|NCT01855789|3617940|P3|2) Week 24 up to End of Study|Lack of Efficacy|5
1104635|NCT01855789|3617941|P2|2) Week 24 up to End of Study|Lack of Efficacy|2
1104636|NCT01855789|3617942|P1|2) Week 24 up to End of Study|Lack of Efficacy|0
1104637|NCT01855789|3617939|P4|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1
1104638|NCT01855789|3617940|P3|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
1104639|NCT01855789|3617941|P2|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
1104640|NCT01855789|3617942|P1|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
1104641|NCT01855789|3617939|P4|2) Week 24 up to End of Study|Adverse Event|21
1104642|NCT01855789|3617940|P3|2) Week 24 up to End of Study|Adverse Event|5
1104643|NCT01855789|3617941|P2|2) Week 24 up to End of Study|Adverse Event|4
1104644|NCT01855789|3617942|P1|2) Week 24 up to End of Study|Adverse Event|0
1104645|NCT01855789|3617939|P4|1) Baseline up to Week 24|Other|0
1104646|NCT01855789|3617940|P3|1) Baseline up to Week 24|Other|0
1104647|NCT01855789|3617941|P2|1) Baseline up to Week 24|Other|0
1104648|NCT01855789|3617942|P1|1) Baseline up to Week 24|Other|4
1104649|NCT01855789|3617939|P4|1) Baseline up to Week 24|Sponsor Decision|0
1104650|NCT01855789|3617940|P3|1) Baseline up to Week 24|Sponsor Decision|0
1104651|NCT01855789|3617941|P2|1) Baseline up to Week 24|Sponsor Decision|0
1104652|NCT01855789|3617942|P1|1) Baseline up to Week 24|Sponsor Decision|3
1104653|NCT01855789|3617939|P4|1) Baseline up to Week 24|Participant Non-compliance|0
1104654|NCT01855789|3617940|P3|1) Baseline up to Week 24|Participant Non-compliance|0
1104655|NCT01855789|3617941|P2|1) Baseline up to Week 24|Participant Non-compliance|0
1104656|NCT01855789|3617942|P1|1) Baseline up to Week 24|Participant Non-compliance|3
1104657|NCT01855789|3617939|P4|1) Baseline up to Week 24|Pregnancy|0
1104658|NCT01855789|3617940|P3|1) Baseline up to Week 24|Pregnancy|0
1104659|NCT01855789|3617941|P2|1) Baseline up to Week 24|Pregnancy|0
1104660|NCT01855789|3617942|P1|1) Baseline up to Week 24|Pregnancy|1
1104661|NCT01855789|3617939|P4|1) Baseline up to Week 24|Physician Decision|0
1104662|NCT01855789|3617940|P3|1) Baseline up to Week 24|Physician Decision|0
1104663|NCT01855789|3617941|P2|1) Baseline up to Week 24|Physician Decision|0
1104664|NCT01855789|3617942|P1|1) Baseline up to Week 24|Physician Decision|4
1104665|NCT01855789|3617939|P4|1) Baseline up to Week 24|Withdrawal by Subject|0
1104666|NCT01855789|3617940|P3|1) Baseline up to Week 24|Withdrawal by Subject|0
1104667|NCT01855789|3617941|P2|1) Baseline up to Week 24|Withdrawal by Subject|0
1104668|NCT01855789|3617942|P1|1) Baseline up to Week 24|Withdrawal by Subject|31
1104669|NCT01855789|3617939|P4|1) Baseline up to Week 24|Protocol Violation|0
1104670|NCT01855789|3617940|P3|1) Baseline up to Week 24|Protocol Violation|0
1104671|NCT01855789|3617941|P2|1) Baseline up to Week 24|Protocol Violation|0
1104672|NCT01855789|3617942|P1|1) Baseline up to Week 24|Protocol Violation|4
1104673|NCT01855789|3617939|P4|1) Baseline up to Week 24|Lost to Follow-up|0
1104674|NCT01855789|3617940|P3|1) Baseline up to Week 24|Lost to Follow-up|0
1104675|NCT01855789|3617941|P2|1) Baseline up to Week 24|Lost to Follow-up|0
1104676|NCT01855789|3617942|P1|1) Baseline up to Week 24|Lost to Follow-up|11
1104677|NCT01855789|3617939|P4|1) Baseline up to Week 24|Lack of Efficacy|0
1104678|NCT01855789|3617940|P3|1) Baseline up to Week 24|Lack of Efficacy|0
1104679|NCT01855789|3617941|P2|1) Baseline up to Week 24|Lack of Efficacy|0
1104680|NCT01855789|3617942|P1|1) Baseline up to Week 24|Lack of Efficacy|16
1104681|NCT01855789|3617939|P4|1) Baseline up to Week 24|Death|0
1104682|NCT01855789|3617940|P3|1) Baseline up to Week 24|Death|0
1104683|NCT01855789|3617941|P2|1) Baseline up to Week 24|Death|0
1104684|NCT01855789|3617942|P1|1) Baseline up to Week 24|Death|2
1104685|NCT01855789|3617939|P4|1) Baseline up to Week 24|Adverse Event|0
1104686|NCT01855789|3617940|P3|1) Baseline up to Week 24|Adverse Event|0
1104687|NCT01855789|3617941|P2|1) Baseline up to Week 24|Adverse Event|0
1104688|NCT01855789|3617942|P1|1) Baseline up to Week 24|Adverse Event|37
1104689|NCT01855425|3617964|P1|Overall Study|Physician Decision|20
1104690|NCT01855074|3617968|P1|Overall Study|Started but not treated|1
1104691|NCT01855074|3617968|P1|Overall Study|Withdrawal by Subject|8
1104692|NCT01855074|3617968|P1|Overall Study|Lost to Follow-up|4
1104693|NCT01855074|3617968|P1|Overall Study|Adverse Event|1
1104694|NCT01854944|3617980|P3|Overall Study|Withdrawal by Subject|1
1104695|NCT01854944|3617981|P2|Overall Study|Withdrawal by Subject|0
1104696|NCT01854944|3617982|P1|Overall Study|Withdrawal by Subject|0
1104697|NCT01854827|3618036|P1|Overall Study|Death|1
1104698|NCT01854710|3618048|P6|Overall Study|CRI procedural error|2
1104699|NCT01854710|3618049|P5|Overall Study|CRI procedural error|2
1104700|NCT01854710|3618050|P4|Overall Study|CRI procedural error|2
1104701|NCT01854710|3618051|P3|Overall Study|CRI procedural error|2
1104702|NCT01854710|3618052|P2|Overall Study|CRI procedural error|2
1104703|NCT01854710|3618053|P1|Overall Study|CRI procedural error|2
1104704|NCT01854710|3618048|P6|Overall Study|Withdrawal by Subject|0
1104705|NCT01854710|3618049|P5|Overall Study|Withdrawal by Subject|0
1104706|NCT01854710|3618050|P4|Overall Study|Withdrawal by Subject|0
1104707|NCT01854710|3618051|P3|Overall Study|Withdrawal by Subject|0
1104708|NCT01854710|3618052|P2|Overall Study|Withdrawal by Subject|1
1104709|NCT01854710|3618053|P1|Overall Study|Withdrawal by Subject|2
1104710|NCT01854697|3618074|P5|Overall Study|Not Specified|0
1104711|NCT01854697|3618075|P4|Overall Study|Not Specified|0
1104712|NCT01854697|3618076|P3|Overall Study|Not Specified|1
1104713|NCT01854697|3618077|P2|Overall Study|Not Specified|1
1104714|NCT01854697|3618078|P1|Overall Study|Not Specified|0
1104715|NCT01854697|3618074|P5|Overall Study|Withdrew Consent|0
1104716|NCT01854697|3618075|P4|Overall Study|Withdrew Consent|1
1104717|NCT01854697|3618076|P3|Overall Study|Withdrew Consent|0
1104718|NCT01854697|3618077|P2|Overall Study|Withdrew Consent|1
1104719|NCT01854697|3618078|P1|Overall Study|Withdrew Consent|0
1104720|NCT01854697|3618074|P5|Overall Study|To enter another AbbVie study|1
1104721|NCT01854697|3618075|P4|Overall Study|To enter another AbbVie study|0
1104722|NCT01854697|3618076|P3|Overall Study|To enter another AbbVie study|0
1104723|NCT01854697|3618077|P2|Overall Study|To enter another AbbVie study|0
1104724|NCT01854697|3618078|P1|Overall Study|To enter another AbbVie study|1
1104725|NCT01854697|3618074|P5|Overall Study|Lost to Follow-up|0
1104726|NCT01854697|3618075|P4|Overall Study|Lost to Follow-up|2
1104727|NCT01854697|3618076|P3|Overall Study|Lost to Follow-up|1
1104728|NCT01854697|3618077|P2|Overall Study|Lost to Follow-up|1
1104729|NCT01854697|3618078|P1|Overall Study|Lost to Follow-up|4
1104730|NCT01854697|3618074|P5|Overall Study|Adverse Event|1
1104731|NCT01854697|3618075|P4|Overall Study|Adverse Event|0
1104732|NCT01854697|3618076|P3|Overall Study|Adverse Event|0
1104733|NCT01854697|3618077|P2|Overall Study|Adverse Event|0
1104734|NCT01854697|3618078|P1|Overall Study|Adverse Event|1
1104735|NCT01854658|3618122|P4|Overall Study|Administrative reasons|2
1104736|NCT01854658|3618123|P3|Overall Study|Administrative reasons|2
1104737|NCT01854658|3618124|P2|Overall Study|Administrative reasons|1
1104738|NCT01854658|3618125|P1|Overall Study|Administrative reasons|5
1104739|NCT01854658|3618122|P4|Overall Study|Adverse Event|19
1104740|NCT01854658|3618123|P3|Overall Study|Adverse Event|23
1104741|NCT01854658|3618124|P2|Overall Study|Adverse Event|14
1104742|NCT01854658|3618125|P1|Overall Study|Adverse Event|21
1104743|NCT01854658|3618122|P4|Overall Study|Lack of Efficacy|7
1104744|NCT01854658|3618123|P3|Overall Study|Lack of Efficacy|4
1104745|NCT01854658|3618124|P2|Overall Study|Lack of Efficacy|8
1104746|NCT01854658|3618125|P1|Overall Study|Lack of Efficacy|3
1104747|NCT01854658|3618122|P4|Overall Study|Protocol-specified criteria|7
1104748|NCT01854658|3618123|P3|Overall Study|Protocol-specified criteria|10
1104749|NCT01854658|3618124|P2|Overall Study|Protocol-specified criteria|15
1104750|NCT01854658|3618125|P1|Overall Study|Protocol-specified criteria|15
1104751|NCT01854658|3618122|P4|Overall Study|Withdrawal by Subject|15
1104752|NCT01854658|3618123|P3|Overall Study|Withdrawal by Subject|29
1104753|NCT01854658|3618124|P2|Overall Study|Withdrawal by Subject|21
1104754|NCT01854658|3618125|P1|Overall Study|Withdrawal by Subject|28
1104755|NCT01854658|3618122|P4|Overall Study|Lost to Follow-up|4
1104756|NCT01854658|3618123|P3|Overall Study|Lost to Follow-up|8
1104757|NCT01854658|3618124|P2|Overall Study|Lost to Follow-up|9
1104758|NCT01854658|3618125|P1|Overall Study|Lost to Follow-up|8
1104759|NCT01854658|3618122|P4|Overall Study|Physician Decision|4
1104760|NCT01854658|3618123|P3|Overall Study|Physician Decision|2
1104761|NCT01854658|3618124|P2|Overall Study|Physician Decision|5
1104762|NCT01854658|3618125|P1|Overall Study|Physician Decision|7
1104763|NCT01854658|3618122|P4|Overall Study|Protocol Violation|1
1104764|NCT01854658|3618123|P3|Overall Study|Protocol Violation|2
1104765|NCT01854658|3618124|P2|Overall Study|Protocol Violation|2
1104766|NCT01854658|3618125|P1|Overall Study|Protocol Violation|6
1104767|NCT01854645|3618160|P5|Overall Study|Adverse Event|11
1104768|NCT01854645|3618161|P4|Overall Study|Adverse Event|20
1104769|NCT01854645|3618162|P3|Overall Study|Adverse Event|19
1104770|NCT01854645|3618163|P2|Overall Study|Adverse Event|31
1104771|NCT01854645|3618164|P1|Overall Study|Adverse Event|33
1104772|NCT01854645|3618160|P5|Overall Study|Lack of Efficacy|9
1104773|NCT01854645|3618161|P4|Overall Study|Lack of Efficacy|3
1104774|NCT01854645|3618162|P3|Overall Study|Lack of Efficacy|9
1104775|NCT01854645|3618163|P2|Overall Study|Lack of Efficacy|12
1104776|NCT01854645|3618164|P1|Overall Study|Lack of Efficacy|7
1104777|NCT01854645|3618160|P5|Overall Study|Withdrawal by Subject|24
1104778|NCT01854645|3618161|P4|Overall Study|Withdrawal by Subject|21
1104779|NCT01854645|3618162|P3|Overall Study|Withdrawal by Subject|30
1104780|NCT01854645|3618163|P2|Overall Study|Withdrawal by Subject|41
1104781|NCT01854645|3618164|P1|Overall Study|Withdrawal by Subject|31
1104782|NCT01854645|3618160|P5|Overall Study|Physician Decision|7
1104783|NCT01854645|3618161|P4|Overall Study|Physician Decision|3
1104784|NCT01854645|3618162|P3|Overall Study|Physician Decision|3
1104785|NCT01854645|3618163|P2|Overall Study|Physician Decision|5
1104786|NCT01854645|3618164|P1|Overall Study|Physician Decision|1
1104787|NCT01854645|3618160|P5|Overall Study|Lost to Follow-up|0
1104788|NCT01854645|3618161|P4|Overall Study|Lost to Follow-up|5
1104789|NCT01854645|3618162|P3|Overall Study|Lost to Follow-up|8
1104790|NCT01854645|3618163|P2|Overall Study|Lost to Follow-up|7
1104791|NCT01854645|3618164|P1|Overall Study|Lost to Follow-up|10
1104792|NCT01854645|3618160|P5|Overall Study|Protocol Violation|1
1104793|NCT01854645|3618161|P4|Overall Study|Protocol Violation|4
1104794|NCT01854645|3618162|P3|Overall Study|Protocol Violation|5
1104795|NCT01854645|3618163|P2|Overall Study|Protocol Violation|0
1104796|NCT01854645|3618164|P1|Overall Study|Protocol Violation|3
1104797|NCT01854645|3618160|P5|Overall Study|Administrative Reasons / Missing|1
1104798|NCT01854645|3618161|P4|Overall Study|Administrative Reasons / Missing|1
1104799|NCT01854645|3618162|P3|Overall Study|Administrative Reasons / Missing|0
1104800|NCT01854645|3618163|P2|Overall Study|Administrative Reasons / Missing|0
1104801|NCT01854645|3618164|P1|Overall Study|Administrative Reasons / Missing|0
1104802|NCT01854645|3618160|P5|Overall Study|Protocol-Specified Criteria|7
1104803|NCT01854645|3618161|P4|Overall Study|Protocol-Specified Criteria|5
1104804|NCT01854645|3618162|P3|Overall Study|Protocol-Specified Criteria|8
1104805|NCT01854645|3618163|P2|Overall Study|Protocol-Specified Criteria|10
1104806|NCT01854645|3618164|P1|Overall Study|Protocol-Specified Criteria|13
1104807|NCT01854528|3618245|P2|Overall Study|Virologic Failure|9
1104808|NCT01854528|3618246|P1|Overall Study|Virologic Failure|0
1104809|NCT01854528|3618245|P2|Overall Study|Withdrawal by Subject|2
1104810|NCT01854528|3618246|P1|Overall Study|Withdrawal by Subject|0
1104811|NCT01854528|3618245|P2|Overall Study|Adverse Event|4
1104812|NCT01854528|3618246|P1|Overall Study|Adverse Event|0
1104813|NCT01854047|3618317|P5|Overall Study|Other than specified above|8
1104814|NCT01854047|3618318|P4|Overall Study|Other than specified above|5
1104815|NCT01854047|3618319|P3|Overall Study|Other than specified above|3
1104816|NCT01854047|3618320|P2|Overall Study|Other than specified above|3
1104817|NCT01854047|3618321|P1|Overall Study|Other than specified above|3
1104818|NCT01854047|3618317|P5|Overall Study|Randomized but not treated|4
1104819|NCT01854047|3618318|P4|Overall Study|Randomized but not treated|0
1104820|NCT01854047|3618319|P3|Overall Study|Randomized but not treated|2
1104821|NCT01854047|3618320|P2|Overall Study|Randomized but not treated|1
1104822|NCT01854047|3618321|P1|Overall Study|Randomized but not treated|0
1104823|NCT01854047|3618317|P5|Overall Study|Adverse Event|7
1104824|NCT01854047|3618318|P4|Overall Study|Adverse Event|10
1104825|NCT01854047|3618319|P3|Overall Study|Adverse Event|6
1104826|NCT01854047|3618320|P2|Overall Study|Adverse Event|4
1104827|NCT01854047|3618321|P1|Overall Study|Adverse Event|5
1104828|NCT01854047|3618317|P5|Overall Study|Poor compliance to protocol|0
1104829|NCT01854047|3618318|P4|Overall Study|Poor compliance to protocol|0
1104830|NCT01854047|3618319|P3|Overall Study|Poor compliance to protocol|2
1104831|NCT01854047|3618320|P2|Overall Study|Poor compliance to protocol|0
1104832|NCT01854047|3618321|P1|Overall Study|Poor compliance to protocol|3
1104833|NCT01854047|3618317|P5|Overall Study|Lack of Efficacy|0
1104834|NCT01854047|3618318|P4|Overall Study|Lack of Efficacy|0
1104835|NCT01854047|3618319|P3|Overall Study|Lack of Efficacy|0
1104836|NCT01854047|3618320|P2|Overall Study|Lack of Efficacy|0
1104837|NCT01854047|3618321|P1|Overall Study|Lack of Efficacy|1
1104838|NCT01853982|3618452|P2|Overall Study|Lost to Follow-up|1
1104839|NCT01853982|3618453|P1|Overall Study|Lost to Follow-up|0
1104840|NCT01853982|3618452|P2|Overall Study|Death|0
1104841|NCT01853982|3618453|P1|Overall Study|Death|1
1104842|NCT01853982|3618452|P2|Overall Study|Withdrawal by Subject|0
1104843|NCT01853982|3618453|P1|Overall Study|Withdrawal by Subject|1
1104844|NCT01853839|3618459|P1|Overall Study|Lost to follow-up or no valid BP measure|336
1104845|NCT01853839|3618459|P1|Overall Study|End of treatment visit too early|33
1104846|NCT01853839|3618459|P1|Overall Study|Not meet ITT population definition|58
1104847|NCT01853839|3618459|P1|Overall Study|Violated inclusion criteria|2
1104848|NCT01853696|3618481|P2|Overall Study|Lost to Follow-up|4
1104849|NCT01853696|3618482|P1|Overall Study|Lost to Follow-up|5
1104850|NCT01853696|3618481|P2|Overall Study|Withdrawal by Subject|1
1104851|NCT01853696|3618482|P1|Overall Study|Withdrawal by Subject|1
1104852|NCT01853475|3618518|P3|Overall Study|Withdrawal by Subject|0
1104853|NCT01853475|3618519|P2|Overall Study|Withdrawal by Subject|1
1104854|NCT01853475|3618520|P1|Overall Study|Withdrawal by Subject|0
1104855|NCT01853462|3618539|P2|Overall Study|Withdrawal by Subject|1
1104856|NCT01853462|3618540|P1|Overall Study|Withdrawal by Subject|1
1104857|NCT01853397|3618610|P4|Overall Study|Subject Noncompliance|1
1104858|NCT01853397|3618611|P3|Overall Study|Subject Noncompliance|0
1104859|NCT01853397|3618612|P2|Overall Study|Subject Noncompliance|0
1104860|NCT01853397|3618613|P1|Overall Study|Subject Noncompliance|0
1104861|NCT01853397|3618610|P4|Overall Study|Withdrawal by Subject|1
1104862|NCT01853397|3618611|P3|Overall Study|Withdrawal by Subject|0
1104863|NCT01853397|3618612|P2|Overall Study|Withdrawal by Subject|0
1104864|NCT01853397|3618613|P1|Overall Study|Withdrawal by Subject|0
1104865|NCT01853384|3618641|P2|Completed Follow up Visit 2|Lost to Follow-up|1
1104866|NCT01853384|3618642|P1|Completed Follow up Visit 2|Lost to Follow-up|0
1104867|NCT01853384|3618641|P2|Completed Follow up Visit 2|Death|0
1104868|NCT01853384|3618642|P1|Completed Follow up Visit 2|Death|1
1104869|NCT01853384|3618641|P2|Completed Follow up Visit 2|Withdrawal by Subject|2
1104870|NCT01853384|3618642|P1|Completed Follow up Visit 2|Withdrawal by Subject|1
1104871|NCT01853384|3618641|P2|Completed Follow up Visit 2|Adverse Event|0
1104872|NCT01853384|3618642|P1|Completed Follow up Visit 2|Adverse Event|1
1104873|NCT01853384|3618641|P2|Completed Follow up Visit 1|Withdrawal by Subject|0
1104874|NCT01853384|3618642|P1|Completed Follow up Visit 1|Withdrawal by Subject|1
1104875|NCT01853384|3618641|P2|Completed Follow up Visit 1|Early Termination|9
1104876|NCT01853384|3618642|P1|Completed Follow up Visit 1|Early Termination|13
1104877|NCT01853384|3618641|P2|Randomized|Other|3
1104878|NCT01853384|3618642|P1|Randomized|Other|3
1104879|NCT01853384|3618641|P2|Randomized|Sponsor Decision|34
1104880|NCT01853384|3618642|P1|Randomized|Sponsor Decision|47
1104881|NCT01853384|3618641|P2|Randomized|Withdrawal by Subject|3
1104882|NCT01853384|3618642|P1|Randomized|Withdrawal by Subject|5
1104883|NCT01853384|3618641|P2|Randomized|Lost to Follow-up|1
1104884|NCT01853384|3618642|P1|Randomized|Lost to Follow-up|1
1104885|NCT01853384|3618641|P2|Randomized|Death|2
1104886|NCT01853384|3618642|P1|Randomized|Death|1
1104887|NCT01853384|3618641|P2|Randomized|Adverse Event|3
1104888|NCT01853384|3618642|P1|Randomized|Adverse Event|5
1104889|NCT01853280|3618682|P2|Overall Study|Ineligible|1
1104890|NCT01853280|3618683|P1|Overall Study|Ineligible|0
1104891|NCT01853280|3618682|P2|Overall Study|Withdrawal by Subject|1
1104892|NCT01853280|3618683|P1|Overall Study|Withdrawal by Subject|0
1104893|NCT01853280|3618682|P2|Overall Study|Physician Decision|1
1104894|NCT01853280|3618683|P1|Overall Study|Physician Decision|0
1104895|NCT01853280|3618682|P2|Overall Study|Lost to Follow-up|1
1104896|NCT01853280|3618683|P1|Overall Study|Lost to Follow-up|0
1104897|NCT01853280|3618682|P2|Overall Study|Lack of Efficacy|2
1104898|NCT01853280|3618683|P1|Overall Study|Lack of Efficacy|2
1104899|NCT01853254|3618689|P1|Overall Study|Administrative/Other|16
1104900|NCT01853254|3618689|P1|Overall Study|Withdrawal of Consent|16
1104901|NCT01853254|3618689|P1|Overall Study|Other Protocol Violation|1
1104902|NCT01853254|3618689|P1|Overall Study|Refusal of Treatment|1
1104903|NCT01853254|3618689|P1|Overall Study|Insufficient Therapeutic Response|22
1104904|NCT01853254|3618689|P1|Overall Study|Failure to Return|43
1104905|NCT01853254|3618689|P1|Overall Study|Death|1
1104906|NCT01853254|3618689|P1|Overall Study|Adverse Event/Intercurrent Illness|3
1104907|NCT01853254|3618689|P1|Overall Study|Abnormal Laboratory Test|1
1104908|NCT01853176|3618706|P2|Overall Study|Study terminated|0
1104909|NCT01853176|3618707|P1|Overall Study|Study terminated|4
1104910|NCT01853072|3618726|P2|Overall Study|Reason not specified|6
1104911|NCT01853072|3618727|P1|Overall Study|Reason not specified|9
1104912|NCT01853072|3618726|P2|Overall Study|Withdrawal by Subject|2
1104913|NCT01853072|3618727|P1|Overall Study|Withdrawal by Subject|1
1104914|NCT01853072|3618726|P2|Overall Study|Physician Decision|1
1104915|NCT01853072|3618727|P1|Overall Study|Physician Decision|1
1104916|NCT01853072|3618726|P2|Overall Study|Non-compliance with study drug|1
1104917|NCT01853072|3618727|P1|Overall Study|Non-compliance with study drug|0
1104918|NCT01853072|3618726|P2|Overall Study|Lost to Follow-up|3
1104919|NCT01853072|3618727|P1|Overall Study|Lost to Follow-up|0
1104920|NCT01853072|3618726|P2|Overall Study|Death|4
1104921|NCT01853072|3618727|P1|Overall Study|Death|1
1104922|NCT01853072|3618726|P2|Overall Study|Adverse Event|3
1104923|NCT01853072|3618727|P1|Overall Study|Adverse Event|0
1104924|NCT01853072|3618726|P2|Overall Study|Adverse event prior to treatment|1
1104925|NCT01853072|3618727|P1|Overall Study|Adverse event prior to treatment|0
1104926|NCT01853046|3618747|P2|Overall Study|Disease progression|3
1104927|NCT01853046|3618748|P1|Overall Study|Disease progression|13
1104928|NCT01853046|3618747|P2|Overall Study|Adverse Event|2
1104929|NCT01853046|3618748|P1|Overall Study|Adverse Event|4
1104930|NCT01853046|3618747|P2|Overall Study|Withdrawal by Subject|1
1104931|NCT01853046|3618748|P1|Overall Study|Withdrawal by Subject|1
1104932|NCT01852825|3618816|P3|Overall Study|Withdrawal by Subject|0
1104933|NCT01852825|3618817|P2|Overall Study|Withdrawal by Subject|0
1104934|NCT01852825|3618818|P1|Overall Study|Withdrawal by Subject|2
1104935|NCT01852812|3618844|P3|Overall Study|Non-compliance With Study Drug|0
1104936|NCT01852812|3618845|P2|Overall Study|Non-compliance With Study Drug|1
1104937|NCT01852812|3618846|P1|Overall Study|Non-compliance With Study Drug|0
1104938|NCT01852812|3618844|P3|Overall Study|Adverse Event|1
1104939|NCT01852812|3618845|P2|Overall Study|Adverse Event|0
1104940|NCT01852812|3618846|P1|Overall Study|Adverse Event|0
1104941|NCT01852591|3618884|P1|Overall Study|Not Evaluable at Time of Analysis|1
1104942|NCT01852591|3618884|P1|Overall Study|Withdrawal by Subject|2
1104943|NCT01852292|3618925|P2|Overall Study|Progressive disease|52
1104944|NCT01852292|3618926|P1|Overall Study|Progressive disease|42
1104945|NCT01852292|3618925|P2|Overall Study|Study terminated by Sponsor|1
1104946|NCT01852292|3618926|P1|Overall Study|Study terminated by Sponsor|0
1104947|NCT01852292|3618925|P2|Overall Study|Non-compliance with study treatment|0
1104948|NCT01852292|3618926|P1|Overall Study|Non-compliance with study treatment|1
1104949|NCT01852292|3618925|P2|Overall Study|Protocol Violation|0
1104950|NCT01852292|3618926|P1|Overall Study|Protocol Violation|2
1104951|NCT01852292|3618925|P2|Overall Study|Physician Decision|2
1104952|NCT01852292|3618926|P1|Overall Study|Physician Decision|6
1104953|NCT01852292|3618925|P2|Overall Study|Adverse Event|11
1104954|NCT01852292|3618926|P1|Overall Study|Adverse Event|8
1104955|NCT01852292|3618925|P2|Overall Study|Patient/guardian decision|4
1104956|NCT01852292|3618926|P1|Overall Study|Patient/guardian decision|8
1104957|NCT01852292|3618925|P2|Overall Study|Death|8
1104958|NCT01852292|3618926|P1|Overall Study|Death|9
1104959|NCT01852292|3618925|P2|Overall Study|Untreated - did not receive study drug|1
1104960|NCT01852292|3618926|P1|Overall Study|Untreated - did not receive study drug|3
1104961|NCT01852214|3618950|P2|Washout Period|Withdrawal by Subject|1
1104962|NCT01852214|3618951|P1|Washout Period|Withdrawal by Subject|0
1104963|NCT01852214|3618950|P2|Period 1|Withdrawal by Subject|1
1104964|NCT01852214|3618951|P1|Period 1|Withdrawal by Subject|0
1104965|NCT01852214|3618950|P2|Period 1|Adverse Event|2
1104966|NCT01852214|3618951|P1|Period 1|Adverse Event|1
1104967|NCT01852162|3618978|P2|Overall Study|Withdrawal by Subject|1
1104968|NCT01852162|3618979|P1|Overall Study|Withdrawal by Subject|3
1104969|NCT01852162|3618978|P2|Overall Study|Adverse Event|0
1104970|NCT01852162|3618979|P1|Overall Study|Adverse Event|1
1104971|NCT01852110|3618995|P6|Overall Study|Withdrawal by Subject|0
1104972|NCT01852110|3618996|P5|Overall Study|Withdrawal by Subject|0
1104973|NCT01852110|3618997|P4|Overall Study|Withdrawal by Subject|0
1104974|NCT01852110|3618998|P3|Overall Study|Withdrawal by Subject|0
1104975|NCT01852110|3618999|P2|Overall Study|Withdrawal by Subject|4
1104976|NCT01852110|3619000|P1|Overall Study|Withdrawal by Subject|4
1104977|NCT01852110|3618995|P6|Overall Study|Study Terminated by Sponsor|0
1104978|NCT01852110|3618996|P5|Overall Study|Study Terminated by Sponsor|0
1104979|NCT01852110|3618997|P4|Overall Study|Study Terminated by Sponsor|0
1104980|NCT01852110|3618998|P3|Overall Study|Study Terminated by Sponsor|0
1104981|NCT01852110|3618999|P2|Overall Study|Study Terminated by Sponsor|32
1104982|NCT01852110|3619000|P1|Overall Study|Study Terminated by Sponsor|30
1104983|NCT01852110|3618995|P6|Overall Study|Protocol Violation|0
1104984|NCT01852110|3618996|P5|Overall Study|Protocol Violation|0
1104985|NCT01852110|3618997|P4|Overall Study|Protocol Violation|0
1104986|NCT01852110|3618998|P3|Overall Study|Protocol Violation|0
1104987|NCT01852110|3618999|P2|Overall Study|Protocol Violation|1
1104988|NCT01852110|3619000|P1|Overall Study|Protocol Violation|0
1104989|NCT01852110|3618995|P6|Overall Study|Physician Decision|0
1104990|NCT01852110|3618996|P5|Overall Study|Physician Decision|0
1104991|NCT01852110|3618997|P4|Overall Study|Physician Decision|0
1104992|NCT01852110|3618998|P3|Overall Study|Physician Decision|0
1104993|NCT01852110|3618999|P2|Overall Study|Physician Decision|0
1104994|NCT01852110|3619000|P1|Overall Study|Physician Decision|1
1104995|NCT01852110|3618995|P6|Overall Study|Non-compliance with Study Drug|0
1104996|NCT01852110|3618996|P5|Overall Study|Non-compliance with Study Drug|0
1104997|NCT01852110|3618997|P4|Overall Study|Non-compliance with Study Drug|0
1104998|NCT01852110|3618998|P3|Overall Study|Non-compliance with Study Drug|0
1104999|NCT01852110|3618999|P2|Overall Study|Non-compliance with Study Drug|1
1105000|NCT01852110|3619000|P1|Overall Study|Non-compliance with Study Drug|2
1105001|NCT01852110|3618995|P6|Overall Study|Lost to Follow-up|0
1105002|NCT01852110|3618996|P5|Overall Study|Lost to Follow-up|0
1105003|NCT01852110|3618997|P4|Overall Study|Lost to Follow-up|0
1105004|NCT01852110|3618998|P3|Overall Study|Lost to Follow-up|0
1105005|NCT01852110|3618999|P2|Overall Study|Lost to Follow-up|3
1105006|NCT01852110|3619000|P1|Overall Study|Lost to Follow-up|1
1105007|NCT01852110|3618995|P6|Overall Study|Adverse Event|0
1105008|NCT01852110|3618996|P5|Overall Study|Adverse Event|0
1105009|NCT01852110|3618997|P4|Overall Study|Adverse Event|0
1105010|NCT01852110|3618998|P3|Overall Study|Adverse Event|0
1105011|NCT01852110|3618999|P2|Overall Study|Adverse Event|5
1105012|NCT01852110|3619000|P1|Overall Study|Adverse Event|12
1105013|NCT01851863|3619074|P4|Overall Study|Lost to Follow-up|3
1105014|NCT01851863|3619075|P3|Overall Study|Lost to Follow-up|2
1105015|NCT01851863|3619076|P2|Overall Study|Lost to Follow-up|4
1105016|NCT01851863|3619077|P1|Overall Study|Lost to Follow-up|3
1105017|NCT01851863|3619074|P4|Overall Study|Did not receive study medication|0
1105018|NCT01851863|3619075|P3|Overall Study|Did not receive study medication|3
1105019|NCT01851863|3619076|P2|Overall Study|Did not receive study medication|5
1105020|NCT01851863|3619077|P1|Overall Study|Did not receive study medication|2
1105021|NCT01851720|3619106|P2|Overall Study|Lost to Follow-up|1
1105022|NCT01851720|3619107|P1|Overall Study|Lost to Follow-up|0
1105023|NCT01851590|3619137|P3|Overall Study|Lack of Efficacy|0
1105024|NCT01851590|3619138|P2|Overall Study|Lack of Efficacy|1
1105025|NCT01851590|3619139|P1|Overall Study|Lack of Efficacy|0
1105026|NCT01851590|3619137|P3|Overall Study|Adverse Event|2
1105027|NCT01851590|3619138|P2|Overall Study|Adverse Event|0
1105028|NCT01851590|3619139|P1|Overall Study|Adverse Event|0
1105029|NCT01851590|3619137|P3|Overall Study|Withdrawal by Subject|1
1105030|NCT01851590|3619138|P2|Overall Study|Withdrawal by Subject|0
1105031|NCT01851590|3619139|P1|Overall Study|Withdrawal by Subject|0
1105032|NCT01851330|3619162|P3|Overall Study|Investigator’s Discretion|1
1105033|NCT01851330|3619163|P2|Overall Study|Investigator’s Discretion|0
1105034|NCT01851330|3619164|P1|Overall Study|Investigator’s Discretion|0
1105035|NCT01851330|3619162|P3|Overall Study|Withdrew Consent|0
1105036|NCT01851330|3619163|P2|Overall Study|Withdrew Consent|1
1105037|NCT01851330|3619164|P1|Overall Study|Withdrew Consent|2
1105038|NCT01851330|3619162|P3|Overall Study|Lost to Follow-up|9
1105039|NCT01851330|3619163|P2|Overall Study|Lost to Follow-up|6
1105040|NCT01851330|3619164|P1|Overall Study|Lost to Follow-up|1
1105041|NCT01851330|3619162|P3|Overall Study|Lack of Efficacy|2
1105042|NCT01851330|3619163|P2|Overall Study|Lack of Efficacy|9
1105043|NCT01851330|3619164|P1|Overall Study|Lack of Efficacy|10
1105044|NCT01850641|3619217|P1|Overall Study|Increase in serum ferritin|1
1105045|NCT01850641|3619217|P1|Overall Study|Decrease in serum calcium|2
1105046|NCT01850641|3619217|P1|Overall Study|Decrease in serum phosphorus|1
1105047|NCT01850641|3619217|P1|Overall Study|Physician Decision|1
1105048|NCT01850615|3619231|P2|Overall Study|Unclassified|1
1105049|NCT01850615|3619232|P1|Overall Study|Unclassified|0
1105050|NCT01850615|3619231|P2|Overall Study|Lost to Follow-up|1
1105051|NCT01850615|3619232|P1|Overall Study|Lost to Follow-up|0
1105052|NCT01850615|3619231|P2|Overall Study|Withdrawal by Subject|1
1105053|NCT01850615|3619232|P1|Overall Study|Withdrawal by Subject|3
1105054|NCT01850615|3619231|P2|Overall Study|Adverse Event|1
1105055|NCT01850615|3619232|P1|Overall Study|Adverse Event|2
1105056|NCT01850615|3619231|P2|Overall Study|Protocol Violation|1
1105057|NCT01850615|3619232|P1|Overall Study|Protocol Violation|4
1105058|NCT01850602|3619250|P2|Overall Study|Increase in serum ferritin|0
1105059|NCT01850602|3619251|P1|Overall Study|Increase in serum ferritin|1
1105060|NCT01850602|3619250|P2|Overall Study|Decrease in serum calcium|3
1105061|NCT01850602|3619251|P1|Overall Study|Decrease in serum calcium|2
1105062|NCT01850602|3619250|P2|Overall Study|Withdrawal by Subject|4
1105063|NCT01850602|3619251|P1|Overall Study|Withdrawal by Subject|2
1105064|NCT01850602|3619250|P2|Overall Study|Physician Decision|1
1105065|NCT01850602|3619251|P1|Overall Study|Physician Decision|2
1105066|NCT01850602|3619250|P2|Overall Study|Adverse Event|10
1105067|NCT01850602|3619251|P1|Overall Study|Adverse Event|7
1105068|NCT01850589|3619265|P2|Overall Study|Withdrawal by Subject|0
1105069|NCT01850589|3619266|P1|Overall Study|Withdrawal by Subject|8
1105070|NCT01850030|3619331|P2|Overall Study|pregnancy not confirmed at visit 4|249
1105071|NCT01850030|3619332|P1|Overall Study|pregnancy not confirmed at visit 4|248
1105072|NCT01850030|3619331|P2|Overall Study|Protocol Violation|28
1105073|NCT01850030|3619332|P1|Overall Study|Protocol Violation|24
1105074|NCT01850030|3619331|P2|Overall Study|Withdrawal by Subject|4
1105075|NCT01850030|3619332|P1|Overall Study|Withdrawal by Subject|3
1105076|NCT01850030|3619331|P2|Overall Study|Lost to Follow-up|5
1105077|NCT01850030|3619332|P1|Overall Study|Lost to Follow-up|5
1105078|NCT01850030|3619331|P2|Overall Study|Lack of Efficacy|1
1105079|NCT01850030|3619332|P1|Overall Study|Lack of Efficacy|3
1105080|NCT01850030|3619331|P2|Overall Study|Adverse Event|82
1105081|NCT01850030|3619332|P1|Overall Study|Adverse Event|64
1105082|NCT01850004|3619344|P1|Overall Study|AE Unrelated to Study Drug|1
1105083|NCT01850004|3619344|P1|Overall Study|Subject Request to Discontinue Treatment|1
1105084|NCT01850004|3619344|P1|Overall Study|Subject Withdrew Consent|4
1105085|NCT01850004|3619344|P1|Overall Study|Poor/Non-compliance|1
1105086|NCT01850004|3619344|P1|Overall Study|Subject Moved|1
1105087|NCT01849848|3619351|P1|Overall Study|Progression of the primary disease|3
1105088|NCT01849848|3619351|P1|Overall Study|Physician Decision|1
1105089|NCT01849588|3619449|P1|Overall Study|Lack of Efficacy|3
1105090|NCT01849562|3619459|P3|Overall Study|Non-compliance with Study Drug|0
1105091|NCT01849562|3619460|P2|Overall Study|Non-compliance with Study Drug|0
1105092|NCT01849562|3619461|P1|Overall Study|Non-compliance with Study Drug|1
1105093|NCT01849562|3619459|P3|Overall Study|Lost to Follow-up|0
1105094|NCT01849562|3619460|P2|Overall Study|Lost to Follow-up|0
1105095|NCT01849562|3619461|P1|Overall Study|Lost to Follow-up|1
1105096|NCT01849497|3619474|P2|Overall Study|Lost to Follow-up|1
1105097|NCT01849497|3619475|P1|Overall Study|Lost to Follow-up|0
1105098|NCT01849497|3619474|P2|Overall Study|Sponsor Decision|1
1105099|NCT01849497|3619475|P1|Overall Study|Sponsor Decision|0
1105100|NCT01849497|3619474|P2|Overall Study|Withdrawal by Subject|2
1105101|NCT01849497|3619475|P1|Overall Study|Withdrawal by Subject|1
1105102|NCT01849458|3619483|P1|Overall Study|Lost to Follow-up|4
1105103|NCT01849289|3619522|P2|Overall Study|Unclassified|18
1105104|NCT01849289|3619523|P1|Overall Study|Unclassified|25
1105105|NCT01849289|3619522|P2|Overall Study|Withdrawal criteria|0
1105106|NCT01849289|3619523|P1|Overall Study|Withdrawal criteria|1
1105107|NCT01849289|3619522|P2|Overall Study|Protocol Violation|3
1105108|NCT01849289|3619523|P1|Overall Study|Protocol Violation|3
1105109|NCT01849289|3619522|P2|Overall Study|Adverse Event|3
1105110|NCT01849289|3619523|P1|Overall Study|Adverse Event|3
1105111|NCT01849276|3619539|P1|Followed for Survival for 5 Years|Early termination of the study|1
1105112|NCT01849276|3619539|P1|Followed for Survival for 5 Years|Death|1
1105113|NCT01849055|3619582|P6|Overall Study|Withdrawal by Subject|0
1105114|NCT01849055|3619583|P5|Overall Study|Withdrawal by Subject|0
1105115|NCT01849055|3619584|P4|Overall Study|Withdrawal by Subject|0
1105116|NCT01849055|3619585|P3|Overall Study|Withdrawal by Subject|1
1105117|NCT01849055|3619586|P2|Overall Study|Withdrawal by Subject|0
1105118|NCT01849055|3619587|P1|Overall Study|Withdrawal by Subject|0
1105119|NCT01848990|3619622|P3|Overall Study|Other|2
1105120|NCT01848990|3619623|P2|Overall Study|Other|4
1105121|NCT01848990|3619624|P1|Overall Study|Other|1
1105122|NCT01848990|3619622|P3|Overall Study|Death|1
1105123|NCT01848990|3619623|P2|Overall Study|Death|0
1105124|NCT01848990|3619624|P1|Overall Study|Death|1
1105125|NCT01848990|3619622|P3|Overall Study|Non Compliance|0
1105126|NCT01848990|3619623|P2|Overall Study|Non Compliance|0
1105127|NCT01848990|3619624|P1|Overall Study|Non Compliance|1
1105128|NCT01848990|3619622|P3|Overall Study|Physician Decision|0
1105129|NCT01848990|3619623|P2|Overall Study|Physician Decision|1
1105130|NCT01848990|3619624|P1|Overall Study|Physician Decision|1
1105131|NCT01848990|3619622|P3|Overall Study|Withdrawal by Subject|11
1105132|NCT01848990|3619623|P2|Overall Study|Withdrawal by Subject|10
1105133|NCT01848990|3619624|P1|Overall Study|Withdrawal by Subject|29
1105134|NCT01848990|3619622|P3|Overall Study|Protocol Violation|0
1105135|NCT01848990|3619623|P2|Overall Study|Protocol Violation|1
1105136|NCT01848990|3619624|P1|Overall Study|Protocol Violation|1
1105137|NCT01848990|3619622|P3|Overall Study|Lost to Follow-up|2
1105138|NCT01848990|3619623|P2|Overall Study|Lost to Follow-up|2
1105139|NCT01848990|3619624|P1|Overall Study|Lost to Follow-up|6
1105140|NCT01848990|3619622|P3|Overall Study|Adverse Event|0
1105141|NCT01848990|3619623|P2|Overall Study|Adverse Event|2
1105142|NCT01848990|3619624|P1|Overall Study|Adverse Event|6
1105143|NCT01848938|3619694|P2|Overall Study|Lost to Follow-up|1
1105144|NCT01848938|3619695|P1|Overall Study|Lost to Follow-up|1
1105145|NCT01848834|3619744|P5|Overall Study|Not Treated|0
1105146|NCT01848834|3619745|P4|Overall Study|Not Treated|0
1105147|NCT01848834|3619746|P3|Overall Study|Not Treated|0
1105148|NCT01848834|3619747|P2|Overall Study|Not Treated|1
1105149|NCT01848834|3619748|P1|Overall Study|Not Treated|0
1105150|NCT01848834|3619744|P5|Overall Study|Withdrawal by Subject|7
1105151|NCT01848834|3619745|P4|Overall Study|Withdrawal by Subject|0
1105152|NCT01848834|3619746|P3|Overall Study|Withdrawal by Subject|3
1105153|NCT01848834|3619747|P2|Overall Study|Withdrawal by Subject|2
1105154|NCT01848834|3619748|P1|Overall Study|Withdrawal by Subject|0
1105155|NCT01848834|3619744|P5|Overall Study|Protocol Violation|2
1105156|NCT01848834|3619745|P4|Overall Study|Protocol Violation|0
1105157|NCT01848834|3619746|P3|Overall Study|Protocol Violation|1
1105158|NCT01848834|3619747|P2|Overall Study|Protocol Violation|0
1105159|NCT01848834|3619748|P1|Overall Study|Protocol Violation|0
1105160|NCT01848834|3619744|P5|Overall Study|Progressive Disease|78
1105161|NCT01848834|3619745|P4|Overall Study|Progressive Disease|36
1105162|NCT01848834|3619746|P3|Overall Study|Progressive Disease|21
1105163|NCT01848834|3619747|P2|Overall Study|Progressive Disease|41
1105164|NCT01848834|3619748|P1|Overall Study|Progressive Disease|27
1105165|NCT01848834|3619744|P5|Overall Study|Death|3
1105166|NCT01848834|3619745|P4|Overall Study|Death|0
1105167|NCT01848834|3619746|P3|Overall Study|Death|0
1105168|NCT01848834|3619747|P2|Overall Study|Death|1
1105169|NCT01848834|3619748|P1|Overall Study|Death|0
1105170|NCT01848834|3619744|P5|Overall Study|Complete Response|0
1105171|NCT01848834|3619745|P4|Overall Study|Complete Response|0
1105172|NCT01848834|3619746|P3|Overall Study|Complete Response|0
1105173|NCT01848834|3619747|P2|Overall Study|Complete Response|1
1105174|NCT01848834|3619748|P1|Overall Study|Complete Response|0
1105175|NCT01848834|3619744|P5|Overall Study|Adverse Event|15
1105176|NCT01848834|3619745|P4|Overall Study|Adverse Event|1
1105177|NCT01848834|3619746|P3|Overall Study|Adverse Event|6
1105178|NCT01848834|3619747|P2|Overall Study|Adverse Event|8
1105179|NCT01848834|3619748|P1|Overall Study|Adverse Event|3
1105180|NCT01848834|3619744|P5|Overall Study|Physician Decision|1
1105181|NCT01848834|3619745|P4|Overall Study|Physician Decision|0
1105182|NCT01848834|3619746|P3|Overall Study|Physician Decision|0
1105183|NCT01848834|3619747|P2|Overall Study|Physician Decision|0
1105184|NCT01848834|3619748|P1|Overall Study|Physician Decision|0
1105185|NCT01848834|3619744|P5|Overall Study|Ongoing in Study|26
1105186|NCT01848834|3619745|P4|Overall Study|Ongoing in Study|0
1105187|NCT01848834|3619746|P3|Overall Study|Ongoing in Study|1
1105188|NCT01848834|3619747|P2|Overall Study|Ongoing in Study|6
1105189|NCT01848834|3619748|P1|Overall Study|Ongoing in Study|0
1105190|NCT01848756|3619783|P1|Overall Study|Enrolled in Error|1
1105191|NCT01848756|3619783|P1|Overall Study|Withdrawal by Subject|1
1105192|NCT01848756|3619783|P1|Overall Study|Adverse Event|1
1105193|NCT01848288|3619797|P1|Overall Study|Withdrawal by Subject|1
1105194|NCT01848288|3619797|P1|Overall Study|Protocol Violation|1
1105195|NCT01848288|3619797|P1|Overall Study|Death|1
1105196|NCT01848210|3619808|P2|Overall Study|Administrative|0
1105197|NCT01848210|3619809|P1|Overall Study|Administrative|1
1105198|NCT01848210|3619808|P2|Overall Study|Chronic Venous Insufficiency Course|2
1105199|NCT01848210|3619809|P1|Overall Study|Chronic Venous Insufficiency Course|1
1105200|NCT01848210|3619808|P2|Overall Study|Hepatic Function Alteration|0
1105201|NCT01848210|3619809|P1|Overall Study|Hepatic Function Alteration|4
1105202|NCT01848210|3619808|P2|Overall Study|Hypesensitivity|0
1105203|NCT01848210|3619809|P1|Overall Study|Hypesensitivity|1
1105204|NCT01848210|3619808|P2|Overall Study|Discontinuation Criterion|7
1105205|NCT01848210|3619809|P1|Overall Study|Discontinuation Criterion|5
1105206|NCT01848210|3619808|P2|Overall Study|Adverse Event|9
1105207|NCT01848210|3619809|P1|Overall Study|Adverse Event|7
1105208|NCT01848210|3619808|P2|Overall Study|Impedition Condition|9
1105209|NCT01848210|3619809|P1|Overall Study|Impedition Condition|5
1105210|NCT01848210|3619808|P2|Overall Study|Use of Forbidden Drugs|10
1105211|NCT01848210|3619809|P1|Overall Study|Use of Forbidden Drugs|9
1105212|NCT01848210|3619808|P2|Overall Study|Protocol Violation|5
1105213|NCT01848210|3619809|P1|Overall Study|Protocol Violation|3
1105214|NCT01848210|3619808|P2|Overall Study|Lost to Follow-up|12
1105215|NCT01848210|3619809|P1|Overall Study|Lost to Follow-up|24
1105216|NCT01848210|3619808|P2|Overall Study|Informed Consent Form Withdrawal|24
1105217|NCT01848210|3619809|P1|Overall Study|Informed Consent Form Withdrawal|28
1105218|NCT01848145|3619831|P1|Subsequent Infusions: Weeks 3-8|Death|1
1105219|NCT01848145|3619831|P1|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3
1105220|NCT01848145|3619831|P1|Subsequent Infusions: Weeks 3-8|Disease Progression|6
1105221|NCT01848145|3619831|P1|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1
1105222|NCT01848145|3619831|P1|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1
1105223|NCT01848145|3619831|P1|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1
1105224|NCT01848145|3619831|P1|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1
1105225|NCT01847885|3619871|P3|Randomization|Screen Failure|0
1105226|NCT01847885|3619872|P2|Randomization|Screen Failure|3
1105227|NCT01847885|3619873|P1|Randomization|Screen Failure|0
1105228|NCT01847885|3619871|P3|Randomization|Withdrawal by Subject|2
1105229|NCT01847885|3619872|P2|Randomization|Withdrawal by Subject|0
1105230|NCT01847885|3619873|P1|Randomization|Withdrawal by Subject|0
1105231|NCT01847885|3619871|P3|Randomization|Protocol Violation|0
1105232|NCT01847885|3619872|P2|Randomization|Protocol Violation|1
1105233|NCT01847885|3619873|P1|Randomization|Protocol Violation|0
1105234|NCT01847885|3619871|P3|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
1105235|NCT01847885|3619872|P2|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
1105236|NCT01847885|3619873|P1|Initial Enrollment (Consented)|Pending prior to enrollment stop|6
1105237|NCT01847885|3619871|P3|Initial Enrollment (Consented)|Screen failure|0
1105238|NCT01847885|3619872|P2|Initial Enrollment (Consented)|Screen failure|0
1105239|NCT01847885|3619873|P1|Initial Enrollment (Consented)|Screen failure|39
1105240|NCT01847885|3619871|P3|Initial Enrollment (Consented)|Withdrawal by Subject|0
1105241|NCT01847885|3619872|P2|Initial Enrollment (Consented)|Withdrawal by Subject|0
1105242|NCT01847885|3619873|P1|Initial Enrollment (Consented)|Withdrawal by Subject|2
1105243|NCT01847885|3619871|P3|Initial Enrollment (Consented)|Protocol Violation|0
1105244|NCT01847885|3619872|P2|Initial Enrollment (Consented)|Protocol Violation|0
1105245|NCT01847885|3619873|P1|Initial Enrollment (Consented)|Protocol Violation|1
1105246|NCT01847443|3619963|P4|Washout Period Before Study Period 4|Positive alcohol test|0
1105247|NCT01847443|3619964|P3|Washout Period Before Study Period 4|Positive alcohol test|0
1105248|NCT01847443|3619965|P2|Washout Period Before Study Period 4|Positive alcohol test|0
1105249|NCT01847443|3619966|P1|Washout Period Before Study Period 4|Positive alcohol test|1
1105250|NCT01847443|3619963|P4|Washout Period Before Study Period 4|Withdrawal by Subject|0
1105251|NCT01847443|3619964|P3|Washout Period Before Study Period 4|Withdrawal by Subject|0
1105252|NCT01847443|3619965|P2|Washout Period Before Study Period 4|Withdrawal by Subject|0
1105253|NCT01847443|3619966|P1|Washout Period Before Study Period 4|Withdrawal by Subject|1
1105254|NCT01847443|3619963|P4|Washout Period Before Study Period 3|Other reason|0
1105255|NCT01847443|3619964|P3|Washout Period Before Study Period 3|Other reason|0
1105256|NCT01847443|3619965|P2|Washout Period Before Study Period 3|Other reason|0
1105257|NCT01847443|3619966|P1|Washout Period Before Study Period 3|Other reason|1
1105258|NCT01847443|3619963|P4|Washout Period Before Study Period 2|Other reason|0
1105259|NCT01847443|3619964|P3|Washout Period Before Study Period 2|Other reason|0
1105260|NCT01847443|3619965|P2|Washout Period Before Study Period 2|Other reason|0
1105261|NCT01847443|3619966|P1|Washout Period Before Study Period 2|Other reason|1
1105262|NCT01847443|3619963|P4|Washout Period Before Study Period 2|Adverse Event|0
1105263|NCT01847443|3619964|P3|Washout Period Before Study Period 2|Adverse Event|0
1105264|NCT01847443|3619965|P2|Washout Period Before Study Period 2|Adverse Event|1
1105265|NCT01847443|3619966|P1|Washout Period Before Study Period 2|Adverse Event|1
1105266|NCT01847443|3619963|P4|Study Period 1|Withdrawal by Subject|0
1105267|NCT01847443|3619964|P3|Study Period 1|Withdrawal by Subject|0
1105268|NCT01847443|3619965|P2|Study Period 1|Withdrawal by Subject|1
1105269|NCT01847443|3619966|P1|Study Period 1|Withdrawal by Subject|0
1105270|NCT01846741|3620027|P1|Baseline Visit|Subject did not meet entry criteria|2
1105271|NCT01846624|3620175|P1|Overall Study|Died during induction, no midostaurin|1
1105272|NCT01846507|3620183|P1|Overall Study|Missing data|2
1105273|NCT01846507|3620183|P1|Overall Study|Protocol Violation|1
1105274|NCT01846507|3620183|P1|Overall Study|Lost to Follow-up|4
1105275|NCT01846442|3620270|P4|Overall Study|Left the city/Lost medication|1
1105276|NCT01846442|3620271|P3|Overall Study|Left the city/Lost medication|1
1105277|NCT01846442|3620272|P2|Overall Study|Left the city/Lost medication|0
1105278|NCT01846442|3620273|P1|Overall Study|Left the city/Lost medication|1
1105279|NCT01846442|3620270|P4|Overall Study|Withdrawal by Subject|1
1105280|NCT01846442|3620271|P3|Overall Study|Withdrawal by Subject|0
1105281|NCT01846442|3620272|P2|Overall Study|Withdrawal by Subject|2
1105282|NCT01846442|3620273|P1|Overall Study|Withdrawal by Subject|3
1105283|NCT01846442|3620270|P4|Overall Study|Lost to Follow-up|0
1105284|NCT01846442|3620271|P3|Overall Study|Lost to Follow-up|1
1105285|NCT01846442|3620272|P2|Overall Study|Lost to Follow-up|0
1105286|NCT01846442|3620273|P1|Overall Study|Lost to Follow-up|0
1105287|NCT01846442|3620270|P4|Overall Study|Adverse Event|1
1105288|NCT01846442|3620271|P3|Overall Study|Adverse Event|2
1105289|NCT01846442|3620272|P2|Overall Study|Adverse Event|4
1105290|NCT01846442|3620273|P1|Overall Study|Adverse Event|2
1105291|NCT01846416|3620314|P3|Overall Study|Lost to Follow-up|1
1105292|NCT01846416|3620315|P2|Overall Study|Lost to Follow-up|2
1105293|NCT01846416|3620316|P1|Overall Study|Lost to Follow-up|0
1105294|NCT01846416|3620314|P3|Overall Study|Ongoing as of 7 January 2015|3
1105295|NCT01846416|3620315|P2|Overall Study|Ongoing as of 7 January 2015|41
1105296|NCT01846416|3620316|P1|Overall Study|Ongoing as of 7 January 2015|21
1105297|NCT01846416|3620314|P3|Overall Study|Other|0
1105298|NCT01846416|3620315|P2|Overall Study|Other|0
1105299|NCT01846416|3620316|P1|Overall Study|Other|1
1105300|NCT01846416|3620314|P3|Overall Study|Withdrawal by Subject|0
1105301|NCT01846416|3620315|P2|Overall Study|Withdrawal by Subject|7
1105302|NCT01846416|3620316|P1|Overall Study|Withdrawal by Subject|1
1105303|NCT01846416|3620314|P3|Overall Study|Death|9
1105304|NCT01846416|3620315|P2|Overall Study|Death|43
1105305|NCT01846416|3620316|P1|Overall Study|Death|8
1105306|NCT01846299|3620361|P2|Overall Study|Adverse Event|0
1105307|NCT01846299|3620362|P1|Overall Study|Adverse Event|2
1105308|NCT01846299|3620361|P2|Overall Study|Withdrawal by Subject|6
1105309|NCT01846299|3620362|P1|Overall Study|Withdrawal by Subject|1
1105310|NCT01846299|3620361|P2|Overall Study|Lost to Follow-up|0
1105311|NCT01846299|3620362|P1|Overall Study|Lost to Follow-up|3
1105312|NCT01846299|3620361|P2|Overall Study|Death|2
1105313|NCT01846299|3620362|P1|Overall Study|Death|1
1105314|NCT01846299|3620361|P2|Overall Study|Protocol deviation|0
1105315|NCT01846299|3620362|P1|Overall Study|Protocol deviation|1
1105316|NCT01846299|3620361|P2|Overall Study|Physician Decision|2
1105317|NCT01846299|3620362|P1|Overall Study|Physician Decision|4
1105318|NCT01846221|3620400|P2|Overall Study|Age Exclusion|0
1105319|NCT01846221|3620401|P1|Overall Study|Age Exclusion|1
1105320|NCT01846221|3620400|P2|Overall Study|Catheter Failure|0
1105321|NCT01846221|3620401|P1|Overall Study|Catheter Failure|2
1105322|NCT01846208|3620418|P3|Overall Study|Refused SU OFC|1
1105323|NCT01846208|3620419|P2|Overall Study|Refused SU OFC|0
1105324|NCT01846208|3620420|P1|Overall Study|Refused SU OFC|0
1105325|NCT01846208|3620418|P3|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0
1105326|NCT01846208|3620419|P2|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0
1105327|NCT01846208|3620420|P1|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1
1105328|NCT01846208|3620418|P3|Overall Study|Non-compliance|0
1105329|NCT01846208|3620419|P2|Overall Study|Non-compliance|1
1105330|NCT01846208|3620420|P1|Overall Study|Non-compliance|1
1105331|NCT01846208|3620418|P3|Overall Study|Withdrawal by Subject|0
1105332|NCT01846208|3620419|P2|Overall Study|Withdrawal by Subject|0
1105333|NCT01846208|3620420|P1|Overall Study|Withdrawal by Subject|5
1105334|NCT01846208|3620418|P3|Overall Study|Dosing Symptoms|6
1105335|NCT01846208|3620419|P2|Overall Study|Dosing Symptoms|2
1105336|NCT01846208|3620420|P1|Overall Study|Dosing Symptoms|1
1105337|NCT01846208|3620418|P3|Overall Study|Withdrew prior to treatment|1
1105338|NCT01846208|3620419|P2|Overall Study|Withdrew prior to treatment|1
1105339|NCT01846208|3620420|P1|Overall Study|Withdrew prior to treatment|1
1105340|NCT01846104|3620437|P1|Overall Study|Withdrawal by Subject|1
1105341|NCT01846039|3620443|P1|Overall Study|Subject Withdrew Consent|1
1105342|NCT01846039|3620443|P1|Overall Study|Protocol Violation|1
1105343|NCT01845974|3620455|P2|Overall Study|screen failure|0
1105344|NCT01845974|3620456|P1|Overall Study|screen failure|1
1105345|NCT01845831|3620464|P5|Inpatient Phase|Withdrawal by Subject|0
1105346|NCT01845831|3620465|P4|Inpatient Phase|Withdrawal by Subject|0
1105347|NCT01845831|3620466|P3|Inpatient Phase|Withdrawal by Subject|0
1105348|NCT01845831|3620467|P2|Inpatient Phase|Withdrawal by Subject|1
1105349|NCT01845831|3620468|P1|Inpatient Phase|Withdrawal by Subject|1
1105350|NCT01845077|3620540|P6|Washout Period|Protocol Violation|0
1105351|NCT01845077|3620541|P5|Washout Period|Protocol Violation|1
1105352|NCT01845077|3620542|P4|Washout Period|Protocol Violation|1
1105353|NCT01845077|3620543|P3|Washout Period|Protocol Violation|0
1105354|NCT01845077|3620544|P2|Washout Period|Protocol Violation|0
1105355|NCT01845077|3620545|P1|Washout Period|Protocol Violation|0
1105356|NCT01845077|3620540|P6|Washout Period|elevated lab values (not clinic. sign.)|0
1105357|NCT01845077|3620541|P5|Washout Period|elevated lab values (not clinic. sign.)|0
1105358|NCT01845077|3620542|P4|Washout Period|elevated lab values (not clinic. sign.)|0
1105359|NCT01845077|3620543|P3|Washout Period|elevated lab values (not clinic. sign.)|1
1105360|NCT01845077|3620544|P2|Washout Period|elevated lab values (not clinic. sign.)|0
1105361|NCT01845077|3620545|P1|Washout Period|elevated lab values (not clinic. sign.)|0
1105362|NCT01845077|3620540|P6|Washout Period|Adverse Event|0
1105363|NCT01845077|3620541|P5|Washout Period|Adverse Event|0
1105364|NCT01845077|3620542|P4|Washout Period|Adverse Event|0
1105365|NCT01845077|3620543|P3|Washout Period|Adverse Event|0
1105366|NCT01845077|3620544|P2|Washout Period|Adverse Event|0
1105367|NCT01845077|3620545|P1|Washout Period|Adverse Event|1
1105368|NCT01845077|3620540|P6|Washout Period|Lost to Follow-up|1
1105369|NCT01845077|3620541|P5|Washout Period|Lost to Follow-up|0
1105370|NCT01845077|3620542|P4|Washout Period|Lost to Follow-up|1
1105371|NCT01845077|3620543|P3|Washout Period|Lost to Follow-up|0
1105372|NCT01845077|3620544|P2|Washout Period|Lost to Follow-up|1
1105373|NCT01845077|3620545|P1|Washout Period|Lost to Follow-up|0
1105374|NCT01845025|3620591|P2|Overall Study|Missing|1
1105375|NCT01845025|3620592|P1|Overall Study|Missing|1
1105376|NCT01845025|3620591|P2|Overall Study|Protocol deviation|6
1105377|NCT01845025|3620592|P1|Overall Study|Protocol deviation|3
1105378|NCT01845025|3620591|P2|Overall Study|Death|0
1105379|NCT01845025|3620592|P1|Overall Study|Death|2
1105380|NCT01845025|3620591|P2|Overall Study|Administrative problems|8
1105381|NCT01845025|3620592|P1|Overall Study|Administrative problems|8
1105382|NCT01845025|3620591|P2|Overall Study|Lost to Follow-up|13
1105383|NCT01845025|3620592|P1|Overall Study|Lost to Follow-up|13
1105384|NCT01845025|3620591|P2|Overall Study|Withdrawal by Subject|44
1105385|NCT01845025|3620592|P1|Overall Study|Withdrawal by Subject|48
1105386|NCT01845025|3620591|P2|Overall Study|Unsatisfactory therapeutic effect|2
1105387|NCT01845025|3620592|P1|Overall Study|Unsatisfactory therapeutic effect|4
1105388|NCT01845025|3620591|P2|Overall Study|Adverse Event|3
1105389|NCT01845025|3620592|P1|Overall Study|Adverse Event|6
1105390|NCT01844895|3620614|P1|Day 29 - Day113 - Autoinjector|planned surgery|1
1105391|NCT01844895|3620614|P1|Day 29 - Day113 - Autoinjector|Difficulty using device|3
1105392|NCT01844895|3620614|P1|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1
1105393|NCT01844895|3620614|P1|Day 29 - Day113 - Autoinjector|Adverse Event|1
1105394|NCT01844895|3620614|P1|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1
1105395|NCT01844895|3620614|P1|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1
1105396|NCT01844895|3620614|P1|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1
1105397|NCT01844856|3620632|P2|Overall Study|Randomized but was a Screen Failure|1
1105398|NCT01844856|3620633|P1|Overall Study|Randomized but was a Screen Failure|0
1105399|NCT01844856|3620632|P2|Overall Study|Inadvertently Not Scheduled|0
1105400|NCT01844856|3620633|P1|Overall Study|Inadvertently Not Scheduled|1
1105401|NCT01844856|3620632|P2|Overall Study|Enterococcus Resistant|1
1105402|NCT01844856|3620633|P1|Overall Study|Enterococcus Resistant|0
1105403|NCT01844856|3620632|P2|Overall Study|Noncompliance|3
1105404|NCT01844856|3620633|P1|Overall Study|Noncompliance|2
1105405|NCT01844856|3620632|P2|Overall Study|Withdrawal by Subject|2
1105406|NCT01844856|3620633|P1|Overall Study|Withdrawal by Subject|3
1105407|NCT01844856|3620632|P2|Overall Study|Adverse Event|6
1105408|NCT01844856|3620633|P1|Overall Study|Adverse Event|3
1105409|NCT01844856|3620632|P2|Overall Study|Lost to Follow-up|3
1105410|NCT01844856|3620633|P1|Overall Study|Lost to Follow-up|15
1105411|NCT01844830|3620645|P2|Overall Study|Withdrawal by Subject|0
1105412|NCT01844830|3620646|P1|Overall Study|Withdrawal by Subject|1
1105413|NCT01844817|3620676|P2|Treatment|Other|3
1105414|NCT01844817|3620677|P1|Treatment|Other|0
1105415|NCT01844817|3620676|P2|Treatment|Lost to Follow-up|1
1105416|NCT01844817|3620677|P1|Treatment|Lost to Follow-up|0
1105417|NCT01844817|3620676|P2|Treatment|Death|8
1105418|NCT01844817|3620677|P1|Treatment|Death|10
1105419|NCT01844817|3620676|P2|Treatment|Withdrawal by Subject|6
1105420|NCT01844817|3620677|P1|Treatment|Withdrawal by Subject|10
1105421|NCT01844817|3620676|P2|Treatment|Adverse Event|9
1105422|NCT01844817|3620677|P1|Treatment|Adverse Event|17
1105423|NCT01844817|3620676|P2|Treatment|Progressive Disease|36
1105424|NCT01844817|3620677|P1|Treatment|Progressive Disease|27
1105425|NCT01844817|3620676|P2|Enrolled and Randomized|Withdrawal by Subject|3
1105426|NCT01844817|3620677|P1|Enrolled and Randomized|Withdrawal by Subject|2
1105427|NCT01844778|3620690|P3|Overall Study|Adverse Event|2
1105428|NCT01844778|3620691|P2|Overall Study|Adverse Event|2
1105429|NCT01844778|3620692|P1|Overall Study|Adverse Event|0
1105430|NCT01844778|3620690|P3|Overall Study|Withdrawal by Subject|0
1105431|NCT01844778|3620691|P2|Overall Study|Withdrawal by Subject|0
1105432|NCT01844778|3620692|P1|Overall Study|Withdrawal by Subject|2
1105433|NCT01844778|3620690|P3|Overall Study|Protocol deviation|2
1105434|NCT01844778|3620691|P2|Overall Study|Protocol deviation|1
1105435|NCT01844778|3620692|P1|Overall Study|Protocol deviation|0
1105436|NCT01844765|3620718|P2|Overall Study|Untreated|0
1105437|NCT01844765|3620719|P1|Overall Study|Untreated|1
1105438|NCT01844765|3620718|P2|Overall Study|Protocol Violation|0
1105439|NCT01844765|3620719|P1|Overall Study|Protocol Violation|1
1105440|NCT01844765|3620718|P2|Overall Study|Disease progression|0
1105441|NCT01844765|3620719|P1|Overall Study|Disease progression|1
1105442|NCT01844765|3620718|P2|Overall Study|Administrative problems|1
1105443|NCT01844765|3620719|P1|Overall Study|Administrative problems|1
1105444|NCT01844765|3620718|P2|Overall Study|Withdrawal by Subject|1
1105445|NCT01844765|3620719|P1|Overall Study|Withdrawal by Subject|0
1105446|NCT01844765|3620718|P2|Overall Study|Adverse Event|4
1105447|NCT01844765|3620719|P1|Overall Study|Adverse Event|5
1105448|NCT01844700|3620739|P2|Overall Study|stopped taking meds|1
1105449|NCT01844700|3620740|P1|Overall Study|stopped taking meds|0
1105450|NCT01844700|3620739|P2|Overall Study|Withdrawal by Subject|0
1105451|NCT01844700|3620740|P1|Overall Study|Withdrawal by Subject|1
1105452|NCT01844700|3620739|P2|Overall Study|refused medication switch|0
1105453|NCT01844700|3620740|P1|Overall Study|refused medication switch|1
1105454|NCT01844700|3620739|P2|Overall Study|Lack of Efficacy|0
1105455|NCT01844700|3620740|P1|Overall Study|Lack of Efficacy|1
1105456|NCT01844687|3620752|P1|Visit 4|Withdrawal by Subject|2
1105457|NCT01844687|3620752|P1|Visit 4|Lost to Follow-up|1
1105458|NCT01844687|3620752|P1|Visit 4|Pregnancy|1
1105459|NCT01844687|3620752|P1|Visit 3|child care problems|1
1105460|NCT01844687|3620752|P1|Visit 3|Withdrawal by Subject|3
1105461|NCT01844687|3620752|P1|Visit 3|Lost to Follow-up|1
1105462|NCT01844687|3620752|P1|Visit 2|Protocol Violation|1
1105463|NCT01844687|3620752|P1|Visit 2|Withdrawal by Subject|1
1105464|NCT01844687|3620752|P1|Visit 1|Lost to Follow-up|5
1105465|NCT01844687|3620752|P1|Visit 1|Protocol Violation|3
1105466|NCT01844531|3620815|P4|Overall Study|Withdrawal by Subject|0
1105467|NCT01844531|3620816|P3|Overall Study|Withdrawal by Subject|0
1105468|NCT01844531|3620817|P2|Overall Study|Withdrawal by Subject|1
1105469|NCT01844531|3620818|P1|Overall Study|Withdrawal by Subject|0
1105470|NCT01844518|3620848|P1|Long-Term Extension|Still in On-Going Study|149
1105471|NCT01844518|3620848|P1|Long-Term Extension|No Longer Met Study Criteria|1
1105472|NCT01844518|3620848|P1|Long-Term Extension|Adverse Event|1
1105473|NCT01844518|3620848|P1|Long-Term Extension|Lack of Efficacy|6
1105474|NCT01844518|3620848|P1|Short-Term (ST) Period|Poor/Non-Compliance|1
1105475|NCT01844518|3620848|P1|Short-Term (ST) Period|Withdrawal of Consent|2
1105476|NCT01844518|3620848|P1|Short-Term (ST) Period|Lack of Efficacy|3
1105477|NCT01844518|3620848|P1|Short-Term (ST) Period|Adverse Event|3
1105478|NCT01844505|3620865|P3|Overall Study|Not Reported|1
1105479|NCT01844505|3620866|P2|Overall Study|Not Reported|0
1105480|NCT01844505|3620867|P1|Overall Study|Not Reported|0
1105481|NCT01844505|3620865|P3|Overall Study|Other Reasons|2
1105482|NCT01844505|3620866|P2|Overall Study|Other Reasons|2
1105483|NCT01844505|3620867|P1|Overall Study|Other Reasons|4
1105484|NCT01844505|3620865|P3|Overall Study|Subject no longer meets criteria|0
1105485|NCT01844505|3620866|P2|Overall Study|Subject no longer meets criteria|1
1105486|NCT01844505|3620867|P1|Overall Study|Subject no longer meets criteria|0
1105487|NCT01844505|3620865|P3|Overall Study|Poor/non-compliance|1
1105488|NCT01844505|3620866|P2|Overall Study|Poor/non-compliance|1
1105489|NCT01844505|3620867|P1|Overall Study|Poor/non-compliance|1
1105490|NCT01844505|3620865|P3|Overall Study|Maximum clinical benefit|2
1105491|NCT01844505|3620866|P2|Overall Study|Maximum clinical benefit|11
1105492|NCT01844505|3620867|P1|Overall Study|Maximum clinical benefit|8
1105493|NCT01844505|3620865|P3|Overall Study|Lost to Follow-up|0
1105494|NCT01844505|3620866|P2|Overall Study|Lost to Follow-up|0
1105495|NCT01844505|3620867|P1|Overall Study|Lost to Follow-up|1
1105496|NCT01844505|3620865|P3|Overall Study|Withdrawal by Subject|0
1105497|NCT01844505|3620866|P2|Overall Study|Withdrawal by Subject|3
1105498|NCT01844505|3620867|P1|Overall Study|Withdrawal by Subject|0
1105499|NCT01844505|3620865|P3|Overall Study|Subject request discontinue treatment|8
1105500|NCT01844505|3620866|P2|Overall Study|Subject request discontinue treatment|14
1105501|NCT01844505|3620867|P1|Overall Study|Subject request discontinue treatment|17
1105502|NCT01844505|3620865|P3|Overall Study|Adverse event unrelated to study drug|6
1105503|NCT01844505|3620866|P2|Overall Study|Adverse event unrelated to study drug|15
1105504|NCT01844505|3620867|P1|Overall Study|Adverse event unrelated to study drug|7
1105505|NCT01844505|3620865|P3|Overall Study|Death|1
1105506|NCT01844505|3620866|P2|Overall Study|Death|3
1105507|NCT01844505|3620867|P1|Overall Study|Death|1
1105508|NCT01844505|3620865|P3|Overall Study|Study drug toxicity|50
1105509|NCT01844505|3620866|P2|Overall Study|Study drug toxicity|131
1105510|NCT01844505|3620867|P1|Overall Study|Study drug toxicity|40
1105511|NCT01844505|3620865|P3|Overall Study|Disease progression|224
1105512|NCT01844505|3620866|P2|Overall Study|Disease progression|88
1105513|NCT01844505|3620867|P1|Overall Study|Disease progression|170
1105514|NCT01843972|3620978|P10|Overall Study|Withdrawal by Subject|0
1105515|NCT01843972|3620979|P9|Overall Study|Withdrawal by Subject|0
1105516|NCT01843972|3620980|P8|Overall Study|Withdrawal by Subject|0
1105517|NCT01843972|3620981|P7|Overall Study|Withdrawal by Subject|0
1105518|NCT01843972|3620982|P6|Overall Study|Withdrawal by Subject|0
1105519|NCT01843972|3620983|P5|Overall Study|Withdrawal by Subject|1
1105520|NCT01843972|3620984|P4|Overall Study|Withdrawal by Subject|0
1105521|NCT01843972|3620985|P3|Overall Study|Withdrawal by Subject|0
1105522|NCT01843972|3620986|P2|Overall Study|Withdrawal by Subject|0
1105523|NCT01843972|3620987|P1|Overall Study|Withdrawal by Subject|0
1105524|NCT01843933|3621057|P2|Overall Study|Data lost|4
1105525|NCT01843933|3621058|P1|Overall Study|Data lost|6
1105526|NCT01843842|3621077|P2|Overall Study|Do not meet inclusion criteria|1
1105527|NCT01843842|3621078|P1|Overall Study|Do not meet inclusion criteria|1
1105528|NCT01843777|3621100|P2|Overall Study|Withdrawal by Subject|0
1105529|NCT01843777|3621101|P1|Overall Study|Withdrawal by Subject|1
1105530|NCT01843673|3621109|P1|Overall Study|Withdrawal by Subject|4
1105531|NCT01843673|3621109|P1|Overall Study|Lack of Efficacy|2
1105532|NCT01843660|3621121|P1|Overall Study|Other|30
1105533|NCT01843374|3621162|P2|Overall Study|Withdrawing due to Other reason|46
1105534|NCT01843374|3621163|P1|Overall Study|Withdrawing due to Other reason|20
1105535|NCT01843374|3621162|P2|Overall Study|Withdrawal by Subject|20
1105536|NCT01843374|3621163|P1|Overall Study|Withdrawal by Subject|14
1105537|NCT01843374|3621162|P2|Overall Study|Death|313
1105538|NCT01843374|3621163|P1|Overall Study|Death|155
1105539|NCT01843348|3621190|P3|Overall Study|Various reasons|6
1105540|NCT01843348|3621191|P2|Overall Study|Various reasons|9
1105541|NCT01843348|3621192|P1|Overall Study|Various reasons|4
1105542|NCT01843348|3621190|P3|Overall Study|Graft loss/retransplantation|11
1105543|NCT01843348|3621191|P2|Overall Study|Graft loss/retransplantation|8
1105544|NCT01843348|3621192|P1|Overall Study|Graft loss/retransplantation|5
1105545|NCT01843348|3621190|P3|Overall Study|Death|4
1105546|NCT01843348|3621191|P2|Overall Study|Death|3
1105547|NCT01843348|3621192|P1|Overall Study|Death|5
1105548|NCT01843348|3621190|P3|Overall Study|Lost to Follow-up|2
1105549|NCT01843348|3621191|P2|Overall Study|Lost to Follow-up|4
1105550|NCT01843348|3621192|P1|Overall Study|Lost to Follow-up|5
1105551|NCT01843348|3621190|P3|Overall Study|Withdrawal by Subject|18
1105552|NCT01843348|3621191|P2|Overall Study|Withdrawal by Subject|16
1105553|NCT01843348|3621192|P1|Overall Study|Withdrawal by Subject|4
1105554|NCT01843205|3621232|P2|First Treatment (11 Days)|Withdrawal by Subject|0
1105555|NCT01843205|3621233|P1|First Treatment (11 Days)|Withdrawal by Subject|1
1105556|NCT01843192|3621294|P3|Overall Study|Intra-operative exclusions per protocol|2
1105557|NCT01843192|3621295|P2|Overall Study|Intra-operative exclusions per protocol|6
1105558|NCT01843192|3621296|P1|Overall Study|Intra-operative exclusions per protocol|2
1105559|NCT01842958|3621327|P2|Overall Study|Lost to Follow-up|1
1105560|NCT01842958|3621328|P1|Overall Study|Lost to Follow-up|1
1105561|NCT01842633|3621403|P3|Overall Study|Technical issues|0
1105562|NCT01842633|3621404|P2|Overall Study|Technical issues|0
1105563|NCT01842633|3621405|P1|Overall Study|Technical issues|1
1105564|NCT01842633|3621403|P3|Overall Study|Withdrawal by Subject|0
1105565|NCT01842633|3621404|P2|Overall Study|Withdrawal by Subject|1
1105566|NCT01842633|3621405|P1|Overall Study|Withdrawal by Subject|0
1105567|NCT01842633|3621403|P3|Overall Study|Adverse Event|0
1105568|NCT01842633|3621404|P2|Overall Study|Adverse Event|1
1105569|NCT01842633|3621405|P1|Overall Study|Adverse Event|1
1105570|NCT01842633|3621403|P3|Overall Study|Screen Failure|0
1105571|NCT01842633|3621404|P2|Overall Study|Screen Failure|0
1105572|NCT01842633|3621405|P1|Overall Study|Screen Failure|1
1105573|NCT01842620|3621452|P2|Period 1|Withdrawal by Subject|0
1105574|NCT01842620|3621453|P1|Period 1|Withdrawal by Subject|1
1105575|NCT01842607|3621469|P1|Overall Study|Withdrawal by Subject|14
1105576|NCT01842607|3621469|P1|Overall Study|Physician Decision|9
1105577|NCT01842607|3621469|P1|Overall Study|Lost to Follow-up|3
1105578|NCT01842607|3621469|P1|Overall Study|Protocol defined stopping criteria|2
1105579|NCT01842607|3621469|P1|Overall Study|Protocol Violation|8
1105580|NCT01842607|3621469|P1|Overall Study|Lack of Efficacy|19
1105581|NCT01842607|3621469|P1|Overall Study|Adverse Event|11
1105582|NCT01842438|3621501|P2|T2: 6month Follow-up|Death|1
1105583|NCT01842438|3621502|P1|T2: 6month Follow-up|Death|0
1105584|NCT01842438|3621501|P2|T2: 6month Follow-up|Withdrawal by Subject|3
1105585|NCT01842438|3621502|P1|T2: 6month Follow-up|Withdrawal by Subject|4
1105586|NCT01842438|3621501|P2|T1: Immediately After the Intervention|Withdrawal by Subject|8
1105587|NCT01842438|3621502|P1|T1: Immediately After the Intervention|Withdrawal by Subject|6
1105588|NCT01842334|3621516|P2|Overall Study|Moved away mid-study|1
1105589|NCT01842334|3621517|P1|Overall Study|Moved away mid-study|0
1105590|NCT01842334|3621516|P2|Overall Study|Withdrawal by Subject|3
1105591|NCT01842334|3621517|P1|Overall Study|Withdrawal by Subject|3
1105592|NCT01841970|3621523|P1|Overall Study|Lost to Follow-up|8
1105593|NCT01841970|3621523|P1|Overall Study|Physician Decision|2
1105594|NCT01841970|3621523|P1|Overall Study|Withdrawal by Subject|1
1105595|NCT01841762|3621547|P1|Post-Treatment Safety Follow-Up Period|Other, administrative error|1
1105596|NCT01841762|3621547|P1|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6
1105597|NCT01841762|3621547|P1|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7
1105598|NCT01841762|3621547|P1|Post-Treatment Safety Follow-Up Period|Death|1
1105599|NCT01841762|3621547|P1|Treatment Period|Other, including non-compliance|5
1105600|NCT01841762|3621547|P1|Treatment Period|Physician Decision|2
1105601|NCT01841762|3621547|P1|Treatment Period|Lost to Follow-up|1
1105602|NCT01841762|3621547|P1|Treatment Period|Withdrawal by Subject|7
1105603|NCT01841762|3621547|P1|Treatment Period|Death|1
1105604|NCT01841762|3621547|P1|Treatment Period|Adverse Event|16
1105605|NCT01841762|3621547|P1|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51
1105606|NCT01841697|3621557|P2|Overall Study|Withdrawal by Subject|16
1105607|NCT01841697|3621558|P1|Overall Study|Withdrawal by Subject|16
1105608|NCT01841697|3621557|P2|Overall Study|Lost to Follow-up|1
1105609|NCT01841697|3621558|P1|Overall Study|Lost to Follow-up|4
1105610|NCT01841697|3621557|P2|Overall Study|Death|1
1105611|NCT01841697|3621558|P1|Overall Study|Death|0
1105612|NCT01841593|3621598|P2|Second Intervention (Days 8 to 14)|Adverse Event|0
1105613|NCT01841593|3621599|P1|Second Intervention (Days 8 to 14)|Adverse Event|1
1105614|NCT01841593|3621598|P2|First Intervention (Days 1 to 7)|Protocol Violation|1
1105615|NCT01841593|3621599|P1|First Intervention (Days 1 to 7)|Protocol Violation|0
1105616|NCT01841567|3621615|P1|Overall Study|Adverse Event|3
1105617|NCT01840943|3621643|P2|Overall Study|Lost to Follow-up|4
1105618|NCT01840943|3621644|P1|Overall Study|Lost to Follow-up|4
1105619|NCT01840943|3621643|P2|Overall Study|Physician Decision|2
1105620|NCT01840943|3621644|P1|Overall Study|Physician Decision|4
1105621|NCT01840943|3621643|P2|Overall Study|Withdrawal by Subject|6
1105622|NCT01840943|3621644|P1|Overall Study|Withdrawal by Subject|5
1105623|NCT01840605|3621680|P2|Overall Study|Physician Decision|1
1105624|NCT01840605|3621681|P1|Overall Study|Physician Decision|2
1105625|NCT01840605|3621680|P2|Overall Study|Adverse Event|1
1105626|NCT01840605|3621681|P1|Overall Study|Adverse Event|0
1105627|NCT01840410|3621695|P2|Overall Study|Adverse Event|1
1105628|NCT01840410|3621696|P1|Overall Study|Adverse Event|1
1105629|NCT01840410|3621695|P2|Overall Study|Withdrawal by Subject|1
1105630|NCT01840410|3621696|P1|Overall Study|Withdrawal by Subject|2
1105631|NCT01840410|3621695|P2|Overall Study|Lost to Follow-up|0
1105632|NCT01840410|3621696|P1|Overall Study|Lost to Follow-up|1
1105633|NCT01840410|3621695|P2|Overall Study|Protocol deviation|0
1105634|NCT01840410|3621696|P1|Overall Study|Protocol deviation|1
1105635|NCT01840410|3621695|P2|Overall Study|Pregnancy|0
1105636|NCT01840410|3621696|P1|Overall Study|Pregnancy|1
1105637|NCT01840410|3621695|P2|Overall Study|Physician Decision|2
1105638|NCT01840410|3621696|P1|Overall Study|Physician Decision|1
1105639|NCT01840163|3621745|P2|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35
1105640|NCT01840163|3621746|P1|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43
1105641|NCT01840163|3621745|P2|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40
1105642|NCT01840163|3621746|P1|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48
1105643|NCT01840163|3621745|P2|First Follow up -Primary Outcome|Lost to Follow-up|16
1105644|NCT01840163|3621746|P1|First Follow up -Primary Outcome|Lost to Follow-up|19
1105645|NCT01839656|3621833|P2|Overall Study|Adverse Event|0
1105646|NCT01839656|3621834|P1|Overall Study|Adverse Event|1
1105647|NCT01839656|3621833|P2|Overall Study|Early study closure|11
1105648|NCT01839656|3621834|P1|Overall Study|Early study closure|0
1105649|NCT01839656|3621833|P2|Overall Study|Adverse event, serious fatal|4
1105650|NCT01839656|3621834|P1|Overall Study|Adverse event, serious fatal|1
1105651|NCT01839656|3621833|P2|Overall Study|Withdrawal by Subject|1
1105652|NCT01839656|3621834|P1|Overall Study|Withdrawal by Subject|1
1105653|NCT01839279|3621922|P3|Overall Study|Classified as 'Other'|0
1105654|NCT01839279|3621923|P2|Overall Study|Classified as 'Other'|0
1105655|NCT01839279|3621924|P1|Overall Study|Classified as 'Other'|5
1105656|NCT01839279|3621922|P3|Overall Study|Withdrawal by Subject|1
1105657|NCT01839279|3621923|P2|Overall Study|Withdrawal by Subject|1
1105658|NCT01839279|3621924|P1|Overall Study|Withdrawal by Subject|4
1105659|NCT01839279|3621922|P3|Overall Study|Adverse Event|1
1105660|NCT01839279|3621923|P2|Overall Study|Adverse Event|1
1105661|NCT01839279|3621924|P1|Overall Study|Adverse Event|4
1105662|NCT01838941|3621975|P1|Overall Study|Withdrawal by Subject|1
1105663|NCT01838941|3621975|P1|Overall Study|Adverse Event|1
1105664|NCT01838694|3622076|P2|Overall Study|Adverse Event|1
1105665|NCT01838694|3622077|P1|Overall Study|Adverse Event|0
1105666|NCT01838681|3622086|P4|Period B/A+|Administrative or other reasons|28
1105667|NCT01838681|3622087|P3|Period B/A+|Administrative or other reasons|10
1105668|NCT01838681|3622088|P2|Period B/A+|Administrative or other reasons|6
1105669|NCT01838681|3622089|P1|Period B/A+|Administrative or other reasons|0
1105670|NCT01838681|3622086|P4|Period B/A+|Withdrawal before treatment|0
1105671|NCT01838681|3622087|P3|Period B/A+|Withdrawal before treatment|0
1105672|NCT01838681|3622088|P2|Period B/A+|Withdrawal before treatment|1
1105673|NCT01838681|3622089|P1|Period B/A+|Withdrawal before treatment|0
1105674|NCT01838681|3622086|P4|Period B/A+|Lost to Follow-up|11
1105675|NCT01838681|3622087|P3|Period B/A+|Lost to Follow-up|5
1105676|NCT01838681|3622088|P2|Period B/A+|Lost to Follow-up|2
1105677|NCT01838681|3622089|P1|Period B/A+|Lost to Follow-up|0
1105678|NCT01838681|3622086|P4|Period B/A+|Non-compliance with IMP|3
1105679|NCT01838681|3622087|P3|Period B/A+|Non-compliance with IMP|3
1105680|NCT01838681|3622088|P2|Period B/A+|Non-compliance with IMP|2
1105681|NCT01838681|3622089|P1|Period B/A+|Non-compliance with IMP|0
1105682|NCT01838681|3622086|P4|Period B/A+|Protocol Violation|6
1105683|NCT01838681|3622087|P3|Period B/A+|Protocol Violation|4
1105684|NCT01838681|3622088|P2|Period B/A+|Protocol Violation|1
1105685|NCT01838681|3622089|P1|Period B/A+|Protocol Violation|0
1105686|NCT01838681|3622086|P4|Period B/A+|Withdrawal by Subject|47
1105687|NCT01838681|3622087|P3|Period B/A+|Withdrawal by Subject|35
1105688|NCT01838681|3622088|P2|Period B/A+|Withdrawal by Subject|28
1105689|NCT01838681|3622089|P1|Period B/A+|Withdrawal by Subject|0
1105690|NCT01838681|3622086|P4|Period B/A+|Lack of Efficacy|6
1105691|NCT01838681|3622087|P3|Period B/A+|Lack of Efficacy|11
1105692|NCT01838681|3622088|P2|Period B/A+|Lack of Efficacy|9
1105693|NCT01838681|3622089|P1|Period B/A+|Lack of Efficacy|0
1105694|NCT01838681|3622086|P4|Period B/A+|Adverse Event|16
1105695|NCT01838681|3622087|P3|Period B/A+|Adverse Event|27
1105696|NCT01838681|3622088|P2|Period B/A+|Adverse Event|13
1105697|NCT01838681|3622089|P1|Period B/A+|Adverse Event|0
1105698|NCT01838681|3622086|P4|Period A|Administrative or other reasons|0
1105699|NCT01838681|3622087|P3|Period A|Administrative or other reasons|0
1105700|NCT01838681|3622088|P2|Period A|Administrative or other reasons|0
1105701|NCT01838681|3622089|P1|Period A|Administrative or other reasons|17
1105702|NCT01838681|3622086|P4|Period A|Withdrawal before treatment|0
1105703|NCT01838681|3622087|P3|Period A|Withdrawal before treatment|0
1105704|NCT01838681|3622088|P2|Period A|Withdrawal before treatment|0
1105705|NCT01838681|3622089|P1|Period A|Withdrawal before treatment|4
1105706|NCT01838681|3622086|P4|Period A|Lost to Follow-up|0
1105707|NCT01838681|3622087|P3|Period A|Lost to Follow-up|0
1105708|NCT01838681|3622088|P2|Period A|Lost to Follow-up|0
1105709|NCT01838681|3622089|P1|Period A|Lost to Follow-up|4
1105710|NCT01838681|3622086|P4|Period A|Non-compliance with IMP|0
1105711|NCT01838681|3622087|P3|Period A|Non-compliance with IMP|0
1105712|NCT01838681|3622088|P2|Period A|Non-compliance with IMP|0
1105713|NCT01838681|3622089|P1|Period A|Non-compliance with IMP|6
1105714|NCT01838681|3622086|P4|Period A|Protocol Violation|0
1105715|NCT01838681|3622087|P3|Period A|Protocol Violation|0
1105716|NCT01838681|3622088|P2|Period A|Protocol Violation|0
1105717|NCT01838681|3622089|P1|Period A|Protocol Violation|16
1105718|NCT01838681|3622086|P4|Period A|Withdrawal by Subject|0
1105719|NCT01838681|3622087|P3|Period A|Withdrawal by Subject|0
1105720|NCT01838681|3622088|P2|Period A|Withdrawal by Subject|0
1105721|NCT01838681|3622089|P1|Period A|Withdrawal by Subject|70
1105722|NCT01838681|3622086|P4|Period A|Early response|0
1105723|NCT01838681|3622087|P3|Period A|Early response|0
1105724|NCT01838681|3622088|P2|Period A|Early response|0
1105725|NCT01838681|3622089|P1|Period A|Early response|148
1105726|NCT01838681|3622086|P4|Period A|Lack of Efficacy|0
1105727|NCT01838681|3622087|P3|Period A|Lack of Efficacy|0
1105728|NCT01838681|3622088|P2|Period A|Lack of Efficacy|0
1105729|NCT01838681|3622089|P1|Period A|Lack of Efficacy|21
1105730|NCT01838681|3622086|P4|Period A|Adverse Event|0
1105731|NCT01838681|3622087|P3|Period A|Adverse Event|0
1105732|NCT01838681|3622088|P2|Period A|Adverse Event|0
1105733|NCT01838681|3622089|P1|Period A|Adverse Event|39
1105734|NCT01838642|3622197|P1|Overall Study|Died on study|1
1105735|NCT01838616|3622210|P2|Pick-up Arm|Technical problems|0
1105736|NCT01838616|3622211|P1|Pick-up Arm|Technical problems|1
1105737|NCT01838616|3622210|P2|Pick-up Arm|Withdrawal by Subject|0
1105738|NCT01838616|3622211|P1|Pick-up Arm|Withdrawal by Subject|1
1105739|NCT01838616|3622210|P2|Pick-up Arm|Adverse Event|0
1105740|NCT01838616|3622211|P1|Pick-up Arm|Adverse Event|9
1105741|NCT01838616|3622210|P2|Pick-up Arm|Lack of Efficacy|0
1105742|NCT01838616|3622211|P1|Pick-up Arm|Lack of Efficacy|4
1105743|NCT01838616|3622210|P2|Continuation Period|Technical problems|1
1105744|NCT01838616|3622211|P1|Continuation Period|Technical problems|0
1105745|NCT01838616|3622210|P2|Continuation Period|Withdrawal by Subject|4
1105746|NCT01838616|3622211|P1|Continuation Period|Withdrawal by Subject|0
1105747|NCT01838616|3622210|P2|Continuation Period|Lost to Follow-up|0
1105748|NCT01838616|3622211|P1|Continuation Period|Lost to Follow-up|1
1105749|NCT01838616|3622210|P2|Continuation Period|Protocol Violation|0
1105750|NCT01838616|3622211|P1|Continuation Period|Protocol Violation|2
1105751|NCT01838616|3622210|P2|Continuation Period|Adverse Event|4
1105752|NCT01838616|3622211|P1|Continuation Period|Adverse Event|8
1105753|NCT01838616|3622210|P2|Continuation Period|Lack of Efficacy|5
1105754|NCT01838616|3622211|P1|Continuation Period|Lack of Efficacy|3
1105755|NCT01838616|3622210|P2|Titration Period|Protocol Violation|1
1105756|NCT01838616|3622211|P1|Titration Period|Protocol Violation|0
1105757|NCT01838616|3622210|P2|Titration Period|Not specified|0
1105758|NCT01838616|3622211|P1|Titration Period|Not specified|1
1105759|NCT01838616|3622210|P2|Titration Period|Technical problems|0
1105760|NCT01838616|3622211|P1|Titration Period|Technical problems|1
1105761|NCT01838616|3622210|P2|Titration Period|Withdrawal by Subject|5
1105762|NCT01838616|3622211|P1|Titration Period|Withdrawal by Subject|5
1105763|NCT01838616|3622210|P2|Titration Period|Lack of Efficacy|12
1105764|NCT01838616|3622211|P1|Titration Period|Lack of Efficacy|5
1105765|NCT01838616|3622210|P2|Titration Period|Adverse Event|48
1105766|NCT01838616|3622211|P1|Titration Period|Adverse Event|18
1105767|NCT01838590|3622282|P2|Overall Study|Lost to Follow-up|1
1105768|NCT01838590|3622283|P1|Overall Study|Lost to Follow-up|0
1105769|NCT01838590|3622282|P2|Overall Study|Lack of Efficacy|4
1105770|NCT01838590|3622283|P1|Overall Study|Lack of Efficacy|12
1105771|NCT01838499|3622307|P2|Overall Study|Withdrawal by Subject|9
1105772|NCT01838499|3622308|P1|Overall Study|Withdrawal by Subject|19
1105773|NCT01838499|3622307|P2|Overall Study|Adverse Event|1
1105774|NCT01838499|3622308|P1|Overall Study|Adverse Event|2
1105775|NCT01838499|3622307|P2|Overall Study|Lack of Efficacy|2
1105776|NCT01838499|3622308|P1|Overall Study|Lack of Efficacy|1
1105777|NCT01838499|3622307|P2|Overall Study|Lost to Follow-up|4
1105778|NCT01838499|3622308|P1|Overall Study|Lost to Follow-up|2
1105779|NCT01838499|3622307|P2|Overall Study|Protocol Violation|1
1105780|NCT01838499|3622308|P1|Overall Study|Protocol Violation|0
1105781|NCT01838213|3622335|P2|Overall Study|Ineligible|191
1105782|NCT01838213|3622336|P1|Overall Study|Ineligible|166
1105783|NCT01838044|3622344|P2|Overall Study|Lost to Follow-up|2
1105784|NCT01838044|3622345|P1|Overall Study|Lost to Follow-up|0
1105785|NCT01838044|3622344|P2|Overall Study|Medication error without associated AE|1
1105786|NCT01838044|3622345|P1|Overall Study|Medication error without associated AE|0
1105787|NCT01838044|3622344|P2|Overall Study|Insufficient clinical response|2
1105788|NCT01838044|3622345|P1|Overall Study|Insufficient clinical response|1
1105789|NCT01838044|3622344|P2|Overall Study|Withdrawal by Subject|2
1105790|NCT01838044|3622345|P1|Overall Study|Withdrawal by Subject|0
1105791|NCT01838044|3622344|P2|Overall Study|Protocol Violation|3
1105792|NCT01838044|3622345|P1|Overall Study|Protocol Violation|3
1105793|NCT01838044|3622344|P2|Overall Study|Adverse Event|6
1105794|NCT01838044|3622345|P1|Overall Study|Adverse Event|4
1105795|NCT01837966|3622378|P2|Overall Study|Withdrawal by Subject|1
1105796|NCT01837966|3622379|P1|Overall Study|Withdrawal by Subject|2
1105797|NCT01837823|3622385|P1|Overall Study|Lost to Follow-up|6
1105798|NCT01837797|3622416|P5|Period 3|Other|2
1105799|NCT01837797|3622417|P4|Period 3|Other|0
1105800|NCT01837797|3622418|P3|Period 3|Other|0
1105801|NCT01837797|3622419|P2|Period 3|Other|0
1105802|NCT01837797|3622420|P1|Period 3|Other|0
1105803|NCT01837797|3622416|P5|Period 3|Administrative reasons|20
1105804|NCT01837797|3622417|P4|Period 3|Administrative reasons|0
1105805|NCT01837797|3622418|P3|Period 3|Administrative reasons|0
1105806|NCT01837797|3622419|P2|Period 3|Administrative reasons|0
1105807|NCT01837797|3622420|P1|Period 3|Administrative reasons|0
1105808|NCT01837797|3622416|P5|Period 3|Adverse Event|1
1105809|NCT01837797|3622417|P4|Period 3|Adverse Event|0
1105810|NCT01837797|3622418|P3|Period 3|Adverse Event|0
1105811|NCT01837797|3622419|P2|Period 3|Adverse Event|0
1105812|NCT01837797|3622420|P1|Period 3|Adverse Event|0
1105813|NCT01837797|3622416|P5|Period 2|Adverse Event|0
1105814|NCT01837797|3622417|P4|Period 2|Adverse Event|1
1105815|NCT01837797|3622418|P3|Period 2|Adverse Event|0
1105816|NCT01837797|3622419|P2|Period 2|Adverse Event|0
1105817|NCT01837797|3622420|P1|Period 2|Adverse Event|0
1105818|NCT01837797|3622416|P5|Period 2|Administrative or other reasons|0
1105819|NCT01837797|3622417|P4|Period 2|Administrative or other reasons|4
1105820|NCT01837797|3622418|P3|Period 2|Administrative or other reasons|2
1105821|NCT01837797|3622419|P2|Period 2|Administrative or other reasons|5
1105822|NCT01837797|3622420|P1|Period 2|Administrative or other reasons|0
1105823|NCT01837797|3622416|P5|Period 1|Other|0
1105824|NCT01837797|3622417|P4|Period 1|Other|0
1105825|NCT01837797|3622418|P3|Period 1|Other|0
1105826|NCT01837797|3622419|P2|Period 1|Other|0
1105827|NCT01837797|3622420|P1|Period 1|Other|10
1105828|NCT01837797|3622416|P5|Period 1|Withdrawal of consent before treatment|0
1105829|NCT01837797|3622417|P4|Period 1|Withdrawal of consent before treatment|0
1105830|NCT01837797|3622418|P3|Period 1|Withdrawal of consent before treatment|0
1105831|NCT01837797|3622419|P2|Period 1|Withdrawal of consent before treatment|0
1105832|NCT01837797|3622420|P1|Period 1|Withdrawal of consent before treatment|1
1105833|NCT01837797|3622416|P5|Period 1|Administrative reasons|0
1105834|NCT01837797|3622417|P4|Period 1|Administrative reasons|0
1105835|NCT01837797|3622418|P3|Period 1|Administrative reasons|0
1105836|NCT01837797|3622419|P2|Period 1|Administrative reasons|0
1105837|NCT01837797|3622420|P1|Period 1|Administrative reasons|76
1105838|NCT01837797|3622416|P5|Period 1|Withdrawal by Subject|0
1105839|NCT01837797|3622417|P4|Period 1|Withdrawal by Subject|0
1105840|NCT01837797|3622418|P3|Period 1|Withdrawal by Subject|0
1105841|NCT01837797|3622419|P2|Period 1|Withdrawal by Subject|0
1105842|NCT01837797|3622420|P1|Period 1|Withdrawal by Subject|6
1105843|NCT01837797|3622416|P5|Period 1|Adverse Event|0
1105844|NCT01837797|3622417|P4|Period 1|Adverse Event|0
1105845|NCT01837797|3622418|P3|Period 1|Adverse Event|0
1105846|NCT01837797|3622419|P2|Period 1|Adverse Event|0
1105847|NCT01837797|3622420|P1|Period 1|Adverse Event|9
1105848|NCT01837719|3622455|P1|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1
1105849|NCT01837719|3622455|P1|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1
1105850|NCT01837680|3622524|P2|Overall Study|switched to oral hypoglycemic or diet|4
1105851|NCT01837680|3622525|P1|Overall Study|switched to oral hypoglycemic or diet|2
1105852|NCT01837680|3622524|P2|Overall Study|allergic reaction|0
1105853|NCT01837680|3622525|P1|Overall Study|allergic reaction|6
1105854|NCT01837680|3622524|P2|Overall Study|lack of insurance|2
1105855|NCT01837680|3622525|P1|Overall Study|lack of insurance|0
1105856|NCT01837680|3622524|P2|Overall Study|Lost to Follow-up|2
1105857|NCT01837680|3622525|P1|Overall Study|Lost to Follow-up|2
1105858|NCT01836549|3622633|P7|Overall Study|Patient inevaluable to start therapy|1
1105859|NCT01836549|3622634|P6|Overall Study|Patient inevaluable to start therapy|0
1105860|NCT01836549|3622635|P5|Overall Study|Patient inevaluable to start therapy|0
1105861|NCT01836549|3622636|P4|Overall Study|Patient inevaluable to start therapy|0
1105862|NCT01836549|3622637|P3|Overall Study|Patient inevaluable to start therapy|0
1105863|NCT01836549|3622638|P2|Overall Study|Patient inevaluable to start therapy|0
1105864|NCT01836549|3622639|P1|Overall Study|Patient inevaluable to start therapy|0
1105865|NCT01836549|3622633|P7|Overall Study|Patient declared ineligible|0
1105866|NCT01836549|3622634|P6|Overall Study|Patient declared ineligible|0
1105867|NCT01836549|3622635|P5|Overall Study|Patient declared ineligible|0
1105868|NCT01836549|3622636|P4|Overall Study|Patient declared ineligible|1
1105869|NCT01836549|3622637|P3|Overall Study|Patient declared ineligible|0
1105870|NCT01836549|3622638|P2|Overall Study|Patient declared ineligible|0
1105871|NCT01836549|3622639|P1|Overall Study|Patient declared ineligible|0
1105872|NCT01836549|3622633|P7|Overall Study|Did not receive study drug|0
1105873|NCT01836549|3622634|P6|Overall Study|Did not receive study drug|0
1105874|NCT01836549|3622635|P5|Overall Study|Did not receive study drug|0
1105875|NCT01836549|3622636|P4|Overall Study|Did not receive study drug|0
1105876|NCT01836549|3622637|P3|Overall Study|Did not receive study drug|1
1105877|NCT01836549|3622638|P2|Overall Study|Did not receive study drug|0
1105878|NCT01836549|3622639|P1|Overall Study|Did not receive study drug|0
1105879|NCT01836523|3622663|P4|Overall Study|Unclassified|29
1105880|NCT01836523|3622664|P3|Overall Study|Unclassified|19
1105881|NCT01836523|3622665|P2|Overall Study|Unclassified|28
1105882|NCT01836523|3622666|P1|Overall Study|Unclassified|17
1105883|NCT01836523|3622663|P4|Overall Study|Met Withdrawal Criteria|27
1105884|NCT01836523|3622664|P3|Overall Study|Met Withdrawal Criteria|21
1105885|NCT01836523|3622665|P2|Overall Study|Met Withdrawal Criteria|13
1105886|NCT01836523|3622666|P1|Overall Study|Met Withdrawal Criteria|13
1105887|NCT01836523|3622663|P4|Overall Study|Protocol Violation|4
1105888|NCT01836523|3622664|P3|Overall Study|Protocol Violation|2
1105889|NCT01836523|3622665|P2|Overall Study|Protocol Violation|3
1105890|NCT01836523|3622666|P1|Overall Study|Protocol Violation|6
1105891|NCT01836523|3622663|P4|Overall Study|Adverse Event|14
1105892|NCT01836523|3622664|P3|Overall Study|Adverse Event|49
1105893|NCT01836523|3622665|P2|Overall Study|Adverse Event|41
1105894|NCT01836523|3622666|P1|Overall Study|Adverse Event|15
1105895|NCT01836471|3622693|P5|Overall Study|Non compliance with tx|0
1105896|NCT01836471|3622694|P4|Overall Study|Non compliance with tx|0
1105897|NCT01836471|3622695|P3|Overall Study|Non compliance with tx|0
1105898|NCT01836471|3622696|P2|Overall Study|Non compliance with tx|1
1105899|NCT01836471|3622697|P1|Overall Study|Non compliance with tx|1
1105900|NCT01836471|3622693|P5|Overall Study|Adverse Event|2
1105901|NCT01836471|3622694|P4|Overall Study|Adverse Event|1
1105902|NCT01836471|3622695|P3|Overall Study|Adverse Event|1
1105903|NCT01836471|3622696|P2|Overall Study|Adverse Event|3
1105904|NCT01836471|3622697|P1|Overall Study|Adverse Event|6
1105905|NCT01836471|3622693|P5|Overall Study|Lost to Follow-up|1
1105906|NCT01836471|3622694|P4|Overall Study|Lost to Follow-up|1
1105907|NCT01836471|3622695|P3|Overall Study|Lost to Follow-up|0
1105908|NCT01836471|3622696|P2|Overall Study|Lost to Follow-up|0
1105909|NCT01836471|3622697|P1|Overall Study|Lost to Follow-up|0
1105910|NCT01836471|3622693|P5|Overall Study|Physician Decision|0
1105911|NCT01836471|3622694|P4|Overall Study|Physician Decision|0
1105912|NCT01836471|3622695|P3|Overall Study|Physician Decision|0
1105913|NCT01836471|3622696|P2|Overall Study|Physician Decision|1
1105914|NCT01836471|3622697|P1|Overall Study|Physician Decision|0
1105915|NCT01836471|3622693|P5|Overall Study|Withdrawal by Subject|2
1105916|NCT01836471|3622694|P4|Overall Study|Withdrawal by Subject|0
1105917|NCT01836471|3622695|P3|Overall Study|Withdrawal by Subject|1
1105918|NCT01836471|3622696|P2|Overall Study|Withdrawal by Subject|4
1105919|NCT01836471|3622697|P1|Overall Study|Withdrawal by Subject|3
1105920|NCT01836471|3622693|P5|Overall Study|Pregnancy|0
1105921|NCT01836471|3622694|P4|Overall Study|Pregnancy|0
1105922|NCT01836471|3622695|P3|Overall Study|Pregnancy|0
1105923|NCT01836471|3622696|P2|Overall Study|Pregnancy|0
1105924|NCT01836471|3622697|P1|Overall Study|Pregnancy|1
1105925|NCT01836458|3622726|P4|Overall Study|Unsatisfactory therapeutic effect|6
1105926|NCT01836458|3622727|P3|Overall Study|Unsatisfactory therapeutic effect|5
1105927|NCT01836458|3622728|P2|Overall Study|Unsatisfactory therapeutic effect|2
1105928|NCT01836458|3622729|P1|Overall Study|Unsatisfactory therapeutic effect|3
1105929|NCT01836276|3622814|P2|Overall Study|Lost to Follow-up|51
1105930|NCT01836276|3622815|P1|Overall Study|Lost to Follow-up|28
1105931|NCT01835899|3622886|P3|Overall Study|Other than stated above|0
1105932|NCT01835899|3622887|P2|Overall Study|Other than stated above|1
1105933|NCT01835899|3622888|P1|Overall Study|Other than stated above|0
1105934|NCT01835899|3622886|P3|Overall Study|Adverse Event|1
1105935|NCT01835899|3622887|P2|Overall Study|Adverse Event|0
1105936|NCT01835899|3622888|P1|Overall Study|Adverse Event|0
1105937|NCT01835587|3622934|P4|Overall Study|Miscellaneous|0
1105938|NCT01835587|3622935|P3|Overall Study|Miscellaneous|0
1105939|NCT01835587|3622936|P2|Overall Study|Miscellaneous|1
1105940|NCT01835587|3622937|P1|Overall Study|Miscellaneous|0
1105941|NCT01835587|3622934|P4|Overall Study|Death|1
1105942|NCT01835587|3622935|P3|Overall Study|Death|0
1105943|NCT01835587|3622936|P2|Overall Study|Death|0
1105944|NCT01835587|3622937|P1|Overall Study|Death|0
1105945|NCT01835587|3622934|P4|Overall Study|Adverse Event|2
1105946|NCT01835587|3622935|P3|Overall Study|Adverse Event|2
1105947|NCT01835587|3622936|P2|Overall Study|Adverse Event|0
1105948|NCT01835587|3622937|P1|Overall Study|Adverse Event|0
1105949|NCT01835587|3622934|P4|Overall Study|Withdrawal by Subject|3
1105950|NCT01835587|3622935|P3|Overall Study|Withdrawal by Subject|0
1105951|NCT01835587|3622936|P2|Overall Study|Withdrawal by Subject|0
1105952|NCT01835587|3622937|P1|Overall Study|Withdrawal by Subject|2
1105953|NCT01835587|3622934|P4|Overall Study|Disease Recurrence or Relapse|3
1105954|NCT01835587|3622935|P3|Overall Study|Disease Recurrence or Relapse|0
1105955|NCT01835587|3622936|P2|Overall Study|Disease Recurrence or Relapse|3
1105956|NCT01835587|3622937|P1|Overall Study|Disease Recurrence or Relapse|0
1105957|NCT01835548|3622998|P3|Double-Blind Treatment Period|Withdrawal by Subject|0
1105958|NCT01835548|3622999|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
1105959|NCT01835548|3623000|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
1105960|NCT01835548|3622998|P3|Double-Blind Treatment Period|Adverse Event|0
1105961|NCT01835548|3622999|P2|Double-Blind Treatment Period|Adverse Event|1
1105962|NCT01835548|3623000|P1|Double-Blind Treatment Period|Adverse Event|0
1105963|NCT01835548|3622998|P3|Dose Optimization Period|Withdrawal by Subject|1
1105964|NCT01835548|3622999|P2|Dose Optimization Period|Withdrawal by Subject|0
1105965|NCT01835548|3623000|P1|Dose Optimization Period|Withdrawal by Subject|0
1105966|NCT01835548|3622998|P3|Dose Optimization Period|Adverse Event|1
1105967|NCT01835548|3622999|P2|Dose Optimization Period|Adverse Event|0
1105968|NCT01835548|3623000|P1|Dose Optimization Period|Adverse Event|0
1105969|NCT01835470|3623029|P1|Long Term Treatment Period|Lack of Efficacy|1
1105970|NCT01835470|3623029|P1|Long Term Treatment Period|Subject Request to Discontinue|1
1105971|NCT01835431|3623041|P2|Overall Study|Protocol Violation|0
1105972|NCT01835431|3623042|P1|Overall Study|Protocol Violation|1
1105973|NCT01835431|3623041|P2|Overall Study|Withdrawal by Subject|10
1105974|NCT01835431|3623042|P1|Overall Study|Withdrawal by Subject|6
1105975|NCT01835431|3623041|P2|Overall Study|other|2
1105976|NCT01835431|3623042|P1|Overall Study|other|0
1105977|NCT01835431|3623041|P2|Overall Study|Adverse Event|0
1105978|NCT01835431|3623042|P1|Overall Study|Adverse Event|1
1105979|NCT01835158|3623082|P2|Overall Study|Withdrawal by Subject|6
1105980|NCT01835158|3623083|P1|Overall Study|Withdrawal by Subject|1
1105981|NCT01835132|3623093|P1|Initial Phase|Insufficient Therapeutic Response|2
1105982|NCT01835015|3623138|P5|Overall Study|Adverse Event|0
1105983|NCT01835015|3623139|P4|Overall Study|Adverse Event|0
1105984|NCT01835015|3623140|P3|Overall Study|Adverse Event|1
1105985|NCT01835015|3623141|P2|Overall Study|Adverse Event|0
1105986|NCT01835015|3623142|P1|Overall Study|Adverse Event|0
1105987|NCT01834586|3623225|P1|Overall Study|Adverse Event|1
1105988|NCT01834274|3623265|P2|Overall Study|Other|1
1105989|NCT01834274|3623266|P1|Overall Study|Other|2
1105990|NCT01834274|3623265|P2|Overall Study|Lost to Follow-up|1
1105991|NCT01834274|3623266|P1|Overall Study|Lost to Follow-up|3
1105992|NCT01834274|3623265|P2|Overall Study|Withdrawal by Subject|1
1105993|NCT01834274|3623266|P1|Overall Study|Withdrawal by Subject|1
1105994|NCT01834274|3623265|P2|Overall Study|Study Termination|38
1105995|NCT01834274|3623266|P1|Overall Study|Study Termination|41
1105996|NCT01834222|3623289|P1|Overall Study|Not meet inclusion/exclusion criteria|1
1105997|NCT01833897|3623384|P1|Overall Study|Lack of Efficacy|1
1105998|NCT01833533|3623509|P2|Overall Study|Not Specified|7
1105999|NCT01833533|3623510|P1|Overall Study|Not Specified|2
1106000|NCT01833533|3623509|P2|Overall Study|To Enter an Extension Study|4
1106001|NCT01833533|3623510|P1|Overall Study|To Enter an Extension Study|0
1106002|NCT01833533|3623509|P2|Overall Study|Lost to Follow-up|9
1106003|NCT01833533|3623510|P1|Overall Study|Lost to Follow-up|4
1106004|NCT01833533|3623509|P2|Overall Study|Adverse Event|1
1106005|NCT01833533|3623510|P1|Overall Study|Adverse Event|0
1106006|NCT01833494|3623524|P1|Overall Study|Increase in serum ferritin|1
1106007|NCT01833494|3623524|P1|Overall Study|Decrease in serum calcium|4
1106008|NCT01833494|3623524|P1|Overall Study|Decrease in serum phosphorus|4
1106009|NCT01833494|3623524|P1|Overall Study|Withdrawal by Subject|6
1106010|NCT01833494|3623524|P1|Overall Study|Physician Decision|6
1106011|NCT01833494|3623524|P1|Overall Study|Adverse Event|24
1106012|NCT01833169|3623561|P1|Overall Study|Physician Decision|2
1106013|NCT01833169|3623561|P1|Overall Study|Death|3
1106014|NCT01833169|3623561|P1|Overall Study|Withdrawal by Subject|9
1106015|NCT01833169|3623561|P1|Overall Study|Adverse Event|33
1106016|NCT01833169|3623561|P1|Overall Study|Disease Progression|99
1106017|NCT01833065|3623630|P5|Overall Study|Others|4
1106018|NCT01833065|3623631|P4|Overall Study|Others|1
1106019|NCT01833065|3623632|P3|Overall Study|Others|1
1106020|NCT01833065|3623633|P2|Overall Study|Others|1
1106021|NCT01833065|3623634|P1|Overall Study|Others|2
1106022|NCT01833065|3623630|P5|Overall Study|Trial terminated by sponsor|13
1106023|NCT01833065|3623631|P4|Overall Study|Trial terminated by sponsor|3
1106024|NCT01833065|3623632|P3|Overall Study|Trial terminated by sponsor|7
1106025|NCT01833065|3623633|P2|Overall Study|Trial terminated by sponsor|8
1106026|NCT01833065|3623634|P1|Overall Study|Trial terminated by sponsor|8
1106027|NCT01833065|3623630|P5|Overall Study|Subject's substantial non-compliance|0
1106028|NCT01833065|3623631|P4|Overall Study|Subject's substantial non-compliance|0
1106029|NCT01833065|3623632|P3|Overall Study|Subject's substantial non-compliance|0
1106030|NCT01833065|3623633|P2|Overall Study|Subject's substantial non-compliance|1
1106031|NCT01833065|3623634|P1|Overall Study|Subject's substantial non-compliance|0
1106032|NCT01833065|3623630|P5|Overall Study|Withdrawal by Subject|11
1106033|NCT01833065|3623631|P4|Overall Study|Withdrawal by Subject|3
1106034|NCT01833065|3623632|P3|Overall Study|Withdrawal by Subject|4
1106035|NCT01833065|3623633|P2|Overall Study|Withdrawal by Subject|2
1106036|NCT01833065|3623634|P1|Overall Study|Withdrawal by Subject|6
1106037|NCT01833065|3623630|P5|Overall Study|Lost to Follow-up|3
1106038|NCT01833065|3623631|P4|Overall Study|Lost to Follow-up|0
1106039|NCT01833065|3623632|P3|Overall Study|Lost to Follow-up|0
1106040|NCT01833065|3623633|P2|Overall Study|Lost to Follow-up|0
1106041|NCT01833065|3623634|P1|Overall Study|Lost to Follow-up|1
1106042|NCT01833065|3623630|P5|Overall Study|Protocol Violation|2
1106043|NCT01833065|3623631|P4|Overall Study|Protocol Violation|0
1106044|NCT01833065|3623632|P3|Overall Study|Protocol Violation|0
1106045|NCT01833065|3623633|P2|Overall Study|Protocol Violation|0
1106046|NCT01833065|3623634|P1|Overall Study|Protocol Violation|1
1106047|NCT01833065|3623630|P5|Overall Study|Adverse Event|3
1106048|NCT01833065|3623631|P4|Overall Study|Adverse Event|2
1106049|NCT01833065|3623632|P3|Overall Study|Adverse Event|0
1106050|NCT01833065|3623633|P2|Overall Study|Adverse Event|1
1106051|NCT01833065|3623634|P1|Overall Study|Adverse Event|6
1106052|NCT01832766|3623665|P2|Washout|Lost to Follow-up|1
1106053|NCT01832766|3623666|P1|Washout|Lost to Follow-up|0
1106054|NCT01832493|3623732|P1|Overall Study|Unable to place LV lead|2
1106055|NCT01832493|3623732|P1|Overall Study|Protocol Violation|4
1106056|NCT01832493|3623732|P1|Overall Study|Physician Decision|2
1106057|NCT01832155|3623754|P2|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0
1106058|NCT01832155|3623755|P1|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1
1106059|NCT01832155|3623754|P2|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0
1106060|NCT01832155|3623755|P1|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1
1106061|NCT01831817|3623860|P4|Overall Study|Withdrawl of Consent|0
1106062|NCT01831817|3623861|P3|Overall Study|Withdrawl of Consent|0
1106063|NCT01831817|3623862|P2|Overall Study|Withdrawl of Consent|0
1106064|NCT01831817|3623863|P1|Overall Study|Withdrawl of Consent|3
1106065|NCT01831817|3623860|P4|Overall Study|Lost to Follow-up|0
1106066|NCT01831817|3623861|P3|Overall Study|Lost to Follow-up|0
1106067|NCT01831817|3623862|P2|Overall Study|Lost to Follow-up|0
1106068|NCT01831817|3623863|P1|Overall Study|Lost to Follow-up|1
1106069|NCT01831791|3623901|P1|Overall Study|Withdrawal by Subject|10
1106070|NCT01831765|3623930|P3|Overall Study|Lost to Follow-up|3
1106071|NCT01831765|3623931|P2|Overall Study|Lost to Follow-up|3
1106072|NCT01831765|3623932|P1|Overall Study|Lost to Follow-up|2
1106073|NCT01831765|3623930|P3|Overall Study|Withdrawal criteria|16
1106074|NCT01831765|3623931|P2|Overall Study|Withdrawal criteria|10
1106075|NCT01831765|3623932|P1|Overall Study|Withdrawal criteria|12
1106076|NCT01831765|3623930|P3|Overall Study|Withdrawal by Subject|17
1106077|NCT01831765|3623931|P2|Overall Study|Withdrawal by Subject|7
1106078|NCT01831765|3623932|P1|Overall Study|Withdrawal by Subject|22
1106079|NCT01831765|3623930|P3|Overall Study|Adverse Event|3
1106080|NCT01831765|3623931|P2|Overall Study|Adverse Event|3
1106081|NCT01831765|3623932|P1|Overall Study|Adverse Event|5
1106082|NCT01831765|3623930|P3|Overall Study|Other, site closed|0
1106083|NCT01831765|3623931|P2|Overall Study|Other, site closed|1
1106084|NCT01831765|3623932|P1|Overall Study|Other, site closed|1
1106085|NCT01831765|3623930|P3|Overall Study|Death|1
1106086|NCT01831765|3623931|P2|Overall Study|Death|1
1106087|NCT01831765|3623932|P1|Overall Study|Death|0
1106088|NCT01831765|3623930|P3|Overall Study|Pregnancy|2
1106089|NCT01831765|3623931|P2|Overall Study|Pregnancy|1
1106090|NCT01831765|3623932|P1|Overall Study|Pregnancy|1
1106091|NCT01831765|3623930|P3|Overall Study|Other, sponsor withdrew subject|0
1106092|NCT01831765|3623931|P2|Overall Study|Other, sponsor withdrew subject|1
1106093|NCT01831765|3623932|P1|Overall Study|Other, sponsor withdrew subject|0
1106094|NCT01831765|3623930|P3|Overall Study|Lack of Efficacy|0
1106095|NCT01831765|3623931|P2|Overall Study|Lack of Efficacy|0
1106096|NCT01831765|3623932|P1|Overall Study|Lack of Efficacy|1
1106097|NCT01831726|3623958|P1|Overall Study|Subject/guardian decision|7
1106098|NCT01831726|3623958|P1|Overall Study|Physician Decision|1
1106099|NCT01831726|3623958|P1|Overall Study|Disease Progression|49
1106100|NCT01831726|3623958|P1|Overall Study|Death|7
1106101|NCT01831726|3623958|P1|Overall Study|Adverse Event|16
1106102|NCT01831466|3623977|P12|Overall Study|Adverse Event|2
1106103|NCT01831466|3623978|P11|Overall Study|Adverse Event|0
1106104|NCT01831466|3623979|P10|Overall Study|Adverse Event|1
1106105|NCT01831466|3623980|P9|Overall Study|Adverse Event|1
1106106|NCT01831466|3623981|P8|Overall Study|Adverse Event|1
1106107|NCT01831466|3623982|P7|Overall Study|Adverse Event|0
1106108|NCT01831466|3623983|P6|Overall Study|Adverse Event|7
1106109|NCT01831466|3623984|P5|Overall Study|Adverse Event|3
1106110|NCT01831466|3623985|P4|Overall Study|Adverse Event|6
1106111|NCT01831466|3623986|P3|Overall Study|Adverse Event|4
1106112|NCT01831466|3623987|P2|Overall Study|Adverse Event|0
1106113|NCT01831466|3623988|P1|Overall Study|Adverse Event|0
1106114|NCT01831466|3623977|P12|Overall Study|Lack of Efficacy|0
1106115|NCT01831466|3623978|P11|Overall Study|Lack of Efficacy|2
1106116|NCT01831466|3623979|P10|Overall Study|Lack of Efficacy|2
1106117|NCT01831466|3623980|P9|Overall Study|Lack of Efficacy|2
1106118|NCT01831466|3623981|P8|Overall Study|Lack of Efficacy|1
1106119|NCT01831466|3623982|P7|Overall Study|Lack of Efficacy|1
1106120|NCT01831466|3623983|P6|Overall Study|Lack of Efficacy|8
1106121|NCT01831466|3623984|P5|Overall Study|Lack of Efficacy|9
1106122|NCT01831466|3623985|P4|Overall Study|Lack of Efficacy|6
1106123|NCT01831466|3623986|P3|Overall Study|Lack of Efficacy|7
1106124|NCT01831466|3623987|P2|Overall Study|Lack of Efficacy|8
1106125|NCT01831466|3623988|P1|Overall Study|Lack of Efficacy|5
1106126|NCT01831466|3623977|P12|Overall Study|Lost to Follow-up|1
1106127|NCT01831466|3623978|P11|Overall Study|Lost to Follow-up|0
1106128|NCT01831466|3623979|P10|Overall Study|Lost to Follow-up|1
1106129|NCT01831466|3623980|P9|Overall Study|Lost to Follow-up|0
1106130|NCT01831466|3623981|P8|Overall Study|Lost to Follow-up|0
1106131|NCT01831466|3623982|P7|Overall Study|Lost to Follow-up|0
1106132|NCT01831466|3623983|P6|Overall Study|Lost to Follow-up|3
1106133|NCT01831466|3623984|P5|Overall Study|Lost to Follow-up|0
1106134|NCT01831466|3623985|P4|Overall Study|Lost to Follow-up|2
1106135|NCT01831466|3623986|P3|Overall Study|Lost to Follow-up|4
1106136|NCT01831466|3623987|P2|Overall Study|Lost to Follow-up|1
1106137|NCT01831466|3623988|P1|Overall Study|Lost to Follow-up|0
1106138|NCT01831466|3623977|P12|Overall Study|Withdrawal by Subject|1
1106139|NCT01831466|3623978|P11|Overall Study|Withdrawal by Subject|0
1106140|NCT01831466|3623979|P10|Overall Study|Withdrawal by Subject|1
1106141|NCT01831466|3623980|P9|Overall Study|Withdrawal by Subject|0
1106142|NCT01831466|3623981|P8|Overall Study|Withdrawal by Subject|0
1106143|NCT01831466|3623982|P7|Overall Study|Withdrawal by Subject|0
1106144|NCT01831466|3623983|P6|Overall Study|Withdrawal by Subject|5
1106145|NCT01831466|3623984|P5|Overall Study|Withdrawal by Subject|3
1106146|NCT01831466|3623985|P4|Overall Study|Withdrawal by Subject|3
1106147|NCT01831466|3623986|P3|Overall Study|Withdrawal by Subject|3
1106148|NCT01831466|3623987|P2|Overall Study|Withdrawal by Subject|3
1106149|NCT01831466|3623988|P1|Overall Study|Withdrawal by Subject|6
1106150|NCT01831466|3623977|P12|Overall Study|Death|0
1106151|NCT01831466|3623978|P11|Overall Study|Death|0
1106152|NCT01831466|3623979|P10|Overall Study|Death|0
1106153|NCT01831466|3623980|P9|Overall Study|Death|0
1106154|NCT01831466|3623981|P8|Overall Study|Death|0
1106155|NCT01831466|3623982|P7|Overall Study|Death|0
1106156|NCT01831466|3623983|P6|Overall Study|Death|0
1106157|NCT01831466|3623984|P5|Overall Study|Death|0
1106158|NCT01831466|3623985|P4|Overall Study|Death|0
1106159|NCT01831466|3623986|P3|Overall Study|Death|0
1106160|NCT01831466|3623987|P2|Overall Study|Death|1
1106161|NCT01831466|3623988|P1|Overall Study|Death|0
1106162|NCT01831466|3623977|P12|Overall Study|Non-compliance with study treatment|0
1106163|NCT01831466|3623978|P11|Overall Study|Non-compliance with study treatment|0
1106164|NCT01831466|3623979|P10|Overall Study|Non-compliance with study treatment|0
1106165|NCT01831466|3623980|P9|Overall Study|Non-compliance with study treatment|0
1106166|NCT01831466|3623981|P8|Overall Study|Non-compliance with study treatment|0
1106167|NCT01831466|3623982|P7|Overall Study|Non-compliance with study treatment|0
1106168|NCT01831466|3623983|P6|Overall Study|Non-compliance with study treatment|1
1106169|NCT01831466|3623984|P5|Overall Study|Non-compliance with study treatment|0
1106170|NCT01831466|3623985|P4|Overall Study|Non-compliance with study treatment|0
1106171|NCT01831466|3623986|P3|Overall Study|Non-compliance with study treatment|1
1106172|NCT01831466|3623987|P2|Overall Study|Non-compliance with study treatment|1
1106173|NCT01831466|3623988|P1|Overall Study|Non-compliance with study treatment|2
1106174|NCT01831466|3623977|P12|Overall Study|Not specified|0
1106175|NCT01831466|3623978|P11|Overall Study|Not specified|0
1106176|NCT01831466|3623979|P10|Overall Study|Not specified|0
1106177|NCT01831466|3623980|P9|Overall Study|Not specified|0
1106178|NCT01831466|3623981|P8|Overall Study|Not specified|0
1106179|NCT01831466|3623982|P7|Overall Study|Not specified|0
1106180|NCT01831466|3623983|P6|Overall Study|Not specified|1
1106181|NCT01831466|3623984|P5|Overall Study|Not specified|2
1106182|NCT01831466|3623985|P4|Overall Study|Not specified|2
1106183|NCT01831466|3623986|P3|Overall Study|Not specified|2
1106184|NCT01831466|3623987|P2|Overall Study|Not specified|3
1106185|NCT01831466|3623988|P1|Overall Study|Not specified|2
1106186|NCT01831466|3623977|P12|Overall Study|Protocol Violation|0
1106187|NCT01831466|3623978|P11|Overall Study|Protocol Violation|0
1106188|NCT01831466|3623979|P10|Overall Study|Protocol Violation|0
1106189|NCT01831466|3623980|P9|Overall Study|Protocol Violation|0
1106190|NCT01831466|3623981|P8|Overall Study|Protocol Violation|0
1106191|NCT01831466|3623982|P7|Overall Study|Protocol Violation|0
1106192|NCT01831466|3623983|P6|Overall Study|Protocol Violation|1
1106193|NCT01831466|3623984|P5|Overall Study|Protocol Violation|0
1106194|NCT01831466|3623985|P4|Overall Study|Protocol Violation|0
1106195|NCT01831466|3623986|P3|Overall Study|Protocol Violation|2
1106196|NCT01831466|3623987|P2|Overall Study|Protocol Violation|1
1106197|NCT01831466|3623988|P1|Overall Study|Protocol Violation|1
1106198|NCT01831258|3624110|P2|Overall Study|Lost to Follow-up|2
1106199|NCT01831258|3624111|P1|Overall Study|Lost to Follow-up|3
1106200|NCT01831258|3624110|P2|Overall Study|Withdrawal by Subject|1
1106201|NCT01831258|3624111|P1|Overall Study|Withdrawal by Subject|2
1106202|NCT01830972|3624206|P2|Part IV|Non-Compliance|0
1106203|NCT01830972|3624207|P1|Part IV|Non-Compliance|1
1106204|NCT01830972|3624206|P2|Part IV|Withdrawal by Subject|1
1106205|NCT01830972|3624207|P1|Part IV|Withdrawal by Subject|2
1106206|NCT01830972|3624206|P2|Part III|Noncompliance|0
1106207|NCT01830972|3624207|P1|Part III|Noncompliance|1
1106208|NCT01830972|3624206|P2|Part III|Withdrawal by Subject|0
1106209|NCT01830972|3624207|P1|Part III|Withdrawal by Subject|1
1106210|NCT01830972|3624206|P2|Part II|Withdrawal by Subject|2
1106211|NCT01830972|3624207|P1|Part II|Withdrawal by Subject|2
1106212|NCT01830920|3624251|P5|Overall Study|Not specified|3
1106213|NCT01830920|3624252|P4|Overall Study|Not specified|5
1106214|NCT01830920|3624253|P3|Overall Study|Not specified|1
1106215|NCT01830920|3624254|P2|Overall Study|Not specified|1
1106216|NCT01830920|3624255|P1|Overall Study|Not specified|15
1106217|NCT01830920|3624251|P5|Overall Study|Death|4
1106218|NCT01830920|3624252|P4|Overall Study|Death|4
1106219|NCT01830920|3624253|P3|Overall Study|Death|5
1106220|NCT01830920|3624254|P2|Overall Study|Death|3
1106221|NCT01830920|3624255|P1|Overall Study|Death|3
1106222|NCT01830920|3624251|P5|Overall Study|Withdrawal by Subject|1
1106223|NCT01830920|3624252|P4|Overall Study|Withdrawal by Subject|7
1106224|NCT01830920|3624253|P3|Overall Study|Withdrawal by Subject|1
1106225|NCT01830920|3624254|P2|Overall Study|Withdrawal by Subject|2
1106226|NCT01830920|3624255|P1|Overall Study|Withdrawal by Subject|2
1106227|NCT01830920|3624251|P5|Overall Study|Adverse Event|0
1106228|NCT01830920|3624252|P4|Overall Study|Adverse Event|0
1106229|NCT01830920|3624253|P3|Overall Study|Adverse Event|1
1106230|NCT01830920|3624254|P2|Overall Study|Adverse Event|0
1106231|NCT01830920|3624255|P1|Overall Study|Adverse Event|1
1106232|NCT01830881|3624294|P2|Overall Study|Changed decision to have an abortion|1
1106233|NCT01830881|3624295|P1|Overall Study|Changed decision to have an abortion|0
1106234|NCT01830855|3624343|P4|Overall Study|Lost to Follow-up|33
1106235|NCT01830855|3624344|P3|Overall Study|Lost to Follow-up|23
1106236|NCT01830855|3624345|P2|Overall Study|Lost to Follow-up|20
1106237|NCT01830855|3624346|P1|Overall Study|Lost to Follow-up|47
1106238|NCT01830855|3624343|P4|Overall Study|No longer willing to participate|17
1106239|NCT01830855|3624344|P3|Overall Study|No longer willing to participate|12
1106240|NCT01830855|3624345|P2|Overall Study|No longer willing to participate|13
1106241|NCT01830855|3624346|P1|Overall Study|No longer willing to participate|32
1106242|NCT01830855|3624343|P4|Overall Study|Withdrawal by Subject|12
1106243|NCT01830855|3624344|P3|Overall Study|Withdrawal by Subject|10
1106244|NCT01830855|3624345|P2|Overall Study|Withdrawal by Subject|14
1106245|NCT01830855|3624346|P1|Overall Study|Withdrawal by Subject|33
1106246|NCT01830855|3624343|P4|Overall Study|Protocol deviation|6
1106247|NCT01830855|3624344|P3|Overall Study|Protocol deviation|6
1106248|NCT01830855|3624345|P2|Overall Study|Protocol deviation|5
1106249|NCT01830855|3624346|P1|Overall Study|Protocol deviation|10
1106250|NCT01830855|3624343|P4|Overall Study|Adverse Event|3
1106251|NCT01830855|3624344|P3|Overall Study|Adverse Event|6
1106252|NCT01830855|3624345|P2|Overall Study|Adverse Event|5
1106253|NCT01830855|3624346|P1|Overall Study|Adverse Event|11
1106254|NCT01830855|3624343|P4|Overall Study|No longer meets eligibility criteria|5
1106255|NCT01830855|3624344|P3|Overall Study|No longer meets eligibility criteria|3
1106256|NCT01830855|3624345|P2|Overall Study|No longer meets eligibility criteria|2
1106257|NCT01830855|3624346|P1|Overall Study|No longer meets eligibility criteria|11
1106258|NCT01830855|3624343|P4|Overall Study|Pregnancy|1
1106259|NCT01830855|3624344|P3|Overall Study|Pregnancy|2
1106260|NCT01830855|3624345|P2|Overall Study|Pregnancy|1
1106261|NCT01830855|3624346|P1|Overall Study|Pregnancy|3
1106262|NCT01830855|3624343|P4|Overall Study|Medication error without associated AE|1
1106263|NCT01830855|3624344|P3|Overall Study|Medication error without associated AE|0
1106264|NCT01830855|3624345|P2|Overall Study|Medication error without associated AE|0
1106265|NCT01830855|3624346|P1|Overall Study|Medication error without associated AE|1
1106266|NCT01830855|3624343|P4|Overall Study|Other|4
1106267|NCT01830855|3624344|P3|Overall Study|Other|4
1106268|NCT01830855|3624345|P2|Overall Study|Other|1
1106269|NCT01830855|3624346|P1|Overall Study|Other|7
1106270|NCT01830595|3624483|P2|Washout|Withdrawal by Subject|2
1106271|NCT01830595|3624484|P1|Washout|Withdrawal by Subject|2
1106272|NCT01830595|3624483|P2|First Period|Withdrawal by Subject|3
1106273|NCT01830595|3624484|P1|First Period|Withdrawal by Subject|1
1106274|NCT01830543|3624501|P3|Overall Study|Other|37
1106275|NCT01830543|3624502|P2|Overall Study|Other|17
1106276|NCT01830543|3624503|P1|Overall Study|Other|12
1106277|NCT01830543|3624501|P3|Overall Study|Withdrawal by consent|3
1106278|NCT01830543|3624502|P2|Overall Study|Withdrawal by consent|3
1106279|NCT01830543|3624503|P1|Overall Study|Withdrawal by consent|3
1106280|NCT01830543|3624501|P3|Overall Study|Physician Decision|12
1106281|NCT01830543|3624502|P2|Overall Study|Physician Decision|5
1106282|NCT01830543|3624503|P1|Overall Study|Physician Decision|11
1106283|NCT01830543|3624501|P3|Overall Study|Protocol Violation|7
1106284|NCT01830543|3624502|P2|Overall Study|Protocol Violation|7
1106285|NCT01830543|3624503|P1|Overall Study|Protocol Violation|3
1106286|NCT01830543|3624501|P3|Overall Study|Death|22
1106287|NCT01830543|3624502|P2|Overall Study|Death|22
1106288|NCT01830543|3624503|P1|Overall Study|Death|20
1106289|NCT01830543|3624501|P3|Overall Study|Adverse Event|76
1106290|NCT01830543|3624502|P2|Overall Study|Adverse Event|77
1106291|NCT01830543|3624503|P1|Overall Study|Adverse Event|91
1106292|NCT01830543|3624501|P3|Overall Study|Subject Decision|57
1106293|NCT01830543|3624502|P2|Overall Study|Subject Decision|21
1106294|NCT01830543|3624503|P1|Overall Study|Subject Decision|19
1106295|NCT01830127|3624635|P2|Overall Study|Other reason not defined above|2
1106296|NCT01830127|3624636|P1|Overall Study|Other reason not defined above|0
1106297|NCT01830127|3624635|P2|Overall Study|Withdrawal by Subject|1
1106298|NCT01830127|3624636|P1|Overall Study|Withdrawal by Subject|1
1106299|NCT01830127|3624635|P2|Overall Study|Lack of Efficacy|0
1106300|NCT01830127|3624636|P1|Overall Study|Lack of Efficacy|3
1106301|NCT01830127|3624635|P2|Overall Study|Adverse Event|6
1106302|NCT01830127|3624636|P1|Overall Study|Adverse Event|1
1106303|NCT01829711|3624660|P1|Overall Study|Still in Follow Up|50
1106304|NCT01829711|3624660|P1|Overall Study|Death|3
1106305|NCT01829711|3624660|P1|Overall Study|Withdrawal by Subject|2
1106306|NCT01829711|3624660|P1|Overall Study|Lost to Follow-up|1
1106307|NCT01829711|3624660|P1|Overall Study|Not specified|24
1106308|NCT01829477|3624715|P2|Overall Study|Withdrawal by Subject|0
1106309|NCT01829477|3624716|P1|Overall Study|Withdrawal by Subject|1
1106310|NCT01829477|3624715|P2|Overall Study|Study Terminated by Sponsor|15
1106311|NCT01829477|3624716|P1|Overall Study|Study Terminated by Sponsor|15
1106312|NCT01829464|3624729|P3|Overall Study|Lack of Efficacy|0
1106313|NCT01829464|3624730|P2|Overall Study|Lack of Efficacy|1
1106314|NCT01829464|3624731|P1|Overall Study|Lack of Efficacy|0
1106315|NCT01829464|3624729|P3|Overall Study|Study terminated by sponsor|25
1106316|NCT01829464|3624730|P2|Overall Study|Study terminated by sponsor|28
1106317|NCT01829464|3624731|P1|Overall Study|Study terminated by sponsor|25
1106318|NCT01829464|3624729|P3|Overall Study|Withdrawal by Subject|0
1106319|NCT01829464|3624730|P2|Overall Study|Withdrawal by Subject|0
1106320|NCT01829464|3624731|P1|Overall Study|Withdrawal by Subject|2
1106321|NCT01829464|3624729|P3|Overall Study|Lost to Follow-up|1
1106322|NCT01829464|3624730|P2|Overall Study|Lost to Follow-up|0
1106323|NCT01829464|3624731|P1|Overall Study|Lost to Follow-up|0
1106324|NCT01829464|3624729|P3|Overall Study|Adverse Event|0
1106325|NCT01829464|3624730|P2|Overall Study|Adverse Event|0
1106326|NCT01829464|3624731|P1|Overall Study|Adverse Event|1
1106327|NCT01829243|3624756|P2|First Intervention|Screen Failure|2
1106328|NCT01829243|3624757|P1|First Intervention|Screen Failure|4
1106329|NCT01829230|3624771|P2|Overall Study|Lost to Follow-up|1
1106330|NCT01829230|3624772|P1|Overall Study|Lost to Follow-up|1
1106331|NCT01829230|3624771|P2|Overall Study|Withdrawal by Subject|1
1106332|NCT01829230|3624772|P1|Overall Study|Withdrawal by Subject|0
1106333|NCT01829230|3624771|P2|Overall Study|Protocol Violation|2
1106334|NCT01829230|3624772|P1|Overall Study|Protocol Violation|0
1106335|NCT01829191|3624786|P2|Overall Study|Subject was fit for ortho - k|1
1106336|NCT01829191|3624787|P1|Overall Study|Subject was fit for ortho - k|0
1106337|NCT01829191|3624786|P2|Overall Study|Lost to Follow-up|1
1106338|NCT01829191|3624787|P1|Overall Study|Lost to Follow-up|0
1106339|NCT01829191|3624786|P2|Overall Study|Withdrawal by Subject|3
1106340|NCT01829191|3624787|P1|Overall Study|Withdrawal by Subject|2
1106341|NCT01829191|3624786|P2|Overall Study|Protocol Violation|1
1106342|NCT01829191|3624787|P1|Overall Study|Protocol Violation|4
1106343|NCT01829191|3624786|P2|Overall Study|Lens handling difficulty|4
1106344|NCT01829191|3624787|P1|Overall Study|Lens handling difficulty|1
1106345|NCT01829191|3624786|P2|Overall Study|Lens discomfort|3
1106346|NCT01829191|3624787|P1|Overall Study|Lens discomfort|0
1106347|NCT01829191|3624786|P2|Overall Study|Relocation|1
1106348|NCT01829191|3624787|P1|Overall Study|Relocation|0
1106349|NCT01829165|3624796|P2|Overall Study|Did not complete intervention|0
1106350|NCT01829165|3624797|P1|Overall Study|Did not complete intervention|2
1106351|NCT01829113|3624805|P2|Overall Study|Physician Decision|1
1106352|NCT01829113|3624806|P1|Overall Study|Physician Decision|1
1106353|NCT01829113|3624805|P2|Overall Study|No Study Treatment Received|2
1106354|NCT01829113|3624806|P1|Overall Study|No Study Treatment Received|3
1106355|NCT01829113|3624805|P2|Overall Study|Sponsor Decision|1
1106356|NCT01829113|3624806|P1|Overall Study|Sponsor Decision|1
1106357|NCT01829113|3624805|P2|Overall Study|Death|6
1106358|NCT01829113|3624806|P1|Overall Study|Death|4
1106359|NCT01829113|3624805|P2|Overall Study|Withdrawal by Subject|10
1106360|NCT01829113|3624806|P1|Overall Study|Withdrawal by Subject|17
1106361|NCT01829113|3624805|P2|Overall Study|Adverse Event|10
1106362|NCT01829113|3624806|P1|Overall Study|Adverse Event|14
1106363|NCT01829113|3624805|P2|Overall Study|Disease Progression|48
1106364|NCT01829113|3624806|P1|Overall Study|Disease Progression|37
1106365|NCT01829048|3624823|P5|Overall Study|Withdrawal by Subject|0
1106366|NCT01829048|3624824|P4|Overall Study|Withdrawal by Subject|2
1106367|NCT01829048|3624825|P3|Overall Study|Withdrawal by Subject|0
1106368|NCT01829048|3624826|P2|Overall Study|Withdrawal by Subject|0
1106369|NCT01829048|3624827|P1|Overall Study|Withdrawal by Subject|0
1106370|NCT01828567|3624940|P2|Overall Study|Excluded - did not meet criteria|1
1106371|NCT01828567|3624941|P1|Overall Study|Excluded - did not meet criteria|4
1106372|NCT01828567|3624940|P2|Overall Study|Lost to Follow-up|9
1106373|NCT01828567|3624941|P1|Overall Study|Lost to Follow-up|27
1106374|NCT01828281|3624989|P2|Overall Study|Withdrawal by Subject|0
1106375|NCT01828281|3624990|P1|Overall Study|Withdrawal by Subject|1
1106376|NCT01828112|3625023|P2|Overall Study|Subject/guardian decision|8
1106377|NCT01828112|3625024|P1|Overall Study|Subject/guardian decision|6
1106378|NCT01828112|3625023|P2|Overall Study|Progressive disease|82
1106379|NCT01828112|3625024|P1|Overall Study|Progressive disease|56
1106380|NCT01828112|3625023|P2|Overall Study|Physician Decision|5
1106381|NCT01828112|3625024|P1|Overall Study|Physician Decision|5
1106382|NCT01828112|3625023|P2|Overall Study|Death|5
1106383|NCT01828112|3625024|P1|Overall Study|Death|9
1106384|NCT01828112|3625023|P2|Overall Study|Adverse Event|8
1106385|NCT01828112|3625024|P1|Overall Study|Adverse Event|6
1106386|NCT01828099|3625032|P2|Overall Study|Subject/guardian decision|23
1106387|NCT01828099|3625033|P1|Overall Study|Subject/guardian decision|7
1106388|NCT01828099|3625032|P2|Overall Study|Protocol Violation|0
1106389|NCT01828099|3625033|P1|Overall Study|Protocol Violation|1
1106390|NCT01828099|3625032|P2|Overall Study|Progressive disease|94
1106391|NCT01828099|3625033|P1|Overall Study|Progressive disease|51
1106392|NCT01828099|3625032|P2|Overall Study|Physician Decision|11
1106393|NCT01828099|3625033|P1|Overall Study|Physician Decision|7
1106394|NCT01828099|3625032|P2|Overall Study|Non-compliance with study treatment|0
1106395|NCT01828099|3625033|P1|Overall Study|Non-compliance with study treatment|2
1106396|NCT01828099|3625032|P2|Overall Study|Lost to Follow-up|0
1106397|NCT01828099|3625033|P1|Overall Study|Lost to Follow-up|2
1106398|NCT01828099|3625032|P2|Overall Study|Death|11
1106399|NCT01828099|3625033|P1|Overall Study|Death|9
1106400|NCT01828099|3625032|P2|Overall Study|Adverse Event|18
1106401|NCT01828099|3625033|P1|Overall Study|Adverse Event|15
1106402|NCT01827839|3625039|P1|Overall Study|Consent Withdrawal|2
1106403|NCT01827839|3625039|P1|Overall Study|Adverse Event|1
1106404|NCT01827670|3625063|P2|Overall Study|Lost to Follow-up|1
1106405|NCT01827670|3625064|P1|Overall Study|Lost to Follow-up|0
1106406|NCT01827670|3625063|P2|Overall Study|Withdrawal of Consent|2
1106407|NCT01827670|3625064|P1|Overall Study|Withdrawal of Consent|3
1106408|NCT01827592|3625083|P3|Overall Study|Others|3
1106409|NCT01827592|3625084|P2|Overall Study|Others|1
1106410|NCT01827592|3625085|P1|Overall Study|Others|0
1106411|NCT01827592|3625083|P3|Overall Study|Trial terminated by Sponsor|51
1106412|NCT01827592|3625084|P2|Overall Study|Trial terminated by Sponsor|53
1106413|NCT01827592|3625085|P1|Overall Study|Trial terminated by Sponsor|47
1106414|NCT01827592|3625083|P3|Overall Study|Patient's substantial non-compliance|6
1106415|NCT01827592|3625084|P2|Overall Study|Patient's substantial non-compliance|1
1106416|NCT01827592|3625085|P1|Overall Study|Patient's substantial non-compliance|1
1106417|NCT01827592|3625083|P3|Overall Study|Withdrawal by Subject|11
1106418|NCT01827592|3625084|P2|Overall Study|Withdrawal by Subject|11
1106419|NCT01827592|3625085|P1|Overall Study|Withdrawal by Subject|12
1106420|NCT01827592|3625083|P3|Overall Study|Lost to Follow-up|2
1106421|NCT01827592|3625084|P2|Overall Study|Lost to Follow-up|2
1106422|NCT01827592|3625085|P1|Overall Study|Lost to Follow-up|1
1106423|NCT01827592|3625083|P3|Overall Study|Protocol Violation|0
1106424|NCT01827592|3625084|P2|Overall Study|Protocol Violation|1
1106425|NCT01827592|3625085|P1|Overall Study|Protocol Violation|2
1106426|NCT01827592|3625083|P3|Overall Study|Physician Decision|1
1106427|NCT01827592|3625084|P2|Overall Study|Physician Decision|2
1106428|NCT01827592|3625085|P1|Overall Study|Physician Decision|0
1106429|NCT01827592|3625083|P3|Overall Study|Adverse Event|2
1106430|NCT01827592|3625084|P2|Overall Study|Adverse Event|9
1106431|NCT01827592|3625085|P1|Overall Study|Adverse Event|11
1106432|NCT01827371|3625150|P4|Overall Study|Temporary study halt to vaccinations|13
1106433|NCT01827371|3625151|P3|Overall Study|Temporary study halt to vaccinations|5
1106434|NCT01827371|3625152|P2|Overall Study|Temporary study halt to vaccinations|2
1106435|NCT01827371|3625153|P1|Overall Study|Temporary study halt to vaccinations|11
1106436|NCT01827371|3625150|P4|Overall Study|Physician Decision|1
1106437|NCT01827371|3625151|P3|Overall Study|Physician Decision|0
1106438|NCT01827371|3625152|P2|Overall Study|Physician Decision|1
1106439|NCT01827371|3625153|P1|Overall Study|Physician Decision|0
1106440|NCT01827371|3625150|P4|Overall Study|Withdrawal by Subject|3
1106441|NCT01827371|3625151|P3|Overall Study|Withdrawal by Subject|2
1106442|NCT01827371|3625152|P2|Overall Study|Withdrawal by Subject|2
1106443|NCT01827371|3625153|P1|Overall Study|Withdrawal by Subject|1
1106444|NCT01827371|3625150|P4|Overall Study|Protocol Violation|0
1106445|NCT01827371|3625151|P3|Overall Study|Protocol Violation|0
1106446|NCT01827371|3625152|P2|Overall Study|Protocol Violation|0
1106447|NCT01827371|3625153|P1|Overall Study|Protocol Violation|1
1106448|NCT01827371|3625150|P4|Overall Study|Lost to Follow-up|4
1106449|NCT01827371|3625151|P3|Overall Study|Lost to Follow-up|0
1106450|NCT01827371|3625152|P2|Overall Study|Lost to Follow-up|2
1106451|NCT01827371|3625153|P1|Overall Study|Lost to Follow-up|0
1106452|NCT01827371|3625150|P4|Overall Study|Adverse Event|2
1106453|NCT01827371|3625151|P3|Overall Study|Adverse Event|4
1106454|NCT01827371|3625152|P2|Overall Study|Adverse Event|0
1106455|NCT01827371|3625153|P1|Overall Study|Adverse Event|0
1106456|NCT01827332|3625212|P2|Overall Study|Lost to Follow-up|1
1106457|NCT01827332|3625213|P1|Overall Study|Lost to Follow-up|2
1106458|NCT01827319|3625221|P1|Overall Study|Lost to Follow-up|3
1106459|NCT01827267|3625244|P2|Overall Study|Still on study|2
1106460|NCT01827267|3625245|P1|Overall Study|Still on study|0
1106461|NCT01827267|3625244|P2|Overall Study|Sponsor Discontinued Study|8
1106462|NCT01827267|3625245|P1|Overall Study|Sponsor Discontinued Study|2
1106463|NCT01827267|3625244|P2|Overall Study|Disease Progression|1
1106464|NCT01827267|3625245|P1|Overall Study|Disease Progression|1
1106465|NCT01827267|3625244|P2|Overall Study|Physician Decision|0
1106466|NCT01827267|3625245|P1|Overall Study|Physician Decision|1
1106467|NCT01827267|3625244|P2|Overall Study|Did not receive study drug|1
1106468|NCT01827267|3625245|P1|Overall Study|Did not receive study drug|1
1106469|NCT01827254|3625260|P1|Overall Study|Intolerance to treatment|4
1106470|NCT01827254|3625260|P1|Overall Study|Disease progression|36
1106471|NCT01827254|3625260|P1|Overall Study|Did not complete re-challenge|1
1106472|NCT01827254|3625260|P1|Overall Study|Discontinued prior initiation: sunitinib|1
1106473|NCT01827254|3625260|P1|Overall Study|Invalidated centre|3
1106474|NCT01827254|3625260|P1|Overall Study|Case report form not completed|4
1106475|NCT01827254|3625260|P1|Overall Study|Death|10
1106476|NCT01826981|3625285|P15|Overall Study|Enrolled/Randomized but Not Treated|0
1106477|NCT01826981|3625286|P14|Overall Study|Enrolled/Randomized but Not Treated|0
1106478|NCT01826981|3625287|P13|Overall Study|Enrolled/Randomized but Not Treated|0
1106479|NCT01826981|3625288|P12|Overall Study|Enrolled/Randomized but Not Treated|0
1106480|NCT01826981|3625289|P11|Overall Study|Enrolled/Randomized but Not Treated|0
1106481|NCT01826981|3625290|P10|Overall Study|Enrolled/Randomized but Not Treated|0
1106482|NCT01826981|3625291|P9|Overall Study|Enrolled/Randomized but Not Treated|0
1106483|NCT01826981|3625292|P8|Overall Study|Enrolled/Randomized but Not Treated|1
1106484|NCT01826981|3625293|P7|Overall Study|Enrolled/Randomized but Not Treated|0
1106485|NCT01826981|3625294|P6|Overall Study|Enrolled/Randomized but Not Treated|0
1106486|NCT01826981|3625295|P5|Overall Study|Enrolled/Randomized but Not Treated|0
1106487|NCT01826981|3625296|P4|Overall Study|Enrolled/Randomized but Not Treated|0
1106488|NCT01826981|3625297|P3|Overall Study|Enrolled/Randomized but Not Treated|0
1106489|NCT01826981|3625298|P2|Overall Study|Enrolled/Randomized but Not Treated|0
1106490|NCT01826981|3625299|P1|Overall Study|Enrolled/Randomized but Not Treated|0
1106491|NCT01826981|3625285|P15|Overall Study|Upper G-I Haemorrhage|0
1106492|NCT01826981|3625286|P14|Overall Study|Upper G-I Haemorrhage|1
1106493|NCT01826981|3625287|P13|Overall Study|Upper G-I Haemorrhage|0
1106494|NCT01826981|3625288|P12|Overall Study|Upper G-I Haemorrhage|0
1106495|NCT01826981|3625289|P11|Overall Study|Upper G-I Haemorrhage|0
1106496|NCT01826981|3625290|P10|Overall Study|Upper G-I Haemorrhage|0
1106497|NCT01826981|3625291|P9|Overall Study|Upper G-I Haemorrhage|0
1106498|NCT01826981|3625292|P8|Overall Study|Upper G-I Haemorrhage|0
1106499|NCT01826981|3625293|P7|Overall Study|Upper G-I Haemorrhage|0
1106500|NCT01826981|3625294|P6|Overall Study|Upper G-I Haemorrhage|0
1106501|NCT01826981|3625295|P5|Overall Study|Upper G-I Haemorrhage|0
1106502|NCT01826981|3625296|P4|Overall Study|Upper G-I Haemorrhage|0
1106503|NCT01826981|3625297|P3|Overall Study|Upper G-I Haemorrhage|0
1106504|NCT01826981|3625298|P2|Overall Study|Upper G-I Haemorrhage|0
1106505|NCT01826981|3625299|P1|Overall Study|Upper G-I Haemorrhage|0
1106506|NCT01826981|3625285|P15|Overall Study|Adverse Event|0
1106507|NCT01826981|3625286|P14|Overall Study|Adverse Event|0
1106508|NCT01826981|3625287|P13|Overall Study|Adverse Event|0
1106509|NCT01826981|3625288|P12|Overall Study|Adverse Event|0
1106510|NCT01826981|3625289|P11|Overall Study|Adverse Event|0
1106511|NCT01826981|3625290|P10|Overall Study|Adverse Event|0
1106512|NCT01826981|3625291|P9|Overall Study|Adverse Event|0
1106513|NCT01826981|3625292|P8|Overall Study|Adverse Event|0
1106514|NCT01826981|3625293|P7|Overall Study|Adverse Event|0
1106515|NCT01826981|3625294|P6|Overall Study|Adverse Event|0
1106516|NCT01826981|3625295|P5|Overall Study|Adverse Event|1
1106517|NCT01826981|3625296|P4|Overall Study|Adverse Event|0
1106518|NCT01826981|3625297|P3|Overall Study|Adverse Event|0
1106519|NCT01826981|3625298|P2|Overall Study|Adverse Event|0
1106520|NCT01826981|3625299|P1|Overall Study|Adverse Event|0
1106521|NCT01826981|3625285|P15|Overall Study|Withdrew Consent|0
1106522|NCT01826981|3625286|P14|Overall Study|Withdrew Consent|1
1106523|NCT01826981|3625287|P13|Overall Study|Withdrew Consent|0
1106524|NCT01826981|3625288|P12|Overall Study|Withdrew Consent|1
1106525|NCT01826981|3625289|P11|Overall Study|Withdrew Consent|0
1106526|NCT01826981|3625290|P10|Overall Study|Withdrew Consent|0
1106527|NCT01826981|3625291|P9|Overall Study|Withdrew Consent|0
1106528|NCT01826981|3625292|P8|Overall Study|Withdrew Consent|1
1106529|NCT01826981|3625293|P7|Overall Study|Withdrew Consent|1
1106530|NCT01826981|3625294|P6|Overall Study|Withdrew Consent|0
1106531|NCT01826981|3625295|P5|Overall Study|Withdrew Consent|0
1106532|NCT01826981|3625296|P4|Overall Study|Withdrew Consent|0
1106533|NCT01826981|3625297|P3|Overall Study|Withdrew Consent|0
1106534|NCT01826981|3625298|P2|Overall Study|Withdrew Consent|0
1106535|NCT01826981|3625299|P1|Overall Study|Withdrew Consent|0
1106536|NCT01826981|3625285|P15|Overall Study|Lost to Follow-up|0
1106537|NCT01826981|3625286|P14|Overall Study|Lost to Follow-up|0
1106538|NCT01826981|3625287|P13|Overall Study|Lost to Follow-up|1
1106539|NCT01826981|3625288|P12|Overall Study|Lost to Follow-up|1
1106540|NCT01826981|3625289|P11|Overall Study|Lost to Follow-up|1
1106541|NCT01826981|3625290|P10|Overall Study|Lost to Follow-up|1
1106542|NCT01826981|3625291|P9|Overall Study|Lost to Follow-up|0
1106543|NCT01826981|3625292|P8|Overall Study|Lost to Follow-up|1
1106544|NCT01826981|3625293|P7|Overall Study|Lost to Follow-up|0
1106545|NCT01826981|3625294|P6|Overall Study|Lost to Follow-up|1
1106546|NCT01826981|3625295|P5|Overall Study|Lost to Follow-up|1
1106547|NCT01826981|3625296|P4|Overall Study|Lost to Follow-up|0
1106548|NCT01826981|3625297|P3|Overall Study|Lost to Follow-up|0
1106549|NCT01826981|3625298|P2|Overall Study|Lost to Follow-up|0
1106550|NCT01826981|3625299|P1|Overall Study|Lost to Follow-up|0
1106551|NCT01826981|3625285|P15|Overall Study|Lack of Efficacy|0
1106552|NCT01826981|3625286|P14|Overall Study|Lack of Efficacy|3
1106553|NCT01826981|3625287|P13|Overall Study|Lack of Efficacy|0
1106554|NCT01826981|3625288|P12|Overall Study|Lack of Efficacy|0
1106555|NCT01826981|3625289|P11|Overall Study|Lack of Efficacy|1
1106556|NCT01826981|3625290|P10|Overall Study|Lack of Efficacy|0
1106557|NCT01826981|3625291|P9|Overall Study|Lack of Efficacy|7
1106558|NCT01826981|3625292|P8|Overall Study|Lack of Efficacy|8
1106559|NCT01826981|3625293|P7|Overall Study|Lack of Efficacy|0
1106560|NCT01826981|3625294|P6|Overall Study|Lack of Efficacy|0
1106561|NCT01826981|3625295|P5|Overall Study|Lack of Efficacy|5
1106562|NCT01826981|3625296|P4|Overall Study|Lack of Efficacy|0
1106563|NCT01826981|3625297|P3|Overall Study|Lack of Efficacy|0
1106564|NCT01826981|3625298|P2|Overall Study|Lack of Efficacy|1
1106565|NCT01826981|3625299|P1|Overall Study|Lack of Efficacy|0
1106566|NCT01826604|3625485|P2|Overall Study|Lost to Follow-up|9
1106567|NCT01826604|3625486|P1|Overall Study|Lost to Follow-up|8
1106568|NCT01826422|3625530|P2|Overall Study|Withdrawal by Subject|3
1106569|NCT01826422|3625531|P1|Overall Study|Withdrawal by Subject|1
1106570|NCT01826370|3625575|P1|Overall Study|Other reason not defined above|2
1106571|NCT01826370|3625575|P1|Overall Study|Lost to Follow-up|12
1106572|NCT01826370|3625575|P1|Overall Study|Protocol Violation|6
1106573|NCT01826214|3625587|P2|Overall Study|Subject/guardian decision|3
1106574|NCT01826214|3625588|P1|Overall Study|Subject/guardian decision|2
1106575|NCT01826214|3625587|P2|Overall Study|Study terminated by Sponsor|1
1106576|NCT01826214|3625588|P1|Overall Study|Study terminated by Sponsor|0
1106577|NCT01826214|3625587|P2|Overall Study|Progressive disease|21
1106578|NCT01826214|3625588|P1|Overall Study|Progressive disease|22
1106579|NCT01826214|3625587|P2|Overall Study|Physician Decision|2
1106580|NCT01826214|3625588|P1|Overall Study|Physician Decision|0
1106581|NCT01826214|3625587|P2|Overall Study|Lost to Follow-up|0
1106582|NCT01826214|3625588|P1|Overall Study|Lost to Follow-up|1
1106583|NCT01826214|3625587|P2|Overall Study|Death|1
1106584|NCT01826214|3625588|P1|Overall Study|Death|3
1106585|NCT01826214|3625587|P2|Overall Study|Adverse Event|6
1106586|NCT01826214|3625588|P1|Overall Study|Adverse Event|7
1106587|NCT01826201|3625606|P1|Overall Study|Non compliance with protocol|4
1106588|NCT01825941|3625614|P2|Overall Study|Lost to Follow-up|1
1106589|NCT01825941|3625615|P1|Overall Study|Lost to Follow-up|4
1106590|NCT01825876|3625634|P2|Period 2|Withdrawal by Subject|1
1106591|NCT01825876|3625635|P1|Period 2|Withdrawal by Subject|0
1106592|NCT01825837|3625656|P4|PART II|reason unspecified|0
1106593|NCT01825837|3625657|P3|PART II|reason unspecified|2
1106594|NCT01825837|3625658|P2|PART II|reason unspecified|2
1106595|NCT01825837|3625659|P1|PART II|reason unspecified|2
1106596|NCT01825837|3625656|P4|PART II|Treatment failure|0
1106597|NCT01825837|3625657|P3|PART II|Treatment failure|5
1106598|NCT01825837|3625658|P2|PART II|Treatment failure|4
1106599|NCT01825837|3625659|P1|PART II|Treatment failure|6
1106600|NCT01825837|3625656|P4|PART II|Adverse Event|0
1106601|NCT01825837|3625657|P3|PART II|Adverse Event|1
1106602|NCT01825837|3625658|P2|PART II|Adverse Event|3
1106603|NCT01825837|3625659|P1|PART II|Adverse Event|3
1106604|NCT01825837|3625656|P4|PART II|Patient non-compliance|0
1106605|NCT01825837|3625657|P3|PART II|Patient non-compliance|4
1106606|NCT01825837|3625658|P2|PART II|Patient non-compliance|2
1106607|NCT01825837|3625659|P1|PART II|Patient non-compliance|5
1106608|NCT01825837|3625656|P4|PART II|Withdrawal by Subject|0
1106609|NCT01825837|3625657|P3|PART II|Withdrawal by Subject|7
1106610|NCT01825837|3625658|P2|PART II|Withdrawal by Subject|3
1106611|NCT01825837|3625659|P1|PART II|Withdrawal by Subject|3
1106612|NCT01825837|3625656|P4|PART I|reason unspecified|3
1106613|NCT01825837|3625657|P3|PART I|reason unspecified|0
1106614|NCT01825837|3625658|P2|PART I|reason unspecified|0
1106615|NCT01825837|3625659|P1|PART I|reason unspecified|0
1106616|NCT01825837|3625656|P4|PART I|Treatment failure|7
1106617|NCT01825837|3625657|P3|PART I|Treatment failure|0
1106618|NCT01825837|3625658|P2|PART I|Treatment failure|0
1106619|NCT01825837|3625659|P1|PART I|Treatment failure|0
1106620|NCT01825837|3625656|P4|PART I|Patient non-compliance|1
1106621|NCT01825837|3625657|P3|PART I|Patient non-compliance|0
1106622|NCT01825837|3625658|P2|PART I|Patient non-compliance|0
1106623|NCT01825837|3625659|P1|PART I|Patient non-compliance|0
1106624|NCT01825837|3625656|P4|PART I|Withdrawal by Subject|6
1106625|NCT01825837|3625657|P3|PART I|Withdrawal by Subject|0
1106626|NCT01825837|3625658|P2|PART I|Withdrawal by Subject|0
1106627|NCT01825837|3625659|P1|PART I|Withdrawal by Subject|0
1106628|NCT01825798|3625669|P2|Overall Study|Lost to Follow-up|0
1106629|NCT01825798|3625670|P1|Overall Study|Lost to Follow-up|1
1106630|NCT01825798|3625669|P2|Overall Study|Adverse Event|5
1106631|NCT01825798|3625670|P1|Overall Study|Adverse Event|1
1106632|NCT01825577|3625707|P1|Overall Study|Lack of Efficacy|3
1106633|NCT01825577|3625707|P1|Overall Study|Withdrawn by family members|2
1106634|NCT01825577|3625707|P1|Overall Study|Withdrawal by Subject|1
1106635|NCT01825577|3625707|P1|Overall Study|Physician Decision|2
1106636|NCT01825200|3625731|P2|Overall Study|Withdrawal by Subject|1
1106637|NCT01825200|3625732|P1|Overall Study|Withdrawal by Subject|0
1106638|NCT01825200|3625731|P2|Overall Study|Lost to Follow-up|6
1106639|NCT01825200|3625732|P1|Overall Study|Lost to Follow-up|5
1106640|NCT01824979|3625755|P2|Overall Study|Protocol Violation|13
1106641|NCT01824979|3625756|P1|Overall Study|Protocol Violation|6
1106642|NCT01824979|3625755|P2|Overall Study|Physician Decision|0
1106643|NCT01824979|3625756|P1|Overall Study|Physician Decision|2
1106644|NCT01824979|3625755|P2|Overall Study|Withdrawal by Subject|0
1106645|NCT01824979|3625756|P1|Overall Study|Withdrawal by Subject|5
1106646|NCT01824823|3625773|P2|Overall Study|Off-treatment reason not submitted|0
1106647|NCT01824823|3625774|P1|Overall Study|Off-treatment reason not submitted|1
1106648|NCT01824823|3625773|P2|Overall Study|Lack of Efficacy|1
1106649|NCT01824823|3625774|P1|Overall Study|Lack of Efficacy|1
1106650|NCT01824693|3625783|P3|Overall Study|No Transplant Planned|10
1106651|NCT01824693|3625784|P2|Overall Study|No Transplant Planned|0
1106652|NCT01824693|3625785|P1|Overall Study|No Transplant Planned|0
1106653|NCT01824693|3625783|P3|Overall Study|Ineligible|3
1106654|NCT01824693|3625784|P2|Overall Study|Ineligible|0
1106655|NCT01824693|3625785|P1|Overall Study|Ineligible|0
1106656|NCT01824693|3625783|P3|Overall Study|Progressive Disease|0
1106657|NCT01824693|3625784|P2|Overall Study|Progressive Disease|5
1106658|NCT01824693|3625785|P1|Overall Study|Progressive Disease|0
1106659|NCT01824693|3625783|P3|Overall Study|Withdrawal by Subject|1
1106660|NCT01824693|3625784|P2|Overall Study|Withdrawal by Subject|0
1106661|NCT01824693|3625785|P1|Overall Study|Withdrawal by Subject|0
1106662|NCT01824693|3625783|P3|Overall Study|Physician Decision|1
1106663|NCT01824693|3625784|P2|Overall Study|Physician Decision|1
1106664|NCT01824693|3625785|P1|Overall Study|Physician Decision|1
1106665|NCT01824693|3625783|P3|Overall Study|Death|0
1106666|NCT01824693|3625784|P2|Overall Study|Death|1
1106667|NCT01824693|3625785|P1|Overall Study|Death|0
1106668|NCT01824602|3625802|P4|Overall Study|Treatment failure|1
1106669|NCT01824602|3625803|P3|Overall Study|Treatment failure|0
1106670|NCT01824602|3625804|P2|Overall Study|Treatment failure|0
1106671|NCT01824602|3625805|P1|Overall Study|Treatment failure|0
1106672|NCT01824602|3625802|P4|Overall Study|Adverse Event|2
1106673|NCT01824602|3625803|P3|Overall Study|Adverse Event|2
1106674|NCT01824602|3625804|P2|Overall Study|Adverse Event|0
1106675|NCT01824602|3625805|P1|Overall Study|Adverse Event|1
1106676|NCT01824602|3625802|P4|Overall Study|Patient non-compliance|0
1106677|NCT01824602|3625803|P3|Overall Study|Patient non-compliance|1
1106678|NCT01824602|3625804|P2|Overall Study|Patient non-compliance|0
1106679|NCT01824602|3625805|P1|Overall Study|Patient non-compliance|0
1106680|NCT01824602|3625802|P4|Overall Study|Withdrawal by Subject|2
1106681|NCT01824602|3625803|P3|Overall Study|Withdrawal by Subject|1
1106682|NCT01824602|3625804|P2|Overall Study|Withdrawal by Subject|0
1106683|NCT01824602|3625805|P1|Overall Study|Withdrawal by Subject|0
1106684|NCT01824576|3625844|P1|Overall Study|Device deficiency|2
1106685|NCT01824498|3625862|P6|Washout (8 Weeks)|Withdrawal by Subject|0
1106686|NCT01824498|3625863|P5|Washout (8 Weeks)|Withdrawal by Subject|1
1106687|NCT01824498|3625864|P4|Washout (8 Weeks)|Withdrawal by Subject|1
1106688|NCT01824498|3625865|P3|Washout (8 Weeks)|Withdrawal by Subject|2
1106689|NCT01824498|3625866|P2|Washout (8 Weeks)|Withdrawal by Subject|0
1106690|NCT01824498|3625867|P1|Washout (8 Weeks)|Withdrawal by Subject|2
1106691|NCT01824394|3625901|P3|Overall Study|Excluded Subjects(No catheter inserted)|21
1106692|NCT01824394|3625902|P2|Overall Study|Excluded Subjects(No catheter inserted)|20
1106693|NCT01824394|3625903|P1|Overall Study|Excluded Subjects(No catheter inserted)|23
1106694|NCT01824394|3625901|P3|Overall Study|Discontinued Subjects|2
1106695|NCT01824394|3625902|P2|Overall Study|Discontinued Subjects|1
1106696|NCT01824394|3625903|P1|Overall Study|Discontinued Subjects|1
1106697|NCT01824394|3625901|P3|Overall Study|Death|4
1106698|NCT01824394|3625902|P2|Overall Study|Death|2
1106699|NCT01824394|3625903|P1|Overall Study|Death|3
1106700|NCT01824394|3625901|P3|Overall Study|Lost to Follow-up|3
1106701|NCT01824394|3625902|P2|Overall Study|Lost to Follow-up|9
1106702|NCT01824394|3625903|P1|Overall Study|Lost to Follow-up|0
1106703|NCT01824394|3625901|P3|Overall Study|Withdrawn due to Study Termination|41
1106704|NCT01824394|3625902|P2|Overall Study|Withdrawn due to Study Termination|83
1106705|NCT01824394|3625903|P1|Overall Study|Withdrawn due to Study Termination|91
1106706|NCT01824394|3625901|P3|Overall Study|Early Termination|3
1106707|NCT01824394|3625902|P2|Overall Study|Early Termination|1
1106708|NCT01824394|3625903|P1|Overall Study|Early Termination|1
1106709|NCT01824355|3625913|P1|Overall Study|unevaluable reference method results per|1
1106710|NCT01824355|3625913|P1|Overall Study|Adverse Event|2
1106711|NCT01824342|3625924|P2|Overall Study|Death|0
1106712|NCT01824342|3625925|P1|Overall Study|Death|2
1106713|NCT01824342|3625924|P2|Overall Study|Physician Decision|0
1106714|NCT01824342|3625925|P1|Overall Study|Physician Decision|5
1106715|NCT01824342|3625924|P2|Overall Study|Disease Progression|1
1106716|NCT01824342|3625925|P1|Overall Study|Disease Progression|1
1106717|NCT01824342|3625924|P2|Overall Study|Adverse Event|1
1106718|NCT01824342|3625925|P1|Overall Study|Adverse Event|1
1106719|NCT01824342|3625924|P2|Overall Study|Withdrawal by Subject|3
1106720|NCT01824342|3625925|P1|Overall Study|Withdrawal by Subject|0
1106721|NCT01824303|3625939|P2|Randomized Study|Other Miscellaneous Reasons|0
1106722|NCT01824303|3625940|P1|Randomized Study|Other Miscellaneous Reasons|1
1106723|NCT01824303|3625939|P2|Randomized Study|Withdrawal by Subject|1
1106724|NCT01824303|3625940|P1|Randomized Study|Withdrawal by Subject|1
1106725|NCT01823679|3625968|P1|Overall Study|Death|1
1106726|NCT01823536|3626021|P6|Overall Study|Subject moved out of the state|0
1106727|NCT01823536|3626022|P5|Overall Study|Subject moved out of the state|1
1106728|NCT01823536|3626023|P4|Overall Study|Subject moved out of the state|0
1106729|NCT01823536|3626024|P3|Overall Study|Subject moved out of the state|0
1106730|NCT01823536|3626025|P2|Overall Study|Subject moved out of the state|0
1106731|NCT01823536|3626026|P1|Overall Study|Subject moved out of the state|0
1106732|NCT01823536|3626021|P6|Overall Study|Met exclusion criterion No 6|0
1106733|NCT01823536|3626022|P5|Overall Study|Met exclusion criterion No 6|0
1106734|NCT01823536|3626023|P4|Overall Study|Met exclusion criterion No 6|1
1106735|NCT01823536|3626024|P3|Overall Study|Met exclusion criterion No 6|0
1106736|NCT01823536|3626025|P2|Overall Study|Met exclusion criterion No 6|0
1106737|NCT01823536|3626026|P1|Overall Study|Met exclusion criterion No 6|0
1106738|NCT01823536|3626021|P6|Overall Study|Visit 1 delayed, unable to reschedule|0
1106739|NCT01823536|3626022|P5|Overall Study|Visit 1 delayed, unable to reschedule|0
1106740|NCT01823536|3626023|P4|Overall Study|Visit 1 delayed, unable to reschedule|0
1106741|NCT01823536|3626024|P3|Overall Study|Visit 1 delayed, unable to reschedule|1
1106742|NCT01823536|3626025|P2|Overall Study|Visit 1 delayed, unable to reschedule|0
1106743|NCT01823536|3626026|P1|Overall Study|Visit 1 delayed, unable to reschedule|0
1106744|NCT01823536|3626021|P6|Overall Study|Withdrawal by Subject|0
1106745|NCT01823536|3626022|P5|Overall Study|Withdrawal by Subject|0
1106746|NCT01823536|3626023|P4|Overall Study|Withdrawal by Subject|0
1106747|NCT01823536|3626024|P3|Overall Study|Withdrawal by Subject|0
1106748|NCT01823536|3626025|P2|Overall Study|Withdrawal by Subject|1
1106749|NCT01823536|3626026|P1|Overall Study|Withdrawal by Subject|1
1106750|NCT01823536|3626021|P6|Overall Study|Protocol Violation|0
1106751|NCT01823536|3626022|P5|Overall Study|Protocol Violation|0
1106752|NCT01823536|3626023|P4|Overall Study|Protocol Violation|0
1106753|NCT01823536|3626024|P3|Overall Study|Protocol Violation|0
1106754|NCT01823536|3626025|P2|Overall Study|Protocol Violation|1
1106755|NCT01823536|3626026|P1|Overall Study|Protocol Violation|0
1106756|NCT01823536|3626021|P6|Overall Study|Lost to Follow-up|0
1106757|NCT01823536|3626022|P5|Overall Study|Lost to Follow-up|1
1106758|NCT01823536|3626023|P4|Overall Study|Lost to Follow-up|1
1106759|NCT01823536|3626024|P3|Overall Study|Lost to Follow-up|0
1106760|NCT01823536|3626025|P2|Overall Study|Lost to Follow-up|0
1106761|NCT01823536|3626026|P1|Overall Study|Lost to Follow-up|1
1106762|NCT01823341|3626077|P1|Overall Study|Adverse Event|1
1106763|NCT01823341|3626077|P1|Overall Study|Withdrawal by Subject|7
1106764|NCT01823341|3626077|P1|Overall Study|Failed run-in|7
1106765|NCT01823289|3626120|P1|Overall Study|Creatinine clearance<30milliliter/minute|1
1106766|NCT01823289|3626120|P1|Overall Study|Drug affected efficacy and safety|1
1106767|NCT01823289|3626120|P1|Overall Study|Transaminase increased more than 3 times|1
1106768|NCT01823289|3626120|P1|Overall Study|Administered contraindicated medicine|1
1106769|NCT01823289|3626120|P1|Overall Study|Physician Decision|9
1106770|NCT01823289|3626120|P1|Overall Study|Lack of Efficacy|1
1106771|NCT01823289|3626120|P1|Overall Study|Adverse Event|5
1106772|NCT01823289|3626120|P1|Overall Study|Lost to Follow-up|5
1106773|NCT01823224|3626128|P2|Overall Study|Withdrawal by Subject|1
1106774|NCT01823224|3626129|P1|Overall Study|Withdrawal by Subject|0
1106775|NCT01823224|3626128|P2|Overall Study|missed med dose|1
1106776|NCT01823224|3626129|P1|Overall Study|missed med dose|0
1106777|NCT01823224|3626128|P2|Overall Study|pharmacy error|1
1106778|NCT01823224|3626129|P1|Overall Study|pharmacy error|0
1106779|NCT01823224|3626128|P2|Overall Study|didn't qualify|2
1106780|NCT01823224|3626129|P1|Overall Study|didn't qualify|1
1106781|NCT01823224|3626128|P2|Overall Study|Lost to Follow-up|6
1106782|NCT01823224|3626129|P1|Overall Study|Lost to Follow-up|5
1106783|NCT01823146|3626139|P2|Overall Study|Lost to Follow-up|1
1106784|NCT01823146|3626140|P1|Overall Study|Lost to Follow-up|2
1106785|NCT01823146|3626139|P2|Overall Study|Withdrawal by Subject|1
1106786|NCT01823146|3626140|P1|Overall Study|Withdrawal by Subject|0
1106787|NCT01822899|3626152|P2|Overall Study|Withdrawal by Subject|7
1106788|NCT01822899|3626153|P1|Overall Study|Withdrawal by Subject|5
1106789|NCT01822899|3626152|P2|Overall Study|Lost to Follow-up|0
1106790|NCT01822899|3626153|P1|Overall Study|Lost to Follow-up|1
1106791|NCT01822899|3626152|P2|Overall Study|Protocol Violation|3
1106792|NCT01822899|3626153|P1|Overall Study|Protocol Violation|6
1106793|NCT01822899|3626152|P2|Overall Study|Lack of Efficacy|3
1106794|NCT01822899|3626153|P1|Overall Study|Lack of Efficacy|6
1106795|NCT01822899|3626152|P2|Overall Study|Adverse Event|5
1106796|NCT01822899|3626153|P1|Overall Study|Adverse Event|6
1106797|NCT01822821|3626163|P2|Overall Study|Other reasons|0
1106798|NCT01822821|3626164|P1|Overall Study|Other reasons|1
1106799|NCT01822821|3626163|P2|Overall Study|Eligible surgery cancelled|1
1106800|NCT01822821|3626164|P1|Overall Study|Eligible surgery cancelled|1
1106801|NCT01822756|3626193|P5|Overall Study|disease progression & patient preference|0
1106802|NCT01822756|3626194|P4|Overall Study|disease progression & patient preference|0
1106803|NCT01822756|3626195|P3|Overall Study|disease progression & patient preference|1
1106804|NCT01822756|3626196|P2|Overall Study|disease progression & patient preference|0
1106805|NCT01822756|3626197|P1|Overall Study|disease progression & patient preference|2
1106806|NCT01822756|3626193|P5|Overall Study|Physician Decision|0
1106807|NCT01822756|3626194|P4|Overall Study|Physician Decision|0
1106808|NCT01822756|3626195|P3|Overall Study|Physician Decision|0
1106809|NCT01822756|3626196|P2|Overall Study|Physician Decision|1
1106810|NCT01822756|3626197|P1|Overall Study|Physician Decision|0
1106811|NCT01822756|3626193|P5|Overall Study|Lost to Follow-up|1
1106812|NCT01822756|3626194|P4|Overall Study|Lost to Follow-up|0
1106813|NCT01822756|3626195|P3|Overall Study|Lost to Follow-up|1
1106814|NCT01822756|3626196|P2|Overall Study|Lost to Follow-up|0
1106815|NCT01822756|3626197|P1|Overall Study|Lost to Follow-up|1
1106816|NCT01822756|3626193|P5|Overall Study|Death|0
1106817|NCT01822756|3626194|P4|Overall Study|Death|0
1106818|NCT01822756|3626195|P3|Overall Study|Death|1
1106819|NCT01822756|3626196|P2|Overall Study|Death|2
1106820|NCT01822756|3626197|P1|Overall Study|Death|2
1106821|NCT01822756|3626193|P5|Overall Study|Disease progression|6
1106822|NCT01822756|3626194|P4|Overall Study|Disease progression|2
1106823|NCT01822756|3626195|P3|Overall Study|Disease progression|7
1106824|NCT01822756|3626196|P2|Overall Study|Disease progression|1
1106825|NCT01822756|3626197|P1|Overall Study|Disease progression|11
1106826|NCT01822756|3626193|P5|Overall Study|Adverse Event|0
1106827|NCT01822756|3626194|P4|Overall Study|Adverse Event|2
1106828|NCT01822756|3626195|P3|Overall Study|Adverse Event|0
1106829|NCT01822756|3626196|P2|Overall Study|Adverse Event|0
1106830|NCT01822756|3626197|P1|Overall Study|Adverse Event|0
1106831|NCT01822691|3626239|P1|Overall Study|Withdrawal by Subject|2
1106832|NCT01822678|3626250|P3|Overall Study|Lost to Follow-up|1
1106833|NCT01822678|3626251|P2|Overall Study|Lost to Follow-up|2
1106834|NCT01822678|3626252|P1|Overall Study|Lost to Follow-up|0
1106835|NCT01822678|3626250|P3|Overall Study|Lack of Efficacy|5
1106836|NCT01822678|3626251|P2|Overall Study|Lack of Efficacy|6
1106837|NCT01822678|3626252|P1|Overall Study|Lack of Efficacy|3
1106838|NCT01822678|3626250|P3|Overall Study|Adverse Event|1
1106839|NCT01822678|3626251|P2|Overall Study|Adverse Event|3
1106840|NCT01822678|3626252|P1|Overall Study|Adverse Event|4
1106841|NCT01822678|3626250|P3|Overall Study|Withdrawal by Subject|4
1106842|NCT01822678|3626251|P2|Overall Study|Withdrawal by Subject|4
1106843|NCT01822678|3626252|P1|Overall Study|Withdrawal by Subject|5
1106844|NCT01822665|3626260|P1|Overall Study|Other Reason|5
1106845|NCT01822665|3626260|P1|Overall Study|Adverse Event|3
1106846|NCT01822561|3626303|P1|Overall Study|Withdrawal by Subject|2
1106847|NCT01822535|3626324|P2|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0
1106848|NCT01822535|3626325|P1|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1
1106849|NCT01822535|3626324|P2|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2
1106850|NCT01822535|3626325|P1|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4
1106851|NCT01822535|3626324|P2|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0
1106852|NCT01822535|3626325|P1|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2
1106853|NCT01822223|3626349|P2|Overall Study|Death|1
1106854|NCT01822223|3626350|P1|Overall Study|Death|0
1106855|NCT01821963|3626395|P1|Overall Study|Adverse Event|1
1106856|NCT01821937|3626401|P2|Overall Study|Adverse Event|3
1106857|NCT01821937|3626402|P1|Overall Study|Adverse Event|0
1106858|NCT01821807|3626426|P2|Overall Study|Lost to Follow-up|1
1106859|NCT01821807|3626427|P1|Overall Study|Lost to Follow-up|3
1106860|NCT01821560|3626437|P2|Overall Study|Protocol Violation|1
1106861|NCT01821560|3626438|P1|Overall Study|Protocol Violation|0
1106862|NCT01821560|3626437|P2|Overall Study|Withdrawal by Subject|1
1106863|NCT01821560|3626438|P1|Overall Study|Withdrawal by Subject|1
1106864|NCT01821560|3626437|P2|Overall Study|Lost to Follow-up|5
1106865|NCT01821560|3626438|P1|Overall Study|Lost to Follow-up|5
1106866|NCT01821118|3626524|P2|Overall Study|Death|1
1106867|NCT01821118|3626525|P1|Overall Study|Death|0
1106868|NCT01820585|3626576|P4|Overall Study|Pregnancy|0
1106869|NCT01820585|3626577|P3|Overall Study|Pregnancy|0
1106870|NCT01820585|3626578|P2|Overall Study|Pregnancy|1
1106871|NCT01820585|3626579|P1|Overall Study|Pregnancy|0
1106872|NCT01820585|3626576|P4|Overall Study|at sponsor request|0
1106873|NCT01820585|3626577|P3|Overall Study|at sponsor request|1
1106874|NCT01820585|3626578|P2|Overall Study|at sponsor request|0
1106875|NCT01820585|3626579|P1|Overall Study|at sponsor request|0
1106876|NCT01820585|3626576|P4|Overall Study|Subject non-compliance|2
1106877|NCT01820585|3626577|P3|Overall Study|Subject non-compliance|1
1106878|NCT01820585|3626578|P2|Overall Study|Subject non-compliance|0
1106879|NCT01820585|3626579|P1|Overall Study|Subject non-compliance|0
1106880|NCT01820585|3626576|P4|Overall Study|Protocol Violation|1
1106881|NCT01820585|3626577|P3|Overall Study|Protocol Violation|1
1106882|NCT01820585|3626578|P2|Overall Study|Protocol Violation|1
1106883|NCT01820585|3626579|P1|Overall Study|Protocol Violation|3
1106884|NCT01820585|3626576|P4|Overall Study|Lost to Follow-up|3
1106885|NCT01820585|3626577|P3|Overall Study|Lost to Follow-up|0
1106886|NCT01820585|3626578|P2|Overall Study|Lost to Follow-up|3
1106887|NCT01820585|3626579|P1|Overall Study|Lost to Follow-up|3
1106888|NCT01820585|3626576|P4|Overall Study|Withdrawal by Subject|8
1106889|NCT01820585|3626577|P3|Overall Study|Withdrawal by Subject|3
1106890|NCT01820585|3626578|P2|Overall Study|Withdrawal by Subject|7
1106891|NCT01820585|3626579|P1|Overall Study|Withdrawal by Subject|3
1106892|NCT01820585|3626576|P4|Overall Study|Lack of Efficacy|1
1106893|NCT01820585|3626577|P3|Overall Study|Lack of Efficacy|5
1106894|NCT01820585|3626578|P2|Overall Study|Lack of Efficacy|7
1106895|NCT01820585|3626579|P1|Overall Study|Lack of Efficacy|9
1106896|NCT01820585|3626576|P4|Overall Study|Adverse Event|34
1106897|NCT01820585|3626577|P3|Overall Study|Adverse Event|23
1106898|NCT01820585|3626578|P2|Overall Study|Adverse Event|13
1106899|NCT01820585|3626579|P1|Overall Study|Adverse Event|9
1106900|NCT01820559|3626592|P3|Overall Study|Lack of Efficacy|3
1106901|NCT01820559|3626593|P2|Overall Study|Lack of Efficacy|2
1106902|NCT01820559|3626594|P1|Overall Study|Lack of Efficacy|3
1106903|NCT01820559|3626592|P3|Overall Study|At sponsor request|1
1106904|NCT01820559|3626593|P2|Overall Study|At sponsor request|0
1106905|NCT01820559|3626594|P1|Overall Study|At sponsor request|0
1106906|NCT01820559|3626592|P3|Overall Study|Lost to Follow-up|2
1106907|NCT01820559|3626593|P2|Overall Study|Lost to Follow-up|2
1106908|NCT01820559|3626594|P1|Overall Study|Lost to Follow-up|3
1106909|NCT01820559|3626592|P3|Overall Study|Subject's non-compliance|2
1106910|NCT01820559|3626593|P2|Overall Study|Subject's non-compliance|0
1106911|NCT01820559|3626594|P1|Overall Study|Subject's non-compliance|1
1106912|NCT01820559|3626592|P3|Overall Study|Protocol Violation|3
1106913|NCT01820559|3626593|P2|Overall Study|Protocol Violation|1
1106914|NCT01820559|3626594|P1|Overall Study|Protocol Violation|2
1106915|NCT01820559|3626592|P3|Overall Study|Withdrawal by Subject|5
1106916|NCT01820559|3626593|P2|Overall Study|Withdrawal by Subject|2
1106917|NCT01820559|3626594|P1|Overall Study|Withdrawal by Subject|1
1106918|NCT01820559|3626592|P3|Overall Study|Adverse Event|13
1106919|NCT01820559|3626593|P2|Overall Study|Adverse Event|6
1106920|NCT01820559|3626594|P1|Overall Study|Adverse Event|4
1106921|NCT01820364|3626615|P2|Part II: LGX818 + MEK162|Study Termination|1
1106922|NCT01820364|3626616|P1|Part II: LGX818 + MEK162|Study Termination|0
1106923|NCT01820364|3626615|P2|Part I: LGX818|Disease Progression|0
1106924|NCT01820364|3626616|P1|Part I: LGX818|Disease Progression|4
1106925|NCT01820364|3626615|P2|Part I: LGX818|Adverse Event|0
1106926|NCT01820364|3626616|P1|Part I: LGX818|Adverse Event|6
1106927|NCT01820364|3626615|P2|Part I: LGX818|Administrative Problems|0
1106928|NCT01820364|3626616|P1|Part I: LGX818|Administrative Problems|3
1106929|NCT01820364|3626615|P2|Part I: LGX818|Death|0
1106930|NCT01820364|3626616|P1|Part I: LGX818|Death|1
1106931|NCT01819727|3626760|P2|Overall Study|Quit due to lack of health benifits|1
1106932|NCT01819727|3626761|P1|Overall Study|Quit due to lack of health benifits|0
1106933|NCT01819727|3626760|P2|Overall Study|Unable to demostrate ability self-inject|1
1106934|NCT01819727|3626761|P1|Overall Study|Unable to demostrate ability self-inject|0
1106935|NCT01819727|3626760|P2|Overall Study|Withdrawal by Subject|11
1106936|NCT01819727|3626761|P1|Overall Study|Withdrawal by Subject|6
1106937|NCT01819727|3626760|P2|Overall Study|Study Terminated by Sponsor|1
1106938|NCT01819727|3626761|P1|Overall Study|Study Terminated by Sponsor|0
1106939|NCT01819727|3626760|P2|Overall Study|Protocol Violation|2
1106940|NCT01819727|3626761|P1|Overall Study|Protocol Violation|0
1106941|NCT01819727|3626760|P2|Overall Study|Pregnancy|0
1106942|NCT01819727|3626761|P1|Overall Study|Pregnancy|1
1106943|NCT01819727|3626760|P2|Overall Study|Physician Decision|2
1106944|NCT01819727|3626761|P1|Overall Study|Physician Decision|3
1106945|NCT01819727|3626760|P2|Overall Study|Lost to Follow-up|1
1106946|NCT01819727|3626761|P1|Overall Study|Lost to Follow-up|1
1106947|NCT01819727|3626760|P2|Overall Study|Death|0
1106948|NCT01819727|3626761|P1|Overall Study|Death|1
1106949|NCT01819727|3626760|P2|Overall Study|Adverse Event|9
1106950|NCT01819727|3626761|P1|Overall Study|Adverse Event|8
1106951|NCT01819272|3626813|P6|Overall Study|Loss of Glucose Control|0
1106952|NCT01819272|3626814|P5|Overall Study|Loss of Glucose Control|2
1106953|NCT01819272|3626815|P4|Overall Study|Loss of Glucose Control|1
1106954|NCT01819272|3626816|P3|Overall Study|Loss of Glucose Control|0
1106955|NCT01819272|3626817|P2|Overall Study|Loss of Glucose Control|1
1106956|NCT01819272|3626818|P1|Overall Study|Loss of Glucose Control|2
1106957|NCT01819272|3626813|P6|Overall Study|Withdrawal of Consent|1
1106958|NCT01819272|3626814|P5|Overall Study|Withdrawal of Consent|0
1106959|NCT01819272|3626815|P4|Overall Study|Withdrawal of Consent|1
1106960|NCT01819272|3626816|P3|Overall Study|Withdrawal of Consent|2
1106961|NCT01819272|3626817|P2|Overall Study|Withdrawal of Consent|1
1106962|NCT01819272|3626818|P1|Overall Study|Withdrawal of Consent|0
1106963|NCT01819272|3626813|P6|Overall Study|Physician Decision|0
1106964|NCT01819272|3626814|P5|Overall Study|Physician Decision|0
1106965|NCT01819272|3626815|P4|Overall Study|Physician Decision|0
1106966|NCT01819272|3626816|P3|Overall Study|Physician Decision|0
1106967|NCT01819272|3626817|P2|Overall Study|Physician Decision|1
1106968|NCT01819272|3626818|P1|Overall Study|Physician Decision|0
1106969|NCT01819272|3626813|P6|Overall Study|Protocol Violation|3
1106970|NCT01819272|3626814|P5|Overall Study|Protocol Violation|2
1106971|NCT01819272|3626815|P4|Overall Study|Protocol Violation|1
1106972|NCT01819272|3626816|P3|Overall Study|Protocol Violation|0
1106973|NCT01819272|3626817|P2|Overall Study|Protocol Violation|0
1106974|NCT01819272|3626818|P1|Overall Study|Protocol Violation|0
1106975|NCT01819272|3626813|P6|Overall Study|Lost to Follow-up|3
1106976|NCT01819272|3626814|P5|Overall Study|Lost to Follow-up|0
1106977|NCT01819272|3626815|P4|Overall Study|Lost to Follow-up|0
1106978|NCT01819272|3626816|P3|Overall Study|Lost to Follow-up|1
1106979|NCT01819272|3626817|P2|Overall Study|Lost to Follow-up|0
1106980|NCT01819272|3626818|P1|Overall Study|Lost to Follow-up|3
1106981|NCT01819272|3626813|P6|Overall Study|Adverse Event|0
1106982|NCT01819272|3626814|P5|Overall Study|Adverse Event|0
1106983|NCT01819272|3626815|P4|Overall Study|Adverse Event|2
1106984|NCT01819272|3626816|P3|Overall Study|Adverse Event|0
1106985|NCT01819272|3626817|P2|Overall Study|Adverse Event|0
1106986|NCT01819272|3626818|P1|Overall Study|Adverse Event|1
1106987|NCT01819194|3626844|P1|Overall Study|Loss of study articles|2
1106988|NCT01819129|3626851|P2|Overall Study|Withdrawal Criteria|15
1106989|NCT01819129|3626852|P1|Overall Study|Withdrawal Criteria|20
1106990|NCT01819129|3626851|P2|Overall Study|Death|1
1106991|NCT01819129|3626852|P1|Overall Study|Death|1
1106992|NCT01819129|3626851|P2|Overall Study|Adverse Event|4
1106993|NCT01819129|3626852|P1|Overall Study|Adverse Event|1
1106994|NCT01819129|3626851|P2|Overall Study|Lack of Efficacy|1
1106995|NCT01819129|3626852|P1|Overall Study|Lack of Efficacy|0
1106996|NCT01819129|3626851|P2|Overall Study|Lost to Follow-up|2
1106997|NCT01819129|3626852|P1|Overall Study|Lost to Follow-up|5
1106998|NCT01819129|3626851|P2|Overall Study|Withdrawal by Subject|15
1106999|NCT01819129|3626852|P1|Overall Study|Withdrawal by Subject|15
1107000|NCT01819129|3626851|P2|Overall Study|Other, Subject moved out of the country|1
1107001|NCT01819129|3626852|P1|Overall Study|Other, Subject moved out of the country|0
1107002|NCT01819129|3626851|P2|Overall Study|Other, weight gain, hypoglycaemic events|0
1107003|NCT01819129|3626852|P1|Overall Study|Other, weight gain, hypoglycaemic events|1
1107004|NCT01819129|3626851|P2|Overall Study|Other, Subject wanted HbA1c to be > 7%|0
1107005|NCT01819129|3626852|P1|Overall Study|Other, Subject wanted HbA1c to be > 7%|1
1107006|NCT01818752|3626866|P2|Overall Study|Randomized but not Dosed|4
1107007|NCT01818752|3626867|P1|Overall Study|Randomized but not Dosed|7
1107008|NCT01818752|3626866|P2|Overall Study|Continuing Treatment|4
1107009|NCT01818752|3626867|P1|Overall Study|Continuing Treatment|1
1107010|NCT01818752|3626866|P2|Overall Study|Other|8
1107011|NCT01818752|3626867|P1|Overall Study|Other|7
1107012|NCT01818752|3626866|P2|Overall Study|Disease Progression|48
1107013|NCT01818752|3626867|P1|Overall Study|Disease Progression|54
1107014|NCT01818752|3626866|P2|Overall Study|Physician Decision|8
1107015|NCT01818752|3626867|P1|Overall Study|Physician Decision|9
1107016|NCT01818752|3626866|P2|Overall Study|Withdrawal by Subject|14
1107017|NCT01818752|3626867|P1|Overall Study|Withdrawal by Subject|15
1107018|NCT01818752|3626866|P2|Overall Study|Non-compliance|20
1107019|NCT01818752|3626867|P1|Overall Study|Non-compliance|16
1107020|NCT01818752|3626866|P2|Overall Study|Death|18
1107021|NCT01818752|3626867|P1|Overall Study|Death|14
1107022|NCT01818752|3626866|P2|Overall Study|Adverse Event|74
1107023|NCT01818752|3626867|P1|Overall Study|Adverse Event|64
1107024|NCT01818700|3626885|P1|Overall Study|Other|1
1107025|NCT01818700|3626885|P1|Overall Study|Protocol Violation|2
1107026|NCT01818700|3626885|P1|Overall Study|Withdrawal by Subject|27
1107027|NCT01818700|3626885|P1|Overall Study|Lost to Follow-up|5
1107028|NCT01818700|3626885|P1|Overall Study|Lack of Efficacy|2
1107029|NCT01818700|3626885|P1|Overall Study|Adverse Event|67
1107030|NCT01818596|3626896|P2|Overall Study|Still on Study|6
1107031|NCT01818596|3626897|P1|Overall Study|Still on Study|232
1107032|NCT01818596|3626896|P2|Overall Study|Lost to Follow-up|0
1107033|NCT01818596|3626897|P1|Overall Study|Lost to Follow-up|2
1107034|NCT01818596|3626896|P2|Overall Study|Protocol Violation|0
1107035|NCT01818596|3626897|P1|Overall Study|Protocol Violation|1
1107036|NCT01818596|3626896|P2|Overall Study|Withdrew Consent|0
1107037|NCT01818596|3626897|P1|Overall Study|Withdrew Consent|3
1107038|NCT01818596|3626896|P2|Overall Study|Adverse Event|0
1107039|NCT01818596|3626897|P1|Overall Study|Adverse Event|4
1107040|NCT01818596|3626896|P2|Overall Study|Enrolled but Not Treated|0
1107041|NCT01818596|3626897|P1|Overall Study|Enrolled but Not Treated|4
1107042|NCT01818531|3626930|P2|Overall Study|Withdrawn for failure to place block|1
1107043|NCT01818531|3626931|P1|Overall Study|Withdrawn for failure to place block|0
1107044|NCT01818531|3626930|P2|Overall Study|Withdrawn for long-acting opioid patch|1
1107045|NCT01818531|3626931|P1|Overall Study|Withdrawn for long-acting opioid patch|0
1107046|NCT01818531|3626930|P2|Overall Study|Withdrawn for case delay after block|0
1107047|NCT01818531|3626931|P1|Overall Study|Withdrawn for case delay after block|1
1107048|NCT01818336|3626979|P2|Overall Study|Lost to Follow-up|1
1107049|NCT01818336|3626980|P1|Overall Study|Lost to Follow-up|0
1107050|NCT01818336|3626979|P2|Overall Study|Declined retest visit|11
1107051|NCT01818336|3626980|P1|Overall Study|Declined retest visit|0
1107052|NCT01818297|3626988|P2|Open Label Phase (3-12 Months)|Early study closure|10
1107053|NCT01818297|3626989|P1|Open Label Phase (3-12 Months)|Early study closure|17
1107054|NCT01818297|3626988|P2|Open Label Phase (3-12 Months)|Physician Decision|0
1107055|NCT01818297|3626989|P1|Open Label Phase (3-12 Months)|Physician Decision|1
1107056|NCT01818297|3626988|P2|Blinded Phase (Randomization - 3 Months)|Adverse Event|1
1107057|NCT01818297|3626989|P1|Blinded Phase (Randomization - 3 Months)|Adverse Event|0
1107058|NCT01818141|3627032|P2|Overall Study|Lost to Follow-up|2
1107059|NCT01818141|3627033|P1|Overall Study|Lost to Follow-up|0
1107060|NCT01818141|3627032|P2|Overall Study|No baseline C.diff colonies|1
1107061|NCT01818141|3627033|P1|Overall Study|No baseline C.diff colonies|1
1107062|NCT01818141|3627032|P2|Overall Study|Withdrawal by Subject|0
1107063|NCT01818141|3627033|P1|Overall Study|Withdrawal by Subject|2
1107064|NCT01817790|3627098|P2|Overall Study|Other: Could not attend appointment|1
1107065|NCT01817790|3627099|P1|Overall Study|Other: Could not attend appointment|1
1107066|NCT01817790|3627098|P2|Overall Study|Withdrawal by Subject|3
1107067|NCT01817790|3627099|P1|Overall Study|Withdrawal by Subject|1
1107068|NCT01817790|3627098|P2|Overall Study|Protocol Violation|1
1107069|NCT01817790|3627099|P1|Overall Study|Protocol Violation|2
1107070|NCT01817790|3627098|P2|Overall Study|Lost to Follow-up|1
1107071|NCT01817790|3627099|P1|Overall Study|Lost to Follow-up|0
1107072|NCT01817790|3627098|P2|Overall Study|Adverse Event|2
1107073|NCT01817790|3627099|P1|Overall Study|Adverse Event|0
1107074|NCT01817777|3627143|P3|Interventional Phase (20 Weeks)|Early Study Termination|3
1107075|NCT01817777|3627144|P2|Interventional Phase (20 Weeks)|Early Study Termination|1
1107076|NCT01817777|3627145|P1|Interventional Phase (20 Weeks)|Early Study Termination|0
1107077|NCT01817777|3627143|P3|Interventional Phase (20 Weeks)|Lost to Follow-up|2
1107078|NCT01817777|3627144|P2|Interventional Phase (20 Weeks)|Lost to Follow-up|1
1107079|NCT01817777|3627145|P1|Interventional Phase (20 Weeks)|Lost to Follow-up|0
1107080|NCT01817777|3627143|P3|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
1107081|NCT01817777|3627144|P2|Interventional Phase (20 Weeks)|Withdrawal by Subject|3
1107082|NCT01817777|3627145|P1|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
1107083|NCT01817777|3627143|P3|Observational Phase (8 Weeks)|Early Study Termination|0
1107084|NCT01817777|3627144|P2|Observational Phase (8 Weeks)|Early Study Termination|0
1107085|NCT01817777|3627145|P1|Observational Phase (8 Weeks)|Early Study Termination|2
1107086|NCT01817777|3627143|P3|Observational Phase (8 Weeks)|Lost to Follow-up|0
1107087|NCT01817777|3627144|P2|Observational Phase (8 Weeks)|Lost to Follow-up|0
1107088|NCT01817777|3627145|P1|Observational Phase (8 Weeks)|Lost to Follow-up|3
1107089|NCT01817764|3627169|P2|Overall Study|Withdrawal by Subject|12
1107090|NCT01817764|3627170|P1|Overall Study|Withdrawal by Subject|10
1107091|NCT01817764|3627169|P2|Overall Study|Lost to Follow-up|4
1107092|NCT01817764|3627170|P1|Overall Study|Lost to Follow-up|1
1107093|NCT01817764|3627169|P2|Overall Study|Protocol Violation|5
1107094|NCT01817764|3627170|P1|Overall Study|Protocol Violation|7
1107095|NCT01817764|3627169|P2|Overall Study|Lack of Efficacy|7
1107096|NCT01817764|3627170|P1|Overall Study|Lack of Efficacy|9
1107097|NCT01817764|3627169|P2|Overall Study|Adverse Event|10
1107098|NCT01817764|3627170|P1|Overall Study|Adverse Event|7
1107099|NCT01817725|3627178|P1|Overall Study|Withdrawal by Subject|1
1107100|NCT01816893|3627246|P2|Washout Period|Withdrawal by Subject|0
1107101|NCT01816893|3627247|P1|Washout Period|Withdrawal by Subject|2
1107102|NCT01816685|3627282|P2|Overall Study|Surgery Cancelled|2
1107103|NCT01816685|3627283|P1|Overall Study|Surgery Cancelled|3
1107104|NCT01816685|3627282|P2|Overall Study|Lost to Follow-up|9
1107105|NCT01816685|3627283|P1|Overall Study|Lost to Follow-up|7
1107106|NCT01816477|3627293|P2|Overall Study|Unable to tolerate catheter placement|0
1107107|NCT01816477|3627294|P1|Overall Study|Unable to tolerate catheter placement|3
1107108|NCT01816477|3627293|P2|Overall Study|Withdrawal by Subject|1
1107109|NCT01816477|3627294|P1|Overall Study|Withdrawal by Subject|13
1107110|NCT01816295|3627348|P2|OLE Phase|Lack of Efficacy|7
1107111|NCT01816295|3627349|P1|OLE Phase|Lack of Efficacy|3
1107112|NCT01816295|3627348|P2|OLE Phase|Withdrawal by Subject|10
1107113|NCT01816295|3627349|P1|OLE Phase|Withdrawal by Subject|10
1107114|NCT01816295|3627348|P2|OLE Phase|Sponsor Decision|9
1107115|NCT01816295|3627349|P1|OLE Phase|Sponsor Decision|7
1107116|NCT01816295|3627348|P2|OLE Phase|Protocol Violation|4
1107117|NCT01816295|3627349|P1|OLE Phase|Protocol Violation|4
1107118|NCT01816295|3627348|P2|OLE Phase|Physician Decision|1
1107119|NCT01816295|3627349|P1|OLE Phase|Physician Decision|3
1107120|NCT01816295|3627348|P2|OLE Phase|Lost to Follow-up|5
1107121|NCT01816295|3627349|P1|OLE Phase|Lost to Follow-up|5
1107122|NCT01816295|3627348|P2|OLE Phase|Entry Criteria Not Met|5
1107123|NCT01816295|3627349|P1|OLE Phase|Entry Criteria Not Met|3
1107124|NCT01816295|3627348|P2|OLE Phase|Death|0
1107125|NCT01816295|3627349|P1|OLE Phase|Death|1
1107126|NCT01816295|3627348|P2|OLE Phase|Adverse Event|15
1107127|NCT01816295|3627349|P1|OLE Phase|Adverse Event|17
1107128|NCT01816295|3627348|P2|Double Blind Phase|Withdrawal by Subject|20
1107129|NCT01816295|3627349|P1|Double Blind Phase|Withdrawal by Subject|22
1107130|NCT01816295|3627348|P2|Double Blind Phase|Sponsor Decision|8
1107131|NCT01816295|3627349|P1|Double Blind Phase|Sponsor Decision|8
1107132|NCT01816295|3627348|P2|Double Blind Phase|Protocol Violation|11
1107133|NCT01816295|3627349|P1|Double Blind Phase|Protocol Violation|17
1107134|NCT01816295|3627348|P2|Double Blind Phase|Physician Decision|2
1107135|NCT01816295|3627349|P1|Double Blind Phase|Physician Decision|2
1107136|NCT01816295|3627348|P2|Double Blind Phase|Lost to Follow-up|5
1107137|NCT01816295|3627349|P1|Double Blind Phase|Lost to Follow-up|3
1107138|NCT01816295|3627348|P2|Double Blind Phase|Entry Criteria Not Met|2
1107139|NCT01816295|3627349|P1|Double Blind Phase|Entry Criteria Not Met|0
1107140|NCT01816295|3627348|P2|Double Blind Phase|Adverse Event|8
1107141|NCT01816295|3627349|P1|Double Blind Phase|Adverse Event|11
1107142|NCT01816243|3627364|P1|Overall Study|Amputation|3
1107143|NCT01816243|3627364|P1|Overall Study|Not eligible for the study|1
1107144|NCT01816243|3627364|P1|Overall Study|Lack of Efficacy|1
1107145|NCT01816243|3627364|P1|Overall Study|Lost to Follow-up|1
1107146|NCT01816243|3627364|P1|Overall Study|Adverse Event|6
1107147|NCT01816074|3627375|P4|Phase 2|Withdrawal by Subject|0
1107148|NCT01816074|3627376|P3|Phase 2|Withdrawal by Subject|0
1107149|NCT01816074|3627377|P2|Phase 2|Withdrawal by Subject|0
1107150|NCT01816074|3627378|P1|Phase 2|Withdrawal by Subject|1
1107151|NCT01816074|3627375|P4|Phase 2|Physician Decision|1
1107152|NCT01816074|3627376|P3|Phase 2|Physician Decision|0
1107153|NCT01816074|3627377|P2|Phase 2|Physician Decision|0
1107154|NCT01816074|3627378|P1|Phase 2|Physician Decision|0
1107155|NCT01816074|3627375|P4|Phase 2|Unsatisfied with Randomization assignmen|0
1107156|NCT01816074|3627376|P3|Phase 2|Unsatisfied with Randomization assignmen|0
1107157|NCT01816074|3627377|P2|Phase 2|Unsatisfied with Randomization assignmen|0
1107158|NCT01816074|3627378|P1|Phase 2|Unsatisfied with Randomization assignmen|1
1107159|NCT01816074|3627375|P4|Phase 2|Time commitment Issues|0
1107160|NCT01816074|3627376|P3|Phase 2|Time commitment Issues|0
1107161|NCT01816074|3627377|P2|Phase 2|Time commitment Issues|2
1107162|NCT01816074|3627378|P1|Phase 2|Time commitment Issues|0
1107163|NCT01816074|3627375|P4|Phase 1|Time commitment issues|0
1107164|NCT01816074|3627376|P3|Phase 1|Time commitment issues|1
1107165|NCT01816074|3627377|P2|Phase 1|Time commitment issues|0
1107166|NCT01816074|3627378|P1|Phase 1|Time commitment issues|0
1107167|NCT01816048|3627406|P1|Overall Study|Disease Progression|3
1107168|NCT01816048|3627406|P1|Overall Study|Withdrawal by Subject|1
1107169|NCT01816048|3627406|P1|Overall Study|Death|1
1107170|NCT01816048|3627406|P1|Overall Study|Adverse Event|1
1107171|NCT01815918|3627421|P2|Overall Study|Lack of Efficacy|15
1107172|NCT01815918|3627422|P1|Overall Study|Lack of Efficacy|15
1107173|NCT01815918|3627421|P2|Overall Study|Patient samples not analyzable|4
1107174|NCT01815918|3627422|P1|Overall Study|Patient samples not analyzable|3
1107175|NCT01815840|3627438|P2|Overall Study|Sponsor Termination Treatment|0
1107176|NCT01815840|3627439|P1|Overall Study|Sponsor Termination Treatment|1
1107177|NCT01815840|3627438|P2|Overall Study|Refused Treatment|1
1107178|NCT01815840|3627439|P1|Overall Study|Refused Treatment|5
1107179|NCT01815840|3627438|P2|Overall Study|Lost to Follow-up|6
1107180|NCT01815840|3627439|P1|Overall Study|Lost to Follow-up|3
1107181|NCT01815840|3627438|P2|Overall Study|Investigators Decision|3
1107182|NCT01815840|3627439|P1|Overall Study|Investigators Decision|2
1107183|NCT01815840|3627438|P2|Overall Study|Disease progression|2
1107184|NCT01815840|3627439|P1|Overall Study|Disease progression|3
1107185|NCT01815840|3627438|P2|Overall Study|Death|2
1107186|NCT01815840|3627439|P1|Overall Study|Death|2
1107187|NCT01815840|3627438|P2|Overall Study|Adverse Event|16
1107188|NCT01815840|3627439|P1|Overall Study|Adverse Event|10
1107189|NCT01815840|3627438|P2|Overall Study|Administrative/Other|3
1107190|NCT01815840|3627439|P1|Overall Study|Administrative/Other|1
1107191|NCT01815840|3627438|P2|Overall Study|Withdrew Consent|30
1107192|NCT01815840|3627439|P1|Overall Study|Withdrew Consent|31
1107193|NCT01815840|3627438|P2|Overall Study|Missing|0
1107194|NCT01815840|3627439|P1|Overall Study|Missing|1
1107195|NCT01815736|3627469|P2|Overall Study|Still on Study|449
1107196|NCT01815736|3627470|P1|Overall Study|Still on Study|929
1107197|NCT01815736|3627469|P2|Overall Study|Lost to Follow-up|7
1107198|NCT01815736|3627470|P1|Overall Study|Lost to Follow-up|6
1107199|NCT01815736|3627469|P2|Overall Study|Withdrew Consent|15
1107200|NCT01815736|3627470|P1|Overall Study|Withdrew Consent|7
1107201|NCT01815736|3627469|P2|Overall Study|Investigator's Discretion|0
1107202|NCT01815736|3627470|P1|Overall Study|Investigator's Discretion|4
1107203|NCT01815736|3627469|P2|Overall Study|Death|0
1107204|NCT01815736|3627470|P1|Overall Study|Death|4
1107205|NCT01815736|3627469|P2|Overall Study|Adverse Event|4
1107206|NCT01815736|3627470|P1|Overall Study|Adverse Event|7
1107207|NCT01815736|3627469|P2|Overall Study|Randomized but Not Treated|3
1107208|NCT01815736|3627470|P1|Overall Study|Randomized but Not Treated|4
1107209|NCT01815138|3627538|P2|Overall Study|Physician Decision|5
1107210|NCT01815138|3627539|P1|Overall Study|Physician Decision|8
1107211|NCT01815138|3627538|P2|Overall Study|Withdrawal by Subject|1
1107212|NCT01815138|3627539|P1|Overall Study|Withdrawal by Subject|0
1107213|NCT01815099|3627551|P1|Overall Study|unable to attend study visits|1
1107214|NCT01815099|3627551|P1|Overall Study|Lack of Efficacy|1
1107215|NCT01814878|3627565|P2|Overall Study|Other|0
1107216|NCT01814878|3627566|P1|Overall Study|Other|2
1107217|NCT01814878|3627565|P2|Overall Study|Screening failure (drop-out)|3
1107218|NCT01814878|3627566|P1|Overall Study|Screening failure (drop-out)|0
1107219|NCT01814878|3627565|P2|Overall Study|Physician Decision|1
1107220|NCT01814878|3627566|P1|Overall Study|Physician Decision|3
1107221|NCT01814878|3627565|P2|Overall Study|Protocol Violation|5
1107222|NCT01814878|3627566|P1|Overall Study|Protocol Violation|5
1107223|NCT01814878|3627565|P2|Overall Study|Withdrawal by Subject|16
1107224|NCT01814878|3627566|P1|Overall Study|Withdrawal by Subject|20
1107225|NCT01814878|3627565|P2|Overall Study|Adverse Event|5
1107226|NCT01814878|3627566|P1|Overall Study|Adverse Event|16
1107227|NCT01814800|3627586|P1|Overall Study|Subject relocation|1
1107228|NCT01814800|3627586|P1|Overall Study|Sponsor decision|1
1107229|NCT01814800|3627586|P1|Overall Study|Pregnancy|1
1107230|NCT01814800|3627586|P1|Overall Study|Adverse Event|2
1107231|NCT01814761|3627646|P2|Overall Study|Lost to Follow-up|5
1107232|NCT01814761|3627647|P1|Overall Study|Lost to Follow-up|1
1107233|NCT01814761|3627646|P2|Overall Study|Ocular Adverse Event|15
1107234|NCT01814761|3627647|P1|Overall Study|Ocular Adverse Event|6
1107235|NCT01814761|3627646|P2|Overall Study|Other Reasons|10
1107236|NCT01814761|3627647|P1|Overall Study|Other Reasons|1
1107237|NCT01814748|3627661|P2|Overall Study|Withdrawal by Subject|4
1107238|NCT01814748|3627662|P1|Overall Study|Withdrawal by Subject|6
1107239|NCT01814748|3627661|P2|Overall Study|Study site terminated by sponsor|1
1107240|NCT01814748|3627662|P1|Overall Study|Study site terminated by sponsor|1
1107241|NCT01814748|3627661|P2|Overall Study|Lost to Follow-up|2
1107242|NCT01814748|3627662|P1|Overall Study|Lost to Follow-up|1
1107243|NCT01814696|3627706|P2|Overall Study|Randomized to wrong group|0
1107244|NCT01814696|3627707|P1|Overall Study|Randomized to wrong group|1
1107245|NCT01814696|3627706|P2|Overall Study|Withdrawal by Subject|0
1107246|NCT01814696|3627707|P1|Overall Study|Withdrawal by Subject|1
1107247|NCT01814670|3627725|P1|Overall Study|Protocol Violation|12
1107248|NCT01814553|3627735|P2|Overall Study|Other than stated|8
1107249|NCT01814553|3627736|P1|Overall Study|Other than stated|7
1107250|NCT01814553|3627735|P2|Overall Study|Withdrawal by Subject|1
1107251|NCT01814553|3627736|P1|Overall Study|Withdrawal by Subject|1
1107252|NCT01814553|3627735|P2|Overall Study|Other Adverse Event|5
1107253|NCT01814553|3627736|P1|Overall Study|Other Adverse Event|4
1107254|NCT01814553|3627735|P2|Overall Study|PD per clinical progression|8
1107255|NCT01814553|3627736|P1|Overall Study|PD per clinical progression|6
1107256|NCT01814397|3627750|P1|Overall Study|Withdrawal by Subject|7
1107257|NCT01814397|3627750|P1|Overall Study|Adverse Event|7
1107258|NCT01814371|3627759|P2|Overall Study|Lost to Follow-up|27
1107259|NCT01814371|3627760|P1|Overall Study|Lost to Follow-up|30
1107260|NCT01814332|3627793|P2|Overall Study|Lost to Follow-up|1
1107261|NCT01814332|3627794|P1|Overall Study|Lost to Follow-up|5
1107262|NCT01814332|3627793|P2|Overall Study|Protocol Violation|4
1107263|NCT01814332|3627794|P1|Overall Study|Protocol Violation|0
1107264|NCT01814332|3627793|P2|Overall Study|Withdrawal by Subject|8
1107265|NCT01814332|3627794|P1|Overall Study|Withdrawal by Subject|3
1107266|NCT01814332|3627793|P2|Overall Study|Adverse Event|3
1107267|NCT01814332|3627794|P1|Overall Study|Adverse Event|8
1107268|NCT01814137|3627816|P2|Overall Study|Unclassified|1
1107269|NCT01814137|3627817|P1|Overall Study|Unclassified|2
1107270|NCT01814137|3627816|P2|Overall Study|Physician Decision|1
1107271|NCT01814137|3627817|P1|Overall Study|Physician Decision|1
1107272|NCT01814137|3627816|P2|Overall Study|Withdrawal by Subject|2
1107273|NCT01814137|3627817|P1|Overall Study|Withdrawal by Subject|2
1107274|NCT01814137|3627816|P2|Overall Study|Adverse Event|1
1107275|NCT01814137|3627817|P1|Overall Study|Adverse Event|0
1107276|NCT01814046|3627833|P3|Drug Administration|Death due to complications of RSV|0
1107277|NCT01814046|3627834|P2|Drug Administration|Death due to complications of RSV|0
1107278|NCT01814046|3627835|P1|Drug Administration|Death due to complications of RSV|1
1107279|NCT01813890|3627849|P3|Overall Study|Lack of Efficacy|2
1107280|NCT01813890|3627850|P2|Overall Study|Lack of Efficacy|1
1107281|NCT01813890|3627851|P1|Overall Study|Lack of Efficacy|9
1107282|NCT01813890|3627849|P3|Overall Study|Adverse Event|4
1107283|NCT01813890|3627850|P2|Overall Study|Adverse Event|3
1107284|NCT01813890|3627851|P1|Overall Study|Adverse Event|0
1107285|NCT01813721|3627880|P1|Overall Study|Withdrawal by Subject|1
1107286|NCT01813721|3627880|P1|Overall Study|Ineligibility determined|63
1107287|NCT01813474|3627935|P3|Overall Study|Death|1
1107288|NCT01813474|3627936|P2|Overall Study|Death|0
1107289|NCT01813474|3627937|P1|Overall Study|Death|0
1107290|NCT01813474|3627935|P3|Overall Study|Lack of Efficacy|9
1107291|NCT01813474|3627936|P2|Overall Study|Lack of Efficacy|6
1107292|NCT01813474|3627937|P1|Overall Study|Lack of Efficacy|2
1107293|NCT01813474|3627935|P3|Overall Study|Adverse Event|0
1107294|NCT01813474|3627936|P2|Overall Study|Adverse Event|1
1107295|NCT01813474|3627937|P1|Overall Study|Adverse Event|1
1107296|NCT01813474|3627935|P3|Overall Study|Withdrawal by Subject|1
1107297|NCT01813474|3627936|P2|Overall Study|Withdrawal by Subject|0
1107298|NCT01813474|3627937|P1|Overall Study|Withdrawal by Subject|0
1107299|NCT01813422|3627961|P2|Overall Study|Lost to Follow-up|4
1107300|NCT01813422|3627962|P1|Overall Study|Lost to Follow-up|2
1107301|NCT01813422|3627961|P2|Overall Study|Sponsor Decision|1
1107302|NCT01813422|3627962|P1|Overall Study|Sponsor Decision|2
1107303|NCT01813422|3627961|P2|Overall Study|Death|3
1107304|NCT01813422|3627962|P1|Overall Study|Death|2
1107305|NCT01813422|3627961|P2|Overall Study|Withdrawal by Subject|8
1107306|NCT01813422|3627962|P1|Overall Study|Withdrawal by Subject|14
1107307|NCT01813019|3628000|P2|Overall Study|Protocol Deviation|1
1107308|NCT01813019|3628001|P1|Overall Study|Protocol Deviation|2
1107309|NCT01813019|3628000|P2|Overall Study|administrative problems|0
1107310|NCT01813019|3628001|P1|Overall Study|administrative problems|2
1107311|NCT01813019|3628000|P2|Overall Study|Withdrawal by Subject|2
1107312|NCT01813019|3628001|P1|Overall Study|Withdrawal by Subject|3
1107313|NCT01813019|3628000|P2|Overall Study|Adverse Event|3
1107314|NCT01813019|3628001|P1|Overall Study|Adverse Event|0
1107315|NCT01812837|3628012|P3|Overall Study|Protocol Violation|0
1107316|NCT01812837|3628013|P2|Overall Study|Protocol Violation|0
1107317|NCT01812837|3628014|P1|Overall Study|Protocol Violation|1
1107318|NCT01812837|3628012|P3|Overall Study|Lost to Follow-up|0
1107319|NCT01812837|3628013|P2|Overall Study|Lost to Follow-up|1
1107320|NCT01812837|3628014|P1|Overall Study|Lost to Follow-up|1
1107321|NCT01812707|3628026|P4|Overall Study|Consent withdrawn by participant|0
1107322|NCT01812707|3628027|P3|Overall Study|Consent withdrawn by participant|0
1107323|NCT01812707|3628028|P2|Overall Study|Consent withdrawn by participant|0
1107324|NCT01812707|3628029|P1|Overall Study|Consent withdrawn by participant|1
1107325|NCT01812707|3628026|P4|Overall Study|Poor compliance to protocol|0
1107326|NCT01812707|3628027|P3|Overall Study|Poor compliance to protocol|0
1107327|NCT01812707|3628028|P2|Overall Study|Poor compliance to protocol|0
1107328|NCT01812707|3628029|P1|Overall Study|Poor compliance to protocol|1
1107329|NCT01812707|3628026|P4|Overall Study|Adverse Event|2
1107330|NCT01812707|3628027|P3|Overall Study|Adverse Event|0
1107331|NCT01812707|3628028|P2|Overall Study|Adverse Event|0
1107332|NCT01812707|3628029|P1|Overall Study|Adverse Event|0
1107333|NCT01812655|3628077|P3|Overall Study|Protocol Violation|0
1107334|NCT01812655|3628078|P2|Overall Study|Protocol Violation|1
1107335|NCT01812655|3628079|P1|Overall Study|Protocol Violation|1
1107336|NCT01812057|3628104|P2|Overall Study|Physician Decision|0
1107337|NCT01812057|3628105|P1|Overall Study|Physician Decision|1
1107338|NCT01812057|3628104|P2|Overall Study|Protocol Violation|0
1107339|NCT01812057|3628105|P1|Overall Study|Protocol Violation|1
1107340|NCT01811953|3628208|P6|Overall Study|Protocol Violation|0
1107341|NCT01811953|3628209|P5|Overall Study|Protocol Violation|1
1107342|NCT01811953|3628210|P4|Overall Study|Protocol Violation|0
1107343|NCT01811953|3628211|P3|Overall Study|Protocol Violation|0
1107344|NCT01811953|3628212|P2|Overall Study|Protocol Violation|0
1107345|NCT01811953|3628213|P1|Overall Study|Protocol Violation|0
1107346|NCT01811953|3628208|P6|Overall Study|Adverse Event|1
1107347|NCT01811953|3628209|P5|Overall Study|Adverse Event|0
1107348|NCT01811953|3628210|P4|Overall Study|Adverse Event|1
1107349|NCT01811953|3628211|P3|Overall Study|Adverse Event|0
1107350|NCT01811953|3628212|P2|Overall Study|Adverse Event|0
1107351|NCT01811953|3628213|P1|Overall Study|Adverse Event|0
1107352|NCT01811732|3628270|P2|Overall Study|Correct study drug not available on site|0
1107353|NCT01811732|3628271|P1|Overall Study|Correct study drug not available on site|1
1107354|NCT01811732|3628270|P2|Overall Study|Admitted to another facility|0
1107355|NCT01811732|3628271|P1|Overall Study|Admitted to another facility|1
1107356|NCT01811732|3628270|P2|Overall Study|Subject incarcerated|2
1107357|NCT01811732|3628271|P1|Overall Study|Subject incarcerated|1
1107358|NCT01811732|3628270|P2|Overall Study|Protocol Violation|1
1107359|NCT01811732|3628271|P1|Overall Study|Protocol Violation|0
1107360|NCT01811732|3628270|P2|Overall Study|Insufficient venous access|1
1107361|NCT01811732|3628271|P1|Overall Study|Insufficient venous access|0
1107362|NCT01811732|3628270|P2|Overall Study|Death|1
1107363|NCT01811732|3628271|P1|Overall Study|Death|1
1107364|NCT01811732|3628270|P2|Overall Study|Physician Decision|0
1107365|NCT01811732|3628271|P1|Overall Study|Physician Decision|2
1107366|NCT01811732|3628270|P2|Overall Study|Non-compliance with study drug/procedure|3
1107367|NCT01811732|3628271|P1|Overall Study|Non-compliance with study drug/procedure|3
1107368|NCT01811732|3628270|P2|Overall Study|Lack of Efficacy|1
1107369|NCT01811732|3628271|P1|Overall Study|Lack of Efficacy|3
1107370|NCT01811732|3628270|P2|Overall Study|Adverse Event|9
1107371|NCT01811732|3628271|P1|Overall Study|Adverse Event|3
1107372|NCT01811732|3628270|P2|Overall Study|Withdrawal by Subject|10
1107373|NCT01811732|3628271|P1|Overall Study|Withdrawal by Subject|16
1107374|NCT01811732|3628270|P2|Overall Study|Lost to Follow-up|30
1107375|NCT01811732|3628271|P1|Overall Study|Lost to Follow-up|24
1107376|NCT01811706|3628281|P2|First Intervention ( 4 Weeks)|Adverse Event|0
1107377|NCT01811706|3628282|P1|First Intervention ( 4 Weeks)|Adverse Event|1
1107378|NCT01811563|3628299|P2|Overall Study|Incorrect Randomization procedure|1
1107379|NCT01811563|3628300|P1|Overall Study|Incorrect Randomization procedure|0
1107380|NCT01811563|3628299|P2|Overall Study|Lost to Follow-up|2
1107381|NCT01811563|3628300|P1|Overall Study|Lost to Follow-up|5
1107382|NCT01811485|3628329|P3|Overall Study|Protocol Deviation|0
1107383|NCT01811485|3628330|P2|Overall Study|Protocol Deviation|1
1107384|NCT01811485|3628331|P1|Overall Study|Protocol Deviation|0
1107385|NCT01811485|3628329|P3|Overall Study|Administrative problems|0
1107386|NCT01811485|3628330|P2|Overall Study|Administrative problems|0
1107387|NCT01811485|3628331|P1|Overall Study|Administrative problems|1
1107388|NCT01811485|3628329|P3|Overall Study|Unsatisfactory therapeutic effect|3
1107389|NCT01811485|3628330|P2|Overall Study|Unsatisfactory therapeutic effect|0
1107390|NCT01811485|3628331|P1|Overall Study|Unsatisfactory therapeutic effect|0
1107391|NCT01811485|3628329|P3|Overall Study|Adverse Event|2
1107392|NCT01811485|3628330|P2|Overall Study|Adverse Event|3
1107393|NCT01811485|3628331|P1|Overall Study|Adverse Event|1
1107394|NCT01811472|3628351|P3|Overall Study|Subject/guardian decision|0
1107395|NCT01811472|3628352|P2|Overall Study|Subject/guardian decision|0
1107396|NCT01811472|3628353|P1|Overall Study|Subject/guardian decision|1
1107397|NCT01811472|3628351|P3|Overall Study|Lost to Follow-up|1
1107398|NCT01811472|3628352|P2|Overall Study|Lost to Follow-up|0
1107399|NCT01811472|3628353|P1|Overall Study|Lost to Follow-up|0
1107400|NCT01811472|3628351|P3|Overall Study|Adverse Event|4
1107401|NCT01811472|3628352|P2|Overall Study|Adverse Event|0
1107402|NCT01811472|3628353|P1|Overall Study|Adverse Event|1
1107403|NCT01811238|3628440|P1|Overall Study|subject refused study medication|6
1107404|NCT01811238|3628440|P1|Overall Study|Lack of Efficacy|4
1107405|NCT01811238|3628440|P1|Overall Study|Protocol Violation|4
1107406|NCT01811238|3628440|P1|Overall Study|Adverse Event|25
1107407|NCT01811238|3628440|P1|Overall Study|Withdrawal by Subject|42
1107408|NCT01811186|3628464|P2|Overall Study|Lost to Follow-up|2
1107409|NCT01811186|3628465|P1|Overall Study|Lost to Follow-up|4
1107410|NCT01811186|3628464|P2|Overall Study|Lack of Efficacy|6
1107411|NCT01811186|3628465|P1|Overall Study|Lack of Efficacy|3
1107412|NCT01811186|3628464|P2|Overall Study|Withdrawal by Subject|10
1107413|NCT01811186|3628465|P1|Overall Study|Withdrawal by Subject|5
1107414|NCT01811186|3628464|P2|Overall Study|Protocol Violation|6
1107415|NCT01811186|3628465|P1|Overall Study|Protocol Violation|5
1107416|NCT01811186|3628464|P2|Overall Study|Adverse Event|38
1107417|NCT01811186|3628465|P1|Overall Study|Adverse Event|54
1107418|NCT01810939|3628498|P3|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
1107419|NCT01810939|3628499|P2|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1
1107420|NCT01810939|3628500|P1|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
1107421|NCT01810939|3628498|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1
1107422|NCT01810939|3628499|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2
1107423|NCT01810939|3628500|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0
1107424|NCT01810939|3628498|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14
1107425|NCT01810939|3628499|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2
1107426|NCT01810939|3628500|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0
1107427|NCT01810939|3628498|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2
1107428|NCT01810939|3628499|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1
1107429|NCT01810939|3628500|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0
1107430|NCT01810939|3628498|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
1107431|NCT01810939|3628499|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
1107432|NCT01810939|3628500|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0
1107433|NCT01810939|3628498|P3|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1
1107434|NCT01810939|3628499|P2|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
1107435|NCT01810939|3628500|P1|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
1107436|NCT01810939|3628498|P3|Part B Placebo-Controlled Withdrawal|Death|1
1107437|NCT01810939|3628499|P2|Part B Placebo-Controlled Withdrawal|Death|0
1107438|NCT01810939|3628500|P1|Part B Placebo-Controlled Withdrawal|Death|0
1107439|NCT01810939|3628498|P3|Part B Placebo-Controlled Withdrawal|Adverse Event|1
1107440|NCT01810939|3628499|P2|Part B Placebo-Controlled Withdrawal|Adverse Event|1
1107441|NCT01810939|3628500|P1|Part B Placebo-Controlled Withdrawal|Adverse Event|0
1107442|NCT01810939|3628498|P3|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
1107443|NCT01810939|3628499|P2|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1
1107444|NCT01810939|3628500|P1|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
1107445|NCT01810939|3628498|P3|Part B Placebo-Controlled Withdrawal|Physician Decision|1
1107446|NCT01810939|3628499|P2|Part B Placebo-Controlled Withdrawal|Physician Decision|1
1107447|NCT01810939|3628500|P1|Part B Placebo-Controlled Withdrawal|Physician Decision|0
1107448|NCT01810939|3628498|P3|Part A Treatment Period|Protocol-specified (Low K+)|0
1107449|NCT01810939|3628499|P2|Part A Treatment Period|Protocol-specified (Low K+)|0
1107450|NCT01810939|3628500|P1|Part A Treatment Period|Protocol-specified (Low K+)|1
1107451|NCT01810939|3628498|P3|Part A Treatment Period|Protocol-specified (High K+)|0
1107452|NCT01810939|3628499|P2|Part A Treatment Period|Protocol-specified (High K+)|0
1107453|NCT01810939|3628500|P1|Part A Treatment Period|Protocol-specified (High K+)|3
1107454|NCT01810939|3628498|P3|Part A Treatment Period|Protocol-specified (eGFR)|0
1107455|NCT01810939|3628499|P2|Part A Treatment Period|Protocol-specified (eGFR)|0
1107456|NCT01810939|3628500|P1|Part A Treatment Period|Protocol-specified (eGFR)|2
1107457|NCT01810939|3628498|P3|Part A Treatment Period|Withdrawal by Subject|0
1107458|NCT01810939|3628499|P2|Part A Treatment Period|Withdrawal by Subject|0
1107459|NCT01810939|3628500|P1|Part A Treatment Period|Withdrawal by Subject|5
1107460|NCT01810939|3628498|P3|Part A Treatment Period|Adverse Event|0
1107461|NCT01810939|3628499|P2|Part A Treatment Period|Adverse Event|0
1107462|NCT01810939|3628500|P1|Part A Treatment Period|Adverse Event|10
1107463|NCT01810939|3628498|P3|Part A Treatment Period|Protocol Violation|0
1107464|NCT01810939|3628499|P2|Part A Treatment Period|Protocol Violation|0
1107465|NCT01810939|3628500|P1|Part A Treatment Period|Protocol Violation|2
1107466|NCT01810939|3628498|P3|Part A Treatment Period|Non-compliance with Study Drug|0
1107467|NCT01810939|3628499|P2|Part A Treatment Period|Non-compliance with Study Drug|0
1107468|NCT01810939|3628500|P1|Part A Treatment Period|Non-compliance with Study Drug|1
1107469|NCT01810783|3628513|P1|Overall Study|Enrolled, not treated|1
1107470|NCT01810783|3628513|P1|Overall Study|Adminstrative or other reason(s)|23
1107471|NCT01810783|3628513|P1|Overall Study|Non-compliance with IMP|4
1107472|NCT01810783|3628513|P1|Overall Study|Protocol Violation|5
1107473|NCT01810783|3628513|P1|Overall Study|Lost to Follow-up|10
1107474|NCT01810783|3628513|P1|Overall Study|Lack of Efficacy|12
1107475|NCT01810783|3628513|P1|Overall Study|Withdrawal by Subject|22
1107476|NCT01810783|3628513|P1|Overall Study|Adverse Event|32
1107477|NCT01810432|3628538|P2|Period 2|Lost to Follow-up|1
1107478|NCT01810432|3628539|P1|Period 2|Lost to Follow-up|1
1107479|NCT01810432|3628538|P2|Period 2|Physician Decision|0
1107480|NCT01810432|3628539|P1|Period 2|Physician Decision|1
1107481|NCT01810432|3628538|P2|Period 2|Withdrawal by Subject|1
1107482|NCT01810432|3628539|P1|Period 2|Withdrawal by Subject|2
1107483|NCT01810432|3628538|P2|Washout|Adverse Event|0
1107484|NCT01810432|3628539|P1|Washout|Adverse Event|1
1107485|NCT01810432|3628538|P2|Washout|Protocol Violation|1
1107486|NCT01810432|3628539|P1|Washout|Protocol Violation|0
1107487|NCT01810380|3628552|P3|Overall Study|Administrative or other reasons|9
1107488|NCT01810380|3628553|P2|Overall Study|Administrative or other reasons|13
1107489|NCT01810380|3628554|P1|Overall Study|Administrative or other reasons|11
1107490|NCT01810380|3628552|P3|Overall Study|Withdrawal by Subject|6
1107491|NCT01810380|3628553|P2|Overall Study|Withdrawal by Subject|0
1107492|NCT01810380|3628554|P1|Overall Study|Withdrawal by Subject|6
1107493|NCT01810380|3628552|P3|Overall Study|Protocol Violation|1
1107494|NCT01810380|3628553|P2|Overall Study|Protocol Violation|0
1107495|NCT01810380|3628554|P1|Overall Study|Protocol Violation|1
1107496|NCT01810380|3628552|P3|Overall Study|Lack of Efficacy|11
1107497|NCT01810380|3628553|P2|Overall Study|Lack of Efficacy|10
1107498|NCT01810380|3628554|P1|Overall Study|Lack of Efficacy|24
1107499|NCT01810380|3628552|P3|Overall Study|Adverse Event|4
1107500|NCT01810380|3628553|P2|Overall Study|Adverse Event|14
1107501|NCT01810380|3628554|P1|Overall Study|Adverse Event|11
1107502|NCT01810380|3628552|P3|Overall Study|Randomised not treated|1
1107503|NCT01810380|3628553|P2|Overall Study|Randomised not treated|1
1107504|NCT01810380|3628554|P1|Overall Study|Randomised not treated|2
1107505|NCT01810302|3628615|P2|Overall Study|Physician Decision|1
1107506|NCT01810302|3628616|P1|Overall Study|Physician Decision|0
1107507|NCT01810302|3628615|P2|Overall Study|Death|0
1107508|NCT01810302|3628616|P1|Overall Study|Death|1
1107509|NCT01810263|3628643|P2|Overall Study|Lost to Follow-up|7
1107510|NCT01810263|3628644|P1|Overall Study|Lost to Follow-up|8
1107511|NCT01810042|3628650|P1|Overall Study|Lost to Follow-up|10
1107512|NCT01810016|3628660|P3|Overall Study|Death|1
1107513|NCT01810016|3628661|P2|Overall Study|Death|0
1107514|NCT01810016|3628662|P1|Overall Study|Death|0
1107515|NCT01810016|3628660|P3|Overall Study|Progressive disease|0
1107516|NCT01810016|3628661|P2|Overall Study|Progressive disease|1
1107517|NCT01810016|3628662|P1|Overall Study|Progressive disease|1
1107518|NCT01809327|3628732|P5|Overall Study|Other|9
1107519|NCT01809327|3628733|P4|Overall Study|Other|4
1107520|NCT01809327|3628734|P3|Overall Study|Other|7
1107521|NCT01809327|3628735|P2|Overall Study|Other|15
1107522|NCT01809327|3628736|P1|Overall Study|Other|14
1107523|NCT01809327|3628732|P5|Overall Study|Pregnancy|0
1107524|NCT01809327|3628733|P4|Overall Study|Pregnancy|0
1107525|NCT01809327|3628734|P3|Overall Study|Pregnancy|0
1107526|NCT01809327|3628735|P2|Overall Study|Pregnancy|0
1107527|NCT01809327|3628736|P1|Overall Study|Pregnancy|1
1107528|NCT01809327|3628732|P5|Overall Study|Physician Decision|0
1107529|NCT01809327|3628733|P4|Overall Study|Physician Decision|0
1107530|NCT01809327|3628734|P3|Overall Study|Physician Decision|0
1107531|NCT01809327|3628735|P2|Overall Study|Physician Decision|1
1107532|NCT01809327|3628736|P1|Overall Study|Physician Decision|1
1107533|NCT01809327|3628732|P5|Overall Study|Protocol Violation|0
1107534|NCT01809327|3628733|P4|Overall Study|Protocol Violation|0
1107535|NCT01809327|3628734|P3|Overall Study|Protocol Violation|0
1107536|NCT01809327|3628735|P2|Overall Study|Protocol Violation|1
1107537|NCT01809327|3628736|P1|Overall Study|Protocol Violation|0
1107538|NCT01809327|3628732|P5|Overall Study|Death|0
1107539|NCT01809327|3628733|P4|Overall Study|Death|0
1107540|NCT01809327|3628734|P3|Overall Study|Death|0
1107541|NCT01809327|3628735|P2|Overall Study|Death|0
1107542|NCT01809327|3628736|P1|Overall Study|Death|1
1107543|NCT01809327|3628732|P5|Overall Study|Adverse Event|8
1107544|NCT01809327|3628733|P4|Overall Study|Adverse Event|4
1107545|NCT01809327|3628734|P3|Overall Study|Adverse Event|7
1107546|NCT01809327|3628735|P2|Overall Study|Adverse Event|3
1107547|NCT01809327|3628736|P1|Overall Study|Adverse Event|4
1107548|NCT01809327|3628732|P5|Overall Study|Withdrawal by Subject|5
1107549|NCT01809327|3628733|P4|Overall Study|Withdrawal by Subject|2
1107550|NCT01809327|3628734|P3|Overall Study|Withdrawal by Subject|4
1107551|NCT01809327|3628735|P2|Overall Study|Withdrawal by Subject|4
1107552|NCT01809327|3628736|P1|Overall Study|Withdrawal by Subject|6
1107553|NCT01809327|3628732|P5|Overall Study|Lost to Follow-up|3
1107554|NCT01809327|3628733|P4|Overall Study|Lost to Follow-up|2
1107555|NCT01809327|3628734|P3|Overall Study|Lost to Follow-up|4
1107556|NCT01809327|3628735|P2|Overall Study|Lost to Follow-up|2
1107557|NCT01809327|3628736|P1|Overall Study|Lost to Follow-up|5
1107558|NCT01809314|3628778|P1|Overall Study|Lost to Follow-up|724
1107559|NCT01809314|3628778|P1|Overall Study|Insufficient Therapeutic Response|14
1107560|NCT01809314|3628778|P1|Overall Study|Adverse Event|6
1107561|NCT01809314|3628778|P1|Overall Study|Withdrawal Prior to Treatment|1
1107562|NCT01809262|3628784|P10|Period 3 (Third Dose + Washout)|Adverse Event|0
1107563|NCT01809262|3628785|P9|Period 3 (Third Dose + Washout)|Adverse Event|0
1107564|NCT01809262|3628786|P8|Period 3 (Third Dose + Washout)|Adverse Event|0
1107565|NCT01809262|3628787|P7|Period 3 (Third Dose + Washout)|Adverse Event|0
1107566|NCT01809262|3628788|P6|Period 3 (Third Dose + Washout)|Adverse Event|0
1107567|NCT01809262|3628789|P5|Period 3 (Third Dose + Washout)|Adverse Event|0
1107568|NCT01809262|3628790|P4|Period 3 (Third Dose + Washout)|Adverse Event|0
1107569|NCT01809262|3628791|P3|Period 3 (Third Dose + Washout)|Adverse Event|0
1107570|NCT01809262|3628792|P2|Period 3 (Third Dose + Washout)|Adverse Event|1
1107571|NCT01809262|3628793|P1|Period 3 (Third Dose + Washout)|Adverse Event|0
1107572|NCT01809262|3628784|P10|Period 1 (First Dose + Washout)|Adverse Event|0
1107573|NCT01809262|3628785|P9|Period 1 (First Dose + Washout)|Adverse Event|0
1107574|NCT01809262|3628786|P8|Period 1 (First Dose + Washout)|Adverse Event|0
1107575|NCT01809262|3628787|P7|Period 1 (First Dose + Washout)|Adverse Event|0
1107576|NCT01809262|3628788|P6|Period 1 (First Dose + Washout)|Adverse Event|0
1107577|NCT01809262|3628789|P5|Period 1 (First Dose + Washout)|Adverse Event|1
1107578|NCT01809262|3628790|P4|Period 1 (First Dose + Washout)|Adverse Event|0
1107579|NCT01809262|3628791|P3|Period 1 (First Dose + Washout)|Adverse Event|0
1107580|NCT01809262|3628792|P2|Period 1 (First Dose + Washout)|Adverse Event|0
1107581|NCT01809262|3628793|P1|Period 1 (First Dose + Washout)|Adverse Event|0
1107582|NCT01809210|3628867|P7|Overall Study|Death|1
1107583|NCT01809210|3628868|P6|Overall Study|Death|3
1107584|NCT01809210|3628869|P5|Overall Study|Death|1
1107585|NCT01809210|3628870|P4|Overall Study|Death|0
1107586|NCT01809210|3628871|P3|Overall Study|Death|2
1107587|NCT01809210|3628872|P2|Overall Study|Death|1
1107588|NCT01809210|3628873|P1|Overall Study|Death|1
1107589|NCT01809210|3628867|P7|Overall Study|Withdrawal by Subject|4
1107590|NCT01809210|3628868|P6|Overall Study|Withdrawal by Subject|0
1107591|NCT01809210|3628869|P5|Overall Study|Withdrawal by Subject|1
1107592|NCT01809210|3628870|P4|Overall Study|Withdrawal by Subject|1
1107593|NCT01809210|3628871|P3|Overall Study|Withdrawal by Subject|1
1107594|NCT01809210|3628872|P2|Overall Study|Withdrawal by Subject|0
1107595|NCT01809210|3628873|P1|Overall Study|Withdrawal by Subject|0
1107596|NCT01809197|3628947|P2|Overall Study|Product not available|1
1107597|NCT01809197|3628948|P1|Overall Study|Product not available|0
1107598|NCT01809197|3628947|P2|Overall Study|Withdrawal by Subject|1
1107599|NCT01809197|3628948|P1|Overall Study|Withdrawal by Subject|1
1107600|NCT01809197|3628947|P2|Overall Study|Decision Unrelated to an Adverse Event|0
1107601|NCT01809197|3628948|P1|Overall Study|Decision Unrelated to an Adverse Event|1
1107602|NCT01809197|3628947|P2|Overall Study|Non-Compliance|1
1107603|NCT01809197|3628948|P1|Overall Study|Non-Compliance|1
1107604|NCT01809197|3628947|P2|Overall Study|Failed slit lamp exam|0
1107605|NCT01809197|3628948|P1|Overall Study|Failed slit lamp exam|1
1107606|NCT01809197|3628947|P2|Overall Study|Adverse Event|3
1107607|NCT01809197|3628948|P1|Overall Study|Adverse Event|2
1107608|NCT01809197|3628947|P2|Overall Study|Lost to Follow-up|2
1107609|NCT01809197|3628948|P1|Overall Study|Lost to Follow-up|4
1107610|NCT01808651|3629019|P3|Study Period 1|Participant Decision|3
1107611|NCT01808651|3629020|P2|Study Period 1|Participant Decision|7
1107612|NCT01808651|3629021|P1|Study Period 1|Participant Decision|9
1107613|NCT01808651|3629019|P3|Study Period 1|Adverse Event|1
1107614|NCT01808651|3629020|P2|Study Period 1|Adverse Event|4
1107615|NCT01808651|3629021|P1|Study Period 1|Adverse Event|10
1107616|NCT01808651|3629019|P3|Study Period 1|Lack of Efficacy|0
1107617|NCT01808651|3629020|P2|Study Period 1|Lack of Efficacy|1
1107618|NCT01808651|3629021|P1|Study Period 1|Lack of Efficacy|2
1107619|NCT01808651|3629019|P3|Study Period 1|Physician Decision|0
1107620|NCT01808651|3629020|P2|Study Period 1|Physician Decision|2
1107621|NCT01808651|3629021|P1|Study Period 1|Physician Decision|3
1107622|NCT01808651|3629019|P3|Study Period 1|Protocol Violation|1
1107623|NCT01808651|3629020|P2|Study Period 1|Protocol Violation|0
1107624|NCT01808651|3629021|P1|Study Period 1|Protocol Violation|1
1107625|NCT01808651|3629019|P3|Study Period 1|Lost to Follow-up|0
1107626|NCT01808651|3629020|P2|Study Period 1|Lost to Follow-up|3
1107627|NCT01808651|3629021|P1|Study Period 1|Lost to Follow-up|1
1107628|NCT01808612|3629056|P3|Discontinuation Period|Lost to Follow-up|0
1107629|NCT01808612|3629057|P2|Discontinuation Period|Lost to Follow-up|1
1107630|NCT01808612|3629058|P1|Discontinuation Period|Lost to Follow-up|0
1107631|NCT01808612|3629056|P3|Discontinuation Period|Physician Decision|0
1107632|NCT01808612|3629057|P2|Discontinuation Period|Physician Decision|0
1107633|NCT01808612|3629058|P1|Discontinuation Period|Physician Decision|1
1107634|NCT01808612|3629056|P3|Discontinuation Period|Adverse Event|0
1107635|NCT01808612|3629057|P2|Discontinuation Period|Adverse Event|0
1107636|NCT01808612|3629058|P1|Discontinuation Period|Adverse Event|1
1107637|NCT01808612|3629056|P3|Treatment Period|Lack of Efficacy|2
1107638|NCT01808612|3629057|P2|Treatment Period|Lack of Efficacy|1
1107639|NCT01808612|3629058|P1|Treatment Period|Lack of Efficacy|1
1107640|NCT01808612|3629056|P3|Treatment Period|Sponsor Decision|0
1107641|NCT01808612|3629057|P2|Treatment Period|Sponsor Decision|0
1107642|NCT01808612|3629058|P1|Treatment Period|Sponsor Decision|1
1107643|NCT01808612|3629056|P3|Treatment Period|Physician Decision|4
1107644|NCT01808612|3629057|P2|Treatment Period|Physician Decision|0
1107645|NCT01808612|3629058|P1|Treatment Period|Physician Decision|1
1107646|NCT01808612|3629056|P3|Treatment Period|Withdrawal by Subject|4
1107647|NCT01808612|3629057|P2|Treatment Period|Withdrawal by Subject|0
1107648|NCT01808612|3629058|P1|Treatment Period|Withdrawal by Subject|1
1107649|NCT01808612|3629056|P3|Treatment Period|Protocol Violation|0
1107650|NCT01808612|3629057|P2|Treatment Period|Protocol Violation|0
1107651|NCT01808612|3629058|P1|Treatment Period|Protocol Violation|1
1107652|NCT01808612|3629056|P3|Treatment Period|Lost to Follow-up|1
1107653|NCT01808612|3629057|P2|Treatment Period|Lost to Follow-up|2
1107654|NCT01808612|3629058|P1|Treatment Period|Lost to Follow-up|2
1107655|NCT01808612|3629056|P3|Treatment Period|Adverse Event|3
1107656|NCT01808612|3629057|P2|Treatment Period|Adverse Event|4
1107657|NCT01808612|3629058|P1|Treatment Period|Adverse Event|8
1107658|NCT01808534|3629124|P1|Overall Study|Physician Decision|1
1107659|NCT01808534|3629124|P1|Overall Study|Disease progression|3
1107660|NCT01808508|3629135|P3|Overall Study|Lost to Follow-up|0
1107661|NCT01808508|3629136|P2|Overall Study|Lost to Follow-up|0
1107662|NCT01808508|3629137|P1|Overall Study|Lost to Follow-up|1
1107663|NCT01808339|3629154|P6|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
1107664|NCT01808339|3629155|P5|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
1107665|NCT01808339|3629156|P4|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
1107666|NCT01808339|3629157|P3|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1
1107667|NCT01808339|3629158|P2|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
1107668|NCT01808339|3629159|P1|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
1107669|NCT01808339|3629154|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1107670|NCT01808339|3629155|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1107671|NCT01808339|3629156|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
1107672|NCT01808339|3629157|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1107673|NCT01808339|3629158|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
1107674|NCT01808339|3629159|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1107675|NCT01808339|3629154|P6|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
1107676|NCT01808339|3629155|P5|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2
1107677|NCT01808339|3629156|P4|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
1107678|NCT01808339|3629157|P3|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
1107679|NCT01808339|3629158|P2|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
1107680|NCT01808339|3629159|P1|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
1107681|NCT01808313|3629203|P1|Overall Study|Physician Decision|1
1107682|NCT01808313|3629203|P1|Overall Study|Lost to Follow-up|1
1107683|NCT01808313|3629203|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
1107684|NCT01808313|3629203|P1|Overall Study|Protocol Violation|2
1107685|NCT01808313|3629203|P1|Overall Study|Adverse Event|5
1107686|NCT01808261|3629233|P2|Overall Study|Lost to Follow-up|1
1107687|NCT01808261|3629234|P1|Overall Study|Lost to Follow-up|3
1107688|NCT01808261|3629233|P2|Overall Study|Consent withdrawn by subject|7
1107689|NCT01808261|3629234|P1|Overall Study|Consent withdrawn by subject|6
1107690|NCT01808261|3629233|P2|Overall Study|Adverse event, non-fatal|0
1107691|NCT01808261|3629234|P1|Overall Study|Adverse event, non-fatal|2
1107692|NCT01808261|3629233|P2|Overall Study|Study Closed/Terminated|23
1107693|NCT01808261|3629234|P1|Overall Study|Study Closed/Terminated|25
1107694|NCT01808261|3629233|P2|Overall Study|Physician Decision|2
1107695|NCT01808261|3629234|P1|Overall Study|Physician Decision|0
1107696|NCT01808248|3629290|P1|Overall Study|Lost to Follow-up|1
1107697|NCT01808248|3629290|P1|Overall Study|Withdrawal by Subject|1
1107698|NCT01808248|3629290|P1|Overall Study|Lack of Efficacy|3
1107699|NCT01808209|3629304|P2|Overall Study|Lost to Follow-up|1
1107700|NCT01808209|3629305|P1|Overall Study|Lost to Follow-up|0
1107701|NCT01808144|3629349|P2|Overall Study|Adverse Event|15
1107702|NCT01808144|3629350|P1|Overall Study|Adverse Event|11
1107703|NCT01808144|3629349|P2|Overall Study|Gout flare|1
1107704|NCT01808144|3629350|P1|Overall Study|Gout flare|0
1107705|NCT01808144|3629349|P2|Overall Study|Protocol Violation|6
1107706|NCT01808144|3629350|P1|Overall Study|Protocol Violation|6
1107707|NCT01808144|3629349|P2|Overall Study|Lost to Follow-up|3
1107708|NCT01808144|3629350|P1|Overall Study|Lost to Follow-up|6
1107709|NCT01808144|3629349|P2|Overall Study|Withdrawal by Subject|23
1107710|NCT01808144|3629350|P1|Overall Study|Withdrawal by Subject|16
1107711|NCT01808144|3629349|P2|Overall Study|Death|0
1107712|NCT01808144|3629350|P1|Overall Study|Death|1
1107713|NCT01808118|3629358|P3|Period 2|Switched to other therapy|0
1107714|NCT01808118|3629359|P2|Period 2|Switched to other therapy|1
1107715|NCT01808118|3629360|P1|Period 2|Switched to other therapy|0
1107716|NCT01808118|3629358|P3|Period 2|Investigator no longer conducting trials|0
1107717|NCT01808118|3629359|P2|Period 2|Investigator no longer conducting trials|1
1107718|NCT01808118|3629360|P1|Period 2|Investigator no longer conducting trials|0
1107719|NCT01808118|3629358|P3|Period 2|Lost to Follow-up|2
1107720|NCT01808118|3629359|P2|Period 2|Lost to Follow-up|0
1107721|NCT01808118|3629360|P1|Period 2|Lost to Follow-up|0
1107722|NCT01808118|3629358|P3|Period 2|Withdrew consent|6
1107723|NCT01808118|3629359|P2|Period 2|Withdrew consent|7
1107724|NCT01808118|3629360|P1|Period 2|Withdrew consent|0
1107725|NCT01808118|3629358|P3|Period 2|Adverse Event|0
1107726|NCT01808118|3629359|P2|Period 2|Adverse Event|4
1107727|NCT01808118|3629360|P1|Period 2|Adverse Event|0
1107728|NCT01808118|3629358|P3|Period 1|Lack of Efficacy|0
1107729|NCT01808118|3629359|P2|Period 1|Lack of Efficacy|0
1107730|NCT01808118|3629360|P1|Period 1|Lack of Efficacy|1
1107731|NCT01808118|3629358|P3|Period 1|Non-compliance per sponsor|0
1107732|NCT01808118|3629359|P2|Period 1|Non-compliance per sponsor|0
1107733|NCT01808118|3629360|P1|Period 1|Non-compliance per sponsor|1
1107734|NCT01808118|3629358|P3|Period 1|Investigator decision: site closure|0
1107735|NCT01808118|3629359|P2|Period 1|Investigator decision: site closure|0
1107736|NCT01808118|3629360|P1|Period 1|Investigator decision: site closure|2
1107737|NCT01808118|3629358|P3|Period 1|Non-conformance with inclusion criteria|0
1107738|NCT01808118|3629359|P2|Period 1|Non-conformance with inclusion criteria|0
1107739|NCT01808118|3629360|P1|Period 1|Non-conformance with inclusion criteria|3
1107740|NCT01808118|3629358|P3|Period 1|Did not meet inclusion criteria|0
1107741|NCT01808118|3629359|P2|Period 1|Did not meet inclusion criteria|0
1107742|NCT01808118|3629360|P1|Period 1|Did not meet inclusion criteria|3
1107743|NCT01808118|3629358|P3|Period 1|Enrolled in error|0
1107744|NCT01808118|3629359|P2|Period 1|Enrolled in error|0
1107745|NCT01808118|3629360|P1|Period 1|Enrolled in error|7
1107746|NCT01808118|3629358|P3|Period 1|Did not meet criteria for remission|0
1107747|NCT01808118|3629359|P2|Period 1|Did not meet criteria for remission|0
1107748|NCT01808118|3629360|P1|Period 1|Did not meet criteria for remission|303
1107749|NCT01808118|3629358|P3|Period 1|Lost to Follow-up|0
1107750|NCT01808118|3629359|P2|Period 1|Lost to Follow-up|0
1107751|NCT01808118|3629360|P1|Period 1|Lost to Follow-up|9
1107752|NCT01808118|3629358|P3|Period 1|Withdrew consent|0
1107753|NCT01808118|3629359|P2|Period 1|Withdrew consent|0
1107754|NCT01808118|3629360|P1|Period 1|Withdrew consent|24
1107755|NCT01808118|3629358|P3|Period 1|Adverse Event|0
1107756|NCT01808118|3629359|P2|Period 1|Adverse Event|0
1107757|NCT01808118|3629360|P1|Period 1|Adverse Event|15
1107758|NCT01808092|3629423|P2|Overall Study|Other Eligibility criteria|5
1107759|NCT01808092|3629424|P1|Overall Study|Other Eligibility criteria|3
1107760|NCT01808092|3629423|P2|Overall Study|Withdrawal by Subject|4
1107761|NCT01808092|3629424|P1|Overall Study|Withdrawal by Subject|9
1107762|NCT01808092|3629423|P2|Overall Study|Lost to Follow-up|7
1107763|NCT01808092|3629424|P1|Overall Study|Lost to Follow-up|3
1107764|NCT01808092|3629423|P2|Overall Study|Death|29
1107765|NCT01808092|3629424|P1|Overall Study|Death|39
1107766|NCT01808066|3629526|P1|Overall Study|Withdrawal by Subject|15
1107767|NCT01807949|3629537|P3|Overall Study|Randomized But Not Treated|2
1107768|NCT01807949|3629538|P2|Overall Study|Randomized But Not Treated|2
1107769|NCT01807949|3629539|P1|Overall Study|Randomized But Not Treated|0
1107770|NCT01807949|3629537|P3|Overall Study|Undefined|2
1107771|NCT01807949|3629538|P2|Overall Study|Undefined|1
1107772|NCT01807949|3629539|P1|Overall Study|Undefined|0
1107773|NCT01807949|3629537|P3|Overall Study|Non-Compliance|1
1107774|NCT01807949|3629538|P2|Overall Study|Non-Compliance|0
1107775|NCT01807949|3629539|P1|Overall Study|Non-Compliance|0
1107776|NCT01807949|3629537|P3|Overall Study|Withdrawal by Subject|2
1107777|NCT01807949|3629538|P2|Overall Study|Withdrawal by Subject|2
1107778|NCT01807949|3629539|P1|Overall Study|Withdrawal by Subject|1
1107779|NCT01807949|3629537|P3|Overall Study|Adverse Event|2
1107780|NCT01807949|3629538|P2|Overall Study|Adverse Event|2
1107781|NCT01807949|3629539|P1|Overall Study|Adverse Event|1
1107782|NCT01807923|3629591|P3|Overall Study|Randomized But Not Treated|5
1107783|NCT01807923|3629592|P2|Overall Study|Randomized But Not Treated|2
1107784|NCT01807923|3629593|P1|Overall Study|Randomized But Not Treated|3
1107785|NCT01807923|3629591|P3|Overall Study|Not Eligible (Genotype)|1
1107786|NCT01807923|3629592|P2|Overall Study|Not Eligible (Genotype)|0
1107787|NCT01807923|3629593|P1|Overall Study|Not Eligible (Genotype)|0
1107788|NCT01807923|3629591|P3|Overall Study|Physician Decision|1
1107789|NCT01807923|3629592|P2|Overall Study|Physician Decision|0
1107790|NCT01807923|3629593|P1|Overall Study|Physician Decision|0
1107791|NCT01807923|3629591|P3|Overall Study|Withdrawal of Consent (not due to AE)|2
1107792|NCT01807923|3629592|P2|Overall Study|Withdrawal of Consent (not due to AE)|3
1107793|NCT01807923|3629593|P1|Overall Study|Withdrawal of Consent (not due to AE)|0
1107794|NCT01807923|3629591|P3|Overall Study|Adverse Event|2
1107795|NCT01807923|3629592|P2|Overall Study|Adverse Event|1
1107796|NCT01807923|3629593|P1|Overall Study|Adverse Event|2
1107797|NCT01807650|3629655|P1|Overall Study|Other|2
1107798|NCT01807650|3629655|P1|Overall Study|Adverse Event|5
1107799|NCT01807650|3629655|P1|Overall Study|Lack of Full Wound Closure at Day 28|13
1107800|NCT01807520|3629762|P7|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1
1107801|NCT01807520|3629763|P6|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2
1107802|NCT01807520|3629764|P5|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
1107803|NCT01807520|3629765|P4|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
1107804|NCT01807520|3629766|P3|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
1107805|NCT01807520|3629767|P2|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
1107806|NCT01807520|3629768|P1|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
1107807|NCT01807520|3629762|P7|Follow-up Period (132-140 Weeks)|Study terminated|0
1107808|NCT01807520|3629763|P6|Follow-up Period (132-140 Weeks)|Study terminated|1
1107809|NCT01807520|3629764|P5|Follow-up Period (132-140 Weeks)|Study terminated|0
1107810|NCT01807520|3629765|P4|Follow-up Period (132-140 Weeks)|Study terminated|0
1107811|NCT01807520|3629766|P3|Follow-up Period (132-140 Weeks)|Study terminated|0
1107812|NCT01807520|3629767|P2|Follow-up Period (132-140 Weeks)|Study terminated|0
1107813|NCT01807520|3629768|P1|Follow-up Period (132-140 Weeks)|Study terminated|0
1107814|NCT01807520|3629762|P7|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
1107815|NCT01807520|3629763|P6|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1
1107816|NCT01807520|3629764|P5|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
1107817|NCT01807520|3629765|P4|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
1107818|NCT01807520|3629766|P3|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
1107819|NCT01807520|3629767|P2|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
1107820|NCT01807520|3629768|P1|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
1107821|NCT01807520|3629762|P7|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
1107822|NCT01807520|3629763|P6|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
1107823|NCT01807520|3629764|P5|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
1107824|NCT01807520|3629765|P4|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
1107825|NCT01807520|3629766|P3|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
1107826|NCT01807520|3629767|P2|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6
1107827|NCT01807520|3629768|P1|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5
1107828|NCT01807520|3629762|P7|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
1107829|NCT01807520|3629763|P6|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
1107830|NCT01807520|3629764|P5|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
1107831|NCT01807520|3629765|P4|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
1107832|NCT01807520|3629766|P3|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
1107833|NCT01807520|3629767|P2|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
1107834|NCT01807520|3629768|P1|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
1107835|NCT01807520|3629762|P7|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
1107836|NCT01807520|3629763|P6|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
1107837|NCT01807520|3629764|P5|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1
1107838|NCT01807520|3629765|P4|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
1107839|NCT01807520|3629766|P3|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
1107840|NCT01807520|3629767|P2|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3
1107841|NCT01807520|3629768|P1|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5
1107842|NCT01807520|3629762|P7|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
1107843|NCT01807520|3629763|P6|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
1107844|NCT01807520|3629764|P5|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
1107845|NCT01807520|3629765|P4|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1
1107846|NCT01807520|3629766|P3|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
1107847|NCT01807520|3629767|P2|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
1107848|NCT01807520|3629768|P1|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4
1107849|NCT01807520|3629762|P7|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
1107850|NCT01807520|3629763|P6|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
1107851|NCT01807520|3629764|P5|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
1107852|NCT01807520|3629765|P4|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
1107853|NCT01807520|3629766|P3|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
1107854|NCT01807520|3629767|P2|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2
1107855|NCT01807520|3629768|P1|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
1107856|NCT01807520|3629762|P7|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
1107857|NCT01807520|3629763|P6|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
1107858|NCT01807520|3629764|P5|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
1107859|NCT01807520|3629765|P4|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
1107860|NCT01807520|3629766|P3|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
1107861|NCT01807520|3629767|P2|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
1107862|NCT01807520|3629768|P1|Treatment Period 2 (16-132 Weeks)|Pregnancy|1
1107863|NCT01807520|3629762|P7|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
1107864|NCT01807520|3629763|P6|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
1107865|NCT01807520|3629764|P5|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
1107866|NCT01807520|3629765|P4|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1
1107867|NCT01807520|3629766|P3|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
1107868|NCT01807520|3629767|P2|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
1107869|NCT01807520|3629768|P1|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
1107870|NCT01807520|3629762|P7|Treatment Period 2 (16-132 Weeks)|Study terminated|0
1107871|NCT01807520|3629763|P6|Treatment Period 2 (16-132 Weeks)|Study terminated|0
1107872|NCT01807520|3629764|P5|Treatment Period 2 (16-132 Weeks)|Study terminated|2
1107873|NCT01807520|3629765|P4|Treatment Period 2 (16-132 Weeks)|Study terminated|0
1107874|NCT01807520|3629766|P3|Treatment Period 2 (16-132 Weeks)|Study terminated|0
1107875|NCT01807520|3629767|P2|Treatment Period 2 (16-132 Weeks)|Study terminated|4
1107876|NCT01807520|3629768|P1|Treatment Period 2 (16-132 Weeks)|Study terminated|7
1107877|NCT01807520|3629762|P7|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
1107878|NCT01807520|3629763|P6|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
1107879|NCT01807520|3629764|P5|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
1107880|NCT01807520|3629765|P4|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
1107881|NCT01807520|3629766|P3|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
1107882|NCT01807520|3629767|P2|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
1107883|NCT01807520|3629768|P1|Treatment Period 1 (0-16 Weeks)|Adverse Event|2
1107884|NCT01807520|3629762|P7|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
1107885|NCT01807520|3629763|P6|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
1107886|NCT01807520|3629764|P5|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
1107887|NCT01807520|3629765|P4|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
1107888|NCT01807520|3629766|P3|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2
1107889|NCT01807520|3629767|P2|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
1107890|NCT01807520|3629768|P1|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
1107891|NCT01807520|3629762|P7|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
1107892|NCT01807520|3629763|P6|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
1107893|NCT01807520|3629764|P5|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
1107894|NCT01807520|3629765|P4|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
1107895|NCT01807520|3629766|P3|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
1107896|NCT01807520|3629767|P2|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
1107897|NCT01807520|3629768|P1|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1
1107898|NCT01807520|3629762|P7|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
1107899|NCT01807520|3629763|P6|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
1107900|NCT01807520|3629764|P5|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
1107901|NCT01807520|3629765|P4|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
1107902|NCT01807520|3629766|P3|Treatment Period 1 (0-16 Weeks)|Physician Decision|1
1107903|NCT01807520|3629767|P2|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
1107904|NCT01807520|3629768|P1|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
1107905|NCT01807520|3629762|P7|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
1107906|NCT01807520|3629763|P6|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
1107907|NCT01807520|3629764|P5|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
1107908|NCT01807520|3629765|P4|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
1107909|NCT01807520|3629766|P3|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
1107910|NCT01807520|3629767|P2|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
1107911|NCT01807520|3629768|P1|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
1107912|NCT01807520|3629762|P7|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
1107913|NCT01807520|3629763|P6|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
1107914|NCT01807520|3629764|P5|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
1107915|NCT01807520|3629765|P4|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
1107916|NCT01807520|3629766|P3|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3
1107917|NCT01807520|3629767|P2|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1
1107918|NCT01807520|3629768|P1|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
1107919|NCT01807234|3629801|P6|Overall Study|Lack of Efficacy|1
1107920|NCT01807234|3629802|P5|Overall Study|Lack of Efficacy|1
1107921|NCT01807234|3629803|P4|Overall Study|Lack of Efficacy|0
1107922|NCT01807234|3629804|P3|Overall Study|Lack of Efficacy|0
1107923|NCT01807234|3629805|P2|Overall Study|Lack of Efficacy|0
1107924|NCT01807234|3629806|P1|Overall Study|Lack of Efficacy|0
1107925|NCT01807234|3629801|P6|Overall Study|Withdrawal by Subject|1
1107926|NCT01807234|3629802|P5|Overall Study|Withdrawal by Subject|2
1107927|NCT01807234|3629803|P4|Overall Study|Withdrawal by Subject|1
1107928|NCT01807234|3629804|P3|Overall Study|Withdrawal by Subject|1
1107929|NCT01807234|3629805|P2|Overall Study|Withdrawal by Subject|1
1107930|NCT01807234|3629806|P1|Overall Study|Withdrawal by Subject|3
1107931|NCT01807234|3629801|P6|Overall Study|Lost to Follow-up|2
1107932|NCT01807234|3629802|P5|Overall Study|Lost to Follow-up|1
1107933|NCT01807234|3629803|P4|Overall Study|Lost to Follow-up|1
1107934|NCT01807234|3629804|P3|Overall Study|Lost to Follow-up|1
1107935|NCT01807234|3629805|P2|Overall Study|Lost to Follow-up|5
1107936|NCT01807234|3629806|P1|Overall Study|Lost to Follow-up|2
1107937|NCT01807156|3629841|P1|Overall Study|Physician Decision|1
1107938|NCT01806961|3629865|P1|Overall Study|sponsor decision|16
1107939|NCT01806896|3629871|P2|Overall Study|Other|0
1107940|NCT01806896|3629872|P1|Overall Study|Other|1
1107941|NCT01806896|3629871|P2|Overall Study|Adverse Event|0
1107942|NCT01806896|3629872|P1|Overall Study|Adverse Event|2
1107943|NCT01806779|3629939|P3|Overall Study|Withdrawal by Subject|22
1107944|NCT01806779|3629940|P2|Overall Study|Withdrawal by Subject|23
1107945|NCT01806779|3629941|P1|Overall Study|Withdrawal by Subject|20
1107946|NCT01806779|3629939|P3|Overall Study|Lost to Follow-up|0
1107947|NCT01806779|3629940|P2|Overall Study|Lost to Follow-up|20
1107948|NCT01806779|3629941|P1|Overall Study|Lost to Follow-up|19
1107949|NCT01806779|3629939|P3|Overall Study|Lack of Efficacy|0
1107950|NCT01806779|3629940|P2|Overall Study|Lack of Efficacy|1
1107951|NCT01806779|3629941|P1|Overall Study|Lack of Efficacy|1
1107952|NCT01806779|3629939|P3|Overall Study|Physician Decision|1
1107953|NCT01806779|3629940|P2|Overall Study|Physician Decision|0
1107954|NCT01806779|3629941|P1|Overall Study|Physician Decision|2
1107955|NCT01806714|3629956|P2|Overall Study|No functioning phone number|170
1107956|NCT01806714|3629957|P1|Overall Study|No functioning phone number|200
1107957|NCT01806662|3629967|P2|Second Intervention (Weeks 16-32)|Lost to Follow-up|1
1107958|NCT01806662|3629968|P1|Second Intervention (Weeks 16-32)|Lost to Follow-up|0
1107959|NCT01806662|3629967|P2|Second Intervention (Weeks 16-32)|Lack of Efficacy|3
1107960|NCT01806662|3629968|P1|Second Intervention (Weeks 16-32)|Lack of Efficacy|2
1107961|NCT01806662|3629967|P2|First Intervention (Weeks 0-16)|Adverse Event|1
1107962|NCT01806662|3629968|P1|First Intervention (Weeks 0-16)|Adverse Event|0
1107963|NCT01806662|3629967|P2|First Intervention (Weeks 0-16)|Withdrawal by Subject|0
1107964|NCT01806662|3629968|P1|First Intervention (Weeks 0-16)|Withdrawal by Subject|4
1107965|NCT01806623|3629974|P1|Overall Study|Did not meet the inclusion criteria|56
1107966|NCT01806623|3629974|P1|Overall Study|Adverse Event|1
1107967|NCT01806623|3629974|P1|Overall Study|Withdrawal by Subject|1
1107968|NCT01806597|3629994|P6|Follow-up Period (Week 132 to Week 140)|Physician Decision|1
1107969|NCT01806597|3629995|P5|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
1107970|NCT01806597|3629996|P4|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
1107971|NCT01806597|3629997|P3|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
1107972|NCT01806597|3629998|P2|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
1107973|NCT01806597|3629999|P1|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
1107974|NCT01806597|3629994|P6|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2
1107975|NCT01806597|3629995|P5|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
1107976|NCT01806597|3629996|P4|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
1107977|NCT01806597|3629997|P3|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
1107978|NCT01806597|3629998|P2|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
1107979|NCT01806597|3629999|P1|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
1107980|NCT01806597|3629994|P6|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2
1107981|NCT01806597|3629995|P5|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
1107982|NCT01806597|3629996|P4|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
1107983|NCT01806597|3629997|P3|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
1107984|NCT01806597|3629998|P2|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
1107985|NCT01806597|3629999|P1|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
1107986|NCT01806597|3629994|P6|Follow-up Period (Week 132 to Week 140)|Adverse Event|2
1107987|NCT01806597|3629995|P5|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
1107988|NCT01806597|3629996|P4|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
1107989|NCT01806597|3629997|P3|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
1107990|NCT01806597|3629998|P2|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
1107991|NCT01806597|3629999|P1|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
1107992|NCT01806597|3629994|P6|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5
1107993|NCT01806597|3629995|P5|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
1107994|NCT01806597|3629996|P4|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
1107995|NCT01806597|3629997|P3|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
1107996|NCT01806597|3629998|P2|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
1107997|NCT01806597|3629999|P1|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
1107998|NCT01806597|3629994|P6|Treatment Period 2 (Week 16 to Week 132)|Death|0
1107999|NCT01806597|3629995|P5|Treatment Period 2 (Week 16 to Week 132)|Death|0
1108000|NCT01806597|3629996|P4|Treatment Period 2 (Week 16 to Week 132)|Death|0
1108001|NCT01806597|3629997|P3|Treatment Period 2 (Week 16 to Week 132)|Death|0
1108002|NCT01806597|3629998|P2|Treatment Period 2 (Week 16 to Week 132)|Death|0
1108003|NCT01806597|3629999|P1|Treatment Period 2 (Week 16 to Week 132)|Death|1
1108004|NCT01806597|3629994|P6|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
1108005|NCT01806597|3629995|P5|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
1108006|NCT01806597|3629996|P4|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
1108007|NCT01806597|3629997|P3|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
1108008|NCT01806597|3629998|P2|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
1108009|NCT01806597|3629999|P1|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
1108010|NCT01806597|3629994|P6|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
1108011|NCT01806597|3629995|P5|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
1108012|NCT01806597|3629996|P4|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
1108013|NCT01806597|3629997|P3|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6
1108014|NCT01806597|3629998|P2|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
1108015|NCT01806597|3629999|P1|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10
1108016|NCT01806597|3629994|P6|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
1108017|NCT01806597|3629995|P5|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
1108018|NCT01806597|3629996|P4|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
1108019|NCT01806597|3629997|P3|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
1108020|NCT01806597|3629998|P2|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
1108021|NCT01806597|3629999|P1|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
1108022|NCT01806597|3629994|P6|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
1108023|NCT01806597|3629995|P5|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
1108024|NCT01806597|3629996|P4|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
1108025|NCT01806597|3629997|P3|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
1108026|NCT01806597|3629998|P2|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
1108027|NCT01806597|3629999|P1|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2
1108028|NCT01806597|3629994|P6|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
1108029|NCT01806597|3629995|P5|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
1108030|NCT01806597|3629996|P4|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
1108031|NCT01806597|3629997|P3|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
1108032|NCT01806597|3629998|P2|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
1108033|NCT01806597|3629999|P1|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
1108034|NCT01806597|3629994|P6|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
1108035|NCT01806597|3629995|P5|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
1108036|NCT01806597|3629996|P4|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
1108037|NCT01806597|3629997|P3|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
1108038|NCT01806597|3629998|P2|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
1108039|NCT01806597|3629999|P1|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2
1108040|NCT01806597|3629994|P6|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
1108041|NCT01806597|3629995|P5|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
1108042|NCT01806597|3629996|P4|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1
1108043|NCT01806597|3629997|P3|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3
1108044|NCT01806597|3629998|P2|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5
1108045|NCT01806597|3629999|P1|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12
1108046|NCT01806597|3629994|P6|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0
1108047|NCT01806597|3629995|P5|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1
1108048|NCT01806597|3629996|P4|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3
1108049|NCT01806597|3629997|P3|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4
1108050|NCT01806597|3629998|P2|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6
1108051|NCT01806597|3629999|P1|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9
1108052|NCT01806597|3629994|P6|Period 1 (Baseline to Week 16)|Physician Decision|0
1108053|NCT01806597|3629995|P5|Period 1 (Baseline to Week 16)|Physician Decision|0
1108054|NCT01806597|3629996|P4|Period 1 (Baseline to Week 16)|Physician Decision|0
1108055|NCT01806597|3629997|P3|Period 1 (Baseline to Week 16)|Physician Decision|0
1108056|NCT01806597|3629998|P2|Period 1 (Baseline to Week 16)|Physician Decision|1
1108057|NCT01806597|3629999|P1|Period 1 (Baseline to Week 16)|Physician Decision|0
1108058|NCT01806597|3629994|P6|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
1108059|NCT01806597|3629995|P5|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
1108060|NCT01806597|3629996|P4|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
1108061|NCT01806597|3629997|P3|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
1108062|NCT01806597|3629998|P2|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
1108063|NCT01806597|3629999|P1|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3
1108064|NCT01806597|3629994|P6|Period 1 (Baseline to Week 16)|Protocol Violation|0
1108065|NCT01806597|3629995|P5|Period 1 (Baseline to Week 16)|Protocol Violation|0
1108066|NCT01806597|3629996|P4|Period 1 (Baseline to Week 16)|Protocol Violation|0
1108067|NCT01806597|3629997|P3|Period 1 (Baseline to Week 16)|Protocol Violation|0
1108068|NCT01806597|3629998|P2|Period 1 (Baseline to Week 16)|Protocol Violation|1
1108069|NCT01806597|3629999|P1|Period 1 (Baseline to Week 16)|Protocol Violation|0
1108070|NCT01806597|3629994|P6|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
1108071|NCT01806597|3629995|P5|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
1108072|NCT01806597|3629996|P4|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
1108073|NCT01806597|3629997|P3|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
1108074|NCT01806597|3629998|P2|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
1108075|NCT01806597|3629999|P1|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
1108076|NCT01806597|3629994|P6|Period 1 (Baseline to Week 16)|Adverse Event|0
1108077|NCT01806597|3629995|P5|Period 1 (Baseline to Week 16)|Adverse Event|2
1108078|NCT01806597|3629996|P4|Period 1 (Baseline to Week 16)|Adverse Event|0
1108079|NCT01806597|3629997|P3|Period 1 (Baseline to Week 16)|Adverse Event|0
1108080|NCT01806597|3629998|P2|Period 1 (Baseline to Week 16)|Adverse Event|1
1108081|NCT01806597|3629999|P1|Period 1 (Baseline to Week 16)|Adverse Event|1
1108082|NCT01806584|3630035|P2|Overall Study|Other unspecified|0
1108083|NCT01806584|3630036|P1|Overall Study|Other unspecified|1
1108084|NCT01806584|3630035|P2|Overall Study|Withdrawal by Subject|1
1108085|NCT01806584|3630036|P1|Overall Study|Withdrawal by Subject|1
1108086|NCT01806584|3630035|P2|Overall Study|Study terminated by sponsor|14
1108087|NCT01806584|3630036|P1|Overall Study|Study terminated by sponsor|9
1108088|NCT01806584|3630035|P2|Overall Study|Lost to Follow-up|2
1108089|NCT01806584|3630036|P1|Overall Study|Lost to Follow-up|0
1108090|NCT01806584|3630035|P2|Overall Study|Death|0
1108091|NCT01806584|3630036|P1|Overall Study|Death|1
1108092|NCT01806584|3630035|P2|Overall Study|Adverse Event|1
1108093|NCT01806584|3630036|P1|Overall Study|Adverse Event|2
1108094|NCT01806545|3630050|P2|Overall Study|Withdrawal by Subject|2
1108095|NCT01806545|3630051|P1|Overall Study|Withdrawal by Subject|3
1108096|NCT01806545|3630050|P2|Overall Study|Lost to Follow-up|0
1108097|NCT01806545|3630051|P1|Overall Study|Lost to Follow-up|1
1108098|NCT01806545|3630050|P2|Overall Study|Adverse Event|3
1108099|NCT01806545|3630051|P1|Overall Study|Adverse Event|2
1108100|NCT01806389|3630073|P1|Overall Study|Withdrawal by Subject|4
1108101|NCT01806298|3630087|P1|Overall Study|Other|5
1108102|NCT01806298|3630087|P1|Overall Study|Withdrawal by Subject|1
1108103|NCT01806298|3630087|P1|Overall Study|Protocol Non-compliance|1
1108104|NCT01806298|3630087|P1|Overall Study|Adverse Event|3
1108105|NCT01806051|3630097|P1|Overall Study|Withdrawal by Subject|6
1108106|NCT01805180|3630195|P3|Lead-in Donor Phase|screen failure|0
1108107|NCT01805180|3630196|P2|Lead-in Donor Phase|screen failure|0
1108108|NCT01805180|3630197|P1|Lead-in Donor Phase|screen failure|1
1108109|NCT01804946|3630235|P2|Overall Study|Do not meet inclusion criteria|2
1108110|NCT01804946|3630236|P1|Overall Study|Do not meet inclusion criteria|1
1108111|NCT01804946|3630235|P2|Overall Study|Insufficient data available|1
1108112|NCT01804946|3630236|P1|Overall Study|Insufficient data available|0
1108113|NCT01804946|3630235|P2|Overall Study|Adverse Event|1
1108114|NCT01804946|3630236|P1|Overall Study|Adverse Event|0
1108115|NCT01804946|3630235|P2|Overall Study|Protocol Violation|0
1108116|NCT01804946|3630236|P1|Overall Study|Protocol Violation|1
1108117|NCT01804842|3630274|P3|Overall Study|Personal Reason|1
1108118|NCT01804842|3630275|P2|Overall Study|Personal Reason|0
1108119|NCT01804842|3630276|P1|Overall Study|Personal Reason|0
1108120|NCT01804842|3630274|P3|Overall Study|Non-Compliance|0
1108121|NCT01804842|3630275|P2|Overall Study|Non-Compliance|1
1108122|NCT01804842|3630276|P1|Overall Study|Non-Compliance|1
1108123|NCT01804842|3630274|P3|Overall Study|Lost to Follow-up|0
1108124|NCT01804842|3630275|P2|Overall Study|Lost to Follow-up|0
1108125|NCT01804842|3630276|P1|Overall Study|Lost to Follow-up|1
1108126|NCT01804842|3630274|P3|Overall Study|Adverse Event|0
1108127|NCT01804842|3630275|P2|Overall Study|Adverse Event|1
1108128|NCT01804842|3630276|P1|Overall Study|Adverse Event|1
1108129|NCT01804673|3630293|P1|Overall Study|Other|4
1108130|NCT01804673|3630293|P1|Overall Study|Use of Prohibited Medication|1
1108131|NCT01804673|3630293|P1|Overall Study|No Further Therapy Required|84
1108132|NCT01804673|3630293|P1|Overall Study|Change to Oral Therapy|37
1108133|NCT01804673|3630293|P1|Overall Study|Lack of Efficacy|9
1108134|NCT01804673|3630293|P1|Overall Study|Withdrawal by Subject|1
1108135|NCT01804673|3630293|P1|Overall Study|Adverse Event|4
1108136|NCT01804140|3630313|P1|Overall Study|No sampling or biopsy procedures done|114
1108137|NCT01803737|3630382|P2|Overall Study|Lost to Follow-up|2
1108138|NCT01803737|3630383|P1|Overall Study|Lost to Follow-up|0
1108139|NCT01803737|3630382|P2|Overall Study|Medical Reason|1
1108140|NCT01803737|3630383|P1|Overall Study|Medical Reason|0
1108141|NCT01803737|3630382|P2|Overall Study|Lack of Time|0
1108142|NCT01803737|3630383|P1|Overall Study|Lack of Time|1
1108143|NCT01803711|3630407|P2|Overall Study|Adverse Event|1
1108144|NCT01803711|3630408|P1|Overall Study|Adverse Event|1
1108145|NCT01803646|3630426|P2|Overall Study|Lost to Follow-up|1
1108146|NCT01803646|3630427|P1|Overall Study|Lost to Follow-up|5
1108147|NCT01803646|3630426|P2|Overall Study|Randomization error|2
1108148|NCT01803646|3630427|P1|Overall Study|Randomization error|1
1108149|NCT01803646|3630426|P2|Overall Study|Withdrawal by Subject|6
1108150|NCT01803646|3630427|P1|Overall Study|Withdrawal by Subject|9
1108151|NCT01803646|3630426|P2|Overall Study|Adverse Event|1
1108152|NCT01803646|3630427|P1|Overall Study|Adverse Event|1
1108153|NCT01803646|3630426|P2|Overall Study|Protocol Violation|0
1108154|NCT01803646|3630427|P1|Overall Study|Protocol Violation|1
1108155|NCT01803607|3630439|P2|Overall Study|Withdrawal by Subject|5
1108156|NCT01803607|3630440|P1|Overall Study|Withdrawal by Subject|6
1108157|NCT01803607|3630439|P2|Overall Study|Study terminated by sponsor|56
1108158|NCT01803607|3630440|P1|Overall Study|Study terminated by sponsor|54
1108159|NCT01803607|3630439|P2|Overall Study|Protocol Violation|2
1108160|NCT01803607|3630440|P1|Overall Study|Protocol Violation|3
1108161|NCT01803607|3630439|P2|Overall Study|Lack of Efficacy|1
1108162|NCT01803607|3630440|P1|Overall Study|Lack of Efficacy|0
1108163|NCT01803607|3630439|P2|Overall Study|Adverse Event|3
1108164|NCT01803607|3630440|P1|Overall Study|Adverse Event|5
1108165|NCT01803464|3630464|P4|Overall Study|Withdrawal by Subject|0
1108166|NCT01803464|3630465|P3|Overall Study|Withdrawal by Subject|0
1108167|NCT01803464|3630466|P2|Overall Study|Withdrawal by Subject|0
1108168|NCT01803464|3630467|P1|Overall Study|Withdrawal by Subject|1
1108169|NCT01803464|3630464|P4|Overall Study|Incomplete data|0
1108170|NCT01803464|3630465|P3|Overall Study|Incomplete data|4
1108171|NCT01803464|3630466|P2|Overall Study|Incomplete data|0
1108172|NCT01803464|3630467|P1|Overall Study|Incomplete data|0
1108173|NCT01802775|3630487|P2|Overall Study|Lost to Follow-up|2
1108174|NCT01802775|3630488|P1|Overall Study|Lost to Follow-up|1
1108175|NCT01802775|3630487|P2|Overall Study|Withdrawal by Subject|5
1108176|NCT01802775|3630488|P1|Overall Study|Withdrawal by Subject|3
1108177|NCT01802775|3630487|P2|Overall Study|Adverse Event|1
1108178|NCT01802775|3630488|P1|Overall Study|Adverse Event|1
1108179|NCT01802775|3630487|P2|Overall Study|Physician Decision|0
1108180|NCT01802775|3630488|P1|Overall Study|Physician Decision|1
1108181|NCT01802775|3630487|P2|Overall Study|Reason not provided|1
1108182|NCT01802775|3630488|P1|Overall Study|Reason not provided|0
1108183|NCT01802775|3630487|P2|Overall Study|Death|3
1108184|NCT01802775|3630488|P1|Overall Study|Death|0
1108185|NCT01802632|3630510|P6|Overall Study|Other (not specified)|1
1108186|NCT01802632|3630511|P5|Overall Study|Other (not specified)|0
1108187|NCT01802632|3630512|P4|Overall Study|Other (not specified)|1
1108188|NCT01802632|3630513|P3|Overall Study|Other (not specified)|7
1108189|NCT01802632|3630514|P2|Overall Study|Other (not specified)|0
1108190|NCT01802632|3630515|P1|Overall Study|Other (not specified)|0
1108191|NCT01802632|3630510|P6|Overall Study|Ongoing Study at Data Cut-off|22
1108192|NCT01802632|3630511|P5|Overall Study|Ongoing Study at Data Cut-off|6
1108193|NCT01802632|3630512|P4|Overall Study|Ongoing Study at Data Cut-off|50
1108194|NCT01802632|3630513|P3|Overall Study|Ongoing Study at Data Cut-off|115
1108195|NCT01802632|3630514|P2|Overall Study|Ongoing Study at Data Cut-off|16
1108196|NCT01802632|3630515|P1|Overall Study|Ongoing Study at Data Cut-off|168
1108197|NCT01802632|3630510|P6|Overall Study|Objective Disease Progression|4
1108198|NCT01802632|3630511|P5|Overall Study|Objective Disease Progression|4
1108199|NCT01802632|3630512|P4|Overall Study|Objective Disease Progression|6
1108200|NCT01802632|3630513|P3|Overall Study|Objective Disease Progression|104
1108201|NCT01802632|3630514|P2|Overall Study|Objective Disease Progression|12
1108202|NCT01802632|3630515|P1|Overall Study|Objective Disease Progression|1
1108203|NCT01802632|3630510|P6|Overall Study|Withdrawal by Subject|1
1108204|NCT01802632|3630511|P5|Overall Study|Withdrawal by Subject|0
1108205|NCT01802632|3630512|P4|Overall Study|Withdrawal by Subject|3
1108206|NCT01802632|3630513|P3|Overall Study|Withdrawal by Subject|7
1108207|NCT01802632|3630514|P2|Overall Study|Withdrawal by Subject|2
1108208|NCT01802632|3630515|P1|Overall Study|Withdrawal by Subject|4
1108209|NCT01802632|3630510|P6|Overall Study|Death|0
1108210|NCT01802632|3630511|P5|Overall Study|Death|2
1108211|NCT01802632|3630512|P4|Overall Study|Death|0
1108212|NCT01802632|3630513|P3|Overall Study|Death|38
1108213|NCT01802632|3630514|P2|Overall Study|Death|1
1108214|NCT01802632|3630515|P1|Overall Study|Death|28
1108215|NCT01802515|3630549|P3|Overall Study|Withdrawal by Subject|0
1108216|NCT01802515|3630550|P2|Overall Study|Withdrawal by Subject|0
1108217|NCT01802515|3630551|P1|Overall Study|Withdrawal by Subject|3
1108218|NCT01802333|3630565|P3|Overall Study|Did not start treatment|5
1108219|NCT01802333|3630566|P2|Overall Study|Did not start treatment|2
1108220|NCT01802333|3630567|P1|Overall Study|Did not start treatment|0
1108221|NCT01802333|3630565|P3|Overall Study|Other - not protocol specified|24
1108222|NCT01802333|3630566|P2|Overall Study|Other - not protocol specified|22
1108223|NCT01802333|3630567|P1|Overall Study|Other - not protocol specified|32
1108224|NCT01802333|3630565|P3|Overall Study|Death|13
1108225|NCT01802333|3630566|P2|Overall Study|Death|14
1108226|NCT01802333|3630567|P1|Overall Study|Death|7
1108227|NCT01802333|3630565|P3|Overall Study|Progression/relapse|0
1108228|NCT01802333|3630566|P2|Overall Study|Progression/relapse|3
1108229|NCT01802333|3630567|P1|Overall Study|Progression/relapse|1
1108230|NCT01802333|3630565|P3|Overall Study|Withdrawal by Subject|5
1108231|NCT01802333|3630566|P2|Overall Study|Withdrawal by Subject|6
1108232|NCT01802333|3630567|P1|Overall Study|Withdrawal by Subject|6
1108233|NCT01802333|3630565|P3|Overall Study|Adverse Event|8
1108234|NCT01802333|3630566|P2|Overall Study|Adverse Event|8
1108235|NCT01802333|3630567|P1|Overall Study|Adverse Event|1
1108236|NCT01802333|3630565|P3|Overall Study|Ineligible|8
1108237|NCT01802333|3630566|P2|Overall Study|Ineligible|6
1108238|NCT01802333|3630567|P1|Overall Study|Ineligible|2
1108239|NCT01802320|3630594|P1|Overall Study|Withdrawal by Subject|1
1108240|NCT01802320|3630594|P1|Overall Study|Death|1
1108241|NCT01802073|3630670|P2|Overall Study|Physician Decision|7
1108242|NCT01802073|3630671|P1|Overall Study|Physician Decision|0
1108243|NCT01802073|3630670|P2|Overall Study|Withdrawal by Subject|1
1108244|NCT01802073|3630671|P1|Overall Study|Withdrawal by Subject|1
1108245|NCT01802073|3630670|P2|Overall Study|Non-compliant|2
1108246|NCT01802073|3630671|P1|Overall Study|Non-compliant|4
1108247|NCT01802073|3630670|P2|Overall Study|Lost to Follow-up|1
1108248|NCT01802073|3630671|P1|Overall Study|Lost to Follow-up|0
1108249|NCT01801982|3630687|P1|Overall Study|Lost to Follow-up|1
1108250|NCT01801917|3630701|P4|Period 1 - Randomized|Adverse Event|0
1108251|NCT01801917|3630702|P3|Period 1 - Randomized|Adverse Event|1
1108252|NCT01801917|3630703|P2|Period 1 - Randomized|Adverse Event|0
1108253|NCT01801917|3630704|P1|Period 1 - Randomized|Adverse Event|1
1108254|NCT01801735|3630724|P1|Overall Study|Other, including site closure|19
1108255|NCT01801735|3630724|P1|Overall Study|Death|1
1108256|NCT01801735|3630724|P1|Overall Study|Physician Decision|3
1108257|NCT01801735|3630724|P1|Overall Study|Non-compliance with Trial Drug|13
1108258|NCT01801735|3630724|P1|Overall Study|Lost to Follow-up|15
1108259|NCT01801735|3630724|P1|Overall Study|Protocol Violation|25
1108260|NCT01801735|3630724|P1|Overall Study|Withdrawal by Subject|27
1108261|NCT01801735|3630724|P1|Overall Study|Lack of Efficacy|28
1108262|NCT01801735|3630724|P1|Overall Study|Adverse Event|79
1108263|NCT01801475|3630731|P5|Overall Study|Withdrawal by Subject|1
1108264|NCT01801475|3630732|P4|Overall Study|Withdrawal by Subject|0
1108265|NCT01801475|3630733|P3|Overall Study|Withdrawal by Subject|0
1108266|NCT01801475|3630734|P2|Overall Study|Withdrawal by Subject|0
1108267|NCT01801475|3630735|P1|Overall Study|Withdrawal by Subject|0
1108268|NCT01801436|3630760|P1|Overall Study|Progressive disease|4
1108269|NCT01801436|3630760|P1|Overall Study|Adverse Event|2
1108270|NCT01801436|3630760|P1|Overall Study|Withdrawal by Subject|3
1108271|NCT01801358|3630798|P6|Overall Study|Withdrawal by Subject|2
1108272|NCT01801358|3630799|P5|Overall Study|Withdrawal by Subject|0
1108273|NCT01801358|3630800|P4|Overall Study|Withdrawal by Subject|1
1108274|NCT01801358|3630801|P3|Overall Study|Withdrawal by Subject|0
1108275|NCT01801358|3630802|P2|Overall Study|Withdrawal by Subject|0
1108276|NCT01801358|3630803|P1|Overall Study|Withdrawal by Subject|0
1108277|NCT01801358|3630798|P6|Overall Study|Progressive Disease|5
1108278|NCT01801358|3630799|P5|Overall Study|Progressive Disease|6
1108279|NCT01801358|3630800|P4|Overall Study|Progressive Disease|5
1108280|NCT01801358|3630801|P3|Overall Study|Progressive Disease|4
1108281|NCT01801358|3630802|P2|Overall Study|Progressive Disease|4
1108282|NCT01801358|3630803|P1|Overall Study|Progressive Disease|6
1108283|NCT01801358|3630798|P6|Overall Study|Physician Decision|0
1108284|NCT01801358|3630799|P5|Overall Study|Physician Decision|0
1108285|NCT01801358|3630800|P4|Overall Study|Physician Decision|0
1108286|NCT01801358|3630801|P3|Overall Study|Physician Decision|1
1108287|NCT01801358|3630802|P2|Overall Study|Physician Decision|0
1108288|NCT01801358|3630803|P1|Overall Study|Physician Decision|0
1108289|NCT01801358|3630798|P6|Overall Study|Adverse Event|1
1108290|NCT01801358|3630799|P5|Overall Study|Adverse Event|0
1108291|NCT01801358|3630800|P4|Overall Study|Adverse Event|0
1108292|NCT01801358|3630801|P3|Overall Study|Adverse Event|1
1108293|NCT01801358|3630802|P2|Overall Study|Adverse Event|2
1108294|NCT01801358|3630803|P1|Overall Study|Adverse Event|0
1108295|NCT01801280|3630925|P4|Period 4|Protocol Violation|0
1108296|NCT01801280|3630926|P3|Period 4|Protocol Violation|1
1108297|NCT01801280|3630927|P2|Period 4|Protocol Violation|0
1108298|NCT01801280|3630928|P1|Period 4|Protocol Violation|0
1108299|NCT01801280|3630925|P4|Period 2|Withdrawal by Subject|0
1108300|NCT01801280|3630926|P3|Period 2|Withdrawal by Subject|0
1108301|NCT01801280|3630927|P2|Period 2|Withdrawal by Subject|0
1108302|NCT01801280|3630928|P1|Period 2|Withdrawal by Subject|1
1108303|NCT01801280|3630925|P4|Period 1|Withdrawal by Subject|0
1108304|NCT01801280|3630926|P3|Period 1|Withdrawal by Subject|0
1108305|NCT01801280|3630927|P2|Period 1|Withdrawal by Subject|1
1108306|NCT01801280|3630928|P1|Period 1|Withdrawal by Subject|0
1108307|NCT01801111|3630943|P1|Overall Study|Progressive Disease|81
1108308|NCT01801111|3630943|P1|Overall Study|Study Terminated by Sponsor|27
1108309|NCT01801111|3630943|P1|Overall Study|Withdrawal by Subject|4
1108310|NCT01801111|3630943|P1|Overall Study|Other|1
1108311|NCT01801111|3630943|P1|Overall Study|Physician Decision|5
1108312|NCT01801111|3630943|P1|Overall Study|Death|8
1108313|NCT01801111|3630943|P1|Overall Study|Adverse Event|12
1108314|NCT01800968|3630984|P2|Overall Study|Physician Decision|0
1108315|NCT01800968|3630985|P1|Overall Study|Physician Decision|1
1108316|NCT01800968|3630984|P2|Overall Study|Withdrawal by Subject|9
1108317|NCT01800968|3630985|P1|Overall Study|Withdrawal by Subject|7
1108318|NCT01800968|3630984|P2|Overall Study|Lost to Follow-up|7
1108319|NCT01800968|3630985|P1|Overall Study|Lost to Follow-up|5
1108320|NCT01800968|3630984|P2|Overall Study|Death|16
1108321|NCT01800968|3630985|P1|Overall Study|Death|23
1108322|NCT01800916|3631027|P9|Test Period 1 (1 Week)|Adverse Event|0
1108323|NCT01800916|3631028|P8|Test Period 1 (1 Week)|Adverse Event|0
1108324|NCT01800916|3631029|P7|Test Period 1 (1 Week)|Adverse Event|0
1108325|NCT01800916|3631030|P6|Test Period 1 (1 Week)|Adverse Event|0
1108326|NCT01800916|3631031|P5|Test Period 1 (1 Week)|Adverse Event|1
1108327|NCT01800916|3631032|P4|Test Period 1 (1 Week)|Adverse Event|0
1108328|NCT01800916|3631033|P3|Test Period 1 (1 Week)|Adverse Event|0
1108329|NCT01800916|3631034|P2|Test Period 1 (1 Week)|Adverse Event|0
1108330|NCT01800916|3631035|P1|Test Period 1 (1 Week)|Adverse Event|0
1108331|NCT01800916|3631027|P9|Test Period 1 (1 Week)|Convex product user|0
1108332|NCT01800916|3631028|P8|Test Period 1 (1 Week)|Convex product user|0
1108333|NCT01800916|3631029|P7|Test Period 1 (1 Week)|Convex product user|0
1108334|NCT01800916|3631030|P6|Test Period 1 (1 Week)|Convex product user|0
1108335|NCT01800916|3631031|P5|Test Period 1 (1 Week)|Convex product user|0
1108336|NCT01800916|3631032|P4|Test Period 1 (1 Week)|Convex product user|1
1108337|NCT01800916|3631033|P3|Test Period 1 (1 Week)|Convex product user|0
1108338|NCT01800916|3631034|P2|Test Period 1 (1 Week)|Convex product user|0
1108339|NCT01800916|3631035|P1|Test Period 1 (1 Week)|Convex product user|0
1108340|NCT01800903|3631045|P6|Second Test Period|unable to catheterise|0
1108341|NCT01800903|3631046|P5|Second Test Period|unable to catheterise|0
1108342|NCT01800903|3631047|P4|Second Test Period|unable to catheterise|0
1108343|NCT01800903|3631048|P3|Second Test Period|unable to catheterise|0
1108344|NCT01800903|3631049|P2|Second Test Period|unable to catheterise|0
1108345|NCT01800903|3631050|P1|Second Test Period|unable to catheterise|1
1108346|NCT01799993|3631147|P2|Overall Study|Subject didn't return for follow-up|1
1108347|NCT01799993|3631148|P1|Overall Study|Subject didn't return for follow-up|0
1108348|NCT01799993|3631147|P2|Overall Study|Other|0
1108349|NCT01799993|3631148|P1|Overall Study|Other|1
1108350|NCT01799993|3631147|P2|Overall Study|Withdrawal by parent/guardian|1
1108351|NCT01799993|3631148|P1|Overall Study|Withdrawal by parent/guardian|0
1108352|NCT01799993|3631147|P2|Overall Study|Non-compliance with medical device|0
1108353|NCT01799993|3631148|P1|Overall Study|Non-compliance with medical device|1
1108354|NCT01799993|3631147|P2|Overall Study|Protocol deviation|0
1108355|NCT01799993|3631148|P1|Overall Study|Protocol deviation|1
1108356|NCT01799993|3631147|P2|Overall Study|Logistical difficulties|0
1108357|NCT01799993|3631148|P1|Overall Study|Logistical difficulties|1
1108358|NCT01799993|3631147|P2|Overall Study|Recovery|1
1108359|NCT01799993|3631148|P1|Overall Study|Recovery|0
1108360|NCT01799993|3631147|P2|Overall Study|Lack of Efficacy|0
1108361|NCT01799993|3631148|P1|Overall Study|Lack of Efficacy|1
1108362|NCT01799993|3631147|P2|Overall Study|Adverse Event|0
1108363|NCT01799993|3631148|P1|Overall Study|Adverse Event|1
1108364|NCT01799993|3631147|P2|Overall Study|Screen failure|1
1108365|NCT01799993|3631148|P1|Overall Study|Screen failure|0
1108366|NCT01799993|3631147|P2|Overall Study|Deterioration of general conditions|0
1108367|NCT01799993|3631148|P1|Overall Study|Deterioration of general conditions|2
1108368|NCT01799993|3631147|P2|Overall Study|Protocol Violation|1
1108369|NCT01799993|3631148|P1|Overall Study|Protocol Violation|1
1108370|NCT01799993|3631147|P2|Overall Study|Protocol driven decision point|3
1108371|NCT01799993|3631148|P1|Overall Study|Protocol driven decision point|0
1108372|NCT01799993|3631147|P2|Overall Study|Withdrawal by parent/guardian/LAR|3
1108373|NCT01799993|3631148|P1|Overall Study|Withdrawal by parent/guardian/LAR|5
1108374|NCT01799993|3631147|P2|Overall Study|Lost to Follow-up|8
1108375|NCT01799993|3631148|P1|Overall Study|Lost to Follow-up|5
1108376|NCT01799993|3631147|P2|Overall Study|Withdrawal by Subject|24
1108377|NCT01799993|3631148|P1|Overall Study|Withdrawal by Subject|23
1108378|NCT01799993|3631147|P2|Overall Study|Death|45
1108379|NCT01799993|3631148|P1|Overall Study|Death|61
1108380|NCT01799993|3631147|P2|Overall Study|"Didn't complete CRF page End of FU"|40
1108381|NCT01799993|3631148|P1|Overall Study|"Didn't complete CRF page End of FU"|30
1108382|NCT01799941|3631180|P1|Overall Study|Not Specified|15
1108383|NCT01799941|3631180|P1|Overall Study|Lost to Follow-up|17
1108384|NCT01799941|3631180|P1|Overall Study|Lack of Efficacy|3
1108385|NCT01799941|3631180|P1|Overall Study|Investigator Decision|4
1108386|NCT01799941|3631180|P1|Overall Study|Death|2
1108387|NCT01799941|3631180|P1|Overall Study|Withdrawal by Subject|21
1108388|NCT01799941|3631180|P1|Overall Study|Adverse Event|34
1108389|NCT01799720|3631237|P3|Overall Study|Pregnancy|1
1108390|NCT01799720|3631238|P2|Overall Study|Pregnancy|0
1108391|NCT01799720|3631239|P1|Overall Study|Pregnancy|0
1108392|NCT01799720|3631237|P3|Overall Study|Protocol Violation|0
1108393|NCT01799720|3631238|P2|Overall Study|Protocol Violation|1
1108394|NCT01799720|3631239|P1|Overall Study|Protocol Violation|0
1108395|NCT01799720|3631237|P3|Overall Study|Withdrawal by Subject|0
1108396|NCT01799720|3631238|P2|Overall Study|Withdrawal by Subject|0
1108397|NCT01799720|3631239|P1|Overall Study|Withdrawal by Subject|3
1108398|NCT01799590|3631277|P3|Overall Study|Other|1
1108399|NCT01799590|3631278|P2|Overall Study|Other|0
1108400|NCT01799590|3631279|P1|Overall Study|Other|3
1108401|NCT01799590|3631277|P3|Overall Study|Use of prohibited concomitant drugs|0
1108402|NCT01799590|3631278|P2|Overall Study|Use of prohibited concomitant drugs|0
1108403|NCT01799590|3631279|P1|Overall Study|Use of prohibited concomitant drugs|1
1108404|NCT01799590|3631277|P3|Overall Study|Using drugs with restricted days of use|2
1108405|NCT01799590|3631278|P2|Overall Study|Using drugs with restricted days of use|3
1108406|NCT01799590|3631279|P1|Overall Study|Using drugs with restricted days of use|0
1108407|NCT01799590|3631277|P3|Overall Study|Aggravation of complications|1
1108408|NCT01799590|3631278|P2|Overall Study|Aggravation of complications|1
1108409|NCT01799590|3631279|P1|Overall Study|Aggravation of complications|0
1108410|NCT01799590|3631277|P3|Overall Study|Participants convenience|2
1108411|NCT01799590|3631278|P2|Overall Study|Participants convenience|4
1108412|NCT01799590|3631279|P1|Overall Study|Participants convenience|4
1108413|NCT01799590|3631277|P3|Overall Study|Lack of Efficacy|3
1108414|NCT01799590|3631278|P2|Overall Study|Lack of Efficacy|1
1108415|NCT01799590|3631279|P1|Overall Study|Lack of Efficacy|3
1108416|NCT01799590|3631277|P3|Overall Study|Pregnancy|0
1108417|NCT01799590|3631278|P2|Overall Study|Pregnancy|0
1108418|NCT01799590|3631279|P1|Overall Study|Pregnancy|2
1108419|NCT01799590|3631277|P3|Overall Study|Adverse Event|5
1108420|NCT01799590|3631278|P2|Overall Study|Adverse Event|7
1108421|NCT01799590|3631279|P1|Overall Study|Adverse Event|13
1108422|NCT01799239|3631322|P2|Period 2 (7 Days)|Protocol Violation|0
1108423|NCT01799239|3631323|P1|Period 2 (7 Days)|Protocol Violation|1
1108424|NCT01799239|3631322|P2|Period 2 (7 Days)|Withdrawal by Subject|1
1108425|NCT01799239|3631323|P1|Period 2 (7 Days)|Withdrawal by Subject|1
1108426|NCT01799239|3631322|P2|Period 1 (7 Days)|Protocol Violation|1
1108427|NCT01799239|3631323|P1|Period 1 (7 Days)|Protocol Violation|0
1108428|NCT01799239|3631322|P2|Period 1 (7 Days)|Withdrawal by Subject|0
1108429|NCT01799239|3631323|P1|Period 1 (7 Days)|Withdrawal by Subject|2
1108430|NCT01799239|3631322|P2|Period 1 (7 Days)|Lack of Efficacy|0
1108431|NCT01799239|3631323|P1|Period 1 (7 Days)|Lack of Efficacy|1
1108432|NCT01799226|3631331|P2|Overall Study|Disqualified at Day 14|0
1108433|NCT01799226|3631332|P1|Overall Study|Disqualified at Day 14|1
1108434|NCT01799226|3631331|P2|Overall Study|Withdrawal by Subject|0
1108435|NCT01799226|3631332|P1|Overall Study|Withdrawal by Subject|1
1108436|NCT01798992|3631344|P4|Overall Study|Insufficient biopsy tissue|0
1108437|NCT01798992|3631345|P3|Overall Study|Insufficient biopsy tissue|1
1108438|NCT01798992|3631346|P2|Overall Study|Insufficient biopsy tissue|0
1108439|NCT01798992|3631347|P1|Overall Study|Insufficient biopsy tissue|0
1108440|NCT01798992|3631344|P4|Overall Study|Lost to Follow-up|0
1108441|NCT01798992|3631345|P3|Overall Study|Lost to Follow-up|1
1108442|NCT01798992|3631346|P2|Overall Study|Lost to Follow-up|1
1108443|NCT01798992|3631347|P1|Overall Study|Lost to Follow-up|0
1108444|NCT01798992|3631344|P4|Overall Study|Administrative withdrawal|1
1108445|NCT01798992|3631345|P3|Overall Study|Administrative withdrawal|0
1108446|NCT01798992|3631346|P2|Overall Study|Administrative withdrawal|1
1108447|NCT01798992|3631347|P1|Overall Study|Administrative withdrawal|0
1108448|NCT01798927|3631367|P1|Overall Study|Withdrawal by Subject|1
1108449|NCT01798706|3631375|P2|Overall Study|Other than specified above|9
1108450|NCT01798706|3631376|P1|Overall Study|Other than specified above|5
1108451|NCT01798706|3631375|P2|Overall Study|Poor compliance to protocol|0
1108452|NCT01798706|3631376|P1|Overall Study|Poor compliance to protocol|1
1108453|NCT01798706|3631375|P2|Overall Study|Lack of Efficacy|2
1108454|NCT01798706|3631376|P1|Overall Study|Lack of Efficacy|0
1108455|NCT01798706|3631375|P2|Overall Study|Adverse Event|10
1108456|NCT01798706|3631376|P1|Overall Study|Adverse Event|15
1108457|NCT01798485|3631438|P2|Overall Study|Clinical Progression|24
1108458|NCT01798485|3631439|P1|Overall Study|Clinical Progression|35
1108459|NCT01798485|3631438|P2|Overall Study|Sponsor Decision|54
1108460|NCT01798485|3631439|P1|Overall Study|Sponsor Decision|61
1108461|NCT01798485|3631438|P2|Overall Study|Death|22
1108462|NCT01798485|3631439|P1|Overall Study|Death|25
1108463|NCT01798485|3631438|P2|Overall Study|Objective Disease Progression|106
1108464|NCT01798485|3631439|P1|Overall Study|Objective Disease Progression|152
1108465|NCT01798485|3631438|P2|Overall Study|Physician Decision|10
1108466|NCT01798485|3631439|P1|Overall Study|Physician Decision|14
1108467|NCT01798485|3631438|P2|Overall Study|Lost to Follow-up|3
1108468|NCT01798485|3631439|P1|Overall Study|Lost to Follow-up|0
1108469|NCT01798485|3631438|P2|Overall Study|Withdrawal by Subject|31
1108470|NCT01798485|3631439|P1|Overall Study|Withdrawal by Subject|27
1108471|NCT01798485|3631438|P2|Overall Study|Adverse Event|40
1108472|NCT01798485|3631439|P1|Overall Study|Adverse Event|32
1108473|NCT01798134|3631576|P1|Overall Study|Liver transplant/surgery|4
1108474|NCT01798134|3631576|P1|Overall Study|Physician Decision|3
1108475|NCT01798134|3631576|P1|Overall Study|Adverse Event|3
1108476|NCT01798134|3631576|P1|Overall Study|Death|2
1108477|NCT01798134|3631576|P1|Overall Study|Withdrawal by Subject|3
1108478|NCT01798134|3631576|P1|Overall Study|Lost to Follow-up|1
1108479|NCT01798056|3631585|P2|Overall Study|Other|2
1108480|NCT01798056|3631586|P1|Overall Study|Other|0
1108481|NCT01798056|3631585|P2|Overall Study|Lost to Follow-up|1
1108482|NCT01798056|3631586|P1|Overall Study|Lost to Follow-up|1
1108483|NCT01798056|3631585|P2|Overall Study|Migrated/moved from study area|1
1108484|NCT01798056|3631586|P1|Overall Study|Migrated/moved from study area|1
1108485|NCT01798056|3631585|P2|Overall Study|Withdrawal by Subject|9
1108486|NCT01798056|3631586|P1|Overall Study|Withdrawal by Subject|12
1108487|NCT01798056|3631585|P2|Overall Study|Serious Adverse Event|12
1108488|NCT01798056|3631586|P1|Overall Study|Serious Adverse Event|13
1108489|NCT01798004|3631620|P1|Overall Study|Enrollment another COG therapeutic trial|32
1108490|NCT01798004|3631620|P1|Overall Study|Initiation of other non-protocol therapy|5
1108491|NCT01798004|3631620|P1|Overall Study|Patient/parent refusal|7
1108492|NCT01798004|3631620|P1|Overall Study|Ineligible|4
1108493|NCT01798004|3631620|P1|Overall Study|Withdrawal by Subject|4
1108494|NCT01798004|3631620|P1|Overall Study|Physician Decision|25
1108495|NCT01798004|3631620|P1|Overall Study|Lack of Efficacy|8
1108496|NCT01798004|3631620|P1|Overall Study|Death|2
1108497|NCT01797783|3631626|P2|Overall Study|Withdrawal by Subject|0
1108498|NCT01797783|3631627|P1|Overall Study|Withdrawal by Subject|1
1108499|NCT01797783|3631626|P2|Overall Study|Adverse Event|1
1108500|NCT01797783|3631627|P1|Overall Study|Adverse Event|1
1108501|NCT01797731|3631651|P2|Overall Study|Didn't have proper radiographs required|3
1108502|NCT01797731|3631652|P1|Overall Study|Didn't have proper radiographs required|3
1108503|NCT01797705|3631660|P1|Overall Study|Withdrawal by Subject|1
1108504|NCT01797705|3631660|P1|Overall Study|Equipment anomalies during sleep studies|4
1108505|NCT01797536|3631725|P4|Overall Study|Adverse Event|0
1108506|NCT01797536|3631726|P3|Overall Study|Adverse Event|0
1108507|NCT01797536|3631727|P2|Overall Study|Adverse Event|1
1108508|NCT01797536|3631728|P1|Overall Study|Adverse Event|0
1108509|NCT01797445|3631800|P2|Overall Study|Still on Study|383
1108510|NCT01797445|3631801|P1|Overall Study|Still on Study|381
1108511|NCT01797445|3631800|P2|Overall Study|Lost to Follow-up|15
1108512|NCT01797445|3631801|P1|Overall Study|Lost to Follow-up|22
1108513|NCT01797445|3631800|P2|Overall Study|Withdrew Consent|19
1108514|NCT01797445|3631801|P1|Overall Study|Withdrew Consent|12
1108515|NCT01797445|3631800|P2|Overall Study|Protocol Violation|1
1108516|NCT01797445|3631801|P1|Overall Study|Protocol Violation|0
1108517|NCT01797445|3631800|P2|Overall Study|Noncompliance with Study Drug|1
1108518|NCT01797445|3631801|P1|Overall Study|Noncompliance with Study Drug|3
1108519|NCT01797445|3631800|P2|Overall Study|Investigator's Discretion|12
1108520|NCT01797445|3631801|P1|Overall Study|Investigator's Discretion|8
1108521|NCT01797445|3631800|P2|Overall Study|Lack of Efficacy|2
1108522|NCT01797445|3631801|P1|Overall Study|Lack of Efficacy|1
1108523|NCT01797445|3631800|P2|Overall Study|Death|2
1108524|NCT01797445|3631801|P1|Overall Study|Death|1
1108525|NCT01797445|3631800|P2|Overall Study|Adverse Event|0
1108526|NCT01797445|3631801|P1|Overall Study|Adverse Event|3
1108527|NCT01797445|3631800|P2|Overall Study|Randomized but Not Treated|2
1108528|NCT01797445|3631801|P1|Overall Study|Randomized but Not Treated|4
1108529|NCT01797120|3631859|P2|Overall Study|never start protocol therapy|0
1108530|NCT01797120|3631860|P1|Overall Study|never start protocol therapy|2
1108531|NCT01797120|3631859|P2|Overall Study|still on treatment|4
1108532|NCT01797120|3631860|P1|Overall Study|still on treatment|2
1108533|NCT01797120|3631859|P2|Overall Study|Physician Decision|0
1108534|NCT01797120|3631860|P1|Overall Study|Physician Decision|3
1108535|NCT01797120|3631859|P2|Overall Study|Non-compliance|0
1108536|NCT01797120|3631860|P1|Overall Study|Non-compliance|1
1108537|NCT01797120|3631859|P2|Overall Study|Symptomatic progression|1
1108538|NCT01797120|3631860|P1|Overall Study|Symptomatic progression|2
1108539|NCT01797120|3631859|P2|Overall Study|Withdrawal by Subject|6
1108540|NCT01797120|3631860|P1|Overall Study|Withdrawal by Subject|6
1108541|NCT01797120|3631859|P2|Overall Study|Adverse Event|5
1108542|NCT01797120|3631860|P1|Overall Study|Adverse Event|13
1108543|NCT01797120|3631859|P2|Overall Study|Disesae progression|49
1108544|NCT01797120|3631860|P1|Overall Study|Disesae progression|37
1108545|NCT01797094|3631874|P2|Overall Study|Other Miscellaneous Reasons|0
1108546|NCT01797094|3631875|P1|Overall Study|Other Miscellaneous Reasons|1
1108547|NCT01797094|3631874|P2|Overall Study|Protocol Violation|1
1108548|NCT01797094|3631875|P1|Overall Study|Protocol Violation|0
1108549|NCT01797094|3631874|P2|Overall Study|Personal Reasons|0
1108550|NCT01797094|3631875|P1|Overall Study|Personal Reasons|4
1108551|NCT01797094|3631874|P2|Overall Study|Adverse Event|1
1108552|NCT01797094|3631875|P1|Overall Study|Adverse Event|1
1108553|NCT01797081|3631897|P4|Overall Study|Protocol Violation|1
1108554|NCT01797081|3631898|P3|Overall Study|Protocol Violation|0
1108555|NCT01797081|3631899|P2|Overall Study|Protocol Violation|0
1108556|NCT01797081|3631900|P1|Overall Study|Protocol Violation|0
1108557|NCT01797081|3631897|P4|Overall Study|Personal Reasons|8
1108558|NCT01797081|3631898|P3|Overall Study|Personal Reasons|4
1108559|NCT01797081|3631899|P2|Overall Study|Personal Reasons|4
1108560|NCT01797081|3631900|P1|Overall Study|Personal Reasons|12
1108561|NCT01797081|3631897|P4|Overall Study|Pregnancy|0
1108562|NCT01797081|3631898|P3|Overall Study|Pregnancy|0
1108563|NCT01797081|3631899|P2|Overall Study|Pregnancy|0
1108564|NCT01797081|3631900|P1|Overall Study|Pregnancy|1
1108565|NCT01797081|3631897|P4|Overall Study|Adverse Event|0
1108566|NCT01797081|3631898|P3|Overall Study|Adverse Event|1
1108567|NCT01797081|3631899|P2|Overall Study|Adverse Event|0
1108568|NCT01797081|3631900|P1|Overall Study|Adverse Event|1
1108569|NCT01796964|3631941|P2|Overall Study|Withdrawal by Subject|1
1108570|NCT01796964|3631942|P1|Overall Study|Withdrawal by Subject|1
1108571|NCT01796964|3631941|P2|Overall Study|Protocol Violation|1
1108572|NCT01796964|3631942|P1|Overall Study|Protocol Violation|0
1108573|NCT01796964|3631941|P2|Overall Study|Death|0
1108574|NCT01796964|3631942|P1|Overall Study|Death|1
1108575|NCT01796964|3631941|P2|Overall Study|Adverse Event|1
1108576|NCT01796964|3631942|P1|Overall Study|Adverse Event|1
1108577|NCT01796860|3631964|P1|Overall Study|Withdrawal by Subject|3
1108578|NCT01796548|3631970|P1|Overall Study|Other|2
1108579|NCT01796548|3631970|P1|Overall Study|Lost to Follow-up|1
1108580|NCT01796301|3631984|P2|Overall Study|Decision by Sponsor|1
1108581|NCT01796301|3631985|P1|Overall Study|Decision by Sponsor|0
1108582|NCT01796301|3631984|P2|Overall Study|Death|1
1108583|NCT01796301|3631985|P1|Overall Study|Death|0
1108584|NCT01796301|3631984|P2|Overall Study|Lost to Follow-up|3
1108585|NCT01796301|3631985|P1|Overall Study|Lost to Follow-up|3
1108586|NCT01796301|3631984|P2|Overall Study|Withdrawal by Subject|15
1108587|NCT01796301|3631985|P1|Overall Study|Withdrawal by Subject|15
1108588|NCT01795937|3632041|P3|Overall Study|Physician Decision|0
1108589|NCT01795937|3632042|P2|Overall Study|Physician Decision|1
1108590|NCT01795937|3632043|P1|Overall Study|Physician Decision|0
1108591|NCT01795937|3632041|P3|Overall Study|Withdrawal by Subject|0
1108592|NCT01795937|3632042|P2|Overall Study|Withdrawal by Subject|0
1108593|NCT01795937|3632043|P1|Overall Study|Withdrawal by Subject|1
1108594|NCT01795898|3632072|P1|Overall Study|Physician Decision|1
1108595|NCT01795898|3632072|P1|Overall Study|Withdrew consent & had adverse events|3
1108596|NCT01795898|3632072|P1|Overall Study|Death|1
1108597|NCT01795898|3632072|P1|Overall Study|No pain|1
1108598|NCT01795898|3632072|P1|Overall Study|Diagnosed with metastasis|1
1108599|NCT01795898|3632072|P1|Overall Study|Withdrawal of consent|6
1108600|NCT01795898|3632072|P1|Overall Study|Lost to Follow-up|20
1108601|NCT01795898|3632072|P1|Overall Study|Adverse Event|27
1108602|NCT01795547|3632108|P2|Overall Study|Not stated|1
1108603|NCT01795547|3632109|P1|Overall Study|Not stated|0
1108604|NCT01795547|3632108|P2|Overall Study|Others|1
1108605|NCT01795547|3632109|P1|Overall Study|Others|4
1108606|NCT01795547|3632108|P2|Overall Study|Non-compliance with IMP|1
1108607|NCT01795547|3632109|P1|Overall Study|Non-compliance with IMP|1
1108608|NCT01795547|3632108|P2|Overall Study|Not Treated|10
1108609|NCT01795547|3632109|P1|Overall Study|Not Treated|4
1108610|NCT01795547|3632108|P2|Overall Study|Withdrawal of consent|12
1108611|NCT01795547|3632109|P1|Overall Study|Withdrawal of consent|7
1108612|NCT01795547|3632108|P2|Overall Study|Lost to Follow-up|5
1108613|NCT01795547|3632109|P1|Overall Study|Lost to Follow-up|2
1108614|NCT01795547|3632108|P2|Overall Study|Protocol Violation|4
1108615|NCT01795547|3632109|P1|Overall Study|Protocol Violation|6
1108616|NCT01795547|3632108|P2|Overall Study|Lack of Efficacy|3
1108617|NCT01795547|3632109|P1|Overall Study|Lack of Efficacy|8
1108618|NCT01795547|3632108|P2|Overall Study|Adverse Event|27
1108619|NCT01795547|3632109|P1|Overall Study|Adverse Event|16
1108620|NCT01795495|3632141|P3|Overall Study|Physician Decision|1
1108621|NCT01795495|3632142|P2|Overall Study|Physician Decision|0
1108622|NCT01795495|3632143|P1|Overall Study|Physician Decision|0
1108623|NCT01795495|3632141|P3|Overall Study|Protocol Violation|1
1108624|NCT01795495|3632142|P2|Overall Study|Protocol Violation|0
1108625|NCT01795495|3632143|P1|Overall Study|Protocol Violation|1
1108626|NCT01794949|3632156|P2|Overall Study|Lost to Follow-up|0
1108627|NCT01794949|3632157|P1|Overall Study|Lost to Follow-up|1
1108628|NCT01794845|3632168|P1|Overall Study|Withdrawal by Subject|1
1108629|NCT01794000|3632231|P2|Open-Label Extension Phase (OLE)|Sponsor Decision|0
1108630|NCT01794000|3632232|P1|Open-Label Extension Phase (OLE)|Sponsor Decision|3
1108631|NCT01794000|3632231|P2|Double-Blind Phase (DBP)|Withdrawal by Subject|11
1108632|NCT01794000|3632232|P1|Double-Blind Phase (DBP)|Withdrawal by Subject|6
1108633|NCT01794000|3632231|P2|Double-Blind Phase (DBP)|Sponsor Decision|149
1108634|NCT01794000|3632232|P1|Double-Blind Phase (DBP)|Sponsor Decision|148
1108635|NCT01794000|3632231|P2|Double-Blind Phase (DBP)|Physician Decision|0
1108636|NCT01794000|3632232|P1|Double-Blind Phase (DBP)|Physician Decision|2
1108637|NCT01794000|3632231|P2|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2
1108638|NCT01794000|3632232|P1|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5
1108639|NCT01794000|3632231|P2|Double-Blind Phase (DBP)|Entry Criteria Not Met|0
1108640|NCT01794000|3632232|P1|Double-Blind Phase (DBP)|Entry Criteria Not Met|2
1108641|NCT01794000|3632231|P2|Double-Blind Phase (DBP)|Death|2
1108642|NCT01794000|3632232|P1|Double-Blind Phase (DBP)|Death|1
1108643|NCT01794000|3632231|P2|Double-Blind Phase (DBP)|Adverse Event|2
1108644|NCT01794000|3632232|P1|Double-Blind Phase (DBP)|Adverse Event|5
1108645|NCT01793935|3632265|P2|Overall Study|Lost to Follow-up|1
1108646|NCT01793935|3632266|P1|Overall Study|Lost to Follow-up|0
1108647|NCT01793935|3632265|P2|Overall Study|Patient did not take study medication|1
1108648|NCT01793935|3632266|P1|Overall Study|Patient did not take study medication|1
1108649|NCT01793935|3632265|P2|Overall Study|Adverse Event|0
1108650|NCT01793935|3632266|P1|Overall Study|Adverse Event|2
1108651|NCT01793935|3632265|P2|Overall Study|Protocol Violation|1
1108652|NCT01793935|3632266|P1|Overall Study|Protocol Violation|2
1108653|NCT01793935|3632265|P2|Overall Study|Pregnancy|0
1108654|NCT01793935|3632266|P1|Overall Study|Pregnancy|1
1108655|NCT01793883|3632303|P3|Overall Study|Respiratory distress during spirometry|1
1108656|NCT01793883|3632304|P2|Overall Study|Respiratory distress during spirometry|0
1108657|NCT01793883|3632305|P1|Overall Study|Respiratory distress during spirometry|0
1108658|NCT01793883|3632303|P3|Overall Study|Dosing error|0
1108659|NCT01793883|3632304|P2|Overall Study|Dosing error|1
1108660|NCT01793883|3632305|P1|Overall Study|Dosing error|0
1108661|NCT01793883|3632303|P3|Overall Study|Met exclusion criteria|0
1108662|NCT01793883|3632304|P2|Overall Study|Met exclusion criteria|0
1108663|NCT01793883|3632305|P1|Overall Study|Met exclusion criteria|1
1108664|NCT01793883|3632303|P3|Overall Study|Unable to complete measurements|0
1108665|NCT01793883|3632304|P2|Overall Study|Unable to complete measurements|0
1108666|NCT01793883|3632305|P1|Overall Study|Unable to complete measurements|1
1108667|NCT01793883|3632303|P3|Overall Study|Unable to complete spriometry|0
1108668|NCT01793883|3632304|P2|Overall Study|Unable to complete spriometry|0
1108669|NCT01793883|3632305|P1|Overall Study|Unable to complete spriometry|1
1108670|NCT01793883|3632303|P3|Overall Study|Randomized in error|0
1108671|NCT01793883|3632304|P2|Overall Study|Randomized in error|0
1108672|NCT01793883|3632305|P1|Overall Study|Randomized in error|1
1108673|NCT01793883|3632303|P3|Overall Study|Lost to Follow-up|3
1108674|NCT01793883|3632304|P2|Overall Study|Lost to Follow-up|1
1108675|NCT01793883|3632305|P1|Overall Study|Lost to Follow-up|5
1108676|NCT01793883|3632303|P3|Overall Study|Subject noncompliance|1
1108677|NCT01793883|3632304|P2|Overall Study|Subject noncompliance|1
1108678|NCT01793883|3632305|P1|Overall Study|Subject noncompliance|0
1108679|NCT01793883|3632303|P3|Overall Study|Withdrawal by Subject|3
1108680|NCT01793883|3632304|P2|Overall Study|Withdrawal by Subject|7
1108681|NCT01793883|3632305|P1|Overall Study|Withdrawal by Subject|3
1108682|NCT01793688|3632313|P1|Overall Study|Protocol Violation|2
1108683|NCT01793142|3632340|P1|Overall Study|Randomized not treated|7
1108684|NCT01792830|3632370|P11|Overall Study|Adverse Event|0
1108685|NCT01792830|3632371|P10|Overall Study|Adverse Event|0
1108686|NCT01792830|3632372|P9|Overall Study|Adverse Event|1
1108687|NCT01792830|3632373|P8|Overall Study|Adverse Event|0
1108688|NCT01792830|3632374|P7|Overall Study|Adverse Event|0
1108689|NCT01792830|3632375|P6|Overall Study|Adverse Event|0
1108690|NCT01792830|3632376|P5|Overall Study|Adverse Event|0
1108691|NCT01792830|3632377|P4|Overall Study|Adverse Event|0
1108692|NCT01792830|3632378|P3|Overall Study|Adverse Event|0
1108693|NCT01792830|3632379|P2|Overall Study|Adverse Event|0
1108694|NCT01792830|3632380|P1|Overall Study|Adverse Event|0
1108695|NCT01792830|3632370|P11|Overall Study|Death|1
1108696|NCT01792830|3632371|P10|Overall Study|Death|0
1108697|NCT01792830|3632372|P9|Overall Study|Death|1
1108698|NCT01792830|3632373|P8|Overall Study|Death|0
1108699|NCT01792830|3632374|P7|Overall Study|Death|1
1108700|NCT01792830|3632375|P6|Overall Study|Death|0
1108701|NCT01792830|3632376|P5|Overall Study|Death|0
1108702|NCT01792830|3632377|P4|Overall Study|Death|1
1108703|NCT01792830|3632378|P3|Overall Study|Death|0
1108704|NCT01792830|3632379|P2|Overall Study|Death|0
1108705|NCT01792830|3632380|P1|Overall Study|Death|3
1108706|NCT01792830|3632370|P11|Overall Study|Withdrawal by Subject|2
1108707|NCT01792830|3632371|P10|Overall Study|Withdrawal by Subject|0
1108708|NCT01792830|3632372|P9|Overall Study|Withdrawal by Subject|7
1108709|NCT01792830|3632373|P8|Overall Study|Withdrawal by Subject|1
1108710|NCT01792830|3632374|P7|Overall Study|Withdrawal by Subject|1
1108711|NCT01792830|3632375|P6|Overall Study|Withdrawal by Subject|1
1108712|NCT01792830|3632376|P5|Overall Study|Withdrawal by Subject|1
1108713|NCT01792830|3632377|P4|Overall Study|Withdrawal by Subject|2
1108714|NCT01792830|3632378|P3|Overall Study|Withdrawal by Subject|0
1108715|NCT01792830|3632379|P2|Overall Study|Withdrawal by Subject|0
1108716|NCT01792830|3632380|P1|Overall Study|Withdrawal by Subject|22
1108717|NCT01792635|3632467|P3|Part B|Study terminated|3
1108718|NCT01792635|3632468|P2|Part B|Study terminated|4
1108719|NCT01792635|3632469|P1|Part B|Study terminated|0
1108720|NCT01792635|3632467|P3|Part B|Adverse Event|1
1108721|NCT01792635|3632468|P2|Part B|Adverse Event|0
1108722|NCT01792635|3632469|P1|Part B|Adverse Event|0
1108723|NCT01792518|3632497|P2|Overall Study|Other Reason|1
1108724|NCT01792518|3632498|P1|Overall Study|Other Reason|0
1108725|NCT01792518|3632497|P2|Overall Study|Withdrawal by Subject|0
1108726|NCT01792518|3632498|P1|Overall Study|Withdrawal by Subject|2
1108727|NCT01792518|3632497|P2|Overall Study|Lost to Follow-up|1
1108728|NCT01792518|3632498|P1|Overall Study|Lost to Follow-up|3
1108729|NCT01792518|3632497|P2|Overall Study|Protocol Violation|1
1108730|NCT01792518|3632498|P1|Overall Study|Protocol Violation|0
1108731|NCT01792518|3632497|P2|Overall Study|Adverse Event|4
1108732|NCT01792518|3632498|P1|Overall Study|Adverse Event|3
1108733|NCT01792284|3632508|P3|Randomization Period 2|Withdrawal by Subject|0
1108734|NCT01792284|3632509|P2|Randomization Period 2|Withdrawal by Subject|2
1108735|NCT01792284|3632510|P1|Randomization Period 2|Withdrawal by Subject|0
1108736|NCT01792284|3632508|P3|Randomization Period 2|Protocol Violation|0
1108737|NCT01792284|3632509|P2|Randomization Period 2|Protocol Violation|1
1108738|NCT01792284|3632510|P1|Randomization Period 2|Protocol Violation|0
1108739|NCT01792284|3632508|P3|Randomization Period 1|Lost to Follow-up|1
1108740|NCT01792284|3632509|P2|Randomization Period 1|Lost to Follow-up|0
1108741|NCT01792284|3632510|P1|Randomization Period 1|Lost to Follow-up|0
1108742|NCT01792284|3632508|P3|Randomization Period 1|Adverse Event|2
1108743|NCT01792284|3632509|P2|Randomization Period 1|Adverse Event|0
1108744|NCT01792284|3632510|P1|Randomization Period 1|Adverse Event|0
1108745|NCT01792284|3632508|P3|Randomization Period 1|Physician Decision|1
1108746|NCT01792284|3632509|P2|Randomization Period 1|Physician Decision|1
1108747|NCT01792284|3632510|P1|Randomization Period 1|Physician Decision|0
1108748|NCT01792284|3632508|P3|Randomization Period 1|Withdrawal by Subject|1
1108749|NCT01792284|3632509|P2|Randomization Period 1|Withdrawal by Subject|1
1108750|NCT01792284|3632510|P1|Randomization Period 1|Withdrawal by Subject|0
1108751|NCT01792284|3632508|P3|Lead-in Period|Protocol Required Discontinuation|0
1108752|NCT01792284|3632509|P2|Lead-in Period|Protocol Required Discontinuation|0
1108753|NCT01792284|3632510|P1|Lead-in Period|Protocol Required Discontinuation|1
1108754|NCT01792284|3632508|P3|Lead-in Period|Physician Decision|0
1108755|NCT01792284|3632509|P2|Lead-in Period|Physician Decision|0
1108756|NCT01792284|3632510|P1|Lead-in Period|Physician Decision|1
1108757|NCT01792284|3632508|P3|Lead-in Period|Withdrawal by Subject|0
1108758|NCT01792284|3632509|P2|Lead-in Period|Withdrawal by Subject|0
1108759|NCT01792284|3632510|P1|Lead-in Period|Withdrawal by Subject|10
1108760|NCT01792284|3632508|P3|Lead-in Period|Protocol Violation|0
1108761|NCT01792284|3632509|P2|Lead-in Period|Protocol Violation|0
1108762|NCT01792284|3632510|P1|Lead-in Period|Protocol Violation|1
1108763|NCT01792284|3632508|P3|Lead-in Period|Lost to Follow-up|0
1108764|NCT01792284|3632509|P2|Lead-in Period|Lost to Follow-up|0
1108765|NCT01792284|3632510|P1|Lead-in Period|Lost to Follow-up|2
1108766|NCT01792284|3632508|P3|Lead-in Period|Adverse Event|0
1108767|NCT01792284|3632509|P2|Lead-in Period|Adverse Event|0
1108768|NCT01792284|3632510|P1|Lead-in Period|Adverse Event|15
1108769|NCT01791894|3632569|P1|Overall Study|Adverse Event|1
1108770|NCT01791803|3632580|P4|Overall Study|Death|2
1108771|NCT01791803|3632581|P3|Overall Study|Death|2
1108772|NCT01791803|3632582|P2|Overall Study|Death|0
1108773|NCT01791803|3632583|P1|Overall Study|Death|0
1108774|NCT01791803|3632580|P4|Overall Study|Physician Decision|1
1108775|NCT01791803|3632581|P3|Overall Study|Physician Decision|0
1108776|NCT01791803|3632582|P2|Overall Study|Physician Decision|2
1108777|NCT01791803|3632583|P1|Overall Study|Physician Decision|0
1108778|NCT01791803|3632580|P4|Overall Study|Withdrawal by Subject|2
1108779|NCT01791803|3632581|P3|Overall Study|Withdrawal by Subject|0
1108780|NCT01791803|3632582|P2|Overall Study|Withdrawal by Subject|0
1108781|NCT01791803|3632583|P1|Overall Study|Withdrawal by Subject|0
1108782|NCT01791725|3632601|P3|Overall Study|Withdrawal by Subject|0
1108783|NCT01791725|3632602|P2|Overall Study|Withdrawal by Subject|1
1108784|NCT01791725|3632603|P1|Overall Study|Withdrawal by Subject|0
1108785|NCT01791517|3632626|P12|Phase II|Pre-Existing Ocular Issue|1
1108786|NCT01791517|3632627|P11|Phase II|Pre-Existing Ocular Issue|0
1108787|NCT01791517|3632628|P10|Phase II|Pre-Existing Ocular Issue|0
1108788|NCT01791517|3632629|P9|Phase II|Pre-Existing Ocular Issue|0
1108789|NCT01791517|3632630|P8|Phase II|Pre-Existing Ocular Issue|0
1108790|NCT01791517|3632631|P7|Phase II|Pre-Existing Ocular Issue|0
1108791|NCT01791517|3632632|P6|Phase II|Pre-Existing Ocular Issue|0
1108792|NCT01791517|3632633|P5|Phase II|Pre-Existing Ocular Issue|0
1108793|NCT01791517|3632634|P4|Phase II|Pre-Existing Ocular Issue|0
1108794|NCT01791517|3632635|P3|Phase II|Pre-Existing Ocular Issue|0
1108795|NCT01791517|3632636|P2|Phase II|Pre-Existing Ocular Issue|0
1108796|NCT01791517|3632637|P1|Phase II|Pre-Existing Ocular Issue|0
1108797|NCT01791517|3632626|P12|Phase II|Unsatisfactory Lens Fitting|0
1108798|NCT01791517|3632627|P11|Phase II|Unsatisfactory Lens Fitting|0
1108799|NCT01791517|3632628|P10|Phase II|Unsatisfactory Lens Fitting|1
1108800|NCT01791517|3632629|P9|Phase II|Unsatisfactory Lens Fitting|0
1108801|NCT01791517|3632630|P8|Phase II|Unsatisfactory Lens Fitting|0
1108802|NCT01791517|3632631|P7|Phase II|Unsatisfactory Lens Fitting|0
1108803|NCT01791517|3632632|P6|Phase II|Unsatisfactory Lens Fitting|0
1108804|NCT01791517|3632633|P5|Phase II|Unsatisfactory Lens Fitting|0
1108805|NCT01791517|3632634|P4|Phase II|Unsatisfactory Lens Fitting|0
1108806|NCT01791517|3632635|P3|Phase II|Unsatisfactory Lens Fitting|0
1108807|NCT01791517|3632636|P2|Phase II|Unsatisfactory Lens Fitting|0
1108808|NCT01791517|3632637|P1|Phase II|Unsatisfactory Lens Fitting|0
1108809|NCT01791517|3632626|P12|Phase II|Lens Handling Difficulties|0
1108810|NCT01791517|3632627|P11|Phase II|Lens Handling Difficulties|0
1108811|NCT01791517|3632628|P10|Phase II|Lens Handling Difficulties|0
1108812|NCT01791517|3632629|P9|Phase II|Lens Handling Difficulties|1
1108813|NCT01791517|3632630|P8|Phase II|Lens Handling Difficulties|0
1108814|NCT01791517|3632631|P7|Phase II|Lens Handling Difficulties|0
1108815|NCT01791517|3632632|P6|Phase II|Lens Handling Difficulties|0
1108816|NCT01791517|3632633|P5|Phase II|Lens Handling Difficulties|0
1108817|NCT01791517|3632634|P4|Phase II|Lens Handling Difficulties|0
1108818|NCT01791517|3632635|P3|Phase II|Lens Handling Difficulties|0
1108819|NCT01791517|3632636|P2|Phase II|Lens Handling Difficulties|0
1108820|NCT01791517|3632637|P1|Phase II|Lens Handling Difficulties|0
1108821|NCT01791517|3632626|P12|Phase II|Adverse Event|0
1108822|NCT01791517|3632627|P11|Phase II|Adverse Event|0
1108823|NCT01791517|3632628|P10|Phase II|Adverse Event|1
1108824|NCT01791517|3632629|P9|Phase II|Adverse Event|0
1108825|NCT01791517|3632630|P8|Phase II|Adverse Event|1
1108826|NCT01791517|3632631|P7|Phase II|Adverse Event|2
1108827|NCT01791517|3632632|P6|Phase II|Adverse Event|0
1108828|NCT01791517|3632633|P5|Phase II|Adverse Event|0
1108829|NCT01791517|3632634|P4|Phase II|Adverse Event|0
1108830|NCT01791517|3632635|P3|Phase II|Adverse Event|0
1108831|NCT01791517|3632636|P2|Phase II|Adverse Event|0
1108832|NCT01791517|3632637|P1|Phase II|Adverse Event|0
1108833|NCT01791517|3632626|P12|Phase II|Lack of Efficacy|0
1108834|NCT01791517|3632627|P11|Phase II|Lack of Efficacy|0
1108835|NCT01791517|3632628|P10|Phase II|Lack of Efficacy|0
1108836|NCT01791517|3632629|P9|Phase II|Lack of Efficacy|0
1108837|NCT01791517|3632630|P8|Phase II|Lack of Efficacy|0
1108838|NCT01791517|3632631|P7|Phase II|Lack of Efficacy|0
1108839|NCT01791517|3632632|P6|Phase II|Lack of Efficacy|0
1108840|NCT01791517|3632633|P5|Phase II|Lack of Efficacy|1
1108841|NCT01791517|3632634|P4|Phase II|Lack of Efficacy|0
1108842|NCT01791517|3632635|P3|Phase II|Lack of Efficacy|0
1108843|NCT01791517|3632636|P2|Phase II|Lack of Efficacy|0
1108844|NCT01791517|3632637|P1|Phase II|Lack of Efficacy|0
1108845|NCT01791517|3632626|P12|Phase II|Withdrawal by Subject|0
1108846|NCT01791517|3632627|P11|Phase II|Withdrawal by Subject|1
1108847|NCT01791517|3632628|P10|Phase II|Withdrawal by Subject|0
1108848|NCT01791517|3632629|P9|Phase II|Withdrawal by Subject|0
1108849|NCT01791517|3632630|P8|Phase II|Withdrawal by Subject|1
1108850|NCT01791517|3632631|P7|Phase II|Withdrawal by Subject|0
1108851|NCT01791517|3632632|P6|Phase II|Withdrawal by Subject|2
1108852|NCT01791517|3632633|P5|Phase II|Withdrawal by Subject|0
1108853|NCT01791517|3632634|P4|Phase II|Withdrawal by Subject|0
1108854|NCT01791517|3632635|P3|Phase II|Withdrawal by Subject|0
1108855|NCT01791517|3632636|P2|Phase II|Withdrawal by Subject|0
1108856|NCT01791517|3632637|P1|Phase II|Withdrawal by Subject|1
1108857|NCT01791517|3632626|P12|Phase II|Lost to Follow-up|0
1108858|NCT01791517|3632627|P11|Phase II|Lost to Follow-up|0
1108859|NCT01791517|3632628|P10|Phase II|Lost to Follow-up|1
1108860|NCT01791517|3632629|P9|Phase II|Lost to Follow-up|1
1108861|NCT01791517|3632630|P8|Phase II|Lost to Follow-up|1
1108862|NCT01791517|3632631|P7|Phase II|Lost to Follow-up|0
1108863|NCT01791517|3632632|P6|Phase II|Lost to Follow-up|2
1108864|NCT01791517|3632633|P5|Phase II|Lost to Follow-up|1
1108865|NCT01791517|3632634|P4|Phase II|Lost to Follow-up|0
1108866|NCT01791517|3632635|P3|Phase II|Lost to Follow-up|1
1108867|NCT01791517|3632636|P2|Phase II|Lost to Follow-up|0
1108868|NCT01791517|3632637|P1|Phase II|Lost to Follow-up|1
1108869|NCT01791517|3632626|P12|Phase I: Period 3|Adverse Event|0
1108870|NCT01791517|3632627|P11|Phase I: Period 3|Adverse Event|0
1108871|NCT01791517|3632628|P10|Phase I: Period 3|Adverse Event|0
1108872|NCT01791517|3632629|P9|Phase I: Period 3|Adverse Event|0
1108873|NCT01791517|3632630|P8|Phase I: Period 3|Adverse Event|0
1108874|NCT01791517|3632631|P7|Phase I: Period 3|Adverse Event|0
1108875|NCT01791517|3632632|P6|Phase I: Period 3|Adverse Event|0
1108876|NCT01791517|3632633|P5|Phase I: Period 3|Adverse Event|0
1108877|NCT01791517|3632634|P4|Phase I: Period 3|Adverse Event|1
1108878|NCT01791517|3632635|P3|Phase I: Period 3|Adverse Event|0
1108879|NCT01791517|3632636|P2|Phase I: Period 3|Adverse Event|0
1108880|NCT01791517|3632637|P1|Phase I: Period 3|Adverse Event|0
1108881|NCT01791517|3632626|P12|Phase I: Period 3|Lost to Follow-up|0
1108882|NCT01791517|3632627|P11|Phase I: Period 3|Lost to Follow-up|0
1108883|NCT01791517|3632628|P10|Phase I: Period 3|Lost to Follow-up|0
1108884|NCT01791517|3632629|P9|Phase I: Period 3|Lost to Follow-up|0
1108885|NCT01791517|3632630|P8|Phase I: Period 3|Lost to Follow-up|0
1108886|NCT01791517|3632631|P7|Phase I: Period 3|Lost to Follow-up|0
1108887|NCT01791517|3632632|P6|Phase I: Period 3|Lost to Follow-up|0
1108888|NCT01791517|3632633|P5|Phase I: Period 3|Lost to Follow-up|1
1108889|NCT01791517|3632634|P4|Phase I: Period 3|Lost to Follow-up|0
1108890|NCT01791517|3632635|P3|Phase I: Period 3|Lost to Follow-up|0
1108891|NCT01791517|3632636|P2|Phase I: Period 3|Lost to Follow-up|1
1108892|NCT01791517|3632637|P1|Phase I: Period 3|Lost to Follow-up|0
1108893|NCT01791517|3632626|P12|Phase I: Period 3|Lens Discomfort|1
1108894|NCT01791517|3632627|P11|Phase I: Period 3|Lens Discomfort|0
1108895|NCT01791517|3632628|P10|Phase I: Period 3|Lens Discomfort|0
1108896|NCT01791517|3632629|P9|Phase I: Period 3|Lens Discomfort|0
1108897|NCT01791517|3632630|P8|Phase I: Period 3|Lens Discomfort|0
1108898|NCT01791517|3632631|P7|Phase I: Period 3|Lens Discomfort|0
1108899|NCT01791517|3632632|P6|Phase I: Period 3|Lens Discomfort|0
1108900|NCT01791517|3632633|P5|Phase I: Period 3|Lens Discomfort|0
1108901|NCT01791517|3632634|P4|Phase I: Period 3|Lens Discomfort|0
1108902|NCT01791517|3632635|P3|Phase I: Period 3|Lens Discomfort|0
1108903|NCT01791517|3632636|P2|Phase I: Period 3|Lens Discomfort|0
1108904|NCT01791517|3632637|P1|Phase I: Period 3|Lens Discomfort|0
1108905|NCT01791517|3632626|P12|Phase I: Period 2|Lost to Follow-up|0
1108906|NCT01791517|3632627|P11|Phase I: Period 2|Lost to Follow-up|0
1108907|NCT01791517|3632628|P10|Phase I: Period 2|Lost to Follow-up|0
1108908|NCT01791517|3632629|P9|Phase I: Period 2|Lost to Follow-up|0
1108909|NCT01791517|3632630|P8|Phase I: Period 2|Lost to Follow-up|0
1108910|NCT01791517|3632631|P7|Phase I: Period 2|Lost to Follow-up|0
1108911|NCT01791517|3632632|P6|Phase I: Period 2|Lost to Follow-up|0
1108912|NCT01791517|3632633|P5|Phase I: Period 2|Lost to Follow-up|0
1108913|NCT01791517|3632634|P4|Phase I: Period 2|Lost to Follow-up|0
1108914|NCT01791517|3632635|P3|Phase I: Period 2|Lost to Follow-up|2
1108915|NCT01791517|3632636|P2|Phase I: Period 2|Lost to Follow-up|3
1108916|NCT01791517|3632637|P1|Phase I: Period 2|Lost to Follow-up|0
1108917|NCT01791517|3632626|P12|Phase I: Period 2|Lens Discomfort|0
1108918|NCT01791517|3632627|P11|Phase I: Period 2|Lens Discomfort|0
1108919|NCT01791517|3632628|P10|Phase I: Period 2|Lens Discomfort|0
1108920|NCT01791517|3632629|P9|Phase I: Period 2|Lens Discomfort|0
1108921|NCT01791517|3632630|P8|Phase I: Period 2|Lens Discomfort|0
1108922|NCT01791517|3632631|P7|Phase I: Period 2|Lens Discomfort|0
1108923|NCT01791517|3632632|P6|Phase I: Period 2|Lens Discomfort|1
1108924|NCT01791517|3632633|P5|Phase I: Period 2|Lens Discomfort|0
1108925|NCT01791517|3632634|P4|Phase I: Period 2|Lens Discomfort|0
1108926|NCT01791517|3632635|P3|Phase I: Period 2|Lens Discomfort|0
1108927|NCT01791517|3632636|P2|Phase I: Period 2|Lens Discomfort|0
1108928|NCT01791517|3632637|P1|Phase I: Period 2|Lens Discomfort|0
1108929|NCT01791517|3632626|P12|Phase I: Period 2|Unsatisfactory Visual Response|0
1108930|NCT01791517|3632627|P11|Phase I: Period 2|Unsatisfactory Visual Response|1
1108931|NCT01791517|3632628|P10|Phase I: Period 2|Unsatisfactory Visual Response|0
1108932|NCT01791517|3632629|P9|Phase I: Period 2|Unsatisfactory Visual Response|0
1108933|NCT01791517|3632630|P8|Phase I: Period 2|Unsatisfactory Visual Response|0
1108934|NCT01791517|3632631|P7|Phase I: Period 2|Unsatisfactory Visual Response|0
1108935|NCT01791517|3632632|P6|Phase I: Period 2|Unsatisfactory Visual Response|0
1108936|NCT01791517|3632633|P5|Phase I: Period 2|Unsatisfactory Visual Response|0
1108937|NCT01791517|3632634|P4|Phase I: Period 2|Unsatisfactory Visual Response|0
1108938|NCT01791517|3632635|P3|Phase I: Period 2|Unsatisfactory Visual Response|0
1109108|NCT01790594|3632966|P1|Overall Study|Withdrawal by Subject|2
1108939|NCT01791517|3632636|P2|Phase I: Period 2|Unsatisfactory Visual Response|0
1108940|NCT01791517|3632637|P1|Phase I: Period 2|Unsatisfactory Visual Response|0
1108941|NCT01791517|3632626|P12|Phase I: Period 2|Withdrawal by Subject|0
1108942|NCT01791517|3632627|P11|Phase I: Period 2|Withdrawal by Subject|1
1108943|NCT01791517|3632628|P10|Phase I: Period 2|Withdrawal by Subject|1
1108944|NCT01791517|3632629|P9|Phase I: Period 2|Withdrawal by Subject|0
1108945|NCT01791517|3632630|P8|Phase I: Period 2|Withdrawal by Subject|0
1108946|NCT01791517|3632631|P7|Phase I: Period 2|Withdrawal by Subject|0
1108947|NCT01791517|3632632|P6|Phase I: Period 2|Withdrawal by Subject|0
1108948|NCT01791517|3632633|P5|Phase I: Period 2|Withdrawal by Subject|0
1108949|NCT01791517|3632634|P4|Phase I: Period 2|Withdrawal by Subject|0
1108950|NCT01791517|3632635|P3|Phase I: Period 2|Withdrawal by Subject|0
1108951|NCT01791517|3632636|P2|Phase I: Period 2|Withdrawal by Subject|0
1108952|NCT01791517|3632637|P1|Phase I: Period 2|Withdrawal by Subject|0
1108953|NCT01791517|3632626|P12|Phase I: Period 2|Protocol Violation|0
1108954|NCT01791517|3632627|P11|Phase I: Period 2|Protocol Violation|0
1108955|NCT01791517|3632628|P10|Phase I: Period 2|Protocol Violation|0
1108956|NCT01791517|3632629|P9|Phase I: Period 2|Protocol Violation|0
1108957|NCT01791517|3632630|P8|Phase I: Period 2|Protocol Violation|0
1108958|NCT01791517|3632631|P7|Phase I: Period 2|Protocol Violation|0
1108959|NCT01791517|3632632|P6|Phase I: Period 2|Protocol Violation|0
1108960|NCT01791517|3632633|P5|Phase I: Period 2|Protocol Violation|0
1108961|NCT01791517|3632634|P4|Phase I: Period 2|Protocol Violation|1
1108962|NCT01791517|3632635|P3|Phase I: Period 2|Protocol Violation|0
1108963|NCT01791517|3632636|P2|Phase I: Period 2|Protocol Violation|0
1108964|NCT01791517|3632637|P1|Phase I: Period 2|Protocol Violation|0
1108965|NCT01791517|3632626|P12|Phase I: Period 2|Unsatisfactory Lens Fit|0
1108966|NCT01791517|3632627|P11|Phase I: Period 2|Unsatisfactory Lens Fit|0
1108967|NCT01791517|3632628|P10|Phase I: Period 2|Unsatisfactory Lens Fit|0
1108968|NCT01791517|3632629|P9|Phase I: Period 2|Unsatisfactory Lens Fit|0
1108969|NCT01791517|3632630|P8|Phase I: Period 2|Unsatisfactory Lens Fit|0
1108970|NCT01791517|3632631|P7|Phase I: Period 2|Unsatisfactory Lens Fit|0
1108971|NCT01791517|3632632|P6|Phase I: Period 2|Unsatisfactory Lens Fit|0
1108972|NCT01791517|3632633|P5|Phase I: Period 2|Unsatisfactory Lens Fit|0
1108973|NCT01791517|3632634|P4|Phase I: Period 2|Unsatisfactory Lens Fit|0
1108974|NCT01791517|3632635|P3|Phase I: Period 2|Unsatisfactory Lens Fit|0
1108975|NCT01791517|3632636|P2|Phase I: Period 2|Unsatisfactory Lens Fit|0
1108976|NCT01791517|3632637|P1|Phase I: Period 2|Unsatisfactory Lens Fit|1
1108977|NCT01791517|3632626|P12|Phase I: Period 1|Lens Handling DIfficulties|1
1108978|NCT01791517|3632627|P11|Phase I: Period 1|Lens Handling DIfficulties|0
1108979|NCT01791517|3632628|P10|Phase I: Period 1|Lens Handling DIfficulties|0
1108980|NCT01791517|3632629|P9|Phase I: Period 1|Lens Handling DIfficulties|0
1108981|NCT01791517|3632630|P8|Phase I: Period 1|Lens Handling DIfficulties|0
1108982|NCT01791517|3632631|P7|Phase I: Period 1|Lens Handling DIfficulties|0
1108983|NCT01791517|3632632|P6|Phase I: Period 1|Lens Handling DIfficulties|0
1108984|NCT01791517|3632633|P5|Phase I: Period 1|Lens Handling DIfficulties|0
1108985|NCT01791517|3632634|P4|Phase I: Period 1|Lens Handling DIfficulties|0
1108986|NCT01791517|3632635|P3|Phase I: Period 1|Lens Handling DIfficulties|0
1108987|NCT01791517|3632636|P2|Phase I: Period 1|Lens Handling DIfficulties|0
1108988|NCT01791517|3632637|P1|Phase I: Period 1|Lens Handling DIfficulties|0
1108989|NCT01791517|3632626|P12|Phase I: Period 1|Lost to Follow-up|0
1108990|NCT01791517|3632627|P11|Phase I: Period 1|Lost to Follow-up|0
1108991|NCT01791517|3632628|P10|Phase I: Period 1|Lost to Follow-up|1
1108992|NCT01791517|3632629|P9|Phase I: Period 1|Lost to Follow-up|1
1108993|NCT01791517|3632630|P8|Phase I: Period 1|Lost to Follow-up|0
1108994|NCT01791517|3632631|P7|Phase I: Period 1|Lost to Follow-up|1
1108995|NCT01791517|3632632|P6|Phase I: Period 1|Lost to Follow-up|0
1108996|NCT01791517|3632633|P5|Phase I: Period 1|Lost to Follow-up|0
1108997|NCT01791517|3632634|P4|Phase I: Period 1|Lost to Follow-up|1
1108998|NCT01791517|3632635|P3|Phase I: Period 1|Lost to Follow-up|0
1108999|NCT01791517|3632636|P2|Phase I: Period 1|Lost to Follow-up|0
1109000|NCT01791517|3632637|P1|Phase I: Period 1|Lost to Follow-up|0
1109001|NCT01791517|3632626|P12|Phase I: Period 1|Protocol Violation|0
1109002|NCT01791517|3632627|P11|Phase I: Period 1|Protocol Violation|0
1109003|NCT01791517|3632628|P10|Phase I: Period 1|Protocol Violation|0
1109004|NCT01791517|3632629|P9|Phase I: Period 1|Protocol Violation|0
1109005|NCT01791517|3632630|P8|Phase I: Period 1|Protocol Violation|0
1109006|NCT01791517|3632631|P7|Phase I: Period 1|Protocol Violation|0
1109007|NCT01791517|3632632|P6|Phase I: Period 1|Protocol Violation|0
1109008|NCT01791517|3632633|P5|Phase I: Period 1|Protocol Violation|0
1109009|NCT01791517|3632634|P4|Phase I: Period 1|Protocol Violation|0
1109010|NCT01791517|3632635|P3|Phase I: Period 1|Protocol Violation|0
1109011|NCT01791517|3632636|P2|Phase I: Period 1|Protocol Violation|1
1109012|NCT01791517|3632637|P1|Phase I: Period 1|Protocol Violation|0
1109013|NCT01791517|3632626|P12|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1109014|NCT01791517|3632627|P11|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1109015|NCT01791517|3632628|P10|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1109016|NCT01791517|3632629|P9|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1109017|NCT01791517|3632630|P8|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1109018|NCT01791517|3632631|P7|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1109019|NCT01791517|3632632|P6|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1109020|NCT01791517|3632633|P5|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1109109|NCT01790594|3632964|P3|Overall Study|Physician Decision|0
1109021|NCT01791517|3632634|P4|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1109022|NCT01791517|3632635|P3|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1109023|NCT01791517|3632636|P2|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1109024|NCT01791517|3632637|P1|Phase I: Period 1|Unsatisfactory Lens Fitting|1
1109025|NCT01791517|3632626|P12|Phase I: Period 1|Adverse Event|0
1109026|NCT01791517|3632627|P11|Phase I: Period 1|Adverse Event|0
1109027|NCT01791517|3632628|P10|Phase I: Period 1|Adverse Event|0
1109028|NCT01791517|3632629|P9|Phase I: Period 1|Adverse Event|0
1109029|NCT01791517|3632630|P8|Phase I: Period 1|Adverse Event|0
1109030|NCT01791517|3632631|P7|Phase I: Period 1|Adverse Event|0
1109031|NCT01791517|3632632|P6|Phase I: Period 1|Adverse Event|0
1109032|NCT01791517|3632633|P5|Phase I: Period 1|Adverse Event|0
1109033|NCT01791517|3632634|P4|Phase I: Period 1|Adverse Event|1
1109034|NCT01791517|3632635|P3|Phase I: Period 1|Adverse Event|1
1109035|NCT01791517|3632636|P2|Phase I: Period 1|Adverse Event|0
1109036|NCT01791517|3632637|P1|Phase I: Period 1|Adverse Event|0
1109037|NCT01791517|3632626|P12|Phase I: Period 1|Withdrawal by Subject|0
1109038|NCT01791517|3632627|P11|Phase I: Period 1|Withdrawal by Subject|0
1109039|NCT01791517|3632628|P10|Phase I: Period 1|Withdrawal by Subject|0
1109040|NCT01791517|3632629|P9|Phase I: Period 1|Withdrawal by Subject|0
1109041|NCT01791517|3632630|P8|Phase I: Period 1|Withdrawal by Subject|0
1109042|NCT01791517|3632631|P7|Phase I: Period 1|Withdrawal by Subject|0
1109043|NCT01791517|3632632|P6|Phase I: Period 1|Withdrawal by Subject|1
1109044|NCT01791517|3632633|P5|Phase I: Period 1|Withdrawal by Subject|1
1109045|NCT01791517|3632634|P4|Phase I: Period 1|Withdrawal by Subject|0
1109046|NCT01791517|3632635|P3|Phase I: Period 1|Withdrawal by Subject|1
1109047|NCT01791517|3632636|P2|Phase I: Period 1|Withdrawal by Subject|1
1109048|NCT01791517|3632637|P1|Phase I: Period 1|Withdrawal by Subject|0
1109049|NCT01791413|3632701|P2|Overall Study|Lost to Follow-up|1
1109050|NCT01791413|3632702|P1|Overall Study|Lost to Follow-up|5
1109051|NCT01791244|3632711|P2|Overall Study|Laboratory Abnormality|1
1109052|NCT01791244|3632712|P1|Overall Study|Laboratory Abnormality|0
1109053|NCT01791244|3632711|P2|Overall Study|Insufficient clinical response|10
1109054|NCT01791244|3632712|P1|Overall Study|Insufficient clinical response|10
1109055|NCT01791244|3632711|P2|Overall Study|Adverse Event|7
1109056|NCT01791244|3632712|P1|Overall Study|Adverse Event|5
1109057|NCT01791205|3632748|P2|Phase II|Physician’s decision|0
1109058|NCT01791205|3632749|P1|Phase II|Physician’s decision|1
1109059|NCT01791205|3632748|P2|Phase II|Remission of disease|0
1109060|NCT01791205|3632749|P1|Phase II|Remission of disease|1
1109061|NCT01791205|3632748|P2|Phase II|Lost to Follow-up|0
1109062|NCT01791205|3632749|P1|Phase II|Lost to Follow-up|1
1109063|NCT01791205|3632748|P2|Phase II|Safety|0
1109064|NCT01791205|3632749|P1|Phase II|Safety|1
1109065|NCT01791205|3632748|P2|Phase II|Adverse Event|0
1109066|NCT01791205|3632749|P1|Phase II|Adverse Event|2
1109067|NCT01791205|3632748|P2|Phase II|Lack of Efficacy|0
1109068|NCT01791205|3632749|P1|Phase II|Lack of Efficacy|6
1109069|NCT01791153|3632833|P4|Overall Study|Withdrawal by Subject|1
1109070|NCT01791153|3632834|P3|Overall Study|Withdrawal by Subject|2
1109071|NCT01791153|3632835|P2|Overall Study|Withdrawal by Subject|2
1109072|NCT01791153|3632836|P1|Overall Study|Withdrawal by Subject|6
1109073|NCT01791153|3632833|P4|Overall Study|Protocol Violation|1
1109074|NCT01791153|3632834|P3|Overall Study|Protocol Violation|0
1109075|NCT01791153|3632835|P2|Overall Study|Protocol Violation|0
1109076|NCT01791153|3632836|P1|Overall Study|Protocol Violation|0
1109077|NCT01791153|3632833|P4|Overall Study|Physician Decision|1
1109078|NCT01791153|3632834|P3|Overall Study|Physician Decision|0
1109079|NCT01791153|3632835|P2|Overall Study|Physician Decision|0
1109080|NCT01791153|3632836|P1|Overall Study|Physician Decision|0
1109081|NCT01791153|3632833|P4|Overall Study|Non-Compliance|0
1109082|NCT01791153|3632834|P3|Overall Study|Non-Compliance|0
1109083|NCT01791153|3632835|P2|Overall Study|Non-Compliance|0
1109084|NCT01791153|3632836|P1|Overall Study|Non-Compliance|1
1109085|NCT01791153|3632833|P4|Overall Study|Lack of Efficacy|2
1109086|NCT01791153|3632834|P3|Overall Study|Lack of Efficacy|2
1109087|NCT01791153|3632835|P2|Overall Study|Lack of Efficacy|3
1109088|NCT01791153|3632836|P1|Overall Study|Lack of Efficacy|1
1109089|NCT01791153|3632833|P4|Overall Study|Adverse Event|0
1109090|NCT01791153|3632834|P3|Overall Study|Adverse Event|2
1109091|NCT01791153|3632835|P2|Overall Study|Adverse Event|3
1109092|NCT01791153|3632836|P1|Overall Study|Adverse Event|7
1109093|NCT01790828|3632892|P1|Overall Study|Not specified|34
1109094|NCT01790633|3632950|P2|Overall Study|RT failure and no follow-up ELISA|3
1109095|NCT01790633|3632951|P1|Overall Study|RT failure and no follow-up ELISA|0
1109096|NCT01790633|3632950|P2|Overall Study|Did not have serology performed|0
1109097|NCT01790633|3632951|P1|Overall Study|Did not have serology performed|47
1109098|NCT01790633|3632950|P2|Overall Study|Protocol Violation|2
1109099|NCT01790633|3632951|P1|Overall Study|Protocol Violation|1
1109100|NCT01790594|3632964|P3|Overall Study|Terminated prior to week 76|0
1109101|NCT01790594|3632965|P2|Overall Study|Terminated prior to week 76|2
1109102|NCT01790594|3632966|P1|Overall Study|Terminated prior to week 76|0
1109103|NCT01790594|3632964|P3|Overall Study|Transplant was not done|3
1109104|NCT01790594|3632965|P2|Overall Study|Transplant was not done|0
1109105|NCT01790594|3632966|P1|Overall Study|Transplant was not done|0
1109106|NCT01790594|3632964|P3|Overall Study|Withdrawal by Subject|0
1109107|NCT01790594|3632965|P2|Overall Study|Withdrawal by Subject|0
1109110|NCT01790594|3632965|P2|Overall Study|Physician Decision|1
1109111|NCT01790594|3632966|P1|Overall Study|Physician Decision|2
1109112|NCT01790594|3632964|P3|Overall Study|Death|0
1109113|NCT01790594|3632965|P2|Overall Study|Death|0
1109114|NCT01790594|3632966|P1|Overall Study|Death|1
1109115|NCT01790568|3633043|P2|Overall Study|Progression prior to transplant|1
1109116|NCT01790568|3633044|P1|Overall Study|Progression prior to transplant|0
1109117|NCT01790516|3633052|P2|Overall Study|Physician Decision|0
1109118|NCT01790516|3633053|P1|Overall Study|Physician Decision|1
1109119|NCT01790438|3633077|P2|Overall Study|Protocol Required Discontinuation|1
1109120|NCT01790438|3633078|P1|Overall Study|Protocol Required Discontinuation|7
1109121|NCT01790438|3633077|P2|Overall Study|Sponsor Decision|3
1109122|NCT01790438|3633078|P1|Overall Study|Sponsor Decision|0
1109123|NCT01790438|3633077|P2|Overall Study|Physician Decision|1
1109124|NCT01790438|3633078|P1|Overall Study|Physician Decision|3
1109125|NCT01790438|3633077|P2|Overall Study|Withdrawal by Subject|2
1109126|NCT01790438|3633078|P1|Overall Study|Withdrawal by Subject|13
1109127|NCT01790438|3633077|P2|Overall Study|Lost to Follow-up|2
1109128|NCT01790438|3633078|P1|Overall Study|Lost to Follow-up|5
1109129|NCT01790438|3633077|P2|Overall Study|Death|0
1109130|NCT01790438|3633078|P1|Overall Study|Death|4
1109131|NCT01790438|3633077|P2|Overall Study|Adverse Event|2
1109132|NCT01790438|3633078|P1|Overall Study|Adverse Event|3
1109133|NCT01789970|3633147|P3|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
1109134|NCT01789970|3633148|P2|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1
1109135|NCT01789970|3633149|P1|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
1109136|NCT01789970|3633147|P3|Double-blind Treatment Period (12 Weeks)|Not specified|3
1109137|NCT01789970|3633148|P2|Double-blind Treatment Period (12 Weeks)|Not specified|1
1109138|NCT01789970|3633149|P1|Double-blind Treatment Period (12 Weeks)|Not specified|0
1109139|NCT01789970|3633147|P3|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
1109140|NCT01789970|3633148|P2|Double-blind Treatment Period (12 Weeks)|Pregnancy|1
1109141|NCT01789970|3633149|P1|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
1109142|NCT01789970|3633147|P3|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2
1109143|NCT01789970|3633148|P2|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1
1109144|NCT01789970|3633149|P1|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0
1109145|NCT01789970|3633147|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1
1109146|NCT01789970|3633148|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2
1109147|NCT01789970|3633149|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0
1109148|NCT01789970|3633147|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
1109149|NCT01789970|3633148|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
1109150|NCT01789970|3633149|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
1109151|NCT01789970|3633147|P3|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7
1109152|NCT01789970|3633148|P2|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
1109153|NCT01789970|3633149|P1|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
1109154|NCT01789970|3633147|P3|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9
1109155|NCT01789970|3633148|P2|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7
1109156|NCT01789970|3633149|P1|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
1109157|NCT01789970|3633147|P3|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
1109158|NCT01789970|3633148|P2|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
1109159|NCT01789970|3633149|P1|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
1109160|NCT01789970|3633147|P3|Double-blind Treatment Period (12 Weeks)|Adverse Event|15
1109161|NCT01789970|3633148|P2|Double-blind Treatment Period (12 Weeks)|Adverse Event|9
1109162|NCT01789970|3633149|P1|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
1109163|NCT01789970|3633147|P3|Open-label Titration Period|Dropped out prior to dosing|0
1109164|NCT01789970|3633148|P2|Open-label Titration Period|Dropped out prior to dosing|0
1109165|NCT01789970|3633149|P1|Open-label Titration Period|Dropped out prior to dosing|2
1109166|NCT01789970|3633147|P3|Open-label Titration Period|Not specified|0
1109167|NCT01789970|3633148|P2|Open-label Titration Period|Not specified|0
1109168|NCT01789970|3633149|P1|Open-label Titration Period|Not specified|76
1109169|NCT01789970|3633147|P3|Open-label Titration Period|Pregnancy|0
1109170|NCT01789970|3633148|P2|Open-label Titration Period|Pregnancy|0
1109171|NCT01789970|3633149|P1|Open-label Titration Period|Pregnancy|2
1109172|NCT01789970|3633147|P3|Open-label Titration Period|Noncompliance with study procedures|0
1109173|NCT01789970|3633148|P2|Open-label Titration Period|Noncompliance with study procedures|0
1109174|NCT01789970|3633149|P1|Open-label Titration Period|Noncompliance with study procedures|8
1109175|NCT01789970|3633147|P3|Open-label Titration Period|Noncompliance with study rescue meds|0
1109176|NCT01789970|3633148|P2|Open-label Titration Period|Noncompliance with study rescue meds|0
1109177|NCT01789970|3633149|P1|Open-label Titration Period|Noncompliance with study rescue meds|2
1109178|NCT01789970|3633147|P3|Open-label Titration Period|Noncompliance to study drug admin|0
1109179|NCT01789970|3633148|P2|Open-label Titration Period|Noncompliance to study drug admin|0
1109180|NCT01789970|3633149|P1|Open-label Titration Period|Noncompliance to study drug admin|11
1109181|NCT01789970|3633147|P3|Open-label Titration Period|Lost to Follow-up|0
1109182|NCT01789970|3633148|P2|Open-label Titration Period|Lost to Follow-up|0
1109183|NCT01789970|3633149|P1|Open-label Titration Period|Lost to Follow-up|5
1109184|NCT01789970|3633147|P3|Open-label Titration Period|Protocol Violation|0
1109185|NCT01789970|3633148|P2|Open-label Titration Period|Protocol Violation|0
1109186|NCT01789970|3633149|P1|Open-label Titration Period|Protocol Violation|18
1109187|NCT01789970|3633147|P3|Open-label Titration Period|Withdrawal by Subject|0
1109188|NCT01789970|3633148|P2|Open-label Titration Period|Withdrawal by Subject|0
1109189|NCT01789970|3633149|P1|Open-label Titration Period|Withdrawal by Subject|31
1109190|NCT01789970|3633147|P3|Open-label Titration Period|Lack of Efficacy|0
1109191|NCT01789970|3633148|P2|Open-label Titration Period|Lack of Efficacy|0
1109192|NCT01789970|3633149|P1|Open-label Titration Period|Lack of Efficacy|31
1109193|NCT01789970|3633147|P3|Open-label Titration Period|Adverse Event|0
1109194|NCT01789970|3633148|P2|Open-label Titration Period|Adverse Event|0
1109195|NCT01789970|3633149|P1|Open-label Titration Period|Adverse Event|68
1109196|NCT01789606|3633207|P2|Overall Study|Ineligible or not Willing to Continue|348
1109197|NCT01789606|3633208|P1|Overall Study|Ineligible or not Willing to Continue|0
1109198|NCT01789606|3633207|P2|Overall Study|Lost to Follow-up|14
1109199|NCT01789606|3633208|P1|Overall Study|Lost to Follow-up|0
1109200|NCT01789606|3633207|P2|Overall Study|Adverse Event|3
1109201|NCT01789606|3633208|P1|Overall Study|Adverse Event|0
1109202|NCT01789606|3633207|P2|Overall Study|Protocol Violation|55
1109203|NCT01789606|3633208|P1|Overall Study|Protocol Violation|0
1109204|NCT01789606|3633207|P2|Overall Study|No Study Medication Taken|1
1109205|NCT01789606|3633208|P1|Overall Study|No Study Medication Taken|0
1109206|NCT01789606|3633207|P2|Overall Study|Administrative Reasons|6
1109207|NCT01789606|3633208|P1|Overall Study|Administrative Reasons|17
1109208|NCT01789606|3633207|P2|Overall Study|Ineligible|2
1109209|NCT01789606|3633208|P1|Overall Study|Ineligible|6
1109210|NCT01789606|3633207|P2|Overall Study|Withdrawal by Subject|1
1109211|NCT01789606|3633208|P1|Overall Study|Withdrawal by Subject|0
1109212|NCT01789606|3633207|P2|Overall Study|Participant not Purchased the Product|20
1109213|NCT01789606|3633208|P1|Overall Study|Participant not Purchased the Product|0
1109214|NCT01789567|3633226|P1|Overall Study|Death|6
1109215|NCT01789476|3633235|P2|Overall Study|Unable to get IV access|0
1109216|NCT01789476|3633236|P1|Overall Study|Unable to get IV access|1
1109217|NCT01789476|3633235|P2|Overall Study|Adverse Event|0
1109218|NCT01789476|3633236|P1|Overall Study|Adverse Event|1
1109219|NCT01789476|3633235|P2|Overall Study|Lack of Efficacy|2
1109220|NCT01789476|3633236|P1|Overall Study|Lack of Efficacy|6
1109221|NCT01788943|3633269|P2|Overall Study|Withdrawal by Subject|0
1109222|NCT01788943|3633270|P1|Overall Study|Withdrawal by Subject|1
1109223|NCT01788566|3633299|P1|Overall Study|Clinical Progressive Disease|3
1109224|NCT01788566|3633299|P1|Overall Study|Adverse Event|1
1109225|NCT01788566|3633299|P1|Overall Study|Death|4
1109226|NCT01788358|3633309|P1|Overall Study|Adverse Event|51
1109227|NCT01788358|3633309|P1|Overall Study|Lack of Efficacy|1
1109228|NCT01788358|3633309|P1|Overall Study|Withdrawal by Subject|26
1109229|NCT01788358|3633309|P1|Overall Study|Protocol Violation|3
1109230|NCT01788358|3633309|P1|Overall Study|Lost to Follow-up|5
1109231|NCT01788358|3633309|P1|Overall Study|Logistical difficulties|1
1109232|NCT01788358|3633309|P1|Overall Study|Other|11
1109233|NCT01788228|3633323|P2|Overall Study|Migrated/moved from study area|0
1109234|NCT01788228|3633324|P1|Overall Study|Migrated/moved from study area|1
1109235|NCT01788215|3633343|P2|Overall Study|Lost to Follow-up|0
1109236|NCT01788215|3633344|P1|Overall Study|Lost to Follow-up|2
1109237|NCT01788215|3633343|P2|Overall Study|Withdrawal by Subject|1
1109238|NCT01788215|3633344|P1|Overall Study|Withdrawal by Subject|0
1109239|NCT01788163|3633373|P9|Overall Study|Withdrawal by Subject|1
1109240|NCT01788163|3633374|P8|Overall Study|Withdrawal by Subject|0
1109241|NCT01788163|3633375|P7|Overall Study|Withdrawal by Subject|0
1109242|NCT01788163|3633376|P6|Overall Study|Withdrawal by Subject|0
1109243|NCT01788163|3633377|P5|Overall Study|Withdrawal by Subject|0
1109244|NCT01788163|3633378|P4|Overall Study|Withdrawal by Subject|0
1109245|NCT01788163|3633379|P3|Overall Study|Withdrawal by Subject|0
1109246|NCT01788163|3633380|P2|Overall Study|Withdrawal by Subject|0
1109247|NCT01788163|3633381|P1|Overall Study|Withdrawal by Subject|2
1109248|NCT01788163|3633373|P9|Overall Study|Other|15
1109249|NCT01788163|3633374|P8|Overall Study|Other|48
1109250|NCT01788163|3633375|P7|Overall Study|Other|1
1109251|NCT01788163|3633376|P6|Overall Study|Other|7
1109252|NCT01788163|3633377|P5|Overall Study|Other|0
1109253|NCT01788163|3633378|P4|Overall Study|Other|0
1109254|NCT01788163|3633379|P3|Overall Study|Other|0
1109255|NCT01788163|3633380|P2|Overall Study|Other|0
1109256|NCT01788163|3633381|P1|Overall Study|Other|53
1109257|NCT01788046|3633544|P2|Overall Study|Protocol Specified Criteria|1
1109258|NCT01788046|3633545|P1|Overall Study|Protocol Specified Criteria|25
1109259|NCT01788046|3633544|P2|Overall Study|Death|5
1109260|NCT01788046|3633545|P1|Overall Study|Death|7
1109261|NCT01788046|3633544|P2|Overall Study|Lost to Follow-up|19
1109262|NCT01788046|3633545|P1|Overall Study|Lost to Follow-up|12
1109263|NCT01788046|3633544|P2|Overall Study|Withdrawal by Subject|12
1109264|NCT01788046|3633545|P1|Overall Study|Withdrawal by Subject|12
1109265|NCT01787838|3633568|P1|Overall Study|refused|1413
1109266|NCT01787825|3633572|P2|Overall Study|Data Not Analyzable|1
1109267|NCT01787825|3633573|P1|Overall Study|Data Not Analyzable|5
1109268|NCT01787825|3633572|P2|Overall Study|Subject Did Not Ingest Capsules|0
1109269|NCT01787825|3633573|P1|Overall Study|Subject Did Not Ingest Capsules|1
1109270|NCT01787760|3633591|P3|Overall Study|Near vision blur|0
1109271|NCT01787760|3633592|P2|Overall Study|Near vision blur|0
1109272|NCT01787760|3633593|P1|Overall Study|Near vision blur|1
1109273|NCT01787760|3633591|P3|Overall Study|Unsatisfactory visual response|0
1109274|NCT01787760|3633592|P2|Overall Study|Unsatisfactory visual response|1
1109275|NCT01787760|3633593|P1|Overall Study|Unsatisfactory visual response|1
1109276|NCT01787760|3633591|P3|Overall Study|Unsatisfactory physiological response|0
1109277|NCT01787760|3633592|P2|Overall Study|Unsatisfactory physiological response|4
1109278|NCT01787760|3633593|P1|Overall Study|Unsatisfactory physiological response|2
1109279|NCT01787760|3633591|P3|Overall Study|Unsatisfactory lens fitting performance|0
1109280|NCT01787760|3633592|P2|Overall Study|Unsatisfactory lens fitting performance|6
1109281|NCT01787760|3633593|P1|Overall Study|Unsatisfactory lens fitting performance|3
1109282|NCT01787760|3633591|P3|Overall Study|Stroke|0
1109283|NCT01787760|3633592|P2|Overall Study|Stroke|0
1109284|NCT01787760|3633593|P1|Overall Study|Stroke|1
1109285|NCT01787760|3633591|P3|Overall Study|Lost to Follow-up|1
1109286|NCT01787760|3633592|P2|Overall Study|Lost to Follow-up|0
1109287|NCT01787760|3633593|P1|Overall Study|Lost to Follow-up|1
1109288|NCT01787760|3633591|P3|Overall Study|Withdrawal by Subject|2
1109289|NCT01787760|3633592|P2|Overall Study|Withdrawal by Subject|1
1109290|NCT01787760|3633593|P1|Overall Study|Withdrawal by Subject|5
1109291|NCT01787760|3633591|P3|Overall Study|Protocol Violation|1
1109292|NCT01787760|3633592|P2|Overall Study|Protocol Violation|0
1109293|NCT01787760|3633593|P1|Overall Study|Protocol Violation|6
1109294|NCT01787760|3633591|P3|Overall Study|Lens handling difficulty|0
1109295|NCT01787760|3633592|P2|Overall Study|Lens handling difficulty|2
1109296|NCT01787760|3633593|P1|Overall Study|Lens handling difficulty|1
1109297|NCT01787760|3633591|P3|Overall Study|Lens discomfort|0
1109298|NCT01787760|3633592|P2|Overall Study|Lens discomfort|0
1109299|NCT01787760|3633593|P1|Overall Study|Lens discomfort|3
1109300|NCT01787760|3633591|P3|Overall Study|Relocation|0
1109301|NCT01787760|3633592|P2|Overall Study|Relocation|1
1109302|NCT01787760|3633593|P1|Overall Study|Relocation|1
1109303|NCT01787760|3633591|P3|Overall Study|Dryness|0
1109304|NCT01787760|3633592|P2|Overall Study|Dryness|1
1109305|NCT01787760|3633593|P1|Overall Study|Dryness|0
1109306|NCT01787760|3633591|P3|Overall Study|Decompensated on left exotropia|1
1109307|NCT01787760|3633592|P2|Overall Study|Decompensated on left exotropia|0
1109308|NCT01787760|3633593|P1|Overall Study|Decompensated on left exotropia|0
1109309|NCT01787760|3633591|P3|Overall Study|Anisometropia > -1.00D in spherical equi|0
1109310|NCT01787760|3633592|P2|Overall Study|Anisometropia > -1.00D in spherical equi|0
1109311|NCT01787760|3633593|P1|Overall Study|Anisometropia > -1.00D in spherical equi|1
1109312|NCT01787591|3633607|P4|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1
1109313|NCT01787591|3633608|P3|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
1109314|NCT01787591|3633609|P2|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
1109315|NCT01787591|3633610|P1|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
1109316|NCT01787461|3633638|P2|Overall Study|Protocol Violation|0
1109317|NCT01787461|3633639|P1|Overall Study|Protocol Violation|3
1109318|NCT01787461|3633638|P2|Overall Study|Withdrawal by Subject|4
1109319|NCT01787461|3633639|P1|Overall Study|Withdrawal by Subject|3
1109320|NCT01787461|3633638|P2|Overall Study|No longer met eligibility criteria|0
1109321|NCT01787461|3633639|P1|Overall Study|No longer met eligibility criteria|1
1109322|NCT01787461|3633638|P2|Overall Study|Lost to Follow-up|2
1109323|NCT01787461|3633639|P1|Overall Study|Lost to Follow-up|3
1109324|NCT01787461|3633638|P2|Overall Study|Adverse Event|3
1109325|NCT01787461|3633639|P1|Overall Study|Adverse Event|4
1109326|NCT01787279|3633695|P1|Overall Study|Lack of Efficacy|1
1109327|NCT01787279|3633695|P1|Overall Study|Lost to Follow-up|2
1109328|NCT01787188|3633721|P3|Overall Study|Other, including patient moved|0
1109329|NCT01787188|3633722|P2|Overall Study|Other, including patient moved|3
1109330|NCT01787188|3633723|P1|Overall Study|Other, including patient moved|0
1109331|NCT01787188|3633721|P3|Overall Study|Lost to Follow-up|2
1109332|NCT01787188|3633722|P2|Overall Study|Lost to Follow-up|2
1109333|NCT01787188|3633723|P1|Overall Study|Lost to Follow-up|1
1109334|NCT01787188|3633721|P3|Overall Study|Protocol Violation|3
1109335|NCT01787188|3633722|P2|Overall Study|Protocol Violation|2
1109336|NCT01787188|3633723|P1|Overall Study|Protocol Violation|3
1109337|NCT01787188|3633721|P3|Overall Study|Withdrawal by Subject|2
1109338|NCT01787188|3633722|P2|Overall Study|Withdrawal by Subject|3
1109339|NCT01787188|3633723|P1|Overall Study|Withdrawal by Subject|4
1109340|NCT01787188|3633721|P3|Overall Study|Non-compliance with Study Drug|0
1109341|NCT01787188|3633722|P2|Overall Study|Non-compliance with Study Drug|1
1109342|NCT01787188|3633723|P1|Overall Study|Non-compliance with Study Drug|0
1109343|NCT01787188|3633721|P3|Overall Study|Lack of Efficacy|5
1109344|NCT01787188|3633722|P2|Overall Study|Lack of Efficacy|3
1109345|NCT01787188|3633723|P1|Overall Study|Lack of Efficacy|7
1109346|NCT01787188|3633721|P3|Overall Study|Adverse Event|6
1109347|NCT01787188|3633722|P2|Overall Study|Adverse Event|4
1109348|NCT01787188|3633723|P1|Overall Study|Adverse Event|2
1109349|NCT01787032|3633795|P6|Overall Study|Protocol Violation|1
1109350|NCT01787032|3633796|P5|Overall Study|Protocol Violation|1
1109351|NCT01787032|3633797|P4|Overall Study|Protocol Violation|0
1109352|NCT01787032|3633798|P3|Overall Study|Protocol Violation|0
1109353|NCT01787032|3633799|P2|Overall Study|Protocol Violation|0
1109354|NCT01787032|3633800|P1|Overall Study|Protocol Violation|0
1109355|NCT01786993|3633824|P2|Overall Study|Hospice Admission|0
1109356|NCT01786993|3633825|P1|Overall Study|Hospice Admission|1
1109357|NCT01786993|3633824|P2|Overall Study|System Explant|0
1109358|NCT01786993|3633825|P1|Overall Study|System Explant|1
1109359|NCT01786993|3633824|P2|Overall Study|Subject Non-Compliance|0
1109360|NCT01786993|3633825|P1|Overall Study|Subject Non-Compliance|1
1109361|NCT01786993|3633824|P2|Overall Study|Lost to Follow-up|1
1109362|NCT01786993|3633825|P1|Overall Study|Lost to Follow-up|0
1109363|NCT01786993|3633824|P2|Overall Study|Withdrawal by Subject|2
1109364|NCT01786993|3633825|P1|Overall Study|Withdrawal by Subject|3
1109365|NCT01786993|3633824|P2|Overall Study|Death|7
1109366|NCT01786993|3633825|P1|Overall Study|Death|6
1109367|NCT01786707|3633884|P2|Overall Study|Lost to Follow-up|1
1109368|NCT01786707|3633885|P1|Overall Study|Lost to Follow-up|1
1109369|NCT01786668|3633897|P4|Overall Study|Lost to Follow-up|0
1109370|NCT01786668|3633898|P3|Overall Study|Lost to Follow-up|1
1109371|NCT01786668|3633899|P2|Overall Study|Lost to Follow-up|0
1109372|NCT01786668|3633900|P1|Overall Study|Lost to Follow-up|1
1109373|NCT01786668|3633897|P4|Overall Study|Pregnancy|1
1109374|NCT01786668|3633898|P3|Overall Study|Pregnancy|0
1109375|NCT01786668|3633899|P2|Overall Study|Pregnancy|0
1109376|NCT01786668|3633900|P1|Overall Study|Pregnancy|0
1109377|NCT01786668|3633897|P4|Overall Study|Withdrawal by Subject|1
1109378|NCT01786668|3633898|P3|Overall Study|Withdrawal by Subject|3
1109379|NCT01786668|3633899|P2|Overall Study|Withdrawal by Subject|0
1109380|NCT01786668|3633900|P1|Overall Study|Withdrawal by Subject|0
1109381|NCT01786668|3633897|P4|Overall Study|Adverse Event|2
1109382|NCT01786668|3633898|P3|Overall Study|Adverse Event|1
1109383|NCT01786668|3633899|P2|Overall Study|Adverse Event|1
1109384|NCT01786668|3633900|P1|Overall Study|Adverse Event|0
1109385|NCT01786629|3634000|P2|Overall Study|Adverse Event|1
1109386|NCT01786629|3634001|P1|Overall Study|Adverse Event|0
1109387|NCT01786629|3634000|P2|Overall Study|Lack of Efficacy|4
1109388|NCT01786629|3634001|P1|Overall Study|Lack of Efficacy|0
1109389|NCT01786551|3634007|P1|Overall Study|Participant withdrew consent|2
1109390|NCT01786330|3634015|P2|Overall Study|Protocol Violation|0
1109391|NCT01786330|3634016|P1|Overall Study|Protocol Violation|1
1109392|NCT01786330|3634015|P2|Overall Study|Excluded intraoperatively|1
1109393|NCT01786330|3634016|P1|Overall Study|Excluded intraoperatively|0
1109394|NCT01786330|3634015|P2|Overall Study|Lost to Follow-up|1
1109395|NCT01786330|3634016|P1|Overall Study|Lost to Follow-up|0
1109396|NCT01786330|3634015|P2|Overall Study|Withdrawal by Subject|1
1109397|NCT01786330|3634016|P1|Overall Study|Withdrawal by Subject|0
1109398|NCT01786174|3634054|P2|Overall Study|Discontinued Study Drug|0
1109399|NCT01786174|3634055|P1|Overall Study|Discontinued Study Drug|2
1109400|NCT01786109|3634085|P3|Overall Study|adverse effects colon preparation|1
1109401|NCT01786109|3634086|P2|Overall Study|adverse effects colon preparation|0
1109402|NCT01786109|3634087|P1|Overall Study|adverse effects colon preparation|0
1109403|NCT01786109|3634085|P3|Overall Study|unrelated illness|1
1109404|NCT01786109|3634086|P2|Overall Study|unrelated illness|0
1109405|NCT01786109|3634087|P1|Overall Study|unrelated illness|0
1109406|NCT01786109|3634085|P3|Overall Study|fail manometry barostat tube placement|0
1109407|NCT01786109|3634086|P2|Overall Study|fail manometry barostat tube placement|0
1109408|NCT01786109|3634087|P1|Overall Study|fail manometry barostat tube placement|1
1109409|NCT01785875|3634116|P3|Overall Study|Missing|3
1109410|NCT01785875|3634117|P2|Overall Study|Missing|1
1109411|NCT01785875|3634118|P1|Overall Study|Missing|0
1109412|NCT01785875|3634116|P3|Overall Study|Protocol Specified Criteria|55
1109413|NCT01785875|3634117|P2|Overall Study|Protocol Specified Criteria|214
1109414|NCT01785875|3634118|P1|Overall Study|Protocol Specified Criteria|207
1109415|NCT01785875|3634116|P3|Overall Study|Sponsor Decision|0
1109416|NCT01785875|3634117|P2|Overall Study|Sponsor Decision|2
1109417|NCT01785875|3634118|P1|Overall Study|Sponsor Decision|0
1109418|NCT01785875|3634116|P3|Overall Study|Death|7
1109419|NCT01785875|3634117|P2|Overall Study|Death|16
1109420|NCT01785875|3634118|P1|Overall Study|Death|27
1109421|NCT01785875|3634116|P3|Overall Study|Lost to Follow-up|6
1109422|NCT01785875|3634117|P2|Overall Study|Lost to Follow-up|22
1109423|NCT01785875|3634118|P1|Overall Study|Lost to Follow-up|19
1109424|NCT01785875|3634116|P3|Overall Study|Withdrawal by Subject|36
1109425|NCT01785875|3634117|P2|Overall Study|Withdrawal by Subject|34
1109426|NCT01785875|3634118|P1|Overall Study|Withdrawal by Subject|41
1109427|NCT01785849|3634187|P2|Overall Study|Lost to Follow-up|11
1109428|NCT01785849|3634188|P1|Overall Study|Lost to Follow-up|10
1109429|NCT01785849|3634187|P2|Overall Study|Sponsor Decision|1
1109430|NCT01785849|3634188|P1|Overall Study|Sponsor Decision|0
1109431|NCT01785849|3634187|P2|Overall Study|Withdrawal by Subject|12
1109432|NCT01785849|3634188|P1|Overall Study|Withdrawal by Subject|15
1109433|NCT01785849|3634187|P2|Overall Study|Protocol Specified Criteria|1
1109434|NCT01785849|3634188|P1|Overall Study|Protocol Specified Criteria|29
1109435|NCT01785849|3634187|P2|Overall Study|Death|9
1109436|NCT01785849|3634188|P1|Overall Study|Death|7
1109437|NCT01785628|3634206|P2|Overall Study|Lost to Follow-up|3
1109438|NCT01785628|3634207|P1|Overall Study|Lost to Follow-up|2
1109439|NCT01785615|3634230|P4|Dietary Phase|Lost to Follow-up|24
1109440|NCT01785615|3634231|P3|Dietary Phase|Lost to Follow-up|0
1109441|NCT01785615|3634232|P2|Dietary Phase|Lost to Follow-up|0
1109442|NCT01785615|3634233|P1|Dietary Phase|Lost to Follow-up|0
1109443|NCT01785602|3634305|P2|Overall Study|Administrative problems|3
1109444|NCT01785602|3634306|P1|Overall Study|Administrative problems|7
1109445|NCT01785602|3634305|P2|Overall Study|Adverse Event|5
1109446|NCT01785602|3634306|P1|Overall Study|Adverse Event|3
1109447|NCT01785602|3634305|P2|Overall Study|Lost to Follow-up|1
1109448|NCT01785602|3634306|P1|Overall Study|Lost to Follow-up|1
1109449|NCT01785602|3634305|P2|Overall Study|Withdrawal by Subject|0
1109450|NCT01785602|3634306|P1|Overall Study|Withdrawal by Subject|2
1109451|NCT01785524|3634316|P2|Overall Study|Withdrawal by Subject|2
1109452|NCT01785524|3634317|P1|Overall Study|Withdrawal by Subject|2
1109453|NCT01785472|3634336|P3|Overall Study|Technical problems|1
1109454|NCT01785472|3634337|P2|Overall Study|Technical problems|0
1109455|NCT01785472|3634338|P1|Overall Study|Technical problems|0
1109456|NCT01785472|3634336|P3|Overall Study|Subject/guardian decision|11
1109457|NCT01785472|3634337|P2|Overall Study|Subject/guardian decision|10
1109458|NCT01785472|3634338|P1|Overall Study|Subject/guardian decision|15
1109459|NCT01785472|3634336|P3|Overall Study|Protocol deviation|2
1109460|NCT01785472|3634337|P2|Overall Study|Protocol deviation|2
1109461|NCT01785472|3634338|P1|Overall Study|Protocol deviation|0
1109462|NCT01785472|3634336|P3|Overall Study|Physician Decision|1
1109463|NCT01785472|3634337|P2|Overall Study|Physician Decision|1
1109464|NCT01785472|3634338|P1|Overall Study|Physician Decision|1
1109465|NCT01785472|3634336|P3|Overall Study|Lost to Follow-up|0
1109466|NCT01785472|3634337|P2|Overall Study|Lost to Follow-up|2
1109467|NCT01785472|3634338|P1|Overall Study|Lost to Follow-up|1
1109468|NCT01785472|3634336|P3|Overall Study|Lack of Efficacy|1
1109469|NCT01785472|3634337|P2|Overall Study|Lack of Efficacy|0
1109470|NCT01785472|3634338|P1|Overall Study|Lack of Efficacy|2
1109471|NCT01785472|3634336|P3|Overall Study|Adverse Event|6
1109472|NCT01785472|3634337|P2|Overall Study|Adverse Event|4
1109473|NCT01785472|3634338|P1|Overall Study|Adverse Event|5
1109474|NCT01785160|3634411|P1|Washout Period of at Least 7 Days|Consent withdrawn|1
1109475|NCT01785160|3634411|P1|Treatment Period 1: Raltegravir|Not treated|1
1109476|NCT01784965|3634446|P2|Overall Study|Adverse Event|8
1109477|NCT01784965|3634447|P1|Overall Study|Adverse Event|0
1109478|NCT01784965|3634446|P2|Overall Study|Withdrawal by Subject|3
1109479|NCT01784965|3634447|P1|Overall Study|Withdrawal by Subject|6
1109480|NCT01784029|3634523|P3|Overall Study|Lost to Follow-up|22
1109481|NCT01784029|3634524|P2|Overall Study|Lost to Follow-up|20
1109482|NCT01784029|3634525|P1|Overall Study|Lost to Follow-up|19
1109483|NCT01783938|3634535|P2|Overall Study|Not Specified|0
1109484|NCT01783938|3634536|P1|Overall Study|Not Specified|1
1109485|NCT01783938|3634535|P2|Overall Study|Withdrew Consent|0
1109486|NCT01783938|3634536|P1|Overall Study|Withdrew Consent|3
1109487|NCT01783938|3634535|P2|Overall Study|Request to Discontinue Study Treatment|2
1109488|NCT01783938|3634536|P1|Overall Study|Request to Discontinue Study Treatment|1
1109489|NCT01783938|3634535|P2|Overall Study|Adverse Event Unrelated to Study Drug|2
1109490|NCT01783938|3634536|P1|Overall Study|Adverse Event Unrelated to Study Drug|2
1109491|NCT01783938|3634535|P2|Overall Study|Study Drug Toxicity|10
1109492|NCT01783938|3634536|P1|Overall Study|Study Drug Toxicity|22
1109493|NCT01783938|3634535|P2|Overall Study|Disease Progression|39
1109494|NCT01783938|3634536|P1|Overall Study|Disease Progression|18
1109495|NCT01783886|3634564|P3|Overall Study|Adverse Event|4
1109496|NCT01783886|3634565|P2|Overall Study|Adverse Event|5
1109497|NCT01783886|3634566|P1|Overall Study|Adverse Event|4
1109498|NCT01783886|3634564|P3|Overall Study|Withdrawal of consent by participant|4
1109499|NCT01783886|3634565|P2|Overall Study|Withdrawal of consent by participant|3
1109500|NCT01783886|3634566|P1|Overall Study|Withdrawal of consent by participant|1
1109501|NCT01783886|3634564|P3|Overall Study|Protocol deviation|2
1109502|NCT01783886|3634565|P2|Overall Study|Protocol deviation|0
1109503|NCT01783886|3634566|P1|Overall Study|Protocol deviation|0
1109504|NCT01783886|3634564|P3|Overall Study|Lost to Follow-up|0
1109505|NCT01783886|3634565|P2|Overall Study|Lost to Follow-up|3
1109506|NCT01783886|3634566|P1|Overall Study|Lost to Follow-up|0
1109507|NCT01783821|3634626|P2|Overall Study|Screen Failure|1
1109508|NCT01783821|3634627|P1|Overall Study|Screen Failure|1
1109509|NCT01783743|3634645|P2|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236
1109510|NCT01783743|3634646|P1|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305
1109511|NCT01783743|3634645|P2|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684
1109512|NCT01783743|3634646|P1|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591
1109513|NCT01783743|3634645|P2|Screening of Subjects by CTA During MDA|Absent at MDA|4439
1109514|NCT01783743|3634646|P1|Screening of Subjects by CTA During MDA|Absent at MDA|3427
1109515|NCT01783730|3634660|P1|Overall Study|Failed to meet inclusion criteria|6
1109516|NCT01783678|3634685|P6|Overall Study|Withdrew Consent|0
1109517|NCT01783678|3634686|P5|Overall Study|Withdrew Consent|0
1109518|NCT01783678|3634687|P4|Overall Study|Withdrew Consent|2
1109519|NCT01783678|3634688|P3|Overall Study|Withdrew Consent|0
1109520|NCT01783678|3634689|P2|Overall Study|Withdrew Consent|1
1109521|NCT01783678|3634690|P1|Overall Study|Withdrew Consent|1
1109522|NCT01783678|3634685|P6|Overall Study|Lost to Follow-up|0
1109523|NCT01783678|3634686|P5|Overall Study|Lost to Follow-up|1
1109524|NCT01783678|3634687|P4|Overall Study|Lost to Follow-up|2
1109525|NCT01783678|3634688|P3|Overall Study|Lost to Follow-up|0
1109526|NCT01783678|3634689|P2|Overall Study|Lost to Follow-up|4
1109527|NCT01783678|3634690|P1|Overall Study|Lost to Follow-up|0
1109528|NCT01783678|3634685|P6|Overall Study|Lack of Efficacy|5
1109529|NCT01783678|3634686|P5|Overall Study|Lack of Efficacy|6
1109530|NCT01783678|3634687|P4|Overall Study|Lack of Efficacy|3
1109531|NCT01783678|3634688|P3|Overall Study|Lack of Efficacy|1
1109532|NCT01783678|3634689|P2|Overall Study|Lack of Efficacy|13
1109533|NCT01783678|3634690|P1|Overall Study|Lack of Efficacy|1
1109534|NCT01783678|3634685|P6|Overall Study|Randomized but Not Treated|0
1109535|NCT01783678|3634686|P5|Overall Study|Randomized but Not Treated|0
1109536|NCT01783678|3634687|P4|Overall Study|Randomized but Not Treated|1
1109537|NCT01783678|3634688|P3|Overall Study|Randomized but Not Treated|0
1109538|NCT01783678|3634689|P2|Overall Study|Randomized but Not Treated|0
1109539|NCT01783678|3634690|P1|Overall Study|Randomized but Not Treated|0
1109540|NCT01783548|3634794|P2|Overall Study|Lack of Efficacy|1
1109541|NCT01783548|3634795|P1|Overall Study|Lack of Efficacy|1
1109542|NCT01783548|3634794|P2|Overall Study|Lost to Follow-up|3
1109543|NCT01783548|3634795|P1|Overall Study|Lost to Follow-up|8
1109544|NCT01783548|3634794|P2|Overall Study|Protocol Violation|2
1109545|NCT01783548|3634795|P1|Overall Study|Protocol Violation|2
1109546|NCT01783548|3634794|P2|Overall Study|Non-compliance|0
1109547|NCT01783548|3634795|P1|Overall Study|Non-compliance|4
1109548|NCT01783548|3634794|P2|Overall Study|Withdrawal by Subject|8
1109549|NCT01783548|3634795|P1|Overall Study|Withdrawal by Subject|11
1109550|NCT01783548|3634794|P2|Overall Study|Adverse Event|4
1109551|NCT01783548|3634795|P1|Overall Study|Adverse Event|8
1109552|NCT01783496|3634813|P6|Overall Study|Withdrawal by Subject|0
1109553|NCT01783496|3634814|P5|Overall Study|Withdrawal by Subject|0
1109554|NCT01783496|3634815|P4|Overall Study|Withdrawal by Subject|0
1109555|NCT01783496|3634816|P3|Overall Study|Withdrawal by Subject|0
1109556|NCT01783496|3634817|P2|Overall Study|Withdrawal by Subject|0
1109557|NCT01783496|3634818|P1|Overall Study|Withdrawal by Subject|1
1109558|NCT01783496|3634813|P6|Overall Study|Lost to Follow-up|1
1109559|NCT01783496|3634814|P5|Overall Study|Lost to Follow-up|0
1109560|NCT01783496|3634815|P4|Overall Study|Lost to Follow-up|2
1109561|NCT01783496|3634816|P3|Overall Study|Lost to Follow-up|0
1109562|NCT01783496|3634817|P2|Overall Study|Lost to Follow-up|0
1109563|NCT01783496|3634818|P1|Overall Study|Lost to Follow-up|0
1109564|NCT01783483|3634846|P2|Overall Study|Physician Decision|1
1109565|NCT01783483|3634847|P1|Overall Study|Physician Decision|1
1109566|NCT01783483|3634846|P2|Overall Study|Withdrawal by Subject|1
1109567|NCT01783483|3634847|P1|Overall Study|Withdrawal by Subject|2
1109568|NCT01783483|3634846|P2|Overall Study|Lost to Follow-up|10
1109569|NCT01783483|3634847|P1|Overall Study|Lost to Follow-up|14
1109570|NCT01783483|3634846|P2|Overall Study|Death|3
1109571|NCT01783483|3634847|P1|Overall Study|Death|3
1109572|NCT01783418|3634885|P2|Overall Study|Withdrawal by Subject|0
1109573|NCT01783418|3634886|P1|Overall Study|Withdrawal by Subject|1
1109574|NCT01783015|3634939|P3|Open Label Treatment|Study Terminated by Sponsor|6
1109575|NCT01783015|3634940|P2|Open Label Treatment|Study Terminated by Sponsor|0
1109576|NCT01783015|3634941|P1|Open Label Treatment|Study Terminated by Sponsor|0
1109577|NCT01783015|3634939|P3|Blinded Treatment|Study Terminated by Sponsor|0
1109578|NCT01783015|3634940|P2|Blinded Treatment|Study Terminated by Sponsor|0
1109579|NCT01783015|3634941|P1|Blinded Treatment|Study Terminated by Sponsor|2
1109580|NCT01783015|3634939|P3|Blinded Treatment|Withdrawal by Subject|0
1109581|NCT01783015|3634940|P2|Blinded Treatment|Withdrawal by Subject|1
1109582|NCT01783015|3634941|P1|Blinded Treatment|Withdrawal by Subject|0
1109583|NCT01783015|3634939|P3|Blinded Treatment|Protocol Violation|0
1109584|NCT01783015|3634940|P2|Blinded Treatment|Protocol Violation|1
1109585|NCT01783015|3634941|P1|Blinded Treatment|Protocol Violation|0
1109586|NCT01783015|3634939|P3|Blinded Treatment|Adverse Event|0
1109587|NCT01783015|3634940|P2|Blinded Treatment|Adverse Event|1
1109588|NCT01783015|3634941|P1|Blinded Treatment|Adverse Event|0
1109589|NCT01782885|3635054|P2|Overall Study|Lost to Follow-up|6
1109590|NCT01782885|3635055|P1|Overall Study|Lost to Follow-up|4
1109591|NCT01782872|3635081|P4|Overall Study|Withdrawal by Subject|0
1109592|NCT01782872|3635082|P3|Overall Study|Withdrawal by Subject|0
1109593|NCT01782872|3635083|P2|Overall Study|Withdrawal by Subject|1
1109594|NCT01782872|3635084|P1|Overall Study|Withdrawal by Subject|0
1109595|NCT01782872|3635081|P4|Overall Study|Protocol Violation|1
1109596|NCT01782872|3635082|P3|Overall Study|Protocol Violation|0
1109597|NCT01782872|3635083|P2|Overall Study|Protocol Violation|0
1109598|NCT01782872|3635084|P1|Overall Study|Protocol Violation|0
1109599|NCT01782859|3635108|P2|Overall Study|Withdrawal by Subject|1
1109600|NCT01782859|3635109|P1|Overall Study|Withdrawal by Subject|0
1109601|NCT01782859|3635108|P2|Overall Study|Protocol Violation|6
1109602|NCT01782859|3635109|P1|Overall Study|Protocol Violation|6
1109603|NCT01782742|3635131|P2|Double-blind Treatment Phase|Adverse Event|0
1109604|NCT01782742|3635132|P1|Double-blind Treatment Phase|Adverse Event|1
1109605|NCT01782690|3635165|P1|Overall Study|Study completion unknown|7
1109606|NCT01782690|3635165|P1|Overall Study|Death|133
1109607|NCT01782690|3635165|P1|Overall Study|Tumor progression|74
1109608|NCT01782690|3635165|P1|Overall Study|Patient's wish|21
1109609|NCT01782690|3635165|P1|Overall Study|Physician Decision|13
1109610|NCT01782690|3635165|P1|Overall Study|Absent rash|9
1109611|NCT01782690|3635165|P1|Overall Study|Withdrawal of informed consent|2
1109612|NCT01782690|3635165|P1|Overall Study|Lost to Follow-up|31
1109613|NCT01782690|3635165|P1|Overall Study|Toxicity of erlotinib|1
1109614|NCT01782690|3635165|P1|Overall Study|Toxicity of gemcitabine|1
1109615|NCT01782690|3635165|P1|Overall Study|Not reported|7
1109616|NCT01782664|3635187|P6|Overall Study|Withdrawal by Subject|0
1109617|NCT01782664|3635188|P5|Overall Study|Withdrawal by Subject|0
1109618|NCT01782664|3635189|P4|Overall Study|Withdrawal by Subject|0
1109619|NCT01782664|3635190|P3|Overall Study|Withdrawal by Subject|0
1109620|NCT01782664|3635191|P2|Overall Study|Withdrawal by Subject|2
1109621|NCT01782664|3635192|P1|Overall Study|Withdrawal by Subject|2
1109622|NCT01782664|3635187|P6|Overall Study|Protocol Violation|0
1109623|NCT01782664|3635188|P5|Overall Study|Protocol Violation|0
1109624|NCT01782664|3635189|P4|Overall Study|Protocol Violation|1
1109625|NCT01782664|3635190|P3|Overall Study|Protocol Violation|0
1109626|NCT01782664|3635191|P2|Overall Study|Protocol Violation|1
1109627|NCT01782664|3635192|P1|Overall Study|Protocol Violation|0
1109628|NCT01782664|3635187|P6|Overall Study|Lack of Efficacy|0
1109629|NCT01782664|3635188|P5|Overall Study|Lack of Efficacy|0
1109630|NCT01782664|3635189|P4|Overall Study|Lack of Efficacy|2
1109631|NCT01782664|3635190|P3|Overall Study|Lack of Efficacy|2
1109632|NCT01782664|3635191|P2|Overall Study|Lack of Efficacy|0
1109633|NCT01782664|3635192|P1|Overall Study|Lack of Efficacy|2
1109634|NCT01782664|3635187|P6|Overall Study|Adverse Event|0
1109635|NCT01782664|3635188|P5|Overall Study|Adverse Event|0
1109636|NCT01782664|3635189|P4|Overall Study|Adverse Event|2
1109637|NCT01782664|3635190|P3|Overall Study|Adverse Event|2
1109638|NCT01782664|3635191|P2|Overall Study|Adverse Event|2
1109639|NCT01782664|3635192|P1|Overall Study|Adverse Event|2
1109640|NCT01782495|3635349|P11|Overall Study|Withdrew Consent|0
1109641|NCT01782495|3635350|P10|Overall Study|Withdrew Consent|0
1109642|NCT01782495|3635351|P9|Overall Study|Withdrew Consent|0
1109643|NCT01782495|3635352|P8|Overall Study|Withdrew Consent|1
1109644|NCT01782495|3635353|P7|Overall Study|Withdrew Consent|0
1109645|NCT01782495|3635354|P6|Overall Study|Withdrew Consent|0
1109646|NCT01782495|3635355|P5|Overall Study|Withdrew Consent|0
1109647|NCT01782495|3635356|P4|Overall Study|Withdrew Consent|0
1109648|NCT01782495|3635357|P3|Overall Study|Withdrew Consent|0
1109649|NCT01782495|3635358|P2|Overall Study|Withdrew Consent|1
1109650|NCT01782495|3635359|P1|Overall Study|Withdrew Consent|0
1109651|NCT01782495|3635349|P11|Overall Study|Adverse Event|0
1109652|NCT01782495|3635350|P10|Overall Study|Adverse Event|0
1109653|NCT01782495|3635351|P9|Overall Study|Adverse Event|0
1109654|NCT01782495|3635352|P8|Overall Study|Adverse Event|2
1109655|NCT01782495|3635353|P7|Overall Study|Adverse Event|0
1109656|NCT01782495|3635354|P6|Overall Study|Adverse Event|0
1109657|NCT01782495|3635355|P5|Overall Study|Adverse Event|0
1109658|NCT01782495|3635356|P4|Overall Study|Adverse Event|0
1109659|NCT01782495|3635357|P3|Overall Study|Adverse Event|0
1109660|NCT01782495|3635358|P2|Overall Study|Adverse Event|0
1109661|NCT01782495|3635359|P1|Overall Study|Adverse Event|0
1109662|NCT01782482|3635418|P2|Overall Study|Habitually wearing toric lens OS|1
1109663|NCT01782482|3635419|P1|Overall Study|Habitually wearing toric lens OS|0
1109664|NCT01782482|3635418|P2|Overall Study|Randomized in Error|2
1109665|NCT01782482|3635419|P1|Overall Study|Randomized in Error|2
1109666|NCT01782482|3635418|P2|Overall Study|Withdrawal by Subject|3
1109667|NCT01782482|3635419|P1|Overall Study|Withdrawal by Subject|2
1109668|NCT01782482|3635418|P2|Overall Study|Protocol Violation|0
1109669|NCT01782482|3635419|P1|Overall Study|Protocol Violation|1
1109670|NCT01782482|3635418|P2|Overall Study|Physician Decision|0
1109671|NCT01782482|3635419|P1|Overall Study|Physician Decision|1
1109672|NCT01782482|3635418|P2|Overall Study|Lost to Follow-up|3
1109673|NCT01782482|3635419|P1|Overall Study|Lost to Follow-up|2
1109674|NCT01782482|3635418|P2|Overall Study|Adverse Event|1
1109675|NCT01782482|3635419|P1|Overall Study|Adverse Event|2
1109676|NCT01782469|3635427|P1|Overall Study|Lost to Follow-up|1
1109677|NCT01782326|3635437|P2|Double-blind Treatment|Technical problems|5
1109678|NCT01782326|3635438|P1|Double-blind Treatment|Technical problems|0
1109679|NCT01782326|3635437|P2|Double-blind Treatment|Protocol deviation|7
1109680|NCT01782326|3635438|P1|Double-blind Treatment|Protocol deviation|8
1109681|NCT01782326|3635437|P2|Double-blind Treatment|Physician Decision|16
1109682|NCT01782326|3635438|P1|Double-blind Treatment|Physician Decision|13
1109683|NCT01782326|3635437|P2|Double-blind Treatment|Lack of Efficacy|22
1109684|NCT01782326|3635438|P1|Double-blind Treatment|Lack of Efficacy|17
1109685|NCT01782326|3635437|P2|Double-blind Treatment|Subject/guardian decision|125
1109686|NCT01782326|3635438|P1|Double-blind Treatment|Subject/guardian decision|111
1109687|NCT01782326|3635437|P2|Double-blind Treatment|Adverse Event|145
1109688|NCT01782326|3635438|P1|Double-blind Treatment|Adverse Event|129
1109689|NCT01782326|3635437|P2|Planned Treatment Epoch|Technical problems|4
1109690|NCT01782326|3635438|P1|Planned Treatment Epoch|Technical problems|0
1109691|NCT01782326|3635437|P2|Planned Treatment Epoch|Lost to Follow-up|4
1109692|NCT01782326|3635438|P1|Planned Treatment Epoch|Lost to Follow-up|4
1109693|NCT01782326|3635437|P2|Planned Treatment Epoch|Protocol deviation|3
1109694|NCT01782326|3635438|P1|Planned Treatment Epoch|Protocol deviation|2
1109695|NCT01782326|3635437|P2|Planned Treatment Epoch|Physician Decision|16
1109696|NCT01782326|3635438|P1|Planned Treatment Epoch|Physician Decision|18
1109697|NCT01782326|3635437|P2|Planned Treatment Epoch|Death|30
1109698|NCT01782326|3635438|P1|Planned Treatment Epoch|Death|29
1109699|NCT01782326|3635437|P2|Planned Treatment Epoch|Subject/guardian decision|151
1109700|NCT01782326|3635438|P1|Planned Treatment Epoch|Subject/guardian decision|149
1109701|NCT01782313|3635498|P1|Survival Follow up|Lost to Follow-up|1
1109702|NCT01782313|3635498|P1|Continued Treatment After 16 Weeks|Withdrawal by Subject|1
1109703|NCT01782313|3635498|P1|Continued Treatment After 16 Weeks|Progressive Disease|6
1109704|NCT01782313|3635498|P1|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1
1109705|NCT01782313|3635498|P1|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5
1109706|NCT01782313|3635498|P1|Treated Cycle 3|Progressive Disease|21
1109707|NCT01782313|3635498|P1|Reached First Response/Completed 2 Cycle|Progressive Disease|3
1109708|NCT01782313|3635498|P1|Reached First Response/Completed 2 Cycle|Adverse Event|3
1109709|NCT01782222|3635512|P3|Overall Study|Moved to other state|0
1109710|NCT01782222|3635513|P2|Overall Study|Moved to other state|1
1109711|NCT01782222|3635514|P1|Overall Study|Moved to other state|0
1109712|NCT01782222|3635512|P3|Overall Study|Withdrawal by Subject|1
1109713|NCT01782222|3635513|P2|Overall Study|Withdrawal by Subject|4
1109714|NCT01782222|3635514|P1|Overall Study|Withdrawal by Subject|1
1109715|NCT01782222|3635512|P3|Overall Study|Protocol Violation|0
1109716|NCT01782222|3635513|P2|Overall Study|Protocol Violation|0
1109717|NCT01782222|3635514|P1|Overall Study|Protocol Violation|1
1109718|NCT01782222|3635512|P3|Overall Study|Lack of Efficacy|0
1109719|NCT01782222|3635513|P2|Overall Study|Lack of Efficacy|1
1109720|NCT01782222|3635514|P1|Overall Study|Lack of Efficacy|2
1109721|NCT01782222|3635512|P3|Overall Study|Adverse Event|3
1109722|NCT01782222|3635513|P2|Overall Study|Adverse Event|5
1109723|NCT01782222|3635514|P1|Overall Study|Adverse Event|4
1109724|NCT01781975|3635548|P2|Overall Study|Withdrawal by Subject|1
1109725|NCT01781975|3635549|P1|Overall Study|Withdrawal by Subject|1
1109726|NCT01781975|3635548|P2|Overall Study|Death|0
1109727|NCT01781975|3635549|P1|Overall Study|Death|1
1109728|NCT01781962|3635555|P1|Overall Study|Other Miscellaneous Reasons|5
1109729|NCT01781832|3635561|P1|Overall Study|Withdrawal by Subject|1
1109730|NCT01781637|3635581|P2|Overall Study|Withdrawal by Subject|0
1109731|NCT01781637|3635582|P1|Overall Study|Withdrawal by Subject|1
1109732|NCT01781637|3635581|P2|Overall Study|Lack of Efficacy|6
1109733|NCT01781637|3635582|P1|Overall Study|Lack of Efficacy|2
1109734|NCT01781637|3635581|P2|Overall Study|Adverse Event|0
1109735|NCT01781637|3635582|P1|Overall Study|Adverse Event|1
1109736|NCT01781299|3635669|P2|Overall Study|Withdrawal by Subject|1
1109737|NCT01781299|3635670|P1|Overall Study|Withdrawal by Subject|0
1109738|NCT01781286|3635678|P6|Overall Study|Noncompliance|0
1109739|NCT01781286|3635679|P5|Overall Study|Noncompliance|0
1109740|NCT01781286|3635680|P4|Overall Study|Noncompliance|1
1109741|NCT01781286|3635681|P3|Overall Study|Noncompliance|0
1109742|NCT01781286|3635682|P2|Overall Study|Noncompliance|0
1109743|NCT01781286|3635683|P1|Overall Study|Noncompliance|0
1109744|NCT01781286|3635678|P6|Overall Study|Time Constraints|0
1109745|NCT01781286|3635679|P5|Overall Study|Time Constraints|0
1109746|NCT01781286|3635680|P4|Overall Study|Time Constraints|0
1109747|NCT01781286|3635681|P3|Overall Study|Time Constraints|2
1109748|NCT01781286|3635682|P2|Overall Study|Time Constraints|0
1109749|NCT01781286|3635683|P1|Overall Study|Time Constraints|2
1109750|NCT01781286|3635678|P6|Overall Study|Lost to Follow-up|1
1109751|NCT01781286|3635679|P5|Overall Study|Lost to Follow-up|0
1109752|NCT01781286|3635680|P4|Overall Study|Lost to Follow-up|0
1109753|NCT01781286|3635681|P3|Overall Study|Lost to Follow-up|0
1109754|NCT01781286|3635682|P2|Overall Study|Lost to Follow-up|0
1109755|NCT01781286|3635683|P1|Overall Study|Lost to Follow-up|0
1109756|NCT01781234|3635708|P2|Overall Study|Withdrawal by Subject|3
1109757|NCT01781234|3635709|P1|Overall Study|Withdrawal by Subject|4
1109758|NCT01781234|3635708|P2|Overall Study|Protocol Violation|0
1109759|NCT01781234|3635709|P1|Overall Study|Protocol Violation|3
1109760|NCT01781234|3635708|P2|Overall Study|Adverse Event|0
1109761|NCT01781234|3635709|P1|Overall Study|Adverse Event|2
1109762|NCT01781026|3635747|P1|Overall Study|Lack of Efficacy|2
1109763|NCT01780987|3635753|P2|Overall Study|Not Receiving any Study Medication|1
1109764|NCT01780987|3635754|P1|Overall Study|Not Receiving any Study Medication|0
1109765|NCT01780987|3635753|P2|Overall Study|Changing Residence|0
1109766|NCT01780987|3635754|P1|Overall Study|Changing Residence|1
1109767|NCT01780987|3635753|P2|Overall Study|Request of Changing Hospital|1
1109768|NCT01780987|3635754|P1|Overall Study|Request of Changing Hospital|0
1109769|NCT01780987|3635753|P2|Overall Study|Withdrawal by Subject|0
1109770|NCT01780987|3635754|P1|Overall Study|Withdrawal by Subject|2
1109771|NCT01780987|3635753|P2|Overall Study|Adverse Event|4
1109772|NCT01780987|3635754|P1|Overall Study|Adverse Event|0
1109773|NCT01780974|3635772|P2|Overall Study|Adverse Event|3
1109774|NCT01780974|3635773|P1|Overall Study|Adverse Event|1
1109775|NCT01780974|3635772|P2|Overall Study|Death|0
1109776|NCT01780974|3635773|P1|Overall Study|Death|1
1109777|NCT01780935|3635783|P2|Overall Study|Patient withdrew consent|9
1109778|NCT01780935|3635784|P1|Overall Study|Patient withdrew consent|8
1109779|NCT01780935|3635783|P2|Overall Study|Protocol deviation|1
1109780|NCT01780935|3635784|P1|Overall Study|Protocol deviation|0
1109781|NCT01780935|3635783|P2|Overall Study|Physician Decision|1
1109782|NCT01780935|3635784|P1|Overall Study|Physician Decision|1
1109783|NCT01780935|3635783|P2|Overall Study|Lost to Follow-up|6
1109784|NCT01780935|3635784|P1|Overall Study|Lost to Follow-up|2
1109785|NCT01780935|3635783|P2|Overall Study|Death|6
1109786|NCT01780935|3635784|P1|Overall Study|Death|1
1109787|NCT01780935|3635783|P2|Overall Study|Adverse Event|4
1109788|NCT01780935|3635784|P1|Overall Study|Adverse Event|2
1109789|NCT01780935|3635783|P2|Overall Study|Admin problems due to early termination|309
1109790|NCT01780935|3635784|P1|Overall Study|Admin problems due to early termination|321
1109791|NCT01780584|3635888|P3|Overall Study|Protocol Violation|1
1109792|NCT01780584|3635889|P2|Overall Study|Protocol Violation|0
1109793|NCT01780584|3635890|P1|Overall Study|Protocol Violation|0
1109794|NCT01780584|3635888|P3|Overall Study|Adverse Event|0
1109795|NCT01780584|3635889|P2|Overall Study|Adverse Event|1
1109796|NCT01780584|3635890|P1|Overall Study|Adverse Event|0
1109797|NCT01780584|3635888|P3|Overall Study|Death|1
1109798|NCT01780584|3635889|P2|Overall Study|Death|0
1109799|NCT01780584|3635890|P1|Overall Study|Death|1
1109800|NCT01780545|3635912|P2|Overall Study|Lost to Follow-up|1
1109801|NCT01780545|3635913|P1|Overall Study|Lost to Follow-up|1
1109802|NCT01780545|3635912|P2|Overall Study|Withdrawal by Subject|1
1109803|NCT01780545|3635913|P1|Overall Study|Withdrawal by Subject|3
1109804|NCT01780506|3635931|P2|Open-Label Extension Phase|Enrolled but not Treated|1
1109805|NCT01780506|3635932|P1|Open-Label Extension Phase|Enrolled but not Treated|0
1109806|NCT01780506|3635931|P2|Double-Blind Phase|Lost to Follow-up|26
1109807|NCT01780506|3635932|P1|Double-Blind Phase|Lost to Follow-up|23
1109808|NCT01780506|3635931|P2|Double-Blind Phase|Withdrew Consent|24
1109809|NCT01780506|3635932|P1|Double-Blind Phase|Withdrew Consent|23
1109810|NCT01780506|3635931|P2|Double-Blind Phase|Protocol Violation|3
1109811|NCT01780506|3635932|P1|Double-Blind Phase|Protocol Violation|4
1109812|NCT01780506|3635931|P2|Double-Blind Phase|Non-Compliance with Study Drug|3
1109813|NCT01780506|3635932|P1|Double-Blind Phase|Non-Compliance with Study Drug|4
1109814|NCT01780506|3635931|P2|Double-Blind Phase|Investigator's Discretion|2
1109815|NCT01780506|3635932|P1|Double-Blind Phase|Investigator's Discretion|5
1109816|NCT01780506|3635931|P2|Double-Blind Phase|Lack of Efficacy|1
1109817|NCT01780506|3635932|P1|Double-Blind Phase|Lack of Efficacy|1
1109818|NCT01780506|3635931|P2|Double-Blind Phase|Pregnancy|1
1109819|NCT01780506|3635932|P1|Double-Blind Phase|Pregnancy|2
1109820|NCT01780506|3635931|P2|Double-Blind Phase|Death|2
1109821|NCT01780506|3635932|P1|Double-Blind Phase|Death|1
1109822|NCT01780506|3635931|P2|Double-Blind Phase|Adverse Event|14
1109823|NCT01780506|3635932|P1|Double-Blind Phase|Adverse Event|4
1109824|NCT01780506|3635931|P2|Double-Blind Phase|Randomized but not Treated|2
1109825|NCT01780506|3635932|P1|Double-Blind Phase|Randomized but not Treated|3
1109826|NCT01780389|3635986|P1|Overall Study|Adverse Event|1
1109827|NCT01779869|3636024|P1|Overall Study|Physician Decision|2
1109828|NCT01779648|3636030|P2|Overall Study|Protocol Violation|0
1109829|NCT01779648|3636031|P1|Overall Study|Protocol Violation|1
1109830|NCT01779440|3636061|P2|Overall Study|Withdrawal by Subject|5
1109831|NCT01779440|3636062|P1|Overall Study|Withdrawal by Subject|3
1109832|NCT01778985|3636120|P2|Overall Study|Protocol Violation|1
1109833|NCT01778985|3636121|P1|Overall Study|Protocol Violation|4
1109834|NCT01778985|3636120|P2|Overall Study|Physician Decision|2
1109835|NCT01778985|3636121|P1|Overall Study|Physician Decision|2
1109836|NCT01778985|3636120|P2|Overall Study|Lost to Follow-up|0
1109837|NCT01778985|3636121|P1|Overall Study|Lost to Follow-up|1
1109838|NCT01778855|3636167|P2|Overall Study|Death|1
1109839|NCT01778855|3636168|P1|Overall Study|Death|0
1109840|NCT01778751|3636176|P2|Overall Study|Transfered care|0
1109841|NCT01778751|3636177|P1|Overall Study|Transfered care|1
1109842|NCT01778751|3636176|P2|Overall Study|Withdrawal by Subject|2
1109843|NCT01778751|3636177|P1|Overall Study|Withdrawal by Subject|0
1109844|NCT01778751|3636176|P2|Overall Study|Lost to Follow-up|0
1109845|NCT01778751|3636177|P1|Overall Study|Lost to Follow-up|1
1109846|NCT01778530|3636228|P1|Overall Study|Adverse event/side effect|1
1109847|NCT01778530|3636228|P1|Overall Study|Progression on study|1
1109848|NCT01778127|3636259|P3|Overall Study|Withdrawal by Subject|4
1109849|NCT01778127|3636260|P2|Overall Study|Withdrawal by Subject|1
1109850|NCT01778127|3636261|P1|Overall Study|Withdrawal by Subject|3
1109851|NCT01778127|3636259|P3|Overall Study|Lost to Follow-up|2
1109852|NCT01778127|3636260|P2|Overall Study|Lost to Follow-up|1
1109853|NCT01778127|3636261|P1|Overall Study|Lost to Follow-up|5
1109854|NCT01778062|3636304|P2|Overall Study|major protocol deviation|3
1109855|NCT01778062|3636305|P1|Overall Study|major protocol deviation|4
1109856|NCT01778062|3636304|P2|Overall Study|Consent Withdrawal|5
1109857|NCT01778062|3636305|P1|Overall Study|Consent Withdrawal|1
1109858|NCT01778062|3636304|P2|Overall Study|Adverse Event|3
1109859|NCT01778062|3636305|P1|Overall Study|Adverse Event|1
1109860|NCT01778049|3636319|P6|Double Blind Treatment Period|Other reason not defined above|1
1109861|NCT01778049|3636320|P5|Double Blind Treatment Period|Other reason not defined above|2
1109862|NCT01778049|3636321|P4|Double Blind Treatment Period|Other reason not defined above|2
1109863|NCT01778049|3636322|P3|Double Blind Treatment Period|Other reason not defined above|4
1109864|NCT01778049|3636323|P2|Double Blind Treatment Period|Other reason not defined above|0
1109865|NCT01778049|3636324|P1|Double Blind Treatment Period|Other reason not defined above|0
1109866|NCT01778049|3636319|P6|Double Blind Treatment Period|Not treated|0
1109867|NCT01778049|3636320|P5|Double Blind Treatment Period|Not treated|2
1109868|NCT01778049|3636321|P4|Double Blind Treatment Period|Not treated|2
1109869|NCT01778049|3636322|P3|Double Blind Treatment Period|Not treated|0
1109870|NCT01778049|3636323|P2|Double Blind Treatment Period|Not treated|0
1109871|NCT01778049|3636324|P1|Double Blind Treatment Period|Not treated|0
1109872|NCT01778049|3636319|P6|Double Blind Treatment Period|Withdrawal by Subject|1
1109873|NCT01778049|3636320|P5|Double Blind Treatment Period|Withdrawal by Subject|0
1109874|NCT01778049|3636321|P4|Double Blind Treatment Period|Withdrawal by Subject|2
1109875|NCT01778049|3636322|P3|Double Blind Treatment Period|Withdrawal by Subject|1
1109876|NCT01778049|3636323|P2|Double Blind Treatment Period|Withdrawal by Subject|0
1109877|NCT01778049|3636324|P1|Double Blind Treatment Period|Withdrawal by Subject|0
1109878|NCT01778049|3636319|P6|Double Blind Treatment Period|Lost to Follow-up|2
1109879|NCT01778049|3636320|P5|Double Blind Treatment Period|Lost to Follow-up|5
1109880|NCT01778049|3636321|P4|Double Blind Treatment Period|Lost to Follow-up|1
1109881|NCT01778049|3636322|P3|Double Blind Treatment Period|Lost to Follow-up|4
1109882|NCT01778049|3636323|P2|Double Blind Treatment Period|Lost to Follow-up|0
1109883|NCT01778049|3636324|P1|Double Blind Treatment Period|Lost to Follow-up|0
1109884|NCT01778049|3636319|P6|Double Blind Treatment Period|Protocol Violation|0
1109885|NCT01778049|3636320|P5|Double Blind Treatment Period|Protocol Violation|0
1109886|NCT01778049|3636321|P4|Double Blind Treatment Period|Protocol Violation|0
1109887|NCT01778049|3636322|P3|Double Blind Treatment Period|Protocol Violation|2
1109888|NCT01778049|3636323|P2|Double Blind Treatment Period|Protocol Violation|0
1109889|NCT01778049|3636324|P1|Double Blind Treatment Period|Protocol Violation|0
1109890|NCT01778049|3636319|P6|Double Blind Treatment Period|Lack of Efficacy|1
1109891|NCT01778049|3636320|P5|Double Blind Treatment Period|Lack of Efficacy|0
1109892|NCT01778049|3636321|P4|Double Blind Treatment Period|Lack of Efficacy|0
1109893|NCT01778049|3636322|P3|Double Blind Treatment Period|Lack of Efficacy|0
1109894|NCT01778049|3636323|P2|Double Blind Treatment Period|Lack of Efficacy|0
1109895|NCT01778049|3636324|P1|Double Blind Treatment Period|Lack of Efficacy|0
1109896|NCT01778049|3636319|P6|Double Blind Treatment Period|Adverse Event|2
1109897|NCT01778049|3636320|P5|Double Blind Treatment Period|Adverse Event|3
1109898|NCT01778049|3636321|P4|Double Blind Treatment Period|Adverse Event|5
1109899|NCT01778049|3636322|P3|Double Blind Treatment Period|Adverse Event|4
1109900|NCT01778049|3636323|P2|Double Blind Treatment Period|Adverse Event|0
1109901|NCT01778049|3636324|P1|Double Blind Treatment Period|Adverse Event|0
1109902|NCT01778049|3636319|P6|Open Label Treatment Period|Other reason not defined above|0
1109903|NCT01778049|3636320|P5|Open Label Treatment Period|Other reason not defined above|0
1109904|NCT01778049|3636321|P4|Open Label Treatment Period|Other reason not defined above|0
1109905|NCT01778049|3636322|P3|Open Label Treatment Period|Other reason not defined above|0
1109906|NCT01778049|3636323|P2|Open Label Treatment Period|Other reason not defined above|94
1109907|NCT01778049|3636324|P1|Open Label Treatment Period|Other reason not defined above|77
1109908|NCT01778049|3636319|P6|Open Label Treatment Period|Not treated|0
1109909|NCT01778049|3636320|P5|Open Label Treatment Period|Not treated|0
1109910|NCT01778049|3636321|P4|Open Label Treatment Period|Not treated|0
1109911|NCT01778049|3636322|P3|Open Label Treatment Period|Not treated|0
1109912|NCT01778049|3636323|P2|Open Label Treatment Period|Not treated|1
1109913|NCT01778049|3636324|P1|Open Label Treatment Period|Not treated|2
1109914|NCT01778049|3636319|P6|Open Label Treatment Period|Withdrawal by Subject|0
1109915|NCT01778049|3636320|P5|Open Label Treatment Period|Withdrawal by Subject|0
1109916|NCT01778049|3636321|P4|Open Label Treatment Period|Withdrawal by Subject|0
1109917|NCT01778049|3636322|P3|Open Label Treatment Period|Withdrawal by Subject|0
1109918|NCT01778049|3636323|P2|Open Label Treatment Period|Withdrawal by Subject|10
1109919|NCT01778049|3636324|P1|Open Label Treatment Period|Withdrawal by Subject|4
1109920|NCT01778049|3636319|P6|Open Label Treatment Period|Lost to Follow-up|0
1109921|NCT01778049|3636320|P5|Open Label Treatment Period|Lost to Follow-up|0
1109922|NCT01778049|3636321|P4|Open Label Treatment Period|Lost to Follow-up|0
1109923|NCT01778049|3636322|P3|Open Label Treatment Period|Lost to Follow-up|0
1109924|NCT01778049|3636323|P2|Open Label Treatment Period|Lost to Follow-up|3
1109925|NCT01778049|3636324|P1|Open Label Treatment Period|Lost to Follow-up|4
1109926|NCT01778049|3636319|P6|Open Label Treatment Period|Protocol Violation|0
1109927|NCT01778049|3636320|P5|Open Label Treatment Period|Protocol Violation|0
1109928|NCT01778049|3636321|P4|Open Label Treatment Period|Protocol Violation|0
1109929|NCT01778049|3636322|P3|Open Label Treatment Period|Protocol Violation|0
1109930|NCT01778049|3636323|P2|Open Label Treatment Period|Protocol Violation|5
1109931|NCT01778049|3636324|P1|Open Label Treatment Period|Protocol Violation|5
1109932|NCT01778049|3636319|P6|Open Label Treatment Period|Lack of Efficacy|0
1109933|NCT01778049|3636320|P5|Open Label Treatment Period|Lack of Efficacy|0
1109934|NCT01778049|3636321|P4|Open Label Treatment Period|Lack of Efficacy|0
1109935|NCT01778049|3636322|P3|Open Label Treatment Period|Lack of Efficacy|0
1109936|NCT01778049|3636323|P2|Open Label Treatment Period|Lack of Efficacy|1
1109937|NCT01778049|3636324|P1|Open Label Treatment Period|Lack of Efficacy|1
1109938|NCT01778049|3636319|P6|Open Label Treatment Period|Adverse Event|0
1109939|NCT01778049|3636320|P5|Open Label Treatment Period|Adverse Event|0
1109940|NCT01778049|3636321|P4|Open Label Treatment Period|Adverse Event|0
1109941|NCT01778049|3636322|P3|Open Label Treatment Period|Adverse Event|0
1109942|NCT01778049|3636323|P2|Open Label Treatment Period|Adverse Event|15
1109943|NCT01778049|3636324|P1|Open Label Treatment Period|Adverse Event|5
1109944|NCT01778023|3636342|P2|Overall Study|Withdrawal by Subject|3
1109945|NCT01778023|3636343|P1|Overall Study|Withdrawal by Subject|0
1109946|NCT01778010|3636360|P1|Overall Study|rash while on placebo|1
1109947|NCT01778010|3636360|P1|Overall Study|Arrested|1
1109948|NCT01778010|3636360|P1|Overall Study|abnormal ECG before meds|1
1109949|NCT01778010|3636360|P1|Overall Study|Withdrawal by Subject|2
1109950|NCT01777997|3636401|P1|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1
1109951|NCT01777997|3636401|P1|Weeks 48 to 72/96 on ART|Death|1
1109952|NCT01777997|3636401|P1|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1
1109953|NCT01777997|3636401|P1|12 Week lead-in of no ART|Severe debilitation|2
1109954|NCT01777932|3636423|P1|Overall Study|Patient refused further treatment|10
1109955|NCT01777932|3636423|P1|Overall Study|Reimbursement limit|9
1109956|NCT01777932|3636423|P1|Overall Study|Investigator decision|10
1109957|NCT01777932|3636423|P1|Overall Study|Lost to Follow-up|3
1109958|NCT01777932|3636423|P1|Overall Study|Adverse Event|34
1109959|NCT01777932|3636423|P1|Overall Study|Death|3
1109960|NCT01777932|3636423|P1|Overall Study|Disease progression|136
1109961|NCT01777854|3636437|P2|Overall Study|Physician Decision|3
1109962|NCT01777854|3636438|P1|Overall Study|Physician Decision|3
1109963|NCT01777776|3636446|P4|Overall Study|Withdrawal by Subject|1
1109964|NCT01777776|3636447|P3|Overall Study|Withdrawal by Subject|0
1109965|NCT01777776|3636448|P2|Overall Study|Withdrawal by Subject|0
1109966|NCT01777776|3636449|P1|Overall Study|Withdrawal by Subject|0
1109967|NCT01777776|3636446|P4|Overall Study|Disease Progression|3
1109968|NCT01777776|3636447|P3|Overall Study|Disease Progression|6
1109969|NCT01777776|3636448|P2|Overall Study|Disease Progression|8
1109970|NCT01777776|3636449|P1|Overall Study|Disease Progression|4
1109971|NCT01777776|3636446|P4|Overall Study|Adverse Event|0
1109972|NCT01777776|3636447|P3|Overall Study|Adverse Event|0
1109973|NCT01777776|3636448|P2|Overall Study|Adverse Event|4
1109974|NCT01777776|3636449|P1|Overall Study|Adverse Event|2
1109975|NCT01777763|3636508|P2|Overall Study|Treatment Failure|6
1109976|NCT01777763|3636509|P1|Overall Study|Treatment Failure|1
1109977|NCT01777763|3636508|P2|Overall Study|Withdrawal by Subject|2
1109978|NCT01777763|3636509|P1|Overall Study|Withdrawal by Subject|0
1109979|NCT01777763|3636508|P2|Overall Study|Protocol Violation|7
1109980|NCT01777763|3636509|P1|Overall Study|Protocol Violation|1
1109981|NCT01777763|3636508|P2|Overall Study|Adverse Event|32
1109982|NCT01777763|3636509|P1|Overall Study|Adverse Event|2
1109983|NCT01777620|3636533|P2|Overall Study|Subject Withdrawal|0
1109984|NCT01777620|3636534|P1|Overall Study|Subject Withdrawal|1
1109985|NCT01777581|3636560|P2|Overall Study|Lack of Efficacy|1
1109986|NCT01777581|3636561|P1|Overall Study|Lack of Efficacy|0
1109987|NCT01777581|3636560|P2|Overall Study|Adverse Event|0
1109988|NCT01777581|3636561|P1|Overall Study|Adverse Event|2
1109989|NCT01777581|3636560|P2|Overall Study|Lost to Follow-up|1
1109990|NCT01777581|3636561|P1|Overall Study|Lost to Follow-up|1
1109991|NCT01777542|3636579|P2|Second Intervention (20 Weeks)|Adverse Event|1
1109992|NCT01777542|3636580|P1|Second Intervention (20 Weeks)|Adverse Event|0
1109993|NCT01777334|3636648|P2|Overall Study|Withdrawal by Subject|11
1109994|NCT01777334|3636649|P1|Overall Study|Withdrawal by Subject|14
1109995|NCT01777334|3636648|P2|Overall Study|Lost to Follow-up|2
1109996|NCT01777334|3636649|P1|Overall Study|Lost to Follow-up|3
1109997|NCT01777334|3636648|P2|Overall Study|Protocol Violation|7
1109998|NCT01777334|3636649|P1|Overall Study|Protocol Violation|3
1109999|NCT01777334|3636648|P2|Overall Study|Lack of Efficacy|29
1110000|NCT01777334|3636649|P1|Overall Study|Lack of Efficacy|15
1110001|NCT01777334|3636648|P2|Overall Study|Adverse Event|14
1110002|NCT01777334|3636649|P1|Overall Study|Adverse Event|18
1110003|NCT01777321|3636659|P2|Overall Study|Withdrawal by Subject|1
1110004|NCT01777321|3636660|P1|Overall Study|Withdrawal by Subject|0
1110005|NCT01777282|3636701|P5|Overall Study|Moved, transfer abroad, did not enter FU|0
1110006|NCT01777282|3636702|P4|Overall Study|Moved, transfer abroad, did not enter FU|0
1110007|NCT01777282|3636703|P3|Overall Study|Moved, transfer abroad, did not enter FU|1
1110008|NCT01777282|3636704|P2|Overall Study|Moved, transfer abroad, did not enter FU|0
1110009|NCT01777282|3636705|P1|Overall Study|Moved, transfer abroad, did not enter FU|1
1110010|NCT01777282|3636701|P5|Overall Study|Protocol Violation|2
1110011|NCT01777282|3636702|P4|Overall Study|Protocol Violation|0
1110012|NCT01777282|3636703|P3|Overall Study|Protocol Violation|1
1110013|NCT01777282|3636704|P2|Overall Study|Protocol Violation|0
1110014|NCT01777282|3636705|P1|Overall Study|Protocol Violation|2
1110015|NCT01777282|3636701|P5|Overall Study|Withdrawal by Subject|2
1110016|NCT01777282|3636702|P4|Overall Study|Withdrawal by Subject|1
1110017|NCT01777282|3636703|P3|Overall Study|Withdrawal by Subject|0
1110018|NCT01777282|3636704|P2|Overall Study|Withdrawal by Subject|0
1110019|NCT01777282|3636705|P1|Overall Study|Withdrawal by Subject|4
1110020|NCT01777282|3636701|P5|Overall Study|Adverse Event|3
1110021|NCT01777282|3636702|P4|Overall Study|Adverse Event|1
1110022|NCT01777282|3636703|P3|Overall Study|Adverse Event|2
1110023|NCT01777282|3636704|P2|Overall Study|Adverse Event|4
1110024|NCT01777282|3636705|P1|Overall Study|Adverse Event|4
1110025|NCT01777282|3636701|P5|Overall Study|New Antidiabetic Medication|0
1110026|NCT01777282|3636702|P4|Overall Study|New Antidiabetic Medication|0
1110027|NCT01777282|3636703|P3|Overall Study|New Antidiabetic Medication|1
1110028|NCT01777282|3636704|P2|Overall Study|New Antidiabetic Medication|0
1110029|NCT01777282|3636705|P1|Overall Study|New Antidiabetic Medication|0
1110030|NCT01777282|3636701|P5|Overall Study|Persistent Hyperglycemia|0
1110031|NCT01777282|3636702|P4|Overall Study|Persistent Hyperglycemia|0
1110032|NCT01777282|3636703|P3|Overall Study|Persistent Hyperglycemia|1
1110033|NCT01777282|3636704|P2|Overall Study|Persistent Hyperglycemia|0
1110034|NCT01777282|3636705|P1|Overall Study|Persistent Hyperglycemia|0
1110035|NCT01777269|3636749|P2|Overall Study|Withdrawal by Subject|9
1110036|NCT01777269|3636750|P1|Overall Study|Withdrawal by Subject|9
1110037|NCT01777269|3636749|P2|Overall Study|Physician Decision|2
1110038|NCT01777269|3636750|P1|Overall Study|Physician Decision|5
1110039|NCT01777269|3636749|P2|Overall Study|Lost to Follow-up|0
1110040|NCT01777269|3636750|P1|Overall Study|Lost to Follow-up|4
1110041|NCT01777269|3636749|P2|Overall Study|Participants reached stopping criteria|1
1110042|NCT01777269|3636750|P1|Overall Study|Participants reached stopping criteria|1
1110043|NCT01777269|3636749|P2|Overall Study|Protocol Violation|4
1110044|NCT01777269|3636750|P1|Overall Study|Protocol Violation|4
1110045|NCT01777269|3636749|P2|Overall Study|Lack of Efficacy|10
1110046|NCT01777269|3636750|P1|Overall Study|Lack of Efficacy|8
1110047|NCT01777269|3636749|P2|Overall Study|Adverse Event|33
1110048|NCT01777269|3636750|P1|Overall Study|Adverse Event|24
1110049|NCT01777191|3636787|P2|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3
1110050|NCT01777191|3636788|P1|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1
1110051|NCT01777191|3636787|P2|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2
1110052|NCT01777191|3636788|P1|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1
1110053|NCT01777191|3636787|P2|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
1110054|NCT01777191|3636788|P1|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
1110055|NCT01777191|3636787|P2|Safety Extension Per (Week 12-Week 48)|Death|1
1110056|NCT01777191|3636788|P1|Safety Extension Per (Week 12-Week 48)|Death|0
1110057|NCT01777191|3636787|P2|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
1110058|NCT01777191|3636788|P1|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
1110059|NCT01777191|3636787|P2|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0
1110060|NCT01777191|3636788|P1|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1
1110061|NCT01777191|3636787|P2|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
1110062|NCT01777191|3636788|P1|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
1110063|NCT01777191|3636787|P2|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3
1110064|NCT01777191|3636788|P1|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0
1110065|NCT01777191|3636787|P2|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2
1110066|NCT01777191|3636788|P1|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1
1110067|NCT01777191|3636787|P2|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
1110068|NCT01777191|3636788|P1|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
1110069|NCT01777191|3636787|P2|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1
1110070|NCT01777191|3636788|P1|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2
1110071|NCT01776554|3636851|P2|Overall Study|Unclassified|1
1110072|NCT01776554|3636852|P1|Overall Study|Unclassified|4
1110073|NCT01776554|3636851|P2|Overall Study|Protocol Violation|0
1110074|NCT01776554|3636852|P1|Overall Study|Protocol Violation|1
1110075|NCT01776554|3636851|P2|Overall Study|Administrative Reason|5
1110076|NCT01776554|3636852|P1|Overall Study|Administrative Reason|2
1110077|NCT01776554|3636851|P2|Overall Study|Lost to Follow-up|9
1110078|NCT01776554|3636852|P1|Overall Study|Lost to Follow-up|6
1110079|NCT01776554|3636851|P2|Overall Study|Withdrawal by Subject|8
1110080|NCT01776554|3636852|P1|Overall Study|Withdrawal by Subject|3
1110081|NCT01776554|3636851|P2|Overall Study|Adverse Event|0
1110082|NCT01776554|3636852|P1|Overall Study|Adverse Event|1
1110083|NCT01776541|3636895|P2|Overall Study|Withdrawal by Subject|20
1110084|NCT01776541|3636896|P1|Overall Study|Withdrawal by Subject|12
1110085|NCT01776541|3636895|P2|Overall Study|Protocol Violation|1
1110086|NCT01776541|3636896|P1|Overall Study|Protocol Violation|2
1110087|NCT01776541|3636895|P2|Overall Study|Unclassified|4
1110088|NCT01776541|3636896|P1|Overall Study|Unclassified|5
1110089|NCT01776541|3636895|P2|Overall Study|Lost to Follow-up|48
1110090|NCT01776541|3636896|P1|Overall Study|Lost to Follow-up|27
1110091|NCT01776541|3636895|P2|Overall Study|Death|0
1110092|NCT01776541|3636896|P1|Overall Study|Death|4
1110093|NCT01776541|3636895|P2|Overall Study|Administrative Reason|2
1110094|NCT01776541|3636896|P1|Overall Study|Administrative Reason|6
1110095|NCT01776424|3636918|P3|Overall Study|Withdrawal by Subject|15
1110096|NCT01776424|3636919|P2|Overall Study|Withdrawal by Subject|11
1110097|NCT01776424|3636920|P1|Overall Study|Withdrawal by Subject|10
1110098|NCT01776424|3636918|P3|Overall Study|Lost to Follow-up|9
1110099|NCT01776424|3636919|P2|Overall Study|Lost to Follow-up|8
1110100|NCT01776424|3636920|P1|Overall Study|Lost to Follow-up|10
1110101|NCT01776008|3636951|P1|Overall Study|ineligible|2
1110102|NCT01775995|3636965|P2|Overall Study|Lost to Follow-up|1
1110103|NCT01775995|3636966|P1|Overall Study|Lost to Follow-up|1
1110104|NCT01775787|3637070|P2|Second 7-10 Days|concerns with using IV|1
1110105|NCT01775787|3637071|P1|Second 7-10 Days|concerns with using IV|0
1110106|NCT01775787|3637070|P2|Second 7-10 Days|time commitment|1
1110107|NCT01775787|3637071|P1|Second 7-10 Days|time commitment|0
1110108|NCT01775787|3637070|P2|First 7-10 Days|concerns with using IV|2
1110109|NCT01775787|3637071|P1|First 7-10 Days|concerns with using IV|1
1110110|NCT01775787|3637070|P2|First 7-10 Days|time commitment|2
1110111|NCT01775787|3637071|P1|First 7-10 Days|time commitment|0
1110112|NCT01775787|3637070|P2|First 7-10 Days|family emergency|1
1110113|NCT01775787|3637071|P1|First 7-10 Days|family emergency|0
1110114|NCT01775787|3637070|P2|First 7-10 Days|Adverse Event|1
1110115|NCT01775787|3637071|P1|First 7-10 Days|Adverse Event|0
1110116|NCT01775670|3637127|P2|Overall Study|Lost to Follow-up|1
1110117|NCT01775670|3637128|P1|Overall Study|Lost to Follow-up|1
1110118|NCT01775553|3637154|P1|Overall Study|Disease Progression|12
1110119|NCT01775553|3637154|P1|Overall Study|Adverse Event|1
1110120|NCT01775189|3637162|P7|Treatment Phase: Washout Period 3|Protocol Violation|1
1110121|NCT01775189|3637163|P6|Treatment Phase: Washout Period 3|Protocol Violation|0
1110122|NCT01775189|3637164|P5|Treatment Phase: Washout Period 3|Protocol Violation|0
1110123|NCT01775189|3637165|P4|Treatment Phase: Washout Period 3|Protocol Violation|1
1110124|NCT01775189|3637166|P3|Treatment Phase: Washout Period 3|Protocol Violation|0
1110125|NCT01775189|3637167|P2|Treatment Phase: Washout Period 3|Protocol Violation|0
1110126|NCT01775189|3637168|P1|Treatment Phase: Washout Period 3|Protocol Violation|0
1110127|NCT01775189|3637162|P7|Treatment Phase: Washout Period 2|Protocol Violation|0
1110128|NCT01775189|3637163|P6|Treatment Phase: Washout Period 2|Protocol Violation|0
1110129|NCT01775189|3637164|P5|Treatment Phase: Washout Period 2|Protocol Violation|0
1110130|NCT01775189|3637165|P4|Treatment Phase: Washout Period 2|Protocol Violation|1
1110131|NCT01775189|3637166|P3|Treatment Phase: Washout Period 2|Protocol Violation|0
1110132|NCT01775189|3637167|P2|Treatment Phase: Washout Period 2|Protocol Violation|0
1110133|NCT01775189|3637168|P1|Treatment Phase: Washout Period 2|Protocol Violation|0
1110134|NCT01775189|3637162|P7|Treatment Phase: Washout Period 1|Protocol Violation|0
1110135|NCT01775189|3637163|P6|Treatment Phase: Washout Period 1|Protocol Violation|1
1110136|NCT01775189|3637164|P5|Treatment Phase: Washout Period 1|Protocol Violation|0
1110137|NCT01775189|3637165|P4|Treatment Phase: Washout Period 1|Protocol Violation|0
1110138|NCT01775189|3637166|P3|Treatment Phase: Washout Period 1|Protocol Violation|0
1110139|NCT01775189|3637167|P2|Treatment Phase: Washout Period 1|Protocol Violation|0
1110140|NCT01775189|3637168|P1|Treatment Phase: Washout Period 1|Protocol Violation|0
1110141|NCT01775189|3637162|P7|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
1110142|NCT01775189|3637163|P6|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
1110143|NCT01775189|3637164|P5|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
1110144|NCT01775189|3637165|P4|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
1110145|NCT01775189|3637166|P3|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7
1110146|NCT01775189|3637167|P2|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2
1110147|NCT01775189|3637168|P1|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
1110148|NCT01775189|3637162|P7|Drug Discrimination Phase: Day 2|Protocol Violation|0
1110149|NCT01775189|3637163|P6|Drug Discrimination Phase: Day 2|Protocol Violation|0
1110150|NCT01775189|3637164|P5|Drug Discrimination Phase: Day 2|Protocol Violation|0
1110151|NCT01775189|3637165|P4|Drug Discrimination Phase: Day 2|Protocol Violation|0
1110152|NCT01775189|3637166|P3|Drug Discrimination Phase: Day 2|Protocol Violation|0
1110153|NCT01775189|3637167|P2|Drug Discrimination Phase: Day 2|Protocol Violation|1
1110154|NCT01775189|3637168|P1|Drug Discrimination Phase: Day 2|Protocol Violation|0
1110155|NCT01775189|3637162|P7|Drug Discrimination Phase: Day 1|Adverse Event|0
1110156|NCT01775189|3637163|P6|Drug Discrimination Phase: Day 1|Adverse Event|0
1110157|NCT01775189|3637164|P5|Drug Discrimination Phase: Day 1|Adverse Event|0
1110158|NCT01775189|3637165|P4|Drug Discrimination Phase: Day 1|Adverse Event|0
1110159|NCT01775189|3637166|P3|Drug Discrimination Phase: Day 1|Adverse Event|0
1110160|NCT01775189|3637167|P2|Drug Discrimination Phase: Day 1|Adverse Event|3
1110161|NCT01775189|3637168|P1|Drug Discrimination Phase: Day 1|Adverse Event|0
1110162|NCT01775137|3637387|P1|Overall Study|Withdrawal by participants|5
1110163|NCT01775137|3637387|P1|Overall Study|Adverse Event|1
1110164|NCT01775137|3637387|P1|Overall Study|Unsatisfactory therapeutic effect|2
1110165|NCT01775137|3637387|P1|Overall Study|Protocol deviation|2
1110166|NCT01775137|3637387|P1|Overall Study|Death|1
1110167|NCT01775124|3637414|P2|Extension Period|Withdrawal by Subject|12
1110168|NCT01775124|3637415|P1|Extension Period|Withdrawal by Subject|9
1110169|NCT01775124|3637414|P2|Extension Period|Lost to Follow-up|1
1110170|NCT01775124|3637415|P1|Extension Period|Lost to Follow-up|0
1110171|NCT01775124|3637414|P2|Extension Period|Administrative problems|1
1110172|NCT01775124|3637415|P1|Extension Period|Administrative problems|0
1110173|NCT01775124|3637414|P2|Extension Period|Physician Decision|2
1110174|NCT01775124|3637415|P1|Extension Period|Physician Decision|0
1110175|NCT01775124|3637414|P2|Extension Period|Adverse Event|2
1110176|NCT01775124|3637415|P1|Extension Period|Adverse Event|3
1110177|NCT01775124|3637414|P2|Core Period|Adverse Event|5
1110178|NCT01775124|3637415|P1|Core Period|Adverse Event|5
1110179|NCT01775124|3637414|P2|Core Period|Withdrawal by Subject|2
1110180|NCT01775124|3637415|P1|Core Period|Withdrawal by Subject|4
1110181|NCT01775124|3637414|P2|Core Period|Administrative problems|0
1110182|NCT01775124|3637415|P1|Core Period|Administrative problems|1
1110183|NCT01775124|3637414|P2|Core Period|Death|1
1110184|NCT01775124|3637415|P1|Core Period|Death|0
1110185|NCT01775124|3637414|P2|Core Period|Physician Decision|1
1110186|NCT01775124|3637415|P1|Core Period|Physician Decision|1
1110187|NCT01775124|3637414|P2|Core Period|Disease Progression|1
1110188|NCT01775124|3637415|P1|Core Period|Disease Progression|0
1110189|NCT01774981|3637450|P8|Overall Study|Death|0
1110190|NCT01774981|3637451|P7|Overall Study|Death|0
1110191|NCT01774981|3637452|P6|Overall Study|Death|0
1110192|NCT01774981|3637453|P5|Overall Study|Death|1
1110193|NCT01774981|3637454|P4|Overall Study|Death|0
1110194|NCT01774981|3637455|P3|Overall Study|Death|0
1110195|NCT01774981|3637456|P2|Overall Study|Death|0
1110196|NCT01774981|3637457|P1|Overall Study|Death|0
1110197|NCT01774981|3637450|P8|Overall Study|Withdrawal by Subject|1
1110198|NCT01774981|3637451|P7|Overall Study|Withdrawal by Subject|0
1110199|NCT01774981|3637452|P6|Overall Study|Withdrawal by Subject|0
1110200|NCT01774981|3637453|P5|Overall Study|Withdrawal by Subject|0
1110201|NCT01774981|3637454|P4|Overall Study|Withdrawal by Subject|0
1110202|NCT01774981|3637455|P3|Overall Study|Withdrawal by Subject|0
1110203|NCT01774981|3637456|P2|Overall Study|Withdrawal by Subject|0
1110204|NCT01774981|3637457|P1|Overall Study|Withdrawal by Subject|0
1110205|NCT01774981|3637450|P8|Overall Study|Adverse Event|0
1110206|NCT01774981|3637451|P7|Overall Study|Adverse Event|0
1110207|NCT01774981|3637452|P6|Overall Study|Adverse Event|1
1110208|NCT01774981|3637453|P5|Overall Study|Adverse Event|0
1110209|NCT01774981|3637454|P4|Overall Study|Adverse Event|0
1110210|NCT01774981|3637455|P3|Overall Study|Adverse Event|0
1110211|NCT01774981|3637456|P2|Overall Study|Adverse Event|0
1110212|NCT01774981|3637457|P1|Overall Study|Adverse Event|0
1110213|NCT01774968|3637489|P2|Overall Study|Withdrawal by Subject|11
1110214|NCT01774968|3637490|P1|Overall Study|Withdrawal by Subject|6
1110215|NCT01774968|3637489|P2|Overall Study|Sponsor Decision|2
1110216|NCT01774968|3637490|P1|Overall Study|Sponsor Decision|0
1110217|NCT01774968|3637489|P2|Overall Study|Protocol Violation|13
1110218|NCT01774968|3637490|P1|Overall Study|Protocol Violation|14
1110219|NCT01774968|3637489|P2|Overall Study|Physician Decision|1
1110220|NCT01774968|3637490|P1|Overall Study|Physician Decision|5
1110221|NCT01774968|3637489|P2|Overall Study|Lost to Follow-up|3
1110222|NCT01774968|3637490|P1|Overall Study|Lost to Follow-up|1
1110223|NCT01774968|3637489|P2|Overall Study|Death|1
1110224|NCT01774968|3637490|P1|Overall Study|Death|0
1110225|NCT01774968|3637489|P2|Overall Study|Adverse Event|4
1110226|NCT01774968|3637490|P1|Overall Study|Adverse Event|4
1110227|NCT01774929|3637524|P1|Overall Study|Adverse Event|3
1110228|NCT01774903|3637530|P1|Overall Study|Ineligible to continue the trial|1
1110229|NCT01774903|3637530|P1|Overall Study|Lack of Efficacy|1
1110230|NCT01774903|3637530|P1|Overall Study|Withdrawal by Subject|2
1110231|NCT01774903|3637530|P1|Overall Study|Adverse Event|7
1110232|NCT01774786|3637548|P2|Overall Study|Ineligible for Study|3
1110233|NCT01774786|3637549|P1|Overall Study|Ineligible for Study|1
1110234|NCT01774786|3637548|P2|Overall Study|Physician Decision|0
1110235|NCT01774786|3637549|P1|Overall Study|Physician Decision|1
1110236|NCT01774786|3637548|P2|Overall Study|Withdrawal by Subject|12
1110237|NCT01774786|3637549|P1|Overall Study|Withdrawal by Subject|15
1110238|NCT01774786|3637548|P2|Overall Study|Lost to Follow-up|4
1110239|NCT01774786|3637549|P1|Overall Study|Lost to Follow-up|3
1110240|NCT01774786|3637548|P2|Overall Study|Death|262
1110241|NCT01774786|3637549|P1|Overall Study|Death|242
1110242|NCT01774786|3637548|P2|Overall Study|In Follow-up|62
1110243|NCT01774786|3637549|P1|Overall Study|In Follow-up|65
1110244|NCT01774786|3637548|P2|Overall Study|Between Treatment and Follow-up|2
1110245|NCT01774786|3637549|P1|Overall Study|Between Treatment and Follow-up|6
1110246|NCT01774786|3637548|P2|Overall Study|On Treatment|47
1110247|NCT01774786|3637549|P1|Overall Study|On Treatment|55
1110248|NCT01774721|3637579|P2|Overall Study|Ongoing in study|120
1110249|NCT01774721|3637580|P1|Overall Study|Ongoing in study|136
1110250|NCT01774721|3637579|P2|Overall Study|Did not meet eligibility criteria|3
1110251|NCT01774721|3637580|P1|Overall Study|Did not meet eligibility criteria|0
1110252|NCT01774721|3637579|P2|Overall Study|Lost to Follow-up|1
1110253|NCT01774721|3637580|P1|Overall Study|Lost to Follow-up|1
1110254|NCT01774721|3637579|P2|Overall Study|Withdrawal by Subject|10
1110255|NCT01774721|3637580|P1|Overall Study|Withdrawal by Subject|14
1110256|NCT01774721|3637579|P2|Overall Study|Death|91
1110257|NCT01774721|3637580|P1|Overall Study|Death|76
1110258|NCT01774591|3637645|P2|Overall Study|Adverse Event|2
1110259|NCT01774591|3637646|P1|Overall Study|Adverse Event|0
1110260|NCT01774591|3637645|P2|Overall Study|Withdrawal by Subject|1
1110261|NCT01774591|3637646|P1|Overall Study|Withdrawal by Subject|0
1110262|NCT01774591|3637645|P2|Overall Study|Physician Decision|1
1110263|NCT01774591|3637646|P1|Overall Study|Physician Decision|1
1110264|NCT01774344|3637658|P2|Overall Study|Non-compliance with study drug|2
1110265|NCT01774344|3637659|P1|Overall Study|Non-compliance with study drug|0
1110266|NCT01774344|3637658|P2|Overall Study|Physician Decision|1
1110267|NCT01774344|3637659|P1|Overall Study|Physician Decision|0
1110268|NCT01774344|3637658|P2|Overall Study|Adverse event (AE)|1
1110269|NCT01774344|3637659|P1|Overall Study|Adverse event (AE)|0
1110270|NCT01774344|3637658|P2|Overall Study|AE not related to disease progression|47
1110271|NCT01774344|3637659|P1|Overall Study|AE not related to disease progression|12
1110272|NCT01774344|3637658|P2|Overall Study|Ongoing with treatment|65
1110273|NCT01774344|3637659|P1|Overall Study|Ongoing with treatment|10
1110274|NCT01774344|3637658|P2|Overall Study|Other|0
1110275|NCT01774344|3637659|P1|Overall Study|Other|1
1110276|NCT01774344|3637658|P2|Overall Study|Study drug never administered|5
1110277|NCT01774344|3637659|P1|Overall Study|Study drug never administered|1
1110278|NCT01774344|3637658|P2|Overall Study|Withdrawal by Subject|26
1110279|NCT01774344|3637659|P1|Overall Study|Withdrawal by Subject|5
1110280|NCT01774344|3637658|P2|Overall Study|Protocol Violation|1
1110281|NCT01774344|3637659|P1|Overall Study|Protocol Violation|3
1110282|NCT01774305|3637675|P2|Overall Study|Physician Decision|0
1110283|NCT01774305|3637676|P1|Overall Study|Physician Decision|1
1110284|NCT01774253|3637684|P1|Overall Study|Death|1
1110285|NCT01774253|3637684|P1|Overall Study|Withdrawal by Subject|2
1110286|NCT01774253|3637684|P1|Overall Study|Physician Decision|2
1110287|NCT01774253|3637684|P1|Overall Study|Lack of Efficacy|4
1110288|NCT01774110|3637703|P1|Overall Study|Lost to Follow-up|7
1110289|NCT01774097|3637711|P2|Overall Study|Adverse Event|1
1110290|NCT01774097|3637712|P1|Overall Study|Adverse Event|1
1110291|NCT01774097|3637711|P2|Overall Study|Withdrawal by Subject|1
1110292|NCT01774097|3637712|P1|Overall Study|Withdrawal by Subject|1
1110293|NCT01774084|3637742|P2|Overall Study|Personal reasons|0
1110294|NCT01774084|3637743|P1|Overall Study|Personal reasons|1
1110295|NCT01773889|3637773|P1|Overall Study|lack of funding|2
1110296|NCT01773473|3637779|P2|Overall Study|Lost to Follow-up|0
1110297|NCT01773473|3637780|P1|Overall Study|Lost to Follow-up|2
1110298|NCT01773473|3637779|P2|Overall Study|Withdrawal by Subject|3
1110299|NCT01773473|3637780|P1|Overall Study|Withdrawal by Subject|5
1110300|NCT01773473|3637779|P2|Overall Study|Non-Compliance with study drug|4
1110301|NCT01773473|3637780|P1|Overall Study|Non-Compliance with study drug|1
1110302|NCT01773473|3637779|P2|Overall Study|Lack of Efficacy|1
1110303|NCT01773473|3637780|P1|Overall Study|Lack of Efficacy|0
1110304|NCT01773473|3637779|P2|Overall Study|Sponsor Decision|0
1110305|NCT01773473|3637780|P1|Overall Study|Sponsor Decision|2
1110306|NCT01773473|3637779|P2|Overall Study|Physician Decision|5
1110307|NCT01773473|3637780|P1|Overall Study|Physician Decision|3
1110308|NCT01773473|3637779|P2|Overall Study|Protocol Violation|4
1110309|NCT01773473|3637780|P1|Overall Study|Protocol Violation|0
1110310|NCT01773473|3637779|P2|Overall Study|Adverse Event|2
1110311|NCT01773473|3637780|P1|Overall Study|Adverse Event|3
1110312|NCT01773291|3637801|P3|Overall Study|Withdrawal by Subject|1
1110313|NCT01773291|3637802|P2|Overall Study|Withdrawal by Subject|0
1110314|NCT01773291|3637803|P1|Overall Study|Withdrawal by Subject|0
1110315|NCT01773291|3637801|P3|Overall Study|Protocol Violation|0
1110316|NCT01773291|3637802|P2|Overall Study|Protocol Violation|0
1110317|NCT01773291|3637803|P1|Overall Study|Protocol Violation|1
1110318|NCT01773226|3637814|P1|Overall Study|Withdrawal by Subject|1
1110319|NCT01773122|3637833|P4|Overall Study|Due to amended age eligibility criteria|1
1110320|NCT01773122|3637834|P3|Overall Study|Due to amended age eligibility criteria|0
1110321|NCT01773122|3637835|P2|Overall Study|Due to amended age eligibility criteria|1
1110322|NCT01773122|3637836|P1|Overall Study|Due to amended age eligibility criteria|3
1110323|NCT01773070|3637850|P1|Overall Study|Death (unrelated to study procedures)|3
1110324|NCT01773070|3637850|P1|Overall Study|Other|15
1110325|NCT01773070|3637850|P1|Overall Study|Lost to Follow-up|39
1110326|NCT01773070|3637850|P1|Overall Study|Withdrawal by Subject|24
1110327|NCT01772823|3637860|P2|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0
1110328|NCT01772823|3637861|P1|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1
1110329|NCT01772823|3637860|P2|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
1110330|NCT01772823|3637861|P1|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
1110331|NCT01772823|3637860|P2|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2
1110332|NCT01772823|3637861|P1|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1
1110333|NCT01772823|3637860|P2|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5
1110334|NCT01772823|3637861|P1|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6
1110335|NCT01772823|3637860|P2|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
1110336|NCT01772823|3637861|P1|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
1110337|NCT01772823|3637860|P2|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0
1110338|NCT01772823|3637861|P1|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1
1110339|NCT01772823|3637860|P2|Treatment Phase (Week 0- Week 48)|Incarcerated|0
1110340|NCT01772823|3637861|P1|Treatment Phase (Week 0- Week 48)|Incarcerated|1
1110341|NCT01772823|3637860|P2|Treatment Phase (Week 0- Week 48)|Moved out of area|3
1110342|NCT01772823|3637861|P1|Treatment Phase (Week 0- Week 48)|Moved out of area|4
1110343|NCT01772823|3637860|P2|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1
1110344|NCT01772823|3637861|P1|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6
1110345|NCT01772823|3637860|P2|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13
1110346|NCT01772823|3637861|P1|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15
1110347|NCT01772823|3637860|P2|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0
1110348|NCT01772823|3637861|P1|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1
1110349|NCT01772823|3637860|P2|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0
1110350|NCT01772823|3637861|P1|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6
1110351|NCT01772823|3637860|P2|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1
1110352|NCT01772823|3637861|P1|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2
1110353|NCT01772823|3637860|P2|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0
1110354|NCT01772823|3637861|P1|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1
1110355|NCT01772823|3637860|P2|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
1110356|NCT01772823|3637861|P1|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
1110357|NCT01772823|3637860|P2|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0
1110358|NCT01772823|3637861|P1|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1
1110359|NCT01772576|3637983|P1|Overall Study|Withdrawal by Subject|6
1110360|NCT01772576|3637983|P1|Overall Study|Adverse Event|6
1110361|NCT01772576|3637983|P1|Overall Study|Study device not used|3
1110362|NCT01772576|3637983|P1|Overall Study|Lost to Follow-up|3
1110363|NCT01772576|3637983|P1|Overall Study|Protocol Violation|1
1110364|NCT01772576|3637983|P1|Overall Study|Death|15
1110365|NCT01772550|3637995|P3|Overall Study|Adverse Event|1
1110366|NCT01772550|3637996|P2|Overall Study|Adverse Event|0
1110367|NCT01772550|3637997|P1|Overall Study|Adverse Event|0
1110368|NCT01772550|3637995|P3|Overall Study|Unable to insert IV in antecubital vein|5
1110369|NCT01772550|3637996|P2|Overall Study|Unable to insert IV in antecubital vein|1
1110370|NCT01772550|3637997|P1|Overall Study|Unable to insert IV in antecubital vein|1
1110371|NCT01772537|3638038|P3|Overall Study|unsuccessful lumbar drain placement|0
1110372|NCT01772537|3638039|P2|Overall Study|unsuccessful lumbar drain placement|0
1110373|NCT01772537|3638040|P1|Overall Study|unsuccessful lumbar drain placement|1
1110374|NCT01772368|3638054|P1|Overall Study|Not specified|1
1110375|NCT01772368|3638054|P1|Overall Study|Protocol Violation|2
1110376|NCT01772368|3638054|P1|Overall Study|Withdrawal by Subject|3
1110377|NCT01772368|3638054|P1|Overall Study|Adverse Event|1
1110378|NCT01772316|3638100|P1|Overall Study|Withdrawn by sponsor decision|5
1110379|NCT01772316|3638100|P1|Overall Study|Inform consent withdrawn|1
1110380|NCT01772316|3638100|P1|Overall Study|Serious adverse event|1
1110381|NCT01772147|3638121|P3|Overall Study|Lack of Efficacy|6
1110382|NCT01772147|3638122|P2|Overall Study|Lack of Efficacy|6
1110383|NCT01772147|3638123|P1|Overall Study|Lack of Efficacy|8
1110384|NCT01772147|3638121|P3|Overall Study|Protocol Deviation|1
1110385|NCT01772147|3638122|P2|Overall Study|Protocol Deviation|1
1110386|NCT01772147|3638123|P1|Overall Study|Protocol Deviation|2
1110387|NCT01772147|3638121|P3|Overall Study|Lost to Follow-up|1
1110388|NCT01772147|3638122|P2|Overall Study|Lost to Follow-up|0
1110389|NCT01772147|3638123|P1|Overall Study|Lost to Follow-up|1
1110390|NCT01772147|3638121|P3|Overall Study|Withdrew Consent|4
1110391|NCT01772147|3638122|P2|Overall Study|Withdrew Consent|8
1110392|NCT01772147|3638123|P1|Overall Study|Withdrew Consent|7
1110393|NCT01772147|3638121|P3|Overall Study|Adverse Event|6
1110394|NCT01772147|3638122|P2|Overall Study|Adverse Event|10
1110395|NCT01772147|3638123|P1|Overall Study|Adverse Event|13
1110396|NCT01772134|3638143|P3|Overall Study|Randomized Study Medication Not Received|1
1110397|NCT01772134|3638144|P2|Overall Study|Randomized Study Medication Not Received|0
1110398|NCT01772134|3638145|P1|Overall Study|Randomized Study Medication Not Received|2
1110399|NCT01772134|3638143|P3|Overall Study|Protocol-defined Stopping Criteria|0
1110400|NCT01772134|3638144|P2|Overall Study|Protocol-defined Stopping Criteria|0
1110401|NCT01772134|3638145|P1|Overall Study|Protocol-defined Stopping Criteria|1
1110402|NCT01772134|3638143|P3|Overall Study|Lack of Efficacy|3
1110403|NCT01772134|3638144|P2|Overall Study|Lack of Efficacy|5
1110404|NCT01772134|3638145|P1|Overall Study|Lack of Efficacy|11
1110405|NCT01772134|3638143|P3|Overall Study|Protocol Deviation|3
1110406|NCT01772134|3638144|P2|Overall Study|Protocol Deviation|3
1110407|NCT01772134|3638145|P1|Overall Study|Protocol Deviation|4
1110408|NCT01772134|3638143|P3|Overall Study|Lost to Follow-up|0
1110409|NCT01772134|3638144|P2|Overall Study|Lost to Follow-up|0
1110410|NCT01772134|3638145|P1|Overall Study|Lost to Follow-up|2
1110411|NCT01772134|3638143|P3|Overall Study|Withdrew Consent|5
1110412|NCT01772134|3638144|P2|Overall Study|Withdrew Consent|1
1110413|NCT01772134|3638145|P1|Overall Study|Withdrew Consent|3
1110414|NCT01772134|3638143|P3|Overall Study|Adverse Event|10
1110415|NCT01772134|3638144|P2|Overall Study|Adverse Event|5
1110416|NCT01772134|3638145|P1|Overall Study|Adverse Event|6
1110417|NCT01771913|3638182|P2|Overall Study|Withdrawal by Subject|0
1110418|NCT01771913|3638183|P1|Overall Study|Withdrawal by Subject|1
1110419|NCT01770860|3638202|P1|Overall Study|Administrative decision made by the PI|1
1110420|NCT01770860|3638202|P1|Overall Study|Lost to Follow-up|1
1110421|NCT01770860|3638202|P1|Overall Study|Withdrawal by Subject|4
1110422|NCT01770743|3638250|P5|Overall Study|Moving Out of State|0
1110423|NCT01770743|3638251|P4|Overall Study|Moving Out of State|0
1110424|NCT01770743|3638252|P3|Overall Study|Moving Out of State|0
1110425|NCT01770743|3638253|P2|Overall Study|Moving Out of State|1
1110426|NCT01770743|3638254|P1|Overall Study|Moving Out of State|0
1110427|NCT01770743|3638250|P5|Overall Study|Sponsor Terminated Subject|0
1110428|NCT01770743|3638251|P4|Overall Study|Sponsor Terminated Subject|1
1110429|NCT01770743|3638252|P3|Overall Study|Sponsor Terminated Subject|0
1110430|NCT01770743|3638253|P2|Overall Study|Sponsor Terminated Subject|0
1110431|NCT01770743|3638254|P1|Overall Study|Sponsor Terminated Subject|1
1110432|NCT01770743|3638250|P5|Overall Study|Lost to Follow-up|1
1110433|NCT01770743|3638251|P4|Overall Study|Lost to Follow-up|0
1110434|NCT01770743|3638252|P3|Overall Study|Lost to Follow-up|0
1110435|NCT01770743|3638253|P2|Overall Study|Lost to Follow-up|2
1110436|NCT01770743|3638254|P1|Overall Study|Lost to Follow-up|0
1110437|NCT01770743|3638250|P5|Overall Study|Withdrawal by Subject|1
1110438|NCT01770743|3638251|P4|Overall Study|Withdrawal by Subject|1
1110439|NCT01770743|3638252|P3|Overall Study|Withdrawal by Subject|1
1110440|NCT01770743|3638253|P2|Overall Study|Withdrawal by Subject|0
1110441|NCT01770743|3638254|P1|Overall Study|Withdrawal by Subject|0
1110442|NCT01770743|3638250|P5|Overall Study|Adverse Event|0
1110443|NCT01770743|3638251|P4|Overall Study|Adverse Event|0
1110444|NCT01770743|3638252|P3|Overall Study|Adverse Event|0
1110445|NCT01770743|3638253|P2|Overall Study|Adverse Event|0
1110446|NCT01770743|3638254|P1|Overall Study|Adverse Event|1
1110447|NCT01770509|3638356|P2|Overall Study|Lost to Follow-up|2
1110448|NCT01770509|3638357|P1|Overall Study|Lost to Follow-up|1
1110449|NCT01770509|3638356|P2|Overall Study|Injury|1
1110450|NCT01770509|3638357|P1|Overall Study|Injury|0
1110451|NCT01770392|3638393|P1|Washout Period of at Least 14 Days|Adverse Event|1
1110452|NCT01770379|3638408|P3|Overall Study|Adverse Event|2
1110453|NCT01770379|3638409|P2|Overall Study|Adverse Event|3
1110454|NCT01770379|3638410|P1|Overall Study|Adverse Event|1
1110455|NCT01770379|3638408|P3|Overall Study|Lack of Efficacy|6
1110456|NCT01770379|3638409|P2|Overall Study|Lack of Efficacy|6
1110457|NCT01770379|3638410|P1|Overall Study|Lack of Efficacy|8
1110458|NCT01770379|3638408|P3|Overall Study|Lost to Follow-up|2
1110459|NCT01770379|3638409|P2|Overall Study|Lost to Follow-up|0
1110460|NCT01770379|3638410|P1|Overall Study|Lost to Follow-up|0
1110461|NCT01770379|3638408|P3|Overall Study|Physician Decision|2
1110462|NCT01770379|3638409|P2|Overall Study|Physician Decision|1
1110463|NCT01770379|3638410|P1|Overall Study|Physician Decision|0
1110464|NCT01770379|3638408|P3|Overall Study|Protocol Violation|1
1110465|NCT01770379|3638409|P2|Overall Study|Protocol Violation|1
1110466|NCT01770379|3638410|P1|Overall Study|Protocol Violation|0
1110467|NCT01770379|3638408|P3|Overall Study|study terminated by sponsor|22
1110468|NCT01770379|3638409|P2|Overall Study|study terminated by sponsor|23
1110469|NCT01770379|3638410|P1|Overall Study|study terminated by sponsor|22
1110470|NCT01770379|3638408|P3|Overall Study|Withdrawal by Subject|7
1110471|NCT01770379|3638409|P2|Overall Study|Withdrawal by Subject|10
1110472|NCT01770379|3638410|P1|Overall Study|Withdrawal by Subject|7
1110473|NCT01770379|3638408|P3|Overall Study|Technical issues|0
1110474|NCT01770379|3638409|P2|Overall Study|Technical issues|0
1110475|NCT01770379|3638410|P1|Overall Study|Technical issues|1
1110476|NCT01770145|3638447|P1|Treatment|Withdrawal by Subject|1
1110477|NCT01770145|3638447|P1|Treatment|Adverse Event|3
1110478|NCT01770145|3638447|P1|Baseline|Unable to define optimal dose|4
1110479|NCT01770145|3638447|P1|Baseline|Lost to Follow-up|1
1110480|NCT01770145|3638447|P1|Baseline|Withdrawal by Subject|1
1110481|NCT01770145|3638447|P1|Baseline|Adverse Event|20
1110482|NCT01769508|3638467|P1|Overall Study|Lost to Follow-up|1
1110483|NCT01769508|3638467|P1|Overall Study|Adverse Event|1
1110484|NCT01769508|3638467|P1|Overall Study|Withdrawal by Subject|1
1110485|NCT01769508|3638467|P1|Overall Study|Death|3
1110486|NCT01769456|3638476|P1|Overall Study|Parental request to youth to withdraw|1
1110487|NCT01769456|3638476|P1|Overall Study|No wk 0 visit w/in 30 days of screening|5
1110488|NCT01769456|3638476|P1|Overall Study|Moved out of the area|3
1110489|NCT01769456|3638476|P1|Overall Study|Did not receive PCC intervention|6
1110490|NCT01769456|3638476|P1|Overall Study|Withdrawal by Subject|3
1110491|NCT01769456|3638476|P1|Overall Study|Lost to Follow-up|19
1110492|NCT01769443|3638497|P2|Overall Study|Study closure|0
1110493|NCT01769443|3638498|P1|Overall Study|Study closure|1
1110494|NCT01769391|3638542|P2|Overall Study|Investigator Decision|0
1110495|NCT01769391|3638543|P1|Overall Study|Investigator Decision|2
1110496|NCT01769391|3638542|P2|Overall Study|Withdrawal by Subject|3
1110497|NCT01769391|3638543|P1|Overall Study|Withdrawal by Subject|4
1110498|NCT01769391|3638542|P2|Overall Study|Progressive Disease|2
1110499|NCT01769391|3638543|P1|Overall Study|Progressive Disease|1
1110500|NCT01769391|3638542|P2|Overall Study|Adverse Event|3
1110501|NCT01769391|3638543|P1|Overall Study|Adverse Event|0
1110502|NCT01769391|3638542|P2|Overall Study|Death|1
1110503|NCT01769391|3638543|P1|Overall Study|Death|10
1110504|NCT01769378|3638562|P2|Overall Study|Lost to Follow-up|0
1110505|NCT01769378|3638563|P1|Overall Study|Lost to Follow-up|2
1110506|NCT01769378|3638562|P2|Overall Study|Sponsor Decision|0
1110507|NCT01769378|3638563|P1|Overall Study|Sponsor Decision|1
1110508|NCT01769378|3638562|P2|Overall Study|Withdrawal by Subject|3
1110509|NCT01769378|3638563|P1|Overall Study|Withdrawal by Subject|10
1110510|NCT01769378|3638562|P2|Overall Study|Protocol Violation|1
1110511|NCT01769378|3638563|P1|Overall Study|Protocol Violation|1
1110512|NCT01769378|3638562|P2|Overall Study|Entry criteria not met|0
1110513|NCT01769378|3638563|P1|Overall Study|Entry criteria not met|1
1110514|NCT01769378|3638562|P2|Overall Study|Adverse Event|0
1110515|NCT01769378|3638563|P1|Overall Study|Adverse Event|10
1110516|NCT01769339|3638643|P1|Overall Study|Adverse Event|1
1110517|NCT01769339|3638643|P1|Overall Study|Lost to Follow-up|42
1110518|NCT01769326|3638654|P4|Overall Study|Got sick and could not complete study|0
1110519|NCT01769326|3638655|P3|Overall Study|Got sick and could not complete study|1
1110520|NCT01769326|3638656|P2|Overall Study|Got sick and could not complete study|0
1110521|NCT01769326|3638657|P1|Overall Study|Got sick and could not complete study|0
1110522|NCT01769326|3638654|P4|Overall Study|got a job|0
1110523|NCT01769326|3638655|P3|Overall Study|got a job|0
1110524|NCT01769326|3638656|P2|Overall Study|got a job|1
1110525|NCT01769326|3638657|P1|Overall Study|got a job|0
1110526|NCT01769326|3638654|P4|Overall Study|unrelated injry|0
1110527|NCT01769326|3638655|P3|Overall Study|unrelated injry|0
1110528|NCT01769326|3638656|P2|Overall Study|unrelated injry|1
1110529|NCT01769326|3638657|P1|Overall Study|unrelated injry|1
1110530|NCT01769326|3638654|P4|Overall Study|Lost to Follow-up|0
1110531|NCT01769326|3638655|P3|Overall Study|Lost to Follow-up|0
1110532|NCT01769326|3638656|P2|Overall Study|Lost to Follow-up|2
1110533|NCT01769326|3638657|P1|Overall Study|Lost to Follow-up|1
1110534|NCT01769196|3638710|P2|Overall Study|Withdrew consent|40
1110535|NCT01769196|3638711|P1|Overall Study|Withdrew consent|36
1110536|NCT01769196|3638710|P2|Overall Study|Participant never dosed with study drug|0
1110537|NCT01769196|3638711|P1|Overall Study|Participant never dosed with study drug|1
1110538|NCT01769196|3638710|P2|Overall Study|Study terminated by sponsor|161
1110539|NCT01769196|3638711|P1|Overall Study|Study terminated by sponsor|160
1110540|NCT01769196|3638710|P2|Overall Study|Protocol Violation|3
1110541|NCT01769196|3638711|P1|Overall Study|Protocol Violation|0
1110542|NCT01769196|3638710|P2|Overall Study|Protocol defined criteria for withdrawal|11
1110543|NCT01769196|3638711|P1|Overall Study|Protocol defined criteria for withdrawal|9
1110544|NCT01769196|3638710|P2|Overall Study|Progressive disease|6
1110545|NCT01769196|3638711|P1|Overall Study|Progressive disease|11
1110546|NCT01769196|3638710|P2|Overall Study|Lack of Efficacy|2
1110547|NCT01769196|3638711|P1|Overall Study|Lack of Efficacy|3
1110548|NCT01769196|3638710|P2|Overall Study|Investigator Discretion|3
1110549|NCT01769196|3638711|P1|Overall Study|Investigator Discretion|7
1110550|NCT01769196|3638710|P2|Overall Study|Death|26
1110551|NCT01769196|3638711|P1|Overall Study|Death|21
1110552|NCT01769196|3638710|P2|Overall Study|Adverse Event|20
1110553|NCT01769196|3638711|P1|Overall Study|Adverse Event|24
1110554|NCT01769105|3638741|P2|Cross-over|Lost to Follow-up|0
1110555|NCT01769105|3638742|P1|Cross-over|Lost to Follow-up|5
1110556|NCT01769105|3638741|P2|First Intervention|Protocol Violation|2
1110557|NCT01769105|3638742|P1|First Intervention|Protocol Violation|2
1110558|NCT01768676|3638800|P2|Overall Study|Withdrawal by Subject|10
1110559|NCT01768676|3638801|P1|Overall Study|Withdrawal by Subject|3
1110560|NCT01768676|3638800|P2|Overall Study|Physician Decision|1
1110561|NCT01768676|3638801|P1|Overall Study|Physician Decision|4
1110562|NCT01768676|3638800|P2|Overall Study|Protocol Violation|1
1110563|NCT01768676|3638801|P1|Overall Study|Protocol Violation|1
1110564|NCT01768676|3638800|P2|Overall Study|Lost to Follow-up|16
1110565|NCT01768676|3638801|P1|Overall Study|Lost to Follow-up|13
1110566|NCT01768676|3638800|P2|Overall Study|Adverse Event|3
1110567|NCT01768676|3638801|P1|Overall Study|Adverse Event|3
1110568|NCT01768572|3638818|P3|Overall Study|Other, Not due to an adverse event|1
1110569|NCT01768572|3638819|P2|Overall Study|Other, Not due to an adverse event|1
1110570|NCT01768572|3638820|P1|Overall Study|Other, Not due to an adverse event|1
1110571|NCT01768572|3638818|P3|Overall Study|Lack of Efficacy|1
1110572|NCT01768572|3638819|P2|Overall Study|Lack of Efficacy|3
1110573|NCT01768572|3638820|P1|Overall Study|Lack of Efficacy|1
1110574|NCT01768572|3638818|P3|Overall Study|Adverse Event|4
1110575|NCT01768572|3638819|P2|Overall Study|Adverse Event|8
1110576|NCT01768572|3638820|P1|Overall Study|Adverse Event|7
1110577|NCT01768559|3638831|P3|Overall Study|Other than specified|5
1110578|NCT01768559|3638832|P2|Overall Study|Other than specified|8
1110579|NCT01768559|3638833|P1|Overall Study|Other than specified|9
1110580|NCT01768559|3638831|P3|Overall Study|Poor compliance to protocol|2
1110581|NCT01768559|3638832|P2|Overall Study|Poor compliance to protocol|3
1110582|NCT01768559|3638833|P1|Overall Study|Poor compliance to protocol|0
1110583|NCT01768559|3638831|P3|Overall Study|Lack of Efficacy|0
1110584|NCT01768559|3638832|P2|Overall Study|Lack of Efficacy|4
1110585|NCT01768559|3638833|P1|Overall Study|Lack of Efficacy|6
1110586|NCT01768559|3638831|P3|Overall Study|Adverse Event|5
1110587|NCT01768559|3638832|P2|Overall Study|Adverse Event|2
1110588|NCT01768559|3638833|P1|Overall Study|Adverse Event|15
1110589|NCT01768559|3638831|P3|Overall Study|Randomized but not treated|1
1110590|NCT01768559|3638832|P2|Overall Study|Randomized but not treated|0
1110591|NCT01768559|3638833|P1|Overall Study|Randomized but not treated|0
1110592|NCT01768286|3638898|P4|Overall Study|Withdrew Consent|0
1110593|NCT01768286|3638899|P3|Overall Study|Withdrew Consent|1
1110594|NCT01768286|3638900|P2|Overall Study|Withdrew Consent|0
1110595|NCT01768286|3638901|P1|Overall Study|Withdrew Consent|0
1110596|NCT01768286|3638898|P4|Overall Study|Lack of Efficacy|1
1110597|NCT01768286|3638899|P3|Overall Study|Lack of Efficacy|0
1110598|NCT01768286|3638900|P2|Overall Study|Lack of Efficacy|4
1110599|NCT01768286|3638901|P1|Overall Study|Lack of Efficacy|7
1110600|NCT01768286|3638898|P4|Overall Study|Randomized But Not Treated|0
1110601|NCT01768286|3638899|P3|Overall Study|Randomized But Not Treated|1
1110602|NCT01768286|3638900|P2|Overall Study|Randomized But Not Treated|0
1110603|NCT01768286|3638901|P1|Overall Study|Randomized But Not Treated|0
1110604|NCT01768117|3638963|P1|Overall Study|Protocol Violation|3
1110605|NCT01768117|3638963|P1|Overall Study|Withdrawal by Subject|2
1110606|NCT01768117|3638963|P1|Overall Study|Lost to Follow-up|1
1110607|NCT01767987|3639027|P2|Overall Study|Physician Decision|1
1110608|NCT01767987|3639028|P1|Overall Study|Physician Decision|4
1110609|NCT01767597|3639094|P2|Overall Study|Withdrawal by Subject|0
1110610|NCT01767597|3639095|P1|Overall Study|Withdrawal by Subject|1
1110611|NCT01767597|3639094|P2|Overall Study|Incomplete intervention|1
1110612|NCT01767597|3639095|P1|Overall Study|Incomplete intervention|3
1110613|NCT01767519|3639104|P3|Overall Study|Adverse Event|1
1110614|NCT01767519|3639105|P2|Overall Study|Adverse Event|5
1110615|NCT01767519|3639106|P1|Overall Study|Adverse Event|5
1110616|NCT01767519|3639104|P3|Overall Study|Lack of Efficacy|0
1110617|NCT01767519|3639105|P2|Overall Study|Lack of Efficacy|0
1110618|NCT01767519|3639106|P1|Overall Study|Lack of Efficacy|1
1110619|NCT01767519|3639104|P3|Overall Study|Lost to Follow-up|2
1110620|NCT01767519|3639105|P2|Overall Study|Lost to Follow-up|1
1110621|NCT01767519|3639106|P1|Overall Study|Lost to Follow-up|3
1110622|NCT01767519|3639104|P3|Overall Study|Personal Reasons|0
1110623|NCT01767519|3639105|P2|Overall Study|Personal Reasons|0
1110624|NCT01767519|3639106|P1|Overall Study|Personal Reasons|1
1110625|NCT01767519|3639104|P3|Overall Study|Protocol Violation|0
1110626|NCT01767519|3639105|P2|Overall Study|Protocol Violation|3
1110627|NCT01767519|3639106|P1|Overall Study|Protocol Violation|0
1110628|NCT01767519|3639104|P3|Overall Study|Other Reasons|2
1110629|NCT01767519|3639105|P2|Overall Study|Other Reasons|4
1110630|NCT01767519|3639106|P1|Overall Study|Other Reasons|4
1110631|NCT01767467|3639147|P2|End of Study Phase (up to Month 13)|Subject Unavailable|2
1110632|NCT01767467|3639148|P1|End of Study Phase (up to Month 13)|Subject Unavailable|0
1110633|NCT01767467|3639147|P2|End of Study Phase (up to Month 13)|Physician Decision|0
1110634|NCT01767467|3639148|P1|End of Study Phase (up to Month 13)|Physician Decision|1
1110635|NCT01767467|3639147|P2|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1
1110636|NCT01767467|3639148|P1|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0
1110637|NCT01767467|3639147|P2|End of Study Phase (up to Month 13)|Lost to Follow-up|4
1110638|NCT01767467|3639148|P1|End of Study Phase (up to Month 13)|Lost to Follow-up|6
1110639|NCT01767467|3639147|P2|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3
1110640|NCT01767467|3639148|P1|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0
1110641|NCT01767467|3639147|P2|End of Study Phase (up to Month 13)|Withdrawal by Subject|14
1110642|NCT01767467|3639148|P1|End of Study Phase (up to Month 13)|Withdrawal by Subject|9
1110643|NCT01767467|3639147|P2|End of Study Phase (up to Month 13)|Protocol Violation|0
1110644|NCT01767467|3639148|P1|End of Study Phase (up to Month 13)|Protocol Violation|2
1110645|NCT01767467|3639147|P2|End of Study Phase (up to Month 13)|Adverse Event|39
1110646|NCT01767467|3639148|P1|End of Study Phase (up to Month 13)|Adverse Event|29
1110647|NCT01767467|3639147|P2|Vaccination Phase (up to Month 2)|Subject unavailable|1
1110648|NCT01767467|3639148|P1|Vaccination Phase (up to Month 2)|Subject unavailable|0
1110649|NCT01767467|3639147|P2|Vaccination Phase (up to Month 2)|Physician Decision|0
1110650|NCT01767467|3639148|P1|Vaccination Phase (up to Month 2)|Physician Decision|1
1110651|NCT01767467|3639147|P2|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1
1110652|NCT01767467|3639148|P1|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0
1110653|NCT01767467|3639147|P2|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10
1110654|NCT01767467|3639148|P1|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7
1110655|NCT01767467|3639147|P2|Vaccination Phase (up to Month 2)|Protocol Violation|0
1110656|NCT01767467|3639148|P1|Vaccination Phase (up to Month 2)|Protocol Violation|1
1110657|NCT01767467|3639147|P2|Vaccination Phase (up to Month 2)|Adverse Event|8
1110658|NCT01767467|3639148|P1|Vaccination Phase (up to Month 2)|Adverse Event|8
1110659|NCT01767376|3639204|P3|Overall Study|Withdrawal by Subject|0
1110660|NCT01767376|3639205|P2|Overall Study|Withdrawal by Subject|1
1110661|NCT01767376|3639206|P1|Overall Study|Withdrawal by Subject|1
1110662|NCT01767376|3639204|P3|Overall Study|Lost to Follow-up|0
1110663|NCT01767376|3639205|P2|Overall Study|Lost to Follow-up|2
1110664|NCT01767376|3639206|P1|Overall Study|Lost to Follow-up|3
1110665|NCT01767116|3639287|P2|Overall Study|Lost to Follow-up|2
1110666|NCT01767116|3639288|P1|Overall Study|Lost to Follow-up|2
1110667|NCT01766921|3639346|P2|Overall Study|Withdrawal by Subject|5
1110668|NCT01766921|3639347|P1|Overall Study|Withdrawal by Subject|14
1110669|NCT01766921|3639346|P2|Overall Study|Protocol Violation|1
1110670|NCT01766921|3639347|P1|Overall Study|Protocol Violation|1
1110671|NCT01766921|3639346|P2|Overall Study|Unclassified|2
1110672|NCT01766921|3639347|P1|Overall Study|Unclassified|2
1110673|NCT01766921|3639346|P2|Overall Study|Lost to Follow-up|3
1110674|NCT01766921|3639347|P1|Overall Study|Lost to Follow-up|1
1110675|NCT01766921|3639346|P2|Overall Study|Death|1
1110676|NCT01766921|3639347|P1|Overall Study|Death|1
1110677|NCT01766921|3639346|P2|Overall Study|Administrative Reason|5
1110678|NCT01766921|3639347|P1|Overall Study|Administrative Reason|5
1110679|NCT01766778|3639368|P2|Overall Study|Withdrawal by Subject|0
1110680|NCT01766778|3639369|P1|Overall Study|Withdrawal by Subject|1
1110681|NCT01766778|3639368|P2|Overall Study|Adverse Event|4
1110682|NCT01766778|3639369|P1|Overall Study|Adverse Event|4
1110683|NCT01766336|3639423|P2|Overall Study|Withdrawal by Subject|15
1110684|NCT01766336|3639424|P1|Overall Study|Withdrawal by Subject|18
1110685|NCT01766336|3639423|P2|Overall Study|Sponsor Decision|43
1110686|NCT01766336|3639424|P1|Overall Study|Sponsor Decision|52
1110687|NCT01766336|3639423|P2|Overall Study|Protocol Violation|1
1110688|NCT01766336|3639424|P1|Overall Study|Protocol Violation|0
1110689|NCT01766336|3639423|P2|Overall Study|Physician Decision|2
1110690|NCT01766336|3639424|P1|Overall Study|Physician Decision|4
1110691|NCT01766336|3639423|P2|Overall Study|Lost to Follow-up|3
1110692|NCT01766336|3639424|P1|Overall Study|Lost to Follow-up|1
1110693|NCT01766336|3639423|P2|Overall Study|Death|3
1110694|NCT01766336|3639424|P1|Overall Study|Death|4
1110695|NCT01766336|3639423|P2|Overall Study|Adverse Event|8
1110696|NCT01766336|3639424|P1|Overall Study|Adverse Event|11
1110697|NCT01766310|3639432|P2|Overall Study|Lost to Follow-up|3
1110698|NCT01766310|3639433|P1|Overall Study|Lost to Follow-up|1
1110699|NCT01766206|3639441|P1|Overall Study|Withdrawal and inappropriate enrollment|1
1110700|NCT01766206|3639441|P1|Overall Study|Inappropriate enrollment|18
1110701|NCT01766206|3639441|P1|Overall Study|Lost to Follow-up|10
1110702|NCT01766206|3639441|P1|Overall Study|Withdrawal by Subject|22
1110703|NCT01766050|3639468|P1|Overall Study|Withdrawal by Subject|2
1110704|NCT01766050|3639468|P1|Overall Study|Lost to Follow-up|1
1110705|NCT01766050|3639468|P1|Overall Study|Adverse Event|1
1110706|NCT01766037|3639603|P2|Overall Study|nausea / discomfort|0
1110707|NCT01766037|3639604|P1|Overall Study|nausea / discomfort|3
1110708|NCT01766037|3639603|P2|Overall Study|medical - unrelated|2
1110709|NCT01766037|3639604|P1|Overall Study|medical - unrelated|1
1110710|NCT01766037|3639603|P2|Overall Study|Moved from area|0
1110711|NCT01766037|3639604|P1|Overall Study|Moved from area|5
1110712|NCT01766037|3639603|P2|Overall Study|Withdrawal by Subject|16
1110713|NCT01766037|3639604|P1|Overall Study|Withdrawal by Subject|18
1110714|NCT01766037|3639603|P2|Overall Study|Physician Decision|1
1110715|NCT01766037|3639604|P1|Overall Study|Physician Decision|0
1110716|NCT01766037|3639603|P2|Overall Study|Lost to Follow-up|10
1110717|NCT01766037|3639604|P1|Overall Study|Lost to Follow-up|0
1110718|NCT01766037|3639603|P2|Overall Study|Lack of Efficacy|0
1110719|NCT01766037|3639604|P1|Overall Study|Lack of Efficacy|1
1110720|NCT01766037|3639603|P2|Overall Study|Adverse Event|0
1110721|NCT01766037|3639604|P1|Overall Study|Adverse Event|1
1110722|NCT01765764|3639673|P3|Treatment Period|Other Miscellaneous Reasons|2
1110723|NCT01765764|3639674|P2|Treatment Period|Other Miscellaneous Reasons|2
1110724|NCT01765764|3639675|P1|Treatment Period|Other Miscellaneous Reasons|1
1110725|NCT01765764|3639673|P3|Treatment Period|Personal Reasons|1
1110726|NCT01765764|3639674|P2|Treatment Period|Personal Reasons|2
1110727|NCT01765764|3639675|P1|Treatment Period|Personal Reasons|1
1110728|NCT01765764|3639673|P3|Treatment Period|Lost to Follow-up|2
1110729|NCT01765764|3639674|P2|Treatment Period|Lost to Follow-up|3
1110730|NCT01765764|3639675|P1|Treatment Period|Lost to Follow-up|0
1110731|NCT01765764|3639673|P3|Treatment Period|Adverse Event|1
1110732|NCT01765764|3639674|P2|Treatment Period|Adverse Event|2
1110733|NCT01765764|3639675|P1|Treatment Period|Adverse Event|1
1110734|NCT01765751|3639695|P3|Overall Study|Lost to Follow-up|1
1110735|NCT01765751|3639696|P2|Overall Study|Lost to Follow-up|2
1110736|NCT01765751|3639697|P1|Overall Study|Lost to Follow-up|0
1110737|NCT01765673|3639729|P1|Overall Study|No transportation for 2nd/3rd visits|1
1110738|NCT01765582|3639755|P3|Overall Study|Withdrawal of Consent|10
1110739|NCT01765582|3639756|P2|Overall Study|Withdrawal of Consent|6
1110740|NCT01765582|3639757|P1|Overall Study|Withdrawal of Consent|11
1110741|NCT01765582|3639755|P3|Overall Study|Sponsor Decision|42
1110742|NCT01765582|3639756|P2|Overall Study|Sponsor Decision|42
1110743|NCT01765582|3639757|P1|Overall Study|Sponsor Decision|46
1110744|NCT01765582|3639755|P3|Overall Study|Death|33
1110745|NCT01765582|3639756|P2|Overall Study|Death|36
1110746|NCT01765582|3639757|P1|Overall Study|Death|31
1110747|NCT01765582|3639755|P3|Overall Study|Lost to Follow-up|1
1110748|NCT01765582|3639756|P2|Overall Study|Lost to Follow-up|2
1110749|NCT01765582|3639757|P1|Overall Study|Lost to Follow-up|2
1110750|NCT01765582|3639755|P3|Overall Study|Other|9
1110751|NCT01765582|3639756|P2|Overall Study|Other|6
1110752|NCT01765582|3639757|P1|Overall Study|Other|3
1110753|NCT01765569|3639790|P1|Period C|Death|1
1110754|NCT01765569|3639790|P1|Period B|Withdrawal by Subject|1
1110755|NCT01765543|3639811|P1|Overall Study|Withdrawal by Subject|2
1110756|NCT01765543|3639811|P1|Overall Study|Death|1
1110757|NCT01765426|3639863|P4|Overall Study|Lost to Follow-up|0
1110758|NCT01765426|3639864|P3|Overall Study|Lost to Follow-up|0
1110759|NCT01765426|3639865|P2|Overall Study|Lost to Follow-up|1
1110760|NCT01765426|3639866|P1|Overall Study|Lost to Follow-up|0
1110761|NCT01765270|3639922|P2|Overall Study|Withdrawal by Subject|1
1110762|NCT01765270|3639923|P1|Overall Study|Withdrawal by Subject|0
1110763|NCT01765270|3639922|P2|Overall Study|Physician Decision|0
1110764|NCT01765270|3639923|P1|Overall Study|Physician Decision|1
1110765|NCT01765192|3639945|P2|End of Treatment Period 2 to Final Visit|Adverse Event|1
1110766|NCT01765192|3639946|P1|End of Treatment Period 2 to Final Visit|Adverse Event|0
1110767|NCT01765192|3639945|P2|Treatment Period 2|Reason not specified|2
1110768|NCT01765192|3639946|P1|Treatment Period 2|Reason not specified|0
1110769|NCT01765192|3639945|P2|Washout Period|Reason not specified|0
1110770|NCT01765192|3639946|P1|Washout Period|Reason not specified|1
1110771|NCT01765192|3639945|P2|Washout Period|Voluntary Withdrawal|1
1110772|NCT01765192|3639946|P1|Washout Period|Voluntary Withdrawal|1
1110773|NCT01765192|3639945|P2|Treatment Period 1|Adverse Event|1
1110774|NCT01765192|3639946|P1|Treatment Period 1|Adverse Event|0
1110775|NCT01765179|3639964|P1|Overall Study|Ca elevated 10.6|1
1110776|NCT01765179|3639964|P1|Overall Study|work conflict|1
1110777|NCT01765179|3639964|P1|Overall Study|lack of venous access|1
1110778|NCT01765179|3639964|P1|Overall Study|Out of country unable to finish study|1
1110779|NCT01765179|3639964|P1|Overall Study|prohibited med|1
1110780|NCT01765179|3639964|P1|Overall Study|Hematocrit >54%|3
1110781|NCT01765179|3639964|P1|Overall Study|Withdrawal by Subject|8
1110782|NCT01765179|3639964|P1|Overall Study|Protocol Violation|1
1110783|NCT01765179|3639964|P1|Overall Study|Non-compliance with study drug|2
1110784|NCT01765179|3639964|P1|Overall Study|Lost to Follow-up|5
1110785|NCT01765179|3639964|P1|Overall Study|Adverse Event|3
1110786|NCT01765153|3639971|P2|Rest Phase 2|Lost to Follow-up|1
1110787|NCT01765153|3639972|P1|Rest Phase 2|Lost to Follow-up|2
1110788|NCT01765153|3639971|P2|Training Phase 2|Withdrawal by Subject|1
1110789|NCT01765153|3639972|P1|Training Phase 2|Withdrawal by Subject|0
1110790|NCT01765153|3639971|P2|Rest Phase 1|Withdrawal by Subject|1
1110791|NCT01765153|3639972|P1|Rest Phase 1|Withdrawal by Subject|0
1110792|NCT01765153|3639971|P2|Training Phase 1|Poor participation in intervention|1
1110793|NCT01765153|3639972|P1|Training Phase 1|Poor participation in intervention|0
1110794|NCT01765153|3639971|P2|Training Phase 1|Format of intervention differed|0
1110795|NCT01765153|3639972|P1|Training Phase 1|Format of intervention differed|1
1110796|NCT01764997|3640079|P5|Study Drug Treatment Period|Other than specified above|10
1110797|NCT01764997|3640080|P4|Study Drug Treatment Period|Other than specified above|0
1110798|NCT01764997|3640081|P3|Study Drug Treatment Period|Other than specified above|0
1110799|NCT01764997|3640082|P2|Study Drug Treatment Period|Other than specified above|0
1110800|NCT01764997|3640083|P1|Study Drug Treatment Period|Other than specified above|0
1110801|NCT01764997|3640079|P5|Study Drug Treatment Period|Lack of Efficacy|2
1110802|NCT01764997|3640080|P4|Study Drug Treatment Period|Lack of Efficacy|0
1110803|NCT01764997|3640081|P3|Study Drug Treatment Period|Lack of Efficacy|0
1110804|NCT01764997|3640082|P2|Study Drug Treatment Period|Lack of Efficacy|0
1110805|NCT01764997|3640083|P1|Study Drug Treatment Period|Lack of Efficacy|0
1110806|NCT01764997|3640079|P5|Study Drug Treatment Period|Adverse Event|24
1110807|NCT01764997|3640080|P4|Study Drug Treatment Period|Adverse Event|0
1110808|NCT01764997|3640081|P3|Study Drug Treatment Period|Adverse Event|0
1110809|NCT01764997|3640082|P2|Study Drug Treatment Period|Adverse Event|1
1110810|NCT01764997|3640083|P1|Study Drug Treatment Period|Adverse Event|0
1110811|NCT01764997|3640079|P5|Run-in Period|Other than specified above|0
1110812|NCT01764997|3640080|P4|Run-in Period|Other than specified above|0
1110813|NCT01764997|3640081|P3|Run-in Period|Other than specified above|0
1110814|NCT01764997|3640082|P2|Run-in Period|Other than specified above|0
1110815|NCT01764997|3640083|P1|Run-in Period|Other than specified above|17
1110816|NCT01764997|3640079|P5|Run-in Period|Poor compliance to protocol|0
1110817|NCT01764997|3640080|P4|Run-in Period|Poor compliance to protocol|0
1110818|NCT01764997|3640081|P3|Run-in Period|Poor compliance to protocol|0
1110819|NCT01764997|3640082|P2|Run-in Period|Poor compliance to protocol|0
1110820|NCT01764997|3640083|P1|Run-in Period|Poor compliance to protocol|1
1110821|NCT01764997|3640079|P5|Run-in Period|Lack of Efficacy|0
1110822|NCT01764997|3640080|P4|Run-in Period|Lack of Efficacy|0
1110823|NCT01764997|3640081|P3|Run-in Period|Lack of Efficacy|0
1110824|NCT01764997|3640082|P2|Run-in Period|Lack of Efficacy|0
1110825|NCT01764997|3640083|P1|Run-in Period|Lack of Efficacy|5
1110826|NCT01764997|3640079|P5|Run-in Period|Adverse Event|0
1110827|NCT01764997|3640080|P4|Run-in Period|Adverse Event|0
1110828|NCT01764997|3640081|P3|Run-in Period|Adverse Event|0
1110829|NCT01764997|3640082|P2|Run-in Period|Adverse Event|0
1110830|NCT01764997|3640083|P1|Run-in Period|Adverse Event|15
1110831|NCT01764945|3640110|P8|Overall Study|Adverse Event|0
1110832|NCT01764945|3640111|P7|Overall Study|Adverse Event|1
1110833|NCT01764945|3640112|P6|Overall Study|Adverse Event|0
1110834|NCT01764945|3640113|P5|Overall Study|Adverse Event|0
1110835|NCT01764945|3640114|P4|Overall Study|Adverse Event|0
1110836|NCT01764945|3640115|P3|Overall Study|Adverse Event|0
1110837|NCT01764945|3640116|P2|Overall Study|Adverse Event|1
1110838|NCT01764945|3640117|P1|Overall Study|Adverse Event|0
1110839|NCT01764841|3640163|P4|Overall Study|Lost to Follow-up|0
1110840|NCT01764841|3640164|P3|Overall Study|Lost to Follow-up|1
1110841|NCT01764841|3640165|P2|Overall Study|Lost to Follow-up|0
1110842|NCT01764841|3640166|P1|Overall Study|Lost to Follow-up|3
1110843|NCT01764841|3640163|P4|Overall Study|Withdrawal by Subject|15
1110844|NCT01764841|3640164|P3|Overall Study|Withdrawal by Subject|11
1110845|NCT01764841|3640165|P2|Overall Study|Withdrawal by Subject|24
1110846|NCT01764841|3640166|P1|Overall Study|Withdrawal by Subject|16
1110847|NCT01764841|3640163|P4|Overall Study|Protocol Violation|0
1110848|NCT01764841|3640164|P3|Overall Study|Protocol Violation|0
1110849|NCT01764841|3640165|P2|Overall Study|Protocol Violation|1
1110850|NCT01764841|3640166|P1|Overall Study|Protocol Violation|0
1110851|NCT01764841|3640163|P4|Overall Study|No Follow Up|0
1110852|NCT01764841|3640164|P3|Overall Study|No Follow Up|1
1110853|NCT01764841|3640165|P2|Overall Study|No Follow Up|0
1110854|NCT01764841|3640166|P1|Overall Study|No Follow Up|1
1110855|NCT01764841|3640163|P4|Overall Study|Death|4
1110856|NCT01764841|3640164|P3|Overall Study|Death|1
1110857|NCT01764841|3640165|P2|Overall Study|Death|0
1110858|NCT01764841|3640166|P1|Overall Study|Death|3
1110859|NCT01764841|3640163|P4|Overall Study|Logistical Difficulties|0
1110860|NCT01764841|3640164|P3|Overall Study|Logistical Difficulties|0
1110861|NCT01764841|3640165|P2|Overall Study|Logistical Difficulties|1
1110862|NCT01764841|3640166|P1|Overall Study|Logistical Difficulties|0
1110863|NCT01764633|3640209|P2|Overall Study|Lost to Follow-up|5
1110864|NCT01764633|3640210|P1|Overall Study|Lost to Follow-up|13
1110865|NCT01764633|3640209|P2|Overall Study|Withdrawal by Subject|88
1110866|NCT01764633|3640210|P1|Overall Study|Withdrawal by Subject|105
1110867|NCT01764386|3640239|P2|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
1110868|NCT01764386|3640240|P1|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
1110869|NCT01764386|3640239|P2|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
1110870|NCT01764386|3640240|P1|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
1110871|NCT01764386|3640239|P2|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26
1110872|NCT01764386|3640240|P1|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0
1110873|NCT01764386|3640239|P2|Uncontrolled Treatment Period (UTP)|Adverse Event|13
1110874|NCT01764386|3640240|P1|Uncontrolled Treatment Period (UTP)|Adverse Event|2
1110875|NCT01764386|3640239|P2|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2
1110876|NCT01764386|3640240|P1|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6
1110877|NCT01764386|3640239|P2|Controlled Treatment Period (CTP)|Lost to Follow-up|5
1110878|NCT01764386|3640240|P1|Controlled Treatment Period (CTP)|Lost to Follow-up|9
1110879|NCT01764386|3640239|P2|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0
1110880|NCT01764386|3640240|P1|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32
1110881|NCT01764386|3640239|P2|Controlled Treatment Period (CTP)|Adverse Event|0
1110882|NCT01764386|3640240|P1|Controlled Treatment Period (CTP)|Adverse Event|35
1110883|NCT01764022|3640283|P2|Overall Study|Protocol Violation|0
1110884|NCT01764022|3640284|P1|Overall Study|Protocol Violation|1
1110885|NCT01764022|3640283|P2|Overall Study|Lost to Follow-up|0
1110886|NCT01764022|3640284|P1|Overall Study|Lost to Follow-up|2
1110887|NCT01764022|3640283|P2|Overall Study|Physician Decision|2
1110888|NCT01764022|3640284|P1|Overall Study|Physician Decision|0
1110889|NCT01764022|3640283|P2|Overall Study|Lack of Efficacy|1
1110890|NCT01764022|3640284|P1|Overall Study|Lack of Efficacy|0
1110891|NCT01764022|3640283|P2|Overall Study|Withdrawal by Subject|6
1110892|NCT01764022|3640284|P1|Overall Study|Withdrawal by Subject|2
1110893|NCT01764022|3640283|P2|Overall Study|Death|5
1110894|NCT01764022|3640284|P1|Overall Study|Death|3
1110895|NCT01763996|3640316|P2|Treatment Period 2|Adverse Event|1
1110896|NCT01763996|3640317|P1|Treatment Period 2|Adverse Event|0
1110897|NCT01763918|3640347|P4|Overall Study|Sponsor Decision|0
1110898|NCT01763918|3640348|P3|Overall Study|Sponsor Decision|9
1110899|NCT01763918|3640349|P2|Overall Study|Sponsor Decision|0
1110900|NCT01763918|3640350|P1|Overall Study|Sponsor Decision|4
1110901|NCT01763918|3640347|P4|Overall Study|Withdrawal by Subject|2
1110902|NCT01763918|3640348|P3|Overall Study|Withdrawal by Subject|1
1110903|NCT01763918|3640349|P2|Overall Study|Withdrawal by Subject|1
1110904|NCT01763918|3640350|P1|Overall Study|Withdrawal by Subject|2
1110905|NCT01763905|3640448|P4|Overall Study|Lost to Follow-up|0
1110906|NCT01763905|3640449|P3|Overall Study|Lost to Follow-up|1
1110907|NCT01763905|3640450|P2|Overall Study|Lost to Follow-up|0
1110908|NCT01763905|3640451|P1|Overall Study|Lost to Follow-up|0
1110909|NCT01763905|3640448|P4|Overall Study|Decision by sponsor|0
1110910|NCT01763905|3640449|P3|Overall Study|Decision by sponsor|8
1110911|NCT01763905|3640450|P2|Overall Study|Decision by sponsor|0
1110912|NCT01763905|3640451|P1|Overall Study|Decision by sponsor|5
1110913|NCT01763905|3640448|P4|Overall Study|Withdrawal by Subject|1
1110914|NCT01763905|3640449|P3|Overall Study|Withdrawal by Subject|0
1110915|NCT01763905|3640450|P2|Overall Study|Withdrawal by Subject|1
1110916|NCT01763905|3640451|P1|Overall Study|Withdrawal by Subject|1
1110917|NCT01763866|3640569|P24|Overall Study|Death|0
1110918|NCT01763866|3640570|P23|Overall Study|Death|0
1110919|NCT01763866|3640571|P22|Overall Study|Death|0
1110920|NCT01763866|3640572|P21|Overall Study|Death|0
1110921|NCT01763866|3640573|P20|Overall Study|Death|0
1110922|NCT01763866|3640574|P19|Overall Study|Death|0
1110923|NCT01763866|3640575|P18|Overall Study|Death|0
1110924|NCT01763866|3640576|P17|Overall Study|Death|1
1110925|NCT01763866|3640577|P16|Overall Study|Death|0
1110926|NCT01763866|3640578|P15|Overall Study|Death|0
1110927|NCT01763866|3640579|P14|Overall Study|Death|0
1110928|NCT01763866|3640580|P13|Overall Study|Death|0
1110929|NCT01763866|3640581|P12|Overall Study|Death|0
1110930|NCT01763866|3640582|P11|Overall Study|Death|0
1110931|NCT01763866|3640583|P10|Overall Study|Death|0
1110932|NCT01763866|3640584|P9|Overall Study|Death|0
1110933|NCT01763866|3640585|P8|Overall Study|Death|0
1110934|NCT01763866|3640586|P7|Overall Study|Death|0
1110935|NCT01763866|3640587|P6|Overall Study|Death|0
1110936|NCT01763866|3640588|P5|Overall Study|Death|0
1110937|NCT01763866|3640589|P4|Overall Study|Death|0
1110938|NCT01763866|3640590|P3|Overall Study|Death|0
1110939|NCT01763866|3640591|P2|Overall Study|Death|0
1110940|NCT01763866|3640592|P1|Overall Study|Death|0
1110941|NCT01763866|3640569|P24|Overall Study|Lost to Follow-up|1
1110942|NCT01763866|3640570|P23|Overall Study|Lost to Follow-up|0
1110943|NCT01763866|3640571|P22|Overall Study|Lost to Follow-up|0
1110944|NCT01763866|3640572|P21|Overall Study|Lost to Follow-up|0
1110945|NCT01763866|3640573|P20|Overall Study|Lost to Follow-up|1
1110946|NCT01763866|3640574|P19|Overall Study|Lost to Follow-up|1
1110947|NCT01763866|3640575|P18|Overall Study|Lost to Follow-up|0
1110948|NCT01763866|3640576|P17|Overall Study|Lost to Follow-up|0
1110949|NCT01763866|3640577|P16|Overall Study|Lost to Follow-up|0
1110950|NCT01763866|3640578|P15|Overall Study|Lost to Follow-up|1
1110951|NCT01763866|3640579|P14|Overall Study|Lost to Follow-up|0
1110952|NCT01763866|3640580|P13|Overall Study|Lost to Follow-up|1
1110953|NCT01763866|3640581|P12|Overall Study|Lost to Follow-up|0
1110954|NCT01763866|3640582|P11|Overall Study|Lost to Follow-up|0
1110955|NCT01763866|3640583|P10|Overall Study|Lost to Follow-up|0
1110956|NCT01763866|3640584|P9|Overall Study|Lost to Follow-up|0
1110957|NCT01763866|3640585|P8|Overall Study|Lost to Follow-up|0
1110958|NCT01763866|3640586|P7|Overall Study|Lost to Follow-up|1
1110959|NCT01763866|3640587|P6|Overall Study|Lost to Follow-up|0
1110960|NCT01763866|3640588|P5|Overall Study|Lost to Follow-up|0
1110961|NCT01763866|3640589|P4|Overall Study|Lost to Follow-up|0
1110962|NCT01763866|3640590|P3|Overall Study|Lost to Follow-up|0
1110963|NCT01763866|3640591|P2|Overall Study|Lost to Follow-up|0
1110964|NCT01763866|3640592|P1|Overall Study|Lost to Follow-up|0
1110965|NCT01763866|3640569|P24|Overall Study|Decision by sponsor|0
1110966|NCT01763866|3640570|P23|Overall Study|Decision by sponsor|1
1110967|NCT01763866|3640571|P22|Overall Study|Decision by sponsor|0
1110968|NCT01763866|3640572|P21|Overall Study|Decision by sponsor|2
1110969|NCT01763866|3640573|P20|Overall Study|Decision by sponsor|0
1110970|NCT01763866|3640574|P19|Overall Study|Decision by sponsor|4
1110971|NCT01763866|3640575|P18|Overall Study|Decision by sponsor|0
1110972|NCT01763866|3640576|P17|Overall Study|Decision by sponsor|0
1110973|NCT01763866|3640577|P16|Overall Study|Decision by sponsor|0
1110974|NCT01763866|3640578|P15|Overall Study|Decision by sponsor|5
1110975|NCT01763866|3640579|P14|Overall Study|Decision by sponsor|0
1110976|NCT01763866|3640580|P13|Overall Study|Decision by sponsor|1
1110977|NCT01763866|3640581|P12|Overall Study|Decision by sponsor|0
1110978|NCT01763866|3640582|P11|Overall Study|Decision by sponsor|6
1110979|NCT01763866|3640583|P10|Overall Study|Decision by sponsor|0
1110980|NCT01763866|3640584|P9|Overall Study|Decision by sponsor|2
1110981|NCT01763866|3640585|P8|Overall Study|Decision by sponsor|0
1110982|NCT01763866|3640586|P7|Overall Study|Decision by sponsor|2
1110983|NCT01763866|3640587|P6|Overall Study|Decision by sponsor|0
1110984|NCT01763866|3640588|P5|Overall Study|Decision by sponsor|2
1110985|NCT01763866|3640589|P4|Overall Study|Decision by sponsor|0
1110986|NCT01763866|3640590|P3|Overall Study|Decision by sponsor|1
1110987|NCT01763866|3640591|P2|Overall Study|Decision by sponsor|0
1110988|NCT01763866|3640592|P1|Overall Study|Decision by sponsor|0
1110989|NCT01763866|3640569|P24|Overall Study|Withdrawal by Subject|1
1110990|NCT01763866|3640570|P23|Overall Study|Withdrawal by Subject|2
1110991|NCT01763866|3640571|P22|Overall Study|Withdrawal by Subject|1
1110992|NCT01763866|3640572|P21|Overall Study|Withdrawal by Subject|2
1110993|NCT01763866|3640573|P20|Overall Study|Withdrawal by Subject|1
1110994|NCT01763866|3640574|P19|Overall Study|Withdrawal by Subject|1
1110995|NCT01763866|3640575|P18|Overall Study|Withdrawal by Subject|1
1110996|NCT01763866|3640576|P17|Overall Study|Withdrawal by Subject|0
1110997|NCT01763866|3640577|P16|Overall Study|Withdrawal by Subject|3
1110998|NCT01763866|3640578|P15|Overall Study|Withdrawal by Subject|6
1110999|NCT01763866|3640579|P14|Overall Study|Withdrawal by Subject|0
1111000|NCT01763866|3640580|P13|Overall Study|Withdrawal by Subject|2
1111001|NCT01763866|3640581|P12|Overall Study|Withdrawal by Subject|2
1111002|NCT01763866|3640582|P11|Overall Study|Withdrawal by Subject|2
1111003|NCT01763866|3640583|P10|Overall Study|Withdrawal by Subject|1
1111004|NCT01763866|3640584|P9|Overall Study|Withdrawal by Subject|1
1111005|NCT01763866|3640585|P8|Overall Study|Withdrawal by Subject|0
1111006|NCT01763866|3640586|P7|Overall Study|Withdrawal by Subject|4
1111007|NCT01763866|3640587|P6|Overall Study|Withdrawal by Subject|3
1111008|NCT01763866|3640588|P5|Overall Study|Withdrawal by Subject|0
1111009|NCT01763866|3640589|P4|Overall Study|Withdrawal by Subject|0
1111010|NCT01763866|3640590|P3|Overall Study|Withdrawal by Subject|4
1111011|NCT01763866|3640591|P2|Overall Study|Withdrawal by Subject|1
1111012|NCT01763866|3640592|P1|Overall Study|Withdrawal by Subject|2
1111013|NCT01763827|3641152|P6|Overall Study|Lost to Follow-up|1
1111014|NCT01763827|3641153|P5|Overall Study|Lost to Follow-up|2
1111015|NCT01763827|3641154|P4|Overall Study|Lost to Follow-up|1
1111016|NCT01763827|3641155|P3|Overall Study|Lost to Follow-up|1
1111017|NCT01763827|3641156|P2|Overall Study|Lost to Follow-up|1
1111018|NCT01763827|3641157|P1|Overall Study|Lost to Follow-up|0
1111019|NCT01763827|3641152|P6|Overall Study|Decision by sponsor|1
1111020|NCT01763827|3641153|P5|Overall Study|Decision by sponsor|2
1111021|NCT01763827|3641154|P4|Overall Study|Decision by sponsor|0
1111022|NCT01763827|3641155|P3|Overall Study|Decision by sponsor|3
1111023|NCT01763827|3641156|P2|Overall Study|Decision by sponsor|0
1111024|NCT01763827|3641157|P1|Overall Study|Decision by sponsor|2
1111025|NCT01763827|3641152|P6|Overall Study|Withdrawal by Subject|0
1111026|NCT01763827|3641153|P5|Overall Study|Withdrawal by Subject|2
1111027|NCT01763827|3641154|P4|Overall Study|Withdrawal by Subject|0
1111028|NCT01763827|3641155|P3|Overall Study|Withdrawal by Subject|0
1111029|NCT01763827|3641156|P2|Overall Study|Withdrawal by Subject|0
1111030|NCT01763827|3641157|P1|Overall Study|Withdrawal by Subject|1
1111031|NCT01763047|3641328|P2|Period 2|Unsatisfactory lens Fitting|1
1111032|NCT01763047|3641329|P1|Period 2|Unsatisfactory lens Fitting|0
1111033|NCT01763047|3641328|P2|Period 2|Protocol Violation|2
1111034|NCT01763047|3641329|P1|Period 2|Protocol Violation|0
1111035|NCT01763047|3641328|P2|Period 2|Unsatisfactory Visual Response|1
1111036|NCT01763047|3641329|P1|Period 2|Unsatisfactory Visual Response|1
1111037|NCT01763047|3641328|P2|Period 2|Study Site office Closed|1
1111038|NCT01763047|3641329|P1|Period 2|Study Site office Closed|1
1111039|NCT01763047|3641328|P2|Period 2|No longer meets Eligibility Criteria|0
1111040|NCT01763047|3641329|P1|Period 2|No longer meets Eligibility Criteria|1
1111041|NCT01763047|3641328|P2|Period 2|Lens Discomfort|0
1111042|NCT01763047|3641329|P1|Period 2|Lens Discomfort|1
1111043|NCT01763047|3641328|P2|Period 1|Study Site office Closed|1
1111044|NCT01763047|3641329|P1|Period 1|Study Site office Closed|0
1111045|NCT01763047|3641328|P2|Period 1|Lens Power Not Available|1
1111046|NCT01763047|3641329|P1|Period 1|Lens Power Not Available|0
1111047|NCT01763047|3641328|P2|Period 1|Unsatisfactory Visual Response|3
1111048|NCT01763047|3641329|P1|Period 1|Unsatisfactory Visual Response|0
1111049|NCT01763047|3641328|P2|Period 1|Adverse Event|1
1111050|NCT01763047|3641329|P1|Period 1|Adverse Event|0
1111051|NCT01763047|3641328|P2|Period 1|No Longer Meets Eligibility criteria|0
1111052|NCT01763047|3641329|P1|Period 1|No Longer Meets Eligibility criteria|1
1111053|NCT01763047|3641328|P2|Period 1|Protocol Violation|4
1111054|NCT01763047|3641329|P1|Period 1|Protocol Violation|4
1111055|NCT01763047|3641328|P2|Period 1|Test Article Not Available|1
1111056|NCT01763047|3641329|P1|Period 1|Test Article Not Available|4
1111057|NCT01762943|3641368|P2|Overall Study|Withdrawal by Subject|1
1111058|NCT01762943|3641369|P1|Overall Study|Withdrawal by Subject|2
1111059|NCT01762943|3641368|P2|Overall Study|Protocol Violation|0
1111060|NCT01762943|3641369|P1|Overall Study|Protocol Violation|1
1111061|NCT01762943|3641368|P2|Overall Study|Physician Decision|1
1111062|NCT01762943|3641369|P1|Overall Study|Physician Decision|1
1111063|NCT01762800|3641386|P2|Overall Study|Withdrawal by Subject|4
1111064|NCT01762800|3641387|P1|Overall Study|Withdrawal by Subject|7
1111065|NCT01762800|3641386|P2|Overall Study|Physician Decision|1
1111066|NCT01762800|3641387|P1|Overall Study|Physician Decision|1
1111067|NCT01762800|3641386|P2|Overall Study|Study Closed/Terminated|1
1111068|NCT01762800|3641387|P1|Overall Study|Study Closed/Terminated|0
1111069|NCT01762800|3641386|P2|Overall Study|Lack of Efficacy|2
1111070|NCT01762800|3641387|P1|Overall Study|Lack of Efficacy|3
1111071|NCT01762800|3641386|P2|Overall Study|Adverse Event|13
1111072|NCT01762800|3641387|P1|Overall Study|Adverse Event|8
1111073|NCT01762761|3641461|P2|Overall Study|Physician Decision|1
1111074|NCT01762761|3641462|P1|Overall Study|Physician Decision|0
1111075|NCT01762761|3641461|P2|Overall Study|Protocol Violation|1
1111076|NCT01762761|3641462|P1|Overall Study|Protocol Violation|0
1111077|NCT01762761|3641461|P2|Overall Study|Lack of Efficacy|0
1111078|NCT01762761|3641462|P1|Overall Study|Lack of Efficacy|1
1111079|NCT01762761|3641461|P2|Overall Study|Adverse Event|2
1111080|NCT01762761|3641462|P1|Overall Study|Adverse Event|1
1111081|NCT01762345|3641540|P1|Overall Study|Protocol Violation|2
1111082|NCT01762345|3641540|P1|Overall Study|Adverse Event|5
1111083|NCT01761565|3641588|P1|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1
1111084|NCT01761266|3641612|P2|Overall Study|Ongoing as of data-cut off|107
1111085|NCT01761266|3641613|P1|Overall Study|Ongoing as of data-cut off|109
1111086|NCT01761266|3641612|P2|Overall Study|Withdrawal by Subject|8
1111087|NCT01761266|3641613|P1|Overall Study|Withdrawal by Subject|13
1111088|NCT01761266|3641612|P2|Overall Study|Lost to Follow-up|11
1111089|NCT01761266|3641613|P1|Overall Study|Lost to Follow-up|5
1111090|NCT01761266|3641612|P2|Overall Study|Death|350
1111091|NCT01761266|3641613|P1|Overall Study|Death|351
1111092|NCT01761162|3641670|P1|Overall Study|Withdrawal by Subject|3
1111093|NCT01760954|3641707|P4|Post-treatment Follow-up (12 Months)|Other|6
1111094|NCT01760954|3641708|P3|Post-treatment Follow-up (12 Months)|Other|9
1111095|NCT01760954|3641709|P2|Post-treatment Follow-up (12 Months)|Other|8
1111096|NCT01760954|3641710|P1|Post-treatment Follow-up (12 Months)|Other|13
1111097|NCT01760954|3641707|P4|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
1111098|NCT01760954|3641708|P3|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1
1111099|NCT01760954|3641709|P2|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
1111100|NCT01760954|3641710|P1|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
1111101|NCT01760954|3641707|P4|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0
1111102|NCT01760954|3641708|P3|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0
1111103|NCT01760954|3641709|P2|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4
1111104|NCT01760954|3641710|P1|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1
1111105|NCT01760954|3641707|P4|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5
1111106|NCT01760954|3641708|P3|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5
1111107|NCT01760954|3641709|P2|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10
1111108|NCT01760954|3641710|P1|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6
1111109|NCT01760954|3641707|P4|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0
1111110|NCT01760954|3641708|P3|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2
1111111|NCT01760954|3641709|P2|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7
1111112|NCT01760954|3641710|P1|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4
1111113|NCT01760954|3641707|P4|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9
1111114|NCT01760954|3641708|P3|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4
1111115|NCT01760954|3641709|P2|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
1111116|NCT01760954|3641710|P1|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
1111117|NCT01760954|3641707|P4|Treatment Period (6 Months)|Exclusionary Medication|0
1111118|NCT01760954|3641708|P3|Treatment Period (6 Months)|Exclusionary Medication|0
1111119|NCT01760954|3641709|P2|Treatment Period (6 Months)|Exclusionary Medication|0
1111120|NCT01760954|3641710|P1|Treatment Period (6 Months)|Exclusionary Medication|1
1111121|NCT01760954|3641707|P4|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0
1111122|NCT01760954|3641708|P3|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0
1111123|NCT01760954|3641709|P2|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6
1111124|NCT01760954|3641710|P1|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1
1111125|NCT01760954|3641707|P4|Treatment Period (6 Months)|Other|1
1111126|NCT01760954|3641708|P3|Treatment Period (6 Months)|Other|3
1111127|NCT01760954|3641709|P2|Treatment Period (6 Months)|Other|3
1111128|NCT01760954|3641710|P1|Treatment Period (6 Months)|Other|0
1111129|NCT01760954|3641707|P4|Treatment Period (6 Months)|Non-compliance|3
1111130|NCT01760954|3641708|P3|Treatment Period (6 Months)|Non-compliance|0
1111131|NCT01760954|3641709|P2|Treatment Period (6 Months)|Non-compliance|4
1111132|NCT01760954|3641710|P1|Treatment Period (6 Months)|Non-compliance|1
1111133|NCT01760954|3641707|P4|Treatment Period (6 Months)|Pregnancy|2
1111134|NCT01760954|3641708|P3|Treatment Period (6 Months)|Pregnancy|3
1111135|NCT01760954|3641709|P2|Treatment Period (6 Months)|Pregnancy|0
1111136|NCT01760954|3641710|P1|Treatment Period (6 Months)|Pregnancy|5
1111137|NCT01760954|3641707|P4|Treatment Period (6 Months)|Surgery or invasive intervention for end|2
1111138|NCT01760954|3641708|P3|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
1111139|NCT01760954|3641709|P2|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
1111140|NCT01760954|3641710|P1|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
1111141|NCT01760954|3641707|P4|Treatment Period (6 Months)|Lost to Follow-up|3
1111142|NCT01760954|3641708|P3|Treatment Period (6 Months)|Lost to Follow-up|4
1111143|NCT01760954|3641709|P2|Treatment Period (6 Months)|Lost to Follow-up|1
1111144|NCT01760954|3641710|P1|Treatment Period (6 Months)|Lost to Follow-up|9
1111145|NCT01760954|3641707|P4|Treatment Period (6 Months)|Adverse Event|10
1111146|NCT01760954|3641708|P3|Treatment Period (6 Months)|Adverse Event|4
1111147|NCT01760954|3641709|P2|Treatment Period (6 Months)|Adverse Event|3
1111148|NCT01760954|3641710|P1|Treatment Period (6 Months)|Adverse Event|5
1111149|NCT01760954|3641707|P4|Treatment Period (6 Months)|Withdrawal by Subject|5
1111150|NCT01760954|3641708|P3|Treatment Period (6 Months)|Withdrawal by Subject|4
1111151|NCT01760954|3641709|P2|Treatment Period (6 Months)|Withdrawal by Subject|8
1111152|NCT01760954|3641710|P1|Treatment Period (6 Months)|Withdrawal by Subject|8
1111153|NCT01760876|3641847|P1|Overall Study|Very poor baseline OCT quality|2
1111154|NCT01760876|3641847|P1|Overall Study|Major depression|1
1111155|NCT01760876|3641847|P1|Overall Study|Impaired renal function|1
1111156|NCT01760876|3641847|P1|Overall Study|Carcinoma of prostate|1
1111157|NCT01760876|3641847|P1|Overall Study|Non-cardiac death (head injury)|1
1111158|NCT01759511|3642144|P1|Overall Study|Withdrawal by Subject|3
1111159|NCT01759511|3642144|P1|Overall Study|Study Terminated by Sponsor|13
1111160|NCT01759511|3642144|P1|Overall Study|Protocol-Specified Criteria for Withdraw|4
1111161|NCT01759511|3642144|P1|Overall Study|Progressive Disease|5
1111162|NCT01759511|3642144|P1|Overall Study|Physician Decision|1
1111163|NCT01759511|3642144|P1|Overall Study|Lack of Efficacy|2
1111164|NCT01759511|3642144|P1|Overall Study|Death|2
1111165|NCT01759511|3642144|P1|Overall Study|Adverse Event|4
1111166|NCT01759446|3642157|P5|Overall Study|Withdrawal by Subject|0
1111167|NCT01759446|3642158|P4|Overall Study|Withdrawal by Subject|1
1111168|NCT01759446|3642159|P3|Overall Study|Withdrawal by Subject|0
1111169|NCT01759446|3642160|P2|Overall Study|Withdrawal by Subject|1
1111170|NCT01759446|3642161|P1|Overall Study|Withdrawal by Subject|0
1111171|NCT01759446|3642157|P5|Overall Study|Protocol Violation|0
1111172|NCT01759446|3642158|P4|Overall Study|Protocol Violation|0
1111173|NCT01759446|3642159|P3|Overall Study|Protocol Violation|1
1111174|NCT01759446|3642160|P2|Overall Study|Protocol Violation|0
1111175|NCT01759446|3642161|P1|Overall Study|Protocol Violation|1
1111176|NCT01759420|3642173|P1|Overall Study|Inaccurate EKG machine readings|1
1111177|NCT01759420|3642173|P1|Overall Study|Screen failure|5
1111178|NCT01759407|3642180|P2|Overall Study|Protocol Violation|2
1111179|NCT01759407|3642181|P1|Overall Study|Protocol Violation|0
1111180|NCT01759381|3642193|P2|Overall Study|Death|0
1111181|NCT01759381|3642194|P1|Overall Study|Death|1
1111182|NCT01759368|3642202|P2|Overall Study|Lost to Follow-up|0
1111183|NCT01759368|3642203|P1|Overall Study|Lost to Follow-up|1
1111184|NCT01759290|3642221|P1|Overall Study|Unknown reason|4
1111185|NCT01759290|3642221|P1|Overall Study|Lost to Follow-up|53
1111186|NCT01759290|3642221|P1|Overall Study|Death|17
1111187|NCT01759290|3642221|P1|Overall Study|Physician Decision|2
1111188|NCT01759290|3642221|P1|Overall Study|Subjects withdrawn consent|5
1111189|NCT01759264|3642281|P1|Overall Study|Discontinued Humira Due to Business Trip|1
1111190|NCT01759264|3642281|P1|Overall Study|Withdrawal by Subject|3
1111191|NCT01759264|3642281|P1|Overall Study|Lost to Follow-up|2
1111192|NCT01759264|3642281|P1|Overall Study|Not Specified|2
1111193|NCT01759264|3642281|P1|Overall Study|Adverse Event|1
1111194|NCT01759264|3642281|P1|Overall Study|Serious Adverse Events (SAEs)|1
1111195|NCT01758900|3642309|P2|Overall Study|difficulty for further intubation|8
1111196|NCT01758900|3642310|P1|Overall Study|difficulty for further intubation|7
1111197|NCT01758289|3642426|P1|Overall Study|Adverse Event|9
1111198|NCT01758289|3642426|P1|Overall Study|Premature Study Termination|44
1111199|NCT01757847|3642452|P2|Overall Study|Withdrawal by Subject|4
1111200|NCT01757847|3642453|P1|Overall Study|Withdrawal by Subject|3
1111201|NCT01757821|3642461|P1|Overall Study|Adverse Event|1
1111202|NCT01757704|3642476|P2|Overall Study|Protocol Violation|3
1111203|NCT01757704|3642477|P1|Overall Study|Protocol Violation|1
1111204|NCT01757691|3642495|P2|Overall Study|Administrative problems|0
1111205|NCT01757691|3642496|P1|Overall Study|Administrative problems|2
1111206|NCT01757405|3642544|P2|Overall Study|Withdrawal by Subject|1
1111207|NCT01757405|3642545|P1|Overall Study|Withdrawal by Subject|0
1111208|NCT01757405|3642544|P2|Overall Study|Lost to Follow-up|1
1111209|NCT01757405|3642545|P1|Overall Study|Lost to Follow-up|1
1111210|NCT01757275|3642563|P2|Overall Study|Not treated|4
1111211|NCT01757275|3642564|P1|Overall Study|Not treated|3
1111212|NCT01757275|3642563|P2|Overall Study|Withdrawal by Subject|4
1111213|NCT01757275|3642564|P1|Overall Study|Withdrawal by Subject|2
1111214|NCT01757275|3642563|P2|Overall Study|Adverse Event|3
1111215|NCT01757275|3642564|P1|Overall Study|Adverse Event|3
1111216|NCT01757275|3642563|P2|Overall Study|Lost to Follow-up|2
1111217|NCT01757275|3642564|P1|Overall Study|Lost to Follow-up|1
1111218|NCT01757197|3642586|P1|Overall Study|Death|2
1111219|NCT01757184|3642595|P2|Double-Blind Period|Adverse Event|0
1111220|NCT01757184|3642596|P1|Double-Blind Period|Adverse Event|1
1111221|NCT01757171|3642620|P2|Overall Study|ECOG decline|0
1111222|NCT01757171|3642621|P1|Overall Study|ECOG decline|1
1111223|NCT01757171|3642620|P2|Overall Study|Hospitalization|0
1111224|NCT01757171|3642621|P1|Overall Study|Hospitalization|1
1111225|NCT01757171|3642620|P2|Overall Study|Disease Progression|0
1111226|NCT01757171|3642621|P1|Overall Study|Disease Progression|1
1111227|NCT01757171|3642620|P2|Overall Study|Adverse Event|1
1111228|NCT01757171|3642621|P1|Overall Study|Adverse Event|5
1111229|NCT01756300|3642655|P1|Overall Study|Withdrawal by Subject|1
1111230|NCT01756300|3642655|P1|Overall Study|Death|1
1111231|NCT01756274|3642677|P1|Overall Study|Laboratory error|1
1111232|NCT01756274|3642677|P1|Overall Study|Protocol Violation|2
1111233|NCT01756235|3642684|P1|Overall Study|Adalimumab Treatment was not Documented|2
1111234|NCT01756157|3642705|P2|First Intervention Period|Lost to Follow-up|2
1111235|NCT01756157|3642706|P1|First Intervention Period|Lost to Follow-up|0
1111236|NCT01756157|3642705|P2|First Intervention Period|Withdrawal by Subject|0
1111237|NCT01756157|3642706|P1|First Intervention Period|Withdrawal by Subject|1
1111238|NCT01756079|3642720|P1|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4
1111239|NCT01756079|3642720|P1|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20
1111240|NCT01756079|3642720|P1|Treatment / Follow-up: Week 4 to Week 72|No information available|2
1111241|NCT01756079|3642720|P1|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5
1111242|NCT01756079|3642720|P1|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4
1111243|NCT01756053|3642726|P2|Period 2 (10 Days)|Protocol Violation|2
1111244|NCT01756053|3642727|P1|Period 2 (10 Days)|Protocol Violation|0
1111245|NCT01756053|3642726|P2|Period 1 (10 Days)|Protocol Violation|1
1111246|NCT01756053|3642727|P1|Period 1 (10 Days)|Protocol Violation|1
1111247|NCT01755702|3642747|P1|Washout Period II|Other Reason|5
1111248|NCT01755702|3642747|P1|Wash Out Period I|Other Reason|3
1111249|NCT01755689|3642794|P5|Overall Study|Pregnancy|2
1111250|NCT01755689|3642795|P4|Overall Study|Pregnancy|4
1111251|NCT01755689|3642796|P3|Overall Study|Pregnancy|2
1111252|NCT01755689|3642797|P2|Overall Study|Pregnancy|1
1111253|NCT01755689|3642798|P1|Overall Study|Pregnancy|1
1111254|NCT01755689|3642794|P5|Overall Study|Lost to Follow-up|2
1111255|NCT01755689|3642795|P4|Overall Study|Lost to Follow-up|0
1111256|NCT01755689|3642796|P3|Overall Study|Lost to Follow-up|1
1111257|NCT01755689|3642797|P2|Overall Study|Lost to Follow-up|0
1111258|NCT01755689|3642798|P1|Overall Study|Lost to Follow-up|1
1111259|NCT01755689|3642794|P5|Overall Study|Migrated/moved from study area|1
1111260|NCT01755689|3642795|P4|Overall Study|Migrated/moved from study area|1
1111261|NCT01755689|3642796|P3|Overall Study|Migrated/moved from study area|1
1111262|NCT01755689|3642797|P2|Overall Study|Migrated/moved from study area|1
1111263|NCT01755689|3642798|P1|Overall Study|Migrated/moved from study area|0
1111264|NCT01755689|3642794|P5|Overall Study|Withdrawal by Subject|1
1111265|NCT01755689|3642795|P4|Overall Study|Withdrawal by Subject|1
1111266|NCT01755689|3642796|P3|Overall Study|Withdrawal by Subject|2
1111267|NCT01755689|3642797|P2|Overall Study|Withdrawal by Subject|3
1111268|NCT01755689|3642798|P1|Overall Study|Withdrawal by Subject|1
1111269|NCT01755637|3642873|P2|Period 1|Adverse Event|1
1111270|NCT01755637|3642874|P1|Period 1|Adverse Event|0
1111271|NCT01755546|3642892|P1|Long Term Treatment|other and ongoing|41
1111272|NCT01755546|3642892|P1|Long Term Treatment|Lost to Follow-up|17
1111273|NCT01755546|3642892|P1|Long Term Treatment|Withdrawal by Subject|35
1111274|NCT01755546|3642892|P1|Long Term Treatment|Protocol Violation|10
1111275|NCT01755546|3642892|P1|Long Term Treatment|Lack of Efficacy|6
1111276|NCT01755546|3642892|P1|Long Term Treatment|Adverse Event|12
1111277|NCT01755546|3642892|P1|Titration Phase|Withdrawal by Subject|8
1111278|NCT01755546|3642892|P1|Titration Phase|Other and Continuing|22
1111279|NCT01755546|3642892|P1|Titration Phase|Lost to Follow-up|2
1111280|NCT01755546|3642892|P1|Titration Phase|Protocol Violation|9
1111281|NCT01755546|3642892|P1|Titration Phase|Lack of Efficacy|18
1111282|NCT01755546|3642892|P1|Titration Phase|Adverse Event|11
1111283|NCT01755546|3642892|P1|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5
1111284|NCT01755546|3642892|P1|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1
1111285|NCT01755546|3642892|P1|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3
1111286|NCT01755546|3642892|P1|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1
1111287|NCT01755416|3642909|P2|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2
1111288|NCT01755416|3642910|P1|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1
1111289|NCT01755234|3642918|P2|Overall Study|unblinded|0
1111290|NCT01755234|3642919|P1|Overall Study|unblinded|1
1111291|NCT01755234|3642918|P2|Overall Study|Withdrawal by Subject|1
1111292|NCT01755234|3642919|P1|Overall Study|Withdrawal by Subject|0
1111293|NCT01755234|3642918|P2|Overall Study|case cancelled|0
1111294|NCT01755234|3642919|P1|Overall Study|case cancelled|1
1111295|NCT01755234|3642918|P2|Overall Study|Change in surgical case|1
1111296|NCT01755234|3642919|P1|Overall Study|Change in surgical case|2
1111297|NCT01755234|3642918|P2|Overall Study|Lost to Follow-up|6
1111298|NCT01755234|3642919|P1|Overall Study|Lost to Follow-up|11
1111299|NCT01755156|3642950|P2|Phase B (Weeks 24-104)|Withdrawal by Subject|31
1111300|NCT01755156|3642951|P1|Phase B (Weeks 24-104)|Withdrawal by Subject|27
1111301|NCT01755156|3642950|P2|Phase B (Weeks 24-104)|Lost to Follow-up|5
1111302|NCT01755156|3642951|P1|Phase B (Weeks 24-104)|Lost to Follow-up|12
1111303|NCT01755156|3642950|P2|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
1111304|NCT01755156|3642951|P1|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
1111305|NCT01755156|3642950|P2|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2
1111306|NCT01755156|3642951|P1|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0
1111307|NCT01755156|3642950|P2|Phase A (Weeks 0-24)|Withdrawal by Subject|13
1111308|NCT01755156|3642951|P1|Phase A (Weeks 0-24)|Withdrawal by Subject|6
1111309|NCT01755156|3642950|P2|Phase A (Weeks 0-24)|Protocol Violation|1
1111310|NCT01755156|3642951|P1|Phase A (Weeks 0-24)|Protocol Violation|1
1111311|NCT01755156|3642950|P2|Phase A (Weeks 0-24)|Physician Decision|1
1111312|NCT01755156|3642951|P1|Phase A (Weeks 0-24)|Physician Decision|0
1111313|NCT01755156|3642950|P2|Phase A (Weeks 0-24)|Non-compliance with study drug|0
1111314|NCT01755156|3642951|P1|Phase A (Weeks 0-24)|Non-compliance with study drug|1
1111315|NCT01755156|3642950|P2|Phase A (Weeks 0-24)|Lost to Follow-up|3
1111316|NCT01755156|3642951|P1|Phase A (Weeks 0-24)|Lost to Follow-up|5
1111317|NCT01755156|3642950|P2|Phase A (Weeks 0-24)|Lack of Efficacy|0
1111318|NCT01755156|3642951|P1|Phase A (Weeks 0-24)|Lack of Efficacy|1
1111319|NCT01755156|3642950|P2|Phase A (Weeks 0-24)|Adverse Event|3
1111320|NCT01755156|3642951|P1|Phase A (Weeks 0-24)|Adverse Event|2
1111321|NCT01755091|3643015|P3|Overall Study|Physician Decision|2
1111322|NCT01755091|3643016|P2|Overall Study|Physician Decision|1
1111323|NCT01755091|3643017|P1|Overall Study|Physician Decision|1
1111324|NCT01755091|3643015|P3|Overall Study|Lost to Follow-up|1
1111325|NCT01755091|3643016|P2|Overall Study|Lost to Follow-up|0
1111326|NCT01755091|3643017|P1|Overall Study|Lost to Follow-up|1
1111327|NCT01755091|3643015|P3|Overall Study|Adverse Event|1
1111328|NCT01755091|3643016|P2|Overall Study|Adverse Event|1
1111329|NCT01755091|3643017|P1|Overall Study|Adverse Event|1
1111330|NCT01755091|3643015|P3|Overall Study|Withdrawal by Subject|3
1111331|NCT01755091|3643016|P2|Overall Study|Withdrawal by Subject|1
1111332|NCT01755091|3643017|P1|Overall Study|Withdrawal by Subject|6
1111333|NCT01755026|3643042|P2|Overall Study|Withdrawal by Subject|1
1111334|NCT01755026|3643043|P1|Overall Study|Withdrawal by Subject|1
1111335|NCT01755026|3643042|P2|Overall Study|Adverse Event|0
1111336|NCT01755026|3643043|P1|Overall Study|Adverse Event|1
1111337|NCT01754922|3643066|P2|Overall Study|Adverse Event|1
1111338|NCT01754922|3643067|P1|Overall Study|Adverse Event|0
1111339|NCT01754766|3643080|P3|Overall Study|Personal reasons|0
1111340|NCT01754766|3643081|P2|Overall Study|Personal reasons|1
1111341|NCT01754766|3643082|P1|Overall Study|Personal reasons|1
1111342|NCT01754727|3643096|P1|Overall Study|Adalimumab Treatment was not Documented|2
1111343|NCT01754493|3643223|P1|Overall Study|Scheduling conflict|1
1111344|NCT01754493|3643223|P1|Overall Study|Moved out of town|1
1111345|NCT01754493|3643223|P1|Overall Study|Withdrawal by Subject|1
1111346|NCT01754493|3643223|P1|Overall Study|Lost to Follow-up|3
1111347|NCT01754493|3643223|P1|Overall Study|Adverse Event|1
1111348|NCT01754467|3643248|P1|Overall Study|Lost to Follow-up|1
1111349|NCT01754402|3643258|P3|Overall Study|Lack of Efficacy|1
1111350|NCT01754402|3643259|P2|Overall Study|Lack of Efficacy|0
1111351|NCT01754402|3643260|P1|Overall Study|Lack of Efficacy|0
1111352|NCT01754402|3643258|P3|Overall Study|Withdrawal by Subject|1
1111353|NCT01754402|3643259|P2|Overall Study|Withdrawal by Subject|0
1111354|NCT01754402|3643260|P1|Overall Study|Withdrawal by Subject|0
1111355|NCT01754402|3643258|P3|Overall Study|Adverse Event|1
1111356|NCT01754402|3643259|P2|Overall Study|Adverse Event|2
1111357|NCT01754402|3643260|P1|Overall Study|Adverse Event|2
1111358|NCT01754402|3643258|P3|Overall Study|Death|1
1111359|NCT01754402|3643259|P2|Overall Study|Death|0
1111360|NCT01754402|3643260|P1|Overall Study|Death|0
1111361|NCT01754376|3643294|P1|Overall Study|Lack of Efficacy|2
1111362|NCT01754376|3643294|P1|Overall Study|Adverse Event|1
1111363|NCT01754259|3643305|P2|Overall Study|Lost to Follow-up|1
1111364|NCT01754259|3643306|P1|Overall Study|Lost to Follow-up|0
1111365|NCT01754259|3643305|P2|Overall Study|Adverse Event|1
1111366|NCT01754259|3643306|P1|Overall Study|Adverse Event|3
1111367|NCT01754259|3643305|P2|Overall Study|Withdrawal by Subject|4
1111368|NCT01754259|3643306|P1|Overall Study|Withdrawal by Subject|2
1111369|NCT01754194|3643316|P2|Overall Study|Not Specified|8
1111370|NCT01754194|3643317|P1|Overall Study|Not Specified|9
1111371|NCT01754194|3643316|P2|Overall Study|Withdrawal by Subject|5
1111372|NCT01754194|3643317|P1|Overall Study|Withdrawal by Subject|4
1111373|NCT01754194|3643316|P2|Overall Study|Lost to Follow-up|14
1111374|NCT01754194|3643317|P1|Overall Study|Lost to Follow-up|39
1111375|NCT01754129|3643337|P1|Overall Study|Inclusion/exclusion criteria violation|3
1111376|NCT01754129|3643337|P1|Overall Study|Withdrew consent|1
1111377|NCT01754129|3643337|P1|Overall Study|Lost to Follow-up|7
1111378|NCT01754129|3643337|P1|Overall Study|Duodopa discontinuation|9
1111379|NCT01754129|3643337|P1|Overall Study|Death|13
1111380|NCT01753999|3643360|P2|Period 2 -Cross to Alternate Arm|Physician Decision|2
1111381|NCT01753999|3643361|P1|Period 2 -Cross to Alternate Arm|Physician Decision|0
1111382|NCT01753999|3643360|P2|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|4
1111383|NCT01753999|3643361|P1|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|2
1111384|NCT01753999|3643360|P2|Period 2 -Cross to Alternate Arm|Lost to Follow-up|20
1111385|NCT01753999|3643361|P1|Period 2 -Cross to Alternate Arm|Lost to Follow-up|15
1111386|NCT01753999|3643360|P2|Period 1 - Initial Assignment|Lost to Follow-up|27
1111387|NCT01753999|3643361|P1|Period 1 - Initial Assignment|Lost to Follow-up|17
1111388|NCT01753999|3643360|P2|Period 1 - Initial Assignment|Withdrawal by Subject|20
1111389|NCT01753999|3643361|P1|Period 1 - Initial Assignment|Withdrawal by Subject|21
1111390|NCT01753999|3643360|P2|Period 1 - Initial Assignment|Physician Decision|3
1111391|NCT01753999|3643361|P1|Period 1 - Initial Assignment|Physician Decision|1
1111392|NCT01753856|3643371|P2|Overall Study|Sponsor Decision|0
1111393|NCT01753856|3643372|P1|Overall Study|Sponsor Decision|2
1111394|NCT01753856|3643371|P2|Overall Study|Withdrawal by Subject|2
1111395|NCT01753856|3643372|P1|Overall Study|Withdrawal by Subject|0
1111396|NCT01753856|3643371|P2|Overall Study|Adverse Event|0
1111397|NCT01753856|3643372|P1|Overall Study|Adverse Event|1
1111398|NCT01753570|3643444|P3|Overall Study|Withdrawal by Subject|0
1111399|NCT01753570|3643445|P2|Overall Study|Withdrawal by Subject|4
1111400|NCT01753570|3643446|P1|Overall Study|Withdrawal by Subject|1
1111401|NCT01753570|3643444|P3|Overall Study|Physician Decision|0
1111402|NCT01753570|3643445|P2|Overall Study|Physician Decision|1
1111403|NCT01753570|3643446|P1|Overall Study|Physician Decision|0
1111404|NCT01753570|3643444|P3|Overall Study|Adverse Event|1
1111405|NCT01753570|3643445|P2|Overall Study|Adverse Event|0
1111406|NCT01753570|3643446|P1|Overall Study|Adverse Event|1
1111407|NCT01753518|3643489|P2|Postpartum Follow-up|Lost to Follow-up|15
1111408|NCT01753518|3643490|P1|Postpartum Follow-up|Lost to Follow-up|22
1111409|NCT01753518|3643489|P2|Intention-to-Treat Analysis|Body Mass Index>50|1
1111410|NCT01753518|3643490|P1|Intention-to-Treat Analysis|Body Mass Index>50|0
1111411|NCT01753518|3643489|P2|Intention-to-Treat Analysis|Multifetal gestation|3
1111412|NCT01753518|3643490|P1|Intention-to-Treat Analysis|Multifetal gestation|2
1111413|NCT01753518|3643489|P2|Intention-to-Treat Analysis|Missing consent form|3
1111414|NCT01753518|3643490|P1|Intention-to-Treat Analysis|Missing consent form|5
1111415|NCT01753336|3643512|P1|Overall Study|Withdrawal by Subject|1
1111416|NCT01753336|3643512|P1|Overall Study|Sponsor's decision|2
1111417|NCT01753336|3643512|P1|Overall Study|Physician Decision|2
1111418|NCT01753336|3643512|P1|Overall Study|Lost to Follow-up|3
1111419|NCT01753336|3643512|P1|Overall Study|Patient decision|12
1111420|NCT01753323|3643524|P3|Overall Study|Adverse Event|1
1111421|NCT01753323|3643525|P2|Overall Study|Adverse Event|0
1111422|NCT01753323|3643526|P1|Overall Study|Adverse Event|0
1111423|NCT01753323|3643524|P3|Overall Study|Protocol deviation|0
1111424|NCT01753323|3643525|P2|Overall Study|Protocol deviation|0
1111425|NCT01753323|3643526|P1|Overall Study|Protocol deviation|1
1111426|NCT01753323|3643524|P3|Overall Study|Lack of Efficacy|8
1111427|NCT01753323|3643525|P2|Overall Study|Lack of Efficacy|0
1111428|NCT01753323|3643526|P1|Overall Study|Lack of Efficacy|0
1111429|NCT01753310|3643564|P2|Overall Study|Withdrawal by Subject|0
1111430|NCT01753310|3643565|P1|Overall Study|Withdrawal by Subject|1
1111431|NCT01753310|3643564|P2|Overall Study|Sponsor decision|0
1111432|NCT01753310|3643565|P1|Overall Study|Sponsor decision|1
1111433|NCT01753310|3643564|P2|Overall Study|Subject decision|2
1111434|NCT01753310|3643565|P1|Overall Study|Subject decision|2
1111435|NCT01753310|3643564|P2|Overall Study|Lost to Follow-up|0
1111436|NCT01753310|3643565|P1|Overall Study|Lost to Follow-up|2
1111437|NCT01753310|3643564|P2|Overall Study|Adverse Event|0
1111438|NCT01753310|3643565|P1|Overall Study|Adverse Event|1
1111439|NCT01753310|3643564|P2|Overall Study|Entered into open label extension study|22
1111440|NCT01753310|3643565|P1|Overall Study|Entered into open label extension study|25
1111441|NCT01753115|3643588|P3|Overall Study|Used excluded drug|0
1111442|NCT01753115|3643589|P2|Overall Study|Used excluded drug|1
1111443|NCT01753115|3643590|P1|Overall Study|Used excluded drug|0
1111444|NCT01753115|3643588|P3|Overall Study|Subject non-compliant|0
1111445|NCT01753115|3643589|P2|Overall Study|Subject non-compliant|3
1111446|NCT01753115|3643590|P1|Overall Study|Subject non-compliant|3
1111447|NCT01753115|3643588|P3|Overall Study|Withdrawal by Subject|6
1111448|NCT01753115|3643589|P2|Overall Study|Withdrawal by Subject|5
1111449|NCT01753115|3643590|P1|Overall Study|Withdrawal by Subject|6
1111450|NCT01753115|3643588|P3|Overall Study|Lost to Follow-up|8
1111451|NCT01753115|3643589|P2|Overall Study|Lost to Follow-up|6
1111452|NCT01753115|3643590|P1|Overall Study|Lost to Follow-up|3
1111453|NCT01753076|3643600|P2|Overall Study|Other-Reached Protocol-defined Stopping|0
1111454|NCT01753076|3643601|P1|Overall Study|Other-Reached Protocol-defined Stopping|1
1111455|NCT01753076|3643600|P2|Overall Study|Withdrawal by Subject|24
1111456|NCT01753076|3643601|P1|Overall Study|Withdrawal by Subject|14
1111457|NCT01753076|3643600|P2|Overall Study|Physician Decision|2
1111458|NCT01753076|3643601|P1|Overall Study|Physician Decision|4
1111459|NCT01753076|3643600|P2|Overall Study|Lost to Follow-up|1
1111460|NCT01753076|3643601|P1|Overall Study|Lost to Follow-up|2
1111461|NCT01753076|3643600|P2|Overall Study|Lack of Efficacy|1
1111462|NCT01753076|3643601|P1|Overall Study|Lack of Efficacy|3
1111463|NCT01753076|3643600|P2|Overall Study|Adverse Event|18
1111464|NCT01753076|3643601|P1|Overall Study|Adverse Event|17
1111465|NCT01752907|3643627|P2|Overall Study|Decision by Sponsor|9
1111466|NCT01752907|3643628|P1|Overall Study|Decision by Sponsor|6
1111467|NCT01752907|3643627|P2|Overall Study|Lost to Follow-up|1
1111468|NCT01752907|3643628|P1|Overall Study|Lost to Follow-up|2
1111469|NCT01752907|3643627|P2|Overall Study|Withdrawal by Subject|10
1111470|NCT01752907|3643628|P1|Overall Study|Withdrawal by Subject|4
1111471|NCT01752855|3643648|P2|Overall Study|Lack of Efficacy|2
1111472|NCT01752855|3643649|P1|Overall Study|Lack of Efficacy|0
1111473|NCT01752855|3643648|P2|Overall Study|Withdrew Consent|2
1111474|NCT01752855|3643649|P1|Overall Study|Withdrew Consent|0
1111475|NCT01752855|3643648|P2|Overall Study|Adverse Event|0
1111476|NCT01752855|3643649|P1|Overall Study|Adverse Event|1
1111477|NCT01752023|3643695|P2|Overall Study|Physician Decision|1
1111478|NCT01752023|3643696|P1|Overall Study|Physician Decision|2
1111479|NCT01751906|3643732|P2|Overall Study|Other|0
1111480|NCT01751906|3643733|P1|Overall Study|Other|1
1111481|NCT01751906|3643732|P2|Overall Study|Death|22
1111482|NCT01751906|3643733|P1|Overall Study|Death|38
1111483|NCT01751906|3643732|P2|Overall Study|Physician Decision|1
1111484|NCT01751906|3643733|P1|Overall Study|Physician Decision|3
1111485|NCT01751906|3643732|P2|Overall Study|Withdrawal by Subject|6
1111486|NCT01751906|3643733|P1|Overall Study|Withdrawal by Subject|14
1111487|NCT01751906|3643732|P2|Overall Study|Lost to Follow-up|18
1111488|NCT01751906|3643733|P1|Overall Study|Lost to Follow-up|28
1111489|NCT01751867|3643937|P2|Overall Study|Randomized but not treated.|1
1111490|NCT01751867|3643938|P1|Overall Study|Randomized but not treated.|2
1111491|NCT01751867|3643937|P2|Overall Study|Other|37
1111492|NCT01751867|3643938|P1|Overall Study|Other|11
1111493|NCT01751867|3643937|P2|Overall Study|Death|5
1111494|NCT01751867|3643938|P1|Overall Study|Death|0
1111495|NCT01751867|3643937|P2|Overall Study|Protocol Violation|2
1111496|NCT01751867|3643938|P1|Overall Study|Protocol Violation|0
1111497|NCT01751867|3643937|P2|Overall Study|Physician Decision|7
1111498|NCT01751867|3643938|P1|Overall Study|Physician Decision|4
1111499|NCT01751867|3643937|P2|Overall Study|Withdrawal by Subject|1
1111500|NCT01751867|3643938|P1|Overall Study|Withdrawal by Subject|3
1111501|NCT01751867|3643937|P2|Overall Study|Poor Compliance|5
1111502|NCT01751867|3643938|P1|Overall Study|Poor Compliance|0
1111503|NCT01751867|3643937|P2|Overall Study|Adverse Event|15
1111504|NCT01751867|3643938|P1|Overall Study|Adverse Event|8
1111505|NCT01751867|3643937|P2|Overall Study|Diease Progression|18
1111506|NCT01751867|3643938|P1|Overall Study|Diease Progression|4
1111507|NCT01751867|3643937|P2|Overall Study|Completed treatment,dropped in follow-up|8
1111508|NCT01751867|3643938|P1|Overall Study|Completed treatment,dropped in follow-up|4
1111509|NCT01751802|3643958|P2|Overall Study|Adverse Event|2
1111510|NCT01751802|3643959|P1|Overall Study|Adverse Event|4
1111511|NCT01751724|3643973|P2|Overall Study|withdrawn by parent|2
1111512|NCT01751724|3643974|P1|Overall Study|withdrawn by parent|0
1111513|NCT01751724|3643973|P2|Overall Study|extubated bef.start assigned treatment|0
1111514|NCT01751724|3643974|P1|Overall Study|extubated bef.start assigned treatment|1
1111515|NCT01751412|3644000|P1|Overall Study|Disease Progression Before Treatment|1
1111516|NCT01751178|3644089|P3|Overall Study|Other Reason (unknown)|2
1111517|NCT01751178|3644090|P2|Overall Study|Other Reason (unknown)|0
1111518|NCT01751178|3644091|P1|Overall Study|Other Reason (unknown)|1
1111519|NCT01751178|3644089|P3|Overall Study|Adverse Event|0
1111520|NCT01751178|3644090|P2|Overall Study|Adverse Event|0
1111521|NCT01751178|3644091|P1|Overall Study|Adverse Event|2
1111522|NCT01751165|3644111|P3|Overall Study|Lost to Follow-up|1
1111523|NCT01751165|3644112|P2|Overall Study|Lost to Follow-up|1
1111524|NCT01751165|3644113|P1|Overall Study|Lost to Follow-up|1
1111525|NCT01751165|3644111|P3|Overall Study|Serious adverse event|0
1111526|NCT01751165|3644112|P2|Overall Study|Serious adverse event|2
1111527|NCT01751165|3644113|P1|Overall Study|Serious adverse event|0
1111528|NCT01751165|3644111|P3|Overall Study|Withdrawal by Subject|1
1111529|NCT01751165|3644112|P2|Overall Study|Withdrawal by Subject|0
1111530|NCT01751165|3644113|P1|Overall Study|Withdrawal by Subject|0
1111531|NCT01751165|3644111|P3|Overall Study|Adverse event, serious fatal|1
1111532|NCT01751165|3644112|P2|Overall Study|Adverse event, serious fatal|0
1111533|NCT01751165|3644113|P1|Overall Study|Adverse event, serious fatal|1
1111534|NCT01751113|3644153|P6|Treatment Period 3 (4 Weeks)|Adverse Event|1
1111535|NCT01751113|3644154|P5|Treatment Period 3 (4 Weeks)|Adverse Event|0
1111536|NCT01751113|3644155|P4|Treatment Period 3 (4 Weeks)|Adverse Event|0
1111537|NCT01751113|3644156|P3|Treatment Period 3 (4 Weeks)|Adverse Event|0
1111538|NCT01751113|3644157|P2|Treatment Period 3 (4 Weeks)|Adverse Event|0
1111539|NCT01751113|3644158|P1|Treatment Period 3 (4 Weeks)|Adverse Event|0
1111540|NCT01751113|3644153|P6|Treatment Period 1 (4 Weeks)|Adverse Event|0
1111541|NCT01751113|3644154|P5|Treatment Period 1 (4 Weeks)|Adverse Event|1
1111542|NCT01751113|3644155|P4|Treatment Period 1 (4 Weeks)|Adverse Event|1
1111543|NCT01751113|3644156|P3|Treatment Period 1 (4 Weeks)|Adverse Event|0
1111544|NCT01751113|3644157|P2|Treatment Period 1 (4 Weeks)|Adverse Event|0
1111545|NCT01751113|3644158|P1|Treatment Period 1 (4 Weeks)|Adverse Event|0
1111546|NCT01751087|3644199|P3|Overall Study|Physician Decision|1
1111547|NCT01751087|3644200|P2|Overall Study|Physician Decision|0
1111548|NCT01751087|3644201|P1|Overall Study|Physician Decision|0
1111549|NCT01751087|3644199|P3|Overall Study|Withdrawal by Subject|0
1111550|NCT01751087|3644200|P2|Overall Study|Withdrawal by Subject|0
1111551|NCT01751087|3644201|P1|Overall Study|Withdrawal by Subject|1
1111552|NCT01750840|3644289|P1|Overall Study|Lost to Follow-up|4
1111553|NCT01750684|3644296|P2|Overall Study|Protocol Violation|0
1111554|NCT01750684|3644297|P1|Overall Study|Protocol Violation|1
1111555|NCT01750684|3644296|P2|Overall Study|Withdrawn by Sponsor|1
1111556|NCT01750684|3644297|P1|Overall Study|Withdrawn by Sponsor|0
1111557|NCT01750684|3644296|P2|Overall Study|Non-compliance with Study Drug|1
1111558|NCT01750684|3644297|P1|Overall Study|Non-compliance with Study Drug|0
1111559|NCT01750684|3644296|P2|Overall Study|Death|0
1111560|NCT01750684|3644297|P1|Overall Study|Death|1
1111561|NCT01750346|3644334|P3|Overall Study|Adverse Event|0
1111562|NCT01750346|3644335|P2|Overall Study|Adverse Event|0
1111563|NCT01750346|3644336|P1|Overall Study|Adverse Event|1
1111564|NCT01750294|3644362|P1|Overall Study|Safety Endpoint|1
1111565|NCT01750294|3644362|P1|Overall Study|Withdrawal by Subject|1
1111566|NCT01750281|3644369|P3|Overall Study|Did not receive treatment|0
1111567|NCT01750281|3644370|P2|Overall Study|Did not receive treatment|1
1111568|NCT01750281|3644371|P1|Overall Study|Did not receive treatment|0
1111569|NCT01750281|3644369|P3|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9
1111570|NCT01750281|3644370|P2|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7
1111571|NCT01750281|3644371|P1|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6
1111572|NCT01750281|3644369|P3|Overall Study|Discontinued Selumetinib/Placebo|75
1111573|NCT01750281|3644370|P2|Overall Study|Discontinued Selumetinib/Placebo|77
1111574|NCT01750281|3644371|P1|Overall Study|Discontinued Selumetinib/Placebo|37
1111575|NCT01750242|3644401|P1|Overall Study|Unreadable Images|3
1111576|NCT01750229|3644406|P1|Long-term Follow-up Phase|Withdrawal by Subject|1
1111577|NCT01750229|3644406|P1|Long-term Follow-up Phase|Adverse Event|2
1111578|NCT01750229|3644406|P1|Randomized Crossover Phase|Withdrawal by Subject|1
1111579|NCT01750229|3644406|P1|Randomized Crossover Phase|Adverse Event|1
1111580|NCT01749982|3644429|P4|Overall Study|Withdrawal by Subject|1
1111581|NCT01749982|3644430|P3|Overall Study|Withdrawal by Subject|0
1111582|NCT01749982|3644431|P2|Overall Study|Withdrawal by Subject|0
1111583|NCT01749982|3644432|P1|Overall Study|Withdrawal by Subject|0
1111584|NCT01749982|3644429|P4|Overall Study|Lost to Follow-up|1
1111585|NCT01749982|3644430|P3|Overall Study|Lost to Follow-up|0
1111586|NCT01749982|3644431|P2|Overall Study|Lost to Follow-up|0
1111587|NCT01749982|3644432|P1|Overall Study|Lost to Follow-up|0
1111588|NCT01749982|3644429|P4|Overall Study|Physician Decision|1
1111589|NCT01749982|3644430|P3|Overall Study|Physician Decision|0
1111590|NCT01749982|3644431|P2|Overall Study|Physician Decision|0
1111591|NCT01749982|3644432|P1|Overall Study|Physician Decision|0
1111592|NCT01749800|3644497|P3|Overall Study|Withdrawal by Subject|0
1111593|NCT01749800|3644498|P2|Overall Study|Withdrawal by Subject|1
1111594|NCT01749800|3644499|P1|Overall Study|Withdrawal by Subject|0
1111595|NCT01749800|3644497|P3|Overall Study|not meeting inclusion criteria|0
1111596|NCT01749800|3644498|P2|Overall Study|not meeting inclusion criteria|0
1111597|NCT01749800|3644499|P1|Overall Study|not meeting inclusion criteria|3
1111598|NCT01749735|3644509|P2|Overall Study|Withdrawal by Subject|0
1111599|NCT01749735|3644510|P1|Overall Study|Withdrawal by Subject|1
1111600|NCT01748890|3644599|P1|Overall Study|Insufficient recruitment for analysis|4
1111601|NCT01748760|3644654|P2|Overall Study|Lost to Follow-up|1
1111602|NCT01748760|3644655|P1|Overall Study|Lost to Follow-up|5
1111603|NCT01748760|3644654|P2|Overall Study|Withdrawal by Subject|1
1111604|NCT01748760|3644655|P1|Overall Study|Withdrawal by Subject|1
1111605|NCT01748292|3644691|P2|Overall Study|Withdrawal by Subject|2
1111606|NCT01748292|3644692|P1|Overall Study|Withdrawal by Subject|0
1111607|NCT01748292|3644691|P2|Overall Study|Death|3
1111608|NCT01748292|3644692|P1|Overall Study|Death|0
1111609|NCT01748292|3644691|P2|Overall Study|Lost to Follow-up|3
1111610|NCT01748292|3644692|P1|Overall Study|Lost to Follow-up|0
1111611|NCT01748292|3644691|P2|Overall Study|Adverse Event|4
1111612|NCT01748292|3644692|P1|Overall Study|Adverse Event|2
1111613|NCT01748162|3644722|P2|Overall Study|reasons not available|2
1111614|NCT01748162|3644723|P1|Overall Study|reasons not available|3
1111615|NCT01748162|3644722|P2|Overall Study|participant consented but did not begin|1
1111616|NCT01748162|3644723|P1|Overall Study|participant consented but did not begin|0
1111617|NCT01748162|3644722|P2|Overall Study|no additional croup episodes to evaluate|2
1111618|NCT01748162|3644723|P1|Overall Study|no additional croup episodes to evaluate|2
1111619|NCT01748071|3644734|P3|Overall Study|Adverse Event|0
1111620|NCT01748071|3644735|P2|Overall Study|Adverse Event|2
1111621|NCT01748071|3644736|P1|Overall Study|Adverse Event|2
1111622|NCT01747811|3645023|P2|Overall Study|Lack of Efficacy|4
1111623|NCT01747811|3645024|P1|Overall Study|Lack of Efficacy|2
1111624|NCT01747772|3645040|P1|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9
1111625|NCT01747655|3645048|P2|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0
1111626|NCT01747655|3645049|P1|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1
1111627|NCT01747655|3645048|P2|PEG-J Period (Duodopa Treatment)|Patient Decision|0
1111628|NCT01747655|3645049|P1|PEG-J Period (Duodopa Treatment)|Patient Decision|8
1111629|NCT01747655|3645048|P2|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0
1111630|NCT01747655|3645049|P1|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5
1111631|NCT01747629|3645079|P2|Overall Study|Not specified|1
1111632|NCT01747629|3645080|P1|Overall Study|Not specified|2
1111633|NCT01747629|3645079|P2|Overall Study|Not treated|0
1111634|NCT01747629|3645080|P1|Overall Study|Not treated|1
1111635|NCT01747629|3645079|P2|Overall Study|Inclusion criteria not met|0
1111636|NCT01747629|3645080|P1|Overall Study|Inclusion criteria not met|1
1111637|NCT01747629|3645079|P2|Overall Study|Noncompliance|1
1111638|NCT01747629|3645080|P1|Overall Study|Noncompliance|1
1111639|NCT01747629|3645079|P2|Overall Study|Withdrawal by Subject|2
1111640|NCT01747629|3645080|P1|Overall Study|Withdrawal by Subject|2
1111641|NCT01747629|3645079|P2|Overall Study|Adverse Event|2
1111642|NCT01747629|3645080|P1|Overall Study|Adverse Event|1
1111643|NCT01747551|3645114|P2|Overall Study|Other|0
1111644|NCT01747551|3645115|P1|Overall Study|Other|2
1111645|NCT01747551|3645114|P2|Overall Study|Physician Decision|1
1111646|NCT01747551|3645115|P1|Overall Study|Physician Decision|2
1111647|NCT01747551|3645114|P2|Overall Study|Withdrawal by Subject|1
1111648|NCT01747551|3645115|P1|Overall Study|Withdrawal by Subject|3
1111649|NCT01747551|3645114|P2|Overall Study|Prolonged Treatment Delay|0
1111650|NCT01747551|3645115|P1|Overall Study|Prolonged Treatment Delay|2
1111651|NCT01747551|3645114|P2|Overall Study|Adverse Event|1
1111652|NCT01747551|3645115|P1|Overall Study|Adverse Event|7
1111653|NCT01747551|3645114|P2|Overall Study|Death|1
1111654|NCT01747551|3645115|P1|Overall Study|Death|3
1111655|NCT01747551|3645114|P2|Overall Study|Progressive Disease|17
1111656|NCT01747551|3645115|P1|Overall Study|Progressive Disease|24
1111657|NCT01746901|3645171|P9|Treatment Phase: Fourth Intervention|Protocol Violation|1
1111658|NCT01746901|3645172|P8|Treatment Phase: Fourth Intervention|Protocol Violation|0
1111659|NCT01746901|3645173|P7|Treatment Phase: Fourth Intervention|Protocol Violation|1
1111660|NCT01746901|3645174|P6|Treatment Phase: Fourth Intervention|Protocol Violation|0
1111661|NCT01746901|3645175|P5|Treatment Phase: Fourth Intervention|Protocol Violation|0
1111662|NCT01746901|3645176|P4|Treatment Phase: Fourth Intervention|Protocol Violation|0
1111663|NCT01746901|3645177|P3|Treatment Phase: Fourth Intervention|Protocol Violation|0
1111664|NCT01746901|3645178|P2|Treatment Phase: Fourth Intervention|Protocol Violation|0
1111665|NCT01746901|3645179|P1|Treatment Phase: Fourth Intervention|Protocol Violation|0
1111666|NCT01746901|3645171|P9|Treatment Phase: Fourth Intervention|Adverse Event|1
1111667|NCT01746901|3645172|P8|Treatment Phase: Fourth Intervention|Adverse Event|0
1111668|NCT01746901|3645173|P7|Treatment Phase: Fourth Intervention|Adverse Event|0
1111669|NCT01746901|3645174|P6|Treatment Phase: Fourth Intervention|Adverse Event|1
1111670|NCT01746901|3645175|P5|Treatment Phase: Fourth Intervention|Adverse Event|0
1111671|NCT01746901|3645176|P4|Treatment Phase: Fourth Intervention|Adverse Event|0
1111672|NCT01746901|3645177|P3|Treatment Phase: Fourth Intervention|Adverse Event|0
1111673|NCT01746901|3645178|P2|Treatment Phase: Fourth Intervention|Adverse Event|0
1111674|NCT01746901|3645179|P1|Treatment Phase: Fourth Intervention|Adverse Event|0
1111675|NCT01746901|3645171|P9|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
1111676|NCT01746901|3645172|P8|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
1111677|NCT01746901|3645173|P7|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
1111678|NCT01746901|3645174|P6|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
1111679|NCT01746901|3645175|P5|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
1111680|NCT01746901|3645176|P4|Treatment Phase: Fourth Intervention|Lost to Follow-up|1
1111681|NCT01746901|3645177|P3|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
1111682|NCT01746901|3645178|P2|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
1111683|NCT01746901|3645179|P1|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
1111684|NCT01746901|3645171|P9|Treatment Phase: Third Intervention|Protocol Violation|0
1111685|NCT01746901|3645172|P8|Treatment Phase: Third Intervention|Protocol Violation|0
1111686|NCT01746901|3645173|P7|Treatment Phase: Third Intervention|Protocol Violation|1
1111687|NCT01746901|3645174|P6|Treatment Phase: Third Intervention|Protocol Violation|1
1111688|NCT01746901|3645175|P5|Treatment Phase: Third Intervention|Protocol Violation|0
1111689|NCT01746901|3645176|P4|Treatment Phase: Third Intervention|Protocol Violation|0
1111690|NCT01746901|3645177|P3|Treatment Phase: Third Intervention|Protocol Violation|0
1111691|NCT01746901|3645178|P2|Treatment Phase: Third Intervention|Protocol Violation|0
1111692|NCT01746901|3645179|P1|Treatment Phase: Third Intervention|Protocol Violation|0
1111693|NCT01746901|3645171|P9|Treatment Phase: Second Intervention|Withdrawal by Subject|0
1111694|NCT01746901|3645172|P8|Treatment Phase: Second Intervention|Withdrawal by Subject|1
1111695|NCT01746901|3645173|P7|Treatment Phase: Second Intervention|Withdrawal by Subject|0
1111696|NCT01746901|3645174|P6|Treatment Phase: Second Intervention|Withdrawal by Subject|0
1111697|NCT01746901|3645175|P5|Treatment Phase: Second Intervention|Withdrawal by Subject|0
1111698|NCT01746901|3645176|P4|Treatment Phase: Second Intervention|Withdrawal by Subject|0
1111699|NCT01746901|3645177|P3|Treatment Phase: Second Intervention|Withdrawal by Subject|0
1111700|NCT01746901|3645178|P2|Treatment Phase: Second Intervention|Withdrawal by Subject|0
1111701|NCT01746901|3645179|P1|Treatment Phase: Second Intervention|Withdrawal by Subject|0
1111702|NCT01746901|3645171|P9|Treatment Phase: First Intervention|Protocol Violation|0
1111703|NCT01746901|3645172|P8|Treatment Phase: First Intervention|Protocol Violation|0
1111704|NCT01746901|3645173|P7|Treatment Phase: First Intervention|Protocol Violation|1
1111705|NCT01746901|3645174|P6|Treatment Phase: First Intervention|Protocol Violation|0
1111706|NCT01746901|3645175|P5|Treatment Phase: First Intervention|Protocol Violation|0
1111707|NCT01746901|3645176|P4|Treatment Phase: First Intervention|Protocol Violation|0
1111708|NCT01746901|3645177|P3|Treatment Phase: First Intervention|Protocol Violation|0
1111709|NCT01746901|3645178|P2|Treatment Phase: First Intervention|Protocol Violation|0
1111710|NCT01746901|3645179|P1|Treatment Phase: First Intervention|Protocol Violation|0
1111711|NCT01746901|3645171|P9|Drug Discrimination Phase: Day 2|Protocol Violation|0
1111712|NCT01746901|3645172|P8|Drug Discrimination Phase: Day 2|Protocol Violation|0
1111713|NCT01746901|3645173|P7|Drug Discrimination Phase: Day 2|Protocol Violation|0
1111714|NCT01746901|3645174|P6|Drug Discrimination Phase: Day 2|Protocol Violation|0
1111715|NCT01746901|3645175|P5|Drug Discrimination Phase: Day 2|Protocol Violation|0
1111716|NCT01746901|3645176|P4|Drug Discrimination Phase: Day 2|Protocol Violation|0
1111717|NCT01746901|3645177|P3|Drug Discrimination Phase: Day 2|Protocol Violation|3
1111718|NCT01746901|3645178|P2|Drug Discrimination Phase: Day 2|Protocol Violation|3
1111719|NCT01746901|3645179|P1|Drug Discrimination Phase: Day 2|Protocol Violation|0
1111720|NCT01746901|3645171|P9|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
1111721|NCT01746901|3645172|P8|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
1111722|NCT01746901|3645173|P7|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
1111723|NCT01746901|3645174|P6|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
1111724|NCT01746901|3645175|P5|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
1111725|NCT01746901|3645176|P4|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
1111726|NCT01746901|3645177|P3|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10
1111727|NCT01746901|3645178|P2|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9
1111728|NCT01746901|3645179|P1|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
1111729|NCT01746901|3645171|P9|Drug Discrimination Phase: Day 2|Adverse Event|0
1111730|NCT01746901|3645172|P8|Drug Discrimination Phase: Day 2|Adverse Event|0
1111731|NCT01746901|3645173|P7|Drug Discrimination Phase: Day 2|Adverse Event|0
1111732|NCT01746901|3645174|P6|Drug Discrimination Phase: Day 2|Adverse Event|0
1111733|NCT01746901|3645175|P5|Drug Discrimination Phase: Day 2|Adverse Event|0
1111734|NCT01746901|3645176|P4|Drug Discrimination Phase: Day 2|Adverse Event|0
1111735|NCT01746901|3645177|P3|Drug Discrimination Phase: Day 2|Adverse Event|1
1111736|NCT01746901|3645178|P2|Drug Discrimination Phase: Day 2|Adverse Event|2
1111737|NCT01746901|3645179|P1|Drug Discrimination Phase: Day 2|Adverse Event|0
1111738|NCT01746901|3645171|P9|Drug Discrimination Phase: Day 1|Adverse Event|0
1111739|NCT01746901|3645172|P8|Drug Discrimination Phase: Day 1|Adverse Event|0
1111740|NCT01746901|3645173|P7|Drug Discrimination Phase: Day 1|Adverse Event|0
1111741|NCT01746901|3645174|P6|Drug Discrimination Phase: Day 1|Adverse Event|0
1111742|NCT01746901|3645175|P5|Drug Discrimination Phase: Day 1|Adverse Event|0
1111743|NCT01746901|3645176|P4|Drug Discrimination Phase: Day 1|Adverse Event|0
1111744|NCT01746901|3645177|P3|Drug Discrimination Phase: Day 1|Adverse Event|0
1111745|NCT01746901|3645178|P2|Drug Discrimination Phase: Day 1|Adverse Event|3
1111746|NCT01746901|3645179|P1|Drug Discrimination Phase: Day 1|Adverse Event|0
1111747|NCT01746901|3645171|P9|Naloxone Challenge Phase|Did not meet entrance criteria|0
1111748|NCT01746901|3645172|P8|Naloxone Challenge Phase|Did not meet entrance criteria|0
1111749|NCT01746901|3645173|P7|Naloxone Challenge Phase|Did not meet entrance criteria|0
1111750|NCT01746901|3645174|P6|Naloxone Challenge Phase|Did not meet entrance criteria|0
1111751|NCT01746901|3645175|P5|Naloxone Challenge Phase|Did not meet entrance criteria|0
1111752|NCT01746901|3645176|P4|Naloxone Challenge Phase|Did not meet entrance criteria|0
1111753|NCT01746901|3645177|P3|Naloxone Challenge Phase|Did not meet entrance criteria|0
1111754|NCT01746901|3645178|P2|Naloxone Challenge Phase|Did not meet entrance criteria|0
1111755|NCT01746901|3645179|P1|Naloxone Challenge Phase|Did not meet entrance criteria|1
1111756|NCT01746901|3645171|P9|Naloxone Challenge Phase|Adverse Event|0
1111757|NCT01746901|3645172|P8|Naloxone Challenge Phase|Adverse Event|0
1111758|NCT01746901|3645173|P7|Naloxone Challenge Phase|Adverse Event|0
1111759|NCT01746901|3645174|P6|Naloxone Challenge Phase|Adverse Event|0
1111760|NCT01746901|3645175|P5|Naloxone Challenge Phase|Adverse Event|0
1111761|NCT01746901|3645176|P4|Naloxone Challenge Phase|Adverse Event|0
1111762|NCT01746901|3645177|P3|Naloxone Challenge Phase|Adverse Event|0
1111763|NCT01746901|3645178|P2|Naloxone Challenge Phase|Adverse Event|0
1111764|NCT01746901|3645179|P1|Naloxone Challenge Phase|Adverse Event|2
1111765|NCT01746862|3645502|P2|Overall Study|Entered puberty during the study|0
1111766|NCT01746862|3645503|P1|Overall Study|Entered puberty during the study|1
1111767|NCT01746862|3645502|P2|Overall Study|Consent withdrawal by parent’s guardian|2
1111768|NCT01746862|3645503|P1|Overall Study|Consent withdrawal by parent’s guardian|5
1111769|NCT01746862|3645502|P2|Overall Study|Protocol Violation|0
1111770|NCT01746862|3645503|P1|Overall Study|Protocol Violation|1
1111771|NCT01746862|3645502|P2|Overall Study|Withdrawal by Subject|1
1111772|NCT01746862|3645503|P1|Overall Study|Withdrawal by Subject|1
1111773|NCT01746732|3645554|P3|Period 2|Lost to Follow-up|1
1111774|NCT01746732|3645555|P2|Period 2|Lost to Follow-up|0
1111775|NCT01746732|3645556|P1|Period 2|Lost to Follow-up|0
1111776|NCT01746732|3645554|P3|Period 2|Adverse Event|1
1111777|NCT01746732|3645555|P2|Period 2|Adverse Event|0
1111778|NCT01746732|3645556|P1|Period 2|Adverse Event|0
1111779|NCT01746732|3645554|P3|Period 2|Withdrawal by Subject|2
1111780|NCT01746732|3645555|P2|Period 2|Withdrawal by Subject|0
1111781|NCT01746732|3645556|P1|Period 2|Withdrawal by Subject|0
1111782|NCT01746732|3645554|P3|Period 1|Physician Decision|0
1111783|NCT01746732|3645555|P2|Period 1|Physician Decision|1
1111784|NCT01746732|3645556|P1|Period 1|Physician Decision|0
1111785|NCT01746732|3645554|P3|Lead-In Period|Withdrawal by Subject|0
1111786|NCT01746732|3645555|P2|Lead-In Period|Withdrawal by Subject|0
1111787|NCT01746732|3645556|P1|Lead-In Period|Withdrawal by Subject|1
1111788|NCT01746368|3645596|P2|Overall Study|Withdrawal by Subject|1
1111789|NCT01746368|3645597|P1|Overall Study|Withdrawal by Subject|0
1111790|NCT01746368|3645596|P2|Overall Study|Lost to Follow-up|0
1111791|NCT01746368|3645597|P1|Overall Study|Lost to Follow-up|2
1111792|NCT01746173|3645624|P1|Overall Study|Disease Progression|2
1111793|NCT01746108|3645632|P3|Overall Study|Lost to Follow-up|0
1111794|NCT01746108|3645633|P2|Overall Study|Lost to Follow-up|1
1111795|NCT01746108|3645634|P1|Overall Study|Lost to Follow-up|0
1111796|NCT01746108|3645632|P3|Overall Study|Withdrawal by Subject|0
1111797|NCT01746108|3645633|P2|Overall Study|Withdrawal by Subject|1
1111798|NCT01746108|3645634|P1|Overall Study|Withdrawal by Subject|0
1111799|NCT01746108|3645632|P3|Overall Study|Adverse event, non-fatal|0
1111800|NCT01746108|3645633|P2|Overall Study|Adverse event, non-fatal|1
1111801|NCT01746108|3645634|P1|Overall Study|Adverse event, non-fatal|0
1111802|NCT01746108|3645632|P3|Overall Study|Migrated /moved from study area|0
1111803|NCT01746108|3645633|P2|Overall Study|Migrated /moved from study area|1
1111804|NCT01746108|3645634|P1|Overall Study|Migrated /moved from study area|0
1111805|NCT01745848|3645732|P1|Overall Study|Adverse Event|6
1111806|NCT01745393|3645739|P2|12-month Follow-up|Lost to Follow-up|5
1111807|NCT01745393|3645740|P1|12-month Follow-up|Lost to Follow-up|6
1111808|NCT01745393|3645739|P2|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0
1111809|NCT01745393|3645740|P1|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1
1111810|NCT01745393|3645739|P2|Treatment to End-of-treatment Assessment|Lost to Follow-up|8
1111811|NCT01745393|3645740|P1|Treatment to End-of-treatment Assessment|Lost to Follow-up|20
1111812|NCT01745380|3645752|P2|Overall Study|Lack of Efficacy|1
1111813|NCT01745380|3645753|P1|Overall Study|Lack of Efficacy|0
1111814|NCT01745380|3645752|P2|Overall Study|Lost to Follow-up|0
1111815|NCT01745380|3645753|P1|Overall Study|Lost to Follow-up|1
1111816|NCT01745146|3645791|P2|Overall Study|Lost to Follow-up|0
1111817|NCT01745146|3645792|P1|Overall Study|Lost to Follow-up|2
1111818|NCT01745146|3645791|P2|Overall Study|Withdrawal by Subject|3
1111819|NCT01745146|3645792|P1|Overall Study|Withdrawal by Subject|1
1111820|NCT01745094|3645816|P4|Overall Study|Untenable Due to Recurrent Cystitis|0
1111821|NCT01745094|3645817|P3|Overall Study|Untenable Due to Recurrent Cystitis|0
1111822|NCT01745094|3645818|P2|Overall Study|Untenable Due to Recurrent Cystitis|0
1111823|NCT01745094|3645819|P1|Overall Study|Untenable Due to Recurrent Cystitis|1
1111824|NCT01745094|3645816|P4|Overall Study|Show no Stable Solifenacin Intake|0
1111825|NCT01745094|3645817|P3|Overall Study|Show no Stable Solifenacin Intake|1
1111826|NCT01745094|3645818|P2|Overall Study|Show no Stable Solifenacin Intake|0
1111827|NCT01745094|3645819|P1|Overall Study|Show no Stable Solifenacin Intake|0
1111828|NCT01745094|3645816|P4|Overall Study|Need Further Examinations Due to Biopsy|0
1111829|NCT01745094|3645817|P3|Overall Study|Need Further Examinations Due to Biopsy|1
1111830|NCT01745094|3645818|P2|Overall Study|Need Further Examinations Due to Biopsy|0
1111831|NCT01745094|3645819|P1|Overall Study|Need Further Examinations Due to Biopsy|0
1111832|NCT01745094|3645816|P4|Overall Study|Protocol Violation|1
1111833|NCT01745094|3645817|P3|Overall Study|Protocol Violation|3
1111834|NCT01745094|3645818|P2|Overall Study|Protocol Violation|0
1111835|NCT01745094|3645819|P1|Overall Study|Protocol Violation|1
1111836|NCT01745094|3645816|P4|Overall Study|Withdrawal by Subject|2
1111837|NCT01745094|3645817|P3|Overall Study|Withdrawal by Subject|1
1111838|NCT01745094|3645818|P2|Overall Study|Withdrawal by Subject|0
1111839|NCT01745094|3645819|P1|Overall Study|Withdrawal by Subject|2
1111840|NCT01745094|3645816|P4|Overall Study|Adverse Event|0
1111841|NCT01745094|3645817|P3|Overall Study|Adverse Event|3
1111842|NCT01745094|3645818|P2|Overall Study|Adverse Event|0
1111843|NCT01745094|3645819|P1|Overall Study|Adverse Event|0
1111844|NCT01745094|3645816|P4|Overall Study|Not Meeting the Eligibility Criteria|0
1111845|NCT01745094|3645817|P3|Overall Study|Not Meeting the Eligibility Criteria|3
1111846|NCT01745094|3645818|P2|Overall Study|Not Meeting the Eligibility Criteria|0
1111847|NCT01745094|3645819|P1|Overall Study|Not Meeting the Eligibility Criteria|1
1111848|NCT01744977|3645920|P2|Overall Study|No longer meets inclusion|0
1111849|NCT01744977|3645921|P1|Overall Study|No longer meets inclusion|6
1111850|NCT01744977|3645920|P2|Overall Study|Lost to Follow-up|0
1111851|NCT01744977|3645921|P1|Overall Study|Lost to Follow-up|2
1111852|NCT01744977|3645920|P2|Overall Study|Death|3
1111853|NCT01744977|3645921|P1|Overall Study|Death|2
1111854|NCT01744977|3645920|P2|Overall Study|Withdrawal by Subject|2
1111855|NCT01744977|3645921|P1|Overall Study|Withdrawal by Subject|1
1111856|NCT01744782|3645992|P1|Overall Study|Death|1
1111857|NCT01744691|3646052|P1|Overall Study|Physician Decision|4
1111858|NCT01744691|3646052|P1|Overall Study|Withdrawal of consent for treatment|3
1111859|NCT01744691|3646052|P1|Overall Study|Unacceptable toxicity, AE or death|18
1111860|NCT01744691|3646052|P1|Overall Study|Progressive Disease|18
1111861|NCT01744496|3646100|P2|Maintenance Period|Subject left town|0
1111862|NCT01744496|3646101|P1|Maintenance Period|Subject left town|1
1111863|NCT01744496|3646100|P2|Maintenance Period|Withdrawal by Subject|1
1111864|NCT01744496|3646101|P1|Maintenance Period|Withdrawal by Subject|1
1111865|NCT01744496|3646100|P2|Maintenance Period|Protocol Violation|0
1111866|NCT01744496|3646101|P1|Maintenance Period|Protocol Violation|1
1111867|NCT01744496|3646100|P2|Maintenance Period|Adverse Event|3
1111868|NCT01744496|3646101|P1|Maintenance Period|Adverse Event|1
1111869|NCT01744496|3646100|P2|Titration Period|Personal reasons|1
1111870|NCT01744496|3646101|P1|Titration Period|Personal reasons|0
1111871|NCT01744496|3646100|P2|Titration Period|Adverse Event|1
1111872|NCT01744496|3646101|P1|Titration Period|Adverse Event|2
1111873|NCT01744483|3646122|P3|Overall Study|Routed to OSH|1
1111874|NCT01744483|3646123|P2|Overall Study|Routed to OSH|0
1111875|NCT01744483|3646124|P1|Overall Study|Routed to OSH|2
1111876|NCT01744483|3646122|P3|Overall Study|No ICU Admit|2
1111877|NCT01744483|3646123|P2|Overall Study|No ICU Admit|1
1111878|NCT01744483|3646124|P1|Overall Study|No ICU Admit|5
1111879|NCT01744483|3646122|P3|Overall Study|Withdrawal by Subject|2
1111880|NCT01744483|3646123|P2|Overall Study|Withdrawal by Subject|6
1111881|NCT01744483|3646124|P1|Overall Study|Withdrawal by Subject|4
1111882|NCT01744483|3646122|P3|Overall Study|Protocol Violation|1
1111883|NCT01744483|3646123|P2|Overall Study|Protocol Violation|2
1111884|NCT01744483|3646124|P1|Overall Study|Protocol Violation|1
1111885|NCT01744483|3646122|P3|Overall Study|Lost to Follow-up|11
1111886|NCT01744483|3646123|P2|Overall Study|Lost to Follow-up|9
1111887|NCT01744483|3646124|P1|Overall Study|Lost to Follow-up|8
1111888|NCT01744483|3646122|P3|Overall Study|Death|11
1111889|NCT01744483|3646123|P2|Overall Study|Death|4
1111890|NCT01744483|3646124|P1|Overall Study|Death|9
1111891|NCT01744392|3646132|P1|Overall Study|Physician Decision|1
1111892|NCT01744197|3646172|P2|Overall Study|No patch received|2
1111893|NCT01744197|3646173|P1|Overall Study|No patch received|2
1111894|NCT01744197|3646172|P2|Overall Study|Received 1 patch|1
1111895|NCT01744197|3646173|P1|Overall Study|Received 1 patch|2
1111896|NCT01743469|3646275|P4|Follow-up Period - Post-Treatment|Lost to Follow-up|0
1111897|NCT01743469|3646276|P3|Follow-up Period - Post-Treatment|Lost to Follow-up|0
1111898|NCT01743469|3646277|P2|Follow-up Period - Post-Treatment|Lost to Follow-up|1
1111899|NCT01743469|3646278|P1|Follow-up Period - Post-Treatment|Lost to Follow-up|1
1111900|NCT01743469|3646275|P4|Follow-up Period - Post-Treatment|Death|16
1111901|NCT01743469|3646276|P3|Follow-up Period - Post-Treatment|Death|22
1111902|NCT01743469|3646277|P2|Follow-up Period - Post-Treatment|Death|47
1111903|NCT01743469|3646278|P1|Follow-up Period - Post-Treatment|Death|43
1111904|NCT01743469|3646275|P4|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
1111905|NCT01743469|3646276|P3|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
1111906|NCT01743469|3646277|P2|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
1111907|NCT01743469|3646278|P1|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
1111908|NCT01743469|3646275|P4|Active Treatment Phase|Missing|0
1111909|NCT01743469|3646276|P3|Active Treatment Phase|Missing|0
1111910|NCT01743469|3646277|P2|Active Treatment Phase|Missing|0
1111911|NCT01743469|3646278|P1|Active Treatment Phase|Missing|1
1111912|NCT01743469|3646275|P4|Active Treatment Phase|Withdrawal by Subject|0
1111913|NCT01743469|3646276|P3|Active Treatment Phase|Withdrawal by Subject|0
1111914|NCT01743469|3646277|P2|Active Treatment Phase|Withdrawal by Subject|3
1111915|NCT01743469|3646278|P1|Active Treatment Phase|Withdrawal by Subject|2
1111916|NCT01743469|3646275|P4|Active Treatment Phase|Disease Progression|20
1111917|NCT01743469|3646276|P3|Active Treatment Phase|Disease Progression|30
1111918|NCT01743469|3646277|P2|Active Treatment Phase|Disease Progression|47
1111919|NCT01743469|3646278|P1|Active Treatment Phase|Disease Progression|40
1111920|NCT01743469|3646275|P4|Active Treatment Phase|Adverse Event|1
1111921|NCT01743469|3646276|P3|Active Treatment Phase|Adverse Event|8
1111922|NCT01743469|3646277|P2|Active Treatment Phase|Adverse Event|5
1111923|NCT01743469|3646278|P1|Active Treatment Phase|Adverse Event|10
1111924|NCT01743092|3646318|P2|Overall Study|Lost to Follow-up|15
1111925|NCT01743092|3646319|P1|Overall Study|Lost to Follow-up|14
1111926|NCT01743027|3646331|P4|Overall Study|Withdrawal by Subject|1
1111927|NCT01743027|3646332|P3|Overall Study|Withdrawal by Subject|3
1111928|NCT01743027|3646333|P2|Overall Study|Withdrawal by Subject|0
1111929|NCT01743027|3646334|P1|Overall Study|Withdrawal by Subject|1
1111930|NCT01743027|3646331|P4|Overall Study|Protocol Violation|0
1111931|NCT01743027|3646332|P3|Overall Study|Protocol Violation|1
1111932|NCT01743027|3646333|P2|Overall Study|Protocol Violation|1
1111933|NCT01743027|3646334|P1|Overall Study|Protocol Violation|1
1111934|NCT01743027|3646331|P4|Overall Study|Progressive Disease|0
1111935|NCT01743027|3646332|P3|Overall Study|Progressive Disease|3
1111936|NCT01743027|3646333|P2|Overall Study|Progressive Disease|4
1111937|NCT01743027|3646334|P1|Overall Study|Progressive Disease|1
1111938|NCT01743027|3646331|P4|Overall Study|Lost to Follow-up|0
1111939|NCT01743027|3646332|P3|Overall Study|Lost to Follow-up|2
1111940|NCT01743027|3646333|P2|Overall Study|Lost to Follow-up|0
1111941|NCT01743027|3646334|P1|Overall Study|Lost to Follow-up|0
1111942|NCT01743027|3646331|P4|Overall Study|Adverse Event|0
1111943|NCT01743027|3646332|P3|Overall Study|Adverse Event|0
1111944|NCT01743027|3646333|P2|Overall Study|Adverse Event|0
1111945|NCT01743027|3646334|P1|Overall Study|Adverse Event|2
1111946|NCT01743001|3646374|P2|Overall Study|Death|0
1111947|NCT01743001|3646375|P1|Overall Study|Death|1
1111948|NCT01743001|3646374|P2|Overall Study|Pregnancy|0
1111949|NCT01743001|3646375|P1|Overall Study|Pregnancy|1
1111950|NCT01743001|3646374|P2|Overall Study|Physician Decision|0
1111951|NCT01743001|3646375|P1|Overall Study|Physician Decision|1
1111952|NCT01742897|3646398|P1|Overall Study|Other|1
1111953|NCT01742897|3646398|P1|Overall Study|Withdrawal by Subject|1
1111954|NCT01742897|3646398|P1|Overall Study|Adverse Event|3
1111955|NCT01742091|3646450|P6|Overall Study|Lost to Follow-up|1
1111956|NCT01742091|3646451|P5|Overall Study|Lost to Follow-up|0
1111957|NCT01742091|3646452|P4|Overall Study|Lost to Follow-up|0
1111958|NCT01742091|3646453|P3|Overall Study|Lost to Follow-up|0
1111959|NCT01742091|3646454|P2|Overall Study|Lost to Follow-up|0
1111960|NCT01742091|3646455|P1|Overall Study|Lost to Follow-up|0
1111961|NCT01742091|3646450|P6|Overall Study|Withdrawal by Subject|0
1111962|NCT01742091|3646451|P5|Overall Study|Withdrawal by Subject|0
1111963|NCT01742091|3646452|P4|Overall Study|Withdrawal by Subject|1
1111964|NCT01742091|3646453|P3|Overall Study|Withdrawal by Subject|0
1111965|NCT01742091|3646454|P2|Overall Study|Withdrawal by Subject|0
1111966|NCT01742091|3646455|P1|Overall Study|Withdrawal by Subject|0
1111967|NCT01742091|3646450|P6|Overall Study|Physician Decision|1
1111968|NCT01742091|3646451|P5|Overall Study|Physician Decision|0
1111969|NCT01742091|3646452|P4|Overall Study|Physician Decision|0
1111970|NCT01742091|3646453|P3|Overall Study|Physician Decision|0
1111971|NCT01742091|3646454|P2|Overall Study|Physician Decision|0
1111972|NCT01742091|3646455|P1|Overall Study|Physician Decision|0
1111973|NCT01742091|3646450|P6|Overall Study|Adverse Event|0
1111974|NCT01742091|3646451|P5|Overall Study|Adverse Event|1
1111975|NCT01742091|3646452|P4|Overall Study|Adverse Event|0
1111976|NCT01742091|3646453|P3|Overall Study|Adverse Event|0
1111977|NCT01742091|3646454|P2|Overall Study|Adverse Event|0
1111978|NCT01742091|3646455|P1|Overall Study|Adverse Event|0
1111979|NCT01741792|3646495|P3|Overall Study|Death|12
1111980|NCT01741792|3646496|P2|Overall Study|Death|1
1111981|NCT01741792|3646497|P1|Overall Study|Death|6
1111982|NCT01741701|3646564|P2|Overall Study|Withdrawal by Subject|1
1111983|NCT01741701|3646565|P1|Overall Study|Withdrawal by Subject|0
1111984|NCT01741701|3646564|P2|Overall Study|Adverse Event|1
1111985|NCT01741701|3646565|P1|Overall Study|Adverse Event|5
1111986|NCT01741688|3646581|P1|Overall Study|Withdrawal by Subject|1
1111987|NCT01741688|3646581|P1|Overall Study|Lack of insurance coverage|2
1111988|NCT01741259|3646763|P2|Overall Study|Withdrawal by Subject|2
1111989|NCT01741259|3646764|P1|Overall Study|Withdrawal by Subject|0
1111990|NCT01741259|3646763|P2|Overall Study|Protocol Violation|4
1111991|NCT01741259|3646764|P1|Overall Study|Protocol Violation|6
1111992|NCT01741012|3646818|P1|Overall Study|Withdrawal by Subject|2
1111993|NCT01741012|3646818|P1|Overall Study|Lost to Follow-up|1
1111994|NCT01740440|3646890|P1|Overall Study|Lost to Follow-up|3
1111995|NCT01740427|3646898|P2|Overall Study|Study terminated by Sponsor|0
1111996|NCT01740427|3646899|P1|Overall Study|Study terminated by Sponsor|1
1111997|NCT01740427|3646898|P2|Overall Study|Lost to Follow-up|0
1111998|NCT01740427|3646899|P1|Overall Study|Lost to Follow-up|1
1111999|NCT01740427|3646898|P2|Overall Study|Protocol Violation|3
1112000|NCT01740427|3646899|P1|Overall Study|Protocol Violation|5
1112001|NCT01740427|3646898|P2|Overall Study|Death|2
1112002|NCT01740427|3646899|P1|Overall Study|Death|6
1112003|NCT01740427|3646898|P2|Overall Study|Unspecified reasons|4
1112004|NCT01740427|3646899|P1|Overall Study|Unspecified reasons|6
1112005|NCT01740427|3646898|P2|Overall Study|Subject refused continued treatment|9
1112006|NCT01740427|3646899|P1|Overall Study|Subject refused continued treatment|12
1112007|NCT01740427|3646898|P2|Overall Study|Global deterioration of health status|9
1112008|NCT01740427|3646899|P1|Overall Study|Global deterioration of health status|16
1112009|NCT01740427|3646898|P2|Overall Study|Adverse Event|9
1112010|NCT01740427|3646899|P1|Overall Study|Adverse Event|20
1112011|NCT01740427|3646898|P2|Overall Study|Objective progression or relapse|125
1112012|NCT01740427|3646899|P1|Overall Study|Objective progression or relapse|172
1112013|NCT01740427|3646898|P2|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|61
1112014|NCT01740427|3646899|P1|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|205
1112015|NCT01740401|3646951|P1|Overall Study|Did not reach primary endpoint|2
1112016|NCT01740401|3646951|P1|Overall Study|Adverse Event|2
1112017|NCT01740401|3646951|P1|Overall Study|Progression of disease|6
1112018|NCT01740388|3646960|P2|Overall Study|Subjects missing data, completed|36
1112019|NCT01740388|3646961|P1|Overall Study|Subjects missing data, completed|41
1112020|NCT01740388|3646960|P2|Overall Study|Physician Decision|6
1112021|NCT01740388|3646961|P1|Overall Study|Physician Decision|2
1112022|NCT01740388|3646960|P2|Overall Study|Lost to Follow-up|0
1112023|NCT01740388|3646961|P1|Overall Study|Lost to Follow-up|2
1112024|NCT01740388|3646960|P2|Overall Study|Withdrawal by Subject|2
1112025|NCT01740388|3646961|P1|Overall Study|Withdrawal by Subject|1
1112026|NCT01740297|3647013|P3|Overall Study|Sponsor Decision|0
1112027|NCT01740297|3647014|P2|Overall Study|Sponsor Decision|1
1112028|NCT01740297|3647015|P1|Overall Study|Sponsor Decision|0
1112029|NCT01740297|3647013|P3|Overall Study|Death|19
1112030|NCT01740297|3647014|P2|Overall Study|Death|23
1112031|NCT01740297|3647015|P1|Overall Study|Death|8
1112032|NCT01740297|3647013|P3|Overall Study|Withdrawal by Subject|11
1112033|NCT01740297|3647014|P2|Overall Study|Withdrawal by Subject|9
1112034|NCT01740297|3647015|P1|Overall Study|Withdrawal by Subject|1
1112035|NCT01740297|3647013|P3|Overall Study|Continuing Study|68
1112036|NCT01740297|3647014|P2|Overall Study|Continuing Study|67
1112037|NCT01740297|3647015|P1|Overall Study|Continuing Study|10
1112038|NCT01740154|3647064|P1|Overall Study|Adverse Event|1
1112039|NCT01740128|3647072|P2|Overall Study|Insufficient protocol compliance|2
1112040|NCT01740128|3647073|P1|Overall Study|Insufficient protocol compliance|2
1112041|NCT01740128|3647072|P2|Overall Study|Withdrawal by Subject|0
1112042|NCT01740128|3647073|P1|Overall Study|Withdrawal by Subject|1
1112043|NCT01740128|3647072|P2|Overall Study|Lost to Follow-up|2
1112044|NCT01740128|3647073|P1|Overall Study|Lost to Follow-up|2
1112045|NCT01740128|3647072|P2|Overall Study|Protocol Violation|2
1112046|NCT01740128|3647073|P1|Overall Study|Protocol Violation|1
1112047|NCT01740128|3647072|P2|Overall Study|Pregnancy|1
1112048|NCT01740128|3647073|P1|Overall Study|Pregnancy|0
1112049|NCT01740089|3647102|P3|After 12 Weeks|Withdrawal by Subject|1
1112050|NCT01740089|3647103|P2|After 12 Weeks|Withdrawal by Subject|1
1112051|NCT01740089|3647104|P1|After 12 Weeks|Withdrawal by Subject|1
1112052|NCT01740089|3647102|P3|After 12 Weeks|Protocol Violation|1
1112053|NCT01740089|3647103|P2|After 12 Weeks|Protocol Violation|1
1112054|NCT01740089|3647104|P1|After 12 Weeks|Protocol Violation|1
1112055|NCT01740089|3647102|P3|After 12 Weeks|Adverse Event|5
1112056|NCT01740089|3647103|P2|After 12 Weeks|Adverse Event|0
1112057|NCT01740089|3647104|P1|After 12 Weeks|Adverse Event|2
1112058|NCT01740089|3647102|P3|After 12 Weeks|Lack of Efficacy|4
1112059|NCT01740089|3647103|P2|After 12 Weeks|Lack of Efficacy|1
1112060|NCT01740089|3647104|P1|After 12 Weeks|Lack of Efficacy|3
1112061|NCT01740089|3647102|P3|First 12 Weeks of Treatment|Withdrawal by Subject|0
1112062|NCT01740089|3647103|P2|First 12 Weeks of Treatment|Withdrawal by Subject|1
1112063|NCT01740089|3647104|P1|First 12 Weeks of Treatment|Withdrawal by Subject|0
1112064|NCT01740089|3647102|P3|First 12 Weeks of Treatment|Adverse Event|2
1112065|NCT01740089|3647103|P2|First 12 Weeks of Treatment|Adverse Event|1
1112066|NCT01740089|3647104|P1|First 12 Weeks of Treatment|Adverse Event|0
1112067|NCT01739803|3647122|P2|Overall Study|Lost to Follow-up|6
1112068|NCT01739803|3647123|P1|Overall Study|Lost to Follow-up|9
1112069|NCT01739790|3647135|P2|Overall Study|Early Trial Termination|4
1112070|NCT01739790|3647136|P1|Overall Study|Early Trial Termination|2
1112071|NCT01739595|3647145|P3|Overall Study|Drug discrepancy|0
1112072|NCT01739595|3647146|P2|Overall Study|Drug discrepancy|0
1112073|NCT01739595|3647147|P1|Overall Study|Drug discrepancy|1
1112074|NCT01739595|3647145|P3|Overall Study|Lab assessment|0
1112075|NCT01739595|3647146|P2|Overall Study|Lab assessment|0
1112076|NCT01739595|3647147|P1|Overall Study|Lab assessment|1
1112077|NCT01739595|3647145|P3|Overall Study|Protocol Violation|0
1112078|NCT01739595|3647146|P2|Overall Study|Protocol Violation|0
1112079|NCT01739595|3647147|P1|Overall Study|Protocol Violation|1
1112080|NCT01739595|3647145|P3|Overall Study|Eligibility issue|0
1112081|NCT01739595|3647146|P2|Overall Study|Eligibility issue|0
1112082|NCT01739595|3647147|P1|Overall Study|Eligibility issue|3
1112083|NCT01739595|3647145|P3|Overall Study|Withdrawal by Subject|2
1112084|NCT01739595|3647146|P2|Overall Study|Withdrawal by Subject|1
1112085|NCT01739595|3647147|P1|Overall Study|Withdrawal by Subject|2
1112086|NCT01739595|3647145|P3|Overall Study|Lost to Follow-up|0
1112087|NCT01739595|3647146|P2|Overall Study|Lost to Follow-up|0
1112088|NCT01739595|3647147|P1|Overall Study|Lost to Follow-up|2
1112089|NCT01739595|3647145|P3|Overall Study|Adverse Event|0
1112090|NCT01739595|3647146|P2|Overall Study|Adverse Event|0
1112091|NCT01739595|3647147|P1|Overall Study|Adverse Event|3
1112092|NCT01739348|3647172|P4|Part II (Extension Study)|Withdrawal by Subject|7
1112093|NCT01739348|3647173|P3|Part II (Extension Study)|Withdrawal by Subject|4
1112094|NCT01739348|3647174|P2|Part II (Extension Study)|Withdrawal by Subject|2
1112095|NCT01739348|3647175|P1|Part II (Extension Study)|Withdrawal by Subject|5
1112096|NCT01739348|3647172|P4|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16
1112097|NCT01739348|3647173|P3|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8
1112098|NCT01739348|3647174|P2|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12
1112099|NCT01739348|3647175|P1|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18
1112100|NCT01739348|3647172|P4|Part II (Extension Study)|Participant Moved|3
1112101|NCT01739348|3647173|P3|Part II (Extension Study)|Participant Moved|0
1112102|NCT01739348|3647174|P2|Part II (Extension Study)|Participant Moved|3
1112103|NCT01739348|3647175|P1|Part II (Extension Study)|Participant Moved|3
1112104|NCT01739348|3647172|P4|Part II (Extension Study)|Study Terminated by Sponsor|323
1112105|NCT01739348|3647173|P3|Part II (Extension Study)|Study Terminated by Sponsor|34
1112106|NCT01739348|3647174|P2|Part II (Extension Study)|Study Terminated by Sponsor|315
1112107|NCT01739348|3647175|P1|Part II (Extension Study)|Study Terminated by Sponsor|329
1112108|NCT01739348|3647172|P4|Part II (Extension Study)|Physician Decision|12
1112109|NCT01739348|3647173|P3|Part II (Extension Study)|Physician Decision|6
1112110|NCT01739348|3647174|P2|Part II (Extension Study)|Physician Decision|11
1112111|NCT01739348|3647175|P1|Part II (Extension Study)|Physician Decision|7
1112112|NCT01739348|3647172|P4|Part II (Extension Study)|Non-Compliance with Study Drug|1
1112113|NCT01739348|3647173|P3|Part II (Extension Study)|Non-Compliance with Study Drug|0
1112114|NCT01739348|3647174|P2|Part II (Extension Study)|Non-Compliance with Study Drug|0
1112115|NCT01739348|3647175|P1|Part II (Extension Study)|Non-Compliance with Study Drug|0
1112116|NCT01739348|3647172|P4|Part II (Extension Study)|Lost to Follow-up|1
1112117|NCT01739348|3647173|P3|Part II (Extension Study)|Lost to Follow-up|0
1112118|NCT01739348|3647174|P2|Part II (Extension Study)|Lost to Follow-up|4
1112119|NCT01739348|3647175|P1|Part II (Extension Study)|Lost to Follow-up|3
1112120|NCT01739348|3647172|P4|Part II (Extension Study)|Lack of Efficacy|1
1112121|NCT01739348|3647173|P3|Part II (Extension Study)|Lack of Efficacy|0
1112122|NCT01739348|3647174|P2|Part II (Extension Study)|Lack of Efficacy|5
1112123|NCT01739348|3647175|P1|Part II (Extension Study)|Lack of Efficacy|1
1112124|NCT01739348|3647172|P4|Part II (Extension Study)|Death|6
1112125|NCT01739348|3647173|P3|Part II (Extension Study)|Death|2
1112126|NCT01739348|3647174|P2|Part II (Extension Study)|Death|3
1112127|NCT01739348|3647175|P1|Part II (Extension Study)|Death|3
1112128|NCT01739348|3647172|P4|Part II (Extension Study)|Adverse Event|26
1112129|NCT01739348|3647173|P3|Part II (Extension Study)|Adverse Event|7
1112130|NCT01739348|3647174|P2|Part II (Extension Study)|Adverse Event|11
1112131|NCT01739348|3647175|P1|Part II (Extension Study)|Adverse Event|10
1112132|NCT01739348|3647172|P4|Part I (Base Study)|Withdrawal by Subject|20
1112133|NCT01739348|3647173|P3|Part I (Base Study)|Withdrawal by Subject|7
1112134|NCT01739348|3647174|P2|Part I (Base Study)|Withdrawal by Subject|21
1112135|NCT01739348|3647175|P1|Part I (Base Study)|Withdrawal by Subject|23
1112136|NCT01739348|3647172|P4|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18
1112137|NCT01739348|3647173|P3|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2
1112138|NCT01739348|3647174|P2|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25
1112139|NCT01739348|3647175|P1|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27
1112140|NCT01739348|3647172|P4|Part I (Base Study)|Participant Moved|7
1112141|NCT01739348|3647173|P3|Part I (Base Study)|Participant Moved|1
1112142|NCT01739348|3647174|P2|Part I (Base Study)|Participant Moved|3
1112143|NCT01739348|3647175|P1|Part I (Base Study)|Participant Moved|4
1112144|NCT01739348|3647172|P4|Part I (Base Study)|Study Terminated by Sponsor|86
1112145|NCT01739348|3647173|P3|Part I (Base Study)|Study Terminated by Sponsor|0
1112146|NCT01739348|3647174|P2|Part I (Base Study)|Study Terminated by Sponsor|73
1112147|NCT01739348|3647175|P1|Part I (Base Study)|Study Terminated by Sponsor|72
1112148|NCT01739348|3647172|P4|Part I (Base Study)|Site Discontinued Study Participation|0
1112149|NCT01739348|3647173|P3|Part I (Base Study)|Site Discontinued Study Participation|0
1112150|NCT01739348|3647174|P2|Part I (Base Study)|Site Discontinued Study Participation|3
1112151|NCT01739348|3647175|P1|Part I (Base Study)|Site Discontinued Study Participation|1
1112152|NCT01739348|3647172|P4|Part I (Base Study)|Screen Failure|0
1112153|NCT01739348|3647173|P3|Part I (Base Study)|Screen Failure|0
1112154|NCT01739348|3647174|P2|Part I (Base Study)|Screen Failure|0
1112155|NCT01739348|3647175|P1|Part I (Base Study)|Screen Failure|2
1112156|NCT01739348|3647172|P4|Part I (Base Study)|Protocol Violation|2
1112157|NCT01739348|3647173|P3|Part I (Base Study)|Protocol Violation|1
1112158|NCT01739348|3647174|P2|Part I (Base Study)|Protocol Violation|0
1112159|NCT01739348|3647175|P1|Part I (Base Study)|Protocol Violation|2
1112160|NCT01739348|3647172|P4|Part I (Base Study)|Physician Decision|4
1112161|NCT01739348|3647173|P3|Part I (Base Study)|Physician Decision|1
1112162|NCT01739348|3647174|P2|Part I (Base Study)|Physician Decision|7
1112163|NCT01739348|3647175|P1|Part I (Base Study)|Physician Decision|10
1112164|NCT01739348|3647172|P4|Part I (Base Study)|Non-Compliance with Study Drug|0
1112165|NCT01739348|3647173|P3|Part I (Base Study)|Non-Compliance with Study Drug|0
1112166|NCT01739348|3647174|P2|Part I (Base Study)|Non-Compliance with Study Drug|2
1112167|NCT01739348|3647175|P1|Part I (Base Study)|Non-Compliance with Study Drug|3
1112168|NCT01739348|3647172|P4|Part I (Base Study)|Lost to Follow-up|4
1112169|NCT01739348|3647173|P3|Part I (Base Study)|Lost to Follow-up|4
1112170|NCT01739348|3647174|P2|Part I (Base Study)|Lost to Follow-up|2
1112171|NCT01739348|3647175|P1|Part I (Base Study)|Lost to Follow-up|4
1112172|NCT01739348|3647172|P4|Part I (Base Study)|Lack of Efficacy|7
1112173|NCT01739348|3647173|P3|Part I (Base Study)|Lack of Efficacy|0
1112174|NCT01739348|3647174|P2|Part I (Base Study)|Lack of Efficacy|8
1112175|NCT01739348|3647175|P1|Part I (Base Study)|Lack of Efficacy|3
1112176|NCT01739348|3647172|P4|Part I (Base Study)|Death|8
1112177|NCT01739348|3647173|P3|Part I (Base Study)|Death|2
1112178|NCT01739348|3647174|P2|Part I (Base Study)|Death|7
1112179|NCT01739348|3647175|P1|Part I (Base Study)|Death|10
1112180|NCT01739348|3647172|P4|Part I (Base Study)|Adverse Event|33
1112181|NCT01739348|3647173|P3|Part I (Base Study)|Adverse Event|8
1112182|NCT01739348|3647174|P2|Part I (Base Study)|Adverse Event|52
1112183|NCT01739348|3647175|P1|Part I (Base Study)|Adverse Event|41
1112184|NCT01739335|3647247|P2|Overall Study|Ineligible patient randomized|1
1112185|NCT01739335|3647248|P1|Overall Study|Ineligible patient randomized|0
1112186|NCT01739335|3647247|P2|Overall Study|Lost to Follow-up|4
1112187|NCT01739335|3647248|P1|Overall Study|Lost to Follow-up|7
1112188|NCT01738984|3647458|P2|Overall Study|Lost to Follow-up|39
1112189|NCT01738984|3647459|P1|Overall Study|Lost to Follow-up|59
1112190|NCT01738984|3647458|P2|Overall Study|Withdrawal by Subject|0
1112191|NCT01738984|3647459|P1|Overall Study|Withdrawal by Subject|1
1112192|NCT01738984|3647458|P2|Overall Study|Pregnancy|0
1112193|NCT01738984|3647459|P1|Overall Study|Pregnancy|4
1112194|NCT01738971|3647472|P3|Overall Study|Lost to Follow-up|17
1112195|NCT01738971|3647473|P2|Overall Study|Lost to Follow-up|30
1112196|NCT01738971|3647474|P1|Overall Study|Lost to Follow-up|19
1112197|NCT01738919|3647490|P2|Overall Study|Not treated in accordance to guidelines|1
1112198|NCT01738919|3647491|P1|Overall Study|Not treated in accordance to guidelines|0
1112199|NCT01738919|3647490|P2|Overall Study|Withdrawal by Subject|1
1112200|NCT01738919|3647491|P1|Overall Study|Withdrawal by Subject|0
1112201|NCT01738919|3647490|P2|Overall Study|Immigrated|1
1112202|NCT01738919|3647491|P1|Overall Study|Immigrated|0
1112203|NCT01738919|3647490|P2|Overall Study|Lost to Follow-up|0
1112204|NCT01738919|3647491|P1|Overall Study|Lost to Follow-up|1
1112205|NCT01738646|3647641|P1|Overall Study|Still Receiving Treatment|2
1112206|NCT01738581|3647651|P2|Overall Study|Lost to Follow-up|0
1112207|NCT01738581|3647652|P1|Overall Study|Lost to Follow-up|1
1112208|NCT01738503|3647676|P7|PET Imaging Sub-study|Scheduling issues with imaging facility|1
1112209|NCT01738503|3647677|P6|PET Imaging Sub-study|Scheduling issues with imaging facility|1
1112210|NCT01738503|3647678|P5|PET Imaging Sub-study|Scheduling issues with imaging facility|0
1112211|NCT01738503|3647679|P4|PET Imaging Sub-study|Scheduling issues with imaging facility|0
1112212|NCT01738503|3647680|P3|PET Imaging Sub-study|Scheduling issues with imaging facility|0
1112213|NCT01738503|3647681|P2|PET Imaging Sub-study|Scheduling issues with imaging facility|0
1112214|NCT01738503|3647682|P1|PET Imaging Sub-study|Scheduling issues with imaging facility|0
1112215|NCT01738503|3647676|P7|PET Imaging Sub-study|Adverse Event|0
1112216|NCT01738503|3647677|P6|PET Imaging Sub-study|Adverse Event|1
1112217|NCT01738503|3647678|P5|PET Imaging Sub-study|Adverse Event|0
1112218|NCT01738503|3647679|P4|PET Imaging Sub-study|Adverse Event|0
1112219|NCT01738503|3647680|P3|PET Imaging Sub-study|Adverse Event|0
1112220|NCT01738503|3647681|P2|PET Imaging Sub-study|Adverse Event|0
1112221|NCT01738503|3647682|P1|PET Imaging Sub-study|Adverse Event|0
1112222|NCT01738503|3647676|P7|Treatment Period|Not specified|0
1112223|NCT01738503|3647677|P6|Treatment Period|Not specified|0
1112224|NCT01738503|3647678|P5|Treatment Period|Not specified|0
1112225|NCT01738503|3647679|P4|Treatment Period|Not specified|0
1112226|NCT01738503|3647680|P3|Treatment Period|Not specified|1
1112227|NCT01738503|3647681|P2|Treatment Period|Not specified|0
1112228|NCT01738503|3647682|P1|Treatment Period|Not specified|0
1112229|NCT01738503|3647676|P7|Treatment Period|Protocol Violation|0
1112230|NCT01738503|3647677|P6|Treatment Period|Protocol Violation|2
1112231|NCT01738503|3647678|P5|Treatment Period|Protocol Violation|4
1112232|NCT01738503|3647679|P4|Treatment Period|Protocol Violation|0
1112233|NCT01738503|3647680|P3|Treatment Period|Protocol Violation|1
1112234|NCT01738503|3647681|P2|Treatment Period|Protocol Violation|3
1112235|NCT01738503|3647682|P1|Treatment Period|Protocol Violation|0
1112236|NCT01738503|3647676|P7|Treatment Period|Withdrawal by Subject|1
1112237|NCT01738503|3647677|P6|Treatment Period|Withdrawal by Subject|1
1112238|NCT01738503|3647678|P5|Treatment Period|Withdrawal by Subject|1
1112239|NCT01738503|3647679|P4|Treatment Period|Withdrawal by Subject|1
1112240|NCT01738503|3647680|P3|Treatment Period|Withdrawal by Subject|0
1112241|NCT01738503|3647681|P2|Treatment Period|Withdrawal by Subject|1
1112242|NCT01738503|3647682|P1|Treatment Period|Withdrawal by Subject|0
1112243|NCT01738503|3647676|P7|Treatment Period|Lost to Follow-up|5
1112244|NCT01738503|3647677|P6|Treatment Period|Lost to Follow-up|1
1112245|NCT01738503|3647678|P5|Treatment Period|Lost to Follow-up|1
1112246|NCT01738503|3647679|P4|Treatment Period|Lost to Follow-up|4
1112247|NCT01738503|3647680|P3|Treatment Period|Lost to Follow-up|3
1112248|NCT01738503|3647681|P2|Treatment Period|Lost to Follow-up|0
1112249|NCT01738503|3647682|P1|Treatment Period|Lost to Follow-up|0
1112250|NCT01738503|3647676|P7|Treatment Period|Adverse Event|2
1112251|NCT01738503|3647677|P6|Treatment Period|Adverse Event|2
1112252|NCT01738503|3647678|P5|Treatment Period|Adverse Event|2
1112253|NCT01738503|3647679|P4|Treatment Period|Adverse Event|1
1112254|NCT01738503|3647680|P3|Treatment Period|Adverse Event|0
1112255|NCT01738503|3647681|P2|Treatment Period|Adverse Event|1
1112256|NCT01738503|3647682|P1|Treatment Period|Adverse Event|0
1112257|NCT01738503|3647676|P7|Induction/Stabilization (Days -14 to -1)|Not specified|0
1112258|NCT01738503|3647677|P6|Induction/Stabilization (Days -14 to -1)|Not specified|0
1112259|NCT01738503|3647678|P5|Induction/Stabilization (Days -14 to -1)|Not specified|0
1112260|NCT01738503|3647679|P4|Induction/Stabilization (Days -14 to -1)|Not specified|0
1112261|NCT01738503|3647680|P3|Induction/Stabilization (Days -14 to -1)|Not specified|0
1112262|NCT01738503|3647681|P2|Induction/Stabilization (Days -14 to -1)|Not specified|0
1112263|NCT01738503|3647682|P1|Induction/Stabilization (Days -14 to -1)|Not specified|35
1112264|NCT01738477|3647880|P2|Overall Study|Lost to Follow-up|4
1112265|NCT01738477|3647881|P1|Overall Study|Lost to Follow-up|1
1112266|NCT01738438|3647909|P1|Overall Study|Adverse Event|3
1112267|NCT01738438|3647909|P1|Overall Study|Disease Progression|32
1112268|NCT01738191|3647926|P2|Overall Study|Withdrawal by Subject|1
1112269|NCT01738191|3647927|P1|Overall Study|Withdrawal by Subject|4
1112270|NCT01737996|3647950|P3|Overall Study|Withdrawal by Subject|1
1112271|NCT01737996|3647951|P2|Overall Study|Withdrawal by Subject|0
1112272|NCT01737996|3647952|P1|Overall Study|Withdrawal by Subject|0
1112273|NCT01737996|3647950|P3|Overall Study|Adverse Event|1
1112274|NCT01737996|3647951|P2|Overall Study|Adverse Event|1
1112275|NCT01737996|3647952|P1|Overall Study|Adverse Event|0
1112276|NCT01737931|3648014|P3|Overall Study|Physician Decision|0
1112277|NCT01737931|3648015|P2|Overall Study|Physician Decision|1
1112278|NCT01737931|3648016|P1|Overall Study|Physician Decision|0
1112279|NCT01737931|3648014|P3|Overall Study|Withdrawal by Subject|1
1112280|NCT01737931|3648015|P2|Overall Study|Withdrawal by Subject|1
1112281|NCT01737931|3648016|P1|Overall Study|Withdrawal by Subject|0
1112282|NCT01737879|3648031|P1|Overall Study|Sponsor decision|40
1112283|NCT01737879|3648031|P1|Overall Study|Death|1
1112284|NCT01737840|3648040|P2|Overall Study|Diagnosed with an other pathology|2
1112285|NCT01737840|3648041|P1|Overall Study|Diagnosed with an other pathology|2
1112286|NCT01737762|3648051|P2|Overall Study|Trial termination|9
1112287|NCT01737762|3648052|P1|Overall Study|Trial termination|11
1112288|NCT01737762|3648051|P2|Overall Study|Moved from area|1
1112289|NCT01737762|3648052|P1|Overall Study|Moved from area|2
1112290|NCT01737762|3648051|P2|Overall Study|Physician Decision|1
1112291|NCT01737762|3648052|P1|Overall Study|Physician Decision|1
1112292|NCT01737762|3648051|P2|Overall Study|Progressive disease|2
1112293|NCT01737762|3648052|P1|Overall Study|Progressive disease|1
1112294|NCT01737762|3648051|P2|Overall Study|Withdrawal by Subject|2
1112295|NCT01737762|3648052|P1|Overall Study|Withdrawal by Subject|2
1112296|NCT01737762|3648051|P2|Overall Study|Lost to Follow-up|0
1112297|NCT01737762|3648052|P1|Overall Study|Lost to Follow-up|1
1112298|NCT01737762|3648051|P2|Overall Study|Adverse Event|2
1112299|NCT01737762|3648052|P1|Overall Study|Adverse Event|2
1112300|NCT01737710|3648065|P5|Overall Study|Vaccinated in Error/Ineligible|0
1112301|NCT01737710|3648066|P4|Overall Study|Vaccinated in Error/Ineligible|0
1112302|NCT01737710|3648067|P3|Overall Study|Vaccinated in Error/Ineligible|0
1112303|NCT01737710|3648068|P2|Overall Study|Vaccinated in Error/Ineligible|1
1112304|NCT01737710|3648069|P1|Overall Study|Vaccinated in Error/Ineligible|1
1112305|NCT01737710|3648065|P5|Overall Study|Withdrawal by Subject|0
1112306|NCT01737710|3648066|P4|Overall Study|Withdrawal by Subject|0
1112307|NCT01737710|3648067|P3|Overall Study|Withdrawal by Subject|1
1112308|NCT01737710|3648068|P2|Overall Study|Withdrawal by Subject|1
1112309|NCT01737710|3648069|P1|Overall Study|Withdrawal by Subject|1
1112310|NCT01737710|3648065|P5|Overall Study|Lost to Follow-up|0
1112311|NCT01737710|3648066|P4|Overall Study|Lost to Follow-up|0
1112312|NCT01737710|3648067|P3|Overall Study|Lost to Follow-up|2
1112313|NCT01737710|3648068|P2|Overall Study|Lost to Follow-up|2
1112314|NCT01737710|3648069|P1|Overall Study|Lost to Follow-up|0
1112315|NCT01737697|3648111|P15|Subacute Phase|Death|0
1112316|NCT01737697|3648112|P14|Subacute Phase|Death|0
1112317|NCT01737697|3648113|P13|Subacute Phase|Death|0
1112318|NCT01737697|3648114|P12|Subacute Phase|Death|0
1112319|NCT01737697|3648115|P11|Subacute Phase|Death|1
1112320|NCT01737697|3648116|P10|Subacute Phase|Death|0
1112321|NCT01737697|3648117|P9|Subacute Phase|Death|0
1112322|NCT01737697|3648118|P8|Subacute Phase|Death|0
1112323|NCT01737697|3648119|P7|Subacute Phase|Death|0
1112324|NCT01737697|3648120|P6|Subacute Phase|Death|0
1112325|NCT01737697|3648121|P5|Subacute Phase|Death|0
1112326|NCT01737697|3648122|P4|Subacute Phase|Death|0
1112327|NCT01737697|3648123|P3|Subacute Phase|Death|0
1112328|NCT01737697|3648124|P2|Subacute Phase|Death|0
1112329|NCT01737697|3648125|P1|Subacute Phase|Death|0
1112330|NCT01737697|3648111|P15|Subacute Phase|Physician Decision|0
1112331|NCT01737697|3648112|P14|Subacute Phase|Physician Decision|0
1112332|NCT01737697|3648113|P13|Subacute Phase|Physician Decision|0
1112333|NCT01737697|3648114|P12|Subacute Phase|Physician Decision|0
1112334|NCT01737697|3648115|P11|Subacute Phase|Physician Decision|0
1112335|NCT01737697|3648116|P10|Subacute Phase|Physician Decision|0
1112336|NCT01737697|3648117|P9|Subacute Phase|Physician Decision|1
1112337|NCT01737697|3648118|P8|Subacute Phase|Physician Decision|0
1112338|NCT01737697|3648119|P7|Subacute Phase|Physician Decision|0
1112339|NCT01737697|3648120|P6|Subacute Phase|Physician Decision|0
1112340|NCT01737697|3648121|P5|Subacute Phase|Physician Decision|0
1112341|NCT01737697|3648122|P4|Subacute Phase|Physician Decision|0
1112342|NCT01737697|3648123|P3|Subacute Phase|Physician Decision|0
1112343|NCT01737697|3648124|P2|Subacute Phase|Physician Decision|0
1112344|NCT01737697|3648125|P1|Subacute Phase|Physician Decision|0
1112345|NCT01737697|3648111|P15|Subacute Phase|Protocol Violation|0
1112346|NCT01737697|3648112|P14|Subacute Phase|Protocol Violation|0
1112347|NCT01737697|3648113|P13|Subacute Phase|Protocol Violation|0
1112348|NCT01737697|3648114|P12|Subacute Phase|Protocol Violation|0
1112349|NCT01737697|3648115|P11|Subacute Phase|Protocol Violation|1
1112350|NCT01737697|3648116|P10|Subacute Phase|Protocol Violation|0
1112351|NCT01737697|3648117|P9|Subacute Phase|Protocol Violation|0
1112352|NCT01737697|3648118|P8|Subacute Phase|Protocol Violation|0
1112353|NCT01737697|3648119|P7|Subacute Phase|Protocol Violation|0
1112354|NCT01737697|3648120|P6|Subacute Phase|Protocol Violation|1
1112355|NCT01737697|3648121|P5|Subacute Phase|Protocol Violation|0
1112356|NCT01737697|3648122|P4|Subacute Phase|Protocol Violation|0
1112357|NCT01737697|3648123|P3|Subacute Phase|Protocol Violation|0
1112358|NCT01737697|3648124|P2|Subacute Phase|Protocol Violation|0
1112359|NCT01737697|3648125|P1|Subacute Phase|Protocol Violation|0
1112360|NCT01737697|3648111|P15|Subacute Phase|Hypo-or hyperkalemia|0
1112361|NCT01737697|3648112|P14|Subacute Phase|Hypo-or hyperkalemia|1
1112362|NCT01737697|3648113|P13|Subacute Phase|Hypo-or hyperkalemia|0
1112363|NCT01737697|3648114|P12|Subacute Phase|Hypo-or hyperkalemia|1
1112364|NCT01737697|3648115|P11|Subacute Phase|Hypo-or hyperkalemia|0
1112365|NCT01737697|3648116|P10|Subacute Phase|Hypo-or hyperkalemia|0
1112366|NCT01737697|3648117|P9|Subacute Phase|Hypo-or hyperkalemia|0
1112367|NCT01737697|3648118|P8|Subacute Phase|Hypo-or hyperkalemia|0
1112368|NCT01737697|3648119|P7|Subacute Phase|Hypo-or hyperkalemia|0
1112369|NCT01737697|3648120|P6|Subacute Phase|Hypo-or hyperkalemia|0
1112370|NCT01737697|3648121|P5|Subacute Phase|Hypo-or hyperkalemia|0
1112371|NCT01737697|3648122|P4|Subacute Phase|Hypo-or hyperkalemia|0
1112372|NCT01737697|3648123|P3|Subacute Phase|Hypo-or hyperkalemia|0
1112373|NCT01737697|3648124|P2|Subacute Phase|Hypo-or hyperkalemia|0
1112374|NCT01737697|3648125|P1|Subacute Phase|Hypo-or hyperkalemia|0
1112375|NCT01737697|3648111|P15|Subacute Phase|Lost to Follow-up|1
1112376|NCT01737697|3648112|P14|Subacute Phase|Lost to Follow-up|0
1112377|NCT01737697|3648113|P13|Subacute Phase|Lost to Follow-up|0
1112378|NCT01737697|3648114|P12|Subacute Phase|Lost to Follow-up|0
1112379|NCT01737697|3648115|P11|Subacute Phase|Lost to Follow-up|0
1112380|NCT01737697|3648116|P10|Subacute Phase|Lost to Follow-up|0
1112381|NCT01737697|3648117|P9|Subacute Phase|Lost to Follow-up|0
1112382|NCT01737697|3648118|P8|Subacute Phase|Lost to Follow-up|0
1112383|NCT01737697|3648119|P7|Subacute Phase|Lost to Follow-up|0
1112384|NCT01737697|3648120|P6|Subacute Phase|Lost to Follow-up|0
1112385|NCT01737697|3648121|P5|Subacute Phase|Lost to Follow-up|0
1112386|NCT01737697|3648122|P4|Subacute Phase|Lost to Follow-up|0
1112387|NCT01737697|3648123|P3|Subacute Phase|Lost to Follow-up|0
1112388|NCT01737697|3648124|P2|Subacute Phase|Lost to Follow-up|0
1112389|NCT01737697|3648125|P1|Subacute Phase|Lost to Follow-up|0
1112390|NCT01737697|3648111|P15|Subacute Phase|Withdrawal by Subject|0
1112391|NCT01737697|3648112|P14|Subacute Phase|Withdrawal by Subject|1
1112392|NCT01737697|3648113|P13|Subacute Phase|Withdrawal by Subject|1
1112393|NCT01737697|3648114|P12|Subacute Phase|Withdrawal by Subject|1
1112394|NCT01737697|3648115|P11|Subacute Phase|Withdrawal by Subject|0
1112395|NCT01737697|3648116|P10|Subacute Phase|Withdrawal by Subject|1
1112396|NCT01737697|3648117|P9|Subacute Phase|Withdrawal by Subject|0
1112397|NCT01737697|3648118|P8|Subacute Phase|Withdrawal by Subject|2
1112398|NCT01737697|3648119|P7|Subacute Phase|Withdrawal by Subject|0
1112399|NCT01737697|3648120|P6|Subacute Phase|Withdrawal by Subject|1
1112400|NCT01737697|3648121|P5|Subacute Phase|Withdrawal by Subject|0
1112401|NCT01737697|3648122|P4|Subacute Phase|Withdrawal by Subject|0
1112402|NCT01737697|3648123|P3|Subacute Phase|Withdrawal by Subject|0
1112403|NCT01737697|3648124|P2|Subacute Phase|Withdrawal by Subject|0
1112404|NCT01737697|3648125|P1|Subacute Phase|Withdrawal by Subject|0
1112405|NCT01737697|3648111|P15|Subacute Phase|Adverse Event|0
1112406|NCT01737697|3648112|P14|Subacute Phase|Adverse Event|0
1112407|NCT01737697|3648113|P13|Subacute Phase|Adverse Event|1
1112408|NCT01737697|3648114|P12|Subacute Phase|Adverse Event|1
1112409|NCT01737697|3648115|P11|Subacute Phase|Adverse Event|4
1112410|NCT01737697|3648116|P10|Subacute Phase|Adverse Event|1
1112411|NCT01737697|3648117|P9|Subacute Phase|Adverse Event|1
1112412|NCT01737697|3648118|P8|Subacute Phase|Adverse Event|1
1112413|NCT01737697|3648119|P7|Subacute Phase|Adverse Event|1
1112414|NCT01737697|3648120|P6|Subacute Phase|Adverse Event|1
1112415|NCT01737697|3648121|P5|Subacute Phase|Adverse Event|0
1112416|NCT01737697|3648122|P4|Subacute Phase|Adverse Event|0
1112417|NCT01737697|3648123|P3|Subacute Phase|Adverse Event|0
1112418|NCT01737697|3648124|P2|Subacute Phase|Adverse Event|0
1112419|NCT01737697|3648125|P1|Subacute Phase|Adverse Event|0
1112420|NCT01737697|3648111|P15|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
1112421|NCT01737697|3648112|P14|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
1112422|NCT01737697|3648113|P13|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
1112423|NCT01737697|3648114|P12|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
1112424|NCT01737697|3648115|P11|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
1112425|NCT01737697|3648116|P10|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
1112426|NCT01737697|3648117|P9|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
1112427|NCT01737697|3648118|P8|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
1112428|NCT01737697|3648119|P7|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
1112429|NCT01737697|3648120|P6|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
1112430|NCT01737697|3648121|P5|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
1112431|NCT01737697|3648122|P4|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4
1112432|NCT01737697|3648123|P3|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
1112433|NCT01737697|3648124|P2|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
1112434|NCT01737697|3648125|P1|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
1112435|NCT01737697|3648111|P15|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1112436|NCT01737697|3648112|P14|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1112437|NCT01737697|3648113|P13|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1112438|NCT01737697|3648114|P12|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1112439|NCT01737697|3648115|P11|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1112440|NCT01737697|3648116|P10|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1112441|NCT01737697|3648117|P9|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1112442|NCT01737697|3648118|P8|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1112443|NCT01737697|3648119|P7|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1112444|NCT01737697|3648120|P6|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1112445|NCT01737697|3648121|P5|Acute Phase-Initial 48 Hours|Lost to Follow-up|1
1112446|NCT01737697|3648122|P4|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1112447|NCT01737697|3648123|P3|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1112448|NCT01737697|3648124|P2|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1112449|NCT01737697|3648125|P1|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1112450|NCT01737697|3648111|P15|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1112451|NCT01737697|3648112|P14|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1112452|NCT01737697|3648113|P13|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1112453|NCT01737697|3648114|P12|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1112454|NCT01737697|3648115|P11|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1112455|NCT01737697|3648116|P10|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1112456|NCT01737697|3648117|P9|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1112457|NCT01737697|3648118|P8|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1112458|NCT01737697|3648119|P7|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1112459|NCT01737697|3648120|P6|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1112460|NCT01737697|3648121|P5|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1112461|NCT01737697|3648122|P4|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1112462|NCT01737697|3648123|P3|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1112463|NCT01737697|3648124|P2|Acute Phase-Initial 48 Hours|Sponsor's decision|1
1112464|NCT01737697|3648125|P1|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1112465|NCT01737697|3648111|P15|Acute Phase-Initial 48 Hours|Family emergency|0
1112466|NCT01737697|3648112|P14|Acute Phase-Initial 48 Hours|Family emergency|0
1112467|NCT01737697|3648113|P13|Acute Phase-Initial 48 Hours|Family emergency|0
1112468|NCT01737697|3648114|P12|Acute Phase-Initial 48 Hours|Family emergency|0
1112469|NCT01737697|3648115|P11|Acute Phase-Initial 48 Hours|Family emergency|0
1112470|NCT01737697|3648116|P10|Acute Phase-Initial 48 Hours|Family emergency|0
1112471|NCT01737697|3648117|P9|Acute Phase-Initial 48 Hours|Family emergency|0
1112472|NCT01737697|3648118|P8|Acute Phase-Initial 48 Hours|Family emergency|0
1112473|NCT01737697|3648119|P7|Acute Phase-Initial 48 Hours|Family emergency|0
1112474|NCT01737697|3648120|P6|Acute Phase-Initial 48 Hours|Family emergency|0
1112475|NCT01737697|3648121|P5|Acute Phase-Initial 48 Hours|Family emergency|0
1112476|NCT01737697|3648122|P4|Acute Phase-Initial 48 Hours|Family emergency|1
1112477|NCT01737697|3648123|P3|Acute Phase-Initial 48 Hours|Family emergency|0
1112478|NCT01737697|3648124|P2|Acute Phase-Initial 48 Hours|Family emergency|0
1112479|NCT01737697|3648125|P1|Acute Phase-Initial 48 Hours|Family emergency|0
1112480|NCT01737697|3648111|P15|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
1112481|NCT01737697|3648112|P14|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
1112482|NCT01737697|3648113|P13|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
1112483|NCT01737697|3648114|P12|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
1112484|NCT01737697|3648115|P11|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
1112485|NCT01737697|3648116|P10|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
1112486|NCT01737697|3648117|P9|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
1112487|NCT01737697|3648118|P8|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
1112488|NCT01737697|3648119|P7|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
1112489|NCT01737697|3648120|P6|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
1112574|NCT01736176|3649066|P1|Overall Study|Withdrawal by Subject|4
1112490|NCT01737697|3648121|P5|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
1112491|NCT01737697|3648122|P4|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
1112492|NCT01737697|3648123|P3|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3
1112493|NCT01737697|3648124|P2|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1
1112494|NCT01737697|3648125|P1|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1
1112495|NCT01737697|3648111|P15|Acute Phase-Initial 48 Hours|Adverse Event|0
1112496|NCT01737697|3648112|P14|Acute Phase-Initial 48 Hours|Adverse Event|0
1112497|NCT01737697|3648113|P13|Acute Phase-Initial 48 Hours|Adverse Event|0
1112498|NCT01737697|3648114|P12|Acute Phase-Initial 48 Hours|Adverse Event|0
1112499|NCT01737697|3648115|P11|Acute Phase-Initial 48 Hours|Adverse Event|0
1112500|NCT01737697|3648116|P10|Acute Phase-Initial 48 Hours|Adverse Event|0
1112501|NCT01737697|3648117|P9|Acute Phase-Initial 48 Hours|Adverse Event|0
1112502|NCT01737697|3648118|P8|Acute Phase-Initial 48 Hours|Adverse Event|0
1112503|NCT01737697|3648119|P7|Acute Phase-Initial 48 Hours|Adverse Event|0
1112504|NCT01737697|3648120|P6|Acute Phase-Initial 48 Hours|Adverse Event|0
1112505|NCT01737697|3648121|P5|Acute Phase-Initial 48 Hours|Adverse Event|1
1112506|NCT01737697|3648122|P4|Acute Phase-Initial 48 Hours|Adverse Event|1
1112507|NCT01737697|3648123|P3|Acute Phase-Initial 48 Hours|Adverse Event|0
1112508|NCT01737697|3648124|P2|Acute Phase-Initial 48 Hours|Adverse Event|1
1112509|NCT01737697|3648125|P1|Acute Phase-Initial 48 Hours|Adverse Event|0
1112510|NCT01737268|3648266|P1|Overall Study|In consideration of the patient’s safety|1
1112511|NCT01737268|3648266|P1|Overall Study|Worsening of Target Disease|2
1112512|NCT01737268|3648266|P1|Overall Study|Adverse Event|6
1112513|NCT01737021|3648280|P2|Overall Study|Lost to Follow-up|3
1112514|NCT01737021|3648281|P1|Overall Study|Lost to Follow-up|5
1112515|NCT01736917|3648327|P1|Overall Study|Protocol Violation|10
1112516|NCT01736917|3648327|P1|Overall Study|Adverse Event|1
1112517|NCT01736696|3648341|P7|Overall Study|Withdrawal by Subject|0
1112518|NCT01736696|3648342|P6|Overall Study|Withdrawal by Subject|0
1112519|NCT01736696|3648343|P5|Overall Study|Withdrawal by Subject|0
1112520|NCT01736696|3648344|P4|Overall Study|Withdrawal by Subject|0
1112521|NCT01736696|3648345|P3|Overall Study|Withdrawal by Subject|1
1112522|NCT01736696|3648346|P2|Overall Study|Withdrawal by Subject|0
1112523|NCT01736696|3648347|P1|Overall Study|Withdrawal by Subject|0
1112524|NCT01736657|3648664|P1|Overall Study|insufficient vascular access|1
1112525|NCT01736579|3648673|P2|Overall Study|Termination of Study by Sponsor|2
1112526|NCT01736579|3648674|P1|Overall Study|Termination of Study by Sponsor|2
1112527|NCT01736566|3648713|P5|Long Term Follow-up|Still collecting data|1
1112528|NCT01736566|3648714|P4|Long Term Follow-up|Still collecting data|0
1112529|NCT01736566|3648715|P3|Long Term Follow-up|Still collecting data|49
1112530|NCT01736566|3648716|P2|Long Term Follow-up|Still collecting data|0
1112531|NCT01736566|3648717|P1|Long Term Follow-up|Still collecting data|42
1112532|NCT01736553|3648802|P2|Overall Study|Lost to Follow-up|2
1112533|NCT01736553|3648803|P1|Overall Study|Lost to Follow-up|2
1112534|NCT01736553|3648802|P2|Overall Study|Withdrawal by Subject|2
1112535|NCT01736553|3648803|P1|Overall Study|Withdrawal by Subject|5
1112536|NCT01736553|3648802|P2|Overall Study|Death|0
1112537|NCT01736553|3648803|P1|Overall Study|Death|12
1112538|NCT01736540|3648854|P1|Overall Study|Unable to make MRI appointment|3
1112539|NCT01736540|3648854|P1|Overall Study|No show for MRI appointment|1
1112540|NCT01736540|3648854|P1|Overall Study|Unable to tolerate MRI; claustrophobic|1
1112541|NCT01736540|3648854|P1|Overall Study|Protocol Violation|1
1112542|NCT01736540|3648854|P1|Overall Study|Withdrawal by Subject|5
1112543|NCT01736540|3648854|P1|Overall Study|Abnormal test procedure|1
1112544|NCT01736540|3648854|P1|Overall Study|Death|1
1112545|NCT01736540|3648854|P1|Overall Study|Did not complete scan within 45 days|2
1112546|NCT01736475|3648920|P2|Overall Study|Other - Surgical procedure|0
1112547|NCT01736475|3648921|P1|Overall Study|Other - Surgical procedure|1
1112548|NCT01736475|3648920|P2|Overall Study|Other - Screen failure|0
1112549|NCT01736475|3648921|P1|Overall Study|Other - Screen failure|1
1112550|NCT01736475|3648920|P2|Overall Study|Protocol Violation|0
1112551|NCT01736475|3648921|P1|Overall Study|Protocol Violation|4
1112552|NCT01736475|3648920|P2|Overall Study|Withdrawal by Subject|0
1112553|NCT01736475|3648921|P1|Overall Study|Withdrawal by Subject|2
1112554|NCT01736475|3648920|P2|Overall Study|Adverse Event|0
1112555|NCT01736475|3648921|P1|Overall Study|Adverse Event|4
1112556|NCT01736397|3648976|P2|Overall Study|Not stated|4
1112557|NCT01736397|3648977|P1|Overall Study|Not stated|1
1112558|NCT01736397|3648976|P2|Overall Study|Adverse Event|3
1112559|NCT01736397|3648977|P1|Overall Study|Adverse Event|6
1112560|NCT01736397|3648976|P2|Overall Study|Lost to Follow-up|1
1112561|NCT01736397|3648977|P1|Overall Study|Lost to Follow-up|0
1112562|NCT01736397|3648976|P2|Overall Study|Withdrawal by Subject|5
1112563|NCT01736397|3648977|P1|Overall Study|Withdrawal by Subject|6
1112564|NCT01736397|3648976|P2|Overall Study|Lack of Efficacy|11
1112565|NCT01736397|3648977|P1|Overall Study|Lack of Efficacy|1
1112566|NCT01736254|3648989|P1|Period 3 (Days 13 to 23)|Adverse Event|1
1112567|NCT01736254|3648989|P1|Period 2 (Days 2 to 12)|Adverse Event|3
1112568|NCT01736215|3649054|P1|Overall Study|Insufficient data to perform analysis|8
1112569|NCT01736215|3649054|P1|Overall Study|Progressive disease stop chemotherapy|1
1112570|NCT01736215|3649054|P1|Overall Study|Adverse Event|4
1112571|NCT01736215|3649054|P1|Overall Study|Early termination of erythropoietin use|1
1112572|NCT01736176|3649066|P1|Overall Study|Unable to Complete PEG Placement|1
1112573|NCT01736176|3649066|P1|Overall Study|Lack of Efficacy|3
1112575|NCT01736176|3649066|P1|Overall Study|Adverse Event|3
1112576|NCT01735916|3649113|P3|Overall Study|Withdrawal by Subject|0
1112577|NCT01735916|3649114|P2|Overall Study|Withdrawal by Subject|0
1112578|NCT01735916|3649115|P1|Overall Study|Withdrawal by Subject|3
1112579|NCT01735916|3649113|P3|Overall Study|Early termination of study by sponsor|7
1112580|NCT01735916|3649114|P2|Overall Study|Early termination of study by sponsor|19
1112581|NCT01735916|3649115|P1|Overall Study|Early termination of study by sponsor|4
1112582|NCT01735916|3649113|P3|Overall Study|Subject not eligible to be randomized|0
1112583|NCT01735916|3649114|P2|Overall Study|Subject not eligible to be randomized|0
1112584|NCT01735916|3649115|P1|Overall Study|Subject not eligible to be randomized|11
1112585|NCT01735630|3649153|P2|Overall Study|Withdrawal by Subject|9
1112586|NCT01735630|3649154|P1|Overall Study|Withdrawal by Subject|7
1112587|NCT01735630|3649153|P2|Overall Study|Sponsor Decision|1
1112588|NCT01735630|3649154|P1|Overall Study|Sponsor Decision|2
1112589|NCT01735630|3649153|P2|Overall Study|Physician Decision|1
1112590|NCT01735630|3649154|P1|Overall Study|Physician Decision|0
1112591|NCT01735630|3649153|P2|Overall Study|Lost to Follow-up|0
1112592|NCT01735630|3649154|P1|Overall Study|Lost to Follow-up|1
1112593|NCT01735630|3649153|P2|Overall Study|Adverse Event|7
1112594|NCT01735630|3649154|P1|Overall Study|Adverse Event|8
1112595|NCT01735396|3649181|P1|Overall Study|not evaluable|1
1112596|NCT01735201|3649210|P8|Overall Study|Other Miscellaneous Reasons|1
1112597|NCT01735201|3649211|P7|Overall Study|Other Miscellaneous Reasons|1
1112598|NCT01735201|3649212|P6|Overall Study|Other Miscellaneous Reasons|2
1112599|NCT01735201|3649213|P5|Overall Study|Other Miscellaneous Reasons|0
1112600|NCT01735201|3649214|P4|Overall Study|Other Miscellaneous Reasons|1
1112601|NCT01735201|3649215|P3|Overall Study|Other Miscellaneous Reasons|0
1112602|NCT01735201|3649216|P2|Overall Study|Other Miscellaneous Reasons|0
1112603|NCT01735201|3649217|P1|Overall Study|Other Miscellaneous Reasons|0
1112604|NCT01735201|3649210|P8|Overall Study|Protocol Violation|0
1112605|NCT01735201|3649211|P7|Overall Study|Protocol Violation|0
1112606|NCT01735201|3649212|P6|Overall Study|Protocol Violation|0
1112607|NCT01735201|3649213|P5|Overall Study|Protocol Violation|0
1112608|NCT01735201|3649214|P4|Overall Study|Protocol Violation|0
1112609|NCT01735201|3649215|P3|Overall Study|Protocol Violation|0
1112610|NCT01735201|3649216|P2|Overall Study|Protocol Violation|0
1112611|NCT01735201|3649217|P1|Overall Study|Protocol Violation|1
1112612|NCT01735201|3649210|P8|Overall Study|Personal Reasons|0
1112613|NCT01735201|3649211|P7|Overall Study|Personal Reasons|0
1112614|NCT01735201|3649212|P6|Overall Study|Personal Reasons|0
1112615|NCT01735201|3649213|P5|Overall Study|Personal Reasons|0
1112616|NCT01735201|3649214|P4|Overall Study|Personal Reasons|0
1112617|NCT01735201|3649215|P3|Overall Study|Personal Reasons|0
1112618|NCT01735201|3649216|P2|Overall Study|Personal Reasons|0
1112619|NCT01735201|3649217|P1|Overall Study|Personal Reasons|1
1112620|NCT01735201|3649210|P8|Overall Study|Adverse Event|1
1112621|NCT01735201|3649211|P7|Overall Study|Adverse Event|2
1112622|NCT01735201|3649212|P6|Overall Study|Adverse Event|3
1112623|NCT01735201|3649213|P5|Overall Study|Adverse Event|1
1112624|NCT01735201|3649214|P4|Overall Study|Adverse Event|1
1112625|NCT01735201|3649215|P3|Overall Study|Adverse Event|0
1112626|NCT01735201|3649216|P2|Overall Study|Adverse Event|1
1112627|NCT01735201|3649217|P1|Overall Study|Adverse Event|1
1112628|NCT01735175|3649253|P2|Overall Study|Other (mostly EOS/EOT visit missing)|7
1112629|NCT01735175|3649254|P1|Overall Study|Other (mostly EOS/EOT visit missing)|13
1112630|NCT01735175|3649253|P2|Overall Study|Death|2
1112631|NCT01735175|3649254|P1|Overall Study|Death|3
1112632|NCT01735175|3649253|P2|Overall Study|Lost to Follow-up|2
1112633|NCT01735175|3649254|P1|Overall Study|Lost to Follow-up|4
1112634|NCT01735175|3649253|P2|Overall Study|Withdrawal by Subject|2
1112635|NCT01735175|3649254|P1|Overall Study|Withdrawal by Subject|9
1112636|NCT01734993|3649274|P1|Overall Study|Lack of Efficacy|1
1112637|NCT01734993|3649274|P1|Overall Study|Adverse Event|1
1112638|NCT01734785|3649311|P4|Double−Blind Period|Not treated|0
1112639|NCT01734785|3649312|P3|Double−Blind Period|Not treated|0
1112640|NCT01734785|3649313|P2|Double−Blind Period|Not treated|0
1112641|NCT01734785|3649314|P1|Double−Blind Period|Not treated|1
1112642|NCT01734785|3649311|P4|Double−Blind Period|Withdrawal by Subject|0
1112643|NCT01734785|3649312|P3|Double−Blind Period|Withdrawal by Subject|0
1112644|NCT01734785|3649313|P2|Double−Blind Period|Withdrawal by Subject|0
1112645|NCT01734785|3649314|P1|Double−Blind Period|Withdrawal by Subject|2
1112646|NCT01734785|3649311|P4|Double−Blind Period|Lost to Follow-up|0
1112647|NCT01734785|3649312|P3|Double−Blind Period|Lost to Follow-up|2
1112648|NCT01734785|3649313|P2|Double−Blind Period|Lost to Follow-up|4
1112649|NCT01734785|3649314|P1|Double−Blind Period|Lost to Follow-up|2
1112650|NCT01734785|3649311|P4|Double−Blind Period|Protocol Violation|0
1112651|NCT01734785|3649312|P3|Double−Blind Period|Protocol Violation|1
1112652|NCT01734785|3649313|P2|Double−Blind Period|Protocol Violation|1
1112653|NCT01734785|3649314|P1|Double−Blind Period|Protocol Violation|0
1112654|NCT01734785|3649311|P4|Double−Blind Period|Lack of Efficacy|0
1112655|NCT01734785|3649312|P3|Double−Blind Period|Lack of Efficacy|0
1112656|NCT01734785|3649313|P2|Double−Blind Period|Lack of Efficacy|1
1112657|NCT01734785|3649314|P1|Double−Blind Period|Lack of Efficacy|0
1112658|NCT01734785|3649311|P4|Double−Blind Period|Adverse Event|0
1112659|NCT01734785|3649312|P3|Double−Blind Period|Adverse Event|2
1112660|NCT01734785|3649313|P2|Double−Blind Period|Adverse Event|3
1112661|NCT01734785|3649314|P1|Double−Blind Period|Adverse Event|0
1112662|NCT01734785|3649311|P4|Open−Label Period|Other Reasons|224
1112663|NCT01734785|3649312|P3|Open−Label Period|Other Reasons|0
1112664|NCT01734785|3649313|P2|Open−Label Period|Other Reasons|0
1112665|NCT01734785|3649314|P1|Open−Label Period|Other Reasons|0
1112666|NCT01734785|3649311|P4|Open−Label Period|Withdrawal by Subject|12
1112667|NCT01734785|3649312|P3|Open−Label Period|Withdrawal by Subject|0
1112668|NCT01734785|3649313|P2|Open−Label Period|Withdrawal by Subject|0
1112669|NCT01734785|3649314|P1|Open−Label Period|Withdrawal by Subject|0
1112670|NCT01734785|3649311|P4|Open−Label Period|Lost to Follow-up|14
1112671|NCT01734785|3649312|P3|Open−Label Period|Lost to Follow-up|0
1112672|NCT01734785|3649313|P2|Open−Label Period|Lost to Follow-up|0
1112673|NCT01734785|3649314|P1|Open−Label Period|Lost to Follow-up|0
1112674|NCT01734785|3649311|P4|Open−Label Period|Protocol Violation|13
1112675|NCT01734785|3649312|P3|Open−Label Period|Protocol Violation|0
1112676|NCT01734785|3649313|P2|Open−Label Period|Protocol Violation|0
1112677|NCT01734785|3649314|P1|Open−Label Period|Protocol Violation|0
1112678|NCT01734785|3649311|P4|Open−Label Period|Lack of Efficacy|1
1112679|NCT01734785|3649312|P3|Open−Label Period|Lack of Efficacy|0
1112680|NCT01734785|3649313|P2|Open−Label Period|Lack of Efficacy|0
1112681|NCT01734785|3649314|P1|Open−Label Period|Lack of Efficacy|0
1112682|NCT01734785|3649311|P4|Open−Label Period|Adverse Event|9
1112683|NCT01734785|3649312|P3|Open−Label Period|Adverse Event|0
1112684|NCT01734785|3649313|P2|Open−Label Period|Adverse Event|0
1112685|NCT01734785|3649314|P1|Open−Label Period|Adverse Event|0
1112686|NCT01734772|3649331|P2|Overall Study|Withdrawal by Subject|1
1112687|NCT01734772|3649332|P1|Overall Study|Withdrawal by Subject|0
1112688|NCT01734772|3649331|P2|Overall Study|Adverse Event|2
1112689|NCT01734772|3649332|P1|Overall Study|Adverse Event|1
1112690|NCT01734434|3649383|P4|Overall Study|17 Yr Old Subject Signed Consent form|0
1112691|NCT01734434|3649384|P3|Overall Study|17 Yr Old Subject Signed Consent form|1
1112692|NCT01734434|3649385|P2|Overall Study|17 Yr Old Subject Signed Consent form|0
1112693|NCT01734434|3649386|P1|Overall Study|17 Yr Old Subject Signed Consent form|0
1112694|NCT01734434|3649383|P4|Overall Study|Wrong Version of Consent Form Signed|0
1112695|NCT01734434|3649384|P3|Overall Study|Wrong Version of Consent Form Signed|1
1112696|NCT01734434|3649385|P2|Overall Study|Wrong Version of Consent Form Signed|0
1112697|NCT01734434|3649386|P1|Overall Study|Wrong Version of Consent Form Signed|0
1112698|NCT01734434|3649383|P4|Overall Study|Treatment Defaulter|0
1112699|NCT01734434|3649384|P3|Overall Study|Treatment Defaulter|1
1112700|NCT01734434|3649385|P2|Overall Study|Treatment Defaulter|0
1112701|NCT01734434|3649386|P1|Overall Study|Treatment Defaulter|0
1112702|NCT01734434|3649383|P4|Overall Study|Subject Not Reachable|0
1112703|NCT01734434|3649384|P3|Overall Study|Subject Not Reachable|1
1112704|NCT01734434|3649385|P2|Overall Study|Subject Not Reachable|0
1112705|NCT01734434|3649386|P1|Overall Study|Subject Not Reachable|0
1112706|NCT01734434|3649383|P4|Overall Study|Signed Adult Version of Consent Form|0
1112707|NCT01734434|3649384|P3|Overall Study|Signed Adult Version of Consent Form|1
1112708|NCT01734434|3649385|P2|Overall Study|Signed Adult Version of Consent Form|0
1112709|NCT01734434|3649386|P1|Overall Study|Signed Adult Version of Consent Form|0
1112710|NCT01734434|3649383|P4|Overall Study|Withdrawal by Subject|1
1112711|NCT01734434|3649384|P3|Overall Study|Withdrawal by Subject|8
1112712|NCT01734434|3649385|P2|Overall Study|Withdrawal by Subject|0
1112713|NCT01734434|3649386|P1|Overall Study|Withdrawal by Subject|4
1112714|NCT01734434|3649383|P4|Overall Study|No Live Birth|6
1112715|NCT01734434|3649384|P3|Overall Study|No Live Birth|32
1112716|NCT01734434|3649385|P2|Overall Study|No Live Birth|2
1112717|NCT01734434|3649386|P1|Overall Study|No Live Birth|1
1112718|NCT01734434|3649383|P4|Overall Study|Lost to Follow-up|11
1112719|NCT01734434|3649384|P3|Overall Study|Lost to Follow-up|67
1112720|NCT01734434|3649385|P2|Overall Study|Lost to Follow-up|9
1112721|NCT01734434|3649386|P1|Overall Study|Lost to Follow-up|2
1112722|NCT01734434|3649383|P4|Overall Study|Death Infant|5
1112723|NCT01734434|3649384|P3|Overall Study|Death Infant|17
1112724|NCT01734434|3649385|P2|Overall Study|Death Infant|1
1112725|NCT01734434|3649386|P1|Overall Study|Death Infant|3
1112726|NCT01734395|3649408|P1|Overall Study|Missing the reasons for not completed|3
1112727|NCT01734395|3649408|P1|Overall Study|Withdrawal by Subject|10
1112728|NCT01734395|3649408|P1|Overall Study|Adverse Event|40
1112729|NCT01734395|3649408|P1|Overall Study|Lack of Efficacy|5
1112730|NCT01734395|3649408|P1|Overall Study|Lost to Follow-up|287
1112731|NCT01734395|3649408|P1|Overall Study|Not specified|65
1112732|NCT01733758|3649466|P4|Overall Study|Inv Decision, HbA1c not controlled|1
1112733|NCT01733758|3649467|P3|Overall Study|Inv Decision, HbA1c not controlled|0
1112734|NCT01733758|3649468|P2|Overall Study|Inv Decision, HbA1c not controlled|1
1112735|NCT01733758|3649469|P1|Overall Study|Inv Decision, HbA1c not controlled|1
1112736|NCT01733758|3649466|P4|Overall Study|Intro of New Anti-Diabetic Medication|1
1112737|NCT01733758|3649467|P3|Overall Study|Intro of New Anti-Diabetic Medication|0
1112738|NCT01733758|3649468|P2|Overall Study|Intro of New Anti-Diabetic Medication|0
1112739|NCT01733758|3649469|P1|Overall Study|Intro of New Anti-Diabetic Medication|4
1112740|NCT01733758|3649466|P4|Overall Study|Non-compliance|0
1112741|NCT01733758|3649467|P3|Overall Study|Non-compliance|0
1112742|NCT01733758|3649468|P2|Overall Study|Non-compliance|0
1112743|NCT01733758|3649469|P1|Overall Study|Non-compliance|1
1112744|NCT01733758|3649466|P4|Overall Study|Protocol Violation|2
1112745|NCT01733758|3649467|P3|Overall Study|Protocol Violation|2
1112746|NCT01733758|3649468|P2|Overall Study|Protocol Violation|1
1112747|NCT01733758|3649469|P1|Overall Study|Protocol Violation|0
1112748|NCT01733758|3649466|P4|Overall Study|Persistent Hyperglycemia|0
1112749|NCT01733758|3649467|P3|Overall Study|Persistent Hyperglycemia|0
1112750|NCT01733758|3649468|P2|Overall Study|Persistent Hyperglycemia|2
1112751|NCT01733758|3649469|P1|Overall Study|Persistent Hyperglycemia|3
1112752|NCT01733758|3649466|P4|Overall Study|Withdrawal by Subject|3
1112753|NCT01733758|3649467|P3|Overall Study|Withdrawal by Subject|5
1112754|NCT01733758|3649468|P2|Overall Study|Withdrawal by Subject|1
1112755|NCT01733758|3649469|P1|Overall Study|Withdrawal by Subject|1
1112756|NCT01733758|3649466|P4|Overall Study|Adverse Event|1
1112757|NCT01733758|3649467|P3|Overall Study|Adverse Event|8
1112758|NCT01733758|3649468|P2|Overall Study|Adverse Event|7
1112759|NCT01733758|3649469|P1|Overall Study|Adverse Event|5
1112760|NCT01733732|3649535|P2|Overall Study|Did not attend all study visits|0
1112761|NCT01733732|3649536|P1|Overall Study|Did not attend all study visits|1
1112762|NCT01733732|3649535|P2|Overall Study|Adverse Event|0
1112763|NCT01733732|3649536|P1|Overall Study|Adverse Event|1
1112764|NCT01733680|3649572|P2|Overall Study|Withdrawal by Subject|1
1112765|NCT01733680|3649573|P1|Overall Study|Withdrawal by Subject|0
1112766|NCT01733329|3649612|P2|Overall Study|Uterine artery injury|0
1112767|NCT01733329|3649613|P1|Overall Study|Uterine artery injury|1
1112768|NCT01733329|3649612|P2|Overall Study|Protocol Violation|1
1112769|NCT01733329|3649613|P1|Overall Study|Protocol Violation|1
1112770|NCT01733316|3649625|P1|Long Term Extension Phase|Sponsor Decision|2
1112771|NCT01733316|3649625|P1|Long Term Extension Phase|Consent Withdrawn by Subject|2
1112772|NCT01733316|3649625|P1|Long Term Extension Phase|Adverse Event|1
1112773|NCT01733316|3649625|P1|RP103 Phase|Non-compliance|1
1112774|NCT01733121|3649663|P2|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
1112775|NCT01733121|3649664|P1|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
1112776|NCT01733121|3649663|P2|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3
1112777|NCT01733121|3649664|P1|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
1112778|NCT01733121|3649663|P2|Double-Blind Period (Week 0 to 6)|Non-compliance|2
1112779|NCT01733121|3649664|P1|Double-Blind Period (Week 0 to 6)|Non-compliance|3
1112780|NCT01733121|3649663|P2|Double-Blind Period (Week 0 to 6)|Adverse Event|0
1112781|NCT01733121|3649664|P1|Double-Blind Period (Week 0 to 6)|Adverse Event|2
1112782|NCT01732926|3649706|P2|Overall Study|Blind Broken by Subject or Study Site|1
1112783|NCT01732926|3649707|P1|Overall Study|Blind Broken by Subject or Study Site|1
1112784|NCT01732926|3649706|P2|Overall Study|Initiation of Other Anti-Cancer Therapy|6
1112785|NCT01732926|3649707|P1|Overall Study|Initiation of Other Anti-Cancer Therapy|7
1112786|NCT01732926|3649706|P2|Overall Study|Other Reason|4
1112787|NCT01732926|3649707|P1|Overall Study|Other Reason|21
1112788|NCT01732926|3649706|P2|Overall Study|Physician Decision|11
1112789|NCT01732926|3649707|P1|Overall Study|Physician Decision|24
1112790|NCT01732926|3649706|P2|Overall Study|Withdrawal by Subject|8
1112791|NCT01732926|3649707|P1|Overall Study|Withdrawal by Subject|46
1112792|NCT01732926|3649706|P2|Overall Study|Study Terminated by Sponsor|80
1112793|NCT01732926|3649707|P1|Overall Study|Study Terminated by Sponsor|168
1112794|NCT01732913|3649723|P2|Overall Study|Initiation of Other Anti-Cancer Therapy|2
1112795|NCT01732913|3649724|P1|Overall Study|Initiation of Other Anti-Cancer Therapy|3
1112796|NCT01732913|3649723|P2|Overall Study|Other|1
1112797|NCT01732913|3649724|P1|Overall Study|Other|7
1112798|NCT01732913|3649723|P2|Overall Study|Physician Decision|7
1112799|NCT01732913|3649724|P1|Overall Study|Physician Decision|14
1112800|NCT01732913|3649723|P2|Overall Study|Withdrawal by Subject|4
1112801|NCT01732913|3649724|P1|Overall Study|Withdrawal by Subject|27
1112802|NCT01732913|3649723|P2|Overall Study|Study Terminated by Sponsor|55
1112803|NCT01732913|3649724|P1|Overall Study|Study Terminated by Sponsor|105
1112804|NCT01732835|3649738|P1|2-year Extended Follow-up|Death|1
1112805|NCT01732835|3649738|P1|2-year Extended Follow-up|Adverse Event|3
1112806|NCT01732835|3649738|P1|2-year Extended Follow-up|Withdrawal by Subject|1
1112807|NCT01732835|3649738|P1|6-month Primary Endpoint|Adverse Event|3
1112808|NCT01732835|3649738|P1|6-month Primary Endpoint|Withdrawal by Subject|2
1112809|NCT01732835|3649738|P1|6-month Primary Endpoint|Did not receive device|19
1112810|NCT01732822|3649771|P2|Overall Study|Withdrawal by Subject|113
1112811|NCT01732822|3649772|P1|Overall Study|Withdrawal by Subject|123
1112812|NCT01732796|3649845|P3|Overall Study|Other reason not defined above|2
1112813|NCT01732796|3649846|P2|Overall Study|Other reason not defined above|0
1112814|NCT01732796|3649847|P1|Overall Study|Other reason not defined above|1
1112815|NCT01732796|3649845|P3|Overall Study|Withdrawal by Subject|2
1112816|NCT01732796|3649846|P2|Overall Study|Withdrawal by Subject|8
1112817|NCT01732796|3649847|P1|Overall Study|Withdrawal by Subject|6
1112818|NCT01732796|3649845|P3|Overall Study|Lost to Follow-up|0
1112819|NCT01732796|3649846|P2|Overall Study|Lost to Follow-up|0
1112820|NCT01732796|3649847|P1|Overall Study|Lost to Follow-up|2
1112821|NCT01732796|3649845|P3|Overall Study|Lack of Efficacy|5
1112822|NCT01732796|3649846|P2|Overall Study|Lack of Efficacy|18
1112823|NCT01732796|3649847|P1|Overall Study|Lack of Efficacy|21
1112824|NCT01732796|3649845|P3|Overall Study|Adverse Event|4
1112825|NCT01732796|3649846|P2|Overall Study|Adverse Event|16
1112826|NCT01732796|3649847|P1|Overall Study|Adverse Event|16
1112827|NCT01732783|3649866|P3|Overall Study|Withdrawal by Subject|0
1112828|NCT01732783|3649867|P2|Overall Study|Withdrawal by Subject|0
1112829|NCT01732783|3649868|P1|Overall Study|Withdrawal by Subject|1
1112830|NCT01732783|3649866|P3|Overall Study|Administrative Decision|1
1112831|NCT01732783|3649867|P2|Overall Study|Administrative Decision|2
1112832|NCT01732783|3649868|P1|Overall Study|Administrative Decision|8
1112833|NCT01732783|3649866|P3|Overall Study|Lost to Follow-up|1
1112834|NCT01732783|3649867|P2|Overall Study|Lost to Follow-up|1
1112835|NCT01732783|3649868|P1|Overall Study|Lost to Follow-up|7
1112836|NCT01732783|3649866|P3|Overall Study|Death|1
1112837|NCT01732783|3649867|P2|Overall Study|Death|4
1112838|NCT01732783|3649868|P1|Overall Study|Death|13
1112839|NCT01732783|3649866|P3|Overall Study|Discontinued Panitumumab Treatment|7
1112840|NCT01732783|3649867|P2|Overall Study|Discontinued Panitumumab Treatment|25
1112841|NCT01732783|3649868|P1|Overall Study|Discontinued Panitumumab Treatment|106
1112842|NCT01732770|3649932|P2|Overall Study|Death|0
1112843|NCT01732770|3649933|P1|Overall Study|Death|1
1112844|NCT01732770|3649932|P2|Overall Study|Decision by Sponsor|2
1112845|NCT01732770|3649933|P1|Overall Study|Decision by Sponsor|2
1112846|NCT01732770|3649932|P2|Overall Study|Withdrawal by Subject|3
1112847|NCT01732770|3649933|P1|Overall Study|Withdrawal by Subject|5
1112848|NCT01732770|3649932|P2|Overall Study|Lost to Follow-up|3
1112849|NCT01732770|3649933|P1|Overall Study|Lost to Follow-up|2
1112850|NCT01732757|3649948|P3|Overall Study|Lost to Follow-up|0
1112851|NCT01732757|3649949|P2|Overall Study|Lost to Follow-up|0
1112852|NCT01732757|3649950|P1|Overall Study|Lost to Follow-up|1
1112853|NCT01732692|3649990|P2|Overall Study|Adverse Event|1
1112854|NCT01732692|3649991|P1|Overall Study|Adverse Event|0
1112855|NCT01732640|3650005|P2|Overall Study|Death|1
1112856|NCT01732640|3650006|P1|Overall Study|Death|0
1112857|NCT01732640|3650005|P2|Overall Study|Adverse Event|1
1112858|NCT01732640|3650006|P1|Overall Study|Adverse Event|0
1112859|NCT01732588|3650024|P3|First Intervention (7 Days)|Adverse Event|0
1112860|NCT01732588|3650025|P2|First Intervention (7 Days)|Adverse Event|1
1112861|NCT01732588|3650026|P1|First Intervention (7 Days)|Adverse Event|0
1112862|NCT01732549|3650042|P2|Overall Study|Not Specified|14
1112863|NCT01732549|3650043|P1|Overall Study|Not Specified|8
1112864|NCT01732549|3650042|P2|Overall Study|Disease progression|50
1112865|NCT01732549|3650043|P1|Overall Study|Disease progression|37
1112866|NCT01732549|3650042|P2|Overall Study|Consent withdrawn|6
1112867|NCT01732549|3650043|P1|Overall Study|Consent withdrawn|13
1112868|NCT01732549|3650042|P2|Overall Study|Adverse Event|3
1112869|NCT01732549|3650043|P1|Overall Study|Adverse Event|13
1112870|NCT01732536|3650065|P2|Overall Study|Withdrawal by Subject|1
1112871|NCT01732536|3650066|P1|Overall Study|Withdrawal by Subject|1
1112872|NCT01732510|3650089|P7|Overall Study|Study Terminated By Sponsor|6
1112873|NCT01732510|3650090|P6|Overall Study|Study Terminated By Sponsor|12
1112874|NCT01732510|3650091|P5|Overall Study|Study Terminated By Sponsor|0
1112875|NCT01732510|3650092|P4|Overall Study|Study Terminated By Sponsor|1
1112876|NCT01732510|3650093|P3|Overall Study|Study Terminated By Sponsor|0
1112877|NCT01732510|3650094|P2|Overall Study|Study Terminated By Sponsor|0
1112878|NCT01732510|3650095|P1|Overall Study|Study Terminated By Sponsor|0
1112879|NCT01732510|3650089|P7|Overall Study|Pregnancy|0
1112880|NCT01732510|3650090|P6|Overall Study|Pregnancy|0
1112881|NCT01732510|3650091|P5|Overall Study|Pregnancy|0
1112882|NCT01732510|3650092|P4|Overall Study|Pregnancy|1
1112883|NCT01732510|3650093|P3|Overall Study|Pregnancy|0
1112884|NCT01732510|3650094|P2|Overall Study|Pregnancy|0
1112885|NCT01732510|3650095|P1|Overall Study|Pregnancy|0
1112886|NCT01732510|3650089|P7|Overall Study|Physician Decision|0
1112887|NCT01732510|3650090|P6|Overall Study|Physician Decision|0
1112888|NCT01732510|3650091|P5|Overall Study|Physician Decision|0
1112889|NCT01732510|3650092|P4|Overall Study|Physician Decision|0
1112890|NCT01732510|3650093|P3|Overall Study|Physician Decision|0
1112891|NCT01732510|3650094|P2|Overall Study|Physician Decision|1
1112892|NCT01732510|3650095|P1|Overall Study|Physician Decision|0
1112893|NCT01732510|3650089|P7|Overall Study|Lost to Follow-up|0
1112894|NCT01732510|3650090|P6|Overall Study|Lost to Follow-up|1
1112895|NCT01732510|3650091|P5|Overall Study|Lost to Follow-up|0
1112896|NCT01732510|3650092|P4|Overall Study|Lost to Follow-up|1
1112897|NCT01732510|3650093|P3|Overall Study|Lost to Follow-up|1
1112898|NCT01732510|3650094|P2|Overall Study|Lost to Follow-up|0
1112899|NCT01732510|3650095|P1|Overall Study|Lost to Follow-up|0
1112900|NCT01732510|3650089|P7|Overall Study|Withdrawal by Subject|1
1112901|NCT01732510|3650090|P6|Overall Study|Withdrawal by Subject|0
1112902|NCT01732510|3650091|P5|Overall Study|Withdrawal by Subject|5
1112903|NCT01732510|3650092|P4|Overall Study|Withdrawal by Subject|1
1112904|NCT01732510|3650093|P3|Overall Study|Withdrawal by Subject|2
1112905|NCT01732510|3650094|P2|Overall Study|Withdrawal by Subject|3
1112906|NCT01732510|3650095|P1|Overall Study|Withdrawal by Subject|1
1112907|NCT01732510|3650089|P7|Overall Study|Protocol Violation|0
1112908|NCT01732510|3650090|P6|Overall Study|Protocol Violation|0
1112909|NCT01732510|3650091|P5|Overall Study|Protocol Violation|0
1112910|NCT01732510|3650092|P4|Overall Study|Protocol Violation|1
1112911|NCT01732510|3650093|P3|Overall Study|Protocol Violation|0
1112912|NCT01732510|3650094|P2|Overall Study|Protocol Violation|0
1112913|NCT01732510|3650095|P1|Overall Study|Protocol Violation|0
1112914|NCT01732510|3650089|P7|Overall Study|Adverse Event|1
1112915|NCT01732510|3650090|P6|Overall Study|Adverse Event|0
1112916|NCT01732510|3650091|P5|Overall Study|Adverse Event|0
1112917|NCT01732510|3650092|P4|Overall Study|Adverse Event|0
1112918|NCT01732510|3650093|P3|Overall Study|Adverse Event|1
1112919|NCT01732510|3650094|P2|Overall Study|Adverse Event|1
1112920|NCT01732510|3650095|P1|Overall Study|Adverse Event|0
1112921|NCT01732484|3650174|P1|Overall Study|chronical illness|5
1112922|NCT01732484|3650174|P1|Overall Study|Lost to Follow-up|14
1112923|NCT01732484|3650174|P1|Overall Study|Death|7
1112924|NCT01732471|3650182|P1|Overall Study|Withdrawal by Subject|1
1112925|NCT01732458|3650193|P4|Overall Study|Screen Failure|0
1112926|NCT01732458|3650194|P3|Overall Study|Screen Failure|0
1112927|NCT01732458|3650195|P2|Overall Study|Screen Failure|1
1112928|NCT01732458|3650196|P1|Overall Study|Screen Failure|0
1112929|NCT01732458|3650193|P4|Overall Study|Protocol Violation|2
1112930|NCT01732458|3650194|P3|Overall Study|Protocol Violation|0
1112931|NCT01732458|3650195|P2|Overall Study|Protocol Violation|0
1112932|NCT01732458|3650196|P1|Overall Study|Protocol Violation|2
1112933|NCT01732458|3650193|P4|Overall Study|Physician Decision|0
1112934|NCT01732458|3650194|P3|Overall Study|Physician Decision|2
1112935|NCT01732458|3650195|P2|Overall Study|Physician Decision|2
1112936|NCT01732458|3650196|P1|Overall Study|Physician Decision|1
1112937|NCT01732458|3650193|P4|Overall Study|Non-Compliance With Study Drug|0
1112938|NCT01732458|3650194|P3|Overall Study|Non-Compliance With Study Drug|1
1112939|NCT01732458|3650195|P2|Overall Study|Non-Compliance With Study Drug|0
1112940|NCT01732458|3650196|P1|Overall Study|Non-Compliance With Study Drug|0
1112941|NCT01732458|3650193|P4|Overall Study|Lost to Follow-up|0
1112942|NCT01732458|3650194|P3|Overall Study|Lost to Follow-up|0
1112943|NCT01732458|3650195|P2|Overall Study|Lost to Follow-up|2
1112944|NCT01732458|3650196|P1|Overall Study|Lost to Follow-up|0
1112945|NCT01732107|3650308|P1|Overall Study|Withdrawal by Subject|2
1112946|NCT01732107|3650308|P1|Overall Study|Physician Decision|1
1112947|NCT01732107|3650308|P1|Overall Study|Disease Progression|8
1112948|NCT01732107|3650308|P1|Overall Study|Adverse Event|2
1112949|NCT01731990|3650325|P2|Overall Study|Death|0
1112950|NCT01731990|3650326|P1|Overall Study|Death|1
1112951|NCT01731990|3650325|P2|Overall Study|Protocol deviation|2
1112952|NCT01731990|3650326|P1|Overall Study|Protocol deviation|1
1112953|NCT01731990|3650325|P2|Overall Study|Withdrawal by Subject|1
1112954|NCT01731990|3650326|P1|Overall Study|Withdrawal by Subject|1
1112955|NCT01731990|3650325|P2|Overall Study|Adverse Event|5
1112956|NCT01731990|3650326|P1|Overall Study|Adverse Event|1
1112957|NCT01731938|3650342|P2|Primary Part II|Missed Week 6 visit|3
1112958|NCT01731938|3650343|P1|Primary Part II|Missed Week 6 visit|2
1112959|NCT01731938|3650342|P2|Primary Part II|Death|1
1112960|NCT01731938|3650343|P1|Primary Part II|Death|2
1112961|NCT01731938|3650342|P2|Primary Part II|Lost to Follow-up|5
1112962|NCT01731938|3650343|P1|Primary Part II|Lost to Follow-up|4
1112963|NCT01731938|3650342|P2|Primary Part II|Withdrawal by Subject|4
1112964|NCT01731938|3650343|P1|Primary Part II|Withdrawal by Subject|5
1112965|NCT01731938|3650342|P2|Preliminary Part I|Missed Week 6 visit|3
1112966|NCT01731938|3650343|P1|Preliminary Part I|Missed Week 6 visit|0
1112967|NCT01731938|3650342|P2|Preliminary Part I|Lost to Follow-up|3
1112968|NCT01731938|3650343|P1|Preliminary Part I|Lost to Follow-up|0
1112969|NCT01731938|3650342|P2|Preliminary Part I|Physician Decision|0
1112970|NCT01731938|3650343|P1|Preliminary Part I|Physician Decision|1
1112971|NCT01731938|3650342|P2|Preliminary Part I|Withdrawal by Subject|2
1112972|NCT01731938|3650343|P1|Preliminary Part I|Withdrawal by Subject|2
1112973|NCT01731470|3650355|P1|Overall Study|Did not meet study criteria|1
1112974|NCT01731470|3650355|P1|Overall Study|Withdrawal by Subject|1
1112975|NCT01731002|3650382|P3|Overall Study|Inappropriate use of study medications|1
1112976|NCT01731002|3650383|P2|Overall Study|Inappropriate use of study medications|0
1112977|NCT01731002|3650384|P1|Overall Study|Inappropriate use of study medications|0
1112978|NCT01731002|3650382|P3|Overall Study|Elevated IOP|0
1112979|NCT01731002|3650383|P2|Overall Study|Elevated IOP|0
1112980|NCT01731002|3650384|P1|Overall Study|Elevated IOP|1
1112981|NCT01731002|3650382|P3|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
1112982|NCT01731002|3650383|P2|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
1112983|NCT01731002|3650384|P1|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2
1112984|NCT01731002|3650382|P3|Overall Study|Test Agent Discontinuation|0
1112985|NCT01731002|3650383|P2|Overall Study|Test Agent Discontinuation|1
1112986|NCT01731002|3650384|P1|Overall Study|Test Agent Discontinuation|0
1112987|NCT01731002|3650382|P3|Overall Study|Lost to Follow-up|0
1112988|NCT01731002|3650383|P2|Overall Study|Lost to Follow-up|0
1112989|NCT01731002|3650384|P1|Overall Study|Lost to Follow-up|1
1112990|NCT01731002|3650382|P3|Overall Study|Non-Compliant|0
1112991|NCT01731002|3650383|P2|Overall Study|Non-Compliant|1
1112992|NCT01731002|3650384|P1|Overall Study|Non-Compliant|0
1112993|NCT01731002|3650382|P3|Overall Study|Adverse Event|2
1112994|NCT01731002|3650383|P2|Overall Study|Adverse Event|2
1112995|NCT01731002|3650384|P1|Overall Study|Adverse Event|0
1112996|NCT01730378|3650413|P2|Overall Study|Lost to Follow-up|0
1112997|NCT01730378|3650414|P1|Overall Study|Lost to Follow-up|1
1112998|NCT01730339|3650445|P2|Overall Study|Un-specified|0
1112999|NCT01730339|3650446|P1|Overall Study|Un-specified|1
1113000|NCT01730339|3650445|P2|Overall Study|Lost to Follow-up|1
1113001|NCT01730339|3650446|P1|Overall Study|Lost to Follow-up|1
1113002|NCT01730339|3650445|P2|Overall Study|Withdrawal by Subject|2
1113003|NCT01730339|3650446|P1|Overall Study|Withdrawal by Subject|3
1113004|NCT01730053|3650486|P6|Overall Study|Other than specified|9
1113005|NCT01730053|3650487|P5|Overall Study|Other than specified|7
1113006|NCT01730053|3650488|P4|Overall Study|Other than specified|4
1113007|NCT01730053|3650489|P3|Overall Study|Other than specified|5
1113008|NCT01730053|3650490|P2|Overall Study|Other than specified|6
1113009|NCT01730053|3650491|P1|Overall Study|Other than specified|2
1113010|NCT01730053|3650486|P6|Overall Study|Poor compliance to protocol|2
1113011|NCT01730053|3650487|P5|Overall Study|Poor compliance to protocol|0
1113012|NCT01730053|3650488|P4|Overall Study|Poor compliance to protocol|0
1113013|NCT01730053|3650489|P3|Overall Study|Poor compliance to protocol|2
1113014|NCT01730053|3650490|P2|Overall Study|Poor compliance to protocol|2
1113015|NCT01730053|3650491|P1|Overall Study|Poor compliance to protocol|1
1113016|NCT01730053|3650486|P6|Overall Study|Adverse Event|2
1113017|NCT01730053|3650487|P5|Overall Study|Adverse Event|2
1113018|NCT01730053|3650488|P4|Overall Study|Adverse Event|3
1113019|NCT01730053|3650489|P3|Overall Study|Adverse Event|3
1113020|NCT01730053|3650490|P2|Overall Study|Adverse Event|6
1113021|NCT01730053|3650491|P1|Overall Study|Adverse Event|2
1113022|NCT01730053|3650486|P6|Overall Study|Physician Decision|0
1113023|NCT01730053|3650487|P5|Overall Study|Physician Decision|0
1113024|NCT01730053|3650488|P4|Overall Study|Physician Decision|1
1113025|NCT01730053|3650489|P3|Overall Study|Physician Decision|0
1113026|NCT01730053|3650490|P2|Overall Study|Physician Decision|0
1113027|NCT01730053|3650491|P1|Overall Study|Physician Decision|0
1113028|NCT01730053|3650486|P6|Overall Study|Participant moved|0
1113029|NCT01730053|3650487|P5|Overall Study|Participant moved|0
1113030|NCT01730053|3650488|P4|Overall Study|Participant moved|0
1113031|NCT01730053|3650489|P3|Overall Study|Participant moved|1
1113032|NCT01730053|3650490|P2|Overall Study|Participant moved|0
1113033|NCT01730053|3650491|P1|Overall Study|Participant moved|0
1113034|NCT01730040|3650650|P7|Overall Study|Poor compliance to protocol|1
1113035|NCT01730040|3650651|P6|Overall Study|Poor compliance to protocol|0
1113036|NCT01730040|3650652|P5|Overall Study|Poor compliance to protocol|0
1113037|NCT01730040|3650653|P4|Overall Study|Poor compliance to protocol|0
1113038|NCT01730040|3650654|P3|Overall Study|Poor compliance to protocol|0
1113039|NCT01730040|3650655|P2|Overall Study|Poor compliance to protocol|4
1113040|NCT01730040|3650656|P1|Overall Study|Poor compliance to protocol|2
1113041|NCT01730040|3650650|P7|Overall Study|Adverse Event|2
1113042|NCT01730040|3650651|P6|Overall Study|Adverse Event|1
1113043|NCT01730040|3650652|P5|Overall Study|Adverse Event|1
1113044|NCT01730040|3650653|P4|Overall Study|Adverse Event|3
1113045|NCT01730040|3650654|P3|Overall Study|Adverse Event|5
1113046|NCT01730040|3650655|P2|Overall Study|Adverse Event|3
1113047|NCT01730040|3650656|P1|Overall Study|Adverse Event|4
1113048|NCT01730040|3650650|P7|Overall Study|Other than specified|4
1113049|NCT01730040|3650651|P6|Overall Study|Other than specified|4
1113050|NCT01730040|3650652|P5|Overall Study|Other than specified|5
1113051|NCT01730040|3650653|P4|Overall Study|Other than specified|5
1113052|NCT01730040|3650654|P3|Overall Study|Other than specified|5
1113053|NCT01730040|3650655|P2|Overall Study|Other than specified|8
1113054|NCT01730040|3650656|P1|Overall Study|Other than specified|7
1113055|NCT01730040|3650650|P7|Overall Study|Physician Decision|1
1113056|NCT01730040|3650651|P6|Overall Study|Physician Decision|1
1113057|NCT01730040|3650652|P5|Overall Study|Physician Decision|0
1113058|NCT01730040|3650653|P4|Overall Study|Physician Decision|0
1113059|NCT01730040|3650654|P3|Overall Study|Physician Decision|0
1113060|NCT01730040|3650655|P2|Overall Study|Physician Decision|0
1113061|NCT01730040|3650656|P1|Overall Study|Physician Decision|0
1113062|NCT01730040|3650650|P7|Overall Study|Subject moved|1
1113063|NCT01730040|3650651|P6|Overall Study|Subject moved|0
1113064|NCT01730040|3650652|P5|Overall Study|Subject moved|0
1113065|NCT01730040|3650653|P4|Overall Study|Subject moved|0
1113066|NCT01730040|3650654|P3|Overall Study|Subject moved|1
1113067|NCT01730040|3650655|P2|Overall Study|Subject moved|0
1113068|NCT01730040|3650656|P1|Overall Study|Subject moved|0
1113069|NCT01730040|3650650|P7|Overall Study|Randomized but not treated|0
1113070|NCT01730040|3650651|P6|Overall Study|Randomized but not treated|1
1113071|NCT01730040|3650652|P5|Overall Study|Randomized but not treated|0
1113072|NCT01730040|3650653|P4|Overall Study|Randomized but not treated|0
1113073|NCT01730040|3650654|P3|Overall Study|Randomized but not treated|0
1113074|NCT01730040|3650655|P2|Overall Study|Randomized but not treated|0
1113075|NCT01730040|3650656|P1|Overall Study|Randomized but not treated|0
1113076|NCT01729871|3650845|P2|Overall Study|Other|9
1113077|NCT01729871|3650846|P1|Overall Study|Other|4
1113078|NCT01729871|3650845|P2|Overall Study|Withdrawal by Subject|3
1113079|NCT01729871|3650846|P1|Overall Study|Withdrawal by Subject|0
1113080|NCT01729871|3650845|P2|Overall Study|Protocol Violation|0
1113081|NCT01729871|3650846|P1|Overall Study|Protocol Violation|1
1113082|NCT01729871|3650845|P2|Overall Study|Physician Decision|2
1113083|NCT01729871|3650846|P1|Overall Study|Physician Decision|0
1113084|NCT01729871|3650845|P2|Overall Study|Lack of Efficacy|1
1113085|NCT01729871|3650846|P1|Overall Study|Lack of Efficacy|0
1113086|NCT01729871|3650845|P2|Overall Study|Death|1
1113087|NCT01729871|3650846|P1|Overall Study|Death|0
1113088|NCT01729871|3650845|P2|Overall Study|Adverse Event|7
1113089|NCT01729871|3650846|P1|Overall Study|Adverse Event|7
1113090|NCT01729819|3650880|P2|Overall Study|Withdrawal by Subject|2
1113091|NCT01729819|3650881|P1|Overall Study|Withdrawal by Subject|0
1113092|NCT01729819|3650880|P2|Overall Study|Protocol Violation|1
1113093|NCT01729819|3650881|P1|Overall Study|Protocol Violation|0
1113094|NCT01729819|3650880|P2|Overall Study|Other reason|0
1113095|NCT01729819|3650881|P1|Overall Study|Other reason|1
1113096|NCT01729819|3650880|P2|Overall Study|Lost to Follow-up|0
1113097|NCT01729819|3650881|P1|Overall Study|Lost to Follow-up|2
1113098|NCT01729819|3650880|P2|Overall Study|Lack of Efficacy|0
1113099|NCT01729819|3650881|P1|Overall Study|Lack of Efficacy|1
1113100|NCT01729819|3650880|P2|Overall Study|Adverse Event|4
1113101|NCT01729819|3650881|P1|Overall Study|Adverse Event|2
1113102|NCT01729754|3650900|P10|Part 3|Other Protocol Specified Criteria|0
1113103|NCT01729754|3650901|P9|Part 3|Other Protocol Specified Criteria|0
1113104|NCT01729754|3650902|P8|Part 3|Other Protocol Specified Criteria|1
1113105|NCT01729754|3650903|P7|Part 3|Other Protocol Specified Criteria|0
1113106|NCT01729754|3650904|P6|Part 3|Other Protocol Specified Criteria|2
1113107|NCT01729754|3650905|P5|Part 3|Other Protocol Specified Criteria|0
1113108|NCT01729754|3650906|P4|Part 3|Other Protocol Specified Criteria|0
1113109|NCT01729754|3650907|P3|Part 3|Other Protocol Specified Criteria|0
1113110|NCT01729754|3650908|P2|Part 3|Other Protocol Specified Criteria|0
1113111|NCT01729754|3650909|P1|Part 3|Other Protocol Specified Criteria|0
1113112|NCT01729754|3650900|P10|Part 3|Withdrawal by Subject|0
1113113|NCT01729754|3650901|P9|Part 3|Withdrawal by Subject|0
1113114|NCT01729754|3650902|P8|Part 3|Withdrawal by Subject|2
1113115|NCT01729754|3650903|P7|Part 3|Withdrawal by Subject|0
1113116|NCT01729754|3650904|P6|Part 3|Withdrawal by Subject|1
1113117|NCT01729754|3650905|P5|Part 3|Withdrawal by Subject|2
1113118|NCT01729754|3650906|P4|Part 3|Withdrawal by Subject|0
1113119|NCT01729754|3650907|P3|Part 3|Withdrawal by Subject|1
1113120|NCT01729754|3650908|P2|Part 3|Withdrawal by Subject|4
1113121|NCT01729754|3650909|P1|Part 3|Withdrawal by Subject|0
1113122|NCT01729754|3650900|P10|Part 3|Physician Decision|0
1113123|NCT01729754|3650901|P9|Part 3|Physician Decision|0
1113124|NCT01729754|3650902|P8|Part 3|Physician Decision|0
1113125|NCT01729754|3650903|P7|Part 3|Physician Decision|0
1113126|NCT01729754|3650904|P6|Part 3|Physician Decision|0
1113127|NCT01729754|3650905|P5|Part 3|Physician Decision|0
1113128|NCT01729754|3650906|P4|Part 3|Physician Decision|0
1113129|NCT01729754|3650907|P3|Part 3|Physician Decision|1
1113130|NCT01729754|3650908|P2|Part 3|Physician Decision|0
1113131|NCT01729754|3650909|P1|Part 3|Physician Decision|0
1113132|NCT01729754|3650900|P10|Part 3|Lost to Follow-up|0
1113133|NCT01729754|3650901|P9|Part 3|Lost to Follow-up|1
1113134|NCT01729754|3650902|P8|Part 3|Lost to Follow-up|0
1113135|NCT01729754|3650903|P7|Part 3|Lost to Follow-up|0
1113136|NCT01729754|3650904|P6|Part 3|Lost to Follow-up|3
1113137|NCT01729754|3650905|P5|Part 3|Lost to Follow-up|0
1113138|NCT01729754|3650906|P4|Part 3|Lost to Follow-up|0
1113139|NCT01729754|3650907|P3|Part 3|Lost to Follow-up|2
1113140|NCT01729754|3650908|P2|Part 3|Lost to Follow-up|1
1113141|NCT01729754|3650909|P1|Part 3|Lost to Follow-up|0
1113142|NCT01729754|3650900|P10|Part 3|Lack of Efficacy|4
1113143|NCT01729754|3650901|P9|Part 3|Lack of Efficacy|0
1113144|NCT01729754|3650902|P8|Part 3|Lack of Efficacy|0
1113145|NCT01729754|3650903|P7|Part 3|Lack of Efficacy|0
1113146|NCT01729754|3650904|P6|Part 3|Lack of Efficacy|0
1113147|NCT01729754|3650905|P5|Part 3|Lack of Efficacy|2
1113148|NCT01729754|3650906|P4|Part 3|Lack of Efficacy|0
1113149|NCT01729754|3650907|P3|Part 3|Lack of Efficacy|0
1113150|NCT01729754|3650908|P2|Part 3|Lack of Efficacy|0
1113151|NCT01729754|3650909|P1|Part 3|Lack of Efficacy|0
1113152|NCT01729754|3650900|P10|Part 3|Death|0
1113153|NCT01729754|3650901|P9|Part 3|Death|0
1113154|NCT01729754|3650902|P8|Part 3|Death|0
1113155|NCT01729754|3650903|P7|Part 3|Death|0
1113156|NCT01729754|3650904|P6|Part 3|Death|2
1113157|NCT01729754|3650905|P5|Part 3|Death|0
1113158|NCT01729754|3650906|P4|Part 3|Death|0
1113159|NCT01729754|3650907|P3|Part 3|Death|0
1113160|NCT01729754|3650908|P2|Part 3|Death|0
1113161|NCT01729754|3650909|P1|Part 3|Death|0
1113162|NCT01729754|3650900|P10|Part 3|Adverse Event|3
1113163|NCT01729754|3650901|P9|Part 3|Adverse Event|0
1113164|NCT01729754|3650902|P8|Part 3|Adverse Event|0
1113165|NCT01729754|3650903|P7|Part 3|Adverse Event|0
1113166|NCT01729754|3650904|P6|Part 3|Adverse Event|5
1113167|NCT01729754|3650905|P5|Part 3|Adverse Event|0
1113168|NCT01729754|3650906|P4|Part 3|Adverse Event|0
1113169|NCT01729754|3650907|P3|Part 3|Adverse Event|1
1113170|NCT01729754|3650908|P2|Part 3|Adverse Event|0
1113171|NCT01729754|3650909|P1|Part 3|Adverse Event|0
1113172|NCT01729754|3650900|P10|Part 2|Other Protocol Specified Criteria|0
1113173|NCT01729754|3650901|P9|Part 2|Other Protocol Specified Criteria|0
1113174|NCT01729754|3650902|P8|Part 2|Other Protocol Specified Criteria|1
1113175|NCT01729754|3650903|P7|Part 2|Other Protocol Specified Criteria|0
1113176|NCT01729754|3650904|P6|Part 2|Other Protocol Specified Criteria|0
1113177|NCT01729754|3650905|P5|Part 2|Other Protocol Specified Criteria|0
1113178|NCT01729754|3650906|P4|Part 2|Other Protocol Specified Criteria|0
1113179|NCT01729754|3650907|P3|Part 2|Other Protocol Specified Criteria|0
1113180|NCT01729754|3650908|P2|Part 2|Other Protocol Specified Criteria|0
1113181|NCT01729754|3650909|P1|Part 2|Other Protocol Specified Criteria|1
1113182|NCT01729754|3650900|P10|Part 2|Withdrawal by Subject|4
1113183|NCT01729754|3650901|P9|Part 2|Withdrawal by Subject|1
1113184|NCT01729754|3650902|P8|Part 2|Withdrawal by Subject|1
1113185|NCT01729754|3650903|P7|Part 2|Withdrawal by Subject|0
1113186|NCT01729754|3650904|P6|Part 2|Withdrawal by Subject|0
1113187|NCT01729754|3650905|P5|Part 2|Withdrawal by Subject|0
1113188|NCT01729754|3650906|P4|Part 2|Withdrawal by Subject|2
1113189|NCT01729754|3650907|P3|Part 2|Withdrawal by Subject|0
1113190|NCT01729754|3650908|P2|Part 2|Withdrawal by Subject|0
1113191|NCT01729754|3650909|P1|Part 2|Withdrawal by Subject|3
1113192|NCT01729754|3650900|P10|Part 2|Pregnancy|1
1113193|NCT01729754|3650901|P9|Part 2|Pregnancy|0
1113194|NCT01729754|3650902|P8|Part 2|Pregnancy|0
1113195|NCT01729754|3650903|P7|Part 2|Pregnancy|0
1113196|NCT01729754|3650904|P6|Part 2|Pregnancy|0
1113197|NCT01729754|3650905|P5|Part 2|Pregnancy|0
1113198|NCT01729754|3650906|P4|Part 2|Pregnancy|1
1113199|NCT01729754|3650907|P3|Part 2|Pregnancy|0
1113200|NCT01729754|3650908|P2|Part 2|Pregnancy|0
1113201|NCT01729754|3650909|P1|Part 2|Pregnancy|0
1113202|NCT01729754|3650900|P10|Part 2|Non-Compliance with Study Drug|1
1113203|NCT01729754|3650901|P9|Part 2|Non-Compliance with Study Drug|0
1113204|NCT01729754|3650902|P8|Part 2|Non-Compliance with Study Drug|0
1113205|NCT01729754|3650903|P7|Part 2|Non-Compliance with Study Drug|0
1113206|NCT01729754|3650904|P6|Part 2|Non-Compliance with Study Drug|0
1113207|NCT01729754|3650905|P5|Part 2|Non-Compliance with Study Drug|0
1113208|NCT01729754|3650906|P4|Part 2|Non-Compliance with Study Drug|0
1113209|NCT01729754|3650907|P3|Part 2|Non-Compliance with Study Drug|0
1113210|NCT01729754|3650908|P2|Part 2|Non-Compliance with Study Drug|0
1113211|NCT01729754|3650909|P1|Part 2|Non-Compliance with Study Drug|0
1113212|NCT01729754|3650900|P10|Part 2|Lost to Follow-up|2
1113213|NCT01729754|3650901|P9|Part 2|Lost to Follow-up|0
1113214|NCT01729754|3650902|P8|Part 2|Lost to Follow-up|1
1113215|NCT01729754|3650903|P7|Part 2|Lost to Follow-up|0
1113216|NCT01729754|3650904|P6|Part 2|Lost to Follow-up|0
1113217|NCT01729754|3650905|P5|Part 2|Lost to Follow-up|0
1113218|NCT01729754|3650906|P4|Part 2|Lost to Follow-up|2
1113219|NCT01729754|3650907|P3|Part 2|Lost to Follow-up|0
1113220|NCT01729754|3650908|P2|Part 2|Lost to Follow-up|0
1113221|NCT01729754|3650909|P1|Part 2|Lost to Follow-up|0
1113222|NCT01729754|3650900|P10|Part 2|Lack of Efficacy|2
1113223|NCT01729754|3650901|P9|Part 2|Lack of Efficacy|2
1113224|NCT01729754|3650902|P8|Part 2|Lack of Efficacy|0
1113225|NCT01729754|3650903|P7|Part 2|Lack of Efficacy|0
1113226|NCT01729754|3650904|P6|Part 2|Lack of Efficacy|0
1113227|NCT01729754|3650905|P5|Part 2|Lack of Efficacy|0
1113228|NCT01729754|3650906|P4|Part 2|Lack of Efficacy|0
1113229|NCT01729754|3650907|P3|Part 2|Lack of Efficacy|0
1113230|NCT01729754|3650908|P2|Part 2|Lack of Efficacy|0
1113231|NCT01729754|3650909|P1|Part 2|Lack of Efficacy|0
1113232|NCT01729754|3650900|P10|Part 2|Adverse Event|2
1113233|NCT01729754|3650901|P9|Part 2|Adverse Event|1
1113234|NCT01729754|3650902|P8|Part 2|Adverse Event|0
1113235|NCT01729754|3650903|P7|Part 2|Adverse Event|0
1113236|NCT01729754|3650904|P6|Part 2|Adverse Event|0
1113237|NCT01729754|3650905|P5|Part 2|Adverse Event|0
1113238|NCT01729754|3650906|P4|Part 2|Adverse Event|0
1113239|NCT01729754|3650907|P3|Part 2|Adverse Event|0
1113240|NCT01729754|3650908|P2|Part 2|Adverse Event|0
1113241|NCT01729754|3650909|P1|Part 2|Adverse Event|2
1113242|NCT01729754|3650900|P10|Part 1|Other Protocol Specified Criteria|4
1113243|NCT01729754|3650901|P9|Part 1|Other Protocol Specified Criteria|0
1113244|NCT01729754|3650902|P8|Part 1|Other Protocol Specified Criteria|0
1113245|NCT01729754|3650903|P7|Part 1|Other Protocol Specified Criteria|1
1113246|NCT01729754|3650904|P6|Part 1|Other Protocol Specified Criteria|0
1113247|NCT01729754|3650905|P5|Part 1|Other Protocol Specified Criteria|0
1113248|NCT01729754|3650906|P4|Part 1|Other Protocol Specified Criteria|0
1113249|NCT01729754|3650907|P3|Part 1|Other Protocol Specified Criteria|0
1113250|NCT01729754|3650908|P2|Part 1|Other Protocol Specified Criteria|0
1113251|NCT01729754|3650909|P1|Part 1|Other Protocol Specified Criteria|2
1113252|NCT01729754|3650900|P10|Part 1|Withdrawal by Subject|6
1113253|NCT01729754|3650901|P9|Part 1|Withdrawal by Subject|0
1113254|NCT01729754|3650902|P8|Part 1|Withdrawal by Subject|0
1113255|NCT01729754|3650903|P7|Part 1|Withdrawal by Subject|5
1113256|NCT01729754|3650904|P6|Part 1|Withdrawal by Subject|0
1113257|NCT01729754|3650905|P5|Part 1|Withdrawal by Subject|0
1113258|NCT01729754|3650906|P4|Part 1|Withdrawal by Subject|7
1113259|NCT01729754|3650907|P3|Part 1|Withdrawal by Subject|0
1113260|NCT01729754|3650908|P2|Part 1|Withdrawal by Subject|0
1113261|NCT01729754|3650909|P1|Part 1|Withdrawal by Subject|5
1113262|NCT01729754|3650900|P10|Part 1|Protocol Violation|0
1113263|NCT01729754|3650901|P9|Part 1|Protocol Violation|0
1113264|NCT01729754|3650902|P8|Part 1|Protocol Violation|0
1113265|NCT01729754|3650903|P7|Part 1|Protocol Violation|1
1113266|NCT01729754|3650904|P6|Part 1|Protocol Violation|0
1113267|NCT01729754|3650905|P5|Part 1|Protocol Violation|0
1113268|NCT01729754|3650906|P4|Part 1|Protocol Violation|1
1113269|NCT01729754|3650907|P3|Part 1|Protocol Violation|0
1113270|NCT01729754|3650908|P2|Part 1|Protocol Violation|0
1113271|NCT01729754|3650909|P1|Part 1|Protocol Violation|2
1113272|NCT01729754|3650900|P10|Part 1|Progressive Disease|1
1113273|NCT01729754|3650901|P9|Part 1|Progressive Disease|0
1113274|NCT01729754|3650902|P8|Part 1|Progressive Disease|0
1113275|NCT01729754|3650903|P7|Part 1|Progressive Disease|0
1113276|NCT01729754|3650904|P6|Part 1|Progressive Disease|0
1113277|NCT01729754|3650905|P5|Part 1|Progressive Disease|0
1113278|NCT01729754|3650906|P4|Part 1|Progressive Disease|0
1113279|NCT01729754|3650907|P3|Part 1|Progressive Disease|0
1113280|NCT01729754|3650908|P2|Part 1|Progressive Disease|0
1113281|NCT01729754|3650909|P1|Part 1|Progressive Disease|0
1113282|NCT01729754|3650900|P10|Part 1|Pregnancy|1
1113283|NCT01729754|3650901|P9|Part 1|Pregnancy|0
1113284|NCT01729754|3650902|P8|Part 1|Pregnancy|0
1113285|NCT01729754|3650903|P7|Part 1|Pregnancy|0
1113286|NCT01729754|3650904|P6|Part 1|Pregnancy|0
1113287|NCT01729754|3650905|P5|Part 1|Pregnancy|0
1113288|NCT01729754|3650906|P4|Part 1|Pregnancy|1
1113289|NCT01729754|3650907|P3|Part 1|Pregnancy|0
1113290|NCT01729754|3650908|P2|Part 1|Pregnancy|0
1113291|NCT01729754|3650909|P1|Part 1|Pregnancy|0
1113292|NCT01729754|3650900|P10|Part 1|Physician Decision|4
1113293|NCT01729754|3650901|P9|Part 1|Physician Decision|0
1113294|NCT01729754|3650902|P8|Part 1|Physician Decision|0
1113295|NCT01729754|3650903|P7|Part 1|Physician Decision|0
1113296|NCT01729754|3650904|P6|Part 1|Physician Decision|0
1113297|NCT01729754|3650905|P5|Part 1|Physician Decision|0
1113298|NCT01729754|3650906|P4|Part 1|Physician Decision|0
1113299|NCT01729754|3650907|P3|Part 1|Physician Decision|0
1113300|NCT01729754|3650908|P2|Part 1|Physician Decision|0
1113301|NCT01729754|3650909|P1|Part 1|Physician Decision|0
1113302|NCT01729754|3650900|P10|Part 1|Non-compliance with Study Drug|0
1113303|NCT01729754|3650901|P9|Part 1|Non-compliance with Study Drug|0
1113304|NCT01729754|3650902|P8|Part 1|Non-compliance with Study Drug|0
1113305|NCT01729754|3650903|P7|Part 1|Non-compliance with Study Drug|0
1113306|NCT01729754|3650904|P6|Part 1|Non-compliance with Study Drug|0
1113307|NCT01729754|3650905|P5|Part 1|Non-compliance with Study Drug|0
1113308|NCT01729754|3650906|P4|Part 1|Non-compliance with Study Drug|0
1113309|NCT01729754|3650907|P3|Part 1|Non-compliance with Study Drug|0
1113310|NCT01729754|3650908|P2|Part 1|Non-compliance with Study Drug|0
1113311|NCT01729754|3650909|P1|Part 1|Non-compliance with Study Drug|1
1113312|NCT01729754|3650900|P10|Part 1|Lost to Follow-up|3
1113313|NCT01729754|3650901|P9|Part 1|Lost to Follow-up|0
1113314|NCT01729754|3650902|P8|Part 1|Lost to Follow-up|0
1113315|NCT01729754|3650903|P7|Part 1|Lost to Follow-up|3
1113316|NCT01729754|3650904|P6|Part 1|Lost to Follow-up|0
1113317|NCT01729754|3650905|P5|Part 1|Lost to Follow-up|0
1113318|NCT01729754|3650906|P4|Part 1|Lost to Follow-up|2
1113319|NCT01729754|3650907|P3|Part 1|Lost to Follow-up|0
1113320|NCT01729754|3650908|P2|Part 1|Lost to Follow-up|0
1113321|NCT01729754|3650909|P1|Part 1|Lost to Follow-up|1
1113322|NCT01729754|3650900|P10|Part 1|Lack of Efficacy|0
1113323|NCT01729754|3650901|P9|Part 1|Lack of Efficacy|0
1113324|NCT01729754|3650902|P8|Part 1|Lack of Efficacy|0
1113325|NCT01729754|3650903|P7|Part 1|Lack of Efficacy|2
1113326|NCT01729754|3650904|P6|Part 1|Lack of Efficacy|0
1113327|NCT01729754|3650905|P5|Part 1|Lack of Efficacy|0
1113328|NCT01729754|3650906|P4|Part 1|Lack of Efficacy|0
1113329|NCT01729754|3650907|P3|Part 1|Lack of Efficacy|0
1113330|NCT01729754|3650908|P2|Part 1|Lack of Efficacy|0
1113331|NCT01729754|3650909|P1|Part 1|Lack of Efficacy|1
1113332|NCT01729754|3650900|P10|Part 1|Adverse Event|5
1113333|NCT01729754|3650901|P9|Part 1|Adverse Event|0
1113334|NCT01729754|3650902|P8|Part 1|Adverse Event|0
1113335|NCT01729754|3650903|P7|Part 1|Adverse Event|2
1113336|NCT01729754|3650904|P6|Part 1|Adverse Event|0
1113337|NCT01729754|3650905|P5|Part 1|Adverse Event|0
1113338|NCT01729754|3650906|P4|Part 1|Adverse Event|1
1113339|NCT01729754|3650907|P3|Part 1|Adverse Event|0
1113340|NCT01729754|3650908|P2|Part 1|Adverse Event|0
1113341|NCT01729754|3650909|P1|Part 1|Adverse Event|2
1113342|NCT01729728|3651116|P3|Overall Study|Protocol Violation|1
1113343|NCT01729728|3651117|P2|Overall Study|Protocol Violation|0
1113344|NCT01729728|3651118|P1|Overall Study|Protocol Violation|1
1113345|NCT01729728|3651116|P3|Overall Study|Adverse Event|0
1113346|NCT01729728|3651117|P2|Overall Study|Adverse Event|6
1113347|NCT01729728|3651118|P1|Overall Study|Adverse Event|0
1113348|NCT01729559|3651251|P2|Overall Study|Protocol Violation|28
1113349|NCT01729559|3651252|P1|Overall Study|Protocol Violation|31
1113350|NCT01729039|3651295|P2|Overall Study|Withdrawal by Subject|7
1113351|NCT01729039|3651296|P1|Overall Study|Withdrawal by Subject|8
1113352|NCT01729039|3651295|P2|Overall Study|disqualified|5
1113353|NCT01729039|3651296|P1|Overall Study|disqualified|2
1113354|NCT01729026|3651312|P2|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2
1113355|NCT01729026|3651313|P1|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1
1113356|NCT01729026|3651312|P2|Randomization to 3-month Follow-up|Lost to Follow-up|2
1113357|NCT01729026|3651313|P1|Randomization to 3-month Follow-up|Lost to Follow-up|2
1113358|NCT01728792|3651324|P5|Overall Study|Lost to Follow-up|0
1113359|NCT01728792|3651325|P4|Overall Study|Lost to Follow-up|2
1113360|NCT01728792|3651326|P3|Overall Study|Lost to Follow-up|4
1113361|NCT01728792|3651327|P2|Overall Study|Lost to Follow-up|1
1113362|NCT01728792|3651328|P1|Overall Study|Lost to Follow-up|2
1113363|NCT01728792|3651324|P5|Overall Study|Withdrawal of Consent|0
1113364|NCT01728792|3651325|P4|Overall Study|Withdrawal of Consent|1
1113365|NCT01728792|3651326|P3|Overall Study|Withdrawal of Consent|0
1113366|NCT01728792|3651327|P2|Overall Study|Withdrawal of Consent|1
1113367|NCT01728792|3651328|P1|Overall Study|Withdrawal of Consent|1
1113368|NCT01728584|3651379|P4|Overall Study|Other reason (not specified)|1
1113369|NCT01728584|3651380|P3|Overall Study|Other reason (not specified)|0
1113370|NCT01728584|3651381|P2|Overall Study|Other reason (not specified)|0
1113371|NCT01728584|3651382|P1|Overall Study|Other reason (not specified)|1
1113372|NCT01728584|3651379|P4|Overall Study|Screen failure|0
1113373|NCT01728584|3651380|P3|Overall Study|Screen failure|0
1113374|NCT01728584|3651381|P2|Overall Study|Screen failure|0
1113375|NCT01728584|3651382|P1|Overall Study|Screen failure|1
1113376|NCT01728584|3651379|P4|Overall Study|Withdrawal by Subject|0
1113377|NCT01728584|3651380|P3|Overall Study|Withdrawal by Subject|0
1113378|NCT01728584|3651381|P2|Overall Study|Withdrawal by Subject|0
1113379|NCT01728584|3651382|P1|Overall Study|Withdrawal by Subject|1
1113380|NCT01728584|3651379|P4|Overall Study|Physician Decision|0
1113381|NCT01728584|3651380|P3|Overall Study|Physician Decision|1
1113382|NCT01728584|3651381|P2|Overall Study|Physician Decision|0
1113383|NCT01728584|3651382|P1|Overall Study|Physician Decision|4
1113384|NCT01728584|3651379|P4|Overall Study|Adverse Event|0
1113385|NCT01728584|3651380|P3|Overall Study|Adverse Event|0
1113386|NCT01728584|3651381|P2|Overall Study|Adverse Event|0
1113387|NCT01728584|3651382|P1|Overall Study|Adverse Event|1
1113388|NCT01728376|3651440|P6|Overall Study|Subject/Parent/Legal Guardian Decision|1
1113389|NCT01728376|3651441|P5|Overall Study|Subject/Parent/Legal Guardian Decision|0
1113390|NCT01728376|3651442|P4|Overall Study|Subject/Parent/Legal Guardian Decision|1
1113391|NCT01728376|3651443|P3|Overall Study|Subject/Parent/Legal Guardian Decision|0
1113392|NCT01728376|3651444|P2|Overall Study|Subject/Parent/Legal Guardian Decision|0
1113393|NCT01728376|3651445|P1|Overall Study|Subject/Parent/Legal Guardian Decision|0
1113394|NCT01728376|3651440|P6|Overall Study|Did not receive treatment|0
1113395|NCT01728376|3651441|P5|Overall Study|Did not receive treatment|0
1113396|NCT01728376|3651442|P4|Overall Study|Did not receive treatment|0
1113397|NCT01728376|3651443|P3|Overall Study|Did not receive treatment|0
1113398|NCT01728376|3651444|P2|Overall Study|Did not receive treatment|1
1113399|NCT01728376|3651445|P1|Overall Study|Did not receive treatment|0
1113400|NCT01728376|3651440|P6|Overall Study|No relevant bacteria|1
1113401|NCT01728376|3651441|P5|Overall Study|No relevant bacteria|1
1113402|NCT01728376|3651442|P4|Overall Study|No relevant bacteria|0
1113403|NCT01728376|3651443|P3|Overall Study|No relevant bacteria|0
1113404|NCT01728376|3651444|P2|Overall Study|No relevant bacteria|0
1113405|NCT01728376|3651445|P1|Overall Study|No relevant bacteria|2
1113406|NCT01728376|3651440|P6|Overall Study|Persistent Positive Blood Cultures|0
1113407|NCT01728376|3651441|P5|Overall Study|Persistent Positive Blood Cultures|0
1113408|NCT01728376|3651442|P4|Overall Study|Persistent Positive Blood Cultures|0
1113409|NCT01728376|3651443|P3|Overall Study|Persistent Positive Blood Cultures|1
1113410|NCT01728376|3651444|P2|Overall Study|Persistent Positive Blood Cultures|0
1113411|NCT01728376|3651445|P1|Overall Study|Persistent Positive Blood Cultures|1
1113412|NCT01728376|3651440|P6|Overall Study|Adverse Event|0
1113413|NCT01728376|3651441|P5|Overall Study|Adverse Event|1
1113414|NCT01728376|3651442|P4|Overall Study|Adverse Event|1
1113415|NCT01728376|3651443|P3|Overall Study|Adverse Event|1
1113416|NCT01728376|3651444|P2|Overall Study|Adverse Event|1
1113417|NCT01728376|3651445|P1|Overall Study|Adverse Event|1
1113418|NCT01728324|3651518|P3|Termination of RBV|Protocol Violation (Placebo Period)|0
1113419|NCT01728324|3651519|P2|Termination of RBV|Protocol Violation (Placebo Period)|1
1113420|NCT01728324|3651520|P1|Termination of RBV|Protocol Violation (Placebo Period)|0
1113421|NCT01728324|3651518|P3|Termination of RBV|Adverse Event (Placebo Period)|0
1113422|NCT01728324|3651519|P2|Termination of RBV|Adverse Event (Placebo Period)|1
1113423|NCT01728324|3651520|P1|Termination of RBV|Adverse Event (Placebo Period)|0
1113424|NCT01728324|3651518|P3|Termination of RBV|Other than stated|1
1113425|NCT01728324|3651519|P2|Termination of RBV|Other than stated|3
1113426|NCT01728324|3651520|P1|Termination of RBV|Other than stated|1
1113427|NCT01728324|3651518|P3|Termination of RBV|Withdrawal by Subject|2
1113428|NCT01728324|3651519|P2|Termination of RBV|Withdrawal by Subject|5
1113429|NCT01728324|3651520|P1|Termination of RBV|Withdrawal by Subject|9
1113430|NCT01728324|3651518|P3|Termination of RBV|Lack of Efficacy|7
1113431|NCT01728324|3651519|P2|Termination of RBV|Lack of Efficacy|11
1113432|NCT01728324|3651520|P1|Termination of RBV|Lack of Efficacy|14
1113433|NCT01728324|3651518|P3|Termination of RBV|Adverse Event|5
1113434|NCT01728324|3651519|P2|Termination of RBV|Adverse Event|16
1113435|NCT01728324|3651520|P1|Termination of RBV|Adverse Event|15
1113436|NCT01728324|3651518|P3|Termination of FDV|Protocol Violation (Placebo Period)|0
1113437|NCT01728324|3651519|P2|Termination of FDV|Protocol Violation (Placebo Period)|1
1113438|NCT01728324|3651520|P1|Termination of FDV|Protocol Violation (Placebo Period)|0
1113439|NCT01728324|3651518|P3|Termination of FDV|Adverse Event (Placebo Period)|0
1113440|NCT01728324|3651519|P2|Termination of FDV|Adverse Event (Placebo Period)|1
1113441|NCT01728324|3651520|P1|Termination of FDV|Adverse Event (Placebo Period)|0
1113442|NCT01728324|3651518|P3|Termination of FDV|Other than stated|0
1113443|NCT01728324|3651519|P2|Termination of FDV|Other than stated|3
1113444|NCT01728324|3651520|P1|Termination of FDV|Other than stated|1
1113445|NCT01728324|3651518|P3|Termination of FDV|Withdrawal by Subject|2
1113446|NCT01728324|3651519|P2|Termination of FDV|Withdrawal by Subject|6
1113447|NCT01728324|3651520|P1|Termination of FDV|Withdrawal by Subject|9
1113448|NCT01728324|3651518|P3|Termination of FDV|Lack of Efficacy|8
1113449|NCT01728324|3651519|P2|Termination of FDV|Lack of Efficacy|12
1113450|NCT01728324|3651520|P1|Termination of FDV|Lack of Efficacy|14
1113451|NCT01728324|3651518|P3|Termination of FDV|Adverse Event|4
1113452|NCT01728324|3651519|P2|Termination of FDV|Adverse Event|13
1113453|NCT01728324|3651520|P1|Termination of FDV|Adverse Event|14
1113454|NCT01728324|3651518|P3|Termination of DBV|Protocol Violation (Placebo Period)|0
1113455|NCT01728324|3651519|P2|Termination of DBV|Protocol Violation (Placebo Period)|1
1113456|NCT01728324|3651520|P1|Termination of DBV|Protocol Violation (Placebo Period)|0
1113457|NCT01728324|3651518|P3|Termination of DBV|Adverse Event (Placebo Period)|0
1113458|NCT01728324|3651519|P2|Termination of DBV|Adverse Event (Placebo Period)|1
1113459|NCT01728324|3651520|P1|Termination of DBV|Adverse Event (Placebo Period)|0
1113460|NCT01728324|3651518|P3|Termination of DBV|Other than stated|0
1113461|NCT01728324|3651519|P2|Termination of DBV|Other than stated|3
1113462|NCT01728324|3651520|P1|Termination of DBV|Other than stated|1
1113463|NCT01728324|3651518|P3|Termination of DBV|Withdrawal by Subject|2
1113464|NCT01728324|3651519|P2|Termination of DBV|Withdrawal by Subject|6
1113465|NCT01728324|3651520|P1|Termination of DBV|Withdrawal by Subject|9
1113466|NCT01728324|3651518|P3|Termination of DBV|Lack of Efficacy|8
1113467|NCT01728324|3651519|P2|Termination of DBV|Lack of Efficacy|12
1113468|NCT01728324|3651520|P1|Termination of DBV|Lack of Efficacy|14
1113469|NCT01728324|3651518|P3|Termination of DBV|Adverse Event|4
1113470|NCT01728324|3651519|P2|Termination of DBV|Adverse Event|13
1113471|NCT01728324|3651520|P1|Termination of DBV|Adverse Event|14
1113472|NCT01728246|3651541|P2|Overall Study|Adverse Event|5
1113473|NCT01728246|3651542|P1|Overall Study|Adverse Event|8
1113474|NCT01728246|3651541|P2|Overall Study|Lack of Efficacy|1
1113475|NCT01728246|3651542|P1|Overall Study|Lack of Efficacy|1
1113476|NCT01728246|3651541|P2|Overall Study|Lost to Follow-up|22
1113477|NCT01728246|3651542|P1|Overall Study|Lost to Follow-up|23
1113478|NCT01728246|3651541|P2|Overall Study|Withdrawal by Subject|3
1113479|NCT01728246|3651542|P1|Overall Study|Withdrawal by Subject|2
1113480|NCT01728246|3651541|P2|Overall Study|Protocol Violation|0
1113481|NCT01728246|3651542|P1|Overall Study|Protocol Violation|1
1113482|NCT01728246|3651541|P2|Overall Study|Participant needed rescue medication|5
1113483|NCT01728246|3651542|P1|Overall Study|Participant needed rescue medication|1
1113484|NCT01728116|3651560|P2|Overall Study|various not noted previously|0
1113485|NCT01728116|3651561|P1|Overall Study|various not noted previously|5
1113486|NCT01728116|3651560|P2|Overall Study|Incorrectly enrolled in Study|1
1113487|NCT01728116|3651561|P1|Overall Study|Incorrectly enrolled in Study|0
1113488|NCT01728116|3651560|P2|Overall Study|Inter-current finding at procedure|0
1113489|NCT01728116|3651561|P1|Overall Study|Inter-current finding at procedure|1
1113490|NCT01728116|3651560|P2|Overall Study|Subject Non-Compliance|0
1113491|NCT01728116|3651561|P1|Overall Study|Subject Non-Compliance|2
1113492|NCT01728116|3651560|P2|Overall Study|Physician Decision|0
1113493|NCT01728116|3651561|P1|Overall Study|Physician Decision|2
1113494|NCT01728116|3651560|P2|Overall Study|Lost to Follow-up|2
1113495|NCT01728116|3651561|P1|Overall Study|Lost to Follow-up|9
1113496|NCT01728116|3651560|P2|Overall Study|Procedure/device failure|0
1113497|NCT01728116|3651561|P1|Overall Study|Procedure/device failure|7
1113498|NCT01728116|3651560|P2|Overall Study|Adverse Event|0
1113499|NCT01728116|3651561|P1|Overall Study|Adverse Event|13
1113500|NCT01728116|3651560|P2|Overall Study|Withdrawal by Subject|9
1113501|NCT01728116|3651561|P1|Overall Study|Withdrawal by Subject|16
1113502|NCT01728116|3651560|P2|Overall Study|Sponsor Terminated Study|35
1113503|NCT01728116|3651561|P1|Overall Study|Sponsor Terminated Study|106
1113504|NCT01728077|3651586|P2|Overall Study|Non compliance|0
1113505|NCT01728077|3651587|P1|Overall Study|Non compliance|1
1113506|NCT01728077|3651586|P2|Overall Study|Patient moving|0
1113507|NCT01728077|3651587|P1|Overall Study|Patient moving|1
1113508|NCT01728077|3651586|P2|Overall Study|Death|1
1113509|NCT01728077|3651587|P1|Overall Study|Death|0
1113510|NCT01728077|3651586|P2|Overall Study|Subject choice|3
1113511|NCT01728077|3651587|P1|Overall Study|Subject choice|2
1113512|NCT01728077|3651586|P2|Overall Study|Lost to Follow-up|0
1113513|NCT01728077|3651587|P1|Overall Study|Lost to Follow-up|1
1113514|NCT01728077|3651586|P2|Overall Study|Lack of Efficacy|1
1113515|NCT01728077|3651587|P1|Overall Study|Lack of Efficacy|3
1113516|NCT01727713|3651676|P1|Overall Study|Protocol Deviation|2
1113517|NCT01727713|3651676|P1|Overall Study|Withdrawal by Subject|13
1113518|NCT01727713|3651676|P1|Overall Study|Participant Met Withdrawal Criteria|5
1113519|NCT01727713|3651676|P1|Overall Study|Adverse Event|10
1113520|NCT01727713|3651676|P1|Overall Study|Lost to Follow-up|5
1113521|NCT01727700|3651703|P3|Overall Study|Protocol Violation|0
1113522|NCT01727700|3651704|P2|Overall Study|Protocol Violation|0
1113523|NCT01727700|3651705|P1|Overall Study|Protocol Violation|2
1113524|NCT01727700|3651703|P3|Overall Study|Particpant withdrew consent|1
1113525|NCT01727700|3651704|P2|Overall Study|Particpant withdrew consent|3
1113526|NCT01727700|3651705|P1|Overall Study|Particpant withdrew consent|0
1113527|NCT01727700|3651703|P3|Overall Study|Adverse Event|1
1113528|NCT01727700|3651704|P2|Overall Study|Adverse Event|7
1113529|NCT01727700|3651705|P1|Overall Study|Adverse Event|0
1113530|NCT01727505|3651728|P2|Second 24 Hours|Missing data|1
1113531|NCT01727505|3651729|P1|Second 24 Hours|Missing data|0
1113532|NCT01727505|3651728|P2|First 24 Hours|Adverse Event|1
1113533|NCT01727505|3651729|P1|First 24 Hours|Adverse Event|0
1113534|NCT01727297|3651754|P2|Overall Study|Other (e.g. AF detection pre-implant)|8
1113535|NCT01727297|3651755|P1|Overall Study|Other (e.g. AF detection pre-implant)|29
1113536|NCT01727297|3651754|P2|Overall Study|Physician Decision|5
1113537|NCT01727297|3651755|P1|Overall Study|Physician Decision|19
1113538|NCT01727297|3651754|P2|Overall Study|Withdrawal by Subject|27
1113539|NCT01727297|3651755|P1|Overall Study|Withdrawal by Subject|26
1113540|NCT01727297|3651754|P2|Overall Study|Lost to Follow-up|0
1113541|NCT01727297|3651755|P1|Overall Study|Lost to Follow-up|11
1113542|NCT01727297|3651754|P2|Overall Study|Adverse Event|1
1113543|NCT01727297|3651755|P1|Overall Study|Adverse Event|3
1113544|NCT01727297|3651754|P2|Overall Study|Protocol Violation|10
1113545|NCT01727297|3651755|P1|Overall Study|Protocol Violation|1
1113546|NCT01727297|3651754|P2|Overall Study|Death|0
1113547|NCT01727297|3651755|P1|Overall Study|Death|13
1113548|NCT01727258|3651771|P3|Overall Study|Lost to Follow-up|0
1113549|NCT01727258|3651772|P2|Overall Study|Lost to Follow-up|0
1113550|NCT01727258|3651773|P1|Overall Study|Lost to Follow-up|1
1113551|NCT01727258|3651771|P3|Overall Study|Withdrawal by Subject|0
1113552|NCT01727258|3651772|P2|Overall Study|Withdrawal by Subject|1
1113553|NCT01727258|3651773|P1|Overall Study|Withdrawal by Subject|1
1113554|NCT01727258|3651771|P3|Overall Study|Noncompliance with Study Drug|1
1113555|NCT01727258|3651772|P2|Overall Study|Noncompliance with Study Drug|0
1113556|NCT01727258|3651773|P1|Overall Study|Noncompliance with Study Drug|0
1113557|NCT01727258|3651771|P3|Overall Study|Adverse Event|0
1113558|NCT01727258|3651772|P2|Overall Study|Adverse Event|2
1113559|NCT01727258|3651773|P1|Overall Study|Adverse Event|0
1113560|NCT01727141|3651815|P4|Overall Study|Withdrawal by Subject|11
1113561|NCT01727141|3651816|P3|Overall Study|Withdrawal by Subject|2
1113562|NCT01727141|3651817|P2|Overall Study|Withdrawal by Subject|4
1113563|NCT01727141|3651818|P1|Overall Study|Withdrawal by Subject|4
1113564|NCT01727141|3651815|P4|Overall Study|Protocol deviation|1
1113565|NCT01727141|3651816|P3|Overall Study|Protocol deviation|0
1113566|NCT01727141|3651817|P2|Overall Study|Protocol deviation|1
1113567|NCT01727141|3651818|P1|Overall Study|Protocol deviation|1
1113568|NCT01727141|3651815|P4|Overall Study|Death|1
1113569|NCT01727141|3651816|P3|Overall Study|Death|1
1113570|NCT01727141|3651817|P2|Overall Study|Death|1
1113571|NCT01727141|3651818|P1|Overall Study|Death|0
1113572|NCT01727141|3651815|P4|Overall Study|Lost to Follow-up|0
1113573|NCT01727141|3651816|P3|Overall Study|Lost to Follow-up|0
1113574|NCT01727141|3651817|P2|Overall Study|Lost to Follow-up|2
1113575|NCT01727141|3651818|P1|Overall Study|Lost to Follow-up|0
1113576|NCT01727141|3651815|P4|Overall Study|Physician Decision|2
1113577|NCT01727141|3651816|P3|Overall Study|Physician Decision|0
1113578|NCT01727141|3651817|P2|Overall Study|Physician Decision|1
1113579|NCT01727141|3651818|P1|Overall Study|Physician Decision|0
1113580|NCT01727024|3651883|P2|Period 1|Withdrawal by Subject|3
1113581|NCT01727024|3651884|P1|Period 1|Withdrawal by Subject|2
1113582|NCT01727024|3651883|P2|Period 1|Lost to Follow-up|1
1113583|NCT01727024|3651884|P1|Period 1|Lost to Follow-up|1
1113584|NCT01726803|3651899|P2|Overall Study|Withdrawal by Subject|0
1113585|NCT01726803|3651900|P1|Overall Study|Withdrawal by Subject|1
1113586|NCT01726803|3651899|P2|Overall Study|Lost to Follow-up|1
1113587|NCT01726803|3651900|P1|Overall Study|Lost to Follow-up|6
1113588|NCT01726517|3651942|P5|Overall Study|Withdrawal by Subject|0
1113589|NCT01726517|3651943|P4|Overall Study|Withdrawal by Subject|0
1113590|NCT01726517|3651944|P3|Overall Study|Withdrawal by Subject|1
1113591|NCT01726517|3651945|P2|Overall Study|Withdrawal by Subject|0
1113592|NCT01726517|3651946|P1|Overall Study|Withdrawal by Subject|0
1113593|NCT01726335|3652002|P1|Overall Study|Exacerbation of psychotic symptoms|1
1113594|NCT01726335|3652002|P1|Overall Study|Lost to Follow-up|2
1113595|NCT01726335|3652002|P1|Overall Study|Adverse Event|4
1113596|NCT01726335|3652002|P1|Overall Study|Withdrawal by Subject|15
1113597|NCT01726335|3652002|P1|Overall Study|Lost to Follow-up|2
1113598|NCT01726049|3652020|P2|Overall Study|refused second HC|2
1113599|NCT01726049|3652021|P1|Overall Study|refused second HC|0
1113600|NCT01726049|3652020|P2|Overall Study|Adverse Event|1
1113601|NCT01726049|3652021|P1|Overall Study|Adverse Event|4
1113602|NCT01726049|3652020|P2|Overall Study|Death|1
1113603|NCT01726049|3652021|P1|Overall Study|Death|1
1113604|NCT01726023|3652035|P2|Overall Study|Withdrawal by Subject|8
1113605|NCT01726023|3652036|P1|Overall Study|Withdrawal by Subject|16
1113606|NCT01726023|3652035|P2|Overall Study|Other Eligibility criteria|7
1113607|NCT01726023|3652036|P1|Overall Study|Other Eligibility criteria|7
1113608|NCT01726023|3652035|P2|Overall Study|Lost to Follow-up|10
1113609|NCT01726023|3652036|P1|Overall Study|Lost to Follow-up|5
1113610|NCT01726023|3652035|P2|Overall Study|Death|1
1113611|NCT01726023|3652036|P1|Overall Study|Death|1
1113612|NCT01725750|3652155|P2|Overall Study|Withdrawal by Subject|9
1113613|NCT01725750|3652156|P1|Overall Study|Withdrawal by Subject|0
1113614|NCT01725750|3652155|P2|Overall Study|Lost to Follow-up|1
1113615|NCT01725750|3652156|P1|Overall Study|Lost to Follow-up|1
1113616|NCT01725750|3652155|P2|Overall Study|Adverse Event|0
1113617|NCT01725750|3652156|P1|Overall Study|Adverse Event|1
1113618|NCT01725529|3652183|P3|Overall Study|Withdrawal by Subject|8
1113619|NCT01725529|3652184|P2|Overall Study|Withdrawal by Subject|14
1113620|NCT01725529|3652185|P1|Overall Study|Withdrawal by Subject|12
1113621|NCT01725529|3652183|P3|Overall Study|Protocol Violation|1
1113622|NCT01725529|3652184|P2|Overall Study|Protocol Violation|1
1113623|NCT01725529|3652185|P1|Overall Study|Protocol Violation|0
1113624|NCT01725529|3652183|P3|Overall Study|Lost to Follow-up|1
1113625|NCT01725529|3652184|P2|Overall Study|Lost to Follow-up|1
1113626|NCT01725529|3652185|P1|Overall Study|Lost to Follow-up|2
1113627|NCT01725529|3652183|P3|Overall Study|Adverse Event|0
1113628|NCT01725529|3652184|P2|Overall Study|Adverse Event|0
1113629|NCT01725529|3652185|P1|Overall Study|Adverse Event|1
1113630|NCT01725451|3652211|P4|Period 4|Adverse Event|0
1113631|NCT01725451|3652212|P3|Period 4|Adverse Event|1
1113632|NCT01725451|3652213|P2|Period 4|Adverse Event|0
1113633|NCT01725451|3652214|P1|Period 4|Adverse Event|0
1113634|NCT01725451|3652211|P4|Washout From Period 3|Adverse Event|0
1113635|NCT01725451|3652212|P3|Washout From Period 3|Adverse Event|0
1113636|NCT01725451|3652213|P2|Washout From Period 3|Adverse Event|1
1113637|NCT01725451|3652214|P1|Washout From Period 3|Adverse Event|0
1113638|NCT01725451|3652211|P4|Washout From Period 3|Protocol Violation|0
1113639|NCT01725451|3652212|P3|Washout From Period 3|Protocol Violation|1
1113640|NCT01725451|3652213|P2|Washout From Period 3|Protocol Violation|0
1113641|NCT01725451|3652214|P1|Washout From Period 3|Protocol Violation|0
1113642|NCT01725451|3652211|P4|Period 1|Withdrawal by Subject|0
1113643|NCT01725451|3652212|P3|Period 1|Withdrawal by Subject|0
1113644|NCT01725451|3652213|P2|Period 1|Withdrawal by Subject|0
1113645|NCT01725451|3652214|P1|Period 1|Withdrawal by Subject|1
1113646|NCT01725386|3652236|P2|Overall Study|Withdrawal by Subject|0
1113647|NCT01725386|3652237|P1|Overall Study|Withdrawal by Subject|10
1113648|NCT01725386|3652236|P2|Overall Study|Lost to Follow-up|6
1113649|NCT01725386|3652237|P1|Overall Study|Lost to Follow-up|81
1113650|NCT01725386|3652236|P2|Overall Study|Death|40
1113651|NCT01725386|3652237|P1|Overall Study|Death|84
1113652|NCT01725308|3652256|P3|Treatment Period II|Miscellaneous|7
1113653|NCT01725308|3652257|P2|Treatment Period II|Miscellaneous|3
1113654|NCT01725308|3652258|P1|Treatment Period II|Miscellaneous|5
1113655|NCT01725308|3652256|P3|Treatment Period II|Protocol Deviations|1
1113656|NCT01725308|3652257|P2|Treatment Period II|Protocol Deviations|0
1113657|NCT01725308|3652258|P1|Treatment Period II|Protocol Deviations|0
1113658|NCT01725308|3652256|P3|Treatment Period II|Lost to Follow-up|3
1113659|NCT01725308|3652257|P2|Treatment Period II|Lost to Follow-up|5
1113660|NCT01725308|3652258|P1|Treatment Period II|Lost to Follow-up|1
1113661|NCT01725308|3652256|P3|Treatment Period II|Withdrawal of Consent|16
1113662|NCT01725308|3652257|P2|Treatment Period II|Withdrawal of Consent|2
1113663|NCT01725308|3652258|P1|Treatment Period II|Withdrawal of Consent|28
1113664|NCT01725308|3652256|P3|Treatment Period II|Changes in the Episodes|5
1113665|NCT01725308|3652257|P2|Treatment Period II|Changes in the Episodes|0
1113666|NCT01725308|3652258|P1|Treatment Period II|Changes in the Episodes|1
1113667|NCT01725308|3652256|P3|Treatment Period II|Worsening of the Target Disease|2
1113668|NCT01725308|3652257|P2|Treatment Period II|Worsening of the Target Disease|4
1113669|NCT01725308|3652258|P1|Treatment Period II|Worsening of the Target Disease|1
1113670|NCT01725308|3652256|P3|Treatment Period II|Insufficient Response|6
1113671|NCT01725308|3652257|P2|Treatment Period II|Insufficient Response|4
1113672|NCT01725308|3652258|P1|Treatment Period II|Insufficient Response|2
1113673|NCT01725308|3652256|P3|Treatment Period II|Adverse Event|20
1113674|NCT01725308|3652257|P2|Treatment Period II|Adverse Event|8
1113675|NCT01725308|3652258|P1|Treatment Period II|Adverse Event|13
1113676|NCT01725308|3652256|P3|Treatment Period II|Did Not Receive Drug|0
1113677|NCT01725308|3652257|P2|Treatment Period II|Did Not Receive Drug|0
1113678|NCT01725308|3652258|P1|Treatment Period II|Did Not Receive Drug|4
1113679|NCT01725308|3652256|P3|Treatment Period II|Did Not Meet Transition Criteria|4
1113680|NCT01725308|3652257|P2|Treatment Period II|Did Not Meet Transition Criteria|3
1113681|NCT01725308|3652258|P1|Treatment Period II|Did Not Meet Transition Criteria|0
1113682|NCT01725308|3652256|P3|Treatment Period I|Miscellaneous|3
1113683|NCT01725308|3652257|P2|Treatment Period I|Miscellaneous|0
1113684|NCT01725308|3652258|P1|Treatment Period I|Miscellaneous|2
1113685|NCT01725308|3652256|P3|Treatment Period I|Protocol Deviations|1
1113686|NCT01725308|3652257|P2|Treatment Period I|Protocol Deviations|1
1113687|NCT01725308|3652258|P1|Treatment Period I|Protocol Deviations|3
1113688|NCT01725308|3652256|P3|Treatment Period I|Lost to Follow-up|2
1113689|NCT01725308|3652257|P2|Treatment Period I|Lost to Follow-up|2
1113690|NCT01725308|3652258|P1|Treatment Period I|Lost to Follow-up|3
1113691|NCT01725308|3652256|P3|Treatment Period I|Withdrawal of Consent|5
1113692|NCT01725308|3652257|P2|Treatment Period I|Withdrawal of Consent|7
1113693|NCT01725308|3652258|P1|Treatment Period I|Withdrawal of Consent|12
1113694|NCT01725308|3652256|P3|Treatment Period I|Changes in the Episodes|2
1113695|NCT01725308|3652257|P2|Treatment Period I|Changes in the Episodes|0
1113696|NCT01725308|3652258|P1|Treatment Period I|Changes in the Episodes|3
1113697|NCT01725308|3652256|P3|Treatment Period I|Worsening of the Target Disease|2
1113698|NCT01725308|3652257|P2|Treatment Period I|Worsening of the Target Disease|0
1113699|NCT01725308|3652258|P1|Treatment Period I|Worsening of the Target Disease|8
1113700|NCT01725308|3652256|P3|Treatment Period I|Insufficient Response|5
1113701|NCT01725308|3652257|P2|Treatment Period I|Insufficient Response|0
1113702|NCT01725308|3652258|P1|Treatment Period I|Insufficient Response|7
1113703|NCT01725308|3652256|P3|Treatment Period I|Adverse Event|21
1113704|NCT01725308|3652257|P2|Treatment Period I|Adverse Event|4
1113705|NCT01725308|3652258|P1|Treatment Period I|Adverse Event|5
1113706|NCT01725308|3652256|P3|Treatment Period I|Did Not Receive Drug|0
1113707|NCT01725308|3652257|P2|Treatment Period I|Did Not Receive Drug|0
1113708|NCT01725308|3652258|P1|Treatment Period I|Did Not Receive Drug|1
1113709|NCT01725282|3652405|P4|Overall Study|Lack of Efficacy|1
1113710|NCT01725282|3652406|P3|Overall Study|Lack of Efficacy|0
1113711|NCT01725282|3652407|P2|Overall Study|Lack of Efficacy|1
1113712|NCT01725282|3652408|P1|Overall Study|Lack of Efficacy|0
1113713|NCT01725282|3652405|P4|Overall Study|Withdrawal by Subject|1
1113714|NCT01725282|3652406|P3|Overall Study|Withdrawal by Subject|1
1113715|NCT01725282|3652407|P2|Overall Study|Withdrawal by Subject|0
1113716|NCT01725282|3652408|P1|Overall Study|Withdrawal by Subject|0
1113717|NCT01725282|3652405|P4|Overall Study|Study Site Withdrawal|0
1113718|NCT01725282|3652406|P3|Overall Study|Study Site Withdrawal|0
1113719|NCT01725282|3652407|P2|Overall Study|Study Site Withdrawal|1
1113720|NCT01725282|3652408|P1|Overall Study|Study Site Withdrawal|0
1113721|NCT01725282|3652405|P4|Overall Study|Met Exclusion Criteria|0
1113722|NCT01725282|3652406|P3|Overall Study|Met Exclusion Criteria|1
1113723|NCT01725282|3652407|P2|Overall Study|Met Exclusion Criteria|0
1113724|NCT01725282|3652408|P1|Overall Study|Met Exclusion Criteria|0
1113725|NCT01725282|3652405|P4|Overall Study|Exacerbation of Target Disease|1
1113726|NCT01725282|3652406|P3|Overall Study|Exacerbation of Target Disease|0
1113727|NCT01725282|3652407|P2|Overall Study|Exacerbation of Target Disease|0
1113728|NCT01725282|3652408|P1|Overall Study|Exacerbation of Target Disease|1
1113729|NCT01725282|3652405|P4|Overall Study|Adverse Event|4
1113730|NCT01725282|3652406|P3|Overall Study|Adverse Event|6
1113731|NCT01725282|3652407|P2|Overall Study|Adverse Event|3
1113732|NCT01725282|3652408|P1|Overall Study|Adverse Event|1
1113733|NCT01725217|3652441|P3|Overall Study|Withdrawal by Subject|0
1113734|NCT01725217|3652442|P2|Overall Study|Withdrawal by Subject|0
1113735|NCT01725217|3652443|P1|Overall Study|Withdrawal by Subject|1
1113736|NCT01725126|3652477|P6|Overall Study|Withdrawal by Subject|0
1113737|NCT01725126|3652478|P5|Overall Study|Withdrawal by Subject|0
1113738|NCT01725126|3652479|P4|Overall Study|Withdrawal by Subject|1
1113739|NCT01725126|3652480|P3|Overall Study|Withdrawal by Subject|0
1113740|NCT01725126|3652481|P2|Overall Study|Withdrawal by Subject|0
1113741|NCT01725126|3652482|P1|Overall Study|Withdrawal by Subject|0
1113742|NCT01725126|3652477|P6|Overall Study|Protocol Violation|0
1113743|NCT01725126|3652478|P5|Overall Study|Protocol Violation|0
1113744|NCT01725126|3652479|P4|Overall Study|Protocol Violation|0
1113745|NCT01725126|3652480|P3|Overall Study|Protocol Violation|0
1113746|NCT01725126|3652481|P2|Overall Study|Protocol Violation|1
1113747|NCT01725126|3652482|P1|Overall Study|Protocol Violation|0
1113748|NCT01724528|3652680|P2|Overall Study|Patient refused to attend last visit|0
1113749|NCT01724528|3652681|P1|Overall Study|Patient refused to attend last visit|1
1113750|NCT01724528|3652680|P2|Overall Study|Protocol Violation|1
1113751|NCT01724528|3652681|P1|Overall Study|Protocol Violation|0
1113752|NCT01724528|3652680|P2|Overall Study|Withdrawal by Subject|2
1113753|NCT01724528|3652681|P1|Overall Study|Withdrawal by Subject|0
1113754|NCT01724528|3652680|P2|Overall Study|Death|0
1113755|NCT01724528|3652681|P1|Overall Study|Death|3
1113756|NCT01724359|3652695|P1|Overall Study|Not specified|20
1113757|NCT01724359|3652695|P1|Overall Study|Death|1
1113758|NCT01724359|3652695|P1|Overall Study|Adverse Event|10
1113759|NCT01724216|3652708|P1|Overall Study|Scan was not completed|1
1113760|NCT01724177|3652712|P1|Overall Study|Serious Adverse Event Related|1
1113761|NCT01724177|3652712|P1|Overall Study|Nervous participant|1
1113762|NCT01724177|3652712|P1|Overall Study|Progressive disease or Relapsed Disease|16
1113763|NCT01724177|3652712|P1|Overall Study|Adverse Event|8
1113764|NCT01724021|3652725|P2|Overall Study|Missing|1
1113765|NCT01724021|3652726|P1|Overall Study|Missing|1
1113766|NCT01724021|3652725|P2|Overall Study|Reason Not Specified|39
1113767|NCT01724021|3652726|P1|Overall Study|Reason Not Specified|36
1113768|NCT01724021|3652725|P2|Overall Study|Lost to Follow-up|15
1113769|NCT01724021|3652726|P1|Overall Study|Lost to Follow-up|15
1113770|NCT01724021|3652725|P2|Overall Study|Participant request/ Withdrew consent|14
1113771|NCT01724021|3652726|P1|Overall Study|Participant request/ Withdrew consent|18
1113772|NCT01724021|3652725|P2|Overall Study|Death|58
1113773|NCT01724021|3652726|P1|Overall Study|Death|46
1113774|NCT01724021|3652725|P2|Overall Study|Adverse Event|6
1113775|NCT01724021|3652726|P1|Overall Study|Adverse Event|11
1113776|NCT01723904|3652758|P1|Overall Study|Unable to follow protocol/ judged by inv|3
1113777|NCT01723904|3652758|P1|Overall Study|Adverse Event|5
1113778|NCT01723904|3652758|P1|Overall Study|Noncompliant|3
1113779|NCT01723397|3652779|P2|Study Period 2|Protocol Violation|1
1113780|NCT01723397|3652780|P1|Study Period 2|Protocol Violation|0
1113781|NCT01723397|3652779|P2|Study Period 1|Protocol Violation|1
1113782|NCT01723397|3652780|P1|Study Period 1|Protocol Violation|0
1113783|NCT01723254|3652794|P8|Overall Study|Withdrawal by Subject|2
1113784|NCT01723254|3652795|P7|Overall Study|Withdrawal by Subject|1
1113785|NCT01723254|3652796|P6|Overall Study|Withdrawal by Subject|1
1113786|NCT01723254|3652797|P5|Overall Study|Withdrawal by Subject|1
1113787|NCT01723254|3652798|P4|Overall Study|Withdrawal by Subject|0
1113788|NCT01723254|3652799|P3|Overall Study|Withdrawal by Subject|1
1113789|NCT01723254|3652800|P2|Overall Study|Withdrawal by Subject|2
1113790|NCT01723254|3652801|P1|Overall Study|Withdrawal by Subject|1
1113791|NCT01723254|3652794|P8|Overall Study|Protocol Violation|0
1113792|NCT01723254|3652795|P7|Overall Study|Protocol Violation|0
1113793|NCT01723254|3652796|P6|Overall Study|Protocol Violation|0
1113794|NCT01723254|3652797|P5|Overall Study|Protocol Violation|0
1113795|NCT01723254|3652798|P4|Overall Study|Protocol Violation|0
1113796|NCT01723254|3652799|P3|Overall Study|Protocol Violation|0
1113797|NCT01723254|3652800|P2|Overall Study|Protocol Violation|1
1113798|NCT01723254|3652801|P1|Overall Study|Protocol Violation|0
1113799|NCT01723254|3652794|P8|Overall Study|Move/Left to another country/city|0
1113800|NCT01723254|3652795|P7|Overall Study|Move/Left to another country/city|0
1113801|NCT01723254|3652796|P6|Overall Study|Move/Left to another country/city|0
1113802|NCT01723254|3652797|P5|Overall Study|Move/Left to another country/city|1
1113803|NCT01723254|3652798|P4|Overall Study|Move/Left to another country/city|1
1113804|NCT01723254|3652799|P3|Overall Study|Move/Left to another country/city|2
1113805|NCT01723254|3652800|P2|Overall Study|Move/Left to another country/city|0
1113806|NCT01723254|3652801|P1|Overall Study|Move/Left to another country/city|0
1113807|NCT01723254|3652794|P8|Overall Study|No longer have time to participate|0
1113808|NCT01723254|3652795|P7|Overall Study|No longer have time to participate|0
1113809|NCT01723254|3652796|P6|Overall Study|No longer have time to participate|0
1113810|NCT01723254|3652797|P5|Overall Study|No longer have time to participate|0
1113811|NCT01723254|3652798|P4|Overall Study|No longer have time to participate|1
1113812|NCT01723254|3652799|P3|Overall Study|No longer have time to participate|0
1113813|NCT01723254|3652800|P2|Overall Study|No longer have time to participate|0
1113814|NCT01723254|3652801|P1|Overall Study|No longer have time to participate|0
1113815|NCT01723254|3652794|P8|Overall Study|Personal issues|0
1113816|NCT01723254|3652795|P7|Overall Study|Personal issues|0
1113817|NCT01723254|3652796|P6|Overall Study|Personal issues|1
1113818|NCT01723254|3652797|P5|Overall Study|Personal issues|0
1113819|NCT01723254|3652798|P4|Overall Study|Personal issues|0
1113820|NCT01723254|3652799|P3|Overall Study|Personal issues|0
1113821|NCT01723254|3652800|P2|Overall Study|Personal issues|0
1113822|NCT01723254|3652801|P1|Overall Study|Personal issues|0
1113823|NCT01723254|3652794|P8|Overall Study|Conflict with work schedule|1
1113824|NCT01723254|3652795|P7|Overall Study|Conflict with work schedule|0
1113825|NCT01723254|3652796|P6|Overall Study|Conflict with work schedule|0
1113826|NCT01723254|3652797|P5|Overall Study|Conflict with work schedule|0
1113827|NCT01723254|3652798|P4|Overall Study|Conflict with work schedule|0
1113828|NCT01723254|3652799|P3|Overall Study|Conflict with work schedule|0
1113829|NCT01723254|3652800|P2|Overall Study|Conflict with work schedule|0
1113830|NCT01723254|3652801|P1|Overall Study|Conflict with work schedule|0
1113831|NCT01723228|3652853|P2|Overall Study|Not Specified|1
1113832|NCT01723228|3652854|P1|Overall Study|Not Specified|2
1113833|NCT01723228|3652853|P2|Overall Study|Lost to Follow-up|1
1113834|NCT01723228|3652854|P1|Overall Study|Lost to Follow-up|2
1113835|NCT01723228|3652853|P2|Overall Study|Protocol Violation|2
1113836|NCT01723228|3652854|P1|Overall Study|Protocol Violation|0
1113837|NCT01723228|3652853|P2|Overall Study|Withdrawal by Subject|1
1113838|NCT01723228|3652854|P1|Overall Study|Withdrawal by Subject|2
1113839|NCT01723228|3652853|P2|Overall Study|Adverse Event|6
1113840|NCT01723228|3652854|P1|Overall Study|Adverse Event|2
1113841|NCT01722994|3652872|P2|Overall Study|Missing data|17
1113842|NCT01722994|3652873|P1|Overall Study|Missing data|25
1113843|NCT01722877|3652892|P1|Overall Study|Lost to Follow-up|1
1113844|NCT01722877|3652892|P1|Overall Study|Death|1
1113845|NCT01722331|3652963|P7|Part 3|Other Protocol Specified Criteria|0
1113846|NCT01722331|3652964|P6|Part 3|Other Protocol Specified Criteria|0
1113847|NCT01722331|3652965|P5|Part 3|Other Protocol Specified Criteria|0
1113848|NCT01722331|3652966|P4|Part 3|Other Protocol Specified Criteria|0
1113849|NCT01722331|3652967|P3|Part 3|Other Protocol Specified Criteria|0
1113850|NCT01722331|3652968|P2|Part 3|Other Protocol Specified Criteria|1
1113851|NCT01722331|3652969|P1|Part 3|Other Protocol Specified Criteria|1
1113852|NCT01722331|3652963|P7|Part 3|Withdrawal by Subject|1
1113853|NCT01722331|3652964|P6|Part 3|Withdrawal by Subject|2
1113854|NCT01722331|3652965|P5|Part 3|Withdrawal by Subject|0
1113855|NCT01722331|3652966|P4|Part 3|Withdrawal by Subject|0
1113856|NCT01722331|3652967|P3|Part 3|Withdrawal by Subject|0
1113857|NCT01722331|3652968|P2|Part 3|Withdrawal by Subject|7
1113858|NCT01722331|3652969|P1|Part 3|Withdrawal by Subject|4
1113859|NCT01722331|3652963|P7|Part 3|Protocol Violation|0
1113860|NCT01722331|3652964|P6|Part 3|Protocol Violation|0
1113861|NCT01722331|3652965|P5|Part 3|Protocol Violation|0
1113862|NCT01722331|3652966|P4|Part 3|Protocol Violation|0
1113863|NCT01722331|3652967|P3|Part 3|Protocol Violation|0
1113864|NCT01722331|3652968|P2|Part 3|Protocol Violation|1
1113865|NCT01722331|3652969|P1|Part 3|Protocol Violation|2
1113866|NCT01722331|3652963|P7|Part 3|Physician Decision|1
1113867|NCT01722331|3652964|P6|Part 3|Physician Decision|0
1113868|NCT01722331|3652965|P5|Part 3|Physician Decision|0
1113869|NCT01722331|3652966|P4|Part 3|Physician Decision|0
1113870|NCT01722331|3652967|P3|Part 3|Physician Decision|0
1113871|NCT01722331|3652968|P2|Part 3|Physician Decision|1
1113872|NCT01722331|3652969|P1|Part 3|Physician Decision|1
1113873|NCT01722331|3652963|P7|Part 3|Non-Compliance with Study Drug|0
1113874|NCT01722331|3652964|P6|Part 3|Non-Compliance with Study Drug|0
1113875|NCT01722331|3652965|P5|Part 3|Non-Compliance with Study Drug|0
1113876|NCT01722331|3652966|P4|Part 3|Non-Compliance with Study Drug|0
1113877|NCT01722331|3652967|P3|Part 3|Non-Compliance with Study Drug|0
1113878|NCT01722331|3652968|P2|Part 3|Non-Compliance with Study Drug|1
1113879|NCT01722331|3652969|P1|Part 3|Non-Compliance with Study Drug|0
1113880|NCT01722331|3652963|P7|Part 3|Lost to Follow-up|0
1113881|NCT01722331|3652964|P6|Part 3|Lost to Follow-up|1
1113882|NCT01722331|3652965|P5|Part 3|Lost to Follow-up|0
1113883|NCT01722331|3652966|P4|Part 3|Lost to Follow-up|0
1113884|NCT01722331|3652967|P3|Part 3|Lost to Follow-up|0
1113885|NCT01722331|3652968|P2|Part 3|Lost to Follow-up|4
1113886|NCT01722331|3652969|P1|Part 3|Lost to Follow-up|3
1113887|NCT01722331|3652963|P7|Part 3|Lack of Efficacy|0
1113888|NCT01722331|3652964|P6|Part 3|Lack of Efficacy|0
1113889|NCT01722331|3652965|P5|Part 3|Lack of Efficacy|0
1113890|NCT01722331|3652966|P4|Part 3|Lack of Efficacy|0
1113891|NCT01722331|3652967|P3|Part 3|Lack of Efficacy|0
1113892|NCT01722331|3652968|P2|Part 3|Lack of Efficacy|0
1113893|NCT01722331|3652969|P1|Part 3|Lack of Efficacy|1
1113894|NCT01722331|3652963|P7|Part 3|Death|0
1113895|NCT01722331|3652964|P6|Part 3|Death|0
1113896|NCT01722331|3652965|P5|Part 3|Death|0
1113897|NCT01722331|3652966|P4|Part 3|Death|0
1113898|NCT01722331|3652967|P3|Part 3|Death|0
1113899|NCT01722331|3652968|P2|Part 3|Death|0
1113900|NCT01722331|3652969|P1|Part 3|Death|1
1113901|NCT01722331|3652963|P7|Part 3|Adverse Event|0
1113902|NCT01722331|3652964|P6|Part 3|Adverse Event|0
1113903|NCT01722331|3652965|P5|Part 3|Adverse Event|0
1113904|NCT01722331|3652966|P4|Part 3|Adverse Event|1
1113905|NCT01722331|3652967|P3|Part 3|Adverse Event|0
1113906|NCT01722331|3652968|P2|Part 3|Adverse Event|2
1113907|NCT01722331|3652969|P1|Part 3|Adverse Event|2
1113908|NCT01722331|3652963|P7|Part 2|Other Protocol Specified Criteria|1
1113909|NCT01722331|3652964|P6|Part 2|Other Protocol Specified Criteria|2
1113910|NCT01722331|3652965|P5|Part 2|Other Protocol Specified Criteria|0
1113911|NCT01722331|3652966|P4|Part 2|Other Protocol Specified Criteria|0
1113912|NCT01722331|3652967|P3|Part 2|Other Protocol Specified Criteria|10
1113913|NCT01722331|3652968|P2|Part 2|Other Protocol Specified Criteria|0
1113914|NCT01722331|3652969|P1|Part 2|Other Protocol Specified Criteria|6
1113915|NCT01722331|3652963|P7|Part 2|Withdrawal by Subject|2
1113916|NCT01722331|3652964|P6|Part 2|Withdrawal by Subject|2
1113917|NCT01722331|3652965|P5|Part 2|Withdrawal by Subject|0
1113918|NCT01722331|3652966|P4|Part 2|Withdrawal by Subject|0
1113919|NCT01722331|3652967|P3|Part 2|Withdrawal by Subject|3
1113920|NCT01722331|3652968|P2|Part 2|Withdrawal by Subject|0
1113921|NCT01722331|3652969|P1|Part 2|Withdrawal by Subject|5
1113922|NCT01722331|3652963|P7|Part 2|Protocol Violation|0
1113923|NCT01722331|3652964|P6|Part 2|Protocol Violation|0
1113924|NCT01722331|3652965|P5|Part 2|Protocol Violation|0
1113925|NCT01722331|3652966|P4|Part 2|Protocol Violation|0
1113926|NCT01722331|3652967|P3|Part 2|Protocol Violation|0
1113927|NCT01722331|3652968|P2|Part 2|Protocol Violation|0
1113928|NCT01722331|3652969|P1|Part 2|Protocol Violation|1
1113929|NCT01722331|3652963|P7|Part 2|Progressive Disease|0
1113930|NCT01722331|3652964|P6|Part 2|Progressive Disease|0
1113931|NCT01722331|3652965|P5|Part 2|Progressive Disease|0
1113932|NCT01722331|3652966|P4|Part 2|Progressive Disease|0
1113933|NCT01722331|3652967|P3|Part 2|Progressive Disease|1
1113934|NCT01722331|3652968|P2|Part 2|Progressive Disease|0
1113935|NCT01722331|3652969|P1|Part 2|Progressive Disease|0
1113936|NCT01722331|3652963|P7|Part 2|Pregnancy|0
1113937|NCT01722331|3652964|P6|Part 2|Pregnancy|1
1113938|NCT01722331|3652965|P5|Part 2|Pregnancy|0
1113939|NCT01722331|3652966|P4|Part 2|Pregnancy|0
1113940|NCT01722331|3652967|P3|Part 2|Pregnancy|0
1113941|NCT01722331|3652968|P2|Part 2|Pregnancy|0
1113942|NCT01722331|3652969|P1|Part 2|Pregnancy|0
1113943|NCT01722331|3652963|P7|Part 2|Physician Decision|0
1113944|NCT01722331|3652964|P6|Part 2|Physician Decision|0
1113945|NCT01722331|3652965|P5|Part 2|Physician Decision|0
1113946|NCT01722331|3652966|P4|Part 2|Physician Decision|0
1113947|NCT01722331|3652967|P3|Part 2|Physician Decision|2
1113948|NCT01722331|3652968|P2|Part 2|Physician Decision|0
1113949|NCT01722331|3652969|P1|Part 2|Physician Decision|0
1113950|NCT01722331|3652963|P7|Part 2|Non-Compliance with Study Drug|0
1113951|NCT01722331|3652964|P6|Part 2|Non-Compliance with Study Drug|0
1113952|NCT01722331|3652965|P5|Part 2|Non-Compliance with Study Drug|0
1113953|NCT01722331|3652966|P4|Part 2|Non-Compliance with Study Drug|0
1113954|NCT01722331|3652967|P3|Part 2|Non-Compliance with Study Drug|1
1113955|NCT01722331|3652968|P2|Part 2|Non-Compliance with Study Drug|0
1113956|NCT01722331|3652969|P1|Part 2|Non-Compliance with Study Drug|1
1113957|NCT01722331|3652963|P7|Part 2|Lost to Follow-up|1
1113958|NCT01722331|3652964|P6|Part 2|Lost to Follow-up|1
1113959|NCT01722331|3652965|P5|Part 2|Lost to Follow-up|0
1113960|NCT01722331|3652966|P4|Part 2|Lost to Follow-up|0
1113961|NCT01722331|3652967|P3|Part 2|Lost to Follow-up|3
1113962|NCT01722331|3652968|P2|Part 2|Lost to Follow-up|0
1113963|NCT01722331|3652969|P1|Part 2|Lost to Follow-up|0
1113964|NCT01722331|3652963|P7|Part 2|Lack of Efficacy|3
1113965|NCT01722331|3652964|P6|Part 2|Lack of Efficacy|3
1113966|NCT01722331|3652965|P5|Part 2|Lack of Efficacy|0
1113967|NCT01722331|3652966|P4|Part 2|Lack of Efficacy|0
1113968|NCT01722331|3652967|P3|Part 2|Lack of Efficacy|11
1113969|NCT01722331|3652968|P2|Part 2|Lack of Efficacy|0
1113970|NCT01722331|3652969|P1|Part 2|Lack of Efficacy|3
1113971|NCT01722331|3652963|P7|Part 2|Adverse Event|0
1113972|NCT01722331|3652964|P6|Part 2|Adverse Event|1
1113973|NCT01722331|3652965|P5|Part 2|Adverse Event|0
1113974|NCT01722331|3652966|P4|Part 2|Adverse Event|0
1113975|NCT01722331|3652967|P3|Part 2|Adverse Event|0
1113976|NCT01722331|3652968|P2|Part 2|Adverse Event|0
1113977|NCT01722331|3652969|P1|Part 2|Adverse Event|3
1113978|NCT01722331|3652963|P7|Part 1|Withdrawal by Subject|0
1113979|NCT01722331|3652964|P6|Part 1|Withdrawal by Subject|0
1113980|NCT01722331|3652965|P5|Part 1|Withdrawal by Subject|3
1113981|NCT01722331|3652966|P4|Part 1|Withdrawal by Subject|0
1113982|NCT01722331|3652967|P3|Part 1|Withdrawal by Subject|3
1113983|NCT01722331|3652968|P2|Part 1|Withdrawal by Subject|0
1113984|NCT01722331|3652969|P1|Part 1|Withdrawal by Subject|2
1113985|NCT01722331|3652963|P7|Part 1|Protocol Violation|0
1113986|NCT01722331|3652964|P6|Part 1|Protocol Violation|0
1113987|NCT01722331|3652965|P5|Part 1|Protocol Violation|1
1113988|NCT01722331|3652966|P4|Part 1|Protocol Violation|0
1113989|NCT01722331|3652967|P3|Part 1|Protocol Violation|0
1113990|NCT01722331|3652968|P2|Part 1|Protocol Violation|0
1113991|NCT01722331|3652969|P1|Part 1|Protocol Violation|1
1113992|NCT01722331|3652963|P7|Part 1|Progressive Disease|0
1113993|NCT01722331|3652964|P6|Part 1|Progressive Disease|0
1113994|NCT01722331|3652965|P5|Part 1|Progressive Disease|1
1113995|NCT01722331|3652966|P4|Part 1|Progressive Disease|0
1113996|NCT01722331|3652967|P3|Part 1|Progressive Disease|0
1113997|NCT01722331|3652968|P2|Part 1|Progressive Disease|0
1113998|NCT01722331|3652969|P1|Part 1|Progressive Disease|0
1113999|NCT01722331|3652963|P7|Part 1|Pregnancy|0
1114000|NCT01722331|3652964|P6|Part 1|Pregnancy|0
1114001|NCT01722331|3652965|P5|Part 1|Pregnancy|0
1114002|NCT01722331|3652966|P4|Part 1|Pregnancy|0
1114003|NCT01722331|3652967|P3|Part 1|Pregnancy|0
1114004|NCT01722331|3652968|P2|Part 1|Pregnancy|0
1114005|NCT01722331|3652969|P1|Part 1|Pregnancy|1
1114006|NCT01722331|3652963|P7|Part 1|Physician Decision|0
1114007|NCT01722331|3652964|P6|Part 1|Physician Decision|0
1114008|NCT01722331|3652965|P5|Part 1|Physician Decision|1
1114009|NCT01722331|3652966|P4|Part 1|Physician Decision|0
1114010|NCT01722331|3652967|P3|Part 1|Physician Decision|3
1114011|NCT01722331|3652968|P2|Part 1|Physician Decision|0
1114012|NCT01722331|3652969|P1|Part 1|Physician Decision|0
1114013|NCT01722331|3652963|P7|Part 1|Lost to Follow-up|0
1114014|NCT01722331|3652964|P6|Part 1|Lost to Follow-up|0
1114015|NCT01722331|3652965|P5|Part 1|Lost to Follow-up|1
1114016|NCT01722331|3652966|P4|Part 1|Lost to Follow-up|0
1114017|NCT01722331|3652967|P3|Part 1|Lost to Follow-up|2
1114018|NCT01722331|3652968|P2|Part 1|Lost to Follow-up|0
1114019|NCT01722331|3652969|P1|Part 1|Lost to Follow-up|1
1114020|NCT01722331|3652963|P7|Part 1|Lack of Efficacy|0
1114021|NCT01722331|3652964|P6|Part 1|Lack of Efficacy|0
1114022|NCT01722331|3652965|P5|Part 1|Lack of Efficacy|2
1114023|NCT01722331|3652966|P4|Part 1|Lack of Efficacy|0
1114024|NCT01722331|3652967|P3|Part 1|Lack of Efficacy|1
1114025|NCT01722331|3652968|P2|Part 1|Lack of Efficacy|0
1114026|NCT01722331|3652969|P1|Part 1|Lack of Efficacy|0
1114027|NCT01722331|3652963|P7|Part 1|Adverse Event|0
1114028|NCT01722331|3652964|P6|Part 1|Adverse Event|0
1114029|NCT01722331|3652965|P5|Part 1|Adverse Event|0
1114030|NCT01722331|3652966|P4|Part 1|Adverse Event|0
1114031|NCT01722331|3652967|P3|Part 1|Adverse Event|0
1114032|NCT01722331|3652968|P2|Part 1|Adverse Event|0
1114033|NCT01722331|3652969|P1|Part 1|Adverse Event|5
1114034|NCT01722266|3653085|P4|Overall Study|Dropped out due to Nausea|0
1114035|NCT01722266|3653086|P3|Overall Study|Dropped out due to Nausea|2
1114036|NCT01722266|3653087|P2|Overall Study|Dropped out due to Nausea|0
1114037|NCT01722266|3653088|P1|Overall Study|Dropped out due to Nausea|0
1114038|NCT01722266|3653085|P4|Overall Study|Tolerated only 0.6 mg liraglutide|0
1114039|NCT01722266|3653086|P3|Overall Study|Tolerated only 0.6 mg liraglutide|3
1114040|NCT01722266|3653087|P2|Overall Study|Tolerated only 0.6 mg liraglutide|1
1114041|NCT01722266|3653088|P1|Overall Study|Tolerated only 0.6 mg liraglutide|0
1114042|NCT01722266|3653085|P4|Overall Study|Withdrawal by Subject|0
1114043|NCT01722266|3653086|P3|Overall Study|Withdrawal by Subject|0
1114044|NCT01722266|3653087|P2|Overall Study|Withdrawal by Subject|2
1114045|NCT01722266|3653088|P1|Overall Study|Withdrawal by Subject|1
1114046|NCT01722162|3653116|P2|Overall Study|Noncompliance|1
1114047|NCT01722162|3653117|P1|Overall Study|Noncompliance|0
1114048|NCT01722162|3653116|P2|Overall Study|Insurance denial post enrollment|1
1114049|NCT01722162|3653117|P1|Overall Study|Insurance denial post enrollment|0
1114050|NCT01722162|3653116|P2|Overall Study|Adverse Event|1
1114051|NCT01722162|3653117|P1|Overall Study|Adverse Event|1
1114052|NCT01722162|3653116|P2|Overall Study|Unrelated to study adverse event|2
1114053|NCT01722162|3653117|P1|Overall Study|Unrelated to study adverse event|2
1114054|NCT01722162|3653116|P2|Overall Study|Found ineligible|0
1114055|NCT01722162|3653117|P1|Overall Study|Found ineligible|1
1114056|NCT01722162|3653116|P2|Overall Study|Withdrawal by Subject|1
1114057|NCT01722162|3653117|P1|Overall Study|Withdrawal by Subject|1
1114058|NCT01722097|3653127|P2|Overall Study|Patient sheets not returned|5
1114059|NCT01722097|3653128|P1|Overall Study|Patient sheets not returned|6
1114060|NCT01722071|3653136|P2|Overall Study|Protocol Violation|0
1114061|NCT01722071|3653137|P1|Overall Study|Protocol Violation|1
1114062|NCT01722045|3653143|P1|Overall Study|Relocation (did not wish to transfer)|1
1114063|NCT01722045|3653143|P1|Overall Study|Physician Decision|3
1114064|NCT01722045|3653143|P1|Overall Study|Protocol Deviation|1
1114065|NCT01722045|3653143|P1|Overall Study|Lost to Follow-up|4
1114066|NCT01722045|3653143|P1|Overall Study|Withdrawal by Subject|8
1114067|NCT01722045|3653143|P1|Overall Study|Death|3
1114068|NCT01722045|3653143|P1|Overall Study|Adverse Event|8
1114069|NCT01721772|3653168|P2|Overall Study|Not specified|1
1114070|NCT01721772|3653169|P1|Overall Study|Not specified|0
1114071|NCT01721772|3653168|P2|Overall Study|Maximum clinical benefit|1
1114072|NCT01721772|3653169|P1|Overall Study|Maximum clinical benefit|1
1114073|NCT01721772|3653168|P2|Overall Study|Withdrawal by Subject|5
1114074|NCT01721772|3653169|P1|Overall Study|Withdrawal by Subject|7
1114075|NCT01721772|3653168|P2|Overall Study|Unrelated adverse event|3
1114076|NCT01721772|3653169|P1|Overall Study|Unrelated adverse event|2
1114077|NCT01721772|3653168|P2|Overall Study|Study drug toxicity|7
1114078|NCT01721772|3653169|P1|Overall Study|Study drug toxicity|5
1114079|NCT01721772|3653168|P2|Overall Study|Disease progression|175
1114080|NCT01721772|3653169|P1|Overall Study|Disease progression|96
1114081|NCT01721759|3653189|P1|Overall Study|Withdrawal by Subject|1
1114082|NCT01721759|3653189|P1|Overall Study|Adverse event unrelated to study drug|9
1114083|NCT01721759|3653189|P1|Overall Study|Study drug toxicity|14
1114084|NCT01721759|3653189|P1|Overall Study|Disease progression|78
1114085|NCT01721746|3653197|P3|Treatment Period|Other|1
1114086|NCT01721746|3653198|P2|Treatment Period|Other|1
1114087|NCT01721746|3653199|P1|Treatment Period|Other|2
1114088|NCT01721746|3653197|P3|Treatment Period|Subject No Longer Met Study Criteria|0
1114089|NCT01721746|3653198|P2|Treatment Period|Subject No Longer Met Study Criteria|0
1114090|NCT01721746|3653199|P1|Treatment Period|Subject No Longer Met Study Criteria|4
1114091|NCT01721746|3653197|P3|Treatment Period|Poor/Non-compliance|0
1114092|NCT01721746|3653198|P2|Treatment Period|Poor/Non-compliance|0
1114093|NCT01721746|3653199|P1|Treatment Period|Poor/Non-compliance|1
1114094|NCT01721746|3653197|P3|Treatment Period|Maximum Clinical Benefit|3
1114095|NCT01721746|3653198|P2|Treatment Period|Maximum Clinical Benefit|0
1114096|NCT01721746|3653199|P1|Treatment Period|Maximum Clinical Benefit|1
1114097|NCT01721746|3653197|P3|Treatment Period|Subject Withdrew Consent|2
1114098|NCT01721746|3653198|P2|Treatment Period|Subject Withdrew Consent|0
1114099|NCT01721746|3653199|P1|Treatment Period|Subject Withdrew Consent|3
1114100|NCT01721746|3653197|P3|Treatment Period|Subject Request to Discontinue Treatment|6
1114101|NCT01721746|3653198|P2|Treatment Period|Subject Request to Discontinue Treatment|1
1114102|NCT01721746|3653199|P1|Treatment Period|Subject Request to Discontinue Treatment|19
1114103|NCT01721746|3653197|P3|Treatment Period|Adverse Event Unrelated to Study Drug|2
1114104|NCT01721746|3653198|P2|Treatment Period|Adverse Event Unrelated to Study Drug|1
1114105|NCT01721746|3653199|P1|Treatment Period|Adverse Event Unrelated to Study Drug|6
1114106|NCT01721746|3653197|P3|Treatment Period|Study Drug Toxicity|9
1114107|NCT01721746|3653198|P2|Treatment Period|Study Drug Toxicity|2
1114108|NCT01721746|3653199|P1|Treatment Period|Study Drug Toxicity|15
1114109|NCT01721746|3653197|P3|Treatment Period|Disease Progression|34
1114110|NCT01721746|3653198|P2|Treatment Period|Disease Progression|40
1114111|NCT01721746|3653199|P1|Treatment Period|Disease Progression|182
1114112|NCT01721486|3653239|P2|Overall Study|Physician Decision|1
1114113|NCT01721486|3653240|P1|Overall Study|Physician Decision|0
1114114|NCT01721486|3653239|P2|Overall Study|Protocol Violation|0
1114115|NCT01721486|3653240|P1|Overall Study|Protocol Violation|1
1114116|NCT01721408|3653261|P2|Overall Study|Does not meet entrance criteria|0
1114117|NCT01721408|3653262|P1|Overall Study|Does not meet entrance criteria|1
1114118|NCT01721408|3653261|P2|Overall Study|Lost to Follow-up|2
1114119|NCT01721408|3653262|P1|Overall Study|Lost to Follow-up|1
1114120|NCT01721408|3653261|P2|Overall Study|Other|3
1114121|NCT01721408|3653262|P1|Overall Study|Other|3
1114122|NCT01721408|3653261|P2|Overall Study|Protocol Violation|2
1114123|NCT01721408|3653262|P1|Overall Study|Protocol Violation|0
1114124|NCT01721408|3653261|P2|Overall Study|No longer willing to participate study|10
1114125|NCT01721408|3653262|P1|Overall Study|No longer willing to participate study|9
1114126|NCT01721408|3653261|P2|Overall Study|Insufficient clinical response|6
1114127|NCT01721408|3653262|P1|Overall Study|Insufficient clinical response|15
1114128|NCT01721408|3653261|P2|Overall Study|Death|0
1114129|NCT01721408|3653262|P1|Overall Study|Death|1
1114130|NCT01721408|3653261|P2|Overall Study|Adverse Event|1
1114131|NCT01721408|3653262|P1|Overall Study|Adverse Event|6
1114132|NCT01721330|3653278|P2|Overall Study|Withdrawal by Subject|1
1114133|NCT01721330|3653279|P1|Overall Study|Withdrawal by Subject|0
1114134|NCT01721317|3653287|P2|Overall Study|Withdrawal by Subject|1
1114135|NCT01721317|3653288|P1|Overall Study|Withdrawal by Subject|0
1114136|NCT01721317|3653287|P2|Overall Study|Physician Decision|1
1114137|NCT01721317|3653288|P1|Overall Study|Physician Decision|0
1114138|NCT01721317|3653287|P2|Overall Study|Study Closed / Terminated|2
1114139|NCT01721317|3653288|P1|Overall Study|Study Closed / Terminated|2
1114140|NCT01721200|3653367|P2|Overall Study|Lost to Follow-up|5
1114141|NCT01721200|3653368|P1|Overall Study|Lost to Follow-up|3
1114142|NCT01721161|3653393|P2|Overall Study|Not Specified|1
1114143|NCT01721161|3653394|P1|Overall Study|Not Specified|0
1114144|NCT01721161|3653393|P2|Overall Study|Withdrawal by Subject|1
1114145|NCT01721161|3653394|P1|Overall Study|Withdrawal by Subject|1
1114146|NCT01721161|3653393|P2|Overall Study|Lost to Follow-up|2
1114147|NCT01721161|3653394|P1|Overall Study|Lost to Follow-up|1
1114148|NCT01721161|3653393|P2|Overall Study|Adverse Event|3
1114149|NCT01721161|3653394|P1|Overall Study|Adverse Event|2
1114150|NCT01721109|3653417|P1|Overall Study|Lost to Follow-up|2
1114151|NCT01721109|3653417|P1|Overall Study|Withdrew Consent|1
1114152|NCT01721109|3653417|P1|Overall Study|Non- Compliance with Study Drug|3
1114153|NCT01721109|3653417|P1|Overall Study|Lack of Efficacy|1
1114154|NCT01721096|3653432|P2|Overall Study|Site didn't entered reason;registrystudy|0
1114155|NCT01721096|3653433|P1|Overall Study|Site didn't entered reason;registrystudy|1
1114156|NCT01721096|3653432|P2|Overall Study|Lost to Follow-up|2
1114157|NCT01721096|3653433|P1|Overall Study|Lost to Follow-up|12
1114158|NCT01721096|3653432|P2|Overall Study|Physician Decision|0
1114159|NCT01721096|3653433|P1|Overall Study|Physician Decision|1
1114160|NCT01721096|3653432|P2|Overall Study|Withdrawal by Subject|0
1114161|NCT01721096|3653433|P1|Overall Study|Withdrawal by Subject|1
1114162|NCT01721096|3653432|P2|Overall Study|Death|8
1114163|NCT01721096|3653433|P1|Overall Study|Death|12
1114164|NCT01721070|3653582|P1|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1
1114165|NCT01721057|3653593|P7|Rescue Period|Lack of Efficacy|0
1114166|NCT01721057|3653594|P6|Rescue Period|Lack of Efficacy|0
1114167|NCT01721057|3653595|P5|Rescue Period|Lack of Efficacy|0
1114168|NCT01721057|3653596|P4|Rescue Period|Lack of Efficacy|2
1114169|NCT01721057|3653597|P3|Rescue Period|Lack of Efficacy|0
1114170|NCT01721057|3653598|P2|Rescue Period|Lack of Efficacy|0
1114171|NCT01721057|3653599|P1|Rescue Period|Lack of Efficacy|0
1114172|NCT01721057|3653593|P7|Rescue Period|Adverse Event|0
1114173|NCT01721057|3653594|P6|Rescue Period|Adverse Event|0
1114174|NCT01721057|3653595|P5|Rescue Period|Adverse Event|0
1114175|NCT01721057|3653596|P4|Rescue Period|Adverse Event|1
1114176|NCT01721057|3653597|P3|Rescue Period|Adverse Event|0
1114177|NCT01721057|3653598|P2|Rescue Period|Adverse Event|0
1114178|NCT01721057|3653599|P1|Rescue Period|Adverse Event|0
1114179|NCT01721057|3653593|P7|Treatment Period|Death|0
1114180|NCT01721057|3653594|P6|Treatment Period|Death|0
1114181|NCT01721057|3653595|P5|Treatment Period|Death|0
1114182|NCT01721057|3653596|P4|Treatment Period|Death|0
1114183|NCT01721057|3653597|P3|Treatment Period|Death|0
1114184|NCT01721057|3653598|P2|Treatment Period|Death|0
1114185|NCT01721057|3653599|P1|Treatment Period|Death|2
1114186|NCT01721057|3653593|P7|Treatment Period|Physician Decision|0
1114187|NCT01721057|3653594|P6|Treatment Period|Physician Decision|0
1114188|NCT01721057|3653595|P5|Treatment Period|Physician Decision|0
1114189|NCT01721057|3653596|P4|Treatment Period|Physician Decision|0
1114190|NCT01721057|3653597|P3|Treatment Period|Physician Decision|3
1114191|NCT01721057|3653598|P2|Treatment Period|Physician Decision|1
1114192|NCT01721057|3653599|P1|Treatment Period|Physician Decision|0
1114193|NCT01721057|3653593|P7|Treatment Period|Lost to Follow-up|0
1114194|NCT01721057|3653594|P6|Treatment Period|Lost to Follow-up|0
1114195|NCT01721057|3653595|P5|Treatment Period|Lost to Follow-up|0
1114196|NCT01721057|3653596|P4|Treatment Period|Lost to Follow-up|0
1114197|NCT01721057|3653597|P3|Treatment Period|Lost to Follow-up|0
1114198|NCT01721057|3653598|P2|Treatment Period|Lost to Follow-up|0
1114199|NCT01721057|3653599|P1|Treatment Period|Lost to Follow-up|1
1114200|NCT01721057|3653593|P7|Treatment Period|Lack of Efficacy|0
1114201|NCT01721057|3653594|P6|Treatment Period|Lack of Efficacy|0
1114202|NCT01721057|3653595|P5|Treatment Period|Lack of Efficacy|0
1114203|NCT01721057|3653596|P4|Treatment Period|Lack of Efficacy|0
1114204|NCT01721057|3653597|P3|Treatment Period|Lack of Efficacy|0
1114205|NCT01721057|3653598|P2|Treatment Period|Lack of Efficacy|3
1114206|NCT01721057|3653599|P1|Treatment Period|Lack of Efficacy|7
1114207|NCT01721057|3653593|P7|Treatment Period|Adverse Event|0
1114208|NCT01721057|3653594|P6|Treatment Period|Adverse Event|0
1114209|NCT01721057|3653595|P5|Treatment Period|Adverse Event|0
1114210|NCT01721057|3653596|P4|Treatment Period|Adverse Event|0
1114211|NCT01721057|3653597|P3|Treatment Period|Adverse Event|12
1114212|NCT01721057|3653598|P2|Treatment Period|Adverse Event|10
1114213|NCT01721057|3653599|P1|Treatment Period|Adverse Event|7
1114214|NCT01721057|3653593|P7|Treatment Period|Withdrawal by Subject|0
1114215|NCT01721057|3653594|P6|Treatment Period|Withdrawal by Subject|0
1114216|NCT01721057|3653595|P5|Treatment Period|Withdrawal by Subject|0
1114217|NCT01721057|3653596|P4|Treatment Period|Withdrawal by Subject|0
1114218|NCT01721057|3653597|P3|Treatment Period|Withdrawal by Subject|8
1114219|NCT01721057|3653598|P2|Treatment Period|Withdrawal by Subject|5
1114220|NCT01721057|3653599|P1|Treatment Period|Withdrawal by Subject|11
1114221|NCT01721044|3653672|P3|Treatment Period|Withdrawal by Subject|1
1114222|NCT01721044|3653673|P2|Treatment Period|Withdrawal by Subject|6
1114223|NCT01721044|3653674|P1|Treatment Period|Withdrawal by Subject|7
1114224|NCT01721044|3653672|P3|Treatment Period|Protocol Violation|0
1114225|NCT01721044|3653673|P2|Treatment Period|Protocol Violation|0
1114226|NCT01721044|3653674|P1|Treatment Period|Protocol Violation|1
1114227|NCT01721044|3653672|P3|Treatment Period|Physician Decision|2
1114228|NCT01721044|3653673|P2|Treatment Period|Physician Decision|0
1114229|NCT01721044|3653674|P1|Treatment Period|Physician Decision|1
1114230|NCT01721044|3653672|P3|Treatment Period|Lost to Follow-up|1
1114231|NCT01721044|3653673|P2|Treatment Period|Lost to Follow-up|0
1114232|NCT01721044|3653674|P1|Treatment Period|Lost to Follow-up|0
1114233|NCT01721044|3653672|P3|Treatment Period|Lack of Efficacy|4
1114234|NCT01721044|3653673|P2|Treatment Period|Lack of Efficacy|4
1114235|NCT01721044|3653674|P1|Treatment Period|Lack of Efficacy|16
1114236|NCT01721044|3653672|P3|Treatment Period|Death|1
1114237|NCT01721044|3653673|P2|Treatment Period|Death|0
1114238|NCT01721044|3653674|P1|Treatment Period|Death|0
1114239|NCT01721044|3653672|P3|Treatment Period|Adverse Event|10
1114240|NCT01721044|3653673|P2|Treatment Period|Adverse Event|7
1114241|NCT01721044|3653674|P1|Treatment Period|Adverse Event|7
1114242|NCT01720797|3653747|P2|Overall Study|Withdrawal by Subject|0
1114243|NCT01720797|3653748|P1|Overall Study|Withdrawal by Subject|3
1114244|NCT01720602|3653754|P1|Overall Study|Progressive disease on therapy|2
1114245|NCT01720602|3653754|P1|Overall Study|Adverse Event|3
1114246|NCT01720446|3653764|P4|Overall Study|Withdrawal by Subject|4
1114247|NCT01720446|3653765|P3|Overall Study|Withdrawal by Subject|4
1114248|NCT01720446|3653766|P2|Overall Study|Withdrawal by Subject|5
1114249|NCT01720446|3653767|P1|Overall Study|Withdrawal by Subject|2
1114250|NCT01720446|3653764|P4|Overall Study|Lost to Follow-up|16
1114251|NCT01720446|3653765|P3|Overall Study|Lost to Follow-up|16
1114252|NCT01720446|3653766|P2|Overall Study|Lost to Follow-up|6
1114253|NCT01720446|3653767|P1|Overall Study|Lost to Follow-up|12
1114254|NCT01720043|3653909|P1|Overall Study|Withdrawal by Subject|1
1114255|NCT01719861|3653913|P1|Cycle 2|Death|1
1114256|NCT01719861|3653913|P1|Cycle 1|Death|4
1114257|NCT01719783|3653923|P2|Dose 2|Physician Decision|0
1114258|NCT01719783|3653924|P1|Dose 2|Physician Decision|1
1114259|NCT01719757|3654010|P1|Overall Study|well controlled pain|27
1114260|NCT01719757|3654010|P1|Overall Study|Protocol Violation|1
1114261|NCT01719757|3654010|P1|Overall Study|Lost to Follow-up|20
1114262|NCT01719757|3654010|P1|Overall Study|Withdrawal by Subject|15
1114263|NCT01719757|3654010|P1|Overall Study|Adverse Event|38
1114264|NCT01719224|3654055|P2|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2
1114265|NCT01719224|3654056|P1|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4
1114266|NCT01719172|3654065|P1|Overall Study|Death|1
1114267|NCT01719172|3654065|P1|Overall Study|Lost to Follow-up|1
1114268|NCT01719003|3654079|P9|Overall Study|Lack of Efficacy|0
1114269|NCT01719003|3654080|P8|Overall Study|Lack of Efficacy|0
1114270|NCT01719003|3654081|P7|Overall Study|Lack of Efficacy|1
1114271|NCT01719003|3654082|P6|Overall Study|Lack of Efficacy|0
1114272|NCT01719003|3654083|P5|Overall Study|Lack of Efficacy|0
1114273|NCT01719003|3654084|P4|Overall Study|Lack of Efficacy|0
1114274|NCT01719003|3654085|P3|Overall Study|Lack of Efficacy|0
1114275|NCT01719003|3654086|P2|Overall Study|Lack of Efficacy|0
1114276|NCT01719003|3654087|P1|Overall Study|Lack of Efficacy|0
1114277|NCT01719003|3654079|P9|Overall Study|Reason other than those specified|1
1114278|NCT01719003|3654080|P8|Overall Study|Reason other than those specified|3
1114279|NCT01719003|3654081|P7|Overall Study|Reason other than those specified|0
1114280|NCT01719003|3654082|P6|Overall Study|Reason other than those specified|1
1114281|NCT01719003|3654083|P5|Overall Study|Reason other than those specified|4
1114282|NCT01719003|3654084|P4|Overall Study|Reason other than those specified|3
1114283|NCT01719003|3654085|P3|Overall Study|Reason other than those specified|2
1114284|NCT01719003|3654086|P2|Overall Study|Reason other than those specified|0
1114285|NCT01719003|3654087|P1|Overall Study|Reason other than those specified|0
1114286|NCT01719003|3654079|P9|Overall Study|Refusal to continue, not due to AE|1
1114287|NCT01719003|3654080|P8|Overall Study|Refusal to continue, not due to AE|7
1114288|NCT01719003|3654081|P7|Overall Study|Refusal to continue, not due to AE|8
1114289|NCT01719003|3654082|P6|Overall Study|Refusal to continue, not due to AE|3
1114290|NCT01719003|3654083|P5|Overall Study|Refusal to continue, not due to AE|4
1114291|NCT01719003|3654084|P4|Overall Study|Refusal to continue, not due to AE|4
1114292|NCT01719003|3654085|P3|Overall Study|Refusal to continue, not due to AE|4
1114293|NCT01719003|3654086|P2|Overall Study|Refusal to continue, not due to AE|5
1114294|NCT01719003|3654087|P1|Overall Study|Refusal to continue, not due to AE|2
1114295|NCT01719003|3654079|P9|Overall Study|Lost to Follow-up|2
1114296|NCT01719003|3654080|P8|Overall Study|Lost to Follow-up|2
1114297|NCT01719003|3654081|P7|Overall Study|Lost to Follow-up|3
1114298|NCT01719003|3654082|P6|Overall Study|Lost to Follow-up|4
1114299|NCT01719003|3654083|P5|Overall Study|Lost to Follow-up|3
1114300|NCT01719003|3654084|P4|Overall Study|Lost to Follow-up|2
1114301|NCT01719003|3654085|P3|Overall Study|Lost to Follow-up|7
1114302|NCT01719003|3654086|P2|Overall Study|Lost to Follow-up|6
1114303|NCT01719003|3654087|P1|Overall Study|Lost to Follow-up|0
1114304|NCT01719003|3654079|P9|Overall Study|Adverse Event|0
1114305|NCT01719003|3654080|P8|Overall Study|Adverse Event|5
1114306|NCT01719003|3654081|P7|Overall Study|Adverse Event|6
1114307|NCT01719003|3654082|P6|Overall Study|Adverse Event|3
1114308|NCT01719003|3654083|P5|Overall Study|Adverse Event|4
1114309|NCT01719003|3654084|P4|Overall Study|Adverse Event|3
1114310|NCT01719003|3654085|P3|Overall Study|Adverse Event|4
1114311|NCT01719003|3654086|P2|Overall Study|Adverse Event|5
1114312|NCT01719003|3654087|P1|Overall Study|Adverse Event|6
1114313|NCT01719003|3654079|P9|Overall Study|Non compliant with protocol|0
1114314|NCT01719003|3654080|P8|Overall Study|Non compliant with protocol|3
1114315|NCT01719003|3654081|P7|Overall Study|Non compliant with protocol|2
1114316|NCT01719003|3654082|P6|Overall Study|Non compliant with protocol|1
1114317|NCT01719003|3654083|P5|Overall Study|Non compliant with protocol|2
1114318|NCT01719003|3654084|P4|Overall Study|Non compliant with protocol|1
1114319|NCT01719003|3654085|P3|Overall Study|Non compliant with protocol|0
1114320|NCT01719003|3654086|P2|Overall Study|Non compliant with protocol|1
1114321|NCT01719003|3654087|P1|Overall Study|Non compliant with protocol|1
1114322|NCT01718535|3654168|P10|Overall Study|Bidirectional Sequencing not possible|0
1114323|NCT01718535|3654169|P9|Overall Study|Bidirectional Sequencing not possible|0
1114324|NCT01718535|3654170|P8|Overall Study|Bidirectional Sequencing not possible|0
1114325|NCT01718535|3654171|P7|Overall Study|Bidirectional Sequencing not possible|0
1114326|NCT01718535|3654172|P6|Overall Study|Bidirectional Sequencing not possible|0
1114327|NCT01718535|3654173|P5|Overall Study|Bidirectional Sequencing not possible|0
1114328|NCT01718535|3654174|P4|Overall Study|Bidirectional Sequencing not possible|1
1114329|NCT01718535|3654175|P3|Overall Study|Bidirectional Sequencing not possible|0
1114330|NCT01718535|3654176|P2|Overall Study|Bidirectional Sequencing not possible|0
1114331|NCT01718535|3654177|P1|Overall Study|Bidirectional Sequencing not possible|1
1114332|NCT01718509|3654201|P2|Overall Study|Lack of Efficacy|0
1114333|NCT01718509|3654202|P1|Overall Study|Lack of Efficacy|1
1114334|NCT01718509|3654201|P2|Overall Study|Protocol Violation|2
1114335|NCT01718509|3654202|P1|Overall Study|Protocol Violation|4
1114336|NCT01718509|3654201|P2|Overall Study|Not specified|11
1114337|NCT01718509|3654202|P1|Overall Study|Not specified|13
1114338|NCT01718509|3654201|P2|Overall Study|Adverse Event|7
1114339|NCT01718509|3654202|P1|Overall Study|Adverse Event|5
1114340|NCT01718509|3654201|P2|Overall Study|Withdrawal by Subject|13
1114341|NCT01718509|3654202|P1|Overall Study|Withdrawal by Subject|7
1114342|NCT01718509|3654201|P2|Overall Study|Lost to Follow-up|15
1114343|NCT01718509|3654202|P1|Overall Study|Lost to Follow-up|18
1114344|NCT01718483|3654248|P2|Overall Study|Lack of Efficacy|0
1114345|NCT01718483|3654249|P1|Overall Study|Lack of Efficacy|1
1114346|NCT01718483|3654248|P2|Overall Study|Pregnancy|1
1114347|NCT01718483|3654249|P1|Overall Study|Pregnancy|1
1114348|NCT01718483|3654248|P2|Overall Study|Not specified|4
1114349|NCT01718483|3654249|P1|Overall Study|Not specified|1
1114350|NCT01718483|3654248|P2|Overall Study|Protocol Violation|2
1114351|NCT01718483|3654249|P1|Overall Study|Protocol Violation|4
1114352|NCT01718483|3654248|P2|Overall Study|Lost to Follow-up|3
1114353|NCT01718483|3654249|P1|Overall Study|Lost to Follow-up|8
1114354|NCT01718483|3654248|P2|Overall Study|Adverse Event|12
1114355|NCT01718483|3654249|P1|Overall Study|Adverse Event|5
1114356|NCT01718483|3654248|P2|Overall Study|Withdrawal by Subject|12
1114357|NCT01718483|3654249|P1|Overall Study|Withdrawal by Subject|14
1114358|NCT01718353|3654295|P2|Overall Study|Randomized but not treated|0
1114359|NCT01718353|3654296|P1|Overall Study|Randomized but not treated|2
1114360|NCT01718353|3654295|P2|Overall Study|Principal Investigator's Decision|4
1114361|NCT01718353|3654296|P1|Overall Study|Principal Investigator's Decision|10
1114362|NCT01718353|3654295|P2|Overall Study|Lost to Follow-up|1
1114363|NCT01718353|3654296|P1|Overall Study|Lost to Follow-up|0
1114364|NCT01717989|3654327|P1|Overall Study|Other|40
1114365|NCT01717989|3654327|P1|Overall Study|Protocol-specified criteria|551
1114366|NCT01717989|3654327|P1|Overall Study|Death|439
1114367|NCT01717989|3654327|P1|Overall Study|Lost to Follow-up|11
1114368|NCT01717989|3654327|P1|Overall Study|Physician Decision|2
1114369|NCT01717989|3654327|P1|Overall Study|Withdrawal by Subject|11
1114370|NCT01717989|3654327|P1|Overall Study|Protocol deviation|6
1114371|NCT01717989|3654327|P1|Overall Study|Ineligibility determined|6
1114372|NCT01717976|3654395|P2|Overall Study|Protocol Violation|1
1114373|NCT01717976|3654396|P1|Overall Study|Protocol Violation|0
1114374|NCT01717859|3654451|P1|Overall Study|Withdrawal by Subject|2
1114375|NCT01717859|3654451|P1|Overall Study|Lost to Follow-up|1
1114376|NCT01717859|3654451|P1|Overall Study|Patient concerned about mental health|1
1114377|NCT01717859|3654451|P1|Overall Study|Moved out of state|1
1114378|NCT01717859|3654451|P1|Overall Study|Adverse Event|5
1114379|NCT01717768|3654472|P12|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1114380|NCT01717768|3654473|P11|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1114381|NCT01717768|3654474|P10|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1
1114382|NCT01717768|3654475|P9|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1114383|NCT01717768|3654476|P8|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1114384|NCT01717768|3654477|P7|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1114385|NCT01717768|3654478|P6|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1114386|NCT01717768|3654479|P5|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1114387|NCT01717768|3654480|P4|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1114388|NCT01717768|3654481|P3|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1114389|NCT01717768|3654482|P2|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1114390|NCT01717768|3654483|P1|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1114391|NCT01717768|3654472|P12|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1114392|NCT01717768|3654473|P11|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1114393|NCT01717768|3654474|P10|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1114394|NCT01717768|3654475|P9|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1114395|NCT01717768|3654476|P8|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2
1114396|NCT01717768|3654477|P7|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1114397|NCT01717768|3654478|P6|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1114398|NCT01717768|3654479|P5|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1114399|NCT01717768|3654480|P4|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1114400|NCT01717768|3654481|P3|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1114401|NCT01717768|3654482|P2|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1114402|NCT01717768|3654483|P1|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1114403|NCT01717768|3654472|P12|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1
1114404|NCT01717768|3654473|P11|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1114405|NCT01717768|3654474|P10|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1114406|NCT01717768|3654475|P9|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1114407|NCT01717768|3654476|P8|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1114408|NCT01717768|3654477|P7|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1114409|NCT01717768|3654478|P6|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1114410|NCT01717768|3654479|P5|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1114411|NCT01717768|3654480|P4|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1114412|NCT01717768|3654481|P3|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1114413|NCT01717768|3654482|P2|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1114414|NCT01717768|3654483|P1|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1114415|NCT01717768|3654472|P12|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1114416|NCT01717768|3654473|P11|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1114417|NCT01717768|3654474|P10|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1114418|NCT01717768|3654475|P9|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1114419|NCT01717768|3654476|P8|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1114420|NCT01717768|3654477|P7|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1114421|NCT01717768|3654478|P6|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1114422|NCT01717768|3654479|P5|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1114423|NCT01717768|3654480|P4|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1114424|NCT01717768|3654481|P3|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1114425|NCT01717768|3654482|P2|Part 1 (Duration of 15 Days)|Lost to Follow-up|1
1114426|NCT01717768|3654483|P1|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1114427|NCT01717638|3654534|P13|Overall Study|Withdrawal by Subject|18
1114428|NCT01717638|3654535|P12|Overall Study|Withdrawal by Subject|0
1114429|NCT01717638|3654536|P11|Overall Study|Withdrawal by Subject|0
1114430|NCT01717638|3654537|P10|Overall Study|Withdrawal by Subject|1
1114431|NCT01717638|3654538|P9|Overall Study|Withdrawal by Subject|2
1114432|NCT01717638|3654539|P8|Overall Study|Withdrawal by Subject|1
1114433|NCT01717638|3654540|P7|Overall Study|Withdrawal by Subject|2
1114434|NCT01717638|3654541|P6|Overall Study|Withdrawal by Subject|0
1114435|NCT01717638|3654542|P5|Overall Study|Withdrawal by Subject|1
1114436|NCT01717638|3654543|P4|Overall Study|Withdrawal by Subject|0
1114437|NCT01717638|3654544|P3|Overall Study|Withdrawal by Subject|1
1114438|NCT01717638|3654545|P2|Overall Study|Withdrawal by Subject|1
1114439|NCT01717638|3654546|P1|Overall Study|Withdrawal by Subject|0
1114440|NCT01717638|3654534|P13|Overall Study|Father in hospital|1
1114441|NCT01717638|3654535|P12|Overall Study|Father in hospital|0
1114442|NCT01717638|3654536|P11|Overall Study|Father in hospital|0
1114443|NCT01717638|3654537|P10|Overall Study|Father in hospital|0
1114444|NCT01717638|3654538|P9|Overall Study|Father in hospital|0
1114445|NCT01717638|3654539|P8|Overall Study|Father in hospital|0
1114446|NCT01717638|3654540|P7|Overall Study|Father in hospital|0
1114447|NCT01717638|3654541|P6|Overall Study|Father in hospital|0
1114448|NCT01717638|3654542|P5|Overall Study|Father in hospital|0
1114449|NCT01717638|3654543|P4|Overall Study|Father in hospital|0
1114450|NCT01717638|3654544|P3|Overall Study|Father in hospital|0
1114451|NCT01717638|3654545|P2|Overall Study|Father in hospital|0
1114452|NCT01717638|3654546|P1|Overall Study|Father in hospital|0
1114453|NCT01717638|3654534|P13|Overall Study|Lost to Follow-up|0
1114454|NCT01717638|3654535|P12|Overall Study|Lost to Follow-up|0
1114455|NCT01717638|3654536|P11|Overall Study|Lost to Follow-up|0
1114456|NCT01717638|3654537|P10|Overall Study|Lost to Follow-up|0
1114457|NCT01717638|3654538|P9|Overall Study|Lost to Follow-up|0
1114458|NCT01717638|3654539|P8|Overall Study|Lost to Follow-up|0
1114459|NCT01717638|3654540|P7|Overall Study|Lost to Follow-up|0
1114460|NCT01717638|3654541|P6|Overall Study|Lost to Follow-up|1
1114461|NCT01717638|3654542|P5|Overall Study|Lost to Follow-up|0
1114462|NCT01717638|3654543|P4|Overall Study|Lost to Follow-up|0
1114463|NCT01717638|3654544|P3|Overall Study|Lost to Follow-up|0
1114464|NCT01717638|3654545|P2|Overall Study|Lost to Follow-up|0
1114465|NCT01717638|3654546|P1|Overall Study|Lost to Follow-up|0
1114466|NCT01717456|3654690|P2|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
1114467|NCT01717456|3654691|P1|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
1114468|NCT01717456|3654690|P2|End of Treatment|Lost to Follow-up|1
1114469|NCT01717456|3654691|P1|End of Treatment|Lost to Follow-up|0
1114470|NCT01717456|3654690|P2|End of Treatment|Physician Decision|1
1114471|NCT01717456|3654691|P1|End of Treatment|Physician Decision|0
1114472|NCT01717391|3654759|P1|Overall Study|FLT technical failure|3
1114473|NCT01717391|3654759|P1|Overall Study|Physician Decision|1
1114474|NCT01717391|3654759|P1|Overall Study|Withdrawal by Subject|5
1114475|NCT01717326|3654788|P20|Overall Study|Withdrawal by Subject|3
1114476|NCT01717326|3654789|P19|Overall Study|Withdrawal by Subject|2
1114477|NCT01717326|3654790|P18|Overall Study|Withdrawal by Subject|0
1114478|NCT01717326|3654791|P17|Overall Study|Withdrawal by Subject|0
1114479|NCT01717326|3654792|P16|Overall Study|Withdrawal by Subject|1
1114480|NCT01717326|3654793|P15|Overall Study|Withdrawal by Subject|0
1114481|NCT01717326|3654794|P14|Overall Study|Withdrawal by Subject|0
1114482|NCT01717326|3654795|P13|Overall Study|Withdrawal by Subject|1
1114483|NCT01717326|3654796|P12|Overall Study|Withdrawal by Subject|0
1114484|NCT01717326|3654797|P11|Overall Study|Withdrawal by Subject|0
1114485|NCT01717326|3654798|P10|Overall Study|Withdrawal by Subject|1
1114486|NCT01717326|3654799|P9|Overall Study|Withdrawal by Subject|0
1114487|NCT01717326|3654800|P8|Overall Study|Withdrawal by Subject|0
1114488|NCT01717326|3654801|P7|Overall Study|Withdrawal by Subject|0
1114489|NCT01717326|3654802|P6|Overall Study|Withdrawal by Subject|0
1114490|NCT01717326|3654803|P5|Overall Study|Withdrawal by Subject|0
1114491|NCT01717326|3654804|P4|Overall Study|Withdrawal by Subject|0
1114492|NCT01717326|3654805|P3|Overall Study|Withdrawal by Subject|0
1114493|NCT01717326|3654806|P2|Overall Study|Withdrawal by Subject|1
1114494|NCT01717326|3654807|P1|Overall Study|Withdrawal by Subject|0
1114495|NCT01717326|3654788|P20|Overall Study|Protocol Violation|0
1114496|NCT01717326|3654789|P19|Overall Study|Protocol Violation|0
1114497|NCT01717326|3654790|P18|Overall Study|Protocol Violation|0
1114498|NCT01717326|3654791|P17|Overall Study|Protocol Violation|0
1114499|NCT01717326|3654792|P16|Overall Study|Protocol Violation|0
1114500|NCT01717326|3654793|P15|Overall Study|Protocol Violation|0
1114501|NCT01717326|3654794|P14|Overall Study|Protocol Violation|0
1114502|NCT01717326|3654795|P13|Overall Study|Protocol Violation|0
1114503|NCT01717326|3654796|P12|Overall Study|Protocol Violation|0
1114504|NCT01717326|3654797|P11|Overall Study|Protocol Violation|0
1114505|NCT01717326|3654798|P10|Overall Study|Protocol Violation|0
1114506|NCT01717326|3654799|P9|Overall Study|Protocol Violation|0
1114507|NCT01717326|3654800|P8|Overall Study|Protocol Violation|0
1114508|NCT01717326|3654801|P7|Overall Study|Protocol Violation|0
1114509|NCT01717326|3654802|P6|Overall Study|Protocol Violation|0
1114510|NCT01717326|3654803|P5|Overall Study|Protocol Violation|1
1114511|NCT01717326|3654804|P4|Overall Study|Protocol Violation|0
1114512|NCT01717326|3654805|P3|Overall Study|Protocol Violation|0
1114513|NCT01717326|3654806|P2|Overall Study|Protocol Violation|0
1114514|NCT01717326|3654807|P1|Overall Study|Protocol Violation|0
1114515|NCT01717326|3654788|P20|Overall Study|Physician Decision|0
1114516|NCT01717326|3654789|P19|Overall Study|Physician Decision|0
1114517|NCT01717326|3654790|P18|Overall Study|Physician Decision|0
1114518|NCT01717326|3654791|P17|Overall Study|Physician Decision|0
1114519|NCT01717326|3654792|P16|Overall Study|Physician Decision|0
1114520|NCT01717326|3654793|P15|Overall Study|Physician Decision|0
1114521|NCT01717326|3654794|P14|Overall Study|Physician Decision|0
1114522|NCT01717326|3654795|P13|Overall Study|Physician Decision|0
1114523|NCT01717326|3654796|P12|Overall Study|Physician Decision|0
1114524|NCT01717326|3654797|P11|Overall Study|Physician Decision|0
1114525|NCT01717326|3654798|P10|Overall Study|Physician Decision|1
1114526|NCT01717326|3654799|P9|Overall Study|Physician Decision|0
1114527|NCT01717326|3654800|P8|Overall Study|Physician Decision|0
1114528|NCT01717326|3654801|P7|Overall Study|Physician Decision|0
1114529|NCT01717326|3654802|P6|Overall Study|Physician Decision|0
1114530|NCT01717326|3654803|P5|Overall Study|Physician Decision|0
1114531|NCT01717326|3654804|P4|Overall Study|Physician Decision|0
1114532|NCT01717326|3654805|P3|Overall Study|Physician Decision|0
1114533|NCT01717326|3654806|P2|Overall Study|Physician Decision|0
1114534|NCT01717326|3654807|P1|Overall Study|Physician Decision|0
1114535|NCT01717326|3654788|P20|Overall Study|Lost to Follow-up|3
1114536|NCT01717326|3654789|P19|Overall Study|Lost to Follow-up|2
1114537|NCT01717326|3654790|P18|Overall Study|Lost to Follow-up|0
1114538|NCT01717326|3654791|P17|Overall Study|Lost to Follow-up|1
1114539|NCT01717326|3654792|P16|Overall Study|Lost to Follow-up|2
1114540|NCT01717326|3654793|P15|Overall Study|Lost to Follow-up|0
1114541|NCT01717326|3654794|P14|Overall Study|Lost to Follow-up|0
1114542|NCT01717326|3654795|P13|Overall Study|Lost to Follow-up|0
1114543|NCT01717326|3654796|P12|Overall Study|Lost to Follow-up|0
1114544|NCT01717326|3654797|P11|Overall Study|Lost to Follow-up|1
1114545|NCT01717326|3654798|P10|Overall Study|Lost to Follow-up|0
1114546|NCT01717326|3654799|P9|Overall Study|Lost to Follow-up|0
1114547|NCT01717326|3654800|P8|Overall Study|Lost to Follow-up|0
1114548|NCT01717326|3654801|P7|Overall Study|Lost to Follow-up|1
1114549|NCT01717326|3654802|P6|Overall Study|Lost to Follow-up|0
1114550|NCT01717326|3654803|P5|Overall Study|Lost to Follow-up|1
1114551|NCT01717326|3654804|P4|Overall Study|Lost to Follow-up|2
1114552|NCT01717326|3654805|P3|Overall Study|Lost to Follow-up|0
1114553|NCT01717326|3654806|P2|Overall Study|Lost to Follow-up|0
1114554|NCT01717326|3654807|P1|Overall Study|Lost to Follow-up|3
1114555|NCT01717326|3654788|P20|Overall Study|Death|0
1114556|NCT01717326|3654789|P19|Overall Study|Death|0
1114557|NCT01717326|3654790|P18|Overall Study|Death|0
1114558|NCT01717326|3654791|P17|Overall Study|Death|0
1114559|NCT01717326|3654792|P16|Overall Study|Death|0
1114560|NCT01717326|3654793|P15|Overall Study|Death|0
1114561|NCT01717326|3654794|P14|Overall Study|Death|0
1114562|NCT01717326|3654795|P13|Overall Study|Death|0
1114563|NCT01717326|3654796|P12|Overall Study|Death|0
1114564|NCT01717326|3654797|P11|Overall Study|Death|1
1114565|NCT01717326|3654798|P10|Overall Study|Death|0
1114566|NCT01717326|3654799|P9|Overall Study|Death|0
1114567|NCT01717326|3654800|P8|Overall Study|Death|0
1114568|NCT01717326|3654801|P7|Overall Study|Death|0
1114569|NCT01717326|3654802|P6|Overall Study|Death|0
1114570|NCT01717326|3654803|P5|Overall Study|Death|0
1114571|NCT01717326|3654804|P4|Overall Study|Death|0
1114572|NCT01717326|3654805|P3|Overall Study|Death|0
1114573|NCT01717326|3654806|P2|Overall Study|Death|0
1114574|NCT01717326|3654807|P1|Overall Study|Death|0
1114575|NCT01717313|3655071|P2|Phase B (Weeks 24 to 54)|Lost to Follow-up|3
1114576|NCT01717313|3655072|P1|Phase B (Weeks 24 to 54)|Lost to Follow-up|1
1114577|NCT01717313|3655071|P2|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9
1114578|NCT01717313|3655072|P1|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7
1114579|NCT01717313|3655071|P2|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
1114580|NCT01717313|3655072|P1|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
1114581|NCT01717313|3655071|P2|Interphase|Completed Phase A Did Not Enter Phase B|0
1114582|NCT01717313|3655072|P1|Interphase|Completed Phase A Did Not Enter Phase B|1
1114583|NCT01717313|3655071|P2|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
1114584|NCT01717313|3655072|P1|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
1114585|NCT01717313|3655071|P2|Phase A (Weeks 0 to 24)|Adverse Event|2
1114586|NCT01717313|3655072|P1|Phase A (Weeks 0 to 24)|Adverse Event|4
1114587|NCT01717313|3655071|P2|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6
1114588|NCT01717313|3655072|P1|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12
1114589|NCT01717313|3655071|P2|Phase A (Weeks 0 to 24)|Lost to Follow-up|3
1114590|NCT01717313|3655072|P1|Phase A (Weeks 0 to 24)|Lost to Follow-up|1
1114591|NCT01717313|3655071|P2|Phase A (Weeks 0 to 24)|Death|1
1114592|NCT01717313|3655072|P1|Phase A (Weeks 0 to 24)|Death|0
1114593|NCT01717287|3655110|P2|Overall Study|Protocol Violation|1
1114594|NCT01717287|3655111|P1|Overall Study|Protocol Violation|0
1114595|NCT01717287|3655110|P2|Overall Study|Lost to Follow-up|2
1114596|NCT01717287|3655111|P1|Overall Study|Lost to Follow-up|0
1114597|NCT01717040|3655148|P2|Overall Study|New Substance Use Disorder|0
1114598|NCT01717040|3655149|P1|Overall Study|New Substance Use Disorder|1
1114599|NCT01717040|3655148|P2|Overall Study|Required Medication Change|1
1114600|NCT01717040|3655149|P1|Overall Study|Required Medication Change|0
1114601|NCT01717040|3655148|P2|Overall Study|Adverse Event|0
1114602|NCT01717040|3655149|P1|Overall Study|Adverse Event|1
1114603|NCT01717040|3655148|P2|Overall Study|Lack of Efficacy|1
1114604|NCT01717040|3655149|P1|Overall Study|Lack of Efficacy|1
1114605|NCT01717040|3655148|P2|Overall Study|Lost to Follow-up|3
1114606|NCT01717040|3655149|P1|Overall Study|Lost to Follow-up|2
1114607|NCT01716754|3655167|P4|Overall Study|Withdrawal by Subject|3
1114608|NCT01716754|3655168|P3|Overall Study|Withdrawal by Subject|4
1114609|NCT01716754|3655169|P2|Overall Study|Withdrawal by Subject|0
1114610|NCT01716754|3655170|P1|Overall Study|Withdrawal by Subject|5
1114611|NCT01716754|3655167|P4|Overall Study|Adverse Event|1
1114612|NCT01716754|3655168|P3|Overall Study|Adverse Event|2
1114613|NCT01716754|3655169|P2|Overall Study|Adverse Event|2
1114614|NCT01716754|3655170|P1|Overall Study|Adverse Event|4
1114615|NCT01716754|3655167|P4|Overall Study|Lost to Follow-up|1
1114616|NCT01716754|3655168|P3|Overall Study|Lost to Follow-up|0
1114617|NCT01716754|3655169|P2|Overall Study|Lost to Follow-up|0
1114618|NCT01716754|3655170|P1|Overall Study|Lost to Follow-up|1
1114619|NCT01716754|3655167|P4|Overall Study|Physician Decision|0
1114620|NCT01716754|3655168|P3|Overall Study|Physician Decision|0
1114621|NCT01716754|3655169|P2|Overall Study|Physician Decision|0
1114622|NCT01716754|3655170|P1|Overall Study|Physician Decision|1
1114623|NCT01716754|3655167|P4|Overall Study|Non-compliance with study treatment|0
1114624|NCT01716754|3655168|P3|Overall Study|Non-compliance with study treatment|1
1114625|NCT01716754|3655169|P2|Overall Study|Non-compliance with study treatment|0
1114626|NCT01716754|3655170|P1|Overall Study|Non-compliance with study treatment|0
1114627|NCT01716754|3655167|P4|Overall Study|Protocol deviation|2
1114628|NCT01716754|3655168|P3|Overall Study|Protocol deviation|7
1114629|NCT01716754|3655169|P2|Overall Study|Protocol deviation|2
1114630|NCT01716754|3655170|P1|Overall Study|Protocol deviation|0
1114631|NCT01716754|3655167|P4|Overall Study|Death|1
1114632|NCT01716754|3655168|P3|Overall Study|Death|0
1114633|NCT01716754|3655169|P2|Overall Study|Death|0
1114634|NCT01716754|3655170|P1|Overall Study|Death|0
1114635|NCT01716663|3655191|P1|Overall Study|Treated with non-study catheter|2
1114636|NCT01716663|3655191|P1|Overall Study|Withdrawn prior to procedure|4
1114637|NCT01716585|3655201|P2|Open-label Treatment|Withdrawal by Subject|3
1114638|NCT01716585|3655202|P1|Open-label Treatment|Withdrawal by Subject|0
1114639|NCT01716585|3655201|P2|Open-label Treatment|Virologic Failure|2
1114640|NCT01716585|3655202|P1|Open-label Treatment|Virologic Failure|0
1114641|NCT01716585|3655201|P2|Open-label Treatment|Adverse Event|2
1114642|NCT01716585|3655202|P1|Open-label Treatment|Adverse Event|0
1114643|NCT01716585|3655201|P2|Double-blind Treatment|Not Specified|0
1114644|NCT01716585|3655202|P1|Double-blind Treatment|Not Specified|1
1114645|NCT01716585|3655201|P2|Double-blind Treatment|Subject Noncompliant|0
1114646|NCT01716585|3655202|P1|Double-blind Treatment|Subject Noncompliant|1
1114647|NCT01716585|3655201|P2|Double-blind Treatment|Lost to Follow-up|0
1114648|NCT01716585|3655202|P1|Double-blind Treatment|Lost to Follow-up|2
1114649|NCT01716585|3655201|P2|Double-blind Treatment|Withdrawal by Subject|0
1114650|NCT01716585|3655202|P1|Double-blind Treatment|Withdrawal by Subject|3
1114651|NCT01716585|3655201|P2|Double-blind Treatment|Adverse Event|1
1114652|NCT01716585|3655202|P1|Double-blind Treatment|Adverse Event|2
1114653|NCT01716585|3655201|P2|Double-blind Treatment|Did Not Receive Study Drug|1
1114654|NCT01716585|3655202|P1|Double-blind Treatment|Did Not Receive Study Drug|4
1114655|NCT01716559|3655214|P1|Overall Study|Other withdrawal reason|75
1114656|NCT01716559|3655214|P1|Overall Study|Withdrawal by Subject|4
1114657|NCT01716559|3655214|P1|Overall Study|Death|21
1114658|NCT01716559|3655214|P1|Overall Study|Adverse Event|11
1114659|NCT01716520|3655222|P6|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1114660|NCT01716520|3655223|P5|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1114661|NCT01716520|3655224|P4|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1114662|NCT01716520|3655225|P3|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
1114663|NCT01716520|3655226|P2|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1114664|NCT01716520|3655227|P1|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1114665|NCT01716520|3655222|P6|Treatment Period 3 (14 Days)|Lack of Efficacy|2
1114666|NCT01716520|3655223|P5|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1114667|NCT01716520|3655224|P4|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1114668|NCT01716520|3655225|P3|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1114669|NCT01716520|3655226|P2|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1114670|NCT01716520|3655227|P1|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1114671|NCT01716520|3655222|P6|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
1114672|NCT01716520|3655223|P5|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
1114673|NCT01716520|3655224|P4|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
1114674|NCT01716520|3655225|P3|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
1114675|NCT01716520|3655226|P2|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1
1114676|NCT01716520|3655227|P1|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
1114677|NCT01716520|3655222|P6|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1
1114678|NCT01716520|3655223|P5|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
1114679|NCT01716520|3655224|P4|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
1114680|NCT01716520|3655225|P3|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
1114681|NCT01716520|3655226|P2|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
1114682|NCT01716520|3655227|P1|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
1114683|NCT01716520|3655222|P6|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
1114684|NCT01716520|3655223|P5|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
1114685|NCT01716520|3655224|P4|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
1114686|NCT01716520|3655225|P3|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
1114687|NCT01716520|3655226|P2|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
1114688|NCT01716520|3655227|P1|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1
1114689|NCT01716520|3655222|P6|Washout Period 2 (10 to 14 Days)|Adverse Event|1
1114690|NCT01716520|3655223|P5|Washout Period 2 (10 to 14 Days)|Adverse Event|0
1114691|NCT01716520|3655224|P4|Washout Period 2 (10 to 14 Days)|Adverse Event|0
1114692|NCT01716520|3655225|P3|Washout Period 2 (10 to 14 Days)|Adverse Event|1
1114693|NCT01716520|3655226|P2|Washout Period 2 (10 to 14 Days)|Adverse Event|0
1114694|NCT01716520|3655227|P1|Washout Period 2 (10 to 14 Days)|Adverse Event|1
1114695|NCT01716520|3655222|P6|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
1114696|NCT01716520|3655223|P5|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
1114697|NCT01716520|3655224|P4|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1
1114698|NCT01716520|3655225|P3|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
1114699|NCT01716520|3655226|P2|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
1114700|NCT01716520|3655227|P1|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
1114701|NCT01716520|3655222|P6|Treatment Period 2 (14 Days)|Protocol Violation|0
1114702|NCT01716520|3655223|P5|Treatment Period 2 (14 Days)|Protocol Violation|1
1114703|NCT01716520|3655224|P4|Treatment Period 2 (14 Days)|Protocol Violation|0
1114704|NCT01716520|3655225|P3|Treatment Period 2 (14 Days)|Protocol Violation|0
1114705|NCT01716520|3655226|P2|Treatment Period 2 (14 Days)|Protocol Violation|0
1114706|NCT01716520|3655227|P1|Treatment Period 2 (14 Days)|Protocol Violation|0
1114707|NCT01716520|3655222|P6|Treatment Period 2 (14 Days)|Adverse Event|0
1114708|NCT01716520|3655223|P5|Treatment Period 2 (14 Days)|Adverse Event|1
1114709|NCT01716520|3655224|P4|Treatment Period 2 (14 Days)|Adverse Event|0
1114710|NCT01716520|3655225|P3|Treatment Period 2 (14 Days)|Adverse Event|0
1114711|NCT01716520|3655226|P2|Treatment Period 2 (14 Days)|Adverse Event|0
1114712|NCT01716520|3655227|P1|Treatment Period 2 (14 Days)|Adverse Event|0
1114713|NCT01716520|3655222|P6|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
1114714|NCT01716520|3655223|P5|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
1114715|NCT01716520|3655224|P4|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
1114716|NCT01716520|3655225|P3|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
1114717|NCT01716520|3655226|P2|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
1114718|NCT01716520|3655227|P1|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
1114719|NCT01716520|3655222|P6|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
1114720|NCT01716520|3655223|P5|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1114721|NCT01716520|3655224|P4|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1114722|NCT01716520|3655225|P3|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1114723|NCT01716520|3655226|P2|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1114724|NCT01716520|3655227|P1|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1114725|NCT01716520|3655222|P6|Washout Period 1 (10 to 14 Days)|Adverse Event|0
1114726|NCT01716520|3655223|P5|Washout Period 1 (10 to 14 Days)|Adverse Event|0
1114727|NCT01716520|3655224|P4|Washout Period 1 (10 to 14 Days)|Adverse Event|0
1114728|NCT01716520|3655225|P3|Washout Period 1 (10 to 14 Days)|Adverse Event|0
1114729|NCT01716520|3655226|P2|Washout Period 1 (10 to 14 Days)|Adverse Event|1
1114730|NCT01716520|3655227|P1|Washout Period 1 (10 to 14 Days)|Adverse Event|0
1114731|NCT01716520|3655222|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1114732|NCT01716520|3655223|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1114733|NCT01716520|3655224|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1114734|NCT01716520|3655225|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1114735|NCT01716520|3655226|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
1114736|NCT01716520|3655227|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1114737|NCT01716520|3655222|P6|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
1114738|NCT01716520|3655223|P5|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
1114739|NCT01716520|3655224|P4|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
1114740|NCT01716520|3655225|P3|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2
1114741|NCT01716520|3655226|P2|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
1114742|NCT01716520|3655227|P1|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
1114743|NCT01716520|3655222|P6|Treatment Period 1 (14 Days)|Adverse Event|0
1114744|NCT01716520|3655223|P5|Treatment Period 1 (14 Days)|Adverse Event|0
1114745|NCT01716520|3655224|P4|Treatment Period 1 (14 Days)|Adverse Event|0
1114746|NCT01716520|3655225|P3|Treatment Period 1 (14 Days)|Adverse Event|0
1114747|NCT01716520|3655226|P2|Treatment Period 1 (14 Days)|Adverse Event|0
1114748|NCT01716520|3655227|P1|Treatment Period 1 (14 Days)|Adverse Event|1
1114749|NCT01716234|3655282|P7|Overall Study|Withdrawal by Subject|0
1114750|NCT01716234|3655283|P6|Overall Study|Withdrawal by Subject|3
1114751|NCT01716234|3655284|P5|Overall Study|Withdrawal by Subject|1
1114752|NCT01716234|3655285|P4|Overall Study|Withdrawal by Subject|2
1114753|NCT01716234|3655286|P3|Overall Study|Withdrawal by Subject|2
1114754|NCT01716234|3655287|P2|Overall Study|Withdrawal by Subject|0
1114755|NCT01716234|3655288|P1|Overall Study|Withdrawal by Subject|3
1114756|NCT01716234|3655282|P7|Overall Study|Adverse Event|0
1114757|NCT01716234|3655283|P6|Overall Study|Adverse Event|6
1114758|NCT01716234|3655284|P5|Overall Study|Adverse Event|3
1114759|NCT01716234|3655285|P4|Overall Study|Adverse Event|8
1114760|NCT01716234|3655286|P3|Overall Study|Adverse Event|2
1114761|NCT01716234|3655287|P2|Overall Study|Adverse Event|10
1114762|NCT01716234|3655288|P1|Overall Study|Adverse Event|7
1114763|NCT01716234|3655282|P7|Overall Study|Did not meet protocol eligibility|0
1114764|NCT01716234|3655283|P6|Overall Study|Did not meet protocol eligibility|4
1114765|NCT01716234|3655284|P5|Overall Study|Did not meet protocol eligibility|0
1114766|NCT01716234|3655285|P4|Overall Study|Did not meet protocol eligibility|0
1114767|NCT01716234|3655286|P3|Overall Study|Did not meet protocol eligibility|1
1114768|NCT01716234|3655287|P2|Overall Study|Did not meet protocol eligibility|0
1114769|NCT01716234|3655288|P1|Overall Study|Did not meet protocol eligibility|0
1114770|NCT01716234|3655282|P7|Overall Study|Lack of Efficacy|0
1114771|NCT01716234|3655283|P6|Overall Study|Lack of Efficacy|0
1114772|NCT01716234|3655284|P5|Overall Study|Lack of Efficacy|0
1114773|NCT01716234|3655285|P4|Overall Study|Lack of Efficacy|1
1114774|NCT01716234|3655286|P3|Overall Study|Lack of Efficacy|0
1114775|NCT01716234|3655287|P2|Overall Study|Lack of Efficacy|0
1114776|NCT01716234|3655288|P1|Overall Study|Lack of Efficacy|0
1114777|NCT01716234|3655282|P7|Overall Study|Protocol Violation|0
1114778|NCT01716234|3655283|P6|Overall Study|Protocol Violation|1
1114779|NCT01716234|3655284|P5|Overall Study|Protocol Violation|1
1114780|NCT01716234|3655285|P4|Overall Study|Protocol Violation|1
1114781|NCT01716234|3655286|P3|Overall Study|Protocol Violation|0
1114782|NCT01716234|3655287|P2|Overall Study|Protocol Violation|0
1114783|NCT01716234|3655288|P1|Overall Study|Protocol Violation|0
1114784|NCT01716169|3655351|P1|Overall Study|inconsistent dressing application|1
1114785|NCT01716169|3655351|P1|Overall Study|Withdrawal by Subject|1
1114786|NCT01716169|3655351|P1|Overall Study|Lost to Follow-up|1
1114787|NCT01716169|3655351|P1|Overall Study|Adverse Event|1
1114788|NCT01716156|3655360|P3|Overall Study|Lost to Follow-up|0
1114789|NCT01716156|3655361|P2|Overall Study|Lost to Follow-up|0
1114790|NCT01716156|3655362|P1|Overall Study|Lost to Follow-up|1
1114791|NCT01716156|3655360|P3|Overall Study|Withdrawal by Subject|2
1114792|NCT01716156|3655361|P2|Overall Study|Withdrawal by Subject|1
1114793|NCT01716156|3655362|P1|Overall Study|Withdrawal by Subject|0
1114794|NCT01716156|3655360|P3|Overall Study|Protocol Violation|0
1114795|NCT01716156|3655361|P2|Overall Study|Protocol Violation|0
1114796|NCT01716156|3655362|P1|Overall Study|Protocol Violation|1
1114797|NCT01716104|3655388|P2|Overall Study|Do not meet inclusion criteria|7
1114798|NCT01716104|3655389|P1|Overall Study|Do not meet inclusion criteria|6
1114799|NCT01716052|3655415|P2|Overall Study|Withdrawal of funding|1
1114800|NCT01716052|3655416|P1|Overall Study|Withdrawal of funding|1
1114801|NCT01715896|3655458|P2|Overall Study|Other|5
1114802|NCT01715896|3655459|P1|Overall Study|Other|2
1114803|NCT01715896|3655458|P2|Overall Study|Withdrawal by Subject|4
1114804|NCT01715896|3655459|P1|Overall Study|Withdrawal by Subject|1
1114805|NCT01715896|3655458|P2|Overall Study|Lost to Follow-up|2
1114806|NCT01715896|3655459|P1|Overall Study|Lost to Follow-up|0
1114807|NCT01715857|3655532|P1|Overall Study|Did Not Meet Eligibility Criteria|96
1114808|NCT01715831|3655542|P1|Overall Study|Adverse Event|1
1114809|NCT01715415|3655560|P2|Open-label Treatment|Subject Noncompliant|1
1114810|NCT01715415|3655561|P1|Open-label Treatment|Subject Noncompliant|0
1114811|NCT01715415|3655560|P2|Open-label Treatment|Adverse Event|1
1114812|NCT01715415|3655561|P1|Open-label Treatment|Adverse Event|0
1114813|NCT01715415|3655560|P2|Double-blind Treatment|Not Specified|0
1114814|NCT01715415|3655561|P1|Double-blind Treatment|Not Specified|1
1114815|NCT01715415|3655560|P2|Double-blind Treatment|Withdrawal by Subject|1
1114816|NCT01715415|3655561|P1|Double-blind Treatment|Withdrawal by Subject|1
1114817|NCT01715415|3655560|P2|Double-blind Treatment|Adverse Event|0
1114818|NCT01715415|3655561|P1|Double-blind Treatment|Adverse Event|3
1114819|NCT01715415|3655560|P2|Double-blind Treatment|Did Not Receive Study Drug|1
1114820|NCT01715415|3655561|P1|Double-blind Treatment|Did Not Receive Study Drug|0
1114821|NCT01715298|3655575|P2|Overall Study|Patient/guardian decision|9
1114822|NCT01715298|3655576|P1|Overall Study|Patient/guardian decision|7
1114823|NCT01715298|3655575|P2|Overall Study|Lost to Follow-up|2
1114824|NCT01715298|3655576|P1|Overall Study|Lost to Follow-up|0
1114825|NCT01715285|3655614|P2|Overall Study|Other|5
1114826|NCT01715285|3655615|P1|Overall Study|Other|7
1114827|NCT01715285|3655614|P2|Overall Study|Ongoing|112
1114828|NCT01715285|3655615|P1|Overall Study|Ongoing|257
1114829|NCT01715285|3655614|P2|Overall Study|Physician Decision|19
1114830|NCT01715285|3655615|P1|Overall Study|Physician Decision|11
1114831|NCT01715285|3655614|P2|Overall Study|Withdrawal Of Consent|41
1114832|NCT01715285|3655615|P1|Overall Study|Withdrawal Of Consent|31
1114833|NCT01715285|3655614|P2|Overall Study|Progressive Disease|369
1114834|NCT01715285|3655615|P1|Overall Study|Progressive Disease|209
1114835|NCT01715285|3655614|P2|Overall Study|Noncompliance With Study Drug|2
1114836|NCT01715285|3655615|P1|Overall Study|Noncompliance With Study Drug|4
1114837|NCT01715285|3655614|P2|Overall Study|Death|21
1114838|NCT01715285|3655615|P1|Overall Study|Death|26
1114839|NCT01715285|3655614|P2|Overall Study|Lost to Follow-up|2
1114840|NCT01715285|3655615|P1|Overall Study|Lost to Follow-up|3
1114841|NCT01715285|3655614|P2|Overall Study|Adverse Event|31
1114842|NCT01715285|3655615|P1|Overall Study|Adverse Event|49
1114843|NCT01715129|3655644|P1|Overall Study|Other|1
1114844|NCT01715129|3655644|P1|Overall Study|Lost to Follow-up|1
1114845|NCT01715129|3655644|P1|Overall Study|Consent Withdrawn|2
1114846|NCT01715129|3655644|P1|Overall Study|Protocol Violation|1
1114847|NCT01715129|3655644|P1|Overall Study|Lack of Efficacy|3
1114848|NCT01715129|3655644|P1|Overall Study|Adverse Event, fatal|1
1114849|NCT01714947|3655670|P1|Part B|Progressive Disease|3
1114850|NCT01714817|3655711|P2|Overall Study|Hypersensitivity to the medication|1
1114851|NCT01714817|3655712|P1|Overall Study|Hypersensitivity to the medication|0
1114852|NCT01714817|3655711|P2|Overall Study|Antiproteinuric changed/dose increased|1
1114853|NCT01714817|3655712|P1|Overall Study|Antiproteinuric changed/dose increased|0
1114854|NCT01714817|3655711|P2|Overall Study|Need of use of Prohibited Medications|0
1114855|NCT01714817|3655712|P1|Overall Study|Need of use of Prohibited Medications|1
1114856|NCT01714817|3655711|P2|Overall Study|Change in Concomitant Medication|1
1114857|NCT01714817|3655712|P1|Overall Study|Change in Concomitant Medication|0
1114858|NCT01714817|3655711|P2|Overall Study|Not treated- received ACE inhibition|0
1114859|NCT01714817|3655712|P1|Overall Study|Not treated- received ACE inhibition|1
1114860|NCT01714817|3655711|P2|Overall Study|Participant no longer meets criteria|2
1114861|NCT01714817|3655712|P1|Overall Study|Participant no longer meets criteria|6
1114862|NCT01714817|3655711|P2|Overall Study|Pregnancy|0
1114863|NCT01714817|3655712|P1|Overall Study|Pregnancy|2
1114864|NCT01714817|3655711|P2|Overall Study|Poor / non-compliance|1
1114865|NCT01714817|3655712|P1|Overall Study|Poor / non-compliance|0
1114866|NCT01714817|3655711|P2|Overall Study|Lost to Follow-up|2
1114867|NCT01714817|3655712|P1|Overall Study|Lost to Follow-up|0
1114868|NCT01714817|3655711|P2|Overall Study|Death|1
1114869|NCT01714817|3655712|P1|Overall Study|Death|1
1114870|NCT01714817|3655711|P2|Overall Study|Withdrawal by Subject|7
1114871|NCT01714817|3655712|P1|Overall Study|Withdrawal by Subject|6
1114872|NCT01714817|3655711|P2|Overall Study|Adverse Event|17
1114873|NCT01714817|3655712|P1|Overall Study|Adverse Event|20
1114874|NCT01714817|3655711|P2|Overall Study|Lack of Efficacy|9
1114875|NCT01714817|3655712|P1|Overall Study|Lack of Efficacy|11
1114876|NCT01714635|3655745|P3|Overall Study|Missed 6-month exam|0
1114877|NCT01714635|3655746|P2|Overall Study|Missed 6-month exam|0
1114878|NCT01714635|3655747|P1|Overall Study|Missed 6-month exam|1
1114879|NCT01714635|3655745|P3|Overall Study|Discontinued|2
1114880|NCT01714635|3655746|P2|Overall Study|Discontinued|0
1114881|NCT01714635|3655747|P1|Overall Study|Discontinued|1
1114882|NCT01714609|3655763|P2|Overall Study|Protocol Violation|0
1114883|NCT01714609|3655764|P1|Overall Study|Protocol Violation|1
1114884|NCT01714544|3655770|P1|Overall Study|Withdrawal by Subject|1
1114885|NCT01714544|3655770|P1|Overall Study|Physician Decision|1
1114886|NCT01714544|3655770|P1|Overall Study|Lost to Follow-up|1
1114887|NCT01714310|3655841|P3|Double Blind Adjunctive Treatment|Protocol Violation|0
1114888|NCT01714310|3655842|P2|Double Blind Adjunctive Treatment|Protocol Violation|2
1114889|NCT01714310|3655843|P1|Double Blind Adjunctive Treatment|Protocol Violation|1
1114890|NCT01714310|3655841|P3|Double Blind Adjunctive Treatment|Adverse Event|0
1114891|NCT01714310|3655842|P2|Double Blind Adjunctive Treatment|Adverse Event|1
1114892|NCT01714310|3655843|P1|Double Blind Adjunctive Treatment|Adverse Event|1
1114893|NCT01714310|3655841|P3|Open Lisdexamfetamine Titration|Adverse Event|3
1114894|NCT01714310|3655842|P2|Open Lisdexamfetamine Titration|Adverse Event|0
1114895|NCT01714310|3655843|P1|Open Lisdexamfetamine Titration|Adverse Event|0
1114896|NCT01714310|3655841|P3|Open Lisdexamfetamine Titration|Protocol Violation|1
1114897|NCT01714310|3655842|P2|Open Lisdexamfetamine Titration|Protocol Violation|0
1114898|NCT01714310|3655843|P1|Open Lisdexamfetamine Titration|Protocol Violation|0
1114899|NCT01713998|3655921|P3|Overall Study|Withdrawal by Subject|0
1114900|NCT01713998|3655922|P2|Overall Study|Withdrawal by Subject|0
1114901|NCT01713998|3655923|P1|Overall Study|Withdrawal by Subject|1
1114902|NCT01713998|3655921|P3|Overall Study|Lost to Follow-up|2
1114903|NCT01713998|3655922|P2|Overall Study|Lost to Follow-up|0
1114904|NCT01713998|3655923|P1|Overall Study|Lost to Follow-up|2
1114905|NCT01713946|3655944|P3|Overall Study|Patients never switched to everolimus|5
1114906|NCT01713946|3655945|P2|Overall Study|Patients never switched to everolimus|0
1114907|NCT01713946|3655946|P1|Overall Study|Patients never switched to everolimus|0
1114908|NCT01713946|3655944|P3|Overall Study|Did not continue in Post-Ext. Phase|0
1114909|NCT01713946|3655945|P2|Overall Study|Did not continue in Post-Ext. Phase|2
1114910|NCT01713946|3655946|P1|Overall Study|Did not continue in Post-Ext. Phase|1
1114911|NCT01713946|3655944|P3|Overall Study|Did not continue in Ext|0
1114912|NCT01713946|3655945|P2|Overall Study|Did not continue in Ext|3
1114913|NCT01713946|3655946|P1|Overall Study|Did not continue in Ext|0
1114914|NCT01713946|3655944|P3|Overall Study|Administrative problems|0
1114915|NCT01713946|3655945|P2|Overall Study|Administrative problems|0
1114916|NCT01713946|3655946|P1|Overall Study|Administrative problems|1
1114917|NCT01713946|3655944|P3|Overall Study|Lost to Follow-up|1
1114918|NCT01713946|3655945|P2|Overall Study|Lost to Follow-up|0
1114919|NCT01713946|3655946|P1|Overall Study|Lost to Follow-up|0
1114920|NCT01713946|3655944|P3|Overall Study|Protocol Violation|1
1114921|NCT01713946|3655945|P2|Overall Study|Protocol Violation|4
1114922|NCT01713946|3655946|P1|Overall Study|Protocol Violation|2
1114923|NCT01713946|3655944|P3|Overall Study|Lack of Efficacy|14
1114924|NCT01713946|3655945|P2|Overall Study|Lack of Efficacy|8
1114925|NCT01713946|3655946|P1|Overall Study|Lack of Efficacy|8
1114926|NCT01713946|3655944|P3|Overall Study|Withdrawal by Subject|8
1114927|NCT01713946|3655945|P2|Overall Study|Withdrawal by Subject|12
1114928|NCT01713946|3655946|P1|Overall Study|Withdrawal by Subject|12
1114929|NCT01713946|3655944|P3|Overall Study|Adverse Event|13
1114930|NCT01713946|3655945|P2|Overall Study|Adverse Event|14
1114931|NCT01713946|3655946|P1|Overall Study|Adverse Event|19
1114932|NCT01713946|3655944|P3|Overall Study|Death|2
1114933|NCT01713946|3655945|P2|Overall Study|Death|2
1114934|NCT01713946|3655946|P1|Overall Study|Death|0
1114935|NCT01713933|3656037|P1|Overall Study|Excluded from analysis as a BMI outlier|1
1114936|NCT01713933|3656037|P1|Overall Study|Withdrawal by Subject|3
1114937|NCT01713933|3656037|P1|Overall Study|Lost to Follow-up|2
1114938|NCT01713686|3656049|P1|Overall Study|Withdrawal by Subject|6
1114939|NCT01713686|3656049|P1|Overall Study|Lost to Follow-up|9
1114940|NCT01713582|3656119|P21|Overall Study|Disease progression and adverse event|0
1114941|NCT01713582|3656120|P20|Overall Study|Disease progression and adverse event|0
1114942|NCT01713582|3656121|P19|Overall Study|Disease progression and adverse event|0
1114943|NCT01713582|3656122|P18|Overall Study|Disease progression and adverse event|0
1114944|NCT01713582|3656123|P17|Overall Study|Disease progression and adverse event|1
1114945|NCT01713582|3656124|P16|Overall Study|Disease progression and adverse event|0
1114946|NCT01713582|3656125|P15|Overall Study|Disease progression and adverse event|0
1114947|NCT01713582|3656126|P14|Overall Study|Disease progression and adverse event|0
1114948|NCT01713582|3656127|P13|Overall Study|Disease progression and adverse event|0
1114949|NCT01713582|3656128|P12|Overall Study|Disease progression and adverse event|0
1114950|NCT01713582|3656129|P11|Overall Study|Disease progression and adverse event|0
1114951|NCT01713582|3656130|P10|Overall Study|Disease progression and adverse event|0
1114952|NCT01713582|3656131|P9|Overall Study|Disease progression and adverse event|0
1114953|NCT01713582|3656132|P8|Overall Study|Disease progression and adverse event|0
1114954|NCT01713582|3656133|P7|Overall Study|Disease progression and adverse event|0
1114955|NCT01713582|3656134|P6|Overall Study|Disease progression and adverse event|0
1114956|NCT01713582|3656135|P5|Overall Study|Disease progression and adverse event|0
1114957|NCT01713582|3656136|P4|Overall Study|Disease progression and adverse event|0
1114958|NCT01713582|3656137|P3|Overall Study|Disease progression and adverse event|0
1114959|NCT01713582|3656138|P2|Overall Study|Disease progression and adverse event|0
1114960|NCT01713582|3656139|P1|Overall Study|Disease progression and adverse event|0
1114961|NCT01713582|3656119|P21|Overall Study|Stopped to receive bone marrow graft|0
1114962|NCT01713582|3656120|P20|Overall Study|Stopped to receive bone marrow graft|0
1114963|NCT01713582|3656121|P19|Overall Study|Stopped to receive bone marrow graft|0
1114964|NCT01713582|3656122|P18|Overall Study|Stopped to receive bone marrow graft|0
1114965|NCT01713582|3656123|P17|Overall Study|Stopped to receive bone marrow graft|1
1114966|NCT01713582|3656124|P16|Overall Study|Stopped to receive bone marrow graft|0
1114967|NCT01713582|3656125|P15|Overall Study|Stopped to receive bone marrow graft|0
1114968|NCT01713582|3656126|P14|Overall Study|Stopped to receive bone marrow graft|0
1114969|NCT01713582|3656127|P13|Overall Study|Stopped to receive bone marrow graft|0
1114970|NCT01713582|3656128|P12|Overall Study|Stopped to receive bone marrow graft|0
1114971|NCT01713582|3656129|P11|Overall Study|Stopped to receive bone marrow graft|0
1114972|NCT01713582|3656130|P10|Overall Study|Stopped to receive bone marrow graft|0
1114973|NCT01713582|3656131|P9|Overall Study|Stopped to receive bone marrow graft|0
1114974|NCT01713582|3656132|P8|Overall Study|Stopped to receive bone marrow graft|0
1114975|NCT01713582|3656133|P7|Overall Study|Stopped to receive bone marrow graft|0
1114976|NCT01713582|3656134|P6|Overall Study|Stopped to receive bone marrow graft|0
1114977|NCT01713582|3656135|P5|Overall Study|Stopped to receive bone marrow graft|0
1114978|NCT01713582|3656136|P4|Overall Study|Stopped to receive bone marrow graft|0
1114979|NCT01713582|3656137|P3|Overall Study|Stopped to receive bone marrow graft|0
1114980|NCT01713582|3656138|P2|Overall Study|Stopped to receive bone marrow graft|0
1114981|NCT01713582|3656139|P1|Overall Study|Stopped to receive bone marrow graft|0
1114982|NCT01713582|3656119|P21|Overall Study|Withdrawal by Subject|0
1114983|NCT01713582|3656120|P20|Overall Study|Withdrawal by Subject|0
1114984|NCT01713582|3656121|P19|Overall Study|Withdrawal by Subject|0
1114985|NCT01713582|3656122|P18|Overall Study|Withdrawal by Subject|1
1114986|NCT01713582|3656123|P17|Overall Study|Withdrawal by Subject|0
1114987|NCT01713582|3656124|P16|Overall Study|Withdrawal by Subject|0
1114988|NCT01713582|3656125|P15|Overall Study|Withdrawal by Subject|0
1114989|NCT01713582|3656126|P14|Overall Study|Withdrawal by Subject|0
1114990|NCT01713582|3656127|P13|Overall Study|Withdrawal by Subject|0
1114991|NCT01713582|3656128|P12|Overall Study|Withdrawal by Subject|0
1114992|NCT01713582|3656129|P11|Overall Study|Withdrawal by Subject|0
1114993|NCT01713582|3656130|P10|Overall Study|Withdrawal by Subject|0
1114994|NCT01713582|3656131|P9|Overall Study|Withdrawal by Subject|0
1114995|NCT01713582|3656132|P8|Overall Study|Withdrawal by Subject|0
1114996|NCT01713582|3656133|P7|Overall Study|Withdrawal by Subject|0
1114997|NCT01713582|3656134|P6|Overall Study|Withdrawal by Subject|0
1114998|NCT01713582|3656135|P5|Overall Study|Withdrawal by Subject|0
1114999|NCT01713582|3656136|P4|Overall Study|Withdrawal by Subject|0
1115000|NCT01713582|3656137|P3|Overall Study|Withdrawal by Subject|0
1115001|NCT01713582|3656138|P2|Overall Study|Withdrawal by Subject|0
1115002|NCT01713582|3656139|P1|Overall Study|Withdrawal by Subject|0
1115003|NCT01713582|3656119|P21|Overall Study|Lack of Efficacy|0
1115004|NCT01713582|3656120|P20|Overall Study|Lack of Efficacy|0
1115005|NCT01713582|3656121|P19|Overall Study|Lack of Efficacy|0
1115006|NCT01713582|3656122|P18|Overall Study|Lack of Efficacy|0
1115007|NCT01713582|3656123|P17|Overall Study|Lack of Efficacy|0
1115008|NCT01713582|3656124|P16|Overall Study|Lack of Efficacy|0
1115009|NCT01713582|3656125|P15|Overall Study|Lack of Efficacy|0
1115010|NCT01713582|3656126|P14|Overall Study|Lack of Efficacy|0
1115011|NCT01713582|3656127|P13|Overall Study|Lack of Efficacy|0
1115012|NCT01713582|3656128|P12|Overall Study|Lack of Efficacy|0
1115013|NCT01713582|3656129|P11|Overall Study|Lack of Efficacy|2
1115014|NCT01713582|3656130|P10|Overall Study|Lack of Efficacy|1
1115015|NCT01713582|3656131|P9|Overall Study|Lack of Efficacy|0
1115016|NCT01713582|3656132|P8|Overall Study|Lack of Efficacy|0
1115017|NCT01713582|3656133|P7|Overall Study|Lack of Efficacy|0
1115018|NCT01713582|3656134|P6|Overall Study|Lack of Efficacy|0
1115019|NCT01713582|3656135|P5|Overall Study|Lack of Efficacy|0
1115020|NCT01713582|3656136|P4|Overall Study|Lack of Efficacy|0
1115021|NCT01713582|3656137|P3|Overall Study|Lack of Efficacy|0
1115022|NCT01713582|3656138|P2|Overall Study|Lack of Efficacy|0
1115023|NCT01713582|3656139|P1|Overall Study|Lack of Efficacy|0
1115024|NCT01713582|3656119|P21|Overall Study|Withdrawal of consent|0
1115025|NCT01713582|3656120|P20|Overall Study|Withdrawal of consent|0
1115026|NCT01713582|3656121|P19|Overall Study|Withdrawal of consent|1
1115027|NCT01713582|3656122|P18|Overall Study|Withdrawal of consent|0
1115028|NCT01713582|3656123|P17|Overall Study|Withdrawal of consent|0
1115029|NCT01713582|3656124|P16|Overall Study|Withdrawal of consent|0
1115030|NCT01713582|3656125|P15|Overall Study|Withdrawal of consent|0
1115031|NCT01713582|3656126|P14|Overall Study|Withdrawal of consent|0
1115032|NCT01713582|3656127|P13|Overall Study|Withdrawal of consent|0
1115033|NCT01713582|3656128|P12|Overall Study|Withdrawal of consent|0
1115034|NCT01713582|3656129|P11|Overall Study|Withdrawal of consent|0
1115035|NCT01713582|3656130|P10|Overall Study|Withdrawal of consent|1
1115036|NCT01713582|3656131|P9|Overall Study|Withdrawal of consent|0
1115037|NCT01713582|3656132|P8|Overall Study|Withdrawal of consent|0
1115038|NCT01713582|3656133|P7|Overall Study|Withdrawal of consent|0
1115039|NCT01713582|3656134|P6|Overall Study|Withdrawal of consent|1
1115040|NCT01713582|3656135|P5|Overall Study|Withdrawal of consent|0
1115041|NCT01713582|3656136|P4|Overall Study|Withdrawal of consent|0
1115042|NCT01713582|3656137|P3|Overall Study|Withdrawal of consent|1
1115043|NCT01713582|3656138|P2|Overall Study|Withdrawal of consent|0
1115044|NCT01713582|3656139|P1|Overall Study|Withdrawal of consent|0
1115045|NCT01713582|3656119|P21|Overall Study|Adverse event-unrelated|0
1115046|NCT01713582|3656120|P20|Overall Study|Adverse event-unrelated|0
1115047|NCT01713582|3656121|P19|Overall Study|Adverse event-unrelated|0
1115048|NCT01713582|3656122|P18|Overall Study|Adverse event-unrelated|0
1115049|NCT01713582|3656123|P17|Overall Study|Adverse event-unrelated|0
1115050|NCT01713582|3656124|P16|Overall Study|Adverse event-unrelated|0
1115051|NCT01713582|3656125|P15|Overall Study|Adverse event-unrelated|1
1115052|NCT01713582|3656126|P14|Overall Study|Adverse event-unrelated|1
1115053|NCT01713582|3656127|P13|Overall Study|Adverse event-unrelated|0
1115054|NCT01713582|3656128|P12|Overall Study|Adverse event-unrelated|0
1115055|NCT01713582|3656129|P11|Overall Study|Adverse event-unrelated|0
1115056|NCT01713582|3656130|P10|Overall Study|Adverse event-unrelated|0
1115057|NCT01713582|3656131|P9|Overall Study|Adverse event-unrelated|0
1115058|NCT01713582|3656132|P8|Overall Study|Adverse event-unrelated|1
1115059|NCT01713582|3656133|P7|Overall Study|Adverse event-unrelated|1
1115060|NCT01713582|3656134|P6|Overall Study|Adverse event-unrelated|1
1115061|NCT01713582|3656135|P5|Overall Study|Adverse event-unrelated|0
1115062|NCT01713582|3656136|P4|Overall Study|Adverse event-unrelated|0
1115063|NCT01713582|3656137|P3|Overall Study|Adverse event-unrelated|0
1115064|NCT01713582|3656138|P2|Overall Study|Adverse event-unrelated|0
1115065|NCT01713582|3656139|P1|Overall Study|Adverse event-unrelated|0
1115066|NCT01713582|3656119|P21|Overall Study|Adverse event-related|0
1115067|NCT01713582|3656120|P20|Overall Study|Adverse event-related|0
1115068|NCT01713582|3656121|P19|Overall Study|Adverse event-related|1
1115069|NCT01713582|3656122|P18|Overall Study|Adverse event-related|0
1115070|NCT01713582|3656123|P17|Overall Study|Adverse event-related|0
1115071|NCT01713582|3656124|P16|Overall Study|Adverse event-related|0
1115072|NCT01713582|3656125|P15|Overall Study|Adverse event-related|0
1115073|NCT01713582|3656126|P14|Overall Study|Adverse event-related|0
1115074|NCT01713582|3656127|P13|Overall Study|Adverse event-related|0
1115075|NCT01713582|3656128|P12|Overall Study|Adverse event-related|0
1115076|NCT01713582|3656129|P11|Overall Study|Adverse event-related|1
1115077|NCT01713582|3656130|P10|Overall Study|Adverse event-related|1
1115078|NCT01713582|3656131|P9|Overall Study|Adverse event-related|0
1115079|NCT01713582|3656132|P8|Overall Study|Adverse event-related|0
1115080|NCT01713582|3656133|P7|Overall Study|Adverse event-related|0
1115081|NCT01713582|3656134|P6|Overall Study|Adverse event-related|0
1115082|NCT01713582|3656135|P5|Overall Study|Adverse event-related|0
1115083|NCT01713582|3656136|P4|Overall Study|Adverse event-related|0
1115084|NCT01713582|3656137|P3|Overall Study|Adverse event-related|0
1115085|NCT01713582|3656138|P2|Overall Study|Adverse event-related|0
1115086|NCT01713582|3656139|P1|Overall Study|Adverse event-related|0
1115087|NCT01713582|3656119|P21|Overall Study|Death|0
1115088|NCT01713582|3656120|P20|Overall Study|Death|0
1115089|NCT01713582|3656121|P19|Overall Study|Death|0
1115090|NCT01713582|3656122|P18|Overall Study|Death|0
1115091|NCT01713582|3656123|P17|Overall Study|Death|0
1115092|NCT01713582|3656124|P16|Overall Study|Death|0
1115093|NCT01713582|3656125|P15|Overall Study|Death|0
1115094|NCT01713582|3656126|P14|Overall Study|Death|0
1115095|NCT01713582|3656127|P13|Overall Study|Death|0
1115096|NCT01713582|3656128|P12|Overall Study|Death|0
1115097|NCT01713582|3656129|P11|Overall Study|Death|3
1115098|NCT01713582|3656130|P10|Overall Study|Death|4
1115099|NCT01713582|3656131|P9|Overall Study|Death|3
1115100|NCT01713582|3656132|P8|Overall Study|Death|2
1115101|NCT01713582|3656133|P7|Overall Study|Death|3
1115102|NCT01713582|3656134|P6|Overall Study|Death|3
1115103|NCT01713582|3656135|P5|Overall Study|Death|1
1115104|NCT01713582|3656136|P4|Overall Study|Death|1
1115105|NCT01713582|3656137|P3|Overall Study|Death|0
1115106|NCT01713582|3656138|P2|Overall Study|Death|0
1115107|NCT01713582|3656139|P1|Overall Study|Death|0
1115108|NCT01713582|3656119|P21|Overall Study|Disease progression|15
1115109|NCT01713582|3656120|P20|Overall Study|Disease progression|5
1115110|NCT01713582|3656121|P19|Overall Study|Disease progression|3
1115111|NCT01713582|3656122|P18|Overall Study|Disease progression|2
1115112|NCT01713582|3656123|P17|Overall Study|Disease progression|5
1115113|NCT01713582|3656124|P16|Overall Study|Disease progression|6
1115114|NCT01713582|3656125|P15|Overall Study|Disease progression|6
1115115|NCT01713582|3656126|P14|Overall Study|Disease progression|3
1115116|NCT01713582|3656127|P13|Overall Study|Disease progression|3
1115117|NCT01713582|3656128|P12|Overall Study|Disease progression|5
1115118|NCT01713582|3656129|P11|Overall Study|Disease progression|10
1115119|NCT01713582|3656130|P10|Overall Study|Disease progression|11
1115120|NCT01713582|3656131|P9|Overall Study|Disease progression|3
1115121|NCT01713582|3656132|P8|Overall Study|Disease progression|3
1115122|NCT01713582|3656133|P7|Overall Study|Disease progression|3
1115123|NCT01713582|3656134|P6|Overall Study|Disease progression|3
1115124|NCT01713582|3656135|P5|Overall Study|Disease progression|3
1115125|NCT01713582|3656136|P4|Overall Study|Disease progression|2
1115126|NCT01713582|3656137|P3|Overall Study|Disease progression|3
1115127|NCT01713582|3656138|P2|Overall Study|Disease progression|3
1115128|NCT01713582|3656139|P1|Overall Study|Disease progression|3
1115129|NCT01713530|3656302|P2|Overall Study|Unclassified|2
1115130|NCT01713530|3656303|P1|Overall Study|Unclassified|4
1115131|NCT01713530|3656302|P2|Overall Study|Withdrawal criteria|12
1115132|NCT01713530|3656303|P1|Overall Study|Withdrawal criteria|21
1115133|NCT01713530|3656302|P2|Overall Study|Adverse Event|5
1115134|NCT01713530|3656303|P1|Overall Study|Adverse Event|0
1115135|NCT01713348|3656334|P4|Overall Study|Lost to Follow-up|0
1115136|NCT01713348|3656335|P3|Overall Study|Lost to Follow-up|0
1115137|NCT01713348|3656336|P2|Overall Study|Lost to Follow-up|0
1115138|NCT01713348|3656337|P1|Overall Study|Lost to Follow-up|1
1115139|NCT01713348|3656334|P4|Overall Study|Withdrawal by Subject|0
1115140|NCT01713348|3656335|P3|Overall Study|Withdrawal by Subject|2
1115141|NCT01713348|3656336|P2|Overall Study|Withdrawal by Subject|2
1115142|NCT01713348|3656337|P1|Overall Study|Withdrawal by Subject|3
1115143|NCT01713283|3656367|P2|Overall Study|Lost to Follow-up|1
1115144|NCT01713283|3656368|P1|Overall Study|Lost to Follow-up|1
1115145|NCT01713283|3656367|P2|Overall Study|Lack of Efficacy|2
1115146|NCT01713283|3656368|P1|Overall Study|Lack of Efficacy|10
1115147|NCT01713036|3656390|P1|Overall Study|Death|1
1115148|NCT01712984|3656430|P3|Overall Study|Withdrawal by Subject|7
1115149|NCT01712984|3656431|P2|Overall Study|Withdrawal by Subject|6
1115150|NCT01712984|3656432|P1|Overall Study|Withdrawal by Subject|6
1115151|NCT01712984|3656430|P3|Overall Study|Lost to Follow-up|1
1115152|NCT01712984|3656431|P2|Overall Study|Lost to Follow-up|10
1115153|NCT01712984|3656432|P1|Overall Study|Lost to Follow-up|8
1115154|NCT01712984|3656430|P3|Overall Study|Protocol Violation|1
1115155|NCT01712984|3656431|P2|Overall Study|Protocol Violation|0
1115156|NCT01712984|3656432|P1|Overall Study|Protocol Violation|2
1115157|NCT01712984|3656430|P3|Overall Study|Adverse Event|1
1115158|NCT01712984|3656431|P2|Overall Study|Adverse Event|0
1115159|NCT01712984|3656432|P1|Overall Study|Adverse Event|0
1115160|NCT01712854|3656452|P1|Overall Study|Physician Decision|1
1115161|NCT01712685|3656475|P1|Overall Study|pt declined to participate before trmt|1
1115162|NCT01712516|3656491|P4|Overall Study|Withdrawal by Subject|9
1115163|NCT01712516|3656492|P3|Overall Study|Withdrawal by Subject|3
1115164|NCT01712516|3656493|P2|Overall Study|Withdrawal by Subject|9
1115165|NCT01712516|3656494|P1|Overall Study|Withdrawal by Subject|3
1115166|NCT01712516|3656491|P4|Overall Study|Physician Decision|1
1115167|NCT01712516|3656492|P3|Overall Study|Physician Decision|0
1115168|NCT01712516|3656493|P2|Overall Study|Physician Decision|0
1115169|NCT01712516|3656494|P1|Overall Study|Physician Decision|2
1115170|NCT01712516|3656491|P4|Overall Study|Protocol deviation|0
1115171|NCT01712516|3656492|P3|Overall Study|Protocol deviation|1
1115172|NCT01712516|3656493|P2|Overall Study|Protocol deviation|0
1115173|NCT01712516|3656494|P1|Overall Study|Protocol deviation|1
1115174|NCT01712516|3656491|P4|Overall Study|Death|0
1115175|NCT01712516|3656492|P3|Overall Study|Death|0
1115176|NCT01712516|3656493|P2|Overall Study|Death|1
1115177|NCT01712516|3656494|P1|Overall Study|Death|0
1115178|NCT01712516|3656491|P4|Overall Study|Lost to Follow-up|1
1115179|NCT01712516|3656492|P3|Overall Study|Lost to Follow-up|2
1115180|NCT01712516|3656493|P2|Overall Study|Lost to Follow-up|0
1115181|NCT01712516|3656494|P1|Overall Study|Lost to Follow-up|0
1115182|NCT01712516|3656491|P4|Overall Study|Technical problems|2
1115183|NCT01712516|3656492|P3|Overall Study|Technical problems|0
1115184|NCT01712516|3656493|P2|Overall Study|Technical problems|0
1115185|NCT01712516|3656494|P1|Overall Study|Technical problems|0
1115186|NCT01712490|3656546|P2|Overall Study|Lost to Follow-up|29
1115187|NCT01712490|3656547|P1|Overall Study|Lost to Follow-up|16
1115188|NCT01712490|3656546|P2|Overall Study|Withdrawal by Subject|44
1115189|NCT01712490|3656547|P1|Overall Study|Withdrawal by Subject|36
1115190|NCT01712490|3656546|P2|Overall Study|Other|11
1115191|NCT01712490|3656547|P1|Overall Study|Other|11
1115192|NCT01712490|3656546|P2|Overall Study|Ongoing|586
1115193|NCT01712490|3656547|P1|Overall Study|Ongoing|601
1115194|NCT01712399|3656584|P1|Overall Study|Study closure|345
1115195|NCT01712399|3656584|P1|Overall Study|Adverse Event|11
1115196|NCT01712399|3656584|P1|Overall Study|Death|1
1115197|NCT01712399|3656584|P1|Overall Study|Withdrawal by Subject|39
1115198|NCT01712399|3656584|P1|Overall Study|Lost to Follow-up|1
1115199|NCT01712334|3656630|P2|Treatment Period 1|Randomized in Error|2
1115200|NCT01712334|3656631|P1|Treatment Period 1|Randomized in Error|0
1115201|NCT01712256|3656639|P1|Overall Study|Lost to Follow-up|1
1115202|NCT01712204|3656650|P2|Overall Study|Protocol Violation|1
1115203|NCT01712204|3656651|P1|Overall Study|Protocol Violation|1
1115204|NCT01712204|3656650|P2|Overall Study|Lost to Follow-up|0
1115205|NCT01712204|3656651|P1|Overall Study|Lost to Follow-up|1
1115206|NCT01712204|3656650|P2|Overall Study|Withdrawal by Subject|3
1115207|NCT01712204|3656651|P1|Overall Study|Withdrawal by Subject|3
1115208|NCT01712204|3656650|P2|Overall Study|Adverse Event|1
1115209|NCT01712204|3656651|P1|Overall Study|Adverse Event|3
1115210|NCT01712178|3656659|P2|Overall Study|Lost to Follow-up|1
1115211|NCT01712178|3656660|P1|Overall Study|Lost to Follow-up|0
1115212|NCT01712178|3656659|P2|Overall Study|Serious adverse event/withdrew consent|1
1115213|NCT01712178|3656660|P1|Overall Study|Serious adverse event/withdrew consent|0
1115214|NCT01712178|3656659|P2|Overall Study|Withdrew consent due to an adverse event|1
1115215|NCT01712178|3656660|P1|Overall Study|Withdrew consent due to an adverse event|1
1115216|NCT01712074|3656685|P3|Double Blind Period|No longer met eligibility criteria|0
1115217|NCT01712074|3656686|P2|Double Blind Period|No longer met eligibility criteria|3
1115218|NCT01712074|3656687|P1|Double Blind Period|No longer met eligibility criteria|0
1115219|NCT01712074|3656685|P3|Double Blind Period|Protocol Violation|1
1115220|NCT01712074|3656686|P2|Double Blind Period|Protocol Violation|0
1115221|NCT01712074|3656687|P1|Double Blind Period|Protocol Violation|0
1115222|NCT01712074|3656685|P3|Double Blind Period|Other|1
1115223|NCT01712074|3656686|P2|Double Blind Period|Other|4
1115224|NCT01712074|3656687|P1|Double Blind Period|Other|0
1115225|NCT01712074|3656685|P3|Double Blind Period|Lost to Follow-up|1
1115226|NCT01712074|3656686|P2|Double Blind Period|Lost to Follow-up|2
1115227|NCT01712074|3656687|P1|Double Blind Period|Lost to Follow-up|0
1115228|NCT01712074|3656685|P3|Double Blind Period|Death|0
1115229|NCT01712074|3656686|P2|Double Blind Period|Death|1
1115230|NCT01712074|3656687|P1|Double Blind Period|Death|0
1115231|NCT01712074|3656685|P3|Double Blind Period|No longer willing to participate|4
1115232|NCT01712074|3656686|P2|Double Blind Period|No longer willing to participate|2
1115233|NCT01712074|3656687|P1|Double Blind Period|No longer willing to participate|0
1115234|NCT01712074|3656685|P3|Double Blind Period|Adverse Event|1
1115235|NCT01712074|3656686|P2|Double Blind Period|Adverse Event|2
1115236|NCT01712074|3656687|P1|Double Blind Period|Adverse Event|0
1115237|NCT01712074|3656685|P3|Placebo Run-in Period|No longer willing to participate|0
1115238|NCT01712074|3656686|P2|Placebo Run-in Period|No longer willing to participate|0
1115239|NCT01712074|3656687|P1|Placebo Run-in Period|No longer willing to participate|1
1115240|NCT01712074|3656685|P3|Placebo Run-in Period|Other|0
1115241|NCT01712074|3656686|P2|Placebo Run-in Period|Other|0
1115242|NCT01712074|3656687|P1|Placebo Run-in Period|Other|1
1115243|NCT01712074|3656685|P3|Placebo Run-in Period|No longer meets eligibility criteria|0
1115244|NCT01712074|3656686|P2|Placebo Run-in Period|No longer meets eligibility criteria|0
1115245|NCT01712074|3656687|P1|Placebo Run-in Period|No longer meets eligibility criteria|5
1115246|NCT01712074|3656685|P3|Placebo Run-in Period|Lost to Follow-up|0
1115247|NCT01712074|3656686|P2|Placebo Run-in Period|Lost to Follow-up|0
1115248|NCT01712074|3656687|P1|Placebo Run-in Period|Lost to Follow-up|1
1115249|NCT01712074|3656685|P3|Placebo Run-in Period|Adverse Event|0
1115250|NCT01712074|3656686|P2|Placebo Run-in Period|Adverse Event|0
1115251|NCT01712074|3656687|P1|Placebo Run-in Period|Adverse Event|2
1115252|NCT01712061|3656743|P3|Overall Study|Other|0
1115253|NCT01712061|3656744|P2|Overall Study|Other|3
1115254|NCT01712061|3656745|P1|Overall Study|Other|0
1115255|NCT01712061|3656743|P3|Overall Study|Withdrawal by Subject|1
1115256|NCT01712061|3656744|P2|Overall Study|Withdrawal by Subject|7
1115257|NCT01712061|3656745|P1|Overall Study|Withdrawal by Subject|1
1115258|NCT01712061|3656743|P3|Overall Study|Medication Error Without Associated AE|0
1115259|NCT01712061|3656744|P2|Overall Study|Medication Error Without Associated AE|1
1115260|NCT01712061|3656745|P1|Overall Study|Medication Error Without Associated AE|0
1115261|NCT01712061|3656743|P3|Overall Study|Did Not Meet Entrance Criteria|3
1115262|NCT01712061|3656744|P2|Overall Study|Did Not Meet Entrance Criteria|6
1115263|NCT01712061|3656745|P1|Overall Study|Did Not Meet Entrance Criteria|4
1115264|NCT01712061|3656743|P3|Overall Study|Lost to Follow-up|1
1115265|NCT01712061|3656744|P2|Overall Study|Lost to Follow-up|0
1115266|NCT01712061|3656745|P1|Overall Study|Lost to Follow-up|1
1115267|NCT01712061|3656743|P3|Overall Study|Death|1
1115268|NCT01712061|3656744|P2|Overall Study|Death|0
1115269|NCT01712061|3656745|P1|Overall Study|Death|0
1115270|NCT01712061|3656743|P3|Overall Study|Adverse Event|5
1115271|NCT01712061|3656744|P2|Overall Study|Adverse Event|9
1115272|NCT01712061|3656745|P1|Overall Study|Adverse Event|4
1115273|NCT01712009|3656785|P3|Overall Study|Decision by Sponsor|12
1115274|NCT01712009|3656786|P2|Overall Study|Decision by Sponsor|14
1115275|NCT01712009|3656787|P1|Overall Study|Decision by Sponsor|12
1115276|NCT01712009|3656785|P3|Overall Study|Lost to Follow-up|1
1115277|NCT01712009|3656786|P2|Overall Study|Lost to Follow-up|0
1115278|NCT01712009|3656787|P1|Overall Study|Lost to Follow-up|2
1115279|NCT01712009|3656785|P3|Overall Study|Withdrawal by Subject|8
1115280|NCT01712009|3656786|P2|Overall Study|Withdrawal by Subject|15
1115281|NCT01712009|3656787|P1|Overall Study|Withdrawal by Subject|24
1115282|NCT01711866|3656821|P1|Overall Study|Adverse Event|2
1115283|NCT01711866|3656821|P1|Overall Study|Withdrawal by Subject|3
1115284|NCT01711866|3656821|P1|Overall Study|Noncompliant|3
1115285|NCT01711853|3656826|P1|Overall Study|Not treated|3
1115286|NCT01711736|3656833|P2|Overall Study|Migrated/moved from study area|1
1115287|NCT01711736|3656834|P1|Overall Study|Migrated/moved from study area|2
1115288|NCT01711736|3656833|P2|Overall Study|Withdrawal by Subject|6
1115289|NCT01711736|3656834|P1|Overall Study|Withdrawal by Subject|6
1115290|NCT01711736|3656833|P2|Overall Study|Lost to Follow-up|1
1115291|NCT01711736|3656834|P1|Overall Study|Lost to Follow-up|4
1115292|NCT01711645|3656862|P1|Overall Study|Physician Decision|5
1115293|NCT01711645|3656862|P1|Overall Study|Lost to Follow-up|6
1115294|NCT01711645|3656862|P1|Overall Study|Withdrawal by Subject|8
1115295|NCT01711619|3656899|P2|Overall Study|Lost to Follow-up|0
1115296|NCT01711619|3656900|P1|Overall Study|Lost to Follow-up|1
1115297|NCT01711619|3656899|P2|Overall Study|Adverse Event|0
1115298|NCT01711619|3656900|P1|Overall Study|Adverse Event|2
1115299|NCT01711619|3656899|P2|Overall Study|Protocol Violation|3
1115300|NCT01711619|3656900|P1|Overall Study|Protocol Violation|2
1115301|NCT01711619|3656899|P2|Overall Study|Withdrawal by Subject|7
1115302|NCT01711619|3656900|P1|Overall Study|Withdrawal by Subject|3
1115303|NCT01711619|3656899|P2|Overall Study|Early study termination|14
1115304|NCT01711619|3656900|P1|Overall Study|Early study termination|10
1115305|NCT01711359|3656922|P3|Treatment Period|Randomized, Not Treated|0
1115306|NCT01711359|3656923|P2|Treatment Period|Randomized, Not Treated|1
1115307|NCT01711359|3656924|P1|Treatment Period|Randomized, Not Treated|3
1115308|NCT01711359|3656922|P3|Treatment Period|Lost to Follow-up|1
1115309|NCT01711359|3656923|P2|Treatment Period|Lost to Follow-up|1
1115310|NCT01711359|3656924|P1|Treatment Period|Lost to Follow-up|1
1115311|NCT01711359|3656922|P3|Treatment Period|Sponsor Decision|0
1115312|NCT01711359|3656923|P2|Treatment Period|Sponsor Decision|0
1115313|NCT01711359|3656924|P1|Treatment Period|Sponsor Decision|1
1115314|NCT01711359|3656922|P3|Treatment Period|Entry Criteria Not Met|0
1115315|NCT01711359|3656923|P2|Treatment Period|Entry Criteria Not Met|0
1115316|NCT01711359|3656924|P1|Treatment Period|Entry Criteria Not Met|1
1115317|NCT01711359|3656922|P3|Treatment Period|Death|0
1115318|NCT01711359|3656923|P2|Treatment Period|Death|0
1115319|NCT01711359|3656924|P1|Treatment Period|Death|3
1115320|NCT01711359|3656922|P3|Treatment Period|Physician Decision|2
1115321|NCT01711359|3656923|P2|Treatment Period|Physician Decision|3
1115322|NCT01711359|3656924|P1|Treatment Period|Physician Decision|4
1115323|NCT01711359|3656922|P3|Treatment Period|Adverse Event|24
1115324|NCT01711359|3656923|P2|Treatment Period|Adverse Event|10
1115325|NCT01711359|3656924|P1|Treatment Period|Adverse Event|8
1115326|NCT01711359|3656922|P3|Treatment Period|Lack of Efficacy|2
1115327|NCT01711359|3656923|P2|Treatment Period|Lack of Efficacy|2
1115328|NCT01711359|3656924|P1|Treatment Period|Lack of Efficacy|13
1115329|NCT01711359|3656922|P3|Treatment Period|Withdrawal by Subject|13
1115330|NCT01711359|3656923|P2|Treatment Period|Withdrawal by Subject|7
1115331|NCT01711359|3656924|P1|Treatment Period|Withdrawal by Subject|18
1115332|NCT01711216|3656995|P1|Overall Study|no reason specified|22
1115333|NCT01711216|3656995|P1|Overall Study|variety of other minor reasons|83
1115334|NCT01711216|3656995|P1|Overall Study|Lost to Follow-up|46
1115335|NCT01711216|3656995|P1|Overall Study|Withdrawal by Subject|6
1115336|NCT01711216|3656995|P1|Overall Study|Pregnancy|56
1115337|NCT01711216|3656995|P1|Overall Study|Adverse Event|4
1115338|NCT01710800|3657054|P1|Overall Study|Protocol Violation|1
1115339|NCT01710800|3657054|P1|Overall Study|Withdrawal by Subject|21
1115340|NCT01710709|3657118|P1|Overall Study|Lack of Efficacy|3
1115341|NCT01710709|3657118|P1|Overall Study|Protocol Violation|5
1115342|NCT01710709|3657118|P1|Overall Study|Withdrawal by Subject|53
1115343|NCT01710709|3657118|P1|Overall Study|Participant withdrawn by investigator|2
1115344|NCT01710709|3657118|P1|Overall Study|Participant met withdrawal criteria|33
1115345|NCT01710709|3657118|P1|Overall Study|Adverse Event|48
1115346|NCT01710709|3657118|P1|Overall Study|Lost to Follow-up|29
1115347|NCT01710657|3657133|P3|Overall Study|Lack of Efficacy|1
1115348|NCT01710657|3657134|P2|Overall Study|Lack of Efficacy|1
1115349|NCT01710657|3657135|P1|Overall Study|Lack of Efficacy|0
1115350|NCT01710657|3657133|P3|Overall Study|Withdrawal by Subject|2
1115351|NCT01710657|3657134|P2|Overall Study|Withdrawal by Subject|1
1115352|NCT01710657|3657135|P1|Overall Study|Withdrawal by Subject|0
1115353|NCT01710657|3657133|P3|Overall Study|Adverse Event|28
1115354|NCT01710657|3657134|P2|Overall Study|Adverse Event|8
1115355|NCT01710657|3657135|P1|Overall Study|Adverse Event|14
1115356|NCT01710657|3657133|P3|Overall Study|Protocol Violation|0
1115357|NCT01710657|3657134|P2|Overall Study|Protocol Violation|2
1115358|NCT01710657|3657135|P1|Overall Study|Protocol Violation|2
1115359|NCT01710657|3657133|P3|Overall Study|Lost to Follow-up|1
1115360|NCT01710657|3657134|P2|Overall Study|Lost to Follow-up|0
1115361|NCT01710657|3657135|P1|Overall Study|Lost to Follow-up|2
1115362|NCT01710527|3657152|P2|Period 2: Washout Period (7 Days)|Personal reasons|1
1115363|NCT01710527|3657153|P1|Period 2: Washout Period (7 Days)|Personal reasons|0
1115364|NCT01710514|3657179|P2|Overall Study|Withdrawal by Subject|0
1115365|NCT01710514|3657180|P1|Overall Study|Withdrawal by Subject|1
1115366|NCT01710514|3657179|P2|Overall Study|Adverse Event|7
1115367|NCT01710514|3657180|P1|Overall Study|Adverse Event|6
1115368|NCT01710501|3657201|P3|Overall Study|Lost to Follow-up|0
1115369|NCT01710501|3657202|P2|Overall Study|Lost to Follow-up|0
1115370|NCT01710501|3657203|P1|Overall Study|Lost to Follow-up|2
1115371|NCT01710358|3657235|P3|Rescue Period|Withdrawal by Subject|0
1115372|NCT01710358|3657236|P2|Rescue Period|Withdrawal by Subject|8
1115373|NCT01710358|3657237|P1|Rescue Period|Withdrawal by Subject|0
1115374|NCT01710358|3657235|P3|Rescue Period|Lack of Efficacy|0
1115375|NCT01710358|3657236|P2|Rescue Period|Lack of Efficacy|7
1115376|NCT01710358|3657237|P1|Rescue Period|Lack of Efficacy|0
1115377|NCT01710358|3657235|P3|Rescue Period|Death|0
1115378|NCT01710358|3657236|P2|Rescue Period|Death|1
1115379|NCT01710358|3657237|P1|Rescue Period|Death|0
1115380|NCT01710358|3657235|P3|Rescue Period|Adverse Event|0
1115381|NCT01710358|3657236|P2|Rescue Period|Adverse Event|15
1115382|NCT01710358|3657237|P1|Rescue Period|Adverse Event|0
1115383|NCT01710358|3657235|P3|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7
1115384|NCT01710358|3657236|P2|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3
1115385|NCT01710358|3657237|P1|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4
1115386|NCT01710358|3657235|P3|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0
1115387|NCT01710358|3657236|P2|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2
1115388|NCT01710358|3657237|P1|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1
1115389|NCT01710358|3657235|P3|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
1115390|NCT01710358|3657236|P2|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1
1115391|NCT01710358|3657237|P1|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
1115392|NCT01710358|3657235|P3|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1
1115393|NCT01710358|3657236|P2|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
1115394|NCT01710358|3657237|P1|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
1115395|NCT01710358|3657235|P3|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1
1115396|NCT01710358|3657236|P2|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
1115397|NCT01710358|3657237|P1|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
1115398|NCT01710358|3657235|P3|Treatment Period Part B (Weeks 24 to 52)|Death|1
1115399|NCT01710358|3657236|P2|Treatment Period Part B (Weeks 24 to 52)|Death|0
1115400|NCT01710358|3657237|P1|Treatment Period Part B (Weeks 24 to 52)|Death|1
1115401|NCT01710358|3657235|P3|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5
1115402|NCT01710358|3657236|P2|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16
1115403|NCT01710358|3657237|P1|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10
1115404|NCT01710358|3657235|P3|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0
1115405|NCT01710358|3657236|P2|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
1115406|NCT01710358|3657237|P1|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
1115407|NCT01710358|3657235|P3|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12
1115408|NCT01710358|3657236|P2|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5
1115409|NCT01710358|3657237|P1|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15
1115410|NCT01710358|3657235|P3|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
1115411|NCT01710358|3657236|P2|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
1115412|NCT01710358|3657237|P1|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4
1115413|NCT01710358|3657235|P3|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
1115414|NCT01710358|3657236|P2|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
1115415|NCT01710358|3657237|P1|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1
1115416|NCT01710358|3657235|P3|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
1115417|NCT01710358|3657236|P2|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1
1115418|NCT01710358|3657237|P1|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
1115419|NCT01710358|3657235|P3|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3
1115420|NCT01710358|3657236|P2|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1
1115421|NCT01710358|3657237|P1|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15
1115422|NCT01710358|3657235|P3|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
1115423|NCT01710358|3657236|P2|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
1115424|NCT01710358|3657237|P1|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0
1115425|NCT01710358|3657235|P3|Treatment Period Part A (Weeks 0 to 24)|Death|0
1115426|NCT01710358|3657236|P2|Treatment Period Part A (Weeks 0 to 24)|Death|2
1115427|NCT01710358|3657237|P1|Treatment Period Part A (Weeks 0 to 24)|Death|0
1115428|NCT01710358|3657235|P3|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7
1115429|NCT01710358|3657236|P2|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18
1115430|NCT01710358|3657237|P1|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15
1115431|NCT01710345|3657308|P3|Overall Study|Drug Dosing Error|0
1115432|NCT01710345|3657309|P2|Overall Study|Drug Dosing Error|0
1115433|NCT01710345|3657310|P1|Overall Study|Drug Dosing Error|1
1115434|NCT01710345|3657308|P3|Overall Study|Lack of Efficacy|1
1115435|NCT01710345|3657309|P2|Overall Study|Lack of Efficacy|3
1115436|NCT01710345|3657310|P1|Overall Study|Lack of Efficacy|2
1115437|NCT01710345|3657308|P3|Overall Study|Adverse Event|0
1115438|NCT01710345|3657309|P2|Overall Study|Adverse Event|2
1115439|NCT01710345|3657310|P1|Overall Study|Adverse Event|0
1115440|NCT01710046|3657337|P2|Overall Study|Lost to Follow-up|0
1115441|NCT01710046|3657338|P1|Overall Study|Lost to Follow-up|1
1115442|NCT01710033|3657378|P5|Stage 2|Adverse Event|1
1115443|NCT01710033|3657379|P4|Stage 2|Adverse Event|0
1115444|NCT01710033|3657380|P3|Stage 2|Adverse Event|0
1115445|NCT01710033|3657381|P2|Stage 2|Adverse Event|0
1115446|NCT01710033|3657382|P1|Stage 2|Adverse Event|0
1115447|NCT01710020|3657463|P1|Period 1|Protocol Violation|1
1115448|NCT01709903|3657482|P2|Overall Study|Adverse Event|18
1115449|NCT01709903|3657483|P1|Overall Study|Adverse Event|11
1115450|NCT01709903|3657482|P2|Overall Study|Withdrawal by Subject|6
1115451|NCT01709903|3657483|P1|Overall Study|Withdrawal by Subject|6
1115452|NCT01709903|3657482|P2|Overall Study|Lack of Efficacy|3
1115453|NCT01709903|3657483|P1|Overall Study|Lack of Efficacy|3
1115454|NCT01709903|3657482|P2|Overall Study|Protocol Violation|2
1115455|NCT01709903|3657483|P1|Overall Study|Protocol Violation|3
1115456|NCT01709903|3657482|P2|Overall Study|Death|0
1115457|NCT01709903|3657483|P1|Overall Study|Death|2
1115458|NCT01709903|3657482|P2|Overall Study|Lost to Follow-up|2
1115459|NCT01709903|3657483|P1|Overall Study|Lost to Follow-up|0
1115460|NCT01709903|3657482|P2|Overall Study|no longer needed study drug|1
1115461|NCT01709903|3657483|P1|Overall Study|no longer needed study drug|0
1115462|NCT01709903|3657482|P2|Overall Study|In ability to use device|1
1115463|NCT01709903|3657483|P1|Overall Study|In ability to use device|1
1115464|NCT01709903|3657482|P2|Overall Study|Abnormal test procedure results|0
1115465|NCT01709903|3657483|P1|Overall Study|Abnormal test procedure results|1
1115466|NCT01709903|3657482|P2|Overall Study|administrative problems|6
1115467|NCT01709903|3657483|P1|Overall Study|administrative problems|2
1115468|NCT01709864|3657507|P2|Overall Study|Death|1
1115469|NCT01709864|3657508|P1|Overall Study|Death|0
1115470|NCT01709864|3657507|P2|Overall Study|Adverse Event|2
1115471|NCT01709864|3657508|P1|Overall Study|Adverse Event|0
1115472|NCT01709864|3657507|P2|Overall Study|non-compliance with study treatment|1
1115473|NCT01709864|3657508|P1|Overall Study|non-compliance with study treatment|1
1115474|NCT01709864|3657507|P2|Overall Study|Lost to Follow-up|0
1115475|NCT01709864|3657508|P1|Overall Study|Lost to Follow-up|1
1115476|NCT01709864|3657507|P2|Overall Study|subject/guardian decision|6
1115477|NCT01709864|3657508|P1|Overall Study|subject/guardian decision|5
1115478|NCT01709864|3657507|P2|Overall Study|Physician Decision|1
1115479|NCT01709864|3657508|P1|Overall Study|Physician Decision|0
1115480|NCT01709708|3657579|P2|Overall Study|Protocol Violation|2
1115481|NCT01709708|3657580|P1|Overall Study|Protocol Violation|1
1115482|NCT01709695|3657604|P2|Overall Study|Withdrawal by Subject|1
1115483|NCT01709695|3657605|P1|Overall Study|Withdrawal by Subject|1
1115484|NCT01709578|3657630|P3|Overall Study|Other, not related to safety or efficacy|5
1115485|NCT01709578|3657631|P2|Overall Study|Other, not related to safety or efficacy|7
1115486|NCT01709578|3657632|P1|Overall Study|Other, not related to safety or efficacy|2
1115487|NCT01709578|3657630|P3|Overall Study|Poor compliance to protocol|1
1115488|NCT01709578|3657631|P2|Overall Study|Poor compliance to protocol|2
1115489|NCT01709578|3657632|P1|Overall Study|Poor compliance to protocol|1
1115490|NCT01709578|3657630|P3|Overall Study|Lack of Efficacy|2
1115491|NCT01709578|3657631|P2|Overall Study|Lack of Efficacy|4
1115492|NCT01709578|3657632|P1|Overall Study|Lack of Efficacy|5
1115493|NCT01709578|3657630|P3|Overall Study|Adverse Event|17
1115494|NCT01709578|3657631|P2|Overall Study|Adverse Event|18
1115495|NCT01709578|3657632|P1|Overall Study|Adverse Event|9
1115496|NCT01709578|3657630|P3|Overall Study|Rescued and entered in long term safety|26
1115497|NCT01709578|3657631|P2|Overall Study|Rescued and entered in long term safety|25
1115498|NCT01709578|3657632|P1|Overall Study|Rescued and entered in long term safety|63
1115499|NCT01709513|3657763|P3|Overall Study|Other|7
1115500|NCT01709513|3657764|P2|Overall Study|Other|11
1115501|NCT01709513|3657765|P1|Overall Study|Other|3
1115502|NCT01709513|3657763|P3|Overall Study|Poor compliance to protocol|0
1115503|NCT01709513|3657764|P2|Overall Study|Poor compliance to protocol|0
1115504|NCT01709513|3657765|P1|Overall Study|Poor compliance to protocol|2
1115505|NCT01709513|3657763|P3|Overall Study|Adverse Event|23
1115506|NCT01709513|3657764|P2|Overall Study|Adverse Event|31
1115507|NCT01709513|3657765|P1|Overall Study|Adverse Event|16
1115508|NCT01709513|3657763|P3|Overall Study|Randomized but not treated|0
1115509|NCT01709513|3657764|P2|Overall Study|Randomized but not treated|1
1115510|NCT01709513|3657765|P1|Overall Study|Randomized but not treated|0
1115511|NCT01709500|3657826|P2|Overall Study|Treatment ongoing|78
1115512|NCT01709500|3657827|P1|Overall Study|Treatment ongoing|156
1115513|NCT01709500|3657826|P2|Overall Study|Related to IMP administration|0
1115514|NCT01709500|3657827|P1|Overall Study|Related to IMP administration|1
1115515|NCT01709500|3657826|P2|Overall Study|Other|1
1115516|NCT01709500|3657827|P1|Overall Study|Other|3
1115517|NCT01709500|3657826|P2|Overall Study|Poor compliance to protocol|1
1115518|NCT01709500|3657827|P1|Overall Study|Poor compliance to protocol|2
1115519|NCT01709500|3657826|P2|Overall Study|Adverse Event|1
1115520|NCT01709500|3657827|P1|Overall Study|Adverse Event|5
1115521|NCT01709500|3657826|P2|Overall Study|Randomized but not treated|1
1115522|NCT01709500|3657827|P1|Overall Study|Randomized but not treated|0
1115523|NCT01709409|3657905|P2|Overall Study|Protocol Violation|0
1115524|NCT01709409|3657906|P1|Overall Study|Protocol Violation|1
1115525|NCT01709383|3657914|P2|Overall Study|Lost to Follow-up|0
1115526|NCT01709383|3657915|P1|Overall Study|Lost to Follow-up|1
1115527|NCT01709331|3657933|P1|Overall Study|Adverse Event|1
1115528|NCT01709305|3657939|P5|Phase 2|Withdrawal by Subject|12
1115529|NCT01709305|3657940|P4|Phase 2|Withdrawal by Subject|15
1115530|NCT01709305|3657941|P3|Phase 2|Withdrawal by Subject|6
1115531|NCT01709305|3657942|P2|Phase 2|Withdrawal by Subject|8
1115532|NCT01709305|3657943|P1|Phase 2|Withdrawal by Subject|0
1115533|NCT01709305|3657939|P5|Phase 2|Protocol Violation|9
1115534|NCT01709305|3657940|P4|Phase 2|Protocol Violation|13
1115535|NCT01709305|3657941|P3|Phase 2|Protocol Violation|19
1115536|NCT01709305|3657942|P2|Phase 2|Protocol Violation|19
1115537|NCT01709305|3657943|P1|Phase 2|Protocol Violation|0
1115538|NCT01709305|3657939|P5|Phase 2|Physician Decision|2
1115539|NCT01709305|3657940|P4|Phase 2|Physician Decision|1
1115540|NCT01709305|3657941|P3|Phase 2|Physician Decision|0
1115541|NCT01709305|3657942|P2|Phase 2|Physician Decision|2
1115542|NCT01709305|3657943|P1|Phase 2|Physician Decision|0
1115543|NCT01709305|3657939|P5|Phase 2|Travel, moving, etc.|5
1115544|NCT01709305|3657940|P4|Phase 2|Travel, moving, etc.|3
1115545|NCT01709305|3657941|P3|Phase 2|Travel, moving, etc.|3
1115546|NCT01709305|3657942|P2|Phase 2|Travel, moving, etc.|2
1115547|NCT01709305|3657943|P1|Phase 2|Travel, moving, etc.|0
1115548|NCT01709305|3657939|P5|Phase 2|Lost to Follow-up|5
1115549|NCT01709305|3657940|P4|Phase 2|Lost to Follow-up|9
1115550|NCT01709305|3657941|P3|Phase 2|Lost to Follow-up|6
1115551|NCT01709305|3657942|P2|Phase 2|Lost to Follow-up|10
1115552|NCT01709305|3657943|P1|Phase 2|Lost to Follow-up|0
1115553|NCT01709305|3657939|P5|Phase 2|Laboratory Adverse Event|1
1115554|NCT01709305|3657940|P4|Phase 2|Laboratory Adverse Event|1
1115555|NCT01709305|3657941|P3|Phase 2|Laboratory Adverse Event|0
1115556|NCT01709305|3657942|P2|Phase 2|Laboratory Adverse Event|1
1115557|NCT01709305|3657943|P1|Phase 2|Laboratory Adverse Event|0
1115558|NCT01709305|3657939|P5|Phase 2|Hyperglycemia (lack of efficacy)|2
1115559|NCT01709305|3657940|P4|Phase 2|Hyperglycemia (lack of efficacy)|0
1115560|NCT01709305|3657941|P3|Phase 2|Hyperglycemia (lack of efficacy)|0
1115561|NCT01709305|3657942|P2|Phase 2|Hyperglycemia (lack of efficacy)|0
1115562|NCT01709305|3657943|P1|Phase 2|Hyperglycemia (lack of efficacy)|0
1115563|NCT01709305|3657939|P5|Phase 2|Death|0
1115564|NCT01709305|3657940|P4|Phase 2|Death|0
1115565|NCT01709305|3657941|P3|Phase 2|Death|1
1115566|NCT01709305|3657942|P2|Phase 2|Death|0
1115567|NCT01709305|3657943|P1|Phase 2|Death|0
1115568|NCT01709305|3657939|P5|Phase 2|Clinical Adverse Event|11
1115569|NCT01709305|3657940|P4|Phase 2|Clinical Adverse Event|6
1115570|NCT01709305|3657941|P3|Phase 2|Clinical Adverse Event|10
1115571|NCT01709305|3657942|P2|Phase 2|Clinical Adverse Event|10
1115572|NCT01709305|3657943|P1|Phase 2|Clinical Adverse Event|0
1115573|NCT01709305|3657939|P5|Phase 1|Withdrawal by Subject|0
1115574|NCT01709305|3657940|P4|Phase 1|Withdrawal by Subject|0
1115575|NCT01709305|3657941|P3|Phase 1|Withdrawal by Subject|0
1115576|NCT01709305|3657942|P2|Phase 1|Withdrawal by Subject|0
1115577|NCT01709305|3657943|P1|Phase 1|Withdrawal by Subject|218
1115578|NCT01709305|3657939|P5|Phase 1|Protocol Violation|0
1115579|NCT01709305|3657940|P4|Phase 1|Protocol Violation|0
1115580|NCT01709305|3657941|P3|Phase 1|Protocol Violation|0
1115581|NCT01709305|3657942|P2|Phase 1|Protocol Violation|0
1115582|NCT01709305|3657943|P1|Phase 1|Protocol Violation|118
1115583|NCT01709305|3657939|P5|Phase 1|Physician Decision|0
1115584|NCT01709305|3657940|P4|Phase 1|Physician Decision|0
1115585|NCT01709305|3657941|P3|Phase 1|Physician Decision|0
1115586|NCT01709305|3657942|P2|Phase 1|Physician Decision|0
1115587|NCT01709305|3657943|P1|Phase 1|Physician Decision|13
1115588|NCT01709305|3657939|P5|Phase 1|Travel, moving, etc.|0
1115589|NCT01709305|3657940|P4|Phase 1|Travel, moving, etc.|0
1115590|NCT01709305|3657941|P3|Phase 1|Travel, moving, etc.|0
1115591|NCT01709305|3657942|P2|Phase 1|Travel, moving, etc.|0
1115592|NCT01709305|3657943|P1|Phase 1|Travel, moving, etc.|30
1115593|NCT01709305|3657939|P5|Phase 1|Lost to Follow-up|0
1115594|NCT01709305|3657940|P4|Phase 1|Lost to Follow-up|0
1115595|NCT01709305|3657941|P3|Phase 1|Lost to Follow-up|0
1115596|NCT01709305|3657942|P2|Phase 1|Lost to Follow-up|0
1115597|NCT01709305|3657943|P1|Phase 1|Lost to Follow-up|147
1115598|NCT01709305|3657939|P5|Phase 1|Laboratory Adverse Event|0
1115599|NCT01709305|3657940|P4|Phase 1|Laboratory Adverse Event|0
1115600|NCT01709305|3657941|P3|Phase 1|Laboratory Adverse Event|0
1115601|NCT01709305|3657942|P2|Phase 1|Laboratory Adverse Event|0
1115602|NCT01709305|3657943|P1|Phase 1|Laboratory Adverse Event|16
1115603|NCT01709305|3657939|P5|Phase 1|Hyperglycemia (lack of efficacy)|0
1115604|NCT01709305|3657940|P4|Phase 1|Hyperglycemia (lack of efficacy)|0
1115605|NCT01709305|3657941|P3|Phase 1|Hyperglycemia (lack of efficacy)|0
1115606|NCT01709305|3657942|P2|Phase 1|Hyperglycemia (lack of efficacy)|0
1115607|NCT01709305|3657943|P1|Phase 1|Hyperglycemia (lack of efficacy)|13
1115608|NCT01709305|3657939|P5|Phase 1|Death|0
1115609|NCT01709305|3657940|P4|Phase 1|Death|0
1115610|NCT01709305|3657941|P3|Phase 1|Death|0
1115611|NCT01709305|3657942|P2|Phase 1|Death|0
1115612|NCT01709305|3657943|P1|Phase 1|Death|2
1115613|NCT01709305|3657939|P5|Phase 1|Clinical Adverse Event|0
1115614|NCT01709305|3657940|P4|Phase 1|Clinical Adverse Event|0
1115615|NCT01709305|3657941|P3|Phase 1|Clinical Adverse Event|0
1115616|NCT01709305|3657942|P2|Phase 1|Clinical Adverse Event|0
1115617|NCT01709305|3657943|P1|Phase 1|Clinical Adverse Event|80
1115618|NCT01709227|3657980|P2|Overall Study|Pleural Peritoneal communication|9
1115619|NCT01709227|3657981|P1|Overall Study|Pleural Peritoneal communication|0
1115620|NCT01709227|3657980|P2|Overall Study|Physician Decision|0
1115621|NCT01709227|3657981|P1|Overall Study|Physician Decision|1
1115622|NCT01709162|3658007|P2|Overall Study|Withdrawal by Subject|1
1115623|NCT01709162|3658008|P1|Overall Study|Withdrawal by Subject|0
1115624|NCT01709162|3658007|P2|Overall Study|Not specified|0
1115625|NCT01709162|3658008|P1|Overall Study|Not specified|1
1115626|NCT01709162|3658007|P2|Overall Study|Administrative reason by sponsor|1
1115627|NCT01709162|3658008|P1|Overall Study|Administrative reason by sponsor|0
1115628|NCT01709162|3658007|P2|Overall Study|Study drug toxicity|0
1115629|NCT01709162|3658008|P1|Overall Study|Study drug toxicity|2
1115630|NCT01709162|3658007|P2|Overall Study|Disease progression|3
1115631|NCT01709162|3658008|P1|Overall Study|Disease progression|3
1115632|NCT01709110|3658029|P2|Overall Study|Caregiver Decision|1
1115633|NCT01709110|3658030|P1|Overall Study|Caregiver Decision|1
1115634|NCT01709110|3658029|P2|Overall Study|Lack of Efficacy|1
1115635|NCT01709110|3658030|P1|Overall Study|Lack of Efficacy|1
1115636|NCT01709110|3658029|P2|Overall Study|Sponsor Decision|2
1115637|NCT01709110|3658030|P1|Overall Study|Sponsor Decision|2
1115638|NCT01709110|3658029|P2|Overall Study|Physician Decision|10
1115639|NCT01709110|3658030|P1|Overall Study|Physician Decision|4
1115640|NCT01709110|3658029|P2|Overall Study|Withdrawal by Subject|89
1115641|NCT01709110|3658030|P1|Overall Study|Withdrawal by Subject|96
1115642|NCT01709110|3658029|P2|Overall Study|Protocol Violation|6
1115643|NCT01709110|3658030|P1|Overall Study|Protocol Violation|4
1115644|NCT01709110|3658029|P2|Overall Study|Lost to Follow-up|5
1115645|NCT01709110|3658030|P1|Overall Study|Lost to Follow-up|7
1115646|NCT01709110|3658029|P2|Overall Study|Death|6
1115647|NCT01709110|3658030|P1|Overall Study|Death|14
1115648|NCT01709110|3658029|P2|Overall Study|Adverse Event|48
1115649|NCT01709110|3658030|P1|Overall Study|Adverse Event|56
1115650|NCT01709084|3658060|P2|Overall Study|Not Treated|2
1115651|NCT01709084|3658061|P1|Overall Study|Not Treated|0
1115652|NCT01709084|3658060|P2|Overall Study|Participant Reached a Virologic Endpoint|1
1115653|NCT01709084|3658061|P1|Overall Study|Participant Reached a Virologic Endpoint|0
1115654|NCT01709084|3658060|P2|Overall Study|Other|3
1115655|NCT01709084|3658061|P1|Overall Study|Other|5
1115656|NCT01709084|3658060|P2|Overall Study|Adverse Event|0
1115657|NCT01709084|3658061|P1|Overall Study|Adverse Event|5
1115658|NCT01709084|3658060|P2|Overall Study|Withdrawal by Subject|2
1115659|NCT01709084|3658061|P1|Overall Study|Withdrawal by Subject|2
1115660|NCT01709084|3658060|P2|Overall Study|Lost to Follow-up|7
1115661|NCT01709084|3658061|P1|Overall Study|Lost to Follow-up|4
1115662|NCT01708954|3658089|P3|Step 2|Withdrawal by Subject|0
1115663|NCT01708954|3658090|P2|Step 2|Withdrawal by Subject|1
1115664|NCT01708954|3658091|P1|Step 2|Withdrawal by Subject|1
1115665|NCT01708954|3658089|P3|Step 2|Adverse Event|0
1115666|NCT01708954|3658090|P2|Step 2|Adverse Event|2
1115667|NCT01708954|3658091|P1|Step 2|Adverse Event|3
1115668|NCT01708954|3658089|P3|Step 2|Disease progression|0
1115669|NCT01708954|3658090|P2|Step 2|Disease progression|4
1115670|NCT01708954|3658091|P1|Step 2|Disease progression|9
1115671|NCT01708954|3658089|P3|Step 1|Ineligible or never received treatment|8
1115672|NCT01708954|3658090|P2|Step 1|Ineligible or never received treatment|2
1115673|NCT01708954|3658091|P1|Step 1|Ineligible or never received treatment|4
1115674|NCT01708954|3658089|P3|Step 1|Off-treatment reason not submitted|1
1115675|NCT01708954|3658090|P2|Step 1|Off-treatment reason not submitted|1
1115676|NCT01708954|3658091|P1|Step 1|Off-treatment reason not submitted|1
1115677|NCT01708954|3658089|P3|Step 1|Symptomatic deterioration|1
1115678|NCT01708954|3658090|P2|Step 1|Symptomatic deterioration|0
1115679|NCT01708954|3658091|P1|Step 1|Symptomatic deterioration|1
1115680|NCT01708954|3658089|P3|Step 1|Crossed over to Step 2|0
1115681|NCT01708954|3658090|P2|Step 1|Crossed over to Step 2|0
1115682|NCT01708954|3658091|P1|Step 1|Crossed over to Step 2|2
1115683|NCT01708954|3658089|P3|Step 1|Other complicating disease|0
1115684|NCT01708954|3658090|P2|Step 1|Other complicating disease|2
1115685|NCT01708954|3658091|P1|Step 1|Other complicating disease|0
1115686|NCT01708954|3658089|P3|Step 1|Withdrawal by Subject|3
1115687|NCT01708954|3658090|P2|Step 1|Withdrawal by Subject|5
1115688|NCT01708954|3658091|P1|Step 1|Withdrawal by Subject|2
1115689|NCT01708954|3658089|P3|Step 1|Death|3
1115690|NCT01708954|3658090|P2|Step 1|Death|2
1115691|NCT01708954|3658091|P1|Step 1|Death|3
1115692|NCT01708954|3658089|P3|Step 1|Adverse Event|13
1115693|NCT01708954|3658090|P2|Step 1|Adverse Event|11
1115694|NCT01708954|3658091|P1|Step 1|Adverse Event|3
1115695|NCT01708954|3658089|P3|Step 1|Disease progression|14
1115696|NCT01708954|3658090|P2|Step 1|Disease progression|17
1115697|NCT01708954|3658091|P1|Step 1|Disease progression|26
1115698|NCT01708915|3658116|P4|Overall Study|Other reasons than stated above|2
1115699|NCT01708915|3658117|P3|Overall Study|Other reasons than stated above|0
1115700|NCT01708915|3658118|P2|Overall Study|Other reasons than stated above|1
1115701|NCT01708915|3658119|P1|Overall Study|Other reasons than stated above|1
1115702|NCT01708915|3658116|P4|Overall Study|Withdrawal by Subject|2
1115703|NCT01708915|3658117|P3|Overall Study|Withdrawal by Subject|2
1115704|NCT01708915|3658118|P2|Overall Study|Withdrawal by Subject|1
1115705|NCT01708915|3658119|P1|Overall Study|Withdrawal by Subject|0
1115706|NCT01708915|3658116|P4|Overall Study|Protocol Violation|1
1115707|NCT01708915|3658117|P3|Overall Study|Protocol Violation|0
1115708|NCT01708915|3658118|P2|Overall Study|Protocol Violation|0
1115709|NCT01708915|3658119|P1|Overall Study|Protocol Violation|0
1115710|NCT01708915|3658116|P4|Overall Study|Lack of Efficacy|15
1115711|NCT01708915|3658117|P3|Overall Study|Lack of Efficacy|35
1115712|NCT01708915|3658118|P2|Overall Study|Lack of Efficacy|60
1115713|NCT01708915|3658119|P1|Overall Study|Lack of Efficacy|84
1115714|NCT01708915|3658116|P4|Overall Study|Adverse Event|13
1115715|NCT01708915|3658117|P3|Overall Study|Adverse Event|9
1115716|NCT01708915|3658118|P2|Overall Study|Adverse Event|0
1115717|NCT01708915|3658119|P1|Overall Study|Adverse Event|1
1115718|NCT01708902|3658148|P7|Overall Study|Other Reason|0
1115719|NCT01708902|3658149|P6|Overall Study|Other Reason|2
1115720|NCT01708902|3658150|P5|Overall Study|Other Reason|1
1115721|NCT01708902|3658151|P4|Overall Study|Other Reason|1
1115722|NCT01708902|3658152|P3|Overall Study|Other Reason|1
1115723|NCT01708902|3658153|P2|Overall Study|Other Reason|0
1115724|NCT01708902|3658154|P1|Overall Study|Other Reason|1
1115725|NCT01708902|3658148|P7|Overall Study|Refused to continue trial medication|1
1115726|NCT01708902|3658149|P6|Overall Study|Refused to continue trial medication|1
1115727|NCT01708902|3658150|P5|Overall Study|Refused to continue trial medication|8
1115728|NCT01708902|3658151|P4|Overall Study|Refused to continue trial medication|2
1115729|NCT01708902|3658152|P3|Overall Study|Refused to continue trial medication|4
1115730|NCT01708902|3658153|P2|Overall Study|Refused to continue trial medication|0
1115731|NCT01708902|3658154|P1|Overall Study|Refused to continue trial medication|8
1115732|NCT01708902|3658148|P7|Overall Study|Lost to Follow-up|1
1115733|NCT01708902|3658149|P6|Overall Study|Lost to Follow-up|0
1115734|NCT01708902|3658150|P5|Overall Study|Lost to Follow-up|0
1115735|NCT01708902|3658151|P4|Overall Study|Lost to Follow-up|2
1115736|NCT01708902|3658152|P3|Overall Study|Lost to Follow-up|2
1115737|NCT01708902|3658153|P2|Overall Study|Lost to Follow-up|1
1115738|NCT01708902|3658154|P1|Overall Study|Lost to Follow-up|2
1115739|NCT01708902|3658148|P7|Overall Study|Non compliance with protocol|0
1115740|NCT01708902|3658149|P6|Overall Study|Non compliance with protocol|0
1115741|NCT01708902|3658150|P5|Overall Study|Non compliance with protocol|0
1115742|NCT01708902|3658151|P4|Overall Study|Non compliance with protocol|3
1115743|NCT01708902|3658152|P3|Overall Study|Non compliance with protocol|1
1115744|NCT01708902|3658153|P2|Overall Study|Non compliance with protocol|2
1115745|NCT01708902|3658154|P1|Overall Study|Non compliance with protocol|0
1115746|NCT01708902|3658148|P7|Overall Study|Lack of Efficacy|0
1115747|NCT01708902|3658149|P6|Overall Study|Lack of Efficacy|1
1115748|NCT01708902|3658150|P5|Overall Study|Lack of Efficacy|0
1115749|NCT01708902|3658151|P4|Overall Study|Lack of Efficacy|0
1115750|NCT01708902|3658152|P3|Overall Study|Lack of Efficacy|0
1115751|NCT01708902|3658153|P2|Overall Study|Lack of Efficacy|1
1115752|NCT01708902|3658154|P1|Overall Study|Lack of Efficacy|3
1115753|NCT01708902|3658148|P7|Overall Study|Adverse Event|5
1115754|NCT01708902|3658149|P6|Overall Study|Adverse Event|3
1115755|NCT01708902|3658150|P5|Overall Study|Adverse Event|7
1115756|NCT01708902|3658151|P4|Overall Study|Adverse Event|2
1115757|NCT01708902|3658152|P3|Overall Study|Adverse Event|9
1115758|NCT01708902|3658153|P2|Overall Study|Adverse Event|4
1115759|NCT01708902|3658154|P1|Overall Study|Adverse Event|3
1115760|NCT01708291|3658227|P2|Overall Study|fighting|1
1115761|NCT01708291|3658228|P1|Overall Study|fighting|2
1115762|NCT01708187|3658267|P2|Overall Study|Lost to Follow-up|1
1115763|NCT01708187|3658268|P1|Overall Study|Lost to Follow-up|0
1115764|NCT01708174|3658277|P3|Treatment Period|Adverse Event|0
1115765|NCT01708174|3658278|P2|Treatment Period|Adverse Event|1
1115766|NCT01708174|3658279|P1|Treatment Period|Adverse Event|0
1115767|NCT01708174|3658277|P3|Treatment Period|Death|1
1115768|NCT01708174|3658278|P2|Treatment Period|Death|0
1115769|NCT01708174|3658279|P1|Treatment Period|Death|0
1115770|NCT01708174|3658277|P3|Treatment Period|Progressive disease|0
1115771|NCT01708174|3658278|P2|Treatment Period|Progressive disease|1
1115772|NCT01708174|3658279|P1|Treatment Period|Progressive disease|0
1115773|NCT01708174|3658277|P3|Treatment Period|Withdrawal by Subject|0
1115774|NCT01708174|3658278|P2|Treatment Period|Withdrawal by Subject|0
1115775|NCT01708174|3658279|P1|Treatment Period|Withdrawal by Subject|1
1115776|NCT01708161|3658311|P6|Overall Study|Disease progression|0
1115777|NCT01708161|3658312|P5|Overall Study|Disease progression|3
1115778|NCT01708161|3658313|P4|Overall Study|Disease progression|13
1115779|NCT01708161|3658314|P3|Overall Study|Disease progression|5
1115780|NCT01708161|3658315|P2|Overall Study|Disease progression|5
1115781|NCT01708161|3658316|P1|Overall Study|Disease progression|3
1115782|NCT01708161|3658311|P6|Overall Study|Administrative problems|0
1115783|NCT01708161|3658312|P5|Overall Study|Administrative problems|0
1115784|NCT01708161|3658313|P4|Overall Study|Administrative problems|0
1115785|NCT01708161|3658314|P3|Overall Study|Administrative problems|0
1115786|NCT01708161|3658315|P2|Overall Study|Administrative problems|1
1115787|NCT01708161|3658316|P1|Overall Study|Administrative problems|0
1115788|NCT01708161|3658311|P6|Overall Study|Withdrawal by Subject|0
1115789|NCT01708161|3658312|P5|Overall Study|Withdrawal by Subject|0
1115790|NCT01708161|3658313|P4|Overall Study|Withdrawal by Subject|0
1115791|NCT01708161|3658314|P3|Overall Study|Withdrawal by Subject|1
1115792|NCT01708161|3658315|P2|Overall Study|Withdrawal by Subject|1
1115793|NCT01708161|3658316|P1|Overall Study|Withdrawal by Subject|0
1115794|NCT01708161|3658311|P6|Overall Study|Death|1
1115795|NCT01708161|3658312|P5|Overall Study|Death|0
1115796|NCT01708161|3658313|P4|Overall Study|Death|1
1115797|NCT01708161|3658314|P3|Overall Study|Death|0
1115798|NCT01708161|3658315|P2|Overall Study|Death|0
1115799|NCT01708161|3658316|P1|Overall Study|Death|0
1115800|NCT01708161|3658311|P6|Overall Study|Adverse Event|0
1115801|NCT01708161|3658312|P5|Overall Study|Adverse Event|3
1115802|NCT01708161|3658313|P4|Overall Study|Adverse Event|2
1115803|NCT01708161|3658314|P3|Overall Study|Adverse Event|4
1115804|NCT01708161|3658315|P2|Overall Study|Adverse Event|3
1115805|NCT01708161|3658316|P1|Overall Study|Adverse Event|1
1115806|NCT01708057|3658367|P3|Overall Study|Withdrawal due to study termination.|1
1115807|NCT01708057|3658368|P2|Overall Study|Withdrawal due to study termination.|1
1115808|NCT01708057|3658369|P1|Overall Study|Withdrawal due to study termination.|1
1115809|NCT01707667|3658427|P2|Period 1|expulsion of colonic sensor catheter|0
1115810|NCT01707667|3658428|P1|Period 1|expulsion of colonic sensor catheter|1
1115811|NCT01707290|3658470|P2|Overall Study|Other unspecified|0
1115812|NCT01707290|3658471|P1|Overall Study|Other unspecified|17
1115813|NCT01707290|3658470|P2|Overall Study|Commercial drug available|1
1115814|NCT01707290|3658471|P1|Overall Study|Commercial drug available|60
1115815|NCT01707290|3658470|P2|Overall Study|Withdrawal of Consent (Not Due to AE)|0
1115816|NCT01707290|3658471|P1|Overall Study|Withdrawal of Consent (Not Due to AE)|4
1115817|NCT01707290|3658470|P2|Overall Study|Lost to Follow-up|0
1115818|NCT01707290|3658471|P1|Overall Study|Lost to Follow-up|3
1115819|NCT01707290|3658470|P2|Overall Study|Physician Decision|0
1115820|NCT01707290|3658471|P1|Overall Study|Physician Decision|1
1115821|NCT01707290|3658470|P2|Overall Study|Adverse event (AE)|0
1115822|NCT01707290|3658471|P1|Overall Study|Adverse event (AE)|1
1115823|NCT01706926|3658565|P4|Overall Study|Other|3
1115824|NCT01706926|3658566|P3|Overall Study|Other|4
1115825|NCT01706926|3658567|P2|Overall Study|Other|4
1115826|NCT01706926|3658568|P1|Overall Study|Other|4
1115827|NCT01706926|3658565|P4|Overall Study|Withdrawal by Subject|2
1115828|NCT01706926|3658566|P3|Overall Study|Withdrawal by Subject|1
1115829|NCT01706926|3658567|P2|Overall Study|Withdrawal by Subject|0
1115830|NCT01706926|3658568|P1|Overall Study|Withdrawal by Subject|2
1115831|NCT01706926|3658565|P4|Overall Study|Lost to Follow-up|0
1115832|NCT01706926|3658566|P3|Overall Study|Lost to Follow-up|1
1115833|NCT01706926|3658567|P2|Overall Study|Lost to Follow-up|0
1115834|NCT01706926|3658568|P1|Overall Study|Lost to Follow-up|0
1115835|NCT01706770|3658687|P2|Overall Study|Physician Decision|0
1115836|NCT01706770|3658688|P1|Overall Study|Physician Decision|1
1115837|NCT01706770|3658687|P2|Overall Study|Lost to Follow-up|0
1115838|NCT01706770|3658688|P1|Overall Study|Lost to Follow-up|1
1115839|NCT01706575|3658736|P1|Overall Study|Started but not Treated|6
1115840|NCT01706575|3658736|P1|Overall Study|Lost to Follow-up|2
1115841|NCT01706575|3658736|P1|Overall Study|Participant Withdrew Consent|4
1115842|NCT01706536|3658757|P5|Overall Study|non compliance|0
1115843|NCT01706536|3658758|P4|Overall Study|non compliance|0
1115844|NCT01706536|3658759|P3|Overall Study|non compliance|0
1115845|NCT01706536|3658760|P2|Overall Study|non compliance|1
1115846|NCT01706536|3658761|P1|Overall Study|non compliance|0
1115847|NCT01706536|3658757|P5|Overall Study|Lack of Efficacy|0
1115848|NCT01706536|3658758|P4|Overall Study|Lack of Efficacy|1
1115849|NCT01706536|3658759|P3|Overall Study|Lack of Efficacy|0
1115850|NCT01706536|3658760|P2|Overall Study|Lack of Efficacy|0
1115851|NCT01706536|3658761|P1|Overall Study|Lack of Efficacy|1
1115852|NCT01706536|3658757|P5|Overall Study|Adverse Event|2
1115853|NCT01706536|3658758|P4|Overall Study|Adverse Event|3
1115854|NCT01706536|3658759|P3|Overall Study|Adverse Event|4
1115855|NCT01706536|3658760|P2|Overall Study|Adverse Event|3
1115856|NCT01706536|3658761|P1|Overall Study|Adverse Event|2
1115857|NCT01706536|3658757|P5|Overall Study|Withdrawal by Subject|0
1115858|NCT01706536|3658758|P4|Overall Study|Withdrawal by Subject|0
1115859|NCT01706536|3658759|P3|Overall Study|Withdrawal by Subject|1
1115860|NCT01706536|3658760|P2|Overall Study|Withdrawal by Subject|0
1115861|NCT01706536|3658761|P1|Overall Study|Withdrawal by Subject|1
1115862|NCT01706458|3658820|P2|Overall Study|Physician Decision|4
1115863|NCT01706458|3658821|P1|Overall Study|Physician Decision|3
1115864|NCT01706328|3658845|P3|12-week Double-blind Treatment Period|Withdrawal by Subject|11
1115865|NCT01706328|3658846|P2|12-week Double-blind Treatment Period|Withdrawal by Subject|8
1115866|NCT01706328|3658847|P1|12-week Double-blind Treatment Period|Withdrawal by Subject|0
1115867|NCT01706328|3658845|P3|12-week Double-blind Treatment Period|Physician Decision|2
1115868|NCT01706328|3658846|P2|12-week Double-blind Treatment Period|Physician Decision|2
1115869|NCT01706328|3658847|P1|12-week Double-blind Treatment Period|Physician Decision|0
1115870|NCT01706328|3658845|P3|12-week Double-blind Treatment Period|Lost to Follow-up|1
1115871|NCT01706328|3658846|P2|12-week Double-blind Treatment Period|Lost to Follow-up|3
1115872|NCT01706328|3658847|P1|12-week Double-blind Treatment Period|Lost to Follow-up|0
1115873|NCT01706328|3658845|P3|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9
1115874|NCT01706328|3658846|P2|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11
1115875|NCT01706328|3658847|P1|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0
1115876|NCT01706328|3658845|P3|12-week Double-blind Treatment Period|Protocol Violation|2
1115877|NCT01706328|3658846|P2|12-week Double-blind Treatment Period|Protocol Violation|4
1115878|NCT01706328|3658847|P1|12-week Double-blind Treatment Period|Protocol Violation|0
1115879|NCT01706328|3658845|P3|12-week Double-blind Treatment Period|Lack of Efficacy|4
1115880|NCT01706328|3658846|P2|12-week Double-blind Treatment Period|Lack of Efficacy|4
1115881|NCT01706328|3658847|P1|12-week Double-blind Treatment Period|Lack of Efficacy|0
1115882|NCT01706328|3658845|P3|12-week Double-blind Treatment Period|Adverse Event|16
1115883|NCT01706328|3658846|P2|12-week Double-blind Treatment Period|Adverse Event|14
1115884|NCT01706328|3658847|P1|12-week Double-blind Treatment Period|Adverse Event|0
1115885|NCT01706328|3658845|P3|2-week Run-in Period|Lost to Follow-up|0
1115886|NCT01706328|3658846|P2|2-week Run-in Period|Lost to Follow-up|0
1115887|NCT01706328|3658847|P1|2-week Run-in Period|Lost to Follow-up|2
1115888|NCT01706328|3658845|P3|2-week Run-in Period|Adverse Event|0
1115889|NCT01706328|3658846|P2|2-week Run-in Period|Adverse Event|0
1115890|NCT01706328|3658847|P1|2-week Run-in Period|Adverse Event|4
1115891|NCT01706328|3658845|P3|2-week Run-in Period|Physician Decision|0
1115892|NCT01706328|3658846|P2|2-week Run-in Period|Physician Decision|0
1115893|NCT01706328|3658847|P1|2-week Run-in Period|Physician Decision|4
1115894|NCT01706328|3658845|P3|2-week Run-in Period|Withdrawal by Subject|0
1115895|NCT01706328|3658846|P2|2-week Run-in Period|Withdrawal by Subject|0
1115896|NCT01706328|3658847|P1|2-week Run-in Period|Withdrawal by Subject|15
1115897|NCT01706328|3658845|P3|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
1115898|NCT01706328|3658846|P2|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
1115899|NCT01706328|3658847|P1|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140
1115900|NCT01706250|3658866|P1|Overall Study|Lost to Follow-up|2
1115901|NCT01706159|3658897|P2|Overall Study|Unclassified|1
1115902|NCT01706159|3658898|P1|Overall Study|Unclassified|6
1115903|NCT01706159|3658897|P2|Overall Study|Withdrawal Criteria|1
1115904|NCT01706159|3658898|P1|Overall Study|Withdrawal Criteria|2
1115905|NCT01706146|3658912|P1|Overall Study|Developed AF and need for antiplatelets|2
1115906|NCT01706146|3658912|P1|Overall Study|Adverse Event|3
1115907|NCT01706146|3658912|P1|Overall Study|Withdrawal by Subject|1
1115908|NCT01705730|3658917|P1|Overall Study|Reason not Specified|4
1115909|NCT01705730|3658917|P1|Overall Study|Lost to Follow-up|1
1115910|NCT01705730|3658917|P1|Overall Study|Adverse Event|3
1115911|NCT01705730|3658917|P1|Overall Study|Lack of Efficacy|1
1115912|NCT01705717|3658957|P2|Overall Study|Not Specified|2
1115913|NCT01705717|3658958|P1|Overall Study|Not Specified|0
1115914|NCT01705717|3658957|P2|Overall Study|Lack of Efficacy|1
1115915|NCT01705717|3658958|P1|Overall Study|Lack of Efficacy|0
1115916|NCT01705717|3658957|P2|Overall Study|Adverse Event|2
1115917|NCT01705717|3658958|P1|Overall Study|Adverse Event|2
1115918|NCT01705691|3658975|P2|Overall Study|Other|1
1115919|NCT01705691|3658976|P1|Overall Study|Other|0
1115920|NCT01705691|3658975|P2|Overall Study|Lost to Follow-up|1
1115921|NCT01705691|3658976|P1|Overall Study|Lost to Follow-up|1
1115922|NCT01705691|3658975|P2|Overall Study|Withdrawal by Subject|2
1115923|NCT01705691|3658976|P1|Overall Study|Withdrawal by Subject|1
1115924|NCT01705691|3658975|P2|Overall Study|Death|2
1115925|NCT01705691|3658976|P1|Overall Study|Death|1
1115926|NCT01705652|3658996|P2|Overall Study|non-compliance|1
1115927|NCT01705652|3658997|P1|Overall Study|non-compliance|1
1115928|NCT01705652|3658996|P2|Overall Study|Withdrawal by Subject|2
1115929|NCT01705652|3658997|P1|Overall Study|Withdrawal by Subject|1
1115930|NCT01705652|3658996|P2|Overall Study|Adverse Event|0
1115931|NCT01705652|3658997|P1|Overall Study|Adverse Event|1
1115932|NCT01705587|3659005|P2|Overall Study|Withdrawal by Subject|1
1115933|NCT01705587|3659006|P1|Overall Study|Withdrawal by Subject|0
1115934|NCT01705574|3659024|P2|Overall Study|Still on Study|125
1115935|NCT01705574|3659025|P1|Overall Study|Still on Study|135
1115936|NCT01705574|3659024|P2|Overall Study|Lost to Follow-up|15
1115937|NCT01705574|3659025|P1|Overall Study|Lost to Follow-up|11
1115938|NCT01705574|3659024|P2|Overall Study|Withdrew Consent|5
1115939|NCT01705574|3659025|P1|Overall Study|Withdrew Consent|8
1115940|NCT01705574|3659024|P2|Overall Study|Protocol Violation|0
1115941|NCT01705574|3659025|P1|Overall Study|Protocol Violation|1
1115942|NCT01705574|3659024|P2|Overall Study|Non-Compliance with Study Drug|4
1115943|NCT01705574|3659025|P1|Overall Study|Non-Compliance with Study Drug|4
1115944|NCT01705574|3659024|P2|Overall Study|Pregnancy|1
1115945|NCT01705574|3659025|P1|Overall Study|Pregnancy|1
1115946|NCT01705574|3659024|P2|Overall Study|Adverse Event|9
1115947|NCT01705574|3659025|P1|Overall Study|Adverse Event|3
1115948|NCT01705574|3659024|P2|Overall Study|Randomized but Not Treated|4
1115949|NCT01705574|3659025|P1|Overall Study|Randomized but Not Treated|4
1115950|NCT01705145|3659043|P1|Part B|Adverse Event|1
1115951|NCT01705080|3659083|P4|Overall Study|Missed 6M Visit|0
1115952|NCT01705080|3659084|P3|Overall Study|Missed 6M Visit|1
1115953|NCT01705080|3659085|P2|Overall Study|Missed 6M Visit|1
1115954|NCT01705080|3659086|P1|Overall Study|Missed 6M Visit|3
1115955|NCT01705080|3659083|P4|Overall Study|Protocol Violation|0
1115956|NCT01705080|3659084|P3|Overall Study|Protocol Violation|0
1115957|NCT01705080|3659085|P2|Overall Study|Protocol Violation|0
1115958|NCT01705080|3659086|P1|Overall Study|Protocol Violation|2
1115959|NCT01705080|3659083|P4|Overall Study|Lost to Follow-up|2
1115960|NCT01705080|3659084|P3|Overall Study|Lost to Follow-up|0
1115961|NCT01705080|3659085|P2|Overall Study|Lost to Follow-up|0
1115962|NCT01705080|3659086|P1|Overall Study|Lost to Follow-up|0
1115963|NCT01705080|3659083|P4|Overall Study|Physician Decision|8
1115964|NCT01705080|3659084|P3|Overall Study|Physician Decision|1
1115965|NCT01705080|3659085|P2|Overall Study|Physician Decision|2
1115966|NCT01705080|3659086|P1|Overall Study|Physician Decision|1
1115967|NCT01705080|3659083|P4|Overall Study|Withdrawal by Subject|12
1115968|NCT01705080|3659084|P3|Overall Study|Withdrawal by Subject|0
1115969|NCT01705080|3659085|P2|Overall Study|Withdrawal by Subject|1
1115970|NCT01705080|3659086|P1|Overall Study|Withdrawal by Subject|1
1115971|NCT01705080|3659083|P4|Overall Study|Death|0
1115972|NCT01705080|3659084|P3|Overall Study|Death|0
1115973|NCT01705080|3659085|P2|Overall Study|Death|1
1115974|NCT01705080|3659086|P1|Overall Study|Death|0
1115975|NCT01705080|3659083|P4|Overall Study|Failed Procedure|0
1115976|NCT01705080|3659084|P3|Overall Study|Failed Procedure|0
1115977|NCT01705080|3659085|P2|Overall Study|Failed Procedure|2
1115978|NCT01705080|3659086|P1|Overall Study|Failed Procedure|0
1115979|NCT01705080|3659083|P4|Overall Study|Screen Failure Post Consent|20
1115980|NCT01705080|3659084|P3|Overall Study|Screen Failure Post Consent|3
1115981|NCT01705080|3659085|P2|Overall Study|Screen Failure Post Consent|9
1115982|NCT01705080|3659086|P1|Overall Study|Screen Failure Post Consent|8
1115983|NCT01704846|3659115|P2|Treatment Period 2|Withdrawal by Subject|1
1115984|NCT01704846|3659116|P1|Treatment Period 2|Withdrawal by Subject|0
1115985|NCT01704755|3659171|P2|Overall Study|Withdrew consent and personal issues|0
1115986|NCT01704755|3659172|P1|Overall Study|Withdrew consent and personal issues|1
1115987|NCT01704755|3659171|P2|Overall Study|Other (not specified)|1
1115988|NCT01704755|3659172|P1|Overall Study|Other (not specified)|3
1115989|NCT01704755|3659171|P2|Overall Study|Withdrew consent|1
1115990|NCT01704755|3659172|P1|Overall Study|Withdrew consent|1
1115991|NCT01704755|3659171|P2|Overall Study|Lost to Follow-up|4
1115992|NCT01704755|3659172|P1|Overall Study|Lost to Follow-up|3
1115993|NCT01704755|3659171|P2|Overall Study|Adverse Event|1
1115994|NCT01704755|3659172|P1|Overall Study|Adverse Event|4
1115995|NCT01704651|3659186|P2|Overall Study|Post-op did not have laparotomy|1
1115996|NCT01704651|3659187|P1|Overall Study|Post-op did not have laparotomy|2
1115997|NCT01704651|3659186|P2|Overall Study|Nasogastric tube placement in surgery|1
1115998|NCT01704651|3659187|P1|Overall Study|Nasogastric tube placement in surgery|1
1115999|NCT01704651|3659186|P2|Overall Study|Pre-op change in treatment plan|4
1116000|NCT01704651|3659187|P1|Overall Study|Pre-op change in treatment plan|1
1116001|NCT01704651|3659186|P2|Overall Study|Pre-op withdrawal by subject|1
1116002|NCT01704651|3659187|P1|Overall Study|Pre-op withdrawal by subject|1
1116003|NCT01704599|3659195|P1|Overall Study|Adverse Event|1
1116004|NCT01704495|3659235|P4|Optional Safety Extension|Withdrawal by Subject|2
1116005|NCT01704495|3659236|P3|Optional Safety Extension|Withdrawal by Subject|1
1116006|NCT01704495|3659237|P2|Optional Safety Extension|Withdrawal by Subject|0
1116007|NCT01704495|3659238|P1|Optional Safety Extension|Withdrawal by Subject|2
1116008|NCT01704495|3659235|P4|Optional Safety Extension|Other reason|28
1116009|NCT01704495|3659236|P3|Optional Safety Extension|Other reason|30
1116010|NCT01704495|3659237|P2|Optional Safety Extension|Other reason|29
1116011|NCT01704495|3659238|P1|Optional Safety Extension|Other reason|27
1116012|NCT01704495|3659235|P4|Optional Safety Extension|Adverse Event|1
1116013|NCT01704495|3659236|P3|Optional Safety Extension|Adverse Event|0
1116014|NCT01704495|3659237|P2|Optional Safety Extension|Adverse Event|4
1116015|NCT01704495|3659238|P1|Optional Safety Extension|Adverse Event|0
1116016|NCT01704495|3659235|P4|Subjects Randomized|Eligibility criteria not fulfilled|3
1116017|NCT01704495|3659236|P3|Subjects Randomized|Eligibility criteria not fulfilled|4
1116018|NCT01704495|3659237|P2|Subjects Randomized|Eligibility criteria not fulfilled|3
1116019|NCT01704495|3659238|P1|Subjects Randomized|Eligibility criteria not fulfilled|1
1116020|NCT01704495|3659235|P4|Subjects Randomized|Protocol Violation|0
1116021|NCT01704495|3659236|P3|Subjects Randomized|Protocol Violation|2
1116022|NCT01704495|3659237|P2|Subjects Randomized|Protocol Violation|1
1116023|NCT01704495|3659238|P1|Subjects Randomized|Protocol Violation|1
1116024|NCT01704495|3659235|P4|Subjects Randomized|Withdrawal by Subject|5
1116025|NCT01704495|3659236|P3|Subjects Randomized|Withdrawal by Subject|5
1116026|NCT01704495|3659237|P2|Subjects Randomized|Withdrawal by Subject|5
1116027|NCT01704495|3659238|P1|Subjects Randomized|Withdrawal by Subject|5
1116028|NCT01704495|3659235|P4|Subjects Randomized|Adverse Event|7
1116029|NCT01704495|3659236|P3|Subjects Randomized|Adverse Event|0
1116030|NCT01704495|3659237|P2|Subjects Randomized|Adverse Event|2
1116031|NCT01704495|3659238|P1|Subjects Randomized|Adverse Event|8
1116032|NCT01704495|3659235|P4|Subjects Randomized|Discontinuation criteria met|0
1116033|NCT01704495|3659236|P3|Subjects Randomized|Discontinuation criteria met|2
1116034|NCT01704495|3659237|P2|Subjects Randomized|Discontinuation criteria met|2
1116035|NCT01704495|3659238|P1|Subjects Randomized|Discontinuation criteria met|4
1116036|NCT01704495|3659235|P4|Subjects Randomized|Other Reason|2
1116037|NCT01704495|3659236|P3|Subjects Randomized|Other Reason|3
1116038|NCT01704495|3659237|P2|Subjects Randomized|Other Reason|2
1116039|NCT01704495|3659238|P1|Subjects Randomized|Other Reason|3
1116040|NCT01704287|3659454|P5|Switch to Pembrolizumab Treatment Period|Ongoing in Study|16
1116041|NCT01704287|3659455|P4|Switch to Pembrolizumab Treatment Period|Ongoing in Study|21
1116042|NCT01704287|3659456|P3|Switch to Pembrolizumab Treatment Period|Ongoing in Study|0
1116043|NCT01704287|3659457|P2|Switch to Pembrolizumab Treatment Period|Ongoing in Study|0
1116044|NCT01704287|3659458|P1|Switch to Pembrolizumab Treatment Period|Ongoing in Study|0
1116045|NCT01704287|3659454|P5|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
1116046|NCT01704287|3659455|P4|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1
1116047|NCT01704287|3659456|P3|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
1116048|NCT01704287|3659457|P2|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
1116131|NCT01703741|3659700|P1|Overall Study|Adverse Event|2
1116049|NCT01704287|3659458|P1|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
1116050|NCT01704287|3659454|P5|Switch to Pembrolizumab Treatment Period|Death|28
1116051|NCT01704287|3659455|P4|Switch to Pembrolizumab Treatment Period|Death|29
1116052|NCT01704287|3659456|P3|Switch to Pembrolizumab Treatment Period|Death|0
1116053|NCT01704287|3659457|P2|Switch to Pembrolizumab Treatment Period|Death|0
1116054|NCT01704287|3659458|P1|Switch to Pembrolizumab Treatment Period|Death|0
1116055|NCT01704287|3659454|P5|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1
1116056|NCT01704287|3659455|P4|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2
1116057|NCT01704287|3659456|P3|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
1116058|NCT01704287|3659457|P2|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
1116059|NCT01704287|3659458|P1|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
1116060|NCT01704287|3659454|P5|Initial Treatment Period|Switched to Pembrolizumab|0
1116061|NCT01704287|3659455|P4|Initial Treatment Period|Switched to Pembrolizumab|0
1116062|NCT01704287|3659456|P3|Initial Treatment Period|Switched to Pembrolizumab|98
1116063|NCT01704287|3659457|P2|Initial Treatment Period|Switched to Pembrolizumab|0
1116064|NCT01704287|3659458|P1|Initial Treatment Period|Switched to Pembrolizumab|0
1116065|NCT01704287|3659454|P5|Initial Treatment Period|Lost to Follow-up|0
1116066|NCT01704287|3659455|P4|Initial Treatment Period|Lost to Follow-up|0
1116067|NCT01704287|3659456|P3|Initial Treatment Period|Lost to Follow-up|3
1116068|NCT01704287|3659457|P2|Initial Treatment Period|Lost to Follow-up|1
1116069|NCT01704287|3659458|P1|Initial Treatment Period|Lost to Follow-up|3
1116070|NCT01704287|3659454|P5|Initial Treatment Period|Ongoing in Study|0
1116071|NCT01704287|3659455|P4|Initial Treatment Period|Ongoing in Study|0
1116072|NCT01704287|3659456|P3|Initial Treatment Period|Ongoing in Study|44
1116073|NCT01704287|3659457|P2|Initial Treatment Period|Ongoing in Study|62
1116074|NCT01704287|3659458|P1|Initial Treatment Period|Ongoing in Study|52
1116075|NCT01704287|3659454|P5|Initial Treatment Period|Other|0
1116076|NCT01704287|3659455|P4|Initial Treatment Period|Other|0
1116077|NCT01704287|3659456|P3|Initial Treatment Period|Other|0
1116078|NCT01704287|3659457|P2|Initial Treatment Period|Other|0
1116079|NCT01704287|3659458|P1|Initial Treatment Period|Other|1
1116080|NCT01704287|3659454|P5|Initial Treatment Period|Withdrawal by Subject|0
1116081|NCT01704287|3659455|P4|Initial Treatment Period|Withdrawal by Subject|0
1116082|NCT01704287|3659456|P3|Initial Treatment Period|Withdrawal by Subject|4
1116083|NCT01704287|3659457|P2|Initial Treatment Period|Withdrawal by Subject|1
1116084|NCT01704287|3659458|P1|Initial Treatment Period|Withdrawal by Subject|1
1116085|NCT01704287|3659454|P5|Initial Treatment Period|Death|0
1116086|NCT01704287|3659455|P4|Initial Treatment Period|Death|0
1116087|NCT01704287|3659456|P3|Initial Treatment Period|Death|30
1116088|NCT01704287|3659457|P2|Initial Treatment Period|Death|117
1116089|NCT01704287|3659458|P1|Initial Treatment Period|Death|123
1116090|NCT01704261|3659493|P2|Overall Study|Lost to Follow-up|0
1116091|NCT01704261|3659494|P1|Overall Study|Lost to Follow-up|1
1116092|NCT01704261|3659493|P2|Overall Study|Withdrawal by Subject|15
1116093|NCT01704261|3659494|P1|Overall Study|Withdrawal by Subject|12
1116094|NCT01704079|3659521|P2|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1
1116095|NCT01704079|3659522|P1|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0
1116096|NCT01704079|3659521|P2|Overall Study|Subject noncompliance|3
1116097|NCT01704079|3659522|P1|Overall Study|Subject noncompliance|2
1116098|NCT01704079|3659521|P2|Overall Study|Protocol Violation|0
1116099|NCT01704079|3659522|P1|Overall Study|Protocol Violation|1
1116100|NCT01704079|3659521|P2|Overall Study|Adverse Event|7
1116101|NCT01704079|3659522|P1|Overall Study|Adverse Event|4
1116102|NCT01704079|3659521|P2|Overall Study|Lost to Follow-up|5
1116103|NCT01704079|3659522|P1|Overall Study|Lost to Follow-up|2
1116104|NCT01704079|3659521|P2|Overall Study|Withdrawal by Subject|7
1116105|NCT01704079|3659522|P1|Overall Study|Withdrawal by Subject|5
1116106|NCT01703988|3659538|P4|Overall Study|Investigator Judgment|1
1116107|NCT01703988|3659539|P3|Overall Study|Investigator Judgment|0
1116108|NCT01703988|3659540|P2|Overall Study|Investigator Judgment|0
1116109|NCT01703988|3659541|P1|Overall Study|Investigator Judgment|0
1116110|NCT01703858|3659571|P3|Overall Study|Withdrawal by Subject|0
1116111|NCT01703858|3659572|P2|Overall Study|Withdrawal by Subject|1
1116112|NCT01703858|3659573|P1|Overall Study|Withdrawal by Subject|0
1116113|NCT01703845|3659598|P2|Overall Study|other than stated above|0
1116114|NCT01703845|3659599|P1|Overall Study|other than stated above|1
1116115|NCT01703845|3659598|P2|Overall Study|Protocol Violation|0
1116116|NCT01703845|3659599|P1|Overall Study|Protocol Violation|1
1116117|NCT01703845|3659598|P2|Overall Study|Adverse Event|0
1116118|NCT01703845|3659599|P1|Overall Study|Adverse Event|1
1116119|NCT01703832|3659636|P2|Overall Study|Withdrawal by Subject|0
1116120|NCT01703832|3659637|P1|Overall Study|Withdrawal by Subject|1
1116121|NCT01703819|3659669|P2|Overall Study|Withdrawal by Subject|1
1116122|NCT01703819|3659670|P1|Overall Study|Withdrawal by Subject|0
1116123|NCT01703819|3659669|P2|Overall Study|Adverse Event|1
1116124|NCT01703819|3659670|P1|Overall Study|Adverse Event|0
1116125|NCT01703741|3659700|P1|Overall Study|Subject started testosterone injections|1
1116126|NCT01703741|3659700|P1|Overall Study|Subject cannot comply with study visits|1
1116127|NCT01703741|3659700|P1|Overall Study|Subject did not want to continue|2
1116128|NCT01703741|3659700|P1|Overall Study|Lost to Follow-up|3
1116129|NCT01703741|3659700|P1|Overall Study|Protocol Violation|1
1116130|NCT01703741|3659700|P1|Overall Study|Physician Decision|2
1119338|NCT01667900|3670747|P6|Part B|Death|0
1116132|NCT01703741|3659700|P1|Overall Study|Withdrawal by Subject|6
1116133|NCT01703286|3659743|P6|Period 2 Including Washout|Adverse Event|0
1116134|NCT01703286|3659744|P5|Period 2 Including Washout|Adverse Event|0
1116135|NCT01703286|3659745|P4|Period 2 Including Washout|Adverse Event|1
1116136|NCT01703286|3659746|P3|Period 2 Including Washout|Adverse Event|0
1116137|NCT01703286|3659747|P2|Period 2 Including Washout|Adverse Event|0
1116138|NCT01703286|3659748|P1|Period 2 Including Washout|Adverse Event|0
1116139|NCT01703286|3659743|P6|Period 1 Including Washout|Withdrawal by Subject|1
1116140|NCT01703286|3659744|P5|Period 1 Including Washout|Withdrawal by Subject|0
1116141|NCT01703286|3659745|P4|Period 1 Including Washout|Withdrawal by Subject|1
1116142|NCT01703286|3659746|P3|Period 1 Including Washout|Withdrawal by Subject|0
1116143|NCT01703286|3659747|P2|Period 1 Including Washout|Withdrawal by Subject|0
1116144|NCT01703286|3659748|P1|Period 1 Including Washout|Withdrawal by Subject|0
1116145|NCT01703260|3659771|P3|Overall Study|Study Termination|0
1116146|NCT01703260|3659772|P2|Overall Study|Study Termination|2
1116147|NCT01703260|3659773|P1|Overall Study|Study Termination|1
1116148|NCT01703260|3659771|P3|Overall Study|Withdrawal by Subject|1
1116149|NCT01703260|3659772|P2|Overall Study|Withdrawal by Subject|0
1116150|NCT01703260|3659773|P1|Overall Study|Withdrawal by Subject|0
1116151|NCT01703260|3659771|P3|Overall Study|Lost to Follow-up|0
1116152|NCT01703260|3659772|P2|Overall Study|Lost to Follow-up|0
1116153|NCT01703260|3659773|P1|Overall Study|Lost to Follow-up|1
1116154|NCT01703260|3659771|P3|Overall Study|Adverse Event|2
1116155|NCT01703260|3659772|P2|Overall Study|Adverse Event|2
1116156|NCT01703260|3659773|P1|Overall Study|Adverse Event|1
1116157|NCT01703221|3659799|P3|Phase B - (Week 25 to 52)|Lack of Efficacy|3
1116158|NCT01703221|3659800|P2|Phase B - (Week 25 to 52)|Lack of Efficacy|10
1116159|NCT01703221|3659801|P1|Phase B - (Week 25 to 52)|Lack of Efficacy|12
1116160|NCT01703221|3659799|P3|Phase B - (Week 25 to 52)|Adverse Event|2
1116161|NCT01703221|3659800|P2|Phase B - (Week 25 to 52)|Adverse Event|3
1116162|NCT01703221|3659801|P1|Phase B - (Week 25 to 52)|Adverse Event|2
1116163|NCT01703221|3659799|P3|Phase B - (Week 25 to 52)|Withdrawal by Subject|0
1116164|NCT01703221|3659800|P2|Phase B - (Week 25 to 52)|Withdrawal by Subject|1
1116165|NCT01703221|3659801|P1|Phase B - (Week 25 to 52)|Withdrawal by Subject|2
1116166|NCT01703221|3659799|P3|Phase A (Up to 24 Weeks)|Protocol Violation|1
1116167|NCT01703221|3659800|P2|Phase A (Up to 24 Weeks)|Protocol Violation|0
1116168|NCT01703221|3659801|P1|Phase A (Up to 24 Weeks)|Protocol Violation|0
1116169|NCT01703221|3659799|P3|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
1116170|NCT01703221|3659800|P2|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
1116171|NCT01703221|3659801|P1|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2
1116172|NCT01703221|3659799|P3|Phase A (Up to 24 Weeks)|Physician Decision|0
1116173|NCT01703221|3659800|P2|Phase A (Up to 24 Weeks)|Physician Decision|0
1116174|NCT01703221|3659801|P1|Phase A (Up to 24 Weeks)|Physician Decision|1
1116175|NCT01703221|3659799|P3|Phase A (Up to 24 Weeks)|Lack of Efficacy|1
1116176|NCT01703221|3659800|P2|Phase A (Up to 24 Weeks)|Lack of Efficacy|0
1116177|NCT01703221|3659801|P1|Phase A (Up to 24 Weeks)|Lack of Efficacy|2
1116178|NCT01703221|3659799|P3|Phase A (Up to 24 Weeks)|Adverse Event|0
1116179|NCT01703221|3659800|P2|Phase A (Up to 24 Weeks)|Adverse Event|4
1116180|NCT01703221|3659801|P1|Phase A (Up to 24 Weeks)|Adverse Event|2
1116181|NCT01703208|3659832|P2|Overall Study|Protocol Deviation|0
1116182|NCT01703208|3659833|P1|Overall Study|Protocol Deviation|2
1116183|NCT01703208|3659832|P2|Overall Study|Technical Problems|1
1116184|NCT01703208|3659833|P1|Overall Study|Technical Problems|0
1116185|NCT01703208|3659832|P2|Overall Study|Adverse Event|19
1116186|NCT01703208|3659833|P1|Overall Study|Adverse Event|14
1116187|NCT01703208|3659832|P2|Overall Study|Withdrawal by Subject|209
1116188|NCT01703208|3659833|P1|Overall Study|Withdrawal by Subject|205
1116189|NCT01703208|3659832|P2|Overall Study|Study Terminated by Sponsor|1716
1116190|NCT01703208|3659833|P1|Overall Study|Study Terminated by Sponsor|1710
1116191|NCT01703208|3659832|P2|Overall Study|Protocol Violation|1
1116192|NCT01703208|3659833|P1|Overall Study|Protocol Violation|1
1116193|NCT01703208|3659832|P2|Overall Study|Progressive disease|2
1116194|NCT01703208|3659833|P1|Overall Study|Progressive disease|2
1116195|NCT01703208|3659832|P2|Overall Study|Physician Decision|13
1116196|NCT01703208|3659833|P1|Overall Study|Physician Decision|11
1116197|NCT01703208|3659832|P2|Overall Study|Site Discontinued Study Participation|27
1116198|NCT01703208|3659833|P1|Overall Study|Site Discontinued Study Participation|23
1116199|NCT01703208|3659832|P2|Overall Study|Excluded Medication|2
1116200|NCT01703208|3659833|P1|Overall Study|Excluded Medication|1
1116201|NCT01703208|3659832|P2|Overall Study|Non-Compliance with Study Drug|0
1116202|NCT01703208|3659833|P1|Overall Study|Non-Compliance with Study Drug|1
1116203|NCT01703208|3659832|P2|Overall Study|Lost to Follow-up|62
1116204|NCT01703208|3659833|P1|Overall Study|Lost to Follow-up|68
1116205|NCT01703208|3659832|P2|Overall Study|Lack of Efficacy|2
1116206|NCT01703208|3659833|P1|Overall Study|Lack of Efficacy|1
1116207|NCT01703208|3659832|P2|Overall Study|Death|48
1116208|NCT01703208|3659833|P1|Overall Study|Death|61
1116209|NCT01703091|3659897|P2|Overall Study|Sponsor Decision|0
1116210|NCT01703091|3659898|P1|Overall Study|Sponsor Decision|1
1116211|NCT01703091|3659897|P2|Overall Study|Withdrawal by Subject|0
1116212|NCT01703091|3659898|P1|Overall Study|Withdrawal by Subject|1
1116213|NCT01703091|3659897|P2|Overall Study|Physician Decision|1
1116214|NCT01703091|3659898|P1|Overall Study|Physician Decision|2
1116215|NCT01703091|3659897|P2|Overall Study|Adverse Event|3
1119339|NCT01667900|3670748|P5|Part B|Death|0
1116216|NCT01703091|3659898|P1|Overall Study|Adverse Event|5
1116217|NCT01703065|3659916|P2|Overall Study|Lack of Efficacy|0
1116218|NCT01703065|3659917|P1|Overall Study|Lack of Efficacy|1
1116219|NCT01703000|3659930|P1|Overall Study|Death|1
1116220|NCT01702987|3659963|P2|Overall Study|Withdrawal by Subject|0
1116221|NCT01702987|3659964|P1|Overall Study|Withdrawal by Subject|1
1116222|NCT01702961|3659970|P1|Overall Study|Ongoing|11
1116223|NCT01702961|3659970|P1|Overall Study|Lost to Follow-up|2
1116224|NCT01702961|3659970|P1|Overall Study|Death|6
1116225|NCT01702961|3659970|P1|Overall Study|Relapse|20
1116226|NCT01702961|3659970|P1|Overall Study|Progressive disease|5
1116227|NCT01702961|3659970|P1|Overall Study|Additional treatment|3
1116228|NCT01702532|3659990|P2|Overall Study|Adverse Event|1
1116229|NCT01702532|3659991|P1|Overall Study|Adverse Event|0
1116230|NCT01702519|3660001|P2|Washout Period|Withdrawal by Subject|2
1116231|NCT01702519|3660002|P1|Washout Period|Withdrawal by Subject|0
1116232|NCT01702519|3660001|P2|Washout Period|Lost to Follow-up|0
1116233|NCT01702519|3660002|P1|Washout Period|Lost to Follow-up|1
1116234|NCT01702454|3660020|P2|Overall Study|Lost to Follow-up|6
1116235|NCT01702454|3660021|P1|Overall Study|Lost to Follow-up|3
1116236|NCT01702454|3660020|P2|Overall Study|Migrated/moved from study area|1
1116237|NCT01702454|3660021|P1|Overall Study|Migrated/moved from study area|0
1116238|NCT01702454|3660020|P2|Overall Study|Consent withdrawal|1
1116239|NCT01702454|3660021|P1|Overall Study|Consent withdrawal|0
1116240|NCT01702428|3660103|P4|Overall Study|Withdrawal by Subject|10
1116241|NCT01702428|3660104|P3|Overall Study|Withdrawal by Subject|14
1116242|NCT01702428|3660105|P2|Overall Study|Withdrawal by Subject|23
1116243|NCT01702428|3660106|P1|Overall Study|Withdrawal by Subject|21
1116244|NCT01702428|3660103|P4|Overall Study|Protocol Violation|0
1116245|NCT01702428|3660104|P3|Overall Study|Protocol Violation|1
1116246|NCT01702428|3660105|P2|Overall Study|Protocol Violation|0
1116247|NCT01702428|3660106|P1|Overall Study|Protocol Violation|3
1116248|NCT01702428|3660103|P4|Overall Study|Parents too busy|0
1116249|NCT01702428|3660104|P3|Overall Study|Parents too busy|0
1116250|NCT01702428|3660105|P2|Overall Study|Parents too busy|0
1116251|NCT01702428|3660106|P1|Overall Study|Parents too busy|1
1116252|NCT01702428|3660103|P4|Overall Study|Mother transferred care|0
1116253|NCT01702428|3660104|P3|Overall Study|Mother transferred care|0
1116254|NCT01702428|3660105|P2|Overall Study|Mother transferred care|1
1116255|NCT01702428|3660106|P1|Overall Study|Mother transferred care|0
1116256|NCT01702428|3660103|P4|Overall Study|Lost Health Plan|2
1116257|NCT01702428|3660104|P3|Overall Study|Lost Health Plan|0
1116258|NCT01702428|3660105|P2|Overall Study|Lost Health Plan|5
1116259|NCT01702428|3660106|P1|Overall Study|Lost Health Plan|3
1116260|NCT01702428|3660103|P4|Overall Study|Lost Coverage|1
1116261|NCT01702428|3660104|P3|Overall Study|Lost Coverage|0
1116262|NCT01702428|3660105|P2|Overall Study|Lost Coverage|0
1116263|NCT01702428|3660106|P1|Overall Study|Lost Coverage|0
1116264|NCT01702428|3660103|P4|Overall Study|Parents cannot assist to site|0
1116265|NCT01702428|3660104|P3|Overall Study|Parents cannot assist to site|1
1116266|NCT01702428|3660105|P2|Overall Study|Parents cannot assist to site|0
1116267|NCT01702428|3660106|P1|Overall Study|Parents cannot assist to site|1
1116268|NCT01702428|3660103|P4|Overall Study|Lost to Follow-up|44
1116269|NCT01702428|3660104|P3|Overall Study|Lost to Follow-up|37
1116270|NCT01702428|3660105|P2|Overall Study|Lost to Follow-up|41
1116271|NCT01702428|3660106|P1|Overall Study|Lost to Follow-up|33
1116272|NCT01702428|3660103|P4|Overall Study|Adverse Event|0
1116273|NCT01702428|3660104|P3|Overall Study|Adverse Event|0
1116274|NCT01702428|3660105|P2|Overall Study|Adverse Event|0
1116275|NCT01702428|3660106|P1|Overall Study|Adverse Event|2
1116276|NCT01702363|3660193|P1|Overall Study|Withdrawal by Subject|2
1116277|NCT01702363|3660193|P1|Overall Study|Lack of Efficacy|4
1116278|NCT01702363|3660193|P1|Overall Study|Adverse Event|14
1116279|NCT01702311|3660210|P2|Overall Study|Physician Decision|4
1116280|NCT01702311|3660211|P1|Overall Study|Physician Decision|3
1116281|NCT01702311|3660210|P2|Overall Study|Discharge less than 24 hours|7
1116282|NCT01702311|3660211|P1|Overall Study|Discharge less than 24 hours|10
1116283|NCT01702311|3660210|P2|Overall Study|Withdrawal by Subject|2
1116284|NCT01702311|3660211|P1|Overall Study|Withdrawal by Subject|3
1116285|NCT01702298|3660241|P1|Overall Study|Withdrawal by Subject|1
1116286|NCT01702246|3660269|P1|Overall Study|Physician Decision|1
1116287|NCT01702246|3660269|P1|Overall Study|Withdrawal by Subject|2
1116288|NCT01702246|3660269|P1|Overall Study|Lost to Follow-up|2
1116289|NCT01702025|3660323|P4|Overall Study|Adverse Event|0
1116290|NCT01702025|3660324|P3|Overall Study|Adverse Event|1
1116291|NCT01702025|3660325|P2|Overall Study|Adverse Event|1
1116292|NCT01702025|3660326|P1|Overall Study|Adverse Event|1
1116293|NCT01702025|3660323|P4|Overall Study|Equipment failure|0
1116294|NCT01702025|3660324|P3|Overall Study|Equipment failure|0
1116295|NCT01702025|3660325|P2|Overall Study|Equipment failure|0
1116296|NCT01702025|3660326|P1|Overall Study|Equipment failure|1
1116297|NCT01701973|3660355|P8|Aim 1: First Intervention (1 Day)|Adverse Event|0
1116298|NCT01701973|3660356|P7|Aim 1: First Intervention (1 Day)|Adverse Event|0
1116299|NCT01701973|3660357|P6|Aim 1: First Intervention (1 Day)|Adverse Event|0
1116300|NCT01701973|3660358|P5|Aim 1: First Intervention (1 Day)|Adverse Event|0
1116301|NCT01701973|3660359|P4|Aim 1: First Intervention (1 Day)|Adverse Event|0
1116302|NCT01701973|3660360|P3|Aim 1: First Intervention (1 Day)|Adverse Event|0
1116303|NCT01701973|3660361|P2|Aim 1: First Intervention (1 Day)|Adverse Event|1
1116304|NCT01701973|3660362|P1|Aim 1: First Intervention (1 Day)|Adverse Event|0
1116305|NCT01701674|3660409|P1|Overall Study|Unable to safely complete treatment|1
1116306|NCT01701401|3660495|P4|Overall Study|Protocol Violation|0
1116307|NCT01701401|3660496|P3|Overall Study|Protocol Violation|1
1116308|NCT01701401|3660497|P2|Overall Study|Protocol Violation|0
1116309|NCT01701401|3660498|P1|Overall Study|Protocol Violation|0
1116310|NCT01701401|3660495|P4|Overall Study|Adverse Event|0
1116311|NCT01701401|3660496|P3|Overall Study|Adverse Event|0
1116312|NCT01701401|3660497|P2|Overall Study|Adverse Event|0
1116313|NCT01701401|3660498|P1|Overall Study|Adverse Event|1
1116314|NCT01701401|3660495|P4|Overall Study|Lack of Efficacy|0
1116315|NCT01701401|3660496|P3|Overall Study|Lack of Efficacy|2
1116316|NCT01701401|3660497|P2|Overall Study|Lack of Efficacy|0
1116317|NCT01701401|3660498|P1|Overall Study|Lack of Efficacy|1
1116318|NCT01701401|3660495|P4|Overall Study|Withdrew Consent|2
1116319|NCT01701401|3660496|P3|Overall Study|Withdrew Consent|1
1116320|NCT01701401|3660497|P2|Overall Study|Withdrew Consent|3
1116321|NCT01701401|3660498|P1|Overall Study|Withdrew Consent|0
1116322|NCT01701401|3660495|P4|Overall Study|Lost to Follow-up|3
1116323|NCT01701401|3660496|P3|Overall Study|Lost to Follow-up|1
1116324|NCT01701401|3660497|P2|Overall Study|Lost to Follow-up|5
1116325|NCT01701401|3660498|P1|Overall Study|Lost to Follow-up|5
1116326|NCT01701401|3660495|P4|Overall Study|Randomized But Not Treated|1
1116327|NCT01701401|3660496|P3|Overall Study|Randomized But Not Treated|0
1116328|NCT01701401|3660497|P2|Overall Study|Randomized But Not Treated|1
1116329|NCT01701401|3660498|P1|Overall Study|Randomized But Not Treated|3
1116330|NCT01701362|3660550|P2|Overall Study|Reasons other than those mentioned above|5
1116331|NCT01701362|3660551|P1|Overall Study|Reasons other than those mentioned above|3
1116332|NCT01701362|3660550|P2|Overall Study|Randomized but not treated|2
1116333|NCT01701362|3660551|P1|Overall Study|Randomized but not treated|1
1116334|NCT01701362|3660550|P2|Overall Study|Death|1
1116335|NCT01701362|3660551|P1|Overall Study|Death|0
1116336|NCT01701362|3660550|P2|Overall Study|Insufficient clinical response|6
1116337|NCT01701362|3660551|P1|Overall Study|Insufficient clinical response|6
1116338|NCT01701362|3660550|P2|Overall Study|Lost to Follow-up|9
1116339|NCT01701362|3660551|P1|Overall Study|Lost to Follow-up|6
1116340|NCT01701362|3660550|P2|Overall Study|No longer willing to participate|14
1116341|NCT01701362|3660551|P1|Overall Study|No longer willing to participate|8
1116342|NCT01701362|3660550|P2|Overall Study|Protocol Violation|3
1116343|NCT01701362|3660551|P1|Overall Study|Protocol Violation|5
1116344|NCT01701362|3660550|P2|Overall Study|Adverse events related to study drug|10
1116345|NCT01701362|3660551|P1|Overall Study|Adverse events related to study drug|12
1116346|NCT01701362|3660550|P2|Overall Study|Adverse events not related to study drug|6
1116347|NCT01701362|3660551|P1|Overall Study|Adverse events not related to study drug|1
1116348|NCT01701258|3660589|P13|Assessment and Scheduling|Investigator Terminated|0
1116349|NCT01701258|3660590|P12|Assessment and Scheduling|Investigator Terminated|0
1116350|NCT01701258|3660591|P11|Assessment and Scheduling|Investigator Terminated|0
1116351|NCT01701258|3660592|P10|Assessment and Scheduling|Investigator Terminated|0
1116352|NCT01701258|3660593|P9|Assessment and Scheduling|Investigator Terminated|0
1116353|NCT01701258|3660594|P8|Assessment and Scheduling|Investigator Terminated|0
1116354|NCT01701258|3660595|P7|Assessment and Scheduling|Investigator Terminated|0
1116355|NCT01701258|3660596|P6|Assessment and Scheduling|Investigator Terminated|0
1116356|NCT01701258|3660597|P5|Assessment and Scheduling|Investigator Terminated|0
1116357|NCT01701258|3660598|P4|Assessment and Scheduling|Investigator Terminated|0
1116358|NCT01701258|3660599|P3|Assessment and Scheduling|Investigator Terminated|0
1116359|NCT01701258|3660600|P2|Assessment and Scheduling|Investigator Terminated|0
1116360|NCT01701258|3660601|P1|Assessment and Scheduling|Investigator Terminated|2
1116361|NCT01701258|3660589|P13|Assessment and Scheduling|Withdrawal by Subject|0
1116362|NCT01701258|3660590|P12|Assessment and Scheduling|Withdrawal by Subject|0
1116363|NCT01701258|3660591|P11|Assessment and Scheduling|Withdrawal by Subject|0
1116364|NCT01701258|3660592|P10|Assessment and Scheduling|Withdrawal by Subject|0
1116365|NCT01701258|3660593|P9|Assessment and Scheduling|Withdrawal by Subject|0
1116366|NCT01701258|3660594|P8|Assessment and Scheduling|Withdrawal by Subject|0
1116367|NCT01701258|3660595|P7|Assessment and Scheduling|Withdrawal by Subject|0
1116368|NCT01701258|3660596|P6|Assessment and Scheduling|Withdrawal by Subject|0
1116369|NCT01701258|3660597|P5|Assessment and Scheduling|Withdrawal by Subject|0
1116370|NCT01701258|3660598|P4|Assessment and Scheduling|Withdrawal by Subject|0
1116371|NCT01701258|3660599|P3|Assessment and Scheduling|Withdrawal by Subject|0
1116372|NCT01701258|3660600|P2|Assessment and Scheduling|Withdrawal by Subject|0
1116373|NCT01701258|3660601|P1|Assessment and Scheduling|Withdrawal by Subject|14
1116374|NCT01701258|3660589|P13|Assessment and Scheduling|Lost to Follow-up|0
1116375|NCT01701258|3660590|P12|Assessment and Scheduling|Lost to Follow-up|0
1116376|NCT01701258|3660591|P11|Assessment and Scheduling|Lost to Follow-up|0
1116377|NCT01701258|3660592|P10|Assessment and Scheduling|Lost to Follow-up|0
1116378|NCT01701258|3660593|P9|Assessment and Scheduling|Lost to Follow-up|0
1116379|NCT01701258|3660594|P8|Assessment and Scheduling|Lost to Follow-up|0
1116380|NCT01701258|3660595|P7|Assessment and Scheduling|Lost to Follow-up|0
1116381|NCT01701258|3660596|P6|Assessment and Scheduling|Lost to Follow-up|0
1116382|NCT01701258|3660597|P5|Assessment and Scheduling|Lost to Follow-up|0
1116383|NCT01701258|3660598|P4|Assessment and Scheduling|Lost to Follow-up|0
1116384|NCT01701258|3660599|P3|Assessment and Scheduling|Lost to Follow-up|0
1116385|NCT01701258|3660600|P2|Assessment and Scheduling|Lost to Follow-up|0
1116386|NCT01701258|3660601|P1|Assessment and Scheduling|Lost to Follow-up|10
1116387|NCT01701258|3660589|P13|Assessment and Scheduling|Found to be Ineligible|0
1116388|NCT01701258|3660590|P12|Assessment and Scheduling|Found to be Ineligible|0
1116389|NCT01701258|3660591|P11|Assessment and Scheduling|Found to be Ineligible|0
1116390|NCT01701258|3660592|P10|Assessment and Scheduling|Found to be Ineligible|0
1116391|NCT01701258|3660593|P9|Assessment and Scheduling|Found to be Ineligible|0
1116392|NCT01701258|3660594|P8|Assessment and Scheduling|Found to be Ineligible|0
1116393|NCT01701258|3660595|P7|Assessment and Scheduling|Found to be Ineligible|0
1116394|NCT01701258|3660596|P6|Assessment and Scheduling|Found to be Ineligible|0
1116395|NCT01701258|3660597|P5|Assessment and Scheduling|Found to be Ineligible|0
1116396|NCT01701258|3660598|P4|Assessment and Scheduling|Found to be Ineligible|0
1116397|NCT01701258|3660599|P3|Assessment and Scheduling|Found to be Ineligible|0
1116398|NCT01701258|3660600|P2|Assessment and Scheduling|Found to be Ineligible|0
1116399|NCT01701258|3660601|P1|Assessment and Scheduling|Found to be Ineligible|57
1116400|NCT01701245|3660655|P2|Overall Study|Did not complete the open label period|12
1116401|NCT01701245|3660656|P1|Overall Study|Did not complete the open label period|11
1116402|NCT01701245|3660655|P2|Overall Study|Protocol Violation|3
1116403|NCT01701245|3660656|P1|Overall Study|Protocol Violation|1
1116404|NCT01701063|3660703|P3|Overall Study|Other|1
1116405|NCT01701063|3660704|P2|Overall Study|Other|0
1116406|NCT01701063|3660705|P1|Overall Study|Other|0
1116407|NCT01701063|3660703|P3|Overall Study|Withdrawal by Subject|1
1116408|NCT01701063|3660704|P2|Overall Study|Withdrawal by Subject|0
1116409|NCT01701063|3660705|P1|Overall Study|Withdrawal by Subject|0
1116410|NCT01701063|3660703|P3|Overall Study|Lost to Follow-up|0
1116411|NCT01701063|3660704|P2|Overall Study|Lost to Follow-up|1
1116412|NCT01701063|3660705|P1|Overall Study|Lost to Follow-up|0
1116413|NCT01700985|3660789|P2|Overall Study|Incarcerated|1
1116414|NCT01700985|3660790|P1|Overall Study|Incarcerated|0
1116415|NCT01700959|3660812|P6|Overall Study|Side effects|1
1116416|NCT01700959|3660813|P5|Overall Study|Side effects|4
1116417|NCT01700959|3660814|P4|Overall Study|Side effects|4
1116418|NCT01700959|3660815|P3|Overall Study|Side effects|8
1116419|NCT01700959|3660816|P2|Overall Study|Side effects|4
1116420|NCT01700959|3660817|P1|Overall Study|Side effects|1
1116421|NCT01700959|3660812|P6|Overall Study|Noncompliant|9
1116422|NCT01700959|3660813|P5|Overall Study|Noncompliant|15
1116423|NCT01700959|3660814|P4|Overall Study|Noncompliant|18
1116424|NCT01700959|3660815|P3|Overall Study|Noncompliant|17
1116425|NCT01700959|3660816|P2|Overall Study|Noncompliant|9
1116426|NCT01700959|3660817|P1|Overall Study|Noncompliant|9
1116427|NCT01700959|3660812|P6|Overall Study|Ineligible|1
1116428|NCT01700959|3660813|P5|Overall Study|Ineligible|0
1116429|NCT01700959|3660814|P4|Overall Study|Ineligible|0
1116430|NCT01700959|3660815|P3|Overall Study|Ineligible|2
1116431|NCT01700959|3660816|P2|Overall Study|Ineligible|1
1116432|NCT01700959|3660817|P1|Overall Study|Ineligible|2
1116433|NCT01700959|3660812|P6|Overall Study|Withdrawal by Subject|12
1116434|NCT01700959|3660813|P5|Overall Study|Withdrawal by Subject|8
1116435|NCT01700959|3660814|P4|Overall Study|Withdrawal by Subject|11
1116436|NCT01700959|3660815|P3|Overall Study|Withdrawal by Subject|12
1116437|NCT01700959|3660816|P2|Overall Study|Withdrawal by Subject|9
1116438|NCT01700959|3660817|P1|Overall Study|Withdrawal by Subject|15
1116439|NCT01700959|3660812|P6|Overall Study|Adverse Event|2
1116440|NCT01700959|3660813|P5|Overall Study|Adverse Event|0
1116441|NCT01700959|3660814|P4|Overall Study|Adverse Event|2
1116442|NCT01700959|3660815|P3|Overall Study|Adverse Event|1
1116443|NCT01700959|3660816|P2|Overall Study|Adverse Event|1
1116444|NCT01700959|3660817|P1|Overall Study|Adverse Event|0
1116445|NCT01700530|3660888|P3|Overall Study|Withdrawal by Subject|1
1116446|NCT01700530|3660889|P2|Overall Study|Withdrawal by Subject|3
1116447|NCT01700530|3660890|P1|Overall Study|Withdrawal by Subject|0
1116448|NCT01700387|3660939|P2|Overall Study|Lost to Follow-up|1
1116449|NCT01700387|3660940|P1|Overall Study|Lost to Follow-up|2
1116450|NCT01700387|3660939|P2|Overall Study|Adverse Event|1
1116451|NCT01700387|3660940|P1|Overall Study|Adverse Event|1
1116452|NCT01700387|3660939|P2|Overall Study|Withdrawal by Subject|2
1116453|NCT01700387|3660940|P1|Overall Study|Withdrawal by Subject|1
1116454|NCT01700348|3660950|P1|Overall Study|Lost to Follow-up|1
1116455|NCT01700348|3660950|P1|Overall Study|Withdrawal by Subject|22
1116456|NCT01700192|3660968|P2|Overall Study|Never received study drug|0
1116457|NCT01700192|3660969|P1|Overall Study|Never received study drug|1
1116458|NCT01700192|3660968|P2|Overall Study|Withdrawal by Subject|64
1116459|NCT01700192|3660969|P1|Overall Study|Withdrawal by Subject|56
1116460|NCT01700192|3660968|P2|Overall Study|Technical problems|1
1116461|NCT01700192|3660969|P1|Overall Study|Technical problems|0
1116462|NCT01700192|3660968|P2|Overall Study|Protocol Violation|4
1116463|NCT01700192|3660969|P1|Overall Study|Protocol Violation|3
1116464|NCT01700192|3660968|P2|Overall Study|Progressive disease|0
1116465|NCT01700192|3660969|P1|Overall Study|Progressive disease|1
1116466|NCT01700192|3660968|P2|Overall Study|Pregnancy|4
1116467|NCT01700192|3660969|P1|Overall Study|Pregnancy|1
1116468|NCT01700192|3660968|P2|Overall Study|Physician Decision|3
1116469|NCT01700192|3660969|P1|Overall Study|Physician Decision|2
1116470|NCT01700192|3660968|P2|Overall Study|Noncompliance with study drug|5
1116471|NCT01700192|3660969|P1|Overall Study|Noncompliance with study drug|0
1116472|NCT01700192|3660968|P2|Overall Study|Lost to Follow-up|29
1119340|NCT01667900|3670749|P4|Part B|Death|0
1116473|NCT01700192|3660969|P1|Overall Study|Lost to Follow-up|42
1116474|NCT01700192|3660968|P2|Overall Study|Lack of Efficacy|0
1116475|NCT01700192|3660969|P1|Overall Study|Lack of Efficacy|1
1116476|NCT01700192|3660968|P2|Overall Study|Adverse Event|18
1116477|NCT01700192|3660969|P1|Overall Study|Adverse Event|73
1116478|NCT01700179|3660987|P1|Overall Study|Physician Decision|2
1116479|NCT01700140|3660994|P3|Overall Study|Inclusion/exclusion criteria deviation|0
1116480|NCT01700140|3660995|P2|Overall Study|Inclusion/exclusion criteria deviation|4
1116481|NCT01700140|3660996|P1|Overall Study|Inclusion/exclusion criteria deviation|1
1116482|NCT01700140|3660994|P3|Overall Study|Adverse Event|0
1116483|NCT01700140|3660995|P2|Overall Study|Adverse Event|1
1116484|NCT01700140|3660996|P1|Overall Study|Adverse Event|0
1116485|NCT01700140|3660994|P3|Overall Study|Aggravation of symptoms|0
1116486|NCT01700140|3660995|P2|Overall Study|Aggravation of symptoms|0
1116487|NCT01700140|3660996|P1|Overall Study|Aggravation of symptoms|1
1116488|NCT01700140|3660994|P3|Overall Study|Use of chemotherapy or surgical therapy|0
1116489|NCT01700140|3660995|P2|Overall Study|Use of chemotherapy or surgical therapy|1
1116490|NCT01700140|3660996|P1|Overall Study|Use of chemotherapy or surgical therapy|0
1116491|NCT01700140|3660994|P3|Overall Study|Discontinuation of radiotherapy|0
1116492|NCT01700140|3660995|P2|Overall Study|Discontinuation of radiotherapy|0
1116493|NCT01700140|3660996|P1|Overall Study|Discontinuation of radiotherapy|1
1116494|NCT01700140|3660994|P3|Overall Study|Use of rescue drugs|1
1116495|NCT01700140|3660995|P2|Overall Study|Use of rescue drugs|3
1116496|NCT01700140|3660996|P1|Overall Study|Use of rescue drugs|3
1116497|NCT01699867|3661037|P1|Overall Study|Screening Failure|3
1116498|NCT01699815|3661044|P2|Overall Study|Adverse Event|1
1116499|NCT01699815|3661045|P1|Overall Study|Adverse Event|0
1116500|NCT01699815|3661044|P2|Overall Study|record could not be located|0
1116501|NCT01699815|3661045|P1|Overall Study|record could not be located|1
1116502|NCT01699815|3661044|P2|Overall Study|Protocol Violation|7
1116503|NCT01699815|3661045|P1|Overall Study|Protocol Violation|4
1116504|NCT01699789|3661057|P2|Overall Study|Lost to Follow-up|101
1116505|NCT01699789|3661058|P1|Overall Study|Lost to Follow-up|83
1116506|NCT01699789|3661057|P2|Overall Study|Death|2
1116507|NCT01699789|3661058|P1|Overall Study|Death|1
1116508|NCT01699789|3661057|P2|Overall Study|Withdrawal by Subject|23
1116509|NCT01699789|3661058|P1|Overall Study|Withdrawal by Subject|18
1116510|NCT01699750|3661128|P2|Overall Study|Other|2
1116511|NCT01699750|3661129|P1|Overall Study|Other|0
1116512|NCT01699750|3661128|P2|Overall Study|Withdrew Consent|1
1116513|NCT01699750|3661129|P1|Overall Study|Withdrew Consent|0
1116514|NCT01699685|3661164|P2|Period 2|Lost to Follow-up|0
1116515|NCT01699685|3661165|P1|Period 2|Lost to Follow-up|1
1116516|NCT01699685|3661164|P2|Period 1|Patient request|1
1116517|NCT01699685|3661165|P1|Period 1|Patient request|0
1116518|NCT01699685|3661164|P2|Period 1|Other|1
1116519|NCT01699685|3661165|P1|Period 1|Other|0
1116520|NCT01699685|3661164|P2|Period 1|Medical or ethical, noncompliance|0
1116521|NCT01699685|3661165|P1|Period 1|Medical or ethical, noncompliance|2
1116522|NCT01699685|3661164|P2|Period 1|Adverse Event|1
1116523|NCT01699685|3661165|P1|Period 1|Adverse Event|1
1116524|NCT01699178|3661200|P2|Overall Study|ineligible/noncompliant/ subject reason|4
1116525|NCT01699178|3661201|P1|Overall Study|ineligible/noncompliant/ subject reason|4
1116526|NCT01699178|3661200|P2|Overall Study|PSA increase of >1.4 ng/mL|3
1116527|NCT01699178|3661201|P1|Overall Study|PSA increase of >1.4 ng/mL|4
1116528|NCT01699178|3661200|P2|Overall Study|Hematocrit >54%|1
1116529|NCT01699178|3661201|P1|Overall Study|Hematocrit >54%|1
1116530|NCT01699178|3661200|P2|Overall Study|Withdrawal by Subject|12
1116531|NCT01699178|3661201|P1|Overall Study|Withdrawal by Subject|4
1116532|NCT01699178|3661200|P2|Overall Study|Physician Decision|0
1116533|NCT01699178|3661201|P1|Overall Study|Physician Decision|1
1116534|NCT01699178|3661200|P2|Overall Study|Non-compliance with Study Drug|1
1116535|NCT01699178|3661201|P1|Overall Study|Non-compliance with Study Drug|3
1116536|NCT01699178|3661200|P2|Overall Study|Lost to Follow-up|6
1116537|NCT01699178|3661201|P1|Overall Study|Lost to Follow-up|1
1116538|NCT01699178|3661200|P2|Overall Study|Adverse Event|5
1116539|NCT01699178|3661201|P1|Overall Study|Adverse Event|1
1116540|NCT01699087|3661217|P1|Overall Study|Unable to make future visits|2
1116541|NCT01699087|3661217|P1|Overall Study|Screen failure (prior to treatment)|15
1116542|NCT01699087|3661217|P1|Overall Study|Lost to Follow-up|7
1116543|NCT01699022|3661231|P1|Overall Study|Early discontinuation from the study|3
1116544|NCT01698814|3661246|P2|Overall Study|Randomized in error|0
1116545|NCT01698814|3661247|P1|Overall Study|Randomized in error|1
1116546|NCT01698814|3661246|P2|Overall Study|Pregnancy|0
1116547|NCT01698814|3661247|P1|Overall Study|Pregnancy|1
1116548|NCT01698814|3661246|P2|Overall Study|Lost to Follow-up|1
1116549|NCT01698814|3661247|P1|Overall Study|Lost to Follow-up|0
1116550|NCT01698814|3661246|P2|Overall Study|Adverse Event|2
1116551|NCT01698814|3661247|P1|Overall Study|Adverse Event|0
1116552|NCT01698801|3661253|P1|Follow Up Phase|Death|4
1116553|NCT01698801|3661253|P1|Follow Up Phase|Withdrawal by Subject|1
1116554|NCT01698801|3661253|P1|Treatment Phase|Disease progression|1
1116555|NCT01698801|3661253|P1|Treatment Phase|Withdrawal by Subject|1
1116556|NCT01698801|3661253|P1|Treatment Phase|Not specified|4
1116557|NCT01698801|3661253|P1|Treatment Phase|Protocol Violation|1
1116558|NCT01698801|3661253|P1|Treatment Phase|Adverse Event|4
1116559|NCT01698775|3661264|P2|Phase B|Withdrawal by Subject|2
1116560|NCT01698775|3661265|P1|Phase B|Withdrawal by Subject|6
1116561|NCT01698775|3661264|P2|Phase B|Protocol Violation|1
1116562|NCT01698775|3661265|P1|Phase B|Protocol Violation|1
1116563|NCT01698775|3661264|P2|Phase B|Physician Decision|1
1116564|NCT01698775|3661265|P1|Phase B|Physician Decision|1
1116565|NCT01698775|3661264|P2|Phase B|Lost to Follow-up|1
1116566|NCT01698775|3661265|P1|Phase B|Lost to Follow-up|0
1116567|NCT01698775|3661264|P2|Phase B|Lack of Efficacy|1
1116568|NCT01698775|3661265|P1|Phase B|Lack of Efficacy|0
1116569|NCT01698775|3661264|P2|Phase B|Death|1
1116570|NCT01698775|3661265|P1|Phase B|Death|0
1116571|NCT01698775|3661264|P2|Phase B|Adverse Event|3
1116572|NCT01698775|3661265|P1|Phase B|Adverse Event|6
1116573|NCT01698775|3661264|P2|Phase B|Hyperglycemia Discontinuation Criteria|1
1116574|NCT01698775|3661265|P1|Phase B|Hyperglycemia Discontinuation Criteria|0
1116575|NCT01698775|3661264|P2|Phase A|Kidney [transplant]|1
1116576|NCT01698775|3661265|P1|Phase A|Kidney [transplant]|0
1116577|NCT01698775|3661264|P2|Phase A|Withdrawal by Subject|4
1116578|NCT01698775|3661265|P1|Phase A|Withdrawal by Subject|3
1116579|NCT01698775|3661264|P2|Phase A|Protocol Violation|0
1116580|NCT01698775|3661265|P1|Phase A|Protocol Violation|1
1116581|NCT01698775|3661264|P2|Phase A|Lost to Follow-up|2
1116582|NCT01698775|3661265|P1|Phase A|Lost to Follow-up|1
1116583|NCT01698775|3661264|P2|Phase A|Lack of Efficacy|0
1116584|NCT01698775|3661265|P1|Phase A|Lack of Efficacy|1
1116585|NCT01698775|3661264|P2|Phase A|Death|1
1116586|NCT01698775|3661265|P1|Phase A|Death|1
1116587|NCT01698775|3661264|P2|Phase A|Adverse Event|1
1116588|NCT01698775|3661265|P1|Phase A|Adverse Event|2
1116589|NCT01698554|3661314|P4|Overall Study|Other Miscellaneous Reasons|0
1116590|NCT01698554|3661315|P3|Overall Study|Other Miscellaneous Reasons|0
1116591|NCT01698554|3661316|P2|Overall Study|Other Miscellaneous Reasons|0
1116592|NCT01698554|3661317|P1|Overall Study|Other Miscellaneous Reasons|1
1116593|NCT01698554|3661314|P4|Overall Study|Protocol Violation|0
1116594|NCT01698554|3661315|P3|Overall Study|Protocol Violation|1
1116595|NCT01698554|3661316|P2|Overall Study|Protocol Violation|0
1116596|NCT01698554|3661317|P1|Overall Study|Protocol Violation|2
1116597|NCT01698554|3661314|P4|Overall Study|Personal Reasons|1
1116598|NCT01698554|3661315|P3|Overall Study|Personal Reasons|1
1116599|NCT01698554|3661316|P2|Overall Study|Personal Reasons|5
1116600|NCT01698554|3661317|P1|Overall Study|Personal Reasons|0
1116601|NCT01698554|3661314|P4|Overall Study|Lost to Follow-up|0
1116602|NCT01698554|3661315|P3|Overall Study|Lost to Follow-up|0
1116603|NCT01698554|3661316|P2|Overall Study|Lost to Follow-up|0
1116604|NCT01698554|3661317|P1|Overall Study|Lost to Follow-up|1
1116605|NCT01698554|3661314|P4|Overall Study|Adverse Event|1
1116606|NCT01698554|3661315|P3|Overall Study|Adverse Event|0
1116607|NCT01698554|3661316|P2|Overall Study|Adverse Event|5
1116608|NCT01698554|3661317|P1|Overall Study|Adverse Event|2
1116609|NCT01698320|3661377|P3|40-Week Open-Label Period|Lost to Follow-up|0
1116610|NCT01698320|3661378|P2|40-Week Open-Label Period|Lost to Follow-up|2
1116611|NCT01698320|3661379|P1|40-Week Open-Label Period|Lost to Follow-up|0
1116612|NCT01698320|3661377|P3|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
1116613|NCT01698320|3661378|P2|40-Week Open-Label Period|Sponsor requested subject withdrawal|1
1116614|NCT01698320|3661379|P1|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
1116615|NCT01698320|3661377|P3|40-Week Open-Label Period|Pregnancy|1
1116616|NCT01698320|3661378|P2|40-Week Open-Label Period|Pregnancy|2
1116617|NCT01698320|3661379|P1|40-Week Open-Label Period|Pregnancy|0
1116618|NCT01698320|3661377|P3|40-Week Open-Label Period|Withdrawal by Subject|7
1116619|NCT01698320|3661378|P2|40-Week Open-Label Period|Withdrawal by Subject|11
1116620|NCT01698320|3661379|P1|40-Week Open-Label Period|Withdrawal by Subject|0
1116621|NCT01698320|3661377|P3|40-Week Open-Label Period|Adverse Event|2
1116622|NCT01698320|3661378|P2|40-Week Open-Label Period|Adverse Event|3
1116623|NCT01698320|3661379|P1|40-Week Open-Label Period|Adverse Event|0
1116624|NCT01698320|3661377|P3|12-Week Double-Blind Period|Lost to Follow-up|4
1116625|NCT01698320|3661378|P2|12-Week Double-Blind Period|Lost to Follow-up|0
1116626|NCT01698320|3661379|P1|12-Week Double-Blind Period|Lost to Follow-up|0
1116627|NCT01698320|3661377|P3|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2
1116628|NCT01698320|3661378|P2|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
1116629|NCT01698320|3661379|P1|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
1116630|NCT01698320|3661377|P3|12-Week Double-Blind Period|Pregnancy|1
1116631|NCT01698320|3661378|P2|12-Week Double-Blind Period|Pregnancy|1
1116632|NCT01698320|3661379|P1|12-Week Double-Blind Period|Pregnancy|0
1116633|NCT01698320|3661377|P3|12-Week Double-Blind Period|Protocol Violation|2
1116634|NCT01698320|3661378|P2|12-Week Double-Blind Period|Protocol Violation|0
1116635|NCT01698320|3661379|P1|12-Week Double-Blind Period|Protocol Violation|0
1116636|NCT01698320|3661377|P3|12-Week Double-Blind Period|Withdrawal by Subject|2
1116637|NCT01698320|3661378|P2|12-Week Double-Blind Period|Withdrawal by Subject|2
1116638|NCT01698320|3661379|P1|12-Week Double-Blind Period|Withdrawal by Subject|0
1116639|NCT01698320|3661377|P3|12-Week Double-Blind Period|Adverse Event|1
1116640|NCT01698320|3661378|P2|12-Week Double-Blind Period|Adverse Event|1
1116641|NCT01698320|3661379|P1|12-Week Double-Blind Period|Adverse Event|0
1116642|NCT01698320|3661377|P3|Run-In Period (Week -1 to Day 0)|Not specified|0
1116643|NCT01698320|3661378|P2|Run-In Period (Week -1 to Day 0)|Not specified|0
1116644|NCT01698320|3661379|P1|Run-In Period (Week -1 to Day 0)|Not specified|1
1116645|NCT01698320|3661377|P3|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
1116646|NCT01698320|3661378|P2|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
1116647|NCT01698320|3661379|P1|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1
1116648|NCT01698320|3661377|P3|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
1116649|NCT01698320|3661378|P2|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
1116650|NCT01698320|3661379|P1|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1
1116651|NCT01698320|3661377|P3|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
1116652|NCT01698320|3661378|P2|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
1116653|NCT01698320|3661379|P1|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24
1116654|NCT01698268|3661399|P2|Overall Study|Physician Decision|1
1116655|NCT01698268|3661400|P1|Overall Study|Physician Decision|2
1116656|NCT01698008|3661408|P2|Overall Study|Withdrawal by Subject|2
1116657|NCT01698008|3661409|P1|Overall Study|Withdrawal by Subject|1
1116658|NCT01697969|3661415|P1|Overall Study|Did not meet inc/exc criteria|3
1116659|NCT01697956|3661422|P2|Overall Study|Protocol Violation|1
1116660|NCT01697956|3661423|P1|Overall Study|Protocol Violation|1
1116661|NCT01697748|3661453|P2|Overall Study|Lost to Follow-up|65
1116662|NCT01697748|3661454|P1|Overall Study|Lost to Follow-up|53
1116663|NCT01697748|3661453|P2|Overall Study|ineligible uterine incision|1
1116664|NCT01697748|3661454|P1|Overall Study|ineligible uterine incision|4
1116665|NCT01697748|3661453|P2|Overall Study|ineligible skin incision|2
1116666|NCT01697748|3661454|P1|Overall Study|ineligible skin incision|1
1116667|NCT01697696|3661464|P2|Overall Study|Subject/guardian decision|35
1116668|NCT01697696|3661465|P1|Overall Study|Subject/guardian decision|31
1116669|NCT01697696|3661464|P2|Overall Study|Lost to Follow-up|7
1116670|NCT01697696|3661465|P1|Overall Study|Lost to Follow-up|10
1116671|NCT01697696|3661464|P2|Overall Study|Death|2
1116672|NCT01697696|3661465|P1|Overall Study|Death|4
1116673|NCT01697696|3661464|P2|Overall Study|Physician Decision|0
1116674|NCT01697696|3661465|P1|Overall Study|Physician Decision|1
1116675|NCT01697696|3661464|P2|Overall Study|Protocol deviation|0
1116676|NCT01697696|3661465|P1|Overall Study|Protocol deviation|1
1116677|NCT01697696|3661464|P2|Overall Study|Study terminated by sponsor|3
1116678|NCT01697696|3661465|P1|Overall Study|Study terminated by sponsor|0
1116679|NCT01697592|3661497|P10|Phase B (Week 25 to Week 52)|Adverse Event|0
1116680|NCT01697592|3661498|P9|Phase B (Week 25 to Week 52)|Adverse Event|2
1116681|NCT01697592|3661499|P8|Phase B (Week 25 to Week 52)|Adverse Event|0
1116682|NCT01697592|3661500|P7|Phase B (Week 25 to Week 52)|Adverse Event|1
1116683|NCT01697592|3661501|P6|Phase B (Week 25 to Week 52)|Adverse Event|1
1116684|NCT01697592|3661502|P5|Phase B (Week 25 to Week 52)|Adverse Event|0
1116685|NCT01697592|3661503|P4|Phase B (Week 25 to Week 52)|Adverse Event|2
1116686|NCT01697592|3661504|P3|Phase B (Week 25 to Week 52)|Adverse Event|1
1116687|NCT01697592|3661505|P2|Phase B (Week 25 to Week 52)|Adverse Event|1
1116688|NCT01697592|3661506|P1|Phase B (Week 25 to Week 52)|Adverse Event|2
1116689|NCT01697592|3661497|P10|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
1116690|NCT01697592|3661498|P9|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
1116691|NCT01697592|3661499|P8|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
1116692|NCT01697592|3661500|P7|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
1116693|NCT01697592|3661501|P6|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
1116694|NCT01697592|3661502|P5|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
1116695|NCT01697592|3661503|P4|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
1116696|NCT01697592|3661504|P3|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
1116697|NCT01697592|3661505|P2|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
1116698|NCT01697592|3661506|P1|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2
1116699|NCT01697592|3661497|P10|Phase B (Week 25 to Week 52)|Physician Decision|0
1116700|NCT01697592|3661498|P9|Phase B (Week 25 to Week 52)|Physician Decision|0
1116701|NCT01697592|3661499|P8|Phase B (Week 25 to Week 52)|Physician Decision|0
1116702|NCT01697592|3661500|P7|Phase B (Week 25 to Week 52)|Physician Decision|0
1116703|NCT01697592|3661501|P6|Phase B (Week 25 to Week 52)|Physician Decision|0
1116704|NCT01697592|3661502|P5|Phase B (Week 25 to Week 52)|Physician Decision|0
1116705|NCT01697592|3661503|P4|Phase B (Week 25 to Week 52)|Physician Decision|1
1116706|NCT01697592|3661504|P3|Phase B (Week 25 to Week 52)|Physician Decision|0
1116707|NCT01697592|3661505|P2|Phase B (Week 25 to Week 52)|Physician Decision|0
1116708|NCT01697592|3661506|P1|Phase B (Week 25 to Week 52)|Physician Decision|1
1116709|NCT01697592|3661497|P10|Phase A (Up to 24 Weeks)|Adverse Event|1
1116710|NCT01697592|3661498|P9|Phase A (Up to 24 Weeks)|Adverse Event|0
1116711|NCT01697592|3661499|P8|Phase A (Up to 24 Weeks)|Adverse Event|0
1116712|NCT01697592|3661500|P7|Phase A (Up to 24 Weeks)|Adverse Event|1
1116713|NCT01697592|3661501|P6|Phase A (Up to 24 Weeks)|Adverse Event|0
1116714|NCT01697592|3661502|P5|Phase A (Up to 24 Weeks)|Adverse Event|0
1116715|NCT01697592|3661503|P4|Phase A (Up to 24 Weeks)|Adverse Event|2
1116716|NCT01697592|3661504|P3|Phase A (Up to 24 Weeks)|Adverse Event|1
1116717|NCT01697592|3661505|P2|Phase A (Up to 24 Weeks)|Adverse Event|2
1116718|NCT01697592|3661506|P1|Phase A (Up to 24 Weeks)|Adverse Event|0
1116719|NCT01697592|3661497|P10|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
1116720|NCT01697592|3661498|P9|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
1116721|NCT01697592|3661499|P8|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
1116722|NCT01697592|3661500|P7|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
1116723|NCT01697592|3661501|P6|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
1119341|NCT01667900|3670750|P3|Part B|Death|0
1116724|NCT01697592|3661502|P5|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
1116725|NCT01697592|3661503|P4|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
1116726|NCT01697592|3661504|P3|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
1116727|NCT01697592|3661505|P2|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
1116728|NCT01697592|3661506|P1|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
1116729|NCT01697592|3661497|P10|Phase A (Up to 24 Weeks)|Protocol Violation|0
1116730|NCT01697592|3661498|P9|Phase A (Up to 24 Weeks)|Protocol Violation|0
1116731|NCT01697592|3661499|P8|Phase A (Up to 24 Weeks)|Protocol Violation|0
1116732|NCT01697592|3661500|P7|Phase A (Up to 24 Weeks)|Protocol Violation|0
1116733|NCT01697592|3661501|P6|Phase A (Up to 24 Weeks)|Protocol Violation|0
1116734|NCT01697592|3661502|P5|Phase A (Up to 24 Weeks)|Protocol Violation|0
1116735|NCT01697592|3661503|P4|Phase A (Up to 24 Weeks)|Protocol Violation|0
1116736|NCT01697592|3661504|P3|Phase A (Up to 24 Weeks)|Protocol Violation|0
1116737|NCT01697592|3661505|P2|Phase A (Up to 24 Weeks)|Protocol Violation|0
1116738|NCT01697592|3661506|P1|Phase A (Up to 24 Weeks)|Protocol Violation|1
1116739|NCT01697592|3661497|P10|Phase A (Up to 24 Weeks)|Physician Decision|0
1116740|NCT01697592|3661498|P9|Phase A (Up to 24 Weeks)|Physician Decision|0
1116741|NCT01697592|3661499|P8|Phase A (Up to 24 Weeks)|Physician Decision|0
1116742|NCT01697592|3661500|P7|Phase A (Up to 24 Weeks)|Physician Decision|0
1116743|NCT01697592|3661501|P6|Phase A (Up to 24 Weeks)|Physician Decision|1
1116744|NCT01697592|3661502|P5|Phase A (Up to 24 Weeks)|Physician Decision|0
1116745|NCT01697592|3661503|P4|Phase A (Up to 24 Weeks)|Physician Decision|0
1116746|NCT01697592|3661504|P3|Phase A (Up to 24 Weeks)|Physician Decision|0
1116747|NCT01697592|3661505|P2|Phase A (Up to 24 Weeks)|Physician Decision|0
1116748|NCT01697592|3661506|P1|Phase A (Up to 24 Weeks)|Physician Decision|0
1116749|NCT01697592|3661497|P10|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
1116750|NCT01697592|3661498|P9|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
1116751|NCT01697592|3661499|P8|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
1116752|NCT01697592|3661500|P7|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
1116753|NCT01697592|3661501|P6|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
1116754|NCT01697592|3661502|P5|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
1116755|NCT01697592|3661503|P4|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
1116756|NCT01697592|3661504|P3|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
1116757|NCT01697592|3661505|P2|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
1116758|NCT01697592|3661506|P1|Phase A (Up to 24 Weeks)|Lost to Follow-up|1
1116759|NCT01697579|3661575|P7|Optional Extension-Cycles 2-6|Lost to Follow-up|1
1116760|NCT01697579|3661576|P6|Optional Extension-Cycles 2-6|Lost to Follow-up|0
1116761|NCT01697579|3661577|P5|Optional Extension-Cycles 2-6|Lost to Follow-up|0
1116762|NCT01697579|3661578|P4|Optional Extension-Cycles 2-6|Lost to Follow-up|0
1116763|NCT01697579|3661579|P3|Optional Extension-Cycles 2-6|Lost to Follow-up|0
1116764|NCT01697579|3661580|P2|Optional Extension-Cycles 2-6|Lost to Follow-up|0
1116765|NCT01697579|3661581|P1|Optional Extension-Cycles 2-6|Lost to Follow-up|0
1116766|NCT01697579|3661575|P7|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4
1116767|NCT01697579|3661576|P6|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6
1116768|NCT01697579|3661577|P5|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
1116769|NCT01697579|3661578|P4|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
1116770|NCT01697579|3661579|P3|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
1116771|NCT01697579|3661580|P2|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
1116772|NCT01697579|3661581|P1|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
1116773|NCT01697579|3661575|P7|Optional Extension-Cycles 2-6|Participant Moved|2
1116774|NCT01697579|3661576|P6|Optional Extension-Cycles 2-6|Participant Moved|0
1116775|NCT01697579|3661577|P5|Optional Extension-Cycles 2-6|Participant Moved|0
1116776|NCT01697579|3661578|P4|Optional Extension-Cycles 2-6|Participant Moved|0
1116777|NCT01697579|3661579|P3|Optional Extension-Cycles 2-6|Participant Moved|0
1116778|NCT01697579|3661580|P2|Optional Extension-Cycles 2-6|Participant Moved|0
1116779|NCT01697579|3661581|P1|Optional Extension-Cycles 2-6|Participant Moved|0
1116780|NCT01697579|3661575|P7|Optional Extension-Cycles 2-6|Technical Problems|1
1116781|NCT01697579|3661576|P6|Optional Extension-Cycles 2-6|Technical Problems|0
1116782|NCT01697579|3661577|P5|Optional Extension-Cycles 2-6|Technical Problems|0
1116783|NCT01697579|3661578|P4|Optional Extension-Cycles 2-6|Technical Problems|0
1116784|NCT01697579|3661579|P3|Optional Extension-Cycles 2-6|Technical Problems|0
1116785|NCT01697579|3661580|P2|Optional Extension-Cycles 2-6|Technical Problems|0
1116786|NCT01697579|3661581|P1|Optional Extension-Cycles 2-6|Technical Problems|0
1116787|NCT01697579|3661575|P7|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2
1116788|NCT01697579|3661576|P6|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
1116789|NCT01697579|3661577|P5|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
1116790|NCT01697579|3661578|P4|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
1116791|NCT01697579|3661579|P3|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
1116792|NCT01697579|3661580|P2|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
1116793|NCT01697579|3661581|P1|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
1116794|NCT01697579|3661575|P7|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11
1116795|NCT01697579|3661576|P6|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4
1116796|NCT01697579|3661577|P5|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
1116797|NCT01697579|3661578|P4|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
1116798|NCT01697579|3661579|P3|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
1116799|NCT01697579|3661580|P2|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
1116800|NCT01697579|3661581|P1|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
1116801|NCT01697579|3661575|P7|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24
1116802|NCT01697579|3661576|P6|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15
1116803|NCT01697579|3661577|P5|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
1116804|NCT01697579|3661578|P4|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
1116805|NCT01697579|3661579|P3|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
1116806|NCT01697579|3661580|P2|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
1116807|NCT01697579|3661581|P1|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
1116808|NCT01697579|3661575|P7|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
1116809|NCT01697579|3661576|P6|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1
1116810|NCT01697579|3661577|P5|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
1116811|NCT01697579|3661578|P4|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
1116812|NCT01697579|3661579|P3|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
1116813|NCT01697579|3661580|P2|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
1116814|NCT01697579|3661581|P1|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
1116815|NCT01697579|3661575|P7|Optional Extension-Cycles 2-6|Excluded Medication|2
1116816|NCT01697579|3661576|P6|Optional Extension-Cycles 2-6|Excluded Medication|1
1116817|NCT01697579|3661577|P5|Optional Extension-Cycles 2-6|Excluded Medication|0
1116818|NCT01697579|3661578|P4|Optional Extension-Cycles 2-6|Excluded Medication|0
1116819|NCT01697579|3661579|P3|Optional Extension-Cycles 2-6|Excluded Medication|0
1116820|NCT01697579|3661580|P2|Optional Extension-Cycles 2-6|Excluded Medication|0
1116821|NCT01697579|3661581|P1|Optional Extension-Cycles 2-6|Excluded Medication|0
1116822|NCT01697579|3661575|P7|Optional Extension-Cycles 2-6|Protocol Violation|4
1116823|NCT01697579|3661576|P6|Optional Extension-Cycles 2-6|Protocol Violation|0
1116824|NCT01697579|3661577|P5|Optional Extension-Cycles 2-6|Protocol Violation|0
1116825|NCT01697579|3661578|P4|Optional Extension-Cycles 2-6|Protocol Violation|0
1116826|NCT01697579|3661579|P3|Optional Extension-Cycles 2-6|Protocol Violation|0
1116827|NCT01697579|3661580|P2|Optional Extension-Cycles 2-6|Protocol Violation|0
1116828|NCT01697579|3661581|P1|Optional Extension-Cycles 2-6|Protocol Violation|0
1116829|NCT01697579|3661575|P7|Optional Extension-Cycles 2-6|Physician Decision|11
1116830|NCT01697579|3661576|P6|Optional Extension-Cycles 2-6|Physician Decision|7
1116831|NCT01697579|3661577|P5|Optional Extension-Cycles 2-6|Physician Decision|0
1116832|NCT01697579|3661578|P4|Optional Extension-Cycles 2-6|Physician Decision|0
1116833|NCT01697579|3661579|P3|Optional Extension-Cycles 2-6|Physician Decision|0
1116834|NCT01697579|3661580|P2|Optional Extension-Cycles 2-6|Physician Decision|0
1116835|NCT01697579|3661581|P1|Optional Extension-Cycles 2-6|Physician Decision|0
1116836|NCT01697579|3661575|P7|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5
1116837|NCT01697579|3661576|P6|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1
1116838|NCT01697579|3661577|P5|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
1116839|NCT01697579|3661578|P4|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
1116840|NCT01697579|3661579|P3|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
1116841|NCT01697579|3661580|P2|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
1116842|NCT01697579|3661581|P1|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
1116843|NCT01697579|3661575|P7|Optional Extension-Cycles 2-6|Death|2
1116844|NCT01697579|3661576|P6|Optional Extension-Cycles 2-6|Death|0
1116845|NCT01697579|3661577|P5|Optional Extension-Cycles 2-6|Death|0
1116846|NCT01697579|3661578|P4|Optional Extension-Cycles 2-6|Death|0
1116847|NCT01697579|3661579|P3|Optional Extension-Cycles 2-6|Death|0
1116848|NCT01697579|3661580|P2|Optional Extension-Cycles 2-6|Death|0
1116849|NCT01697579|3661581|P1|Optional Extension-Cycles 2-6|Death|0
1116850|NCT01697579|3661575|P7|Base Study-Cycle 1|Technical Problems|0
1116851|NCT01697579|3661576|P6|Base Study-Cycle 1|Technical Problems|0
1116852|NCT01697579|3661577|P5|Base Study-Cycle 1|Technical Problems|0
1116853|NCT01697579|3661578|P4|Base Study-Cycle 1|Technical Problems|1
1116854|NCT01697579|3661579|P3|Base Study-Cycle 1|Technical Problems|1
1116855|NCT01697579|3661580|P2|Base Study-Cycle 1|Technical Problems|0
1116856|NCT01697579|3661581|P1|Base Study-Cycle 1|Technical Problems|0
1116857|NCT01697579|3661575|P7|Base Study-Cycle 1|Consent Withdrawn by Participant|0
1116858|NCT01697579|3661576|P6|Base Study-Cycle 1|Consent Withdrawn by Participant|0
1116859|NCT01697579|3661577|P5|Base Study-Cycle 1|Consent Withdrawn by Participant|0
1116860|NCT01697579|3661578|P4|Base Study-Cycle 1|Consent Withdrawn by Participant|0
1116861|NCT01697579|3661579|P3|Base Study-Cycle 1|Consent Withdrawn by Participant|0
1116862|NCT01697579|3661580|P2|Base Study-Cycle 1|Consent Withdrawn by Participant|1
1116863|NCT01697579|3661581|P1|Base Study-Cycle 1|Consent Withdrawn by Participant|0
1116864|NCT01697579|3661575|P7|Base Study-Cycle 1|Protocol Violation|0
1116865|NCT01697579|3661576|P6|Base Study-Cycle 1|Protocol Violation|0
1116866|NCT01697579|3661577|P5|Base Study-Cycle 1|Protocol Violation|3
1116867|NCT01697579|3661578|P4|Base Study-Cycle 1|Protocol Violation|0
1116868|NCT01697579|3661579|P3|Base Study-Cycle 1|Protocol Violation|0
1116869|NCT01697579|3661580|P2|Base Study-Cycle 1|Protocol Violation|0
1116870|NCT01697579|3661581|P1|Base Study-Cycle 1|Protocol Violation|0
1116871|NCT01697579|3661575|P7|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
1116872|NCT01697579|3661576|P6|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
1119342|NCT01667900|3670751|P2|Part B|Death|0
1116873|NCT01697579|3661577|P5|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
1116874|NCT01697579|3661578|P4|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
1116875|NCT01697579|3661579|P3|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
1116876|NCT01697579|3661580|P2|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
1116877|NCT01697579|3661581|P1|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1
1116878|NCT01697579|3661575|P7|Base Study-Cycle 1|Adverse Event|0
1116879|NCT01697579|3661576|P6|Base Study-Cycle 1|Adverse Event|0
1116880|NCT01697579|3661577|P5|Base Study-Cycle 1|Adverse Event|0
1116881|NCT01697579|3661578|P4|Base Study-Cycle 1|Adverse Event|0
1116882|NCT01697579|3661579|P3|Base Study-Cycle 1|Adverse Event|0
1116883|NCT01697579|3661580|P2|Base Study-Cycle 1|Adverse Event|0
1116884|NCT01697579|3661581|P1|Base Study-Cycle 1|Adverse Event|1
1116885|NCT01697501|3661693|P1|Overall Study|Protocol Violation|2
1116886|NCT01697462|3661736|P1|Overall Study|Missing|5
1116887|NCT01697462|3661736|P1|Overall Study|Other|10
1116888|NCT01697462|3661736|P1|Overall Study|Death|1
1116889|NCT01697462|3661736|P1|Overall Study|Investigator Decision|21
1116890|NCT01697462|3661736|P1|Overall Study|Withdrawal by Subject|12
1116891|NCT01697462|3661736|P1|Overall Study|Lost to Follow-up|21
1116892|NCT01697462|3661736|P1|Overall Study|Adverse Event|6
1116893|NCT01697462|3661736|P1|Overall Study|Disease Progression|1
1116894|NCT01697449|3661743|P1|Overall Study|Missing|25
1116895|NCT01697449|3661743|P1|Overall Study|Other|1
1116896|NCT01697449|3661743|P1|Overall Study|Death|2
1116897|NCT01697449|3661743|P1|Overall Study|Physician Decision|1
1116898|NCT01697449|3661743|P1|Overall Study|Withdrawal by Subject|2
1116899|NCT01697449|3661743|P1|Overall Study|Lost to Follow-up|5
1116900|NCT01697449|3661743|P1|Overall Study|Adverse Event|7
1116901|NCT01697449|3661743|P1|Overall Study|Disease progression|47
1116902|NCT01697358|3661754|P2|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26
1116903|NCT01697358|3661755|P1|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34
1116904|NCT01697358|3661754|P2|Period II: 6-24M Long-term Follow-up|Adverse Event|3
1116905|NCT01697358|3661755|P1|Period II: 6-24M Long-term Follow-up|Adverse Event|0
1116906|NCT01697358|3661754|P2|Period II: 6-24M Long-term Follow-up|Death|1
1116907|NCT01697358|3661755|P1|Period II: 6-24M Long-term Follow-up|Death|1
1116908|NCT01697358|3661754|P2|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
1116909|NCT01697358|3661755|P1|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
1116910|NCT01697358|3661754|P2|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10
1116911|NCT01697358|3661755|P1|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8
1116912|NCT01697358|3661754|P2|Period II: 6-24M Long-term Follow-up|Physician Decision|12
1116913|NCT01697358|3661755|P1|Period II: 6-24M Long-term Follow-up|Physician Decision|3
1116914|NCT01697358|3661754|P2|Period I: Randomization to 6 Months|Lost to Follow-up|0
1116915|NCT01697358|3661755|P1|Period I: Randomization to 6 Months|Lost to Follow-up|2
1116916|NCT01697358|3661754|P2|Period I: Randomization to 6 Months|Adverse Event|1
1116917|NCT01697358|3661755|P1|Period I: Randomization to 6 Months|Adverse Event|1
1116918|NCT01697358|3661754|P2|Period I: Randomization to 6 Months|Physician Decision|0
1116919|NCT01697358|3661755|P1|Period I: Randomization to 6 Months|Physician Decision|4
1116920|NCT01697358|3661754|P2|Period I: Randomization to 6 Months|Withdrawal by Subject|0
1116921|NCT01697358|3661755|P1|Period I: Randomization to 6 Months|Withdrawal by Subject|6
1116922|NCT01697345|3661771|P1|Overall Study|Withdrawal by Subject|1
1116923|NCT01697319|3661796|P1|Extension Phase|Terminated by Sponsor|15
1116924|NCT01697319|3661796|P1|Primary Phase|Withdrawal by Subject|1
1116925|NCT01696994|3661805|P2|Overall Study|Refused Screen (Ovarian Screening)|3582
1116926|NCT01696994|3661806|P1|Overall Study|Refused Screen (Ovarian Screening)|0
1116927|NCT01696994|3661805|P2|Overall Study|Refused ASU (Control)|0
1116928|NCT01696994|3661806|P1|Overall Study|Refused ASU (Control)|311
1116929|NCT01696994|3661805|P2|Overall Study|No Ovaries at Baseline|4851
1116930|NCT01696994|3661806|P1|Overall Study|No Ovaries at Baseline|4807
1116931|NCT01696994|3661805|P2|Overall Study|Died Before ASU (Control)|0
1116932|NCT01696994|3661806|P1|Overall Study|Died Before ASU (Control)|73
1116933|NCT01696994|3661805|P2|Overall Study|Died Before Randomization|2
1116934|NCT01696994|3661806|P1|Overall Study|Died Before Randomization|1
1116935|NCT01696994|3661805|P2|Overall Study|Cancer Before Rand. (Ovarian Screening)|2
1116936|NCT01696994|3661806|P1|Overall Study|Cancer Before Rand. (Ovarian Screening)|0
1116937|NCT01696981|3661834|P2|Overall Study|Refused Screen (Colorectal Screening)|10346
1116938|NCT01696981|3661835|P1|Overall Study|Refused Screen (Colorectal Screening)|0
1116939|NCT01696981|3661834|P2|Overall Study|Refused ASU (Control)|0
1116940|NCT01696981|3661835|P1|Overall Study|Refused ASU (Control)|920
1116941|NCT01696981|3661834|P2|Overall Study|Died Before ASU (Control)|0
1116942|NCT01696981|3661835|P1|Overall Study|Died Before ASU (Control)|278
1116943|NCT01696981|3661834|P2|Overall Study|Died Before Randomization|8
1116944|NCT01696981|3661835|P1|Overall Study|Died Before Randomization|3
1116945|NCT01696981|3661834|P2|Overall Study|Cancer Before Rand. (Colo. Screening)|20
1116946|NCT01696981|3661835|P1|Overall Study|Cancer Before Rand. (Colo. Screening)|0
1116947|NCT01696968|3661855|P2|Overall Study|Refused Screen (Lung Screening)|6796
1116948|NCT01696968|3661856|P1|Overall Study|Refused Screen (Lung Screening)|0
1116949|NCT01696968|3661855|P2|Overall Study|Refused ASU (Control)|0
1116950|NCT01696968|3661856|P1|Overall Study|Refused ASU (Control)|920
1116951|NCT01696968|3661855|P2|Overall Study|Died Before ASU (Control)|0
1116952|NCT01696968|3661856|P1|Overall Study|Died Before ASU (Control)|278
1116953|NCT01696968|3661855|P2|Overall Study|Died Before Randomization|8
1116954|NCT01696968|3661856|P1|Overall Study|Died Before Randomization|3
1116955|NCT01696968|3661855|P2|Overall Study|Cancer Before Rand. (Lung Screening)|8
1116956|NCT01696968|3661856|P1|Overall Study|Cancer Before Rand. (Lung Screening)|0
1116957|NCT01696955|3661878|P2|Main Study|Withdrawal by Subject|1
1116958|NCT01696955|3661879|P1|Main Study|Withdrawal by Subject|1
1116959|NCT01696955|3661878|P2|Main Study|Protocol Violation|0
1116960|NCT01696955|3661879|P1|Main Study|Protocol Violation|1
1116961|NCT01696942|3661904|P2|Overall Study|screen failure|1
1116962|NCT01696942|3661905|P1|Overall Study|screen failure|0
1116963|NCT01696942|3661904|P2|Overall Study|Protocol Violation|2
1116964|NCT01696942|3661905|P1|Overall Study|Protocol Violation|1
1116965|NCT01696942|3661904|P2|Overall Study|Withdrawal by Subject|0
1116966|NCT01696942|3661905|P1|Overall Study|Withdrawal by Subject|1
1116967|NCT01696929|3661913|P1|Overall Study|Physician Decision|1
1116968|NCT01696877|3661920|P2|Overall Study|Adverse Event|1
1116969|NCT01696877|3661921|P1|Overall Study|Adverse Event|0
1116970|NCT01696773|3661935|P2|Days 15-27, Washout|Adverse Event|0
1116971|NCT01696773|3661936|P1|Days 15-27, Washout|Adverse Event|1
1116972|NCT01696695|3661963|P1|Overall Study|Major Protocol Violation|192
1116973|NCT01696695|3661963|P1|Overall Study|Other|74
1116974|NCT01696695|3661963|P1|Overall Study|Lost to Follow-up|48
1116975|NCT01696695|3661963|P1|Overall Study|Withdrawal by Subject|92
1116976|NCT01696695|3661963|P1|Overall Study|Adverse Event|74
1116977|NCT01696695|3661963|P1|Overall Study|Death|29
1116978|NCT01696695|3661963|P1|Overall Study|Disease progression|373
1116979|NCT01696643|3661975|P2|Overall Study|Participant Did Not Receive Study Drug|2
1116980|NCT01696643|3661976|P1|Overall Study|Participant Did Not Receive Study Drug|2
1116981|NCT01696643|3661975|P2|Overall Study|Medical Monitor Decision|2
1116982|NCT01696643|3661976|P1|Overall Study|Medical Monitor Decision|0
1116983|NCT01696643|3661975|P2|Overall Study|Participant Incarcerated|1
1116984|NCT01696643|3661976|P1|Overall Study|Participant Incarcerated|0
1116985|NCT01696643|3661975|P2|Overall Study|Site Error|1
1116986|NCT01696643|3661976|P1|Overall Study|Site Error|2
1116987|NCT01696643|3661975|P2|Overall Study|Participant on Restricted Bed Rest|0
1116988|NCT01696643|3661976|P1|Overall Study|Participant on Restricted Bed Rest|1
1116989|NCT01696643|3661975|P2|Overall Study|Withdrawal by Subject|149
1116990|NCT01696643|3661976|P1|Overall Study|Withdrawal by Subject|142
1116991|NCT01696643|3661975|P2|Overall Study|Study Terminated by Sponsor|294
1116992|NCT01696643|3661976|P1|Overall Study|Study Terminated by Sponsor|286
1116993|NCT01696643|3661975|P2|Overall Study|Protocol Violation|7
1116994|NCT01696643|3661976|P1|Overall Study|Protocol Violation|7
1116995|NCT01696643|3661975|P2|Overall Study|Pregnancy|1
1116996|NCT01696643|3661976|P1|Overall Study|Pregnancy|0
1116997|NCT01696643|3661975|P2|Overall Study|Physician Decision|2
1116998|NCT01696643|3661976|P1|Overall Study|Physician Decision|3
1116999|NCT01696643|3661975|P2|Overall Study|Lost to Follow-up|67
1117000|NCT01696643|3661976|P1|Overall Study|Lost to Follow-up|67
1117001|NCT01696643|3661975|P2|Overall Study|Lack of Efficacy|0
1117002|NCT01696643|3661976|P1|Overall Study|Lack of Efficacy|3
1117003|NCT01696643|3661975|P2|Overall Study|Death|2
1117004|NCT01696643|3661976|P1|Overall Study|Death|1
1117005|NCT01696643|3661975|P2|Overall Study|Adverse Event|7
1117006|NCT01696643|3661976|P1|Overall Study|Adverse Event|15
1117007|NCT01696214|3662004|P4|Overall Study|Lost to Follow-up|0
1117008|NCT01696214|3662005|P3|Overall Study|Lost to Follow-up|0
1117009|NCT01696214|3662006|P2|Overall Study|Lost to Follow-up|1
1117010|NCT01696214|3662007|P1|Overall Study|Lost to Follow-up|0
1117011|NCT01696188|3662027|P2|Overall Study|Protocol Violation|1
1117012|NCT01696188|3662028|P1|Overall Study|Protocol Violation|1
1117013|NCT01696071|3662059|P2|Treatment Period 2: 4 Weeks|Adverse Event|0
1117014|NCT01696071|3662060|P1|Treatment Period 2: 4 Weeks|Adverse Event|1
1117015|NCT01696058|3662088|P2|Overall Study|Other reason prematurely discontinued|3
1117016|NCT01696058|3662089|P1|Overall Study|Other reason prematurely discontinued|5
1117017|NCT01696058|3662088|P2|Overall Study|Withdrawal by Subject|6
1117018|NCT01696058|3662089|P1|Overall Study|Withdrawal by Subject|4
1117019|NCT01696058|3662088|P2|Overall Study|Lost to Follow-up|5
1117020|NCT01696058|3662089|P1|Overall Study|Lost to Follow-up|2
1117021|NCT01696058|3662088|P2|Overall Study|Protocol Violation|3
1117022|NCT01696058|3662089|P1|Overall Study|Protocol Violation|9
1117023|NCT01696058|3662088|P2|Overall Study|Lack of Efficacy|3
1117024|NCT01696058|3662089|P1|Overall Study|Lack of Efficacy|2
1117025|NCT01696058|3662088|P2|Overall Study|Adverse Event|11
1117026|NCT01696058|3662089|P1|Overall Study|Adverse Event|21
1117027|NCT01696045|3662117|P2|Overall Study|Disease progression|2
1117028|NCT01696045|3662118|P1|Overall Study|Disease progression|2
1117029|NCT01696045|3662117|P2|Overall Study|Study drug toxicity|5
1117030|NCT01696045|3662118|P1|Overall Study|Study drug toxicity|1
1117031|NCT01695993|3662137|P3|Overall Study|Changed Medical Facility|1
1117032|NCT01695993|3662138|P2|Overall Study|Changed Medical Facility|0
1117033|NCT01695993|3662139|P1|Overall Study|Changed Medical Facility|0
1117034|NCT01695993|3662137|P3|Overall Study|To ill to continue|0
1117035|NCT01695993|3662138|P2|Overall Study|To ill to continue|2
1117036|NCT01695993|3662139|P1|Overall Study|To ill to continue|1
1117037|NCT01695993|3662137|P3|Overall Study|Withdrawal by Subject|2
1117038|NCT01695993|3662138|P2|Overall Study|Withdrawal by Subject|2
1117039|NCT01695993|3662139|P1|Overall Study|Withdrawal by Subject|2
1117040|NCT01695993|3662137|P3|Overall Study|Lost to Follow-up|3
1117041|NCT01695993|3662138|P2|Overall Study|Lost to Follow-up|1
1117042|NCT01695993|3662139|P1|Overall Study|Lost to Follow-up|2
1117043|NCT01695772|3662147|P1|Overall Study|Unspecified Reason|1
1117044|NCT01695772|3662147|P1|Overall Study|Protocol Violation|2
1117045|NCT01695772|3662147|P1|Overall Study|Lost to Follow-up|4
1117046|NCT01695772|3662147|P1|Overall Study|Investigator Decision|5
1117047|NCT01695772|3662147|P1|Overall Study|Progressive Disease|8
1117048|NCT01695772|3662147|P1|Overall Study|Withdrawal by Subject|18
1117049|NCT01695746|3662159|P1|Overall Study|Participant not willing to participate|3
1117050|NCT01695746|3662159|P1|Overall Study|Protocol Violation|5
1117051|NCT01695746|3662159|P1|Overall Study|Non-compliance by the participant|3
1117052|NCT01695746|3662159|P1|Overall Study|Adverse Event|1
1117053|NCT01695239|3662208|P4|Overall Study|Protocol Violation|0
1117054|NCT01695239|3662209|P3|Overall Study|Protocol Violation|0
1117055|NCT01695239|3662210|P2|Overall Study|Protocol Violation|0
1117056|NCT01695239|3662211|P1|Overall Study|Protocol Violation|1
1117057|NCT01695239|3662208|P4|Overall Study|Lost to Follow-up|0
1117058|NCT01695239|3662209|P3|Overall Study|Lost to Follow-up|0
1117059|NCT01695239|3662210|P2|Overall Study|Lost to Follow-up|0
1117060|NCT01695239|3662211|P1|Overall Study|Lost to Follow-up|1
1117061|NCT01695239|3662208|P4|Overall Study|Sponsor Decision|0
1117062|NCT01695239|3662209|P3|Overall Study|Sponsor Decision|1
1117063|NCT01695239|3662210|P2|Overall Study|Sponsor Decision|0
1117064|NCT01695239|3662211|P1|Overall Study|Sponsor Decision|3
1117065|NCT01695239|3662208|P4|Overall Study|Withdrawal by Subject|0
1117066|NCT01695239|3662209|P3|Overall Study|Withdrawal by Subject|1
1117067|NCT01695239|3662210|P2|Overall Study|Withdrawal by Subject|1
1117068|NCT01695239|3662211|P1|Overall Study|Withdrawal by Subject|3
1117069|NCT01695239|3662208|P4|Overall Study|Lack of Efficacy|0
1117070|NCT01695239|3662209|P3|Overall Study|Lack of Efficacy|2
1117071|NCT01695239|3662210|P2|Overall Study|Lack of Efficacy|0
1117072|NCT01695239|3662211|P1|Overall Study|Lack of Efficacy|4
1117073|NCT01695239|3662208|P4|Overall Study|Adverse Event|3
1117074|NCT01695239|3662209|P3|Overall Study|Adverse Event|2
1117075|NCT01695239|3662210|P2|Overall Study|Adverse Event|2
1117076|NCT01695239|3662211|P1|Overall Study|Adverse Event|2
1117077|NCT01695239|3662208|P4|Overall Study|Entry Criteria Not Met|3
1117078|NCT01695239|3662209|P3|Overall Study|Entry Criteria Not Met|3
1117079|NCT01695239|3662210|P2|Overall Study|Entry Criteria Not Met|1
1117080|NCT01695239|3662211|P1|Overall Study|Entry Criteria Not Met|1
1117081|NCT01695239|3662208|P4|Overall Study|On Study Treatment|0
1117082|NCT01695239|3662209|P3|Overall Study|On Study Treatment|1
1117083|NCT01695239|3662210|P2|Overall Study|On Study Treatment|0
1117084|NCT01695239|3662211|P1|Overall Study|On Study Treatment|0
1117085|NCT01694771|3662327|P2|Overall Study|Other reasons|6
1117086|NCT01694771|3662328|P1|Overall Study|Other reasons|5
1117087|NCT01694771|3662327|P2|Overall Study|Consent withdrawn|9
1117088|NCT01694771|3662328|P1|Overall Study|Consent withdrawn|7
1117089|NCT01694771|3662327|P2|Overall Study|Lost to Follow-up|3
1117090|NCT01694771|3662328|P1|Overall Study|Lost to Follow-up|2
1117091|NCT01694771|3662327|P2|Overall Study|Non compliance protocol|6
1117092|NCT01694771|3662328|P1|Overall Study|Non compliance protocol|7
1117093|NCT01694771|3662327|P2|Overall Study|Lack of Efficacy|0
1117094|NCT01694771|3662328|P1|Overall Study|Lack of Efficacy|1
1117095|NCT01694771|3662327|P2|Overall Study|Adverse Event|16
1117096|NCT01694771|3662328|P1|Overall Study|Adverse Event|18
1117097|NCT01694706|3662352|P3|Overall Study|other reason not defined above|0
1117098|NCT01694706|3662353|P2|Overall Study|other reason not defined above|0
1117099|NCT01694706|3662354|P1|Overall Study|other reason not defined above|1
1117100|NCT01694706|3662352|P3|Overall Study|Adverse Event|0
1117101|NCT01694706|3662353|P2|Overall Study|Adverse Event|1
1117102|NCT01694706|3662354|P1|Overall Study|Adverse Event|0
1117103|NCT01694420|3662399|P1|Overall Study|Lost to Follow-up|3
1117104|NCT01694121|3662427|P2|Overall Study|Participant used false ID, was withdrawn|0
1117105|NCT01694121|3662428|P1|Overall Study|Participant used false ID, was withdrawn|1
1117106|NCT01693614|3662542|P3|Overall Study|Withdrawal by Subject|5
1117107|NCT01693614|3662543|P2|Overall Study|Withdrawal by Subject|0
1117108|NCT01693614|3662544|P1|Overall Study|Withdrawal by Subject|1
1117109|NCT01693614|3662542|P3|Overall Study|Withdrawal by subject/guardian|2
1117110|NCT01693614|3662543|P2|Overall Study|Withdrawal by subject/guardian|0
1117111|NCT01693614|3662544|P1|Overall Study|Withdrawal by subject/guardian|0
1117112|NCT01693614|3662542|P3|Overall Study|Physician Decision|4
1117113|NCT01693614|3662543|P2|Overall Study|Physician Decision|1
1117114|NCT01693614|3662544|P1|Overall Study|Physician Decision|1
1117115|NCT01693614|3662542|P3|Overall Study|Death|0
1117116|NCT01693614|3662543|P2|Overall Study|Death|0
1117117|NCT01693614|3662544|P1|Overall Study|Death|1
1117118|NCT01693614|3662542|P3|Overall Study|Protocol Violation|1
1117119|NCT01693614|3662543|P2|Overall Study|Protocol Violation|2
1117120|NCT01693614|3662544|P1|Overall Study|Protocol Violation|5
1117121|NCT01693614|3662542|P3|Overall Study|Disease progression|7
1117122|NCT01693614|3662543|P2|Overall Study|Disease progression|8
1117123|NCT01693614|3662544|P1|Overall Study|Disease progression|11
1117124|NCT01693614|3662542|P3|Overall Study|Adverse Event|5
1117125|NCT01693614|3662543|P2|Overall Study|Adverse Event|11
1117126|NCT01693614|3662544|P1|Overall Study|Adverse Event|7
1117127|NCT01693367|3662572|P2|Overall Study|Physician Decision|1
1117128|NCT01693367|3662573|P1|Overall Study|Physician Decision|0
1117129|NCT01693367|3662572|P2|Overall Study|Withdrawal by Subject|1
1117130|NCT01693367|3662573|P1|Overall Study|Withdrawal by Subject|1
1117131|NCT01693185|3662591|P2|Overall Study|diagnostic procedure after colonoscopy|6
1117132|NCT01693185|3662592|P1|Overall Study|diagnostic procedure after colonoscopy|0
1117133|NCT01693120|3662608|P1|Phased RF Study Procedure and Follow-up|Other reasons|7
1117134|NCT01693120|3662608|P1|Phased RF Study Procedure and Follow-up|Protocol Violation|1
1117135|NCT01693120|3662608|P1|Phased RF Study Procedure and Follow-up|Physician Decision|3
1117136|NCT01693120|3662608|P1|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5
1117137|NCT01693120|3662608|P1|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1
1117138|NCT01693120|3662608|P1|Enrollment|Not specified|1
1117139|NCT01693120|3662608|P1|Enrollment|Study closed|8
1117140|NCT01693120|3662608|P1|Enrollment|Adverse Event|1
1117141|NCT01693120|3662608|P1|Enrollment|Physician Decision|3
1117142|NCT01693120|3662608|P1|Enrollment|Protocol Violation|46
1117143|NCT01693120|3662608|P1|Enrollment|Withdrawal by Subject|10
1117144|NCT01693120|3662608|P1|Enrollment|Lost to Follow-up|1
1117145|NCT01693068|3662617|P3|Cross-over (Dacarbazine To Pimasertib)|On-study|1
1117146|NCT01693068|3662618|P2|Cross-over (Dacarbazine To Pimasertib)|On-study|0
1117147|NCT01693068|3662619|P1|Cross-over (Dacarbazine To Pimasertib)|On-study|0
1117148|NCT01693068|3662617|P3|Randomization Period|On-study|0
1117149|NCT01693068|3662618|P2|Randomization Period|On-study|5
1117150|NCT01693068|3662619|P1|Randomization Period|On-study|2
1117151|NCT01693029|3662651|P2|Overall Study|Non-compliance|1
1117152|NCT01693029|3662652|P1|Overall Study|Non-compliance|2
1117153|NCT01693029|3662651|P2|Overall Study|Death|8
1117154|NCT01693029|3662652|P1|Overall Study|Death|5
1117155|NCT01693029|3662651|P2|Overall Study|Adverse Event|6
1117156|NCT01693029|3662652|P1|Overall Study|Adverse Event|1
1117157|NCT01693029|3662651|P2|Overall Study|Lost to Follow-up|1
1117158|NCT01693029|3662652|P1|Overall Study|Lost to Follow-up|0
1117159|NCT01693029|3662651|P2|Overall Study|Physician Decision|2
1117160|NCT01693029|3662652|P1|Overall Study|Physician Decision|0
1117161|NCT01693029|3662651|P2|Overall Study|Change in dialysis modality|1
1117162|NCT01693029|3662652|P1|Overall Study|Change in dialysis modality|2
1117163|NCT01693029|3662651|P2|Overall Study|Protocol Violation|7
1117164|NCT01693029|3662652|P1|Overall Study|Protocol Violation|6
1117165|NCT01693029|3662651|P2|Overall Study|Bindinging anti-EPO antibodies|2
1117166|NCT01693029|3662652|P1|Overall Study|Bindinging anti-EPO antibodies|6
1117167|NCT01693029|3662651|P2|Overall Study|Kidney transplantation|7
1117168|NCT01693029|3662652|P1|Overall Study|Kidney transplantation|7
1117169|NCT01693029|3662651|P2|Overall Study|Withdrawal by Subject|22
1117170|NCT01693029|3662652|P1|Overall Study|Withdrawal by Subject|15
1117171|NCT01692938|3662683|P2|Overall Study|Study completed prior to site completion|3
1117172|NCT01692938|3662684|P1|Overall Study|Study completed prior to site completion|3
1117173|NCT01692938|3662683|P2|Overall Study|Protocol Deviation|1
1117174|NCT01692938|3662684|P1|Overall Study|Protocol Deviation|1
1117175|NCT01692782|3662695|P3|Overall Study|Withdrawal by Subject|3
1117176|NCT01692782|3662696|P2|Overall Study|Withdrawal by Subject|10
1117177|NCT01692782|3662697|P1|Overall Study|Withdrawal by Subject|3
1117178|NCT01692782|3662695|P3|Overall Study|SAE not related to study drug|0
1117179|NCT01692782|3662696|P2|Overall Study|SAE not related to study drug|1
1117180|NCT01692782|3662697|P1|Overall Study|SAE not related to study drug|0
1117181|NCT01692782|3662695|P3|Overall Study|Non-compliant with study visits|1
1117182|NCT01692782|3662696|P2|Overall Study|Non-compliant with study visits|0
1117183|NCT01692782|3662697|P1|Overall Study|Non-compliant with study visits|0
1117184|NCT01692782|3662695|P3|Overall Study|Non-complance with study drug|1
1117185|NCT01692782|3662696|P2|Overall Study|Non-complance with study drug|4
1117186|NCT01692782|3662697|P1|Overall Study|Non-complance with study drug|0
1117187|NCT01692782|3662695|P3|Overall Study|Protocol Violation|2
1117188|NCT01692782|3662696|P2|Overall Study|Protocol Violation|0
1117189|NCT01692782|3662697|P1|Overall Study|Protocol Violation|1
1117190|NCT01692782|3662695|P3|Overall Study|Pregnancy|0
1117191|NCT01692782|3662696|P2|Overall Study|Pregnancy|0
1117192|NCT01692782|3662697|P1|Overall Study|Pregnancy|1
1117193|NCT01692782|3662695|P3|Overall Study|Lost to Follow-up|1
1117194|NCT01692782|3662696|P2|Overall Study|Lost to Follow-up|7
1117195|NCT01692782|3662697|P1|Overall Study|Lost to Follow-up|2
1117196|NCT01692782|3662695|P3|Overall Study|Lack of Efficacy|0
1117197|NCT01692782|3662696|P2|Overall Study|Lack of Efficacy|2
1117198|NCT01692782|3662697|P1|Overall Study|Lack of Efficacy|1
1117199|NCT01692782|3662695|P3|Overall Study|Adverse Event|2
1117200|NCT01692782|3662696|P2|Overall Study|Adverse Event|32
1117201|NCT01692782|3662697|P1|Overall Study|Adverse Event|12
1117202|NCT01692730|3662787|P2|Overall Study|Lost to Follow-up|227
1117203|NCT01692730|3662788|P1|Overall Study|Lost to Follow-up|225
1117204|NCT01692626|3662802|P2|Overall Study|Withdrawal by Subject|0
1117205|NCT01692626|3662803|P1|Overall Study|Withdrawal by Subject|1
1117206|NCT01692626|3662802|P2|Overall Study|Protocol Violation|2
1117207|NCT01692626|3662803|P1|Overall Study|Protocol Violation|1
1117208|NCT01692626|3662802|P2|Overall Study|Adverse Event|3
1117209|NCT01692626|3662803|P1|Overall Study|Adverse Event|2
1117210|NCT01692626|3662802|P2|Overall Study|Death|1
1117211|NCT01692626|3662803|P1|Overall Study|Death|0
1117212|NCT01692301|3662830|P2|Overall Study|Lost to Follow-up|1
1117213|NCT01692301|3662831|P1|Overall Study|Lost to Follow-up|1
1117214|NCT01692301|3662830|P2|Overall Study|Physician Decision|2
1117215|NCT01692301|3662831|P1|Overall Study|Physician Decision|2
1117216|NCT01692301|3662830|P2|Overall Study|Technical problems|1
1117217|NCT01692301|3662831|P1|Overall Study|Technical problems|0
1117218|NCT01692301|3662830|P2|Overall Study|Patient/guardian decision|15
1117219|NCT01692301|3662831|P1|Overall Study|Patient/guardian decision|16
1117220|NCT01692301|3662830|P2|Overall Study|Protocol deviation|2
1117221|NCT01692301|3662831|P1|Overall Study|Protocol deviation|9
1117222|NCT01692301|3662830|P2|Overall Study|Non-compliance with study treatment|2
1117223|NCT01692301|3662831|P1|Overall Study|Non-compliance with study treatment|1
1117224|NCT01692301|3662830|P2|Overall Study|Lack of Efficacy|5
1117225|NCT01692301|3662831|P1|Overall Study|Lack of Efficacy|0
1117226|NCT01692301|3662830|P2|Overall Study|Death|2
1117227|NCT01692301|3662831|P1|Overall Study|Death|1
1117228|NCT01692301|3662830|P2|Overall Study|Adverse Event|12
1117229|NCT01692301|3662831|P1|Overall Study|Adverse Event|15
1117230|NCT01692275|3662863|P2|Overall Study|Withdrawal by Subject|11
1117231|NCT01692275|3662864|P1|Overall Study|Withdrawal by Subject|9
1117232|NCT01692275|3662863|P2|Overall Study|Lost to Follow-up|48
1117233|NCT01692275|3662864|P1|Overall Study|Lost to Follow-up|57
1117234|NCT01692197|3662924|P1|Overall Study|Failed Screening|3
1117235|NCT01691898|3662937|P6|Overall Study|Other|1
1117236|NCT01691898|3662938|P5|Overall Study|Other|0
1117237|NCT01691898|3662939|P4|Overall Study|Other|0
1117238|NCT01691898|3662940|P3|Overall Study|Other|1
1117239|NCT01691898|3662941|P2|Overall Study|Other|2
1117240|NCT01691898|3662942|P1|Overall Study|Other|0
1117241|NCT01691898|3662937|P6|Overall Study|Withdrawal by Subject|3
1117242|NCT01691898|3662938|P5|Overall Study|Withdrawal by Subject|2
1117243|NCT01691898|3662939|P4|Overall Study|Withdrawal by Subject|1
1117244|NCT01691898|3662940|P3|Overall Study|Withdrawal by Subject|1
1117245|NCT01691898|3662941|P2|Overall Study|Withdrawal by Subject|5
1117246|NCT01691898|3662942|P1|Overall Study|Withdrawal by Subject|8
1117247|NCT01691898|3662937|P6|Overall Study|Lost to Follow-up|0
1117248|NCT01691898|3662938|P5|Overall Study|Lost to Follow-up|0
1117249|NCT01691898|3662939|P4|Overall Study|Lost to Follow-up|0
1117250|NCT01691898|3662940|P3|Overall Study|Lost to Follow-up|0
1117251|NCT01691898|3662941|P2|Overall Study|Lost to Follow-up|0
1117252|NCT01691898|3662942|P1|Overall Study|Lost to Follow-up|1
1117253|NCT01691898|3662937|P6|Overall Study|Progression of Disease|2
1117254|NCT01691898|3662938|P5|Overall Study|Progression of Disease|1
1117255|NCT01691898|3662939|P4|Overall Study|Progression of Disease|0
1117256|NCT01691898|3662940|P3|Overall Study|Progression of Disease|1
1117257|NCT01691898|3662941|P2|Overall Study|Progression of Disease|3
1117258|NCT01691898|3662942|P1|Overall Study|Progression of Disease|2
1117259|NCT01691898|3662937|P6|Overall Study|Adverse Event|0
1117260|NCT01691898|3662938|P5|Overall Study|Adverse Event|0
1117261|NCT01691898|3662939|P4|Overall Study|Adverse Event|1
1117262|NCT01691898|3662940|P3|Overall Study|Adverse Event|0
1117263|NCT01691898|3662941|P2|Overall Study|Adverse Event|1
1117264|NCT01691898|3662942|P1|Overall Study|Adverse Event|0
1117265|NCT01691898|3662937|P6|Overall Study|Death|20
1117266|NCT01691898|3662938|P5|Overall Study|Death|5
1117267|NCT01691898|3662939|P4|Overall Study|Death|2
1117268|NCT01691898|3662940|P3|Overall Study|Death|4
1117269|NCT01691898|3662941|P2|Overall Study|Death|28
1117270|NCT01691898|3662942|P1|Overall Study|Death|31
1117271|NCT01691898|3662937|P6|Overall Study|Ongoing in Study|14
1117272|NCT01691898|3662938|P5|Overall Study|Ongoing in Study|31
1117273|NCT01691898|3662939|P4|Overall Study|Ongoing in Study|5
1117274|NCT01691898|3662940|P3|Overall Study|Ongoing in Study|11
1117275|NCT01691898|3662941|P2|Overall Study|Ongoing in Study|19
1117276|NCT01691898|3662942|P1|Overall Study|Ongoing in Study|18
1117277|NCT01691885|3663088|P2|Washout Period (7-9 Days)|Adverse Event|1
1117278|NCT01691885|3663089|P1|Washout Period (7-9 Days)|Adverse Event|0
1117279|NCT01691885|3663088|P2|Treatment Period 1(7-14 Days)|Adverse Event|1
1117280|NCT01691885|3663089|P1|Treatment Period 1(7-14 Days)|Adverse Event|1
1117281|NCT01691859|3663095|P1|Overall Study|Withdrawal by Subject|31
1117282|NCT01691859|3663095|P1|Overall Study|Physician Decision|6
1117283|NCT01691859|3663095|P1|Overall Study|Lost to Follow-up|5
1117284|NCT01691859|3663095|P1|Overall Study|Study closed/terminated|50
1117285|NCT01691859|3663095|P1|Overall Study|Product commercially available|221
1117286|NCT01691859|3663095|P1|Overall Study|Protocol Violation|4
1117287|NCT01691859|3663095|P1|Overall Study|Lack of Efficacy|11
1117288|NCT01691859|3663095|P1|Overall Study|Adverse Event|19
1117289|NCT01691794|3663117|P3|Overall Study|Did not complete first 24 weeks of study|3
1117290|NCT01691794|3663118|P2|Overall Study|Did not complete first 24 weeks of study|3
1117291|NCT01691794|3663119|P1|Overall Study|Did not complete first 24 weeks of study|0
1117292|NCT01691794|3663117|P3|Overall Study|Completed Only first 24 weeks of study|3
1117293|NCT01691794|3663118|P2|Overall Study|Completed Only first 24 weeks of study|2
1117294|NCT01691794|3663119|P1|Overall Study|Completed Only first 24 weeks of study|0
1117295|NCT01691794|3663117|P3|Overall Study|Adverse Event|1
1117296|NCT01691794|3663118|P2|Overall Study|Adverse Event|1
1117297|NCT01691794|3663119|P1|Overall Study|Adverse Event|0
1117298|NCT01691794|3663117|P3|Overall Study|Participant request to discontinue|0
1117299|NCT01691794|3663118|P2|Overall Study|Participant request to discontinue|1
1117300|NCT01691794|3663119|P1|Overall Study|Participant request to discontinue|0
1117301|NCT01691794|3663117|P3|Overall Study|Lack of Efficacy|1
1117302|NCT01691794|3663118|P2|Overall Study|Lack of Efficacy|7
1117303|NCT01691794|3663119|P1|Overall Study|Lack of Efficacy|0
1117304|NCT01691794|3663117|P3|Overall Study|Death|1
1117305|NCT01691794|3663118|P2|Overall Study|Death|0
1119343|NCT01667900|3670752|P1|Part B|Death|0
1117306|NCT01691794|3663119|P1|Overall Study|Death|0
1117307|NCT01691794|3663117|P3|Overall Study|Poor/Non-Compliance|1
1117308|NCT01691794|3663118|P2|Overall Study|Poor/Non-Compliance|4
1117309|NCT01691794|3663119|P1|Overall Study|Poor/Non-Compliance|1
1117310|NCT01691781|3663135|P2|Overall Study|Adverse Event|1
1117311|NCT01691781|3663136|P1|Overall Study|Adverse Event|0
1117312|NCT01691781|3663135|P2|Overall Study|Protocol Violation|2
1117313|NCT01691781|3663136|P1|Overall Study|Protocol Violation|2
1117314|NCT01691781|3663135|P2|Overall Study|Physician Decision|1
1117315|NCT01691781|3663136|P1|Overall Study|Physician Decision|1
1117316|NCT01691781|3663135|P2|Overall Study|Withdrawal by Subject|3
1117317|NCT01691781|3663136|P1|Overall Study|Withdrawal by Subject|4
1117318|NCT01691612|3663159|P1|Overall Study|Adverse Event|1
1117319|NCT01691612|3663159|P1|Overall Study|deemed ineligible after 1st visit|6
1117320|NCT01691521|3663270|P3|Overall Study|Withdrawal by Subject|4
1117321|NCT01691521|3663271|P2|Overall Study|Withdrawal by Subject|9
1117322|NCT01691521|3663272|P1|Overall Study|Withdrawal by Subject|5
1117323|NCT01691521|3663270|P3|Overall Study|Physician Decision|0
1117324|NCT01691521|3663271|P2|Overall Study|Physician Decision|1
1117325|NCT01691521|3663272|P1|Overall Study|Physician Decision|2
1117326|NCT01691521|3663270|P3|Overall Study|Lost to Follow-up|2
1117327|NCT01691521|3663271|P2|Overall Study|Lost to Follow-up|2
1117328|NCT01691521|3663272|P1|Overall Study|Lost to Follow-up|0
1117329|NCT01691521|3663270|P3|Overall Study|Protocol Violation|0
1117330|NCT01691521|3663271|P2|Overall Study|Protocol Violation|3
1117331|NCT01691521|3663272|P1|Overall Study|Protocol Violation|0
1117332|NCT01691521|3663270|P3|Overall Study|Lack of Efficacy|2
1117333|NCT01691521|3663271|P2|Overall Study|Lack of Efficacy|1
1117334|NCT01691521|3663272|P1|Overall Study|Lack of Efficacy|1
1117335|NCT01691521|3663270|P3|Overall Study|Adverse Event|1
1117336|NCT01691521|3663271|P2|Overall Study|Adverse Event|0
1117337|NCT01691521|3663272|P1|Overall Study|Adverse Event|4
1117338|NCT01691508|3663294|P2|Overall Study|Withdrawal by Subject|0
1117339|NCT01691508|3663295|P1|Overall Study|Withdrawal by Subject|1
1117340|NCT01691508|3663294|P2|Overall Study|Adverse Event|3
1117341|NCT01691508|3663295|P1|Overall Study|Adverse Event|3
1117342|NCT01691482|3663309|P2|Treatment Period 2|Protocol Violation|1
1117343|NCT01691482|3663310|P1|Treatment Period 2|Protocol Violation|1
1117344|NCT01691482|3663309|P2|Treatment Period 2|Adverse Event|1
1117345|NCT01691482|3663310|P1|Treatment Period 2|Adverse Event|0
1117346|NCT01691430|3663328|P2|Overall Study|Lost to Follow-up|3
1117347|NCT01691430|3663329|P1|Overall Study|Lost to Follow-up|0
1117348|NCT01691430|3663328|P2|Overall Study|Withdrawal by Subject|1
1117349|NCT01691430|3663329|P1|Overall Study|Withdrawal by Subject|5
1117350|NCT01691430|3663328|P2|Overall Study|Death|16
1117351|NCT01691430|3663329|P1|Overall Study|Death|17
1117352|NCT01691248|3663426|P2|Overall Study|Not Treated|7
1117353|NCT01691248|3663427|P1|Overall Study|Not Treated|4
1117354|NCT01691248|3663426|P2|Overall Study|Reason not provided|4
1117355|NCT01691248|3663427|P1|Overall Study|Reason not provided|4
1117356|NCT01691248|3663426|P2|Overall Study|Lost to Follow-up|5
1117357|NCT01691248|3663427|P1|Overall Study|Lost to Follow-up|2
1117358|NCT01691248|3663426|P2|Overall Study|Confirmed CDAD|31
1117359|NCT01691248|3663427|P1|Overall Study|Confirmed CDAD|14
1117360|NCT01691248|3663426|P2|Overall Study|Withdrawal by Subject|18
1117361|NCT01691248|3663427|P1|Overall Study|Withdrawal by Subject|20
1117362|NCT01691248|3663426|P2|Overall Study|Adverse Event|22
1117363|NCT01691248|3663427|P1|Overall Study|Adverse Event|24
1117364|NCT01691248|3663426|P2|Overall Study|Protocol Violation|27
1117365|NCT01691248|3663427|P1|Overall Study|Protocol Violation|43
1117366|NCT01691105|3663439|P2|12 Month Biochemical Verification|subject did not self-report abstinence|401
1117367|NCT01691105|3663440|P1|12 Month Biochemical Verification|subject did not self-report abstinence|352
1117368|NCT01691105|3663439|P2|12 Month Biochemical Verification|Lost to Follow-up|71
1117369|NCT01691105|3663440|P1|12 Month Biochemical Verification|Lost to Follow-up|50
1117370|NCT01691105|3663439|P2|12 Month Biochemical Verification|Death|30
1117371|NCT01691105|3663440|P1|12 Month Biochemical Verification|Death|22
1117372|NCT01691105|3663439|P2|12 Month Follow-up|Death|30
1117373|NCT01691105|3663440|P1|12 Month Follow-up|Death|22
1117374|NCT01691105|3663439|P2|12 Month Follow-up|Lost to Follow-up|71
1117375|NCT01691105|3663440|P1|12 Month Follow-up|Lost to Follow-up|50
1117376|NCT01691105|3663439|P2|6 Month Follow-up|Death|13
1117377|NCT01691105|3663440|P1|6 Month Follow-up|Death|13
1117378|NCT01691105|3663439|P2|6 Month Follow-up|Lost to Follow-up|58
1117379|NCT01691105|3663440|P1|6 Month Follow-up|Lost to Follow-up|39
1117380|NCT01691105|3663439|P2|1 Month Follow-up|Death|3
1117381|NCT01691105|3663440|P1|1 Month Follow-up|Death|2
1117382|NCT01691105|3663439|P2|1 Month Follow-up|Lost to Follow-up|38
1117383|NCT01691105|3663440|P1|1 Month Follow-up|Lost to Follow-up|41
1117384|NCT01691092|3663460|P1|Overall Study|screen fail|19
1117385|NCT01691092|3663460|P1|Overall Study|used for different study|2
1117386|NCT01691092|3663460|P1|Overall Study|non-compliance|3
1117387|NCT01691092|3663460|P1|Overall Study|Withdrawal by Subject|3
1117388|NCT01691092|3663460|P1|Overall Study|Physician Decision|4
1117389|NCT01691092|3663460|P1|Overall Study|Lost to Follow-up|10
1117390|NCT01691014|3663473|P4|Overall Study|Lack of Efficacy|0
1117391|NCT01691014|3663474|P3|Overall Study|Lack of Efficacy|7
1117392|NCT01691014|3663475|P2|Overall Study|Lack of Efficacy|3
1117393|NCT01691014|3663476|P1|Overall Study|Lack of Efficacy|2
1117394|NCT01691014|3663473|P4|Overall Study|Adverse Event|1
1117395|NCT01691014|3663474|P3|Overall Study|Adverse Event|1
1117396|NCT01691014|3663475|P2|Overall Study|Adverse Event|5
1117397|NCT01691014|3663476|P1|Overall Study|Adverse Event|0
1117398|NCT01691014|3663473|P4|Overall Study|Withdrawal by Subject|1
1117399|NCT01691014|3663474|P3|Overall Study|Withdrawal by Subject|1
1117400|NCT01691014|3663475|P2|Overall Study|Withdrawal by Subject|1
1117401|NCT01691014|3663476|P1|Overall Study|Withdrawal by Subject|0
1117402|NCT01691014|3663473|P4|Overall Study|Other|0
1117403|NCT01691014|3663474|P3|Overall Study|Other|2
1117404|NCT01691014|3663475|P2|Overall Study|Other|0
1117405|NCT01691014|3663476|P1|Overall Study|Other|0
1117406|NCT01691014|3663473|P4|Overall Study|Premature Termination|3
1117407|NCT01691014|3663474|P3|Overall Study|Premature Termination|0
1117408|NCT01691014|3663475|P2|Overall Study|Premature Termination|6
1117409|NCT01691014|3663476|P1|Overall Study|Premature Termination|1
1117410|NCT01690988|3663521|P3|Overall Study|Sedated|2
1117411|NCT01690988|3663522|P2|Overall Study|Sedated|1
1117412|NCT01690988|3663523|P1|Overall Study|Sedated|1
1117413|NCT01690988|3663521|P3|Overall Study|Death|1
1117414|NCT01690988|3663522|P2|Overall Study|Death|1
1117415|NCT01690988|3663523|P1|Overall Study|Death|1
1117416|NCT01690988|3663521|P3|Overall Study|Determined ineligible|0
1117417|NCT01690988|3663522|P2|Overall Study|Determined ineligible|0
1117418|NCT01690988|3663523|P1|Overall Study|Determined ineligible|1
1117419|NCT01690988|3663521|P3|Overall Study|Operation Cancelled|0
1117420|NCT01690988|3663522|P2|Overall Study|Operation Cancelled|1
1117421|NCT01690988|3663523|P1|Overall Study|Operation Cancelled|1
1117422|NCT01690988|3663521|P3|Overall Study|Physician Decision|1
1117423|NCT01690988|3663522|P2|Overall Study|Physician Decision|0
1117424|NCT01690988|3663523|P1|Overall Study|Physician Decision|0
1117425|NCT01690988|3663521|P3|Overall Study|Withdrawal by Subject|3
1117426|NCT01690988|3663522|P2|Overall Study|Withdrawal by Subject|2
1117427|NCT01690988|3663523|P1|Overall Study|Withdrawal by Subject|2
1117428|NCT01690299|3663591|P6|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1
1117429|NCT01690299|3663592|P5|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
1117430|NCT01690299|3663593|P4|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
1117431|NCT01690299|3663594|P3|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
1117432|NCT01690299|3663595|P2|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
1117433|NCT01690299|3663596|P1|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
1117434|NCT01690299|3663591|P6|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
1117435|NCT01690299|3663592|P5|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13
1117436|NCT01690299|3663593|P4|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
1117437|NCT01690299|3663594|P3|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
1117438|NCT01690299|3663595|P2|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
1117439|NCT01690299|3663596|P1|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
1117440|NCT01690299|3663591|P6|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11
1117441|NCT01690299|3663592|P5|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5
1117442|NCT01690299|3663593|P4|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8
1117443|NCT01690299|3663594|P3|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
1117444|NCT01690299|3663595|P2|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
1117445|NCT01690299|3663596|P1|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
1117446|NCT01690299|3663591|P6|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
1117447|NCT01690299|3663592|P5|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
1117448|NCT01690299|3663593|P4|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
1117449|NCT01690299|3663594|P3|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
1117450|NCT01690299|3663595|P2|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
1117451|NCT01690299|3663596|P1|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
1117452|NCT01690299|3663591|P6|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8
1117453|NCT01690299|3663592|P5|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10
1117454|NCT01690299|3663593|P4|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9
1117455|NCT01690299|3663594|P3|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
1117456|NCT01690299|3663595|P2|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
1117457|NCT01690299|3663596|P1|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
1117458|NCT01690299|3663591|P6|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
1117459|NCT01690299|3663592|P5|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4
1117460|NCT01690299|3663593|P4|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
1117461|NCT01690299|3663594|P3|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
1117462|NCT01690299|3663595|P2|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
1117463|NCT01690299|3663596|P1|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
1117464|NCT01690299|3663591|P6|Placebo-controlled Phase (Weeks 0-16)|Other|0
1117465|NCT01690299|3663592|P5|Placebo-controlled Phase (Weeks 0-16)|Other|0
1117466|NCT01690299|3663593|P4|Placebo-controlled Phase (Weeks 0-16)|Other|0
1117467|NCT01690299|3663594|P3|Placebo-controlled Phase (Weeks 0-16)|Other|1
1117468|NCT01690299|3663595|P2|Placebo-controlled Phase (Weeks 0-16)|Other|1
1117469|NCT01690299|3663596|P1|Placebo-controlled Phase (Weeks 0-16)|Other|2
1117470|NCT01690299|3663591|P6|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1117471|NCT01690299|3663592|P5|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1117472|NCT01690299|3663593|P4|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1117473|NCT01690299|3663594|P3|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1117474|NCT01690299|3663595|P2|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3
1117475|NCT01690299|3663596|P1|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1
1117476|NCT01690299|3663591|P6|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1117477|NCT01690299|3663592|P5|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1117478|NCT01690299|3663593|P4|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1117479|NCT01690299|3663594|P3|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1117480|NCT01690299|3663595|P2|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1117481|NCT01690299|3663596|P1|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4
1117482|NCT01690299|3663591|P6|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
1117483|NCT01690299|3663592|P5|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
1117484|NCT01690299|3663593|P4|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
1117485|NCT01690299|3663594|P3|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1
1117486|NCT01690299|3663595|P2|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
1117487|NCT01690299|3663596|P1|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
1117488|NCT01690143|3663693|P1|Overall Study|Withdrawal by Subject|1
1117489|NCT01690130|3663703|P2|Overall Study|Subject have cancelled visit.|0
1117490|NCT01690130|3663704|P1|Overall Study|Subject have cancelled visit.|1
1117491|NCT01690052|3663751|P2|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2
1117492|NCT01690052|3663752|P1|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1
1117493|NCT01689974|3663769|P2|Overall Study|Termination of Study|5
1117494|NCT01689974|3663770|P1|Overall Study|Termination of Study|5
1117495|NCT01689857|3663799|P2|Overall Study|Lost to Follow-up|2
1117496|NCT01689857|3663800|P1|Overall Study|Lost to Follow-up|5
1117497|NCT01689649|3663825|P1|Overall Study|Lost to Follow-up|5
1117498|NCT01689649|3663825|P1|Overall Study|Protocol Violation|3
1117499|NCT01689649|3663825|P1|Overall Study|Non-compliance|11
1117500|NCT01689649|3663825|P1|Overall Study|Lack of Efficacy|3
1117501|NCT01689532|3663837|P2|Overall Study|Physician Decision|0
1117502|NCT01689532|3663838|P1|Overall Study|Physician Decision|2
1117503|NCT01689532|3663837|P2|Overall Study|Withdrawal by Subject|2
1117504|NCT01689532|3663838|P1|Overall Study|Withdrawal by Subject|1
1117505|NCT01689532|3663837|P2|Overall Study|Lack of Efficacy|2
1117506|NCT01689532|3663838|P1|Overall Study|Lack of Efficacy|2
1117507|NCT01689532|3663837|P2|Overall Study|Adverse Event|5
1117508|NCT01689532|3663838|P1|Overall Study|Adverse Event|9
1117509|NCT01689519|3663902|P2|Overall Study|Physician Decision|3
1117510|NCT01689519|3663903|P1|Overall Study|Physician Decision|0
1117511|NCT01689519|3663902|P2|Overall Study|Withdrawal by Subject|17
1117512|NCT01689519|3663903|P1|Overall Study|Withdrawal by Subject|17
1117513|NCT01689519|3663902|P2|Overall Study|Lost to Follow-up|2
1117514|NCT01689519|3663903|P1|Overall Study|Lost to Follow-up|6
1117515|NCT01689519|3663902|P2|Overall Study|Death|116
1117516|NCT01689519|3663903|P1|Overall Study|Death|143
1117517|NCT01689363|3663930|P8|Overall Study|Protocol Violation|0
1117518|NCT01689363|3663931|P7|Overall Study|Protocol Violation|0
1117519|NCT01689363|3663932|P6|Overall Study|Protocol Violation|0
1117520|NCT01689363|3663933|P5|Overall Study|Protocol Violation|0
1117521|NCT01689363|3663934|P4|Overall Study|Protocol Violation|0
1117522|NCT01689363|3663935|P3|Overall Study|Protocol Violation|0
1117523|NCT01689363|3663936|P2|Overall Study|Protocol Violation|1
1117524|NCT01689363|3663937|P1|Overall Study|Protocol Violation|0
1117525|NCT01689337|3663992|P1|Overall Study|Study Discontinuation|1
1117526|NCT01689207|3664031|P11|Overall Study|Adverse Event|0
1117527|NCT01689207|3664032|P10|Overall Study|Adverse Event|0
1117528|NCT01689207|3664033|P9|Overall Study|Adverse Event|1
1117529|NCT01689207|3664034|P8|Overall Study|Adverse Event|0
1117530|NCT01689207|3664035|P7|Overall Study|Adverse Event|0
1117531|NCT01689207|3664036|P6|Overall Study|Adverse Event|1
1117532|NCT01689207|3664037|P5|Overall Study|Adverse Event|2
1117533|NCT01689207|3664038|P4|Overall Study|Adverse Event|0
1117534|NCT01689207|3664039|P3|Overall Study|Adverse Event|0
1117535|NCT01689207|3664040|P2|Overall Study|Adverse Event|1
1117536|NCT01689207|3664041|P1|Overall Study|Adverse Event|0
1117537|NCT01688921|3664148|P2|Overall Study|informed consent|0
1117538|NCT01688921|3664149|P1|Overall Study|informed consent|3
1117539|NCT01688921|3664148|P2|Overall Study|Protocol Violation|1
1117540|NCT01688921|3664149|P1|Overall Study|Protocol Violation|0
1117541|NCT01688921|3664148|P2|Overall Study|Physician Decision|1
1117542|NCT01688921|3664149|P1|Overall Study|Physician Decision|6
1117543|NCT01688921|3664148|P2|Overall Study|Lost to Follow-up|13
1117544|NCT01688921|3664149|P1|Overall Study|Lost to Follow-up|7
1117545|NCT01688882|3664174|P2|Overall Study|Administrative problems|0
1117546|NCT01688882|3664175|P1|Overall Study|Administrative problems|1
1117547|NCT01688882|3664174|P2|Overall Study|Unsatisfactory therapeutic effect|1
1117548|NCT01688882|3664175|P1|Overall Study|Unsatisfactory therapeutic effect|1
1117549|NCT01688882|3664174|P2|Overall Study|Adverse Event|0
1117550|NCT01688882|3664175|P1|Overall Study|Adverse Event|1
1117551|NCT01688830|3664220|P21|Overall Study|Lost to Follow-up|0
1117552|NCT01688830|3664221|P20|Overall Study|Lost to Follow-up|0
1117553|NCT01688830|3664222|P19|Overall Study|Lost to Follow-up|0
1117554|NCT01688830|3664223|P18|Overall Study|Lost to Follow-up|0
1117555|NCT01688830|3664224|P17|Overall Study|Lost to Follow-up|0
1117556|NCT01688830|3664225|P16|Overall Study|Lost to Follow-up|0
1117557|NCT01688830|3664226|P15|Overall Study|Lost to Follow-up|0
1117558|NCT01688830|3664227|P14|Overall Study|Lost to Follow-up|0
1117559|NCT01688830|3664228|P13|Overall Study|Lost to Follow-up|0
1117560|NCT01688830|3664229|P12|Overall Study|Lost to Follow-up|0
1117561|NCT01688830|3664230|P11|Overall Study|Lost to Follow-up|1
1117562|NCT01688830|3664231|P10|Overall Study|Lost to Follow-up|0
1117563|NCT01688830|3664232|P9|Overall Study|Lost to Follow-up|0
1117564|NCT01688830|3664233|P8|Overall Study|Lost to Follow-up|0
1117565|NCT01688830|3664234|P7|Overall Study|Lost to Follow-up|0
1117566|NCT01688830|3664235|P6|Overall Study|Lost to Follow-up|0
1117567|NCT01688830|3664236|P5|Overall Study|Lost to Follow-up|0
1117568|NCT01688830|3664237|P4|Overall Study|Lost to Follow-up|0
1117569|NCT01688830|3664238|P3|Overall Study|Lost to Follow-up|0
1117570|NCT01688830|3664239|P2|Overall Study|Lost to Follow-up|0
1117571|NCT01688830|3664240|P1|Overall Study|Lost to Follow-up|0
1117572|NCT01688726|3664386|P2|Overall Study|Relocated abroad|1
1117573|NCT01688726|3664387|P1|Overall Study|Relocated abroad|0
1117574|NCT01688726|3664386|P2|Overall Study|Adverse Event|0
1117575|NCT01688726|3664387|P1|Overall Study|Adverse Event|1
1117576|NCT01688635|3664399|P2|Washout 3|Withdrawal by Subject|0
1117577|NCT01688635|3664400|P1|Washout 3|Withdrawal by Subject|1
1117578|NCT01688635|3664399|P2|Washout 2|Sponsor Decision|2
1117579|NCT01688635|3664400|P1|Washout 2|Sponsor Decision|1
1117580|NCT01688635|3664399|P2|Washout 2|Withdrawal by Subject|0
1117581|NCT01688635|3664400|P1|Washout 2|Withdrawal by Subject|1
1117582|NCT01688635|3664399|P2|Washout 2|Physician Decision|0
1117583|NCT01688635|3664400|P1|Washout 2|Physician Decision|1
1117584|NCT01688635|3664399|P2|Washout 1|Physician Decision|1
1117585|NCT01688635|3664400|P1|Washout 1|Physician Decision|0
1117586|NCT01688635|3664399|P2|Washout 1|Adverse Event|1
1117587|NCT01688635|3664400|P1|Washout 1|Adverse Event|0
1117588|NCT01688635|3664399|P2|Washout 1|Withdrawal by Subject|0
1117589|NCT01688635|3664400|P1|Washout 1|Withdrawal by Subject|1
1117590|NCT01688466|3664422|P2|Overall Study|Not evaluable|1
1117591|NCT01688466|3664423|P1|Overall Study|Not evaluable|0
1117592|NCT01688466|3664422|P2|Overall Study|Adverse Event|4
1117593|NCT01688466|3664423|P1|Overall Study|Adverse Event|0
1117594|NCT01688466|3664422|P2|Overall Study|Death|1
1117595|NCT01688466|3664423|P1|Overall Study|Death|0
1117596|NCT01688466|3664422|P2|Overall Study|Withdrawal by Subject|1
1117597|NCT01688466|3664423|P1|Overall Study|Withdrawal by Subject|2
1117598|NCT01688050|3664493|P1|Overall Study|Still be eligible for follow-up|37
1117599|NCT01688050|3664493|P1|Overall Study|Withdrawal by Subject|2
1117600|NCT01688050|3664493|P1|Overall Study|Lost to Follow-up|5
1117601|NCT01688050|3664493|P1|Overall Study|Conversion to open repair|1
1117602|NCT01688050|3664493|P1|Overall Study|Death|5
1117603|NCT01688037|3664502|P3|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
1117604|NCT01688037|3664503|P2|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1
1117605|NCT01688037|3664504|P1|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
1117606|NCT01688037|3664502|P3|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1
1117607|NCT01688037|3664503|P2|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
1117608|NCT01688037|3664504|P1|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
1117609|NCT01688037|3664502|P3|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0
1117610|NCT01688037|3664503|P2|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2
1117611|NCT01688037|3664504|P1|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1
1117612|NCT01688037|3664502|P3|Open-Label Period (Week 6 to 12)|Non-compliance|2
1117613|NCT01688037|3664503|P2|Open-Label Period (Week 6 to 12)|Non-compliance|0
1117614|NCT01688037|3664504|P1|Open-Label Period (Week 6 to 12)|Non-compliance|0
1117615|NCT01688037|3664502|P3|Open-Label Period (Week 6 to 12)|Adverse Event|1
1117616|NCT01688037|3664503|P2|Open-Label Period (Week 6 to 12)|Adverse Event|1
1117617|NCT01688037|3664504|P1|Open-Label Period (Week 6 to 12)|Adverse Event|4
1117618|NCT01688037|3664502|P3|Double-Blind Period (Week 0 to 6)|Physician Decision|0
1117619|NCT01688037|3664503|P2|Double-Blind Period (Week 0 to 6)|Physician Decision|1
1117620|NCT01688037|3664504|P1|Double-Blind Period (Week 0 to 6)|Physician Decision|0
1117621|NCT01688037|3664502|P3|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
1117622|NCT01688037|3664503|P2|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
1117623|NCT01688037|3664504|P1|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
1117624|NCT01688037|3664502|P3|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
1117625|NCT01688037|3664503|P2|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0
1117626|NCT01688037|3664504|P1|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4
1117627|NCT01688037|3664502|P3|Double-Blind Period (Week 0 to 6)|Non-compliance|3
1117628|NCT01688037|3664503|P2|Double-Blind Period (Week 0 to 6)|Non-compliance|2
1117629|NCT01688037|3664504|P1|Double-Blind Period (Week 0 to 6)|Non-compliance|1
1117630|NCT01688037|3664502|P3|Double-Blind Period (Week 0 to 6)|Adverse Event|1
1117631|NCT01688037|3664503|P2|Double-Blind Period (Week 0 to 6)|Adverse Event|0
1117632|NCT01688037|3664504|P1|Double-Blind Period (Week 0 to 6)|Adverse Event|1
1117633|NCT01687998|3664520|P2|Overall Study|Lost to Follow-up|7
1117634|NCT01687998|3664521|P1|Overall Study|Lost to Follow-up|9
1117635|NCT01687998|3664520|P2|Overall Study|Known to be Alive at Study End|62
1117636|NCT01687998|3664521|P1|Overall Study|Known to be Alive at Study End|54
1117637|NCT01687998|3664520|P2|Overall Study|Withdrawal by Subject|51
1117638|NCT01687998|3664521|P1|Overall Study|Withdrawal by Subject|49
1117639|NCT01687712|3664557|P2|Cycle 3|Miscarriage/Spontaneous Abortion|0
1117640|NCT01687712|3664558|P1|Cycle 3|Miscarriage/Spontaneous Abortion|1
1117641|NCT01687712|3664557|P2|Cycle 3|Ectopic Pregnancy|0
1117642|NCT01687712|3664558|P1|Cycle 3|Ectopic Pregnancy|1
1117643|NCT01687712|3664557|P2|Cycle 3|Early Pregnancy Loss|2
1117644|NCT01687712|3664558|P1|Cycle 3|Early Pregnancy Loss|1
1117645|NCT01687712|3664557|P2|Cycle 3|Not Biochemically Pregnant|22
1117646|NCT01687712|3664558|P1|Cycle 3|Not Biochemically Pregnant|21
1117647|NCT01687712|3664557|P2|Cycle 2|Miscarriage/Spontaneous Abortion|1
1117648|NCT01687712|3664558|P1|Cycle 2|Miscarriage/Spontaneous Abortion|0
1117649|NCT01687712|3664557|P2|Cycle 2|Still Birth|0
1117650|NCT01687712|3664558|P1|Cycle 2|Still Birth|1
1117651|NCT01687712|3664557|P2|Cycle 2|Ectopic Pregnancy|1
1117652|NCT01687712|3664558|P1|Cycle 2|Ectopic Pregnancy|0
1117653|NCT01687712|3664557|P2|Cycle 2|Early Pregnancy Loss|16
1117654|NCT01687712|3664558|P1|Cycle 2|Early Pregnancy Loss|18
1117655|NCT01687712|3664557|P2|Cycle 2|Not Biochemically Pregnant|77
1117656|NCT01687712|3664558|P1|Cycle 2|Not Biochemically Pregnant|74
1117657|NCT01687712|3664557|P2|Cycle 1|Lost to Follow-up|1
1117658|NCT01687712|3664558|P1|Cycle 1|Lost to Follow-up|1
1117659|NCT01687712|3664557|P2|Cycle 1|Intrauterine Fetal Death|1
1117660|NCT01687712|3664558|P1|Cycle 1|Intrauterine Fetal Death|0
1117661|NCT01687712|3664557|P2|Cycle 1|Abortion|0
1117662|NCT01687712|3664558|P1|Cycle 1|Abortion|3
1117663|NCT01687712|3664557|P2|Cycle 1|Miscarriage/Spontaneous Abortion|14
1117664|NCT01687712|3664558|P1|Cycle 1|Miscarriage/Spontaneous Abortion|9
1117665|NCT01687712|3664557|P2|Cycle 1|Heterotropic Pregnancy|0
1117666|NCT01687712|3664558|P1|Cycle 1|Heterotropic Pregnancy|1
1117667|NCT01687712|3664557|P2|Cycle 1|Ectopic Pregnancy|5
1117668|NCT01687712|3664558|P1|Cycle 1|Ectopic Pregnancy|5
1117669|NCT01687712|3664557|P2|Cycle 1|Early Pregnancy Loss|60
1117670|NCT01687712|3664558|P1|Cycle 1|Early Pregnancy Loss|43
1117671|NCT01687712|3664557|P2|Cycle 1|Not Biochemically Pregnant|348
1117672|NCT01687712|3664558|P1|Cycle 1|Not Biochemically Pregnant|386
1117673|NCT01687478|3664598|P2|Overall Study|Entry Criteria Not Met|2
1117674|NCT01687478|3664599|P1|Overall Study|Entry Criteria Not Met|6
1117675|NCT01687478|3664598|P2|Overall Study|Physician Decision|3
1117676|NCT01687478|3664599|P1|Overall Study|Physician Decision|1
1117677|NCT01687478|3664598|P2|Overall Study|Withdrawal by Subject|19
1117678|NCT01687478|3664599|P1|Overall Study|Withdrawal by Subject|21
1117679|NCT01687478|3664598|P2|Overall Study|Protocol Violation|2
1117680|NCT01687478|3664599|P1|Overall Study|Protocol Violation|0
1117681|NCT01687478|3664598|P2|Overall Study|Lost to Follow-up|3
1117682|NCT01687478|3664599|P1|Overall Study|Lost to Follow-up|1
1117683|NCT01687478|3664598|P2|Overall Study|Adverse Event|10
1117684|NCT01687478|3664599|P1|Overall Study|Adverse Event|3
1117685|NCT01687296|3664634|P2|Overall Study|Withdrawal by Subject|3
1117686|NCT01687296|3664635|P1|Overall Study|Withdrawal by Subject|6
1117687|NCT01687296|3664634|P2|Overall Study|Protocol Violation|1
1117688|NCT01687296|3664635|P1|Overall Study|Protocol Violation|0
1117689|NCT01687296|3664634|P2|Overall Study|Lack of Efficacy|1
1117690|NCT01687296|3664635|P1|Overall Study|Lack of Efficacy|1
1117691|NCT01687283|3664657|P2|Overall Study|Withdrawal by Subject|8
1117692|NCT01687283|3664658|P1|Overall Study|Withdrawal by Subject|9
1117693|NCT01687283|3664657|P2|Overall Study|Investigator discretion|0
1117694|NCT01687283|3664658|P1|Overall Study|Investigator discretion|2
1117695|NCT01687283|3664657|P2|Overall Study|Lost to Follow-up|1
1117696|NCT01687283|3664658|P1|Overall Study|Lost to Follow-up|1
1117697|NCT01687283|3664657|P2|Overall Study|protocol defined stopping criteria|10
1117698|NCT01687283|3664658|P1|Overall Study|protocol defined stopping criteria|8
1117699|NCT01687283|3664657|P2|Overall Study|Protocol Violation|3
1117700|NCT01687283|3664658|P1|Overall Study|Protocol Violation|1
1117701|NCT01687283|3664657|P2|Overall Study|Lack of Efficacy|1
1117702|NCT01687283|3664658|P1|Overall Study|Lack of Efficacy|3
1117703|NCT01687283|3664657|P2|Overall Study|Adverse Event|4
1117704|NCT01687283|3664658|P1|Overall Study|Adverse Event|11
1117705|NCT01687270|3664681|P1|Overall Study|Lost to Follow-up|1
1117706|NCT01687270|3664681|P1|Overall Study|Lack of Efficacy|11
1117707|NCT01687257|3664692|P3|Overall Study|Investigator's Discretion|0
1117708|NCT01687257|3664693|P2|Overall Study|Investigator's Discretion|3
1117709|NCT01687257|3664694|P1|Overall Study|Investigator's Discretion|0
1117710|NCT01687257|3664692|P3|Overall Study|Adverse Event|0
1117711|NCT01687257|3664693|P2|Overall Study|Adverse Event|0
1117712|NCT01687257|3664694|P1|Overall Study|Adverse Event|1
1117713|NCT01687257|3664692|P3|Overall Study|Subject Withdrew Consent|1
1117714|NCT01687257|3664693|P2|Overall Study|Subject Withdrew Consent|1
1117715|NCT01687257|3664694|P1|Overall Study|Subject Withdrew Consent|1
1117716|NCT01687257|3664692|P3|Overall Study|Efficacy Failure|5
1117717|NCT01687257|3664693|P2|Overall Study|Efficacy Failure|0
1117718|NCT01687257|3664694|P1|Overall Study|Efficacy Failure|6
1117719|NCT01687218|3664759|P6|Overall Study|Relocated, no follow-up planned|0
1117720|NCT01687218|3664760|P5|Overall Study|Relocated, no follow-up planned|0
1117721|NCT01687218|3664761|P4|Overall Study|Relocated, no follow-up planned|1
1117722|NCT01687218|3664762|P3|Overall Study|Relocated, no follow-up planned|1
1117723|NCT01687218|3664763|P2|Overall Study|Relocated, no follow-up planned|0
1117724|NCT01687218|3664764|P1|Overall Study|Relocated, no follow-up planned|1
1117725|NCT01687218|3664759|P6|Overall Study|Withdrawal by Subject|0
1117726|NCT01687218|3664760|P5|Overall Study|Withdrawal by Subject|1
1117727|NCT01687218|3664761|P4|Overall Study|Withdrawal by Subject|1
1117728|NCT01687218|3664762|P3|Overall Study|Withdrawal by Subject|0
1117729|NCT01687218|3664763|P2|Overall Study|Withdrawal by Subject|3
1117730|NCT01687218|3664764|P1|Overall Study|Withdrawal by Subject|2
1117731|NCT01687166|3664795|P4|Overall Study|Insurance|1
1117732|NCT01687166|3664796|P3|Overall Study|Insurance|1
1117733|NCT01687166|3664797|P2|Overall Study|Insurance|0
1117734|NCT01687166|3664798|P1|Overall Study|Insurance|0
1117735|NCT01687166|3664795|P4|Overall Study|Physician choice to use different device|0
1117736|NCT01687166|3664796|P3|Overall Study|Physician choice to use different device|4
1117737|NCT01687166|3664797|P2|Overall Study|Physician choice to use different device|2
1117738|NCT01687166|3664798|P1|Overall Study|Physician choice to use different device|1
1117739|NCT01687166|3664795|P4|Overall Study|Patient unable to be compliant|0
1117740|NCT01687166|3664796|P3|Overall Study|Patient unable to be compliant|0
1117741|NCT01687166|3664797|P2|Overall Study|Patient unable to be compliant|0
1117742|NCT01687166|3664798|P1|Overall Study|Patient unable to be compliant|1
1117743|NCT01687166|3664795|P4|Overall Study|Subject moved out of state|0
1117744|NCT01687166|3664796|P3|Overall Study|Subject moved out of state|0
1117745|NCT01687166|3664797|P2|Overall Study|Subject moved out of state|1
1117746|NCT01687166|3664798|P1|Overall Study|Subject moved out of state|0
1117747|NCT01687166|3664795|P4|Overall Study|Protocol Violation|0
1117748|NCT01687166|3664796|P3|Overall Study|Protocol Violation|1
1117749|NCT01687166|3664797|P2|Overall Study|Protocol Violation|1
1117750|NCT01687166|3664798|P1|Overall Study|Protocol Violation|1
1117751|NCT01687166|3664795|P4|Overall Study|Death|0
1117752|NCT01687166|3664796|P3|Overall Study|Death|0
1117753|NCT01687166|3664797|P2|Overall Study|Death|1
1117754|NCT01687166|3664798|P1|Overall Study|Death|1
1117755|NCT01687166|3664795|P4|Overall Study|Equipment/Device Availability|0
1117756|NCT01687166|3664796|P3|Overall Study|Equipment/Device Availability|0
1117757|NCT01687166|3664797|P2|Overall Study|Equipment/Device Availability|1
1117758|NCT01687166|3664798|P1|Overall Study|Equipment/Device Availability|0
1117759|NCT01687166|3664795|P4|Overall Study|Lost to Follow-up|0
1117760|NCT01687166|3664796|P3|Overall Study|Lost to Follow-up|1
1117761|NCT01687166|3664797|P2|Overall Study|Lost to Follow-up|5
1117762|NCT01687166|3664798|P1|Overall Study|Lost to Follow-up|2
1117763|NCT01687166|3664795|P4|Overall Study|Withdrawal by Subject|0
1117764|NCT01687166|3664796|P3|Overall Study|Withdrawal by Subject|3
1117765|NCT01687166|3664797|P2|Overall Study|Withdrawal by Subject|4
1117766|NCT01687166|3664798|P1|Overall Study|Withdrawal by Subject|11
1117767|NCT01687166|3664795|P4|Overall Study|Physician Decision|0
1117768|NCT01687166|3664796|P3|Overall Study|Physician Decision|1
1117769|NCT01687166|3664797|P2|Overall Study|Physician Decision|2
1117770|NCT01687166|3664798|P1|Overall Study|Physician Decision|3
1117771|NCT01687166|3664795|P4|Overall Study|Adverse Event|0
1117772|NCT01687166|3664796|P3|Overall Study|Adverse Event|0
1117773|NCT01687166|3664797|P2|Overall Study|Adverse Event|1
1117774|NCT01687166|3664798|P1|Overall Study|Adverse Event|2
1117775|NCT01687166|3664795|P4|Overall Study|Did not meet eligibility criteria|1
1117776|NCT01687166|3664796|P3|Overall Study|Did not meet eligibility criteria|1
1117777|NCT01687166|3664797|P2|Overall Study|Did not meet eligibility criteria|6
1117778|NCT01687166|3664798|P1|Overall Study|Did not meet eligibility criteria|4
1117779|NCT01687166|3664795|P4|Overall Study|Attempt subject|0
1117780|NCT01687166|3664796|P3|Overall Study|Attempt subject|2
1117781|NCT01687166|3664797|P2|Overall Study|Attempt subject|3
1117782|NCT01687166|3664798|P1|Overall Study|Attempt subject|2
1117783|NCT01687101|3664814|P1|Overall Study|Lost to Follow-up|7
1117784|NCT01686958|3664839|P1|Overall Study|Withdrawal by Subject|1
1117785|NCT01686932|3664852|P2|Period 1|Adverse Event|1
1117786|NCT01686932|3664853|P1|Period 1|Adverse Event|1
1117787|NCT01686828|3664883|P4|Overall Study|Weight Loss|0
1117788|NCT01686828|3664884|P3|Overall Study|Weight Loss|1
1117789|NCT01686828|3664885|P2|Overall Study|Weight Loss|0
1117790|NCT01686828|3664886|P1|Overall Study|Weight Loss|0
1117791|NCT01686828|3664883|P4|Overall Study|New Job|0
1117792|NCT01686828|3664884|P3|Overall Study|New Job|0
1117793|NCT01686828|3664885|P2|Overall Study|New Job|1
1117794|NCT01686828|3664886|P1|Overall Study|New Job|0
1117795|NCT01686828|3664883|P4|Overall Study|Physician Decision|0
1117796|NCT01686828|3664884|P3|Overall Study|Physician Decision|0
1117797|NCT01686828|3664885|P2|Overall Study|Physician Decision|0
1117798|NCT01686828|3664886|P1|Overall Study|Physician Decision|1
1117799|NCT01686633|3664960|P3|Overall Study|Lost to Follow-up|1
1117800|NCT01686633|3664961|P2|Overall Study|Lost to Follow-up|1
1117801|NCT01686633|3664962|P1|Overall Study|Lost to Follow-up|0
1117802|NCT01686633|3664960|P3|Overall Study|Protocol-defined Stopping Criteria|1
1117803|NCT01686633|3664961|P2|Overall Study|Protocol-defined Stopping Criteria|0
1117804|NCT01686633|3664962|P1|Overall Study|Protocol-defined Stopping Criteria|1
1117805|NCT01686633|3664960|P3|Overall Study|Protocol Violation|0
1117806|NCT01686633|3664961|P2|Overall Study|Protocol Violation|3
1117807|NCT01686633|3664962|P1|Overall Study|Protocol Violation|2
1117808|NCT01686633|3664960|P3|Overall Study|Adverse Event|3
1117809|NCT01686633|3664961|P2|Overall Study|Adverse Event|3
1117810|NCT01686633|3664962|P1|Overall Study|Adverse Event|4
1117811|NCT01686633|3664960|P3|Overall Study|Physician Decision|4
1117812|NCT01686633|3664961|P2|Overall Study|Physician Decision|4
1117813|NCT01686633|3664962|P1|Overall Study|Physician Decision|3
1117814|NCT01686633|3664960|P3|Overall Study|Withdrawal by Subject|5
1117815|NCT01686633|3664961|P2|Overall Study|Withdrawal by Subject|8
1117816|NCT01686633|3664962|P1|Overall Study|Withdrawal by Subject|8
1117817|NCT01686633|3664960|P3|Overall Study|Lack of Efficacy|11
1117818|NCT01686633|3664961|P2|Overall Study|Lack of Efficacy|13
1117819|NCT01686633|3664962|P1|Overall Study|Lack of Efficacy|33
1117820|NCT01686581|3664985|P1|Overall Study|Reason Missing|1
1117821|NCT01686581|3664985|P1|Overall Study|Other Miscellaneous Reasons|36
1117822|NCT01686581|3664985|P1|Overall Study|Thinks it is Inconvenient|17
1117823|NCT01686581|3664985|P1|Overall Study|Trying to get Pregnant or Nursing|2
1117824|NCT01686581|3664985|P1|Overall Study|Thinks Injections Take Too Much Time|2
1117825|NCT01686581|3664985|P1|Overall Study|Thinks Injections Too Painful|8
1117826|NCT01686581|3664985|P1|Overall Study|Participant Concerned about Risks|6
1117827|NCT01686581|3664985|P1|Overall Study|Lack of Efficacy|90
1117828|NCT01686581|3664985|P1|Overall Study|Side-effects or Health Problems|15
1117829|NCT01686568|3664998|P2|Sub-Study|Not consented for sub-study|2
1117830|NCT01686568|3664999|P1|Sub-Study|Not consented for sub-study|2
1117831|NCT01686568|3664998|P2|Main Study|Liver enzymes above range of exclusion|0
1117832|NCT01686568|3664999|P1|Main Study|Liver enzymes above range of exclusion|1
1117833|NCT01686568|3664998|P2|Main Study|Noncompliance with protocol|1
1117834|NCT01686568|3664999|P1|Main Study|Noncompliance with protocol|0
1117835|NCT01686568|3664998|P2|Main Study|Withdrawal by Subject|3
1117836|NCT01686568|3664999|P1|Main Study|Withdrawal by Subject|1
1117837|NCT01685983|3665091|P1|Overall Study|Other|7
1117838|NCT01685983|3665091|P1|Overall Study|Noncompliance with Study Drug|1
1117839|NCT01685983|3665091|P1|Overall Study|Physician Decision|13
1117840|NCT01685983|3665091|P1|Overall Study|Progressive Disease|32
1117841|NCT01685983|3665091|P1|Overall Study|Protocol Violation|2
1117842|NCT01685983|3665091|P1|Overall Study|Withdrawal by Subject|19
1117843|NCT01685983|3665091|P1|Overall Study|Death|1
1117844|NCT01685983|3665091|P1|Overall Study|Adverse Event|7
1117845|NCT01685840|3665103|P2|Overall Study|Had VAD, Dialysis or Transplant|17
1117846|NCT01685840|3665104|P1|Overall Study|Had VAD, Dialysis or Transplant|11
1117847|NCT01685840|3665103|P2|Overall Study|Futility|200
1117848|NCT01685840|3665104|P1|Overall Study|Futility|197
1117849|NCT01685840|3665103|P2|Overall Study|Withdrawal by Subject|17
1117850|NCT01685840|3665104|P1|Overall Study|Withdrawal by Subject|14
1117851|NCT01685840|3665103|P2|Overall Study|Physician Decision|7
1117852|NCT01685840|3665104|P1|Overall Study|Physician Decision|3
1117853|NCT01685840|3665103|P2|Overall Study|Lost to Follow-up|25
1117854|NCT01685840|3665104|P1|Overall Study|Lost to Follow-up|27
1117855|NCT01685840|3665103|P2|Overall Study|Death|66
1117856|NCT01685840|3665104|P1|Overall Study|Death|77
1117857|NCT01685801|3665148|P4|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
1117858|NCT01685801|3665149|P3|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
1117859|NCT01685801|3665150|P2|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
1117860|NCT01685801|3665151|P1|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
1117861|NCT01685801|3665148|P4|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1
1117862|NCT01685801|3665149|P3|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
1117863|NCT01685801|3665150|P2|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
1117864|NCT01685801|3665151|P1|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
1117865|NCT01685697|3665173|P2|Overall Study|Protocol Violation|3
1117866|NCT01685697|3665174|P1|Overall Study|Protocol Violation|3
1117867|NCT01685606|3665208|P1|Overall Study|Withdrawal by Subject|1
1117868|NCT01685437|3665236|P1|Overall Study|Unable to make visits due to work|1
1117869|NCT01685437|3665236|P1|Overall Study|Protocol Violation|4
1117870|NCT01685437|3665236|P1|Overall Study|Adverse Event|1
1117871|NCT01685437|3665236|P1|Overall Study|Lost to Follow-up|3
1117872|NCT01685437|3665236|P1|Overall Study|Withdrawal by Subject|22
1117873|NCT01685372|3665250|P2|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4
1117874|NCT01685372|3665251|P1|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3
1117875|NCT01685216|3665339|P1|Overall Study|Did not receive study drug|1
1117876|NCT01685203|3665356|P7|Overall Study|Patient's decision|0
1117877|NCT01685203|3665357|P6|Overall Study|Patient's decision|1
1117878|NCT01685203|3665358|P5|Overall Study|Patient's decision|0
1117879|NCT01685203|3665359|P4|Overall Study|Patient's decision|0
1117880|NCT01685203|3665360|P3|Overall Study|Patient's decision|0
1117881|NCT01685203|3665361|P2|Overall Study|Patient's decision|0
1117882|NCT01685203|3665362|P1|Overall Study|Patient's decision|0
1117883|NCT01685203|3665356|P7|Overall Study|Adverse event and withdrew consent|0
1117884|NCT01685203|3665357|P6|Overall Study|Adverse event and withdrew consent|0
1117885|NCT01685203|3665358|P5|Overall Study|Adverse event and withdrew consent|0
1117886|NCT01685203|3665359|P4|Overall Study|Adverse event and withdrew consent|0
1117887|NCT01685203|3665360|P3|Overall Study|Adverse event and withdrew consent|0
1117888|NCT01685203|3665361|P2|Overall Study|Adverse event and withdrew consent|0
1117889|NCT01685203|3665362|P1|Overall Study|Adverse event and withdrew consent|1
1117890|NCT01685203|3665356|P7|Overall Study|Adverse Event|0
1117891|NCT01685203|3665357|P6|Overall Study|Adverse Event|2
1117892|NCT01685203|3665358|P5|Overall Study|Adverse Event|0
1117893|NCT01685203|3665359|P4|Overall Study|Adverse Event|0
1117894|NCT01685203|3665360|P3|Overall Study|Adverse Event|0
1117895|NCT01685203|3665361|P2|Overall Study|Adverse Event|0
1117896|NCT01685203|3665362|P1|Overall Study|Adverse Event|0
1117897|NCT01685203|3665356|P7|Overall Study|Lost to Follow-up|0
1117898|NCT01685203|3665357|P6|Overall Study|Lost to Follow-up|0
1117899|NCT01685203|3665358|P5|Overall Study|Lost to Follow-up|0
1117900|NCT01685203|3665359|P4|Overall Study|Lost to Follow-up|1
1117901|NCT01685203|3665360|P3|Overall Study|Lost to Follow-up|0
1117902|NCT01685203|3665361|P2|Overall Study|Lost to Follow-up|3
1117903|NCT01685203|3665362|P1|Overall Study|Lost to Follow-up|3
1117904|NCT01685060|3665406|P1|Overall Study|Death|8
1117905|NCT01685060|3665406|P1|Overall Study|Lost to Follow-up|1
1117906|NCT01685060|3665406|P1|Overall Study|Subject/guardian decision|20
1117907|NCT01685060|3665406|P1|Overall Study|Physician Decision|14
1117908|NCT01685060|3665406|P1|Overall Study|Progressive disease|69
1117909|NCT01685060|3665406|P1|Overall Study|Adverse Event|12
1117910|NCT01685060|3665406|P1|Overall Study|Rollover patients|16
1117911|NCT01684930|3665432|P2|Overall Study|Withdrawal by Subject|1
1117912|NCT01684930|3665433|P1|Overall Study|Withdrawal by Subject|3
1117913|NCT01684878|3665453|P4|Part 2: Randomized Phase|Participant noncompliance|1
1117914|NCT01684878|3665454|P3|Part 2: Randomized Phase|Participant noncompliance|0
1117915|NCT01684878|3665455|P2|Part 2: Randomized Phase|Participant noncompliance|0
1117916|NCT01684878|3665456|P1|Part 2: Randomized Phase|Participant noncompliance|0
1117917|NCT01684878|3665453|P4|Part 2: Randomized Phase|Alive at data-cut|7
1117918|NCT01684878|3665454|P3|Part 2: Randomized Phase|Alive at data-cut|13
1117919|NCT01684878|3665455|P2|Part 2: Randomized Phase|Alive at data-cut|0
1117920|NCT01684878|3665456|P1|Part 2: Randomized Phase|Alive at data-cut|0
1117921|NCT01684878|3665453|P4|Part 2: Randomized Phase|Death|68
1117922|NCT01684878|3665454|P3|Part 2: Randomized Phase|Death|62
1117923|NCT01684878|3665455|P2|Part 2: Randomized Phase|Death|0
1117924|NCT01684878|3665456|P1|Part 2: Randomized Phase|Death|0
1117925|NCT01684878|3665453|P4|Part 2: Randomized Phase|Lost to Follow-up|0
1117926|NCT01684878|3665454|P3|Part 2: Randomized Phase|Lost to Follow-up|2
1117927|NCT01684878|3665455|P2|Part 2: Randomized Phase|Lost to Follow-up|0
1117928|NCT01684878|3665456|P1|Part 2: Randomized Phase|Lost to Follow-up|0
1117929|NCT01684878|3665453|P4|Part 2: Randomized Phase|Participant withdrew consent|2
1117930|NCT01684878|3665454|P3|Part 2: Randomized Phase|Participant withdrew consent|1
1117931|NCT01684878|3665455|P2|Part 2: Randomized Phase|Participant withdrew consent|0
1117932|NCT01684878|3665456|P1|Part 2: Randomized Phase|Participant withdrew consent|0
1117933|NCT01684878|3665453|P4|Part 1: Safety Run in Phase|Lost to Follow-up|0
1117934|NCT01684878|3665454|P3|Part 1: Safety Run in Phase|Lost to Follow-up|0
1117935|NCT01684878|3665455|P2|Part 1: Safety Run in Phase|Lost to Follow-up|2
1117936|NCT01684878|3665456|P1|Part 1: Safety Run in Phase|Lost to Follow-up|0
1117937|NCT01684878|3665453|P4|Part 1: Safety Run in Phase|Death|0
1117938|NCT01684878|3665454|P3|Part 1: Safety Run in Phase|Death|0
1117939|NCT01684878|3665455|P2|Part 1: Safety Run in Phase|Death|20
1117940|NCT01684878|3665456|P1|Part 1: Safety Run in Phase|Death|15
1117941|NCT01684878|3665453|P4|Part 1: Safety Run in Phase|Participants withdrawn consent|0
1117942|NCT01684878|3665454|P3|Part 1: Safety Run in Phase|Participants withdrawn consent|0
1117943|NCT01684878|3665455|P2|Part 1: Safety Run in Phase|Participants withdrawn consent|1
1117944|NCT01684878|3665456|P1|Part 1: Safety Run in Phase|Participants withdrawn consent|1
1117945|NCT01684423|3665560|P5|Overall Study|Withdrawal by Subject|0
1117946|NCT01684423|3665561|P4|Overall Study|Withdrawal by Subject|0
1117947|NCT01684423|3665562|P3|Overall Study|Withdrawal by Subject|1
1117948|NCT01684423|3665563|P2|Overall Study|Withdrawal by Subject|0
1117949|NCT01684423|3665564|P1|Overall Study|Withdrawal by Subject|0
1117950|NCT01684215|3665621|P4|Overall Study|Ongoing at date of cut-off|38
1117951|NCT01684215|3665622|P3|Overall Study|Ongoing at date of cut-off|4
1117952|NCT01684215|3665623|P2|Overall Study|Ongoing at date of cut-off|0
1117953|NCT01684215|3665624|P1|Overall Study|Ongoing at date of cut-off|0
1117954|NCT01684215|3665621|P4|Overall Study|Death|1
1117955|NCT01684215|3665622|P3|Overall Study|Death|0
1117956|NCT01684215|3665623|P2|Overall Study|Death|0
1117957|NCT01684215|3665624|P1|Overall Study|Death|0
1117958|NCT01684215|3665621|P4|Overall Study|Other|0
1117959|NCT01684215|3665622|P3|Overall Study|Other|1
1117960|NCT01684215|3665623|P2|Overall Study|Other|0
1117961|NCT01684215|3665624|P1|Overall Study|Other|0
1117962|NCT01684215|3665621|P4|Overall Study|Objective progression or relapse|0
1117963|NCT01684215|3665622|P3|Overall Study|Objective progression or relapse|0
1117964|NCT01684215|3665623|P2|Overall Study|Objective progression or relapse|6
1117965|NCT01684215|3665624|P1|Overall Study|Objective progression or relapse|5
1117966|NCT01684215|3665621|P4|Overall Study|Adverse Event|4
1117967|NCT01684215|3665622|P3|Overall Study|Adverse Event|1
1117968|NCT01684215|3665623|P2|Overall Study|Adverse Event|0
1117969|NCT01684215|3665624|P1|Overall Study|Adverse Event|1
1117970|NCT01684046|3665698|P2|Period 1, First 30 Days|Adverse Event|2
1117971|NCT01684046|3665699|P1|Period 1, First 30 Days|Adverse Event|0
1117972|NCT01684033|3665705|P2|Period 2, Second 30 Days|Adverse Event|0
1117973|NCT01684033|3665706|P1|Period 2, Second 30 Days|Adverse Event|1
1117974|NCT01684033|3665705|P2|Period 1, First 30 Days|Lost to Follow-up|0
1117975|NCT01684033|3665706|P1|Period 1, First 30 Days|Lost to Follow-up|1
1117976|NCT01684033|3665705|P2|Period 1, First 30 Days|Withdrawal by Subject|0
1117977|NCT01684033|3665706|P1|Period 1, First 30 Days|Withdrawal by Subject|1
1117978|NCT01684033|3665705|P2|Period 1, First 30 Days|Noncompliance|0
1117979|NCT01684033|3665706|P1|Period 1, First 30 Days|Noncompliance|1
1117980|NCT01684033|3665705|P2|Period 1, First 30 Days|Adverse Event|1
1117981|NCT01684033|3665706|P1|Period 1, First 30 Days|Adverse Event|1
1117982|NCT01683838|3665740|P2|Overall Study|not specified|3
1117983|NCT01683838|3665741|P1|Overall Study|not specified|4
1117984|NCT01683838|3665740|P2|Overall Study|Lost to Follow-up|1
1117985|NCT01683838|3665741|P1|Overall Study|Lost to Follow-up|1
1117986|NCT01683838|3665740|P2|Overall Study|Withdrawal by Subject|5
1117987|NCT01683838|3665741|P1|Overall Study|Withdrawal by Subject|6
1117988|NCT01683838|3665740|P2|Overall Study|Protocol Violation|1
1117989|NCT01683838|3665741|P1|Overall Study|Protocol Violation|3
1117990|NCT01683838|3665740|P2|Overall Study|Adverse Event|2
1117991|NCT01683838|3665741|P1|Overall Study|Adverse Event|12
1117992|NCT01683604|3665781|P1|Overall Study|Other|2
1117993|NCT01683604|3665781|P1|Overall Study|Lack of Efficacy|1
1117994|NCT01683604|3665781|P1|Overall Study|Adverse Event|2
1117995|NCT01683409|3665966|P5|Washout Period 2 (Weeks 29-32)|Physician Decision|0
1117996|NCT01683409|3665967|P4|Washout Period 2 (Weeks 29-32)|Physician Decision|0
1117997|NCT01683409|3665968|P3|Washout Period 2 (Weeks 29-32)|Physician Decision|1
1117998|NCT01683409|3665969|P2|Washout Period 2 (Weeks 29-32)|Physician Decision|0
1117999|NCT01683409|3665970|P1|Washout Period 2 (Weeks 29-32)|Physician Decision|0
1118000|NCT01683409|3665966|P5|Washout Period 2 (Weeks 29-32)|Adverse Event|3
1118001|NCT01683409|3665967|P4|Washout Period 2 (Weeks 29-32)|Adverse Event|0
1118002|NCT01683409|3665968|P3|Washout Period 2 (Weeks 29-32)|Adverse Event|0
1118003|NCT01683409|3665969|P2|Washout Period 2 (Weeks 29-32)|Adverse Event|0
1118004|NCT01683409|3665970|P1|Washout Period 2 (Weeks 29-32)|Adverse Event|0
1118005|NCT01683409|3665966|P5|Washout Period 1 (Weeks 25-28)|Adverse Event|2
1118006|NCT01683409|3665967|P4|Washout Period 1 (Weeks 25-28)|Adverse Event|1
1118007|NCT01683409|3665968|P3|Washout Period 1 (Weeks 25-28)|Adverse Event|0
1118008|NCT01683409|3665969|P2|Washout Period 1 (Weeks 25-28)|Adverse Event|4
1118009|NCT01683409|3665970|P1|Washout Period 1 (Weeks 25-28)|Adverse Event|0
1118010|NCT01683409|3665966|P5|Washout Period 1 (Weeks 25-28)|Physician Decision|0
1118011|NCT01683409|3665967|P4|Washout Period 1 (Weeks 25-28)|Physician Decision|0
1118012|NCT01683409|3665968|P3|Washout Period 1 (Weeks 25-28)|Physician Decision|0
1118013|NCT01683409|3665969|P2|Washout Period 1 (Weeks 25-28)|Physician Decision|0
1118014|NCT01683409|3665970|P1|Washout Period 1 (Weeks 25-28)|Physician Decision|1
1118015|NCT01683409|3665966|P5|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
1118016|NCT01683409|3665967|P4|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
1118017|NCT01683409|3665968|P3|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
1118018|NCT01683409|3665969|P2|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
1118019|NCT01683409|3665970|P1|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
1118020|NCT01683409|3665966|P5|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
1118021|NCT01683409|3665967|P4|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
1118022|NCT01683409|3665968|P3|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
1118023|NCT01683409|3665969|P2|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
1118024|NCT01683409|3665970|P1|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
1118025|NCT01683409|3665966|P5|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
1118026|NCT01683409|3665967|P4|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
1118027|NCT01683409|3665968|P3|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1
1118028|NCT01683409|3665969|P2|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
1118029|NCT01683409|3665970|P1|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
1118030|NCT01683409|3665966|P5|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
1118031|NCT01683409|3665967|P4|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
1118032|NCT01683409|3665968|P3|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
1118033|NCT01683409|3665969|P2|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
1118034|NCT01683409|3665970|P1|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
1118035|NCT01683409|3665966|P5|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
1118036|NCT01683409|3665967|P4|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
1118037|NCT01683409|3665968|P3|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
1118038|NCT01683409|3665969|P2|Treatment Period (Weeks 1-24)|Lost to Follow-up|1
1118039|NCT01683409|3665970|P1|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
1118040|NCT01683409|3665966|P5|Treatment Period (Weeks 1-24)|Adverse Event|1
1118041|NCT01683409|3665967|P4|Treatment Period (Weeks 1-24)|Adverse Event|1
1118042|NCT01683409|3665968|P3|Treatment Period (Weeks 1-24)|Adverse Event|0
1118043|NCT01683409|3665969|P2|Treatment Period (Weeks 1-24)|Adverse Event|3
1118044|NCT01683409|3665970|P1|Treatment Period (Weeks 1-24)|Adverse Event|0
1118045|NCT01683409|3665966|P5|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
1118046|NCT01683409|3665967|P4|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
1118047|NCT01683409|3665968|P3|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1
1118048|NCT01683409|3665969|P2|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
1118049|NCT01683409|3665970|P1|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
1118050|NCT01683383|3666013|P2|Overall Study|Infant was not transported|0
1118051|NCT01683383|3666014|P1|Overall Study|Infant was not transported|1
1118052|NCT01683266|3666030|P2|Overall Study|Serious Adverse Event of Hypoglycemia|1
1118053|NCT01683266|3666031|P1|Overall Study|Serious Adverse Event of Hypoglycemia|0
1118054|NCT01683266|3666030|P2|Overall Study|Possibly Hypoglycemia|0
1118055|NCT01683266|3666031|P1|Overall Study|Possibly Hypoglycemia|1
1118056|NCT01683266|3666030|P2|Overall Study|Perceived Lack of Efficacy|1
1118057|NCT01683266|3666031|P1|Overall Study|Perceived Lack of Efficacy|1
1118058|NCT01683266|3666030|P2|Overall Study|Nonserious Hypoglycemia|3
1118059|NCT01683266|3666031|P1|Overall Study|Nonserious Hypoglycemia|0
1118060|NCT01683266|3666030|P2|Overall Study|Site Closure / Site Withdrawal|3
1118061|NCT01683266|3666031|P1|Overall Study|Site Closure / Site Withdrawal|1
1118062|NCT01683266|3666030|P2|Overall Study|Lost to Follow-up|0
1118063|NCT01683266|3666031|P1|Overall Study|Lost to Follow-up|5
1118064|NCT01683266|3666030|P2|Overall Study|Selection Criterion / Protocol Violation|5
1118065|NCT01683266|3666031|P1|Overall Study|Selection Criterion / Protocol Violation|7
1118066|NCT01683266|3666030|P2|Overall Study|Personal Reason|25
1118067|NCT01683266|3666031|P1|Overall Study|Personal Reason|17
1118068|NCT01683266|3666030|P2|Overall Study|Protocol Violation|6
1118069|NCT01683266|3666031|P1|Overall Study|Protocol Violation|13
1118070|NCT01683266|3666030|P2|Overall Study|Lack of Efficacy|2
1118071|NCT01683266|3666031|P1|Overall Study|Lack of Efficacy|5
1118072|NCT01683266|3666030|P2|Overall Study|Adverse Event|4
1118073|NCT01683266|3666031|P1|Overall Study|Adverse Event|5
1118074|NCT01683058|3666059|P1|Overall Study|Lack of Efficacy|2
1118075|NCT01683058|3666059|P1|Overall Study|Withdrawal by Subject|7
1118076|NCT01683058|3666059|P1|Overall Study|Subject Met Withdrawal Criteria|5
1118077|NCT01683058|3666059|P1|Overall Study|Adverse Event|6
1118078|NCT01683058|3666059|P1|Overall Study|Lost to Follow-up|9
1118079|NCT01683019|3666090|P3|Overall Study|Withdrawal by Subject|4
1118080|NCT01683019|3666091|P2|Overall Study|Withdrawal by Subject|1
1118081|NCT01683019|3666092|P1|Overall Study|Withdrawal by Subject|2
1118082|NCT01682876|3666115|P4|Overall Study|Other|1
1118083|NCT01682876|3666116|P3|Overall Study|Other|1
1118084|NCT01682876|3666117|P2|Overall Study|Other|0
1118085|NCT01682876|3666118|P1|Overall Study|Other|1
1118086|NCT01682876|3666115|P4|Overall Study|Withdrawal by Subject|2
1118087|NCT01682876|3666116|P3|Overall Study|Withdrawal by Subject|0
1118088|NCT01682876|3666117|P2|Overall Study|Withdrawal by Subject|0
1118089|NCT01682876|3666118|P1|Overall Study|Withdrawal by Subject|4
1118090|NCT01682876|3666115|P4|Overall Study|Protocol Violation|1
1118091|NCT01682876|3666116|P3|Overall Study|Protocol Violation|1
1118092|NCT01682876|3666117|P2|Overall Study|Protocol Violation|1
1118093|NCT01682876|3666118|P1|Overall Study|Protocol Violation|1
1118094|NCT01682876|3666115|P4|Overall Study|Lost to Follow-up|11
1118095|NCT01682876|3666116|P3|Overall Study|Lost to Follow-up|9
1118096|NCT01682876|3666117|P2|Overall Study|Lost to Follow-up|15
1118097|NCT01682876|3666118|P1|Overall Study|Lost to Follow-up|11
1118098|NCT01682876|3666115|P4|Overall Study|Adverse Event|1
1118099|NCT01682876|3666116|P3|Overall Study|Adverse Event|0
1118100|NCT01682876|3666117|P2|Overall Study|Adverse Event|0
1118101|NCT01682876|3666118|P1|Overall Study|Adverse Event|0
1118102|NCT01682876|3666115|P4|Overall Study|Administrative reason|3
1118103|NCT01682876|3666116|P3|Overall Study|Administrative reason|0
1118104|NCT01682876|3666117|P2|Overall Study|Administrative reason|4
1118105|NCT01682876|3666118|P1|Overall Study|Administrative reason|4
1118106|NCT01682863|3666164|P3|Overall Study|Physician Decision|1
1118107|NCT01682863|3666165|P2|Overall Study|Physician Decision|0
1118108|NCT01682863|3666166|P1|Overall Study|Physician Decision|0
1118109|NCT01682863|3666164|P3|Overall Study|Adverse Event|2
1118110|NCT01682863|3666165|P2|Overall Study|Adverse Event|1
1118111|NCT01682863|3666166|P1|Overall Study|Adverse Event|0
1118112|NCT01682863|3666164|P3|Overall Study|Technical problems|0
1118113|NCT01682863|3666165|P2|Overall Study|Technical problems|0
1118114|NCT01682863|3666166|P1|Overall Study|Technical problems|1
1118115|NCT01682863|3666164|P3|Overall Study|Protocol deviation|1
1118116|NCT01682863|3666165|P2|Overall Study|Protocol deviation|0
1118117|NCT01682863|3666166|P1|Overall Study|Protocol deviation|1
1118118|NCT01682863|3666164|P3|Overall Study|Death|4
1118119|NCT01682863|3666165|P2|Overall Study|Death|3
1118120|NCT01682863|3666166|P1|Overall Study|Death|1
1118121|NCT01682863|3666164|P3|Overall Study|Lost to Follow-up|6
1118122|NCT01682863|3666165|P2|Overall Study|Lost to Follow-up|1
1118123|NCT01682863|3666166|P1|Overall Study|Lost to Follow-up|5
1118124|NCT01682863|3666164|P3|Overall Study|Subject/guardian decision|10
1118125|NCT01682863|3666165|P2|Overall Study|Subject/guardian decision|12
1118126|NCT01682863|3666166|P1|Overall Study|Subject/guardian decision|19
1118127|NCT01682837|3666195|P1|Baseline|Withdrawal by Subject|5
1118128|NCT01682759|3666239|P2|Overall Study|Withdrawal by Subject|55
1118129|NCT01682759|3666240|P1|Overall Study|Withdrawal by Subject|56
1118130|NCT01682759|3666239|P2|Overall Study|Physician Decision|1
1118131|NCT01682759|3666240|P1|Overall Study|Physician Decision|1
1118132|NCT01682759|3666239|P2|Overall Study|Lost to Follow-up|13
1118133|NCT01682759|3666240|P1|Overall Study|Lost to Follow-up|10
1118134|NCT01682759|3666239|P2|Overall Study|Death|1
1118135|NCT01682759|3666240|P1|Overall Study|Death|2
1118136|NCT01682720|3666264|P4|Overall Study|Adverse Event|1
1118137|NCT01682720|3666265|P3|Overall Study|Adverse Event|1
1118138|NCT01682720|3666266|P2|Overall Study|Adverse Event|0
1118139|NCT01682720|3666267|P1|Overall Study|Adverse Event|1
1118140|NCT01682720|3666264|P4|Overall Study|Subject Withdrew Consent|2
1118141|NCT01682720|3666265|P3|Overall Study|Subject Withdrew Consent|2
1118142|NCT01682720|3666266|P2|Overall Study|Subject Withdrew Consent|0
1118143|NCT01682720|3666267|P1|Overall Study|Subject Withdrew Consent|0
1118144|NCT01682720|3666264|P4|Overall Study|Lost to Follow-up|6
1118145|NCT01682720|3666265|P3|Overall Study|Lost to Follow-up|0
1118146|NCT01682720|3666266|P2|Overall Study|Lost to Follow-up|1
1118147|NCT01682720|3666267|P1|Overall Study|Lost to Follow-up|1
1118148|NCT01682720|3666264|P4|Overall Study|Efficacy Failure|30
1118149|NCT01682720|3666265|P3|Overall Study|Efficacy Failure|3
1118150|NCT01682720|3666266|P2|Overall Study|Efficacy Failure|3
1118151|NCT01682720|3666267|P1|Overall Study|Efficacy Failure|0
1118152|NCT01682720|3666264|P4|Overall Study|Terminated by Sponsor|0
1118153|NCT01682720|3666265|P3|Overall Study|Terminated by Sponsor|0
1118154|NCT01682720|3666266|P2|Overall Study|Terminated by Sponsor|0
1118155|NCT01682720|3666267|P1|Overall Study|Terminated by Sponsor|83
1118156|NCT01682720|3666264|P4|Overall Study|Randomized but Not Treated|0
1118157|NCT01682720|3666265|P3|Overall Study|Randomized but Not Treated|1
1118158|NCT01682720|3666266|P2|Overall Study|Randomized but Not Treated|1
1118159|NCT01682720|3666267|P1|Overall Study|Randomized but Not Treated|0
1118160|NCT01682681|3666284|P1|Overall Study|Low compliance|13
1118161|NCT01682681|3666284|P1|Overall Study|Other|21
1118162|NCT01682681|3666284|P1|Overall Study|tapering of topiramate|5
1118163|NCT01682681|3666284|P1|Overall Study|Adverse Event|46
1118164|NCT01682681|3666284|P1|Overall Study|Lost to Follow-up|174
1118165|NCT01682681|3666284|P1|Overall Study|Moved to other hospital|10
1118166|NCT01682681|3666284|P1|Overall Study|Withdrawal by Subject|1
1118167|NCT01682681|3666284|P1|Overall Study|Lack of Efficacy|62
1118168|NCT01682603|3666313|P1|Overall Study|Lost to Follow-up|3
1118169|NCT01682512|3666358|P3|Overall Study|Other than stated above|2
1118170|NCT01682512|3666359|P2|Overall Study|Other than stated above|4
1118171|NCT01682512|3666360|P1|Overall Study|Other than stated above|2
1118172|NCT01682512|3666358|P3|Overall Study|Secondary lack of efficacy|0
1118173|NCT01682512|3666359|P2|Overall Study|Secondary lack of efficacy|1
1118174|NCT01682512|3666360|P1|Overall Study|Secondary lack of efficacy|1
1118175|NCT01682512|3666358|P3|Overall Study|Primary lack of efficacy|7
1118176|NCT01682512|3666359|P2|Overall Study|Primary lack of efficacy|7
1118177|NCT01682512|3666360|P1|Overall Study|Primary lack of efficacy|10
1118178|NCT01682512|3666358|P3|Overall Study|Protocol Violation|2
1118179|NCT01682512|3666359|P2|Overall Study|Protocol Violation|3
1118180|NCT01682512|3666360|P1|Overall Study|Protocol Violation|2
1118181|NCT01682512|3666358|P3|Overall Study|Lost to Follow-up|2
1118182|NCT01682512|3666359|P2|Overall Study|Lost to Follow-up|0
1118183|NCT01682512|3666360|P1|Overall Study|Lost to Follow-up|3
1118184|NCT01682512|3666358|P3|Overall Study|Study terminated by sponsor|0
1118185|NCT01682512|3666359|P2|Overall Study|Study terminated by sponsor|43
1118186|NCT01682512|3666360|P1|Overall Study|Study terminated by sponsor|46
1118187|NCT01682512|3666358|P3|Overall Study|Physician Decision|0
1118188|NCT01682512|3666359|P2|Overall Study|Physician Decision|2
1118189|NCT01682512|3666360|P1|Overall Study|Physician Decision|0
1118190|NCT01682512|3666358|P3|Overall Study|Withdrawal by Subject|3
1118191|NCT01682512|3666359|P2|Overall Study|Withdrawal by Subject|6
1118192|NCT01682512|3666360|P1|Overall Study|Withdrawal by Subject|2
1118193|NCT01682512|3666358|P3|Overall Study|Adverse Event|2
1118194|NCT01682512|3666359|P2|Overall Study|Adverse Event|5
1118195|NCT01682512|3666360|P1|Overall Study|Adverse Event|6
1118196|NCT01682460|3666385|P1|Overall Study|Did not meet inclusion criteria|2
1118197|NCT01682460|3666385|P1|Overall Study|Withdrawal by Subject|2
1118198|NCT01682083|3666439|P2|Overall Study|Physician Decision|4
1118199|NCT01682083|3666440|P1|Overall Study|Physician Decision|5
1118200|NCT01682083|3666439|P2|Overall Study|Death|93
1118201|NCT01682083|3666440|P1|Overall Study|Death|60
1118202|NCT01682083|3666439|P2|Overall Study|Withdrawal by Subject|40
1118203|NCT01682083|3666440|P1|Overall Study|Withdrawal by Subject|31
1118204|NCT01682083|3666439|P2|Overall Study|Lost to Follow-up|18
1118205|NCT01682083|3666440|P1|Overall Study|Lost to Follow-up|11
1118206|NCT01682044|3666452|P1|Overall Study|Progression|3
1118207|NCT01682044|3666452|P1|Overall Study|Death|1
1118208|NCT01682031|3666464|P2|Overall Study|Patient stopped selenium on his own|1
1118209|NCT01682031|3666465|P1|Overall Study|Patient stopped selenium on his own|0
1118210|NCT01682031|3666464|P2|Overall Study|Patient could not swallow tablets|0
1118211|NCT01682031|3666465|P1|Overall Study|Patient could not swallow tablets|1
1118212|NCT01682031|3666464|P2|Overall Study|MRI results indicate increased nodul|1
1118213|NCT01682031|3666465|P1|Overall Study|MRI results indicate increased nodul|0
1118214|NCT01682031|3666464|P2|Overall Study|Adverse Event|2
1118215|NCT01682031|3666465|P1|Overall Study|Adverse Event|0
1118216|NCT01682031|3666464|P2|Overall Study|Withdrawal by Subject|1
1118217|NCT01682031|3666465|P1|Overall Study|Withdrawal by Subject|0
1118218|NCT01681992|3666488|P3|Overall Study|Withdrawal by Subject|25
1118219|NCT01681992|3666489|P2|Overall Study|Withdrawal by Subject|30
1118220|NCT01681992|3666490|P1|Overall Study|Withdrawal by Subject|27
1118221|NCT01681992|3666488|P3|Overall Study|Protocol Violation|1
1118222|NCT01681992|3666489|P2|Overall Study|Protocol Violation|0
1118223|NCT01681992|3666490|P1|Overall Study|Protocol Violation|0
1118224|NCT01681992|3666488|P3|Overall Study|As Per Sponsor Decision|1
1118225|NCT01681992|3666489|P2|Overall Study|As Per Sponsor Decision|0
1118226|NCT01681992|3666490|P1|Overall Study|As Per Sponsor Decision|0
1118227|NCT01681992|3666488|P3|Overall Study|Lost to Follow-up|53
1118228|NCT01681992|3666489|P2|Overall Study|Lost to Follow-up|38
1118229|NCT01681992|3666490|P1|Overall Study|Lost to Follow-up|36
1118230|NCT01681992|3666488|P3|Overall Study|Adverse Event|3
1118231|NCT01681992|3666489|P2|Overall Study|Adverse Event|2
1118232|NCT01681992|3666490|P1|Overall Study|Adverse Event|3
1118233|NCT01681849|3666579|P3|Overall Study|Lost to Follow-up|6
1118234|NCT01681849|3666580|P2|Overall Study|Lost to Follow-up|2
1118235|NCT01681849|3666581|P1|Overall Study|Lost to Follow-up|3
1118236|NCT01681849|3666579|P3|Overall Study|Withdrawal by Subject|33
1118237|NCT01681849|3666580|P2|Overall Study|Withdrawal by Subject|5
1118238|NCT01681849|3666581|P1|Overall Study|Withdrawal by Subject|3
1118239|NCT01681849|3666579|P3|Overall Study|Protocol Violation|0
1118240|NCT01681849|3666580|P2|Overall Study|Protocol Violation|0
1118241|NCT01681849|3666581|P1|Overall Study|Protocol Violation|2
1118242|NCT01681836|3666590|P2|Second Intervention|Withdrawal by Subject|1
1118243|NCT01681836|3666591|P1|Second Intervention|Withdrawal by Subject|0
1118244|NCT01681628|3666617|P2|19 Months Follow-up|Lost to Follow-up|43
1118245|NCT01681628|3666618|P1|19 Months Follow-up|Lost to Follow-up|61
1118246|NCT01681628|3666617|P2|19 Months Follow-up|Death|0
1118247|NCT01681628|3666618|P1|19 Months Follow-up|Death|1
1118248|NCT01681628|3666617|P2|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15
1118249|NCT01681628|3666618|P1|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0
1118250|NCT01681628|3666617|P2|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6
1118251|NCT01681628|3666618|P1|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14
1118252|NCT01681576|3666631|P2|Period 2|Non-compliance with study treatment|0
1118253|NCT01681576|3666632|P1|Period 2|Non-compliance with study treatment|1
1118254|NCT01681576|3666631|P2|Period 2|subject/guardian decision|1
1118255|NCT01681576|3666632|P1|Period 2|subject/guardian decision|3
1118256|NCT01681576|3666631|P2|Period 1|Protocol Deviation|0
1118257|NCT01681576|3666632|P1|Period 1|Protocol Deviation|1
1118258|NCT01681576|3666631|P2|Period 1|Adverse Event|0
1118259|NCT01681576|3666632|P1|Period 1|Adverse Event|1
1118260|NCT01681511|3666648|P2|Overall Study|No post-catheter sample collected|4
1118261|NCT01681511|3666649|P1|Overall Study|No post-catheter sample collected|11
1118262|NCT01681511|3666648|P2|Overall Study|No Daily Urine Sample Collected|1
1118263|NCT01681511|3666649|P1|Overall Study|No Daily Urine Sample Collected|0
1118264|NCT01681511|3666648|P2|Overall Study|No Baseline Dips Stick & Urine Culture|6
1118265|NCT01681511|3666649|P1|Overall Study|No Baseline Dips Stick & Urine Culture|3
1118266|NCT01681511|3666648|P2|Overall Study|Failed Inclusion/Exclusion|0
1118267|NCT01681511|3666649|P1|Overall Study|Failed Inclusion/Exclusion|3
1118268|NCT01681511|3666648|P2|Overall Study|No Treatment Received|3
1118269|NCT01681511|3666649|P1|Overall Study|No Treatment Received|1
1118270|NCT01681472|3666667|P4|Overall Study|Adverse Event|0
1118271|NCT01681472|3666668|P3|Overall Study|Adverse Event|0
1118272|NCT01681472|3666669|P2|Overall Study|Adverse Event|1
1118273|NCT01681472|3666670|P1|Overall Study|Adverse Event|0
1118274|NCT01681433|3666682|P2|Overall Study|Lost to Follow-up|1
1118275|NCT01681433|3666683|P1|Overall Study|Lost to Follow-up|0
1118276|NCT01681433|3666682|P2|Overall Study|Adverse Event|4
1118277|NCT01681433|3666683|P1|Overall Study|Adverse Event|2
1118278|NCT01681433|3666682|P2|Overall Study|Protocol Violation|0
1118279|NCT01681433|3666683|P1|Overall Study|Protocol Violation|2
1118280|NCT01681433|3666682|P2|Overall Study|Withdrawal by Subject|5
1118281|NCT01681433|3666683|P1|Overall Study|Withdrawal by Subject|5
1118282|NCT01681433|3666682|P2|Overall Study|Lack of Efficacy|23
1118283|NCT01681433|3666683|P1|Overall Study|Lack of Efficacy|23
1118284|NCT01681368|3666701|P1|Overall Study|Refused further follow up|1
1118285|NCT01681368|3666701|P1|Overall Study|Refused further treatment|1
1118286|NCT01681277|3666718|P5|Overall Study|Adverse Event|0
1118287|NCT01681277|3666719|P4|Overall Study|Adverse Event|0
1118288|NCT01681277|3666720|P3|Overall Study|Adverse Event|0
1118289|NCT01681277|3666721|P2|Overall Study|Adverse Event|0
1118290|NCT01681277|3666722|P1|Overall Study|Adverse Event|1
1118291|NCT01681212|3666763|P1|Overall Study|Administrative reason by sponsor|1
1118292|NCT01681212|3666763|P1|Overall Study|No longer met study criteria|5
1118293|NCT01681069|3666821|P2|Overall Study|Adverse Event|1
1118294|NCT01681069|3666822|P1|Overall Study|Adverse Event|0
1118295|NCT01681069|3666821|P2|Overall Study|Protocol Violation|1
1118296|NCT01681069|3666822|P1|Overall Study|Protocol Violation|1
1118297|NCT01681069|3666821|P2|Overall Study|Withdrawal by Subject|5
1118298|NCT01681069|3666822|P1|Overall Study|Withdrawal by Subject|4
1118299|NCT01681004|3666859|P2|Study Completion|Death|1
1118300|NCT01681004|3666860|P1|Study Completion|Death|1
1118301|NCT01681004|3666859|P2|Study Completion|Site Termination|1
1118302|NCT01681004|3666860|P1|Study Completion|Site Termination|2
1118303|NCT01681004|3666859|P2|Study Completion|Physician Decision|3
1118304|NCT01681004|3666860|P1|Study Completion|Physician Decision|1
1118305|NCT01681004|3666859|P2|Study Completion|Lost to Follow-up|3
1118306|NCT01681004|3666860|P1|Study Completion|Lost to Follow-up|8
1118307|NCT01681004|3666859|P2|Primary Endpoint: 6 Months|Withdrawal by Subject|2
1118308|NCT01681004|3666860|P1|Primary Endpoint: 6 Months|Withdrawal by Subject|1
1118309|NCT01680991|3666917|P3|Overall Study|PD confirmed in other hospital|0
1118310|NCT01680991|3666918|P2|Overall Study|PD confirmed in other hospital|0
1118311|NCT01680991|3666919|P1|Overall Study|PD confirmed in other hospital|1
1118312|NCT01680991|3666917|P3|Overall Study|Bad physical condition|1
1118313|NCT01680991|3666918|P2|Overall Study|Bad physical condition|0
1118314|NCT01680991|3666919|P1|Overall Study|Bad physical condition|0
1118315|NCT01680991|3666917|P3|Overall Study|Physician Decision|2
1118316|NCT01680991|3666918|P2|Overall Study|Physician Decision|7
1118317|NCT01680991|3666919|P1|Overall Study|Physician Decision|0
1118318|NCT01680991|3666917|P3|Overall Study|Progressive disease (PD)|0
1118319|NCT01680991|3666918|P2|Overall Study|Progressive disease (PD)|10
1118320|NCT01680991|3666919|P1|Overall Study|Progressive disease (PD)|0
1118321|NCT01680991|3666917|P3|Overall Study|Withdrawal by Subject|0
1118322|NCT01680991|3666918|P2|Overall Study|Withdrawal by Subject|1
1118323|NCT01680991|3666919|P1|Overall Study|Withdrawal by Subject|5
1118324|NCT01680991|3666917|P3|Overall Study|Protocol Violation|0
1118325|NCT01680991|3666918|P2|Overall Study|Protocol Violation|1
1118326|NCT01680991|3666919|P1|Overall Study|Protocol Violation|0
1118327|NCT01680991|3666917|P3|Overall Study|Death|1
1118328|NCT01680991|3666918|P2|Overall Study|Death|0
1118329|NCT01680991|3666919|P1|Overall Study|Death|1
1118330|NCT01680991|3666917|P3|Overall Study|Adverse Event|0
1118331|NCT01680991|3666918|P2|Overall Study|Adverse Event|0
1118332|NCT01680991|3666919|P1|Overall Study|Adverse Event|1
1118333|NCT01680861|3666999|P2|Early Post-transplant Period|Protocol Violation|1
1118334|NCT01680861|3667000|P1|Early Post-transplant Period|Protocol Violation|1
1118335|NCT01680497|3667073|P1|Overall Study|Lost to Follow-up|2
1118336|NCT01680458|3667083|P1|Overall Study|Protocol Violation|3
1118337|NCT01680341|3667094|P2|Overall Study|Unclassified|15
1118338|NCT01680341|3667095|P1|Overall Study|Unclassified|18
1118339|NCT01680341|3667094|P2|Overall Study|Adverse Event|2
1118340|NCT01680341|3667095|P1|Overall Study|Adverse Event|3
1118341|NCT01680159|3667166|P1|Increased Dose Period|Withdrawal by Subject|2
1118342|NCT01680159|3667166|P1|Increased Dose Period|Adverse Event|6
1118343|NCT01680159|3667166|P1|Screening Period|Not meet criteria for dose-up period|7
1118344|NCT01680016|3667193|P4|Overall Study|Withdrawal by Subject|1
1118345|NCT01680016|3667194|P3|Overall Study|Withdrawal by Subject|1
1118346|NCT01680016|3667195|P2|Overall Study|Withdrawal by Subject|7
1118347|NCT01680016|3667196|P1|Overall Study|Withdrawal by Subject|5
1118348|NCT01680016|3667193|P4|Overall Study|Protocol Violation|0
1118349|NCT01680016|3667194|P3|Overall Study|Protocol Violation|0
1118350|NCT01680016|3667195|P2|Overall Study|Protocol Violation|1
1118351|NCT01680016|3667196|P1|Overall Study|Protocol Violation|0
1118352|NCT01680016|3667193|P4|Overall Study|The Subject went out of The Trial|0
1118353|NCT01680016|3667194|P3|Overall Study|The Subject went out of The Trial|3
1118354|NCT01680016|3667195|P2|Overall Study|The Subject went out of The Trial|0
1118355|NCT01680016|3667196|P1|Overall Study|The Subject went out of The Trial|1
1118356|NCT01680016|3667193|P4|Overall Study|Adverse Event|4
1118357|NCT01680016|3667194|P3|Overall Study|Adverse Event|1
1118358|NCT01680016|3667195|P2|Overall Study|Adverse Event|0
1118359|NCT01680016|3667196|P1|Overall Study|Adverse Event|0
1118360|NCT01679613|3667258|P4|Overall Study|other than stated above|2
1118361|NCT01679613|3667259|P3|Overall Study|other than stated above|2
1118362|NCT01679613|3667260|P2|Overall Study|other than stated above|1
1118363|NCT01679613|3667261|P1|Overall Study|other than stated above|0
1118364|NCT01679301|3667302|P3|Screening Period|screen failure|0
1118365|NCT01679301|3667303|P2|Screening Period|screen failure|0
1118366|NCT01679301|3667304|P1|Screening Period|screen failure|3
1118367|NCT01679236|3667312|P2|Overall Study|Lost to Follow-up|15
1118368|NCT01679236|3667313|P1|Overall Study|Lost to Follow-up|15
1118369|NCT01679002|3667360|P3|Overall Study|Adverse Event|0
1118370|NCT01679002|3667361|P2|Overall Study|Adverse Event|1
1118371|NCT01679002|3667362|P1|Overall Study|Adverse Event|1
1118372|NCT01678911|3667389|P2|Second Intervention|Lost to Follow-up|0
1118373|NCT01678911|3667390|P1|Second Intervention|Lost to Follow-up|2
1118374|NCT01678820|3667436|P3|Overall Study|Not treated with double-blind study drug|2
1118375|NCT01678820|3667437|P2|Overall Study|Not treated with double-blind study drug|2
1118376|NCT01678820|3667438|P1|Overall Study|Not treated with double-blind study drug|0
1118377|NCT01678820|3667436|P3|Overall Study|Protocol Violation|4
1118378|NCT01678820|3667437|P2|Overall Study|Protocol Violation|5
1118379|NCT01678820|3667438|P1|Overall Study|Protocol Violation|4
1118380|NCT01678820|3667436|P3|Overall Study|Physician Decision|1
1118381|NCT01678820|3667437|P2|Overall Study|Physician Decision|0
1118382|NCT01678820|3667438|P1|Overall Study|Physician Decision|0
1118383|NCT01678820|3667436|P3|Overall Study|Non-compliance with study drug|0
1118384|NCT01678820|3667437|P2|Overall Study|Non-compliance with study drug|1
1118385|NCT01678820|3667438|P1|Overall Study|Non-compliance with study drug|0
1118386|NCT01678820|3667436|P3|Overall Study|Lost to Follow-up|2
1118387|NCT01678820|3667437|P2|Overall Study|Lost to Follow-up|2
1118388|NCT01678820|3667438|P1|Overall Study|Lost to Follow-up|7
1118389|NCT01678820|3667436|P3|Overall Study|Adverse Event|2
1118390|NCT01678820|3667437|P2|Overall Study|Adverse Event|2
1118391|NCT01678820|3667438|P1|Overall Study|Adverse Event|2
1118392|NCT01678820|3667436|P3|Overall Study|Protocol Specified Criteria|1
1118393|NCT01678820|3667437|P2|Overall Study|Protocol Specified Criteria|3
1118394|NCT01678820|3667438|P1|Overall Study|Protocol Specified Criteria|2
1118395|NCT01678820|3667436|P3|Overall Study|Withdrawal by Subject|2
1118396|NCT01678820|3667437|P2|Overall Study|Withdrawal by Subject|5
1118397|NCT01678820|3667438|P1|Overall Study|Withdrawal by Subject|2
1118398|NCT01678820|3667436|P3|Overall Study|Study Terminated by Sponsor|43
1118399|NCT01678820|3667437|P2|Overall Study|Study Terminated by Sponsor|43
1118400|NCT01678820|3667438|P1|Overall Study|Study Terminated by Sponsor|45
1118401|NCT01678807|3667483|P3|Overall Study|Withdrawn by Parent/Guardian|0
1118402|NCT01678807|3667484|P2|Overall Study|Withdrawn by Parent/Guardian|1
1118403|NCT01678807|3667485|P1|Overall Study|Withdrawn by Parent/Guardian|0
1118404|NCT01678807|3667483|P3|Overall Study|Adverse Event|0
1118405|NCT01678807|3667484|P2|Overall Study|Adverse Event|4
1118406|NCT01678807|3667485|P1|Overall Study|Adverse Event|4
1118407|NCT01678313|3667503|P2|Prostate Biopsy at 3 Months|Not received prostate biopsy|12
1118408|NCT01678313|3667504|P1|Prostate Biopsy at 3 Months|Not received prostate biopsy|11
1118409|NCT01678313|3667503|P2|PSA >4 ng/dL at 3 Months|PSA≦4|9
1118410|NCT01678313|3667504|P1|PSA >4 ng/dL at 3 Months|PSA≦4|8
1118411|NCT01678313|3667503|P2|Completed the 3-month Therapy|Physician Decision|4
1118412|NCT01678313|3667504|P1|Completed the 3-month Therapy|Physician Decision|3
1118413|NCT01678313|3667503|P2|Completed the 3-month Therapy|Lost to Follow-up|8
1118414|NCT01678313|3667504|P1|Completed the 3-month Therapy|Lost to Follow-up|3
1118415|NCT01678131|3667538|P3|Overall Study|Withdrawal by Subject|2
1118416|NCT01678131|3667539|P2|Overall Study|Withdrawal by Subject|0
1118417|NCT01678131|3667540|P1|Overall Study|Withdrawal by Subject|0
1118418|NCT01678131|3667538|P3|Overall Study|Adverse Event|0
1118419|NCT01678131|3667539|P2|Overall Study|Adverse Event|1
1118420|NCT01678131|3667540|P1|Overall Study|Adverse Event|0
1118421|NCT01677988|3667548|P1|Overall Study|Lack of Efficacy|2
1118422|NCT01677936|3667561|P2|Overall Study|Protocol Violation|4
1118423|NCT01677936|3667562|P1|Overall Study|Protocol Violation|0
1118424|NCT01677936|3667561|P2|Overall Study|Lost to Follow-up|0
1118425|NCT01677936|3667562|P1|Overall Study|Lost to Follow-up|1
1118426|NCT01677936|3667561|P2|Overall Study|Adverse Event|0
1118427|NCT01677936|3667562|P1|Overall Study|Adverse Event|1
1118428|NCT01677936|3667561|P2|Overall Study|Protocol Violation|0
1118429|NCT01677936|3667562|P1|Overall Study|Protocol Violation|3
1118430|NCT01677936|3667561|P2|Overall Study|Lost to Follow-up|1
1118431|NCT01677936|3667562|P1|Overall Study|Lost to Follow-up|4
1118432|NCT01677910|3667573|P4|Open-Label Extension Period (OLE)|Lost to Follow-up|1
1118433|NCT01677910|3667574|P3|Open-Label Extension Period (OLE)|Lost to Follow-up|0
1118434|NCT01677910|3667575|P2|Open-Label Extension Period (OLE)|Lost to Follow-up|0
1118435|NCT01677910|3667576|P1|Open-Label Extension Period (OLE)|Lost to Follow-up|0
1118436|NCT01677910|3667573|P4|Open-Label Extension Period (OLE)|Adverse Event|15
1118437|NCT01677910|3667574|P3|Open-Label Extension Period (OLE)|Adverse Event|0
1118438|NCT01677910|3667575|P2|Open-Label Extension Period (OLE)|Adverse Event|0
1118439|NCT01677910|3667576|P1|Open-Label Extension Period (OLE)|Adverse Event|0
1118440|NCT01677910|3667573|P4|Open-Label Extension Period (OLE)|Lack of Efficacy|5
1118441|NCT01677910|3667574|P3|Open-Label Extension Period (OLE)|Lack of Efficacy|0
1118442|NCT01677910|3667575|P2|Open-Label Extension Period (OLE)|Lack of Efficacy|0
1118443|NCT01677910|3667576|P1|Open-Label Extension Period (OLE)|Lack of Efficacy|0
1118444|NCT01677910|3667573|P4|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
1118445|NCT01677910|3667574|P3|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
1118446|NCT01677910|3667575|P2|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
1118447|NCT01677910|3667576|P1|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
1118448|NCT01677910|3667573|P4|Open-Label Extension Period (OLE)|Reason not Specified|2
1118449|NCT01677910|3667574|P3|Open-Label Extension Period (OLE)|Reason not Specified|0
1118450|NCT01677910|3667575|P2|Open-Label Extension Period (OLE)|Reason not Specified|0
1118451|NCT01677910|3667576|P1|Open-Label Extension Period (OLE)|Reason not Specified|0
1118452|NCT01677910|3667573|P4|Open-Label Extension Period (OLE)|Physician Decision|4
1118453|NCT01677910|3667574|P3|Open-Label Extension Period (OLE)|Physician Decision|0
1118454|NCT01677910|3667575|P2|Open-Label Extension Period (OLE)|Physician Decision|0
1118455|NCT01677910|3667576|P1|Open-Label Extension Period (OLE)|Physician Decision|0
1118456|NCT01677910|3667573|P4|Double-Blind Treatment Period|Reason Not Specified|0
1118457|NCT01677910|3667574|P3|Double-Blind Treatment Period|Reason Not Specified|0
1118458|NCT01677910|3667575|P2|Double-Blind Treatment Period|Reason Not Specified|1
1118459|NCT01677910|3667576|P1|Double-Blind Treatment Period|Reason Not Specified|0
1118460|NCT01677910|3667573|P4|Double-Blind Treatment Period|Withdrawal of consent|0
1118461|NCT01677910|3667574|P3|Double-Blind Treatment Period|Withdrawal of consent|3
1118462|NCT01677910|3667575|P2|Double-Blind Treatment Period|Withdrawal of consent|0
1118463|NCT01677910|3667576|P1|Double-Blind Treatment Period|Withdrawal of consent|1
1118464|NCT01677910|3667573|P4|Double-Blind Treatment Period|Physician Decision|0
1118465|NCT01677910|3667574|P3|Double-Blind Treatment Period|Physician Decision|1
1118466|NCT01677910|3667575|P2|Double-Blind Treatment Period|Physician Decision|0
1118467|NCT01677910|3667576|P1|Double-Blind Treatment Period|Physician Decision|0
1118468|NCT01677910|3667573|P4|Double-Blind Treatment Period|Adverse Event|0
1118469|NCT01677910|3667574|P3|Double-Blind Treatment Period|Adverse Event|3
1118470|NCT01677910|3667575|P2|Double-Blind Treatment Period|Adverse Event|2
1118471|NCT01677910|3667576|P1|Double-Blind Treatment Period|Adverse Event|6
1118472|NCT01677858|3667603|P5|Overall Study|Lost to Follow-up|1
1118473|NCT01677858|3667604|P4|Overall Study|Lost to Follow-up|0
1118474|NCT01677858|3667605|P3|Overall Study|Lost to Follow-up|0
1118475|NCT01677858|3667606|P2|Overall Study|Lost to Follow-up|0
1118476|NCT01677858|3667607|P1|Overall Study|Lost to Follow-up|0
1118477|NCT01677858|3667603|P5|Overall Study|Withdrawal by Subject|15
1118478|NCT01677858|3667604|P4|Overall Study|Withdrawal by Subject|0
1118479|NCT01677858|3667605|P3|Overall Study|Withdrawal by Subject|1
1118480|NCT01677858|3667606|P2|Overall Study|Withdrawal by Subject|1
1118481|NCT01677858|3667607|P1|Overall Study|Withdrawal by Subject|0
1118482|NCT01677858|3667603|P5|Overall Study|Progressive Disease|43
1118483|NCT01677858|3667604|P4|Overall Study|Progressive Disease|3
1118484|NCT01677858|3667605|P3|Overall Study|Progressive Disease|9
1118485|NCT01677858|3667606|P2|Overall Study|Progressive Disease|1
1118486|NCT01677858|3667607|P1|Overall Study|Progressive Disease|2
1118487|NCT01677858|3667603|P5|Overall Study|Physician Decision|12
1118488|NCT01677858|3667604|P4|Overall Study|Physician Decision|0
1118489|NCT01677858|3667605|P3|Overall Study|Physician Decision|2
1118490|NCT01677858|3667606|P2|Overall Study|Physician Decision|0
1118491|NCT01677858|3667607|P1|Overall Study|Physician Decision|1
1118492|NCT01677858|3667603|P5|Overall Study|Death|1
1118493|NCT01677858|3667604|P4|Overall Study|Death|0
1118494|NCT01677858|3667605|P3|Overall Study|Death|0
1118495|NCT01677858|3667606|P2|Overall Study|Death|0
1118496|NCT01677858|3667607|P1|Overall Study|Death|0
1118497|NCT01677858|3667603|P5|Overall Study|Adverse Event|13
1118498|NCT01677858|3667604|P4|Overall Study|Adverse Event|3
1118499|NCT01677858|3667605|P3|Overall Study|Adverse Event|2
1118500|NCT01677858|3667606|P2|Overall Study|Adverse Event|0
1118501|NCT01677858|3667607|P1|Overall Study|Adverse Event|0
1118502|NCT01677767|3667680|P1|Overall Study|Non-compliance by the participants|3
1118503|NCT01677767|3667680|P1|Overall Study|Withdrawal by Subject|10
1118504|NCT01677767|3667680|P1|Overall Study|Protocol Violation|4
1118505|NCT01677767|3667680|P1|Overall Study|Death|4
1118506|NCT01677767|3667680|P1|Overall Study|Adverse Event|1
1118507|NCT01677624|3667694|P1|Overall Study|Insuf Resp: intra-articular hemorrhage|1
1118508|NCT01677507|3667699|P2|Second Assigment|Adverse Event|3
1118509|NCT01677507|3667700|P1|Second Assigment|Adverse Event|1
1118510|NCT01677507|3667699|P2|Second Assigment|Withdrawal by Subject|2
1118511|NCT01677507|3667700|P1|Second Assigment|Withdrawal by Subject|2
1118512|NCT01677507|3667699|P2|Initial Assignment|Protocol Violation|1
1118513|NCT01677507|3667700|P1|Initial Assignment|Protocol Violation|0
1118514|NCT01677507|3667699|P2|Initial Assignment|Adverse Event|1
1118515|NCT01677507|3667700|P1|Initial Assignment|Adverse Event|0
1118516|NCT01677377|3667713|P3|Overall Study|Pregnancy|1
1118517|NCT01677377|3667714|P2|Overall Study|Pregnancy|0
1118518|NCT01677377|3667715|P1|Overall Study|Pregnancy|0
1118519|NCT01677377|3667713|P3|Overall Study|Lack of Efficacy|1
1118520|NCT01677377|3667714|P2|Overall Study|Lack of Efficacy|0
1118521|NCT01677377|3667715|P1|Overall Study|Lack of Efficacy|0
1118522|NCT01677377|3667713|P3|Overall Study|Withdrawal by Subject|3
1118523|NCT01677377|3667714|P2|Overall Study|Withdrawal by Subject|0
1118524|NCT01677377|3667715|P1|Overall Study|Withdrawal by Subject|0
1118525|NCT01677377|3667713|P3|Overall Study|Lost to Follow-up|1
1118526|NCT01677377|3667714|P2|Overall Study|Lost to Follow-up|1
1118527|NCT01677377|3667715|P1|Overall Study|Lost to Follow-up|0
1118528|NCT01677377|3667713|P3|Overall Study|Protocol Violation|0
1118529|NCT01677377|3667714|P2|Overall Study|Protocol Violation|0
1118530|NCT01677377|3667715|P1|Overall Study|Protocol Violation|1
1118531|NCT01677299|3667916|P4|Overall Study|Withdrawal by Subject|1
1118532|NCT01677299|3667917|P3|Overall Study|Withdrawal by Subject|0
1118533|NCT01677299|3667918|P2|Overall Study|Withdrawal by Subject|1
1118534|NCT01677299|3667919|P1|Overall Study|Withdrawal by Subject|0
1118535|NCT01677299|3667916|P4|Overall Study|Adverse Event|0
1118536|NCT01677299|3667917|P3|Overall Study|Adverse Event|1
1118537|NCT01677299|3667918|P2|Overall Study|Adverse Event|2
1118538|NCT01677299|3667919|P1|Overall Study|Adverse Event|0
1118539|NCT01677195|3667951|P3|Overall Study|Protocol Violation|4
1118540|NCT01677195|3667952|P2|Overall Study|Protocol Violation|3
1118541|NCT01677195|3667953|P1|Overall Study|Protocol Violation|7
1118542|NCT01677195|3667951|P3|Overall Study|Pregnancy|0
1118543|NCT01677195|3667952|P2|Overall Study|Pregnancy|1
1118544|NCT01677195|3667953|P1|Overall Study|Pregnancy|0
1118545|NCT01677195|3667951|P3|Overall Study|Physician Decision|2
1118546|NCT01677195|3667952|P2|Overall Study|Physician Decision|2
1118547|NCT01677195|3667953|P1|Overall Study|Physician Decision|1
1118548|NCT01677195|3667951|P3|Overall Study|Adverse Event|1
1118549|NCT01677195|3667952|P2|Overall Study|Adverse Event|4
1118550|NCT01677195|3667953|P1|Overall Study|Adverse Event|6
1118551|NCT01677195|3667951|P3|Overall Study|Withdrawal by Subject|1
1118552|NCT01677195|3667952|P2|Overall Study|Withdrawal by Subject|0
1118553|NCT01677195|3667953|P1|Overall Study|Withdrawal by Subject|1
1118554|NCT01677195|3667951|P3|Overall Study|Lost to Follow-up|22
1118555|NCT01677195|3667952|P2|Overall Study|Lost to Follow-up|22
1118556|NCT01677195|3667953|P1|Overall Study|Lost to Follow-up|14
1118557|NCT01677182|3667964|P3|Overall Study|Other reasons|2
1118558|NCT01677182|3667965|P2|Overall Study|Other reasons|5
1118559|NCT01677182|3667966|P1|Overall Study|Other reasons|1
1118560|NCT01677182|3667964|P3|Overall Study|Lack of Efficacy|1
1118561|NCT01677182|3667965|P2|Overall Study|Lack of Efficacy|0
1118562|NCT01677182|3667966|P1|Overall Study|Lack of Efficacy|3
1118563|NCT01677182|3667964|P3|Overall Study|Study termination|11
1118564|NCT01677182|3667965|P2|Overall Study|Study termination|9
1118565|NCT01677182|3667966|P1|Overall Study|Study termination|12
1118566|NCT01677182|3667964|P3|Overall Study|Withdrawal by Subject|10
1118567|NCT01677182|3667965|P2|Overall Study|Withdrawal by Subject|12
1118568|NCT01677182|3667966|P1|Overall Study|Withdrawal by Subject|7
1118569|NCT01677182|3667964|P3|Overall Study|Lost to Follow-up|3
1118570|NCT01677182|3667965|P2|Overall Study|Lost to Follow-up|0
1118571|NCT01677182|3667966|P1|Overall Study|Lost to Follow-up|4
1118572|NCT01677182|3667964|P3|Overall Study|Protocol Violation|4
1118573|NCT01677182|3667965|P2|Overall Study|Protocol Violation|1
1118574|NCT01677182|3667966|P1|Overall Study|Protocol Violation|5
1118575|NCT01677182|3667964|P3|Overall Study|Adverse Event|8
1118576|NCT01677182|3667965|P2|Overall Study|Adverse Event|1
1118577|NCT01677182|3667966|P1|Overall Study|Adverse Event|2
1118578|NCT01676961|3667998|P1|Overall Study|Withdrawal by Subject|1
1118579|NCT01676961|3667998|P1|Overall Study|Lost to Follow-up|1
1118580|NCT01676961|3667998|P1|Overall Study|Death|3
1118581|NCT01676896|3668006|P3|Overall Study|Withdrawal by Subject|19
1118582|NCT01676896|3668007|P2|Overall Study|Withdrawal by Subject|7
1118583|NCT01676896|3668008|P1|Overall Study|Withdrawal by Subject|12
1118584|NCT01676727|3668103|P1|Overall Study|Valve explanted|1
1118585|NCT01676727|3668103|P1|Overall Study|Not willing to attend 1-year visit|2
1118586|NCT01676727|3668103|P1|Overall Study|Screening failure|5
1118587|NCT01676727|3668103|P1|Overall Study|Withdrawal by Subject|6
1118588|NCT01676727|3668103|P1|Overall Study|Death|18
1118589|NCT01676701|3668117|P2|Overall Study|Sponsor Decision|4
1118590|NCT01676701|3668118|P1|Overall Study|Sponsor Decision|3
1118591|NCT01676701|3668117|P2|Overall Study|Protocol Violation|0
1118592|NCT01676701|3668118|P1|Overall Study|Protocol Violation|1
1118593|NCT01676220|3668203|P2|Overall Study|No More Need of Insulin|0
1118594|NCT01676220|3668204|P1|Overall Study|No More Need of Insulin|1
1118595|NCT01676220|3668203|P2|Overall Study|Non Serious Hypoglycemia|0
1118596|NCT01676220|3668204|P1|Overall Study|Non Serious Hypoglycemia|2
1118597|NCT01676220|3668203|P2|Overall Study|Perceived Lack of Efficacy|1
1118598|NCT01676220|3668204|P1|Overall Study|Perceived Lack of Efficacy|3
1118599|NCT01676220|3668203|P2|Overall Study|Site Closure/Site Withdrawal|4
1118600|NCT01676220|3668204|P1|Overall Study|Site Closure/Site Withdrawal|1
1118601|NCT01676220|3668203|P2|Overall Study|Selection Criterion/Protocol Violation|9
1118602|NCT01676220|3668204|P1|Overall Study|Selection Criterion/Protocol Violation|9
1118603|NCT01676220|3668203|P2|Overall Study|Lost to Follow-up|18
1118604|NCT01676220|3668204|P1|Overall Study|Lost to Follow-up|11
1118605|NCT01676220|3668203|P2|Overall Study|Personal Reason|45
1118606|NCT01676220|3668204|P1|Overall Study|Personal Reason|34
1118607|NCT01676220|3668203|P2|Overall Study|Received Rescue Therapy|22
1118608|NCT01676220|3668204|P1|Overall Study|Received Rescue Therapy|14
1118609|NCT01676220|3668203|P2|Overall Study|Protocol Violation|12
1118610|NCT01676220|3668204|P1|Overall Study|Protocol Violation|11
1118611|NCT01676220|3668203|P2|Overall Study|Lack of Efficacy|5
1118612|NCT01676220|3668204|P1|Overall Study|Lack of Efficacy|2
1118613|NCT01676220|3668203|P2|Overall Study|Adverse Event|8
1118614|NCT01676220|3668204|P1|Overall Study|Adverse Event|10
1118615|NCT01676220|3668203|P2|Overall Study|Randomized But Not Treated|1
1118616|NCT01676220|3668204|P1|Overall Study|Randomized But Not Treated|4
1118617|NCT01676116|3668236|P2|Overall Study|Protocol Violation|3
1118618|NCT01676116|3668237|P1|Overall Study|Protocol Violation|9
1118619|NCT01676116|3668236|P2|Overall Study|Unclassified|10
1118620|NCT01676116|3668237|P1|Overall Study|Unclassified|4
1118621|NCT01676116|3668236|P2|Overall Study|Adverse Event|2
1118622|NCT01676116|3668237|P1|Overall Study|Adverse Event|1
1118623|NCT01676116|3668236|P2|Overall Study|Withdrawal criteria|14
1118624|NCT01676116|3668237|P1|Overall Study|Withdrawal criteria|2
1118625|NCT01676012|3668259|P1|Overall Study|incomplete set of videos|1
1118626|NCT01676012|3668259|P1|Overall Study|Adverse Event|2
1118627|NCT01675661|3668270|P2|Overall Study|Other reason|2
1118628|NCT01675661|3668271|P1|Overall Study|Other reason|1
1118629|NCT01675661|3668270|P2|Overall Study|Death|1
1118630|NCT01675661|3668271|P1|Overall Study|Death|0
1118631|NCT01675661|3668270|P2|Overall Study|Physician Decision|2
1118632|NCT01675661|3668271|P1|Overall Study|Physician Decision|0
1118633|NCT01675661|3668270|P2|Overall Study|Withdrawal by Subject|7
1118634|NCT01675661|3668271|P1|Overall Study|Withdrawal by Subject|3
1118635|NCT01675661|3668270|P2|Overall Study|Moved away|6
1118636|NCT01675661|3668271|P1|Overall Study|Moved away|5
1118637|NCT01675661|3668270|P2|Overall Study|Practical problems|5
1118638|NCT01675661|3668271|P1|Overall Study|Practical problems|9
1118639|NCT01675661|3668270|P2|Overall Study|Lost to Follow-up|23
1118640|NCT01675661|3668271|P1|Overall Study|Lost to Follow-up|22
1118641|NCT01675622|3668300|P2|Overall Study|not specified|4
1118642|NCT01675622|3668301|P1|Overall Study|not specified|5
1118643|NCT01675622|3668300|P2|Overall Study|Lost to Follow-up|3
1118644|NCT01675622|3668301|P1|Overall Study|Lost to Follow-up|1
1118645|NCT01675622|3668300|P2|Overall Study|Lack of Efficacy|4
1118646|NCT01675622|3668301|P1|Overall Study|Lack of Efficacy|2
1118647|NCT01675622|3668300|P2|Overall Study|Protocol Violation|1
1118648|NCT01675622|3668301|P1|Overall Study|Protocol Violation|4
1118649|NCT01675622|3668300|P2|Overall Study|Adverse Event|10
1118650|NCT01675622|3668301|P1|Overall Study|Adverse Event|12
1118651|NCT01675622|3668300|P2|Overall Study|Withdrawal by Subject|2
1118652|NCT01675622|3668301|P1|Overall Study|Withdrawal by Subject|2
1118653|NCT01675544|3668325|P1|Overall Study|Withdrawal by Subject|2
1118654|NCT01675531|3668330|P1|Overall Study|Protocol Violation|8
1118655|NCT01675531|3668330|P1|Overall Study|Lack of Efficacy|1
1118656|NCT01675531|3668330|P1|Overall Study|Withdrawal by Subject|7
1118657|NCT01675531|3668330|P1|Overall Study|Adverse Event|9
1118658|NCT01675492|3668337|P1|Overall Study|study completed early - product approval|42
1118659|NCT01675479|3668342|P1|Overall Study|Lost to Follow-up|11
1118660|NCT01675427|3668356|P1|Overall Study|Not Specified|2
1118661|NCT01675427|3668356|P1|Overall Study|Lost to Follow-up|5
1118662|NCT01675427|3668356|P1|Overall Study|Sample not Collected by Mistake|2
1118663|NCT01675427|3668356|P1|Overall Study|Participant Refused Sample Collection|18
1118664|NCT01675427|3668356|P1|Overall Study|Withdrawal by Subject|7
1118665|NCT01675167|3668643|P3|Double-blind Treatment Phase|Not specified|5
1118666|NCT01675167|3668644|P2|Double-blind Treatment Phase|Not specified|7
1118667|NCT01675167|3668645|P1|Double-blind Treatment Phase|Not specified|0
1118668|NCT01675167|3668643|P3|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9
1118669|NCT01675167|3668644|P2|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
1118670|NCT01675167|3668645|P1|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
1118671|NCT01675167|3668643|P3|Double-blind Treatment Phase|Lost to Follow-up|5
1118672|NCT01675167|3668644|P2|Double-blind Treatment Phase|Lost to Follow-up|1
1118673|NCT01675167|3668645|P1|Double-blind Treatment Phase|Lost to Follow-up|0
1118674|NCT01675167|3668643|P3|Double-blind Treatment Phase|Protocol Violation|11
1118675|NCT01675167|3668644|P2|Double-blind Treatment Phase|Protocol Violation|4
1118676|NCT01675167|3668645|P1|Double-blind Treatment Phase|Protocol Violation|0
1118677|NCT01675167|3668643|P3|Double-blind Treatment Phase|Adverse Event|13
1118678|NCT01675167|3668644|P2|Double-blind Treatment Phase|Adverse Event|5
1118679|NCT01675167|3668645|P1|Double-blind Treatment Phase|Adverse Event|0
1118680|NCT01675167|3668643|P3|Double-blind Treatment Phase|Withdrawal by Subject|6
1118681|NCT01675167|3668644|P2|Double-blind Treatment Phase|Withdrawal by Subject|11
1118682|NCT01675167|3668645|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
1118683|NCT01675167|3668643|P3|Double-blind Treatment Phase|Lack of Efficacy|61
1118684|NCT01675167|3668644|P2|Double-blind Treatment Phase|Lack of Efficacy|19
1118685|NCT01675167|3668645|P1|Double-blind Treatment Phase|Lack of Efficacy|0
1118686|NCT01675167|3668643|P3|Open-label Titration Phase|Not specified|0
1118687|NCT01675167|3668644|P2|Open-label Titration Phase|Not specified|0
1118688|NCT01675167|3668645|P1|Open-label Titration Phase|Not specified|55
1118689|NCT01675167|3668643|P3|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
1118690|NCT01675167|3668644|P2|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
1118691|NCT01675167|3668645|P1|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1
1118692|NCT01675167|3668643|P3|Open-label Titration Phase|Lost to Follow-up|0
1118693|NCT01675167|3668644|P2|Open-label Titration Phase|Lost to Follow-up|0
1118694|NCT01675167|3668645|P1|Open-label Titration Phase|Lost to Follow-up|15
1118695|NCT01675167|3668643|P3|Open-label Titration Phase|Protocol Violation|0
1118696|NCT01675167|3668644|P2|Open-label Titration Phase|Protocol Violation|0
1118697|NCT01675167|3668645|P1|Open-label Titration Phase|Protocol Violation|43
1118698|NCT01675167|3668643|P3|Open-label Titration Phase|Withdrawal by Subject|0
1118699|NCT01675167|3668644|P2|Open-label Titration Phase|Withdrawal by Subject|0
1118700|NCT01675167|3668645|P1|Open-label Titration Phase|Withdrawal by Subject|46
1118701|NCT01675167|3668643|P3|Open-label Titration Phase|Lack of Efficacy|0
1118702|NCT01675167|3668644|P2|Open-label Titration Phase|Lack of Efficacy|0
1118703|NCT01675167|3668645|P1|Open-label Titration Phase|Lack of Efficacy|63
1118704|NCT01675167|3668643|P3|Open-label Titration Phase|Adverse Event|0
1118705|NCT01675167|3668644|P2|Open-label Titration Phase|Adverse Event|0
1118706|NCT01675167|3668645|P1|Open-label Titration Phase|Adverse Event|81
1118707|NCT01675141|3668667|P1|Overall Study|No treatment, per protocol|1
1118708|NCT01675141|3668667|P1|Overall Study|Physician Decision|4
1118709|NCT01675141|3668667|P1|Overall Study|Withdrawal by Subject|3
1118710|NCT01675141|3668667|P1|Overall Study|Lenalidomide outside NIH|3
1118711|NCT01675128|3668680|P3|Overall Study|Pulmonary complication; off study|0
1118712|NCT01675128|3668681|P2|Overall Study|Pulmonary complication; off study|1
1118713|NCT01675128|3668682|P1|Overall Study|Pulmonary complication; off study|0
1118714|NCT01675128|3668680|P3|Overall Study|Refused further treatment|0
1118715|NCT01675128|3668681|P2|Overall Study|Refused further treatment|0
1118716|NCT01675128|3668682|P1|Overall Study|Refused further treatment|1
1118717|NCT01675128|3668680|P3|Overall Study|Disease progression on study|1
1118718|NCT01675128|3668681|P2|Overall Study|Disease progression on study|1
1118719|NCT01675128|3668682|P1|Overall Study|Disease progression on study|1
1118720|NCT01675050|3668710|P2|Period One Treatment|Withdrawal by Subject|0
1118721|NCT01675050|3668711|P1|Period One Treatment|Withdrawal by Subject|1
1118722|NCT01675011|3668721|P2|Overall Study|Trial terminated by Sponsor|1
1118723|NCT01675011|3668722|P1|Overall Study|Trial terminated by Sponsor|3
1118724|NCT01674725|3668730|P2|Overall Study|Lost to Follow-up|1
1118725|NCT01674725|3668731|P1|Overall Study|Lost to Follow-up|0
1118726|NCT01674725|3668730|P2|Overall Study|Withdrawal by Subject|0
1118727|NCT01674725|3668731|P1|Overall Study|Withdrawal by Subject|1
1118728|NCT01674725|3668730|P2|Overall Study|Did not receive study drug|0
1118729|NCT01674725|3668731|P1|Overall Study|Did not receive study drug|1
1118730|NCT01674725|3668730|P2|Overall Study|Adverse Event|0
1118731|NCT01674725|3668731|P1|Overall Study|Adverse Event|1
1118732|NCT01674712|3668750|P5|Overall Study|Lack of Efficacy|1
1118733|NCT01674712|3668751|P4|Overall Study|Lack of Efficacy|0
1118734|NCT01674712|3668752|P3|Overall Study|Lack of Efficacy|1
1118735|NCT01674712|3668753|P2|Overall Study|Lack of Efficacy|0
1118736|NCT01674712|3668754|P1|Overall Study|Lack of Efficacy|0
1118737|NCT01674712|3668750|P5|Overall Study|Administrative|1
1118738|NCT01674712|3668751|P4|Overall Study|Administrative|0
1118739|NCT01674712|3668752|P3|Overall Study|Administrative|0
1118740|NCT01674712|3668753|P2|Overall Study|Administrative|1
1118741|NCT01674712|3668754|P1|Overall Study|Administrative|0
1118742|NCT01674712|3668750|P5|Overall Study|Withdrawal by Subject|3
1118743|NCT01674712|3668751|P4|Overall Study|Withdrawal by Subject|4
1118744|NCT01674712|3668752|P3|Overall Study|Withdrawal by Subject|5
1118745|NCT01674712|3668753|P2|Overall Study|Withdrawal by Subject|2
1118746|NCT01674712|3668754|P1|Overall Study|Withdrawal by Subject|2
1118747|NCT01674712|3668750|P5|Overall Study|Protocol Violation|0
1118748|NCT01674712|3668751|P4|Overall Study|Protocol Violation|0
1118749|NCT01674712|3668752|P3|Overall Study|Protocol Violation|0
1118750|NCT01674712|3668753|P2|Overall Study|Protocol Violation|0
1118751|NCT01674712|3668754|P1|Overall Study|Protocol Violation|2
1118752|NCT01674712|3668750|P5|Overall Study|Lost to Follow-up|0
1118753|NCT01674712|3668751|P4|Overall Study|Lost to Follow-up|0
1118754|NCT01674712|3668752|P3|Overall Study|Lost to Follow-up|0
1118755|NCT01674712|3668753|P2|Overall Study|Lost to Follow-up|0
1118756|NCT01674712|3668754|P1|Overall Study|Lost to Follow-up|1
1118757|NCT01674712|3668750|P5|Overall Study|Adverse Event|6
1118758|NCT01674712|3668751|P4|Overall Study|Adverse Event|4
1118759|NCT01674712|3668752|P3|Overall Study|Adverse Event|3
1118760|NCT01674712|3668753|P2|Overall Study|Adverse Event|6
1118761|NCT01674712|3668754|P1|Overall Study|Adverse Event|5
1118762|NCT01674647|3668778|P2|30-day Safety Follow-up Period|Lost to Follow-up|5
1118763|NCT01674647|3668779|P1|30-day Safety Follow-up Period|Lost to Follow-up|8
1118764|NCT01674647|3668778|P2|30-day Safety Follow-up Period|Withdrawal by Subject|8
1118765|NCT01674647|3668779|P1|30-day Safety Follow-up Period|Withdrawal by Subject|7
1118766|NCT01674647|3668778|P2|30-day Safety Follow-up Period|Logistical difficulties|3
1118767|NCT01674647|3668779|P1|30-day Safety Follow-up Period|Logistical difficulties|1
1118768|NCT01674647|3668778|P2|30-day Safety Follow-up Period|Protocol Violation|22
1118769|NCT01674647|3668779|P1|30-day Safety Follow-up Period|Protocol Violation|39
1118770|NCT01674647|3668778|P2|30-day Safety Follow-up Period|Non-compliance with study drug|1
1118771|NCT01674647|3668779|P1|30-day Safety Follow-up Period|Non-compliance with study drug|0
1118772|NCT01674647|3668778|P2|30-day Safety Follow-up Period|Death|2
1118773|NCT01674647|3668779|P1|30-day Safety Follow-up Period|Death|3
1118774|NCT01674647|3668778|P2|Treatment Period|Protocol Violation|36
1118775|NCT01674647|3668779|P1|Treatment Period|Protocol Violation|56
1118776|NCT01674647|3668778|P2|Treatment Period|Treatment failure|14
1118777|NCT01674647|3668779|P1|Treatment Period|Treatment failure|0
1118778|NCT01674647|3668778|P2|Treatment Period|Logistical difficulties|8
1118779|NCT01674647|3668779|P1|Treatment Period|Logistical difficulties|5
1118780|NCT01674647|3668778|P2|Treatment Period|Switching to other therapy|2
1118781|NCT01674647|3668779|P1|Treatment Period|Switching to other therapy|5
1118782|NCT01674647|3668778|P2|Treatment Period|Withdrawal by Subject|16
1118783|NCT01674647|3668779|P1|Treatment Period|Withdrawal by Subject|19
1118784|NCT01674647|3668778|P2|Treatment Period|Lost to Follow-up|1
1118785|NCT01674647|3668779|P1|Treatment Period|Lost to Follow-up|1
1118786|NCT01674647|3668778|P2|Treatment Period|Non-compliance with study drug|0
1118787|NCT01674647|3668779|P1|Treatment Period|Non-compliance with study drug|3
1118788|NCT01674647|3668778|P2|Treatment Period|Adverse Event|22
1118789|NCT01674647|3668779|P1|Treatment Period|Adverse Event|60
1118790|NCT01674647|3668778|P2|Treatment Period|Physician Decision|1
1118791|NCT01674647|3668779|P1|Treatment Period|Physician Decision|3
1118792|NCT01674647|3668778|P2|Treatment Period|Efficacy outcome reached|1
1118793|NCT01674647|3668779|P1|Treatment Period|Efficacy outcome reached|0
1118794|NCT01674647|3668778|P2|Treatment Period|Death|1
1118795|NCT01674647|3668779|P1|Treatment Period|Death|4
1118796|NCT01674634|3668805|P1|Overall Study|Lost to Follow-up|3
1118797|NCT01674634|3668805|P1|Overall Study|Withdrawal by Subject|3
1118798|NCT01674569|3668851|P6|Overall Study|Withdrawal by Subject|0
1118799|NCT01674569|3668852|P5|Overall Study|Withdrawal by Subject|0
1118800|NCT01674569|3668853|P4|Overall Study|Withdrawal by Subject|0
1118801|NCT01674569|3668854|P3|Overall Study|Withdrawal by Subject|1
1118802|NCT01674569|3668855|P2|Overall Study|Withdrawal by Subject|0
1118803|NCT01674569|3668856|P1|Overall Study|Withdrawal by Subject|0
1118804|NCT01674569|3668851|P6|Overall Study|Protocol Violation|0
1118805|NCT01674569|3668852|P5|Overall Study|Protocol Violation|0
1118806|NCT01674569|3668853|P4|Overall Study|Protocol Violation|0
1118807|NCT01674569|3668854|P3|Overall Study|Protocol Violation|1
1118808|NCT01674569|3668855|P2|Overall Study|Protocol Violation|1
1118809|NCT01674569|3668856|P1|Overall Study|Protocol Violation|0
1118810|NCT01674569|3668851|P6|Overall Study|Adverse Event|2
1118811|NCT01674569|3668852|P5|Overall Study|Adverse Event|2
1118812|NCT01674569|3668853|P4|Overall Study|Adverse Event|1
1118813|NCT01674569|3668854|P3|Overall Study|Adverse Event|0
1118814|NCT01674569|3668855|P2|Overall Study|Adverse Event|2
1118815|NCT01674569|3668856|P1|Overall Study|Adverse Event|0
1118816|NCT01674062|3668877|P2|Overall Study|Programming Error|0
1118817|NCT01674062|3668878|P1|Overall Study|Programming Error|1
1118818|NCT01674062|3668877|P2|Overall Study|Death|1
1118819|NCT01674062|3668878|P1|Overall Study|Death|0
1118820|NCT01674062|3668877|P2|Overall Study|Adverse Event|1
1118821|NCT01674062|3668878|P1|Overall Study|Adverse Event|1
1118822|NCT01674062|3668877|P2|Overall Study|Not Specified|1
1118823|NCT01674062|3668878|P1|Overall Study|Not Specified|8
1118824|NCT01674062|3668877|P2|Overall Study|Insufficient Therapeutic Response|26
1118825|NCT01674062|3668878|P1|Overall Study|Insufficient Therapeutic Response|56
1118826|NCT01674010|3668893|P3|Randomization Phase 2|Withdrawal by Subject|7
1118827|NCT01674010|3668894|P2|Randomization Phase 2|Withdrawal by Subject|8
1118828|NCT01674010|3668895|P1|Randomization Phase 2|Withdrawal by Subject|0
1118829|NCT01674010|3668893|P3|Randomization Phase 2|Sponsor Decision|45
1118830|NCT01674010|3668894|P2|Randomization Phase 2|Sponsor Decision|42
1118831|NCT01674010|3668895|P1|Randomization Phase 2|Sponsor Decision|0
1118832|NCT01674010|3668893|P3|Randomization Phase 2|Protocol Violation|1
1118833|NCT01674010|3668894|P2|Randomization Phase 2|Protocol Violation|1
1118834|NCT01674010|3668895|P1|Randomization Phase 2|Protocol Violation|0
1118835|NCT01674010|3668893|P3|Randomization Phase 2|Pregnancy|1
1118836|NCT01674010|3668894|P2|Randomization Phase 2|Pregnancy|1
1118837|NCT01674010|3668895|P1|Randomization Phase 2|Pregnancy|0
1118838|NCT01674010|3668893|P3|Randomization Phase 2|Physician Decision|2
1118839|NCT01674010|3668894|P2|Randomization Phase 2|Physician Decision|0
1118840|NCT01674010|3668895|P1|Randomization Phase 2|Physician Decision|0
1118841|NCT01674010|3668893|P3|Randomization Phase 2|Mood episode recurrence|2
1118842|NCT01674010|3668894|P2|Randomization Phase 2|Mood episode recurrence|8
1118843|NCT01674010|3668895|P1|Randomization Phase 2|Mood episode recurrence|0
1118844|NCT01674010|3668893|P3|Randomization Phase 2|Lost to Follow-up|2
1118845|NCT01674010|3668894|P2|Randomization Phase 2|Lost to Follow-up|1
1118846|NCT01674010|3668895|P1|Randomization Phase 2|Lost to Follow-up|0
1118847|NCT01674010|3668893|P3|Randomization Phase 2|Adverse Event|1
1118848|NCT01674010|3668894|P2|Randomization Phase 2|Adverse Event|1
1118849|NCT01674010|3668895|P1|Randomization Phase 2|Adverse Event|0
1118850|NCT01674010|3668893|P3|Open Treatment Phase 1|Withdrawal by Subject|0
1118851|NCT01674010|3668894|P2|Open Treatment Phase 1|Withdrawal by Subject|0
1118852|NCT01674010|3668895|P1|Open Treatment Phase 1|Withdrawal by Subject|25
1118853|NCT01674010|3668893|P3|Open Treatment Phase 1|Did not remain in a stable remission|0
1118854|NCT01674010|3668894|P2|Open Treatment Phase 1|Did not remain in a stable remission|0
1118855|NCT01674010|3668895|P1|Open Treatment Phase 1|Did not remain in a stable remission|30
1118856|NCT01674010|3668893|P3|Open Treatment Phase 1|Sponsor Decision|0
1118857|NCT01674010|3668894|P2|Open Treatment Phase 1|Sponsor Decision|0
1118858|NCT01674010|3668895|P1|Open Treatment Phase 1|Sponsor Decision|79
1118859|NCT01674010|3668893|P3|Open Treatment Phase 1|Protocol Violation|0
1118860|NCT01674010|3668894|P2|Open Treatment Phase 1|Protocol Violation|0
1118861|NCT01674010|3668895|P1|Open Treatment Phase 1|Protocol Violation|7
1118862|NCT01674010|3668893|P3|Open Treatment Phase 1|Physician Decision|0
1118863|NCT01674010|3668894|P2|Open Treatment Phase 1|Physician Decision|0
1118864|NCT01674010|3668895|P1|Open Treatment Phase 1|Physician Decision|9
1118865|NCT01674010|3668893|P3|Open Treatment Phase 1|Lost to Follow-up|0
1118866|NCT01674010|3668894|P2|Open Treatment Phase 1|Lost to Follow-up|0
1118867|NCT01674010|3668895|P1|Open Treatment Phase 1|Lost to Follow-up|19
1118868|NCT01674010|3668893|P3|Open Treatment Phase 1|Death|0
1118869|NCT01674010|3668894|P2|Open Treatment Phase 1|Death|0
1118870|NCT01674010|3668895|P1|Open Treatment Phase 1|Death|1
1118871|NCT01674010|3668893|P3|Open Treatment Phase 1|Adverse Event|0
1118872|NCT01674010|3668894|P2|Open Treatment Phase 1|Adverse Event|0
1118873|NCT01674010|3668895|P1|Open Treatment Phase 1|Adverse Event|10
1118874|NCT01673984|3668914|P2|Overall Study|Study termination|6
1118875|NCT01673984|3668915|P1|Overall Study|Study termination|9
1118876|NCT01673984|3668914|P2|Overall Study|Adverse Event|0
1118877|NCT01673984|3668915|P1|Overall Study|Adverse Event|1
1118878|NCT01673867|3668965|P2|Treatment|Physician Decision|1
1118879|NCT01673867|3668966|P1|Treatment|Physician Decision|0
1118880|NCT01673867|3668965|P2|Treatment|Symptomatic deterioration|1
1118881|NCT01673867|3668966|P1|Treatment|Symptomatic deterioration|0
1118882|NCT01673867|3668965|P2|Treatment|Required prolonged hospitalization|1
1118883|NCT01673867|3668966|P1|Treatment|Required prolonged hospitalization|0
1118884|NCT01673867|3668965|P2|Treatment|Health status not improved|0
1118885|NCT01673867|3668966|P1|Treatment|Health status not improved|1
1118886|NCT01673867|3668965|P2|Treatment|Required steroid therapy|0
1118887|NCT01673867|3668966|P1|Treatment|Required steroid therapy|1
1118888|NCT01673867|3668965|P2|Treatment|No longer meets criteria|0
1118889|NCT01673867|3668966|P1|Treatment|No longer meets criteria|2
1118890|NCT01673867|3668965|P2|Treatment|Maximum clinical benefit|10
1118891|NCT01673867|3668966|P1|Treatment|Maximum clinical benefit|0
1118892|NCT01673867|3668965|P2|Treatment|Withdrawal by Subject|6
1118893|NCT01673867|3668966|P1|Treatment|Withdrawal by Subject|4
1118894|NCT01673867|3668965|P2|Treatment|Requested treatment discontinuation|16
1118895|NCT01673867|3668966|P1|Treatment|Requested treatment discontinuation|5
1118896|NCT01673867|3668965|P2|Treatment|AE unrelated to study drug|11
1118897|NCT01673867|3668966|P1|Treatment|AE unrelated to study drug|19
1118898|NCT01673867|3668965|P2|Treatment|Death|1
1118899|NCT01673867|3668966|P1|Treatment|Death|1
1118900|NCT01673867|3668965|P2|Treatment|Study Drug Toxicity|42
1118901|NCT01673867|3668966|P1|Treatment|Study Drug Toxicity|17
1118902|NCT01673867|3668965|P2|Treatment|Disease Progression|179
1118903|NCT01673867|3668966|P1|Treatment|Disease Progression|194
1118904|NCT01673867|3668965|P2|Randomization|No longer meets criteria|5
1118905|NCT01673867|3668966|P1|Randomization|No longer meets criteria|4
1118906|NCT01673867|3668965|P2|Randomization|Lost to Follow-up|1
1118907|NCT01673867|3668966|P1|Randomization|Lost to Follow-up|0
1118908|NCT01673867|3668965|P2|Randomization|Withdrawal by Subject|12
1118909|NCT01673867|3668966|P1|Randomization|Withdrawal by Subject|0
1118910|NCT01673867|3668965|P2|Randomization|Requested treatment discontinuation|4
1118911|NCT01673867|3668966|P1|Randomization|Requested treatment discontinuation|0
1118912|NCT01673867|3668965|P2|Randomization|AE unrelated to study drug|0
1118913|NCT01673867|3668966|P1|Randomization|AE unrelated to study drug|1
1118914|NCT01673854|3668992|P1|Vem 2 Phase (Vemurafenib Retreatment)|Death|1
1118915|NCT01673854|3668992|P1|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1
1118916|NCT01673854|3668992|P1|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5
1118917|NCT01673854|3668992|P1|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12
1118918|NCT01673854|3668992|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7
1118919|NCT01673854|3668992|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2
1118920|NCT01673854|3668992|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1
1118921|NCT01673854|3668992|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1
1118922|NCT01673854|3668992|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1
1118923|NCT01673854|3668992|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2
1118924|NCT01673854|3668992|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6
1118925|NCT01673854|3668992|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7
1118926|NCT01673698|3669015|P2|Overall Study|Lost to Follow-up|13
1118927|NCT01673698|3669016|P1|Overall Study|Lost to Follow-up|51
1118928|NCT01673620|3669026|P2|Overall Study|Adverse Event|0
1118929|NCT01673620|3669027|P1|Overall Study|Adverse Event|1
1118930|NCT01673594|3669037|P2|Overall Study|Withdrawal by Subject|1
1118931|NCT01673594|3669038|P1|Overall Study|Withdrawal by Subject|0
1118932|NCT01673594|3669037|P2|Overall Study|Physician Decision|4
1118933|NCT01673594|3669038|P1|Overall Study|Physician Decision|2
1118934|NCT01673594|3669037|P2|Overall Study|Lost to Follow-up|0
1118935|NCT01673594|3669038|P1|Overall Study|Lost to Follow-up|1
1118936|NCT01673594|3669037|P2|Overall Study|Adverse Event|1
1118937|NCT01673594|3669038|P1|Overall Study|Adverse Event|3
1118938|NCT01673490|3669057|P1|Overall Study|Withdrawal by Subject|3
1118939|NCT01673490|3669057|P1|Overall Study|Adverse Event|3
1118940|NCT01673490|3669057|P1|Overall Study|Lost to Follow-up|1
1118941|NCT01673347|3669074|P1|Overall Study|failure of allograft|7
1118942|NCT01673282|3669083|P2|Overall Study|Other|6
1118943|NCT01673282|3669084|P1|Overall Study|Other|1
1118944|NCT01673282|3669083|P2|Overall Study|Withdrawal by Subject|3
1118945|NCT01673282|3669084|P1|Overall Study|Withdrawal by Subject|3
1118946|NCT01673282|3669083|P2|Overall Study|Lost to Follow-up|10
1118947|NCT01673282|3669084|P1|Overall Study|Lost to Follow-up|11
1118948|NCT01673282|3669083|P2|Overall Study|Lack of Efficacy|2
1118949|NCT01673282|3669084|P1|Overall Study|Lack of Efficacy|9
1118950|NCT01673282|3669083|P2|Overall Study|Adverse Drug Reaction - Vimpat|5
1118951|NCT01673282|3669084|P1|Overall Study|Adverse Drug Reaction - Vimpat|9
1118952|NCT01673178|3669120|P5|Overall Study|Other|0
1118953|NCT01673178|3669121|P4|Overall Study|Other|1
1118954|NCT01673178|3669122|P3|Overall Study|Other|2
1118955|NCT01673178|3669123|P2|Overall Study|Other|0
1118956|NCT01673178|3669124|P1|Overall Study|Other|1
1118957|NCT01673178|3669120|P5|Overall Study|Adverse Event|0
1118958|NCT01673178|3669121|P4|Overall Study|Adverse Event|2
1118959|NCT01673178|3669122|P3|Overall Study|Adverse Event|0
1118960|NCT01673178|3669123|P2|Overall Study|Adverse Event|0
1118961|NCT01673178|3669124|P1|Overall Study|Adverse Event|1
1118962|NCT01673178|3669120|P5|Overall Study|Protocol Violation|0
1118963|NCT01673178|3669121|P4|Overall Study|Protocol Violation|1
1118964|NCT01673178|3669122|P3|Overall Study|Protocol Violation|0
1118965|NCT01673178|3669123|P2|Overall Study|Protocol Violation|1
1118966|NCT01673178|3669124|P1|Overall Study|Protocol Violation|1
1118967|NCT01673178|3669120|P5|Overall Study|Withdrawal by Subject|2
1118968|NCT01673178|3669121|P4|Overall Study|Withdrawal by Subject|4
1118969|NCT01673178|3669122|P3|Overall Study|Withdrawal by Subject|1
1118970|NCT01673178|3669123|P2|Overall Study|Withdrawal by Subject|0
1118971|NCT01673178|3669124|P1|Overall Study|Withdrawal by Subject|0
1118972|NCT01673178|3669120|P5|Overall Study|Lost to Follow-up|0
1118973|NCT01673178|3669121|P4|Overall Study|Lost to Follow-up|0
1118974|NCT01673178|3669122|P3|Overall Study|Lost to Follow-up|0
1118975|NCT01673178|3669123|P2|Overall Study|Lost to Follow-up|1
1118976|NCT01673178|3669124|P1|Overall Study|Lost to Follow-up|0
1118977|NCT01673126|3669363|P2|Overall Study|change of diagnosis|3
1118978|NCT01673126|3669364|P1|Overall Study|change of diagnosis|4
1118979|NCT01673009|3669384|P1|Overall Study|Withdrawal by Subject|8
1118980|NCT01673009|3669384|P1|Overall Study|Physician Decision|5
1118981|NCT01672970|3669469|P1|Overall Study|Enrolled but not treated|1
1118982|NCT01672970|3669469|P1|Overall Study|Other|9
1118983|NCT01672970|3669469|P1|Overall Study|Lost to Follow-up|5
1118984|NCT01672970|3669469|P1|Overall Study|Withdrawal by Subject|2
1118985|NCT01672970|3669469|P1|Overall Study|Adverse Event|18
1118986|NCT01672970|3669469|P1|Overall Study|Lack of Efficacy|12
1118987|NCT01672957|3669505|P1|Overall Study|ICF Signed After Transplantation|5
1118988|NCT01672957|3669505|P1|Overall Study|Death|2
1118989|NCT01672957|3669505|P1|Overall Study|Protocol Violation|48
1118990|NCT01672892|3669520|P2|Overall Study|Protocol Violation|3
1118991|NCT01672892|3669521|P1|Overall Study|Protocol Violation|8
1118992|NCT01672788|3669541|P4|Washout Period 2 (7 Days)|Adverse Event|1
1118993|NCT01672788|3669542|P3|Washout Period 2 (7 Days)|Adverse Event|0
1118994|NCT01672788|3669543|P2|Washout Period 2 (7 Days)|Adverse Event|0
1118995|NCT01672788|3669544|P1|Washout Period 2 (7 Days)|Adverse Event|0
1118996|NCT01672736|3669574|P1|Overall Study|Available drug expired on 31 May 16|3
1118997|NCT01672723|3669578|P2|First Intervention|Adverse Event|0
1118998|NCT01672723|3669579|P1|First Intervention|Adverse Event|3
1118999|NCT01672710|3669591|P2|3 Month Follow up|follow up due after termination date|1
1119000|NCT01672710|3669592|P1|3 Month Follow up|follow up due after termination date|4
1119001|NCT01672710|3669591|P2|3 Month Follow up|Lost to Follow-up|3
1119002|NCT01672710|3669592|P1|3 Month Follow up|Lost to Follow-up|2
1119003|NCT01672710|3669591|P2|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1
1119004|NCT01672710|3669592|P1|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0
1119005|NCT01672294|3669629|P4|Overall Study|Lost to Follow-up|9
1119006|NCT01672294|3669630|P3|Overall Study|Lost to Follow-up|7
1119007|NCT01672294|3669631|P2|Overall Study|Lost to Follow-up|16
1119008|NCT01672294|3669632|P1|Overall Study|Lost to Follow-up|1
1119009|NCT01672294|3669629|P4|Overall Study|Excluded by study|0
1119010|NCT01672294|3669630|P3|Overall Study|Excluded by study|0
1119011|NCT01672294|3669631|P2|Overall Study|Excluded by study|1
1119012|NCT01672294|3669632|P1|Overall Study|Excluded by study|1
1119013|NCT01672294|3669629|P4|Overall Study|Withdrawal by Subject|4
1119014|NCT01672294|3669630|P3|Overall Study|Withdrawal by Subject|4
1119015|NCT01672294|3669631|P2|Overall Study|Withdrawal by Subject|4
1119016|NCT01672294|3669632|P1|Overall Study|Withdrawal by Subject|4
1119017|NCT01671748|3669672|P2|4 Week run-in Phase|Not eligible|0
1119018|NCT01671748|3669673|P1|4 Week run-in Phase|Not eligible|9
1119019|NCT01671748|3669672|P2|4 Week run-in Phase|Adverse Event|0
1119020|NCT01671748|3669673|P1|4 Week run-in Phase|Adverse Event|1
1119021|NCT01671748|3669672|P2|4 Week run-in Phase|Withdrawal by Subject|0
1119022|NCT01671748|3669673|P1|4 Week run-in Phase|Withdrawal by Subject|1
1119023|NCT01671488|3669700|P1|Overall Study|Withdrawal by Subject|1
1119024|NCT01671319|3669706|P1|Overall Study|Withdrawal by Subject|1
1119025|NCT01671280|3669721|P1|Overall Study|Withdrawal by Subject|2
1119026|NCT01671111|3669732|P1|Overall Study|Other|24
1119027|NCT01671111|3669732|P1|Overall Study|Physician Decision|1
1119028|NCT01671111|3669732|P1|Overall Study|Withdrawal by Subject|2
1119029|NCT01671111|3669732|P1|Overall Study|Lack of Efficacy|1
1119030|NCT01671111|3669732|P1|Overall Study|Adverse Event|2
1119031|NCT01671059|3669742|P1|Overall Study|Lack of Efficacy|1
1119032|NCT01671059|3669742|P1|Overall Study|Adverse Event|4
1119033|NCT01670721|3669834|P1|Overall Study|Other than specified above|38
1119034|NCT01670721|3669834|P1|Overall Study|Participant's decision|15
1119035|NCT01670656|3669846|P5|Overall Study|Subject moved|0
1119036|NCT01670656|3669847|P4|Overall Study|Subject moved|1
1119037|NCT01670656|3669848|P3|Overall Study|Subject moved|0
1119038|NCT01670656|3669849|P2|Overall Study|Subject moved|0
1119039|NCT01670656|3669850|P1|Overall Study|Subject moved|0
1119040|NCT01670656|3669846|P5|Overall Study|Lost to Follow-up|3
1119041|NCT01670656|3669847|P4|Overall Study|Lost to Follow-up|0
1119042|NCT01670656|3669848|P3|Overall Study|Lost to Follow-up|0
1119043|NCT01670656|3669849|P2|Overall Study|Lost to Follow-up|0
1119044|NCT01670656|3669850|P1|Overall Study|Lost to Follow-up|0
1119045|NCT01670656|3669846|P5|Overall Study|Subject withdrew consent|1
1119046|NCT01670656|3669847|P4|Overall Study|Subject withdrew consent|1
1119047|NCT01670656|3669848|P3|Overall Study|Subject withdrew consent|2
1119048|NCT01670656|3669849|P2|Overall Study|Subject withdrew consent|1
1119049|NCT01670656|3669850|P1|Overall Study|Subject withdrew consent|0
1119050|NCT01670656|3669846|P5|Overall Study|Adverse Event|3
1119051|NCT01670656|3669847|P4|Overall Study|Adverse Event|3
1119052|NCT01670656|3669848|P3|Overall Study|Adverse Event|2
1119053|NCT01670656|3669849|P2|Overall Study|Adverse Event|2
1119054|NCT01670656|3669850|P1|Overall Study|Adverse Event|2
1119055|NCT01670656|3669846|P5|Overall Study|Non-compliance with protocol|2
1119056|NCT01670656|3669847|P4|Overall Study|Non-compliance with protocol|1
1119057|NCT01670656|3669848|P3|Overall Study|Non-compliance with protocol|1
1119058|NCT01670656|3669849|P2|Overall Study|Non-compliance with protocol|3
1119059|NCT01670656|3669850|P1|Overall Study|Non-compliance with protocol|0
1119060|NCT01670656|3669846|P5|Overall Study|Withdrawal by Subject|0
1119061|NCT01670656|3669847|P4|Overall Study|Withdrawal by Subject|0
1119062|NCT01670656|3669848|P3|Overall Study|Withdrawal by Subject|0
1119063|NCT01670656|3669849|P2|Overall Study|Withdrawal by Subject|1
1119064|NCT01670656|3669850|P1|Overall Study|Withdrawal by Subject|1
1119065|NCT01670656|3669846|P5|Overall Study|Pregnancy|1
1119066|NCT01670656|3669847|P4|Overall Study|Pregnancy|0
1119067|NCT01670656|3669848|P3|Overall Study|Pregnancy|0
1119068|NCT01670656|3669849|P2|Overall Study|Pregnancy|0
1119069|NCT01670656|3669850|P1|Overall Study|Pregnancy|0
1119070|NCT01670656|3669846|P5|Overall Study|Non-compliance with study drug|1
1119071|NCT01670656|3669847|P4|Overall Study|Non-compliance with study drug|0
1119072|NCT01670656|3669848|P3|Overall Study|Non-compliance with study drug|3
1119073|NCT01670656|3669849|P2|Overall Study|Non-compliance with study drug|0
1119074|NCT01670656|3669850|P1|Overall Study|Non-compliance with study drug|0
1119075|NCT01670526|3669879|P2|Overall Study|Lost to Follow-up|5
1119076|NCT01670526|3669880|P1|Overall Study|Lost to Follow-up|9
1119077|NCT01670526|3669879|P2|Overall Study|Withdrawal by Subject|1
1119078|NCT01670526|3669880|P1|Overall Study|Withdrawal by Subject|3
1119079|NCT01670292|3669901|P1|Overall Study|Lost to Follow-up|14
1119080|NCT01670279|3669942|P4|Overall Study|Participant met withdrawal criteria|1
1119081|NCT01670279|3669943|P3|Overall Study|Participant met withdrawal criteria|0
1119082|NCT01670279|3669944|P2|Overall Study|Participant met withdrawal criteria|0
1119083|NCT01670279|3669945|P1|Overall Study|Participant met withdrawal criteria|0
1119084|NCT01670279|3669942|P4|Overall Study|Physician Decision|0
1119085|NCT01670279|3669943|P3|Overall Study|Physician Decision|0
1119086|NCT01670279|3669944|P2|Overall Study|Physician Decision|1
1119087|NCT01670279|3669945|P1|Overall Study|Physician Decision|0
1119088|NCT01670279|3669942|P4|Overall Study|Adverse Event|0
1119089|NCT01670279|3669943|P3|Overall Study|Adverse Event|0
1119090|NCT01670279|3669944|P2|Overall Study|Adverse Event|1
1119091|NCT01670279|3669945|P1|Overall Study|Adverse Event|0
1119092|NCT01670188|3669987|P2|Overall Study|Death|1
1119093|NCT01670188|3669988|P1|Overall Study|Death|0
1119094|NCT01670045|3669994|P1|Overall Study|Lost to Follow-up|11
1119095|NCT01670045|3669994|P1|Overall Study|Death|1
1119096|NCT01670045|3669994|P1|Overall Study|Adverse Event|1
1119097|NCT01670045|3669994|P1|Overall Study|Withdrawal by Subject|3
1119098|NCT01670019|3670012|P2|Overall Study|Withdrawal by Subject|0
1119099|NCT01670019|3670013|P1|Overall Study|Withdrawal by Subject|6
1119100|NCT01670019|3670012|P2|Overall Study|Adverse Event|0
1119101|NCT01670019|3670013|P1|Overall Study|Adverse Event|3
1119102|NCT01669902|3670027|P1|Overall Study|Other|8
1119103|NCT01669902|3670027|P1|Overall Study|Lack of Efficacy|10
1119104|NCT01669902|3670027|P1|Overall Study|Adverse Event|11
1119105|NCT01669811|3670062|P2|Overall Study|Eligibility Criteria Not Fulfilled|2
1119106|NCT01669811|3670063|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
1119107|NCT01669811|3670062|P2|Overall Study|Adverse Event|6
1119108|NCT01669811|3670063|P1|Overall Study|Adverse Event|2
1119109|NCT01669811|3670062|P2|Overall Study|Withdrawal by Subject|2
1119110|NCT01669811|3670063|P1|Overall Study|Withdrawal by Subject|1
1119111|NCT01669811|3670062|P2|Overall Study|Investigator decision|1
1119112|NCT01669811|3670063|P1|Overall Study|Investigator decision|0
1119113|NCT01669798|3670081|P1|Overall Study|Physician Decision|5
1119114|NCT01669629|3670187|P2|Period 1|protocol deviation|2
1119115|NCT01669629|3670188|P1|Period 1|protocol deviation|1
1119116|NCT01669577|3670211|P1|Overall Study|Physician Decision|34
1119117|NCT01669577|3670211|P1|Overall Study|Lost to Follow-up|78
1119118|NCT01669577|3670211|P1|Overall Study|Death|22
1119119|NCT01669174|3670236|P2|Overall Study|Administrative problems|2
1119120|NCT01669174|3670237|P1|Overall Study|Administrative problems|1
1119121|NCT01669174|3670236|P2|Overall Study|Adverse Event|2
1119122|NCT01669174|3670237|P1|Overall Study|Adverse Event|2
1119123|NCT01669174|3670236|P2|Overall Study|Lost to Follow-up|0
1119124|NCT01669174|3670237|P1|Overall Study|Lost to Follow-up|1
1119125|NCT01669174|3670236|P2|Overall Study|Subject withdrew consent|2
1119126|NCT01669174|3670237|P1|Overall Study|Subject withdrew consent|2
1119127|NCT01669122|3670253|P1|Washout Period II|Protocol Violation|2
1119128|NCT01669122|3670253|P1|Period I|Lost to Follow-up|1
1119129|NCT01668797|3670346|P4|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38
1119130|NCT01668797|3670347|P3|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49
1119131|NCT01668797|3670348|P2|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
1119132|NCT01668797|3670349|P1|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
1119133|NCT01668797|3670346|P4|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2
1119134|NCT01668797|3670347|P3|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4
1119135|NCT01668797|3670348|P2|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
1119136|NCT01668797|3670349|P1|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
1119137|NCT01668797|3670346|P4|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30
1119138|NCT01668797|3670347|P3|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11
1119139|NCT01668797|3670348|P2|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
1119140|NCT01668797|3670349|P1|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
1119141|NCT01668797|3670346|P4|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10
1119142|NCT01668797|3670347|P3|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2
1119143|NCT01668797|3670348|P2|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
1119144|NCT01668797|3670349|P1|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
1119145|NCT01668797|3670346|P4|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
1119146|NCT01668797|3670347|P3|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2
1119147|NCT01668797|3670348|P2|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
1119148|NCT01668797|3670349|P1|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
1119149|NCT01668797|3670346|P4|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5
1119150|NCT01668797|3670347|P3|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3
1119151|NCT01668797|3670348|P2|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
1119152|NCT01668797|3670349|P1|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
1119153|NCT01668797|3670346|P4|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2
1119154|NCT01668797|3670347|P3|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5
1119155|NCT01668797|3670348|P2|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
1119156|NCT01668797|3670349|P1|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
1119157|NCT01668797|3670346|P4|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
1119158|NCT01668797|3670347|P3|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
1119159|NCT01668797|3670348|P2|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
1119160|NCT01668797|3670349|P1|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
1119161|NCT01668797|3670346|P4|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6
1119162|NCT01668797|3670347|P3|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4
1119163|NCT01668797|3670348|P2|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
1119164|NCT01668797|3670349|P1|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
1119165|NCT01668797|3670346|P4|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
1119166|NCT01668797|3670347|P3|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
1119167|NCT01668797|3670348|P2|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86
1119168|NCT01668797|3670349|P1|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
1119169|NCT01668797|3670346|P4|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
1119170|NCT01668797|3670347|P3|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
1119171|NCT01668797|3670348|P2|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43
1119172|NCT01668797|3670349|P1|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
1119173|NCT01668797|3670346|P4|Phase B (Stabilization Phase)|Lack of Efficacy|0
1119174|NCT01668797|3670347|P3|Phase B (Stabilization Phase)|Lack of Efficacy|0
1119175|NCT01668797|3670348|P2|Phase B (Stabilization Phase)|Lack of Efficacy|21
1119176|NCT01668797|3670349|P1|Phase B (Stabilization Phase)|Lack of Efficacy|0
1119177|NCT01668797|3670346|P4|Phase B (Stabilization Phase)|Protocol Violation|0
1119178|NCT01668797|3670347|P3|Phase B (Stabilization Phase)|Protocol Violation|0
1119179|NCT01668797|3670348|P2|Phase B (Stabilization Phase)|Protocol Violation|3
1119180|NCT01668797|3670349|P1|Phase B (Stabilization Phase)|Protocol Violation|0
1119181|NCT01668797|3670346|P4|Phase B (Stabilization Phase)|Withdrawal by Subject|0
1119182|NCT01668797|3670347|P3|Phase B (Stabilization Phase)|Withdrawal by Subject|0
1119183|NCT01668797|3670348|P2|Phase B (Stabilization Phase)|Withdrawal by Subject|60
1119184|NCT01668797|3670349|P1|Phase B (Stabilization Phase)|Withdrawal by Subject|0
1119185|NCT01668797|3670346|P4|Phase B (Stabilization Phase)|Physician Decision|0
1119186|NCT01668797|3670347|P3|Phase B (Stabilization Phase)|Physician Decision|0
1119187|NCT01668797|3670348|P2|Phase B (Stabilization Phase)|Physician Decision|11
1119188|NCT01668797|3670349|P1|Phase B (Stabilization Phase)|Physician Decision|0
1119189|NCT01668797|3670346|P4|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
1119190|NCT01668797|3670347|P3|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
1119191|NCT01668797|3670348|P2|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22
1119192|NCT01668797|3670349|P1|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
1119193|NCT01668797|3670346|P4|Phase B (Stabilization Phase)|Lost to Follow-up|0
1119194|NCT01668797|3670347|P3|Phase B (Stabilization Phase)|Lost to Follow-up|0
1119195|NCT01668797|3670348|P2|Phase B (Stabilization Phase)|Lost to Follow-up|16
1119196|NCT01668797|3670349|P1|Phase B (Stabilization Phase)|Lost to Follow-up|0
1119197|NCT01668797|3670346|P4|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
1119198|NCT01668797|3670347|P3|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
1119199|NCT01668797|3670348|P2|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
1119200|NCT01668797|3670349|P1|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19
1119201|NCT01668797|3670346|P4|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
1119202|NCT01668797|3670347|P3|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
1119203|NCT01668797|3670348|P2|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
1119204|NCT01668797|3670349|P1|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8
1119205|NCT01668797|3670346|P4|Phase A (Conversion Phase)|Lack of Efficacy|0
1119206|NCT01668797|3670347|P3|Phase A (Conversion Phase)|Lack of Efficacy|0
1119207|NCT01668797|3670348|P2|Phase A (Conversion Phase)|Lack of Efficacy|0
1119208|NCT01668797|3670349|P1|Phase A (Conversion Phase)|Lack of Efficacy|7
1119209|NCT01668797|3670346|P4|Phase A (Conversion Phase)|Protocol Violation|0
1119210|NCT01668797|3670347|P3|Phase A (Conversion Phase)|Protocol Violation|0
1119211|NCT01668797|3670348|P2|Phase A (Conversion Phase)|Protocol Violation|0
1119212|NCT01668797|3670349|P1|Phase A (Conversion Phase)|Protocol Violation|2
1119213|NCT01668797|3670346|P4|Phase A (Conversion Phase)|Withdrawal by Subject|0
1119214|NCT01668797|3670347|P3|Phase A (Conversion Phase)|Withdrawal by Subject|0
1119215|NCT01668797|3670348|P2|Phase A (Conversion Phase)|Withdrawal by Subject|0
1119216|NCT01668797|3670349|P1|Phase A (Conversion Phase)|Withdrawal by Subject|16
1119217|NCT01668797|3670346|P4|Phase A (Conversion Phase)|Physician Decision|0
1119218|NCT01668797|3670347|P3|Phase A (Conversion Phase)|Physician Decision|0
1119219|NCT01668797|3670348|P2|Phase A (Conversion Phase)|Physician Decision|0
1119220|NCT01668797|3670349|P1|Phase A (Conversion Phase)|Physician Decision|2
1119221|NCT01668797|3670346|P4|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
1119222|NCT01668797|3670347|P3|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
1119223|NCT01668797|3670348|P2|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
1119224|NCT01668797|3670349|P1|Phase A (Conversion Phase)|Met Withdrawal Criteria|3
1119225|NCT01668797|3670346|P4|Phase A (Conversion Phase)|Lost to Follow-up|0
1119226|NCT01668797|3670347|P3|Phase A (Conversion Phase)|Lost to Follow-up|0
1119227|NCT01668797|3670348|P2|Phase A (Conversion Phase)|Lost to Follow-up|0
1119228|NCT01668797|3670349|P1|Phase A (Conversion Phase)|Lost to Follow-up|3
1119229|NCT01668784|3670414|P2|Treated (Overall)|Not Specified|4
1119230|NCT01668784|3670415|P1|Treated (Overall)|Not Specified|0
1119231|NCT01668784|3670414|P2|Treated (Overall)|Maximal Clinical Benefit|3
1119232|NCT01668784|3670415|P1|Treated (Overall)|Maximal Clinical Benefit|2
1119233|NCT01668784|3670414|P2|Treated (Overall)|Withdrawal by Subject|3
1119234|NCT01668784|3670415|P1|Treated (Overall)|Withdrawal by Subject|2
1119235|NCT01668784|3670414|P2|Treated (Overall)|Request to Discontinue Study Treatment|18
1119236|NCT01668784|3670415|P1|Treated (Overall)|Request to Discontinue Study Treatment|5
1119237|NCT01668784|3670414|P2|Treated (Overall)|Adverse Event Unrelated to Study Drug|14
1119238|NCT01668784|3670415|P1|Treated (Overall)|Adverse Event Unrelated to Study Drug|9
1119239|NCT01668784|3670414|P2|Treated (Overall)|Death|1
1119240|NCT01668784|3670415|P1|Treated (Overall)|Death|1
1119241|NCT01668784|3670414|P2|Treated (Overall)|Study Drug Toxicity|53
1119242|NCT01668784|3670415|P1|Treated (Overall)|Study Drug Toxicity|35
1119243|NCT01668784|3670414|P2|Treated (Overall)|Disease Progression|273
1119244|NCT01668784|3670415|P1|Treated (Overall)|Disease Progression|285
1119245|NCT01668784|3670414|P2|Randomized (Pre-treatment)|Not Specified|1
1119246|NCT01668784|3670415|P1|Randomized (Pre-treatment)|Not Specified|0
1119247|NCT01668784|3670414|P2|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1
1119248|NCT01668784|3670415|P1|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2
1119249|NCT01668784|3670414|P2|Randomized (Pre-treatment)|Poor/Non-Compliance|0
1119250|NCT01668784|3670415|P1|Randomized (Pre-treatment)|Poor/Non-Compliance|1
1119251|NCT01668784|3670414|P2|Randomized (Pre-treatment)|Withdrawal by Subject|8
1119252|NCT01668784|3670415|P1|Randomized (Pre-treatment)|Withdrawal by Subject|1
1119253|NCT01668784|3670414|P2|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3
1119254|NCT01668784|3670415|P1|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0
1119255|NCT01668784|3670414|P2|Randomized (Pre-treatment)|Disease Progression|1
1119256|NCT01668784|3670415|P1|Randomized (Pre-treatment)|Disease Progression|0
1119257|NCT01668667|3670443|P4|Overall Study|Withdrawal by Subject|5
1119258|NCT01668667|3670444|P3|Overall Study|Withdrawal by Subject|5
1119259|NCT01668667|3670445|P2|Overall Study|Withdrawal by Subject|4
1119260|NCT01668667|3670446|P1|Overall Study|Withdrawal by Subject|7
1119261|NCT01668667|3670443|P4|Overall Study|Physician Decision|0
1119262|NCT01668667|3670444|P3|Overall Study|Physician Decision|1
1119263|NCT01668667|3670445|P2|Overall Study|Physician Decision|0
1119264|NCT01668667|3670446|P1|Overall Study|Physician Decision|3
1119265|NCT01668667|3670443|P4|Overall Study|Lost to Follow-up|6
1119266|NCT01668667|3670444|P3|Overall Study|Lost to Follow-up|7
1119267|NCT01668667|3670445|P2|Overall Study|Lost to Follow-up|4
1119268|NCT01668667|3670446|P1|Overall Study|Lost to Follow-up|9
1119269|NCT01668667|3670443|P4|Overall Study|Protocol Violation|5
1119270|NCT01668667|3670444|P3|Overall Study|Protocol Violation|12
1119271|NCT01668667|3670445|P2|Overall Study|Protocol Violation|10
1119272|NCT01668667|3670446|P1|Overall Study|Protocol Violation|6
1119273|NCT01668667|3670443|P4|Overall Study|Lack of Efficacy|3
1119274|NCT01668667|3670444|P3|Overall Study|Lack of Efficacy|2
1119275|NCT01668667|3670445|P2|Overall Study|Lack of Efficacy|2
1119276|NCT01668667|3670446|P1|Overall Study|Lack of Efficacy|3
1119277|NCT01668667|3670443|P4|Overall Study|Adverse Event|4
1119278|NCT01668667|3670444|P3|Overall Study|Adverse Event|4
1119279|NCT01668667|3670445|P2|Overall Study|Adverse Event|6
1119280|NCT01668667|3670446|P1|Overall Study|Adverse Event|3
1119281|NCT01668654|3670468|P1|Overall Study|Withdrawal by Subject|1
1119282|NCT01668654|3670468|P1|Overall Study|Study Closed/Terminated|3
1119283|NCT01668589|3670529|P4|Overall Study|Other|15
1119284|NCT01668589|3670530|P3|Overall Study|Other|7
1119285|NCT01668589|3670531|P2|Overall Study|Other|10
1119286|NCT01668589|3670532|P1|Overall Study|Other|44
1119287|NCT01668589|3670529|P4|Overall Study|Death|11
1119288|NCT01668589|3670530|P3|Overall Study|Death|2
1119289|NCT01668589|3670531|P2|Overall Study|Death|3
1119290|NCT01668589|3670532|P1|Overall Study|Death|12
1119291|NCT01668589|3670529|P4|Overall Study|Full Consent/Agreement Withdrawn|4
1119292|NCT01668589|3670530|P3|Overall Study|Full Consent/Agreement Withdrawn|11
1119293|NCT01668589|3670531|P2|Overall Study|Full Consent/Agreement Withdrawn|8
1119294|NCT01668589|3670532|P1|Overall Study|Full Consent/Agreement Withdrawn|54
1119295|NCT01668589|3670529|P4|Overall Study|Lost to Follow-up|5
1119296|NCT01668589|3670530|P3|Overall Study|Lost to Follow-up|15
1119297|NCT01668589|3670531|P2|Overall Study|Lost to Follow-up|37
1119298|NCT01668589|3670532|P1|Overall Study|Lost to Follow-up|29
1119299|NCT01668173|3670570|P1|Overall Study|Trial suspension|4
1119300|NCT01668173|3670570|P1|Overall Study|Adverse Event|3
1119301|NCT01668004|3670696|P1|Overall Study|Non-compliance with treatment|2
1119302|NCT01668004|3670696|P1|Overall Study|Lack of Efficacy|9
1119303|NCT01668004|3670696|P1|Overall Study|Lost to Follow-up|5
1119304|NCT01668004|3670696|P1|Overall Study|Withdrawal by Subject|2
1119305|NCT01668004|3670696|P1|Overall Study|Adverse Event|7
1119306|NCT01667926|3670718|P3|Overall Study|Side effects|0
1119307|NCT01667926|3670719|P2|Overall Study|Side effects|0
1119308|NCT01667926|3670720|P1|Overall Study|Side effects|3
1119309|NCT01667926|3670718|P3|Overall Study|Lost to Follow-up|1
1119310|NCT01667926|3670719|P2|Overall Study|Lost to Follow-up|2
1119311|NCT01667926|3670720|P1|Overall Study|Lost to Follow-up|1
1119312|NCT01667926|3670718|P3|Overall Study|Inclusion/Exclusion Criteria|5
1119313|NCT01667926|3670719|P2|Overall Study|Inclusion/Exclusion Criteria|0
1119314|NCT01667926|3670720|P1|Overall Study|Inclusion/Exclusion Criteria|0
1119315|NCT01667926|3670718|P3|Overall Study|Time committment|2
1119316|NCT01667926|3670719|P2|Overall Study|Time committment|0
1119317|NCT01667926|3670720|P1|Overall Study|Time committment|0
1119318|NCT01667926|3670718|P3|Overall Study|Physician Decision|1
1119319|NCT01667926|3670719|P2|Overall Study|Physician Decision|0
1119320|NCT01667926|3670720|P1|Overall Study|Physician Decision|0
1119321|NCT01667926|3670718|P3|Overall Study|Withdrawal by Subject|2
1119322|NCT01667926|3670719|P2|Overall Study|Withdrawal by Subject|2
1119323|NCT01667926|3670720|P1|Overall Study|Withdrawal by Subject|1
1119324|NCT01667900|3670733|P20|Part B|Death|0
1119325|NCT01667900|3670734|P19|Part B|Death|0
1119326|NCT01667900|3670735|P18|Part B|Death|0
1119327|NCT01667900|3670736|P17|Part B|Death|1
1119328|NCT01667900|3670737|P16|Part B|Death|0
1119329|NCT01667900|3670738|P15|Part B|Death|0
1119330|NCT01667900|3670739|P14|Part B|Death|0
1119331|NCT01667900|3670740|P13|Part B|Death|0
1119332|NCT01667900|3670741|P12|Part B|Death|0
1119333|NCT01667900|3670742|P11|Part B|Death|0
1119334|NCT01667900|3670743|P10|Part B|Death|0
1119335|NCT01667900|3670744|P9|Part B|Death|0
1119336|NCT01667900|3670745|P8|Part B|Death|0
1119337|NCT01667900|3670746|P7|Part B|Death|0
1119344|NCT01667731|3670822|P5|Overall Study|Death|0
1119345|NCT01667731|3670823|P4|Overall Study|Death|0
1119346|NCT01667731|3670824|P3|Overall Study|Death|0
1119347|NCT01667731|3670825|P2|Overall Study|Death|1
1119348|NCT01667731|3670826|P1|Overall Study|Death|0
1119349|NCT01667731|3670822|P5|Overall Study|Subject Withdrew Consent|1
1119350|NCT01667731|3670823|P4|Overall Study|Subject Withdrew Consent|0
1119351|NCT01667731|3670824|P3|Overall Study|Subject Withdrew Consent|1
1119352|NCT01667731|3670825|P2|Overall Study|Subject Withdrew Consent|0
1119353|NCT01667731|3670826|P1|Overall Study|Subject Withdrew Consent|2
1119354|NCT01667731|3670822|P5|Overall Study|Lost to Follow-up|2
1119355|NCT01667731|3670823|P4|Overall Study|Lost to Follow-up|1
1119356|NCT01667731|3670824|P3|Overall Study|Lost to Follow-up|1
1119357|NCT01667731|3670825|P2|Overall Study|Lost to Follow-up|3
1119358|NCT01667731|3670826|P1|Overall Study|Lost to Follow-up|2
1119359|NCT01667731|3670822|P5|Overall Study|Efficacy Failure|24
1119360|NCT01667731|3670823|P4|Overall Study|Efficacy Failure|1
1119361|NCT01667731|3670824|P3|Overall Study|Efficacy Failure|0
1119362|NCT01667731|3670825|P2|Overall Study|Efficacy Failure|12
1119363|NCT01667731|3670826|P1|Overall Study|Efficacy Failure|1
1119364|NCT01667731|3670822|P5|Overall Study|Enrolled but not treated|1
1119365|NCT01667731|3670823|P4|Overall Study|Enrolled but not treated|0
1119366|NCT01667731|3670824|P3|Overall Study|Enrolled but not treated|0
1119367|NCT01667731|3670825|P2|Overall Study|Enrolled but not treated|0
1119368|NCT01667731|3670826|P1|Overall Study|Enrolled but not treated|0
1119369|NCT01667679|3670881|P2|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1
1119370|NCT01667679|3670882|P1|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0
1119371|NCT01667679|3670881|P2|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1
1119372|NCT01667679|3670882|P1|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0
1119373|NCT01667679|3670881|P2|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1
1119374|NCT01667679|3670882|P1|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0
1119375|NCT01667679|3670881|P2|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1
1119376|NCT01667679|3670882|P1|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0
1119377|NCT01667679|3670881|P2|Treatment Period 2 (<=12 Weeks)|Adverse Event|0
1119378|NCT01667679|3670882|P1|Treatment Period 2 (<=12 Weeks)|Adverse Event|1
1119379|NCT01667679|3670881|P2|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0
1119380|NCT01667679|3670882|P1|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1
1119381|NCT01667679|3670881|P2|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0
1119382|NCT01667679|3670882|P1|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1
1119383|NCT01667679|3670881|P2|Treatment Period 2 (<=12 Weeks)|Non-compliance|4
1119384|NCT01667679|3670882|P1|Treatment Period 2 (<=12 Weeks)|Non-compliance|3
1119385|NCT01667679|3670881|P2|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10
1119386|NCT01667679|3670882|P1|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8
1119387|NCT01667679|3670881|P2|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0
1119388|NCT01667679|3670882|P1|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2
1119389|NCT01667679|3670881|P2|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4
1119390|NCT01667679|3670882|P1|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6
1119391|NCT01667679|3670881|P2|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1
1119392|NCT01667679|3670882|P1|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0
1119393|NCT01667679|3670881|P2|Treatment Period 1 (<=12 Weeks)|Non-compliance|3
1119394|NCT01667679|3670882|P1|Treatment Period 1 (<=12 Weeks)|Non-compliance|0
1119395|NCT01667679|3670881|P2|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2
1119396|NCT01667679|3670882|P1|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0
1119397|NCT01667679|3670881|P2|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2
1119398|NCT01667679|3670882|P1|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0
1119399|NCT01667679|3670881|P2|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
1119400|NCT01667679|3670882|P1|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
1119401|NCT01667679|3670881|P2|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13
1119402|NCT01667679|3670882|P1|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6
1119403|NCT01667679|3670881|P2|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0
1119404|NCT01667679|3670882|P1|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1
1119405|NCT01667679|3670881|P2|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0
1119406|NCT01667679|3670882|P1|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2
1119407|NCT01667679|3670881|P2|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0
1119408|NCT01667679|3670882|P1|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2
1119409|NCT01667679|3670881|P2|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6
1119410|NCT01667679|3670882|P1|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2
1119411|NCT01667432|3670967|P1|Overall Study|Missing Information|4
1119412|NCT01667432|3670967|P1|Overall Study|Reason Not Specified|2
1119413|NCT01667432|3670967|P1|Overall Study|Principal Investigator Decision|1
1119414|NCT01667432|3670967|P1|Overall Study|Protocol Deviation|2
1119415|NCT01667432|3670967|P1|Overall Study|Adverse Event|1
1119416|NCT01667432|3670967|P1|Overall Study|Insufficient Therapeutic Response|4
1119417|NCT01667432|3670967|P1|Overall Study|Refused Treatment/Withdrew Consent|1
1119418|NCT01667432|3670967|P1|Overall Study|Lost to Follow-up|3
1119419|NCT01667432|3670967|P1|Overall Study|Moved to Another Center|3
1119420|NCT01667432|3670967|P1|Overall Study|Failure to Return|10
1119421|NCT01667432|3670967|P1|Overall Study|Premature Study Termination|26
1119422|NCT01667419|3670976|P4|Overall Study|Continued in ongoing study|60
1119423|NCT01667419|3670977|P3|Overall Study|Continued in ongoing study|65
1119424|NCT01667419|3670978|P2|Overall Study|Continued in ongoing study|116
1119425|NCT01667419|3670979|P1|Overall Study|Continued in ongoing study|121
1119426|NCT01667419|3670976|P4|Overall Study|Death|20
1119427|NCT01667419|3670977|P3|Overall Study|Death|19
1119428|NCT01667419|3670978|P2|Overall Study|Death|28
1119429|NCT01667419|3670979|P1|Overall Study|Death|16
1119430|NCT01667419|3670976|P4|Overall Study|Lost to Follow-up|2
1119431|NCT01667419|3670977|P3|Overall Study|Lost to Follow-up|0
1119432|NCT01667419|3670978|P2|Overall Study|Lost to Follow-up|5
1119433|NCT01667419|3670979|P1|Overall Study|Lost to Follow-up|2
1119434|NCT01667419|3670976|P4|Overall Study|Protocol Violation|0
1119435|NCT01667419|3670977|P3|Overall Study|Protocol Violation|0
1119436|NCT01667419|3670978|P2|Overall Study|Protocol Violation|0
1119437|NCT01667419|3670979|P1|Overall Study|Protocol Violation|1
1119438|NCT01667419|3670976|P4|Overall Study|Non-compliance|1
1119439|NCT01667419|3670977|P3|Overall Study|Non-compliance|0
1119440|NCT01667419|3670978|P2|Overall Study|Non-compliance|0
1119441|NCT01667419|3670979|P1|Overall Study|Non-compliance|0
1119442|NCT01667419|3670976|P4|Overall Study|Withdrawal by Subject|8
1119443|NCT01667419|3670977|P3|Overall Study|Withdrawal by Subject|9
1119444|NCT01667419|3670978|P2|Overall Study|Withdrawal by Subject|8
1119445|NCT01667419|3670979|P1|Overall Study|Withdrawal by Subject|15
1119446|NCT01667419|3670976|P4|Overall Study|Reason Not Specified|0
1119447|NCT01667419|3670977|P3|Overall Study|Reason Not Specified|0
1119448|NCT01667419|3670978|P2|Overall Study|Reason Not Specified|0
1119449|NCT01667419|3670979|P1|Overall Study|Reason Not Specified|2
1119450|NCT01667224|3671027|P2|Overall Study|Protocol Violation|1
1119451|NCT01667224|3671028|P1|Overall Study|Protocol Violation|1
1119452|NCT01667224|3671027|P2|Overall Study|Withdrawal by Subject|1
1119453|NCT01667224|3671028|P1|Overall Study|Withdrawal by Subject|3
1119454|NCT01667107|3671042|P2|Overall Study|Lack of Efficacy|1
1119455|NCT01667107|3671043|P1|Overall Study|Lack of Efficacy|0
1119456|NCT01667107|3671042|P2|Overall Study|Protocol Violation|1
1119457|NCT01667107|3671043|P1|Overall Study|Protocol Violation|0
1119458|NCT01667107|3671042|P2|Overall Study|Tolerability issues|2
1119459|NCT01667107|3671043|P1|Overall Study|Tolerability issues|0
1119460|NCT01667107|3671042|P2|Overall Study|Adverse Event|3
1119461|NCT01667107|3671043|P1|Overall Study|Adverse Event|4
1119462|NCT01666951|3671102|P2|Overall Study|Not dosed|1
1119463|NCT01666951|3671103|P1|Overall Study|Not dosed|1
1119464|NCT01666782|3671154|P2|Overall Study|Enrolled both years; year 1 data used|0
1119465|NCT01666782|3671155|P1|Overall Study|Enrolled both years; year 1 data used|4
1119466|NCT01666782|3671154|P2|Overall Study|Received 2 doses of vaccine|1
1119467|NCT01666782|3671155|P1|Overall Study|Received 2 doses of vaccine|0
1119468|NCT01666314|3671179|P4|Overall Study|Reason not Specified|5
1119469|NCT01666314|3671180|P3|Overall Study|Reason not Specified|5
1119470|NCT01666314|3671181|P2|Overall Study|Reason not Specified|7
1119471|NCT01666314|3671182|P1|Overall Study|Reason not Specified|10
1119472|NCT01666314|3671179|P4|Overall Study|Withdrawal by Subject|3
1119473|NCT01666314|3671180|P3|Overall Study|Withdrawal by Subject|2
1119474|NCT01666314|3671181|P2|Overall Study|Withdrawal by Subject|1
1119475|NCT01666314|3671182|P1|Overall Study|Withdrawal by Subject|1
1119476|NCT01666314|3671179|P4|Overall Study|Unsatisfactory Therapeutic Response|1
1119477|NCT01666314|3671180|P3|Overall Study|Unsatisfactory Therapeutic Response|1
1119478|NCT01666314|3671181|P2|Overall Study|Unsatisfactory Therapeutic Response|2
1119479|NCT01666314|3671182|P1|Overall Study|Unsatisfactory Therapeutic Response|7
1119480|NCT01666314|3671179|P4|Overall Study|Symptomatic Deterioration|0
1119481|NCT01666314|3671180|P3|Overall Study|Symptomatic Deterioration|2
1119482|NCT01666314|3671181|P2|Overall Study|Symptomatic Deterioration|0
1119483|NCT01666314|3671182|P1|Overall Study|Symptomatic Deterioration|1
1119484|NCT01666314|3671179|P4|Overall Study|Progressive Disease|20
1119485|NCT01666314|3671180|P3|Overall Study|Progressive Disease|19
1119486|NCT01666314|3671181|P2|Overall Study|Progressive Disease|9
1119487|NCT01666314|3671182|P1|Overall Study|Progressive Disease|11
1119488|NCT01666314|3671179|P4|Overall Study|Adverse Event|7
1119489|NCT01666314|3671180|P3|Overall Study|Adverse Event|7
1119490|NCT01666314|3671181|P2|Overall Study|Adverse Event|13
1119491|NCT01666314|3671182|P1|Overall Study|Adverse Event|3
1119492|NCT01666119|3671318|P1|Overall Study|Subject experiencing withdrawal symptoms|5
1119493|NCT01666119|3671318|P1|Overall Study|non compliance with study medication, pa|18
1119494|NCT01666119|3671318|P1|Overall Study|Lost to Follow-up|7
1119495|NCT01666119|3671318|P1|Overall Study|Withdrawal by Subject|16
1119496|NCT01666119|3671318|P1|Overall Study|Adverse Event|6
1119497|NCT01666002|3671325|P2|Overall Study|Lost to Follow-up|0
1119498|NCT01666002|3671326|P1|Overall Study|Lost to Follow-up|5
1119499|NCT01665911|3671347|P1|Overall Study|Adverse Event|1
1119500|NCT01665911|3671347|P1|Overall Study|Withdrawal by Subject|1
1119501|NCT01665911|3671347|P1|Overall Study|Protocol Violation|4
1119502|NCT01665807|3671356|P3|Overall Study|Withdrawal by Subject|1
1119503|NCT01665807|3671357|P2|Overall Study|Withdrawal by Subject|0
1119504|NCT01665807|3671358|P1|Overall Study|Withdrawal by Subject|2
1119505|NCT01665768|3671369|P1|Overall Study|Withdrawal by Subject|1
1119506|NCT01665768|3671369|P1|Overall Study|Lack of Efficacy|19
1119507|NCT01665768|3671369|P1|Overall Study|Adverse Event|3
1119508|NCT01665599|3671374|P1|Overall Study|Could Not Continue Due to Time Constrain|1
1119509|NCT01665599|3671374|P1|Overall Study|Participant Left for More Than 3 Months|1
1119510|NCT01665599|3671374|P1|Overall Study|Lost to Follow-up|2
1119511|NCT01665599|3671374|P1|Overall Study|Death|1
1119512|NCT01665599|3671374|P1|Overall Study|Investigator/Sponsor decision|1
1119513|NCT01665599|3671374|P1|Overall Study|Consent Withdrawn|1
1119514|NCT01665599|3671374|P1|Overall Study|Adverse Event|1
1119515|NCT01665430|3671410|P1|Overall Study|Other Unspecified|2
1119516|NCT01665430|3671410|P1|Overall Study|Withdrawal by Subject|6
1119517|NCT01665430|3671410|P1|Overall Study|Adverse Event|1
1119518|NCT01665144|3671508|P2|Overall Study|Withdrawal by Subject|77
1119519|NCT01665144|3671509|P1|Overall Study|Withdrawal by Subject|96
1119520|NCT01665144|3671508|P2|Overall Study|Adverse Event|18
1119521|NCT01665144|3671509|P1|Overall Study|Adverse Event|45
1119522|NCT01665144|3671508|P2|Overall Study|Lack of Efficacy|11
1119523|NCT01665144|3671509|P1|Overall Study|Lack of Efficacy|16
1119524|NCT01665144|3671508|P2|Overall Study|Physician Decision|1
1119525|NCT01665144|3671509|P1|Overall Study|Physician Decision|13
1119526|NCT01665144|3671508|P2|Overall Study|Lost to Follow-up|8
1119527|NCT01665144|3671509|P1|Overall Study|Lost to Follow-up|9
1119528|NCT01665144|3671508|P2|Overall Study|Progressive disease|4
1119529|NCT01665144|3671509|P1|Overall Study|Progressive disease|8
1119530|NCT01665144|3671508|P2|Overall Study|Non-compliance w/study treatment|0
1119531|NCT01665144|3671509|P1|Overall Study|Non-compliance w/study treatment|5
1119532|NCT01665144|3671508|P2|Overall Study|Protocol deviation|1
1119533|NCT01665144|3671509|P1|Overall Study|Protocol deviation|3
1119534|NCT01665144|3671508|P2|Overall Study|Death|1
1119535|NCT01665144|3671509|P1|Overall Study|Death|3
1119536|NCT01665144|3671508|P2|Overall Study|Technical problems|0
1119537|NCT01665144|3671509|P1|Overall Study|Technical problems|2
1119538|NCT01665144|3671508|P2|Overall Study|New therapy for study indication|1
1119539|NCT01665144|3671509|P1|Overall Study|New therapy for study indication|2
1119540|NCT01664949|3671567|P2|Overall Study|Other Miscellaneous Reasons|1
1119541|NCT01664949|3671568|P1|Overall Study|Other Miscellaneous Reasons|3
1119542|NCT01664949|3671567|P2|Overall Study|Protocol Violation|5
1119543|NCT01664949|3671568|P1|Overall Study|Protocol Violation|5
1119544|NCT01664949|3671567|P2|Overall Study|Personal Reasons|4
1119545|NCT01664949|3671568|P1|Overall Study|Personal Reasons|3
1119546|NCT01664949|3671567|P2|Overall Study|Lost to Follow-up|2
1119547|NCT01664949|3671568|P1|Overall Study|Lost to Follow-up|1
1119548|NCT01664949|3671567|P2|Overall Study|Lack of Efficacy|1
1119549|NCT01664949|3671568|P1|Overall Study|Lack of Efficacy|1
1119550|NCT01664949|3671567|P2|Overall Study|Adverse Event|12
1119551|NCT01664949|3671568|P1|Overall Study|Adverse Event|11
1119552|NCT01664923|3671584|P2|Overall Study|Miscellaneous|1
1119553|NCT01664923|3671585|P1|Overall Study|Miscellaneous|5
1119554|NCT01664923|3671584|P2|Overall Study|Adverse Event|12
1119555|NCT01664923|3671585|P1|Overall Study|Adverse Event|16
1119556|NCT01664923|3671584|P2|Overall Study|Disease Progression|139
1119557|NCT01664923|3671585|P1|Overall Study|Disease Progression|58
1119558|NCT01664923|3671584|P2|Overall Study|Withdrawal by Subject|5
1119559|NCT01664923|3671585|P1|Overall Study|Withdrawal by Subject|11
1119560|NCT01664923|3671584|P2|Overall Study|Protocol Violation|0
1119561|NCT01664923|3671585|P1|Overall Study|Protocol Violation|2
1119562|NCT01664923|3671584|P2|Overall Study|Lost to Follow-up|1
1119563|NCT01664923|3671585|P1|Overall Study|Lost to Follow-up|0
1119564|NCT01664923|3671584|P2|Overall Study|Death|0
1119565|NCT01664923|3671585|P1|Overall Study|Death|1
1119566|NCT01664624|3671648|P4|Overall Study|Adverse Event|0
1119567|NCT01664624|3671649|P3|Overall Study|Adverse Event|0
1119568|NCT01664624|3671650|P2|Overall Study|Adverse Event|1
1119569|NCT01664624|3671651|P1|Overall Study|Adverse Event|0
1119570|NCT01664533|3671698|P1|Overall Study|Protocol Violation|3
1119571|NCT01664533|3671698|P1|Overall Study|Study termination|9
1119572|NCT01664533|3671698|P1|Overall Study|Lost to Follow-up|3
1119573|NCT01664533|3671698|P1|Overall Study|Death|42
1119574|NCT01664494|3671706|P1|Overall Study|Lost to Follow-up|99
1119575|NCT01664494|3671706|P1|Overall Study|Not specified|49
1119576|NCT01664494|3671706|P1|Overall Study|Death|18
1119577|NCT01664494|3671706|P1|Overall Study|Withdrawal by Subject|27
1119578|NCT01664247|3671713|P2|Overall Study|Unclassified|29
1119579|NCT01664247|3671714|P1|Overall Study|Unclassified|5
1119580|NCT01664247|3671713|P2|Overall Study|Withdrawal Criteria|4
1119581|NCT01664247|3671714|P1|Overall Study|Withdrawal Criteria|1
1119582|NCT01664247|3671713|P2|Overall Study|Protocol Violation|5
1119583|NCT01664247|3671714|P1|Overall Study|Protocol Violation|3
1119584|NCT01664247|3671713|P2|Overall Study|Adverse Event|3
1119585|NCT01664247|3671714|P1|Overall Study|Adverse Event|5
1119586|NCT01664104|3671791|P1|Overall Study|Unknown: Reason Unrelated to TCZ|2
1119587|NCT01664104|3671791|P1|Overall Study|Other|1
1119588|NCT01664104|3671791|P1|Overall Study|Lost to Follow-up|4
1119589|NCT01664104|3671791|P1|Overall Study|Withdrawal by Subject|1
1119590|NCT01664104|3671791|P1|Overall Study|Lack of Efficacy|2
1119591|NCT01664104|3671791|P1|Overall Study|Adverse Event|6
1119592|NCT01664052|3671860|P2|Phase 2|No device placement|4
1119593|NCT01664052|3671861|P1|Phase 2|No device placement|0
1119594|NCT01664052|3671860|P2|Phase 1|No HSG 1 hr post placement|0
1119595|NCT01664052|3671861|P1|Phase 1|No HSG 1 hr post placement|1
1119596|NCT01664052|3671860|P2|Phase 1|No device placement|0
1119597|NCT01664052|3671861|P1|Phase 1|No device placement|6
1119598|NCT01664039|3671879|P2|Overall Study|Noncompliance|1
1119599|NCT01664039|3671880|P1|Overall Study|Noncompliance|1
1119600|NCT01664039|3671879|P2|Overall Study|Withdrawal by Subject|3
1119601|NCT01664039|3671880|P1|Overall Study|Withdrawal by Subject|1
1119602|NCT01664039|3671879|P2|Overall Study|Lost to Follow-up|1
1119603|NCT01664039|3671880|P1|Overall Study|Lost to Follow-up|1
1119604|NCT01664039|3671879|P2|Overall Study|Adverse Event|4
1119605|NCT01664039|3671880|P1|Overall Study|Adverse Event|3
1119606|NCT01663987|3671902|P2|Overall Study|Other reason not defined above|0
1119607|NCT01663987|3671903|P1|Overall Study|Other reason not defined above|3
1119608|NCT01663987|3671902|P2|Overall Study|Withdrawal by Subject|3
1119609|NCT01663987|3671903|P1|Overall Study|Withdrawal by Subject|2
1119610|NCT01663987|3671902|P2|Overall Study|Lost to Follow-up|1
1119611|NCT01663987|3671903|P1|Overall Study|Lost to Follow-up|1
1119612|NCT01663987|3671902|P2|Overall Study|Adverse Event|2
1119613|NCT01663987|3671903|P1|Overall Study|Adverse Event|7
1119614|NCT01663740|3671948|P2|Overall Study|No end of study status|0
1119615|NCT01663740|3671949|P1|Overall Study|No end of study status|3
1119616|NCT01663740|3671948|P2|Overall Study|Withdrawal by Subject|1
1119617|NCT01663740|3671949|P1|Overall Study|Withdrawal by Subject|2
1119618|NCT01663740|3671948|P2|Overall Study|Death|1
1119619|NCT01663740|3671949|P1|Overall Study|Death|0
1119620|NCT01663740|3671948|P2|Overall Study|Inclusion/Exclusion not met|0
1119621|NCT01663740|3671949|P1|Overall Study|Inclusion/Exclusion not met|1
1119622|NCT01663740|3671948|P2|Overall Study|Other|2
1119623|NCT01663740|3671949|P1|Overall Study|Other|9
1119624|NCT01663740|3671948|P2|Overall Study|Lost to Follow-up|4
1119625|NCT01663740|3671949|P1|Overall Study|Lost to Follow-up|1
1119626|NCT01663727|3672009|P2|Overall Study|Withdrawal prior to dosing.|0
1119627|NCT01663727|3672010|P1|Overall Study|Withdrawal prior to dosing.|1
1119628|NCT01663727|3672009|P2|Overall Study|Withdrawal by subject and Adverse Event.|0
1119629|NCT01663727|3672010|P1|Overall Study|Withdrawal by subject and Adverse Event.|1
1119630|NCT01663727|3672009|P2|Overall Study|Study Terminated|50
1119631|NCT01663727|3672010|P1|Overall Study|Study Terminated|51
1119632|NCT01663727|3672009|P2|Overall Study|Withdrawal by Subject|25
1119633|NCT01663727|3672010|P1|Overall Study|Withdrawal by Subject|18
1119634|NCT01663727|3672009|P2|Overall Study|Lost to Follow-up|8
1119635|NCT01663727|3672010|P1|Overall Study|Lost to Follow-up|10
1119636|NCT01663727|3672009|P2|Overall Study|Death|155
1119637|NCT01663727|3672010|P1|Overall Study|Death|161
1119638|NCT01663714|3672042|P1|Long-Term Follow-Up|Non-compliance|1
1119639|NCT01663714|3672042|P1|Long-Term Follow-Up|Death|4
1119640|NCT01663714|3672042|P1|Long-Term Follow-Up|Lost to Follow-up|1
1119641|NCT01663714|3672042|P1|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16
1119642|NCT01663714|3672042|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|11
1119643|NCT01663714|3672042|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
1119644|NCT01663636|3672071|P2|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31
1119645|NCT01663636|3672072|P1|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25
1119646|NCT01663623|3672080|P2|Overall Study|Withdrawal by Subject|1
1119647|NCT01663623|3672081|P1|Overall Study|Withdrawal by Subject|2
1119648|NCT01663623|3672080|P2|Overall Study|Physician Decision|4
1119649|NCT01663623|3672081|P1|Overall Study|Physician Decision|1
1119650|NCT01663623|3672080|P2|Overall Study|Other-Study closed/terminated|1
1119651|NCT01663623|3672081|P1|Overall Study|Other-Study closed/terminated|1
1119652|NCT01663623|3672080|P2|Overall Study|Protocol Violation|1
1119653|NCT01663623|3672081|P1|Overall Study|Protocol Violation|0
1119654|NCT01663623|3672080|P2|Overall Study|Lack of Efficacy|6
1119655|NCT01663623|3672081|P1|Overall Study|Lack of Efficacy|5
1119656|NCT01663623|3672080|P2|Overall Study|Adverse Event|7
1119657|NCT01663623|3672081|P1|Overall Study|Adverse Event|3
1119658|NCT01663532|3672091|P2|Overall Study|Lack of Efficacy|60
1119659|NCT01663532|3672092|P1|Overall Study|Lack of Efficacy|15
1119660|NCT01663532|3672091|P2|Overall Study|Withdrawal by Subject|17
1119661|NCT01663532|3672092|P1|Overall Study|Withdrawal by Subject|35
1119662|NCT01663532|3672091|P2|Overall Study|Physician Decision|1
1119663|NCT01663532|3672092|P1|Overall Study|Physician Decision|1
1119664|NCT01663532|3672091|P2|Overall Study|Met Withdrawal Criteria|6
1119665|NCT01663532|3672092|P1|Overall Study|Met Withdrawal Criteria|7
1119666|NCT01663532|3672091|P2|Overall Study|Adverse Event|13
1119667|NCT01663532|3672092|P1|Overall Study|Adverse Event|7
1119668|NCT01663532|3672091|P2|Overall Study|Lost to Follow-up|10
1119669|NCT01663532|3672092|P1|Overall Study|Lost to Follow-up|9
1119670|NCT01663506|3672110|P1|Overall Study|Switched to Subcutaneous Tocilizumab|2
1119671|NCT01663506|3672110|P1|Overall Study|Adverse Event|1
1119672|NCT01663506|3672110|P1|Overall Study|Lost to Follow-up|1
1119673|NCT01663506|3672110|P1|Overall Study|Consent Withdrawal by Subject|1
1119674|NCT01663506|3672110|P1|Overall Study|Lack of Efficacy|3
1119675|NCT01663233|3672159|P2|Overall Study|Lost to Follow-up|1
1119676|NCT01663233|3672160|P1|Overall Study|Lost to Follow-up|0
1119677|NCT01663233|3672159|P2|Overall Study|Protocol Deviation|4
1119678|NCT01663233|3672160|P1|Overall Study|Protocol Deviation|1
1119679|NCT01663233|3672159|P2|Overall Study|Withdrawal by Subject|2
1119680|NCT01663233|3672160|P1|Overall Study|Withdrawal by Subject|3
1119681|NCT01663103|3672184|P2|Overall Study|dog bite|0
1119682|NCT01663103|3672185|P1|Overall Study|dog bite|1
1119683|NCT01663103|3672184|P2|Overall Study|Adverse Event|0
1119684|NCT01663103|3672185|P1|Overall Study|Adverse Event|1
1119685|NCT01663103|3672184|P2|Overall Study|Withdrawal by Subject|2
1119686|NCT01663103|3672185|P1|Overall Study|Withdrawal by Subject|1
1119687|NCT01662999|3672213|P6|Period 3|Withdrawal by Subject|0
1119688|NCT01662999|3672214|P5|Period 3|Withdrawal by Subject|0
1119689|NCT01662999|3672215|P4|Period 3|Withdrawal by Subject|0
1119690|NCT01662999|3672216|P3|Period 3|Withdrawal by Subject|0
1119691|NCT01662999|3672217|P2|Period 3|Withdrawal by Subject|1
1119692|NCT01662999|3672218|P1|Period 3|Withdrawal by Subject|0
1119693|NCT01662986|3672289|P2|Overall Study|Other than stated above|0
1119694|NCT01662986|3672290|P1|Overall Study|Other than stated above|3
1119695|NCT01662986|3672289|P2|Overall Study|Not Treated|0
1119696|NCT01662986|3672290|P1|Overall Study|Not Treated|1
1119697|NCT01662986|3672289|P2|Overall Study|Withdrawal by Subject|2
1119698|NCT01662986|3672290|P1|Overall Study|Withdrawal by Subject|2
1119699|NCT01662986|3672289|P2|Overall Study|Lost to Follow-up|4
1119700|NCT01662986|3672290|P1|Overall Study|Lost to Follow-up|5
1119701|NCT01662986|3672289|P2|Overall Study|Protocol Violation|3
1119702|NCT01662986|3672290|P1|Overall Study|Protocol Violation|2
1119703|NCT01662986|3672289|P2|Overall Study|Adverse Event|4
1119704|NCT01662986|3672290|P1|Overall Study|Adverse Event|5
1119705|NCT01662648|3672412|P2|Overall Study|LOE and Participant non-compliant|1
1119706|NCT01662648|3672413|P1|Overall Study|LOE and Participant non-compliant|0
1119707|NCT01662648|3672412|P2|Overall Study|LOE and other reason unspecified|0
1119708|NCT01662648|3672413|P1|Overall Study|LOE and other reason unspecified|1
1119709|NCT01662648|3672412|P2|Overall Study|Adverse event and lack of efficacy (LOE)|0
1119710|NCT01662648|3672413|P1|Overall Study|Adverse event and lack of efficacy (LOE)|3
1119711|NCT01662648|3672412|P2|Overall Study|Other|11
1119712|NCT01662648|3672413|P1|Overall Study|Other|8
1119713|NCT01662648|3672412|P2|Overall Study|Participant non-compliant|20
1119714|NCT01662648|3672413|P1|Overall Study|Participant non-compliant|16
1119715|NCT01662648|3672412|P2|Overall Study|Withdrawal by Subject|53
1119716|NCT01662648|3672413|P1|Overall Study|Withdrawal by Subject|36
1119717|NCT01662648|3672412|P2|Overall Study|Lost to Follow-up|36
1119718|NCT01662648|3672413|P1|Overall Study|Lost to Follow-up|24
1119719|NCT01662648|3672412|P2|Overall Study|Participant ineligible to continue trial|1
1119720|NCT01662648|3672413|P1|Overall Study|Participant ineligible to continue trial|1
1119721|NCT01662648|3672412|P2|Overall Study|Lack of Efficacy|16
1119722|NCT01662648|3672413|P1|Overall Study|Lack of Efficacy|17
1119723|NCT01662648|3672412|P2|Overall Study|Adverse Event|37
1119724|NCT01662648|3672413|P1|Overall Study|Adverse Event|40
1119725|NCT01662648|3672412|P2|Overall Study|Death|3
1119726|NCT01662648|3672413|P1|Overall Study|Death|1
1119727|NCT01662635|3672435|P1|Overall Study|scarce samples for evaluation|30
1119728|NCT01662505|3672486|P3|Overall Study|Not specified above|2
1119729|NCT01662505|3672487|P2|Overall Study|Not specified above|3
1119730|NCT01662505|3672488|P1|Overall Study|Not specified above|1
1119731|NCT01662505|3672486|P3|Overall Study|Refused cont. medication|1
1119732|NCT01662505|3672487|P2|Overall Study|Refused cont. medication|0
1119733|NCT01662505|3672488|P1|Overall Study|Refused cont. medication|0
1119734|NCT01662505|3672486|P3|Overall Study|Progressive disease|5
1119735|NCT01662505|3672487|P2|Overall Study|Progressive disease|1
1119736|NCT01662505|3672488|P1|Overall Study|Progressive disease|6
1119737|NCT01662492|3672512|P3|Overall Study|Lack of Efficacy|2
1119738|NCT01662492|3672513|P2|Overall Study|Lack of Efficacy|1
1119739|NCT01662492|3672514|P1|Overall Study|Lack of Efficacy|1
1119740|NCT01662492|3672512|P3|Overall Study|Lost to Follow-up|2
1119741|NCT01662492|3672513|P2|Overall Study|Lost to Follow-up|0
1119742|NCT01662492|3672514|P1|Overall Study|Lost to Follow-up|0
1119743|NCT01662492|3672512|P3|Overall Study|Protocol Violation|0
1119744|NCT01662492|3672513|P2|Overall Study|Protocol Violation|0
1119745|NCT01662492|3672514|P1|Overall Study|Protocol Violation|1
1119746|NCT01662492|3672512|P3|Overall Study|Withdrawal by Subject|1
1119747|NCT01662492|3672513|P2|Overall Study|Withdrawal by Subject|0
1119748|NCT01662492|3672514|P1|Overall Study|Withdrawal by Subject|0
1119749|NCT01662492|3672512|P3|Overall Study|Other miscellaneous reasons.|1
1119750|NCT01662492|3672513|P2|Overall Study|Other miscellaneous reasons.|0
1119751|NCT01662492|3672514|P1|Overall Study|Other miscellaneous reasons.|1
1119752|NCT01662440|3672538|P4|Overall Study|Withdrawal by Subject|2
1119753|NCT01662440|3672539|P3|Overall Study|Withdrawal by Subject|2
1119754|NCT01662440|3672540|P2|Overall Study|Withdrawal by Subject|2
1119755|NCT01662440|3672541|P1|Overall Study|Withdrawal by Subject|5
1119756|NCT01662440|3672538|P4|Overall Study|Protocol Violation|0
1119757|NCT01662440|3672539|P3|Overall Study|Protocol Violation|0
1119758|NCT01662440|3672540|P2|Overall Study|Protocol Violation|0
1119759|NCT01662440|3672541|P1|Overall Study|Protocol Violation|1
1119760|NCT01662440|3672538|P4|Overall Study|Subject moved to another country.|0
1119761|NCT01662440|3672539|P3|Overall Study|Subject moved to another country.|0
1119762|NCT01662440|3672540|P2|Overall Study|Subject moved to another country.|1
1119763|NCT01662440|3672541|P1|Overall Study|Subject moved to another country.|0
1119764|NCT01662440|3672538|P4|Overall Study|Lost to Follow-up|1
1119765|NCT01662440|3672539|P3|Overall Study|Lost to Follow-up|4
1119766|NCT01662440|3672540|P2|Overall Study|Lost to Follow-up|2
1119767|NCT01662440|3672541|P1|Overall Study|Lost to Follow-up|2
1119768|NCT01662440|3672538|P4|Overall Study|Death|0
1119769|NCT01662440|3672539|P3|Overall Study|Death|0
1119770|NCT01662440|3672540|P2|Overall Study|Death|1
1119771|NCT01662440|3672541|P1|Overall Study|Death|0
1119772|NCT01662440|3672538|P4|Overall Study|Adverse Event|1
1119773|NCT01662440|3672539|P3|Overall Study|Adverse Event|0
1119774|NCT01662440|3672540|P2|Overall Study|Adverse Event|0
1119775|NCT01662440|3672541|P1|Overall Study|Adverse Event|1
1119776|NCT01662362|3672589|P1|Overall Study|Lost to Follow-up|38
1119777|NCT01662336|3672594|P1|Overall Study|Withdrawal by Subject|6
1119778|NCT01662336|3672594|P1|Overall Study|Other|29
1119779|NCT01662336|3672594|P1|Overall Study|No longer on LPV/r|30
1119780|NCT01662336|3672594|P1|Overall Study|Adverse Event|1
1119781|NCT01662310|3672620|P5|Open-Label Extension Phase|Withdrawal by Subject|7
1119782|NCT01662310|3672621|P4|Open-Label Extension Phase|Withdrawal by Subject|2
1119783|NCT01662310|3672622|P3|Open-Label Extension Phase|Withdrawal by Subject|0
1119784|NCT01662310|3672623|P2|Open-Label Extension Phase|Withdrawal by Subject|0
1119785|NCT01662310|3672624|P1|Open-Label Extension Phase|Withdrawal by Subject|0
1119786|NCT01662310|3672620|P5|Open-Label Extension Phase|Pregnancy|0
1119787|NCT01662310|3672621|P4|Open-Label Extension Phase|Pregnancy|1
1119788|NCT01662310|3672622|P3|Open-Label Extension Phase|Pregnancy|0
1119789|NCT01662310|3672623|P2|Open-Label Extension Phase|Pregnancy|0
1119790|NCT01662310|3672624|P1|Open-Label Extension Phase|Pregnancy|0
1119791|NCT01662310|3672620|P5|Open-Label Extension Phase|Lost to Follow-up|1
1119792|NCT01662310|3672621|P4|Open-Label Extension Phase|Lost to Follow-up|2
1119793|NCT01662310|3672622|P3|Open-Label Extension Phase|Lost to Follow-up|0
1119794|NCT01662310|3672623|P2|Open-Label Extension Phase|Lost to Follow-up|0
1119795|NCT01662310|3672624|P1|Open-Label Extension Phase|Lost to Follow-up|0
1119796|NCT01662310|3672620|P5|Open-Label Extension Phase|Lack of Efficacy|2
1119797|NCT01662310|3672621|P4|Open-Label Extension Phase|Lack of Efficacy|2
1119798|NCT01662310|3672622|P3|Open-Label Extension Phase|Lack of Efficacy|0
1119799|NCT01662310|3672623|P2|Open-Label Extension Phase|Lack of Efficacy|0
1119800|NCT01662310|3672624|P1|Open-Label Extension Phase|Lack of Efficacy|0
1119801|NCT01662310|3672620|P5|Open-Label Extension Phase|Death|0
1119802|NCT01662310|3672621|P4|Open-Label Extension Phase|Death|1
1119803|NCT01662310|3672622|P3|Open-Label Extension Phase|Death|0
1119804|NCT01662310|3672623|P2|Open-Label Extension Phase|Death|0
1119805|NCT01662310|3672624|P1|Open-Label Extension Phase|Death|0
1119806|NCT01662310|3672620|P5|Open-Label Extension Phase|Adverse Event|0
1119807|NCT01662310|3672621|P4|Open-Label Extension Phase|Adverse Event|3
1119808|NCT01662310|3672622|P3|Open-Label Extension Phase|Adverse Event|0
1119809|NCT01662310|3672623|P2|Open-Label Extension Phase|Adverse Event|0
1119810|NCT01662310|3672624|P1|Open-Label Extension Phase|Adverse Event|0
1119811|NCT01662310|3672620|P5|Double-Blind Phase|Randomized but not treated|0
1119812|NCT01662310|3672621|P4|Double-Blind Phase|Randomized but not treated|0
1119813|NCT01662310|3672622|P3|Double-Blind Phase|Randomized but not treated|0
1119814|NCT01662310|3672623|P2|Double-Blind Phase|Randomized but not treated|1
1119815|NCT01662310|3672624|P1|Double-Blind Phase|Randomized but not treated|0
1119816|NCT01662310|3672620|P5|Double-Blind Phase|Other|0
1119817|NCT01662310|3672621|P4|Double-Blind Phase|Other|0
1119818|NCT01662310|3672622|P3|Double-Blind Phase|Other|1
1119819|NCT01662310|3672623|P2|Double-Blind Phase|Other|0
1119820|NCT01662310|3672624|P1|Double-Blind Phase|Other|0
1119821|NCT01662310|3672620|P5|Double-Blind Phase|Withdrawal by Subject|0
1119822|NCT01662310|3672621|P4|Double-Blind Phase|Withdrawal by Subject|0
1119823|NCT01662310|3672622|P3|Double-Blind Phase|Withdrawal by Subject|3
1119824|NCT01662310|3672623|P2|Double-Blind Phase|Withdrawal by Subject|9
1119825|NCT01662310|3672624|P1|Double-Blind Phase|Withdrawal by Subject|0
1119826|NCT01662310|3672620|P5|Double-Blind Phase|Pregnancy|0
1119827|NCT01662310|3672621|P4|Double-Blind Phase|Pregnancy|0
1119828|NCT01662310|3672622|P3|Double-Blind Phase|Pregnancy|0
1119829|NCT01662310|3672623|P2|Double-Blind Phase|Pregnancy|2
1119830|NCT01662310|3672624|P1|Double-Blind Phase|Pregnancy|0
1119831|NCT01662310|3672620|P5|Double-Blind Phase|Lost to Follow-up|0
1119832|NCT01662310|3672621|P4|Double-Blind Phase|Lost to Follow-up|0
1119833|NCT01662310|3672622|P3|Double-Blind Phase|Lost to Follow-up|0
1119834|NCT01662310|3672623|P2|Double-Blind Phase|Lost to Follow-up|3
1119835|NCT01662310|3672624|P1|Double-Blind Phase|Lost to Follow-up|0
1119836|NCT01662310|3672620|P5|Double-Blind Phase|Adverse Event|0
1119837|NCT01662310|3672621|P4|Double-Blind Phase|Adverse Event|0
1119838|NCT01662310|3672622|P3|Double-Blind Phase|Adverse Event|1
1119839|NCT01662310|3672623|P2|Double-Blind Phase|Adverse Event|0
1119840|NCT01662310|3672624|P1|Double-Blind Phase|Adverse Event|0
1119841|NCT01662310|3672620|P5|Run-In or Stabilization Phase|Other|0
1119842|NCT01662310|3672621|P4|Run-In or Stabilization Phase|Other|0
1119843|NCT01662310|3672622|P3|Run-In or Stabilization Phase|Other|0
1119844|NCT01662310|3672623|P2|Run-In or Stabilization Phase|Other|0
1119845|NCT01662310|3672624|P1|Run-In or Stabilization Phase|Other|1
1119846|NCT01662310|3672620|P5|Run-In or Stabilization Phase|Withdrawal by Subject|0
1119847|NCT01662310|3672621|P4|Run-In or Stabilization Phase|Withdrawal by Subject|0
1119848|NCT01662310|3672622|P3|Run-In or Stabilization Phase|Withdrawal by Subject|0
1119849|NCT01662310|3672623|P2|Run-In or Stabilization Phase|Withdrawal by Subject|0
1119850|NCT01662310|3672624|P1|Run-In or Stabilization Phase|Withdrawal by Subject|25
1119851|NCT01662310|3672620|P5|Run-In or Stabilization Phase|Protocol Violation|0
1119852|NCT01662310|3672621|P4|Run-In or Stabilization Phase|Protocol Violation|0
1119853|NCT01662310|3672622|P3|Run-In or Stabilization Phase|Protocol Violation|0
1119854|NCT01662310|3672623|P2|Run-In or Stabilization Phase|Protocol Violation|0
1119855|NCT01662310|3672624|P1|Run-In or Stabilization Phase|Protocol Violation|15
1119856|NCT01662310|3672620|P5|Run-In or Stabilization Phase|Lost to Follow-up|0
1119857|NCT01662310|3672621|P4|Run-In or Stabilization Phase|Lost to Follow-up|0
1119858|NCT01662310|3672622|P3|Run-In or Stabilization Phase|Lost to Follow-up|0
1119859|NCT01662310|3672623|P2|Run-In or Stabilization Phase|Lost to Follow-up|0
1119860|NCT01662310|3672624|P1|Run-In or Stabilization Phase|Lost to Follow-up|4
1119861|NCT01662310|3672620|P5|Run-In or Stabilization Phase|Lack of Efficacy|0
1119862|NCT01662310|3672621|P4|Run-In or Stabilization Phase|Lack of Efficacy|0
1119863|NCT01662310|3672622|P3|Run-In or Stabilization Phase|Lack of Efficacy|0
1119864|NCT01662310|3672623|P2|Run-In or Stabilization Phase|Lack of Efficacy|0
1119865|NCT01662310|3672624|P1|Run-In or Stabilization Phase|Lack of Efficacy|9
1119866|NCT01662310|3672620|P5|Run-In or Stabilization Phase|Adverse Event|0
1119867|NCT01662310|3672621|P4|Run-In or Stabilization Phase|Adverse Event|0
1119868|NCT01662310|3672622|P3|Run-In or Stabilization Phase|Adverse Event|0
1119869|NCT01662310|3672623|P2|Run-In or Stabilization Phase|Adverse Event|0
1119870|NCT01662310|3672624|P1|Run-In or Stabilization Phase|Adverse Event|11
1119871|NCT01662102|3672705|P2|Overall Study|Sponsor's decision|0
1119872|NCT01662102|3672706|P1|Overall Study|Sponsor's decision|1
1119873|NCT01662063|3672714|P3|Overall Study|Not Specified|0
1119874|NCT01662063|3672715|P2|Overall Study|Not Specified|1
1119875|NCT01662063|3672716|P1|Overall Study|Not Specified|0
1119876|NCT01662063|3672714|P3|Overall Study|Physician Decision|0
1119877|NCT01662063|3672715|P2|Overall Study|Physician Decision|2
1119878|NCT01662063|3672716|P1|Overall Study|Physician Decision|0
1119879|NCT01662063|3672714|P3|Overall Study|Withdrawal by Subject|1
1119880|NCT01662063|3672715|P2|Overall Study|Withdrawal by Subject|4
1119881|NCT01662063|3672716|P1|Overall Study|Withdrawal by Subject|2
1119882|NCT01662063|3672714|P3|Overall Study|Protocol Violation|0
1119883|NCT01662063|3672715|P2|Overall Study|Protocol Violation|0
1119884|NCT01662063|3672716|P1|Overall Study|Protocol Violation|1
1119885|NCT01662063|3672714|P3|Overall Study|Lost to Follow-up|0
1119886|NCT01662063|3672715|P2|Overall Study|Lost to Follow-up|4
1119887|NCT01662063|3672716|P1|Overall Study|Lost to Follow-up|0
1119888|NCT01662063|3672714|P3|Overall Study|Lack of Efficacy|0
1119889|NCT01662063|3672715|P2|Overall Study|Lack of Efficacy|6
1119890|NCT01662063|3672716|P1|Overall Study|Lack of Efficacy|1
1119891|NCT01662063|3672714|P3|Overall Study|Adverse Event or Intercurrent Illness|0
1119892|NCT01662063|3672715|P2|Overall Study|Adverse Event or Intercurrent Illness|12
1119893|NCT01662063|3672716|P1|Overall Study|Adverse Event or Intercurrent Illness|1
1119894|NCT01662024|3672795|P1|Overall Study|Withdrawal by Subject|3
1119895|NCT01662024|3672795|P1|Overall Study|Pregnancy|2
1119896|NCT01661972|3672807|P2|Overall Study|Withdrawal by Subject|1
1119897|NCT01661972|3672808|P1|Overall Study|Withdrawal by Subject|0
1119898|NCT01661972|3672807|P2|Overall Study|Death during Treatment period|1
1119899|NCT01661972|3672808|P1|Overall Study|Death during Treatment period|1
1119900|NCT01661972|3672807|P2|Overall Study|Adverse Event|2
1119901|NCT01661972|3672808|P1|Overall Study|Adverse Event|1
1119902|NCT01661933|3672818|P1|High-dose Gluten Challenge|Withdrawal by Subject|2
1119903|NCT01661933|3672818|P1|Low-dose Gluten Challenge|Physician Decision|2
1119904|NCT01661881|3672825|P1|Overall Study|Disease Progression|1
1119905|NCT01661790|3672833|P2|Overall Study|Lost to Follow-up|2
1119906|NCT01661790|3672834|P1|Overall Study|Lost to Follow-up|0
1119907|NCT01661595|3672959|P4|Phase 2: Week 5-8.|Protocol Violation|0
1119908|NCT01661595|3672960|P3|Phase 2: Week 5-8.|Protocol Violation|1
1119909|NCT01661595|3672961|P2|Phase 2: Week 5-8.|Protocol Violation|0
1119910|NCT01661595|3672962|P1|Phase 2: Week 5-8.|Protocol Violation|0
1119911|NCT01661595|3672959|P4|Phase 1: Week 0-4|Adverse Event|0
1119912|NCT01661595|3672960|P3|Phase 1: Week 0-4|Adverse Event|0
1119913|NCT01661595|3672961|P2|Phase 1: Week 0-4|Adverse Event|0
1119914|NCT01661595|3672962|P1|Phase 1: Week 0-4|Adverse Event|1
1119915|NCT01661205|3673081|P1|Overall Study|Physician Decision|2
1119916|NCT01661179|3673092|P1|Overall Study|Other Eligibility criteria|4
1119917|NCT01661179|3673092|P1|Overall Study|Withdrawal by Subject|1
1119918|NCT01661179|3673092|P1|Overall Study|Death|1
1119919|NCT01661140|3673096|P3|Double-Blind Period|Administrative/Other|6
1119920|NCT01661140|3673097|P2|Double-Blind Period|Administrative/Other|7
1119921|NCT01661140|3673098|P1|Double-Blind Period|Administrative/Other|0
1119922|NCT01661140|3673096|P3|Double-Blind Period|Sponsor Termination|17
1119923|NCT01661140|3673097|P2|Double-Blind Period|Sponsor Termination|14
1119924|NCT01661140|3673098|P1|Double-Blind Period|Sponsor Termination|0
1119925|NCT01661140|3673096|P3|Double-Blind Period|Investigator's Decision|2
1119926|NCT01661140|3673097|P2|Double-Blind Period|Investigator's Decision|1
1119927|NCT01661140|3673098|P1|Double-Blind Period|Investigator's Decision|0
1119928|NCT01661140|3673096|P3|Double-Blind Period|Withdrawal by Subject|3
1119929|NCT01661140|3673097|P2|Double-Blind Period|Withdrawal by Subject|1
1119930|NCT01661140|3673098|P1|Double-Blind Period|Withdrawal by Subject|0
1119931|NCT01661140|3673096|P3|Double-Blind Period|Protocol Violation|3
1119932|NCT01661140|3673097|P2|Double-Blind Period|Protocol Violation|2
1119933|NCT01661140|3673098|P1|Double-Blind Period|Protocol Violation|0
1119934|NCT01661140|3673096|P3|Double-Blind Period|Adverse Event|18
1119935|NCT01661140|3673097|P2|Double-Blind Period|Adverse Event|16
1119936|NCT01661140|3673098|P1|Double-Blind Period|Adverse Event|0
1119937|NCT01661140|3673096|P3|Double-Blind Period|Refused Treatment|1
1119938|NCT01661140|3673097|P2|Double-Blind Period|Refused Treatment|0
1119939|NCT01661140|3673098|P1|Double-Blind Period|Refused Treatment|0
1119940|NCT01661140|3673096|P3|Open-Label Period|Lost to Follow-up|0
1119941|NCT01661140|3673097|P2|Open-Label Period|Lost to Follow-up|0
1119942|NCT01661140|3673098|P1|Open-Label Period|Lost to Follow-up|2
1119943|NCT01661140|3673096|P3|Open-Label Period|Did not meet EULAR criteria|0
1119944|NCT01661140|3673097|P2|Open-Label Period|Did not meet EULAR criteria|0
1119945|NCT01661140|3673098|P1|Open-Label Period|Did not meet EULAR criteria|1
1119946|NCT01661140|3673096|P3|Open-Label Period|Sponsor termination|0
1119947|NCT01661140|3673097|P2|Open-Label Period|Sponsor termination|0
1119948|NCT01661140|3673098|P1|Open-Label Period|Sponsor termination|16
1119949|NCT01661140|3673096|P3|Open-Label Period|Administrative/Other|0
1119950|NCT01661140|3673097|P2|Open-Label Period|Administrative/Other|0
1119951|NCT01661140|3673098|P1|Open-Label Period|Administrative/Other|1
1119952|NCT01661140|3673096|P3|Open-Label Period|Death|0
1119953|NCT01661140|3673097|P2|Open-Label Period|Death|0
1119954|NCT01661140|3673098|P1|Open-Label Period|Death|1
1119955|NCT01661140|3673096|P3|Open-Label Period|Investigator Decision|0
1119956|NCT01661140|3673097|P2|Open-Label Period|Investigator Decision|0
1119957|NCT01661140|3673098|P1|Open-Label Period|Investigator Decision|3
1119958|NCT01661140|3673096|P3|Open-Label Period|Withdrawal by Subject|0
1119959|NCT01661140|3673097|P2|Open-Label Period|Withdrawal by Subject|0
1119960|NCT01661140|3673098|P1|Open-Label Period|Withdrawal by Subject|5
1119961|NCT01661140|3673096|P3|Open-Label Period|Protocol Violation|0
1119962|NCT01661140|3673097|P2|Open-Label Period|Protocol Violation|0
1119963|NCT01661140|3673098|P1|Open-Label Period|Protocol Violation|3
1119964|NCT01661140|3673096|P3|Open-Label Period|Adverse Event|0
1119965|NCT01661140|3673097|P2|Open-Label Period|Adverse Event|0
1119966|NCT01661140|3673098|P1|Open-Label Period|Adverse Event|44
1119967|NCT01661062|3673150|P1|Overall Study|Withdrawal by Subject|2
1119968|NCT01661062|3673150|P1|Overall Study|Completed Treatment Off Study|3
1119969|NCT01660906|3673155|P1|Overall Study|Discontinued due to study drug toxicity|3
1119970|NCT01660763|3673238|P2|Overall Study|Patient ready for early discharge|4
1119971|NCT01660763|3673239|P1|Overall Study|Patient ready for early discharge|28
1119972|NCT01660763|3673238|P2|Overall Study|Withdrawal by Subject|0
1119973|NCT01660763|3673239|P1|Overall Study|Withdrawal by Subject|4
1119974|NCT01660763|3673238|P2|Overall Study|Protocol Violation|0
1119975|NCT01660763|3673239|P1|Overall Study|Protocol Violation|1
1119976|NCT01660763|3673238|P2|Overall Study|Adverse Event|7
1119977|NCT01660763|3673239|P1|Overall Study|Adverse Event|22
1119978|NCT01660763|3673238|P2|Overall Study|Lack of Efficacy|50
1119979|NCT01660763|3673239|P1|Overall Study|Lack of Efficacy|45
1119980|NCT01660451|3673287|P3|Overall Study|Ongoing with treatment|46
1119981|NCT01660451|3673288|P2|Overall Study|Ongoing with treatment|3
1119982|NCT01660451|3673289|P1|Overall Study|Ongoing with treatment|3
1119983|NCT01660451|3673287|P3|Overall Study|Withdrawal by Subject|16
1119984|NCT01660451|3673288|P2|Overall Study|Withdrawal by Subject|0
1119985|NCT01660451|3673289|P1|Overall Study|Withdrawal by Subject|1
1119986|NCT01660451|3673287|P3|Overall Study|Physician Decision|5
1119987|NCT01660451|3673288|P2|Overall Study|Physician Decision|2
1119988|NCT01660451|3673289|P1|Overall Study|Physician Decision|1
1119989|NCT01660451|3673287|P3|Overall Study|Protocol Deviation|1
1119990|NCT01660451|3673288|P2|Overall Study|Protocol Deviation|0
1119991|NCT01660451|3673289|P1|Overall Study|Protocol Deviation|0
1119992|NCT01660451|3673287|P3|Overall Study|Sponsor Decision|1
1119993|NCT01660451|3673288|P2|Overall Study|Sponsor Decision|0
1119994|NCT01660451|3673289|P1|Overall Study|Sponsor Decision|0
1119995|NCT01660451|3673287|P3|Overall Study|AE with Clinical PD|9
1119996|NCT01660451|3673288|P2|Overall Study|AE with Clinical PD|3
1119997|NCT01660451|3673289|P1|Overall Study|AE with Clinical PD|1
1119998|NCT01660451|3673287|P3|Overall Study|Adverse Event (AE) without Clinical PD|26
1119999|NCT01660451|3673288|P2|Overall Study|Adverse Event (AE) without Clinical PD|8
1120000|NCT01660451|3673289|P1|Overall Study|Adverse Event (AE) without Clinical PD|11
1120001|NCT01660451|3673287|P3|Overall Study|Protocol Violation|1
1120002|NCT01660451|3673288|P2|Overall Study|Protocol Violation|1
1120003|NCT01660451|3673289|P1|Overall Study|Protocol Violation|0
1120004|NCT01660412|3673317|P2|Overall Study|Protocol Violation|3
1120005|NCT01660412|3673318|P1|Overall Study|Protocol Violation|0
1120006|NCT01660334|3673324|P1|Overall Study|Lost to Follow-up|1
1120007|NCT01660022|3673567|P6|First Sequence (7 Days)|Protocol Violation|1
1120008|NCT01660022|3673568|P5|First Sequence (7 Days)|Protocol Violation|0
1120009|NCT01660022|3673569|P4|First Sequence (7 Days)|Protocol Violation|0
1120010|NCT01660022|3673570|P3|First Sequence (7 Days)|Protocol Violation|0
1120011|NCT01660022|3673571|P2|First Sequence (7 Days)|Protocol Violation|0
1120012|NCT01660022|3673572|P1|First Sequence (7 Days)|Protocol Violation|0
1120013|NCT01660022|3673567|P6|First Sequence (7 Days)|Adverse Event|3
1120014|NCT01660022|3673568|P5|First Sequence (7 Days)|Adverse Event|1
1120015|NCT01660022|3673569|P4|First Sequence (7 Days)|Adverse Event|0
1120016|NCT01660022|3673570|P3|First Sequence (7 Days)|Adverse Event|0
1120017|NCT01660022|3673571|P2|First Sequence (7 Days)|Adverse Event|0
1120018|NCT01660022|3673572|P1|First Sequence (7 Days)|Adverse Event|0
1120019|NCT01660022|3673567|P6|First Sequence (7 Days)|Withdrawal by Subject|0
1120020|NCT01660022|3673568|P5|First Sequence (7 Days)|Withdrawal by Subject|0
1120021|NCT01660022|3673569|P4|First Sequence (7 Days)|Withdrawal by Subject|1
1120022|NCT01660022|3673570|P3|First Sequence (7 Days)|Withdrawal by Subject|0
1120023|NCT01660022|3673571|P2|First Sequence (7 Days)|Withdrawal by Subject|1
1120024|NCT01660022|3673572|P1|First Sequence (7 Days)|Withdrawal by Subject|0
1120025|NCT01659996|3673631|P3|Overall Study|Withdrawal by Subject|5
1120026|NCT01659996|3673632|P2|Overall Study|Withdrawal by Subject|1
1120027|NCT01659996|3673633|P1|Overall Study|Withdrawal by Subject|4
1120028|NCT01659996|3673631|P3|Overall Study|Adverse Event|1
1120029|NCT01659996|3673632|P2|Overall Study|Adverse Event|0
1120030|NCT01659996|3673633|P1|Overall Study|Adverse Event|0
1120031|NCT01659996|3673631|P3|Overall Study|Lost to Follow-up|2
1120032|NCT01659996|3673632|P2|Overall Study|Lost to Follow-up|3
1120033|NCT01659996|3673633|P1|Overall Study|Lost to Follow-up|1
1120034|NCT01659996|3673631|P3|Overall Study|Protocol Violation|3
1120035|NCT01659996|3673632|P2|Overall Study|Protocol Violation|3
1120036|NCT01659996|3673633|P1|Overall Study|Protocol Violation|3
1120037|NCT01659853|3673665|P2|Washout , 3 to 7 Days|Protocol Violation|0
1120038|NCT01659853|3673666|P1|Washout , 3 to 7 Days|Protocol Violation|1
1120039|NCT01659853|3673665|P2|Washout , 3 to 7 Days|Adverse Event|0
1120040|NCT01659853|3673666|P1|Washout , 3 to 7 Days|Adverse Event|1
1120041|NCT01659736|3673676|P2|3-month Follow-up|Lost to Follow-up|1
1120042|NCT01659736|3673677|P1|3-month Follow-up|Lost to Follow-up|0
1120043|NCT01659736|3673676|P2|Treatment Period|Withdrawal by Subject|0
1120044|NCT01659736|3673677|P1|Treatment Period|Withdrawal by Subject|1
1120045|NCT01659736|3673676|P2|Treatment Period|Protocol Violation|1
1120046|NCT01659736|3673677|P1|Treatment Period|Protocol Violation|3
1120047|NCT01659736|3673676|P2|Treatment Period|Adverse Event|1
1120048|NCT01659736|3673677|P1|Treatment Period|Adverse Event|1
1120049|NCT01659567|3673691|P1|Overall Study|Other|13
1120050|NCT01659567|3673691|P1|Overall Study|Progression of the main disease|1
1120051|NCT01659567|3673691|P1|Overall Study|Withdrawal by Subject|64
1120052|NCT01659567|3673691|P1|Overall Study|Good result at early stage of treatment|5
1120053|NCT01659567|3673691|P1|Overall Study|Adverse Event|12
1120054|NCT01659567|3673691|P1|Overall Study|Switched to Pegferon|6
1120055|NCT01659567|3673691|P1|Overall Study|Lack of Efficacy|22
1120056|NCT01659554|3673708|P1|Overall Study|Study Termination|4
1120057|NCT01659320|3673715|P1|Overall Study|Physician Decision|1
1120058|NCT01659320|3673715|P1|Overall Study|Withdrawal by Subject|2
1120059|NCT01659125|3673734|P1|Overall Study|Failed to Start Treatment|2
1120060|NCT01659125|3673734|P1|Overall Study|Time Constraints|2
1120061|NCT01659125|3673734|P1|Overall Study|Technical Problem|1
1120062|NCT01659125|3673734|P1|Overall Study|Lost to Follow-up|7
1120063|NCT01659125|3673734|P1|Overall Study|Withdrawal by Subject|2
1120064|NCT01659021|3673741|P2|Overall Study|Still on Study|1
1120065|NCT01659021|3673742|P1|Overall Study|Still on Study|34
1120066|NCT01659021|3673741|P2|Overall Study|Withdrawal by Subject|16
1120067|NCT01659021|3673742|P1|Overall Study|Withdrawal by Subject|18
1120068|NCT01659021|3673741|P2|Overall Study|Physician Decision|16
1120069|NCT01659021|3673742|P1|Overall Study|Physician Decision|32
1120070|NCT01659021|3673741|P2|Overall Study|Other?|1
1120071|NCT01659021|3673742|P1|Overall Study|Other?|1
1120072|NCT01659021|3673741|P2|Overall Study|Lost to Follow-up|0
1120073|NCT01659021|3673742|P1|Overall Study|Lost to Follow-up|1
1120074|NCT01659021|3673741|P2|Overall Study|Adverse Event|3
1120075|NCT01659021|3673742|P1|Overall Study|Adverse Event|2
1120076|NCT01658943|3673760|P2|Overall Study|Withdrew prior to beginning protocol Tx|0
1120077|NCT01658943|3673761|P1|Overall Study|Withdrew prior to beginning protocol Tx|1
1120078|NCT01658943|3673760|P2|Overall Study|Not eligible|9
1120079|NCT01658943|3673761|P1|Overall Study|Not eligible|7
1120080|NCT01658943|3673760|P2|Overall Study|not protocol specified|1
1120081|NCT01658943|3673761|P1|Overall Study|not protocol specified|4
1120082|NCT01658943|3673760|P2|Overall Study|Death|2
1120083|NCT01658943|3673761|P1|Overall Study|Death|4
1120084|NCT01658943|3673760|P2|Overall Study|Progression/Relapse|40
1120085|NCT01658943|3673761|P1|Overall Study|Progression/Relapse|39
1120086|NCT01658943|3673760|P2|Overall Study|Withdrawal by Subject|2
1120087|NCT01658943|3673761|P1|Overall Study|Withdrawal by Subject|9
1120088|NCT01658943|3673760|P2|Overall Study|Adverse Event|13
1120089|NCT01658943|3673761|P1|Overall Study|Adverse Event|6
1120090|NCT01658904|3673776|P3|Overall Study|Principal Investigator discretion|0
1120091|NCT01658904|3673777|P2|Overall Study|Principal Investigator discretion|0
1120092|NCT01658904|3673778|P1|Overall Study|Principal Investigator discretion|2
1120093|NCT01658813|3673804|P1|Overall Study|Disease progression|3
1120094|NCT01658735|3673815|P3|Overall Study|Withdrawal by Subject|3
1120095|NCT01658735|3673816|P2|Overall Study|Withdrawal by Subject|5
1120096|NCT01658735|3673817|P1|Overall Study|Withdrawal by Subject|3
1120097|NCT01658735|3673815|P3|Overall Study|Protocol Violation|0
1120098|NCT01658735|3673816|P2|Overall Study|Protocol Violation|1
1120099|NCT01658735|3673817|P1|Overall Study|Protocol Violation|0
1120100|NCT01658735|3673815|P3|Overall Study|Lost to Follow-up|0
1120101|NCT01658735|3673816|P2|Overall Study|Lost to Follow-up|1
1120102|NCT01658735|3673817|P1|Overall Study|Lost to Follow-up|1
1120103|NCT01658735|3673815|P3|Overall Study|Lack of Efficacy|1
1120104|NCT01658735|3673816|P2|Overall Study|Lack of Efficacy|0
1120105|NCT01658735|3673817|P1|Overall Study|Lack of Efficacy|1
1120106|NCT01658579|3673859|P4|Treatment Period B|Other|1
1120107|NCT01658579|3673860|P3|Treatment Period B|Other|0
1120108|NCT01658579|3673861|P2|Treatment Period B|Other|0
1120109|NCT01658579|3673862|P1|Treatment Period B|Other|0
1120110|NCT01658579|3673859|P4|Treatment Period A|Adverse Event|0
1120111|NCT01658579|3673860|P3|Treatment Period A|Adverse Event|0
1120112|NCT01658579|3673861|P2|Treatment Period A|Adverse Event|0
1120113|NCT01658579|3673862|P1|Treatment Period A|Adverse Event|1
1120114|NCT01658579|3673859|P4|Treatment Period A|Other|1
1120115|NCT01658579|3673860|P3|Treatment Period A|Other|1
1120116|NCT01658579|3673861|P2|Treatment Period A|Other|0
1120117|NCT01658579|3673862|P1|Treatment Period A|Other|0
1120118|NCT01658514|3673890|P3|Overall Study|Protocol Violation|2
1120119|NCT01658514|3673891|P2|Overall Study|Protocol Violation|0
1120120|NCT01658514|3673892|P1|Overall Study|Protocol Violation|1
1120121|NCT01658436|3673903|P2|Overall Study|Death|0
1120122|NCT01658436|3673904|P1|Overall Study|Death|1
1120123|NCT01658436|3673903|P2|Overall Study|Subject/guardian decision|1
1120124|NCT01658436|3673904|P1|Overall Study|Subject/guardian decision|0
1120125|NCT01658436|3673903|P2|Overall Study|Study terminated by sponsor|1
1120126|NCT01658436|3673904|P1|Overall Study|Study terminated by sponsor|0
1120127|NCT01658436|3673903|P2|Overall Study|Progressive disease|4
1120128|NCT01658436|3673904|P1|Overall Study|Progressive disease|12
1120129|NCT01658436|3673903|P2|Overall Study|Physician Decision|0
1120130|NCT01658436|3673904|P1|Overall Study|Physician Decision|1
1120131|NCT01658436|3673903|P2|Overall Study|Adverse Event|5
1120132|NCT01658436|3673904|P1|Overall Study|Adverse Event|6
1120133|NCT01658150|3673924|P1|Overall Study|Withdrawal by Subject|1
1120134|NCT01658072|3673946|P2|Overall Study|Protocol Violation|2
1120135|NCT01658072|3673947|P1|Overall Study|Protocol Violation|4
1120136|NCT01658020|3673955|P2|Overall Study|Protocol Violation|1
1120137|NCT01658020|3673956|P1|Overall Study|Protocol Violation|0
1120138|NCT01658020|3673955|P2|Overall Study|Withdrawal by Subject|5
1120139|NCT01658020|3673956|P1|Overall Study|Withdrawal by Subject|4
1120140|NCT01658020|3673955|P2|Overall Study|Lost to Follow-up|0
1120141|NCT01658020|3673956|P1|Overall Study|Lost to Follow-up|1
1120142|NCT01658020|3673955|P2|Overall Study|Adverse Event|3
1120143|NCT01658020|3673956|P1|Overall Study|Adverse Event|3
1120144|NCT01657903|3673972|P1|Overall Study|Withdrawal by Subject|1
1120145|NCT01657903|3673972|P1|Overall Study|Lost to Follow-up|1
1120146|NCT01657877|3673994|P1|Overall Study|Other Reason|2
1120147|NCT01657877|3673994|P1|Overall Study|Adverse Event|2
1120148|NCT01657877|3673994|P1|Overall Study|Protocol Violation|6
1120149|NCT01657877|3673994|P1|Overall Study|Withdrawal by Subject|4
1120150|NCT01657799|3674014|P3|Overall Study|Other|49
1120151|NCT01657799|3674015|P2|Overall Study|Other|62
1120152|NCT01657799|3674016|P1|Overall Study|Other|52
1120153|NCT01657799|3674014|P3|Overall Study|Radiographic & Clinical Progression|15
1120154|NCT01657799|3674015|P2|Overall Study|Radiographic & Clinical Progression|11
1120155|NCT01657799|3674016|P1|Overall Study|Radiographic & Clinical Progression|16
1120156|NCT01657799|3674014|P3|Overall Study|Progressive Disease Clinical|7
1120157|NCT01657799|3674015|P2|Overall Study|Progressive Disease Clinical|4
1120158|NCT01657799|3674016|P1|Overall Study|Progressive Disease Clinical|7
1120159|NCT01657799|3674014|P3|Overall Study|Disease Progression|4
1120160|NCT01657799|3674015|P2|Overall Study|Disease Progression|4
1120161|NCT01657799|3674016|P1|Overall Study|Disease Progression|2
1120162|NCT01657799|3674014|P3|Overall Study|Lost to Follow-up|1
1120163|NCT01657799|3674015|P2|Overall Study|Lost to Follow-up|0
1120164|NCT01657799|3674016|P1|Overall Study|Lost to Follow-up|1
1120165|NCT01657799|3674014|P3|Overall Study|Withdrawal by Subject|10
1120166|NCT01657799|3674015|P2|Overall Study|Withdrawal by Subject|10
1120167|NCT01657799|3674016|P1|Overall Study|Withdrawal by Subject|13
1120168|NCT01657799|3674014|P3|Overall Study|Adverse Event Not Related to Progression|4
1120169|NCT01657799|3674015|P2|Overall Study|Adverse Event Not Related to Progression|4
1120170|NCT01657799|3674016|P1|Overall Study|Adverse Event Not Related to Progression|5
1120171|NCT01657799|3674014|P3|Overall Study|Adverse Event Related to progression|12
1120172|NCT01657799|3674015|P2|Overall Study|Adverse Event Related to progression|8
1120173|NCT01657799|3674016|P1|Overall Study|Adverse Event Related to progression|6
1120174|NCT01657461|3674040|P2|Overall Study|Withdrawal by Subject|3
1120175|NCT01657461|3674041|P1|Overall Study|Withdrawal by Subject|1
1120176|NCT01657461|3674040|P2|Overall Study|Physician Decision|2
1120177|NCT01657461|3674041|P1|Overall Study|Physician Decision|0
1120178|NCT01657461|3674040|P2|Overall Study|Lost to Follow-up|3
1120179|NCT01657461|3674041|P1|Overall Study|Lost to Follow-up|0
1120180|NCT01657461|3674040|P2|Overall Study|Death|12
1120181|NCT01657461|3674041|P1|Overall Study|Death|9
1120182|NCT01657370|3674071|P6|Overall Study|Lost to Follow-up|1
1120183|NCT01657370|3674072|P5|Overall Study|Lost to Follow-up|0
1120184|NCT01657370|3674073|P4|Overall Study|Lost to Follow-up|0
1120185|NCT01657370|3674074|P3|Overall Study|Lost to Follow-up|1
1120186|NCT01657370|3674075|P2|Overall Study|Lost to Follow-up|0
1120187|NCT01657370|3674076|P1|Overall Study|Lost to Follow-up|2
1120188|NCT01657370|3674071|P6|Overall Study|Protocol Violation|0
1120189|NCT01657370|3674072|P5|Overall Study|Protocol Violation|0
1120190|NCT01657370|3674073|P4|Overall Study|Protocol Violation|1
1120191|NCT01657370|3674074|P3|Overall Study|Protocol Violation|1
1120192|NCT01657370|3674075|P2|Overall Study|Protocol Violation|1
1120193|NCT01657370|3674076|P1|Overall Study|Protocol Violation|1
1120194|NCT01657370|3674071|P6|Overall Study|Adverse Event|0
1120195|NCT01657370|3674072|P5|Overall Study|Adverse Event|1
1120196|NCT01657370|3674073|P4|Overall Study|Adverse Event|0
1120197|NCT01657370|3674074|P3|Overall Study|Adverse Event|0
1120198|NCT01657370|3674075|P2|Overall Study|Adverse Event|0
1120199|NCT01657370|3674076|P1|Overall Study|Adverse Event|0
1120200|NCT01657370|3674071|P6|Overall Study|Lack of Qualifying Event|2
1120201|NCT01657370|3674072|P5|Overall Study|Lack of Qualifying Event|1
1120202|NCT01657370|3674073|P4|Overall Study|Lack of Qualifying Event|2
1120203|NCT01657370|3674074|P3|Overall Study|Lack of Qualifying Event|3
1120204|NCT01657370|3674075|P2|Overall Study|Lack of Qualifying Event|0
1120205|NCT01657370|3674076|P1|Overall Study|Lack of Qualifying Event|1
1120206|NCT01657370|3674071|P6|Overall Study|Physician Decision|0
1120207|NCT01657370|3674072|P5|Overall Study|Physician Decision|5
1120208|NCT01657370|3674073|P4|Overall Study|Physician Decision|2
1120209|NCT01657370|3674074|P3|Overall Study|Physician Decision|1
1120210|NCT01657370|3674075|P2|Overall Study|Physician Decision|3
1120211|NCT01657370|3674076|P1|Overall Study|Physician Decision|2
1120212|NCT01657370|3674071|P6|Overall Study|Withdrawal by Subject|1
1120213|NCT01657370|3674072|P5|Overall Study|Withdrawal by Subject|0
1120214|NCT01657370|3674073|P4|Overall Study|Withdrawal by Subject|0
1120215|NCT01657370|3674074|P3|Overall Study|Withdrawal by Subject|1
1120216|NCT01657370|3674075|P2|Overall Study|Withdrawal by Subject|0
1120217|NCT01657370|3674076|P1|Overall Study|Withdrawal by Subject|0
1120218|NCT01657305|3674158|P1|Overall Study|Did not Adhere to Protocol/Procedures|4
1120219|NCT01657305|3674158|P1|Overall Study|Lost to Follow-up|1
1120220|NCT01657305|3674158|P1|Overall Study|Adverse Event|1
1120221|NCT01657305|3674158|P1|Overall Study|Withdrawal by Subject|4
1120222|NCT01657305|3674158|P1|Overall Study|Lack of Wound Closure at Day 28|15
1120223|NCT01657292|3674208|P1|Overall Study|Change of therapy|1
1120224|NCT01657292|3674208|P1|Overall Study|Violation of eligibility criteria|1
1120225|NCT01657292|3674208|P1|Overall Study|Withdrawal by Subject|2
1120226|NCT01657292|3674208|P1|Overall Study|Adverse Event|6
1120227|NCT01657266|3674217|P2|Overall Study|Adverse Event|3
1120228|NCT01657266|3674218|P1|Overall Study|Adverse Event|2
1120229|NCT01657266|3674217|P2|Overall Study|Lost to Follow-up|2
1120230|NCT01657266|3674218|P1|Overall Study|Lost to Follow-up|2
1120231|NCT01657253|3674240|P2|Overall Study|Adverse Event|1
1120232|NCT01657253|3674241|P1|Overall Study|Adverse Event|0
1120233|NCT01657253|3674240|P2|Overall Study|Withdrawal by Subject|12
1120234|NCT01657253|3674241|P1|Overall Study|Withdrawal by Subject|11
1120235|NCT01657253|3674240|P2|Overall Study|Lost to Follow-up|5
1120236|NCT01657253|3674241|P1|Overall Study|Lost to Follow-up|6
1120237|NCT01657032|3674253|P2|Overall Study|Lost to Follow-up|7
1120238|NCT01657032|3674254|P1|Overall Study|Lost to Follow-up|0
1120239|NCT01657019|3674280|P1|Overall Study|Not Specified|58
1120240|NCT01657019|3674280|P1|Overall Study|Lack of Efficacy|3
1120241|NCT01657019|3674280|P1|Overall Study|Protocol Violation|6
1120242|NCT01657019|3674280|P1|Overall Study|Lost to Follow-up|48
1120243|NCT01657019|3674280|P1|Overall Study|Adverse Event|55
1120244|NCT01657019|3674280|P1|Overall Study|Withdrawal by Subject|65
1120245|NCT01656967|3674294|P2|Overall Study|unsuccessful ETT insertion|2
1120246|NCT01656967|3674295|P1|Overall Study|unsuccessful ETT insertion|3
1120247|NCT01656967|3674294|P2|Overall Study|faulty monitor|0
1120248|NCT01656967|3674295|P1|Overall Study|faulty monitor|1
1120249|NCT01656889|3674321|P2|Post Treatment Follow-Up, 3 Months|Site Closure|1
1120250|NCT01656889|3674322|P1|Post Treatment Follow-Up, 3 Months|Site Closure|0
1120251|NCT01656889|3674321|P2|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1
1120252|NCT01656889|3674322|P1|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2
1120253|NCT01656889|3674321|P2|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2
1120254|NCT01656889|3674322|P1|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1
1120255|NCT01656889|3674321|P2|Post Treatment Follow-Up, 3 Months|Death|5
1120256|NCT01656889|3674322|P1|Post Treatment Follow-Up, 3 Months|Death|1
1120257|NCT01656889|3674321|P2|Treatment Period, 12 Weeks|Moved out of the area|2
1120258|NCT01656889|3674322|P1|Treatment Period, 12 Weeks|Moved out of the area|0
1120259|NCT01656889|3674321|P2|Treatment Period, 12 Weeks|Protocol Violation|1
1120260|NCT01656889|3674322|P1|Treatment Period, 12 Weeks|Protocol Violation|0
1120261|NCT01656889|3674321|P2|Treatment Period, 12 Weeks|Withdrawal by Subject|2
1120262|NCT01656889|3674322|P1|Treatment Period, 12 Weeks|Withdrawal by Subject|1
1120263|NCT01656889|3674321|P2|Treatment Period, 12 Weeks|Lost to Follow-up|1
1120264|NCT01656889|3674322|P1|Treatment Period, 12 Weeks|Lost to Follow-up|1
1120265|NCT01656889|3674321|P2|Treatment Period, 12 Weeks|Death|1
1120266|NCT01656889|3674322|P1|Treatment Period, 12 Weeks|Death|0
1120267|NCT01656889|3674321|P2|Treatment Period, 12 Weeks|Adverse Event|4
1120268|NCT01656889|3674322|P1|Treatment Period, 12 Weeks|Adverse Event|10
1120269|NCT01656850|3674342|P2|First Intervention (3 Months)|Withdrawal by Subject|4
1120270|NCT01656850|3674343|P1|First Intervention (3 Months)|Withdrawal by Subject|3
1120271|NCT01656759|3674434|P2|Overall Study|Protocol Violation|3
1120272|NCT01656759|3674435|P1|Overall Study|Protocol Violation|2
1120273|NCT01656434|3674466|P2|Overall Study|Withdrawal by Subject|7
1120274|NCT01656434|3674467|P1|Overall Study|Withdrawal by Subject|64
1120275|NCT01656434|3674466|P2|Overall Study|Participant withdrew consent|9
1120276|NCT01656434|3674467|P1|Overall Study|Participant withdrew consent|28
1120277|NCT01656434|3674466|P2|Overall Study|Participant moved|12
1120278|NCT01656434|3674467|P1|Overall Study|Participant moved|40
1120279|NCT01656434|3674466|P2|Overall Study|Non-compliance with protocol|15
1120280|NCT01656434|3674467|P1|Overall Study|Non-compliance with protocol|39
1120281|NCT01656434|3674466|P2|Overall Study|Part. discontinued; unrelated to drug|10
1120282|NCT01656434|3674467|P1|Overall Study|Part. discontinued; unrelated to drug|55
1120283|NCT01656434|3674466|P2|Overall Study|Participant discontinued; drug related|4
1120284|NCT01656434|3674467|P1|Overall Study|Participant discontinued; drug related|13
1120285|NCT01656434|3674466|P2|Overall Study|Study terminated by sponsor|348
1120286|NCT01656434|3674467|P1|Overall Study|Study terminated by sponsor|1501
1120287|NCT01656434|3674466|P2|Overall Study|Non-compliance with study drug|9
1120288|NCT01656434|3674467|P1|Overall Study|Non-compliance with study drug|48
1120289|NCT01656434|3674466|P2|Overall Study|Physician Decision|2
1120290|NCT01656434|3674467|P1|Overall Study|Physician Decision|7
1120291|NCT01656434|3674466|P2|Overall Study|Pregnancy|10
1120292|NCT01656434|3674467|P1|Overall Study|Pregnancy|45
1120293|NCT01656434|3674466|P2|Overall Study|Pregnancy wish|6
1120294|NCT01656434|3674467|P1|Overall Study|Pregnancy wish|18
1120295|NCT01656434|3674466|P2|Overall Study|Protocol Violation|0
1120296|NCT01656434|3674467|P1|Overall Study|Protocol Violation|7
1120297|NCT01656434|3674466|P2|Overall Study|Screen failure|0
1120298|NCT01656434|3674467|P1|Overall Study|Screen failure|2
1120299|NCT01656434|3674466|P2|Overall Study|Site discontinued study participation|9
1120300|NCT01656434|3674467|P1|Overall Study|Site discontinued study participation|24
1120301|NCT01656434|3674466|P2|Overall Study|Lost to Follow-up|76
1120302|NCT01656434|3674467|P1|Overall Study|Lost to Follow-up|309
1120303|NCT01656434|3674466|P2|Overall Study|Enrollment terminated at trial site|0
1120304|NCT01656434|3674467|P1|Overall Study|Enrollment terminated at trial site|2
1120305|NCT01656434|3674466|P2|Overall Study|Adverse Event|63
1120306|NCT01656434|3674467|P1|Overall Study|Adverse Event|199
1120307|NCT01656408|3674493|P10|Overall Study|Physician Decision|3
1120308|NCT01656408|3674494|P9|Overall Study|Physician Decision|1
1120309|NCT01656408|3674495|P8|Overall Study|Physician Decision|1
1120310|NCT01656408|3674496|P7|Overall Study|Physician Decision|0
1120311|NCT01656408|3674497|P6|Overall Study|Physician Decision|1
1120312|NCT01656408|3674498|P5|Overall Study|Physician Decision|1
1120313|NCT01656408|3674499|P4|Overall Study|Physician Decision|0
1120314|NCT01656408|3674500|P3|Overall Study|Physician Decision|1
1120315|NCT01656408|3674501|P2|Overall Study|Physician Decision|0
1120316|NCT01656408|3674502|P1|Overall Study|Physician Decision|1
1120317|NCT01656408|3674493|P10|Overall Study|Adverse Event|0
1120318|NCT01656408|3674494|P9|Overall Study|Adverse Event|1
1120319|NCT01656408|3674495|P8|Overall Study|Adverse Event|0
1120320|NCT01656408|3674496|P7|Overall Study|Adverse Event|1
1120321|NCT01656408|3674497|P6|Overall Study|Adverse Event|1
1120322|NCT01656408|3674498|P5|Overall Study|Adverse Event|0
1120323|NCT01656408|3674499|P4|Overall Study|Adverse Event|0
1120324|NCT01656408|3674500|P3|Overall Study|Adverse Event|1
1120325|NCT01656408|3674501|P2|Overall Study|Adverse Event|0
1120326|NCT01656408|3674502|P1|Overall Study|Adverse Event|0
1120327|NCT01656395|3674697|P8|Overall Study|Withdrawal by Subject|0
1120328|NCT01656395|3674698|P7|Overall Study|Withdrawal by Subject|0
1120329|NCT01656395|3674699|P6|Overall Study|Withdrawal by Subject|3
1120330|NCT01656395|3674700|P5|Overall Study|Withdrawal by Subject|0
1120331|NCT01656395|3674701|P4|Overall Study|Withdrawal by Subject|2
1120332|NCT01656395|3674702|P3|Overall Study|Withdrawal by Subject|4
1120333|NCT01656395|3674703|P2|Overall Study|Withdrawal by Subject|1
1120334|NCT01656395|3674704|P1|Overall Study|Withdrawal by Subject|3
1120335|NCT01656395|3674697|P8|Overall Study|Screen Failure|0
1120336|NCT01656395|3674698|P7|Overall Study|Screen Failure|0
1120337|NCT01656395|3674699|P6|Overall Study|Screen Failure|8
1120338|NCT01656395|3674700|P5|Overall Study|Screen Failure|0
1120339|NCT01656395|3674701|P4|Overall Study|Screen Failure|1
1120340|NCT01656395|3674702|P3|Overall Study|Screen Failure|7
1120341|NCT01656395|3674703|P2|Overall Study|Screen Failure|1
1120342|NCT01656395|3674704|P1|Overall Study|Screen Failure|2
1120343|NCT01656395|3674697|P8|Overall Study|Protocol Violation|0
1120344|NCT01656395|3674698|P7|Overall Study|Protocol Violation|0
1120345|NCT01656395|3674699|P6|Overall Study|Protocol Violation|10
1120346|NCT01656395|3674700|P5|Overall Study|Protocol Violation|4
1120347|NCT01656395|3674701|P4|Overall Study|Protocol Violation|2
1120348|NCT01656395|3674702|P3|Overall Study|Protocol Violation|9
1120349|NCT01656395|3674703|P2|Overall Study|Protocol Violation|6
1120350|NCT01656395|3674704|P1|Overall Study|Protocol Violation|6
1120351|NCT01656395|3674697|P8|Overall Study|Progressive Disease|0
1120352|NCT01656395|3674698|P7|Overall Study|Progressive Disease|0
1120353|NCT01656395|3674699|P6|Overall Study|Progressive Disease|1
1120354|NCT01656395|3674700|P5|Overall Study|Progressive Disease|0
1120355|NCT01656395|3674701|P4|Overall Study|Progressive Disease|0
1120356|NCT01656395|3674702|P3|Overall Study|Progressive Disease|0
1120357|NCT01656395|3674703|P2|Overall Study|Progressive Disease|0
1120358|NCT01656395|3674704|P1|Overall Study|Progressive Disease|0
1120359|NCT01656395|3674697|P8|Overall Study|Pregnancy|0
1120360|NCT01656395|3674698|P7|Overall Study|Pregnancy|0
1120361|NCT01656395|3674699|P6|Overall Study|Pregnancy|0
1120362|NCT01656395|3674700|P5|Overall Study|Pregnancy|0
1120363|NCT01656395|3674701|P4|Overall Study|Pregnancy|0
1120364|NCT01656395|3674702|P3|Overall Study|Pregnancy|1
1120365|NCT01656395|3674703|P2|Overall Study|Pregnancy|0
1120366|NCT01656395|3674704|P1|Overall Study|Pregnancy|0
1120367|NCT01656395|3674697|P8|Overall Study|Physician Decision|0
1120368|NCT01656395|3674698|P7|Overall Study|Physician Decision|0
1120369|NCT01656395|3674699|P6|Overall Study|Physician Decision|3
1120370|NCT01656395|3674700|P5|Overall Study|Physician Decision|3
1120371|NCT01656395|3674701|P4|Overall Study|Physician Decision|2
1120372|NCT01656395|3674702|P3|Overall Study|Physician Decision|3
1120373|NCT01656395|3674703|P2|Overall Study|Physician Decision|3
1120374|NCT01656395|3674704|P1|Overall Study|Physician Decision|2
1120375|NCT01656395|3674697|P8|Overall Study|Other|0
1120376|NCT01656395|3674698|P7|Overall Study|Other|0
1120377|NCT01656395|3674699|P6|Overall Study|Other|1
1120378|NCT01656395|3674700|P5|Overall Study|Other|0
1120379|NCT01656395|3674701|P4|Overall Study|Other|0
1120380|NCT01656395|3674702|P3|Overall Study|Other|1
1120381|NCT01656395|3674703|P2|Overall Study|Other|0
1120382|NCT01656395|3674704|P1|Overall Study|Other|0
1120383|NCT01656395|3674697|P8|Overall Study|Non-Compliance with Study Drug|0
1120384|NCT01656395|3674698|P7|Overall Study|Non-Compliance with Study Drug|0
1120385|NCT01656395|3674699|P6|Overall Study|Non-Compliance with Study Drug|1
1120386|NCT01656395|3674700|P5|Overall Study|Non-Compliance with Study Drug|1
1120387|NCT01656395|3674701|P4|Overall Study|Non-Compliance with Study Drug|0
1120388|NCT01656395|3674702|P3|Overall Study|Non-Compliance with Study Drug|0
1120389|NCT01656395|3674703|P2|Overall Study|Non-Compliance with Study Drug|1
1120390|NCT01656395|3674704|P1|Overall Study|Non-Compliance with Study Drug|1
1120391|NCT01656395|3674697|P8|Overall Study|Lost to Follow-up|0
1120392|NCT01656395|3674698|P7|Overall Study|Lost to Follow-up|0
1120393|NCT01656395|3674699|P6|Overall Study|Lost to Follow-up|0
1120394|NCT01656395|3674700|P5|Overall Study|Lost to Follow-up|0
1120395|NCT01656395|3674701|P4|Overall Study|Lost to Follow-up|0
1120396|NCT01656395|3674702|P3|Overall Study|Lost to Follow-up|0
1120397|NCT01656395|3674703|P2|Overall Study|Lost to Follow-up|0
1120398|NCT01656395|3674704|P1|Overall Study|Lost to Follow-up|1
1120399|NCT01656395|3674697|P8|Overall Study|Lack of Efficacy|0
1120400|NCT01656395|3674698|P7|Overall Study|Lack of Efficacy|0
1120401|NCT01656395|3674699|P6|Overall Study|Lack of Efficacy|6
1120402|NCT01656395|3674700|P5|Overall Study|Lack of Efficacy|1
1120403|NCT01656395|3674701|P4|Overall Study|Lack of Efficacy|1
1120404|NCT01656395|3674702|P3|Overall Study|Lack of Efficacy|6
1120405|NCT01656395|3674703|P2|Overall Study|Lack of Efficacy|8
1120406|NCT01656395|3674704|P1|Overall Study|Lack of Efficacy|1
1120407|NCT01656395|3674697|P8|Overall Study|Adverse Event|0
1120408|NCT01656395|3674698|P7|Overall Study|Adverse Event|0
1120409|NCT01656395|3674699|P6|Overall Study|Adverse Event|7
1120410|NCT01656395|3674700|P5|Overall Study|Adverse Event|5
1120411|NCT01656395|3674701|P4|Overall Study|Adverse Event|4
1120412|NCT01656395|3674702|P3|Overall Study|Adverse Event|5
1120413|NCT01656395|3674703|P2|Overall Study|Adverse Event|14
1120414|NCT01656395|3674704|P1|Overall Study|Adverse Event|1
1120415|NCT01656304|3674790|P1|Overall Study|Ineligible, uncontrolled hypertension|1
1120416|NCT01656161|3674831|P1|Overall Study|Withdrawal by Subject|1
1120417|NCT01656161|3674831|P1|Overall Study|Protocol Violation|1
1120418|NCT01656161|3674831|P1|Overall Study|Adverse Event|2
1120419|NCT01656161|3674831|P1|Overall Study|Death|3
1120420|NCT01655823|3674854|P5|Overall Study|Withdrawal by Subject|0
1120421|NCT01655823|3674855|P4|Overall Study|Withdrawal by Subject|1
1120422|NCT01655823|3674856|P3|Overall Study|Withdrawal by Subject|0
1120423|NCT01655823|3674857|P2|Overall Study|Withdrawal by Subject|1
1120424|NCT01655823|3674858|P1|Overall Study|Withdrawal by Subject|0
1120425|NCT01655823|3674854|P5|Overall Study|Lost to Follow-up|1
1120426|NCT01655823|3674855|P4|Overall Study|Lost to Follow-up|0
1120427|NCT01655823|3674856|P3|Overall Study|Lost to Follow-up|0
1120428|NCT01655823|3674857|P2|Overall Study|Lost to Follow-up|1
1120429|NCT01655823|3674858|P1|Overall Study|Lost to Follow-up|0
1120430|NCT01655498|3674876|P1|Overall Study|Withdrawal by Subject|1
1120431|NCT01655498|3674876|P1|Overall Study|Protocol Violation|2
1120432|NCT01655498|3674876|P1|Overall Study|Unrelated health issue|2
1120433|NCT01655381|3674883|P1|Overall Study|Insufficient Treatment Response|1
1120434|NCT01655381|3674883|P1|Overall Study|Moved to Another City|1
1120435|NCT01655381|3674883|P1|Overall Study|Investigator Decision|1
1120436|NCT01655069|3674923|P4|Overall Study|Withdrawal by Subject|0
1120437|NCT01655069|3674924|P3|Overall Study|Withdrawal by Subject|0
1120438|NCT01655069|3674925|P2|Overall Study|Withdrawal by Subject|3
1120439|NCT01655069|3674926|P1|Overall Study|Withdrawal by Subject|2
1120440|NCT01655069|3674923|P4|Overall Study|No Treatment Needed|0
1120441|NCT01655069|3674924|P3|Overall Study|No Treatment Needed|0
1120442|NCT01655069|3674925|P2|Overall Study|No Treatment Needed|1
1120443|NCT01655069|3674926|P1|Overall Study|No Treatment Needed|0
1120444|NCT01655069|3674923|P4|Overall Study|Lack of Efficacy|0
1120445|NCT01655069|3674924|P3|Overall Study|Lack of Efficacy|0
1120446|NCT01655069|3674925|P2|Overall Study|Lack of Efficacy|1
1120447|NCT01655069|3674926|P1|Overall Study|Lack of Efficacy|0
1120448|NCT01655069|3674923|P4|Overall Study|Adverse Event|3
1120449|NCT01655069|3674924|P3|Overall Study|Adverse Event|2
1120450|NCT01655069|3674925|P2|Overall Study|Adverse Event|7
1120451|NCT01655069|3674926|P1|Overall Study|Adverse Event|6
1120452|NCT01655069|3674923|P4|Overall Study|Physician Decision|1
1120453|NCT01655069|3674924|P3|Overall Study|Physician Decision|0
1120454|NCT01655069|3674925|P2|Overall Study|Physician Decision|0
1120455|NCT01655069|3674926|P1|Overall Study|Physician Decision|0
1120456|NCT01654666|3674986|P3|Overall Study|Withdrawal by Subject|1
1120457|NCT01654666|3674987|P2|Overall Study|Withdrawal by Subject|4
1120458|NCT01654666|3674988|P1|Overall Study|Withdrawal by Subject|4
1120459|NCT01654666|3674986|P3|Overall Study|Lost to Follow-up|5
1120460|NCT01654666|3674987|P2|Overall Study|Lost to Follow-up|5
1120461|NCT01654666|3674988|P1|Overall Study|Lost to Follow-up|4
1120462|NCT01654666|3674986|P3|Overall Study|Protocol Violation|8
1120463|NCT01654666|3674987|P2|Overall Study|Protocol Violation|4
1120464|NCT01654666|3674988|P1|Overall Study|Protocol Violation|7
1120465|NCT01654601|3675013|P2|2nd Administration|Protocol Violation|1
1120466|NCT01654601|3675014|P1|2nd Administration|Protocol Violation|0
1120467|NCT01654601|3675013|P2|2nd Administration|Adverse Event|0
1120468|NCT01654601|3675014|P1|2nd Administration|Adverse Event|1
1120469|NCT01654601|3675013|P2|1st Administration|Protocol Violation|2
1120470|NCT01654601|3675014|P1|1st Administration|Protocol Violation|0
1120471|NCT01654601|3675013|P2|1st Administration|Withdrawal by Subject|0
1120472|NCT01654601|3675014|P1|1st Administration|Withdrawal by Subject|2
1120473|NCT01654549|3675028|P2|Overall Study|H.pylori eradication not successful|1
1120474|NCT01654549|3675029|P1|Overall Study|H.pylori eradication not successful|0
1120475|NCT01654536|3675041|P2|Overall Study|Withdrawal by Subject|25
1120476|NCT01654536|3675042|P1|Overall Study|Withdrawal by Subject|27
1120477|NCT01654536|3675041|P2|Overall Study|Physician Decision|8
1120478|NCT01654536|3675042|P1|Overall Study|Physician Decision|12
1120479|NCT01654536|3675041|P2|Overall Study|Lost to Follow-up|5
1120480|NCT01654536|3675042|P1|Overall Study|Lost to Follow-up|5
1120481|NCT01654523|3675078|P1|Overall Study|Withdrawal by Subject|1
1120482|NCT01654302|3675084|P2|Second Intervention (Day 7)|Lost to Follow-up|1
1120483|NCT01654302|3675085|P1|Second Intervention (Day 7)|Lost to Follow-up|1
1120484|NCT01654289|3675094|P3|Overall Study|Withdrew from intervention only|0
1120485|NCT01654289|3675095|P2|Overall Study|Withdrew from intervention only|20
1120486|NCT01654289|3675096|P1|Overall Study|Withdrew from intervention only|17
1120487|NCT01654289|3675094|P3|Overall Study|Withdrawal by Subject|5
1120488|NCT01654289|3675095|P2|Overall Study|Withdrawal by Subject|8
1120489|NCT01654289|3675096|P1|Overall Study|Withdrawal by Subject|10
1120490|NCT01654276|3675134|P1|Overall Study|Withdrawal by Subject|1
1120491|NCT01654276|3675134|P1|Overall Study|Lost to Follow-up|4
1120492|NCT01654276|3675134|P1|Overall Study|Lack of Efficacy|1
1120493|NCT01654250|3675188|P2|Overall Study|Lost to Follow-up|0
1120494|NCT01654250|3675189|P1|Overall Study|Lost to Follow-up|1
1120495|NCT01654224|3675206|P2|Overall Study|Insufficient blood sample|2
1120496|NCT01654224|3675207|P1|Overall Study|Insufficient blood sample|3
1120497|NCT01654224|3675206|P2|Overall Study|Did not receive allocation|8
1120498|NCT01654224|3675207|P1|Overall Study|Did not receive allocation|1
1120499|NCT01654224|3675206|P2|Overall Study|Lost to Follow-up|2
1120500|NCT01654224|3675207|P1|Overall Study|Lost to Follow-up|2
1120501|NCT01653912|3675232|P6|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1
1120502|NCT01653912|3675233|P5|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
1120503|NCT01653912|3675234|P4|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
1120504|NCT01653912|3675235|P3|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
1120505|NCT01653912|3675236|P2|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
1120506|NCT01653912|3675237|P1|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
1120507|NCT01653912|3675232|P6|Phase 2: GSK2110183 125 mg|Clinical Progression|6
1120508|NCT01653912|3675233|P5|Phase 2: GSK2110183 125 mg|Clinical Progression|0
1120509|NCT01653912|3675234|P4|Phase 2: GSK2110183 125 mg|Clinical Progression|0
1120510|NCT01653912|3675235|P3|Phase 2: GSK2110183 125 mg|Clinical Progression|0
1120511|NCT01653912|3675236|P2|Phase 2: GSK2110183 125 mg|Clinical Progression|0
1120512|NCT01653912|3675237|P1|Phase 2: GSK2110183 125 mg|Clinical Progression|0
1120513|NCT01653912|3675232|P6|Phase 2: GSK2110183 125 mg|Adverse Event|1
1120514|NCT01653912|3675233|P5|Phase 2: GSK2110183 125 mg|Adverse Event|0
1120515|NCT01653912|3675234|P4|Phase 2: GSK2110183 125 mg|Adverse Event|0
1120516|NCT01653912|3675235|P3|Phase 2: GSK2110183 125 mg|Adverse Event|0
1120517|NCT01653912|3675236|P2|Phase 2: GSK2110183 125 mg|Adverse Event|0
1120518|NCT01653912|3675237|P1|Phase 2: GSK2110183 125 mg|Adverse Event|0
1120519|NCT01653912|3675232|P6|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
1120520|NCT01653912|3675233|P5|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
1120521|NCT01653912|3675234|P4|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1
1120522|NCT01653912|3675235|P3|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
1120523|NCT01653912|3675236|P2|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
1120524|NCT01653912|3675237|P1|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
1120525|NCT01653912|3675232|P6|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
1120526|NCT01653912|3675233|P5|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
1120527|NCT01653912|3675234|P4|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1
1120528|NCT01653912|3675235|P3|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
1120529|NCT01653912|3675236|P2|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
1120530|NCT01653912|3675237|P1|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
1120531|NCT01653912|3675232|P6|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
1120532|NCT01653912|3675233|P5|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
1120533|NCT01653912|3675234|P4|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
1120534|NCT01653912|3675235|P3|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2
1120535|NCT01653912|3675236|P2|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
1120536|NCT01653912|3675237|P1|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
1120537|NCT01653912|3675232|P6|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
1120538|NCT01653912|3675233|P5|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
1120539|NCT01653912|3675234|P4|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
1120540|NCT01653912|3675235|P3|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
1120541|NCT01653912|3675236|P2|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1
1120542|NCT01653912|3675237|P1|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
1120543|NCT01653782|3675255|P3|Overall Study|Lost to Follow-up|2
1120544|NCT01653782|3675256|P2|Overall Study|Lost to Follow-up|3
1120545|NCT01653782|3675257|P1|Overall Study|Lost to Follow-up|7
1120546|NCT01653782|3675255|P3|Overall Study|Withdrawal by Subject|4
1120547|NCT01653782|3675256|P2|Overall Study|Withdrawal by Subject|15
1120548|NCT01653782|3675257|P1|Overall Study|Withdrawal by Subject|9
1120549|NCT01653743|3675267|P2|Overall Study|Investigator discretion|0
1120550|NCT01653743|3675268|P1|Overall Study|Investigator discretion|3
1120551|NCT01653743|3675267|P2|Overall Study|Withdrawal by Subject|0
1120552|NCT01653743|3675268|P1|Overall Study|Withdrawal by Subject|1
1120553|NCT01653327|3675328|P1|Overall Study|Withdrawal by Subject|1
1120554|NCT01653262|3675336|P1|Overall Study|AE, non-serious non-fatal|1
1120555|NCT01653262|3675336|P1|Overall Study|SAE, non-fatal|1
1120556|NCT01653262|3675336|P1|Overall Study|Lack of Efficacy|1
1120557|NCT01653158|3675349|P8|Overall Study|Withdrawal by Subject|0
1120558|NCT01653158|3675350|P7|Overall Study|Withdrawal by Subject|0
1120559|NCT01653158|3675351|P6|Overall Study|Withdrawal by Subject|0
1120560|NCT01653158|3675352|P5|Overall Study|Withdrawal by Subject|0
1120561|NCT01653158|3675353|P4|Overall Study|Withdrawal by Subject|0
1120562|NCT01653158|3675354|P3|Overall Study|Withdrawal by Subject|0
1120563|NCT01653158|3675355|P2|Overall Study|Withdrawal by Subject|0
1120564|NCT01653158|3675356|P1|Overall Study|Withdrawal by Subject|1
1120565|NCT01653158|3675349|P8|Overall Study|Progressive disease|9
1120566|NCT01653158|3675350|P7|Overall Study|Progressive disease|2
1120567|NCT01653158|3675351|P6|Overall Study|Progressive disease|1
1120568|NCT01653158|3675352|P5|Overall Study|Progressive disease|1
1120569|NCT01653158|3675353|P4|Overall Study|Progressive disease|0
1120570|NCT01653158|3675354|P3|Overall Study|Progressive disease|0
1120571|NCT01653158|3675355|P2|Overall Study|Progressive disease|0
1120572|NCT01653158|3675356|P1|Overall Study|Progressive disease|0
1120573|NCT01653158|3675349|P8|Overall Study|Other|1
1120574|NCT01653158|3675350|P7|Overall Study|Other|0
1120575|NCT01653158|3675351|P6|Overall Study|Other|0
1120576|NCT01653158|3675352|P5|Overall Study|Other|0
1120577|NCT01653158|3675353|P4|Overall Study|Other|0
1120578|NCT01653158|3675354|P3|Overall Study|Other|0
1120579|NCT01653158|3675355|P2|Overall Study|Other|0
1120580|NCT01653158|3675356|P1|Overall Study|Other|0
1120581|NCT01653158|3675349|P8|Overall Study|Adverse Event|3
1120582|NCT01653158|3675350|P7|Overall Study|Adverse Event|0
1120583|NCT01653158|3675351|P6|Overall Study|Adverse Event|0
1120584|NCT01653158|3675352|P5|Overall Study|Adverse Event|0
1120585|NCT01653158|3675353|P4|Overall Study|Adverse Event|1
1120586|NCT01653158|3675354|P3|Overall Study|Adverse Event|0
1120587|NCT01653158|3675355|P2|Overall Study|Adverse Event|0
1120588|NCT01653158|3675356|P1|Overall Study|Adverse Event|0
1120589|NCT01653158|3675349|P8|Overall Study|Death|2
1120590|NCT01653158|3675350|P7|Overall Study|Death|0
1120591|NCT01653158|3675351|P6|Overall Study|Death|0
1120592|NCT01653158|3675352|P5|Overall Study|Death|0
1120593|NCT01653158|3675353|P4|Overall Study|Death|1
1120594|NCT01653158|3675354|P3|Overall Study|Death|0
1120595|NCT01653158|3675355|P2|Overall Study|Death|0
1120596|NCT01653158|3675356|P1|Overall Study|Death|0
1120597|NCT01653132|3675628|P2|First Intervention|Protocol Violation|0
1120598|NCT01653132|3675629|P1|First Intervention|Protocol Violation|1
1120599|NCT01652885|3675679|P1|Overall Study|Adverse Event|1
1120600|NCT01652872|3675706|P2|Overall Study|Withdrawal by Subject|84
1120601|NCT01652872|3675707|P1|Overall Study|Withdrawal by Subject|76
1120602|NCT01652872|3675706|P2|Overall Study|Decision by sponsor|7
1120603|NCT01652872|3675707|P1|Overall Study|Decision by sponsor|5
1120604|NCT01652872|3675706|P2|Overall Study|Lost to Follow-up|23
1120605|NCT01652872|3675707|P1|Overall Study|Lost to Follow-up|28
1120606|NCT01652872|3675706|P2|Overall Study|Death|39
1120607|NCT01652872|3675707|P1|Overall Study|Death|36
1120608|NCT01652729|3675724|P3|Overall Study|Administrative|0
1120609|NCT01652729|3675725|P2|Overall Study|Administrative|0
1120610|NCT01652729|3675726|P1|Overall Study|Administrative|1
1120611|NCT01652729|3675724|P3|Overall Study|Lost to Follow-up|3
1120612|NCT01652729|3675725|P2|Overall Study|Lost to Follow-up|6
1120613|NCT01652729|3675726|P1|Overall Study|Lost to Follow-up|6
1120614|NCT01652729|3675724|P3|Overall Study|Protocol Violation|0
1120615|NCT01652729|3675725|P2|Overall Study|Protocol Violation|0
1120616|NCT01652729|3675726|P1|Overall Study|Protocol Violation|1
1120617|NCT01652729|3675724|P3|Overall Study|Physician Decision|1
1120618|NCT01652729|3675725|P2|Overall Study|Physician Decision|0
1120619|NCT01652729|3675726|P1|Overall Study|Physician Decision|1
1120620|NCT01652729|3675724|P3|Overall Study|Adverse Event|3
1120621|NCT01652729|3675725|P2|Overall Study|Adverse Event|0
1120622|NCT01652729|3675726|P1|Overall Study|Adverse Event|4
1120623|NCT01652729|3675724|P3|Overall Study|Withdrawal by Subject|7
1120624|NCT01652729|3675725|P2|Overall Study|Withdrawal by Subject|7
1120625|NCT01652729|3675726|P1|Overall Study|Withdrawal by Subject|14
1120626|NCT01652716|3675748|P2|Overall Study|Withdrawal by Subject|18
1120627|NCT01652716|3675749|P1|Overall Study|Withdrawal by Subject|33
1120628|NCT01652716|3675748|P2|Overall Study|Adverse Event|10
1120629|NCT01652716|3675749|P1|Overall Study|Adverse Event|7
1120630|NCT01652716|3675748|P2|Overall Study|Protocol Violation|1
1120631|NCT01652716|3675749|P1|Overall Study|Protocol Violation|2
1120632|NCT01652716|3675748|P2|Overall Study|Lost to Follow-up|11
1120633|NCT01652716|3675749|P1|Overall Study|Lost to Follow-up|12
1120634|NCT01652716|3675748|P2|Overall Study|Investigator decision|4
1120635|NCT01652716|3675749|P1|Overall Study|Investigator decision|1
1120636|NCT01652716|3675748|P2|Overall Study|Administrative|2
1120637|NCT01652716|3675749|P1|Overall Study|Administrative|0
1120638|NCT01652716|3675748|P2|Overall Study|Loss of glucose control|0
1120639|NCT01652716|3675749|P1|Overall Study|Loss of glucose control|1
1120640|NCT01652703|3675769|P6|Overall Study|Other|1
1120641|NCT01652703|3675770|P5|Overall Study|Other|1
1120642|NCT01652703|3675771|P4|Overall Study|Other|1
1120643|NCT01652703|3675772|P3|Overall Study|Other|0
1120644|NCT01652703|3675773|P2|Overall Study|Other|0
1120645|NCT01652703|3675774|P1|Overall Study|Other|0
1120646|NCT01652703|3675769|P6|Overall Study|Withdrawal by Subject|1
1120647|NCT01652703|3675770|P5|Overall Study|Withdrawal by Subject|0
1120648|NCT01652703|3675771|P4|Overall Study|Withdrawal by Subject|1
1120649|NCT01652703|3675772|P3|Overall Study|Withdrawal by Subject|3
1120650|NCT01652703|3675773|P2|Overall Study|Withdrawal by Subject|1
1120651|NCT01652703|3675774|P1|Overall Study|Withdrawal by Subject|0
1120652|NCT01652690|3675832|P2|Overall Study|Death|2
1120653|NCT01652690|3675833|P1|Overall Study|Death|5
1120654|NCT01652690|3675832|P2|Overall Study|Lost to Follow-up|6
1120655|NCT01652690|3675833|P1|Overall Study|Lost to Follow-up|6
1120656|NCT01652690|3675832|P2|Overall Study|Other|9
1120657|NCT01652690|3675833|P1|Overall Study|Other|8
1120658|NCT01652690|3675832|P2|Overall Study|Withdrawal by Subject|4
1120659|NCT01652690|3675833|P1|Overall Study|Withdrawal by Subject|16
1120660|NCT01652664|3675867|P2|Overall Study|Inadequate IOP control|0
1120661|NCT01652664|3675868|P1|Overall Study|Inadequate IOP control|1
1120662|NCT01652664|3675867|P2|Overall Study|Treatment Failure|1
1120663|NCT01652664|3675868|P1|Overall Study|Treatment Failure|5
1120664|NCT01652573|3675877|P2|Overall Study|Adverse Event|1
1120665|NCT01652573|3675878|P1|Overall Study|Adverse Event|0
1120666|NCT01652287|3675933|P2|Overall Study|Withdrawal by Subject|0
1120667|NCT01652287|3675934|P1|Overall Study|Withdrawal by Subject|2
1120668|NCT01651949|3675965|P3|Overall Study|Withdrawal by Subject|9
1120669|NCT01651949|3675966|P2|Overall Study|Withdrawal by Subject|18
1120670|NCT01651949|3675967|P1|Overall Study|Withdrawal by Subject|17
1120671|NCT01651949|3675965|P3|Overall Study|Screen failure|0
1120672|NCT01651949|3675966|P2|Overall Study|Screen failure|2
1120673|NCT01651949|3675967|P1|Overall Study|Screen failure|2
1120674|NCT01651949|3675965|P3|Overall Study|Adverse Event|1
1120675|NCT01651949|3675966|P2|Overall Study|Adverse Event|2
1120676|NCT01651949|3675967|P1|Overall Study|Adverse Event|0
1120677|NCT01651949|3675965|P3|Overall Study|Physician Decision|0
1120678|NCT01651949|3675966|P2|Overall Study|Physician Decision|2
1120679|NCT01651949|3675967|P1|Overall Study|Physician Decision|0
1120680|NCT01651949|3675965|P3|Overall Study|Protocol Violation|1
1120681|NCT01651949|3675966|P2|Overall Study|Protocol Violation|2
1120682|NCT01651949|3675967|P1|Overall Study|Protocol Violation|0
1120683|NCT01651949|3675965|P3|Overall Study|Lost to Follow-up|20
1120684|NCT01651949|3675966|P2|Overall Study|Lost to Follow-up|56
1120685|NCT01651949|3675967|P1|Overall Study|Lost to Follow-up|30
1120686|NCT01651949|3675965|P3|Overall Study|Unknown status|0
1120687|NCT01651949|3675966|P2|Overall Study|Unknown status|4
1120688|NCT01651949|3675967|P1|Overall Study|Unknown status|4
1120689|NCT01651936|3675987|P3|Extension Study|Study terminated by sponsor|13
1120690|NCT01651936|3675988|P2|Extension Study|Study terminated by sponsor|0
1120691|NCT01651936|3675989|P1|Extension Study|Study terminated by sponsor|0
1120692|NCT01651936|3675987|P3|Extension Study|Lack of Efficacy|1
1120693|NCT01651936|3675988|P2|Extension Study|Lack of Efficacy|0
1120694|NCT01651936|3675989|P1|Extension Study|Lack of Efficacy|0
1120695|NCT01651936|3675987|P3|Base Study|Study terminated by sponsor|0
1120696|NCT01651936|3675988|P2|Base Study|Study terminated by sponsor|16
1120697|NCT01651936|3675989|P1|Base Study|Study terminated by sponsor|21
1120698|NCT01651936|3675987|P3|Base Study|Early Escape|0
1120699|NCT01651936|3675988|P2|Base Study|Early Escape|8
1120700|NCT01651936|3675989|P1|Base Study|Early Escape|2
1120701|NCT01651936|3675987|P3|Base Study|Withdrawal by Subject|0
1120702|NCT01651936|3675988|P2|Base Study|Withdrawal by Subject|1
1120703|NCT01651936|3675989|P1|Base Study|Withdrawal by Subject|1
1120704|NCT01651936|3675987|P3|Base Study|Adverse Event|0
1120705|NCT01651936|3675988|P2|Base Study|Adverse Event|0
1120706|NCT01651936|3675989|P1|Base Study|Adverse Event|3
1120707|NCT01651780|3676059|P2|Overall Study|Physician decision: Day 30 visit <23 day|5
1120708|NCT01651780|3676060|P1|Overall Study|Physician decision: Day 30 visit <23 day|1
1120709|NCT01651780|3676059|P2|Overall Study|Lost to Follow-up|2
1120710|NCT01651780|3676060|P1|Overall Study|Lost to Follow-up|1
1120711|NCT01651780|3676059|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1120712|NCT01651780|3676060|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|3
1120713|NCT01651780|3676059|P2|Overall Study|Withdrawal by Subject|0
1120714|NCT01651780|3676060|P1|Overall Study|Withdrawal by Subject|2
1120715|NCT01651780|3676059|P2|Overall Study|Reason Not Specified: No 30-day visit|2
1120716|NCT01651780|3676060|P1|Overall Study|Reason Not Specified: No 30-day visit|2
1120717|NCT01651780|3676059|P2|Overall Study|Physician decision: No 30-day visit|1
1120718|NCT01651780|3676060|P1|Overall Study|Physician decision: No 30-day visit|2
1120719|NCT01651403|3676092|P2|Overall Study|Subjects Randomized and Not Treated|1
1120720|NCT01651403|3676093|P1|Overall Study|Subjects Randomized and Not Treated|0
1120721|NCT01651403|3676092|P2|Overall Study|Investigator Decision|0
1120722|NCT01651403|3676093|P1|Overall Study|Investigator Decision|1
1120723|NCT01651403|3676092|P2|Overall Study|Withdrew Consent/Assent|5
1120724|NCT01651403|3676093|P1|Overall Study|Withdrew Consent/Assent|5
1120725|NCT01651403|3676092|P2|Overall Study|Subject Noncompliance|1
1120726|NCT01651403|3676093|P1|Overall Study|Subject Noncompliance|1
1120727|NCT01651403|3676092|P2|Overall Study|Continuing Study|22
1120728|NCT01651403|3676093|P1|Overall Study|Continuing Study|48
1120729|NCT01651260|3676139|P1|Overall Study|unable to apply product|3
1120730|NCT01651208|3676146|P2|Overall Study|Lost to Follow-up|16
1120731|NCT01651208|3676147|P1|Overall Study|Lost to Follow-up|14
1120732|NCT01651039|3676162|P1|Overall Study|Progressive Disease|22
1120733|NCT01651039|3676162|P1|Overall Study|Withdrawal by Subject|1
1120734|NCT01651039|3676162|P1|Overall Study|Physician Decision|2
1120735|NCT01651039|3676162|P1|Overall Study|Non-evaluables|5
1120736|NCT01651000|3676175|P2|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1
1120737|NCT01651000|3676176|P1|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0
1120738|NCT01651000|3676175|P2|Overall Study|Administrative reason|0
1120739|NCT01651000|3676176|P1|Overall Study|Administrative reason|1
1120740|NCT01651000|3676175|P2|Overall Study|Physician Decision|0
1120741|NCT01651000|3676176|P1|Overall Study|Physician Decision|1
1120742|NCT01651000|3676175|P2|Overall Study|Lack of Efficacy|1
1120743|NCT01651000|3676176|P1|Overall Study|Lack of Efficacy|1
1120744|NCT01651000|3676175|P2|Overall Study|Subject noncompliance|3
1120745|NCT01651000|3676176|P1|Overall Study|Subject noncompliance|0
1120746|NCT01651000|3676175|P2|Overall Study|Withdrawal by Subject|10
1120747|NCT01651000|3676176|P1|Overall Study|Withdrawal by Subject|2
1120748|NCT01651000|3676175|P2|Overall Study|Protocol Violation|3
1120749|NCT01651000|3676176|P1|Overall Study|Protocol Violation|0
1120750|NCT01651000|3676175|P2|Overall Study|Lost to Follow-up|2
1120751|NCT01651000|3676176|P1|Overall Study|Lost to Follow-up|3
1120752|NCT01651000|3676175|P2|Overall Study|Adverse Event|8
1120753|NCT01651000|3676176|P1|Overall Study|Adverse Event|2
1120754|NCT01650831|3676197|P1|Overall Study|Screen failure|1
1120755|NCT01650805|3676207|P2|Overall Study|Withdrawal by Subject|0
1120756|NCT01650805|3676208|P1|Overall Study|Withdrawal by Subject|1
1120757|NCT01650779|3676218|P1|Overall Study|Withdrawal by Subject|1
1120758|NCT01650636|3676227|P2|Washout up to 9 Months|Lost to Follow-up|1
1120759|NCT01650636|3676228|P1|Washout up to 9 Months|Lost to Follow-up|2
1120760|NCT01650636|3676227|P2|Washout up to 9 Months|Withdrawal by Subject|2
1120761|NCT01650636|3676228|P1|Washout up to 9 Months|Withdrawal by Subject|4
1120762|NCT01650636|3676227|P2|Washout up to 5 Months|Lost to Follow-up|8
1120763|NCT01650636|3676228|P1|Washout up to 5 Months|Lost to Follow-up|2
1120764|NCT01650636|3676227|P2|Washout up to 5 Months|Death|0
1120765|NCT01650636|3676228|P1|Washout up to 5 Months|Death|1
1120766|NCT01650636|3676227|P2|Washout up to 5 Months|Physician Decision|2
1120767|NCT01650636|3676228|P1|Washout up to 5 Months|Physician Decision|2
1120768|NCT01650636|3676227|P2|Washout up to 5 Months|Withdrawal by Subject|8
1120769|NCT01650636|3676228|P1|Washout up to 5 Months|Withdrawal by Subject|4
1120770|NCT01650519|3676261|P2|Overall Study|Withdrawal by Subject|0
1120771|NCT01650519|3676262|P1|Overall Study|Withdrawal by Subject|1
1120772|NCT01650285|3676323|P1|Overall Study|Adverse Event|1
1120773|NCT01650246|3676328|P1|Overall Study|Lack of Efficacy|30
1120774|NCT01650246|3676328|P1|Overall Study|Death|1
1120775|NCT01650246|3676328|P1|Overall Study|Withdrawal by Subject|26
1120776|NCT01650246|3676328|P1|Overall Study|Lost to Follow-up|5
1120777|NCT01650246|3676328|P1|Overall Study|Sponsor terminated study|53
1120778|NCT01650246|3676328|P1|Overall Study|Protocol Violation|5
1120779|NCT01650246|3676328|P1|Overall Study|Adverse Event|23
1120780|NCT01649856|3676335|P2|Overall Study|Not Specified|5
1120781|NCT01649856|3676336|P1|Overall Study|Not Specified|20
1120782|NCT01649856|3676335|P2|Overall Study|Lack of Compliance|1
1120783|NCT01649856|3676336|P1|Overall Study|Lack of Compliance|6
1120784|NCT01649856|3676335|P2|Overall Study|Lost to Follow-up|16
1120785|NCT01649856|3676336|P1|Overall Study|Lost to Follow-up|20
1120786|NCT01649856|3676335|P2|Overall Study|Stable or Progressed Disease|3
1120787|NCT01649856|3676336|P1|Overall Study|Stable or Progressed Disease|5
1120788|NCT01649856|3676335|P2|Overall Study|Death|34
1120789|NCT01649856|3676336|P1|Overall Study|Death|69
1120790|NCT01649856|3676335|P2|Overall Study|Treatment Failure|1
1120791|NCT01649856|3676336|P1|Overall Study|Treatment Failure|1
1120792|NCT01649856|3676335|P2|Overall Study|Protocol Violation|4
1120793|NCT01649856|3676336|P1|Overall Study|Protocol Violation|4
1120794|NCT01649856|3676335|P2|Overall Study|Withdrawal by Subject|14
1120795|NCT01649856|3676336|P1|Overall Study|Withdrawal by Subject|14
1120796|NCT01649804|3676368|P1|Overall Study|Administrative/Other|8
1120797|NCT01649791|3676380|P1|Overall Study|Adverse Event|1
1120798|NCT01649791|3676380|P1|Overall Study|Disease Progression|2
1120799|NCT01649765|3676389|P2|Overall Study|Withdrawal by Subject|1
1120800|NCT01649765|3676390|P1|Overall Study|Withdrawal by Subject|2
1120801|NCT01649765|3676389|P2|Overall Study|Protocol Violation|0
1120802|NCT01649765|3676390|P1|Overall Study|Protocol Violation|1
1120803|NCT01649765|3676389|P2|Overall Study|Physician Decision|3
1120804|NCT01649765|3676390|P1|Overall Study|Physician Decision|0
1120805|NCT01649765|3676389|P2|Overall Study|Lack of Efficacy|1
1120806|NCT01649765|3676390|P1|Overall Study|Lack of Efficacy|1
1120807|NCT01649765|3676389|P2|Overall Study|Adverse Event|3
1120808|NCT01649765|3676390|P1|Overall Study|Adverse Event|5
1120809|NCT01649557|3676441|P3|Overall Study|Lack of Efficacy|0
1120810|NCT01649557|3676442|P2|Overall Study|Lack of Efficacy|0
1120811|NCT01649557|3676443|P1|Overall Study|Lack of Efficacy|5
1120812|NCT01649557|3676441|P3|Overall Study|Protocol deviation|0
1120813|NCT01649557|3676442|P2|Overall Study|Protocol deviation|2
1120814|NCT01649557|3676443|P1|Overall Study|Protocol deviation|0
1120815|NCT01649557|3676441|P3|Overall Study|Withdrawal by Subject|4
1120816|NCT01649557|3676442|P2|Overall Study|Withdrawal by Subject|5
1120817|NCT01649557|3676443|P1|Overall Study|Withdrawal by Subject|15
1120818|NCT01649557|3676441|P3|Overall Study|Physician Decision|1
1120819|NCT01649557|3676442|P2|Overall Study|Physician Decision|2
1120820|NCT01649557|3676443|P1|Overall Study|Physician Decision|8
1120821|NCT01649557|3676441|P3|Overall Study|Met withdrawal criteria|0
1120822|NCT01649557|3676442|P2|Overall Study|Met withdrawal criteria|0
1120823|NCT01649557|3676443|P1|Overall Study|Met withdrawal criteria|4
1120824|NCT01649557|3676441|P3|Overall Study|Adverse Event|1
1120825|NCT01649557|3676442|P2|Overall Study|Adverse Event|5
1120826|NCT01649557|3676443|P1|Overall Study|Adverse Event|7
1120827|NCT01649557|3676441|P3|Overall Study|Lost to Follow-up|3
1120828|NCT01649557|3676442|P2|Overall Study|Lost to Follow-up|0
1120829|NCT01649557|3676443|P1|Overall Study|Lost to Follow-up|5
1120830|NCT01649297|3676505|P5|Overall Study|For other reason|0
1120831|NCT01649297|3676506|P4|Overall Study|For other reason|0
1120832|NCT01649297|3676507|P3|Overall Study|For other reason|2
1120833|NCT01649297|3676508|P2|Overall Study|For other reason|1
1120834|NCT01649297|3676509|P1|Overall Study|For other reason|4
1120835|NCT01649297|3676505|P5|Overall Study|Patient withdrawal (not due to AE)|1
1120836|NCT01649297|3676506|P4|Overall Study|Patient withdrawal (not due to AE)|1
1120837|NCT01649297|3676507|P3|Overall Study|Patient withdrawal (not due to AE)|4
1120838|NCT01649297|3676508|P2|Overall Study|Patient withdrawal (not due to AE)|6
1120839|NCT01649297|3676509|P1|Overall Study|Patient withdrawal (not due to AE)|3
1120840|NCT01649297|3676505|P5|Overall Study|Lost to Follow-up|0
1120841|NCT01649297|3676506|P4|Overall Study|Lost to Follow-up|3
1120842|NCT01649297|3676507|P3|Overall Study|Lost to Follow-up|4
1120843|NCT01649297|3676508|P2|Overall Study|Lost to Follow-up|1
1120844|NCT01649297|3676509|P1|Overall Study|Lost to Follow-up|1
1120845|NCT01649297|3676505|P5|Overall Study|Non compliant with Protocol|1
1120846|NCT01649297|3676506|P4|Overall Study|Non compliant with Protocol|2
1120847|NCT01649297|3676507|P3|Overall Study|Non compliant with Protocol|3
1120848|NCT01649297|3676508|P2|Overall Study|Non compliant with Protocol|0
1120849|NCT01649297|3676509|P1|Overall Study|Non compliant with Protocol|1
1120850|NCT01649297|3676505|P5|Overall Study|Lack of Efficacy|1
1120851|NCT01649297|3676506|P4|Overall Study|Lack of Efficacy|0
1120852|NCT01649297|3676507|P3|Overall Study|Lack of Efficacy|0
1120853|NCT01649297|3676508|P2|Overall Study|Lack of Efficacy|0
1120854|NCT01649297|3676509|P1|Overall Study|Lack of Efficacy|0
1120855|NCT01649297|3676505|P5|Overall Study|Adverse Event|1
1120856|NCT01649297|3676506|P4|Overall Study|Adverse Event|13
1120857|NCT01649297|3676507|P3|Overall Study|Adverse Event|4
1120858|NCT01649297|3676508|P2|Overall Study|Adverse Event|5
1120859|NCT01649297|3676509|P1|Overall Study|Adverse Event|5
1120860|NCT01649271|3676528|P2|Overall Study|Other than stated above|0
1120861|NCT01649271|3676529|P1|Overall Study|Other than stated above|1
1120862|NCT01649271|3676528|P2|Overall Study|Withdrawal by Subject|0
1120863|NCT01649271|3676529|P1|Overall Study|Withdrawal by Subject|1
1120864|NCT01649271|3676528|P2|Overall Study|Other Adverse Event|2
1120865|NCT01649271|3676529|P1|Overall Study|Other Adverse Event|0
1120866|NCT01649271|3676528|P2|Overall Study|Progressive disease|5
1120867|NCT01649271|3676529|P1|Overall Study|Progressive disease|4
1120868|NCT01649232|3676544|P2|Overall Study|Physician Decision|0
1120869|NCT01649232|3676545|P1|Overall Study|Physician Decision|2
1120870|NCT01648790|3676597|P5|Treatment 3|Withdrawal by Subject|0
1120871|NCT01648790|3676598|P4|Treatment 3|Withdrawal by Subject|1
1120872|NCT01648790|3676599|P3|Treatment 3|Withdrawal by Subject|0
1120873|NCT01648790|3676600|P2|Treatment 3|Withdrawal by Subject|0
1120874|NCT01648790|3676601|P1|Treatment 3|Withdrawal by Subject|0
1120875|NCT01648699|3676622|P1|Overall Study|Unspecified/unable to complete 4 visits|2
1120876|NCT01648699|3676622|P1|Overall Study|Lost to Follow-up|2
1120877|NCT01648699|3676622|P1|Overall Study|Death|1
1120878|NCT01648582|3676651|P3|Overall Study|Sponsor Decision|1
1120879|NCT01648582|3676652|P2|Overall Study|Sponsor Decision|1
1120880|NCT01648582|3676653|P1|Overall Study|Sponsor Decision|0
1120881|NCT01648582|3676651|P3|Overall Study|Death|0
1120882|NCT01648582|3676652|P2|Overall Study|Death|0
1120883|NCT01648582|3676653|P1|Overall Study|Death|1
1120884|NCT01648582|3676651|P3|Overall Study|Physician Decision|3
1120885|NCT01648582|3676652|P2|Overall Study|Physician Decision|1
1120886|NCT01648582|3676653|P1|Overall Study|Physician Decision|0
1120887|NCT01648582|3676651|P3|Overall Study|Withdrawal by Subject|17
1120888|NCT01648582|3676652|P2|Overall Study|Withdrawal by Subject|17
1120889|NCT01648582|3676653|P1|Overall Study|Withdrawal by Subject|15
1120890|NCT01648582|3676651|P3|Overall Study|Protocol Violation|1
1120891|NCT01648582|3676652|P2|Overall Study|Protocol Violation|2
1120892|NCT01648582|3676653|P1|Overall Study|Protocol Violation|1
1120893|NCT01648582|3676651|P3|Overall Study|Lost to Follow-up|8
1120894|NCT01648582|3676652|P2|Overall Study|Lost to Follow-up|6
1120895|NCT01648582|3676653|P1|Overall Study|Lost to Follow-up|9
1120896|NCT01648582|3676651|P3|Overall Study|Adverse Event|2
1120897|NCT01648582|3676652|P2|Overall Study|Adverse Event|11
1120898|NCT01648582|3676653|P1|Overall Study|Adverse Event|6
1120899|NCT01648348|3676756|P6|Overall Study|Replaced for MTD analysis|0
1120900|NCT01648348|3676757|P5|Overall Study|Replaced for MTD analysis|0
1120901|NCT01648348|3676758|P4|Overall Study|Replaced for MTD analysis|0
1120902|NCT01648348|3676759|P3|Overall Study|Replaced for MTD analysis|1
1120903|NCT01648348|3676760|P2|Overall Study|Replaced for MTD analysis|0
1120904|NCT01648348|3676761|P1|Overall Study|Replaced for MTD analysis|1
1120905|NCT01648348|3676756|P6|Overall Study|Cancel|6
1120906|NCT01648348|3676757|P5|Overall Study|Cancel|3
1120907|NCT01648348|3676758|P4|Overall Study|Cancel|0
1120908|NCT01648348|3676759|P3|Overall Study|Cancel|0
1120909|NCT01648348|3676760|P2|Overall Study|Cancel|0
1120910|NCT01648348|3676761|P1|Overall Study|Cancel|1
1120911|NCT01648283|3676837|P1|Overall Study|Withdrawal by Subject|14
1120912|NCT01648140|3676847|P4|Overall Study|Lost to Follow-up|0
1120913|NCT01648140|3676848|P3|Overall Study|Lost to Follow-up|2
1120914|NCT01648140|3676849|P2|Overall Study|Lost to Follow-up|1
1120915|NCT01648140|3676850|P1|Overall Study|Lost to Follow-up|2
1120916|NCT01648140|3676847|P4|Overall Study|Withdrawal by Subject|2
1120917|NCT01648140|3676848|P3|Overall Study|Withdrawal by Subject|3
1120918|NCT01648140|3676849|P2|Overall Study|Withdrawal by Subject|3
1120919|NCT01648140|3676850|P1|Overall Study|Withdrawal by Subject|2
1120920|NCT01648140|3676847|P4|Overall Study|Adverse Event|0
1120921|NCT01648140|3676848|P3|Overall Study|Adverse Event|2
1120922|NCT01648140|3676849|P2|Overall Study|Adverse Event|1
1120923|NCT01648140|3676850|P1|Overall Study|Adverse Event|3
1120924|NCT01648140|3676847|P4|Overall Study|Lack of Efficacy|0
1120925|NCT01648140|3676848|P3|Overall Study|Lack of Efficacy|1
1120926|NCT01648140|3676849|P2|Overall Study|Lack of Efficacy|7
1120927|NCT01648140|3676850|P1|Overall Study|Lack of Efficacy|4
1120928|NCT01648140|3676847|P4|Overall Study|Physician Decision|0
1120929|NCT01648140|3676848|P3|Overall Study|Physician Decision|0
1120930|NCT01648140|3676849|P2|Overall Study|Physician Decision|0
1120931|NCT01648140|3676850|P1|Overall Study|Physician Decision|1
1120932|NCT01648101|3677015|P3|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
1120933|NCT01648101|3677016|P2|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1
1120934|NCT01648101|3677017|P1|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
1120935|NCT01648101|3677015|P3|Transition Phase (4 Weeks)|Study Terminated|0
1120936|NCT01648101|3677016|P2|Transition Phase (4 Weeks)|Study Terminated|0
1120937|NCT01648101|3677017|P1|Transition Phase (4 Weeks)|Study Terminated|1
1120938|NCT01648101|3677015|P3|Transition Phase (4 Weeks)|Withdrawal by Subject|2
1120939|NCT01648101|3677016|P2|Transition Phase (4 Weeks)|Withdrawal by Subject|0
1120940|NCT01648101|3677017|P1|Transition Phase (4 Weeks)|Withdrawal by Subject|0
1120941|NCT01648101|3677015|P3|Transition Phase (4 Weeks)|Lack of Efficacy|0
1120942|NCT01648101|3677016|P2|Transition Phase (4 Weeks)|Lack of Efficacy|2
1120943|NCT01648101|3677017|P1|Transition Phase (4 Weeks)|Lack of Efficacy|0
1120944|NCT01648101|3677015|P3|Transition Phase (4 Weeks)|Adverse Event|2
1120945|NCT01648101|3677016|P2|Transition Phase (4 Weeks)|Adverse Event|3
1120946|NCT01648101|3677017|P1|Transition Phase (4 Weeks)|Adverse Event|4
1120947|NCT01648101|3677015|P3|Maintenance Phase (12 Weeks)|Adverse Event|4
1120948|NCT01648101|3677016|P2|Maintenance Phase (12 Weeks)|Adverse Event|3
1120949|NCT01648101|3677017|P1|Maintenance Phase (12 Weeks)|Adverse Event|1
1120950|NCT01648101|3677015|P3|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
1120951|NCT01648101|3677016|P2|Maintenance Phase (12 Weeks)|Lack of Efficacy|0
1120952|NCT01648101|3677017|P1|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
1120953|NCT01648101|3677015|P3|Maintenance Phase (12 Weeks)|Withdrew Consent|1
1120954|NCT01648101|3677016|P2|Maintenance Phase (12 Weeks)|Withdrew Consent|0
1120955|NCT01648101|3677017|P1|Maintenance Phase (12 Weeks)|Withdrew Consent|1
1120956|NCT01648101|3677015|P3|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1
1120957|NCT01648101|3677016|P2|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
1120958|NCT01648101|3677017|P1|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
1120959|NCT01648101|3677015|P3|Titration Phase (4 Weeks)|Adverse Event|3
1120960|NCT01648101|3677016|P2|Titration Phase (4 Weeks)|Adverse Event|2
1120961|NCT01648101|3677017|P1|Titration Phase (4 Weeks)|Adverse Event|0
1120962|NCT01648101|3677015|P3|Titration Phase (4 Weeks)|Protocol Violation|2
1120963|NCT01648101|3677016|P2|Titration Phase (4 Weeks)|Protocol Violation|1
1120964|NCT01648101|3677017|P1|Titration Phase (4 Weeks)|Protocol Violation|2
1120965|NCT01647711|3677104|P5|Overall Study|Other reason not defined|0
1120966|NCT01647711|3677105|P4|Overall Study|Other reason not defined|1
1120967|NCT01647711|3677106|P3|Overall Study|Other reason not defined|1
1120968|NCT01647711|3677107|P2|Overall Study|Other reason not defined|1
1120969|NCT01647711|3677108|P1|Overall Study|Other reason not defined|0
1120970|NCT01647711|3677104|P5|Overall Study|Refused to continue taking medication|1
1120971|NCT01647711|3677105|P4|Overall Study|Refused to continue taking medication|2
1120972|NCT01647711|3677106|P3|Overall Study|Refused to continue taking medication|0
1120973|NCT01647711|3677107|P2|Overall Study|Refused to continue taking medication|0
1120974|NCT01647711|3677108|P1|Overall Study|Refused to continue taking medication|0
1120975|NCT01647711|3677104|P5|Overall Study|Protocol Violation|1
1120976|NCT01647711|3677105|P4|Overall Study|Protocol Violation|0
1120977|NCT01647711|3677106|P3|Overall Study|Protocol Violation|0
1120978|NCT01647711|3677107|P2|Overall Study|Protocol Violation|0
1120979|NCT01647711|3677108|P1|Overall Study|Protocol Violation|0
1120980|NCT01647711|3677104|P5|Overall Study|Other adverse event|2
1120981|NCT01647711|3677105|P4|Overall Study|Other adverse event|0
1120982|NCT01647711|3677106|P3|Overall Study|Other adverse event|2
1120983|NCT01647711|3677107|P2|Overall Study|Other adverse event|0
1120984|NCT01647711|3677108|P1|Overall Study|Other adverse event|0
1120985|NCT01647711|3677104|P5|Overall Study|Progressive disease|2
1120986|NCT01647711|3677105|P4|Overall Study|Progressive disease|8
1120987|NCT01647711|3677106|P3|Overall Study|Progressive disease|6
1120988|NCT01647711|3677107|P2|Overall Study|Progressive disease|2
1120989|NCT01647711|3677108|P1|Overall Study|Progressive disease|6
1120990|NCT01647542|3677136|P3|Overall Study|Death|1
1120991|NCT01647542|3677137|P2|Overall Study|Death|0
1120992|NCT01647542|3677138|P1|Overall Study|Death|0
1120993|NCT01647542|3677136|P3|Overall Study|Lack of Efficacy|0
1120994|NCT01647542|3677137|P2|Overall Study|Lack of Efficacy|1
1120995|NCT01647542|3677138|P1|Overall Study|Lack of Efficacy|1
1120996|NCT01647542|3677136|P3|Overall Study|Study Termination|65
1120997|NCT01647542|3677137|P2|Overall Study|Study Termination|61
1120998|NCT01647542|3677138|P1|Overall Study|Study Termination|64
1120999|NCT01647542|3677136|P3|Overall Study|Withdrawal by Subject|0
1121000|NCT01647542|3677137|P2|Overall Study|Withdrawal by Subject|4
1121001|NCT01647542|3677138|P1|Overall Study|Withdrawal by Subject|6
1121002|NCT01647542|3677136|P3|Overall Study|Lost to Follow-up|2
1121003|NCT01647542|3677137|P2|Overall Study|Lost to Follow-up|2
1121004|NCT01647542|3677138|P1|Overall Study|Lost to Follow-up|0
1121005|NCT01647542|3677136|P3|Overall Study|Adverse Event|4
1121006|NCT01647542|3677137|P2|Overall Study|Adverse Event|5
1121007|NCT01647542|3677138|P1|Overall Study|Adverse Event|4
1121008|NCT01647542|3677136|P3|Overall Study|Major Protocol Deviation|0
1121009|NCT01647542|3677137|P2|Overall Study|Major Protocol Deviation|0
1121010|NCT01647542|3677138|P1|Overall Study|Major Protocol Deviation|1
1121011|NCT01647282|3677172|P2|Overall Study|Physician Decision|5
1121012|NCT01647282|3677173|P1|Overall Study|Physician Decision|7
1121013|NCT01646827|3677194|P2|Overall Study|Withdrawal by Subject|0
1121014|NCT01646827|3677195|P1|Overall Study|Withdrawal by Subject|1
1121015|NCT01646827|3677194|P2|Overall Study|Physician Decision|2
1121016|NCT01646827|3677195|P1|Overall Study|Physician Decision|1
1121017|NCT01646827|3677194|P2|Overall Study|Lost to Follow-up|3
1121018|NCT01646827|3677195|P1|Overall Study|Lost to Follow-up|0
1121019|NCT01646398|3677282|P2|Overall Study|Withdrawal by Subject|0
1121020|NCT01646398|3677283|P1|Overall Study|Withdrawal by Subject|1
1121021|NCT01646385|3677299|P2|Overall Study|Switched to alternate biologic|649
1121022|NCT01646385|3677300|P1|Overall Study|Switched to alternate biologic|636
1121023|NCT01646385|3677299|P2|Overall Study|Death|222
1121024|NCT01646385|3677300|P1|Overall Study|Death|202
1121025|NCT01646320|3677343|P2|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2
1121026|NCT01646320|3677344|P1|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0
1121027|NCT01646320|3677343|P2|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1
1121028|NCT01646320|3677344|P1|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0
1121029|NCT01646320|3677343|P2|Long-term Period (Weeks 24 to 52)|Adverse Event|2
1121030|NCT01646320|3677344|P1|Long-term Period (Weeks 24 to 52)|Adverse Event|4
1121031|NCT01646320|3677343|P2|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2
1121032|NCT01646320|3677344|P1|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0
1121033|NCT01646320|3677343|P2|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0
1121034|NCT01646320|3677344|P1|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2
1121035|NCT01646320|3677343|P2|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0
1121036|NCT01646320|3677344|P1|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2
1121037|NCT01646320|3677343|P2|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
1121038|NCT01646320|3677344|P1|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
1121039|NCT01646320|3677343|P2|Short-term Period (Day 1 to Week 24)|Not specified|0
1121040|NCT01646320|3677344|P1|Short-term Period (Day 1 to Week 24)|Not specified|1
1121041|NCT01646320|3677343|P2|Short-term Period (Day 1 to Week 24)|Not reported|2
1121042|NCT01646320|3677344|P1|Short-term Period (Day 1 to Week 24)|Not reported|2
1121043|NCT01646320|3677343|P2|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1
1121044|NCT01646320|3677344|P1|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
1121045|NCT01646320|3677343|P2|Short-term Period (Day 1 to Week 24)|Adverse Event|0
1121046|NCT01646320|3677344|P1|Short-term Period (Day 1 to Week 24)|Adverse Event|3
1121047|NCT01646268|3677360|P2|Overall Study|Other|0
1121048|NCT01646268|3677361|P1|Overall Study|Other|2
1121049|NCT01646268|3677360|P2|Overall Study|Withdrawal by Subject|5
1121050|NCT01646268|3677361|P1|Overall Study|Withdrawal by Subject|2
1121051|NCT01646268|3677360|P2|Overall Study|Protocol Violation|1
1121052|NCT01646268|3677361|P1|Overall Study|Protocol Violation|0
1121053|NCT01646268|3677360|P2|Overall Study|Lack of Efficacy|3
1121054|NCT01646268|3677361|P1|Overall Study|Lack of Efficacy|1
1121055|NCT01646268|3677360|P2|Overall Study|Adverse Event|7
1121056|NCT01646268|3677361|P1|Overall Study|Adverse Event|6
1121057|NCT01646255|3677375|P2|Overall Study|Inclusion Criteria Deviation|0
1121058|NCT01646255|3677376|P1|Overall Study|Inclusion Criteria Deviation|1
1121059|NCT01646255|3677375|P2|Overall Study|Compliance is not well|0
1121060|NCT01646255|3677376|P1|Overall Study|Compliance is not well|1
1121061|NCT01646255|3677375|P2|Overall Study|Withdrawal by Subject|6
1121062|NCT01646255|3677376|P1|Overall Study|Withdrawal by Subject|10
1121063|NCT01646255|3677375|P2|Overall Study|Lack of Efficacy|0
1121064|NCT01646255|3677376|P1|Overall Study|Lack of Efficacy|2
1121065|NCT01646255|3677375|P2|Overall Study|Adverse Event|8
1121066|NCT01646255|3677376|P1|Overall Study|Adverse Event|7
1121067|NCT01646216|3677408|P2|Overall Study|Investigator decision|1
1121068|NCT01646216|3677409|P1|Overall Study|Investigator decision|1
1121069|NCT01646216|3677408|P2|Overall Study|Did not complete training|2
1121070|NCT01646216|3677409|P1|Overall Study|Did not complete training|0
1121071|NCT01646216|3677408|P2|Overall Study|Baseline step length difference (<5cm)|10
1121072|NCT01646216|3677409|P1|Overall Study|Baseline step length difference (<5cm)|10
1121073|NCT01646177|3677432|P4|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
1121074|NCT01646177|3677433|P3|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
1121075|NCT01646177|3677434|P2|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
1121076|NCT01646177|3677435|P1|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3
1121077|NCT01646177|3677432|P4|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1
1121078|NCT01646177|3677433|P3|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2
1121079|NCT01646177|3677434|P2|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
1121080|NCT01646177|3677435|P1|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
1121081|NCT01646177|3677432|P4|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
1121082|NCT01646177|3677433|P3|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
1121083|NCT01646177|3677434|P2|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
1121084|NCT01646177|3677435|P1|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
1121085|NCT01646177|3677432|P4|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
1121086|NCT01646177|3677433|P3|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
1121087|NCT01646177|3677434|P2|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2
1121088|NCT01646177|3677435|P1|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3
1121089|NCT01646177|3677432|P4|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7
1121090|NCT01646177|3677433|P3|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8
1121091|NCT01646177|3677434|P2|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3
1121092|NCT01646177|3677435|P1|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1
1121093|NCT01646177|3677432|P4|Blinded Induction Dosing (Week 0-12)|Adverse Event|8
1121094|NCT01646177|3677433|P3|Blinded Induction Dosing (Week 0-12)|Adverse Event|9
1121095|NCT01646177|3677434|P2|Blinded Induction Dosing (Week 0-12)|Adverse Event|4
1121096|NCT01646177|3677435|P1|Blinded Induction Dosing (Week 0-12)|Adverse Event|2
1121097|NCT01646138|3677529|P5|Overall Study|Lost to Follow-up|2
1121098|NCT01646138|3677530|P4|Overall Study|Lost to Follow-up|0
1121099|NCT01646138|3677531|P3|Overall Study|Lost to Follow-up|0
1121100|NCT01646138|3677532|P2|Overall Study|Lost to Follow-up|0
1121101|NCT01646138|3677533|P1|Overall Study|Lost to Follow-up|0
1121102|NCT01646125|3677547|P2|Overall Study|Subject/Guardian decision|1
1121103|NCT01646125|3677548|P1|Overall Study|Subject/Guardian decision|1
1121104|NCT01646125|3677547|P2|Overall Study|Study terminated by sponsor|1
1121105|NCT01646125|3677548|P1|Overall Study|Study terminated by sponsor|2
1121106|NCT01646125|3677547|P2|Overall Study|Progressive disease|16
1121107|NCT01646125|3677548|P1|Overall Study|Progressive disease|22
1121108|NCT01646125|3677547|P2|Overall Study|Physician Decision|3
1121109|NCT01646125|3677548|P1|Overall Study|Physician Decision|1
1121110|NCT01646125|3677547|P2|Overall Study|Death|1
1121111|NCT01646125|3677548|P1|Overall Study|Death|1
1121112|NCT01646125|3677547|P2|Overall Study|Adverse Event|1
1121113|NCT01646125|3677548|P1|Overall Study|Adverse Event|2
1121114|NCT01646125|3677547|P2|Overall Study|Untreated|5
1121115|NCT01646125|3677548|P1|Overall Study|Untreated|2
1121116|NCT01646073|3677573|P2|Period B (12 Weeks)|Lost to Follow-up|1
1121117|NCT01646073|3677574|P1|Period B (12 Weeks)|Lost to Follow-up|0
1121118|NCT01646073|3677573|P2|Period B (12 Weeks)|Withdrawal by Subject|5
1121119|NCT01646073|3677574|P1|Period B (12 Weeks)|Withdrawal by Subject|1
1121120|NCT01646073|3677573|P2|Period B (12 Weeks)|Adverse Event|7
1121121|NCT01646073|3677574|P1|Period B (12 Weeks)|Adverse Event|0
1121122|NCT01646073|3677573|P2|Period A (12 Weeks)|Not Specified|1
1121123|NCT01646073|3677574|P1|Period A (12 Weeks)|Not Specified|0
1121124|NCT01646073|3677573|P2|Period A (12 Weeks)|Protocol Violation|1
1121125|NCT01646073|3677574|P1|Period A (12 Weeks)|Protocol Violation|0
1121126|NCT01646073|3677573|P2|Period A (12 Weeks)|Lack of Efficacy|0
1121127|NCT01646073|3677574|P1|Period A (12 Weeks)|Lack of Efficacy|1
1121128|NCT01646073|3677573|P2|Period A (12 Weeks)|Withdrawal by Subject|1
1121129|NCT01646073|3677574|P1|Period A (12 Weeks)|Withdrawal by Subject|1
1121130|NCT01646073|3677573|P2|Period A (12 Weeks)|Adverse Event|2
1121131|NCT01646073|3677574|P1|Period A (12 Weeks)|Adverse Event|0
1121132|NCT01646021|3677615|P2|Overall Study|Withdrawal by Subject|15
1121133|NCT01646021|3677616|P1|Overall Study|Withdrawal by Subject|10
1121134|NCT01646021|3677615|P2|Overall Study|Lost to Follow-up|2
1121135|NCT01646021|3677616|P1|Overall Study|Lost to Follow-up|2
1121136|NCT01646021|3677615|P2|Overall Study|Study Terminated by Sponsor|41
1121137|NCT01646021|3677616|P1|Overall Study|Study Terminated by Sponsor|50
1121138|NCT01646021|3677615|P2|Overall Study|Death|83
1121139|NCT01646021|3677616|P1|Overall Study|Death|77
1121140|NCT01645930|3677653|P1|Overall Study|Reason not Defined|1
1121141|NCT01645930|3677653|P1|Overall Study|Withdrawal by Participant|2
1121142|NCT01645930|3677653|P1|Overall Study|Unsatisfactory Therapeutic Response|2
1121143|NCT01645930|3677653|P1|Overall Study|Adverse Event|4
1121144|NCT01645930|3677653|P1|Overall Study|Progressive Disease|12
1121145|NCT01645930|3677653|P1|Overall Study|Participants Ongoing on Study Treatment|22
1121146|NCT01645735|3677670|P2|Overall Study|Adverse Event|1
1121147|NCT01645735|3677671|P1|Overall Study|Adverse Event|0
1121148|NCT01645735|3677670|P2|Overall Study|Protocol Violation|0
1121149|NCT01645735|3677671|P1|Overall Study|Protocol Violation|1
1121150|NCT01645735|3677670|P2|Overall Study|Withdrawal by Subject|0
1121151|NCT01645735|3677671|P1|Overall Study|Withdrawal by Subject|1
1121152|NCT01645735|3677670|P2|Overall Study|Physician Decision|0
1121153|NCT01645735|3677671|P1|Overall Study|Physician Decision|2
1121154|NCT01645280|3677713|P5|Overall Study|Treatment not completed/Completed f/u|2
1121155|NCT01645280|3677714|P4|Overall Study|Treatment not completed/Completed f/u|0
1121156|NCT01645280|3677715|P3|Overall Study|Treatment not completed/Completed f/u|2
1121157|NCT01645280|3677716|P2|Overall Study|Treatment not completed/Completed f/u|1
1121158|NCT01645280|3677717|P1|Overall Study|Treatment not completed/Completed f/u|1
1121159|NCT01645280|3677713|P5|Overall Study|Other|0
1121160|NCT01645280|3677714|P4|Overall Study|Other|0
1121161|NCT01645280|3677715|P3|Overall Study|Other|2
1121162|NCT01645280|3677716|P2|Overall Study|Other|1
1121163|NCT01645280|3677717|P1|Overall Study|Other|1
1121164|NCT01645280|3677713|P5|Overall Study|Lost to Follow-up|1
1121165|NCT01645280|3677714|P4|Overall Study|Lost to Follow-up|2
1121166|NCT01645280|3677715|P3|Overall Study|Lost to Follow-up|0
1121167|NCT01645280|3677716|P2|Overall Study|Lost to Follow-up|0
1121168|NCT01645280|3677717|P1|Overall Study|Lost to Follow-up|0
1121169|NCT01645280|3677713|P5|Overall Study|Withdrawal by Subject|5
1121170|NCT01645280|3677714|P4|Overall Study|Withdrawal by Subject|4
1121171|NCT01645280|3677715|P3|Overall Study|Withdrawal by Subject|2
1121172|NCT01645280|3677716|P2|Overall Study|Withdrawal by Subject|0
1121173|NCT01645280|3677717|P1|Overall Study|Withdrawal by Subject|4
1121174|NCT01645280|3677713|P5|Overall Study|Death|0
1121175|NCT01645280|3677714|P4|Overall Study|Death|0
1121176|NCT01645280|3677715|P3|Overall Study|Death|0
1121177|NCT01645280|3677716|P2|Overall Study|Death|1
1121178|NCT01645280|3677717|P1|Overall Study|Death|0
1121179|NCT01645176|3677745|P1|Overall Study|did not complete final MRI|1
1121180|NCT01645176|3677745|P1|Overall Study|Lack of Efficacy|4
1121181|NCT01645111|3677749|P1|Overall Study|Did not require Clevidipine|15
1121182|NCT01644734|3677788|P1|Overall Study|Missing documentation|238
1121183|NCT01644734|3677788|P1|Overall Study|Reasons other than stated above|7
1121184|NCT01644734|3677788|P1|Overall Study|Lost to Follow-up|17
1121185|NCT01644734|3677788|P1|Overall Study|Adverse Event|4
1121186|NCT01644643|3677802|P4|Overall Study|Other Eligibility criteria|2
1121187|NCT01644643|3677803|P3|Overall Study|Other Eligibility criteria|0
1121188|NCT01644643|3677804|P2|Overall Study|Other Eligibility criteria|0
1121189|NCT01644643|3677805|P1|Overall Study|Other Eligibility criteria|0
1121190|NCT01644643|3677802|P4|Overall Study|Withdrawal by Subject|1
1121191|NCT01644643|3677803|P3|Overall Study|Withdrawal by Subject|2
1121192|NCT01644643|3677804|P2|Overall Study|Withdrawal by Subject|0
1121193|NCT01644643|3677805|P1|Overall Study|Withdrawal by Subject|1
1121194|NCT01644643|3677802|P4|Overall Study|Lost to Follow-up|4
1121195|NCT01644643|3677803|P3|Overall Study|Lost to Follow-up|0
1121196|NCT01644643|3677804|P2|Overall Study|Lost to Follow-up|0
1121197|NCT01644643|3677805|P1|Overall Study|Lost to Follow-up|0
1121198|NCT01644643|3677802|P4|Overall Study|Death|3
1121199|NCT01644643|3677803|P3|Overall Study|Death|3
1121200|NCT01644643|3677804|P2|Overall Study|Death|0
1121201|NCT01644643|3677805|P1|Overall Study|Death|1
1121202|NCT01644617|3677970|P3|Overall Study|Adverse Event|6
1121203|NCT01644617|3677971|P2|Overall Study|Adverse Event|0
1121204|NCT01644617|3677972|P1|Overall Study|Adverse Event|3
1121205|NCT01644617|3677970|P3|Overall Study|Lost to Follow-up|0
1121206|NCT01644617|3677971|P2|Overall Study|Lost to Follow-up|1
1121207|NCT01644617|3677972|P1|Overall Study|Lost to Follow-up|0
1121208|NCT01644617|3677970|P3|Overall Study|Withdrawal by Subject|1
1121209|NCT01644617|3677971|P2|Overall Study|Withdrawal by Subject|4
1121210|NCT01644617|3677972|P1|Overall Study|Withdrawal by Subject|3
1121211|NCT01644500|3678025|P3|Overall Study|Physician Decision|1
1121212|NCT01644500|3678026|P2|Overall Study|Physician Decision|1
1121213|NCT01644500|3678027|P1|Overall Study|Physician Decision|1
1121214|NCT01644500|3678025|P3|Overall Study|Withdrawal by Subject|12
1121215|NCT01644500|3678026|P2|Overall Study|Withdrawal by Subject|12
1121216|NCT01644500|3678027|P1|Overall Study|Withdrawal by Subject|11
1121217|NCT01644500|3678025|P3|Overall Study|Protocol Violation|0
1121218|NCT01644500|3678026|P2|Overall Study|Protocol Violation|1
1121219|NCT01644500|3678027|P1|Overall Study|Protocol Violation|1
1121220|NCT01644500|3678025|P3|Overall Study|Lost to Follow-up|0
1121221|NCT01644500|3678026|P2|Overall Study|Lost to Follow-up|8
1121222|NCT01644500|3678027|P1|Overall Study|Lost to Follow-up|3
1121223|NCT01644500|3678025|P3|Overall Study|Death|0
1121224|NCT01644500|3678026|P2|Overall Study|Death|1
1121225|NCT01644500|3678027|P1|Overall Study|Death|0
1121226|NCT01644500|3678025|P3|Overall Study|Adverse Event|2
1121227|NCT01644500|3678026|P2|Overall Study|Adverse Event|1
1121228|NCT01644500|3678027|P1|Overall Study|Adverse Event|6
1121229|NCT01644474|3678097|P2|Overall Study|Protocol Violation|0
1121230|NCT01644474|3678098|P1|Overall Study|Protocol Violation|1
1121231|NCT01644474|3678097|P2|Overall Study|Site scheduling error|1
1121232|NCT01644474|3678098|P1|Overall Study|Site scheduling error|1
1121233|NCT01644474|3678097|P2|Overall Study|Adverse Event|5
1121234|NCT01644474|3678098|P1|Overall Study|Adverse Event|4
1121235|NCT01644474|3678097|P2|Overall Study|Participant moved|1
1121236|NCT01644474|3678098|P1|Overall Study|Participant moved|0
1121237|NCT01644474|3678097|P2|Overall Study|Consent withdrawn by participant|1
1121238|NCT01644474|3678098|P1|Overall Study|Consent withdrawn by participant|0
1121239|NCT01644474|3678097|P2|Overall Study|Poor compliance to protocol|0
1121240|NCT01644474|3678098|P1|Overall Study|Poor compliance to protocol|1
1121241|NCT01644188|3678282|P2|Overall Study|Other than specified above|7
1121242|NCT01644188|3678283|P1|Overall Study|Other than specified above|6
1121243|NCT01644188|3678282|P2|Overall Study|Site closure|1
1121244|NCT01644188|3678283|P1|Overall Study|Site closure|1
1121245|NCT01644188|3678282|P2|Overall Study|Last visit outside protocol visit window|16
1121246|NCT01644188|3678283|P1|Overall Study|Last visit outside protocol visit window|14
1121247|NCT01644188|3678282|P2|Overall Study|Death|3
1121248|NCT01644188|3678283|P1|Overall Study|Death|4
1121249|NCT01644188|3678282|P2|Overall Study|Lost to Follow-up|0
1121250|NCT01644188|3678283|P1|Overall Study|Lost to Follow-up|1
1121251|NCT01644188|3678282|P2|Overall Study|Selection criteria finally not met|0
1121252|NCT01644188|3678283|P1|Overall Study|Selection criteria finally not met|2
1121253|NCT01644188|3678282|P2|Overall Study|Consent withdrawn by participant|7
1121254|NCT01644188|3678283|P1|Overall Study|Consent withdrawn by participant|14
1121255|NCT01644188|3678282|P2|Overall Study|Related to auto-injector administration|2
1121256|NCT01644188|3678283|P1|Overall Study|Related to auto-injector administration|2
1121257|NCT01644188|3678282|P2|Overall Study|Participant moved|2
1121258|NCT01644188|3678283|P1|Overall Study|Participant moved|7
1121259|NCT01644188|3678282|P2|Overall Study|Physician Decision|3
1121260|NCT01644188|3678283|P1|Overall Study|Physician Decision|1
1121261|NCT01644188|3678282|P2|Overall Study|Poor compliance to protocol|14
1121262|NCT01644188|3678283|P1|Overall Study|Poor compliance to protocol|26
1121263|NCT01644188|3678282|P2|Overall Study|Adverse Event|20
1121264|NCT01644188|3678283|P1|Overall Study|Adverse Event|44
1121265|NCT01644175|3678341|P2|Overall Study|Other than specified above|3
1121266|NCT01644175|3678342|P1|Overall Study|Other than specified above|0
1121267|NCT01644175|3678341|P2|Overall Study|Lost to Follow-up|0
1121268|NCT01644175|3678342|P1|Overall Study|Lost to Follow-up|1
1121269|NCT01644175|3678341|P2|Overall Study|Site closure|2
1121270|NCT01644175|3678342|P1|Overall Study|Site closure|2
1121271|NCT01644175|3678341|P2|Overall Study|Selection criteria finally not met|1
1121272|NCT01644175|3678342|P1|Overall Study|Selection criteria finally not met|0
1121273|NCT01644175|3678341|P2|Overall Study|Last visit outside protocol visit window|11
1121274|NCT01644175|3678342|P1|Overall Study|Last visit outside protocol visit window|4
1121275|NCT01644175|3678341|P2|Overall Study|Related to Autoinjector Administration|1
1121276|NCT01644175|3678342|P1|Overall Study|Related to Autoinjector Administration|2
1121277|NCT01644175|3678341|P2|Overall Study|Consent withdrawn by participant|4
1121278|NCT01644175|3678342|P1|Overall Study|Consent withdrawn by participant|3
1121279|NCT01644175|3678341|P2|Overall Study|Participant Moved|2
1121280|NCT01644175|3678342|P1|Overall Study|Participant Moved|1
1121281|NCT01644175|3678341|P2|Overall Study|Physician Decision|2
1121282|NCT01644175|3678342|P1|Overall Study|Physician Decision|1
1121283|NCT01644175|3678341|P2|Overall Study|Poor compliance to protocol|10
1121284|NCT01644175|3678342|P1|Overall Study|Poor compliance to protocol|9
1121285|NCT01644175|3678341|P2|Overall Study|Death|2
1121286|NCT01644175|3678342|P1|Overall Study|Death|1
1121287|NCT01644175|3678341|P2|Overall Study|Adverse Event|13
1121288|NCT01644175|3678342|P1|Overall Study|Adverse Event|8
1121289|NCT01644175|3678341|P2|Overall Study|Randomized But Not Treated|2
1121290|NCT01644175|3678342|P1|Overall Study|Randomized But Not Treated|0
1121291|NCT01643928|3678402|P5|Overall Study|Adverse Event|2
1121292|NCT01643928|3678403|P4|Overall Study|Adverse Event|1
1121293|NCT01643928|3678404|P3|Overall Study|Adverse Event|0
1121294|NCT01643928|3678405|P2|Overall Study|Adverse Event|1
1121295|NCT01643928|3678406|P1|Overall Study|Adverse Event|2
1121296|NCT01643928|3678402|P5|Overall Study|Other|0
1121297|NCT01643928|3678403|P4|Overall Study|Other|0
1121298|NCT01643928|3678404|P3|Overall Study|Other|1
1121299|NCT01643928|3678405|P2|Overall Study|Other|1
1121300|NCT01643928|3678406|P1|Overall Study|Other|5
1121301|NCT01643928|3678402|P5|Overall Study|Pregnancy|0
1121302|NCT01643928|3678403|P4|Overall Study|Pregnancy|1
1121303|NCT01643928|3678404|P3|Overall Study|Pregnancy|0
1121304|NCT01643928|3678405|P2|Overall Study|Pregnancy|0
1121305|NCT01643928|3678406|P1|Overall Study|Pregnancy|0
1121306|NCT01643928|3678402|P5|Overall Study|Withdrawal by Subject|0
1121307|NCT01643928|3678403|P4|Overall Study|Withdrawal by Subject|1
1121308|NCT01643928|3678404|P3|Overall Study|Withdrawal by Subject|0
1121309|NCT01643928|3678405|P2|Overall Study|Withdrawal by Subject|0
1121310|NCT01643928|3678406|P1|Overall Study|Withdrawal by Subject|2
1121311|NCT01643928|3678402|P5|Overall Study|Lost to Follow-up|0
1121312|NCT01643928|3678403|P4|Overall Study|Lost to Follow-up|0
1121313|NCT01643928|3678404|P3|Overall Study|Lost to Follow-up|2
1121314|NCT01643928|3678405|P2|Overall Study|Lost to Follow-up|0
1121315|NCT01643928|3678406|P1|Overall Study|Lost to Follow-up|1
1121316|NCT01643798|3678701|P2|Pretreatment 1 and Stimulation|Withdrawal by Subject|0
1121317|NCT01643798|3678702|P1|Pretreatment 1 and Stimulation|Withdrawal by Subject|1
1121318|NCT01643668|3678713|P1|Overall Study|Death|1
1121319|NCT01643044|3678753|P2|Overall Study|Delivered outside of hospital|2
1121320|NCT01643044|3678754|P1|Overall Study|Delivered outside of hospital|1
1121321|NCT01643044|3678753|P2|Overall Study|Miscarried baby|2
1121322|NCT01643044|3678754|P1|Overall Study|Miscarried baby|2
1121323|NCT01643044|3678753|P2|Overall Study|Lost to Follow-up|1
1121324|NCT01643044|3678754|P1|Overall Study|Lost to Follow-up|1
1121325|NCT01642914|3678763|P3|Overall Study|Other Reason|0
1121326|NCT01642914|3678764|P2|Overall Study|Other Reason|0
1121327|NCT01642914|3678765|P1|Overall Study|Other Reason|1
1121328|NCT01642914|3678763|P3|Overall Study|Lost to Follow-up|7
1121329|NCT01642914|3678764|P2|Overall Study|Lost to Follow-up|3
1121330|NCT01642914|3678765|P1|Overall Study|Lost to Follow-up|5
1121331|NCT01642914|3678763|P3|Overall Study|Withdrawal by Subject|10
1121332|NCT01642914|3678764|P2|Overall Study|Withdrawal by Subject|5
1121333|NCT01642914|3678765|P1|Overall Study|Withdrawal by Subject|5
1121334|NCT01642914|3678763|P3|Overall Study|Protocol Violation|6
1121335|NCT01642914|3678764|P2|Overall Study|Protocol Violation|13
1121336|NCT01642914|3678765|P1|Overall Study|Protocol Violation|15
1121337|NCT01642914|3678763|P3|Overall Study|Lack of Efficacy|2
1121338|NCT01642914|3678764|P2|Overall Study|Lack of Efficacy|4
1121339|NCT01642914|3678765|P1|Overall Study|Lack of Efficacy|9
1121340|NCT01642914|3678763|P3|Overall Study|Adverse Event|15
1121341|NCT01642914|3678764|P2|Overall Study|Adverse Event|7
1121342|NCT01642914|3678765|P1|Overall Study|Adverse Event|11
1121343|NCT01642732|3678840|P1|Overall Study|Withdrawal by Subject|1
1121344|NCT01642615|3678845|P3|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1
1121345|NCT01642615|3678846|P2|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
1121346|NCT01642615|3678847|P1|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
1121347|NCT01642615|3678845|P3|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
1121348|NCT01642615|3678846|P2|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1
1121349|NCT01642615|3678847|P1|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
1121350|NCT01642615|3678845|P3|Double Blind Maintenance Phase|Voluntary Withdrawal|2
1121351|NCT01642615|3678846|P2|Double Blind Maintenance Phase|Voluntary Withdrawal|5
1121352|NCT01642615|3678847|P1|Double Blind Maintenance Phase|Voluntary Withdrawal|0
1121353|NCT01642615|3678845|P3|Double Blind Maintenance Phase|Lack of Efficacy|3
1121354|NCT01642615|3678846|P2|Double Blind Maintenance Phase|Lack of Efficacy|1
1121355|NCT01642615|3678847|P1|Double Blind Maintenance Phase|Lack of Efficacy|0
1121356|NCT01642615|3678845|P3|Open Label Maintenance Phase|Did not receive treatment|0
1121357|NCT01642615|3678846|P2|Open Label Maintenance Phase|Did not receive treatment|0
1121358|NCT01642615|3678847|P1|Open Label Maintenance Phase|Did not receive treatment|1
1121359|NCT01642615|3678845|P3|Open Label Maintenance Phase|Voluntary Withdrawal|0
1121360|NCT01642615|3678846|P2|Open Label Maintenance Phase|Voluntary Withdrawal|0
1121361|NCT01642615|3678847|P1|Open Label Maintenance Phase|Voluntary Withdrawal|1
1121362|NCT01642615|3678845|P3|Open Label Maintenance Phase|Lost to Follow-up|0
1121363|NCT01642615|3678846|P2|Open Label Maintenance Phase|Lost to Follow-up|0
1121364|NCT01642615|3678847|P1|Open Label Maintenance Phase|Lost to Follow-up|1
1121365|NCT01642615|3678845|P3|Open Label Maintenance Phase|Major Protocol Deviation|0
1121366|NCT01642615|3678846|P2|Open Label Maintenance Phase|Major Protocol Deviation|0
1121367|NCT01642615|3678847|P1|Open Label Maintenance Phase|Major Protocol Deviation|1
1121368|NCT01642615|3678845|P3|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
1121369|NCT01642615|3678846|P2|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
1121370|NCT01642615|3678847|P1|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1
1121371|NCT01642602|3678861|P1|Overall Study|Adverse Event|2
1121372|NCT01642589|3678868|P2|Overall Study|Withdrawal by Subject|1
1121373|NCT01642589|3678869|P1|Overall Study|Withdrawal by Subject|1
1121374|NCT01642407|3678908|P1|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1
1121375|NCT01642407|3678908|P1|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1
1121376|NCT01642407|3678908|P1|Part 1 (Screening Till Week 16)|Insufficient clinical response|3
1121377|NCT01642277|3678955|P2|Overall Study|Withdrawal by Subject|0
1121378|NCT01642277|3678956|P1|Overall Study|Withdrawal by Subject|11
1121379|NCT01642277|3678955|P2|Overall Study|Protocol Violation|0
1121380|NCT01642277|3678956|P1|Overall Study|Protocol Violation|1
1121381|NCT01642277|3678955|P2|Overall Study|Physician Decision|0
1121382|NCT01642277|3678956|P1|Overall Study|Physician Decision|2
1121383|NCT01642277|3678955|P2|Overall Study|Adverse Event|0
1121384|NCT01642277|3678956|P1|Overall Study|Adverse Event|10
1121385|NCT01642212|3678988|P5|Open-label Extension|Not Specified|1
1121386|NCT01642212|3678989|P4|Open-label Extension|Not Specified|0
1121387|NCT01642212|3678990|P3|Open-label Extension|Not Specified|0
1121388|NCT01642212|3678991|P2|Open-label Extension|Not Specified|0
1121389|NCT01642212|3678992|P1|Open-label Extension|Not Specified|0
1121390|NCT01642212|3678988|P5|Open-label Extension|Lost to Follow-up|1
1121391|NCT01642212|3678989|P4|Open-label Extension|Lost to Follow-up|0
1121392|NCT01642212|3678990|P3|Open-label Extension|Lost to Follow-up|0
1121393|NCT01642212|3678991|P2|Open-label Extension|Lost to Follow-up|0
1121394|NCT01642212|3678992|P1|Open-label Extension|Lost to Follow-up|0
1121395|NCT01642212|3678988|P5|Open-label Extension|Consent Withdrawn|2
1121396|NCT01642212|3678989|P4|Open-label Extension|Consent Withdrawn|0
1121397|NCT01642212|3678990|P3|Open-label Extension|Consent Withdrawn|0
1121398|NCT01642212|3678991|P2|Open-label Extension|Consent Withdrawn|0
1121399|NCT01642212|3678992|P1|Open-label Extension|Consent Withdrawn|0
1121400|NCT01642212|3678988|P5|Open-label Extension|Sponsor Decision|4
1121401|NCT01642212|3678989|P4|Open-label Extension|Sponsor Decision|7
1121402|NCT01642212|3678990|P3|Open-label Extension|Sponsor Decision|0
1121403|NCT01642212|3678991|P2|Open-label Extension|Sponsor Decision|0
1121404|NCT01642212|3678992|P1|Open-label Extension|Sponsor Decision|0
1121405|NCT01642212|3678988|P5|Open-label Extension|Adverse Event|0
1121406|NCT01642212|3678989|P4|Open-label Extension|Adverse Event|3
1121407|NCT01642212|3678990|P3|Open-label Extension|Adverse Event|0
1121408|NCT01642212|3678991|P2|Open-label Extension|Adverse Event|0
1121409|NCT01642212|3678992|P1|Open-label Extension|Adverse Event|0
1121410|NCT01642212|3678988|P5|Double-blind Treatment|Adverse Event|0
1121411|NCT01642212|3678989|P4|Double-blind Treatment|Adverse Event|0
1121412|NCT01642212|3678990|P3|Double-blind Treatment|Adverse Event|1
1121413|NCT01642212|3678991|P2|Double-blind Treatment|Adverse Event|0
1121414|NCT01642212|3678992|P1|Double-blind Treatment|Adverse Event|0
1121415|NCT01642212|3678988|P5|Double-blind Treatment|Non-compliance|0
1121416|NCT01642212|3678989|P4|Double-blind Treatment|Non-compliance|0
1121417|NCT01642212|3678990|P3|Double-blind Treatment|Non-compliance|0
1121418|NCT01642212|3678991|P2|Double-blind Treatment|Non-compliance|1
1121419|NCT01642212|3678992|P1|Double-blind Treatment|Non-compliance|0
1121420|NCT01642212|3678988|P5|Double-blind Treatment|Not Specified|0
1121421|NCT01642212|3678989|P4|Double-blind Treatment|Not Specified|0
1121422|NCT01642212|3678990|P3|Double-blind Treatment|Not Specified|1
1121423|NCT01642212|3678991|P2|Double-blind Treatment|Not Specified|2
1121424|NCT01642212|3678992|P1|Double-blind Treatment|Not Specified|0
1121425|NCT01642212|3678988|P5|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
1121426|NCT01642212|3678989|P4|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
1121427|NCT01642212|3678990|P3|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
1121428|NCT01642212|3678991|P2|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
1121429|NCT01642212|3678992|P1|Single-blind Baseline|Did Not Meet Eligibility Criteria|26
1121430|NCT01642004|3679087|P2|Treatment|Missing from data|1
1121431|NCT01642004|3679088|P1|Treatment|Missing from data|0
1121432|NCT01642004|3679087|P2|Treatment|Other|2
1121433|NCT01642004|3679088|P1|Treatment|Other|1
1121434|NCT01642004|3679087|P2|Treatment|No longer meets study criteria|2
1121435|NCT01642004|3679088|P1|Treatment|No longer meets study criteria|1
1121436|NCT01642004|3679087|P2|Treatment|Poor/non-compliance|0
1121437|NCT01642004|3679088|P1|Treatment|Poor/non-compliance|1
1121438|NCT01642004|3679087|P2|Treatment|Maximum clinical benefit|7
1121439|NCT01642004|3679088|P1|Treatment|Maximum clinical benefit|2
1121440|NCT01642004|3679087|P2|Treatment|Withdrawal by Subject|9
1121441|NCT01642004|3679088|P1|Treatment|Withdrawal by Subject|5
1121442|NCT01642004|3679087|P2|Treatment|Adverse event unrelated to study drug|13
1121443|NCT01642004|3679088|P1|Treatment|Adverse event unrelated to study drug|6
1121444|NCT01642004|3679087|P2|Treatment|Death|0
1121445|NCT01642004|3679088|P1|Treatment|Death|1
1121446|NCT01642004|3679087|P2|Treatment|Study drug toxicity|13
1121447|NCT01642004|3679088|P1|Treatment|Study drug toxicity|5
1121448|NCT01642004|3679087|P2|Treatment|Disease progression|80
1121449|NCT01642004|3679088|P1|Treatment|Disease progression|88
1121450|NCT01642004|3679087|P2|Randomization|No longer meets study criteria|2
1121451|NCT01642004|3679088|P1|Randomization|No longer meets study criteria|2
1121452|NCT01642004|3679087|P2|Randomization|Withdrawal by Subject|6
1121453|NCT01642004|3679088|P1|Randomization|Withdrawal by Subject|1
1121454|NCT01642004|3679087|P2|Randomization|Adverse Event unrelated to study drug|0
1121455|NCT01642004|3679088|P1|Randomization|Adverse Event unrelated to study drug|1
1121456|NCT01641991|3679122|P4|Overall Study|no longer eligible|4
1121457|NCT01641991|3679123|P3|Overall Study|no longer eligible|0
1121458|NCT01641991|3679124|P2|Overall Study|no longer eligible|1
1121459|NCT01641991|3679125|P1|Overall Study|no longer eligible|2
1121460|NCT01641991|3679122|P4|Overall Study|Pregnancy|0
1121461|NCT01641991|3679123|P3|Overall Study|Pregnancy|1
1121462|NCT01641991|3679124|P2|Overall Study|Pregnancy|0
1121463|NCT01641991|3679125|P1|Overall Study|Pregnancy|0
1121464|NCT01641991|3679122|P4|Overall Study|Protocol Violation|0
1121465|NCT01641991|3679123|P3|Overall Study|Protocol Violation|3
1121466|NCT01641991|3679124|P2|Overall Study|Protocol Violation|1
1121467|NCT01641991|3679125|P1|Overall Study|Protocol Violation|1
1121468|NCT01641991|3679122|P4|Overall Study|Lost to Follow-up|1
1121469|NCT01641991|3679123|P3|Overall Study|Lost to Follow-up|3
1121470|NCT01641991|3679124|P2|Overall Study|Lost to Follow-up|2
1121471|NCT01641991|3679125|P1|Overall Study|Lost to Follow-up|0
1121472|NCT01641991|3679122|P4|Overall Study|Adverse Event|1
1121473|NCT01641991|3679123|P3|Overall Study|Adverse Event|2
1121474|NCT01641991|3679124|P2|Overall Study|Adverse Event|1
1121475|NCT01641991|3679125|P1|Overall Study|Adverse Event|2
1121476|NCT01641991|3679122|P4|Overall Study|Withdrawal by Subject|5
1121477|NCT01641991|3679123|P3|Overall Study|Withdrawal by Subject|1
1121478|NCT01641991|3679124|P2|Overall Study|Withdrawal by Subject|2
1121479|NCT01641991|3679125|P1|Overall Study|Withdrawal by Subject|4
1121480|NCT01641991|3679122|P4|Overall Study|Physician Decision|5
1121481|NCT01641991|3679123|P3|Overall Study|Physician Decision|7
1121482|NCT01641991|3679124|P2|Overall Study|Physician Decision|1
1121483|NCT01641991|3679125|P1|Overall Study|Physician Decision|0
1121484|NCT01641952|3679209|P1|Overall Study|Adverse Event|6
1121485|NCT01641952|3679209|P1|Overall Study|Lost to Follow-up|28
1121486|NCT01641939|3679225|P3|Overall Study|Study Terminated by Sponsor|3
1121487|NCT01641939|3679226|P2|Overall Study|Study Terminated by Sponsor|28
1121488|NCT01641939|3679227|P1|Overall Study|Study Terminated by Sponsor|10
1121489|NCT01641939|3679225|P3|Overall Study|Withdrawal by Subject|5
1121490|NCT01641939|3679226|P2|Overall Study|Withdrawal by Subject|11
1121491|NCT01641939|3679227|P1|Overall Study|Withdrawal by Subject|14
1121492|NCT01641939|3679225|P3|Overall Study|Lost to Follow-up|1
1121493|NCT01641939|3679226|P2|Overall Study|Lost to Follow-up|2
1121494|NCT01641939|3679227|P1|Overall Study|Lost to Follow-up|3
1121495|NCT01641939|3679225|P3|Overall Study|Death|61
1121496|NCT01641939|3679226|P2|Overall Study|Death|187
1121497|NCT01641939|3679227|P1|Overall Study|Death|90
1121498|NCT01641926|3679270|P4|Overall Study|Not Treated|0
1121499|NCT01641926|3679271|P3|Overall Study|Not Treated|1
1121500|NCT01641926|3679272|P2|Overall Study|Not Treated|1
1121501|NCT01641926|3679273|P1|Overall Study|Not Treated|1
1121502|NCT01641926|3679270|P4|Overall Study|Withdrawal by Subject|1
1121503|NCT01641926|3679271|P3|Overall Study|Withdrawal by Subject|6
1121504|NCT01641926|3679272|P2|Overall Study|Withdrawal by Subject|5
1121505|NCT01641926|3679273|P1|Overall Study|Withdrawal by Subject|13
1121506|NCT01641926|3679270|P4|Overall Study|Protocol Violation|1
1121507|NCT01641926|3679271|P3|Overall Study|Protocol Violation|0
1121508|NCT01641926|3679272|P2|Overall Study|Protocol Violation|0
1121509|NCT01641926|3679273|P1|Overall Study|Protocol Violation|1
1121510|NCT01641926|3679270|P4|Overall Study|Physician Decision|1
1121511|NCT01641926|3679271|P3|Overall Study|Physician Decision|0
1121512|NCT01641926|3679272|P2|Overall Study|Physician Decision|5
1121513|NCT01641926|3679273|P1|Overall Study|Physician Decision|6
1121514|NCT01641926|3679270|P4|Overall Study|Lost to Follow-up|0
1121515|NCT01641926|3679271|P3|Overall Study|Lost to Follow-up|1
1121516|NCT01641926|3679272|P2|Overall Study|Lost to Follow-up|2
1121517|NCT01641926|3679273|P1|Overall Study|Lost to Follow-up|2
1121518|NCT01641926|3679270|P4|Overall Study|Adverse Event|1
1121519|NCT01641926|3679271|P3|Overall Study|Adverse Event|3
1121520|NCT01641926|3679272|P2|Overall Study|Adverse Event|2
1121521|NCT01641926|3679273|P1|Overall Study|Adverse Event|5
1121522|NCT01641900|3679301|P2|Overall Study|Withdrawal by Subject|2
1121523|NCT01641900|3679302|P1|Overall Study|Withdrawal by Subject|2
1121524|NCT01641861|3679314|P2|Overall Study|Died due to drowning|1
1121525|NCT01641861|3679315|P1|Overall Study|Died due to drowning|0
1121526|NCT01641861|3679314|P2|Overall Study|Lost the tooth due to normal exfoliation|8
1121527|NCT01641861|3679315|P1|Overall Study|Lost the tooth due to normal exfoliation|14
1121528|NCT01641861|3679314|P2|Overall Study|Lost to Follow-up|16
1121529|NCT01641861|3679315|P1|Overall Study|Lost to Follow-up|21
1121530|NCT01641822|3679336|P3|Comparative Phase|Protocol-specified criteria for withdraw|1
1121531|NCT01641822|3679337|P2|Comparative Phase|Protocol-specified criteria for withdraw|1
1121532|NCT01641822|3679338|P1|Comparative Phase|Protocol-specified criteria for withdraw|0
1121533|NCT01641822|3679336|P3|Comparative Phase|Withdrew consent|7
1121534|NCT01641822|3679337|P2|Comparative Phase|Withdrew consent|3
1121535|NCT01641822|3679338|P1|Comparative Phase|Withdrew consent|0
1121536|NCT01641822|3679336|P3|Comparative Phase|Adverse event, serious fatal|0
1121537|NCT01641822|3679337|P2|Comparative Phase|Adverse event, serious fatal|1
1121538|NCT01641822|3679338|P1|Comparative Phase|Adverse event, serious fatal|0
1121539|NCT01641822|3679336|P3|Comparative Phase|Pregnancy|1
1121540|NCT01641822|3679337|P2|Comparative Phase|Pregnancy|0
1121541|NCT01641822|3679338|P1|Comparative Phase|Pregnancy|0
1121542|NCT01641822|3679336|P3|Comparative Phase|Investigator's discretion|1
1121543|NCT01641822|3679337|P2|Comparative Phase|Investigator's discretion|0
1121544|NCT01641822|3679338|P1|Comparative Phase|Investigator's discretion|0
1121545|NCT01641822|3679336|P3|Comparative Phase|Noncompliance with study drug|0
1121546|NCT01641822|3679337|P2|Comparative Phase|Noncompliance with study drug|1
1121547|NCT01641822|3679338|P1|Comparative Phase|Noncompliance with study drug|0
1121548|NCT01641822|3679336|P3|Run-in Phase|Protocol-specified criteria for withdraw|0
1121549|NCT01641822|3679337|P2|Run-in Phase|Protocol-specified criteria for withdraw|0
1121550|NCT01641822|3679338|P1|Run-in Phase|Protocol-specified criteria for withdraw|9
1121551|NCT01641822|3679336|P3|Run-in Phase|Withdrew consent|0
1121552|NCT01641822|3679337|P2|Run-in Phase|Withdrew consent|0
1121553|NCT01641822|3679338|P1|Run-in Phase|Withdrew consent|1
1121554|NCT01641822|3679336|P3|Run-in Phase|Adverse Event|0
1121555|NCT01641822|3679337|P2|Run-in Phase|Adverse Event|0
1121556|NCT01641822|3679338|P1|Run-in Phase|Adverse Event|3
1121557|NCT01641822|3679336|P3|Run-in Phase|Noncompliance with study drug|0
1121558|NCT01641822|3679337|P2|Run-in Phase|Noncompliance with study drug|0
1121559|NCT01641822|3679338|P1|Run-in Phase|Noncompliance with study drug|1
1121560|NCT01641692|3679355|P8|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
1121561|NCT01641692|3679356|P7|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
1121562|NCT01641692|3679357|P6|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
1121563|NCT01641692|3679358|P5|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
1121564|NCT01641692|3679359|P4|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
1121565|NCT01641692|3679360|P3|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
1121566|NCT01641692|3679361|P2|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
1121567|NCT01641692|3679362|P1|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
1121568|NCT01641692|3679355|P8|Washout Period 3 or Follow-up|Protocol Violation|0
1121569|NCT01641692|3679356|P7|Washout Period 3 or Follow-up|Protocol Violation|0
1121570|NCT01641692|3679357|P6|Washout Period 3 or Follow-up|Protocol Violation|1
1121571|NCT01641692|3679358|P5|Washout Period 3 or Follow-up|Protocol Violation|0
1121572|NCT01641692|3679359|P4|Washout Period 3 or Follow-up|Protocol Violation|0
1121573|NCT01641692|3679360|P3|Washout Period 3 or Follow-up|Protocol Violation|0
1121574|NCT01641692|3679361|P2|Washout Period 3 or Follow-up|Protocol Violation|0
1121575|NCT01641692|3679362|P1|Washout Period 3 or Follow-up|Protocol Violation|0
1121576|NCT01641692|3679355|P8|Treatment Period 3|Lost to Follow-up|0
1121577|NCT01641692|3679356|P7|Treatment Period 3|Lost to Follow-up|0
1121578|NCT01641692|3679357|P6|Treatment Period 3|Lost to Follow-up|0
1121579|NCT01641692|3679358|P5|Treatment Period 3|Lost to Follow-up|0
1121580|NCT01641692|3679359|P4|Treatment Period 3|Lost to Follow-up|0
1121581|NCT01641692|3679360|P3|Treatment Period 3|Lost to Follow-up|0
1121582|NCT01641692|3679361|P2|Treatment Period 3|Lost to Follow-up|1
1121583|NCT01641692|3679362|P1|Treatment Period 3|Lost to Follow-up|0
1121584|NCT01641692|3679355|P8|Treatment Period 3|Protocol-defined Stopping Criteria|0
1121585|NCT01641692|3679356|P7|Treatment Period 3|Protocol-defined Stopping Criteria|1
1121586|NCT01641692|3679357|P6|Treatment Period 3|Protocol-defined Stopping Criteria|0
1121587|NCT01641692|3679358|P5|Treatment Period 3|Protocol-defined Stopping Criteria|0
1121588|NCT01641692|3679359|P4|Treatment Period 3|Protocol-defined Stopping Criteria|0
1121589|NCT01641692|3679360|P3|Treatment Period 3|Protocol-defined Stopping Criteria|0
1121590|NCT01641692|3679361|P2|Treatment Period 3|Protocol-defined Stopping Criteria|0
1121591|NCT01641692|3679362|P1|Treatment Period 3|Protocol-defined Stopping Criteria|0
1121592|NCT01641692|3679355|P8|Treatment Period 3|Protocol Violation|0
1121593|NCT01641692|3679356|P7|Treatment Period 3|Protocol Violation|0
1121594|NCT01641692|3679357|P6|Treatment Period 3|Protocol Violation|0
1121595|NCT01641692|3679358|P5|Treatment Period 3|Protocol Violation|0
1121596|NCT01641692|3679359|P4|Treatment Period 3|Protocol Violation|0
1121597|NCT01641692|3679360|P3|Treatment Period 3|Protocol Violation|1
1121598|NCT01641692|3679361|P2|Treatment Period 3|Protocol Violation|0
1121599|NCT01641692|3679362|P1|Treatment Period 3|Protocol Violation|0
1121600|NCT01641692|3679355|P8|Treatment Period 3|Adverse Event|0
1121601|NCT01641692|3679356|P7|Treatment Period 3|Adverse Event|1
1121602|NCT01641692|3679357|P6|Treatment Period 3|Adverse Event|0
1121603|NCT01641692|3679358|P5|Treatment Period 3|Adverse Event|0
1121604|NCT01641692|3679359|P4|Treatment Period 3|Adverse Event|0
1121605|NCT01641692|3679360|P3|Treatment Period 3|Adverse Event|0
1121606|NCT01641692|3679361|P2|Treatment Period 3|Adverse Event|0
1121607|NCT01641692|3679362|P1|Treatment Period 3|Adverse Event|0
1121608|NCT01641692|3679355|P8|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
1121609|NCT01641692|3679356|P7|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1121610|NCT01641692|3679357|P6|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
1121611|NCT01641692|3679358|P5|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1121612|NCT01641692|3679359|P4|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1121613|NCT01641692|3679360|P3|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
1121614|NCT01641692|3679361|P2|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1121615|NCT01641692|3679362|P1|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1121616|NCT01641692|3679355|P8|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
1121617|NCT01641692|3679356|P7|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1
1121618|NCT01641692|3679357|P6|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
1121619|NCT01641692|3679358|P5|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3
1121620|NCT01641692|3679359|P4|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
1121621|NCT01641692|3679360|P3|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
1121622|NCT01641692|3679361|P2|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
1121623|NCT01641692|3679362|P1|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
1121624|NCT01641692|3679355|P8|Treatment Period 2|Withdrawal by Subject|1
1121625|NCT01641692|3679356|P7|Treatment Period 2|Withdrawal by Subject|0
1121626|NCT01641692|3679357|P6|Treatment Period 2|Withdrawal by Subject|1
1121627|NCT01641692|3679358|P5|Treatment Period 2|Withdrawal by Subject|0
1121628|NCT01641692|3679359|P4|Treatment Period 2|Withdrawal by Subject|0
1121629|NCT01641692|3679360|P3|Treatment Period 2|Withdrawal by Subject|0
1121630|NCT01641692|3679361|P2|Treatment Period 2|Withdrawal by Subject|0
1121631|NCT01641692|3679362|P1|Treatment Period 2|Withdrawal by Subject|1
1121632|NCT01641692|3679355|P8|Treatment Period 2|Lost to Follow-up|0
1121633|NCT01641692|3679356|P7|Treatment Period 2|Lost to Follow-up|0
1121634|NCT01641692|3679357|P6|Treatment Period 2|Lost to Follow-up|1
1121635|NCT01641692|3679358|P5|Treatment Period 2|Lost to Follow-up|0
1121636|NCT01641692|3679359|P4|Treatment Period 2|Lost to Follow-up|0
1121637|NCT01641692|3679360|P3|Treatment Period 2|Lost to Follow-up|0
1121638|NCT01641692|3679361|P2|Treatment Period 2|Lost to Follow-up|0
1121639|NCT01641692|3679362|P1|Treatment Period 2|Lost to Follow-up|0
1121640|NCT01641692|3679355|P8|Treatment Period 2|Protocol-defined Stopping Criteria|0
1121641|NCT01641692|3679356|P7|Treatment Period 2|Protocol-defined Stopping Criteria|0
1121642|NCT01641692|3679357|P6|Treatment Period 2|Protocol-defined Stopping Criteria|0
1121643|NCT01641692|3679358|P5|Treatment Period 2|Protocol-defined Stopping Criteria|0
1121644|NCT01641692|3679359|P4|Treatment Period 2|Protocol-defined Stopping Criteria|0
1121645|NCT01641692|3679360|P3|Treatment Period 2|Protocol-defined Stopping Criteria|0
1121646|NCT01641692|3679361|P2|Treatment Period 2|Protocol-defined Stopping Criteria|0
1121647|NCT01641692|3679362|P1|Treatment Period 2|Protocol-defined Stopping Criteria|1
1121648|NCT01641692|3679355|P8|Treatment Period 2|Lack of Efficacy|0
1121649|NCT01641692|3679356|P7|Treatment Period 2|Lack of Efficacy|0
1121650|NCT01641692|3679357|P6|Treatment Period 2|Lack of Efficacy|0
1121651|NCT01641692|3679358|P5|Treatment Period 2|Lack of Efficacy|0
1121652|NCT01641692|3679359|P4|Treatment Period 2|Lack of Efficacy|0
1121653|NCT01641692|3679360|P3|Treatment Period 2|Lack of Efficacy|0
1121654|NCT01641692|3679361|P2|Treatment Period 2|Lack of Efficacy|0
1121655|NCT01641692|3679362|P1|Treatment Period 2|Lack of Efficacy|1
1121656|NCT01641692|3679355|P8|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
1121657|NCT01641692|3679356|P7|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
1121658|NCT01641692|3679357|P6|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
1121659|NCT01641692|3679358|P5|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
1121660|NCT01641692|3679359|P4|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
1121661|NCT01641692|3679360|P3|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
1121662|NCT01641692|3679361|P2|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
1121663|NCT01641692|3679362|P1|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
1121664|NCT01641692|3679355|P8|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
1121665|NCT01641692|3679356|P7|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
1121666|NCT01641692|3679357|P6|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
1121667|NCT01641692|3679358|P5|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
1121668|NCT01641692|3679359|P4|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
1121669|NCT01641692|3679360|P3|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
1121670|NCT01641692|3679361|P2|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
1121671|NCT01641692|3679362|P1|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
1121672|NCT01641692|3679355|P8|Washout Period 1 (12-14 Days)|Protocol Violation|0
1121673|NCT01641692|3679356|P7|Washout Period 1 (12-14 Days)|Protocol Violation|1
1121674|NCT01641692|3679357|P6|Washout Period 1 (12-14 Days)|Protocol Violation|0
1121675|NCT01641692|3679358|P5|Washout Period 1 (12-14 Days)|Protocol Violation|0
1121676|NCT01641692|3679359|P4|Washout Period 1 (12-14 Days)|Protocol Violation|0
1121677|NCT01641692|3679360|P3|Washout Period 1 (12-14 Days)|Protocol Violation|0
1121678|NCT01641692|3679361|P2|Washout Period 1 (12-14 Days)|Protocol Violation|0
1121679|NCT01641692|3679362|P1|Washout Period 1 (12-14 Days)|Protocol Violation|0
1121680|NCT01641692|3679355|P8|Washout Period 1 (12-14 Days)|Adverse Event|0
1121681|NCT01641692|3679356|P7|Washout Period 1 (12-14 Days)|Adverse Event|0
1121682|NCT01641692|3679357|P6|Washout Period 1 (12-14 Days)|Adverse Event|0
1121683|NCT01641692|3679358|P5|Washout Period 1 (12-14 Days)|Adverse Event|0
1121684|NCT01641692|3679359|P4|Washout Period 1 (12-14 Days)|Adverse Event|0
1121685|NCT01641692|3679360|P3|Washout Period 1 (12-14 Days)|Adverse Event|0
1121686|NCT01641692|3679361|P2|Washout Period 1 (12-14 Days)|Adverse Event|0
1121687|NCT01641692|3679362|P1|Washout Period 1 (12-14 Days)|Adverse Event|2
1121688|NCT01641692|3679355|P8|Treatment Period 1|Withdrawal by Subject|1
1121689|NCT01641692|3679356|P7|Treatment Period 1|Withdrawal by Subject|0
1121690|NCT01641692|3679357|P6|Treatment Period 1|Withdrawal by Subject|2
1121691|NCT01641692|3679358|P5|Treatment Period 1|Withdrawal by Subject|0
1121692|NCT01641692|3679359|P4|Treatment Period 1|Withdrawal by Subject|0
1121693|NCT01641692|3679360|P3|Treatment Period 1|Withdrawal by Subject|0
1121694|NCT01641692|3679361|P2|Treatment Period 1|Withdrawal by Subject|0
1121695|NCT01641692|3679362|P1|Treatment Period 1|Withdrawal by Subject|0
1121696|NCT01641692|3679355|P8|Treatment Period 1|Physician Decision|0
1121697|NCT01641692|3679356|P7|Treatment Period 1|Physician Decision|0
1121698|NCT01641692|3679357|P6|Treatment Period 1|Physician Decision|0
1121699|NCT01641692|3679358|P5|Treatment Period 1|Physician Decision|1
1121700|NCT01641692|3679359|P4|Treatment Period 1|Physician Decision|0
1121701|NCT01641692|3679360|P3|Treatment Period 1|Physician Decision|0
1121702|NCT01641692|3679361|P2|Treatment Period 1|Physician Decision|0
1121703|NCT01641692|3679362|P1|Treatment Period 1|Physician Decision|0
1121704|NCT01641692|3679355|P8|Treatment Period 1|Lost to Follow-up|0
1121705|NCT01641692|3679356|P7|Treatment Period 1|Lost to Follow-up|0
1121706|NCT01641692|3679357|P6|Treatment Period 1|Lost to Follow-up|0
1121707|NCT01641692|3679358|P5|Treatment Period 1|Lost to Follow-up|0
1121708|NCT01641692|3679359|P4|Treatment Period 1|Lost to Follow-up|0
1121709|NCT01641692|3679360|P3|Treatment Period 1|Lost to Follow-up|1
1121710|NCT01641692|3679361|P2|Treatment Period 1|Lost to Follow-up|0
1121711|NCT01641692|3679362|P1|Treatment Period 1|Lost to Follow-up|0
1121712|NCT01641692|3679355|P8|Treatment Period 1|Protocol-defined Stopping Criteria|1
1121713|NCT01641692|3679356|P7|Treatment Period 1|Protocol-defined Stopping Criteria|0
1121714|NCT01641692|3679357|P6|Treatment Period 1|Protocol-defined Stopping Criteria|0
1121715|NCT01641692|3679358|P5|Treatment Period 1|Protocol-defined Stopping Criteria|1
1121716|NCT01641692|3679359|P4|Treatment Period 1|Protocol-defined Stopping Criteria|0
1121717|NCT01641692|3679360|P3|Treatment Period 1|Protocol-defined Stopping Criteria|0
1121718|NCT01641692|3679361|P2|Treatment Period 1|Protocol-defined Stopping Criteria|0
1121719|NCT01641692|3679362|P1|Treatment Period 1|Protocol-defined Stopping Criteria|0
1121720|NCT01641692|3679355|P8|Treatment Period 1|Protocol Violation|0
1121721|NCT01641692|3679356|P7|Treatment Period 1|Protocol Violation|0
1121722|NCT01641692|3679357|P6|Treatment Period 1|Protocol Violation|0
1121723|NCT01641692|3679358|P5|Treatment Period 1|Protocol Violation|2
1121724|NCT01641692|3679359|P4|Treatment Period 1|Protocol Violation|0
1121725|NCT01641692|3679360|P3|Treatment Period 1|Protocol Violation|0
1121726|NCT01641692|3679361|P2|Treatment Period 1|Protocol Violation|0
1121727|NCT01641692|3679362|P1|Treatment Period 1|Protocol Violation|1
1121728|NCT01641692|3679355|P8|Treatment Period 1|Lack of Efficacy|1
1121729|NCT01641692|3679356|P7|Treatment Period 1|Lack of Efficacy|0
1121730|NCT01641692|3679357|P6|Treatment Period 1|Lack of Efficacy|0
1121731|NCT01641692|3679358|P5|Treatment Period 1|Lack of Efficacy|0
1121732|NCT01641692|3679359|P4|Treatment Period 1|Lack of Efficacy|0
1121733|NCT01641692|3679360|P3|Treatment Period 1|Lack of Efficacy|0
1121734|NCT01641692|3679361|P2|Treatment Period 1|Lack of Efficacy|0
1121735|NCT01641692|3679362|P1|Treatment Period 1|Lack of Efficacy|0
1121736|NCT01641692|3679355|P8|Treatment Period 1|Adverse Event|0
1121737|NCT01641692|3679356|P7|Treatment Period 1|Adverse Event|0
1121738|NCT01641692|3679357|P6|Treatment Period 1|Adverse Event|0
1121739|NCT01641692|3679358|P5|Treatment Period 1|Adverse Event|0
1121740|NCT01641692|3679359|P4|Treatment Period 1|Adverse Event|0
1121741|NCT01641692|3679360|P3|Treatment Period 1|Adverse Event|0
1121742|NCT01641692|3679361|P2|Treatment Period 1|Adverse Event|0
1121743|NCT01641692|3679362|P1|Treatment Period 1|Adverse Event|1
1121744|NCT01641640|3679562|P1|Overall Study|Adverse Event|1
1121745|NCT01641640|3679562|P1|Overall Study|Withdrawal by Subject|2
1121746|NCT01641640|3679562|P1|Overall Study|Lost to Follow-up|3
1121747|NCT01641640|3679562|P1|Overall Study|Efficacy failure|29
1121748|NCT01641640|3679562|P1|Overall Study|Enrolled but not treated|1
1121749|NCT01641471|3679573|P2|Overall Study|Protocol Violation|4
1121750|NCT01641471|3679574|P1|Overall Study|Protocol Violation|2
1121751|NCT01641471|3679573|P2|Overall Study|Lost to Follow-up|4
1121752|NCT01641471|3679574|P1|Overall Study|Lost to Follow-up|2
1121753|NCT01641471|3679573|P2|Overall Study|Withdrawal by Subject|19
1121754|NCT01641471|3679574|P1|Overall Study|Withdrawal by Subject|19
1121755|NCT01641367|3679601|P6|Overall Study|Lost to Follow-up|0
1121756|NCT01641367|3679602|P5|Overall Study|Lost to Follow-up|2
1121757|NCT01641367|3679603|P4|Overall Study|Lost to Follow-up|0
1121758|NCT01641367|3679604|P3|Overall Study|Lost to Follow-up|2
1121759|NCT01641367|3679605|P2|Overall Study|Lost to Follow-up|0
1121760|NCT01641367|3679606|P1|Overall Study|Lost to Follow-up|16
1121761|NCT01641367|3679601|P6|Overall Study|Death|1
1121762|NCT01641367|3679602|P5|Overall Study|Death|1
1121763|NCT01641367|3679603|P4|Overall Study|Death|0
1121764|NCT01641367|3679604|P3|Overall Study|Death|2
1121765|NCT01641367|3679605|P2|Overall Study|Death|1
1121766|NCT01641367|3679606|P1|Overall Study|Death|18
1121767|NCT01641237|3679621|P4|Period III|Lost to Follow-up|0
1121768|NCT01641237|3679622|P3|Period III|Lost to Follow-up|0
1121769|NCT01641237|3679623|P2|Period III|Lost to Follow-up|0
1121770|NCT01641237|3679624|P1|Period III|Lost to Follow-up|1
1121771|NCT01641237|3679621|P4|Period II|Withdrawal by Subject|0
1121772|NCT01641237|3679622|P3|Period II|Withdrawal by Subject|0
1121773|NCT01641237|3679623|P2|Period II|Withdrawal by Subject|0
1121774|NCT01641237|3679624|P1|Period II|Withdrawal by Subject|1
1121775|NCT01641159|3679648|P2|Overall Study|Withdrawal by Subject|1
1121776|NCT01641159|3679649|P1|Overall Study|Withdrawal by Subject|0
1121777|NCT01641159|3679648|P2|Overall Study|Lost to Follow-up|1
1121778|NCT01641159|3679649|P1|Overall Study|Lost to Follow-up|2
1121779|NCT01641133|3679660|P3|Overall Study|Lost to Follow-up|2
1121780|NCT01641133|3679661|P2|Overall Study|Lost to Follow-up|2
1121781|NCT01641133|3679662|P1|Overall Study|Lost to Follow-up|0
1121782|NCT01641133|3679660|P3|Overall Study|Withdrawal by Subject|3
1121783|NCT01641133|3679661|P2|Overall Study|Withdrawal by Subject|3
1121784|NCT01641133|3679662|P1|Overall Study|Withdrawal by Subject|5
1121785|NCT01641133|3679660|P3|Overall Study|Adverse Event|1
1121786|NCT01641133|3679661|P2|Overall Study|Adverse Event|0
1121787|NCT01641133|3679662|P1|Overall Study|Adverse Event|0
1121788|NCT01641133|3679660|P3|Overall Study|Migrated/moved from study area|1
1121789|NCT01641133|3679661|P2|Overall Study|Migrated/moved from study area|3
1121790|NCT01641133|3679662|P1|Overall Study|Migrated/moved from study area|5
1121791|NCT01641133|3679660|P3|Overall Study|Protocol Violation|1
1121792|NCT01641133|3679661|P2|Overall Study|Protocol Violation|1
1121793|NCT01641133|3679662|P1|Overall Study|Protocol Violation|0
1121794|NCT01641081|3679712|P10|Period 5|Adverse Event|0
1121795|NCT01641081|3679713|P9|Period 5|Adverse Event|0
1121796|NCT01641081|3679714|P8|Period 5|Adverse Event|0
1121797|NCT01641081|3679715|P7|Period 5|Adverse Event|0
1121798|NCT01641081|3679716|P6|Period 5|Adverse Event|0
1121799|NCT01641081|3679717|P5|Period 5|Adverse Event|0
1121800|NCT01641081|3679718|P4|Period 5|Adverse Event|0
1121801|NCT01641081|3679719|P3|Period 5|Adverse Event|2
1121802|NCT01641081|3679720|P2|Period 5|Adverse Event|0
1121803|NCT01641081|3679721|P1|Period 5|Adverse Event|0
1121804|NCT01641081|3679712|P10|Period 4|Adverse Event|0
1121805|NCT01641081|3679713|P9|Period 4|Adverse Event|0
1121806|NCT01641081|3679714|P8|Period 4|Adverse Event|0
1121807|NCT01641081|3679715|P7|Period 4|Adverse Event|0
1121808|NCT01641081|3679716|P6|Period 4|Adverse Event|0
1121809|NCT01641081|3679717|P5|Period 4|Adverse Event|0
1121810|NCT01641081|3679718|P4|Period 4|Adverse Event|1
1121811|NCT01641081|3679719|P3|Period 4|Adverse Event|0
1121812|NCT01641081|3679720|P2|Period 4|Adverse Event|1
1121813|NCT01641081|3679721|P1|Period 4|Adverse Event|0
1121814|NCT01641081|3679712|P10|Period 3|Withdrawal by Subject|0
1121815|NCT01641081|3679713|P9|Period 3|Withdrawal by Subject|1
1121816|NCT01641081|3679714|P8|Period 3|Withdrawal by Subject|0
1121817|NCT01641081|3679715|P7|Period 3|Withdrawal by Subject|0
1121818|NCT01641081|3679716|P6|Period 3|Withdrawal by Subject|0
1121819|NCT01641081|3679717|P5|Period 3|Withdrawal by Subject|0
1121820|NCT01641081|3679718|P4|Period 3|Withdrawal by Subject|0
1121821|NCT01641081|3679719|P3|Period 3|Withdrawal by Subject|0
1121822|NCT01641081|3679720|P2|Period 3|Withdrawal by Subject|0
1121823|NCT01641081|3679721|P1|Period 3|Withdrawal by Subject|0
1121824|NCT01641081|3679712|P10|Period 3|Adverse Event|0
1121825|NCT01641081|3679713|P9|Period 3|Adverse Event|0
1121826|NCT01641081|3679714|P8|Period 3|Adverse Event|0
1121827|NCT01641081|3679715|P7|Period 3|Adverse Event|0
1121828|NCT01641081|3679716|P6|Period 3|Adverse Event|0
1121829|NCT01641081|3679717|P5|Period 3|Adverse Event|0
1121830|NCT01641081|3679718|P4|Period 3|Adverse Event|0
1121831|NCT01641081|3679719|P3|Period 3|Adverse Event|1
1121832|NCT01641081|3679720|P2|Period 3|Adverse Event|0
1121833|NCT01641081|3679721|P1|Period 3|Adverse Event|0
1121834|NCT01641081|3679712|P10|Period 2|Protocol Violation|0
1121835|NCT01641081|3679713|P9|Period 2|Protocol Violation|0
1121836|NCT01641081|3679714|P8|Period 2|Protocol Violation|0
1121837|NCT01641081|3679715|P7|Period 2|Protocol Violation|0
1121838|NCT01641081|3679716|P6|Period 2|Protocol Violation|0
1121839|NCT01641081|3679717|P5|Period 2|Protocol Violation|0
1121840|NCT01641081|3679718|P4|Period 2|Protocol Violation|0
1121841|NCT01641081|3679719|P3|Period 2|Protocol Violation|0
1121842|NCT01641081|3679720|P2|Period 2|Protocol Violation|0
1121843|NCT01641081|3679721|P1|Period 2|Protocol Violation|1
1121844|NCT01641081|3679712|P10|Period 2|Withdrawal by Subject|0
1121845|NCT01641081|3679713|P9|Period 2|Withdrawal by Subject|0
1121846|NCT01641081|3679714|P8|Period 2|Withdrawal by Subject|0
1121847|NCT01641081|3679715|P7|Period 2|Withdrawal by Subject|2
1121848|NCT01641081|3679716|P6|Period 2|Withdrawal by Subject|0
1121849|NCT01641081|3679717|P5|Period 2|Withdrawal by Subject|0
1121850|NCT01641081|3679718|P4|Period 2|Withdrawal by Subject|1
1121851|NCT01641081|3679719|P3|Period 2|Withdrawal by Subject|0
1121852|NCT01641081|3679720|P2|Period 2|Withdrawal by Subject|0
1121853|NCT01641081|3679721|P1|Period 2|Withdrawal by Subject|0
1121854|NCT01641081|3679712|P10|Period 2|Adverse Event|0
1121855|NCT01641081|3679713|P9|Period 2|Adverse Event|0
1121856|NCT01641081|3679714|P8|Period 2|Adverse Event|0
1121857|NCT01641081|3679715|P7|Period 2|Adverse Event|0
1121858|NCT01641081|3679716|P6|Period 2|Adverse Event|1
1121859|NCT01641081|3679717|P5|Period 2|Adverse Event|0
1121860|NCT01641081|3679718|P4|Period 2|Adverse Event|0
1121861|NCT01641081|3679719|P3|Period 2|Adverse Event|0
1121862|NCT01641081|3679720|P2|Period 2|Adverse Event|0
1121863|NCT01641081|3679721|P1|Period 2|Adverse Event|0
1121864|NCT01641081|3679712|P10|Period 1|Adverse Event|0
1121865|NCT01641081|3679713|P9|Period 1|Adverse Event|0
1121866|NCT01641081|3679714|P8|Period 1|Adverse Event|2
1121867|NCT01641081|3679715|P7|Period 1|Adverse Event|0
1121868|NCT01641081|3679716|P6|Period 1|Adverse Event|0
1121869|NCT01641081|3679717|P5|Period 1|Adverse Event|0
1121870|NCT01641081|3679718|P4|Period 1|Adverse Event|0
1121871|NCT01641081|3679719|P3|Period 1|Adverse Event|0
1121872|NCT01641081|3679720|P2|Period 1|Adverse Event|0
1121873|NCT01641081|3679721|P1|Period 1|Adverse Event|1
1121874|NCT01641081|3679712|P10|Period 1|Protocol Violation|0
1121875|NCT01641081|3679713|P9|Period 1|Protocol Violation|0
1121876|NCT01641081|3679714|P8|Period 1|Protocol Violation|1
1121877|NCT01641081|3679715|P7|Period 1|Protocol Violation|0
1121878|NCT01641081|3679716|P6|Period 1|Protocol Violation|0
1121879|NCT01641081|3679717|P5|Period 1|Protocol Violation|1
1121880|NCT01641081|3679718|P4|Period 1|Protocol Violation|0
1121881|NCT01641081|3679719|P3|Period 1|Protocol Violation|0
1121882|NCT01641081|3679720|P2|Period 1|Protocol Violation|0
1121883|NCT01641081|3679721|P1|Period 1|Protocol Violation|0
1121884|NCT01641081|3679712|P10|Period 1|Sponsor request (potential unblinding)|0
1121885|NCT01641081|3679713|P9|Period 1|Sponsor request (potential unblinding)|0
1121886|NCT01641081|3679714|P8|Period 1|Sponsor request (potential unblinding)|0
1121887|NCT01641081|3679715|P7|Period 1|Sponsor request (potential unblinding)|1
1121888|NCT01641081|3679716|P6|Period 1|Sponsor request (potential unblinding)|0
1121889|NCT01641081|3679717|P5|Period 1|Sponsor request (potential unblinding)|0
1121890|NCT01641081|3679718|P4|Period 1|Sponsor request (potential unblinding)|0
1121891|NCT01641081|3679719|P3|Period 1|Sponsor request (potential unblinding)|0
1121892|NCT01641081|3679720|P2|Period 1|Sponsor request (potential unblinding)|0
1121893|NCT01641081|3679721|P1|Period 1|Sponsor request (potential unblinding)|0
1121894|NCT01640964|3679790|P3|Overall Study|Protocol Deviation|2
1121895|NCT01640964|3679791|P2|Overall Study|Protocol Deviation|1
1121896|NCT01640964|3679792|P1|Overall Study|Protocol Deviation|1
1121897|NCT01640964|3679790|P3|Overall Study|Lost to Follow-up|1
1121898|NCT01640964|3679791|P2|Overall Study|Lost to Follow-up|0
1121899|NCT01640964|3679792|P1|Overall Study|Lost to Follow-up|0
1121900|NCT01640951|3679815|P8|Overall Study|Death|2
1121901|NCT01640951|3679816|P7|Overall Study|Death|0
1121902|NCT01640951|3679817|P6|Overall Study|Death|0
1121903|NCT01640951|3679818|P5|Overall Study|Death|0
1121904|NCT01640951|3679819|P4|Overall Study|Death|0
1121905|NCT01640951|3679820|P3|Overall Study|Death|1
1121906|NCT01640951|3679821|P2|Overall Study|Death|1
1121907|NCT01640951|3679822|P1|Overall Study|Death|0
1121908|NCT01640951|3679815|P8|Overall Study|Subject/Guardian decision|4
1121909|NCT01640951|3679816|P7|Overall Study|Subject/Guardian decision|5
1121910|NCT01640951|3679817|P6|Overall Study|Subject/Guardian decision|19
1121911|NCT01640951|3679818|P5|Overall Study|Subject/Guardian decision|7
1121912|NCT01640951|3679819|P4|Overall Study|Subject/Guardian decision|15
1121913|NCT01640951|3679820|P3|Overall Study|Subject/Guardian decision|13
1121914|NCT01640951|3679821|P2|Overall Study|Subject/Guardian decision|4
1121915|NCT01640951|3679822|P1|Overall Study|Subject/Guardian decision|12
1121916|NCT01640951|3679815|P8|Overall Study|Protocol Deviation|0
1121917|NCT01640951|3679816|P7|Overall Study|Protocol Deviation|0
1121918|NCT01640951|3679817|P6|Overall Study|Protocol Deviation|1
1121919|NCT01640951|3679818|P5|Overall Study|Protocol Deviation|0
1121920|NCT01640951|3679819|P4|Overall Study|Protocol Deviation|1
1121921|NCT01640951|3679820|P3|Overall Study|Protocol Deviation|2
1121922|NCT01640951|3679821|P2|Overall Study|Protocol Deviation|1
1121923|NCT01640951|3679822|P1|Overall Study|Protocol Deviation|0
1121924|NCT01640951|3679815|P8|Overall Study|Pregnancy|0
1121925|NCT01640951|3679816|P7|Overall Study|Pregnancy|2
1121926|NCT01640951|3679817|P6|Overall Study|Pregnancy|0
1121927|NCT01640951|3679818|P5|Overall Study|Pregnancy|0
1121928|NCT01640951|3679819|P4|Overall Study|Pregnancy|4
1121929|NCT01640951|3679820|P3|Overall Study|Pregnancy|0
1121930|NCT01640951|3679821|P2|Overall Study|Pregnancy|0
1121931|NCT01640951|3679822|P1|Overall Study|Pregnancy|3
1121932|NCT01640951|3679815|P8|Overall Study|Physician Decision|0
1121933|NCT01640951|3679816|P7|Overall Study|Physician Decision|3
1121934|NCT01640951|3679817|P6|Overall Study|Physician Decision|3
1121935|NCT01640951|3679818|P5|Overall Study|Physician Decision|2
1121936|NCT01640951|3679819|P4|Overall Study|Physician Decision|2
1121937|NCT01640951|3679820|P3|Overall Study|Physician Decision|2
1121938|NCT01640951|3679821|P2|Overall Study|Physician Decision|5
1121939|NCT01640951|3679822|P1|Overall Study|Physician Decision|2
1121940|NCT01640951|3679815|P8|Overall Study|Non-compliance with study treatment|0
1121941|NCT01640951|3679816|P7|Overall Study|Non-compliance with study treatment|1
1121942|NCT01640951|3679817|P6|Overall Study|Non-compliance with study treatment|4
1121943|NCT01640951|3679818|P5|Overall Study|Non-compliance with study treatment|1
1121944|NCT01640951|3679819|P4|Overall Study|Non-compliance with study treatment|1
1121945|NCT01640951|3679820|P3|Overall Study|Non-compliance with study treatment|1
1121946|NCT01640951|3679821|P2|Overall Study|Non-compliance with study treatment|0
1121947|NCT01640951|3679822|P1|Overall Study|Non-compliance with study treatment|0
1121948|NCT01640951|3679815|P8|Overall Study|Lost to Follow-up|1
1121949|NCT01640951|3679816|P7|Overall Study|Lost to Follow-up|1
1121950|NCT01640951|3679817|P6|Overall Study|Lost to Follow-up|3
1121951|NCT01640951|3679818|P5|Overall Study|Lost to Follow-up|2
1121952|NCT01640951|3679819|P4|Overall Study|Lost to Follow-up|2
1121953|NCT01640951|3679820|P3|Overall Study|Lost to Follow-up|6
1121954|NCT01640951|3679821|P2|Overall Study|Lost to Follow-up|0
1121955|NCT01640951|3679822|P1|Overall Study|Lost to Follow-up|1
1121956|NCT01640951|3679815|P8|Overall Study|Lack of Efficacy|6
1121957|NCT01640951|3679816|P7|Overall Study|Lack of Efficacy|5
1121958|NCT01640951|3679817|P6|Overall Study|Lack of Efficacy|6
1121959|NCT01640951|3679818|P5|Overall Study|Lack of Efficacy|0
1121960|NCT01640951|3679819|P4|Overall Study|Lack of Efficacy|14
1121961|NCT01640951|3679820|P3|Overall Study|Lack of Efficacy|7
1121962|NCT01640951|3679821|P2|Overall Study|Lack of Efficacy|1
1121963|NCT01640951|3679822|P1|Overall Study|Lack of Efficacy|20
1121964|NCT01640951|3679815|P8|Overall Study|Adverse Event|3
1121965|NCT01640951|3679816|P7|Overall Study|Adverse Event|1
1121966|NCT01640951|3679817|P6|Overall Study|Adverse Event|11
1121967|NCT01640951|3679818|P5|Overall Study|Adverse Event|1
1121968|NCT01640951|3679819|P4|Overall Study|Adverse Event|6
1121969|NCT01640951|3679820|P3|Overall Study|Adverse Event|10
1121970|NCT01640951|3679821|P2|Overall Study|Adverse Event|3
1121971|NCT01640951|3679822|P1|Overall Study|Adverse Event|8
1121972|NCT01640925|3679924|P2|Overall Study|Previously enrolled in this trial|11
1121973|NCT01640925|3679925|P1|Overall Study|Previously enrolled in this trial|13
1121974|NCT01640925|3679924|P2|Overall Study|Withdrawal by Subject|0
1121975|NCT01640925|3679925|P1|Overall Study|Withdrawal by Subject|1
1121976|NCT01640873|3679939|P2|Overall Study|Protocol Violation|1
1121977|NCT01640873|3679940|P1|Overall Study|Protocol Violation|2
1121978|NCT01640353|3680013|P1|Overall Study|Physician Decision|1
1121979|NCT01640353|3680013|P1|Overall Study|Lost to Follow-up|12
1121980|NCT01640353|3680013|P1|Overall Study|Early site termination|3
1121981|NCT01640353|3680013|P1|Overall Study|Death|2
1121982|NCT01640353|3680013|P1|Overall Study|Withdrawal by Subject|5
1121983|NCT01640353|3680013|P1|Overall Study|Withdrawn from analysis at term site|12
1121984|NCT01640353|3680013|P1|Overall Study|Withdrew prior to treatment|10
1121985|NCT01640314|3680061|P2|Overall Study|Protocol Violation|1
1121986|NCT01640314|3680062|P1|Overall Study|Protocol Violation|0
1121987|NCT01640184|3680100|P3|Overall Study|Protocol Violation|1
1121988|NCT01640184|3680101|P2|Overall Study|Protocol Violation|0
1121989|NCT01640184|3680102|P1|Overall Study|Protocol Violation|0
1121990|NCT01640184|3680100|P3|Overall Study|Withdrawal by Subject|1
1121991|NCT01640184|3680101|P2|Overall Study|Withdrawal by Subject|1
1121992|NCT01640184|3680102|P1|Overall Study|Withdrawal by Subject|0
1121993|NCT01640184|3680100|P3|Overall Study|Physician Decision|0
1121994|NCT01640184|3680101|P2|Overall Study|Physician Decision|0
1121995|NCT01640184|3680102|P1|Overall Study|Physician Decision|3
1121996|NCT01640184|3680100|P3|Overall Study|Lost to Follow-up|0
1121997|NCT01640184|3680101|P2|Overall Study|Lost to Follow-up|1
1121998|NCT01640184|3680102|P1|Overall Study|Lost to Follow-up|4
1121999|NCT01640184|3680100|P3|Overall Study|Death|0
1122000|NCT01640184|3680101|P2|Overall Study|Death|0
1122001|NCT01640184|3680102|P1|Overall Study|Death|1
1122002|NCT01640054|3680131|P1|Overall Study|Adverse Event|2
1122003|NCT01640054|3680131|P1|Overall Study|Lack of Efficacy|3
1122004|NCT01640054|3680131|P1|Overall Study|Study-specific disc criteria|1
1122005|NCT01639833|3680141|P2|Overall Study|Withdrawal by Subject|2
1122006|NCT01639833|3680142|P1|Overall Study|Withdrawal by Subject|2
1122007|NCT01639833|3680141|P2|Overall Study|Death|2
1122008|NCT01639833|3680142|P1|Overall Study|Death|4
1122009|NCT01639755|3680150|P1|Overall Study|Patient had device explantation|4
1122010|NCT01639755|3680150|P1|Overall Study|Study Ongoing|15
1122011|NCT01639742|3680158|P1|Overall Study|Lost to Follow-up|1
1122012|NCT01639742|3680158|P1|Overall Study|Study Ongoing|17
1122013|NCT01639729|3680166|P6|Overall Study|Withdrawal by Subject|0
1122014|NCT01639729|3680167|P5|Overall Study|Withdrawal by Subject|0
1122015|NCT01639729|3680168|P4|Overall Study|Withdrawal by Subject|1
1122016|NCT01639729|3680169|P3|Overall Study|Withdrawal by Subject|1
1122017|NCT01639729|3680170|P2|Overall Study|Withdrawal by Subject|0
1122018|NCT01639729|3680171|P1|Overall Study|Withdrawal by Subject|1
1122019|NCT01639703|3680193|P1|Overall Study|Other reason|7
1122020|NCT01639703|3680193|P1|Overall Study|Withdrawal by Subject|5
1122021|NCT01639560|3680236|P2|Overall Study|Adverse Event|2
1122022|NCT01639560|3680237|P1|Overall Study|Adverse Event|0
1122023|NCT01639560|3680236|P2|Overall Study|Lost to Follow-up|11
1122024|NCT01639560|3680237|P1|Overall Study|Lost to Follow-up|9
1122025|NCT01639560|3680236|P2|Overall Study|Lack of Efficacy|2
1122026|NCT01639560|3680237|P1|Overall Study|Lack of Efficacy|1
1122027|NCT01639560|3680236|P2|Overall Study|Withdrawal by Subject|14
1122028|NCT01639560|3680237|P1|Overall Study|Withdrawal by Subject|9
1122029|NCT01639495|3680249|P1|Overall Study|No radiofrequency energy applied|2
1122030|NCT01639495|3680249|P1|Overall Study|Not meeting inclusion/exclusion criteria|4
1122031|NCT01639495|3680249|P1|Overall Study|Consented but didn’t have study catheter|4
1122032|NCT01639495|3680249|P1|Overall Study|Lost to Follow-up|6
1122033|NCT01639469|3680259|P2|Overall Study|Lost to Follow-up|1
1122034|NCT01639469|3680260|P1|Overall Study|Lost to Follow-up|1
1122035|NCT01639469|3680259|P2|Overall Study|Death|2
1122036|NCT01639469|3680260|P1|Overall Study|Death|4
1122037|NCT01639144|3680365|P2|Overall Study|Met postoperative exclusion criteria|3
1122038|NCT01639144|3680366|P1|Overall Study|Met postoperative exclusion criteria|4
1122039|NCT01639144|3680365|P2|Overall Study|Physician Decision|0
1122040|NCT01639144|3680366|P1|Overall Study|Physician Decision|2
1122041|NCT01639144|3680365|P2|Overall Study|Withdrawal by Subject|2
1122042|NCT01639144|3680366|P1|Overall Study|Withdrawal by Subject|4
1122043|NCT01639040|3680374|P2|Overall Study|Adverse Event|0
1122044|NCT01639040|3680375|P1|Overall Study|Adverse Event|1
1122045|NCT01639001|3680393|P2|Overall Study|Death|35
1122046|NCT01639001|3680394|P1|Overall Study|Death|35
1122047|NCT01639001|3680393|P2|Overall Study|Lost to Follow-up|0
1122048|NCT01639001|3680394|P1|Overall Study|Lost to Follow-up|1
1122049|NCT01639001|3680393|P2|Overall Study|Refused further follow-up|6
1122050|NCT01639001|3680394|P1|Overall Study|Refused further follow-up|3
1122051|NCT01639001|3680393|P2|Overall Study|Ongoing at date of cutoff|60
1122052|NCT01639001|3680394|P1|Overall Study|Ongoing at date of cutoff|65
1122053|NCT01639001|3680393|P2|Overall Study|Randomized but not treated|2
1122054|NCT01639001|3680394|P1|Overall Study|Randomized but not treated|0
1122055|NCT01638819|3680440|P2|Overall Study|Lost to Follow-up|0
1122056|NCT01638819|3680441|P1|Overall Study|Lost to Follow-up|1
1122057|NCT01638546|3680456|P2|Overall Study|Adverse Event|3
1122058|NCT01638546|3680457|P1|Overall Study|Adverse Event|1
1122059|NCT01638000|3680503|P2|Overall Study|Miscellaneous|2
1122060|NCT01638000|3680504|P1|Overall Study|Miscellaneous|2
1122061|NCT01638000|3680503|P2|Overall Study|Withdrawal by Subject|24
1122062|NCT01638000|3680504|P1|Overall Study|Withdrawal by Subject|21
1122063|NCT01638000|3680503|P2|Overall Study|Protocol Violation|13
1122064|NCT01638000|3680504|P1|Overall Study|Protocol Violation|11
1122065|NCT01638000|3680503|P2|Overall Study|Lack of Efficacy|6
1122066|NCT01638000|3680504|P1|Overall Study|Lack of Efficacy|5
1122067|NCT01638000|3680503|P2|Overall Study|Adverse Event|16
1122068|NCT01638000|3680504|P1|Overall Study|Adverse Event|14
1122069|NCT01638000|3680503|P2|Overall Study|Randomized but Never Received Drug|10
1122070|NCT01638000|3680504|P1|Overall Study|Randomized but Never Received Drug|7
1122071|NCT01637961|3680602|P1|Overall Study|Ineligible: inadequate pathology|1
1122072|NCT01637961|3680602|P1|Overall Study|Ineligible: wrong primary|1
1122073|NCT01637922|3680634|P2|Overall Study|Lost to Follow-up|0
1122074|NCT01637922|3680635|P1|Overall Study|Lost to Follow-up|2
1122075|NCT01637922|3680634|P2|Overall Study|Withdrawal by Subject|3
1122076|NCT01637922|3680635|P1|Overall Study|Withdrawal by Subject|0
1122077|NCT01637922|3680634|P2|Overall Study|Protocol Violation|1
1122078|NCT01637922|3680635|P1|Overall Study|Protocol Violation|0
1122079|NCT01637922|3680634|P2|Overall Study|Adverse Event|1
1122080|NCT01637922|3680635|P1|Overall Study|Adverse Event|0
1122081|NCT01637584|3680664|P2|Overall Study|Withdrawal by Subject|3
1122082|NCT01637584|3680665|P1|Overall Study|Withdrawal by Subject|1
1122083|NCT01637272|3680672|P1|Overall Study|Protocol Violation|2
1122084|NCT01637272|3680672|P1|Overall Study|Administrative problems|1
1122085|NCT01637272|3680672|P1|Overall Study|completed core, did not enter ext. phase|4
1122086|NCT01637272|3680672|P1|Overall Study|Lost to Follow-up|2
1122087|NCT01637272|3680672|P1|Overall Study|Withdrawal by Subject|3
1122088|NCT01637272|3680672|P1|Overall Study|Unsatisfactory therapeutic effect|2
1122089|NCT01637272|3680672|P1|Overall Study|Adverse Event|6
1122090|NCT01637077|3680752|P2|Overall Study|No cycle 1 questionnaire data|0
1122091|NCT01637077|3680753|P1|Overall Study|No cycle 1 questionnaire data|2
1122092|NCT01637077|3680752|P2|Overall Study|Withdrawal by Subject|0
1122093|NCT01637077|3680753|P1|Overall Study|Withdrawal by Subject|1
1122094|NCT01637077|3680752|P2|Overall Study|Cancel|1
1122095|NCT01637077|3680753|P1|Overall Study|Cancel|1
1122096|NCT01636986|3680781|P2|Overall Study|Corneal Staining|1
1122097|NCT01636986|3680782|P1|Overall Study|Corneal Staining|0
1122098|NCT01636986|3680781|P2|Overall Study|Withdrawal by Subject|1
1122099|NCT01636986|3680782|P1|Overall Study|Withdrawal by Subject|0
1122100|NCT01636960|3680788|P1|Maintenance Phase|Progressive disease|1
1122101|NCT01636960|3680788|P1|Maintenance Phase|Adverse Event|3
1122102|NCT01636960|3680788|P1|Maintenance Phase|Continued drug after regulatory approval|3
1122103|NCT01636960|3680788|P1|Induction Phase|Adverse Event|2
1122104|NCT01636947|3680796|P2|Overall Study|Did Not Meet Eligibility Criteria|4
1122105|NCT01636947|3680797|P1|Overall Study|Did Not Meet Eligibility Criteria|1
1122106|NCT01636947|3680796|P2|Overall Study|Adverse Event|1
1122107|NCT01636947|3680797|P1|Overall Study|Adverse Event|1
1122108|NCT01636947|3680796|P2|Overall Study|Withdrawal by Subject|3
1122109|NCT01636947|3680797|P1|Overall Study|Withdrawal by Subject|3
1122110|NCT01636947|3680796|P2|Overall Study|Protocol Violation|1
1122111|NCT01636947|3680797|P1|Overall Study|Protocol Violation|1
1122112|NCT01636947|3680796|P2|Overall Study|Lost to Follow-up|0
1122113|NCT01636947|3680797|P1|Overall Study|Lost to Follow-up|4
1122114|NCT01636947|3680796|P2|Overall Study|Not Treated|2
1122115|NCT01636947|3680797|P1|Overall Study|Not Treated|2
1122116|NCT01636778|3680821|P3|Follow-up Period After Part 2|Withdrawal by Subject|2
1122117|NCT01636778|3680822|P2|Follow-up Period After Part 2|Withdrawal by Subject|0
1122118|NCT01636778|3680823|P1|Follow-up Period After Part 2|Withdrawal by Subject|0
1122119|NCT01636778|3680821|P3|Follow-up Period After Part 2|Not entered FU period after withdrawal|1
1122120|NCT01636778|3680822|P2|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
1122121|NCT01636778|3680823|P1|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
1122122|NCT01636778|3680821|P3|Follow-up Period After Part 2|Other|1
1122123|NCT01636778|3680822|P2|Follow-up Period After Part 2|Other|0
1122124|NCT01636778|3680823|P1|Follow-up Period After Part 2|Other|0
1122125|NCT01636778|3680821|P3|Antiviral Treatment Period (Part 2)|Physician Decision|0
1122126|NCT01636778|3680822|P2|Antiviral Treatment Period (Part 2)|Physician Decision|2
1122127|NCT01636778|3680823|P1|Antiviral Treatment Period (Part 2)|Physician Decision|0
1122128|NCT01636778|3680821|P3|Antiviral Treatment Period (Part 2)|Protocol Violation|0
1122129|NCT01636778|3680822|P2|Antiviral Treatment Period (Part 2)|Protocol Violation|1
1122130|NCT01636778|3680823|P1|Antiviral Treatment Period (Part 2)|Protocol Violation|0
1122131|NCT01636778|3680821|P3|Antiviral Treatment Period (Part 2)|Adverse Event|0
1122132|NCT01636778|3680822|P2|Antiviral Treatment Period (Part 2)|Adverse Event|7
1122133|NCT01636778|3680823|P1|Antiviral Treatment Period (Part 2)|Adverse Event|0
1122134|NCT01636778|3680821|P3|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
1122135|NCT01636778|3680822|P2|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
1122136|NCT01636778|3680823|P1|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1
1122137|NCT01636778|3680821|P3|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
1122138|NCT01636778|3680822|P2|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
1122139|NCT01636778|3680823|P1|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3
1122140|NCT01636713|3680894|P3|Overall Study|Met Protocol-defined Stopping Criteria|4
1122141|NCT01636713|3680895|P2|Overall Study|Met Protocol-defined Stopping Criteria|2
1122142|NCT01636713|3680896|P1|Overall Study|Met Protocol-defined Stopping Criteria|2
1122143|NCT01636713|3680894|P3|Overall Study|Withdrawal by Subject|8
1122144|NCT01636713|3680895|P2|Overall Study|Withdrawal by Subject|4
1122145|NCT01636713|3680896|P1|Overall Study|Withdrawal by Subject|5
1122146|NCT01636713|3680894|P3|Overall Study|Lost to Follow-up|1
1122147|NCT01636713|3680895|P2|Overall Study|Lost to Follow-up|0
1122148|NCT01636713|3680896|P1|Overall Study|Lost to Follow-up|0
1122149|NCT01636713|3680894|P3|Overall Study|Protocol Violation|1
1122150|NCT01636713|3680895|P2|Overall Study|Protocol Violation|0
1122151|NCT01636713|3680896|P1|Overall Study|Protocol Violation|3
1122152|NCT01636713|3680894|P3|Overall Study|Lack of Efficacy|2
1122153|NCT01636713|3680895|P2|Overall Study|Lack of Efficacy|6
1122154|NCT01636713|3680896|P1|Overall Study|Lack of Efficacy|6
1122155|NCT01636713|3680894|P3|Overall Study|Adverse Event|7
1122156|NCT01636713|3680895|P2|Overall Study|Adverse Event|16
1122157|NCT01636713|3680896|P1|Overall Study|Adverse Event|16
1122158|NCT01636687|3680913|P5|Follow-up Period|Withdrawal by Subject|1
1122159|NCT01636687|3680914|P4|Follow-up Period|Withdrawal by Subject|0
1122160|NCT01636687|3680915|P3|Follow-up Period|Withdrawal by Subject|0
1122161|NCT01636687|3680916|P2|Follow-up Period|Withdrawal by Subject|0
1122162|NCT01636687|3680917|P1|Follow-up Period|Withdrawal by Subject|1
1122163|NCT01636687|3680913|P5|Extension Period|Withdrawal by Subject|0
1122164|NCT01636687|3680914|P4|Extension Period|Withdrawal by Subject|1
1122165|NCT01636687|3680915|P3|Extension Period|Withdrawal by Subject|1
1122166|NCT01636687|3680916|P2|Extension Period|Withdrawal by Subject|0
1122167|NCT01636687|3680917|P1|Extension Period|Withdrawal by Subject|1
1122168|NCT01636687|3680913|P5|Extension Period|study terminated by sponsor|0
1122169|NCT01636687|3680914|P4|Extension Period|study terminated by sponsor|23
1122170|NCT01636687|3680915|P3|Extension Period|study terminated by sponsor|17
1122171|NCT01636687|3680916|P2|Extension Period|study terminated by sponsor|50
1122172|NCT01636687|3680917|P1|Extension Period|study terminated by sponsor|33
1122173|NCT01636687|3680913|P5|Extension Period|Physician Decision|0
1122174|NCT01636687|3680914|P4|Extension Period|Physician Decision|1
1122175|NCT01636687|3680915|P3|Extension Period|Physician Decision|0
1122176|NCT01636687|3680916|P2|Extension Period|Physician Decision|0
1122177|NCT01636687|3680917|P1|Extension Period|Physician Decision|1
1122178|NCT01636687|3680913|P5|Extension Period|Lost to Follow-up|0
1122179|NCT01636687|3680914|P4|Extension Period|Lost to Follow-up|0
1122180|NCT01636687|3680915|P3|Extension Period|Lost to Follow-up|1
1122181|NCT01636687|3680916|P2|Extension Period|Lost to Follow-up|0
1122182|NCT01636687|3680917|P1|Extension Period|Lost to Follow-up|1
1122183|NCT01636687|3680913|P5|Extension Period|Lack of Efficacy|0
1122184|NCT01636687|3680914|P4|Extension Period|Lack of Efficacy|1
1122185|NCT01636687|3680915|P3|Extension Period|Lack of Efficacy|2
1122186|NCT01636687|3680916|P2|Extension Period|Lack of Efficacy|0
1122187|NCT01636687|3680917|P1|Extension Period|Lack of Efficacy|7
1122188|NCT01636687|3680913|P5|Extension Period|Adverse Event|0
1122189|NCT01636687|3680914|P4|Extension Period|Adverse Event|1
1122190|NCT01636687|3680915|P3|Extension Period|Adverse Event|2
1122191|NCT01636687|3680916|P2|Extension Period|Adverse Event|3
1122192|NCT01636687|3680917|P1|Extension Period|Adverse Event|4
1122193|NCT01636687|3680913|P5|Extension Period|technical problems|0
1122194|NCT01636687|3680914|P4|Extension Period|technical problems|1
1122195|NCT01636687|3680915|P3|Extension Period|technical problems|2
1122196|NCT01636687|3680916|P2|Extension Period|technical problems|1
1122197|NCT01636687|3680917|P1|Extension Period|technical problems|0
1122198|NCT01636687|3680913|P5|Maintenance Period|Physician Decision|1
1122199|NCT01636687|3680914|P4|Maintenance Period|Physician Decision|0
1122200|NCT01636687|3680915|P3|Maintenance Period|Physician Decision|0
1122201|NCT01636687|3680916|P2|Maintenance Period|Physician Decision|0
1122202|NCT01636687|3680917|P1|Maintenance Period|Physician Decision|0
1122203|NCT01636687|3680913|P5|Maintenance Period|Lost to Follow-up|1
1122204|NCT01636687|3680914|P4|Maintenance Period|Lost to Follow-up|0
1122205|NCT01636687|3680915|P3|Maintenance Period|Lost to Follow-up|0
1122206|NCT01636687|3680916|P2|Maintenance Period|Lost to Follow-up|1
1122207|NCT01636687|3680917|P1|Maintenance Period|Lost to Follow-up|1
1122208|NCT01636687|3680913|P5|Maintenance Period|Lack of Efficacy|0
1122209|NCT01636687|3680914|P4|Maintenance Period|Lack of Efficacy|0
1122210|NCT01636687|3680915|P3|Maintenance Period|Lack of Efficacy|0
1122211|NCT01636687|3680916|P2|Maintenance Period|Lack of Efficacy|1
1122212|NCT01636687|3680917|P1|Maintenance Period|Lack of Efficacy|4
1122213|NCT01636687|3680913|P5|Maintenance Period|Adverse Event|0
1122214|NCT01636687|3680914|P4|Maintenance Period|Adverse Event|0
1122215|NCT01636687|3680915|P3|Maintenance Period|Adverse Event|0
1122216|NCT01636687|3680916|P2|Maintenance Period|Adverse Event|0
1122217|NCT01636687|3680917|P1|Maintenance Period|Adverse Event|1
1122218|NCT01636687|3680913|P5|Maintenance Period|Withdrawal by Subject|0
1122219|NCT01636687|3680914|P4|Maintenance Period|Withdrawal by Subject|0
1122220|NCT01636687|3680915|P3|Maintenance Period|Withdrawal by Subject|2
1122221|NCT01636687|3680916|P2|Maintenance Period|Withdrawal by Subject|0
1122222|NCT01636687|3680917|P1|Maintenance Period|Withdrawal by Subject|2
1122223|NCT01636687|3680913|P5|Induction Period|Physician Decision|0
1122224|NCT01636687|3680914|P4|Induction Period|Physician Decision|0
1122225|NCT01636687|3680915|P3|Induction Period|Physician Decision|0
1122226|NCT01636687|3680916|P2|Induction Period|Physician Decision|0
1122227|NCT01636687|3680917|P1|Induction Period|Physician Decision|1
1122228|NCT01636687|3680913|P5|Induction Period|Lack of Efficacy|1
1122229|NCT01636687|3680914|P4|Induction Period|Lack of Efficacy|0
1122230|NCT01636687|3680915|P3|Induction Period|Lack of Efficacy|0
1122231|NCT01636687|3680916|P2|Induction Period|Lack of Efficacy|0
1122232|NCT01636687|3680917|P1|Induction Period|Lack of Efficacy|0
1122233|NCT01636687|3680913|P5|Induction Period|Adverse Event|1
1122234|NCT01636687|3680914|P4|Induction Period|Adverse Event|0
1122235|NCT01636687|3680915|P3|Induction Period|Adverse Event|0
1122236|NCT01636687|3680916|P2|Induction Period|Adverse Event|0
1122237|NCT01636687|3680917|P1|Induction Period|Adverse Event|1
1122238|NCT01636687|3680913|P5|Induction Period|Withdrawal by Subject|0
1122239|NCT01636687|3680914|P4|Induction Period|Withdrawal by Subject|0
1122240|NCT01636687|3680915|P3|Induction Period|Withdrawal by Subject|0
1122241|NCT01636687|3680916|P2|Induction Period|Withdrawal by Subject|0
1122242|NCT01636687|3680917|P1|Induction Period|Withdrawal by Subject|1
1122243|NCT01636362|3681058|P1|Overall Study|Withdrawal by Subject|1
1122244|NCT01636362|3681058|P1|Overall Study|Subject healed, not returning|1
1122245|NCT01636362|3681058|P1|Overall Study|Physician Decision|6
1122246|NCT01636258|3681085|P2|Overall Study|Lost to Follow-up|0
1122247|NCT01636258|3681086|P1|Overall Study|Lost to Follow-up|1
1122248|NCT01636076|3681126|P2|Overall Study|Withdrawal by Subject|10
1122249|NCT01636076|3681127|P1|Overall Study|Withdrawal by Subject|7
1122250|NCT01636076|3681126|P2|Overall Study|Adverse Event|11
1122251|NCT01636076|3681127|P1|Overall Study|Adverse Event|6
1122252|NCT01636076|3681126|P2|Overall Study|Non-compliance with study treatment|1
1122253|NCT01636076|3681127|P1|Overall Study|Non-compliance with study treatment|1
1122254|NCT01636076|3681126|P2|Overall Study|Physician Decision|1
1122255|NCT01636076|3681127|P1|Overall Study|Physician Decision|1
1122256|NCT01636076|3681126|P2|Overall Study|Lost to Follow-up|0
1122257|NCT01636076|3681127|P1|Overall Study|Lost to Follow-up|1
1122258|NCT01636076|3681126|P2|Overall Study|Lack of Efficacy|1
1122259|NCT01636076|3681127|P1|Overall Study|Lack of Efficacy|0
1122260|NCT01636076|3681126|P2|Overall Study|Terminated by sponsor|1
1122261|NCT01636076|3681127|P1|Overall Study|Terminated by sponsor|1
1122262|NCT01635933|3681198|P2|Overall Study|No longer had transportation|1
1122263|NCT01635933|3681199|P1|Overall Study|No longer had transportation|0
1122264|NCT01635933|3681198|P2|Overall Study|Noncompliance|1
1122265|NCT01635933|3681199|P1|Overall Study|Noncompliance|0
1122266|NCT01635933|3681198|P2|Overall Study|Subject decision|1
1122267|NCT01635933|3681199|P1|Overall Study|Subject decision|1
1122268|NCT01635933|3681198|P2|Overall Study|Lost to Follow-up|5
1122269|NCT01635933|3681199|P1|Overall Study|Lost to Follow-up|0
1122270|NCT01635933|3681198|P2|Overall Study|Adverse Event|0
1122271|NCT01635933|3681199|P1|Overall Study|Adverse Event|1
1122272|NCT01635920|3681211|P2|Overall Study|Subject decision|0
1122273|NCT01635920|3681212|P1|Overall Study|Subject decision|2
1122274|NCT01635920|3681211|P2|Overall Study|Lost to Follow-up|1
1122275|NCT01635920|3681212|P1|Overall Study|Lost to Follow-up|0
1122276|NCT01635920|3681211|P2|Overall Study|Adverse Event|0
1122277|NCT01635920|3681212|P1|Overall Study|Adverse Event|1
1122278|NCT01635855|3681225|P1|Overall Study|Withdrawal by Subject|4
1122279|NCT01635764|3681234|P1|Overall Study|Not Specified|28
1122280|NCT01635764|3681234|P1|Overall Study|Lost to Follow-up|53
1122281|NCT01635764|3681234|P1|Overall Study|Withdrew Consent|67
1122282|NCT01635764|3681234|P1|Overall Study|Protocol Deviation|1
1122283|NCT01635764|3681234|P1|Overall Study|Exceed Protocol-specified Interventions|2
1122284|NCT01635764|3681234|P1|Overall Study|Lack of Efficacy|76
1122285|NCT01635764|3681234|P1|Overall Study|Adverse Event|46
1122286|NCT01635218|3681300|P3|Overall Study|Lost to Follow-up|6
1122287|NCT01635218|3681301|P2|Overall Study|Lost to Follow-up|7
1122288|NCT01635218|3681302|P1|Overall Study|Lost to Follow-up|3
1122289|NCT01634854|3681337|P2|Overall Study|Cesarean delivery|7
1122290|NCT01634854|3681338|P1|Overall Study|Cesarean delivery|2
1122291|NCT01634659|3681358|P2|Period 2 - Second 8 Days of Wear|Physician Decision|0
1122292|NCT01634659|3681359|P1|Period 2 - Second 8 Days of Wear|Physician Decision|1
1122293|NCT01634659|3681358|P2|Period 2 - Second 8 Days of Wear|Adverse Event|0
1122294|NCT01634659|3681359|P1|Period 2 - Second 8 Days of Wear|Adverse Event|2
1122295|NCT01634555|3681389|P1|Overall Study|Ongoing receiving treatment|13
1122296|NCT01634555|3681389|P1|Overall Study|Physician Decision|1
1122297|NCT01634555|3681389|P1|Overall Study|Adverse Event|3
1122298|NCT01634360|3681399|P2|Overall Study|Study termination by sponsor|44
1122299|NCT01634360|3681400|P1|Overall Study|Study termination by sponsor|18
1122300|NCT01634360|3681399|P2|Overall Study|Not specified|20
1122301|NCT01634360|3681400|P1|Overall Study|Not specified|3
1122302|NCT01634360|3681399|P2|Overall Study|Lack of Efficacy|14
1122303|NCT01634360|3681400|P1|Overall Study|Lack of Efficacy|4
1122304|NCT01634360|3681399|P2|Overall Study|Protocol Violation|1
1122305|NCT01634360|3681400|P1|Overall Study|Protocol Violation|1
1122306|NCT01634360|3681399|P2|Overall Study|subject withdrew consent|23
1122307|NCT01634360|3681400|P1|Overall Study|subject withdrew consent|13
1122308|NCT01634360|3681399|P2|Overall Study|Adverse Event|34
1122309|NCT01634360|3681400|P1|Overall Study|Adverse Event|10
1122310|NCT01634243|3681474|P2|Overall Study|Lack of Efficacy|0
1122311|NCT01634243|3681475|P1|Overall Study|Lack of Efficacy|1
1122312|NCT01634243|3681474|P2|Overall Study|Adverse Event|5
1122313|NCT01634243|3681475|P1|Overall Study|Adverse Event|5
1122314|NCT01634165|3681501|P4|Period 2|Adverse Event|0
1122315|NCT01634165|3681502|P3|Period 2|Adverse Event|0
1122316|NCT01634165|3681503|P2|Period 2|Adverse Event|1
1122317|NCT01634165|3681504|P1|Period 2|Adverse Event|0
1122318|NCT01634152|3681537|P3|Overall Study|Other reason not defined above|1
1122319|NCT01634152|3681538|P2|Overall Study|Other reason not defined above|0
1122320|NCT01634152|3681539|P1|Overall Study|Other reason not defined above|1
1122321|NCT01634152|3681537|P3|Overall Study|Not treated|0
1122322|NCT01634152|3681538|P2|Overall Study|Not treated|1
1122323|NCT01634152|3681539|P1|Overall Study|Not treated|0
1122324|NCT01634152|3681537|P3|Overall Study|Consent withdrawn not due to AE|1
1122325|NCT01634152|3681538|P2|Overall Study|Consent withdrawn not due to AE|0
1122326|NCT01634152|3681539|P1|Overall Study|Consent withdrawn not due to AE|1
1122327|NCT01634152|3681537|P3|Overall Study|Adverse Event|2
1122328|NCT01634152|3681538|P2|Overall Study|Adverse Event|0
1122329|NCT01634152|3681539|P1|Overall Study|Adverse Event|2
1122330|NCT01634139|3681622|P3|Overall Study|Not treated|0
1122331|NCT01634139|3681623|P2|Overall Study|Not treated|1
1122332|NCT01634139|3681624|P1|Overall Study|Not treated|1
1122333|NCT01634139|3681622|P3|Overall Study|Lost to Follow-up|0
1122334|NCT01634139|3681623|P2|Overall Study|Lost to Follow-up|2
1122335|NCT01634139|3681624|P1|Overall Study|Lost to Follow-up|0
1122336|NCT01634139|3681622|P3|Overall Study|Other|3
1122337|NCT01634139|3681623|P2|Overall Study|Other|0
1122338|NCT01634139|3681624|P1|Overall Study|Other|4
1122339|NCT01634139|3681622|P3|Overall Study|Consent withdrawn not due to AE|2
1122340|NCT01634139|3681623|P2|Overall Study|Consent withdrawn not due to AE|3
1122341|NCT01634139|3681624|P1|Overall Study|Consent withdrawn not due to AE|4
1122342|NCT01634139|3681622|P3|Overall Study|Non compliant with protocol|0
1122343|NCT01634139|3681623|P2|Overall Study|Non compliant with protocol|0
1122344|NCT01634139|3681624|P1|Overall Study|Non compliant with protocol|1
1122345|NCT01634113|3681725|P3|Overall Study|Not treated|1
1122346|NCT01634113|3681726|P2|Overall Study|Not treated|0
1122347|NCT01634113|3681727|P1|Overall Study|Not treated|0
1122348|NCT01634100|3681771|P6|Overall Study|Withdrawal by Subject|0
1122349|NCT01634100|3681772|P5|Overall Study|Withdrawal by Subject|0
1122350|NCT01634100|3681773|P4|Overall Study|Withdrawal by Subject|0
1122351|NCT01634100|3681774|P3|Overall Study|Withdrawal by Subject|1
1122352|NCT01634100|3681775|P2|Overall Study|Withdrawal by Subject|0
1122353|NCT01634100|3681776|P1|Overall Study|Withdrawal by Subject|1
1122354|NCT01633944|3681792|P3|Double-blind Treatment Phase|Not specified|0
1122355|NCT01633944|3681793|P2|Double-blind Treatment Phase|Not specified|7
1122356|NCT01633944|3681794|P1|Double-blind Treatment Phase|Not specified|0
1122357|NCT01633944|3681792|P3|Double-blind Treatment Phase|Not exposed to DB study medication|0
1122358|NCT01633944|3681793|P2|Double-blind Treatment Phase|Not exposed to DB study medication|1
1122359|NCT01633944|3681794|P1|Double-blind Treatment Phase|Not exposed to DB study medication|0
1122360|NCT01633944|3681792|P3|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
1122361|NCT01633944|3681793|P2|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3
1122362|NCT01633944|3681794|P1|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
1122363|NCT01633944|3681792|P3|Double-blind Treatment Phase|Lost to Follow-up|9
1122364|NCT01633944|3681793|P2|Double-blind Treatment Phase|Lost to Follow-up|4
1122365|NCT01633944|3681794|P1|Double-blind Treatment Phase|Lost to Follow-up|0
1122366|NCT01633944|3681792|P3|Double-blind Treatment Phase|Protocol Violation|10
1122367|NCT01633944|3681793|P2|Double-blind Treatment Phase|Protocol Violation|7
1122368|NCT01633944|3681794|P1|Double-blind Treatment Phase|Protocol Violation|0
1122369|NCT01633944|3681792|P3|Double-blind Treatment Phase|Withdrawal by Subject|8
1122370|NCT01633944|3681793|P2|Double-blind Treatment Phase|Withdrawal by Subject|11
1122371|NCT01633944|3681794|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
1122372|NCT01633944|3681792|P3|Double-blind Treatment Phase|Lack of Efficacy|23
1122373|NCT01633944|3681793|P2|Double-blind Treatment Phase|Lack of Efficacy|8
1122374|NCT01633944|3681794|P1|Double-blind Treatment Phase|Lack of Efficacy|0
1122375|NCT01633944|3681792|P3|Double-blind Treatment Phase|Adverse Event|7
1122376|NCT01633944|3681793|P2|Double-blind Treatment Phase|Adverse Event|13
1122377|NCT01633944|3681794|P1|Double-blind Treatment Phase|Adverse Event|0
1122378|NCT01633944|3681792|P3|Open-label Titration Phase|Not specified|0
1122379|NCT01633944|3681793|P2|Open-label Titration Phase|Not specified|0
1122380|NCT01633944|3681794|P1|Open-label Titration Phase|Not specified|68
1122381|NCT01633944|3681792|P3|Open-label Titration Phase|Lost to Follow-up|0
1122382|NCT01633944|3681793|P2|Open-label Titration Phase|Lost to Follow-up|0
1122383|NCT01633944|3681794|P1|Open-label Titration Phase|Lost to Follow-up|22
1122384|NCT01633944|3681792|P3|Open-label Titration Phase|Protocol Violation|0
1122385|NCT01633944|3681793|P2|Open-label Titration Phase|Protocol Violation|0
1122386|NCT01633944|3681794|P1|Open-label Titration Phase|Protocol Violation|24
1122387|NCT01633944|3681792|P3|Open-label Titration Phase|Withdrawal by Subject|0
1122388|NCT01633944|3681793|P2|Open-label Titration Phase|Withdrawal by Subject|0
1122389|NCT01633944|3681794|P1|Open-label Titration Phase|Withdrawal by Subject|34
1122390|NCT01633944|3681792|P3|Open-label Titration Phase|Lack of Efficacy|0
1122391|NCT01633944|3681793|P2|Open-label Titration Phase|Lack of Efficacy|0
1122392|NCT01633944|3681794|P1|Open-label Titration Phase|Lack of Efficacy|33
1122393|NCT01633944|3681792|P3|Open-label Titration Phase|Adverse Event|0
1122394|NCT01633944|3681793|P2|Open-label Titration Phase|Adverse Event|0
1122395|NCT01633944|3681794|P1|Open-label Titration Phase|Adverse Event|109
1122396|NCT01633788|3681862|P4|Overall Study|Other Reasons|7
1122397|NCT01633788|3681863|P3|Overall Study|Other Reasons|3
1122398|NCT01633788|3681864|P2|Overall Study|Other Reasons|2
1122399|NCT01633788|3681865|P1|Overall Study|Other Reasons|0
1122400|NCT01633788|3681862|P4|Overall Study|Protocol Violation|0
1122401|NCT01633788|3681863|P3|Overall Study|Protocol Violation|1
1122402|NCT01633788|3681864|P2|Overall Study|Protocol Violation|0
1122403|NCT01633788|3681865|P1|Overall Study|Protocol Violation|1
1122404|NCT01633788|3681862|P4|Overall Study|Personal Reasons|3
1122405|NCT01633788|3681863|P3|Overall Study|Personal Reasons|1
1122406|NCT01633788|3681864|P2|Overall Study|Personal Reasons|1
1122407|NCT01633788|3681865|P1|Overall Study|Personal Reasons|3
1122408|NCT01633788|3681862|P4|Overall Study|Lost to Follow-up|0
1122409|NCT01633788|3681863|P3|Overall Study|Lost to Follow-up|2
1122410|NCT01633788|3681864|P2|Overall Study|Lost to Follow-up|2
1122411|NCT01633788|3681865|P1|Overall Study|Lost to Follow-up|2
1122412|NCT01633788|3681862|P4|Overall Study|Adverse Event|3
1122413|NCT01633788|3681863|P3|Overall Study|Adverse Event|3
1122414|NCT01633788|3681864|P2|Overall Study|Adverse Event|3
1122415|NCT01633788|3681865|P1|Overall Study|Adverse Event|1
1122416|NCT01632904|3681909|P2|Overall Study|Reason for discontinuation not available|1
1122417|NCT01632904|3681910|P1|Overall Study|Reason for discontinuation not available|0
1122418|NCT01632904|3681909|P2|Overall Study|Disease Progression|1
1122419|NCT01632904|3681910|P1|Overall Study|Disease Progression|0
1122420|NCT01632904|3681909|P2|Overall Study|Subject decision|2
1122421|NCT01632904|3681910|P1|Overall Study|Subject decision|3
1122422|NCT01632904|3681909|P2|Overall Study|Physician Decision|1
1122423|NCT01632904|3681910|P1|Overall Study|Physician Decision|0
1122424|NCT01632904|3681909|P2|Overall Study|Adverse Event|1
1122425|NCT01632904|3681910|P1|Overall Study|Adverse Event|4
1122426|NCT01632878|3681921|P1|Treatment|no information on study completion|43
1122427|NCT01632878|3681921|P1|Treatment|missing information|4
1122428|NCT01632878|3681921|P1|Treatment|Physician Decision|34
1122429|NCT01632878|3681921|P1|Treatment|Withdrawal by Subject|36
1122430|NCT01632878|3681921|P1|Treatment|Lost to Follow-up|41
1122431|NCT01632878|3681921|P1|Screening|Physician Decision|268
1122432|NCT01632800|3681925|P1|Overall Study|Subject did not fit in apparatus|1
1122433|NCT01632579|3681992|P9|Period 2 (Second Intervention)|Adverse Event|0
1122434|NCT01632579|3681993|P8|Period 2 (Second Intervention)|Adverse Event|0
1122435|NCT01632579|3681994|P7|Period 2 (Second Intervention)|Adverse Event|0
1122436|NCT01632579|3681995|P6|Period 2 (Second Intervention)|Adverse Event|0
1122437|NCT01632579|3681996|P5|Period 2 (Second Intervention)|Adverse Event|0
1122438|NCT01632579|3681997|P4|Period 2 (Second Intervention)|Adverse Event|0
1122439|NCT01632579|3681998|P3|Period 2 (Second Intervention)|Adverse Event|0
1122440|NCT01632579|3681999|P2|Period 2 (Second Intervention)|Adverse Event|0
1122441|NCT01632579|3682000|P1|Period 2 (Second Intervention)|Adverse Event|1
1122442|NCT01632579|3681992|P9|Washout Period|Adverse Event|0
1122443|NCT01632579|3681993|P8|Washout Period|Adverse Event|0
1122444|NCT01632579|3681994|P7|Washout Period|Adverse Event|0
1122445|NCT01632579|3681995|P6|Washout Period|Adverse Event|0
1122446|NCT01632579|3681996|P5|Washout Period|Adverse Event|0
1122447|NCT01632579|3681997|P4|Washout Period|Adverse Event|0
1122448|NCT01632579|3681998|P3|Washout Period|Adverse Event|0
1122449|NCT01632579|3681999|P2|Washout Period|Adverse Event|0
1122450|NCT01632579|3682000|P1|Washout Period|Adverse Event|1
1122451|NCT01632345|3682075|P7|Treatment: Part II|Withdrawal by Subject|2
1122452|NCT01632345|3682076|P6|Treatment: Part II|Withdrawal by Subject|2
1122453|NCT01632345|3682077|P5|Treatment: Part II|Withdrawal by Subject|0
1122454|NCT01632345|3682078|P4|Treatment: Part II|Withdrawal by Subject|0
1122455|NCT01632345|3682079|P3|Treatment: Part II|Withdrawal by Subject|0
1122456|NCT01632345|3682080|P2|Treatment: Part II|Withdrawal by Subject|0
1122457|NCT01632345|3682081|P1|Treatment: Part II|Withdrawal by Subject|0
1122458|NCT01632345|3682075|P7|Treatment: Part II|Non-Compliance with Study Drug|0
1122459|NCT01632345|3682076|P6|Treatment: Part II|Non-Compliance with Study Drug|3
1122460|NCT01632345|3682077|P5|Treatment: Part II|Non-Compliance with Study Drug|0
1122461|NCT01632345|3682078|P4|Treatment: Part II|Non-Compliance with Study Drug|0
1122462|NCT01632345|3682079|P3|Treatment: Part II|Non-Compliance with Study Drug|0
1122463|NCT01632345|3682080|P2|Treatment: Part II|Non-Compliance with Study Drug|0
1122464|NCT01632345|3682081|P1|Treatment: Part II|Non-Compliance with Study Drug|0
1122465|NCT01632345|3682075|P7|Treatment: Part II|Lost to Follow-up|1
1122466|NCT01632345|3682076|P6|Treatment: Part II|Lost to Follow-up|3
1122467|NCT01632345|3682077|P5|Treatment: Part II|Lost to Follow-up|0
1122468|NCT01632345|3682078|P4|Treatment: Part II|Lost to Follow-up|0
1122469|NCT01632345|3682079|P3|Treatment: Part II|Lost to Follow-up|0
1122470|NCT01632345|3682080|P2|Treatment: Part II|Lost to Follow-up|0
1122471|NCT01632345|3682081|P1|Treatment: Part II|Lost to Follow-up|0
1122472|NCT01632345|3682075|P7|Treatment: Part II|Adverse Event|8
1122473|NCT01632345|3682076|P6|Treatment: Part II|Adverse Event|3
1122474|NCT01632345|3682077|P5|Treatment: Part II|Adverse Event|0
1122475|NCT01632345|3682078|P4|Treatment: Part II|Adverse Event|0
1122476|NCT01632345|3682079|P3|Treatment: Part II|Adverse Event|0
1122477|NCT01632345|3682080|P2|Treatment: Part II|Adverse Event|0
1122478|NCT01632345|3682081|P1|Treatment: Part II|Adverse Event|0
1122479|NCT01632345|3682075|P7|Treatment: Part I|Withdrawal by Subject|0
1122480|NCT01632345|3682076|P6|Treatment: Part I|Withdrawal by Subject|0
1122481|NCT01632345|3682077|P5|Treatment: Part I|Withdrawal by Subject|4
1122482|NCT01632345|3682078|P4|Treatment: Part I|Withdrawal by Subject|1
1122483|NCT01632345|3682079|P3|Treatment: Part I|Withdrawal by Subject|4
1122484|NCT01632345|3682080|P2|Treatment: Part I|Withdrawal by Subject|4
1122485|NCT01632345|3682081|P1|Treatment: Part I|Withdrawal by Subject|3
1122486|NCT01632345|3682075|P7|Treatment: Part I|Protocol Deviation|0
1122487|NCT01632345|3682076|P6|Treatment: Part I|Protocol Deviation|0
1122488|NCT01632345|3682077|P5|Treatment: Part I|Protocol Deviation|0
1122489|NCT01632345|3682078|P4|Treatment: Part I|Protocol Deviation|1
1122490|NCT01632345|3682079|P3|Treatment: Part I|Protocol Deviation|1
1122491|NCT01632345|3682080|P2|Treatment: Part I|Protocol Deviation|0
1122492|NCT01632345|3682081|P1|Treatment: Part I|Protocol Deviation|0
1122493|NCT01632345|3682075|P7|Treatment: Part I|Pregnancy|0
1122494|NCT01632345|3682076|P6|Treatment: Part I|Pregnancy|0
1122495|NCT01632345|3682077|P5|Treatment: Part I|Pregnancy|0
1122496|NCT01632345|3682078|P4|Treatment: Part I|Pregnancy|0
1122497|NCT01632345|3682079|P3|Treatment: Part I|Pregnancy|0
1122498|NCT01632345|3682080|P2|Treatment: Part I|Pregnancy|1
1122499|NCT01632345|3682081|P1|Treatment: Part I|Pregnancy|0
1122500|NCT01632345|3682075|P7|Treatment: Part I|Physician Decision|0
1122501|NCT01632345|3682076|P6|Treatment: Part I|Physician Decision|0
1122502|NCT01632345|3682077|P5|Treatment: Part I|Physician Decision|1
1122503|NCT01632345|3682078|P4|Treatment: Part I|Physician Decision|0
1122504|NCT01632345|3682079|P3|Treatment: Part I|Physician Decision|0
1122505|NCT01632345|3682080|P2|Treatment: Part I|Physician Decision|1
1122506|NCT01632345|3682081|P1|Treatment: Part I|Physician Decision|2
1122507|NCT01632345|3682075|P7|Treatment: Part I|Non-Compliance with Study Drug|0
1122508|NCT01632345|3682076|P6|Treatment: Part I|Non-Compliance with Study Drug|0
1122509|NCT01632345|3682077|P5|Treatment: Part I|Non-Compliance with Study Drug|0
1122510|NCT01632345|3682078|P4|Treatment: Part I|Non-Compliance with Study Drug|1
1122511|NCT01632345|3682079|P3|Treatment: Part I|Non-Compliance with Study Drug|2
1122512|NCT01632345|3682080|P2|Treatment: Part I|Non-Compliance with Study Drug|2
1122513|NCT01632345|3682081|P1|Treatment: Part I|Non-Compliance with Study Drug|3
1122514|NCT01632345|3682075|P7|Treatment: Part I|Lost to Follow-up|0
1122515|NCT01632345|3682076|P6|Treatment: Part I|Lost to Follow-up|0
1122516|NCT01632345|3682077|P5|Treatment: Part I|Lost to Follow-up|4
1122517|NCT01632345|3682078|P4|Treatment: Part I|Lost to Follow-up|3
1122518|NCT01632345|3682079|P3|Treatment: Part I|Lost to Follow-up|1
1122519|NCT01632345|3682080|P2|Treatment: Part I|Lost to Follow-up|2
1122520|NCT01632345|3682081|P1|Treatment: Part I|Lost to Follow-up|3
1122521|NCT01632345|3682075|P7|Treatment: Part I|Lack of Efficacy|0
1122522|NCT01632345|3682076|P6|Treatment: Part I|Lack of Efficacy|0
1122523|NCT01632345|3682077|P5|Treatment: Part I|Lack of Efficacy|1
1122524|NCT01632345|3682078|P4|Treatment: Part I|Lack of Efficacy|1
1122525|NCT01632345|3682079|P3|Treatment: Part I|Lack of Efficacy|0
1122526|NCT01632345|3682080|P2|Treatment: Part I|Lack of Efficacy|1
1122527|NCT01632345|3682081|P1|Treatment: Part I|Lack of Efficacy|0
1122528|NCT01632345|3682075|P7|Treatment: Part I|Adverse Event|0
1122529|NCT01632345|3682076|P6|Treatment: Part I|Adverse Event|0
1122530|NCT01632345|3682077|P5|Treatment: Part I|Adverse Event|3
1122531|NCT01632345|3682078|P4|Treatment: Part I|Adverse Event|1
1122532|NCT01632345|3682079|P3|Treatment: Part I|Adverse Event|2
1122533|NCT01632345|3682080|P2|Treatment: Part I|Adverse Event|4
1122534|NCT01632345|3682081|P1|Treatment: Part I|Adverse Event|1
1122535|NCT01632306|3682143|P3|Overall Study|Protocol Violation|0
1122536|NCT01632306|3682144|P2|Overall Study|Protocol Violation|0
1122537|NCT01632306|3682145|P1|Overall Study|Protocol Violation|1
1122538|NCT01632280|3682161|P2|Overall Study|Withdrawal by Subject|0
1122539|NCT01632280|3682162|P1|Overall Study|Withdrawal by Subject|1
1122540|NCT01632150|3682185|P1|Overall Study|Moved to compassionate program|2
1122541|NCT01632150|3682185|P1|Overall Study|Patient underwent autologous transplant|1
1122542|NCT01632150|3682185|P1|Overall Study|Withdrawal by Subject|2
1122543|NCT01632150|3682185|P1|Overall Study|Unrelated adverse event|7
1122544|NCT01632150|3682185|P1|Overall Study|Study drug toxicity|1
1122545|NCT01632150|3682185|P1|Overall Study|Disease progression|27
1122546|NCT01632020|3682194|P2|Overall Study|Adverse Event|0
1122547|NCT01632020|3682195|P1|Overall Study|Adverse Event|1
1122548|NCT01632020|3682194|P2|Overall Study|Withdrawal by Subject|0
1122549|NCT01632020|3682195|P1|Overall Study|Withdrawal by Subject|1
1122550|NCT01631864|3682214|P2|Overall Study|Adverse Event|3
1122551|NCT01631864|3682215|P1|Overall Study|Adverse Event|2
1122552|NCT01631864|3682214|P2|Overall Study|Withdrawal by Subject|1
1122553|NCT01631864|3682215|P1|Overall Study|Withdrawal by Subject|0
1122554|NCT01631825|3682227|P1|Overall Study|Physician Decision|2
1122555|NCT01631825|3682227|P1|Overall Study|Discontinuation criteria|1
1122556|NCT01631825|3682227|P1|Overall Study|Protocol Violation|4
1122557|NCT01631825|3682227|P1|Overall Study|Withdrawal by Subject|9
1122558|NCT01631825|3682227|P1|Overall Study|Lack of Efficacy|7
1122559|NCT01631825|3682227|P1|Overall Study|Adverse Event|42
1122560|NCT01631812|3682247|P1|Overall Study|Physician Decision|3
1122561|NCT01631812|3682247|P1|Overall Study|Withdrawal by Subject|4
1122562|NCT01631812|3682247|P1|Overall Study|Lack of Efficacy|5
1122563|NCT01631812|3682247|P1|Overall Study|Adverse Event|25
1122564|NCT01631747|3682257|P2|One Year Infant Outcomes|Patient Refused|9
1122565|NCT01631747|3682258|P1|One Year Infant Outcomes|Patient Refused|13
1122566|NCT01631747|3682257|P2|Live Birth|Stillbirth|1
1122567|NCT01631747|3682258|P1|Live Birth|Stillbirth|1
1122568|NCT01631747|3682257|P2|Live Birth|MIscarriage|0
1122569|NCT01631747|3682258|P1|Live Birth|MIscarriage|2
1122570|NCT01631747|3682257|P2|Live Birth|Pregnancy Termination|0
1122571|NCT01631747|3682258|P1|Live Birth|Pregnancy Termination|1
1122572|NCT01631747|3682257|P2|Randomization Through End of Pregnancy|Lost to Follow-up|0
1122573|NCT01631747|3682258|P1|Randomization Through End of Pregnancy|Lost to Follow-up|1
1122574|NCT01631435|3682435|P1|Overall Study|incomplete study procedure|5
1122575|NCT01631435|3682435|P1|Overall Study|Withdrawal by Subject|2
1122576|NCT01631435|3682435|P1|Overall Study|Adverse Event|2
1122577|NCT01631227|3682449|P2|Overall Study|administrative|1
1122578|NCT01631227|3682450|P1|Overall Study|administrative|2
1122579|NCT01631227|3682449|P2|Overall Study|Adverse Event|0
1122580|NCT01631227|3682450|P1|Overall Study|Adverse Event|1
1122581|NCT01631227|3682449|P2|Overall Study|withdrawn consent|21
1122582|NCT01631227|3682450|P1|Overall Study|withdrawn consent|27
1122583|NCT01631214|3682458|P2|Overall Study|Administrative Decision|0
1122584|NCT01631214|3682459|P1|Overall Study|Administrative Decision|1
1122585|NCT01631214|3682458|P2|Overall Study|Ineligibility determined|2
1122586|NCT01631214|3682459|P1|Overall Study|Ineligibility determined|5
1122587|NCT01631214|3682458|P2|Overall Study|Protocol Deviation|3
1122588|NCT01631214|3682459|P1|Overall Study|Protocol Deviation|4
1122589|NCT01631214|3682458|P2|Overall Study|Requirement for Alternative Therapy|3
1122590|NCT01631214|3682459|P1|Overall Study|Requirement for Alternative Therapy|8
1122591|NCT01631214|3682458|P2|Overall Study|Noncompliance|15
1122592|NCT01631214|3682459|P1|Overall Study|Noncompliance|16
1122593|NCT01631214|3682458|P2|Overall Study|Other|19
1122594|NCT01631214|3682459|P1|Overall Study|Other|22
1122595|NCT01631214|3682458|P2|Overall Study|Adverse Event|45
1122596|NCT01631214|3682459|P1|Overall Study|Adverse Event|45
1122597|NCT01631214|3682458|P2|Overall Study|Lost to Follow-up|40
1122598|NCT01631214|3682459|P1|Overall Study|Lost to Follow-up|54
1122599|NCT01631214|3682458|P2|Overall Study|Death|106
1122600|NCT01631214|3682459|P1|Overall Study|Death|113
1122601|NCT01631214|3682458|P2|Overall Study|Withdrawal by Subject|290
1122602|NCT01631214|3682459|P1|Overall Study|Withdrawal by Subject|276
1122603|NCT01630811|3682568|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|0
1122604|NCT01630811|3682569|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|1
1122605|NCT01630616|3682596|P6|Overall Study|Withdrawal by Subject|0
1122606|NCT01630616|3682597|P5|Overall Study|Withdrawal by Subject|0
1122607|NCT01630616|3682598|P4|Overall Study|Withdrawal by Subject|2
1122608|NCT01630616|3682599|P3|Overall Study|Withdrawal by Subject|0
1122609|NCT01630616|3682600|P2|Overall Study|Withdrawal by Subject|0
1122610|NCT01630616|3682601|P1|Overall Study|Withdrawal by Subject|0
1122611|NCT01630616|3682596|P6|Overall Study|Adverse Event|0
1122612|NCT01630616|3682597|P5|Overall Study|Adverse Event|0
1122613|NCT01630616|3682598|P4|Overall Study|Adverse Event|1
1122614|NCT01630616|3682599|P3|Overall Study|Adverse Event|0
1122615|NCT01630616|3682600|P2|Overall Study|Adverse Event|0
1122616|NCT01630616|3682601|P1|Overall Study|Adverse Event|0
1122617|NCT01630135|3682676|P2|Overall Study|Protocol-defined Stopping Criteria Met|2
1122618|NCT01630135|3682677|P1|Overall Study|Protocol-defined Stopping Criteria Met|0
1122619|NCT01629953|3682740|P2|Overall Study|Lost to Follow-up|14
1122620|NCT01629953|3682741|P1|Overall Study|Lost to Follow-up|10
1122621|NCT01629953|3682740|P2|Overall Study|Death|1
1122622|NCT01629953|3682741|P1|Overall Study|Death|3
1122623|NCT01629823|3682761|P3|Washout Period|Protocol Violation|0
1122624|NCT01629823|3682762|P2|Washout Period|Protocol Violation|1
1122625|NCT01629823|3682763|P1|Washout Period|Protocol Violation|0
1122626|NCT01629823|3682761|P3|Washout Period|Pregnancy|0
1122627|NCT01629823|3682762|P2|Washout Period|Pregnancy|0
1122628|NCT01629823|3682763|P1|Washout Period|Pregnancy|1
1122629|NCT01629823|3682761|P3|Washout Period|Safety|0
1122630|NCT01629823|3682762|P2|Washout Period|Safety|5
1122631|NCT01629823|3682763|P1|Washout Period|Safety|2
1122632|NCT01629823|3682761|P3|Trial Period|Failed to hold medication|1
1122633|NCT01629823|3682762|P2|Trial Period|Failed to hold medication|0
1122634|NCT01629823|3682763|P1|Trial Period|Failed to hold medication|0
1122635|NCT01629823|3682761|P3|Trial Period|Out-of-window visit|0
1122636|NCT01629823|3682762|P2|Trial Period|Out-of-window visit|2
1122637|NCT01629823|3682763|P1|Trial Period|Out-of-window visit|0
1122638|NCT01629823|3682761|P3|Trial Period|Adverse Event|0
1122639|NCT01629823|3682762|P2|Trial Period|Adverse Event|1
1122640|NCT01629823|3682763|P1|Trial Period|Adverse Event|0
1122641|NCT01629823|3682761|P3|Trial Period|Pregnancy|0
1122642|NCT01629823|3682762|P2|Trial Period|Pregnancy|0
1122643|NCT01629823|3682763|P1|Trial Period|Pregnancy|1
1122644|NCT01629823|3682761|P3|Trial Period|Pre-diluent FEV₁ predicted <70%|1
1122645|NCT01629823|3682762|P2|Trial Period|Pre-diluent FEV₁ predicted <70%|1
1122646|NCT01629823|3682763|P1|Trial Period|Pre-diluent FEV₁ predicted <70%|1
1122647|NCT01629823|3682761|P3|Trial Period|Missed visit|8
1122648|NCT01629823|3682762|P2|Trial Period|Missed visit|9
1122649|NCT01629823|3682763|P1|Trial Period|Missed visit|11
1122650|NCT01629706|3682798|P1|Phase 2 Habitual|Lost to Follow Up after Dispense|1
1122651|NCT01629706|3682798|P1|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1
1122652|NCT01629706|3682798|P1|Phase 2 Habitual|Relocation prior to Dispense|1
1122653|NCT01629706|3682798|P1|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1
1122654|NCT01629706|3682798|P1|Phase 2 Habitual|Screen Failure|6
1122655|NCT01629706|3682798|P1|Phase 1 PureVision|No Solution-Induced Corneal Staining|3
1122656|NCT01629706|3682798|P1|Phase 1 PureVision|Inconvenience prior to Dispense|1
1122657|NCT01629706|3682798|P1|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1
1122658|NCT01629706|3682798|P1|Phase 1 PureVision|Screen Failure|4
1122659|NCT01629693|3682826|P2|Overall Study|Subject decision unrelated to AE|1
1122660|NCT01629693|3682827|P1|Overall Study|Subject decision unrelated to AE|0
1122661|NCT01629693|3682826|P2|Overall Study|Poor comfort of study lenses|2
1122662|NCT01629693|3682827|P1|Overall Study|Poor comfort of study lenses|0
1122663|NCT01629693|3682826|P2|Overall Study|Investigator decision|1
1122664|NCT01629693|3682827|P1|Overall Study|Investigator decision|0
1122665|NCT01629693|3682826|P2|Overall Study|Adverse Event|0
1122666|NCT01629693|3682827|P1|Overall Study|Adverse Event|1
1122667|NCT01629693|3682826|P2|Overall Study|Withdrawal by Subject|2
1122668|NCT01629693|3682827|P1|Overall Study|Withdrawal by Subject|2
1122669|NCT01629693|3682826|P2|Overall Study|Lost to Follow-up|4
1122670|NCT01629693|3682827|P1|Overall Study|Lost to Follow-up|2
1122671|NCT01629667|3682836|P3|Overall Study|Code break|0
1122672|NCT01629667|3682837|P2|Overall Study|Code break|0
1122673|NCT01629667|3682838|P1|Overall Study|Code break|1
1122674|NCT01629667|3682836|P3|Overall Study|Enrolled in another clinical study|0
1122675|NCT01629667|3682837|P2|Overall Study|Enrolled in another clinical study|1
1122676|NCT01629667|3682838|P1|Overall Study|Enrolled in another clinical study|0
1122677|NCT01629667|3682836|P3|Overall Study|Site error in safety follow-up|1
1122678|NCT01629667|3682837|P2|Overall Study|Site error in safety follow-up|0
1122679|NCT01629667|3682838|P1|Overall Study|Site error in safety follow-up|0
1122680|NCT01629667|3682836|P3|Overall Study|Started other medicine|1
1122681|NCT01629667|3682837|P2|Overall Study|Started other medicine|0
1122682|NCT01629667|3682838|P1|Overall Study|Started other medicine|1
1122683|NCT01629667|3682836|P3|Overall Study|Early tretmt termntd, cmpltd safety f-up|8
1122684|NCT01629667|3682837|P2|Overall Study|Early tretmt termntd, cmpltd safety f-up|11
1122685|NCT01629667|3682838|P1|Overall Study|Early tretmt termntd, cmpltd safety f-up|9
1122686|NCT01629667|3682836|P3|Overall Study|Requiring lung transplant|3
1122687|NCT01629667|3682837|P2|Overall Study|Requiring lung transplant|1
1122688|NCT01629667|3682838|P1|Overall Study|Requiring lung transplant|2
1122689|NCT01629667|3682836|P3|Overall Study|Ongoing AE worsening right heart failure|0
1122690|NCT01629667|3682837|P2|Overall Study|Ongoing AE worsening right heart failure|1
1122691|NCT01629667|3682838|P1|Overall Study|Ongoing AE worsening right heart failure|0
1122692|NCT01629667|3682836|P3|Overall Study|Randomized, not treated|0
1122693|NCT01629667|3682837|P2|Overall Study|Randomized, not treated|1
1122694|NCT01629667|3682838|P1|Overall Study|Randomized, not treated|2
1122695|NCT01629667|3682836|P3|Overall Study|Death|3
1122696|NCT01629667|3682837|P2|Overall Study|Death|5
1122697|NCT01629667|3682838|P1|Overall Study|Death|1
1122698|NCT01629667|3682836|P3|Overall Study|Withdrawal by Subject|28
1122699|NCT01629667|3682837|P2|Overall Study|Withdrawal by Subject|20
1122700|NCT01629667|3682838|P1|Overall Study|Withdrawal by Subject|31
1122701|NCT01629667|3682836|P3|Overall Study|Lost to Follow-up|1
1122702|NCT01629667|3682837|P2|Overall Study|Lost to Follow-up|1
1122703|NCT01629667|3682838|P1|Overall Study|Lost to Follow-up|0
1122704|NCT01629589|3682922|P2|Overall Study|Did not receive study vaccine|1
1122705|NCT01629589|3682923|P1|Overall Study|Did not receive study vaccine|0
1122706|NCT01629589|3682922|P2|Overall Study|Withdrawal by Subject|3
1122707|NCT01629589|3682923|P1|Overall Study|Withdrawal by Subject|2
1122708|NCT01629589|3682922|P2|Overall Study|Lost to Follow-up|1
1122709|NCT01629589|3682923|P1|Overall Study|Lost to Follow-up|2
1122710|NCT01629589|3682922|P2|Overall Study|Protocol Violation|2
1122711|NCT01629589|3682923|P1|Overall Study|Protocol Violation|4
1122712|NCT01628965|3682962|P1|Overall Study|Discontinuation criteria|8
1122713|NCT01628965|3682962|P1|Overall Study|Lost to Follow-up|1
1122714|NCT01628965|3682962|P1|Overall Study|Withdrawal by Subject|3
1122715|NCT01628965|3682962|P1|Overall Study|Lack of Efficacy|7
1122716|NCT01628965|3682962|P1|Overall Study|Adverse Event|30
1122717|NCT01628926|3682971|P3|Overall Study|Physician Decision|1
1122718|NCT01628926|3682972|P2|Overall Study|Physician Decision|2
1122719|NCT01628926|3682973|P1|Overall Study|Physician Decision|2
1122720|NCT01628926|3682971|P3|Overall Study|Discontinuation criteria|0
1122721|NCT01628926|3682972|P2|Overall Study|Discontinuation criteria|4
1122722|NCT01628926|3682973|P1|Overall Study|Discontinuation criteria|3
1122723|NCT01628926|3682971|P3|Overall Study|Protocol Violation|0
1122724|NCT01628926|3682972|P2|Overall Study|Protocol Violation|1
1122725|NCT01628926|3682973|P1|Overall Study|Protocol Violation|0
1122726|NCT01628926|3682971|P3|Overall Study|Withdrawal by Subject|2
1122727|NCT01628926|3682972|P2|Overall Study|Withdrawal by Subject|4
1122728|NCT01628926|3682973|P1|Overall Study|Withdrawal by Subject|6
1122729|NCT01628926|3682971|P3|Overall Study|Lack of Efficacy|5
1122730|NCT01628926|3682972|P2|Overall Study|Lack of Efficacy|1
1122731|NCT01628926|3682973|P1|Overall Study|Lack of Efficacy|2
1122732|NCT01628926|3682971|P3|Overall Study|Adverse Event|9
1122733|NCT01628926|3682972|P2|Overall Study|Adverse Event|11
1122734|NCT01628926|3682973|P1|Overall Study|Adverse Event|13
1122735|NCT01628913|3683022|P2|Overall Study|Physician Decision|3
1122736|NCT01628913|3683023|P1|Overall Study|Physician Decision|1
1122737|NCT01628913|3683022|P2|Overall Study|Withdrawal by Subject|0
1122738|NCT01628913|3683023|P1|Overall Study|Withdrawal by Subject|1
1122739|NCT01628913|3683022|P2|Overall Study|study terminated by Sponsor|9
1122740|NCT01628913|3683023|P1|Overall Study|study terminated by Sponsor|4
1122741|NCT01628913|3683022|P2|Overall Study|Death|0
1122742|NCT01628913|3683023|P1|Overall Study|Death|1
1122743|NCT01628913|3683022|P2|Overall Study|Protocol Violation|0
1122744|NCT01628913|3683023|P1|Overall Study|Protocol Violation|1
1122745|NCT01628913|3683022|P2|Overall Study|Disease Progression|14
1122746|NCT01628913|3683023|P1|Overall Study|Disease Progression|11
1122747|NCT01628913|3683022|P2|Overall Study|Adverse Event|5
1122748|NCT01628913|3683023|P1|Overall Study|Adverse Event|12
1122749|NCT01628848|3683037|P2|Overall Study|Physician Decision|1
1122750|NCT01628848|3683038|P1|Overall Study|Physician Decision|3
1122751|NCT01628848|3683037|P2|Overall Study|Withdrawal by Subject|2
1122752|NCT01628848|3683038|P1|Overall Study|Withdrawal by Subject|0
1122753|NCT01628848|3683037|P2|Overall Study|Lack of Efficacy|4
1122754|NCT01628848|3683038|P1|Overall Study|Lack of Efficacy|0
1122755|NCT01628848|3683037|P2|Overall Study|Adverse Event|7
1122756|NCT01628848|3683038|P1|Overall Study|Adverse Event|9
1122757|NCT01628692|3683072|P6|Overall Study|Completed 12 Week only|1
1122758|NCT01628692|3683073|P5|Overall Study|Completed 12 Week only|0
1122759|NCT01628692|3683074|P4|Overall Study|Completed 12 Week only|0
1122760|NCT01628692|3683075|P3|Overall Study|Completed 12 Week only|0
1122761|NCT01628692|3683076|P2|Overall Study|Completed 12 Week only|0
1122762|NCT01628692|3683077|P1|Overall Study|Completed 12 Week only|0
1122763|NCT01628692|3683072|P6|Overall Study|Administrative reason by sponsor|1
1122764|NCT01628692|3683073|P5|Overall Study|Administrative reason by sponsor|0
1122765|NCT01628692|3683074|P4|Overall Study|Administrative reason by sponsor|0
1122766|NCT01628692|3683075|P3|Overall Study|Administrative reason by sponsor|0
1122767|NCT01628692|3683076|P2|Overall Study|Administrative reason by sponsor|0
1122768|NCT01628692|3683077|P1|Overall Study|Administrative reason by sponsor|0
1122769|NCT01628692|3683072|P6|Overall Study|Poor compliance/noncompliance|0
1122770|NCT01628692|3683073|P5|Overall Study|Poor compliance/noncompliance|0
1122771|NCT01628692|3683074|P4|Overall Study|Poor compliance/noncompliance|0
1122772|NCT01628692|3683075|P3|Overall Study|Poor compliance/noncompliance|0
1122773|NCT01628692|3683076|P2|Overall Study|Poor compliance/noncompliance|0
1122774|NCT01628692|3683077|P1|Overall Study|Poor compliance/noncompliance|1
1122775|NCT01628692|3683072|P6|Overall Study|Death|0
1122776|NCT01628692|3683073|P5|Overall Study|Death|0
1122777|NCT01628692|3683074|P4|Overall Study|Death|0
1122778|NCT01628692|3683075|P3|Overall Study|Death|0
1122779|NCT01628692|3683076|P2|Overall Study|Death|1
1122780|NCT01628692|3683077|P1|Overall Study|Death|0
1122781|NCT01628692|3683072|P6|Overall Study|Withdrawal by Subject|0
1122782|NCT01628692|3683073|P5|Overall Study|Withdrawal by Subject|0
1122783|NCT01628692|3683074|P4|Overall Study|Withdrawal by Subject|0
1122784|NCT01628692|3683075|P3|Overall Study|Withdrawal by Subject|1
1122785|NCT01628692|3683076|P2|Overall Study|Withdrawal by Subject|1
1122786|NCT01628692|3683077|P1|Overall Study|Withdrawal by Subject|0
1122787|NCT01628692|3683072|P6|Overall Study|Adverse Event|0
1122788|NCT01628692|3683073|P5|Overall Study|Adverse Event|0
1122789|NCT01628692|3683074|P4|Overall Study|Adverse Event|0
1122790|NCT01628692|3683075|P3|Overall Study|Adverse Event|2
1122791|NCT01628692|3683076|P2|Overall Study|Adverse Event|0
1122792|NCT01628692|3683077|P1|Overall Study|Adverse Event|2
1122793|NCT01628692|3683072|P6|Overall Study|Lack of Efficacy|7
1122794|NCT01628692|3683073|P5|Overall Study|Lack of Efficacy|4
1122795|NCT01628692|3683074|P4|Overall Study|Lack of Efficacy|1
1122796|NCT01628692|3683075|P3|Overall Study|Lack of Efficacy|5
1122797|NCT01628692|3683076|P2|Overall Study|Lack of Efficacy|4
1122798|NCT01628692|3683077|P1|Overall Study|Lack of Efficacy|4
1122799|NCT01628510|3683145|P2|Overall Study|Death|1
1122800|NCT01628510|3683146|P1|Overall Study|Death|3
1122801|NCT01628510|3683145|P2|Overall Study|Withdrawal by Subject|4
1122802|NCT01628510|3683146|P1|Overall Study|Withdrawal by Subject|0
1122803|NCT01628367|3683156|P2|Overall Study|Adverse Event|0
1122804|NCT01628367|3683157|P1|Overall Study|Adverse Event|1
1122805|NCT01628198|3683176|P1|Overall Study|Screen failure|1
1122806|NCT01628198|3683176|P1|Overall Study|Withdrawal by Subject|10
1122807|NCT01628198|3683176|P1|Overall Study|Lost to Follow-up|7
1122808|NCT01628120|3683189|P1|Overall Study|Use of Standard of Care|1
1122809|NCT01628120|3683189|P1|Overall Study|Kidney Transplant|2
1122810|NCT01628120|3683189|P1|Overall Study|Moved or Relocated|5
1122811|NCT01628120|3683189|P1|Overall Study|Missed Study Drug More than 2 Weeks|3
1122812|NCT01628120|3683189|P1|Overall Study|Switched Dialysis Method|2
1122813|NCT01628120|3683189|P1|Overall Study|Sponsor Decision|5
1122814|NCT01628120|3683189|P1|Overall Study|Not Treated|3
1122815|NCT01628120|3683189|P1|Overall Study|Non-compliant with Study Procedures|1
1122816|NCT01628120|3683189|P1|Overall Study|Not met Inclusion/Exclusion Criteria|2
1122817|NCT01628120|3683189|P1|Overall Study|Lost to Follow-up|1
1122818|NCT01628120|3683189|P1|Overall Study|Adverse Event|12
1122819|NCT01628120|3683189|P1|Overall Study|Withdrawal by Subject|7
1122820|NCT01628107|3683214|P1|Overall Study|Use of Standard of Care|9
1122821|NCT01628107|3683214|P1|Overall Study|Kidney Transplant|9
1122822|NCT01628107|3683214|P1|Overall Study|Relocated|8
1122823|NCT01628107|3683214|P1|Overall Study|Missed Study Drug More than 2 Weeks|7
1122824|NCT01628107|3683214|P1|Overall Study|Sponsor Decision|11
1122825|NCT01628107|3683214|P1|Overall Study|Not Treated|8
1122826|NCT01628107|3683214|P1|Overall Study|Non-compliant with Study Procedures|10
1122827|NCT01628107|3683214|P1|Overall Study|Not met Inclusion/Exclusion Criteria|1
1122828|NCT01628107|3683214|P1|Overall Study|Physician Decision|2
1122829|NCT01628107|3683214|P1|Overall Study|Adverse Event|33
1122830|NCT01628107|3683214|P1|Overall Study|Lost to Follow-up|4
1122831|NCT01628107|3683214|P1|Overall Study|Withdrawal by Subject|17
1122832|NCT01627899|3683264|P1|Overall Study|Study terminated early by sponsor.|5
1122833|NCT01627860|3683274|P2|Overall Study|Protocol Violation|0
1122834|NCT01627860|3683275|P1|Overall Study|Protocol Violation|1
1122835|NCT01627860|3683274|P2|Overall Study|Seizure frequency doubled|1
1122836|NCT01627860|3683275|P1|Overall Study|Seizure frequency doubled|0
1122837|NCT01627860|3683274|P2|Overall Study|Withdrawal by Subject|1
1122838|NCT01627860|3683275|P1|Overall Study|Withdrawal by Subject|2
1122839|NCT01627860|3683274|P2|Overall Study|Adverse Event|4
1122840|NCT01627860|3683275|P1|Overall Study|Adverse Event|9
1122841|NCT01627782|3683289|P4|Overall Study|Randomized But Not Treated|0
1122842|NCT01627782|3683290|P3|Overall Study|Randomized But Not Treated|0
1122843|NCT01627782|3683291|P2|Overall Study|Randomized But Not Treated|0
1122844|NCT01627782|3683292|P1|Overall Study|Randomized But Not Treated|1
1122845|NCT01627782|3683289|P4|Overall Study|Other|3
1122846|NCT01627782|3683290|P3|Overall Study|Other|0
1122847|NCT01627782|3683291|P2|Overall Study|Other|2
1122848|NCT01627782|3683292|P1|Overall Study|Other|0
1122849|NCT01627782|3683289|P4|Overall Study|Withdrawal by Subject|0
1122850|NCT01627782|3683290|P3|Overall Study|Withdrawal by Subject|0
1122851|NCT01627782|3683291|P2|Overall Study|Withdrawal by Subject|1
1122852|NCT01627782|3683292|P1|Overall Study|Withdrawal by Subject|2
1122853|NCT01627782|3683289|P4|Overall Study|Protocol Violation|0
1122854|NCT01627782|3683290|P3|Overall Study|Protocol Violation|0
1122855|NCT01627782|3683291|P2|Overall Study|Protocol Violation|0
1122856|NCT01627782|3683292|P1|Overall Study|Protocol Violation|1
1122857|NCT01627782|3683289|P4|Overall Study|Lack of Efficacy|2
1122858|NCT01627782|3683290|P3|Overall Study|Lack of Efficacy|15
1122859|NCT01627782|3683291|P2|Overall Study|Lack of Efficacy|1
1122860|NCT01627782|3683292|P1|Overall Study|Lack of Efficacy|11
1122861|NCT01627782|3683289|P4|Overall Study|Adverse Event|1
1122862|NCT01627782|3683290|P3|Overall Study|Adverse Event|0
1122863|NCT01627782|3683291|P2|Overall Study|Adverse Event|2
1122864|NCT01627782|3683292|P1|Overall Study|Adverse Event|1
1122865|NCT01627561|3683350|P2|Overall Study|Withdrawal by Subject|2
1122866|NCT01627561|3683351|P1|Overall Study|Withdrawal by Subject|0
1122867|NCT01627561|3683350|P2|Overall Study|Migrated/moved from study area|1
1122868|NCT01627561|3683351|P1|Overall Study|Migrated/moved from study area|0
1122869|NCT01627340|3683399|P2|Overall Study|Withdrawal by Subject|0
1122870|NCT01627340|3683400|P1|Overall Study|Withdrawal by Subject|2
1122871|NCT01627340|3683399|P2|Overall Study|Pregnancy|0
1122872|NCT01627340|3683400|P1|Overall Study|Pregnancy|1
1122873|NCT01627340|3683399|P2|Overall Study|Lost to Follow-up|4
1122874|NCT01627340|3683400|P1|Overall Study|Lost to Follow-up|8
1122875|NCT01627340|3683399|P2|Overall Study|Adverse Event|0
1122876|NCT01627340|3683400|P1|Overall Study|Adverse Event|1
1122877|NCT01627327|3683418|P2|Overall Study|Withdrawal by Subject|3
1122878|NCT01627327|3683419|P1|Overall Study|Withdrawal by Subject|3
1122879|NCT01627327|3683418|P2|Overall Study|Physician Decision|0
1122880|NCT01627327|3683419|P1|Overall Study|Physician Decision|1
1122881|NCT01627327|3683418|P2|Overall Study|Lost to Follow-up|3
1122882|NCT01627327|3683419|P1|Overall Study|Lost to Follow-up|1
1122883|NCT01627327|3683418|P2|Overall Study|Protocol Violation|10
1122884|NCT01627327|3683419|P1|Overall Study|Protocol Violation|4
1122885|NCT01627327|3683418|P2|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9
1122886|NCT01627327|3683419|P1|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4
1122887|NCT01627327|3683418|P2|Overall Study|Lack of Efficacy-No Sub-Reason|2
1122888|NCT01627327|3683419|P1|Overall Study|Lack of Efficacy-No Sub-Reason|0
1122889|NCT01627327|3683418|P2|Overall Study|Adverse Event|12
1122890|NCT01627327|3683419|P1|Overall Study|Adverse Event|6
1122891|NCT01627249|3683432|P3|Overall Study|Missed Visit|0
1122892|NCT01627249|3683433|P2|Overall Study|Missed Visit|1
1122893|NCT01627249|3683434|P1|Overall Study|Missed Visit|1
1122894|NCT01627249|3683432|P3|Overall Study|Withdrawal by Subject|9
1122895|NCT01627249|3683433|P2|Overall Study|Withdrawal by Subject|6
1122896|NCT01627249|3683434|P1|Overall Study|Withdrawal by Subject|12
1122897|NCT01627249|3683432|P3|Overall Study|Death|3
1122898|NCT01627249|3683433|P2|Overall Study|Death|5
1122899|NCT01627249|3683434|P1|Overall Study|Death|3
1122900|NCT01626690|3683555|P2|Overall Study|Adverse Event|0
1122901|NCT01626690|3683556|P1|Overall Study|Adverse Event|1
1122902|NCT01626690|3683555|P2|Overall Study|Protocol Violation|0
1122903|NCT01626690|3683556|P1|Overall Study|Protocol Violation|1
1122904|NCT01626456|3683595|P2|Overall Study|Incarceration|2
1122905|NCT01626456|3683596|P1|Overall Study|Incarceration|0
1122906|NCT01626456|3683595|P2|Overall Study|Site Closure|3
1122907|NCT01626456|3683596|P1|Overall Study|Site Closure|2
1122908|NCT01626456|3683595|P2|Overall Study|Protocol Violation|1
1122909|NCT01626456|3683596|P1|Overall Study|Protocol Violation|1
1122910|NCT01626456|3683595|P2|Overall Study|Physician Decision|4
1122911|NCT01626456|3683596|P1|Overall Study|Physician Decision|1
1122912|NCT01626456|3683595|P2|Overall Study|Lack of Efficacy|7
1122913|NCT01626456|3683596|P1|Overall Study|Lack of Efficacy|6
1122914|NCT01626456|3683595|P2|Overall Study|Lost to Follow-up|27
1122915|NCT01626456|3683596|P1|Overall Study|Lost to Follow-up|2
1122916|NCT01626456|3683595|P2|Overall Study|Adverse Event|27
1122917|NCT01626456|3683596|P1|Overall Study|Adverse Event|2
1122918|NCT01626456|3683595|P2|Overall Study|Withdrawal by Subject|46
1122919|NCT01626456|3683596|P1|Overall Study|Withdrawal by Subject|21
1122920|NCT01626391|3683626|P2|Overall Study|Withdrawal by Subject|0
1122921|NCT01626391|3683627|P1|Overall Study|Withdrawal by Subject|1
1122922|NCT01626391|3683626|P2|Overall Study|Physician Decision|0
1122923|NCT01626391|3683627|P1|Overall Study|Physician Decision|1
1122924|NCT01626352|3683633|P1|Overall Study|Never Treated|1
1122925|NCT01626352|3683633|P1|Overall Study|Non-Compliance|1
1122926|NCT01626352|3683633|P1|Overall Study|Withdrawal by Subject|1
1122927|NCT01626352|3683633|P1|Overall Study|Death|2
1122928|NCT01626352|3683633|P1|Overall Study|Intercurrent Illness|2
1122929|NCT01626352|3683633|P1|Overall Study|Disease Progression|3
1122930|NCT01626118|3683647|P4|Overall Study|Investigator Decision|0
1122931|NCT01626118|3683648|P3|Overall Study|Investigator Decision|0
1122932|NCT01626118|3683649|P2|Overall Study|Investigator Decision|1
1122933|NCT01626118|3683650|P1|Overall Study|Investigator Decision|0
1122934|NCT01626118|3683647|P4|Overall Study|Adverse Event|0
1122935|NCT01626118|3683648|P3|Overall Study|Adverse Event|1
1122936|NCT01626118|3683649|P2|Overall Study|Adverse Event|1
1122937|NCT01626118|3683650|P1|Overall Study|Adverse Event|0
1122938|NCT01626118|3683647|P4|Overall Study|Lost to Follow-up|0
1122939|NCT01626118|3683648|P3|Overall Study|Lost to Follow-up|0
1122940|NCT01626118|3683649|P2|Overall Study|Lost to Follow-up|0
1122941|NCT01626118|3683650|P1|Overall Study|Lost to Follow-up|1
1122942|NCT01626118|3683647|P4|Overall Study|Lack of Efficacy|3
1122943|NCT01626118|3683648|P3|Overall Study|Lack of Efficacy|1
1122944|NCT01626118|3683649|P2|Overall Study|Lack of Efficacy|0
1122945|NCT01626118|3683650|P1|Overall Study|Lack of Efficacy|1
1122946|NCT01625910|3683696|P2|Overall Study|Lost to Follow-up|4
1122947|NCT01625910|3683697|P1|Overall Study|Lost to Follow-up|3
1122948|NCT01625845|3683707|P2|Overall Study|Withdrawal by Subject|0
1122949|NCT01625845|3683708|P1|Overall Study|Withdrawal by Subject|2
1122950|NCT01625845|3683707|P2|Overall Study|Lost to Follow-up|1
1122951|NCT01625845|3683708|P1|Overall Study|Lost to Follow-up|2
1122952|NCT01625845|3683707|P2|Overall Study|Adverse Event|2
1122953|NCT01625845|3683708|P1|Overall Study|Adverse Event|1
1122954|NCT01625689|3683728|P2|Overall Study|Migration|1
1122955|NCT01625689|3683729|P1|Overall Study|Migration|2
1122956|NCT01625377|3683784|P2|Overall Study|Abnormal laboratory values|0
1122957|NCT01625377|3683785|P1|Overall Study|Abnormal laboratory values|1
1122958|NCT01625377|3683784|P2|Overall Study|Unsatisfactory therapeutic effect|1
1122959|NCT01625377|3683785|P1|Overall Study|Unsatisfactory therapeutic effect|0
1122960|NCT01625377|3683784|P2|Overall Study|Graft loss|0
1122961|NCT01625377|3683785|P1|Overall Study|Graft loss|1
1122962|NCT01625377|3683784|P2|Overall Study|Adverse Event|16
1122963|NCT01625377|3683785|P1|Overall Study|Adverse Event|3
1122964|NCT01625377|3683784|P2|Overall Study|Protocol Violation|3
1122965|NCT01625377|3683785|P1|Overall Study|Protocol Violation|0
1122966|NCT01625377|3683784|P2|Overall Study|Administrative Problem|1
1122967|NCT01625377|3683785|P1|Overall Study|Administrative Problem|1
1122968|NCT01625377|3683784|P2|Overall Study|Death|1
1122969|NCT01625377|3683785|P1|Overall Study|Death|1
1122970|NCT01625338|3683818|P3|Overall Study|Study Discontinued by Sponsor|1
1122971|NCT01625338|3683819|P2|Overall Study|Study Discontinued by Sponsor|0
1122972|NCT01625338|3683820|P1|Overall Study|Study Discontinued by Sponsor|0
1122973|NCT01625338|3683818|P3|Overall Study|Adverse Event|1
1122974|NCT01625338|3683819|P2|Overall Study|Adverse Event|0
1122975|NCT01625338|3683820|P1|Overall Study|Adverse Event|1
1122976|NCT01625338|3683818|P3|Overall Study|Subject Withdrew Consent|2
1122977|NCT01625338|3683819|P2|Overall Study|Subject Withdrew Consent|0
1122978|NCT01625338|3683820|P1|Overall Study|Subject Withdrew Consent|1
1122979|NCT01625338|3683818|P3|Overall Study|Investigator Decision|1
1122980|NCT01625338|3683819|P2|Overall Study|Investigator Decision|2
1122981|NCT01625338|3683820|P1|Overall Study|Investigator Decision|0
1122982|NCT01625338|3683818|P3|Overall Study|Lost to Follow-up|2
1122983|NCT01625338|3683819|P2|Overall Study|Lost to Follow-up|3
1122984|NCT01625338|3683820|P1|Overall Study|Lost to Follow-up|3
1122985|NCT01625338|3683818|P3|Overall Study|Efficacy Failure|31
1122986|NCT01625338|3683819|P2|Overall Study|Efficacy Failure|39
1122987|NCT01625338|3683820|P1|Overall Study|Efficacy Failure|27
1122988|NCT01625338|3683818|P3|Overall Study|Enrolled but not Treated|1
1122989|NCT01625338|3683819|P2|Overall Study|Enrolled but not Treated|0
1122990|NCT01625338|3683820|P1|Overall Study|Enrolled but not Treated|0
1122991|NCT01625182|3683847|P2|Overall Study|Lack of Efficacy|8
1122992|NCT01625182|3683848|P1|Overall Study|Lack of Efficacy|12
1122993|NCT01625182|3683847|P2|Overall Study|Withdrawal by Subject|1
1122994|NCT01625182|3683848|P1|Overall Study|Withdrawal by Subject|5
1122995|NCT01625182|3683847|P2|Overall Study|Adverse Event|0
1122996|NCT01625182|3683848|P1|Overall Study|Adverse Event|2
1122997|NCT01625182|3683847|P2|Overall Study|Protocol deviation|2
1122998|NCT01625182|3683848|P1|Overall Study|Protocol deviation|0
1122999|NCT01625182|3683847|P2|Overall Study|Administrative problems|0
1123000|NCT01625182|3683848|P1|Overall Study|Administrative problems|1
1123001|NCT01625091|3683885|P2|Post-intervention|Study termination|1
1123002|NCT01625091|3683886|P1|Post-intervention|Study termination|2
1123003|NCT01625091|3683885|P2|Post-intervention|Lost to Follow-up|0
1123004|NCT01625091|3683886|P1|Post-intervention|Lost to Follow-up|2
1123005|NCT01625091|3683885|P2|Post-intervention|Death|1
1123006|NCT01625091|3683886|P1|Post-intervention|Death|0
1123007|NCT01625091|3683885|P2|Intervention|Study termination|3
1123008|NCT01625091|3683886|P1|Intervention|Study termination|2
1123009|NCT01625091|3683885|P2|Intervention|Lost to Follow-up|4
1123010|NCT01625091|3683886|P1|Intervention|Lost to Follow-up|4
1123011|NCT01625091|3683885|P2|Intervention|Adverse Event|2
1123012|NCT01625091|3683886|P1|Intervention|Adverse Event|0
1123013|NCT01625091|3683885|P2|Intervention|Withdrawal by Subject|1
1123014|NCT01625091|3683886|P1|Intervention|Withdrawal by Subject|4
1123015|NCT01625091|3683885|P2|Intervention|Death|1
1123016|NCT01625091|3683886|P1|Intervention|Death|1
1123017|NCT01624974|3683900|P2|Period V of Treatment (4 Weeks)|Adverse Event|0
1123018|NCT01624974|3683901|P1|Period V of Treatment (4 Weeks)|Adverse Event|1
1123019|NCT01624974|3683900|P2|Period V of Treatment (4 Weeks)|Physician Decision|0
1123020|NCT01624974|3683901|P1|Period V of Treatment (4 Weeks)|Physician Decision|3
1123021|NCT01624974|3683900|P2|Period V of Treatment (4 Weeks)|Lack of Efficacy|0
1123022|NCT01624974|3683901|P1|Period V of Treatment (4 Weeks)|Lack of Efficacy|1
1123023|NCT01624974|3683900|P2|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1
1123024|NCT01624974|3683901|P1|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0
1123025|NCT01624974|3683900|P2|Period IV Washout (4 Weeks)|Adverse Event|0
1123026|NCT01624974|3683901|P1|Period IV Washout (4 Weeks)|Adverse Event|2
1123027|NCT01624974|3683900|P2|Period IV Washout (4 Weeks)|Withdrawal by Subject|1
1123028|NCT01624974|3683901|P1|Period IV Washout (4 Weeks)|Withdrawal by Subject|0
1123029|NCT01624974|3683900|P2|Period IV Washout (4 Weeks)|Lack of Efficacy|1
1123030|NCT01624974|3683901|P1|Period IV Washout (4 Weeks)|Lack of Efficacy|1
1123031|NCT01624974|3683900|P2|Period III of Treatment (4 Weeks)|Adverse Event|1
1123032|NCT01624974|3683901|P1|Period III of Treatment (4 Weeks)|Adverse Event|0
1123033|NCT01624974|3683900|P2|Period III of Treatment (4 Weeks)|Protocol Violation|0
1123034|NCT01624974|3683901|P1|Period III of Treatment (4 Weeks)|Protocol Violation|1
1123035|NCT01624974|3683900|P2|Period III of Treatment (4 Weeks)|Physician Decision|3
1123036|NCT01624974|3683901|P1|Period III of Treatment (4 Weeks)|Physician Decision|5
1123037|NCT01624974|3683900|P2|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2
1123038|NCT01624974|3683901|P1|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1
1123039|NCT01624974|3683900|P2|Period III of Treatment (4 Weeks)|Lack of Efficacy|2
1123040|NCT01624974|3683901|P1|Period III of Treatment (4 Weeks)|Lack of Efficacy|0
1123041|NCT01624870|3683942|P1|Overall Study|Lost to follow up|1
1123042|NCT01624870|3683942|P1|Overall Study|CoreValve not implanted|6
1123043|NCT01624870|3683942|P1|Overall Study|Withdrawal by Subject|1
1123044|NCT01624870|3683942|P1|Overall Study|Death|19
1123045|NCT01624662|3683962|P4|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
1123046|NCT01624662|3683963|P3|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
1123047|NCT01624662|3683964|P2|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
1123048|NCT01624662|3683965|P1|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
1123049|NCT01624662|3683962|P4|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
1123050|NCT01624662|3683963|P3|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
1123051|NCT01624662|3683964|P2|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1
1123052|NCT01624662|3683965|P1|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
1123053|NCT01624662|3683962|P4|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
1123054|NCT01624662|3683963|P3|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
1123055|NCT01624662|3683964|P2|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
1123056|NCT01624662|3683965|P1|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
1123057|NCT01624662|3683962|P4|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
1123058|NCT01624662|3683963|P3|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3
1123059|NCT01624662|3683964|P2|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
1123060|NCT01624662|3683965|P1|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3
1123061|NCT01624662|3683962|P4|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
1123062|NCT01624662|3683963|P3|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
1123063|NCT01624662|3683964|P2|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1
1123064|NCT01624662|3683965|P1|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
1123065|NCT01624662|3683962|P4|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
1123066|NCT01624662|3683963|P3|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
1123067|NCT01624662|3683964|P2|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1
1123068|NCT01624662|3683965|P1|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5
1123069|NCT01624662|3683962|P4|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0
1123070|NCT01624662|3683963|P3|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
1123071|NCT01624662|3683964|P2|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
1123072|NCT01624662|3683965|P1|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2
1123073|NCT01624467|3684036|P1|Overall Study|Subject Withdrew from Treatment|1
1123074|NCT01624467|3684036|P1|Overall Study|Per Sponsor Requirement|1
1123075|NCT01624467|3684036|P1|Overall Study|Progressive Disease|19
1123076|NCT01624467|3684036|P1|Overall Study|Adverse Event|7
1123077|NCT01624467|3684036|P1|Overall Study|Lost to Follow-up|1
1123078|NCT01624467|3684036|P1|Overall Study|Withdrawal by Subject|2
1123079|NCT01624259|3684075|P2|Overall Study|Abnormal laboratory measure|0
1123080|NCT01624259|3684076|P1|Overall Study|Abnormal laboratory measure|3
1123081|NCT01624259|3684075|P2|Overall Study|Lost to Follow-up|3
1123082|NCT01624259|3684076|P1|Overall Study|Lost to Follow-up|2
1123083|NCT01624259|3684075|P2|Overall Study|Physician Decision|1
1123084|NCT01624259|3684076|P1|Overall Study|Physician Decision|1
1123085|NCT01624259|3684075|P2|Overall Study|Withdrawal by Subject|7
1123086|NCT01624259|3684076|P1|Overall Study|Withdrawal by Subject|5
1123087|NCT01624259|3684075|P2|Overall Study|Protocol Violation|2
1123088|NCT01624259|3684076|P1|Overall Study|Protocol Violation|1
1123089|NCT01624259|3684075|P2|Overall Study|Adverse Event|18
1123090|NCT01624259|3684076|P1|Overall Study|Adverse Event|18
1123091|NCT01624233|3684125|P1|Period 6: Follow-up|Withdrawal by Subject|3
1123092|NCT01624233|3684125|P1|Period 6: Follow-up|Physician Decision|1
1123093|NCT01624233|3684125|P1|Period 6: Follow-up|Lack of Efficacy|2
1123094|NCT01624233|3684125|P1|Period 6: Follow-up|Adverse Event|3
1123095|NCT01624233|3684125|P1|Period 5 - Retreatment Period|Withdrawal by Subject|3
1123096|NCT01624233|3684125|P1|Period 5 - Retreatment Period|Physician Decision|1
1123097|NCT01624233|3684125|P1|Period 5 - Retreatment Period|Lack of Efficacy|1
1123098|NCT01624233|3684125|P1|Period 5 - Retreatment Period|Adverse Event|5
1123099|NCT01624233|3684125|P1|Period 4 - Drug Free Period|Relapsed|61
1123100|NCT01624233|3684125|P1|Period 3 - Maintenance|Withdrawal by Subject|2
1123101|NCT01624233|3684125|P1|Period 3 - Maintenance|Physician Decision|2
1123102|NCT01624233|3684125|P1|Period 3 - Maintenance|Lack of Efficacy|1
1123103|NCT01624233|3684125|P1|Period 3 - Maintenance|Adverse Event|2
1123104|NCT01624233|3684125|P1|Period 2 - Induction|Adverse Event|1
1123105|NCT01624194|3684157|P2|Overall Study|Withdrawal by Subject|0
1123106|NCT01624194|3684158|P1|Overall Study|Withdrawal by Subject|1
1123107|NCT01624194|3684157|P2|Overall Study|Lost to Follow-up|0
1123108|NCT01624194|3684158|P1|Overall Study|Lost to Follow-up|1
1123109|NCT01623830|3684232|P2|Overall Study|Exclusion from Study|2
1123110|NCT01623830|3684233|P1|Overall Study|Exclusion from Study|1
1123111|NCT01623830|3684232|P2|Overall Study|Withdrawal by Subject|7
1123112|NCT01623830|3684233|P1|Overall Study|Withdrawal by Subject|6
1123113|NCT01623596|3684267|P2|Overall Study|Lack of Efficacy|3
1123114|NCT01623596|3684268|P1|Overall Study|Lack of Efficacy|5
1123115|NCT01623596|3684267|P2|Overall Study|Protocol Violation|6
1123116|NCT01623596|3684268|P1|Overall Study|Protocol Violation|0
1123117|NCT01623596|3684267|P2|Overall Study|Patient no longer requires study drug|0
1123118|NCT01623596|3684268|P1|Overall Study|Patient no longer requires study drug|1
1123119|NCT01623596|3684267|P2|Overall Study|Withdrawal by Subject|31
1123120|NCT01623596|3684268|P1|Overall Study|Withdrawal by Subject|13
1123121|NCT01623596|3684267|P2|Overall Study|Lost to Follow-up|16
1123122|NCT01623596|3684268|P1|Overall Study|Lost to Follow-up|12
1123123|NCT01623596|3684267|P2|Overall Study|Death|2
1123124|NCT01623596|3684268|P1|Overall Study|Death|0
1123125|NCT01623596|3684267|P2|Overall Study|Adverse Event|29
1123126|NCT01623596|3684268|P1|Overall Study|Adverse Event|20
1123127|NCT01623596|3684267|P2|Overall Study|Administrative problems|13
1123128|NCT01623596|3684268|P1|Overall Study|Administrative problems|9
1123129|NCT01623596|3684267|P2|Overall Study|Abnormal laboratory values|0
1123130|NCT01623596|3684268|P1|Overall Study|Abnormal laboratory values|2
1123131|NCT01623310|3684311|P1|Overall Study|Investigators Discretion-Noncompliant|1
1123132|NCT01623310|3684311|P1|Overall Study|Diagnoses of bilateral cateracts|1
1123133|NCT01623310|3684311|P1|Overall Study|Became potentially child-bearing|1
1123134|NCT01623310|3684311|P1|Overall Study|Withdrawal by Subject|25
1123135|NCT01623310|3684311|P1|Overall Study|Protocol Violation|6
1123136|NCT01623310|3684311|P1|Overall Study|Lack of Efficacy|6
1123137|NCT01623310|3684311|P1|Overall Study|Lost to Follow-up|18
1123138|NCT01623310|3684311|P1|Overall Study|Adverse Event|21
1123139|NCT01623271|3684320|P1|Overall Study|Withdrawal by Subject|2
1123140|NCT01623154|3684324|P1|Overall Study|Did not drink Pranactin Citric|4
1123141|NCT01623115|3684332|P2|Overall Study|Other than specified above|3
1123142|NCT01623115|3684333|P1|Overall Study|Other than specified above|0
1123143|NCT01623115|3684332|P2|Overall Study|Death|4
1123144|NCT01623115|3684333|P1|Overall Study|Death|0
1123145|NCT01623115|3684332|P2|Overall Study|Site closure|7
1123146|NCT01623115|3684333|P1|Overall Study|Site closure|1
1123147|NCT01623115|3684332|P2|Overall Study|Last visit outside protocol visit window|26
1123148|NCT01623115|3684333|P1|Overall Study|Last visit outside protocol visit window|14
1123149|NCT01623115|3684332|P2|Overall Study|Related to study drug administration|2
1123150|NCT01623115|3684333|P1|Overall Study|Related to study drug administration|0
1123151|NCT01623115|3684332|P2|Overall Study|Consent withdrawn by participant|6
1123152|NCT01623115|3684333|P1|Overall Study|Consent withdrawn by participant|2
1123153|NCT01623115|3684332|P2|Overall Study|Poor compliance to protocol|10
1123154|NCT01623115|3684333|P1|Overall Study|Poor compliance to protocol|4
1123155|NCT01623115|3684332|P2|Overall Study|Adverse Event|13
1123156|NCT01623115|3684333|P1|Overall Study|Adverse Event|10
1123157|NCT01623115|3684332|P2|Overall Study|Participants moved|5
1123158|NCT01623115|3684333|P1|Overall Study|Participants moved|1
1123159|NCT01623115|3684332|P2|Overall Study|Physician Decision|0
1123160|NCT01623115|3684333|P1|Overall Study|Physician Decision|1
1123161|NCT01623115|3684332|P2|Overall Study|Randomized but not treated|1
1123162|NCT01623115|3684333|P1|Overall Study|Randomized but not treated|0
1123163|NCT01623050|3684393|P1|Overall Study|Lost to Follow-up|9
1123164|NCT01622673|3684407|P6|Treatment Period 3|Protocol Violation|0
1123165|NCT01622673|3684408|P5|Treatment Period 3|Protocol Violation|0
1123166|NCT01622673|3684409|P4|Treatment Period 3|Protocol Violation|0
1123167|NCT01622673|3684410|P3|Treatment Period 3|Protocol Violation|0
1123168|NCT01622673|3684411|P2|Treatment Period 3|Protocol Violation|1
1123169|NCT01622673|3684412|P1|Treatment Period 3|Protocol Violation|0
1123170|NCT01622673|3684407|P6|Treatment Period 2|Withdrawal by Subject|0
1123171|NCT01622673|3684408|P5|Treatment Period 2|Withdrawal by Subject|0
1123172|NCT01622673|3684409|P4|Treatment Period 2|Withdrawal by Subject|1
1123173|NCT01622673|3684410|P3|Treatment Period 2|Withdrawal by Subject|0
1123174|NCT01622673|3684411|P2|Treatment Period 2|Withdrawal by Subject|0
1123175|NCT01622673|3684412|P1|Treatment Period 2|Withdrawal by Subject|0
1123176|NCT01622673|3684407|P6|Treatment Period 1|Protocol Violation|0
1123177|NCT01622673|3684408|P5|Treatment Period 1|Protocol Violation|0
1123178|NCT01622673|3684409|P4|Treatment Period 1|Protocol Violation|0
1123179|NCT01622673|3684410|P3|Treatment Period 1|Protocol Violation|0
1123180|NCT01622673|3684411|P2|Treatment Period 1|Protocol Violation|1
1123181|NCT01622673|3684412|P1|Treatment Period 1|Protocol Violation|0
1123182|NCT01622673|3684407|P6|Treatment Period 1|Withdrawal by Subject|0
1123183|NCT01622673|3684408|P5|Treatment Period 1|Withdrawal by Subject|0
1123184|NCT01622673|3684409|P4|Treatment Period 1|Withdrawal by Subject|1
1123185|NCT01622673|3684410|P3|Treatment Period 1|Withdrawal by Subject|0
1123186|NCT01622673|3684411|P2|Treatment Period 1|Withdrawal by Subject|0
1123187|NCT01622673|3684412|P1|Treatment Period 1|Withdrawal by Subject|0
1123188|NCT01622660|3684447|P1|Overall Study|Adverse Event|1
1123189|NCT01622569|3684455|P4|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1
1123190|NCT01622569|3684456|P3|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
1123191|NCT01622569|3684457|P2|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
1123192|NCT01622569|3684458|P1|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
1123193|NCT01622569|3684455|P4|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
1123194|NCT01622569|3684456|P3|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2
1123195|NCT01622569|3684457|P2|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
1123196|NCT01622569|3684458|P1|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
1123197|NCT01622569|3684455|P4|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
1123198|NCT01622569|3684456|P3|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
1123199|NCT01622569|3684457|P2|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2
1123200|NCT01622569|3684458|P1|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
1123201|NCT01622569|3684455|P4|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
1123202|NCT01622569|3684456|P3|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
1123203|NCT01622569|3684457|P2|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
1123204|NCT01622569|3684458|P1|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
1123205|NCT01622569|3684455|P4|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1
1123206|NCT01622569|3684456|P3|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
1123207|NCT01622569|3684457|P2|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2
1123208|NCT01622569|3684458|P1|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
1123209|NCT01622569|3684455|P4|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2
1123210|NCT01622569|3684456|P3|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3
1123211|NCT01622569|3684457|P2|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
1123212|NCT01622569|3684458|P1|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6
1123213|NCT01622569|3684455|P4|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
1123214|NCT01622569|3684456|P3|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1
1123215|NCT01622569|3684457|P2|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
1123216|NCT01622569|3684458|P1|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
1123217|NCT01622569|3684455|P4|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
1123218|NCT01622569|3684456|P3|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3
1123219|NCT01622569|3684457|P2|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2
1123220|NCT01622569|3684458|P1|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4
1123221|NCT01622348|3684528|P3|Overall Study|Withdrawal by Subject|1
1123222|NCT01622348|3684529|P2|Overall Study|Withdrawal by Subject|0
1123223|NCT01622348|3684530|P1|Overall Study|Withdrawal by Subject|1
1123224|NCT01622231|3684569|P1|Overall Study|Withdrawal by Subject|1
1123225|NCT01622231|3684569|P1|Overall Study|Physician Decision|1
1123226|NCT01621880|3684599|P2|Overall Study|Withdrawal by Subject|4
1123227|NCT01621880|3684600|P1|Overall Study|Withdrawal by Subject|5
1123228|NCT01621880|3684599|P2|Overall Study|Adverse Event|1
1123229|NCT01621880|3684600|P1|Overall Study|Adverse Event|5
1123230|NCT01621802|3684614|P6|Overall Study|Lost to Follow-up|11
1123231|NCT01621802|3684615|P5|Overall Study|Lost to Follow-up|31
1123232|NCT01621802|3684616|P4|Overall Study|Lost to Follow-up|7
1123233|NCT01621802|3684617|P3|Overall Study|Lost to Follow-up|24
1123234|NCT01621802|3684618|P2|Overall Study|Lost to Follow-up|16
1123235|NCT01621802|3684619|P1|Overall Study|Lost to Follow-up|36
1123236|NCT01621802|3684614|P6|Overall Study|Others|0
1123237|NCT01621802|3684615|P5|Overall Study|Others|1
1123238|NCT01621802|3684616|P4|Overall Study|Others|2
1123239|NCT01621802|3684617|P3|Overall Study|Others|3
1123240|NCT01621802|3684618|P2|Overall Study|Others|3
1123241|NCT01621802|3684619|P1|Overall Study|Others|3
1123242|NCT01621802|3684614|P6|Overall Study|Migrated/moved from study area|0
1123243|NCT01621802|3684615|P5|Overall Study|Migrated/moved from study area|1
1123244|NCT01621802|3684616|P4|Overall Study|Migrated/moved from study area|0
1123245|NCT01621802|3684617|P3|Overall Study|Migrated/moved from study area|2
1123246|NCT01621802|3684618|P2|Overall Study|Migrated/moved from study area|0
1123247|NCT01621802|3684619|P1|Overall Study|Migrated/moved from study area|0
1123248|NCT01621802|3684614|P6|Overall Study|Withdrawal by Subject|0
1123249|NCT01621802|3684615|P5|Overall Study|Withdrawal by Subject|2
1123250|NCT01621802|3684616|P4|Overall Study|Withdrawal by Subject|2
1123251|NCT01621802|3684617|P3|Overall Study|Withdrawal by Subject|4
1123252|NCT01621802|3684618|P2|Overall Study|Withdrawal by Subject|4
1123253|NCT01621802|3684619|P1|Overall Study|Withdrawal by Subject|8
1123254|NCT01621802|3684614|P6|Overall Study|Protocol Violation|1
1123255|NCT01621802|3684615|P5|Overall Study|Protocol Violation|0
1123256|NCT01621802|3684616|P4|Overall Study|Protocol Violation|0
1123257|NCT01621802|3684617|P3|Overall Study|Protocol Violation|0
1123258|NCT01621802|3684618|P2|Overall Study|Protocol Violation|0
1123259|NCT01621802|3684619|P1|Overall Study|Protocol Violation|0
1123260|NCT01621191|3684790|P1|Overall Study|Site Removed From Study|1
1123261|NCT01621191|3684790|P1|Overall Study|Lost to Follow-up|1
1123262|NCT01621191|3684790|P1|Overall Study|Lack of Efficacy|6
1123263|NCT01621191|3684790|P1|Overall Study|Withdrawal by Subject|8
1123264|NCT01621191|3684790|P1|Overall Study|Adverse Event|9
1123265|NCT01621178|3684804|P3|Overall Study|Physician Decision|7
1123266|NCT01621178|3684805|P2|Overall Study|Physician Decision|2
1123267|NCT01621178|3684806|P1|Overall Study|Physician Decision|5
1123268|NCT01621178|3684804|P3|Overall Study|Withdrawal by Subject|18
1123269|NCT01621178|3684805|P2|Overall Study|Withdrawal by Subject|17
1123270|NCT01621178|3684806|P1|Overall Study|Withdrawal by Subject|14
1123271|NCT01621178|3684804|P3|Overall Study|Lost to Follow-up|1
1123272|NCT01621178|3684805|P2|Overall Study|Lost to Follow-up|2
1123273|NCT01621178|3684806|P1|Overall Study|Lost to Follow-up|1
1123274|NCT01621178|3684804|P3|Overall Study|Death|2
1123275|NCT01621178|3684805|P2|Overall Study|Death|7
1123276|NCT01621178|3684806|P1|Overall Study|Death|6
1123277|NCT01621178|3684804|P3|Overall Study|Adverse Event|8
1123278|NCT01621178|3684805|P2|Overall Study|Adverse Event|2
1123279|NCT01621178|3684806|P1|Overall Study|Adverse Event|5
1123280|NCT01621126|3684898|P1|Overall Study|Physician Decision|6
1123281|NCT01620983|3684920|P3|Overall Study|Physician Decision|5
1123282|NCT01620983|3684921|P2|Overall Study|Physician Decision|10
1123283|NCT01620983|3684922|P1|Overall Study|Physician Decision|3
1123284|NCT01620983|3684920|P3|Overall Study|Death|0
1123285|NCT01620983|3684921|P2|Overall Study|Death|0
1123286|NCT01620983|3684922|P1|Overall Study|Death|2
1123287|NCT01620983|3684920|P3|Overall Study|Withdrawal by Subject|1
1123288|NCT01620983|3684921|P2|Overall Study|Withdrawal by Subject|8
1123289|NCT01620983|3684922|P1|Overall Study|Withdrawal by Subject|6
1123290|NCT01620983|3684920|P3|Overall Study|Lost to Follow-up|9
1123291|NCT01620983|3684921|P2|Overall Study|Lost to Follow-up|4
1123292|NCT01620983|3684922|P1|Overall Study|Lost to Follow-up|8
1123293|NCT01620762|3684951|P3|Overall Study|Use of prohibted therapies|1
1123294|NCT01620762|3684952|P2|Overall Study|Use of prohibted therapies|1
1123295|NCT01620762|3684953|P1|Overall Study|Use of prohibted therapies|0
1123296|NCT01620762|3684951|P3|Overall Study|Non-specified|5
1123297|NCT01620762|3684952|P2|Overall Study|Non-specified|6
1123298|NCT01620762|3684953|P1|Overall Study|Non-specified|3
1123299|NCT01620762|3684951|P3|Overall Study|Subject deterioration|1
1123300|NCT01620762|3684952|P2|Overall Study|Subject deterioration|1
1123301|NCT01620762|3684953|P1|Overall Study|Subject deterioration|0
1123302|NCT01620762|3684951|P3|Overall Study|Protocol deviation|6
1123303|NCT01620762|3684952|P2|Overall Study|Protocol deviation|1
1123304|NCT01620762|3684953|P1|Overall Study|Protocol deviation|1
1123305|NCT01620762|3684951|P3|Overall Study|Lost to Follow-up|10
1123306|NCT01620762|3684952|P2|Overall Study|Lost to Follow-up|17
1123307|NCT01620762|3684953|P1|Overall Study|Lost to Follow-up|11
1123308|NCT01620762|3684951|P3|Overall Study|Withdrawal by Subject|27
1123309|NCT01620762|3684952|P2|Overall Study|Withdrawal by Subject|26
1123310|NCT01620762|3684953|P1|Overall Study|Withdrawal by Subject|23
1123311|NCT01620762|3684951|P3|Overall Study|Adverse Event|2
1123312|NCT01620762|3684952|P2|Overall Study|Adverse Event|5
1123313|NCT01620762|3684953|P1|Overall Study|Adverse Event|9
1123314|NCT01620762|3684951|P3|Overall Study|Protocol Violation|1
1123315|NCT01620762|3684952|P2|Overall Study|Protocol Violation|1
1123316|NCT01620762|3684953|P1|Overall Study|Protocol Violation|1
1123317|NCT01620528|3684999|P3|Post-Treatment Follow-Up Period|Not Specified|2
1123318|NCT01620528|3685000|P2|Post-Treatment Follow-Up Period|Not Specified|4
1123319|NCT01620528|3685001|P1|Post-Treatment Follow-Up Period|Not Specified|6
1123320|NCT01620528|3684999|P3|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4
1123321|NCT01620528|3685000|P2|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3
1123322|NCT01620528|3685001|P1|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8
1123323|NCT01620528|3684999|P3|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1
1123324|NCT01620528|3685000|P2|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1
1123325|NCT01620528|3685001|P1|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0
1123326|NCT01620528|3684999|P3|Post-Treatment Follow-Up Period|Lost to Follow-up|4
1123327|NCT01620528|3685000|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|2
1123328|NCT01620528|3685001|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|3
1123329|NCT01620528|3684999|P3|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
1123330|NCT01620528|3685000|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|7
1123331|NCT01620528|3685001|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
1123332|NCT01620528|3684999|P3|Treatment Period|Exclusionary Medication Received|0
1123333|NCT01620528|3685000|P2|Treatment Period|Exclusionary Medication Received|1
1123334|NCT01620528|3685001|P1|Treatment Period|Exclusionary Medication Received|0
1123335|NCT01620528|3684999|P3|Treatment Period|Surgery/Invasive Intervention|3
1123336|NCT01620528|3685000|P2|Treatment Period|Surgery/Invasive Intervention|1
1123337|NCT01620528|3685001|P1|Treatment Period|Surgery/Invasive Intervention|5
1123338|NCT01620528|3684999|P3|Treatment Period|Pregnancy|2
1123339|NCT01620528|3685000|P2|Treatment Period|Pregnancy|2
1123340|NCT01620528|3685001|P1|Treatment Period|Pregnancy|7
1123341|NCT01620528|3684999|P3|Treatment Period|Subject Noncompliant|2
1123342|NCT01620528|3685000|P2|Treatment Period|Subject Noncompliant|2
1123343|NCT01620528|3685001|P1|Treatment Period|Subject Noncompliant|11
1123344|NCT01620528|3684999|P3|Treatment Period|Not Specified|7
1123345|NCT01620528|3685000|P2|Treatment Period|Not Specified|5
1123346|NCT01620528|3685001|P1|Treatment Period|Not Specified|9
1123347|NCT01620528|3684999|P3|Treatment Period|Lost to Follow-up|14
1123348|NCT01620528|3685000|P2|Treatment Period|Lost to Follow-up|8
1123349|NCT01620528|3685001|P1|Treatment Period|Lost to Follow-up|16
1123350|NCT01620528|3684999|P3|Treatment Period|Adverse Event|21
1123351|NCT01620528|3685000|P2|Treatment Period|Adverse Event|13
1123352|NCT01620528|3685001|P1|Treatment Period|Adverse Event|17
1123353|NCT01620528|3684999|P3|Treatment Period|Withdrawal by Subject|16
1123354|NCT01620528|3685000|P2|Treatment Period|Withdrawal by Subject|21
1123355|NCT01620528|3685001|P1|Treatment Period|Withdrawal by Subject|35
1123356|NCT01620528|3684999|P3|Treatment Period|Did Not Receive Study Drug|1
1123357|NCT01620528|3685000|P2|Treatment Period|Did Not Receive Study Drug|0
1123358|NCT01620528|3685001|P1|Treatment Period|Did Not Receive Study Drug|0
1123359|NCT01620489|3685341|P2|Overall Study|Unclassified|2
1123360|NCT01620489|3685342|P1|Overall Study|Unclassified|1
1123361|NCT01620489|3685341|P2|Overall Study|Withdrawal Criteria|25
1123362|NCT01620489|3685342|P1|Overall Study|Withdrawal Criteria|17
1123363|NCT01620489|3685341|P2|Overall Study|Protocol Violation|3
1123364|NCT01620489|3685342|P1|Overall Study|Protocol Violation|0
1123365|NCT01620489|3685341|P2|Overall Study|Adverse Event|4
1123366|NCT01620489|3685342|P1|Overall Study|Adverse Event|17
1123367|NCT01620255|3685363|P5|Overall Study|Withdrawn at discretion of investigator|1
1123368|NCT01620255|3685364|P4|Overall Study|Withdrawn at discretion of investigator|0
1123369|NCT01620255|3685365|P3|Overall Study|Withdrawn at discretion of investigator|0
1123541|NCT01617681|3685954|P1|Period 2 Open Label|Withdrawal by Subject|0
1123370|NCT01620255|3685366|P2|Overall Study|Withdrawn at discretion of investigator|0
1123371|NCT01620255|3685367|P1|Overall Study|Withdrawn at discretion of investigator|0
1123372|NCT01620255|3685363|P5|Overall Study|Adverse Event|1
1123373|NCT01620255|3685364|P4|Overall Study|Adverse Event|1
1123374|NCT01620255|3685365|P3|Overall Study|Adverse Event|0
1123375|NCT01620255|3685366|P2|Overall Study|Adverse Event|4
1123376|NCT01620255|3685367|P1|Overall Study|Adverse Event|0
1123377|NCT01620255|3685363|P5|Overall Study|Non-compliance|0
1123378|NCT01620255|3685364|P4|Overall Study|Non-compliance|0
1123379|NCT01620255|3685365|P3|Overall Study|Non-compliance|0
1123380|NCT01620255|3685366|P2|Overall Study|Non-compliance|1
1123381|NCT01620255|3685367|P1|Overall Study|Non-compliance|0
1123382|NCT01620255|3685363|P5|Overall Study|Participant underwent fecal transplant|0
1123383|NCT01620255|3685364|P4|Overall Study|Participant underwent fecal transplant|0
1123384|NCT01620255|3685365|P3|Overall Study|Participant underwent fecal transplant|1
1123385|NCT01620255|3685366|P2|Overall Study|Participant underwent fecal transplant|0
1123386|NCT01620255|3685367|P1|Overall Study|Participant underwent fecal transplant|0
1123387|NCT01620255|3685363|P5|Overall Study|Withdrawal by Subject|4
1123388|NCT01620255|3685364|P4|Overall Study|Withdrawal by Subject|2
1123389|NCT01620255|3685365|P3|Overall Study|Withdrawal by Subject|1
1123390|NCT01620255|3685366|P2|Overall Study|Withdrawal by Subject|1
1123391|NCT01620255|3685367|P1|Overall Study|Withdrawal by Subject|4
1123392|NCT01620177|3685444|P1|Overall Study|Randomized, Not Active due to Scheduling|1
1123393|NCT01620177|3685444|P1|Overall Study|Physician Decision|2
1123394|NCT01620177|3685444|P1|Overall Study|Lost to Follow-up|7
1123395|NCT01620177|3685444|P1|Overall Study|Withdrawal by Subject|26
1123396|NCT01620177|3685444|P1|Overall Study|Failure at Screening Visit|43
1123397|NCT01620138|3685469|P2|Overall Study|Adverse Event|0
1123398|NCT01620138|3685470|P1|Overall Study|Adverse Event|2
1123399|NCT01620138|3685469|P2|Overall Study|Lack of Efficacy|0
1123400|NCT01620138|3685470|P1|Overall Study|Lack of Efficacy|1
1123401|NCT01620138|3685469|P2|Overall Study|Withdrawal by Subject|0
1123402|NCT01620138|3685470|P1|Overall Study|Withdrawal by Subject|3
1123403|NCT01620086|3685478|P3|Overall Study|Physician Decision|0
1123404|NCT01620086|3685479|P2|Overall Study|Physician Decision|0
1123405|NCT01620086|3685480|P1|Overall Study|Physician Decision|1
1123406|NCT01620086|3685478|P3|Overall Study|failed study criteria|0
1123407|NCT01620086|3685479|P2|Overall Study|failed study criteria|4
1123408|NCT01620086|3685480|P1|Overall Study|failed study criteria|1
1123409|NCT01620086|3685478|P3|Overall Study|Withdrawal by Subject|0
1123410|NCT01620086|3685479|P2|Overall Study|Withdrawal by Subject|3
1123411|NCT01620086|3685480|P1|Overall Study|Withdrawal by Subject|3
1123412|NCT01620060|3685499|P1|Overall Study|Per Sponsor Decision|2
1123413|NCT01620060|3685499|P1|Overall Study|Family emergency|1
1123414|NCT01620060|3685499|P1|Overall Study|Did not comply with Study Produre|1
1123415|NCT01620060|3685499|P1|Overall Study|Withdrawal by Subject|1
1123416|NCT01620060|3685499|P1|Overall Study|Protocol Violation|1
1123417|NCT01620060|3685499|P1|Overall Study|Adverse Event|9
1123418|NCT01619878|3685537|P1|Follow-up at 12 Months of Age|Death|2
1123419|NCT01619878|3685537|P1|Follow-up at 12 Months of Age|Lost to Follow-up|1
1123420|NCT01619878|3685537|P1|6 Week Follow-up Phase|Adverse Event|1
1123421|NCT01619800|3685551|P2|Overall Study|study terminated|0
1123422|NCT01619800|3685552|P1|Overall Study|study terminated|2
1123423|NCT01619787|3685560|P1|Overall Study|Lost to Follow-up|5
1123424|NCT01619579|3685577|P2|Overall Study|Withdrawal by Subject|3
1123425|NCT01619579|3685578|P1|Overall Study|Withdrawal by Subject|0
1123426|NCT01619423|3685592|P4|Part 1 (Dose Escalation)|High basal Mn|0
1123427|NCT01619423|3685593|P3|Part 1 (Dose Escalation)|High basal Mn|0
1123428|NCT01619423|3685594|P2|Part 1 (Dose Escalation)|High basal Mn|2
1123429|NCT01619423|3685595|P1|Part 1 (Dose Escalation)|High basal Mn|0
1123430|NCT01619085|3685606|P1|Overall Study|Ongoing on trial|27
1123431|NCT01619085|3685606|P1|Overall Study|Not treated|1
1123432|NCT01619085|3685606|P1|Overall Study|Other than specified|94
1123433|NCT01619085|3685606|P1|Overall Study|Withdrawal by Subject|15
1123434|NCT01619085|3685606|P1|Overall Study|Lost to Follow-up|10
1123435|NCT01619085|3685606|P1|Overall Study|Protocol Violation|10
1123436|NCT01619085|3685606|P1|Overall Study|Adverse Event|212
1123437|NCT01619059|3685612|P2|Long-Term (LT) Treatment Period|Not Met Study Criteria|1
1123438|NCT01619059|3685613|P1|Long-Term (LT) Treatment Period|Not Met Study Criteria|0
1123439|NCT01619059|3685612|P2|Long-Term (LT) Treatment Period|Lost to Follow-up|2
1123440|NCT01619059|3685613|P1|Long-Term (LT) Treatment Period|Lost to Follow-up|2
1123441|NCT01619059|3685612|P2|Long-Term (LT) Treatment Period|Death|0
1123442|NCT01619059|3685613|P1|Long-Term (LT) Treatment Period|Death|1
1123443|NCT01619059|3685612|P2|Long-Term (LT) Treatment Period|Withdrawal by Subject|2
1123444|NCT01619059|3685613|P1|Long-Term (LT) Treatment Period|Withdrawal by Subject|3
1123445|NCT01619059|3685612|P2|Long-Term (LT) Treatment Period|Adverse Event|3
1123446|NCT01619059|3685613|P1|Long-Term (LT) Treatment Period|Adverse Event|2
1123447|NCT01619059|3685612|P2|Long-Term (LT) Treatment Period|Lack of Efficacy|1
1123448|NCT01619059|3685613|P1|Long-Term (LT) Treatment Period|Lack of Efficacy|0
1123449|NCT01619059|3685612|P2|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2
1123450|NCT01619059|3685613|P1|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1
1123451|NCT01619059|3685612|P2|Short-Term (ST) Treatment Period|Lost to Follow-up|4
1123452|NCT01619059|3685613|P1|Short-Term (ST) Treatment Period|Lost to Follow-up|2
1123542|NCT01617681|3685950|P5|Period 2 Open Label|Adverse Event|3
1123453|NCT01619059|3685612|P2|Short-Term (ST) Treatment Period|Withdrawal by Subject|5
1123454|NCT01619059|3685613|P1|Short-Term (ST) Treatment Period|Withdrawal by Subject|2
1123455|NCT01619059|3685612|P2|Short-Term (ST) Treatment Period|Adverse Event|0
1123456|NCT01619059|3685613|P1|Short-Term (ST) Treatment Period|Adverse Event|1
1123457|NCT01618968|3685629|P4|Overall Study|Death|1
1123458|NCT01618968|3685630|P3|Overall Study|Death|0
1123459|NCT01618968|3685631|P2|Overall Study|Death|0
1123460|NCT01618968|3685632|P1|Overall Study|Death|0
1123461|NCT01618968|3685629|P4|Overall Study|Adverse Event|0
1123462|NCT01618968|3685630|P3|Overall Study|Adverse Event|0
1123463|NCT01618968|3685631|P2|Overall Study|Adverse Event|0
1123464|NCT01618968|3685632|P1|Overall Study|Adverse Event|1
1123465|NCT01618864|3685699|P1|Overall Study|Lost to Follow-up|2
1123466|NCT01618864|3685699|P1|Overall Study|Withdrawal by Subject|2
1123467|NCT01618838|3685708|P1|Overall Study|slow accrual, trial closed prematurely.|4
1123468|NCT01618708|3685716|P2|Overall Study|Randomized but not treated|2
1123469|NCT01618708|3685717|P1|Overall Study|Randomized but not treated|3
1123470|NCT01618708|3685716|P2|Overall Study|Other than specified above|1
1123471|NCT01618708|3685717|P1|Overall Study|Other than specified above|1
1123472|NCT01618708|3685716|P2|Overall Study|Technical problems|0
1123473|NCT01618708|3685717|P1|Overall Study|Technical problems|2
1123474|NCT01618708|3685716|P2|Overall Study|Lack of Efficacy|8
1123475|NCT01618708|3685717|P1|Overall Study|Lack of Efficacy|8
1123476|NCT01618708|3685716|P2|Overall Study|Withdrawal by Subject|22
1123477|NCT01618708|3685717|P1|Overall Study|Withdrawal by Subject|17
1123478|NCT01618708|3685716|P2|Overall Study|Lost to Follow-up|3
1123479|NCT01618708|3685717|P1|Overall Study|Lost to Follow-up|3
1123480|NCT01618708|3685716|P2|Overall Study|Adverse Event|10
1123481|NCT01618708|3685717|P1|Overall Study|Adverse Event|10
1123482|NCT01618669|3685731|P2|Overall Study|Miscellaneous Reason|1
1123483|NCT01618669|3685732|P1|Overall Study|Miscellaneous Reason|0
1123484|NCT01618669|3685731|P2|Overall Study|Withdrawal by Subject|9
1123485|NCT01618669|3685732|P1|Overall Study|Withdrawal by Subject|9
1123486|NCT01618669|3685731|P2|Overall Study|Protocol Violation|3
1123487|NCT01618669|3685732|P1|Overall Study|Protocol Violation|5
1123488|NCT01618669|3685731|P2|Overall Study|Adverse Event|7
1123489|NCT01618669|3685732|P1|Overall Study|Adverse Event|16
1123490|NCT01618669|3685731|P2|Overall Study|Randomized but Never Received Study Drug|2
1123491|NCT01618669|3685732|P1|Overall Study|Randomized but Never Received Study Drug|3
1123492|NCT01618669|3685731|P2|Overall Study|Lost to Follow-up|1
1123493|NCT01618669|3685732|P1|Overall Study|Lost to Follow-up|1
1123494|NCT01618266|3685789|P1|Overall Study|Protocol Violation|43
1123495|NCT01618266|3685789|P1|Overall Study|Lack of Efficacy|23
1123496|NCT01618266|3685789|P1|Overall Study|Other reasons|11
1123497|NCT01618266|3685789|P1|Overall Study|Treatment satisfaction|10
1123498|NCT01618266|3685789|P1|Overall Study|Lost to Follow-up|9
1123499|NCT01618214|3685826|P2|Overall Study|Unclassified|5
1123500|NCT01618214|3685827|P1|Overall Study|Unclassified|4
1123501|NCT01618214|3685826|P2|Overall Study|Withdrawal Criteria|2
1123502|NCT01618214|3685827|P1|Overall Study|Withdrawal Criteria|1
1123503|NCT01618214|3685826|P2|Overall Study|Protocol Violation|4
1123504|NCT01618214|3685827|P1|Overall Study|Protocol Violation|1
1123505|NCT01618214|3685826|P2|Overall Study|Lack of Efficacy|1
1123506|NCT01618214|3685827|P1|Overall Study|Lack of Efficacy|1
1123507|NCT01618214|3685826|P2|Overall Study|Adverse Event|1
1123508|NCT01618214|3685827|P1|Overall Study|Adverse Event|3
1123509|NCT01618162|3685843|P2|Overall Study|Unclassified|13
1123510|NCT01618162|3685844|P1|Overall Study|Unclassified|14
1123511|NCT01618162|3685843|P2|Overall Study|Withdrawal Criteria|10
1123512|NCT01618162|3685844|P1|Overall Study|Withdrawal Criteria|2
1123513|NCT01618162|3685843|P2|Overall Study|Adverse Event|2
1123514|NCT01618162|3685844|P1|Overall Study|Adverse Event|9
1123515|NCT01618162|3685843|P2|Overall Study|Protocol Violation|10
1123516|NCT01618162|3685844|P1|Overall Study|Protocol Violation|13
1123517|NCT01618019|3685864|P2|Overall Study|Withdrawal by Subject|14
1123518|NCT01618019|3685865|P1|Overall Study|Withdrawal by Subject|14
1123519|NCT01617967|3685891|P6|Overall Study|Dosing Suspended by Sponsor|0
1123520|NCT01617967|3685892|P5|Overall Study|Dosing Suspended by Sponsor|0
1123521|NCT01617967|3685893|P4|Overall Study|Dosing Suspended by Sponsor|0
1123522|NCT01617967|3685894|P3|Overall Study|Dosing Suspended by Sponsor|0
1123523|NCT01617967|3685895|P2|Overall Study|Dosing Suspended by Sponsor|0
1123524|NCT01617967|3685896|P1|Overall Study|Dosing Suspended by Sponsor|1
1123525|NCT01617967|3685891|P6|Overall Study|Withdrawal by Subject|1
1123526|NCT01617967|3685892|P5|Overall Study|Withdrawal by Subject|0
1123527|NCT01617967|3685893|P4|Overall Study|Withdrawal by Subject|0
1123528|NCT01617967|3685894|P3|Overall Study|Withdrawal by Subject|0
1123529|NCT01617967|3685895|P2|Overall Study|Withdrawal by Subject|0
1123530|NCT01617967|3685896|P1|Overall Study|Withdrawal by Subject|0
1123531|NCT01617967|3685891|P6|Overall Study|Protocol Violation|0
1123532|NCT01617967|3685892|P5|Overall Study|Protocol Violation|0
1123533|NCT01617967|3685893|P4|Overall Study|Protocol Violation|1
1123534|NCT01617967|3685894|P3|Overall Study|Protocol Violation|0
1123535|NCT01617967|3685895|P2|Overall Study|Protocol Violation|0
1123536|NCT01617967|3685896|P1|Overall Study|Protocol Violation|0
1123537|NCT01617681|3685950|P5|Period 2 Open Label|Withdrawal by Subject|3
1123538|NCT01617681|3685951|P4|Period 2 Open Label|Withdrawal by Subject|0
1123539|NCT01617681|3685952|P3|Period 2 Open Label|Withdrawal by Subject|0
1123540|NCT01617681|3685953|P2|Period 2 Open Label|Withdrawal by Subject|0
1123543|NCT01617681|3685951|P4|Period 2 Open Label|Adverse Event|0
1123544|NCT01617681|3685952|P3|Period 2 Open Label|Adverse Event|0
1123545|NCT01617681|3685953|P2|Period 2 Open Label|Adverse Event|0
1123546|NCT01617681|3685954|P1|Period 2 Open Label|Adverse Event|0
1123547|NCT01617681|3685950|P5|Period 1 Double Blind|Withdrawal by Subject|0
1123548|NCT01617681|3685951|P4|Period 1 Double Blind|Withdrawal by Subject|0
1123549|NCT01617681|3685952|P3|Period 1 Double Blind|Withdrawal by Subject|1
1123550|NCT01617681|3685953|P2|Period 1 Double Blind|Withdrawal by Subject|1
1123551|NCT01617681|3685954|P1|Period 1 Double Blind|Withdrawal by Subject|1
1123552|NCT01617681|3685950|P5|Period 1 Double Blind|Adverse Event|0
1123553|NCT01617681|3685951|P4|Period 1 Double Blind|Adverse Event|2
1123554|NCT01617681|3685952|P3|Period 1 Double Blind|Adverse Event|0
1123555|NCT01617681|3685953|P2|Period 1 Double Blind|Adverse Event|0
1123556|NCT01617681|3685954|P1|Period 1 Double Blind|Adverse Event|2
1123557|NCT01617668|3685975|P4|Overall Study|Subject/guardian decision|1
1123558|NCT01617668|3685976|P3|Overall Study|Subject/guardian decision|2
1123559|NCT01617668|3685977|P2|Overall Study|Subject/guardian decision|3
1123560|NCT01617668|3685978|P1|Overall Study|Subject/guardian decision|1
1123561|NCT01617668|3685975|P4|Overall Study|Progressive Disease|9
1123562|NCT01617668|3685976|P3|Overall Study|Progressive Disease|6
1123563|NCT01617668|3685977|P2|Overall Study|Progressive Disease|4
1123564|NCT01617668|3685978|P1|Overall Study|Progressive Disease|4
1123565|NCT01617668|3685975|P4|Overall Study|Physician Decision|0
1123566|NCT01617668|3685976|P3|Overall Study|Physician Decision|3
1123567|NCT01617668|3685977|P2|Overall Study|Physician Decision|2
1123568|NCT01617668|3685978|P1|Overall Study|Physician Decision|1
1123569|NCT01617668|3685975|P4|Overall Study|Adverse Event|5
1123570|NCT01617668|3685976|P3|Overall Study|Adverse Event|12
1123571|NCT01617668|3685977|P2|Overall Study|Adverse Event|0
1123572|NCT01617668|3685978|P1|Overall Study|Adverse Event|7
1123573|NCT01617655|3686019|P2|Overall Study|Other than specified above|2
1123574|NCT01617655|3686020|P1|Overall Study|Other than specified above|1
1123575|NCT01617655|3686019|P2|Overall Study|Site closure|5
1123576|NCT01617655|3686020|P1|Overall Study|Site closure|3
1123577|NCT01617655|3686019|P2|Overall Study|Last visit outside protocol visit window|10
1123578|NCT01617655|3686020|P1|Overall Study|Last visit outside protocol visit window|1
1123579|NCT01617655|3686019|P2|Overall Study|Consent withdrawn by participant|1
1123580|NCT01617655|3686020|P1|Overall Study|Consent withdrawn by participant|1
1123581|NCT01617655|3686019|P2|Overall Study|Participants moved|4
1123582|NCT01617655|3686020|P1|Overall Study|Participants moved|0
1123583|NCT01617655|3686019|P2|Overall Study|Poor compliance to protocol|4
1123584|NCT01617655|3686020|P1|Overall Study|Poor compliance to protocol|1
1123585|NCT01617655|3686019|P2|Overall Study|Adverse Event|3
1123586|NCT01617655|3686020|P1|Overall Study|Adverse Event|2
1123587|NCT01617629|3686080|P1|Overall Study|Participant Withdrew Consent|2
1123588|NCT01617629|3686080|P1|Overall Study|Reason Not Specified|1
1123589|NCT01617629|3686080|P1|Overall Study|Investigator's Clinical Judgement|1
1123590|NCT01617629|3686080|P1|Overall Study|Death|2
1123591|NCT01617460|3686108|P1|Overall Study|Withdrawal by Subject|9
1123592|NCT01617460|3686108|P1|Overall Study|Protocol Violation|5
1123593|NCT01617460|3686108|P1|Overall Study|Physician Decision|16
1123594|NCT01617460|3686108|P1|Overall Study|Adverse Event|10
1123595|NCT01617447|3686114|P2|Overall Study|Physician Decision|2
1123596|NCT01617447|3686115|P1|Overall Study|Physician Decision|0
1123597|NCT01617447|3686114|P2|Overall Study|Adverse Event|1
1123598|NCT01617447|3686115|P1|Overall Study|Adverse Event|0
1123599|NCT01617434|3686123|P2|Overall Study|Unclassified|4
1123600|NCT01617434|3686124|P1|Overall Study|Unclassified|3
1123601|NCT01617434|3686123|P2|Overall Study|Withdrawal Criteria|37
1123602|NCT01617434|3686124|P1|Overall Study|Withdrawal Criteria|12
1123603|NCT01617434|3686123|P2|Overall Study|Protocol Violation|7
1123604|NCT01617434|3686124|P1|Overall Study|Protocol Violation|8
1123605|NCT01617434|3686123|P2|Overall Study|Adverse Event|3
1123606|NCT01617434|3686124|P1|Overall Study|Adverse Event|12
1123607|NCT01617187|3686156|P4|Treatment Through Study Completion|Protocol Violation|1
1123608|NCT01617187|3686157|P3|Treatment Through Study Completion|Protocol Violation|0
1123609|NCT01617187|3686158|P2|Treatment Through Study Completion|Protocol Violation|0
1123610|NCT01617187|3686159|P1|Treatment Through Study Completion|Protocol Violation|1
1123611|NCT01617187|3686156|P4|Treatment Through Study Completion|Withdrawal by Subject|6
1123612|NCT01617187|3686157|P3|Treatment Through Study Completion|Withdrawal by Subject|3
1123613|NCT01617187|3686158|P2|Treatment Through Study Completion|Withdrawal by Subject|8
1123614|NCT01617187|3686159|P1|Treatment Through Study Completion|Withdrawal by Subject|5
1123615|NCT01617187|3686156|P4|Treatment Through Study Completion|Lost to Follow-up|2
1123616|NCT01617187|3686157|P3|Treatment Through Study Completion|Lost to Follow-up|2
1123617|NCT01617187|3686158|P2|Treatment Through Study Completion|Lost to Follow-up|2
1123618|NCT01617187|3686159|P1|Treatment Through Study Completion|Lost to Follow-up|4
1123619|NCT01617187|3686156|P4|Treatment Through Study Completion|Adverse Event|1
1123620|NCT01617187|3686157|P3|Treatment Through Study Completion|Adverse Event|0
1123621|NCT01617187|3686158|P2|Treatment Through Study Completion|Adverse Event|1
1123622|NCT01617187|3686159|P1|Treatment Through Study Completion|Adverse Event|1
1123623|NCT01617187|3686156|P4|Randomization Through Start Treatment|Not Treated: Completed study in database|0
1123624|NCT01617187|3686157|P3|Randomization Through Start Treatment|Not Treated: Completed study in database|0
1123708|NCT01615198|3686634|P1|Overall Study|Physician Decision|5
1123625|NCT01617187|3686158|P2|Randomization Through Start Treatment|Not Treated: Completed study in database|0
1123626|NCT01617187|3686159|P1|Randomization Through Start Treatment|Not Treated: Completed study in database|1
1123627|NCT01617187|3686156|P4|Randomization Through Start Treatment|Not Treated: Adverse Event|1
1123628|NCT01617187|3686157|P3|Randomization Through Start Treatment|Not Treated: Adverse Event|0
1123629|NCT01617187|3686158|P2|Randomization Through Start Treatment|Not Treated: Adverse Event|0
1123630|NCT01617187|3686159|P1|Randomization Through Start Treatment|Not Treated: Adverse Event|0
1123631|NCT01617187|3686156|P4|Randomization Through Start Treatment|Not Treated: Administrative Reason|1
1123632|NCT01617187|3686157|P3|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
1123633|NCT01617187|3686158|P2|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
1123634|NCT01617187|3686159|P1|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
1123635|NCT01617070|3686256|P1|BH4 and LNAA (4 Weeks)|started medication interfere with study|1
1123636|NCT01617005|3686274|P1|Overall Study|Lack of motivation for treatment|1
1123637|NCT01617005|3686274|P1|Overall Study|Pregnancy|1
1123638|NCT01616953|3686283|P2|Overall Study|lack of bone and soft tissue|0
1123639|NCT01616953|3686284|P1|Overall Study|lack of bone and soft tissue|1
1123640|NCT01616953|3686283|P2|Overall Study|Lost to Follow-up|0
1123641|NCT01616953|3686284|P1|Overall Study|Lost to Follow-up|1
1123642|NCT01616771|3686292|P1|Smaller Sized GVL for 5 Sec|lack of GVL size|4
1123643|NCT01616693|3686305|P4|Blood Analyzed for Immunogenicity|Protocol Violation|1
1123644|NCT01616693|3686306|P3|Blood Analyzed for Immunogenicity|Protocol Violation|6
1123645|NCT01616693|3686307|P2|Blood Analyzed for Immunogenicity|Protocol Violation|2
1123646|NCT01616693|3686308|P1|Blood Analyzed for Immunogenicity|Protocol Violation|4
1123647|NCT01616693|3686305|P4|Received Both Vaccines|Lost to Follow-up|4
1123648|NCT01616693|3686306|P3|Received Both Vaccines|Lost to Follow-up|4
1123649|NCT01616693|3686307|P2|Received Both Vaccines|Lost to Follow-up|3
1123650|NCT01616693|3686308|P1|Received Both Vaccines|Lost to Follow-up|4
1123651|NCT01616693|3686305|P4|Received Both Vaccines|Withdrawal by Subject|15
1123652|NCT01616693|3686306|P3|Received Both Vaccines|Withdrawal by Subject|8
1123653|NCT01616693|3686307|P2|Received Both Vaccines|Withdrawal by Subject|7
1123654|NCT01616693|3686308|P1|Received Both Vaccines|Withdrawal by Subject|7
1123655|NCT01616693|3686305|P4|Received Both Vaccines|Adverse Event|0
1123656|NCT01616693|3686306|P3|Received Both Vaccines|Adverse Event|0
1123657|NCT01616693|3686307|P2|Received Both Vaccines|Adverse Event|0
1123658|NCT01616693|3686308|P1|Received Both Vaccines|Adverse Event|2
1123659|NCT01616693|3686305|P4|Evaluated for Safety|Physician Decision|0
1123660|NCT01616693|3686306|P3|Evaluated for Safety|Physician Decision|1
1123661|NCT01616693|3686307|P2|Evaluated for Safety|Physician Decision|0
1123662|NCT01616693|3686308|P1|Evaluated for Safety|Physician Decision|1
1123663|NCT01616459|3686374|P4|Overall Study|Other reason|0
1123664|NCT01616459|3686375|P3|Overall Study|Other reason|1
1123665|NCT01616459|3686376|P2|Overall Study|Other reason|1
1123666|NCT01616459|3686377|P1|Overall Study|Other reason|0
1123667|NCT01616459|3686374|P4|Overall Study|Withdrawal by Subject|4
1123668|NCT01616459|3686375|P3|Overall Study|Withdrawal by Subject|4
1123669|NCT01616459|3686376|P2|Overall Study|Withdrawal by Subject|4
1123670|NCT01616459|3686377|P1|Overall Study|Withdrawal by Subject|2
1123671|NCT01616459|3686374|P4|Overall Study|Protocol Violation|2
1123672|NCT01616459|3686375|P3|Overall Study|Protocol Violation|0
1123673|NCT01616459|3686376|P2|Overall Study|Protocol Violation|0
1123674|NCT01616459|3686377|P1|Overall Study|Protocol Violation|0
1123675|NCT01616459|3686374|P4|Overall Study|Lost to Follow-up|2
1123676|NCT01616459|3686375|P3|Overall Study|Lost to Follow-up|3
1123677|NCT01616459|3686376|P2|Overall Study|Lost to Follow-up|11
1123678|NCT01616459|3686377|P1|Overall Study|Lost to Follow-up|1
1123679|NCT01616459|3686374|P4|Overall Study|Adverse Event|0
1123680|NCT01616459|3686375|P3|Overall Study|Adverse Event|2
1123681|NCT01616459|3686376|P2|Overall Study|Adverse Event|1
1123682|NCT01616459|3686377|P1|Overall Study|Adverse Event|1
1123683|NCT01616173|3686466|P3|Overall Study|Lost to Follow-up|0
1123684|NCT01616173|3686467|P2|Overall Study|Lost to Follow-up|2
1123685|NCT01616173|3686468|P1|Overall Study|Lost to Follow-up|0
1123686|NCT01615939|3686501|P2|Overall Study|Lost to Follow-up|0
1123687|NCT01615939|3686502|P1|Overall Study|Lost to Follow-up|5
1123688|NCT01615822|3686515|P3|Period 2|Lost to Follow-up|2
1123689|NCT01615822|3686516|P2|Period 2|Lost to Follow-up|1
1123690|NCT01615822|3686517|P1|Period 2|Lost to Follow-up|0
1123691|NCT01615822|3686515|P3|Period 1|Adverse Event|0
1123692|NCT01615822|3686516|P2|Period 1|Adverse Event|1
1123693|NCT01615822|3686517|P1|Period 1|Adverse Event|1
1123694|NCT01615822|3686515|P3|Period 1|Withdrawal by Subject|0
1123695|NCT01615822|3686516|P2|Period 1|Withdrawal by Subject|1
1123696|NCT01615822|3686517|P1|Period 1|Withdrawal by Subject|0
1123697|NCT01615328|3686605|P2|Overall Study|Lost to Follow-up|5
1123698|NCT01615328|3686606|P1|Overall Study|Lost to Follow-up|3
1123699|NCT01615263|3686618|P2|Overall Study|Post-randomization exclusion|2
1123700|NCT01615263|3686619|P1|Overall Study|Post-randomization exclusion|0
1123701|NCT01615198|3686633|P2|Overall Study|Adverse Event|5
1123702|NCT01615198|3686634|P1|Overall Study|Adverse Event|11
1123703|NCT01615198|3686633|P2|Overall Study|Lack of Efficacy|6
1123704|NCT01615198|3686634|P1|Overall Study|Lack of Efficacy|1
1123705|NCT01615198|3686633|P2|Overall Study|Lost to Follow-up|1
1123706|NCT01615198|3686634|P1|Overall Study|Lost to Follow-up|1
1123707|NCT01615198|3686633|P2|Overall Study|Physician Decision|1
1123709|NCT01615198|3686633|P2|Overall Study|Protocol deviation|1
1123710|NCT01615198|3686634|P1|Overall Study|Protocol deviation|1
1123711|NCT01615198|3686633|P2|Overall Study|Withdrawal by Subject|5
1123712|NCT01615198|3686634|P1|Overall Study|Withdrawal by Subject|5
1123713|NCT01615029|3686667|P5|Overall Study|Ongoing|23
1123714|NCT01615029|3686668|P4|Overall Study|Ongoing|2
1123715|NCT01615029|3686669|P3|Overall Study|Ongoing|3
1123716|NCT01615029|3686670|P2|Overall Study|Ongoing|2
1123717|NCT01615029|3686671|P1|Overall Study|Ongoing|1
1123718|NCT01615029|3686667|P5|Overall Study|Physician Decision|1
1123719|NCT01615029|3686668|P4|Overall Study|Physician Decision|0
1123720|NCT01615029|3686669|P3|Overall Study|Physician Decision|0
1123721|NCT01615029|3686670|P2|Overall Study|Physician Decision|0
1123722|NCT01615029|3686671|P1|Overall Study|Physician Decision|0
1123723|NCT01615029|3686667|P5|Overall Study|Progressive disease|5
1123724|NCT01615029|3686668|P4|Overall Study|Progressive disease|1
1123725|NCT01615029|3686669|P3|Overall Study|Progressive disease|1
1123726|NCT01615029|3686670|P2|Overall Study|Progressive disease|1
1123727|NCT01615029|3686671|P1|Overall Study|Progressive disease|2
1123728|NCT01615029|3686667|P5|Overall Study|Lost to Follow-up|1
1123729|NCT01615029|3686668|P4|Overall Study|Lost to Follow-up|0
1123730|NCT01615029|3686669|P3|Overall Study|Lost to Follow-up|0
1123731|NCT01615029|3686670|P2|Overall Study|Lost to Follow-up|0
1123732|NCT01615029|3686671|P1|Overall Study|Lost to Follow-up|0
1123733|NCT01615029|3686667|P5|Overall Study|Death|1
1123734|NCT01615029|3686668|P4|Overall Study|Death|0
1123735|NCT01615029|3686669|P3|Overall Study|Death|0
1123736|NCT01615029|3686670|P2|Overall Study|Death|0
1123737|NCT01615029|3686671|P1|Overall Study|Death|0
1123738|NCT01615029|3686667|P5|Overall Study|Adverse Event|1
1123739|NCT01615029|3686668|P4|Overall Study|Adverse Event|0
1123740|NCT01615029|3686669|P3|Overall Study|Adverse Event|0
1123741|NCT01615029|3686670|P2|Overall Study|Adverse Event|0
1123742|NCT01615029|3686671|P1|Overall Study|Adverse Event|0
1123743|NCT01614886|3686739|P2|Overall Study|Protocol deviation|2
1123744|NCT01614886|3686740|P1|Overall Study|Protocol deviation|0
1123745|NCT01614886|3686739|P2|Overall Study|Death|0
1123746|NCT01614886|3686740|P1|Overall Study|Death|1
1123747|NCT01614886|3686739|P2|Overall Study|Withdrawal by Subject|4
1123748|NCT01614886|3686740|P1|Overall Study|Withdrawal by Subject|4
1123749|NCT01614886|3686739|P2|Overall Study|Adverse Event|20
1123750|NCT01614886|3686740|P1|Overall Study|Adverse Event|15
1123751|NCT01614795|3686758|P4|Overall Study|Ineligible|0
1123752|NCT01614795|3686759|P3|Overall Study|Ineligible|0
1123753|NCT01614795|3686760|P2|Overall Study|Ineligible|1
1123754|NCT01614795|3686761|P1|Overall Study|Ineligible|0
1123755|NCT01614795|3686758|P4|Overall Study|Withdrawal by Subject|2
1123756|NCT01614795|3686759|P3|Overall Study|Withdrawal by Subject|0
1123757|NCT01614795|3686760|P2|Overall Study|Withdrawal by Subject|1
1123758|NCT01614795|3686761|P1|Overall Study|Withdrawal by Subject|0
1123759|NCT01614795|3686758|P4|Overall Study|Physician Decision|1
1123760|NCT01614795|3686759|P3|Overall Study|Physician Decision|1
1123761|NCT01614795|3686760|P2|Overall Study|Physician Decision|0
1123762|NCT01614795|3686761|P1|Overall Study|Physician Decision|1
1123763|NCT01614795|3686758|P4|Overall Study|Lack of Efficacy|8
1123764|NCT01614795|3686759|P3|Overall Study|Lack of Efficacy|9
1123765|NCT01614795|3686760|P2|Overall Study|Lack of Efficacy|10
1123766|NCT01614795|3686761|P1|Overall Study|Lack of Efficacy|10
1123767|NCT01614795|3686758|P4|Overall Study|Adverse Event|1
1123768|NCT01614795|3686759|P3|Overall Study|Adverse Event|1
1123769|NCT01614795|3686760|P2|Overall Study|Adverse Event|0
1123770|NCT01614795|3686761|P1|Overall Study|Adverse Event|0
1123771|NCT01614769|3686781|P6|Period 3|Withdrawal by Subject|0
1123772|NCT01614769|3686782|P5|Period 3|Withdrawal by Subject|0
1123773|NCT01614769|3686783|P4|Period 3|Withdrawal by Subject|0
1123774|NCT01614769|3686784|P3|Period 3|Withdrawal by Subject|1
1123775|NCT01614769|3686785|P2|Period 3|Withdrawal by Subject|0
1123776|NCT01614769|3686786|P1|Period 3|Withdrawal by Subject|0
1123777|NCT01614769|3686781|P6|Period 1|Withdrawal by Subject|0
1123778|NCT01614769|3686782|P5|Period 1|Withdrawal by Subject|0
1123779|NCT01614769|3686783|P4|Period 1|Withdrawal by Subject|0
1123780|NCT01614769|3686784|P3|Period 1|Withdrawal by Subject|0
1123781|NCT01614769|3686785|P2|Period 1|Withdrawal by Subject|0
1123782|NCT01614769|3686786|P1|Period 1|Withdrawal by Subject|1
1123783|NCT01614769|3686781|P6|Period 1|Protocol Violation|0
1123784|NCT01614769|3686782|P5|Period 1|Protocol Violation|0
1123785|NCT01614769|3686783|P4|Period 1|Protocol Violation|1
1123786|NCT01614769|3686784|P3|Period 1|Protocol Violation|0
1123787|NCT01614769|3686785|P2|Period 1|Protocol Violation|0
1123788|NCT01614769|3686786|P1|Period 1|Protocol Violation|0
1123789|NCT01614769|3686781|P6|Period 1|Discontinued due to Hypoglycemia|1
1123790|NCT01614769|3686782|P5|Period 1|Discontinued due to Hypoglycemia|0
1123791|NCT01614769|3686783|P4|Period 1|Discontinued due to Hypoglycemia|1
1123792|NCT01614769|3686784|P3|Period 1|Discontinued due to Hypoglycemia|0
1123793|NCT01614769|3686785|P2|Period 1|Discontinued due to Hypoglycemia|0
1123794|NCT01614769|3686786|P1|Period 1|Discontinued due to Hypoglycemia|0
1123795|NCT01614600|3686808|P1|Overall Study|Protocol deviation|1
1123796|NCT01614600|3686808|P1|Overall Study|Unable to remove lens at the end of day|1
1123797|NCT01614600|3686808|P1|Overall Study|Discomfort|1
1123798|NCT01614600|3686808|P1|Overall Study|Unacceptable fit|1
1123799|NCT01614470|3686839|P3|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0
1123800|NCT01614470|3686840|P2|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
1123801|NCT01614470|3686841|P1|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
1123802|NCT01614470|3686839|P3|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
1123803|NCT01614470|3686840|P2|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
1123804|NCT01614470|3686841|P1|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
1123805|NCT01614457|3686863|P2|Overall Study|Pregnancy (Self or Partner)|0
1123806|NCT01614457|3686864|P1|Overall Study|Pregnancy (Self or Partner)|1
1123807|NCT01614457|3686863|P2|Overall Study|Non-Compliance|0
1123808|NCT01614457|3686864|P1|Overall Study|Non-Compliance|1
1123809|NCT01614249|3686891|P2|Overall Study|Lost to Follow-up|23
1123810|NCT01614249|3686892|P1|Overall Study|Lost to Follow-up|11
1123811|NCT01614093|3686906|P1|Overall Study|Withdrawal by Subject|1
1123812|NCT01613716|3686919|P1|Overall Study|Lost to Follow-up|4
1123813|NCT01613716|3686919|P1|Overall Study|screen failures|3
1123814|NCT01613599|3686924|P1|Overall Study|Reason not specified|3
1123815|NCT01613599|3686924|P1|Overall Study|Withdrawal by Subject|8
1123816|NCT01613599|3686924|P1|Overall Study|Lost to Follow-up|5
1123817|NCT01613599|3686924|P1|Overall Study|Death|9
1123818|NCT01613417|3686939|P2|Washout (no Second Injection/MRI)|Withdrawal by Subject|7
1123819|NCT01613417|3686940|P1|Washout (no Second Injection/MRI)|Withdrawal by Subject|13
1123820|NCT01613378|3686977|P1|Overall Study|Other Reason|4
1123821|NCT01613378|3686977|P1|Overall Study|Lost to Follow-up|1
1123822|NCT01613378|3686977|P1|Overall Study|Death|2
1123823|NCT01613378|3686977|P1|Overall Study|Withdrawal by Subject|8
1123824|NCT01613378|3686977|P1|Overall Study|Adverse Event|11
1123825|NCT01613378|3686977|P1|Overall Study|Lack of Efficacy|13
1123826|NCT01613326|3687007|P2|Overall Study|Protocol Violation|1
1123827|NCT01613326|3687008|P1|Overall Study|Protocol Violation|0
1123828|NCT01613326|3687007|P2|Overall Study|Administrative|2
1123829|NCT01613326|3687008|P1|Overall Study|Administrative|0
1123830|NCT01613326|3687007|P2|Overall Study|Lost to Follow-up|1
1123831|NCT01613326|3687008|P1|Overall Study|Lost to Follow-up|0
1123832|NCT01613326|3687007|P2|Overall Study|Lack of Efficacy|1
1123833|NCT01613326|3687008|P1|Overall Study|Lack of Efficacy|0
1123834|NCT01613326|3687007|P2|Overall Study|inability to use device|0
1123835|NCT01613326|3687008|P1|Overall Study|inability to use device|1
1123836|NCT01613326|3687007|P2|Overall Study|Abnormal test procedure result(s)|0
1123837|NCT01613326|3687008|P1|Overall Study|Abnormal test procedure result(s)|2
1123838|NCT01613326|3687007|P2|Overall Study|Withdrawal by Subject|4
1123839|NCT01613326|3687008|P1|Overall Study|Withdrawal by Subject|3
1123840|NCT01613326|3687007|P2|Overall Study|Adverse Event|5
1123841|NCT01613326|3687008|P1|Overall Study|Adverse Event|7
1123842|NCT01613248|3687065|P6|Overall Study|Pregnancy|0
1123843|NCT01613248|3687066|P5|Overall Study|Pregnancy|0
1123844|NCT01613248|3687067|P4|Overall Study|Pregnancy|1
1123845|NCT01613248|3687068|P3|Overall Study|Pregnancy|0
1123846|NCT01613248|3687069|P2|Overall Study|Pregnancy|0
1123847|NCT01613248|3687070|P1|Overall Study|Pregnancy|0
1123848|NCT01613248|3687065|P6|Overall Study|Lack of Qualifying Event|18
1123849|NCT01613248|3687066|P5|Overall Study|Lack of Qualifying Event|15
1123850|NCT01613248|3687067|P4|Overall Study|Lack of Qualifying Event|11
1123851|NCT01613248|3687068|P3|Overall Study|Lack of Qualifying Event|10
1123852|NCT01613248|3687069|P2|Overall Study|Lack of Qualifying Event|11
1123853|NCT01613248|3687070|P1|Overall Study|Lack of Qualifying Event|9
1123854|NCT01613248|3687065|P6|Overall Study|Physician Decision|6
1123855|NCT01613248|3687066|P5|Overall Study|Physician Decision|7
1123856|NCT01613248|3687067|P4|Overall Study|Physician Decision|4
1123857|NCT01613248|3687068|P3|Overall Study|Physician Decision|9
1123858|NCT01613248|3687069|P2|Overall Study|Physician Decision|8
1123859|NCT01613248|3687070|P1|Overall Study|Physician Decision|8
1123860|NCT01613248|3687065|P6|Overall Study|Study Terminated by Sponsor|11
1123861|NCT01613248|3687066|P5|Overall Study|Study Terminated by Sponsor|9
1123862|NCT01613248|3687067|P4|Overall Study|Study Terminated by Sponsor|8
1123863|NCT01613248|3687068|P3|Overall Study|Study Terminated by Sponsor|8
1123864|NCT01613248|3687069|P2|Overall Study|Study Terminated by Sponsor|6
1123865|NCT01613248|3687070|P1|Overall Study|Study Terminated by Sponsor|4
1123866|NCT01613248|3687065|P6|Overall Study|Lost to Follow-up|2
1123867|NCT01613248|3687066|P5|Overall Study|Lost to Follow-up|4
1123868|NCT01613248|3687067|P4|Overall Study|Lost to Follow-up|8
1123869|NCT01613248|3687068|P3|Overall Study|Lost to Follow-up|4
1123870|NCT01613248|3687069|P2|Overall Study|Lost to Follow-up|7
1123871|NCT01613248|3687070|P1|Overall Study|Lost to Follow-up|5
1123872|NCT01613248|3687065|P6|Overall Study|Withdrawal by Subject|1
1123873|NCT01613248|3687066|P5|Overall Study|Withdrawal by Subject|0
1123874|NCT01613248|3687067|P4|Overall Study|Withdrawal by Subject|5
1123875|NCT01613248|3687068|P3|Overall Study|Withdrawal by Subject|2
1123876|NCT01613248|3687069|P2|Overall Study|Withdrawal by Subject|2
1123877|NCT01613248|3687070|P1|Overall Study|Withdrawal by Subject|3
1123878|NCT01613248|3687065|P6|Overall Study|Adverse Event|0
1123879|NCT01613248|3687066|P5|Overall Study|Adverse Event|0
1123880|NCT01613248|3687067|P4|Overall Study|Adverse Event|1
1123881|NCT01613248|3687068|P3|Overall Study|Adverse Event|0
1123882|NCT01613248|3687069|P2|Overall Study|Adverse Event|0
1123883|NCT01613248|3687070|P1|Overall Study|Adverse Event|0
1123884|NCT01613131|3687170|P2|Overall Study|Withdrawal by Subject|5
1123885|NCT01613131|3687171|P1|Overall Study|Withdrawal by Subject|3
1124139|NCT01609023|3688384|P1|Overall Study|Death|2
1123886|NCT01613027|3687199|P1|Overall Study|Patient’s Decision Due to Adverse Event|1
1123887|NCT01613027|3687199|P1|Overall Study|Lack of Efficacy|1
1123888|NCT01613027|3687199|P1|Overall Study|Switched Physician|1
1123889|NCT01613027|3687199|P1|Overall Study|Lost to Follow-up|5
1123890|NCT01612858|3687242|P2|Overall Study|Withdrawal by Subject|1
1123891|NCT01612858|3687243|P1|Overall Study|Withdrawal by Subject|5
1123892|NCT01612702|3687307|P2|Overall Study|Protocol Violation|11
1123893|NCT01612702|3687308|P1|Overall Study|Protocol Violation|11
1123894|NCT01612676|3687322|P4|Overall Study|Protocol Violation|0
1123895|NCT01612676|3687323|P3|Overall Study|Protocol Violation|0
1123896|NCT01612676|3687324|P2|Overall Study|Protocol Violation|1
1123897|NCT01612676|3687325|P1|Overall Study|Protocol Violation|0
1123898|NCT01612676|3687322|P4|Overall Study|Adverse Event|3
1123899|NCT01612676|3687323|P3|Overall Study|Adverse Event|1
1123900|NCT01612676|3687324|P2|Overall Study|Adverse Event|3
1123901|NCT01612676|3687325|P1|Overall Study|Adverse Event|2
1123902|NCT01612156|3687423|P2|Overall Study|Protocol Violation|0
1123903|NCT01612156|3687424|P1|Overall Study|Protocol Violation|2
1123904|NCT01612000|3687436|P4|Overall Study|Withdrawal by Subject|2
1123905|NCT01612000|3687437|P3|Overall Study|Withdrawal by Subject|2
1123906|NCT01612000|3687438|P2|Overall Study|Withdrawal by Subject|1
1123907|NCT01612000|3687439|P1|Overall Study|Withdrawal by Subject|3
1123908|NCT01612000|3687436|P4|Overall Study|Physician Decision|0
1123909|NCT01612000|3687437|P3|Overall Study|Physician Decision|1
1123910|NCT01612000|3687438|P2|Overall Study|Physician Decision|0
1123911|NCT01612000|3687439|P1|Overall Study|Physician Decision|0
1123912|NCT01612000|3687436|P4|Overall Study|Lost to Follow-up|8
1123913|NCT01612000|3687437|P3|Overall Study|Lost to Follow-up|4
1123914|NCT01612000|3687438|P2|Overall Study|Lost to Follow-up|4
1123915|NCT01612000|3687439|P1|Overall Study|Lost to Follow-up|6
1123916|NCT01611974|3687464|P3|Overall Study|Withdrawal by Subject|4
1123917|NCT01611974|3687465|P2|Overall Study|Withdrawal by Subject|1
1123918|NCT01611974|3687466|P1|Overall Study|Withdrawal by Subject|0
1123919|NCT01611974|3687464|P3|Overall Study|Physician Decision|2
1123920|NCT01611974|3687465|P2|Overall Study|Physician Decision|1
1123921|NCT01611974|3687466|P1|Overall Study|Physician Decision|5
1123922|NCT01611974|3687464|P3|Overall Study|Lost to Follow-up|0
1123923|NCT01611974|3687465|P2|Overall Study|Lost to Follow-up|1
1123924|NCT01611974|3687466|P1|Overall Study|Lost to Follow-up|0
1123925|NCT01611974|3687464|P3|Overall Study|Death|10
1123926|NCT01611974|3687465|P2|Overall Study|Death|12
1123927|NCT01611974|3687466|P1|Overall Study|Death|10
1123928|NCT01611883|3687512|P2|Overall Study|Adverse Event|1
1123929|NCT01611883|3687513|P1|Overall Study|Adverse Event|1
1123930|NCT01611857|3687539|P2|Overall Study|Withdrawal by Subject|2
1123931|NCT01611857|3687540|P1|Overall Study|Withdrawal by Subject|0
1123932|NCT01611792|3687552|P2|Followup: at 6 Months|Lost to Follow-up|13
1123933|NCT01611792|3687553|P1|Followup: at 6 Months|Lost to Follow-up|6
1123934|NCT01611792|3687552|P2|Initial Period: Time 0|unable to schedule 10 consecutive appts|9
1123935|NCT01611792|3687553|P1|Initial Period: Time 0|unable to schedule 10 consecutive appts|12
1123936|NCT01611558|3687607|P1|Maintenance Phase|Study drug toxicity|1
1123937|NCT01611558|3687607|P1|Maintenance Phase|Withdrawal by Subject|1
1123938|NCT01611558|3687607|P1|Induction Phase|Death|1
1123939|NCT01611558|3687607|P1|Induction Phase|Adverse event unrelated to study drug|1
1123940|NCT01611558|3687607|P1|Induction Phase|Not reported|5
1123941|NCT01611558|3687607|P1|Induction Phase|Disease progression|14
1123942|NCT01611558|3687607|P1|Induction Phase|Study drug toxicity|17
1123943|NCT01611259|3687613|P1|Overall Study|Withdrawal by Subject|7
1123944|NCT01611259|3687613|P1|Overall Study|Adverse Event|4
1123945|NCT01611259|3687613|P1|Overall Study|Lack of Efficacy|2
1123946|NCT01611259|3687613|P1|Overall Study|Physician Decision|1
1123947|NCT01611194|3687619|P2|Overall Study|drug use|1
1123948|NCT01611194|3687620|P1|Overall Study|drug use|0
1123949|NCT01611194|3687619|P2|Overall Study|Withdrawal by Subject|1
1123950|NCT01611194|3687620|P1|Overall Study|Withdrawal by Subject|0
1123951|NCT01611194|3687619|P2|Overall Study|Lost to Follow-up|1
1123952|NCT01611194|3687620|P1|Overall Study|Lost to Follow-up|0
1123953|NCT01610791|3687656|P1|Overall Study|Not determined|5
1123954|NCT01610791|3687656|P1|Overall Study|Death|1
1123955|NCT01610791|3687656|P1|Overall Study|Adverse event and Investigator decision|1
1123956|NCT01610791|3687656|P1|Overall Study|Physician Decision|1
1123957|NCT01610791|3687656|P1|Overall Study|Adverse Event|6
1123958|NCT01610791|3687656|P1|Overall Study|Lost to Follow-up|7
1123959|NCT01610752|3687680|P3|Overall Study|Miscarriage/Pregnancy loss|4
1123960|NCT01610752|3687681|P2|Overall Study|Miscarriage/Pregnancy loss|0
1123961|NCT01610752|3687682|P1|Overall Study|Miscarriage/Pregnancy loss|0
1123962|NCT01610713|3687704|P2|Overall Study|Lost to Follow-up|1
1123963|NCT01610713|3687705|P1|Overall Study|Lost to Follow-up|0
1123964|NCT01610713|3687704|P2|Overall Study|adv. to use original dose/amitriptyline|0
1123965|NCT01610713|3687705|P1|Overall Study|adv. to use original dose/amitriptyline|1
1123966|NCT01610713|3687704|P2|Overall Study|low mood and poor motivation|0
1123967|NCT01610713|3687705|P1|Overall Study|low mood and poor motivation|1
1123968|NCT01610713|3687704|P2|Overall Study|Lack of Efficacy|0
1123969|NCT01610713|3687705|P1|Overall Study|Lack of Efficacy|1
1123970|NCT01610713|3687704|P2|Overall Study|Adverse Event|0
1123971|NCT01610713|3687705|P1|Overall Study|Adverse Event|3
1123972|NCT01610700|3687763|P2|Overall Study|subject took one dose of street cannabis|1
1123973|NCT01610700|3687764|P1|Overall Study|subject took one dose of street cannabis|0
1123974|NCT01610700|3687763|P2|Overall Study|Withdrawal by Subject|1
1123975|NCT01610700|3687764|P1|Overall Study|Withdrawal by Subject|0
1123976|NCT01610700|3687763|P2|Overall Study|Adverse Event|1
1123977|NCT01610700|3687764|P1|Overall Study|Adverse Event|3
1123978|NCT01610687|3687818|P1|Overall Study|Felt more alter without study medication|1
1123979|NCT01610687|3687818|P1|Overall Study|Cannabis affecting job|1
1123980|NCT01610687|3687818|P1|Overall Study|Death|1
1123981|NCT01610687|3687818|P1|Overall Study|Unable to make journey|1
1123982|NCT01610687|3687818|P1|Overall Study|Symptom control without study medication|2
1123983|NCT01610687|3687818|P1|Overall Study|Lost to Follow-up|4
1123984|NCT01610687|3687818|P1|Overall Study|Withdrawal by Subject|7
1123985|NCT01610687|3687818|P1|Overall Study|Moved out of area|6
1123986|NCT01610687|3687818|P1|Overall Study|Adverse Event|18
1123987|NCT01610687|3687818|P1|Overall Study|Lack of Efficacy|26
1123988|NCT01610596|3687831|P2|Overall Study|Lost to Follow-up|1
1123989|NCT01610596|3687832|P1|Overall Study|Lost to Follow-up|0
1123990|NCT01610557|3687890|P5|Post-36-Week Extension Phase|Withdrawal by Subject|3
1123991|NCT01610557|3687891|P4|Post-36-Week Extension Phase|Withdrawal by Subject|0
1123992|NCT01610557|3687892|P3|Post-36-Week Extension Phase|Withdrawal by Subject|0
1123993|NCT01610557|3687893|P2|Post-36-Week Extension Phase|Withdrawal by Subject|0
1123994|NCT01610557|3687894|P1|Post-36-Week Extension Phase|Withdrawal by Subject|0
1123995|NCT01610557|3687890|P5|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
1123996|NCT01610557|3687891|P4|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
1123997|NCT01610557|3687892|P3|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
1123998|NCT01610557|3687893|P2|36-Week Randomized Crossover Phase|Withdrawal by Subject|1
1123999|NCT01610557|3687894|P1|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
1124000|NCT01610492|3687907|P1|Overall Study|Other:Treatment stopped due to remission|1
1124001|NCT01610492|3687907|P1|Overall Study|Other: Reached stopping criteria|1
1124002|NCT01610492|3687907|P1|Overall Study|Lack of Efficacy|3
1124003|NCT01610492|3687907|P1|Overall Study|Adverse Event|1
1124004|NCT01610414|3687958|P2|After Month 25|Study end not reached|53
1124005|NCT01610414|3687959|P1|After Month 25|Study end not reached|48
1124006|NCT01610414|3687958|P2|Month 13 - Month 25|Other reasons for withdrawal|7
1124007|NCT01610414|3687959|P1|Month 13 - Month 25|Other reasons for withdrawal|6
1124008|NCT01610414|3687958|P2|Month 13 - Month 25|Lost to Follow-up|9
1124009|NCT01610414|3687959|P1|Month 13 - Month 25|Lost to Follow-up|5
1124010|NCT01610414|3687958|P2|Month 13 - Month 25|Protocol Violation|2
1124011|NCT01610414|3687959|P1|Month 13 - Month 25|Protocol Violation|0
1124012|NCT01610414|3687958|P2|Month 13 - Month 25|Migrated/moved from study area|2
1124013|NCT01610414|3687959|P1|Month 13 - Month 25|Migrated/moved from study area|4
1124014|NCT01610414|3687958|P2|Month 13 - Month 25|Withdrawal by Subject|8
1124015|NCT01610414|3687959|P1|Month 13 - Month 25|Withdrawal by Subject|7
1124016|NCT01610414|3687958|P2|Month 13 - Month 25|Adverse Event|4
1124017|NCT01610414|3687959|P1|Month 13 - Month 25|Adverse Event|8
1124018|NCT01610414|3687958|P2|Month 13 - Month 25|Serious Adverse Event|38
1124019|NCT01610414|3687959|P1|Month 13 - Month 25|Serious Adverse Event|35
1124020|NCT01610414|3687958|P2|Study Start - Month 13|Other reasons for withdrawal|4
1124021|NCT01610414|3687959|P1|Study Start - Month 13|Other reasons for withdrawal|3
1124022|NCT01610414|3687958|P2|Study Start - Month 13|Suspected HZ episode|3
1124023|NCT01610414|3687959|P1|Study Start - Month 13|Suspected HZ episode|1
1124024|NCT01610414|3687958|P2|Study Start - Month 13|Lost to Follow-up|6
1124025|NCT01610414|3687959|P1|Study Start - Month 13|Lost to Follow-up|4
1124026|NCT01610414|3687958|P2|Study Start - Month 13|Migrated/moved from study area|4
1124027|NCT01610414|3687959|P1|Study Start - Month 13|Migrated/moved from study area|2
1124028|NCT01610414|3687958|P2|Study Start - Month 13|Withdrawal by Subject|30
1124029|NCT01610414|3687959|P1|Study Start - Month 13|Withdrawal by Subject|23
1124030|NCT01610414|3687958|P2|Study Start - Month 13|Protocol Violation|1
1124031|NCT01610414|3687959|P1|Study Start - Month 13|Protocol Violation|3
1124032|NCT01610414|3687958|P2|Study Start - Month 13|Adverse Event|14
1124033|NCT01610414|3687959|P1|Study Start - Month 13|Adverse Event|14
1124034|NCT01610414|3687958|P2|Study Start - Month 13|Serious Adverse Event|67
1124035|NCT01610414|3687959|P1|Study Start - Month 13|Serious Adverse Event|65
1124036|NCT01610297|3687988|P1|Overall Study|Lost to Follow-up|1
1124037|NCT01610271|3687998|P2|Overall Study|Prosthesis not implanted|3
1124038|NCT01610271|3687999|P1|Overall Study|Prosthesis not implanted|2
1124039|NCT01610271|3687998|P2|Overall Study|Surgery not complete|1
1124040|NCT01610271|3687999|P1|Overall Study|Surgery not complete|0
1124041|NCT01610167|3688014|P3|Overall Study|Scheduling conflict.|2
1124042|NCT01610167|3688015|P2|Overall Study|Scheduling conflict.|0
1124043|NCT01610167|3688016|P1|Overall Study|Scheduling conflict.|0
1124044|NCT01610076|3688053|P2|Overall Study|Lost to Follow-up|4
1124045|NCT01610076|3688054|P1|Overall Study|Lost to Follow-up|3
1124046|NCT01610076|3688053|P2|Overall Study|Technical issue with video|1
1124047|NCT01610076|3688054|P1|Overall Study|Technical issue with video|0
1124048|NCT01610063|3688065|P2|Overall Study|Lost to Follow-up|20
1124049|NCT01610063|3688066|P1|Overall Study|Lost to Follow-up|42
1124050|NCT01610037|3688089|P3|Treatment and Follow up Period|Lost to Follow-up|4
1124051|NCT01610037|3688090|P2|Treatment and Follow up Period|Lost to Follow-up|6
1124052|NCT01610037|3688091|P1|Treatment and Follow up Period|Lost to Follow-up|1
1124053|NCT01610037|3688089|P3|Treatment and Follow up Period|Administrative problems|2
1124054|NCT01610037|3688090|P2|Treatment and Follow up Period|Administrative problems|3
1124055|NCT01610037|3688091|P1|Treatment and Follow up Period|Administrative problems|1
1124056|NCT01610037|3688089|P3|Treatment and Follow up Period|Death|4
1124057|NCT01610037|3688090|P2|Treatment and Follow up Period|Death|5
1124058|NCT01610037|3688091|P1|Treatment and Follow up Period|Death|10
1124059|NCT01610037|3688089|P3|Treatment and Follow up Period|Subject withdrew consent|16
1124060|NCT01610037|3688090|P2|Treatment and Follow up Period|Subject withdrew consent|14
1124061|NCT01610037|3688091|P1|Treatment and Follow up Period|Subject withdrew consent|13
1124062|NCT01610037|3688089|P3|All Patients|Abnormal test procedure result(s)|3
1124063|NCT01610037|3688090|P2|All Patients|Abnormal test procedure result(s)|1
1124064|NCT01610037|3688091|P1|All Patients|Abnormal test procedure result(s)|0
1124065|NCT01610037|3688089|P3|All Patients|Lost to Follow-up|0
1124066|NCT01610037|3688090|P2|All Patients|Lost to Follow-up|0
1124067|NCT01610037|3688091|P1|All Patients|Lost to Follow-up|1
1124068|NCT01610037|3688089|P3|All Patients|Administrative problems|4
1124069|NCT01610037|3688090|P2|All Patients|Administrative problems|4
1124070|NCT01610037|3688091|P1|All Patients|Administrative problems|1
1124071|NCT01610037|3688089|P3|All Patients|Abnormal laboratory value|0
1124072|NCT01610037|3688090|P2|All Patients|Abnormal laboratory value|1
1124073|NCT01610037|3688091|P1|All Patients|Abnormal laboratory value|1
1124074|NCT01610037|3688089|P3|All Patients|Protocol deviation|3
1124075|NCT01610037|3688090|P2|All Patients|Protocol deviation|3
1124076|NCT01610037|3688091|P1|All Patients|Protocol deviation|4
1124077|NCT01610037|3688089|P3|All Patients|Death|1
1124078|NCT01610037|3688090|P2|All Patients|Death|2
1124079|NCT01610037|3688091|P1|All Patients|Death|4
1124080|NCT01610037|3688089|P3|All Patients|Unsatisfactory therapeutic effect|27
1124081|NCT01610037|3688090|P2|All Patients|Unsatisfactory therapeutic effect|8
1124082|NCT01610037|3688091|P1|All Patients|Unsatisfactory therapeutic effect|9
1124083|NCT01610037|3688089|P3|All Patients|Withdrawal by Subject|20
1124084|NCT01610037|3688090|P2|All Patients|Withdrawal by Subject|10
1124085|NCT01610037|3688091|P1|All Patients|Withdrawal by Subject|12
1124086|NCT01610037|3688089|P3|All Patients|Adverse Event|26
1124087|NCT01610037|3688090|P2|All Patients|Adverse Event|22
1124088|NCT01610037|3688091|P1|All Patients|Adverse Event|27
1124089|NCT01609933|3688141|P1|Overall Study|Withdrawal by Subject|3
1124090|NCT01609933|3688141|P1|Overall Study|Adverse Event|1
1124091|NCT01609790|3688151|P3|Overall Study|Protocol Violation|8
1124092|NCT01609790|3688152|P2|Overall Study|Protocol Violation|7
1124093|NCT01609790|3688153|P1|Overall Study|Protocol Violation|1
1124094|NCT01609582|3688172|P2|Overall Study|Randomized, but not treated|3
1124095|NCT01609582|3688173|P1|Overall Study|Randomized, but not treated|0
1124096|NCT01609582|3688172|P2|Overall Study|Other|10
1124097|NCT01609582|3688173|P1|Overall Study|Other|9
1124098|NCT01609582|3688172|P2|Overall Study|Study Terminated by Sponsor|1548
1124099|NCT01609582|3688173|P1|Overall Study|Study Terminated by Sponsor|1543
1124100|NCT01609582|3688172|P2|Overall Study|Withdrawal by Subject|15
1124101|NCT01609582|3688173|P1|Overall Study|Withdrawal by Subject|21
1124102|NCT01609582|3688172|P2|Overall Study|Lost to Follow-up|10
1124103|NCT01609582|3688173|P1|Overall Study|Lost to Follow-up|10
1124104|NCT01609582|3688172|P2|Overall Study|Adverse Event|18
1124105|NCT01609582|3688173|P1|Overall Study|Adverse Event|20
1124106|NCT01609543|3688181|P1|Overall Study|Death|7
1124107|NCT01609543|3688181|P1|Overall Study|Protocol Violation|1
1124108|NCT01609543|3688181|P1|Overall Study|Withdrawal by Subject|1
1124109|NCT01609543|3688181|P1|Overall Study|Adverse Event|5
1124110|NCT01609543|3688181|P1|Overall Study|Disease Progression|28
1124111|NCT01609478|3688190|P3|Overall Study|Withdrawal by Subject|2
1124112|NCT01609478|3688191|P2|Overall Study|Withdrawal by Subject|0
1124113|NCT01609478|3688192|P1|Overall Study|Withdrawal by Subject|2
1124114|NCT01609478|3688190|P3|Overall Study|Physician Decision|1
1124115|NCT01609478|3688191|P2|Overall Study|Physician Decision|0
1124116|NCT01609478|3688192|P1|Overall Study|Physician Decision|1
1124117|NCT01609478|3688190|P3|Overall Study|Non-Compliance with study treatment|0
1124118|NCT01609478|3688191|P2|Overall Study|Non-Compliance with study treatment|0
1124119|NCT01609478|3688192|P1|Overall Study|Non-Compliance with study treatment|1
1124120|NCT01609478|3688190|P3|Overall Study|Protocol Deviation|1
1124121|NCT01609478|3688191|P2|Overall Study|Protocol Deviation|1
1124122|NCT01609478|3688192|P1|Overall Study|Protocol Deviation|0
1124123|NCT01609478|3688190|P3|Overall Study|Adverse Event|5
1124124|NCT01609478|3688191|P2|Overall Study|Adverse Event|1
1124125|NCT01609478|3688192|P1|Overall Study|Adverse Event|3
1124126|NCT01609257|3688267|P2|Overall Study|Non-compliance/Protocol deviation|6
1124127|NCT01609257|3688268|P1|Overall Study|Non-compliance/Protocol deviation|4
1124128|NCT01609257|3688267|P2|Overall Study|Voluntary Withdrawal by Subject|1
1124129|NCT01609257|3688268|P1|Overall Study|Voluntary Withdrawal by Subject|0
1124130|NCT01609257|3688267|P2|Overall Study|Lost to Follow-up|1
1124131|NCT01609257|3688268|P1|Overall Study|Lost to Follow-up|2
1124132|NCT01609062|3688340|P2|Extension Phase|Anticipated surgery & transition to EAP|1
1124133|NCT01609062|3688341|P1|Extension Phase|Anticipated surgery & transition to EAP|0
1124134|NCT01609062|3688340|P2|Extension Phase|Discontinued drug and then was pregnant|0
1124135|NCT01609062|3688341|P1|Extension Phase|Discontinued drug and then was pregnant|1
1124136|NCT01609062|3688340|P2|Extension Phase|Terminated by Sponsor|9
1124137|NCT01609062|3688341|P1|Extension Phase|Terminated by Sponsor|14
1124138|NCT01609023|3688384|P1|Overall Study|Personal reasons|1
1124140|NCT01609023|3688384|P1|Overall Study|Physician Decision|2
1124141|NCT01609023|3688384|P1|Overall Study|Disease progression|10
1124142|NCT01609023|3688384|P1|Overall Study|Toxicity|3
1124143|NCT01609023|3688384|P1|Overall Study|Lost to Follow-up|8
1124144|NCT01609023|3688384|P1|Overall Study|Withdrawal by Subject|4
1124145|NCT01609023|3688384|P1|Overall Study|Lack of Efficacy|3
1124146|NCT01609010|3688396|P2|Overall Study|Lost to Follow-up|1
1124147|NCT01609010|3688397|P1|Overall Study|Lost to Follow-up|1
1124148|NCT01609010|3688396|P2|Overall Study|New cancer|0
1124149|NCT01609010|3688397|P1|Overall Study|New cancer|1
1124150|NCT01609010|3688396|P2|Overall Study|Protocol Violation|1
1124151|NCT01609010|3688397|P1|Overall Study|Protocol Violation|1
1124152|NCT01609010|3688396|P2|Overall Study|Pathology review|1
1124153|NCT01609010|3688397|P1|Overall Study|Pathology review|2
1124154|NCT01609010|3688396|P2|Overall Study|Other malignancy|0
1124155|NCT01609010|3688397|P1|Overall Study|Other malignancy|1
1124156|NCT01609010|3688396|P2|Overall Study|Not specified|0
1124157|NCT01609010|3688397|P1|Overall Study|Not specified|2
1124158|NCT01609010|3688396|P2|Overall Study|Withdrawal by Subject|2
1124159|NCT01609010|3688397|P1|Overall Study|Withdrawal by Subject|2
1124160|NCT01609010|3688396|P2|Overall Study|Adverse Event|6
1124161|NCT01609010|3688397|P1|Overall Study|Adverse Event|3
1124162|NCT01609010|3688396|P2|Overall Study|Progressive disease (PD)|10
1124163|NCT01609010|3688397|P1|Overall Study|Progressive disease (PD)|8
1124164|NCT01609010|3688396|P2|Overall Study|Stable disease (SD)|16
1124165|NCT01609010|3688397|P1|Overall Study|Stable disease (SD)|22
1124166|NCT01608724|3688458|P1|Overall Study|Safety reasons|1
1124167|NCT01608724|3688458|P1|Overall Study|bood sugar too high, etc.|3
1124168|NCT01608724|3688458|P1|Overall Study|Protocol Violation|6
1124169|NCT01608724|3688458|P1|Overall Study|Adverse Event|29
1124170|NCT01608724|3688458|P1|Overall Study|Study-specific discontinuation criteria|32
1124171|NCT01608724|3688458|P1|Overall Study|Lost to Follow-up|41
1124172|NCT01608724|3688458|P1|Overall Study|Withdrawal by Subject|131
1124173|NCT01608321|3688490|P2|Overall Study|Withdrawal by Subject|0
1124174|NCT01608321|3688491|P1|Overall Study|Withdrawal by Subject|1
1124175|NCT01608308|3688499|P2|Overall Study|pretreatment medical and billing reasons|2
1124176|NCT01608308|3688500|P1|Overall Study|pretreatment medical and billing reasons|0
1124177|NCT01607593|3688729|P1|Overall Study|Other|4
1124178|NCT01607593|3688729|P1|Overall Study|Continuation|33
1124179|NCT01607593|3688729|P1|Overall Study|Lost to Follow-up|25
1124180|NCT01607593|3688729|P1|Overall Study|Lack of Efficacy|16
1124181|NCT01607593|3688729|P1|Overall Study|Adverse Event|15
1124182|NCT01607554|3688735|P1|Overall Study|Disease progression|2
1124183|NCT01607476|3688748|P3|Overall Study|Lost to Follow-up|2
1124184|NCT01607476|3688749|P2|Overall Study|Lost to Follow-up|0
1124185|NCT01607476|3688750|P1|Overall Study|Lost to Follow-up|0
1124186|NCT01607476|3688748|P3|Overall Study|Withdrawal by Subject|1
1124187|NCT01607476|3688749|P2|Overall Study|Withdrawal by Subject|0
1124188|NCT01607476|3688750|P1|Overall Study|Withdrawal by Subject|1
1124189|NCT01607398|3688844|P2|Overall Study|Severe COPD|0
1124190|NCT01607398|3688845|P1|Overall Study|Severe COPD|2
1124191|NCT01607398|3688844|P2|Overall Study|Adverse Event|2
1124192|NCT01607398|3688845|P1|Overall Study|Adverse Event|0
1124193|NCT01607346|3688889|P1|Overall Study|Adverse Event|3
1124194|NCT01606800|3688974|P2|Overall Study|Missing completion status|0
1124195|NCT01606800|3688975|P1|Overall Study|Missing completion status|2
1124196|NCT01606800|3688974|P2|Overall Study|Participant withdrew consent|1
1124197|NCT01606800|3688975|P1|Overall Study|Participant withdrew consent|0
1124198|NCT01606800|3688974|P2|Overall Study|Adverse Event|1
1124199|NCT01606800|3688975|P1|Overall Study|Adverse Event|3
1124200|NCT01606787|3688983|P2|Overall Study|Surgery canceled|2
1124201|NCT01606787|3688984|P1|Overall Study|Surgery canceled|0
1124202|NCT01606787|3688983|P2|Overall Study|Withdrawal by Subject|5
1124203|NCT01606787|3688984|P1|Overall Study|Withdrawal by Subject|4
1124204|NCT01606761|3688995|P5|Safety Follow-up Period (Week 52-68)|Other|3
1124205|NCT01606761|3688996|P4|Safety Follow-up Period (Week 52-68)|Other|1
1124206|NCT01606761|3688997|P3|Safety Follow-up Period (Week 52-68)|Other|9
1124207|NCT01606761|3688998|P2|Safety Follow-up Period (Week 52-68)|Other|3
1124208|NCT01606761|3688999|P1|Safety Follow-up Period (Week 52-68)|Other|0
1124209|NCT01606761|3688995|P5|Safety Follow-up Period (Week 52-68)|Death|1
1124210|NCT01606761|3688996|P4|Safety Follow-up Period (Week 52-68)|Death|0
1124211|NCT01606761|3688997|P3|Safety Follow-up Period (Week 52-68)|Death|0
1124212|NCT01606761|3688998|P2|Safety Follow-up Period (Week 52-68)|Death|0
1124213|NCT01606761|3688999|P1|Safety Follow-up Period (Week 52-68)|Death|0
1124214|NCT01606761|3688995|P5|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3
1124215|NCT01606761|3688996|P4|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1
1124216|NCT01606761|3688997|P3|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
1124217|NCT01606761|3688998|P2|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
1124218|NCT01606761|3688999|P1|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4
1124219|NCT01606761|3688995|P5|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
1124220|NCT01606761|3688996|P4|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
1124221|NCT01606761|3688997|P3|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2
1124222|NCT01606761|3688998|P2|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
1124223|NCT01606761|3688999|P1|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
1124224|NCT01606761|3688995|P5|Week 24 to Week 52|Other|2
1124225|NCT01606761|3688996|P4|Week 24 to Week 52|Other|2
1124226|NCT01606761|3688997|P3|Week 24 to Week 52|Other|5
1124227|NCT01606761|3688998|P2|Week 24 to Week 52|Other|1
1124228|NCT01606761|3688999|P1|Week 24 to Week 52|Other|0
1124229|NCT01606761|3688995|P5|Week 24 to Week 52|Physician Decision|0
1124230|NCT01606761|3688996|P4|Week 24 to Week 52|Physician Decision|0
1124231|NCT01606761|3688997|P3|Week 24 to Week 52|Physician Decision|1
1124232|NCT01606761|3688998|P2|Week 24 to Week 52|Physician Decision|1
1124233|NCT01606761|3688999|P1|Week 24 to Week 52|Physician Decision|0
1124234|NCT01606761|3688995|P5|Week 24 to Week 52|Lack of Efficacy|3
1124235|NCT01606761|3688996|P4|Week 24 to Week 52|Lack of Efficacy|10
1124236|NCT01606761|3688997|P3|Week 24 to Week 52|Lack of Efficacy|7
1124237|NCT01606761|3688998|P2|Week 24 to Week 52|Lack of Efficacy|13
1124238|NCT01606761|3688999|P1|Week 24 to Week 52|Lack of Efficacy|0
1124239|NCT01606761|3688995|P5|Week 24 to Week 52|Death|0
1124240|NCT01606761|3688996|P4|Week 24 to Week 52|Death|1
1124241|NCT01606761|3688997|P3|Week 24 to Week 52|Death|2
1124242|NCT01606761|3688998|P2|Week 24 to Week 52|Death|0
1124243|NCT01606761|3688999|P1|Week 24 to Week 52|Death|0
1124244|NCT01606761|3688995|P5|Week 24 to Week 52|Adverse Event|15
1124245|NCT01606761|3688996|P4|Week 24 to Week 52|Adverse Event|3
1124246|NCT01606761|3688997|P3|Week 24 to Week 52|Adverse Event|14
1124247|NCT01606761|3688998|P2|Week 24 to Week 52|Adverse Event|11
1124248|NCT01606761|3688999|P1|Week 24 to Week 52|Adverse Event|0
1124249|NCT01606761|3688995|P5|Week 24 to Week 52|Withdrawal by Subject|0
1124250|NCT01606761|3688996|P4|Week 24 to Week 52|Withdrawal by Subject|0
1124251|NCT01606761|3688997|P3|Week 24 to Week 52|Withdrawal by Subject|3
1124252|NCT01606761|3688998|P2|Week 24 to Week 52|Withdrawal by Subject|6
1124253|NCT01606761|3688999|P1|Week 24 to Week 52|Withdrawal by Subject|0
1124254|NCT01606761|3688995|P5|Week 24 to Week 52|Lost to Follow-up|0
1124255|NCT01606761|3688996|P4|Week 24 to Week 52|Lost to Follow-up|1
1124256|NCT01606761|3688997|P3|Week 24 to Week 52|Lost to Follow-up|1
1124257|NCT01606761|3688998|P2|Week 24 to Week 52|Lost to Follow-up|1
1124258|NCT01606761|3688999|P1|Week 24 to Week 52|Lost to Follow-up|0
1124259|NCT01606761|3688995|P5|Prior to Week 24|Other|0
1124260|NCT01606761|3688996|P4|Prior to Week 24|Other|0
1124261|NCT01606761|3688997|P3|Prior to Week 24|Other|5
1124262|NCT01606761|3688998|P2|Prior to Week 24|Other|7
1124263|NCT01606761|3688999|P1|Prior to Week 24|Other|4
1124264|NCT01606761|3688995|P5|Prior to Week 24|Physician Decision|0
1124265|NCT01606761|3688996|P4|Prior to Week 24|Physician Decision|0
1124266|NCT01606761|3688997|P3|Prior to Week 24|Physician Decision|1
1124267|NCT01606761|3688998|P2|Prior to Week 24|Physician Decision|3
1124268|NCT01606761|3688999|P1|Prior to Week 24|Physician Decision|0
1124269|NCT01606761|3688995|P5|Prior to Week 24|Lack of Efficacy|0
1124270|NCT01606761|3688996|P4|Prior to Week 24|Lack of Efficacy|0
1124271|NCT01606761|3688997|P3|Prior to Week 24|Lack of Efficacy|8
1124272|NCT01606761|3688998|P2|Prior to Week 24|Lack of Efficacy|14
1124273|NCT01606761|3688999|P1|Prior to Week 24|Lack of Efficacy|15
1124274|NCT01606761|3688995|P5|Prior to Week 24|Adverse Event|0
1124275|NCT01606761|3688996|P4|Prior to Week 24|Adverse Event|0
1124276|NCT01606761|3688997|P3|Prior to Week 24|Adverse Event|22
1124277|NCT01606761|3688998|P2|Prior to Week 24|Adverse Event|18
1124278|NCT01606761|3688999|P1|Prior to Week 24|Adverse Event|11
1124279|NCT01606761|3688995|P5|Prior to Week 24|Withdrawal by Subject|0
1124280|NCT01606761|3688996|P4|Prior to Week 24|Withdrawal by Subject|0
1124281|NCT01606761|3688997|P3|Prior to Week 24|Withdrawal by Subject|9
1124282|NCT01606761|3688998|P2|Prior to Week 24|Withdrawal by Subject|10
1124283|NCT01606761|3688999|P1|Prior to Week 24|Withdrawal by Subject|12
1124284|NCT01606761|3688995|P5|Prior to Week 24|Lost to Follow-up|0
1124285|NCT01606761|3688996|P4|Prior to Week 24|Lost to Follow-up|0
1124286|NCT01606761|3688997|P3|Prior to Week 24|Lost to Follow-up|2
1124287|NCT01606761|3688998|P2|Prior to Week 24|Lost to Follow-up|3
1124288|NCT01606761|3688999|P1|Prior to Week 24|Lost to Follow-up|0
1124289|NCT01606748|3689025|P2|Overall Study|Withdrawal by Subject|0
1124290|NCT01606748|3689026|P1|Overall Study|Withdrawal by Subject|1
1124291|NCT01606748|3689025|P2|Overall Study|Progressive Disease|0
1124292|NCT01606748|3689026|P1|Overall Study|Progressive Disease|1
1124293|NCT01606748|3689025|P2|Overall Study|Adverse Event|0
1124294|NCT01606748|3689026|P1|Overall Study|Adverse Event|1
1124295|NCT01606670|3689078|P1|Overall Study|Other Reason|2
1124296|NCT01606670|3689078|P1|Overall Study|Withdrawal by Subject|3
1124297|NCT01606670|3689078|P1|Overall Study|Lost to Follow-up|3
1124298|NCT01606670|3689078|P1|Overall Study|Lack of Efficacy|2
1124299|NCT01606670|3689078|P1|Overall Study|Adverse Event|6
1124300|NCT01606319|3689088|P2|Overall Study|Adverse Event|4
1124301|NCT01606319|3689089|P1|Overall Study|Adverse Event|1
1124302|NCT01606319|3689088|P2|Overall Study|Lack of Efficacy|8
1124303|NCT01606319|3689089|P1|Overall Study|Lack of Efficacy|6
1124304|NCT01606319|3689088|P2|Overall Study|Physician Decision|2
1124305|NCT01606319|3689089|P1|Overall Study|Physician Decision|1
1124306|NCT01606319|3689088|P2|Overall Study|Withdrawal by Subject|12
1124307|NCT01606319|3689089|P1|Overall Study|Withdrawal by Subject|9
1124308|NCT01606319|3689088|P2|Overall Study|Lost to Follow-up|14
1124309|NCT01606319|3689089|P1|Overall Study|Lost to Follow-up|17
1124310|NCT01606306|3689107|P6|Overall Study|Physician Decision|0
1124311|NCT01606306|3689108|P5|Overall Study|Physician Decision|0
1124312|NCT01606306|3689109|P4|Overall Study|Physician Decision|0
1124313|NCT01606306|3689110|P3|Overall Study|Physician Decision|0
1124314|NCT01606306|3689111|P2|Overall Study|Physician Decision|2
1124315|NCT01606306|3689112|P1|Overall Study|Physician Decision|1
1124316|NCT01606306|3689107|P6|Overall Study|Withdrawal by Subject|4
1124317|NCT01606306|3689108|P5|Overall Study|Withdrawal by Subject|5
1124318|NCT01606306|3689109|P4|Overall Study|Withdrawal by Subject|4
1124319|NCT01606306|3689110|P3|Overall Study|Withdrawal by Subject|4
1124320|NCT01606306|3689111|P2|Overall Study|Withdrawal by Subject|3
1124321|NCT01606306|3689112|P1|Overall Study|Withdrawal by Subject|4
1124322|NCT01606306|3689107|P6|Overall Study|Lost to Follow-up|5
1124323|NCT01606306|3689108|P5|Overall Study|Lost to Follow-up|3
1124324|NCT01606306|3689109|P4|Overall Study|Lost to Follow-up|4
1124325|NCT01606306|3689110|P3|Overall Study|Lost to Follow-up|5
1124326|NCT01606306|3689111|P2|Overall Study|Lost to Follow-up|4
1124327|NCT01606306|3689112|P1|Overall Study|Lost to Follow-up|7
1124328|NCT01606306|3689107|P6|Overall Study|Adverse Event|0
1124329|NCT01606306|3689108|P5|Overall Study|Adverse Event|2
1124330|NCT01606306|3689109|P4|Overall Study|Adverse Event|1
1124331|NCT01606306|3689110|P3|Overall Study|Adverse Event|1
1124332|NCT01606306|3689111|P2|Overall Study|Adverse Event|0
1124333|NCT01606306|3689112|P1|Overall Study|Adverse Event|1
1124334|NCT01606306|3689107|P6|Overall Study|Lack of Efficacy|2
1124335|NCT01606306|3689108|P5|Overall Study|Lack of Efficacy|1
1124336|NCT01606306|3689109|P4|Overall Study|Lack of Efficacy|4
1124337|NCT01606306|3689110|P3|Overall Study|Lack of Efficacy|4
1124338|NCT01606306|3689111|P2|Overall Study|Lack of Efficacy|1
1124339|NCT01606306|3689112|P1|Overall Study|Lack of Efficacy|2
1124340|NCT01606254|3689122|P4|Overall Study|Adverse Event|1
1124341|NCT01606254|3689123|P3|Overall Study|Adverse Event|0
1124342|NCT01606254|3689124|P2|Overall Study|Adverse Event|1
1124343|NCT01606254|3689125|P1|Overall Study|Adverse Event|1
1124344|NCT01606254|3689122|P4|Overall Study|Withdrawal by Subject|2
1124345|NCT01606254|3689123|P3|Overall Study|Withdrawal by Subject|0
1124346|NCT01606254|3689124|P2|Overall Study|Withdrawal by Subject|3
1124347|NCT01606254|3689125|P1|Overall Study|Withdrawal by Subject|1
1124348|NCT01606228|3689207|P1|Overall Study|Adverse Event|1
1124349|NCT01606228|3689207|P1|Overall Study|Lack of Efficacy|2
1124350|NCT01606228|3689207|P1|Overall Study|Non-compliant|3
1124351|NCT01606228|3689207|P1|Overall Study|Withdrawal by Subject|3
1124352|NCT01606228|3689207|P1|Overall Study|Lost to Follow-up|20
1124353|NCT01606202|3689224|P2|Overall Study|Problems with administration|1
1124354|NCT01606202|3689225|P1|Overall Study|Problems with administration|0
1124355|NCT01606202|3689224|P2|Overall Study|Personal problems|1
1124356|NCT01606202|3689225|P1|Overall Study|Personal problems|0
1124357|NCT01606202|3689224|P2|Overall Study|Withdrawal by Subject|1
1124358|NCT01606202|3689225|P1|Overall Study|Withdrawal by Subject|2
1124359|NCT01606202|3689224|P2|Overall Study|Adverse Event|0
1124360|NCT01606202|3689225|P1|Overall Study|Adverse Event|5
1124361|NCT01606189|3689257|P6|Third Intenvention (14-20 Days)|Withdrawal by Subject|1
1124362|NCT01606189|3689258|P5|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
1124363|NCT01606189|3689259|P4|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
1124364|NCT01606189|3689260|P3|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
1124365|NCT01606189|3689261|P2|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
1124366|NCT01606189|3689262|P1|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
1124367|NCT01606189|3689257|P6|Second Intenvention (14-20 Days)|Adverse Event|1
1124368|NCT01606189|3689258|P5|Second Intenvention (14-20 Days)|Adverse Event|0
1124369|NCT01606189|3689259|P4|Second Intenvention (14-20 Days)|Adverse Event|0
1124370|NCT01606189|3689260|P3|Second Intenvention (14-20 Days)|Adverse Event|0
1124371|NCT01606189|3689261|P2|Second Intenvention (14-20 Days)|Adverse Event|0
1124372|NCT01606189|3689262|P1|Second Intenvention (14-20 Days)|Adverse Event|0
1124373|NCT01606176|3689296|P2|Overall Study|Withdrawal by Subject|0
1124374|NCT01606176|3689297|P1|Overall Study|Withdrawal by Subject|1
1124375|NCT01606176|3689296|P2|Overall Study|Disease progression|0
1124376|NCT01606176|3689297|P1|Overall Study|Disease progression|1
1124377|NCT01606176|3689296|P2|Overall Study|Adverse Event|3
1124378|NCT01606176|3689297|P1|Overall Study|Adverse Event|2
1124379|NCT01606137|3689342|P1|Overall Study|Unable to collect consistent data|1
1124380|NCT01606137|3689342|P1|Overall Study|Patient moving|1
1124381|NCT01606137|3689342|P1|Overall Study|Unable to tolerate study med. taste|1
1124382|NCT01606137|3689342|P1|Overall Study|Personal reasons|1
1124383|NCT01606137|3689342|P1|Overall Study|Patient leaving country|1
1124384|NCT01606137|3689342|P1|Overall Study|Wanted to try another treatment|1
1124385|NCT01606137|3689342|P1|Overall Study|Not enough improvement|4
1124386|NCT01606137|3689342|P1|Overall Study|Spray causes nausea|1
1124387|NCT01606137|3689342|P1|Overall Study|Increased bilirubin|1
1124388|NCT01606137|3689342|P1|Overall Study|multiple sclerosis less stable|1
1124389|NCT01606137|3689342|P1|Overall Study|Issues with driving|4
1124390|NCT01606137|3689342|P1|Overall Study|Decreased/no pain|4
1124391|NCT01606137|3689342|P1|Overall Study|Death|1
1124392|NCT01606137|3689342|P1|Overall Study|Patient non-compliance|9
1124393|NCT01606137|3689342|P1|Overall Study|Protocol Violation|1
1124394|NCT01606137|3689342|P1|Overall Study|Lost to Follow-up|15
1124395|NCT01606137|3689342|P1|Overall Study|Lack of Efficacy|56
1124396|NCT01606137|3689342|P1|Overall Study|Withdrawal by Subject|74
1124397|NCT01606137|3689342|P1|Overall Study|Adverse Event|85
1124398|NCT01606007|3689376|P3|Overall Study|Poor/Non-compliance|0
1124399|NCT01606007|3689377|P2|Overall Study|Poor/Non-compliance|0
1124400|NCT01606007|3689378|P1|Overall Study|Poor/Non-compliance|1
1124401|NCT01606007|3689376|P3|Overall Study|Lost to Follow-up|5
1124402|NCT01606007|3689377|P2|Overall Study|Lost to Follow-up|8
1124403|NCT01606007|3689378|P1|Overall Study|Lost to Follow-up|6
1124404|NCT01606007|3689376|P3|Overall Study|discontinue study treatment|1
1124405|NCT01606007|3689377|P2|Overall Study|discontinue study treatment|2
1124406|NCT01606007|3689378|P1|Overall Study|discontinue study treatment|0
1124407|NCT01606007|3689376|P3|Overall Study|Adverse Event|1
1124408|NCT01606007|3689377|P2|Overall Study|Adverse Event|1
1124409|NCT01606007|3689378|P1|Overall Study|Adverse Event|0
1124410|NCT01606007|3689376|P3|Overall Study|Withdrawal by Subject|1
1124411|NCT01606007|3689377|P2|Overall Study|Withdrawal by Subject|6
1124412|NCT01606007|3689378|P1|Overall Study|Withdrawal by Subject|8
1124413|NCT01606007|3689376|P3|Overall Study|Pregnancy|1
1124414|NCT01606007|3689377|P2|Overall Study|Pregnancy|1
1124415|NCT01606007|3689378|P1|Overall Study|Pregnancy|0
1124416|NCT01606007|3689376|P3|Overall Study|Reason 'Other' in the protocol|1
1124417|NCT01606007|3689377|P2|Overall Study|Reason 'Other' in the protocol|1
1124418|NCT01606007|3689378|P1|Overall Study|Reason 'Other' in the protocol|0
1124419|NCT01605916|3689413|P5|Overall Study|Withdrawal by Subject|2
1124420|NCT01605916|3689414|P4|Overall Study|Withdrawal by Subject|0
1124421|NCT01605916|3689415|P3|Overall Study|Withdrawal by Subject|0
1124422|NCT01605916|3689416|P2|Overall Study|Withdrawal by Subject|1
1124423|NCT01605916|3689417|P1|Overall Study|Withdrawal by Subject|1
1124424|NCT01605916|3689413|P5|Overall Study|Lack of Efficacy|4
1124425|NCT01605916|3689414|P4|Overall Study|Lack of Efficacy|5
1124426|NCT01605916|3689415|P3|Overall Study|Lack of Efficacy|3
1124427|NCT01605916|3689416|P2|Overall Study|Lack of Efficacy|3
1124428|NCT01605916|3689417|P1|Overall Study|Lack of Efficacy|2
1124429|NCT01605916|3689413|P5|Overall Study|Adverse Event|0
1124430|NCT01605916|3689414|P4|Overall Study|Adverse Event|1
1124431|NCT01605916|3689415|P3|Overall Study|Adverse Event|0
1124432|NCT01605916|3689416|P2|Overall Study|Adverse Event|0
1124433|NCT01605916|3689417|P1|Overall Study|Adverse Event|1
1124434|NCT01605877|3689514|P1|Overall Study|Withdrawal by Subject|1
1124435|NCT01605825|3689578|P2|Overall Study|Non-Compliance with Protocol|0
1124436|NCT01605825|3689579|P1|Overall Study|Non-Compliance with Protocol|3
1124437|NCT01605825|3689578|P2|Overall Study|Non-Compliance -Investigational Drug|0
1124438|NCT01605825|3689579|P1|Overall Study|Non-Compliance -Investigational Drug|3
1124439|NCT01605825|3689578|P2|Overall Study|Withdrawal by Subject|1
1124440|NCT01605825|3689579|P1|Overall Study|Withdrawal by Subject|0
1124441|NCT01605825|3689578|P2|Overall Study|Adverse Event|2
1124442|NCT01605825|3689579|P1|Overall Study|Adverse Event|4
1124443|NCT01605799|3689587|P2|Overall Study|Withdrawal by Subject|1
1124444|NCT01605799|3689588|P1|Overall Study|Withdrawal by Subject|2
1124445|NCT01605617|3689603|P2|Washout Period of 4 Weeks|Study Terminated|1
1124446|NCT01605617|3689604|P1|Washout Period of 4 Weeks|Study Terminated|2
1124447|NCT01605617|3689603|P2|First Intervention|Adverse Event|1
1124448|NCT01605617|3689604|P1|First Intervention|Adverse Event|0
1124449|NCT01605461|3689663|P1|Overall Study|Withdrawal by Subject|1
1124450|NCT01605461|3689663|P1|Overall Study|Lost to Follow-up|3
1124451|NCT01605370|3689722|P2|Overall Study|Adverse Event|0
1124452|NCT01605370|3689723|P1|Overall Study|Adverse Event|1
1124453|NCT01605227|3689758|P2|Overall Study|Dose Held >6 weeks|1
1124454|NCT01605227|3689759|P1|Overall Study|Dose Held >6 weeks|0
1124455|NCT01605227|3689758|P2|Overall Study|Subject Decision|1
1124456|NCT01605227|3689759|P1|Overall Study|Subject Decision|0
1124457|NCT01605227|3689758|P2|Overall Study|Started New Therapy|0
1124458|NCT01605227|3689759|P1|Overall Study|Started New Therapy|1
1124459|NCT01605227|3689758|P2|Overall Study|Sponsor Decision|0
1124460|NCT01605227|3689759|P1|Overall Study|Sponsor Decision|2
1124461|NCT01605227|3689758|P2|Overall Study|Withdrawal by Subject|14
1124462|NCT01605227|3689759|P1|Overall Study|Withdrawal by Subject|18
1124463|NCT01605227|3689758|P2|Overall Study|Physician Decision|7
1124464|NCT01605227|3689759|P1|Overall Study|Physician Decision|9
1124465|NCT01605227|3689758|P2|Overall Study|Protocol Violation|0
1124466|NCT01605227|3689759|P1|Overall Study|Protocol Violation|1
1124467|NCT01605227|3689758|P2|Overall Study|Lost to Follow-up|0
1124468|NCT01605227|3689759|P1|Overall Study|Lost to Follow-up|1
1124469|NCT01605227|3689758|P2|Overall Study|Clinical Deterioration|133
1124470|NCT01605227|3689759|P1|Overall Study|Clinical Deterioration|227
1124471|NCT01605227|3689758|P2|Overall Study|Progressive Disease|128
1124472|NCT01605227|3689759|P1|Overall Study|Progressive Disease|132
1124473|NCT01605227|3689758|P2|Overall Study|Adverse Event|42
1124474|NCT01605227|3689759|P1|Overall Study|Adverse Event|228
1124475|NCT01605227|3689758|P2|Overall Study|Did not receive study treatment|3
1124476|NCT01605227|3689759|P1|Overall Study|Did not receive study treatment|2
1124477|NCT01605019|3689771|P2|Overall Study|pt did not meet transplant endpoint|0
1124478|NCT01605019|3689772|P1|Overall Study|pt did not meet transplant endpoint|3
1124479|NCT01604941|3689782|P6|Overall Study|Early Study Termination|0
1124480|NCT01604941|3689783|P5|Overall Study|Early Study Termination|0
1124481|NCT01604941|3689784|P4|Overall Study|Early Study Termination|3
1124482|NCT01604941|3689785|P3|Overall Study|Early Study Termination|3
1124483|NCT01604941|3689786|P2|Overall Study|Early Study Termination|2
1124484|NCT01604941|3689787|P1|Overall Study|Early Study Termination|9
1124485|NCT01604941|3689782|P6|Overall Study|Participant Decision|2
1124486|NCT01604941|3689783|P5|Overall Study|Participant Decision|0
1124487|NCT01604941|3689784|P4|Overall Study|Participant Decision|0
1124488|NCT01604941|3689785|P3|Overall Study|Participant Decision|0
1124489|NCT01604941|3689786|P2|Overall Study|Participant Decision|0
1124490|NCT01604941|3689787|P1|Overall Study|Participant Decision|0
1124491|NCT01604941|3689782|P6|Overall Study|Non-compliance|0
1124492|NCT01604941|3689783|P5|Overall Study|Non-compliance|0
1124493|NCT01604941|3689784|P4|Overall Study|Non-compliance|0
1124494|NCT01604941|3689785|P3|Overall Study|Non-compliance|0
1124495|NCT01604941|3689786|P2|Overall Study|Non-compliance|0
1124496|NCT01604941|3689787|P1|Overall Study|Non-compliance|1
1124497|NCT01604941|3689782|P6|Overall Study|Adverse Event|5
1124498|NCT01604941|3689783|P5|Overall Study|Adverse Event|1
1124499|NCT01604941|3689784|P4|Overall Study|Adverse Event|0
1124500|NCT01604941|3689785|P3|Overall Study|Adverse Event|0
1124501|NCT01604941|3689786|P2|Overall Study|Adverse Event|2
1124502|NCT01604941|3689787|P1|Overall Study|Adverse Event|1
1124503|NCT01604850|3689815|P2|Overall Study|Subject withdrew consent|0
1124504|NCT01604850|3689816|P1|Overall Study|Subject withdrew consent|1
1124505|NCT01604850|3689815|P2|Overall Study|Lost to Follow-up|0
1124506|NCT01604850|3689816|P1|Overall Study|Lost to Follow-up|1
1124507|NCT01604850|3689815|P2|Overall Study|Efficacy Failure|29
1124508|NCT01604850|3689816|P1|Overall Study|Efficacy Failure|50
1124509|NCT01604850|3689815|P2|Overall Study|Enrolled but never treated|1
1124510|NCT01604850|3689816|P1|Overall Study|Enrolled but never treated|0
1124511|NCT01604785|3689834|P2|Overall Study|Repeat Visits Not Included in Analysis|1
1124512|NCT01604785|3689835|P1|Overall Study|Repeat Visits Not Included in Analysis|7
1124513|NCT01604408|3689853|P2|Observation Period|Withdrawal by Subject|2
1124514|NCT01604408|3689854|P1|Observation Period|Withdrawal by Subject|0
1124515|NCT01604408|3689853|P2|Observation Period|Adverse Event|1
1124516|NCT01604408|3689854|P1|Observation Period|Adverse Event|1
1124517|NCT01604408|3689853|P2|Treatment Period 6|Sponsor decision|1
1124518|NCT01604408|3689854|P1|Treatment Period 6|Sponsor decision|0
1124519|NCT01604408|3689853|P2|Treatment Period 6|Adverse Event|0
1124520|NCT01604408|3689854|P1|Treatment Period 6|Adverse Event|2
1124521|NCT01604408|3689853|P2|Treatment Period 6|Lost to Follow-up|1
1124522|NCT01604408|3689854|P1|Treatment Period 6|Lost to Follow-up|0
1124523|NCT01604408|3689853|P2|Treatment Period 5|Adverse Event|0
1124524|NCT01604408|3689854|P1|Treatment Period 5|Adverse Event|4
1124525|NCT01604408|3689853|P2|Treatment Period 4|Adverse Event|1
1124526|NCT01604408|3689854|P1|Treatment Period 4|Adverse Event|0
1124527|NCT01604408|3689853|P2|Treatment Period 4|Withdrawal by Subject|1
1124528|NCT01604408|3689854|P1|Treatment Period 4|Withdrawal by Subject|2
1124529|NCT01604408|3689853|P2|Treatment Period 4|Death|0
1124530|NCT01604408|3689854|P1|Treatment Period 4|Death|1
1124531|NCT01604408|3689853|P2|Treatment Period 3|Sponsor Decision|0
1124532|NCT01604408|3689854|P1|Treatment Period 3|Sponsor Decision|1
1124533|NCT01604408|3689853|P2|Treatment Period 3|Withdrawal by Subject|1
1124534|NCT01604408|3689854|P1|Treatment Period 3|Withdrawal by Subject|3
1124535|NCT01604408|3689853|P2|Treatment Period 3|Adverse Event|3
1124536|NCT01604408|3689854|P1|Treatment Period 3|Adverse Event|0
1124537|NCT01604408|3689853|P2|Treatment Period 3|Protocol Violation|1
1124538|NCT01604408|3689854|P1|Treatment Period 3|Protocol Violation|1
1124539|NCT01604408|3689853|P2|Treatment Period 2|Adverse Event|1
1124540|NCT01604408|3689854|P1|Treatment Period 2|Adverse Event|0
1124541|NCT01604408|3689853|P2|Treatment Period 2|Protocol Violation|0
1124542|NCT01604408|3689854|P1|Treatment Period 2|Protocol Violation|1
1124543|NCT01604408|3689853|P2|Treatment Period 2|Withdrawal by Subject|1
1124544|NCT01604408|3689854|P1|Treatment Period 2|Withdrawal by Subject|1
1124545|NCT01604408|3689853|P2|Treatment Period 1|Protocol Violation|1
1124546|NCT01604408|3689854|P1|Treatment Period 1|Protocol Violation|0
1124547|NCT01604343|3689869|P5|Safety Follow-up Period (Week 104-120)|Other|14
1124548|NCT01604343|3689870|P4|Safety Follow-up Period (Week 104-120)|Other|6
1124549|NCT01604343|3689871|P3|Safety Follow-up Period (Week 104-120)|Other|20
1124550|NCT01604343|3689872|P2|Safety Follow-up Period (Week 104-120)|Other|2
1124551|NCT01604343|3689873|P1|Safety Follow-up Period (Week 104-120)|Other|15
1124552|NCT01604343|3689869|P5|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14
1124553|NCT01604343|3689870|P4|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3
1124554|NCT01604343|3689871|P3|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11
1124555|NCT01604343|3689872|P2|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4
1124556|NCT01604343|3689873|P1|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12
1124557|NCT01604343|3689869|P5|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
1124558|NCT01604343|3689870|P4|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
1124559|NCT01604343|3689871|P3|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2
1124560|NCT01604343|3689872|P2|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
1124561|NCT01604343|3689873|P1|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3
1124562|NCT01604343|3689869|P5|Week 52 to Week 104|Other|3
1124563|NCT01604343|3689870|P4|Week 52 to Week 104|Other|6
1124564|NCT01604343|3689871|P3|Week 52 to Week 104|Other|11
1124565|NCT01604343|3689872|P2|Week 52 to Week 104|Other|11
1124566|NCT01604343|3689873|P1|Week 52 to Week 104|Other|0
1124567|NCT01604343|3689869|P5|Week 52 to Week 104|Pregnancy|1
1124568|NCT01604343|3689870|P4|Week 52 to Week 104|Pregnancy|2
1124569|NCT01604343|3689871|P3|Week 52 to Week 104|Pregnancy|1
1124570|NCT01604343|3689872|P2|Week 52 to Week 104|Pregnancy|0
1124571|NCT01604343|3689873|P1|Week 52 to Week 104|Pregnancy|0
1124572|NCT01604343|3689869|P5|Week 52 to Week 104|Physician Decision|2
1124573|NCT01604343|3689870|P4|Week 52 to Week 104|Physician Decision|0
1124574|NCT01604343|3689871|P3|Week 52 to Week 104|Physician Decision|0
1124575|NCT01604343|3689872|P2|Week 52 to Week 104|Physician Decision|1
1124576|NCT01604343|3689873|P1|Week 52 to Week 104|Physician Decision|0
1124577|NCT01604343|3689869|P5|Week 52 to Week 104|Lack of Efficacy|3
1124578|NCT01604343|3689870|P4|Week 52 to Week 104|Lack of Efficacy|2
1124579|NCT01604343|3689871|P3|Week 52 to Week 104|Lack of Efficacy|11
1124580|NCT01604343|3689872|P2|Week 52 to Week 104|Lack of Efficacy|6
1124581|NCT01604343|3689873|P1|Week 52 to Week 104|Lack of Efficacy|0
1124582|NCT01604343|3689869|P5|Week 52 to Week 104|Death|0
1124583|NCT01604343|3689870|P4|Week 52 to Week 104|Death|5
1124584|NCT01604343|3689871|P3|Week 52 to Week 104|Death|2
1124585|NCT01604343|3689872|P2|Week 52 to Week 104|Death|4
1124586|NCT01604343|3689873|P1|Week 52 to Week 104|Death|0
1124587|NCT01604343|3689869|P5|Week 52 to Week 104|Adverse Event|27
1124588|NCT01604343|3689870|P4|Week 52 to Week 104|Adverse Event|21
1124589|NCT01604343|3689871|P3|Week 52 to Week 104|Adverse Event|26
1124590|NCT01604343|3689872|P2|Week 52 to Week 104|Adverse Event|12
1124591|NCT01604343|3689873|P1|Week 52 to Week 104|Adverse Event|0
1124592|NCT01604343|3689869|P5|Week 52 to Week 104|Withdrawal by Subject|4
1124593|NCT01604343|3689870|P4|Week 52 to Week 104|Withdrawal by Subject|8
1124594|NCT01604343|3689871|P3|Week 52 to Week 104|Withdrawal by Subject|12
1124595|NCT01604343|3689872|P2|Week 52 to Week 104|Withdrawal by Subject|7
1124596|NCT01604343|3689873|P1|Week 52 to Week 104|Withdrawal by Subject|0
1124597|NCT01604343|3689869|P5|Week 52 to Week 104|Lost to Follow-up|1
1124598|NCT01604343|3689870|P4|Week 52 to Week 104|Lost to Follow-up|2
1124599|NCT01604343|3689871|P3|Week 52 to Week 104|Lost to Follow-up|4
1124600|NCT01604343|3689872|P2|Week 52 to Week 104|Lost to Follow-up|2
1124601|NCT01604343|3689873|P1|Week 52 to Week 104|Lost to Follow-up|0
1124602|NCT01604343|3689869|P5|Prior to W52 Administration(Through W52)|Other|6
1124603|NCT01604343|3689870|P4|Prior to W52 Administration(Through W52)|Other|0
1124604|NCT01604343|3689871|P3|Prior to W52 Administration(Through W52)|Other|10
1124605|NCT01604343|3689872|P2|Prior to W52 Administration(Through W52)|Other|0
1124606|NCT01604343|3689873|P1|Prior to W52 Administration(Through W52)|Other|15
1124607|NCT01604343|3689869|P5|Prior to W52 Administration(Through W52)|Pregnancy|0
1124608|NCT01604343|3689870|P4|Prior to W52 Administration(Through W52)|Pregnancy|0
1124609|NCT01604343|3689871|P3|Prior to W52 Administration(Through W52)|Pregnancy|1
1124610|NCT01604343|3689872|P2|Prior to W52 Administration(Through W52)|Pregnancy|0
1124611|NCT01604343|3689873|P1|Prior to W52 Administration(Through W52)|Pregnancy|1
1124612|NCT01604343|3689869|P5|Prior to W52 Administration(Through W52)|Physician Decision|2
1124613|NCT01604343|3689870|P4|Prior to W52 Administration(Through W52)|Physician Decision|0
1124614|NCT01604343|3689871|P3|Prior to W52 Administration(Through W52)|Physician Decision|1
1124615|NCT01604343|3689872|P2|Prior to W52 Administration(Through W52)|Physician Decision|0
1124616|NCT01604343|3689873|P1|Prior to W52 Administration(Through W52)|Physician Decision|4
1124617|NCT01604343|3689869|P5|Prior to W52 Administration(Through W52)|Lack of Efficacy|14
1124618|NCT01604343|3689870|P4|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
1124619|NCT01604343|3689871|P3|Prior to W52 Administration(Through W52)|Lack of Efficacy|5
1124620|NCT01604343|3689872|P2|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
1124621|NCT01604343|3689873|P1|Prior to W52 Administration(Through W52)|Lack of Efficacy|24
1124622|NCT01604343|3689869|P5|Prior to W52 Administration(Through W52)|Death|4
1124623|NCT01604343|3689870|P4|Prior to W52 Administration(Through W52)|Death|0
1124624|NCT01604343|3689871|P3|Prior to W52 Administration(Through W52)|Death|2
1124625|NCT01604343|3689872|P2|Prior to W52 Administration(Through W52)|Death|0
1124626|NCT01604343|3689873|P1|Prior to W52 Administration(Through W52)|Death|5
1124627|NCT01604343|3689869|P5|Prior to W52 Administration(Through W52)|Adverse Event|42
1124628|NCT01604343|3689870|P4|Prior to W52 Administration(Through W52)|Adverse Event|0
1124629|NCT01604343|3689871|P3|Prior to W52 Administration(Through W52)|Adverse Event|41
1124630|NCT01604343|3689872|P2|Prior to W52 Administration(Through W52)|Adverse Event|0
1124631|NCT01604343|3689873|P1|Prior to W52 Administration(Through W52)|Adverse Event|25
1124632|NCT01604343|3689869|P5|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16
1124633|NCT01604343|3689870|P4|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
1124634|NCT01604343|3689871|P3|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12
1124635|NCT01604343|3689872|P2|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
1124636|NCT01604343|3689873|P1|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19
1124637|NCT01604343|3689869|P5|Prior to W52 Administration(Through W52)|Lost to Follow-up|3
1124638|NCT01604343|3689870|P4|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
1124639|NCT01604343|3689871|P3|Prior to W52 Administration(Through W52)|Lost to Follow-up|4
1124640|NCT01604343|3689872|P2|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
1124641|NCT01604343|3689873|P1|Prior to W52 Administration(Through W52)|Lost to Follow-up|5
1124642|NCT01604278|3689984|P2|Overall Study|Protocol Deviation|3
1124643|NCT01604278|3689985|P1|Overall Study|Protocol Deviation|5
1124644|NCT01604278|3689984|P2|Overall Study|Adverse Event|5
1124645|NCT01604278|3689985|P1|Overall Study|Adverse Event|3
1124646|NCT01604278|3689984|P2|Overall Study|Withdrawal by Subject|3
1124647|NCT01604278|3689985|P1|Overall Study|Withdrawal by Subject|3
1124648|NCT01604278|3689984|P2|Overall Study|Administrative problems|1
1124649|NCT01604278|3689985|P1|Overall Study|Administrative problems|2
1124650|NCT01604278|3689984|P2|Overall Study|Lost to Follow-up|0
1124651|NCT01604278|3689985|P1|Overall Study|Lost to Follow-up|1
1124652|NCT01604278|3689984|P2|Overall Study|Lack of Efficacy|1
1124653|NCT01604278|3689985|P1|Overall Study|Lack of Efficacy|0
1124654|NCT01604265|3690011|P2|Overall Study|Withdrawal by Subject|0
1124655|NCT01604265|3690012|P1|Overall Study|Withdrawal by Subject|1
1124656|NCT01604265|3690011|P2|Overall Study|Adverse Event|0
1124657|NCT01604265|3690012|P1|Overall Study|Adverse Event|1
1124658|NCT01603875|3690123|P3|Overall Study|Protocol Violation|0
1124659|NCT01603875|3690124|P2|Overall Study|Protocol Violation|1
1124660|NCT01603875|3690125|P1|Overall Study|Protocol Violation|0
1124661|NCT01603875|3690123|P3|Overall Study|Lost to Follow-up|6
1124662|NCT01603875|3690124|P2|Overall Study|Lost to Follow-up|3
1124663|NCT01603875|3690125|P1|Overall Study|Lost to Follow-up|4
1124664|NCT01603875|3690123|P3|Overall Study|Preexisting rabies antibody|3
1124665|NCT01603875|3690124|P2|Overall Study|Preexisting rabies antibody|4
1124666|NCT01603875|3690125|P1|Overall Study|Preexisting rabies antibody|3
1124667|NCT01603628|3690148|P3|Overall Study|Other Miscellaneous Reason|0
1124668|NCT01603628|3690149|P2|Overall Study|Other Miscellaneous Reason|0
1124669|NCT01603628|3690150|P1|Overall Study|Other Miscellaneous Reason|1
1124670|NCT01603628|3690148|P3|Overall Study|Lost to Follow-up|0
1124671|NCT01603628|3690149|P2|Overall Study|Lost to Follow-up|1
1124672|NCT01603628|3690150|P1|Overall Study|Lost to Follow-up|0
1124673|NCT01603628|3690148|P3|Overall Study|Protocol Violation|0
1124674|NCT01603628|3690149|P2|Overall Study|Protocol Violation|1
1124675|NCT01603628|3690150|P1|Overall Study|Protocol Violation|1
1124676|NCT01603628|3690148|P3|Overall Study|Personal Reasons|2
1124677|NCT01603628|3690149|P2|Overall Study|Personal Reasons|1
1124678|NCT01603628|3690150|P1|Overall Study|Personal Reasons|1
1124679|NCT01603602|3690170|P3|Overall Study|Personal Reasons|1
1124680|NCT01603602|3690171|P2|Overall Study|Personal Reasons|0
1124681|NCT01603602|3690172|P1|Overall Study|Personal Reasons|1
1124682|NCT01603602|3690170|P3|Overall Study|Adverse Event|0
1124683|NCT01603602|3690171|P2|Overall Study|Adverse Event|0
1124684|NCT01603602|3690172|P1|Overall Study|Adverse Event|1
1124685|NCT01603459|3690192|P1|Overall Study|Administrative reason|1
1124686|NCT01603459|3690192|P1|Overall Study|Non-compliance|1
1124687|NCT01603459|3690192|P1|Overall Study|Predefined discontinuation criteria|3
1124688|NCT01603459|3690192|P1|Overall Study|Lost to Follow-up|3
1124689|NCT01603459|3690192|P1|Overall Study|Withdrawal by Subject|5
1124690|NCT01603459|3690192|P1|Overall Study|Adverse Event|5
1124691|NCT01603394|3690343|P1|Overall Study|Adverse Event|1
1124692|NCT01603355|3690358|P1|Overall Study|Lack of Efficacy|2
1124693|NCT01603277|3690364|P2|Overall Study|Non-Compliance|1
1124694|NCT01603277|3690365|P1|Overall Study|Non-Compliance|2
1124695|NCT01603277|3690364|P2|Overall Study|Withdrawal by Subject|4
1124696|NCT01603277|3690365|P1|Overall Study|Withdrawal by Subject|5
1124697|NCT01603277|3690364|P2|Overall Study|Protocol Violation|10
1124698|NCT01603277|3690365|P1|Overall Study|Protocol Violation|6
1124699|NCT01603277|3690364|P2|Overall Study|Physician Decision|1
1124700|NCT01603277|3690365|P1|Overall Study|Physician Decision|0
1124701|NCT01603277|3690364|P2|Overall Study|Adverse Event|2
1124702|NCT01603277|3690365|P1|Overall Study|Adverse Event|1
1124703|NCT01603121|3690371|P2|Second Intervention, 10 Hours|Adverse Event|0
1124704|NCT01603121|3690372|P1|Second Intervention, 10 Hours|Adverse Event|1
1124705|NCT01603082|3690384|P2|Overall Study|Failed inclusion criterion after dosed|0
1124706|NCT01603082|3690385|P1|Overall Study|Failed inclusion criterion after dosed|1
1124707|NCT01603082|3690384|P2|Overall Study|Withdrawal by Subject|0
1124708|NCT01603082|3690385|P1|Overall Study|Withdrawal by Subject|1
1124709|NCT01603082|3690384|P2|Overall Study|Adverse Event|1
1124710|NCT01603082|3690385|P1|Overall Study|Adverse Event|0
1124711|NCT01603043|3690426|P2|Overall Study|Study Futility|3
1124712|NCT01603043|3690427|P1|Overall Study|Study Futility|7
1124713|NCT01602965|3690439|P2|Overall Study|Lost to Follow-up|2
1124714|NCT01602965|3690440|P1|Overall Study|Lost to Follow-up|4
1124715|NCT01602744|3690448|P2|Overall Study|Lost to Follow-up|8
1124716|NCT01602744|3690449|P1|Overall Study|Lost to Follow-up|13
1124717|NCT01602744|3690448|P2|Overall Study|Death|15
1124718|NCT01602744|3690449|P1|Overall Study|Death|17
1124719|NCT01602562|3690486|P2|Overall Study|Withdrawal by Subject|1
1124720|NCT01602562|3690487|P1|Overall Study|Withdrawal by Subject|1
1124721|NCT01602562|3690486|P2|Overall Study|Physician Decision|1
1124722|NCT01602562|3690487|P1|Overall Study|Physician Decision|1
1124723|NCT01602562|3690486|P2|Overall Study|Adverse Event|1
1124724|NCT01602562|3690487|P1|Overall Study|Adverse Event|3
1124725|NCT01602549|3690523|P2|Overall Study|Withdrawal by Subject|0
1124726|NCT01602549|3690524|P1|Overall Study|Withdrawal by Subject|1
1124727|NCT01602549|3690523|P2|Overall Study|Protocol Violation|1
1124728|NCT01602549|3690524|P1|Overall Study|Protocol Violation|0
1124729|NCT01602510|3690603|P3|Randomized Phase|Withdrawal by Subject|7
1124730|NCT01602510|3690604|P2|Randomized Phase|Withdrawal by Subject|6
1124731|NCT01602510|3690605|P1|Randomized Phase|Withdrawal by Subject|0
1124732|NCT01602510|3690603|P3|Randomized Phase|Physician Decision|2
1124733|NCT01602510|3690604|P2|Randomized Phase|Physician Decision|0
1124734|NCT01602510|3690605|P1|Randomized Phase|Physician Decision|0
1124735|NCT01602510|3690603|P3|Randomized Phase|Lost to Follow-up|3
1124736|NCT01602510|3690604|P2|Randomized Phase|Lost to Follow-up|1
1124737|NCT01602510|3690605|P1|Randomized Phase|Lost to Follow-up|0
1124738|NCT01602510|3690603|P3|Randomized Phase|Met protocol-defined stopping criteria|48
1124739|NCT01602510|3690604|P2|Randomized Phase|Met protocol-defined stopping criteria|58
1124740|NCT01602510|3690605|P1|Randomized Phase|Met protocol-defined stopping criteria|0
1124741|NCT01602510|3690603|P3|Randomized Phase|Protocol Violation|3
1124742|NCT01602510|3690604|P2|Randomized Phase|Protocol Violation|3
1124743|NCT01602510|3690605|P1|Randomized Phase|Protocol Violation|0
1124744|NCT01602510|3690603|P3|Randomized Phase|Lack of Efficacy|4
1124745|NCT01602510|3690604|P2|Randomized Phase|Lack of Efficacy|4
1124746|NCT01602510|3690605|P1|Randomized Phase|Lack of Efficacy|0
1124747|NCT01602510|3690603|P3|Randomized Phase|Adverse Event|6
1124748|NCT01602510|3690604|P2|Randomized Phase|Adverse Event|2
1124749|NCT01602510|3690605|P1|Randomized Phase|Adverse Event|0
1124750|NCT01602510|3690603|P3|Open Label Phase|Withdrawal by Subject|0
1124751|NCT01602510|3690604|P2|Open Label Phase|Withdrawal by Subject|0
1124752|NCT01602510|3690605|P1|Open Label Phase|Withdrawal by Subject|57
1124753|NCT01602510|3690603|P3|Open Label Phase|Physician Decision|0
1124754|NCT01602510|3690604|P2|Open Label Phase|Physician Decision|0
1124755|NCT01602510|3690605|P1|Open Label Phase|Physician Decision|19
1124756|NCT01602510|3690603|P3|Open Label Phase|Lost to Follow-up|0
1124757|NCT01602510|3690604|P2|Open Label Phase|Lost to Follow-up|0
1124758|NCT01602510|3690605|P1|Open Label Phase|Lost to Follow-up|22
1124759|NCT01602510|3690603|P3|Open Label Phase|Met protocol-defined stopping criteria|0
1124760|NCT01602510|3690604|P2|Open Label Phase|Met protocol-defined stopping criteria|0
1124761|NCT01602510|3690605|P1|Open Label Phase|Met protocol-defined stopping criteria|122
1124762|NCT01602510|3690603|P3|Open Label Phase|Protocol Violation|0
1124763|NCT01602510|3690604|P2|Open Label Phase|Protocol Violation|0
1124764|NCT01602510|3690605|P1|Open Label Phase|Protocol Violation|15
1124765|NCT01602510|3690603|P3|Open Label Phase|Lack of Efficacy|0
1124766|NCT01602510|3690604|P2|Open Label Phase|Lack of Efficacy|0
1124767|NCT01602510|3690605|P1|Open Label Phase|Lack of Efficacy|22
1124768|NCT01602510|3690603|P3|Open Label Phase|Adverse Event|0
1124769|NCT01602510|3690604|P2|Open Label Phase|Adverse Event|0
1124770|NCT01602510|3690605|P1|Open Label Phase|Adverse Event|46
1124771|NCT01602484|3690631|P2|Overall Study|Airway issues unrelated to study|1
1124772|NCT01602484|3690632|P1|Overall Study|Airway issues unrelated to study|0
1124773|NCT01602380|3690650|P2|Overall Study|Eligibility criteria not fulfilled|3
1124774|NCT01602380|3690651|P1|Overall Study|Eligibility criteria not fulfilled|2
1124775|NCT01602380|3690650|P2|Overall Study|Lost to Follow-up|1
1124776|NCT01602380|3690651|P1|Overall Study|Lost to Follow-up|6
1124777|NCT01602380|3690650|P2|Overall Study|Withdrawal by Subject|29
1124778|NCT01602380|3690651|P1|Overall Study|Withdrawal by Subject|22
1124779|NCT01602380|3690650|P2|Overall Study|Death|68
1124780|NCT01602380|3690651|P1|Overall Study|Death|63
1124781|NCT01602341|3690675|P2|Overall Study|Adverse Event|1
1124782|NCT01602341|3690676|P1|Overall Study|Adverse Event|0
1124783|NCT01602315|3690717|P7|Overall Study|Cross-over patients to combo treatment|0
1124784|NCT01602315|3690718|P6|Overall Study|Cross-over patients to combo treatment|16
1124785|NCT01602315|3690719|P5|Overall Study|Cross-over patients to combo treatment|0
1124786|NCT01602315|3690720|P4|Overall Study|Cross-over patients to combo treatment|0
1124787|NCT01602315|3690721|P3|Overall Study|Cross-over patients to combo treatment|0
1124788|NCT01602315|3690722|P2|Overall Study|Cross-over patients to combo treatment|0
1124789|NCT01602315|3690723|P1|Overall Study|Cross-over patients to combo treatment|0
1124790|NCT01602315|3690717|P7|Overall Study|Subject/guardian decision|1
1124791|NCT01602315|3690718|P6|Overall Study|Subject/guardian decision|0
1124792|NCT01602315|3690719|P5|Overall Study|Subject/guardian decision|0
1124793|NCT01602315|3690720|P4|Overall Study|Subject/guardian decision|0
1124794|NCT01602315|3690721|P3|Overall Study|Subject/guardian decision|0
1124795|NCT01602315|3690722|P2|Overall Study|Subject/guardian decision|0
1124796|NCT01602315|3690723|P1|Overall Study|Subject/guardian decision|0
1124797|NCT01602315|3690717|P7|Overall Study|Adverse Event|9
1124798|NCT01602315|3690718|P6|Overall Study|Adverse Event|3
1124799|NCT01602315|3690719|P5|Overall Study|Adverse Event|15
1124800|NCT01602315|3690720|P4|Overall Study|Adverse Event|4
1124801|NCT01602315|3690721|P3|Overall Study|Adverse Event|5
1124802|NCT01602315|3690722|P2|Overall Study|Adverse Event|1
1124803|NCT01602315|3690723|P1|Overall Study|Adverse Event|5
1124804|NCT01602315|3690717|P7|Overall Study|Withdrawal by Subject|1
1124805|NCT01602315|3690718|P6|Overall Study|Withdrawal by Subject|0
1124806|NCT01602315|3690719|P5|Overall Study|Withdrawal by Subject|6
1124807|NCT01602315|3690720|P4|Overall Study|Withdrawal by Subject|0
1124808|NCT01602315|3690721|P3|Overall Study|Withdrawal by Subject|2
1124809|NCT01602315|3690722|P2|Overall Study|Withdrawal by Subject|0
1124810|NCT01602315|3690723|P1|Overall Study|Withdrawal by Subject|2
1124811|NCT01602315|3690717|P7|Overall Study|Death|2
1124812|NCT01602315|3690718|P6|Overall Study|Death|2
1124813|NCT01602315|3690719|P5|Overall Study|Death|7
1124814|NCT01602315|3690720|P4|Overall Study|Death|1
1124815|NCT01602315|3690721|P3|Overall Study|Death|1
1124816|NCT01602315|3690722|P2|Overall Study|Death|1
1124817|NCT01602315|3690723|P1|Overall Study|Death|1
1124818|NCT01602315|3690717|P7|Overall Study|Disease progression|15
1124819|NCT01602315|3690718|P6|Overall Study|Disease progression|12
1124820|NCT01602315|3690719|P5|Overall Study|Disease progression|41
1124821|NCT01602315|3690720|P4|Overall Study|Disease progression|1
1124822|NCT01602315|3690721|P3|Overall Study|Disease progression|10
1124823|NCT01602315|3690722|P2|Overall Study|Disease progression|3
1124824|NCT01602315|3690723|P1|Overall Study|Disease progression|6
1124825|NCT01602315|3690717|P7|Overall Study|Physician Decision|1
1124826|NCT01602315|3690718|P6|Overall Study|Physician Decision|1
1124827|NCT01602315|3690719|P5|Overall Study|Physician Decision|2
1124828|NCT01602315|3690720|P4|Overall Study|Physician Decision|0
1124829|NCT01602315|3690721|P3|Overall Study|Physician Decision|0
1124830|NCT01602315|3690722|P2|Overall Study|Physician Decision|0
1124831|NCT01602315|3690723|P1|Overall Study|Physician Decision|2
1124832|NCT01602315|3690717|P7|Overall Study|Protocol Violation|0
1124833|NCT01602315|3690718|P6|Overall Study|Protocol Violation|1
1124834|NCT01602315|3690719|P5|Overall Study|Protocol Violation|0
1124835|NCT01602315|3690720|P4|Overall Study|Protocol Violation|0
1124836|NCT01602315|3690721|P3|Overall Study|Protocol Violation|0
1124837|NCT01602315|3690722|P2|Overall Study|Protocol Violation|0
1124838|NCT01602315|3690723|P1|Overall Study|Protocol Violation|0
1124839|NCT01602224|3690812|P3|Overall Study|Withdrawal by Subject|3
1124840|NCT01602224|3690813|P2|Overall Study|Withdrawal by Subject|3
1124841|NCT01602224|3690814|P1|Overall Study|Withdrawal by Subject|5
1124842|NCT01602224|3690812|P3|Overall Study|Sponsor Decision|2
1124843|NCT01602224|3690813|P2|Overall Study|Sponsor Decision|3
1124844|NCT01602224|3690814|P1|Overall Study|Sponsor Decision|2
1124845|NCT01602224|3690812|P3|Overall Study|Protocol Violation|0
1124846|NCT01602224|3690813|P2|Overall Study|Protocol Violation|1
1124847|NCT01602224|3690814|P1|Overall Study|Protocol Violation|0
1124848|NCT01602224|3690812|P3|Overall Study|Lost to Follow-up|1
1124849|NCT01602224|3690813|P2|Overall Study|Lost to Follow-up|0
1124850|NCT01602224|3690814|P1|Overall Study|Lost to Follow-up|0
1124851|NCT01602224|3690812|P3|Overall Study|Investigator Decison|0
1124852|NCT01602224|3690813|P2|Overall Study|Investigator Decison|0
1124853|NCT01602224|3690814|P1|Overall Study|Investigator Decison|1
1124854|NCT01602224|3690812|P3|Overall Study|Adverse Event|0
1124855|NCT01602224|3690813|P2|Overall Study|Adverse Event|1
1124856|NCT01602224|3690814|P1|Overall Study|Adverse Event|0
1124857|NCT01601847|3690903|P2|Overall Study|Lost to Follow-up|3
1124858|NCT01601847|3690904|P1|Overall Study|Lost to Follow-up|1
1124859|NCT01601847|3690903|P2|Overall Study|Withdrawal by Subject|7
1124860|NCT01601847|3690904|P1|Overall Study|Withdrawal by Subject|11
1124861|NCT01601847|3690903|P2|Overall Study|Death|0
1124862|NCT01601847|3690904|P1|Overall Study|Death|1
1124863|NCT01601821|3690916|P2|Overall Study|Other|1
1124864|NCT01601821|3690917|P1|Overall Study|Other|5
1124865|NCT01601821|3690916|P2|Overall Study|Study Events|1
1124866|NCT01601821|3690917|P1|Overall Study|Study Events|7
1124867|NCT01601821|3690916|P2|Overall Study|Graft Loss|6
1124868|NCT01601821|3690917|P1|Overall Study|Graft Loss|6
1124869|NCT01601821|3690916|P2|Overall Study|Withdrawal by Subject|0
1124870|NCT01601821|3690917|P1|Overall Study|Withdrawal by Subject|1
1124871|NCT01601821|3690916|P2|Overall Study|Lost to Follow-up|14
1124872|NCT01601821|3690917|P1|Overall Study|Lost to Follow-up|6
1124873|NCT01601821|3690916|P2|Overall Study|Protocol Violation|2
1124874|NCT01601821|3690917|P1|Overall Study|Protocol Violation|2
1124875|NCT01601821|3690916|P2|Overall Study|Death|5
1124876|NCT01601821|3690917|P1|Overall Study|Death|2
1124877|NCT01601704|3690953|P2|Overall Study|Randomized but not dispensed study med|4
1124878|NCT01601704|3690954|P1|Overall Study|Randomized but not dispensed study med|1
1124879|NCT01601626|3690975|P3|Overall Study|Not Willing to Adhere to Requirements|0
1124880|NCT01601626|3690976|P2|Overall Study|Not Willing to Adhere to Requirements|0
1124881|NCT01601626|3690977|P1|Overall Study|Not Willing to Adhere to Requirements|1
1124882|NCT01601626|3690975|P3|Overall Study|Withdrawal by Subject|1
1124883|NCT01601626|3690976|P2|Overall Study|Withdrawal by Subject|1
1124884|NCT01601626|3690977|P1|Overall Study|Withdrawal by Subject|0
1124885|NCT01601626|3690975|P3|Overall Study|Unable to Get to Clinic|0
1124886|NCT01601626|3690976|P2|Overall Study|Unable to Get to Clinic|1
1124887|NCT01601626|3690977|P1|Overall Study|Unable to Get to Clinic|0
1124888|NCT01601626|3690975|P3|Overall Study|Lost to Follow-up|0
1124889|NCT01601626|3690976|P2|Overall Study|Lost to Follow-up|2
1124890|NCT01601626|3690977|P1|Overall Study|Lost to Follow-up|1
1124891|NCT01601626|3690975|P3|Overall Study|Death|1
1124892|NCT01601626|3690976|P2|Overall Study|Death|1
1124893|NCT01601626|3690977|P1|Overall Study|Death|1
1124894|NCT01601470|3691060|P1|Period 2 - LCZ696|Physician Decision|1
1124895|NCT01601132|3691131|P1|Overall Study|Protocol deviation|1
1124896|NCT01601132|3691131|P1|Overall Study|Patient withdrew consent|1
1124897|NCT01600885|3691165|P2|First Period|moved out of area|0
1124898|NCT01600885|3691166|P1|First Period|moved out of area|1
1124899|NCT01600885|3691165|P2|First Period|Adverse Event|1
1124900|NCT01600885|3691166|P1|First Period|Adverse Event|1
1124901|NCT01600716|3691183|P2|Overall Study|Adverse Event|1
1124902|NCT01600716|3691184|P1|Overall Study|Adverse Event|1
1124903|NCT01600716|3691183|P2|Overall Study|Lack of Efficacy|1
1124904|NCT01600716|3691184|P1|Overall Study|Lack of Efficacy|2
1124905|NCT01600716|3691183|P2|Overall Study|Pregnancy|0
1124906|NCT01600716|3691184|P1|Overall Study|Pregnancy|1
1124907|NCT01600716|3691183|P2|Overall Study|Lost to Follow-up|2
1124908|NCT01600716|3691184|P1|Overall Study|Lost to Follow-up|0
1124909|NCT01600716|3691183|P2|Overall Study|Personal Reasons|2
1124910|NCT01600716|3691184|P1|Overall Study|Personal Reasons|0
1124911|NCT01600716|3691183|P2|Overall Study|Other Reasons|1
1124912|NCT01600716|3691184|P1|Overall Study|Other Reasons|3
1124913|NCT01600586|3691224|P2|Overall Study|Physician Decision|3
1124914|NCT01600586|3691225|P1|Overall Study|Physician Decision|3
1124915|NCT01600326|3691277|P2|Overall Study|Lost to Follow-up|1
1124916|NCT01600326|3691278|P1|Overall Study|Lost to Follow-up|1
1124917|NCT01600092|3691354|P2|Overall Study|Randomized but not vaccinated|3
1124918|NCT01600092|3691355|P1|Overall Study|Randomized but not vaccinated|3
1124919|NCT01600092|3691354|P2|Overall Study|Physician Decision|1
1124920|NCT01600092|3691355|P1|Overall Study|Physician Decision|1
1124921|NCT01600092|3691354|P2|Overall Study|Withdrawal by parent/guardian|6
1124922|NCT01600092|3691355|P1|Overall Study|Withdrawal by parent/guardian|8
1124923|NCT01600092|3691354|P2|Overall Study|Lost to Follow-up|6
1124924|NCT01600092|3691355|P1|Overall Study|Lost to Follow-up|4
1124925|NCT01600092|3691354|P2|Overall Study|Adverse Event|0
1124926|NCT01600092|3691355|P1|Overall Study|Adverse Event|2
1124927|NCT01600053|3691369|P1|Overall Study|trial will not meet the interim endpoint|9
1124928|NCT01600053|3691369|P1|Overall Study|Adverse Event|2
1124929|NCT01600014|3691374|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0
1124930|NCT01600014|3691375|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1
1124931|NCT01600014|3691374|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0
1124932|NCT01600014|3691375|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1
1124933|NCT01600014|3691374|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0
1124934|NCT01600014|3691375|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1
1124935|NCT01600014|3691374|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3
1124936|NCT01600014|3691375|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1
1124937|NCT01600014|3691374|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
1124938|NCT01600014|3691375|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
1124939|NCT01600014|3691374|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0
1124940|NCT01600014|3691375|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5
1124941|NCT01600014|3691374|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0
1124942|NCT01600014|3691375|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1
1124943|NCT01600014|3691374|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1
1124944|NCT01600014|3691375|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2
1124945|NCT01600014|3691374|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3
1124946|NCT01600014|3691375|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1
1124947|NCT01600014|3691374|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2
1124948|NCT01600014|3691375|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1
1124949|NCT01600014|3691374|P2|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0
1124950|NCT01600014|3691375|P1|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8
1124951|NCT01600014|3691374|P2|1. Cycle & Observation Period D1 to W52|Protocol Violation|0
1124952|NCT01600014|3691375|P1|1. Cycle & Observation Period D1 to W52|Protocol Violation|6
1124953|NCT01600014|3691374|P2|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0
1124954|NCT01600014|3691375|P1|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14
1124955|NCT01600014|3691374|P2|1. Cycle & Observation Period D1 to W52|Other|0
1124956|NCT01600014|3691375|P1|1. Cycle & Observation Period D1 to W52|Other|27
1124957|NCT01600014|3691374|P2|1. Cycle & Observation Period D1 to W52|Adverse Event|0
1124958|NCT01600014|3691375|P1|1. Cycle & Observation Period D1 to W52|Adverse Event|6
1124959|NCT01600014|3691374|P2|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0
1124960|NCT01600014|3691375|P1|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203
1124961|NCT01600014|3691374|P2|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0
1124962|NCT01600014|3691375|P1|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24
1124963|NCT01599806|3691403|P2|Overall Study|Other Eligibility criteria|9
1124964|NCT01599806|3691404|P1|Overall Study|Other Eligibility criteria|11
1124965|NCT01599806|3691403|P2|Overall Study|Withdrawal by Subject|12
1124966|NCT01599806|3691404|P1|Overall Study|Withdrawal by Subject|12
1124967|NCT01599806|3691403|P2|Overall Study|Lost to Follow-up|20
1124968|NCT01599806|3691404|P1|Overall Study|Lost to Follow-up|20
1124969|NCT01599650|3691537|P3|Overall Study|Adverse Event|4
1124970|NCT01599650|3691538|P2|Overall Study|Adverse Event|8
1124971|NCT01599650|3691539|P1|Overall Study|Adverse Event|3
1124972|NCT01599650|3691537|P3|Overall Study|Withdrawal by Subject|10
1124973|NCT01599650|3691538|P2|Overall Study|Withdrawal by Subject|11
1124974|NCT01599650|3691539|P1|Overall Study|Withdrawal by Subject|11
1124975|NCT01599650|3691537|P3|Overall Study|Lost to Follow-up|3
1124976|NCT01599650|3691538|P2|Overall Study|Lost to Follow-up|3
1124977|NCT01599650|3691539|P1|Overall Study|Lost to Follow-up|3
1124978|NCT01599650|3691537|P3|Overall Study|Death|2
1124979|NCT01599650|3691538|P2|Overall Study|Death|1
1124980|NCT01599650|3691539|P1|Overall Study|Death|2
1124981|NCT01599650|3691537|P3|Overall Study|Protocol Violation|0
1124982|NCT01599650|3691538|P2|Overall Study|Protocol Violation|3
1124983|NCT01599650|3691539|P1|Overall Study|Protocol Violation|0
1124984|NCT01599650|3691537|P3|Overall Study|Physician Decision|7
1124985|NCT01599650|3691538|P2|Overall Study|Physician Decision|0
1124986|NCT01599650|3691539|P1|Overall Study|Physician Decision|2
1124987|NCT01599650|3691537|P3|Overall Study|Administrative issue|1
1124988|NCT01599650|3691538|P2|Overall Study|Administrative issue|0
1124989|NCT01599650|3691539|P1|Overall Study|Administrative issue|1
1124990|NCT01599637|3691578|P3|Overall Study|Adverse Event|0
1124991|NCT01599637|3691579|P2|Overall Study|Adverse Event|0
1124992|NCT01599637|3691580|P1|Overall Study|Adverse Event|1
1124993|NCT01599637|3691578|P3|Overall Study|administrative problems|0
1124994|NCT01599637|3691579|P2|Overall Study|administrative problems|2
1124995|NCT01599637|3691580|P1|Overall Study|administrative problems|0
1124996|NCT01599585|3691627|P2|Overall Study|randomized did not start treatment|3
1124997|NCT01599585|3691628|P1|Overall Study|randomized did not start treatment|3
1124998|NCT01599585|3691627|P2|Overall Study|Lost to Follow-up|5
1124999|NCT01599585|3691628|P1|Overall Study|Lost to Follow-up|3
1125000|NCT01599585|3691627|P2|Overall Study|Withdrawal by Subject|9
1125001|NCT01599585|3691628|P1|Overall Study|Withdrawal by Subject|16
1125002|NCT01599325|3691666|P1|Overall Study|Other|2
1125003|NCT01599325|3691666|P1|Overall Study|Lack of Therapeutic Effect|9
1125004|NCT01599325|3691666|P1|Overall Study|Protocol Violation|1
1125005|NCT01599325|3691666|P1|Overall Study|Death|13
1125006|NCT01599325|3691666|P1|Overall Study|Withdrawal by Subject|20
1125007|NCT01599325|3691666|P1|Overall Study|Disease Progression|7
1125008|NCT01599325|3691666|P1|Overall Study|Adverse Event|5
1125009|NCT01599234|3691688|P2|Overall Study|Pregnancy|1
1125010|NCT01599234|3691689|P1|Overall Study|Pregnancy|0
1125011|NCT01599234|3691688|P2|Overall Study|Contra-indication discovered|1
1125012|NCT01599234|3691689|P1|Overall Study|Contra-indication discovered|0
1125013|NCT01599234|3691688|P2|Overall Study|Patient would not stop driving|0
1125014|NCT01599234|3691689|P1|Overall Study|Patient would not stop driving|1
1125015|NCT01599234|3691688|P2|Overall Study|Death|0
1125016|NCT01599234|3691689|P1|Overall Study|Death|1
1125017|NCT01599234|3691688|P2|Overall Study|Sponsor request as creatinine levels <50|1
1125018|NCT01599234|3691689|P1|Overall Study|Sponsor request as creatinine levels <50|0
1125019|NCT01599234|3691688|P2|Overall Study|Unable to operate spray|0
1125020|NCT01599234|3691689|P1|Overall Study|Unable to operate spray|1
1125021|NCT01599234|3691688|P2|Overall Study|Lack of Efficacy|4
1125022|NCT01599234|3691689|P1|Overall Study|Lack of Efficacy|2
1125023|NCT01599234|3691688|P2|Overall Study|Lost to Follow-up|2
1125024|NCT01599234|3691689|P1|Overall Study|Lost to Follow-up|1
1125025|NCT01599234|3691688|P2|Overall Study|Withdrawal by Subject|1
1125026|NCT01599234|3691689|P1|Overall Study|Withdrawal by Subject|2
1125027|NCT01599234|3691688|P2|Overall Study|Adverse Event|5
1125028|NCT01599234|3691689|P1|Overall Study|Adverse Event|9
1125029|NCT01599104|3691714|P3|Overall Study|Adverse Event|12
1125030|NCT01599104|3691715|P2|Overall Study|Adverse Event|6
1125031|NCT01599104|3691716|P1|Overall Study|Adverse Event|7
1125032|NCT01599104|3691714|P3|Overall Study|Lack of Efficacy|10
1125033|NCT01599104|3691715|P2|Overall Study|Lack of Efficacy|4
1125034|NCT01599104|3691716|P1|Overall Study|Lack of Efficacy|4
1125035|NCT01599104|3691714|P3|Overall Study|Non-compliance with study treatment|0
1125036|NCT01599104|3691715|P2|Overall Study|Non-compliance with study treatment|1
1125037|NCT01599104|3691716|P1|Overall Study|Non-compliance with study treatment|0
1125038|NCT01599104|3691714|P3|Overall Study|Physician Decision|2
1125039|NCT01599104|3691715|P2|Overall Study|Physician Decision|2
1125040|NCT01599104|3691716|P1|Overall Study|Physician Decision|3
1125041|NCT01599104|3691714|P3|Overall Study|Technical Problems|0
1125042|NCT01599104|3691715|P2|Overall Study|Technical Problems|0
1125043|NCT01599104|3691716|P1|Overall Study|Technical Problems|1
1125044|NCT01599104|3691714|P3|Overall Study|Withdrawal by Subject|2
1125045|NCT01599104|3691715|P2|Overall Study|Withdrawal by Subject|1
1125046|NCT01599104|3691716|P1|Overall Study|Withdrawal by Subject|1
1125047|NCT01598987|3691754|P1|Baseline to 24 Month|Lost to Follow-up|1
1125048|NCT01598987|3691754|P1|Baseline to 24 Month|Administrative problems|2
1125049|NCT01598987|3691754|P1|Baseline to 24 Month|Withdrawal by Subject|5
1125050|NCT01598987|3691754|P1|Baseline to Month 12|Withdrawal by Subject|4
1125051|NCT01598987|3691754|P1|Baseline to Month 12|Administrative problems|2
1125052|NCT01598896|3691790|P2|Overall Study|Lack of Efficacy|1
1125053|NCT01598896|3691791|P1|Overall Study|Lack of Efficacy|0
1125054|NCT01598896|3691790|P2|Overall Study|Withdrawal by Subject|1
1125055|NCT01598896|3691791|P1|Overall Study|Withdrawal by Subject|0
1125056|NCT01598662|3691837|P2|Overall Study|IUD expelled before month 6|2
1125057|NCT01598662|3691838|P1|Overall Study|IUD expelled before month 6|0
1125058|NCT01598662|3691837|P2|Overall Study|Physician Decision|2
1125059|NCT01598662|3691838|P1|Overall Study|Physician Decision|1
1125060|NCT01598662|3691837|P2|Overall Study|Lost to Follow-up|17
1125061|NCT01598662|3691838|P1|Overall Study|Lost to Follow-up|10
1125062|NCT01598610|3691844|P1|Overall Study|Adverse Event|1
1125063|NCT01598532|3691861|P1|Overall Study|Did not meet inclusion criteria|8
1125064|NCT01598532|3691861|P1|Overall Study|Lost to Follow-up|3
1125065|NCT01598506|3691870|P1|Overall Study|Withdrawal by Subject|2
1125066|NCT01598311|3691890|P2|Overall Study|Assigned to CB but received vancomycin|0
1125067|NCT01598311|3691891|P1|Overall Study|Assigned to CB but received vancomycin|1
1125068|NCT01598311|3691890|P2|Overall Study|Treated but no confirmed CDAD|8
1125069|NCT01598311|3691891|P1|Overall Study|Treated but no confirmed CDAD|9
1125070|NCT01598311|3691890|P2|Overall Study|Randomized but never treated|5
1125071|NCT01598311|3691891|P1|Overall Study|Randomized but never treated|8
1125072|NCT01598311|3691890|P2|Overall Study|No reason provided.|5
1125073|NCT01598311|3691891|P1|Overall Study|No reason provided.|0
1125074|NCT01598311|3691890|P2|Overall Study|Withdrawal by Subject|13
1125075|NCT01598311|3691891|P1|Overall Study|Withdrawal by Subject|9
1125076|NCT01598311|3691890|P2|Overall Study|Lost to Follow-up|12
1125077|NCT01598311|3691891|P1|Overall Study|Lost to Follow-up|7
1125078|NCT01598311|3691890|P2|Overall Study|Adverse Event|13
1125079|NCT01598311|3691891|P1|Overall Study|Adverse Event|9
1125080|NCT01598311|3691890|P2|Overall Study|Physician Decision|5
1125081|NCT01598311|3691891|P1|Overall Study|Physician Decision|4
1125082|NCT01598298|3691907|P2|Overall Study|Other reason (not protocol specified)|0
1125083|NCT01598298|3691908|P1|Overall Study|Other reason (not protocol specified)|4
1125084|NCT01598298|3691907|P2|Overall Study|Withdrawal by Subject|15
1125085|NCT01598298|3691908|P1|Overall Study|Withdrawal by Subject|10
1125086|NCT01598298|3691907|P2|Overall Study|Progression/relapse|2
1125087|NCT01598298|3691908|P1|Overall Study|Progression/relapse|0
1125088|NCT01598298|3691907|P2|Overall Study|Adverse Event|19
1125089|NCT01598298|3691908|P1|Overall Study|Adverse Event|21
1125090|NCT01598298|3691907|P2|Overall Study|Not eligible|5
1125091|NCT01598298|3691908|P1|Overall Study|Not eligible|5
1125092|NCT01598129|3691952|P1|Overall Study|Withdrawal by Subject|1
1125093|NCT01598129|3691952|P1|Overall Study|Deterioration of WHO status to WHO 4|2
1125094|NCT01598129|3691952|P1|Overall Study|Disease progression|6
1125095|NCT01597908|3691984|P2|Overall Study|Ongoing|202
1125096|NCT01597908|3691985|P1|Overall Study|Ongoing|236
1125097|NCT01597908|3691984|P2|Overall Study|Withdrawal by Subject|18
1125098|NCT01597908|3691985|P1|Overall Study|Withdrawal by Subject|10
1125099|NCT01597908|3691984|P2|Overall Study|Physician Decision|1
1125100|NCT01597908|3691985|P1|Overall Study|Physician Decision|2
1125101|NCT01597908|3691984|P2|Overall Study|Lost to Follow-up|9
1125102|NCT01597908|3691985|P1|Overall Study|Lost to Follow-up|4
1125103|NCT01597908|3691984|P2|Overall Study|Death|122
1125104|NCT01597908|3691985|P1|Overall Study|Death|100
1125105|NCT01597791|3692012|P2|Overall Study|Protocol Violation|1
1125106|NCT01597791|3692013|P1|Overall Study|Protocol Violation|0
1125107|NCT01597791|3692012|P2|Overall Study|Subject withdrawal|1
1125108|NCT01597791|3692013|P1|Overall Study|Subject withdrawal|0
1125109|NCT01597791|3692012|P2|Overall Study|Cesarean Section|7
1125110|NCT01597791|3692013|P1|Overall Study|Cesarean Section|6
1125111|NCT01597791|3692012|P2|Overall Study|Physician Decision|1
1125112|NCT01597791|3692013|P1|Overall Study|Physician Decision|2
1125113|NCT01597635|3692022|P3|Part B|Withdrawal by Subject|0
1125114|NCT01597635|3692023|P2|Part B|Withdrawal by Subject|1
1125115|NCT01597635|3692024|P1|Part B|Withdrawal by Subject|0
1125116|NCT01597635|3692022|P3|Part B|Protocol-defined stopping criteria|3
1125117|NCT01597635|3692023|P2|Part B|Protocol-defined stopping criteria|4
1125118|NCT01597635|3692024|P1|Part B|Protocol-defined stopping criteria|0
1125119|NCT01597635|3692022|P3|Part B|Protocol Violation|0
1125120|NCT01597635|3692023|P2|Part B|Protocol Violation|1
1125121|NCT01597635|3692024|P1|Part B|Protocol Violation|0
1125122|NCT01597635|3692022|P3|Part B|Adverse Event|1
1125123|NCT01597635|3692023|P2|Part B|Adverse Event|0
1125124|NCT01597635|3692024|P1|Part B|Adverse Event|0
1125125|NCT01597635|3692022|P3|Part A|Adverse Event|0
1125126|NCT01597635|3692023|P2|Part A|Adverse Event|0
1125127|NCT01597635|3692024|P1|Part A|Adverse Event|3
1125128|NCT01597596|3692089|P2|Overall Study|Physician Decision|1
1125129|NCT01597596|3692090|P1|Overall Study|Physician Decision|0
1125130|NCT01597596|3692089|P2|Overall Study|Study terminated by sponsor|0
1125131|NCT01597596|3692090|P1|Overall Study|Study terminated by sponsor|1
1125132|NCT01597505|3692104|P2|Overall Study|Missing|0
1125133|NCT01597505|3692105|P1|Overall Study|Missing|1
1125134|NCT01597505|3692104|P2|Overall Study|Other|6
1125135|NCT01597505|3692105|P1|Overall Study|Other|5
1125136|NCT01597505|3692104|P2|Overall Study|Withdrawal by Subject|18
1125137|NCT01597505|3692105|P1|Overall Study|Withdrawal by Subject|10
1125138|NCT01597505|3692104|P2|Overall Study|Lost to Follow-up|2
1125139|NCT01597505|3692105|P1|Overall Study|Lost to Follow-up|4
1125140|NCT01597505|3692104|P2|Overall Study|Adverse Event|7
1125141|NCT01597505|3692105|P1|Overall Study|Adverse Event|19
1125142|NCT01597505|3692104|P2|Overall Study|Physician Decision|0
1125143|NCT01597505|3692105|P1|Overall Study|Physician Decision|5
1125144|NCT01597492|3692139|P2|Overall Study|Other Reason|0
1125145|NCT01597492|3692140|P1|Overall Study|Other Reason|2
1125146|NCT01597492|3692139|P2|Overall Study|Lost to Follow-up|2
1125147|NCT01597492|3692140|P1|Overall Study|Lost to Follow-up|0
1125148|NCT01597492|3692139|P2|Overall Study|Adverse Event|0
1125149|NCT01597492|3692140|P1|Overall Study|Adverse Event|3
1125150|NCT01597492|3692139|P2|Overall Study|Withdrawal by Subject|2
1125151|NCT01597492|3692140|P1|Overall Study|Withdrawal by Subject|1
1125152|NCT01597479|3692148|P2|Overall Study|Lost to Follow-up|0
1125153|NCT01597479|3692149|P1|Overall Study|Lost to Follow-up|1
1125154|NCT01597479|3692148|P2|Overall Study|Protocol Violation|0
1125155|NCT01597479|3692149|P1|Overall Study|Protocol Violation|1
1125156|NCT01597375|3692435|P2|Second Intervention|Failed to react at both Aspirin|1
1125157|NCT01597375|3692436|P1|Second Intervention|Failed to react at both Aspirin|1
1125158|NCT01597375|3692435|P2|Washout (2 Weeks)|Adverse Event|0
1125159|NCT01597375|3692436|P1|Washout (2 Weeks)|Adverse Event|1
1125160|NCT01597375|3692435|P2|First Intervention (4 Weeks)|Lost to Follow-up|1
1125161|NCT01597375|3692436|P1|First Intervention (4 Weeks)|Lost to Follow-up|0
1125162|NCT01597375|3692435|P2|First Intervention (4 Weeks)|Needed surgery|0
1125163|NCT01597375|3692436|P1|First Intervention (4 Weeks)|Needed surgery|1
1125164|NCT01597375|3692435|P2|First Intervention (4 Weeks)|Uncontrolled Asthma|0
1125165|NCT01597375|3692436|P1|First Intervention (4 Weeks)|Uncontrolled Asthma|1
1125166|NCT01597245|3692457|P13|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1125167|NCT01597245|3692458|P12|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1125168|NCT01597245|3692459|P11|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1
1125169|NCT01597245|3692460|P10|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1125170|NCT01597245|3692461|P9|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1125171|NCT01597245|3692462|P8|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1125172|NCT01597245|3692463|P7|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1125173|NCT01597245|3692464|P6|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1125174|NCT01597245|3692465|P5|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1125175|NCT01597245|3692466|P4|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1125176|NCT01597245|3692467|P3|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1125177|NCT01597245|3692468|P2|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1125178|NCT01597245|3692469|P1|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1125179|NCT01597245|3692457|P13|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1125180|NCT01597245|3692458|P12|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
1125181|NCT01597245|3692459|P11|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
1125182|NCT01597245|3692460|P10|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
1125183|NCT01597245|3692461|P9|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
1125184|NCT01597245|3692462|P8|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1125185|NCT01597245|3692463|P7|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
1125186|NCT01597245|3692464|P6|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1125187|NCT01597245|3692465|P5|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1125188|NCT01597245|3692466|P4|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1125189|NCT01597245|3692467|P3|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1125190|NCT01597245|3692468|P2|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1125191|NCT01597245|3692469|P1|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1125192|NCT01597245|3692457|P13|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
1125193|NCT01597245|3692458|P12|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
1125194|NCT01597245|3692459|P11|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
1125195|NCT01597245|3692460|P10|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
1125196|NCT01597245|3692461|P9|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
1125197|NCT01597245|3692462|P8|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
1125198|NCT01597245|3692463|P7|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4
1125199|NCT01597245|3692464|P6|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
1125200|NCT01597245|3692465|P5|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3
1125201|NCT01597245|3692466|P4|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
1125202|NCT01597245|3692467|P3|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
1125203|NCT01597245|3692468|P2|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
1125204|NCT01597245|3692469|P1|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
1125205|NCT01597245|3692457|P13|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
1125206|NCT01597245|3692458|P12|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1125207|NCT01597245|3692459|P11|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2
1125208|NCT01597245|3692460|P10|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
1125209|NCT01597245|3692461|P9|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3
1125210|NCT01597245|3692462|P8|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1125211|NCT01597245|3692463|P7|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1125212|NCT01597245|3692464|P6|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1125213|NCT01597245|3692465|P5|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
1125214|NCT01597245|3692466|P4|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1125215|NCT01597245|3692467|P3|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1125216|NCT01597245|3692468|P2|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1125217|NCT01597245|3692469|P1|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1125218|NCT01597245|3692457|P13|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
1125219|NCT01597245|3692458|P12|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5
1125220|NCT01597245|3692459|P11|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6
1125221|NCT01597245|3692460|P10|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
1125222|NCT01597245|3692461|P9|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
1125223|NCT01597245|3692462|P8|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
1125224|NCT01597245|3692463|P7|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
1125225|NCT01597245|3692464|P6|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
1125226|NCT01597245|3692465|P5|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
1125227|NCT01597245|3692466|P4|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
1125228|NCT01597245|3692467|P3|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
1125229|NCT01597245|3692468|P2|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
1125230|NCT01597245|3692469|P1|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
1125231|NCT01597245|3692457|P13|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
1125232|NCT01597245|3692458|P12|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
1125233|NCT01597245|3692459|P11|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
1125234|NCT01597245|3692460|P10|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
1125235|NCT01597245|3692461|P9|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
1125236|NCT01597245|3692462|P8|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
1125237|NCT01597245|3692463|P7|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
1125238|NCT01597245|3692464|P6|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
1125239|NCT01597245|3692465|P5|Maintenance Period (Week 12 to Week 60)|Adverse Event|4
1125240|NCT01597245|3692466|P4|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
1125241|NCT01597245|3692467|P3|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
1125242|NCT01597245|3692468|P2|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
1125243|NCT01597245|3692469|P1|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
1125244|NCT01597245|3692457|P13|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4
1125245|NCT01597245|3692458|P12|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10
1125246|NCT01597245|3692459|P11|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2
1125247|NCT01597245|3692460|P10|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1125248|NCT01597245|3692461|P9|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3
1125249|NCT01597245|3692462|P8|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1125250|NCT01597245|3692463|P7|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1
1125251|NCT01597245|3692464|P6|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1125252|NCT01597245|3692465|P5|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1125253|NCT01597245|3692466|P4|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1125254|NCT01597245|3692467|P3|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1125255|NCT01597245|3692468|P2|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1125256|NCT01597245|3692469|P1|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1125257|NCT01597245|3692457|P13|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1125258|NCT01597245|3692458|P12|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1125259|NCT01597245|3692459|P11|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1125260|NCT01597245|3692460|P10|Maintenance Period (Week 12 to Week 60)|Relapsed|111
1125261|NCT01597245|3692461|P9|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1125262|NCT01597245|3692462|P8|Maintenance Period (Week 12 to Week 60)|Relapsed|2
1125263|NCT01597245|3692463|P7|Maintenance Period (Week 12 to Week 60)|Relapsed|21
1125264|NCT01597245|3692464|P6|Maintenance Period (Week 12 to Week 60)|Relapsed|80
1125265|NCT01597245|3692465|P5|Maintenance Period (Week 12 to Week 60)|Relapsed|148
1125266|NCT01597245|3692466|P4|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1125267|NCT01597245|3692467|P3|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1125268|NCT01597245|3692468|P2|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1125269|NCT01597245|3692469|P1|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1125270|NCT01597245|3692457|P13|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1125271|NCT01597245|3692458|P12|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1125272|NCT01597245|3692459|P11|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1125273|NCT01597245|3692460|P10|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1125274|NCT01597245|3692461|P9|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1125275|NCT01597245|3692462|P8|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1125276|NCT01597245|3692463|P7|Maintenance Period (Week 12 to Week 60)|On study treatment|1
1125277|NCT01597245|3692464|P6|Maintenance Period (Week 12 to Week 60)|On study treatment|1
1125278|NCT01597245|3692465|P5|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1125279|NCT01597245|3692466|P4|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1125280|NCT01597245|3692467|P3|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1125281|NCT01597245|3692468|P2|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1125282|NCT01597245|3692469|P1|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1125283|NCT01597245|3692457|P13|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1125284|NCT01597245|3692458|P12|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1125285|NCT01597245|3692459|P11|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1125286|NCT01597245|3692460|P10|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1125287|NCT01597245|3692461|P9|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1125288|NCT01597245|3692462|P8|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1125289|NCT01597245|3692463|P7|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1125290|NCT01597245|3692464|P6|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1125291|NCT01597245|3692465|P5|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1125292|NCT01597245|3692466|P4|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1125293|NCT01597245|3692467|P3|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1
1125294|NCT01597245|3692468|P2|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
1125295|NCT01597245|3692469|P1|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
1125296|NCT01597245|3692457|P13|Induction Period (Week 0 - Week 12)|Physician Decision|0
1125297|NCT01597245|3692458|P12|Induction Period (Week 0 - Week 12)|Physician Decision|0
1125298|NCT01597245|3692459|P11|Induction Period (Week 0 - Week 12)|Physician Decision|0
1125299|NCT01597245|3692460|P10|Induction Period (Week 0 - Week 12)|Physician Decision|0
1125300|NCT01597245|3692461|P9|Induction Period (Week 0 - Week 12)|Physician Decision|0
1125301|NCT01597245|3692462|P8|Induction Period (Week 0 - Week 12)|Physician Decision|0
1125302|NCT01597245|3692463|P7|Induction Period (Week 0 - Week 12)|Physician Decision|0
1125303|NCT01597245|3692464|P6|Induction Period (Week 0 - Week 12)|Physician Decision|0
1125304|NCT01597245|3692465|P5|Induction Period (Week 0 - Week 12)|Physician Decision|0
1125305|NCT01597245|3692466|P4|Induction Period (Week 0 - Week 12)|Physician Decision|1
1125306|NCT01597245|3692467|P3|Induction Period (Week 0 - Week 12)|Physician Decision|0
1125307|NCT01597245|3692468|P2|Induction Period (Week 0 - Week 12)|Physician Decision|0
1125308|NCT01597245|3692469|P1|Induction Period (Week 0 - Week 12)|Physician Decision|1
1125309|NCT01597245|3692457|P13|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1125385|NCT01596062|3692762|P3|Overall Study|Lack of Efficacy|1
1125310|NCT01597245|3692458|P12|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1125311|NCT01597245|3692459|P11|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1125312|NCT01597245|3692460|P10|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1125313|NCT01597245|3692461|P9|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1125314|NCT01597245|3692462|P8|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1125315|NCT01597245|3692463|P7|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1125316|NCT01597245|3692464|P6|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1125317|NCT01597245|3692465|P5|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1125318|NCT01597245|3692466|P4|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1125319|NCT01597245|3692467|P3|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2
1125320|NCT01597245|3692468|P2|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5
1125321|NCT01597245|3692469|P1|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1
1125322|NCT01597245|3692457|P13|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1125323|NCT01597245|3692458|P12|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1125324|NCT01597245|3692459|P11|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1125325|NCT01597245|3692460|P10|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1125326|NCT01597245|3692461|P9|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1125327|NCT01597245|3692462|P8|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1125328|NCT01597245|3692463|P7|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1125329|NCT01597245|3692464|P6|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1125330|NCT01597245|3692465|P5|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1125331|NCT01597245|3692466|P4|Induction Period (Week 0 - Week 12)|Protocol Violation|2
1125332|NCT01597245|3692467|P3|Induction Period (Week 0 - Week 12)|Protocol Violation|5
1125333|NCT01597245|3692468|P2|Induction Period (Week 0 - Week 12)|Protocol Violation|4
1125334|NCT01597245|3692469|P1|Induction Period (Week 0 - Week 12)|Protocol Violation|2
1125335|NCT01597245|3692457|P13|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1125336|NCT01597245|3692458|P12|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1125337|NCT01597245|3692459|P11|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1125338|NCT01597245|3692460|P10|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1125339|NCT01597245|3692461|P9|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1125340|NCT01597245|3692462|P8|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1125341|NCT01597245|3692463|P7|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1125342|NCT01597245|3692464|P6|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1125343|NCT01597245|3692465|P5|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1125344|NCT01597245|3692466|P4|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
1125345|NCT01597245|3692467|P3|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6
1125346|NCT01597245|3692468|P2|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8
1125347|NCT01597245|3692469|P1|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
1125348|NCT01597245|3692457|P13|Induction Period (Week 0 - Week 12)|Adverse Event|0
1125349|NCT01597245|3692458|P12|Induction Period (Week 0 - Week 12)|Adverse Event|0
1125350|NCT01597245|3692459|P11|Induction Period (Week 0 - Week 12)|Adverse Event|0
1125351|NCT01597245|3692460|P10|Induction Period (Week 0 - Week 12)|Adverse Event|0
1125352|NCT01597245|3692461|P9|Induction Period (Week 0 - Week 12)|Adverse Event|0
1125353|NCT01597245|3692462|P8|Induction Period (Week 0 - Week 12)|Adverse Event|0
1125354|NCT01597245|3692463|P7|Induction Period (Week 0 - Week 12)|Adverse Event|0
1125355|NCT01597245|3692464|P6|Induction Period (Week 0 - Week 12)|Adverse Event|0
1125356|NCT01597245|3692465|P5|Induction Period (Week 0 - Week 12)|Adverse Event|0
1125357|NCT01597245|3692466|P4|Induction Period (Week 0 - Week 12)|Adverse Event|4
1125358|NCT01597245|3692467|P3|Induction Period (Week 0 - Week 12)|Adverse Event|5
1125359|NCT01597245|3692468|P2|Induction Period (Week 0 - Week 12)|Adverse Event|5
1125360|NCT01597245|3692469|P1|Induction Period (Week 0 - Week 12)|Adverse Event|1
1125361|NCT01597050|3692592|P2|Overall Study|Withdrawal by Subject|0
1125362|NCT01597050|3692593|P1|Overall Study|Withdrawal by Subject|1
1125363|NCT01596972|3692601|P2|Overall Study|Withdrawal by Subject|1
1125364|NCT01596972|3692602|P1|Overall Study|Withdrawal by Subject|0
1125365|NCT01596972|3692601|P2|Overall Study|Lost to Follow-up|4
1125366|NCT01596972|3692602|P1|Overall Study|Lost to Follow-up|0
1125367|NCT01596972|3692601|P2|Overall Study|Physician Decision|9
1125368|NCT01596972|3692602|P1|Overall Study|Physician Decision|1
1125369|NCT01596582|3692625|P2|Overall Study|Missing all outcome data|1
1125370|NCT01596582|3692626|P1|Overall Study|Missing all outcome data|1
1125371|NCT01596582|3692625|P2|Overall Study|Deemed ineligible after study visit|6
1125372|NCT01596582|3692626|P1|Overall Study|Deemed ineligible after study visit|3
1125373|NCT01596504|3692653|P3|Overall Study|Withdrawal by Subject|0
1125374|NCT01596504|3692654|P2|Overall Study|Withdrawal by Subject|0
1125375|NCT01596504|3692655|P1|Overall Study|Withdrawal by Subject|1
1125376|NCT01596504|3692653|P3|Overall Study|Adverse Event|1
1125377|NCT01596504|3692654|P2|Overall Study|Adverse Event|2
1125378|NCT01596504|3692655|P1|Overall Study|Adverse Event|1
1125379|NCT01596504|3692653|P3|Overall Study|Participant's Private Reason|0
1125380|NCT01596504|3692654|P2|Overall Study|Participant's Private Reason|1
1125381|NCT01596504|3692655|P1|Overall Study|Participant's Private Reason|0
1125382|NCT01596335|3692713|P2|Overall Study|exacerbation of primary disease|9
1125383|NCT01596335|3692714|P1|Overall Study|exacerbation of primary disease|5
1125384|NCT01596127|3692750|P1|Overall Study|Patient Ineligible|1
1125386|NCT01596062|3692763|P2|Overall Study|Lack of Efficacy|0
1125387|NCT01596062|3692764|P1|Overall Study|Lack of Efficacy|0
1125388|NCT01596062|3692762|P3|Overall Study|Adverse Event|2
1125389|NCT01596062|3692763|P2|Overall Study|Adverse Event|0
1125390|NCT01596062|3692764|P1|Overall Study|Adverse Event|1
1125391|NCT01595646|3692828|P3|Overall Study|Withdrawal by Subject|0
1125392|NCT01595646|3692829|P2|Overall Study|Withdrawal by Subject|0
1125393|NCT01595646|3692830|P1|Overall Study|Withdrawal by Subject|1
1125394|NCT01595438|3692852|P2|Overall Study|Other Eligibility criteria|9
1125395|NCT01595438|3692853|P1|Overall Study|Other Eligibility criteria|11
1125396|NCT01595438|3692852|P2|Overall Study|Withdrawal by Subject|12
1125397|NCT01595438|3692853|P1|Overall Study|Withdrawal by Subject|12
1125398|NCT01595438|3692852|P2|Overall Study|Lost to Follow-up|20
1125399|NCT01595438|3692853|P1|Overall Study|Lost to Follow-up|20
1125400|NCT01595009|3693021|P4|Extension|Adverse Event|1
1125401|NCT01595009|3693022|P3|Extension|Adverse Event|0
1125402|NCT01595009|3693023|P2|Extension|Adverse Event|0
1125403|NCT01595009|3693024|P1|Extension|Adverse Event|0
1125404|NCT01595009|3693021|P4|Extension|Disease progression|7
1125405|NCT01595009|3693022|P3|Extension|Disease progression|4
1125406|NCT01595009|3693023|P2|Extension|Disease progression|0
1125407|NCT01595009|3693024|P1|Extension|Disease progression|0
1125408|NCT01595009|3693021|P4|Extension|Patients completed per protocol|2
1125409|NCT01595009|3693022|P3|Extension|Patients completed per protocol|0
1125410|NCT01595009|3693023|P2|Extension|Patients completed per protocol|0
1125411|NCT01595009|3693024|P1|Extension|Patients completed per protocol|0
1125412|NCT01595009|3693021|P4|Extension|Administrative problems|1
1125413|NCT01595009|3693022|P3|Extension|Administrative problems|0
1125414|NCT01595009|3693023|P2|Extension|Administrative problems|0
1125415|NCT01595009|3693024|P1|Extension|Administrative problems|0
1125416|NCT01595009|3693021|P4|Core|Administrative problems|0
1125417|NCT01595009|3693022|P3|Core|Administrative problems|0
1125418|NCT01595009|3693023|P2|Core|Administrative problems|1
1125419|NCT01595009|3693024|P1|Core|Administrative problems|0
1125420|NCT01595009|3693021|P4|Core|Protocol deviation|0
1125421|NCT01595009|3693022|P3|Core|Protocol deviation|0
1125422|NCT01595009|3693023|P2|Core|Protocol deviation|1
1125423|NCT01595009|3693024|P1|Core|Protocol deviation|0
1125424|NCT01595009|3693021|P4|Core|Lost to Follow-up|0
1125425|NCT01595009|3693022|P3|Core|Lost to Follow-up|0
1125426|NCT01595009|3693023|P2|Core|Lost to Follow-up|2
1125427|NCT01595009|3693024|P1|Core|Lost to Follow-up|1
1125428|NCT01595009|3693021|P4|Core|Death|0
1125429|NCT01595009|3693022|P3|Core|Death|0
1125430|NCT01595009|3693023|P2|Core|Death|6
1125431|NCT01595009|3693024|P1|Core|Death|3
1125432|NCT01595009|3693021|P4|Core|Withdrawal by Subject|0
1125433|NCT01595009|3693022|P3|Core|Withdrawal by Subject|0
1125434|NCT01595009|3693023|P2|Core|Withdrawal by Subject|17
1125435|NCT01595009|3693024|P1|Core|Withdrawal by Subject|4
1125436|NCT01595009|3693021|P4|Core|Disease progression|0
1125437|NCT01595009|3693022|P3|Core|Disease progression|0
1125438|NCT01595009|3693023|P2|Core|Disease progression|26
1125439|NCT01595009|3693024|P1|Core|Disease progression|14
1125440|NCT01595009|3693021|P4|Core|Adverse Event|0
1125441|NCT01595009|3693022|P3|Core|Adverse Event|0
1125442|NCT01595009|3693023|P2|Core|Adverse Event|23
1125443|NCT01595009|3693024|P1|Core|Adverse Event|19
1125444|NCT01595009|3693021|P4|Core|Patients completed per protocol|0
1125445|NCT01595009|3693022|P3|Core|Patients completed per protocol|0
1125446|NCT01595009|3693023|P2|Core|Patients completed per protocol|44
1125447|NCT01595009|3693024|P1|Core|Patients completed per protocol|85
1125448|NCT01594970|3693059|P3|Overall Study|Lost to Follow-up|37
1125449|NCT01594970|3693060|P2|Overall Study|Lost to Follow-up|54
1125450|NCT01594970|3693061|P1|Overall Study|Lost to Follow-up|54
1125451|NCT01594970|3693059|P3|Overall Study|Adverse Event|23
1125452|NCT01594970|3693060|P2|Overall Study|Adverse Event|23
1125453|NCT01594970|3693061|P1|Overall Study|Adverse Event|17
1125454|NCT01594970|3693059|P3|Overall Study|Non-Adverse Event Related|6
1125455|NCT01594970|3693060|P2|Overall Study|Non-Adverse Event Related|5
1125456|NCT01594970|3693061|P1|Overall Study|Non-Adverse Event Related|4
1125457|NCT01594853|3693080|P2|Overall Study|noncompliance with exercise|1
1125458|NCT01594853|3693081|P1|Overall Study|noncompliance with exercise|0
1125459|NCT01594853|3693080|P2|Overall Study|Lost to Follow-up|1
1125460|NCT01594853|3693081|P1|Overall Study|Lost to Follow-up|1
1125461|NCT01594853|3693080|P2|Overall Study|Withdrawal by Subject|1
1125462|NCT01594853|3693081|P1|Overall Study|Withdrawal by Subject|1
1125463|NCT01594827|3693089|P2|Overall Study|Physician Decision|0
1125464|NCT01594827|3693090|P1|Overall Study|Physician Decision|3
1125465|NCT01594827|3693089|P2|Overall Study|Adverse Event|0
1125466|NCT01594827|3693090|P1|Overall Study|Adverse Event|1
1125467|NCT01594762|3693102|P2|Overall Study|Lost to Follow-up|10
1125468|NCT01594762|3693103|P1|Overall Study|Lost to Follow-up|10
1125469|NCT01594762|3693102|P2|Overall Study|Withdrawal by Subject|0
1125470|NCT01594762|3693103|P1|Overall Study|Withdrawal by Subject|1
1125471|NCT01594749|3693115|P2|Overall Study|Lost Source Documentation|0
1125472|NCT01594749|3693116|P1|Overall Study|Lost Source Documentation|1
1125473|NCT01594749|3693115|P2|Overall Study|Not Treated|10
1125474|NCT01594749|3693116|P1|Overall Study|Not Treated|4
1125475|NCT01594749|3693115|P2|Overall Study|Death|3
1125476|NCT01594749|3693116|P1|Overall Study|Death|9
1125477|NCT01594749|3693115|P2|Overall Study|Lost to Follow-up|0
1125478|NCT01594749|3693116|P1|Overall Study|Lost to Follow-up|1
1125479|NCT01594749|3693115|P2|Overall Study|Non-compliance with Protocol|1
1125480|NCT01594749|3693116|P1|Overall Study|Non-compliance with Protocol|0
1125481|NCT01594749|3693115|P2|Overall Study|Physician Decision|1
1125482|NCT01594749|3693116|P1|Overall Study|Physician Decision|1
1125483|NCT01594749|3693115|P2|Overall Study|Protocol Violation|0
1125484|NCT01594749|3693116|P1|Overall Study|Protocol Violation|2
1125485|NCT01594749|3693115|P2|Overall Study|Withdrawal by Subject|2
1125486|NCT01594749|3693116|P1|Overall Study|Withdrawal by Subject|2
1125487|NCT01594749|3693115|P2|Overall Study|Adverse Event|1
1125488|NCT01594749|3693116|P1|Overall Study|Adverse Event|2
1125489|NCT01594411|3693245|P1|Overall Study|Lost to Follow-up|2
1125490|NCT01594125|3693299|P5|Overall Study|Progressive Disease|7
1125491|NCT01594125|3693300|P4|Overall Study|Progressive Disease|3
1125492|NCT01594125|3693301|P3|Overall Study|Progressive Disease|3
1125493|NCT01594125|3693302|P2|Overall Study|Progressive Disease|12
1125494|NCT01594125|3693303|P1|Overall Study|Progressive Disease|3
1125495|NCT01594125|3693299|P5|Overall Study|Withdrawal by Subject|0
1125496|NCT01594125|3693300|P4|Overall Study|Withdrawal by Subject|1
1125497|NCT01594125|3693301|P3|Overall Study|Withdrawal by Subject|0
1125498|NCT01594125|3693302|P2|Overall Study|Withdrawal by Subject|0
1125499|NCT01594125|3693303|P1|Overall Study|Withdrawal by Subject|1
1125500|NCT01593787|3693363|P3|Overall Study|Adverse Event|0
1125501|NCT01593787|3693364|P2|Overall Study|Adverse Event|0
1125502|NCT01593787|3693365|P1|Overall Study|Adverse Event|1
1125503|NCT01592864|3693452|P2|Overall Study|Withdrawal by Subject|1
1125504|NCT01592864|3693453|P1|Overall Study|Withdrawal by Subject|0
1125505|NCT01592786|3693514|P1|Overall Study|Other|3
1125506|NCT01592786|3693514|P1|Overall Study|Lost to Follow-up|19
1125507|NCT01592786|3693514|P1|Overall Study|Withdrawal by Subject|23
1125508|NCT01592786|3693514|P1|Overall Study|Protocol Violation|14
1125509|NCT01592786|3693514|P1|Overall Study|Lack of Efficacy|19
1125510|NCT01592786|3693514|P1|Overall Study|Adverse Event|60
1125511|NCT01592773|3693518|P1|Overall Study|Other Reason|1
1125512|NCT01592773|3693518|P1|Overall Study|Inclusion/exclusion not meet|1
1125513|NCT01592773|3693518|P1|Overall Study|Protocol Violation|2
1125514|NCT01592773|3693518|P1|Overall Study|Lack of Efficacy|9
1125515|NCT01592773|3693518|P1|Overall Study|Adverse Event|17
1125516|NCT01592773|3693518|P1|Overall Study|Lost to Follow-up|19
1125517|NCT01592773|3693518|P1|Overall Study|Withdrawal by Subject|35
1125518|NCT01592773|3693518|P1|Overall Study|Study Terminated by Sponsor|582
1125519|NCT01592760|3693525|P3|24-hour Follow-Up|Lost to Follow-up|2
1125520|NCT01592760|3693526|P2|24-hour Follow-Up|Lost to Follow-up|3
1125521|NCT01592760|3693527|P1|24-hour Follow-Up|Lost to Follow-up|4
1125522|NCT01592708|3693570|P2|Overall Study|Protocol Violation|0
1125523|NCT01592708|3693571|P1|Overall Study|Protocol Violation|3
1125524|NCT01592695|3693587|P2|Overall Study|Lost to Follow-up|4
1125525|NCT01592695|3693588|P1|Overall Study|Lost to Follow-up|8
1125526|NCT01592383|3693630|P1|Overall Study|Adverse Event|1
1125527|NCT01592344|3693641|P2|Overall Study|not available at primary outcome visit|4
1125528|NCT01592344|3693642|P1|Overall Study|not available at primary outcome visit|2
1125529|NCT01592344|3693641|P2|Overall Study|Lack of Efficacy|0
1125530|NCT01592344|3693642|P1|Overall Study|Lack of Efficacy|1
1125531|NCT01592344|3693641|P2|Overall Study|Adverse Event|1
1125532|NCT01592344|3693642|P1|Overall Study|Adverse Event|1
1125533|NCT01592292|3693656|P4|Overall Study|Not specified|1
1125534|NCT01592292|3693657|P3|Overall Study|Not specified|2
1125535|NCT01592292|3693658|P2|Overall Study|Not specified|1
1125536|NCT01592292|3693659|P1|Overall Study|Not specified|1
1125537|NCT01592292|3693656|P4|Overall Study|Withdrew consent|0
1125538|NCT01592292|3693657|P3|Overall Study|Withdrew consent|0
1125539|NCT01592292|3693658|P2|Overall Study|Withdrew consent|1
1125540|NCT01592292|3693659|P1|Overall Study|Withdrew consent|2
1125541|NCT01592292|3693656|P4|Overall Study|Follow-up loss|0
1125542|NCT01592292|3693657|P3|Overall Study|Follow-up loss|1
1125543|NCT01592292|3693658|P2|Overall Study|Follow-up loss|3
1125544|NCT01592292|3693659|P1|Overall Study|Follow-up loss|3
1125545|NCT01592240|3693698|P7|Overall Study|Did Not Meet Entrance Criteria|0
1125546|NCT01592240|3693699|P6|Overall Study|Did Not Meet Entrance Criteria|0
1125547|NCT01592240|3693700|P5|Overall Study|Did Not Meet Entrance Criteria|0
1125548|NCT01592240|3693701|P4|Overall Study|Did Not Meet Entrance Criteria|0
1125549|NCT01592240|3693702|P3|Overall Study|Did Not Meet Entrance Criteria|1
1125550|NCT01592240|3693703|P2|Overall Study|Did Not Meet Entrance Criteria|0
1125551|NCT01592240|3693704|P1|Overall Study|Did Not Meet Entrance Criteria|1
1125552|NCT01592240|3693698|P7|Overall Study|Other|1
1125553|NCT01592240|3693699|P6|Overall Study|Other|0
1125554|NCT01592240|3693700|P5|Overall Study|Other|0
1125555|NCT01592240|3693701|P4|Overall Study|Other|1
1125556|NCT01592240|3693702|P3|Overall Study|Other|1
1125557|NCT01592240|3693703|P2|Overall Study|Other|3
1125558|NCT01592240|3693704|P1|Overall Study|Other|0
1125559|NCT01592240|3693698|P7|Overall Study|Withdrawal by Subject|2
1125560|NCT01592240|3693699|P6|Overall Study|Withdrawal by Subject|0
1125561|NCT01592240|3693700|P5|Overall Study|Withdrawal by Subject|3
1125562|NCT01592240|3693701|P4|Overall Study|Withdrawal by Subject|1
1125563|NCT01592240|3693702|P3|Overall Study|Withdrawal by Subject|4
1125564|NCT01592240|3693703|P2|Overall Study|Withdrawal by Subject|4
1125565|NCT01592240|3693704|P1|Overall Study|Withdrawal by Subject|0
1125566|NCT01592240|3693698|P7|Overall Study|Protocol Violation|0
1125567|NCT01592240|3693699|P6|Overall Study|Protocol Violation|1
1125568|NCT01592240|3693700|P5|Overall Study|Protocol Violation|0
1125569|NCT01592240|3693701|P4|Overall Study|Protocol Violation|0
1125570|NCT01592240|3693702|P3|Overall Study|Protocol Violation|0
1125571|NCT01592240|3693703|P2|Overall Study|Protocol Violation|0
1125572|NCT01592240|3693704|P1|Overall Study|Protocol Violation|0
1125573|NCT01592240|3693698|P7|Overall Study|Lost to Follow-up|0
1125574|NCT01592240|3693699|P6|Overall Study|Lost to Follow-up|2
1125575|NCT01592240|3693700|P5|Overall Study|Lost to Follow-up|3
1125576|NCT01592240|3693701|P4|Overall Study|Lost to Follow-up|0
1125577|NCT01592240|3693702|P3|Overall Study|Lost to Follow-up|1
1125578|NCT01592240|3693703|P2|Overall Study|Lost to Follow-up|3
1125579|NCT01592240|3693704|P1|Overall Study|Lost to Follow-up|1
1125580|NCT01592240|3693698|P7|Overall Study|Death|0
1125581|NCT01592240|3693699|P6|Overall Study|Death|0
1125582|NCT01592240|3693700|P5|Overall Study|Death|0
1125583|NCT01592240|3693701|P4|Overall Study|Death|0
1125584|NCT01592240|3693702|P3|Overall Study|Death|0
1125585|NCT01592240|3693703|P2|Overall Study|Death|1
1125586|NCT01592240|3693704|P1|Overall Study|Death|0
1125587|NCT01592240|3693698|P7|Overall Study|Adverse Event|0
1125588|NCT01592240|3693699|P6|Overall Study|Adverse Event|0
1125589|NCT01592240|3693700|P5|Overall Study|Adverse Event|1
1125590|NCT01592240|3693701|P4|Overall Study|Adverse Event|1
1125591|NCT01592240|3693702|P3|Overall Study|Adverse Event|0
1125592|NCT01592240|3693703|P2|Overall Study|Adverse Event|0
1125593|NCT01592240|3693704|P1|Overall Study|Adverse Event|1
1125594|NCT01592045|3693897|P2|Overall Study|Moved out of country|0
1125595|NCT01592045|3693898|P1|Overall Study|Moved out of country|2
1125596|NCT01592045|3693897|P2|Overall Study|Withdrawal by Subject|0
1125597|NCT01592045|3693898|P1|Overall Study|Withdrawal by Subject|1
1125598|NCT01592045|3693897|P2|Overall Study|Adverse Event|1
1125599|NCT01592045|3693898|P1|Overall Study|Adverse Event|1
1125600|NCT01592045|3693897|P2|Overall Study|Disease Progression|1
1125601|NCT01592045|3693898|P1|Overall Study|Disease Progression|1
1125602|NCT01591863|3693916|P1|Overall Study|Lack of Efficacy|1
1125603|NCT01591863|3693916|P1|Overall Study|recurrence|9
1125604|NCT01591863|3693916|P1|Overall Study|Withdrawal by Subject|1
1125605|NCT01591863|3693916|P1|Overall Study|Adverse Event|3
1125606|NCT01591681|3693954|P1|Overall Study|Failed to use system during run-in|1
1125607|NCT01591681|3693954|P1|Overall Study|Didn't meet min hypoglycemia requirement|3
1125608|NCT01591616|3693980|P1|Overall Study|Withdrawal by Subject|1
1125609|NCT01591499|3694121|P4|Second Intervention (up to 24 Days)|Lost to Follow-up|3
1125610|NCT01591499|3694122|P3|Second Intervention (up to 24 Days)|Lost to Follow-up|1
1125611|NCT01591499|3694123|P2|Second Intervention (up to 24 Days)|Lost to Follow-up|3
1125612|NCT01591499|3694124|P1|Second Intervention (up to 24 Days)|Lost to Follow-up|4
1125613|NCT01591499|3694121|P4|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
1125614|NCT01591499|3694122|P3|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
1125615|NCT01591499|3694123|P2|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
1125616|NCT01591499|3694124|P1|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
1125617|NCT01591499|3694121|P4|Baseline Visit|Withdrawal by Subject|2
1125618|NCT01591499|3694122|P3|Baseline Visit|Withdrawal by Subject|0
1125619|NCT01591499|3694123|P2|Baseline Visit|Withdrawal by Subject|2
1125620|NCT01591499|3694124|P1|Baseline Visit|Withdrawal by Subject|0
1125621|NCT01591460|3694190|P1|Overall Study|Protocol Violation|1
1125622|NCT01591460|3694190|P1|Overall Study|Withdrawal by Subject|1
1125623|NCT01591460|3694190|P1|Overall Study|Participant Refusal|3
1125624|NCT01591460|3694190|P1|Overall Study|Noncompliance|1
1125625|NCT01591460|3694190|P1|Overall Study|Lost to Follow-up|1
1125626|NCT01591460|3694190|P1|Overall Study|Treatment Discontinued by Error|1
1125627|NCT01591460|3694190|P1|Overall Study|Rebound or Breakthrough|3
1125628|NCT01591460|3694190|P1|Overall Study|Futility Rule (Week 24)|3
1125629|NCT01591460|3694190|P1|Overall Study|Futility Rule (Week 12)|7
1125630|NCT01591460|3694190|P1|Overall Study|Adverse Event or Intercurrent Illness|5
1125631|NCT01591382|3694281|P2|Overall Study|Participant Opted for Morphine PCA|1
1125632|NCT01591382|3694282|P1|Overall Study|Participant Opted for Morphine PCA|1
1125633|NCT01591382|3694281|P2|Overall Study|Discharged Prior to Study Completion|1
1125634|NCT01591382|3694282|P1|Overall Study|Discharged Prior to Study Completion|2
1125635|NCT01591096|3694327|P1|Overall Study|Adverse Event|1
1125636|NCT01590888|3694412|P3|Overall Study|Lost to Follow-up|0
1125637|NCT01590888|3694413|P2|Overall Study|Lost to Follow-up|0
1125638|NCT01590888|3694414|P1|Overall Study|Lost to Follow-up|1
1125639|NCT01590888|3694412|P3|Overall Study|Adverse Event|1
1125640|NCT01590888|3694413|P2|Overall Study|Adverse Event|0
1125641|NCT01590888|3694414|P1|Overall Study|Adverse Event|3
1125642|NCT01590810|3694474|P5|Overall Study|Physician Decision|0
1125643|NCT01590810|3694475|P4|Overall Study|Physician Decision|0
1125644|NCT01590810|3694476|P3|Overall Study|Physician Decision|1
1125645|NCT01590810|3694477|P2|Overall Study|Physician Decision|1
1125646|NCT01590810|3694478|P1|Overall Study|Physician Decision|0
1125647|NCT01590797|3694623|P2|Overall Study|Other Protocol Specified Criteria|4
1125648|NCT01590797|3694624|P1|Overall Study|Other Protocol Specified Criteria|2
1125649|NCT01590797|3694623|P2|Overall Study|Withdrawal by Subject|5
1125650|NCT01590797|3694624|P1|Overall Study|Withdrawal by Subject|7
1125651|NCT01590797|3694623|P2|Overall Study|Protocol Violation|1
1125652|NCT01590797|3694624|P1|Overall Study|Protocol Violation|4
1125653|NCT01590797|3694623|P2|Overall Study|Lost to Follow-up|1
1125654|NCT01590797|3694624|P1|Overall Study|Lost to Follow-up|0
1125655|NCT01590797|3694623|P2|Overall Study|Lack of Efficacy|2
1125656|NCT01590797|3694624|P1|Overall Study|Lack of Efficacy|0
1125657|NCT01590797|3694623|P2|Overall Study|Adverse Event|3
1125658|NCT01590797|3694624|P1|Overall Study|Adverse Event|4
1125659|NCT01590771|3694640|P2|Overall Study|Adverse Event|7
1125660|NCT01590771|3694641|P1|Overall Study|Adverse Event|3
1125661|NCT01590771|3694640|P2|Overall Study|Lack of Efficacy|0
1125662|NCT01590771|3694641|P1|Overall Study|Lack of Efficacy|1
1125663|NCT01590771|3694640|P2|Overall Study|Lost to Follow-up|1
1125664|NCT01590771|3694641|P1|Overall Study|Lost to Follow-up|1
1125665|NCT01590771|3694640|P2|Overall Study|Protocol Violation|2
1125666|NCT01590771|3694641|P1|Overall Study|Protocol Violation|1
1125667|NCT01590771|3694640|P2|Overall Study|Withdrawal by Subject|15
1125668|NCT01590771|3694641|P1|Overall Study|Withdrawal by Subject|8
1125669|NCT01590771|3694640|P2|Overall Study|Other Protocol Specified Criteria|14
1125670|NCT01590771|3694641|P1|Overall Study|Other Protocol Specified Criteria|5
1125671|NCT01590758|3694669|P2|Overall Study|Lost to Follow-up|2
1125672|NCT01590758|3694670|P1|Overall Study|Lost to Follow-up|4
1125673|NCT01590758|3694669|P2|Overall Study|Physician Decision|2
1125674|NCT01590758|3694670|P1|Overall Study|Physician Decision|1
1125675|NCT01590758|3694669|P2|Overall Study|Withdrawal by Subject|3
1125676|NCT01590758|3694670|P1|Overall Study|Withdrawal by Subject|0
1125677|NCT01590563|3694680|P1|Overall Study|simple uterine hyperplasia - not related|1
1125678|NCT01590212|3694708|P3|Overall Study|Lost to Follow-up|3
1125679|NCT01590212|3694709|P2|Overall Study|Lost to Follow-up|2
1125680|NCT01590212|3694710|P1|Overall Study|Lost to Follow-up|1
1125681|NCT01590212|3694708|P3|Overall Study|Withdrawal by Subject|2
1125682|NCT01590212|3694709|P2|Overall Study|Withdrawal by Subject|2
1125683|NCT01590212|3694710|P1|Overall Study|Withdrawal by Subject|2
1125684|NCT01589822|3694775|P3|Overall Study|Missed 90 day visit|1
1125685|NCT01589822|3694776|P2|Overall Study|Missed 90 day visit|1
1125686|NCT01589822|3694777|P1|Overall Study|Missed 90 day visit|2
1125687|NCT01589822|3694775|P3|Overall Study|Death|0
1125688|NCT01589822|3694776|P2|Overall Study|Death|0
1125689|NCT01589822|3694777|P1|Overall Study|Death|1
1125690|NCT01589822|3694775|P3|Overall Study|Withdrawal by Subject|0
1125691|NCT01589822|3694776|P2|Overall Study|Withdrawal by Subject|2
1125692|NCT01589822|3694777|P1|Overall Study|Withdrawal by Subject|1
1125693|NCT01589653|3694796|P2|Overall Study|Unclassified|3
1125694|NCT01589653|3694797|P1|Overall Study|Unclassified|0
1125695|NCT01589653|3694796|P2|Overall Study|Withdrawal criteria|7
1125696|NCT01589653|3694797|P1|Overall Study|Withdrawal criteria|4
1125697|NCT01589653|3694796|P2|Overall Study|Protocol Violation|1
1125698|NCT01589653|3694797|P1|Overall Study|Protocol Violation|3
1125699|NCT01589497|3694845|P4|Overall Study|Pre-entry overnight sputum< 10ML|0
1125700|NCT01589497|3694846|P3|Overall Study|Pre-entry overnight sputum< 10ML|1
1125701|NCT01589497|3694847|P2|Overall Study|Pre-entry overnight sputum< 10ML|0
1125702|NCT01589497|3694848|P1|Overall Study|Pre-entry overnight sputum< 10ML|0
1125703|NCT01589497|3694845|P4|Overall Study|Death|0
1125704|NCT01589497|3694846|P3|Overall Study|Death|0
1125705|NCT01589497|3694847|P2|Overall Study|Death|0
1125706|NCT01589497|3694848|P1|Overall Study|Death|1
1125707|NCT01589497|3694845|P4|Overall Study|Withdrawal by Subject|1
1125708|NCT01589497|3694846|P3|Overall Study|Withdrawal by Subject|0
1125709|NCT01589497|3694847|P2|Overall Study|Withdrawal by Subject|1
1125710|NCT01589497|3694848|P1|Overall Study|Withdrawal by Subject|0
1125711|NCT01589445|3694954|P1|002 (Metformin)-3 Months|Husbands of female patients refrained|2
1125712|NCT01589445|3694954|P1|002 (Metformin)-3 Months|Adverse Event|2
1125713|NCT01589445|3694954|P1|002 (Metformin)-3 Months|Protocol Violation|2
1125714|NCT01589445|3694954|P1|002 (Metformin)-3 Months|Lost to Follow-up|2
1125715|NCT01589445|3694954|P1|002 (Metformin)-3 Months|Lack of Efficacy|1
1125716|NCT01589445|3694954|P1|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2
1125717|NCT01589445|3694954|P1|001 (Pioglitazone) -3 Months|Lack of Efficacy|1
1125718|NCT01589445|3694954|P1|001 (Pioglitazone) -3 Months|Lost to Follow-up|2
1125719|NCT01589445|3694954|P1|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1
1125720|NCT01589445|3694954|P1|001 (Pioglitazone) -3 Months|Protocol Violation|1
1125721|NCT01589237|3694974|P4|Part B (Planned for 78 Week-terminated)|Physician Decision|1
1125722|NCT01589237|3694975|P3|Part B (Planned for 78 Week-terminated)|Physician Decision|0
1125723|NCT01589237|3694976|P2|Part B (Planned for 78 Week-terminated)|Physician Decision|0
1125724|NCT01589237|3694977|P1|Part B (Planned for 78 Week-terminated)|Physician Decision|0
1125725|NCT01589237|3694974|P4|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3
1125726|NCT01589237|3694975|P3|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4
1125727|NCT01589237|3694976|P2|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
1125728|NCT01589237|3694977|P1|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
1125729|NCT01589237|3694974|P4|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
1125730|NCT01589237|3694975|P3|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
1125731|NCT01589237|3694976|P2|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1
1125732|NCT01589237|3694977|P1|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
1125733|NCT01589237|3694974|P4|Part A (52 Weeks)|Subject/guardian decision|0
1125734|NCT01589237|3694975|P3|Part A (52 Weeks)|Subject/guardian decision|2
1125735|NCT01589237|3694976|P2|Part A (52 Weeks)|Subject/guardian decision|3
1125736|NCT01589237|3694977|P1|Part A (52 Weeks)|Subject/guardian decision|2
1125737|NCT01588951|3695026|P3|Overall Study|Ineligible in retrospect|1
1125738|NCT01588951|3695027|P2|Overall Study|Ineligible in retrospect|0
1125739|NCT01588951|3695028|P1|Overall Study|Ineligible in retrospect|0
1125740|NCT01588548|3695059|P6|Overall Study|Condition Under Investigation Worsened|3
1125741|NCT01588548|3695060|P5|Overall Study|Condition Under Investigation Worsened|3
1125742|NCT01588548|3695061|P4|Overall Study|Condition Under Investigation Worsened|4
1125743|NCT01588548|3695062|P3|Overall Study|Condition Under Investigation Worsened|4
1125744|NCT01588548|3695063|P2|Overall Study|Condition Under Investigation Worsened|6
1125745|NCT01588548|3695064|P1|Overall Study|Condition Under Investigation Worsened|3
1125746|NCT01588548|3695059|P6|Overall Study|Adverse Event|0
1125747|NCT01588548|3695060|P5|Overall Study|Adverse Event|1
1125748|NCT01588548|3695061|P4|Overall Study|Adverse Event|2
1125749|NCT01588548|3695062|P3|Overall Study|Adverse Event|1
1125750|NCT01588548|3695063|P2|Overall Study|Adverse Event|0
1125751|NCT01588548|3695064|P1|Overall Study|Adverse Event|0
1125752|NCT01588548|3695059|P6|Overall Study|Withdrawal by Subject|3
1125753|NCT01588548|3695060|P5|Overall Study|Withdrawal by Subject|2
1125754|NCT01588548|3695061|P4|Overall Study|Withdrawal by Subject|1
1125755|NCT01588548|3695062|P3|Overall Study|Withdrawal by Subject|1
1125756|NCT01588548|3695063|P2|Overall Study|Withdrawal by Subject|1
1125757|NCT01588548|3695064|P1|Overall Study|Withdrawal by Subject|0
1125758|NCT01588496|3695081|P3|Overall Study|Withdrawal by Subject|0
1125759|NCT01588496|3695082|P2|Overall Study|Withdrawal by Subject|1
1125760|NCT01588496|3695083|P1|Overall Study|Withdrawal by Subject|0
1125761|NCT01588405|3695133|P1|Overall Study|Clinical Worsening|1
1125762|NCT01588405|3695133|P1|Overall Study|Adverse Event|1
1125763|NCT01588353|3695160|P3|Step3|Adverse Event|2
1125764|NCT01588353|3695161|P2|Step3|Adverse Event|0
1125765|NCT01588353|3695162|P1|Step3|Adverse Event|0
1125766|NCT01588353|3695160|P3|Step2|Withdrawal by Subject|0
1125767|NCT01588353|3695161|P2|Step2|Withdrawal by Subject|1
1125768|NCT01588353|3695162|P1|Step2|Withdrawal by Subject|0
1125769|NCT01588106|3695205|P2|Overall Study|Withdrawal by Subject|4
1125770|NCT01588106|3695206|P1|Overall Study|Withdrawal by Subject|5
1125771|NCT01587989|3695214|P3|Randomized Study Treatment|Physician Decision|1
1125772|NCT01587989|3695215|P2|Randomized Study Treatment|Physician Decision|0
1125773|NCT01587989|3695216|P1|Randomized Study Treatment|Physician Decision|0
1125774|NCT01587989|3695214|P3|Randomized Study Treatment|Screening failure|0
1125775|NCT01587989|3695215|P2|Randomized Study Treatment|Screening failure|1
1125776|NCT01587989|3695216|P1|Randomized Study Treatment|Screening failure|0
1125777|NCT01587989|3695214|P3|Randomized Study Treatment|Withdrawal by Subject|0
1125778|NCT01587989|3695215|P2|Randomized Study Treatment|Withdrawal by Subject|1
1125779|NCT01587989|3695216|P1|Randomized Study Treatment|Withdrawal by Subject|0
1125780|NCT01587989|3695214|P3|12-Week Open-Label Run-In Period|No EULAR Response|0
1125781|NCT01587989|3695215|P2|12-Week Open-Label Run-In Period|No EULAR Response|0
1125782|NCT01587989|3695216|P1|12-Week Open-Label Run-In Period|No EULAR Response|4
1125783|NCT01587989|3695214|P3|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
1125784|NCT01587989|3695215|P2|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
1125785|NCT01587989|3695216|P1|12-Week Open-Label Run-In Period|Withdrawal by Subject|1
1125786|NCT01587989|3695214|P3|12-Week Open-Label Run-In Period|Physician Decision|0
1125787|NCT01587989|3695215|P2|12-Week Open-Label Run-In Period|Physician Decision|0
1125788|NCT01587989|3695216|P1|12-Week Open-Label Run-In Period|Physician Decision|7
1125789|NCT01587924|3695281|P4|Overall Study|Withdrawal by Subject|0
1125790|NCT01587924|3695282|P3|Overall Study|Withdrawal by Subject|1
1125791|NCT01587924|3695283|P2|Overall Study|Withdrawal by Subject|1
1125792|NCT01587924|3695284|P1|Overall Study|Withdrawal by Subject|0
1125793|NCT01587924|3695281|P4|Overall Study|Met Hemoglobin stopping criteria|0
1125794|NCT01587924|3695282|P3|Overall Study|Met Hemoglobin stopping criteria|1
1125795|NCT01587924|3695283|P2|Overall Study|Met Hemoglobin stopping criteria|0
1125796|NCT01587924|3695284|P1|Overall Study|Met Hemoglobin stopping criteria|2
1125797|NCT01587924|3695281|P4|Overall Study|Protocol Violation|1
1125798|NCT01587924|3695282|P3|Overall Study|Protocol Violation|2
1125799|NCT01587924|3695283|P2|Overall Study|Protocol Violation|1
1125800|NCT01587924|3695284|P1|Overall Study|Protocol Violation|2
1125801|NCT01587924|3695281|P4|Overall Study|Adverse Event|0
1125802|NCT01587924|3695282|P3|Overall Study|Adverse Event|0
1125803|NCT01587924|3695283|P2|Overall Study|Adverse Event|2
1125804|NCT01587924|3695284|P1|Overall Study|Adverse Event|0
1125805|NCT01587898|3695385|P4|Overall Study|Met haemoglobin stopping criteria|0
1125806|NCT01587898|3695386|P3|Overall Study|Met haemoglobin stopping criteria|1
1125807|NCT01587898|3695387|P2|Overall Study|Met haemoglobin stopping criteria|1
1125808|NCT01587898|3695388|P1|Overall Study|Met haemoglobin stopping criteria|1
1125809|NCT01587898|3695385|P4|Overall Study|Withdrawal by Subject|0
1125810|NCT01587898|3695386|P3|Overall Study|Withdrawal by Subject|0
1125811|NCT01587898|3695387|P2|Overall Study|Withdrawal by Subject|1
1125812|NCT01587898|3695388|P1|Overall Study|Withdrawal by Subject|2
1125813|NCT01587898|3695385|P4|Overall Study|Lost to Follow-up|1
1125814|NCT01587898|3695386|P3|Overall Study|Lost to Follow-up|0
1125815|NCT01587898|3695387|P2|Overall Study|Lost to Follow-up|0
1125816|NCT01587898|3695388|P1|Overall Study|Lost to Follow-up|0
1125817|NCT01587898|3695385|P4|Overall Study|Protocol Violation|1
1125818|NCT01587898|3695386|P3|Overall Study|Protocol Violation|1
1125819|NCT01587898|3695387|P2|Overall Study|Protocol Violation|2
1125820|NCT01587898|3695388|P1|Overall Study|Protocol Violation|0
1125821|NCT01587898|3695385|P4|Overall Study|Adverse Event|0
1125822|NCT01587898|3695386|P3|Overall Study|Adverse Event|0
1125823|NCT01587898|3695387|P2|Overall Study|Adverse Event|1
1125824|NCT01587898|3695388|P1|Overall Study|Adverse Event|1
1125825|NCT01587885|3695564|P2|Treatment Period 1|Protocol Violation|2
1125826|NCT01587885|3695565|P1|Treatment Period 1|Protocol Violation|0
1125827|NCT01587885|3695564|P2|Treatment Period 1|Failure to Return|1
1125828|NCT01587885|3695565|P1|Treatment Period 1|Failure to Return|0
1125829|NCT01587651|3695581|P3|Overall Study|Withdrawal by Subject|0
1125830|NCT01587651|3695582|P2|Overall Study|Withdrawal by Subject|1
1125831|NCT01587651|3695583|P1|Overall Study|Withdrawal by Subject|0
1125832|NCT01587651|3695581|P3|Overall Study|Protocol Violation|1
1125833|NCT01587651|3695582|P2|Overall Study|Protocol Violation|1
1125834|NCT01587651|3695583|P1|Overall Study|Protocol Violation|0
1125835|NCT01587651|3695581|P3|Overall Study|Adverse Event|0
1125836|NCT01587651|3695582|P2|Overall Study|Adverse Event|1
1125837|NCT01587651|3695583|P1|Overall Study|Adverse Event|0
1125838|NCT01587274|3695613|P3|Overall Study|Lost to Follow-up|3
1125839|NCT01587274|3695614|P2|Overall Study|Lost to Follow-up|5
1125840|NCT01587274|3695615|P1|Overall Study|Lost to Follow-up|4
1125841|NCT01587118|3695623|P1|Overall Study|nonresponse|1
1125842|NCT01587118|3695623|P1|Overall Study|Relocation|1
1125843|NCT01587118|3695623|P1|Overall Study|Lost to Follow-up|2
1125844|NCT01587118|3695623|P1|Overall Study|Adverse Event|3
1125845|NCT01587079|3695647|P1|Overall Study|Adverse Event|14
1125846|NCT01587079|3695647|P1|Overall Study|Withdrawal by Subject|7
1125847|NCT01587079|3695647|P1|Overall Study|Physician Decision|2
1125848|NCT01587079|3695647|P1|Overall Study|Lost to Follow-up|2
1125849|NCT01587079|3695647|P1|Overall Study|Protocol Violation|5
1125850|NCT01587079|3695647|P1|Overall Study|Protocol-specified criteria|9
1125851|NCT01587014|3695778|P1|Overall Study|Death|2
1125852|NCT01587001|3695785|P2|Overall Study|Insufficient samples to complete testing|1
1125853|NCT01587001|3695786|P1|Overall Study|Insufficient samples to complete testing|4
1125854|NCT01587001|3695785|P2|Overall Study|Lost to Follow-up|0
1125855|NCT01587001|3695786|P1|Overall Study|Lost to Follow-up|2
1125856|NCT01586819|3695834|P2|Overall Study|Withdrawal by Subject|0
1125857|NCT01586819|3695835|P1|Overall Study|Withdrawal by Subject|1
1125858|NCT01586806|3695846|P3|Overall Study|Lost to Follow-up|2
1125859|NCT01586806|3695847|P2|Overall Study|Lost to Follow-up|3
1125860|NCT01586806|3695848|P1|Overall Study|Lost to Follow-up|2
1125861|NCT01586806|3695846|P3|Overall Study|Withdrawal by Subject|0
1125862|NCT01586806|3695847|P2|Overall Study|Withdrawal by Subject|0
1125863|NCT01586806|3695848|P1|Overall Study|Withdrawal by Subject|1
1125864|NCT01586806|3695846|P3|Overall Study|Protocol Violation|0
1125865|NCT01586806|3695847|P2|Overall Study|Protocol Violation|1
1125866|NCT01586806|3695848|P1|Overall Study|Protocol Violation|0
1125867|NCT01586364|3695868|P1|Overall Study|Other-Not specified|1
1125868|NCT01586364|3695868|P1|Overall Study|Other-PI discretion, site closing|2
1125869|NCT01586364|3695868|P1|Overall Study|Other-Site closure due to PI illness|1
1125870|NCT01586364|3695868|P1|Overall Study|Other-Subject wasn't getting much relief|1
1125871|NCT01586364|3695868|P1|Overall Study|Other-Did not feel better post-treatment|1
1125872|NCT01586364|3695868|P1|Overall Study|Lack of Efficacy|1
1125873|NCT01586364|3695868|P1|Overall Study|Protocol Violation|16
1125874|NCT01586364|3695868|P1|Overall Study|Lost to Follow-up|17
1125875|NCT01586364|3695868|P1|Overall Study|Adverse Event|37
1125876|NCT01586364|3695868|P1|Overall Study|Withdrawal by Subject|40
1125877|NCT01586338|3695921|P1|Overall Study|Other|1
1125878|NCT01586338|3695921|P1|Overall Study|Withdrawal by participant|3
1125879|NCT01586338|3695921|P1|Overall Study|Lost to Follow-up|1
1125880|NCT01586338|3695921|P1|Overall Study|Adverse Event|3
1125881|NCT01586195|3695944|P1|Overall Study|Reason not specified|9
1125882|NCT01586195|3695944|P1|Overall Study|Started new anti-melanoma therapy|1
1125883|NCT01586195|3695944|P1|Overall Study|Withdrawal of Consent|5
1125884|NCT01586195|3695944|P1|Overall Study|Death|11
1125885|NCT01586156|3695958|P3|Overall Study|Pregnancy|0
1125886|NCT01586156|3695959|P2|Overall Study|Pregnancy|1
1125887|NCT01586156|3695960|P1|Overall Study|Pregnancy|0
1125888|NCT01585987|3695998|P2|Treated|Poor/Non-Compliance|1
1125889|NCT01585987|3695999|P1|Treated|Poor/Non-Compliance|0
1125890|NCT01585987|3695998|P2|Treated|Subject Request|1
1125891|NCT01585987|3695999|P1|Treated|Subject Request|0
1125892|NCT01585987|3695998|P2|Treated|Non-Specified|2
1125893|NCT01585987|3695999|P1|Treated|Non-Specified|1
1125894|NCT01585987|3695998|P2|Treated|Maximum Clinical Benefit|1
1125895|NCT01585987|3695999|P1|Treated|Maximum Clinical Benefit|0
1125896|NCT01585987|3695998|P2|Treated|Lost to Follow-up|1
1125897|NCT01585987|3695999|P1|Treated|Lost to Follow-up|0
1125898|NCT01585987|3695998|P2|Treated|Death|0
1125899|NCT01585987|3695999|P1|Treated|Death|1
1125900|NCT01585987|3695998|P2|Treated|Withdrawal by Subject|2
1125901|NCT01585987|3695999|P1|Treated|Withdrawal by Subject|1
1125902|NCT01585987|3695998|P2|Treated|Adverse Event|0
1125903|NCT01585987|3695999|P1|Treated|Adverse Event|3
1125904|NCT01585987|3695998|P2|Treated|Study Drug Toxicity|5
1125905|NCT01585987|3695999|P1|Treated|Study Drug Toxicity|9
1125906|NCT01585987|3695998|P2|Treated|Disease Progression|36
1125907|NCT01585987|3695999|P1|Treated|Disease Progression|39
1125908|NCT01585987|3695998|P2|Randomized|No longer met criteria|2
1125909|NCT01585987|3695999|P1|Randomized|No longer met criteria|0
1125910|NCT01585987|3695998|P2|Randomized|Withdrawal by Subject|4
1125911|NCT01585987|3695999|P1|Randomized|Withdrawal by Subject|0
1125912|NCT01585961|3696014|P1|Overall Study|Ablation cancelled for slow-heal wound|1
1125913|NCT01585961|3696014|P1|Overall Study|Lost to Follow-up|23
1125914|NCT01585961|3696014|P1|Overall Study|Withdrawal by Subject|1
1125915|NCT01585961|3696014|P1|Overall Study|Decision to use non-study catheter|1
1125916|NCT01585961|3696014|P1|Overall Study|Physician Decision|1
1125917|NCT01585961|3696014|P1|Overall Study|Death|6
1125918|NCT01585766|3696092|P6|Overall Study|Physician Decision|0
1125919|NCT01585766|3696093|P5|Overall Study|Physician Decision|0
1125920|NCT01585766|3696094|P4|Overall Study|Physician Decision|0
1125921|NCT01585766|3696095|P3|Overall Study|Physician Decision|1
1125922|NCT01585766|3696096|P2|Overall Study|Physician Decision|0
1125923|NCT01585766|3696097|P1|Overall Study|Physician Decision|0
1125924|NCT01585766|3696092|P6|Overall Study|Death|0
1125925|NCT01585766|3696093|P5|Overall Study|Death|0
1125926|NCT01585766|3696094|P4|Overall Study|Death|0
1125927|NCT01585766|3696095|P3|Overall Study|Death|0
1125928|NCT01585766|3696096|P2|Overall Study|Death|1
1125929|NCT01585766|3696097|P1|Overall Study|Death|0
1125930|NCT01585766|3696092|P6|Overall Study|Withdrawal by Subject|0
1125931|NCT01585766|3696093|P5|Overall Study|Withdrawal by Subject|0
1125932|NCT01585766|3696094|P4|Overall Study|Withdrawal by Subject|0
1125933|NCT01585766|3696095|P3|Overall Study|Withdrawal by Subject|1
1125934|NCT01585766|3696096|P2|Overall Study|Withdrawal by Subject|1
1125935|NCT01585766|3696097|P1|Overall Study|Withdrawal by Subject|0
1125936|NCT01585584|3696201|P1|Overall Study|Physician Decision|2
1125937|NCT01585584|3696201|P1|Overall Study|Withdrawal by Subject|1
1125938|NCT01585584|3696201|P1|Overall Study|Lack of Efficacy|1
1125939|NCT01585558|3696208|P3|Overall Study|Lack of Efficacy|1
1125940|NCT01585558|3696209|P2|Overall Study|Lack of Efficacy|0
1125941|NCT01585558|3696210|P1|Overall Study|Lack of Efficacy|0
1125942|NCT01585558|3696208|P3|Overall Study|Protocol Violation|2
1125943|NCT01585558|3696209|P2|Overall Study|Protocol Violation|3
1125944|NCT01585558|3696210|P1|Overall Study|Protocol Violation|4
1125945|NCT01585558|3696208|P3|Overall Study|Adverse Event|1
1125946|NCT01585558|3696209|P2|Overall Study|Adverse Event|4
1125947|NCT01585558|3696210|P1|Overall Study|Adverse Event|3
1125948|NCT01585558|3696208|P3|Overall Study|Lost to Follow-up|3
1125949|NCT01585558|3696209|P2|Overall Study|Lost to Follow-up|0
1125950|NCT01585558|3696210|P1|Overall Study|Lost to Follow-up|2
1125951|NCT01585558|3696208|P3|Overall Study|Withdrawal by Subject|8
1125952|NCT01585558|3696209|P2|Overall Study|Withdrawal by Subject|5
1125953|NCT01585558|3696210|P1|Overall Study|Withdrawal by Subject|4
1125954|NCT01585428|3696444|P2|Overall Study|Death during treatment|0
1125955|NCT01585428|3696445|P1|Overall Study|Death during treatment|1
1125956|NCT01585272|3696469|P1|Overall Study|Withdrawal by Subject|10
1125957|NCT01585272|3696469|P1|Overall Study|Protocol Violation|7
1125958|NCT01585272|3696469|P1|Overall Study|Adverse Event|22
1125959|NCT01585246|3696482|P5|Overall Study|Other|0
1125960|NCT01585246|3696483|P4|Overall Study|Other|1
1125961|NCT01585246|3696484|P3|Overall Study|Other|1
1125962|NCT01585246|3696485|P2|Overall Study|Other|1
1125963|NCT01585246|3696486|P1|Overall Study|Other|0
1125964|NCT01585246|3696482|P5|Overall Study|Withdrawal by Subject|1
1125965|NCT01585246|3696483|P4|Overall Study|Withdrawal by Subject|2
1125966|NCT01585246|3696484|P3|Overall Study|Withdrawal by Subject|1
1125967|NCT01585246|3696485|P2|Overall Study|Withdrawal by Subject|0
1125968|NCT01585246|3696486|P1|Overall Study|Withdrawal by Subject|0
1125969|NCT01585246|3696482|P5|Overall Study|Protocol Violation|1
1125970|NCT01585246|3696483|P4|Overall Study|Protocol Violation|0
1125971|NCT01585246|3696484|P3|Overall Study|Protocol Violation|0
1125972|NCT01585246|3696485|P2|Overall Study|Protocol Violation|0
1125973|NCT01585246|3696486|P1|Overall Study|Protocol Violation|0
1125974|NCT01585246|3696482|P5|Overall Study|Lost to Follow-up|0
1125975|NCT01585246|3696483|P4|Overall Study|Lost to Follow-up|1
1125976|NCT01585246|3696484|P3|Overall Study|Lost to Follow-up|2
1125977|NCT01585246|3696485|P2|Overall Study|Lost to Follow-up|0
1125978|NCT01585246|3696486|P1|Overall Study|Lost to Follow-up|0
1125979|NCT01585168|3696507|P4|Overall Study|Lost to Follow-up|1
1125980|NCT01585168|3696508|P3|Overall Study|Lost to Follow-up|1
1125981|NCT01585168|3696509|P2|Overall Study|Lost to Follow-up|1
1125982|NCT01585168|3696510|P1|Overall Study|Lost to Follow-up|3
1125983|NCT01585038|3696545|P2|Overall Study|Adverse Event|2
1125984|NCT01585038|3696546|P1|Overall Study|Adverse Event|2
1125985|NCT01584843|3696562|P6|Second Treatment Period|Withdrawal by Subject|1
1125986|NCT01584843|3696563|P5|Second Treatment Period|Withdrawal by Subject|0
1125987|NCT01584843|3696564|P4|Second Treatment Period|Withdrawal by Subject|0
1125988|NCT01584843|3696565|P3|Second Treatment Period|Withdrawal by Subject|0
1125989|NCT01584843|3696566|P2|Second Treatment Period|Withdrawal by Subject|0
1125990|NCT01584843|3696567|P1|Second Treatment Period|Withdrawal by Subject|0
1125991|NCT01584843|3696562|P6|First Treatment Period|Met Protocol-defined Stopping Criteria|1
1125992|NCT01584843|3696563|P5|First Treatment Period|Met Protocol-defined Stopping Criteria|0
1125993|NCT01584843|3696564|P4|First Treatment Period|Met Protocol-defined Stopping Criteria|0
1125994|NCT01584843|3696565|P3|First Treatment Period|Met Protocol-defined Stopping Criteria|0
1125995|NCT01584843|3696566|P2|First Treatment Period|Met Protocol-defined Stopping Criteria|0
1125996|NCT01584843|3696567|P1|First Treatment Period|Met Protocol-defined Stopping Criteria|0
1125997|NCT01584843|3696562|P6|First Treatment Period|Protocol Violation|1
1125998|NCT01584843|3696563|P5|First Treatment Period|Protocol Violation|0
1125999|NCT01584843|3696564|P4|First Treatment Period|Protocol Violation|0
1126000|NCT01584843|3696565|P3|First Treatment Period|Protocol Violation|0
1126001|NCT01584843|3696566|P2|First Treatment Period|Protocol Violation|0
1126002|NCT01584843|3696567|P1|First Treatment Period|Protocol Violation|0
1126003|NCT01584843|3696562|P6|First Treatment Period|Adverse Event|0
1126004|NCT01584843|3696563|P5|First Treatment Period|Adverse Event|0
1126005|NCT01584843|3696564|P4|First Treatment Period|Adverse Event|0
1126006|NCT01584843|3696565|P3|First Treatment Period|Adverse Event|1
1126007|NCT01584843|3696566|P2|First Treatment Period|Adverse Event|0
1126008|NCT01584843|3696567|P1|First Treatment Period|Adverse Event|0
1126009|NCT01584648|3696678|P2|Overall Study|Ongoing|147
1126010|NCT01584648|3696679|P1|Overall Study|Ongoing|154
1126011|NCT01584648|3696678|P2|Overall Study|Death|55
1126012|NCT01584648|3696679|P1|Overall Study|Death|40
1126013|NCT01584648|3696678|P2|Overall Study|Withdrawal by Subject|5
1126014|NCT01584648|3696679|P1|Overall Study|Withdrawal by Subject|11
1126015|NCT01584648|3696678|P2|Overall Study|Physician Decision|2
1126016|NCT01584648|3696679|P1|Overall Study|Physician Decision|2
1126017|NCT01584648|3696678|P2|Overall Study|Lost to Follow-up|3
1126018|NCT01584648|3696679|P1|Overall Study|Lost to Follow-up|4
1126019|NCT01584232|3696807|P2|Overall Study|Lost to Follow-up|0
1126020|NCT01584232|3696808|P1|Overall Study|Lost to Follow-up|1
1126021|NCT01584232|3696807|P2|Overall Study|Physician Decision|1
1126022|NCT01584232|3696808|P1|Overall Study|Physician Decision|2
1126023|NCT01584232|3696807|P2|Overall Study|Withdrawal by Subject|1
1126024|NCT01584232|3696808|P1|Overall Study|Withdrawal by Subject|2
1126025|NCT01584232|3696807|P2|Overall Study|Adverse Event|1
1126026|NCT01584232|3696808|P1|Overall Study|Adverse Event|3
1126027|NCT01583530|3696854|P6|Overall Study|Lack of compliance|0
1126028|NCT01583530|3696855|P5|Overall Study|Lack of compliance|1
1126029|NCT01583530|3696856|P4|Overall Study|Lack of compliance|0
1126030|NCT01583530|3696857|P3|Overall Study|Lack of compliance|0
1126031|NCT01583530|3696858|P2|Overall Study|Lack of compliance|0
1126032|NCT01583530|3696859|P1|Overall Study|Lack of compliance|0
1126033|NCT01583530|3696854|P6|Overall Study|Lost to Follow-up|0
1126034|NCT01583530|3696855|P5|Overall Study|Lost to Follow-up|3
1126035|NCT01583530|3696856|P4|Overall Study|Lost to Follow-up|0
1126036|NCT01583530|3696857|P3|Overall Study|Lost to Follow-up|0
1126037|NCT01583530|3696858|P2|Overall Study|Lost to Follow-up|0
1126038|NCT01583530|3696859|P1|Overall Study|Lost to Follow-up|0
1126039|NCT01583530|3696854|P6|Overall Study|Withdrawal by Subject|2
1126040|NCT01583530|3696855|P5|Overall Study|Withdrawal by Subject|1
1126041|NCT01583530|3696856|P4|Overall Study|Withdrawal by Subject|1
1126042|NCT01583530|3696857|P3|Overall Study|Withdrawal by Subject|0
1126043|NCT01583530|3696858|P2|Overall Study|Withdrawal by Subject|3
1126044|NCT01583530|3696859|P1|Overall Study|Withdrawal by Subject|0
1126045|NCT01583530|3696854|P6|Overall Study|Adverse Event|1
1126046|NCT01583530|3696855|P5|Overall Study|Adverse Event|0
1126047|NCT01583530|3696856|P4|Overall Study|Adverse Event|0
1126048|NCT01583530|3696857|P3|Overall Study|Adverse Event|0
1126049|NCT01583530|3696858|P2|Overall Study|Adverse Event|0
1126050|NCT01583530|3696859|P1|Overall Study|Adverse Event|0
1126051|NCT01583374|3696921|P3|Overall Study|Other|0
1126052|NCT01583374|3696922|P2|Overall Study|Other|1
1126053|NCT01583374|3696923|P1|Overall Study|Other|0
1126054|NCT01583374|3696921|P3|Overall Study|Protocol Violation|3
1126055|NCT01583374|3696922|P2|Overall Study|Protocol Violation|0
1126056|NCT01583374|3696923|P1|Overall Study|Protocol Violation|0
1126057|NCT01583374|3696921|P3|Overall Study|Lost to Follow-up|0
1126058|NCT01583374|3696922|P2|Overall Study|Lost to Follow-up|2
1126059|NCT01583374|3696923|P1|Overall Study|Lost to Follow-up|1
1126060|NCT01583374|3696921|P3|Overall Study|Withdrawal by Subject|5
1126061|NCT01583374|3696922|P2|Overall Study|Withdrawal by Subject|3
1126062|NCT01583374|3696923|P1|Overall Study|Withdrawal by Subject|8
1126063|NCT01583374|3696921|P3|Overall Study|Non-compliance with study drug|0
1126064|NCT01583374|3696922|P2|Overall Study|Non-compliance with study drug|1
1126065|NCT01583374|3696923|P1|Overall Study|Non-compliance with study drug|1
1126066|NCT01583374|3696921|P3|Overall Study|Lack of Efficacy|5
1126067|NCT01583374|3696922|P2|Overall Study|Lack of Efficacy|2
1126068|NCT01583374|3696923|P1|Overall Study|Lack of Efficacy|3
1126069|NCT01583374|3696921|P3|Overall Study|Adverse Event|12
1126070|NCT01583374|3696922|P2|Overall Study|Adverse Event|7
1126071|NCT01583374|3696923|P1|Overall Study|Adverse Event|6
1126072|NCT01583218|3696935|P2|Overall Study|Withdraw of consent on day of random|0
1126073|NCT01583218|3696936|P1|Overall Study|Withdraw of consent on day of random|1
1126074|NCT01583218|3696935|P2|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1
1126075|NCT01583218|3696936|P1|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0
1126076|NCT01583218|3696935|P2|Overall Study|Patient was randomized due to mistake|0
1126077|NCT01583218|3696936|P1|Overall Study|Patient was randomized due to mistake|1
1126078|NCT01583218|3696935|P2|Overall Study|Patient was early terminated from study|1
1126079|NCT01583218|3696936|P1|Overall Study|Patient was early terminated from study|0
1126080|NCT01583218|3696935|P2|Overall Study|Patient deemed ineligible after random|0
1126081|NCT01583218|3696936|P1|Overall Study|Patient deemed ineligible after random|2
1126082|NCT01583218|3696935|P2|Overall Study|Patient was assessed via phone in person|0
1126083|NCT01583218|3696936|P1|Overall Study|Patient was assessed via phone in person|1
1126084|NCT01583218|3696935|P2|Overall Study|Patient randomized but not dosed|16
1126085|NCT01583218|3696936|P1|Overall Study|Patient randomized but not dosed|17
1126086|NCT01583218|3696935|P2|Overall Study|Patient did not wish to attend visits|1
1126087|NCT01583218|3696936|P1|Overall Study|Patient did not wish to attend visits|0
1126088|NCT01583218|3696935|P2|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2
1126089|NCT01583218|3696936|P1|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0
1126090|NCT01583218|3696935|P2|Overall Study|Cannot contact patient directly|2
1126091|NCT01583218|3696936|P1|Overall Study|Cannot contact patient directly|1
1126092|NCT01583218|3696935|P2|Overall Study|Patient /Family decision|0
1126093|NCT01583218|3696936|P1|Overall Study|Patient /Family decision|3
1126094|NCT01583218|3696935|P2|Overall Study|Adverse event or serious adverse event|3
1126095|NCT01583218|3696936|P1|Overall Study|Adverse event or serious adverse event|3
1126096|NCT01583218|3696935|P2|Overall Study|Lost to Follow-up|17
1126097|NCT01583218|3696936|P1|Overall Study|Lost to Follow-up|11
1126098|NCT01583218|3696935|P2|Overall Study|Death|211
1126099|NCT01583218|3696936|P1|Overall Study|Death|206
1126100|NCT01583218|3696935|P2|Overall Study|Withdrawal by Subject|29
1126101|NCT01583218|3696936|P1|Overall Study|Withdrawal by Subject|43
1126102|NCT01583166|3696956|P2|Overall Study|Withdrawal by Subject|6
1126103|NCT01583166|3696957|P1|Overall Study|Withdrawal by Subject|4
1126104|NCT01582971|3696980|P2|Overall Study|Other|13
1126105|NCT01582971|3696981|P1|Overall Study|Other|15
1126106|NCT01582971|3696980|P2|Overall Study|Withdrawal by Subject|2
1126107|NCT01582971|3696981|P1|Overall Study|Withdrawal by Subject|4
1126108|NCT01582971|3696980|P2|Overall Study|Lost to Follow-up|21
1126109|NCT01582971|3696981|P1|Overall Study|Lost to Follow-up|18
1126110|NCT01582971|3696980|P2|Overall Study|Death|1
1126111|NCT01582971|3696981|P1|Overall Study|Death|2
1126112|NCT01582945|3696999|P1|Overall Study|Scheduling conflicts|1
1126113|NCT01582945|3696999|P1|Overall Study|Intolerable side-effects|1
1126114|NCT01582854|3697013|P2|Overall Study|Other Miscellaneous Reason|0
1126115|NCT01582854|3697014|P1|Overall Study|Other Miscellaneous Reason|1
1126116|NCT01582854|3697013|P2|Overall Study|General Anaesthesia|1
1126117|NCT01582854|3697014|P1|Overall Study|General Anaesthesia|0
1126118|NCT01582854|3697013|P2|Overall Study|Carotid or Neurosurgery|1
1126119|NCT01582854|3697014|P1|Overall Study|Carotid or Neurosurgery|0
1126120|NCT01582854|3697013|P2|Overall Study|Disallowed Concomitant Medication|2
1126121|NCT01582854|3697014|P1|Overall Study|Disallowed Concomitant Medication|3
1126122|NCT01582854|3697013|P2|Overall Study|Recurrent Stroke|8
1126123|NCT01582854|3697014|P1|Overall Study|Recurrent Stroke|13
1126124|NCT01582854|3697013|P2|Overall Study|Physician Decision|1
1126125|NCT01582854|3697014|P1|Overall Study|Physician Decision|0
1126126|NCT01582854|3697013|P2|Overall Study|Lost to Follow-up|2
1126127|NCT01582854|3697014|P1|Overall Study|Lost to Follow-up|1
1126128|NCT01582854|3697013|P2|Overall Study|Withdrawal by Participant|11
1126129|NCT01582854|3697014|P1|Overall Study|Withdrawal by Participant|8
1126130|NCT01582854|3697013|P2|Overall Study|Adverse Event|3
1126131|NCT01582854|3697014|P1|Overall Study|Adverse Event|2
1126132|NCT01582854|3697013|P2|Overall Study|Death|5
1126133|NCT01582854|3697014|P1|Overall Study|Death|8
1126134|NCT01582789|3697042|P2|Second Intervention (14 Days)|Withdrawal by Subject|0
1126135|NCT01582789|3697043|P1|Second Intervention (14 Days)|Withdrawal by Subject|1
1126136|NCT01582451|3697103|P2|Overall Study|Sponsor Decision|0
1126137|NCT01582451|3697104|P1|Overall Study|Sponsor Decision|1
1126138|NCT01582451|3697103|P2|Overall Study|Physician Decision|0
1126139|NCT01582451|3697104|P1|Overall Study|Physician Decision|3
1126140|NCT01582451|3697103|P2|Overall Study|Withdrawal by Subject|9
1126141|NCT01582451|3697104|P1|Overall Study|Withdrawal by Subject|13
1126142|NCT01582451|3697103|P2|Overall Study|Protocol Violation|3
1126143|NCT01582451|3697104|P1|Overall Study|Protocol Violation|11
1126144|NCT01582451|3697103|P2|Overall Study|Lost to Follow-up|2
1126145|NCT01582451|3697104|P1|Overall Study|Lost to Follow-up|0
1126146|NCT01582451|3697103|P2|Overall Study|Death|3
1126147|NCT01582451|3697104|P1|Overall Study|Death|3
1126148|NCT01582451|3697103|P2|Overall Study|Adverse Event|3
1126149|NCT01582451|3697104|P1|Overall Study|Adverse Event|1
1126150|NCT01582308|3697146|P10|Period 4|Physician Decision|1
1126151|NCT01582308|3697147|P9|Period 4|Physician Decision|0
1126152|NCT01582308|3697148|P8|Period 4|Physician Decision|0
1126153|NCT01582308|3697149|P7|Period 4|Physician Decision|0
1126154|NCT01582308|3697150|P6|Period 4|Physician Decision|1
1126155|NCT01582308|3697151|P5|Period 4|Physician Decision|0
1126156|NCT01582308|3697152|P4|Period 4|Physician Decision|0
1126157|NCT01582308|3697153|P3|Period 4|Physician Decision|0
1126158|NCT01582308|3697154|P2|Period 4|Physician Decision|0
1126159|NCT01582308|3697155|P1|Period 4|Physician Decision|1
1126160|NCT01582308|3697146|P10|10-day Washout Following Period 1|Physician Decision|0
1126161|NCT01582308|3697147|P9|10-day Washout Following Period 1|Physician Decision|0
1126162|NCT01582308|3697148|P8|10-day Washout Following Period 1|Physician Decision|0
1126163|NCT01582308|3697149|P7|10-day Washout Following Period 1|Physician Decision|0
1126164|NCT01582308|3697150|P6|10-day Washout Following Period 1|Physician Decision|0
1126165|NCT01582308|3697151|P5|10-day Washout Following Period 1|Physician Decision|1
1126166|NCT01582308|3697152|P4|10-day Washout Following Period 1|Physician Decision|0
1126167|NCT01582308|3697153|P3|10-day Washout Following Period 1|Physician Decision|0
1126168|NCT01582308|3697154|P2|10-day Washout Following Period 1|Physician Decision|0
1126169|NCT01582308|3697155|P1|10-day Washout Following Period 1|Physician Decision|0
1126170|NCT01582308|3697146|P10|Period 1|Withdrawal by Subject|0
1126171|NCT01582308|3697147|P9|Period 1|Withdrawal by Subject|0
1126172|NCT01582308|3697148|P8|Period 1|Withdrawal by Subject|0
1126173|NCT01582308|3697149|P7|Period 1|Withdrawal by Subject|1
1126174|NCT01582308|3697150|P6|Period 1|Withdrawal by Subject|0
1126175|NCT01582308|3697151|P5|Period 1|Withdrawal by Subject|0
1126176|NCT01582308|3697152|P4|Period 1|Withdrawal by Subject|0
1126177|NCT01582308|3697153|P3|Period 1|Withdrawal by Subject|0
1126178|NCT01582308|3697154|P2|Period 1|Withdrawal by Subject|0
1126179|NCT01582308|3697155|P1|Period 1|Withdrawal by Subject|0
1126180|NCT01582282|3697183|P3|Overall Study|fasting blood glucose outside Protocol|0
1126181|NCT01582282|3697184|P2|Overall Study|fasting blood glucose outside Protocol|1
1126182|NCT01582282|3697185|P1|Overall Study|fasting blood glucose outside Protocol|0
1126183|NCT01582282|3697183|P3|Overall Study|Lost to Follow-up|0
1126184|NCT01582282|3697184|P2|Overall Study|Lost to Follow-up|0
1126185|NCT01582282|3697185|P1|Overall Study|Lost to Follow-up|1
1126186|NCT01582282|3697183|P3|Overall Study|Adverse Event|0
1126187|NCT01582282|3697184|P2|Overall Study|Adverse Event|1
1126188|NCT01582282|3697185|P1|Overall Study|Adverse Event|1
1126189|NCT01582243|3697208|P1|Overall Study|Lost to Follow-up|1
1126190|NCT01582243|3697208|P1|Overall Study|Adverse Event|1
1126191|NCT01582243|3697208|P1|Overall Study|Withdrawal by Subject|1
1126192|NCT01582178|3697219|P2|Overall Study|Physician Decision|5
1126193|NCT01582178|3697220|P1|Overall Study|Physician Decision|6
1126194|NCT01582100|3697241|P1|Overall Study|Withdrawal by Subject|1
1126195|NCT01582100|3697241|P1|Overall Study|Adverse Event|1
1126196|NCT01582061|3697247|P2|Overall Study|Lost to Follow-up|0
1126197|NCT01582061|3697248|P1|Overall Study|Lost to Follow-up|1
1126198|NCT01582061|3697247|P2|Overall Study|condition no longer requires study drug|0
1126199|NCT01582061|3697248|P1|Overall Study|condition no longer requires study drug|1
1126200|NCT01582061|3697247|P2|Overall Study|Death|1
1126201|NCT01582061|3697248|P1|Overall Study|Death|0
1126202|NCT01582061|3697247|P2|Overall Study|Abnormal laboratory value(s)|0
1126203|NCT01582061|3697248|P1|Overall Study|Abnormal laboratory value(s)|1
1126204|NCT01582061|3697247|P2|Overall Study|Withdrawal by Subject|4
1126205|NCT01582061|3697248|P1|Overall Study|Withdrawal by Subject|10
1126206|NCT01582061|3697247|P2|Overall Study|Adverse Event|8
1126207|NCT01582061|3697248|P1|Overall Study|Adverse Event|12
1126208|NCT01582061|3697247|P2|Overall Study|Lack of Efficacy|23
1126209|NCT01582061|3697248|P1|Overall Study|Lack of Efficacy|3
1126210|NCT01582009|3697298|P1|Overall Study|Physician Decision|1
1126211|NCT01582009|3697298|P1|Overall Study|Withdrawal by Subject|1
1126212|NCT01581931|3697306|P2|Washout|Adverse Event|1
1126213|NCT01581931|3697307|P1|Washout|Adverse Event|0
1126214|NCT01581684|3697360|P10|Overall Study|Other reason not defined|0
1126215|NCT01581684|3697361|P9|Overall Study|Other reason not defined|1
1126216|NCT01581684|3697362|P8|Overall Study|Other reason not defined|0
1126217|NCT01581684|3697363|P7|Overall Study|Other reason not defined|0
1126218|NCT01581684|3697364|P6|Overall Study|Other reason not defined|0
1126219|NCT01581684|3697365|P5|Overall Study|Other reason not defined|0
1126220|NCT01581684|3697366|P4|Overall Study|Other reason not defined|0
1126221|NCT01581684|3697367|P3|Overall Study|Other reason not defined|0
1126222|NCT01581684|3697368|P2|Overall Study|Other reason not defined|0
1126223|NCT01581684|3697369|P1|Overall Study|Other reason not defined|0
1126224|NCT01581619|3697465|P1|Overall Study|Lost to Follow-up|1
1126225|NCT01581619|3697465|P1|Overall Study|Withdrawal by Subject|1
1126226|NCT01581307|3697618|P1|Overall Study|Withdrawal by Subject|1
1126227|NCT01581281|3697627|P3|Overall Study|Early Study Closure|12
1126228|NCT01581281|3697628|P2|Overall Study|Early Study Closure|6
1126229|NCT01581281|3697629|P1|Overall Study|Early Study Closure|15
1126230|NCT01581021|3697651|P2|Overall Study|Lack of Efficacy|1
1126231|NCT01581021|3697652|P1|Overall Study|Lack of Efficacy|0
1126232|NCT01581021|3697651|P2|Overall Study|Lenke 6 Classification|1
1126233|NCT01581021|3697652|P1|Overall Study|Lenke 6 Classification|0
1126234|NCT01581021|3697651|P2|Overall Study|Not Randomized|2
1126235|NCT01581021|3697652|P1|Overall Study|Not Randomized|1
1126236|NCT01581021|3697651|P2|Overall Study|Neuromuscular|1
1126237|NCT01581021|3697652|P1|Overall Study|Neuromuscular|2
1126238|NCT01581021|3697651|P2|Overall Study|More than 2 hooks in thoracic|0
1126239|NCT01581021|3697652|P1|Overall Study|More than 2 hooks in thoracic|3
1126240|NCT01581021|3697651|P2|Overall Study|Lost to Follow-up|6
1126241|NCT01581021|3697652|P1|Overall Study|Lost to Follow-up|4
1126242|NCT01580995|3697679|P2|Overall Study|Lost to Follow-up|2
1126243|NCT01580995|3697680|P1|Overall Study|Lost to Follow-up|2
1126244|NCT01580488|3697733|P1|Overall Study|Withdrawal by Subject|1
1126245|NCT01580293|3697839|P3|Part B|Part B ongoing|1
1126246|NCT01580293|3697840|P2|Part B|Part B ongoing|0
1126247|NCT01580293|3697841|P1|Part B|Part B ongoing|0
1126248|NCT01580293|3697839|P3|Part B|Other reason|1
1126249|NCT01580293|3697840|P2|Part B|Other reason|0
1126250|NCT01580293|3697841|P1|Part B|Other reason|0
1126251|NCT01580293|3697839|P3|Part B|Withdrawal by Subject|1
1126252|NCT01580293|3697840|P2|Part B|Withdrawal by Subject|0
1126253|NCT01580293|3697841|P1|Part B|Withdrawal by Subject|0
1126254|NCT01580293|3697839|P3|Part A_Extension|Extension ongoing|0
1126255|NCT01580293|3697840|P2|Part A_Extension|Extension ongoing|69
1126256|NCT01580293|3697841|P1|Part A_Extension|Extension ongoing|9
1126257|NCT01580293|3697839|P3|Part A_Extension|Other Reason|0
1126258|NCT01580293|3697840|P2|Part A_Extension|Other Reason|1
1126259|NCT01580293|3697841|P1|Part A_Extension|Other Reason|0
1126260|NCT01580293|3697839|P3|Part A_Extension|Lost to Follow-up|0
1126261|NCT01580293|3697840|P2|Part A_Extension|Lost to Follow-up|1
1126262|NCT01580293|3697841|P1|Part A_Extension|Lost to Follow-up|0
1126263|NCT01580293|3697839|P3|Part A_Extension|Withdrawal by Subject|0
1126264|NCT01580293|3697840|P2|Part A_Extension|Withdrawal by Subject|2
1126265|NCT01580293|3697841|P1|Part A_Extension|Withdrawal by Subject|0
1126266|NCT01580293|3697839|P3|Part A_Extension|Adverse Event|0
1126267|NCT01580293|3697840|P2|Part A_Extension|Adverse Event|2
1126268|NCT01580293|3697841|P1|Part A_Extension|Adverse Event|0
1126269|NCT01580293|3697839|P3|Part A_Main Trial|Non-adherence to the protocol|0
1126270|NCT01580293|3697840|P2|Part A_Main Trial|Non-adherence to the protocol|0
1126271|NCT01580293|3697841|P1|Part A_Main Trial|Non-adherence to the protocol|1
1126272|NCT01580293|3697839|P3|Part A_Main Trial|Withdrawal by Subject|0
1126273|NCT01580293|3697840|P2|Part A_Main Trial|Withdrawal by Subject|4
1126274|NCT01580293|3697841|P1|Part A_Main Trial|Withdrawal by Subject|1
1126275|NCT01580293|3697839|P3|Part A_Main Trial|Adverse Event|0
1126276|NCT01580293|3697840|P2|Part A_Main Trial|Adverse Event|2
1126277|NCT01580293|3697841|P1|Part A_Main Trial|Adverse Event|0
1126278|NCT01580020|3697981|P4|Overall Study|Lost to Follow-up|0
1126279|NCT01580020|3697982|P3|Overall Study|Lost to Follow-up|1
1126280|NCT01580020|3697983|P2|Overall Study|Lost to Follow-up|0
1126281|NCT01580020|3697984|P1|Overall Study|Lost to Follow-up|0
1126282|NCT01580020|3697981|P4|Overall Study|Administrative Problems|0
1126283|NCT01580020|3697982|P3|Overall Study|Administrative Problems|1
1126284|NCT01580020|3697983|P2|Overall Study|Administrative Problems|0
1126285|NCT01580020|3697984|P1|Overall Study|Administrative Problems|0
1126286|NCT01580020|3697981|P4|Overall Study|Adverse Event|1
1126287|NCT01580020|3697982|P3|Overall Study|Adverse Event|1
1126288|NCT01580020|3697983|P2|Overall Study|Adverse Event|1
1126289|NCT01580020|3697984|P1|Overall Study|Adverse Event|1
1126290|NCT01580020|3697981|P4|Overall Study|Withdrawal by Subject|0
1126291|NCT01580020|3697982|P3|Overall Study|Withdrawal by Subject|1
1126292|NCT01580020|3697983|P2|Overall Study|Withdrawal by Subject|1
1126293|NCT01580020|3697984|P1|Overall Study|Withdrawal by Subject|0
1126294|NCT01580020|3697981|P4|Overall Study|Lack of Efficacy|1
1126295|NCT01580020|3697982|P3|Overall Study|Lack of Efficacy|0
1126296|NCT01580020|3697983|P2|Overall Study|Lack of Efficacy|5
1126297|NCT01580020|3697984|P1|Overall Study|Lack of Efficacy|0
1126298|NCT01579916|3698028|P2|Overall Study|Death|0
1126299|NCT01579916|3698029|P1|Overall Study|Death|1
1126300|NCT01579916|3698028|P2|Overall Study|Withdrawal by Subject|1
1126301|NCT01579916|3698029|P1|Overall Study|Withdrawal by Subject|1
1126302|NCT01579916|3698028|P2|Overall Study|Lost to Follow-up|1
1126303|NCT01579916|3698029|P1|Overall Study|Lost to Follow-up|6
1126304|NCT01579812|3698055|P1|Overall Study|Withdrawal by Subject|6
1126305|NCT01579812|3698055|P1|Overall Study|Noncompliance|3
1126306|NCT01579812|3698055|P1|Overall Study|Patient choice|3
1126307|NCT01579812|3698055|P1|Overall Study|Ineligible after treatment start|40
1126308|NCT01579578|3698089|P2|Overall Study|Ongoing|0
1126309|NCT01579578|3698090|P1|Overall Study|Ongoing|3
1126310|NCT01579578|3698089|P2|Overall Study|Eligibility criteria|9
1126311|NCT01579578|3698090|P1|Overall Study|Eligibility criteria|3
1126312|NCT01579578|3698089|P2|Overall Study|Withdrawal by Subject|1
1126313|NCT01579578|3698090|P1|Overall Study|Withdrawal by Subject|2
1126314|NCT01579578|3698089|P2|Overall Study|Lost to Follow-up|1
1126315|NCT01579578|3698090|P1|Overall Study|Lost to Follow-up|1
1126316|NCT01579578|3698089|P2|Overall Study|Death|1
1126317|NCT01579578|3698090|P1|Overall Study|Death|4
1126318|NCT01579565|3698102|P2|Treated|declined to return for final visit|1
1126319|NCT01579565|3698103|P1|Treated|declined to return for final visit|0
1126320|NCT01579565|3698102|P2|Treated|Lost to Follow-up|1
1126321|NCT01579565|3698103|P1|Treated|Lost to Follow-up|2
1126322|NCT01579565|3698102|P2|Treated|Physician Decision|1
1126323|NCT01579565|3698103|P1|Treated|Physician Decision|0
1126324|NCT01579565|3698102|P2|Randomized|prohibited preoperative medication|1
1126325|NCT01579565|3698103|P1|Randomized|prohibited preoperative medication|0
1126326|NCT01579565|3698102|P2|Randomized|prohibited preoperative eating|0
1126327|NCT01579565|3698103|P1|Randomized|prohibited preoperative eating|1
1126328|NCT01579565|3698102|P2|Randomized|inadequate preoperative pupil dilation|1
1126329|NCT01579565|3698103|P1|Randomized|inadequate preoperative pupil dilation|0
1126330|NCT01579565|3698102|P2|Randomized|Withdrawal by Subject|0
1126331|NCT01579565|3698103|P1|Randomized|Withdrawal by Subject|3
1126332|NCT01579565|3698102|P2|Randomized|Adverse Event|3
1126333|NCT01579565|3698103|P1|Randomized|Adverse Event|1
1126334|NCT01579474|3698137|P6|Overall Study|Withdrawal by Subject|0
1126335|NCT01579474|3698138|P5|Overall Study|Withdrawal by Subject|0
1126336|NCT01579474|3698139|P4|Overall Study|Withdrawal by Subject|0
1126337|NCT01579474|3698140|P3|Overall Study|Withdrawal by Subject|0
1126338|NCT01579474|3698141|P2|Overall Study|Withdrawal by Subject|0
1126339|NCT01579474|3698142|P1|Overall Study|Withdrawal by Subject|1
1126340|NCT01579474|3698137|P6|Overall Study|Lack of Efficacy|0
1126341|NCT01579474|3698138|P5|Overall Study|Lack of Efficacy|1
1126342|NCT01579474|3698139|P4|Overall Study|Lack of Efficacy|0
1126343|NCT01579474|3698140|P3|Overall Study|Lack of Efficacy|0
1126344|NCT01579474|3698141|P2|Overall Study|Lack of Efficacy|0
1126345|NCT01579474|3698142|P1|Overall Study|Lack of Efficacy|1
1126346|NCT01579474|3698137|P6|Overall Study|Adverse Event|1
1126347|NCT01579474|3698138|P5|Overall Study|Adverse Event|0
1126348|NCT01579474|3698139|P4|Overall Study|Adverse Event|0
1126349|NCT01579474|3698140|P3|Overall Study|Adverse Event|2
1126350|NCT01579474|3698141|P2|Overall Study|Adverse Event|13
1126351|NCT01579474|3698142|P1|Overall Study|Adverse Event|1
1126352|NCT01579318|3698216|P1|Overall Study|Disease Progression|1
1126353|NCT01579006|3698311|P1|Overall Study|Scheduled surgery|1
1126354|NCT01579006|3698311|P1|Overall Study|Due to participant's health fund|1
1126355|NCT01579006|3698311|P1|Overall Study|Non-compliance|3
1126356|NCT01579006|3698311|P1|Overall Study|Withdrawal by Subject|5
1126357|NCT01579006|3698311|P1|Overall Study|Adverse Event|13
1126358|NCT01579006|3698311|P1|Overall Study|Lack of Efficacy|10
1126359|NCT01578850|3698370|P3|Period 2|Unspecified Reasons|0
1126360|NCT01578850|3698371|P2|Period 2|Unspecified Reasons|1
1126361|NCT01578850|3698372|P1|Period 2|Unspecified Reasons|0
1126362|NCT01578850|3698370|P3|Period 2|Study Terminated by Sponsor|4
1126363|NCT01578850|3698371|P2|Period 2|Study Terminated by Sponsor|5
1126364|NCT01578850|3698372|P1|Period 2|Study Terminated by Sponsor|0
1126365|NCT01578850|3698370|P3|Period 2|Withdrawal by Subject|2
1126366|NCT01578850|3698371|P2|Period 2|Withdrawal by Subject|2
1126367|NCT01578850|3698372|P1|Period 2|Withdrawal by Subject|0
1126368|NCT01578850|3698370|P3|Period 2|Lost to Follow-up|2
1126369|NCT01578850|3698371|P2|Period 2|Lost to Follow-up|1
1126370|NCT01578850|3698372|P1|Period 2|Lost to Follow-up|0
1126371|NCT01578850|3698370|P3|Period 2|Adverse Event|6
1126372|NCT01578850|3698371|P2|Period 2|Adverse Event|3
1126373|NCT01578850|3698372|P1|Period 2|Adverse Event|0
1126374|NCT01578850|3698370|P3|Period 2|Insufficient Clinical Response|0
1126375|NCT01578850|3698371|P2|Period 2|Insufficient Clinical Response|1
1126376|NCT01578850|3698372|P1|Period 2|Insufficient Clinical Response|0
1126377|NCT01578850|3698370|P3|Period 1|Study Terminated by Sponsor|0
1126378|NCT01578850|3698371|P2|Period 1|Study Terminated by Sponsor|0
1126379|NCT01578850|3698372|P1|Period 1|Study Terminated by Sponsor|3
1126380|NCT01578850|3698370|P3|Period 1|Withdrawal by Subject|0
1126381|NCT01578850|3698371|P2|Period 1|Withdrawal by Subject|0
1126382|NCT01578850|3698372|P1|Period 1|Withdrawal by Subject|9
1126383|NCT01578850|3698370|P3|Period 1|Does Not Meet Entrance Criteria|0
1126384|NCT01578850|3698371|P2|Period 1|Does Not Meet Entrance Criteria|0
1126385|NCT01578850|3698372|P1|Period 1|Does Not Meet Entrance Criteria|12
1126386|NCT01578850|3698370|P3|Period 1|Death|0
1126387|NCT01578850|3698371|P2|Period 1|Death|0
1126388|NCT01578850|3698372|P1|Period 1|Death|1
1126389|NCT01578850|3698370|P3|Period 1|Adverse Event|0
1126390|NCT01578850|3698371|P2|Period 1|Adverse Event|0
1126391|NCT01578850|3698372|P1|Period 1|Adverse Event|11
1126392|NCT01578850|3698370|P3|Period 1|Insufficient Clinical Response|0
1126393|NCT01578850|3698371|P2|Period 1|Insufficient Clinical Response|0
1126394|NCT01578850|3698372|P1|Period 1|Insufficient Clinical Response|1
1126395|NCT01578785|3698424|P2|Overall Study|Study terminated by sponsor|118
1126396|NCT01578785|3698425|P1|Overall Study|Study terminated by sponsor|59
1126397|NCT01578785|3698424|P2|Overall Study|Withdrawal by Subject|1
1126398|NCT01578785|3698425|P1|Overall Study|Withdrawal by Subject|0
1126399|NCT01578551|3698457|P2|Overall Study|Adverse Event|0
1126400|NCT01578551|3698458|P1|Overall Study|Adverse Event|1
1126401|NCT01578499|3698470|P2|Overall Study|Participants on Study Treatment|0
1126402|NCT01578499|3698471|P1|Overall Study|Participants on Study Treatment|3
1126403|NCT01578499|3698470|P2|Overall Study|Participants in Follow-up|39
1126404|NCT01578499|3698471|P1|Overall Study|Participants in Follow-up|42
1126405|NCT01578499|3698470|P2|Overall Study|Reason not Specified|1
1126406|NCT01578499|3698471|P1|Overall Study|Reason not Specified|0
1126407|NCT01578499|3698470|P2|Overall Study|Lost to Follow-up|1
1126408|NCT01578499|3698471|P1|Overall Study|Lost to Follow-up|2
1126409|NCT01578499|3698470|P2|Overall Study|Withdrawal by Participant|10
1126410|NCT01578499|3698471|P1|Overall Study|Withdrawal by Participant|8
1126411|NCT01578499|3698470|P2|Overall Study|Death|14
1126412|NCT01578499|3698471|P1|Overall Study|Death|11
1126413|NCT01578486|3698505|P1|Overall Study|Withdrawal by Subject|2
1126414|NCT01578486|3698505|P1|Overall Study|Physician Decision|3
1126415|NCT01578330|3698516|P1|Overall Study|Protocol Violation|5
1126416|NCT01578330|3698516|P1|Overall Study|Adverse Event|2
1126417|NCT01578187|3698532|P1|Usability Phase|Withdrawal by Subject|1
1126418|NCT01577758|3698566|P8|mCRC Expansion Phase|Progression Disease|19
1126419|NCT01577758|3698567|P7|mCRC Expansion Phase|Progression Disease|0
1126420|NCT01577758|3698568|P6|mCRC Expansion Phase|Progression Disease|0
1126421|NCT01577758|3698569|P5|mCRC Expansion Phase|Progression Disease|0
1126422|NCT01577758|3698570|P4|mCRC Expansion Phase|Progression Disease|0
1126423|NCT01577758|3698571|P3|mCRC Expansion Phase|Progression Disease|0
1126424|NCT01577758|3698572|P2|mCRC Expansion Phase|Progression Disease|0
1126425|NCT01577758|3698573|P1|mCRC Expansion Phase|Progression Disease|0
1126426|NCT01577758|3698566|P8|mCRC Expansion Phase|Withdrawal by Subject|2
1126427|NCT01577758|3698567|P7|mCRC Expansion Phase|Withdrawal by Subject|0
1126428|NCT01577758|3698568|P6|mCRC Expansion Phase|Withdrawal by Subject|0
1126429|NCT01577758|3698569|P5|mCRC Expansion Phase|Withdrawal by Subject|0
1126430|NCT01577758|3698570|P4|mCRC Expansion Phase|Withdrawal by Subject|0
1126431|NCT01577758|3698571|P3|mCRC Expansion Phase|Withdrawal by Subject|0
1126432|NCT01577758|3698572|P2|mCRC Expansion Phase|Withdrawal by Subject|0
1126433|NCT01577758|3698573|P1|mCRC Expansion Phase|Withdrawal by Subject|0
1126434|NCT01577758|3698566|P8|mCRC Expansion Phase|Symptomatic Deterioration|4
1126435|NCT01577758|3698567|P7|mCRC Expansion Phase|Symptomatic Deterioration|0
1126436|NCT01577758|3698568|P6|mCRC Expansion Phase|Symptomatic Deterioration|0
1126437|NCT01577758|3698569|P5|mCRC Expansion Phase|Symptomatic Deterioration|0
1126438|NCT01577758|3698570|P4|mCRC Expansion Phase|Symptomatic Deterioration|0
1126439|NCT01577758|3698571|P3|mCRC Expansion Phase|Symptomatic Deterioration|0
1126440|NCT01577758|3698572|P2|mCRC Expansion Phase|Symptomatic Deterioration|0
1126441|NCT01577758|3698573|P1|mCRC Expansion Phase|Symptomatic Deterioration|0
1126442|NCT01577758|3698566|P8|Dose Escalation Phase|Progression Disease|0
1126443|NCT01577758|3698567|P7|Dose Escalation Phase|Progression Disease|0
1126444|NCT01577758|3698568|P6|Dose Escalation Phase|Progression Disease|0
1126445|NCT01577758|3698569|P5|Dose Escalation Phase|Progression Disease|5
1126446|NCT01577758|3698570|P4|Dose Escalation Phase|Progression Disease|2
1126447|NCT01577758|3698571|P3|Dose Escalation Phase|Progression Disease|1
1126448|NCT01577758|3698572|P2|Dose Escalation Phase|Progression Disease|2
1126449|NCT01577758|3698573|P1|Dose Escalation Phase|Progression Disease|2
1126450|NCT01577758|3698566|P8|Dose Escalation Phase|Withdrawal by Subject|0
1126451|NCT01577758|3698567|P7|Dose Escalation Phase|Withdrawal by Subject|0
1126452|NCT01577758|3698568|P6|Dose Escalation Phase|Withdrawal by Subject|1
1126453|NCT01577758|3698569|P5|Dose Escalation Phase|Withdrawal by Subject|0
1126454|NCT01577758|3698570|P4|Dose Escalation Phase|Withdrawal by Subject|0
1126455|NCT01577758|3698571|P3|Dose Escalation Phase|Withdrawal by Subject|0
1126456|NCT01577758|3698572|P2|Dose Escalation Phase|Withdrawal by Subject|0
1126457|NCT01577758|3698573|P1|Dose Escalation Phase|Withdrawal by Subject|0
1126458|NCT01577758|3698566|P8|Dose Escalation Phase|Symptomatic Deterioration|0
1126459|NCT01577758|3698567|P7|Dose Escalation Phase|Symptomatic Deterioration|0
1126460|NCT01577758|3698568|P6|Dose Escalation Phase|Symptomatic Deterioration|1
1126461|NCT01577758|3698569|P5|Dose Escalation Phase|Symptomatic Deterioration|1
1126462|NCT01577758|3698570|P4|Dose Escalation Phase|Symptomatic Deterioration|0
1126463|NCT01577758|3698571|P3|Dose Escalation Phase|Symptomatic Deterioration|1
1126464|NCT01577758|3698572|P2|Dose Escalation Phase|Symptomatic Deterioration|0
1126465|NCT01577758|3698573|P1|Dose Escalation Phase|Symptomatic Deterioration|0
1126466|NCT01577758|3698566|P8|Dose Escalation Phase|Adverse Event|0
1126467|NCT01577758|3698567|P7|Dose Escalation Phase|Adverse Event|1
1126468|NCT01577758|3698568|P6|Dose Escalation Phase|Adverse Event|2
1126469|NCT01577758|3698569|P5|Dose Escalation Phase|Adverse Event|0
1126470|NCT01577758|3698570|P4|Dose Escalation Phase|Adverse Event|0
1126471|NCT01577758|3698571|P3|Dose Escalation Phase|Adverse Event|0
1126472|NCT01577758|3698572|P2|Dose Escalation Phase|Adverse Event|0
1126473|NCT01577758|3698573|P1|Dose Escalation Phase|Adverse Event|0
1126474|NCT01577745|3698612|P6|Overall Study|Alternative Therapy|0
1126475|NCT01577745|3698613|P5|Overall Study|Alternative Therapy|1
1126476|NCT01577745|3698614|P4|Overall Study|Alternative Therapy|1
1126477|NCT01577745|3698615|P3|Overall Study|Alternative Therapy|0
1126478|NCT01577745|3698616|P2|Overall Study|Alternative Therapy|0
1126479|NCT01577745|3698617|P1|Overall Study|Alternative Therapy|0
1126480|NCT01577745|3698612|P6|Overall Study|Lost to Follow-up|1
1126481|NCT01577745|3698613|P5|Overall Study|Lost to Follow-up|0
1126482|NCT01577745|3698614|P4|Overall Study|Lost to Follow-up|0
1126483|NCT01577745|3698615|P3|Overall Study|Lost to Follow-up|0
1126484|NCT01577745|3698616|P2|Overall Study|Lost to Follow-up|0
1126485|NCT01577745|3698617|P1|Overall Study|Lost to Follow-up|0
1126486|NCT01577745|3698612|P6|Overall Study|Physician Decision|0
1126487|NCT01577745|3698613|P5|Overall Study|Physician Decision|1
1126488|NCT01577745|3698614|P4|Overall Study|Physician Decision|1
1126489|NCT01577745|3698615|P3|Overall Study|Physician Decision|0
1126490|NCT01577745|3698616|P2|Overall Study|Physician Decision|0
1126491|NCT01577745|3698617|P1|Overall Study|Physician Decision|0
1126492|NCT01577745|3698612|P6|Overall Study|Death|3
1126493|NCT01577745|3698613|P5|Overall Study|Death|1
1126494|NCT01577745|3698614|P4|Overall Study|Death|1
1126495|NCT01577745|3698615|P3|Overall Study|Death|2
1126496|NCT01577745|3698616|P2|Overall Study|Death|2
1126497|NCT01577745|3698617|P1|Overall Study|Death|3
1126498|NCT01577745|3698612|P6|Overall Study|Withdrawal by Subject|0
1126499|NCT01577745|3698613|P5|Overall Study|Withdrawal by Subject|2
1126500|NCT01577745|3698614|P4|Overall Study|Withdrawal by Subject|3
1126501|NCT01577745|3698615|P3|Overall Study|Withdrawal by Subject|0
1126502|NCT01577745|3698616|P2|Overall Study|Withdrawal by Subject|1
1126503|NCT01577745|3698617|P1|Overall Study|Withdrawal by Subject|0
1126504|NCT01577381|3698801|P4|Overall Study|Ongoing at Date of Cut-Off|0
1126505|NCT01577381|3698802|P3|Overall Study|Ongoing at Date of Cut-Off|1
1126506|NCT01577381|3698803|P2|Overall Study|Ongoing at Date of Cut-Off|2
1126507|NCT01577381|3698804|P1|Overall Study|Ongoing at Date of Cut-Off|0
1126508|NCT01577381|3698801|P4|Overall Study|Discontinued|2
1126509|NCT01577381|3698802|P3|Overall Study|Discontinued|2
1126510|NCT01577381|3698803|P2|Overall Study|Discontinued|1
1126511|NCT01577381|3698804|P1|Overall Study|Discontinued|2
1126512|NCT01577186|3698942|P1|Overall Study|Other|2
1126513|NCT01577186|3698942|P1|Overall Study|Non-Compliant|8
1126514|NCT01577186|3698942|P1|Overall Study|Ineligible to Continue|15
1126515|NCT01577186|3698942|P1|Overall Study|Insufficient Response|18
1126516|NCT01577186|3698942|P1|Overall Study|Withdrawal by Subject|35
1126517|NCT01577186|3698942|P1|Overall Study|Lost to Follow-up|28
1126518|NCT01577186|3698942|P1|Overall Study|Death|1
1126519|NCT01577186|3698942|P1|Overall Study|Adverse Event|23
1126520|NCT01577160|3698950|P1|Overall Study|Other|9
1126521|NCT01577160|3698950|P1|Overall Study|Subject Uncooperative|7
1126522|NCT01577160|3698950|P1|Overall Study|Withdrawal by Subject|18
1126523|NCT01577160|3698950|P1|Overall Study|Lost to Follow-up|40
1126524|NCT01577160|3698950|P1|Overall Study|Lack of Efficacy|15
1126525|NCT01577160|3698950|P1|Overall Study|Adverse Event|9
1126526|NCT01576718|3699009|P7|Treatment Period|Noncompliance to study medication|1
1126527|NCT01576718|3699010|P6|Treatment Period|Noncompliance to study medication|1
1126528|NCT01576718|3699011|P5|Treatment Period|Noncompliance to study medication|0
1126529|NCT01576718|3699012|P4|Treatment Period|Noncompliance to study medication|0
1126530|NCT01576718|3699013|P3|Treatment Period|Noncompliance to study medication|0
1126531|NCT01576718|3699014|P2|Treatment Period|Noncompliance to study medication|0
1126532|NCT01576718|3699015|P1|Treatment Period|Noncompliance to study medication|0
1126533|NCT01576718|3699009|P7|Treatment Period|Lost to Follow-up|0
1126534|NCT01576718|3699010|P6|Treatment Period|Lost to Follow-up|0
1126535|NCT01576718|3699011|P5|Treatment Period|Lost to Follow-up|1
1126536|NCT01576718|3699012|P4|Treatment Period|Lost to Follow-up|0
1126537|NCT01576718|3699013|P3|Treatment Period|Lost to Follow-up|0
1126538|NCT01576718|3699014|P2|Treatment Period|Lost to Follow-up|0
1126539|NCT01576718|3699015|P1|Treatment Period|Lost to Follow-up|0
1126540|NCT01576718|3699009|P7|Treatment Period|Met stopping criteria|15
1126541|NCT01576718|3699010|P6|Treatment Period|Met stopping criteria|33
1126542|NCT01576718|3699011|P5|Treatment Period|Met stopping criteria|16
1126543|NCT01576718|3699012|P4|Treatment Period|Met stopping criteria|19
1126544|NCT01576718|3699013|P3|Treatment Period|Met stopping criteria|13
1126545|NCT01576718|3699014|P2|Treatment Period|Met stopping criteria|16
1126546|NCT01576718|3699015|P1|Treatment Period|Met stopping criteria|0
1126547|NCT01576718|3699009|P7|Treatment Period|Sponsor request|0
1126548|NCT01576718|3699010|P6|Treatment Period|Sponsor request|1
1126549|NCT01576718|3699011|P5|Treatment Period|Sponsor request|0
1126550|NCT01576718|3699012|P4|Treatment Period|Sponsor request|0
1126551|NCT01576718|3699013|P3|Treatment Period|Sponsor request|0
1126552|NCT01576718|3699014|P2|Treatment Period|Sponsor request|1
1126553|NCT01576718|3699015|P1|Treatment Period|Sponsor request|0
1126554|NCT01576718|3699009|P7|Treatment Period|Protocol Violation|12
1126555|NCT01576718|3699010|P6|Treatment Period|Protocol Violation|8
1126556|NCT01576718|3699011|P5|Treatment Period|Protocol Violation|6
1126557|NCT01576718|3699012|P4|Treatment Period|Protocol Violation|10
1126558|NCT01576718|3699013|P3|Treatment Period|Protocol Violation|4
1126559|NCT01576718|3699014|P2|Treatment Period|Protocol Violation|5
1126560|NCT01576718|3699015|P1|Treatment Period|Protocol Violation|0
1126561|NCT01576718|3699009|P7|Treatment Period|Physician Decision|0
1126562|NCT01576718|3699010|P6|Treatment Period|Physician Decision|0
1126563|NCT01576718|3699011|P5|Treatment Period|Physician Decision|1
1126564|NCT01576718|3699012|P4|Treatment Period|Physician Decision|1
1126565|NCT01576718|3699013|P3|Treatment Period|Physician Decision|1
1126566|NCT01576718|3699014|P2|Treatment Period|Physician Decision|1
1126567|NCT01576718|3699015|P1|Treatment Period|Physician Decision|0
1126568|NCT01576718|3699009|P7|Treatment Period|Withdrawal by Subject|2
1126569|NCT01576718|3699010|P6|Treatment Period|Withdrawal by Subject|4
1126570|NCT01576718|3699011|P5|Treatment Period|Withdrawal by Subject|2
1126571|NCT01576718|3699012|P4|Treatment Period|Withdrawal by Subject|0
1126572|NCT01576718|3699013|P3|Treatment Period|Withdrawal by Subject|1
1126573|NCT01576718|3699014|P2|Treatment Period|Withdrawal by Subject|1
1126574|NCT01576718|3699015|P1|Treatment Period|Withdrawal by Subject|0
1126575|NCT01576718|3699009|P7|Treatment Period|Adverse Event|0
1126576|NCT01576718|3699010|P6|Treatment Period|Adverse Event|1
1126577|NCT01576718|3699011|P5|Treatment Period|Adverse Event|1
1126578|NCT01576718|3699012|P4|Treatment Period|Adverse Event|1
1126579|NCT01576718|3699013|P3|Treatment Period|Adverse Event|1
1126580|NCT01576718|3699014|P2|Treatment Period|Adverse Event|1
1126581|NCT01576718|3699015|P1|Treatment Period|Adverse Event|0
1126582|NCT01576718|3699009|P7|Pre-Assignment Period (Run-In Placebo)|Not specified|0
1126583|NCT01576718|3699010|P6|Pre-Assignment Period (Run-In Placebo)|Not specified|0
1126584|NCT01576718|3699011|P5|Pre-Assignment Period (Run-In Placebo)|Not specified|0
1126585|NCT01576718|3699012|P4|Pre-Assignment Period (Run-In Placebo)|Not specified|0
1126586|NCT01576718|3699013|P3|Pre-Assignment Period (Run-In Placebo)|Not specified|0
1126587|NCT01576718|3699014|P2|Pre-Assignment Period (Run-In Placebo)|Not specified|0
1126588|NCT01576718|3699015|P1|Pre-Assignment Period (Run-In Placebo)|Not specified|15
1126589|NCT01576718|3699009|P7|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1126590|NCT01576718|3699010|P6|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1126591|NCT01576718|3699011|P5|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1126592|NCT01576718|3699012|P4|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1126593|NCT01576718|3699013|P3|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1126594|NCT01576718|3699014|P2|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1126595|NCT01576718|3699015|P1|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2
1126596|NCT01576718|3699009|P7|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1126597|NCT01576718|3699010|P6|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1126598|NCT01576718|3699011|P5|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1126599|NCT01576718|3699012|P4|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1126600|NCT01576718|3699013|P3|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1126601|NCT01576718|3699014|P2|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1126602|NCT01576718|3699015|P1|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166
1126603|NCT01576718|3699009|P7|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1126604|NCT01576718|3699010|P6|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1126605|NCT01576718|3699011|P5|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1126606|NCT01576718|3699012|P4|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1126607|NCT01576718|3699013|P3|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1126608|NCT01576718|3699014|P2|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1126609|NCT01576718|3699015|P1|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17
1126610|NCT01576718|3699009|P7|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1126611|NCT01576718|3699010|P6|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1126612|NCT01576718|3699011|P5|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1126613|NCT01576718|3699012|P4|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1126614|NCT01576718|3699013|P3|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1126615|NCT01576718|3699014|P2|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1126616|NCT01576718|3699015|P1|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49
1126617|NCT01576549|3699107|P1|Overall Study|Sponsor Decision|2
1126618|NCT01576406|3699130|P6|Overall Study|Other|0
1126619|NCT01576406|3699131|P5|Overall Study|Other|0
1126620|NCT01576406|3699132|P4|Overall Study|Other|2
1126621|NCT01576406|3699133|P3|Overall Study|Other|2
1126622|NCT01576406|3699134|P2|Overall Study|Other|0
1126623|NCT01576406|3699135|P1|Overall Study|Other|0
1126624|NCT01576406|3699130|P6|Overall Study|Withdrawal the consent|3
1126625|NCT01576406|3699131|P5|Overall Study|Withdrawal the consent|1
1126626|NCT01576406|3699132|P4|Overall Study|Withdrawal the consent|1
1126627|NCT01576406|3699133|P3|Overall Study|Withdrawal the consent|5
1126628|NCT01576406|3699134|P2|Overall Study|Withdrawal the consent|2
1126629|NCT01576406|3699135|P1|Overall Study|Withdrawal the consent|2
1126630|NCT01576406|3699130|P6|Overall Study|Non-clinical trial supply of Crizotinib|0
1126631|NCT01576406|3699131|P5|Overall Study|Non-clinical trial supply of Crizotinib|0
1126632|NCT01576406|3699132|P4|Overall Study|Non-clinical trial supply of Crizotinib|1
1126633|NCT01576406|3699133|P3|Overall Study|Non-clinical trial supply of Crizotinib|1
1126634|NCT01576406|3699134|P2|Overall Study|Non-clinical trial supply of Crizotinib|0
1126635|NCT01576406|3699135|P1|Overall Study|Non-clinical trial supply of Crizotinib|0
1126636|NCT01576406|3699130|P6|Overall Study|Death|9
1126637|NCT01576406|3699131|P5|Overall Study|Death|7
1126638|NCT01576406|3699132|P4|Overall Study|Death|5
1126639|NCT01576406|3699133|P3|Overall Study|Death|8
1126640|NCT01576406|3699134|P2|Overall Study|Death|4
1126641|NCT01576406|3699135|P1|Overall Study|Death|3
1126642|NCT01576406|3699130|P6|Overall Study|Lost to Follow-up|0
1126643|NCT01576406|3699131|P5|Overall Study|Lost to Follow-up|0
1126644|NCT01576406|3699132|P4|Overall Study|Lost to Follow-up|0
1126645|NCT01576406|3699133|P3|Overall Study|Lost to Follow-up|0
1126646|NCT01576406|3699134|P2|Overall Study|Lost to Follow-up|2
1126647|NCT01576406|3699135|P1|Overall Study|Lost to Follow-up|1
1126648|NCT01576367|3699383|P1|Overall Study|Moved to commercial use after 6 months|1
1126649|NCT01576367|3699383|P1|Overall Study|Unsatisfactory therapeutic effect|2
1126650|NCT01576341|3699391|P1|Overall Study|Other|12
1126651|NCT01576341|3699391|P1|Overall Study|Protocol Violation|12
1126652|NCT01576341|3699391|P1|Overall Study|Kidney transplantation|10
1126653|NCT01576341|3699391|P1|Overall Study|Lost to Follow-up|2
1126654|NCT01576341|3699391|P1|Overall Study|Physician Decision|2
1126655|NCT01576341|3699391|P1|Overall Study|Death|21
1126656|NCT01576341|3699391|P1|Overall Study|Adverse Event|10
1126657|NCT01576341|3699391|P1|Overall Study|Withdrawal by Subject|24
1126658|NCT01576159|3699412|P4|Overall Study|Protocol Violation|0
1126659|NCT01576159|3699413|P3|Overall Study|Protocol Violation|0
1126660|NCT01576159|3699414|P2|Overall Study|Protocol Violation|0
1126661|NCT01576159|3699415|P1|Overall Study|Protocol Violation|1
1126662|NCT01576159|3699412|P4|Overall Study|Lost to Follow-up|1
1126663|NCT01576159|3699413|P3|Overall Study|Lost to Follow-up|0
1126664|NCT01576159|3699414|P2|Overall Study|Lost to Follow-up|0
1126665|NCT01576159|3699415|P1|Overall Study|Lost to Follow-up|0
1126666|NCT01576159|3699412|P4|Overall Study|Physician Decision|0
1126667|NCT01576159|3699413|P3|Overall Study|Physician Decision|1
1126668|NCT01576159|3699414|P2|Overall Study|Physician Decision|0
1126669|NCT01576159|3699415|P1|Overall Study|Physician Decision|0
1126670|NCT01576159|3699412|P4|Overall Study|Withdrawal by Subject|0
1126671|NCT01576159|3699413|P3|Overall Study|Withdrawal by Subject|0
1126672|NCT01576159|3699414|P2|Overall Study|Withdrawal by Subject|1
1126673|NCT01576159|3699415|P1|Overall Study|Withdrawal by Subject|0
1126674|NCT01576146|3699433|P1|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1
1126675|NCT01576146|3699433|P1|Extension Period 2|Renal Transplant|1
1126676|NCT01576146|3699433|P1|Extension Period 2|Adverse Event|1
1126677|NCT01576146|3699433|P1|Extension Period 2|Death|1
1126678|NCT01576146|3699433|P1|Extension Period 2|Sponsor Decision|13
1126679|NCT01576146|3699433|P1|Extension Period 1|Renal Transplant|1
1126680|NCT01576146|3699433|P1|Extension Period 1|Parathyroidectomy|1
1126681|NCT01576146|3699433|P1|Extension Period 1|Lost to Follow-up|1
1126682|NCT01576146|3699433|P1|Extension Period 1|Withdrawal by Subject|1
1126683|NCT01576146|3699433|P1|Extension Period 1|Physician Decision|2
1126684|NCT01576146|3699433|P1|Extension Period 1|Death|2
1126685|NCT01576146|3699433|P1|Extension Period 1|Adverse Event|2
1126686|NCT01576042|3699466|P2|Overall Study|Physician Decision|0
1126687|NCT01576042|3699467|P1|Overall Study|Physician Decision|2
1126688|NCT01575899|3699503|P3|Overall Study|Protocol Violation|0
1126689|NCT01575899|3699504|P2|Overall Study|Protocol Violation|1
1126690|NCT01575899|3699505|P1|Overall Study|Protocol Violation|2
1126691|NCT01575899|3699503|P3|Overall Study|Lost to Follow-up|2
1126692|NCT01575899|3699504|P2|Overall Study|Lost to Follow-up|4
1126693|NCT01575899|3699505|P1|Overall Study|Lost to Follow-up|3
1126694|NCT01575873|3699519|P4|Overall Study|Other|2
1126695|NCT01575873|3699520|P3|Overall Study|Other|4
1126696|NCT01575873|3699521|P2|Overall Study|Other|0
1126697|NCT01575873|3699522|P1|Overall Study|Other|0
1126698|NCT01575873|3699519|P4|Overall Study|Requirement for Alternative Therapy|1
1126699|NCT01575873|3699520|P3|Overall Study|Requirement for Alternative Therapy|1
1126700|NCT01575873|3699521|P2|Overall Study|Requirement for Alternative Therapy|0
1126701|NCT01575873|3699522|P1|Overall Study|Requirement for Alternative Therapy|0
1126702|NCT01575873|3699519|P4|Overall Study|Protocol deviation|1
1126703|NCT01575873|3699520|P3|Overall Study|Protocol deviation|0
1126704|NCT01575873|3699521|P2|Overall Study|Protocol deviation|1
1126705|NCT01575873|3699522|P1|Overall Study|Protocol deviation|0
1126706|NCT01575873|3699519|P4|Overall Study|Administrative decision|0
1126707|NCT01575873|3699520|P3|Overall Study|Administrative decision|1
1126708|NCT01575873|3699521|P2|Overall Study|Administrative decision|1
1126709|NCT01575873|3699522|P1|Overall Study|Administrative decision|1
1126710|NCT01575873|3699519|P4|Overall Study|Noncompliance|3
1126711|NCT01575873|3699520|P3|Overall Study|Noncompliance|4
1126712|NCT01575873|3699521|P2|Overall Study|Noncompliance|2
1126713|NCT01575873|3699522|P1|Overall Study|Noncompliance|1
1126714|NCT01575873|3699519|P4|Overall Study|Death|9
1126715|NCT01575873|3699520|P3|Overall Study|Death|8
1126716|NCT01575873|3699521|P2|Overall Study|Death|2
1126717|NCT01575873|3699522|P1|Overall Study|Death|3
1126718|NCT01575873|3699519|P4|Overall Study|Lost to Follow-up|5
1126719|NCT01575873|3699520|P3|Overall Study|Lost to Follow-up|13
1126720|NCT01575873|3699521|P2|Overall Study|Lost to Follow-up|3
1126721|NCT01575873|3699522|P1|Overall Study|Lost to Follow-up|1
1126722|NCT01575873|3699519|P4|Overall Study|Adverse Event|12
1126723|NCT01575873|3699520|P3|Overall Study|Adverse Event|9
1126724|NCT01575873|3699521|P2|Overall Study|Adverse Event|7
1126725|NCT01575873|3699522|P1|Overall Study|Adverse Event|7
1126726|NCT01575873|3699519|P4|Overall Study|Withdrawal by Subject|34
1126727|NCT01575873|3699520|P3|Overall Study|Withdrawal by Subject|34
1126728|NCT01575873|3699521|P2|Overall Study|Withdrawal by Subject|20
1126729|NCT01575873|3699522|P1|Overall Study|Withdrawal by Subject|15
1126730|NCT01575834|3699548|P2|Overall Study|Requirement for Alternative Therapy|4
1126731|NCT01575834|3699549|P1|Overall Study|Requirement for Alternative Therapy|2
1126732|NCT01575834|3699548|P2|Overall Study|Protocol Deviation|3
1126733|NCT01575834|3699549|P1|Overall Study|Protocol Deviation|4
1126734|NCT01575834|3699548|P2|Overall Study|Ineligibility Determined|8
1126735|NCT01575834|3699549|P1|Overall Study|Ineligibility Determined|5
1126736|NCT01575834|3699548|P2|Overall Study|Administrative decision|33
1126737|NCT01575834|3699549|P1|Overall Study|Administrative decision|15
1126738|NCT01575834|3699548|P2|Overall Study|Noncompliance|27
1126739|NCT01575834|3699549|P1|Overall Study|Noncompliance|52
1126740|NCT01575834|3699548|P2|Overall Study|Lost to Follow-up|68
1126741|NCT01575834|3699549|P1|Overall Study|Lost to Follow-up|55
1126742|NCT01575834|3699548|P2|Overall Study|Adverse Event|61
1126743|NCT01575834|3699549|P1|Overall Study|Adverse Event|63
1126744|NCT01575834|3699548|P2|Overall Study|Other|70
1126745|NCT01575834|3699549|P1|Overall Study|Other|70
1126746|NCT01575834|3699548|P2|Overall Study|Death|74
1126747|NCT01575834|3699549|P1|Overall Study|Death|81
1126748|NCT01575834|3699548|P2|Overall Study|Withdrawal by Subject|390
1126749|NCT01575834|3699549|P1|Overall Study|Withdrawal by Subject|352
1126750|NCT01575808|3699601|P2|Overall Study|Withdrawal by Subject|0
1126751|NCT01575808|3699602|P1|Overall Study|Withdrawal by Subject|1
1126752|NCT01575808|3699601|P2|Overall Study|Death|0
1126753|NCT01575808|3699602|P1|Overall Study|Death|2
1126754|NCT01575769|3699649|P1|Overall Study|Study terminated by sponsor|40
1126755|NCT01575769|3699649|P1|Overall Study|Adverse Event|1
1126756|NCT01575561|3699707|P1|Overall Study|administration|1
1126757|NCT01575561|3699707|P1|Overall Study|Withdrawal by Subject|11
1126758|NCT01575561|3699707|P1|Overall Study|Protocol Violation|4
1126759|NCT01575561|3699707|P1|Overall Study|Lost to Follow-up|6
1126760|NCT01575561|3699707|P1|Overall Study|Lack of Efficacy|8
1126761|NCT01575561|3699707|P1|Overall Study|Adverse Event|9
1126762|NCT01575197|3699737|P3|Overall Study|Protocol Violation|1
1126763|NCT01575197|3699738|P2|Overall Study|Protocol Violation|1
1126764|NCT01575197|3699739|P1|Overall Study|Protocol Violation|2
1126765|NCT01575197|3699737|P3|Overall Study|Withdrawal by Subject|1
1126766|NCT01575197|3699738|P2|Overall Study|Withdrawal by Subject|1
1126767|NCT01575197|3699739|P1|Overall Study|Withdrawal by Subject|0
1126768|NCT01575197|3699737|P3|Overall Study|Lost to Follow-up|0
1126769|NCT01575197|3699738|P2|Overall Study|Lost to Follow-up|1
1126770|NCT01575197|3699739|P1|Overall Study|Lost to Follow-up|0
1126771|NCT01575197|3699737|P3|Overall Study|SAE|0
1126772|NCT01575197|3699738|P2|Overall Study|SAE|1
1126773|NCT01575197|3699739|P1|Overall Study|SAE|0
1126774|NCT01575197|3699737|P3|Overall Study|Migration out of study area|4
1126775|NCT01575197|3699738|P2|Overall Study|Migration out of study area|5
1126776|NCT01575197|3699739|P1|Overall Study|Migration out of study area|1
1126777|NCT01575054|3699767|P2|Overall Study|Adverse Event|8
1126778|NCT01575054|3699768|P1|Overall Study|Adverse Event|9
1126779|NCT01575054|3699767|P2|Overall Study|Lost to Follow-up|3
1126780|NCT01575054|3699768|P1|Overall Study|Lost to Follow-up|3
1126781|NCT01575054|3699767|P2|Overall Study|Personal Reasons|11
1126782|NCT01575054|3699768|P1|Overall Study|Personal Reasons|10
1126783|NCT01575054|3699767|P2|Overall Study|Protocol Violation|1
1126784|NCT01575054|3699768|P1|Overall Study|Protocol Violation|2
1126785|NCT01575054|3699767|P2|Overall Study|Other Reasons|3
1126786|NCT01575054|3699768|P1|Overall Study|Other Reasons|5
1126787|NCT01575028|3699784|P2|Overall Study|Physician Decision|1
1126788|NCT01575028|3699785|P1|Overall Study|Physician Decision|0
1126789|NCT01574703|3699795|P4|Overall Study|Death|0
1126790|NCT01574703|3699796|P3|Overall Study|Death|1
1126791|NCT01574703|3699797|P2|Overall Study|Death|1
1126792|NCT01574703|3699798|P1|Overall Study|Death|2
1126793|NCT01574703|3699795|P4|Overall Study|Lost to Follow-up|35
1126794|NCT01574703|3699796|P3|Overall Study|Lost to Follow-up|46
1126795|NCT01574703|3699797|P2|Overall Study|Lost to Follow-up|41
1126796|NCT01574703|3699798|P1|Overall Study|Lost to Follow-up|43
1126797|NCT01574703|3699795|P4|Overall Study|Met Withdrawal Criteria|0
1126798|NCT01574703|3699796|P3|Overall Study|Met Withdrawal Criteria|1
1126799|NCT01574703|3699797|P2|Overall Study|Met Withdrawal Criteria|1
1126800|NCT01574703|3699798|P1|Overall Study|Met Withdrawal Criteria|0
1126801|NCT01574703|3699795|P4|Overall Study|Withdrawal by Subject|61
1126802|NCT01574703|3699796|P3|Overall Study|Withdrawal by Subject|36
1126803|NCT01574703|3699797|P2|Overall Study|Withdrawal by Subject|52
1126804|NCT01574703|3699798|P1|Overall Study|Withdrawal by Subject|53
1126805|NCT01574703|3699795|P4|Overall Study|Unspecified Reason|16
1126806|NCT01574703|3699796|P3|Overall Study|Unspecified Reason|20
1126807|NCT01574703|3699797|P2|Overall Study|Unspecified Reason|15
1126808|NCT01574703|3699798|P1|Overall Study|Unspecified Reason|27
1126809|NCT01574703|3699795|P4|Overall Study|Protocol Violation|1
1126810|NCT01574703|3699796|P3|Overall Study|Protocol Violation|0
1126811|NCT01574703|3699797|P2|Overall Study|Protocol Violation|0
1126812|NCT01574703|3699798|P1|Overall Study|Protocol Violation|0
1126813|NCT01574703|3699795|P4|Overall Study|Adverse Event|1
1126814|NCT01574703|3699796|P3|Overall Study|Adverse Event|1
1126815|NCT01574703|3699797|P2|Overall Study|Adverse Event|2
1126816|NCT01574703|3699798|P1|Overall Study|Adverse Event|0
1126817|NCT01574651|3699842|P2|Overall Study|Withdrawal by Subject|10
1126818|NCT01574651|3699843|P1|Overall Study|Withdrawal by Subject|9
1126819|NCT01574651|3699842|P2|Overall Study|Protocol Violation|5
1126820|NCT01574651|3699843|P1|Overall Study|Protocol Violation|3
1126821|NCT01574651|3699842|P2|Overall Study|Unsatisfactory therapeutic effect|0
1126822|NCT01574651|3699843|P1|Overall Study|Unsatisfactory therapeutic effect|6
1126823|NCT01574651|3699842|P2|Overall Study|Abnormal test procedure result(s)|1
1126824|NCT01574651|3699843|P1|Overall Study|Abnormal test procedure result(s)|1
1126825|NCT01574651|3699842|P2|Overall Study|Abnormal laboratory value(s)|0
1126826|NCT01574651|3699843|P1|Overall Study|Abnormal laboratory value(s)|1
1126827|NCT01574651|3699842|P2|Overall Study|Adverse Event|27
1126828|NCT01574651|3699843|P1|Overall Study|Adverse Event|36
1126829|NCT01574651|3699842|P2|Overall Study|Patient's inability to use the device|1
1126830|NCT01574651|3699843|P1|Overall Study|Patient's inability to use the device|0
1126831|NCT01574651|3699842|P2|Overall Study|Death|3
1126832|NCT01574651|3699843|P1|Overall Study|Death|3
1126833|NCT01574651|3699842|P2|Overall Study|Administrative problems|1
1126834|NCT01574651|3699843|P1|Overall Study|Administrative problems|0
1126835|NCT01574651|3699842|P2|Overall Study|Lost to Follow-up|4
1126836|NCT01574651|3699843|P1|Overall Study|Lost to Follow-up|2
1126837|NCT01574612|3699865|P1|Overall Study|Lost to Follow-up|2
1126838|NCT01574612|3699865|P1|Overall Study|Withdrawal by Subject|1
1126839|NCT01574612|3699865|P1|Overall Study|non compliant with drug|2
1126840|NCT01574612|3699865|P1|Overall Study|Adverse Event|3
1126841|NCT01574326|3699871|P2|Overall Study|Other: Mainly kidney transplant|8
1126842|NCT01574326|3699872|P1|Overall Study|Other: Mainly kidney transplant|8
1126843|NCT01574326|3699871|P2|Overall Study|Adverse Event|3
1126844|NCT01574326|3699872|P1|Overall Study|Adverse Event|1
1126845|NCT01574326|3699871|P2|Overall Study|Physician Decision|3
1126846|NCT01574326|3699872|P1|Overall Study|Physician Decision|5
1126847|NCT01574326|3699871|P2|Overall Study|Withdrawal by Participant|4
1126848|NCT01574326|3699872|P1|Overall Study|Withdrawal by Participant|2
1126849|NCT01574326|3699871|P2|Overall Study|Randomized but not treated|1
1126850|NCT01574326|3699872|P1|Overall Study|Randomized but not treated|0
1126851|NCT01574248|3699885|P2|Overall Study|Missing primary endpoint data|0
1126852|NCT01574248|3699886|P1|Overall Study|Missing primary endpoint data|1
1126853|NCT01574248|3699885|P2|Overall Study|Withdrawal by Subject|0
1126854|NCT01574248|3699886|P1|Overall Study|Withdrawal by Subject|2
1126855|NCT01574079|3699935|P2|Overall Study|Lost to Follow-up|0
1126856|NCT01574079|3699936|P1|Overall Study|Lost to Follow-up|1
1126857|NCT01574079|3699935|P2|Overall Study|Physician Decision|2
1126858|NCT01574079|3699936|P1|Overall Study|Physician Decision|0
1126859|NCT01573910|3699948|P2|Overall Study|Patient decision unrelated to Advs Event|11
1126860|NCT01573910|3699949|P1|Overall Study|Patient decision unrelated to Advs Event|11
1126861|NCT01573910|3699948|P2|Overall Study|Protocol Violation|0
1126862|NCT01573910|3699949|P1|Overall Study|Protocol Violation|3
1126863|NCT01573910|3699948|P2|Overall Study|Withdrawal by Subject|1
1126864|NCT01573910|3699949|P1|Overall Study|Withdrawal by Subject|0
1126865|NCT01573910|3699948|P2|Overall Study|Lost to Follow-up|1
1126866|NCT01573910|3699949|P1|Overall Study|Lost to Follow-up|2
1126867|NCT01573910|3699948|P2|Overall Study|Adverse Event|4
1126868|NCT01573910|3699949|P1|Overall Study|Adverse Event|4
1126869|NCT01573767|3699961|P4|Overall Study|Withdrawal by Subject|0
1126870|NCT01573767|3699962|P3|Overall Study|Withdrawal by Subject|0
1126871|NCT01573767|3699963|P2|Overall Study|Withdrawal by Subject|1
1126872|NCT01573767|3699964|P1|Overall Study|Withdrawal by Subject|0
1126873|NCT01573767|3699961|P4|Overall Study|Physician Decision|2
1126874|NCT01573767|3699962|P3|Overall Study|Physician Decision|0
1126875|NCT01573767|3699963|P2|Overall Study|Physician Decision|2
1126876|NCT01573767|3699964|P1|Overall Study|Physician Decision|1
1126877|NCT01573767|3699961|P4|Overall Study|Lost to Follow-up|1
1126878|NCT01573767|3699962|P3|Overall Study|Lost to Follow-up|1
1126879|NCT01573767|3699963|P2|Overall Study|Lost to Follow-up|1
1126880|NCT01573767|3699964|P1|Overall Study|Lost to Follow-up|0
1126881|NCT01573767|3699961|P4|Overall Study|Protocol Violation|3
1126882|NCT01573767|3699962|P3|Overall Study|Protocol Violation|1
1126883|NCT01573767|3699963|P2|Overall Study|Protocol Violation|1
1126884|NCT01573767|3699964|P1|Overall Study|Protocol Violation|3
1126885|NCT01573767|3699961|P4|Overall Study|Lack of Efficacy|17
1126886|NCT01573767|3699962|P3|Overall Study|Lack of Efficacy|12
1126887|NCT01573767|3699963|P2|Overall Study|Lack of Efficacy|15
1126888|NCT01573767|3699964|P1|Overall Study|Lack of Efficacy|18
1126889|NCT01573767|3699961|P4|Overall Study|Adverse Event|1
1126890|NCT01573767|3699962|P3|Overall Study|Adverse Event|0
1126891|NCT01573767|3699963|P2|Overall Study|Adverse Event|1
1126892|NCT01573767|3699964|P1|Overall Study|Adverse Event|0
1126893|NCT01573624|3699998|P7|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
1126894|NCT01573624|3699999|P6|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
1126895|NCT01573624|3700000|P5|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
1126896|NCT01573624|3700001|P4|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
1126897|NCT01573624|3700002|P3|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
1126898|NCT01573624|3700003|P2|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
1126899|NCT01573624|3700004|P1|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1
1126900|NCT01573624|3699998|P7|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
1126901|NCT01573624|3699999|P6|Period 6 : Follow-up Period (7 Days)|Adverse Event|1
1126902|NCT01573624|3700000|P5|Period 6 : Follow-up Period (7 Days)|Adverse Event|2
1126903|NCT01573624|3700001|P4|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
1126904|NCT01573624|3700002|P3|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
1126905|NCT01573624|3700003|P2|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
1126906|NCT01573624|3700004|P1|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
1126907|NCT01573624|3699998|P7|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
1126908|NCT01573624|3699999|P6|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
1126909|NCT01573624|3700000|P5|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
1126910|NCT01573624|3700001|P4|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
1126911|NCT01573624|3700002|P3|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
1126912|NCT01573624|3700003|P2|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
1126913|NCT01573624|3700004|P1|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1
1126914|NCT01573624|3699998|P7|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
1126915|NCT01573624|3699999|P6|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
1126916|NCT01573624|3700000|P5|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
1126917|NCT01573624|3700001|P4|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
1126918|NCT01573624|3700002|P3|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
1126919|NCT01573624|3700003|P2|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
1126920|NCT01573624|3700004|P1|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
1126921|NCT01573624|3699998|P7|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4
1126922|NCT01573624|3699999|P6|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
1126923|NCT01573624|3700000|P5|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
1126924|NCT01573624|3700001|P4|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
1126925|NCT01573624|3700002|P3|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
1126926|NCT01573624|3700003|P2|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
1126927|NCT01573624|3700004|P1|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2
1126928|NCT01573624|3699998|P7|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
1126929|NCT01573624|3699999|P6|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
1126930|NCT01573624|3700000|P5|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
1126931|NCT01573624|3700001|P4|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
1126932|NCT01573624|3700002|P3|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
1126933|NCT01573624|3700003|P2|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
1126934|NCT01573624|3700004|P1|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
1126935|NCT01573624|3699998|P7|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
1126936|NCT01573624|3699999|P6|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
1126937|NCT01573624|3700000|P5|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1126938|NCT01573624|3700001|P4|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1126939|NCT01573624|3700002|P3|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1126940|NCT01573624|3700003|P2|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1126941|NCT01573624|3700004|P1|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1126942|NCT01573624|3699998|P7|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
1126943|NCT01573624|3699999|P6|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
1126944|NCT01573624|3700000|P5|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
1126945|NCT01573624|3700001|P4|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
1126946|NCT01573624|3700002|P3|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
1126947|NCT01573624|3700003|P2|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1
1126948|NCT01573624|3700004|P1|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
1126949|NCT01573624|3699998|P7|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
1126950|NCT01573624|3699999|P6|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
1126951|NCT01573624|3700000|P5|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
1126952|NCT01573624|3700001|P4|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
1126953|NCT01573624|3700002|P3|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
1126954|NCT01573624|3700003|P2|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1
1126955|NCT01573624|3700004|P1|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
1126956|NCT01573624|3699998|P7|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
1126957|NCT01573624|3699999|P6|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
1126958|NCT01573624|3700000|P5|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
1126959|NCT01573624|3700001|P4|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
1126960|NCT01573624|3700002|P3|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
1126961|NCT01573624|3700003|P2|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
1126962|NCT01573624|3700004|P1|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
1126963|NCT01573624|3699998|P7|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
1126964|NCT01573624|3699999|P6|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
1126965|NCT01573624|3700000|P5|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
1126966|NCT01573624|3700001|P4|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
1126967|NCT01573624|3700002|P3|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
1126968|NCT01573624|3700003|P2|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
1126969|NCT01573624|3700004|P1|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
1126970|NCT01573624|3699998|P7|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
1126971|NCT01573624|3699999|P6|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
1126972|NCT01573624|3700000|P5|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
1126973|NCT01573624|3700001|P4|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
1126974|NCT01573624|3700002|P3|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
1126975|NCT01573624|3700003|P2|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
1126976|NCT01573624|3700004|P1|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1
1126977|NCT01573624|3699998|P7|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
1126978|NCT01573624|3699999|P6|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
1126979|NCT01573624|3700000|P5|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
1126980|NCT01573624|3700001|P4|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
1126981|NCT01573624|3700002|P3|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
1126982|NCT01573624|3700003|P2|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
1126983|NCT01573624|3700004|P1|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
1126984|NCT01573624|3699998|P7|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
1126985|NCT01573624|3699999|P6|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
1126986|NCT01573624|3700000|P5|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
1126987|NCT01573624|3700001|P4|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
1126988|NCT01573624|3700002|P3|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
1126989|NCT01573624|3700003|P2|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
1126990|NCT01573624|3700004|P1|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1
1126991|NCT01573624|3699998|P7|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
1126992|NCT01573624|3699999|P6|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2
1126993|NCT01573624|3700000|P5|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
1126994|NCT01573624|3700001|P4|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
1126995|NCT01573624|3700002|P3|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
1126996|NCT01573624|3700003|P2|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1
1126997|NCT01573624|3700004|P1|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
1126998|NCT01573624|3699998|P7|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0
1126999|NCT01573624|3699999|P6|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
1127000|NCT01573624|3700000|P5|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3
1127001|NCT01573624|3700001|P4|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1
1127002|NCT01573624|3700002|P3|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
1127003|NCT01573624|3700003|P2|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4
1127004|NCT01573624|3700004|P1|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5
1127005|NCT01573624|3699998|P7|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
1127006|NCT01573624|3699999|P6|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
1127007|NCT01573624|3700000|P5|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
1127008|NCT01573624|3700001|P4|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
1127009|NCT01573624|3700002|P3|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
1127010|NCT01573624|3700003|P2|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
1127011|NCT01573624|3700004|P1|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
1127012|NCT01573624|3699998|P7|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
1127013|NCT01573624|3699999|P6|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
1127014|NCT01573624|3700000|P5|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
1127015|NCT01573624|3700001|P4|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2
1127016|NCT01573624|3700002|P3|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
1127017|NCT01573624|3700003|P2|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
1127018|NCT01573624|3700004|P1|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
1127019|NCT01573624|3699998|P7|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
1127020|NCT01573624|3699999|P6|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1
1127021|NCT01573624|3700000|P5|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
1127022|NCT01573624|3700001|P4|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
1127023|NCT01573624|3700002|P3|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
1127024|NCT01573624|3700003|P2|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
1127025|NCT01573624|3700004|P1|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
1127026|NCT01573624|3699998|P7|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
1127027|NCT01573624|3699999|P6|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
1127028|NCT01573624|3700000|P5|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
1127029|NCT01573624|3700001|P4|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
1127030|NCT01573624|3700002|P3|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2
1127031|NCT01573624|3700003|P2|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
1127032|NCT01573624|3700004|P1|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
1127033|NCT01573624|3699998|P7|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
1127034|NCT01573624|3699999|P6|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
1127035|NCT01573624|3700000|P5|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
1127036|NCT01573624|3700001|P4|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
1127037|NCT01573624|3700002|P3|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
1127038|NCT01573624|3700003|P2|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
1127039|NCT01573624|3700004|P1|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
1127040|NCT01573624|3699998|P7|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
1127041|NCT01573624|3699999|P6|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1
1127042|NCT01573624|3700000|P5|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
1127043|NCT01573624|3700001|P4|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
1127044|NCT01573624|3700002|P3|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
1127045|NCT01573624|3700003|P2|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
1127046|NCT01573624|3700004|P1|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
1127047|NCT01573624|3699998|P7|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
1127048|NCT01573624|3699999|P6|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
1127049|NCT01573624|3700000|P5|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
1127050|NCT01573624|3700001|P4|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
1127051|NCT01573624|3700002|P3|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
1127052|NCT01573624|3700003|P2|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
1127053|NCT01573624|3700004|P1|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
1127054|NCT01573624|3699998|P7|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1127055|NCT01573624|3699999|P6|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2
1127056|NCT01573624|3700000|P5|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1127057|NCT01573624|3700001|P4|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1127058|NCT01573624|3700002|P3|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
1127059|NCT01573624|3700003|P2|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1127060|NCT01573624|3700004|P1|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
1127061|NCT01573624|3699998|P7|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
1127062|NCT01573624|3699999|P6|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
1127063|NCT01573624|3700000|P5|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
1127064|NCT01573624|3700001|P4|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
1127065|NCT01573624|3700002|P3|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
1127066|NCT01573624|3700003|P2|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
1127067|NCT01573624|3700004|P1|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1
1127068|NCT01573624|3699998|P7|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
1127069|NCT01573624|3699999|P6|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0
1127070|NCT01573624|3700000|P5|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2
1127071|NCT01573624|3700001|P4|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
1127072|NCT01573624|3700002|P3|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6
1127073|NCT01573624|3700003|P2|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3
1127074|NCT01573624|3700004|P1|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4
1127157|NCT01572792|3700230|P1|Lead-in Study|Protocol Violation|19
1127075|NCT01573624|3699998|P7|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
1127076|NCT01573624|3699999|P6|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
1127077|NCT01573624|3700000|P5|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
1127078|NCT01573624|3700001|P4|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
1127079|NCT01573624|3700002|P3|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
1127080|NCT01573624|3700003|P2|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
1127081|NCT01573624|3700004|P1|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
1127082|NCT01573000|3700093|P2|Long-Term Follow-Up|Lost to Follow-up|1
1127083|NCT01573000|3700094|P1|Long-Term Follow-Up|Lost to Follow-up|0
1127084|NCT01573000|3700093|P2|Long-Term Follow-Up|Death|0
1127085|NCT01573000|3700094|P1|Long-Term Follow-Up|Death|3
1127086|NCT01573000|3700093|P2|Crossover Phase|Death|3
1127087|NCT01573000|3700094|P1|Crossover Phase|Death|0
1127088|NCT01573000|3700093|P2|Crossover Phase|Lost to Follow-up|2
1127089|NCT01573000|3700094|P1|Crossover Phase|Lost to Follow-up|0
1127090|NCT01573000|3700093|P2|Crossover Phase|Lack of Efficacy|13
1127091|NCT01573000|3700094|P1|Crossover Phase|Lack of Efficacy|0
1127092|NCT01573000|3700093|P2|Dosimetric and Therapeutic Treatment|Received Other Treatment|0
1127093|NCT01573000|3700094|P1|Dosimetric and Therapeutic Treatment|Received Other Treatment|2
1127094|NCT01573000|3700093|P2|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0
1127095|NCT01573000|3700094|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2
1127096|NCT01573000|3700093|P2|Dosimetric and Therapeutic Treatment|Death|1
1127097|NCT01573000|3700094|P1|Dosimetric and Therapeutic Treatment|Death|0
1127098|NCT01573000|3700093|P2|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
1127099|NCT01573000|3700094|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4
1127100|NCT01573000|3700093|P2|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32
1127101|NCT01573000|3700094|P1|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27
1127102|NCT01572948|3700190|P2|Overall Study|unable to contact|1
1127103|NCT01572948|3700191|P1|Overall Study|unable to contact|0
1127104|NCT01572948|3700190|P2|Overall Study|Lost to Follow-up|0
1127105|NCT01572948|3700191|P1|Overall Study|Lost to Follow-up|1
1127106|NCT01572844|3700207|P2|Overall Study|Physician Decision|1
1127107|NCT01572844|3700208|P1|Overall Study|Physician Decision|1
1127108|NCT01572792|3700226|P5|Extension Study|Site termination/COPD exacerbation/other|6
1127109|NCT01572792|3700227|P4|Extension Study|Site termination/COPD exacerbation/other|6
1127110|NCT01572792|3700228|P3|Extension Study|Site termination/COPD exacerbation/other|4
1127111|NCT01572792|3700229|P2|Extension Study|Site termination/COPD exacerbation/other|8
1127112|NCT01572792|3700230|P1|Extension Study|Site termination/COPD exacerbation/other|3
1127113|NCT01572792|3700226|P5|Extension Study|Adverse Event|4
1127114|NCT01572792|3700227|P4|Extension Study|Adverse Event|6
1127115|NCT01572792|3700228|P3|Extension Study|Adverse Event|5
1127116|NCT01572792|3700229|P2|Extension Study|Adverse Event|6
1127117|NCT01572792|3700230|P1|Extension Study|Adverse Event|7
1127118|NCT01572792|3700226|P5|Extension Study|Lack of Efficacy|2
1127119|NCT01572792|3700227|P4|Extension Study|Lack of Efficacy|2
1127120|NCT01572792|3700228|P3|Extension Study|Lack of Efficacy|3
1127121|NCT01572792|3700229|P2|Extension Study|Lack of Efficacy|3
1127122|NCT01572792|3700230|P1|Extension Study|Lack of Efficacy|2
1127123|NCT01572792|3700226|P5|Extension Study|Protocol Violation|3
1127124|NCT01572792|3700227|P4|Extension Study|Protocol Violation|4
1127125|NCT01572792|3700228|P3|Extension Study|Protocol Violation|3
1127126|NCT01572792|3700229|P2|Extension Study|Protocol Violation|4
1127127|NCT01572792|3700230|P1|Extension Study|Protocol Violation|0
1127128|NCT01572792|3700226|P5|Extension Study|Withdrawal by Subject|14
1127129|NCT01572792|3700227|P4|Extension Study|Withdrawal by Subject|8
1127130|NCT01572792|3700228|P3|Extension Study|Withdrawal by Subject|11
1127131|NCT01572792|3700229|P2|Extension Study|Withdrawal by Subject|6
1127132|NCT01572792|3700230|P1|Extension Study|Withdrawal by Subject|7
1127133|NCT01572792|3700226|P5|Extension Study|Lost to Follow-up|3
1127134|NCT01572792|3700227|P4|Extension Study|Lost to Follow-up|3
1127135|NCT01572792|3700228|P3|Extension Study|Lost to Follow-up|0
1127136|NCT01572792|3700229|P2|Extension Study|Lost to Follow-up|2
1127137|NCT01572792|3700230|P1|Extension Study|Lost to Follow-up|6
1127138|NCT01572792|3700226|P5|Lead-in Study|Site termination/COPD exacerbation/other|9
1127139|NCT01572792|3700227|P4|Lead-in Study|Site termination/COPD exacerbation/other|9
1127140|NCT01572792|3700228|P3|Lead-in Study|Site termination/COPD exacerbation/other|8
1127141|NCT01572792|3700229|P2|Lead-in Study|Site termination/COPD exacerbation/other|10
1127142|NCT01572792|3700230|P1|Lead-in Study|Site termination/COPD exacerbation/other|14
1127143|NCT01572792|3700226|P5|Lead-in Study|Adverse Event|14
1127144|NCT01572792|3700227|P4|Lead-in Study|Adverse Event|16
1127145|NCT01572792|3700228|P3|Lead-in Study|Adverse Event|22
1127146|NCT01572792|3700229|P2|Lead-in Study|Adverse Event|21
1127147|NCT01572792|3700230|P1|Lead-in Study|Adverse Event|21
1127148|NCT01572792|3700226|P5|Lead-in Study|Lack of Efficacy|10
1127149|NCT01572792|3700227|P4|Lead-in Study|Lack of Efficacy|8
1127150|NCT01572792|3700228|P3|Lead-in Study|Lack of Efficacy|4
1127151|NCT01572792|3700229|P2|Lead-in Study|Lack of Efficacy|5
1127152|NCT01572792|3700230|P1|Lead-in Study|Lack of Efficacy|20
1127153|NCT01572792|3700226|P5|Lead-in Study|Protocol Violation|21
1127154|NCT01572792|3700227|P4|Lead-in Study|Protocol Violation|13
1127155|NCT01572792|3700228|P3|Lead-in Study|Protocol Violation|12
1127156|NCT01572792|3700229|P2|Lead-in Study|Protocol Violation|10
1127158|NCT01572792|3700226|P5|Lead-in Study|Withdrawal by Subject|11
1127159|NCT01572792|3700227|P4|Lead-in Study|Withdrawal by Subject|24
1127160|NCT01572792|3700228|P3|Lead-in Study|Withdrawal by Subject|12
1127161|NCT01572792|3700229|P2|Lead-in Study|Withdrawal by Subject|11
1127162|NCT01572792|3700230|P1|Lead-in Study|Withdrawal by Subject|22
1127163|NCT01572792|3700226|P5|Lead-in Study|Lost to Follow-up|4
1127164|NCT01572792|3700227|P4|Lead-in Study|Lost to Follow-up|2
1127165|NCT01572792|3700228|P3|Lead-in Study|Lost to Follow-up|4
1127166|NCT01572792|3700229|P2|Lead-in Study|Lost to Follow-up|9
1127167|NCT01572792|3700230|P1|Lead-in Study|Lost to Follow-up|5
1127168|NCT01572740|3700279|P2|Overall Study|unclassified|3
1127169|NCT01572740|3700280|P1|Overall Study|unclassified|4
1127170|NCT01572740|3700279|P2|Overall Study|Withdrawal by Subject|1
1127171|NCT01572740|3700280|P1|Overall Study|Withdrawal by Subject|1
1127172|NCT01572740|3700279|P2|Overall Study|Adverse Event|1
1127173|NCT01572740|3700280|P1|Overall Study|Adverse Event|1
1127174|NCT01572727|3700310|P2|Overall Study|Untreated|7
1127175|NCT01572727|3700311|P1|Overall Study|Untreated|4
1127176|NCT01572727|3700310|P2|Overall Study|Death|2
1127177|NCT01572727|3700311|P1|Overall Study|Death|2
1127178|NCT01572727|3700310|P2|Overall Study|Parent/guardian decision|9
1127179|NCT01572727|3700311|P1|Overall Study|Parent/guardian decision|14
1127180|NCT01572727|3700310|P2|Overall Study|Study terminated by sponsor|83
1127181|NCT01572727|3700311|P1|Overall Study|Study terminated by sponsor|61
1127182|NCT01572727|3700310|P2|Overall Study|Protocol Violation|1
1127183|NCT01572727|3700311|P1|Overall Study|Protocol Violation|0
1127184|NCT01572727|3700310|P2|Overall Study|Progressive disease|82
1127185|NCT01572727|3700311|P1|Overall Study|Progressive disease|59
1127186|NCT01572727|3700310|P2|Overall Study|Physician Decision|9
1127187|NCT01572727|3700311|P1|Overall Study|Physician Decision|23
1127188|NCT01572727|3700310|P2|Overall Study|Lost to Follow-up|1
1127189|NCT01572727|3700311|P1|Overall Study|Lost to Follow-up|1
1127190|NCT01572727|3700310|P2|Overall Study|Adverse Event|15
1127191|NCT01572727|3700311|P1|Overall Study|Adverse Event|43
1127192|NCT01572675|3700333|P2|Overall Study|Lost to Follow-up|27
1127193|NCT01572675|3700334|P1|Overall Study|Lost to Follow-up|22
1127194|NCT01572675|3700333|P2|Overall Study|Missing data|4
1127195|NCT01572675|3700334|P1|Overall Study|Missing data|1
1127196|NCT01572675|3700333|P2|Overall Study|Rheumatologist new evaluation|1
1127197|NCT01572675|3700334|P1|Overall Study|Rheumatologist new evaluation|0
1127198|NCT01572675|3700333|P2|Overall Study|Unknown reason|1
1127199|NCT01572675|3700334|P1|Overall Study|Unknown reason|1
1127200|NCT01572675|3700333|P2|Overall Study|Other disease detected|1
1127201|NCT01572675|3700334|P1|Overall Study|Other disease detected|1
1127202|NCT01572675|3700333|P2|Overall Study|Death unrelated to coxibs|1
1127203|NCT01572675|3700334|P1|Overall Study|Death unrelated to coxibs|1
1127204|NCT01572675|3700333|P2|Overall Study|Physician Decision|2
1127205|NCT01572675|3700334|P1|Overall Study|Physician Decision|2
1127206|NCT01572675|3700333|P2|Overall Study|Withdrawal by Subject|1
1127207|NCT01572675|3700334|P1|Overall Study|Withdrawal by Subject|5
1127208|NCT01572675|3700333|P2|Overall Study|Surgical intervention|6
1127209|NCT01572675|3700334|P1|Overall Study|Surgical intervention|3
1127210|NCT01572675|3700333|P2|Overall Study|Improved symptoms|2
1127211|NCT01572675|3700334|P1|Overall Study|Improved symptoms|8
1127212|NCT01572675|3700333|P2|Overall Study|Intolerance|5
1127213|NCT01572675|3700334|P1|Overall Study|Intolerance|6
1127214|NCT01572675|3700333|P2|Overall Study|Lack of Efficacy|31
1127215|NCT01572675|3700334|P1|Overall Study|Lack of Efficacy|31
1127216|NCT01572675|3700333|P2|Overall Study|Recovery|23
1127217|NCT01572675|3700334|P1|Overall Study|Recovery|16
1127218|NCT01572675|3700333|P2|Overall Study|End of prescribed treatment|118
1127219|NCT01572675|3700334|P1|Overall Study|End of prescribed treatment|140
1127220|NCT01572389|3700433|P2|Overall Study|Only A1C or Assessment was Collected|2
1127221|NCT01572389|3700434|P1|Overall Study|Only A1C or Assessment was Collected|6
1127222|NCT01572389|3700433|P2|Overall Study|Lost to Follow-up|14
1127223|NCT01572389|3700434|P1|Overall Study|Lost to Follow-up|25
1127224|NCT01572389|3700433|P2|Overall Study|Withdrawal by Subject|2
1127225|NCT01572389|3700434|P1|Overall Study|Withdrawal by Subject|14
1127226|NCT01572389|3700433|P2|Overall Study|Death|3
1127227|NCT01572389|3700434|P1|Overall Study|Death|1
1127228|NCT01571453|3700475|P2|Overall Study|Administrative or other reason(s)|3
1127229|NCT01571453|3700476|P1|Overall Study|Administrative or other reason(s)|4
1127230|NCT01571453|3700475|P2|Overall Study|Lost to Follow-up|2
1127231|NCT01571453|3700476|P1|Overall Study|Lost to Follow-up|4
1127232|NCT01571453|3700475|P2|Overall Study|Withdrawal of consent|13
1127233|NCT01571453|3700476|P1|Overall Study|Withdrawal of consent|5
1127234|NCT01571453|3700475|P2|Overall Study|Protocol Violation|5
1127235|NCT01571453|3700476|P1|Overall Study|Protocol Violation|1
1127236|NCT01571453|3700475|P2|Overall Study|Non-compliance|4
1127237|NCT01571453|3700476|P1|Overall Study|Non-compliance|2
1127238|NCT01571453|3700475|P2|Overall Study|Lack of Efficacy|3
1127239|NCT01571453|3700476|P1|Overall Study|Lack of Efficacy|8
1127240|NCT01571453|3700475|P2|Overall Study|Adverse Event|32
1127241|NCT01571453|3700476|P1|Overall Study|Adverse Event|14
1127242|NCT01571362|3700492|P3|Double-Blind Treatment Period|Other - unspecified|1
1127243|NCT01571362|3700493|P2|Double-Blind Treatment Period|Other - unspecified|6
1127244|NCT01571362|3700494|P1|Double-Blind Treatment Period|Other - unspecified|0
1127245|NCT01571362|3700492|P3|Double-Blind Treatment Period|Insufficient clinical response|4
1127246|NCT01571362|3700493|P2|Double-Blind Treatment Period|Insufficient clinical response|16
1127247|NCT01571362|3700494|P1|Double-Blind Treatment Period|Insufficient clinical response|0
1127248|NCT01571362|3700492|P3|Double-Blind Treatment Period|Lost to Follow-up|6
1127249|NCT01571362|3700493|P2|Double-Blind Treatment Period|Lost to Follow-up|3
1127250|NCT01571362|3700494|P1|Double-Blind Treatment Period|Lost to Follow-up|0
1127251|NCT01571362|3700492|P3|Double-Blind Treatment Period|Adverse Event|14
1127252|NCT01571362|3700493|P2|Double-Blind Treatment Period|Adverse Event|9
1127253|NCT01571362|3700494|P1|Double-Blind Treatment Period|Adverse Event|0
1127254|NCT01571362|3700492|P3|Double-Blind Treatment Period|Protocol Violation|9
1127255|NCT01571362|3700493|P2|Double-Blind Treatment Period|Protocol Violation|8
1127256|NCT01571362|3700494|P1|Double-Blind Treatment Period|Protocol Violation|0
1127257|NCT01571362|3700492|P3|Double-Blind Treatment Period|Withdrawal by Subject|5
1127258|NCT01571362|3700493|P2|Double-Blind Treatment Period|Withdrawal by Subject|11
1127259|NCT01571362|3700494|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
1127260|NCT01571362|3700492|P3|Open-Label Conversion + Titration Period|Other - unspecified|0
1127261|NCT01571362|3700493|P2|Open-Label Conversion + Titration Period|Other - unspecified|0
1127262|NCT01571362|3700494|P1|Open-Label Conversion + Titration Period|Other - unspecified|3
1127263|NCT01571362|3700492|P3|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
1127264|NCT01571362|3700493|P2|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
1127265|NCT01571362|3700494|P1|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41
1127266|NCT01571362|3700492|P3|Open-Label Conversion + Titration Period|Lost to Follow-up|0
1127267|NCT01571362|3700493|P2|Open-Label Conversion + Titration Period|Lost to Follow-up|0
1127268|NCT01571362|3700494|P1|Open-Label Conversion + Titration Period|Lost to Follow-up|10
1127269|NCT01571362|3700492|P3|Open-Label Conversion + Titration Period|Adverse Event|0
1127270|NCT01571362|3700493|P2|Open-Label Conversion + Titration Period|Adverse Event|0
1127271|NCT01571362|3700494|P1|Open-Label Conversion + Titration Period|Adverse Event|57
1127272|NCT01571362|3700492|P3|Open-Label Conversion + Titration Period|Protocol Violation|0
1127273|NCT01571362|3700493|P2|Open-Label Conversion + Titration Period|Protocol Violation|0
1127274|NCT01571362|3700494|P1|Open-Label Conversion + Titration Period|Protocol Violation|7
1127275|NCT01571362|3700492|P3|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
1127276|NCT01571362|3700493|P2|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
1127277|NCT01571362|3700494|P1|Open-Label Conversion + Titration Period|Withdrawal by Subject|11
1127278|NCT01571284|3700664|P1|Overall Study|Other than specified above|80
1127279|NCT01571284|3700664|P1|Overall Study|Enrolled but not treated|2
1127280|NCT01571284|3700664|P1|Overall Study|Lost to Follow-up|3
1127281|NCT01571284|3700664|P1|Overall Study|Participant's decision|84
1127282|NCT01571232|3700687|P2|Overall Study|Withdrawal by Subject|0
1127283|NCT01571232|3700688|P1|Overall Study|Withdrawal by Subject|1
1127284|NCT01571232|3700687|P2|Overall Study|Lost to Follow-up|1
1127285|NCT01571232|3700688|P1|Overall Study|Lost to Follow-up|0
1127286|NCT01570751|3700700|P2|Period B (16 Weeks)|Protocol Violation|1
1127287|NCT01570751|3700701|P1|Period B (16 Weeks)|Protocol Violation|0
1127288|NCT01570751|3700700|P2|Period B (16 Weeks)|Adverse Event|0
1127289|NCT01570751|3700701|P1|Period B (16 Weeks)|Adverse Event|1
1127290|NCT01570751|3700700|P2|Period A (16 Weeks)|Unclassified|3
1127291|NCT01570751|3700701|P1|Period A (16 Weeks)|Unclassified|2
1127292|NCT01570751|3700700|P2|Period A (16 Weeks)|Withdrawal criteria|1
1127293|NCT01570751|3700701|P1|Period A (16 Weeks)|Withdrawal criteria|0
1127294|NCT01570751|3700700|P2|Period A (16 Weeks)|Protocol Violation|1
1127295|NCT01570751|3700701|P1|Period A (16 Weeks)|Protocol Violation|1
1127296|NCT01570686|3700719|P2|Overall Study|Unsatisfactory therapeutic effect|1
1127297|NCT01570686|3700720|P1|Overall Study|Unsatisfactory therapeutic effect|2
1127298|NCT01570686|3700719|P2|Overall Study|Withdrawal by Subject|4
1127299|NCT01570686|3700720|P1|Overall Study|Withdrawal by Subject|4
1127300|NCT01570686|3700719|P2|Overall Study|Protocol Deviation|0
1127301|NCT01570686|3700720|P1|Overall Study|Protocol Deviation|3
1127302|NCT01570686|3700719|P2|Overall Study|Lost to Follow-up|3
1127303|NCT01570686|3700720|P1|Overall Study|Lost to Follow-up|4
1127304|NCT01570686|3700719|P2|Overall Study|Adverse Event|6
1127305|NCT01570686|3700720|P1|Overall Study|Adverse Event|8
1127306|NCT01570686|3700719|P2|Overall Study|Administrative problems|1
1127307|NCT01570686|3700720|P1|Overall Study|Administrative problems|0
1127308|NCT01570686|3700719|P2|Overall Study|Abnormal test procedure result(s)|1
1127309|NCT01570686|3700720|P1|Overall Study|Abnormal test procedure result(s)|1
1127310|NCT01570309|3700756|P2|Overall Study|Withdrawal by Subject|3
1127311|NCT01570309|3700757|P1|Overall Study|Withdrawal by Subject|3
1127312|NCT01570244|3700771|P1|Microgynon+Faldaprevir|Adverse Event|1
1127313|NCT01570192|3700793|P2|Overall Study|Physician Decision|1
1127314|NCT01570192|3700794|P1|Overall Study|Physician Decision|0
1127315|NCT01570192|3700793|P2|Overall Study|changed to palliative care|0
1127316|NCT01570192|3700794|P1|Overall Study|changed to palliative care|1
1127317|NCT01570192|3700793|P2|Overall Study|no qualifying organism|12
1127318|NCT01570192|3700794|P1|Overall Study|no qualifying organism|6
1127319|NCT01569841|3700832|P2|Period A (6 Weeks)|Withdrawal by Subject|1
1127320|NCT01569841|3700833|P1|Period A (6 Weeks)|Withdrawal by Subject|0
1127321|NCT01569763|3700922|P2|Overall Study|Adverse Event|0
1127322|NCT01569763|3700923|P1|Overall Study|Adverse Event|1
1127323|NCT01569763|3700922|P2|Overall Study|Lack of Efficacy|7
1127324|NCT01569763|3700923|P1|Overall Study|Lack of Efficacy|2
1127325|NCT01569568|3700960|P2|Overall Study|Physician Decision|2
1127326|NCT01569568|3700961|P1|Overall Study|Physician Decision|0
1127327|NCT01569464|3700984|P2|Overall Study|Other|1
1127328|NCT01569464|3700985|P1|Overall Study|Other|1
1127329|NCT01569464|3700984|P2|Overall Study|Withdrawal by Subject|1
1127330|NCT01569464|3700985|P1|Overall Study|Withdrawal by Subject|1
1127331|NCT01569464|3700984|P2|Overall Study|Lost to Follow-up|3
1127332|NCT01569464|3700985|P1|Overall Study|Lost to Follow-up|2
1127333|NCT01569464|3700984|P2|Overall Study|Protocol Violation|0
1127334|NCT01569464|3700985|P1|Overall Study|Protocol Violation|1
1127335|NCT01569464|3700984|P2|Overall Study|Lack of Efficacy|0
1127336|NCT01569464|3700985|P1|Overall Study|Lack of Efficacy|1
1127337|NCT01569464|3700984|P2|Overall Study|Adverse Event|0
1127338|NCT01569464|3700985|P1|Overall Study|Adverse Event|4
1127339|NCT01569438|3701052|P2|Overall Study|Protocol Violation|0
1127340|NCT01569438|3701053|P1|Overall Study|Protocol Violation|1
1127341|NCT01569438|3701052|P2|Overall Study|Withdrawal by Subject|1
1127342|NCT01569438|3701053|P1|Overall Study|Withdrawal by Subject|0
1127343|NCT01569438|3701052|P2|Overall Study|Lack of Efficacy|1
1127344|NCT01569438|3701053|P1|Overall Study|Lack of Efficacy|1
1127345|NCT01569438|3701052|P2|Overall Study|Adverse Event|7
1127346|NCT01569438|3701053|P1|Overall Study|Adverse Event|0
1127347|NCT01569295|3701067|P2|Overall Study|Lost to Follow-up|0
1127348|NCT01569295|3701068|P1|Overall Study|Lost to Follow-up|1
1127349|NCT01569295|3701067|P2|Overall Study|Other Anticancer/Experimental Therapy|1
1127350|NCT01569295|3701068|P1|Overall Study|Other Anticancer/Experimental Therapy|2
1127351|NCT01569295|3701067|P2|Overall Study|Noncompliance with Study Drug|0
1127352|NCT01569295|3701068|P1|Overall Study|Noncompliance with Study Drug|3
1127353|NCT01569295|3701067|P2|Overall Study|Other|3
1127354|NCT01569295|3701068|P1|Overall Study|Other|4
1127355|NCT01569295|3701067|P2|Overall Study|Physician Decision|19
1127356|NCT01569295|3701068|P1|Overall Study|Physician Decision|7
1127357|NCT01569295|3701067|P2|Overall Study|Withdrawal by Subject|8
1127358|NCT01569295|3701068|P1|Overall Study|Withdrawal by Subject|20
1127359|NCT01569295|3701067|P2|Overall Study|Adverse Event|13
1127360|NCT01569295|3701068|P1|Overall Study|Adverse Event|27
1127361|NCT01569295|3701067|P2|Overall Study|Ongoing in Study|23
1127362|NCT01569295|3701068|P1|Overall Study|Ongoing in Study|70
1127363|NCT01569152|3701105|P3|Safety Extension, Period 3|Study terminated by Sponsor|47
1127364|NCT01569152|3701106|P2|Safety Extension, Period 3|Study terminated by Sponsor|0
1127365|NCT01569152|3701107|P1|Safety Extension, Period 3|Study terminated by Sponsor|0
1127366|NCT01569152|3701105|P3|Safety Extension, Period 3|Physician Decision|2
1127367|NCT01569152|3701106|P2|Safety Extension, Period 3|Physician Decision|0
1127368|NCT01569152|3701107|P1|Safety Extension, Period 3|Physician Decision|0
1127369|NCT01569152|3701105|P3|Safety Extension, Period 3|Withdrawal by Subject|2
1127370|NCT01569152|3701106|P2|Safety Extension, Period 3|Withdrawal by Subject|0
1127371|NCT01569152|3701107|P1|Safety Extension, Period 3|Withdrawal by Subject|0
1127372|NCT01569152|3701105|P3|Safety Extension, Period 3|Adverse Event|4
1127373|NCT01569152|3701106|P2|Safety Extension, Period 3|Adverse Event|0
1127374|NCT01569152|3701107|P1|Safety Extension, Period 3|Adverse Event|0
1127375|NCT01569152|3701105|P3|Phase IIa, Period 1|Withdrawal by Subject|0
1127376|NCT01569152|3701106|P2|Phase IIa, Period 1|Withdrawal by Subject|1
1127377|NCT01569152|3701107|P1|Phase IIa, Period 1|Withdrawal by Subject|2
1127378|NCT01569152|3701105|P3|Phase IIa, Period 1|Protocol Violation|0
1127379|NCT01569152|3701106|P2|Phase IIa, Period 1|Protocol Violation|1
1127380|NCT01569152|3701107|P1|Phase IIa, Period 1|Protocol Violation|0
1127381|NCT01569152|3701105|P3|Phase IIa, Period 1|Study Terminated by Sponsor|0
1127382|NCT01569152|3701106|P2|Phase IIa, Period 1|Study Terminated by Sponsor|8
1127383|NCT01569152|3701107|P1|Phase IIa, Period 1|Study Terminated by Sponsor|9
1127384|NCT01569152|3701105|P3|Phase IIa, Period 1|Lost to Follow-up|0
1127385|NCT01569152|3701106|P2|Phase IIa, Period 1|Lost to Follow-up|0
1127386|NCT01569152|3701107|P1|Phase IIa, Period 1|Lost to Follow-up|1
1127387|NCT01569152|3701105|P3|Phase IIa, Period 1|Adverse Event|0
1127388|NCT01569152|3701106|P2|Phase IIa, Period 1|Adverse Event|0
1127389|NCT01569152|3701107|P1|Phase IIa, Period 1|Adverse Event|4
1127390|NCT01569152|3701105|P3|Phase IIa, Period 1|Early Escape|0
1127391|NCT01569152|3701106|P2|Phase IIa, Period 1|Early Escape|22
1127392|NCT01569152|3701107|P1|Phase IIa, Period 1|Early Escape|5
1127393|NCT01569074|3701243|P5|Overall Study|Adverse Event|0
1127394|NCT01569074|3701244|P4|Overall Study|Adverse Event|0
1127395|NCT01569074|3701245|P3|Overall Study|Adverse Event|3
1127396|NCT01569074|3701246|P2|Overall Study|Adverse Event|0
1127397|NCT01569074|3701247|P1|Overall Study|Adverse Event|1
1127398|NCT01569074|3701243|P5|Overall Study|eg change in circumstances|1
1127399|NCT01569074|3701244|P4|Overall Study|eg change in circumstances|1
1127400|NCT01569074|3701245|P3|Overall Study|eg change in circumstances|0
1127401|NCT01569074|3701246|P2|Overall Study|eg change in circumstances|2
1127402|NCT01569074|3701247|P1|Overall Study|eg change in circumstances|0
1127403|NCT01569074|3701243|P5|Overall Study|Severe non-compliance to protocol|0
1127404|NCT01569074|3701244|P4|Overall Study|Severe non-compliance to protocol|0
1127405|NCT01569074|3701245|P3|Overall Study|Severe non-compliance to protocol|1
1127406|NCT01569074|3701246|P2|Overall Study|Severe non-compliance to protocol|0
1127407|NCT01569074|3701247|P1|Overall Study|Severe non-compliance to protocol|0
1127408|NCT01569074|3701243|P5|Overall Study|Study-specific discontinuation criteria|0
1127409|NCT01569074|3701244|P4|Overall Study|Study-specific discontinuation criteria|0
1127410|NCT01569074|3701245|P3|Overall Study|Study-specific discontinuation criteria|0
1127411|NCT01569074|3701246|P2|Overall Study|Study-specific discontinuation criteria|1
1127412|NCT01569074|3701247|P1|Overall Study|Study-specific discontinuation criteria|0
1127413|NCT01569074|3701243|P5|Overall Study|Study stopped|7
1127414|NCT01569074|3701244|P4|Overall Study|Study stopped|7
1127415|NCT01569074|3701245|P3|Overall Study|Study stopped|8
1127416|NCT01569074|3701246|P2|Overall Study|Study stopped|6
1127417|NCT01569074|3701247|P1|Overall Study|Study stopped|6
1127418|NCT01569022|3701303|P2|Second Intervention|Lost to Follow-up|2
1127419|NCT01569022|3701304|P1|Second Intervention|Lost to Follow-up|2
1127420|NCT01569022|3701303|P2|First Intervention|Lost to Follow-up|1
1127421|NCT01569022|3701304|P1|First Intervention|Lost to Follow-up|2
1127422|NCT01568892|3701340|P2|Open-label Phase|Lost to Follow-up|1
1127423|NCT01568892|3701341|P1|Open-label Phase|Lost to Follow-up|0
1127424|NCT01568892|3701340|P2|Open-label Phase|Lack of Efficacy|2
1127425|NCT01568892|3701341|P1|Open-label Phase|Lack of Efficacy|4
1127426|NCT01568892|3701340|P2|Open-label Phase|Adverse Event|0
1127427|NCT01568892|3701341|P1|Open-label Phase|Adverse Event|2
1127428|NCT01568866|3701411|P2|Overall Study|Randomized but Not Dosed|1
1127429|NCT01568866|3701412|P1|Overall Study|Randomized but Not Dosed|9
1127430|NCT01568866|3701411|P2|Overall Study|Lost to Follow-up|0
1127431|NCT01568866|3701412|P1|Overall Study|Lost to Follow-up|1
1127432|NCT01568866|3701411|P2|Overall Study|Protocol Non-compliance|4
1127433|NCT01568866|3701412|P1|Overall Study|Protocol Non-compliance|2
1127434|NCT01568866|3701411|P2|Overall Study|Death|18
1127435|NCT01568866|3701412|P1|Overall Study|Death|10
1127436|NCT01568866|3701411|P2|Overall Study|Withdrawal by Subject|11
1127437|NCT01568866|3701412|P1|Overall Study|Withdrawal by Subject|19
1127438|NCT01568866|3701411|P2|Overall Study|Physician Decision|32
1127439|NCT01568866|3701412|P1|Overall Study|Physician Decision|40
1127440|NCT01568866|3701411|P2|Overall Study|Patient Request|71
1127441|NCT01568866|3701412|P1|Overall Study|Patient Request|55
1127442|NCT01568866|3701411|P2|Overall Study|Adverse Event|96
1127443|NCT01568866|3701412|P1|Overall Study|Adverse Event|94
1127444|NCT01568866|3701411|P2|Overall Study|Disease Progression|183
1127445|NCT01568866|3701412|P1|Overall Study|Disease Progression|208
1127446|NCT01568593|3701443|P2|Overall Study|Adverse Event|2
1127447|NCT01568593|3701444|P1|Overall Study|Adverse Event|3
1127448|NCT01568593|3701443|P2|Overall Study|Lack of Efficacy|1
1127449|NCT01568593|3701444|P1|Overall Study|Lack of Efficacy|4
1127450|NCT01568112|3701464|P4|Overall Study|Withdrawal by Physician|1
1127451|NCT01568112|3701465|P3|Overall Study|Withdrawal by Physician|1
1127452|NCT01568112|3701466|P2|Overall Study|Withdrawal by Physician|0
1127453|NCT01568112|3701467|P1|Overall Study|Withdrawal by Physician|1
1127454|NCT01568112|3701464|P4|Overall Study|Withdrawal by Subject|7
1127455|NCT01568112|3701465|P3|Overall Study|Withdrawal by Subject|0
1127456|NCT01568112|3701466|P2|Overall Study|Withdrawal by Subject|3
1127457|NCT01568112|3701467|P1|Overall Study|Withdrawal by Subject|2
1127458|NCT01568112|3701464|P4|Overall Study|Lost to Follow-up|1
1127459|NCT01568112|3701465|P3|Overall Study|Lost to Follow-up|0
1127460|NCT01568112|3701466|P2|Overall Study|Lost to Follow-up|0
1127461|NCT01568112|3701467|P1|Overall Study|Lost to Follow-up|0
1127462|NCT01568112|3701464|P4|Overall Study|Withdrew due to Adverse Event|3
1127463|NCT01568112|3701465|P3|Overall Study|Withdrew due to Adverse Event|6
1127464|NCT01568112|3701466|P2|Overall Study|Withdrew due to Adverse Event|4
1127465|NCT01568112|3701467|P1|Overall Study|Withdrew due to Adverse Event|2
1127466|NCT01568112|3701464|P4|Overall Study|Randomized But Not Treated|0
1127467|NCT01568112|3701465|P3|Overall Study|Randomized But Not Treated|0
1127468|NCT01568112|3701466|P2|Overall Study|Randomized But Not Treated|1
1127469|NCT01568112|3701467|P1|Overall Study|Randomized But Not Treated|0
1127470|NCT01568047|3701625|P4|Overall Study|Adverse Event|1
1127471|NCT01568047|3701626|P3|Overall Study|Adverse Event|1
1127472|NCT01568047|3701627|P2|Overall Study|Adverse Event|0
1127473|NCT01568047|3701628|P1|Overall Study|Adverse Event|0
1127474|NCT01568047|3701625|P4|Overall Study|Withdrawal by Subject|0
1127475|NCT01568047|3701626|P3|Overall Study|Withdrawal by Subject|0
1127476|NCT01568047|3701627|P2|Overall Study|Withdrawal by Subject|1
1127477|NCT01568047|3701628|P1|Overall Study|Withdrawal by Subject|0
1127478|NCT01568047|3701625|P4|Overall Study|Ineligibility|0
1127479|NCT01568047|3701626|P3|Overall Study|Ineligibility|0
1127480|NCT01568047|3701627|P2|Overall Study|Ineligibility|0
1127481|NCT01568047|3701628|P1|Overall Study|Ineligibility|1
1127482|NCT01568034|3701646|P4|Overall Study|Withdrawal by Subject|0
1127483|NCT01568034|3701647|P3|Overall Study|Withdrawal by Subject|0
1127484|NCT01568034|3701648|P2|Overall Study|Withdrawal by Subject|0
1127485|NCT01568034|3701649|P1|Overall Study|Withdrawal by Subject|1
1127486|NCT01567865|3701698|P4|Evaluated for Immunogenicity|Missing blood sample|28
1127487|NCT01567865|3701699|P3|Evaluated for Immunogenicity|Missing blood sample|16
1127488|NCT01567865|3701700|P2|Evaluated for Immunogenicity|Missing blood sample|24
1127489|NCT01567865|3701701|P1|Evaluated for Immunogenicity|Missing blood sample|17
1127490|NCT01567865|3701698|P4|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2
1127491|NCT01567865|3701699|P3|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3
1127492|NCT01567865|3701700|P2|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1
1127493|NCT01567865|3701701|P1|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0
1127494|NCT01567852|3701731|P2|Overall Study|ECT discontinued|1
1127495|NCT01567852|3701732|P1|Overall Study|ECT discontinued|1
1127496|NCT01567852|3701731|P2|Overall Study|Withdrawal by Subject|6
1127497|NCT01567852|3701732|P1|Overall Study|Withdrawal by Subject|3
1127498|NCT01567826|3701750|P2|Overall Study|Lost to Follow-up|2
1127499|NCT01567826|3701751|P1|Overall Study|Lost to Follow-up|3
1127500|NCT01567527|3701777|P5|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5
1127501|NCT01567527|3701778|P4|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8
1127502|NCT01567527|3701779|P3|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
1127503|NCT01567527|3701780|P2|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
1127504|NCT01567527|3701781|P1|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
1127505|NCT01567527|3701777|P5|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35
1127506|NCT01567527|3701778|P4|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19
1127507|NCT01567527|3701779|P3|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
1127508|NCT01567527|3701780|P2|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
1127509|NCT01567527|3701781|P1|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
1127510|NCT01567527|3701777|P5|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3
1127511|NCT01567527|3701778|P4|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1
1127512|NCT01567527|3701779|P3|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
1127513|NCT01567527|3701780|P2|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
1127514|NCT01567527|3701781|P1|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
1127515|NCT01567527|3701777|P5|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10
1127516|NCT01567527|3701778|P4|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13
1127517|NCT01567527|3701779|P3|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
1127518|NCT01567527|3701780|P2|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
1127519|NCT01567527|3701781|P1|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
1127520|NCT01567527|3701777|P5|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1
1127521|NCT01567527|3701778|P4|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7
1127522|NCT01567527|3701779|P3|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
1127523|NCT01567527|3701780|P2|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
1127524|NCT01567527|3701781|P1|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
1127525|NCT01567527|3701777|P5|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7
1127526|NCT01567527|3701778|P4|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4
1127527|NCT01567527|3701779|P3|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
1127528|NCT01567527|3701780|P2|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
1127529|NCT01567527|3701781|P1|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
1127530|NCT01567527|3701777|P5|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33
1127531|NCT01567527|3701778|P4|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16
1127532|NCT01567527|3701779|P3|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
1127533|NCT01567527|3701780|P2|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
1127534|NCT01567527|3701781|P1|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
1127535|NCT01567527|3701777|P5|Double-blind, Placebo-controlled Phase|Protocol deviation|1
1127536|NCT01567527|3701778|P4|Double-blind, Placebo-controlled Phase|Protocol deviation|1
1127537|NCT01567527|3701779|P3|Double-blind, Placebo-controlled Phase|Protocol deviation|0
1127538|NCT01567527|3701780|P2|Double-blind, Placebo-controlled Phase|Protocol deviation|0
1127539|NCT01567527|3701781|P1|Double-blind, Placebo-controlled Phase|Protocol deviation|0
1127540|NCT01567527|3701777|P5|IM Depot Stabilization.|Withdrawn by the investigator|0
1127541|NCT01567527|3701778|P4|IM Depot Stabilization.|Withdrawn by the investigator|0
1127542|NCT01567527|3701779|P3|IM Depot Stabilization.|Withdrawn by the investigator|6
1127543|NCT01567527|3701780|P2|IM Depot Stabilization.|Withdrawn by the investigator|0
1127544|NCT01567527|3701781|P1|IM Depot Stabilization.|Withdrawn by the investigator|0
1127545|NCT01567527|3701777|P5|IM Depot Stabilization.|Adverse Event|0
1127546|NCT01567527|3701778|P4|IM Depot Stabilization.|Adverse Event|0
1127547|NCT01567527|3701779|P3|IM Depot Stabilization.|Adverse Event|37
1127548|NCT01567527|3701780|P2|IM Depot Stabilization.|Adverse Event|0
1127549|NCT01567527|3701781|P1|IM Depot Stabilization.|Adverse Event|0
1127550|NCT01567527|3701777|P5|IM Depot Stabilization.|Lack of Efficacy|0
1127551|NCT01567527|3701778|P4|IM Depot Stabilization.|Lack of Efficacy|0
1127552|NCT01567527|3701779|P3|IM Depot Stabilization.|Lack of Efficacy|7
1127553|NCT01567527|3701780|P2|IM Depot Stabilization.|Lack of Efficacy|0
1127554|NCT01567527|3701781|P1|IM Depot Stabilization.|Lack of Efficacy|0
1127555|NCT01567527|3701777|P5|IM Depot Stabilization.|Lost to Follow-up|0
1127556|NCT01567527|3701778|P4|IM Depot Stabilization.|Lost to Follow-up|0
1127557|NCT01567527|3701779|P3|IM Depot Stabilization.|Lost to Follow-up|21
1127558|NCT01567527|3701780|P2|IM Depot Stabilization.|Lost to Follow-up|0
1127559|NCT01567527|3701781|P1|IM Depot Stabilization.|Lost to Follow-up|0
1127560|NCT01567527|3701777|P5|IM Depot Stabilization.|Sponsor discontinued study|0
1127561|NCT01567527|3701778|P4|IM Depot Stabilization.|Sponsor discontinued study|0
1127562|NCT01567527|3701779|P3|IM Depot Stabilization.|Sponsor discontinued study|1
1127563|NCT01567527|3701780|P2|IM Depot Stabilization.|Sponsor discontinued study|0
1127564|NCT01567527|3701781|P1|IM Depot Stabilization.|Sponsor discontinued study|0
1127565|NCT01567527|3701777|P5|IM Depot Stabilization.|Withdrawal by Subject|0
1127566|NCT01567527|3701778|P4|IM Depot Stabilization.|Withdrawal by Subject|0
1127567|NCT01567527|3701779|P3|IM Depot Stabilization.|Withdrawal by Subject|56
1127568|NCT01567527|3701780|P2|IM Depot Stabilization.|Withdrawal by Subject|0
1127569|NCT01567527|3701781|P1|IM Depot Stabilization.|Withdrawal by Subject|0
1127570|NCT01567527|3701777|P5|IM Depot Stabilization.|Met withdrawal criteria|0
1127571|NCT01567527|3701778|P4|IM Depot Stabilization.|Met withdrawal criteria|0
1127572|NCT01567527|3701779|P3|IM Depot Stabilization.|Met withdrawal criteria|26
1127573|NCT01567527|3701780|P2|IM Depot Stabilization.|Met withdrawal criteria|0
1127574|NCT01567527|3701781|P1|IM Depot Stabilization.|Met withdrawal criteria|0
1127575|NCT01567527|3701777|P5|IM Depot Stabilization.|Protocol deviation|0
1127576|NCT01567527|3701778|P4|IM Depot Stabilization.|Protocol deviation|0
1127577|NCT01567527|3701779|P3|IM Depot Stabilization.|Protocol deviation|5
1127578|NCT01567527|3701780|P2|IM Depot Stabilization.|Protocol deviation|0
1127579|NCT01567527|3701781|P1|IM Depot Stabilization.|Protocol deviation|0
1127580|NCT01567527|3701777|P5|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
1127581|NCT01567527|3701778|P4|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
1127582|NCT01567527|3701779|P3|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
1127583|NCT01567527|3701780|P2|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2
1127584|NCT01567527|3701781|P1|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
1127585|NCT01567527|3701777|P5|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
1127586|NCT01567527|3701778|P4|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
1127587|NCT01567527|3701779|P3|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
1127588|NCT01567527|3701780|P2|Oral Aripiprazole Stabilization Phase.|Adverse Event|63
1127589|NCT01567527|3701781|P1|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
1127590|NCT01567527|3701777|P5|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
1127591|NCT01567527|3701778|P4|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
1127592|NCT01567527|3701779|P3|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
1127593|NCT01567527|3701780|P2|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12
1127594|NCT01567527|3701781|P1|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
1127595|NCT01567527|3701777|P5|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
1127596|NCT01567527|3701778|P4|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
1127597|NCT01567527|3701779|P3|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
1127598|NCT01567527|3701780|P2|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44
1127599|NCT01567527|3701781|P1|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
1127600|NCT01567527|3701777|P5|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
1127601|NCT01567527|3701778|P4|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
1127602|NCT01567527|3701779|P3|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
1127603|NCT01567527|3701780|P2|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45
1127604|NCT01567527|3701781|P1|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
1127605|NCT01567527|3701777|P5|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
1127606|NCT01567527|3701778|P4|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
1127607|NCT01567527|3701779|P3|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
1127608|NCT01567527|3701780|P2|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41
1127609|NCT01567527|3701781|P1|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
1127610|NCT01567527|3701777|P5|Conversion Phase.|Withdrawn by the investigator|0
1127611|NCT01567527|3701778|P4|Conversion Phase.|Withdrawn by the investigator|0
1127612|NCT01567527|3701779|P3|Conversion Phase.|Withdrawn by the investigator|0
1127613|NCT01567527|3701780|P2|Conversion Phase.|Withdrawn by the investigator|0
1127614|NCT01567527|3701781|P1|Conversion Phase.|Withdrawn by the investigator|3
1127615|NCT01567527|3701777|P5|Conversion Phase.|Adverse Event|0
1127616|NCT01567527|3701778|P4|Conversion Phase.|Adverse Event|0
1127617|NCT01567527|3701779|P3|Conversion Phase.|Adverse Event|0
1127618|NCT01567527|3701780|P2|Conversion Phase.|Adverse Event|0
1127619|NCT01567527|3701781|P1|Conversion Phase.|Adverse Event|33
1127620|NCT01567527|3701777|P5|Conversion Phase.|Lack of Efficacy|0
1127621|NCT01567527|3701778|P4|Conversion Phase.|Lack of Efficacy|0
1127622|NCT01567527|3701779|P3|Conversion Phase.|Lack of Efficacy|0
1127623|NCT01567527|3701780|P2|Conversion Phase.|Lack of Efficacy|0
1127624|NCT01567527|3701781|P1|Conversion Phase.|Lack of Efficacy|2
1127625|NCT01567527|3701777|P5|Conversion Phase.|Lost to Follow-up|0
1127626|NCT01567527|3701778|P4|Conversion Phase.|Lost to Follow-up|0
1127627|NCT01567527|3701779|P3|Conversion Phase.|Lost to Follow-up|0
1127628|NCT01567527|3701780|P2|Conversion Phase.|Lost to Follow-up|0
1127629|NCT01567527|3701781|P1|Conversion Phase.|Lost to Follow-up|16
1127630|NCT01567527|3701777|P5|Conversion Phase.|Withdrawal by Subject|0
1127631|NCT01567527|3701778|P4|Conversion Phase.|Withdrawal by Subject|0
1127632|NCT01567527|3701779|P3|Conversion Phase.|Withdrawal by Subject|0
1127633|NCT01567527|3701780|P2|Conversion Phase.|Withdrawal by Subject|0
1127634|NCT01567527|3701781|P1|Conversion Phase.|Withdrawal by Subject|32
1127635|NCT01567527|3701777|P5|Conversion Phase.|Met withdrawal criteria|0
1127636|NCT01567527|3701778|P4|Conversion Phase.|Met withdrawal criteria|0
1127637|NCT01567527|3701779|P3|Conversion Phase.|Met withdrawal criteria|0
1127638|NCT01567527|3701780|P2|Conversion Phase.|Met withdrawal criteria|0
1127639|NCT01567527|3701781|P1|Conversion Phase.|Met withdrawal criteria|10
1127640|NCT01567527|3701777|P5|Conversion Phase.|Protocol deviation|0
1127641|NCT01567527|3701778|P4|Conversion Phase.|Protocol deviation|0
1127642|NCT01567527|3701779|P3|Conversion Phase.|Protocol deviation|0
1127643|NCT01567527|3701780|P2|Conversion Phase.|Protocol deviation|0
1127644|NCT01567527|3701781|P1|Conversion Phase.|Protocol deviation|3
1127645|NCT01567462|3701798|P2|Overall Study|Withdrawal by Subject|7
1127646|NCT01567462|3701799|P1|Overall Study|Withdrawal by Subject|4
1127647|NCT01567163|3701816|P1|Overall Study|Lost to Follow-up|2
1127648|NCT01567163|3701816|P1|Overall Study|Progressive Disease|2
1127649|NCT01566981|3701856|P2|Overall Study|Lost to Follow-up|8
1127650|NCT01566981|3701857|P1|Overall Study|Lost to Follow-up|5
1127651|NCT01566773|3701886|P1|Overall Study|Physician Decision|2
1127652|NCT01566773|3701886|P1|Overall Study|Adverse Event|10
1127653|NCT01566773|3701886|P1|Overall Study|Administrative reason|1
1127654|NCT01566773|3701886|P1|Overall Study|Withdrawal by Subject|9
1127655|NCT01566773|3701886|P1|Overall Study|Protocol Violation|4
1127656|NCT01566773|3701886|P1|Overall Study|Protocol specified criteria|4
1127657|NCT01566721|3702095|P2|Overall Study|Withdrew Prior to Treatment|1
1127658|NCT01566721|3702096|P1|Overall Study|Withdrew Prior to Treatment|3
1127659|NCT01566721|3702095|P2|Overall Study|Not Specified|4
1127660|NCT01566721|3702096|P1|Overall Study|Not Specified|10
1127661|NCT01566721|3702095|P2|Overall Study|Death|3
1127662|NCT01566721|3702096|P1|Overall Study|Death|6
1127663|NCT01566721|3702095|P2|Overall Study|Lost to Follow-up|0
1127664|NCT01566721|3702096|P1|Overall Study|Lost to Follow-up|18
1127665|NCT01566721|3702095|P2|Overall Study|Disease Progression/Recurrence|28
1127666|NCT01566721|3702096|P1|Overall Study|Disease Progression/Recurrence|123
1127667|NCT01566721|3702095|P2|Overall Study|Withdrawal by Subject|15
1127668|NCT01566721|3702096|P1|Overall Study|Withdrawal by Subject|58
1127669|NCT01566721|3702095|P2|Overall Study|Ongoing Study|659
1127670|NCT01566721|3702096|P1|Overall Study|Ongoing Study|1649
1127671|NCT01566604|3702178|P2|Overall Study|Withdrawal by Subject|6
1127672|NCT01566604|3702179|P1|Overall Study|Withdrawal by Subject|9
1127673|NCT01566604|3702178|P2|Overall Study|Adverse Event|2
1127674|NCT01566604|3702179|P1|Overall Study|Adverse Event|4
1127675|NCT01566604|3702178|P2|Overall Study|Death|1
1127676|NCT01566604|3702179|P1|Overall Study|Death|4
1127677|NCT01566604|3702178|P2|Overall Study|Abnormal laboratory value|0
1127678|NCT01566604|3702179|P1|Overall Study|Abnormal laboratory value|2
1127679|NCT01566604|3702178|P2|Overall Study|Protocol deviation|0
1127680|NCT01566604|3702179|P1|Overall Study|Protocol deviation|2
1127681|NCT01566604|3702178|P2|Overall Study|Lack of Efficacy|2
1127682|NCT01566604|3702179|P1|Overall Study|Lack of Efficacy|1
1127683|NCT01566604|3702178|P2|Overall Study|Administrative problems|0
1127684|NCT01566604|3702179|P1|Overall Study|Administrative problems|1
1127685|NCT01566604|3702178|P2|Overall Study|Patient's inability to use the device|0
1127686|NCT01566604|3702179|P1|Overall Study|Patient's inability to use the device|1
1127687|NCT01566435|3702335|P1|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1
1127688|NCT01566214|3702396|P2|Overall Study|Lost to Follow-up|0
1127689|NCT01566214|3702397|P1|Overall Study|Lost to Follow-up|3
1127690|NCT01566149|3702441|P2|Overall Study|Withdrawal by Subject|0
1127691|NCT01566149|3702442|P1|Overall Study|Withdrawal by Subject|1
1127692|NCT01566149|3702441|P2|Overall Study|Protocol Violation|1
1127693|NCT01566149|3702442|P1|Overall Study|Protocol Violation|0
1127694|NCT01566149|3702441|P2|Overall Study|Non-compliance with study medication|0
1127695|NCT01566149|3702442|P1|Overall Study|Non-compliance with study medication|2
1127696|NCT01566149|3702441|P2|Overall Study|Adverse Event|1
1127697|NCT01566149|3702442|P1|Overall Study|Adverse Event|0
1127698|NCT01565993|3702475|P2|Overall Study|Physician Decision|3
1127699|NCT01565993|3702476|P1|Overall Study|Physician Decision|0
1127700|NCT01565980|3702484|P2|Overall Study|Withdrawal by Subject|3
1127701|NCT01565980|3702485|P1|Overall Study|Withdrawal by Subject|0
1127702|NCT01565980|3702484|P2|Overall Study|stopped medical treatment|0
1127703|NCT01565980|3702485|P1|Overall Study|stopped medical treatment|1
1127704|NCT01565980|3702484|P2|Overall Study|health complications|1
1127705|NCT01565980|3702485|P1|Overall Study|health complications|1
1127706|NCT01565980|3702484|P2|Overall Study|Lost to Follow-up|0
1127707|NCT01565980|3702485|P1|Overall Study|Lost to Follow-up|1
1127708|NCT01565980|3702484|P2|Overall Study|Death|0
1127709|NCT01565980|3702485|P1|Overall Study|Death|1
1127710|NCT01565941|3702505|P2|Overall Study|Randomized; did not receive intevention|2
1127711|NCT01565941|3702506|P1|Overall Study|Randomized; did not receive intevention|8
1127712|NCT01565941|3702505|P2|Overall Study|Withdrawn by parent/guardian|2
1127713|NCT01565941|3702506|P1|Overall Study|Withdrawn by parent/guardian|3
1127714|NCT01565889|3702585|P6|Part B|Lost to Follow-up|1
1127715|NCT01565889|3702586|P5|Part B|Lost to Follow-up|0
1127716|NCT01565889|3702587|P4|Part B|Lost to Follow-up|0
1127717|NCT01565889|3702588|P3|Part B|Lost to Follow-up|0
1127718|NCT01565889|3702589|P2|Part B|Lost to Follow-up|0
1127719|NCT01565889|3702590|P1|Part B|Lost to Follow-up|0
1127720|NCT01565889|3702585|P6|Part B|Lack of Efficacy|2
1127721|NCT01565889|3702586|P5|Part B|Lack of Efficacy|0
1127722|NCT01565889|3702587|P4|Part B|Lack of Efficacy|0
1127723|NCT01565889|3702588|P3|Part B|Lack of Efficacy|0
1127724|NCT01565889|3702589|P2|Part B|Lack of Efficacy|0
1127725|NCT01565889|3702590|P1|Part B|Lack of Efficacy|0
1127726|NCT01565889|3702585|P6|Part B|Withdrawal by Subject|1
1127727|NCT01565889|3702586|P5|Part B|Withdrawal by Subject|0
1127728|NCT01565889|3702587|P4|Part B|Withdrawal by Subject|0
1127729|NCT01565889|3702588|P3|Part B|Withdrawal by Subject|0
1127730|NCT01565889|3702589|P2|Part B|Withdrawal by Subject|0
1127731|NCT01565889|3702590|P1|Part B|Withdrawal by Subject|0
1127732|NCT01565889|3702585|P6|Part A|Withdrawal by Subject|0
1127733|NCT01565889|3702586|P5|Part A|Withdrawal by Subject|0
1127734|NCT01565889|3702587|P4|Part A|Withdrawal by Subject|0
1127735|NCT01565889|3702588|P3|Part A|Withdrawal by Subject|0
1127736|NCT01565889|3702589|P2|Part A|Withdrawal by Subject|0
1127737|NCT01565889|3702590|P1|Part A|Withdrawal by Subject|1
1127738|NCT01565850|3702621|P2|Overall Study|Withdrew Consent|2
1127739|NCT01565850|3702622|P1|Overall Study|Withdrew Consent|4
1127740|NCT01565850|3702621|P2|Overall Study|Participant noncompliance|0
1127741|NCT01565850|3702622|P1|Overall Study|Participant noncompliance|2
1127742|NCT01565850|3702621|P2|Overall Study|Investigator’s Discretion|1
1127743|NCT01565850|3702622|P1|Overall Study|Investigator’s Discretion|2
1127744|NCT01565850|3702621|P2|Overall Study|Lost to Follow-up|4
1127745|NCT01565850|3702622|P1|Overall Study|Lost to Follow-up|12
1127746|NCT01565850|3702621|P2|Overall Study|Adverse Event|1
1127747|NCT01565850|3702622|P1|Overall Study|Adverse Event|0
1127748|NCT01565707|3702642|P4|Overall Study|Miscellaneous|2
1127749|NCT01565707|3702643|P3|Overall Study|Miscellaneous|0
1127750|NCT01565707|3702644|P2|Overall Study|Miscellaneous|1
1127751|NCT01565707|3702645|P1|Overall Study|Miscellaneous|1
1127752|NCT01565707|3702642|P4|Overall Study|Randomized but not evaluable|0
1127753|NCT01565707|3702643|P3|Overall Study|Randomized but not evaluable|0
1127754|NCT01565707|3702644|P2|Overall Study|Randomized but not evaluable|0
1127755|NCT01565707|3702645|P1|Overall Study|Randomized but not evaluable|2
1127756|NCT01565707|3702642|P4|Overall Study|Withdrawal by Subject|1
1127757|NCT01565707|3702643|P3|Overall Study|Withdrawal by Subject|1
1127758|NCT01565707|3702644|P2|Overall Study|Withdrawal by Subject|1
1127759|NCT01565707|3702645|P1|Overall Study|Withdrawal by Subject|3
1127760|NCT01565707|3702642|P4|Overall Study|Protocol Violation|1
1127761|NCT01565707|3702643|P3|Overall Study|Protocol Violation|0
1127762|NCT01565707|3702644|P2|Overall Study|Protocol Violation|0
1127763|NCT01565707|3702645|P1|Overall Study|Protocol Violation|1
1127764|NCT01565707|3702642|P4|Overall Study|Lost to Follow-up|0
1127765|NCT01565707|3702643|P3|Overall Study|Lost to Follow-up|0
1127766|NCT01565707|3702644|P2|Overall Study|Lost to Follow-up|0
1127767|NCT01565707|3702645|P1|Overall Study|Lost to Follow-up|1
1127768|NCT01565707|3702642|P4|Overall Study|Adverse Event|1
1127769|NCT01565707|3702643|P3|Overall Study|Adverse Event|2
1127770|NCT01565707|3702644|P2|Overall Study|Adverse Event|6
1127771|NCT01565707|3702645|P1|Overall Study|Adverse Event|1
1127772|NCT01565642|3702738|P2|Overall Study|Withdrawal by Subject|1
1127773|NCT01565642|3702739|P1|Overall Study|Withdrawal by Subject|2
1127774|NCT01565564|3702774|P2|Overall Study|Lost to Follow-up|1
1127775|NCT01565564|3702775|P1|Overall Study|Lost to Follow-up|5
1127776|NCT01565343|3702825|P3|Overall Study|Administrative decision/technical issues|0
1127777|NCT01565343|3702826|P2|Overall Study|Administrative decision/technical issues|0
1127778|NCT01565343|3702827|P1|Overall Study|Administrative decision/technical issues|1
1127779|NCT01565291|3702857|P2|Overall Study|Withdrawal by Subject|0
1127780|NCT01565291|3702858|P1|Overall Study|Withdrawal by Subject|1
1127781|NCT01565148|3702870|P4|Overall Study|Physician Decision|0
1127782|NCT01565148|3702871|P3|Overall Study|Physician Decision|0
1127783|NCT01565148|3702872|P2|Overall Study|Physician Decision|5
1127784|NCT01565148|3702873|P1|Overall Study|Physician Decision|2
1127785|NCT01565148|3702870|P4|Overall Study|Death|0
1127786|NCT01565148|3702871|P3|Overall Study|Death|1
1127787|NCT01565148|3702872|P2|Overall Study|Death|0
1127788|NCT01565148|3702873|P1|Overall Study|Death|0
1127789|NCT01565148|3702870|P4|Overall Study|Rescue Therapy|8
1127790|NCT01565148|3702871|P3|Overall Study|Rescue Therapy|5
1127791|NCT01565148|3702872|P2|Overall Study|Rescue Therapy|5
1127792|NCT01565148|3702873|P1|Overall Study|Rescue Therapy|8
1127793|NCT01565148|3702870|P4|Overall Study|Lost to Follow-up|3
1127794|NCT01565148|3702871|P3|Overall Study|Lost to Follow-up|0
1127795|NCT01565148|3702872|P2|Overall Study|Lost to Follow-up|4
1127796|NCT01565148|3702873|P1|Overall Study|Lost to Follow-up|4
1127797|NCT01565148|3702870|P4|Overall Study|Withdrawal by Subject|2
1127798|NCT01565148|3702871|P3|Overall Study|Withdrawal by Subject|1
1127799|NCT01565148|3702872|P2|Overall Study|Withdrawal by Subject|1
1127800|NCT01565148|3702873|P1|Overall Study|Withdrawal by Subject|1
1127801|NCT01565083|3702909|P2|Overall Study|Other|5
1127802|NCT01565083|3702910|P1|Overall Study|Other|3
1127803|NCT01565083|3702909|P2|Overall Study|Death|23
1127804|NCT01565083|3702910|P1|Overall Study|Death|22
1127805|NCT01565083|3702909|P2|Overall Study|Lost to Follow-up|7
1127806|NCT01565083|3702910|P1|Overall Study|Lost to Follow-up|2
1127807|NCT01565083|3702909|P2|Overall Study|Withdrawal by Subject|4
1127808|NCT01565083|3702910|P1|Overall Study|Withdrawal by Subject|6
1127809|NCT01564862|3702947|P3|Overall Study|Other reason(s)|0
1127810|NCT01564862|3702948|P2|Overall Study|Other reason(s)|0
1127811|NCT01564862|3702949|P1|Overall Study|Other reason(s)|1
1127812|NCT01564862|3702947|P3|Overall Study|Lack of Efficacy|6
1127813|NCT01564862|3702948|P2|Overall Study|Lack of Efficacy|5
1127814|NCT01564862|3702949|P1|Overall Study|Lack of Efficacy|1
1127815|NCT01564862|3702947|P3|Overall Study|Voluntary Withdrawal|8
1127816|NCT01564862|3702948|P2|Overall Study|Voluntary Withdrawal|6
1127817|NCT01564862|3702949|P1|Overall Study|Voluntary Withdrawal|9
1127818|NCT01564862|3702947|P3|Overall Study|Lost to Follow-up|6
1127819|NCT01564862|3702948|P2|Overall Study|Lost to Follow-up|8
1127820|NCT01564862|3702949|P1|Overall Study|Lost to Follow-up|10
1127821|NCT01564862|3702947|P3|Overall Study|Major Protocol Deviation|4
1127822|NCT01564862|3702948|P2|Overall Study|Major Protocol Deviation|3
1127823|NCT01564862|3702949|P1|Overall Study|Major Protocol Deviation|3
1127824|NCT01564862|3702947|P3|Overall Study|Pretreatment Event or Adverse Event|6
1127825|NCT01564862|3702948|P2|Overall Study|Pretreatment Event or Adverse Event|12
1127826|NCT01564862|3702949|P1|Overall Study|Pretreatment Event or Adverse Event|6
1127827|NCT01564784|3703000|P2|Overall Study|Death|126
1127828|NCT01564784|3703001|P1|Overall Study|Death|131
1127829|NCT01564784|3703000|P2|Overall Study|Lost to Follow-up|1
1127830|NCT01564784|3703001|P1|Overall Study|Lost to Follow-up|1
1127831|NCT01564784|3703000|P2|Overall Study|Subject refused further follow-up|6
1127832|NCT01564784|3703001|P1|Overall Study|Subject refused further follow-up|1
1127833|NCT01564784|3703000|P2|Overall Study|Other|0
1127834|NCT01564784|3703001|P1|Overall Study|Other|1
1127835|NCT01564758|3703028|P1|Overall Study|Other|3
1127836|NCT01564758|3703028|P1|Overall Study|Adverse Event|3
1127837|NCT01564758|3703028|P1|Overall Study|Death|8
1127838|NCT01564732|3703035|P2|Overall Study|Early termination by the study sponsor|5
1127839|NCT01564732|3703036|P1|Overall Study|Early termination by the study sponsor|6
1127840|NCT01564537|3703071|P2|Overall Study|Other Miscellaneous Reasons|2
1127841|NCT01564537|3703072|P1|Overall Study|Other Miscellaneous Reasons|1
1127842|NCT01564537|3703071|P2|Overall Study|Lost to Follow-up|0
1127843|NCT01564537|3703072|P1|Overall Study|Lost to Follow-up|1
1127844|NCT01564537|3703071|P2|Overall Study|Withdrawal by Participant|4
1127845|NCT01564537|3703072|P1|Overall Study|Withdrawal by Participant|4
1127846|NCT01564459|3703095|P3|Double-blind Treatment|Adverse Event|1
1127847|NCT01564459|3703096|P2|Double-blind Treatment|Adverse Event|0
1127848|NCT01564459|3703097|P1|Double-blind Treatment|Adverse Event|0
1127849|NCT01564459|3703095|P3|Run-In|Withdrawal by Subject|0
1127850|NCT01564459|3703096|P2|Run-In|Withdrawal by Subject|0
1127851|NCT01564459|3703097|P1|Run-In|Withdrawal by Subject|1
1127852|NCT01564459|3703095|P3|Run-In|Protocol Violation|0
1127853|NCT01564459|3703096|P2|Run-In|Protocol Violation|0
1127854|NCT01564459|3703097|P1|Run-In|Protocol Violation|1
1127855|NCT01564459|3703095|P3|Run-In|Non-compliance with study drug|0
1127856|NCT01564459|3703096|P2|Run-In|Non-compliance with study drug|0
1127857|NCT01564459|3703097|P1|Run-In|Non-compliance with study drug|2
1127858|NCT01564459|3703095|P3|Run-In|Lost to Follow-up|0
1127859|NCT01564459|3703096|P2|Run-In|Lost to Follow-up|0
1127860|NCT01564459|3703097|P1|Run-In|Lost to Follow-up|1
1127861|NCT01564459|3703095|P3|Run-In|Adverse Event|0
1127862|NCT01564459|3703096|P2|Run-In|Adverse Event|0
1127863|NCT01564459|3703097|P1|Run-In|Adverse Event|7
1127864|NCT01564407|3703121|P5|Overall Study|funding lost, study ended|0
1127865|NCT01564407|3703122|P4|Overall Study|funding lost, study ended|1
1127866|NCT01564407|3703123|P3|Overall Study|funding lost, study ended|0
1127867|NCT01564407|3703124|P2|Overall Study|funding lost, study ended|0
1127868|NCT01564407|3703125|P1|Overall Study|funding lost, study ended|0
1127869|NCT01564407|3703121|P5|Overall Study|Withdrawal by Subject|0
1127870|NCT01564407|3703122|P4|Overall Study|Withdrawal by Subject|0
1127871|NCT01564407|3703123|P3|Overall Study|Withdrawal by Subject|0
1127872|NCT01564407|3703124|P2|Overall Study|Withdrawal by Subject|1
1127873|NCT01564407|3703125|P1|Overall Study|Withdrawal by Subject|0
1127874|NCT01564407|3703121|P5|Overall Study|Lost to Follow-up|0
1127875|NCT01564407|3703122|P4|Overall Study|Lost to Follow-up|0
1127876|NCT01564407|3703123|P3|Overall Study|Lost to Follow-up|0
1127877|NCT01564407|3703124|P2|Overall Study|Lost to Follow-up|1
1127878|NCT01564407|3703125|P1|Overall Study|Lost to Follow-up|0
1127879|NCT01564394|3703166|P2|Overall Study|Withdrawal by Subject|10
1127880|NCT01564394|3703167|P1|Overall Study|Withdrawal by Subject|6
1127881|NCT01564277|3703181|P2|Overall Study|Physician Decision|0
1127882|NCT01564277|3703182|P1|Overall Study|Physician Decision|1
1127883|NCT01564277|3703181|P2|Overall Study|Protocol Violation|1
1127884|NCT01564277|3703182|P1|Overall Study|Protocol Violation|0
1127885|NCT01563978|3703200|P2|Overall Study|Adverse Event|2
1127886|NCT01563978|3703201|P1|Overall Study|Adverse Event|1
1127887|NCT01563978|3703200|P2|Overall Study|Dev. of study specific discont. criteria|0
1127888|NCT01563978|3703201|P1|Overall Study|Dev. of study specific discont. criteria|1
1127889|NCT01563978|3703200|P2|Overall Study|Lost to Follow-up|0
1127890|NCT01563978|3703201|P1|Overall Study|Lost to Follow-up|1
1127891|NCT01563978|3703200|P2|Overall Study|Physician Decision|0
1127892|NCT01563978|3703201|P1|Overall Study|Physician Decision|1
1127893|NCT01563913|3703227|P2|Overall Study|Spouse Passed Away|0
1127894|NCT01563913|3703228|P1|Overall Study|Spouse Passed Away|1
1127895|NCT01563913|3703227|P2|Overall Study|Physician Decision|0
1127896|NCT01563913|3703228|P1|Overall Study|Physician Decision|1
1127897|NCT01563536|3703240|P2|Overall Study|Lost to Follow-up|0
1127898|NCT01563536|3703241|P1|Overall Study|Lost to Follow-up|1
1127899|NCT01563536|3703240|P2|Overall Study|Withdrawal by Subject|2
1127900|NCT01563536|3703241|P1|Overall Study|Withdrawal by Subject|0
1127901|NCT01563185|3703300|P1|Overall Study|Non-Compliance with study drug|1
1127902|NCT01563185|3703300|P1|Overall Study|Withdrawal by Subject|1
1127903|NCT01563172|3703314|P1|Overall Study|Other (Not specified)|1
1127904|NCT01563172|3703314|P1|Overall Study|Other (Protocol deviation)|5
1127905|NCT01563172|3703314|P1|Overall Study|Lost to Follow-up|2
1127906|NCT01563172|3703314|P1|Overall Study|Adverse Event|5
1127907|NCT01563029|3703420|P5|Overall Study|Withdrawal by Subject|3
1127908|NCT01563029|3703421|P4|Overall Study|Withdrawal by Subject|4
1127909|NCT01563029|3703422|P3|Overall Study|Withdrawal by Subject|3
1127910|NCT01563029|3703423|P2|Overall Study|Withdrawal by Subject|1
1127911|NCT01563029|3703424|P1|Overall Study|Withdrawal by Subject|4
1127912|NCT01563029|3703420|P5|Overall Study|Physician Decision|2
1127913|NCT01563029|3703421|P4|Overall Study|Physician Decision|4
1127914|NCT01563029|3703422|P3|Overall Study|Physician Decision|2
1127915|NCT01563029|3703423|P2|Overall Study|Physician Decision|5
1127916|NCT01563029|3703424|P1|Overall Study|Physician Decision|3
1127917|NCT01563029|3703420|P5|Overall Study|Lost to Follow-up|1
1127918|NCT01563029|3703421|P4|Overall Study|Lost to Follow-up|1
1127919|NCT01563029|3703422|P3|Overall Study|Lost to Follow-up|1
1127920|NCT01563029|3703423|P2|Overall Study|Lost to Follow-up|0
1127921|NCT01563029|3703424|P1|Overall Study|Lost to Follow-up|1
1127922|NCT01563029|3703420|P5|Overall Study|Protocol defined stopping criteria|0
1127923|NCT01563029|3703421|P4|Overall Study|Protocol defined stopping criteria|0
1127924|NCT01563029|3703422|P3|Overall Study|Protocol defined stopping criteria|0
1127925|NCT01563029|3703423|P2|Overall Study|Protocol defined stopping criteria|0
1127926|NCT01563029|3703424|P1|Overall Study|Protocol defined stopping criteria|1
1127927|NCT01563029|3703420|P5|Overall Study|Protocol Violation|3
1127928|NCT01563029|3703421|P4|Overall Study|Protocol Violation|1
1127929|NCT01563029|3703422|P3|Overall Study|Protocol Violation|3
1127930|NCT01563029|3703423|P2|Overall Study|Protocol Violation|2
1127931|NCT01563029|3703424|P1|Overall Study|Protocol Violation|1
1127932|NCT01563029|3703420|P5|Overall Study|Lack of Efficacy|19
1127933|NCT01563029|3703421|P4|Overall Study|Lack of Efficacy|21
1127934|NCT01563029|3703422|P3|Overall Study|Lack of Efficacy|23
1127935|NCT01563029|3703423|P2|Overall Study|Lack of Efficacy|16
1127936|NCT01563029|3703424|P1|Overall Study|Lack of Efficacy|42
1127937|NCT01563029|3703420|P5|Overall Study|Adverse Event|1
1127938|NCT01563029|3703421|P4|Overall Study|Adverse Event|2
1127939|NCT01563029|3703422|P3|Overall Study|Adverse Event|1
1127940|NCT01563029|3703423|P2|Overall Study|Adverse Event|0
1127941|NCT01563029|3703424|P1|Overall Study|Adverse Event|1
1127942|NCT01562873|3703490|P2|Overall Study|Clinical PD and adverse event|0
1127943|NCT01562873|3703491|P1|Overall Study|Clinical PD and adverse event|1
1127944|NCT01562873|3703490|P2|Overall Study|Clinical Disease Progression|0
1127945|NCT01562873|3703491|P1|Overall Study|Clinical Disease Progression|9
1127946|NCT01562873|3703490|P2|Overall Study|Adverse Event|0
1127947|NCT01562873|3703491|P1|Overall Study|Adverse Event|1
1127948|NCT01562873|3703490|P2|Overall Study|Disease Progression per RECIST|0
1127949|NCT01562873|3703491|P1|Overall Study|Disease Progression per RECIST|10
1127950|NCT01562743|3703503|P1|Overall Study|Physician Decision|2
1127951|NCT01562743|3703503|P1|Overall Study|Lost to Follow-up|2
1127952|NCT01562743|3703503|P1|Overall Study|Discontinuation criteria|2
1127953|NCT01562743|3703503|P1|Overall Study|Protocol Violation|1
1127954|NCT01562743|3703503|P1|Overall Study|Withdrawal by Subject|13
1127955|NCT01562743|3703503|P1|Overall Study|Lack of Efficacy|3
1127956|NCT01562743|3703503|P1|Overall Study|Adverse Event|29
1127957|NCT01562613|3703522|P1|Overall Study|Withdrawal by Subject|2
1127958|NCT01562613|3703522|P1|Overall Study|Lost to Follow-up|2
1127959|NCT01562548|3703532|P4|Overall Study|Lost to Follow-up|0
1127960|NCT01562548|3703533|P3|Overall Study|Lost to Follow-up|1
1127961|NCT01562548|3703534|P2|Overall Study|Lost to Follow-up|0
1127962|NCT01562548|3703535|P1|Overall Study|Lost to Follow-up|0
1127963|NCT01562444|3703588|P3|Overall Study|Protocol forbidden medication|0
1127964|NCT01562444|3703589|P2|Overall Study|Protocol forbidden medication|0
1127965|NCT01562444|3703590|P1|Overall Study|Protocol forbidden medication|1
1127966|NCT01562444|3703588|P3|Overall Study|Protocol forbidden concomitant vaccine|1
1127967|NCT01562444|3703589|P2|Overall Study|Protocol forbidden concomitant vaccine|0
1127968|NCT01562444|3703590|P1|Overall Study|Protocol forbidden concomitant vaccine|1
1127969|NCT01562444|3703588|P3|Overall Study|Unavailable serological results|2
1127970|NCT01562444|3703589|P2|Overall Study|Unavailable serological results|2
1127971|NCT01562444|3703590|P1|Overall Study|Unavailable serological results|0
1127972|NCT01562444|3703588|P3|Overall Study|Did not comply with blood draw schedule|1
1127973|NCT01562444|3703589|P2|Overall Study|Did not comply with blood draw schedule|0
1127974|NCT01562444|3703590|P1|Overall Study|Did not comply with blood draw schedule|1
1127975|NCT01562444|3703588|P3|Overall Study|Did not meet entry criteria|3
1127976|NCT01562444|3703589|P2|Overall Study|Did not meet entry criteria|0
1127977|NCT01562444|3703590|P1|Overall Study|Did not meet entry criteria|2
1127978|NCT01562327|3703856|P1|Overall Study|Infusion not received at 6 month window|4
1127979|NCT01562327|3703856|P1|Overall Study|Participant drop-out|1
1127980|NCT01562327|3703856|P1|Overall Study|Lack of Efficacy|1
1127981|NCT01562327|3703856|P1|Overall Study|Adverse Event|2
1127982|NCT01562314|3703886|P2|Overall Study|Withdrawal by Subject|1
1127983|NCT01562314|3703887|P1|Overall Study|Withdrawal by Subject|0
1127984|NCT01562314|3703886|P2|Overall Study|Met Withdrawal Criteria|2
1127985|NCT01562314|3703887|P1|Overall Study|Met Withdrawal Criteria|3
1127986|NCT01562314|3703886|P2|Overall Study|Adverse Event|5
1127987|NCT01562314|3703887|P1|Overall Study|Adverse Event|10
1127988|NCT01562275|3703944|P13|Stage 2|Progression of Disease|4
1127989|NCT01562275|3703945|P12|Stage 2|Progression of Disease|12
1127990|NCT01562275|3703946|P11|Stage 2|Progression of Disease|0
1127991|NCT01562275|3703947|P10|Stage 2|Progression of Disease|0
1127992|NCT01562275|3703948|P9|Stage 2|Progression of Disease|0
1127993|NCT01562275|3703949|P8|Stage 2|Progression of Disease|0
1127994|NCT01562275|3703950|P7|Stage 2|Progression of Disease|0
1127995|NCT01562275|3703951|P6|Stage 2|Progression of Disease|0
1127996|NCT01562275|3703952|P5|Stage 2|Progression of Disease|0
1127997|NCT01562275|3703953|P4|Stage 2|Progression of Disease|0
1127998|NCT01562275|3703954|P3|Stage 2|Progression of Disease|0
1127999|NCT01562275|3703955|P2|Stage 2|Progression of Disease|0
1128000|NCT01562275|3703956|P1|Stage 2|Progression of Disease|0
1128001|NCT01562275|3703944|P13|Stage 2|Death|1
1128002|NCT01562275|3703945|P12|Stage 2|Death|2
1128003|NCT01562275|3703946|P11|Stage 2|Death|0
1128004|NCT01562275|3703947|P10|Stage 2|Death|0
1128005|NCT01562275|3703948|P9|Stage 2|Death|0
1128006|NCT01562275|3703949|P8|Stage 2|Death|0
1128007|NCT01562275|3703950|P7|Stage 2|Death|0
1128008|NCT01562275|3703951|P6|Stage 2|Death|0
1128009|NCT01562275|3703952|P5|Stage 2|Death|0
1128010|NCT01562275|3703953|P4|Stage 2|Death|0
1128011|NCT01562275|3703954|P3|Stage 2|Death|0
1128012|NCT01562275|3703955|P2|Stage 2|Death|0
1128013|NCT01562275|3703956|P1|Stage 2|Death|0
1128014|NCT01562275|3703944|P13|Stage 1|Withdrawal by Subject|0
1128015|NCT01562275|3703945|P12|Stage 1|Withdrawal by Subject|0
1128016|NCT01562275|3703946|P11|Stage 1|Withdrawal by Subject|0
1128017|NCT01562275|3703947|P10|Stage 1|Withdrawal by Subject|1
1128018|NCT01562275|3703948|P9|Stage 1|Withdrawal by Subject|0
1128019|NCT01562275|3703949|P8|Stage 1|Withdrawal by Subject|0
1128020|NCT01562275|3703950|P7|Stage 1|Withdrawal by Subject|1
1128021|NCT01562275|3703951|P6|Stage 1|Withdrawal by Subject|0
1128022|NCT01562275|3703952|P5|Stage 1|Withdrawal by Subject|0
1128023|NCT01562275|3703953|P4|Stage 1|Withdrawal by Subject|2
1128024|NCT01562275|3703954|P3|Stage 1|Withdrawal by Subject|0
1128025|NCT01562275|3703955|P2|Stage 1|Withdrawal by Subject|1
1128026|NCT01562275|3703956|P1|Stage 1|Withdrawal by Subject|0
1128027|NCT01562275|3703944|P13|Stage 1|Progression of Disease|0
1128028|NCT01562275|3703945|P12|Stage 1|Progression of Disease|0
1128029|NCT01562275|3703946|P11|Stage 1|Progression of Disease|3
1128030|NCT01562275|3703947|P10|Stage 1|Progression of Disease|5
1128031|NCT01562275|3703948|P9|Stage 1|Progression of Disease|2
1128032|NCT01562275|3703949|P8|Stage 1|Progression of Disease|7
1128033|NCT01562275|3703950|P7|Stage 1|Progression of Disease|1
1128034|NCT01562275|3703951|P6|Stage 1|Progression of Disease|4
1128035|NCT01562275|3703952|P5|Stage 1|Progression of Disease|2
1128036|NCT01562275|3703953|P4|Stage 1|Progression of Disease|1
1128037|NCT01562275|3703954|P3|Stage 1|Progression of Disease|2
1128038|NCT01562275|3703955|P2|Stage 1|Progression of Disease|6
1128039|NCT01562275|3703956|P1|Stage 1|Progression of Disease|2
1128040|NCT01562275|3703944|P13|Stage 1|Physician Decision|0
1128041|NCT01562275|3703945|P12|Stage 1|Physician Decision|0
1128042|NCT01562275|3703946|P11|Stage 1|Physician Decision|0
1128043|NCT01562275|3703947|P10|Stage 1|Physician Decision|0
1128044|NCT01562275|3703948|P9|Stage 1|Physician Decision|1
1128045|NCT01562275|3703949|P8|Stage 1|Physician Decision|0
1128046|NCT01562275|3703950|P7|Stage 1|Physician Decision|1
1128047|NCT01562275|3703951|P6|Stage 1|Physician Decision|0
1128048|NCT01562275|3703952|P5|Stage 1|Physician Decision|1
1128049|NCT01562275|3703953|P4|Stage 1|Physician Decision|0
1128050|NCT01562275|3703954|P3|Stage 1|Physician Decision|0
1128051|NCT01562275|3703955|P2|Stage 1|Physician Decision|0
1128052|NCT01562275|3703956|P1|Stage 1|Physician Decision|0
1128053|NCT01562275|3703944|P13|Stage 1|Non Compliance|0
1128054|NCT01562275|3703945|P12|Stage 1|Non Compliance|0
1128055|NCT01562275|3703946|P11|Stage 1|Non Compliance|0
1128056|NCT01562275|3703947|P10|Stage 1|Non Compliance|0
1128057|NCT01562275|3703948|P9|Stage 1|Non Compliance|0
1128058|NCT01562275|3703949|P8|Stage 1|Non Compliance|0
1128059|NCT01562275|3703950|P7|Stage 1|Non Compliance|0
1128060|NCT01562275|3703951|P6|Stage 1|Non Compliance|0
1128061|NCT01562275|3703952|P5|Stage 1|Non Compliance|0
1128062|NCT01562275|3703953|P4|Stage 1|Non Compliance|0
1128063|NCT01562275|3703954|P3|Stage 1|Non Compliance|1
1128064|NCT01562275|3703955|P2|Stage 1|Non Compliance|0
1128065|NCT01562275|3703956|P1|Stage 1|Non Compliance|0
1128066|NCT01562275|3703944|P13|Stage 1|Death|0
1128067|NCT01562275|3703945|P12|Stage 1|Death|0
1128068|NCT01562275|3703946|P11|Stage 1|Death|0
1128069|NCT01562275|3703947|P10|Stage 1|Death|0
1128070|NCT01562275|3703948|P9|Stage 1|Death|0
1128071|NCT01562275|3703949|P8|Stage 1|Death|0
1128072|NCT01562275|3703950|P7|Stage 1|Death|0
1128073|NCT01562275|3703951|P6|Stage 1|Death|0
1128074|NCT01562275|3703952|P5|Stage 1|Death|0
1128075|NCT01562275|3703953|P4|Stage 1|Death|0
1128076|NCT01562275|3703954|P3|Stage 1|Death|0
1128077|NCT01562275|3703955|P2|Stage 1|Death|0
1128078|NCT01562275|3703956|P1|Stage 1|Death|1
1128079|NCT01562275|3703944|P13|Stage 1|Adverse Event|0
1128080|NCT01562275|3703945|P12|Stage 1|Adverse Event|0
1128081|NCT01562275|3703946|P11|Stage 1|Adverse Event|0
1128082|NCT01562275|3703947|P10|Stage 1|Adverse Event|1
1128083|NCT01562275|3703948|P9|Stage 1|Adverse Event|0
1128084|NCT01562275|3703949|P8|Stage 1|Adverse Event|0
1128085|NCT01562275|3703950|P7|Stage 1|Adverse Event|0
1128086|NCT01562275|3703951|P6|Stage 1|Adverse Event|0
1128087|NCT01562275|3703952|P5|Stage 1|Adverse Event|1
1128088|NCT01562275|3703953|P4|Stage 1|Adverse Event|1
1128089|NCT01562275|3703954|P3|Stage 1|Adverse Event|0
1128090|NCT01562275|3703955|P2|Stage 1|Adverse Event|0
1128091|NCT01562275|3703956|P1|Stage 1|Adverse Event|0
1128092|NCT01561976|3704101|P6|Washout Period 2 (7 Days)|Non-compliance|0
1128093|NCT01561976|3704102|P5|Washout Period 2 (7 Days)|Non-compliance|0
1128094|NCT01561976|3704103|P4|Washout Period 2 (7 Days)|Non-compliance|0
1128095|NCT01561976|3704104|P3|Washout Period 2 (7 Days)|Non-compliance|1
1128096|NCT01561976|3704105|P2|Washout Period 2 (7 Days)|Non-compliance|0
1128097|NCT01561976|3704106|P1|Washout Period 2 (7 Days)|Non-compliance|1
1128098|NCT01561976|3704101|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|1
1128099|NCT01561976|3704102|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1128100|NCT01561976|3704103|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1128101|NCT01561976|3704104|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1128102|NCT01561976|3704105|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1128103|NCT01561976|3704106|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1128104|NCT01561976|3704101|P6|Washout Period 1 (7 Days)|Adverse Event|0
1128105|NCT01561976|3704102|P5|Washout Period 1 (7 Days)|Adverse Event|0
1128106|NCT01561976|3704103|P4|Washout Period 1 (7 Days)|Adverse Event|1
1128107|NCT01561976|3704104|P3|Washout Period 1 (7 Days)|Adverse Event|0
1128108|NCT01561976|3704105|P2|Washout Period 1 (7 Days)|Adverse Event|0
1128109|NCT01561976|3704106|P1|Washout Period 1 (7 Days)|Adverse Event|0
1128110|NCT01561976|3704101|P6|Period 1|Adverse Event|0
1128111|NCT01561976|3704102|P5|Period 1|Adverse Event|0
1128112|NCT01561976|3704103|P4|Period 1|Adverse Event|0
1128113|NCT01561976|3704104|P3|Period 1|Adverse Event|1
1128114|NCT01561976|3704105|P2|Period 1|Adverse Event|0
1128115|NCT01561976|3704106|P1|Period 1|Adverse Event|0
1128116|NCT01561898|3704139|P4|Overall Study|Physician Decision|1
1128117|NCT01561898|3704140|P3|Overall Study|Physician Decision|7
1128118|NCT01561898|3704141|P2|Overall Study|Physician Decision|5
1128119|NCT01561898|3704142|P1|Overall Study|Physician Decision|1
1128120|NCT01561898|3704139|P4|Overall Study|Adverse Event|9
1128121|NCT01561898|3704140|P3|Overall Study|Adverse Event|14
1128122|NCT01561898|3704141|P2|Overall Study|Adverse Event|19
1128123|NCT01561898|3704142|P1|Overall Study|Adverse Event|1
1128124|NCT01561898|3704139|P4|Overall Study|Lost to Follow-up|0
1128125|NCT01561898|3704140|P3|Overall Study|Lost to Follow-up|1
1128126|NCT01561898|3704141|P2|Overall Study|Lost to Follow-up|0
1128127|NCT01561898|3704142|P1|Overall Study|Lost to Follow-up|0
1128128|NCT01561898|3704139|P4|Overall Study|Worsening of complications|0
1128129|NCT01561898|3704140|P3|Overall Study|Worsening of complications|0
1128130|NCT01561898|3704141|P2|Overall Study|Worsening of complications|1
1128131|NCT01561898|3704142|P1|Overall Study|Worsening of complications|0
1128132|NCT01561898|3704139|P4|Overall Study|Lack of Efficacy|5
1128133|NCT01561898|3704140|P3|Overall Study|Lack of Efficacy|10
1128134|NCT01561898|3704141|P2|Overall Study|Lack of Efficacy|8
1128135|NCT01561898|3704142|P1|Overall Study|Lack of Efficacy|0
1128136|NCT01561898|3704139|P4|Overall Study|Withdrawal by Subject|5
1128137|NCT01561898|3704140|P3|Overall Study|Withdrawal by Subject|12
1128138|NCT01561898|3704141|P2|Overall Study|Withdrawal by Subject|8
1128139|NCT01561898|3704142|P1|Overall Study|Withdrawal by Subject|0
1128140|NCT01561755|3704156|P2|Overall Study|Lost to Follow-up|1
1128141|NCT01561755|3704157|P1|Overall Study|Lost to Follow-up|0
1128142|NCT01561560|3704209|P2|Second Two Weeks of Wear|Adverse Event|1
1128143|NCT01561560|3704210|P1|Second Two Weeks of Wear|Adverse Event|0
1128144|NCT01561560|3704209|P2|First Two Weeks of Wear|Adverse Event|1
1128145|NCT01561560|3704210|P1|First Two Weeks of Wear|Adverse Event|0
1128146|NCT01561560|3704209|P2|First Two Weeks of Wear|Time/job conflict|1
1128147|NCT01561560|3704210|P1|First Two Weeks of Wear|Time/job conflict|0
1128148|NCT01561430|3704241|P4|Overall Study|Sponsor Decision|12
1128149|NCT01561430|3704242|P3|Overall Study|Sponsor Decision|13
1128150|NCT01561430|3704243|P2|Overall Study|Sponsor Decision|14
1128151|NCT01561430|3704244|P1|Overall Study|Sponsor Decision|1
1128152|NCT01561430|3704241|P4|Overall Study|Physician Decision|0
1128153|NCT01561430|3704242|P3|Overall Study|Physician Decision|0
1128154|NCT01561430|3704243|P2|Overall Study|Physician Decision|1
1128155|NCT01561430|3704244|P1|Overall Study|Physician Decision|0
1128156|NCT01561430|3704241|P4|Overall Study|Withdrawal by Subject|0
1128157|NCT01561430|3704242|P3|Overall Study|Withdrawal by Subject|1
1128158|NCT01561430|3704243|P2|Overall Study|Withdrawal by Subject|0
1128159|NCT01561430|3704244|P1|Overall Study|Withdrawal by Subject|0
1128160|NCT01561430|3704241|P4|Overall Study|Adverse Event|1
1128161|NCT01561430|3704242|P3|Overall Study|Adverse Event|3
1128162|NCT01561430|3704243|P2|Overall Study|Adverse Event|0
1128163|NCT01561430|3704244|P1|Overall Study|Adverse Event|0
1128164|NCT01561313|3704284|P2|Overall Study|Adverse event and withdrawal by subject|0
1128165|NCT01561313|3704285|P1|Overall Study|Adverse event and withdrawal by subject|1
1128166|NCT01561313|3704284|P2|Overall Study|Withdrawal by Subject|0
1128167|NCT01561313|3704285|P1|Overall Study|Withdrawal by Subject|1
1128168|NCT01561300|3704303|P2|Run in on Placebo|Adverse Event|0
1128169|NCT01561300|3704304|P1|Run in on Placebo|Adverse Event|1
1128170|NCT01561079|3704315|P1|Overall Study|Protocol Violation|2
1128171|NCT01561079|3704315|P1|Overall Study|Withdrawal by Subject|59
1128172|NCT01561079|3704315|P1|Overall Study|Physician Decision|17
1128173|NCT01560988|3704358|P2|Washout (Six Weeks)|Lost to Follow-up|2
1128174|NCT01560988|3704359|P1|Washout (Six Weeks)|Lost to Follow-up|2
1128175|NCT01560988|3704358|P2|First Intervention (Six Weeks)|Withdrawal by Subject|0
1128176|NCT01560988|3704359|P1|First Intervention (Six Weeks)|Withdrawal by Subject|3
1128177|NCT01560988|3704358|P2|First Intervention (Six Weeks)|Lost to Follow-up|4
1128178|NCT01560988|3704359|P1|First Intervention (Six Weeks)|Lost to Follow-up|7
1128179|NCT01560819|3704397|P2|Overall Study|Physician Decision|0
1128180|NCT01560819|3704398|P1|Overall Study|Physician Decision|1
1128181|NCT01560507|3704405|P3|Overall Study|Withdrawal by Subject|0
1128182|NCT01560507|3704406|P2|Overall Study|Withdrawal by Subject|1
1128183|NCT01560507|3704407|P1|Overall Study|Withdrawal by Subject|1
1128184|NCT01560507|3704405|P3|Overall Study|Lost to Follow-up|2
1128185|NCT01560507|3704406|P2|Overall Study|Lost to Follow-up|1
1128186|NCT01560507|3704407|P1|Overall Study|Lost to Follow-up|3
1128187|NCT01560429|3704420|P2|Overall Study|Protocol Violation|6
1128188|NCT01560429|3704421|P1|Overall Study|Protocol Violation|3
1128189|NCT01560403|3704431|P2|Overall Study|Lost to Follow-up|1
1128190|NCT01560403|3704432|P1|Overall Study|Lost to Follow-up|0
1128191|NCT01560234|3704467|P8|Overall Study|Lost to Follow-up|2
1128192|NCT01560234|3704468|P7|Overall Study|Lost to Follow-up|0
1128193|NCT01560234|3704469|P6|Overall Study|Lost to Follow-up|2
1128194|NCT01560234|3704470|P5|Overall Study|Lost to Follow-up|0
1128195|NCT01560234|3704471|P4|Overall Study|Lost to Follow-up|0
1128196|NCT01560234|3704472|P3|Overall Study|Lost to Follow-up|1
1128197|NCT01560234|3704473|P2|Overall Study|Lost to Follow-up|0
1128198|NCT01560234|3704474|P1|Overall Study|Lost to Follow-up|3
1128199|NCT01559935|3704552|P1|Maintenance Phase|Non-compliance|2
1128200|NCT01559935|3704552|P1|Maintenance Phase|Withdrawal by Subject|5
1128201|NCT01559935|3704552|P1|Maintenance Phase|Lack of Efficacy|18
1128202|NCT01559935|3704552|P1|Maintenance Phase|Toxicity|1
1128203|NCT01559935|3704552|P1|Maintenance Phase|Remains on study|28
1128204|NCT01559935|3704552|P1|BiRD Phase|Withdrawal by Subject|2
1128205|NCT01559935|3704552|P1|BiRD Phase|Lack of Efficacy|1
1128206|NCT01559935|3704552|P1|BiRD Phase|Toxicity|1
1128207|NCT01559935|3704552|P1|Car Phase|non-compliance|1
1128208|NCT01559935|3704552|P1|Car Phase|Insurance|1
1128209|NCT01559935|3704552|P1|Car Phase|Per protocol|1
1128210|NCT01559935|3704552|P1|Car Phase|Withdrawal by Subject|2
1128211|NCT01559935|3704552|P1|Car Phase|Physician Decision|1
1128212|NCT01559935|3704552|P1|Car Phase|Lost to Follow-up|1
1128213|NCT01559935|3704552|P1|Car Phase|Lack of Efficacy|2
1128214|NCT01559935|3704552|P1|Car Phase|Death|1
1128215|NCT01559935|3704552|P1|Car Phase|Toxicity|4
1128216|NCT01559844|3704588|P1|Overall Study|No Longer A Transplant Candidate|3
1128217|NCT01559844|3704588|P1|Overall Study|Efficacy Failure|10
1128218|NCT01559844|3704588|P1|Overall Study|Death|5
1128219|NCT01559844|3704588|P1|Overall Study|Consent Withdrawn|7
1128220|NCT01559675|3704601|P2|Overall Study|2nd operation on same patient excluded|12
1128221|NCT01559675|3704602|P1|Overall Study|2nd operation on same patient excluded|14
1128222|NCT01559675|3704601|P2|Overall Study|Protocol Violation|2
1128223|NCT01559675|3704602|P1|Overall Study|Protocol Violation|1
1128224|NCT01559454|3704633|P2|Overall Study|Lack of Efficacy|1
1128225|NCT01559454|3704634|P1|Overall Study|Lack of Efficacy|0
1128226|NCT01559454|3704633|P2|Overall Study|Protocol Violation|1
1128227|NCT01559454|3704634|P1|Overall Study|Protocol Violation|0
1128228|NCT01559454|3704633|P2|Overall Study|Physician Decision|1
1128229|NCT01559454|3704634|P1|Overall Study|Physician Decision|0
1128230|NCT01559454|3704633|P2|Overall Study|Withdrawal by Subject|1
1128231|NCT01559454|3704634|P1|Overall Study|Withdrawal by Subject|0
1128232|NCT01559454|3704633|P2|Overall Study|Lost to Follow-up|2
1128233|NCT01559454|3704634|P1|Overall Study|Lost to Follow-up|3
1128234|NCT01559311|3704653|P3|Overall Study|Adverse Event|1
1128235|NCT01559311|3704654|P2|Overall Study|Adverse Event|0
1128236|NCT01559311|3704655|P1|Overall Study|Adverse Event|0
1128237|NCT01559311|3704653|P3|Overall Study|Lost to Follow-up|2
1128238|NCT01559311|3704654|P2|Overall Study|Lost to Follow-up|3
1128239|NCT01559311|3704655|P1|Overall Study|Lost to Follow-up|0
1128240|NCT01559311|3704653|P3|Overall Study|Death|3
1128241|NCT01559311|3704654|P2|Overall Study|Death|2
1128242|NCT01559311|3704655|P1|Overall Study|Death|0
1128243|NCT01559311|3704653|P3|Overall Study|Withdrawal by Subject|0
1128244|NCT01559311|3704654|P2|Overall Study|Withdrawal by Subject|1
1128245|NCT01559311|3704655|P1|Overall Study|Withdrawal by Subject|2
1128246|NCT01559311|3704653|P3|Overall Study|Difficulty in cannulating the lateral ve|0
1128247|NCT01559311|3704654|P2|Overall Study|Difficulty in cannulating the lateral ve|0
1128248|NCT01559311|3704655|P1|Overall Study|Difficulty in cannulating the lateral ve|1
1128249|NCT01559311|3704653|P3|Overall Study|Protocol Violation|2
1128250|NCT01559311|3704654|P2|Overall Study|Protocol Violation|0
1128251|NCT01559311|3704655|P1|Overall Study|Protocol Violation|0
1128252|NCT01559116|3704666|P1|Overall Study|other than stated above|9
1128253|NCT01559116|3704666|P1|Overall Study|Withdrawal by Subject|4
1128254|NCT01559116|3704666|P1|Overall Study|Protocol Violation|1
1128255|NCT01559116|3704666|P1|Overall Study|Lost to Follow-up|1
1128256|NCT01559116|3704666|P1|Overall Study|Lack of Efficacy|1
1128257|NCT01559116|3704666|P1|Overall Study|Adverse Event|10
1128258|NCT01559012|3704749|P2|Overall Study|Withdrawal by Subject|1
1128259|NCT01559012|3704750|P1|Overall Study|Withdrawal by Subject|0
1128260|NCT01558739|3704786|P1|Overall Study|Protocol Violation|1
1128261|NCT01558739|3704786|P1|Overall Study|Disease Progression|4
1128262|NCT01558739|3704786|P1|Overall Study|Death|3
1128263|NCT01558739|3704786|P1|Overall Study|Withdrawal by Subject|2
1128264|NCT01558739|3704786|P1|Overall Study|Adverse Event|7
1128265|NCT01558674|3704811|P2|Part 1|Withdrawal by Subject|0
1128266|NCT01558674|3704812|P1|Part 1|Withdrawal by Subject|1
1128267|NCT01558674|3704811|P2|Part 1|Study Terminated by Sponsor|0
1128268|NCT01558674|3704812|P1|Part 1|Study Terminated by Sponsor|10
1128269|NCT01558596|3704865|P2|Overall Study|Protocol Violation|0
1128270|NCT01558596|3704866|P1|Overall Study|Protocol Violation|1
1128271|NCT01558596|3704865|P2|Overall Study|surgery elsewhere or cancelled|1
1128272|NCT01558596|3704866|P1|Overall Study|surgery elsewhere or cancelled|1
1128273|NCT01558596|3704865|P2|Overall Study|Withdrawal by Subject|0
1128274|NCT01558596|3704866|P1|Overall Study|Withdrawal by Subject|1
1128275|NCT01558297|3704881|P3|Overall Study|Withdrawal by Subject|1
1128276|NCT01558297|3704882|P2|Overall Study|Withdrawal by Subject|2
1128277|NCT01558297|3704883|P1|Overall Study|Withdrawal by Subject|2
1128278|NCT01558271|3704900|P3|Overall Study|Physician Decision|1
1128279|NCT01558271|3704901|P2|Overall Study|Physician Decision|2
1128280|NCT01558271|3704902|P1|Overall Study|Physician Decision|0
1128281|NCT01558271|3704900|P3|Overall Study|Withdrawal by Subject|12
1128282|NCT01558271|3704901|P2|Overall Study|Withdrawal by Subject|6
1128283|NCT01558271|3704902|P1|Overall Study|Withdrawal by Subject|10
1128284|NCT01558271|3704900|P3|Overall Study|Protocol Violation|0
1128285|NCT01558271|3704901|P2|Overall Study|Protocol Violation|0
1128286|NCT01558271|3704902|P1|Overall Study|Protocol Violation|1
1128287|NCT01558271|3704900|P3|Overall Study|Lost to Follow-up|0
1128288|NCT01558271|3704901|P2|Overall Study|Lost to Follow-up|0
1128289|NCT01558271|3704902|P1|Overall Study|Lost to Follow-up|1
1128290|NCT01558271|3704900|P3|Overall Study|Adverse Event|4
1128291|NCT01558271|3704901|P2|Overall Study|Adverse Event|3
1128292|NCT01558271|3704902|P1|Overall Study|Adverse Event|6
1128293|NCT01558089|3704968|P1|Overall Study|Withdrawal by Subject|6
1128294|NCT01558089|3704968|P1|Overall Study|Lost to Follow-up|5
1128295|NCT01558089|3704968|P1|Overall Study|Lack of Efficacy|1
1128296|NCT01558089|3704968|P1|Overall Study|Adverse Event|1
1128297|NCT01557946|3704989|P2|Overall Study|Adverse Event|0
1128298|NCT01557946|3704990|P1|Overall Study|Adverse Event|3
1128299|NCT01557920|3704996|P2|Overall Study|Lack of Efficacy|0
1128300|NCT01557920|3704997|P1|Overall Study|Lack of Efficacy|1
1128301|NCT01557920|3704996|P2|Overall Study|Withdrawal by Subject|3
1128302|NCT01557920|3704997|P1|Overall Study|Withdrawal by Subject|2
1128303|NCT01557842|3705060|P2|Overall Study|Not Ablated|0
1128304|NCT01557842|3705061|P1|Overall Study|Not Ablated|2
1128305|NCT01557842|3705060|P2|Overall Study|Study Terminated by Sponsor|4
1128306|NCT01557842|3705061|P1|Overall Study|Study Terminated by Sponsor|3
1128307|NCT01557842|3705060|P2|Overall Study|Not Meet Inclusion/Exclusion Criteria|0
1128308|NCT01557842|3705061|P1|Overall Study|Not Meet Inclusion/Exclusion Criteria|3
1128309|NCT01557842|3705060|P2|Overall Study|Lack of Efficacy|1
1128310|NCT01557842|3705061|P1|Overall Study|Lack of Efficacy|0
1128311|NCT01557842|3705060|P2|Overall Study|Death|0
1128312|NCT01557842|3705061|P1|Overall Study|Death|1
1128313|NCT01557842|3705060|P2|Overall Study|Lost to Follow-up|1
1128314|NCT01557842|3705061|P1|Overall Study|Lost to Follow-up|0
1128315|NCT01557751|3705069|P1|Overall Study|Physician Decision|3
1128316|NCT01557582|3705114|P1|Overall Study|Operator error|2
1128317|NCT01557582|3705114|P1|Overall Study|Protocol Violation|4
1128318|NCT01557569|3705122|P2|Overall Study|noncompliance with rules of residential|1
1128319|NCT01557569|3705123|P1|Overall Study|noncompliance with rules of residential|0
1128320|NCT01557569|3705122|P2|Overall Study|Withdrawal by Subject|5
1128321|NCT01557569|3705123|P1|Overall Study|Withdrawal by Subject|3
1128322|NCT01557569|3705122|P2|Overall Study|high blood pressure|1
1128323|NCT01557569|3705123|P1|Overall Study|high blood pressure|0
1128324|NCT01557569|3705122|P2|Overall Study|Adverse Event|0
1128325|NCT01557569|3705123|P1|Overall Study|Adverse Event|2
1128326|NCT01557504|3705131|P2|Overall Study|Physician Decision|0
1128327|NCT01557504|3705132|P1|Overall Study|Physician Decision|1
1128328|NCT01557348|3705157|P2|Overall Study|Administrative|11
1128329|NCT01557348|3705158|P1|Overall Study|Administrative|18
1128330|NCT01557348|3705157|P2|Overall Study|Lost to Follow-up|22
1128331|NCT01557348|3705158|P1|Overall Study|Lost to Follow-up|26
1128332|NCT01557348|3705157|P2|Overall Study|Withdrawal by Subject|4
1128333|NCT01557348|3705158|P1|Overall Study|Withdrawal by Subject|5
1128334|NCT01557348|3705157|P2|Overall Study|Insufficient Therapeutic Response|28
1128335|NCT01557348|3705158|P1|Overall Study|Insufficient Therapeutic Response|13
1128336|NCT01557348|3705157|P2|Overall Study|Death|4
1128337|NCT01557348|3705158|P1|Overall Study|Death|7
1128338|NCT01557348|3705157|P2|Overall Study|Infusion reaction event|5
1128339|NCT01557348|3705158|P1|Overall Study|Infusion reaction event|5
1128340|NCT01557348|3705157|P2|Overall Study|Adverse Event|16
1128341|NCT01557348|3705158|P1|Overall Study|Adverse Event|6
1128342|NCT01557283|3705275|P1|Overall Study|Other|6
1128343|NCT01557283|3705275|P1|Overall Study|Worsening of psoriasis|1
1128344|NCT01557283|3705275|P1|Overall Study|Participant’s weight too high for dose|1
1128345|NCT01557283|3705275|P1|Overall Study|Withdrawal by Subject|1
1128346|NCT01557283|3705275|P1|Overall Study|Non-compliance|1
1128347|NCT01557283|3705275|P1|Overall Study|Lack of Efficacy|1
1128348|NCT01557283|3705275|P1|Overall Study|Adverse Event|7
1128349|NCT01557283|3705275|P1|Overall Study|Non-responder|19
1128350|NCT01557283|3705275|P1|Overall Study|Lost to Follow-up|7
1128351|NCT01557166|3705287|P2|Overall Study|Unclassified|5
1128352|NCT01557166|3705288|P1|Overall Study|Unclassified|2
1128353|NCT01557166|3705287|P2|Overall Study|Psychiatric disorder|0
1128354|NCT01557166|3705288|P1|Overall Study|Psychiatric disorder|1
1128355|NCT01557166|3705287|P2|Overall Study|Target dose not tolerated|0
1128356|NCT01557166|3705288|P1|Overall Study|Target dose not tolerated|1
1128357|NCT01557166|3705287|P2|Overall Study|Withdrawn consent|20
1128358|NCT01557166|3705288|P1|Overall Study|Withdrawn consent|12
1128359|NCT01557166|3705287|P2|Overall Study|Protocol Violation|5
1128360|NCT01557166|3705288|P1|Overall Study|Protocol Violation|8
1128361|NCT01557166|3705287|P2|Overall Study|Lack of Efficacy|1
1128362|NCT01557166|3705288|P1|Overall Study|Lack of Efficacy|2
1128363|NCT01557166|3705287|P2|Overall Study|Adverse Event|6
1128364|NCT01557166|3705288|P1|Overall Study|Adverse Event|20
1128365|NCT01556997|3705303|P3|Overall Study|Not specified|7
1128366|NCT01556997|3705304|P2|Overall Study|Not specified|3
1128367|NCT01556997|3705305|P1|Overall Study|Not specified|2
1128368|NCT01556997|3705303|P3|Overall Study|Withdrawal by Subject|8
1128369|NCT01556997|3705304|P2|Overall Study|Withdrawal by Subject|6
1128370|NCT01556997|3705305|P1|Overall Study|Withdrawal by Subject|7
1128371|NCT01556997|3705303|P3|Overall Study|Physician Decision|1
1128372|NCT01556997|3705304|P2|Overall Study|Physician Decision|1
1128373|NCT01556997|3705305|P1|Overall Study|Physician Decision|1
1128374|NCT01556997|3705303|P3|Overall Study|Lost to Follow-up|4
1128375|NCT01556997|3705304|P2|Overall Study|Lost to Follow-up|6
1128376|NCT01556997|3705305|P1|Overall Study|Lost to Follow-up|6
1128377|NCT01556997|3705303|P3|Overall Study|Adverse Event|12
1128378|NCT01556997|3705304|P2|Overall Study|Adverse Event|12
1128379|NCT01556997|3705305|P1|Overall Study|Adverse Event|10
1128380|NCT01556932|3705316|P2|Time Point 60 Minutes|Withdrawal by Subject|1
1128381|NCT01556932|3705317|P1|Time Point 60 Minutes|Withdrawal by Subject|1
1128382|NCT01556763|3705343|P3|Overall Study|Withdrawal by Subject|0
1128383|NCT01556763|3705344|P2|Overall Study|Withdrawal by Subject|1
1128384|NCT01556763|3705345|P1|Overall Study|Withdrawal by Subject|0
1128385|NCT01556165|3705531|P2|Overall Study|Withdrawal of Consent|1
1128386|NCT01556165|3705532|P1|Overall Study|Withdrawal of Consent|7
1128387|NCT01556165|3705531|P2|Overall Study|Protocol Violation|3
1128388|NCT01556165|3705532|P1|Overall Study|Protocol Violation|0
1128389|NCT01556165|3705531|P2|Overall Study|Adverse Event|3
1128390|NCT01556165|3705532|P1|Overall Study|Adverse Event|5
1128391|NCT01555983|3705562|P6|Overall Study|Withdrawal by Subject|1
1128392|NCT01555983|3705563|P5|Overall Study|Withdrawal by Subject|1
1128393|NCT01555983|3705564|P4|Overall Study|Withdrawal by Subject|0
1128394|NCT01555983|3705565|P3|Overall Study|Withdrawal by Subject|0
1128395|NCT01555983|3705566|P2|Overall Study|Withdrawal by Subject|0
1128396|NCT01555983|3705567|P1|Overall Study|Withdrawal by Subject|1
1128397|NCT01555931|3705577|P2|Overall Study|Lost to Follow-up|5
1128398|NCT01555931|3705578|P1|Overall Study|Lost to Follow-up|2
1128399|NCT01555463|3705614|P2|Follow up|Other reason|3
1128400|NCT01555463|3705615|P1|Follow up|Other reason|3
1128401|NCT01555463|3705614|P2|Follow up|Protocol Violation|4
1128402|NCT01555463|3705615|P1|Follow up|Protocol Violation|2
1128403|NCT01555463|3705614|P2|Follow up|Lost to Follow-up|10
1128404|NCT01555463|3705615|P1|Follow up|Lost to Follow-up|9
1128405|NCT01555463|3705614|P2|Follow up|Withdrawal by Subject|22
1128406|NCT01555463|3705615|P1|Follow up|Withdrawal by Subject|22
1128407|NCT01555463|3705614|P2|Follow up|Death|1
1128408|NCT01555463|3705615|P1|Follow up|Death|0
1128409|NCT01555463|3705614|P2|Follow up|Adverse Event|5
1128410|NCT01555463|3705615|P1|Follow up|Adverse Event|2
1128411|NCT01555463|3705614|P2|Treatment|Other reason|3
1128412|NCT01555463|3705615|P1|Treatment|Other reason|2
1128413|NCT01555463|3705614|P2|Treatment|Protocol Violation|5
1128414|NCT01555463|3705615|P1|Treatment|Protocol Violation|4
1128415|NCT01555463|3705614|P2|Treatment|Lost to Follow-up|23
1128416|NCT01555463|3705615|P1|Treatment|Lost to Follow-up|28
1128417|NCT01555463|3705614|P2|Treatment|Withdrawal by Subject|36
1128418|NCT01555463|3705615|P1|Treatment|Withdrawal by Subject|24
1128419|NCT01555463|3705614|P2|Treatment|Adverse Event|12
1128420|NCT01555463|3705615|P1|Treatment|Adverse Event|6
1128421|NCT01555164|3705657|P2|Overall Study|Subject Withdrew Consent|11
1128422|NCT01555164|3705658|P1|Overall Study|Subject Withdrew Consent|6
1128423|NCT01555164|3705657|P2|Overall Study|Subject Non-compliance|6
1128424|NCT01555164|3705658|P1|Overall Study|Subject Non-compliance|14
1128425|NCT01555164|3705657|P2|Overall Study|Protocol Violation|5
1128426|NCT01555164|3705658|P1|Overall Study|Protocol Violation|9
1128427|NCT01555164|3705657|P2|Overall Study|Lost to Follow-up|3
1128428|NCT01555164|3705658|P1|Overall Study|Lost to Follow-up|4
1128429|NCT01555164|3705657|P2|Overall Study|Investigator's Discretion|2
1128430|NCT01555164|3705658|P1|Overall Study|Investigator's Discretion|2
1128431|NCT01555164|3705657|P2|Overall Study|Hyperglycemia|1
1128432|NCT01555164|3705658|P1|Overall Study|Hyperglycemia|0
1128433|NCT01555164|3705657|P2|Overall Study|Adverse Event|7
1128434|NCT01555164|3705658|P1|Overall Study|Adverse Event|5
1128435|NCT01555151|3705672|P4|Overall Study|Lost to Follow-up|1
1128436|NCT01555151|3705673|P3|Overall Study|Lost to Follow-up|0
1128437|NCT01555151|3705674|P2|Overall Study|Lost to Follow-up|0
1128438|NCT01555151|3705675|P1|Overall Study|Lost to Follow-up|0
1128439|NCT01555151|3705672|P4|Overall Study|Adverse Event|2
1128440|NCT01555151|3705673|P3|Overall Study|Adverse Event|1
1128441|NCT01555151|3705674|P2|Overall Study|Adverse Event|2
1128442|NCT01555151|3705675|P1|Overall Study|Adverse Event|1
1128443|NCT01555151|3705672|P4|Overall Study|Protocol Violation|5
1128444|NCT01555151|3705673|P3|Overall Study|Protocol Violation|3
1128445|NCT01555151|3705674|P2|Overall Study|Protocol Violation|3
1128446|NCT01555151|3705675|P1|Overall Study|Protocol Violation|3
1128447|NCT01555151|3705672|P4|Overall Study|Administrative|0
1128448|NCT01555151|3705673|P3|Overall Study|Administrative|2
1128449|NCT01555151|3705674|P2|Overall Study|Administrative|1
1128450|NCT01555151|3705675|P1|Overall Study|Administrative|3
1128451|NCT01555151|3705672|P4|Overall Study|Withdrawal by Subject|2
1128452|NCT01555151|3705673|P3|Overall Study|Withdrawal by Subject|0
1128453|NCT01555151|3705674|P2|Overall Study|Withdrawal by Subject|2
1128454|NCT01555151|3705675|P1|Overall Study|Withdrawal by Subject|6
1128455|NCT01555138|3705728|P2|Overall Study|Adverse Event|14
1128456|NCT01555138|3705729|P1|Overall Study|Adverse Event|14
1128457|NCT01555138|3705728|P2|Overall Study|Withdrawal by Subject|15
1128458|NCT01555138|3705729|P1|Overall Study|Withdrawal by Subject|16
1128459|NCT01555138|3705728|P2|Overall Study|Administrative problems|0
1128460|NCT01555138|3705729|P1|Overall Study|Administrative problems|8
1128461|NCT01555138|3705728|P2|Overall Study|Protocol Violation|3
1128462|NCT01555138|3705729|P1|Overall Study|Protocol Violation|5
1128463|NCT01555138|3705728|P2|Overall Study|Lack of Efficacy|2
1128464|NCT01555138|3705729|P1|Overall Study|Lack of Efficacy|2
1128465|NCT01555138|3705728|P2|Overall Study|Abnormal Lab reults|3
1128466|NCT01555138|3705729|P1|Overall Study|Abnormal Lab reults|1
1128467|NCT01555138|3705728|P2|Overall Study|Lost to Follow-up|0
1128468|NCT01555138|3705729|P1|Overall Study|Lost to Follow-up|1
1128469|NCT01555138|3705728|P2|Overall Study|Death|1
1128470|NCT01555138|3705729|P1|Overall Study|Death|0
1128471|NCT01555125|3705758|P5|Follow-Up Period|Subject / guardian decision|0
1128472|NCT01555125|3705759|P4|Follow-Up Period|Subject / guardian decision|1
1128473|NCT01555125|3705760|P3|Follow-Up Period|Subject / guardian decision|1
1128474|NCT01555125|3705761|P2|Follow-Up Period|Subject / guardian decision|1
1128475|NCT01555125|3705762|P1|Follow-Up Period|Subject / guardian decision|3
1128476|NCT01555125|3705758|P5|Follow-Up Period|Lost to Follow-up|0
1128477|NCT01555125|3705759|P4|Follow-Up Period|Lost to Follow-up|0
1128478|NCT01555125|3705760|P3|Follow-Up Period|Lost to Follow-up|0
1128479|NCT01555125|3705761|P2|Follow-Up Period|Lost to Follow-up|0
1128480|NCT01555125|3705762|P1|Follow-Up Period|Lost to Follow-up|1
1128481|NCT01555125|3705758|P5|Extension|Technical Problems|0
1128482|NCT01555125|3705759|P4|Extension|Technical Problems|1
1128483|NCT01555125|3705760|P3|Extension|Technical Problems|0
1128484|NCT01555125|3705761|P2|Extension|Technical Problems|0
1128485|NCT01555125|3705762|P1|Extension|Technical Problems|1
1128486|NCT01555125|3705758|P5|Extension|Subject/guardian decision|0
1128487|NCT01555125|3705759|P4|Extension|Subject/guardian decision|0
1128488|NCT01555125|3705760|P3|Extension|Subject/guardian decision|1
1128489|NCT01555125|3705761|P2|Extension|Subject/guardian decision|9
1128490|NCT01555125|3705762|P1|Extension|Subject/guardian decision|1
1128491|NCT01555125|3705758|P5|Extension|Study terminated by sponsor|0
1128492|NCT01555125|3705759|P4|Extension|Study terminated by sponsor|20
1128493|NCT01555125|3705760|P3|Extension|Study terminated by sponsor|16
1128494|NCT01555125|3705761|P2|Extension|Study terminated by sponsor|33
1128495|NCT01555125|3705762|P1|Extension|Study terminated by sponsor|32
1128496|NCT01555125|3705758|P5|Extension|Lost to Follow-up|0
1128497|NCT01555125|3705759|P4|Extension|Lost to Follow-up|0
1128498|NCT01555125|3705760|P3|Extension|Lost to Follow-up|2
1128499|NCT01555125|3705761|P2|Extension|Lost to Follow-up|1
1128500|NCT01555125|3705762|P1|Extension|Lost to Follow-up|2
1128501|NCT01555125|3705758|P5|Extension|Lack of Efficacy|0
1128502|NCT01555125|3705759|P4|Extension|Lack of Efficacy|0
1128503|NCT01555125|3705760|P3|Extension|Lack of Efficacy|3
1128504|NCT01555125|3705761|P2|Extension|Lack of Efficacy|6
1128505|NCT01555125|3705762|P1|Extension|Lack of Efficacy|7
1128506|NCT01555125|3705758|P5|Extension|Protocol deviation|0
1128507|NCT01555125|3705759|P4|Extension|Protocol deviation|0
1128508|NCT01555125|3705760|P3|Extension|Protocol deviation|0
1128509|NCT01555125|3705761|P2|Extension|Protocol deviation|0
1128510|NCT01555125|3705762|P1|Extension|Protocol deviation|1
1128511|NCT01555125|3705758|P5|Extension|Adverse Event|0
1128512|NCT01555125|3705759|P4|Extension|Adverse Event|1
1128513|NCT01555125|3705760|P3|Extension|Adverse Event|1
1128514|NCT01555125|3705761|P2|Extension|Adverse Event|2
1128515|NCT01555125|3705762|P1|Extension|Adverse Event|1
1128516|NCT01555125|3705758|P5|Maintenance Period|Death|0
1128517|NCT01555125|3705759|P4|Maintenance Period|Death|1
1128518|NCT01555125|3705760|P3|Maintenance Period|Death|0
1128519|NCT01555125|3705761|P2|Maintenance Period|Death|0
1128520|NCT01555125|3705762|P1|Maintenance Period|Death|0
1128521|NCT01555125|3705758|P5|Maintenance Period|Physician Decision|0
1128522|NCT01555125|3705759|P4|Maintenance Period|Physician Decision|0
1128523|NCT01555125|3705760|P3|Maintenance Period|Physician Decision|1
1128524|NCT01555125|3705761|P2|Maintenance Period|Physician Decision|0
1128525|NCT01555125|3705762|P1|Maintenance Period|Physician Decision|0
1128526|NCT01555125|3705758|P5|Maintenance Period|Lack of Efficacy|0
1128527|NCT01555125|3705759|P4|Maintenance Period|Lack of Efficacy|0
1128528|NCT01555125|3705760|P3|Maintenance Period|Lack of Efficacy|3
1128529|NCT01555125|3705761|P2|Maintenance Period|Lack of Efficacy|1
1128530|NCT01555125|3705762|P1|Maintenance Period|Lack of Efficacy|6
1128531|NCT01555125|3705758|P5|Maintenance Period|Lost to Follow-up|0
1128532|NCT01555125|3705759|P4|Maintenance Period|Lost to Follow-up|1
1128533|NCT01555125|3705760|P3|Maintenance Period|Lost to Follow-up|0
1128534|NCT01555125|3705761|P2|Maintenance Period|Lost to Follow-up|0
1128535|NCT01555125|3705762|P1|Maintenance Period|Lost to Follow-up|2
1128536|NCT01555125|3705758|P5|Maintenance Period|Subject / guardian decision|0
1128537|NCT01555125|3705759|P4|Maintenance Period|Subject / guardian decision|0
1128538|NCT01555125|3705760|P3|Maintenance Period|Subject / guardian decision|0
1128539|NCT01555125|3705761|P2|Maintenance Period|Subject / guardian decision|2
1128540|NCT01555125|3705762|P1|Maintenance Period|Subject / guardian decision|1
1128541|NCT01555125|3705758|P5|Maintenance Period|Adverse Event|0
1128542|NCT01555125|3705759|P4|Maintenance Period|Adverse Event|0
1128543|NCT01555125|3705760|P3|Maintenance Period|Adverse Event|0
1128544|NCT01555125|3705761|P2|Maintenance Period|Adverse Event|1
1128545|NCT01555125|3705762|P1|Maintenance Period|Adverse Event|1
1128546|NCT01555125|3705758|P5|Induction Period|Death|0
1128547|NCT01555125|3705759|P4|Induction Period|Death|0
1128548|NCT01555125|3705760|P3|Induction Period|Death|0
1128549|NCT01555125|3705761|P2|Induction Period|Death|0
1128550|NCT01555125|3705762|P1|Induction Period|Death|1
1128551|NCT01555125|3705758|P5|Induction Period|Subject / guardian decision|2
1128552|NCT01555125|3705759|P4|Induction Period|Subject / guardian decision|0
1128553|NCT01555125|3705760|P3|Induction Period|Subject / guardian decision|0
1128554|NCT01555125|3705761|P2|Induction Period|Subject / guardian decision|0
1128555|NCT01555125|3705762|P1|Induction Period|Subject / guardian decision|0
1128556|NCT01555125|3705758|P5|Induction Period|Adverse Event|1
1128557|NCT01555125|3705759|P4|Induction Period|Adverse Event|0
1128558|NCT01555125|3705760|P3|Induction Period|Adverse Event|0
1128559|NCT01555125|3705761|P2|Induction Period|Adverse Event|1
1128560|NCT01555125|3705762|P1|Induction Period|Adverse Event|0
1128561|NCT01555125|3705758|P5|Induction Period|Lost to Follow-up|0
1128562|NCT01555125|3705759|P4|Induction Period|Lost to Follow-up|0
1128563|NCT01555125|3705760|P3|Induction Period|Lost to Follow-up|0
1128564|NCT01555125|3705761|P2|Induction Period|Lost to Follow-up|2
1128565|NCT01555125|3705762|P1|Induction Period|Lost to Follow-up|0
1128566|NCT01555073|3705855|P4|Overall Study|Lost to Follow-up|5
1128567|NCT01555073|3705856|P3|Overall Study|Lost to Follow-up|0
1128568|NCT01555073|3705857|P2|Overall Study|Lost to Follow-up|2
1128569|NCT01555073|3705858|P1|Overall Study|Lost to Follow-up|1
1128570|NCT01555021|3705874|P2|Overall Study|Lost to Follow-up|2
1128571|NCT01555021|3705875|P1|Overall Study|Lost to Follow-up|1
1128572|NCT01554904|3705900|P1|Overall Study|Had sleep apnea on Home Study 1|1
1128573|NCT01554904|3705900|P1|Overall Study|Withdrawal by Subject|3
1128574|NCT01554579|3705920|P2|Overall Study|Withdrawal by Subject|1
1128575|NCT01554579|3705921|P1|Overall Study|Withdrawal by Subject|2
1128576|NCT01554579|3705920|P2|Overall Study|Lack of Efficacy|1
1128577|NCT01554579|3705921|P1|Overall Study|Lack of Efficacy|2
1128578|NCT01554579|3705920|P2|Overall Study|Adverse Event|25
1128579|NCT01554579|3705921|P1|Overall Study|Adverse Event|6
1128580|NCT01554241|3705935|P4|Overall Study|Withdrawal by Subject|0
1128581|NCT01554241|3705936|P3|Overall Study|Withdrawal by Subject|2
1128582|NCT01554241|3705937|P2|Overall Study|Withdrawal by Subject|0
1128583|NCT01554241|3705938|P1|Overall Study|Withdrawal by Subject|0
1128584|NCT01554241|3705935|P4|Overall Study|protocol specified change in eGFR|0
1128585|NCT01554241|3705936|P3|Overall Study|protocol specified change in eGFR|1
1128586|NCT01554241|3705937|P2|Overall Study|protocol specified change in eGFR|0
1128587|NCT01554241|3705938|P1|Overall Study|protocol specified change in eGFR|0
1128588|NCT01554241|3705935|P4|Overall Study|protocol specified renal stone|1
1128589|NCT01554241|3705936|P3|Overall Study|protocol specified renal stone|0
1128590|NCT01554241|3705937|P2|Overall Study|protocol specified renal stone|0
1128591|NCT01554241|3705938|P1|Overall Study|protocol specified renal stone|0
1128592|NCT01554241|3705935|P4|Overall Study|Death|0
1128593|NCT01554241|3705936|P3|Overall Study|Death|1
1128594|NCT01554241|3705937|P2|Overall Study|Death|1
1128595|NCT01554241|3705938|P1|Overall Study|Death|3
1128596|NCT01554176|3705954|P5|Run-out Phase|Protocol Violation|0
1128597|NCT01554176|3705955|P4|Run-out Phase|Protocol Violation|1
1128598|NCT01554176|3705956|P3|Run-out Phase|Protocol Violation|0
1128599|NCT01554176|3705957|P2|Run-out Phase|Protocol Violation|0
1128600|NCT01554176|3705958|P1|Run-out Phase|Protocol Violation|0
1128601|NCT01554176|3705954|P5|Treatment Phase|Lost to Follow-up|0
1128602|NCT01554176|3705955|P4|Treatment Phase|Lost to Follow-up|0
1128603|NCT01554176|3705956|P3|Treatment Phase|Lost to Follow-up|0
1128604|NCT01554176|3705957|P2|Treatment Phase|Lost to Follow-up|0
1128605|NCT01554176|3705958|P1|Treatment Phase|Lost to Follow-up|3
1128606|NCT01554176|3705954|P5|Treatment Phase|Withdrawal by Subject|0
1128607|NCT01554176|3705955|P4|Treatment Phase|Withdrawal by Subject|0
1128608|NCT01554176|3705956|P3|Treatment Phase|Withdrawal by Subject|0
1128609|NCT01554176|3705957|P2|Treatment Phase|Withdrawal by Subject|0
1128610|NCT01554176|3705958|P1|Treatment Phase|Withdrawal by Subject|1
1128611|NCT01554176|3705954|P5|Treatment Phase|Non-compliance with study drug|0
1128612|NCT01554176|3705955|P4|Treatment Phase|Non-compliance with study drug|0
1128613|NCT01554176|3705956|P3|Treatment Phase|Non-compliance with study drug|0
1128614|NCT01554176|3705957|P2|Treatment Phase|Non-compliance with study drug|0
1128615|NCT01554176|3705958|P1|Treatment Phase|Non-compliance with study drug|1
1128616|NCT01554176|3705954|P5|Treatment Phase|Adverse event, non-fatal|0
1128617|NCT01554176|3705955|P4|Treatment Phase|Adverse event, non-fatal|0
1128618|NCT01554176|3705956|P3|Treatment Phase|Adverse event, non-fatal|0
1128619|NCT01554176|3705957|P2|Treatment Phase|Adverse event, non-fatal|1
1128620|NCT01554176|3705958|P1|Treatment Phase|Adverse event, non-fatal|1
1128621|NCT01554176|3705954|P5|Treatment Phase|Lack of Efficacy|0
1128622|NCT01554176|3705955|P4|Treatment Phase|Lack of Efficacy|0
1128623|NCT01554176|3705956|P3|Treatment Phase|Lack of Efficacy|0
1128624|NCT01554176|3705957|P2|Treatment Phase|Lack of Efficacy|1
1128625|NCT01554176|3705958|P1|Treatment Phase|Lack of Efficacy|0
1128626|NCT01554176|3705954|P5|Treatment Phase|Physician Decision|0
1128627|NCT01554176|3705955|P4|Treatment Phase|Physician Decision|0
1128628|NCT01554176|3705956|P3|Treatment Phase|Physician Decision|0
1128629|NCT01554176|3705957|P2|Treatment Phase|Physician Decision|1
1128630|NCT01554176|3705958|P1|Treatment Phase|Physician Decision|1
1128631|NCT01554176|3705954|P5|Treatment Phase|Protocol Violation|0
1128632|NCT01554176|3705955|P4|Treatment Phase|Protocol Violation|0
1128633|NCT01554176|3705956|P3|Treatment Phase|Protocol Violation|0
1128634|NCT01554176|3705957|P2|Treatment Phase|Protocol Violation|2
1128635|NCT01554176|3705958|P1|Treatment Phase|Protocol Violation|1
1128636|NCT01554163|3705985|P2|Overall Study|Not Treated|0
1128637|NCT01554163|3705986|P1|Overall Study|Not Treated|1
1128638|NCT01554163|3705985|P2|Overall Study|Withdrawal by Subject|5
1128639|NCT01554163|3705986|P1|Overall Study|Withdrawal by Subject|1
1128640|NCT01554163|3705985|P2|Overall Study|Protocol Violation|4
1128641|NCT01554163|3705986|P1|Overall Study|Protocol Violation|0
1128642|NCT01554163|3705985|P2|Overall Study|Non-Compliance With Study Drug|1
1128643|NCT01554163|3705986|P1|Overall Study|Non-Compliance With Study Drug|1
1128644|NCT01554163|3705985|P2|Overall Study|Lost to Follow-up|0
1128645|NCT01554163|3705986|P1|Overall Study|Lost to Follow-up|1
1128646|NCT01554163|3705985|P2|Overall Study|Lack of Efficacy|0
1128647|NCT01554163|3705986|P1|Overall Study|Lack of Efficacy|1
1128648|NCT01554163|3705985|P2|Overall Study|Adverse Event|0
1128649|NCT01554163|3705986|P1|Overall Study|Adverse Event|3
1128650|NCT01553916|3706004|P1|Overall Study|Pre-treatment MRI metastatic disease|1
1128651|NCT01553916|3706004|P1|Overall Study|Withdrawal by Subject|2
1128652|NCT01553851|3706021|P1|Overall Study|constipation|1
1128653|NCT01553851|3706021|P1|Overall Study|Adverse Event|2
1128654|NCT01553747|3706036|P3|Overall Study|Physician decision: lack of efficacy|3
1128655|NCT01553747|3706037|P2|Overall Study|Physician decision: lack of efficacy|5
1128656|NCT01553747|3706038|P1|Overall Study|Physician decision: lack of efficacy|1
1128657|NCT01553747|3706036|P3|Overall Study|Sponsor decision, specify|0
1128658|NCT01553747|3706037|P2|Overall Study|Sponsor decision, specify|5
1128659|NCT01553747|3706038|P1|Overall Study|Sponsor decision, specify|7
1128660|NCT01553747|3706036|P3|Overall Study|Lost to Follow-up|6
1128661|NCT01553747|3706037|P2|Overall Study|Lost to Follow-up|5
1128662|NCT01553747|3706038|P1|Overall Study|Lost to Follow-up|11
1128663|NCT01553747|3706036|P3|Overall Study|Physician decision: other|7
1128664|NCT01553747|3706037|P2|Overall Study|Physician decision: other|8
1128665|NCT01553747|3706038|P1|Overall Study|Physician decision: other|10
1128666|NCT01553747|3706036|P3|Overall Study|Adverse event or SAE|19
1128667|NCT01553747|3706037|P2|Overall Study|Adverse event or SAE|28
1128668|NCT01553747|3706038|P1|Overall Study|Adverse event or SAE|32
1128669|NCT01553747|3706036|P3|Overall Study|Voluntarily withdrew|74
1128670|NCT01553747|3706037|P2|Overall Study|Voluntarily withdrew|66
1128671|NCT01553747|3706038|P1|Overall Study|Voluntarily withdrew|70
1128672|NCT01553747|3706036|P3|Overall Study|Protocol Violation|0
1128673|NCT01553747|3706037|P2|Overall Study|Protocol Violation|2
1128674|NCT01553747|3706038|P1|Overall Study|Protocol Violation|0
1128675|NCT01553591|3706100|P3|Overall Study|Randomized and never dispensed drug|0
1128676|NCT01553591|3706101|P2|Overall Study|Randomized and never dispensed drug|1
1128677|NCT01553591|3706102|P1|Overall Study|Randomized and never dispensed drug|0
1128678|NCT01553591|3706100|P3|Overall Study|Sponsor decision|3
1128679|NCT01553591|3706101|P2|Overall Study|Sponsor decision|0
1128680|NCT01553591|3706102|P1|Overall Study|Sponsor decision|1
1128681|NCT01553591|3706100|P3|Overall Study|Protocol Violation|4
1128682|NCT01553591|3706101|P2|Overall Study|Protocol Violation|4
1128683|NCT01553591|3706102|P1|Overall Study|Protocol Violation|3
1128684|NCT01553591|3706100|P3|Overall Study|Physician decision: lack of efficacy|7
1128685|NCT01553591|3706101|P2|Overall Study|Physician decision: lack of efficacy|3
1128686|NCT01553591|3706102|P1|Overall Study|Physician decision: lack of efficacy|2
1128687|NCT01553591|3706100|P3|Overall Study|Physician decision: other|16
1128688|NCT01553591|3706101|P2|Overall Study|Physician decision: other|14
1128689|NCT01553591|3706102|P1|Overall Study|Physician decision: other|11
1128690|NCT01553591|3706100|P3|Overall Study|Lost to Follow-up|16
1128691|NCT01553591|3706101|P2|Overall Study|Lost to Follow-up|23
1128692|NCT01553591|3706102|P1|Overall Study|Lost to Follow-up|25
1128693|NCT01553591|3706100|P3|Overall Study|Adverse Event|16
1128694|NCT01553591|3706101|P2|Overall Study|Adverse Event|45
1128695|NCT01553591|3706102|P1|Overall Study|Adverse Event|36
1128696|NCT01553591|3706100|P3|Overall Study|Voluntarily withdrew|96
1128697|NCT01553591|3706101|P2|Overall Study|Voluntarily withdrew|79
1128698|NCT01553591|3706102|P1|Overall Study|Voluntarily withdrew|94
1128699|NCT01553318|3706162|P2|Overall Study|Protocol Violation|2
1128700|NCT01553318|3706163|P1|Overall Study|Protocol Violation|3
1128701|NCT01553188|3706200|P4|Overall Study|Intercurrent illness and adverse event|0
1128702|NCT01553188|3706201|P3|Overall Study|Intercurrent illness and adverse event|2
1128703|NCT01553188|3706202|P2|Overall Study|Intercurrent illness and adverse event|1
1128704|NCT01553188|3706203|P1|Overall Study|Intercurrent illness and adverse event|0
1128705|NCT01553188|3706200|P4|Overall Study|Patient choice|0
1128706|NCT01553188|3706201|P3|Overall Study|Patient choice|0
1128707|NCT01553188|3706202|P2|Overall Study|Patient choice|0
1128708|NCT01553188|3706203|P1|Overall Study|Patient choice|1
1128709|NCT01553136|3706230|P2|Overall Study|Scheduling Difficulties|4
1128710|NCT01553136|3706231|P1|Overall Study|Scheduling Difficulties|5
1128711|NCT01553136|3706230|P2|Overall Study|Physician Decision|3
1128712|NCT01553136|3706231|P1|Overall Study|Physician Decision|2
1128713|NCT01553136|3706230|P2|Overall Study|Lost to Follow-up|10
1128714|NCT01553136|3706231|P1|Overall Study|Lost to Follow-up|4
1128715|NCT01553136|3706230|P2|Overall Study|Withdrawal by Subject|3
1128716|NCT01553136|3706231|P1|Overall Study|Withdrawal by Subject|2
1128717|NCT01553136|3706230|P2|Overall Study|Adverse Event|2
1128718|NCT01553136|3706231|P1|Overall Study|Adverse Event|3
1128719|NCT01552954|3706311|P2|Overall Study|diagnosed DM|0
1128720|NCT01552954|3706312|P1|Overall Study|diagnosed DM|1
1128721|NCT01552954|3706311|P2|Overall Study|Protocol Violation|2
1128722|NCT01552954|3706312|P1|Overall Study|Protocol Violation|1
1128723|NCT01552954|3706311|P2|Overall Study|Withdrawal by Subject|1
1128724|NCT01552954|3706312|P1|Overall Study|Withdrawal by Subject|1
1128725|NCT01552954|3706311|P2|Overall Study|Lost to Follow-up|1
1128726|NCT01552954|3706312|P1|Overall Study|Lost to Follow-up|1
1128727|NCT01552954|3706311|P2|Overall Study|Adverse Event|2
1128728|NCT01552954|3706312|P1|Overall Study|Adverse Event|1
1128729|NCT01552928|3706328|P4|Period 3|Adverse Event|0
1128730|NCT01552928|3706329|P3|Period 3|Adverse Event|1
1128731|NCT01552928|3706330|P2|Period 3|Adverse Event|0
1128732|NCT01552928|3706331|P1|Period 3|Adverse Event|0
1128733|NCT01552915|3706378|P3|Overall Study|Not specified|6
1128734|NCT01552915|3706379|P2|Overall Study|Not specified|0
1128735|NCT01552915|3706380|P1|Overall Study|Not specified|2
1128736|NCT01552915|3706378|P3|Overall Study|Lack of Efficacy|4
1128737|NCT01552915|3706379|P2|Overall Study|Lack of Efficacy|1
1128738|NCT01552915|3706380|P1|Overall Study|Lack of Efficacy|8
1128739|NCT01552915|3706378|P3|Overall Study|Protocol Violation|4
1128740|NCT01552915|3706379|P2|Overall Study|Protocol Violation|4
1128741|NCT01552915|3706380|P1|Overall Study|Protocol Violation|0
1128742|NCT01552915|3706378|P3|Overall Study|Withdrawal by Subject|5
1128743|NCT01552915|3706379|P2|Overall Study|Withdrawal by Subject|4
1128744|NCT01552915|3706380|P1|Overall Study|Withdrawal by Subject|6
1128745|NCT01552915|3706378|P3|Overall Study|Lost to Follow-up|5
1128746|NCT01552915|3706379|P2|Overall Study|Lost to Follow-up|6
1128747|NCT01552915|3706380|P1|Overall Study|Lost to Follow-up|4
1128748|NCT01552915|3706378|P3|Overall Study|Adverse Event|3
1128749|NCT01552915|3706379|P2|Overall Study|Adverse Event|14
1128750|NCT01552915|3706380|P1|Overall Study|Adverse Event|3
1128751|NCT01552902|3706403|P3|Overall Study|Other|3
1128752|NCT01552902|3706404|P2|Overall Study|Other|4
1128753|NCT01552902|3706405|P1|Overall Study|Other|3
1128754|NCT01552902|3706403|P3|Overall Study|Lost to Follow-up|6
1128755|NCT01552902|3706404|P2|Overall Study|Lost to Follow-up|3
1128756|NCT01552902|3706405|P1|Overall Study|Lost to Follow-up|1
1128757|NCT01552902|3706403|P3|Overall Study|Withdrawal by Subject|6
1128758|NCT01552902|3706404|P2|Overall Study|Withdrawal by Subject|9
1128759|NCT01552902|3706405|P1|Overall Study|Withdrawal by Subject|1
1128760|NCT01552902|3706403|P3|Overall Study|Lack of Efficacy|1
1128761|NCT01552902|3706404|P2|Overall Study|Lack of Efficacy|3
1128762|NCT01552902|3706405|P1|Overall Study|Lack of Efficacy|4
1128763|NCT01552902|3706403|P3|Overall Study|Protocol Violation|3
1128764|NCT01552902|3706404|P2|Overall Study|Protocol Violation|3
1128765|NCT01552902|3706405|P1|Overall Study|Protocol Violation|3
1128766|NCT01552902|3706403|P3|Overall Study|Adverse Event|14
1128767|NCT01552902|3706404|P2|Overall Study|Adverse Event|15
1128768|NCT01552902|3706405|P1|Overall Study|Adverse Event|1
1128769|NCT01552772|3706455|P1|Overall Study|Protocol Deviation|1
1128770|NCT01552772|3706455|P1|Overall Study|Adverse Event|1
1128771|NCT01552772|3706455|P1|Overall Study|Lost to Follow-up|2
1128772|NCT01552694|3706471|P2|Overall Study|Protocol Violation|1
1128773|NCT01552694|3706472|P1|Overall Study|Protocol Violation|0
1128774|NCT01552694|3706471|P2|Overall Study|Lost to Follow-up|1
1128775|NCT01552694|3706472|P1|Overall Study|Lost to Follow-up|0
1128776|NCT01552681|3706488|P2|Overall Study|Subject moved away|1
1128777|NCT01552681|3706489|P1|Overall Study|Subject moved away|0
1128778|NCT01552681|3706488|P2|Overall Study|Physician Decision|0
1128779|NCT01552681|3706489|P1|Overall Study|Physician Decision|1
1128780|NCT01552681|3706488|P2|Overall Study|Withdrawal by Subject|0
1128781|NCT01552681|3706489|P1|Overall Study|Withdrawal by Subject|4
1128782|NCT01552603|3706537|P1|Overall Study|Physician Decision|1
1128783|NCT01552408|3706544|P2|Overall Study|Withdrawal by Subject|1
1128784|NCT01552408|3706545|P1|Overall Study|Withdrawal by Subject|2
1128785|NCT01552408|3706544|P2|Overall Study|Relocation|1
1128786|NCT01552408|3706545|P1|Overall Study|Relocation|0
1128787|NCT01552408|3706544|P2|Overall Study|Lost to Follow-up|0
1128788|NCT01552408|3706545|P1|Overall Study|Lost to Follow-up|2
1128789|NCT01552057|3706591|P2|Overall Study|Physician Decision|0
1128790|NCT01552057|3706592|P1|Overall Study|Physician Decision|1
1128791|NCT01552057|3706591|P2|Overall Study|Entry Criteria Not Met|2
1128792|NCT01552057|3706592|P1|Overall Study|Entry Criteria Not Met|2
1128793|NCT01552057|3706591|P2|Overall Study|Withdrawal by Subject|8
1128794|NCT01552057|3706592|P1|Overall Study|Withdrawal by Subject|5
1128795|NCT01552057|3706591|P2|Overall Study|Lack of Efficacy|23
1128796|NCT01552057|3706592|P1|Overall Study|Lack of Efficacy|8
1128797|NCT01552057|3706591|P2|Overall Study|Adverse Event|15
1128798|NCT01552057|3706592|P1|Overall Study|Adverse Event|14
1128799|NCT01551758|3706658|P2|Overall Study|Withdrawal by Subject|17
1128800|NCT01551758|3706659|P1|Overall Study|Withdrawal by Subject|14
1128801|NCT01551758|3706658|P2|Overall Study|Physician Decision|3
1128802|NCT01551758|3706659|P1|Overall Study|Physician Decision|9
1128803|NCT01551758|3706658|P2|Overall Study|Lost to Follow-up|25
1128804|NCT01551758|3706659|P1|Overall Study|Lost to Follow-up|29
1128805|NCT01551758|3706658|P2|Overall Study|Met Protocol-defined stopping criteria|10
1128806|NCT01551758|3706659|P1|Overall Study|Met Protocol-defined stopping criteria|8
1128807|NCT01551758|3706658|P2|Overall Study|Protocol Violation|6
1128808|NCT01551758|3706659|P1|Overall Study|Protocol Violation|5
1128809|NCT01551758|3706658|P2|Overall Study|Lack of Efficacy|1
1128810|NCT01551758|3706659|P1|Overall Study|Lack of Efficacy|0
1128811|NCT01551758|3706658|P2|Overall Study|Adverse Event|43
1128812|NCT01551758|3706659|P1|Overall Study|Adverse Event|29
1128813|NCT01551745|3706697|P1|Overall Study|Disease Progression|2
1128814|NCT01551745|3706697|P1|Overall Study|Withdrawal by Subject|1
1128815|NCT01551693|3706706|P2|Overall Study|Withdrawal by Subject|1
1128816|NCT01551693|3706707|P1|Overall Study|Withdrawal by Subject|0
1128817|NCT01551693|3706706|P2|Overall Study|Adverse Event|1
1128818|NCT01551693|3706707|P1|Overall Study|Adverse Event|0
1128819|NCT01551693|3706706|P2|Overall Study|Disease Progression|0
1128820|NCT01551693|3706707|P1|Overall Study|Disease Progression|1
1128821|NCT01551355|3706723|P6|Overall Study|Lost to Follow-up|6
1128822|NCT01551355|3706724|P5|Overall Study|Lost to Follow-up|9
1128823|NCT01551355|3706725|P4|Overall Study|Lost to Follow-up|24
1128824|NCT01551355|3706726|P3|Overall Study|Lost to Follow-up|34
1128825|NCT01551355|3706727|P2|Overall Study|Lost to Follow-up|49
1128826|NCT01551355|3706728|P1|Overall Study|Lost to Follow-up|51
1128827|NCT01551303|3706742|P2|Overall Study|failed awareness check on vision test|7
1128828|NCT01551303|3706743|P1|Overall Study|failed awareness check on vision test|4
1128829|NCT01551173|3706766|P2|Overall Study|Not specified|3
1128830|NCT01551173|3706767|P1|Overall Study|Not specified|5
1128831|NCT01551173|3706766|P2|Overall Study|Lost to Follow-up|7
1128832|NCT01551173|3706767|P1|Overall Study|Lost to Follow-up|5
1128833|NCT01551173|3706766|P2|Overall Study|Adverse Event|6
1128834|NCT01551173|3706767|P1|Overall Study|Adverse Event|7
1128835|NCT01551173|3706766|P2|Overall Study|Withdrawal by Subject|16
1128836|NCT01551173|3706767|P1|Overall Study|Withdrawal by Subject|11
1128837|NCT01550965|3706844|P1|Overall Study|Not Specified|13
1128838|NCT01550965|3706844|P1|Overall Study|Lack of Efficacy|59
1128839|NCT01550965|3706844|P1|Overall Study|Lost to Follow-up|2
1128840|NCT01550965|3706844|P1|Overall Study|Withdrawal by Subject|10
1128841|NCT01550965|3706844|P1|Overall Study|Adverse Event|26
1128842|NCT01550757|3706888|P4|Overall Study|Withdrawal by Subject|1
1128843|NCT01550757|3706889|P3|Overall Study|Withdrawal by Subject|3
1128844|NCT01550757|3706890|P2|Overall Study|Withdrawal by Subject|0
1128845|NCT01550757|3706891|P1|Overall Study|Withdrawal by Subject|2
1128846|NCT01550757|3706888|P4|Overall Study|Lost to Follow-up|53
1128847|NCT01550757|3706889|P3|Overall Study|Lost to Follow-up|42
1128848|NCT01550757|3706890|P2|Overall Study|Lost to Follow-up|14
1128849|NCT01550757|3706891|P1|Overall Study|Lost to Follow-up|21
1128850|NCT01550744|3706901|P3|Double-Blind|Other|10
1128851|NCT01550744|3706902|P2|Double-Blind|Other|2
1128852|NCT01550744|3706903|P1|Double-Blind|Other|0
1128853|NCT01550744|3706901|P3|Double-Blind|Pregnancy|3
1128854|NCT01550744|3706902|P2|Double-Blind|Pregnancy|0
1128855|NCT01550744|3706903|P1|Double-Blind|Pregnancy|0
1128856|NCT01550744|3706901|P3|Double-Blind|Protocol Violation|4
1128857|NCT01550744|3706902|P2|Double-Blind|Protocol Violation|0
1128858|NCT01550744|3706903|P1|Double-Blind|Protocol Violation|0
1128859|NCT01550744|3706901|P3|Double-Blind|Lack of Efficacy|8
1128860|NCT01550744|3706902|P2|Double-Blind|Lack of Efficacy|2
1128861|NCT01550744|3706903|P1|Double-Blind|Lack of Efficacy|0
1128862|NCT01550744|3706901|P3|Double-Blind|Death|0
1128863|NCT01550744|3706902|P2|Double-Blind|Death|1
1128864|NCT01550744|3706903|P1|Double-Blind|Death|0
1128865|NCT01550744|3706901|P3|Double-Blind|Adverse Event|15
1128866|NCT01550744|3706902|P2|Double-Blind|Adverse Event|4
1128867|NCT01550744|3706903|P1|Double-Blind|Adverse Event|0
1128868|NCT01550744|3706901|P3|Double-Blind|Withdrawal by Subject|15
1128869|NCT01550744|3706902|P2|Double-Blind|Withdrawal by Subject|2
1128870|NCT01550744|3706903|P1|Double-Blind|Withdrawal by Subject|0
1128871|NCT01550744|3706901|P3|Double-Blind|Lost to Follow-up|12
1128872|NCT01550744|3706902|P2|Double-Blind|Lost to Follow-up|6
1128873|NCT01550744|3706903|P1|Double-Blind|Lost to Follow-up|0
1128874|NCT01550744|3706901|P3|Open-Label|Other|0
1128875|NCT01550744|3706902|P2|Open-Label|Other|0
1128876|NCT01550744|3706903|P1|Open-Label|Other|1
1128877|NCT01550744|3706901|P3|Open-Label|Static PGA-cleared/minimal not achieved|0
1128878|NCT01550744|3706902|P2|Open-Label|Static PGA-cleared/minimal not achieved|0
1128879|NCT01550744|3706903|P1|Open-Label|Static PGA-cleared/minimal not achieved|58
1128880|NCT01550744|3706901|P3|Open-Label|Not all 3 study drug injections received|0
1128881|NCT01550744|3706902|P2|Open-Label|Not all 3 study drug injections received|0
1128882|NCT01550744|3706903|P1|Open-Label|Not all 3 study drug injections received|2
1128883|NCT01550744|3706901|P3|Open-Label|Protocol Violation|0
1128884|NCT01550744|3706902|P2|Open-Label|Protocol Violation|0
1128885|NCT01550744|3706903|P1|Open-Label|Protocol Violation|4
1128886|NCT01550744|3706901|P3|Open-Label|Lack of Efficacy|0
1128887|NCT01550744|3706902|P2|Open-Label|Lack of Efficacy|0
1128888|NCT01550744|3706903|P1|Open-Label|Lack of Efficacy|4
1128889|NCT01550744|3706901|P3|Open-Label|Adverse Event|0
1128890|NCT01550744|3706902|P2|Open-Label|Adverse Event|0
1128891|NCT01550744|3706903|P1|Open-Label|Adverse Event|11
1128892|NCT01550744|3706901|P3|Open-Label|Withdrawal by Subject|0
1128893|NCT01550744|3706902|P2|Open-Label|Withdrawal by Subject|0
1128894|NCT01550744|3706903|P1|Open-Label|Withdrawal by Subject|13
1128895|NCT01550744|3706901|P3|Open-Label|Lost to Follow-up|0
1128896|NCT01550744|3706902|P2|Open-Label|Lost to Follow-up|0
1128897|NCT01550744|3706903|P1|Open-Label|Lost to Follow-up|7
1128898|NCT01550289|3706961|P2|Overall Study|Withdrawal by Subject|3
1128899|NCT01550289|3706962|P1|Overall Study|Withdrawal by Subject|11
1128900|NCT01550289|3706961|P2|Overall Study|Lost to Follow-up|1
1128901|NCT01550289|3706962|P1|Overall Study|Lost to Follow-up|1
1128902|NCT01550289|3706961|P2|Overall Study|Protocol Violation|0
1128903|NCT01550289|3706962|P1|Overall Study|Protocol Violation|1
1128904|NCT01549964|3707038|P4|80-Week Extension Period|Pretreatment Event/Adverse Event|2
1128905|NCT01549964|3707039|P3|80-Week Extension Period|Pretreatment Event/Adverse Event|1
1128906|NCT01549964|3707040|P2|80-Week Extension Period|Pretreatment Event/Adverse Event|0
1128907|NCT01549964|3707041|P1|80-Week Extension Period|Pretreatment Event/Adverse Event|0
1128908|NCT01549964|3707038|P4|80-Week Extension Period|Lost to Follow-up|1
1128909|NCT01549964|3707039|P3|80-Week Extension Period|Lost to Follow-up|2
1128910|NCT01549964|3707040|P2|80-Week Extension Period|Lost to Follow-up|0
1128911|NCT01549964|3707041|P1|80-Week Extension Period|Lost to Follow-up|1
1128912|NCT01549964|3707038|P4|80-Week Extension Period|Voluntary Withdrawal|2
1128913|NCT01549964|3707039|P3|80-Week Extension Period|Voluntary Withdrawal|4
1128914|NCT01549964|3707040|P2|80-Week Extension Period|Voluntary Withdrawal|1
1128915|NCT01549964|3707041|P1|80-Week Extension Period|Voluntary Withdrawal|0
1128916|NCT01549964|3707038|P4|80-Week Extension Period|Study Terminated by Sponsor|132
1128917|NCT01549964|3707039|P3|80-Week Extension Period|Study Terminated by Sponsor|132
1128918|NCT01549964|3707040|P2|80-Week Extension Period|Study Terminated by Sponsor|137
1128919|NCT01549964|3707041|P1|80-Week Extension Period|Study Terminated by Sponsor|65
1128920|NCT01549964|3707038|P4|80-Week Extension Period|Pregnancy|0
1128921|NCT01549964|3707039|P3|80-Week Extension Period|Pregnancy|1
1128922|NCT01549964|3707040|P2|80-Week Extension Period|Pregnancy|0
1128923|NCT01549964|3707041|P1|80-Week Extension Period|Pregnancy|0
1128924|NCT01549964|3707038|P4|24-Week Treatment Period|Completion Status Unknown|0
1128925|NCT01549964|3707039|P3|24-Week Treatment Period|Completion Status Unknown|1
1128926|NCT01549964|3707040|P2|24-Week Treatment Period|Completion Status Unknown|0
1128927|NCT01549964|3707041|P1|24-Week Treatment Period|Completion Status Unknown|1
1128928|NCT01549964|3707038|P4|24-Week Treatment Period|Randomized but Not Treated|1
1128929|NCT01549964|3707039|P3|24-Week Treatment Period|Randomized but Not Treated|0
1128930|NCT01549964|3707040|P2|24-Week Treatment Period|Randomized but Not Treated|0
1128931|NCT01549964|3707041|P1|24-Week Treatment Period|Randomized but Not Treated|0
1128932|NCT01549964|3707038|P4|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
1128933|NCT01549964|3707039|P3|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1
1128934|NCT01549964|3707040|P2|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
1128935|NCT01549964|3707041|P1|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
1128936|NCT01549964|3707038|P4|24-Week Treatment Period|Other|0
1128937|NCT01549964|3707039|P3|24-Week Treatment Period|Other|1
1128938|NCT01549964|3707040|P2|24-Week Treatment Period|Other|0
1128939|NCT01549964|3707041|P1|24-Week Treatment Period|Other|1
1128940|NCT01549964|3707038|P4|24-Week Treatment Period|Lack of Efficacy|1
1128941|NCT01549964|3707039|P3|24-Week Treatment Period|Lack of Efficacy|1
1128942|NCT01549964|3707040|P2|24-Week Treatment Period|Lack of Efficacy|0
1128943|NCT01549964|3707041|P1|24-Week Treatment Period|Lack of Efficacy|1
1128944|NCT01549964|3707038|P4|24-Week Treatment Period|Lost to Follow-up|2
1128945|NCT01549964|3707039|P3|24-Week Treatment Period|Lost to Follow-up|1
1128946|NCT01549964|3707040|P2|24-Week Treatment Period|Lost to Follow-up|0
1128947|NCT01549964|3707041|P1|24-Week Treatment Period|Lost to Follow-up|1
1128948|NCT01549964|3707038|P4|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
1128949|NCT01549964|3707039|P3|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
1128950|NCT01549964|3707040|P2|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
1128951|NCT01549964|3707041|P1|24-Week Treatment Period|Pretreatment Event/Adverse Event|1
1128952|NCT01549964|3707038|P4|24-Week Treatment Period|Voluntary Withdrawal|8
1128953|NCT01549964|3707039|P3|24-Week Treatment Period|Voluntary Withdrawal|3
1128954|NCT01549964|3707040|P2|24-Week Treatment Period|Voluntary Withdrawal|3
1128955|NCT01549964|3707041|P1|24-Week Treatment Period|Voluntary Withdrawal|6
1128956|NCT01549964|3707038|P4|24-Week Treatment Period|Study Terminated by Sponsor|105
1128957|NCT01549964|3707039|P3|24-Week Treatment Period|Study Terminated by Sponsor|104
1128958|NCT01549964|3707040|P2|24-Week Treatment Period|Study Terminated by Sponsor|104
1128959|NCT01549964|3707041|P1|24-Week Treatment Period|Study Terminated by Sponsor|50
1128960|NCT01549951|3707059|P1|Overall Study|Other|2
1128961|NCT01549951|3707059|P1|Overall Study|Symptomatic deterioration|1
1128962|NCT01549951|3707059|P1|Overall Study|Progressive disease|29
1128963|NCT01549951|3707059|P1|Overall Study|Unsatisfactory therapeutic response|1
1128964|NCT01549951|3707059|P1|Overall Study|Withdrawal by Subject|2
1128965|NCT01549951|3707059|P1|Overall Study|Adverse Event|15
1128966|NCT01549873|3707086|P2|Overall Study|Physician Decision|1
1128967|NCT01549873|3707087|P1|Overall Study|Physician Decision|0
1128968|NCT01549860|3707099|P2|Overall Study|Physician Decision|1
1128969|NCT01549860|3707100|P1|Overall Study|Physician Decision|1
1128970|NCT01549860|3707099|P2|Overall Study|Withdrawal by Subject|0
1128971|NCT01549860|3707100|P1|Overall Study|Withdrawal by Subject|1
1128972|NCT01549613|3707112|P2|Overall Study|Lost to Follow-up|11
1128973|NCT01549613|3707113|P1|Overall Study|Lost to Follow-up|11
1128974|NCT01549392|3707132|P2|Overall Study|Withdrawal by Subject|0
1128975|NCT01549392|3707133|P1|Overall Study|Withdrawal by Subject|1
1128976|NCT01549275|3707152|P2|Overall Study|Lost to Follow-up|0
1128977|NCT01549275|3707153|P1|Overall Study|Lost to Follow-up|1
1128978|NCT01549041|3707176|P2|Overall Study|Adverse Event|4
1128979|NCT01549041|3707177|P1|Overall Study|Adverse Event|0
1128980|NCT01549041|3707176|P2|Overall Study|Lack of Efficacy|4
1128981|NCT01549041|3707177|P1|Overall Study|Lack of Efficacy|2
1128982|NCT01549002|3707187|P2|Overall Study|Moderate sedation required|2
1128983|NCT01549002|3707188|P1|Overall Study|Moderate sedation required|0
1128984|NCT01549002|3707187|P2|Overall Study|Excessive pain|2
1128985|NCT01549002|3707188|P1|Overall Study|Excessive pain|0
1128986|NCT01548638|3707261|P1|Overall Study|Withdrawal by Subject|1
1128987|NCT01548638|3707261|P1|Overall Study|Protocol Violation|3
1128988|NCT01548573|3707271|P1|Overall Study|Withdrawal by Subject|2
1128989|NCT01548573|3707271|P1|Overall Study|Death|3
1128990|NCT01548417|3707280|P2|Overall Study|Withdrawal by Subject|2
1128991|NCT01548417|3707281|P1|Overall Study|Withdrawal by Subject|0
1128992|NCT01548404|3707291|P2|Overall Study|Other than specified above|2
1128993|NCT01548404|3707292|P1|Overall Study|Other than specified above|0
1128994|NCT01548404|3707291|P2|Overall Study|Withdrawal by Subject|3
1128995|NCT01548404|3707292|P1|Overall Study|Withdrawal by Subject|0
1128996|NCT01548404|3707291|P2|Overall Study|Lost to Follow-up|0
1128997|NCT01548404|3707292|P1|Overall Study|Lost to Follow-up|2
1128998|NCT01548404|3707291|P2|Overall Study|Inadequate response to study treatment|7
1128999|NCT01548404|3707292|P1|Overall Study|Inadequate response to study treatment|23
1129000|NCT01548404|3707291|P2|Overall Study|Physician Decision|1
1129001|NCT01548404|3707292|P1|Overall Study|Physician Decision|2
1129002|NCT01548404|3707291|P2|Overall Study|Adverse Event|1
1129003|NCT01548404|3707292|P1|Overall Study|Adverse Event|3
1129004|NCT01548287|3707318|P5|Randomized Period|Adverse Event|0
1129005|NCT01548287|3707319|P4|Randomized Period|Adverse Event|0
1129006|NCT01548287|3707320|P3|Randomized Period|Adverse Event|5
1129007|NCT01548287|3707321|P2|Randomized Period|Adverse Event|2
1129008|NCT01548287|3707322|P1|Randomized Period|Adverse Event|0
1129009|NCT01548287|3707318|P5|Randomized Period|Did not meet inclusion criteria|0
1129010|NCT01548287|3707319|P4|Randomized Period|Did not meet inclusion criteria|0
1129011|NCT01548287|3707320|P3|Randomized Period|Did not meet inclusion criteria|2
1129012|NCT01548287|3707321|P2|Randomized Period|Did not meet inclusion criteria|0
1129013|NCT01548287|3707322|P1|Randomized Period|Did not meet inclusion criteria|0
1129014|NCT01548287|3707318|P5|Screening|Did not meet eligibility criteria|74
1129015|NCT01548287|3707319|P4|Screening|Did not meet eligibility criteria|0
1129016|NCT01548287|3707320|P3|Screening|Did not meet eligibility criteria|0
1129017|NCT01548287|3707321|P2|Screening|Did not meet eligibility criteria|0
1129018|NCT01548287|3707322|P1|Screening|Did not meet eligibility criteria|0
1129019|NCT01548287|3707318|P5|Screening|No reason provided|9
1129020|NCT01548287|3707319|P4|Screening|No reason provided|0
1129021|NCT01548287|3707320|P3|Screening|No reason provided|0
1129022|NCT01548287|3707321|P2|Screening|No reason provided|0
1129023|NCT01548287|3707322|P1|Screening|No reason provided|0
1129024|NCT01547728|3707379|P1|Overall Study|Screen failure|39
1129025|NCT01547728|3707379|P1|Overall Study|Drug not ready for subject|1
1129026|NCT01547728|3707379|P1|Overall Study|Change in procedure and equipment|1
1129027|NCT01547598|3707488|P2|Overall Study|Other Miscellaneous Reasons|1
1129028|NCT01547598|3707489|P1|Overall Study|Other Miscellaneous Reasons|2
1129029|NCT01547598|3707488|P2|Overall Study|Protocol Violation|1
1129030|NCT01547598|3707489|P1|Overall Study|Protocol Violation|1
1129031|NCT01547598|3707488|P2|Overall Study|Adverse Event|1
1129032|NCT01547598|3707489|P1|Overall Study|Adverse Event|1
1129033|NCT01547598|3707488|P2|Overall Study|Lost to Follow-up|1
1129034|NCT01547598|3707489|P1|Overall Study|Lost to Follow-up|1
1129035|NCT01547598|3707488|P2|Overall Study|Withdrew consent|1
1129036|NCT01547598|3707489|P1|Overall Study|Withdrew consent|1
1129037|NCT01547390|3707506|P2|Overall Study|Adverse Event|0
1129038|NCT01547390|3707507|P1|Overall Study|Adverse Event|3
1129039|NCT01547390|3707506|P2|Overall Study|Lost to Follow-up|2
1129040|NCT01547390|3707507|P1|Overall Study|Lost to Follow-up|0
1129041|NCT01547390|3707506|P2|Overall Study|termination of pregnancy|1
1129042|NCT01547390|3707507|P1|Overall Study|termination of pregnancy|0
1129043|NCT01547390|3707506|P2|Overall Study|Withdrawal by Subject|7
1129044|NCT01547390|3707507|P1|Overall Study|Withdrawal by Subject|10
1129045|NCT01547299|3707517|P2|Overall Study|Withdrawal by Subject|2
1129046|NCT01547299|3707518|P1|Overall Study|Withdrawal by Subject|2
1129047|NCT01547286|3707584|P1|Overall Study|Physician Decision|1
1129048|NCT01547286|3707584|P1|Overall Study|Did not meet all eligibility criteria|1
1129049|NCT01547130|3707604|P2|Overall Study|Lost to Follow-up|5
1129050|NCT01547130|3707605|P1|Overall Study|Lost to Follow-up|9
1129051|NCT01546922|3707628|P2|Second Period of 10 Weeks|Withdrawal by Subject|2
1129052|NCT01546922|3707629|P1|Second Period of 10 Weeks|Withdrawal by Subject|0
1129053|NCT01546922|3707628|P2|Second Period of 10 Weeks|Protocol Violation|1
1129054|NCT01546922|3707629|P1|Second Period of 10 Weeks|Protocol Violation|3
1129055|NCT01546922|3707628|P2|First Period of 10 Weeks|Investigator's judgment|0
1129056|NCT01546922|3707629|P1|First Period of 10 Weeks|Investigator's judgment|1
1129057|NCT01546922|3707628|P2|First Period of 10 Weeks|Withdrawal by Subject|1
1129058|NCT01546922|3707629|P1|First Period of 10 Weeks|Withdrawal by Subject|1
1129059|NCT01546922|3707628|P2|First Period of 10 Weeks|Protocol Violation|1
1129060|NCT01546922|3707629|P1|First Period of 10 Weeks|Protocol Violation|3
1129061|NCT01546883|3707635|P1|Overall Study|other unrelated illness|1
1129062|NCT01546883|3707635|P1|Overall Study|early closure of study|2
1129063|NCT01546883|3707635|P1|Overall Study|Lost to Follow-up|2
1129064|NCT01546883|3707635|P1|Overall Study|Adverse Event|4
1129065|NCT01546883|3707635|P1|Overall Study|Withdrawal by Subject|3
1129066|NCT01546688|3707641|P2|Overall Study|Lack of Efficacy|0
1129067|NCT01546688|3707642|P1|Overall Study|Lack of Efficacy|1
1129068|NCT01546688|3707641|P2|Overall Study|Withdrawal by Subject|1
1129069|NCT01546688|3707642|P1|Overall Study|Withdrawal by Subject|2
1129070|NCT01546688|3707641|P2|Overall Study|Adverse Event|4
1129071|NCT01546688|3707642|P1|Overall Study|Adverse Event|0
1129072|NCT01546649|3707674|P2|Overall Study|Withdrawal by Subject|2
1129073|NCT01546649|3707675|P1|Overall Study|Withdrawal by Subject|1
1129074|NCT01546649|3707674|P2|Overall Study|Discovery of secondary cancer|1
1129075|NCT01546649|3707675|P1|Overall Study|Discovery of secondary cancer|0
1129076|NCT01546649|3707674|P2|Overall Study|Recurrence|1
1129077|NCT01546649|3707675|P1|Overall Study|Recurrence|1
1129078|NCT01546649|3707674|P2|Overall Study|Lack of Efficacy|0
1129079|NCT01546649|3707675|P1|Overall Study|Lack of Efficacy|1
1129080|NCT01546649|3707674|P2|Overall Study|Protocol Violation|0
1129081|NCT01546649|3707675|P1|Overall Study|Protocol Violation|1
1129082|NCT01546649|3707674|P2|Overall Study|Adverse Event|5
1129083|NCT01546649|3707675|P1|Overall Study|Adverse Event|4
1129084|NCT01546623|3707710|P2|Overall Study|Did Not Receive Study Drug|1
1129085|NCT01546623|3707711|P1|Overall Study|Did Not Receive Study Drug|1
1129086|NCT01546623|3707710|P2|Overall Study|High Prostate specific antigen|1
1129087|NCT01546623|3707711|P1|Overall Study|High Prostate specific antigen|2
1129088|NCT01546623|3707710|P2|Overall Study|Major Protocol Deviation|1
1129089|NCT01546623|3707711|P1|Overall Study|Major Protocol Deviation|1
1129090|NCT01546623|3707710|P2|Overall Study|Adverse Event|3
1129091|NCT01546623|3707711|P1|Overall Study|Adverse Event|2
1129092|NCT01546519|3707741|P4|Overall Study|Withdrawal by Subject|0
1129093|NCT01546519|3707742|P3|Overall Study|Withdrawal by Subject|0
1129094|NCT01546519|3707743|P2|Overall Study|Withdrawal by Subject|0
1129095|NCT01546519|3707744|P1|Overall Study|Withdrawal by Subject|1
1129096|NCT01546519|3707741|P4|Overall Study|Physician Decision|3
1129097|NCT01546519|3707742|P3|Overall Study|Physician Decision|2
1129098|NCT01546519|3707743|P2|Overall Study|Physician Decision|5
1129099|NCT01546519|3707744|P1|Overall Study|Physician Decision|6
1129100|NCT01546519|3707741|P4|Overall Study|related to disease progression|1
1129101|NCT01546519|3707742|P3|Overall Study|related to disease progression|2
1129102|NCT01546519|3707743|P2|Overall Study|related to disease progression|2
1129103|NCT01546519|3707744|P1|Overall Study|related to disease progression|2
1129104|NCT01546519|3707741|P4|Overall Study|Death|1
1129105|NCT01546519|3707742|P3|Overall Study|Death|3
1129106|NCT01546519|3707743|P2|Overall Study|Death|1
1129107|NCT01546519|3707744|P1|Overall Study|Death|0
1129108|NCT01546519|3707741|P4|Overall Study|Adverse Event|1
1129109|NCT01546519|3707742|P3|Overall Study|Adverse Event|1
1129110|NCT01546519|3707743|P2|Overall Study|Adverse Event|0
1129111|NCT01546519|3707744|P1|Overall Study|Adverse Event|0
1129112|NCT01546207|3707809|P1|Overall Study|Death|1
1129113|NCT01546168|3707824|P2|Overall Study|ineligible after signing consent|0
1129114|NCT01546168|3707825|P1|Overall Study|ineligible after signing consent|2
1129115|NCT01546168|3707824|P2|Overall Study|Withdrawal by Subject|0
1129116|NCT01546168|3707825|P1|Overall Study|Withdrawal by Subject|1
1129117|NCT01546168|3707824|P2|Overall Study|Lost to Follow-up|0
1129118|NCT01546168|3707825|P1|Overall Study|Lost to Follow-up|1
1129119|NCT01546155|3707837|P1|Overall Study|could not tolerate long scan duration|3
1129120|NCT01546142|3707843|P2|Overall Study|Subject Randomized but Not Treated|0
1129121|NCT01546142|3707844|P1|Overall Study|Subject Randomized but Not Treated|1
1129122|NCT01546142|3707843|P2|Overall Study|Consent Withdrawn (Subject Discomfort)|0
1129123|NCT01546142|3707844|P1|Overall Study|Consent Withdrawn (Subject Discomfort)|1
1129124|NCT01546142|3707843|P2|Overall Study|Lost to Follow-up|15
1129125|NCT01546142|3707844|P1|Overall Study|Lost to Follow-up|20
1129126|NCT01546142|3707843|P2|Overall Study|Adverse Event|3
1129127|NCT01546142|3707844|P1|Overall Study|Adverse Event|6
1129128|NCT01546142|3707843|P2|Overall Study|Subject Noncompliance|1
1129129|NCT01546142|3707844|P1|Overall Study|Subject Noncompliance|1
1129130|NCT01546142|3707843|P2|Overall Study|Consent Withdrawn (Subject Convenience)|15
1129131|NCT01546142|3707844|P1|Overall Study|Consent Withdrawn (Subject Convenience)|15
1129132|NCT01546038|3707862|P9|Overall Study|: Randomized, not treated|3
1129133|NCT01546038|3707863|P8|Overall Study|: Randomized, not treated|4
1129134|NCT01546038|3707864|P7|Overall Study|: Randomized, not treated|2
1129135|NCT01546038|3707865|P6|Overall Study|: Randomized, not treated|0
1129136|NCT01546038|3707866|P5|Overall Study|: Randomized, not treated|0
1129137|NCT01546038|3707867|P4|Overall Study|: Randomized, not treated|0
1129138|NCT01546038|3707868|P3|Overall Study|: Randomized, not treated|0
1129139|NCT01546038|3707869|P2|Overall Study|: Randomized, not treated|0
1129140|NCT01546038|3707870|P1|Overall Study|: Randomized, not treated|0
1129141|NCT01546038|3707862|P9|Overall Study|: Study ongoing at cutoff date|1
1129142|NCT01546038|3707863|P8|Overall Study|: Study ongoing at cutoff date|16
1129143|NCT01546038|3707864|P7|Overall Study|: Study ongoing at cutoff date|24
1129144|NCT01546038|3707865|P6|Overall Study|: Study ongoing at cutoff date|2
1129145|NCT01546038|3707866|P5|Overall Study|: Study ongoing at cutoff date|8
1129146|NCT01546038|3707867|P4|Overall Study|: Study ongoing at cutoff date|0
1129147|NCT01546038|3707868|P3|Overall Study|: Study ongoing at cutoff date|0
1129148|NCT01546038|3707869|P2|Overall Study|: Study ongoing at cutoff date|0
1129149|NCT01546038|3707870|P1|Overall Study|: Study ongoing at cutoff date|1
1129150|NCT01546038|3707862|P9|Overall Study|Withdrawal by Subject|0
1129151|NCT01546038|3707863|P8|Overall Study|Withdrawal by Subject|3
1129152|NCT01546038|3707864|P7|Overall Study|Withdrawal by Subject|3
1129153|NCT01546038|3707865|P6|Overall Study|Withdrawal by Subject|1
1129154|NCT01546038|3707866|P5|Overall Study|Withdrawal by Subject|0
1129155|NCT01546038|3707867|P4|Overall Study|Withdrawal by Subject|1
1129156|NCT01546038|3707868|P3|Overall Study|Withdrawal by Subject|0
1129157|NCT01546038|3707869|P2|Overall Study|Withdrawal by Subject|0
1129158|NCT01546038|3707870|P1|Overall Study|Withdrawal by Subject|1
1129159|NCT01546038|3707862|P9|Overall Study|Lost to Follow-up|0
1129160|NCT01546038|3707863|P8|Overall Study|Lost to Follow-up|1
1129161|NCT01546038|3707864|P7|Overall Study|Lost to Follow-up|1
1129162|NCT01546038|3707865|P6|Overall Study|Lost to Follow-up|0
1129163|NCT01546038|3707866|P5|Overall Study|Lost to Follow-up|1
1129164|NCT01546038|3707867|P4|Overall Study|Lost to Follow-up|0
1129165|NCT01546038|3707868|P3|Overall Study|Lost to Follow-up|0
1129166|NCT01546038|3707869|P2|Overall Study|Lost to Follow-up|0
1129167|NCT01546038|3707870|P1|Overall Study|Lost to Follow-up|0
1129168|NCT01546038|3707862|P9|Overall Study|Death|40
1129169|NCT01546038|3707863|P8|Overall Study|Death|64
1129170|NCT01546038|3707864|P7|Overall Study|Death|41
1129171|NCT01546038|3707865|P6|Overall Study|Death|3
1129172|NCT01546038|3707866|P5|Overall Study|Death|7
1129173|NCT01546038|3707867|P4|Overall Study|Death|2
1129174|NCT01546038|3707868|P3|Overall Study|Death|4
1129175|NCT01546038|3707869|P2|Overall Study|Death|6
1129176|NCT01546038|3707870|P1|Overall Study|Death|15
1129177|NCT01545388|3708196|P3|Overall Study|Not specified|0
1129178|NCT01545388|3708197|P2|Overall Study|Not specified|1
1129179|NCT01545388|3708198|P1|Overall Study|Not specified|1
1129180|NCT01545388|3708196|P3|Overall Study|Withdrawal by Subject|2
1129181|NCT01545388|3708197|P2|Overall Study|Withdrawal by Subject|4
1129182|NCT01545388|3708198|P1|Overall Study|Withdrawal by Subject|1
1129183|NCT01545388|3708196|P3|Overall Study|Participant moved or relocated|0
1129184|NCT01545388|3708197|P2|Overall Study|Participant moved or relocated|0
1129185|NCT01545388|3708198|P1|Overall Study|Participant moved or relocated|1
1129186|NCT01545388|3708196|P3|Overall Study|Lack of Efficacy|5
1129187|NCT01545388|3708197|P2|Overall Study|Lack of Efficacy|2
1129188|NCT01545388|3708198|P1|Overall Study|Lack of Efficacy|3
1129189|NCT01545388|3708196|P3|Overall Study|Adverse Event|1
1129190|NCT01545388|3708197|P2|Overall Study|Adverse Event|4
1129191|NCT01545388|3708198|P1|Overall Study|Adverse Event|2
1129192|NCT01545375|3708217|P2|Overall Study|Withdrawal by Subject|55
1129193|NCT01545375|3708218|P1|Overall Study|Withdrawal by Subject|58
1129194|NCT01545375|3708217|P2|Overall Study|Protocol Violation|3
1129195|NCT01545375|3708218|P1|Overall Study|Protocol Violation|3
1129196|NCT01545375|3708217|P2|Overall Study|Lost to Follow-up|31
1129197|NCT01545375|3708218|P1|Overall Study|Lost to Follow-up|34
1129198|NCT01545375|3708217|P2|Overall Study|Adverse Event|1
1129199|NCT01545375|3708218|P1|Overall Study|Adverse Event|2
1129200|NCT01545076|3708325|P5|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0
1129201|NCT01545076|3708326|P4|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3
1129202|NCT01545076|3708327|P3|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2
1129203|NCT01545076|3708328|P2|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8
1129204|NCT01545076|3708329|P1|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0
1129205|NCT01545076|3708325|P5|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
1129206|NCT01545076|3708326|P4|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
1129207|NCT01545076|3708327|P3|IgPro20 Subcutaneous Treatment Period|Adverse Event|1
1129208|NCT01545076|3708328|P2|IgPro20 Subcutaneous Treatment Period|Adverse Event|1
1129209|NCT01545076|3708329|P1|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
1129210|NCT01545076|3708325|P5|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0
1129211|NCT01545076|3708326|P4|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32
1129212|NCT01545076|3708327|P3|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18
1129213|NCT01545076|3708328|P2|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10
1129214|NCT01545076|3708329|P1|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0
1129215|NCT01545076|3708325|P5|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
1129216|NCT01545076|3708326|P4|IgPro20 Subcutaneous Treatment Period|Physician Decision|1
1129217|NCT01545076|3708327|P3|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
1129218|NCT01545076|3708328|P2|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
1129219|NCT01545076|3708329|P1|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
1129220|NCT01545076|3708325|P5|IgPro10 Restabilization Period|Withdrawal by Subject|0
1129221|NCT01545076|3708326|P4|IgPro10 Restabilization Period|Withdrawal by Subject|0
1129222|NCT01545076|3708327|P3|IgPro10 Restabilization Period|Withdrawal by Subject|0
1129223|NCT01545076|3708328|P2|IgPro10 Restabilization Period|Withdrawal by Subject|0
1129224|NCT01545076|3708329|P1|IgPro10 Restabilization Period|Withdrawal by Subject|7
1129225|NCT01545076|3708325|P5|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
1129226|NCT01545076|3708326|P4|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
1129227|NCT01545076|3708327|P3|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
1129228|NCT01545076|3708328|P2|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
1129229|NCT01545076|3708329|P1|IgPro10 Restabilization Period|Failure to meet randomization criteria|22
1129230|NCT01545076|3708325|P5|IgPro10 Restabilization Period|Protocol Violation|0
1129231|NCT01545076|3708326|P4|IgPro10 Restabilization Period|Protocol Violation|0
1129232|NCT01545076|3708327|P3|IgPro10 Restabilization Period|Protocol Violation|0
1129233|NCT01545076|3708328|P2|IgPro10 Restabilization Period|Protocol Violation|0
1129234|NCT01545076|3708329|P1|IgPro10 Restabilization Period|Protocol Violation|1
1129235|NCT01545076|3708325|P5|IgPro10 Restabilization Period|Physician Decision|0
1129236|NCT01545076|3708326|P4|IgPro10 Restabilization Period|Physician Decision|0
1129237|NCT01545076|3708327|P3|IgPro10 Restabilization Period|Physician Decision|0
1129238|NCT01545076|3708328|P2|IgPro10 Restabilization Period|Physician Decision|0
1129239|NCT01545076|3708329|P1|IgPro10 Restabilization Period|Physician Decision|2
1129240|NCT01545076|3708325|P5|IgPro10 Restabilization Period|Adverse Event|0
1129241|NCT01545076|3708326|P4|IgPro10 Restabilization Period|Adverse Event|0
1129242|NCT01545076|3708327|P3|IgPro10 Restabilization Period|Adverse Event|0
1129243|NCT01545076|3708328|P2|IgPro10 Restabilization Period|Adverse Event|0
1129244|NCT01545076|3708329|P1|IgPro10 Restabilization Period|Adverse Event|4
1129245|NCT01544920|3708400|P2|Overall Study|Withdrawal by Subject|4
1129246|NCT01544920|3708401|P1|Overall Study|Withdrawal by Subject|4
1129247|NCT01544920|3708400|P2|Overall Study|Physician Decision|1
1129248|NCT01544920|3708401|P1|Overall Study|Physician Decision|4
1129249|NCT01544920|3708400|P2|Overall Study|Protocol Violation|2
1129250|NCT01544920|3708401|P1|Overall Study|Protocol Violation|0
1129251|NCT01544920|3708400|P2|Overall Study|Lost to Follow-up|12
1129252|NCT01544920|3708401|P1|Overall Study|Lost to Follow-up|11
1129253|NCT01544920|3708400|P2|Overall Study|Death|1
1129254|NCT01544920|3708401|P1|Overall Study|Death|0
1129255|NCT01544920|3708400|P2|Overall Study|Adverse Event|3
1129256|NCT01544920|3708401|P1|Overall Study|Adverse Event|0
1129257|NCT01544595|3708415|P6|Status at Week 156|Lack of Efficacy|5
1129258|NCT01544595|3708416|P5|Status at Week 156|Lack of Efficacy|10
1129259|NCT01544595|3708417|P4|Status at Week 156|Lack of Efficacy|4
1129260|NCT01544595|3708418|P3|Status at Week 156|Lack of Efficacy|1
1129261|NCT01544595|3708419|P2|Status at Week 156|Lack of Efficacy|0
1129262|NCT01544595|3708420|P1|Status at Week 156|Lack of Efficacy|1
1129263|NCT01544595|3708415|P6|Status at Week 156|Moved to treatment period ≤ wk 156|0
1129264|NCT01544595|3708416|P5|Status at Week 156|Moved to treatment period ≤ wk 156|0
1129265|NCT01544595|3708417|P4|Status at Week 156|Moved to treatment period ≤ wk 156|145
1129266|NCT01544595|3708418|P3|Status at Week 156|Moved to treatment period ≤ wk 156|131
1129267|NCT01544595|3708419|P2|Status at Week 156|Moved to treatment period ≤ wk 156|44
1129268|NCT01544595|3708420|P1|Status at Week 156|Moved to treatment period ≤ wk 156|86
1129269|NCT01544595|3708415|P6|Status at Week 156|Technical problems|0
1129270|NCT01544595|3708416|P5|Status at Week 156|Technical problems|0
1129271|NCT01544595|3708417|P4|Status at Week 156|Technical problems|1
1129272|NCT01544595|3708418|P3|Status at Week 156|Technical problems|0
1129273|NCT01544595|3708419|P2|Status at Week 156|Technical problems|1
1129274|NCT01544595|3708420|P1|Status at Week 156|Technical problems|3
1129275|NCT01544595|3708415|P6|Status at Week 156|Protocol Violation|0
1129276|NCT01544595|3708416|P5|Status at Week 156|Protocol Violation|0
1129277|NCT01544595|3708417|P4|Status at Week 156|Protocol Violation|2
1129278|NCT01544595|3708418|P3|Status at Week 156|Protocol Violation|2
1129279|NCT01544595|3708419|P2|Status at Week 156|Protocol Violation|1
1129280|NCT01544595|3708420|P1|Status at Week 156|Protocol Violation|3
1129281|NCT01544595|3708415|P6|Status at Week 156|Pregnancy|0
1129282|NCT01544595|3708416|P5|Status at Week 156|Pregnancy|0
1129283|NCT01544595|3708417|P4|Status at Week 156|Pregnancy|0
1129284|NCT01544595|3708418|P3|Status at Week 156|Pregnancy|0
1129285|NCT01544595|3708419|P2|Status at Week 156|Pregnancy|3
1129286|NCT01544595|3708420|P1|Status at Week 156|Pregnancy|2
1129287|NCT01544595|3708415|P6|Status at Week 156|Physician Decision|0
1129288|NCT01544595|3708416|P5|Status at Week 156|Physician Decision|0
1129289|NCT01544595|3708417|P4|Status at Week 156|Physician Decision|0
1129290|NCT01544595|3708418|P3|Status at Week 156|Physician Decision|1
1129291|NCT01544595|3708419|P2|Status at Week 156|Physician Decision|3
1129292|NCT01544595|3708420|P1|Status at Week 156|Physician Decision|0
1129293|NCT01544595|3708415|P6|Status at Week 156|Non-compliance with study treatement|1
1129294|NCT01544595|3708416|P5|Status at Week 156|Non-compliance with study treatement|0
1129295|NCT01544595|3708417|P4|Status at Week 156|Non-compliance with study treatement|1
1129296|NCT01544595|3708418|P3|Status at Week 156|Non-compliance with study treatement|0
1129297|NCT01544595|3708419|P2|Status at Week 156|Non-compliance with study treatement|1
1129298|NCT01544595|3708420|P1|Status at Week 156|Non-compliance with study treatement|0
1129299|NCT01544595|3708415|P6|Status at Week 156|Lost to Follow-up|1
1129300|NCT01544595|3708416|P5|Status at Week 156|Lost to Follow-up|4
1129301|NCT01544595|3708417|P4|Status at Week 156|Lost to Follow-up|1
1129302|NCT01544595|3708418|P3|Status at Week 156|Lost to Follow-up|0
1129303|NCT01544595|3708419|P2|Status at Week 156|Lost to Follow-up|4
1129304|NCT01544595|3708420|P1|Status at Week 156|Lost to Follow-up|4
1129305|NCT01544595|3708415|P6|Status at Week 156|Adverse Event|2
1129306|NCT01544595|3708416|P5|Status at Week 156|Adverse Event|4
1129307|NCT01544595|3708417|P4|Status at Week 156|Adverse Event|3
1129308|NCT01544595|3708418|P3|Status at Week 156|Adverse Event|1
1129309|NCT01544595|3708419|P2|Status at Week 156|Adverse Event|11
1129310|NCT01544595|3708420|P1|Status at Week 156|Adverse Event|9
1129311|NCT01544595|3708415|P6|Status at Week 156|Withdrawal by Subject|6
1129312|NCT01544595|3708416|P5|Status at Week 156|Withdrawal by Subject|20
1129313|NCT01544595|3708417|P4|Status at Week 156|Withdrawal by Subject|9
1129314|NCT01544595|3708418|P3|Status at Week 156|Withdrawal by Subject|4
1129315|NCT01544595|3708419|P2|Status at Week 156|Withdrawal by Subject|10
1129316|NCT01544595|3708420|P1|Status at Week 156|Withdrawal by Subject|9
1129317|NCT01544595|3708415|P6|Status at Week 68|Moved to treatment period ≤ wk 68|0
1129318|NCT01544595|3708416|P5|Status at Week 68|Moved to treatment period ≤ wk 68|0
1129319|NCT01544595|3708417|P4|Status at Week 68|Moved to treatment period ≤ wk 68|46
1129320|NCT01544595|3708418|P3|Status at Week 68|Moved to treatment period ≤ wk 68|60
1129321|NCT01544595|3708419|P2|Status at Week 68|Moved to treatment period ≤ wk 68|13
1129322|NCT01544595|3708420|P1|Status at Week 68|Moved to treatment period ≤ wk 68|30
1129323|NCT01544595|3708415|P6|Status at Week 68|Withdrawal by Subject|0
1129324|NCT01544595|3708416|P5|Status at Week 68|Withdrawal by Subject|0
1129325|NCT01544595|3708417|P4|Status at Week 68|Withdrawal by Subject|2
1129326|NCT01544595|3708418|P3|Status at Week 68|Withdrawal by Subject|1
1129327|NCT01544595|3708419|P2|Status at Week 68|Withdrawal by Subject|1
1129328|NCT01544595|3708420|P1|Status at Week 68|Withdrawal by Subject|0
1129329|NCT01544595|3708415|P6|Status at Week 68|Technical problems|0
1129330|NCT01544595|3708416|P5|Status at Week 68|Technical problems|0
1129331|NCT01544595|3708417|P4|Status at Week 68|Technical problems|1
1129332|NCT01544595|3708418|P3|Status at Week 68|Technical problems|0
1129333|NCT01544595|3708419|P2|Status at Week 68|Technical problems|0
1129334|NCT01544595|3708420|P1|Status at Week 68|Technical problems|1
1129335|NCT01544595|3708415|P6|Status at Week 68|Protocol Violation|0
1129336|NCT01544595|3708416|P5|Status at Week 68|Protocol Violation|0
1129337|NCT01544595|3708417|P4|Status at Week 68|Protocol Violation|1
1129338|NCT01544595|3708418|P3|Status at Week 68|Protocol Violation|1
1129339|NCT01544595|3708419|P2|Status at Week 68|Protocol Violation|0
1129340|NCT01544595|3708420|P1|Status at Week 68|Protocol Violation|2
1129341|NCT01544595|3708415|P6|Status at Week 68|Non-compliance with study treatment|0
1129342|NCT01544595|3708416|P5|Status at Week 68|Non-compliance with study treatment|0
1129343|NCT01544595|3708417|P4|Status at Week 68|Non-compliance with study treatment|1
1129344|NCT01544595|3708418|P3|Status at Week 68|Non-compliance with study treatment|0
1129345|NCT01544595|3708419|P2|Status at Week 68|Non-compliance with study treatment|0
1129346|NCT01544595|3708420|P1|Status at Week 68|Non-compliance with study treatment|1
1129347|NCT01544595|3708415|P6|Status at Week 68|Lost to Follow-up|0
1129348|NCT01544595|3708416|P5|Status at Week 68|Lost to Follow-up|0
1129349|NCT01544595|3708417|P4|Status at Week 68|Lost to Follow-up|0
1129350|NCT01544595|3708418|P3|Status at Week 68|Lost to Follow-up|0
1129351|NCT01544595|3708419|P2|Status at Week 68|Lost to Follow-up|1
1129352|NCT01544595|3708420|P1|Status at Week 68|Lost to Follow-up|1
1129353|NCT01544595|3708415|P6|Status at Week 68|Lack of Efficacy|0
1129354|NCT01544595|3708416|P5|Status at Week 68|Lack of Efficacy|0
1129355|NCT01544595|3708417|P4|Status at Week 68|Lack of Efficacy|0
1129356|NCT01544595|3708418|P3|Status at Week 68|Lack of Efficacy|0
1129357|NCT01544595|3708419|P2|Status at Week 68|Lack of Efficacy|0
1129358|NCT01544595|3708420|P1|Status at Week 68|Lack of Efficacy|1
1129359|NCT01544595|3708415|P6|Status at Week 68|Adverse Event|0
1129360|NCT01544595|3708416|P5|Status at Week 68|Adverse Event|0
1129361|NCT01544595|3708417|P4|Status at Week 68|Adverse Event|0
1129362|NCT01544595|3708418|P3|Status at Week 68|Adverse Event|1
1129363|NCT01544595|3708419|P2|Status at Week 68|Adverse Event|2
1129364|NCT01544595|3708420|P1|Status at Week 68|Adverse Event|3
1129365|NCT01544582|3708496|P4|Analysis Population|Participant in Jail|0
1129366|NCT01544582|3708497|P3|Analysis Population|Participant in Jail|1
1129367|NCT01544582|3708498|P2|Analysis Population|Participant in Jail|0
1129368|NCT01544582|3708499|P1|Analysis Population|Participant in Jail|0
1129369|NCT01544582|3708496|P4|Analysis Population|Programmed Surgery|0
1129370|NCT01544582|3708497|P3|Analysis Population|Programmed Surgery|0
1129371|NCT01544582|3708498|P2|Analysis Population|Programmed Surgery|1
1129372|NCT01544582|3708499|P1|Analysis Population|Programmed Surgery|0
1129373|NCT01544582|3708496|P4|Analysis Population|Poor Participant Compliance|0
1129374|NCT01544582|3708497|P3|Analysis Population|Poor Participant Compliance|0
1129375|NCT01544582|3708498|P2|Analysis Population|Poor Participant Compliance|1
1129376|NCT01544582|3708499|P1|Analysis Population|Poor Participant Compliance|0
1129377|NCT01544582|3708496|P4|Analysis Population|Poor Adherence|0
1129378|NCT01544582|3708497|P3|Analysis Population|Poor Adherence|1
1129379|NCT01544582|3708498|P2|Analysis Population|Poor Adherence|0
1129380|NCT01544582|3708499|P1|Analysis Population|Poor Adherence|0
1129381|NCT01544582|3708496|P4|Analysis Population|No Social Insurance|0
1129382|NCT01544582|3708497|P3|Analysis Population|No Social Insurance|1
1129383|NCT01544582|3708498|P2|Analysis Population|No Social Insurance|0
1129384|NCT01544582|3708499|P1|Analysis Population|No Social Insurance|0
1129385|NCT01544582|3708496|P4|Analysis Population|Liver Transplantation|0
1129386|NCT01544582|3708497|P3|Analysis Population|Liver Transplantation|1
1129387|NCT01544582|3708498|P2|Analysis Population|Liver Transplantation|0
1129388|NCT01544582|3708499|P1|Analysis Population|Liver Transplantation|0
1129389|NCT01544582|3708496|P4|Analysis Population|Intolerance|0
1129390|NCT01544582|3708497|P3|Analysis Population|Intolerance|0
1129391|NCT01544582|3708498|P2|Analysis Population|Intolerance|1
1129392|NCT01544582|3708499|P1|Analysis Population|Intolerance|0
1129393|NCT01544582|3708496|P4|Analysis Population|Did Not Meet Inclusion Criteria|0
1129394|NCT01544582|3708497|P3|Analysis Population|Did Not Meet Inclusion Criteria|3
1129395|NCT01544582|3708498|P2|Analysis Population|Did Not Meet Inclusion Criteria|0
1129396|NCT01544582|3708499|P1|Analysis Population|Did Not Meet Inclusion Criteria|0
1129397|NCT01544582|3708496|P4|Analysis Population|Bad Tolerance to Treatment|0
1129398|NCT01544582|3708497|P3|Analysis Population|Bad Tolerance to Treatment|2
1129399|NCT01544582|3708498|P2|Analysis Population|Bad Tolerance to Treatment|0
1129400|NCT01544582|3708499|P1|Analysis Population|Bad Tolerance to Treatment|0
1129401|NCT01544582|3708496|P4|Analysis Population|Lost to Follow-up|5
1129402|NCT01544582|3708497|P3|Analysis Population|Lost to Follow-up|6
1129403|NCT01544582|3708498|P2|Analysis Population|Lost to Follow-up|6
1129404|NCT01544582|3708499|P1|Analysis Population|Lost to Follow-up|0
1129405|NCT01544582|3708496|P4|Analysis Population|New Contraindication-Alcohol Abuse|1
1129406|NCT01544582|3708497|P3|Analysis Population|New Contraindication-Alcohol Abuse|0
1129407|NCT01544582|3708498|P2|Analysis Population|New Contraindication-Alcohol Abuse|0
1129408|NCT01544582|3708499|P1|Analysis Population|New Contraindication-Alcohol Abuse|0
1129409|NCT01544582|3708496|P4|Analysis Population|Effectiveness Reason|12
1129410|NCT01544582|3708497|P3|Analysis Population|Effectiveness Reason|29
1129411|NCT01544582|3708498|P2|Analysis Population|Effectiveness Reason|48
1129412|NCT01544582|3708499|P1|Analysis Population|Effectiveness Reason|0
1129413|NCT01544582|3708496|P4|Analysis Population|Safety Reason|8
1129414|NCT01544582|3708497|P3|Analysis Population|Safety Reason|31
1129415|NCT01544582|3708498|P2|Analysis Population|Safety Reason|33
1129416|NCT01544582|3708499|P1|Analysis Population|Safety Reason|0
1129417|NCT01544582|3708496|P4|Analysis Population|Physician Decision|9
1129418|NCT01544582|3708497|P3|Analysis Population|Physician Decision|10
1129419|NCT01544582|3708498|P2|Analysis Population|Physician Decision|13
1129420|NCT01544582|3708499|P1|Analysis Population|Physician Decision|0
1129421|NCT01544582|3708496|P4|Analysis Population|Participant Refuses to Continue Study|4
1129422|NCT01544582|3708497|P3|Analysis Population|Participant Refuses to Continue Study|17
1129423|NCT01544582|3708498|P2|Analysis Population|Participant Refuses to Continue Study|15
1129424|NCT01544582|3708499|P1|Analysis Population|Participant Refuses to Continue Study|0
1129425|NCT01544582|3708496|P4|Screening/Eligibility|Eligibility Criteria Not Met|0
1129426|NCT01544582|3708497|P3|Screening/Eligibility|Eligibility Criteria Not Met|0
1129427|NCT01544582|3708498|P2|Screening/Eligibility|Eligibility Criteria Not Met|0
1129428|NCT01544582|3708499|P1|Screening/Eligibility|Eligibility Criteria Not Met|33
1129429|NCT01544582|3708496|P4|Screening/Eligibility|Initiated Different CHC Treatment|0
1129430|NCT01544582|3708497|P3|Screening/Eligibility|Initiated Different CHC Treatment|0
1129431|NCT01544582|3708498|P2|Screening/Eligibility|Initiated Different CHC Treatment|0
1129432|NCT01544582|3708499|P1|Screening/Eligibility|Initiated Different CHC Treatment|1
1129433|NCT01544478|3708557|P1|Overall Study|Withdrawal by Subject|52
1129434|NCT01544478|3708557|P1|Overall Study|Pregnancy|1
1129435|NCT01544478|3708557|P1|Overall Study|Physician Decision|15
1129436|NCT01544478|3708557|P1|Overall Study|Lost to Follow-up|48
1129437|NCT01544478|3708557|P1|Overall Study|Death|1
1129438|NCT01544478|3708557|P1|Overall Study|Adverse Event|1
1129439|NCT01544348|3708600|P8|Overall Study|Physician Decision|0
1129440|NCT01544348|3708601|P7|Overall Study|Physician Decision|0
1129441|NCT01544348|3708602|P6|Overall Study|Physician Decision|1
1129442|NCT01544348|3708603|P5|Overall Study|Physician Decision|0
1129443|NCT01544348|3708604|P4|Overall Study|Physician Decision|0
1129444|NCT01544348|3708605|P3|Overall Study|Physician Decision|0
1129445|NCT01544348|3708606|P2|Overall Study|Physician Decision|0
1129446|NCT01544348|3708607|P1|Overall Study|Physician Decision|0
1129447|NCT01544348|3708600|P8|Overall Study|Withdrawal by Subject|0
1129448|NCT01544348|3708601|P7|Overall Study|Withdrawal by Subject|1
1129449|NCT01544348|3708602|P6|Overall Study|Withdrawal by Subject|2
1129450|NCT01544348|3708603|P5|Overall Study|Withdrawal by Subject|1
1129451|NCT01544348|3708604|P4|Overall Study|Withdrawal by Subject|0
1129452|NCT01544348|3708605|P3|Overall Study|Withdrawal by Subject|0
1129453|NCT01544348|3708606|P2|Overall Study|Withdrawal by Subject|0
1129454|NCT01544348|3708607|P1|Overall Study|Withdrawal by Subject|1
1129455|NCT01544348|3708600|P8|Overall Study|Lost to Follow-up|0
1129456|NCT01544348|3708601|P7|Overall Study|Lost to Follow-up|1
1129457|NCT01544348|3708602|P6|Overall Study|Lost to Follow-up|0
1129458|NCT01544348|3708603|P5|Overall Study|Lost to Follow-up|0
1129459|NCT01544348|3708604|P4|Overall Study|Lost to Follow-up|0
1129460|NCT01544348|3708605|P3|Overall Study|Lost to Follow-up|0
1129461|NCT01544348|3708606|P2|Overall Study|Lost to Follow-up|0
1129462|NCT01544348|3708607|P1|Overall Study|Lost to Follow-up|1
1129463|NCT01544309|3708649|P2|Overall Study|Administered prohibit prior medication|0
1129464|NCT01544309|3708650|P1|Overall Study|Administered prohibit prior medication|1
1129465|NCT01544309|3708649|P2|Overall Study|Not performed pre-dose examination|2
1129466|NCT01544309|3708650|P1|Overall Study|Not performed pre-dose examination|1
1129467|NCT01544309|3708649|P2|Overall Study|Physician Decision|1
1129468|NCT01544309|3708650|P1|Overall Study|Physician Decision|4
1129469|NCT01544309|3708649|P2|Overall Study|Protocol Violation|1
1129470|NCT01544309|3708650|P1|Overall Study|Protocol Violation|2
1129471|NCT01544309|3708649|P2|Overall Study|Withdrawal by Subject|7
1129472|NCT01544309|3708650|P1|Overall Study|Withdrawal by Subject|12
1129473|NCT01544179|3708688|P2|Overall Study|Eligibility criteria not fulfilled|0
1129474|NCT01544179|3708689|P1|Overall Study|Eligibility criteria not fulfilled|1
1129475|NCT01544179|3708688|P2|Overall Study|Withdrawal by Subject|7
1129476|NCT01544179|3708689|P1|Overall Study|Withdrawal by Subject|12
1129477|NCT01544179|3708688|P2|Overall Study|Adverse Event|1
1129478|NCT01544179|3708689|P1|Overall Study|Adverse Event|0
1129479|NCT01544179|3708688|P2|Overall Study|Lost to Follow-up|1
1129480|NCT01544179|3708689|P1|Overall Study|Lost to Follow-up|0
1129481|NCT01544179|3708688|P2|Overall Study|Death|37
1129482|NCT01544179|3708689|P1|Overall Study|Death|50
1129483|NCT01544153|3708782|P4|Overall Study|Non-smoker|0
1129484|NCT01544153|3708783|P3|Overall Study|Non-smoker|1
1129485|NCT01544153|3708784|P2|Overall Study|Non-smoker|0
1129486|NCT01544153|3708785|P1|Overall Study|Non-smoker|0
1129487|NCT01544153|3708782|P4|Overall Study|Under 18|0
1129488|NCT01544153|3708783|P3|Overall Study|Under 18|0
1129489|NCT01544153|3708784|P2|Overall Study|Under 18|1
1129490|NCT01544153|3708785|P1|Overall Study|Under 18|0
1129491|NCT01544114|3708802|P3|Overall Study|Protocol Violation|0
1129492|NCT01544114|3708803|P2|Overall Study|Protocol Violation|1
1129493|NCT01544114|3708804|P1|Overall Study|Protocol Violation|0
1129494|NCT01544114|3708802|P3|Overall Study|Adverse Event|2
1129495|NCT01544114|3708803|P2|Overall Study|Adverse Event|1
1129496|NCT01544114|3708804|P1|Overall Study|Adverse Event|1
1129497|NCT01544114|3708802|P3|Overall Study|Lost to Follow-up|0
1129498|NCT01544114|3708803|P2|Overall Study|Lost to Follow-up|2
1129499|NCT01544114|3708804|P1|Overall Study|Lost to Follow-up|0
1129500|NCT01544114|3708802|P3|Overall Study|Withdrawal by Subject|3
1129501|NCT01544114|3708803|P2|Overall Study|Withdrawal by Subject|0
1129502|NCT01544114|3708804|P1|Overall Study|Withdrawal by Subject|0
1129503|NCT01543958|3708887|P1|Overall Study|ART initiation|1
1129504|NCT01543958|3708887|P1|Overall Study|Loss to follow-up|3
1129505|NCT01543828|3708942|P2|Treatment 2|Lost to Follow-up|0
1129506|NCT01543828|3708943|P1|Treatment 2|Lost to Follow-up|1
1129507|NCT01543685|3708956|P5|Overall Study|Adverse Event|2
1129508|NCT01543685|3708957|P4|Overall Study|Adverse Event|0
1129509|NCT01543685|3708958|P3|Overall Study|Adverse Event|0
1129510|NCT01543685|3708959|P2|Overall Study|Adverse Event|1
1129511|NCT01543685|3708960|P1|Overall Study|Adverse Event|2
1129512|NCT01543685|3708956|P5|Overall Study|Lack of Efficacy|2
1129513|NCT01543685|3708957|P4|Overall Study|Lack of Efficacy|0
1129514|NCT01543685|3708958|P3|Overall Study|Lack of Efficacy|2
1129515|NCT01543685|3708959|P2|Overall Study|Lack of Efficacy|2
1129516|NCT01543685|3708960|P1|Overall Study|Lack of Efficacy|1
1129517|NCT01543503|3709032|P2|Overall Study|Screen failure|0
1129518|NCT01543503|3709033|P1|Overall Study|Screen failure|1
1129519|NCT01543503|3709032|P2|Overall Study|Participant went to United States|0
1129520|NCT01543503|3709033|P1|Overall Study|Participant went to United States|1
1129521|NCT01543503|3709032|P2|Overall Study|Participant consented to another study|2
1129522|NCT01543503|3709033|P1|Overall Study|Participant consented to another study|0
1129523|NCT01543503|3709032|P2|Overall Study|Moved to other rheumatologic site|1
1129524|NCT01543503|3709033|P1|Overall Study|Moved to other rheumatologic site|0
1129525|NCT01543503|3709032|P2|Overall Study|Participant did not attend a visit|0
1129526|NCT01543503|3709033|P1|Overall Study|Participant did not attend a visit|1
1129527|NCT01543503|3709032|P2|Overall Study|Site stopped participation|1
1129528|NCT01543503|3709033|P1|Overall Study|Site stopped participation|5
1129529|NCT01543503|3709032|P2|Overall Study|Participant recruited after closing date|1
1129530|NCT01543503|3709033|P1|Overall Study|Participant recruited after closing date|0
1129531|NCT01543503|3709032|P2|Overall Study|Investigator did not wish to participate|1
1129532|NCT01543503|3709033|P1|Overall Study|Investigator did not wish to participate|1
1129533|NCT01543503|3709032|P2|Overall Study|Participant decision to stop treatment|0
1129534|NCT01543503|3709033|P1|Overall Study|Participant decision to stop treatment|1
1129535|NCT01543503|3709032|P2|Overall Study|Participant moved to Scotland|0
1129536|NCT01543503|3709033|P1|Overall Study|Participant moved to Scotland|1
1129537|NCT01543503|3709032|P2|Overall Study|Participant transferred to another city|0
1129538|NCT01543503|3709033|P1|Overall Study|Participant transferred to another city|1
1129539|NCT01543503|3709032|P2|Overall Study|Participant will not return for visits|2
1129540|NCT01543503|3709033|P1|Overall Study|Participant will not return for visits|0
1129541|NCT01543503|3709032|P2|Overall Study|Participant moved to another city|0
1129542|NCT01543503|3709033|P1|Overall Study|Participant moved to another city|2
1129543|NCT01543503|3709032|P2|Overall Study|Incorrect medication received|0
1129544|NCT01543503|3709033|P1|Overall Study|Incorrect medication received|1
1129545|NCT01543503|3709032|P2|Overall Study|Refused to continue treatment|0
1129546|NCT01543503|3709033|P1|Overall Study|Refused to continue treatment|7
1129547|NCT01543503|3709032|P2|Overall Study|Participant did not complete last visit|2
1129548|NCT01543503|3709033|P1|Overall Study|Participant did not complete last visit|0
1129549|NCT01543503|3709032|P2|Overall Study|Probable overlap of RA with fibromyalgia|0
1129550|NCT01543503|3709033|P1|Overall Study|Probable overlap of RA with fibromyalgia|1
1129551|NCT01543503|3709032|P2|Overall Study|Intolerance to the biologic treatment|1
1129552|NCT01543503|3709033|P1|Overall Study|Intolerance to the biologic treatment|0
1129553|NCT01543503|3709032|P2|Overall Study|Change of jobs|1
1129554|NCT01543503|3709033|P1|Overall Study|Change of jobs|0
1129555|NCT01543503|3709032|P2|Overall Study|Participant withdrew informed consent|10
1129556|NCT01543503|3709033|P1|Overall Study|Participant withdrew informed consent|8
1129557|NCT01543503|3709032|P2|Overall Study|Lack of Efficacy|16
1129558|NCT01543503|3709033|P1|Overall Study|Lack of Efficacy|4
1129559|NCT01543503|3709032|P2|Overall Study|Adverse Event|13
1129560|NCT01543503|3709033|P1|Overall Study|Adverse Event|9
1129561|NCT01543503|3709032|P2|Overall Study|Lost to Follow-up|36
1129562|NCT01543503|3709033|P1|Overall Study|Lost to Follow-up|32
1129563|NCT01543204|3709077|P1|Overall Study|Lost to Follow-up|1
1129564|NCT01543204|3709077|P1|Overall Study|Requirement for Alternative Therapy|1
1129565|NCT01543204|3709077|P1|Overall Study|Withdrawal by Subject|4
1129566|NCT01543204|3709077|P1|Overall Study|Adverse Event|1
1129567|NCT01543204|3709077|P1|Overall Study|Non-compliance|1
1129568|NCT01542788|3709169|P2|Overall Study|Withdrawal by Subject|0
1129569|NCT01542788|3709170|P1|Overall Study|Withdrawal by Subject|1
1129570|NCT01542788|3709169|P2|Overall Study|Physician Decision|0
1129571|NCT01542788|3709170|P1|Overall Study|Physician Decision|1
1129572|NCT01542788|3709169|P2|Overall Study|Protocol Violation|0
1129573|NCT01542788|3709170|P1|Overall Study|Protocol Violation|2
1129574|NCT01542788|3709169|P2|Overall Study|Death|0
1129575|NCT01542788|3709170|P1|Overall Study|Death|3
1129576|NCT01542788|3709169|P2|Overall Study|Lost to Follow-up|0
1129577|NCT01542788|3709170|P1|Overall Study|Lost to Follow-up|5
1129578|NCT01542788|3709169|P2|Overall Study|Lack of Efficacy|71
1129579|NCT01542788|3709170|P1|Overall Study|Lack of Efficacy|41
1129580|NCT01542788|3709169|P2|Overall Study|Randomized but Not Treated|0
1129581|NCT01542788|3709170|P1|Overall Study|Randomized but Not Treated|2
1129582|NCT01542632|3709209|P6|Overall Study|Sponsor/Investigator Decision|0
1129583|NCT01542632|3709210|P5|Overall Study|Sponsor/Investigator Decision|1
1129584|NCT01542632|3709211|P4|Overall Study|Sponsor/Investigator Decision|0
1129585|NCT01542632|3709212|P3|Overall Study|Sponsor/Investigator Decision|0
1129586|NCT01542632|3709213|P2|Overall Study|Sponsor/Investigator Decision|0
1129587|NCT01542632|3709214|P1|Overall Study|Sponsor/Investigator Decision|0
1129588|NCT01542632|3709209|P6|Overall Study|Lost to Follow-up|0
1129589|NCT01542632|3709210|P5|Overall Study|Lost to Follow-up|0
1129590|NCT01542632|3709211|P4|Overall Study|Lost to Follow-up|0
1129591|NCT01542632|3709212|P3|Overall Study|Lost to Follow-up|0
1129592|NCT01542632|3709213|P2|Overall Study|Lost to Follow-up|1
1129593|NCT01542632|3709214|P1|Overall Study|Lost to Follow-up|0
1129594|NCT01542632|3709209|P6|Overall Study|Adverse Event|0
1129595|NCT01542632|3709210|P5|Overall Study|Adverse Event|0
1129596|NCT01542632|3709211|P4|Overall Study|Adverse Event|0
1129597|NCT01542632|3709212|P3|Overall Study|Adverse Event|1
1129598|NCT01542632|3709213|P2|Overall Study|Adverse Event|0
1129599|NCT01542632|3709214|P1|Overall Study|Adverse Event|0
1129600|NCT01542632|3709209|P6|Overall Study|Withdrawal of Consent|0
1129601|NCT01542632|3709210|P5|Overall Study|Withdrawal of Consent|3
1129602|NCT01542632|3709211|P4|Overall Study|Withdrawal of Consent|2
1129603|NCT01542632|3709212|P3|Overall Study|Withdrawal of Consent|0
1129604|NCT01542632|3709213|P2|Overall Study|Withdrawal of Consent|0
1129605|NCT01542632|3709214|P1|Overall Study|Withdrawal of Consent|0
1129606|NCT01542528|3709271|P2|Overall Study|Withdrawal by Subject|6
1129607|NCT01542528|3709272|P1|Overall Study|Withdrawal by Subject|9
1129608|NCT01542528|3709271|P2|Overall Study|Physician Decision|0
1129609|NCT01542528|3709272|P1|Overall Study|Physician Decision|1
1129610|NCT01542528|3709271|P2|Overall Study|Lost to Follow-up|1
1129611|NCT01542528|3709272|P1|Overall Study|Lost to Follow-up|2
1129612|NCT01542034|3709352|P2|Overall Study|Lost to Follow-up|6
1129613|NCT01542034|3709353|P1|Overall Study|Lost to Follow-up|7
1129614|NCT01542034|3709352|P2|Overall Study|Adverse Event|2
1129615|NCT01542034|3709353|P1|Overall Study|Adverse Event|2
1129616|NCT01542034|3709352|P2|Overall Study|Subject Noncompliance|0
1129617|NCT01542034|3709353|P1|Overall Study|Subject Noncompliance|1
1129618|NCT01542034|3709352|P2|Overall Study|Administrative decision|3
1129619|NCT01542034|3709353|P1|Overall Study|Administrative decision|0
1129620|NCT01542034|3709352|P2|Overall Study|Consent Withdrawn (Subject Convenience)|12
1129621|NCT01542034|3709353|P1|Overall Study|Consent Withdrawn (Subject Convenience)|20
1129622|NCT01541969|3709367|P2|Open Label Extension (12-36 Weeks)|Adverse Event|3
1129623|NCT01541969|3709368|P1|Open Label Extension (12-36 Weeks)|Adverse Event|2
1129624|NCT01541969|3709367|P2|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8
1129625|NCT01541969|3709368|P1|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6
1129626|NCT01541969|3709367|P2|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
1129627|NCT01541969|3709368|P1|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
1129628|NCT01541969|3709367|P2|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0
1129629|NCT01541969|3709368|P1|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1
1129630|NCT01541969|3709367|P2|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
1129631|NCT01541969|3709368|P1|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
1129632|NCT01541969|3709367|P2|Double-blind (0-12 Weeks)|Adverse Event|0
1129633|NCT01541969|3709368|P1|Double-blind (0-12 Weeks)|Adverse Event|2
1129634|NCT01541969|3709367|P2|Double-blind (0-12 Weeks)|Lost to Follow-up|0
1129635|NCT01541969|3709368|P1|Double-blind (0-12 Weeks)|Lost to Follow-up|1
1129636|NCT01541969|3709367|P2|Double-blind (0-12 Weeks)|Withdrawal by Subject|0
1129637|NCT01541969|3709368|P1|Double-blind (0-12 Weeks)|Withdrawal by Subject|2
1129638|NCT01541969|3709367|P2|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
1129639|NCT01541969|3709368|P1|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
1129640|NCT01541969|3709367|P2|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1
1129641|NCT01541969|3709368|P1|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0
1129642|NCT01541930|3709384|P1|Overall Study|Withdrawal by Subject|1
1129643|NCT01541917|3709406|P2|Overall Study|Withdrawal by Subject|7
1129644|NCT01541917|3709407|P1|Overall Study|Withdrawal by Subject|13
1129645|NCT01541917|3709406|P2|Overall Study|Lost to Follow-up|2
1129646|NCT01541917|3709407|P1|Overall Study|Lost to Follow-up|2
1129647|NCT01541865|3709436|P1|Overall Study|Protocol Violation|1
1129648|NCT01541865|3709436|P1|Overall Study|Adverse Event|1
1129649|NCT01541865|3709436|P1|Overall Study|Withdrawal by Subject|9
1129650|NCT01541865|3709436|P1|Overall Study|Lost to Follow-up|11
1129651|NCT01541826|3709454|P3|Overall Study|Withdrawal by Subject|0
1129652|NCT01541826|3709455|P2|Overall Study|Withdrawal by Subject|0
1129653|NCT01541826|3709456|P1|Overall Study|Withdrawal by Subject|2
1129654|NCT01541826|3709454|P3|Overall Study|Lost to Follow-up|0
1129655|NCT01541826|3709455|P2|Overall Study|Lost to Follow-up|3
1129656|NCT01541826|3709456|P1|Overall Study|Lost to Follow-up|2
1129657|NCT01541644|3709538|P1|Overall Study|Withdrawal by Subject|3
1129658|NCT01541397|3709557|P2|Overall Study|Study ended prior to data collection|2
1129659|NCT01541397|3709558|P1|Overall Study|Study ended prior to data collection|4
1129660|NCT01541371|3709583|P1|Overall Study|Other|6
1129661|NCT01541371|3709583|P1|Overall Study|Study medication non-compliance|3
1129662|NCT01541371|3709583|P1|Overall Study|Protocol Violation|6
1129663|NCT01541371|3709583|P1|Overall Study|Lack of Efficacy|12
1129664|NCT01541371|3709583|P1|Overall Study|Adverse Event|15
1129665|NCT01541371|3709583|P1|Overall Study|Lost to Follow-up|21
1129666|NCT01541371|3709583|P1|Overall Study|Withdrawal by Subject|14
1129667|NCT01541254|3709612|P1|Overall Study|alternate stent used|1
1129668|NCT01541254|3709612|P1|Overall Study|stent not required|1
1129669|NCT01541254|3709612|P1|Overall Study|GI bleed prior to procedure|1
1129670|NCT01541254|3709612|P1|Overall Study|enrolled after study closed|1
1129671|NCT01541254|3709612|P1|Overall Study|excluded - metal allergy|1
1129672|NCT01541254|3709612|P1|Overall Study|Withdrawal by Subject|1
1129673|NCT01541215|3709619|P2|Overall Study|Unclassified|3
1129674|NCT01541215|3709620|P1|Overall Study|Unclassified|0
1129675|NCT01541215|3709619|P2|Overall Study|Adverse Event|1
1129676|NCT01541215|3709620|P1|Overall Study|Adverse Event|0
1129677|NCT01541215|3709619|P2|Overall Study|Non-compliance|4
1129678|NCT01541215|3709620|P1|Overall Study|Non-compliance|4
1129679|NCT01541215|3709619|P2|Overall Study|Withdrawal criteria|8
1129680|NCT01541215|3709620|P1|Overall Study|Withdrawal criteria|6
1129681|NCT01540981|3709758|P2|Overall Study|Withdrawal by Subject|0
1129682|NCT01540981|3709759|P1|Overall Study|Withdrawal by Subject|1
1129683|NCT01540851|3709769|P2|Overall Study|Withdrawal by Subject|3
1129684|NCT01540851|3709770|P1|Overall Study|Withdrawal by Subject|7
1129685|NCT01540851|3709769|P2|Overall Study|Lost to Follow-up|15
1129686|NCT01540851|3709770|P1|Overall Study|Lost to Follow-up|14
1129687|NCT01540487|3709917|P2|Overall Study|Protocol Violation|0
1129688|NCT01540487|3709918|P1|Overall Study|Protocol Violation|1
1129689|NCT01539759|3710053|P2|Overall Study|Lost to Follow-up|8
1129690|NCT01539759|3710054|P1|Overall Study|Lost to Follow-up|6
1129691|NCT01539642|3710066|P2|Overall Study|Withdrawal by Subject|2
1129692|NCT01539642|3710067|P1|Overall Study|Withdrawal by Subject|2
1129693|NCT01539642|3710066|P2|Overall Study|Adverse Event|4
1129694|NCT01539642|3710067|P1|Overall Study|Adverse Event|6
1129695|NCT01539642|3710066|P2|Overall Study|Patient ready for early discharge|7
1129696|NCT01539642|3710067|P1|Overall Study|Patient ready for early discharge|8
1129697|NCT01539642|3710066|P2|Overall Study|Lack of Efficacy|18
1129698|NCT01539642|3710067|P1|Overall Study|Lack of Efficacy|20
1129699|NCT01539538|3710084|P2|Overall Study|PCA no longer required or PCA problem|7
1129700|NCT01539538|3710085|P1|Overall Study|PCA no longer required or PCA problem|3
1129701|NCT01539538|3710084|P2|Overall Study|Withdrawal by Subject|3
1129702|NCT01539538|3710085|P1|Overall Study|Withdrawal by Subject|2
1129703|NCT01539538|3710084|P2|Overall Study|Lack of Efficacy|16
1129704|NCT01539538|3710085|P1|Overall Study|Lack of Efficacy|13
1129705|NCT01539538|3710084|P2|Overall Study|Adverse Event|18
1129706|NCT01539538|3710085|P1|Overall Study|Adverse Event|13
1129707|NCT01539525|3710094|P3|Overall Study|Protocol Violation|4
1129708|NCT01539525|3710095|P2|Overall Study|Protocol Violation|1
1129709|NCT01539525|3710096|P1|Overall Study|Protocol Violation|1
1129710|NCT01539525|3710094|P3|Overall Study|Withdrawal by Subject|2
1129711|NCT01539525|3710095|P2|Overall Study|Withdrawal by Subject|3
1129712|NCT01539525|3710096|P1|Overall Study|Withdrawal by Subject|0
1129713|NCT01539525|3710094|P3|Overall Study|Lost to Follow-up|11
1129714|NCT01539525|3710095|P2|Overall Study|Lost to Follow-up|12
1129715|NCT01539525|3710096|P1|Overall Study|Lost to Follow-up|19
1129716|NCT01539512|3710115|P2|Overall Study|Richter's Transformation|0
1129717|NCT01539512|3710116|P1|Overall Study|Richter's Transformation|1
1129718|NCT01539512|3710115|P2|Overall Study|Withdrawal by Subject|5
1129719|NCT01539512|3710116|P1|Overall Study|Withdrawal by Subject|12
1129720|NCT01539512|3710115|P2|Overall Study|Physician Decision|1
1129721|NCT01539512|3710116|P1|Overall Study|Physician Decision|1
1129722|NCT01539512|3710115|P2|Overall Study|Adverse Event|7
1129723|NCT01539512|3710116|P1|Overall Study|Adverse Event|9
1129724|NCT01539317|3710132|P2|Overall Study|Screening Error. Deleted from analysis.|0
1129725|NCT01539317|3710133|P1|Overall Study|Screening Error. Deleted from analysis.|1
1129726|NCT01539083|3710163|P3|After Randomization (TP and VTP)|Death|11
1129727|NCT01539083|3710164|P2|After Randomization (TP and VTP)|Death|6
1129728|NCT01539083|3710165|P1|After Randomization (TP and VTP)|Death|0
1129729|NCT01539083|3710163|P3|After Randomization (TP and VTP)|Progressive Disease|3
1129730|NCT01539083|3710164|P2|After Randomization (TP and VTP)|Progressive Disease|6
1129731|NCT01539083|3710165|P1|After Randomization (TP and VTP)|Progressive Disease|0
1129732|NCT01539083|3710163|P3|After Randomization (TP and VTP)|Withdrawal by Subject|4
1129733|NCT01539083|3710164|P2|After Randomization (TP and VTP)|Withdrawal by Subject|5
1129734|NCT01539083|3710165|P1|After Randomization (TP and VTP)|Withdrawal by Subject|0
1129735|NCT01539083|3710163|P3|After Randomization (TP and VTP)|Lost to Follow-up|2
1129736|NCT01539083|3710164|P2|After Randomization (TP and VTP)|Lost to Follow-up|2
1129737|NCT01539083|3710165|P1|After Randomization (TP and VTP)|Lost to Follow-up|0
1129738|NCT01539083|3710163|P3|After Randomization (TP and VTP)|Adverse Event|1
1129739|NCT01539083|3710164|P2|After Randomization (TP and VTP)|Adverse Event|1
1129740|NCT01539083|3710165|P1|After Randomization (TP and VTP)|Adverse Event|0
1129741|NCT01539083|3710163|P3|After Randomization (TP and VTP)|Other|1
1129742|NCT01539083|3710164|P2|After Randomization (TP and VTP)|Other|1
1129743|NCT01539083|3710165|P1|After Randomization (TP and VTP)|Other|0
1129744|NCT01539083|3710163|P3|After Randomization (TP and VTP)|Physician Decision|1
1129745|NCT01539083|3710164|P2|After Randomization (TP and VTP)|Physician Decision|0
1129746|NCT01539083|3710165|P1|After Randomization (TP and VTP)|Physician Decision|0
1129747|NCT01539083|3710163|P3|Before Randomization (VCD Induction)|Other|0
1129748|NCT01539083|3710164|P2|Before Randomization (VCD Induction)|Other|0
1129749|NCT01539083|3710165|P1|Before Randomization (VCD Induction)|Other|5
1129750|NCT01539083|3710163|P3|Before Randomization (VCD Induction)|Progressive Disease|0
1129751|NCT01539083|3710164|P2|Before Randomization (VCD Induction)|Progressive Disease|0
1129752|NCT01539083|3710165|P1|Before Randomization (VCD Induction)|Progressive Disease|8
1129753|NCT01539083|3710163|P3|Before Randomization (VCD Induction)|Physician Decision|0
1129754|NCT01539083|3710164|P2|Before Randomization (VCD Induction)|Physician Decision|0
1129755|NCT01539083|3710165|P1|Before Randomization (VCD Induction)|Physician Decision|14
1129756|NCT01539083|3710163|P3|Before Randomization (VCD Induction)|Protocol Violation|0
1129757|NCT01539083|3710164|P2|Before Randomization (VCD Induction)|Protocol Violation|0
1129758|NCT01539083|3710165|P1|Before Randomization (VCD Induction)|Protocol Violation|2
1129759|NCT01539083|3710163|P3|Before Randomization (VCD Induction)|Death|0
1129760|NCT01539083|3710164|P2|Before Randomization (VCD Induction)|Death|0
1129761|NCT01539083|3710165|P1|Before Randomization (VCD Induction)|Death|6
1129762|NCT01539083|3710163|P3|Before Randomization (VCD Induction)|Adverse Event|0
1129763|NCT01539083|3710164|P2|Before Randomization (VCD Induction)|Adverse Event|0
1129764|NCT01539083|3710165|P1|Before Randomization (VCD Induction)|Adverse Event|14
1129765|NCT01539083|3710163|P3|Before Randomization (VCD Induction)|Withdrawal by Subject|0
1129766|NCT01539083|3710164|P2|Before Randomization (VCD Induction)|Withdrawal by Subject|0
1129767|NCT01539083|3710165|P1|Before Randomization (VCD Induction)|Withdrawal by Subject|4
1129768|NCT01538719|3710209|P2|Overall Study|Lost to Follow-up|0
1129769|NCT01538719|3710210|P1|Overall Study|Lost to Follow-up|2
1129770|NCT01538472|3710233|P1|Overall Study|Death|1
1129771|NCT01538472|3710233|P1|Overall Study|Disease Progression|3
1129772|NCT01538199|3710244|P4|Overall Study|Lack of Efficacy|0
1129773|NCT01538199|3710245|P3|Overall Study|Lack of Efficacy|0
1129774|NCT01538199|3710246|P2|Overall Study|Lack of Efficacy|1
1129775|NCT01538199|3710247|P1|Overall Study|Lack of Efficacy|0
1129776|NCT01538199|3710244|P4|Overall Study|participant did not have time|2
1129777|NCT01538199|3710245|P3|Overall Study|participant did not have time|0
1129778|NCT01538199|3710246|P2|Overall Study|participant did not have time|0
1129779|NCT01538199|3710247|P1|Overall Study|participant did not have time|1
1129780|NCT01538199|3710244|P4|Overall Study|Lost to Follow-up|0
1129781|NCT01538199|3710245|P3|Overall Study|Lost to Follow-up|1
1129782|NCT01538199|3710246|P2|Overall Study|Lost to Follow-up|2
1129783|NCT01538199|3710247|P1|Overall Study|Lost to Follow-up|1
1129784|NCT01537783|3710299|P2|Overall Study|Lost to Follow-up|2
1129785|NCT01537783|3710300|P1|Overall Study|Lost to Follow-up|11
1129786|NCT01537549|3710351|P1|Overall Study|Withdrawal by Subject|2
1129787|NCT01537549|3710351|P1|Overall Study|Lost to Follow-up|1
1129788|NCT01537432|3710359|P2|Overall Study|Unsatisfactory therapeutic effect|0
1129789|NCT01537432|3710360|P1|Overall Study|Unsatisfactory therapeutic effect|1
1129790|NCT01537432|3710359|P2|Overall Study|Adverse Event|0
1129791|NCT01537432|3710360|P1|Overall Study|Adverse Event|1
1129792|NCT01537432|3710359|P2|Overall Study|Administrative problems|0
1129793|NCT01537432|3710360|P1|Overall Study|Administrative problems|1
1129794|NCT01537432|3710359|P2|Overall Study|Withdrawal by Subject|1
1129795|NCT01537432|3710360|P1|Overall Study|Withdrawal by Subject|0
1129796|NCT01537432|3710359|P2|Overall Study|Lost to Follow-up|1
1129797|NCT01537432|3710360|P1|Overall Study|Lost to Follow-up|3
1129798|NCT01537393|3710383|P2|Overall Study|Censored (severe event unrelated to PT)|1
1129962|NCT01536379|3710862|P2|Overall Study|Withdrawal by Subject|1
1129799|NCT01537393|3710384|P1|Overall Study|Censored (severe event unrelated to PT)|1
1129800|NCT01537393|3710383|P2|Overall Study|Failure - Not regrafted|6
1129801|NCT01537393|3710384|P1|Overall Study|Failure - Not regrafted|2
1129802|NCT01537393|3710383|P2|Overall Study|Failure - Regrafted|43
1129803|NCT01537393|3710384|P1|Overall Study|Failure - Regrafted|28
1129804|NCT01537393|3710383|P2|Overall Study|Lost to Follow-up|48
1129805|NCT01537393|3710384|P1|Overall Study|Lost to Follow-up|53
1129806|NCT01537393|3710383|P2|Overall Study|Withdrawal by Subject|17
1129807|NCT01537393|3710384|P1|Overall Study|Withdrawal by Subject|18
1129808|NCT01537393|3710383|P2|Overall Study|Death|32
1129809|NCT01537393|3710384|P1|Overall Study|Death|20
1129810|NCT01537393|3710383|P2|Overall Study|Exclude prior to study|44
1129811|NCT01537393|3710384|P1|Overall Study|Exclude prior to study|32
1129812|NCT01537302|3710420|P1|Overall Study|Withdrawal by Subject|1
1129813|NCT01537302|3710420|P1|Overall Study|Lost to Follow-up|1
1129814|NCT01537198|3710427|P1|Overall Study|Not Specified|111
1129815|NCT01537198|3710427|P1|Overall Study|No Further Visits to the Clinic|37
1129816|NCT01537198|3710427|P1|Overall Study|Adverse Event|4
1129817|NCT01537198|3710427|P1|Overall Study|RSV infection|2
1129818|NCT01537133|3710456|P4|Overall Study|Lost to Follow-up|0
1129819|NCT01537133|3710457|P3|Overall Study|Lost to Follow-up|0
1129820|NCT01537133|3710458|P2|Overall Study|Lost to Follow-up|0
1129821|NCT01537133|3710459|P1|Overall Study|Lost to Follow-up|1
1129822|NCT01537133|3710456|P4|Overall Study|Withdrawal by Subject|0
1129823|NCT01537133|3710457|P3|Overall Study|Withdrawal by Subject|0
1129824|NCT01537133|3710458|P2|Overall Study|Withdrawal by Subject|0
1129825|NCT01537133|3710459|P1|Overall Study|Withdrawal by Subject|2
1129826|NCT01537120|3710475|P1|3 Weeks Placebo|Withdrawal by Subject|1
1129827|NCT01537120|3710475|P1|8 Weeks Washout|Inclusion/exclusion criteria not met|1
1129828|NCT01537081|3710488|P3|Overall Study|Assigned but never dosed|0
1129829|NCT01537081|3710489|P2|Overall Study|Assigned but never dosed|0
1129830|NCT01537081|3710490|P1|Overall Study|Assigned but never dosed|1
1129831|NCT01537081|3710488|P3|Overall Study|Sponsor decision|0
1129832|NCT01537081|3710489|P2|Overall Study|Sponsor decision|1
1129833|NCT01537081|3710490|P1|Overall Study|Sponsor decision|0
1129834|NCT01537081|3710488|P3|Overall Study|Physician Decision|0
1129835|NCT01537081|3710489|P2|Overall Study|Physician Decision|6
1129836|NCT01537081|3710490|P1|Overall Study|Physician Decision|5
1129837|NCT01537081|3710488|P3|Overall Study|Withdrawal by Subject|3
1129838|NCT01537081|3710489|P2|Overall Study|Withdrawal by Subject|11
1129839|NCT01537081|3710490|P1|Overall Study|Withdrawal by Subject|6
1129840|NCT01537081|3710488|P3|Overall Study|Protocol Violation|2
1129841|NCT01537081|3710489|P2|Overall Study|Protocol Violation|2
1129842|NCT01537081|3710490|P1|Overall Study|Protocol Violation|3
1129843|NCT01537081|3710488|P3|Overall Study|Lost to Follow-up|9
1129844|NCT01537081|3710489|P2|Overall Study|Lost to Follow-up|15
1129845|NCT01537081|3710490|P1|Overall Study|Lost to Follow-up|17
1129846|NCT01537081|3710488|P3|Overall Study|Lack of Efficacy|0
1129847|NCT01537081|3710489|P2|Overall Study|Lack of Efficacy|1
1129848|NCT01537081|3710490|P1|Overall Study|Lack of Efficacy|2
1129849|NCT01537081|3710488|P3|Overall Study|Adverse Event|2
1129850|NCT01537081|3710489|P2|Overall Study|Adverse Event|2
1129851|NCT01537081|3710490|P1|Overall Study|Adverse Event|5
1129852|NCT01537068|3710503|P2|Overall Study|Lack of Efficacy|0
1129853|NCT01537068|3710504|P1|Overall Study|Lack of Efficacy|1
1129854|NCT01537068|3710503|P2|Overall Study|Withdrawal by Subject|1
1129855|NCT01537068|3710504|P1|Overall Study|Withdrawal by Subject|1
1129856|NCT01537068|3710503|P2|Overall Study|Adverse Event|1
1129857|NCT01537068|3710504|P1|Overall Study|Adverse Event|0
1129858|NCT01537068|3710503|P2|Overall Study|Lost to Follow-up|1
1129859|NCT01537068|3710504|P1|Overall Study|Lost to Follow-up|2
1129860|NCT01537042|3710516|P2|Overall Study|Other|1
1129861|NCT01537042|3710517|P1|Overall Study|Other|0
1129862|NCT01537042|3710516|P2|Overall Study|Protocol Violation|1
1129863|NCT01537042|3710517|P1|Overall Study|Protocol Violation|0
1129864|NCT01537042|3710516|P2|Overall Study|Lack of Efficacy|1
1129865|NCT01537042|3710517|P1|Overall Study|Lack of Efficacy|0
1129866|NCT01537042|3710516|P2|Overall Study|Adverse Event|2
1129867|NCT01537042|3710517|P1|Overall Study|Adverse Event|0
1129868|NCT01536951|3710559|P9|Second Intervention and Washout Period 2|Adverse Event|0
1129869|NCT01536951|3710560|P8|Second Intervention and Washout Period 2|Adverse Event|1
1129870|NCT01536951|3710561|P7|Second Intervention and Washout Period 2|Adverse Event|0
1129871|NCT01536951|3710562|P6|Second Intervention and Washout Period 2|Adverse Event|0
1129872|NCT01536951|3710563|P5|Second Intervention and Washout Period 2|Adverse Event|0
1129873|NCT01536951|3710564|P4|Second Intervention and Washout Period 2|Adverse Event|0
1129874|NCT01536951|3710565|P3|Second Intervention and Washout Period 2|Adverse Event|0
1129875|NCT01536951|3710566|P2|Second Intervention and Washout Period 2|Adverse Event|0
1129876|NCT01536951|3710567|P1|Second Intervention and Washout Period 2|Adverse Event|0
1129877|NCT01536951|3710559|P9|First Intervention and Washout Period 1|Withdrawal by Subject|0
1129878|NCT01536951|3710560|P8|First Intervention and Washout Period 1|Withdrawal by Subject|0
1129879|NCT01536951|3710561|P7|First Intervention and Washout Period 1|Withdrawal by Subject|0
1129880|NCT01536951|3710562|P6|First Intervention and Washout Period 1|Withdrawal by Subject|0
1129881|NCT01536951|3710563|P5|First Intervention and Washout Period 1|Withdrawal by Subject|0
1129882|NCT01536951|3710564|P4|First Intervention and Washout Period 1|Withdrawal by Subject|0
1129883|NCT01536951|3710565|P3|First Intervention and Washout Period 1|Withdrawal by Subject|1
1129884|NCT01536951|3710566|P2|First Intervention and Washout Period 1|Withdrawal by Subject|0
1129885|NCT01536951|3710567|P1|First Intervention and Washout Period 1|Withdrawal by Subject|0
1129886|NCT01536860|3710624|P3|Washout Period (3 Days)|Lost to Follow-up|0
1129887|NCT01536860|3710625|P2|Washout Period (3 Days)|Lost to Follow-up|0
1129888|NCT01536860|3710626|P1|Washout Period (3 Days)|Lost to Follow-up|1
1129889|NCT01536704|3710634|P4|Washout Period 3|Adverse Event|0
1129890|NCT01536704|3710635|P3|Washout Period 3|Adverse Event|1
1129891|NCT01536704|3710636|P2|Washout Period 3|Adverse Event|0
1129892|NCT01536704|3710637|P1|Washout Period 3|Adverse Event|0
1129893|NCT01536704|3710634|P4|Period 3|Adverse Event|1
1129894|NCT01536704|3710635|P3|Period 3|Adverse Event|0
1129895|NCT01536704|3710636|P2|Period 3|Adverse Event|0
1129896|NCT01536704|3710637|P1|Period 3|Adverse Event|0
1129897|NCT01536704|3710634|P4|Washout Period 2|Withdrawal by Subject|1
1129898|NCT01536704|3710635|P3|Washout Period 2|Withdrawal by Subject|0
1129899|NCT01536704|3710636|P2|Washout Period 2|Withdrawal by Subject|0
1129900|NCT01536704|3710637|P1|Washout Period 2|Withdrawal by Subject|0
1129901|NCT01536704|3710634|P4|Washout Period 2|Adverse Event|0
1129902|NCT01536704|3710635|P3|Washout Period 2|Adverse Event|0
1129903|NCT01536704|3710636|P2|Washout Period 2|Adverse Event|0
1129904|NCT01536704|3710637|P1|Washout Period 2|Adverse Event|1
1129905|NCT01536704|3710634|P4|Washout Period 1|Withdrawal by Subject|0
1129906|NCT01536704|3710635|P3|Washout Period 1|Withdrawal by Subject|0
1129907|NCT01536704|3710636|P2|Washout Period 1|Withdrawal by Subject|2
1129908|NCT01536704|3710637|P1|Washout Period 1|Withdrawal by Subject|1
1129909|NCT01536587|3710667|P1|Overall Study|Adverse Event|2
1129910|NCT01536574|3710706|P2|Overall Study|Lack of Efficacy|0
1129911|NCT01536574|3710707|P1|Overall Study|Lack of Efficacy|1
1129912|NCT01536574|3710706|P2|Overall Study|Withdrawal by Subject|2
1129913|NCT01536574|3710707|P1|Overall Study|Withdrawal by Subject|1
1129914|NCT01536574|3710706|P2|Overall Study|Adverse Event|5
1129915|NCT01536574|3710707|P1|Overall Study|Adverse Event|4
1129916|NCT01536561|3710725|P1|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13
1129917|NCT01536561|3710725|P1|Dosimetric and Therapeutic Treatment|Death|2
1129918|NCT01536561|3710725|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1
1129919|NCT01536561|3710725|P1|Dosimetric and Therapeutic Treatment|Adverse Event|1
1129920|NCT01536561|3710725|P1|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2
1129921|NCT01536561|3710725|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|40
1129922|NCT01536418|3710802|P2|Overall Study|Withdrawal by Subject|3
1129923|NCT01536418|3710803|P1|Overall Study|Withdrawal by Subject|5
1129924|NCT01536418|3710802|P2|Overall Study|Met Liver Chemistry Stopping criteria|0
1129925|NCT01536418|3710803|P1|Overall Study|Met Liver Chemistry Stopping criteria|1
1129926|NCT01536418|3710802|P2|Overall Study|Adverse Event|4
1129927|NCT01536418|3710803|P1|Overall Study|Adverse Event|9
1129928|NCT01536418|3710802|P2|Overall Study|Lack of Efficacy|16
1129929|NCT01536418|3710803|P1|Overall Study|Lack of Efficacy|10
1129930|NCT01536418|3710802|P2|Overall Study|Study closed/terminated|37
1129931|NCT01536418|3710803|P1|Overall Study|Study closed/terminated|41
1129932|NCT01536418|3710802|P2|Overall Study|Physician Decision|3
1129933|NCT01536418|3710803|P1|Overall Study|Physician Decision|1
1129934|NCT01536418|3710802|P2|Overall Study|Protocol Violation|3
1129935|NCT01536418|3710803|P1|Overall Study|Protocol Violation|2
1129936|NCT01536405|3710823|P2|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
1129937|NCT01536405|3710824|P1|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
1129938|NCT01536405|3710823|P2|Visit 4 to Extended Study Follow-up|Adverse Event|1
1129939|NCT01536405|3710824|P1|Visit 4 to Extended Study Follow-up|Adverse Event|0
1129940|NCT01536405|3710823|P2|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2
1129941|NCT01536405|3710824|P1|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0
1129942|NCT01536405|3710823|P2|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14
1129943|NCT01536405|3710824|P1|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16
1129944|NCT01536405|3710823|P2|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0
1129945|NCT01536405|3710824|P1|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1
1129946|NCT01536405|3710823|P2|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2
1129947|NCT01536405|3710824|P1|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3
1129948|NCT01536405|3710823|P2|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
1129949|NCT01536405|3710824|P1|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
1129950|NCT01536405|3710823|P2|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10
1129951|NCT01536405|3710824|P1|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9
1129952|NCT01536405|3710823|P2|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
1129953|NCT01536405|3710824|P1|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
1129954|NCT01536405|3710823|P2|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13
1129955|NCT01536405|3710824|P1|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17
1129956|NCT01536405|3710823|P2|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22
1129957|NCT01536405|3710824|P1|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20
1129958|NCT01536405|3710823|P2|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18
1129959|NCT01536405|3710824|P1|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12
1129960|NCT01536405|3710823|P2|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4
1129961|NCT01536405|3710824|P1|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8
1129963|NCT01536379|3710863|P1|Overall Study|Withdrawal by Subject|1
1129964|NCT01536379|3710862|P2|Overall Study|Adverse Event|2
1129965|NCT01536379|3710863|P1|Overall Study|Adverse Event|1
1129966|NCT01536262|3710955|P3|Overall Study|Other than stated above|0
1129967|NCT01536262|3710956|P2|Overall Study|Other than stated above|0
1129968|NCT01536262|3710957|P1|Overall Study|Other than stated above|1
1129969|NCT01536262|3710955|P3|Overall Study|Withdrawal by Subject|0
1129970|NCT01536262|3710956|P2|Overall Study|Withdrawal by Subject|1
1129971|NCT01536262|3710957|P1|Overall Study|Withdrawal by Subject|1
1129972|NCT01536262|3710955|P3|Overall Study|Adverse Event|2
1129973|NCT01536262|3710956|P2|Overall Study|Adverse Event|1
1129974|NCT01536262|3710957|P1|Overall Study|Adverse Event|6
1129975|NCT01536171|3710999|P1|Overall Study|Withdrawal by Subject|1
1129976|NCT01536145|3711004|P11|Overall Study|Adverse Event|3
1129977|NCT01536145|3711005|P10|Overall Study|Adverse Event|0
1129978|NCT01536145|3711006|P9|Overall Study|Adverse Event|0
1129979|NCT01536145|3711007|P8|Overall Study|Adverse Event|2
1129980|NCT01536145|3711008|P7|Overall Study|Adverse Event|0
1129981|NCT01536145|3711009|P6|Overall Study|Adverse Event|0
1129982|NCT01536145|3711010|P5|Overall Study|Adverse Event|0
1129983|NCT01536145|3711011|P4|Overall Study|Adverse Event|0
1129984|NCT01536145|3711012|P3|Overall Study|Adverse Event|0
1129985|NCT01536145|3711013|P2|Overall Study|Adverse Event|0
1129986|NCT01536145|3711014|P1|Overall Study|Adverse Event|0
1129987|NCT01536145|3711004|P11|Overall Study|Death|0
1129988|NCT01536145|3711005|P10|Overall Study|Death|0
1129989|NCT01536145|3711006|P9|Overall Study|Death|0
1129990|NCT01536145|3711007|P8|Overall Study|Death|0
1129991|NCT01536145|3711008|P7|Overall Study|Death|1
1129992|NCT01536145|3711009|P6|Overall Study|Death|0
1129993|NCT01536145|3711010|P5|Overall Study|Death|0
1129994|NCT01536145|3711011|P4|Overall Study|Death|0
1129995|NCT01536145|3711012|P3|Overall Study|Death|0
1129996|NCT01536145|3711013|P2|Overall Study|Death|0
1129997|NCT01536145|3711014|P1|Overall Study|Death|0
1129998|NCT01536145|3711004|P11|Overall Study|Other|2
1129999|NCT01536145|3711005|P10|Overall Study|Other|3
1130000|NCT01536145|3711006|P9|Overall Study|Other|0
1130001|NCT01536145|3711007|P8|Overall Study|Other|0
1130002|NCT01536145|3711008|P7|Overall Study|Other|0
1130003|NCT01536145|3711009|P6|Overall Study|Other|0
1130004|NCT01536145|3711010|P5|Overall Study|Other|1
1130005|NCT01536145|3711011|P4|Overall Study|Other|0
1130006|NCT01536145|3711012|P3|Overall Study|Other|0
1130007|NCT01536145|3711013|P2|Overall Study|Other|0
1130008|NCT01536145|3711014|P1|Overall Study|Other|0
1130009|NCT01536145|3711004|P11|Overall Study|Withdrawal by Subject|2
1130010|NCT01536145|3711005|P10|Overall Study|Withdrawal by Subject|0
1130011|NCT01536145|3711006|P9|Overall Study|Withdrawal by Subject|2
1130012|NCT01536145|3711007|P8|Overall Study|Withdrawal by Subject|0
1130013|NCT01536145|3711008|P7|Overall Study|Withdrawal by Subject|0
1130014|NCT01536145|3711009|P6|Overall Study|Withdrawal by Subject|1
1130015|NCT01536145|3711010|P5|Overall Study|Withdrawal by Subject|0
1130016|NCT01536145|3711011|P4|Overall Study|Withdrawal by Subject|0
1130017|NCT01536145|3711012|P3|Overall Study|Withdrawal by Subject|1
1130018|NCT01536145|3711013|P2|Overall Study|Withdrawal by Subject|0
1130019|NCT01536145|3711014|P1|Overall Study|Withdrawal by Subject|0
1130020|NCT01536145|3711004|P11|Overall Study|Progressive disease|3
1130021|NCT01536145|3711005|P10|Overall Study|Progressive disease|3
1130022|NCT01536145|3711006|P9|Overall Study|Progressive disease|1
1130023|NCT01536145|3711007|P8|Overall Study|Progressive disease|2
1130024|NCT01536145|3711008|P7|Overall Study|Progressive disease|1
1130025|NCT01536145|3711009|P6|Overall Study|Progressive disease|2
1130026|NCT01536145|3711010|P5|Overall Study|Progressive disease|1
1130027|NCT01536145|3711011|P4|Overall Study|Progressive disease|2
1130028|NCT01536145|3711012|P3|Overall Study|Progressive disease|1
1130029|NCT01536145|3711013|P2|Overall Study|Progressive disease|4
1130030|NCT01536145|3711014|P1|Overall Study|Progressive disease|3
1130031|NCT01536119|3711121|P2|Overall Study|Lost to Follow-up|14
1130032|NCT01536119|3711122|P1|Overall Study|Lost to Follow-up|17
1130033|NCT01536093|3711148|P2|Overall Study|Withdrawal by Subject|1
1130034|NCT01536093|3711149|P1|Overall Study|Withdrawal by Subject|0
1130035|NCT01536093|3711148|P2|Overall Study|absence of maternal colostrum|0
1130036|NCT01536093|3711149|P1|Overall Study|absence of maternal colostrum|2
1130037|NCT01536093|3711148|P2|Overall Study|Death|2
1130038|NCT01536093|3711149|P1|Overall Study|Death|1
1130039|NCT01536067|3711165|P1|Overall Study|Disease Progression|1
1130040|NCT01536015|3711178|P2|Overall Study|Study closure|5
1130041|NCT01536015|3711179|P1|Overall Study|Study closure|5
1130042|NCT01536015|3711178|P2|Overall Study|Inclusion Criterion not met|0
1130043|NCT01536015|3711179|P1|Overall Study|Inclusion Criterion not met|2
1130044|NCT01536015|3711178|P2|Overall Study|Lost to Follow-up|1
1130045|NCT01536015|3711179|P1|Overall Study|Lost to Follow-up|0
1130046|NCT01536015|3711178|P2|Overall Study|Adverse Event|4
1130047|NCT01536015|3711179|P1|Overall Study|Adverse Event|1
1130048|NCT01535807|3711217|P2|Overall Study|Data collection error|1
1130049|NCT01535807|3711218|P1|Overall Study|Data collection error|1
1130050|NCT01535807|3711217|P2|Overall Study|Withdrawal by Subject|1
1130051|NCT01535807|3711218|P1|Overall Study|Withdrawal by Subject|1
1130052|NCT01535729|3711224|P1|Overall Study|No participant record available|5
1130053|NCT01535729|3711224|P1|Overall Study|Not treated|9
1130054|NCT01535729|3711224|P1|Overall Study|Screening failure|1
1130055|NCT01535729|3711224|P1|Overall Study|Protocol Violation|11
1130056|NCT01535729|3711224|P1|Overall Study|NSCLC grade IV histology not confirmed|20
1130057|NCT01535729|3711224|P1|Overall Study|No previous chemotherapy|33
1130058|NCT01535729|3711224|P1|Overall Study|Did not sign informed consent|1
1130059|NCT01535729|3711224|P1|Overall Study|Other|19
1130060|NCT01535729|3711224|P1|Overall Study|Death|52
1130061|NCT01535729|3711224|P1|Overall Study|Lost to Follow-up|8
1130062|NCT01535729|3711224|P1|Overall Study|Discontinued treatment|25
1130063|NCT01535729|3711224|P1|Overall Study|Disease progression|230
1130064|NCT01535729|3711224|P1|Overall Study|Withdrawal by Subject|2
1130065|NCT01535638|3711265|P6|Treatment 3 (Single Dose)|Protocol Violation|0
1130066|NCT01535638|3711266|P5|Treatment 3 (Single Dose)|Protocol Violation|0
1130067|NCT01535638|3711267|P4|Treatment 3 (Single Dose)|Protocol Violation|1
1130068|NCT01535638|3711268|P3|Treatment 3 (Single Dose)|Protocol Violation|0
1130069|NCT01535638|3711269|P2|Treatment 3 (Single Dose)|Protocol Violation|0
1130070|NCT01535638|3711270|P1|Treatment 3 (Single Dose)|Protocol Violation|0
1130071|NCT01535638|3711265|P6|Treatment 1 (Single Dose)|Protocol Violation|1
1130072|NCT01535638|3711266|P5|Treatment 1 (Single Dose)|Protocol Violation|0
1130073|NCT01535638|3711267|P4|Treatment 1 (Single Dose)|Protocol Violation|0
1130074|NCT01535638|3711268|P3|Treatment 1 (Single Dose)|Protocol Violation|0
1130075|NCT01535638|3711269|P2|Treatment 1 (Single Dose)|Protocol Violation|0
1130076|NCT01535638|3711270|P1|Treatment 1 (Single Dose)|Protocol Violation|0
1130077|NCT01535599|3711284|P2|Overall Study|Noncompliance|1
1130078|NCT01535599|3711285|P1|Overall Study|Noncompliance|0
1130079|NCT01535599|3711284|P2|Overall Study|Stopped medication|1
1130080|NCT01535599|3711285|P1|Overall Study|Stopped medication|0
1130081|NCT01535599|3711284|P2|Overall Study|Other|0
1130082|NCT01535599|3711285|P1|Overall Study|Other|1
1130083|NCT01535599|3711284|P2|Overall Study|Did not use product|0
1130084|NCT01535599|3711285|P1|Overall Study|Did not use product|1
1130085|NCT01535599|3711284|P2|Overall Study|Randomized in Error|4
1130086|NCT01535599|3711285|P1|Overall Study|Randomized in Error|2
1130087|NCT01535599|3711284|P2|Overall Study|BL Culture + for Yeast//Fungi|1
1130088|NCT01535599|3711285|P1|Overall Study|BL Culture + for Yeast//Fungi|0
1130089|NCT01535599|3711284|P2|Overall Study|BL Culture + for Group A Strep|1
1130090|NCT01535599|3711285|P1|Overall Study|BL Culture + for Group A Strep|0
1130091|NCT01535599|3711284|P2|Overall Study|Treatment Failure|66
1130092|NCT01535599|3711285|P1|Overall Study|Treatment Failure|33
1130093|NCT01535599|3711284|P2|Overall Study|Subj Decision Unrelated to Adverse Event|3
1130094|NCT01535599|3711285|P1|Overall Study|Subj Decision Unrelated to Adverse Event|4
1130095|NCT01535599|3711284|P2|Overall Study|Lost to Follow-up|4
1130096|NCT01535599|3711285|P1|Overall Study|Lost to Follow-up|3
1130097|NCT01535599|3711284|P2|Overall Study|Adverse Event|15
1130098|NCT01535599|3711285|P1|Overall Study|Adverse Event|6
1130099|NCT01535560|3711297|P2|Overall Study|Randomized in Error|1
1130100|NCT01535560|3711298|P1|Overall Study|Randomized in Error|0
1130101|NCT01535560|3711297|P2|Overall Study|Other|1
1130102|NCT01535560|3711298|P1|Overall Study|Other|0
1130103|NCT01535560|3711297|P2|Overall Study|Treatment Failure|83
1130104|NCT01535560|3711298|P1|Overall Study|Treatment Failure|21
1130105|NCT01535560|3711297|P2|Overall Study|Subj Decision Unrel to an Adverse Event|1
1130106|NCT01535560|3711298|P1|Overall Study|Subj Decision Unrel to an Adverse Event|3
1130107|NCT01535560|3711297|P2|Overall Study|Lost to Follow-up|3
1130108|NCT01535560|3711298|P1|Overall Study|Lost to Follow-up|1
1130109|NCT01535560|3711297|P2|Overall Study|Adverse Event|7
1130110|NCT01535560|3711298|P1|Overall Study|Adverse Event|12
1130111|NCT01535287|3711343|P2|Overall Study|drug not prepared in time|6
1130112|NCT01535287|3711344|P1|Overall Study|drug not prepared in time|5
1130113|NCT01535261|3711360|P1|Overall Study|Adverse Event|12
1130114|NCT01535261|3711360|P1|Overall Study|Withdrawal by Subject|14
1130115|NCT01535261|3711360|P1|Overall Study|Lost to Follow-up|8
1130116|NCT01535261|3711360|P1|Overall Study|Death|5
1130117|NCT01535261|3711360|P1|Overall Study|Protocol Violation|3
1130118|NCT01535261|3711360|P1|Overall Study|Physician Decision|8
1130119|NCT01535235|3711373|P2|Overall Study|Adverse Event|0
1130120|NCT01535235|3711374|P1|Overall Study|Adverse Event|1
1130121|NCT01535222|3711388|P6|Overall Study|Inclusion/exclusion|0
1130122|NCT01535222|3711389|P5|Overall Study|Inclusion/exclusion|0
1130123|NCT01535222|3711390|P4|Overall Study|Inclusion/exclusion|0
1130124|NCT01535222|3711391|P3|Overall Study|Inclusion/exclusion|1
1130125|NCT01535222|3711392|P2|Overall Study|Inclusion/exclusion|0
1130126|NCT01535222|3711393|P1|Overall Study|Inclusion/exclusion|0
1130127|NCT01535040|3711424|P2|Overall Study|Multiple Reasons|1
1130128|NCT01535040|3711425|P1|Overall Study|Multiple Reasons|1
1130129|NCT01535040|3711424|P2|Overall Study|Toxicity|5
1130130|NCT01535040|3711425|P1|Overall Study|Toxicity|7
1130131|NCT01535040|3711424|P2|Overall Study|Never Started|4
1130132|NCT01535040|3711425|P1|Overall Study|Never Started|9
1130133|NCT01535040|3711424|P2|Overall Study|Withdrawal by Subject|10
1130134|NCT01535040|3711425|P1|Overall Study|Withdrawal by Subject|13
1130135|NCT01535040|3711424|P2|Overall Study|Physician Decision|1
1130136|NCT01535040|3711425|P1|Overall Study|Physician Decision|0
1130137|NCT01534962|3711522|P4|Overall Study|Discontinued at AF recurrence|31
1130138|NCT01534962|3711523|P3|Overall Study|Discontinued at AF recurrence|24
1130139|NCT01534962|3711524|P2|Overall Study|Discontinued at AF recurrence|26
1130140|NCT01534962|3711525|P1|Overall Study|Discontinued at AF recurrence|35
1130141|NCT01534962|3711522|P4|Overall Study|Randomized but did not start treatment|1
1130142|NCT01534962|3711523|P3|Overall Study|Randomized but did not start treatment|0
1130143|NCT01534962|3711524|P2|Overall Study|Randomized but did not start treatment|0
1130144|NCT01534962|3711525|P1|Overall Study|Randomized but did not start treatment|2
1130145|NCT01534676|3711582|P2|Overall Study|Study closed due to poor enrollment|1
1130146|NCT01534676|3711583|P1|Overall Study|Study closed due to poor enrollment|2
1130147|NCT01534637|3711589|P1|Overall Study|Liver Mets before treatment|1
1130148|NCT01534637|3711589|P1|Overall Study|Adverse Event|1
1130149|NCT01534637|3711589|P1|Overall Study|Withdrawal by Subject|1
1130150|NCT01534637|3711589|P1|Overall Study|Lack of Efficacy|3
1130151|NCT01534637|3711589|P1|Overall Study|Physician Decision|3
1130152|NCT01534533|3711599|P4|Overall Study|Withdrawal by Subject|1
1130153|NCT01534533|3711600|P3|Overall Study|Withdrawal by Subject|4
1130154|NCT01534533|3711601|P2|Overall Study|Withdrawal by Subject|3
1130155|NCT01534533|3711602|P1|Overall Study|Withdrawal by Subject|5
1130156|NCT01534533|3711599|P4|Overall Study|Lost to Follow-up|3
1130157|NCT01534533|3711600|P3|Overall Study|Lost to Follow-up|4
1130158|NCT01534533|3711601|P2|Overall Study|Lost to Follow-up|0
1130159|NCT01534533|3711602|P1|Overall Study|Lost to Follow-up|3
1130160|NCT01534520|3711630|P2|Overall Study|Adverse Event|1
1130161|NCT01534520|3711631|P1|Overall Study|Adverse Event|0
1130162|NCT01534351|3711665|P3|Overall Study|Study Terminated Early|0
1130163|NCT01534351|3711666|P2|Overall Study|Study Terminated Early|0
1130164|NCT01534351|3711667|P1|Overall Study|Study Terminated Early|1
1130165|NCT01534260|3711686|P2|Overall Study|No treatment, per protocol|1
1130166|NCT01534260|3711687|P1|Overall Study|No treatment, per protocol|0
1130167|NCT01534260|3711686|P2|Overall Study|Physician Decision|1
1130168|NCT01534260|3711687|P1|Overall Study|Physician Decision|3
1130169|NCT01534260|3711686|P2|Overall Study|Disease Progression|6
1130170|NCT01534260|3711687|P1|Overall Study|Disease Progression|8
1130171|NCT01534260|3711686|P2|Overall Study|Withdrawal by Subject|3
1130172|NCT01534260|3711687|P1|Overall Study|Withdrawal by Subject|1
1130173|NCT01534260|3711686|P2|Overall Study|Lack of Efficacy|1
1130174|NCT01534260|3711687|P1|Overall Study|Lack of Efficacy|1
1130175|NCT01534260|3711686|P2|Overall Study|Death|0
1130176|NCT01534260|3711687|P1|Overall Study|Death|2
1130177|NCT01534260|3711686|P2|Overall Study|Adverse Event|8
1130178|NCT01534260|3711687|P1|Overall Study|Adverse Event|1
1130179|NCT01534208|3711697|P2|Overall Study|Needed prohibited meds|0
1130180|NCT01534208|3711698|P1|Overall Study|Needed prohibited meds|1
1130181|NCT01534208|3711697|P2|Overall Study|PCP decision|0
1130182|NCT01534208|3711698|P1|Overall Study|PCP decision|1
1130183|NCT01534208|3711697|P2|Overall Study|Eligibility error|0
1130184|NCT01534208|3711698|P1|Overall Study|Eligibility error|3
1130185|NCT01534208|3711697|P2|Overall Study|Lab assessment|1
1130186|NCT01534208|3711698|P1|Overall Study|Lab assessment|2
1130187|NCT01534208|3711697|P2|Overall Study|Subject relocation|0
1130188|NCT01534208|3711698|P1|Overall Study|Subject relocation|2
1130189|NCT01534208|3711697|P2|Overall Study|Sponsor decision|1
1130190|NCT01534208|3711698|P1|Overall Study|Sponsor decision|4
1130191|NCT01534208|3711697|P2|Overall Study|Protocol Violation|2
1130192|NCT01534208|3711698|P1|Overall Study|Protocol Violation|2
1130193|NCT01534208|3711697|P2|Overall Study|Lack of Efficacy|3
1130194|NCT01534208|3711698|P1|Overall Study|Lack of Efficacy|0
1130195|NCT01534208|3711697|P2|Overall Study|Physician Decision|0
1130196|NCT01534208|3711698|P1|Overall Study|Physician Decision|2
1130197|NCT01534208|3711697|P2|Overall Study|Adverse Event|8
1130198|NCT01534208|3711698|P1|Overall Study|Adverse Event|15
1130199|NCT01534208|3711697|P2|Overall Study|Withdrawal by Subject|20
1130200|NCT01534208|3711698|P1|Overall Study|Withdrawal by Subject|6
1130201|NCT01534208|3711697|P2|Overall Study|Lost to Follow-up|14
1130202|NCT01534208|3711698|P1|Overall Study|Lost to Follow-up|19
1130203|NCT01534182|3711716|P2|Overall Study|Adverse Event|3
1130204|NCT01534182|3711717|P1|Overall Study|Adverse Event|7
1130205|NCT01534182|3711716|P2|Overall Study|Withdrawal by Subject|7
1130206|NCT01534182|3711717|P1|Overall Study|Withdrawal by Subject|4
1130207|NCT01534182|3711716|P2|Overall Study|Administrative problems|0
1130208|NCT01534182|3711717|P1|Overall Study|Administrative problems|1
1130209|NCT01534078|3711748|P1|Overall Study|Withdrawal by Subject|1
1130210|NCT01534078|3711748|P1|Overall Study|Death|1
1130211|NCT01533935|3711776|P5|Overall Study|Other reason not defined above|1
1130212|NCT01533935|3711777|P4|Overall Study|Other reason not defined above|0
1130213|NCT01533935|3711778|P3|Overall Study|Other reason not defined above|1
1130214|NCT01533935|3711779|P2|Overall Study|Other reason not defined above|0
1130215|NCT01533935|3711780|P1|Overall Study|Other reason not defined above|1
1130216|NCT01533935|3711776|P5|Overall Study|Withdrawal by Subject|4
1130217|NCT01533935|3711777|P4|Overall Study|Withdrawal by Subject|2
1130218|NCT01533935|3711778|P3|Overall Study|Withdrawal by Subject|5
1130219|NCT01533935|3711779|P2|Overall Study|Withdrawal by Subject|4
1130220|NCT01533935|3711780|P1|Overall Study|Withdrawal by Subject|0
1130221|NCT01533935|3711776|P5|Overall Study|Lost to Follow-up|0
1130222|NCT01533935|3711777|P4|Overall Study|Lost to Follow-up|0
1130223|NCT01533935|3711778|P3|Overall Study|Lost to Follow-up|1
1130224|NCT01533935|3711779|P2|Overall Study|Lost to Follow-up|0
1130225|NCT01533935|3711780|P1|Overall Study|Lost to Follow-up|0
1130226|NCT01533935|3711776|P5|Overall Study|Protocol Violation|0
1130227|NCT01533935|3711777|P4|Overall Study|Protocol Violation|0
1130228|NCT01533935|3711778|P3|Overall Study|Protocol Violation|0
1130229|NCT01533935|3711779|P2|Overall Study|Protocol Violation|2
1130230|NCT01533935|3711780|P1|Overall Study|Protocol Violation|0
1130231|NCT01533935|3711776|P5|Overall Study|Adverse Event|3
1130232|NCT01533935|3711777|P4|Overall Study|Adverse Event|5
1130233|NCT01533935|3711778|P3|Overall Study|Adverse Event|1
1130234|NCT01533935|3711779|P2|Overall Study|Adverse Event|7
1130235|NCT01533935|3711780|P1|Overall Study|Adverse Event|5
1130236|NCT01533922|3711807|P5|Overall Study|Other reason not defined above|0
1130237|NCT01533922|3711808|P4|Overall Study|Other reason not defined above|0
1130238|NCT01533922|3711809|P3|Overall Study|Other reason not defined above|1
1130239|NCT01533922|3711810|P2|Overall Study|Other reason not defined above|0
1130240|NCT01533922|3711811|P1|Overall Study|Other reason not defined above|2
1130241|NCT01533922|3711807|P5|Overall Study|Withdrawal by Subject|1
1130242|NCT01533922|3711808|P4|Overall Study|Withdrawal by Subject|2
1130243|NCT01533922|3711809|P3|Overall Study|Withdrawal by Subject|2
1130244|NCT01533922|3711810|P2|Overall Study|Withdrawal by Subject|1
1130245|NCT01533922|3711811|P1|Overall Study|Withdrawal by Subject|3
1130246|NCT01533922|3711807|P5|Overall Study|Protocol Violation|1
1130247|NCT01533922|3711808|P4|Overall Study|Protocol Violation|0
1130248|NCT01533922|3711809|P3|Overall Study|Protocol Violation|0
1130249|NCT01533922|3711810|P2|Overall Study|Protocol Violation|3
1130250|NCT01533922|3711811|P1|Overall Study|Protocol Violation|0
1130251|NCT01533922|3711807|P5|Overall Study|Lack of Efficacy|0
1130252|NCT01533922|3711808|P4|Overall Study|Lack of Efficacy|0
1130253|NCT01533922|3711809|P3|Overall Study|Lack of Efficacy|1
1130254|NCT01533922|3711810|P2|Overall Study|Lack of Efficacy|0
1130255|NCT01533922|3711811|P1|Overall Study|Lack of Efficacy|0
1130256|NCT01533922|3711807|P5|Overall Study|Adverse Event|4
1130257|NCT01533922|3711808|P4|Overall Study|Adverse Event|3
1130258|NCT01533922|3711809|P3|Overall Study|Adverse Event|6
1130259|NCT01533922|3711810|P2|Overall Study|Adverse Event|8
1130260|NCT01533922|3711811|P1|Overall Study|Adverse Event|5
1130261|NCT01533688|3711856|P3|Overall Study|Had colonoscopy at outside hospital|2
1130262|NCT01533688|3711857|P2|Overall Study|Had colonoscopy at outside hospital|3
1130263|NCT01533688|3711858|P1|Overall Study|Had colonoscopy at outside hospital|2
1130264|NCT01533688|3711856|P3|Overall Study|Medically unstable|3
1130265|NCT01533688|3711857|P2|Overall Study|Medically unstable|3
1130266|NCT01533688|3711858|P1|Overall Study|Medically unstable|1
1130267|NCT01533688|3711856|P3|Overall Study|Withdrawal by Subject|3
1130268|NCT01533688|3711857|P2|Overall Study|Withdrawal by Subject|4
1130269|NCT01533688|3711858|P1|Overall Study|Withdrawal by Subject|5
1130270|NCT01533493|3711890|P2|Overall Study|Lost to Follow-up|0
1130271|NCT01533493|3711891|P1|Overall Study|Lost to Follow-up|2
1130272|NCT01533493|3711890|P2|Overall Study|Withdrawal by Subject|2
1130273|NCT01533493|3711891|P1|Overall Study|Withdrawal by Subject|1
1130274|NCT01533493|3711890|P2|Overall Study|Adverse Event|1
1130275|NCT01533493|3711891|P1|Overall Study|Adverse Event|2
1130276|NCT01533428|3711899|P2|Overall Study|Withdrawal by Subject|6
1130277|NCT01533428|3711900|P1|Overall Study|Withdrawal by Subject|7
1130278|NCT01533428|3711899|P2|Overall Study|Lost to Follow-up|1
1130279|NCT01533428|3711900|P1|Overall Study|Lost to Follow-up|2
1130280|NCT01533428|3711899|P2|Overall Study|Adverse Event|1
1130281|NCT01533428|3711900|P1|Overall Study|Adverse Event|0
1130282|NCT01533246|3711946|P1|Overall Study|Withdrawal by Subject|1
1130283|NCT01533246|3711946|P1|Overall Study|Adverse Event|1
1130284|NCT01533181|3711957|P2|Overall Study|Patient withdrawal pre-active treatment|0
1130285|NCT01533181|3711958|P1|Overall Study|Patient withdrawal pre-active treatment|1
1130286|NCT01533181|3711957|P2|Overall Study|Disease progression pre-active treatment|1
1130287|NCT01533181|3711958|P1|Overall Study|Disease progression pre-active treatment|0
1130288|NCT01532999|3712075|P2|Overall Study|New job|2
1130289|NCT01532999|3712076|P1|Overall Study|New job|0
1130290|NCT01532999|3712075|P2|Overall Study|incarcerated|1
1130291|NCT01532999|3712076|P1|Overall Study|incarcerated|0
1130292|NCT01532999|3712075|P2|Overall Study|Adverse Event|1
1130293|NCT01532999|3712076|P1|Overall Study|Adverse Event|0
1130294|NCT01532999|3712075|P2|Overall Study|no show for week 9 assessments|4
1130295|NCT01532999|3712076|P1|Overall Study|no show for week 9 assessments|6
1130296|NCT01532999|3712075|P2|Overall Study|substantial noncompliance|0
1130297|NCT01532999|3712076|P1|Overall Study|substantial noncompliance|2
1130298|NCT01532999|3712075|P2|Overall Study|should not have been randomized|0
1130299|NCT01532999|3712076|P1|Overall Study|should not have been randomized|1
1130300|NCT01532999|3712075|P2|Overall Study|Relocated|0
1130301|NCT01532999|3712076|P1|Overall Study|Relocated|2
1130302|NCT01532999|3712075|P2|Overall Study|Withdrawal by Subject|0
1130303|NCT01532999|3712076|P1|Overall Study|Withdrawal by Subject|5
1130304|NCT01532999|3712075|P2|Overall Study|Physician Decision|2
1130305|NCT01532999|3712076|P1|Overall Study|Physician Decision|1
1130306|NCT01532999|3712075|P2|Overall Study|Lost to Follow-up|8
1130307|NCT01532999|3712076|P1|Overall Study|Lost to Follow-up|14
1130308|NCT01532934|3712158|P2|Overall Study|In controlled environment|2
1130309|NCT01532934|3712159|P1|Overall Study|In controlled environment|3
1130310|NCT01532934|3712158|P2|Overall Study|Lost to Follow-up|11
1130311|NCT01532934|3712159|P1|Overall Study|Lost to Follow-up|11
1130312|NCT01532921|3712169|P1|Overall Study|Device was explanted during procedure|1
1130313|NCT01532921|3712169|P1|Overall Study|Physician Decision|7
1130314|NCT01532921|3712169|P1|Overall Study|Lost to Follow-up|3
1130315|NCT01532921|3712169|P1|Overall Study|Withdrawal by Subject|2
1130316|NCT01532921|3712169|P1|Overall Study|Death|3
1130317|NCT01532869|3712191|P2|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
1130318|NCT01532869|3712192|P1|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
1130319|NCT01532869|3712191|P2|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
1130320|NCT01532869|3712192|P1|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
1130321|NCT01532869|3712191|P2|Open-label Period (Week 48 to Week 96)|Non-compliance|0
1130322|NCT01532869|3712192|P1|Open-label Period (Week 48 to Week 96)|Non-compliance|1
1130323|NCT01532869|3712191|P2|Open-label Period (Week 48 to Week 96)|Adverse Event|1
1130324|NCT01532869|3712192|P1|Open-label Period (Week 48 to Week 96)|Adverse Event|4
1130325|NCT01532869|3712191|P2|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0
1130326|NCT01532869|3712192|P1|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1
1130327|NCT01532869|3712191|P2|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3
1130328|NCT01532869|3712192|P1|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5
1130329|NCT01532869|3712191|P2|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1
1130330|NCT01532869|3712192|P1|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0
1130331|NCT01532869|3712191|P2|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0
1130332|NCT01532869|3712192|P1|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1
1130333|NCT01532869|3712191|P2|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1
1130334|NCT01532869|3712192|P1|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0
1130335|NCT01532869|3712191|P2|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5
1130336|NCT01532869|3712192|P1|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4
1130337|NCT01532869|3712191|P2|Blinded-Treatment Period (Up to Week 48)|Death|3
1130338|NCT01532869|3712192|P1|Blinded-Treatment Period (Up to Week 48)|Death|0
1130339|NCT01532869|3712191|P2|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2
1130340|NCT01532869|3712192|P1|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4
1130341|NCT01532869|3712191|P2|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
1130342|NCT01532869|3712192|P1|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
1130343|NCT01532869|3712191|P2|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0
1130344|NCT01532869|3712192|P1|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1
1130345|NCT01532869|3712191|P2|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1
1130346|NCT01532869|3712192|P1|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0
1130347|NCT01532869|3712191|P2|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3
1130348|NCT01532869|3712192|P1|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2
1130349|NCT01532869|3712191|P2|Blinded-Treatment Period (Up to Week 24)|Death|1
1130350|NCT01532869|3712192|P1|Blinded-Treatment Period (Up to Week 24)|Death|0
1130351|NCT01532570|3712258|P4|Overall Study|Withdrawal by Subject|0
1130352|NCT01532570|3712259|P3|Overall Study|Withdrawal by Subject|0
1130353|NCT01532570|3712260|P2|Overall Study|Withdrawal by Subject|1
1130354|NCT01532570|3712261|P1|Overall Study|Withdrawal by Subject|0
1130355|NCT01532570|3712258|P4|Overall Study|Lack of Efficacy|0
1130356|NCT01532570|3712259|P3|Overall Study|Lack of Efficacy|0
1130357|NCT01532570|3712260|P2|Overall Study|Lack of Efficacy|0
1130358|NCT01532570|3712261|P1|Overall Study|Lack of Efficacy|1
1130359|NCT01532414|3712306|P3|Overall Study|Withdrawn by sponsor|0
1130360|NCT01532414|3712307|P2|Overall Study|Withdrawn by sponsor|0
1130361|NCT01532414|3712308|P1|Overall Study|Withdrawn by sponsor|1
1130362|NCT01532414|3712306|P3|Overall Study|Unable to complete 24 hour PK|1
1130363|NCT01532414|3712307|P2|Overall Study|Unable to complete 24 hour PK|0
1130364|NCT01532414|3712308|P1|Overall Study|Unable to complete 24 hour PK|0
1130365|NCT01532414|3712306|P3|Overall Study|Adverse Event|1
1130366|NCT01532414|3712307|P2|Overall Study|Adverse Event|1
1130367|NCT01532414|3712308|P1|Overall Study|Adverse Event|0
1130368|NCT01532414|3712306|P3|Overall Study|No V6 semen sample|0
1130369|NCT01532414|3712307|P2|Overall Study|No V6 semen sample|1
1130370|NCT01532414|3712308|P1|Overall Study|No V6 semen sample|0
1130371|NCT01532414|3712306|P3|Overall Study|Withdrawal by Subject|0
1130372|NCT01532414|3712307|P2|Overall Study|Withdrawal by Subject|0
1130373|NCT01532414|3712308|P1|Overall Study|Withdrawal by Subject|3
1130374|NCT01532414|3712306|P3|Overall Study|Lost to Follow-up|1
1130375|NCT01532414|3712307|P2|Overall Study|Lost to Follow-up|0
1130376|NCT01532414|3712308|P1|Overall Study|Lost to Follow-up|3
1130377|NCT01531998|3712374|P1|Overall Study|Withdrawal by Subject|3
1130378|NCT01531725|3712379|P1|Overall Study|Protocol Violation|5
1130379|NCT01531673|3712397|P13|Overall Study|Other|0
1130380|NCT01531673|3712398|P12|Overall Study|Other|0
1130381|NCT01531673|3712399|P11|Overall Study|Other|0
1130382|NCT01531673|3712400|P10|Overall Study|Other|1
1130383|NCT01531673|3712401|P9|Overall Study|Other|0
1130384|NCT01531673|3712402|P8|Overall Study|Other|0
1130385|NCT01531673|3712403|P7|Overall Study|Other|0
1130386|NCT01531673|3712404|P6|Overall Study|Other|0
1130387|NCT01531673|3712405|P5|Overall Study|Other|0
1130388|NCT01531673|3712406|P4|Overall Study|Other|1
1130389|NCT01531673|3712407|P3|Overall Study|Other|0
1130390|NCT01531673|3712408|P2|Overall Study|Other|0
1130391|NCT01531673|3712409|P1|Overall Study|Other|0
1130392|NCT01531673|3712397|P13|Overall Study|Lost to Follow-up|0
1130393|NCT01531673|3712398|P12|Overall Study|Lost to Follow-up|0
1130394|NCT01531673|3712399|P11|Overall Study|Lost to Follow-up|0
1130395|NCT01531673|3712400|P10|Overall Study|Lost to Follow-up|0
1130396|NCT01531673|3712401|P9|Overall Study|Lost to Follow-up|0
1130397|NCT01531673|3712402|P8|Overall Study|Lost to Follow-up|0
1130398|NCT01531673|3712403|P7|Overall Study|Lost to Follow-up|0
1130399|NCT01531673|3712404|P6|Overall Study|Lost to Follow-up|0
1130400|NCT01531673|3712405|P5|Overall Study|Lost to Follow-up|1
1130401|NCT01531673|3712406|P4|Overall Study|Lost to Follow-up|0
1130402|NCT01531673|3712407|P3|Overall Study|Lost to Follow-up|0
1130403|NCT01531673|3712408|P2|Overall Study|Lost to Follow-up|0
1130404|NCT01531673|3712409|P1|Overall Study|Lost to Follow-up|0
1130405|NCT01531673|3712397|P13|Overall Study|Adverse Event|0
1130406|NCT01531673|3712398|P12|Overall Study|Adverse Event|0
1130407|NCT01531673|3712399|P11|Overall Study|Adverse Event|0
1130408|NCT01531673|3712400|P10|Overall Study|Adverse Event|0
1130409|NCT01531673|3712401|P9|Overall Study|Adverse Event|0
1130410|NCT01531673|3712402|P8|Overall Study|Adverse Event|0
1130411|NCT01531673|3712403|P7|Overall Study|Adverse Event|0
1130412|NCT01531673|3712404|P6|Overall Study|Adverse Event|0
1130413|NCT01531673|3712405|P5|Overall Study|Adverse Event|0
1130414|NCT01531673|3712406|P4|Overall Study|Adverse Event|0
1130415|NCT01531673|3712407|P3|Overall Study|Adverse Event|0
1130416|NCT01531673|3712408|P2|Overall Study|Adverse Event|1
1130417|NCT01531673|3712409|P1|Overall Study|Adverse Event|0
1130418|NCT01531673|3712397|P13|Overall Study|Non-Compliance|0
1130419|NCT01531673|3712398|P12|Overall Study|Non-Compliance|0
1130420|NCT01531673|3712399|P11|Overall Study|Non-Compliance|0
1130421|NCT01531673|3712400|P10|Overall Study|Non-Compliance|0
1130422|NCT01531673|3712401|P9|Overall Study|Non-Compliance|0
1130423|NCT01531673|3712402|P8|Overall Study|Non-Compliance|0
1130424|NCT01531673|3712403|P7|Overall Study|Non-Compliance|0
1130425|NCT01531673|3712404|P6|Overall Study|Non-Compliance|1
1130426|NCT01531673|3712405|P5|Overall Study|Non-Compliance|0
1130427|NCT01531673|3712406|P4|Overall Study|Non-Compliance|0
1130428|NCT01531673|3712407|P3|Overall Study|Non-Compliance|0
1130429|NCT01531673|3712408|P2|Overall Study|Non-Compliance|0
1130430|NCT01531673|3712409|P1|Overall Study|Non-Compliance|0
1130431|NCT01531387|3712520|P2|Overall Study|Early termination of study|11
1130432|NCT01531387|3712521|P1|Overall Study|Early termination of study|11
1130433|NCT01531205|3712613|P1|Overall Study|Did not proceed to surgery|1
1130434|NCT01531153|3712625|P3|Overall Study|Withdrawal by Subject|15
1130435|NCT01531153|3712626|P2|Overall Study|Withdrawal by Subject|9
1130436|NCT01531153|3712627|P1|Overall Study|Withdrawal by Subject|10
1130437|NCT01530997|3712683|P1|Overall Study|Withdrawal by Subject|1
1130438|NCT01530997|3712683|P1|Overall Study|Physician Decision|1
1130439|NCT01530464|3712727|P2|Washout (24h)|Withdrawal by Subject|1
1130440|NCT01530464|3712728|P1|Washout (24h)|Withdrawal by Subject|0
1130441|NCT01530464|3712727|P2|Washout (24h)|Withdrawal by Subject|0
1130442|NCT01530464|3712728|P1|Washout (24h)|Withdrawal by Subject|1
1130443|NCT01530334|3712780|P1|Overall Study|Progressive disease|47
1130444|NCT01530334|3712780|P1|Overall Study|unknown reason|1
1130445|NCT01530334|3712780|P1|Overall Study|Adverse Event|3
1130446|NCT01530087|3712827|P1|Overall Study|Physician Decision|2
1130447|NCT01529645|3712849|P10|Overall Study|Withdrawal by Subject|0
1130448|NCT01529645|3712850|P9|Overall Study|Withdrawal by Subject|0
1130449|NCT01529645|3712851|P8|Overall Study|Withdrawal by Subject|0
1130450|NCT01529645|3712852|P7|Overall Study|Withdrawal by Subject|0
1130451|NCT01529645|3712853|P6|Overall Study|Withdrawal by Subject|1
1130452|NCT01529645|3712854|P5|Overall Study|Withdrawal by Subject|1
1130453|NCT01529645|3712855|P4|Overall Study|Withdrawal by Subject|1
1130454|NCT01529645|3712856|P3|Overall Study|Withdrawal by Subject|0
1130455|NCT01529645|3712857|P2|Overall Study|Withdrawal by Subject|0
1130456|NCT01529645|3712858|P1|Overall Study|Withdrawal by Subject|2
1130457|NCT01529645|3712849|P10|Overall Study|SAE - Premature contractions|0
1130458|NCT01529645|3712850|P9|Overall Study|SAE - Premature contractions|0
1130459|NCT01529645|3712851|P8|Overall Study|SAE - Premature contractions|0
1130460|NCT01529645|3712852|P7|Overall Study|SAE - Premature contractions|0
1130461|NCT01529645|3712853|P6|Overall Study|SAE - Premature contractions|0
1130462|NCT01529645|3712854|P5|Overall Study|SAE - Premature contractions|0
1130463|NCT01529645|3712855|P4|Overall Study|SAE - Premature contractions|0
1130464|NCT01529645|3712856|P3|Overall Study|SAE - Premature contractions|1
1130465|NCT01529645|3712857|P2|Overall Study|SAE - Premature contractions|0
1130466|NCT01529645|3712858|P1|Overall Study|SAE - Premature contractions|0
1130467|NCT01529645|3712849|P10|Overall Study|Lost to Follow-up|0
1130468|NCT01529645|3712850|P9|Overall Study|Lost to Follow-up|1
1130469|NCT01529645|3712851|P8|Overall Study|Lost to Follow-up|0
1130470|NCT01529645|3712852|P7|Overall Study|Lost to Follow-up|2
1130471|NCT01529645|3712853|P6|Overall Study|Lost to Follow-up|0
1130472|NCT01529645|3712854|P5|Overall Study|Lost to Follow-up|1
1130473|NCT01529645|3712855|P4|Overall Study|Lost to Follow-up|1
1130474|NCT01529645|3712856|P3|Overall Study|Lost to Follow-up|1
1130475|NCT01529645|3712857|P2|Overall Study|Lost to Follow-up|1
1130476|NCT01529645|3712858|P1|Overall Study|Lost to Follow-up|0
1130477|NCT01529632|3712956|P2|Overall Study|Adverse Event|1
1130478|NCT01529632|3712957|P1|Overall Study|Adverse Event|1
1130479|NCT01529632|3712956|P2|Overall Study|Protocol Violation|1
1130480|NCT01529632|3712957|P1|Overall Study|Protocol Violation|0
1130481|NCT01529632|3712956|P2|Overall Study|Administrative problem|1
1130482|NCT01529632|3712957|P1|Overall Study|Administrative problem|2
1130483|NCT01529515|3712977|P4|DOUBLE BLIND PHASE|Other|2
1130484|NCT01529515|3712978|P3|DOUBLE BLIND PHASE|Other|9
1130485|NCT01529515|3712979|P2|DOUBLE BLIND PHASE|Other|0
1130486|NCT01529515|3712980|P1|DOUBLE BLIND PHASE|Other|0
1130487|NCT01529515|3712977|P4|DOUBLE BLIND PHASE|Protocol Violation|0
1130488|NCT01529515|3712978|P3|DOUBLE BLIND PHASE|Protocol Violation|1
1130489|NCT01529515|3712979|P2|DOUBLE BLIND PHASE|Protocol Violation|0
1130490|NCT01529515|3712980|P1|DOUBLE BLIND PHASE|Protocol Violation|0
1130491|NCT01529515|3712977|P4|DOUBLE BLIND PHASE|Withdrawal by Subject|7
1130492|NCT01529515|3712978|P3|DOUBLE BLIND PHASE|Withdrawal by Subject|10
1130493|NCT01529515|3712979|P2|DOUBLE BLIND PHASE|Withdrawal by Subject|0
1130494|NCT01529515|3712980|P1|DOUBLE BLIND PHASE|Withdrawal by Subject|0
1130495|NCT01529515|3712977|P4|DOUBLE BLIND PHASE|Pregnancy|0
1130496|NCT01529515|3712978|P3|DOUBLE BLIND PHASE|Pregnancy|1
1130497|NCT01529515|3712979|P2|DOUBLE BLIND PHASE|Pregnancy|0
1130498|NCT01529515|3712980|P1|DOUBLE BLIND PHASE|Pregnancy|0
1130499|NCT01529515|3712977|P4|DOUBLE BLIND PHASE|Lost to Follow-up|3
1130500|NCT01529515|3712978|P3|DOUBLE BLIND PHASE|Lost to Follow-up|1
1130501|NCT01529515|3712979|P2|DOUBLE BLIND PHASE|Lost to Follow-up|0
1130502|NCT01529515|3712980|P1|DOUBLE BLIND PHASE|Lost to Follow-up|0
1130503|NCT01529515|3712977|P4|DOUBLE BLIND PHASE|Adverse Event|0
1130504|NCT01529515|3712978|P3|DOUBLE BLIND PHASE|Adverse Event|1
1130505|NCT01529515|3712979|P2|DOUBLE BLIND PHASE|Adverse Event|0
1130506|NCT01529515|3712980|P1|DOUBLE BLIND PHASE|Adverse Event|0
1130507|NCT01529515|3712977|P4|MAINTENANCE PHASE|Other|0
1130508|NCT01529515|3712978|P3|MAINTENANCE PHASE|Other|0
1130509|NCT01529515|3712979|P2|MAINTENANCE PHASE|Other|10
1130510|NCT01529515|3712980|P1|MAINTENANCE PHASE|Other|0
1130511|NCT01529515|3712977|P4|MAINTENANCE PHASE|Failed Randomization Criteria|0
1130512|NCT01529515|3712978|P3|MAINTENANCE PHASE|Failed Randomization Criteria|0
1130513|NCT01529515|3712979|P2|MAINTENANCE PHASE|Failed Randomization Criteria|13
1130514|NCT01529515|3712980|P1|MAINTENANCE PHASE|Failed Randomization Criteria|0
1130515|NCT01529515|3712977|P4|MAINTENANCE PHASE|Withdrawal by Subject|0
1130516|NCT01529515|3712978|P3|MAINTENANCE PHASE|Withdrawal by Subject|0
1130517|NCT01529515|3712979|P2|MAINTENANCE PHASE|Withdrawal by Subject|15
1130518|NCT01529515|3712980|P1|MAINTENANCE PHASE|Withdrawal by Subject|0
1130519|NCT01529515|3712977|P4|MAINTENANCE PHASE|Protocol Violation|0
1130520|NCT01529515|3712978|P3|MAINTENANCE PHASE|Protocol Violation|0
1130521|NCT01529515|3712979|P2|MAINTENANCE PHASE|Protocol Violation|12
1130522|NCT01529515|3712980|P1|MAINTENANCE PHASE|Protocol Violation|0
1130523|NCT01529515|3712977|P4|MAINTENANCE PHASE|Lost to Follow-up|0
1130524|NCT01529515|3712978|P3|MAINTENANCE PHASE|Lost to Follow-up|0
1130525|NCT01529515|3712979|P2|MAINTENANCE PHASE|Lost to Follow-up|5
1130526|NCT01529515|3712980|P1|MAINTENANCE PHASE|Lost to Follow-up|0
1130527|NCT01529515|3712977|P4|MAINTENANCE PHASE|Lack of Efficacy|0
1130528|NCT01529515|3712978|P3|MAINTENANCE PHASE|Lack of Efficacy|0
1130529|NCT01529515|3712979|P2|MAINTENANCE PHASE|Lack of Efficacy|9
1130530|NCT01529515|3712980|P1|MAINTENANCE PHASE|Lack of Efficacy|0
1130531|NCT01529515|3712977|P4|MAINTENANCE PHASE|Adverse Event|0
1130532|NCT01529515|3712978|P3|MAINTENANCE PHASE|Adverse Event|0
1130533|NCT01529515|3712979|P2|MAINTENANCE PHASE|Adverse Event|10
1130534|NCT01529515|3712980|P1|MAINTENANCE PHASE|Adverse Event|0
1130535|NCT01529515|3712977|P4|TRANSITION PHASE|Other|0
1130536|NCT01529515|3712978|P3|TRANSITION PHASE|Other|0
1130537|NCT01529515|3712979|P2|TRANSITION PHASE|Other|0
1130538|NCT01529515|3712980|P1|TRANSITION PHASE|Other|9
1130539|NCT01529515|3712977|P4|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
1130540|NCT01529515|3712978|P3|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
1130541|NCT01529515|3712979|P2|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
1130542|NCT01529515|3712980|P1|TRANSITION PHASE|Failed Maintenance Phase Criteria|8
1130543|NCT01529515|3712977|P4|TRANSITION PHASE|Withdrawal by Subject|0
1130544|NCT01529515|3712978|P3|TRANSITION PHASE|Withdrawal by Subject|0
1130545|NCT01529515|3712979|P2|TRANSITION PHASE|Withdrawal by Subject|0
1130546|NCT01529515|3712980|P1|TRANSITION PHASE|Withdrawal by Subject|51
1130547|NCT01529515|3712977|P4|TRANSITION PHASE|Protocol Violation|0
1130548|NCT01529515|3712978|P3|TRANSITION PHASE|Protocol Violation|0
1130549|NCT01529515|3712979|P2|TRANSITION PHASE|Protocol Violation|0
1130550|NCT01529515|3712980|P1|TRANSITION PHASE|Protocol Violation|4
1130551|NCT01529515|3712977|P4|TRANSITION PHASE|Lost to Follow-up|0
1130552|NCT01529515|3712978|P3|TRANSITION PHASE|Lost to Follow-up|0
1130553|NCT01529515|3712979|P2|TRANSITION PHASE|Lost to Follow-up|0
1130554|NCT01529515|3712980|P1|TRANSITION PHASE|Lost to Follow-up|19
1130555|NCT01529515|3712977|P4|TRANSITION PHASE|Lack of Efficacy|0
1130556|NCT01529515|3712978|P3|TRANSITION PHASE|Lack of Efficacy|0
1130557|NCT01529515|3712979|P2|TRANSITION PHASE|Lack of Efficacy|0
1130558|NCT01529515|3712980|P1|TRANSITION PHASE|Lack of Efficacy|19
1130559|NCT01529515|3712977|P4|TRANSITION PHASE|Death|0
1130560|NCT01529515|3712978|P3|TRANSITION PHASE|Death|0
1130561|NCT01529515|3712979|P2|TRANSITION PHASE|Death|0
1130562|NCT01529515|3712980|P1|TRANSITION PHASE|Death|1
1130563|NCT01529515|3712977|P4|TRANSITION PHASE|Adverse Event|0
1130564|NCT01529515|3712978|P3|TRANSITION PHASE|Adverse Event|0
1130565|NCT01529515|3712979|P2|TRANSITION PHASE|Adverse Event|0
1130566|NCT01529515|3712980|P1|TRANSITION PHASE|Adverse Event|16
1130567|NCT01529385|3713027|P2|Overall Study|Lost to Follow-up|1
1130568|NCT01529385|3713028|P1|Overall Study|Lost to Follow-up|2
1130569|NCT01529346|3713057|P5|Overall Study|Other|0
1130570|NCT01529346|3713058|P4|Overall Study|Other|0
1130571|NCT01529346|3713059|P3|Overall Study|Other|1
1130572|NCT01529346|3713060|P2|Overall Study|Other|1
1130573|NCT01529346|3713061|P1|Overall Study|Other|0
1130574|NCT01529346|3713057|P5|Overall Study|Lost to Follow-up|0
1130575|NCT01529346|3713058|P4|Overall Study|Lost to Follow-up|0
1130576|NCT01529346|3713059|P3|Overall Study|Lost to Follow-up|1
1130577|NCT01529346|3713060|P2|Overall Study|Lost to Follow-up|0
1130578|NCT01529346|3713061|P1|Overall Study|Lost to Follow-up|2
1130579|NCT01529268|3713149|P2|Overall Study|Moved|0
1130580|NCT01529268|3713150|P1|Overall Study|Moved|3
1130581|NCT01529268|3713149|P2|Overall Study|Lost to Follow-up|3
1130582|NCT01529268|3713150|P1|Overall Study|Lost to Follow-up|9
1130583|NCT01529112|3713212|P2|Overall Study|Withdrawal by Subject|3
1130584|NCT01529112|3713213|P1|Overall Study|Withdrawal by Subject|7
1130585|NCT01529112|3713212|P2|Overall Study|Protocol Violation|0
1130586|NCT01529112|3713213|P1|Overall Study|Protocol Violation|1
1130587|NCT01529112|3713212|P2|Overall Study|Death|38
1130588|NCT01529112|3713213|P1|Overall Study|Death|59
1130589|NCT01529112|3713212|P2|Overall Study|Adverse Event|0
1130590|NCT01529112|3713213|P1|Overall Study|Adverse Event|2
1130591|NCT01528969|3713240|P2|Overall Study|absent from the school at baseline|0
1130592|NCT01528969|3713241|P1|Overall Study|absent from the school at baseline|2
1130593|NCT01528787|3713274|P4|Overall Study|Family Emergency|0
1130594|NCT01528787|3713275|P3|Overall Study|Family Emergency|1
1130595|NCT01528787|3713276|P2|Overall Study|Family Emergency|0
1130596|NCT01528787|3713277|P1|Overall Study|Family Emergency|0
1130597|NCT01528787|3713274|P4|Overall Study|Withdrawal by Subject|1
1130598|NCT01528787|3713275|P3|Overall Study|Withdrawal by Subject|0
1130599|NCT01528787|3713276|P2|Overall Study|Withdrawal by Subject|0
1130600|NCT01528787|3713277|P1|Overall Study|Withdrawal by Subject|0
1130601|NCT01528735|3713289|P2|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0
1130602|NCT01528735|3713290|P1|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1
1130603|NCT01528735|3713289|P2|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
1130604|NCT01528735|3713290|P1|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
1130605|NCT01528709|3713392|P2|Overall Study|allergy|0
1130606|NCT01528709|3713393|P1|Overall Study|allergy|1
1130607|NCT01528709|3713392|P2|Overall Study|Withdrawal by Subject|15
1130608|NCT01528709|3713393|P1|Overall Study|Withdrawal by Subject|10
1130609|NCT01528709|3713392|P2|Overall Study|Death|0
1130610|NCT01528709|3713393|P1|Overall Study|Death|2
1130611|NCT01528696|3713403|P2|Overall Study|See detailed description|19
1130612|NCT01528696|3713404|P1|Overall Study|See detailed description|18
1130613|NCT01528605|3713420|P6|Overall Study|Death|0
1130614|NCT01528605|3713421|P5|Overall Study|Death|0
1130615|NCT01528605|3713422|P4|Overall Study|Death|0
1130616|NCT01528605|3713423|P3|Overall Study|Death|0
1130617|NCT01528605|3713424|P2|Overall Study|Death|0
1130618|NCT01528605|3713425|P1|Overall Study|Death|1
1130619|NCT01528605|3713420|P6|Overall Study|Lost to Follow-up|0
1130620|NCT01528605|3713421|P5|Overall Study|Lost to Follow-up|0
1130621|NCT01528605|3713422|P4|Overall Study|Lost to Follow-up|1
1130622|NCT01528605|3713423|P3|Overall Study|Lost to Follow-up|1
1130623|NCT01528605|3713424|P2|Overall Study|Lost to Follow-up|0
1130624|NCT01528605|3713425|P1|Overall Study|Lost to Follow-up|1
1130625|NCT01528345|3713455|P2|Overall Study|Subject/Guardian Decision|0
1130626|NCT01528345|3713456|P1|Overall Study|Subject/Guardian Decision|5
1130627|NCT01528345|3713455|P2|Overall Study|Study Terminated by Sponsor|8
1130628|NCT01528345|3713456|P1|Overall Study|Study Terminated by Sponsor|4
1130629|NCT01528345|3713455|P2|Overall Study|Progressive Disease|40
1130630|NCT01528345|3713456|P1|Overall Study|Progressive Disease|26
1130631|NCT01528345|3713455|P2|Overall Study|Non-compliance with study treatment|0
1130632|NCT01528345|3713456|P1|Overall Study|Non-compliance with study treatment|1
1130633|NCT01528345|3713455|P2|Overall Study|Death|1
1130634|NCT01528345|3713456|P1|Overall Study|Death|1
1130635|NCT01528345|3713455|P2|Overall Study|Adverse Event|1
1130636|NCT01528345|3713456|P1|Overall Study|Adverse Event|10
1130637|NCT01527500|3713595|P2|Part B|Adverse Event|0
1130638|NCT01527500|3713596|P1|Part B|Adverse Event|1
1130639|NCT01527500|3713595|P2|Part A|Withdrawal by Subject|0
1130640|NCT01527500|3713596|P1|Part A|Withdrawal by Subject|2
1130641|NCT01527500|3713595|P2|Part A|Protocol Deviation|2
1130642|NCT01527500|3713596|P1|Part A|Protocol Deviation|9
1130643|NCT01527500|3713595|P2|Part A|Lost to Follow-up|1
1130644|NCT01527500|3713596|P1|Part A|Lost to Follow-up|0
1130645|NCT01527500|3713595|P2|Part A|Death|1
1130646|NCT01527500|3713596|P1|Part A|Death|4
1130647|NCT01527500|3713595|P2|Part A|Adverse Event|2
1130648|NCT01527500|3713596|P1|Part A|Adverse Event|4
1130649|NCT01527500|3713595|P2|Part A|Administrative|7
1130650|NCT01527500|3713596|P1|Part A|Administrative|11
1130651|NCT01527487|3713626|P2|Overall Study|Death|1
1130652|NCT01527487|3713627|P1|Overall Study|Death|0
1130653|NCT01527487|3713626|P2|Overall Study|Adverse Event|1
1130654|NCT01527487|3713627|P1|Overall Study|Adverse Event|1
1130655|NCT01527487|3713626|P2|Overall Study|Disease Progression|1
1130656|NCT01527487|3713627|P1|Overall Study|Disease Progression|4
1130657|NCT01527487|3713626|P2|Overall Study|MD Discretion/Lack of Efficacy|4
1130658|NCT01527487|3713627|P1|Overall Study|MD Discretion/Lack of Efficacy|3
1130659|NCT01527370|3713639|P1|Overall Study|Death|1
1130660|NCT01527370|3713639|P1|Overall Study|Physician Decision|1
1130661|NCT01527370|3713639|P1|Overall Study|Withdrawal by Subject|4
1130662|NCT01527110|3713656|P1|Overall Study|Adverse Event|1
1130663|NCT01527006|3713703|P2|Extension Phase|Not Specified|3
1130664|NCT01527006|3713704|P1|Extension Phase|Not Specified|0
1130665|NCT01527006|3713703|P2|Extension Phase|Inadequate therapeutic effect|1
1130666|NCT01527006|3713704|P1|Extension Phase|Inadequate therapeutic effect|1
1130667|NCT01527006|3713703|P2|Extension Phase|Subject Choice|1
1130668|NCT01527006|3713704|P1|Extension Phase|Subject Choice|1
1130669|NCT01527006|3713703|P2|Extension Phase|Lost to Follow-up|1
1130670|NCT01527006|3713704|P1|Extension Phase|Lost to Follow-up|0
1130671|NCT01527006|3713703|P2|Extension Phase|Adverse Event|2
1130672|NCT01527006|3713704|P1|Extension Phase|Adverse Event|4
1130673|NCT01527006|3713703|P2|Core Study|Not Specified|2
1130674|NCT01527006|3713704|P1|Core Study|Not Specified|0
1130675|NCT01527006|3713703|P2|Core Study|Withdrawal by Subject|1
1130676|NCT01527006|3713704|P1|Core Study|Withdrawal by Subject|0
1130677|NCT01527006|3713703|P2|Core Study|Inadequate Therapeutic Effect|0
1130678|NCT01527006|3713704|P1|Core Study|Inadequate Therapeutic Effect|1
1130679|NCT01527006|3713703|P2|Core Study|Subject Choice|0
1130680|NCT01527006|3713704|P1|Core Study|Subject Choice|1
1130681|NCT01527006|3713703|P2|Core Study|Lost to Follow-up|1
1130682|NCT01527006|3713704|P1|Core Study|Lost to Follow-up|0
1130683|NCT01527006|3713703|P2|Core Study|Adverse Event|2
1130684|NCT01527006|3713704|P1|Core Study|Adverse Event|0
1130685|NCT01526889|3713773|P2|Treatment Extension Period|Administrative problems|0
1130686|NCT01526889|3713774|P1|Treatment Extension Period|Administrative problems|1
1130687|NCT01526889|3713773|P2|Treatment Period|Adverse Event|0
1130688|NCT01526889|3713774|P1|Treatment Period|Adverse Event|2
1130689|NCT01526785|3713795|P1|Overall Study|Withdrawal by Subject|2
1130690|NCT01526785|3713795|P1|Overall Study|Physician Decision|1
1130691|NCT01526785|3713795|P1|Overall Study|Death|2
1130692|NCT01526785|3713795|P1|Overall Study|Study Terminated by Sponsor|8
1130693|NCT01526733|3713805|P2|Phase 1|Withdrawal by Subject|1
1130694|NCT01526733|3713806|P1|Phase 1|Withdrawal by Subject|1
1130695|NCT01526733|3713805|P2|Phase 1|Protocol Violation|0
1130696|NCT01526733|3713806|P1|Phase 1|Protocol Violation|1
1130697|NCT01526551|3713845|P1|Overall Study|Lack of returned parental consent form|424
1130698|NCT01526148|3713892|P2|Overall Study|Incarcerated|2
1130699|NCT01526148|3713893|P1|Overall Study|Incarcerated|0
1130700|NCT01526148|3713892|P2|Overall Study|Moved out of state|0
1130701|NCT01526148|3713893|P1|Overall Study|Moved out of state|1
1130702|NCT01526148|3713892|P2|Overall Study|Unable to discontinue concomitant med|0
1130703|NCT01526148|3713893|P1|Overall Study|Unable to discontinue concomitant med|1
1130704|NCT01526148|3713892|P2|Overall Study|Unstable Medical Condition|0
1130705|NCT01526148|3713893|P1|Overall Study|Unstable Medical Condition|1
1130706|NCT01526148|3713892|P2|Overall Study|Withdrawal by Subject|0
1130707|NCT01526148|3713893|P1|Overall Study|Withdrawal by Subject|2
1130708|NCT01526148|3713892|P2|Overall Study|Lost to Follow-up|6
1130709|NCT01526148|3713893|P1|Overall Study|Lost to Follow-up|3
1130710|NCT01526148|3713892|P2|Overall Study|Adverse Event|5
1130711|NCT01526148|3713893|P1|Overall Study|Adverse Event|6
1130712|NCT01525849|3713917|P2|Overall Study|Anatomic exclusion criteria identified|3
1130713|NCT01525849|3713918|P1|Overall Study|Anatomic exclusion criteria identified|0
1130714|NCT01525849|3713917|P2|Overall Study|Unrelated medical issue (not treated)|2
1130715|NCT01525849|3713918|P1|Overall Study|Unrelated medical issue (not treated)|1
1130716|NCT01525849|3713917|P2|Overall Study|Withdrawal by Subject|9
1130717|NCT01525849|3713918|P1|Overall Study|Withdrawal by Subject|1
1130718|NCT01525849|3713917|P2|Overall Study|Lost to Follow-up|2
1130719|NCT01525849|3713918|P1|Overall Study|Lost to Follow-up|3
1130720|NCT01525641|3713974|P1|Overall Study|Other than stated above|7
1130721|NCT01525641|3713974|P1|Overall Study|Lost to follow-up (Changing hospital)|19
1130722|NCT01525641|3713974|P1|Overall Study|Lost to follow-up (Unknown reason)|10
1130723|NCT01525641|3713974|P1|Overall Study|Lost to follow-up (relocation)|1
1130724|NCT01525641|3713974|P1|Overall Study|Improvement|5
1130725|NCT01525641|3713974|P1|Overall Study|Lack of Efficacy|24
1130726|NCT01525641|3713974|P1|Overall Study|Adverse Event|73
1130727|NCT01525641|3713974|P1|Overall Study|No visit since the first visit|16
1130728|NCT01525641|3713974|P1|Overall Study|Case report form not collected|25
1130729|NCT01525628|3713988|P5|Overall Study|Other reason not defined above|0
1130730|NCT01525628|3713989|P4|Overall Study|Other reason not defined above|3
1130731|NCT01525628|3713990|P3|Overall Study|Other reason not defined above|0
1130732|NCT01525628|3713991|P2|Overall Study|Other reason not defined above|0
1130733|NCT01525628|3713992|P1|Overall Study|Other reason not defined above|0
1130734|NCT01525628|3713988|P5|Overall Study|Withdrawal by Subject|0
1130735|NCT01525628|3713989|P4|Overall Study|Withdrawal by Subject|0
1130736|NCT01525628|3713990|P3|Overall Study|Withdrawal by Subject|0
1130737|NCT01525628|3713991|P2|Overall Study|Withdrawal by Subject|1
1130738|NCT01525628|3713992|P1|Overall Study|Withdrawal by Subject|0
1130739|NCT01525628|3713988|P5|Overall Study|Lost to Follow-up|0
1130740|NCT01525628|3713989|P4|Overall Study|Lost to Follow-up|0
1130741|NCT01525628|3713990|P3|Overall Study|Lost to Follow-up|0
1130742|NCT01525628|3713991|P2|Overall Study|Lost to Follow-up|1
1130743|NCT01525628|3713992|P1|Overall Study|Lost to Follow-up|1
1130744|NCT01525628|3713988|P5|Overall Study|Protocol Violation|0
1130745|NCT01525628|3713989|P4|Overall Study|Protocol Violation|0
1130746|NCT01525628|3713990|P3|Overall Study|Protocol Violation|1
1130747|NCT01525628|3713991|P2|Overall Study|Protocol Violation|0
1130748|NCT01525628|3713992|P1|Overall Study|Protocol Violation|0
1130749|NCT01525628|3713988|P5|Overall Study|Lack of Efficacy|2
1130750|NCT01525628|3713989|P4|Overall Study|Lack of Efficacy|1
1130751|NCT01525628|3713990|P3|Overall Study|Lack of Efficacy|2
1130752|NCT01525628|3713991|P2|Overall Study|Lack of Efficacy|2
1130753|NCT01525628|3713992|P1|Overall Study|Lack of Efficacy|0
1130754|NCT01525628|3713988|P5|Overall Study|Adverse Event|1
1130755|NCT01525628|3713989|P4|Overall Study|Adverse Event|0
1130756|NCT01525628|3713990|P3|Overall Study|Adverse Event|2
1130757|NCT01525628|3713991|P2|Overall Study|Adverse Event|1
1130758|NCT01525628|3713992|P1|Overall Study|Adverse Event|1
1130759|NCT01525615|3714059|P3|Overall Study|Other reason not described above|1
1130760|NCT01525615|3714060|P2|Overall Study|Other reason not described above|0
1130761|NCT01525615|3714061|P1|Overall Study|Other reason not described above|1
1130762|NCT01525615|3714059|P3|Overall Study|Withdrawal by Subject|0
1130763|NCT01525615|3714060|P2|Overall Study|Withdrawal by Subject|0
1130764|NCT01525615|3714061|P1|Overall Study|Withdrawal by Subject|1
1130765|NCT01525615|3714059|P3|Overall Study|Lost to Follow-up|0
1130766|NCT01525615|3714060|P2|Overall Study|Lost to Follow-up|0
1130767|NCT01525615|3714061|P1|Overall Study|Lost to Follow-up|1
1130768|NCT01525615|3714059|P3|Overall Study|Adverse Event|5
1130769|NCT01525615|3714060|P2|Overall Study|Adverse Event|7
1130770|NCT01525615|3714061|P1|Overall Study|Adverse Event|11
1130771|NCT01525550|3714117|P2|Overall Study|Ongoing|23
1130772|NCT01525550|3714118|P1|Overall Study|Ongoing|45
1130773|NCT01525550|3714117|P2|Overall Study|Other Unspecified|2
1130774|NCT01525550|3714118|P1|Overall Study|Other Unspecified|0
1130775|NCT01525550|3714117|P2|Overall Study|Death|19
1130776|NCT01525550|3714118|P1|Overall Study|Death|10
1130777|NCT01525550|3714117|P2|Overall Study|Lost to Follow-up|1
1130778|NCT01525550|3714118|P1|Overall Study|Lost to Follow-up|4
1130779|NCT01525550|3714117|P2|Overall Study|Withdrawal by Subject|0
1130780|NCT01525550|3714118|P1|Overall Study|Withdrawal by Subject|2
1130781|NCT01525407|3714189|P2|Overall Study|Delay in Transplant|0
1130782|NCT01525407|3714190|P1|Overall Study|Delay in Transplant|1
1130783|NCT01525407|3714189|P2|Overall Study|Transplant was delayed|1
1130784|NCT01525407|3714190|P1|Overall Study|Transplant was delayed|0
1130785|NCT01525407|3714189|P2|Overall Study|Withdrawal by Subject|1
1130786|NCT01525407|3714190|P1|Overall Study|Withdrawal by Subject|0
1130787|NCT01525407|3714189|P2|Overall Study|Change in recipient treatment plan|2
1130788|NCT01525407|3714190|P1|Overall Study|Change in recipient treatment plan|2
1130789|NCT01525238|3714222|P3|Overall Study|Withdrawal by Subject|0
1130790|NCT01525238|3714223|P2|Overall Study|Withdrawal by Subject|0
1130791|NCT01525238|3714224|P1|Overall Study|Withdrawal by Subject|1
1130792|NCT01525225|3714289|P1|Enrollment|Not Specified|1
1130793|NCT01525225|3714289|P1|Enrollment|No longer met study criteria|1
1130794|NCT01524978|3714314|P11|Overall Study|Death|17
1130795|NCT01524978|3714315|P10|Overall Study|Death|6
1130796|NCT01524978|3714316|P9|Overall Study|Death|5
1130797|NCT01524978|3714317|P8|Overall Study|Death|9
1130798|NCT01524978|3714318|P7|Overall Study|Death|1
1130799|NCT01524978|3714319|P6|Overall Study|Death|4
1130800|NCT01524978|3714320|P5|Overall Study|Death|4
1130801|NCT01524978|3714321|P4|Overall Study|Death|24
1130802|NCT01524978|3714322|P3|Overall Study|Death|5
1130803|NCT01524978|3714323|P2|Overall Study|Death|2
1130804|NCT01524978|3714324|P1|Overall Study|Death|34
1130805|NCT01524978|3714314|P11|Overall Study|Lost to Follow-up|1
1130806|NCT01524978|3714315|P10|Overall Study|Lost to Follow-up|1
1130807|NCT01524978|3714316|P9|Overall Study|Lost to Follow-up|1
1130808|NCT01524978|3714317|P8|Overall Study|Lost to Follow-up|0
1130809|NCT01524978|3714318|P7|Overall Study|Lost to Follow-up|2
1130810|NCT01524978|3714319|P6|Overall Study|Lost to Follow-up|1
1130811|NCT01524978|3714320|P5|Overall Study|Lost to Follow-up|1
1130812|NCT01524978|3714321|P4|Overall Study|Lost to Follow-up|0
1130813|NCT01524978|3714322|P3|Overall Study|Lost to Follow-up|3
1130814|NCT01524978|3714323|P2|Overall Study|Lost to Follow-up|0
1130815|NCT01524978|3714324|P1|Overall Study|Lost to Follow-up|0
1130816|NCT01524978|3714314|P11|Overall Study|Withdrawal by Subject|5
1130817|NCT01524978|3714315|P10|Overall Study|Withdrawal by Subject|0
1130818|NCT01524978|3714316|P9|Overall Study|Withdrawal by Subject|4
1130819|NCT01524978|3714317|P8|Overall Study|Withdrawal by Subject|2
1130820|NCT01524978|3714318|P7|Overall Study|Withdrawal by Subject|6
1130821|NCT01524978|3714319|P6|Overall Study|Withdrawal by Subject|1
1130822|NCT01524978|3714320|P5|Overall Study|Withdrawal by Subject|3
1130823|NCT01524978|3714321|P4|Overall Study|Withdrawal by Subject|1
1130824|NCT01524978|3714322|P3|Overall Study|Withdrawal by Subject|1
1130825|NCT01524978|3714323|P2|Overall Study|Withdrawal by Subject|0
1130826|NCT01524978|3714324|P1|Overall Study|Withdrawal by Subject|12
1130827|NCT01524978|3714314|P11|Overall Study|Other|5
1130828|NCT01524978|3714315|P10|Overall Study|Other|2
1130829|NCT01524978|3714316|P9|Overall Study|Other|2
1130830|NCT01524978|3714317|P8|Overall Study|Other|1
1130831|NCT01524978|3714318|P7|Overall Study|Other|17
1130832|NCT01524978|3714319|P6|Overall Study|Other|3
1130833|NCT01524978|3714320|P5|Overall Study|Other|1
1130834|NCT01524978|3714321|P4|Overall Study|Other|2
1130835|NCT01524978|3714322|P3|Overall Study|Other|1
1130836|NCT01524978|3714323|P2|Overall Study|Other|2
1130837|NCT01524978|3714324|P1|Overall Study|Other|16
1130838|NCT01524913|3714452|P3|Overall Study|Lost to Follow-up|0
1130839|NCT01524913|3714453|P2|Overall Study|Lost to Follow-up|0
1130840|NCT01524913|3714454|P1|Overall Study|Lost to Follow-up|4
1130841|NCT01524900|3714476|P5|Overall Study|No reason documented|0
1130842|NCT01524900|3714477|P4|Overall Study|No reason documented|1
1130843|NCT01524900|3714478|P3|Overall Study|No reason documented|0
1130844|NCT01524900|3714479|P2|Overall Study|No reason documented|1
1130845|NCT01524900|3714480|P1|Overall Study|No reason documented|2
1130846|NCT01524900|3714476|P5|Overall Study|Other reason than stated above|0
1130847|NCT01524900|3714477|P4|Overall Study|Other reason than stated above|0
1130848|NCT01524900|3714478|P3|Overall Study|Other reason than stated above|0
1130849|NCT01524900|3714479|P2|Overall Study|Other reason than stated above|1
1130850|NCT01524900|3714480|P1|Overall Study|Other reason than stated above|1
1130851|NCT01524900|3714476|P5|Overall Study|Lost to Follow-up|0
1130852|NCT01524900|3714477|P4|Overall Study|Lost to Follow-up|0
1130853|NCT01524900|3714478|P3|Overall Study|Lost to Follow-up|1
1130854|NCT01524900|3714479|P2|Overall Study|Lost to Follow-up|12
1130855|NCT01524900|3714480|P1|Overall Study|Lost to Follow-up|3
1130856|NCT01524887|3714525|P3|Overall Study|Use of prohibited medication|0
1130857|NCT01524887|3714526|P2|Overall Study|Use of prohibited medication|0
1130858|NCT01524887|3714527|P1|Overall Study|Use of prohibited medication|1
1130859|NCT01524887|3714525|P3|Overall Study|Withdrawal by Caregiver|2
1130860|NCT01524887|3714526|P2|Overall Study|Withdrawal by Caregiver|0
1130861|NCT01524887|3714527|P1|Overall Study|Withdrawal by Caregiver|0
1130862|NCT01524887|3714525|P3|Overall Study|Study termination|79
1130863|NCT01524887|3714526|P2|Overall Study|Study termination|87
1130864|NCT01524887|3714527|P1|Overall Study|Study termination|73
1130865|NCT01524887|3714525|P3|Overall Study|Protocol Violation|1
1130866|NCT01524887|3714526|P2|Overall Study|Protocol Violation|0
1130867|NCT01524887|3714527|P1|Overall Study|Protocol Violation|0
1130868|NCT01524887|3714525|P3|Overall Study|Adverse Event|1
1130869|NCT01524887|3714526|P2|Overall Study|Adverse Event|1
1130870|NCT01524887|3714527|P1|Overall Study|Adverse Event|5
1130871|NCT01524887|3714525|P3|Overall Study|Withdrawal by Subject|3
1130872|NCT01524887|3714526|P2|Overall Study|Withdrawal by Subject|2
1130873|NCT01524887|3714527|P1|Overall Study|Withdrawal by Subject|6
1130874|NCT01524796|3714571|P1|Overall Study|Adverse Event and Lack of Efficacy|1
1130875|NCT01524796|3714571|P1|Overall Study|Switch to carbamazapine|1
1130876|NCT01524796|3714571|P1|Overall Study|Nervous about confidentiality|1
1130877|NCT01524796|3714571|P1|Overall Study|Gall stone surgery|1
1130878|NCT01524796|3714571|P1|Overall Study|Deterioration of pains|1
1130879|NCT01524796|3714571|P1|Overall Study|Move|1
1130880|NCT01524796|3714571|P1|Overall Study|Withdrawal by Subject|4
1130881|NCT01524796|3714571|P1|Overall Study|The price|1
1130882|NCT01524796|3714571|P1|Overall Study|Lost to Follow-up|1
1130883|NCT01524796|3714571|P1|Overall Study|Lack of Efficacy|3
1130884|NCT01524796|3714571|P1|Overall Study|Adverse Event|13
1130885|NCT01524783|3714586|P2|Randomized and Treated|Death|1
1130886|NCT01524783|3714587|P1|Randomized and Treated|Death|4
1130887|NCT01524783|3714586|P2|Randomized and Treated|Protocol Violation|1
1130888|NCT01524783|3714587|P1|Randomized and Treated|Protocol Violation|1
1130889|NCT01524783|3714586|P2|Randomized and Treated|Withdrawal by Subject|5
1130890|NCT01524783|3714587|P1|Randomized and Treated|Withdrawal by Subject|15
1130891|NCT01524783|3714586|P2|Randomized and Treated|Disease Progression|70
1130892|NCT01524783|3714587|P1|Randomized and Treated|Disease Progression|76
1130893|NCT01524783|3714586|P2|Randomized and Treated|Adverse Event|7
1130894|NCT01524783|3714587|P1|Randomized and Treated|Adverse Event|59
1130895|NCT01524783|3714586|P2|Randomized But Not Treated|Randomized, did not receive drug|0
1130896|NCT01524783|3714587|P1|Randomized But Not Treated|Randomized, did not receive drug|2
1130897|NCT01524770|3714595|P2|First Intervention|Protocol Violation|0
1130898|NCT01524770|3714596|P1|First Intervention|Protocol Violation|1
1130899|NCT01524770|3714595|P2|First Intervention|Adverse Event|1
1130900|NCT01524770|3714596|P1|First Intervention|Adverse Event|1
1130901|NCT01524770|3714595|P2|First Intervention|Withdrawal by Subject|0
1130902|NCT01524770|3714596|P1|First Intervention|Withdrawal by Subject|1
1130903|NCT01524692|3714606|P1|Overall Study|Withdrawal by Subject|3
1130904|NCT01524627|3714616|P2|Overall Study|Lost to Follow-up|1
1130905|NCT01524627|3714617|P1|Overall Study|Lost to Follow-up|1
1130906|NCT01524627|3714616|P2|Overall Study|Physician Decision|1
1130907|NCT01524627|3714617|P1|Overall Study|Physician Decision|0
1130908|NCT01524198|3714644|P2|Overall Study|Withdrawal by Subject|10
1130909|NCT01524198|3714645|P1|Overall Study|Withdrawal by Subject|15
1130910|NCT01524198|3714644|P2|Overall Study|Protocol Violation|6
1130911|NCT01524198|3714645|P1|Overall Study|Protocol Violation|8
1130912|NCT01524133|3714656|P3|Overall Study 52 Weeks|Lost to Follow-up|15
1130913|NCT01524133|3714657|P2|Overall Study 52 Weeks|Lost to Follow-up|15
1130914|NCT01524133|3714658|P1|Overall Study 52 Weeks|Lost to Follow-up|16
1130915|NCT01524133|3714656|P3|Overall Study 52 Weeks|Physician Decision|2
1130916|NCT01524133|3714657|P2|Overall Study 52 Weeks|Physician Decision|0
1130917|NCT01524133|3714658|P1|Overall Study 52 Weeks|Physician Decision|1
1130918|NCT01524133|3714656|P3|Overall Study 52 Weeks|Withdrawal by Subject|10
1130919|NCT01524133|3714657|P2|Overall Study 52 Weeks|Withdrawal by Subject|5
1130920|NCT01524133|3714658|P1|Overall Study 52 Weeks|Withdrawal by Subject|4
1130921|NCT01524133|3714656|P3|Treatment Phase|Lost to Follow-up|2
1130922|NCT01524133|3714657|P2|Treatment Phase|Lost to Follow-up|1
1130923|NCT01524133|3714658|P1|Treatment Phase|Lost to Follow-up|0
1130924|NCT01524133|3714656|P3|Treatment Phase|Physician Decision|3
1130925|NCT01524133|3714657|P2|Treatment Phase|Physician Decision|3
1130926|NCT01524133|3714658|P1|Treatment Phase|Physician Decision|6
1130927|NCT01524133|3714656|P3|Treatment Phase|Withdrawal by Subject|31
1130928|NCT01524133|3714657|P2|Treatment Phase|Withdrawal by Subject|28
1130929|NCT01524133|3714658|P1|Treatment Phase|Withdrawal by Subject|13
1130930|NCT01523886|3714701|P2|Overall Study|surgery cancelled|1
1130931|NCT01523886|3714702|P1|Overall Study|surgery cancelled|0
1130932|NCT01523873|3714708|P1|Overall Study|Protocol Violation|422
1130933|NCT01523756|3714795|P2|Test Period 2|Withdrawal by Subject|1
1130934|NCT01523756|3714796|P1|Test Period 2|Withdrawal by Subject|0
1130935|NCT01523756|3714795|P2|Test Period 1|Adverse Event|0
1130936|NCT01523756|3714796|P1|Test Period 1|Adverse Event|1
1130937|NCT01523756|3714795|P2|Baseline Period|Adverse Event|1
1130938|NCT01523756|3714796|P1|Baseline Period|Adverse Event|0
1130939|NCT01523743|3714804|P2|Period 2|Adverse Event|0
1130940|NCT01523743|3714805|P1|Period 2|Adverse Event|1
1130941|NCT01523743|3714804|P2|Period 2|Withdrawal by Subject|2
1130942|NCT01523743|3714805|P1|Period 2|Withdrawal by Subject|0
1130943|NCT01523743|3714804|P2|Period 1|Felt unable to empty bladder|0
1130944|NCT01523743|3714805|P1|Period 1|Felt unable to empty bladder|1
1130945|NCT01523743|3714804|P2|Period 1|Lack of Efficacy|0
1130946|NCT01523743|3714805|P1|Period 1|Lack of Efficacy|1
1130947|NCT01523743|3714804|P2|Period 1|Lost to Follow-up|0
1130948|NCT01523743|3714805|P1|Period 1|Lost to Follow-up|1
1130949|NCT01523743|3714804|P2|Period 1|Withdrawal by Subject|2
1130950|NCT01523743|3714805|P1|Period 1|Withdrawal by Subject|6
1130951|NCT01523743|3714804|P2|Period 1|Adverse Event|0
1130952|NCT01523743|3714805|P1|Period 1|Adverse Event|1
1130953|NCT01523587|3714828|P2|Overall Study|Randomised but not treated|2
1130954|NCT01523587|3714829|P1|Overall Study|Randomised but not treated|6
1130955|NCT01523587|3714828|P2|Overall Study|no reason given|3
1130956|NCT01523587|3714829|P1|Overall Study|no reason given|2
1130957|NCT01523587|3714828|P2|Overall Study|Withdrawal by Subject|12
1130958|NCT01523587|3714829|P1|Overall Study|Withdrawal by Subject|23
1130959|NCT01523587|3714828|P2|Overall Study|Lost to Follow-up|2
1130960|NCT01523587|3714829|P1|Overall Study|Lost to Follow-up|2
1130961|NCT01523587|3714828|P2|Overall Study|Non Compliance with protocol|1
1130962|NCT01523587|3714829|P1|Overall Study|Non Compliance with protocol|2
1130963|NCT01523587|3714828|P2|Overall Study|Adverse Event|34
1130964|NCT01523587|3714829|P1|Overall Study|Adverse Event|52
1130965|NCT01523457|3714870|P2|Overall Study|Withdrawal by Subject|2
1130966|NCT01523457|3714871|P1|Overall Study|Withdrawal by Subject|7
1130967|NCT01523392|3714889|P2|Washout Period - 10 to 14 Days|Adverse Event|0
1130968|NCT01523392|3714890|P1|Washout Period - 10 to 14 Days|Adverse Event|1
1130969|NCT01523392|3714889|P2|Treatment Period 1|Did not complete 7-9 days of treatment.|0
1130970|NCT01523392|3714890|P1|Treatment Period 1|Did not complete 7-9 days of treatment.|1
1130971|NCT01523392|3714889|P2|Treatment Period 1|Withdrawal by Subject|0
1130972|NCT01523392|3714890|P1|Treatment Period 1|Withdrawal by Subject|2
1130973|NCT01523366|3714906|P2|Treatment Period 2|Not completed at least 7 days treatment|0
1130974|NCT01523366|3714907|P1|Treatment Period 2|Not completed at least 7 days treatment|1
1130975|NCT01523366|3714906|P2|Treatment Period 1|Withdrawal by Subject|0
1130976|NCT01523366|3714907|P1|Treatment Period 1|Withdrawal by Subject|1
1130977|NCT01523301|3714923|P2|Overall Study|Other Reason|2
1130978|NCT01523301|3714924|P1|Overall Study|Other Reason|0
1130979|NCT01523301|3714923|P2|Overall Study|Withdrawal by Subject|8
1130980|NCT01523301|3714924|P1|Overall Study|Withdrawal by Subject|6
1130981|NCT01523301|3714923|P2|Overall Study|Lost to Follow-up|0
1130982|NCT01523301|3714924|P1|Overall Study|Lost to Follow-up|1
1130983|NCT01523301|3714923|P2|Overall Study|Protocol Violation|4
1130984|NCT01523301|3714924|P1|Overall Study|Protocol Violation|3
1130985|NCT01523301|3714923|P2|Overall Study|Lack of Efficacy|2
1130986|NCT01523301|3714924|P1|Overall Study|Lack of Efficacy|0
1130987|NCT01523301|3714923|P2|Overall Study|Adverse Event|16
1130988|NCT01523301|3714924|P1|Overall Study|Adverse Event|25
1130989|NCT01522976|3714945|P3|Overall Study|Not protocol specified|27
1130990|NCT01522976|3714946|P2|Overall Study|Not protocol specified|27
1130991|NCT01522976|3714947|P1|Overall Study|Not protocol specified|22
1130992|NCT01522976|3714945|P3|Overall Study|Refusal unrelated to adverse event|14
1130993|NCT01522976|3714946|P2|Overall Study|Refusal unrelated to adverse event|13
1130994|NCT01522976|3714947|P1|Overall Study|Refusal unrelated to adverse event|10
1130995|NCT01522976|3714945|P3|Overall Study|Adverse Event|18
1130996|NCT01522976|3714946|P2|Overall Study|Adverse Event|7
1130997|NCT01522976|3714947|P1|Overall Study|Adverse Event|17
1130998|NCT01522976|3714945|P3|Overall Study|Disease progression|25
1130999|NCT01522976|3714946|P2|Overall Study|Disease progression|30
1131000|NCT01522976|3714947|P1|Overall Study|Disease progression|28
1131001|NCT01522976|3714945|P3|Overall Study|Still on treatment|6
1131002|NCT01522976|3714946|P2|Overall Study|Still on treatment|9
1131003|NCT01522976|3714947|P1|Overall Study|Still on treatment|9
1131004|NCT01522976|3714945|P3|Overall Study|Death|2
1131005|NCT01522976|3714946|P2|Overall Study|Death|6
1131006|NCT01522976|3714947|P1|Overall Study|Death|7
1131007|NCT01522976|3714945|P3|Overall Study|Ineligible|1
1131008|NCT01522976|3714946|P2|Overall Study|Ineligible|0
1131009|NCT01522976|3714947|P1|Overall Study|Ineligible|4
1131010|NCT01522456|3715027|P1|Overall Study|Tolerability Assessment|1
1131011|NCT01522456|3715027|P1|Overall Study|Pregnancy|1
1131012|NCT01522456|3715027|P1|Overall Study|Withdrawal by Subject|2
1131013|NCT01522456|3715027|P1|Overall Study|Lost to Follow-up|2
1131014|NCT01522456|3715027|P1|Overall Study|Adverse Event|2
1131015|NCT01522443|3715090|P2|Overall Study|Other|3
1131016|NCT01522443|3715091|P1|Overall Study|Other|1
1131017|NCT01522443|3715090|P2|Overall Study|No study treatment given|1
1131018|NCT01522443|3715091|P1|Overall Study|No study treatment given|1
1131019|NCT01522443|3715090|P2|Overall Study|Withdrawal by Subject|8
1131020|NCT01522443|3715091|P1|Overall Study|Withdrawal by Subject|5
1131021|NCT01522443|3715090|P2|Overall Study|Adverse Event|15
1131022|NCT01522443|3715091|P1|Overall Study|Adverse Event|10
1131023|NCT01522443|3715090|P2|Overall Study|No longer receiving clinical benefit|28
1131024|NCT01522443|3715091|P1|Overall Study|No longer receiving clinical benefit|36
1131025|NCT01522404|3715103|P2|Second Intervention (up to Week 58)|Withdrawal by Subject|0
1131026|NCT01522404|3715104|P1|Second Intervention (up to Week 58)|Withdrawal by Subject|1
1131027|NCT01522404|3715103|P2|First Intervention (up to Week 29)|Adverse Event|0
1131028|NCT01522404|3715104|P1|First Intervention (up to Week 29)|Adverse Event|1
1131029|NCT01522404|3715103|P2|First Intervention (up to Week 29)|Withdrawal by Subject|0
1131030|NCT01522404|3715104|P1|First Intervention (up to Week 29)|Withdrawal by Subject|1
1131031|NCT01522235|3715186|P2|Overall Study|Physician Decision|1
1131032|NCT01522235|3715187|P1|Overall Study|Physician Decision|1
1131033|NCT01521923|3715223|P4|Overall Study|AE, captured in Period 1|1
1131034|NCT01521923|3715224|P3|Overall Study|AE, captured in Period 1|0
1131035|NCT01521923|3715225|P2|Overall Study|AE, captured in Period 1|1
1131036|NCT01521923|3715226|P1|Overall Study|AE, captured in Period 1|0
1131037|NCT01521923|3715223|P4|Overall Study|Other|6
1131038|NCT01521923|3715224|P3|Overall Study|Other|3
1131039|NCT01521923|3715225|P2|Overall Study|Other|1
1131040|NCT01521923|3715226|P1|Overall Study|Other|2
1131041|NCT01521923|3715223|P4|Overall Study|Withdrawal by Subject|2
1131042|NCT01521923|3715224|P3|Overall Study|Withdrawal by Subject|1
1131043|NCT01521923|3715225|P2|Overall Study|Withdrawal by Subject|1
1131044|NCT01521923|3715226|P1|Overall Study|Withdrawal by Subject|1
1131045|NCT01521923|3715223|P4|Overall Study|Lost to Follow-up|1
1131046|NCT01521923|3715224|P3|Overall Study|Lost to Follow-up|2
1131047|NCT01521923|3715225|P2|Overall Study|Lost to Follow-up|0
1131048|NCT01521923|3715226|P1|Overall Study|Lost to Follow-up|1
1131049|NCT01521923|3715223|P4|Overall Study|Protocol Violation|0
1131050|NCT01521923|3715224|P3|Overall Study|Protocol Violation|1
1131051|NCT01521923|3715225|P2|Overall Study|Protocol Violation|0
1131052|NCT01521923|3715226|P1|Overall Study|Protocol Violation|0
1131053|NCT01521923|3715223|P4|Overall Study|Lack of Efficacy|0
1131054|NCT01521923|3715224|P3|Overall Study|Lack of Efficacy|0
1131055|NCT01521923|3715225|P2|Overall Study|Lack of Efficacy|1
1131056|NCT01521923|3715226|P1|Overall Study|Lack of Efficacy|1
1131057|NCT01521923|3715223|P4|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1
1131058|NCT01521923|3715224|P3|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
1131059|NCT01521923|3715225|P2|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
1131060|NCT01521923|3715226|P1|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
1131061|NCT01521923|3715223|P4|Overall Study|AE, non-serious, non-fatal|2
1131062|NCT01521923|3715224|P3|Overall Study|AE, non-serious, non-fatal|6
1131063|NCT01521923|3715225|P2|Overall Study|AE, non-serious, non-fatal|3
1131064|NCT01521923|3715226|P1|Overall Study|AE, non-serious, non-fatal|1
1131065|NCT01521923|3715223|P4|Overall Study|SAE, non-fatal|0
1131066|NCT01521923|3715224|P3|Overall Study|SAE, non-fatal|2
1131067|NCT01521923|3715225|P2|Overall Study|SAE, non-fatal|2
1131068|NCT01521923|3715226|P1|Overall Study|SAE, non-fatal|0
1131069|NCT01521923|3715223|P4|Overall Study|AE, serious fatal|0
1131070|NCT01521923|3715224|P3|Overall Study|AE, serious fatal|0
1131071|NCT01521923|3715225|P2|Overall Study|AE, serious fatal|0
1131072|NCT01521923|3715226|P1|Overall Study|AE, serious fatal|1
1131073|NCT01521897|3715346|P1|Overall Study|Lost to Follow-up|5
1131074|NCT01521897|3715346|P1|Overall Study|Protocol Violation|18
1131075|NCT01521884|3715358|P1|Overall Study|Lost to Follow-up|4
1131076|NCT01521884|3715358|P1|Overall Study|Participant non-eligible|1
1131077|NCT01521884|3715358|P1|Overall Study|Protocol Violation|3
1131078|NCT01521884|3715358|P1|Overall Study|Physician Decision|2
1131079|NCT01521884|3715358|P1|Overall Study|Withdrawal by Subject|1
1131080|NCT01521884|3715358|P1|Overall Study|Pregnancy|1
1131081|NCT01521884|3715358|P1|Overall Study|Adverse Event|5
1131082|NCT01521884|3715358|P1|Overall Study|Non Responders|10
1131083|NCT01521559|3715455|P2|Overall Study|Other|2
1131084|NCT01521559|3715456|P1|Overall Study|Other|1
1131085|NCT01521559|3715455|P2|Overall Study|Protocol Violation|0
1131086|NCT01521559|3715456|P1|Overall Study|Protocol Violation|1
1131087|NCT01521559|3715455|P2|Overall Study|Lost to Follow-up|1
1131088|NCT01521559|3715456|P1|Overall Study|Lost to Follow-up|3
1131089|NCT01521559|3715455|P2|Overall Study|Withdrawal by Subject|11
1131090|NCT01521559|3715456|P1|Overall Study|Withdrawal by Subject|9
1131091|NCT01521559|3715455|P2|Overall Study|Death|0
1131092|NCT01521559|3715456|P1|Overall Study|Death|1
1131093|NCT01521559|3715455|P2|Overall Study|Adverse Event|4
1131094|NCT01521559|3715456|P1|Overall Study|Adverse Event|0
1131095|NCT01521507|3715479|P2|Stage 2: Observational Design|Physician Decision|0
1131096|NCT01521507|3715480|P1|Stage 2: Observational Design|Physician Decision|1
1131097|NCT01521507|3715479|P2|Stage 2: Observational Design|Withdrawal by Subject|1
1131098|NCT01521507|3715480|P1|Stage 2: Observational Design|Withdrawal by Subject|3
1131099|NCT01521507|3715479|P2|Stage 2: Observational Design|Device did not fit, No Treatment|1
1131100|NCT01521507|3715480|P1|Stage 2: Observational Design|Device did not fit, No Treatment|0
1131101|NCT01521507|3715479|P2|Stage 1: Randomized Design|Lost to Follow-up|2
1131102|NCT01521507|3715480|P1|Stage 1: Randomized Design|Lost to Follow-up|0
1131103|NCT01521507|3715479|P2|Stage 1: Randomized Design|Withdrawal by Subject|3
1131104|NCT01521507|3715480|P1|Stage 1: Randomized Design|Withdrawal by Subject|1
1131105|NCT01521507|3715479|P2|Stage 1: Randomized Design|Device did not fit, No Treatment|0
1131106|NCT01521507|3715480|P1|Stage 1: Randomized Design|Device did not fit, No Treatment|2
1131107|NCT01521494|3715502|P5|Overall Study|Physician Decision|2
1131108|NCT01521494|3715503|P4|Overall Study|Physician Decision|0
1131109|NCT01521494|3715504|P3|Overall Study|Physician Decision|0
1131110|NCT01521494|3715505|P2|Overall Study|Physician Decision|0
1131111|NCT01521494|3715506|P1|Overall Study|Physician Decision|0
1131112|NCT01521494|3715502|P5|Overall Study|Decrease in serum calcium|1
1131113|NCT01521494|3715503|P4|Overall Study|Decrease in serum calcium|1
1131114|NCT01521494|3715504|P3|Overall Study|Decrease in serum calcium|0
1131115|NCT01521494|3715505|P2|Overall Study|Decrease in serum calcium|0
1131116|NCT01521494|3715506|P1|Overall Study|Decrease in serum calcium|0
1131117|NCT01521494|3715502|P5|Overall Study|Decrease in serum phosphate|0
1131118|NCT01521494|3715503|P4|Overall Study|Decrease in serum phosphate|12
1131119|NCT01521494|3715504|P3|Overall Study|Decrease in serum phosphate|3
1131120|NCT01521494|3715505|P2|Overall Study|Decrease in serum phosphate|2
1131121|NCT01521494|3715506|P1|Overall Study|Decrease in serum phosphate|0
1131122|NCT01521494|3715502|P5|Overall Study|Withdrawal by Subject|0
1131123|NCT01521494|3715503|P4|Overall Study|Withdrawal by Subject|2
1131124|NCT01521494|3715504|P3|Overall Study|Withdrawal by Subject|0
1131125|NCT01521494|3715505|P2|Overall Study|Withdrawal by Subject|1
1131126|NCT01521494|3715506|P1|Overall Study|Withdrawal by Subject|1
1131127|NCT01521494|3715502|P5|Overall Study|Lack of Efficacy|2
1131128|NCT01521494|3715503|P4|Overall Study|Lack of Efficacy|0
1131129|NCT01521494|3715504|P3|Overall Study|Lack of Efficacy|0
1131130|NCT01521494|3715505|P2|Overall Study|Lack of Efficacy|0
1131131|NCT01521494|3715506|P1|Overall Study|Lack of Efficacy|0
1131132|NCT01521494|3715502|P5|Overall Study|Adverse Event|2
1131133|NCT01521494|3715503|P4|Overall Study|Adverse Event|6
1131134|NCT01521494|3715504|P3|Overall Study|Adverse Event|9
1131135|NCT01521494|3715505|P2|Overall Study|Adverse Event|2
1131136|NCT01521494|3715506|P1|Overall Study|Adverse Event|1
1131137|NCT01521364|3715528|P1|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1
1131138|NCT01521364|3715528|P1|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1
1131139|NCT01520987|3715604|P8|Overall Study|Withdrawal by Subject|0
1131140|NCT01520987|3715605|P7|Overall Study|Withdrawal by Subject|0
1131141|NCT01520987|3715606|P6|Overall Study|Withdrawal by Subject|1
1131142|NCT01520987|3715607|P5|Overall Study|Withdrawal by Subject|0
1131143|NCT01520987|3715608|P4|Overall Study|Withdrawal by Subject|0
1131144|NCT01520987|3715609|P3|Overall Study|Withdrawal by Subject|0
1131145|NCT01520987|3715610|P2|Overall Study|Withdrawal by Subject|0
1131146|NCT01520987|3715611|P1|Overall Study|Withdrawal by Subject|1
1131147|NCT01520922|3715671|P2|Survival Follow-up|Withdrawal by Subject|0
1131148|NCT01520922|3715672|P1|Survival Follow-up|Withdrawal by Subject|1
1131149|NCT01520922|3715671|P2|Follow up|Lost to Follow-up|1
1131150|NCT01520922|3715672|P1|Follow up|Lost to Follow-up|0
1131151|NCT01520922|3715671|P2|Treatment Phase|Adverse Event|5
1131152|NCT01520922|3715672|P1|Treatment Phase|Adverse Event|3
1131153|NCT01520922|3715671|P2|Treatment Phase|Progression|2
1131154|NCT01520922|3715672|P1|Treatment Phase|Progression|0
1131155|NCT01520922|3715671|P2|Treatment Phase|Physician Decision|1
1131156|NCT01520922|3715672|P1|Treatment Phase|Physician Decision|2
1131157|NCT01520909|3715734|P3|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1
1131158|NCT01520909|3715735|P2|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
1131159|NCT01520909|3715736|P1|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
1131160|NCT01520909|3715734|P3|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2
1131161|NCT01520909|3715735|P2|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
1131162|NCT01520909|3715736|P1|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
1131163|NCT01520909|3715734|P3|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4
1131164|NCT01520909|3715735|P2|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
1131165|NCT01520909|3715736|P1|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
1131166|NCT01520909|3715734|P3|Part 1 (Randomized Period)|Adverse Event|0
1131167|NCT01520909|3715735|P2|Part 1 (Randomized Period)|Adverse Event|2
1131168|NCT01520909|3715736|P1|Part 1 (Randomized Period)|Adverse Event|1
1131169|NCT01520714|3715853|P2|Overall Study|Lack of Efficacy|1
1131170|NCT01520714|3715854|P1|Overall Study|Lack of Efficacy|0
1131171|NCT01520714|3715853|P2|Overall Study|Adverse Event|2
1131172|NCT01520714|3715854|P1|Overall Study|Adverse Event|0
1131173|NCT01520714|3715853|P2|Overall Study|Protocol Violation|3
1131174|NCT01520714|3715854|P1|Overall Study|Protocol Violation|0
1131175|NCT01520506|3715879|P1|Overall Study|Withdrawal by Subject|1
1131176|NCT01520506|3715879|P1|Overall Study|Lost to Follow-up|1
1131177|NCT01520506|3715879|P1|Overall Study|Missed Visit|4
1131178|NCT01520402|3715934|P1|Overall Study|Physician Decision|3
1131179|NCT01520402|3715934|P1|Overall Study|Withdrawal by Subject|2
1131180|NCT01520363|3715947|P2|Overall Study|Withdrawal by Subject|0
1131181|NCT01520363|3715948|P1|Overall Study|Withdrawal by Subject|2
1131182|NCT01519960|3716034|P3|Overall Study|Lost to Follow-up|0
1131183|NCT01519960|3716035|P2|Overall Study|Lost to Follow-up|1
1131184|NCT01519960|3716036|P1|Overall Study|Lost to Follow-up|0
1131185|NCT01519960|3716034|P3|Overall Study|Withdrawal by Subject|0
1131186|NCT01519960|3716035|P2|Overall Study|Withdrawal by Subject|4
1131187|NCT01519960|3716036|P1|Overall Study|Withdrawal by Subject|0
1131188|NCT01519960|3716034|P3|Overall Study|Adverse Event|0
1131189|NCT01519960|3716035|P2|Overall Study|Adverse Event|1
1131190|NCT01519960|3716036|P1|Overall Study|Adverse Event|0
1131191|NCT01519960|3716034|P3|Overall Study|Ongoing/Switched to PEG-IFN|0
1131192|NCT01519960|3716035|P2|Overall Study|Ongoing/Switched to PEG-IFN|33
1131193|NCT01519960|3716036|P1|Overall Study|Ongoing/Switched to PEG-IFN|0
1131194|NCT01519960|3716034|P3|Overall Study|Ongoing in Follow-Up|10
1131195|NCT01519960|3716035|P2|Overall Study|Ongoing in Follow-Up|11
1131196|NCT01519960|3716036|P1|Overall Study|Ongoing in Follow-Up|101
1131197|NCT01519947|3716146|P4|Overall Study|Adverse Event|1
1131198|NCT01519947|3716147|P3|Overall Study|Adverse Event|1
1131199|NCT01519947|3716148|P2|Overall Study|Adverse Event|0
1131200|NCT01519947|3716149|P1|Overall Study|Adverse Event|1
1131201|NCT01519947|3716146|P4|Overall Study|Poor Response|1
1131202|NCT01519947|3716147|P3|Overall Study|Poor Response|0
1131203|NCT01519947|3716148|P2|Overall Study|Poor Response|0
1131204|NCT01519947|3716149|P1|Overall Study|Poor Response|1
1131205|NCT01519947|3716146|P4|Overall Study|Lost to Follow-up|2
1131206|NCT01519947|3716147|P3|Overall Study|Lost to Follow-up|3
1131207|NCT01519947|3716148|P2|Overall Study|Lost to Follow-up|0
1131208|NCT01519947|3716149|P1|Overall Study|Lost to Follow-up|0
1131209|NCT01519947|3716146|P4|Overall Study|Withdrawal by Subject|1
1131210|NCT01519947|3716147|P3|Overall Study|Withdrawal by Subject|0
1131211|NCT01519947|3716148|P2|Overall Study|Withdrawal by Subject|1
1131212|NCT01519947|3716149|P1|Overall Study|Withdrawal by Subject|0
1131213|NCT01519947|3716146|P4|Overall Study|Blood Transfusion|0
1131214|NCT01519947|3716147|P3|Overall Study|Blood Transfusion|1
1131215|NCT01519947|3716148|P2|Overall Study|Blood Transfusion|1
1131216|NCT01519947|3716149|P1|Overall Study|Blood Transfusion|0
1131217|NCT01519947|3716146|P4|Overall Study|Development of Anemia|1
1131218|NCT01519947|3716147|P3|Overall Study|Development of Anemia|0
1131219|NCT01519947|3716148|P2|Overall Study|Development of Anemia|1
1131220|NCT01519947|3716149|P1|Overall Study|Development of Anemia|0
1131221|NCT01519947|3716146|P4|Overall Study|Peritoneal Dialysis Needed|0
1131222|NCT01519947|3716147|P3|Overall Study|Peritoneal Dialysis Needed|0
1131223|NCT01519947|3716148|P2|Overall Study|Peritoneal Dialysis Needed|1
1131224|NCT01519947|3716149|P1|Overall Study|Peritoneal Dialysis Needed|0
1131225|NCT01519947|3716146|P4|Overall Study|Protocol Violation|1
1131226|NCT01519947|3716147|P3|Overall Study|Protocol Violation|2
1131227|NCT01519947|3716148|P2|Overall Study|Protocol Violation|0
1131228|NCT01519947|3716149|P1|Overall Study|Protocol Violation|0
1131229|NCT01519947|3716146|P4|Overall Study|Death|1
1131230|NCT01519947|3716147|P3|Overall Study|Death|0
1131231|NCT01519947|3716148|P2|Overall Study|Death|0
1131232|NCT01519947|3716149|P1|Overall Study|Death|0
1131233|NCT01519934|3716179|P1|Overall Study|Lost to Follow-up|3
1131234|NCT01519921|3716188|P2|Overall Study|High alanine aminotransferase (ALT)|1
1131235|NCT01519921|3716189|P1|Overall Study|High alanine aminotransferase (ALT)|0
1131236|NCT01519921|3716188|P2|Overall Study|Treatment refusal|1
1131237|NCT01519921|3716189|P1|Overall Study|Treatment refusal|2
1131238|NCT01519921|3716188|P2|Overall Study|Lost to Follow-up|1
1131239|NCT01519921|3716189|P1|Overall Study|Lost to Follow-up|2
1131240|NCT01519921|3716188|P2|Overall Study|Withdrawal by Subject|0
1131241|NCT01519921|3716189|P1|Overall Study|Withdrawal by Subject|3
1131242|NCT01519921|3716188|P2|Overall Study|Lack of Efficacy|3
1131243|NCT01519921|3716189|P1|Overall Study|Lack of Efficacy|4
1131244|NCT01519921|3716188|P2|Overall Study|Adverse Event|9
1131245|NCT01519921|3716189|P1|Overall Study|Adverse Event|10
1131246|NCT01519817|3716238|P4|Overall Study|Off study due to infection|1
1131247|NCT01519817|3716239|P3|Overall Study|Off study due to infection|0
1131248|NCT01519817|3716240|P2|Overall Study|Off study due to infection|0
1131249|NCT01519817|3716241|P1|Overall Study|Off study due to infection|0
1131250|NCT01519817|3716238|P4|Overall Study|Withdrawal by Subject|0
1131251|NCT01519817|3716239|P3|Overall Study|Withdrawal by Subject|0
1131252|NCT01519817|3716240|P2|Overall Study|Withdrawal by Subject|0
1131253|NCT01519817|3716241|P1|Overall Study|Withdrawal by Subject|1
1131254|NCT01519791|3716281|P2|Overall Study|Lost to Follow-up|14
1131255|NCT01519791|3716282|P1|Overall Study|Lost to Follow-up|6
1131256|NCT01519791|3716281|P2|Overall Study|Withdrawal by Subject|37
1131257|NCT01519791|3716282|P1|Overall Study|Withdrawal by Subject|15
1131258|NCT01519791|3716281|P2|Overall Study|AE, non-serious non-fatal|31
1131259|NCT01519791|3716282|P1|Overall Study|AE, non-serious non-fatal|12
1131260|NCT01519791|3716281|P2|Overall Study|SAE, fatal + SAE, non-fatal|1
1131261|NCT01519791|3716282|P1|Overall Study|SAE, fatal + SAE, non-fatal|0
1131262|NCT01519791|3716281|P2|Overall Study|AE, serious fatal|1
1131263|NCT01519791|3716282|P1|Overall Study|AE, serious fatal|0
1131264|NCT01519791|3716281|P2|Overall Study|SAE, non-fatal|22
1131265|NCT01519791|3716282|P1|Overall Study|SAE, non-fatal|6
1131266|NCT01519791|3716281|P2|Overall Study|Lack of Efficacy|20
1131267|NCT01519791|3716282|P1|Overall Study|Lack of Efficacy|16
1131268|NCT01519791|3716281|P2|Overall Study|subjects randomized in error|0
1131269|NCT01519791|3716282|P1|Overall Study|subjects randomized in error|2
1131270|NCT01519791|3716281|P2|Overall Study|Other Reason|222
1131271|NCT01519791|3716282|P1|Overall Study|Other Reason|87
1131272|NCT01519791|3716281|P2|Overall Study|Protocol Violation|19
1131273|NCT01519791|3716282|P1|Overall Study|Protocol Violation|6
1131274|NCT01519791|3716281|P2|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1
1131275|NCT01519791|3716282|P1|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2
1131276|NCT01519778|3716346|P1|Overall Study|Physician Decision|1
1131277|NCT01519778|3716346|P1|Overall Study|Lost to Follow-up|10
1131278|NCT01519778|3716346|P1|Overall Study|Withdrawal by Subject|3
1131279|NCT01519765|3716352|P2|Overall Study|Withdrawal by Subject|1
1131280|NCT01519765|3716353|P1|Overall Study|Withdrawal by Subject|0
1131281|NCT01519765|3716352|P2|Overall Study|Protocol Violation|0
1131282|NCT01519765|3716353|P1|Overall Study|Protocol Violation|1
1131283|NCT01519765|3716352|P2|Overall Study|Lack of Efficacy|0
1131284|NCT01519765|3716353|P1|Overall Study|Lack of Efficacy|2
1131285|NCT01519765|3716352|P2|Overall Study|Adverse Event|1
1131286|NCT01519765|3716353|P1|Overall Study|Adverse Event|0
1131287|NCT01519700|3716431|P4|Overall Study|Other Reason|4
1131288|NCT01519700|3716432|P3|Overall Study|Other Reason|0
1131289|NCT01519700|3716433|P2|Overall Study|Other Reason|2
1131290|NCT01519700|3716434|P1|Overall Study|Other Reason|2
1131291|NCT01519700|3716431|P4|Overall Study|Withdrawal by Subject|2
1131292|NCT01519700|3716432|P3|Overall Study|Withdrawal by Subject|3
1131293|NCT01519700|3716433|P2|Overall Study|Withdrawal by Subject|3
1131294|NCT01519700|3716434|P1|Overall Study|Withdrawal by Subject|5
1131295|NCT01519700|3716431|P4|Overall Study|Physician Decision|0
1131296|NCT01519700|3716432|P3|Overall Study|Physician Decision|3
1131297|NCT01519700|3716433|P2|Overall Study|Physician Decision|1
1131298|NCT01519700|3716434|P1|Overall Study|Physician Decision|1
1131299|NCT01519700|3716431|P4|Overall Study|Lost to Follow-up|1
1131300|NCT01519700|3716432|P3|Overall Study|Lost to Follow-up|1
1131301|NCT01519700|3716433|P2|Overall Study|Lost to Follow-up|0
1131302|NCT01519700|3716434|P1|Overall Study|Lost to Follow-up|0
1131303|NCT01519700|3716431|P4|Overall Study|Death|0
1131304|NCT01519700|3716432|P3|Overall Study|Death|0
1131305|NCT01519700|3716433|P2|Overall Study|Death|0
1131306|NCT01519700|3716434|P1|Overall Study|Death|1
1131307|NCT01519674|3716469|P3|Overall Study|Unsclassified|3
1131308|NCT01519674|3716470|P2|Overall Study|Unsclassified|4
1131309|NCT01519674|3716471|P1|Overall Study|Unsclassified|10
1131310|NCT01519674|3716469|P3|Overall Study|Withdrawal Criteria|7
1131311|NCT01519674|3716470|P2|Overall Study|Withdrawal Criteria|2
1131312|NCT01519674|3716471|P1|Overall Study|Withdrawal Criteria|7
1131313|NCT01519674|3716469|P3|Overall Study|Protocol Violation|1
1131314|NCT01519674|3716470|P2|Overall Study|Protocol Violation|3
1131315|NCT01519674|3716471|P1|Overall Study|Protocol Violation|0
1131316|NCT01519674|3716469|P3|Overall Study|Lack of Efficacy|1
1131317|NCT01519674|3716470|P2|Overall Study|Lack of Efficacy|1
1131318|NCT01519674|3716471|P1|Overall Study|Lack of Efficacy|1
1131319|NCT01519674|3716469|P3|Overall Study|Adverse Event|0
1131320|NCT01519674|3716470|P2|Overall Study|Adverse Event|3
1131321|NCT01519674|3716471|P1|Overall Study|Adverse Event|3
1131322|NCT01519661|3716509|P1|Overall Study|Adverse Event|29
1131323|NCT01519661|3716509|P1|Overall Study|Lack of Efficacy|6
1131324|NCT01519661|3716509|P1|Overall Study|Withdrawal by Subject|17
1131325|NCT01519661|3716509|P1|Overall Study|Lost to Follow-up|3
1131326|NCT01519661|3716509|P1|Overall Study|Protocol deviation|6
1131327|NCT01519518|3716535|P2|Overall Study|Consent not available|10
1131328|NCT01519518|3716536|P1|Overall Study|Consent not available|7
1131329|NCT01519427|3716561|P1|Overall Study|disease progression|2
1131330|NCT01519323|3716593|P2|Overall Study|Study terminated by sponsor|1
1131331|NCT01519323|3716594|P1|Overall Study|Study terminated by sponsor|0
1131332|NCT01519323|3716593|P2|Overall Study|Death|2
1131333|NCT01519323|3716594|P1|Overall Study|Death|3
1131334|NCT01519245|3716654|P2|Overall Study|Met exclusion criteria, not analysed|2
1131335|NCT01519245|3716655|P1|Overall Study|Met exclusion criteria, not analysed|1
1131336|NCT01519206|3716667|P1|Overall Study|Missed Visit|2
1131337|NCT01519206|3716667|P1|Overall Study|Lost to Follow-up|3
1131338|NCT01519167|3716681|P2|Overall Study|Physician Decision|1
1131339|NCT01519167|3716682|P1|Overall Study|Physician Decision|0
1131340|NCT01519167|3716681|P2|Overall Study|Medical condition changes&deep sedation|2
1131341|NCT01519167|3716682|P1|Overall Study|Medical condition changes&deep sedation|0
1131342|NCT01519167|3716681|P2|Overall Study|Lack of Efficacy|1
1131343|NCT01519167|3716682|P1|Overall Study|Lack of Efficacy|0
1131344|NCT01519167|3716681|P2|Overall Study|Adverse Event|1
1131345|NCT01519167|3716682|P1|Overall Study|Adverse Event|0
1131346|NCT01519167|3716681|P2|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3
1131347|NCT01519167|3716682|P1|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0
1131348|NCT01519089|3716708|P2|Overall Study|Not received study drug|1
1131349|NCT01519089|3716709|P1|Overall Study|Not received study drug|0
1131350|NCT01519089|3716708|P2|Overall Study|Other|6
1131351|NCT01519089|3716709|P1|Overall Study|Other|2
1131352|NCT01519089|3716708|P2|Overall Study|Withdrawal by Subject|2
1131353|NCT01519089|3716709|P1|Overall Study|Withdrawal by Subject|0
1131354|NCT01519089|3716708|P2|Overall Study|Lost to Follow-up|0
1131355|NCT01519089|3716709|P1|Overall Study|Lost to Follow-up|1
1131356|NCT01519089|3716708|P2|Overall Study|Lack of Efficacy|2
1131357|NCT01519089|3716709|P1|Overall Study|Lack of Efficacy|0
1131358|NCT01519089|3716708|P2|Overall Study|Adverse Event|4
1131359|NCT01519089|3716709|P1|Overall Study|Adverse Event|4
1131360|NCT01518946|3716830|P3|Randomized Phase (First Intervention)|Not specified|0
1131361|NCT01518946|3716831|P2|Randomized Phase (First Intervention)|Not specified|1
1131362|NCT01518946|3716832|P1|Randomized Phase (First Intervention)|Not specified|0
1131363|NCT01518946|3716830|P3|Open-label Phase|Not specified|0
1131364|NCT01518946|3716831|P2|Open-label Phase|Not specified|0
1131365|NCT01518946|3716832|P1|Open-label Phase|Not specified|4
1131366|NCT01518374|3716843|P1|Overall Study|Lost to Follow-up|2
1131367|NCT01518374|3716843|P1|Overall Study|Protocol Violation|3
1131368|NCT01518374|3716843|P1|Overall Study|Withdrawal by Subject|2
1131369|NCT01518322|3716847|P1|Overall Study|FeNO measurement was missing|13
1131370|NCT01518257|3716868|P2|Overall Study|Other Miscellaneous Reason|0
1131371|NCT01518257|3716869|P1|Overall Study|Other Miscellaneous Reason|1
1131372|NCT01518257|3716868|P2|Overall Study|Lost to Follow-up|0
1131373|NCT01518257|3716869|P1|Overall Study|Lost to Follow-up|1
1131374|NCT01518244|3716891|P1|Overall Study|Adverse Event|3
1131375|NCT01518192|3716899|P3|Overall Study|Lost to Follow-up|35
1131376|NCT01518192|3716900|P2|Overall Study|Lost to Follow-up|26
1131377|NCT01518192|3716901|P1|Overall Study|Lost to Follow-up|29
1131378|NCT01518153|3716922|P3|Donor Lymphocyte Infusion|Death|1
1131379|NCT01518153|3716923|P2|Donor Lymphocyte Infusion|Death|2
1131380|NCT01518153|3716924|P1|Donor Lymphocyte Infusion|Death|0
1131381|NCT01518153|3716922|P3|Stem Cell Transplant|Adverse Event|0
1131382|NCT01518153|3716923|P2|Stem Cell Transplant|Adverse Event|0
1131383|NCT01518153|3716924|P1|Stem Cell Transplant|Adverse Event|1
1131384|NCT01518153|3716922|P3|Stem Cell Transplant|Secondary graft failure|0
1131385|NCT01518153|3716923|P2|Stem Cell Transplant|Secondary graft failure|0
1131386|NCT01518153|3716924|P1|Stem Cell Transplant|Secondary graft failure|1
1131387|NCT01518153|3716922|P3|Stem Cell Transplant|Death|0
1131388|NCT01518153|3716923|P2|Stem Cell Transplant|Death|0
1131389|NCT01518153|3716924|P1|Stem Cell Transplant|Death|2
1131390|NCT01518153|3716922|P3|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
1131391|NCT01518153|3716923|P2|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
1131392|NCT01518153|3716924|P1|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5
1131393|NCT01517984|3716935|P4|Overall Study|Ineligible for randomization|0
1131394|NCT01517984|3716936|P3|Overall Study|Ineligible for randomization|0
1131395|NCT01517984|3716937|P2|Overall Study|Ineligible for randomization|14
1131396|NCT01517984|3716938|P1|Overall Study|Ineligible for randomization|0
1131397|NCT01517984|3716935|P4|Overall Study|Screen Failure|0
1131398|NCT01517984|3716936|P3|Overall Study|Screen Failure|0
1131399|NCT01517984|3716937|P2|Overall Study|Screen Failure|0
1131400|NCT01517984|3716938|P1|Overall Study|Screen Failure|4
1131401|NCT01517984|3716935|P4|Overall Study|Withdrawal by Subject|1
1131402|NCT01517984|3716936|P3|Overall Study|Withdrawal by Subject|4
1131403|NCT01517984|3716937|P2|Overall Study|Withdrawal by Subject|8
1131404|NCT01517984|3716938|P1|Overall Study|Withdrawal by Subject|1
1131405|NCT01517984|3716935|P4|Overall Study|Lost to Follow-up|0
1131406|NCT01517984|3716936|P3|Overall Study|Lost to Follow-up|0
1131407|NCT01517984|3716937|P2|Overall Study|Lost to Follow-up|1
1131408|NCT01517984|3716938|P1|Overall Study|Lost to Follow-up|0
1131409|NCT01517893|3716964|P2|Overall Study|Withdrawal by Subject|0
1131410|NCT01517893|3716965|P1|Overall Study|Withdrawal by Subject|3
1131411|NCT01517867|3716987|P2|Overall Study|Still in treatment at study end|3
1131412|NCT01517867|3716988|P1|Overall Study|Still in treatment at study end|0
1131413|NCT01517867|3716987|P2|Overall Study|Withdrawal by Subject|30
1131414|NCT01517867|3716988|P1|Overall Study|Withdrawal by Subject|34
1131415|NCT01517867|3716987|P2|Overall Study|never started treatment|32
1131416|NCT01517867|3716988|P1|Overall Study|never started treatment|29
1131417|NCT01517750|3717000|P4|Overall Study|Lost to Follow-up|1
1131418|NCT01517750|3717001|P3|Overall Study|Lost to Follow-up|4
1131419|NCT01517750|3717002|P2|Overall Study|Lost to Follow-up|2
1131420|NCT01517750|3717003|P1|Overall Study|Lost to Follow-up|1
1131421|NCT01517412|3717040|P2|Overall Study|Other than specified above|5
1131422|NCT01517412|3717041|P1|Overall Study|Other than specified above|8
1131423|NCT01517412|3717040|P2|Overall Study|Poor compliance to protocol|3
1131424|NCT01517412|3717041|P1|Overall Study|Poor compliance to protocol|8
1131425|NCT01517412|3717040|P2|Overall Study|Lack of Efficacy|5
1131426|NCT01517412|3717041|P1|Overall Study|Lack of Efficacy|10
1131427|NCT01517412|3717040|P2|Overall Study|Adverse Event|11
1131428|NCT01517412|3717041|P1|Overall Study|Adverse Event|10
1131429|NCT01517373|3717070|P6|Treatment Period|Medication error without AEs|2
1131430|NCT01517373|3717071|P5|Treatment Period|Medication error without AEs|0
1131431|NCT01517373|3717072|P4|Treatment Period|Medication error without AEs|1
1131432|NCT01517373|3717073|P3|Treatment Period|Medication error without AEs|2
1131433|NCT01517373|3717074|P2|Treatment Period|Medication error without AEs|0
1131434|NCT01517373|3717075|P1|Treatment Period|Medication error without AEs|0
1131435|NCT01517373|3717070|P6|Treatment Period|Lack of Efficacy|0
1131436|NCT01517373|3717071|P5|Treatment Period|Lack of Efficacy|2
1131437|NCT01517373|3717072|P4|Treatment Period|Lack of Efficacy|3
1131438|NCT01517373|3717073|P3|Treatment Period|Lack of Efficacy|1
1131439|NCT01517373|3717074|P2|Treatment Period|Lack of Efficacy|1
1131440|NCT01517373|3717075|P1|Treatment Period|Lack of Efficacy|0
1131441|NCT01517373|3717070|P6|Treatment Period|Protocol Violation|0
1131442|NCT01517373|3717071|P5|Treatment Period|Protocol Violation|1
1131443|NCT01517373|3717072|P4|Treatment Period|Protocol Violation|0
1131444|NCT01517373|3717073|P3|Treatment Period|Protocol Violation|0
1131445|NCT01517373|3717074|P2|Treatment Period|Protocol Violation|0
1131446|NCT01517373|3717075|P1|Treatment Period|Protocol Violation|0
1131447|NCT01517373|3717070|P6|Treatment Period|Other|0
1131448|NCT01517373|3717071|P5|Treatment Period|Other|1
1131449|NCT01517373|3717072|P4|Treatment Period|Other|0
1131450|NCT01517373|3717073|P3|Treatment Period|Other|0
1131451|NCT01517373|3717074|P2|Treatment Period|Other|0
1131452|NCT01517373|3717075|P1|Treatment Period|Other|0
1131453|NCT01517373|3717070|P6|Treatment Period|Withdrawal by Subject|3
1131454|NCT01517373|3717071|P5|Treatment Period|Withdrawal by Subject|2
1131455|NCT01517373|3717072|P4|Treatment Period|Withdrawal by Subject|2
1131456|NCT01517373|3717073|P3|Treatment Period|Withdrawal by Subject|2
1131457|NCT01517373|3717074|P2|Treatment Period|Withdrawal by Subject|3
1131458|NCT01517373|3717075|P1|Treatment Period|Withdrawal by Subject|0
1131459|NCT01517373|3717070|P6|Treatment Period|Lost to Follow-up|0
1131460|NCT01517373|3717071|P5|Treatment Period|Lost to Follow-up|0
1131461|NCT01517373|3717072|P4|Treatment Period|Lost to Follow-up|1
1131462|NCT01517373|3717073|P3|Treatment Period|Lost to Follow-up|1
1131463|NCT01517373|3717074|P2|Treatment Period|Lost to Follow-up|0
1131464|NCT01517373|3717075|P1|Treatment Period|Lost to Follow-up|0
1131465|NCT01517373|3717070|P6|Treatment Period|Adverse Event|2
1131466|NCT01517373|3717071|P5|Treatment Period|Adverse Event|0
1131467|NCT01517373|3717072|P4|Treatment Period|Adverse Event|0
1131468|NCT01517373|3717073|P3|Treatment Period|Adverse Event|0
1131469|NCT01517373|3717074|P2|Treatment Period|Adverse Event|0
1131470|NCT01517373|3717075|P1|Treatment Period|Adverse Event|0
1131471|NCT01517373|3717070|P6|Run-in Period|Other|0
1131472|NCT01517373|3717071|P5|Run-in Period|Other|0
1131473|NCT01517373|3717072|P4|Run-in Period|Other|0
1131474|NCT01517373|3717073|P3|Run-in Period|Other|0
1131475|NCT01517373|3717074|P2|Run-in Period|Other|0
1131476|NCT01517373|3717075|P1|Run-in Period|Other|1
1131477|NCT01517373|3717070|P6|Run-in Period|Sponsor Decision|0
1131478|NCT01517373|3717071|P5|Run-in Period|Sponsor Decision|0
1131479|NCT01517373|3717072|P4|Run-in Period|Sponsor Decision|0
1131480|NCT01517373|3717073|P3|Run-in Period|Sponsor Decision|0
1131481|NCT01517373|3717074|P2|Run-in Period|Sponsor Decision|0
1131482|NCT01517373|3717075|P1|Run-in Period|Sponsor Decision|3
1131483|NCT01517373|3717070|P6|Run-in Period|Withdrawal by Subject|0
1131484|NCT01517373|3717071|P5|Run-in Period|Withdrawal by Subject|0
1131485|NCT01517373|3717072|P4|Run-in Period|Withdrawal by Subject|0
1131486|NCT01517373|3717073|P3|Run-in Period|Withdrawal by Subject|0
1131487|NCT01517373|3717074|P2|Run-in Period|Withdrawal by Subject|0
1131488|NCT01517373|3717075|P1|Run-in Period|Withdrawal by Subject|12
1131489|NCT01517373|3717070|P6|Run-in Period|Lost to Follow-up|0
1131490|NCT01517373|3717071|P5|Run-in Period|Lost to Follow-up|0
1131491|NCT01517373|3717072|P4|Run-in Period|Lost to Follow-up|0
1131492|NCT01517373|3717073|P3|Run-in Period|Lost to Follow-up|0
1131493|NCT01517373|3717074|P2|Run-in Period|Lost to Follow-up|0
1131494|NCT01517373|3717075|P1|Run-in Period|Lost to Follow-up|1
1131495|NCT01517373|3717070|P6|Run-in Period|Did not meet eligibility criteria|0
1131496|NCT01517373|3717071|P5|Run-in Period|Did not meet eligibility criteria|0
1131497|NCT01517373|3717072|P4|Run-in Period|Did not meet eligibility criteria|0
1131498|NCT01517373|3717073|P3|Run-in Period|Did not meet eligibility criteria|0
1131499|NCT01517373|3717074|P2|Run-in Period|Did not meet eligibility criteria|0
1131500|NCT01517373|3717075|P1|Run-in Period|Did not meet eligibility criteria|34
1131501|NCT01517373|3717070|P6|Run-in Period|Adverse Event|0
1131502|NCT01517373|3717071|P5|Run-in Period|Adverse Event|0
1131503|NCT01517373|3717072|P4|Run-in Period|Adverse Event|0
1131504|NCT01517373|3717073|P3|Run-in Period|Adverse Event|0
1131505|NCT01517373|3717074|P2|Run-in Period|Adverse Event|0
1131506|NCT01517373|3717075|P1|Run-in Period|Adverse Event|5
1131507|NCT01517373|3717070|P6|Run-in Period|Death|0
1131508|NCT01517373|3717071|P5|Run-in Period|Death|0
1131509|NCT01517373|3717072|P4|Run-in Period|Death|0
1131510|NCT01517373|3717073|P3|Run-in Period|Death|0
1131511|NCT01517373|3717074|P2|Run-in Period|Death|0
1131512|NCT01517373|3717075|P1|Run-in Period|Death|1
1131513|NCT01517295|3717145|P2|Overall Study|Physician Decision|0
1131514|NCT01517295|3717146|P1|Overall Study|Physician Decision|1
1131515|NCT01517282|3717160|P4|Overall Study|Physician Decision|0
1131516|NCT01517282|3717161|P3|Overall Study|Physician Decision|0
1131517|NCT01517282|3717162|P2|Overall Study|Physician Decision|0
1131518|NCT01517282|3717163|P1|Overall Study|Physician Decision|1
1131519|NCT01517282|3717160|P4|Overall Study|Consent withdrawn|1
1131520|NCT01517282|3717161|P3|Overall Study|Consent withdrawn|1
1131521|NCT01517282|3717162|P2|Overall Study|Consent withdrawn|1
1131522|NCT01517282|3717163|P1|Overall Study|Consent withdrawn|0
1131523|NCT01517178|3717197|P2|Period 2|E.g. study termination|2
1131524|NCT01517178|3717198|P1|Period 2|E.g. study termination|2
1131525|NCT01517178|3717197|P2|Period 2|Withdrawal by Subject|0
1131526|NCT01517178|3717198|P1|Period 2|Withdrawal by Subject|3
1131527|NCT01517178|3717197|P2|Period 2|Adverse Event|0
1131528|NCT01517178|3717198|P1|Period 2|Adverse Event|1
1131529|NCT01517178|3717197|P2|Period 1|Withdrawal by Subject|1
1131530|NCT01517178|3717198|P1|Period 1|Withdrawal by Subject|0
1131531|NCT01517178|3717197|P2|Period 1|E.g. study termination|1
1131532|NCT01517178|3717198|P1|Period 1|E.g. study termination|3
1131533|NCT01517178|3717197|P2|Period 1|Lack of Efficacy|1
1131534|NCT01517178|3717198|P1|Period 1|Lack of Efficacy|0
1131535|NCT01517178|3717197|P2|Period 1|Adverse Event|2
1131536|NCT01517178|3717198|P1|Period 1|Adverse Event|1
1131537|NCT01516970|3717217|P2|Overall Study|Other|7
1131538|NCT01516970|3717218|P1|Overall Study|Other|9
1131539|NCT01516970|3717217|P2|Overall Study|Withdrawal by Subject|1
1131540|NCT01516970|3717218|P1|Overall Study|Withdrawal by Subject|1
1131541|NCT01516970|3717217|P2|Overall Study|Adverse Event|5
1131542|NCT01516970|3717218|P1|Overall Study|Adverse Event|1
1131543|NCT01516970|3717217|P2|Overall Study|Lost to Follow-up|8
1131544|NCT01516970|3717218|P1|Overall Study|Lost to Follow-up|7
1131545|NCT01516892|3717230|P1|Overall Study|Missing|1
1131546|NCT01516892|3717230|P1|Overall Study|Other Miscellaneous Reasons|43
1131547|NCT01516892|3717230|P1|Overall Study|Protocol Violation|60
1131548|NCT01516892|3717230|P1|Overall Study|Subject Withdrew Consent|92
1131549|NCT01516892|3717230|P1|Overall Study|Lost to Follow-up|82
1131550|NCT01516892|3717230|P1|Overall Study|Pregnancy|5
1131551|NCT01516892|3717230|P1|Overall Study|Lack of Efficacy|35
1131552|NCT01516892|3717230|P1|Overall Study|Adverse Event|25
1131553|NCT01516879|3717238|P2|Overall Study|Other|10
1131554|NCT01516879|3717239|P1|Overall Study|Other|5
1131555|NCT01516879|3717238|P2|Overall Study|Lost to Follow-up|11
1131556|NCT01516879|3717239|P1|Overall Study|Lost to Follow-up|2
1131557|NCT01516879|3717238|P2|Overall Study|Death|2
1131558|NCT01516879|3717239|P1|Overall Study|Death|0
1131559|NCT01516879|3717238|P2|Overall Study|Withdrawal by Subject|11
1131560|NCT01516879|3717239|P1|Overall Study|Withdrawal by Subject|9
1131561|NCT01516749|3717273|P1|Follow-up Off Therapy|Lost to Follow-up|1
1131562|NCT01516749|3717273|P1|Active Therapy|Lost to Follow-up|1
1131563|NCT01516736|3717282|P2|Overall Study|Other (not specified)|1
1131564|NCT01516736|3717283|P1|Overall Study|Other (not specified)|0
1131565|NCT01516736|3717282|P2|Overall Study|Protocol Violation|1
1131566|NCT01516736|3717283|P1|Overall Study|Protocol Violation|0
1131567|NCT01516736|3717282|P2|Overall Study|Lack of Efficacy|0
1131568|NCT01516736|3717283|P1|Overall Study|Lack of Efficacy|1
1131569|NCT01516736|3717282|P2|Overall Study|Physician Decision|1
1131570|NCT01516736|3717283|P1|Overall Study|Physician Decision|2
1131571|NCT01516736|3717282|P2|Overall Study|Death|1
1131572|NCT01516736|3717283|P1|Overall Study|Death|3
1131573|NCT01516736|3717282|P2|Overall Study|Adverse Event|5
1131574|NCT01516736|3717283|P1|Overall Study|Adverse Event|4
1131575|NCT01516736|3717282|P2|Overall Study|Withdrawal by Subject|4
1131576|NCT01516736|3717283|P1|Overall Study|Withdrawal by Subject|10
1131577|NCT01516437|3717320|P4|Overall Study|Reason not specified|1
1131578|NCT01516437|3717321|P3|Overall Study|Reason not specified|1
1131579|NCT01516437|3717322|P2|Overall Study|Reason not specified|0
1131580|NCT01516437|3717323|P1|Overall Study|Reason not specified|0
1131581|NCT01516034|3717395|P1|Overall Study|Lack of Efficacy|7
1131582|NCT01516034|3717395|P1|Overall Study|Physician Decision|1
1131583|NCT01516008|3717402|P3|Overall Study|Reason not specified|1
1131584|NCT01516008|3717403|P2|Overall Study|Reason not specified|0
1131585|NCT01516008|3717404|P1|Overall Study|Reason not specified|0
1131586|NCT01516008|3717402|P3|Overall Study|Protocol Violation|0
1131587|NCT01516008|3717403|P2|Overall Study|Protocol Violation|0
1131588|NCT01516008|3717404|P1|Overall Study|Protocol Violation|1
1131589|NCT01516008|3717402|P3|Overall Study|Lack of Efficacy|10
1131590|NCT01516008|3717403|P2|Overall Study|Lack of Efficacy|14
1131591|NCT01516008|3717404|P1|Overall Study|Lack of Efficacy|44
1131592|NCT01516008|3717402|P3|Overall Study|Adverse Event|7
1131593|NCT01516008|3717403|P2|Overall Study|Adverse Event|2
1131594|NCT01516008|3717404|P1|Overall Study|Adverse Event|0
1131595|NCT01515865|3717500|P3|Part B (Open-label)|Not Specified|0
1131596|NCT01515865|3717501|P2|Part B (Open-label)|Not Specified|0
1131597|NCT01515865|3717502|P1|Part B (Open-label)|Not Specified|1
1131598|NCT01515865|3717500|P3|Part B (Open-label)|Withdrawal by Subject|0
1131599|NCT01515865|3717501|P2|Part B (Open-label)|Withdrawal by Subject|0
1131600|NCT01515865|3717502|P1|Part B (Open-label)|Withdrawal by Subject|1
1131601|NCT01515865|3717500|P3|Part A (Open-label)|Not Specified|0
1131602|NCT01515865|3717501|P2|Part A (Open-label)|Not Specified|0
1131603|NCT01515865|3717502|P1|Part A (Open-label)|Not Specified|3
1131604|NCT01515423|3717570|P3|DOUBLE BLIND|Blind broken by investigator|0
1131605|NCT01515423|3717571|P2|DOUBLE BLIND|Blind broken by investigator|1
1131606|NCT01515423|3717572|P1|DOUBLE BLIND|Blind broken by investigator|0
1131607|NCT01515423|3717570|P3|DOUBLE BLIND|Other|12
1131608|NCT01515423|3717571|P2|DOUBLE BLIND|Other|6
1131609|NCT01515423|3717572|P1|DOUBLE BLIND|Other|0
1131610|NCT01515423|3717570|P3|DOUBLE BLIND|Withdrawal by Subject|53
1131611|NCT01515423|3717571|P2|DOUBLE BLIND|Withdrawal by Subject|50
1131612|NCT01515423|3717572|P1|DOUBLE BLIND|Withdrawal by Subject|0
1131613|NCT01515423|3717570|P3|DOUBLE BLIND|Pregnancy|0
1131614|NCT01515423|3717571|P2|DOUBLE BLIND|Pregnancy|2
1131615|NCT01515423|3717572|P1|DOUBLE BLIND|Pregnancy|0
1131616|NCT01515423|3717570|P3|DOUBLE BLIND|Lost to Follow-up|12
1131617|NCT01515423|3717571|P2|DOUBLE BLIND|Lost to Follow-up|7
1131618|NCT01515423|3717572|P1|DOUBLE BLIND|Lost to Follow-up|0
1131619|NCT01515423|3717570|P3|DOUBLE BLIND|Death|2
1131620|NCT01515423|3717571|P2|DOUBLE BLIND|Death|1
1131621|NCT01515423|3717572|P1|DOUBLE BLIND|Death|0
1131622|NCT01515423|3717570|P3|DOUBLE BLIND|Adverse Event|13
1131623|NCT01515423|3717571|P2|DOUBLE BLIND|Adverse Event|15
1131624|NCT01515423|3717572|P1|DOUBLE BLIND|Adverse Event|0
1131625|NCT01515423|3717570|P3|Open Label Phase|Other|0
1131626|NCT01515423|3717571|P2|Open Label Phase|Other|0
1131627|NCT01515423|3717572|P1|Open Label Phase|Other|28
1131628|NCT01515423|3717570|P3|Open Label Phase|excluded from DB Phase|0
1131629|NCT01515423|3717571|P2|Open Label Phase|excluded from DB Phase|0
1131630|NCT01515423|3717572|P1|Open Label Phase|excluded from DB Phase|70
1131631|NCT01515423|3717570|P3|Open Label Phase|Withdrawal by Subject|0
1131632|NCT01515423|3717571|P2|Open Label Phase|Withdrawal by Subject|0
1131633|NCT01515423|3717572|P1|Open Label Phase|Withdrawal by Subject|118
1131634|NCT01515423|3717570|P3|Open Label Phase|Lost to Follow-up|0
1131635|NCT01515423|3717571|P2|Open Label Phase|Lost to Follow-up|0
1131636|NCT01515423|3717572|P1|Open Label Phase|Lost to Follow-up|21
1131637|NCT01515423|3717570|P3|Open Label Phase|Lack of Efficacy|0
1131638|NCT01515423|3717571|P2|Open Label Phase|Lack of Efficacy|0
1131639|NCT01515423|3717572|P1|Open Label Phase|Lack of Efficacy|117
1131640|NCT01515423|3717570|P3|Open Label Phase|Death|0
1131641|NCT01515423|3717571|P2|Open Label Phase|Death|0
1131642|NCT01515423|3717572|P1|Open Label Phase|Death|2
1131643|NCT01515423|3717570|P3|Open Label Phase|Adverse Event|0
1131644|NCT01515423|3717571|P2|Open Label Phase|Adverse Event|0
1131645|NCT01515423|3717572|P1|Open Label Phase|Adverse Event|57
1131646|NCT01515306|3717613|P2|Overall Study|Ongoing receiving treatment|14
1131647|NCT01515306|3717614|P1|Overall Study|Ongoing receiving treatment|9
1131648|NCT01515306|3717613|P2|Overall Study|Progressive Disease|0
1131649|NCT01515306|3717614|P1|Overall Study|Progressive Disease|1
1131650|NCT01515306|3717613|P2|Overall Study|Adverse Event|0
1131651|NCT01515306|3717614|P1|Overall Study|Adverse Event|2
1131652|NCT01515189|3717627|P2|First Re-Induction Phase|Other|0
1131653|NCT01515189|3717628|P1|First Re-Induction Phase|Other|1
1131654|NCT01515189|3717627|P2|First Re-Induction Phase|No longer meets study criteria|0
1131655|NCT01515189|3717628|P1|First Re-Induction Phase|No longer meets study criteria|1
1131656|NCT01515189|3717627|P2|First Re-Induction Phase|Withdrawal by Subject|1
1131657|NCT01515189|3717628|P1|First Re-Induction Phase|Withdrawal by Subject|1
1131658|NCT01515189|3717627|P2|First Re-Induction Phase|Study drug toxicity|0
1131659|NCT01515189|3717628|P1|First Re-Induction Phase|Study drug toxicity|5
1131660|NCT01515189|3717627|P2|First Re-Induction Phase|Disease progression|14
1131661|NCT01515189|3717628|P1|First Re-Induction Phase|Disease progression|6
1131662|NCT01515189|3717627|P2|Induction|Other|4
1131663|NCT01515189|3717628|P1|Induction|Other|0
1131664|NCT01515189|3717627|P2|Induction|Lost to Follow-up|0
1131665|NCT01515189|3717628|P1|Induction|Lost to Follow-up|1
1131666|NCT01515189|3717627|P2|Induction|No longer meets study criteria|2
1131667|NCT01515189|3717628|P1|Induction|No longer meets study criteria|0
1131668|NCT01515189|3717627|P2|Induction|Withdrawal by Subject|9
1131669|NCT01515189|3717628|P1|Induction|Withdrawal by Subject|3
1131670|NCT01515189|3717627|P2|Induction|Adverse Event|9
1131671|NCT01515189|3717628|P1|Induction|Adverse Event|14
1131672|NCT01515189|3717627|P2|Induction|Death|17
1131673|NCT01515189|3717628|P1|Induction|Death|24
1131674|NCT01515189|3717627|P2|Induction|Study drug toxicity|36
1131675|NCT01515189|3717628|P1|Induction|Study drug toxicity|86
1131676|NCT01515189|3717627|P2|Induction|Disease Progression|155
1131677|NCT01515189|3717628|P1|Induction|Disease Progression|109
1131678|NCT01514864|3717716|P2|Overall Study|Study drug toxicity|0
1131679|NCT01514864|3717717|P1|Overall Study|Study drug toxicity|2
1131680|NCT01514864|3717716|P2|Overall Study|Disease progression|5
1131681|NCT01514864|3717717|P1|Overall Study|Disease progression|7
1131682|NCT01514760|3717742|P1|Overall Study|Lost to Follow-up|2
1131683|NCT01514682|3717755|P2|Overall Study|Physician Decision|3
1131684|NCT01514682|3717756|P1|Overall Study|Physician Decision|4
1131685|NCT01514682|3717755|P2|Overall Study|Withdrawal by Subject|3
1131686|NCT01514682|3717756|P1|Overall Study|Withdrawal by Subject|2
1131687|NCT01514461|3717790|P3|Overall Study|Death|0
1131688|NCT01514461|3717791|P2|Overall Study|Death|0
1131689|NCT01514461|3717792|P1|Overall Study|Death|1
1131690|NCT01514461|3717790|P3|Overall Study|Patient/guardian decision|1
1131691|NCT01514461|3717791|P2|Overall Study|Patient/guardian decision|1
1131692|NCT01514461|3717792|P1|Overall Study|Patient/guardian decision|1
1131693|NCT01514461|3717790|P3|Overall Study|Physician Decision|0
1131694|NCT01514461|3717791|P2|Overall Study|Physician Decision|1
1131695|NCT01514461|3717792|P1|Overall Study|Physician Decision|1
1131696|NCT01514461|3717790|P3|Overall Study|Adverse Event|3
1131697|NCT01514461|3717791|P2|Overall Study|Adverse Event|1
1131698|NCT01514461|3717792|P1|Overall Study|Adverse Event|2
1131699|NCT01514448|3717831|P2|Overall Study|New Cancer Therapy|0
1131700|NCT01514448|3717832|P1|Overall Study|New Cancer Therapy|1
1131701|NCT01514448|3717831|P2|Overall Study|Lost to Follow-up|0
1131702|NCT01514448|3717832|P1|Overall Study|Lost to Follow-up|2
1131703|NCT01514448|3717831|P2|Overall Study|Withdrawal by Subject|0
1131704|NCT01514448|3717832|P1|Overall Study|Withdrawal by Subject|2
1131705|NCT01514448|3717831|P2|Overall Study|Death|8
1131706|NCT01514448|3717832|P1|Overall Study|Death|7
1131707|NCT01514422|3717847|P1|Overall Study|Lost to Follow-up|1
1131708|NCT01514357|3717860|P2|Overall Study|Withdrawal by Subject|0
1131709|NCT01514357|3717861|P1|Overall Study|Withdrawal by Subject|2
1131710|NCT01514357|3717860|P2|Overall Study|Screen failure|0
1131711|NCT01514357|3717861|P1|Overall Study|Screen failure|2
1131712|NCT01514240|3717879|P2|Overall Study|Subject Decision|7
1131713|NCT01514240|3717880|P1|Overall Study|Subject Decision|2
1131714|NCT01514240|3717879|P2|Overall Study|Adverse Event|4
1131715|NCT01514240|3717880|P1|Overall Study|Adverse Event|4
1131716|NCT01514136|3717993|P8|Test Period 2; Test C*|Protocol Violation|0
1131717|NCT01514136|3717994|P7|Test Period 2; Test C*|Protocol Violation|1
1131718|NCT01514136|3717995|P6|Test Period 2; Test C*|Protocol Violation|0
1131719|NCT01514136|3717996|P5|Test Period 2; Test C*|Protocol Violation|0
1131720|NCT01514136|3717997|P4|Test Period 2; Test C*|Protocol Violation|0
1131721|NCT01514136|3717998|P3|Test Period 2; Test C*|Protocol Violation|0
1131722|NCT01514136|3717999|P2|Test Period 2; Test C*|Protocol Violation|0
1131723|NCT01514136|3718000|P1|Test Period 2; Test C*|Protocol Violation|0
1131724|NCT01514136|3717993|P8|Test Period 2; Test C*|holiday|0
1131725|NCT01514136|3717994|P7|Test Period 2; Test C*|holiday|1
1131726|NCT01514136|3717995|P6|Test Period 2; Test C*|holiday|0
1131727|NCT01514136|3717996|P5|Test Period 2; Test C*|holiday|0
1131728|NCT01514136|3717997|P4|Test Period 2; Test C*|holiday|0
1131729|NCT01514136|3717998|P3|Test Period 2; Test C*|holiday|0
1131730|NCT01514136|3717999|P2|Test Period 2; Test C*|holiday|0
1131731|NCT01514136|3718000|P1|Test Period 2; Test C*|holiday|0
1131732|NCT01514136|3717993|P8|Test Period 2; Test C*|Withdrawal by Subject|0
1131733|NCT01514136|3717994|P7|Test Period 2; Test C*|Withdrawal by Subject|1
1131734|NCT01514136|3717995|P6|Test Period 2; Test C*|Withdrawal by Subject|0
1131735|NCT01514136|3717996|P5|Test Period 2; Test C*|Withdrawal by Subject|0
1131736|NCT01514136|3717997|P4|Test Period 2; Test C*|Withdrawal by Subject|0
1131737|NCT01514136|3717998|P3|Test Period 2; Test C*|Withdrawal by Subject|0
1131738|NCT01514136|3717999|P2|Test Period 2; Test C*|Withdrawal by Subject|0
1131739|NCT01514136|3718000|P1|Test Period 2; Test C*|Withdrawal by Subject|0
1131740|NCT01514136|3717993|P8|Test Period 2; Test B*|Withdrawal by Subject|0
1131741|NCT01514136|3717994|P7|Test Period 2; Test B*|Withdrawal by Subject|0
1131742|NCT01514136|3717995|P6|Test Period 2; Test B*|Withdrawal by Subject|2
1131743|NCT01514136|3717996|P5|Test Period 2; Test B*|Withdrawal by Subject|0
1131744|NCT01514136|3717997|P4|Test Period 2; Test B*|Withdrawal by Subject|0
1131745|NCT01514136|3717998|P3|Test Period 2; Test B*|Withdrawal by Subject|0
1131746|NCT01514136|3717999|P2|Test Period 2; Test B*|Withdrawal by Subject|0
1131747|NCT01514136|3718000|P1|Test Period 2; Test B*|Withdrawal by Subject|0
1131748|NCT01514136|3717993|P8|Test Period 2; Test A*|Holiday|0
1131749|NCT01514136|3717994|P7|Test Period 2; Test A*|Holiday|0
1131750|NCT01514136|3717995|P6|Test Period 2; Test A*|Holiday|0
1131751|NCT01514136|3717996|P5|Test Period 2; Test A*|Holiday|1
1131752|NCT01514136|3717997|P4|Test Period 2; Test A*|Holiday|0
1131753|NCT01514136|3717998|P3|Test Period 2; Test A*|Holiday|0
1131754|NCT01514136|3717999|P2|Test Period 2; Test A*|Holiday|0
1131755|NCT01514136|3718000|P1|Test Period 2; Test A*|Holiday|0
1131756|NCT01514136|3717993|P8|Test Period 2; Test A*|Adverse Event|0
1131757|NCT01514136|3717994|P7|Test Period 2; Test A*|Adverse Event|0
1131758|NCT01514136|3717995|P6|Test Period 2; Test A*|Adverse Event|0
1131759|NCT01514136|3717996|P5|Test Period 2; Test A*|Adverse Event|1
1131760|NCT01514136|3717997|P4|Test Period 2; Test A*|Adverse Event|0
1131761|NCT01514136|3717998|P3|Test Period 2; Test A*|Adverse Event|0
1131762|NCT01514136|3717999|P2|Test Period 2; Test A*|Adverse Event|0
1131763|NCT01514136|3718000|P1|Test Period 2; Test A*|Adverse Event|0
1131764|NCT01514136|3717993|P8|Test Period 1; Test D|Subject took a break due to holiday|0
1131765|NCT01514136|3717994|P7|Test Period 1; Test D|Subject took a break due to holiday|0
1131766|NCT01514136|3717995|P6|Test Period 1; Test D|Subject took a break due to holiday|0
1131767|NCT01514136|3717996|P5|Test Period 1; Test D|Subject took a break due to holiday|0
1131768|NCT01514136|3717997|P4|Test Period 1; Test D|Subject took a break due to holiday|2
1131769|NCT01514136|3717998|P3|Test Period 1; Test D|Subject took a break due to holiday|0
1131770|NCT01514136|3717999|P2|Test Period 1; Test D|Subject took a break due to holiday|0
1131771|NCT01514136|3718000|P1|Test Period 1; Test D|Subject took a break due to holiday|0
1131772|NCT01514136|3717993|P8|Test Period 1; Test B|Withdrawal by Subject|0
1131773|NCT01514136|3717994|P7|Test Period 1; Test B|Withdrawal by Subject|0
1131774|NCT01514136|3717995|P6|Test Period 1; Test B|Withdrawal by Subject|0
1131775|NCT01514136|3717996|P5|Test Period 1; Test B|Withdrawal by Subject|0
1131776|NCT01514136|3717997|P4|Test Period 1; Test B|Withdrawal by Subject|0
1131777|NCT01514136|3717998|P3|Test Period 1; Test B|Withdrawal by Subject|0
1131778|NCT01514136|3717999|P2|Test Period 1; Test B|Withdrawal by Subject|1
1131779|NCT01514136|3718000|P1|Test Period 1; Test B|Withdrawal by Subject|0
1131780|NCT01514136|3717993|P8|Test Period 1; Test A|Break from study holiday|0
1131781|NCT01514136|3717994|P7|Test Period 1; Test A|Break from study holiday|0
1131782|NCT01514136|3717995|P6|Test Period 1; Test A|Break from study holiday|0
1131783|NCT01514136|3717996|P5|Test Period 1; Test A|Break from study holiday|0
1131784|NCT01514136|3717997|P4|Test Period 1; Test A|Break from study holiday|0
1131785|NCT01514136|3717998|P3|Test Period 1; Test A|Break from study holiday|0
1131786|NCT01514136|3717999|P2|Test Period 1; Test A|Break from study holiday|0
1131787|NCT01514136|3718000|P1|Test Period 1; Test A|Break from study holiday|2
1131788|NCT01514136|3717993|P8|Test Period 1; Test A|Protocol Violation|0
1131789|NCT01514136|3717994|P7|Test Period 1; Test A|Protocol Violation|0
1131790|NCT01514136|3717995|P6|Test Period 1; Test A|Protocol Violation|0
1131791|NCT01514136|3717996|P5|Test Period 1; Test A|Protocol Violation|0
1131792|NCT01514136|3717997|P4|Test Period 1; Test A|Protocol Violation|0
1131793|NCT01514136|3717998|P3|Test Period 1; Test A|Protocol Violation|0
1131794|NCT01514136|3717999|P2|Test Period 1; Test A|Protocol Violation|0
1131795|NCT01514136|3718000|P1|Test Period 1; Test A|Protocol Violation|1
1131796|NCT01513590|3718068|P2|Overall Study|Unclassified|10
1131797|NCT01513590|3718069|P1|Overall Study|Unclassified|5
1131798|NCT01513590|3718068|P2|Overall Study|Withdrawal Criteria|0
1131799|NCT01513590|3718069|P1|Overall Study|Withdrawal Criteria|3
1131800|NCT01513590|3718068|P2|Overall Study|Adverse Event|3
1131801|NCT01513590|3718069|P1|Overall Study|Adverse Event|2
1131802|NCT01513551|3718090|P3|Overall Study|Randomized but not vaccinated|1
1131803|NCT01513551|3718091|P2|Overall Study|Randomized but not vaccinated|0
1131804|NCT01513551|3718092|P1|Overall Study|Randomized but not vaccinated|0
1131805|NCT01513551|3718090|P3|Overall Study|Withdrawal by Subject|2
1131806|NCT01513551|3718091|P2|Overall Study|Withdrawal by Subject|0
1131807|NCT01513551|3718092|P1|Overall Study|Withdrawal by Subject|1
1131808|NCT01513551|3718090|P3|Overall Study|Lost to Follow-up|2
1131809|NCT01513551|3718091|P2|Overall Study|Lost to Follow-up|5
1131810|NCT01513551|3718092|P1|Overall Study|Lost to Follow-up|3
1131811|NCT01513551|3718090|P3|Overall Study|Death|0
1131812|NCT01513551|3718091|P2|Overall Study|Death|1
1131813|NCT01513551|3718092|P1|Overall Study|Death|0
1131814|NCT01513473|3718124|P2|Extension Trial (26 Weeks)|Withdrawal by Subject|5
1131815|NCT01513473|3718125|P1|Extension Trial (26 Weeks)|Withdrawal by Subject|1
1131816|NCT01513473|3718124|P2|Extension Trial (26 Weeks)|Adverse Event|1
1131817|NCT01513473|3718125|P1|Extension Trial (26 Weeks)|Adverse Event|0
1131818|NCT01513473|3718124|P2|Main Trial (26 Weeks)|Unclassified|2
1131819|NCT01513473|3718125|P1|Main Trial (26 Weeks)|Unclassified|0
1131820|NCT01513473|3718124|P2|Main Trial (26 Weeks)|Withdrawal by Subject|7
1131821|NCT01513473|3718125|P1|Main Trial (26 Weeks)|Withdrawal by Subject|4
1131822|NCT01513473|3718124|P2|Main Trial (26 Weeks)|Adverse Event|2
1131823|NCT01513473|3718125|P1|Main Trial (26 Weeks)|Adverse Event|0
1131824|NCT01513460|3718152|P3|Overall Study|Abnormal test procedure|0
1131825|NCT01513460|3718153|P2|Overall Study|Abnormal test procedure|0
1131826|NCT01513460|3718154|P1|Overall Study|Abnormal test procedure|1
1131827|NCT01513460|3718152|P3|Overall Study|Adverse Event|23
1131828|NCT01513460|3718153|P2|Overall Study|Adverse Event|18
1131829|NCT01513460|3718154|P1|Overall Study|Adverse Event|16
1131830|NCT01513460|3718152|P3|Overall Study|Withdrawal by Subject|21
1131831|NCT01513460|3718153|P2|Overall Study|Withdrawal by Subject|8
1131832|NCT01513460|3718154|P1|Overall Study|Withdrawal by Subject|7
1131833|NCT01513460|3718152|P3|Overall Study|Protocol deviations|3
1131834|NCT01513460|3718153|P2|Overall Study|Protocol deviations|4
1131835|NCT01513460|3718154|P1|Overall Study|Protocol deviations|3
1131836|NCT01513460|3718152|P3|Overall Study|Lack of Efficacy|5
1131837|NCT01513460|3718153|P2|Overall Study|Lack of Efficacy|2
1131838|NCT01513460|3718154|P1|Overall Study|Lack of Efficacy|1
1131839|NCT01513460|3718152|P3|Overall Study|Abnormal laboratory value|1
1131840|NCT01513460|3718153|P2|Overall Study|Abnormal laboratory value|0
1131841|NCT01513460|3718154|P1|Overall Study|Abnormal laboratory value|1
1131842|NCT01513460|3718152|P3|Overall Study|Lost to Follow-up|2
1131843|NCT01513460|3718153|P2|Overall Study|Lost to Follow-up|0
1131844|NCT01513460|3718154|P1|Overall Study|Lost to Follow-up|0
1131845|NCT01513460|3718152|P3|Overall Study|Death|1
1131846|NCT01513460|3718153|P2|Overall Study|Death|0
1131847|NCT01513460|3718154|P1|Overall Study|Death|0
1131848|NCT01513330|3718189|P2|Standard Care First,|Other|0
1131849|NCT01513330|3718190|P1|Standard Care First,|Other|1
1131850|NCT01513330|3718189|P2|Standard Care First,|Withdrawal by Subject|2
1131851|NCT01513330|3718190|P1|Standard Care First,|Withdrawal by Subject|1
1131852|NCT01513330|3718189|P2|Standard Care First,|Lack of Efficacy|2
1131853|NCT01513330|3718190|P1|Standard Care First,|Lack of Efficacy|2
1131854|NCT01513330|3718189|P2|SenSura Mio First,|Other|0
1131855|NCT01513330|3718190|P1|SenSura Mio First,|Other|1
1131856|NCT01513330|3718189|P2|SenSura Mio First,|Withdrawal by Subject|1
1131857|NCT01513330|3718190|P1|SenSura Mio First,|Withdrawal by Subject|1
1131858|NCT01513330|3718189|P2|SenSura Mio First,|Lack of Efficacy|1
1131859|NCT01513330|3718190|P1|SenSura Mio First,|Lack of Efficacy|0
1131860|NCT01513330|3718189|P2|SenSura Mio First,|Adverse Event|0
1131861|NCT01513330|3718190|P1|SenSura Mio First,|Adverse Event|2
1131862|NCT01513317|3718198|P2|Overall Study|Not specified|1
1131863|NCT01513317|3718199|P1|Overall Study|Not specified|0
1131864|NCT01513317|3718198|P2|Overall Study|Study terminated by sponsor|18
1131865|NCT01513317|3718199|P1|Overall Study|Study terminated by sponsor|18
1131866|NCT01513317|3718198|P2|Overall Study|Death|1
1131867|NCT01513317|3718199|P1|Overall Study|Death|1
1131868|NCT01513317|3718198|P2|Overall Study|Withdrawal by Subject|4
1131869|NCT01513317|3718199|P1|Overall Study|Withdrawal by Subject|15
1131870|NCT01513291|3718217|P5|Run-out Period|Withdrawal by Subject|0
1131871|NCT01513291|3718218|P4|Run-out Period|Withdrawal by Subject|1
1131872|NCT01513291|3718219|P3|Run-out Period|Withdrawal by Subject|0
1131873|NCT01513291|3718220|P2|Run-out Period|Withdrawal by Subject|0
1131874|NCT01513291|3718221|P1|Run-out Period|Withdrawal by Subject|0
1131875|NCT01513291|3718217|P5|Run-out Period|Lost to Follow-up|0
1131876|NCT01513291|3718218|P4|Run-out Period|Lost to Follow-up|1
1131877|NCT01513291|3718219|P3|Run-out Period|Lost to Follow-up|0
1131878|NCT01513291|3718220|P2|Run-out Period|Lost to Follow-up|0
1131879|NCT01513291|3718221|P1|Run-out Period|Lost to Follow-up|0
1131880|NCT01513291|3718217|P5|Treatment Period|Randomized not treated|0
1131881|NCT01513291|3718218|P4|Treatment Period|Randomized not treated|0
1131882|NCT01513291|3718219|P3|Treatment Period|Randomized not treated|0
1131883|NCT01513291|3718220|P2|Treatment Period|Randomized not treated|2
1131884|NCT01513291|3718221|P1|Treatment Period|Randomized not treated|0
1131885|NCT01513291|3718217|P5|Treatment Period|Withdrawal by Subject|0
1131886|NCT01513291|3718218|P4|Treatment Period|Withdrawal by Subject|0
1131887|NCT01513291|3718219|P3|Treatment Period|Withdrawal by Subject|0
1131888|NCT01513291|3718220|P2|Treatment Period|Withdrawal by Subject|5
1131889|NCT01513291|3718221|P1|Treatment Period|Withdrawal by Subject|8
1131890|NCT01513291|3718217|P5|Treatment Period|Protocol Violation|0
1131891|NCT01513291|3718218|P4|Treatment Period|Protocol Violation|0
1131892|NCT01513291|3718219|P3|Treatment Period|Protocol Violation|0
1131893|NCT01513291|3718220|P2|Treatment Period|Protocol Violation|2
1131894|NCT01513291|3718221|P1|Treatment Period|Protocol Violation|1
1131895|NCT01513291|3718217|P5|Treatment Period|Physician Decision|0
1131896|NCT01513291|3718218|P4|Treatment Period|Physician Decision|0
1131897|NCT01513291|3718219|P3|Treatment Period|Physician Decision|0
1131898|NCT01513291|3718220|P2|Treatment Period|Physician Decision|0
1131899|NCT01513291|3718221|P1|Treatment Period|Physician Decision|1
1131900|NCT01513291|3718217|P5|Treatment Period|Lost to Follow-up|0
1131901|NCT01513291|3718218|P4|Treatment Period|Lost to Follow-up|0
1131902|NCT01513291|3718219|P3|Treatment Period|Lost to Follow-up|0
1131903|NCT01513291|3718220|P2|Treatment Period|Lost to Follow-up|3
1131904|NCT01513291|3718221|P1|Treatment Period|Lost to Follow-up|2
1131905|NCT01513291|3718217|P5|Treatment Period|Lack of Efficacy|0
1131906|NCT01513291|3718218|P4|Treatment Period|Lack of Efficacy|0
1131907|NCT01513291|3718219|P3|Treatment Period|Lack of Efficacy|0
1131908|NCT01513291|3718220|P2|Treatment Period|Lack of Efficacy|0
1131909|NCT01513291|3718221|P1|Treatment Period|Lack of Efficacy|3
1131910|NCT01513291|3718217|P5|Treatment Period|Adverse Event|0
1131911|NCT01513291|3718218|P4|Treatment Period|Adverse Event|0
1131912|NCT01513291|3718219|P3|Treatment Period|Adverse Event|0
1131913|NCT01513291|3718220|P2|Treatment Period|Adverse Event|4
1131914|NCT01513291|3718221|P1|Treatment Period|Adverse Event|8
1131915|NCT01513239|3718249|P6|Period 2: 9 Month Extension Phase|Technical Problems|1
1131916|NCT01513239|3718250|P5|Period 2: 9 Month Extension Phase|Technical Problems|1
1131917|NCT01513239|3718251|P4|Period 2: 9 Month Extension Phase|Technical Problems|0
1131918|NCT01513239|3718252|P3|Period 2: 9 Month Extension Phase|Technical Problems|0
1131919|NCT01513239|3718253|P2|Period 2: 9 Month Extension Phase|Technical Problems|0
1131920|NCT01513239|3718254|P1|Period 2: 9 Month Extension Phase|Technical Problems|0
1131921|NCT01513239|3718249|P6|Period 2: 9 Month Extension Phase|Physician Decision|0
1131922|NCT01513239|3718250|P5|Period 2: 9 Month Extension Phase|Physician Decision|0
1131923|NCT01513239|3718251|P4|Period 2: 9 Month Extension Phase|Physician Decision|1
1131924|NCT01513239|3718252|P3|Period 2: 9 Month Extension Phase|Physician Decision|0
1131925|NCT01513239|3718253|P2|Period 2: 9 Month Extension Phase|Physician Decision|0
1131926|NCT01513239|3718254|P1|Period 2: 9 Month Extension Phase|Physician Decision|0
1131927|NCT01513239|3718249|P6|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
1131928|NCT01513239|3718250|P5|Period 2: 9 Month Extension Phase|Lost to Follow-up|1
1131929|NCT01513239|3718251|P4|Period 2: 9 Month Extension Phase|Lost to Follow-up|2
1131930|NCT01513239|3718252|P3|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
1131931|NCT01513239|3718253|P2|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
1131932|NCT01513239|3718254|P1|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
1131933|NCT01513239|3718249|P6|Period 2: 9 Month Extension Phase|Death|2
1131934|NCT01513239|3718250|P5|Period 2: 9 Month Extension Phase|Death|5
1131935|NCT01513239|3718251|P4|Period 2: 9 Month Extension Phase|Death|2
1131936|NCT01513239|3718252|P3|Period 2: 9 Month Extension Phase|Death|0
1131937|NCT01513239|3718253|P2|Period 2: 9 Month Extension Phase|Death|0
1131938|NCT01513239|3718254|P1|Period 2: 9 Month Extension Phase|Death|0
1131939|NCT01513239|3718249|P6|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2
1131940|NCT01513239|3718250|P5|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3
1131941|NCT01513239|3718251|P4|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5
1131942|NCT01513239|3718252|P3|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
1131943|NCT01513239|3718253|P2|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
1131944|NCT01513239|3718254|P1|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
1131945|NCT01513239|3718249|P6|Period 1: Main Phase|Withdrawal by Subject|0
1131946|NCT01513239|3718250|P5|Period 1: Main Phase|Withdrawal by Subject|0
1131947|NCT01513239|3718251|P4|Period 1: Main Phase|Withdrawal by Subject|0
1131948|NCT01513239|3718252|P3|Period 1: Main Phase|Withdrawal by Subject|42
1131949|NCT01513239|3718253|P2|Period 1: Main Phase|Withdrawal by Subject|29
1131950|NCT01513239|3718254|P1|Period 1: Main Phase|Withdrawal by Subject|27
1131951|NCT01513239|3718249|P6|Period 1: Main Phase|Technical Problems|0
1131952|NCT01513239|3718250|P5|Period 1: Main Phase|Technical Problems|0
1131953|NCT01513239|3718251|P4|Period 1: Main Phase|Technical Problems|0
1131954|NCT01513239|3718252|P3|Period 1: Main Phase|Technical Problems|0
1131955|NCT01513239|3718253|P2|Period 1: Main Phase|Technical Problems|2
1131956|NCT01513239|3718254|P1|Period 1: Main Phase|Technical Problems|1
1131957|NCT01513239|3718249|P6|Period 1: Main Phase|Protocol Violation|0
1131958|NCT01513239|3718250|P5|Period 1: Main Phase|Protocol Violation|0
1131959|NCT01513239|3718251|P4|Period 1: Main Phase|Protocol Violation|0
1131960|NCT01513239|3718252|P3|Period 1: Main Phase|Protocol Violation|2
1131961|NCT01513239|3718253|P2|Period 1: Main Phase|Protocol Violation|2
1131962|NCT01513239|3718254|P1|Period 1: Main Phase|Protocol Violation|2
1131963|NCT01513239|3718249|P6|Period 1: Main Phase|Physician Decision|0
1131964|NCT01513239|3718250|P5|Period 1: Main Phase|Physician Decision|0
1131965|NCT01513239|3718251|P4|Period 1: Main Phase|Physician Decision|0
1131966|NCT01513239|3718252|P3|Period 1: Main Phase|Physician Decision|4
1131967|NCT01513239|3718253|P2|Period 1: Main Phase|Physician Decision|4
1131968|NCT01513239|3718254|P1|Period 1: Main Phase|Physician Decision|4
1131969|NCT01513239|3718249|P6|Period 1: Main Phase|Lost to Follow-up|0
1131970|NCT01513239|3718250|P5|Period 1: Main Phase|Lost to Follow-up|0
1131971|NCT01513239|3718251|P4|Period 1: Main Phase|Lost to Follow-up|0
1131972|NCT01513239|3718252|P3|Period 1: Main Phase|Lost to Follow-up|6
1131973|NCT01513239|3718253|P2|Period 1: Main Phase|Lost to Follow-up|10
1131974|NCT01513239|3718254|P1|Period 1: Main Phase|Lost to Follow-up|11
1131975|NCT01513239|3718249|P6|Period 1: Main Phase|Death|0
1131976|NCT01513239|3718250|P5|Period 1: Main Phase|Death|0
1131977|NCT01513239|3718251|P4|Period 1: Main Phase|Death|0
1131978|NCT01513239|3718252|P3|Period 1: Main Phase|Death|32
1131979|NCT01513239|3718253|P2|Period 1: Main Phase|Death|22
1131980|NCT01513239|3718254|P1|Period 1: Main Phase|Death|29
1131981|NCT01513239|3718249|P6|Period 1: Main Phase|Adverse Event|0
1131982|NCT01513239|3718250|P5|Period 1: Main Phase|Adverse Event|0
1131983|NCT01513239|3718251|P4|Period 1: Main Phase|Adverse Event|0
1131984|NCT01513239|3718252|P3|Period 1: Main Phase|Adverse Event|2
1131985|NCT01513239|3718253|P2|Period 1: Main Phase|Adverse Event|1
1131986|NCT01513239|3718254|P1|Period 1: Main Phase|Adverse Event|1
1131987|NCT01513148|3718307|P2|Overall Study|Protocol Violation|2
1131988|NCT01513148|3718308|P1|Overall Study|Protocol Violation|2
1131989|NCT01512979|3718375|P2|Overall Study|Reason other than stated above|9
1131990|NCT01512979|3718376|P1|Overall Study|Reason other than stated above|13
1131991|NCT01512979|3718375|P2|Overall Study|Withdrawal by Subject|2
1131992|NCT01512979|3718376|P1|Overall Study|Withdrawal by Subject|1
1131993|NCT01512979|3718375|P2|Overall Study|Lost to Follow-up|5
1131994|NCT01512979|3718376|P1|Overall Study|Lost to Follow-up|2
1131995|NCT01512979|3718375|P2|Overall Study|Protocol Violation|4
1131996|NCT01512979|3718376|P1|Overall Study|Protocol Violation|1
1131997|NCT01512979|3718375|P2|Overall Study|Adverse Event|2
1131998|NCT01512979|3718376|P1|Overall Study|Adverse Event|2
1131999|NCT01512745|3718440|P2|Overall Study|Protocol Violation|0
1132000|NCT01512745|3718441|P1|Overall Study|Protocol Violation|1
1132001|NCT01512745|3718440|P2|Overall Study|Lack of Efficacy|2
1132002|NCT01512745|3718441|P1|Overall Study|Lack of Efficacy|2
1132003|NCT01512745|3718440|P2|Overall Study|Lost to Follow-up|0
1132004|NCT01512745|3718441|P1|Overall Study|Lost to Follow-up|4
1132005|NCT01512745|3718440|P2|Overall Study|Withdrawal by Subject|2
1132006|NCT01512745|3718441|P1|Overall Study|Withdrawal by Subject|2
1132007|NCT01512745|3718440|P2|Overall Study|Death|13
1132008|NCT01512745|3718441|P1|Overall Study|Death|9
1132009|NCT01512745|3718440|P2|Overall Study|Adverse Event|3
1132010|NCT01512745|3718441|P1|Overall Study|Adverse Event|22
1132011|NCT01512693|3718457|P2|Overall Study|Withdrawal by Subject|1
1132012|NCT01512693|3718458|P1|Overall Study|Withdrawal by Subject|0
1132013|NCT01512368|3718485|P1|Overall Study|Protocol Violation|3
1132014|NCT01512160|3718543|P4|Overall Study|Withdrawal by Subject|1
1132015|NCT01512160|3718544|P3|Overall Study|Withdrawal by Subject|0
1132016|NCT01512160|3718545|P2|Overall Study|Withdrawal by Subject|0
1132017|NCT01512160|3718546|P1|Overall Study|Withdrawal by Subject|1
1132018|NCT01512160|3718543|P4|Overall Study|Lost to Follow-up|0
1132019|NCT01512160|3718544|P3|Overall Study|Lost to Follow-up|0
1132020|NCT01512160|3718545|P2|Overall Study|Lost to Follow-up|0
1132021|NCT01512160|3718546|P1|Overall Study|Lost to Follow-up|1
1132022|NCT01512108|3718638|P2|Overall Study|Unclassified|3
1132023|NCT01512108|3718639|P1|Overall Study|Unclassified|11
1132024|NCT01512108|3718638|P2|Overall Study|Withdrawal Criteria|0
1132025|NCT01512108|3718639|P1|Overall Study|Withdrawal Criteria|1
1132026|NCT01512108|3718638|P2|Overall Study|Protocol Violation|2
1132027|NCT01512108|3718639|P1|Overall Study|Protocol Violation|1
1132028|NCT01512108|3718638|P2|Overall Study|Adverse Event|4
1132029|NCT01512108|3718639|P1|Overall Study|Adverse Event|9
1132030|NCT01511939|3718665|P3|Overall Study|Withdrawal by Subject|0
1132031|NCT01511939|3718666|P2|Overall Study|Withdrawal by Subject|1
1132032|NCT01511939|3718667|P1|Overall Study|Withdrawal by Subject|2
1132033|NCT01511536|3718696|P3|Phase 2|Other|9
1132034|NCT01511536|3718697|P2|Phase 2|Other|0
1132035|NCT01511536|3718698|P1|Phase 2|Other|0
1132036|NCT01511536|3718696|P3|Phase 1|Other|0
1132037|NCT01511536|3718697|P2|Phase 1|Other|1
1132038|NCT01511536|3718698|P1|Phase 1|Other|0
1132039|NCT01511445|3718720|P2|Overall Study|Protocol Violation|0
1132040|NCT01511445|3718721|P1|Overall Study|Protocol Violation|1
1132041|NCT01511445|3718720|P2|Overall Study|Protocol Violation|3
1132042|NCT01511445|3718721|P1|Overall Study|Protocol Violation|1
1132043|NCT01511445|3718720|P2|Overall Study|Lost to Follow-up|1
1132044|NCT01511445|3718721|P1|Overall Study|Lost to Follow-up|3
1132045|NCT01511250|3718749|P10|Overall Study|Protocol Violation|0
1132046|NCT01511250|3718750|P9|Overall Study|Protocol Violation|0
1132047|NCT01511250|3718751|P8|Overall Study|Protocol Violation|0
1132048|NCT01511250|3718752|P7|Overall Study|Protocol Violation|0
1132049|NCT01511250|3718753|P6|Overall Study|Protocol Violation|0
1132050|NCT01511250|3718754|P5|Overall Study|Protocol Violation|0
1132051|NCT01511250|3718755|P4|Overall Study|Protocol Violation|0
1132052|NCT01511250|3718756|P3|Overall Study|Protocol Violation|1
1132053|NCT01511250|3718757|P2|Overall Study|Protocol Violation|2
1132054|NCT01511250|3718758|P1|Overall Study|Protocol Violation|0
1132055|NCT01511250|3718749|P10|Overall Study|Lost to Follow-up|5
1132056|NCT01511250|3718750|P9|Overall Study|Lost to Follow-up|13
1132057|NCT01511250|3718751|P8|Overall Study|Lost to Follow-up|3
1132058|NCT01511250|3718752|P7|Overall Study|Lost to Follow-up|2
1132059|NCT01511250|3718753|P6|Overall Study|Lost to Follow-up|0
1132060|NCT01511250|3718754|P5|Overall Study|Lost to Follow-up|0
1132061|NCT01511250|3718755|P4|Overall Study|Lost to Follow-up|3
1132062|NCT01511250|3718756|P3|Overall Study|Lost to Follow-up|3
1132063|NCT01511250|3718757|P2|Overall Study|Lost to Follow-up|3
1132064|NCT01511250|3718758|P1|Overall Study|Lost to Follow-up|7
1132065|NCT01511250|3718749|P10|Overall Study|Sponsor/Investigator Decision|0
1132066|NCT01511250|3718750|P9|Overall Study|Sponsor/Investigator Decision|0
1132067|NCT01511250|3718751|P8|Overall Study|Sponsor/Investigator Decision|0
1132068|NCT01511250|3718752|P7|Overall Study|Sponsor/Investigator Decision|0
1132069|NCT01511250|3718753|P6|Overall Study|Sponsor/Investigator Decision|0
1132070|NCT01511250|3718754|P5|Overall Study|Sponsor/Investigator Decision|0
1132071|NCT01511250|3718755|P4|Overall Study|Sponsor/Investigator Decision|0
1132072|NCT01511250|3718756|P3|Overall Study|Sponsor/Investigator Decision|0
1132073|NCT01511250|3718757|P2|Overall Study|Sponsor/Investigator Decision|0
1132074|NCT01511250|3718758|P1|Overall Study|Sponsor/Investigator Decision|1
1132075|NCT01511250|3718749|P10|Overall Study|Withdrawal of Consent|0
1132076|NCT01511250|3718750|P9|Overall Study|Withdrawal of Consent|1
1132077|NCT01511250|3718751|P8|Overall Study|Withdrawal of Consent|1
1132078|NCT01511250|3718752|P7|Overall Study|Withdrawal of Consent|0
1132079|NCT01511250|3718753|P6|Overall Study|Withdrawal of Consent|0
1132080|NCT01511250|3718754|P5|Overall Study|Withdrawal of Consent|0
1132081|NCT01511250|3718755|P4|Overall Study|Withdrawal of Consent|0
1132082|NCT01511250|3718756|P3|Overall Study|Withdrawal of Consent|0
1132083|NCT01511250|3718757|P2|Overall Study|Withdrawal of Consent|0
1132084|NCT01511250|3718758|P1|Overall Study|Withdrawal of Consent|1
1132085|NCT01511107|3718906|P2|Overall Study|Withdrawal by Subject|20
1132086|NCT01511107|3718907|P1|Overall Study|Withdrawal by Subject|9
1132087|NCT01511107|3718906|P2|Overall Study|Lost to Follow-up|19
1132088|NCT01511107|3718907|P1|Overall Study|Lost to Follow-up|10
1132089|NCT01511107|3718906|P2|Overall Study|Ineligible|2
1132090|NCT01511107|3718907|P1|Overall Study|Ineligible|3
1132091|NCT01510912|3718985|P1|Overall Study|Other, including joint replacement|5
1132092|NCT01510912|3718985|P1|Overall Study|Lost to Follow-up|26
1132093|NCT01510912|3718985|P1|Overall Study|Protocol Violation|27
1132094|NCT01510912|3718985|P1|Overall Study|Physician Decision|1
1132095|NCT01510912|3718985|P1|Overall Study|Withdrawal by Subject|49
1132096|NCT01510912|3718985|P1|Overall Study|Non-compliance with trial drug|23
1132097|NCT01510912|3718985|P1|Overall Study|Lack of Efficacy|12
1132098|NCT01510912|3718985|P1|Overall Study|Adverse Event|99
1132099|NCT01510769|3719001|P3|Overall Study|Death|0
1132100|NCT01510769|3719002|P2|Overall Study|Death|1
1132101|NCT01510769|3719003|P1|Overall Study|Death|1
1132102|NCT01510769|3719001|P3|Overall Study|Withdrawal by Subject|3
1132103|NCT01510769|3719002|P2|Overall Study|Withdrawal by Subject|4
1132104|NCT01510769|3719003|P1|Overall Study|Withdrawal by Subject|3
1132105|NCT01510769|3719001|P3|Overall Study|Lost to Follow-up|5
1132106|NCT01510769|3719002|P2|Overall Study|Lost to Follow-up|1
1132107|NCT01510769|3719003|P1|Overall Study|Lost to Follow-up|5
1132108|NCT01510769|3719001|P3|Overall Study|Protocol Violation|9
1132109|NCT01510769|3719002|P2|Overall Study|Protocol Violation|10
1132110|NCT01510769|3719003|P1|Overall Study|Protocol Violation|11
1132111|NCT01510769|3719001|P3|Overall Study|Gout Flare|1
1132112|NCT01510769|3719002|P2|Overall Study|Gout Flare|3
1132113|NCT01510769|3719003|P1|Overall Study|Gout Flare|0
1132114|NCT01510769|3719001|P3|Overall Study|Adverse Event|4
1132115|NCT01510769|3719002|P2|Overall Study|Adverse Event|6
1132116|NCT01510769|3719003|P1|Overall Study|Adverse Event|7
1132117|NCT01510756|3719020|P1|Overall Study|Physician Decision|1
1132118|NCT01510756|3719020|P1|Overall Study|Lack of Efficacy|2
1132119|NCT01510756|3719020|P1|Overall Study|Death|1
1132120|NCT01510717|3719028|P2|Overall Study|Withdrawal by Subject|2
1132121|NCT01510717|3719029|P1|Overall Study|Withdrawal by Subject|0
1132122|NCT01510717|3719028|P2|Overall Study|Lost to Follow-up|1
1132123|NCT01510717|3719029|P1|Overall Study|Lost to Follow-up|0
1132124|NCT01510717|3719028|P2|Overall Study|Death|0
1132125|NCT01510717|3719029|P1|Overall Study|Death|1
1132126|NCT01510717|3719028|P2|Overall Study|Adverse Event|2
1132127|NCT01510717|3719029|P1|Overall Study|Adverse Event|1
1132128|NCT01510158|3719149|P3|Overall Study|Death|0
1132129|NCT01510158|3719150|P2|Overall Study|Death|0
1132130|NCT01510158|3719151|P1|Overall Study|Death|1
1132131|NCT01510158|3719149|P3|Overall Study|Withdrawal by Subject|10
1132132|NCT01510158|3719150|P2|Overall Study|Withdrawal by Subject|13
1132133|NCT01510158|3719151|P1|Overall Study|Withdrawal by Subject|10
1132134|NCT01510158|3719149|P3|Overall Study|Lost to Follow-up|9
1132135|NCT01510158|3719150|P2|Overall Study|Lost to Follow-up|16
1132136|NCT01510158|3719151|P1|Overall Study|Lost to Follow-up|13
1132137|NCT01510158|3719149|P3|Overall Study|Sponsor terminated study.|2
1132138|NCT01510158|3719150|P2|Overall Study|Sponsor terminated study.|0
1132139|NCT01510158|3719151|P1|Overall Study|Sponsor terminated study.|2
1132140|NCT01510158|3719149|P3|Overall Study|Protocol Violation|24
1132141|NCT01510158|3719150|P2|Overall Study|Protocol Violation|16
1132142|NCT01510158|3719151|P1|Overall Study|Protocol Violation|17
1132143|NCT01510158|3719149|P3|Overall Study|Gout flare|0
1132144|NCT01510158|3719150|P2|Overall Study|Gout flare|0
1132145|NCT01510158|3719151|P1|Overall Study|Gout flare|1
1132146|NCT01510158|3719149|P3|Overall Study|Adverse Event|5
1132147|NCT01510158|3719150|P2|Overall Study|Adverse Event|8
1132148|NCT01510158|3719151|P1|Overall Study|Adverse Event|7
1132149|NCT01510145|3719165|P1|Overall Study|Relative reported subject withdrew|1
1132150|NCT01510145|3719165|P1|Overall Study|Withdrawal by Subject|6
1132151|NCT01510145|3719165|P1|Overall Study|Lost to Follow-up|5
1132152|NCT01510145|3719165|P1|Overall Study|Adverse Event|6
1132153|NCT01510028|3719174|P4|Overall Study|Lack of Efficacy|0
1132154|NCT01510028|3719175|P3|Overall Study|Lack of Efficacy|0
1132155|NCT01510028|3719176|P2|Overall Study|Lack of Efficacy|0
1132156|NCT01510028|3719177|P1|Overall Study|Lack of Efficacy|1
1132157|NCT01509664|3719320|P2|Overall Study|Lost to Follow-up|21
1132158|NCT01509664|3719321|P1|Overall Study|Lost to Follow-up|15
1132159|NCT01509079|3719432|P2|Overall Study|started an excluded medication|1
1132160|NCT01509079|3719433|P1|Overall Study|started an excluded medication|0
1132161|NCT01509079|3719432|P2|Overall Study|Lack of Efficacy|2
1132162|NCT01509079|3719433|P1|Overall Study|Lack of Efficacy|0
1132163|NCT01509053|3719449|P1|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3
1132164|NCT01509053|3719449|P1|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1
1132165|NCT01509053|3719449|P1|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1
1132166|NCT01509053|3719449|P1|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13
1132167|NCT01509053|3719449|P1|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1
1132168|NCT01509053|3719449|P1|Oral Aripirazole (Phase A)|Sponsor discontinued study|11
1132169|NCT01508936|3719511|P2|Overall Study|Data from 2 sites deemed invalid|11
1132170|NCT01508936|3719512|P1|Overall Study|Data from 2 sites deemed invalid|4
1132171|NCT01508936|3719511|P2|Overall Study|Not specified|5
1132172|NCT01508936|3719512|P1|Overall Study|Not specified|0
1132173|NCT01508936|3719511|P2|Overall Study|Lost to Follow-up|9
1132174|NCT01508936|3719512|P1|Overall Study|Lost to Follow-up|2
1132175|NCT01508936|3719511|P2|Overall Study|Protocol Violation|3
1132176|NCT01508936|3719512|P1|Overall Study|Protocol Violation|2
1132177|NCT01508936|3719511|P2|Overall Study|Withdrawal by Subject|18
1132178|NCT01508936|3719512|P1|Overall Study|Withdrawal by Subject|4
1132179|NCT01508936|3719511|P2|Overall Study|Lack of Efficacy|1
1132180|NCT01508936|3719512|P1|Overall Study|Lack of Efficacy|0
1132181|NCT01508936|3719511|P2|Overall Study|Adverse Event|32
1132182|NCT01508936|3719512|P1|Overall Study|Adverse Event|11
1132183|NCT01508910|3719551|P4|Treatment|Sponsor Decision|1
1132184|NCT01508910|3719552|P3|Treatment|Sponsor Decision|0
1132185|NCT01508910|3719553|P2|Treatment|Sponsor Decision|0
1132186|NCT01508910|3719554|P1|Treatment|Sponsor Decision|0
1132187|NCT01508910|3719551|P4|Treatment|Withdrawal by Subject|1
1132188|NCT01508910|3719552|P3|Treatment|Withdrawal by Subject|6
1132189|NCT01508910|3719553|P2|Treatment|Withdrawal by Subject|1
1132190|NCT01508910|3719554|P1|Treatment|Withdrawal by Subject|0
1132191|NCT01508910|3719551|P4|Treatment|Lost to Follow-up|1
1132192|NCT01508910|3719552|P3|Treatment|Lost to Follow-up|2
1132193|NCT01508910|3719553|P2|Treatment|Lost to Follow-up|0
1132194|NCT01508910|3719554|P1|Treatment|Lost to Follow-up|0
1132195|NCT01508910|3719551|P4|Treatment|Death|0
1132196|NCT01508910|3719552|P3|Treatment|Death|2
1132197|NCT01508910|3719553|P2|Treatment|Death|3
1132198|NCT01508910|3719554|P1|Treatment|Death|2
1132199|NCT01508702|3719587|P2|Overall Study|Withdrawal by Subject|7
1132200|NCT01508702|3719588|P1|Overall Study|Withdrawal by Subject|11
1132201|NCT01508702|3719587|P2|Overall Study|Lost to Follow-up|2
1132202|NCT01508702|3719588|P1|Overall Study|Lost to Follow-up|1
1132203|NCT01508702|3719587|P2|Overall Study|Protocol Violation|1
1132204|NCT01508702|3719588|P1|Overall Study|Protocol Violation|2
1132205|NCT01508702|3719587|P2|Overall Study|Gout flare|0
1132206|NCT01508702|3719588|P1|Overall Study|Gout flare|2
1132207|NCT01508702|3719587|P2|Overall Study|Adverse Event|3
1132208|NCT01508702|3719588|P1|Overall Study|Adverse Event|7
1132209|NCT01508676|3719596|P2|Phase II (2 Weeks)|Medication Exclusion|0
1132210|NCT01508676|3719597|P1|Phase II (2 Weeks)|Medication Exclusion|1
1132211|NCT01508676|3719596|P2|Phase II (2 Weeks)|Skin Sensitivity|1
1132212|NCT01508676|3719597|P1|Phase II (2 Weeks)|Skin Sensitivity|0
1132213|NCT01508676|3719596|P2|Phase I (2 Weeks)|Positive Drug Screen|2
1132214|NCT01508676|3719597|P1|Phase I (2 Weeks)|Positive Drug Screen|0
1132215|NCT01508676|3719596|P2|Phase I (2 Weeks)|Wrong Pain Type|0
1132216|NCT01508676|3719597|P1|Phase I (2 Weeks)|Wrong Pain Type|1
1132217|NCT01508676|3719596|P2|Phase I (2 Weeks)|Medication Exclusion|1
1132218|NCT01508676|3719597|P1|Phase I (2 Weeks)|Medication Exclusion|1
1132219|NCT01508325|3719618|P2|Overall Study|Other|2
1132220|NCT01508325|3719619|P1|Overall Study|Other|2
1132221|NCT01508325|3719618|P2|Overall Study|Lost to Follow-up|6
1132222|NCT01508325|3719619|P1|Overall Study|Lost to Follow-up|5
1132223|NCT01508325|3719618|P2|Overall Study|Adverse Event|0
1132224|NCT01508325|3719619|P1|Overall Study|Adverse Event|1
1132225|NCT01508325|3719618|P2|Overall Study|Physician Decision|1
1132226|NCT01508325|3719619|P1|Overall Study|Physician Decision|2
1132227|NCT01508325|3719618|P2|Overall Study|Protocol Violation|3
1132228|NCT01508325|3719619|P1|Overall Study|Protocol Violation|0
1132229|NCT01508325|3719618|P2|Overall Study|Withdrawal by Subject|9
1132230|NCT01508325|3719619|P1|Overall Study|Withdrawal by Subject|8
1132231|NCT01508169|3719649|P2|Overall Study|Lost to Follow-up|2
1132232|NCT01508169|3719650|P1|Overall Study|Lost to Follow-up|1
1132233|NCT01508169|3719649|P2|Overall Study|Withdrawal by Subject|0
1132234|NCT01508169|3719650|P1|Overall Study|Withdrawal by Subject|1
1132235|NCT01508169|3719649|P2|Overall Study|Adverse Event|0
1132236|NCT01508169|3719650|P1|Overall Study|Adverse Event|1
1132237|NCT01508130|3719664|P2|Overall Study|Administrative|3
1132238|NCT01508130|3719665|P1|Overall Study|Administrative|14
1132239|NCT01508130|3719664|P2|Overall Study|Insufficient therapeutic response|23
1132240|NCT01508130|3719665|P1|Overall Study|Insufficient therapeutic response|74
1132241|NCT01508130|3719664|P2|Overall Study|Subject’s substantial non-compliance|9
1132242|NCT01508130|3719665|P1|Overall Study|Subject’s substantial non-compliance|25
1132243|NCT01508130|3719664|P2|Overall Study|Withdrawal by Subject|3
1132244|NCT01508130|3719665|P1|Overall Study|Withdrawal by Subject|3
1132245|NCT01508130|3719664|P2|Overall Study|Lost to Follow-up|2
1132246|NCT01508130|3719665|P1|Overall Study|Lost to Follow-up|25
1132247|NCT01508130|3719664|P2|Overall Study|Protocol Violation|0
1132248|NCT01508130|3719665|P1|Overall Study|Protocol Violation|2
1132249|NCT01508130|3719664|P2|Overall Study|Death|1
1132250|NCT01508130|3719665|P1|Overall Study|Death|3
1132251|NCT01508130|3719664|P2|Overall Study|Adverse Event|28
1132252|NCT01508130|3719665|P1|Overall Study|Adverse Event|81
1132253|NCT01507896|3719733|P1|Overall Study|The surgery was denied by the sponsor.|1
1132254|NCT01507896|3719733|P1|Overall Study|Withdrawal by Subject|1
1132255|NCT01507831|3719776|P2|Overall Study|Other|6
1132256|NCT01507831|3719777|P1|Overall Study|Other|3
1132257|NCT01507831|3719776|P2|Overall Study|Potential lost to follow-up|0
1132258|NCT01507831|3719777|P1|Overall Study|Potential lost to follow-up|3
1132259|NCT01507831|3719776|P2|Overall Study|Site closure|3
1132260|NCT01507831|3719777|P1|Overall Study|Site closure|0
1132261|NCT01507831|3719776|P2|Overall Study|Selection criteria finally not met|1
1132262|NCT01507831|3719777|P1|Overall Study|Selection criteria finally not met|0
1132263|NCT01507831|3719776|P2|Overall Study|Last visit outside protocol visit window|143
1132264|NCT01507831|3719777|P1|Overall Study|Last visit outside protocol visit window|51
1132265|NCT01507831|3719776|P2|Overall Study|Related to study drug administration|14
1132266|NCT01507831|3719777|P1|Overall Study|Related to study drug administration|5
1132267|NCT01507831|3719776|P2|Overall Study|Consent withdrawn by participant|72
1132268|NCT01507831|3719777|P1|Overall Study|Consent withdrawn by participant|34
1132269|NCT01507831|3719776|P2|Overall Study|Participant moved|19
1132270|NCT01507831|3719777|P1|Overall Study|Participant moved|5
1132271|NCT01507831|3719776|P2|Overall Study|Physician Decision|4
1132272|NCT01507831|3719777|P1|Overall Study|Physician Decision|0
1132273|NCT01507831|3719776|P2|Overall Study|Poor compliance to protocol|60
1132274|NCT01507831|3719777|P1|Overall Study|Poor compliance to protocol|38
1132275|NCT01507831|3719776|P2|Overall Study|Death|2
1132276|NCT01507831|3719777|P1|Overall Study|Death|6
1132277|NCT01507831|3719776|P2|Overall Study|Adverse Event|113
1132278|NCT01507831|3719777|P1|Overall Study|Adverse Event|48
1132279|NCT01507831|3719776|P2|Overall Study|Randomized but not treated|3
1132280|NCT01507831|3719777|P1|Overall Study|Randomized but not treated|0
1132281|NCT01507662|3719847|P2|Overall Study|Proxy interview done|3
1132282|NCT01507662|3719848|P1|Overall Study|Proxy interview done|2
1132283|NCT01507662|3719847|P2|Overall Study|Lost to Follow-up|523
1132284|NCT01507662|3719848|P1|Overall Study|Lost to Follow-up|498
1132285|NCT01507662|3719847|P2|Overall Study|Withdrawal by Subject|287
1132286|NCT01507662|3719848|P1|Overall Study|Withdrawal by Subject|290
1132287|NCT01507662|3719847|P2|Overall Study|Death|18
1132288|NCT01507662|3719848|P1|Overall Study|Death|26
1132289|NCT01507246|3719873|P2|Overall Study|Required different surgical procedures|1
1132290|NCT01507246|3719874|P1|Overall Study|Required different surgical procedures|2
1132291|NCT01507090|3719972|P1|Overall Study|incomplete dataset|18
1132292|NCT01507051|3720011|P4|Overall Study|Adverse Event|0
1132293|NCT01507051|3720012|P3|Overall Study|Adverse Event|0
1132294|NCT01507051|3720013|P2|Overall Study|Adverse Event|0
1132295|NCT01507051|3720014|P1|Overall Study|Adverse Event|1
1132296|NCT01507051|3720011|P4|Overall Study|Physician Decision|1
1132297|NCT01507051|3720012|P3|Overall Study|Physician Decision|0
1132298|NCT01507051|3720013|P2|Overall Study|Physician Decision|0
1132299|NCT01507051|3720014|P1|Overall Study|Physician Decision|0
1132300|NCT01507051|3720011|P4|Overall Study|Withdrawal by Subject|6
1132301|NCT01507051|3720012|P3|Overall Study|Withdrawal by Subject|1
1132302|NCT01507051|3720013|P2|Overall Study|Withdrawal by Subject|3
1132303|NCT01507051|3720014|P1|Overall Study|Withdrawal by Subject|1
1132304|NCT01506960|3720132|P1|Overall Study|Did not meet angiographic criteria|47
1132305|NCT01506947|3720138|P1|Overall Study|Did Not Meet Eligibility Criteria|3
1132306|NCT01506947|3720138|P1|Overall Study|Death|1
1132307|NCT01506947|3720138|P1|Overall Study|Adverse Event|5
1132308|NCT01506947|3720138|P1|Overall Study|Lost to Follow-up|7
1132309|NCT01506908|3720156|P2|Overall Study|Adverse Event|0
1132310|NCT01506908|3720157|P1|Overall Study|Adverse Event|1
1132311|NCT01506882|3720175|P2|Overall Study|Other Reason|0
1132312|NCT01506882|3720176|P1|Overall Study|Other Reason|2
1132313|NCT01506882|3720175|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
1132314|NCT01506882|3720176|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
1132315|NCT01506882|3720175|P2|Overall Study|AE, non-serious non-fatal|1
1132316|NCT01506882|3720176|P1|Overall Study|AE, non-serious non-fatal|3
1132317|NCT01506882|3720175|P2|Overall Study|SAE, non-fatal|0
1132318|NCT01506882|3720176|P1|Overall Study|SAE, non-fatal|2
1132319|NCT01506882|3720175|P2|Overall Study|Withdrawal by Subject|3
1132320|NCT01506882|3720176|P1|Overall Study|Withdrawal by Subject|9
1132321|NCT01506882|3720175|P2|Overall Study|Lost to Follow-up|0
1132322|NCT01506882|3720176|P1|Overall Study|Lost to Follow-up|1
1132323|NCT01506882|3720175|P2|Overall Study|Lack of Efficacy|3
1132324|NCT01506882|3720176|P1|Overall Study|Lack of Efficacy|4
1132325|NCT01506726|3720190|P2|Overall Study|Adverse Event|2
1132326|NCT01506726|3720191|P1|Overall Study|Adverse Event|1
1132327|NCT01506596|3720231|P1|Overall Study|ineligible pathology|1
1132328|NCT01506479|3720242|P3|Overall Study|Adverse Event|0
1132329|NCT01506479|3720243|P2|Overall Study|Adverse Event|1
1132330|NCT01506479|3720244|P1|Overall Study|Adverse Event|0
1132331|NCT01506479|3720242|P3|Overall Study|Missing assessment|0
1132332|NCT01506479|3720243|P2|Overall Study|Missing assessment|0
1132333|NCT01506479|3720244|P1|Overall Study|Missing assessment|1
1132334|NCT01506479|3720242|P3|Overall Study|Withdrawal by Subject|1
1132335|NCT01506479|3720243|P2|Overall Study|Withdrawal by Subject|2
1132336|NCT01506479|3720244|P1|Overall Study|Withdrawal by Subject|1
1132337|NCT01506479|3720242|P3|Overall Study|Lost to Follow-up|2
1132338|NCT01506479|3720243|P2|Overall Study|Lost to Follow-up|2
1132339|NCT01506479|3720244|P1|Overall Study|Lost to Follow-up|1
1132340|NCT01506323|3720262|P2|Overall Study|Started another treatment|0
1132341|NCT01506323|3720263|P1|Overall Study|Started another treatment|1
1132342|NCT01506323|3720262|P2|Overall Study|Schedule or Transportation conflict|0
1132343|NCT01506323|3720263|P1|Overall Study|Schedule or Transportation conflict|8
1132344|NCT01506323|3720262|P2|Overall Study|Moved out of area|2
1132345|NCT01506323|3720263|P1|Overall Study|Moved out of area|5
1132346|NCT01506323|3720262|P2|Overall Study|Lack of Efficacy|3
1132347|NCT01506323|3720263|P1|Overall Study|Lack of Efficacy|1
1132348|NCT01506323|3720262|P2|Overall Study|Withdrawal by Subject|4
1132349|NCT01506323|3720263|P1|Overall Study|Withdrawal by Subject|4
1132350|NCT01506323|3720262|P2|Overall Study|Lost to Follow-up|4
1132351|NCT01506323|3720263|P1|Overall Study|Lost to Follow-up|5
1132352|NCT01506193|3720292|P3|Overall Study|Lost to Follow-up|3
1132353|NCT01506193|3720293|P2|Overall Study|Lost to Follow-up|3
1132354|NCT01506193|3720294|P1|Overall Study|Lost to Follow-up|8
1132355|NCT01506193|3720292|P3|Overall Study|Withdrawal by Subject|8
1132356|NCT01506193|3720293|P2|Overall Study|Withdrawal by Subject|1
1132357|NCT01506193|3720294|P1|Overall Study|Withdrawal by Subject|5
1132358|NCT01506193|3720292|P3|Overall Study|Adverse event, non-fatal|1
1132359|NCT01506193|3720293|P2|Overall Study|Adverse event, non-fatal|0
1132360|NCT01506193|3720294|P1|Overall Study|Adverse event, non-fatal|0
1132361|NCT01506193|3720292|P3|Overall Study|Migrated/moved from study area|1
1132362|NCT01506193|3720293|P2|Overall Study|Migrated/moved from study area|0
1132363|NCT01506193|3720294|P1|Overall Study|Migrated/moved from study area|0
1132364|NCT01506193|3720292|P3|Overall Study|Protocol Violation|1
1132365|NCT01506193|3720293|P2|Overall Study|Protocol Violation|0
1132366|NCT01506193|3720294|P1|Overall Study|Protocol Violation|1
1132367|NCT01505881|3720327|P2|Overall Study|Withdrawal by Subject|0
1132368|NCT01505881|3720328|P1|Overall Study|Withdrawal by Subject|2
1132369|NCT01505881|3720327|P2|Overall Study|Lost to Follow-up|0
1132370|NCT01505881|3720328|P1|Overall Study|Lost to Follow-up|2
1132371|NCT01505881|3720327|P2|Overall Study|Adverse Event|1
1132372|NCT01505881|3720328|P1|Overall Study|Adverse Event|0
1132373|NCT01505647|3720434|P2|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2
1132374|NCT01505647|3720435|P1|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1
1132375|NCT01505647|3720434|P2|Day 43 Through Day 182 Follow-up|Death|1
1132376|NCT01505647|3720435|P1|Day 43 Through Day 182 Follow-up|Death|0
1132377|NCT01505647|3720434|P2|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0
1132378|NCT01505647|3720435|P1|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1
1132379|NCT01505647|3720434|P2|Day 1 Through Day 42 Follow-up|Physician Decision|0
1132380|NCT01505647|3720435|P1|Day 1 Through Day 42 Follow-up|Physician Decision|1
1132381|NCT01505647|3720434|P2|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0
1132382|NCT01505647|3720435|P1|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1
1132383|NCT01505608|3720451|P2|Phase II|Protocol Violation|1
1132384|NCT01505608|3720452|P1|Phase II|Protocol Violation|0
1132385|NCT01505608|3720451|P2|Phase II|Lack of Efficacy|1
1132386|NCT01505608|3720452|P1|Phase II|Lack of Efficacy|2
1132387|NCT01505608|3720451|P2|Phase I|Withdrawal by Subject|1
1132388|NCT01505608|3720452|P1|Phase I|Withdrawal by Subject|0
1132389|NCT01505608|3720451|P2|Phase I|Adverse Event|1
1132390|NCT01505608|3720452|P1|Phase I|Adverse Event|0
1132391|NCT01505608|3720451|P2|Phase I|Lack of Efficacy|4
1132392|NCT01505608|3720452|P1|Phase I|Lack of Efficacy|0
1132393|NCT01505530|3720471|P3|Overall Study|entry criteria not met|0
1132394|NCT01505530|3720472|P2|Overall Study|entry criteria not met|1
1132395|NCT01505530|3720473|P1|Overall Study|entry criteria not met|0
1132396|NCT01505530|3720471|P3|Overall Study|Death|5
1132397|NCT01505530|3720472|P2|Overall Study|Death|6
1132398|NCT01505530|3720473|P1|Overall Study|Death|7
1132399|NCT01505530|3720471|P3|Overall Study|Sponsor Decision|7
1132400|NCT01505530|3720472|P2|Overall Study|Sponsor Decision|8
1132401|NCT01505530|3720473|P1|Overall Study|Sponsor Decision|1
1132402|NCT01505530|3720471|P3|Overall Study|Physician Decision|5
1132403|NCT01505530|3720472|P2|Overall Study|Physician Decision|2
1132404|NCT01505530|3720473|P1|Overall Study|Physician Decision|6
1132405|NCT01505530|3720471|P3|Overall Study|Withdrawal by Subject|6
1132406|NCT01505530|3720472|P2|Overall Study|Withdrawal by Subject|8
1132407|NCT01505530|3720473|P1|Overall Study|Withdrawal by Subject|7
1132408|NCT01505530|3720471|P3|Overall Study|Adverse Event|0
1132409|NCT01505530|3720472|P2|Overall Study|Adverse Event|1
1132410|NCT01505530|3720473|P1|Overall Study|Adverse Event|1
1132411|NCT01505530|3720471|P3|Overall Study|Progressive Disease|18
1132412|NCT01505530|3720472|P2|Overall Study|Progressive Disease|17
1132413|NCT01505530|3720473|P1|Overall Study|Progressive Disease|19
1132414|NCT01505387|3720533|P2|Overall Study|Withdrawal by Subject|1
1132415|NCT01505387|3720534|P1|Overall Study|Withdrawal by Subject|1
1132416|NCT01505387|3720533|P2|Overall Study|Protocol Violation|0
1132417|NCT01505387|3720534|P1|Overall Study|Protocol Violation|1
1132418|NCT01505374|3720540|P2|Overall Study|Lost to Follow-up|0
1132419|NCT01505374|3720541|P1|Overall Study|Lost to Follow-up|1
1132420|NCT01505114|3720576|P4|Overall Study|investigator decision|0
1132421|NCT01505114|3720577|P3|Overall Study|investigator decision|1
1132422|NCT01505114|3720578|P2|Overall Study|investigator decision|0
1132423|NCT01505114|3720579|P1|Overall Study|investigator decision|1
1132424|NCT01505114|3720576|P4|Overall Study|staff safety concerns|1
1132425|NCT01505114|3720577|P3|Overall Study|staff safety concerns|0
1132426|NCT01505114|3720578|P2|Overall Study|staff safety concerns|0
1132427|NCT01505114|3720579|P1|Overall Study|staff safety concerns|0
1132428|NCT01505114|3720576|P4|Overall Study|inadvertent enrollment due to peanut all|1
1132429|NCT01505114|3720577|P3|Overall Study|inadvertent enrollment due to peanut all|0
1132430|NCT01505114|3720578|P2|Overall Study|inadvertent enrollment due to peanut all|0
1132431|NCT01505114|3720579|P1|Overall Study|inadvertent enrollment due to peanut all|0
1132432|NCT01505114|3720576|P4|Overall Study|relocated|3
1132433|NCT01505114|3720577|P3|Overall Study|relocated|2
1132434|NCT01505114|3720578|P2|Overall Study|relocated|2
1132435|NCT01505114|3720579|P1|Overall Study|relocated|4
1132436|NCT01505114|3720576|P4|Overall Study|Lost to Follow-up|7
1132437|NCT01505114|3720577|P3|Overall Study|Lost to Follow-up|8
1132438|NCT01505114|3720578|P2|Overall Study|Lost to Follow-up|5
1132439|NCT01505114|3720579|P1|Overall Study|Lost to Follow-up|11
1132440|NCT01505114|3720576|P4|Overall Study|unable to adhere to visit schedule|3
1132441|NCT01505114|3720577|P3|Overall Study|unable to adhere to visit schedule|3
1132442|NCT01505114|3720578|P2|Overall Study|unable to adhere to visit schedule|2
1132443|NCT01505114|3720579|P1|Overall Study|unable to adhere to visit schedule|3
1132444|NCT01505114|3720576|P4|Overall Study|Death|1
1132445|NCT01505114|3720577|P3|Overall Study|Death|0
1132446|NCT01505114|3720578|P2|Overall Study|Death|0
1132447|NCT01505114|3720579|P1|Overall Study|Death|1
1132448|NCT01505114|3720576|P4|Overall Study|Withdrawal by Subject|7
1132449|NCT01505114|3720577|P3|Overall Study|Withdrawal by Subject|4
1132450|NCT01505114|3720578|P2|Overall Study|Withdrawal by Subject|4
1132451|NCT01505114|3720579|P1|Overall Study|Withdrawal by Subject|5
1132452|NCT01504971|3720593|P1|Overall Study|Physician Decision|13
1132453|NCT01504867|3720622|P2|Overall Study|Consent revoked|1
1132454|NCT01504867|3720623|P1|Overall Study|Consent revoked|5
1132455|NCT01504867|3720622|P2|Overall Study|Inclusion criteria not met|2
1132456|NCT01504867|3720623|P1|Overall Study|Inclusion criteria not met|2
1132457|NCT01504204|3720660|P2|Overall Study|Lost to Follow-up|1
1132458|NCT01504204|3720661|P1|Overall Study|Lost to Follow-up|1
1132459|NCT01503164|3720718|P2|Overall Study|Withdrawal by Subject|1
1132460|NCT01503164|3720719|P1|Overall Study|Withdrawal by Subject|2
1132461|NCT01503021|3720749|P2|Overall Study|Moved, received transplant, etc.|7
1132462|NCT01503021|3720750|P1|Overall Study|Moved, received transplant, etc.|5
1132463|NCT01503021|3720749|P2|Overall Study|Withdrawal by Subject|8
1132464|NCT01503021|3720750|P1|Overall Study|Withdrawal by Subject|9
1132465|NCT01503021|3720749|P2|Overall Study|Protocol Violation|3
1132466|NCT01503021|3720750|P1|Overall Study|Protocol Violation|1
1132467|NCT01503021|3720749|P2|Overall Study|Physician Decision|0
1132468|NCT01503021|3720750|P1|Overall Study|Physician Decision|3
1132469|NCT01503021|3720749|P2|Overall Study|Lost to Follow-up|0
1132470|NCT01503021|3720750|P1|Overall Study|Lost to Follow-up|2
1132471|NCT01503021|3720749|P2|Overall Study|Death|2
1132472|NCT01503021|3720750|P1|Overall Study|Death|0
1132473|NCT01503021|3720749|P2|Overall Study|Adverse Event|6
1132474|NCT01503021|3720750|P1|Overall Study|Adverse Event|7
1132475|NCT01502956|3720799|P2|Overall Study|Withdrawal by Subject|10
1132476|NCT01502956|3720800|P1|Overall Study|Withdrawal by Subject|8
1132477|NCT01502956|3720799|P2|Overall Study|Physician Decision|3
1132478|NCT01502956|3720800|P1|Overall Study|Physician Decision|2
1132479|NCT01502956|3720799|P2|Overall Study|Lost to Follow-up|11
1132480|NCT01502956|3720800|P1|Overall Study|Lost to Follow-up|14
1132481|NCT01502956|3720799|P2|Overall Study|Death|2
1132482|NCT01502956|3720800|P1|Overall Study|Death|0
1132483|NCT01502709|3720858|P2|Overall Study|Lost to Follow-up|0
1132484|NCT01502709|3720859|P1|Overall Study|Lost to Follow-up|4
1132485|NCT01502644|3720872|P4|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
1132486|NCT01502644|3720873|P3|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
1132487|NCT01502644|3720874|P2|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
1132488|NCT01502644|3720875|P1|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
1132489|NCT01502644|3720872|P4|Assigned to NA Groups|Drop Out due to Side Effects|7
1132490|NCT01502644|3720873|P3|Assigned to NA Groups|Drop Out due to Side Effects|2
1132491|NCT01502644|3720874|P2|Assigned to NA Groups|Drop Out due to Side Effects|6
1132492|NCT01502644|3720875|P1|Assigned to NA Groups|Drop Out due to Side Effects|0
1132493|NCT01502644|3720872|P4|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
1132494|NCT01502644|3720873|P3|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
1132495|NCT01502644|3720874|P2|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
1132496|NCT01502644|3720875|P1|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6
1132497|NCT01502644|3720872|P4|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
1132498|NCT01502644|3720873|P3|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
1132499|NCT01502644|3720874|P2|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
1132587|NCT01500694|3721101|P1|Overall Study|Lost to Follow-up|2
1132500|NCT01502644|3720875|P1|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2
1132501|NCT01502644|3720872|P4|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
1132502|NCT01502644|3720873|P3|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
1132503|NCT01502644|3720874|P2|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
1132504|NCT01502644|3720875|P1|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1
1132505|NCT01502423|3720885|P2|Overall Study|Withdrawal by Subject|1
1132506|NCT01502423|3720886|P1|Overall Study|Withdrawal by Subject|0
1132507|NCT01502410|3720908|P4|Overall Study|Withdrawal by Subject|0
1132508|NCT01502410|3720909|P3|Overall Study|Withdrawal by Subject|0
1132509|NCT01502410|3720910|P2|Overall Study|Withdrawal by Subject|0
1132510|NCT01502410|3720911|P1|Overall Study|Withdrawal by Subject|2
1132511|NCT01502410|3720908|P4|Overall Study|Physician Decision|0
1132512|NCT01502410|3720909|P3|Overall Study|Physician Decision|0
1132513|NCT01502410|3720910|P2|Overall Study|Physician Decision|1
1132514|NCT01502410|3720911|P1|Overall Study|Physician Decision|0
1132515|NCT01502410|3720908|P4|Overall Study|Lack of Efficacy|0
1132516|NCT01502410|3720909|P3|Overall Study|Lack of Efficacy|0
1132517|NCT01502410|3720910|P2|Overall Study|Lack of Efficacy|7
1132518|NCT01502410|3720911|P1|Overall Study|Lack of Efficacy|7
1132519|NCT01502410|3720908|P4|Overall Study|Adverse Event|0
1132520|NCT01502410|3720909|P3|Overall Study|Adverse Event|0
1132521|NCT01502410|3720910|P2|Overall Study|Adverse Event|2
1132522|NCT01502410|3720911|P1|Overall Study|Adverse Event|1
1132523|NCT01502371|3720929|P5|Overall Study|Excluded Medication|1
1132524|NCT01502371|3720930|P4|Overall Study|Excluded Medication|0
1132525|NCT01502371|3720931|P3|Overall Study|Excluded Medication|1
1132526|NCT01502371|3720932|P2|Overall Study|Excluded Medication|1
1132527|NCT01502371|3720933|P1|Overall Study|Excluded Medication|0
1132528|NCT01502371|3720929|P5|Overall Study|Protocol Violation|10
1132529|NCT01502371|3720930|P4|Overall Study|Protocol Violation|5
1132530|NCT01502371|3720931|P3|Overall Study|Protocol Violation|6
1132531|NCT01502371|3720932|P2|Overall Study|Protocol Violation|5
1132532|NCT01502371|3720933|P1|Overall Study|Protocol Violation|9
1132533|NCT01502371|3720929|P5|Overall Study|Technical Problems|1
1132534|NCT01502371|3720930|P4|Overall Study|Technical Problems|4
1132535|NCT01502371|3720931|P3|Overall Study|Technical Problems|2
1132536|NCT01502371|3720932|P2|Overall Study|Technical Problems|0
1132537|NCT01502371|3720933|P1|Overall Study|Technical Problems|1
1132538|NCT01502371|3720929|P5|Overall Study|Noncompliance with Study Drug|1
1132539|NCT01502371|3720930|P4|Overall Study|Noncompliance with Study Drug|2
1132540|NCT01502371|3720931|P3|Overall Study|Noncompliance with Study Drug|1
1132541|NCT01502371|3720932|P2|Overall Study|Noncompliance with Study Drug|0
1132542|NCT01502371|3720933|P1|Overall Study|Noncompliance with Study Drug|0
1132543|NCT01502371|3720929|P5|Overall Study|Physician Decision|1
1132544|NCT01502371|3720930|P4|Overall Study|Physician Decision|0
1132545|NCT01502371|3720931|P3|Overall Study|Physician Decision|0
1132546|NCT01502371|3720932|P2|Overall Study|Physician Decision|0
1132547|NCT01502371|3720933|P1|Overall Study|Physician Decision|3
1132548|NCT01502371|3720929|P5|Overall Study|Lack of Efficacy|4
1132549|NCT01502371|3720930|P4|Overall Study|Lack of Efficacy|2
1132550|NCT01502371|3720931|P3|Overall Study|Lack of Efficacy|2
1132551|NCT01502371|3720932|P2|Overall Study|Lack of Efficacy|3
1132552|NCT01502371|3720933|P1|Overall Study|Lack of Efficacy|3
1132553|NCT01502371|3720929|P5|Overall Study|Treatment Failure|30
1132554|NCT01502371|3720930|P4|Overall Study|Treatment Failure|19
1132555|NCT01502371|3720931|P3|Overall Study|Treatment Failure|12
1132556|NCT01502371|3720932|P2|Overall Study|Treatment Failure|20
1132557|NCT01502371|3720933|P1|Overall Study|Treatment Failure|22
1132558|NCT01502371|3720929|P5|Overall Study|Adverse Event|3
1132559|NCT01502371|3720930|P4|Overall Study|Adverse Event|4
1132560|NCT01502371|3720931|P3|Overall Study|Adverse Event|0
1132561|NCT01502371|3720932|P2|Overall Study|Adverse Event|1
1132562|NCT01502371|3720933|P1|Overall Study|Adverse Event|2
1132563|NCT01502371|3720929|P5|Overall Study|Withdrawal by Subject|1
1132564|NCT01502371|3720930|P4|Overall Study|Withdrawal by Subject|1
1132565|NCT01502371|3720931|P3|Overall Study|Withdrawal by Subject|1
1132566|NCT01502371|3720932|P2|Overall Study|Withdrawal by Subject|2
1132567|NCT01502371|3720933|P1|Overall Study|Withdrawal by Subject|1
1132568|NCT01502228|3720973|P1|Overall Study|Death|1
1132569|NCT01502033|3720978|P1|Overall Study|1 participant went back to school|1
1132570|NCT01502033|3720978|P1|Overall Study|1 participant had worsening depression|1
1132571|NCT01502033|3720978|P1|Overall Study|1 participant had scalp discomfort|1
1132572|NCT01501955|3720986|P2|Overall Study|Adverse Event|3
1132573|NCT01501955|3720987|P1|Overall Study|Adverse Event|1
1132574|NCT01501955|3720986|P2|Overall Study|Withdrawal by Subject|0
1132575|NCT01501955|3720987|P1|Overall Study|Withdrawal by Subject|1
1132576|NCT01501110|3721051|P2|Overall Study|Death|1
1132577|NCT01501110|3721052|P1|Overall Study|Death|0
1132578|NCT01500720|3721085|P2|Overall Study|Other|8
1132579|NCT01500720|3721086|P1|Overall Study|Other|4
1132580|NCT01500720|3721085|P2|Overall Study|Randomized But Not Treated|1
1132581|NCT01500720|3721086|P1|Overall Study|Randomized But Not Treated|1
1132582|NCT01500694|3721100|P2|Overall Study|Other|3
1132583|NCT01500694|3721101|P1|Overall Study|Other|9
1132584|NCT01500694|3721100|P2|Overall Study|Lack of Efficacy|5
1132585|NCT01500694|3721101|P1|Overall Study|Lack of Efficacy|14
1132586|NCT01500694|3721100|P2|Overall Study|Lost to Follow-up|3
1132588|NCT01500694|3721100|P2|Overall Study|Withdrawal by Subject|14
1132589|NCT01500694|3721101|P1|Overall Study|Withdrawal by Subject|23
1132590|NCT01500694|3721100|P2|Overall Study|Protocol Violation|1
1132591|NCT01500694|3721101|P1|Overall Study|Protocol Violation|0
1132592|NCT01500694|3721100|P2|Overall Study|Adverse Event|3
1132593|NCT01500694|3721101|P1|Overall Study|Adverse Event|4
1132594|NCT01500629|3721127|P2|Washout Period of 14 to 30 Days|Pregnancy|0
1132595|NCT01500629|3721128|P1|Washout Period of 14 to 30 Days|Pregnancy|1
1132596|NCT01500434|3721212|P1|Overall Study|Missed 12-month follow-up|5
1132597|NCT01500434|3721212|P1|Overall Study|Withdrawal by Subject|1
1132598|NCT01500434|3721212|P1|Overall Study|Death|1
1132599|NCT01500382|3721245|P4|Washout Period|Study site went out of business|0
1132600|NCT01500382|3721246|P3|Washout Period|Study site went out of business|1
1132601|NCT01500382|3721247|P2|Washout Period|Study site went out of business|0
1132602|NCT01500382|3721248|P1|Washout Period|Study site went out of business|0
1132603|NCT01500317|3721273|P3|Overall Study|Withdrawal by Subject|0
1132604|NCT01500317|3721274|P2|Overall Study|Withdrawal by Subject|2
1132605|NCT01500317|3721275|P1|Overall Study|Withdrawal by Subject|3
1132606|NCT01500278|3721297|P2|Week 13 - Week 104|Adverse Event|54
1132607|NCT01500278|3721298|P1|Week 13 - Week 104|Adverse Event|54
1132608|NCT01500278|3721297|P2|Week 13 - Week 104|Death|4
1132609|NCT01500278|3721298|P1|Week 13 - Week 104|Death|2
1132610|NCT01500278|3721297|P2|Week 13 - Week 104|Not completed|1
1132611|NCT01500278|3721298|P1|Week 13 - Week 104|Not completed|0
1132612|NCT01500278|3721297|P2|Week 13 - Week 104|Personal reason|1
1132613|NCT01500278|3721298|P1|Week 13 - Week 104|Personal reason|0
1132614|NCT01500278|3721297|P2|Week 13 - Week 104|Medical monitor decision|2
1132615|NCT01500278|3721298|P1|Week 13 - Week 104|Medical monitor decision|0
1132616|NCT01500278|3721297|P2|Week 13 - Week 104|Sponsor decision|2
1132617|NCT01500278|3721298|P1|Week 13 - Week 104|Sponsor decision|0
1132618|NCT01500278|3721297|P2|Week 13 - Week 104|Relocation|1
1132619|NCT01500278|3721298|P1|Week 13 - Week 104|Relocation|0
1132620|NCT01500278|3721297|P2|Week 13 - Week 104|Abnormal questionable chest X-ray|2
1132621|NCT01500278|3721298|P1|Week 13 - Week 104|Abnormal questionable chest X-ray|0
1132622|NCT01500278|3721297|P2|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0
1132623|NCT01500278|3721298|P1|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1
1132624|NCT01500278|3721297|P2|Week 13 - Week 104|Principal investigator retiring|0
1132625|NCT01500278|3721298|P1|Week 13 - Week 104|Principal investigator retiring|1
1132626|NCT01500278|3721297|P2|Week 13 - Week 104|Protocol deviation|0
1132627|NCT01500278|3721298|P1|Week 13 - Week 104|Protocol deviation|1
1132628|NCT01500278|3721297|P2|Week 13 - Week 104|Exclusion criteria not met|0
1132629|NCT01500278|3721298|P1|Week 13 - Week 104|Exclusion criteria not met|1
1132630|NCT01500278|3721297|P2|Week 13 - Week 104|Withdrawn in error|0
1132631|NCT01500278|3721298|P1|Week 13 - Week 104|Withdrawn in error|1
1132632|NCT01500278|3721297|P2|Week 13 - Week 104|Sponsor request|0
1132633|NCT01500278|3721298|P1|Week 13 - Week 104|Sponsor request|4
1132634|NCT01500278|3721297|P2|Week 13 - Week 104|False positive test|2
1132635|NCT01500278|3721298|P1|Week 13 - Week 104|False positive test|1
1132636|NCT01500278|3721297|P2|Week 13 - Week 104|Recurrent infections|0
1132637|NCT01500278|3721298|P1|Week 13 - Week 104|Recurrent infections|1
1132638|NCT01500278|3721297|P2|Week 13 - Week 104|Non/bad compliance|5
1132639|NCT01500278|3721298|P1|Week 13 - Week 104|Non/bad compliance|7
1132640|NCT01500278|3721297|P2|Week 13 - Week 104|Week 24 Non-Responder|16
1132641|NCT01500278|3721298|P1|Week 13 - Week 104|Week 24 Non-Responder|20
1132642|NCT01500278|3721297|P2|Week 13 - Week 104|Withdrawal by Subject|13
1132643|NCT01500278|3721298|P1|Week 13 - Week 104|Withdrawal by Subject|22
1132644|NCT01500278|3721297|P2|Week 13 - Week 104|Lost to Follow-up|5
1132645|NCT01500278|3721298|P1|Week 13 - Week 104|Lost to Follow-up|6
1132646|NCT01500278|3721297|P2|Week 13 - Week 104|Protocol Violation|6
1132647|NCT01500278|3721298|P1|Week 13 - Week 104|Protocol Violation|6
1132648|NCT01500278|3721297|P2|Week 13 - Week 104|Lack of Efficacy|12
1132649|NCT01500278|3721298|P1|Week 13 - Week 104|Lack of Efficacy|11
1132650|NCT01500278|3721297|P2|Week 0 - Week 12|Adverse event (AE), not fatal|8
1132651|NCT01500278|3721298|P1|Week 0 - Week 12|Adverse event (AE), not fatal|7
1132652|NCT01500278|3721297|P2|Week 0 - Week 12|Other serious disease|1
1132653|NCT01500278|3721298|P1|Week 0 - Week 12|Other serious disease|0
1132654|NCT01500278|3721297|P2|Week 0 - Week 12|Personal reason|1
1132655|NCT01500278|3721298|P1|Week 0 - Week 12|Personal reason|0
1132656|NCT01500278|3721297|P2|Week 0 - Week 12|Sponsor decision|0
1132657|NCT01500278|3721298|P1|Week 0 - Week 12|Sponsor decision|1
1132658|NCT01500278|3721297|P2|Week 0 - Week 12|Prior history of serious disease|0
1132659|NCT01500278|3721298|P1|Week 0 - Week 12|Prior history of serious disease|1
1132660|NCT01500278|3721297|P2|Week 0 - Week 12|Investigator decision|0
1132661|NCT01500278|3721298|P1|Week 0 - Week 12|Investigator decision|1
1132662|NCT01500278|3721297|P2|Week 0 - Week 12|Exclusion criteria not met|0
1132663|NCT01500278|3721298|P1|Week 0 - Week 12|Exclusion criteria not met|1
1132664|NCT01500278|3721297|P2|Week 0 - Week 12|Patient decision|0
1132665|NCT01500278|3721298|P1|Week 0 - Week 12|Patient decision|1
1132666|NCT01500278|3721297|P2|Week 0 - Week 12|Protocol violation on screening X-ray|0
1132667|NCT01500278|3721298|P1|Week 0 - Week 12|Protocol violation on screening X-ray|1
1132668|NCT01500278|3721297|P2|Week 0 - Week 12|Withdrawal by Subject|2
1132669|NCT01500278|3721298|P1|Week 0 - Week 12|Withdrawal by Subject|7
1132670|NCT01500278|3721297|P2|Week 0 - Week 12|Lost to Follow-up|1
1132671|NCT01500278|3721298|P1|Week 0 - Week 12|Lost to Follow-up|1
1132672|NCT01500278|3721297|P2|Week 0 - Week 12|Protocol Violation|16
1132673|NCT01500278|3721298|P1|Week 0 - Week 12|Protocol Violation|10
1132674|NCT01500278|3721297|P2|Week 0 - Week 12|Lack of Efficacy|1
1132675|NCT01500278|3721298|P1|Week 0 - Week 12|Lack of Efficacy|0
1132676|NCT01500252|3721322|P2|Overall Study|Lost to Follow-up|4
1132677|NCT01500252|3721323|P1|Overall Study|Lost to Follow-up|5
1132678|NCT01500252|3721322|P2|Overall Study|Death|2
1132679|NCT01500252|3721323|P1|Overall Study|Death|4
1132680|NCT01500226|3721349|P2|Overall Study|Other Reasons|16
1132681|NCT01500226|3721350|P1|Overall Study|Other Reasons|19
1132682|NCT01500226|3721349|P2|Overall Study|Lost to Follow-up|5
1132683|NCT01500226|3721350|P1|Overall Study|Lost to Follow-up|9
1132684|NCT01500226|3721349|P2|Overall Study|Lack of Efficacy|30
1132685|NCT01500226|3721350|P1|Overall Study|Lack of Efficacy|14
1132686|NCT01500226|3721349|P2|Overall Study|Physician Decision|15
1132687|NCT01500226|3721350|P1|Overall Study|Physician Decision|17
1132688|NCT01500226|3721349|P2|Overall Study|Protocol Violation|39
1132689|NCT01500226|3721350|P1|Overall Study|Protocol Violation|53
1132690|NCT01500226|3721349|P2|Overall Study|Disease Progression|14
1132691|NCT01500226|3721350|P1|Overall Study|Disease Progression|16
1132692|NCT01500226|3721349|P2|Overall Study|Death|4
1132693|NCT01500226|3721350|P1|Overall Study|Death|12
1132694|NCT01500226|3721349|P2|Overall Study|Withdrawal by Subject|96
1132695|NCT01500226|3721350|P1|Overall Study|Withdrawal by Subject|93
1132696|NCT01500226|3721349|P2|Overall Study|Chemo Completed or Change in Therapy|237
1132697|NCT01500226|3721350|P1|Overall Study|Chemo Completed or Change in Therapy|235
1132698|NCT01500226|3721349|P2|Overall Study|Adverse Event|38
1132699|NCT01500226|3721350|P1|Overall Study|Adverse Event|31
1132700|NCT01500213|3721362|P2|Overall Study|Other Reasons|5
1132701|NCT01500213|3721363|P1|Overall Study|Other Reasons|7
1132702|NCT01500213|3721362|P2|Overall Study|Lost to Follow-up|6
1132703|NCT01500213|3721363|P1|Overall Study|Lost to Follow-up|3
1132704|NCT01500213|3721362|P2|Overall Study|Lack of Efficacy|7
1132705|NCT01500213|3721363|P1|Overall Study|Lack of Efficacy|9
1132706|NCT01500213|3721362|P2|Overall Study|Physician Decision|10
1132707|NCT01500213|3721363|P1|Overall Study|Physician Decision|12
1132708|NCT01500213|3721362|P2|Overall Study|Protocol Violation|19
1132709|NCT01500213|3721363|P1|Overall Study|Protocol Violation|19
1132710|NCT01500213|3721362|P2|Overall Study|Disease Progression|21
1132711|NCT01500213|3721363|P1|Overall Study|Disease Progression|13
1132712|NCT01500213|3721362|P2|Overall Study|Death|3
1132713|NCT01500213|3721363|P1|Overall Study|Death|7
1132714|NCT01500213|3721362|P2|Overall Study|Withdrawal by Subject|37
1132715|NCT01500213|3721363|P1|Overall Study|Withdrawal by Subject|28
1132716|NCT01500213|3721362|P2|Overall Study|Chemo Completed or Change in Therapy|81
1132717|NCT01500213|3721363|P1|Overall Study|Chemo Completed or Change in Therapy|84
1132718|NCT01500213|3721362|P2|Overall Study|Adverse Event|35
1132719|NCT01500213|3721363|P1|Overall Study|Adverse Event|35
1132720|NCT01500135|3721375|P2|Overall Study|Patient Unable to Make Follow-up Visit|1
1132721|NCT01500135|3721376|P1|Overall Study|Patient Unable to Make Follow-up Visit|0
1132722|NCT01500135|3721375|P2|Overall Study|Participant was a Safety Concern|0
1132723|NCT01500135|3721376|P1|Overall Study|Participant was a Safety Concern|1
1132724|NCT01500135|3721375|P2|Overall Study|Patient Missed Scheduled Appointments|1
1132725|NCT01500135|3721376|P1|Overall Study|Patient Missed Scheduled Appointments|0
1132726|NCT01500135|3721375|P2|Overall Study|Principal Investigator (PI) Discretion|0
1132727|NCT01500135|3721376|P1|Overall Study|Principal Investigator (PI) Discretion|1
1132728|NCT01500135|3721375|P2|Overall Study|Fatal Adverse Event (AE)|5
1132729|NCT01500135|3721376|P1|Overall Study|Fatal Adverse Event (AE)|5
1132730|NCT01500135|3721375|P2|Overall Study|Lost to Follow-up|4
1132731|NCT01500135|3721376|P1|Overall Study|Lost to Follow-up|6
1132732|NCT01500135|3721375|P2|Overall Study|Withdrawal of Consent|0
1132733|NCT01500135|3721376|P1|Overall Study|Withdrawal of Consent|4
1132734|NCT01500096|3721403|P4|Overall Study|Lost to Follow-up|2
1132735|NCT01500096|3721404|P3|Overall Study|Lost to Follow-up|0
1132736|NCT01500096|3721405|P2|Overall Study|Lost to Follow-up|0
1132737|NCT01500096|3721406|P1|Overall Study|Lost to Follow-up|1
1132738|NCT01500083|3721462|P2|Overall Study|Other Reasons|5
1132739|NCT01500083|3721463|P1|Overall Study|Other Reasons|2
1132740|NCT01500083|3721462|P2|Overall Study|Investigator Discretion|8
1132741|NCT01500083|3721463|P1|Overall Study|Investigator Discretion|3
1132742|NCT01500083|3721462|P2|Overall Study|Disease Progression|10
1132743|NCT01500083|3721463|P1|Overall Study|Disease Progression|2
1132744|NCT01500083|3721462|P2|Overall Study|Withdrawal of Consent|1
1132745|NCT01500083|3721463|P1|Overall Study|Withdrawal of Consent|0
1132746|NCT01500083|3721462|P2|Overall Study|Lost to Follow-up|0
1132747|NCT01500083|3721463|P1|Overall Study|Lost to Follow-up|1
1132748|NCT01500083|3721462|P2|Overall Study|Death|2
1132749|NCT01500083|3721463|P1|Overall Study|Death|0
1132750|NCT01500083|3721462|P2|Overall Study|Adverse Event|17
1132751|NCT01500083|3721463|P1|Overall Study|Adverse Event|4
1132752|NCT01500057|3721471|P2|Overall Study|Lost to Follow-up|4
1132753|NCT01500057|3721472|P1|Overall Study|Lost to Follow-up|6
1132754|NCT01500031|3721482|P1|Overall Study|Withdrawal by Subject|4
1132755|NCT01500031|3721482|P1|Overall Study|Death|1
1132756|NCT01499849|3721517|P2|Overall Study|Other Reasons|30
1132757|NCT01499849|3721518|P1|Overall Study|Other Reasons|27
1132758|NCT01499849|3721517|P2|Overall Study|Lost to Follow-up|3
1132759|NCT01499849|3721518|P1|Overall Study|Lost to Follow-up|6
1132760|NCT01499849|3721517|P2|Overall Study|Lack of Efficacy|4
1132761|NCT01499849|3721518|P1|Overall Study|Lack of Efficacy|3
1132762|NCT01499849|3721517|P2|Overall Study|Physician Decision|19
1132763|NCT01499849|3721518|P1|Overall Study|Physician Decision|20
1132764|NCT01499849|3721517|P2|Overall Study|Protocol Violation|11
1132765|NCT01499849|3721518|P1|Overall Study|Protocol Violation|11
1132766|NCT01499849|3721517|P2|Overall Study|Disease Progression|10
1132767|NCT01499849|3721518|P1|Overall Study|Disease Progression|11
1132768|NCT01499849|3721517|P2|Overall Study|Death|7
1132769|NCT01499849|3721518|P1|Overall Study|Death|5
1132770|NCT01499849|3721517|P2|Overall Study|Withdrawal by Subject|43
1132771|NCT01499849|3721518|P1|Overall Study|Withdrawal by Subject|43
1132772|NCT01499849|3721517|P2|Overall Study|Chemo completed or Change in Therapy|67
1132773|NCT01499849|3721518|P1|Overall Study|Chemo completed or Change in Therapy|70
1132774|NCT01499849|3721517|P2|Overall Study|Adverse Event|32
1132775|NCT01499849|3721518|P1|Overall Study|Adverse Event|28
1132776|NCT01499810|3721528|P1|Overall Study|Withdrawal by Subject|1
1132777|NCT01499810|3721528|P1|Overall Study|Protocol Violation|1
1132778|NCT01499810|3721528|P1|Overall Study|Lost to Follow-up|10
1132779|NCT01499667|3721578|P3|Overall Study|Lack of Efficacy|0
1132780|NCT01499667|3721579|P2|Overall Study|Lack of Efficacy|0
1132781|NCT01499667|3721580|P1|Overall Study|Lack of Efficacy|2
1132782|NCT01499667|3721578|P3|Overall Study|Withdrawal by Subject|1
1132783|NCT01499667|3721579|P2|Overall Study|Withdrawal by Subject|1
1132784|NCT01499667|3721580|P1|Overall Study|Withdrawal by Subject|2
1132785|NCT01499667|3721578|P3|Overall Study|Adverse Event|2
1132786|NCT01499667|3721579|P2|Overall Study|Adverse Event|2
1132787|NCT01499667|3721580|P1|Overall Study|Adverse Event|0
1132788|NCT01499667|3721578|P3|Overall Study|Protocol Violation|2
1132789|NCT01499667|3721579|P2|Overall Study|Protocol Violation|3
1132790|NCT01499667|3721580|P1|Overall Study|Protocol Violation|1
1132791|NCT01499667|3721578|P3|Overall Study|administrative problems|5
1132792|NCT01499667|3721579|P2|Overall Study|administrative problems|5
1132793|NCT01499667|3721580|P1|Overall Study|administrative problems|4
1132794|NCT01499576|3721628|P1|Overall Study|Withdrawal by Subject|9
1132795|NCT01499576|3721628|P1|Overall Study|Physician Decision|12
1132796|NCT01499355|3721642|P4|Double-Blind Period|Lost to Follow-up|0
1132797|NCT01499355|3721643|P3|Double-Blind Period|Lost to Follow-up|0
1132798|NCT01499355|3721644|P2|Double-Blind Period|Lost to Follow-up|1
1132799|NCT01499355|3721645|P1|Double-Blind Period|Lost to Follow-up|0
1132800|NCT01499355|3721642|P4|Double-Blind Period|Consent Withdrawn|2
1132801|NCT01499355|3721643|P3|Double-Blind Period|Consent Withdrawn|1
1132802|NCT01499355|3721644|P2|Double-Blind Period|Consent Withdrawn|0
1132803|NCT01499355|3721645|P1|Double-Blind Period|Consent Withdrawn|0
1132804|NCT01499355|3721642|P4|Double-Blind Period|Investigator Decision|3
1132805|NCT01499355|3721643|P3|Double-Blind Period|Investigator Decision|3
1132806|NCT01499355|3721644|P2|Double-Blind Period|Investigator Decision|0
1132807|NCT01499355|3721645|P1|Double-Blind Period|Investigator Decision|0
1132808|NCT01499355|3721642|P4|Double-Blind Period|Death|0
1132809|NCT01499355|3721643|P3|Double-Blind Period|Death|0
1132810|NCT01499355|3721644|P2|Double-Blind Period|Death|1
1132811|NCT01499355|3721645|P1|Double-Blind Period|Death|0
1132812|NCT01499355|3721642|P4|Double-Blind Period|Not Specified|2
1132813|NCT01499355|3721643|P3|Double-Blind Period|Not Specified|2
1132814|NCT01499355|3721644|P2|Double-Blind Period|Not Specified|1
1132815|NCT01499355|3721645|P1|Double-Blind Period|Not Specified|0
1132816|NCT01499355|3721642|P4|Double-Blind Period|Study Termination|14
1132817|NCT01499355|3721643|P3|Double-Blind Period|Study Termination|16
1132818|NCT01499355|3721644|P2|Double-Blind Period|Study Termination|18
1132819|NCT01499355|3721645|P1|Double-Blind Period|Study Termination|0
1132820|NCT01499355|3721642|P4|Double-Blind Period|Adverse Event|2
1132821|NCT01499355|3721643|P3|Double-Blind Period|Adverse Event|3
1132822|NCT01499355|3721644|P2|Double-Blind Period|Adverse Event|2
1132823|NCT01499355|3721645|P1|Double-Blind Period|Adverse Event|0
1132824|NCT01499355|3721642|P4|Run-In Period|Adverse Event|0
1132825|NCT01499355|3721643|P3|Run-In Period|Adverse Event|0
1132826|NCT01499355|3721644|P2|Run-In Period|Adverse Event|0
1132827|NCT01499355|3721645|P1|Run-In Period|Adverse Event|8
1132828|NCT01499355|3721642|P4|Run-In Period|Consent Withdrawn|0
1132829|NCT01499355|3721643|P3|Run-In Period|Consent Withdrawn|0
1132830|NCT01499355|3721644|P2|Run-In Period|Consent Withdrawn|0
1132831|NCT01499355|3721645|P1|Run-In Period|Consent Withdrawn|1
1132832|NCT01499355|3721642|P4|Run-In Period|Investigator Decision|0
1132833|NCT01499355|3721643|P3|Run-In Period|Investigator Decision|0
1132834|NCT01499355|3721644|P2|Run-In Period|Investigator Decision|0
1132835|NCT01499355|3721645|P1|Run-In Period|Investigator Decision|2
1132836|NCT01499355|3721642|P4|Run-In Period|Death|0
1132837|NCT01499355|3721643|P3|Run-In Period|Death|0
1132838|NCT01499355|3721644|P2|Run-In Period|Death|0
1132839|NCT01499355|3721645|P1|Run-In Period|Death|2
1132840|NCT01499355|3721642|P4|Run-In Period|Not Specified|0
1132841|NCT01499355|3721643|P3|Run-In Period|Not Specified|0
1132842|NCT01499355|3721644|P2|Run-In Period|Not Specified|0
1132843|NCT01499355|3721645|P1|Run-In Period|Not Specified|3
1132844|NCT01499355|3721642|P4|Run-In Period|Study Termination|0
1132845|NCT01499355|3721643|P3|Run-In Period|Study Termination|0
1132846|NCT01499355|3721644|P2|Run-In Period|Study Termination|0
1132847|NCT01499355|3721645|P1|Run-In Period|Study Termination|15
1132848|NCT01499303|3721678|P2|Overall Study|Other|1
1132849|NCT01499303|3721679|P1|Overall Study|Other|0
1132850|NCT01499303|3721678|P2|Overall Study|Adverse Event|4
1132851|NCT01499303|3721679|P1|Overall Study|Adverse Event|1
1132852|NCT01499303|3721678|P2|Overall Study|Withdrawal by Subject|1
1132853|NCT01499303|3721679|P1|Overall Study|Withdrawal by Subject|0
1132854|NCT01499303|3721678|P2|Overall Study|Ongoing|1
1132855|NCT01499303|3721679|P1|Overall Study|Ongoing|2
1132856|NCT01499290|3721687|P2|Overall Study|Adverse Event|7
1132857|NCT01499290|3721688|P1|Overall Study|Adverse Event|14
1132858|NCT01499290|3721687|P2|Overall Study|Lack of Efficacy|8
1132859|NCT01499290|3721688|P1|Overall Study|Lack of Efficacy|7
1132860|NCT01499290|3721687|P2|Overall Study|Condition improved/subject recovered|0
1132861|NCT01499290|3721688|P1|Overall Study|Condition improved/subject recovered|1
1132862|NCT01499290|3721687|P2|Overall Study|Not specified in study report|5
1132863|NCT01499290|3721688|P1|Overall Study|Not specified in study report|11
1132864|NCT01499290|3721687|P2|Overall Study|Withdrawal by Subject|15
1132865|NCT01499290|3721688|P1|Overall Study|Withdrawal by Subject|22
1132866|NCT01499277|3721738|P2|Overall Study|Lack of therapeutic response and other|7
1132867|NCT01499277|3721739|P1|Overall Study|Lack of therapeutic response and other|8
1132868|NCT01499277|3721738|P2|Overall Study|Withdrawal by Subject|6
1132869|NCT01499277|3721739|P1|Overall Study|Withdrawal by Subject|16
1132870|NCT01499277|3721738|P2|Overall Study|Protocol Violation|3
1132871|NCT01499277|3721739|P1|Overall Study|Protocol Violation|2
1132872|NCT01499277|3721738|P2|Overall Study|Lost to Follow-up|8
1132873|NCT01499277|3721739|P1|Overall Study|Lost to Follow-up|15
1132874|NCT01499277|3721738|P2|Overall Study|Death|2
1132875|NCT01499277|3721739|P1|Overall Study|Death|3
1132876|NCT01499277|3721738|P2|Overall Study|Adverse Event|6
1132877|NCT01499277|3721739|P1|Overall Study|Adverse Event|3
1132878|NCT01499199|3721761|P1|Overall Study|Lack of Efficacy|1
1132879|NCT01499199|3721761|P1|Overall Study|Adverse Event|1
1132880|NCT01499160|3721790|P1|Overall Study|Withdrawal by Subject|1
1132881|NCT01499160|3721790|P1|Overall Study|Adverse Event|1
1132882|NCT01499134|3721813|P2|Overall Study|Withdrawal by Subject|1
1132883|NCT01499134|3721814|P1|Overall Study|Withdrawal by Subject|0
1132884|NCT01499095|3721836|P2|Overall Study|Perceived Lack of Efficacy|1
1132885|NCT01499095|3721837|P1|Overall Study|Perceived Lack of Efficacy|1
1132886|NCT01499095|3721836|P2|Overall Study|Change in Injection Schedule|0
1132887|NCT01499095|3721837|P1|Overall Study|Change in Injection Schedule|2
1132888|NCT01499095|3721836|P2|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1
1132889|NCT01499095|3721837|P1|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2
1132890|NCT01499095|3721836|P2|Overall Study|Hypoglycemia|1
1132891|NCT01499095|3721837|P1|Overall Study|Hypoglycemia|3
1132892|NCT01499095|3721836|P2|Overall Study|Insulin Dropped Below Authorized Dose|5
1132893|NCT01499095|3721837|P1|Overall Study|Insulin Dropped Below Authorized Dose|0
1132894|NCT01499095|3721836|P2|Overall Study|Lost to Follow-up|4
1132895|NCT01499095|3721837|P1|Overall Study|Lost to Follow-up|6
1132896|NCT01499095|3721836|P2|Overall Study|Diverse Reasons|25
1132897|NCT01499095|3721837|P1|Overall Study|Diverse Reasons|22
1132898|NCT01499095|3721836|P2|Overall Study|Received Rescue Therapy|40
1132899|NCT01499095|3721837|P1|Overall Study|Received Rescue Therapy|32
1132900|NCT01499095|3721836|P2|Overall Study|Protocol Violation|7
1132901|NCT01499095|3721837|P1|Overall Study|Protocol Violation|6
1132902|NCT01499095|3721836|P2|Overall Study|Lack of Efficacy|1
1132903|NCT01499095|3721837|P1|Overall Study|Lack of Efficacy|2
1132904|NCT01499095|3721836|P2|Overall Study|Adverse Event|7
1132905|NCT01499095|3721837|P1|Overall Study|Adverse Event|12
1132906|NCT01499095|3721836|P2|Overall Study|Randomized But Not Treated|1
1132907|NCT01499095|3721837|P1|Overall Study|Randomized But Not Treated|1
1132908|NCT01499082|3721867|P2|Overall Study|Lost to Follow-up|3
1132909|NCT01499082|3721868|P1|Overall Study|Lost to Follow-up|1
1132910|NCT01499082|3721867|P2|Overall Study|Hypoglycemia|3
1132911|NCT01499082|3721868|P1|Overall Study|Hypoglycemia|2
1132912|NCT01499082|3721867|P2|Overall Study|Site Closure for Noncompliance|2
1132913|NCT01499082|3721868|P1|Overall Study|Site Closure for Noncompliance|5
1132914|NCT01499082|3721867|P2|Overall Study|Diverse Reasons|14
1132915|NCT01499082|3721868|P1|Overall Study|Diverse Reasons|18
1132916|NCT01499082|3721867|P2|Overall Study|Protocol Violation|8
1132917|NCT01499082|3721868|P1|Overall Study|Protocol Violation|6
1132918|NCT01499082|3721867|P2|Overall Study|Lack of Efficacy|1
1132919|NCT01499082|3721868|P1|Overall Study|Lack of Efficacy|1
1132920|NCT01499082|3721867|P2|Overall Study|Adverse Event|16
1132921|NCT01499082|3721868|P1|Overall Study|Adverse Event|12
1132922|NCT01499082|3721867|P2|Overall Study|Randomized but not Treated|1
1132923|NCT01499082|3721868|P1|Overall Study|Randomized but not Treated|0
1132924|NCT01498822|3721918|P2|Overall Study|Lost to Follow-up|3
1132925|NCT01498822|3721919|P1|Overall Study|Lost to Follow-up|8
1132926|NCT01498822|3721918|P2|Overall Study|Withdrawal by Subject|25
1132927|NCT01498822|3721919|P1|Overall Study|Withdrawal by Subject|15
1132928|NCT01498822|3721918|P2|Overall Study|Adverse Event, serious fatal|1
1132929|NCT01498822|3721919|P1|Overall Study|Adverse Event, serious fatal|1
1132930|NCT01498822|3721918|P2|Overall Study|SAE, non-fatal|2
1132931|NCT01498822|3721919|P1|Overall Study|SAE, non-fatal|2
1132932|NCT01498822|3721918|P2|Overall Study|AE, non-serious non-fatal|17
1132933|NCT01498822|3721919|P1|Overall Study|AE, non-serious non-fatal|8
1132934|NCT01498822|3721918|P2|Overall Study|Lack of Efficacy|2
1132935|NCT01498822|3721919|P1|Overall Study|Lack of Efficacy|7
1132936|NCT01498822|3721918|P2|Overall Study|Other Reason|2
1132937|NCT01498822|3721919|P1|Overall Study|Other Reason|5
1132938|NCT01498822|3721918|P2|Overall Study|Protocol Violation|4
1132939|NCT01498822|3721919|P1|Overall Study|Protocol Violation|8
1132940|NCT01498692|3721946|P1|Overall Study|Missed 12-month visit|3
1132941|NCT01498692|3721946|P1|Overall Study|Withdrawal by Subject|1
1132942|NCT01498692|3721946|P1|Overall Study|Death|4
1132943|NCT01498679|3721977|P2|Overall Study|Withdrawal by Subject|4
1132944|NCT01498679|3721978|P1|Overall Study|Withdrawal by Subject|12
1132945|NCT01498679|3721977|P2|Overall Study|Physician Decision|2
1132946|NCT01498679|3721978|P1|Overall Study|Physician Decision|0
1132947|NCT01498679|3721977|P2|Overall Study|Protocol Violation|0
1132948|NCT01498679|3721978|P1|Overall Study|Protocol Violation|4
1132949|NCT01498679|3721977|P2|Overall Study|Lack of Efficacy|12
1132950|NCT01498679|3721978|P1|Overall Study|Lack of Efficacy|72
1132951|NCT01498679|3721977|P2|Overall Study|Adverse Event|4
1132952|NCT01498679|3721978|P1|Overall Study|Adverse Event|1
1132953|NCT01498653|3721994|P2|Overall Study|Withdrawal by Subject|3
1132954|NCT01498653|3721995|P1|Overall Study|Withdrawal by Subject|2
1132955|NCT01498653|3721994|P2|Overall Study|Physician Decision|0
1132956|NCT01498653|3721995|P1|Overall Study|Physician Decision|2
1132957|NCT01498653|3721994|P2|Overall Study|Lost to Follow-up|0
1132958|NCT01498653|3721995|P1|Overall Study|Lost to Follow-up|1
1132959|NCT01498653|3721994|P2|Overall Study|Protocol Violation|4
1132960|NCT01498653|3721995|P1|Overall Study|Protocol Violation|0
1132961|NCT01498653|3721994|P2|Overall Study|Lack of Efficacy|26
1132962|NCT01498653|3721995|P1|Overall Study|Lack of Efficacy|12
1132963|NCT01498653|3721994|P2|Overall Study|Adverse Event|2
1132964|NCT01498653|3721995|P1|Overall Study|Adverse Event|2
1132965|NCT01498640|3722009|P1|Overall Study|not specified|3
1132966|NCT01498640|3722009|P1|Overall Study|Death|1
1132967|NCT01498640|3722009|P1|Overall Study|Lost to Follow-up|1
1132968|NCT01498575|3722039|P2|On the Road Driving Assessment (ODA)|Protocol Violation|18
1132969|NCT01498575|3722040|P1|On the Road Driving Assessment (ODA)|Protocol Violation|23
1132970|NCT01498575|3722039|P2|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6
1132971|NCT01498575|3722040|P1|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19
1132972|NCT01498575|3722039|P2|Overall Sample|Withdrawal by Subject|14
1132973|NCT01498575|3722040|P1|Overall Sample|Withdrawal by Subject|60
1132974|NCT01498458|3722057|P1|Overall Study|Physician Decision|3
1132975|NCT01498458|3722057|P1|Overall Study|Adverse Event|4
1132976|NCT01498185|3722112|P5|Overall Study|No longer met criteria, etc|2
1132977|NCT01498185|3722113|P4|Overall Study|No longer met criteria, etc|0
1132978|NCT01498185|3722114|P3|Overall Study|No longer met criteria, etc|0
1132979|NCT01498185|3722115|P2|Overall Study|No longer met criteria, etc|0
1132980|NCT01498185|3722116|P1|Overall Study|No longer met criteria, etc|0
1132981|NCT01498185|3722112|P5|Overall Study|Withdrawal by Subject|1
1132982|NCT01498185|3722113|P4|Overall Study|Withdrawal by Subject|2
1132983|NCT01498185|3722114|P3|Overall Study|Withdrawal by Subject|0
1132984|NCT01498185|3722115|P2|Overall Study|Withdrawal by Subject|1
1132985|NCT01498185|3722116|P1|Overall Study|Withdrawal by Subject|1
1132986|NCT01498185|3722112|P5|Overall Study|Adverse Event|0
1132987|NCT01498185|3722113|P4|Overall Study|Adverse Event|1
1132988|NCT01498185|3722114|P3|Overall Study|Adverse Event|0
1132989|NCT01498185|3722115|P2|Overall Study|Adverse Event|0
1132990|NCT01498185|3722116|P1|Overall Study|Adverse Event|0
1132991|NCT01498120|3722156|P1|Overall Study|Other|4
1132992|NCT01498120|3722156|P1|Overall Study|AE, non-serious non-fatal|3
1132993|NCT01498120|3722156|P1|Overall Study|Withdrawal by Subject|5
1132994|NCT01498120|3722156|P1|Overall Study|Lost to Follow-up|1
1132995|NCT01498068|3722163|P2|Overall Study|Withdrawal by Subject|1
1132996|NCT01498068|3722164|P1|Overall Study|Withdrawal by Subject|1
1132997|NCT01497938|3722182|P2|Overall Study|Device Violation|0
1132998|NCT01497938|3722183|P1|Overall Study|Device Violation|1
1132999|NCT01497938|3722182|P2|Overall Study|Withdrawal by Subject|0
1133000|NCT01497938|3722183|P1|Overall Study|Withdrawal by Subject|4
1133001|NCT01497938|3722182|P2|Overall Study|Physician Decision|1
1133002|NCT01497938|3722183|P1|Overall Study|Physician Decision|0
1133003|NCT01497938|3722182|P2|Overall Study|Adverse Event|1
1133004|NCT01497938|3722183|P1|Overall Study|Adverse Event|0
1133005|NCT01497899|3722195|P4|Open-Label Extension Phase|Lost to Follow-up|5
1133006|NCT01497899|3722196|P3|Open-Label Extension Phase|Lost to Follow-up|5
1133007|NCT01497899|3722197|P2|Open-Label Extension Phase|Lost to Follow-up|3
1133008|NCT01497899|3722198|P1|Open-Label Extension Phase|Lost to Follow-up|9
1133009|NCT01497899|3722195|P4|Open-Label Extension Phase|Protocol Violation|0
1133010|NCT01497899|3722196|P3|Open-Label Extension Phase|Protocol Violation|1
1133011|NCT01497899|3722197|P2|Open-Label Extension Phase|Protocol Violation|0
1133012|NCT01497899|3722198|P1|Open-Label Extension Phase|Protocol Violation|0
1133013|NCT01497899|3722195|P4|Open-Label Extension Phase|Pregnancy|0
1133014|NCT01497899|3722196|P3|Open-Label Extension Phase|Pregnancy|1
1133015|NCT01497899|3722197|P2|Open-Label Extension Phase|Pregnancy|1
1133016|NCT01497899|3722198|P1|Open-Label Extension Phase|Pregnancy|0
1133017|NCT01497899|3722195|P4|Open-Label Extension Phase|Withdrew Consent|0
1133018|NCT01497899|3722196|P3|Open-Label Extension Phase|Withdrew Consent|2
1133019|NCT01497899|3722197|P2|Open-Label Extension Phase|Withdrew Consent|3
1133020|NCT01497899|3722198|P1|Open-Label Extension Phase|Withdrew Consent|8
1133021|NCT01497899|3722195|P4|Open-Label Extension Phase|Death|0
1133022|NCT01497899|3722196|P3|Open-Label Extension Phase|Death|0
1133023|NCT01497899|3722197|P2|Open-Label Extension Phase|Death|0
1133024|NCT01497899|3722198|P1|Open-Label Extension Phase|Death|1
1133025|NCT01497899|3722195|P4|Open-Label Extension Phase|Adverse Event|0
1133026|NCT01497899|3722196|P3|Open-Label Extension Phase|Adverse Event|0
1133027|NCT01497899|3722197|P2|Open-Label Extension Phase|Adverse Event|0
1133028|NCT01497899|3722198|P1|Open-Label Extension Phase|Adverse Event|1
1133029|NCT01497899|3722195|P4|Double-Blind Phase|Subject Non-Compliance|0
1133030|NCT01497899|3722196|P3|Double-Blind Phase|Subject Non-Compliance|0
1133031|NCT01497899|3722197|P2|Double-Blind Phase|Subject Non-Compliance|1
1133032|NCT01497899|3722198|P1|Double-Blind Phase|Subject Non-Compliance|0
1133033|NCT01497899|3722195|P4|Double-Blind Phase|Lost to Follow-up|0
1133034|NCT01497899|3722196|P3|Double-Blind Phase|Lost to Follow-up|0
1133035|NCT01497899|3722197|P2|Double-Blind Phase|Lost to Follow-up|2
1133036|NCT01497899|3722198|P1|Double-Blind Phase|Lost to Follow-up|3
1133037|NCT01497899|3722195|P4|Double-Blind Phase|Withdrew Consent|0
1133038|NCT01497899|3722196|P3|Double-Blind Phase|Withdrew Consent|0
1133039|NCT01497899|3722197|P2|Double-Blind Phase|Withdrew Consent|1
1133040|NCT01497899|3722198|P1|Double-Blind Phase|Withdrew Consent|0
1133041|NCT01497899|3722195|P4|Double-Blind Phase|Investigator's Discretion|0
1133042|NCT01497899|3722196|P3|Double-Blind Phase|Investigator's Discretion|0
1133043|NCT01497899|3722197|P2|Double-Blind Phase|Investigator's Discretion|0
1133044|NCT01497899|3722198|P1|Double-Blind Phase|Investigator's Discretion|1
1133045|NCT01497899|3722195|P4|Double-Blind Phase|Lack of Efficacy|0
1133046|NCT01497899|3722196|P3|Double-Blind Phase|Lack of Efficacy|0
1133047|NCT01497899|3722197|P2|Double-Blind Phase|Lack of Efficacy|1
1133048|NCT01497899|3722198|P1|Double-Blind Phase|Lack of Efficacy|0
1133049|NCT01497899|3722195|P4|Double-Blind Phase|Adverse Event|0
1133050|NCT01497899|3722196|P3|Double-Blind Phase|Adverse Event|0
1133051|NCT01497899|3722197|P2|Double-Blind Phase|Adverse Event|0
1133052|NCT01497899|3722198|P1|Double-Blind Phase|Adverse Event|1
1133053|NCT01497899|3722195|P4|Double-Blind Phase|Randomized but not Treated|0
1133054|NCT01497899|3722196|P3|Double-Blind Phase|Randomized but not Treated|0
1133055|NCT01497899|3722197|P2|Double-Blind Phase|Randomized but not Treated|0
1133056|NCT01497899|3722198|P1|Double-Blind Phase|Randomized but not Treated|1
1133057|NCT01497366|3722265|P2|Overall Study|Randomized but not treated|21
1133058|NCT01497366|3722266|P1|Overall Study|Randomized but not treated|7
1133059|NCT01497366|3722265|P2|Overall Study|Death|1
1133060|NCT01497366|3722266|P1|Overall Study|Death|1
1133061|NCT01497366|3722265|P2|Overall Study|Other|0
1133062|NCT01497366|3722266|P1|Overall Study|Other|5
1133063|NCT01497366|3722265|P2|Overall Study|Initiated Non-protocol HCV Treatment|0
1133064|NCT01497366|3722266|P1|Overall Study|Initiated Non-protocol HCV Treatment|7
1133065|NCT01497366|3722265|P2|Overall Study|Withdrawal by Subject|6
1133066|NCT01497366|3722266|P1|Overall Study|Withdrawal by Subject|6
1133067|NCT01497366|3722265|P2|Overall Study|Lost to Follow-up|10
1133068|NCT01497366|3722266|P1|Overall Study|Lost to Follow-up|11
1133069|NCT01497366|3722265|P2|Overall Study|Virologic failure|50
1133070|NCT01497366|3722266|P1|Overall Study|Virologic failure|2
1133071|NCT01497275|3722284|P1|Overall Study|Adverse Event|1
1133072|NCT01497275|3722284|P1|Overall Study|Death|1
1133073|NCT01497262|3722291|P1|Overall Study|Protocol Violation|1
1133074|NCT01497262|3722291|P1|Overall Study|Adverse Event|2
1133075|NCT01497262|3722291|P1|Overall Study|Withdrawal by Subject|2
1133076|NCT01497262|3722291|P1|Overall Study|Physician Decision|1
1133077|NCT01497262|3722291|P1|Overall Study|Abnormal Test Procedure Result|1
1133078|NCT01497262|3722291|P1|Overall Study|Abnormal Lab Values|4
1133079|NCT01497197|3722298|P2|Overall Study|Other|1
1133080|NCT01497197|3722299|P1|Overall Study|Other|3
1133081|NCT01497197|3722298|P2|Overall Study|All embryos discarded|3
1133082|NCT01497197|3722299|P1|Overall Study|All embryos discarded|0
1133083|NCT01497197|3722298|P2|Overall Study|Intention to freeze all embryos|1
1133084|NCT01497197|3722299|P1|Overall Study|Intention to freeze all embryos|0
1133085|NCT01497197|3722298|P2|Overall Study|No fertilisation|5
1133086|NCT01497197|3722299|P1|Overall Study|No fertilisation|6
1133087|NCT01497197|3722298|P2|Overall Study|No oocytes retrieved|2
1133088|NCT01497197|3722299|P1|Overall Study|No oocytes retrieved|3
1133089|NCT01497197|3722298|P2|Overall Study|Risk of OHSS|0
1133090|NCT01497197|3722299|P1|Overall Study|Risk of OHSS|1
1133091|NCT01497197|3722298|P2|Overall Study|Excessive/lack of response to treatment|0
1133092|NCT01497197|3722299|P1|Overall Study|Excessive/lack of response to treatment|1
1133093|NCT01497197|3722298|P2|Overall Study|Withdrawal by Subject|1
1133094|NCT01497197|3722299|P1|Overall Study|Withdrawal by Subject|2
1133095|NCT01497197|3722298|P2|Overall Study|Protocol Violation|2
1133096|NCT01497197|3722299|P1|Overall Study|Protocol Violation|0
1133097|NCT01497197|3722298|P2|Overall Study|Lost to Follow-up|0
1133098|NCT01497197|3722299|P1|Overall Study|Lost to Follow-up|1
1133099|NCT01496846|3722340|P6|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
1133100|NCT01496846|3722341|P5|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
1133101|NCT01496846|3722342|P4|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
1133102|NCT01496846|3722343|P3|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
1133103|NCT01496846|3722344|P2|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
1133104|NCT01496846|3722345|P1|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
1133105|NCT01496807|3722356|P1|Overall Study|Change in diagnosis|1
1133106|NCT01496807|3722356|P1|Overall Study|Participant preference/toxicity|8
1133107|NCT01496807|3722356|P1|Overall Study|Progressive Disease|21
1133108|NCT01496469|3722368|P2|Overall Study|Other|1
1133109|NCT01496469|3722369|P1|Overall Study|Other|1
1133110|NCT01496469|3722368|P2|Overall Study|BP exceeds protocol limits|2
1133111|NCT01496469|3722369|P1|Overall Study|BP exceeds protocol limits|1
1133112|NCT01496469|3722368|P2|Overall Study|Withdrawal by Subject|4
1133113|NCT01496469|3722369|P1|Overall Study|Withdrawal by Subject|4
1133114|NCT01496469|3722368|P2|Overall Study|Lost to Follow-up|1
1133115|NCT01496469|3722369|P1|Overall Study|Lost to Follow-up|1
1133116|NCT01496469|3722368|P2|Overall Study|Protocol Violation|0
1133117|NCT01496469|3722369|P1|Overall Study|Protocol Violation|2
1133118|NCT01496469|3722368|P2|Overall Study|Adverse Event|0
1133119|NCT01496469|3722369|P1|Overall Study|Adverse Event|1
1133120|NCT01496456|3722379|P1|Overall Study|Lost to Follow-up|7
1133121|NCT01496456|3722379|P1|Overall Study|Protocol Violation|1
1133122|NCT01496430|3722392|P3|Overall Study|Other|0
1133123|NCT01496430|3722393|P2|Overall Study|Other|0
1133124|NCT01496430|3722394|P1|Overall Study|Other|2
1133125|NCT01496430|3722392|P3|Overall Study|Principal Investigator Discretion|1
1133126|NCT01496430|3722393|P2|Overall Study|Principal Investigator Discretion|1
1133127|NCT01496430|3722394|P1|Overall Study|Principal Investigator Discretion|0
1133128|NCT01496430|3722392|P3|Overall Study|Voluntary Withdrawal|6
1133129|NCT01496430|3722393|P2|Overall Study|Voluntary Withdrawal|1
1133130|NCT01496430|3722394|P1|Overall Study|Voluntary Withdrawal|2
1133131|NCT01496430|3722392|P3|Overall Study|Lost to Follow-up|1
1133132|NCT01496430|3722393|P2|Overall Study|Lost to Follow-up|3
1133133|NCT01496430|3722394|P1|Overall Study|Lost to Follow-up|2
1133134|NCT01496430|3722392|P3|Overall Study|Major Protocol Deviation|1
1133135|NCT01496430|3722393|P2|Overall Study|Major Protocol Deviation|0
1133136|NCT01496430|3722394|P1|Overall Study|Major Protocol Deviation|0
1133137|NCT01496430|3722392|P3|Overall Study|Adverse Event|1
1133138|NCT01496430|3722393|P2|Overall Study|Adverse Event|0
1133139|NCT01496430|3722394|P1|Overall Study|Adverse Event|0
1133140|NCT01496287|3722506|P1|Overall Study|Incomplete anesthesia|5
1133141|NCT01496287|3722506|P1|Overall Study|Lost to Follow-up|1
1133142|NCT01496274|3722516|P2|Overall Study|Lost to Follow-up|3
1133143|NCT01496274|3722517|P1|Overall Study|Lost to Follow-up|0
1133144|NCT01496274|3722516|P2|Overall Study|Withdrawal by Subject|0
1133145|NCT01496274|3722517|P1|Overall Study|Withdrawal by Subject|2
1133146|NCT01496274|3722516|P2|Overall Study|Adverse Event|1
1133147|NCT01496274|3722517|P1|Overall Study|Adverse Event|1
1133148|NCT01496274|3722516|P2|Overall Study|Protocol Violation|1
1133149|NCT01496274|3722517|P1|Overall Study|Protocol Violation|0
1133150|NCT01496183|3722562|P2|Overall Study|Withdrawal by Subject|1
1133151|NCT01496183|3722563|P1|Overall Study|Withdrawal by Subject|0
1133152|NCT01496183|3722562|P2|Overall Study|Physician Decision|1
1133153|NCT01496183|3722563|P1|Overall Study|Physician Decision|3
1133154|NCT01496066|3722615|P2|Overall Study|Death|4
1133155|NCT01496066|3722616|P1|Overall Study|Death|1
1133156|NCT01496066|3722615|P2|Overall Study|Explant|0
1133157|NCT01496066|3722616|P1|Overall Study|Explant|3
1133158|NCT01496066|3722615|P2|Overall Study|Lost to Follow-up|5
1133159|NCT01496066|3722616|P1|Overall Study|Lost to Follow-up|8
1133160|NCT01495975|3722678|P2|Overall Study|Lost to Follow-up|0
1133161|NCT01495975|3722679|P1|Overall Study|Lost to Follow-up|1
1133162|NCT01495793|3722803|P1|Overall Study|Violation of inclusion criteria|1
1133163|NCT01495793|3722803|P1|Overall Study|Lost to Follow-up|1
1133164|NCT01495702|3722816|P2|Randomized Phase|Protocol Violation|1
1133165|NCT01495702|3722817|P1|Randomized Phase|Protocol Violation|3
1133166|NCT01495702|3722816|P2|Randomized Phase|Participant Noncompliance|0
1133167|NCT01495702|3722817|P1|Randomized Phase|Participant Noncompliance|1
1133168|NCT01495702|3722816|P2|Randomized Phase|Lost to Follow-up|3
1133169|NCT01495702|3722817|P1|Randomized Phase|Lost to Follow-up|4
1133170|NCT01495702|3722816|P2|Randomized Phase|Withdrew Consent|18
1133171|NCT01495702|3722817|P1|Randomized Phase|Withdrew Consent|10
1133172|NCT01495702|3722816|P2|Randomized Phase|Investigators Discretion|0
1133173|NCT01495702|3722817|P1|Randomized Phase|Investigators Discretion|2
1133174|NCT01495702|3722816|P2|Randomized Phase|Lack of Efficacy|0
1133175|NCT01495702|3722817|P1|Randomized Phase|Lack of Efficacy|2
1133176|NCT01495702|3722816|P2|Randomized Phase|Death|0
1133177|NCT01495702|3722817|P1|Randomized Phase|Death|1
1133178|NCT01495702|3722816|P2|Randomized Phase|Adverse Event|2
1133179|NCT01495702|3722817|P1|Randomized Phase|Adverse Event|2
1133180|NCT01495702|3722816|P2|Randomized Phase|Randomized But Not Treated|4
1133181|NCT01495702|3722817|P1|Randomized Phase|Randomized But Not Treated|1
1133182|NCT01495000|3722895|P2|Overall Study|Withdrawal by Subject|10
1133183|NCT01495000|3722896|P1|Overall Study|Withdrawal by Subject|10
1133184|NCT01495000|3722895|P2|Overall Study|Protocol Violation|0
1133185|NCT01495000|3722896|P1|Overall Study|Protocol Violation|1
1133186|NCT01495000|3722895|P2|Overall Study|Lost to Follow-up|2
1133187|NCT01495000|3722896|P1|Overall Study|Lost to Follow-up|2
1133188|NCT01494987|3722938|P2|Overall Study|Subject Withdrew Consent|3
1133189|NCT01494987|3722939|P1|Overall Study|Subject Withdrew Consent|2
1133190|NCT01494987|3722938|P2|Overall Study|Subject Non-Compliance|10
1133191|NCT01494987|3722939|P1|Overall Study|Subject Non-Compliance|9
1133192|NCT01494987|3722938|P2|Overall Study|Protocol Violation|3
1133193|NCT01494987|3722939|P1|Overall Study|Protocol Violation|3
1133194|NCT01494987|3722938|P2|Overall Study|Lost to Follow-up|1
1133195|NCT01494987|3722939|P1|Overall Study|Lost to Follow-up|1
1133196|NCT01494987|3722938|P2|Overall Study|Investigator's Discretion|2
1133197|NCT01494987|3722939|P1|Overall Study|Investigator's Discretion|1
1133198|NCT01494987|3722938|P2|Overall Study|Hyperglycemia|4
1133199|NCT01494987|3722939|P1|Overall Study|Hyperglycemia|6
1133200|NCT01494987|3722938|P2|Overall Study|Adverse Event|5
1133201|NCT01494987|3722939|P1|Overall Study|Adverse Event|6
1133202|NCT01494818|3722953|P2|Overall Study|Lost to Follow-up|0
1133203|NCT01494818|3722954|P1|Overall Study|Lost to Follow-up|1
1133204|NCT01494818|3722953|P2|Overall Study|Relocation|2
1133205|NCT01494818|3722954|P1|Overall Study|Relocation|1
1133206|NCT01494649|3722985|P2|Overall Study|Lost to Follow-up|1
1133207|NCT01494649|3722986|P1|Overall Study|Lost to Follow-up|0
1133208|NCT01494610|3723002|P2|Period 4|Protocol Violation|0
1133209|NCT01494610|3723003|P1|Period 4|Protocol Violation|1
1133210|NCT01494610|3723002|P2|Period 3|Withdrawal by Subject|0
1133211|NCT01494610|3723003|P1|Period 3|Withdrawal by Subject|1
1133212|NCT01494610|3723002|P2|Period 3|Adverse Event|0
1133213|NCT01494610|3723003|P1|Period 3|Adverse Event|1
1133214|NCT01494610|3723002|P2|Period 1|Withdrawal by Subject|1
1133215|NCT01494610|3723003|P1|Period 1|Withdrawal by Subject|1
1133216|NCT01494584|3723071|P1|Overall Study|Study Closed/Terminated|1
1133217|NCT01494532|3723203|P6|Overall Study|Withdrawal by Subject|0
1133218|NCT01494532|3723204|P5|Overall Study|Withdrawal by Subject|2
1133219|NCT01494532|3723205|P4|Overall Study|Withdrawal by Subject|3
1133220|NCT01494532|3723206|P3|Overall Study|Withdrawal by Subject|4
1133221|NCT01494532|3723207|P2|Overall Study|Withdrawal by Subject|1
1133222|NCT01494532|3723208|P1|Overall Study|Withdrawal by Subject|3
1133223|NCT01494532|3723203|P6|Overall Study|Physician Decision|0
1133224|NCT01494532|3723204|P5|Overall Study|Physician Decision|0
1133225|NCT01494532|3723205|P4|Overall Study|Physician Decision|2
1133226|NCT01494532|3723206|P3|Overall Study|Physician Decision|1
1133227|NCT01494532|3723207|P2|Overall Study|Physician Decision|1
1133228|NCT01494532|3723208|P1|Overall Study|Physician Decision|0
1133229|NCT01494532|3723203|P6|Overall Study|Lost to Follow-up|0
1133230|NCT01494532|3723204|P5|Overall Study|Lost to Follow-up|0
1133231|NCT01494532|3723205|P4|Overall Study|Lost to Follow-up|2
1133232|NCT01494532|3723206|P3|Overall Study|Lost to Follow-up|0
1133233|NCT01494532|3723207|P2|Overall Study|Lost to Follow-up|0
1133234|NCT01494532|3723208|P1|Overall Study|Lost to Follow-up|1
1133235|NCT01494532|3723203|P6|Overall Study|Protocol-defined stopping criteria|0
1133236|NCT01494532|3723204|P5|Overall Study|Protocol-defined stopping criteria|0
1133237|NCT01494532|3723205|P4|Overall Study|Protocol-defined stopping criteria|0
1133238|NCT01494532|3723206|P3|Overall Study|Protocol-defined stopping criteria|1
1133239|NCT01494532|3723207|P2|Overall Study|Protocol-defined stopping criteria|0
1133240|NCT01494532|3723208|P1|Overall Study|Protocol-defined stopping criteria|0
1133241|NCT01494532|3723203|P6|Overall Study|Protocol deviation|0
1133242|NCT01494532|3723204|P5|Overall Study|Protocol deviation|3
1133243|NCT01494532|3723205|P4|Overall Study|Protocol deviation|2
1133244|NCT01494532|3723206|P3|Overall Study|Protocol deviation|3
1133245|NCT01494532|3723207|P2|Overall Study|Protocol deviation|1
1133246|NCT01494532|3723208|P1|Overall Study|Protocol deviation|2
1133247|NCT01494532|3723203|P6|Overall Study|Lack of Efficacy|0
1133248|NCT01494532|3723204|P5|Overall Study|Lack of Efficacy|2
1133249|NCT01494532|3723205|P4|Overall Study|Lack of Efficacy|0
1133250|NCT01494532|3723206|P3|Overall Study|Lack of Efficacy|0
1133251|NCT01494532|3723207|P2|Overall Study|Lack of Efficacy|0
1133252|NCT01494532|3723208|P1|Overall Study|Lack of Efficacy|0
1133253|NCT01494532|3723203|P6|Overall Study|Adverse Event|0
1133254|NCT01494532|3723204|P5|Overall Study|Adverse Event|5
1133255|NCT01494532|3723205|P4|Overall Study|Adverse Event|6
1133256|NCT01494532|3723206|P3|Overall Study|Adverse Event|8
1133257|NCT01494532|3723207|P2|Overall Study|Adverse Event|1
1133258|NCT01494532|3723208|P1|Overall Study|Adverse Event|4
1133259|NCT01494506|3723363|P3|Overall Study|Other|1
1133260|NCT01494506|3723364|P2|Overall Study|Other|3
1133261|NCT01494506|3723365|P1|Overall Study|Other|0
1133262|NCT01494506|3723363|P3|Overall Study|Sponsor Decision|1
1133263|NCT01494506|3723364|P2|Overall Study|Sponsor Decision|0
1133264|NCT01494506|3723365|P1|Overall Study|Sponsor Decision|0
1133265|NCT01494506|3723363|P3|Overall Study|Clinical Deterioration|13
1133266|NCT01494506|3723364|P2|Overall Study|Clinical Deterioration|17
1133267|NCT01494506|3723365|P1|Overall Study|Clinical Deterioration|21
1133268|NCT01494506|3723363|P3|Overall Study|Withdrawal by Subject|14
1133269|NCT01494506|3723364|P2|Overall Study|Withdrawal by Subject|20
1133270|NCT01494506|3723365|P1|Overall Study|Withdrawal by Subject|17
1133271|NCT01494506|3723363|P3|Overall Study|Physician Decision|4
1133272|NCT01494506|3723364|P2|Overall Study|Physician Decision|5
1133273|NCT01494506|3723365|P1|Overall Study|Physician Decision|7
1133274|NCT01494506|3723363|P3|Overall Study|Death|2
1133275|NCT01494506|3723364|P2|Overall Study|Death|5
1133276|NCT01494506|3723365|P1|Overall Study|Death|9
1133277|NCT01494506|3723363|P3|Overall Study|Adverse Event|11
1133278|NCT01494506|3723364|P2|Overall Study|Adverse Event|10
1133279|NCT01494506|3723365|P1|Overall Study|Adverse Event|17
1133280|NCT01494506|3723363|P3|Overall Study|Lack of Efficacy|57
1133281|NCT01494506|3723364|P2|Overall Study|Lack of Efficacy|83
1133282|NCT01494506|3723365|P1|Overall Study|Lack of Efficacy|77
1133283|NCT01494467|3723402|P2|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2
1133284|NCT01494467|3723403|P1|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8
1133285|NCT01494467|3723402|P2|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
1133286|NCT01494467|3723403|P1|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26
1133287|NCT01494467|3723402|P2|Part B Long Term Active Control 40 Weeks|Protocol Violation|5
1133288|NCT01494467|3723403|P1|Part B Long Term Active Control 40 Weeks|Protocol Violation|3
1133289|NCT01494467|3723402|P2|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24
1133290|NCT01494467|3723403|P1|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32
1133291|NCT01494467|3723402|P2|Part B Long Term Active Control 40 Weeks|Adverse Event|5
1133292|NCT01494467|3723403|P1|Part B Long Term Active Control 40 Weeks|Adverse Event|3
1133293|NCT01494467|3723402|P2|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
1133294|NCT01494467|3723403|P1|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1
1133295|NCT01494467|3723402|P2|Part B Long Term Active Control 40 Weeks|Pregnancy|0
1133296|NCT01494467|3723403|P1|Part B Long Term Active Control 40 Weeks|Pregnancy|2
1133297|NCT01494467|3723402|P2|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
1133298|NCT01494467|3723403|P1|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
1133299|NCT01494467|3723402|P2|Part A Vehicle Control (12 Weeks)|Other|1
1133300|NCT01494467|3723403|P1|Part A Vehicle Control (12 Weeks)|Other|1
1133301|NCT01494467|3723402|P2|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
1133302|NCT01494467|3723403|P1|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
1133303|NCT01494467|3723402|P2|Part A Vehicle Control (12 Weeks)|Protocol Violation|0
1133304|NCT01494467|3723403|P1|Part A Vehicle Control (12 Weeks)|Protocol Violation|4
1133305|NCT01494467|3723402|P2|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8
1133306|NCT01494467|3723403|P1|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9
1133307|NCT01494467|3723402|P2|Part A Vehicle Control (12 Weeks)|Adverse Event|4
1133308|NCT01494467|3723403|P1|Part A Vehicle Control (12 Weeks)|Adverse Event|6
1133309|NCT01494467|3723402|P2|Part A Vehicle Control (12 Weeks)|Pregnancy|0
1133310|NCT01494467|3723403|P1|Part A Vehicle Control (12 Weeks)|Pregnancy|1
1133311|NCT01494350|3723419|P1|Overall Study|Worsening of lesion|1
1133312|NCT01494298|3723429|P2|Overall Study|Protocol Violation|8
1133313|NCT01494298|3723430|P1|Overall Study|Protocol Violation|2
1133314|NCT01494038|3723442|P2|Overall Study|Death|4
1133315|NCT01494038|3723443|P1|Overall Study|Death|2
1133316|NCT01494038|3723442|P2|Overall Study|Not willing to adhere to reqs|9
1133317|NCT01494038|3723443|P1|Overall Study|Not willing to adhere to reqs|2
1133318|NCT01494038|3723442|P2|Overall Study|Not able to get to clinic|15
1133319|NCT01494038|3723443|P1|Overall Study|Not able to get to clinic|21
1133320|NCT01494038|3723442|P2|Overall Study|Withdrawal by Subject|34
1133321|NCT01494038|3723443|P1|Overall Study|Withdrawal by Subject|44
1133322|NCT01494038|3723442|P2|Overall Study|Lost to Follow-up|20
1133323|NCT01494038|3723443|P1|Overall Study|Lost to Follow-up|18
1133324|NCT01494038|3723442|P2|Overall Study|Protocol Violation|1
1133325|NCT01494038|3723443|P1|Overall Study|Protocol Violation|1
1133326|NCT01493960|3723531|P2|Overall Study|Non-specified|4
1133327|NCT01493960|3723532|P1|Overall Study|Non-specified|4
1133328|NCT01493960|3723531|P2|Overall Study|Withdrawal by Subject|4
1133329|NCT01493960|3723532|P1|Overall Study|Withdrawal by Subject|10
1133330|NCT01493960|3723531|P2|Overall Study|Protocol Violation|0
1133331|NCT01493960|3723532|P1|Overall Study|Protocol Violation|3
1133332|NCT01493960|3723531|P2|Overall Study|Lack of Efficacy|9
1133333|NCT01493960|3723532|P1|Overall Study|Lack of Efficacy|15
1133334|NCT01493960|3723531|P2|Overall Study|Adverse Event|1
1133335|NCT01493960|3723532|P1|Overall Study|Adverse Event|0
1133336|NCT01493778|3723563|P1|Overall Study|treatment ongoing|1
1133337|NCT01493778|3723563|P1|Overall Study|unclassified|2
1133338|NCT01493687|3723591|P2|Part C Safety Follow up (4 Weeks)|Adverse Event|1
1133339|NCT01493687|3723592|P1|Part C Safety Follow up (4 Weeks)|Adverse Event|0
1133340|NCT01493687|3723591|P2|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1
1133341|NCT01493687|3723592|P1|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5
1133342|NCT01493687|3723591|P2|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
1133343|NCT01493687|3723592|P1|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16
1133344|NCT01493687|3723591|P2|Part B Long Term Active Control 40 Weeks|Protocol Violation|0
1133345|NCT01493687|3723592|P1|Part B Long Term Active Control 40 Weeks|Protocol Violation|1
1133346|NCT01493687|3723591|P2|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16
1133347|NCT01493687|3723592|P1|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27
1133348|NCT01493687|3723591|P2|Part B Long Term Active Control 40 Weeks|Adverse Event|4
1133349|NCT01493687|3723592|P1|Part B Long Term Active Control 40 Weeks|Adverse Event|5
1133350|NCT01493687|3723591|P2|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
1133351|NCT01493687|3723592|P1|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2
1133352|NCT01493687|3723591|P2|Part B Long Term Active Control 40 Weeks|Pregnancy|1
1133353|NCT01493687|3723592|P1|Part B Long Term Active Control 40 Weeks|Pregnancy|5
1133354|NCT01493687|3723591|P2|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
1133355|NCT01493687|3723592|P1|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
1133356|NCT01493687|3723591|P2|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
1133357|NCT01493687|3723592|P1|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7
1133358|NCT01493687|3723591|P2|Part A Vehicle Control (12 Weeks)|Protocol Violation|1
1133359|NCT01493687|3723592|P1|Part A Vehicle Control (12 Weeks)|Protocol Violation|2
1133360|NCT01493687|3723591|P2|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7
1133361|NCT01493687|3723592|P1|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18
1133362|NCT01493687|3723591|P2|Part A Vehicle Control (12 Weeks)|Adverse Event|4
1133363|NCT01493687|3723592|P1|Part A Vehicle Control (12 Weeks)|Adverse Event|7
1133364|NCT01493687|3723591|P2|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
1133365|NCT01493687|3723592|P1|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
1133366|NCT01493687|3723591|P2|Part A Vehicle Control (12 Weeks)|Pregnancy|0
1133367|NCT01493687|3723592|P1|Part A Vehicle Control (12 Weeks)|Pregnancy|2
1133368|NCT01493557|3723611|P3|Adding the Second Strategy|Withdrawal by Subject|0
1133369|NCT01493557|3723612|P2|Adding the Second Strategy|Withdrawal by Subject|1
1133370|NCT01493557|3723613|P1|Adding the Second Strategy|Withdrawal by Subject|0
1133371|NCT01493557|3723611|P3|Adding the Second Strategy|Other adverse event|0
1133372|NCT01493557|3723612|P2|Adding the Second Strategy|Other adverse event|2
1133373|NCT01493557|3723613|P1|Adding the Second Strategy|Other adverse event|1
1133374|NCT01493557|3723611|P3|Adding the Second Strategy|Worsening of events associate with GIS|0
1133375|NCT01493557|3723612|P2|Adding the Second Strategy|Worsening of events associate with GIS|1
1133376|NCT01493557|3723613|P1|Adding the Second Strategy|Worsening of events associate with GIS|1
1133377|NCT01493557|3723611|P3|Randomized to Management Strategies|Other than stated above|0
1133378|NCT01493557|3723612|P2|Randomized to Management Strategies|Other than stated above|3
1133379|NCT01493557|3723613|P1|Randomized to Management Strategies|Other than stated above|1
1133380|NCT01493557|3723611|P3|Randomized to Management Strategies|Withdrawal by Subject|0
1133381|NCT01493557|3723612|P2|Randomized to Management Strategies|Withdrawal by Subject|1
1133382|NCT01493557|3723613|P1|Randomized to Management Strategies|Withdrawal by Subject|0
1133383|NCT01493557|3723611|P3|Randomized to Management Strategies|Protocol Violation|0
1133384|NCT01493557|3723612|P2|Randomized to Management Strategies|Protocol Violation|0
1133385|NCT01493557|3723613|P1|Randomized to Management Strategies|Protocol Violation|3
1133386|NCT01493557|3723611|P3|Randomized to Management Strategies|Other adverse event|0
1133387|NCT01493557|3723612|P2|Randomized to Management Strategies|Other adverse event|5
1133388|NCT01493557|3723613|P1|Randomized to Management Strategies|Other adverse event|8
1133389|NCT01493557|3723611|P3|Randomized to Management Strategies|Worsening of events associate with GIS|0
1133390|NCT01493557|3723612|P2|Randomized to Management Strategies|Worsening of events associate with GIS|2
1133391|NCT01493557|3723613|P1|Randomized to Management Strategies|Worsening of events associate with GIS|3
1133392|NCT01493557|3723611|P3|Not Randomized to Management Strategies|Other than stated above|21
1133393|NCT01493557|3723612|P2|Not Randomized to Management Strategies|Other than stated above|0
1133394|NCT01493557|3723613|P1|Not Randomized to Management Strategies|Other than stated above|0
1133395|NCT01493557|3723611|P3|Not Randomized to Management Strategies|Early termination|34
1133396|NCT01493557|3723612|P2|Not Randomized to Management Strategies|Early termination|0
1133397|NCT01493557|3723613|P1|Not Randomized to Management Strategies|Early termination|0
1133398|NCT01493557|3723611|P3|Not Randomized to Management Strategies|Withdrawal by Subject|10
1133399|NCT01493557|3723612|P2|Not Randomized to Management Strategies|Withdrawal by Subject|0
1133400|NCT01493557|3723613|P1|Not Randomized to Management Strategies|Withdrawal by Subject|0
1133401|NCT01493557|3723611|P3|Not Randomized to Management Strategies|Lost to Follow-up|4
1133402|NCT01493557|3723612|P2|Not Randomized to Management Strategies|Lost to Follow-up|0
1133403|NCT01493557|3723613|P1|Not Randomized to Management Strategies|Lost to Follow-up|0
1133404|NCT01493557|3723611|P3|Not Randomized to Management Strategies|Protocol Violation|1
1133405|NCT01493557|3723612|P2|Not Randomized to Management Strategies|Protocol Violation|0
1133406|NCT01493557|3723613|P1|Not Randomized to Management Strategies|Protocol Violation|0
1133407|NCT01493557|3723611|P3|Not Randomized to Management Strategies|Other adverse event|54
1133408|NCT01493557|3723612|P2|Not Randomized to Management Strategies|Other adverse event|0
1133409|NCT01493557|3723613|P1|Not Randomized to Management Strategies|Other adverse event|0
1133410|NCT01493557|3723611|P3|Not Randomized to Management Strategies|Worsening of other pre−existing disease|9
1133411|NCT01493557|3723612|P2|Not Randomized to Management Strategies|Worsening of other pre−existing disease|0
1133412|NCT01493557|3723613|P1|Not Randomized to Management Strategies|Worsening of other pre−existing disease|0
1133413|NCT01493557|3723611|P3|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1
1133414|NCT01493557|3723612|P2|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
1133415|NCT01493557|3723613|P1|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
1133416|NCT01493531|3723641|P3|Overall Study|Death|0
1133417|NCT01493531|3723642|P2|Overall Study|Death|1
1133418|NCT01493531|3723643|P1|Overall Study|Death|0
1133419|NCT01493531|3723641|P3|Overall Study|Withdrawal by Subject|11
1133420|NCT01493531|3723642|P2|Overall Study|Withdrawal by Subject|13
1133421|NCT01493531|3723643|P1|Overall Study|Withdrawal by Subject|16
1133422|NCT01493531|3723641|P3|Overall Study|Lost to Follow-up|11
1133423|NCT01493531|3723642|P2|Overall Study|Lost to Follow-up|7
1133424|NCT01493531|3723643|P1|Overall Study|Lost to Follow-up|5
1133425|NCT01493531|3723641|P3|Overall Study|Sponsor terminated study|3
1133426|NCT01493531|3723642|P2|Overall Study|Sponsor terminated study|2
1133427|NCT01493531|3723643|P1|Overall Study|Sponsor terminated study|5
1133428|NCT01493531|3723641|P3|Overall Study|Protocol Violation|12
1133429|NCT01493531|3723642|P2|Overall Study|Protocol Violation|15
1133430|NCT01493531|3723643|P1|Overall Study|Protocol Violation|8
1133431|NCT01493531|3723641|P3|Overall Study|Gout flare|2
1133432|NCT01493531|3723642|P2|Overall Study|Gout flare|0
1133433|NCT01493531|3723643|P1|Overall Study|Gout flare|3
1133434|NCT01493531|3723641|P3|Overall Study|Adverse Event|9
1133435|NCT01493531|3723642|P2|Overall Study|Adverse Event|12
1133436|NCT01493531|3723643|P1|Overall Study|Adverse Event|4
1133437|NCT01493427|3723657|P1|Overall Study|Other|2
1133438|NCT01493427|3723657|P1|Overall Study|Inability to Follow Instructions|2
1133439|NCT01493427|3723657|P1|Overall Study|Lost to Follow-up|2
1133440|NCT01493427|3723657|P1|Overall Study|Personal Reasons|4
1133441|NCT01493427|3723657|P1|Overall Study|Adverse Event|10
1133442|NCT01493284|3723662|P1|Overall Study|Withdrawal by Subject|32
1133443|NCT01493284|3723662|P1|Overall Study|Death|29
1133444|NCT01493089|3723684|P2|Overall Study|Physician Decision|1
1133445|NCT01493089|3723685|P1|Overall Study|Physician Decision|0
1133446|NCT01493089|3723684|P2|Overall Study|Withdrawal by Subject|0
1133447|NCT01493089|3723685|P1|Overall Study|Withdrawal by Subject|1
1133448|NCT01493089|3723684|P2|Overall Study|Protocol Violation|2
1133449|NCT01493089|3723685|P1|Overall Study|Protocol Violation|2
1133450|NCT01492686|3723784|P2|Open-label Phase|Due to a discontinuation criterion|9
1133451|NCT01492686|3723785|P1|Open-label Phase|Due to a discontinuation criterion|4
1133452|NCT01492686|3723784|P2|Open-label Phase|Withdrawal by Subject|7
1133453|NCT01492686|3723785|P1|Open-label Phase|Withdrawal by Subject|6
1133454|NCT01492686|3723784|P2|Open-label Phase|Physician Decision|0
1133455|NCT01492686|3723785|P1|Open-label Phase|Physician Decision|1
1133456|NCT01492686|3723784|P2|Open-label Phase|Adverse Event|2
1133457|NCT01492686|3723785|P1|Open-label Phase|Adverse Event|1
1133458|NCT01492686|3723784|P2|Double-blind Phase|Due to a discontinuation criterion|3
1133459|NCT01492686|3723785|P1|Double-blind Phase|Due to a discontinuation criterion|2
1133460|NCT01492686|3723784|P2|Double-blind Phase|Withdrawal by Subject|2
1133461|NCT01492686|3723785|P1|Double-blind Phase|Withdrawal by Subject|0
1133462|NCT01492686|3723784|P2|Double-blind Phase|Physician Decision|1
1133463|NCT01492686|3723785|P1|Double-blind Phase|Physician Decision|0
1133464|NCT01492686|3723784|P2|Double-blind Phase|Adverse Event|2
1133465|NCT01492686|3723785|P1|Double-blind Phase|Adverse Event|0
1133466|NCT01492439|3723811|P2|Overall Study|Withdrew from RTE|9
1133467|NCT01492439|3723812|P1|Overall Study|Withdrew from RTE|4
1133468|NCT01492426|3723860|P2|Follow-Up|Lost to Follow-up|6
1133469|NCT01492426|3723861|P1|Follow-Up|Lost to Follow-up|12
1133470|NCT01492426|3723860|P2|Follow-Up|Participant Withdrew Consent|1
1133471|NCT01492426|3723861|P1|Follow-Up|Participant Withdrew Consent|6
1133472|NCT01492426|3723860|P2|Follow-Up|Other|2
1133473|NCT01492426|3723861|P1|Follow-Up|Other|4
1133474|NCT01492426|3723860|P2|Follow-Up|Death|0
1133475|NCT01492426|3723861|P1|Follow-Up|Death|1
1133476|NCT01492426|3723860|P2|Follow-Up|Protocol Requires no Follow-Up|1
1133477|NCT01492426|3723861|P1|Follow-Up|Protocol Requires no Follow-Up|2
1133478|NCT01492426|3723860|P2|Treatment|Participant does not meet study criteria|0
1133479|NCT01492426|3723861|P1|Treatment|Participant does not meet study criteria|1
1133480|NCT01492426|3723860|P2|Treatment|Lost to Follow-up|4
1133481|NCT01492426|3723861|P1|Treatment|Lost to Follow-up|9
1133482|NCT01492426|3723860|P2|Treatment|Subject requested discontinue study drug|3
1133483|NCT01492426|3723861|P1|Treatment|Subject requested discontinue study drug|7
1133484|NCT01492426|3723860|P2|Treatment|Poor compliance/noncompliance|0
1133485|NCT01492426|3723861|P1|Treatment|Poor compliance/noncompliance|1
1133486|NCT01492426|3723860|P2|Treatment|Participant withdrew consent|2
1133487|NCT01492426|3723861|P1|Treatment|Participant withdrew consent|1
1133488|NCT01492426|3723860|P2|Treatment|Lack of Efficacy|5
1133489|NCT01492426|3723861|P1|Treatment|Lack of Efficacy|38
1133490|NCT01492426|3723860|P2|Treatment|Adverse Event|25
1133491|NCT01492426|3723861|P1|Treatment|Adverse Event|25
1133492|NCT01492426|3723860|P2|Treatment|Other|0
1133493|NCT01492426|3723861|P1|Treatment|Other|1
1133494|NCT01492426|3723860|P2|Treatment|Death|1
1133495|NCT01492426|3723861|P1|Treatment|Death|0
1133496|NCT01492400|3723879|P2|Overall Study|Adverse Event|5
1133497|NCT01492400|3723880|P1|Overall Study|Adverse Event|10
1133498|NCT01492400|3723879|P2|Overall Study|Lack of Efficacy|1
1133499|NCT01492400|3723880|P1|Overall Study|Lack of Efficacy|1
1133500|NCT01492400|3723879|P2|Overall Study|Pregnancy|1
1133501|NCT01492400|3723880|P1|Overall Study|Pregnancy|0
1133502|NCT01492400|3723879|P2|Overall Study|Lost to Follow-up|1
1133503|NCT01492400|3723880|P1|Overall Study|Lost to Follow-up|3
1133504|NCT01492400|3723879|P2|Overall Study|Personal Reasons|5
1133505|NCT01492400|3723880|P1|Overall Study|Personal Reasons|0
1133506|NCT01492400|3723879|P2|Overall Study|Miscellaneous Reasons|3
1133507|NCT01492400|3723880|P1|Overall Study|Miscellaneous Reasons|2
1133508|NCT01492088|3723904|P3|Overall Study|Alive at Last Follow-up|11
1133509|NCT01492088|3723905|P2|Overall Study|Alive at Last Follow-up|6
1133510|NCT01492088|3723906|P1|Overall Study|Alive at Last Follow-up|0
1133511|NCT01492088|3723904|P3|Overall Study|Completed Post Treatment Followup (PTFU)|1
1133512|NCT01492088|3723905|P2|Overall Study|Completed Post Treatment Followup (PTFU)|0
1133513|NCT01492088|3723906|P1|Overall Study|Completed Post Treatment Followup (PTFU)|2
1133514|NCT01492088|3723904|P3|Overall Study|Death|2
1133515|NCT01492088|3723905|P2|Overall Study|Death|6
1133516|NCT01492088|3723906|P1|Overall Study|Death|1
1133517|NCT01492088|3723904|P3|Overall Study|Withdrawal by Patient|0
1133518|NCT01492088|3723905|P2|Overall Study|Withdrawal by Patient|2
1133519|NCT01492088|3723906|P1|Overall Study|Withdrawal by Patient|0
1133520|NCT01491919|3723987|P3|Overall Study|Insufficient PK sampling|1
1133521|NCT01491919|3723988|P2|Overall Study|Insufficient PK sampling|2
1133522|NCT01491919|3723989|P1|Overall Study|Insufficient PK sampling|1
1133523|NCT01491802|3724060|P2|Overall Study|Withdrawal by Subject|1
1133524|NCT01491802|3724061|P1|Overall Study|Withdrawal by Subject|0
1133525|NCT01491802|3724060|P2|Overall Study|Adverse Event|1
1133526|NCT01491802|3724061|P1|Overall Study|Adverse Event|1
1133527|NCT01491737|3724088|P2|Overall Study|Reason not specified|3
1133528|NCT01491737|3724089|P1|Overall Study|Reason not specified|2
1133529|NCT01491737|3724088|P2|Overall Study|Death|28
1133530|NCT01491737|3724089|P1|Overall Study|Death|33
1133531|NCT01491737|3724088|P2|Overall Study|Lost to Follow-up|6
1133532|NCT01491737|3724089|P1|Overall Study|Lost to Follow-up|1
1133533|NCT01491737|3724088|P2|Overall Study|Withdrawal of consent|13
1133534|NCT01491737|3724089|P1|Overall Study|Withdrawal of consent|13
1133535|NCT01491672|3724112|P3|Overall Study|Death|0
1133536|NCT01491672|3724113|P2|Overall Study|Death|4
1133537|NCT01491672|3724114|P1|Overall Study|Death|0
1133538|NCT01491672|3724112|P3|Overall Study|Protocol deviation|0
1133539|NCT01491672|3724113|P2|Overall Study|Protocol deviation|1
1133540|NCT01491672|3724114|P1|Overall Study|Protocol deviation|0
1133541|NCT01491672|3724112|P3|Overall Study|Disease progression|6
1133542|NCT01491672|3724113|P2|Overall Study|Disease progression|34
1133543|NCT01491672|3724114|P1|Overall Study|Disease progression|42
1133544|NCT01491672|3724112|P3|Overall Study|Adverse Event|4
1133545|NCT01491672|3724113|P2|Overall Study|Adverse Event|10
1133546|NCT01491672|3724114|P1|Overall Study|Adverse Event|8
1133547|NCT01491672|3724112|P3|Overall Study|Withdrawal by Subject|0
1133548|NCT01491672|3724113|P2|Overall Study|Withdrawal by Subject|7
1133549|NCT01491672|3724114|P1|Overall Study|Withdrawal by Subject|6
1133550|NCT01491672|3724112|P3|Overall Study|Lost to Follow-up|1
1133551|NCT01491672|3724113|P2|Overall Study|Lost to Follow-up|4
1133552|NCT01491672|3724114|P1|Overall Study|Lost to Follow-up|0
1133553|NCT01491607|3724151|P1|Overall Study|Withdrawal by Subject|3
1133554|NCT01491607|3724151|P1|Overall Study|Lost to Follow-up|7
1133555|NCT01491178|3724256|P1|Overall Study|Other than specified above|657
1133556|NCT01491178|3724256|P1|Overall Study|To take a contraindication|20
1133557|NCT01491178|3724256|P1|Overall Study|Lost to follow−up (changing hospital)|545
1133558|NCT01491178|3724256|P1|Overall Study|Lost to follow−up (unknown reason)|287
1133559|NCT01491178|3724256|P1|Overall Study|To conduct invasive treatment|59
1133560|NCT01491178|3724256|P1|Overall Study|Improvement of NVAF|210
1133561|NCT01491178|3724256|P1|Overall Study|Adverse Event|1016
1133562|NCT01491035|3724365|P8|Overall Study|Lost to Follow-up|0
1133563|NCT01491035|3724366|P7|Overall Study|Lost to Follow-up|0
1133564|NCT01491035|3724367|P6|Overall Study|Lost to Follow-up|0
1133565|NCT01491035|3724368|P5|Overall Study|Lost to Follow-up|1
1133566|NCT01491035|3724369|P4|Overall Study|Lost to Follow-up|0
1133567|NCT01491035|3724370|P3|Overall Study|Lost to Follow-up|0
1133568|NCT01491035|3724371|P2|Overall Study|Lost to Follow-up|0
1133569|NCT01491035|3724372|P1|Overall Study|Lost to Follow-up|0
1133570|NCT01490866|3724473|P1|Axitinib Maintenance Therapy|Intercurrent illness|2
1133571|NCT01490866|3724473|P1|Axitinib Maintenance Therapy|Protocol Violation|2
1133572|NCT01490866|3724473|P1|Axitinib Maintenance Therapy|Withdrawal by Subject|3
1133573|NCT01490866|3724473|P1|Axitinib Maintenance Therapy|Adverse Event|12
1133574|NCT01490866|3724473|P1|Axitinib Maintenance Therapy|Disease Progression|30
1133575|NCT01490866|3724473|P1|FOLFOX/Bevacizumab Treatment|Physician Decision|2
1133576|NCT01490866|3724473|P1|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1
1133577|NCT01490866|3724473|P1|FOLFOX/Bevacizumab Treatment|Protocol Violation|1
1133578|NCT01490866|3724473|P1|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5
1133579|NCT01490866|3724473|P1|FOLFOX/Bevacizumab Treatment|Adverse Event|6
1133580|NCT01490866|3724473|P1|FOLFOX/Bevacizumab Treatment|Disease Progression|6
1133581|NCT01490840|3724484|P2|Phase 2|Adverse Event|1
1133582|NCT01490840|3724485|P1|Phase 2|Adverse Event|1
1133583|NCT01490840|3724484|P2|Phase 2|Lost to Follow-up|1
1133584|NCT01490840|3724485|P1|Phase 2|Lost to Follow-up|1
1133585|NCT01490840|3724484|P2|Phase 2|Permanent interruption of fingolimod|1
1133586|NCT01490840|3724485|P1|Phase 2|Permanent interruption of fingolimod|0
1133587|NCT01490840|3724484|P2|Phase 2|Withdrawal by Subject|3
1133588|NCT01490840|3724485|P1|Phase 2|Withdrawal by Subject|4
1133589|NCT01490840|3724484|P2|Phase 1|Visit 6a omitted|0
1133590|NCT01490840|3724485|P1|Phase 1|Visit 6a omitted|1
1133591|NCT01490840|3724484|P2|Phase 1|Withdrawal by Subject|5
1133592|NCT01490840|3724485|P1|Phase 1|Withdrawal by Subject|6
1133593|NCT01490840|3724484|P2|Phase 1|Adverse Event|1
1133594|NCT01490840|3724485|P1|Phase 1|Adverse Event|2
1133595|NCT01490840|3724484|P2|Phase 1|Lost to Follow-up|0
1133596|NCT01490840|3724485|P1|Phase 1|Lost to Follow-up|1
1133597|NCT01490814|3724509|P2|Overall Study|Withdrawal by Subject|5
1133598|NCT01490814|3724510|P1|Overall Study|Withdrawal by Subject|0
1133599|NCT01490814|3724509|P2|Overall Study|Physician Decision|0
1133600|NCT01490814|3724510|P1|Overall Study|Physician Decision|1
1133601|NCT01490814|3724509|P2|Overall Study|Inclusion/Exclusion Criteria Violation|3
1133602|NCT01490814|3724510|P1|Overall Study|Inclusion/Exclusion Criteria Violation|3
1133603|NCT01490697|3724548|P2|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2
1133604|NCT01490697|3724549|P1|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1
1133605|NCT01490632|3724569|P20|Part D: Re-Treatment Period|Withdrawal by Subject|1
1133606|NCT01490632|3724570|P19|Part D: Re-Treatment Period|Withdrawal by Subject|1
1133607|NCT01490632|3724571|P18|Part D: Re-Treatment Period|Withdrawal by Subject|1
1133608|NCT01490632|3724572|P17|Part D: Re-Treatment Period|Withdrawal by Subject|0
1133609|NCT01490632|3724573|P16|Part D: Re-Treatment Period|Withdrawal by Subject|0
1133610|NCT01490632|3724574|P15|Part D: Re-Treatment Period|Withdrawal by Subject|0
1133611|NCT01490632|3724575|P14|Part D: Re-Treatment Period|Withdrawal by Subject|0
1133612|NCT01490632|3724576|P13|Part D: Re-Treatment Period|Withdrawal by Subject|0
1133613|NCT01490632|3724577|P12|Part D: Re-Treatment Period|Withdrawal by Subject|0
1133614|NCT01490632|3724578|P11|Part D: Re-Treatment Period|Withdrawal by Subject|0
1133615|NCT01490632|3724579|P10|Part D: Re-Treatment Period|Withdrawal by Subject|0
1133616|NCT01490632|3724580|P9|Part D: Re-Treatment Period|Withdrawal by Subject|0
1133617|NCT01490632|3724581|P8|Part D: Re-Treatment Period|Withdrawal by Subject|0
1133618|NCT01490632|3724582|P7|Part D: Re-Treatment Period|Withdrawal by Subject|0
1133619|NCT01490632|3724583|P6|Part D: Re-Treatment Period|Withdrawal by Subject|0
1133620|NCT01490632|3724584|P5|Part D: Re-Treatment Period|Withdrawal by Subject|0
1133621|NCT01490632|3724585|P4|Part D: Re-Treatment Period|Withdrawal by Subject|0
1133622|NCT01490632|3724586|P3|Part D: Re-Treatment Period|Withdrawal by Subject|0
1133623|NCT01490632|3724587|P2|Part D: Re-Treatment Period|Withdrawal by Subject|0
1133624|NCT01490632|3724588|P1|Part D: Re-Treatment Period|Withdrawal by Subject|0
1133625|NCT01490632|3724569|P20|Part D: Re-Treatment Period|Protocol Violation|0
1133626|NCT01490632|3724570|P19|Part D: Re-Treatment Period|Protocol Violation|1
1133627|NCT01490632|3724571|P18|Part D: Re-Treatment Period|Protocol Violation|0
1133628|NCT01490632|3724572|P17|Part D: Re-Treatment Period|Protocol Violation|0
1133629|NCT01490632|3724573|P16|Part D: Re-Treatment Period|Protocol Violation|0
1133630|NCT01490632|3724574|P15|Part D: Re-Treatment Period|Protocol Violation|0
1133631|NCT01490632|3724575|P14|Part D: Re-Treatment Period|Protocol Violation|0
1133632|NCT01490632|3724576|P13|Part D: Re-Treatment Period|Protocol Violation|0
1133633|NCT01490632|3724577|P12|Part D: Re-Treatment Period|Protocol Violation|0
1133634|NCT01490632|3724578|P11|Part D: Re-Treatment Period|Protocol Violation|0
1133635|NCT01490632|3724579|P10|Part D: Re-Treatment Period|Protocol Violation|0
1133636|NCT01490632|3724580|P9|Part D: Re-Treatment Period|Protocol Violation|0
1133637|NCT01490632|3724581|P8|Part D: Re-Treatment Period|Protocol Violation|0
1133638|NCT01490632|3724582|P7|Part D: Re-Treatment Period|Protocol Violation|0
1133639|NCT01490632|3724583|P6|Part D: Re-Treatment Period|Protocol Violation|0
1133640|NCT01490632|3724584|P5|Part D: Re-Treatment Period|Protocol Violation|0
1133641|NCT01490632|3724585|P4|Part D: Re-Treatment Period|Protocol Violation|0
1133642|NCT01490632|3724586|P3|Part D: Re-Treatment Period|Protocol Violation|0
1133643|NCT01490632|3724587|P2|Part D: Re-Treatment Period|Protocol Violation|0
1133644|NCT01490632|3724588|P1|Part D: Re-Treatment Period|Protocol Violation|0
1133645|NCT01490632|3724569|P20|Part D: Re-Treatment Period|Physician Decision|1
1133646|NCT01490632|3724570|P19|Part D: Re-Treatment Period|Physician Decision|1
1133647|NCT01490632|3724571|P18|Part D: Re-Treatment Period|Physician Decision|0
1133648|NCT01490632|3724572|P17|Part D: Re-Treatment Period|Physician Decision|0
1133649|NCT01490632|3724573|P16|Part D: Re-Treatment Period|Physician Decision|0
1133650|NCT01490632|3724574|P15|Part D: Re-Treatment Period|Physician Decision|0
1133651|NCT01490632|3724575|P14|Part D: Re-Treatment Period|Physician Decision|0
1133652|NCT01490632|3724576|P13|Part D: Re-Treatment Period|Physician Decision|0
1133653|NCT01490632|3724577|P12|Part D: Re-Treatment Period|Physician Decision|0
1133654|NCT01490632|3724578|P11|Part D: Re-Treatment Period|Physician Decision|0
1133655|NCT01490632|3724579|P10|Part D: Re-Treatment Period|Physician Decision|0
1133656|NCT01490632|3724580|P9|Part D: Re-Treatment Period|Physician Decision|0
1133657|NCT01490632|3724581|P8|Part D: Re-Treatment Period|Physician Decision|0
1133658|NCT01490632|3724582|P7|Part D: Re-Treatment Period|Physician Decision|0
1133659|NCT01490632|3724583|P6|Part D: Re-Treatment Period|Physician Decision|0
1133660|NCT01490632|3724584|P5|Part D: Re-Treatment Period|Physician Decision|0
1133661|NCT01490632|3724585|P4|Part D: Re-Treatment Period|Physician Decision|0
1133662|NCT01490632|3724586|P3|Part D: Re-Treatment Period|Physician Decision|0
1133663|NCT01490632|3724587|P2|Part D: Re-Treatment Period|Physician Decision|0
1133664|NCT01490632|3724588|P1|Part D: Re-Treatment Period|Physician Decision|0
1133665|NCT01490632|3724569|P20|Part D: Re-Treatment Period|Lost to Follow-up|0
1133666|NCT01490632|3724570|P19|Part D: Re-Treatment Period|Lost to Follow-up|1
1133667|NCT01490632|3724571|P18|Part D: Re-Treatment Period|Lost to Follow-up|0
1133668|NCT01490632|3724572|P17|Part D: Re-Treatment Period|Lost to Follow-up|0
1133669|NCT01490632|3724573|P16|Part D: Re-Treatment Period|Lost to Follow-up|0
1133670|NCT01490632|3724574|P15|Part D: Re-Treatment Period|Lost to Follow-up|0
1133671|NCT01490632|3724575|P14|Part D: Re-Treatment Period|Lost to Follow-up|0
1133672|NCT01490632|3724576|P13|Part D: Re-Treatment Period|Lost to Follow-up|0
1133673|NCT01490632|3724577|P12|Part D: Re-Treatment Period|Lost to Follow-up|0
1133674|NCT01490632|3724578|P11|Part D: Re-Treatment Period|Lost to Follow-up|0
1133675|NCT01490632|3724579|P10|Part D: Re-Treatment Period|Lost to Follow-up|0
1133676|NCT01490632|3724580|P9|Part D: Re-Treatment Period|Lost to Follow-up|0
1133677|NCT01490632|3724581|P8|Part D: Re-Treatment Period|Lost to Follow-up|0
1133678|NCT01490632|3724582|P7|Part D: Re-Treatment Period|Lost to Follow-up|0
1133679|NCT01490632|3724583|P6|Part D: Re-Treatment Period|Lost to Follow-up|0
1133680|NCT01490632|3724584|P5|Part D: Re-Treatment Period|Lost to Follow-up|0
1133681|NCT01490632|3724585|P4|Part D: Re-Treatment Period|Lost to Follow-up|0
1133682|NCT01490632|3724586|P3|Part D: Re-Treatment Period|Lost to Follow-up|0
1133683|NCT01490632|3724587|P2|Part D: Re-Treatment Period|Lost to Follow-up|0
1133684|NCT01490632|3724588|P1|Part D: Re-Treatment Period|Lost to Follow-up|0
1133685|NCT01490632|3724569|P20|Part D: Re-Treatment Period|Lack of Efficacy|2
1133686|NCT01490632|3724570|P19|Part D: Re-Treatment Period|Lack of Efficacy|1
1133687|NCT01490632|3724571|P18|Part D: Re-Treatment Period|Lack of Efficacy|3
1133688|NCT01490632|3724572|P17|Part D: Re-Treatment Period|Lack of Efficacy|0
1133689|NCT01490632|3724573|P16|Part D: Re-Treatment Period|Lack of Efficacy|0
1133690|NCT01490632|3724574|P15|Part D: Re-Treatment Period|Lack of Efficacy|0
1133691|NCT01490632|3724575|P14|Part D: Re-Treatment Period|Lack of Efficacy|0
1133692|NCT01490632|3724576|P13|Part D: Re-Treatment Period|Lack of Efficacy|0
1133693|NCT01490632|3724577|P12|Part D: Re-Treatment Period|Lack of Efficacy|0
1133694|NCT01490632|3724578|P11|Part D: Re-Treatment Period|Lack of Efficacy|0
1133695|NCT01490632|3724579|P10|Part D: Re-Treatment Period|Lack of Efficacy|0
1133696|NCT01490632|3724580|P9|Part D: Re-Treatment Period|Lack of Efficacy|0
1133697|NCT01490632|3724581|P8|Part D: Re-Treatment Period|Lack of Efficacy|0
1133698|NCT01490632|3724582|P7|Part D: Re-Treatment Period|Lack of Efficacy|0
1133699|NCT01490632|3724583|P6|Part D: Re-Treatment Period|Lack of Efficacy|0
1133700|NCT01490632|3724584|P5|Part D: Re-Treatment Period|Lack of Efficacy|0
1133701|NCT01490632|3724585|P4|Part D: Re-Treatment Period|Lack of Efficacy|0
1133702|NCT01490632|3724586|P3|Part D: Re-Treatment Period|Lack of Efficacy|0
1133703|NCT01490632|3724587|P2|Part D: Re-Treatment Period|Lack of Efficacy|0
1133704|NCT01490632|3724588|P1|Part D: Re-Treatment Period|Lack of Efficacy|0
1133705|NCT01490632|3724569|P20|Part D: Re-Treatment Period|Death|0
1133706|NCT01490632|3724570|P19|Part D: Re-Treatment Period|Death|1
1133707|NCT01490632|3724571|P18|Part D: Re-Treatment Period|Death|0
1133708|NCT01490632|3724572|P17|Part D: Re-Treatment Period|Death|0
1133709|NCT01490632|3724573|P16|Part D: Re-Treatment Period|Death|0
1133710|NCT01490632|3724574|P15|Part D: Re-Treatment Period|Death|0
1133711|NCT01490632|3724575|P14|Part D: Re-Treatment Period|Death|0
1133712|NCT01490632|3724576|P13|Part D: Re-Treatment Period|Death|0
1133713|NCT01490632|3724577|P12|Part D: Re-Treatment Period|Death|0
1133714|NCT01490632|3724578|P11|Part D: Re-Treatment Period|Death|0
1133715|NCT01490632|3724579|P10|Part D: Re-Treatment Period|Death|0
1133716|NCT01490632|3724580|P9|Part D: Re-Treatment Period|Death|0
1133717|NCT01490632|3724581|P8|Part D: Re-Treatment Period|Death|0
1133718|NCT01490632|3724582|P7|Part D: Re-Treatment Period|Death|0
1133719|NCT01490632|3724583|P6|Part D: Re-Treatment Period|Death|0
1133720|NCT01490632|3724584|P5|Part D: Re-Treatment Period|Death|0
1133721|NCT01490632|3724585|P4|Part D: Re-Treatment Period|Death|0
1133722|NCT01490632|3724586|P3|Part D: Re-Treatment Period|Death|0
1133723|NCT01490632|3724587|P2|Part D: Re-Treatment Period|Death|0
1133724|NCT01490632|3724588|P1|Part D: Re-Treatment Period|Death|0
1133725|NCT01490632|3724569|P20|Part D: Re-Treatment Period|Adverse Event|3
1133726|NCT01490632|3724570|P19|Part D: Re-Treatment Period|Adverse Event|1
1133727|NCT01490632|3724571|P18|Part D: Re-Treatment Period|Adverse Event|1
1133728|NCT01490632|3724572|P17|Part D: Re-Treatment Period|Adverse Event|0
1133729|NCT01490632|3724573|P16|Part D: Re-Treatment Period|Adverse Event|0
1133730|NCT01490632|3724574|P15|Part D: Re-Treatment Period|Adverse Event|0
1133731|NCT01490632|3724575|P14|Part D: Re-Treatment Period|Adverse Event|0
1133732|NCT01490632|3724576|P13|Part D: Re-Treatment Period|Adverse Event|0
1133733|NCT01490632|3724577|P12|Part D: Re-Treatment Period|Adverse Event|0
1133734|NCT01490632|3724578|P11|Part D: Re-Treatment Period|Adverse Event|0
1133735|NCT01490632|3724579|P10|Part D: Re-Treatment Period|Adverse Event|0
1133736|NCT01490632|3724580|P9|Part D: Re-Treatment Period|Adverse Event|0
1133737|NCT01490632|3724581|P8|Part D: Re-Treatment Period|Adverse Event|0
1133738|NCT01490632|3724582|P7|Part D: Re-Treatment Period|Adverse Event|0
1133739|NCT01490632|3724583|P6|Part D: Re-Treatment Period|Adverse Event|0
1133740|NCT01490632|3724584|P5|Part D: Re-Treatment Period|Adverse Event|0
1133741|NCT01490632|3724585|P4|Part D: Re-Treatment Period|Adverse Event|0
1133742|NCT01490632|3724586|P3|Part D: Re-Treatment Period|Adverse Event|0
1133743|NCT01490632|3724587|P2|Part D: Re-Treatment Period|Adverse Event|0
1133744|NCT01490632|3724588|P1|Part D: Re-Treatment Period|Adverse Event|0
1133745|NCT01490632|3724569|P20|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1133746|NCT01490632|3724570|P19|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1133747|NCT01490632|3724571|P18|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1133748|NCT01490632|3724572|P17|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1133749|NCT01490632|3724573|P16|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34
1133750|NCT01490632|3724574|P15|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14
1133751|NCT01490632|3724575|P14|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9
1133752|NCT01490632|3724576|P13|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5
1133753|NCT01490632|3724577|P12|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1133754|NCT01490632|3724578|P11|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1133755|NCT01490632|3724579|P10|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1133756|NCT01490632|3724580|P9|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1133757|NCT01490632|3724581|P8|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1133758|NCT01490632|3724582|P7|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1133759|NCT01490632|3724583|P6|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1133760|NCT01490632|3724584|P5|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1134117|NCT01490190|3724980|P1|Overall Study|Protocol Violation|5
1133761|NCT01490632|3724585|P4|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1133762|NCT01490632|3724586|P3|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1133763|NCT01490632|3724587|P2|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1133764|NCT01490632|3724588|P1|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1133765|NCT01490632|3724569|P20|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1133766|NCT01490632|3724570|P19|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1133767|NCT01490632|3724571|P18|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1133768|NCT01490632|3724572|P17|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1133769|NCT01490632|3724573|P16|Part C: Washout or Step-Down Period|Withdrawal by Subject|1
1133770|NCT01490632|3724574|P15|Part C: Washout or Step-Down Period|Withdrawal by Subject|2
1133771|NCT01490632|3724575|P14|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1133772|NCT01490632|3724576|P13|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1133773|NCT01490632|3724577|P12|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1133774|NCT01490632|3724578|P11|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1133775|NCT01490632|3724579|P10|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1133776|NCT01490632|3724580|P9|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1133777|NCT01490632|3724581|P8|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1133778|NCT01490632|3724582|P7|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1133779|NCT01490632|3724583|P6|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1133780|NCT01490632|3724584|P5|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1133781|NCT01490632|3724585|P4|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1133782|NCT01490632|3724586|P3|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1133783|NCT01490632|3724587|P2|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1133784|NCT01490632|3724588|P1|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1133785|NCT01490632|3724569|P20|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1133786|NCT01490632|3724570|P19|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1133787|NCT01490632|3724571|P18|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1133788|NCT01490632|3724572|P17|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1133789|NCT01490632|3724573|P16|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1133790|NCT01490632|3724574|P15|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1133791|NCT01490632|3724575|P14|Part C: Washout or Step-Down Period|Lost to Follow-up|1
1133792|NCT01490632|3724576|P13|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1133793|NCT01490632|3724577|P12|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1133794|NCT01490632|3724578|P11|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1133795|NCT01490632|3724579|P10|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1133796|NCT01490632|3724580|P9|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1133797|NCT01490632|3724581|P8|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1133798|NCT01490632|3724582|P7|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1133799|NCT01490632|3724583|P6|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1133800|NCT01490632|3724584|P5|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1133801|NCT01490632|3724585|P4|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1133802|NCT01490632|3724586|P3|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1133803|NCT01490632|3724587|P2|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1133804|NCT01490632|3724588|P1|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1133805|NCT01490632|3724569|P20|Part C: Washout or Step-Down Period|Adverse Event|0
1133806|NCT01490632|3724570|P19|Part C: Washout or Step-Down Period|Adverse Event|0
1133807|NCT01490632|3724571|P18|Part C: Washout or Step-Down Period|Adverse Event|0
1133808|NCT01490632|3724572|P17|Part C: Washout or Step-Down Period|Adverse Event|0
1133809|NCT01490632|3724573|P16|Part C: Washout or Step-Down Period|Adverse Event|2
1133810|NCT01490632|3724574|P15|Part C: Washout or Step-Down Period|Adverse Event|2
1133811|NCT01490632|3724575|P14|Part C: Washout or Step-Down Period|Adverse Event|0
1133812|NCT01490632|3724576|P13|Part C: Washout or Step-Down Period|Adverse Event|0
1133813|NCT01490632|3724577|P12|Part C: Washout or Step-Down Period|Adverse Event|0
1133814|NCT01490632|3724578|P11|Part C: Washout or Step-Down Period|Adverse Event|0
1133815|NCT01490632|3724579|P10|Part C: Washout or Step-Down Period|Adverse Event|0
1133816|NCT01490632|3724580|P9|Part C: Washout or Step-Down Period|Adverse Event|0
1133817|NCT01490632|3724581|P8|Part C: Washout or Step-Down Period|Adverse Event|0
1133818|NCT01490632|3724582|P7|Part C: Washout or Step-Down Period|Adverse Event|0
1133819|NCT01490632|3724583|P6|Part C: Washout or Step-Down Period|Adverse Event|0
1133820|NCT01490632|3724584|P5|Part C: Washout or Step-Down Period|Adverse Event|0
1133821|NCT01490632|3724585|P4|Part C: Washout or Step-Down Period|Adverse Event|0
1133822|NCT01490632|3724586|P3|Part C: Washout or Step-Down Period|Adverse Event|0
1133823|NCT01490632|3724587|P2|Part C: Washout or Step-Down Period|Adverse Event|0
1133824|NCT01490632|3724588|P1|Part C: Washout or Step-Down Period|Adverse Event|0
1133825|NCT01490632|3724569|P20|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1133826|NCT01490632|3724570|P19|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1133827|NCT01490632|3724571|P18|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1133828|NCT01490632|3724572|P17|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1133829|NCT01490632|3724573|P16|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1133830|NCT01490632|3724574|P15|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1133831|NCT01490632|3724575|P14|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1133832|NCT01490632|3724576|P13|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1133833|NCT01490632|3724577|P12|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5
1133834|NCT01490632|3724578|P11|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16
1133835|NCT01490632|3724579|P10|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19
1133836|NCT01490632|3724580|P9|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8
1133837|NCT01490632|3724581|P8|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
1133838|NCT01490632|3724582|P7|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
1133839|NCT01490632|3724583|P6|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1
1133840|NCT01490632|3724584|P5|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1133841|NCT01490632|3724585|P4|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1133842|NCT01490632|3724586|P3|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1133843|NCT01490632|3724587|P2|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1133844|NCT01490632|3724588|P1|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1133845|NCT01490632|3724569|P20|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1133846|NCT01490632|3724570|P19|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1133847|NCT01490632|3724571|P18|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1133848|NCT01490632|3724572|P17|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1133849|NCT01490632|3724573|P16|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1133850|NCT01490632|3724574|P15|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1133851|NCT01490632|3724575|P14|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1133852|NCT01490632|3724576|P13|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1133853|NCT01490632|3724577|P12|Part B: Extension or Step-Up Period|Withdrawal by Subject|2
1133854|NCT01490632|3724578|P11|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
1133855|NCT01490632|3724579|P10|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1133856|NCT01490632|3724580|P9|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
1133857|NCT01490632|3724581|P8|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1133858|NCT01490632|3724582|P7|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
1133859|NCT01490632|3724583|P6|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1133860|NCT01490632|3724584|P5|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1133861|NCT01490632|3724585|P4|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1133862|NCT01490632|3724586|P3|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1133863|NCT01490632|3724587|P2|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1133864|NCT01490632|3724588|P1|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1133865|NCT01490632|3724569|P20|Part B: Extension or Step-Up Period|Sponsor Decision|0
1133866|NCT01490632|3724570|P19|Part B: Extension or Step-Up Period|Sponsor Decision|0
1133867|NCT01490632|3724571|P18|Part B: Extension or Step-Up Period|Sponsor Decision|0
1133868|NCT01490632|3724572|P17|Part B: Extension or Step-Up Period|Sponsor Decision|0
1133869|NCT01490632|3724573|P16|Part B: Extension or Step-Up Period|Sponsor Decision|0
1133870|NCT01490632|3724574|P15|Part B: Extension or Step-Up Period|Sponsor Decision|0
1133871|NCT01490632|3724575|P14|Part B: Extension or Step-Up Period|Sponsor Decision|0
1133872|NCT01490632|3724576|P13|Part B: Extension or Step-Up Period|Sponsor Decision|0
1133873|NCT01490632|3724577|P12|Part B: Extension or Step-Up Period|Sponsor Decision|0
1133874|NCT01490632|3724578|P11|Part B: Extension or Step-Up Period|Sponsor Decision|0
1133875|NCT01490632|3724579|P10|Part B: Extension or Step-Up Period|Sponsor Decision|0
1133876|NCT01490632|3724580|P9|Part B: Extension or Step-Up Period|Sponsor Decision|0
1133877|NCT01490632|3724581|P8|Part B: Extension or Step-Up Period|Sponsor Decision|0
1133878|NCT01490632|3724582|P7|Part B: Extension or Step-Up Period|Sponsor Decision|0
1133879|NCT01490632|3724583|P6|Part B: Extension or Step-Up Period|Sponsor Decision|1
1133880|NCT01490632|3724584|P5|Part B: Extension or Step-Up Period|Sponsor Decision|0
1133881|NCT01490632|3724585|P4|Part B: Extension or Step-Up Period|Sponsor Decision|0
1133882|NCT01490632|3724586|P3|Part B: Extension or Step-Up Period|Sponsor Decision|0
1133883|NCT01490632|3724587|P2|Part B: Extension or Step-Up Period|Sponsor Decision|0
1133884|NCT01490632|3724588|P1|Part B: Extension or Step-Up Period|Sponsor Decision|0
1133885|NCT01490632|3724569|P20|Part B: Extension or Step-Up Period|Physician Decision|0
1133886|NCT01490632|3724570|P19|Part B: Extension or Step-Up Period|Physician Decision|0
1133887|NCT01490632|3724571|P18|Part B: Extension or Step-Up Period|Physician Decision|0
1133888|NCT01490632|3724572|P17|Part B: Extension or Step-Up Period|Physician Decision|0
1133889|NCT01490632|3724573|P16|Part B: Extension or Step-Up Period|Physician Decision|0
1133890|NCT01490632|3724574|P15|Part B: Extension or Step-Up Period|Physician Decision|0
1133891|NCT01490632|3724575|P14|Part B: Extension or Step-Up Period|Physician Decision|0
1133892|NCT01490632|3724576|P13|Part B: Extension or Step-Up Period|Physician Decision|0
1133893|NCT01490632|3724577|P12|Part B: Extension or Step-Up Period|Physician Decision|0
1133894|NCT01490632|3724578|P11|Part B: Extension or Step-Up Period|Physician Decision|0
1133895|NCT01490632|3724579|P10|Part B: Extension or Step-Up Period|Physician Decision|0
1133896|NCT01490632|3724580|P9|Part B: Extension or Step-Up Period|Physician Decision|0
1133897|NCT01490632|3724581|P8|Part B: Extension or Step-Up Period|Physician Decision|0
1133898|NCT01490632|3724582|P7|Part B: Extension or Step-Up Period|Physician Decision|1
1133899|NCT01490632|3724583|P6|Part B: Extension or Step-Up Period|Physician Decision|0
1133900|NCT01490632|3724584|P5|Part B: Extension or Step-Up Period|Physician Decision|0
1133901|NCT01490632|3724585|P4|Part B: Extension or Step-Up Period|Physician Decision|0
1133902|NCT01490632|3724586|P3|Part B: Extension or Step-Up Period|Physician Decision|0
1133903|NCT01490632|3724587|P2|Part B: Extension or Step-Up Period|Physician Decision|0
1133904|NCT01490632|3724588|P1|Part B: Extension or Step-Up Period|Physician Decision|0
1133905|NCT01490632|3724569|P20|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1133906|NCT01490632|3724570|P19|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1133907|NCT01490632|3724571|P18|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1133908|NCT01490632|3724572|P17|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1133909|NCT01490632|3724573|P16|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1133910|NCT01490632|3724574|P15|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1133911|NCT01490632|3724575|P14|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1133912|NCT01490632|3724576|P13|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1133913|NCT01490632|3724577|P12|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1133914|NCT01490632|3724578|P11|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1133915|NCT01490632|3724579|P10|Part B: Extension or Step-Up Period|Lost to Follow-up|1
1133916|NCT01490632|3724580|P9|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1133917|NCT01490632|3724581|P8|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1133918|NCT01490632|3724582|P7|Part B: Extension or Step-Up Period|Lost to Follow-up|2
1133919|NCT01490632|3724583|P6|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1133920|NCT01490632|3724584|P5|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1133921|NCT01490632|3724585|P4|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1133922|NCT01490632|3724586|P3|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1133923|NCT01490632|3724587|P2|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1133924|NCT01490632|3724588|P1|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1133925|NCT01490632|3724569|P20|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1133926|NCT01490632|3724570|P19|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1133927|NCT01490632|3724571|P18|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1133928|NCT01490632|3724572|P17|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1133929|NCT01490632|3724573|P16|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1133930|NCT01490632|3724574|P15|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1133931|NCT01490632|3724575|P14|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1133932|NCT01490632|3724576|P13|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1133933|NCT01490632|3724577|P12|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1133934|NCT01490632|3724578|P11|Part B: Extension or Step-Up Period|Lack of Efficacy|1
1133935|NCT01490632|3724579|P10|Part B: Extension or Step-Up Period|Lack of Efficacy|3
1133936|NCT01490632|3724580|P9|Part B: Extension or Step-Up Period|Lack of Efficacy|1
1133937|NCT01490632|3724581|P8|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1133938|NCT01490632|3724582|P7|Part B: Extension or Step-Up Period|Lack of Efficacy|1
1133939|NCT01490632|3724583|P6|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1133940|NCT01490632|3724584|P5|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1133941|NCT01490632|3724585|P4|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1133942|NCT01490632|3724586|P3|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1133943|NCT01490632|3724587|P2|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1133944|NCT01490632|3724588|P1|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1133945|NCT01490632|3724569|P20|Part B: Extension or Step-Up Period|Adverse Event|0
1133946|NCT01490632|3724570|P19|Part B: Extension or Step-Up Period|Adverse Event|0
1133947|NCT01490632|3724571|P18|Part B: Extension or Step-Up Period|Adverse Event|0
1133948|NCT01490632|3724572|P17|Part B: Extension or Step-Up Period|Adverse Event|0
1133949|NCT01490632|3724573|P16|Part B: Extension or Step-Up Period|Adverse Event|0
1133950|NCT01490632|3724574|P15|Part B: Extension or Step-Up Period|Adverse Event|0
1133951|NCT01490632|3724575|P14|Part B: Extension or Step-Up Period|Adverse Event|0
1133952|NCT01490632|3724576|P13|Part B: Extension or Step-Up Period|Adverse Event|0
1133953|NCT01490632|3724577|P12|Part B: Extension or Step-Up Period|Adverse Event|1
1133954|NCT01490632|3724578|P11|Part B: Extension or Step-Up Period|Adverse Event|3
1133955|NCT01490632|3724579|P10|Part B: Extension or Step-Up Period|Adverse Event|2
1133956|NCT01490632|3724580|P9|Part B: Extension or Step-Up Period|Adverse Event|0
1133957|NCT01490632|3724581|P8|Part B: Extension or Step-Up Period|Adverse Event|0
1133958|NCT01490632|3724582|P7|Part B: Extension or Step-Up Period|Adverse Event|2
1133959|NCT01490632|3724583|P6|Part B: Extension or Step-Up Period|Adverse Event|2
1133960|NCT01490632|3724584|P5|Part B: Extension or Step-Up Period|Adverse Event|0
1133961|NCT01490632|3724585|P4|Part B: Extension or Step-Up Period|Adverse Event|0
1133962|NCT01490632|3724586|P3|Part B: Extension or Step-Up Period|Adverse Event|0
1133963|NCT01490632|3724587|P2|Part B: Extension or Step-Up Period|Adverse Event|0
1133964|NCT01490632|3724588|P1|Part B: Extension or Step-Up Period|Adverse Event|0
1133965|NCT01490632|3724569|P20|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1133966|NCT01490632|3724570|P19|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1133967|NCT01490632|3724571|P18|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1133968|NCT01490632|3724572|P17|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1133969|NCT01490632|3724573|P16|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1133970|NCT01490632|3724574|P15|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1133971|NCT01490632|3724575|P14|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1133972|NCT01490632|3724576|P13|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1133973|NCT01490632|3724577|P12|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1133974|NCT01490632|3724578|P11|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1133975|NCT01490632|3724579|P10|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1133976|NCT01490632|3724580|P9|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1133977|NCT01490632|3724581|P8|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1133978|NCT01490632|3724582|P7|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1133979|NCT01490632|3724583|P6|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1133980|NCT01490632|3724584|P5|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9
1133981|NCT01490632|3724585|P4|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1133982|NCT01490632|3724586|P3|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1133983|NCT01490632|3724587|P2|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1133984|NCT01490632|3724588|P1|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1133985|NCT01490632|3724569|P20|Part A: Initial Treatment Period|Withdrawal by Subject|0
1133986|NCT01490632|3724570|P19|Part A: Initial Treatment Period|Withdrawal by Subject|0
1133987|NCT01490632|3724571|P18|Part A: Initial Treatment Period|Withdrawal by Subject|0
1133988|NCT01490632|3724572|P17|Part A: Initial Treatment Period|Withdrawal by Subject|0
1133989|NCT01490632|3724573|P16|Part A: Initial Treatment Period|Withdrawal by Subject|0
1133990|NCT01490632|3724574|P15|Part A: Initial Treatment Period|Withdrawal by Subject|0
1133991|NCT01490632|3724575|P14|Part A: Initial Treatment Period|Withdrawal by Subject|0
1133992|NCT01490632|3724576|P13|Part A: Initial Treatment Period|Withdrawal by Subject|0
1133993|NCT01490632|3724577|P12|Part A: Initial Treatment Period|Withdrawal by Subject|0
1133994|NCT01490632|3724578|P11|Part A: Initial Treatment Period|Withdrawal by Subject|0
1133995|NCT01490632|3724579|P10|Part A: Initial Treatment Period|Withdrawal by Subject|0
1133996|NCT01490632|3724580|P9|Part A: Initial Treatment Period|Withdrawal by Subject|0
1133997|NCT01490632|3724581|P8|Part A: Initial Treatment Period|Withdrawal by Subject|0
1133998|NCT01490632|3724582|P7|Part A: Initial Treatment Period|Withdrawal by Subject|0
1133999|NCT01490632|3724583|P6|Part A: Initial Treatment Period|Withdrawal by Subject|0
1134000|NCT01490632|3724584|P5|Part A: Initial Treatment Period|Withdrawal by Subject|2
1134001|NCT01490632|3724585|P4|Part A: Initial Treatment Period|Withdrawal by Subject|1
1134002|NCT01490632|3724586|P3|Part A: Initial Treatment Period|Withdrawal by Subject|0
1134003|NCT01490632|3724587|P2|Part A: Initial Treatment Period|Withdrawal by Subject|2
1134004|NCT01490632|3724588|P1|Part A: Initial Treatment Period|Withdrawal by Subject|2
1134005|NCT01490632|3724569|P20|Part A: Initial Treatment Period|Sponsor Decision|0
1134006|NCT01490632|3724570|P19|Part A: Initial Treatment Period|Sponsor Decision|0
1134007|NCT01490632|3724571|P18|Part A: Initial Treatment Period|Sponsor Decision|0
1134008|NCT01490632|3724572|P17|Part A: Initial Treatment Period|Sponsor Decision|0
1134009|NCT01490632|3724573|P16|Part A: Initial Treatment Period|Sponsor Decision|0
1134010|NCT01490632|3724574|P15|Part A: Initial Treatment Period|Sponsor Decision|0
1134011|NCT01490632|3724575|P14|Part A: Initial Treatment Period|Sponsor Decision|0
1134012|NCT01490632|3724576|P13|Part A: Initial Treatment Period|Sponsor Decision|0
1134013|NCT01490632|3724577|P12|Part A: Initial Treatment Period|Sponsor Decision|0
1134014|NCT01490632|3724578|P11|Part A: Initial Treatment Period|Sponsor Decision|0
1134015|NCT01490632|3724579|P10|Part A: Initial Treatment Period|Sponsor Decision|0
1134016|NCT01490632|3724580|P9|Part A: Initial Treatment Period|Sponsor Decision|0
1134017|NCT01490632|3724581|P8|Part A: Initial Treatment Period|Sponsor Decision|0
1134018|NCT01490632|3724582|P7|Part A: Initial Treatment Period|Sponsor Decision|0
1134019|NCT01490632|3724583|P6|Part A: Initial Treatment Period|Sponsor Decision|0
1134020|NCT01490632|3724584|P5|Part A: Initial Treatment Period|Sponsor Decision|0
1134021|NCT01490632|3724585|P4|Part A: Initial Treatment Period|Sponsor Decision|0
1134022|NCT01490632|3724586|P3|Part A: Initial Treatment Period|Sponsor Decision|0
1134023|NCT01490632|3724587|P2|Part A: Initial Treatment Period|Sponsor Decision|0
1134024|NCT01490632|3724588|P1|Part A: Initial Treatment Period|Sponsor Decision|2
1134025|NCT01490632|3724569|P20|Part A: Initial Treatment Period|Physician Decision|0
1134026|NCT01490632|3724570|P19|Part A: Initial Treatment Period|Physician Decision|0
1134027|NCT01490632|3724571|P18|Part A: Initial Treatment Period|Physician Decision|0
1134028|NCT01490632|3724572|P17|Part A: Initial Treatment Period|Physician Decision|0
1134029|NCT01490632|3724573|P16|Part A: Initial Treatment Period|Physician Decision|0
1134030|NCT01490632|3724574|P15|Part A: Initial Treatment Period|Physician Decision|0
1134031|NCT01490632|3724575|P14|Part A: Initial Treatment Period|Physician Decision|0
1134032|NCT01490632|3724576|P13|Part A: Initial Treatment Period|Physician Decision|0
1134033|NCT01490632|3724577|P12|Part A: Initial Treatment Period|Physician Decision|0
1134034|NCT01490632|3724578|P11|Part A: Initial Treatment Period|Physician Decision|0
1134035|NCT01490632|3724579|P10|Part A: Initial Treatment Period|Physician Decision|0
1134036|NCT01490632|3724580|P9|Part A: Initial Treatment Period|Physician Decision|0
1134037|NCT01490632|3724581|P8|Part A: Initial Treatment Period|Physician Decision|0
1134038|NCT01490632|3724582|P7|Part A: Initial Treatment Period|Physician Decision|0
1134039|NCT01490632|3724583|P6|Part A: Initial Treatment Period|Physician Decision|0
1134040|NCT01490632|3724584|P5|Part A: Initial Treatment Period|Physician Decision|0
1134041|NCT01490632|3724585|P4|Part A: Initial Treatment Period|Physician Decision|1
1134042|NCT01490632|3724586|P3|Part A: Initial Treatment Period|Physician Decision|0
1134043|NCT01490632|3724587|P2|Part A: Initial Treatment Period|Physician Decision|1
1134044|NCT01490632|3724588|P1|Part A: Initial Treatment Period|Physician Decision|0
1134045|NCT01490632|3724569|P20|Part A: Initial Treatment Period|Lost to Follow-up|0
1134046|NCT01490632|3724570|P19|Part A: Initial Treatment Period|Lost to Follow-up|0
1134047|NCT01490632|3724571|P18|Part A: Initial Treatment Period|Lost to Follow-up|0
1134048|NCT01490632|3724572|P17|Part A: Initial Treatment Period|Lost to Follow-up|0
1134049|NCT01490632|3724573|P16|Part A: Initial Treatment Period|Lost to Follow-up|0
1134050|NCT01490632|3724574|P15|Part A: Initial Treatment Period|Lost to Follow-up|0
1134051|NCT01490632|3724575|P14|Part A: Initial Treatment Period|Lost to Follow-up|0
1134052|NCT01490632|3724576|P13|Part A: Initial Treatment Period|Lost to Follow-up|0
1134053|NCT01490632|3724577|P12|Part A: Initial Treatment Period|Lost to Follow-up|0
1134054|NCT01490632|3724578|P11|Part A: Initial Treatment Period|Lost to Follow-up|0
1134055|NCT01490632|3724579|P10|Part A: Initial Treatment Period|Lost to Follow-up|0
1134056|NCT01490632|3724580|P9|Part A: Initial Treatment Period|Lost to Follow-up|0
1134057|NCT01490632|3724581|P8|Part A: Initial Treatment Period|Lost to Follow-up|0
1134058|NCT01490632|3724582|P7|Part A: Initial Treatment Period|Lost to Follow-up|0
1134059|NCT01490632|3724583|P6|Part A: Initial Treatment Period|Lost to Follow-up|0
1134060|NCT01490632|3724584|P5|Part A: Initial Treatment Period|Lost to Follow-up|2
1134061|NCT01490632|3724585|P4|Part A: Initial Treatment Period|Lost to Follow-up|1
1134062|NCT01490632|3724586|P3|Part A: Initial Treatment Period|Lost to Follow-up|1
1134063|NCT01490632|3724587|P2|Part A: Initial Treatment Period|Lost to Follow-up|0
1134064|NCT01490632|3724588|P1|Part A: Initial Treatment Period|Lost to Follow-up|0
1134065|NCT01490632|3724569|P20|Part A: Initial Treatment Period|Lack of Efficacy|0
1134066|NCT01490632|3724570|P19|Part A: Initial Treatment Period|Lack of Efficacy|0
1134067|NCT01490632|3724571|P18|Part A: Initial Treatment Period|Lack of Efficacy|0
1134068|NCT01490632|3724572|P17|Part A: Initial Treatment Period|Lack of Efficacy|0
1134069|NCT01490632|3724573|P16|Part A: Initial Treatment Period|Lack of Efficacy|0
1134070|NCT01490632|3724574|P15|Part A: Initial Treatment Period|Lack of Efficacy|0
1134071|NCT01490632|3724575|P14|Part A: Initial Treatment Period|Lack of Efficacy|0
1134072|NCT01490632|3724576|P13|Part A: Initial Treatment Period|Lack of Efficacy|0
1134073|NCT01490632|3724577|P12|Part A: Initial Treatment Period|Lack of Efficacy|0
1134074|NCT01490632|3724578|P11|Part A: Initial Treatment Period|Lack of Efficacy|0
1134075|NCT01490632|3724579|P10|Part A: Initial Treatment Period|Lack of Efficacy|0
1134076|NCT01490632|3724580|P9|Part A: Initial Treatment Period|Lack of Efficacy|0
1134077|NCT01490632|3724581|P8|Part A: Initial Treatment Period|Lack of Efficacy|0
1134078|NCT01490632|3724582|P7|Part A: Initial Treatment Period|Lack of Efficacy|0
1134079|NCT01490632|3724583|P6|Part A: Initial Treatment Period|Lack of Efficacy|0
1134080|NCT01490632|3724584|P5|Part A: Initial Treatment Period|Lack of Efficacy|0
1134081|NCT01490632|3724585|P4|Part A: Initial Treatment Period|Lack of Efficacy|2
1134082|NCT01490632|3724586|P3|Part A: Initial Treatment Period|Lack of Efficacy|2
1134083|NCT01490632|3724587|P2|Part A: Initial Treatment Period|Lack of Efficacy|1
1134084|NCT01490632|3724588|P1|Part A: Initial Treatment Period|Lack of Efficacy|3
1134085|NCT01490632|3724569|P20|Part A: Initial Treatment Period|Adverse Event|0
1134086|NCT01490632|3724570|P19|Part A: Initial Treatment Period|Adverse Event|0
1134087|NCT01490632|3724571|P18|Part A: Initial Treatment Period|Adverse Event|0
1134088|NCT01490632|3724572|P17|Part A: Initial Treatment Period|Adverse Event|0
1134089|NCT01490632|3724573|P16|Part A: Initial Treatment Period|Adverse Event|0
1134090|NCT01490632|3724574|P15|Part A: Initial Treatment Period|Adverse Event|0
1134091|NCT01490632|3724575|P14|Part A: Initial Treatment Period|Adverse Event|0
1134092|NCT01490632|3724576|P13|Part A: Initial Treatment Period|Adverse Event|0
1134093|NCT01490632|3724577|P12|Part A: Initial Treatment Period|Adverse Event|0
1134094|NCT01490632|3724578|P11|Part A: Initial Treatment Period|Adverse Event|0
1134095|NCT01490632|3724579|P10|Part A: Initial Treatment Period|Adverse Event|0
1134096|NCT01490632|3724580|P9|Part A: Initial Treatment Period|Adverse Event|0
1134097|NCT01490632|3724581|P8|Part A: Initial Treatment Period|Adverse Event|0
1134098|NCT01490632|3724582|P7|Part A: Initial Treatment Period|Adverse Event|0
1134099|NCT01490632|3724583|P6|Part A: Initial Treatment Period|Adverse Event|0
1134100|NCT01490632|3724584|P5|Part A: Initial Treatment Period|Adverse Event|4
1134101|NCT01490632|3724585|P4|Part A: Initial Treatment Period|Adverse Event|4
1134102|NCT01490632|3724586|P3|Part A: Initial Treatment Period|Adverse Event|2
1134103|NCT01490632|3724587|P2|Part A: Initial Treatment Period|Adverse Event|0
1134104|NCT01490632|3724588|P1|Part A: Initial Treatment Period|Adverse Event|0
1134105|NCT01490294|3724743|P4|Overall Study|Adverse Event|0
1134106|NCT01490294|3724744|P3|Overall Study|Adverse Event|0
1134107|NCT01490294|3724745|P2|Overall Study|Adverse Event|0
1134108|NCT01490294|3724746|P1|Overall Study|Adverse Event|1
1134109|NCT01490294|3724743|P4|Overall Study|Prematurely discontinuation|1
1134110|NCT01490294|3724744|P3|Overall Study|Prematurely discontinuation|1
1134111|NCT01490294|3724745|P2|Overall Study|Prematurely discontinuation|0
1134112|NCT01490294|3724746|P1|Overall Study|Prematurely discontinuation|4
1134113|NCT01490190|3724980|P1|Overall Study|Ring expulsion|2
1134114|NCT01490190|3724980|P1|Overall Study|Inconvenience|1
1134115|NCT01490190|3724980|P1|Overall Study|Relocation|1
1134116|NCT01490190|3724980|P1|Overall Study|Lost to Follow-up|13
1134118|NCT01490190|3724980|P1|Overall Study|Adverse Event|17
1134119|NCT01490190|3724980|P1|Overall Study|Withdrawal by Subject|9
1134120|NCT01490125|3725007|P6|Period III|Lack of Efficacy|0
1134121|NCT01490125|3725008|P5|Period III|Lack of Efficacy|1
1134122|NCT01490125|3725009|P4|Period III|Lack of Efficacy|0
1134123|NCT01490125|3725010|P3|Period III|Lack of Efficacy|0
1134124|NCT01490125|3725011|P2|Period III|Lack of Efficacy|0
1134125|NCT01490125|3725012|P1|Period III|Lack of Efficacy|0
1134126|NCT01490125|3725007|P6|Period III|Death|0
1134127|NCT01490125|3725008|P5|Period III|Death|0
1134128|NCT01490125|3725009|P4|Period III|Death|1
1134129|NCT01490125|3725010|P3|Period III|Death|0
1134130|NCT01490125|3725011|P2|Period III|Death|0
1134131|NCT01490125|3725012|P1|Period III|Death|0
1134132|NCT01490125|3725007|P6|Period III|Adverse Event|0
1134133|NCT01490125|3725008|P5|Period III|Adverse Event|0
1134134|NCT01490125|3725009|P4|Period III|Adverse Event|1
1134135|NCT01490125|3725010|P3|Period III|Adverse Event|0
1134136|NCT01490125|3725011|P2|Period III|Adverse Event|1
1134137|NCT01490125|3725012|P1|Period III|Adverse Event|3
1134138|NCT01490125|3725007|P6|Period II|Withdrawal by Subject|0
1134139|NCT01490125|3725008|P5|Period II|Withdrawal by Subject|0
1134140|NCT01490125|3725009|P4|Period II|Withdrawal by Subject|0
1134141|NCT01490125|3725010|P3|Period II|Withdrawal by Subject|0
1134142|NCT01490125|3725011|P2|Period II|Withdrawal by Subject|0
1134143|NCT01490125|3725012|P1|Period II|Withdrawal by Subject|1
1134144|NCT01490125|3725007|P6|Period II|Lost to Follow-up|0
1134145|NCT01490125|3725008|P5|Period II|Lost to Follow-up|0
1134146|NCT01490125|3725009|P4|Period II|Lost to Follow-up|0
1134147|NCT01490125|3725010|P3|Period II|Lost to Follow-up|0
1134148|NCT01490125|3725011|P2|Period II|Lost to Follow-up|1
1134149|NCT01490125|3725012|P1|Period II|Lost to Follow-up|0
1134150|NCT01490125|3725007|P6|Period II|Protocol Violation|0
1134151|NCT01490125|3725008|P5|Period II|Protocol Violation|0
1134152|NCT01490125|3725009|P4|Period II|Protocol Violation|1
1134153|NCT01490125|3725010|P3|Period II|Protocol Violation|1
1134154|NCT01490125|3725011|P2|Period II|Protocol Violation|0
1134155|NCT01490125|3725012|P1|Period II|Protocol Violation|0
1134156|NCT01490125|3725007|P6|Period II|Adverse Event|2
1134157|NCT01490125|3725008|P5|Period II|Adverse Event|4
1134158|NCT01490125|3725009|P4|Period II|Adverse Event|2
1134159|NCT01490125|3725010|P3|Period II|Adverse Event|2
1134160|NCT01490125|3725011|P2|Period II|Adverse Event|3
1134161|NCT01490125|3725012|P1|Period II|Adverse Event|2
1134162|NCT01490125|3725007|P6|Period I|Withdrawal by Subject|1
1134163|NCT01490125|3725008|P5|Period I|Withdrawal by Subject|2
1134164|NCT01490125|3725009|P4|Period I|Withdrawal by Subject|1
1134165|NCT01490125|3725010|P3|Period I|Withdrawal by Subject|2
1134166|NCT01490125|3725011|P2|Period I|Withdrawal by Subject|3
1134167|NCT01490125|3725012|P1|Period I|Withdrawal by Subject|1
1134168|NCT01490125|3725007|P6|Period I|Protocol Violation|0
1134169|NCT01490125|3725008|P5|Period I|Protocol Violation|0
1134170|NCT01490125|3725009|P4|Period I|Protocol Violation|1
1134171|NCT01490125|3725010|P3|Period I|Protocol Violation|1
1134172|NCT01490125|3725011|P2|Period I|Protocol Violation|1
1134173|NCT01490125|3725012|P1|Period I|Protocol Violation|1
1134174|NCT01490125|3725007|P6|Period I|Adverse Event|4
1134175|NCT01490125|3725008|P5|Period I|Adverse Event|2
1134176|NCT01490125|3725009|P4|Period I|Adverse Event|3
1134177|NCT01490125|3725010|P3|Period I|Adverse Event|1
1134178|NCT01490125|3725011|P2|Period I|Adverse Event|1
1134179|NCT01490125|3725012|P1|Period I|Adverse Event|4
1134180|NCT01490086|3725040|P5|Overall Study|Subject left hospital|0
1134181|NCT01490086|3725041|P4|Overall Study|Subject left hospital|1
1134182|NCT01490086|3725042|P3|Overall Study|Subject left hospital|0
1134183|NCT01490086|3725043|P2|Overall Study|Subject left hospital|1
1134184|NCT01490086|3725044|P1|Overall Study|Subject left hospital|0
1134185|NCT01490086|3725040|P5|Overall Study|Subject uncontrollable and abusive|0
1134186|NCT01490086|3725041|P4|Overall Study|Subject uncontrollable and abusive|0
1134187|NCT01490086|3725042|P3|Overall Study|Subject uncontrollable and abusive|0
1134188|NCT01490086|3725043|P2|Overall Study|Subject uncontrollable and abusive|1
1134189|NCT01490086|3725044|P1|Overall Study|Subject uncontrollable and abusive|0
1134190|NCT01490086|3725040|P5|Overall Study|Worsening of symptoms|0
1134191|NCT01490086|3725041|P4|Overall Study|Worsening of symptoms|1
1134192|NCT01490086|3725042|P3|Overall Study|Worsening of symptoms|0
1134193|NCT01490086|3725043|P2|Overall Study|Worsening of symptoms|1
1134194|NCT01490086|3725044|P1|Overall Study|Worsening of symptoms|0
1134195|NCT01490086|3725040|P5|Overall Study|Lack of Efficacy|8
1134196|NCT01490086|3725041|P4|Overall Study|Lack of Efficacy|0
1134197|NCT01490086|3725042|P3|Overall Study|Lack of Efficacy|1
1134198|NCT01490086|3725043|P2|Overall Study|Lack of Efficacy|3
1134199|NCT01490086|3725044|P1|Overall Study|Lack of Efficacy|0
1134200|NCT01490086|3725040|P5|Overall Study|Adverse Event|0
1134201|NCT01490086|3725041|P4|Overall Study|Adverse Event|2
1134202|NCT01490086|3725042|P3|Overall Study|Adverse Event|1
1134203|NCT01490086|3725043|P2|Overall Study|Adverse Event|0
1134204|NCT01490086|3725044|P1|Overall Study|Adverse Event|0
1134205|NCT01490086|3725040|P5|Overall Study|Physician Decision|1
1134206|NCT01490086|3725041|P4|Overall Study|Physician Decision|3
1134207|NCT01490086|3725042|P3|Overall Study|Physician Decision|2
1134208|NCT01490086|3725043|P2|Overall Study|Physician Decision|4
1134209|NCT01490086|3725044|P1|Overall Study|Physician Decision|3
1134210|NCT01490086|3725040|P5|Overall Study|Lost to Follow-up|1
1134211|NCT01490086|3725041|P4|Overall Study|Lost to Follow-up|0
1134212|NCT01490086|3725042|P3|Overall Study|Lost to Follow-up|0
1134213|NCT01490086|3725043|P2|Overall Study|Lost to Follow-up|0
1134214|NCT01490086|3725044|P1|Overall Study|Lost to Follow-up|0
1134215|NCT01490086|3725040|P5|Overall Study|Abnormal laboratory findings|0
1134216|NCT01490086|3725041|P4|Overall Study|Abnormal laboratory findings|0
1134217|NCT01490086|3725042|P3|Overall Study|Abnormal laboratory findings|0
1134218|NCT01490086|3725043|P2|Overall Study|Abnormal laboratory findings|0
1134219|NCT01490086|3725044|P1|Overall Study|Abnormal laboratory findings|1
1134220|NCT01490086|3725040|P5|Overall Study|Non-compliance|0
1134221|NCT01490086|3725041|P4|Overall Study|Non-compliance|0
1134222|NCT01490086|3725042|P3|Overall Study|Non-compliance|0
1134223|NCT01490086|3725043|P2|Overall Study|Non-compliance|1
1134224|NCT01490086|3725044|P1|Overall Study|Non-compliance|0
1134225|NCT01490086|3725040|P5|Overall Study|Consent withdrawn|1
1134226|NCT01490086|3725041|P4|Overall Study|Consent withdrawn|0
1134227|NCT01490086|3725042|P3|Overall Study|Consent withdrawn|3
1134228|NCT01490086|3725043|P2|Overall Study|Consent withdrawn|4
1134229|NCT01490086|3725044|P1|Overall Study|Consent withdrawn|4
1134230|NCT01490060|3725078|P4|Cycle 2|Adverse Event Related to Chemotherapy|0
1134231|NCT01490060|3725079|P3|Cycle 2|Adverse Event Related to Chemotherapy|0
1134232|NCT01490060|3725080|P2|Cycle 2|Adverse Event Related to Chemotherapy|0
1134233|NCT01490060|3725081|P1|Cycle 2|Adverse Event Related to Chemotherapy|1
1134234|NCT01490060|3725078|P4|Cycle 2|Non-Compliance|0
1134235|NCT01490060|3725079|P3|Cycle 2|Non-Compliance|1
1134236|NCT01490060|3725080|P2|Cycle 2|Non-Compliance|0
1134237|NCT01490060|3725081|P1|Cycle 2|Non-Compliance|0
1134238|NCT01490060|3725078|P4|Cycle 2|Change of Treatment|0
1134239|NCT01490060|3725079|P3|Cycle 2|Change of Treatment|0
1134240|NCT01490060|3725080|P2|Cycle 2|Change of Treatment|1
1134241|NCT01490060|3725081|P1|Cycle 2|Change of Treatment|1
1134242|NCT01490060|3725078|P4|Cycle 1|Treatment at Another Facility|1
1134243|NCT01490060|3725079|P3|Cycle 1|Treatment at Another Facility|0
1134244|NCT01490060|3725080|P2|Cycle 1|Treatment at Another Facility|0
1134245|NCT01490060|3725081|P1|Cycle 1|Treatment at Another Facility|0
1134246|NCT01490060|3725078|P4|Cycle 1|Withdrawal by Subject|1
1134247|NCT01490060|3725079|P3|Cycle 1|Withdrawal by Subject|0
1134248|NCT01490060|3725080|P2|Cycle 1|Withdrawal by Subject|0
1134249|NCT01490060|3725081|P1|Cycle 1|Withdrawal by Subject|0
1134250|NCT01490060|3725078|P4|Cycle 1|Insurance Denied|0
1134251|NCT01490060|3725079|P3|Cycle 1|Insurance Denied|2
1134252|NCT01490060|3725080|P2|Cycle 1|Insurance Denied|0
1134253|NCT01490060|3725081|P1|Cycle 1|Insurance Denied|0
1134254|NCT01490060|3725078|P4|Cycle 1|Change of Treatment|1
1134255|NCT01490060|3725079|P3|Cycle 1|Change of Treatment|1
1134256|NCT01490060|3725080|P2|Cycle 1|Change of Treatment|1
1134257|NCT01490060|3725081|P1|Cycle 1|Change of Treatment|0
1134258|NCT01489956|3725110|P3|Overall Study|Withdrawal by Subject|1
1134259|NCT01489956|3725111|P2|Overall Study|Withdrawal by Subject|0
1134260|NCT01489956|3725112|P1|Overall Study|Withdrawal by Subject|0
1134261|NCT01489956|3725110|P3|Overall Study|Lost to Follow-up|0
1134262|NCT01489956|3725111|P2|Overall Study|Lost to Follow-up|0
1134263|NCT01489956|3725112|P1|Overall Study|Lost to Follow-up|1
1134264|NCT01489891|3725149|P2|Overall Study|Endoscopy failure|0
1134265|NCT01489891|3725150|P1|Overall Study|Endoscopy failure|1
1134266|NCT01489527|3725288|P2|Overall Study|Not compliant|0
1134267|NCT01489527|3725289|P1|Overall Study|Not compliant|1
1134268|NCT01489527|3725288|P2|Overall Study|Procedures|0
1134269|NCT01489527|3725289|P1|Overall Study|Procedures|1
1134270|NCT01489527|3725288|P2|Overall Study|Lost to Follow-up|1
1134271|NCT01489527|3725289|P1|Overall Study|Lost to Follow-up|5
1134272|NCT01489527|3725288|P2|Overall Study|Withdrawal by Subject|4
1134273|NCT01489527|3725289|P1|Overall Study|Withdrawal by Subject|0
1134274|NCT01489527|3725288|P2|Overall Study|Participant moved|7
1134275|NCT01489527|3725289|P1|Overall Study|Participant moved|6
1134276|NCT01489527|3725288|P2|Overall Study|Pregnancy|14
1134277|NCT01489527|3725289|P1|Overall Study|Pregnancy|9
1134278|NCT01489358|3725306|P3|Overall Study|Lost to Follow-up|2
1134279|NCT01489358|3725307|P2|Overall Study|Lost to Follow-up|0
1134280|NCT01489358|3725308|P1|Overall Study|Lost to Follow-up|0
1134281|NCT01489254|3725358|P4|Open-label Extension Part|Other reasons for not completing study|5
1134282|NCT01489254|3725359|P3|Open-label Extension Part|Other reasons for not completing study|0
1134283|NCT01489254|3725360|P2|Open-label Extension Part|Other reasons for not completing study|0
1134284|NCT01489254|3725361|P1|Open-label Extension Part|Other reasons for not completing study|0
1134285|NCT01489254|3725358|P4|Open-label Extension Part|Lost to Follow-up|9
1134286|NCT01489254|3725359|P3|Open-label Extension Part|Lost to Follow-up|0
1134287|NCT01489254|3725360|P2|Open-label Extension Part|Lost to Follow-up|0
1134288|NCT01489254|3725361|P1|Open-label Extension Part|Lost to Follow-up|0
1134289|NCT01489254|3725358|P4|Open-label Extension Part|Protocol Violation|1
1134290|NCT01489254|3725359|P3|Open-label Extension Part|Protocol Violation|0
1134291|NCT01489254|3725360|P2|Open-label Extension Part|Protocol Violation|0
1134292|NCT01489254|3725361|P1|Open-label Extension Part|Protocol Violation|0
1134293|NCT01489254|3725358|P4|Open-label Extension Part|Withdrawal by Subject|30
1134294|NCT01489254|3725359|P3|Open-label Extension Part|Withdrawal by Subject|0
1134295|NCT01489254|3725360|P2|Open-label Extension Part|Withdrawal by Subject|0
1134296|NCT01489254|3725361|P1|Open-label Extension Part|Withdrawal by Subject|0
1134297|NCT01489254|3725358|P4|Open-label Extension Part|Pregnancy|3
1134298|NCT01489254|3725359|P3|Open-label Extension Part|Pregnancy|0
1134299|NCT01489254|3725360|P2|Open-label Extension Part|Pregnancy|0
1134300|NCT01489254|3725361|P1|Open-label Extension Part|Pregnancy|0
1134301|NCT01489254|3725358|P4|Open-label Extension Part|Adverse Event|10
1134302|NCT01489254|3725359|P3|Open-label Extension Part|Adverse Event|0
1134303|NCT01489254|3725360|P2|Open-label Extension Part|Adverse Event|0
1134304|NCT01489254|3725361|P1|Open-label Extension Part|Adverse Event|0
1134305|NCT01489254|3725358|P4|Double-blind Part|Other reasons for not completing study|0
1134306|NCT01489254|3725359|P3|Double-blind Part|Other reasons for not completing study|0
1134307|NCT01489254|3725360|P2|Double-blind Part|Other reasons for not completing study|6
1134308|NCT01489254|3725361|P1|Double-blind Part|Other reasons for not completing study|4
1134309|NCT01489254|3725358|P4|Double-blind Part|Lost to Follow-up|0
1134310|NCT01489254|3725359|P3|Double-blind Part|Lost to Follow-up|0
1134311|NCT01489254|3725360|P2|Double-blind Part|Lost to Follow-up|2
1134312|NCT01489254|3725361|P1|Double-blind Part|Lost to Follow-up|1
1134313|NCT01489254|3725358|P4|Double-blind Part|Withdrawal by Subject|0
1134314|NCT01489254|3725359|P3|Double-blind Part|Withdrawal by Subject|1
1134315|NCT01489254|3725360|P2|Double-blind Part|Withdrawal by Subject|20
1134316|NCT01489254|3725361|P1|Double-blind Part|Withdrawal by Subject|12
1134317|NCT01489254|3725358|P4|Double-blind Part|Pregnancy|0
1134318|NCT01489254|3725359|P3|Double-blind Part|Pregnancy|0
1134319|NCT01489254|3725360|P2|Double-blind Part|Pregnancy|3
1134320|NCT01489254|3725361|P1|Double-blind Part|Pregnancy|1
1134321|NCT01489254|3725358|P4|Double-blind Part|Adverse Event|0
1134322|NCT01489254|3725359|P3|Double-blind Part|Adverse Event|2
1134323|NCT01489254|3725360|P2|Double-blind Part|Adverse Event|2
1134324|NCT01489254|3725361|P1|Double-blind Part|Adverse Event|7
1134325|NCT01489189|3725372|P2|Overall Study|Missed Visit|4
1134326|NCT01489189|3725373|P1|Overall Study|Missed Visit|1
1134327|NCT01489189|3725372|P2|Overall Study|Death|8
1134328|NCT01489189|3725373|P1|Overall Study|Death|10
1134329|NCT01489189|3725372|P2|Overall Study|Withdrawal by Subject|23
1134330|NCT01489189|3725373|P1|Overall Study|Withdrawal by Subject|20
1134331|NCT01488994|3725400|P2|Overall Study|Withdrawal by Subject|1
1134332|NCT01488994|3725401|P1|Overall Study|Withdrawal by Subject|0
1134333|NCT01488578|3725528|P1|Overall Study|Protocol Violation|1836
1134334|NCT01488487|3725562|P1|Overall Study|Withdrawal by Subject|2
1134335|NCT01488487|3725562|P1|Overall Study|Death|1
1134336|NCT01488487|3725562|P1|Overall Study|Adverse Event|6
1134337|NCT01488448|3725571|P2|Overall Study|Protocol Violation|3
1134338|NCT01488448|3725572|P1|Overall Study|Protocol Violation|4
1134339|NCT01488448|3725571|P2|Overall Study|Physician Decision|9
1134340|NCT01488448|3725572|P1|Overall Study|Physician Decision|4
1134341|NCT01488448|3725571|P2|Overall Study|Adverse Event|4
1134342|NCT01488448|3725572|P1|Overall Study|Adverse Event|9
1134343|NCT01488448|3725571|P2|Overall Study|Withdrawal by Subject|1
1134344|NCT01488448|3725572|P1|Overall Study|Withdrawal by Subject|3
1134345|NCT01488370|3725614|P3|Overall Study|Protocol Violation|1
1134346|NCT01488370|3725615|P2|Overall Study|Protocol Violation|1
1134347|NCT01488370|3725616|P1|Overall Study|Protocol Violation|0
1134348|NCT01488097|3725675|P1|Overall Study|Lost to Follow-up|1
1134349|NCT01488071|3725688|P2|Overall Study|Administrative or Other Reason(s)|4
1134350|NCT01488071|3725689|P1|Overall Study|Administrative or Other Reason(s)|5
1134351|NCT01488071|3725688|P2|Overall Study|Lost to Follow-up|0
1134352|NCT01488071|3725689|P1|Overall Study|Lost to Follow-up|1
1134353|NCT01488071|3725688|P2|Overall Study|Withdrawal of Consent|12
1134354|NCT01488071|3725689|P1|Overall Study|Withdrawal of Consent|14
1134355|NCT01488071|3725688|P2|Overall Study|Protocol Violation|7
1134356|NCT01488071|3725689|P1|Overall Study|Protocol Violation|5
1134357|NCT01488071|3725688|P2|Overall Study|Non-compliance with study drug|0
1134358|NCT01488071|3725689|P1|Overall Study|Non-compliance with study drug|2
1134359|NCT01488071|3725688|P2|Overall Study|Lack of Efficacy|17
1134360|NCT01488071|3725689|P1|Overall Study|Lack of Efficacy|11
1134361|NCT01488071|3725688|P2|Overall Study|Adverse Event|23
1134362|NCT01488071|3725689|P1|Overall Study|Adverse Event|15
1134363|NCT01487863|3725769|P2|Overall Study|Death|19
1134364|NCT01487863|3725770|P1|Overall Study|Death|19
1134365|NCT01487577|3725787|P1|Overall Study|Became ineligible after signing consent|1
1134366|NCT01487525|3725801|P2|Overall Study|Withdrawal by Subject|1
1134367|NCT01487525|3725802|P1|Overall Study|Withdrawal by Subject|0
1134368|NCT01487265|3725818|P1|Overall Study|Still on Treatment|1
1134369|NCT01487265|3725818|P1|Overall Study|Death|2
1134370|NCT01487265|3725818|P1|Overall Study|Disease Progression|21
1134371|NCT01487265|3725818|P1|Overall Study|Withdrawal by Subject|5
1134372|NCT01487265|3725818|P1|Overall Study|Adverse Event|8
1134373|NCT01487161|3725830|P4|Overall Study|missing data|0
1134374|NCT01487161|3725831|P3|Overall Study|missing data|0
1134375|NCT01487161|3725832|P2|Overall Study|missing data|1
1134376|NCT01487161|3725833|P1|Overall Study|missing data|0
1134377|NCT01487161|3725830|P4|Overall Study|Withdrawal by Subject|2
1134378|NCT01487161|3725831|P3|Overall Study|Withdrawal by Subject|1
1134379|NCT01487161|3725832|P2|Overall Study|Withdrawal by Subject|1
1134380|NCT01487161|3725833|P1|Overall Study|Withdrawal by Subject|1
1134381|NCT01487161|3725830|P4|Overall Study|Adverse Event|0
1134382|NCT01487161|3725831|P3|Overall Study|Adverse Event|0
1134383|NCT01487161|3725832|P2|Overall Study|Adverse Event|0
1134384|NCT01487161|3725833|P1|Overall Study|Adverse Event|1
1134385|NCT01486966|3725898|P2|Overall Study|Withdrawal by Subject|1
1134386|NCT01486966|3725899|P1|Overall Study|Withdrawal by Subject|0
1134387|NCT01486966|3725898|P2|Overall Study|Adverse Event|1
1134388|NCT01486966|3725899|P1|Overall Study|Adverse Event|0
1134389|NCT01486927|3725923|P1|Overall Study|Subject did not reach 6 mo of treatment|1
1134390|NCT01486927|3725923|P1|Overall Study|Withdrawal by Subject|8
1134391|NCT01486927|3725923|P1|Overall Study|50 Exposure days not reached|2
1134392|NCT01486927|3725923|P1|Overall Study|Physician Decision|1
1134393|NCT01486927|3725923|P1|Overall Study|Knee surgery (prior to surgery substudy)|1
1134394|NCT01486758|3725961|P2|Overall Study|Lost to Follow-up|1
1134395|NCT01486758|3725962|P1|Overall Study|Lost to Follow-up|0
1134396|NCT01486446|3726029|P2|Overall Study|Adverse Event|0
1134397|NCT01486446|3726030|P1|Overall Study|Adverse Event|1
1134398|NCT01486316|3726053|P4|Overall Study|Death|0
1134399|NCT01486316|3726054|P3|Overall Study|Death|0
1134400|NCT01486316|3726055|P2|Overall Study|Death|1
1134401|NCT01486316|3726056|P1|Overall Study|Death|0
1134402|NCT01486316|3726053|P4|Overall Study|Physician Decision|0
1134403|NCT01486316|3726054|P3|Overall Study|Physician Decision|1
1134404|NCT01486316|3726055|P2|Overall Study|Physician Decision|0
1134405|NCT01486316|3726056|P1|Overall Study|Physician Decision|0
1134406|NCT01486316|3726053|P4|Overall Study|Withdrawal by Subject|0
1134407|NCT01486316|3726054|P3|Overall Study|Withdrawal by Subject|3
1134408|NCT01486316|3726055|P2|Overall Study|Withdrawal by Subject|0
1134409|NCT01486316|3726056|P1|Overall Study|Withdrawal by Subject|1
1134410|NCT01486316|3726053|P4|Overall Study|Not meeting eligibility criteria|0
1134411|NCT01486316|3726054|P3|Overall Study|Not meeting eligibility criteria|1
1134412|NCT01486316|3726055|P2|Overall Study|Not meeting eligibility criteria|0
1134413|NCT01486316|3726056|P1|Overall Study|Not meeting eligibility criteria|0
1134414|NCT01486316|3726053|P4|Overall Study|Device explanted with/without re-implant|2
1134415|NCT01486316|3726054|P3|Overall Study|Device explanted with/without re-implant|0
1134416|NCT01486316|3726055|P2|Overall Study|Device explanted with/without re-implant|2
1134417|NCT01486316|3726056|P1|Overall Study|Device explanted with/without re-implant|3
1134418|NCT01486238|3726068|P2|Overall Study|Lost to Follow-up|3
1134419|NCT01486238|3726069|P1|Overall Study|Lost to Follow-up|0
1134420|NCT01486238|3726068|P2|Overall Study|Withdrawal by Subject|1
1134421|NCT01486238|3726069|P1|Overall Study|Withdrawal by Subject|2
1134422|NCT01486238|3726068|P2|Overall Study|Death|2
1134423|NCT01486238|3726069|P1|Overall Study|Death|0
1134424|NCT01486199|3726077|P2|Two Year Period Between Study Days|Physician Decision|0
1134425|NCT01486199|3726078|P1|Two Year Period Between Study Days|Physician Decision|1
1134426|NCT01485991|3726098|P2|Overall Study|randomized but not treated|2
1134427|NCT01485991|3726099|P1|Overall Study|randomized but not treated|6
1134428|NCT01485991|3726098|P2|Overall Study|Withdrawal by Subject|20
1134429|NCT01485991|3726099|P1|Overall Study|Withdrawal by Subject|13
1134430|NCT01485991|3726098|P2|Overall Study|Lost to Follow-up|10
1134431|NCT01485991|3726099|P1|Overall Study|Lost to Follow-up|13
1134432|NCT01485991|3726098|P2|Overall Study|Adverse Event|4
1134433|NCT01485991|3726099|P1|Overall Study|Adverse Event|0
1134434|NCT01485887|3726109|P1|Overall Study|Primary disease markedly improved|1
1134435|NCT01485887|3726109|P1|Overall Study|Deterioration of primary disease|1
1134436|NCT01485887|3726109|P1|Overall Study|Adverse Event|8
1134437|NCT01485887|3726109|P1|Overall Study|Withdrawal by Subject|2
1134438|NCT01485796|3726121|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2
1134439|NCT01485796|3726121|P1|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3
1134440|NCT01485796|3726121|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6
1134441|NCT01485796|3726121|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1
1134442|NCT01485796|3726121|P1|Period 2: Epoch 2|Switch to safety follow-up|26
1134443|NCT01485796|3726121|P1|Period 2: Epoch 2|Adverse Event|3
1134444|NCT01485796|3726121|P1|Period 2: Epoch 2|Withdrawal by Subject|6
1134445|NCT01485796|3726121|P1|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1
1134446|NCT01485640|3726143|P1|Overall Study|Terminated by Sponsor|95
1134447|NCT01485640|3726143|P1|Overall Study|Withdrawal by Subject|14
1134448|NCT01485640|3726143|P1|Overall Study|Protocol Violation|1
1134449|NCT01485640|3726143|P1|Overall Study|Lack of Efficacy|2
1134450|NCT01485640|3726143|P1|Overall Study|Adverse Event|10
1134451|NCT01485536|3726148|P1|Overall Study|Adverse Event|1
1134452|NCT01485536|3726148|P1|Overall Study|Withdrawal by Subject|3
1134453|NCT01485354|3726157|P1|Overall Study|Withdrawal by Subject|5
1134454|NCT01485172|3726171|P6|Overall Study|Withdrawal by Subject|1
1134455|NCT01485172|3726172|P5|Overall Study|Withdrawal by Subject|1
1134456|NCT01485172|3726173|P4|Overall Study|Withdrawal by Subject|1
1134457|NCT01485172|3726174|P3|Overall Study|Withdrawal by Subject|0
1134458|NCT01485172|3726175|P2|Overall Study|Withdrawal by Subject|0
1134459|NCT01485172|3726176|P1|Overall Study|Withdrawal by Subject|2
1134460|NCT01485172|3726171|P6|Overall Study|Physician Decision|0
1134461|NCT01485172|3726172|P5|Overall Study|Physician Decision|1
1134462|NCT01485172|3726173|P4|Overall Study|Physician Decision|0
1134463|NCT01485172|3726174|P3|Overall Study|Physician Decision|0
1134464|NCT01485172|3726175|P2|Overall Study|Physician Decision|0
1134465|NCT01485172|3726176|P1|Overall Study|Physician Decision|0
1134466|NCT01485172|3726171|P6|Overall Study|Lost to Follow-up|1
1134467|NCT01485172|3726172|P5|Overall Study|Lost to Follow-up|0
1134468|NCT01485172|3726173|P4|Overall Study|Lost to Follow-up|0
1134469|NCT01485172|3726174|P3|Overall Study|Lost to Follow-up|1
1134470|NCT01485172|3726175|P2|Overall Study|Lost to Follow-up|0
1134471|NCT01485172|3726176|P1|Overall Study|Lost to Follow-up|0
1134472|NCT01485172|3726171|P6|Overall Study|Protocol defined stopping criteria|0
1134473|NCT01485172|3726172|P5|Overall Study|Protocol defined stopping criteria|1
1134474|NCT01485172|3726173|P4|Overall Study|Protocol defined stopping criteria|0
1134475|NCT01485172|3726174|P3|Overall Study|Protocol defined stopping criteria|0
1134476|NCT01485172|3726175|P2|Overall Study|Protocol defined stopping criteria|0
1134477|NCT01485172|3726176|P1|Overall Study|Protocol defined stopping criteria|1
1134478|NCT01485172|3726171|P6|Overall Study|Protocol Violation|0
1134479|NCT01485172|3726172|P5|Overall Study|Protocol Violation|1
1134480|NCT01485172|3726173|P4|Overall Study|Protocol Violation|5
1134481|NCT01485172|3726174|P3|Overall Study|Protocol Violation|4
1134482|NCT01485172|3726175|P2|Overall Study|Protocol Violation|0
1134483|NCT01485172|3726176|P1|Overall Study|Protocol Violation|0
1134484|NCT01485172|3726171|P6|Overall Study|Lack of Efficacy|0
1134485|NCT01485172|3726172|P5|Overall Study|Lack of Efficacy|0
1134486|NCT01485172|3726173|P4|Overall Study|Lack of Efficacy|0
1134487|NCT01485172|3726174|P3|Overall Study|Lack of Efficacy|0
1134488|NCT01485172|3726175|P2|Overall Study|Lack of Efficacy|0
1134489|NCT01485172|3726176|P1|Overall Study|Lack of Efficacy|2
1134490|NCT01485172|3726171|P6|Overall Study|Adverse Event|2
1134491|NCT01485172|3726172|P5|Overall Study|Adverse Event|1
1134492|NCT01485172|3726173|P4|Overall Study|Adverse Event|2
1134493|NCT01485172|3726174|P3|Overall Study|Adverse Event|2
1134494|NCT01485172|3726175|P2|Overall Study|Adverse Event|1
1134495|NCT01485172|3726176|P1|Overall Study|Adverse Event|2
1134496|NCT01485094|3726253|P3|Overall Study|Withdrawal by Subject|0
1134497|NCT01485094|3726254|P2|Overall Study|Withdrawal by Subject|1
1134498|NCT01485094|3726255|P1|Overall Study|Withdrawal by Subject|1
1134499|NCT01485094|3726253|P3|Overall Study|Lost to Follow-up|0
1134500|NCT01485094|3726254|P2|Overall Study|Lost to Follow-up|0
1134501|NCT01485094|3726255|P1|Overall Study|Lost to Follow-up|1
1134502|NCT01485094|3726253|P3|Overall Study|Adverse Event|1
1134503|NCT01485094|3726254|P2|Overall Study|Adverse Event|1
1134504|NCT01485094|3726255|P1|Overall Study|Adverse Event|1
1134505|NCT01484977|3726296|P1|Overall Study|Lack of Compliance|1
1134506|NCT01484977|3726296|P1|Overall Study|Low White Blood Cell Count|1
1134507|NCT01484977|3726296|P1|Overall Study|Moving Overseas|1
1134508|NCT01484977|3726296|P1|Overall Study|Subject Protocol Non-compliant|1
1134509|NCT01484977|3726296|P1|Overall Study|Withdrawal by Subject|4
1134510|NCT01484977|3726296|P1|Overall Study|Lost to Follow-up|1
1134511|NCT01484977|3726296|P1|Overall Study|Protocol Violation|6
1134512|NCT01484977|3726296|P1|Overall Study|Lack of Efficacy|4
1134513|NCT01484977|3726296|P1|Overall Study|Adverse Event|8
1134514|NCT01484951|3726300|P1|Overall Study|Non-Compliance|1
1134515|NCT01484951|3726300|P1|Overall Study|Personal Reasons|1
1134516|NCT01484951|3726300|P1|Overall Study|Adverse Event|3
1134517|NCT01484938|3726305|P1|Overall Study|Noncompliance|1
1134518|NCT01484938|3726305|P1|Overall Study|Lost to Follow-up|1
1134519|NCT01484938|3726305|P1|Overall Study|Adverse Event|2
1134520|NCT01484912|3726312|P2|Overall Study|Physician Decision|1
1134521|NCT01484912|3726313|P1|Overall Study|Physician Decision|0
1134522|NCT01484912|3726312|P2|Overall Study|Withdrawal by Subject|0
1134523|NCT01484912|3726313|P1|Overall Study|Withdrawal by Subject|1
1134524|NCT01484873|3726323|P1|Overall Study|Withdrawal by Subject|2
1134525|NCT01484834|3726335|P4|Overall Study|Lost to Follow-up|4
1134526|NCT01484834|3726336|P3|Overall Study|Lost to Follow-up|1
1134527|NCT01484834|3726337|P2|Overall Study|Lost to Follow-up|8
1134528|NCT01484834|3726338|P1|Overall Study|Lost to Follow-up|5
1134529|NCT01484561|3726379|P2|Overall Study|Adverse Event|4
1134530|NCT01484561|3726380|P1|Overall Study|Adverse Event|1
1134531|NCT01484561|3726379|P2|Overall Study|Not specified|1
1134532|NCT01484561|3726380|P1|Overall Study|Not specified|1
1134533|NCT01484561|3726379|P2|Overall Study|Withdrawal by Subject|0
1134534|NCT01484561|3726380|P1|Overall Study|Withdrawal by Subject|3
1134535|NCT01484561|3726379|P2|Overall Study|Lost to Follow-up|0
1134536|NCT01484561|3726380|P1|Overall Study|Lost to Follow-up|1
1134537|NCT01484561|3726379|P2|Overall Study|Lack of Efficacy|1
1134538|NCT01484561|3726380|P1|Overall Study|Lack of Efficacy|3
1134539|NCT01484496|3726470|P4|Period 2|Other|6
1134540|NCT01484496|3726471|P3|Period 2|Other|9
1134541|NCT01484496|3726472|P2|Period 2|Other|0
1134542|NCT01484496|3726473|P1|Period 2|Other|0
1134543|NCT01484496|3726470|P4|Period 2|Adverse Event|13
1134544|NCT01484496|3726471|P3|Period 2|Adverse Event|5
1134545|NCT01484496|3726472|P2|Period 2|Adverse Event|0
1134546|NCT01484496|3726473|P1|Period 2|Adverse Event|0
1134547|NCT01484496|3726470|P4|Period 2|Lack of Efficacy|3
1134548|NCT01484496|3726471|P3|Period 2|Lack of Efficacy|1
1134549|NCT01484496|3726472|P2|Period 2|Lack of Efficacy|0
1134550|NCT01484496|3726473|P1|Period 2|Lack of Efficacy|0
1134551|NCT01484496|3726470|P4|Period 1|Unable to Visit Site|0
1134552|NCT01484496|3726471|P3|Period 1|Unable to Visit Site|0
1134553|NCT01484496|3726472|P2|Period 1|Unable to Visit Site|2
1134554|NCT01484496|3726473|P1|Period 1|Unable to Visit Site|0
1134555|NCT01484496|3726470|P4|Period 1|Lack of Compliance|0
1134556|NCT01484496|3726471|P3|Period 1|Lack of Compliance|0
1134557|NCT01484496|3726472|P2|Period 1|Lack of Compliance|1
1134558|NCT01484496|3726473|P1|Period 1|Lack of Compliance|2
1134559|NCT01484496|3726470|P4|Period 1|Treatment Failure|0
1134560|NCT01484496|3726471|P3|Period 1|Treatment Failure|0
1134561|NCT01484496|3726472|P2|Period 1|Treatment Failure|6
1134562|NCT01484496|3726473|P1|Period 1|Treatment Failure|3
1134563|NCT01484496|3726470|P4|Period 1|Positive Pregnancy|0
1134564|NCT01484496|3726471|P3|Period 1|Positive Pregnancy|0
1134565|NCT01484496|3726472|P2|Period 1|Positive Pregnancy|6
1134566|NCT01484496|3726473|P1|Period 1|Positive Pregnancy|1
1134567|NCT01484496|3726470|P4|Period 1|Lost to Follow-up|0
1134568|NCT01484496|3726471|P3|Period 1|Lost to Follow-up|0
1134569|NCT01484496|3726472|P2|Period 1|Lost to Follow-up|6
1134570|NCT01484496|3726473|P1|Period 1|Lost to Follow-up|2
1134571|NCT01484496|3726470|P4|Period 1|Withdrawal by Subject|0
1134572|NCT01484496|3726471|P3|Period 1|Withdrawal by Subject|0
1134573|NCT01484496|3726472|P2|Period 1|Withdrawal by Subject|12
1134574|NCT01484496|3726473|P1|Period 1|Withdrawal by Subject|15
1134575|NCT01484496|3726470|P4|Period 1|Adverse Event|0
1134576|NCT01484496|3726471|P3|Period 1|Adverse Event|0
1134577|NCT01484496|3726472|P2|Period 1|Adverse Event|40
1134578|NCT01484496|3726473|P1|Period 1|Adverse Event|25
1134579|NCT01484496|3726470|P4|Period 1|Lack of Efficacy|0
1134580|NCT01484496|3726471|P3|Period 1|Lack of Efficacy|0
1134581|NCT01484496|3726472|P2|Period 1|Lack of Efficacy|15
1134582|NCT01484496|3726473|P1|Period 1|Lack of Efficacy|10
1134583|NCT01484496|3726470|P4|Period 1|Physician Decision|0
1134584|NCT01484496|3726471|P3|Period 1|Physician Decision|0
1134585|NCT01484496|3726472|P2|Period 1|Physician Decision|1
1134586|NCT01484496|3726473|P1|Period 1|Physician Decision|5
1134587|NCT01484496|3726470|P4|Period 1|Protocol Violation|0
1134588|NCT01484496|3726471|P3|Period 1|Protocol Violation|0
1134589|NCT01484496|3726472|P2|Period 1|Protocol Violation|4
1134590|NCT01484496|3726473|P1|Period 1|Protocol Violation|3
1134591|NCT01484197|3726506|P4|Treatment Period 2|Subject withdrew consent|1
1134592|NCT01484197|3726507|P3|Treatment Period 2|Subject withdrew consent|0
1134593|NCT01484197|3726508|P2|Treatment Period 2|Subject withdrew consent|0
1134594|NCT01484197|3726509|P1|Treatment Period 2|Subject withdrew consent|0
1134595|NCT01484197|3726506|P4|Treatment Period 1|Adverse Event|0
1134596|NCT01484197|3726507|P3|Treatment Period 1|Adverse Event|0
1134597|NCT01484197|3726508|P2|Treatment Period 1|Adverse Event|0
1134598|NCT01484197|3726509|P1|Treatment Period 1|Adverse Event|1
1134599|NCT01484132|3726592|P1|Overall Study|No post-treatment urine sample collected|10
1134600|NCT01484132|3726592|P1|Overall Study|No pre-treatment urine sample collected|1
1134601|NCT01484132|3726592|P1|Overall Study|Ineligible|1
1134602|NCT01484132|3726592|P1|Overall Study|Difficulty with time commitment|2
1134603|NCT01484132|3726592|P1|Overall Study|Lost to Follow-up|8
1134604|NCT01484054|3726600|P2|Period 1|Withdrawal by Subject|1
1134605|NCT01484054|3726601|P1|Period 1|Withdrawal by Subject|0
1134606|NCT01484028|3726619|P4|Period 1|Lens Discomfort|0
1134607|NCT01484028|3726620|P3|Period 1|Lens Discomfort|0
1134608|NCT01484028|3726621|P2|Period 1|Lens Discomfort|1
1134609|NCT01484028|3726622|P1|Period 1|Lens Discomfort|0
1134610|NCT01484028|3726619|P4|Period 1|Non-Compliance to Protocol|1
1134611|NCT01484028|3726620|P3|Period 1|Non-Compliance to Protocol|0
1134612|NCT01484028|3726621|P2|Period 1|Non-Compliance to Protocol|1
1134613|NCT01484028|3726622|P1|Period 1|Non-Compliance to Protocol|0
1134614|NCT01484028|3726619|P4|Period 1|Lost to Follow-up|0
1134615|NCT01484028|3726620|P3|Period 1|Lost to Follow-up|0
1134616|NCT01484028|3726621|P2|Period 1|Lost to Follow-up|1
1134617|NCT01484028|3726622|P1|Period 1|Lost to Follow-up|0
1134618|NCT01483937|3726715|P2|Overall Study|Withdrawal by Subject|3
1134619|NCT01483937|3726716|P1|Overall Study|Withdrawal by Subject|4
1134620|NCT01483924|3726743|P5|Overall Study|Sponsor concern over ECG result|0
1134621|NCT01483924|3726744|P4|Overall Study|Sponsor concern over ECG result|1
1134622|NCT01483924|3726745|P3|Overall Study|Sponsor concern over ECG result|0
1134623|NCT01483924|3726746|P2|Overall Study|Sponsor concern over ECG result|0
1134624|NCT01483924|3726747|P1|Overall Study|Sponsor concern over ECG result|0
1134625|NCT01483924|3726743|P5|Overall Study|Non-compliance|1
1134626|NCT01483924|3726744|P4|Overall Study|Non-compliance|1
1134627|NCT01483924|3726745|P3|Overall Study|Non-compliance|0
1134628|NCT01483924|3726746|P2|Overall Study|Non-compliance|0
1134629|NCT01483924|3726747|P1|Overall Study|Non-compliance|0
1134630|NCT01483924|3726743|P5|Overall Study|Adverse Event|0
1134631|NCT01483924|3726744|P4|Overall Study|Adverse Event|1
1134632|NCT01483924|3726745|P3|Overall Study|Adverse Event|1
1134633|NCT01483924|3726746|P2|Overall Study|Adverse Event|0
1134634|NCT01483924|3726747|P1|Overall Study|Adverse Event|0
1134635|NCT01483924|3726743|P5|Overall Study|Withdrawal by Subject|1
1134636|NCT01483924|3726744|P4|Overall Study|Withdrawal by Subject|1
1134637|NCT01483924|3726745|P3|Overall Study|Withdrawal by Subject|0
1134638|NCT01483924|3726746|P2|Overall Study|Withdrawal by Subject|0
1134639|NCT01483924|3726747|P1|Overall Study|Withdrawal by Subject|2
1134640|NCT01483820|3726795|P1|Overall Study|Death|1
1134641|NCT01483820|3726795|P1|Overall Study|Adverse Event|1
1134642|NCT01483820|3726795|P1|Overall Study|Lack of Efficacy|6
1134643|NCT01483651|3726804|P6|Overall Study|Withdrawal by Subject|1
1134644|NCT01483651|3726805|P5|Overall Study|Withdrawal by Subject|0
1134645|NCT01483651|3726806|P4|Overall Study|Withdrawal by Subject|0
1134646|NCT01483651|3726807|P3|Overall Study|Withdrawal by Subject|1
1134647|NCT01483651|3726808|P2|Overall Study|Withdrawal by Subject|1
1134648|NCT01483651|3726809|P1|Overall Study|Withdrawal by Subject|0
1134649|NCT01483625|3726819|P2|Overall Study|Due to other reason|0
1134650|NCT01483625|3726820|P1|Overall Study|Due to other reason|1
1134651|NCT01483625|3726819|P2|Overall Study|Refused to continue medication|1
1134652|NCT01483625|3726820|P1|Overall Study|Refused to continue medication|2
1134653|NCT01483625|3726819|P2|Overall Study|Adverse Event|1
1134654|NCT01483625|3726820|P1|Overall Study|Adverse Event|1
1134655|NCT01483599|3726843|P14|After Controlled Period(Week 16-Week 40)|Other|0
1134656|NCT01483599|3726844|P13|After Controlled Period(Week 16-Week 40)|Other|1
1134657|NCT01483599|3726845|P12|After Controlled Period(Week 16-Week 40)|Other|0
1134658|NCT01483599|3726846|P11|After Controlled Period(Week 16-Week 40)|Other|0
1134659|NCT01483599|3726847|P10|After Controlled Period(Week 16-Week 40)|Other|4
1134660|NCT01483599|3726848|P9|After Controlled Period(Week 16-Week 40)|Other|0
1134661|NCT01483599|3726849|P8|After Controlled Period(Week 16-Week 40)|Other|1
1134662|NCT01483599|3726850|P7|After Controlled Period(Week 16-Week 40)|Other|0
1134663|NCT01483599|3726851|P6|After Controlled Period(Week 16-Week 40)|Other|0
1134664|NCT01483599|3726852|P5|After Controlled Period(Week 16-Week 40)|Other|0
1134665|NCT01483599|3726853|P4|After Controlled Period(Week 16-Week 40)|Other|0
1134666|NCT01483599|3726854|P3|After Controlled Period(Week 16-Week 40)|Other|0
1134667|NCT01483599|3726855|P2|After Controlled Period(Week 16-Week 40)|Other|0
1134668|NCT01483599|3726856|P1|After Controlled Period(Week 16-Week 40)|Other|0
1134669|NCT01483599|3726843|P14|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4
1134670|NCT01483599|3726844|P13|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1
1134671|NCT01483599|3726845|P12|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1134672|NCT01483599|3726846|P11|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1134673|NCT01483599|3726847|P10|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1134674|NCT01483599|3726848|P9|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5
1134675|NCT01483599|3726849|P8|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1134676|NCT01483599|3726850|P7|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1134677|NCT01483599|3726851|P6|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1134678|NCT01483599|3726852|P5|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1134679|NCT01483599|3726853|P4|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1134680|NCT01483599|3726854|P3|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1134681|NCT01483599|3726855|P2|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1134682|NCT01483599|3726856|P1|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1134683|NCT01483599|3726843|P14|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
1134684|NCT01483599|3726844|P13|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1134685|NCT01483599|3726845|P12|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1134686|NCT01483599|3726846|P11|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2
1134687|NCT01483599|3726847|P10|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1134688|NCT01483599|3726848|P9|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
1134689|NCT01483599|3726849|P8|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1134690|NCT01483599|3726850|P7|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1134691|NCT01483599|3726851|P6|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1134692|NCT01483599|3726852|P5|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1134693|NCT01483599|3726853|P4|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1134694|NCT01483599|3726854|P3|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1134695|NCT01483599|3726855|P2|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1134696|NCT01483599|3726856|P1|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1134697|NCT01483599|3726843|P14|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
1134698|NCT01483599|3726844|P13|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1134699|NCT01483599|3726845|P12|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
1134700|NCT01483599|3726846|P11|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1134701|NCT01483599|3726847|P10|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1134702|NCT01483599|3726848|P9|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
1134703|NCT01483599|3726849|P8|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1134704|NCT01483599|3726850|P7|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1134705|NCT01483599|3726851|P6|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1134706|NCT01483599|3726852|P5|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1134707|NCT01483599|3726853|P4|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1134708|NCT01483599|3726854|P3|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1134709|NCT01483599|3726855|P2|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1134710|NCT01483599|3726856|P1|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1134711|NCT01483599|3726843|P14|After Controlled Period(Week 16-Week 40)|Adverse Event|1
1134712|NCT01483599|3726844|P13|After Controlled Period(Week 16-Week 40)|Adverse Event|1
1134713|NCT01483599|3726845|P12|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1134714|NCT01483599|3726846|P11|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1134715|NCT01483599|3726847|P10|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1134716|NCT01483599|3726848|P9|After Controlled Period(Week 16-Week 40)|Adverse Event|1
1134717|NCT01483599|3726849|P8|After Controlled Period(Week 16-Week 40)|Adverse Event|1
1134718|NCT01483599|3726850|P7|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1134719|NCT01483599|3726851|P6|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1134720|NCT01483599|3726852|P5|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1134721|NCT01483599|3726853|P4|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1134722|NCT01483599|3726854|P3|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1134723|NCT01483599|3726855|P2|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1134724|NCT01483599|3726856|P1|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1134725|NCT01483599|3726843|P14|After Controlled Period(Week 16-Week 40)|Death|0
1134726|NCT01483599|3726844|P13|After Controlled Period(Week 16-Week 40)|Death|0
1134727|NCT01483599|3726845|P12|After Controlled Period(Week 16-Week 40)|Death|0
1134728|NCT01483599|3726846|P11|After Controlled Period(Week 16-Week 40)|Death|0
1134729|NCT01483599|3726847|P10|After Controlled Period(Week 16-Week 40)|Death|0
1134730|NCT01483599|3726848|P9|After Controlled Period(Week 16-Week 40)|Death|1
1134731|NCT01483599|3726849|P8|After Controlled Period(Week 16-Week 40)|Death|0
1134732|NCT01483599|3726850|P7|After Controlled Period(Week 16-Week 40)|Death|0
1134733|NCT01483599|3726851|P6|After Controlled Period(Week 16-Week 40)|Death|0
1134734|NCT01483599|3726852|P5|After Controlled Period(Week 16-Week 40)|Death|0
1134735|NCT01483599|3726853|P4|After Controlled Period(Week 16-Week 40)|Death|0
1134736|NCT01483599|3726854|P3|After Controlled Period(Week 16-Week 40)|Death|0
1134737|NCT01483599|3726855|P2|After Controlled Period(Week 16-Week 40)|Death|0
1134738|NCT01483599|3726856|P1|After Controlled Period(Week 16-Week 40)|Death|0
1134739|NCT01483599|3726843|P14|Controlled Period (CP) (up to Week 16)|Other|0
1134740|NCT01483599|3726844|P13|Controlled Period (CP) (up to Week 16)|Other|0
1134741|NCT01483599|3726845|P12|Controlled Period (CP) (up to Week 16)|Other|0
1134742|NCT01483599|3726846|P11|Controlled Period (CP) (up to Week 16)|Other|0
1134743|NCT01483599|3726847|P10|Controlled Period (CP) (up to Week 16)|Other|0
1134744|NCT01483599|3726848|P9|Controlled Period (CP) (up to Week 16)|Other|0
1134745|NCT01483599|3726849|P8|Controlled Period (CP) (up to Week 16)|Other|0
1134746|NCT01483599|3726850|P7|Controlled Period (CP) (up to Week 16)|Other|0
1134747|NCT01483599|3726851|P6|Controlled Period (CP) (up to Week 16)|Other|0
1134748|NCT01483599|3726852|P5|Controlled Period (CP) (up to Week 16)|Other|1
1134749|NCT01483599|3726853|P4|Controlled Period (CP) (up to Week 16)|Other|1
1134750|NCT01483599|3726854|P3|Controlled Period (CP) (up to Week 16)|Other|0
1134751|NCT01483599|3726855|P2|Controlled Period (CP) (up to Week 16)|Other|2
1134752|NCT01483599|3726856|P1|Controlled Period (CP) (up to Week 16)|Other|0
1134753|NCT01483599|3726843|P14|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1134754|NCT01483599|3726844|P13|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1134755|NCT01483599|3726845|P12|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1134756|NCT01483599|3726846|P11|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1134757|NCT01483599|3726847|P10|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1134758|NCT01483599|3726848|P9|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1134759|NCT01483599|3726849|P8|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1134760|NCT01483599|3726850|P7|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1134761|NCT01483599|3726851|P6|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1134762|NCT01483599|3726852|P5|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1134763|NCT01483599|3726853|P4|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1134764|NCT01483599|3726854|P3|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1134765|NCT01483599|3726855|P2|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1134766|NCT01483599|3726856|P1|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1
1134767|NCT01483599|3726843|P14|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1134768|NCT01483599|3726844|P13|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1134769|NCT01483599|3726845|P12|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1134770|NCT01483599|3726846|P11|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1134771|NCT01483599|3726847|P10|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1134772|NCT01483599|3726848|P9|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1134773|NCT01483599|3726849|P8|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1134774|NCT01483599|3726850|P7|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
1134775|NCT01483599|3726851|P6|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1134776|NCT01483599|3726852|P5|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1134777|NCT01483599|3726853|P4|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
1134778|NCT01483599|3726854|P3|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1134779|NCT01483599|3726855|P2|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
1134780|NCT01483599|3726856|P1|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1134781|NCT01483599|3726843|P14|Controlled Period (CP) (up to Week 16)|Adverse Event|0
1134782|NCT01483599|3726844|P13|Controlled Period (CP) (up to Week 16)|Adverse Event|0
1134783|NCT01483599|3726845|P12|Controlled Period (CP) (up to Week 16)|Adverse Event|0
1134784|NCT01483599|3726846|P11|Controlled Period (CP) (up to Week 16)|Adverse Event|0
1134785|NCT01483599|3726847|P10|Controlled Period (CP) (up to Week 16)|Adverse Event|0
1134786|NCT01483599|3726848|P9|Controlled Period (CP) (up to Week 16)|Adverse Event|0
1134787|NCT01483599|3726849|P8|Controlled Period (CP) (up to Week 16)|Adverse Event|0
1134788|NCT01483599|3726850|P7|Controlled Period (CP) (up to Week 16)|Adverse Event|3
1134789|NCT01483599|3726851|P6|Controlled Period (CP) (up to Week 16)|Adverse Event|4
1134790|NCT01483599|3726852|P5|Controlled Period (CP) (up to Week 16)|Adverse Event|1
1134791|NCT01483599|3726853|P4|Controlled Period (CP) (up to Week 16)|Adverse Event|1
1134792|NCT01483599|3726854|P3|Controlled Period (CP) (up to Week 16)|Adverse Event|0
1134793|NCT01483599|3726855|P2|Controlled Period (CP) (up to Week 16)|Adverse Event|0
1134794|NCT01483599|3726856|P1|Controlled Period (CP) (up to Week 16)|Adverse Event|2
1134795|NCT01483183|3726946|P10|Overall Study|Withdrawal by Subject|1
1134796|NCT01483183|3726947|P9|Overall Study|Withdrawal by Subject|0
1134797|NCT01483183|3726948|P8|Overall Study|Withdrawal by Subject|0
1134798|NCT01483183|3726949|P7|Overall Study|Withdrawal by Subject|0
1134799|NCT01483183|3726950|P6|Overall Study|Withdrawal by Subject|0
1134800|NCT01483183|3726951|P5|Overall Study|Withdrawal by Subject|0
1134801|NCT01483183|3726952|P4|Overall Study|Withdrawal by Subject|0
1134802|NCT01483183|3726953|P3|Overall Study|Withdrawal by Subject|0
1134803|NCT01483183|3726954|P2|Overall Study|Withdrawal by Subject|0
1134804|NCT01483183|3726955|P1|Overall Study|Withdrawal by Subject|0
1134805|NCT01483183|3726946|P10|Overall Study|Physician Decision|0
1134806|NCT01483183|3726947|P9|Overall Study|Physician Decision|0
1134807|NCT01483183|3726948|P8|Overall Study|Physician Decision|0
1134808|NCT01483183|3726949|P7|Overall Study|Physician Decision|2
1134809|NCT01483183|3726950|P6|Overall Study|Physician Decision|0
1134810|NCT01483183|3726951|P5|Overall Study|Physician Decision|0
1134811|NCT01483183|3726952|P4|Overall Study|Physician Decision|0
1134812|NCT01483183|3726953|P3|Overall Study|Physician Decision|0
1134813|NCT01483183|3726954|P2|Overall Study|Physician Decision|0
1134814|NCT01483183|3726955|P1|Overall Study|Physician Decision|0
1134815|NCT01483118|3727025|P2|Overall Study|Lost to Follow-up|16
1134816|NCT01483118|3727026|P1|Overall Study|Lost to Follow-up|12
1134817|NCT01482962|3727038|P2|Overall Study|Did not Receive Study Drug|6
1134818|NCT01482962|3727039|P1|Overall Study|Did not Receive Study Drug|1
1134819|NCT01482962|3727038|P2|Overall Study|Study Terminated by Sponsor|2
1134820|NCT01482962|3727039|P1|Overall Study|Study Terminated by Sponsor|5
1134821|NCT01482962|3727038|P2|Overall Study|Other Reason|5
1134822|NCT01482962|3727039|P1|Overall Study|Other Reason|1
1134823|NCT01482962|3727038|P2|Overall Study|Hematopoietic Stem Cell Transplant|9
1134824|NCT01482962|3727039|P1|Overall Study|Hematopoietic Stem Cell Transplant|3
1134825|NCT01482962|3727038|P2|Overall Study|Withdrawal by Participant|13
1134826|NCT01482962|3727039|P1|Overall Study|Withdrawal by Participant|8
1134827|NCT01482962|3727038|P2|Overall Study|Adverse Event|22
1134828|NCT01482962|3727039|P1|Overall Study|Adverse Event|18
1134829|NCT01482962|3727038|P2|Overall Study|Unsatisfactory Therapeutic Response|23
1134830|NCT01482962|3727039|P1|Overall Study|Unsatisfactory Therapeutic Response|37
1134831|NCT01482962|3727038|P2|Overall Study|Progressive Disease|53
1134832|NCT01482962|3727039|P1|Overall Study|Progressive Disease|65
1134833|NCT01482910|3727072|P2|Overall Study|Death|0
1134834|NCT01482910|3727073|P1|Overall Study|Death|1
1134835|NCT01482910|3727072|P2|Overall Study|Withdrawal by Subject|2
1134836|NCT01482910|3727073|P1|Overall Study|Withdrawal by Subject|7
1134837|NCT01482910|3727072|P2|Overall Study|Protocol Violation|1
1134838|NCT01482910|3727073|P1|Overall Study|Protocol Violation|1
1134839|NCT01482910|3727072|P2|Overall Study|Lost to Follow-up|1
1134840|NCT01482910|3727073|P1|Overall Study|Lost to Follow-up|0
1134841|NCT01482910|3727072|P2|Overall Study|Adverse Event|5
1134842|NCT01482910|3727073|P1|Overall Study|Adverse Event|6
1134843|NCT01482884|3727085|P2|Overall Study|Withdrawal by Subject|13
1134844|NCT01482884|3727086|P1|Overall Study|Withdrawal by Subject|8
1134845|NCT01482884|3727085|P2|Overall Study|Adverse Event|1
1134846|NCT01482884|3727086|P1|Overall Study|Adverse Event|2
1134847|NCT01482884|3727085|P2|Overall Study|Lack of Efficacy|1
1134848|NCT01482884|3727086|P1|Overall Study|Lack of Efficacy|0
1134849|NCT01482884|3727085|P2|Overall Study|Lost to Follow-up|2
1134850|NCT01482884|3727086|P1|Overall Study|Lost to Follow-up|2
1134851|NCT01482884|3727085|P2|Overall Study|Protocol Violation|0
1134852|NCT01482884|3727086|P1|Overall Study|Protocol Violation|1
1134853|NCT01482884|3727085|P2|Overall Study|Medical decision due to lack of efficacy|1
1134854|NCT01482884|3727086|P1|Overall Study|Medical decision due to lack of efficacy|0
1134855|NCT01482819|3727112|P1|Overall Study|Lost to Follow-up|2
1134856|NCT01482767|3727132|P2|Overall Study|Nurse error|0
1134857|NCT01482767|3727133|P1|Overall Study|Nurse error|1
1134858|NCT01482767|3727132|P2|Overall Study|Ineligible|5
1134859|NCT01482767|3727133|P1|Overall Study|Ineligible|0
1134860|NCT01482767|3727132|P2|Overall Study|Alternate HCV treatment|8
1134861|NCT01482767|3727133|P1|Overall Study|Alternate HCV treatment|7
1134862|NCT01482767|3727132|P2|Overall Study|Non-adherence to study requirements|7
1134863|NCT01482767|3727133|P1|Overall Study|Non-adherence to study requirements|4
1134864|NCT01482767|3727132|P2|Overall Study|Site closure|14
1134865|NCT01482767|3727133|P1|Overall Study|Site closure|22
1134866|NCT01482767|3727132|P2|Overall Study|Adverse Event|3
1134867|NCT01482767|3727133|P1|Overall Study|Adverse Event|0
1134868|NCT01482767|3727132|P2|Overall Study|Lost to Follow-up|6
1134869|NCT01482767|3727133|P1|Overall Study|Lost to Follow-up|12
1134870|NCT01482767|3727132|P2|Overall Study|Withdrawal by Subject|5
1134871|NCT01482767|3727133|P1|Overall Study|Withdrawal by Subject|7
1134872|NCT01482767|3727132|P2|Overall Study|Death|1
1134873|NCT01482767|3727133|P1|Overall Study|Death|1
1134874|NCT01482429|3727155|P2|Protocol|Protocol Violation|0
1134875|NCT01482429|3727156|P1|Protocol|Protocol Violation|275
1134876|NCT01482429|3727155|P2|Care Usual|Lost to Follow-up|1
1134877|NCT01482429|3727156|P1|Care Usual|Lost to Follow-up|0
1134878|NCT01482429|3727155|P2|Care Usual|Protocol Violation|172
1134879|NCT01482429|3727156|P1|Care Usual|Protocol Violation|0
1134880|NCT01482312|3727168|P3|Period 2, 90 Minutes of Wear|Other|0
1134881|NCT01482312|3727169|P2|Period 2, 90 Minutes of Wear|Other|0
1134882|NCT01482312|3727170|P1|Period 2, 90 Minutes of Wear|Other|1
1134883|NCT01482312|3727168|P3|Period 1, 90 Minutes of Wear|Other|0
1134884|NCT01482312|3727169|P2|Period 1, 90 Minutes of Wear|Other|0
1134885|NCT01482312|3727170|P1|Period 1, 90 Minutes of Wear|Other|1
1134886|NCT01482221|3727184|P3|Overall Study|Physician Decision|0
1134887|NCT01482221|3727185|P2|Overall Study|Physician Decision|1
1134888|NCT01482221|3727186|P1|Overall Study|Physician Decision|0
1134889|NCT01482221|3727184|P3|Overall Study|Incorrect randomization|0
1134890|NCT01482221|3727185|P2|Overall Study|Incorrect randomization|1
1134891|NCT01482221|3727186|P1|Overall Study|Incorrect randomization|0
1134892|NCT01482221|3727184|P3|Overall Study|Withdrawal by Subject|12
1134893|NCT01482221|3727185|P2|Overall Study|Withdrawal by Subject|7
1134894|NCT01482221|3727186|P1|Overall Study|Withdrawal by Subject|10
1134895|NCT01482221|3727184|P3|Overall Study|Adverse Event|3
1134896|NCT01482221|3727185|P2|Overall Study|Adverse Event|7
1134897|NCT01482221|3727186|P1|Overall Study|Adverse Event|1
1134898|NCT01482221|3727184|P3|Overall Study|Severe Non-Compliance to Protocol|1
1134899|NCT01482221|3727185|P2|Overall Study|Severe Non-Compliance to Protocol|0
1134900|NCT01482221|3727186|P1|Overall Study|Severe Non-Compliance to Protocol|1
1134901|NCT01482221|3727184|P3|Overall Study|Condition under Investigation Worsened|4
1134902|NCT01482221|3727185|P2|Overall Study|Condition under Investigation Worsened|2
1134903|NCT01482221|3727186|P1|Overall Study|Condition under Investigation Worsened|3
1134904|NCT01482221|3727184|P3|Overall Study|Study-Specific Withdrawal Criteria|1
1134905|NCT01482221|3727185|P2|Overall Study|Study-Specific Withdrawal Criteria|0
1134906|NCT01482221|3727186|P1|Overall Study|Study-Specific Withdrawal Criteria|2
1134907|NCT01482221|3727184|P3|Overall Study|Lost to Follow-up|1
1134908|NCT01482221|3727185|P2|Overall Study|Lost to Follow-up|2
1134909|NCT01482221|3727186|P1|Overall Study|Lost to Follow-up|3
1134910|NCT01482221|3727184|P3|Overall Study|Lack of Efficacy|1
1134911|NCT01482221|3727185|P2|Overall Study|Lack of Efficacy|0
1134912|NCT01482221|3727186|P1|Overall Study|Lack of Efficacy|1
1134913|NCT01482169|3727227|P1|Overall Study|Physician Decision|2
1134914|NCT01482065|3727269|P2|Overall Study|Withdrawal by Subject|1
1134915|NCT01482065|3727270|P1|Overall Study|Withdrawal by Subject|0
1134916|NCT01481896|3727291|P1|Overall Study|Lost to Follow-up|12
1134917|NCT01481779|3727307|P2|Overall Study|Sponsor Decision|1
1134918|NCT01481779|3727308|P1|Overall Study|Sponsor Decision|3
1134919|NCT01481779|3727307|P2|Overall Study|Physician Decision|4
1134920|NCT01481779|3727308|P1|Overall Study|Physician Decision|13
1134921|NCT01481779|3727307|P2|Overall Study|Withdrawal by Subject|13
1134922|NCT01481779|3727308|P1|Overall Study|Withdrawal by Subject|26
1134923|NCT01481779|3727307|P2|Overall Study|Protocol Violation|3
1134924|NCT01481779|3727308|P1|Overall Study|Protocol Violation|2
1134925|NCT01481779|3727307|P2|Overall Study|Lost to Follow-up|2
1134926|NCT01481779|3727308|P1|Overall Study|Lost to Follow-up|3
1134927|NCT01481779|3727307|P2|Overall Study|Adverse Event|5
1134928|NCT01481779|3727308|P1|Overall Study|Adverse Event|23
1134929|NCT01481324|3727393|P3|Overall Study|Missing Data|2
1134930|NCT01481324|3727394|P2|Overall Study|Missing Data|2
1134931|NCT01481324|3727395|P1|Overall Study|Missing Data|0
1134932|NCT01481116|3727414|P3|Overall Study|Hypoglycemic Event|0
1134933|NCT01481116|3727415|P2|Overall Study|Hypoglycemic Event|0
1134934|NCT01481116|3727416|P1|Overall Study|Hypoglycemic Event|4
1134935|NCT01481116|3727414|P3|Overall Study|Death|0
1134936|NCT01481116|3727415|P2|Overall Study|Death|1
1134937|NCT01481116|3727416|P1|Overall Study|Death|2
1134938|NCT01481116|3727414|P3|Overall Study|Investigator's Discretion|0
1134939|NCT01481116|3727415|P2|Overall Study|Investigator's Discretion|0
1134940|NCT01481116|3727416|P1|Overall Study|Investigator's Discretion|2
1134941|NCT01481116|3727414|P3|Overall Study|Non-Compliant With Study Drug|1
1134942|NCT01481116|3727415|P2|Overall Study|Non-Compliant With Study Drug|1
1134943|NCT01481116|3727416|P1|Overall Study|Non-Compliant With Study Drug|0
1134944|NCT01481116|3727414|P3|Overall Study|Sponsor Decision|3
1134945|NCT01481116|3727415|P2|Overall Study|Sponsor Decision|1
1134946|NCT01481116|3727416|P1|Overall Study|Sponsor Decision|0
1134947|NCT01481116|3727414|P3|Overall Study|Investigator Decision|1
1134948|NCT01481116|3727415|P2|Overall Study|Investigator Decision|2
1134949|NCT01481116|3727416|P1|Overall Study|Investigator Decision|3
1134950|NCT01481116|3727414|P3|Overall Study|Participant Moved Out of Country|1
1134951|NCT01481116|3727415|P2|Overall Study|Participant Moved Out of Country|0
1134952|NCT01481116|3727416|P1|Overall Study|Participant Moved Out of Country|1
1134953|NCT01481116|3727414|P3|Overall Study|Participant Moved Out of Area|1
1134954|NCT01481116|3727415|P2|Overall Study|Participant Moved Out of Area|0
1134955|NCT01481116|3727416|P1|Overall Study|Participant Moved Out of Area|2
1134956|NCT01481116|3727414|P3|Overall Study|Participant Started Taking Glipizide|0
1134957|NCT01481116|3727415|P2|Overall Study|Participant Started Taking Glipizide|0
1134958|NCT01481116|3727416|P1|Overall Study|Participant Started Taking Glipizide|1
1134959|NCT01481116|3727414|P3|Overall Study|Other|0
1134960|NCT01481116|3727415|P2|Overall Study|Other|1
1134961|NCT01481116|3727416|P1|Overall Study|Other|1
1134962|NCT01481116|3727414|P3|Overall Study|Contraindications|0
1134963|NCT01481116|3727415|P2|Overall Study|Contraindications|1
1134964|NCT01481116|3727416|P1|Overall Study|Contraindications|1
1134965|NCT01481116|3727414|P3|Overall Study|Lack of Efficacy|1
1134966|NCT01481116|3727415|P2|Overall Study|Lack of Efficacy|3
1134967|NCT01481116|3727416|P1|Overall Study|Lack of Efficacy|3
1134968|NCT01481116|3727414|P3|Overall Study|Pregnancy|1
1134969|NCT01481116|3727415|P2|Overall Study|Pregnancy|0
1134970|NCT01481116|3727416|P1|Overall Study|Pregnancy|0
1134971|NCT01481116|3727414|P3|Overall Study|Study Termination|713
1134972|NCT01481116|3727415|P2|Overall Study|Study Termination|729
1134973|NCT01481116|3727416|P1|Overall Study|Study Termination|730
1134974|NCT01481116|3727414|P3|Overall Study|Withdrawal by Subject|37
1134975|NCT01481116|3727415|P2|Overall Study|Withdrawal by Subject|33
1134976|NCT01481116|3727416|P1|Overall Study|Withdrawal by Subject|37
1134977|NCT01481116|3727414|P3|Overall Study|Lost to Follow-up|11
1134978|NCT01481116|3727415|P2|Overall Study|Lost to Follow-up|12
1134979|NCT01481116|3727416|P1|Overall Study|Lost to Follow-up|8
1134980|NCT01481116|3727414|P3|Overall Study|Major Protocol Deviation|1
1134981|NCT01481116|3727415|P2|Overall Study|Major Protocol Deviation|7
1134982|NCT01481116|3727416|P1|Overall Study|Major Protocol Deviation|3
1134983|NCT01481116|3727414|P3|Overall Study|Adverse Event|42
1134984|NCT01481116|3727415|P2|Overall Study|Adverse Event|26
1134985|NCT01481116|3727416|P1|Overall Study|Adverse Event|26
1134986|NCT01480674|3727447|P1|Overall Study|visit not done|10
1134987|NCT01480674|3727447|P1|Overall Study|Lost to Follow-up|2
1134988|NCT01480674|3727447|P1|Overall Study|Death|23
1134989|NCT01480596|3727461|P2|Overall Study|MG exacerbation or change in medication|2
1134990|NCT01480596|3727462|P1|Overall Study|MG exacerbation or change in medication|2
1134991|NCT01480596|3727461|P2|Overall Study|Adverse Event|0
1134992|NCT01480596|3727462|P1|Overall Study|Adverse Event|3
1134993|NCT01480284|3727510|P2|Overall Study|Physician Decision|0
1134994|NCT01480284|3727511|P1|Overall Study|Physician Decision|1
1134995|NCT01480284|3727510|P2|Overall Study|Lost to Follow-up|0
1134996|NCT01480284|3727511|P1|Overall Study|Lost to Follow-up|1
1134997|NCT01480284|3727510|P2|Overall Study|Study closed/terminated|0
1134998|NCT01480284|3727511|P1|Overall Study|Study closed/terminated|3
1134999|NCT01480284|3727510|P2|Overall Study|Adverse Event|0
1135000|NCT01480284|3727511|P1|Overall Study|Adverse Event|1
1135001|NCT01480284|3727510|P2|Overall Study|Withdrawal by Subject|0
1135002|NCT01480284|3727511|P1|Overall Study|Withdrawal by Subject|2
1135003|NCT01480076|3727594|P1|Overall Study|Not Specified|52
1135004|NCT01480076|3727594|P1|Overall Study|Investigator Decision|13
1135005|NCT01480076|3727594|P1|Overall Study|Lost to Follow-up|7
1135006|NCT01480076|3727594|P1|Overall Study|Withdrawal by Subject|105
1135007|NCT01480076|3727594|P1|Overall Study|Non-compliance With Study Protocol|15
1135008|NCT01480076|3727594|P1|Overall Study|Disease Progression|5
1135009|NCT01480076|3727594|P1|Overall Study|Death|2
1135010|NCT01480076|3727594|P1|Overall Study|Adverse Event|39
1135011|NCT01480076|3727594|P1|Overall Study|Run-in Failure|52
1135012|NCT01479868|3727724|P1|Overall Study|Initiation of new HCV Therapy|1
1135013|NCT01479868|3727724|P1|Overall Study|Sponsor's Decision|1
1135014|NCT01479868|3727724|P1|Overall Study|Withdrawal by Subject|1
1135015|NCT01479868|3727724|P1|Overall Study|Protocol Violation|1
1135016|NCT01479868|3727724|P1|Overall Study|Lost to Follow-up|4
1135017|NCT01479868|3727724|P1|Overall Study|Adverse Event|1
1135018|NCT01479777|3727739|P1|Overall Study|Physician Decision|2
1135019|NCT01479764|3727751|P2|Treated|Lost to Follow-up|2
1135020|NCT01479764|3727752|P1|Treated|Lost to Follow-up|0
1135021|NCT01479764|3727751|P2|Randomized|Withdrawal by Subject|0
1135022|NCT01479764|3727752|P1|Randomized|Withdrawal by Subject|1
1135023|NCT01479764|3727751|P2|Randomized|Adverse Event|1
1135024|NCT01479764|3727752|P1|Randomized|Adverse Event|1
1135025|NCT01479621|3727775|P7|Treatment Period|Met stopping criteria|6
1135026|NCT01479621|3727776|P6|Treatment Period|Met stopping criteria|20
1135027|NCT01479621|3727777|P5|Treatment Period|Met stopping criteria|9
1135028|NCT01479621|3727778|P4|Treatment Period|Met stopping criteria|4
1135029|NCT01479621|3727779|P3|Treatment Period|Met stopping criteria|7
1135030|NCT01479621|3727780|P2|Treatment Period|Met stopping criteria|8
1135031|NCT01479621|3727781|P1|Treatment Period|Met stopping criteria|0
1135032|NCT01479621|3727775|P7|Treatment Period|Lost to Follow-up|1
1135033|NCT01479621|3727776|P6|Treatment Period|Lost to Follow-up|2
1135034|NCT01479621|3727777|P5|Treatment Period|Lost to Follow-up|2
1135035|NCT01479621|3727778|P4|Treatment Period|Lost to Follow-up|0
1135036|NCT01479621|3727779|P3|Treatment Period|Lost to Follow-up|1
1135037|NCT01479621|3727780|P2|Treatment Period|Lost to Follow-up|0
1135038|NCT01479621|3727781|P1|Treatment Period|Lost to Follow-up|0
1135039|NCT01479621|3727775|P7|Treatment Period|Sponsor request subject to be withdrawn|3
1135040|NCT01479621|3727776|P6|Treatment Period|Sponsor request subject to be withdrawn|1
1135041|NCT01479621|3727777|P5|Treatment Period|Sponsor request subject to be withdrawn|1
1135042|NCT01479621|3727778|P4|Treatment Period|Sponsor request subject to be withdrawn|1
1135043|NCT01479621|3727779|P3|Treatment Period|Sponsor request subject to be withdrawn|3
1135044|NCT01479621|3727780|P2|Treatment Period|Sponsor request subject to be withdrawn|2
1135045|NCT01479621|3727781|P1|Treatment Period|Sponsor request subject to be withdrawn|0
1135046|NCT01479621|3727775|P7|Treatment Period|Pregnancy|0
1135047|NCT01479621|3727776|P6|Treatment Period|Pregnancy|0
1135048|NCT01479621|3727777|P5|Treatment Period|Pregnancy|0
1135049|NCT01479621|3727778|P4|Treatment Period|Pregnancy|0
1135050|NCT01479621|3727779|P3|Treatment Period|Pregnancy|2
1135051|NCT01479621|3727780|P2|Treatment Period|Pregnancy|0
1135052|NCT01479621|3727781|P1|Treatment Period|Pregnancy|0
1135053|NCT01479621|3727775|P7|Treatment Period|Protocol Violation|6
1135054|NCT01479621|3727776|P6|Treatment Period|Protocol Violation|10
1135055|NCT01479621|3727777|P5|Treatment Period|Protocol Violation|2
1135056|NCT01479621|3727778|P4|Treatment Period|Protocol Violation|5
1135057|NCT01479621|3727779|P3|Treatment Period|Protocol Violation|6
1135058|NCT01479621|3727780|P2|Treatment Period|Protocol Violation|9
1135059|NCT01479621|3727781|P1|Treatment Period|Protocol Violation|0
1135060|NCT01479621|3727775|P7|Treatment Period|Non-compliance to study drug|1
1135061|NCT01479621|3727776|P6|Treatment Period|Non-compliance to study drug|0
1135062|NCT01479621|3727777|P5|Treatment Period|Non-compliance to study drug|0
1135063|NCT01479621|3727778|P4|Treatment Period|Non-compliance to study drug|0
1135064|NCT01479621|3727779|P3|Treatment Period|Non-compliance to study drug|0
1135065|NCT01479621|3727780|P2|Treatment Period|Non-compliance to study drug|1
1135066|NCT01479621|3727781|P1|Treatment Period|Non-compliance to study drug|0
1135067|NCT01479621|3727775|P7|Treatment Period|Physician Decision|0
1135068|NCT01479621|3727776|P6|Treatment Period|Physician Decision|1
1135069|NCT01479621|3727777|P5|Treatment Period|Physician Decision|1
1135070|NCT01479621|3727778|P4|Treatment Period|Physician Decision|0
1135071|NCT01479621|3727779|P3|Treatment Period|Physician Decision|0
1135072|NCT01479621|3727780|P2|Treatment Period|Physician Decision|0
1135073|NCT01479621|3727781|P1|Treatment Period|Physician Decision|0
1135074|NCT01479621|3727775|P7|Treatment Period|Withdrawal by Subject|1
1135075|NCT01479621|3727776|P6|Treatment Period|Withdrawal by Subject|5
1135076|NCT01479621|3727777|P5|Treatment Period|Withdrawal by Subject|5
1135077|NCT01479621|3727778|P4|Treatment Period|Withdrawal by Subject|2
1135078|NCT01479621|3727779|P3|Treatment Period|Withdrawal by Subject|2
1135079|NCT01479621|3727780|P2|Treatment Period|Withdrawal by Subject|4
1135080|NCT01479621|3727781|P1|Treatment Period|Withdrawal by Subject|0
1135081|NCT01479621|3727775|P7|Treatment Period|Adverse Event|2
1135082|NCT01479621|3727776|P6|Treatment Period|Adverse Event|2
1135083|NCT01479621|3727777|P5|Treatment Period|Adverse Event|1
1135084|NCT01479621|3727778|P4|Treatment Period|Adverse Event|0
1135085|NCT01479621|3727779|P3|Treatment Period|Adverse Event|0
1135086|NCT01479621|3727780|P2|Treatment Period|Adverse Event|0
1135087|NCT01479621|3727781|P1|Treatment Period|Adverse Event|0
1135088|NCT01479621|3727775|P7|Pre-Assignment Period (Run-In Placebo)|Not specified|0
1135089|NCT01479621|3727776|P6|Pre-Assignment Period (Run-In Placebo)|Not specified|0
1135090|NCT01479621|3727777|P5|Pre-Assignment Period (Run-In Placebo)|Not specified|0
1135091|NCT01479621|3727778|P4|Pre-Assignment Period (Run-In Placebo)|Not specified|0
1135092|NCT01479621|3727779|P3|Pre-Assignment Period (Run-In Placebo)|Not specified|0
1135093|NCT01479621|3727780|P2|Pre-Assignment Period (Run-In Placebo)|Not specified|0
1135094|NCT01479621|3727781|P1|Pre-Assignment Period (Run-In Placebo)|Not specified|15
1135095|NCT01479621|3727775|P7|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1135096|NCT01479621|3727776|P6|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1135097|NCT01479621|3727777|P5|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1135098|NCT01479621|3727778|P4|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1135099|NCT01479621|3727779|P3|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1135100|NCT01479621|3727780|P2|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1135101|NCT01479621|3727781|P1|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7
1135102|NCT01479621|3727775|P7|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1135103|NCT01479621|3727776|P6|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1135104|NCT01479621|3727777|P5|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1135105|NCT01479621|3727778|P4|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1135106|NCT01479621|3727779|P3|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1135107|NCT01479621|3727780|P2|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1135108|NCT01479621|3727781|P1|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153
1135109|NCT01479621|3727775|P7|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1135110|NCT01479621|3727776|P6|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1135111|NCT01479621|3727777|P5|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1135112|NCT01479621|3727778|P4|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1135113|NCT01479621|3727779|P3|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1135114|NCT01479621|3727780|P2|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1135115|NCT01479621|3727781|P1|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19
1135116|NCT01479621|3727775|P7|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1135117|NCT01479621|3727776|P6|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1135118|NCT01479621|3727777|P5|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1135119|NCT01479621|3727778|P4|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1135120|NCT01479621|3727779|P3|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1135121|NCT01479621|3727780|P2|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1135122|NCT01479621|3727781|P1|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93
1135123|NCT01479595|3727869|P2|Overall Study|Adverse Event|1
1135124|NCT01479595|3727870|P1|Overall Study|Adverse Event|2
1135125|NCT01479595|3727869|P2|Overall Study|Protocol deviation|1
1135126|NCT01479595|3727870|P1|Overall Study|Protocol deviation|0
1135127|NCT01479530|3727915|P2|Overall Study|Withdrawal of Consent|2
1135128|NCT01479530|3727916|P1|Overall Study|Withdrawal of Consent|3
1135129|NCT01479530|3727915|P2|Overall Study|Protocol Violation|3
1135130|NCT01479530|3727916|P1|Overall Study|Protocol Violation|2
1135131|NCT01479530|3727915|P2|Overall Study|Lack of Efficacy|1
1135132|NCT01479530|3727916|P1|Overall Study|Lack of Efficacy|0
1135133|NCT01479530|3727915|P2|Overall Study|Adverse Event|6
1135134|NCT01479530|3727916|P1|Overall Study|Adverse Event|5
1135135|NCT01479374|3727996|P3|Overall Study|Other|5
1135136|NCT01479374|3727997|P2|Overall Study|Other|4
1135137|NCT01479374|3727998|P1|Overall Study|Other|0
1135138|NCT01479374|3727996|P3|Overall Study|Decision Unrelated to Adverse Event|0
1135139|NCT01479374|3727997|P2|Overall Study|Decision Unrelated to Adverse Event|1
1135140|NCT01479374|3727998|P1|Overall Study|Decision Unrelated to Adverse Event|0
1135141|NCT01479374|3727996|P3|Overall Study|Lost to Follow-up|0
1135142|NCT01479374|3727997|P2|Overall Study|Lost to Follow-up|2
1135143|NCT01479374|3727998|P1|Overall Study|Lost to Follow-up|1
1135144|NCT01479374|3727996|P3|Overall Study|Adverse Event|0
1135145|NCT01479374|3727997|P2|Overall Study|Adverse Event|1
1135146|NCT01479374|3727998|P1|Overall Study|Adverse Event|2
1135147|NCT01478971|3728084|P1|Peginesatide Treatment Period|Other|4
1135148|NCT01478971|3728084|P1|Peginesatide Treatment Period|Lost to Follow-up|4
1135149|NCT01478971|3728084|P1|Peginesatide Treatment Period|Death|4
1135150|NCT01478971|3728084|P1|Peginesatide Treatment Period|Withdrawal by Subject|1
1135151|NCT01478971|3728084|P1|Peginesatide Treatment Period|Adverse Event|1
1135152|NCT01478971|3728084|P1|Standard of Care Period|Other|4
1135153|NCT01478971|3728084|P1|Standard of Care Period|Lost to Follow-up|9
1135154|NCT01478971|3728084|P1|Standard of Care Period|Death|8
1135155|NCT01478971|3728084|P1|Standard of Care Period|Withdrawal by Subject|3
1135156|NCT01478971|3728084|P1|Standard of Care Period|Adverse Event|1
1135157|NCT01478958|3728101|P3|Overall Study|Unable to comply|2
1135158|NCT01478958|3728102|P2|Overall Study|Unable to comply|0
1135159|NCT01478958|3728103|P1|Overall Study|Unable to comply|0
1135160|NCT01478958|3728101|P3|Overall Study|Re-located|0
1135161|NCT01478958|3728102|P2|Overall Study|Re-located|1
1135162|NCT01478958|3728103|P1|Overall Study|Re-located|0
1135163|NCT01478958|3728101|P3|Overall Study|Weight loss|0
1135164|NCT01478958|3728102|P2|Overall Study|Weight loss|0
1135165|NCT01478958|3728103|P1|Overall Study|Weight loss|1
1135166|NCT01478958|3728101|P3|Overall Study|Withdrawal by Subject|1
1135167|NCT01478958|3728102|P2|Overall Study|Withdrawal by Subject|1
1135168|NCT01478958|3728103|P1|Overall Study|Withdrawal by Subject|1
1135169|NCT01478828|3728111|P1|Overall Study|Adverse Event|1
1135170|NCT01478620|3728116|P1|Overall Study|Lost to Follow-up|6
1135171|NCT01478594|3728122|P2|Overall Study|Study Closed by Sponsor|5
1135172|NCT01478594|3728123|P1|Overall Study|Study Closed by Sponsor|8
1135173|NCT01478594|3728122|P2|Overall Study|Withdrawal by Subject|3
1135174|NCT01478594|3728123|P1|Overall Study|Withdrawal by Subject|9
1135175|NCT01478594|3728122|P2|Overall Study|Lost to Follow-up|1
1135176|NCT01478594|3728123|P1|Overall Study|Lost to Follow-up|3
1135177|NCT01478594|3728122|P2|Overall Study|Death|18
1135178|NCT01478594|3728123|P1|Overall Study|Death|45
1135179|NCT01478594|3728122|P2|Overall Study|Randomized but Never Received Study Drug|1
1135180|NCT01478594|3728123|P1|Overall Study|Randomized but Never Received Study Drug|0
1135181|NCT01478373|3728248|P1|Survival Phase|Progressive Disease|27
1135182|NCT01478373|3728248|P1|Survival Phase|crossover to another study|2
1135183|NCT01478373|3728248|P1|Survival Phase|Protocol Violation|1
1135184|NCT01478373|3728248|P1|Survival Phase|Adverse Event|8
1135185|NCT01478373|3728248|P1|Treatment Phase|Protocol Violation|1
1135186|NCT01478360|3728261|P2|Overall Study|Administrative problems|2
1135187|NCT01478360|3728262|P1|Overall Study|Administrative problems|1
1135188|NCT01478360|3728261|P2|Overall Study|Adverse Event|1
1135189|NCT01478360|3728262|P1|Overall Study|Adverse Event|0
1135190|NCT01478360|3728261|P2|Overall Study|Lost to Follow-up|0
1135191|NCT01478360|3728262|P1|Overall Study|Lost to Follow-up|1
1135192|NCT01478347|3728268|P1|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4
1135193|NCT01478347|3728268|P1|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4
1135194|NCT01478347|3728268|P1|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1
1135195|NCT01478113|3728286|P2|Overall Study|Physician Decision|0
1135196|NCT01478113|3728287|P1|Overall Study|Physician Decision|1
1135197|NCT01478113|3728286|P2|Overall Study|Withdrawal by Subject|1
1135198|NCT01478113|3728287|P1|Overall Study|Withdrawal by Subject|0
1135199|NCT01478087|3728305|P1|Overall Study|due to sponsor closing study|1
1135200|NCT01478048|3728312|P2|Overall Study|no longer meets study criteria|0
1135201|NCT01478048|3728313|P1|Overall Study|no longer meets study criteria|1
1135202|NCT01478048|3728312|P2|Overall Study|poor/non-compliance|1
1135203|NCT01478048|3728313|P1|Overall Study|poor/non-compliance|0
1135204|NCT01478048|3728312|P2|Overall Study|non-specified|4
1135205|NCT01478048|3728313|P1|Overall Study|non-specified|6
1135206|NCT01478048|3728312|P2|Overall Study|Withdrawal by Subject|5
1135207|NCT01478048|3728313|P1|Overall Study|Withdrawal by Subject|2
1135208|NCT01478048|3728312|P2|Overall Study|subject request to discontinue treatment|5
1135209|NCT01478048|3728313|P1|Overall Study|subject request to discontinue treatment|3
1135210|NCT01478048|3728312|P2|Overall Study|Adverse Event|11
1135211|NCT01478048|3728313|P1|Overall Study|Adverse Event|2
1135212|NCT01478048|3728312|P2|Overall Study|study drug toxicity|14
1135213|NCT01478048|3728313|P1|Overall Study|study drug toxicity|11
1135214|NCT01478048|3728312|P2|Overall Study|Disease Progression|35
1135215|NCT01478048|3728313|P1|Overall Study|Disease Progression|52
1135216|NCT01477892|3728342|P2|Overall Study|Withdrawal by Subject|2
1135217|NCT01477892|3728343|P1|Overall Study|Withdrawal by Subject|0
1135218|NCT01477853|3728354|P3|Phase B|Study terminated by sponsor|11
1135219|NCT01477853|3728355|P2|Phase B|Study terminated by sponsor|10
1135220|NCT01477853|3728356|P1|Phase B|Study terminated by sponsor|12
1135221|NCT01477853|3728354|P3|Phase B|Lost to Follow-up|0
1135222|NCT01477853|3728355|P2|Phase B|Lost to Follow-up|1
1135223|NCT01477853|3728356|P1|Phase B|Lost to Follow-up|0
1135224|NCT01477853|3728354|P3|Phase A|Study terminated by sponsor|39
1135225|NCT01477853|3728355|P2|Phase A|Study terminated by sponsor|40
1135226|NCT01477853|3728356|P1|Phase A|Study terminated by sponsor|37
1135227|NCT01477853|3728354|P3|Phase A|Physician Decision|1
1135228|NCT01477853|3728355|P2|Phase A|Physician Decision|0
1135229|NCT01477853|3728356|P1|Phase A|Physician Decision|1
1135230|NCT01477853|3728354|P3|Phase A|Lost to Follow-up|2
1135231|NCT01477853|3728355|P2|Phase A|Lost to Follow-up|3
1135232|NCT01477853|3728356|P1|Phase A|Lost to Follow-up|4
1135233|NCT01477853|3728354|P3|Phase A|Adverse Event|2
1135234|NCT01477853|3728355|P2|Phase A|Adverse Event|2
1135235|NCT01477853|3728356|P1|Phase A|Adverse Event|1
1135236|NCT01477749|3728423|P1|Overall Study|Physician Decision|4
1135237|NCT01477333|3728531|P1|Overall Study|Clinical Deterioration|1
1135238|NCT01477333|3728531|P1|Overall Study|Withdrawal by Subject|1
1135239|NCT01477333|3728531|P1|Overall Study|Adverse Event|1
1135240|NCT01476722|3728574|P1|Overall Study|Adverse Event|1
1135241|NCT01476696|3728581|P3|Overall Study|Withdrawal by Subject|0
1135242|NCT01476696|3728582|P2|Overall Study|Withdrawal by Subject|0
1135243|NCT01476696|3728583|P1|Overall Study|Withdrawal by Subject|1
1135244|NCT01476696|3728581|P3|Overall Study|Sponsor decision|0
1135245|NCT01476696|3728582|P2|Overall Study|Sponsor decision|1
1135246|NCT01476696|3728583|P1|Overall Study|Sponsor decision|2
1135247|NCT01476475|3728599|P2|Overall Study|Other reasons|2
1135248|NCT01476475|3728600|P1|Overall Study|Other reasons|4
1135249|NCT01476475|3728599|P2|Overall Study|Poor compliance to protocol|1
1135250|NCT01476475|3728600|P1|Overall Study|Poor compliance to protocol|1
1135251|NCT01476475|3728599|P2|Overall Study|Adverse Event|0
1135252|NCT01476475|3728600|P1|Overall Study|Adverse Event|6
1135253|NCT01475851|3729029|P2|Overall Study|Protocol defined stopping criteria|0
1135254|NCT01475851|3729030|P1|Overall Study|Protocol defined stopping criteria|1
1135255|NCT01475838|3729058|P2|Extension Phase|Participant Noncompliance|0
1135256|NCT01475838|3729059|P1|Extension Phase|Participant Noncompliance|1
1135257|NCT01475838|3729058|P2|Randomized Phase|Protocol Violation|4
1135258|NCT01475838|3729059|P1|Randomized Phase|Protocol Violation|9
1135259|NCT01475838|3729058|P2|Randomized Phase|Participant Noncompliance|5
1135260|NCT01475838|3729059|P1|Randomized Phase|Participant Noncompliance|1
1135261|NCT01475838|3729058|P2|Randomized Phase|Lost to Follow-up|4
1135262|NCT01475838|3729059|P1|Randomized Phase|Lost to Follow-up|3
1135263|NCT01475838|3729058|P2|Randomized Phase|Withdrew Consent|14
1135264|NCT01475838|3729059|P1|Randomized Phase|Withdrew Consent|10
1135265|NCT01475838|3729058|P2|Randomized Phase|Investigators Discretion|2
1135266|NCT01475838|3729059|P1|Randomized Phase|Investigators Discretion|1
1135267|NCT01475838|3729058|P2|Randomized Phase|Pregnancy|1
1135268|NCT01475838|3729059|P1|Randomized Phase|Pregnancy|0
1135269|NCT01475838|3729058|P2|Randomized Phase|Adverse Event|1
1135270|NCT01475838|3729059|P1|Randomized Phase|Adverse Event|6
1135271|NCT01475838|3729058|P2|Randomized Phase|Randomized but Not Treated|5
1135272|NCT01475838|3729059|P1|Randomized Phase|Randomized but Not Treated|0
1135273|NCT01475734|3729074|P2|Overall Study|Physician Decision|1
1135274|NCT01475734|3729075|P1|Overall Study|Physician Decision|0
1135275|NCT01475734|3729074|P2|Overall Study|Protocol Violation|0
1135276|NCT01475734|3729075|P1|Overall Study|Protocol Violation|1
1135277|NCT01475734|3729074|P2|Overall Study|Withdrawal by Subject|0
1135278|NCT01475734|3729075|P1|Overall Study|Withdrawal by Subject|1
1135279|NCT01475721|3729103|P2|Overall Study|Withdrawal by Subject|8
1135280|NCT01475721|3729104|P1|Overall Study|Withdrawal by Subject|8
1135281|NCT01475721|3729103|P2|Overall Study|Death|6
1135282|NCT01475721|3729104|P1|Overall Study|Death|3
1135283|NCT01475487|3729159|P2|Overall Study|had to leave early for personal reasons|1
1135284|NCT01475487|3729160|P1|Overall Study|had to leave early for personal reasons|2
1135285|NCT01475474|3729172|P1|Baseline Period - 4 Weeks|Withdrawal by Subject|2
1135286|NCT01475474|3729172|P1|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4
1135287|NCT01475461|3729183|P7|Treatment Period|Adverse Event|0
1135288|NCT01475461|3729184|P6|Treatment Period|Adverse Event|0
1135289|NCT01475461|3729185|P5|Treatment Period|Adverse Event|0
1135290|NCT01475461|3729186|P4|Treatment Period|Adverse Event|1
1135291|NCT01475461|3729187|P3|Treatment Period|Adverse Event|0
1135292|NCT01475461|3729188|P2|Treatment Period|Adverse Event|0
1135293|NCT01475461|3729189|P1|Treatment Period|Adverse Event|0
1135294|NCT01475461|3729183|P7|Treatment Period|Medication Error|0
1135295|NCT01475461|3729184|P6|Treatment Period|Medication Error|0
1135296|NCT01475461|3729185|P5|Treatment Period|Medication Error|0
1135297|NCT01475461|3729186|P4|Treatment Period|Medication Error|1
1135298|NCT01475461|3729187|P3|Treatment Period|Medication Error|0
1135299|NCT01475461|3729188|P2|Treatment Period|Medication Error|0
1135300|NCT01475461|3729189|P1|Treatment Period|Medication Error|0
1135301|NCT01475461|3729183|P7|Treatment Period|Lack of Efficacy|0
1135302|NCT01475461|3729184|P6|Treatment Period|Lack of Efficacy|1
1135303|NCT01475461|3729185|P5|Treatment Period|Lack of Efficacy|1
1135304|NCT01475461|3729186|P4|Treatment Period|Lack of Efficacy|2
1135305|NCT01475461|3729187|P3|Treatment Period|Lack of Efficacy|0
1135306|NCT01475461|3729188|P2|Treatment Period|Lack of Efficacy|2
1135307|NCT01475461|3729189|P1|Treatment Period|Lack of Efficacy|0
1135308|NCT01475461|3729183|P7|Treatment Period|Protocol Violation|1
1135309|NCT01475461|3729184|P6|Treatment Period|Protocol Violation|0
1135310|NCT01475461|3729185|P5|Treatment Period|Protocol Violation|0
1135311|NCT01475461|3729186|P4|Treatment Period|Protocol Violation|0
1135312|NCT01475461|3729187|P3|Treatment Period|Protocol Violation|0
1135313|NCT01475461|3729188|P2|Treatment Period|Protocol Violation|1
1135314|NCT01475461|3729189|P1|Treatment Period|Protocol Violation|0
1135315|NCT01475461|3729183|P7|Treatment Period|Other|0
1135316|NCT01475461|3729184|P6|Treatment Period|Other|0
1135317|NCT01475461|3729185|P5|Treatment Period|Other|0
1135318|NCT01475461|3729186|P4|Treatment Period|Other|0
1135319|NCT01475461|3729187|P3|Treatment Period|Other|0
1135320|NCT01475461|3729188|P2|Treatment Period|Other|1
1135321|NCT01475461|3729189|P1|Treatment Period|Other|0
1135322|NCT01475461|3729183|P7|Treatment Period|Withdrawal by Subject|0
1135323|NCT01475461|3729184|P6|Treatment Period|Withdrawal by Subject|2
1135324|NCT01475461|3729185|P5|Treatment Period|Withdrawal by Subject|2
1135325|NCT01475461|3729186|P4|Treatment Period|Withdrawal by Subject|0
1135326|NCT01475461|3729187|P3|Treatment Period|Withdrawal by Subject|2
1135327|NCT01475461|3729188|P2|Treatment Period|Withdrawal by Subject|2
1135328|NCT01475461|3729189|P1|Treatment Period|Withdrawal by Subject|0
1135329|NCT01475461|3729183|P7|Treatment Period|Lost to Follow-up|1
1135330|NCT01475461|3729184|P6|Treatment Period|Lost to Follow-up|2
1135331|NCT01475461|3729185|P5|Treatment Period|Lost to Follow-up|1
1135332|NCT01475461|3729186|P4|Treatment Period|Lost to Follow-up|3
1135333|NCT01475461|3729187|P3|Treatment Period|Lost to Follow-up|2
1135334|NCT01475461|3729188|P2|Treatment Period|Lost to Follow-up|3
1135335|NCT01475461|3729189|P1|Treatment Period|Lost to Follow-up|0
1135336|NCT01475461|3729183|P7|Treatment Period|Death|0
1135337|NCT01475461|3729184|P6|Treatment Period|Death|0
1135338|NCT01475461|3729185|P5|Treatment Period|Death|0
1135339|NCT01475461|3729186|P4|Treatment Period|Death|1
1135340|NCT01475461|3729187|P3|Treatment Period|Death|0
1135341|NCT01475461|3729188|P2|Treatment Period|Death|0
1135342|NCT01475461|3729189|P1|Treatment Period|Death|0
1135343|NCT01475461|3729183|P7|Run-in Period|Protocol Violation|0
1135344|NCT01475461|3729184|P6|Run-in Period|Protocol Violation|0
1135345|NCT01475461|3729185|P5|Run-in Period|Protocol Violation|0
1135346|NCT01475461|3729186|P4|Run-in Period|Protocol Violation|0
1135347|NCT01475461|3729187|P3|Run-in Period|Protocol Violation|0
1135348|NCT01475461|3729188|P2|Run-in Period|Protocol Violation|0
1135349|NCT01475461|3729189|P1|Run-in Period|Protocol Violation|4
1135350|NCT01475461|3729183|P7|Run-in Period|Other|0
1135351|NCT01475461|3729184|P6|Run-in Period|Other|0
1135352|NCT01475461|3729185|P5|Run-in Period|Other|0
1135353|NCT01475461|3729186|P4|Run-in Period|Other|0
1135354|NCT01475461|3729187|P3|Run-in Period|Other|0
1135355|NCT01475461|3729188|P2|Run-in Period|Other|0
1135356|NCT01475461|3729189|P1|Run-in Period|Other|3
1135357|NCT01475461|3729183|P7|Run-in Period|Withdrawal by Subject|0
1135358|NCT01475461|3729184|P6|Run-in Period|Withdrawal by Subject|0
1135359|NCT01475461|3729185|P5|Run-in Period|Withdrawal by Subject|0
1135360|NCT01475461|3729186|P4|Run-in Period|Withdrawal by Subject|0
1135361|NCT01475461|3729187|P3|Run-in Period|Withdrawal by Subject|0
1135362|NCT01475461|3729188|P2|Run-in Period|Withdrawal by Subject|0
1135363|NCT01475461|3729189|P1|Run-in Period|Withdrawal by Subject|11
1135364|NCT01475461|3729183|P7|Run-in Period|Lost to Follow-up|0
1135365|NCT01475461|3729184|P6|Run-in Period|Lost to Follow-up|0
1135366|NCT01475461|3729185|P5|Run-in Period|Lost to Follow-up|0
1135367|NCT01475461|3729186|P4|Run-in Period|Lost to Follow-up|0
1135368|NCT01475461|3729187|P3|Run-in Period|Lost to Follow-up|0
1135369|NCT01475461|3729188|P2|Run-in Period|Lost to Follow-up|0
1135370|NCT01475461|3729189|P1|Run-in Period|Lost to Follow-up|7
1135371|NCT01475461|3729183|P7|Run-in Period|Not meet eligibility criteria|0
1135372|NCT01475461|3729184|P6|Run-in Period|Not meet eligibility criteria|0
1135373|NCT01475461|3729185|P5|Run-in Period|Not meet eligibility criteria|0
1135374|NCT01475461|3729186|P4|Run-in Period|Not meet eligibility criteria|0
1135375|NCT01475461|3729187|P3|Run-in Period|Not meet eligibility criteria|0
1135376|NCT01475461|3729188|P2|Run-in Period|Not meet eligibility criteria|0
1135377|NCT01475461|3729189|P1|Run-in Period|Not meet eligibility criteria|16
1135378|NCT01475331|3729269|P2|Overall Study|cyst found to be prohibitively small|1
1135379|NCT01475331|3729270|P1|Overall Study|cyst found to be prohibitively small|0
1135380|NCT01475331|3729269|P2|Overall Study|Sign of malignancy during the procedure|0
1135381|NCT01475331|3729270|P1|Overall Study|Sign of malignancy during the procedure|2
1135382|NCT01475331|3729269|P2|Overall Study|Loss of needle positioning due pt. cough|0
1135383|NCT01475331|3729270|P1|Overall Study|Loss of needle positioning due pt. cough|1
1135384|NCT01475331|3729269|P2|Overall Study|excessive main duct communication|1
1135385|NCT01475331|3729270|P1|Overall Study|excessive main duct communication|1
1135386|NCT01475331|3729269|P2|Overall Study|Osteophyte obstruction of the proximal|0
1135387|NCT01475331|3729270|P1|Overall Study|Osteophyte obstruction of the proximal|1
1135388|NCT01475253|3729322|P4|Randomized, Blinded Study|Lost to Follow-up|0
1135389|NCT01475253|3729323|P3|Randomized, Blinded Study|Lost to Follow-up|0
1135390|NCT01475253|3729324|P2|Randomized, Blinded Study|Lost to Follow-up|0
1135391|NCT01475253|3729325|P1|Randomized, Blinded Study|Lost to Follow-up|1
1135392|NCT01475253|3729322|P4|Randomized, Blinded Study|Withdrawal by Subject|0
1135393|NCT01475253|3729323|P3|Randomized, Blinded Study|Withdrawal by Subject|0
1135394|NCT01475253|3729324|P2|Randomized, Blinded Study|Withdrawal by Subject|1
1135395|NCT01475253|3729325|P1|Randomized, Blinded Study|Withdrawal by Subject|1
1135396|NCT01475214|3729354|P3|Overall Study|Withdrawal by Subject|1
1135397|NCT01475214|3729355|P2|Overall Study|Withdrawal by Subject|4
1135398|NCT01475214|3729356|P1|Overall Study|Withdrawal by Subject|2
1135399|NCT01475214|3729354|P3|Overall Study|Physician Decision|0
1135400|NCT01475214|3729355|P2|Overall Study|Physician Decision|0
1135401|NCT01475214|3729356|P1|Overall Study|Physician Decision|2
1135402|NCT01475214|3729354|P3|Overall Study|Lost to Follow-up|1
1135403|NCT01475214|3729355|P2|Overall Study|Lost to Follow-up|0
1135404|NCT01475214|3729356|P1|Overall Study|Lost to Follow-up|1
1135405|NCT01475097|3729381|P2|Overall Study|Protocol Violation|1
1135406|NCT01475097|3729382|P1|Overall Study|Protocol Violation|1
1135407|NCT01475071|3729390|P1|Overall Study|Lost to Follow-up|1
1135408|NCT01475071|3729390|P1|Overall Study|Withdrawal by Subject|6
1135409|NCT01475071|3729390|P1|Overall Study|Physician Decision|1
1135410|NCT01474993|3729400|P2|Overall Study|Adverse Event|1
1135411|NCT01474993|3729401|P1|Overall Study|Adverse Event|0
1135412|NCT01474993|3729400|P2|Overall Study|Lost to Follow-up|2
1135413|NCT01474993|3729401|P1|Overall Study|Lost to Follow-up|1
1135414|NCT01474876|3729443|P3|Overall Study|Investigator's decision and pt request|0
1135415|NCT01474876|3729444|P2|Overall Study|Investigator's decision and pt request|0
1135416|NCT01474876|3729445|P1|Overall Study|Investigator's decision and pt request|1
1135417|NCT01474876|3729443|P3|Overall Study|Patient's request|0
1135418|NCT01474876|3729444|P2|Overall Study|Patient's request|5
1135419|NCT01474876|3729445|P1|Overall Study|Patient's request|19
1135420|NCT01474876|3729443|P3|Overall Study|Investigator's decision|0
1135421|NCT01474876|3729444|P2|Overall Study|Investigator's decision|6
1135422|NCT01474876|3729445|P1|Overall Study|Investigator's decision|28
1135423|NCT01474876|3729443|P3|Overall Study|Lost to Follow-up|0
1135424|NCT01474876|3729444|P2|Overall Study|Lost to Follow-up|4
1135425|NCT01474876|3729445|P1|Overall Study|Lost to Follow-up|5
1135426|NCT01474876|3729443|P3|Overall Study|Serious Adverse Event|0
1135427|NCT01474876|3729444|P2|Overall Study|Serious Adverse Event|3
1135428|NCT01474876|3729445|P1|Overall Study|Serious Adverse Event|2
1135429|NCT01474876|3729443|P3|Overall Study|Adverse Event|0
1135430|NCT01474876|3729444|P2|Overall Study|Adverse Event|5
1135431|NCT01474876|3729445|P1|Overall Study|Adverse Event|11
1135432|NCT01474772|3729491|P2|Follow-up|AE not Related to Study Drug|1
1135433|NCT01474772|3729492|P1|Follow-up|AE not Related to Study Drug|0
1135434|NCT01474772|3729491|P2|Period 2|Reason not Specified|2
1135435|NCT01474772|3729492|P1|Period 2|Reason not Specified|0
1135436|NCT01474772|3729491|P2|Period 2|Lost to Follow-up|1
1135437|NCT01474772|3729492|P1|Period 2|Lost to Follow-up|1
1135438|NCT01474772|3729491|P2|Period 2|Withdrawal by Subject|4
1135439|NCT01474772|3729492|P1|Period 2|Withdrawal by Subject|3
1135440|NCT01474772|3729491|P2|Period 2|Lack of Efficacy|0
1135441|NCT01474772|3729492|P1|Period 2|Lack of Efficacy|1
1135442|NCT01474772|3729491|P2|Period 2|AE not Related to Study Drug|1
1135443|NCT01474772|3729492|P1|Period 2|AE not Related to Study Drug|4
1135444|NCT01474772|3729491|P2|Period 2|AE Related to Study Drug|1
1135445|NCT01474772|3729492|P1|Period 2|AE Related to Study Drug|0
1135446|NCT01474772|3729491|P2|Period 2|Death|1
1135447|NCT01474772|3729492|P1|Period 2|Death|0
1135448|NCT01474772|3729491|P2|Washout|Reason not Specified|1
1135449|NCT01474772|3729492|P1|Washout|Reason not Specified|0
1135450|NCT01474772|3729491|P2|Washout|Lost to Follow-up|1
1135451|NCT01474772|3729492|P1|Washout|Lost to Follow-up|0
1135452|NCT01474772|3729491|P2|Washout|Withdrawal by Subject|0
1135453|NCT01474772|3729492|P1|Washout|Withdrawal by Subject|1
1135454|NCT01474772|3729491|P2|Washout|AE not Related to Study Drug|0
1135455|NCT01474772|3729492|P1|Washout|AE not Related to Study Drug|2
1135456|NCT01474772|3729491|P2|Period 1|Reason not Specified|1
1135457|NCT01474772|3729492|P1|Period 1|Reason not Specified|1
1135458|NCT01474772|3729491|P2|Period 1|Lost to Follow-up|0
1135459|NCT01474772|3729492|P1|Period 1|Lost to Follow-up|1
1135460|NCT01474772|3729491|P2|Period 1|Withdrawal by Subject|1
1135461|NCT01474772|3729492|P1|Period 1|Withdrawal by Subject|3
1135462|NCT01474772|3729491|P2|Period 1|AE not Related to Study Drug|0
1135463|NCT01474772|3729492|P1|Period 1|AE not Related to Study Drug|1
1135464|NCT01474772|3729491|P2|Period 1|Adverse Event (AE) Related to Study Drug|1
1135465|NCT01474772|3729492|P1|Period 1|Adverse Event (AE) Related to Study Drug|6
1135466|NCT01474746|3729542|P2|Overall Study|Withdrawal by Subject|1
1135467|NCT01474746|3729543|P1|Overall Study|Withdrawal by Subject|2
1135468|NCT01474746|3729542|P2|Overall Study|Lost to Follow-up|1
1135469|NCT01474746|3729543|P1|Overall Study|Lost to Follow-up|1
1135470|NCT01474681|3729607|P4|Overall Study|Death|6
1135471|NCT01474681|3729608|P3|Overall Study|Death|2
1135472|NCT01474681|3729609|P2|Overall Study|Death|3
1135473|NCT01474681|3729610|P1|Overall Study|Death|0
1135474|NCT01474551|3729661|P1|Overall Study|Death|1
1135475|NCT01474538|3729667|P2|Treatment Period 2|Protocol Violation|0
1135476|NCT01474538|3729668|P1|Treatment Period 2|Protocol Violation|1
1135477|NCT01474538|3729667|P2|Treatment Period 2|Physician Decision|1
1135478|NCT01474538|3729668|P1|Treatment Period 2|Physician Decision|0
1135479|NCT01474538|3729667|P2|Treatment Period 2|Sponsor decision|0
1135480|NCT01474538|3729668|P1|Treatment Period 2|Sponsor decision|1
1135481|NCT01474538|3729667|P2|Treatment Period 2|Withdrawal by Subject|0
1135482|NCT01474538|3729668|P1|Treatment Period 2|Withdrawal by Subject|2
1135483|NCT01474538|3729667|P2|Treatment Period 2|Adverse Event|1
1135484|NCT01474538|3729668|P1|Treatment Period 2|Adverse Event|1
1135485|NCT01474538|3729667|P2|Treatment Period 2|Death|0
1135486|NCT01474538|3729668|P1|Treatment Period 2|Death|1
1135487|NCT01474538|3729667|P2|Treatment Period 1|Protocol Violation|1
1135488|NCT01474538|3729668|P1|Treatment Period 1|Protocol Violation|0
1135489|NCT01474538|3729667|P2|Treatment Period 1|Withdrawal by Subject|3
1135490|NCT01474538|3729668|P1|Treatment Period 1|Withdrawal by Subject|1
1135491|NCT01474538|3729667|P2|Treatment Period 1|Physician Decision|0
1135492|NCT01474538|3729668|P1|Treatment Period 1|Physician Decision|1
1135493|NCT01474538|3729667|P2|Treatment Period 1|Death|0
1135494|NCT01474538|3729668|P1|Treatment Period 1|Death|1
1135495|NCT01474512|3729685|P10|Maintenance Period|Treated but Discontinued in Induction|0
1135496|NCT01474512|3729686|P9|Maintenance Period|Treated but Discontinued in Induction|0
1135497|NCT01474512|3729687|P8|Maintenance Period|Treated but Discontinued in Induction|0
1135498|NCT01474512|3729688|P7|Maintenance Period|Treated but Discontinued in Induction|0
1135499|NCT01474512|3729689|P6|Maintenance Period|Treated but Discontinued in Induction|0
1135500|NCT01474512|3729690|P5|Maintenance Period|Treated but Discontinued in Induction|1
1135501|NCT01474512|3729691|P4|Maintenance Period|Treated but Discontinued in Induction|0
1135502|NCT01474512|3729692|P3|Maintenance Period|Treated but Discontinued in Induction|0
1135503|NCT01474512|3729693|P2|Maintenance Period|Treated but Discontinued in Induction|0
1135504|NCT01474512|3729694|P1|Maintenance Period|Treated but Discontinued in Induction|0
1135505|NCT01474512|3729685|P10|Maintenance Period|Protocol Violation|1
1135506|NCT01474512|3729686|P9|Maintenance Period|Protocol Violation|0
1135507|NCT01474512|3729687|P8|Maintenance Period|Protocol Violation|1
1135508|NCT01474512|3729688|P7|Maintenance Period|Protocol Violation|0
1135509|NCT01474512|3729689|P6|Maintenance Period|Protocol Violation|0
1135510|NCT01474512|3729690|P5|Maintenance Period|Protocol Violation|0
1135511|NCT01474512|3729691|P4|Maintenance Period|Protocol Violation|1
1135512|NCT01474512|3729692|P3|Maintenance Period|Protocol Violation|0
1135513|NCT01474512|3729693|P2|Maintenance Period|Protocol Violation|0
1135514|NCT01474512|3729694|P1|Maintenance Period|Protocol Violation|0
1135515|NCT01474512|3729685|P10|Maintenance Period|Lack of Efficacy|12
1135516|NCT01474512|3729686|P9|Maintenance Period|Lack of Efficacy|11
1135517|NCT01474512|3729687|P8|Maintenance Period|Lack of Efficacy|11
1135518|NCT01474512|3729688|P7|Maintenance Period|Lack of Efficacy|0
1135519|NCT01474512|3729689|P6|Maintenance Period|Lack of Efficacy|0
1135520|NCT01474512|3729690|P5|Maintenance Period|Lack of Efficacy|0
1135521|NCT01474512|3729691|P4|Maintenance Period|Lack of Efficacy|1
1135522|NCT01474512|3729692|P3|Maintenance Period|Lack of Efficacy|0
1135523|NCT01474512|3729693|P2|Maintenance Period|Lack of Efficacy|0
1135524|NCT01474512|3729694|P1|Maintenance Period|Lack of Efficacy|0
1135525|NCT01474512|3729685|P10|Maintenance Period|Clinical Relapse|0
1135526|NCT01474512|3729686|P9|Maintenance Period|Clinical Relapse|0
1135527|NCT01474512|3729687|P8|Maintenance Period|Clinical Relapse|0
1135528|NCT01474512|3729688|P7|Maintenance Period|Clinical Relapse|0
1135529|NCT01474512|3729689|P6|Maintenance Period|Clinical Relapse|0
1135530|NCT01474512|3729690|P5|Maintenance Period|Clinical Relapse|0
1135531|NCT01474512|3729691|P4|Maintenance Period|Clinical Relapse|1
1135532|NCT01474512|3729692|P3|Maintenance Period|Clinical Relapse|0
1135533|NCT01474512|3729693|P2|Maintenance Period|Clinical Relapse|0
1135534|NCT01474512|3729694|P1|Maintenance Period|Clinical Relapse|0
1135535|NCT01474512|3729685|P10|Maintenance Period|Investigator Decision|0
1135536|NCT01474512|3729686|P9|Maintenance Period|Investigator Decision|0
1135537|NCT01474512|3729687|P8|Maintenance Period|Investigator Decision|2
1135538|NCT01474512|3729688|P7|Maintenance Period|Investigator Decision|0
1135539|NCT01474512|3729689|P6|Maintenance Period|Investigator Decision|1
1135540|NCT01474512|3729690|P5|Maintenance Period|Investigator Decision|0
1135541|NCT01474512|3729691|P4|Maintenance Period|Investigator Decision|0
1135542|NCT01474512|3729692|P3|Maintenance Period|Investigator Decision|0
1135543|NCT01474512|3729693|P2|Maintenance Period|Investigator Decision|0
1135544|NCT01474512|3729694|P1|Maintenance Period|Investigator Decision|0
1135545|NCT01474512|3729685|P10|Maintenance Period|Death|0
1135546|NCT01474512|3729686|P9|Maintenance Period|Death|0
1135547|NCT01474512|3729687|P8|Maintenance Period|Death|0
1135548|NCT01474512|3729688|P7|Maintenance Period|Death|0
1135549|NCT01474512|3729689|P6|Maintenance Period|Death|2
1135550|NCT01474512|3729690|P5|Maintenance Period|Death|0
1135551|NCT01474512|3729691|P4|Maintenance Period|Death|0
1135552|NCT01474512|3729692|P3|Maintenance Period|Death|0
1135553|NCT01474512|3729693|P2|Maintenance Period|Death|0
1135554|NCT01474512|3729694|P1|Maintenance Period|Death|0
1135555|NCT01474512|3729685|P10|Maintenance Period|Lost to Follow-up|1
1135556|NCT01474512|3729686|P9|Maintenance Period|Lost to Follow-up|1
1135557|NCT01474512|3729687|P8|Maintenance Period|Lost to Follow-up|2
1135558|NCT01474512|3729688|P7|Maintenance Period|Lost to Follow-up|0
1135559|NCT01474512|3729689|P6|Maintenance Period|Lost to Follow-up|0
1135560|NCT01474512|3729690|P5|Maintenance Period|Lost to Follow-up|3
1135561|NCT01474512|3729691|P4|Maintenance Period|Lost to Follow-up|3
1135562|NCT01474512|3729692|P3|Maintenance Period|Lost to Follow-up|0
1135563|NCT01474512|3729693|P2|Maintenance Period|Lost to Follow-up|0
1135564|NCT01474512|3729694|P1|Maintenance Period|Lost to Follow-up|0
1135565|NCT01474512|3729685|P10|Maintenance Period|Withdrawal by Subject|1
1135566|NCT01474512|3729686|P9|Maintenance Period|Withdrawal by Subject|3
1135567|NCT01474512|3729687|P8|Maintenance Period|Withdrawal by Subject|6
1135568|NCT01474512|3729688|P7|Maintenance Period|Withdrawal by Subject|1
1135569|NCT01474512|3729689|P6|Maintenance Period|Withdrawal by Subject|3
1135570|NCT01474512|3729690|P5|Maintenance Period|Withdrawal by Subject|2
1135571|NCT01474512|3729691|P4|Maintenance Period|Withdrawal by Subject|6
1135572|NCT01474512|3729692|P3|Maintenance Period|Withdrawal by Subject|0
1135573|NCT01474512|3729693|P2|Maintenance Period|Withdrawal by Subject|0
1135574|NCT01474512|3729694|P1|Maintenance Period|Withdrawal by Subject|0
1135575|NCT01474512|3729685|P10|Maintenance Period|Adverse Event|3
1135576|NCT01474512|3729686|P9|Maintenance Period|Adverse Event|1
1135577|NCT01474512|3729687|P8|Maintenance Period|Adverse Event|19
1135578|NCT01474512|3729688|P7|Maintenance Period|Adverse Event|0
1135579|NCT01474512|3729689|P6|Maintenance Period|Adverse Event|7
1135580|NCT01474512|3729690|P5|Maintenance Period|Adverse Event|2
1135581|NCT01474512|3729691|P4|Maintenance Period|Adverse Event|4
1135582|NCT01474512|3729692|P3|Maintenance Period|Adverse Event|0
1135583|NCT01474512|3729693|P2|Maintenance Period|Adverse Event|0
1135584|NCT01474512|3729694|P1|Maintenance Period|Adverse Event|0
1135585|NCT01474512|3729685|P10|Maintenance Period|Relapsed (sPGA ≥3)|0
1135586|NCT01474512|3729686|P9|Maintenance Period|Relapsed (sPGA ≥3)|0
1135587|NCT01474512|3729687|P8|Maintenance Period|Relapsed (sPGA ≥3)|0
1135588|NCT01474512|3729688|P7|Maintenance Period|Relapsed (sPGA ≥3)|9
1135589|NCT01474512|3729689|P6|Maintenance Period|Relapsed (sPGA ≥3)|39
1135590|NCT01474512|3729690|P5|Maintenance Period|Relapsed (sPGA ≥3)|111
1135591|NCT01474512|3729691|P4|Maintenance Period|Relapsed (sPGA ≥3)|186
1135592|NCT01474512|3729692|P3|Maintenance Period|Relapsed (sPGA ≥3)|0
1135593|NCT01474512|3729693|P2|Maintenance Period|Relapsed (sPGA ≥3)|0
1135594|NCT01474512|3729694|P1|Maintenance Period|Relapsed (sPGA ≥3)|0
1135595|NCT01474512|3729685|P10|Induction Period|Lost to Follow-up|0
1135596|NCT01474512|3729686|P9|Induction Period|Lost to Follow-up|0
1135597|NCT01474512|3729687|P8|Induction Period|Lost to Follow-up|0
1135598|NCT01474512|3729688|P7|Induction Period|Lost to Follow-up|0
1135599|NCT01474512|3729689|P6|Induction Period|Lost to Follow-up|0
1135600|NCT01474512|3729690|P5|Induction Period|Lost to Follow-up|0
1135601|NCT01474512|3729691|P4|Induction Period|Lost to Follow-up|0
1135602|NCT01474512|3729692|P3|Induction Period|Lost to Follow-up|2
1135603|NCT01474512|3729693|P2|Induction Period|Lost to Follow-up|0
1135604|NCT01474512|3729694|P1|Induction Period|Lost to Follow-up|1
1135605|NCT01474512|3729685|P10|Induction Period|Sponsor Decision|0
1135606|NCT01474512|3729686|P9|Induction Period|Sponsor Decision|0
1135607|NCT01474512|3729687|P8|Induction Period|Sponsor Decision|0
1135608|NCT01474512|3729688|P7|Induction Period|Sponsor Decision|0
1135609|NCT01474512|3729689|P6|Induction Period|Sponsor Decision|0
1135610|NCT01474512|3729690|P5|Induction Period|Sponsor Decision|0
1135611|NCT01474512|3729691|P4|Induction Period|Sponsor Decision|0
1135612|NCT01474512|3729692|P3|Induction Period|Sponsor Decision|1
1135613|NCT01474512|3729693|P2|Induction Period|Sponsor Decision|1
1135614|NCT01474512|3729694|P1|Induction Period|Sponsor Decision|1
1135615|NCT01474512|3729685|P10|Induction Period|Protocol Violation|0
1135616|NCT01474512|3729686|P9|Induction Period|Protocol Violation|0
1135617|NCT01474512|3729687|P8|Induction Period|Protocol Violation|0
1135618|NCT01474512|3729688|P7|Induction Period|Protocol Violation|0
1135619|NCT01474512|3729689|P6|Induction Period|Protocol Violation|0
1135620|NCT01474512|3729690|P5|Induction Period|Protocol Violation|0
1135621|NCT01474512|3729691|P4|Induction Period|Protocol Violation|0
1135622|NCT01474512|3729692|P3|Induction Period|Protocol Violation|0
1135623|NCT01474512|3729693|P2|Induction Period|Protocol Violation|6
1135624|NCT01474512|3729694|P1|Induction Period|Protocol Violation|3
1135625|NCT01474512|3729685|P10|Induction Period|Withdrawal by Subject|0
1135626|NCT01474512|3729686|P9|Induction Period|Withdrawal by Subject|0
1135627|NCT01474512|3729687|P8|Induction Period|Withdrawal by Subject|0
1135628|NCT01474512|3729688|P7|Induction Period|Withdrawal by Subject|0
1135629|NCT01474512|3729689|P6|Induction Period|Withdrawal by Subject|0
1135630|NCT01474512|3729690|P5|Induction Period|Withdrawal by Subject|0
1135631|NCT01474512|3729691|P4|Induction Period|Withdrawal by Subject|0
1135632|NCT01474512|3729692|P3|Induction Period|Withdrawal by Subject|5
1135633|NCT01474512|3729693|P2|Induction Period|Withdrawal by Subject|6
1135634|NCT01474512|3729694|P1|Induction Period|Withdrawal by Subject|6
1135635|NCT01474512|3729685|P10|Induction Period|Lack of Efficacy|0
1135636|NCT01474512|3729686|P9|Induction Period|Lack of Efficacy|0
1135637|NCT01474512|3729687|P8|Induction Period|Lack of Efficacy|0
1135638|NCT01474512|3729688|P7|Induction Period|Lack of Efficacy|0
1135639|NCT01474512|3729689|P6|Induction Period|Lack of Efficacy|0
1135640|NCT01474512|3729690|P5|Induction Period|Lack of Efficacy|0
1135641|NCT01474512|3729691|P4|Induction Period|Lack of Efficacy|0
1135642|NCT01474512|3729692|P3|Induction Period|Lack of Efficacy|0
1135643|NCT01474512|3729693|P2|Induction Period|Lack of Efficacy|1
1135644|NCT01474512|3729694|P1|Induction Period|Lack of Efficacy|7
1135645|NCT01474512|3729685|P10|Induction Period|Adverse Event|0
1135646|NCT01474512|3729686|P9|Induction Period|Adverse Event|0
1135647|NCT01474512|3729687|P8|Induction Period|Adverse Event|0
1135648|NCT01474512|3729688|P7|Induction Period|Adverse Event|0
1135649|NCT01474512|3729689|P6|Induction Period|Adverse Event|0
1135650|NCT01474512|3729690|P5|Induction Period|Adverse Event|0
1135651|NCT01474512|3729691|P4|Induction Period|Adverse Event|0
1135652|NCT01474512|3729692|P3|Induction Period|Adverse Event|10
1135653|NCT01474512|3729693|P2|Induction Period|Adverse Event|10
1135654|NCT01474512|3729694|P1|Induction Period|Adverse Event|6
1135655|NCT01474434|3729763|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
1135656|NCT01474434|3729764|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
1135657|NCT01474434|3729765|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
1135658|NCT01474434|3729766|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1
1135659|NCT01474434|3729763|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1
1135660|NCT01474434|3729764|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
1135661|NCT01474434|3729765|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
1135662|NCT01474434|3729766|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
1135663|NCT01474434|3729763|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
1135664|NCT01474434|3729764|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
1135665|NCT01474434|3729765|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
1135666|NCT01474434|3729766|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
1135667|NCT01474317|3729808|P1|Overall Study|Subject ineligible for study|1
1135668|NCT01474317|3729808|P1|Overall Study|Adverse Event|1
1135669|NCT01474291|3729817|P1|Overall Study|Death|2
1135670|NCT01474291|3729817|P1|Overall Study|No Reason Reported|10
1135671|NCT01474291|3729817|P1|Overall Study|Patient No Longer Wanted to Participate|12
1135672|NCT01474291|3729817|P1|Overall Study|Lost to Follow-up|29
1135673|NCT01474291|3729817|P1|Overall Study|Adverse Event|53
1135674|NCT01474291|3729817|P1|Overall Study|Lack of Treatment Efficacy|88
1135675|NCT01474291|3729817|P1|Overall Study|Not Evaluable for Efficacy|26
1135676|NCT01474239|3729861|P2|Overall Study|Withdrawal for Economic Reason|0
1135677|NCT01474239|3729862|P1|Overall Study|Withdrawal for Economic Reason|1
1135678|NCT01474239|3729861|P2|Overall Study|Clinical Disease Progression|1
1135679|NCT01474239|3729862|P1|Overall Study|Clinical Disease Progression|7
1135680|NCT01474239|3729861|P2|Overall Study|Death|1
1135681|NCT01474239|3729862|P1|Overall Study|Death|1
1135682|NCT01474239|3729861|P2|Overall Study|Withdrawal by Subject|2
1135683|NCT01474239|3729862|P1|Overall Study|Withdrawal by Subject|1
1135684|NCT01474239|3729861|P2|Overall Study|Adverse Event|3
1135685|NCT01474239|3729862|P1|Overall Study|Adverse Event|12
1135686|NCT01474239|3729861|P2|Overall Study|Disease Progression|25
1135687|NCT01474239|3729862|P1|Overall Study|Disease Progression|37
1135688|NCT01473953|3730056|P5|Overall Study|Other|0
1135689|NCT01473953|3730057|P4|Overall Study|Other|0
1135690|NCT01473953|3730058|P3|Overall Study|Other|0
1135691|NCT01473953|3730059|P2|Overall Study|Other|0
1135692|NCT01473953|3730060|P1|Overall Study|Other|1
1135693|NCT01473836|3730102|P1|Overall Study|Does not meet entrance criteria|1
1135694|NCT01473836|3730102|P1|Overall Study|Lack of Efficacy|1
1135695|NCT01473836|3730102|P1|Overall Study|Adverse Event|4
1135696|NCT01473758|3730113|P4|Cycle 2|Adverse Event|0
1135697|NCT01473758|3730114|P3|Cycle 2|Adverse Event|5
1135698|NCT01473758|3730115|P2|Cycle 2|Adverse Event|0
1135699|NCT01473758|3730116|P1|Cycle 2|Adverse Event|0
1135700|NCT01473758|3730113|P4|Cycle 1|Withdrawal by Subject|0
1135701|NCT01473758|3730114|P3|Cycle 1|Withdrawal by Subject|0
1135702|NCT01473758|3730115|P2|Cycle 1|Withdrawal by Subject|1
1135703|NCT01473758|3730116|P1|Cycle 1|Withdrawal by Subject|1
1135704|NCT01473758|3730113|P4|Cycle 1|Adverse Event|0
1135705|NCT01473758|3730114|P3|Cycle 1|Adverse Event|0
1135706|NCT01473758|3730115|P2|Cycle 1|Adverse Event|2
1135707|NCT01473758|3730116|P1|Cycle 1|Adverse Event|10
1135708|NCT01473732|3730253|P2|Overall Study|Death|0
1135709|NCT01473732|3730254|P1|Overall Study|Death|1
1135710|NCT01473732|3730253|P2|Overall Study|Adverse Event|0
1135711|NCT01473732|3730254|P1|Overall Study|Adverse Event|1
1135712|NCT01473602|3730262|P2|Overall Study|Physician Decision|0
1135713|NCT01473602|3730263|P1|Overall Study|Physician Decision|1
1135714|NCT01473602|3730262|P2|Overall Study|Withdrawal by Subject|4
1135715|NCT01473602|3730263|P1|Overall Study|Withdrawal by Subject|5
1135716|NCT01473602|3730262|P2|Overall Study|Lost to Follow-up|1
1135717|NCT01473602|3730263|P1|Overall Study|Lost to Follow-up|1
1135718|NCT01473602|3730262|P2|Overall Study|Death|1
1135719|NCT01473602|3730263|P1|Overall Study|Death|0
1135720|NCT01473602|3730262|P2|Overall Study|Adverse Event|2
1135721|NCT01473602|3730263|P1|Overall Study|Adverse Event|1
1135722|NCT01473589|3730299|P2|Overall Study|Entry criteria not met|1
1135723|NCT01473589|3730300|P1|Overall Study|Entry criteria not met|0
1135724|NCT01473589|3730299|P2|Overall Study|Physician Decision|1
1135725|NCT01473589|3730300|P1|Overall Study|Physician Decision|0
1135726|NCT01473589|3730299|P2|Overall Study|Withdrawal by Subject|11
1135727|NCT01473589|3730300|P1|Overall Study|Withdrawal by Subject|5
1135728|NCT01473589|3730299|P2|Overall Study|Protocol Violation|0
1135729|NCT01473589|3730300|P1|Overall Study|Protocol Violation|1
1135730|NCT01473589|3730299|P2|Overall Study|Lost to Follow-up|2
1135731|NCT01473589|3730300|P1|Overall Study|Lost to Follow-up|2
1135732|NCT01473589|3730299|P2|Overall Study|Death|0
1135733|NCT01473589|3730300|P1|Overall Study|Death|2
1135734|NCT01473589|3730299|P2|Overall Study|Adverse Event|1
1135735|NCT01473589|3730300|P1|Overall Study|Adverse Event|1
1135736|NCT01473563|3730334|P1|Overall Study|Lost to FU post tx discontinuation|1
1135737|NCT01473524|3730356|P3|Overall Study|Withdrawal by Subject|1
1135738|NCT01473524|3730357|P2|Overall Study|Withdrawal by Subject|1
1135739|NCT01473524|3730358|P1|Overall Study|Withdrawal by Subject|2
1135740|NCT01473524|3730356|P3|Overall Study|Death|0
1135741|NCT01473524|3730357|P2|Overall Study|Death|0
1135742|NCT01473524|3730358|P1|Overall Study|Death|1
1135743|NCT01473524|3730356|P3|Overall Study|Adverse Event|2
1135744|NCT01473524|3730357|P2|Overall Study|Adverse Event|8
1135745|NCT01473524|3730358|P1|Overall Study|Adverse Event|4
1135746|NCT01473420|3730391|P2|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0
1135747|NCT01473420|3730392|P1|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1
1135748|NCT01473420|3730391|P2|Maintenance Period (16 Weeks)|Sponsor's Decision|0
1135749|NCT01473420|3730392|P1|Maintenance Period (16 Weeks)|Sponsor's Decision|1
1135750|NCT01473420|3730391|P2|Maintenance Period (16 Weeks)|Long term hospitalization|1
1135751|NCT01473420|3730392|P1|Maintenance Period (16 Weeks)|Long term hospitalization|0
1135752|NCT01473420|3730391|P2|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0
1135753|NCT01473420|3730392|P1|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1
1135754|NCT01473420|3730391|P2|Maintenance Period (16 Weeks)|Site closure|1
1135755|NCT01473420|3730392|P1|Maintenance Period (16 Weeks)|Site closure|3
1135756|NCT01473420|3730391|P2|Maintenance Period (16 Weeks)|Withdrawal by Subject|6
1135757|NCT01473420|3730392|P1|Maintenance Period (16 Weeks)|Withdrawal by Subject|4
1135758|NCT01473420|3730391|P2|Maintenance Period (16 Weeks)|Lost to Follow-up|2
1135759|NCT01473420|3730392|P1|Maintenance Period (16 Weeks)|Lost to Follow-up|1
1135760|NCT01473420|3730391|P2|Maintenance Period (16 Weeks)|Kidney transplant|1
1135761|NCT01473420|3730392|P1|Maintenance Period (16 Weeks)|Kidney transplant|3
1135762|NCT01473420|3730391|P2|Maintenance Period (16 Weeks)|Did not meet criteria|2
1135763|NCT01473420|3730392|P1|Maintenance Period (16 Weeks)|Did not meet criteria|0
1135764|NCT01473420|3730391|P2|Maintenance Period (16 Weeks)|Physician Decision|2
1135765|NCT01473420|3730392|P1|Maintenance Period (16 Weeks)|Physician Decision|1
1135766|NCT01473420|3730391|P2|Maintenance Period (16 Weeks)|Adverse Event|2
1135767|NCT01473420|3730392|P1|Maintenance Period (16 Weeks)|Adverse Event|3
1135768|NCT01473420|3730391|P2|Titration Period (18 Weeks)|Did not meet criteria|32
1135769|NCT01473420|3730392|P1|Titration Period (18 Weeks)|Did not meet criteria|32
1135770|NCT01473420|3730391|P2|Titration Period (18 Weeks)|Adverse Event|6
1135771|NCT01473420|3730392|P1|Titration Period (18 Weeks)|Adverse Event|4
1135772|NCT01473407|3730476|P2|Overall Study|Site Closure|0
1135773|NCT01473407|3730477|P1|Overall Study|Site Closure|1
1135774|NCT01473407|3730476|P2|Overall Study|Sponsor's Decision|10
1135775|NCT01473407|3730477|P1|Overall Study|Sponsor's Decision|10
1135776|NCT01473407|3730476|P2|Overall Study|Transfer to Another Facility/Unit|3
1135777|NCT01473407|3730477|P1|Overall Study|Transfer to Another Facility/Unit|4
1135778|NCT01473407|3730476|P2|Overall Study|Temperature Excursion|3
1135779|NCT01473407|3730477|P1|Overall Study|Temperature Excursion|2
1135780|NCT01473407|3730476|P2|Overall Study|Patient Lost Green Card Status|0
1135781|NCT01473407|3730477|P1|Overall Study|Patient Lost Green Card Status|1
1135782|NCT01473407|3730476|P2|Overall Study|Patient Received Aranesp|0
1135783|NCT01473407|3730477|P1|Overall Study|Patient Received Aranesp|1
1135784|NCT01473407|3730476|P2|Overall Study|Elevated Hemoglobin|0
1135785|NCT01473407|3730477|P1|Overall Study|Elevated Hemoglobin|1
1135786|NCT01473407|3730476|P2|Overall Study|Vacation/Travel|1
1135787|NCT01473407|3730477|P1|Overall Study|Vacation/Travel|1
1135788|NCT01473407|3730476|P2|Overall Study|Kidney Transplant|6
1135789|NCT01473407|3730477|P1|Overall Study|Kidney Transplant|7
1135790|NCT01473407|3730476|P2|Overall Study|Withdrawal by Subject|7
1135791|NCT01473407|3730477|P1|Overall Study|Withdrawal by Subject|4
1135792|NCT01473407|3730476|P2|Overall Study|Randomization Error|1
1135793|NCT01473407|3730477|P1|Overall Study|Randomization Error|3
1135794|NCT01473407|3730476|P2|Overall Study|Adverse Event|8
1135795|NCT01473407|3730477|P1|Overall Study|Adverse Event|8
1135796|NCT01473407|3730476|P2|Overall Study|Lost to Follow-up|4
1135797|NCT01473407|3730477|P1|Overall Study|Lost to Follow-up|10
1135798|NCT01473407|3730476|P2|Overall Study|Physician Decision|4
1135799|NCT01473407|3730477|P1|Overall Study|Physician Decision|1
1135800|NCT01473394|3730531|P2|Overall Study|Lost to Follow-up|11
1135801|NCT01473394|3730532|P1|Overall Study|Lost to Follow-up|9
1135802|NCT01473394|3730531|P2|Overall Study|Withdrew Consent|10
1135803|NCT01473394|3730532|P1|Overall Study|Withdrew Consent|12
1135804|NCT01473394|3730531|P2|Overall Study|Protocol Violation|5
1135805|NCT01473394|3730532|P1|Overall Study|Protocol Violation|7
1135806|NCT01473394|3730531|P2|Overall Study|Insufficient Therapeutic Response|1
1135807|NCT01473394|3730532|P1|Overall Study|Insufficient Therapeutic Response|4
1135808|NCT01473394|3730531|P2|Overall Study|Adverse Event|16
1135809|NCT01473394|3730532|P1|Overall Study|Adverse Event|13
1135810|NCT01473381|3730546|P4|Overall Study|Other Reasons|3
1135811|NCT01473381|3730547|P3|Overall Study|Other Reasons|1
1135812|NCT01473381|3730548|P2|Overall Study|Other Reasons|0
1135813|NCT01473381|3730549|P1|Overall Study|Other Reasons|0
1135814|NCT01473381|3730546|P4|Overall Study|Lost to Follow-up|23
1135815|NCT01473381|3730547|P3|Overall Study|Lost to Follow-up|35
1135816|NCT01473381|3730548|P2|Overall Study|Lost to Follow-up|28
1135817|NCT01473381|3730549|P1|Overall Study|Lost to Follow-up|25
1135818|NCT01473381|3730546|P4|Overall Study|Withdrawal of Consent|26
1135819|NCT01473381|3730547|P3|Overall Study|Withdrawal of Consent|20
1135820|NCT01473381|3730548|P2|Overall Study|Withdrawal of Consent|21
1135821|NCT01473381|3730549|P1|Overall Study|Withdrawal of Consent|20
1135822|NCT01473381|3730546|P4|Overall Study|Protocol Violation|17
1135823|NCT01473381|3730547|P3|Overall Study|Protocol Violation|19
1135824|NCT01473381|3730548|P2|Overall Study|Protocol Violation|23
1135825|NCT01473381|3730549|P1|Overall Study|Protocol Violation|17
1135826|NCT01473381|3730546|P4|Overall Study|Insufficient Therapeutic Response|3
1135827|NCT01473381|3730547|P3|Overall Study|Insufficient Therapeutic Response|2
1135828|NCT01473381|3730548|P2|Overall Study|Insufficient Therapeutic Response|1
1135829|NCT01473381|3730549|P1|Overall Study|Insufficient Therapeutic Response|10
1135830|NCT01473381|3730546|P4|Overall Study|Adverse Event|17
1135831|NCT01473381|3730547|P3|Overall Study|Adverse Event|25
1135832|NCT01473381|3730548|P2|Overall Study|Adverse Event|20
1135833|NCT01473381|3730549|P1|Overall Study|Adverse Event|8
1135834|NCT01472965|3730631|P2|Overall Study|Withdrawal by Subject|0
1135835|NCT01472965|3730632|P1|Overall Study|Withdrawal by Subject|1
1135836|NCT01472939|3730652|P4|Overall Study|Withdrawal by Subject|4
1135837|NCT01472939|3730653|P3|Overall Study|Withdrawal by Subject|1
1135838|NCT01472939|3730654|P2|Overall Study|Withdrawal by Subject|3
1135839|NCT01472939|3730655|P1|Overall Study|Withdrawal by Subject|9
1135840|NCT01472939|3730652|P4|Overall Study|Protocol Violation|1
1135841|NCT01472939|3730653|P3|Overall Study|Protocol Violation|0
1135842|NCT01472939|3730654|P2|Overall Study|Protocol Violation|3
1135843|NCT01472939|3730655|P1|Overall Study|Protocol Violation|3
1135844|NCT01472939|3730652|P4|Overall Study|Withdrawal By PI|0
1135845|NCT01472939|3730653|P3|Overall Study|Withdrawal By PI|0
1135846|NCT01472939|3730654|P2|Overall Study|Withdrawal By PI|0
1135847|NCT01472939|3730655|P1|Overall Study|Withdrawal By PI|1
1135848|NCT01472939|3730652|P4|Overall Study|Prohibited Medication|0
1135849|NCT01472939|3730653|P3|Overall Study|Prohibited Medication|0
1135850|NCT01472939|3730654|P2|Overall Study|Prohibited Medication|1
1135851|NCT01472939|3730655|P1|Overall Study|Prohibited Medication|0
1135852|NCT01472939|3730652|P4|Overall Study|Clinically Significant Pre-Dose ECG|0
1135853|NCT01472939|3730653|P3|Overall Study|Clinically Significant Pre-Dose ECG|1
1135854|NCT01472939|3730654|P2|Overall Study|Clinically Significant Pre-Dose ECG|0
1135855|NCT01472939|3730655|P1|Overall Study|Clinically Significant Pre-Dose ECG|0
1135856|NCT01472939|3730652|P4|Overall Study|Lost to Follow-up|0
1135857|NCT01472939|3730653|P3|Overall Study|Lost to Follow-up|2
1135858|NCT01472939|3730654|P2|Overall Study|Lost to Follow-up|0
1135859|NCT01472939|3730655|P1|Overall Study|Lost to Follow-up|3
1135860|NCT01472939|3730652|P4|Overall Study|Lack of Efficacy|1
1135861|NCT01472939|3730653|P3|Overall Study|Lack of Efficacy|0
1135862|NCT01472939|3730654|P2|Overall Study|Lack of Efficacy|0
1135863|NCT01472939|3730655|P1|Overall Study|Lack of Efficacy|1
1135864|NCT01472939|3730652|P4|Overall Study|Adverse Event|14
1135865|NCT01472939|3730653|P3|Overall Study|Adverse Event|7
1135866|NCT01472939|3730654|P2|Overall Study|Adverse Event|7
1135867|NCT01472939|3730655|P1|Overall Study|Adverse Event|3
1135868|NCT01472835|3730699|P2|Overall Study|Lost to Follow-up|0
1135869|NCT01472835|3730700|P1|Overall Study|Lost to Follow-up|2
1135870|NCT01472380|3730778|P1|1 Day Period Between Dosing|Protocol Violation|1
1135871|NCT01472380|3730778|P1|Efavirenz Alone|Withdrawal by Subject|1
1135872|NCT01472341|3730789|P1|Overall Study|Death|9
1135873|NCT01472341|3730789|P1|Overall Study|Laboratory parameters unavailable|25
1135874|NCT01472341|3730789|P1|Overall Study|Lost to Follow-up|52
1135875|NCT01472341|3730789|P1|Overall Study|Withdrawal by Subject|39
1135876|NCT01472341|3730789|P1|Overall Study|Started therapy with a DPP-IV/GLP-1|92
1135877|NCT01472341|3730789|P1|Overall Study|Started insulin therapy|55
1135878|NCT01472289|3730795|P1|Overall Study|Death|2
1135879|NCT01472185|3730807|P2|Overall Study|Subject Withdrew Consent|3
1135880|NCT01472185|3730808|P1|Overall Study|Subject Withdrew Consent|6
1135881|NCT01472185|3730807|P2|Overall Study|Subject Noncompliance|15
1135882|NCT01472185|3730808|P1|Overall Study|Subject Noncompliance|8
1135883|NCT01472185|3730807|P2|Overall Study|Protocol Violation|1
1135884|NCT01472185|3730808|P1|Overall Study|Protocol Violation|5
1135885|NCT01472185|3730807|P2|Overall Study|Lost to Follow-up|1
1135886|NCT01472185|3730808|P1|Overall Study|Lost to Follow-up|4
1135887|NCT01472185|3730807|P2|Overall Study|Investigator’s Discretion|1
1135888|NCT01472185|3730808|P1|Overall Study|Investigator’s Discretion|3
1135889|NCT01472185|3730807|P2|Overall Study|Hyperglycemia|2
1135890|NCT01472185|3730808|P1|Overall Study|Hyperglycemia|5
1135891|NCT01472185|3730807|P2|Overall Study|Adverse Event Other than Hyperglycemia|10
1135892|NCT01472185|3730808|P1|Overall Study|Adverse Event Other than Hyperglycemia|3
1135893|NCT01472185|3730807|P2|Overall Study|Randomized but Not Treated|1
1135894|NCT01472185|3730808|P1|Overall Study|Randomized but Not Treated|0
1135895|NCT01471782|3730828|P6|Overall Study|Death|1
1135896|NCT01471782|3730829|P5|Overall Study|Death|0
1135897|NCT01471782|3730830|P4|Overall Study|Death|0
1135898|NCT01471782|3730831|P3|Overall Study|Death|0
1135899|NCT01471782|3730832|P2|Overall Study|Death|0
1135900|NCT01471782|3730833|P1|Overall Study|Death|0
1135901|NCT01471782|3730828|P6|Overall Study|Withdrawal by Parent/Guardian|0
1135902|NCT01471782|3730829|P5|Overall Study|Withdrawal by Parent/Guardian|1
1135903|NCT01471782|3730830|P4|Overall Study|Withdrawal by Parent/Guardian|0
1135904|NCT01471782|3730831|P3|Overall Study|Withdrawal by Parent/Guardian|0
1135905|NCT01471782|3730832|P2|Overall Study|Withdrawal by Parent/Guardian|0
1135906|NCT01471782|3730833|P1|Overall Study|Withdrawal by Parent/Guardian|0
1135907|NCT01471782|3730828|P6|Overall Study|Physician Decision|8
1135908|NCT01471782|3730829|P5|Overall Study|Physician Decision|3
1135909|NCT01471782|3730830|P4|Overall Study|Physician Decision|0
1135910|NCT01471782|3730831|P3|Overall Study|Physician Decision|0
1135911|NCT01471782|3730832|P2|Overall Study|Physician Decision|0
1135912|NCT01471782|3730833|P1|Overall Study|Physician Decision|0
1135913|NCT01471782|3730828|P6|Overall Study|Disease Relapse|1
1135914|NCT01471782|3730829|P5|Overall Study|Disease Relapse|2
1135915|NCT01471782|3730830|P4|Overall Study|Disease Relapse|1
1135916|NCT01471782|3730831|P3|Overall Study|Disease Relapse|0
1135917|NCT01471782|3730832|P2|Overall Study|Disease Relapse|0
1135918|NCT01471782|3730833|P1|Overall Study|Disease Relapse|0
1135919|NCT01471782|3730828|P6|Overall Study|Change of Chemotherapy|4
1135920|NCT01471782|3730829|P5|Overall Study|Change of Chemotherapy|1
1135921|NCT01471782|3730830|P4|Overall Study|Change of Chemotherapy|0
1135922|NCT01471782|3730831|P3|Overall Study|Change of Chemotherapy|0
1135923|NCT01471782|3730832|P2|Overall Study|Change of Chemotherapy|1
1135924|NCT01471782|3730833|P1|Overall Study|Change of Chemotherapy|1
1135925|NCT01471782|3730828|P6|Overall Study|Other|5
1135926|NCT01471782|3730829|P5|Overall Study|Other|6
1135927|NCT01471782|3730830|P4|Overall Study|Other|1
1135928|NCT01471782|3730831|P3|Overall Study|Other|1
1135929|NCT01471782|3730832|P2|Overall Study|Other|0
1135930|NCT01471782|3730833|P1|Overall Study|Other|0
1135931|NCT01471782|3730828|P6|Overall Study|Adverse Event|1
1135932|NCT01471782|3730829|P5|Overall Study|Adverse Event|3
1135933|NCT01471782|3730830|P4|Overall Study|Adverse Event|2
1135934|NCT01471782|3730831|P3|Overall Study|Adverse Event|2
1135935|NCT01471782|3730832|P2|Overall Study|Adverse Event|1
1135936|NCT01471782|3730833|P1|Overall Study|Adverse Event|1
1135937|NCT01471782|3730828|P6|Overall Study|Lack of Efficacy|18
1135938|NCT01471782|3730829|P5|Overall Study|Lack of Efficacy|5
1135939|NCT01471782|3730830|P4|Overall Study|Lack of Efficacy|1
1135940|NCT01471782|3730831|P3|Overall Study|Lack of Efficacy|1
1135941|NCT01471782|3730832|P2|Overall Study|Lack of Efficacy|2
1135942|NCT01471782|3730833|P1|Overall Study|Lack of Efficacy|1
1135943|NCT01471782|3730828|P6|Overall Study|Hematopoietic Stem Cell Transplantation|3
1135944|NCT01471782|3730829|P5|Overall Study|Hematopoietic Stem Cell Transplantation|5
1135945|NCT01471782|3730830|P4|Overall Study|Hematopoietic Stem Cell Transplantation|0
1135946|NCT01471782|3730831|P3|Overall Study|Hematopoietic Stem Cell Transplantation|1
1135947|NCT01471782|3730832|P2|Overall Study|Hematopoietic Stem Cell Transplantation|2
1135948|NCT01471782|3730833|P1|Overall Study|Hematopoietic Stem Cell Transplantation|2
1135949|NCT01471691|3730887|P2|Overall Study|Lack of Efficacy|1
1135950|NCT01471691|3730888|P1|Overall Study|Lack of Efficacy|0
1135951|NCT01471379|3730897|P3|Overall Study|Study terminated|0
1135952|NCT01471379|3730898|P2|Overall Study|Study terminated|1
1135953|NCT01471379|3730899|P1|Overall Study|Study terminated|0
1135954|NCT01471379|3730897|P3|Overall Study|Adverse Event|0
1135955|NCT01471379|3730898|P2|Overall Study|Adverse Event|0
1135956|NCT01471379|3730899|P1|Overall Study|Adverse Event|1
1135957|NCT01471353|3730919|P1|Overall Study|remain on study|3
1135958|NCT01471340|3730930|P2|Overall Study|Invalid informed consent|0
1135959|NCT01471340|3730931|P1|Overall Study|Invalid informed consent|1
1135960|NCT01471340|3730930|P2|Overall Study|Investigational site closure|1
1135961|NCT01471340|3730931|P1|Overall Study|Investigational site closure|0
1135962|NCT01471340|3730930|P2|Overall Study|Lost to Follow-up|1
1135963|NCT01471340|3730931|P1|Overall Study|Lost to Follow-up|0
1135964|NCT01471340|3730930|P2|Overall Study|Death|4
1135965|NCT01471340|3730931|P1|Overall Study|Death|5
1135966|NCT01471574|3730954|P4|Follow-up Period|Follow-up no longer required|0
1135967|NCT01471574|3730955|P3|Follow-up Period|Follow-up no longer required|0
1135968|NCT01471574|3730956|P2|Follow-up Period|Follow-up no longer required|1
1135969|NCT01471574|3730957|P1|Follow-up Period|Follow-up no longer required|0
1135970|NCT01471574|3730954|P4|Follow-up Period|Death|0
1135971|NCT01471574|3730955|P3|Follow-up Period|Death|1
1135972|NCT01471574|3730956|P2|Follow-up Period|Death|0
1135973|NCT01471574|3730957|P1|Follow-up Period|Death|0
1135974|NCT01471574|3730954|P4|Follow-up Period|Lost to Follow-up|2
1135975|NCT01471574|3730955|P3|Follow-up Period|Lost to Follow-up|3
1135976|NCT01471574|3730956|P2|Follow-up Period|Lost to Follow-up|1
1135977|NCT01471574|3730957|P1|Follow-up Period|Lost to Follow-up|4
1135978|NCT01471574|3730954|P4|Follow-up Period|Withdrawal by Subject|1
1135979|NCT01471574|3730955|P3|Follow-up Period|Withdrawal by Subject|3
1135980|NCT01471574|3730956|P2|Follow-up Period|Withdrawal by Subject|0
1135981|NCT01471574|3730957|P1|Follow-up Period|Withdrawal by Subject|3
1135982|NCT01471574|3730954|P4|Treatment Period|Not specified|0
1135983|NCT01471574|3730955|P3|Treatment Period|Not specified|0
1135984|NCT01471574|3730956|P2|Treatment Period|Not specified|0
1135985|NCT01471574|3730957|P1|Treatment Period|Not specified|1
1135986|NCT01471574|3730954|P4|Treatment Period|Patient no Longer Meets Study Criteria|0
1135987|NCT01471574|3730955|P3|Treatment Period|Patient no Longer Meets Study Criteria|0
1135988|NCT01471574|3730956|P2|Treatment Period|Patient no Longer Meets Study Criteria|0
1135989|NCT01471574|3730957|P1|Treatment Period|Patient no Longer Meets Study Criteria|1
1135990|NCT01471574|3730954|P4|Treatment Period|Lost to Follow-up|0
1135991|NCT01471574|3730955|P3|Treatment Period|Lost to Follow-up|2
1135992|NCT01471574|3730956|P2|Treatment Period|Lost to Follow-up|2
1135993|NCT01471574|3730957|P1|Treatment Period|Lost to Follow-up|1
1135994|NCT01471574|3730954|P4|Treatment Period|Patient Requested Discontinue Study drug|1
1135995|NCT01471574|3730955|P3|Treatment Period|Patient Requested Discontinue Study drug|1
1135996|NCT01471574|3730956|P2|Treatment Period|Patient Requested Discontinue Study drug|0
1135997|NCT01471574|3730957|P1|Treatment Period|Patient Requested Discontinue Study drug|4
1135998|NCT01471574|3730954|P4|Treatment Period|Withdrawal by Subject|0
1135999|NCT01471574|3730955|P3|Treatment Period|Withdrawal by Subject|1
1136000|NCT01471574|3730956|P2|Treatment Period|Withdrawal by Subject|1
1136001|NCT01471574|3730957|P1|Treatment Period|Withdrawal by Subject|5
1136002|NCT01471574|3730954|P4|Treatment Period|Adverse Event|1
1136003|NCT01471574|3730955|P3|Treatment Period|Adverse Event|6
1136004|NCT01471574|3730956|P2|Treatment Period|Adverse Event|3
1136005|NCT01471574|3730957|P1|Treatment Period|Adverse Event|7
1136006|NCT01471574|3730954|P4|Treatment Period|Lack of Efficacy|1
1136007|NCT01471574|3730955|P3|Treatment Period|Lack of Efficacy|14
1136008|NCT01471574|3730956|P2|Treatment Period|Lack of Efficacy|4
1136009|NCT01471574|3730957|P1|Treatment Period|Lack of Efficacy|12
1136010|NCT01471197|3730988|P2|Overall Study|Study Drug Toxicity|0
1136011|NCT01471197|3730989|P1|Overall Study|Study Drug Toxicity|1
1136012|NCT01471197|3730988|P2|Overall Study|Death|0
1136013|NCT01471197|3730989|P1|Overall Study|Death|1
1136014|NCT01471197|3730988|P2|Overall Study|Disease Progression|2
1136015|NCT01471197|3730989|P1|Overall Study|Disease Progression|4
1136016|NCT01471171|3730999|P2|Treatment Period 2|Adverse Event|0
1136017|NCT01471171|3731000|P1|Treatment Period 2|Adverse Event|1
1136018|NCT01471171|3730999|P2|Treatment Period 1|Adverse Event|1
1136019|NCT01471171|3731000|P1|Treatment Period 1|Adverse Event|4
1136020|NCT01471015|3731018|P3|Overall Study|Death|1
1136021|NCT01471015|3731019|P2|Overall Study|Death|1
1136022|NCT01471015|3731020|P1|Overall Study|Death|0
1136023|NCT01470599|3731062|P2|Overall Study|Adverse event not related to study drug|5
1136024|NCT01470599|3731063|P1|Overall Study|Adverse event not related to study drug|1
1136025|NCT01470599|3731062|P2|Overall Study|Insufficient clinical response|27
1136026|NCT01470599|3731063|P1|Overall Study|Insufficient clinical response|6
1136027|NCT01470599|3731062|P2|Overall Study|Adverse event related to study drug|5
1136028|NCT01470599|3731063|P1|Overall Study|Adverse event related to study drug|2
1136029|NCT01470599|3731062|P2|Overall Study|Protocol Violation|1
1136030|NCT01470599|3731063|P1|Overall Study|Protocol Violation|3
1136031|NCT01470599|3731062|P2|Overall Study|Other|0
1136032|NCT01470599|3731063|P1|Overall Study|Other|1
1136033|NCT01470599|3731062|P2|Overall Study|Withdrawal by Subject|4
1136034|NCT01470599|3731063|P1|Overall Study|Withdrawal by Subject|3
1136035|NCT01470599|3731062|P2|Overall Study|Lost to Follow-up|1
1136036|NCT01470599|3731063|P1|Overall Study|Lost to Follow-up|2
1136037|NCT01470599|3731062|P2|Overall Study|Did not meet entrance criteria|0
1136038|NCT01470599|3731063|P1|Overall Study|Did not meet entrance criteria|1
1136039|NCT01470469|3731127|P2|Overall Study|Not specified|1
1136040|NCT01470469|3731128|P1|Overall Study|Not specified|2
1136041|NCT01470469|3731127|P2|Overall Study|Protocol Violation|1
1136042|NCT01470469|3731128|P1|Overall Study|Protocol Violation|1
1136043|NCT01470469|3731127|P2|Overall Study|Lost to Follow-up|2
1136044|NCT01470469|3731128|P1|Overall Study|Lost to Follow-up|2
1136045|NCT01470469|3731127|P2|Overall Study|Adverse Event|7
1136046|NCT01470469|3731128|P1|Overall Study|Adverse Event|0
1136047|NCT01470469|3731127|P2|Overall Study|Lack of Efficacy|7
1136048|NCT01470469|3731128|P1|Overall Study|Lack of Efficacy|1
1136049|NCT01470469|3731127|P2|Overall Study|Withdrawal by Subject|6
1136050|NCT01470469|3731128|P1|Overall Study|Withdrawal by Subject|4
1136051|NCT01470417|3731148|P2|Overall Study|Disease progression|2
1136052|NCT01470417|3731149|P1|Overall Study|Disease progression|0
1136053|NCT01470326|3731161|P1|Overall Study|No Visit After 1st Day of Treatment|119
1136054|NCT01470326|3731161|P1|Overall Study|No Drug Administration Information|2
1136055|NCT01470326|3731161|P1|Overall Study|Protocol Violation|32
1136056|NCT01470248|3731172|P1|Overall Study|Withdrawal by Subject|1
1136057|NCT01470144|3731228|P1|Overall Study|Patient’s and investigator’s decision|1
1136058|NCT01470144|3731228|P1|Overall Study|Lung transplant|6
1136059|NCT01470144|3731228|P1|Overall Study|Death|1
1136060|NCT01470144|3731228|P1|Overall Study|Adverse Event|2
1136061|NCT01470001|3731333|P2|Overall Study|Withdrawal by Subject|1
1136062|NCT01470001|3731334|P1|Overall Study|Withdrawal by Subject|2
1136063|NCT01470001|3731333|P2|Overall Study|Physician Decision|0
1136064|NCT01470001|3731334|P1|Overall Study|Physician Decision|2
1136065|NCT01470001|3731333|P2|Overall Study|Lost to Follow-up|1
1136066|NCT01470001|3731334|P1|Overall Study|Lost to Follow-up|1
1136067|NCT01469819|3731344|P1|Overall Study|Technical malfunction of SmartPill data|3
1136068|NCT01469819|3731344|P1|Overall Study|Could not swallow SmartPill|2
1136069|NCT01469819|3731344|P1|Overall Study|Did not meet inclusionary criteria|2
1136070|NCT01469819|3731344|P1|Overall Study|Withdrawal by Subject|1
1136071|NCT01469637|3731368|P2|Second Intervention|Incarcerated|0
1136072|NCT01469637|3731369|P1|Second Intervention|Incarcerated|1
1136073|NCT01469637|3731368|P2|First Intervention|Unacceptable behavior|1
1136074|NCT01469637|3731369|P1|First Intervention|Unacceptable behavior|0
1136075|NCT01469546|3731377|P1|Received 5 mg Dose|Physician Decision|3
1136076|NCT01469546|3731377|P1|Received 5 mg Dose|Progressive Disease|3
1136077|NCT01469546|3731377|P1|Received 5 mg Dose|Protocol Violation|2
1136078|NCT01469546|3731377|P1|Received 5 mg Dose|Death|2
1136079|NCT01469546|3731377|P1|Received 5 mg Dose|Adverse Event|13
1136080|NCT01469377|3731387|P3|Overall Study|Other Miscellaneous Reasons|0
1136081|NCT01469377|3731388|P2|Overall Study|Other Miscellaneous Reasons|0
1136082|NCT01469377|3731389|P1|Overall Study|Other Miscellaneous Reasons|2
1136083|NCT01469377|3731387|P3|Overall Study|Insufficient Therapeutic Response|0
1136084|NCT01469377|3731388|P2|Overall Study|Insufficient Therapeutic Response|4
1136085|NCT01469377|3731389|P1|Overall Study|Insufficient Therapeutic Response|3
1136086|NCT01469377|3731387|P3|Overall Study|Adverse Event|36
1136087|NCT01469377|3731388|P2|Overall Study|Adverse Event|18
1136088|NCT01469377|3731389|P1|Overall Study|Adverse Event|8
1136089|NCT01469377|3731387|P3|Overall Study|Withdrawal of Consent|15
1136090|NCT01469377|3731388|P2|Overall Study|Withdrawal of Consent|14
1136091|NCT01469377|3731389|P1|Overall Study|Withdrawal of Consent|12
1136092|NCT01469377|3731387|P3|Overall Study|Lost to Follow-up|5
1136093|NCT01469377|3731388|P2|Overall Study|Lost to Follow-up|2
1136094|NCT01469377|3731389|P1|Overall Study|Lost to Follow-up|3
1136095|NCT01469377|3731387|P3|Overall Study|Protocol Deviation|10
1136096|NCT01469377|3731388|P2|Overall Study|Protocol Deviation|10
1136097|NCT01469377|3731389|P1|Overall Study|Protocol Deviation|7
1136098|NCT01469364|3731400|P1|Overall Study|Withdrawal by Subject|1
1136099|NCT01469364|3731400|P1|Overall Study|Adverse Event|1
1136100|NCT01469221|3731451|P3|Double Blind Phase|Sponsor Terminate Study|0
1136101|NCT01469221|3731452|P2|Double Blind Phase|Sponsor Terminate Study|16
1136102|NCT01469221|3731453|P1|Double Blind Phase|Sponsor Terminate Study|12
1136103|NCT01469221|3731451|P3|Double Blind Phase|Physician Decision|0
1136104|NCT01469221|3731452|P2|Double Blind Phase|Physician Decision|1
1136105|NCT01469221|3731453|P1|Double Blind Phase|Physician Decision|1
1136106|NCT01469221|3731451|P3|Double Blind Phase|Protocol Violation|0
1136107|NCT01469221|3731452|P2|Double Blind Phase|Protocol Violation|0
1136108|NCT01469221|3731453|P1|Double Blind Phase|Protocol Violation|1
1136109|NCT01469182|3731464|P2|Overall Study|Did not meet Protocol Eligibility|0
1136110|NCT01469182|3731465|P1|Overall Study|Did not meet Protocol Eligibility|3
1136111|NCT01469182|3731464|P2|Overall Study|Protocol Violation|2
1136112|NCT01469182|3731465|P1|Overall Study|Protocol Violation|4
1136113|NCT01469182|3731464|P2|Overall Study|Withdrawal by Subject|1
1136114|NCT01469182|3731465|P1|Overall Study|Withdrawal by Subject|4
1136115|NCT01469182|3731464|P2|Overall Study|Lost to Follow-up|0
1136116|NCT01469182|3731465|P1|Overall Study|Lost to Follow-up|3
1136117|NCT01469182|3731464|P2|Overall Study|Adverse Event|3
1136118|NCT01469182|3731465|P1|Overall Study|Adverse Event|21
1136119|NCT01469065|3731492|P5|Overall Study|Not specified|0
1136120|NCT01469065|3731493|P4|Overall Study|Not specified|0
1136121|NCT01469065|3731494|P3|Overall Study|Not specified|0
1136122|NCT01469065|3731495|P2|Overall Study|Not specified|1
1136123|NCT01469065|3731496|P1|Overall Study|Not specified|0
1136124|NCT01469065|3731492|P5|Overall Study|Lack of Efficacy|1
1136125|NCT01469065|3731493|P4|Overall Study|Lack of Efficacy|0
1136126|NCT01469065|3731494|P3|Overall Study|Lack of Efficacy|0
1136127|NCT01469065|3731495|P2|Overall Study|Lack of Efficacy|0
1136128|NCT01469065|3731496|P1|Overall Study|Lack of Efficacy|0
1136129|NCT01469052|3731592|P6|Overall Study|Other|0
1136130|NCT01469052|3731593|P5|Overall Study|Other|1
1136131|NCT01469052|3731594|P4|Overall Study|Other|0
1136132|NCT01469052|3731595|P3|Overall Study|Other|0
1136133|NCT01469052|3731596|P2|Overall Study|Other|1
1136134|NCT01469052|3731597|P1|Overall Study|Other|0
1136135|NCT01469052|3731592|P6|Overall Study|Moved to rollover protocol|1
1136136|NCT01469052|3731593|P5|Overall Study|Moved to rollover protocol|0
1136137|NCT01469052|3731594|P4|Overall Study|Moved to rollover protocol|0
1136138|NCT01469052|3731595|P3|Overall Study|Moved to rollover protocol|1
1136139|NCT01469052|3731596|P2|Overall Study|Moved to rollover protocol|0
1136140|NCT01469052|3731597|P1|Overall Study|Moved to rollover protocol|1
1136141|NCT01469052|3731592|P6|Overall Study|Lack of Efficacy|2
1136142|NCT01469052|3731593|P5|Overall Study|Lack of Efficacy|0
1136143|NCT01469052|3731594|P4|Overall Study|Lack of Efficacy|0
1136144|NCT01469052|3731595|P3|Overall Study|Lack of Efficacy|0
1136145|NCT01469052|3731596|P2|Overall Study|Lack of Efficacy|0
1136146|NCT01469052|3731597|P1|Overall Study|Lack of Efficacy|0
1136147|NCT01469052|3731592|P6|Overall Study|Progressive disease|2
1136148|NCT01469052|3731593|P5|Overall Study|Progressive disease|7
1136149|NCT01469052|3731594|P4|Overall Study|Progressive disease|3
1136150|NCT01469052|3731595|P3|Overall Study|Progressive disease|5
1136151|NCT01469052|3731596|P2|Overall Study|Progressive disease|0
1136152|NCT01469052|3731597|P1|Overall Study|Progressive disease|3
1136153|NCT01469052|3731592|P6|Overall Study|Adverse Event|1
1136154|NCT01469052|3731593|P5|Overall Study|Adverse Event|0
1136155|NCT01469052|3731594|P4|Overall Study|Adverse Event|2
1136156|NCT01469052|3731595|P3|Overall Study|Adverse Event|0
1136157|NCT01469052|3731596|P2|Overall Study|Adverse Event|3
1136158|NCT01469052|3731597|P1|Overall Study|Adverse Event|2
1136159|NCT01469013|3731662|P13|Part B (Extension Period)|Withdrawal by Subject|3
1136160|NCT01469013|3731663|P12|Part B (Extension Period)|Withdrawal by Subject|0
1136161|NCT01469013|3731664|P11|Part B (Extension Period)|Withdrawal by Subject|1
1136162|NCT01469013|3731665|P10|Part B (Extension Period)|Withdrawal by Subject|0
1136163|NCT01469013|3731666|P9|Part B (Extension Period)|Withdrawal by Subject|1
1136164|NCT01469013|3731667|P8|Part B (Extension Period)|Withdrawal by Subject|0
1136165|NCT01469013|3731668|P7|Part B (Extension Period)|Withdrawal by Subject|0
1136166|NCT01469013|3731669|P6|Part B (Extension Period)|Withdrawal by Subject|0
1136167|NCT01469013|3731670|P5|Part B (Extension Period)|Withdrawal by Subject|0
1136168|NCT01469013|3731671|P4|Part B (Extension Period)|Withdrawal by Subject|0
1136169|NCT01469013|3731672|P3|Part B (Extension Period)|Withdrawal by Subject|0
1136170|NCT01469013|3731673|P2|Part B (Extension Period)|Withdrawal by Subject|0
1136171|NCT01469013|3731674|P1|Part B (Extension Period)|Withdrawal by Subject|0
1136172|NCT01469013|3731662|P13|Part B (Extension Period)|Adverse Event|3
1136173|NCT01469013|3731663|P12|Part B (Extension Period)|Adverse Event|6
1136174|NCT01469013|3731664|P11|Part B (Extension Period)|Adverse Event|1
1136175|NCT01469013|3731665|P10|Part B (Extension Period)|Adverse Event|3
1136176|NCT01469013|3731666|P9|Part B (Extension Period)|Adverse Event|3
1136177|NCT01469013|3731667|P8|Part B (Extension Period)|Adverse Event|5
1136178|NCT01469013|3731668|P7|Part B (Extension Period)|Adverse Event|5
1136179|NCT01469013|3731669|P6|Part B (Extension Period)|Adverse Event|2
1136180|NCT01469013|3731670|P5|Part B (Extension Period)|Adverse Event|0
1136181|NCT01469013|3731671|P4|Part B (Extension Period)|Adverse Event|0
1136182|NCT01469013|3731672|P3|Part B (Extension Period)|Adverse Event|0
1136183|NCT01469013|3731673|P2|Part B (Extension Period)|Adverse Event|0
1136184|NCT01469013|3731674|P1|Part B (Extension Period)|Adverse Event|0
1136185|NCT01469013|3731662|P13|Part A (Treatment Period)|Withdrawal by Subject|0
1136186|NCT01469013|3731663|P12|Part A (Treatment Period)|Withdrawal by Subject|0
1136187|NCT01469013|3731664|P11|Part A (Treatment Period)|Withdrawal by Subject|0
1136188|NCT01469013|3731665|P10|Part A (Treatment Period)|Withdrawal by Subject|0
1136189|NCT01469013|3731666|P9|Part A (Treatment Period)|Withdrawal by Subject|0
1136190|NCT01469013|3731667|P8|Part A (Treatment Period)|Withdrawal by Subject|0
1136191|NCT01469013|3731668|P7|Part A (Treatment Period)|Withdrawal by Subject|0
1136192|NCT01469013|3731669|P6|Part A (Treatment Period)|Withdrawal by Subject|0
1136193|NCT01469013|3731670|P5|Part A (Treatment Period)|Withdrawal by Subject|0
1136194|NCT01469013|3731671|P4|Part A (Treatment Period)|Withdrawal by Subject|0
1136195|NCT01469013|3731672|P3|Part A (Treatment Period)|Withdrawal by Subject|1
1136196|NCT01469013|3731673|P2|Part A (Treatment Period)|Withdrawal by Subject|0
1136197|NCT01469013|3731674|P1|Part A (Treatment Period)|Withdrawal by Subject|0
1136198|NCT01469013|3731662|P13|Part A (Treatment Period)|Adverse Event|0
1136199|NCT01469013|3731663|P12|Part A (Treatment Period)|Adverse Event|0
1136200|NCT01469013|3731664|P11|Part A (Treatment Period)|Adverse Event|0
1136201|NCT01469013|3731665|P10|Part A (Treatment Period)|Adverse Event|0
1136202|NCT01469013|3731666|P9|Part A (Treatment Period)|Adverse Event|0
1136203|NCT01469013|3731667|P8|Part A (Treatment Period)|Adverse Event|0
1136204|NCT01469013|3731668|P7|Part A (Treatment Period)|Adverse Event|0
1136205|NCT01469013|3731669|P6|Part A (Treatment Period)|Adverse Event|0
1136206|NCT01469013|3731670|P5|Part A (Treatment Period)|Adverse Event|1
1136207|NCT01469013|3731671|P4|Part A (Treatment Period)|Adverse Event|0
1136208|NCT01469013|3731672|P3|Part A (Treatment Period)|Adverse Event|0
1136209|NCT01469013|3731673|P2|Part A (Treatment Period)|Adverse Event|0
1136210|NCT01469013|3731674|P1|Part A (Treatment Period)|Adverse Event|1
1136211|NCT01469000|3731759|P2|Overall Study|On treatment, not yet died or PD|7
1136212|NCT01469000|3731760|P1|Overall Study|On treatment, not yet died or PD|23
1136213|NCT01469000|3731759|P2|Overall Study|Entry Criteria Not Met|0
1136214|NCT01469000|3731760|P1|Overall Study|Entry Criteria Not Met|1
1136215|NCT01469000|3731759|P2|Overall Study|Physician Decision|1
1136216|NCT01469000|3731760|P1|Overall Study|Physician Decision|0
1136217|NCT01469000|3731759|P2|Overall Study|Withdrawal by Subject|1
1136218|NCT01469000|3731760|P1|Overall Study|Withdrawal by Subject|9
1136219|NCT01468987|3731776|P2|Overall Study|Sponsor Decision|0
1136220|NCT01468987|3731777|P1|Overall Study|Sponsor Decision|1
1136221|NCT01468987|3731776|P2|Overall Study|Physician Decision|15
1136222|NCT01468987|3731777|P1|Overall Study|Physician Decision|8
1136223|NCT01468987|3731776|P2|Overall Study|Withdrawal by Subject|28
1136224|NCT01468987|3731777|P1|Overall Study|Withdrawal by Subject|28
1136225|NCT01468987|3731776|P2|Overall Study|Protocol Violation|2
1136226|NCT01468987|3731777|P1|Overall Study|Protocol Violation|8
1136227|NCT01468987|3731776|P2|Overall Study|Lost to Follow-up|5
1136228|NCT01468987|3731777|P1|Overall Study|Lost to Follow-up|10
1136229|NCT01468987|3731776|P2|Overall Study|Death|1
1136230|NCT01468987|3731777|P1|Overall Study|Death|4
1136231|NCT01468987|3731776|P2|Overall Study|Adverse Event|9
1136232|NCT01468987|3731777|P1|Overall Study|Adverse Event|12
1136233|NCT01468818|3731840|P1|Overall Study|Death during treatment|2
1136234|NCT01468311|3731898|P1|Overall Study|Withdrawal by Subject|1
1136235|NCT01468311|3731898|P1|Overall Study|mobilization failure|1
1136236|NCT01468233|3731910|P6|Treatment Period 2|Not specified|0
1136237|NCT01468233|3731911|P5|Treatment Period 2|Not specified|1
1136238|NCT01468233|3731912|P4|Treatment Period 2|Not specified|0
1136239|NCT01468233|3731913|P3|Treatment Period 2|Not specified|3
1136240|NCT01468233|3731914|P2|Treatment Period 2|Not specified|0
1136241|NCT01468233|3731915|P1|Treatment Period 2|Not specified|0
1136242|NCT01468233|3731910|P6|Treatment Period 2|Lost to Follow-up|0
1136243|NCT01468233|3731911|P5|Treatment Period 2|Lost to Follow-up|2
1136244|NCT01468233|3731912|P4|Treatment Period 2|Lost to Follow-up|0
1136245|NCT01468233|3731913|P3|Treatment Period 2|Lost to Follow-up|3
1136246|NCT01468233|3731914|P2|Treatment Period 2|Lost to Follow-up|0
1136247|NCT01468233|3731915|P1|Treatment Period 2|Lost to Follow-up|0
1136248|NCT01468233|3731910|P6|Treatment Period 2|Loss/absence of response (per protocol)|20
1136249|NCT01468233|3731911|P5|Treatment Period 2|Loss/absence of response (per protocol)|22
1136250|NCT01468233|3731912|P4|Treatment Period 2|Loss/absence of response (per protocol)|25
1136251|NCT01468233|3731913|P3|Treatment Period 2|Loss/absence of response (per protocol)|84
1136252|NCT01468233|3731914|P2|Treatment Period 2|Loss/absence of response (per protocol)|0
1136253|NCT01468233|3731915|P1|Treatment Period 2|Loss/absence of response (per protocol)|0
1136254|NCT01468233|3731910|P6|Treatment Period 2|Withdrawal by Subject|1
1136255|NCT01468233|3731911|P5|Treatment Period 2|Withdrawal by Subject|1
1136256|NCT01468233|3731912|P4|Treatment Period 2|Withdrawal by Subject|1
1136257|NCT01468233|3731913|P3|Treatment Period 2|Withdrawal by Subject|9
1136258|NCT01468233|3731914|P2|Treatment Period 2|Withdrawal by Subject|0
1136259|NCT01468233|3731915|P1|Treatment Period 2|Withdrawal by Subject|0
1136260|NCT01468233|3731910|P6|Treatment Period 2|Lack of Efficacy|1
1136261|NCT01468233|3731911|P5|Treatment Period 2|Lack of Efficacy|0
1136262|NCT01468233|3731912|P4|Treatment Period 2|Lack of Efficacy|2
1136263|NCT01468233|3731913|P3|Treatment Period 2|Lack of Efficacy|9
1136264|NCT01468233|3731914|P2|Treatment Period 2|Lack of Efficacy|0
1136265|NCT01468233|3731915|P1|Treatment Period 2|Lack of Efficacy|0
1136266|NCT01468233|3731910|P6|Treatment Period 2|Adverse Event|1
1136267|NCT01468233|3731911|P5|Treatment Period 2|Adverse Event|2
1136268|NCT01468233|3731912|P4|Treatment Period 2|Adverse Event|0
1136269|NCT01468233|3731913|P3|Treatment Period 2|Adverse Event|3
1136270|NCT01468233|3731914|P2|Treatment Period 2|Adverse Event|0
1136271|NCT01468233|3731915|P1|Treatment Period 2|Adverse Event|0
1136272|NCT01468233|3731910|P6|Treatment Period 1|Not specified|0
1136273|NCT01468233|3731911|P5|Treatment Period 1|Not specified|0
1136274|NCT01468233|3731912|P4|Treatment Period 1|Not specified|0
1136275|NCT01468233|3731913|P3|Treatment Period 1|Not specified|0
1136276|NCT01468233|3731914|P2|Treatment Period 1|Not specified|1
1136277|NCT01468233|3731915|P1|Treatment Period 1|Not specified|1
1136278|NCT01468233|3731910|P6|Treatment Period 1|Lost to Follow-up|0
1136279|NCT01468233|3731911|P5|Treatment Period 1|Lost to Follow-up|0
1136280|NCT01468233|3731912|P4|Treatment Period 1|Lost to Follow-up|0
1136281|NCT01468233|3731913|P3|Treatment Period 1|Lost to Follow-up|0
1136282|NCT01468233|3731914|P2|Treatment Period 1|Lost to Follow-up|0
1136283|NCT01468233|3731915|P1|Treatment Period 1|Lost to Follow-up|3
1136284|NCT01468233|3731910|P6|Treatment Period 1|Withdrawal by Subject|0
1136285|NCT01468233|3731911|P5|Treatment Period 1|Withdrawal by Subject|0
1136286|NCT01468233|3731912|P4|Treatment Period 1|Withdrawal by Subject|0
1136287|NCT01468233|3731913|P3|Treatment Period 1|Withdrawal by Subject|0
1136288|NCT01468233|3731914|P2|Treatment Period 1|Withdrawal by Subject|4
1136289|NCT01468233|3731915|P1|Treatment Period 1|Withdrawal by Subject|3
1136290|NCT01468233|3731910|P6|Treatment Period 1|Adverse Event|0
1136291|NCT01468233|3731911|P5|Treatment Period 1|Adverse Event|0
1136292|NCT01468233|3731912|P4|Treatment Period 1|Adverse Event|0
1136293|NCT01468233|3731913|P3|Treatment Period 1|Adverse Event|0
1136294|NCT01468233|3731914|P2|Treatment Period 1|Adverse Event|3
1136295|NCT01468233|3731915|P1|Treatment Period 1|Adverse Event|5
1136296|NCT01468207|3731937|P6|Treatment Period 2|Not specified|2
1136297|NCT01468207|3731938|P5|Treatment Period 2|Not specified|1
1136298|NCT01468207|3731939|P4|Treatment Period 2|Not specified|1
1136299|NCT01468207|3731940|P3|Treatment Period 2|Not specified|5
1136300|NCT01468207|3731941|P2|Treatment Period 2|Not specified|0
1136301|NCT01468207|3731942|P1|Treatment Period 2|Not specified|0
1136302|NCT01468207|3731937|P6|Treatment Period 2|Lost to Follow-up|0
1136303|NCT01468207|3731938|P5|Treatment Period 2|Lost to Follow-up|0
1136304|NCT01468207|3731939|P4|Treatment Period 2|Lost to Follow-up|1
1136305|NCT01468207|3731940|P3|Treatment Period 2|Lost to Follow-up|5
1136306|NCT01468207|3731941|P2|Treatment Period 2|Lost to Follow-up|0
1136307|NCT01468207|3731942|P1|Treatment Period 2|Lost to Follow-up|0
1136308|NCT01468207|3731937|P6|Treatment Period 2|Loss/abscence of response (per protocol)|13
1136309|NCT01468207|3731938|P5|Treatment Period 2|Loss/abscence of response (per protocol)|18
1136310|NCT01468207|3731939|P4|Treatment Period 2|Loss/abscence of response (per protocol)|23
1136311|NCT01468207|3731940|P3|Treatment Period 2|Loss/abscence of response (per protocol)|30
1136312|NCT01468207|3731941|P2|Treatment Period 2|Loss/abscence of response (per protocol)|0
1136313|NCT01468207|3731942|P1|Treatment Period 2|Loss/abscence of response (per protocol)|0
1136314|NCT01468207|3731937|P6|Treatment Period 2|Withdrawal by Subject|2
1136315|NCT01468207|3731938|P5|Treatment Period 2|Withdrawal by Subject|0
1136316|NCT01468207|3731939|P4|Treatment Period 2|Withdrawal by Subject|0
1136317|NCT01468207|3731940|P3|Treatment Period 2|Withdrawal by Subject|5
1136318|NCT01468207|3731941|P2|Treatment Period 2|Withdrawal by Subject|0
1136319|NCT01468207|3731942|P1|Treatment Period 2|Withdrawal by Subject|0
1136320|NCT01468207|3731937|P6|Treatment Period 2|Lack of Efficacy|2
1136321|NCT01468207|3731938|P5|Treatment Period 2|Lack of Efficacy|0
1136322|NCT01468207|3731939|P4|Treatment Period 2|Lack of Efficacy|1
1136323|NCT01468207|3731940|P3|Treatment Period 2|Lack of Efficacy|1
1136324|NCT01468207|3731941|P2|Treatment Period 2|Lack of Efficacy|0
1136325|NCT01468207|3731942|P1|Treatment Period 2|Lack of Efficacy|0
1136326|NCT01468207|3731937|P6|Treatment Period 2|Adverse Event|1
1136327|NCT01468207|3731938|P5|Treatment Period 2|Adverse Event|2
1136328|NCT01468207|3731939|P4|Treatment Period 2|Adverse Event|1
1136329|NCT01468207|3731940|P3|Treatment Period 2|Adverse Event|6
1136330|NCT01468207|3731941|P2|Treatment Period 2|Adverse Event|0
1136331|NCT01468207|3731942|P1|Treatment Period 2|Adverse Event|0
1136332|NCT01468207|3731937|P6|Treatment Period 1|Not specified|0
1136333|NCT01468207|3731938|P5|Treatment Period 1|Not specified|0
1136334|NCT01468207|3731939|P4|Treatment Period 1|Not specified|0
1136335|NCT01468207|3731940|P3|Treatment Period 1|Not specified|0
1136336|NCT01468207|3731941|P2|Treatment Period 1|Not specified|2
1136337|NCT01468207|3731942|P1|Treatment Period 1|Not specified|0
1136338|NCT01468207|3731937|P6|Treatment Period 1|Lost to Follow-up|0
1136339|NCT01468207|3731938|P5|Treatment Period 1|Lost to Follow-up|0
1136340|NCT01468207|3731939|P4|Treatment Period 1|Lost to Follow-up|0
1136341|NCT01468207|3731940|P3|Treatment Period 1|Lost to Follow-up|0
1136342|NCT01468207|3731941|P2|Treatment Period 1|Lost to Follow-up|1
1136343|NCT01468207|3731942|P1|Treatment Period 1|Lost to Follow-up|2
1136344|NCT01468207|3731937|P6|Treatment Period 1|Withdrawal by Subject|0
1136345|NCT01468207|3731938|P5|Treatment Period 1|Withdrawal by Subject|0
1136346|NCT01468207|3731939|P4|Treatment Period 1|Withdrawal by Subject|0
1136347|NCT01468207|3731940|P3|Treatment Period 1|Withdrawal by Subject|0
1136348|NCT01468207|3731941|P2|Treatment Period 1|Withdrawal by Subject|4
1136349|NCT01468207|3731942|P1|Treatment Period 1|Withdrawal by Subject|5
1136350|NCT01468207|3731937|P6|Treatment Period 1|Protocol Violation|0
1136351|NCT01468207|3731938|P5|Treatment Period 1|Protocol Violation|0
1136352|NCT01468207|3731939|P4|Treatment Period 1|Protocol Violation|0
1136353|NCT01468207|3731940|P3|Treatment Period 1|Protocol Violation|0
1136354|NCT01468207|3731941|P2|Treatment Period 1|Protocol Violation|1
1136355|NCT01468207|3731942|P1|Treatment Period 1|Protocol Violation|1
1136356|NCT01468207|3731937|P6|Treatment Period 1|Adverse Event|0
1136357|NCT01468207|3731938|P5|Treatment Period 1|Adverse Event|0
1136358|NCT01468207|3731939|P4|Treatment Period 1|Adverse Event|0
1136359|NCT01468207|3731940|P3|Treatment Period 1|Adverse Event|0
1136360|NCT01468207|3731941|P2|Treatment Period 1|Adverse Event|0
1136361|NCT01468207|3731942|P1|Treatment Period 1|Adverse Event|1
1136362|NCT01468181|3731967|P5|Overall Study|Withdrawal by Subject|0
1136363|NCT01468181|3731968|P4|Overall Study|Withdrawal by Subject|0
1136364|NCT01468181|3731969|P3|Overall Study|Withdrawal by Subject|0
1136365|NCT01468181|3731970|P2|Overall Study|Withdrawal by Subject|1
1136366|NCT01468181|3731971|P1|Overall Study|Withdrawal by Subject|0
1136367|NCT01468181|3731967|P5|Overall Study|Lost to Follow-up|1
1136368|NCT01468181|3731968|P4|Overall Study|Lost to Follow-up|0
1136369|NCT01468181|3731969|P3|Overall Study|Lost to Follow-up|1
1136370|NCT01468181|3731970|P2|Overall Study|Lost to Follow-up|0
1136371|NCT01468181|3731971|P1|Overall Study|Lost to Follow-up|0
1136372|NCT01468181|3731967|P5|Overall Study|Physician Decision|1
1136373|NCT01468181|3731968|P4|Overall Study|Physician Decision|1
1136374|NCT01468181|3731969|P3|Overall Study|Physician Decision|0
1136375|NCT01468181|3731970|P2|Overall Study|Physician Decision|0
1136376|NCT01468181|3731971|P1|Overall Study|Physician Decision|0
1136377|NCT01468181|3731967|P5|Overall Study|Protocol Violation|1
1136378|NCT01468181|3731968|P4|Overall Study|Protocol Violation|0
1136379|NCT01468181|3731969|P3|Overall Study|Protocol Violation|1
1136380|NCT01468181|3731970|P2|Overall Study|Protocol Violation|0
1136381|NCT01468181|3731971|P1|Overall Study|Protocol Violation|2
1136382|NCT01468181|3731967|P5|Overall Study|Adverse Event|2
1136383|NCT01468181|3731968|P4|Overall Study|Adverse Event|2
1136384|NCT01468181|3731969|P3|Overall Study|Adverse Event|6
1136385|NCT01468181|3731970|P2|Overall Study|Adverse Event|1
1136386|NCT01468181|3731971|P1|Overall Study|Adverse Event|8
1136387|NCT01468077|3732020|P2|Overall Study|Physician Decision|0
1136388|NCT01468077|3732021|P1|Overall Study|Physician Decision|1
1136389|NCT01468077|3732020|P2|Overall Study|Lack of Efficacy|1
1136390|NCT01468077|3732021|P1|Overall Study|Lack of Efficacy|1
1136391|NCT01468077|3732020|P2|Overall Study|Adverse Event|2
1136392|NCT01468077|3732021|P1|Overall Study|Adverse Event|2
1136393|NCT01467960|3732083|P6|Overall Study|Enrollment of patients (PD) in 09/2013|30
1136394|NCT01467960|3732084|P5|Overall Study|Enrollment of patients (PD) in 09/2013|30
1136395|NCT01467960|3732085|P4|Overall Study|Enrollment of patients (PD) in 09/2013|30
1136396|NCT01467960|3732086|P3|Overall Study|Enrollment of patients (PD) in 09/2013|0
1136397|NCT01467960|3732087|P2|Overall Study|Enrollment of patients (PD) in 09/2013|0
1136398|NCT01467960|3732088|P1|Overall Study|Enrollment of patients (PD) in 09/2013|0
1136399|NCT01467713|3732147|P4|Overall Study|Reason not Specified|7
1136400|NCT01467713|3732148|P3|Overall Study|Reason not Specified|8
1136401|NCT01467713|3732149|P2|Overall Study|Reason not Specified|11
1136402|NCT01467713|3732150|P1|Overall Study|Reason not Specified|6
1136403|NCT01467713|3732147|P4|Overall Study|Relapse|35
1136404|NCT01467713|3732148|P3|Overall Study|Relapse|28
1136405|NCT01467713|3732149|P2|Overall Study|Relapse|25
1136406|NCT01467713|3732150|P1|Overall Study|Relapse|35
1136407|NCT01467713|3732147|P4|Overall Study|Pregnancy|3
1136408|NCT01467713|3732148|P3|Overall Study|Pregnancy|1
1136409|NCT01467713|3732149|P2|Overall Study|Pregnancy|1
1136410|NCT01467713|3732150|P1|Overall Study|Pregnancy|0
1136411|NCT01467713|3732147|P4|Overall Study|Study Termination|29
1136412|NCT01467713|3732148|P3|Overall Study|Study Termination|28
1136413|NCT01467713|3732149|P2|Overall Study|Study Termination|33
1136414|NCT01467713|3732150|P1|Overall Study|Study Termination|23
1136415|NCT01467713|3732147|P4|Overall Study|Voluntary Withdrawal|20
1136416|NCT01467713|3732148|P3|Overall Study|Voluntary Withdrawal|21
1136417|NCT01467713|3732149|P2|Overall Study|Voluntary Withdrawal|14
1136418|NCT01467713|3732150|P1|Overall Study|Voluntary Withdrawal|18
1136419|NCT01467713|3732147|P4|Overall Study|Lost to Follow-up|9
1136420|NCT01467713|3732148|P3|Overall Study|Lost to Follow-up|6
1136421|NCT01467713|3732149|P2|Overall Study|Lost to Follow-up|12
1136422|NCT01467713|3732150|P1|Overall Study|Lost to Follow-up|9
1136423|NCT01467713|3732147|P4|Overall Study|Major Protocol Deviation|1
1136424|NCT01467713|3732148|P3|Overall Study|Major Protocol Deviation|4
1136425|NCT01467713|3732149|P2|Overall Study|Major Protocol Deviation|4
1136426|NCT01467713|3732150|P1|Overall Study|Major Protocol Deviation|2
1136427|NCT01467713|3732147|P4|Overall Study|Pretreatment Event or Adverse Event|5
1136428|NCT01467713|3732148|P3|Overall Study|Pretreatment Event or Adverse Event|6
1136429|NCT01467713|3732149|P2|Overall Study|Pretreatment Event or Adverse Event|4
1136430|NCT01467713|3732150|P1|Overall Study|Pretreatment Event or Adverse Event|9
1136431|NCT01467700|3732204|P4|Overall Study|Reason not Specified|8
1136432|NCT01467700|3732205|P3|Overall Study|Reason not Specified|2
1136433|NCT01467700|3732206|P2|Overall Study|Reason not Specified|3
1136434|NCT01467700|3732207|P1|Overall Study|Reason not Specified|1
1136435|NCT01467700|3732204|P4|Overall Study|Lack of Efficacy|1
1136436|NCT01467700|3732205|P3|Overall Study|Lack of Efficacy|2
1136437|NCT01467700|3732206|P2|Overall Study|Lack of Efficacy|0
1136438|NCT01467700|3732207|P1|Overall Study|Lack of Efficacy|2
1136439|NCT01467700|3732204|P4|Overall Study|Pregnancy|0
1136440|NCT01467700|3732205|P3|Overall Study|Pregnancy|1
1136441|NCT01467700|3732206|P2|Overall Study|Pregnancy|1
1136442|NCT01467700|3732207|P1|Overall Study|Pregnancy|0
1136443|NCT01467700|3732204|P4|Overall Study|Study Termination|7
1136444|NCT01467700|3732205|P3|Overall Study|Study Termination|10
1136445|NCT01467700|3732206|P2|Overall Study|Study Termination|5
1136446|NCT01467700|3732207|P1|Overall Study|Study Termination|6
1136447|NCT01467700|3732204|P4|Overall Study|Voluntary Withdrawal|2
1136448|NCT01467700|3732205|P3|Overall Study|Voluntary Withdrawal|6
1136449|NCT01467700|3732206|P2|Overall Study|Voluntary Withdrawal|7
1136450|NCT01467700|3732207|P1|Overall Study|Voluntary Withdrawal|5
1136451|NCT01467700|3732204|P4|Overall Study|Lost to Follow-up|3
1136452|NCT01467700|3732205|P3|Overall Study|Lost to Follow-up|2
1136453|NCT01467700|3732206|P2|Overall Study|Lost to Follow-up|5
1136454|NCT01467700|3732207|P1|Overall Study|Lost to Follow-up|6
1136455|NCT01467700|3732204|P4|Overall Study|Major Protocol Deviation|3
1136456|NCT01467700|3732205|P3|Overall Study|Major Protocol Deviation|2
1136457|NCT01467700|3732206|P2|Overall Study|Major Protocol Deviation|3
1136458|NCT01467700|3732207|P1|Overall Study|Major Protocol Deviation|3
1136459|NCT01467700|3732204|P4|Overall Study|Pretreatment Event or Adverse Event|3
1136460|NCT01467700|3732205|P3|Overall Study|Pretreatment Event or Adverse Event|2
1136461|NCT01467700|3732206|P2|Overall Study|Pretreatment Event or Adverse Event|4
1136462|NCT01467700|3732207|P1|Overall Study|Pretreatment Event or Adverse Event|6
1136463|NCT01467661|3732249|P1|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1
1136464|NCT01467661|3732249|P1|Overall Study|Lack of Efficacy|3
1136465|NCT01467661|3732249|P1|Overall Study|Withdrawal by Subject|1
1136466|NCT01467661|3732249|P1|Overall Study|Adverse Event|16
1136467|NCT01467583|3732269|P3|Overall Study|Protocol Violation|2
1136468|NCT01467583|3732270|P2|Overall Study|Protocol Violation|0
1136469|NCT01467583|3732271|P1|Overall Study|Protocol Violation|0
1136470|NCT01467583|3732269|P3|Overall Study|Withdrawal by Subject|0
1136471|NCT01467583|3732270|P2|Overall Study|Withdrawal by Subject|0
1136472|NCT01467583|3732271|P1|Overall Study|Withdrawal by Subject|1
1136473|NCT01467583|3732269|P3|Overall Study|Death|0
1136474|NCT01467583|3732270|P2|Overall Study|Death|1
1136475|NCT01467583|3732271|P1|Overall Study|Death|1
1136476|NCT01467570|3732284|P2|Overall Study|Lost to Follow-up|9
1136477|NCT01467570|3732285|P1|Overall Study|Lost to Follow-up|8
1136478|NCT01467505|3732322|P2|Overall Study|Study Terminated by Sponsor|3
1136479|NCT01467505|3732323|P1|Overall Study|Study Terminated by Sponsor|28
1136480|NCT01467505|3732322|P2|Overall Study|Withdrawal by Subject|0
1136481|NCT01467505|3732323|P1|Overall Study|Withdrawal by Subject|4
1136482|NCT01467505|3732322|P2|Overall Study|Adverse Event|0
1136483|NCT01467505|3732323|P1|Overall Study|Adverse Event|1
1136484|NCT01467492|3732355|P2|Overall Study|Enrolled But Not Treated|0
1136485|NCT01467492|3732356|P1|Overall Study|Enrolled But Not Treated|1
1136486|NCT01467492|3732355|P2|Overall Study|Undefined|0
1136487|NCT01467492|3732356|P1|Overall Study|Undefined|2
1136488|NCT01467492|3732355|P2|Overall Study|Lost to Follow-up|2
1136489|NCT01467492|3732356|P1|Overall Study|Lost to Follow-up|3
1136490|NCT01467492|3732355|P2|Overall Study|Adverse Event|3
1136491|NCT01467492|3732356|P1|Overall Study|Adverse Event|4
1136492|NCT01467492|3732355|P2|Overall Study|Study Terminated by Sponsor|4
1136493|NCT01467492|3732356|P1|Overall Study|Study Terminated by Sponsor|6
1136494|NCT01467492|3732355|P2|Overall Study|Withdrawal by Subject|4
1136495|NCT01467492|3732356|P1|Overall Study|Withdrawal by Subject|6
1136496|NCT01467479|3732380|P3|Overall Study|Other|0
1136497|NCT01467479|3732381|P2|Overall Study|Other|0
1136498|NCT01467479|3732382|P1|Overall Study|Other|1
1136499|NCT01467479|3732380|P3|Overall Study|Study Terminated by Sponsor|3
1136500|NCT01467479|3732381|P2|Overall Study|Study Terminated by Sponsor|3
1136501|NCT01467479|3732382|P1|Overall Study|Study Terminated by Sponsor|1
1136502|NCT01467479|3732380|P3|Overall Study|Withdrawal of Consent|7
1136503|NCT01467479|3732381|P2|Overall Study|Withdrawal of Consent|7
1136504|NCT01467479|3732382|P1|Overall Study|Withdrawal of Consent|3
1136505|NCT01467479|3732380|P3|Overall Study|Lost to Follow-up|3
1136506|NCT01467479|3732381|P2|Overall Study|Lost to Follow-up|5
1136507|NCT01467479|3732382|P1|Overall Study|Lost to Follow-up|2
1136508|NCT01467479|3732380|P3|Overall Study|Death|1
1136509|NCT01467479|3732381|P2|Overall Study|Death|0
1136510|NCT01467479|3732382|P1|Overall Study|Death|0
1136511|NCT01467479|3732380|P3|Overall Study|Adverse Event|0
1136512|NCT01467479|3732381|P2|Overall Study|Adverse Event|2
1136513|NCT01467479|3732382|P1|Overall Study|Adverse Event|1
1136514|NCT01467479|3732380|P3|Overall Study|No Study Medication|2
1136515|NCT01467479|3732381|P2|Overall Study|No Study Medication|0
1136516|NCT01467479|3732382|P1|Overall Study|No Study Medication|1
1136517|NCT01467466|3732413|P4|Overall Study|No Endpoint Blood Draw|43
1136518|NCT01467466|3732414|P3|Overall Study|No Endpoint Blood Draw|51
1136519|NCT01467466|3732415|P2|Overall Study|No Endpoint Blood Draw|32
1136520|NCT01467466|3732416|P1|Overall Study|No Endpoint Blood Draw|38
1136521|NCT01467466|3732413|P4|Overall Study|Procedure Cancelled|29
1136522|NCT01467466|3732414|P3|Overall Study|Procedure Cancelled|25
1136523|NCT01467466|3732415|P2|Overall Study|Procedure Cancelled|45
1136524|NCT01467466|3732416|P1|Overall Study|Procedure Cancelled|46
1136525|NCT01467466|3732413|P4|Overall Study|Revoked Consent Prior To Procedure|5
1136526|NCT01467466|3732414|P3|Overall Study|Revoked Consent Prior To Procedure|15
1136527|NCT01467466|3732415|P2|Overall Study|Revoked Consent Prior To Procedure|9
1136528|NCT01467466|3732416|P1|Overall Study|Revoked Consent Prior To Procedure|10
1136529|NCT01467466|3732413|P4|Overall Study|Withdrawal by Subject|11
1136530|NCT01467466|3732414|P3|Overall Study|Withdrawal by Subject|13
1136531|NCT01467466|3732415|P2|Overall Study|Withdrawal by Subject|18
1136532|NCT01467466|3732416|P1|Overall Study|Withdrawal by Subject|15
1136533|NCT01467427|3732428|P2|Overall Study|Not continuing in extension phase|2
1136534|NCT01467427|3732429|P1|Overall Study|Not continuing in extension phase|0
1136535|NCT01467427|3732428|P2|Overall Study|Entered extension phase|11
1136536|NCT01467427|3732429|P1|Overall Study|Entered extension phase|11
1136537|NCT01467427|3732428|P2|Overall Study|Withdrawal by Subject|0
1136538|NCT01467427|3732429|P1|Overall Study|Withdrawal by Subject|1
1136539|NCT01467076|3732450|P3|Overall Study|Lost to Follow-up|0
1136540|NCT01467076|3732451|P2|Overall Study|Lost to Follow-up|0
1136541|NCT01467076|3732452|P1|Overall Study|Lost to Follow-up|1
1136542|NCT01466881|3732469|P1|Overall Study|Other reason not protocol specified|5
1136543|NCT01466881|3732469|P1|Overall Study|Death|4
1136544|NCT01466881|3732469|P1|Overall Study|Progression/relapse|20
1136545|NCT01466881|3732469|P1|Overall Study|Adverse Event|6
1136546|NCT01466881|3732469|P1|Overall Study|Ineligible|5
1136547|NCT01466790|3732486|P8|Overall Study|Withdrawal by Subject|1
1136548|NCT01466790|3732487|P7|Overall Study|Withdrawal by Subject|1
1136549|NCT01466790|3732488|P6|Overall Study|Withdrawal by Subject|0
1136550|NCT01466790|3732489|P5|Overall Study|Withdrawal by Subject|1
1136551|NCT01466790|3732490|P4|Overall Study|Withdrawal by Subject|0
1136552|NCT01466790|3732491|P3|Overall Study|Withdrawal by Subject|0
1136553|NCT01466790|3732492|P2|Overall Study|Withdrawal by Subject|1
1136554|NCT01466790|3732493|P1|Overall Study|Withdrawal by Subject|1
1136555|NCT01466790|3732486|P8|Overall Study|Lost to Follow-up|0
1136556|NCT01466790|3732487|P7|Overall Study|Lost to Follow-up|0
1136557|NCT01466790|3732488|P6|Overall Study|Lost to Follow-up|0
1136558|NCT01466790|3732489|P5|Overall Study|Lost to Follow-up|0
1136559|NCT01466790|3732490|P4|Overall Study|Lost to Follow-up|0
1136560|NCT01466790|3732491|P3|Overall Study|Lost to Follow-up|0
1136561|NCT01466790|3732492|P2|Overall Study|Lost to Follow-up|0
1136562|NCT01466790|3732493|P1|Overall Study|Lost to Follow-up|2
1136563|NCT01466790|3732486|P8|Overall Study|Adverse Event|0
1136564|NCT01466790|3732487|P7|Overall Study|Adverse Event|0
1136565|NCT01466790|3732488|P6|Overall Study|Adverse Event|0
1136566|NCT01466790|3732489|P5|Overall Study|Adverse Event|2
1136567|NCT01466790|3732490|P4|Overall Study|Adverse Event|0
1136568|NCT01466790|3732491|P3|Overall Study|Adverse Event|0
1136569|NCT01466790|3732492|P2|Overall Study|Adverse Event|0
1136570|NCT01466790|3732493|P1|Overall Study|Adverse Event|1
1136571|NCT01466673|3732578|P2|Overall Study|Adverse Event|1
1136572|NCT01466673|3732579|P1|Overall Study|Adverse Event|2
1136573|NCT01466673|3732578|P2|Overall Study|Lost to Follow-up|5
1136574|NCT01466673|3732579|P1|Overall Study|Lost to Follow-up|3
1136575|NCT01466673|3732578|P2|Overall Study|Non-compliance with study treatment|0
1136576|NCT01466673|3732579|P1|Overall Study|Non-compliance with study treatment|2
1136577|NCT01466660|3732605|P2|Overall Study|Other reason not defined above|6
1136578|NCT01466660|3732606|P1|Overall Study|Other reason not defined above|3
1136579|NCT01466660|3732605|P2|Overall Study|Refused continuation of trial medication|3
1136580|NCT01466660|3732606|P1|Overall Study|Refused continuation of trial medication|4
1136581|NCT01466660|3732605|P2|Overall Study|Protocol Violation|1
1136582|NCT01466660|3732606|P1|Overall Study|Protocol Violation|1
1136583|NCT01466660|3732605|P2|Overall Study|Other adverse event|17
1136584|NCT01466660|3732606|P1|Overall Study|Other adverse event|18
1136585|NCT01466660|3732605|P2|Overall Study|Worsening of underlying cancer disease|2
1136586|NCT01466660|3732606|P1|Overall Study|Worsening of underlying cancer disease|5
1136587|NCT01466660|3732605|P2|Overall Study|Progressive Disease (RECIST 1.1)|122
1136588|NCT01466660|3732606|P1|Overall Study|Progressive Disease (RECIST 1.1)|115
1136589|NCT01466595|3732632|P2|Overall Study|Withdrawal by Subject|1
1136590|NCT01466595|3732633|P1|Overall Study|Withdrawal by Subject|0
1136591|NCT01466491|3732727|P4|Overall Study|Missing Data|0
1136592|NCT01466491|3732728|P3|Overall Study|Missing Data|1
1136593|NCT01466491|3732729|P2|Overall Study|Missing Data|0
1136594|NCT01466491|3732730|P1|Overall Study|Missing Data|0
1136595|NCT01466491|3732727|P4|Overall Study|Protocol Violation|0
1136596|NCT01466491|3732728|P3|Overall Study|Protocol Violation|2
1136597|NCT01466491|3732729|P2|Overall Study|Protocol Violation|3
1136598|NCT01466491|3732730|P1|Overall Study|Protocol Violation|0
1136599|NCT01466387|3732750|P6|Overall Study|Protocol Violation|0
1136600|NCT01466387|3732751|P5|Overall Study|Protocol Violation|0
1136601|NCT01466387|3732752|P4|Overall Study|Protocol Violation|1
1136602|NCT01466387|3732753|P3|Overall Study|Protocol Violation|0
1136603|NCT01466387|3732754|P2|Overall Study|Protocol Violation|0
1136604|NCT01466387|3732755|P1|Overall Study|Protocol Violation|1
1136605|NCT01466387|3732750|P6|Overall Study|Lost to Follow-up|1
1136606|NCT01466387|3732751|P5|Overall Study|Lost to Follow-up|0
1136607|NCT01466387|3732752|P4|Overall Study|Lost to Follow-up|0
1136608|NCT01466387|3732753|P3|Overall Study|Lost to Follow-up|0
1136609|NCT01466387|3732754|P2|Overall Study|Lost to Follow-up|0
1136610|NCT01466387|3732755|P1|Overall Study|Lost to Follow-up|0
1136611|NCT01466387|3732750|P6|Overall Study|Adverse Event|0
1136612|NCT01466387|3732751|P5|Overall Study|Adverse Event|0
1136613|NCT01466387|3732752|P4|Overall Study|Adverse Event|1
1136614|NCT01466387|3732753|P3|Overall Study|Adverse Event|1
1136615|NCT01466387|3732754|P2|Overall Study|Adverse Event|0
1136616|NCT01466387|3732755|P1|Overall Study|Adverse Event|0
1136617|NCT01466348|3732816|P2|Period I - First Intervention|Withdrawal by Subject|1
1136618|NCT01466348|3732817|P1|Period I - First Intervention|Withdrawal by Subject|0
1136619|NCT01466270|3732845|P2|Overall Study|Multiple|1
1136620|NCT01466270|3732846|P1|Overall Study|Multiple|1
1136621|NCT01466270|3732845|P2|Overall Study|Toxicity|1
1136622|NCT01466270|3732846|P1|Overall Study|Toxicity|4
1136623|NCT01466270|3732845|P2|Overall Study|Progression|0
1136624|NCT01466270|3732846|P1|Overall Study|Progression|1
1136625|NCT01466270|3732845|P2|Overall Study|Lost to Follow-up|3
1136626|NCT01466270|3732846|P1|Overall Study|Lost to Follow-up|1
1136627|NCT01466270|3732845|P2|Overall Study|Physician Decision|0
1136628|NCT01466270|3732846|P1|Overall Study|Physician Decision|1
1136629|NCT01466270|3732845|P2|Overall Study|Withdrawal by Subject|1
1136630|NCT01466270|3732846|P1|Overall Study|Withdrawal by Subject|4
1136631|NCT01466192|3732858|P1|Overall Study|Withdrawal by Subject|3
1136632|NCT01466192|3732858|P1|Overall Study|Physician Decision|1
1136633|NCT01466179|3732862|P1|Overall Study|Other|3
1136634|NCT01466179|3732862|P1|Overall Study|Protocol Violation|2
1136635|NCT01466179|3732862|P1|Overall Study|Withdrawal by Subject|7
1136636|NCT01466179|3732862|P1|Overall Study|Death|7
1136637|NCT01466179|3732862|P1|Overall Study|Lack of Efficacy|14
1136638|NCT01466179|3732862|P1|Overall Study|Disease relapse|23
1136639|NCT01466179|3732862|P1|Overall Study|Adverse Event|32
1136640|NCT01466179|3732862|P1|Overall Study|Progressive disease|43
1136641|NCT01466179|3732862|P1|Overall Study|Physician Decision|46
1136642|NCT01466179|3732862|P1|Overall Study|Ongoing in core study|2
1136643|NCT01466153|3732885|P3|Overall Study|Other-Unspecified|2
1136644|NCT01466153|3732886|P2|Overall Study|Other-Unspecified|4
1136645|NCT01466153|3732887|P1|Overall Study|Other-Unspecified|6
1136646|NCT01466153|3732885|P3|Overall Study|Randomized-Not Treated|4
1136647|NCT01466153|3732886|P2|Overall Study|Randomized-Not Treated|3
1136648|NCT01466153|3732887|P1|Overall Study|Randomized-Not Treated|2
1136649|NCT01466153|3732885|P3|Overall Study|Investigator Discretion|2
1136650|NCT01466153|3732886|P2|Overall Study|Investigator Discretion|2
1136651|NCT01466153|3732887|P1|Overall Study|Investigator Discretion|3
1136652|NCT01466153|3732885|P3|Overall Study|Withdrawal of Consent|0
1136653|NCT01466153|3732886|P2|Overall Study|Withdrawal of Consent|0
1136654|NCT01466153|3732887|P1|Overall Study|Withdrawal of Consent|2
1136655|NCT01466153|3732885|P3|Overall Study|Adverse Event|17
1136656|NCT01466153|3732886|P2|Overall Study|Adverse Event|13
1136657|NCT01466153|3732887|P1|Overall Study|Adverse Event|14
1136658|NCT01466153|3732885|P3|Overall Study|Disease Progression|0
1136659|NCT01466153|3732886|P2|Overall Study|Disease Progression|2
1136660|NCT01466153|3732887|P1|Overall Study|Disease Progression|2
1136661|NCT01466062|3732942|P1|Overall Study|Withdrawal by Subject|1
1136662|NCT01466062|3732942|P1|Overall Study|Adverse Event|1
1136663|NCT01465997|3732965|P2|Overall Study|subject left participation SP0993|1
1136664|NCT01465997|3732966|P1|Overall Study|subject left participation SP0993|0
1136665|NCT01465997|3732965|P2|Overall Study|decision by site staff|1
1136666|NCT01465997|3732966|P1|Overall Study|decision by site staff|0
1136667|NCT01465997|3732965|P2|Overall Study|withdrew before follow-up|13
1136668|NCT01465997|3732966|P1|Overall Study|withdrew before follow-up|0
1136669|NCT01465997|3732965|P2|Overall Study|local lab unblinded site|0
1136670|NCT01465997|3732966|P1|Overall Study|local lab unblinded site|1
1136671|NCT01465997|3732965|P2|Overall Study|subject withdrew consent|0
1136672|NCT01465997|3732966|P1|Overall Study|subject withdrew consent|1
1136673|NCT01465997|3732965|P2|Overall Study|sponsor's decision|1
1136674|NCT01465997|3732966|P1|Overall Study|sponsor's decision|1
1136675|NCT01465997|3732965|P2|Overall Study|Death|1
1136676|NCT01465997|3732966|P1|Overall Study|Death|0
1136677|NCT01465997|3732965|P2|Overall Study|investigator's decision|1
1136678|NCT01465997|3732966|P1|Overall Study|investigator's decision|1
1136679|NCT01465997|3732965|P2|Overall Study|Withdrawal by Subject|35
1136680|NCT01465997|3732966|P1|Overall Study|Withdrawal by Subject|32
1136681|NCT01465997|3732965|P2|Overall Study|Lost to Follow-up|9
1136682|NCT01465997|3732966|P1|Overall Study|Lost to Follow-up|6
1136683|NCT01465997|3732965|P2|Overall Study|Protocol Violation|4
1136684|NCT01465997|3732966|P1|Overall Study|Protocol Violation|1
1136685|NCT01465997|3732965|P2|Overall Study|Lack of Efficacy|1
1136686|NCT01465997|3732966|P1|Overall Study|Lack of Efficacy|13
1136687|NCT01465997|3732965|P2|Overall Study|Adverse Event|22
1136688|NCT01465997|3732966|P1|Overall Study|Adverse Event|12
1136689|NCT01465958|3732976|P2|Subcutaneous (SC) Phase|Adverse Event|1
1136690|NCT01465958|3732977|P1|Subcutaneous (SC) Phase|Adverse Event|0
1136691|NCT01465958|3732976|P2|Run-in Phase|Protocol Violation|0
1136692|NCT01465958|3732977|P1|Run-in Phase|Protocol Violation|1
1136693|NCT01465802|3732990|P5|Overall Study|Death|2
1136694|NCT01465802|3732991|P4|Overall Study|Death|10
1136695|NCT01465802|3732992|P3|Overall Study|Death|0
1136696|NCT01465802|3732993|P2|Overall Study|Death|12
1136697|NCT01465802|3732994|P1|Overall Study|Death|15
1136698|NCT01465802|3732990|P5|Overall Study|Reason not specified|2
1136699|NCT01465802|3732991|P4|Overall Study|Reason not specified|10
1136700|NCT01465802|3732992|P3|Overall Study|Reason not specified|0
1136701|NCT01465802|3732993|P2|Overall Study|Reason not specified|4
1136702|NCT01465802|3732994|P1|Overall Study|Reason not specified|9
1136703|NCT01465802|3732990|P5|Overall Study|Lost to Follow-up|0
1136704|NCT01465802|3732991|P4|Overall Study|Lost to Follow-up|0
1136705|NCT01465802|3732992|P3|Overall Study|Lost to Follow-up|0
1136706|NCT01465802|3732993|P2|Overall Study|Lost to Follow-up|1
1136707|NCT01465802|3732994|P1|Overall Study|Lost to Follow-up|1
1136708|NCT01465802|3732990|P5|Overall Study|Withdrawal by Subject|1
1136709|NCT01465802|3732991|P4|Overall Study|Withdrawal by Subject|8
1136710|NCT01465802|3732992|P3|Overall Study|Withdrawal by Subject|0
1136711|NCT01465802|3732993|P2|Overall Study|Withdrawal by Subject|7
1136712|NCT01465802|3732994|P1|Overall Study|Withdrawal by Subject|7
1136713|NCT01465802|3732990|P5|Overall Study|Study terminated by sponsor|7
1136714|NCT01465802|3732991|P4|Overall Study|Study terminated by sponsor|1
1136715|NCT01465802|3732992|P3|Overall Study|Study terminated by sponsor|0
1136716|NCT01465802|3732993|P2|Overall Study|Study terminated by sponsor|0
1136717|NCT01465802|3732994|P1|Overall Study|Study terminated by sponsor|1
1136718|NCT01465763|3733046|P3|Overall Study|Death|0
1136719|NCT01465763|3733047|P2|Overall Study|Death|0
1136720|NCT01465763|3733048|P1|Overall Study|Death|1
1136721|NCT01465763|3733046|P3|Overall Study|Protocol Violation|1
1136722|NCT01465763|3733047|P2|Overall Study|Protocol Violation|1
1136723|NCT01465763|3733048|P1|Overall Study|Protocol Violation|4
1136724|NCT01465763|3733046|P3|Overall Study|Other|0
1136725|NCT01465763|3733047|P2|Overall Study|Other|0
1136726|NCT01465763|3733048|P1|Overall Study|Other|2
1136727|NCT01465763|3733046|P3|Overall Study|Adverse Event|1
1136728|NCT01465763|3733047|P2|Overall Study|Adverse Event|0
1136729|NCT01465763|3733048|P1|Overall Study|Adverse Event|9
1136730|NCT01465763|3733046|P3|Overall Study|Insufficient Clinical Response|1
1136731|NCT01465763|3733047|P2|Overall Study|Insufficient Clinical Response|0
1136732|NCT01465763|3733048|P1|Overall Study|Insufficient Clinical Response|11
1136733|NCT01465763|3733046|P3|Overall Study|Withdrawal by Subject|1
1136734|NCT01465763|3733047|P2|Overall Study|Withdrawal by Subject|0
1136735|NCT01465763|3733048|P1|Overall Study|Withdrawal by Subject|4
1136736|NCT01465386|3733118|P1|Overall Study|Adverse Event|1
1136737|NCT01465386|3733118|P1|Overall Study|Lack of Efficacy|3
1136738|NCT01465347|3733122|P2|Overall Study|Admitted to hospice|1
1136739|NCT01465347|3733123|P1|Overall Study|Admitted to hospice|0
1136740|NCT01465347|3733122|P2|Overall Study|Physician Decision|1
1136741|NCT01465347|3733123|P1|Overall Study|Physician Decision|0
1136742|NCT01465347|3733122|P2|Overall Study|Withdrawal by Subject|1
1136743|NCT01465347|3733123|P1|Overall Study|Withdrawal by Subject|1
1136744|NCT01465230|3733133|P1|Overall Study|Withdrawal by Subject|2
1136745|NCT01465178|3733139|P2|Overall Study|Withdrawal by Subject|0
1136746|NCT01465178|3733140|P1|Overall Study|Withdrawal by Subject|1
1136747|NCT01465022|3733164|P3|Overall Study|Not Randomized|70
1136748|NCT01465022|3733165|P2|Overall Study|Not Randomized|0
1136749|NCT01465022|3733166|P1|Overall Study|Not Randomized|0
1136750|NCT01465022|3733164|P3|Overall Study|Breastfeeding discontinuation before 8 w|0
1136751|NCT01465022|3733165|P2|Overall Study|Breastfeeding discontinuation before 8 w|9
1136752|NCT01465022|3733166|P1|Overall Study|Breastfeeding discontinuation before 8 w|8
1136753|NCT01465022|3733164|P3|Overall Study|Lost to Follow-up|0
1136754|NCT01465022|3733165|P2|Overall Study|Lost to Follow-up|14
1136755|NCT01465022|3733166|P1|Overall Study|Lost to Follow-up|15
1136756|NCT01464931|3733200|P2|Overall Study|Withdrawal by Subject|0
1136757|NCT01464931|3733201|P1|Overall Study|Withdrawal by Subject|1
1136758|NCT01464879|3733238|P1|Overall Study|Non-compliance|1
1136759|NCT01464879|3733238|P1|Overall Study|Physician Decision|1
1136760|NCT01464827|3733299|P14|Overall Study|Not Treated|2
1136761|NCT01464827|3733300|P13|Overall Study|Not Treated|0
1136762|NCT01464827|3733301|P12|Overall Study|Not Treated|1
1136763|NCT01464827|3733302|P11|Overall Study|Not Treated|0
1136764|NCT01464827|3733303|P10|Overall Study|Not Treated|2
1136765|NCT01464827|3733304|P9|Overall Study|Not Treated|0
1136766|NCT01464827|3733305|P8|Overall Study|Not Treated|0
1136767|NCT01464827|3733306|P7|Overall Study|Not Treated|1
1136768|NCT01464827|3733307|P6|Overall Study|Not Treated|0
1136769|NCT01464827|3733308|P5|Overall Study|Not Treated|1
1136770|NCT01464827|3733309|P4|Overall Study|Not Treated|0
1136771|NCT01464827|3733310|P3|Overall Study|Not Treated|0
1136772|NCT01464827|3733311|P2|Overall Study|Not Treated|2
1136773|NCT01464827|3733312|P1|Overall Study|Not Treated|0
1136774|NCT01464827|3733299|P14|Overall Study|Other|0
1136775|NCT01464827|3733300|P13|Overall Study|Other|1
1136776|NCT01464827|3733301|P12|Overall Study|Other|0
1136777|NCT01464827|3733302|P11|Overall Study|Other|2
1136778|NCT01464827|3733303|P10|Overall Study|Other|1
1136779|NCT01464827|3733304|P9|Overall Study|Other|3
1136780|NCT01464827|3733305|P8|Overall Study|Other|0
1136781|NCT01464827|3733306|P7|Overall Study|Other|1
1136782|NCT01464827|3733307|P6|Overall Study|Other|0
1136783|NCT01464827|3733308|P5|Overall Study|Other|3
1136784|NCT01464827|3733309|P4|Overall Study|Other|2
1136785|NCT01464827|3733310|P3|Overall Study|Other|0
1136786|NCT01464827|3733311|P2|Overall Study|Other|3
1136787|NCT01464827|3733312|P1|Overall Study|Other|2
1136788|NCT01464827|3733299|P14|Overall Study|Lost to Follow-up|1
1136789|NCT01464827|3733300|P13|Overall Study|Lost to Follow-up|0
1136790|NCT01464827|3733301|P12|Overall Study|Lost to Follow-up|1
1136791|NCT01464827|3733302|P11|Overall Study|Lost to Follow-up|0
1136792|NCT01464827|3733303|P10|Overall Study|Lost to Follow-up|0
1136793|NCT01464827|3733304|P9|Overall Study|Lost to Follow-up|0
1136794|NCT01464827|3733305|P8|Overall Study|Lost to Follow-up|2
1136795|NCT01464827|3733306|P7|Overall Study|Lost to Follow-up|2
1136796|NCT01464827|3733307|P6|Overall Study|Lost to Follow-up|1
1136797|NCT01464827|3733308|P5|Overall Study|Lost to Follow-up|3
1136798|NCT01464827|3733309|P4|Overall Study|Lost to Follow-up|2
1136799|NCT01464827|3733310|P3|Overall Study|Lost to Follow-up|0
1136800|NCT01464827|3733311|P2|Overall Study|Lost to Follow-up|2
1136801|NCT01464827|3733312|P1|Overall Study|Lost to Follow-up|0
1136802|NCT01464827|3733299|P14|Overall Study|Withdrawal by Subject|0
1136803|NCT01464827|3733300|P13|Overall Study|Withdrawal by Subject|0
1136804|NCT01464827|3733301|P12|Overall Study|Withdrawal by Subject|0
1136805|NCT01464827|3733302|P11|Overall Study|Withdrawal by Subject|0
1136806|NCT01464827|3733303|P10|Overall Study|Withdrawal by Subject|0
1136807|NCT01464827|3733304|P9|Overall Study|Withdrawal by Subject|0
1136808|NCT01464827|3733305|P8|Overall Study|Withdrawal by Subject|1
1136809|NCT01464827|3733306|P7|Overall Study|Withdrawal by Subject|0
1136810|NCT01464827|3733307|P6|Overall Study|Withdrawal by Subject|0
1136811|NCT01464827|3733308|P5|Overall Study|Withdrawal by Subject|1
1136812|NCT01464827|3733309|P4|Overall Study|Withdrawal by Subject|0
1136813|NCT01464827|3733310|P3|Overall Study|Withdrawal by Subject|0
1136814|NCT01464827|3733311|P2|Overall Study|Withdrawal by Subject|0
1136815|NCT01464827|3733312|P1|Overall Study|Withdrawal by Subject|1
1136816|NCT01464827|3733299|P14|Overall Study|Adverse Event|0
1136817|NCT01464827|3733300|P13|Overall Study|Adverse Event|1
1136818|NCT01464827|3733301|P12|Overall Study|Adverse Event|0
1136819|NCT01464827|3733302|P11|Overall Study|Adverse Event|0
1136820|NCT01464827|3733303|P10|Overall Study|Adverse Event|0
1136821|NCT01464827|3733304|P9|Overall Study|Adverse Event|0
1136822|NCT01464827|3733305|P8|Overall Study|Adverse Event|0
1136823|NCT01464827|3733306|P7|Overall Study|Adverse Event|0
1136824|NCT01464827|3733307|P6|Overall Study|Adverse Event|0
1136825|NCT01464827|3733308|P5|Overall Study|Adverse Event|0
1136826|NCT01464827|3733309|P4|Overall Study|Adverse Event|0
1136827|NCT01464827|3733310|P3|Overall Study|Adverse Event|0
1136828|NCT01464827|3733311|P2|Overall Study|Adverse Event|0
1136829|NCT01464827|3733312|P1|Overall Study|Adverse Event|0
1136830|NCT01464788|3733359|P3|Overall Study|Patient had hemorrhage after tPA started|0
1136831|NCT01464788|3733360|P2|Overall Study|Patient had hemorrhage after tPA started|1
1136832|NCT01464788|3733361|P1|Overall Study|Patient had hemorrhage after tPA started|0
1136833|NCT01464788|3733359|P3|Overall Study|Lost to Follow-up|0
1136834|NCT01464788|3733360|P2|Overall Study|Lost to Follow-up|1
1136835|NCT01464788|3733361|P1|Overall Study|Lost to Follow-up|0
1136836|NCT01464619|3733374|P2|Overall Study|Lost to Follow-up|4
1136837|NCT01464619|3733375|P1|Overall Study|Lost to Follow-up|3
1136838|NCT01464424|3733395|P2|Period 1, First 6 Weeks|Adverse Event|1
1136839|NCT01464424|3733396|P1|Period 1, First 6 Weeks|Adverse Event|0
1136840|NCT01464346|3733416|P3|Overall Study|Withdrawal by Subject|1
1136841|NCT01464346|3733417|P2|Overall Study|Withdrawal by Subject|0
1136842|NCT01464346|3733418|P1|Overall Study|Withdrawal by Subject|0
1136843|NCT01464307|3733429|P2|Open-Label Extension Period|Predefined discontinuation criteria|0
1136844|NCT01464307|3733430|P1|Open-Label Extension Period|Predefined discontinuation criteria|6
1136845|NCT01464307|3733429|P2|Open-Label Extension Period|Non-compliance|0
1136846|NCT01464307|3733430|P1|Open-Label Extension Period|Non-compliance|9
1136847|NCT01464307|3733429|P2|Open-Label Extension Period|Lost to Follow-up|0
1136848|NCT01464307|3733430|P1|Open-Label Extension Period|Lost to Follow-up|1
1136849|NCT01464307|3733429|P2|Open-Label Extension Period|Death|0
1136850|NCT01464307|3733430|P1|Open-Label Extension Period|Death|1
1136851|NCT01464307|3733429|P2|Open-Label Extension Period|Lack of Efficacy|0
1136852|NCT01464307|3733430|P1|Open-Label Extension Period|Lack of Efficacy|5
1136853|NCT01464307|3733429|P2|Open-Label Extension Period|Withdrawal by Subject|0
1136854|NCT01464307|3733430|P1|Open-Label Extension Period|Withdrawal by Subject|14
1136855|NCT01464307|3733429|P2|Open-Label Extension Period|Adverse Event|0
1136856|NCT01464307|3733430|P1|Open-Label Extension Period|Adverse Event|15
1136857|NCT01464307|3733429|P2|Main Period|Predefined discontinuation criteria|1
1136858|NCT01464307|3733430|P1|Main Period|Predefined discontinuation criteria|2
1136859|NCT01464307|3733429|P2|Main Period|Withdrawal by Subject|2
1136860|NCT01464307|3733430|P1|Main Period|Withdrawal by Subject|5
1136861|NCT01464307|3733429|P2|Main Period|Lack of Efficacy|0
1136862|NCT01464307|3733430|P1|Main Period|Lack of Efficacy|2
1136863|NCT01464307|3733429|P2|Main Period|Adverse Event|1
1136864|NCT01464307|3733430|P1|Main Period|Adverse Event|6
1136865|NCT01464307|3733429|P2|Main Period|Death|1
1136866|NCT01464307|3733430|P1|Main Period|Death|0
1136867|NCT01464255|3733445|P2|Overall Study|unresolve corneal staining|1
1136868|NCT01464255|3733446|P1|Overall Study|unresolve corneal staining|0
1136869|NCT01464021|3733491|P1|Overall Study|various|11
1136870|NCT01464021|3733491|P1|Overall Study|Lack of Efficacy|1
1136871|NCT01464021|3733491|P1|Overall Study|Lost to Follow-up|1
1136872|NCT01464021|3733491|P1|Overall Study|Withdrawal by Subject|13
1136873|NCT01463982|3733507|P4|Overall Study|Treatment delay over 5 week|0
1136874|NCT01463982|3733508|P3|Overall Study|Treatment delay over 5 week|1
1136875|NCT01463982|3733509|P2|Overall Study|Treatment delay over 5 week|0
1136876|NCT01463982|3733510|P1|Overall Study|Treatment delay over 5 week|0
1136877|NCT01463982|3733507|P4|Overall Study|Withdrawal by Subject|0
1136878|NCT01463982|3733508|P3|Overall Study|Withdrawal by Subject|1
1136879|NCT01463982|3733509|P2|Overall Study|Withdrawal by Subject|1
1136880|NCT01463982|3733510|P1|Overall Study|Withdrawal by Subject|0
1136881|NCT01463878|3733526|P2|Overall Study|no longer met criteria for tube feed|2
1136882|NCT01463878|3733527|P1|Overall Study|no longer met criteria for tube feed|2
1136883|NCT01463696|3733541|P8|Overall Study|Not Treated|0
1136884|NCT01463696|3733542|P7|Overall Study|Not Treated|1
1136885|NCT01463696|3733543|P6|Overall Study|Not Treated|0
1136886|NCT01463696|3733544|P5|Overall Study|Not Treated|0
1136887|NCT01463696|3733545|P4|Overall Study|Not Treated|0
1136888|NCT01463696|3733546|P3|Overall Study|Not Treated|0
1136889|NCT01463696|3733547|P2|Overall Study|Not Treated|0
1136890|NCT01463696|3733548|P1|Overall Study|Not Treated|0
1136891|NCT01463696|3733541|P8|Overall Study|Withdrawal by Subject|0
1136892|NCT01463696|3733542|P7|Overall Study|Withdrawal by Subject|2
1136893|NCT01463696|3733543|P6|Overall Study|Withdrawal by Subject|1
1136894|NCT01463696|3733544|P5|Overall Study|Withdrawal by Subject|1
1136895|NCT01463696|3733545|P4|Overall Study|Withdrawal by Subject|1
1136896|NCT01463696|3733546|P3|Overall Study|Withdrawal by Subject|0
1136897|NCT01463696|3733547|P2|Overall Study|Withdrawal by Subject|0
1136898|NCT01463696|3733548|P1|Overall Study|Withdrawal by Subject|0
1136899|NCT01463696|3733541|P8|Overall Study|Progressive Disease|2
1136900|NCT01463696|3733542|P7|Overall Study|Progressive Disease|4
1136901|NCT01463696|3733543|P6|Overall Study|Progressive Disease|1
1136902|NCT01463696|3733544|P5|Overall Study|Progressive Disease|0
1136903|NCT01463696|3733545|P4|Overall Study|Progressive Disease|1
1136904|NCT01463696|3733546|P3|Overall Study|Progressive Disease|0
1136905|NCT01463696|3733547|P2|Overall Study|Progressive Disease|1
1136906|NCT01463696|3733548|P1|Overall Study|Progressive Disease|0
1136907|NCT01463696|3733541|P8|Overall Study|Lost to Follow-up|0
1136908|NCT01463696|3733542|P7|Overall Study|Lost to Follow-up|0
1136909|NCT01463696|3733543|P6|Overall Study|Lost to Follow-up|0
1136910|NCT01463696|3733544|P5|Overall Study|Lost to Follow-up|0
1136911|NCT01463696|3733545|P4|Overall Study|Lost to Follow-up|0
1136912|NCT01463696|3733546|P3|Overall Study|Lost to Follow-up|1
1136913|NCT01463696|3733547|P2|Overall Study|Lost to Follow-up|0
1136914|NCT01463696|3733548|P1|Overall Study|Lost to Follow-up|0
1136915|NCT01463696|3733541|P8|Overall Study|Adverse Event|2
1136916|NCT01463696|3733542|P7|Overall Study|Adverse Event|3
1136917|NCT01463696|3733543|P6|Overall Study|Adverse Event|1
1136918|NCT01463696|3733544|P5|Overall Study|Adverse Event|0
1136919|NCT01463696|3733545|P4|Overall Study|Adverse Event|2
1136920|NCT01463696|3733546|P3|Overall Study|Adverse Event|0
1136921|NCT01463696|3733547|P2|Overall Study|Adverse Event|1
1136922|NCT01463696|3733548|P1|Overall Study|Adverse Event|0
1136923|NCT01463683|3733601|P3|Overall Study|Withdrawal by Subject|2
1136924|NCT01463683|3733602|P2|Overall Study|Withdrawal by Subject|17
1136925|NCT01463683|3733603|P1|Overall Study|Withdrawal by Subject|5
1136926|NCT01463683|3733601|P3|Overall Study|Pregnancy|1
1136927|NCT01463683|3733602|P2|Overall Study|Pregnancy|2
1136928|NCT01463683|3733603|P1|Overall Study|Pregnancy|2
1136929|NCT01463683|3733601|P3|Overall Study|Physician Decision|1
1136930|NCT01463683|3733602|P2|Overall Study|Physician Decision|3
1136931|NCT01463683|3733603|P1|Overall Study|Physician Decision|0
1136932|NCT01463683|3733601|P3|Overall Study|Lost to Follow-up|7
1136933|NCT01463683|3733602|P2|Overall Study|Lost to Follow-up|9
1136934|NCT01463683|3733603|P1|Overall Study|Lost to Follow-up|10
1136935|NCT01463683|3733601|P3|Overall Study|Adverse Event|0
1136936|NCT01463683|3733602|P2|Overall Study|Adverse Event|0
1136937|NCT01463683|3733603|P1|Overall Study|Adverse Event|2
1136938|NCT01463631|3733620|P4|Overall Study|Progressive Disease|5
1136939|NCT01463631|3733621|P3|Overall Study|Progressive Disease|0
1136940|NCT01463631|3733622|P2|Overall Study|Progressive Disease|0
1136941|NCT01463631|3733623|P1|Overall Study|Progressive Disease|0
1136942|NCT01463631|3733620|P4|Overall Study|Death|0
1136943|NCT01463631|3733621|P3|Overall Study|Death|1
1136944|NCT01463631|3733622|P2|Overall Study|Death|0
1136945|NCT01463631|3733623|P1|Overall Study|Death|0
1136946|NCT01463631|3733620|P4|Overall Study|Withdrawal by Subject|1
1136947|NCT01463631|3733621|P3|Overall Study|Withdrawal by Subject|0
1136948|NCT01463631|3733622|P2|Overall Study|Withdrawal by Subject|0
1136949|NCT01463631|3733623|P1|Overall Study|Withdrawal by Subject|0
1136950|NCT01463527|3733645|P2|Overall Study|Crying >20% of sedation|6
1136951|NCT01463527|3733646|P1|Overall Study|Crying >20% of sedation|5
1136952|NCT01463527|3733645|P2|Overall Study|Protocol Violation|1
1136953|NCT01463527|3733646|P1|Overall Study|Protocol Violation|1
1136954|NCT01463293|3733669|P3|Overall Study|Other|2
1136955|NCT01463293|3733670|P2|Overall Study|Other|0
1136956|NCT01463293|3733671|P1|Overall Study|Other|0
1136957|NCT01463293|3733669|P3|Overall Study|Withdrawal by Subject|5
1136958|NCT01463293|3733670|P2|Overall Study|Withdrawal by Subject|10
1136959|NCT01463293|3733671|P1|Overall Study|Withdrawal by Subject|4
1136960|NCT01463293|3733669|P3|Overall Study|Adverse Event|0
1136961|NCT01463293|3733670|P2|Overall Study|Adverse Event|2
1136962|NCT01463293|3733671|P1|Overall Study|Adverse Event|1
1136963|NCT01463293|3733669|P3|Overall Study|Lost to Follow-up|5
1136964|NCT01463293|3733670|P2|Overall Study|Lost to Follow-up|4
1136965|NCT01463293|3733671|P1|Overall Study|Lost to Follow-up|1
1136966|NCT01463111|3733694|P1|Overall Study|Physician Decision|2
1136967|NCT01463111|3733694|P1|Overall Study|Lost to Follow-up|5
1136968|NCT01463111|3733694|P1|Overall Study|Withdrawal by Subject|2
1136969|NCT01463033|3733704|P2|Overall Study|Death|2
1136970|NCT01463033|3733705|P1|Overall Study|Death|3
1136971|NCT01463033|3733704|P2|Overall Study|Lost to Follow-up|4
1136972|NCT01463033|3733705|P1|Overall Study|Lost to Follow-up|4
1136973|NCT01463007|3733712|P1|Overall Study|Physician Decision|1
1136974|NCT01462942|3733723|P5|Overall Study|Protocol Violation|6
1136975|NCT01462942|3733724|P4|Overall Study|Protocol Violation|9
1136976|NCT01462942|3733725|P3|Overall Study|Protocol Violation|9
1136977|NCT01462942|3733726|P2|Overall Study|Protocol Violation|6
1136978|NCT01462942|3733727|P1|Overall Study|Protocol Violation|4
1136979|NCT01462942|3733723|P5|Overall Study|Lost to Follow-up|1
1136980|NCT01462942|3733724|P4|Overall Study|Lost to Follow-up|1
1136981|NCT01462942|3733725|P3|Overall Study|Lost to Follow-up|1
1136982|NCT01462942|3733726|P2|Overall Study|Lost to Follow-up|1
1136983|NCT01462942|3733727|P1|Overall Study|Lost to Follow-up|0
1136984|NCT01462942|3733723|P5|Overall Study|Lack of Efficacy|3
1136985|NCT01462942|3733724|P4|Overall Study|Lack of Efficacy|5
1136986|NCT01462942|3733725|P3|Overall Study|Lack of Efficacy|4
1136987|NCT01462942|3733726|P2|Overall Study|Lack of Efficacy|0
1136988|NCT01462942|3733727|P1|Overall Study|Lack of Efficacy|6
1136989|NCT01462942|3733723|P5|Overall Study|Withdrawal by Subject|19
1136990|NCT01462942|3733724|P4|Overall Study|Withdrawal by Subject|16
1136991|NCT01462942|3733725|P3|Overall Study|Withdrawal by Subject|14
1136992|NCT01462942|3733726|P2|Overall Study|Withdrawal by Subject|10
1136993|NCT01462942|3733727|P1|Overall Study|Withdrawal by Subject|14
1136994|NCT01462942|3733723|P5|Overall Study|Other, including COPD exacerbation|5
1136995|NCT01462942|3733724|P4|Overall Study|Other, including COPD exacerbation|8
1136996|NCT01462942|3733725|P3|Overall Study|Other, including COPD exacerbation|2
1136997|NCT01462942|3733726|P2|Overall Study|Other, including COPD exacerbation|5
1136998|NCT01462942|3733727|P1|Overall Study|Other, including COPD exacerbation|3
1136999|NCT01462942|3733723|P5|Overall Study|Adverse Event|11
1137000|NCT01462942|3733724|P4|Overall Study|Adverse Event|11
1137001|NCT01462942|3733725|P3|Overall Study|Adverse Event|10
1137002|NCT01462942|3733726|P2|Overall Study|Adverse Event|12
1137003|NCT01462942|3733727|P1|Overall Study|Adverse Event|7
1137004|NCT01462929|3733757|P3|Overall Study|Lack of Efficacy|1
1137005|NCT01462929|3733758|P2|Overall Study|Lack of Efficacy|0
1137006|NCT01462929|3733759|P1|Overall Study|Lack of Efficacy|0
1137007|NCT01462929|3733757|P3|Overall Study|Withdrawal by Subject|0
1137008|NCT01462929|3733758|P2|Overall Study|Withdrawal by Subject|1
1137009|NCT01462929|3733759|P1|Overall Study|Withdrawal by Subject|2
1137010|NCT01462929|3733757|P3|Overall Study|Adverse Event|4
1137011|NCT01462929|3733758|P2|Overall Study|Adverse Event|3
1137012|NCT01462929|3733759|P1|Overall Study|Adverse Event|3
1137013|NCT01462695|3733800|P2|Overall Study|Inevaluable (did not receive study drug)|0
1137014|NCT01462695|3733801|P1|Overall Study|Inevaluable (did not receive study drug)|1
1137015|NCT01462695|3733800|P2|Overall Study|Withdrawal by Subject|0
1137016|NCT01462695|3733801|P1|Overall Study|Withdrawal by Subject|2
1137017|NCT01462695|3733800|P2|Overall Study|Physician Decision|0
1137018|NCT01462695|3733801|P1|Overall Study|Physician Decision|5
1137019|NCT01462695|3733800|P2|Overall Study|Lack of Efficacy|12
1137020|NCT01462695|3733801|P1|Overall Study|Lack of Efficacy|6
1137021|NCT01462695|3733800|P2|Overall Study|Death|0
1137022|NCT01462695|3733801|P1|Overall Study|Death|2
1137023|NCT01462695|3733800|P2|Overall Study|Adverse Event|1
1137024|NCT01462695|3733801|P1|Overall Study|Adverse Event|1
1137025|NCT01462435|3733829|P4|Overall Study|Lost to Follow-up|1
1137026|NCT01462435|3733830|P3|Overall Study|Lost to Follow-up|0
1137027|NCT01462435|3733831|P2|Overall Study|Lost to Follow-up|0
1137028|NCT01462435|3733832|P1|Overall Study|Lost to Follow-up|0
1137029|NCT01462435|3733829|P4|Overall Study|Withdrawal by Subject|1
1137030|NCT01462435|3733830|P3|Overall Study|Withdrawal by Subject|0
1137031|NCT01462435|3733831|P2|Overall Study|Withdrawal by Subject|0
1137032|NCT01462435|3733832|P1|Overall Study|Withdrawal by Subject|0
1137033|NCT01462435|3733829|P4|Overall Study|Physician Decision|0
1137034|NCT01462435|3733830|P3|Overall Study|Physician Decision|1
1137035|NCT01462435|3733831|P2|Overall Study|Physician Decision|0
1137036|NCT01462435|3733832|P1|Overall Study|Physician Decision|0
1137037|NCT01462435|3733829|P4|Overall Study|Lack of Efficacy|3
1137038|NCT01462435|3733830|P3|Overall Study|Lack of Efficacy|0
1137039|NCT01462435|3733831|P2|Overall Study|Lack of Efficacy|0
1137040|NCT01462435|3733832|P1|Overall Study|Lack of Efficacy|1
1137041|NCT01462370|3733870|P2|Overall Study|Withdrawal by Subject|3
1137042|NCT01462370|3733871|P1|Overall Study|Withdrawal by Subject|0
1137043|NCT01462370|3733870|P2|Overall Study|Physician Decision|1
1137044|NCT01462370|3733871|P1|Overall Study|Physician Decision|0
1137045|NCT01462370|3733870|P2|Overall Study|Lack of Qualifying Event|1
1137046|NCT01462370|3733871|P1|Overall Study|Lack of Qualifying Event|1
1137047|NCT01462357|3733906|P3|Month 24|Migrated/moved from study area|0
1137048|NCT01462357|3733907|P2|Month 24|Migrated/moved from study area|2
1137049|NCT01462357|3733908|P1|Month 24|Migrated/moved from study area|0
1137050|NCT01462357|3733906|P3|Month 24|Lost to Follow-up|6
1137051|NCT01462357|3733907|P2|Month 24|Lost to Follow-up|4
1137052|NCT01462357|3733908|P1|Month 24|Lost to Follow-up|2
1137053|NCT01462357|3733906|P3|Month 24|Withdrawal by Subject|3
1137054|NCT01462357|3733907|P2|Month 24|Withdrawal by Subject|8
1137055|NCT01462357|3733908|P1|Month 24|Withdrawal by Subject|2
1137056|NCT01462357|3733906|P3|Month 18|Other|1
1137057|NCT01462357|3733907|P2|Month 18|Other|1
1137058|NCT01462357|3733908|P1|Month 18|Other|0
1137059|NCT01462357|3733906|P3|Month 18|Lost to Follow-up|5
1137060|NCT01462357|3733907|P2|Month 18|Lost to Follow-up|4
1137061|NCT01462357|3733908|P1|Month 18|Lost to Follow-up|1
1137062|NCT01462357|3733906|P3|Month 18|Withdrawal by Subject|3
1137063|NCT01462357|3733907|P2|Month 18|Withdrawal by Subject|6
1137064|NCT01462357|3733908|P1|Month 18|Withdrawal by Subject|2
1137065|NCT01462357|3733906|P3|Month 12|Lost to Follow-up|5
1137066|NCT01462357|3733907|P2|Month 12|Lost to Follow-up|4
1137067|NCT01462357|3733908|P1|Month 12|Lost to Follow-up|1
1137068|NCT01462357|3733906|P3|Month 12|Withdrawal by Subject|3
1137069|NCT01462357|3733907|P2|Month 12|Withdrawal by Subject|6
1137070|NCT01462357|3733908|P1|Month 12|Withdrawal by Subject|2
1137071|NCT01462357|3733906|P3|Month 7|Withdrawal by Subject|6
1137072|NCT01462357|3733907|P2|Month 7|Withdrawal by Subject|5
1137073|NCT01462357|3733908|P1|Month 7|Withdrawal by Subject|1
1137074|NCT01462344|3733981|P2|Overall Study|Lost to Follow-up|7
1137075|NCT01462344|3733982|P1|Overall Study|Lost to Follow-up|7
1137076|NCT01462344|3733981|P2|Overall Study|Protocol Violation|53
1137077|NCT01462344|3733982|P1|Overall Study|Protocol Violation|68
1137078|NCT01462344|3733981|P2|Overall Study|Lack of Efficacy|6
1137079|NCT01462344|3733982|P1|Overall Study|Lack of Efficacy|5
1137080|NCT01462344|3733981|P2|Overall Study|Asthma Exacerbation|35
1137081|NCT01462344|3733982|P1|Overall Study|Asthma Exacerbation|34
1137082|NCT01462344|3733981|P2|Overall Study|Adverse Event|23
1137083|NCT01462344|3733982|P1|Overall Study|Adverse Event|24
1137084|NCT01462344|3733981|P2|Overall Study|Withdrawal by Subject|226
1137085|NCT01462344|3733982|P1|Overall Study|Withdrawal by Subject|245
1137086|NCT01462318|3734004|P3|Extension Phase|Adverse Event|22
1137087|NCT01462318|3734005|P2|Extension Phase|Adverse Event|0
1137088|NCT01462318|3734006|P1|Extension Phase|Adverse Event|0
1137089|NCT01462318|3734004|P3|Extension Phase|Investigator Decision|5
1137090|NCT01462318|3734005|P2|Extension Phase|Investigator Decision|0
1137091|NCT01462318|3734006|P1|Extension Phase|Investigator Decision|0
1137092|NCT01462318|3734004|P3|Extension Phase|Withdrawal by Subject|15
1137093|NCT01462318|3734005|P2|Extension Phase|Withdrawal by Subject|0
1137094|NCT01462318|3734006|P1|Extension Phase|Withdrawal by Subject|0
1137095|NCT01462318|3734004|P3|Extension Phase|Disease Progression|1
1137096|NCT01462318|3734005|P2|Extension Phase|Disease Progression|0
1137097|NCT01462318|3734006|P1|Extension Phase|Disease Progression|0
1137098|NCT01462318|3734004|P3|Extension Phase|Not Specified|1
1137099|NCT01462318|3734005|P2|Extension Phase|Not Specified|0
1137100|NCT01462318|3734006|P1|Extension Phase|Not Specified|0
1137101|NCT01462318|3734004|P3|Extension Phase|Lost to Follow-up|1
1137102|NCT01462318|3734005|P2|Extension Phase|Lost to Follow-up|0
1137103|NCT01462318|3734006|P1|Extension Phase|Lost to Follow-up|0
1137104|NCT01462318|3734004|P3|Main Study / TP-DI Study|Adverse Event|0
1137105|NCT01462318|3734005|P2|Main Study / TP-DI Study|Adverse Event|0
1137106|NCT01462318|3734006|P1|Main Study / TP-DI Study|Adverse Event|4
1137107|NCT01462318|3734004|P3|Main Study / TP-DI Study|Withdrawal by Subject|0
1137108|NCT01462318|3734005|P2|Main Study / TP-DI Study|Withdrawal by Subject|0
1137109|NCT01462318|3734006|P1|Main Study / TP-DI Study|Withdrawal by Subject|2
1137110|NCT01462318|3734004|P3|Main Study / TP-DI Study|Not Specified|0
1137111|NCT01462318|3734005|P2|Main Study / TP-DI Study|Not Specified|0
1137112|NCT01462318|3734006|P1|Main Study / TP-DI Study|Not Specified|2
1137113|NCT01462266|3734094|P2|Overall Study|Screen failure|1
1137114|NCT01462266|3734095|P1|Overall Study|Screen failure|1
1137115|NCT01462266|3734094|P2|Overall Study|Withdrawal by Subject|2
1137116|NCT01462266|3734095|P1|Overall Study|Withdrawal by Subject|7
1137117|NCT01462266|3734094|P2|Overall Study|Protocol Violation|3
1137118|NCT01462266|3734095|P1|Overall Study|Protocol Violation|1
1137119|NCT01462266|3734094|P2|Overall Study|Physician Decision|5
1137120|NCT01462266|3734095|P1|Overall Study|Physician Decision|2
1137121|NCT01462266|3734094|P2|Overall Study|Creatinine and eGFR, excluded medication|4
1137122|NCT01462266|3734095|P1|Overall Study|Creatinine and eGFR, excluded medication|8
1137123|NCT01462266|3734094|P2|Overall Study|Non-compliance with study drug|0
1137124|NCT01462266|3734095|P1|Overall Study|Non-compliance with study drug|3
1137125|NCT01462266|3734094|P2|Overall Study|Lost to Follow-up|3
1137126|NCT01462266|3734095|P1|Overall Study|Lost to Follow-up|4
1137127|NCT01462266|3734094|P2|Overall Study|Lack of Efficacy|2
1137128|NCT01462266|3734095|P1|Overall Study|Lack of Efficacy|0
1137129|NCT01462266|3734094|P2|Overall Study|Death|1
1137130|NCT01462266|3734095|P1|Overall Study|Death|2
1137131|NCT01462266|3734094|P2|Overall Study|Adverse Event|6
1137132|NCT01462266|3734095|P1|Overall Study|Adverse Event|7
1137133|NCT01462227|3734111|P4|Second Assignment|Protocol Violation|0
1137134|NCT01462227|3734112|P3|Second Assignment|Protocol Violation|1
1137135|NCT01462227|3734113|P2|Second Assignment|Protocol Violation|1
1137136|NCT01462227|3734114|P1|Second Assignment|Protocol Violation|0
1137137|NCT01462227|3734111|P4|Second Assignment|Lost to Follow-up|0
1137138|NCT01462227|3734112|P3|Second Assignment|Lost to Follow-up|0
1137139|NCT01462227|3734113|P2|Second Assignment|Lost to Follow-up|0
1137140|NCT01462227|3734114|P1|Second Assignment|Lost to Follow-up|1
1137141|NCT01462162|3734132|P1|Overall Study|Other|2
1137142|NCT01462162|3734132|P1|Overall Study|Abnormal laboratory parameters|1
1137143|NCT01462162|3734132|P1|Overall Study|Lack of Efficacy|4
1137144|NCT01462162|3734132|P1|Overall Study|Adverse Event|5
1137145|NCT01462084|3734157|P2|Overall Study|Protocol Violation|1
1137146|NCT01462084|3734158|P1|Overall Study|Protocol Violation|1
1137147|NCT01462084|3734157|P2|Overall Study|Withdrawal by Subject|0
1137148|NCT01462084|3734158|P1|Overall Study|Withdrawal by Subject|1
1137149|NCT01462045|3734169|P3|Overall Study|Family matter|0
1137150|NCT01462045|3734170|P2|Overall Study|Family matter|1
1137151|NCT01462045|3734171|P1|Overall Study|Family matter|0
1137152|NCT01461993|3734185|P3|Overall Study|Other|6
1137153|NCT01461993|3734186|P2|Overall Study|Other|15
1137154|NCT01461993|3734187|P1|Overall Study|Other|13
1137155|NCT01461993|3734185|P3|Overall Study|Did not meet entrance criteria|0
1137156|NCT01461993|3734186|P2|Overall Study|Did not meet entrance criteria|3
1137157|NCT01461993|3734187|P1|Overall Study|Did not meet entrance criteria|2
1137158|NCT01461993|3734185|P3|Overall Study|No longer met eligibility criteria|10
1137159|NCT01461993|3734186|P2|Overall Study|No longer met eligibility criteria|18
1137160|NCT01461993|3734187|P1|Overall Study|No longer met eligibility criteria|13
1137161|NCT01461993|3734185|P3|Overall Study|Adverse Event|3
1137162|NCT01461993|3734186|P2|Overall Study|Adverse Event|11
1137163|NCT01461993|3734187|P1|Overall Study|Adverse Event|9
1137164|NCT01461993|3734185|P3|Overall Study|Protocol Violation|7
1137165|NCT01461993|3734186|P2|Overall Study|Protocol Violation|9
1137166|NCT01461993|3734187|P1|Overall Study|Protocol Violation|10
1137167|NCT01461993|3734185|P3|Overall Study|Lost to Follow-up|22
1137168|NCT01461993|3734186|P2|Overall Study|Lost to Follow-up|48
1137169|NCT01461993|3734187|P1|Overall Study|Lost to Follow-up|44
1137170|NCT01461993|3734185|P3|Overall Study|Withdrawal by Subject|16
1137171|NCT01461993|3734186|P2|Overall Study|Withdrawal by Subject|53
1137172|NCT01461993|3734187|P1|Overall Study|Withdrawal by Subject|60
1137173|NCT01461980|3734212|P3|Overall Study|Randomized but not vaccinated|7
1137174|NCT01461980|3734213|P2|Overall Study|Randomized but not vaccinated|8
1137175|NCT01461980|3734214|P1|Overall Study|Randomized but not vaccinated|4
1137176|NCT01461980|3734212|P3|Overall Study|No longer willing to participate|54
1137177|NCT01461980|3734213|P2|Overall Study|No longer willing to participate|38
1137178|NCT01461980|3734214|P1|Overall Study|No longer willing to participate|52
1137179|NCT01461980|3734212|P3|Overall Study|Lost to Follow-up|51
1137180|NCT01461980|3734213|P2|Overall Study|Lost to Follow-up|53
1137181|NCT01461980|3734214|P1|Overall Study|Lost to Follow-up|52
1137182|NCT01461980|3734212|P3|Overall Study|No longer meets eligibility criteria|19
1137183|NCT01461980|3734213|P2|Overall Study|No longer meets eligibility criteria|9
1137184|NCT01461980|3734214|P1|Overall Study|No longer meets eligibility criteria|18
1137185|NCT01461980|3734212|P3|Overall Study|Protocol Violation|16
1137186|NCT01461980|3734213|P2|Overall Study|Protocol Violation|19
1137187|NCT01461980|3734214|P1|Overall Study|Protocol Violation|12
1137188|NCT01461980|3734212|P3|Overall Study|Adverse Event|6
1137189|NCT01461980|3734213|P2|Overall Study|Adverse Event|5
1137190|NCT01461980|3734214|P1|Overall Study|Adverse Event|12
1137191|NCT01461980|3734212|P3|Overall Study|Medication error|6
1137192|NCT01461980|3734213|P2|Overall Study|Medication error|5
1137193|NCT01461980|3734214|P1|Overall Study|Medication error|7
1137194|NCT01461980|3734212|P3|Overall Study|Other|6
1137195|NCT01461980|3734213|P2|Overall Study|Other|8
1137196|NCT01461980|3734214|P1|Overall Study|Other|9
1137197|NCT01461811|3734276|P2|Overall Study|Noncompliance|1
1137198|NCT01461811|3734277|P1|Overall Study|Noncompliance|1
1137199|NCT01461811|3734276|P2|Overall Study|Subject decision unrelated to an AE|1
1137200|NCT01461811|3734277|P1|Overall Study|Subject decision unrelated to an AE|1
1137201|NCT01461811|3734276|P2|Overall Study|Adverse Event|1
1137202|NCT01461811|3734277|P1|Overall Study|Adverse Event|2
1137203|NCT01461707|3734316|P2|Overall Study|Withdrawal by Subject|0
1137204|NCT01461707|3734317|P1|Overall Study|Withdrawal by Subject|1
1137205|NCT01461551|3734354|P3|Overall Study|Physician Decision|2
1137206|NCT01461551|3734355|P2|Overall Study|Physician Decision|1
1137207|NCT01461551|3734356|P1|Overall Study|Physician Decision|2
1137208|NCT01461538|3734367|P3|Overall Study|Withdrawal by Subject|0
1137209|NCT01461538|3734368|P2|Overall Study|Withdrawal by Subject|1
1137210|NCT01461538|3734369|P1|Overall Study|Withdrawal by Subject|1
1137211|NCT01461538|3734367|P3|Overall Study|Study Stopped by Sponsor|0
1137212|NCT01461538|3734368|P2|Overall Study|Study Stopped by Sponsor|1
1137213|NCT01461538|3734369|P1|Overall Study|Study Stopped by Sponsor|2
1137214|NCT01461538|3734367|P3|Overall Study|Death|2
1137215|NCT01461538|3734368|P2|Overall Study|Death|6
1137216|NCT01461538|3734369|P1|Overall Study|Death|15
1137217|NCT01461369|3734438|P3|Overall Study|Withdrawal by Subject|2
1137218|NCT01461369|3734439|P2|Overall Study|Withdrawal by Subject|3
1137219|NCT01461369|3734440|P1|Overall Study|Withdrawal by Subject|1
1137220|NCT01461369|3734438|P3|Overall Study|Protocol Violation|2
1137221|NCT01461369|3734439|P2|Overall Study|Protocol Violation|2
1137222|NCT01461369|3734440|P1|Overall Study|Protocol Violation|1
1137223|NCT01461369|3734438|P3|Overall Study|Adverse Event|4
1137224|NCT01461369|3734439|P2|Overall Study|Adverse Event|12
1137225|NCT01461369|3734440|P1|Overall Study|Adverse Event|9
1137226|NCT01461369|3734438|P3|Overall Study|Lost to Follow-up|3
1137227|NCT01461369|3734439|P2|Overall Study|Lost to Follow-up|0
1137228|NCT01461369|3734440|P1|Overall Study|Lost to Follow-up|0
1137229|NCT01461369|3734438|P3|Overall Study|Lack of Efficacy|6
1137230|NCT01461369|3734439|P2|Overall Study|Lack of Efficacy|0
1137231|NCT01461369|3734440|P1|Overall Study|Lack of Efficacy|2
1137232|NCT01461096|3734465|P2|Overall Study|Lost to Follow-up|4
1137233|NCT01461096|3734466|P1|Overall Study|Lost to Follow-up|8
1137234|NCT01461096|3734465|P2|Overall Study|Subj not willing to adhere to reqs|4
1137235|NCT01461096|3734466|P1|Overall Study|Subj not willing to adhere to reqs|3
1137236|NCT01461096|3734465|P2|Overall Study|Withdrawal by Subject|3
1137237|NCT01461096|3734466|P1|Overall Study|Withdrawal by Subject|5
1137238|NCT01461096|3734465|P2|Overall Study|Site is closing|30
1137239|NCT01461096|3734466|P1|Overall Study|Site is closing|27
1137240|NCT01461096|3734465|P2|Overall Study|Subj not able to get to clinic|13
1137241|NCT01461096|3734466|P1|Overall Study|Subj not able to get to clinic|15
1137242|NCT01461096|3734465|P2|Overall Study|Severe debilitation, unable to continue|1
1137243|NCT01461096|3734466|P1|Overall Study|Severe debilitation, unable to continue|1
1137244|NCT01461096|3734465|P2|Overall Study|Death|6
1137245|NCT01461096|3734466|P1|Overall Study|Death|3
1137246|NCT01461057|3734482|P2|Overall Study|Study Terminated by Sponsor|0
1137247|NCT01461057|3734483|P1|Overall Study|Study Terminated by Sponsor|2
1137248|NCT01461057|3734482|P2|Overall Study|Progression of Disease|0
1137249|NCT01461057|3734483|P1|Overall Study|Progression of Disease|1
1137250|NCT01461057|3734482|P2|Overall Study|Adverse Event|1
1137251|NCT01461057|3734483|P1|Overall Study|Adverse Event|0
1137252|NCT01461057|3734482|P2|Overall Study|Physician Decision|2
1137253|NCT01461057|3734483|P1|Overall Study|Physician Decision|0
1137254|NCT01461057|3734482|P2|Overall Study|Withdrawal by Subject|3
1137255|NCT01461057|3734483|P1|Overall Study|Withdrawal by Subject|2
1137256|NCT01461057|3734482|P2|Overall Study|Death|9
1137257|NCT01461057|3734483|P1|Overall Study|Death|10
1137258|NCT01461044|3734493|P2|Overall Study|Lost to Follow-up|5
1137259|NCT01461044|3734494|P1|Overall Study|Lost to Follow-up|12
1137260|NCT01461044|3734493|P2|Overall Study|Death|35
1137261|NCT01461044|3734494|P1|Overall Study|Death|58
1137262|NCT01460628|3734605|P1|Overall Study|Withdrawal by Subject|2
1137263|NCT01460628|3734605|P1|Overall Study|Adverse Event|3
1137264|NCT01460446|3734617|P2|Overall Study|Other Reasons Incl. Lost for Follow-Up|3
1137265|NCT01460446|3734618|P1|Overall Study|Other Reasons Incl. Lost for Follow-Up|0
1137266|NCT01460446|3734617|P2|Overall Study|Pregnancy|0
1137267|NCT01460446|3734618|P1|Overall Study|Pregnancy|1
1137268|NCT01460446|3734617|P2|Overall Study|Surgery/Illness|1
1137269|NCT01460446|3734618|P1|Overall Study|Surgery/Illness|1
1137270|NCT01460446|3734617|P2|Overall Study|Non-compliance & Consent Withdrawn|3
1137271|NCT01460446|3734618|P1|Overall Study|Non-compliance & Consent Withdrawn|1
1137272|NCT01460446|3734617|P2|Overall Study|Consent Withdrawn|4
1137273|NCT01460446|3734618|P1|Overall Study|Consent Withdrawn|0
1137274|NCT01460446|3734617|P2|Overall Study|Non-compliance|9
1137275|NCT01460446|3734618|P1|Overall Study|Non-compliance|2
1137276|NCT01460407|3734645|P2|Period 2: Day 6 to Day 14|Adverse Event|1
1137277|NCT01460407|3734646|P1|Period 2: Day 6 to Day 14|Adverse Event|0
1137278|NCT01460381|3734659|P2|Period 2 (Days 8-15)|Lost to Follow-up|0
1137279|NCT01460381|3734660|P1|Period 2 (Days 8-15)|Lost to Follow-up|1
1137280|NCT01460368|3734676|P7|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
1137281|NCT01460368|3734677|P6|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
1137282|NCT01460368|3734678|P5|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
1137283|NCT01460368|3734679|P4|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
1137284|NCT01460368|3734680|P3|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
1137285|NCT01460368|3734681|P2|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
1137286|NCT01460368|3734682|P1|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
1137287|NCT01460368|3734676|P7|Part B: Washout (up to 15 Days)|Protocol Violation|0
1137288|NCT01460368|3734677|P6|Part B: Washout (up to 15 Days)|Protocol Violation|0
1137289|NCT01460368|3734678|P5|Part B: Washout (up to 15 Days)|Protocol Violation|0
1137290|NCT01460368|3734679|P4|Part B: Washout (up to 15 Days)|Protocol Violation|0
1137291|NCT01460368|3734680|P3|Part B: Washout (up to 15 Days)|Protocol Violation|1
1137292|NCT01460368|3734681|P2|Part B: Washout (up to 15 Days)|Protocol Violation|0
1137293|NCT01460368|3734682|P1|Part B: Washout (up to 15 Days)|Protocol Violation|0
1137294|NCT01460368|3734676|P7|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
1137295|NCT01460368|3734677|P6|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
1137296|NCT01460368|3734678|P5|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
1137297|NCT01460368|3734679|P4|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
1137298|NCT01460368|3734680|P3|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
1137299|NCT01460368|3734681|P2|Part B: Second Intervention (Period 2)|Lost to Follow-up|1
1137300|NCT01460368|3734682|P1|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
1137301|NCT01460368|3734676|P7|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1
1137302|NCT01460368|3734677|P6|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
1137303|NCT01460368|3734678|P5|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
1137304|NCT01460368|3734679|P4|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
1137305|NCT01460368|3734680|P3|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
1137306|NCT01460368|3734681|P2|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1
1137307|NCT01460368|3734682|P1|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
1137308|NCT01460368|3734676|P7|Part B: First Intervention (Period 1)|Lost to Follow-up|0
1137309|NCT01460368|3734677|P6|Part B: First Intervention (Period 1)|Lost to Follow-up|0
1137310|NCT01460368|3734678|P5|Part B: First Intervention (Period 1)|Lost to Follow-up|1
1137311|NCT01460368|3734679|P4|Part B: First Intervention (Period 1)|Lost to Follow-up|0
1137312|NCT01460368|3734680|P3|Part B: First Intervention (Period 1)|Lost to Follow-up|0
1137313|NCT01460368|3734681|P2|Part B: First Intervention (Period 1)|Lost to Follow-up|0
1137314|NCT01460368|3734682|P1|Part B: First Intervention (Period 1)|Lost to Follow-up|0
1137315|NCT01460342|3734694|P2|Overall Study|Lack of Efficacy|0
1137316|NCT01460342|3734695|P1|Overall Study|Lack of Efficacy|1
1137317|NCT01460342|3734694|P2|Overall Study|Physician Decision|3
1137318|NCT01460342|3734695|P1|Overall Study|Physician Decision|1
1137319|NCT01460342|3734694|P2|Overall Study|Withdrawal by Subject|4
1137320|NCT01460342|3734695|P1|Overall Study|Withdrawal by Subject|3
1137321|NCT01460342|3734694|P2|Overall Study|Protocol Violation|1
1137322|NCT01460342|3734695|P1|Overall Study|Protocol Violation|0
1137323|NCT01460342|3734694|P2|Overall Study|Lost to Follow-up|2
1137324|NCT01460342|3734695|P1|Overall Study|Lost to Follow-up|1
1137325|NCT01460342|3734694|P2|Overall Study|Adverse Event|4
1137326|NCT01460342|3734695|P1|Overall Study|Adverse Event|5
1137327|NCT01460290|3734726|P1|Overall Study|Elevated liver function|1
1137328|NCT01460290|3734726|P1|Overall Study|Adverse Event|3
1137329|NCT01460160|3734753|P2|Follow-up|Lost to Follow-up|0
1137330|NCT01460160|3734754|P1|Follow-up|Lost to Follow-up|1
1137331|NCT01460160|3734753|P2|Follow-up|Death|2
1137332|NCT01460160|3734754|P1|Follow-up|Death|7
1137333|NCT01460160|3734753|P2|Follow-up|Withdrawal by Subject|0
1137334|NCT01460160|3734754|P1|Follow-up|Withdrawal by Subject|3
1137335|NCT01460160|3734753|P2|Treatment|Subject refused to continue Chemo|0
1137336|NCT01460160|3734754|P1|Treatment|Subject refused to continue Chemo|1
1137337|NCT01460160|3734753|P2|Treatment|Family did not wish to restart after SCT|0
1137338|NCT01460160|3734754|P1|Treatment|Family did not wish to restart after SCT|1
1137339|NCT01460160|3734753|P2|Treatment|PI decision to pursue other options|1
1137340|NCT01460160|3734754|P1|Treatment|PI decision to pursue other options|1
1137341|NCT01460160|3734753|P2|Treatment|PI not to follow protocol therapy|0
1137342|NCT01460160|3734754|P1|Treatment|PI not to follow protocol therapy|1
1137343|NCT01460160|3734753|P2|Treatment|PI decision to not re-initiate after SCT|2
1137344|NCT01460160|3734754|P1|Treatment|PI decision to not re-initiate after SCT|2
1137345|NCT01460160|3734753|P2|Treatment|Death|2
1137346|NCT01460160|3734754|P1|Treatment|Death|0
1137347|NCT01460160|3734753|P2|Treatment|Withdrawal by Subject|0
1137348|NCT01460160|3734754|P1|Treatment|Withdrawal by Subject|4
1137349|NCT01460160|3734753|P2|Treatment|Adverse Event|0
1137350|NCT01460160|3734754|P1|Treatment|Adverse Event|8
1137351|NCT01460160|3734753|P2|Treatment|Study Drug Toxicity|0
1137352|NCT01460160|3734754|P1|Treatment|Study Drug Toxicity|2
1137353|NCT01460160|3734753|P2|Treatment|Lack of Efficacy|0
1137354|NCT01460160|3734754|P1|Treatment|Lack of Efficacy|3
1137355|NCT01459913|3734795|P4|Overall Study|Did Not Meet Inclusion Criteria|1
1137356|NCT01459913|3734796|P3|Overall Study|Did Not Meet Inclusion Criteria|0
1137357|NCT01459913|3734797|P2|Overall Study|Did Not Meet Inclusion Criteria|0
1137358|NCT01459913|3734798|P1|Overall Study|Did Not Meet Inclusion Criteria|0
1137359|NCT01459913|3734795|P4|Overall Study|Other|1
1137360|NCT01459913|3734796|P3|Overall Study|Other|3
1137361|NCT01459913|3734797|P2|Overall Study|Other|0
1137362|NCT01459913|3734798|P1|Overall Study|Other|0
1137363|NCT01459913|3734795|P4|Overall Study|Study Terminated by Sponsor|11
1137364|NCT01459913|3734796|P3|Overall Study|Study Terminated by Sponsor|9
1137365|NCT01459913|3734797|P2|Overall Study|Study Terminated by Sponsor|15
1137366|NCT01459913|3734798|P1|Overall Study|Study Terminated by Sponsor|30
1137367|NCT01459913|3734795|P4|Overall Study|Physician Decision|0
1137368|NCT01459913|3734796|P3|Overall Study|Physician Decision|0
1137369|NCT01459913|3734797|P2|Overall Study|Physician Decision|1
1137370|NCT01459913|3734798|P1|Overall Study|Physician Decision|0
1137371|NCT01459913|3734795|P4|Overall Study|Non- Compliance|3
1137372|NCT01459913|3734796|P3|Overall Study|Non- Compliance|0
1137373|NCT01459913|3734797|P2|Overall Study|Non- Compliance|0
1137374|NCT01459913|3734798|P1|Overall Study|Non- Compliance|0
1137375|NCT01459913|3734795|P4|Overall Study|Death|1
1137376|NCT01459913|3734796|P3|Overall Study|Death|0
1137377|NCT01459913|3734797|P2|Overall Study|Death|0
1137378|NCT01459913|3734798|P1|Overall Study|Death|0
1137379|NCT01459913|3734795|P4|Overall Study|Lost to Follow-up|8
1137380|NCT01459913|3734796|P3|Overall Study|Lost to Follow-up|1
1137381|NCT01459913|3734797|P2|Overall Study|Lost to Follow-up|4
1137382|NCT01459913|3734798|P1|Overall Study|Lost to Follow-up|7
1137383|NCT01459913|3734795|P4|Overall Study|Withdrawal by Subject|5
1137384|NCT01459913|3734796|P3|Overall Study|Withdrawal by Subject|0
1137385|NCT01459913|3734797|P2|Overall Study|Withdrawal by Subject|0
1137386|NCT01459913|3734798|P1|Overall Study|Withdrawal by Subject|4
1137387|NCT01459913|3734795|P4|Overall Study|Adverse Event|3
1137388|NCT01459913|3734796|P3|Overall Study|Adverse Event|0
1137389|NCT01459913|3734797|P2|Overall Study|Adverse Event|0
1137390|NCT01459913|3734798|P1|Overall Study|Adverse Event|0
1137391|NCT01459796|3734829|P2|Overall Study|Decision by the sponsor|108
1137392|NCT01459796|3734830|P1|Overall Study|Decision by the sponsor|75
1137393|NCT01459796|3734829|P2|Overall Study|Reason unspecified|2
1137394|NCT01459796|3734830|P1|Overall Study|Reason unspecified|1
1137395|NCT01459796|3734829|P2|Overall Study|Lost to Follow-up|4
1137396|NCT01459796|3734830|P1|Overall Study|Lost to Follow-up|5
1137397|NCT01459796|3734829|P2|Overall Study|Withdrawal by Subject|3
1137398|NCT01459796|3734830|P1|Overall Study|Withdrawal by Subject|6
1137399|NCT01459796|3734829|P2|Overall Study|Adverse Event|5
1137400|NCT01459796|3734830|P1|Overall Study|Adverse Event|5
1137401|NCT01459796|3734829|P2|Overall Study|Non compliance with protocol|4
1137402|NCT01459796|3734830|P1|Overall Study|Non compliance with protocol|2
1137403|NCT01459783|3734848|P2|6 Months to 12 Months|Study ended before 12-month follow-up|17
1137404|NCT01459783|3734849|P1|6 Months to 12 Months|Study ended before 12-month follow-up|11
1137405|NCT01459783|3734848|P2|6 Months to 12 Months|Lost to Follow-up|7
1137406|NCT01459783|3734849|P1|6 Months to 12 Months|Lost to Follow-up|2
1137407|NCT01459783|3734848|P2|6 Months to 12 Months|Withdrawal by Subject|5
1137408|NCT01459783|3734849|P1|6 Months to 12 Months|Withdrawal by Subject|6
1137409|NCT01459783|3734848|P2|6 Months to 12 Months|Death|1
1137410|NCT01459783|3734849|P1|6 Months to 12 Months|Death|0
1137411|NCT01459783|3734848|P2|Baseline to 6 Months|Lost to Follow-up|14
1137412|NCT01459783|3734849|P1|Baseline to 6 Months|Lost to Follow-up|19
1137413|NCT01459783|3734848|P2|Baseline to 6 Months|Withdrawal by Subject|6
1137414|NCT01459783|3734849|P1|Baseline to 6 Months|Withdrawal by Subject|12
1137415|NCT01459783|3734848|P2|Baseline to 6 Months|Death|0
1137416|NCT01459783|3734849|P1|Baseline to 6 Months|Death|1
1137417|NCT01459068|3735061|P2|Overall Study|Death|1
1137418|NCT01459068|3735062|P1|Overall Study|Death|0
1137419|NCT01459068|3735061|P2|Overall Study|Lost to Follow-up|15
1137420|NCT01459068|3735062|P1|Overall Study|Lost to Follow-up|31
1137421|NCT01459068|3735061|P2|Overall Study|Withdrawal by Subject|18
1137422|NCT01459068|3735062|P1|Overall Study|Withdrawal by Subject|8
1137423|NCT01459016|3735078|P1|Overall Study|Amendment Discontinuation Criteria|4
1137424|NCT01459016|3735078|P1|Overall Study|Withdrawal by Subject|11
1137425|NCT01458951|3735106|P3|Overall Study|Insufficient Clinical Response|11
1137426|NCT01458951|3735107|P2|Overall Study|Insufficient Clinical Response|0
1137427|NCT01458951|3735108|P1|Overall Study|Insufficient Clinical Response|17
1137428|NCT01458951|3735106|P3|Overall Study|Adverse Event|2
1137429|NCT01458951|3735107|P2|Overall Study|Adverse Event|0
1137430|NCT01458951|3735108|P1|Overall Study|Adverse Event|7
1137431|NCT01458951|3735106|P3|Overall Study|Withdrawal by Subject|2
1137432|NCT01458951|3735107|P2|Overall Study|Withdrawal by Subject|0
1137433|NCT01458951|3735108|P1|Overall Study|Withdrawal by Subject|2
1137434|NCT01458951|3735106|P3|Overall Study|Protocol Violation|0
1137435|NCT01458951|3735107|P2|Overall Study|Protocol Violation|1
1137436|NCT01458951|3735108|P1|Overall Study|Protocol Violation|5
1137437|NCT01458951|3735106|P3|Overall Study|Other|0
1137438|NCT01458951|3735107|P2|Overall Study|Other|0
1137439|NCT01458951|3735108|P1|Overall Study|Other|1
1137440|NCT01458639|3735133|P1|Overall Study|Inability to obtain subject blood sample|1
1137441|NCT01458639|3735133|P1|Overall Study|Equipment issue|1
1137442|NCT01458639|3735133|P1|Overall Study|Physician Decision|4
1137443|NCT01458587|3735145|P2|Overall Study|Withdrawal by Subject|0
1137444|NCT01458587|3735146|P1|Overall Study|Withdrawal by Subject|1
1137445|NCT01458574|3735309|P3|Overall Study|Randomized but not treated|0
1137446|NCT01458574|3735310|P2|Overall Study|Randomized but not treated|1
1137447|NCT01458574|3735311|P1|Overall Study|Randomized but not treated|0
1137448|NCT01458574|3735309|P3|Overall Study|Other|0
1137449|NCT01458574|3735310|P2|Overall Study|Other|1
1137450|NCT01458574|3735311|P1|Overall Study|Other|2
1137451|NCT01458574|3735309|P3|Overall Study|Withdrawal by Subject|5
1137452|NCT01458574|3735310|P2|Overall Study|Withdrawal by Subject|3
1137453|NCT01458574|3735311|P1|Overall Study|Withdrawal by Subject|6
1137454|NCT01458574|3735309|P3|Overall Study|Protocol Violation|0
1137455|NCT01458574|3735310|P2|Overall Study|Protocol Violation|1
1137456|NCT01458574|3735311|P1|Overall Study|Protocol Violation|0
1137457|NCT01458574|3735309|P3|Overall Study|Pregnancy|0
1137458|NCT01458574|3735310|P2|Overall Study|Pregnancy|1
1137459|NCT01458574|3735311|P1|Overall Study|Pregnancy|1
1137460|NCT01458574|3735309|P3|Overall Study|Lost to Follow-up|1
1137461|NCT01458574|3735310|P2|Overall Study|Lost to Follow-up|2
1137462|NCT01458574|3735311|P1|Overall Study|Lost to Follow-up|3
1137463|NCT01458574|3735309|P3|Overall Study|Lack of Efficacy|132
1137464|NCT01458574|3735310|P2|Overall Study|Lack of Efficacy|53
1137465|NCT01458574|3735311|P1|Overall Study|Lack of Efficacy|70
1137466|NCT01458574|3735309|P3|Overall Study|Adverse Event|7
1137467|NCT01458574|3735310|P2|Overall Study|Adverse Event|9
1137468|NCT01458574|3735311|P1|Overall Study|Adverse Event|5
1137469|NCT01458535|3735441|P6|Overall Study|Adverse Event|0
1137470|NCT01458535|3735442|P5|Overall Study|Adverse Event|0
1137471|NCT01458535|3735443|P4|Overall Study|Adverse Event|1
1137472|NCT01458535|3735444|P3|Overall Study|Adverse Event|0
1137473|NCT01458535|3735445|P2|Overall Study|Adverse Event|0
1137474|NCT01458535|3735446|P1|Overall Study|Adverse Event|0
1137475|NCT01458535|3735441|P6|Overall Study|Lost to Follow-up|2
1137476|NCT01458535|3735442|P5|Overall Study|Lost to Follow-up|2
1137477|NCT01458535|3735443|P4|Overall Study|Lost to Follow-up|3
1137478|NCT01458535|3735444|P3|Overall Study|Lost to Follow-up|0
1137479|NCT01458535|3735445|P2|Overall Study|Lost to Follow-up|2
1137480|NCT01458535|3735446|P1|Overall Study|Lost to Follow-up|0
1137481|NCT01458535|3735441|P6|Overall Study|Withdrawal by Subject|1
1137482|NCT01458535|3735442|P5|Overall Study|Withdrawal by Subject|1
1137483|NCT01458535|3735443|P4|Overall Study|Withdrawal by Subject|0
1137484|NCT01458535|3735444|P3|Overall Study|Withdrawal by Subject|2
1137485|NCT01458535|3735445|P2|Overall Study|Withdrawal by Subject|0
1137486|NCT01458535|3735446|P1|Overall Study|Withdrawal by Subject|0
1137487|NCT01458535|3735441|P6|Overall Study|Other|1
1137488|NCT01458535|3735442|P5|Overall Study|Other|1
1137489|NCT01458535|3735443|P4|Overall Study|Other|0
1137490|NCT01458535|3735444|P3|Overall Study|Other|0
1137491|NCT01458535|3735445|P2|Overall Study|Other|0
1137492|NCT01458535|3735446|P1|Overall Study|Other|0
1137493|NCT01458522|3735498|P2|Overall Study|Physician Decision|9
1137494|NCT01458522|3735499|P1|Overall Study|Physician Decision|1
1137495|NCT01458522|3735498|P2|Overall Study|Withdrawal by Subject|2
1137496|NCT01458522|3735499|P1|Overall Study|Withdrawal by Subject|2
1137497|NCT01458392|3735528|P3|Overall Study|Patient unwilling to comply with protoco|2
1137498|NCT01458392|3735529|P2|Overall Study|Patient unwilling to comply with protoco|0
1137499|NCT01458392|3735530|P1|Overall Study|Patient unwilling to comply with protoco|0
1137500|NCT01458392|3735528|P3|Overall Study|At the discretion of the sponsor|7
1137501|NCT01458392|3735529|P2|Overall Study|At the discretion of the sponsor|2
1137502|NCT01458392|3735530|P1|Overall Study|At the discretion of the sponsor|0
1137503|NCT01458392|3735528|P3|Overall Study|Death|22
1137504|NCT01458392|3735529|P2|Overall Study|Death|11
1137505|NCT01458392|3735530|P1|Overall Study|Death|2
1137506|NCT01458275|3735562|P3|Overall Study|Withdrawal by Subject|1
1137507|NCT01458275|3735563|P2|Overall Study|Withdrawal by Subject|2
1137508|NCT01458275|3735564|P1|Overall Study|Withdrawal by Subject|3
1137509|NCT01458275|3735562|P3|Overall Study|Protocol Violation|2
1137510|NCT01458275|3735563|P2|Overall Study|Protocol Violation|5
1137511|NCT01458275|3735564|P1|Overall Study|Protocol Violation|5
1137512|NCT01458275|3735562|P3|Overall Study|Lost to Follow-up|5
1137513|NCT01458275|3735563|P2|Overall Study|Lost to Follow-up|2
1137514|NCT01458275|3735564|P1|Overall Study|Lost to Follow-up|3
1137515|NCT01458275|3735562|P3|Overall Study|Adverse Event|1
1137516|NCT01458275|3735563|P2|Overall Study|Adverse Event|4
1137517|NCT01458275|3735564|P1|Overall Study|Adverse Event|3
1137518|NCT01458249|3735606|P1|Overall Study|Ongoing|1
1137519|NCT01458249|3735606|P1|Overall Study|Not specified|2
1137520|NCT01458249|3735606|P1|Overall Study|Adverse Event|4
1137521|NCT01458249|3735606|P1|Overall Study|Not treated|1
1137522|NCT01458210|3735625|P1|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1
1137523|NCT01458210|3735625|P1|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2
1137524|NCT01458210|3735625|P1|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2
1137525|NCT01458210|3735625|P1|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2
1137526|NCT01458171|3735642|P1|Overall Study|Adverse Event|1
1137527|NCT01458119|3735663|P1|Overall Study|Non-compliance With Study Drug|3
1137528|NCT01458119|3735663|P1|Overall Study|Consent Withdrawn by Participant|8
1137529|NCT01458119|3735663|P1|Overall Study|Adverse Event|1
1137530|NCT01458119|3735663|P1|Overall Study|Death|2
1137531|NCT01458119|3735663|P1|Overall Study|Pregnancy|1
1137532|NCT01458119|3735663|P1|Overall Study|Withdrawal Due to Nonamenable Mutation|1
1137533|NCT01458119|3735663|P1|Overall Study|Physician Decision|4
1137534|NCT01458106|3735670|P2|Overall Study|Withdrawn Per Protocol|1
1137535|NCT01458106|3735671|P1|Overall Study|Withdrawn Per Protocol|0
1137536|NCT01458106|3735670|P2|Overall Study|Pre-rFVIIIFc Adverse Event|0
1137537|NCT01458106|3735671|P1|Overall Study|Pre-rFVIIIFc Adverse Event|1
1137538|NCT01458106|3735670|P2|Overall Study|Withdrawal by Subject|0
1137539|NCT01458106|3735671|P1|Overall Study|Withdrawal by Subject|2
1137540|NCT01457950|3735748|P4|Open-Label Phase|Withdrawal by Subject|0
1137541|NCT01457950|3735749|P3|Open-Label Phase|Withdrawal by Subject|2
1137542|NCT01457950|3735750|P2|Open-Label Phase|Withdrawal by Subject|0
1137543|NCT01457950|3735751|P1|Open-Label Phase|Withdrawal by Subject|0
1137544|NCT01457950|3735748|P4|Open-Label Phase|Protocol Violation|1
1137545|NCT01457950|3735749|P3|Open-Label Phase|Protocol Violation|0
1137546|NCT01457950|3735750|P2|Open-Label Phase|Protocol Violation|0
1137547|NCT01457950|3735751|P1|Open-Label Phase|Protocol Violation|0
1137548|NCT01457950|3735748|P4|Open-Label Phase|Adverse Event|1
1137549|NCT01457950|3735749|P3|Open-Label Phase|Adverse Event|0
1137550|NCT01457950|3735750|P2|Open-Label Phase|Adverse Event|0
1137551|NCT01457950|3735751|P1|Open-Label Phase|Adverse Event|0
1137552|NCT01457950|3735748|P4|Double-Blind Phase|Withdrawal by Subject|0
1137553|NCT01457950|3735749|P3|Double-Blind Phase|Withdrawal by Subject|0
1137554|NCT01457950|3735750|P2|Double-Blind Phase|Withdrawal by Subject|2
1137555|NCT01457950|3735751|P1|Double-Blind Phase|Withdrawal by Subject|6
1137556|NCT01457950|3735748|P4|Double-Blind Phase|Protocol Violation|0
1137557|NCT01457950|3735749|P3|Double-Blind Phase|Protocol Violation|0
1137558|NCT01457950|3735750|P2|Double-Blind Phase|Protocol Violation|1
1137559|NCT01457950|3735751|P1|Double-Blind Phase|Protocol Violation|2
1137560|NCT01457950|3735748|P4|Double-Blind Phase|Continuation Criteria Not Met|0
1137561|NCT01457950|3735749|P3|Double-Blind Phase|Continuation Criteria Not Met|0
1137562|NCT01457950|3735750|P2|Double-Blind Phase|Continuation Criteria Not Met|0
1137563|NCT01457950|3735751|P1|Double-Blind Phase|Continuation Criteria Not Met|1
1137564|NCT01457924|3735830|P5|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
1137565|NCT01457924|3735831|P4|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2
1137566|NCT01457924|3735832|P3|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
1137567|NCT01457924|3735833|P2|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0
1137568|NCT01457924|3735834|P1|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
1137569|NCT01457924|3735830|P5|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5
1137570|NCT01457924|3735831|P4|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
1137571|NCT01457924|3735832|P3|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2
1137572|NCT01457924|3735833|P2|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4
1137573|NCT01457924|3735834|P1|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
1137574|NCT01457924|3735830|P5|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
1137575|NCT01457924|3735831|P4|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
1137576|NCT01457924|3735832|P3|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
1137577|NCT01457924|3735833|P2|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
1137578|NCT01457924|3735834|P1|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
1137579|NCT01457924|3735830|P5|FUP (Weeks 24-48)|Withdrawal by Subject|2
1137580|NCT01457924|3735831|P4|FUP (Weeks 24-48)|Withdrawal by Subject|0
1137581|NCT01457924|3735832|P3|FUP (Weeks 24-48)|Withdrawal by Subject|0
1137582|NCT01457924|3735833|P2|FUP (Weeks 24-48)|Withdrawal by Subject|1
1137583|NCT01457924|3735834|P1|FUP (Weeks 24-48)|Withdrawal by Subject|2
1137584|NCT01457924|3735830|P5|FUP (Weeks 24-48)|Lost to Follow-up|0
1137585|NCT01457924|3735831|P4|FUP (Weeks 24-48)|Lost to Follow-up|1
1137586|NCT01457924|3735832|P3|FUP (Weeks 24-48)|Lost to Follow-up|0
1137587|NCT01457924|3735833|P2|FUP (Weeks 24-48)|Lost to Follow-up|0
1137588|NCT01457924|3735834|P1|FUP (Weeks 24-48)|Lost to Follow-up|0
1137589|NCT01457924|3735830|P5|FUP (Weeks 24-48)|Physician Decision|0
1137590|NCT01457924|3735831|P4|FUP (Weeks 24-48)|Physician Decision|0
1137591|NCT01457924|3735832|P3|FUP (Weeks 24-48)|Physician Decision|1
1137592|NCT01457924|3735833|P2|FUP (Weeks 24-48)|Physician Decision|0
1137593|NCT01457924|3735834|P1|FUP (Weeks 24-48)|Physician Decision|1
1137594|NCT01457924|3735830|P5|FUP (Weeks 24-48)|Adverse Event|0
1137595|NCT01457924|3735831|P4|FUP (Weeks 24-48)|Adverse Event|0
1137596|NCT01457924|3735832|P3|FUP (Weeks 24-48)|Adverse Event|1
1137597|NCT01457924|3735833|P2|FUP (Weeks 24-48)|Adverse Event|0
1137598|NCT01457924|3735834|P1|FUP (Weeks 24-48)|Adverse Event|0
1137599|NCT01457924|3735830|P5|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2
1137600|NCT01457924|3735831|P4|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
1137601|NCT01457924|3735832|P3|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
1137602|NCT01457924|3735833|P2|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
1137603|NCT01457924|3735834|P1|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
1137604|NCT01457924|3735830|P5|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
1137605|NCT01457924|3735831|P4|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
1137606|NCT01457924|3735832|P3|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
1137607|NCT01457924|3735833|P2|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
1137608|NCT01457924|3735834|P1|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
1137609|NCT01457924|3735830|P5|Treatment Phase (Weeks 0-24)|Protocol Violation|0
1137610|NCT01457924|3735831|P4|Treatment Phase (Weeks 0-24)|Protocol Violation|0
1137611|NCT01457924|3735832|P3|Treatment Phase (Weeks 0-24)|Protocol Violation|1
1137612|NCT01457924|3735833|P2|Treatment Phase (Weeks 0-24)|Protocol Violation|0
1137613|NCT01457924|3735834|P1|Treatment Phase (Weeks 0-24)|Protocol Violation|1
1137614|NCT01457924|3735830|P5|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
1137615|NCT01457924|3735831|P4|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
1137616|NCT01457924|3735832|P3|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
1137617|NCT01457924|3735833|P2|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
1137618|NCT01457924|3735834|P1|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1
1137619|NCT01457924|3735830|P5|Treatment Phase (Weeks 0-24)|Physician Decision|1
1137620|NCT01457924|3735831|P4|Treatment Phase (Weeks 0-24)|Physician Decision|0
1137621|NCT01457924|3735832|P3|Treatment Phase (Weeks 0-24)|Physician Decision|0
1137622|NCT01457924|3735833|P2|Treatment Phase (Weeks 0-24)|Physician Decision|0
1137623|NCT01457924|3735834|P1|Treatment Phase (Weeks 0-24)|Physician Decision|0
1137624|NCT01457924|3735830|P5|Treatment Phase (Weeks 0-24)|Adverse Event|2
1137625|NCT01457924|3735831|P4|Treatment Phase (Weeks 0-24)|Adverse Event|0
1137626|NCT01457924|3735832|P3|Treatment Phase (Weeks 0-24)|Adverse Event|1
1137627|NCT01457924|3735833|P2|Treatment Phase (Weeks 0-24)|Adverse Event|4
1137628|NCT01457924|3735834|P1|Treatment Phase (Weeks 0-24)|Adverse Event|0
1137629|NCT01457846|3735904|P2|Overall Study|Lost to Follow-up|0
1137630|NCT01457846|3735905|P1|Overall Study|Lost to Follow-up|1
1137631|NCT01457846|3735904|P2|Overall Study|Withdrawal by Subject|1
1137632|NCT01457846|3735905|P1|Overall Study|Withdrawal by Subject|1
1137633|NCT01457846|3735904|P2|Overall Study|Unclassified reason for not completed|10
1137634|NCT01457846|3735905|P1|Overall Study|Unclassified reason for not completed|11
1137635|NCT01457846|3735904|P2|Overall Study|Death|16
1137636|NCT01457846|3735905|P1|Overall Study|Death|27
1137637|NCT01457846|3735904|P2|Overall Study|Did not receive treatment|1
1137638|NCT01457846|3735905|P1|Overall Study|Did not receive treatment|0
1137639|NCT01457846|3735904|P2|Overall Study|Death before treatment|2
1137640|NCT01457846|3735905|P1|Overall Study|Death before treatment|1
1137641|NCT01457703|3735921|P2|Overall Study|Withdrawal by Subject|4
1137642|NCT01457703|3735922|P1|Overall Study|Withdrawal by Subject|1
1137643|NCT01457703|3735921|P2|Overall Study|Screen Failure|7
1137644|NCT01457703|3735922|P1|Overall Study|Screen Failure|5
1137645|NCT01457339|3736033|P2|Period 6 (250 mg)|Personal appointment|1
1137646|NCT01457339|3736034|P1|Period 6 (250 mg)|Personal appointment|0
1137647|NCT01457339|3736033|P2|Period 6 (250 mg)|Family Emergency|0
1137648|NCT01457339|3736034|P1|Period 6 (250 mg)|Family Emergency|1
1137649|NCT01457339|3736033|P2|Period 5 (200 mg)|Met stopping criteria for PANSS score|1
1137650|NCT01457339|3736034|P1|Period 5 (200 mg)|Met stopping criteria for PANSS score|0
1137651|NCT01457339|3736033|P2|Period 3 (100 mg)|Adverse Event|1
1137652|NCT01457339|3736034|P1|Period 3 (100 mg)|Adverse Event|0
1137653|NCT01457053|3736200|P2|Overall Study|Unable to undergo selected treatment|1
1137654|NCT01457053|3736201|P1|Overall Study|Unable to undergo selected treatment|1
1137655|NCT01457014|3736207|P4|First Night|Withdrawal by Subject|0
1137656|NCT01457014|3736208|P3|First Night|Withdrawal by Subject|0
1137657|NCT01457014|3736209|P2|First Night|Withdrawal by Subject|0
1137658|NCT01457014|3736210|P1|First Night|Withdrawal by Subject|3
1137659|NCT01457014|3736207|P4|First Night|Didn't meet inclusion/exclusion criteria|0
1137660|NCT01457014|3736208|P3|First Night|Didn't meet inclusion/exclusion criteria|0
1137661|NCT01457014|3736209|P2|First Night|Didn't meet inclusion/exclusion criteria|0
1137662|NCT01457014|3736210|P1|First Night|Didn't meet inclusion/exclusion criteria|37
1137663|NCT01456962|3736227|P2|Overall Study|Lost to Follow-up|1
1137664|NCT01456962|3736228|P1|Overall Study|Lost to Follow-up|2
1137665|NCT01456936|3736238|P4|Overall Study|Randomized but not treated|21
1137666|NCT01456936|3736239|P3|Overall Study|Randomized but not treated|16
1137667|NCT01456936|3736240|P2|Overall Study|Randomized but not treated|28
1137668|NCT01456936|3736241|P1|Overall Study|Randomized but not treated|21
1137669|NCT01456936|3736238|P4|Overall Study|Death|3
1137670|NCT01456936|3736239|P3|Overall Study|Death|1
1137671|NCT01456936|3736240|P2|Overall Study|Death|3
1137672|NCT01456936|3736241|P1|Overall Study|Death|0
1137673|NCT01456936|3736238|P4|Overall Study|Adverse event (study drug unrelated)|9
1137674|NCT01456936|3736239|P3|Overall Study|Adverse event (study drug unrelated)|9
1137675|NCT01456936|3736240|P2|Overall Study|Adverse event (study drug unrelated)|7
1137676|NCT01456936|3736241|P1|Overall Study|Adverse event (study drug unrelated)|9
1137677|NCT01456936|3736238|P4|Overall Study|Adverse event (study drug)|17
1137678|NCT01456936|3736239|P3|Overall Study|Adverse event (study drug)|26
1137679|NCT01456936|3736240|P2|Overall Study|Adverse event (study drug)|21
1137680|NCT01456936|3736241|P1|Overall Study|Adverse event (study drug)|25
1137681|NCT01456936|3736238|P4|Overall Study|Medication error|1
1137682|NCT01456936|3736239|P3|Overall Study|Medication error|0
1137683|NCT01456936|3736240|P2|Overall Study|Medication error|1
1137684|NCT01456936|3736241|P1|Overall Study|Medication error|0
1137685|NCT01456936|3736238|P4|Overall Study|Lost to Follow-up|127
1137686|NCT01456936|3736239|P3|Overall Study|Lost to Follow-up|144
1137687|NCT01456936|3736240|P2|Overall Study|Lost to Follow-up|126
1137688|NCT01456936|3736241|P1|Overall Study|Lost to Follow-up|135
1137689|NCT01456936|3736238|P4|Overall Study|No longer willing to participate|248
1137690|NCT01456936|3736239|P3|Overall Study|No longer willing to participate|224
1137691|NCT01456936|3736240|P2|Overall Study|No longer willing to participate|218
1137692|NCT01456936|3736241|P1|Overall Study|No longer willing to participate|195
1137693|NCT01456936|3736238|P4|Overall Study|Insufficient clinical response|13
1137694|NCT01456936|3736239|P3|Overall Study|Insufficient clinical response|14
1137695|NCT01456936|3736240|P2|Overall Study|Insufficient clinical response|4
1137696|NCT01456936|3736241|P1|Overall Study|Insufficient clinical response|4
1137697|NCT01456936|3736238|P4|Overall Study|Pregnancy|1
1137698|NCT01456936|3736239|P3|Overall Study|Pregnancy|0
1137699|NCT01456936|3736240|P2|Overall Study|Pregnancy|0
1137700|NCT01456936|3736241|P1|Overall Study|Pregnancy|1
1137701|NCT01456936|3736238|P4|Overall Study|Protocol Violation|5
1137702|NCT01456936|3736239|P3|Overall Study|Protocol Violation|5
1137703|NCT01456936|3736240|P2|Overall Study|Protocol Violation|2
1137704|NCT01456936|3736241|P1|Overall Study|Protocol Violation|4
1137705|NCT01456936|3736238|P4|Overall Study|No longer meets eligibility criteria|5
1137706|NCT01456936|3736239|P3|Overall Study|No longer meets eligibility criteria|6
1137707|NCT01456936|3736240|P2|Overall Study|No longer meets eligibility criteria|8
1137708|NCT01456936|3736241|P1|Overall Study|No longer meets eligibility criteria|4
1137709|NCT01456936|3736238|P4|Overall Study|Other reason|33
1137710|NCT01456936|3736239|P3|Overall Study|Other reason|36
1137711|NCT01456936|3736240|P2|Overall Study|Other reason|30
1137712|NCT01456936|3736241|P1|Overall Study|Other reason|41
1137713|NCT01456780|3736350|P3|Overall Study|Lost to Follow-up|0
1137714|NCT01456780|3736351|P2|Overall Study|Lost to Follow-up|3
1137715|NCT01456780|3736352|P1|Overall Study|Lost to Follow-up|3
1137716|NCT01456195|3736385|P3|Overall Study|Other Reasons|3
1137717|NCT01456195|3736386|P2|Overall Study|Other Reasons|1
1137718|NCT01456195|3736387|P1|Overall Study|Other Reasons|2
1137719|NCT01456195|3736385|P3|Overall Study|Lack of Efficacy|0
1137720|NCT01456195|3736386|P2|Overall Study|Lack of Efficacy|1
1137721|NCT01456195|3736387|P1|Overall Study|Lack of Efficacy|0
1137722|NCT01456195|3736385|P3|Overall Study|Voluntary Withdrawal|7
1137723|NCT01456195|3736386|P2|Overall Study|Voluntary Withdrawal|3
1137724|NCT01456195|3736387|P1|Overall Study|Voluntary Withdrawal|5
1137725|NCT01456195|3736385|P3|Overall Study|Lost to Follow-up|3
1137726|NCT01456195|3736386|P2|Overall Study|Lost to Follow-up|1
1137727|NCT01456195|3736387|P1|Overall Study|Lost to Follow-up|3
1137728|NCT01456195|3736385|P3|Overall Study|Pretreatment Event/Adverse Event|1
1137729|NCT01456195|3736386|P2|Overall Study|Pretreatment Event/Adverse Event|4
1137730|NCT01456195|3736387|P1|Overall Study|Pretreatment Event/Adverse Event|1
1137731|NCT01456169|3736407|P3|Overall Study|Other|0
1137732|NCT01456169|3736408|P2|Overall Study|Other|1
1137733|NCT01456169|3736409|P1|Overall Study|Other|1
1137734|NCT01456169|3736407|P3|Overall Study|Lack of Efficacy|0
1137735|NCT01456169|3736408|P2|Overall Study|Lack of Efficacy|0
1137736|NCT01456169|3736409|P1|Overall Study|Lack of Efficacy|2
1137737|NCT01456169|3736407|P3|Overall Study|Voluntary Withdrawal|2
1137738|NCT01456169|3736408|P2|Overall Study|Voluntary Withdrawal|0
1137739|NCT01456169|3736409|P1|Overall Study|Voluntary Withdrawal|3
1137740|NCT01456169|3736407|P3|Overall Study|Major Protocol Deviation|3
1137741|NCT01456169|3736408|P2|Overall Study|Major Protocol Deviation|2
1137742|NCT01456169|3736409|P1|Overall Study|Major Protocol Deviation|3
1137743|NCT01456169|3736407|P3|Overall Study|Adverse Event|7
1137744|NCT01456169|3736408|P2|Overall Study|Adverse Event|2
1137745|NCT01456169|3736409|P1|Overall Study|Adverse Event|1
1137746|NCT01456130|3736469|P1|Overall Study|Other|1
1137747|NCT01456130|3736469|P1|Overall Study|Lack of Efficacy|4
1137748|NCT01456130|3736469|P1|Overall Study|Voluntary Withdrawal|1
1137749|NCT01456130|3736469|P1|Overall Study|Adverse Event|4
1137750|NCT01456052|3736479|P3|Overall Study|Treatment Failure|1
1137751|NCT01456052|3736480|P2|Overall Study|Treatment Failure|1
1137752|NCT01456052|3736481|P1|Overall Study|Treatment Failure|0
1137753|NCT01456052|3736479|P3|Overall Study|Physician Decision|1
1137754|NCT01456052|3736480|P2|Overall Study|Physician Decision|0
1137755|NCT01456052|3736481|P1|Overall Study|Physician Decision|1
1137756|NCT01456052|3736479|P3|Overall Study|Protocol Violation|0
1137757|NCT01456052|3736480|P2|Overall Study|Protocol Violation|1
1137758|NCT01456052|3736481|P1|Overall Study|Protocol Violation|0
1137759|NCT01456052|3736479|P3|Overall Study|Consent withdrawn|1
1137760|NCT01456052|3736480|P2|Overall Study|Consent withdrawn|2
1137761|NCT01456052|3736481|P1|Overall Study|Consent withdrawn|0
1137762|NCT01456052|3736479|P3|Overall Study|Adverse Event|2
1137763|NCT01456052|3736480|P2|Overall Study|Adverse Event|1
1137764|NCT01456052|3736481|P1|Overall Study|Adverse Event|1
1137765|NCT01456039|3736501|P3|Phase 2 (Second Step)|Other|1
1137766|NCT01456039|3736502|P2|Phase 2 (Second Step)|Other|0
1137767|NCT01456039|3736503|P1|Phase 2 (Second Step)|Other|0
1137768|NCT01456039|3736501|P3|Phase 2 (Second Step)|Protocol Violation|1
1137769|NCT01456039|3736502|P2|Phase 2 (Second Step)|Protocol Violation|0
1137770|NCT01456039|3736503|P1|Phase 2 (Second Step)|Protocol Violation|0
1137771|NCT01456039|3736501|P3|Phase 2 (Second Step)|Withdrawal by Subject|4
1137772|NCT01456039|3736502|P2|Phase 2 (Second Step)|Withdrawal by Subject|0
1137773|NCT01456039|3736503|P1|Phase 2 (Second Step)|Withdrawal by Subject|0
1137774|NCT01456039|3736501|P3|Phase 2 (Second Step)|Adverse Event|10
1137775|NCT01456039|3736502|P2|Phase 2 (Second Step)|Adverse Event|0
1137776|NCT01456039|3736503|P1|Phase 2 (Second Step)|Adverse Event|0
1137777|NCT01456039|3736501|P3|Phase 2 (Second Step)|Disease Progression|17
1137778|NCT01456039|3736502|P2|Phase 2 (Second Step)|Disease Progression|0
1137779|NCT01456039|3736503|P1|Phase 2 (Second Step)|Disease Progression|0
1137780|NCT01456039|3736501|P3|Phase 1 (First Step)|Not specified|0
1137781|NCT01456039|3736502|P2|Phase 1 (First Step)|Not specified|1
1137782|NCT01456039|3736503|P1|Phase 1 (First Step)|Not specified|0
1137783|NCT01456039|3736501|P3|Phase 1 (First Step)|Adverse Event|0
1137784|NCT01456039|3736502|P2|Phase 1 (First Step)|Adverse Event|3
1137785|NCT01456039|3736503|P1|Phase 1 (First Step)|Adverse Event|0
1137786|NCT01456039|3736501|P3|Phase 1 (First Step)|Withdrawal by Subject|0
1137787|NCT01456039|3736502|P2|Phase 1 (First Step)|Withdrawal by Subject|2
1137788|NCT01456039|3736503|P1|Phase 1 (First Step)|Withdrawal by Subject|1
1137789|NCT01456039|3736501|P3|Phase 1 (First Step)|Disease Progression|0
1137790|NCT01456039|3736502|P2|Phase 1 (First Step)|Disease Progression|1
1137791|NCT01456039|3736503|P1|Phase 1 (First Step)|Disease Progression|1
1137792|NCT01455428|3736646|P2|Overall Study|Other|4
1137793|NCT01455428|3736647|P1|Overall Study|Other|2
1137794|NCT01455428|3736646|P2|Overall Study|Did not receive treatment|1
1137795|NCT01455428|3736647|P1|Overall Study|Did not receive treatment|1
1137796|NCT01455428|3736646|P2|Overall Study|Insufficient clinical response|2
1137797|NCT01455428|3736647|P1|Overall Study|Insufficient clinical response|0
1137798|NCT01455428|3736646|P2|Overall Study|Did not meet entrance criteria|2
1137799|NCT01455428|3736647|P1|Overall Study|Did not meet entrance criteria|0
1137800|NCT01455428|3736646|P2|Overall Study|Withdrawal by Subject|5
1137801|NCT01455428|3736647|P1|Overall Study|Withdrawal by Subject|2
1137802|NCT01455428|3736646|P2|Overall Study|Lost to Follow-up|1
1137803|NCT01455428|3736647|P1|Overall Study|Lost to Follow-up|1
1137804|NCT01455428|3736646|P2|Overall Study|Adverse Event|2
1137805|NCT01455428|3736647|P1|Overall Study|Adverse Event|6
1137806|NCT01455428|3736646|P2|Overall Study|Protocol Violation|1
1137807|NCT01455428|3736647|P1|Overall Study|Protocol Violation|2
1137808|NCT01455415|3736703|P2|Follow-up|Unspecified Reason|0
1137809|NCT01455415|3736704|P1|Follow-up|Unspecified Reason|1
1137810|NCT01455415|3736703|P2|Follow-up|Withdrawal by Subject|0
1137811|NCT01455415|3736704|P1|Follow-up|Withdrawal by Subject|2
1137812|NCT01455415|3736703|P2|Follow-up|Lack of Efficacy|1
1137813|NCT01455415|3736704|P1|Follow-up|Lack of Efficacy|0
1137814|NCT01455415|3736703|P2|Follow-up|AE Related to Study Drug|1
1137815|NCT01455415|3736704|P1|Follow-up|AE Related to Study Drug|0
1137816|NCT01455415|3736703|P2|Period 2|Protocol Violation|0
1137817|NCT01455415|3736704|P1|Period 2|Protocol Violation|2
1137818|NCT01455415|3736703|P2|Period 2|Unspecified Reason|3
1137819|NCT01455415|3736704|P1|Period 2|Unspecified Reason|2
1137820|NCT01455415|3736703|P2|Period 2|Withdrawal by Subject|3
1137821|NCT01455415|3736704|P1|Period 2|Withdrawal by Subject|2
1137822|NCT01455415|3736703|P2|Period 2|Lack of Efficacy|0
1137823|NCT01455415|3736704|P1|Period 2|Lack of Efficacy|2
1137824|NCT01455415|3736703|P2|Period 2|AE Not Related to Study Drug|1
1137825|NCT01455415|3736704|P1|Period 2|AE Not Related to Study Drug|2
1137826|NCT01455415|3736703|P2|Period 2|Lost to Follow-up|1
1137827|NCT01455415|3736704|P1|Period 2|Lost to Follow-up|2
1137828|NCT01455415|3736703|P2|Period 2|AE Related to Study Drug|2
1137829|NCT01455415|3736704|P1|Period 2|AE Related to Study Drug|1
1137830|NCT01455415|3736703|P2|Washout|Protocol Violation|1
1137831|NCT01455415|3736704|P1|Washout|Protocol Violation|0
1137832|NCT01455415|3736703|P2|Washout|Unspecified Reason|2
1137833|NCT01455415|3736704|P1|Washout|Unspecified Reason|1
1137834|NCT01455415|3736703|P2|Washout|AE Not Related to Study Drug|3
1137835|NCT01455415|3736704|P1|Washout|AE Not Related to Study Drug|2
1137836|NCT01455415|3736703|P2|Washout|Drug Error not Associated to AE|1
1137837|NCT01455415|3736704|P1|Washout|Drug Error not Associated to AE|2
1137838|NCT01455415|3736703|P2|Washout|Lost to Follow-up|0
1137839|NCT01455415|3736704|P1|Washout|Lost to Follow-up|1
1137840|NCT01455415|3736703|P2|Washout|AE Related to Study Drug|0
1137841|NCT01455415|3736704|P1|Washout|AE Related to Study Drug|2
1137842|NCT01455415|3736703|P2|Period 1|Protocol Violation|2
1137843|NCT01455415|3736704|P1|Period 1|Protocol Violation|0
1137844|NCT01455415|3736703|P2|Period 1|Unspecified Reason|1
1137845|NCT01455415|3736704|P1|Period 1|Unspecified Reason|1
1137846|NCT01455415|3736703|P2|Period 1|Withdrawal by Subject|5
1137847|NCT01455415|3736704|P1|Period 1|Withdrawal by Subject|4
1137848|NCT01455415|3736703|P2|Period 1|AE Not Related to Study Drug|6
1137849|NCT01455415|3736704|P1|Period 1|AE Not Related to Study Drug|2
1137850|NCT01455415|3736703|P2|Period 1|Drug Error not Associated to AE|1
1137851|NCT01455415|3736704|P1|Period 1|Drug Error not Associated to AE|0
1137852|NCT01455415|3736703|P2|Period 1|Lost To Follow-up Related to Study Drug|3
1137853|NCT01455415|3736704|P1|Period 1|Lost To Follow-up Related to Study Drug|3
1137854|NCT01455415|3736703|P2|Period 1|Adverse Event (AE) Related to Study Drug|6
1137855|NCT01455415|3736704|P1|Period 1|Adverse Event (AE) Related to Study Drug|9
1137856|NCT01455220|3736754|P1|Overall Study|screen fail|30
1137857|NCT01455194|3736764|P4|Overall Study|Miscellaneous|4
1137858|NCT01455194|3736765|P3|Overall Study|Miscellaneous|1
1137859|NCT01455194|3736766|P2|Overall Study|Miscellaneous|5
1137860|NCT01455194|3736767|P1|Overall Study|Miscellaneous|4
1137861|NCT01455194|3736764|P4|Overall Study|Discontinuation criterion fulfilled|2
1137862|NCT01455194|3736765|P3|Overall Study|Discontinuation criterion fulfilled|0
1137863|NCT01455194|3736766|P2|Overall Study|Discontinuation criterion fulfilled|2
1137864|NCT01455194|3736767|P1|Overall Study|Discontinuation criterion fulfilled|3
1137865|NCT01455194|3736764|P4|Overall Study|Pregnancy|0
1137866|NCT01455194|3736765|P3|Overall Study|Pregnancy|1
1137867|NCT01455194|3736766|P2|Overall Study|Pregnancy|1
1137868|NCT01455194|3736767|P1|Overall Study|Pregnancy|0
1137869|NCT01455194|3736764|P4|Overall Study|Lost to Follow-up|1
1137870|NCT01455194|3736765|P3|Overall Study|Lost to Follow-up|1
1137871|NCT01455194|3736766|P2|Overall Study|Lost to Follow-up|0
1137872|NCT01455194|3736767|P1|Overall Study|Lost to Follow-up|2
1137873|NCT01455194|3736764|P4|Overall Study|Withdrawal by Subject|9
1137874|NCT01455194|3736765|P3|Overall Study|Withdrawal by Subject|12
1137875|NCT01455194|3736766|P2|Overall Study|Withdrawal by Subject|16
1137876|NCT01455194|3736767|P1|Overall Study|Withdrawal by Subject|21
1137877|NCT01455194|3736764|P4|Overall Study|Adverse Event|3
1137878|NCT01455194|3736765|P3|Overall Study|Adverse Event|1
1137879|NCT01455194|3736766|P2|Overall Study|Adverse Event|1
1137880|NCT01455194|3736767|P1|Overall Study|Adverse Event|1
1137881|NCT01455194|3736764|P4|Overall Study|Deterioration in asthma|9
1137882|NCT01455194|3736765|P3|Overall Study|Deterioration in asthma|14
1137883|NCT01455194|3736766|P2|Overall Study|Deterioration in asthma|6
1137884|NCT01455194|3736767|P1|Overall Study|Deterioration in asthma|12
1137885|NCT01455194|3736764|P4|Overall Study|Randomisation Failure|0
1137886|NCT01455194|3736765|P3|Overall Study|Randomisation Failure|0
1137887|NCT01455194|3736766|P2|Overall Study|Randomisation Failure|0
1137888|NCT01455194|3736767|P1|Overall Study|Randomisation Failure|90
1137889|NCT01455194|3736764|P4|Overall Study|Screen Failure|0
1137890|NCT01455194|3736765|P3|Overall Study|Screen Failure|0
1137891|NCT01455194|3736766|P2|Overall Study|Screen Failure|0
1137892|NCT01455194|3736767|P1|Overall Study|Screen Failure|20
1137893|NCT01455012|3736830|P2|Overall Study|Unknown reason|0
1137894|NCT01455012|3736831|P1|Overall Study|Unknown reason|2
1137895|NCT01455012|3736830|P2|Overall Study|Withdrawal by Subject|1
1137896|NCT01455012|3736831|P1|Overall Study|Withdrawal by Subject|3
1137897|NCT01455012|3736830|P2|Overall Study|Lack of Efficacy|1
1137898|NCT01455012|3736831|P1|Overall Study|Lack of Efficacy|6
1137899|NCT01455012|3736830|P2|Overall Study|Adverse Event|2
1137900|NCT01455012|3736831|P1|Overall Study|Adverse Event|0
1137901|NCT01454934|3736898|P2|Overall Study|Ongoing, survival follow-up|2
1137902|NCT01454934|3736899|P1|Overall Study|Ongoing, survival follow-up|1
1137903|NCT01454934|3736898|P2|Overall Study|Not treated|2
1137904|NCT01454934|3736899|P1|Overall Study|Not treated|1
1137905|NCT01454934|3736898|P2|Overall Study|Not specified|16
1137906|NCT01454934|3736899|P1|Overall Study|Not specified|5
1137907|NCT01454934|3736898|P2|Overall Study|Clinical progression|25
1137908|NCT01454934|3736899|P1|Overall Study|Clinical progression|28
1137909|NCT01454934|3736898|P2|Overall Study|Withdrawn consent|5
1137910|NCT01454934|3736899|P1|Overall Study|Withdrawn consent|2
1137911|NCT01454934|3736898|P2|Overall Study|Lost to Follow-up|1
1137912|NCT01454934|3736899|P1|Overall Study|Lost to Follow-up|0
1137913|NCT01454934|3736898|P2|Overall Study|Withdrawal by Subject|15
1137914|NCT01454934|3736899|P1|Overall Study|Withdrawal by Subject|11
1137915|NCT01454934|3736898|P2|Overall Study|Adverse Event|24
1137916|NCT01454934|3736899|P1|Overall Study|Adverse Event|28
1137917|NCT01454934|3736898|P2|Overall Study|Disease progression|180
1137918|NCT01454934|3736899|P1|Overall Study|Disease progression|194
1137919|NCT01454830|3736911|P2|Overall Study|Withdrawal - no polysomnography|2
1137920|NCT01454830|3736912|P1|Overall Study|Withdrawal - no polysomnography|3
1137921|NCT01454830|3736911|P2|Overall Study|Post-allocation Exclude-other treatment|7
1137922|NCT01454830|3736912|P1|Overall Study|Post-allocation Exclude-other treatment|6
1137923|NCT01454830|3736911|P2|Overall Study|Post-allocation Exclude-refused PAP|2
1137924|NCT01454830|3736912|P1|Overall Study|Post-allocation Exclude-refused PAP|0
1137925|NCT01454830|3736911|P2|Overall Study|Post-allocation Exclude- AHI<10|12
1137926|NCT01454830|3736912|P1|Overall Study|Post-allocation Exclude- AHI<10|18
1137927|NCT01454830|3736911|P2|Overall Study|Withdrawal by Subject|4
1137928|NCT01454830|3736912|P1|Overall Study|Withdrawal by Subject|4
1137929|NCT01454778|3736943|P1|Overall Study|Death|1
1137930|NCT01454778|3736943|P1|Overall Study|Lost to Follow-up|2
1137931|NCT01454739|3736954|P2|Overall Study|Adverse Event|1
1137932|NCT01454739|3736955|P1|Overall Study|Adverse Event|0
1137933|NCT01454739|3736954|P2|Overall Study|Lost to Follow-up|1
1137934|NCT01454739|3736955|P1|Overall Study|Lost to Follow-up|0
1137935|NCT01454739|3736954|P2|Overall Study|Physician Decision|5
1137936|NCT01454739|3736955|P1|Overall Study|Physician Decision|0
1137937|NCT01454739|3736954|P2|Overall Study|Other|5
1137938|NCT01454739|3736955|P1|Overall Study|Other|3
1137939|NCT01454739|3736954|P2|Overall Study|Withdrawal by Subject|6
1137940|NCT01454739|3736955|P1|Overall Study|Withdrawal by Subject|2
1137941|NCT01454739|3736954|P2|Overall Study|Protocol Violation|3
1137942|NCT01454739|3736955|P1|Overall Study|Protocol Violation|2
1137943|NCT01454726|3736984|P2|Overall Study|Withdrawal by Subject|1
1137944|NCT01454726|3736985|P1|Overall Study|Withdrawal by Subject|0
1137945|NCT01454583|3736994|P3|3rd Year|Lost to Follow-up|297
1137946|NCT01454583|3736995|P2|3rd Year|Lost to Follow-up|512
1137947|NCT01454583|3736996|P1|3rd Year|Lost to Follow-up|1959
1137948|NCT01454583|3736994|P3|2nd Year|Lost to Follow-up|737
1137949|NCT01454583|3736995|P2|2nd Year|Lost to Follow-up|1049
1137950|NCT01454583|3736996|P1|2nd Year|Lost to Follow-up|3965
1137951|NCT01454583|3736994|P3|1st Year|Lost to Follow-up|180
1137952|NCT01454583|3736995|P2|1st Year|Lost to Follow-up|318
1137953|NCT01454583|3736996|P1|1st Year|Lost to Follow-up|1057
1137954|NCT01454531|3737064|P1|Overall Study|Other|1
1137955|NCT01454531|3737064|P1|Overall Study|Delay in IMP administration|1
1137956|NCT01454531|3737064|P1|Overall Study|Physician Decision|1
1137957|NCT01454531|3737064|P1|Overall Study|Lost to Follow-up|1
1137958|NCT01454531|3737064|P1|Overall Study|Withdrawal by Subject|5
1137959|NCT01454531|3737064|P1|Overall Study|Adverse Event|14
1137960|NCT01454401|3737100|P1|Overall Study|non-adherence|1
1137961|NCT01454401|3737100|P1|Overall Study|osteomyelitis|2
1137962|NCT01454401|3737100|P1|Overall Study|hospitalised|1
1137963|NCT01454401|3737100|P1|Overall Study|Death|1
1137964|NCT01454284|3737107|P2|Overall Study|Sponsor Decision|2
1137965|NCT01454284|3737108|P1|Overall Study|Sponsor Decision|0
1137966|NCT01454284|3737107|P2|Overall Study|Physician Decision|11
1137967|NCT01454284|3737108|P1|Overall Study|Physician Decision|16
1137968|NCT01454284|3737107|P2|Overall Study|Withdrawal by Subject|36
1137969|NCT01454284|3737108|P1|Overall Study|Withdrawal by Subject|58
1137970|NCT01454284|3737107|P2|Overall Study|Protocol Violation|6
1137971|NCT01454284|3737108|P1|Overall Study|Protocol Violation|9
1137972|NCT01454284|3737107|P2|Overall Study|Lost to Follow-up|8
1137973|NCT01454284|3737108|P1|Overall Study|Lost to Follow-up|13
1137974|NCT01454284|3737107|P2|Overall Study|Death|3
1137975|NCT01454284|3737108|P1|Overall Study|Death|0
1137976|NCT01454284|3737107|P2|Overall Study|Adverse Event|7
1137977|NCT01454284|3737108|P1|Overall Study|Adverse Event|20
1137978|NCT01454076|3737167|P5|Overall Study|Adverse Event|2
1137979|NCT01454076|3737168|P4|Overall Study|Adverse Event|0
1137980|NCT01454076|3737169|P3|Overall Study|Adverse Event|7
1137981|NCT01454076|3737170|P2|Overall Study|Adverse Event|2
1137982|NCT01454076|3737171|P1|Overall Study|Adverse Event|8
1137983|NCT01454076|3737167|P5|Overall Study|Withdrawal by Subject|2
1137984|NCT01454076|3737168|P4|Overall Study|Withdrawal by Subject|1
1137985|NCT01454076|3737169|P3|Overall Study|Withdrawal by Subject|2
1137986|NCT01454076|3737170|P2|Overall Study|Withdrawal by Subject|4
1137987|NCT01454076|3737171|P1|Overall Study|Withdrawal by Subject|3
1137988|NCT01454076|3737167|P5|Overall Study|Other|2
1137989|NCT01454076|3737168|P4|Overall Study|Other|1
1137990|NCT01454076|3737169|P3|Overall Study|Other|0
1137991|NCT01454076|3737170|P2|Overall Study|Other|0
1137992|NCT01454076|3737171|P1|Overall Study|Other|2
1137993|NCT01454063|3737224|P2|Randomized|Protocol Violation|1
1137994|NCT01454063|3737225|P1|Randomized|Protocol Violation|0
1137995|NCT01454063|3737224|P2|Randomized|Adverse Event|1
1137996|NCT01454063|3737225|P1|Randomized|Adverse Event|1
1137997|NCT01453998|3737246|P3|After Protocol Amendment 2.|Withdrawal by Subject|0
1137998|NCT01453998|3737247|P2|After Protocol Amendment 2.|Withdrawal by Subject|0
1137999|NCT01453998|3737248|P1|After Protocol Amendment 2.|Withdrawal by Subject|1
1138000|NCT01453946|3737313|P1|Overall Study|Adverse Event|3
1138001|NCT01453946|3737313|P1|Overall Study|Lack of Efficacy|3
1138002|NCT01453946|3737313|P1|Overall Study|Protocol Violation|2
1138003|NCT01453946|3737313|P1|Overall Study|Did not receive drug for the taper phase|1
1138004|NCT01453855|3737330|P2|Overall Study|Other|1
1138005|NCT01453855|3737331|P1|Overall Study|Other|0
1138006|NCT01453855|3737330|P2|Overall Study|Inadequate Control of IOP|5
1138007|NCT01453855|3737331|P1|Overall Study|Inadequate Control of IOP|1
1138008|NCT01453855|3737330|P2|Overall Study|Noncompliance|0
1138009|NCT01453855|3737331|P1|Overall Study|Noncompliance|1
1138010|NCT01453855|3737330|P2|Overall Study|Patient Decision Unrel to Adverse Event|3
1138011|NCT01453855|3737331|P1|Overall Study|Patient Decision Unrel to Adverse Event|3
1138012|NCT01453855|3737330|P2|Overall Study|Lost to Follow-up|1
1138013|NCT01453855|3737331|P1|Overall Study|Lost to Follow-up|2
1138014|NCT01453855|3737330|P2|Overall Study|Adverse Event|4
1138015|NCT01453855|3737331|P1|Overall Study|Adverse Event|3
1138016|NCT01453725|3737339|P2|Overall Study|Physician Decision|1
1138017|NCT01453725|3737340|P1|Overall Study|Physician Decision|1
1138018|NCT01453725|3737339|P2|Overall Study|Pregnancy|0
1138019|NCT01453725|3737340|P1|Overall Study|Pregnancy|1
1138020|NCT01453725|3737339|P2|Overall Study|Pregnancy Wish|2
1138021|NCT01453725|3737340|P1|Overall Study|Pregnancy Wish|0
1138022|NCT01453725|3737339|P2|Overall Study|Withdrawal by Subject|3
1138023|NCT01453725|3737340|P1|Overall Study|Withdrawal by Subject|2
1138024|NCT01453725|3737339|P2|Overall Study|Protocol Violation|0
1138025|NCT01453725|3737340|P1|Overall Study|Protocol Violation|1
1138026|NCT01453725|3737339|P2|Overall Study|Non-compliance With Protocol|2
1138027|NCT01453725|3737340|P1|Overall Study|Non-compliance With Protocol|1
1138028|NCT01453725|3737339|P2|Overall Study|Lost to Follow-up|0
1138029|NCT01453725|3737340|P1|Overall Study|Lost to Follow-up|4
1138030|NCT01453725|3737339|P2|Overall Study|Adverse Event|3
1138031|NCT01453725|3737340|P1|Overall Study|Adverse Event|3
1138032|NCT01453595|3737363|P3|Overall Study|Dose Limiting Toxicity (DLT)|2
1138033|NCT01453595|3737364|P2|Overall Study|Dose Limiting Toxicity (DLT)|1
1138034|NCT01453595|3737365|P1|Overall Study|Dose Limiting Toxicity (DLT)|2
1138035|NCT01453374|3737484|P1|Overall Study|Incarcerated|2
1138036|NCT01453374|3737484|P1|Overall Study|Withdrawal by Subject|5
1138037|NCT01453374|3737484|P1|Overall Study|Lost to Follow-up|3
1138038|NCT01453374|3737484|P1|Overall Study|Lack of Efficacy|1
1138039|NCT01453374|3737484|P1|Overall Study|Adverse Event|7
1138040|NCT01453361|3737500|P1|Overall Study|Screen-Failures|10
1138041|NCT01453361|3737500|P1|Overall Study|Disease Progression|6
1138042|NCT01453348|3737508|P3|Overall Study|Protocol Violation|0
1138043|NCT01453348|3737509|P2|Overall Study|Protocol Violation|0
1138044|NCT01453348|3737510|P1|Overall Study|Protocol Violation|1
1138045|NCT01453348|3737508|P3|Overall Study|Withdrawal by Subject|0
1138046|NCT01453348|3737509|P2|Overall Study|Withdrawal by Subject|1
1138047|NCT01453348|3737510|P1|Overall Study|Withdrawal by Subject|0
1138048|NCT01453348|3737508|P3|Overall Study|Death|1
1138049|NCT01453348|3737509|P2|Overall Study|Death|0
1138050|NCT01453348|3737510|P1|Overall Study|Death|0
1138051|NCT01453296|3737526|P2|Treatment Period 2|Withdrawal by Subject|0
1138052|NCT01453296|3737527|P1|Treatment Period 2|Withdrawal by Subject|1
1138053|NCT01453296|3737526|P2|Treatment Period 2|Adverse Event|0
1138054|NCT01453296|3737527|P1|Treatment Period 2|Adverse Event|1
1138055|NCT01453296|3737526|P2|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0
1138056|NCT01453296|3737527|P1|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1
1138057|NCT01453296|3737526|P2|Treatment Period 1|Adverse Event|1
1138058|NCT01453296|3737527|P1|Treatment Period 1|Adverse Event|0
1138059|NCT01453205|3737594|P3|Overall Study|Other|35
1138060|NCT01453205|3737595|P2|Overall Study|Other|27
1138061|NCT01453205|3737596|P1|Overall Study|Other|45
1138062|NCT01453205|3737594|P3|Overall Study|Death|18
1138063|NCT01453205|3737595|P2|Overall Study|Death|22
1138064|NCT01453205|3737596|P1|Overall Study|Death|24
1138065|NCT01453205|3737594|P3|Overall Study|Withdrawal by Subject|0
1138066|NCT01453205|3737595|P2|Overall Study|Withdrawal by Subject|3
1138067|NCT01453205|3737596|P1|Overall Study|Withdrawal by Subject|8
1138068|NCT01453205|3737594|P3|Overall Study|Lost to Follow-up|1
1138069|NCT01453205|3737595|P2|Overall Study|Lost to Follow-up|0
1138070|NCT01453205|3737596|P1|Overall Study|Lost to Follow-up|3
1138071|NCT01453153|3737672|P3|Overall Study|Adverse Event|1
1138072|NCT01453153|3737673|P2|Overall Study|Adverse Event|1
1138073|NCT01453153|3737674|P1|Overall Study|Adverse Event|1
1138074|NCT01453153|3737672|P3|Overall Study|Withdrawal by Subject|2
1138075|NCT01453153|3737673|P2|Overall Study|Withdrawal by Subject|1
1138076|NCT01453153|3737674|P1|Overall Study|Withdrawal by Subject|0
1138077|NCT01453153|3737672|P3|Overall Study|Progressive Disease|16
1138078|NCT01453153|3737673|P2|Overall Study|Progressive Disease|2
1138079|NCT01453153|3737674|P1|Overall Study|Progressive Disease|3
1138080|NCT01453153|3737672|P3|Overall Study|Physician Decision|1
1138081|NCT01453153|3737673|P2|Overall Study|Physician Decision|0
1138082|NCT01453153|3737674|P1|Overall Study|Physician Decision|0
1138083|NCT01453049|3737756|P2|Overall Study|Randomized in Error|0
1138084|NCT01453049|3737757|P1|Overall Study|Randomized in Error|1
1138085|NCT01453049|3737756|P2|Overall Study|Withdrawal by Subject|0
1138086|NCT01453049|3737757|P1|Overall Study|Withdrawal by Subject|1
1138087|NCT01453049|3737756|P2|Overall Study|Withdrawn When Sponsor Terminated Study|36
1138088|NCT01453049|3737757|P1|Overall Study|Withdrawn When Sponsor Terminated Study|35
1138089|NCT01453049|3737756|P2|Overall Study|Lost to Follow-up|1
1138090|NCT01453049|3737757|P1|Overall Study|Lost to Follow-up|2
1138091|NCT01453049|3737756|P2|Overall Study|Protocol Violation|5
1138092|NCT01453049|3737757|P1|Overall Study|Protocol Violation|2
1138093|NCT01453036|3737830|P3|Overall Study|Lost to Follow-up|31
1138094|NCT01453036|3737831|P2|Overall Study|Lost to Follow-up|115
1138095|NCT01453036|3737832|P1|Overall Study|Lost to Follow-up|26
1138096|NCT01453023|3737840|P2|Treatment Period 2|Protocol Violation|1
1138097|NCT01453023|3737841|P1|Treatment Period 2|Protocol Violation|0
1138098|NCT01453023|3737840|P2|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1
1138099|NCT01453023|3737841|P1|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0
1138100|NCT01453023|3737840|P2|Treatment Period (TP) 1|Protocol Violation|0
1138101|NCT01453023|3737841|P1|Treatment Period (TP) 1|Protocol Violation|1
1138102|NCT01452529|3737915|P3|Double-blind (DB) Period|Administrative|7
1138103|NCT01452529|3737916|P2|Double-blind (DB) Period|Administrative|11
1138104|NCT01452529|3737917|P1|Double-blind (DB) Period|Administrative|0
1138105|NCT01452529|3737915|P3|Double-blind (DB) Period|Confirmed or suspected diversion|3
1138106|NCT01452529|3737916|P2|Double-blind (DB) Period|Confirmed or suspected diversion|2
1138107|NCT01452529|3737917|P1|Double-blind (DB) Period|Confirmed or suspected diversion|0
1138108|NCT01452529|3737915|P3|Double-blind (DB) Period|Lack of Efficacy|44
1138109|NCT01452529|3737916|P2|Double-blind (DB) Period|Lack of Efficacy|16
1138110|NCT01452529|3737917|P1|Double-blind (DB) Period|Lack of Efficacy|0
1138111|NCT01452529|3737915|P3|Double-blind (DB) Period|Lost to Follow-up|3
1138112|NCT01452529|3737916|P2|Double-blind (DB) Period|Lost to Follow-up|5
1138113|NCT01452529|3737917|P1|Double-blind (DB) Period|Lost to Follow-up|0
1138114|NCT01452529|3737915|P3|Double-blind (DB) Period|Withdrawal by Subject|14
1138115|NCT01452529|3737916|P2|Double-blind (DB) Period|Withdrawal by Subject|15
1138116|NCT01452529|3737917|P1|Double-blind (DB) Period|Withdrawal by Subject|0
1138117|NCT01452529|3737915|P3|Double-blind (DB) Period|Adverse Event|11
1138118|NCT01452529|3737916|P2|Double-blind (DB) Period|Adverse Event|18
1138119|NCT01452529|3737917|P1|Double-blind (DB) Period|Adverse Event|0
1138120|NCT01452529|3737915|P3|Run-in Period|Did not qualify for Double-Blind Phase|0
1138121|NCT01452529|3737916|P2|Run-in Period|Did not qualify for Double-Blind Phase|0
1138122|NCT01452529|3737917|P1|Run-in Period|Did not qualify for Double-Blind Phase|59
1138123|NCT01452529|3737915|P3|Run-in Period|Administrative|0
1138124|NCT01452529|3737916|P2|Run-in Period|Administrative|0
1138125|NCT01452529|3737917|P1|Run-in Period|Administrative|21
1138126|NCT01452529|3737915|P3|Run-in Period|Confirmed or suspected diversion|0
1138127|NCT01452529|3737916|P2|Run-in Period|Confirmed or suspected diversion|0
1138128|NCT01452529|3737917|P1|Run-in Period|Confirmed or suspected diversion|23
1138129|NCT01452529|3737915|P3|Run-in Period|Lack of Efficacy|0
1138130|NCT01452529|3737916|P2|Run-in Period|Lack of Efficacy|0
1138131|NCT01452529|3737917|P1|Run-in Period|Lack of Efficacy|46
1138132|NCT01452529|3737915|P3|Run-in Period|Lost to Follow-up|0
1138133|NCT01452529|3737916|P2|Run-in Period|Lost to Follow-up|0
1138134|NCT01452529|3737917|P1|Run-in Period|Lost to Follow-up|19
1138135|NCT01452529|3737915|P3|Run-in Period|Withdrawal by Subject|0
1138136|NCT01452529|3737916|P2|Run-in Period|Withdrawal by Subject|0
1138137|NCT01452529|3737917|P1|Run-in Period|Withdrawal by Subject|49
1138138|NCT01452529|3737915|P3|Run-in Period|Adverse Event|0
1138139|NCT01452529|3737916|P2|Run-in Period|Adverse Event|0
1138140|NCT01452529|3737917|P1|Run-in Period|Adverse Event|96
1138141|NCT01452347|3737939|P2|Overall Study|Other reason not defined above|0
1138142|NCT01452347|3737940|P1|Overall Study|Other reason not defined above|2
1138143|NCT01452347|3737939|P2|Overall Study|Not treated|3
1138144|NCT01452347|3737940|P1|Overall Study|Not treated|6
1138145|NCT01452347|3737939|P2|Overall Study|Withdrawal by Subject|3
1138146|NCT01452347|3737940|P1|Overall Study|Withdrawal by Subject|3
1138147|NCT01452347|3737939|P2|Overall Study|Lost to Follow-up|0
1138148|NCT01452347|3737940|P1|Overall Study|Lost to Follow-up|2
1138149|NCT01452347|3737939|P2|Overall Study|Non compliance protocol|0
1138150|NCT01452347|3737940|P1|Overall Study|Non compliance protocol|2
1138151|NCT01452347|3737939|P2|Overall Study|Adverse Event|1
1138152|NCT01452347|3737940|P1|Overall Study|Adverse Event|2
1138153|NCT01452152|3737972|P3|Overall Study|Study termination by sponsor|4
1138154|NCT01452152|3737973|P2|Overall Study|Study termination by sponsor|0
1138155|NCT01452152|3737974|P1|Overall Study|Study termination by sponsor|5
1138156|NCT01451931|3738046|P3|Overall Study|Withdrawal by Subject|22
1138157|NCT01451931|3738047|P2|Overall Study|Withdrawal by Subject|22
1138158|NCT01451931|3738048|P1|Overall Study|Withdrawal by Subject|16
1138159|NCT01451931|3738046|P3|Overall Study|Lost to Follow-up|21
1138160|NCT01451931|3738047|P2|Overall Study|Lost to Follow-up|36
1138161|NCT01451931|3738048|P1|Overall Study|Lost to Follow-up|17
1138162|NCT01451827|3738072|P4|Overall Study|Withdrawal by Subject|1
1138163|NCT01451827|3738073|P3|Overall Study|Withdrawal by Subject|1
1138164|NCT01451827|3738074|P2|Overall Study|Withdrawal by Subject|0
1138165|NCT01451827|3738075|P1|Overall Study|Withdrawal by Subject|0
1138166|NCT01451827|3738072|P4|Overall Study|Participant met withdrawal criteria|0
1138167|NCT01451827|3738073|P3|Overall Study|Participant met withdrawal criteria|0
1138168|NCT01451827|3738074|P2|Overall Study|Participant met withdrawal criteria|2
1138169|NCT01451827|3738075|P1|Overall Study|Participant met withdrawal criteria|0
1138170|NCT01451827|3738072|P4|Overall Study|Lost to Follow-up|2
1138171|NCT01451827|3738073|P3|Overall Study|Lost to Follow-up|0
1138172|NCT01451827|3738074|P2|Overall Study|Lost to Follow-up|3
1138173|NCT01451827|3738075|P1|Overall Study|Lost to Follow-up|0
1138174|NCT01451827|3738072|P4|Overall Study|Protocol deviation|0
1138175|NCT01451827|3738073|P3|Overall Study|Protocol deviation|0
1138176|NCT01451827|3738074|P2|Overall Study|Protocol deviation|0
1138177|NCT01451827|3738075|P1|Overall Study|Protocol deviation|1
1138178|NCT01451827|3738072|P4|Overall Study|Adverse Event|1
1138179|NCT01451827|3738073|P3|Overall Study|Adverse Event|1
1138180|NCT01451827|3738074|P2|Overall Study|Adverse Event|0
1138181|NCT01451827|3738075|P1|Overall Study|Adverse Event|2
1138182|NCT01451814|3738095|P2|Overall Study|Lost to Follow-up|4
1138183|NCT01451814|3738096|P1|Overall Study|Lost to Follow-up|5
1138184|NCT01451814|3738095|P2|Overall Study|Withdrawal by Subject|1
1138185|NCT01451814|3738096|P1|Overall Study|Withdrawal by Subject|1
1138186|NCT01451762|3738128|P3|Overall Study|Lost to Follow-up|6
1138187|NCT01451762|3738129|P2|Overall Study|Lost to Follow-up|6
1138188|NCT01451762|3738130|P1|Overall Study|Lost to Follow-up|3
1138189|NCT01451749|3738140|P2|Overall Study|Withdrawal by Subject|1
1138190|NCT01451749|3738141|P1|Overall Study|Withdrawal by Subject|0
1138191|NCT01451749|3738140|P2|Overall Study|Adverse Event|0
1138192|NCT01451749|3738141|P1|Overall Study|Adverse Event|2
1138193|NCT01451749|3738140|P2|Overall Study|Meet the exclusion criteria,and|1
1138194|NCT01451749|3738141|P1|Overall Study|Meet the exclusion criteria,and|1
1138195|NCT01451749|3738140|P2|Overall Study|Lost to Follow-up|5
1138196|NCT01451749|3738141|P1|Overall Study|Lost to Follow-up|15
1138197|NCT01451749|3738140|P2|Overall Study|Protocol Violation|7
1138198|NCT01451749|3738141|P1|Overall Study|Protocol Violation|14
1138199|NCT01451723|3738153|P2|Overall Study|study halted|5
1138200|NCT01451723|3738154|P1|Overall Study|study halted|6
1138201|NCT01451645|3738164|P2|Overall Study|Lost to Follow-up|3
1138202|NCT01451645|3738165|P1|Overall Study|Lost to Follow-up|4
1138203|NCT01451645|3738164|P2|Overall Study|Withdrawal by Subject|2
1138204|NCT01451645|3738165|P1|Overall Study|Withdrawal by Subject|4
1138205|NCT01451645|3738164|P2|Overall Study|Adverse Event|3
1138206|NCT01451645|3738165|P1|Overall Study|Adverse Event|0
1138207|NCT01451645|3738164|P2|Overall Study|Protocol Violation|0
1138208|NCT01451645|3738165|P1|Overall Study|Protocol Violation|1
1138209|NCT01451606|3738236|P2|Overall Study|Withdrawal by Subject|3
1138210|NCT01451606|3738237|P1|Overall Study|Withdrawal by Subject|4
1138211|NCT01451554|3738247|P2|Overall Study|Withdrawal by Subject|9
1138212|NCT01451554|3738248|P1|Overall Study|Withdrawal by Subject|14
1138213|NCT01451541|3738259|P3|Overall Study|randomization error, noncompliance|8
1138214|NCT01451541|3738260|P2|Overall Study|randomization error, noncompliance|10
1138215|NCT01451541|3738261|P1|Overall Study|randomization error, noncompliance|11
1138216|NCT01451541|3738259|P3|Overall Study|Withdrawal by Subject|6
1138217|NCT01451541|3738260|P2|Overall Study|Withdrawal by Subject|8
1138218|NCT01451541|3738261|P1|Overall Study|Withdrawal by Subject|15
1138219|NCT01451541|3738259|P3|Overall Study|Lost to Follow-up|7
1138220|NCT01451541|3738260|P2|Overall Study|Lost to Follow-up|4
1138221|NCT01451541|3738261|P1|Overall Study|Lost to Follow-up|4
1138222|NCT01451541|3738259|P3|Overall Study|Lack of Efficacy|0
1138223|NCT01451541|3738260|P2|Overall Study|Lack of Efficacy|0
1138224|NCT01451541|3738261|P1|Overall Study|Lack of Efficacy|2
1138225|NCT01451541|3738259|P3|Overall Study|Adverse Event|6
1138226|NCT01451541|3738260|P2|Overall Study|Adverse Event|3
1138227|NCT01451541|3738261|P1|Overall Study|Adverse Event|4
1138228|NCT01451437|3738319|P9|Overall Study|Withdrawal by Subject|0
1138229|NCT01451437|3738320|P8|Overall Study|Withdrawal by Subject|0
1138230|NCT01451437|3738321|P7|Overall Study|Withdrawal by Subject|1
1138231|NCT01451437|3738322|P6|Overall Study|Withdrawal by Subject|0
1138232|NCT01451437|3738323|P5|Overall Study|Withdrawal by Subject|1
1138233|NCT01451437|3738324|P4|Overall Study|Withdrawal by Subject|0
1138234|NCT01451437|3738325|P3|Overall Study|Withdrawal by Subject|0
1138235|NCT01451437|3738326|P2|Overall Study|Withdrawal by Subject|0
1138236|NCT01451437|3738327|P1|Overall Study|Withdrawal by Subject|0
1138237|NCT01451437|3738319|P9|Overall Study|Protocol Violation|0
1138238|NCT01451437|3738320|P8|Overall Study|Protocol Violation|0
1138239|NCT01451437|3738321|P7|Overall Study|Protocol Violation|1
1138240|NCT01451437|3738322|P6|Overall Study|Protocol Violation|0
1138241|NCT01451437|3738323|P5|Overall Study|Protocol Violation|0
1138242|NCT01451437|3738324|P4|Overall Study|Protocol Violation|0
1138243|NCT01451437|3738325|P3|Overall Study|Protocol Violation|0
1138244|NCT01451437|3738326|P2|Overall Study|Protocol Violation|0
1138245|NCT01451437|3738327|P1|Overall Study|Protocol Violation|0
1138246|NCT01451437|3738319|P9|Overall Study|Disease Progression|3
1138247|NCT01451437|3738320|P8|Overall Study|Disease Progression|1
1138248|NCT01451437|3738321|P7|Overall Study|Disease Progression|3
1138249|NCT01451437|3738322|P6|Overall Study|Disease Progression|2
1138250|NCT01451437|3738323|P5|Overall Study|Disease Progression|3
1138251|NCT01451437|3738324|P4|Overall Study|Disease Progression|1
1138252|NCT01451437|3738325|P3|Overall Study|Disease Progression|1
1138253|NCT01451437|3738326|P2|Overall Study|Disease Progression|0
1138254|NCT01451437|3738327|P1|Overall Study|Disease Progression|0
1138255|NCT01451437|3738319|P9|Overall Study|Physician Decision|0
1138256|NCT01451437|3738320|P8|Overall Study|Physician Decision|0
1138257|NCT01451437|3738321|P7|Overall Study|Physician Decision|0
1138258|NCT01451437|3738322|P6|Overall Study|Physician Decision|0
1138259|NCT01451437|3738323|P5|Overall Study|Physician Decision|0
1138260|NCT01451437|3738324|P4|Overall Study|Physician Decision|0
1138261|NCT01451437|3738325|P3|Overall Study|Physician Decision|2
1138262|NCT01451437|3738326|P2|Overall Study|Physician Decision|1
1138263|NCT01451437|3738327|P1|Overall Study|Physician Decision|1
1138264|NCT01451437|3738319|P9|Overall Study|Adverse Event|1
1138265|NCT01451437|3738320|P8|Overall Study|Adverse Event|2
1138266|NCT01451437|3738321|P7|Overall Study|Adverse Event|1
1138267|NCT01451437|3738322|P6|Overall Study|Adverse Event|1
1138268|NCT01451437|3738323|P5|Overall Study|Adverse Event|0
1138269|NCT01451437|3738324|P4|Overall Study|Adverse Event|0
1138270|NCT01451437|3738325|P3|Overall Study|Adverse Event|0
1138271|NCT01451437|3738326|P2|Overall Study|Adverse Event|0
1138272|NCT01451437|3738327|P1|Overall Study|Adverse Event|0
1138273|NCT01451424|3738459|P4|Overall Study|Adverse Event|1
1138274|NCT01451424|3738460|P3|Overall Study|Adverse Event|0
1138275|NCT01451424|3738461|P2|Overall Study|Adverse Event|0
1138276|NCT01451424|3738462|P1|Overall Study|Adverse Event|0
1138277|NCT01451424|3738459|P4|Overall Study|Physician Decision|1
1138278|NCT01451424|3738460|P3|Overall Study|Physician Decision|1
1138279|NCT01451424|3738461|P2|Overall Study|Physician Decision|0
1138280|NCT01451424|3738462|P1|Overall Study|Physician Decision|0
1138281|NCT01451424|3738459|P4|Overall Study|Lost to Follow-up|1
1138282|NCT01451424|3738460|P3|Overall Study|Lost to Follow-up|0
1138283|NCT01451424|3738461|P2|Overall Study|Lost to Follow-up|1
1138284|NCT01451424|3738462|P1|Overall Study|Lost to Follow-up|0
1138285|NCT01451424|3738459|P4|Overall Study|Withdrawal by Subject|2
1138286|NCT01451424|3738460|P3|Overall Study|Withdrawal by Subject|0
1138287|NCT01451424|3738461|P2|Overall Study|Withdrawal by Subject|1
1138288|NCT01451424|3738462|P1|Overall Study|Withdrawal by Subject|1
1138289|NCT01451398|3738520|P2|Overall Study|Lack of Efficacy|1
1138290|NCT01451398|3738521|P1|Overall Study|Lack of Efficacy|0
1138291|NCT01451398|3738520|P2|Overall Study|Adverse Event + Elevated Fasting Glucose|1
1138292|NCT01451398|3738521|P1|Overall Study|Adverse Event + Elevated Fasting Glucose|0
1138293|NCT01451398|3738520|P2|Overall Study|Moved out of country|1
1138294|NCT01451398|3738521|P1|Overall Study|Moved out of country|0
1138295|NCT01451398|3738520|P2|Overall Study|Non-compliance with protocol|1
1138296|NCT01451398|3738521|P1|Overall Study|Non-compliance with protocol|1
1138297|NCT01451398|3738520|P2|Overall Study|Non-compliance with study drug|3
1138298|NCT01451398|3738521|P1|Overall Study|Non-compliance with study drug|1
1138299|NCT01451398|3738520|P2|Overall Study|Lost to Follow-up|4
1138300|NCT01451398|3738521|P1|Overall Study|Lost to Follow-up|6
1138301|NCT01451398|3738520|P2|Overall Study|Withdrawal by Subject|14
1138302|NCT01451398|3738521|P1|Overall Study|Withdrawal by Subject|10
1138303|NCT01451398|3738520|P2|Overall Study|Physician Decision|1
1138304|NCT01451398|3738521|P1|Overall Study|Physician Decision|1
1138305|NCT01451398|3738520|P2|Overall Study|Protocol Violation|2
1138306|NCT01451398|3738521|P1|Overall Study|Protocol Violation|1
1138307|NCT01451398|3738520|P2|Overall Study|Adverse Event|9
1138308|NCT01451398|3738521|P1|Overall Study|Adverse Event|7
1138309|NCT01451203|3738555|P2|Post-treatment Period|Investigator decision|1
1138310|NCT01451203|3738556|P1|Post-treatment Period|Investigator decision|0
1138311|NCT01451203|3738555|P2|Post-treatment Period|Adverse Event|1
1138312|NCT01451203|3738556|P1|Post-treatment Period|Adverse Event|0
1138313|NCT01451203|3738555|P2|Post-treatment Period|Lack of Efficacy|28
1138314|NCT01451203|3738556|P1|Post-treatment Period|Lack of Efficacy|12
1138315|NCT01451203|3738555|P2|Post-treatment Period|Consent withdrawn|4
1138316|NCT01451203|3738556|P1|Post-treatment Period|Consent withdrawn|2
1138317|NCT01451203|3738555|P2|Double-blind Treatment Period|Investigator decision|0
1138318|NCT01451203|3738556|P1|Double-blind Treatment Period|Investigator decision|2
1138319|NCT01451203|3738555|P2|Double-blind Treatment Period|Violation of eligibility criteria|0
1138320|NCT01451203|3738556|P1|Double-blind Treatment Period|Violation of eligibility criteria|1
1138321|NCT01451203|3738555|P2|Double-blind Treatment Period|Missing study medication ≥6 times|0
1138322|NCT01451203|3738556|P1|Double-blind Treatment Period|Missing study medication ≥6 times|1
1138323|NCT01451203|3738555|P2|Double-blind Treatment Period|Adverse Event|9
1138324|NCT01451203|3738556|P1|Double-blind Treatment Period|Adverse Event|6
1138325|NCT01451203|3738555|P2|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1
1138326|NCT01451203|3738556|P1|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0
1138327|NCT01451203|3738555|P2|Double-blind Treatment Period|Lack of Efficacy|36
1138328|NCT01451203|3738556|P1|Double-blind Treatment Period|Lack of Efficacy|71
1138329|NCT01451203|3738555|P2|Double-blind Treatment Period|Consent Withdrawn|2
1138330|NCT01451203|3738556|P1|Double-blind Treatment Period|Consent Withdrawn|3
1138331|NCT01451203|3738555|P2|Double-blind Treatment Period|Did not receive treatment|2
1138332|NCT01451203|3738556|P1|Double-blind Treatment Period|Did not receive treatment|1
1138333|NCT01450813|3738589|P4|Overall Study|Physician Decision|3
1138334|NCT01450813|3738590|P3|Overall Study|Physician Decision|0
1138335|NCT01450813|3738591|P2|Overall Study|Physician Decision|1
1138336|NCT01450813|3738592|P1|Overall Study|Physician Decision|1
1138337|NCT01450800|3738606|P2|Overall Study|Protocol Violation|3
1138338|NCT01450800|3738607|P1|Overall Study|Protocol Violation|1
1138339|NCT01450761|3738642|P2|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3
1138340|NCT01450761|3738643|P1|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2
1138341|NCT01450761|3738642|P2|Treatment With Blinded Study Therapy|Poor/non-compliance|0
1138342|NCT01450761|3738643|P1|Treatment With Blinded Study Therapy|Poor/non-compliance|1
1138343|NCT01450761|3738642|P2|Treatment With Blinded Study Therapy|Not reported|2
1138344|NCT01450761|3738643|P1|Treatment With Blinded Study Therapy|Not reported|2
1138345|NCT01450761|3738642|P2|Treatment With Blinded Study Therapy|No longer meets study criteria|2
1138346|NCT01450761|3738643|P1|Treatment With Blinded Study Therapy|No longer meets study criteria|1
1138347|NCT01450761|3738642|P2|Treatment With Blinded Study Therapy|Maximum clinical benefit|2
1138348|NCT01450761|3738643|P1|Treatment With Blinded Study Therapy|Maximum clinical benefit|1
1138349|NCT01450761|3738642|P2|Treatment With Blinded Study Therapy|Lost to Follow-up|1
1138350|NCT01450761|3738643|P1|Treatment With Blinded Study Therapy|Lost to Follow-up|2
1138351|NCT01450761|3738642|P2|Treatment With Blinded Study Therapy|Other/Unspecified|4
1138352|NCT01450761|3738643|P1|Treatment With Blinded Study Therapy|Other/Unspecified|5
1138353|NCT01450761|3738642|P2|Treatment With Blinded Study Therapy|Death|6
1138354|NCT01450761|3738643|P1|Treatment With Blinded Study Therapy|Death|5
1138355|NCT01450761|3738642|P2|Treatment With Blinded Study Therapy|Withdrawal by Subject|5
1138356|NCT01450761|3738643|P1|Treatment With Blinded Study Therapy|Withdrawal by Subject|12
1138357|NCT01450761|3738642|P2|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8
1138358|NCT01450761|3738643|P1|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15
1138359|NCT01450761|3738642|P2|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19
1138360|NCT01450761|3738643|P1|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27
1138361|NCT01450761|3738642|P2|Treatment With Blinded Study Therapy|Study drug toxicity|9
1138362|NCT01450761|3738643|P1|Treatment With Blinded Study Therapy|Study drug toxicity|87
1138363|NCT01450761|3738642|P2|Treatment With Blinded Study Therapy|Disease progression|415
1138364|NCT01450761|3738643|P1|Treatment With Blinded Study Therapy|Disease progression|318
1138365|NCT01450761|3738642|P2|Lead-in Chemotherapy|Lost to Follow-up|0
1138366|NCT01450761|3738643|P1|Lead-in Chemotherapy|Lost to Follow-up|2
1138367|NCT01450761|3738642|P2|Lead-in Chemotherapy|Other|2
1138368|NCT01450761|3738643|P1|Lead-in Chemotherapy|Other|2
1138369|NCT01450761|3738642|P2|Lead-in Chemotherapy|Death|3
1138370|NCT01450761|3738643|P1|Lead-in Chemotherapy|Death|3
1138371|NCT01450761|3738642|P2|Lead-in Chemotherapy|No longer meets study criteria|7
1138372|NCT01450761|3738643|P1|Lead-in Chemotherapy|No longer meets study criteria|3
1138373|NCT01450761|3738642|P2|Lead-in Chemotherapy|Study drug toxicity|10
1138374|NCT01450761|3738643|P1|Lead-in Chemotherapy|Study drug toxicity|6
1138375|NCT01450761|3738642|P2|Lead-in Chemotherapy|Withdrawal by Subject|12
1138376|NCT01450761|3738643|P1|Lead-in Chemotherapy|Withdrawal by Subject|14
1138377|NCT01450761|3738642|P2|Lead-in Chemotherapy|Adverse event unrelated to study drug|19
1138378|NCT01450761|3738643|P1|Lead-in Chemotherapy|Adverse event unrelated to study drug|21
1138379|NCT01450761|3738642|P2|Lead-in Chemotherapy|Disease progression|32
1138380|NCT01450761|3738643|P1|Lead-in Chemotherapy|Disease progression|33
1138381|NCT01450761|3738642|P2|Randomization|Other|1
1138382|NCT01450761|3738643|P1|Randomization|Other|0
1138383|NCT01450761|3738642|P2|Randomization|Adverse Event unrelated to study drug|0
1138384|NCT01450761|3738643|P1|Randomization|Adverse Event unrelated to study drug|1
1138385|NCT01450761|3738642|P2|Randomization|Disease progression|2
1138386|NCT01450761|3738643|P1|Randomization|Disease progression|0
1138387|NCT01450761|3738642|P2|Randomization|Withdrawal by Subject|0
1138388|NCT01450761|3738643|P1|Randomization|Withdrawal by Subject|2
1138389|NCT01450761|3738642|P2|Randomization|Subject no longer meets study criteria|2
1138390|NCT01450761|3738643|P1|Randomization|Subject no longer meets study criteria|1
1138391|NCT01450696|3738655|P2|Overall Study|Study Terminated by Sponsor|58
1138392|NCT01450696|3738656|P1|Overall Study|Study Terminated by Sponsor|53
1138393|NCT01450696|3738655|P2|Overall Study|Withdrawal by Subject|2
1138394|NCT01450696|3738656|P1|Overall Study|Withdrawal by Subject|13
1138395|NCT01450696|3738655|P2|Overall Study|Non-Compliance|0
1138396|NCT01450696|3738656|P1|Overall Study|Non-Compliance|1
1138397|NCT01450696|3738655|P2|Overall Study|Lost to Follow-up|3
1138398|NCT01450696|3738656|P1|Overall Study|Lost to Follow-up|3
1138399|NCT01450696|3738655|P2|Overall Study|Death|84
1138400|NCT01450696|3738656|P1|Overall Study|Death|77
1138401|NCT01450696|3738655|P2|Overall Study|Never Treated|1
1138402|NCT01450696|3738656|P1|Overall Study|Never Treated|1
1138403|NCT01450683|3738678|P1|Overall Study|Adverse Event|2
1138404|NCT01450631|3738684|P2|Overall Study|Withdrawal by Subject|0
1138405|NCT01450631|3738685|P1|Overall Study|Withdrawal by Subject|1
1138406|NCT01450631|3738684|P2|Overall Study|Lost to Follow-up|4
1138407|NCT01450631|3738685|P1|Overall Study|Lost to Follow-up|2
1138408|NCT01450098|3738815|P2|Period 3|Withdrawal by Subject|2
1138409|NCT01450098|3738816|P1|Period 3|Withdrawal by Subject|0
1138410|NCT01450098|3738815|P2|Period 3|Protocol Violation|1
1138411|NCT01450098|3738816|P1|Period 3|Protocol Violation|0
1138412|NCT01450007|3738835|P3|Overall Study|Adverse Event|0
1138413|NCT01450007|3738836|P2|Overall Study|Adverse Event|1
1138414|NCT01450007|3738837|P1|Overall Study|Adverse Event|0
1138415|NCT01450007|3738835|P3|Overall Study|Protocol Violation|1
1138416|NCT01450007|3738836|P2|Overall Study|Protocol Violation|1
1138417|NCT01450007|3738837|P1|Overall Study|Protocol Violation|0
1138418|NCT01450007|3738835|P3|Overall Study|Late exclusion before treatment|2
1138419|NCT01450007|3738836|P2|Overall Study|Late exclusion before treatment|3
1138420|NCT01450007|3738837|P1|Overall Study|Late exclusion before treatment|2
1138421|NCT01449955|3738856|P2|Overall Study|Withdrawal by Subject|2
1138422|NCT01449955|3738857|P1|Overall Study|Withdrawal by Subject|1
1138423|NCT01449929|3738885|P3|Extension Phase Approximately 3 Years|Lost to Follow-up|4
1138424|NCT01449929|3738886|P2|Extension Phase Approximately 3 Years|Lost to Follow-up|0
1138425|NCT01449929|3738887|P1|Extension Phase Approximately 3 Years|Lost to Follow-up|0
1138508|NCT01449461|3739163|P1|Overall Study|Documented progressive disease|4
1138426|NCT01449929|3738885|P3|Extension Phase Approximately 3 Years|Lack of Efficacy|2
1138427|NCT01449929|3738886|P2|Extension Phase Approximately 3 Years|Lack of Efficacy|0
1138428|NCT01449929|3738887|P1|Extension Phase Approximately 3 Years|Lack of Efficacy|0
1138429|NCT01449929|3738885|P3|Extension Phase Approximately 3 Years|Adverse Event|2
1138430|NCT01449929|3738886|P2|Extension Phase Approximately 3 Years|Adverse Event|0
1138431|NCT01449929|3738887|P1|Extension Phase Approximately 3 Years|Adverse Event|0
1138432|NCT01449929|3738885|P3|Randomization Phase 96 Week|Other: study closed/terminated|0
1138433|NCT01449929|3738886|P2|Randomization Phase 96 Week|Other: study closed/terminated|1
1138434|NCT01449929|3738887|P1|Randomization Phase 96 Week|Other: study closed/terminated|0
1138435|NCT01449929|3738885|P3|Randomization Phase 96 Week|Physician Decision|0
1138436|NCT01449929|3738886|P2|Randomization Phase 96 Week|Physician Decision|3
1138437|NCT01449929|3738887|P1|Randomization Phase 96 Week|Physician Decision|2
1138438|NCT01449929|3738885|P3|Randomization Phase 96 Week|Withdrawal by Subject|0
1138439|NCT01449929|3738886|P2|Randomization Phase 96 Week|Withdrawal by Subject|8
1138440|NCT01449929|3738887|P1|Randomization Phase 96 Week|Withdrawal by Subject|2
1138441|NCT01449929|3738885|P3|Randomization Phase 96 Week|Lost to Follow-up|0
1138442|NCT01449929|3738886|P2|Randomization Phase 96 Week|Lost to Follow-up|18
1138443|NCT01449929|3738887|P1|Randomization Phase 96 Week|Lost to Follow-up|15
1138444|NCT01449929|3738885|P3|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
1138445|NCT01449929|3738886|P2|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
1138446|NCT01449929|3738887|P1|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1
1138447|NCT01449929|3738885|P3|Randomization Phase 96 Week|Protocol Violation|0
1138448|NCT01449929|3738886|P2|Randomization Phase 96 Week|Protocol Violation|6
1138449|NCT01449929|3738887|P1|Randomization Phase 96 Week|Protocol Violation|5
1138450|NCT01449929|3738885|P3|Randomization Phase 96 Week|Lack of Efficacy|0
1138451|NCT01449929|3738886|P2|Randomization Phase 96 Week|Lack of Efficacy|4
1138452|NCT01449929|3738887|P1|Randomization Phase 96 Week|Lack of Efficacy|3
1138453|NCT01449929|3738885|P3|Randomization Phase 96 Week|Adverse Event|0
1138454|NCT01449929|3738886|P2|Randomization Phase 96 Week|Adverse Event|13
1138455|NCT01449929|3738887|P1|Randomization Phase 96 Week|Adverse Event|5
1138456|NCT01449812|3738927|P3|Overall Study|Lost to Follow-up|0
1138457|NCT01449812|3738928|P2|Overall Study|Lost to Follow-up|0
1138458|NCT01449812|3738929|P1|Overall Study|Lost to Follow-up|1
1138459|NCT01449812|3738927|P3|Overall Study|Withdrawal by Subject|1
1138460|NCT01449812|3738928|P2|Overall Study|Withdrawal by Subject|0
1138461|NCT01449812|3738929|P1|Overall Study|Withdrawal by Subject|0
1138462|NCT01449812|3738927|P3|Overall Study|Migrated/moved from study area|0
1138463|NCT01449812|3738928|P2|Overall Study|Migrated/moved from study area|0
1138464|NCT01449812|3738929|P1|Overall Study|Migrated/moved from study area|1
1138465|NCT01449721|3739044|P2|Overall Study|Physician Decision|1
1138466|NCT01449721|3739045|P1|Overall Study|Physician Decision|0
1138467|NCT01449721|3739044|P2|Overall Study|Physician Decision|1
1138468|NCT01449721|3739045|P1|Overall Study|Physician Decision|0
1138469|NCT01449708|3739057|P2|Overall Study|respiratory failure|0
1138470|NCT01449708|3739058|P1|Overall Study|respiratory failure|1
1138471|NCT01449708|3739057|P2|Overall Study|surgical complication|2
1138472|NCT01449708|3739058|P1|Overall Study|surgical complication|1
1138473|NCT01449708|3739057|P2|Overall Study|Protocol Violation|1
1138474|NCT01449708|3739058|P1|Overall Study|Protocol Violation|0
1138475|NCT01449682|3739069|P2|Overall Study|Adverse Event|0
1138476|NCT01449682|3739070|P1|Overall Study|Adverse Event|1
1138477|NCT01449682|3739069|P2|Overall Study|Death|1
1138478|NCT01449682|3739070|P1|Overall Study|Death|0
1138479|NCT01449539|3739082|P1|Overall Study|Toxicity not study related|1
1138480|NCT01449539|3739082|P1|Overall Study|Withdrawal by Subject|3
1138481|NCT01449526|3739088|P2|Overall Study|Cannot maintain visits|1
1138482|NCT01449526|3739089|P1|Overall Study|Cannot maintain visits|0
1138483|NCT01449526|3739088|P2|Overall Study|Lack of Motivation|1
1138484|NCT01449526|3739089|P1|Overall Study|Lack of Motivation|0
1138485|NCT01449526|3739088|P2|Overall Study|Symptoms/complaints|1
1138486|NCT01449526|3739089|P1|Overall Study|Symptoms/complaints|0
1138487|NCT01449526|3739088|P2|Overall Study|Withdrawal by Subject|1
1138488|NCT01449526|3739089|P1|Overall Study|Withdrawal by Subject|1
1138489|NCT01449526|3739088|P2|Overall Study|Lost to Follow-up|2
1138490|NCT01449526|3739089|P1|Overall Study|Lost to Follow-up|1
1138491|NCT01449461|3739158|P6|Overall Study|Reason not specified|1
1138492|NCT01449461|3739159|P5|Overall Study|Reason not specified|0
1138493|NCT01449461|3739160|P4|Overall Study|Reason not specified|3
1138494|NCT01449461|3739161|P3|Overall Study|Reason not specified|0
1138495|NCT01449461|3739162|P2|Overall Study|Reason not specified|1
1138496|NCT01449461|3739163|P1|Overall Study|Reason not specified|0
1138497|NCT01449461|3739158|P6|Overall Study|Clinical progressive disease|3
1138498|NCT01449461|3739159|P5|Overall Study|Clinical progressive disease|3
1138499|NCT01449461|3739160|P4|Overall Study|Clinical progressive disease|0
1138500|NCT01449461|3739161|P3|Overall Study|Clinical progressive disease|0
1138501|NCT01449461|3739162|P2|Overall Study|Clinical progressive disease|1
1138502|NCT01449461|3739163|P1|Overall Study|Clinical progressive disease|2
1138503|NCT01449461|3739158|P6|Overall Study|Documented progressive disease|5
1138504|NCT01449461|3739159|P5|Overall Study|Documented progressive disease|21
1138505|NCT01449461|3739160|P4|Overall Study|Documented progressive disease|11
1138506|NCT01449461|3739161|P3|Overall Study|Documented progressive disease|14
1138507|NCT01449461|3739162|P2|Overall Study|Documented progressive disease|6
1138509|NCT01449461|3739158|P6|Overall Study|Death|1
1138510|NCT01449461|3739159|P5|Overall Study|Death|4
1138511|NCT01449461|3739160|P4|Overall Study|Death|0
1138512|NCT01449461|3739161|P3|Overall Study|Death|0
1138513|NCT01449461|3739162|P2|Overall Study|Death|1
1138514|NCT01449461|3739163|P1|Overall Study|Death|0
1138515|NCT01449461|3739158|P6|Overall Study|Adverse Event|3
1138516|NCT01449461|3739159|P5|Overall Study|Adverse Event|3
1138517|NCT01449461|3739160|P4|Overall Study|Adverse Event|3
1138518|NCT01449461|3739161|P3|Overall Study|Adverse Event|2
1138519|NCT01449461|3739162|P2|Overall Study|Adverse Event|3
1138520|NCT01449461|3739163|P1|Overall Study|Adverse Event|0
1138521|NCT01449461|3739158|P6|Overall Study|Ongoing|2
1138522|NCT01449461|3739159|P5|Overall Study|Ongoing|17
1138523|NCT01449461|3739160|P4|Overall Study|Ongoing|15
1138524|NCT01449461|3739161|P3|Overall Study|Ongoing|2
1138525|NCT01449461|3739162|P2|Overall Study|Ongoing|6
1138526|NCT01449461|3739163|P1|Overall Study|Ongoing|0
1138527|NCT01449370|3739300|P25|Overall Study|Death|1
1138528|NCT01449370|3739301|P24|Overall Study|Death|0
1138529|NCT01449370|3739302|P23|Overall Study|Death|0
1138530|NCT01449370|3739303|P22|Overall Study|Death|0
1138531|NCT01449370|3739304|P21|Overall Study|Death|0
1138532|NCT01449370|3739305|P20|Overall Study|Death|0
1138533|NCT01449370|3739306|P19|Overall Study|Death|0
1138534|NCT01449370|3739307|P18|Overall Study|Death|0
1138535|NCT01449370|3739308|P17|Overall Study|Death|0
1138536|NCT01449370|3739309|P16|Overall Study|Death|0
1138537|NCT01449370|3739310|P15|Overall Study|Death|0
1138538|NCT01449370|3739311|P14|Overall Study|Death|0
1138539|NCT01449370|3739312|P13|Overall Study|Death|0
1138540|NCT01449370|3739313|P12|Overall Study|Death|0
1138541|NCT01449370|3739314|P11|Overall Study|Death|0
1138542|NCT01449370|3739315|P10|Overall Study|Death|0
1138543|NCT01449370|3739316|P9|Overall Study|Death|0
1138544|NCT01449370|3739317|P8|Overall Study|Death|0
1138545|NCT01449370|3739318|P7|Overall Study|Death|0
1138546|NCT01449370|3739319|P6|Overall Study|Death|0
1138547|NCT01449370|3739320|P5|Overall Study|Death|0
1138548|NCT01449370|3739321|P4|Overall Study|Death|0
1138549|NCT01449370|3739322|P3|Overall Study|Death|0
1138550|NCT01449370|3739323|P2|Overall Study|Death|0
1138551|NCT01449370|3739324|P1|Overall Study|Death|0
1138552|NCT01449370|3739300|P25|Overall Study|Medication Prohibited by Protocol|0
1138553|NCT01449370|3739301|P24|Overall Study|Medication Prohibited by Protocol|1
1138554|NCT01449370|3739302|P23|Overall Study|Medication Prohibited by Protocol|0
1138555|NCT01449370|3739303|P22|Overall Study|Medication Prohibited by Protocol|0
1138556|NCT01449370|3739304|P21|Overall Study|Medication Prohibited by Protocol|0
1138557|NCT01449370|3739305|P20|Overall Study|Medication Prohibited by Protocol|0
1138558|NCT01449370|3739306|P19|Overall Study|Medication Prohibited by Protocol|0
1138559|NCT01449370|3739307|P18|Overall Study|Medication Prohibited by Protocol|0
1138560|NCT01449370|3739308|P17|Overall Study|Medication Prohibited by Protocol|0
1138561|NCT01449370|3739309|P16|Overall Study|Medication Prohibited by Protocol|0
1138562|NCT01449370|3739310|P15|Overall Study|Medication Prohibited by Protocol|0
1138563|NCT01449370|3739311|P14|Overall Study|Medication Prohibited by Protocol|0
1138564|NCT01449370|3739312|P13|Overall Study|Medication Prohibited by Protocol|0
1138565|NCT01449370|3739313|P12|Overall Study|Medication Prohibited by Protocol|0
1138566|NCT01449370|3739314|P11|Overall Study|Medication Prohibited by Protocol|0
1138567|NCT01449370|3739315|P10|Overall Study|Medication Prohibited by Protocol|0
1138568|NCT01449370|3739316|P9|Overall Study|Medication Prohibited by Protocol|0
1138569|NCT01449370|3739317|P8|Overall Study|Medication Prohibited by Protocol|0
1138570|NCT01449370|3739318|P7|Overall Study|Medication Prohibited by Protocol|0
1138571|NCT01449370|3739319|P6|Overall Study|Medication Prohibited by Protocol|0
1138572|NCT01449370|3739320|P5|Overall Study|Medication Prohibited by Protocol|0
1138573|NCT01449370|3739321|P4|Overall Study|Medication Prohibited by Protocol|0
1138574|NCT01449370|3739322|P3|Overall Study|Medication Prohibited by Protocol|0
1138575|NCT01449370|3739323|P2|Overall Study|Medication Prohibited by Protocol|0
1138576|NCT01449370|3739324|P1|Overall Study|Medication Prohibited by Protocol|0
1138577|NCT01449370|3739300|P25|Overall Study|Other|0
1138578|NCT01449370|3739301|P24|Overall Study|Other|1
1138579|NCT01449370|3739302|P23|Overall Study|Other|1
1138580|NCT01449370|3739303|P22|Overall Study|Other|0
1138581|NCT01449370|3739304|P21|Overall Study|Other|0
1138582|NCT01449370|3739305|P20|Overall Study|Other|0
1138583|NCT01449370|3739306|P19|Overall Study|Other|0
1138584|NCT01449370|3739307|P18|Overall Study|Other|0
1138585|NCT01449370|3739308|P17|Overall Study|Other|0
1138586|NCT01449370|3739309|P16|Overall Study|Other|0
1138587|NCT01449370|3739310|P15|Overall Study|Other|0
1138588|NCT01449370|3739311|P14|Overall Study|Other|0
1138589|NCT01449370|3739312|P13|Overall Study|Other|0
1138590|NCT01449370|3739313|P12|Overall Study|Other|0
1138591|NCT01449370|3739314|P11|Overall Study|Other|0
1138592|NCT01449370|3739315|P10|Overall Study|Other|1
1138593|NCT01449370|3739316|P9|Overall Study|Other|1
1138594|NCT01449370|3739317|P8|Overall Study|Other|0
1138595|NCT01449370|3739318|P7|Overall Study|Other|0
1138596|NCT01449370|3739319|P6|Overall Study|Other|0
1138597|NCT01449370|3739320|P5|Overall Study|Other|0
1138598|NCT01449370|3739321|P4|Overall Study|Other|0
1138599|NCT01449370|3739322|P3|Overall Study|Other|0
1138600|NCT01449370|3739323|P2|Overall Study|Other|0
1138601|NCT01449370|3739324|P1|Overall Study|Other|0
1138602|NCT01449370|3739300|P25|Overall Study|Lost to Follow-up|0
1138603|NCT01449370|3739301|P24|Overall Study|Lost to Follow-up|0
1138604|NCT01449370|3739302|P23|Overall Study|Lost to Follow-up|0
1138605|NCT01449370|3739303|P22|Overall Study|Lost to Follow-up|0
1138606|NCT01449370|3739304|P21|Overall Study|Lost to Follow-up|1
1138607|NCT01449370|3739305|P20|Overall Study|Lost to Follow-up|0
1138608|NCT01449370|3739306|P19|Overall Study|Lost to Follow-up|0
1138609|NCT01449370|3739307|P18|Overall Study|Lost to Follow-up|0
1138610|NCT01449370|3739308|P17|Overall Study|Lost to Follow-up|0
1138611|NCT01449370|3739309|P16|Overall Study|Lost to Follow-up|0
1138612|NCT01449370|3739310|P15|Overall Study|Lost to Follow-up|0
1138613|NCT01449370|3739311|P14|Overall Study|Lost to Follow-up|0
1138614|NCT01449370|3739312|P13|Overall Study|Lost to Follow-up|0
1138615|NCT01449370|3739313|P12|Overall Study|Lost to Follow-up|0
1138616|NCT01449370|3739314|P11|Overall Study|Lost to Follow-up|0
1138617|NCT01449370|3739315|P10|Overall Study|Lost to Follow-up|0
1138618|NCT01449370|3739316|P9|Overall Study|Lost to Follow-up|0
1138619|NCT01449370|3739317|P8|Overall Study|Lost to Follow-up|0
1138620|NCT01449370|3739318|P7|Overall Study|Lost to Follow-up|0
1138621|NCT01449370|3739319|P6|Overall Study|Lost to Follow-up|0
1138622|NCT01449370|3739320|P5|Overall Study|Lost to Follow-up|0
1138623|NCT01449370|3739321|P4|Overall Study|Lost to Follow-up|0
1138624|NCT01449370|3739322|P3|Overall Study|Lost to Follow-up|0
1138625|NCT01449370|3739323|P2|Overall Study|Lost to Follow-up|0
1138626|NCT01449370|3739324|P1|Overall Study|Lost to Follow-up|0
1138627|NCT01449370|3739300|P25|Overall Study|Participant Decision|1
1138628|NCT01449370|3739301|P24|Overall Study|Participant Decision|0
1138629|NCT01449370|3739302|P23|Overall Study|Participant Decision|0
1138630|NCT01449370|3739303|P22|Overall Study|Participant Decision|1
1138631|NCT01449370|3739304|P21|Overall Study|Participant Decision|0
1138632|NCT01449370|3739305|P20|Overall Study|Participant Decision|0
1138633|NCT01449370|3739306|P19|Overall Study|Participant Decision|1
1138634|NCT01449370|3739307|P18|Overall Study|Participant Decision|0
1138635|NCT01449370|3739308|P17|Overall Study|Participant Decision|3
1138636|NCT01449370|3739309|P16|Overall Study|Participant Decision|1
1138637|NCT01449370|3739310|P15|Overall Study|Participant Decision|0
1138638|NCT01449370|3739311|P14|Overall Study|Participant Decision|1
1138639|NCT01449370|3739312|P13|Overall Study|Participant Decision|1
1138640|NCT01449370|3739313|P12|Overall Study|Participant Decision|0
1138641|NCT01449370|3739314|P11|Overall Study|Participant Decision|0
1138642|NCT01449370|3739315|P10|Overall Study|Participant Decision|0
1138643|NCT01449370|3739316|P9|Overall Study|Participant Decision|1
1138644|NCT01449370|3739317|P8|Overall Study|Participant Decision|1
1138645|NCT01449370|3739318|P7|Overall Study|Participant Decision|0
1138646|NCT01449370|3739319|P6|Overall Study|Participant Decision|0
1138647|NCT01449370|3739320|P5|Overall Study|Participant Decision|0
1138648|NCT01449370|3739321|P4|Overall Study|Participant Decision|0
1138649|NCT01449370|3739322|P3|Overall Study|Participant Decision|0
1138650|NCT01449370|3739323|P2|Overall Study|Participant Decision|0
1138651|NCT01449370|3739324|P1|Overall Study|Participant Decision|0
1138652|NCT01449370|3739300|P25|Overall Study|Adverse Event|3
1138653|NCT01449370|3739301|P24|Overall Study|Adverse Event|1
1138654|NCT01449370|3739302|P23|Overall Study|Adverse Event|0
1138655|NCT01449370|3739303|P22|Overall Study|Adverse Event|1
1138656|NCT01449370|3739304|P21|Overall Study|Adverse Event|0
1138657|NCT01449370|3739305|P20|Overall Study|Adverse Event|1
1138658|NCT01449370|3739306|P19|Overall Study|Adverse Event|1
1138659|NCT01449370|3739307|P18|Overall Study|Adverse Event|0
1138660|NCT01449370|3739308|P17|Overall Study|Adverse Event|0
1138661|NCT01449370|3739309|P16|Overall Study|Adverse Event|1
1138662|NCT01449370|3739310|P15|Overall Study|Adverse Event|0
1138663|NCT01449370|3739311|P14|Overall Study|Adverse Event|2
1138664|NCT01449370|3739312|P13|Overall Study|Adverse Event|0
1138665|NCT01449370|3739313|P12|Overall Study|Adverse Event|0
1138666|NCT01449370|3739314|P11|Overall Study|Adverse Event|0
1138667|NCT01449370|3739315|P10|Overall Study|Adverse Event|1
1138668|NCT01449370|3739316|P9|Overall Study|Adverse Event|1
1138669|NCT01449370|3739317|P8|Overall Study|Adverse Event|0
1138670|NCT01449370|3739318|P7|Overall Study|Adverse Event|0
1138671|NCT01449370|3739319|P6|Overall Study|Adverse Event|0
1138672|NCT01449370|3739320|P5|Overall Study|Adverse Event|0
1138673|NCT01449370|3739321|P4|Overall Study|Adverse Event|1
1138674|NCT01449370|3739322|P3|Overall Study|Adverse Event|0
1138675|NCT01449370|3739323|P2|Overall Study|Adverse Event|2
1138676|NCT01449370|3739324|P1|Overall Study|Adverse Event|1
1138677|NCT01449370|3739300|P25|Overall Study|Disease Progression|3
1138678|NCT01449370|3739301|P24|Overall Study|Disease Progression|7
1138679|NCT01449370|3739302|P23|Overall Study|Disease Progression|3
1138680|NCT01449370|3739303|P22|Overall Study|Disease Progression|2
1138681|NCT01449370|3739304|P21|Overall Study|Disease Progression|5
1138682|NCT01449370|3739305|P20|Overall Study|Disease Progression|2
1138683|NCT01449370|3739306|P19|Overall Study|Disease Progression|1
1138684|NCT01449370|3739307|P18|Overall Study|Disease Progression|3
1138685|NCT01449370|3739308|P17|Overall Study|Disease Progression|4
1138686|NCT01449370|3739309|P16|Overall Study|Disease Progression|1
1138687|NCT01449370|3739310|P15|Overall Study|Disease Progression|3
1138688|NCT01449370|3739311|P14|Overall Study|Disease Progression|8
1138689|NCT01449370|3739312|P13|Overall Study|Disease Progression|2
1138690|NCT01449370|3739313|P12|Overall Study|Disease Progression|3
1138691|NCT01449370|3739314|P11|Overall Study|Disease Progression|3
1138692|NCT01449370|3739315|P10|Overall Study|Disease Progression|1
1138693|NCT01449370|3739316|P9|Overall Study|Disease Progression|9
1138694|NCT01449370|3739317|P8|Overall Study|Disease Progression|2
1138695|NCT01449370|3739318|P7|Overall Study|Disease Progression|3
1138696|NCT01449370|3739319|P6|Overall Study|Disease Progression|3
1138697|NCT01449370|3739320|P5|Overall Study|Disease Progression|3
1138698|NCT01449370|3739321|P4|Overall Study|Disease Progression|3
1138699|NCT01449370|3739322|P3|Overall Study|Disease Progression|8
1138700|NCT01449370|3739323|P2|Overall Study|Disease Progression|4
1138701|NCT01449370|3739324|P1|Overall Study|Disease Progression|5
1138702|NCT01449279|3739702|P1|Overall Study|Toxicity|2
1138703|NCT01449279|3739702|P1|Overall Study|Lack of Efficacy|5
1138704|NCT01449006|3739727|P2|Overall Study|Protocol Violation|0
1138705|NCT01449006|3739728|P1|Overall Study|Protocol Violation|1
1138706|NCT01449006|3739727|P2|Overall Study|Withdrawal by Subject|0
1138707|NCT01449006|3739728|P1|Overall Study|Withdrawal by Subject|1
1138708|NCT01449006|3739727|P2|Overall Study|Lost to Follow-up|0
1138709|NCT01449006|3739728|P1|Overall Study|Lost to Follow-up|1
1138710|NCT01448850|3739742|P2|Overall Study|Other|12
1138711|NCT01448850|3739743|P1|Overall Study|Other|15
1138712|NCT01448850|3739742|P2|Overall Study|Lost to Follow-up|1
1138713|NCT01448850|3739743|P1|Overall Study|Lost to Follow-up|3
1138714|NCT01448850|3739742|P2|Overall Study|Withdrawal by Subject|21
1138715|NCT01448850|3739743|P1|Overall Study|Withdrawal by Subject|13
1138716|NCT01448850|3739742|P2|Overall Study|Death|6
1138717|NCT01448850|3739743|P1|Overall Study|Death|3
1138718|NCT01448707|3739768|P2|Overall Study|Other|4
1138719|NCT01448707|3739769|P1|Overall Study|Other|7
1138720|NCT01448707|3739768|P2|Overall Study|Withdrawal by Subject|7
1138721|NCT01448707|3739769|P1|Overall Study|Withdrawal by Subject|6
1138722|NCT01448707|3739768|P2|Overall Study|Lost to Follow-up|6
1138723|NCT01448707|3739769|P1|Overall Study|Lost to Follow-up|2
1138724|NCT01448707|3739768|P2|Overall Study|Adverse Event|1
1138725|NCT01448707|3739769|P1|Overall Study|Adverse Event|3
1138726|NCT01448616|3739790|P4|Study Drug (Treatment Phase)|Withdrawal by Subject|2
1138727|NCT01448616|3739791|P3|Study Drug (Treatment Phase)|Withdrawal by Subject|2
1138728|NCT01448616|3739792|P2|Study Drug (Treatment Phase)|Withdrawal by Subject|1
1138729|NCT01448616|3739793|P1|Study Drug (Treatment Phase)|Withdrawal by Subject|0
1138730|NCT01448616|3739790|P4|Study Drug (Treatment Phase)|Never initiated study drug|2
1138731|NCT01448616|3739791|P3|Study Drug (Treatment Phase)|Never initiated study drug|1
1138732|NCT01448616|3739792|P2|Study Drug (Treatment Phase)|Never initiated study drug|0
1138733|NCT01448616|3739793|P1|Study Drug (Treatment Phase)|Never initiated study drug|0
1138734|NCT01448616|3739790|P4|Study Drug (Treatment Phase)|Adverse Event|0
1138735|NCT01448616|3739791|P3|Study Drug (Treatment Phase)|Adverse Event|1
1138736|NCT01448616|3739792|P2|Study Drug (Treatment Phase)|Adverse Event|1
1138737|NCT01448616|3739793|P1|Study Drug (Treatment Phase)|Adverse Event|0
1138738|NCT01448616|3739790|P4|Lead-In (Observational Phase)|Collected <90% of required swabs|0
1138739|NCT01448616|3739791|P3|Lead-In (Observational Phase)|Collected <90% of required swabs|0
1138740|NCT01448616|3739792|P2|Lead-In (Observational Phase)|Collected <90% of required swabs|0
1138741|NCT01448616|3739793|P1|Lead-In (Observational Phase)|Collected <90% of required swabs|6
1138742|NCT01448616|3739790|P4|Lead-In (Observational Phase)|Collected no genital swabs|0
1138743|NCT01448616|3739791|P3|Lead-In (Observational Phase)|Collected no genital swabs|0
1138744|NCT01448616|3739792|P2|Lead-In (Observational Phase)|Collected no genital swabs|0
1138745|NCT01448616|3739793|P1|Lead-In (Observational Phase)|Collected no genital swabs|3
1138746|NCT01448213|3739840|P2|Overall Study|Protocol Violation|2
1138747|NCT01448213|3739841|P1|Overall Study|Protocol Violation|1
1138748|NCT01448213|3739840|P2|Overall Study|Adverse Event|10
1138749|NCT01448213|3739841|P1|Overall Study|Adverse Event|4
1138750|NCT01448213|3739840|P2|Overall Study|Lost to Follow-up|10
1138751|NCT01448213|3739841|P1|Overall Study|Lost to Follow-up|12
1138752|NCT01448057|3739851|P2|Overall Study|Withdrawal by Subject|0
1138753|NCT01448057|3739852|P1|Overall Study|Withdrawal by Subject|2
1138754|NCT01448057|3739851|P2|Overall Study|Adverse Event|2
1138755|NCT01448057|3739852|P1|Overall Study|Adverse Event|0
1138756|NCT01448057|3739851|P2|Overall Study|Lost to Follow-up|0
1138757|NCT01448057|3739852|P1|Overall Study|Lost to Follow-up|3
1138758|NCT01448057|3739851|P2|Overall Study|Protocol Violation|2
1138759|NCT01448057|3739852|P1|Overall Study|Protocol Violation|3
1138760|NCT01448044|3739862|P2|Follow Up Period|not specified|11
1138761|NCT01448044|3739863|P1|Follow Up Period|not specified|5
1138762|NCT01448044|3739862|P2|Follow Up Period|Lost to Follow-up|2
1138763|NCT01448044|3739863|P1|Follow Up Period|Lost to Follow-up|6
1138764|NCT01448044|3739862|P2|Follow Up Period|Withdrawal by Subject|1
1138765|NCT01448044|3739863|P1|Follow Up Period|Withdrawal by Subject|1
1138766|NCT01448044|3739862|P2|Treatment Period|Other reason|0
1138767|NCT01448044|3739863|P1|Treatment Period|Other reason|2
1138768|NCT01448044|3739862|P2|Treatment Period|Lost to Follow-up|1
1138769|NCT01448044|3739863|P1|Treatment Period|Lost to Follow-up|2
1138770|NCT01448044|3739862|P2|Treatment Period|Participant does not meet study criteria|0
1138771|NCT01448044|3739863|P1|Treatment Period|Participant does not meet study criteria|1
1138772|NCT01448044|3739862|P2|Treatment Period|Completed 24 weeks treatment period only|0
1138773|NCT01448044|3739863|P1|Treatment Period|Completed 24 weeks treatment period only|8
1138774|NCT01448044|3739862|P2|Treatment Period|Subject requested discontinue study drug|0
1138775|NCT01448044|3739863|P1|Treatment Period|Subject requested discontinue study drug|1
1138776|NCT01448044|3739862|P2|Treatment Period|Lack of Efficacy|12
1138777|NCT01448044|3739863|P1|Treatment Period|Lack of Efficacy|5
1138778|NCT01448044|3739862|P2|Treatment Period|Adverse Event|3
1138779|NCT01448044|3739863|P1|Treatment Period|Adverse Event|4
1138780|NCT01447927|3739879|P2|Overall Study|Withdrawal by Subject|0
1138781|NCT01447927|3739880|P1|Overall Study|Withdrawal by Subject|1
1138782|NCT01447927|3739879|P2|Overall Study|Adverse Event|3
1138783|NCT01447927|3739880|P1|Overall Study|Adverse Event|4
1138784|NCT01447719|3739910|P1|Overall Study|Family withdrew autopsy consent|7
1138785|NCT01447719|3739910|P1|Overall Study|Withdrawal by Subject|2
1138786|NCT01447719|3739910|P1|Overall Study|Subject still living at end of study|79
1138787|NCT01447719|3739910|P1|Overall Study|Invalid image or not imaged|3
1138788|NCT01447719|3739910|P1|Overall Study|Image acquisition failure|2
1138789|NCT01447576|3739936|P1|Overall Study|Physician Decision|6
1138790|NCT01447576|3739936|P1|Overall Study|Lack of Efficacy|68
1138791|NCT01447576|3739936|P1|Overall Study|Protocol deviation|83
1138792|NCT01447576|3739936|P1|Overall Study|Withdrawal by Subject|100
1138793|NCT01447576|3739936|P1|Overall Study|Participant met withdrawal criteria|40
1138794|NCT01447576|3739936|P1|Overall Study|Adverse Event|127
1138795|NCT01447576|3739936|P1|Overall Study|Lost to Follow-up|52
1138796|NCT01447446|3739969|P6|Overall Study|Reason not Specified|0
1138797|NCT01447446|3739970|P5|Overall Study|Reason not Specified|1
1138798|NCT01447446|3739971|P4|Overall Study|Reason not Specified|1
1138799|NCT01447446|3739972|P3|Overall Study|Reason not Specified|1
1138800|NCT01447446|3739973|P2|Overall Study|Reason not Specified|1
1138801|NCT01447446|3739974|P1|Overall Study|Reason not Specified|1
1138802|NCT01447446|3739969|P6|Overall Study|New Treatment Started|0
1138803|NCT01447446|3739970|P5|Overall Study|New Treatment Started|2
1138804|NCT01447446|3739971|P4|Overall Study|New Treatment Started|0
1138805|NCT01447446|3739972|P3|Overall Study|New Treatment Started|1
1138806|NCT01447446|3739973|P2|Overall Study|New Treatment Started|2
1138807|NCT01447446|3739974|P1|Overall Study|New Treatment Started|8
1138808|NCT01447446|3739969|P6|Overall Study|SVR12 Assessment|5
1138809|NCT01447446|3739970|P5|Overall Study|SVR12 Assessment|5
1138810|NCT01447446|3739971|P4|Overall Study|SVR12 Assessment|1
1138811|NCT01447446|3739972|P3|Overall Study|SVR12 Assessment|2
1138812|NCT01447446|3739973|P2|Overall Study|SVR12 Assessment|1
1138813|NCT01447446|3739974|P1|Overall Study|SVR12 Assessment|13
1138814|NCT01447446|3739969|P6|Overall Study|Administrative/Other|4
1138815|NCT01447446|3739970|P5|Overall Study|Administrative/Other|33
1138816|NCT01447446|3739971|P4|Overall Study|Administrative/Other|2
1138817|NCT01447446|3739972|P3|Overall Study|Administrative/Other|10
1138818|NCT01447446|3739973|P2|Overall Study|Administrative/Other|9
1138819|NCT01447446|3739974|P1|Overall Study|Administrative/Other|34
1138820|NCT01447446|3739969|P6|Overall Study|Insuff. VR/TRT too Short to Expect VR|14
1138821|NCT01447446|3739970|P5|Overall Study|Insuff. VR/TRT too Short to Expect VR|92
1138822|NCT01447446|3739971|P4|Overall Study|Insuff. VR/TRT too Short to Expect VR|21
1138823|NCT01447446|3739972|P3|Overall Study|Insuff. VR/TRT too Short to Expect VR|52
1138824|NCT01447446|3739973|P2|Overall Study|Insuff. VR/TRT too Short to Expect VR|71
1138825|NCT01447446|3739974|P1|Overall Study|Insuff. VR/TRT too Short to Expect VR|300
1138826|NCT01447446|3739969|P6|Overall Study|Failure to Return/Consent Withdrawn|9
1138827|NCT01447446|3739970|P5|Overall Study|Failure to Return/Consent Withdrawn|69
1138828|NCT01447446|3739971|P4|Overall Study|Failure to Return/Consent Withdrawn|7
1138829|NCT01447446|3739972|P3|Overall Study|Failure to Return/Consent Withdrawn|31
1138830|NCT01447446|3739973|P2|Overall Study|Failure to Return/Consent Withdrawn|78
1138831|NCT01447446|3739974|P1|Overall Study|Failure to Return/Consent Withdrawn|357
1138832|NCT01447446|3739969|P6|Overall Study|Adverse Event|0
1138833|NCT01447446|3739970|P5|Overall Study|Adverse Event|2
1138834|NCT01447446|3739971|P4|Overall Study|Adverse Event|0
1138835|NCT01447446|3739972|P3|Overall Study|Adverse Event|1
1138836|NCT01447446|3739973|P2|Overall Study|Adverse Event|0
1138837|NCT01447446|3739974|P1|Overall Study|Adverse Event|3
1138838|NCT01447446|3739969|P6|Overall Study|Death|0
1138839|NCT01447446|3739970|P5|Overall Study|Death|7
1138840|NCT01447446|3739971|P4|Overall Study|Death|1
1138841|NCT01447446|3739972|P3|Overall Study|Death|2
1138842|NCT01447446|3739973|P2|Overall Study|Death|3
1138843|NCT01447446|3739974|P1|Overall Study|Death|6
1138844|NCT01447433|3740064|P2|Overall Study|Protocol Violation|1
1138845|NCT01447433|3740065|P1|Overall Study|Protocol Violation|1
1138846|NCT01447433|3740064|P2|Overall Study|Withdrawal by Subject|3
1138847|NCT01447433|3740065|P1|Overall Study|Withdrawal by Subject|3
1138848|NCT01447433|3740064|P2|Overall Study|Lost to Follow-up|2
1138849|NCT01447433|3740065|P1|Overall Study|Lost to Follow-up|0
1138850|NCT01447420|3740092|P3|Overall Study|Lack of Efficacy|8
1138851|NCT01447420|3740093|P2|Overall Study|Lack of Efficacy|19
1138852|NCT01447420|3740094|P1|Overall Study|Lack of Efficacy|1
1138853|NCT01447420|3740092|P3|Overall Study|Withdrawal by Subject|0
1138854|NCT01447420|3740093|P2|Overall Study|Withdrawal by Subject|1
1138855|NCT01447420|3740094|P1|Overall Study|Withdrawal by Subject|4
1138856|NCT01447420|3740092|P3|Overall Study|Protocol Violation|0
1138857|NCT01447420|3740093|P2|Overall Study|Protocol Violation|3
1138858|NCT01447420|3740094|P1|Overall Study|Protocol Violation|3
1138859|NCT01447420|3740092|P3|Overall Study|Adverse Event|2
1138860|NCT01447420|3740093|P2|Overall Study|Adverse Event|4
1138861|NCT01447420|3740094|P1|Overall Study|Adverse Event|2
1138862|NCT01446874|3740210|P3|Overall Study|Withdrawal by Subject|4
1138863|NCT01446874|3740211|P2|Overall Study|Withdrawal by Subject|0
1138864|NCT01446874|3740212|P1|Overall Study|Withdrawal by Subject|0
1138955|NCT01445951|3740451|P2|Overall Study|Adverse Event|9
1138865|NCT01446874|3740210|P3|Overall Study|Antibiotics for pre-op infection|2
1138866|NCT01446874|3740211|P2|Overall Study|Antibiotics for pre-op infection|0
1138867|NCT01446874|3740212|P1|Overall Study|Antibiotics for pre-op infection|0
1138868|NCT01446874|3740210|P3|Overall Study|Non-compliance|0
1138869|NCT01446874|3740211|P2|Overall Study|Non-compliance|4
1138870|NCT01446874|3740212|P1|Overall Study|Non-compliance|0
1138871|NCT01446874|3740210|P3|Overall Study|No surgery/No qualifying surgery|12
1138872|NCT01446874|3740211|P2|Overall Study|No surgery/No qualifying surgery|0
1138873|NCT01446874|3740212|P1|Overall Study|No surgery/No qualifying surgery|1
1138874|NCT01446874|3740210|P3|Overall Study|Not eligible|0
1138875|NCT01446874|3740211|P2|Overall Study|Not eligible|0
1138876|NCT01446874|3740212|P1|Overall Study|Not eligible|1
1138877|NCT01446796|3740238|P2|Overall Study|Withdrawal by Subject|0
1138878|NCT01446796|3740239|P1|Overall Study|Withdrawal by Subject|1
1138879|NCT01446419|3740264|P2|Overall Study|Terminated per protocol|0
1138880|NCT01446419|3740265|P1|Overall Study|Terminated per protocol|3
1138881|NCT01446419|3740264|P2|Overall Study|Withdrawal by Subject|1
1138882|NCT01446419|3740265|P1|Overall Study|Withdrawal by Subject|1
1138883|NCT01446419|3740264|P2|Overall Study|Death|0
1138884|NCT01446419|3740265|P1|Overall Study|Death|1
1138885|NCT01446289|3740279|P4|Overall Study|Withdrawal by Subject|0
1138886|NCT01446289|3740280|P3|Overall Study|Withdrawal by Subject|1
1138887|NCT01446289|3740281|P2|Overall Study|Withdrawal by Subject|0
1138888|NCT01446289|3740282|P1|Overall Study|Withdrawal by Subject|1
1138889|NCT01446237|3740325|P1|Overall Study|Withdrawal by Subject|7
1138890|NCT01446237|3740325|P1|Overall Study|Lost to Follow-up|2
1138891|NCT01446237|3740325|P1|Overall Study|Adverse Event|1
1138892|NCT01446159|3740337|P4|Overall Study|Not specified|13
1138893|NCT01446159|3740338|P3|Overall Study|Not specified|14
1138894|NCT01446159|3740339|P2|Overall Study|Not specified|0
1138895|NCT01446159|3740340|P1|Overall Study|Not specified|0
1138896|NCT01446159|3740337|P4|Overall Study|Death|36
1138897|NCT01446159|3740338|P3|Overall Study|Death|43
1138898|NCT01446159|3740339|P2|Overall Study|Death|3
1138899|NCT01446159|3740340|P1|Overall Study|Death|2
1138900|NCT01446159|3740337|P4|Overall Study|Lost to Follow-up|2
1138901|NCT01446159|3740338|P3|Overall Study|Lost to Follow-up|1
1138902|NCT01446159|3740339|P2|Overall Study|Lost to Follow-up|0
1138903|NCT01446159|3740340|P1|Overall Study|Lost to Follow-up|0
1138904|NCT01446159|3740337|P4|Overall Study|Withdrawal by Subject|11
1138905|NCT01446159|3740338|P3|Overall Study|Withdrawal by Subject|14
1138906|NCT01446159|3740339|P2|Overall Study|Withdrawal by Subject|0
1138907|NCT01446159|3740340|P1|Overall Study|Withdrawal by Subject|1
1138908|NCT01446042|3740415|P3|Overall Study|Other reasons|1
1138909|NCT01446042|3740416|P2|Overall Study|Other reasons|1
1138910|NCT01446042|3740417|P1|Overall Study|Other reasons|2
1138911|NCT01446042|3740415|P3|Overall Study|Lost to Follow-up|0
1138912|NCT01446042|3740416|P2|Overall Study|Lost to Follow-up|0
1138913|NCT01446042|3740417|P1|Overall Study|Lost to Follow-up|5
1138914|NCT01446042|3740415|P3|Overall Study|Adverse Event|4
1138915|NCT01446042|3740416|P2|Overall Study|Adverse Event|0
1138916|NCT01446042|3740417|P1|Overall Study|Adverse Event|1
1138917|NCT01446042|3740415|P3|Overall Study|Withdrawal by Subject|4
1138918|NCT01446042|3740416|P2|Overall Study|Withdrawal by Subject|2
1138919|NCT01446042|3740417|P1|Overall Study|Withdrawal by Subject|12
1138920|NCT01446003|3740428|P2|Period 2|Adverse Event|0
1138921|NCT01446003|3740429|P1|Period 2|Adverse Event|1
1138922|NCT01446003|3740428|P2|Period 1|Protocol Violation|0
1138923|NCT01446003|3740429|P1|Period 1|Protocol Violation|2
1138924|NCT01445951|3740450|P3|Overall Study|Cough|0
1138925|NCT01445951|3740451|P2|Overall Study|Cough|1
1138926|NCT01445951|3740452|P1|Overall Study|Cough|0
1138927|NCT01445951|3740450|P3|Overall Study|Sponsor decision - subject travel|0
1138928|NCT01445951|3740451|P2|Overall Study|Sponsor decision - subject travel|1
1138929|NCT01445951|3740452|P1|Overall Study|Sponsor decision - subject travel|0
1138930|NCT01445951|3740450|P3|Overall Study|Non-compliance with protocol|0
1138931|NCT01445951|3740451|P2|Overall Study|Non-compliance with protocol|1
1138932|NCT01445951|3740452|P1|Overall Study|Non-compliance with protocol|0
1138933|NCT01445951|3740450|P3|Overall Study|Non-compliance with study drug|0
1138934|NCT01445951|3740451|P2|Overall Study|Non-compliance with study drug|2
1138935|NCT01445951|3740452|P1|Overall Study|Non-compliance with study drug|1
1138936|NCT01445951|3740450|P3|Overall Study|Death|1
1138937|NCT01445951|3740451|P2|Overall Study|Death|0
1138938|NCT01445951|3740452|P1|Overall Study|Death|0
1138939|NCT01445951|3740450|P3|Overall Study|Pregnancy|4
1138940|NCT01445951|3740451|P2|Overall Study|Pregnancy|1
1138941|NCT01445951|3740452|P1|Overall Study|Pregnancy|0
1138942|NCT01445951|3740450|P3|Overall Study|Lost to Follow-up|4
1138943|NCT01445951|3740451|P2|Overall Study|Lost to Follow-up|2
1138944|NCT01445951|3740452|P1|Overall Study|Lost to Follow-up|1
1138945|NCT01445951|3740450|P3|Overall Study|Physician Decision|0
1138946|NCT01445951|3740451|P2|Overall Study|Physician Decision|1
1138947|NCT01445951|3740452|P1|Overall Study|Physician Decision|3
1138948|NCT01445951|3740450|P3|Overall Study|Withdrawal by Subject|8
1138949|NCT01445951|3740451|P2|Overall Study|Withdrawal by Subject|16
1138950|NCT01445951|3740452|P1|Overall Study|Withdrawal by Subject|21
1138951|NCT01445951|3740450|P3|Overall Study|Protocol Violation|2
1138952|NCT01445951|3740451|P2|Overall Study|Protocol Violation|2
1138953|NCT01445951|3740452|P1|Overall Study|Protocol Violation|2
1138954|NCT01445951|3740450|P3|Overall Study|Adverse Event|0
1138956|NCT01445951|3740452|P1|Overall Study|Adverse Event|16
1138957|NCT01445847|3740520|P2|Overall Study|Missed Data|0
1138958|NCT01445847|3740521|P1|Overall Study|Missed Data|1
1138959|NCT01445847|3740520|P2|Overall Study|Protocol Violation|14
1138960|NCT01445847|3740521|P1|Overall Study|Protocol Violation|13
1138961|NCT01445769|3740527|P1|Overall Study|Lost to Follow-up|5
1138962|NCT01445769|3740527|P1|Overall Study|Disease Progression|1
1138963|NCT01445769|3740527|P1|Overall Study|Consent Withdrawn|2
1138964|NCT01445678|3740547|P2|Overall Study|Withdrawal by Subject|5
1138965|NCT01445678|3740548|P1|Overall Study|Withdrawal by Subject|9
1138966|NCT01445678|3740547|P2|Overall Study|Protocol Violation|1
1138967|NCT01445678|3740548|P1|Overall Study|Protocol Violation|1
1138968|NCT01445678|3740547|P2|Overall Study|Lost to Follow-up|5
1138969|NCT01445678|3740548|P1|Overall Study|Lost to Follow-up|8
1138970|NCT01445678|3740547|P2|Overall Study|Lack of Efficacy|2
1138971|NCT01445678|3740548|P1|Overall Study|Lack of Efficacy|0
1138972|NCT01445678|3740547|P2|Overall Study|Adverse Event|8
1138973|NCT01445678|3740548|P1|Overall Study|Adverse Event|12
1138974|NCT01445652|3740566|P2|Overall Study|Adverse Event|0
1138975|NCT01445652|3740567|P1|Overall Study|Adverse Event|1
1138976|NCT01445652|3740566|P2|Overall Study|Failed teach session|0
1138977|NCT01445652|3740567|P1|Overall Study|Failed teach session|2
1138978|NCT01445652|3740566|P2|Overall Study|Failed to attend scheduled visit|3
1138979|NCT01445652|3740567|P1|Overall Study|Failed to attend scheduled visit|2
1138980|NCT01445652|3740566|P2|Overall Study|Not comfortable in lenses|0
1138981|NCT01445652|3740567|P1|Overall Study|Not comfortable in lenses|5
1138982|NCT01445613|3740585|P1|1-year Follow-up|Received a non-study stent|2
1138983|NCT01445613|3740585|P1|1-year Follow-up|Physician Decision|2
1138984|NCT01445613|3740585|P1|1-year Follow-up|Death|30
1138985|NCT01445613|3740585|P1|1-year Follow-up|Lost to Follow-up|2
1138986|NCT01445613|3740585|P1|1-year Follow-up|Missed visit|29
1138987|NCT01445613|3740585|P1|1-year Follow-up|Withdrawal by Subject|12
1138988|NCT01445613|3740585|P1|30-day Follow-up|Death|3
1138989|NCT01445613|3740585|P1|30-day Follow-up|Missed visit|23
1138990|NCT01445613|3740585|P1|30-day Follow-up|Physician Decision|3
1138991|NCT01445613|3740585|P1|30-day Follow-up|Withdrawal by Subject|6
1138992|NCT01445548|3740603|P1|Overall Study|Adverse Event|1
1138993|NCT01445301|3740627|P3|Overall Study|Withdrawal by Subject|4
1138994|NCT01445301|3740628|P2|Overall Study|Withdrawal by Subject|6
1138995|NCT01445301|3740629|P1|Overall Study|Withdrawal by Subject|5
1138996|NCT01445301|3740627|P3|Overall Study|Physician Decision|0
1138997|NCT01445301|3740628|P2|Overall Study|Physician Decision|2
1138998|NCT01445301|3740629|P1|Overall Study|Physician Decision|0
1138999|NCT01445301|3740627|P3|Overall Study|Protocol-Defined Stopping Criteria|1
1139000|NCT01445301|3740628|P2|Overall Study|Protocol-Defined Stopping Criteria|1
1139001|NCT01445301|3740629|P1|Overall Study|Protocol-Defined Stopping Criteria|0
1139002|NCT01445301|3740627|P3|Overall Study|Protocol Violation|0
1139003|NCT01445301|3740628|P2|Overall Study|Protocol Violation|0
1139004|NCT01445301|3740629|P1|Overall Study|Protocol Violation|1
1139005|NCT01445301|3740627|P3|Overall Study|Lack of Efficacy|0
1139006|NCT01445301|3740628|P2|Overall Study|Lack of Efficacy|1
1139007|NCT01445301|3740629|P1|Overall Study|Lack of Efficacy|0
1139008|NCT01445301|3740627|P3|Overall Study|Adverse Event|4
1139009|NCT01445301|3740628|P2|Overall Study|Adverse Event|25
1139010|NCT01445301|3740629|P1|Overall Study|Adverse Event|15
1139011|NCT01444898|3740699|P1|Overall Study|Withdrawal by Subject|1
1139012|NCT01444781|3740714|P3|Overall Study|Withdrawal by Subject|2
1139013|NCT01444781|3740715|P2|Overall Study|Withdrawal by Subject|1
1139014|NCT01444781|3740716|P1|Overall Study|Withdrawal by Subject|3
1139015|NCT01444781|3740714|P3|Overall Study|Lost to Follow-up|1
1139016|NCT01444781|3740715|P2|Overall Study|Lost to Follow-up|3
1139017|NCT01444781|3740716|P1|Overall Study|Lost to Follow-up|0
1139018|NCT01444742|3740754|P1|Overall Study|Death|1
1139019|NCT01444651|3740761|P2|Overall Study|Missing data|1
1139020|NCT01444651|3740762|P1|Overall Study|Missing data|1
1139021|NCT01444651|3740761|P2|Overall Study|Non-fasting|1
1139022|NCT01444651|3740762|P1|Overall Study|Non-fasting|2
1139023|NCT01444651|3740761|P2|Overall Study|Lost to Follow-up|5
1139024|NCT01444651|3740762|P1|Overall Study|Lost to Follow-up|5
1139025|NCT01444651|3740761|P2|Overall Study|Adverse Event|2
1139026|NCT01444651|3740762|P1|Overall Study|Adverse Event|3
1139027|NCT01444456|3740778|P1|Overall Study|Not treated|104
1139028|NCT01444456|3740778|P1|Overall Study|Other|18
1139029|NCT01444456|3740778|P1|Overall Study|Ineligibility determined|23
1139030|NCT01444456|3740778|P1|Overall Study|Death|73
1139031|NCT01444456|3740778|P1|Overall Study|Lost to Follow-up|37
1139032|NCT01444456|3740778|P1|Overall Study|Physician Decision|9
1139033|NCT01444456|3740778|P1|Overall Study|Withdrawal by Subject|21
1139034|NCT01444430|3740789|P2|Overall Study|CRF termination module not completed.|1
1139035|NCT01444430|3740790|P1|Overall Study|CRF termination module not completed.|0
1139036|NCT01444430|3740789|P2|Overall Study|Lost to Follow-up|0
1139037|NCT01444430|3740790|P1|Overall Study|Lost to Follow-up|2
1139038|NCT01444430|3740789|P2|Overall Study|Death|8
1139039|NCT01444430|3740790|P1|Overall Study|Death|6
1139040|NCT01444430|3740789|P2|Overall Study|Withdrawal by Subject|72
1139041|NCT01444430|3740790|P1|Overall Study|Withdrawal by Subject|53
1139042|NCT01444417|3740812|P2|Overall Study|Withdrawal by Subject|0
1139043|NCT01444417|3740813|P1|Overall Study|Withdrawal by Subject|2
1139044|NCT01444417|3740812|P2|Overall Study|Ineligibility Determined|1
1139045|NCT01444417|3740813|P1|Overall Study|Ineligibility Determined|0
1139046|NCT01444391|3740829|P1|Overall Study|Death|1
1139047|NCT01444378|3740837|P1|Overall Study|Missed Visits|10
1139048|NCT01444378|3740837|P1|Overall Study|Administrative Closure Of The Study|2
1139049|NCT01444378|3740837|P1|Overall Study|Death|3
1139050|NCT01444378|3740837|P1|Overall Study|Withdrawal by Subject|1
1139051|NCT01444378|3740837|P1|Overall Study|Lost to Follow-up|1
1139052|NCT01444300|3740949|P2|Overall Study|Adverse Event|0
1139053|NCT01444300|3740950|P1|Overall Study|Adverse Event|4
1139054|NCT01444092|3740982|P1|Overall Study|Other Eligibility criteria|7
1139055|NCT01444092|3740982|P1|Overall Study|Withdrawal by Subject|1
1139056|NCT01444092|3740982|P1|Overall Study|Protocol Violation|1
1139057|NCT01444092|3740982|P1|Overall Study|Adverse Event|8
1139058|NCT01444027|3740991|P3|Overall Study|Lost to Follow-up|14
1139059|NCT01444027|3740992|P2|Overall Study|Lost to Follow-up|20
1139060|NCT01444027|3740993|P1|Overall Study|Lost to Follow-up|26
1139061|NCT01444027|3740991|P3|Overall Study|Withdrawal by Subject|24
1139062|NCT01444027|3740992|P2|Overall Study|Withdrawal by Subject|10
1139063|NCT01444027|3740993|P1|Overall Study|Withdrawal by Subject|4
1139064|NCT01443923|3741015|P2|Overall Study|Adverse Event|0
1139065|NCT01443923|3741016|P1|Overall Study|Adverse Event|1
1139066|NCT01443858|3741033|P3|Overall Study|Lost to Follow-up|2
1139067|NCT01443858|3741034|P2|Overall Study|Lost to Follow-up|5
1139068|NCT01443858|3741035|P1|Overall Study|Lost to Follow-up|5
1139069|NCT01443858|3741033|P3|Overall Study|Lack of Efficacy|0
1139070|NCT01443858|3741034|P2|Overall Study|Lack of Efficacy|0
1139071|NCT01443858|3741035|P1|Overall Study|Lack of Efficacy|1
1139072|NCT01443858|3741033|P3|Overall Study|Withdrawal by Subject|5
1139073|NCT01443858|3741034|P2|Overall Study|Withdrawal by Subject|8
1139074|NCT01443858|3741035|P1|Overall Study|Withdrawal by Subject|9
1139075|NCT01443845|3741057|P2|Overall Study|Lost to Follow-up|13
1139076|NCT01443845|3741058|P1|Overall Study|Lost to Follow-up|9
1139077|NCT01443845|3741057|P2|Overall Study|Military Conflict - Site Terminated|21
1139078|NCT01443845|3741058|P1|Overall Study|Military Conflict - Site Terminated|20
1139079|NCT01443845|3741057|P2|Overall Study|Withdrawal by Subject|67
1139080|NCT01443845|3741058|P1|Overall Study|Withdrawal by Subject|63
1139081|NCT01443845|3741057|P2|Overall Study|Adverse Event|138
1139082|NCT01443845|3741058|P1|Overall Study|Adverse Event|64
1139083|NCT01443845|3741057|P2|Overall Study|Lack of Efficacy|5
1139084|NCT01443845|3741058|P1|Overall Study|Lack of Efficacy|10
1139085|NCT01443845|3741057|P2|Overall Study|Deterioration in pulmonary function|4
1139086|NCT01443845|3741058|P1|Overall Study|Deterioration in pulmonary function|1
1139087|NCT01443845|3741057|P2|Overall Study|Other reasons, such as COPD exacerbation|44
1139088|NCT01443845|3741058|P1|Overall Study|Other reasons, such as COPD exacerbation|44
1139089|NCT01443845|3741057|P2|Overall Study|Protocol Violation|45
1139090|NCT01443845|3741058|P1|Overall Study|Protocol Violation|43
1139091|NCT01443403|3741079|P4|Overall Study|Other - Miscellaneous|1
1139092|NCT01443403|3741080|P3|Overall Study|Other - Miscellaneous|0
1139093|NCT01443403|3741081|P2|Overall Study|Other - Miscellaneous|0
1139094|NCT01443403|3741082|P1|Overall Study|Other - Miscellaneous|1
1139095|NCT01443403|3741079|P4|Overall Study|Use of Prohibited Treatment|0
1139096|NCT01443403|3741080|P3|Overall Study|Use of Prohibited Treatment|0
1139097|NCT01443403|3741081|P2|Overall Study|Use of Prohibited Treatment|3
1139098|NCT01443403|3741082|P1|Overall Study|Use of Prohibited Treatment|2
1139099|NCT01443403|3741079|P4|Overall Study|Protocol Violation|1
1139100|NCT01443403|3741080|P3|Overall Study|Protocol Violation|1
1139101|NCT01443403|3741081|P2|Overall Study|Protocol Violation|1
1139102|NCT01443403|3741082|P1|Overall Study|Protocol Violation|2
1139103|NCT01443403|3741079|P4|Overall Study|Lost to Follow-up|1
1139104|NCT01443403|3741080|P3|Overall Study|Lost to Follow-up|0
1139105|NCT01443403|3741081|P2|Overall Study|Lost to Follow-up|0
1139106|NCT01443403|3741082|P1|Overall Study|Lost to Follow-up|0
1139107|NCT01443403|3741079|P4|Overall Study|Withdrawal by Subject|1
1139108|NCT01443403|3741080|P3|Overall Study|Withdrawal by Subject|2
1139109|NCT01443403|3741081|P2|Overall Study|Withdrawal by Subject|1
1139110|NCT01443403|3741082|P1|Overall Study|Withdrawal by Subject|0
1139111|NCT01443403|3741079|P4|Overall Study|Adverse Event|5
1139112|NCT01443403|3741080|P3|Overall Study|Adverse Event|4
1139113|NCT01443403|3741081|P2|Overall Study|Adverse Event|1
1139114|NCT01443403|3741082|P1|Overall Study|Adverse Event|1
1139115|NCT01443364|3741229|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
1139116|NCT01443364|3741229|P1|Overall Study|AE, non-serious non-fatal|8
1139117|NCT01443364|3741229|P1|Overall Study|SAE, non-fatal|6
1139118|NCT01443364|3741229|P1|Overall Study|Other Reason|4
1139119|NCT01443364|3741229|P1|Overall Study|Withdrawal by Subject|5
1139120|NCT01443364|3741229|P1|Overall Study|Lost to Follow-up|3
1139121|NCT01443364|3741229|P1|Overall Study|Lack of Efficacy|14
1139122|NCT01443130|3741358|P6|Overall Study|Death of Subject's Infant|0
1139123|NCT01443130|3741359|P5|Overall Study|Death of Subject's Infant|0
1139124|NCT01443130|3741360|P4|Overall Study|Death of Subject's Infant|0
1139125|NCT01443130|3741361|P3|Overall Study|Death of Subject's Infant|11
1139126|NCT01443130|3741362|P2|Overall Study|Death of Subject's Infant|10
1139127|NCT01443130|3741363|P1|Overall Study|Death of Subject's Infant|5
1139128|NCT01443130|3741358|P6|Overall Study|Withdrawal by Subject|2
1139129|NCT01443130|3741359|P5|Overall Study|Withdrawal by Subject|7
1139130|NCT01443130|3741360|P4|Overall Study|Withdrawal by Subject|7
1139131|NCT01443130|3741361|P3|Overall Study|Withdrawal by Subject|12
1139132|NCT01443130|3741362|P2|Overall Study|Withdrawal by Subject|14
1139133|NCT01443130|3741363|P1|Overall Study|Withdrawal by Subject|15
1139134|NCT01443130|3741358|P6|Overall Study|Protocol Violation|3
1139135|NCT01443130|3741359|P5|Overall Study|Protocol Violation|2
1139136|NCT01443130|3741360|P4|Overall Study|Protocol Violation|2
1139137|NCT01443130|3741361|P3|Overall Study|Protocol Violation|3
1139138|NCT01443130|3741362|P2|Overall Study|Protocol Violation|1
1139139|NCT01443130|3741363|P1|Overall Study|Protocol Violation|2
1139140|NCT01443130|3741358|P6|Overall Study|Adverse Event|0
1139141|NCT01443130|3741359|P5|Overall Study|Adverse Event|0
1139142|NCT01443130|3741360|P4|Overall Study|Adverse Event|0
1139143|NCT01443130|3741361|P3|Overall Study|Adverse Event|1
1139144|NCT01443130|3741362|P2|Overall Study|Adverse Event|1
1139145|NCT01443130|3741363|P1|Overall Study|Adverse Event|2
1139146|NCT01443130|3741358|P6|Overall Study|Death|8
1139147|NCT01443130|3741359|P5|Overall Study|Death|10
1139148|NCT01443130|3741360|P4|Overall Study|Death|7
1139149|NCT01443130|3741361|P3|Overall Study|Death|0
1139150|NCT01443130|3741362|P2|Overall Study|Death|1
1139151|NCT01443130|3741363|P1|Overall Study|Death|0
1139152|NCT01443130|3741358|P6|Overall Study|Lost to Follow-up|21
1139153|NCT01443130|3741359|P5|Overall Study|Lost to Follow-up|25
1139154|NCT01443130|3741360|P4|Overall Study|Lost to Follow-up|23
1139155|NCT01443130|3741361|P3|Overall Study|Lost to Follow-up|50
1139156|NCT01443130|3741362|P2|Overall Study|Lost to Follow-up|42
1139157|NCT01443130|3741363|P1|Overall Study|Lost to Follow-up|44
1139158|NCT01443078|3741413|P1|Overall Study|Patient had brain mets|1
1139159|NCT01443078|3741413|P1|Overall Study|Withdrawal by Subject|1
1139160|NCT01443078|3741413|P1|Overall Study|Responded to neoadjuvant platinum txt|27
1139161|NCT01443026|3741420|P2|Overall Study|Lost to Follow-up|1
1139162|NCT01443026|3741421|P1|Overall Study|Lost to Follow-up|2
1139163|NCT01443026|3741420|P2|Overall Study|Withdrawal by Subject|3
1139164|NCT01443026|3741421|P1|Overall Study|Withdrawal by Subject|0
1139165|NCT01443026|3741420|P2|Overall Study|Death|1
1139166|NCT01443026|3741421|P1|Overall Study|Death|0
1139167|NCT01443026|3741420|P2|Overall Study|Physician Decision|0
1139168|NCT01443026|3741421|P1|Overall Study|Physician Decision|1
1139169|NCT01442779|3741436|P1|Overall Study|Non-compliance|1
1139170|NCT01442779|3741436|P1|Overall Study|Death|3
1139171|NCT01442779|3741436|P1|Overall Study|Withdrawal by Subject|3
1139172|NCT01442714|3741442|P1|Overall Study|Withdrawal by Subject|1
1139173|NCT01442714|3741442|P1|Overall Study|Death|11
1139174|NCT01442688|3741450|P2|Second Intervention|Adverse Event|0
1139175|NCT01442688|3741451|P1|Second Intervention|Adverse Event|1
1139176|NCT01442688|3741450|P2|First Intervention|subject incarcerated|0
1139177|NCT01442688|3741451|P1|First Intervention|subject incarcerated|1
1139178|NCT01442688|3741450|P2|First Intervention|Withdrawal by Subject|0
1139179|NCT01442688|3741451|P1|First Intervention|Withdrawal by Subject|1
1139180|NCT01442675|3741459|P1|Overall Study|Withdrawal by Subject|4
1139181|NCT01442675|3741459|P1|Overall Study|Lost to Follow-up|2
1139182|NCT01442675|3741459|P1|Overall Study|Protocol Violation|6
1139183|NCT01442493|3741471|P2|Overall Study|withdrawn from study|2
1139184|NCT01442493|3741472|P1|Overall Study|withdrawn from study|3
1139185|NCT01442376|3741493|P3|Overall Study|Not eligible for subsequent cycles|0
1139186|NCT01442376|3741494|P2|Overall Study|Not eligible for subsequent cycles|2
1139187|NCT01442376|3741495|P1|Overall Study|Not eligible for subsequent cycles|1
1139188|NCT01442376|3741493|P3|Overall Study|Patients not treated|1
1139189|NCT01442376|3741494|P2|Overall Study|Patients not treated|3
1139190|NCT01442376|3741495|P1|Overall Study|Patients not treated|2
1139191|NCT01442376|3741493|P3|Overall Study|Withdrawal of consent|1
1139192|NCT01442376|3741494|P2|Overall Study|Withdrawal of consent|0
1139193|NCT01442376|3741495|P1|Overall Study|Withdrawal of consent|0
1139194|NCT01442376|3741493|P3|Overall Study|Death|1
1139195|NCT01442376|3741494|P2|Overall Study|Death|1
1139196|NCT01442376|3741495|P1|Overall Study|Death|0
1139197|NCT01442376|3741493|P3|Overall Study|Adverse Event|2
1139198|NCT01442376|3741494|P2|Overall Study|Adverse Event|3
1139199|NCT01442376|3741495|P1|Overall Study|Adverse Event|0
1139200|NCT01442181|3741508|P2|Overall Study|atrial fibrillation not noted|1
1139201|NCT01442181|3741509|P1|Overall Study|atrial fibrillation not noted|0
1139202|NCT01442181|3741508|P2|Overall Study|patient in an additional study|0
1139203|NCT01442181|3741509|P1|Overall Study|patient in an additional study|1
1139204|NCT01442181|3741508|P2|Overall Study|Lost to Follow-up|1
1139205|NCT01442181|3741509|P1|Overall Study|Lost to Follow-up|1
1139206|NCT01442181|3741508|P2|Overall Study|low ejection factor|1
1139207|NCT01442181|3741509|P1|Overall Study|low ejection factor|0
1139208|NCT01442181|3741508|P2|Overall Study|no insurance for surgery|0
1139209|NCT01442181|3741509|P1|Overall Study|no insurance for surgery|1
1139210|NCT01442181|3741508|P2|Overall Study|patient refused surgery|0
1139211|NCT01442181|3741509|P1|Overall Study|patient refused surgery|1
1139212|NCT01442155|3741533|P1|Overall Study|Lost to Follow-up|2
1139213|NCT01442155|3741533|P1|Overall Study|Adverse Event|2
1139214|NCT01442155|3741533|P1|Overall Study|Recurrence|26
1139215|NCT01442155|3741533|P1|Overall Study|Complete remission|35
1139216|NCT01442103|3741549|P1|Overall Study|Lost to Follow-up|2
1139217|NCT01442064|3741559|P6|Overall Study|Condition mandated other intervention|2
1139218|NCT01442064|3741560|P5|Overall Study|Condition mandated other intervention|0
1139219|NCT01442064|3741561|P4|Overall Study|Condition mandated other intervention|0
1139220|NCT01442064|3741562|P3|Overall Study|Condition mandated other intervention|2
1139221|NCT01442064|3741563|P2|Overall Study|Condition mandated other intervention|1
1139222|NCT01442064|3741564|P1|Overall Study|Condition mandated other intervention|1
1139223|NCT01442064|3741559|P6|Overall Study|Subject non-compliance|2
1139224|NCT01442064|3741560|P5|Overall Study|Subject non-compliance|0
1139225|NCT01442064|3741561|P4|Overall Study|Subject non-compliance|0
1139226|NCT01442064|3741562|P3|Overall Study|Subject non-compliance|0
1139227|NCT01442064|3741563|P2|Overall Study|Subject non-compliance|0
1139228|NCT01442064|3741564|P1|Overall Study|Subject non-compliance|0
1139229|NCT01442064|3741559|P6|Overall Study|Sponsor decision|87
1139230|NCT01442064|3741560|P5|Overall Study|Sponsor decision|95
1139231|NCT01442064|3741561|P4|Overall Study|Sponsor decision|88
1139232|NCT01442064|3741562|P3|Overall Study|Sponsor decision|92
1139233|NCT01442064|3741563|P2|Overall Study|Sponsor decision|88
1139234|NCT01442064|3741564|P1|Overall Study|Sponsor decision|82
1139235|NCT01442064|3741559|P6|Overall Study|Withdrawal by Subject|1
1139236|NCT01442064|3741560|P5|Overall Study|Withdrawal by Subject|2
1139237|NCT01442064|3741561|P4|Overall Study|Withdrawal by Subject|2
1139238|NCT01442064|3741562|P3|Overall Study|Withdrawal by Subject|2
1139239|NCT01442064|3741563|P2|Overall Study|Withdrawal by Subject|3
1139240|NCT01442064|3741564|P1|Overall Study|Withdrawal by Subject|6
1139241|NCT01442064|3741559|P6|Overall Study|Physician Decision|1
1139242|NCT01442064|3741560|P5|Overall Study|Physician Decision|3
1139243|NCT01442064|3741561|P4|Overall Study|Physician Decision|3
1139244|NCT01442064|3741562|P3|Overall Study|Physician Decision|2
1139245|NCT01442064|3741563|P2|Overall Study|Physician Decision|1
1139246|NCT01442064|3741564|P1|Overall Study|Physician Decision|1
1139247|NCT01442064|3741559|P6|Overall Study|Lost to Follow-up|3
1139248|NCT01442064|3741560|P5|Overall Study|Lost to Follow-up|3
1139249|NCT01442064|3741561|P4|Overall Study|Lost to Follow-up|1
1139250|NCT01442064|3741562|P3|Overall Study|Lost to Follow-up|1
1139251|NCT01442064|3741563|P2|Overall Study|Lost to Follow-up|5
1139252|NCT01442064|3741564|P1|Overall Study|Lost to Follow-up|5
1139253|NCT01442064|3741559|P6|Overall Study|Death|3
1139254|NCT01442064|3741560|P5|Overall Study|Death|1
1139255|NCT01442064|3741561|P4|Overall Study|Death|3
1139256|NCT01442064|3741562|P3|Overall Study|Death|3
1139257|NCT01442064|3741563|P2|Overall Study|Death|1
1139258|NCT01442064|3741564|P1|Overall Study|Death|0
1139259|NCT01442064|3741559|P6|Overall Study|Adverse Event|0
1139260|NCT01442064|3741560|P5|Overall Study|Adverse Event|2
1139261|NCT01442064|3741561|P4|Overall Study|Adverse Event|1
1139262|NCT01442064|3741562|P3|Overall Study|Adverse Event|2
1139263|NCT01442064|3741563|P2|Overall Study|Adverse Event|2
1139264|NCT01442064|3741564|P1|Overall Study|Adverse Event|2
1139265|NCT01442038|3741601|P2|Overall Study|Study Terminated By Sponsor|3
1139266|NCT01442038|3741602|P1|Overall Study|Study Terminated By Sponsor|2
1139267|NCT01442038|3741601|P2|Overall Study|Investigator's Discretion|16
1139268|NCT01442038|3741602|P1|Overall Study|Investigator's Discretion|13
1139269|NCT01442038|3741601|P2|Overall Study|Protocol Deviation|20
1139270|NCT01442038|3741602|P1|Overall Study|Protocol Deviation|9
1139271|NCT01442038|3741601|P2|Overall Study|Adverse Event|15
1139272|NCT01442038|3741602|P1|Overall Study|Adverse Event|26
1139273|NCT01442038|3741601|P2|Overall Study|Lost to Follow-up|51
1139274|NCT01442038|3741602|P1|Overall Study|Lost to Follow-up|37
1139275|NCT01442038|3741601|P2|Overall Study|Participant Withdrew Consent|102
1139276|NCT01442038|3741602|P1|Overall Study|Participant Withdrew Consent|137
1139277|NCT01442038|3741601|P2|Overall Study|Investigator-Initiated Early Closure|43
1139278|NCT01442038|3741602|P1|Overall Study|Investigator-Initiated Early Closure|44
1139279|NCT01442038|3741601|P2|Overall Study|Death|29
1139280|NCT01442038|3741602|P1|Overall Study|Death|35
1139281|NCT01441973|3741616|P2|Overall Study|Participant withdrew consent|1
1139282|NCT01441973|3741617|P1|Overall Study|Participant withdrew consent|0
1139283|NCT01441973|3741616|P2|Overall Study|Administrative reason by sponsor|5
1139284|NCT01441973|3741617|P1|Overall Study|Administrative reason by sponsor|3
1139285|NCT01441973|3741616|P2|Overall Study|Poor compliance/noncompliance|1
1139286|NCT01441973|3741617|P1|Overall Study|Poor compliance/noncompliance|0
1139287|NCT01441973|3741616|P2|Overall Study|Participant request to discontinue|1
1139288|NCT01441973|3741617|P1|Overall Study|Participant request to discontinue|1
1139289|NCT01441973|3741616|P2|Overall Study|Adverse event unrelated to study drug|2
1139290|NCT01441973|3741617|P1|Overall Study|Adverse event unrelated to study drug|3
1139291|NCT01441973|3741616|P2|Overall Study|Disease progression|6
1139292|NCT01441973|3741617|P1|Overall Study|Disease progression|8
1139293|NCT01441960|3741639|P2|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0
1139294|NCT01441960|3741640|P1|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1
1139295|NCT01441960|3741639|P2|First Neuromuscular Blocking Agent:|Protocol Violation|1
1139296|NCT01441960|3741640|P1|First Neuromuscular Blocking Agent:|Protocol Violation|1
1139297|NCT01441960|3741639|P2|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5
1139298|NCT01441960|3741640|P1|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6
1139299|NCT01441765|3741665|P2|Overall Study|Death|0
1139300|NCT01441765|3741666|P1|Overall Study|Death|1
1139301|NCT01441596|3741683|P3|Overall Study|Not treated|1
1139302|NCT01441596|3741684|P2|Overall Study|Not treated|1
1139303|NCT01441596|3741685|P1|Overall Study|Not treated|0
1139304|NCT01441596|3741683|P3|Overall Study|Withdrawal by Subject|2
1139305|NCT01441596|3741684|P2|Overall Study|Withdrawal by Subject|0
1139306|NCT01441596|3741685|P1|Overall Study|Withdrawal by Subject|4
1139307|NCT01441596|3741683|P3|Overall Study|Other reason not defined below|1
1139308|NCT01441596|3741684|P2|Overall Study|Other reason not defined below|2
1139309|NCT01441596|3741685|P1|Overall Study|Other reason not defined below|0
1139310|NCT01441440|3741732|P3|Overall Study|Difficllty in keeping the schedule|0
1139311|NCT01441440|3741733|P2|Overall Study|Difficllty in keeping the schedule|1
1139312|NCT01441440|3741734|P1|Overall Study|Difficllty in keeping the schedule|1
1139313|NCT01441440|3741732|P3|Overall Study|Work-related matter|0
1139314|NCT01441440|3741733|P2|Overall Study|Work-related matter|1
1139315|NCT01441440|3741734|P1|Overall Study|Work-related matter|0
1139316|NCT01441440|3741732|P3|Overall Study|Moving|1
1139317|NCT01441440|3741733|P2|Overall Study|Moving|1
1139318|NCT01441440|3741734|P1|Overall Study|Moving|0
1139319|NCT01441440|3741732|P3|Overall Study|Lack of Efficacy|1
1139320|NCT01441440|3741733|P2|Overall Study|Lack of Efficacy|0
1139321|NCT01441440|3741734|P1|Overall Study|Lack of Efficacy|1
1139322|NCT01441440|3741732|P3|Overall Study|Pregnancy|0
1139323|NCT01441440|3741733|P2|Overall Study|Pregnancy|0
1139324|NCT01441440|3741734|P1|Overall Study|Pregnancy|1
1139325|NCT01441440|3741732|P3|Overall Study|Withdrawal by Subject|9
1139326|NCT01441440|3741733|P2|Overall Study|Withdrawal by Subject|9
1139327|NCT01441440|3741734|P1|Overall Study|Withdrawal by Subject|11
1139328|NCT01441440|3741732|P3|Overall Study|Lost to Follow-up|1
1139329|NCT01441440|3741733|P2|Overall Study|Lost to Follow-up|2
1139330|NCT01441440|3741734|P1|Overall Study|Lost to Follow-up|0
1139331|NCT01441440|3741732|P3|Overall Study|Adverse Event|9
1139332|NCT01441440|3741733|P2|Overall Study|Adverse Event|9
1139333|NCT01441440|3741734|P1|Overall Study|Adverse Event|2
1139334|NCT01441440|3741732|P3|Overall Study|Death|1
1139335|NCT01441440|3741733|P2|Overall Study|Death|0
1139336|NCT01441440|3741734|P1|Overall Study|Death|1
1139337|NCT01441414|3741757|P1|Overall Study|Subject refused further follow-up|1
1139338|NCT01441414|3741757|P1|Overall Study|Study terminated by sponsor|2
1139339|NCT01441414|3741757|P1|Overall Study|Other reasons|3
1139340|NCT01441414|3741757|P1|Overall Study|Participant died|9
1139341|NCT01441180|3741836|P3|Overall Study|Discontinued|2
1139342|NCT01441180|3741837|P2|Overall Study|Discontinued|0
1139343|NCT01441180|3741838|P1|Overall Study|Discontinued|0
1139344|NCT01441180|3741836|P3|Overall Study|Lost to Follow-up|1
1139345|NCT01441180|3741837|P2|Overall Study|Lost to Follow-up|1
1139346|NCT01441180|3741838|P1|Overall Study|Lost to Follow-up|1
1139347|NCT01441102|3741849|P1|Overall Study|Withdrawal by Subject|2
1139348|NCT01441102|3741849|P1|Overall Study|Adverse Event|1
1139349|NCT01440972|3741893|P2|Overall Study|Withdrawal by Subject|2
1139350|NCT01440972|3741894|P1|Overall Study|Withdrawal by Subject|3
1139351|NCT01440946|3741918|P2|Overall Study|Physician Decision|0
1139352|NCT01440946|3741919|P1|Overall Study|Physician Decision|1
1139353|NCT01440946|3741918|P2|Overall Study|Lost to Follow-up|1
1139354|NCT01440946|3741919|P1|Overall Study|Lost to Follow-up|1
1139355|NCT01440881|3741958|P2|Overall Study|Death|1
1139356|NCT01440881|3741959|P1|Overall Study|Death|0
1139357|NCT01440816|3741973|P2|Overall Study|To Be Seen By Local Oncologist|2
1139358|NCT01440816|3741974|P1|Overall Study|To Be Seen By Local Oncologist|1
1139359|NCT01440816|3741973|P2|Overall Study|Disease Progression|9
1139360|NCT01440816|3741974|P1|Overall Study|Disease Progression|0
1139361|NCT01440647|3742017|P2|Overall Study|Death|3
1139362|NCT01440647|3742018|P1|Overall Study|Death|2
1139363|NCT01440595|3742037|P3|Overall Study|Study terminated by sponsor.|1
1139364|NCT01440595|3742038|P2|Overall Study|Study terminated by sponsor.|2
1139365|NCT01440595|3742039|P1|Overall Study|Study terminated by sponsor.|1
1139366|NCT01440595|3742037|P3|Overall Study|Lost to Follow-up|0
1139367|NCT01440595|3742038|P2|Overall Study|Lost to Follow-up|1
1139368|NCT01440595|3742039|P1|Overall Study|Lost to Follow-up|0
1139369|NCT01440569|3742059|P2|Open-Label Rollover Phase|Subject Non-Compliance|1
1139370|NCT01440569|3742060|P1|Open-Label Rollover Phase|Subject Non-Compliance|1
1139371|NCT01440569|3742059|P2|Open-Label Rollover Phase|Lost to Follow-up|3
1139372|NCT01440569|3742060|P1|Open-Label Rollover Phase|Lost to Follow-up|26
1139373|NCT01440569|3742059|P2|Open-Label Rollover Phase|Withdrew Consent|1
1139374|NCT01440569|3742060|P1|Open-Label Rollover Phase|Withdrew Consent|11
1139375|NCT01440569|3742059|P2|Open-Label Rollover Phase|Investigator’s Discretion|1
1139376|NCT01440569|3742060|P1|Open-Label Rollover Phase|Investigator’s Discretion|3
1139377|NCT01440569|3742059|P2|Open-Label Rollover Phase|Lack of Efficacy|0
1139378|NCT01440569|3742060|P1|Open-Label Rollover Phase|Lack of Efficacy|2
1139379|NCT01440569|3742059|P2|Open-Label Rollover Phase|Pregnancy|0
1139380|NCT01440569|3742060|P1|Open-Label Rollover Phase|Pregnancy|1
1139381|NCT01440569|3742059|P2|Open-Label Rollover Phase|Adverse Event|0
1139382|NCT01440569|3742060|P1|Open-Label Rollover Phase|Adverse Event|3
1139383|NCT01440569|3742059|P2|Main Study|Protocol Violation|0
1139384|NCT01440569|3742060|P1|Main Study|Protocol Violation|1
1139385|NCT01440569|3742059|P2|Main Study|Subject Non-Compliance|0
1139386|NCT01440569|3742060|P1|Main Study|Subject Non-Compliance|3
1139387|NCT01440569|3742059|P2|Main Study|Lost to Follow-up|2
1139388|NCT01440569|3742060|P1|Main Study|Lost to Follow-up|13
1139389|NCT01440569|3742059|P2|Main Study|Withdrew Consent|1
1139390|NCT01440569|3742060|P1|Main Study|Withdrew Consent|7
1139391|NCT01440569|3742059|P2|Main Study|Investigator's Discretion|1
1139392|NCT01440569|3742060|P1|Main Study|Investigator's Discretion|1
1139393|NCT01440569|3742059|P2|Main Study|Pregnancy|0
1139394|NCT01440569|3742060|P1|Main Study|Pregnancy|1
1139395|NCT01440569|3742059|P2|Main Study|Adverse Event|0
1139396|NCT01440569|3742060|P1|Main Study|Adverse Event|9
1139397|NCT01440569|3742059|P2|Main Study|Enrolled but not treated|0
1139398|NCT01440569|3742060|P1|Main Study|Enrolled but not treated|1
1139399|NCT01440517|3742095|P1|Overall Study|Subject withdrawn prior to dosing|1
1139400|NCT01440374|3742126|P4|Part 3: Extension|Physician Decision|14
1139401|NCT01440374|3742127|P3|Part 3: Extension|Physician Decision|0
1139402|NCT01440374|3742128|P2|Part 3: Extension|Physician Decision|0
1139403|NCT01440374|3742129|P1|Part 3: Extension|Physician Decision|0
1139404|NCT01440374|3742126|P4|Part 3: Extension|Adverse Event|13
1139405|NCT01440374|3742127|P3|Part 3: Extension|Adverse Event|0
1139406|NCT01440374|3742128|P2|Part 3: Extension|Adverse Event|0
1139407|NCT01440374|3742129|P1|Part 3: Extension|Adverse Event|0
1139408|NCT01440374|3742126|P4|Part 3: Extension|Withdrawal by Subject|5
1139409|NCT01440374|3742127|P3|Part 3: Extension|Withdrawal by Subject|0
1139410|NCT01440374|3742128|P2|Part 3: Extension|Withdrawal by Subject|0
1139411|NCT01440374|3742129|P1|Part 3: Extension|Withdrawal by Subject|0
1139412|NCT01440374|3742126|P4|Part 2; Double-blind Phase|Not treated|0
1139413|NCT01440374|3742127|P3|Part 2; Double-blind Phase|Not treated|1
1139414|NCT01440374|3742128|P2|Part 2; Double-blind Phase|Not treated|0
1139415|NCT01440374|3742129|P1|Part 2; Double-blind Phase|Not treated|0
1139416|NCT01440374|3742126|P4|Part 2; Double-blind Phase|Adverse Event|0
1139417|NCT01440374|3742127|P3|Part 2; Double-blind Phase|Adverse Event|31
1139418|NCT01440374|3742128|P2|Part 2; Double-blind Phase|Adverse Event|7
1139419|NCT01440374|3742129|P1|Part 2; Double-blind Phase|Adverse Event|0
1139420|NCT01440374|3742126|P4|Part 2; Double-blind Phase|Lack of Efficacy|0
1139421|NCT01440374|3742127|P3|Part 2; Double-blind Phase|Lack of Efficacy|0
1139422|NCT01440374|3742128|P2|Part 2; Double-blind Phase|Lack of Efficacy|1
1139423|NCT01440374|3742129|P1|Part 2; Double-blind Phase|Lack of Efficacy|0
1139424|NCT01440374|3742126|P4|Part 2; Double-blind Phase|Protocol Violation|0
1139425|NCT01440374|3742127|P3|Part 2; Double-blind Phase|Protocol Violation|1
1139426|NCT01440374|3742128|P2|Part 2; Double-blind Phase|Protocol Violation|0
1139427|NCT01440374|3742129|P1|Part 2; Double-blind Phase|Protocol Violation|0
1139428|NCT01440374|3742126|P4|Part 2; Double-blind Phase|Withdrawal by Subject|0
1139429|NCT01440374|3742127|P3|Part 2; Double-blind Phase|Withdrawal by Subject|5
1139430|NCT01440374|3742128|P2|Part 2; Double-blind Phase|Withdrawal by Subject|4
1139431|NCT01440374|3742129|P1|Part 2; Double-blind Phase|Withdrawal by Subject|0
1139432|NCT01440374|3742126|P4|Part 2; Double-blind Phase|Physician Decision|0
1139433|NCT01440374|3742127|P3|Part 2; Double-blind Phase|Physician Decision|17
1139434|NCT01440374|3742128|P2|Part 2; Double-blind Phase|Physician Decision|8
1139435|NCT01440374|3742129|P1|Part 2; Double-blind Phase|Physician Decision|0
1139436|NCT01440374|3742126|P4|Part 1: Open-label Phase|Physician Decision|0
1139437|NCT01440374|3742127|P3|Part 1: Open-label Phase|Physician Decision|0
1139438|NCT01440374|3742128|P2|Part 1: Open-label Phase|Physician Decision|0
1139439|NCT01440374|3742129|P1|Part 1: Open-label Phase|Physician Decision|1
1139440|NCT01440374|3742126|P4|Part 1: Open-label Phase|Adverse Event|0
1139441|NCT01440374|3742127|P3|Part 1: Open-label Phase|Adverse Event|0
1139442|NCT01440374|3742128|P2|Part 1: Open-label Phase|Adverse Event|0
1139443|NCT01440374|3742129|P1|Part 1: Open-label Phase|Adverse Event|5
1139444|NCT01440322|3742164|P2|Overall Study|Other Non-Product Related|0
1139445|NCT01440322|3742165|P1|Overall Study|Other Non-Product Related|1
1139446|NCT01440322|3742164|P2|Overall Study|Unrelated Medical Problem|1
1139447|NCT01440322|3742165|P1|Overall Study|Unrelated Medical Problem|0
1139448|NCT01440322|3742164|P2|Overall Study|Other Product Related|0
1139449|NCT01440322|3742165|P1|Overall Study|Other Product Related|1
1139450|NCT01440322|3742164|P2|Overall Study|Unacceptable Subjective Vision|0
1139451|NCT01440322|3742165|P1|Overall Study|Unacceptable Subjective Vision|1
1139452|NCT01440322|3742164|P2|Overall Study|Symptoms and Problems|0
1139453|NCT01440322|3742165|P1|Overall Study|Symptoms and Problems|1
1139454|NCT01440322|3742164|P2|Overall Study|Biomicroscopy|0
1139455|NCT01440322|3742165|P1|Overall Study|Biomicroscopy|1
1139456|NCT01440322|3742164|P2|Overall Study|Discomfort|0
1139457|NCT01440322|3742165|P1|Overall Study|Discomfort|2
1139458|NCT01440283|3742187|P1|Overall Study|Physician Decision|3
1139459|NCT01440283|3742187|P1|Overall Study|Withdrawal by Subject|4
1139460|NCT01440283|3742187|P1|Overall Study|Death|3
1139461|NCT01440101|3742202|P3|Overall Study|Not Specified|0
1139462|NCT01440101|3742203|P2|Overall Study|Not Specified|1
1139463|NCT01440101|3742204|P1|Overall Study|Not Specified|0
1139464|NCT01440101|3742202|P3|Overall Study|Withdrawal by Subject|1
1139465|NCT01440101|3742203|P2|Overall Study|Withdrawal by Subject|3
1139466|NCT01440101|3742204|P1|Overall Study|Withdrawal by Subject|0
1139467|NCT01440101|3742202|P3|Overall Study|Adverse Event|0
1139468|NCT01440101|3742203|P2|Overall Study|Adverse Event|0
1139469|NCT01440101|3742204|P1|Overall Study|Adverse Event|2
1139470|NCT01440049|3742237|P1|Overall Study|Adverse Event|5
1139471|NCT01439971|3742269|P5|Overall Study|Required number in cohort dosed|1
1139472|NCT01439971|3742270|P4|Overall Study|Required number in cohort dosed|0
1139473|NCT01439971|3742271|P3|Overall Study|Required number in cohort dosed|2
1139474|NCT01439971|3742272|P2|Overall Study|Required number in cohort dosed|1
1139475|NCT01439971|3742273|P1|Overall Study|Required number in cohort dosed|0
1139476|NCT01439945|3742453|P4|Double-Blind Treatment Phase|Ineligible|1
1139477|NCT01439945|3742454|P3|Double-Blind Treatment Phase|Ineligible|0
1139478|NCT01439945|3742455|P2|Double-Blind Treatment Phase|Ineligible|2
1139479|NCT01439945|3742456|P1|Double-Blind Treatment Phase|Ineligible|1
1139480|NCT01439945|3742453|P4|Double-Blind Treatment Phase|Withdrawal by Subject|1
1139481|NCT01439945|3742454|P3|Double-Blind Treatment Phase|Withdrawal by Subject|3
1139482|NCT01439945|3742455|P2|Double-Blind Treatment Phase|Withdrawal by Subject|3
1139483|NCT01439945|3742456|P1|Double-Blind Treatment Phase|Withdrawal by Subject|3
1139484|NCT01439867|3742481|P2|Overall Study|Protocol-specified Criteria|0
1139485|NCT01439867|3742482|P1|Overall Study|Protocol-specified Criteria|1
1139486|NCT01439867|3742481|P2|Overall Study|Administrative Decision|5
1139487|NCT01439867|3742482|P1|Overall Study|Administrative Decision|4
1139488|NCT01439867|3742481|P2|Overall Study|Withdrawal by Subject|2
1139489|NCT01439867|3742482|P1|Overall Study|Withdrawal by Subject|1
1139490|NCT01439867|3742481|P2|Overall Study|Non-compliance|1
1139491|NCT01439867|3742482|P1|Overall Study|Non-compliance|0
1139492|NCT01439724|3742523|P2|Overall Study|missing consultation|8
1139493|NCT01439724|3742524|P1|Overall Study|missing consultation|9
1139494|NCT01439711|3742530|P1|Overall Study|No MRI|9
1139495|NCT01439711|3742530|P1|Overall Study|Noncompliance|3
1139496|NCT01439711|3742530|P1|Overall Study|Progression During Active Tx|3
1139497|NCT01439711|3742530|P1|Overall Study|Withdrawal by Subject|3
1139498|NCT01439711|3742530|P1|Overall Study|Adverse Event|5
1139499|NCT01439711|3742530|P1|Overall Study|Progression Prior to Beginning Tx|1
1139500|NCT01439711|3742530|P1|Overall Study|Cancel|3
1139501|NCT01439711|3742530|P1|Overall Study|Ineligible|13
1139502|NCT01439373|3742564|P2|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0
1139503|NCT01439373|3742565|P1|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2
1139504|NCT01439373|3742564|P2|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1
1139505|NCT01439373|3742565|P1|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0
1139506|NCT01439360|3742608|P2|Overall Study|Withdrawal by Subject|129
1139507|NCT01439360|3742609|P1|Overall Study|Withdrawal by Subject|140
1139508|NCT01439360|3742608|P2|Overall Study|Protocol Violation|0
1139509|NCT01439360|3742609|P1|Overall Study|Protocol Violation|1
1139510|NCT01439360|3742608|P2|Overall Study|Others|5
1139511|NCT01439360|3742609|P1|Overall Study|Others|10
1139512|NCT01439360|3742608|P2|Overall Study|Lost to Follow-up|58
1139513|NCT01439360|3742609|P1|Overall Study|Lost to Follow-up|43
1139514|NCT01439360|3742608|P2|Overall Study|Adverse Event|16
1139515|NCT01439360|3742609|P1|Overall Study|Adverse Event|4
1139516|NCT01439282|3742659|P2|Overall Study|Not specified|1
1139517|NCT01439282|3742660|P1|Overall Study|Not specified|1
1139518|NCT01439282|3742659|P2|Overall Study|Withdrawal by Subject|0
1139519|NCT01439282|3742660|P1|Overall Study|Withdrawal by Subject|2
1139520|NCT01439282|3742659|P2|Overall Study|Adverse Event|0
1139521|NCT01439282|3742660|P1|Overall Study|Adverse Event|5
1139522|NCT01439204|3742670|P2|Overall Study|poor/non-compliance|0
1139523|NCT01439204|3742671|P1|Overall Study|poor/non-compliance|3
1139524|NCT01439204|3742670|P2|Overall Study|No longer meets study criteria|0
1139525|NCT01439204|3742671|P1|Overall Study|No longer meets study criteria|1
1139526|NCT01439204|3742670|P2|Overall Study|Lost to Follow-up|2
1139527|NCT01439204|3742671|P1|Overall Study|Lost to Follow-up|0
1139528|NCT01439204|3742670|P2|Overall Study|Withdrawal by Subject|1
1139529|NCT01439204|3742671|P1|Overall Study|Withdrawal by Subject|0
1139530|NCT01439165|3742705|P2|Overall Study|Withdrawal by Subject|1
1139531|NCT01439165|3742706|P1|Overall Study|Withdrawal by Subject|7
1139532|NCT01439165|3742705|P2|Overall Study|Lost to Follow-up|1
1139533|NCT01439165|3742706|P1|Overall Study|Lost to Follow-up|11
1139534|NCT01439165|3742705|P2|Overall Study|Protocol Violation|0
1139535|NCT01439165|3742706|P1|Overall Study|Protocol Violation|3
1139536|NCT01439126|3742720|P2|Overall Study|Other-Miscellaneous|12
1139537|NCT01439126|3742721|P1|Overall Study|Other-Miscellaneous|12
1139538|NCT01439126|3742720|P2|Overall Study|Other-Use of prohibited treatment|2
1139539|NCT01439126|3742721|P1|Overall Study|Other-Use of prohibited treatment|0
1139540|NCT01439126|3742720|P2|Overall Study|Lost to Follow-up|3
1139541|NCT01439126|3742721|P1|Overall Study|Lost to Follow-up|6
1139542|NCT01439126|3742720|P2|Overall Study|Protocol Violation|4
1139543|NCT01439126|3742721|P1|Overall Study|Protocol Violation|6
1139544|NCT01439126|3742720|P2|Overall Study|Withdrawal by Subject|21
1139545|NCT01439126|3742721|P1|Overall Study|Withdrawal by Subject|5
1139546|NCT01439126|3742720|P2|Overall Study|Adverse Event|0
1139547|NCT01439126|3742721|P1|Overall Study|Adverse Event|2
1139548|NCT01439074|3742743|P2|Overall Study|Other|4
1139549|NCT01439074|3742744|P1|Overall Study|Other|4
1139550|NCT01439074|3742743|P2|Overall Study|Withdrawal by Subject|5
1139551|NCT01439074|3742744|P1|Overall Study|Withdrawal by Subject|1
1139552|NCT01439074|3742743|P2|Overall Study|Subject shedding|0
1139553|NCT01439074|3742744|P1|Overall Study|Subject shedding|1
1139554|NCT01439074|3742743|P2|Overall Study|Lost to Follow-up|4
1139555|NCT01439074|3742744|P1|Overall Study|Lost to Follow-up|3
1139556|NCT01438996|3742763|P3|Overall Study|Not meeting Inclusion Criteria|0
1139557|NCT01438996|3742764|P2|Overall Study|Not meeting Inclusion Criteria|1
1139558|NCT01438996|3742765|P1|Overall Study|Not meeting Inclusion Criteria|4
1139559|NCT01438840|3742799|P3|Extension Phase|Not specified|1
1139560|NCT01438840|3742800|P2|Extension Phase|Not specified|0
1139561|NCT01438840|3742801|P1|Extension Phase|Not specified|0
1139562|NCT01438840|3742799|P3|Extension Phase|Lack of Efficacy|2
1139563|NCT01438840|3742800|P2|Extension Phase|Lack of Efficacy|0
1139564|NCT01438840|3742801|P1|Extension Phase|Lack of Efficacy|0
1139565|NCT01438840|3742799|P3|Extension Phase|Withdrawal by Subject|3
1139566|NCT01438840|3742800|P2|Extension Phase|Withdrawal by Subject|0
1139567|NCT01438840|3742801|P1|Extension Phase|Withdrawal by Subject|0
1139568|NCT01438840|3742799|P3|Extension Phase|Lost to Follow-up|1
1139569|NCT01438840|3742800|P2|Extension Phase|Lost to Follow-up|0
1139570|NCT01438840|3742801|P1|Extension Phase|Lost to Follow-up|0
1139571|NCT01438840|3742799|P3|Extension Phase|Adverse Event|3
1139572|NCT01438840|3742800|P2|Extension Phase|Adverse Event|0
1139573|NCT01438840|3742801|P1|Extension Phase|Adverse Event|0
1139574|NCT01438840|3742799|P3|Core Study|Withdrawal of consent|0
1139575|NCT01438840|3742800|P2|Core Study|Withdrawal of consent|0
1139576|NCT01438840|3742801|P1|Core Study|Withdrawal of consent|1
1139577|NCT01438840|3742799|P3|Core Study|Lack of Efficacy|0
1139578|NCT01438840|3742800|P2|Core Study|Lack of Efficacy|7
1139579|NCT01438840|3742801|P1|Core Study|Lack of Efficacy|15
1139580|NCT01438840|3742799|P3|Core Study|Adverse Event|0
1139581|NCT01438840|3742800|P2|Core Study|Adverse Event|3
1139582|NCT01438840|3742801|P1|Core Study|Adverse Event|0
1139583|NCT01438814|3742814|P2|Overall Study|Not specified|4
1139584|NCT01438814|3742815|P1|Overall Study|Not specified|2
1139585|NCT01438814|3742814|P2|Overall Study|Withdrawal by Subject|2
1139586|NCT01438814|3742815|P1|Overall Study|Withdrawal by Subject|4
1139587|NCT01438814|3742814|P2|Overall Study|Lost to Follow-up|3
1139588|NCT01438814|3742815|P1|Overall Study|Lost to Follow-up|4
1139589|NCT01438814|3742814|P2|Overall Study|Protocol Violation|2
1139590|NCT01438814|3742815|P1|Overall Study|Protocol Violation|1
1139591|NCT01438814|3742814|P2|Overall Study|Adverse Event|3
1139592|NCT01438814|3742815|P1|Overall Study|Adverse Event|3
1139593|NCT01438541|3742851|P1|Overall Study|discharge from the hospital|5
1139594|NCT01438541|3742851|P1|Overall Study|Withdrawal by Subject|1
1139595|NCT01438541|3742851|P1|Overall Study|Physician Decision|1
1139596|NCT01438489|3742860|P3|Overall Study|Inadequate venous access|0
1139597|NCT01438489|3742861|P2|Overall Study|Inadequate venous access|2
1139598|NCT01438489|3742862|P1|Overall Study|Inadequate venous access|0
1139599|NCT01438489|3742860|P3|Overall Study|Did not complete all 3 follow-up visits|2
1139600|NCT01438489|3742861|P2|Overall Study|Did not complete all 3 follow-up visits|5
1139601|NCT01438489|3742862|P1|Overall Study|Did not complete all 3 follow-up visits|2
1139602|NCT01438489|3742860|P3|Overall Study|Received prohibited medication|0
1139603|NCT01438489|3742861|P2|Overall Study|Received prohibited medication|0
1139604|NCT01438489|3742862|P1|Overall Study|Received prohibited medication|1
1139605|NCT01438489|3742860|P3|Overall Study|AE/SAEs|1
1139606|NCT01438489|3742861|P2|Overall Study|AE/SAEs|1
1139607|NCT01438489|3742862|P1|Overall Study|AE/SAEs|2
1139608|NCT01438489|3742860|P3|Overall Study|Investigator decision|0
1139609|NCT01438489|3742861|P2|Overall Study|Investigator decision|1
1139610|NCT01438489|3742862|P1|Overall Study|Investigator decision|0
1139611|NCT01438489|3742860|P3|Overall Study|Subject choice/Subject moved|1
1139612|NCT01438489|3742861|P2|Overall Study|Subject choice/Subject moved|1
1139613|NCT01438489|3742862|P1|Overall Study|Subject choice/Subject moved|2
1139614|NCT01438489|3742860|P3|Overall Study|Sponsor decision|4
1139615|NCT01438489|3742861|P2|Overall Study|Sponsor decision|1
1139616|NCT01438489|3742862|P1|Overall Study|Sponsor decision|4
1139617|NCT01438489|3742860|P3|Overall Study|Death|1
1139618|NCT01438489|3742861|P2|Overall Study|Death|0
1139619|NCT01438489|3742862|P1|Overall Study|Death|0
1139620|NCT01438489|3742860|P3|Overall Study|Withdrawal by Subject|8
1139621|NCT01438489|3742861|P2|Overall Study|Withdrawal by Subject|3
1139622|NCT01438489|3742862|P1|Overall Study|Withdrawal by Subject|11
1139623|NCT01438489|3742860|P3|Overall Study|Lost to Follow-up|2
1139624|NCT01438489|3742861|P2|Overall Study|Lost to Follow-up|2
1139625|NCT01438489|3742862|P1|Overall Study|Lost to Follow-up|4
1139626|NCT01438424|3742905|P1|Overall Study|Participant noncompliance|20
1139627|NCT01438424|3742905|P1|Overall Study|No longer met inclusion criteria|1
1139628|NCT01438424|3742905|P1|Overall Study|Pregnancy|7
1139629|NCT01438424|3742905|P1|Overall Study|Need for drug prohibited by protocol|14
1139630|NCT01438424|3742905|P1|Overall Study|Abnormal laboratory test result|14
1139631|NCT01438424|3742905|P1|Overall Study|Lost to Follow-up|17
1139632|NCT01438424|3742905|P1|Overall Study|Adverse Event|17
1139633|NCT01438424|3742905|P1|Overall Study|Death|22
1139634|NCT01438424|3742905|P1|Overall Study|Progression of chronic hepatitis B|22
1139635|NCT01438424|3742905|P1|Overall Study|Withdrawal by Subject|104
1139636|NCT01438424|3742905|P1|Overall Study|Not identified|55
1139637|NCT01438424|3742905|P1|Overall Study|Minimal virologic response|95
1139638|NCT01438424|3742905|P1|Overall Study|Continuing treatment|29
1139639|NCT01438307|3742943|P2|Overall Study|Death|1
1139640|NCT01438307|3742944|P1|Overall Study|Death|1
1139641|NCT01438294|3742958|P2|Overall Study|Lost to Follow-up|7
1139642|NCT01438294|3742959|P1|Overall Study|Lost to Follow-up|3
1139643|NCT01438177|3743002|P1|Overall Study|Initiation of new therapy|1
1139644|NCT01438177|3743002|P1|Overall Study|Withdrawal by Subject|1
1139645|NCT01438151|3743008|P1|Overall Study|study terminated|8
1139646|NCT01438060|3743014|P2|On Study Beyond Week 140|Other Reason|3
1139647|NCT01438060|3743015|P1|On Study Beyond Week 140|Other Reason|0
1139648|NCT01438060|3743014|P2|On Study Beyond Week 140|Death|1
1139649|NCT01438060|3743015|P1|On Study Beyond Week 140|Death|0
1139650|NCT01438060|3743014|P2|On Study Beyond Week 140|Withdrawal by Subject|1
1139651|NCT01438060|3743015|P1|On Study Beyond Week 140|Withdrawal by Subject|0
1139652|NCT01438060|3743014|P2|On Study Beyond Week 140|Lack of Efficacy|1
1139653|NCT01438060|3743015|P1|On Study Beyond Week 140|Lack of Efficacy|0
1139654|NCT01438060|3743014|P2|On Study Beyond Week 140|Adverse Event|2
1139655|NCT01438060|3743015|P1|On Study Beyond Week 140|Adverse Event|0
1139656|NCT01438060|3743014|P2|Extension Phase: Week 10 to Week 130|Other Reason|15
1139657|NCT01438060|3743015|P1|Extension Phase: Week 10 to Week 130|Other Reason|7
1139658|NCT01438060|3743014|P2|Extension Phase: Week 10 to Week 130|Death|12
1139659|NCT01438060|3743015|P1|Extension Phase: Week 10 to Week 130|Death|22
1139660|NCT01438060|3743014|P2|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0
1139661|NCT01438060|3743015|P1|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2
1139662|NCT01438060|3743014|P2|Extension Phase: Week 10 to Week 130|Participant Unreliability|0
1139663|NCT01438060|3743015|P1|Extension Phase: Week 10 to Week 130|Participant Unreliability|1
1139664|NCT01438060|3743014|P2|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5
1139665|NCT01438060|3743015|P1|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3
1139666|NCT01438060|3743014|P2|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
1139667|NCT01438060|3743015|P1|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
1139668|NCT01438060|3743014|P2|Extension Phase: Week 10 to Week 130|Adverse Event|16
1139669|NCT01438060|3743015|P1|Extension Phase: Week 10 to Week 130|Adverse Event|15
1139670|NCT01438060|3743014|P2|Acute Phase: Double-blind, 10 Weeks|Other Reason|0
1139671|NCT01438060|3743015|P1|Acute Phase: Double-blind, 10 Weeks|Other Reason|1
1139672|NCT01438060|3743014|P2|Acute Phase: Double-blind, 10 Weeks|Death|2
1139673|NCT01438060|3743015|P1|Acute Phase: Double-blind, 10 Weeks|Death|0
1139674|NCT01438060|3743014|P2|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0
1139675|NCT01438060|3743015|P1|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1
1139676|NCT01438060|3743014|P2|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4
1139677|NCT01438060|3743015|P1|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3
1139678|NCT01438060|3743014|P2|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3
1139679|NCT01438060|3743015|P1|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6
1139680|NCT01438060|3743014|P2|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9
1139681|NCT01438060|3743015|P1|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7
1139682|NCT01437995|3743096|P3|Overall Study|Lost to Follow-up|20
1139683|NCT01437995|3743097|P2|Overall Study|Lost to Follow-up|18
1139684|NCT01437995|3743098|P1|Overall Study|Lost to Follow-up|11
1139685|NCT01437943|3743120|P2|Overall Study|Adverse Event|0
1139686|NCT01437943|3743121|P1|Overall Study|Adverse Event|2
1139687|NCT01437943|3743120|P2|Overall Study|Subject expressed pregnancy plans|0
1139688|NCT01437943|3743121|P1|Overall Study|Subject expressed pregnancy plans|1
1139689|NCT01437943|3743120|P2|Overall Study|Aliskiren trials terminated by Novartis|2
1139690|NCT01437943|3743121|P1|Overall Study|Aliskiren trials terminated by Novartis|4
1139691|NCT01437878|3743129|P2|Overall Study|Withdrawal by Subject|0
1139692|NCT01437878|3743130|P1|Overall Study|Withdrawal by Subject|1
1139693|NCT01437540|3743178|P2|Overall Study|Withdrawal by Subject|15
1139694|NCT01437540|3743179|P1|Overall Study|Withdrawal by Subject|31
1139695|NCT01437540|3743178|P2|Overall Study|Adverse Event|13
1139696|NCT01437540|3743179|P1|Overall Study|Adverse Event|26
1139697|NCT01437540|3743178|P2|Overall Study|Protocol Violation|12
1139698|NCT01437540|3743179|P1|Overall Study|Protocol Violation|24
1139699|NCT01437540|3743178|P2|Overall Study|Lack of Efficacy|11
1139700|NCT01437540|3743179|P1|Overall Study|Lack of Efficacy|23
1139701|NCT01437540|3743178|P2|Overall Study|Lost to Follow-up|5
1139702|NCT01437540|3743179|P1|Overall Study|Lost to Follow-up|3
1139703|NCT01437540|3743178|P2|Overall Study|COPD exacerbation|3
1139704|NCT01437540|3743179|P1|Overall Study|COPD exacerbation|13
1139705|NCT01437540|3743178|P2|Overall Study|Not listed below|6
1139706|NCT01437540|3743179|P1|Overall Study|Not listed below|7
1139707|NCT01437423|3743209|P1|Overall Study|Off label usage|3
1139708|NCT01437423|3743209|P1|Overall Study|Lost to Follow-up|12
1139709|NCT01437397|3743221|P5|Overall Study|Site termination/COPD exacerbation/other|14
1139710|NCT01437397|3743222|P4|Overall Study|Site termination/COPD exacerbation/other|9
1139711|NCT01437397|3743223|P3|Overall Study|Site termination/COPD exacerbation/other|9
1139712|NCT01437397|3743224|P2|Overall Study|Site termination/COPD exacerbation/other|8
1139713|NCT01437397|3743225|P1|Overall Study|Site termination/COPD exacerbation/other|10
1139714|NCT01437397|3743221|P5|Overall Study|Adverse Event|21
1139715|NCT01437397|3743222|P4|Overall Study|Adverse Event|14
1139716|NCT01437397|3743223|P3|Overall Study|Adverse Event|16
1139717|NCT01437397|3743224|P2|Overall Study|Adverse Event|22
1139718|NCT01437397|3743225|P1|Overall Study|Adverse Event|21
1139719|NCT01437397|3743221|P5|Overall Study|Lack of Efficacy|20
1139720|NCT01437397|3743222|P4|Overall Study|Lack of Efficacy|10
1139721|NCT01437397|3743223|P3|Overall Study|Lack of Efficacy|8
1139722|NCT01437397|3743224|P2|Overall Study|Lack of Efficacy|4
1139723|NCT01437397|3743225|P1|Overall Study|Lack of Efficacy|5
1139724|NCT01437397|3743221|P5|Overall Study|Protocol Violation|19
1139725|NCT01437397|3743222|P4|Overall Study|Protocol Violation|21
1139726|NCT01437397|3743223|P3|Overall Study|Protocol Violation|13
1139727|NCT01437397|3743224|P2|Overall Study|Protocol Violation|12
1139728|NCT01437397|3743225|P1|Overall Study|Protocol Violation|10
1139729|NCT01437397|3743221|P5|Overall Study|Withdrawal by Subject|22
1139730|NCT01437397|3743222|P4|Overall Study|Withdrawal by Subject|11
1139731|NCT01437397|3743223|P3|Overall Study|Withdrawal by Subject|24
1139732|NCT01437397|3743224|P2|Overall Study|Withdrawal by Subject|12
1139733|NCT01437397|3743225|P1|Overall Study|Withdrawal by Subject|11
1139734|NCT01437397|3743221|P5|Overall Study|Lost to Follow-up|5
1139735|NCT01437397|3743222|P4|Overall Study|Lost to Follow-up|4
1139736|NCT01437397|3743223|P3|Overall Study|Lost to Follow-up|2
1139737|NCT01437397|3743224|P2|Overall Study|Lost to Follow-up|4
1139738|NCT01437397|3743225|P1|Overall Study|Lost to Follow-up|9
1139739|NCT01437319|3743252|P3|Phase II|Protocol Violation|0
1139740|NCT01437319|3743253|P2|Phase II|Protocol Violation|1
1139741|NCT01437319|3743254|P1|Phase II|Protocol Violation|0
1139742|NCT01437319|3743252|P3|Phase II|Study related symptoms/complaints|19
1139743|NCT01437319|3743253|P2|Phase II|Study related symptoms/complaints|28
1139744|NCT01437319|3743254|P1|Phase II|Study related symptoms/complaints|0
1139745|NCT01437319|3743252|P3|Phase II|Lost to Follow-up|2
1139746|NCT01437319|3743253|P2|Phase II|Lost to Follow-up|7
1139747|NCT01437319|3743254|P1|Phase II|Lost to Follow-up|0
1139748|NCT01437319|3743252|P3|Phase II|Withdrawal by Subject|16
1139749|NCT01437319|3743253|P2|Phase II|Withdrawal by Subject|8
1139750|NCT01437319|3743254|P1|Phase II|Withdrawal by Subject|0
1139751|NCT01437319|3743252|P3|Phase I|Withdrawal by Subject|0
1139752|NCT01437319|3743253|P2|Phase I|Withdrawal by Subject|0
1139753|NCT01437319|3743254|P1|Phase I|Withdrawal by Subject|25
1139754|NCT01437319|3743252|P3|Phase I|Study related symptoms/complaints|0
1139755|NCT01437319|3743253|P2|Phase I|Study related symptoms/complaints|0
1139756|NCT01437319|3743254|P1|Phase I|Study related symptoms/complaints|27
1139757|NCT01437319|3743252|P3|Phase I|Protocol Violation|0
1139758|NCT01437319|3743253|P2|Phase I|Protocol Violation|0
1139759|NCT01437319|3743254|P1|Phase I|Protocol Violation|1
1139760|NCT01437319|3743252|P3|Phase I|Lost to Follow-up|0
1139761|NCT01437319|3743253|P2|Phase I|Lost to Follow-up|0
1139762|NCT01437319|3743254|P1|Phase I|Lost to Follow-up|2
1139763|NCT01437267|3743269|P6|Overall Study|Protocol Violation|0
1139764|NCT01437267|3743270|P5|Overall Study|Protocol Violation|0
1139765|NCT01437267|3743271|P4|Overall Study|Protocol Violation|0
1139766|NCT01437267|3743272|P3|Overall Study|Protocol Violation|0
1139767|NCT01437267|3743273|P2|Overall Study|Protocol Violation|1
1139768|NCT01437267|3743274|P1|Overall Study|Protocol Violation|0
1139769|NCT01437267|3743269|P6|Overall Study|Withdrawal by Subject|0
1139770|NCT01437267|3743270|P5|Overall Study|Withdrawal by Subject|0
1139771|NCT01437267|3743271|P4|Overall Study|Withdrawal by Subject|1
1139772|NCT01437267|3743272|P3|Overall Study|Withdrawal by Subject|0
1139773|NCT01437267|3743273|P2|Overall Study|Withdrawal by Subject|0
1139774|NCT01437267|3743274|P1|Overall Study|Withdrawal by Subject|0
1139775|NCT01437111|3743317|P1|Overall Study|Protocol Violation|1
1139776|NCT01437111|3743317|P1|Overall Study|Lost to Follow-up|5
1139777|NCT01437111|3743317|P1|Overall Study|Physician Decision|1
1139778|NCT01437111|3743317|P1|Overall Study|Not reported|5
1139779|NCT01437111|3743317|P1|Overall Study|Withdrawal by Subject|4
1139780|NCT01437111|3743317|P1|Overall Study|Adverse Event|2
1139781|NCT01436643|3743395|P4|Core Phase (16 Weeks)|Protocol Violation|0
1139782|NCT01436643|3743396|P3|Core Phase (16 Weeks)|Protocol Violation|1
1139783|NCT01436643|3743397|P2|Core Phase (16 Weeks)|Protocol Violation|1
1139784|NCT01436643|3743398|P1|Core Phase (16 Weeks)|Protocol Violation|1
1139785|NCT01436643|3743395|P4|Core Phase (16 Weeks)|Abnormal Test result|0
1139786|NCT01436643|3743396|P3|Core Phase (16 Weeks)|Abnormal Test result|1
1139787|NCT01436643|3743397|P2|Core Phase (16 Weeks)|Abnormal Test result|0
1139788|NCT01436643|3743398|P1|Core Phase (16 Weeks)|Abnormal Test result|0
1139789|NCT01436643|3743395|P4|Core Phase (16 Weeks)|Adverse Event|0
1139790|NCT01436643|3743396|P3|Core Phase (16 Weeks)|Adverse Event|1
1139791|NCT01436643|3743397|P2|Core Phase (16 Weeks)|Adverse Event|3
1139792|NCT01436643|3743398|P1|Core Phase (16 Weeks)|Adverse Event|0
1139793|NCT01436643|3743395|P4|2-week Pre-treatment|Protocol Violation|4
1139794|NCT01436643|3743396|P3|2-week Pre-treatment|Protocol Violation|0
1139795|NCT01436643|3743397|P2|2-week Pre-treatment|Protocol Violation|0
1139796|NCT01436643|3743398|P1|2-week Pre-treatment|Protocol Violation|0
1139797|NCT01436643|3743395|P4|2-week Pre-treatment|Adverse Event|5
1139798|NCT01436643|3743396|P3|2-week Pre-treatment|Adverse Event|0
1139799|NCT01436643|3743397|P2|2-week Pre-treatment|Adverse Event|0
1139800|NCT01436643|3743398|P1|2-week Pre-treatment|Adverse Event|0
1139801|NCT01436643|3743395|P4|2-week Pre-treatment|Abnormal test result|1
1139802|NCT01436643|3743396|P3|2-week Pre-treatment|Abnormal test result|0
1139803|NCT01436643|3743397|P2|2-week Pre-treatment|Abnormal test result|0
1139804|NCT01436643|3743398|P1|2-week Pre-treatment|Abnormal test result|0
1139805|NCT01436500|3743433|P5|Overall Study|not specified|0
1139806|NCT01436500|3743434|P4|Overall Study|not specified|1
1139807|NCT01436500|3743435|P3|Overall Study|not specified|0
1139808|NCT01436500|3743436|P2|Overall Study|not specified|1
1139809|NCT01436500|3743437|P1|Overall Study|not specified|0
1139810|NCT01436500|3743433|P5|Overall Study|discontinued study drug|0
1139811|NCT01436500|3743434|P4|Overall Study|discontinued study drug|0
1139812|NCT01436500|3743435|P3|Overall Study|discontinued study drug|0
1139813|NCT01436500|3743436|P2|Overall Study|discontinued study drug|0
1139814|NCT01436500|3743437|P1|Overall Study|discontinued study drug|1
1139815|NCT01436500|3743433|P5|Overall Study|initiation of dialysis|1
1139816|NCT01436500|3743434|P4|Overall Study|initiation of dialysis|0
1139817|NCT01436500|3743435|P3|Overall Study|initiation of dialysis|0
1139818|NCT01436500|3743436|P2|Overall Study|initiation of dialysis|0
1139819|NCT01436500|3743437|P1|Overall Study|initiation of dialysis|0
1139820|NCT01436500|3743433|P5|Overall Study|liver transplant|0
1139821|NCT01436500|3743434|P4|Overall Study|liver transplant|0
1139822|NCT01436500|3743435|P3|Overall Study|liver transplant|0
1139823|NCT01436500|3743436|P2|Overall Study|liver transplant|0
1139824|NCT01436500|3743437|P1|Overall Study|liver transplant|1
1139825|NCT01436500|3743433|P5|Overall Study|Physician Decision|0
1139826|NCT01436500|3743434|P4|Overall Study|Physician Decision|0
1139827|NCT01436500|3743435|P3|Overall Study|Physician Decision|1
1139828|NCT01436500|3743436|P2|Overall Study|Physician Decision|0
1139829|NCT01436500|3743437|P1|Overall Study|Physician Decision|0
1139830|NCT01436500|3743433|P5|Overall Study|Withdrawal by Subject|2
1139831|NCT01436500|3743434|P4|Overall Study|Withdrawal by Subject|0
1139832|NCT01436500|3743435|P3|Overall Study|Withdrawal by Subject|2
1139833|NCT01436500|3743436|P2|Overall Study|Withdrawal by Subject|0
1139834|NCT01436500|3743437|P1|Overall Study|Withdrawal by Subject|0
1139835|NCT01436500|3743433|P5|Overall Study|Adverse Event|1
1139836|NCT01436500|3743434|P4|Overall Study|Adverse Event|0
1139837|NCT01436500|3743435|P3|Overall Study|Adverse Event|2
1139838|NCT01436500|3743436|P2|Overall Study|Adverse Event|2
1139839|NCT01436500|3743437|P1|Overall Study|Adverse Event|0
1139840|NCT01436500|3743433|P5|Overall Study|Death|0
1139841|NCT01436500|3743434|P4|Overall Study|Death|0
1139842|NCT01436500|3743435|P3|Overall Study|Death|0
1139843|NCT01436500|3743436|P2|Overall Study|Death|0
1139844|NCT01436500|3743437|P1|Overall Study|Death|1
1139845|NCT01436370|3743487|P8|Overall Study|Lost to Follow-up|0
1139846|NCT01436370|3743488|P7|Overall Study|Lost to Follow-up|0
1139847|NCT01436370|3743489|P6|Overall Study|Lost to Follow-up|0
1139848|NCT01436370|3743490|P5|Overall Study|Lost to Follow-up|1
1139849|NCT01436370|3743491|P4|Overall Study|Lost to Follow-up|0
1139850|NCT01436370|3743492|P3|Overall Study|Lost to Follow-up|0
1139851|NCT01436370|3743493|P2|Overall Study|Lost to Follow-up|0
1139852|NCT01436370|3743494|P1|Overall Study|Lost to Follow-up|0
1139853|NCT01436305|3743575|P3|Overall Study|Withdrawal by Subject|0
1139854|NCT01436305|3743576|P2|Overall Study|Withdrawal by Subject|3
1139855|NCT01436305|3743577|P1|Overall Study|Withdrawal by Subject|1
1139856|NCT01436305|3743575|P3|Overall Study|Lost to Follow-up|0
1139857|NCT01436305|3743576|P2|Overall Study|Lost to Follow-up|1
1139858|NCT01436305|3743577|P1|Overall Study|Lost to Follow-up|0
1139859|NCT01436305|3743575|P3|Overall Study|Death|0
1139860|NCT01436305|3743576|P2|Overall Study|Death|0
1139861|NCT01436305|3743577|P1|Overall Study|Death|1
1139862|NCT01436253|3743704|P1|Overall Study|Not meeting all eligibility criteria|117
1139863|NCT01436253|3743704|P1|Overall Study|Lost to Follow-up|182
1139864|NCT01436201|3743709|P1|Overall Study|Protocol Violation|1
1139865|NCT01436201|3743709|P1|Overall Study|Withdrawal by Subject|1
1139866|NCT01436201|3743709|P1|Overall Study|Adverse Event|2
1139867|NCT01436175|3743719|P1|Overall Study|Other|826
1139868|NCT01436175|3743719|P1|Overall Study|Met blood pressure or pulse withdrawal|63
1139869|NCT01436175|3743719|P1|Overall Study|Lack of Efficacy|24
1139870|NCT01436175|3743719|P1|Overall Study|Lost to Follow-up|89
1139871|NCT01436175|3743719|P1|Overall Study|Withdrawal by Subject|108
1139872|NCT01436175|3743719|P1|Overall Study|Protocol Violation|49
1139873|NCT01436175|3743719|P1|Overall Study|Adverse Event|111
1139874|NCT01436162|3743746|P3|Randomized Phase|Not Specified|4
1139875|NCT01436162|3743747|P2|Randomized Phase|Not Specified|5
1139876|NCT01436162|3743748|P1|Randomized Phase|Not Specified|2
1139877|NCT01436162|3743746|P3|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0
1139878|NCT01436162|3743747|P2|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
1139879|NCT01436162|3743748|P1|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4
1139880|NCT01436162|3743746|P3|Randomized Phase|Lack of Efficacy|1
1139881|NCT01436162|3743747|P2|Randomized Phase|Lack of Efficacy|1
1139882|NCT01436162|3743748|P1|Randomized Phase|Lack of Efficacy|0
1139883|NCT01436162|3743746|P3|Randomized Phase|Lost to Follow-up|4
1139884|NCT01436162|3743747|P2|Randomized Phase|Lost to Follow-up|5
1139885|NCT01436162|3743748|P1|Randomized Phase|Lost to Follow-up|17
1139886|NCT01436162|3743746|P3|Randomized Phase|Withdrawal by Subject|8
1139887|NCT01436162|3743747|P2|Randomized Phase|Withdrawal by Subject|9
1139888|NCT01436162|3743748|P1|Randomized Phase|Withdrawal by Subject|16
1139889|NCT01436162|3743746|P3|Randomized Phase|Protocol Violation|2
1139890|NCT01436162|3743747|P2|Randomized Phase|Protocol Violation|4
1139891|NCT01436162|3743748|P1|Randomized Phase|Protocol Violation|4
1139892|NCT01436162|3743746|P3|Randomized Phase|Adverse Event|6
1139893|NCT01436162|3743747|P2|Randomized Phase|Adverse Event|5
1139894|NCT01436162|3743748|P1|Randomized Phase|Adverse Event|1
1139895|NCT01436162|3743746|P3|Single-blind Lead-in Phase|Not Specified|0
1139896|NCT01436162|3743747|P2|Single-blind Lead-in Phase|Not Specified|0
1139897|NCT01436162|3743748|P1|Single-blind Lead-in Phase|Not Specified|107
1139898|NCT01436162|3743746|P3|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
1139899|NCT01436162|3743747|P2|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
1139900|NCT01436162|3743748|P1|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13
1139901|NCT01436162|3743746|P3|Single-blind Lead-in Phase|Lost to Follow-up|0
1139902|NCT01436162|3743747|P2|Single-blind Lead-in Phase|Lost to Follow-up|0
1139903|NCT01436162|3743748|P1|Single-blind Lead-in Phase|Lost to Follow-up|43
1139904|NCT01436162|3743746|P3|Single-blind Lead-in Phase|Withdrawal by Subject|0
1139905|NCT01436162|3743747|P2|Single-blind Lead-in Phase|Withdrawal by Subject|0
1139906|NCT01436162|3743748|P1|Single-blind Lead-in Phase|Withdrawal by Subject|69
1139907|NCT01436162|3743746|P3|Single-blind Lead-in Phase|Protocol Violation|0
1139908|NCT01436162|3743747|P2|Single-blind Lead-in Phase|Protocol Violation|0
1139909|NCT01436162|3743748|P1|Single-blind Lead-in Phase|Protocol Violation|24
1139910|NCT01436162|3743746|P3|Single-blind Lead-in Phase|Adverse Event|0
1139911|NCT01436162|3743747|P2|Single-blind Lead-in Phase|Adverse Event|0
1139912|NCT01436162|3743748|P1|Single-blind Lead-in Phase|Adverse Event|26
1139913|NCT01436149|3743782|P3|Randomized Phase|Not Specified|11
1139914|NCT01436149|3743783|P2|Randomized Phase|Not Specified|5
1139915|NCT01436149|3743784|P1|Randomized Phase|Not Specified|12
1139916|NCT01436149|3743782|P3|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
1139917|NCT01436149|3743783|P2|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
1139918|NCT01436149|3743784|P1|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
1139919|NCT01436149|3743782|P3|Randomized Phase|Lack of Efficacy|1
1139920|NCT01436149|3743783|P2|Randomized Phase|Lack of Efficacy|0
1139921|NCT01436149|3743784|P1|Randomized Phase|Lack of Efficacy|0
1139922|NCT01436149|3743782|P3|Randomized Phase|Lost to Follow-up|6
1139923|NCT01436149|3743783|P2|Randomized Phase|Lost to Follow-up|5
1139924|NCT01436149|3743784|P1|Randomized Phase|Lost to Follow-up|34
1139925|NCT01436149|3743782|P3|Randomized Phase|Withdrawal by Subject|10
1139926|NCT01436149|3743783|P2|Randomized Phase|Withdrawal by Subject|10
1139927|NCT01436149|3743784|P1|Randomized Phase|Withdrawal by Subject|16
1139928|NCT01436149|3743782|P3|Randomized Phase|Protocol Violation|0
1139929|NCT01436149|3743783|P2|Randomized Phase|Protocol Violation|5
1139930|NCT01436149|3743784|P1|Randomized Phase|Protocol Violation|4
1139931|NCT01436149|3743782|P3|Randomized Phase|Adverse Event|11
1139932|NCT01436149|3743783|P2|Randomized Phase|Adverse Event|10
1139933|NCT01436149|3743784|P1|Randomized Phase|Adverse Event|9
1139934|NCT01436149|3743782|P3|Antidepressant Lead-in Phase|Not Specified|0
1139935|NCT01436149|3743783|P2|Antidepressant Lead-in Phase|Not Specified|0
1139936|NCT01436149|3743784|P1|Antidepressant Lead-in Phase|Not Specified|119
1139937|NCT01436149|3743782|P3|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
1139938|NCT01436149|3743783|P2|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
1139939|NCT01436149|3743784|P1|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22
1139940|NCT01436149|3743782|P3|Antidepressant Lead-in Phase|Lost to Follow-up|0
1139941|NCT01436149|3743783|P2|Antidepressant Lead-in Phase|Lost to Follow-up|0
1139942|NCT01436149|3743784|P1|Antidepressant Lead-in Phase|Lost to Follow-up|96
1139943|NCT01436149|3743782|P3|Antidepressant Lead-in Phase|Withdrawal by Subject|0
1139944|NCT01436149|3743783|P2|Antidepressant Lead-in Phase|Withdrawal by Subject|0
1139945|NCT01436149|3743784|P1|Antidepressant Lead-in Phase|Withdrawal by Subject|61
1139946|NCT01436149|3743782|P3|Antidepressant Lead-in Phase|Protocol Violation|0
1139947|NCT01436149|3743783|P2|Antidepressant Lead-in Phase|Protocol Violation|0
1139948|NCT01436149|3743784|P1|Antidepressant Lead-in Phase|Protocol Violation|29
1139949|NCT01436149|3743782|P3|Antidepressant Lead-in Phase|Adverse Event|0
1139950|NCT01436149|3743783|P2|Antidepressant Lead-in Phase|Adverse Event|0
1139951|NCT01436149|3743784|P1|Antidepressant Lead-in Phase|Adverse Event|39
1139952|NCT01436110|3743815|P3|Overall Study|Did Not Receive Trial Medication|3
1139953|NCT01436110|3743816|P2|Overall Study|Did Not Receive Trial Medication|0
1139954|NCT01436110|3743817|P1|Overall Study|Did Not Receive Trial Medication|1
1139955|NCT01436110|3743815|P3|Overall Study|Protocol Violation|1
1139956|NCT01436110|3743816|P2|Overall Study|Protocol Violation|1
1139957|NCT01436110|3743817|P1|Overall Study|Protocol Violation|3
1139958|NCT01436110|3743815|P3|Overall Study|Lost to Follow-up|3
1139959|NCT01436110|3743816|P2|Overall Study|Lost to Follow-up|1
1139960|NCT01436110|3743817|P1|Overall Study|Lost to Follow-up|1
1139961|NCT01436110|3743815|P3|Overall Study|Physician Decision|1
1139962|NCT01436110|3743816|P2|Overall Study|Physician Decision|1
1139963|NCT01436110|3743817|P1|Overall Study|Physician Decision|3
1139964|NCT01436110|3743815|P3|Overall Study|Adverse Event|2
1139965|NCT01436110|3743816|P2|Overall Study|Adverse Event|1
1139966|NCT01436110|3743817|P1|Overall Study|Adverse Event|2
1139967|NCT01436110|3743815|P3|Overall Study|Withdrawal by Subject|4
1139968|NCT01436110|3743816|P2|Overall Study|Withdrawal by Subject|8
1139969|NCT01436110|3743817|P1|Overall Study|Withdrawal by Subject|6
1139970|NCT01436110|3743815|P3|Overall Study|Lack of Efficacy|9
1139971|NCT01436110|3743816|P2|Overall Study|Lack of Efficacy|14
1139972|NCT01436110|3743817|P1|Overall Study|Lack of Efficacy|23
1139973|NCT01436084|3743840|P1|Overall Study|Early Closure of Study|1
1139974|NCT01436084|3743840|P1|Overall Study|Withdrawal by Subject|1
1139975|NCT01436084|3743840|P1|Overall Study|Disease Progression|2
1139976|NCT01436071|3743846|P2|Overall Study|Did Not Receive Trial Medication|3
1139977|NCT01436071|3743847|P1|Overall Study|Did Not Receive Trial Medication|3
1139978|NCT01436071|3743846|P2|Overall Study|Withdrawal by Subject|2
1139979|NCT01436071|3743847|P1|Overall Study|Withdrawal by Subject|2
1139980|NCT01436071|3743846|P2|Overall Study|Physician Decision|0
1139981|NCT01436071|3743847|P1|Overall Study|Physician Decision|1
1139982|NCT01436071|3743846|P2|Overall Study|Lost to Follow-up|1
1139983|NCT01436071|3743847|P1|Overall Study|Lost to Follow-up|3
1139984|NCT01436071|3743846|P2|Overall Study|Protocol Violation|1
1139985|NCT01436071|3743847|P1|Overall Study|Protocol Violation|0
1139986|NCT01436071|3743846|P2|Overall Study|Lack of Efficacy|7
1139987|NCT01436071|3743847|P1|Overall Study|Lack of Efficacy|16
1139988|NCT01436071|3743846|P2|Overall Study|Adverse Event|0
1139989|NCT01436071|3743847|P1|Overall Study|Adverse Event|1
1139990|NCT01435928|3743889|P3|Double Blind Phase - 28 Weeks|Administrative|2
1139991|NCT01435928|3743890|P2|Double Blind Phase - 28 Weeks|Administrative|5
1139992|NCT01435928|3743891|P1|Double Blind Phase - 28 Weeks|Administrative|0
1139993|NCT01435928|3743889|P3|Double Blind Phase - 28 Weeks|Relapse criteria met|58
1139994|NCT01435928|3743890|P2|Double Blind Phase - 28 Weeks|Relapse criteria met|43
1139995|NCT01435928|3743891|P1|Double Blind Phase - 28 Weeks|Relapse criteria met|0
1139996|NCT01435928|3743889|P3|Double Blind Phase - 28 Weeks|Terminated at study completion|39
1139997|NCT01435928|3743890|P2|Double Blind Phase - 28 Weeks|Terminated at study completion|47
1139998|NCT01435928|3743891|P1|Double Blind Phase - 28 Weeks|Terminated at study completion|0
1139999|NCT01435928|3743889|P3|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12
1140000|NCT01435928|3743890|P2|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5
1140001|NCT01435928|3743891|P1|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0
1140002|NCT01435928|3743889|P3|Double Blind Phase - 28 Weeks|Protocol Violation|4
1140003|NCT01435928|3743890|P2|Double Blind Phase - 28 Weeks|Protocol Violation|11
1140004|NCT01435928|3743891|P1|Double Blind Phase - 28 Weeks|Protocol Violation|0
1140005|NCT01435928|3743889|P3|Double Blind Phase - 28 Weeks|Lost to Follow-up|5
1140006|NCT01435928|3743890|P2|Double Blind Phase - 28 Weeks|Lost to Follow-up|2
1140007|NCT01435928|3743891|P1|Double Blind Phase - 28 Weeks|Lost to Follow-up|0
1140008|NCT01435928|3743889|P3|Double Blind Phase - 28 Weeks|Adverse Event|1
1140009|NCT01435928|3743890|P2|Double Blind Phase - 28 Weeks|Adverse Event|3
1140010|NCT01435928|3743891|P1|Double Blind Phase - 28 Weeks|Adverse Event|0
1140011|NCT01435928|3743889|P3|Open Label Phase - up to 24 Weeks|Administrative|0
1140012|NCT01435928|3743890|P2|Open Label Phase - up to 24 Weeks|Administrative|0
1140013|NCT01435928|3743891|P1|Open Label Phase - up to 24 Weeks|Administrative|14
1140014|NCT01435928|3743889|P3|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
1140015|NCT01435928|3743890|P2|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
1140016|NCT01435928|3743891|P1|Open Label Phase - up to 24 Weeks|Terminated at study completion|6
1140017|NCT01435928|3743889|P3|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
1140018|NCT01435928|3743890|P2|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
1140019|NCT01435928|3743891|P1|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44
1140020|NCT01435928|3743889|P3|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
1140021|NCT01435928|3743890|P2|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
1140022|NCT01435928|3743891|P1|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96
1140023|NCT01435928|3743889|P3|Open Label Phase - up to 24 Weeks|Protocol Violation|0
1140024|NCT01435928|3743890|P2|Open Label Phase - up to 24 Weeks|Protocol Violation|0
1140025|NCT01435928|3743891|P1|Open Label Phase - up to 24 Weeks|Protocol Violation|39
1140026|NCT01435928|3743889|P3|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
1140027|NCT01435928|3743890|P2|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
1140028|NCT01435928|3743891|P1|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60
1140029|NCT01435928|3743889|P3|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
1140030|NCT01435928|3743890|P2|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
1140031|NCT01435928|3743891|P1|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46
1140032|NCT01435928|3743889|P3|Open Label Phase - up to 24 Weeks|Death|0
1140033|NCT01435928|3743890|P2|Open Label Phase - up to 24 Weeks|Death|0
1140034|NCT01435928|3743891|P1|Open Label Phase - up to 24 Weeks|Death|1
1140035|NCT01435928|3743889|P3|Open Label Phase - up to 24 Weeks|Adverse Event|0
1140036|NCT01435928|3743890|P2|Open Label Phase - up to 24 Weeks|Adverse Event|0
1140037|NCT01435928|3743891|P1|Open Label Phase - up to 24 Weeks|Adverse Event|83
1140038|NCT01435798|3743918|P1|Overall Study|Withdrawal by Subject|1
1140039|NCT01435772|3743935|P3|Overall Study|Other - study termination|10
1140040|NCT01435772|3743936|P2|Overall Study|Other - study termination|2
1140041|NCT01435772|3743937|P1|Overall Study|Other - study termination|2
1140042|NCT01435772|3743935|P3|Overall Study|Withdrawal by Subject|3
1140043|NCT01435772|3743936|P2|Overall Study|Withdrawal by Subject|1
1140044|NCT01435772|3743937|P1|Overall Study|Withdrawal by Subject|0
1140045|NCT01435772|3743935|P3|Overall Study|Adverse Event|2
1140046|NCT01435772|3743936|P2|Overall Study|Adverse Event|0
1140047|NCT01435772|3743937|P1|Overall Study|Adverse Event|1
1140048|NCT01435759|3743987|P6|Double-blind Phase|Not Specified|0
1140049|NCT01435759|3743988|P5|Double-blind Phase|Not Specified|0
1140050|NCT01435759|3743989|P4|Double-blind Phase|Not Specified|2
1140051|NCT01435759|3743990|P3|Double-blind Phase|Not Specified|0
1140052|NCT01435759|3743991|P2|Double-blind Phase|Not Specified|2
1140053|NCT01435759|3743992|P1|Double-blind Phase|Not Specified|8
1140054|NCT01435759|3743987|P6|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
1140055|NCT01435759|3743988|P5|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3
1140056|NCT01435759|3743989|P4|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
1140057|NCT01435759|3743990|P3|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
1140058|NCT01435759|3743991|P2|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
1140059|NCT01435759|3743992|P1|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1
1140060|NCT01435759|3743987|P6|Double-blind Phase|Lost to Follow-up|3
1140061|NCT01435759|3743988|P5|Double-blind Phase|Lost to Follow-up|3
1140062|NCT01435759|3743989|P4|Double-blind Phase|Lost to Follow-up|0
1140063|NCT01435759|3743990|P3|Double-blind Phase|Lost to Follow-up|2
1140064|NCT01435759|3743991|P2|Double-blind Phase|Lost to Follow-up|1
1140065|NCT01435759|3743992|P1|Double-blind Phase|Lost to Follow-up|31
1140066|NCT01435759|3743987|P6|Double-blind Phase|Withdrawal by Subject|2
1140067|NCT01435759|3743988|P5|Double-blind Phase|Withdrawal by Subject|2
1140068|NCT01435759|3743989|P4|Double-blind Phase|Withdrawal by Subject|4
1140069|NCT01435759|3743990|P3|Double-blind Phase|Withdrawal by Subject|3
1140070|NCT01435759|3743991|P2|Double-blind Phase|Withdrawal by Subject|4
1140071|NCT01435759|3743992|P1|Double-blind Phase|Withdrawal by Subject|17
1140072|NCT01435759|3743987|P6|Double-blind Phase|Protocol Violation|1
1140073|NCT01435759|3743988|P5|Double-blind Phase|Protocol Violation|0
1140074|NCT01435759|3743989|P4|Double-blind Phase|Protocol Violation|2
1140075|NCT01435759|3743990|P3|Double-blind Phase|Protocol Violation|1
1140076|NCT01435759|3743991|P2|Double-blind Phase|Protocol Violation|0
1140077|NCT01435759|3743992|P1|Double-blind Phase|Protocol Violation|2
1140078|NCT01435759|3743987|P6|Double-blind Phase|Adverse Event|3
1140079|NCT01435759|3743988|P5|Double-blind Phase|Adverse Event|1
1140080|NCT01435759|3743989|P4|Double-blind Phase|Adverse Event|1
1140081|NCT01435759|3743990|P3|Double-blind Phase|Adverse Event|1
1140082|NCT01435759|3743991|P2|Double-blind Phase|Adverse Event|0
1140083|NCT01435759|3743992|P1|Double-blind Phase|Adverse Event|7
1140084|NCT01435759|3743987|P6|Antidepressant Lead-in Phase|Not Specified|0
1140085|NCT01435759|3743988|P5|Antidepressant Lead-in Phase|Not Specified|0
1140086|NCT01435759|3743989|P4|Antidepressant Lead-in Phase|Not Specified|0
1140087|NCT01435759|3743990|P3|Antidepressant Lead-in Phase|Not Specified|0
1140088|NCT01435759|3743991|P2|Antidepressant Lead-in Phase|Not Specified|0
1140089|NCT01435759|3743992|P1|Antidepressant Lead-in Phase|Not Specified|119
1140090|NCT01435759|3743987|P6|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
1140091|NCT01435759|3743988|P5|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
1140092|NCT01435759|3743989|P4|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
1140093|NCT01435759|3743990|P3|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
1140094|NCT01435759|3743991|P2|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
1140095|NCT01435759|3743992|P1|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10
1140096|NCT01435759|3743987|P6|Antidepressant Lead-in Phase|Lost to Follow-up|0
1140097|NCT01435759|3743988|P5|Antidepressant Lead-in Phase|Lost to Follow-up|0
1140098|NCT01435759|3743989|P4|Antidepressant Lead-in Phase|Lost to Follow-up|0
1140099|NCT01435759|3743990|P3|Antidepressant Lead-in Phase|Lost to Follow-up|0
1140100|NCT01435759|3743991|P2|Antidepressant Lead-in Phase|Lost to Follow-up|0
1140101|NCT01435759|3743992|P1|Antidepressant Lead-in Phase|Lost to Follow-up|83
1140102|NCT01435759|3743987|P6|Antidepressant Lead-in Phase|Withdrawal by Subject|0
1140103|NCT01435759|3743988|P5|Antidepressant Lead-in Phase|Withdrawal by Subject|0
1140104|NCT01435759|3743989|P4|Antidepressant Lead-in Phase|Withdrawal by Subject|0
1140105|NCT01435759|3743990|P3|Antidepressant Lead-in Phase|Withdrawal by Subject|0
1140106|NCT01435759|3743991|P2|Antidepressant Lead-in Phase|Withdrawal by Subject|0
1140107|NCT01435759|3743992|P1|Antidepressant Lead-in Phase|Withdrawal by Subject|74
1140108|NCT01435759|3743987|P6|Antidepressant Lead-in Phase|Protocol Violation|0
1140109|NCT01435759|3743988|P5|Antidepressant Lead-in Phase|Protocol Violation|0
1140110|NCT01435759|3743989|P4|Antidepressant Lead-in Phase|Protocol Violation|0
1140111|NCT01435759|3743990|P3|Antidepressant Lead-in Phase|Protocol Violation|0
1140112|NCT01435759|3743991|P2|Antidepressant Lead-in Phase|Protocol Violation|0
1140113|NCT01435759|3743992|P1|Antidepressant Lead-in Phase|Protocol Violation|16
1140114|NCT01435759|3743987|P6|Antidepressant Lead-in Phase|Adverse Event|0
1140115|NCT01435759|3743988|P5|Antidepressant Lead-in Phase|Adverse Event|0
1140116|NCT01435759|3743989|P4|Antidepressant Lead-in Phase|Adverse Event|0
1140117|NCT01435759|3743990|P3|Antidepressant Lead-in Phase|Adverse Event|0
1140118|NCT01435759|3743991|P2|Antidepressant Lead-in Phase|Adverse Event|0
1140119|NCT01435759|3743992|P1|Antidepressant Lead-in Phase|Adverse Event|40
1140120|NCT01435655|3744019|P1|Overall Study|Other|1
1140121|NCT01435655|3744019|P1|Overall Study|Death|2
1140122|NCT01435616|3744033|P2|Overall Study|Sponsor Decision|0
1140123|NCT01435616|3744034|P1|Overall Study|Sponsor Decision|1
1140124|NCT01435616|3744033|P2|Overall Study|Physician Decision|7
1140125|NCT01435616|3744034|P1|Overall Study|Physician Decision|20
1140126|NCT01435616|3744033|P2|Overall Study|Withdrawal by Subject|24
1140127|NCT01435616|3744034|P1|Overall Study|Withdrawal by Subject|66
1140128|NCT01435616|3744033|P2|Overall Study|Protocol Violation|13
1140129|NCT01435616|3744034|P1|Overall Study|Protocol Violation|16
1140130|NCT01435616|3744033|P2|Overall Study|Lost to Follow-up|13
1140131|NCT01435616|3744034|P1|Overall Study|Lost to Follow-up|22
1140132|NCT01435616|3744033|P2|Overall Study|Death|2
1140133|NCT01435616|3744034|P1|Overall Study|Death|7
1140134|NCT01435616|3744033|P2|Overall Study|Adverse Event|21
1140135|NCT01435616|3744034|P1|Overall Study|Adverse Event|39
1140136|NCT01435577|3744089|P2|Overall Study|Alternative treatment started|1
1140137|NCT01435577|3744090|P1|Overall Study|Alternative treatment started|0
1140138|NCT01435577|3744089|P2|Overall Study|Lack of Efficacy|51
1140139|NCT01435577|3744090|P1|Overall Study|Lack of Efficacy|7
1140140|NCT01435577|3744089|P2|Overall Study|Adverse Event|0
1140141|NCT01435577|3744090|P1|Overall Study|Adverse Event|10
1140142|NCT01435460|3744140|P2|Overall Study|Did not meet eligibility criteria|0
1140143|NCT01435460|3744141|P1|Overall Study|Did not meet eligibility criteria|2
1140144|NCT01435460|3744140|P2|Overall Study|Protocol Violation|1
1140145|NCT01435460|3744141|P1|Overall Study|Protocol Violation|0
1140146|NCT01435460|3744140|P2|Overall Study|Withdrawal by Subject|3
1140147|NCT01435460|3744141|P1|Overall Study|Withdrawal by Subject|1
1140148|NCT01435460|3744140|P2|Overall Study|Lost to Follow-up|1
1140149|NCT01435460|3744141|P1|Overall Study|Lost to Follow-up|6
1140150|NCT01435460|3744140|P2|Overall Study|Adverse Event|1
1140151|NCT01435460|3744141|P1|Overall Study|Adverse Event|2
1140152|NCT01435382|3744157|P4|Overall Study|Withdrawal by Subject|1
1140153|NCT01435382|3744158|P3|Overall Study|Withdrawal by Subject|0
1140154|NCT01435382|3744159|P2|Overall Study|Withdrawal by Subject|2
1140155|NCT01435382|3744160|P1|Overall Study|Withdrawal by Subject|0
1140156|NCT01435382|3744157|P4|Overall Study|Lost to Follow-up|0
1140157|NCT01435382|3744158|P3|Overall Study|Lost to Follow-up|1
1140158|NCT01435382|3744159|P2|Overall Study|Lost to Follow-up|0
1140159|NCT01435382|3744160|P1|Overall Study|Lost to Follow-up|1
1140160|NCT01435265|3744268|P2|Overall Study|Lost to Follow-up|1
1140161|NCT01435265|3744269|P1|Overall Study|Lost to Follow-up|0
1140162|NCT01435122|3744283|P1|Overall Study|Early withdrawal due to toxicity|8
1140163|NCT01435031|3744292|P1|ITT at 4 Years|Lost to Follow-up|1
1140164|NCT01435031|3744292|P1|ITT at 4 Years|Withdrawal by Subject|2
1140165|NCT01435031|3744292|P1|ITT at 4 Years|Death|4
1140166|NCT01435031|3744292|P1|ITT at 3 Years|Lost to Follow-up|4
1140167|NCT01435031|3744292|P1|ITT at 3 Years|Withdrawal by Subject|2
1140168|NCT01435031|3744292|P1|ITT at 3 Years|Death|5
1140169|NCT01435031|3744292|P1|ITT at 2 Years|Lost to Follow-up|4
1140170|NCT01435031|3744292|P1|ITT at 2 Years|Withdrawal by Subject|2
1140171|NCT01435031|3744292|P1|ITT at 2 Years|Death|7
1140172|NCT01435031|3744292|P1|ITT at 1 Year|Lost to Follow-up|6
1140173|NCT01435031|3744292|P1|ITT at 1 Year|Withdrawal by Subject|2
1140174|NCT01435031|3744292|P1|ITT at 1 Year|Death|1
1140175|NCT01435031|3744292|P1|ITT at 6 Months|Lost to Follow-up|3
1140176|NCT01435031|3744292|P1|ITT at 6 Months|Death|2
1140177|NCT01435031|3744292|P1|ITT at 1 Month|Lost to Follow-up|4
1140178|NCT01435031|3744292|P1|ITT at 1 Month|Death|1
1140179|NCT01435031|3744292|P1|ITT at 1 Month|Withdrawal by Subject|1
1140180|NCT01434823|3744392|P2|Overall Study|Incomplete data in medical record|7
1140181|NCT01434823|3744393|P1|Overall Study|Incomplete data in medical record|4
1140182|NCT01434693|3744413|P4|Overall Study|Lost to Follow-up|0
1140183|NCT01434693|3744414|P3|Overall Study|Lost to Follow-up|0
1140184|NCT01434693|3744415|P2|Overall Study|Lost to Follow-up|0
1140185|NCT01434693|3744416|P1|Overall Study|Lost to Follow-up|1
1140186|NCT01434693|3744413|P4|Overall Study|Withdrawal by Subject|1
1140187|NCT01434693|3744414|P3|Overall Study|Withdrawal by Subject|1
1140188|NCT01434693|3744415|P2|Overall Study|Withdrawal by Subject|0
1140189|NCT01434693|3744416|P1|Overall Study|Withdrawal by Subject|1
1140190|NCT01434693|3744413|P4|Overall Study|Adverse Event|0
1140191|NCT01434693|3744414|P3|Overall Study|Adverse Event|0
1140192|NCT01434693|3744415|P2|Overall Study|Adverse Event|0
1140193|NCT01434693|3744416|P1|Overall Study|Adverse Event|1
1140194|NCT01434680|3744430|P4|Overall Study|Protocol Violation|0
1140195|NCT01434680|3744431|P3|Overall Study|Protocol Violation|0
1140196|NCT01434680|3744432|P2|Overall Study|Protocol Violation|1
1140197|NCT01434680|3744433|P1|Overall Study|Protocol Violation|1
1140198|NCT01434680|3744430|P4|Overall Study|Lost to Follow-up|0
1140199|NCT01434680|3744431|P3|Overall Study|Lost to Follow-up|0
1140200|NCT01434680|3744432|P2|Overall Study|Lost to Follow-up|1
1140201|NCT01434680|3744433|P1|Overall Study|Lost to Follow-up|1
1140202|NCT01434680|3744430|P4|Overall Study|Withdrawal by Subject|0
1140203|NCT01434680|3744431|P3|Overall Study|Withdrawal by Subject|2
1140204|NCT01434680|3744432|P2|Overall Study|Withdrawal by Subject|0
1140205|NCT01434680|3744433|P1|Overall Study|Withdrawal by Subject|1
1140206|NCT01434667|3744450|P2|Overall Study|Lost to Follow-up|10
1140207|NCT01434667|3744451|P1|Overall Study|Lost to Follow-up|5
1140208|NCT01434654|3744477|P2|Overall Study|Lost to Follow-up|0
1140209|NCT01434654|3744478|P1|Overall Study|Lost to Follow-up|1
1140210|NCT01434654|3744477|P2|Overall Study|Withdrawal by Subject|0
1140211|NCT01434654|3744478|P1|Overall Study|Withdrawal by Subject|1
1140212|NCT01434290|3744525|P2|Overall Study|No protocol treatment|4
1140213|NCT01434290|3744526|P1|Overall Study|No protocol treatment|2
1140214|NCT01434290|3744525|P2|Overall Study|Protocol Violation|3
1140215|NCT01434290|3744526|P1|Overall Study|Protocol Violation|6
1140216|NCT01433978|3744599|P3|Extension Phase|Study Terminated by Sponsor|4
1140217|NCT01433978|3744600|P2|Extension Phase|Study Terminated by Sponsor|0
1140218|NCT01433978|3744601|P1|Extension Phase|Study Terminated by Sponsor|0
1140219|NCT01433978|3744599|P3|Extension Phase|Lack of Efficacy|1
1140220|NCT01433978|3744600|P2|Extension Phase|Lack of Efficacy|0
1140221|NCT01433978|3744601|P1|Extension Phase|Lack of Efficacy|0
1140222|NCT01433978|3744599|P3|Extension Phase|Adverse Event, Non-Fatal|1
1140223|NCT01433978|3744600|P2|Extension Phase|Adverse Event, Non-Fatal|0
1140224|NCT01433978|3744601|P1|Extension Phase|Adverse Event, Non-Fatal|0
1140225|NCT01433978|3744599|P3|Core Study|Study Terminated by Sponsor|0
1140226|NCT01433978|3744600|P2|Core Study|Study Terminated by Sponsor|9
1140227|NCT01433978|3744601|P1|Core Study|Study Terminated by Sponsor|6
1140228|NCT01433978|3744599|P3|Core Study|Lack of Efficacy|0
1140229|NCT01433978|3744600|P2|Core Study|Lack of Efficacy|1
1140230|NCT01433978|3744601|P1|Core Study|Lack of Efficacy|5
1140231|NCT01433978|3744599|P3|Core Study|Adverse Event, Non-Fatal|0
1140232|NCT01433978|3744600|P2|Core Study|Adverse Event, Non-Fatal|1
1140233|NCT01433978|3744601|P1|Core Study|Adverse Event, Non-Fatal|0
1140234|NCT01433549|3744658|P2|Phase 2: Second Study Product|Adverse Event|1
1140235|NCT01433549|3744659|P1|Phase 2: Second Study Product|Adverse Event|0
1140236|NCT01433471|3744669|P2|Overall Study|Withdrawal by Subject|1
1140237|NCT01433471|3744670|P1|Overall Study|Withdrawal by Subject|0
1140238|NCT01433354|3744686|P1|Overall Study|Subject Withdrew Consent|3
1140239|NCT01433354|3744686|P1|Overall Study|Lack of Efficacy|17
1140240|NCT01433354|3744686|P1|Overall Study|Protocol Violation|2
1140241|NCT01433354|3744686|P1|Overall Study|Administrative problems|90
1140242|NCT01433354|3744686|P1|Overall Study|Lost to Follow-up|1
1140243|NCT01433354|3744686|P1|Overall Study|Adverse Event|6
1140244|NCT01433263|3744702|P2|Overall Study|Withdrawal by Subject|7
1140245|NCT01433263|3744703|P1|Overall Study|Withdrawal by Subject|10
1140246|NCT01433263|3744702|P2|Overall Study|Protocol Deviation|0
1140247|NCT01433263|3744703|P1|Overall Study|Protocol Deviation|1
1140248|NCT01433263|3744702|P2|Overall Study|Lost to Follow-up|1
1140249|NCT01433263|3744703|P1|Overall Study|Lost to Follow-up|0
1140250|NCT01433263|3744702|P2|Overall Study|Death|3
1140251|NCT01433263|3744703|P1|Overall Study|Death|5
1140252|NCT01433263|3744702|P2|Overall Study|Adverse Event|1
1140253|NCT01433263|3744703|P1|Overall Study|Adverse Event|3
1140254|NCT01433250|3744732|P2|Overall Study|Withdrawal by Subject|2
1140255|NCT01433250|3744733|P1|Overall Study|Withdrawal by Subject|3
1140256|NCT01433250|3744732|P2|Overall Study|Protocol Violation|1
1140257|NCT01433250|3744733|P1|Overall Study|Protocol Violation|0
1140258|NCT01433172|3744752|P3|Overall Study|Death|0
1140259|NCT01433172|3744753|P2|Overall Study|Death|2
1140260|NCT01433172|3744754|P1|Overall Study|Death|0
1140261|NCT01433172|3744752|P3|Overall Study|Disease Progression|1
1140262|NCT01433172|3744753|P2|Overall Study|Disease Progression|0
1140263|NCT01433172|3744754|P1|Overall Study|Disease Progression|0
1140264|NCT01433172|3744752|P3|Overall Study|Withdrawal by Subject|0
1140265|NCT01433172|3744753|P2|Overall Study|Withdrawal by Subject|1
1140266|NCT01433172|3744754|P1|Overall Study|Withdrawal by Subject|0
1140267|NCT01433159|3744766|P2|Overall Study|Protocol Violation|1
1140268|NCT01433159|3744767|P1|Overall Study|Protocol Violation|0
1140269|NCT01433159|3744766|P2|Overall Study|Physician Decision|0
1140270|NCT01433159|3744767|P1|Overall Study|Physician Decision|1
1140271|NCT01433159|3744766|P2|Overall Study|Adverse Event|0
1140272|NCT01433159|3744767|P1|Overall Study|Adverse Event|1
1140273|NCT01433055|3744799|P2|Overall Study|Severely elevated triglycerides at entry|0
1140274|NCT01433055|3744800|P1|Overall Study|Severely elevated triglycerides at entry|1
1140275|NCT01433055|3744799|P2|Overall Study|Diagnosed with cancer unrelated to study|0
1140276|NCT01433055|3744800|P1|Overall Study|Diagnosed with cancer unrelated to study|1
1140277|NCT01432938|3744822|P2|Second Intervention|Adverse Event|0
1140278|NCT01432938|3744823|P1|Second Intervention|Adverse Event|1
1140279|NCT01432938|3744822|P2|First Intervention|Physician Decision|0
1140280|NCT01432938|3744823|P1|First Intervention|Physician Decision|1
1140281|NCT01432938|3744822|P2|First Intervention|Protocol Violation|0
1140282|NCT01432938|3744823|P1|First Intervention|Protocol Violation|1
1140283|NCT01432756|3744853|P4|Overall Study|Lost to Follow-up|1
1140284|NCT01432756|3744854|P3|Overall Study|Lost to Follow-up|2
1140285|NCT01432756|3744855|P2|Overall Study|Lost to Follow-up|0
1140286|NCT01432756|3744856|P1|Overall Study|Lost to Follow-up|1
1140287|NCT01432626|3744864|P1|Overall Study|Imaging agent not available|1
1140288|NCT01432626|3744864|P1|Overall Study|Only 1 image competed|2
1140289|NCT01432626|3744864|P1|Overall Study|Withdrawal by Subject|2
1140290|NCT01432626|3744864|P1|Overall Study|LV function recovered|2
1140291|NCT01432600|3744871|P3|Overall Study|Rapid PD, allocated intv. not rec'd|1
1140292|NCT01432600|3744872|P2|Overall Study|Rapid PD, allocated intv. not rec'd|1
1140293|NCT01432600|3744873|P1|Overall Study|Rapid PD, allocated intv. not rec'd|0
1140294|NCT01432574|3744889|P1|Overall Study|Not interested|1
1140295|NCT01432574|3744889|P1|Overall Study|Moved|2
1140296|NCT01432457|3744935|P3|Overall Study|Did not take study drug|3
1140297|NCT01432457|3744936|P2|Overall Study|Did not take study drug|6
1140298|NCT01432457|3744937|P1|Overall Study|Did not take study drug|6
1140299|NCT01432457|3744935|P3|Overall Study|Reasons not defined|4
1140300|NCT01432457|3744936|P2|Overall Study|Reasons not defined|3
1140301|NCT01432457|3744937|P1|Overall Study|Reasons not defined|2
1140302|NCT01432457|3744935|P3|Overall Study|Withdrawal by Subject|9
1140303|NCT01432457|3744936|P2|Overall Study|Withdrawal by Subject|11
1140304|NCT01432457|3744937|P1|Overall Study|Withdrawal by Subject|6
1140305|NCT01432457|3744935|P3|Overall Study|Protocol Violation|6
1140306|NCT01432457|3744936|P2|Overall Study|Protocol Violation|2
1140307|NCT01432457|3744937|P1|Overall Study|Protocol Violation|3
1140308|NCT01432457|3744935|P3|Overall Study|Lost to Follow-up|20
1140309|NCT01432457|3744936|P2|Overall Study|Lost to Follow-up|15
1140310|NCT01432457|3744937|P1|Overall Study|Lost to Follow-up|11
1140311|NCT01432457|3744935|P3|Overall Study|Lack of Efficacy|1
1140312|NCT01432457|3744936|P2|Overall Study|Lack of Efficacy|1
1140313|NCT01432457|3744937|P1|Overall Study|Lack of Efficacy|2
1140314|NCT01432457|3744935|P3|Overall Study|Adverse Event|16
1140315|NCT01432457|3744936|P2|Overall Study|Adverse Event|10
1140316|NCT01432457|3744937|P1|Overall Study|Adverse Event|7
1140317|NCT01432444|3744966|P3|Extension Phase|Withdrawal by Subject|13
1140318|NCT01432444|3744967|P2|Extension Phase|Withdrawal by Subject|0
1140319|NCT01432444|3744968|P1|Extension Phase|Withdrawal by Subject|0
1140320|NCT01432444|3744966|P3|Extension Phase|Physician Decision|1
1140321|NCT01432444|3744967|P2|Extension Phase|Physician Decision|0
1140322|NCT01432444|3744968|P1|Extension Phase|Physician Decision|0
1140323|NCT01432444|3744966|P3|Extension Phase|Met Withdrawal Criteria|144
1140324|NCT01432444|3744967|P2|Extension Phase|Met Withdrawal Criteria|0
1140325|NCT01432444|3744968|P1|Extension Phase|Met Withdrawal Criteria|0
1140326|NCT01432444|3744966|P3|Extension Phase|Sponsor Discontinued Trial|7
1140327|NCT01432444|3744967|P2|Extension Phase|Sponsor Discontinued Trial|0
1140328|NCT01432444|3744968|P1|Extension Phase|Sponsor Discontinued Trial|0
1140329|NCT01432444|3744966|P3|Extension Phase|Adverse Event|10
1140330|NCT01432444|3744967|P2|Extension Phase|Adverse Event|0
1140331|NCT01432444|3744968|P1|Extension Phase|Adverse Event|0
1140332|NCT01432444|3744966|P3|Extension Phase|Lost to Follow-up|17
1140333|NCT01432444|3744967|P2|Extension Phase|Lost to Follow-up|0
1140334|NCT01432444|3744968|P1|Extension Phase|Lost to Follow-up|0
1140335|NCT01432444|3744966|P3|Treatment Phase|Lack of Efficacy|0
1140336|NCT01432444|3744967|P2|Treatment Phase|Lack of Efficacy|10
1140337|NCT01432444|3744968|P1|Treatment Phase|Lack of Efficacy|0
1140338|NCT01432444|3744966|P3|Treatment Phase|Protocol Deviation|0
1140339|NCT01432444|3744967|P2|Treatment Phase|Protocol Deviation|3
1140340|NCT01432444|3744968|P1|Treatment Phase|Protocol Deviation|0
1140341|NCT01432444|3744966|P3|Treatment Phase|Withdrawal by Subject|0
1140342|NCT01432444|3744967|P2|Treatment Phase|Withdrawal by Subject|41
1140343|NCT01432444|3744968|P1|Treatment Phase|Withdrawal by Subject|0
1140344|NCT01432444|3744966|P3|Treatment Phase|Physician Decision|0
1140345|NCT01432444|3744967|P2|Treatment Phase|Physician Decision|5
1140346|NCT01432444|3744968|P1|Treatment Phase|Physician Decision|0
1140347|NCT01432444|3744966|P3|Treatment Phase|Met Withdrawal Criteria|0
1140348|NCT01432444|3744967|P2|Treatment Phase|Met Withdrawal Criteria|11
1140349|NCT01432444|3744968|P1|Treatment Phase|Met Withdrawal Criteria|0
1140350|NCT01432444|3744966|P3|Treatment Phase|Adverse Event|0
1140351|NCT01432444|3744967|P2|Treatment Phase|Adverse Event|37
1140352|NCT01432444|3744968|P1|Treatment Phase|Adverse Event|0
1140353|NCT01432444|3744966|P3|Treatment Phase|Lost to Follow-up|0
1140354|NCT01432444|3744967|P2|Treatment Phase|Lost to Follow-up|33
1140355|NCT01432444|3744968|P1|Treatment Phase|Lost to Follow-up|0
1140356|NCT01432444|3744966|P3|Tolerability/Cross-titration Phase|Lack of Efficacy|0
1140357|NCT01432444|3744967|P2|Tolerability/Cross-titration Phase|Lack of Efficacy|0
1140358|NCT01432444|3744968|P1|Tolerability/Cross-titration Phase|Lack of Efficacy|5
1140359|NCT01432444|3744966|P3|Tolerability/Cross-titration Phase|Protocol Deviation|0
1140360|NCT01432444|3744967|P2|Tolerability/Cross-titration Phase|Protocol Deviation|0
1140361|NCT01432444|3744968|P1|Tolerability/Cross-titration Phase|Protocol Deviation|1
1140362|NCT01432444|3744966|P3|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
1140363|NCT01432444|3744967|P2|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
1140364|NCT01432444|3744968|P1|Tolerability/Cross-titration Phase|Withdrawal by Subject|15
1140365|NCT01432444|3744966|P3|Tolerability/Cross-titration Phase|Physician Decision|0
1140366|NCT01432444|3744967|P2|Tolerability/Cross-titration Phase|Physician Decision|0
1140367|NCT01432444|3744968|P1|Tolerability/Cross-titration Phase|Physician Decision|8
1140368|NCT01432444|3744966|P3|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
1140369|NCT01432444|3744967|P2|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
1140370|NCT01432444|3744968|P1|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5
1140371|NCT01432444|3744966|P3|Tolerability/Cross-titration Phase|Adverse Event|0
1140372|NCT01432444|3744967|P2|Tolerability/Cross-titration Phase|Adverse Event|0
1140373|NCT01432444|3744968|P1|Tolerability/Cross-titration Phase|Adverse Event|16
1140374|NCT01432444|3744966|P3|Tolerability/Cross-titration Phase|Lost to Follow-up|0
1140375|NCT01432444|3744967|P2|Tolerability/Cross-titration Phase|Lost to Follow-up|0
1140376|NCT01432444|3744968|P1|Tolerability/Cross-titration Phase|Lost to Follow-up|10
1140377|NCT01432366|3744994|P1|Overall Study|Other|14
1140378|NCT01432366|3744994|P1|Overall Study|Investigator Forget to Complete Visits|1
1140379|NCT01432366|3744994|P1|Overall Study|Site Closed|20
1140380|NCT01432366|3744994|P1|Overall Study|Lack of Efficacy|1
1140381|NCT01432366|3744994|P1|Overall Study|Lost to Follow-up|13
1140382|NCT01432366|3744994|P1|Overall Study|Pregnancy|1
1140383|NCT01432366|3744994|P1|Overall Study|Withdrawal Due to Non-Compliance|3
1140384|NCT01432366|3744994|P1|Overall Study|Adverse Event|8
1140385|NCT01432366|3744994|P1|Overall Study|Non-Responder|7
1140386|NCT01432327|3745016|P4|Posttest 1 Year|Allergic reaction|1
1140387|NCT01432327|3745017|P3|Posttest 1 Year|Allergic reaction|1
1140388|NCT01432327|3745018|P2|Posttest 1 Year|Allergic reaction|0
1140389|NCT01432327|3745019|P1|Posttest 1 Year|Allergic reaction|0
1140390|NCT01432327|3745016|P4|Posttest 1 Year|Lost to Follow-up|2
1140391|NCT01432327|3745017|P3|Posttest 1 Year|Lost to Follow-up|4
1140392|NCT01432327|3745018|P2|Posttest 1 Year|Lost to Follow-up|0
1140393|NCT01432327|3745019|P1|Posttest 1 Year|Lost to Follow-up|0
1140394|NCT01432327|3745016|P4|Posttest 1 Year|Measurement have to take place in future|20
1140395|NCT01432327|3745017|P3|Posttest 1 Year|Measurement have to take place in future|15
1140396|NCT01432327|3745018|P2|Posttest 1 Year|Measurement have to take place in future|28
1140397|NCT01432327|3745019|P1|Posttest 1 Year|Measurement have to take place in future|24
1140398|NCT01432327|3745016|P4|Posttest 6 Months|Withdrawal by Subject|0
1140399|NCT01432327|3745017|P3|Posttest 6 Months|Withdrawal by Subject|1
1140400|NCT01432327|3745018|P2|Posttest 6 Months|Withdrawal by Subject|0
1140401|NCT01432327|3745019|P1|Posttest 6 Months|Withdrawal by Subject|0
1140402|NCT01432327|3745016|P4|Posttest 6 Months|Allergic reaction|0
1140403|NCT01432327|3745017|P3|Posttest 6 Months|Allergic reaction|1
1140404|NCT01432327|3745018|P2|Posttest 6 Months|Allergic reaction|0
1140405|NCT01432327|3745019|P1|Posttest 6 Months|Allergic reaction|0
1140406|NCT01432327|3745016|P4|Posttest 6 Months|Lost to Follow-up|2
1140407|NCT01432327|3745017|P3|Posttest 6 Months|Lost to Follow-up|3
1140408|NCT01432327|3745018|P2|Posttest 6 Months|Lost to Follow-up|0
1140409|NCT01432327|3745019|P1|Posttest 6 Months|Lost to Follow-up|0
1140410|NCT01432327|3745016|P4|Posttest 3 Months|Allergic reaction|0
1140411|NCT01432327|3745017|P3|Posttest 3 Months|Allergic reaction|0
1140412|NCT01432327|3745018|P2|Posttest 3 Months|Allergic reaction|2
1140413|NCT01432327|3745019|P1|Posttest 3 Months|Allergic reaction|0
1140414|NCT01432327|3745016|P4|Posttest 3 Months|Lost to Follow-up|1
1140415|NCT01432327|3745017|P3|Posttest 3 Months|Lost to Follow-up|2
1140416|NCT01432327|3745018|P2|Posttest 3 Months|Lost to Follow-up|0
1140417|NCT01432327|3745019|P1|Posttest 3 Months|Lost to Follow-up|1
1140418|NCT01432327|3745016|P4|Posttest 3 Months|depression|0
1140419|NCT01432327|3745017|P3|Posttest 3 Months|depression|0
1140420|NCT01432327|3745018|P2|Posttest 3 Months|depression|0
1140421|NCT01432327|3745019|P1|Posttest 3 Months|depression|3
1140422|NCT01432275|3745029|P2|ADC With Calculator (10 Days)|Protocol Violation|1
1140423|NCT01432275|3745030|P1|ADC With Calculator (10 Days)|Protocol Violation|0
1140424|NCT01432275|3745029|P2|ADC With Calculator (10 Days)|Withdrawal by Subject|0
1140425|NCT01432275|3745030|P1|ADC With Calculator (10 Days)|Withdrawal by Subject|2
1140426|NCT01432275|3745029|P2|ADC With Calculator (10 Days)|Physician Decision|1
1140427|NCT01432275|3745030|P1|ADC With Calculator (10 Days)|Physician Decision|1
1140428|NCT01432275|3745029|P2|Second BG Meter System (7 Days)|Withdrawal by Subject|1
1140429|NCT01432275|3745030|P1|Second BG Meter System (7 Days)|Withdrawal by Subject|0
1140430|NCT01432275|3745029|P2|Second BG Meter System (7 Days)|Physician Decision|1
1140431|NCT01432275|3745030|P1|Second BG Meter System (7 Days)|Physician Decision|0
1140432|NCT01432275|3745029|P2|Second BG Meter System (7 Days)|Lost to Follow-up|0
1140433|NCT01432275|3745030|P1|Second BG Meter System (7 Days)|Lost to Follow-up|1
1140434|NCT01432275|3745029|P2|Second BG Meter System (7 Days)|Adverse Event|1
1140435|NCT01432275|3745030|P1|Second BG Meter System (7 Days)|Adverse Event|1
1140436|NCT01432275|3745029|P2|First BG Meter System (7 Days)|Withdrawal by Subject|1
1140437|NCT01432275|3745030|P1|First BG Meter System (7 Days)|Withdrawal by Subject|0
1140438|NCT01432275|3745029|P2|First BG Meter System (7 Days)|Adverse Event|2
1140439|NCT01432275|3745030|P1|First BG Meter System (7 Days)|Adverse Event|0
1140440|NCT01432262|3745039|P2|Overall Study|Withdrawal by Subject|1
1140441|NCT01432262|3745040|P1|Overall Study|Withdrawal by Subject|2
1140442|NCT01432171|3745106|P2|Overall Study|Patient moved to palliative care|0
1140443|NCT01432171|3745107|P1|Overall Study|Patient moved to palliative care|1
1140444|NCT01432171|3745106|P2|Overall Study|Insurance denial trial coverage|0
1140445|NCT01432171|3745107|P1|Overall Study|Insurance denial trial coverage|1
1140446|NCT01432171|3745106|P2|Overall Study|Noncompliance|3
1140447|NCT01432171|3745107|P1|Overall Study|Noncompliance|2
1140448|NCT01432171|3745106|P2|Overall Study|Withdrawal by Subject|1
1140449|NCT01432171|3745107|P1|Overall Study|Withdrawal by Subject|3
1140450|NCT01432171|3745106|P2|Overall Study|Lost to Follow-up|5
1140451|NCT01432171|3745107|P1|Overall Study|Lost to Follow-up|6
1140452|NCT01432171|3745106|P2|Overall Study|Death|2
1140453|NCT01432171|3745107|P1|Overall Study|Death|1
1140454|NCT01431976|3745143|P1|Overall Study|Withdrawal by Subject|1
1140455|NCT01431976|3745143|P1|Overall Study|Physician Decision|1
1140456|NCT01431976|3745143|P1|Overall Study|Met Protocol-defined Stopping Criteria|4
1140457|NCT01431976|3745143|P1|Overall Study|Lack of Efficacy|2
1140458|NCT01431976|3745143|P1|Overall Study|Adverse Event|6
1140459|NCT01431963|3745154|P1|Overall Study|Withdrawal by Subject|3
1140460|NCT01431963|3745154|P1|Overall Study|Physician Decision|4
1140461|NCT01431963|3745154|P1|Overall Study|Protocol-defined Stopping Criteria|2
1140462|NCT01431963|3745154|P1|Overall Study|Protocol Violation|1
1140463|NCT01431963|3745154|P1|Overall Study|Lack of Efficacy|7
1140464|NCT01431963|3745154|P1|Overall Study|Adverse Event|18
1140465|NCT01431950|3745162|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
1140466|NCT01431950|3745163|P1|Overall Study|Met Protocol-defined Stopping Criteria|0
1140467|NCT01431950|3745162|P2|Overall Study|Lost to Follow-up|1
1140468|NCT01431950|3745163|P1|Overall Study|Lost to Follow-up|0
1140469|NCT01431950|3745162|P2|Overall Study|Lack of Efficacy|1
1140470|NCT01431950|3745163|P1|Overall Study|Lack of Efficacy|2
1140471|NCT01431950|3745162|P2|Overall Study|Physician Decision|1
1140472|NCT01431950|3745163|P1|Overall Study|Physician Decision|2
1140473|NCT01431950|3745162|P2|Overall Study|Adverse Event|2
1140474|NCT01431950|3745163|P1|Overall Study|Adverse Event|2
1140475|NCT01431950|3745162|P2|Overall Study|Protocol Violation|3
1140476|NCT01431950|3745163|P1|Overall Study|Protocol Violation|2
1140477|NCT01431950|3745162|P2|Overall Study|Withdrawal by Subject|3
1140478|NCT01431950|3745163|P1|Overall Study|Withdrawal by Subject|4
1140479|NCT01431950|3745162|P2|Overall Study|Study Site Closed/Terminated|3
1140480|NCT01431950|3745163|P1|Overall Study|Study Site Closed/Terminated|7
1140481|NCT01431716|3745201|P1|Overall Study|Withdrawal of consent|1
1140482|NCT01431521|3745226|P4|Overall Study|Withdrawal by Subject|0
1140483|NCT01431521|3745227|P3|Overall Study|Withdrawal by Subject|1
1140484|NCT01431521|3745228|P2|Overall Study|Withdrawal by Subject|0
1140485|NCT01431521|3745229|P1|Overall Study|Withdrawal by Subject|0
1140486|NCT01431508|3745250|P1|Overall Study|Unable to Follow Protocol Procedures|1
1140487|NCT01431508|3745250|P1|Overall Study|Lack of Efficacy|1
1140488|NCT01431287|3745301|P5|Overall Study|not stated above|1
1140489|NCT01431287|3745302|P4|Overall Study|not stated above|2
1140490|NCT01431287|3745303|P3|Overall Study|not stated above|2
1140491|NCT01431287|3745304|P2|Overall Study|not stated above|2
1140492|NCT01431287|3745305|P1|Overall Study|not stated above|4
1140493|NCT01431287|3745301|P5|Overall Study|Consent withdrawn not due to AE|29
1140494|NCT01431287|3745302|P4|Overall Study|Consent withdrawn not due to AE|19
1140495|NCT01431287|3745303|P3|Overall Study|Consent withdrawn not due to AE|34
1140496|NCT01431287|3745304|P2|Overall Study|Consent withdrawn not due to AE|30
1140497|NCT01431287|3745305|P1|Overall Study|Consent withdrawn not due to AE|29
1140498|NCT01431287|3745301|P5|Overall Study|Lost to Follow-up|1
1140499|NCT01431287|3745302|P4|Overall Study|Lost to Follow-up|3
1140500|NCT01431287|3745303|P3|Overall Study|Lost to Follow-up|2
1140501|NCT01431287|3745304|P2|Overall Study|Lost to Follow-up|3
1140502|NCT01431287|3745305|P1|Overall Study|Lost to Follow-up|0
1140503|NCT01431287|3745301|P5|Overall Study|Non compliant with protocol|5
1140504|NCT01431287|3745302|P4|Overall Study|Non compliant with protocol|6
1140505|NCT01431287|3745303|P3|Overall Study|Non compliant with protocol|5
1140506|NCT01431287|3745304|P2|Overall Study|Non compliant with protocol|6
1140507|NCT01431287|3745305|P1|Overall Study|Non compliant with protocol|6
1140508|NCT01431287|3745301|P5|Overall Study|Adverse Event|41
1140509|NCT01431287|3745302|P4|Overall Study|Adverse Event|33
1140510|NCT01431287|3745303|P3|Overall Study|Adverse Event|53
1140511|NCT01431287|3745304|P2|Overall Study|Adverse Event|57
1140512|NCT01431287|3745305|P1|Overall Study|Adverse Event|59
1140513|NCT01431287|3745301|P5|Overall Study|not treated|0
1140514|NCT01431287|3745302|P4|Overall Study|not treated|0
1140515|NCT01431287|3745303|P3|Overall Study|not treated|1
1140516|NCT01431287|3745304|P2|Overall Study|not treated|0
1140517|NCT01431287|3745305|P1|Overall Study|not treated|0
1140518|NCT01431274|3745467|P5|Overall Study|Other reason not stated above|4
1140519|NCT01431274|3745468|P4|Overall Study|Other reason not stated above|2
1140520|NCT01431274|3745469|P3|Overall Study|Other reason not stated above|7
1140521|NCT01431274|3745470|P2|Overall Study|Other reason not stated above|5
1140522|NCT01431274|3745471|P1|Overall Study|Other reason not stated above|6
1140523|NCT01431274|3745467|P5|Overall Study|Lost to Follow-up|0
1140524|NCT01431274|3745468|P4|Overall Study|Lost to Follow-up|4
1140525|NCT01431274|3745469|P3|Overall Study|Lost to Follow-up|1
1140526|NCT01431274|3745470|P2|Overall Study|Lost to Follow-up|7
1140527|NCT01431274|3745471|P1|Overall Study|Lost to Follow-up|6
1140528|NCT01431274|3745467|P5|Overall Study|Non compliant with protocol|4
1140529|NCT01431274|3745468|P4|Overall Study|Non compliant with protocol|4
1140530|NCT01431274|3745469|P3|Overall Study|Non compliant with protocol|4
1140531|NCT01431274|3745470|P2|Overall Study|Non compliant with protocol|8
1140532|NCT01431274|3745471|P1|Overall Study|Non compliant with protocol|5
1140533|NCT01431274|3745467|P5|Overall Study|Consent withdrawn not due to AE|11
1140534|NCT01431274|3745468|P4|Overall Study|Consent withdrawn not due to AE|20
1140535|NCT01431274|3745469|P3|Overall Study|Consent withdrawn not due to AE|17
1140536|NCT01431274|3745470|P2|Overall Study|Consent withdrawn not due to AE|20
1140537|NCT01431274|3745471|P1|Overall Study|Consent withdrawn not due to AE|29
1140538|NCT01431274|3745467|P5|Overall Study|Adverse Event|37
1140539|NCT01431274|3745468|P4|Overall Study|Adverse Event|30
1140540|NCT01431274|3745469|P3|Overall Study|Adverse Event|43
1140541|NCT01431274|3745470|P2|Overall Study|Adverse Event|37
1140542|NCT01431274|3745471|P1|Overall Study|Adverse Event|51
1140543|NCT01431144|3745649|P2|Overall Study|Implant mobility and removal|0
1140544|NCT01431144|3745650|P1|Overall Study|Implant mobility and removal|2
1140545|NCT01431079|3745669|P2|Overall Study|Lost to Follow-up|39
1140546|NCT01431079|3745670|P1|Overall Study|Lost to Follow-up|35
1140547|NCT01430754|3745749|P2|Run-In Phase|Lost to Follow-up|0
1140548|NCT01430754|3745750|P1|Run-In Phase|Lost to Follow-up|1
1140549|NCT01430754|3745749|P2|Run-In Phase|Withdrawal by Subject|0
1140550|NCT01430754|3745750|P1|Run-In Phase|Withdrawal by Subject|2
1140551|NCT01430754|3745749|P2|Run-In Phase|Other|0
1140552|NCT01430754|3745750|P1|Run-In Phase|Other|2
1140553|NCT01430754|3745749|P2|Run-In Phase|Adverse Event|0
1140554|NCT01430754|3745750|P1|Run-In Phase|Adverse Event|2
1140555|NCT01430754|3745749|P2|Run-In Phase|Protocol Violation|0
1140556|NCT01430754|3745750|P1|Run-In Phase|Protocol Violation|6
1140557|NCT01430754|3745749|P2|Run-In Phase|Circadian Period Ineligible|0
1140558|NCT01430754|3745750|P1|Run-In Phase|Circadian Period Ineligible|24
1140559|NCT01430624|3745808|P3|Overall Study|technical or eligibility|2
1140560|NCT01430624|3745809|P2|Overall Study|technical or eligibility|5
1140561|NCT01430624|3745810|P1|Overall Study|technical or eligibility|5
1140562|NCT01430624|3745808|P3|Overall Study|Lost to Follow-up|27
1140563|NCT01430624|3745809|P2|Overall Study|Lost to Follow-up|29
1140564|NCT01430624|3745810|P1|Overall Study|Lost to Follow-up|23
1140565|NCT01430611|3745841|P2|Overall Study|Withdrawal by Subject|14
1140566|NCT01430611|3745842|P1|Overall Study|Withdrawal by Subject|15
1140567|NCT01430611|3745841|P2|Overall Study|Lost to Follow-up|0
1140568|NCT01430611|3745842|P1|Overall Study|Lost to Follow-up|1
1140569|NCT01430611|3745841|P2|Overall Study|Protocol Violation|0
1140570|NCT01430611|3745842|P1|Overall Study|Protocol Violation|1
1140571|NCT01430611|3745841|P2|Overall Study|Adverse Event|1
1140572|NCT01430611|3745842|P1|Overall Study|Adverse Event|0
1140573|NCT01430585|3745860|P1|Overall Study|Other|7
1140574|NCT01430585|3745860|P1|Overall Study|Study Terminated by Sponsor|3
1140575|NCT01430585|3745860|P1|Overall Study|Objective Progression or Relapse|3
1140576|NCT01430585|3745860|P1|Overall Study|Death|1
1140577|NCT01430468|3745895|P2|Overall Study|Withdrawal by Subject|1
1140578|NCT01430468|3745896|P1|Overall Study|Withdrawal by Subject|1
1140579|NCT01430468|3745895|P2|Overall Study|Physician Decision|1
1140580|NCT01430468|3745896|P1|Overall Study|Physician Decision|2
1140581|NCT01430455|3745902|P1|Overall Study|Switched to follow-up phase|1
1140582|NCT01430455|3745902|P1|Overall Study|Withdrawal by Subject|1
1140583|NCT01430403|3745909|P3|Overall Study|Withdrawal by Subject|3
1140584|NCT01430403|3745910|P2|Overall Study|Withdrawal by Subject|1
1140585|NCT01430403|3745911|P1|Overall Study|Withdrawal by Subject|9
1140586|NCT01430403|3745909|P3|Overall Study|Protocol Violation|2
1140587|NCT01430403|3745910|P2|Overall Study|Protocol Violation|3
1140588|NCT01430403|3745911|P1|Overall Study|Protocol Violation|2
1140589|NCT01430403|3745909|P3|Overall Study|Physician Decision|0
1140590|NCT01430403|3745910|P2|Overall Study|Physician Decision|0
1140591|NCT01430403|3745911|P1|Overall Study|Physician Decision|1
1140592|NCT01430403|3745909|P3|Overall Study|Lost to Follow-up|3
1140593|NCT01430403|3745910|P2|Overall Study|Lost to Follow-up|5
1140594|NCT01430403|3745911|P1|Overall Study|Lost to Follow-up|5
1140595|NCT01430130|3746018|P1|Overall Study|Infection on Control Side of Incision|1
1140596|NCT01430130|3746018|P1|Overall Study|Lost to Follow-up|1
1140597|NCT01430104|3746024|P1|28-Day Teriparatide Treatment Period|Adverse Event|1
1140598|NCT01429792|3746091|P1|Overall Study|Lost to Follow-up|88
1140599|NCT01429792|3746091|P1|Overall Study|Withdrawal by Subject|70
1140600|NCT01429792|3746091|P1|Overall Study|Positive HCV-RNA at Week 24|50
1140601|NCT01429792|3746091|P1|Overall Study|Decrease of less than 2-log in HCV RNA|32
1140602|NCT01429792|3746091|P1|Overall Study|Negative HCV-RNA at Week 12|4
1140603|NCT01429792|3746091|P1|Overall Study|Negative HCV-RNA at Week 4|1
1140604|NCT01429792|3746091|P1|Overall Study|Unknown Disposition|94
1140605|NCT01429792|3746091|P1|Overall Study|Other Reasons|67
1140606|NCT01429623|3746105|P2|Overall Study|No post baseline data|4
1140607|NCT01429623|3746106|P1|Overall Study|No post baseline data|4
1140608|NCT01429623|3746105|P2|Overall Study|Conversion to Alzheimer's disease|21
1140609|NCT01429623|3746106|P1|Overall Study|Conversion to Alzheimer's disease|14
1140610|NCT01429623|3746105|P2|Overall Study|Assorted|2
1140611|NCT01429623|3746106|P1|Overall Study|Assorted|1
1140612|NCT01429623|3746105|P2|Overall Study|Protocol Violation|2
1140613|NCT01429623|3746106|P1|Overall Study|Protocol Violation|3
1140614|NCT01429623|3746105|P2|Overall Study|Physician Decision|3
1140615|NCT01429623|3746106|P1|Overall Study|Physician Decision|2
1140616|NCT01429623|3746105|P2|Overall Study|Withdrawal by Subject|13
1140617|NCT01429623|3746106|P1|Overall Study|Withdrawal by Subject|19
1140618|NCT01429623|3746105|P2|Overall Study|Adverse Event|14
1140619|NCT01429623|3746106|P1|Overall Study|Adverse Event|7
1140620|NCT01429623|3746105|P2|Overall Study|Death|0
1140621|NCT01429623|3746106|P1|Overall Study|Death|1
1140622|NCT01429584|3746120|P2|Overall Study|Protocol Violation|1
1140623|NCT01429584|3746121|P1|Overall Study|Protocol Violation|0
1140624|NCT01429584|3746120|P2|Overall Study|Withdrawal by Subject|0
1140625|NCT01429584|3746121|P1|Overall Study|Withdrawal by Subject|1
1140626|NCT01429441|3746152|P2|Overall Study|Withdrawal by Subject|18
1140627|NCT01429441|3746153|P1|Overall Study|Withdrawal by Subject|27
1140628|NCT01429441|3746152|P2|Overall Study|Physician Decision|0
1140629|NCT01429441|3746153|P1|Overall Study|Physician Decision|1
1140630|NCT01429441|3746152|P2|Overall Study|Lost to Follow-up|2
1140631|NCT01429441|3746153|P1|Overall Study|Lost to Follow-up|5
1140632|NCT01429441|3746152|P2|Overall Study|Death|2
1140633|NCT01429441|3746153|P1|Overall Study|Death|0
1140634|NCT01429441|3746152|P2|Overall Study|Adverse Event|1
1140635|NCT01429441|3746153|P1|Overall Study|Adverse Event|5
1140636|NCT01429298|3746163|P2|Overall Study|Protocol Violation|6
1140637|NCT01429298|3746164|P1|Overall Study|Protocol Violation|4
1140638|NCT01429285|3746180|P2|Overall Study|Erroneously Enrolled Twice|2
1140639|NCT01429285|3746181|P1|Overall Study|Erroneously Enrolled Twice|8
1140640|NCT01429285|3746180|P2|Overall Study|Missing Data|3
1140641|NCT01429285|3746181|P1|Overall Study|Missing Data|5
1140642|NCT01429285|3746180|P2|Overall Study|Protocol Violation|4
1140643|NCT01429285|3746181|P1|Overall Study|Protocol Violation|9
1140644|NCT01429077|3746227|P2|Overall Study|Lost to Follow-up|3
1140645|NCT01429077|3746228|P1|Overall Study|Lost to Follow-up|0
1140646|NCT01429051|3746251|P1|Tolerability Phase|Other|2
1140647|NCT01429051|3746251|P1|Tolerability Phase|Physician Decision|1
1140648|NCT01429051|3746251|P1|Tolerability Phase|Withdrawal by Subject|5
1140649|NCT01429051|3746251|P1|Tolerability Phase|Adverse Event|2
1140650|NCT01429051|3746251|P1|Tolerability Phase|Death|5
1140651|NCT01429051|3746251|P1|Efficacy Phase|Death|1
1140652|NCT01429051|3746251|P1|Efficacy Phase|Adverse Event|1
1140653|NCT01429051|3746251|P1|Titration Phase|Less than 3 BTP episodes per week|2
1140654|NCT01429051|3746251|P1|Titration Phase|Unsuccessful titration at any dose|1
1140655|NCT01429051|3746251|P1|Titration Phase|Physician Decision|1
1140656|NCT01429051|3746251|P1|Titration Phase|Withdrawal by Subject|7
1140657|NCT01429051|3746251|P1|Titration Phase|Death|1
1140658|NCT01428882|3746274|P2|Overall Study|Protocol Violation|3
1140659|NCT01428882|3746275|P1|Overall Study|Protocol Violation|4
1140660|NCT01428882|3746274|P2|Overall Study|Lack of Efficacy|7
1140661|NCT01428882|3746275|P1|Overall Study|Lack of Efficacy|2
1140662|NCT01428713|3746298|P2|Overall Study|Adverse Event|2
1140663|NCT01428713|3746299|P1|Overall Study|Adverse Event|0
1140664|NCT01428713|3746298|P2|Overall Study|Withdrawal by Subject|1
1140665|NCT01428713|3746299|P1|Overall Study|Withdrawal by Subject|1
1140666|NCT01428713|3746298|P2|Overall Study|Non-compliance|2
1140667|NCT01428713|3746299|P1|Overall Study|Non-compliance|2
1140668|NCT01428661|3746308|P3|Open Label Extension|**Various|185
1140669|NCT01428661|3746309|P2|Open Label Extension|**Various|0
1140670|NCT01428661|3746310|P1|Open Label Extension|**Various|0
1140671|NCT01428661|3746308|P3|Open Label Extension|Lack of Efficacy|24
1140672|NCT01428661|3746309|P2|Open Label Extension|Lack of Efficacy|0
1140673|NCT01428661|3746310|P1|Open Label Extension|Lack of Efficacy|0
1140674|NCT01428661|3746308|P3|Open Label Extension|Withdrawal by Subject|49
1140675|NCT01428661|3746309|P2|Open Label Extension|Withdrawal by Subject|0
1140676|NCT01428661|3746310|P1|Open Label Extension|Withdrawal by Subject|0
1140677|NCT01428661|3746308|P3|Open Label Extension|Lost to Follow-up|38
1140678|NCT01428661|3746309|P2|Open Label Extension|Lost to Follow-up|0
1140679|NCT01428661|3746310|P1|Open Label Extension|Lost to Follow-up|0
1140680|NCT01428661|3746308|P3|Open Label Extension|Adverse Event|15
1140681|NCT01428661|3746309|P2|Open Label Extension|Adverse Event|0
1140682|NCT01428661|3746310|P1|Open Label Extension|Adverse Event|0
1140683|NCT01428661|3746308|P3|Open Label Extension|Protocol Violation|9
1140684|NCT01428661|3746309|P2|Open Label Extension|Protocol Violation|0
1140685|NCT01428661|3746310|P1|Open Label Extension|Protocol Violation|0
1140686|NCT01428661|3746308|P3|Double-Masked Phase|*Various|0
1140687|NCT01428661|3746309|P2|Double-Masked Phase|*Various|6
1140688|NCT01428661|3746310|P1|Double-Masked Phase|*Various|1
1140689|NCT01428661|3746308|P3|Double-Masked Phase|Lack of Efficacy|0
1140690|NCT01428661|3746309|P2|Double-Masked Phase|Lack of Efficacy|1
1140691|NCT01428661|3746310|P1|Double-Masked Phase|Lack of Efficacy|2
1140692|NCT01428661|3746308|P3|Double-Masked Phase|Withdrawal by Subject|0
1140693|NCT01428661|3746309|P2|Double-Masked Phase|Withdrawal by Subject|20
1140694|NCT01428661|3746310|P1|Double-Masked Phase|Withdrawal by Subject|18
1140695|NCT01428661|3746308|P3|Double-Masked Phase|Lost to Follow-up|0
1140696|NCT01428661|3746309|P2|Double-Masked Phase|Lost to Follow-up|14
1140697|NCT01428661|3746310|P1|Double-Masked Phase|Lost to Follow-up|14
1140698|NCT01428661|3746308|P3|Double-Masked Phase|Adverse Event|0
1140699|NCT01428661|3746309|P2|Double-Masked Phase|Adverse Event|4
1140700|NCT01428661|3746310|P1|Double-Masked Phase|Adverse Event|13
1140701|NCT01428661|3746308|P3|Double-Masked Phase|Protocol Violation|0
1140702|NCT01428661|3746309|P2|Double-Masked Phase|Protocol Violation|4
1140703|NCT01428661|3746310|P1|Double-Masked Phase|Protocol Violation|9
1140704|NCT01428583|3746318|P1|Overall Study|Other|6
1140705|NCT01428583|3746318|P1|Overall Study|Sponsor’s request|3
1140706|NCT01428583|3746318|P1|Overall Study|Confirmed positive urine drug test|8
1140707|NCT01428583|3746318|P1|Overall Study|Non-compliant|25
1140708|NCT01428583|3746318|P1|Overall Study|Physician Decision|12
1140709|NCT01428583|3746318|P1|Overall Study|Protocol Violation|1
1140710|NCT01428583|3746318|P1|Overall Study|Pregnancy|1
1140711|NCT01428583|3746318|P1|Overall Study|Death|1
1140712|NCT01428583|3746318|P1|Overall Study|Lost to Follow-up|17
1140713|NCT01428583|3746318|P1|Overall Study|Lack of Efficacy|37
1140714|NCT01428583|3746318|P1|Overall Study|Withdrawal by Subject|51
1140715|NCT01428583|3746318|P1|Overall Study|Adverse Event|75
1140716|NCT01428453|3746342|P2|Overall Study|Withdrawal by Subject|1
1140717|NCT01428453|3746343|P1|Overall Study|Withdrawal by Subject|3
1140718|NCT01428453|3746342|P2|Overall Study|Lost to Follow-up|1
1140719|NCT01428453|3746343|P1|Overall Study|Lost to Follow-up|0
1140720|NCT01428453|3746342|P2|Overall Study|Protocol Violation|0
1140721|NCT01428453|3746343|P1|Overall Study|Protocol Violation|1
1140722|NCT01428453|3746342|P2|Overall Study|Adverse Event|7
1140723|NCT01428453|3746343|P1|Overall Study|Adverse Event|2
1140724|NCT01428258|3746382|P2|Intervention 1|Withdrawal by Subject|0
1140725|NCT01428258|3746383|P1|Intervention 1|Withdrawal by Subject|2
1140726|NCT01428219|3746401|P1|Overall Study|25 patients enrolled, 3 were not treated|3
1140727|NCT01428193|3746412|P1|Overall Study|Elevated screening liver enzymes|1
1140728|NCT01428193|3746412|P1|Overall Study|Physician Decision|1
1140729|NCT01428128|3746416|P1|Overall Study|Adverse Event|1
1140730|NCT01428128|3746416|P1|Overall Study|Received Neulasta in one cycle|2
1140731|NCT01428128|3746416|P1|Overall Study|Screen failure by p53|10
1140732|NCT01428128|3746416|P1|Overall Study|Withdrawal by Subject|4
1140733|NCT01428115|3746421|P1|Overall Study|Withdrawal by Subject|4
1140734|NCT01428115|3746421|P1|Overall Study|Protocol Violation|3
1140735|NCT01428115|3746421|P1|Overall Study|Pregnancy|1
1140736|NCT01428115|3746421|P1|Overall Study|Lost to Follow-up|10
1140737|NCT01428115|3746421|P1|Overall Study|Lack of Efficacy|3
1140738|NCT01428076|3746436|P2|Overall Study|Adverse Event|1
1140739|NCT01428076|3746437|P1|Overall Study|Adverse Event|0
1140740|NCT01428063|3746448|P3|Overall Study|No longer meets study criteria|0
1140741|NCT01428063|3746449|P2|Overall Study|No longer meets study criteria|1
1140742|NCT01428063|3746450|P1|Overall Study|No longer meets study criteria|0
1140743|NCT01428063|3746448|P3|Overall Study|Lost to Follow-up|0
1140744|NCT01428063|3746449|P2|Overall Study|Lost to Follow-up|2
1140745|NCT01428063|3746450|P1|Overall Study|Lost to Follow-up|0
1140746|NCT01428063|3746448|P3|Overall Study|Adverse Event|0
1140747|NCT01428063|3746449|P2|Overall Study|Adverse Event|3
1140748|NCT01428063|3746450|P1|Overall Study|Adverse Event|2
1140749|NCT01428063|3746448|P3|Overall Study|Lack of Efficacy|1
1140750|NCT01428063|3746449|P2|Overall Study|Lack of Efficacy|4
1140751|NCT01428063|3746450|P1|Overall Study|Lack of Efficacy|8
1140752|NCT01427933|3746541|P2|Overall Study|Investigator's Decision|0
1140753|NCT01427933|3746542|P1|Overall Study|Investigator's Decision|1
1140754|NCT01427933|3746541|P2|Overall Study|Not Specified|0
1140755|NCT01427933|3746542|P1|Overall Study|Not Specified|1
1140756|NCT01427933|3746541|P2|Overall Study|Lost to Follow-up|5
1140757|NCT01427933|3746542|P1|Overall Study|Lost to Follow-up|1
1140758|NCT01427933|3746541|P2|Overall Study|Withdrawal by Subject|8
1140759|NCT01427933|3746542|P1|Overall Study|Withdrawal by Subject|5
1140760|NCT01427920|3746562|P2|Overall Study|Unclassified|8
1140761|NCT01427920|3746563|P1|Overall Study|Unclassified|2
1140762|NCT01427920|3746562|P2|Overall Study|Withdrawal Criteria|4
1140763|NCT01427920|3746563|P1|Overall Study|Withdrawal Criteria|4
1140764|NCT01427920|3746562|P2|Overall Study|Protocol Violation|3
1140765|NCT01427920|3746563|P1|Overall Study|Protocol Violation|1
1140766|NCT01427920|3746562|P2|Overall Study|Lack of Efficacy|0
1140767|NCT01427920|3746563|P1|Overall Study|Lack of Efficacy|1
1140768|NCT01427920|3746562|P2|Overall Study|Adverse Event|2
1140769|NCT01427920|3746563|P1|Overall Study|Adverse Event|1
1140770|NCT01427907|3746583|P2|Overall Study|Withdrawal by Subject|4
1140771|NCT01427907|3746584|P1|Overall Study|Withdrawal by Subject|3
1140772|NCT01427803|3746605|P2|Overall Study|did not take product|0
1140773|NCT01427803|3746606|P1|Overall Study|did not take product|1
1140774|NCT01427803|3746605|P2|Overall Study|Physician Decision|0
1140775|NCT01427803|3746606|P1|Overall Study|Physician Decision|3
1140776|NCT01427803|3746605|P2|Overall Study|Protocol Violation|0
1140777|NCT01427803|3746606|P1|Overall Study|Protocol Violation|1
1140778|NCT01427803|3746605|P2|Overall Study|Unable to complete full treatment period|0
1140779|NCT01427803|3746606|P1|Overall Study|Unable to complete full treatment period|6
1140780|NCT01427803|3746605|P2|Overall Study|Withdrawal by Subject|0
1140781|NCT01427803|3746606|P1|Overall Study|Withdrawal by Subject|20
1140782|NCT01427803|3746605|P2|Overall Study|Lost to Follow-up|26
1140783|NCT01427803|3746606|P1|Overall Study|Lost to Follow-up|32
1140784|NCT01427751|3746620|P2|Overall Study|Other miscellaneous reasons|4
1140785|NCT01427751|3746621|P1|Overall Study|Other miscellaneous reasons|6
1140786|NCT01427751|3746620|P2|Overall Study|Death|0
1140787|NCT01427751|3746621|P1|Overall Study|Death|2
1140788|NCT01427751|3746620|P2|Overall Study|Protocol Violation|4
1140789|NCT01427751|3746621|P1|Overall Study|Protocol Violation|6
1140790|NCT01427751|3746620|P2|Overall Study|Withdrawal of consent|2
1140791|NCT01427751|3746621|P1|Overall Study|Withdrawal of consent|2
1140792|NCT01427751|3746620|P2|Overall Study|Lost to Follow-up|1
1140793|NCT01427751|3746621|P1|Overall Study|Lost to Follow-up|3
1140794|NCT01427751|3746620|P2|Overall Study|No further treatment benefit expected|1
1140795|NCT01427751|3746621|P1|Overall Study|No further treatment benefit expected|5
1140796|NCT01427751|3746620|P2|Overall Study|Adverse Event|2
1140797|NCT01427751|3746621|P1|Overall Study|Adverse Event|18
1140798|NCT01427738|3746641|P2|Overall Study|Lost to Follow-up|5
1140799|NCT01427738|3746642|P1|Overall Study|Lost to Follow-up|1
1140800|NCT01427738|3746641|P2|Overall Study|Subject not willing to adhere to reqs|2
1140801|NCT01427738|3746642|P1|Overall Study|Subject not willing to adhere to reqs|1
1140802|NCT01427738|3746641|P2|Overall Study|Withdrawal by Subject|2
1140803|NCT01427738|3746642|P1|Overall Study|Withdrawal by Subject|0
1140804|NCT01427738|3746641|P2|Overall Study|Subject unable to get to clinic|2
1140805|NCT01427738|3746642|P1|Overall Study|Subject unable to get to clinic|5
1140806|NCT01427738|3746641|P2|Overall Study|Severe debilitation, unable to continue|1
1140807|NCT01427738|3746642|P1|Overall Study|Severe debilitation, unable to continue|0
1140808|NCT01427738|3746641|P2|Overall Study|Death|9
1140809|NCT01427738|3746642|P1|Overall Study|Death|12
1140810|NCT01427309|3746705|P4|Overall Study|Withdrawal by Subject|55
1140811|NCT01427309|3746706|P3|Overall Study|Withdrawal by Subject|61
1140812|NCT01427309|3746707|P2|Overall Study|Withdrawal by Subject|148
1140813|NCT01427309|3746708|P1|Overall Study|Withdrawal by Subject|148
1140814|NCT01427309|3746705|P4|Overall Study|Serious adverse event|61
1140815|NCT01427309|3746706|P3|Overall Study|Serious adverse event|50
1140816|NCT01427309|3746707|P2|Overall Study|Serious adverse event|45
1140817|NCT01427309|3746708|P1|Overall Study|Serious adverse event|52
1140818|NCT01427309|3746705|P4|Overall Study|Adverse Event|1
1140819|NCT01427309|3746706|P3|Overall Study|Adverse Event|3
1140820|NCT01427309|3746707|P2|Overall Study|Adverse Event|0
1140821|NCT01427309|3746708|P1|Overall Study|Adverse Event|0
1140822|NCT01427309|3746705|P4|Overall Study|Protocol Violation|124
1140823|NCT01427309|3746706|P3|Overall Study|Protocol Violation|125
1140824|NCT01427309|3746707|P2|Overall Study|Protocol Violation|69
1140825|NCT01427309|3746708|P1|Overall Study|Protocol Violation|42
1140826|NCT01427309|3746705|P4|Overall Study|Lost to Follow-up|135
1140827|NCT01427309|3746706|P3|Overall Study|Lost to Follow-up|122
1140828|NCT01427309|3746707|P2|Overall Study|Lost to Follow-up|145
1140829|NCT01427309|3746708|P1|Overall Study|Lost to Follow-up|130
1140830|NCT01426958|3746755|P1|Overall Study|Adverse Event|2
1140831|NCT01426854|3746784|P2|Overall Study|Other|2
1140832|NCT01426854|3746785|P1|Overall Study|Other|3
1140833|NCT01426854|3746784|P2|Overall Study|Protocol Deviation|1
1140834|NCT01426854|3746785|P1|Overall Study|Protocol Deviation|0
1140835|NCT01426854|3746784|P2|Overall Study|Treatment Failure|16
1140836|NCT01426854|3746785|P1|Overall Study|Treatment Failure|0
1140837|NCT01426854|3746784|P2|Overall Study|Noncompliance|1
1140838|NCT01426854|3746785|P1|Overall Study|Noncompliance|0
1140839|NCT01426854|3746784|P2|Overall Study|Lost to Follow-up|0
1140840|NCT01426854|3746785|P1|Overall Study|Lost to Follow-up|3
1140841|NCT01426854|3746784|P2|Overall Study|Subject Decision Unrelated to AE|6
1140842|NCT01426854|3746785|P1|Overall Study|Subject Decision Unrelated to AE|5
1140843|NCT01426854|3746784|P2|Overall Study|Adverse Event|5
1140844|NCT01426854|3746785|P1|Overall Study|Adverse Event|1
1140845|NCT01426789|3746795|P6|Part 2|Adverse Event|0
1140846|NCT01426789|3746796|P5|Part 2|Adverse Event|1
1140847|NCT01426789|3746797|P4|Part 2|Adverse Event|0
1140848|NCT01426789|3746798|P3|Part 2|Adverse Event|2
1140849|NCT01426789|3746799|P2|Part 2|Adverse Event|0
1140850|NCT01426789|3746800|P1|Part 2|Adverse Event|0
1140851|NCT01426789|3746795|P6|Part 2|Lack of Efficacy|0
1140852|NCT01426789|3746796|P5|Part 2|Lack of Efficacy|2
1140853|NCT01426789|3746797|P4|Part 2|Lack of Efficacy|0
1140854|NCT01426789|3746798|P3|Part 2|Lack of Efficacy|5
1140855|NCT01426789|3746799|P2|Part 2|Lack of Efficacy|0
1140856|NCT01426789|3746800|P1|Part 2|Lack of Efficacy|0
1140857|NCT01426789|3746795|P6|Part 2|Withdrawal by Subject|0
1140858|NCT01426789|3746796|P5|Part 2|Withdrawal by Subject|2
1140859|NCT01426789|3746797|P4|Part 2|Withdrawal by Subject|1
1140860|NCT01426789|3746798|P3|Part 2|Withdrawal by Subject|0
1140861|NCT01426789|3746799|P2|Part 2|Withdrawal by Subject|0
1140862|NCT01426789|3746800|P1|Part 2|Withdrawal by Subject|0
1140863|NCT01426789|3746795|P6|Part 2|Lost to Follow-up|0
1140864|NCT01426789|3746796|P5|Part 2|Lost to Follow-up|1
1140865|NCT01426789|3746797|P4|Part 2|Lost to Follow-up|0
1140866|NCT01426789|3746798|P3|Part 2|Lost to Follow-up|4
1140867|NCT01426789|3746799|P2|Part 2|Lost to Follow-up|0
1140868|NCT01426789|3746800|P1|Part 2|Lost to Follow-up|0
1140869|NCT01426789|3746795|P6|Part 2|Administrative problems|0
1140870|NCT01426789|3746796|P5|Part 2|Administrative problems|1
1140871|NCT01426789|3746797|P4|Part 2|Administrative problems|0
1140872|NCT01426789|3746798|P3|Part 2|Administrative problems|2
1140873|NCT01426789|3746799|P2|Part 2|Administrative problems|0
1140874|NCT01426789|3746800|P1|Part 2|Administrative problems|0
1140875|NCT01426789|3746795|P6|Part 2|Death|0
1140876|NCT01426789|3746796|P5|Part 2|Death|1
1140877|NCT01426789|3746797|P4|Part 2|Death|0
1140878|NCT01426789|3746798|P3|Part 2|Death|1
1140879|NCT01426789|3746799|P2|Part 2|Death|0
1140880|NCT01426789|3746800|P1|Part 2|Death|0
1140881|NCT01426789|3746795|P6|Part 2|Protocol deviation|0
1140882|NCT01426789|3746796|P5|Part 2|Protocol deviation|0
1140883|NCT01426789|3746797|P4|Part 2|Protocol deviation|0
1140884|NCT01426789|3746798|P3|Part 2|Protocol deviation|1
1140885|NCT01426789|3746799|P2|Part 2|Protocol deviation|0
1140886|NCT01426789|3746800|P1|Part 2|Protocol deviation|0
1140887|NCT01426789|3746795|P6|Part 1|Adverse Event|0
1140888|NCT01426789|3746796|P5|Part 1|Adverse Event|0
1140889|NCT01426789|3746797|P4|Part 1|Adverse Event|0
1140890|NCT01426789|3746798|P3|Part 1|Adverse Event|0
1140891|NCT01426789|3746799|P2|Part 1|Adverse Event|0
1140892|NCT01426789|3746800|P1|Part 1|Adverse Event|3
1140893|NCT01426789|3746795|P6|Part 1|Lack of Efficacy|0
1140894|NCT01426789|3746796|P5|Part 1|Lack of Efficacy|0
1140895|NCT01426789|3746797|P4|Part 1|Lack of Efficacy|0
1140896|NCT01426789|3746798|P3|Part 1|Lack of Efficacy|0
1140897|NCT01426789|3746799|P2|Part 1|Lack of Efficacy|1
1140898|NCT01426789|3746800|P1|Part 1|Lack of Efficacy|2
1140899|NCT01426789|3746795|P6|Part 1|Lost to Follow-up|0
1140900|NCT01426789|3746796|P5|Part 1|Lost to Follow-up|0
1140901|NCT01426789|3746797|P4|Part 1|Lost to Follow-up|0
1140902|NCT01426789|3746798|P3|Part 1|Lost to Follow-up|0
1140903|NCT01426789|3746799|P2|Part 1|Lost to Follow-up|2
1140904|NCT01426789|3746800|P1|Part 1|Lost to Follow-up|1
1140905|NCT01426789|3746795|P6|Part 1|Protocol deviation|0
1140906|NCT01426789|3746796|P5|Part 1|Protocol deviation|0
1140907|NCT01426789|3746797|P4|Part 1|Protocol deviation|0
1140908|NCT01426789|3746798|P3|Part 1|Protocol deviation|0
1140909|NCT01426789|3746799|P2|Part 1|Protocol deviation|1
1140910|NCT01426789|3746800|P1|Part 1|Protocol deviation|0
1140911|NCT01426438|3746845|P2|Overall Study|Missed Scan|2
1140912|NCT01426438|3746846|P1|Overall Study|Missed Scan|2
1140913|NCT01426438|3746845|P2|Overall Study|Poor scan quality|2
1140914|NCT01426438|3746846|P1|Overall Study|Poor scan quality|3
1140915|NCT01426438|3746845|P2|Overall Study|Off study Treatment|3
1140916|NCT01426438|3746846|P1|Overall Study|Off study Treatment|9
1140917|NCT01426438|3746845|P2|Overall Study|Lost to Follow-up|3
1140918|NCT01426438|3746846|P1|Overall Study|Lost to Follow-up|1
1140919|NCT01426425|3746878|P1|Overall Study|Met inclusion/exclusion, not treated|2
1140920|NCT01426425|3746878|P1|Overall Study|Inclusion/exclusion criteria not met|151
1140921|NCT01426425|3746878|P1|Overall Study|Exited prior to EP study|22
1140922|NCT01426386|3746890|P6|Overall Study|Personal reasons|0
1140923|NCT01426386|3746891|P5|Overall Study|Personal reasons|1
1140924|NCT01426386|3746892|P4|Overall Study|Personal reasons|0
1140925|NCT01426386|3746893|P3|Overall Study|Personal reasons|0
1140926|NCT01426386|3746894|P2|Overall Study|Personal reasons|0
1140927|NCT01426386|3746895|P1|Overall Study|Personal reasons|0
1140928|NCT01426386|3746890|P6|Overall Study|Poor response|0
1140929|NCT01426386|3746891|P5|Overall Study|Poor response|1
1140930|NCT01426386|3746892|P4|Overall Study|Poor response|0
1140931|NCT01426386|3746893|P3|Overall Study|Poor response|2
1140932|NCT01426386|3746894|P2|Overall Study|Poor response|1
1140933|NCT01426386|3746895|P1|Overall Study|Poor response|2
1140934|NCT01426386|3746890|P6|Overall Study|Did not attend scheduled visit|1
1140935|NCT01426386|3746891|P5|Overall Study|Did not attend scheduled visit|2
1140936|NCT01426386|3746892|P4|Overall Study|Did not attend scheduled visit|0
1140937|NCT01426386|3746893|P3|Overall Study|Did not attend scheduled visit|0
1140938|NCT01426386|3746894|P2|Overall Study|Did not attend scheduled visit|4
1140939|NCT01426386|3746895|P1|Overall Study|Did not attend scheduled visit|1
1140940|NCT01426386|3746890|P6|Overall Study|Adverse Event|0
1140941|NCT01426386|3746891|P5|Overall Study|Adverse Event|0
1140942|NCT01426386|3746892|P4|Overall Study|Adverse Event|0
1140943|NCT01426386|3746893|P3|Overall Study|Adverse Event|0
1140944|NCT01426386|3746894|P2|Overall Study|Adverse Event|1
1140945|NCT01426386|3746895|P1|Overall Study|Adverse Event|0
1140946|NCT01426373|3746951|P1|Overall Study|Miscellaneous Reasons|4
1140947|NCT01426373|3746951|P1|Overall Study|Participant Convenience|10
1140948|NCT01426373|3746951|P1|Overall Study|Lost to Follow-up|14
1140949|NCT01426373|3746951|P1|Overall Study|Adverse Event|6
1140950|NCT01426347|3746984|P2|Overall Study|Withdrawal by Subject|0
1140951|NCT01426347|3746985|P1|Overall Study|Withdrawal by Subject|5
1140952|NCT01426347|3746984|P2|Overall Study|Protocol Violation|0
1140953|NCT01426347|3746985|P1|Overall Study|Protocol Violation|2
1140954|NCT01426347|3746984|P2|Overall Study|Lost to Follow-up|3
1140955|NCT01426347|3746985|P1|Overall Study|Lost to Follow-up|0
1140956|NCT01426269|3746993|P3|Period 2: 40 Weeks|Relapsed|18
1140957|NCT01426269|3746994|P2|Period 2: 40 Weeks|Relapsed|9
1140958|NCT01426269|3746995|P1|Period 2: 40 Weeks|Relapsed|0
1140959|NCT01426269|3746993|P3|Period 2: 40 Weeks|Site closed|5
1140960|NCT01426269|3746994|P2|Period 2: 40 Weeks|Site closed|6
1140961|NCT01426269|3746995|P1|Period 2: 40 Weeks|Site closed|0
1140962|NCT01426269|3746993|P3|Period 2: 40 Weeks|Lost to Follow-up|6
1140963|NCT01426269|3746994|P2|Period 2: 40 Weeks|Lost to Follow-up|8
1140964|NCT01426269|3746995|P1|Period 2: 40 Weeks|Lost to Follow-up|0
1140965|NCT01426269|3746993|P3|Period 2: 40 Weeks|Protocol Violation|5
1140966|NCT01426269|3746994|P2|Period 2: 40 Weeks|Protocol Violation|5
1140967|NCT01426269|3746995|P1|Period 2: 40 Weeks|Protocol Violation|0
1140968|NCT01426269|3746993|P3|Period 2: 40 Weeks|Withdrawal by Subject|11
1140969|NCT01426269|3746994|P2|Period 2: 40 Weeks|Withdrawal by Subject|9
1140970|NCT01426269|3746995|P1|Period 2: 40 Weeks|Withdrawal by Subject|0
1140971|NCT01426269|3746993|P3|Period 2: 40 Weeks|Adverse Event|2
1140972|NCT01426269|3746994|P2|Period 2: 40 Weeks|Adverse Event|1
1140973|NCT01426269|3746995|P1|Period 2: 40 Weeks|Adverse Event|0
1140974|NCT01426269|3746993|P3|Eligibility for Period 2, Randomization|Qualified, opted out|0
1140975|NCT01426269|3746994|P2|Eligibility for Period 2, Randomization|Qualified, opted out|0
1140976|NCT01426269|3746995|P1|Eligibility for Period 2, Randomization|Qualified, opted out|8
1140977|NCT01426269|3746993|P3|Eligibility for Period 2, Randomization|Did not qualify|0
1140978|NCT01426269|3746994|P2|Eligibility for Period 2, Randomization|Did not qualify|0
1140979|NCT01426269|3746995|P1|Eligibility for Period 2, Randomization|Did not qualify|42
1140980|NCT01426269|3746993|P3|Period 1: 12 Weeks|Pregnancy|0
1140981|NCT01426269|3746994|P2|Period 1: 12 Weeks|Pregnancy|0
1140982|NCT01426269|3746995|P1|Period 1: 12 Weeks|Pregnancy|1
1140983|NCT01426269|3746993|P3|Period 1: 12 Weeks|Lost to Follow-up|0
1140984|NCT01426269|3746994|P2|Period 1: 12 Weeks|Lost to Follow-up|0
1140985|NCT01426269|3746995|P1|Period 1: 12 Weeks|Lost to Follow-up|22
1140986|NCT01426269|3746993|P3|Period 1: 12 Weeks|Protocol Violation|0
1140987|NCT01426269|3746994|P2|Period 1: 12 Weeks|Protocol Violation|0
1140988|NCT01426269|3746995|P1|Period 1: 12 Weeks|Protocol Violation|5
1140989|NCT01426269|3746993|P3|Period 1: 12 Weeks|Withdrawal by Subject|0
1140990|NCT01426269|3746994|P2|Period 1: 12 Weeks|Withdrawal by Subject|0
1140991|NCT01426269|3746995|P1|Period 1: 12 Weeks|Withdrawal by Subject|22
1140992|NCT01426269|3746993|P3|Period 1: 12 Weeks|Adverse Event|0
1140993|NCT01426269|3746994|P2|Period 1: 12 Weeks|Adverse Event|0
1140994|NCT01426269|3746995|P1|Period 1: 12 Weeks|Adverse Event|5
1140995|NCT01426217|3747030|P2|Overall Study|lost sample|14
1140996|NCT01426217|3747031|P1|Overall Study|lost sample|8
1140997|NCT01426113|3747039|P2|Overall Study|Adverse Event|1
1140998|NCT01426113|3747040|P1|Overall Study|Adverse Event|0
1140999|NCT01426113|3747039|P2|Overall Study|Study Discontinued|1
1141000|NCT01426113|3747040|P1|Overall Study|Study Discontinued|1
1141001|NCT01426009|3747046|P1|Washout 4|Lost to Follow-up|1
1141002|NCT01426009|3747046|P1|Period 4-Fourth Intervention (7 Days)|personal reasons|1
1141003|NCT01426009|3747046|P1|Washout 3|personal reasons|1
1141004|NCT01426009|3747046|P1|Washout 2|electrive surgery|1
1141005|NCT01426009|3747046|P1|Period 2-Second Intervention (7 Days)|personal reasons|1
1141006|NCT01426009|3747046|P1|Period 2-Second Intervention (7 Days)|Adverse Event|4
1141007|NCT01426009|3747046|P1|Washout 1|Personal Reasons|1
1141008|NCT01426009|3747046|P1|Washout 1|Withdrawal by Subject|1
1141009|NCT01426009|3747046|P1|Period 1-First Intervention (7 Days)|Personal Reasons|1
1141010|NCT01426009|3747046|P1|Period 1-First Intervention (7 Days)|Adverse Event|1
1141011|NCT01425814|3747142|P6|Period 5|Stability criteria not fulfilled|1
1141012|NCT01425814|3747143|P5|Period 5|Stability criteria not fulfilled|0
1141013|NCT01425814|3747144|P4|Period 5|Stability criteria not fulfilled|0
1141014|NCT01425814|3747145|P3|Period 5|Stability criteria not fulfilled|1
1141015|NCT01425814|3747146|P2|Period 5|Stability criteria not fulfilled|0
1141016|NCT01425814|3747147|P1|Period 5|Stability criteria not fulfilled|0
1141017|NCT01425814|3747142|P6|Period 4|Adverse Event|0
1141018|NCT01425814|3747143|P5|Period 4|Adverse Event|0
1141019|NCT01425814|3747144|P4|Period 4|Adverse Event|0
1141020|NCT01425814|3747145|P3|Period 4|Adverse Event|1
1141021|NCT01425814|3747146|P2|Period 4|Adverse Event|0
1141022|NCT01425814|3747147|P1|Period 4|Adverse Event|1
1141023|NCT01425814|3747142|P6|Period 3|Adverse Event|1
1141024|NCT01425814|3747143|P5|Period 3|Adverse Event|0
1141025|NCT01425814|3747144|P4|Period 3|Adverse Event|0
1141026|NCT01425814|3747145|P3|Period 3|Adverse Event|0
1141027|NCT01425814|3747146|P2|Period 3|Adverse Event|0
1141028|NCT01425814|3747147|P1|Period 3|Adverse Event|0
1141029|NCT01425814|3747142|P6|Period 2|Stability criteria not fulfilled|0
1141030|NCT01425814|3747143|P5|Period 2|Stability criteria not fulfilled|0
1141031|NCT01425814|3747144|P4|Period 2|Stability criteria not fulfilled|0
1141032|NCT01425814|3747145|P3|Period 2|Stability criteria not fulfilled|0
1141033|NCT01425814|3747146|P2|Period 2|Stability criteria not fulfilled|1
1141034|NCT01425814|3747147|P1|Period 2|Stability criteria not fulfilled|0
1141035|NCT01425814|3747142|P6|Period 1|Stability criteria not fulfilled|0
1141036|NCT01425814|3747143|P5|Period 1|Stability criteria not fulfilled|0
1141037|NCT01425814|3747144|P4|Period 1|Stability criteria not fulfilled|0
1141038|NCT01425814|3747145|P3|Period 1|Stability criteria not fulfilled|0
1141039|NCT01425814|3747146|P2|Period 1|Stability criteria not fulfilled|1
1141040|NCT01425814|3747147|P1|Period 1|Stability criteria not fulfilled|0
1141041|NCT01425801|3747239|P6|Period 4|Not able to maintain visit schedule|0
1141042|NCT01425801|3747240|P5|Period 4|Not able to maintain visit schedule|0
1141043|NCT01425801|3747241|P4|Period 4|Not able to maintain visit schedule|0
1141044|NCT01425801|3747242|P3|Period 4|Not able to maintain visit schedule|1
1141045|NCT01425801|3747243|P2|Period 4|Not able to maintain visit schedule|0
1141046|NCT01425801|3747244|P1|Period 4|Not able to maintain visit schedule|0
1141047|NCT01425801|3747239|P6|Period 3|Stability criteria not fullfilled|0
1141048|NCT01425801|3747240|P5|Period 3|Stability criteria not fullfilled|0
1141049|NCT01425801|3747241|P4|Period 3|Stability criteria not fullfilled|0
1141050|NCT01425801|3747242|P3|Period 3|Stability criteria not fullfilled|1
1141051|NCT01425801|3747243|P2|Period 3|Stability criteria not fullfilled|0
1141052|NCT01425801|3747244|P1|Period 3|Stability criteria not fullfilled|0
1141053|NCT01425801|3747239|P6|Period 2|Withdrawal by Subject|0
1141054|NCT01425801|3747240|P5|Period 2|Withdrawal by Subject|1
1141055|NCT01425801|3747241|P4|Period 2|Withdrawal by Subject|0
1141056|NCT01425801|3747242|P3|Period 2|Withdrawal by Subject|0
1141057|NCT01425801|3747243|P2|Period 2|Withdrawal by Subject|0
1141058|NCT01425801|3747244|P1|Period 2|Withdrawal by Subject|0
1141059|NCT01425801|3747239|P6|Period 1|Withdrawal by Subject|0
1141060|NCT01425801|3747240|P5|Period 1|Withdrawal by Subject|1
1141061|NCT01425801|3747241|P4|Period 1|Withdrawal by Subject|0
1141062|NCT01425801|3747242|P3|Period 1|Withdrawal by Subject|0
1141063|NCT01425801|3747243|P2|Period 1|Withdrawal by Subject|0
1141064|NCT01425801|3747244|P1|Period 1|Withdrawal by Subject|0
1141065|NCT01425749|3747350|P2|Overall Study|progression of melanoma|1
1141066|NCT01425749|3747351|P1|Overall Study|progression of melanoma|0
1141067|NCT01425723|3747368|P2|Overall Study|Other|10
1141068|NCT01425723|3747369|P1|Overall Study|Other|1
1141069|NCT01425723|3747368|P2|Overall Study|Physician Decision|0
1141070|NCT01425723|3747369|P1|Overall Study|Physician Decision|2
1141071|NCT01425723|3747368|P2|Overall Study|Lost to Follow-up|3
1141072|NCT01425723|3747369|P1|Overall Study|Lost to Follow-up|0
1141073|NCT01425723|3747368|P2|Overall Study|Withdrawal by Subject|4
1141074|NCT01425723|3747369|P1|Overall Study|Withdrawal by Subject|1
1141075|NCT01425723|3747368|P2|Overall Study|Lack of Efficacy|1
1141076|NCT01425723|3747369|P1|Overall Study|Lack of Efficacy|0
1141077|NCT01425632|3747399|P3|Overall Study|Withdrawal by Subject|1
1141078|NCT01425632|3747400|P2|Overall Study|Withdrawal by Subject|0
1141079|NCT01425632|3747401|P1|Overall Study|Withdrawal by Subject|0
1141080|NCT01425632|3747399|P3|Overall Study|Protocol Violation|2
1141081|NCT01425632|3747400|P2|Overall Study|Protocol Violation|0
1141082|NCT01425632|3747401|P1|Overall Study|Protocol Violation|0
1141083|NCT01425632|3747399|P3|Overall Study|Physician Decision|0
1141084|NCT01425632|3747400|P2|Overall Study|Physician Decision|0
1141085|NCT01425632|3747401|P1|Overall Study|Physician Decision|1
1141086|NCT01425632|3747399|P3|Overall Study|Adverse Event|1
1141087|NCT01425632|3747400|P2|Overall Study|Adverse Event|1
1141088|NCT01425632|3747401|P1|Overall Study|Adverse Event|0
1141089|NCT01425528|3747411|P2|Overall Study|Withdrawal by Subject|1
1141090|NCT01425528|3747412|P1|Overall Study|Withdrawal by Subject|1
1141091|NCT01425463|3747420|P2|Overall Study|Unknown Reason|7
1141092|NCT01425463|3747421|P1|Overall Study|Unknown Reason|4
1141093|NCT01425463|3747420|P2|Overall Study|Withdrawal by Subject|5
1141094|NCT01425463|3747421|P1|Overall Study|Withdrawal by Subject|7
1141095|NCT01425463|3747420|P2|Overall Study|Lost to Follow-up|2
1141096|NCT01425463|3747421|P1|Overall Study|Lost to Follow-up|5
1141097|NCT01425463|3747420|P2|Overall Study|Protocol Violation|2
1141098|NCT01425463|3747421|P1|Overall Study|Protocol Violation|2
1141099|NCT01425463|3747420|P2|Overall Study|Lack of Efficacy|1
1141100|NCT01425463|3747421|P1|Overall Study|Lack of Efficacy|1
1141101|NCT01425463|3747420|P2|Overall Study|Adverse Event|7
1141102|NCT01425463|3747421|P1|Overall Study|Adverse Event|5
1141103|NCT01425359|3747437|P2|Overall Study|Did Not Meet Qualifying Criteria|5
1141104|NCT01425359|3747438|P1|Overall Study|Did Not Meet Qualifying Criteria|3
1141105|NCT01425359|3747437|P2|Overall Study|Investigator’s Discretion|0
1141106|NCT01425359|3747438|P1|Overall Study|Investigator’s Discretion|2
1141107|NCT01425359|3747437|P2|Overall Study|Subject Withdrew Consent|2
1141108|NCT01425359|3747438|P1|Overall Study|Subject Withdrew Consent|1
1141109|NCT01425359|3747437|P2|Overall Study|Protocol Violation|2
1141110|NCT01425359|3747438|P1|Overall Study|Protocol Violation|1
1141111|NCT01425359|3747437|P2|Overall Study|Unsatisfactory Response|0
1141112|NCT01425359|3747438|P1|Overall Study|Unsatisfactory Response|1
1141113|NCT01425359|3747437|P2|Overall Study|Death|1
1141114|NCT01425359|3747438|P1|Overall Study|Death|0
1141115|NCT01425359|3747437|P2|Overall Study|Revascularization|1
1141116|NCT01425359|3747438|P1|Overall Study|Revascularization|0
1141117|NCT01425359|3747437|P2|Overall Study|Adverse Event|8
1141118|NCT01425359|3747438|P1|Overall Study|Adverse Event|9
1141119|NCT01425359|3747437|P2|Overall Study|Randomized but Not Treated|3
1141120|NCT01425359|3747438|P1|Overall Study|Randomized but Not Treated|2
1141121|NCT01425268|3747469|P2|Overall Study|Physician Decision|0
1141122|NCT01425268|3747470|P1|Overall Study|Physician Decision|1
1141123|NCT01425268|3747469|P2|Overall Study|Sponsor Decision|0
1141124|NCT01425268|3747470|P1|Overall Study|Sponsor Decision|5
1141125|NCT01425268|3747469|P2|Overall Study|Withdrawal by Subject|0
1141126|NCT01425268|3747470|P1|Overall Study|Withdrawal by Subject|2
1141127|NCT01425203|3747491|P3|Crossover Phase|Other virologic failure criteria|3
1141128|NCT01425203|3747492|P2|Crossover Phase|Other virologic failure criteria|0
1141129|NCT01425203|3747493|P1|Crossover Phase|Other virologic failure criteria|0
1141130|NCT01425203|3747491|P3|Crossover Phase|Failure at futility timepoint|3
1141131|NCT01425203|3747492|P2|Crossover Phase|Failure at futility timepoint|0
1141132|NCT01425203|3747493|P1|Crossover Phase|Failure at futility timepoint|0
1141133|NCT01425203|3747491|P3|Treatment Phase|Did not receive treatment|0
1141134|NCT01425203|3747492|P2|Treatment Phase|Did not receive treatment|1
1141135|NCT01425203|3747493|P1|Treatment Phase|Did not receive treatment|0
1141136|NCT01425203|3747491|P3|Treatment Phase|Unidentified reasons|0
1141137|NCT01425203|3747492|P2|Treatment Phase|Unidentified reasons|5
1141138|NCT01425203|3747493|P1|Treatment Phase|Unidentified reasons|11
1141139|NCT01425203|3747491|P3|Treatment Phase|Other virologic failure criteria|0
1141140|NCT01425203|3747492|P2|Treatment Phase|Other virologic failure criteria|3
1141141|NCT01425203|3747493|P1|Treatment Phase|Other virologic failure criteria|5
1141142|NCT01425203|3747491|P3|Treatment Phase|Failure at futility timepoint|0
1141143|NCT01425203|3747492|P2|Treatment Phase|Failure at futility timepoint|27
1141144|NCT01425203|3747493|P1|Treatment Phase|Failure at futility timepoint|8
1141145|NCT01425203|3747491|P3|Treatment Phase|DC during PR Lead-in Phase|0
1141146|NCT01425203|3747492|P2|Treatment Phase|DC during PR Lead-in Phase|1
1141147|NCT01425203|3747493|P1|Treatment Phase|DC during PR Lead-in Phase|3
1141148|NCT01425190|3747510|P3|Overall Study|Full dose not consumed.|0
1141149|NCT01425190|3747511|P2|Overall Study|Full dose not consumed.|0
1141150|NCT01425190|3747512|P1|Overall Study|Full dose not consumed.|1
1141151|NCT01424930|3747548|P2|Overall Study|Reason not specified|6
1141152|NCT01424930|3747549|P1|Overall Study|Reason not specified|0
1141153|NCT01424930|3747548|P2|Overall Study|Screen Failure|1
1141154|NCT01424930|3747549|P1|Overall Study|Screen Failure|0
1141155|NCT01424930|3747548|P2|Overall Study|Progressive Disease|6
1141156|NCT01424930|3747549|P1|Overall Study|Progressive Disease|3
1141157|NCT01424930|3747548|P2|Overall Study|Death|0
1141158|NCT01424930|3747549|P1|Overall Study|Death|1
1141159|NCT01424930|3747548|P2|Overall Study|Adverse Event|1
1141160|NCT01424930|3747549|P1|Overall Study|Adverse Event|0
1141161|NCT01424813|3747563|P2|Overall Study|not specified|2
1141162|NCT01424813|3747564|P1|Overall Study|not specified|1
1141163|NCT01424813|3747563|P2|Overall Study|Protocol Violation|0
1141164|NCT01424813|3747564|P1|Overall Study|Protocol Violation|1
1141165|NCT01424813|3747563|P2|Overall Study|Withdrawal by Subject|0
1141166|NCT01424813|3747564|P1|Overall Study|Withdrawal by Subject|3
1141167|NCT01424644|3747584|P2|Overall Study|Unable to Classify|0
1141168|NCT01424644|3747585|P1|Overall Study|Unable to Classify|1
1141169|NCT01424644|3747584|P2|Overall Study|Administrative Reason|0
1141170|NCT01424644|3747585|P1|Overall Study|Administrative Reason|1
1141171|NCT01424644|3747584|P2|Overall Study|Protocol Violation|3
1141172|NCT01424644|3747585|P1|Overall Study|Protocol Violation|4
1141173|NCT01424644|3747584|P2|Overall Study|Lost to Follow-up|12
1141174|NCT01424644|3747585|P1|Overall Study|Lost to Follow-up|16
1141175|NCT01424644|3747584|P2|Overall Study|Withdrawal by Subject|12
1141176|NCT01424644|3747585|P1|Overall Study|Withdrawal by Subject|9
1141177|NCT01424644|3747584|P2|Overall Study|Adverse Event|0
1141178|NCT01424644|3747585|P1|Overall Study|Adverse Event|2
1141179|NCT01424566|3747599|P3|Double-blind Treatment|Lack of Efficacy|1
1141180|NCT01424566|3747600|P2|Double-blind Treatment|Lack of Efficacy|1
1141181|NCT01424566|3747601|P1|Double-blind Treatment|Lack of Efficacy|0
1141182|NCT01424566|3747599|P3|Double-blind Treatment|Withdrawal by Investigator|1
1141183|NCT01424566|3747600|P2|Double-blind Treatment|Withdrawal by Investigator|1
1141184|NCT01424566|3747601|P1|Double-blind Treatment|Withdrawal by Investigator|0
1141185|NCT01424566|3747599|P3|Double-blind Treatment|Withdrawal by Subject|0
1141186|NCT01424566|3747600|P2|Double-blind Treatment|Withdrawal by Subject|2
1141187|NCT01424566|3747601|P1|Double-blind Treatment|Withdrawal by Subject|0
1141188|NCT01424566|3747599|P3|Double-blind Treatment|Adverse Event|13
1141189|NCT01424566|3747600|P2|Double-blind Treatment|Adverse Event|21
1141190|NCT01424566|3747601|P1|Double-blind Treatment|Adverse Event|0
1141191|NCT01424566|3747599|P3|Single-blind Treatment|Did Not Administer Any Study Drug|0
1141192|NCT01424566|3747600|P2|Single-blind Treatment|Did Not Administer Any Study Drug|0
1141193|NCT01424566|3747601|P1|Single-blind Treatment|Did Not Administer Any Study Drug|2
1141194|NCT01424566|3747599|P3|Single-blind Treatment|Met Exclusion Criteria|0
1141195|NCT01424566|3747600|P2|Single-blind Treatment|Met Exclusion Criteria|0
1141196|NCT01424566|3747601|P1|Single-blind Treatment|Met Exclusion Criteria|1
1141197|NCT01424566|3747599|P3|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
1141198|NCT01424566|3747600|P2|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
1141199|NCT01424566|3747601|P1|Single-blind Treatment|Did Not Meet Inclusion Criteria|108
1141200|NCT01424566|3747599|P3|Single-blind Treatment|Withdrawal by Investigator|0
1141201|NCT01424566|3747600|P2|Single-blind Treatment|Withdrawal by Investigator|0
1141202|NCT01424566|3747601|P1|Single-blind Treatment|Withdrawal by Investigator|2
1141203|NCT01424566|3747599|P3|Single-blind Treatment|Withdrawal by Subject|0
1141204|NCT01424566|3747600|P2|Single-blind Treatment|Withdrawal by Subject|0
1141205|NCT01424566|3747601|P1|Single-blind Treatment|Withdrawal by Subject|16
1141206|NCT01424566|3747599|P3|Single-blind Treatment|Adverse Event|0
1141207|NCT01424566|3747600|P2|Single-blind Treatment|Adverse Event|0
1141208|NCT01424566|3747601|P1|Single-blind Treatment|Adverse Event|71
1141209|NCT01424514|3747628|P2|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0
1141210|NCT01424514|3747629|P1|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1
1141211|NCT01424514|3747628|P2|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
1141212|NCT01424514|3747629|P1|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
1141213|NCT01424501|3747674|P6|Overall Study|Lost to Follow-up|0
1141214|NCT01424501|3747675|P5|Overall Study|Lost to Follow-up|0
1141215|NCT01424501|3747676|P4|Overall Study|Lost to Follow-up|0
1141216|NCT01424501|3747677|P3|Overall Study|Lost to Follow-up|1
1141217|NCT01424501|3747678|P2|Overall Study|Lost to Follow-up|1
1141218|NCT01424501|3747679|P1|Overall Study|Lost to Follow-up|0
1141219|NCT01424501|3747674|P6|Overall Study|Withdrawal by Subject|0
1141220|NCT01424501|3747675|P5|Overall Study|Withdrawal by Subject|0
1141221|NCT01424501|3747676|P4|Overall Study|Withdrawal by Subject|0
1141222|NCT01424501|3747677|P3|Overall Study|Withdrawal by Subject|1
1141223|NCT01424501|3747678|P2|Overall Study|Withdrawal by Subject|0
1141224|NCT01424501|3747679|P1|Overall Study|Withdrawal by Subject|1
1141225|NCT01424306|3747843|P6|Overall Study|Protocol Violation|0
1141226|NCT01424306|3747844|P5|Overall Study|Protocol Violation|1
1141227|NCT01424306|3747845|P4|Overall Study|Protocol Violation|0
1141228|NCT01424306|3747846|P3|Overall Study|Protocol Violation|0
1141229|NCT01424306|3747847|P2|Overall Study|Protocol Violation|0
1141230|NCT01424306|3747848|P1|Overall Study|Protocol Violation|0
1141231|NCT01424228|3747897|P2|Overall Study|Unplanned journey|1
1141232|NCT01424228|3747898|P1|Overall Study|Unplanned journey|0
1141233|NCT01424228|3747897|P2|Overall Study|Worsening of symptoms|0
1141234|NCT01424228|3747898|P1|Overall Study|Worsening of symptoms|1
1141235|NCT01424228|3747897|P2|Overall Study|Non-compliance|0
1141236|NCT01424228|3747898|P1|Overall Study|Non-compliance|2
1141237|NCT01424228|3747897|P2|Overall Study|inclusion/exclusion criteria not met|2
1141238|NCT01424228|3747898|P1|Overall Study|inclusion/exclusion criteria not met|2
1141239|NCT01424228|3747897|P2|Overall Study|Lack of Efficacy|7
1141240|NCT01424228|3747898|P1|Overall Study|Lack of Efficacy|5
1141241|NCT01424228|3747897|P2|Overall Study|Sponsor's decision|12
1141242|NCT01424228|3747898|P1|Overall Study|Sponsor's decision|9
1141243|NCT01424228|3747897|P2|Overall Study|Adverse Event|14
1141244|NCT01424228|3747898|P1|Overall Study|Adverse Event|10
1141245|NCT01424228|3747897|P2|Overall Study|Withdrawal by Subject|11
1141246|NCT01424228|3747898|P1|Overall Study|Withdrawal by Subject|27
1141247|NCT01424189|3747938|P2|Overall Study|Death|1
1141248|NCT01424189|3747939|P1|Overall Study|Death|3
1141249|NCT01424189|3747938|P2|Overall Study|Subject moved|0
1141250|NCT01424189|3747939|P1|Overall Study|Subject moved|1
1141251|NCT01424189|3747938|P2|Overall Study|Withdrawal by Subject|4
1141252|NCT01424189|3747939|P1|Overall Study|Withdrawal by Subject|4
1141253|NCT01424189|3747938|P2|Overall Study|Lost to Follow-up|1
1141254|NCT01424189|3747939|P1|Overall Study|Lost to Follow-up|4
1141255|NCT01424189|3747938|P2|Overall Study|Adverse Event|0
1141256|NCT01424189|3747939|P1|Overall Study|Adverse Event|1
1141257|NCT01423916|3747980|P3|Overall Study|Protocol Deviation|0
1141258|NCT01423916|3747981|P2|Overall Study|Protocol Deviation|0
1141259|NCT01423916|3747982|P1|Overall Study|Protocol Deviation|1
1141260|NCT01423916|3747980|P3|Overall Study|Withdrawal by Subject|3
1141261|NCT01423916|3747981|P2|Overall Study|Withdrawal by Subject|10
1141262|NCT01423916|3747982|P1|Overall Study|Withdrawal by Subject|3
1141263|NCT01423916|3747980|P3|Overall Study|Physician Decision|1
1141264|NCT01423916|3747981|P2|Overall Study|Physician Decision|0
1141265|NCT01423916|3747982|P1|Overall Study|Physician Decision|1
1141266|NCT01423916|3747980|P3|Overall Study|Met Withdrawal Criteria|1
1141267|NCT01423916|3747981|P2|Overall Study|Met Withdrawal Criteria|1
1141268|NCT01423916|3747982|P1|Overall Study|Met Withdrawal Criteria|1
1141269|NCT01423916|3747980|P3|Overall Study|Adverse Event|2
1141270|NCT01423916|3747981|P2|Overall Study|Adverse Event|9
1141271|NCT01423916|3747982|P1|Overall Study|Adverse Event|5
1141272|NCT01423812|3748038|P2|Overall Study|Withdrawal by Subject|2
1141273|NCT01423812|3748039|P1|Overall Study|Withdrawal by Subject|1
1141274|NCT01423812|3748038|P2|Overall Study|Lost to Follow-up|2
1141275|NCT01423812|3748039|P1|Overall Study|Lost to Follow-up|2
1141276|NCT01423617|3748067|P2|Overall Study|Lost to Follow-up|1
1141277|NCT01423617|3748068|P1|Overall Study|Lost to Follow-up|0
1141278|NCT01423604|3748085|P2|Randomized|Patient decision|9
1141279|NCT01423604|3748086|P1|Randomized|Patient decision|5
1141280|NCT01423604|3748085|P2|Randomized|Other - unspecified|31
1141281|NCT01423604|3748086|P1|Randomized|Other - unspecified|37
1141282|NCT01423604|3748085|P2|Randomized|Physician Decision|13
1141283|NCT01423604|3748086|P1|Randomized|Physician Decision|16
1141284|NCT01423604|3748085|P2|Randomized|Death|0
1141285|NCT01423604|3748086|P1|Randomized|Death|1
1141286|NCT01423604|3748085|P2|Randomized|Adverse Event|10
1141287|NCT01423604|3748086|P1|Randomized|Adverse Event|4
1141288|NCT01423604|3748085|P2|Safety Run-In|Patient decision|0
1141289|NCT01423604|3748086|P1|Safety Run-In|Patient decision|1
1141290|NCT01423604|3748085|P2|Safety Run-In|Disease progression|0
1141291|NCT01423604|3748086|P1|Safety Run-In|Disease progression|3
1141292|NCT01423604|3748085|P2|Safety Run-In|Physician Decision|0
1141293|NCT01423604|3748086|P1|Safety Run-In|Physician Decision|1
1141294|NCT01423604|3748085|P2|Safety Run-In|Death|0
1141295|NCT01423604|3748086|P1|Safety Run-In|Death|1
1141296|NCT01423604|3748085|P2|Safety Run-In|Adverse Event|0
1141297|NCT01423604|3748086|P1|Safety Run-In|Adverse Event|3
1141298|NCT01423253|3748101|P1|Overall Study|Withdrawal by Subject|2
1141299|NCT01423253|3748101|P1|Overall Study|Protocol Violation|2
1141300|NCT01423253|3748101|P1|Overall Study|Lost to Follow-up|1
1141301|NCT01423253|3748101|P1|Overall Study|Lack of Efficacy|2
1141302|NCT01423253|3748101|P1|Overall Study|Adverse Event|2
1141303|NCT01423084|3748123|P2|Overall Study|Withdrawal by Subject|3
1141304|NCT01423084|3748124|P1|Overall Study|Withdrawal by Subject|2
1141305|NCT01423084|3748123|P2|Overall Study|Adverse Event|1
1141306|NCT01423084|3748124|P1|Overall Study|Adverse Event|0
1141307|NCT01422915|3748154|P1|Overall Study|Adverse Event|1
1141308|NCT01422889|3748159|P1|Overall Study|No Data Entered for Study Stent|9
1141309|NCT01422876|3748174|P10|Week 52|Death|0
1141310|NCT01422876|3748175|P9|Week 52|Death|1
1141311|NCT01422876|3748176|P8|Week 52|Death|3
1141312|NCT01422876|3748177|P7|Week 52|Death|1
1141313|NCT01422876|3748178|P6|Week 52|Death|0
1141314|NCT01422876|3748179|P5|Week 52|Death|0
1141315|NCT01422876|3748180|P4|Week 52|Death|1
1141316|NCT01422876|3748181|P3|Week 52|Death|0
1141317|NCT01422876|3748182|P2|Week 52|Death|1
1141318|NCT01422876|3748183|P1|Week 52|Death|0
1141319|NCT01422876|3748174|P10|Week 52|Consent withdrawn|9
1141320|NCT01422876|3748175|P9|Week 52|Consent withdrawn|13
1141321|NCT01422876|3748176|P8|Week 52|Consent withdrawn|12
1141322|NCT01422876|3748177|P7|Week 52|Consent withdrawn|10
1141323|NCT01422876|3748178|P6|Week 52|Consent withdrawn|12
1141324|NCT01422876|3748179|P5|Week 52|Consent withdrawn|7
1141325|NCT01422876|3748180|P4|Week 52|Consent withdrawn|12
1141326|NCT01422876|3748181|P3|Week 52|Consent withdrawn|6
1141327|NCT01422876|3748182|P2|Week 52|Consent withdrawn|4
1141328|NCT01422876|3748183|P1|Week 52|Consent withdrawn|9
1141329|NCT01422876|3748174|P10|Week 52|Lost to Follow-up|8
1141330|NCT01422876|3748175|P9|Week 52|Lost to Follow-up|7
1141331|NCT01422876|3748176|P8|Week 52|Lost to Follow-up|8
1141332|NCT01422876|3748177|P7|Week 52|Lost to Follow-up|5
1141333|NCT01422876|3748178|P6|Week 52|Lost to Follow-up|5
1141334|NCT01422876|3748179|P5|Week 52|Lost to Follow-up|8
1141335|NCT01422876|3748180|P4|Week 52|Lost to Follow-up|5
1141336|NCT01422876|3748181|P3|Week 52|Lost to Follow-up|7
1141337|NCT01422876|3748182|P2|Week 52|Lost to Follow-up|5
1141338|NCT01422876|3748183|P1|Week 52|Lost to Follow-up|3
1141339|NCT01422876|3748174|P10|Week 24|Death|0
1141340|NCT01422876|3748175|P9|Week 24|Death|0
1141341|NCT01422876|3748176|P8|Week 24|Death|0
1141342|NCT01422876|3748177|P7|Week 24|Death|0
1141343|NCT01422876|3748178|P6|Week 24|Death|0
1141344|NCT01422876|3748179|P5|Week 24|Death|0
1141345|NCT01422876|3748180|P4|Week 24|Death|0
1141346|NCT01422876|3748181|P3|Week 24|Death|0
1141347|NCT01422876|3748182|P2|Week 24|Death|1
1141348|NCT01422876|3748183|P1|Week 24|Death|0
1141349|NCT01422876|3748174|P10|Week 24|Consent withdrawn|6
1141350|NCT01422876|3748175|P9|Week 24|Consent withdrawn|3
1141351|NCT01422876|3748176|P8|Week 24|Consent withdrawn|4
1141352|NCT01422876|3748177|P7|Week 24|Consent withdrawn|5
1141353|NCT01422876|3748178|P6|Week 24|Consent withdrawn|6
1141354|NCT01422876|3748179|P5|Week 24|Consent withdrawn|5
1141355|NCT01422876|3748180|P4|Week 24|Consent withdrawn|4
1141356|NCT01422876|3748181|P3|Week 24|Consent withdrawn|3
1141357|NCT01422876|3748182|P2|Week 24|Consent withdrawn|1
1141358|NCT01422876|3748183|P1|Week 24|Consent withdrawn|5
1141359|NCT01422876|3748174|P10|Week 24|Lost to Follow-up|4
1141360|NCT01422876|3748175|P9|Week 24|Lost to Follow-up|3
1141361|NCT01422876|3748176|P8|Week 24|Lost to Follow-up|3
1141362|NCT01422876|3748177|P7|Week 24|Lost to Follow-up|1
1141363|NCT01422876|3748178|P6|Week 24|Lost to Follow-up|0
1141364|NCT01422876|3748179|P5|Week 24|Lost to Follow-up|2
1141365|NCT01422876|3748180|P4|Week 24|Lost to Follow-up|4
1141366|NCT01422876|3748181|P3|Week 24|Lost to Follow-up|2
1141367|NCT01422876|3748182|P2|Week 24|Lost to Follow-up|1
1141368|NCT01422876|3748183|P1|Week 24|Lost to Follow-up|1
1141369|NCT01422850|3748230|P1|Overall Study|Physician Decision|3
1141370|NCT01422824|3748236|P1|Overall Study|Lost to Follow-up|37
1141371|NCT01422824|3748236|P1|Overall Study|Case record form not evaluated|1
1141372|NCT01422720|3748241|P1|Overall Study|Ineligibility|1
1141373|NCT01422720|3748241|P1|Overall Study|Withdrawal by Subject|4
1141374|NCT01422720|3748241|P1|Overall Study|Lack of Efficacy|1
1141375|NCT01422720|3748241|P1|Overall Study|Adverse Event|16
1141376|NCT01422538|3748252|P3|Overall Study|Missed visit|1
1141377|NCT01422538|3748253|P2|Overall Study|Missed visit|1
1141378|NCT01422538|3748254|P1|Overall Study|Missed visit|0
1141379|NCT01422538|3748252|P3|Overall Study|Lost to Follow-up|1
1141380|NCT01422538|3748253|P2|Overall Study|Lost to Follow-up|1
1141381|NCT01422538|3748254|P1|Overall Study|Lost to Follow-up|0
1141382|NCT01422408|3748298|P1|Overall Study|Withdrawal by Subject|3
1141383|NCT01422408|3748298|P1|Overall Study|Adverse Event|1
1141384|NCT01422382|3748327|P1|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1
1141385|NCT01422304|3748343|P2|Overall Study|Not Treated|11
1141386|NCT01422304|3748344|P1|Overall Study|Not Treated|3
1141387|NCT01422304|3748343|P2|Overall Study|Did Not Meet Protocol Eligibility|2
1141388|NCT01422304|3748344|P1|Overall Study|Did Not Meet Protocol Eligibility|0
1141389|NCT01422304|3748343|P2|Overall Study|Withdrawal by Subject|2
1141390|NCT01422304|3748344|P1|Overall Study|Withdrawal by Subject|4
1141391|NCT01422304|3748343|P2|Overall Study|Protocol Violation|0
1141392|NCT01422304|3748344|P1|Overall Study|Protocol Violation|1
1141393|NCT01422304|3748343|P2|Overall Study|Never Entered Follow-up|1
1141394|NCT01422304|3748344|P1|Overall Study|Never Entered Follow-up|2
1141395|NCT01422304|3748343|P2|Overall Study|Lost to Follow-up|20
1141396|NCT01422304|3748344|P1|Overall Study|Lost to Follow-up|14
1141397|NCT01422304|3748343|P2|Overall Study|Adverse Event|1
1141398|NCT01422304|3748344|P1|Overall Study|Adverse Event|0
1141399|NCT01422239|3748376|P2|Overall Study|Lost to Follow-up|3
1141400|NCT01422239|3748377|P1|Overall Study|Lost to Follow-up|4
1141401|NCT01422213|3748399|P3|Overall Study|Administrative or Other Reason(s)|2
1141402|NCT01422213|3748400|P2|Overall Study|Administrative or Other Reason(s)|4
1141403|NCT01422213|3748401|P1|Overall Study|Administrative or Other Reason(s)|5
1141404|NCT01422213|3748399|P3|Overall Study|Lost to Follow-up|5
1141405|NCT01422213|3748400|P2|Overall Study|Lost to Follow-up|3
1141406|NCT01422213|3748401|P1|Overall Study|Lost to Follow-up|3
1141407|NCT01422213|3748399|P3|Overall Study|Withdrawal of Consent|5
1141408|NCT01422213|3748400|P2|Overall Study|Withdrawal of Consent|3
1141409|NCT01422213|3748401|P1|Overall Study|Withdrawal of Consent|7
1141410|NCT01422213|3748399|P3|Overall Study|Protocol Violation|4
1141411|NCT01422213|3748400|P2|Overall Study|Protocol Violation|2
1141412|NCT01422213|3748401|P1|Overall Study|Protocol Violation|0
1141413|NCT01422213|3748399|P3|Overall Study|Non-compliance with study drug|0
1141414|NCT01422213|3748400|P2|Overall Study|Non-compliance with study drug|1
1141415|NCT01422213|3748401|P1|Overall Study|Non-compliance with study drug|0
1141416|NCT01422213|3748399|P3|Overall Study|Lack of Efficacy|2
1141417|NCT01422213|3748400|P2|Overall Study|Lack of Efficacy|2
1141418|NCT01422213|3748401|P1|Overall Study|Lack of Efficacy|10
1141419|NCT01422213|3748399|P3|Overall Study|Adverse Event|11
1141420|NCT01422213|3748400|P2|Overall Study|Adverse Event|7
1141421|NCT01422213|3748401|P1|Overall Study|Adverse Event|8
1141422|NCT01422187|3748462|P3|Overall Study|Lost to Follow-up|0
1141423|NCT01422187|3748463|P2|Overall Study|Lost to Follow-up|1
1141424|NCT01422187|3748464|P1|Overall Study|Lost to Follow-up|0
1141425|NCT01422187|3748462|P3|Overall Study|Personal reason|0
1141426|NCT01422187|3748463|P2|Overall Study|Personal reason|0
1141427|NCT01422187|3748464|P1|Overall Study|Personal reason|1
1141428|NCT01421719|3748509|P1|Overall Study|Withdrawal by Subject|4
1141429|NCT01421667|3748518|P4|Overall Study|Lost to Follow-up|0
1141430|NCT01421667|3748519|P3|Overall Study|Lost to Follow-up|0
1141431|NCT01421667|3748520|P2|Overall Study|Lost to Follow-up|1
1141432|NCT01421667|3748521|P1|Overall Study|Lost to Follow-up|0
1141433|NCT01421667|3748518|P4|Overall Study|Withdrawal by Subject|1
1141434|NCT01421667|3748519|P3|Overall Study|Withdrawal by Subject|2
1141435|NCT01421667|3748520|P2|Overall Study|Withdrawal by Subject|1
1141436|NCT01421667|3748521|P1|Overall Study|Withdrawal by Subject|0
1141437|NCT01421641|3748582|P2|Overall Study|Protocol Violation|2
1141438|NCT01421641|3748583|P1|Overall Study|Protocol Violation|2
1141439|NCT01421511|3748605|P2|Overall Study|Death|1
1141440|NCT01421511|3748606|P1|Overall Study|Death|1
1141441|NCT01421511|3748605|P2|Overall Study|Withdrawal by Subject|5
1141442|NCT01421511|3748606|P1|Overall Study|Withdrawal by Subject|6
1141443|NCT01421511|3748605|P2|Overall Study|Physician Decision|1
1141444|NCT01421511|3748606|P1|Overall Study|Physician Decision|0
1141445|NCT01421511|3748605|P2|Overall Study|Randomized but didn't receive study drug|7
1141446|NCT01421511|3748606|P1|Overall Study|Randomized but didn't receive study drug|1
1141447|NCT01421511|3748605|P2|Overall Study|Lost to Follow-up|14
1141448|NCT01421511|3748606|P1|Overall Study|Lost to Follow-up|11
1141449|NCT01421459|3748656|P2|Overall Study|Withdrawal by Subject|16
1141450|NCT01421459|3748657|P1|Overall Study|Withdrawal by Subject|12
1141451|NCT01421459|3748656|P2|Overall Study|Protocol Violation|5
1141452|NCT01421459|3748657|P1|Overall Study|Protocol Violation|8
1141453|NCT01421459|3748656|P2|Overall Study|Physician Decision|9
1141454|NCT01421459|3748657|P1|Overall Study|Physician Decision|9
1141455|NCT01421459|3748656|P2|Overall Study|Lost to Follow-up|9
1141456|NCT01421459|3748657|P1|Overall Study|Lost to Follow-up|8
1141457|NCT01421459|3748656|P2|Overall Study|Lack of Efficacy|2
1141458|NCT01421459|3748657|P1|Overall Study|Lack of Efficacy|1
1141459|NCT01421459|3748656|P2|Overall Study|Death|1
1141460|NCT01421459|3748657|P1|Overall Study|Death|1
1141461|NCT01421459|3748656|P2|Overall Study|Adverse Event|10
1141462|NCT01421459|3748657|P1|Overall Study|Adverse Event|6
1141463|NCT01421342|3748698|P3|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7
1141464|NCT01421342|3748699|P2|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0
1141465|NCT01421342|3748700|P1|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6
1141466|NCT01421342|3748698|P3|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
1141467|NCT01421342|3748699|P2|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
1141468|NCT01421342|3748700|P1|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
1141469|NCT01421342|3748698|P3|Continuation of Treatment (Week 12 - 36)|Participant moved away|3
1141470|NCT01421342|3748699|P2|Continuation of Treatment (Week 12 - 36)|Participant moved away|1
1141471|NCT01421342|3748700|P1|Continuation of Treatment (Week 12 - 36)|Participant moved away|4
1141472|NCT01421342|3748698|P3|Continuation of Treatment (Week 12 - 36)|End of Study Time|14
1141473|NCT01421342|3748699|P2|Continuation of Treatment (Week 12 - 36)|End of Study Time|20
1141474|NCT01421342|3748700|P1|Continuation of Treatment (Week 12 - 36)|End of Study Time|15
1141475|NCT01421342|3748698|P3|Continuation of Treatment (Week 12 - 36)|Non-adherence|4
1141476|NCT01421342|3748699|P2|Continuation of Treatment (Week 12 - 36)|Non-adherence|8
1141477|NCT01421342|3748700|P1|Continuation of Treatment (Week 12 - 36)|Non-adherence|3
1141478|NCT01421342|3748698|P3|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9
1141479|NCT01421342|3748699|P2|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11
1141480|NCT01421342|3748700|P1|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4
1141481|NCT01421342|3748698|P3|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4
1141482|NCT01421342|3748699|P2|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6
1141483|NCT01421342|3748700|P1|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7
1141484|NCT01421342|3748698|P3|Continuation of Treatment (Week 12 - 36)|Adverse Event|11
1141485|NCT01421342|3748699|P2|Continuation of Treatment (Week 12 - 36)|Adverse Event|6
1141486|NCT01421342|3748700|P1|Continuation of Treatment (Week 12 - 36)|Adverse Event|0
1141487|NCT01421342|3748698|P3|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
1141488|NCT01421342|3748699|P2|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5
1141489|NCT01421342|3748700|P1|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
1141490|NCT01421342|3748698|P3|Completed to Week 12 But Then Withdrawn|End of Study Time|2
1141491|NCT01421342|3748699|P2|Completed to Week 12 But Then Withdrawn|End of Study Time|0
1141492|NCT01421342|3748700|P1|Completed to Week 12 But Then Withdrawn|End of Study Time|0
1141493|NCT01421342|3748698|P3|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4
1141494|NCT01421342|3748699|P2|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
1141495|NCT01421342|3748700|P1|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
1141496|NCT01421342|3748698|P3|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
1141497|NCT01421342|3748699|P2|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
1141498|NCT01421342|3748700|P1|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1
1141499|NCT01421342|3748698|P3|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2
1141500|NCT01421342|3748699|P2|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0
1141501|NCT01421342|3748700|P1|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1
1141502|NCT01421342|3748698|P3|Completed to Week 12 But Then Withdrawn|Non-adherence|5
1141503|NCT01421342|3748699|P2|Completed to Week 12 But Then Withdrawn|Non-adherence|4
1141504|NCT01421342|3748700|P1|Completed to Week 12 But Then Withdrawn|Non-adherence|5
1141505|NCT01421342|3748698|P3|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
1141506|NCT01421342|3748699|P2|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
1141507|NCT01421342|3748700|P1|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4
1141508|NCT01421342|3748698|P3|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11
1141509|NCT01421342|3748699|P2|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4
1141510|NCT01421342|3748700|P1|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13
1141511|NCT01421342|3748698|P3|Completed to Week 12 But Then Withdrawn|Adverse Event|6
1141512|NCT01421342|3748699|P2|Completed to Week 12 But Then Withdrawn|Adverse Event|3
1141513|NCT01421342|3748700|P1|Completed to Week 12 But Then Withdrawn|Adverse Event|4
1141514|NCT01421342|3748698|P3|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12
1141515|NCT01421342|3748699|P2|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10
1141516|NCT01421342|3748700|P1|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7
1141517|NCT01421342|3748698|P3|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88
1141518|NCT01421342|3748699|P2|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93
1141519|NCT01421342|3748700|P1|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111
1141520|NCT01421342|3748698|P3|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4
1141521|NCT01421342|3748699|P2|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9
1141522|NCT01421342|3748700|P1|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8
1141523|NCT01421342|3748698|P3|Acute Treatment Phase (12 Weeks)|Participant moved away|1
1141524|NCT01421342|3748699|P2|Acute Treatment Phase (12 Weeks)|Participant moved away|6
1141525|NCT01421342|3748700|P1|Acute Treatment Phase (12 Weeks)|Participant moved away|1
1141526|NCT01421342|3748698|P3|Acute Treatment Phase (12 Weeks)|Dure to other illness|4
1141527|NCT01421342|3748699|P2|Acute Treatment Phase (12 Weeks)|Dure to other illness|2
1141528|NCT01421342|3748700|P1|Acute Treatment Phase (12 Weeks)|Dure to other illness|3
1141529|NCT01421342|3748698|P3|Acute Treatment Phase (12 Weeks)|Non-adherence|13
1141530|NCT01421342|3748699|P2|Acute Treatment Phase (12 Weeks)|Non-adherence|7
1141531|NCT01421342|3748700|P1|Acute Treatment Phase (12 Weeks)|Non-adherence|15
1141532|NCT01421342|3748698|P3|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21
1141533|NCT01421342|3748699|P2|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18
1141534|NCT01421342|3748700|P1|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6
1141535|NCT01421342|3748698|P3|Acute Treatment Phase (12 Weeks)|Death|3
1141536|NCT01421342|3748699|P2|Acute Treatment Phase (12 Weeks)|Death|0
1141537|NCT01421342|3748700|P1|Acute Treatment Phase (12 Weeks)|Death|0
1141538|NCT01421342|3748698|P3|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13
1141539|NCT01421342|3748699|P2|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20
1141540|NCT01421342|3748700|P1|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23
1141541|NCT01421342|3748698|P3|Acute Treatment Phase (12 Weeks)|Adverse Event|27
1141542|NCT01421342|3748699|P2|Acute Treatment Phase (12 Weeks)|Adverse Event|38
1141543|NCT01421342|3748700|P1|Acute Treatment Phase (12 Weeks)|Adverse Event|53
1141544|NCT01421342|3748698|P3|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13
1141545|NCT01421342|3748699|P2|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28
1141546|NCT01421342|3748700|P1|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49
1141547|NCT01421303|3748717|P1|Overall Study|Withdrawal by Subject|1
1141548|NCT01421303|3748717|P1|Overall Study|Other|7
1141549|NCT01421303|3748717|P1|Overall Study|Non compliance with study procedure|1
1141550|NCT01421303|3748717|P1|Overall Study|Lost to Follow-up|13
1141551|NCT01421277|3748744|P2|Overall Study|Incomplete baseline data|31
1141552|NCT01421277|3748745|P1|Overall Study|Incomplete baseline data|0
1141553|NCT01421277|3748744|P2|Overall Study|Lack of qualifying event|61
1141554|NCT01421277|3748745|P1|Overall Study|Lack of qualifying event|0
1141555|NCT01421225|3748757|P2|Overall Study|Withdrawal by Subject|1
1141556|NCT01421225|3748758|P1|Overall Study|Withdrawal by Subject|0
1141557|NCT01421147|3748772|P2|Extension Period|Withdrawal by Subject|3
1141558|NCT01421147|3748773|P1|Extension Period|Withdrawal by Subject|5
1141559|NCT01421147|3748772|P2|Extension Period|Physician Decision|0
1141560|NCT01421147|3748773|P1|Extension Period|Physician Decision|1
1141561|NCT01421147|3748772|P2|Extension Period|Lost to Follow-up|5
1141562|NCT01421147|3748773|P1|Extension Period|Lost to Follow-up|2
1141563|NCT01421147|3748772|P2|Extension Period|Death|1
1141564|NCT01421147|3748773|P1|Extension Period|Death|0
1141565|NCT01421147|3748772|P2|Extension Period|Adverse Event|2
1141566|NCT01421147|3748773|P1|Extension Period|Adverse Event|0
1141567|NCT01421147|3748772|P2|Treatment Period|Withdrawal by Subject|5
1141568|NCT01421147|3748773|P1|Treatment Period|Withdrawal by Subject|10
1141569|NCT01421147|3748772|P2|Treatment Period|Physician Decision|2
1141570|NCT01421147|3748773|P1|Treatment Period|Physician Decision|2
1141571|NCT01421147|3748772|P2|Treatment Period|Lost to Follow-up|1
1141572|NCT01421147|3748773|P1|Treatment Period|Lost to Follow-up|2
1141573|NCT01421147|3748772|P2|Treatment Period|Adverse Event|3
1141574|NCT01421147|3748773|P1|Treatment Period|Adverse Event|2
1141575|NCT01421134|3748805|P2|Overall Study|Lost to Follow-up|1
1141576|NCT01421134|3748806|P1|Overall Study|Lost to Follow-up|1
1141577|NCT01421134|3748805|P2|Overall Study|Administrative|1
1141578|NCT01421134|3748806|P1|Overall Study|Administrative|0
1141579|NCT01421134|3748805|P2|Overall Study|Withdrawal by Subject|1
1141580|NCT01421134|3748806|P1|Overall Study|Withdrawal by Subject|1
1141581|NCT01421134|3748805|P2|Overall Study|Protocol Violation|3
1141582|NCT01421134|3748806|P1|Overall Study|Protocol Violation|0
1141583|NCT01421134|3748805|P2|Overall Study|Lack of Efficacy|4
1141584|NCT01421134|3748806|P1|Overall Study|Lack of Efficacy|2
1141585|NCT01421134|3748805|P2|Overall Study|Adverse Event|5
1141586|NCT01421134|3748806|P1|Overall Study|Adverse Event|3
1141587|NCT01420926|3748826|P2|Overall Study|Continues on active treatment|3
1141588|NCT01420926|3748827|P1|Overall Study|Continues on active treatment|1
1141589|NCT01420926|3748826|P2|Overall Study|Physician Decision|5
1141590|NCT01420926|3748827|P1|Overall Study|Physician Decision|7
1141591|NCT01420926|3748826|P2|Overall Study|Non-protocol treatment|20
1141592|NCT01420926|3748827|P1|Overall Study|Non-protocol treatment|17
1141593|NCT01420926|3748826|P2|Overall Study|Withdrawal by Subject|16
1141594|NCT01420926|3748827|P1|Overall Study|Withdrawal by Subject|11
1141595|NCT01420926|3748826|P2|Overall Study|Death|17
1141596|NCT01420926|3748827|P1|Overall Study|Death|18
1141597|NCT01420926|3748826|P2|Overall Study|Adverse Event|4
1141598|NCT01420926|3748827|P1|Overall Study|Adverse Event|6
1141599|NCT01420081|3748902|P9|Overall Study|Other Reasons|0
1141600|NCT01420081|3748903|P8|Overall Study|Other Reasons|0
1141601|NCT01420081|3748904|P7|Overall Study|Other Reasons|0
1141602|NCT01420081|3748905|P6|Overall Study|Other Reasons|0
1141603|NCT01420081|3748906|P5|Overall Study|Other Reasons|0
1141604|NCT01420081|3748907|P4|Overall Study|Other Reasons|0
1141605|NCT01420081|3748908|P3|Overall Study|Other Reasons|1
1141606|NCT01420081|3748909|P2|Overall Study|Other Reasons|0
1141607|NCT01420081|3748910|P1|Overall Study|Other Reasons|0
1141608|NCT01420081|3748902|P9|Overall Study|Subject Refused Futher Follow-up|0
1141609|NCT01420081|3748903|P8|Overall Study|Subject Refused Futher Follow-up|0
1141610|NCT01420081|3748904|P7|Overall Study|Subject Refused Futher Follow-up|0
1141611|NCT01420081|3748905|P6|Overall Study|Subject Refused Futher Follow-up|0
1141612|NCT01420081|3748906|P5|Overall Study|Subject Refused Futher Follow-up|1
1141613|NCT01420081|3748907|P4|Overall Study|Subject Refused Futher Follow-up|0
1141614|NCT01420081|3748908|P3|Overall Study|Subject Refused Futher Follow-up|1
1141615|NCT01420081|3748909|P2|Overall Study|Subject Refused Futher Follow-up|0
1141616|NCT01420081|3748910|P1|Overall Study|Subject Refused Futher Follow-up|0
1141617|NCT01420081|3748902|P9|Overall Study|Study Terminated by Sponsor|2
1141618|NCT01420081|3748903|P8|Overall Study|Study Terminated by Sponsor|2
1141619|NCT01420081|3748904|P7|Overall Study|Study Terminated by Sponsor|3
1141620|NCT01420081|3748905|P6|Overall Study|Study Terminated by Sponsor|7
1141621|NCT01420081|3748906|P5|Overall Study|Study Terminated by Sponsor|11
1141622|NCT01420081|3748907|P4|Overall Study|Study Terminated by Sponsor|3
1141623|NCT01420081|3748908|P3|Overall Study|Study Terminated by Sponsor|1
1141624|NCT01420081|3748909|P2|Overall Study|Study Terminated by Sponsor|1
1141625|NCT01420081|3748910|P1|Overall Study|Study Terminated by Sponsor|2
1141626|NCT01420081|3748902|P9|Overall Study|Lost to Follow-up|0
1141627|NCT01420081|3748903|P8|Overall Study|Lost to Follow-up|0
1141628|NCT01420081|3748904|P7|Overall Study|Lost to Follow-up|0
1141629|NCT01420081|3748905|P6|Overall Study|Lost to Follow-up|1
1141630|NCT01420081|3748906|P5|Overall Study|Lost to Follow-up|1
1141631|NCT01420081|3748907|P4|Overall Study|Lost to Follow-up|0
1141632|NCT01420081|3748908|P3|Overall Study|Lost to Follow-up|0
1141633|NCT01420081|3748909|P2|Overall Study|Lost to Follow-up|0
1141634|NCT01420081|3748910|P1|Overall Study|Lost to Follow-up|0
1141635|NCT01420081|3748902|P9|Overall Study|Death|1
1141636|NCT01420081|3748903|P8|Overall Study|Death|1
1141637|NCT01420081|3748904|P7|Overall Study|Death|0
1141638|NCT01420081|3748905|P6|Overall Study|Death|12
1141639|NCT01420081|3748906|P5|Overall Study|Death|7
1141640|NCT01420081|3748907|P4|Overall Study|Death|0
1141641|NCT01420081|3748908|P3|Overall Study|Death|8
1141642|NCT01420081|3748909|P2|Overall Study|Death|0
1141643|NCT01420081|3748910|P1|Overall Study|Death|1
1141644|NCT01419769|3749040|P1|Overall Study|Not evaluable due to pigtail stents|1
1141645|NCT01419769|3749040|P1|Overall Study|Did not receive the AXIOS stent|3
1141646|NCT01419314|3749061|P2|Follow-up at Week 6 of the Trial|Lost to Follow-up|2
1141647|NCT01419314|3749062|P1|Follow-up at Week 6 of the Trial|Lost to Follow-up|1
1141648|NCT01419314|3749061|P2|Follow-up at Week 3 of the Trial|Lost to Follow-up|0
1141649|NCT01419314|3749062|P1|Follow-up at Week 3 of the Trial|Lost to Follow-up|3
1141650|NCT01419314|3749061|P2|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1
1141651|NCT01419314|3749062|P1|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3
1141652|NCT01419236|3749103|P2|Overall Study|Entry Criteria Not Met|0
1141653|NCT01419236|3749104|P1|Overall Study|Entry Criteria Not Met|1
1141654|NCT01419236|3749103|P2|Overall Study|Withdrawal by Subject|4
1141655|NCT01419236|3749104|P1|Overall Study|Withdrawal by Subject|1
1141656|NCT01419236|3749103|P2|Overall Study|Physician Decision|0
1141657|NCT01419236|3749104|P1|Overall Study|Physician Decision|1
1141658|NCT01419236|3749103|P2|Overall Study|Lost to Follow-up|0
1141659|NCT01419236|3749104|P1|Overall Study|Lost to Follow-up|1
1141660|NCT01419236|3749103|P2|Overall Study|Lack of Efficacy|1
1141661|NCT01419236|3749104|P1|Overall Study|Lack of Efficacy|0
1141662|NCT01419236|3749103|P2|Overall Study|Adverse Event|0
1141663|NCT01419236|3749104|P1|Overall Study|Adverse Event|1
1141664|NCT01419197|3749128|P2|Overall Study|Lost to Follow-up|4
1141665|NCT01419197|3749129|P1|Overall Study|Lost to Follow-up|14
1141666|NCT01419197|3749128|P2|Overall Study|Reason Not Specified|1
1141667|NCT01419197|3749129|P1|Overall Study|Reason Not Specified|0
1141668|NCT01419197|3749128|P2|Overall Study|Study Completed by Sponsor|34
1141669|NCT01419197|3749129|P1|Overall Study|Study Completed by Sponsor|103
1141670|NCT01419197|3749128|P2|Overall Study|Withdrawal by Subject|32
1141671|NCT01419197|3749129|P1|Overall Study|Withdrawal by Subject|33
1141672|NCT01419197|3749128|P2|Overall Study|Non-compliance|1
1141673|NCT01419197|3749129|P1|Overall Study|Non-compliance|3
1141674|NCT01419197|3749128|P2|Overall Study|Physician Decision|4
1141675|NCT01419197|3749129|P1|Overall Study|Physician Decision|4
1141676|NCT01419197|3749128|P2|Overall Study|Death|122
1141677|NCT01419197|3749129|P1|Overall Study|Death|247
1141678|NCT01419184|3749154|P2|Overall Study|Participant randomized, not treated|0
1141679|NCT01419184|3749155|P1|Overall Study|Participant randomized, not treated|1
1141680|NCT01419184|3749154|P2|Overall Study|No IRLOS-No adverse event treatment date|1
1141681|NCT01419184|3749155|P1|Overall Study|No IRLOS-No adverse event treatment date|0
1141682|NCT01419184|3749154|P2|Overall Study|No IRLOS-non trial antibiotic used|2
1141683|NCT01419184|3749155|P1|Overall Study|No IRLOS-non trial antibiotic used|1
1141684|NCT01419184|3749154|P2|Overall Study|No IRLOS-randomized, not treated|4
1141685|NCT01419184|3749155|P1|Overall Study|No IRLOS-randomized, not treated|2
1141686|NCT01419184|3749154|P2|Overall Study|No IRLOS-No in-patient end date reported|6
1141687|NCT01419184|3749155|P1|Overall Study|No IRLOS-No in-patient end date reported|3
1141688|NCT01419184|3749154|P2|Overall Study|Site data not available|2
1141689|NCT01419184|3749155|P1|Overall Study|Site data not available|3
1141690|NCT01418937|3749193|P1|Overall Study|Withdrawal by Subject|1
1141691|NCT01418937|3749193|P1|Overall Study|Pregnancy|1
1141692|NCT01418937|3749193|P1|Overall Study|Protocol Violation|1
1141693|NCT01418937|3749193|P1|Overall Study|Lost to Follow-up|5
1141694|NCT01418365|3749224|P2|Second Intervention|Withdrawal by Subject|1
1141695|NCT01418365|3749225|P1|Second Intervention|Withdrawal by Subject|0
1141696|NCT01418365|3749224|P2|First Intervention|Non-compliance|0
1141697|NCT01418365|3749225|P1|First Intervention|Non-compliance|1
1141698|NCT01418365|3749224|P2|First Intervention|Withdrawal by Subject|1
1141699|NCT01418365|3749225|P1|First Intervention|Withdrawal by Subject|0
1141700|NCT01418209|3749236|P3|Overall Study|Did not provide hot flash diary data|3
1141701|NCT01418209|3749237|P2|Overall Study|Did not provide hot flash diary data|3
1141702|NCT01418209|3749238|P1|Overall Study|Did not provide hot flash diary data|1
1141703|NCT01418209|3749236|P3|Overall Study|Withdrawal by Subject|1
1141704|NCT01418209|3749237|P2|Overall Study|Withdrawal by Subject|0
1141705|NCT01418209|3749238|P1|Overall Study|Withdrawal by Subject|1
1141706|NCT01417481|3749293|P2|First Intervention (8 Weeks)|Withdrawal by Subject|2
1141707|NCT01417481|3749294|P1|First Intervention (8 Weeks)|Withdrawal by Subject|0
1141708|NCT01417377|3749359|P1|Overall Study|Enrolled, but not treated|1
1141709|NCT01417377|3749359|P1|Overall Study|Lost to Follow-up|12
1141710|NCT01417195|3749368|P2|Overall Study|No transfer due to elevated progesterone|0
1141711|NCT01417195|3749369|P1|Overall Study|No transfer due to elevated progesterone|1
1141712|NCT01417195|3749368|P2|Overall Study|No transfer due to risk of OHSS|0
1141713|NCT01417195|3749369|P1|Overall Study|No transfer due to risk of OHSS|1
1141714|NCT01417195|3749368|P2|Overall Study|No embryos for transfer|1
1141715|NCT01417195|3749369|P1|Overall Study|No embryos for transfer|0
1141716|NCT01417195|3749368|P2|Overall Study|Stimulation failure|0
1141717|NCT01417195|3749369|P1|Overall Study|Stimulation failure|1
1141718|NCT01417156|3749385|P1|Overall Study|Protocol Violation|2
1141719|NCT01417156|3749385|P1|Overall Study|Adverse Event|12
1141720|NCT01417104|3749395|P2|Overall Study|Adverse Event|0
1141721|NCT01417104|3749396|P1|Overall Study|Adverse Event|1
1141722|NCT01417104|3749395|P2|Overall Study|Failure to make contact|1
1141723|NCT01417104|3749396|P1|Overall Study|Failure to make contact|0
1141724|NCT01417104|3749395|P2|Overall Study|Withdrawal by Subject|1
1141725|NCT01417104|3749396|P1|Overall Study|Withdrawal by Subject|5
1141726|NCT01417078|3749406|P1|Overall Study|Withdrawal by Subject|1
1141727|NCT01417000|3749431|P2|Overall Study|Study Terminated by Sponsor|1
1141728|NCT01417000|3749432|P1|Overall Study|Study Terminated by Sponsor|1
1141729|NCT01417000|3749431|P2|Overall Study|Lost to Follow-up|0
1141730|NCT01417000|3749432|P1|Overall Study|Lost to Follow-up|1
1141731|NCT01417000|3749431|P2|Overall Study|Death|28
1141732|NCT01417000|3749432|P1|Overall Study|Death|59
1141733|NCT01416610|3749440|P1|Overall Study|Sufficient treatment duration (PCR neg.)|7
1141734|NCT01416610|3749440|P1|Overall Study|Lost to Follow-up|7
1141735|NCT01416610|3749440|P1|Overall Study|Withdrawal by Subject|13
1141736|NCT01416610|3749440|P1|Overall Study|No reason given|5
1141737|NCT01416610|3749440|P1|Overall Study|Lack of Efficacy|4
1141738|NCT01416610|3749440|P1|Overall Study|Adverse Event -Patient decision|3
1141739|NCT01416610|3749440|P1|Overall Study|Adverse Event|4
1141740|NCT01416571|3749494|P1|Overall Study|Lost to Follow-up|2
1141741|NCT01416389|3749523|P2|Overall Study|Started New Therapy|0
1141742|NCT01416389|3749524|P1|Overall Study|Started New Therapy|2
1141743|NCT01416389|3749523|P2|Overall Study|Lost to Follow-up|0
1141744|NCT01416389|3749524|P1|Overall Study|Lost to Follow-up|1
1141745|NCT01416272|3749541|P1|Overall Study|Study related complaints|1
1141746|NCT01416272|3749541|P1|Overall Study|Lost to Follow-up|1
1141747|NCT01416272|3749541|P1|Overall Study|Unacceptable distance visual acuity|2
1141748|NCT01416181|3749549|P2|Part 2|Lost to Follow-up|2
1141749|NCT01416181|3749550|P1|Part 2|Lost to Follow-up|2
1141750|NCT01416181|3749549|P2|Part 2|Lack of Efficacy|1
1141751|NCT01416181|3749550|P1|Part 2|Lack of Efficacy|4
1141752|NCT01416181|3749549|P2|Part 2|Withdrawal by Subject|5
1141753|NCT01416181|3749550|P1|Part 2|Withdrawal by Subject|14
1141754|NCT01416181|3749549|P2|Part 2|Investigator Decision|7
1141755|NCT01416181|3749550|P1|Part 2|Investigator Decision|6
1141756|NCT01416181|3749549|P2|Part 2|Not Specified|267
1141757|NCT01416181|3749550|P1|Part 2|Not Specified|234
1141758|NCT01416181|3749549|P2|Part 2|Adverse Event|4
1141759|NCT01416181|3749550|P1|Part 2|Adverse Event|11
1141760|NCT01416181|3749549|P2|Part 1|Ongoing in Follow-Up|8
1141761|NCT01416181|3749550|P1|Part 1|Ongoing in Follow-Up|14
1141762|NCT01416181|3749549|P2|Part 1|Adverse Event|18
1141763|NCT01416181|3749550|P1|Part 1|Adverse Event|15
1141764|NCT01416181|3749549|P2|Part 1|Lost to Follow-up|1
1141765|NCT01416181|3749550|P1|Part 1|Lost to Follow-up|1
1141766|NCT01416181|3749549|P2|Part 1|Lack of Efficacy|8
1141767|NCT01416181|3749550|P1|Part 1|Lack of Efficacy|16
1141768|NCT01416181|3749549|P2|Part 1|Withdrawal by Subject|48
1141769|NCT01416181|3749550|P1|Part 1|Withdrawal by Subject|74
1141770|NCT01416181|3749549|P2|Part 1|Investigator Decision|6
1141771|NCT01416181|3749550|P1|Part 1|Investigator Decision|7
1141772|NCT01416181|3749549|P2|Part 1|Death|1
1141773|NCT01416181|3749550|P1|Part 1|Death|0
1141774|NCT01416181|3749549|P2|Part 1|Not Specified|24
1141775|NCT01416181|3749550|P1|Part 1|Not Specified|10
1141776|NCT01416155|3749612|P1|Overall Study|Not specified|7
1141777|NCT01416155|3749612|P1|Overall Study|Investigator decision|8
1141778|NCT01416155|3749612|P1|Overall Study|Withdrawal by Subject|33
1141779|NCT01416155|3749612|P1|Overall Study|Positive for anti-BG00002 antibodies|2
1141780|NCT01416155|3749612|P1|Overall Study|Adverse Event|8
1141781|NCT01416142|3749619|P3|PureVision2 HD|Inability to maintain lens wear|1
1141782|NCT01416142|3749620|P2|PureVision2 HD|Inability to maintain lens wear|0
1141783|NCT01416142|3749621|P1|PureVision2 HD|Inability to maintain lens wear|0
1141784|NCT01415986|3749648|P1|Overall Study|Lost to Follow-up|1
1141785|NCT01415921|3749674|P2|Overall Study|Other|0
1141786|NCT01415921|3749675|P1|Overall Study|Other|2
1141787|NCT01415921|3749674|P2|Overall Study|Withdrawal by Subject|1
1141788|NCT01415921|3749675|P1|Overall Study|Withdrawal by Subject|0
1141789|NCT01415921|3749674|P2|Overall Study|Physician Decision|1
1141790|NCT01415921|3749675|P1|Overall Study|Physician Decision|1
1141791|NCT01415921|3749674|P2|Overall Study|Adverse Event|1
1141792|NCT01415921|3749675|P1|Overall Study|Adverse Event|0
1141793|NCT01415908|3749685|P2|Overall Study|Withdrawal by Subject|0
1141794|NCT01415908|3749686|P1|Overall Study|Withdrawal by Subject|1
1141795|NCT01415531|3749723|P2|Overall Study|Other Reasons|2
1141796|NCT01415531|3749724|P1|Overall Study|Other Reasons|3
1141797|NCT01415531|3749723|P2|Overall Study|Lack of Compliance|4
1141798|NCT01415531|3749724|P1|Overall Study|Lack of Compliance|1
1141799|NCT01415531|3749723|P2|Overall Study|Lost to Follow-up|14
1141800|NCT01415531|3749724|P1|Overall Study|Lost to Follow-up|6
1141801|NCT01415531|3749723|P2|Overall Study|Withdrawal by Subject|4
1141802|NCT01415531|3749724|P1|Overall Study|Withdrawal by Subject|5
1141803|NCT01415531|3749723|P2|Overall Study|Protocol Violation|1
1141804|NCT01415531|3749724|P1|Overall Study|Protocol Violation|0
1141805|NCT01415531|3749723|P2|Overall Study|Lack of Efficacy|2
1141806|NCT01415531|3749724|P1|Overall Study|Lack of Efficacy|3
1141807|NCT01415531|3749723|P2|Overall Study|Adverse Event|10
1141808|NCT01415531|3749724|P1|Overall Study|Adverse Event|7
1141809|NCT01415518|3749734|P2|Overall Study|Condition under Investigation Worsened|1
1141810|NCT01415518|3749735|P1|Overall Study|Condition under Investigation Worsened|1
1141811|NCT01415518|3749734|P2|Overall Study|Death|1
1141812|NCT01415518|3749735|P1|Overall Study|Death|1
1141813|NCT01415518|3749734|P2|Overall Study|Adverse Event|4
1141814|NCT01415518|3749735|P1|Overall Study|Adverse Event|3
1141815|NCT01415518|3749734|P2|Overall Study|Lost to Follow-up|5
1141816|NCT01415518|3749735|P1|Overall Study|Lost to Follow-up|3
1141817|NCT01415518|3749734|P2|Overall Study|Protocol Violation|8
1141818|NCT01415518|3749735|P1|Overall Study|Protocol Violation|6
1141819|NCT01415518|3749734|P2|Overall Study|Withdrawal by Subject|12
1141820|NCT01415518|3749735|P1|Overall Study|Withdrawal by Subject|2
1141821|NCT01415401|3749835|P1|Overall Study|Terminated by Sponsor|1
1141822|NCT01415401|3749835|P1|Overall Study|DId not meet inclusion/exclusion criteri|1
1141823|NCT01415401|3749835|P1|Overall Study|Adverse Event|5
1141824|NCT01415349|3749840|P2|Treatment Period 1|Withdrawal by Subject|1
1141825|NCT01415349|3749841|P1|Treatment Period 1|Withdrawal by Subject|0
1141826|NCT01415349|3749840|P2|Treatment Period 1|Adverse Event|1
1141827|NCT01415349|3749841|P1|Treatment Period 1|Adverse Event|0
1141828|NCT01414855|3749853|P1|Overall Study|Withdrawal by Subject|7
1141829|NCT01414855|3749853|P1|Overall Study|Lost to Follow-up|5
1141830|NCT01414855|3749853|P1|Overall Study|Death|17
1141831|NCT01414257|3749902|P1|Overall Study|Protocol Violation|10
1141832|NCT01414257|3749902|P1|Overall Study|No Visit After First Day of Treatment|12
1141833|NCT01414205|3749930|P2|Overall Study|Randomized but not Treated|1
1141834|NCT01414205|3749931|P1|Overall Study|Randomized but not Treated|1
1141835|NCT01414205|3749930|P2|Overall Study|Physician Decision|1
1141836|NCT01414205|3749931|P1|Overall Study|Physician Decision|0
1141837|NCT01414205|3749930|P2|Overall Study|Lost to Follow-up|4
1141838|NCT01414205|3749931|P1|Overall Study|Lost to Follow-up|1
1141839|NCT01414205|3749930|P2|Overall Study|Death|1
1141840|NCT01414205|3749931|P1|Overall Study|Death|5
1141841|NCT01414166|3750000|P2|Overall Study|Withdrawal by Subject|5
1141842|NCT01414166|3750001|P1|Overall Study|Withdrawal by Subject|3
1141843|NCT01414166|3750000|P2|Overall Study|Study terminated by Sponsor|75
1141844|NCT01414166|3750001|P1|Overall Study|Study terminated by Sponsor|68
1141845|NCT01414166|3750000|P2|Overall Study|Protocol Violation|0
1141846|NCT01414166|3750001|P1|Overall Study|Protocol Violation|2
1141847|NCT01414166|3750000|P2|Overall Study|Physician Decision|0
1141848|NCT01414166|3750001|P1|Overall Study|Physician Decision|2
1141849|NCT01414166|3750000|P2|Overall Study|Non-compliance with study drug|0
1141850|NCT01414166|3750001|P1|Overall Study|Non-compliance with study drug|2
1141851|NCT01414166|3750000|P2|Overall Study|Lost to Follow-up|1
1141852|NCT01414166|3750001|P1|Overall Study|Lost to Follow-up|4
1141853|NCT01414166|3750000|P2|Overall Study|Adverse Event|2
1141854|NCT01414166|3750001|P1|Overall Study|Adverse Event|10
1141855|NCT01414114|3750064|P1|Overall Study|Other|2
1141856|NCT01414114|3750064|P1|Overall Study|Withdrawal by Subject|1
1141857|NCT01414114|3750064|P1|Overall Study|Adverse Event|2
1141858|NCT01413958|3750120|P2|Overall Study|Lost to Follow-up|1
1141859|NCT01413958|3750121|P1|Overall Study|Lost to Follow-up|0
1141860|NCT01413542|3750172|P4|Overall Study|Adverse Event|1
1141861|NCT01413542|3750173|P3|Overall Study|Adverse Event|0
1141862|NCT01413542|3750174|P2|Overall Study|Adverse Event|0
1141863|NCT01413542|3750175|P1|Overall Study|Adverse Event|0
1141864|NCT01413542|3750172|P4|Overall Study|Physician Decision|0
1141865|NCT01413542|3750173|P3|Overall Study|Physician Decision|3
1141866|NCT01413542|3750174|P2|Overall Study|Physician Decision|0
1141867|NCT01413542|3750175|P1|Overall Study|Physician Decision|1
1141868|NCT01413503|3750197|P1|Overall Study|Lost to Follow-up|1
1141869|NCT01413360|3750201|P1|Overall Study|Adverse Event|1
1141870|NCT01413360|3750201|P1|Overall Study|Lost to Follow-up|2
1141871|NCT01413204|3750209|P3|Overall Study|Fasting plasma glucose level increased|10
1141872|NCT01413204|3750210|P2|Overall Study|Fasting plasma glucose level increased|0
1141873|NCT01413204|3750211|P1|Overall Study|Fasting plasma glucose level increased|1
1141874|NCT01413204|3750209|P3|Overall Study|Clearly not eligible for the study|1
1141875|NCT01413204|3750210|P2|Overall Study|Clearly not eligible for the study|0
1141876|NCT01413204|3750211|P1|Overall Study|Clearly not eligible for the study|0
1141877|NCT01413204|3750209|P3|Overall Study|Withdrawal by Subject|4
1141878|NCT01413204|3750210|P2|Overall Study|Withdrawal by Subject|4
1141879|NCT01413204|3750211|P1|Overall Study|Withdrawal by Subject|1
1141880|NCT01413204|3750209|P3|Overall Study|Physician Decision|2
1141881|NCT01413204|3750210|P2|Overall Study|Physician Decision|0
1141882|NCT01413204|3750211|P1|Overall Study|Physician Decision|3
1141883|NCT01413204|3750209|P3|Overall Study|Adverse Event|2
1141884|NCT01413204|3750210|P2|Overall Study|Adverse Event|2
1141885|NCT01413204|3750211|P1|Overall Study|Adverse Event|1
1141886|NCT01413191|3750219|P1|Overall Study|Death|1
1141887|NCT01413191|3750219|P1|Overall Study|Disease Progression|5
1141888|NCT01413191|3750219|P1|Overall Study|Lost to Follow-up|5
1141889|NCT01412983|3750223|P2|1st Period|Inability to maintain wear|1
1141890|NCT01412983|3750224|P1|1st Period|Inability to maintain wear|0
1141891|NCT01412983|3750223|P2|1st Period|Unacceptable lens movement|1
1141892|NCT01412983|3750224|P1|1st Period|Unacceptable lens movement|0
1141893|NCT01412983|3750223|P2|1st Period|Positive slit lamp finding|1
1141894|NCT01412983|3750224|P1|1st Period|Positive slit lamp finding|0
1141895|NCT01412983|3750223|P2|1st Period|Ineligible|1
1141896|NCT01412983|3750224|P1|1st Period|Ineligible|0
1141897|NCT01412957|3750234|P2|Overall Study|Death|133
1141898|NCT01412957|3750235|P1|Overall Study|Death|136
1141899|NCT01412957|3750234|P2|Overall Study|Lost to Follow-up|2
1141900|NCT01412957|3750235|P1|Overall Study|Lost to Follow-up|7
1141901|NCT01412957|3750234|P2|Overall Study|Withdrawal by Subject|22
1141902|NCT01412957|3750235|P1|Overall Study|Withdrawal by Subject|6
1141903|NCT01412944|3750257|P6|Entire: IV + Maintenance|Adverse Event|0
1141904|NCT01412944|3750258|P5|Entire: IV + Maintenance|Adverse Event|0
1141905|NCT01412944|3750259|P4|Entire: IV + Maintenance|Adverse Event|0
1141906|NCT01412944|3750260|P3|Entire: IV + Maintenance|Adverse Event|0
1141907|NCT01412944|3750261|P2|Entire: IV + Maintenance|Adverse Event|1
1141908|NCT01412944|3750262|P1|Entire: IV + Maintenance|Adverse Event|0
1141909|NCT01412944|3750257|P6|Entire: IV + Maintenance|Lack of Efficacy|0
1141910|NCT01412944|3750258|P5|Entire: IV + Maintenance|Lack of Efficacy|0
1141911|NCT01412944|3750259|P4|Entire: IV + Maintenance|Lack of Efficacy|0
1141912|NCT01412944|3750260|P3|Entire: IV + Maintenance|Lack of Efficacy|0
1141913|NCT01412944|3750261|P2|Entire: IV + Maintenance|Lack of Efficacy|1
1141914|NCT01412944|3750262|P1|Entire: IV + Maintenance|Lack of Efficacy|0
1141915|NCT01412944|3750257|P6|Entire: IV + Maintenance|Lost to Follow-up|0
1141916|NCT01412944|3750258|P5|Entire: IV + Maintenance|Lost to Follow-up|0
1141917|NCT01412944|3750259|P4|Entire: IV + Maintenance|Lost to Follow-up|0
1141918|NCT01412944|3750260|P3|Entire: IV + Maintenance|Lost to Follow-up|0
1141919|NCT01412944|3750261|P2|Entire: IV + Maintenance|Lost to Follow-up|1
1141920|NCT01412944|3750262|P1|Entire: IV + Maintenance|Lost to Follow-up|0
1141921|NCT01412944|3750257|P6|Entire: IV + Maintenance|Protocol deviation|0
1141922|NCT01412944|3750258|P5|Entire: IV + Maintenance|Protocol deviation|0
1141923|NCT01412944|3750259|P4|Entire: IV + Maintenance|Protocol deviation|0
1141924|NCT01412944|3750260|P3|Entire: IV + Maintenance|Protocol deviation|0
1141925|NCT01412944|3750261|P2|Entire: IV + Maintenance|Protocol deviation|1
1141926|NCT01412944|3750262|P1|Entire: IV + Maintenance|Protocol deviation|0
1141927|NCT01412944|3750257|P6|Entire: IV + Maintenance|Withdrawal by Subject|0
1141928|NCT01412944|3750258|P5|Entire: IV + Maintenance|Withdrawal by Subject|0
1141929|NCT01412944|3750259|P4|Entire: IV + Maintenance|Withdrawal by Subject|0
1141930|NCT01412944|3750260|P3|Entire: IV + Maintenance|Withdrawal by Subject|0
1141931|NCT01412944|3750261|P2|Entire: IV + Maintenance|Withdrawal by Subject|1
1141932|NCT01412944|3750262|P1|Entire: IV + Maintenance|Withdrawal by Subject|2
1141933|NCT01412944|3750257|P6|Entire: IV + Maintenance|Lack of Efficacy|0
1141934|NCT01412944|3750258|P5|Entire: IV + Maintenance|Lack of Efficacy|1
1141935|NCT01412944|3750259|P4|Entire: IV + Maintenance|Lack of Efficacy|0
1141936|NCT01412944|3750260|P3|Entire: IV + Maintenance|Lack of Efficacy|0
1141937|NCT01412944|3750261|P2|Entire: IV + Maintenance|Lack of Efficacy|0
1141938|NCT01412944|3750262|P1|Entire: IV + Maintenance|Lack of Efficacy|0
1141939|NCT01412944|3750257|P6|Entire: IV + Maintenance|Lost to Follow-up|1
1141940|NCT01412944|3750258|P5|Entire: IV + Maintenance|Lost to Follow-up|0
1141941|NCT01412944|3750259|P4|Entire: IV + Maintenance|Lost to Follow-up|0
1141942|NCT01412944|3750260|P3|Entire: IV + Maintenance|Lost to Follow-up|0
1141943|NCT01412944|3750261|P2|Entire: IV + Maintenance|Lost to Follow-up|0
1141944|NCT01412944|3750262|P1|Entire: IV + Maintenance|Lost to Follow-up|0
1141945|NCT01412944|3750257|P6|Entire: IV + Maintenance|Protocol deviation|1
1141946|NCT01412944|3750258|P5|Entire: IV + Maintenance|Protocol deviation|0
1141947|NCT01412944|3750259|P4|Entire: IV + Maintenance|Protocol deviation|0
1141948|NCT01412944|3750260|P3|Entire: IV + Maintenance|Protocol deviation|0
1141949|NCT01412944|3750261|P2|Entire: IV + Maintenance|Protocol deviation|0
1141950|NCT01412944|3750262|P1|Entire: IV + Maintenance|Protocol deviation|0
1141951|NCT01412944|3750257|P6|Entire: IV + Maintenance|Adverse Event|0
1141952|NCT01412944|3750258|P5|Entire: IV + Maintenance|Adverse Event|1
1141953|NCT01412944|3750259|P4|Entire: IV + Maintenance|Adverse Event|0
1141954|NCT01412944|3750260|P3|Entire: IV + Maintenance|Adverse Event|0
1141955|NCT01412944|3750261|P2|Entire: IV + Maintenance|Adverse Event|0
1141956|NCT01412944|3750262|P1|Entire: IV + Maintenance|Adverse Event|0
1141957|NCT01412944|3750257|P6|Entire: IV + Maintenance|Withdrawal by Subject|0
1141958|NCT01412944|3750258|P5|Entire: IV + Maintenance|Withdrawal by Subject|1
1141959|NCT01412944|3750259|P4|Entire: IV + Maintenance|Withdrawal by Subject|1
1141960|NCT01412944|3750260|P3|Entire: IV + Maintenance|Withdrawal by Subject|1
1141961|NCT01412944|3750261|P2|Entire: IV + Maintenance|Withdrawal by Subject|0
1141962|NCT01412944|3750262|P1|Entire: IV + Maintenance|Withdrawal by Subject|0
1141963|NCT01412944|3750257|P6|IV: Per CAIN457A2307|Lost to Follow-up|0
1141964|NCT01412944|3750258|P5|IV: Per CAIN457A2307|Lost to Follow-up|0
1141965|NCT01412944|3750259|P4|IV: Per CAIN457A2307|Lost to Follow-up|0
1141966|NCT01412944|3750260|P3|IV: Per CAIN457A2307|Lost to Follow-up|0
1141967|NCT01412944|3750261|P2|IV: Per CAIN457A2307|Lost to Follow-up|1
1141968|NCT01412944|3750262|P1|IV: Per CAIN457A2307|Lost to Follow-up|0
1141969|NCT01412944|3750257|P6|IV: Per CAIN457A2307|Protocol deviation|0
1141970|NCT01412944|3750258|P5|IV: Per CAIN457A2307|Protocol deviation|0
1141971|NCT01412944|3750259|P4|IV: Per CAIN457A2307|Protocol deviation|0
1141972|NCT01412944|3750260|P3|IV: Per CAIN457A2307|Protocol deviation|0
1141973|NCT01412944|3750261|P2|IV: Per CAIN457A2307|Protocol deviation|1
1141974|NCT01412944|3750262|P1|IV: Per CAIN457A2307|Protocol deviation|0
1141975|NCT01412944|3750257|P6|IV: Per CAIN457A2307|Withdrawal by Subject|0
1141976|NCT01412944|3750258|P5|IV: Per CAIN457A2307|Withdrawal by Subject|0
1141977|NCT01412944|3750259|P4|IV: Per CAIN457A2307|Withdrawal by Subject|0
1141978|NCT01412944|3750260|P3|IV: Per CAIN457A2307|Withdrawal by Subject|0
1141979|NCT01412944|3750261|P2|IV: Per CAIN457A2307|Withdrawal by Subject|0
1141980|NCT01412944|3750262|P1|IV: Per CAIN457A2307|Withdrawal by Subject|1
1141981|NCT01412944|3750257|P6|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1
1141982|NCT01412944|3750258|P5|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
1141983|NCT01412944|3750259|P4|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
1141984|NCT01412944|3750260|P3|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
1141985|NCT01412944|3750261|P2|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
1141986|NCT01412944|3750262|P1|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
1141987|NCT01412944|3750257|P6|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1
1141988|NCT01412944|3750258|P5|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
1141989|NCT01412944|3750259|P4|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
1141990|NCT01412944|3750260|P3|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
1141991|NCT01412944|3750261|P2|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
1141992|NCT01412944|3750262|P1|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
1141993|NCT01412944|3750257|P6|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
1141994|NCT01412944|3750258|P5|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
1141995|NCT01412944|3750259|P4|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
1141996|NCT01412944|3750260|P3|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1
1141997|NCT01412944|3750261|P2|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
1141998|NCT01412944|3750262|P1|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
1141999|NCT01412879|3750308|P3|Initial Registration (Induction Therapy)|Treatment not Given|0
1142000|NCT01412879|3750309|P2|Initial Registration (Induction Therapy)|Treatment not Given|0
1142001|NCT01412879|3750310|P1|Initial Registration (Induction Therapy)|Treatment not Given|1
1142002|NCT01412879|3750308|P3|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0
1142003|NCT01412879|3750309|P2|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1
1142004|NCT01412879|3750310|P1|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6
1142005|NCT01412879|3750308|P3|Initial Registration (Induction Therapy)|Progression/Relapse|0
1142006|NCT01412879|3750309|P2|Initial Registration (Induction Therapy)|Progression/Relapse|1
1142007|NCT01412879|3750310|P1|Initial Registration (Induction Therapy)|Progression/Relapse|0
1142008|NCT01412879|3750308|P3|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0
1142009|NCT01412879|3750309|P2|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3
1142010|NCT01412879|3750310|P1|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1
1142011|NCT01412879|3750308|P3|Initial Registration (Induction Therapy)|Adverse Event|0
1142012|NCT01412879|3750309|P2|Initial Registration (Induction Therapy)|Adverse Event|3
1142013|NCT01412879|3750310|P1|Initial Registration (Induction Therapy)|Adverse Event|5
1142014|NCT01412801|3750339|P6|Overall Study|Relocated to another area|0
1142015|NCT01412801|3750340|P5|Overall Study|Relocated to another area|0
1142016|NCT01412801|3750341|P4|Overall Study|Relocated to another area|0
1142017|NCT01412801|3750342|P3|Overall Study|Relocated to another area|2
1142018|NCT01412801|3750343|P2|Overall Study|Relocated to another area|0
1142019|NCT01412801|3750344|P1|Overall Study|Relocated to another area|0
1142020|NCT01412801|3750339|P6|Overall Study|Withdrawal by Subject|0
1142021|NCT01412801|3750340|P5|Overall Study|Withdrawal by Subject|0
1142022|NCT01412801|3750341|P4|Overall Study|Withdrawal by Subject|0
1142023|NCT01412801|3750342|P3|Overall Study|Withdrawal by Subject|1
1142024|NCT01412801|3750343|P2|Overall Study|Withdrawal by Subject|2
1142025|NCT01412801|3750344|P1|Overall Study|Withdrawal by Subject|3
1142026|NCT01412801|3750339|P6|Overall Study|Lost to Follow-up|1
1142027|NCT01412801|3750340|P5|Overall Study|Lost to Follow-up|1
1142028|NCT01412801|3750341|P4|Overall Study|Lost to Follow-up|0
1142029|NCT01412801|3750342|P3|Overall Study|Lost to Follow-up|4
1142030|NCT01412801|3750343|P2|Overall Study|Lost to Follow-up|2
1142031|NCT01412801|3750344|P1|Overall Study|Lost to Follow-up|1
1142032|NCT01412801|3750339|P6|Overall Study|Death|2
1142033|NCT01412801|3750340|P5|Overall Study|Death|2
1142034|NCT01412801|3750341|P4|Overall Study|Death|4
1142035|NCT01412801|3750342|P3|Overall Study|Death|0
1142036|NCT01412801|3750343|P2|Overall Study|Death|1
1142037|NCT01412801|3750344|P1|Overall Study|Death|0
1142038|NCT01412424|3750503|P1|Extension Treatment Period|Patient Request|2
1142039|NCT01412424|3750503|P1|Extension Treatment Period|Treatment Failure|2
1142040|NCT01412424|3750503|P1|Extension Treatment Period|Adverse Event|2
1142041|NCT01412424|3750503|P1|Core Treatment Period|Sponsor Request|1
1142042|NCT01412424|3750503|P1|Core Treatment Period|Lost to Follow-up|2
1142043|NCT01412424|3750503|P1|Core Treatment Period|Patient Request|5
1142044|NCT01412424|3750503|P1|Core Treatment Period|Adverse Event|21
1142045|NCT01412424|3750503|P1|Core Treatment Period|Treatment Failure|24
1142046|NCT01412333|3750521|P2|Overall Study|Lost to Follow-up|6
1142047|NCT01412333|3750522|P1|Overall Study|Lost to Follow-up|10
1142048|NCT01412333|3750521|P2|Overall Study|Adverse Event|16
1142049|NCT01412333|3750522|P1|Overall Study|Adverse Event|25
1142050|NCT01412333|3750521|P2|Overall Study|Consent withdrawn by participant|12
1142051|NCT01412333|3750522|P1|Overall Study|Consent withdrawn by participant|25
1142052|NCT01412333|3750521|P2|Overall Study|Pregnancy|0
1142053|NCT01412333|3750522|P1|Overall Study|Pregnancy|3
1142054|NCT01412333|3750521|P2|Overall Study|Lack of Efficacy|6
1142055|NCT01412333|3750522|P1|Overall Study|Lack of Efficacy|15
1142056|NCT01412333|3750521|P2|Overall Study|Non-compliance|3
1142057|NCT01412333|3750522|P1|Overall Study|Non-compliance|1
1142058|NCT01412333|3750521|P2|Overall Study|Protocol Violation|1
1142059|NCT01412333|3750522|P1|Overall Study|Protocol Violation|1
1142060|NCT01412333|3750521|P2|Overall Study|Non-compliance with study drug|1
1142061|NCT01412333|3750522|P1|Overall Study|Non-compliance with study drug|1
1142062|NCT01412333|3750521|P2|Overall Study|Reason not specified|10
1142063|NCT01412333|3750522|P1|Overall Study|Reason not specified|16
1142064|NCT01412333|3750521|P2|Overall Study|Physician Decision|1
1142065|NCT01412333|3750522|P1|Overall Study|Physician Decision|0
1142066|NCT01412333|3750521|P2|Overall Study|Death|1
1142067|NCT01412333|3750522|P1|Overall Study|Death|1
1142068|NCT01412229|3750582|P1|Overall Study|Physician Decision|1
1142069|NCT01412151|3750598|P1|Week 306 - 310 - Washout Period|Withdrawal by Subject|2
1142070|NCT01412151|3750598|P1|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3
1142071|NCT01412151|3750598|P1|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1
1142072|NCT01412151|3750598|P1|Week 0 - 306 - Treatment Period|Death|1
1142073|NCT01412060|3750609|P3|Double-blind Treatment Phase (DBP)|Relapse|25
1142074|NCT01412060|3750610|P2|Double-blind Treatment Phase (DBP)|Relapse|47
1142075|NCT01412060|3750611|P1|Double-blind Treatment Phase (DBP)|Relapse|0
1142076|NCT01412060|3750609|P3|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27
1142077|NCT01412060|3750610|P2|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11
1142078|NCT01412060|3750611|P1|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0
1142079|NCT01412060|3750609|P3|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5
1142080|NCT01412060|3750610|P2|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6
1142081|NCT01412060|3750611|P1|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0
1142082|NCT01412060|3750609|P3|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15
1142083|NCT01412060|3750610|P2|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10
1142084|NCT01412060|3750611|P1|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0
1142085|NCT01412060|3750609|P3|Double-blind Treatment Phase (DBP)|Protocol Violation|5
1142086|NCT01412060|3750610|P2|Double-blind Treatment Phase (DBP)|Protocol Violation|4
1142087|NCT01412060|3750611|P1|Double-blind Treatment Phase (DBP)|Protocol Violation|0
1142088|NCT01412060|3750609|P3|Double-blind Treatment Phase (DBP)|Adverse Event|6
1142089|NCT01412060|3750610|P2|Double-blind Treatment Phase (DBP)|Adverse Event|5
1142090|NCT01412060|3750611|P1|Double-blind Treatment Phase (DBP)|Adverse Event|0
1142091|NCT01412060|3750609|P3|Period Between SP and DBP|Other Miscellaneous Reasons|0
1142092|NCT01412060|3750610|P2|Period Between SP and DBP|Other Miscellaneous Reasons|0
1142093|NCT01412060|3750611|P1|Period Between SP and DBP|Other Miscellaneous Reasons|55
1142094|NCT01412060|3750609|P3|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0
1142095|NCT01412060|3750610|P2|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0
1142096|NCT01412060|3750611|P1|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4
1142097|NCT01412060|3750609|P3|Period Between SP and DBP|Lost to Follow-up|0
1142098|NCT01412060|3750610|P2|Period Between SP and DBP|Lost to Follow-up|0
1142099|NCT01412060|3750611|P1|Period Between SP and DBP|Lost to Follow-up|1
1142100|NCT01412060|3750609|P3|Period Between SP and DBP|Withdrawal of Consent|0
1142101|NCT01412060|3750610|P2|Period Between SP and DBP|Withdrawal of Consent|0
1142102|NCT01412060|3750611|P1|Period Between SP and DBP|Withdrawal of Consent|2
1142103|NCT01412060|3750609|P3|Period Between SP and DBP|Protocol Violation|0
1142104|NCT01412060|3750610|P2|Period Between SP and DBP|Protocol Violation|0
1142105|NCT01412060|3750611|P1|Period Between SP and DBP|Protocol Violation|2
1142106|NCT01412060|3750609|P3|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0
1142107|NCT01412060|3750610|P2|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0
1142108|NCT01412060|3750611|P1|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19
1142109|NCT01412060|3750609|P3|Open-label Stabilization Period (SP)|Lost to Follow-up|0
1142110|NCT01412060|3750610|P2|Open-label Stabilization Period (SP)|Lost to Follow-up|0
1142111|NCT01412060|3750611|P1|Open-label Stabilization Period (SP)|Lost to Follow-up|9
1142112|NCT01412060|3750609|P3|Open-label Stabilization Period (SP)|Withdrawal of Consent|0
1142113|NCT01412060|3750610|P2|Open-label Stabilization Period (SP)|Withdrawal of Consent|0
1142114|NCT01412060|3750611|P1|Open-label Stabilization Period (SP)|Withdrawal of Consent|40
1142115|NCT01412060|3750609|P3|Open-label Stabilization Period (SP)|Protocol Violation|0
1142116|NCT01412060|3750610|P2|Open-label Stabilization Period (SP)|Protocol Violation|0
1142117|NCT01412060|3750611|P1|Open-label Stabilization Period (SP)|Protocol Violation|14
1142118|NCT01412060|3750609|P3|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0
1142119|NCT01412060|3750610|P2|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0
1142120|NCT01412060|3750611|P1|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9
1142121|NCT01412060|3750609|P3|Open-label Stabilization Period (SP)|Adverse Event|0
1142122|NCT01412060|3750610|P2|Open-label Stabilization Period (SP)|Adverse Event|0
1142123|NCT01412060|3750611|P1|Open-label Stabilization Period (SP)|Adverse Event|9
1142124|NCT01412060|3750609|P3|Period Between RIP and SP|Other Miscellaneous Reasons|0
1142125|NCT01412060|3750610|P2|Period Between RIP and SP|Other Miscellaneous Reasons|0
1142126|NCT01412060|3750611|P1|Period Between RIP and SP|Other Miscellaneous Reasons|23
1142127|NCT01412060|3750609|P3|Period Between RIP and SP|Lost to Follow-up|0
1142128|NCT01412060|3750610|P2|Period Between RIP and SP|Lost to Follow-up|0
1142129|NCT01412060|3750611|P1|Period Between RIP and SP|Lost to Follow-up|5
1142130|NCT01412060|3750609|P3|Period Between RIP and SP|Withdrawal of Consent|0
1142131|NCT01412060|3750610|P2|Period Between RIP and SP|Withdrawal of Consent|0
1142132|NCT01412060|3750611|P1|Period Between RIP and SP|Withdrawal of Consent|1
1142133|NCT01412060|3750609|P3|Period Between RIP and SP|Protocol Violation|0
1142134|NCT01412060|3750610|P2|Period Between RIP and SP|Protocol Violation|0
1142135|NCT01412060|3750611|P1|Period Between RIP and SP|Protocol Violation|2
1142136|NCT01412060|3750609|P3|Period Between RIP and SP|Insufficient Therapeutic Response|0
1142137|NCT01412060|3750610|P2|Period Between RIP and SP|Insufficient Therapeutic Response|0
1142138|NCT01412060|3750611|P1|Period Between RIP and SP|Insufficient Therapeutic Response|19
1142139|NCT01412060|3750609|P3|Period Between RIP and SP|Adverse Event|0
1142140|NCT01412060|3750610|P2|Period Between RIP and SP|Adverse Event|0
1142141|NCT01412060|3750611|P1|Period Between RIP and SP|Adverse Event|4
1142142|NCT01412060|3750609|P3|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0
1142143|NCT01412060|3750610|P2|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0
1142144|NCT01412060|3750611|P1|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19
1142145|NCT01412060|3750609|P3|Open-label Run-in Period (RIP)|Lost to Follow-up|0
1142146|NCT01412060|3750610|P2|Open-label Run-in Period (RIP)|Lost to Follow-up|0
1142147|NCT01412060|3750611|P1|Open-label Run-in Period (RIP)|Lost to Follow-up|32
1142148|NCT01412060|3750609|P3|Open-label Run-in Period (RIP)|Withdrawal of Consent|0
1142149|NCT01412060|3750610|P2|Open-label Run-in Period (RIP)|Withdrawal of Consent|0
1142150|NCT01412060|3750611|P1|Open-label Run-in Period (RIP)|Withdrawal of Consent|117
1142151|NCT01412060|3750609|P3|Open-label Run-in Period (RIP)|Protocol Violation|0
1142152|NCT01412060|3750610|P2|Open-label Run-in Period (RIP)|Protocol Violation|0
1142153|NCT01412060|3750611|P1|Open-label Run-in Period (RIP)|Protocol Violation|27
1142154|NCT01412060|3750609|P3|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0
1142155|NCT01412060|3750610|P2|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0
1142156|NCT01412060|3750611|P1|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66
1142157|NCT01412060|3750609|P3|Open-label Run-in Period (RIP)|Adverse Event|0
1142158|NCT01412060|3750610|P2|Open-label Run-in Period (RIP)|Adverse Event|0
1142159|NCT01412060|3750611|P1|Open-label Run-in Period (RIP)|Adverse Event|86
1142160|NCT01411995|3750623|P2|Overall Study|Failed IUD insertion|1
1142161|NCT01411995|3750624|P1|Overall Study|Failed IUD insertion|0
1142162|NCT01411891|3750632|P2|Overall Study|Catheter dislodgement or loss to follow-|2
1142163|NCT01411891|3750633|P1|Overall Study|Catheter dislodgement or loss to follow-|3
1142164|NCT01411852|3750643|P2|Hospital Intervention Phase|Vascular access failed|0
1142165|NCT01411852|3750644|P1|Hospital Intervention Phase|Vascular access failed|1
1142166|NCT01411852|3750643|P2|Hospital Intervention Phase|Withdrawal by Subject|0
1142167|NCT01411852|3750644|P1|Hospital Intervention Phase|Withdrawal by Subject|1
1142168|NCT01411852|3750643|P2|Hospital Intervention Phase|Spinal cord injury|0
1142169|NCT01411852|3750644|P1|Hospital Intervention Phase|Spinal cord injury|2
1142170|NCT01411852|3750643|P2|Hospital Intervention Phase|Other ineligible|2
1142171|NCT01411852|3750644|P1|Hospital Intervention Phase|Other ineligible|2
1142172|NCT01411852|3750643|P2|Hospital Intervention Phase|Physician/hospital staff noncompliance|4
1142173|NCT01411852|3750644|P1|Hospital Intervention Phase|Physician/hospital staff noncompliance|0
1142174|NCT01411852|3750643|P2|Hospital Intervention Phase|Diagnosis of dehydration|1
1142175|NCT01411852|3750644|P1|Hospital Intervention Phase|Diagnosis of dehydration|0
1142176|NCT01411852|3750643|P2|Hospital Intervention Phase|Diagnosis of sepsis|2
1142177|NCT01411852|3750644|P1|Hospital Intervention Phase|Diagnosis of sepsis|0
1142178|NCT01411852|3750643|P2|Hospital Intervention Phase|Misunderstanding of protocol|1
1142179|NCT01411852|3750644|P1|Hospital Intervention Phase|Misunderstanding of protocol|4
1142180|NCT01411852|3750643|P2|Hospital Intervention Phase|CPR administered|1
1142181|NCT01411852|3750644|P1|Hospital Intervention Phase|CPR administered|3
1142182|NCT01411852|3750643|P2|Hospital Intervention Phase|Miscommunication error|2
1142183|NCT01411852|3750644|P1|Hospital Intervention Phase|Miscommunication error|1
1142184|NCT01411852|3750643|P2|Hospital Intervention Phase|No qualifying SBP|1
1142185|NCT01411852|3750644|P1|Hospital Intervention Phase|No qualifying SBP|5
1142186|NCT01411852|3750643|P2|Hospital Intervention Phase|Severe head injury|4
1142187|NCT01411852|3750644|P1|Hospital Intervention Phase|Severe head injury|5
1142188|NCT01411852|3750643|P2|Prehospital Intervention Phase|Severe head injury with GCS≤8|0
1142189|NCT01411852|3750644|P1|Prehospital Intervention Phase|Severe head injury with GCS≤8|5
1142190|NCT01411852|3750643|P2|Prehospital Intervention Phase|Found to be under age|1
1142191|NCT01411852|3750644|P1|Prehospital Intervention Phase|Found to be under age|0
1142192|NCT01411852|3750643|P2|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
1142193|NCT01411852|3750644|P1|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
1142194|NCT01411852|3750643|P2|Prehospital Intervention Phase|No qualifying SBP|4
1142195|NCT01411852|3750644|P1|Prehospital Intervention Phase|No qualifying SBP|5
1142196|NCT01411839|3750689|P2|Overall Study|Lost to Follow-up|3
1142197|NCT01411839|3750690|P1|Overall Study|Lost to Follow-up|4
1142198|NCT01411774|3750702|P2|Overall Study|Withdrawal by Subject|3
1142199|NCT01411774|3750703|P1|Overall Study|Withdrawal by Subject|0
1142200|NCT01411228|3750778|P3|Overall Study|Withdrawal by Subject|0
1142201|NCT01411228|3750779|P2|Overall Study|Withdrawal by Subject|0
1142202|NCT01411228|3750780|P1|Overall Study|Withdrawal by Subject|1
1142203|NCT01411228|3750778|P3|Overall Study|Lost to Follow-up|1
1142204|NCT01411228|3750779|P2|Overall Study|Lost to Follow-up|0
1142205|NCT01411228|3750780|P1|Overall Study|Lost to Follow-up|0
1142206|NCT01411215|3750802|P2|Overall Study|Screen failure|1
1142207|NCT01411215|3750803|P1|Overall Study|Screen failure|0
1142208|NCT01411215|3750802|P2|Overall Study|Other|17
1142209|NCT01411215|3750803|P1|Overall Study|Other|12
1142210|NCT01411215|3750802|P2|Overall Study|Withdrawal by Subject|21
1142211|NCT01411215|3750803|P1|Overall Study|Withdrawal by Subject|34
1142212|NCT01411215|3750802|P2|Overall Study|Protocol Violation|5
1142213|NCT01411215|3750803|P1|Overall Study|Protocol Violation|3
1142214|NCT01411215|3750802|P2|Overall Study|Study terminated by sponsor|15
1142215|NCT01411215|3750803|P1|Overall Study|Study terminated by sponsor|2
1142216|NCT01411215|3750802|P2|Overall Study|Did not meet entrance criteria|1
1142217|NCT01411215|3750803|P1|Overall Study|Did not meet entrance criteria|0
1142218|NCT01411215|3750802|P2|Overall Study|Lost to Follow-up|18
1142219|NCT01411215|3750803|P1|Overall Study|Lost to Follow-up|12
1142220|NCT01411215|3750802|P2|Overall Study|Lack of Efficacy|4
1142221|NCT01411215|3750803|P1|Overall Study|Lack of Efficacy|2
1142222|NCT01411215|3750802|P2|Overall Study|Adverse Event|2
1142223|NCT01411215|3750803|P1|Overall Study|Adverse Event|1
1142224|NCT01411085|3750855|P1|Overall Study|Adverse Event|1
1142225|NCT01411085|3750855|P1|Overall Study|Protocol Violation|1
1142226|NCT01411085|3750855|P1|Overall Study|Physician Decision|1
1142227|NCT01410604|3750882|P2|Overall Study|Physician Decision|1
1142228|NCT01410604|3750883|P1|Overall Study|Physician Decision|0
1142229|NCT01410604|3750882|P2|Overall Study|Lost to Follow-up|0
1142230|NCT01410604|3750883|P1|Overall Study|Lost to Follow-up|1
1142231|NCT01410604|3750882|P2|Overall Study|Adverse Event|1
1142232|NCT01410604|3750883|P1|Overall Study|Adverse Event|2
1142233|NCT01410474|3750924|P2|Overall Study|Withdrawal by Subject|1
1142234|NCT01410474|3750925|P1|Overall Study|Withdrawal by Subject|0
1142235|NCT01410448|3750948|P2|Overall Study|Death|3
1142236|NCT01410448|3750949|P1|Overall Study|Death|2
1142237|NCT01410448|3750948|P2|Overall Study|Protocol Violation|4
1142238|NCT01410448|3750949|P1|Overall Study|Protocol Violation|0
1142239|NCT01410448|3750948|P2|Overall Study|Withdrawal by Subject|2
1142240|NCT01410448|3750949|P1|Overall Study|Withdrawal by Subject|3
1142241|NCT01410448|3750948|P2|Overall Study|Lost to Follow-up|0
1142242|NCT01410448|3750949|P1|Overall Study|Lost to Follow-up|1
1142243|NCT01410448|3750948|P2|Overall Study|Administrative issues|1
1142244|NCT01410448|3750949|P1|Overall Study|Administrative issues|2
1142245|NCT01410448|3750948|P2|Overall Study|Graft loss|1
1142246|NCT01410448|3750949|P1|Overall Study|Graft loss|4
1142247|NCT01410448|3750948|P2|Overall Study|No conversion to everolimus|24
1142248|NCT01410448|3750949|P1|Overall Study|No conversion to everolimus|0
1142249|NCT01410357|3751014|P2|Overall Study|Lost to Follow-up|21
1142250|NCT01410357|3751015|P1|Overall Study|Lost to Follow-up|23
1142251|NCT01410357|3751014|P2|Overall Study|Withdrawal by Subject|2
1142252|NCT01410357|3751015|P1|Overall Study|Withdrawal by Subject|1
1142253|NCT01410357|3751014|P2|Overall Study|Death|1
1142254|NCT01410357|3751015|P1|Overall Study|Death|2
1142255|NCT01410240|3751086|P3|Overall Study|Missed week 6 assessments|1
1142256|NCT01410240|3751087|P2|Overall Study|Missed week 6 assessments|1
1142257|NCT01410240|3751088|P1|Overall Study|Missed week 6 assessments|1
1142258|NCT01410240|3751086|P3|Overall Study|Physician Decision|1
1142259|NCT01410240|3751087|P2|Overall Study|Physician Decision|0
1142260|NCT01410240|3751088|P1|Overall Study|Physician Decision|0
1142261|NCT01410227|3751159|P4|Overall Study|Met Excl. Criteria After Starting Study|0
1142262|NCT01410227|3751160|P3|Overall Study|Met Excl. Criteria After Starting Study|1
1142263|NCT01410227|3751161|P2|Overall Study|Met Excl. Criteria After Starting Study|0
1142264|NCT01410227|3751162|P1|Overall Study|Met Excl. Criteria After Starting Study|0
1142265|NCT01410227|3751159|P4|Overall Study|Pregnancy|1
1142266|NCT01410227|3751160|P3|Overall Study|Pregnancy|0
1142267|NCT01410227|3751161|P2|Overall Study|Pregnancy|0
1142268|NCT01410227|3751162|P1|Overall Study|Pregnancy|0
1142269|NCT01410227|3751159|P4|Overall Study|Withdrawal by Subject|0
1142270|NCT01410227|3751160|P3|Overall Study|Withdrawal by Subject|1
1142271|NCT01410227|3751161|P2|Overall Study|Withdrawal by Subject|0
1142272|NCT01410227|3751162|P1|Overall Study|Withdrawal by Subject|3
1142273|NCT01410227|3751159|P4|Overall Study|Adverse Event|0
1142274|NCT01410227|3751160|P3|Overall Study|Adverse Event|0
1142275|NCT01410227|3751161|P2|Overall Study|Adverse Event|0
1142276|NCT01410227|3751162|P1|Overall Study|Adverse Event|1
1142277|NCT01410110|3751234|P2|Overall Study|Withdrawal by Subject|2
1142278|NCT01410110|3751235|P1|Overall Study|Withdrawal by Subject|4
1142279|NCT01409993|3751284|P4|Overall Study|Lost to Follow-up|0
1142280|NCT01409993|3751285|P3|Overall Study|Lost to Follow-up|0
1142281|NCT01409993|3751286|P2|Overall Study|Lost to Follow-up|1
1142282|NCT01409993|3751287|P1|Overall Study|Lost to Follow-up|0
1142283|NCT01409993|3751284|P4|Overall Study|Withdrawal by Subject|4
1142284|NCT01409993|3751285|P3|Overall Study|Withdrawal by Subject|0
1142285|NCT01409993|3751286|P2|Overall Study|Withdrawal by Subject|0
1142286|NCT01409993|3751287|P1|Overall Study|Withdrawal by Subject|0
1142287|NCT01409993|3751284|P4|Overall Study|Adverse Event|1
1142288|NCT01409993|3751285|P3|Overall Study|Adverse Event|3
1142289|NCT01409993|3751286|P2|Overall Study|Adverse Event|4
1142290|NCT01409993|3751287|P1|Overall Study|Adverse Event|4
1142291|NCT01409837|3751307|P2|Overall Study|Physician Decision|1
1142292|NCT01409837|3751308|P1|Overall Study|Physician Decision|0
1142293|NCT01409837|3751307|P2|Overall Study|Lost to Follow-up|0
1142294|NCT01409837|3751308|P1|Overall Study|Lost to Follow-up|1
1142295|NCT01409837|3751307|P2|Overall Study|Withdrawal by Subject|1
1142296|NCT01409837|3751308|P1|Overall Study|Withdrawal by Subject|2
1142297|NCT01409707|3751333|P3|Overall Study|Withdrawal by Subject|16
1142298|NCT01409707|3751334|P2|Overall Study|Withdrawal by Subject|17
1142299|NCT01409707|3751335|P1|Overall Study|Withdrawal by Subject|5
1142300|NCT01409564|3751347|P2|Overall Study|brain abnormalities found in T1 MR|2
1142301|NCT01409564|3751348|P1|Overall Study|brain abnormalities found in T1 MR|1
1142302|NCT01409564|3751347|P2|Overall Study|low medication compliance|3
1142303|NCT01409564|3751348|P1|Overall Study|low medication compliance|4
1142304|NCT01409434|3751366|P1|Overall Study|Protocol Violation|4
1142305|NCT01409382|3751376|P2|Overall Study|Had a 2nd trimester loss after accident|0
1142306|NCT01409382|3751377|P1|Overall Study|Had a 2nd trimester loss after accident|1
1142307|NCT01409382|3751376|P2|Overall Study|Did not manage to get pregnant|70
1142308|NCT01409382|3751377|P1|Overall Study|Did not manage to get pregnant|64
1142309|NCT01409382|3751376|P2|Overall Study|Still pregnant when study ended|2
1142310|NCT01409382|3751377|P1|Overall Study|Still pregnant when study ended|13
1142311|NCT01409382|3751376|P2|Overall Study|Multiple pregnancy|4
1142312|NCT01409382|3751377|P1|Overall Study|Multiple pregnancy|2
1142313|NCT01409382|3751376|P2|Overall Study|Protocol Violation|3
1142314|NCT01409382|3751377|P1|Overall Study|Protocol Violation|0
1142315|NCT01409382|3751376|P2|Overall Study|Lost to Follow-up|1
1142316|NCT01409382|3751377|P1|Overall Study|Lost to Follow-up|1
1142317|NCT01408914|3751444|P3|Overall Study|Change in local TB/HIV norms|1
1142318|NCT01408914|3751445|P2|Overall Study|Change in local TB/HIV norms|1
1142319|NCT01408914|3751446|P1|Overall Study|Change in local TB/HIV norms|0
1142320|NCT01408914|3751444|P3|Overall Study|Late exclusion|3
1142321|NCT01408914|3751445|P2|Overall Study|Late exclusion|3
1142322|NCT01408914|3751446|P1|Overall Study|Late exclusion|0
1142323|NCT01408914|3751444|P3|Overall Study|Moved out of study jurisdiction|0
1142324|NCT01408914|3751445|P2|Overall Study|Moved out of study jurisdiction|1
1142325|NCT01408914|3751446|P1|Overall Study|Moved out of study jurisdiction|1
1142326|NCT01408914|3751444|P3|Overall Study|Withdrawal by Subject|1
1142327|NCT01408914|3751445|P2|Overall Study|Withdrawal by Subject|0
1142328|NCT01408914|3751446|P1|Overall Study|Withdrawal by Subject|1
1142329|NCT01408914|3751444|P3|Overall Study|Physician Decision|0
1142330|NCT01408914|3751445|P2|Overall Study|Physician Decision|1
1142331|NCT01408914|3751446|P1|Overall Study|Physician Decision|1
1142332|NCT01408914|3751444|P3|Overall Study|Lost to Follow-up|2
1142333|NCT01408914|3751445|P2|Overall Study|Lost to Follow-up|1
1142334|NCT01408914|3751446|P1|Overall Study|Lost to Follow-up|4
1142335|NCT01408914|3751444|P3|Overall Study|Could not complete tx in protocol period|6
1142336|NCT01408914|3751445|P2|Overall Study|Could not complete tx in protocol period|5
1142337|NCT01408914|3751446|P1|Overall Study|Could not complete tx in protocol period|5
1142338|NCT01408888|3751460|P2|Second Intervention|Adverse Event|0
1142339|NCT01408888|3751461|P1|Second Intervention|Adverse Event|1
1142340|NCT01408888|3751460|P2|Second Intervention|Withdrawal by Subject|0
1142341|NCT01408888|3751461|P1|Second Intervention|Withdrawal by Subject|1
1142342|NCT01408888|3751460|P2|First Intervention|Withdrawal by Subject|2
1142343|NCT01408888|3751461|P1|First Intervention|Withdrawal by Subject|0
1142344|NCT01408888|3751460|P2|First Intervention|Adverse Event|1
1142345|NCT01408888|3751461|P1|First Intervention|Adverse Event|0
1142346|NCT01408732|3751489|P2|Overall Study|Withdrawal by Subject|2
1142347|NCT01408732|3751490|P1|Overall Study|Withdrawal by Subject|2
1142348|NCT01408706|3751547|P2|Overall Study|Physician Decision|0
1142349|NCT01408706|3751548|P1|Overall Study|Physician Decision|1
1142350|NCT01408641|3751560|P2|Overall Study|Physician Decision|0
1142351|NCT01408641|3751561|P1|Overall Study|Physician Decision|1
1142352|NCT01408628|3751569|P1|Completed 6 Month Follow-Up|Withdrawal by Subject|5
1142353|NCT01408628|3751569|P1|Completed 6 Month Follow-Up|Protocol Violation|6
1142354|NCT01408628|3751569|P1|Completed 6 Month Follow-Up|Lost to Follow-up|3
1142355|NCT01408628|3751569|P1|Consented|Withdrawal by Subject|12
1142356|NCT01408576|3751578|P3|Overall Study|Not specified|18
1142357|NCT01408576|3751579|P2|Overall Study|Not specified|16
1142358|NCT01408576|3751580|P1|Overall Study|Not specified|10
1142359|NCT01408576|3751578|P3|Overall Study|AE, unknown type|0
1142360|NCT01408576|3751579|P2|Overall Study|AE, unknown type|1
1142361|NCT01408576|3751580|P1|Overall Study|AE, unknown type|0
1142362|NCT01408576|3751578|P3|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
1142363|NCT01408576|3751579|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
1142364|NCT01408576|3751580|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
1142365|NCT01408576|3751578|P3|Overall Study|AE, non-serious non-fatal|11
1142366|NCT01408576|3751579|P2|Overall Study|AE, non-serious non-fatal|19
1142367|NCT01408576|3751580|P1|Overall Study|AE, non-serious non-fatal|12
1142368|NCT01408576|3751578|P3|Overall Study|SAE, non-fatal|14
1142369|NCT01408576|3751579|P2|Overall Study|SAE, non-fatal|23
1142370|NCT01408576|3751580|P1|Overall Study|SAE, non-fatal|11
1142371|NCT01408576|3751578|P3|Overall Study|AE, serious fatal|1
1142372|NCT01408576|3751579|P2|Overall Study|AE, serious fatal|4
1142373|NCT01408576|3751580|P1|Overall Study|AE, serious fatal|4
1142374|NCT01408576|3751578|P3|Overall Study|Sponsor terminated study|330
1142375|NCT01408576|3751579|P2|Overall Study|Sponsor terminated study|333
1142376|NCT01408576|3751580|P1|Overall Study|Sponsor terminated study|89
1142377|NCT01408576|3751578|P3|Overall Study|Withdrawal by Subject|66
1142378|NCT01408576|3751579|P2|Overall Study|Withdrawal by Subject|60
1142379|NCT01408576|3751580|P1|Overall Study|Withdrawal by Subject|34
1142380|NCT01408576|3751578|P3|Overall Study|Lost to Follow-up|17
1142381|NCT01408576|3751579|P2|Overall Study|Lost to Follow-up|9
1142382|NCT01408576|3751580|P1|Overall Study|Lost to Follow-up|10
1142383|NCT01408576|3751578|P3|Overall Study|Protocol Violation|2
1142384|NCT01408576|3751579|P2|Overall Study|Protocol Violation|2
1142385|NCT01408576|3751580|P1|Overall Study|Protocol Violation|1
1142386|NCT01408576|3751578|P3|Overall Study|Lack of Efficacy|48
1142387|NCT01408576|3751579|P2|Overall Study|Lack of Efficacy|30
1142388|NCT01408576|3751580|P1|Overall Study|Lack of Efficacy|17
1142389|NCT01408563|3751627|P1|Overall Study|Ineligible after consent/ registration|2
1142390|NCT01408537|3751638|P1|Overall Study|Lost to Follow-up|3
1142391|NCT01408537|3751638|P1|Overall Study|Protocol Violation|3
1142392|NCT01408537|3751638|P1|Overall Study|Withdrawal by Subject|2
1142393|NCT01408485|3751654|P1|Overall Study|Withdrawal by Subject|21
1142394|NCT01408303|3751672|P3|Overall Study|Noncompliance|1
1142395|NCT01408303|3751673|P2|Overall Study|Noncompliance|0
1142396|NCT01408303|3751674|P1|Overall Study|Noncompliance|1
1142397|NCT01408303|3751672|P3|Overall Study|Protocol Violation|0
1142398|NCT01408303|3751673|P2|Overall Study|Protocol Violation|1
1142399|NCT01408303|3751674|P1|Overall Study|Protocol Violation|0
1142400|NCT01408303|3751672|P3|Overall Study|Withdrawal by Subject|1
1142401|NCT01408303|3751673|P2|Overall Study|Withdrawal by Subject|3
1142402|NCT01408303|3751674|P1|Overall Study|Withdrawal by Subject|2
1142403|NCT01408303|3751672|P3|Overall Study|Lost to Follow-up|2
1142404|NCT01408303|3751673|P2|Overall Study|Lost to Follow-up|1
1142405|NCT01408303|3751674|P1|Overall Study|Lost to Follow-up|0
1142406|NCT01408303|3751672|P3|Overall Study|Adverse Event|2
1142407|NCT01408303|3751673|P2|Overall Study|Adverse Event|7
1142408|NCT01408303|3751674|P1|Overall Study|Adverse Event|3
1142409|NCT01408277|3751684|P2|Overall Study|Protocol Violation|0
1142410|NCT01408277|3751685|P1|Overall Study|Protocol Violation|2
1142411|NCT01408277|3751684|P2|Overall Study|Withdrawal by Subject|0
1142412|NCT01408277|3751685|P1|Overall Study|Withdrawal by Subject|2
1142413|NCT01408277|3751684|P2|Overall Study|Lost to Follow-up|0
1142414|NCT01408277|3751685|P1|Overall Study|Lost to Follow-up|1
1142415|NCT01408277|3751684|P2|Overall Study|Adverse Event|4
1142416|NCT01408277|3751685|P1|Overall Study|Adverse Event|3
1142417|NCT01408030|3751695|P4|Observation Phase (Off Drug)|Other|1
1142418|NCT01408030|3751696|P3|Observation Phase (Off Drug)|Other|1
1142419|NCT01408030|3751697|P2|Observation Phase (Off Drug)|Other|1
1142420|NCT01408030|3751698|P1|Observation Phase (Off Drug)|Other|1
1142421|NCT01408030|3751695|P4|Observation Phase (Off Drug)|Physician Decision|0
1142422|NCT01408030|3751696|P3|Observation Phase (Off Drug)|Physician Decision|2
1142423|NCT01408030|3751697|P2|Observation Phase (Off Drug)|Physician Decision|1
1142424|NCT01408030|3751698|P1|Observation Phase (Off Drug)|Physician Decision|0
1142425|NCT01408030|3751695|P4|Observation Phase (Off Drug)|Withdrawal by Subject|3
1142426|NCT01408030|3751696|P3|Observation Phase (Off Drug)|Withdrawal by Subject|1
1142427|NCT01408030|3751697|P2|Observation Phase (Off Drug)|Withdrawal by Subject|2
1142428|NCT01408030|3751698|P1|Observation Phase (Off Drug)|Withdrawal by Subject|3
1142429|NCT01408030|3751695|P4|Observation Phase (Off Drug)|Lost to Follow-up|0
1142430|NCT01408030|3751696|P3|Observation Phase (Off Drug)|Lost to Follow-up|2
1142431|NCT01408030|3751697|P2|Observation Phase (Off Drug)|Lost to Follow-up|2
1142432|NCT01408030|3751698|P1|Observation Phase (Off Drug)|Lost to Follow-up|0
1142433|NCT01408030|3751695|P4|Treatment Phase (on Drug)|Protocol Violation|0
1142434|NCT01408030|3751696|P3|Treatment Phase (on Drug)|Protocol Violation|0
1142435|NCT01408030|3751697|P2|Treatment Phase (on Drug)|Protocol Violation|1
1142436|NCT01408030|3751698|P1|Treatment Phase (on Drug)|Protocol Violation|0
1142437|NCT01408030|3751695|P4|Treatment Phase (on Drug)|Lack of Efficacy|3
1142438|NCT01408030|3751696|P3|Treatment Phase (on Drug)|Lack of Efficacy|0
1142439|NCT01408030|3751697|P2|Treatment Phase (on Drug)|Lack of Efficacy|6
1142440|NCT01408030|3751698|P1|Treatment Phase (on Drug)|Lack of Efficacy|2
1142441|NCT01408030|3751695|P4|Treatment Phase (on Drug)|Lost to Follow-up|0
1142442|NCT01408030|3751696|P3|Treatment Phase (on Drug)|Lost to Follow-up|1
1142443|NCT01408030|3751697|P2|Treatment Phase (on Drug)|Lost to Follow-up|0
1142444|NCT01408030|3751698|P1|Treatment Phase (on Drug)|Lost to Follow-up|1
1142445|NCT01407367|3751761|P2|Overall Study|Lost to Follow-up|2
1142446|NCT01407367|3751762|P1|Overall Study|Lost to Follow-up|0
1142447|NCT01407367|3751761|P2|Overall Study|Withdrawal by Subject|15
1142448|NCT01407367|3751762|P1|Overall Study|Withdrawal by Subject|4
1142449|NCT01407367|3751761|P2|Overall Study|Renal Replacement Therapy (RRT)|29
1142450|NCT01407367|3751762|P1|Overall Study|Renal Replacement Therapy (RRT)|12
1142451|NCT01407367|3751761|P2|Overall Study|Death|32
1142452|NCT01407367|3751762|P1|Overall Study|Death|24
1142453|NCT01407354|3751776|P2|First Intervention|Physician Decision|0
1142454|NCT01407354|3751777|P1|First Intervention|Physician Decision|1
1142455|NCT01407354|3751776|P2|First Intervention|Adverse Event|0
1142456|NCT01407354|3751777|P1|First Intervention|Adverse Event|1
1142457|NCT01407354|3751776|P2|First Intervention|Withdrawal by Subject|2
1142458|NCT01407354|3751777|P1|First Intervention|Withdrawal by Subject|0
1142459|NCT01407276|3751793|P8|Overall Study|Withdrawal by Subject|1
1142460|NCT01407276|3751794|P7|Overall Study|Withdrawal by Subject|0
1142461|NCT01407276|3751795|P6|Overall Study|Withdrawal by Subject|0
1142462|NCT01407276|3751796|P5|Overall Study|Withdrawal by Subject|0
1142463|NCT01407276|3751797|P4|Overall Study|Withdrawal by Subject|0
1142464|NCT01407276|3751798|P3|Overall Study|Withdrawal by Subject|0
1142465|NCT01407276|3751799|P2|Overall Study|Withdrawal by Subject|0
1142466|NCT01407276|3751800|P1|Overall Study|Withdrawal by Subject|0
1142467|NCT01406938|3751952|P6|Follow up|Lost to Follow-up|1
1142468|NCT01406938|3751953|P5|Follow up|Lost to Follow-up|2
1142469|NCT01406938|3751954|P4|Follow up|Lost to Follow-up|1
1142470|NCT01406938|3751955|P3|Follow up|Lost to Follow-up|0
1142471|NCT01406938|3751956|P2|Follow up|Lost to Follow-up|1
1142472|NCT01406938|3751957|P1|Follow up|Lost to Follow-up|1
1142473|NCT01406938|3751952|P6|Follow up|Physician Decision|1
1142474|NCT01406938|3751953|P5|Follow up|Physician Decision|3
1142475|NCT01406938|3751954|P4|Follow up|Physician Decision|0
1142476|NCT01406938|3751955|P3|Follow up|Physician Decision|2
1142477|NCT01406938|3751956|P2|Follow up|Physician Decision|0
1142478|NCT01406938|3751957|P1|Follow up|Physician Decision|0
1142479|NCT01406938|3751952|P6|Follow up|Protocol Violation|0
1142480|NCT01406938|3751953|P5|Follow up|Protocol Violation|0
1142481|NCT01406938|3751954|P4|Follow up|Protocol Violation|0
1142482|NCT01406938|3751955|P3|Follow up|Protocol Violation|1
1142483|NCT01406938|3751956|P2|Follow up|Protocol Violation|0
1142484|NCT01406938|3751957|P1|Follow up|Protocol Violation|0
1142485|NCT01406938|3751952|P6|Follow up|Patient/guardian decision|1
1142486|NCT01406938|3751953|P5|Follow up|Patient/guardian decision|4
1142487|NCT01406938|3751954|P4|Follow up|Patient/guardian decision|2
1142488|NCT01406938|3751955|P3|Follow up|Patient/guardian decision|4
1142489|NCT01406938|3751956|P2|Follow up|Patient/guardian decision|2
1142490|NCT01406938|3751957|P1|Follow up|Patient/guardian decision|4
1142491|NCT01406938|3751952|P6|Follow up|Lack of Efficacy|0
1142492|NCT01406938|3751953|P5|Follow up|Lack of Efficacy|0
1142493|NCT01406938|3751954|P4|Follow up|Lack of Efficacy|0
1142494|NCT01406938|3751955|P3|Follow up|Lack of Efficacy|1
1142495|NCT01406938|3751956|P2|Follow up|Lack of Efficacy|2
1142496|NCT01406938|3751957|P1|Follow up|Lack of Efficacy|3
1142497|NCT01406938|3751952|P6|Maintenance Period|Lack of Efficacy|5
1142498|NCT01406938|3751953|P5|Maintenance Period|Lack of Efficacy|3
1142499|NCT01406938|3751954|P4|Maintenance Period|Lack of Efficacy|1
1142500|NCT01406938|3751955|P3|Maintenance Period|Lack of Efficacy|2
1142501|NCT01406938|3751956|P2|Maintenance Period|Lack of Efficacy|0
1142502|NCT01406938|3751957|P1|Maintenance Period|Lack of Efficacy|0
1142503|NCT01406938|3751952|P6|Maintenance Period|Lost to Follow-up|0
1142504|NCT01406938|3751953|P5|Maintenance Period|Lost to Follow-up|4
1142505|NCT01406938|3751954|P4|Maintenance Period|Lost to Follow-up|0
1142506|NCT01406938|3751955|P3|Maintenance Period|Lost to Follow-up|0
1142507|NCT01406938|3751956|P2|Maintenance Period|Lost to Follow-up|0
1142508|NCT01406938|3751957|P1|Maintenance Period|Lost to Follow-up|0
1142509|NCT01406938|3751952|P6|Maintenance Period|Pregnancy|0
1142510|NCT01406938|3751953|P5|Maintenance Period|Pregnancy|1
1142511|NCT01406938|3751954|P4|Maintenance Period|Pregnancy|0
1142512|NCT01406938|3751955|P3|Maintenance Period|Pregnancy|0
1142513|NCT01406938|3751956|P2|Maintenance Period|Pregnancy|0
1142514|NCT01406938|3751957|P1|Maintenance Period|Pregnancy|0
1142515|NCT01406938|3751952|P6|Maintenance Period|Protocol Violation|2
1142516|NCT01406938|3751953|P5|Maintenance Period|Protocol Violation|2
1142517|NCT01406938|3751954|P4|Maintenance Period|Protocol Violation|2
1142518|NCT01406938|3751955|P3|Maintenance Period|Protocol Violation|2
1142519|NCT01406938|3751956|P2|Maintenance Period|Protocol Violation|0
1142520|NCT01406938|3751957|P1|Maintenance Period|Protocol Violation|0
1142521|NCT01406938|3751952|P6|Maintenance Period|Subject/guardian decision|7
1142522|NCT01406938|3751953|P5|Maintenance Period|Subject/guardian decision|10
1142523|NCT01406938|3751954|P4|Maintenance Period|Subject/guardian decision|7
1142524|NCT01406938|3751955|P3|Maintenance Period|Subject/guardian decision|11
1142525|NCT01406938|3751956|P2|Maintenance Period|Subject/guardian decision|0
1142526|NCT01406938|3751957|P1|Maintenance Period|Subject/guardian decision|0
1142527|NCT01406938|3751952|P6|Maintenance Period|Death|0
1142528|NCT01406938|3751953|P5|Maintenance Period|Death|1
1142529|NCT01406938|3751954|P4|Maintenance Period|Death|0
1142530|NCT01406938|3751955|P3|Maintenance Period|Death|0
1142531|NCT01406938|3751956|P2|Maintenance Period|Death|0
1142532|NCT01406938|3751957|P1|Maintenance Period|Death|0
1142533|NCT01406938|3751952|P6|Maintenance Period|Adverse Event|2
1142534|NCT01406938|3751953|P5|Maintenance Period|Adverse Event|4
1142535|NCT01406938|3751954|P4|Maintenance Period|Adverse Event|8
1142536|NCT01406938|3751955|P3|Maintenance Period|Adverse Event|2
1142537|NCT01406938|3751956|P2|Maintenance Period|Adverse Event|0
1142538|NCT01406938|3751957|P1|Maintenance Period|Adverse Event|0
1142539|NCT01406938|3751952|P6|Induction Period|Lost to Follow-up|0
1142540|NCT01406938|3751953|P5|Induction Period|Lost to Follow-up|0
1142541|NCT01406938|3751954|P4|Induction Period|Lost to Follow-up|0
1142542|NCT01406938|3751955|P3|Induction Period|Lost to Follow-up|0
1142543|NCT01406938|3751956|P2|Induction Period|Lost to Follow-up|3
1142544|NCT01406938|3751957|P1|Induction Period|Lost to Follow-up|2
1142545|NCT01406938|3751952|P6|Induction Period|Lack of Efficacy|0
1142546|NCT01406938|3751953|P5|Induction Period|Lack of Efficacy|0
1142547|NCT01406938|3751954|P4|Induction Period|Lack of Efficacy|0
1142548|NCT01406938|3751955|P3|Induction Period|Lack of Efficacy|0
1142549|NCT01406938|3751956|P2|Induction Period|Lack of Efficacy|0
1142550|NCT01406938|3751957|P1|Induction Period|Lack of Efficacy|1
1142551|NCT01406938|3751952|P6|Induction Period|Adverse Event|0
1142552|NCT01406938|3751953|P5|Induction Period|Adverse Event|0
1142553|NCT01406938|3751954|P4|Induction Period|Adverse Event|0
1142554|NCT01406938|3751955|P3|Induction Period|Adverse Event|0
1142555|NCT01406938|3751956|P2|Induction Period|Adverse Event|9
1142556|NCT01406938|3751957|P1|Induction Period|Adverse Event|8
1142557|NCT01406938|3751952|P6|Induction Period|Protocol deviation|0
1142558|NCT01406938|3751953|P5|Induction Period|Protocol deviation|0
1142559|NCT01406938|3751954|P4|Induction Period|Protocol deviation|0
1142560|NCT01406938|3751955|P3|Induction Period|Protocol deviation|0
1142561|NCT01406938|3751956|P2|Induction Period|Protocol deviation|0
1142562|NCT01406938|3751957|P1|Induction Period|Protocol deviation|1
1142563|NCT01406938|3751952|P6|Induction Period|Subject/guardian decision|0
1142564|NCT01406938|3751953|P5|Induction Period|Subject/guardian decision|0
1142565|NCT01406938|3751954|P4|Induction Period|Subject/guardian decision|0
1142566|NCT01406938|3751955|P3|Induction Period|Subject/guardian decision|0
1142567|NCT01406938|3751956|P2|Induction Period|Subject/guardian decision|8
1142568|NCT01406938|3751957|P1|Induction Period|Subject/guardian decision|6
1142569|NCT01406873|3752075|P2|Overall Study|Withdrawal by Subject|1
1142570|NCT01406873|3752076|P1|Overall Study|Withdrawal by Subject|1
1142571|NCT01406795|3752107|P1|Overall Study|Withdrawal by Subject|1
1142572|NCT01406574|3752121|P4|Overall Study|Definite progression of primary disease|0
1142573|NCT01406574|3752122|P3|Overall Study|Definite progression of primary disease|0
1142574|NCT01406574|3752123|P2|Overall Study|Definite progression of primary disease|0
1142575|NCT01406574|3752124|P1|Overall Study|Definite progression of primary disease|1
1142576|NCT01406574|3752121|P4|Overall Study|Withdrawal by Subject|0
1142577|NCT01406574|3752122|P3|Overall Study|Withdrawal by Subject|0
1142578|NCT01406574|3752123|P2|Overall Study|Withdrawal by Subject|1
1142579|NCT01406574|3752124|P1|Overall Study|Withdrawal by Subject|0
1142580|NCT01406574|3752121|P4|Overall Study|Physician Decision|1
1142581|NCT01406574|3752122|P3|Overall Study|Physician Decision|0
1142582|NCT01406574|3752123|P2|Overall Study|Physician Decision|0
1142583|NCT01406574|3752124|P1|Overall Study|Physician Decision|0
1142584|NCT01406574|3752121|P4|Overall Study|Adverse Event|3
1142585|NCT01406574|3752122|P3|Overall Study|Adverse Event|1
1142586|NCT01406574|3752123|P2|Overall Study|Adverse Event|0
1142587|NCT01406574|3752124|P1|Overall Study|Adverse Event|0
1142588|NCT01406015|3752159|P2|Overall Study|Withdrawal by Subject|3
1142589|NCT01406015|3752160|P1|Overall Study|Withdrawal by Subject|3
1142590|NCT01405950|3752176|P4|Overall Study|Withdrawal by Subject|0
1142591|NCT01405950|3752177|P3|Overall Study|Withdrawal by Subject|0
1142592|NCT01405950|3752178|P2|Overall Study|Withdrawal by Subject|0
1142593|NCT01405950|3752179|P1|Overall Study|Withdrawal by Subject|1
1142594|NCT01405924|3752214|P1|Overall Study|Missing/Incomplete Data|2
1142595|NCT01405924|3752214|P1|Overall Study|Protocol Violation|8
1142596|NCT01405898|3752226|P2|Overall Study|Withdrawal by Subject|2
1142597|NCT01405898|3752227|P1|Overall Study|Withdrawal by Subject|2
1142598|NCT01405820|3752251|P6|Open-Label Treatment Period|Adverse Event|0
1142599|NCT01405820|3752252|P5|Open-Label Treatment Period|Adverse Event|0
1142600|NCT01405820|3752253|P4|Open-Label Treatment Period|Adverse Event|1
1142601|NCT01405820|3752254|P3|Open-Label Treatment Period|Adverse Event|0
1142602|NCT01405820|3752255|P2|Open-Label Treatment Period|Adverse Event|0
1142603|NCT01405820|3752256|P1|Open-Label Treatment Period|Adverse Event|0
1142604|NCT01405820|3752251|P6|Open-Label Treatment Period|Physician Decision|0
1142605|NCT01405820|3752252|P5|Open-Label Treatment Period|Physician Decision|1
1142606|NCT01405820|3752253|P4|Open-Label Treatment Period|Physician Decision|2
1142607|NCT01405820|3752254|P3|Open-Label Treatment Period|Physician Decision|1
1142608|NCT01405820|3752255|P2|Open-Label Treatment Period|Physician Decision|0
1142609|NCT01405820|3752256|P1|Open-Label Treatment Period|Physician Decision|0
1142610|NCT01405820|3752251|P6|Open-Label Treatment Period|Not Specified|1
1142611|NCT01405820|3752252|P5|Open-Label Treatment Period|Not Specified|1
1142612|NCT01405820|3752253|P4|Open-Label Treatment Period|Not Specified|1
1142613|NCT01405820|3752254|P3|Open-Label Treatment Period|Not Specified|1
1142614|NCT01405820|3752255|P2|Open-Label Treatment Period|Not Specified|1
1142615|NCT01405820|3752256|P1|Open-Label Treatment Period|Not Specified|1
1142616|NCT01405820|3752251|P6|Open-Label Treatment Period|Withdrawal by Subject|1
1142617|NCT01405820|3752252|P5|Open-Label Treatment Period|Withdrawal by Subject|0
1142618|NCT01405820|3752253|P4|Open-Label Treatment Period|Withdrawal by Subject|1
1142619|NCT01405820|3752254|P3|Open-Label Treatment Period|Withdrawal by Subject|1
1142620|NCT01405820|3752255|P2|Open-Label Treatment Period|Withdrawal by Subject|1
1142621|NCT01405820|3752256|P1|Open-Label Treatment Period|Withdrawal by Subject|3
1142622|NCT01405820|3752251|P6|Randomized Treatment Period|Withdrew Prior to Dosing|0
1142623|NCT01405820|3752252|P5|Randomized Treatment Period|Withdrew Prior to Dosing|0
1142624|NCT01405820|3752253|P4|Randomized Treatment Period|Withdrew Prior to Dosing|1
1142625|NCT01405820|3752254|P3|Randomized Treatment Period|Withdrew Prior to Dosing|0
1142626|NCT01405820|3752255|P2|Randomized Treatment Period|Withdrew Prior to Dosing|0
1142627|NCT01405820|3752256|P1|Randomized Treatment Period|Withdrew Prior to Dosing|0
1142628|NCT01405820|3752251|P6|Randomized Treatment Period|Death|0
1142629|NCT01405820|3752252|P5|Randomized Treatment Period|Death|0
1142630|NCT01405820|3752253|P4|Randomized Treatment Period|Death|1
1142631|NCT01405820|3752254|P3|Randomized Treatment Period|Death|0
1142632|NCT01405820|3752255|P2|Randomized Treatment Period|Death|0
1142633|NCT01405820|3752256|P1|Randomized Treatment Period|Death|0
1142634|NCT01405820|3752251|P6|Randomized Treatment Period|Treatment Arm Closed|28
1142635|NCT01405820|3752252|P5|Randomized Treatment Period|Treatment Arm Closed|33
1142636|NCT01405820|3752253|P4|Randomized Treatment Period|Treatment Arm Closed|36
1142637|NCT01405820|3752254|P3|Randomized Treatment Period|Treatment Arm Closed|20
1142638|NCT01405820|3752255|P2|Randomized Treatment Period|Treatment Arm Closed|0
1142639|NCT01405820|3752256|P1|Randomized Treatment Period|Treatment Arm Closed|0
1142640|NCT01405820|3752251|P6|Randomized Treatment Period|Incorrect Study Treatment|0
1142641|NCT01405820|3752252|P5|Randomized Treatment Period|Incorrect Study Treatment|2
1142642|NCT01405820|3752253|P4|Randomized Treatment Period|Incorrect Study Treatment|0
1142643|NCT01405820|3752254|P3|Randomized Treatment Period|Incorrect Study Treatment|3
1142644|NCT01405820|3752255|P2|Randomized Treatment Period|Incorrect Study Treatment|0
1142645|NCT01405820|3752256|P1|Randomized Treatment Period|Incorrect Study Treatment|0
1142646|NCT01405820|3752251|P6|Randomized Treatment Period|Rescue|8
1142647|NCT01405820|3752252|P5|Randomized Treatment Period|Rescue|8
1142648|NCT01405820|3752253|P4|Randomized Treatment Period|Rescue|10
1142649|NCT01405820|3752254|P3|Randomized Treatment Period|Rescue|13
1142650|NCT01405820|3752255|P2|Randomized Treatment Period|Rescue|1
1142651|NCT01405820|3752256|P1|Randomized Treatment Period|Rescue|0
1142652|NCT01405820|3752251|P6|Randomized Treatment Period|Physician Decision|0
1142653|NCT01405820|3752252|P5|Randomized Treatment Period|Physician Decision|0
1142654|NCT01405820|3752253|P4|Randomized Treatment Period|Physician Decision|0
1142655|NCT01405820|3752254|P3|Randomized Treatment Period|Physician Decision|1
1142656|NCT01405820|3752255|P2|Randomized Treatment Period|Physician Decision|2
1142657|NCT01405820|3752256|P1|Randomized Treatment Period|Physician Decision|0
1142658|NCT01405820|3752251|P6|Randomized Treatment Period|Not Specified|0
1142659|NCT01405820|3752252|P5|Randomized Treatment Period|Not Specified|0
1142660|NCT01405820|3752253|P4|Randomized Treatment Period|Not Specified|1
1142661|NCT01405820|3752254|P3|Randomized Treatment Period|Not Specified|1
1142662|NCT01405820|3752255|P2|Randomized Treatment Period|Not Specified|2
1142663|NCT01405820|3752256|P1|Randomized Treatment Period|Not Specified|2
1142664|NCT01405820|3752251|P6|Randomized Treatment Period|Withdrawal by Subject|0
1142665|NCT01405820|3752252|P5|Randomized Treatment Period|Withdrawal by Subject|0
1142666|NCT01405820|3752253|P4|Randomized Treatment Period|Withdrawal by Subject|2
1142667|NCT01405820|3752254|P3|Randomized Treatment Period|Withdrawal by Subject|2
1142668|NCT01405820|3752255|P2|Randomized Treatment Period|Withdrawal by Subject|2
1142669|NCT01405820|3752256|P1|Randomized Treatment Period|Withdrawal by Subject|6
1142670|NCT01405820|3752251|P6|Randomized Treatment Period|Adverse Event|1
1142671|NCT01405820|3752252|P5|Randomized Treatment Period|Adverse Event|2
1142672|NCT01405820|3752253|P4|Randomized Treatment Period|Adverse Event|0
1142673|NCT01405820|3752254|P3|Randomized Treatment Period|Adverse Event|3
1142674|NCT01405820|3752255|P2|Randomized Treatment Period|Adverse Event|3
1142675|NCT01405820|3752256|P1|Randomized Treatment Period|Adverse Event|3
1142676|NCT01405768|3752352|P2|Overall Study|Didn't complete questionnaire correctly|0
1142677|NCT01405768|3752353|P1|Overall Study|Didn't complete questionnaire correctly|4
1142678|NCT01405742|3752365|P2|Overall Study|Lost to Follow-up|0
1142679|NCT01405742|3752366|P1|Overall Study|Lost to Follow-up|1
1142680|NCT01405560|3752376|P1|Overall Study|Physician Decision|1
1142681|NCT01405508|3752391|P4|Overall Study|AE, non-serious non-fatal|0
1142682|NCT01405508|3752392|P3|Overall Study|AE, non-serious non-fatal|0
1142683|NCT01405508|3752393|P2|Overall Study|AE, non-serious non-fatal|1
1142684|NCT01405508|3752394|P1|Overall Study|AE, non-serious non-fatal|1
1142685|NCT01405456|3752426|P2|Overall Study|Physician Decision|0
1142686|NCT01405456|3752427|P1|Overall Study|Physician Decision|1
1142687|NCT01405456|3752426|P2|Overall Study|Lost to Follow-up|1
1142688|NCT01405456|3752427|P1|Overall Study|Lost to Follow-up|2
1142689|NCT01405196|3752467|P4|Overall Study|Lost to Follow-up|1
1142690|NCT01405196|3752468|P3|Overall Study|Lost to Follow-up|3
1142691|NCT01405196|3752469|P2|Overall Study|Lost to Follow-up|2
1142692|NCT01405196|3752470|P1|Overall Study|Lost to Follow-up|2
1142693|NCT01405196|3752467|P4|Overall Study|Death|0
1142694|NCT01405196|3752468|P3|Overall Study|Death|3
1142695|NCT01405196|3752469|P2|Overall Study|Death|0
1142696|NCT01405196|3752470|P1|Overall Study|Death|1
1142697|NCT01405196|3752467|P4|Overall Study|Adverse Event|2
1142698|NCT01405196|3752468|P3|Overall Study|Adverse Event|0
1142699|NCT01405196|3752469|P2|Overall Study|Adverse Event|2
1142700|NCT01405196|3752470|P1|Overall Study|Adverse Event|2
1142701|NCT01405196|3752467|P4|Overall Study|Withdrawal by Subject|6
1142702|NCT01405196|3752468|P3|Overall Study|Withdrawal by Subject|3
1142703|NCT01405196|3752469|P2|Overall Study|Withdrawal by Subject|6
1142704|NCT01405196|3752470|P1|Overall Study|Withdrawal by Subject|4
1142705|NCT01405196|3752467|P4|Overall Study|Other|0
1142706|NCT01405196|3752468|P3|Overall Study|Other|5
1142707|NCT01405196|3752469|P2|Overall Study|Other|2
1142708|NCT01405196|3752470|P1|Overall Study|Other|2
1142709|NCT01405196|3752467|P4|Overall Study|Study Terminated by Sponsor|0
1142710|NCT01405196|3752468|P3|Overall Study|Study Terminated by Sponsor|9
1142711|NCT01405196|3752469|P2|Overall Study|Study Terminated by Sponsor|0
1142712|NCT01405196|3752470|P1|Overall Study|Study Terminated by Sponsor|0
1142713|NCT01405027|3752557|P2|Overall Study|Other or Unknown|25
1142714|NCT01405027|3752558|P1|Overall Study|Other or Unknown|12
1142715|NCT01405027|3752557|P2|Overall Study|Death|0
1142716|NCT01405027|3752558|P1|Overall Study|Death|1
1142717|NCT01405027|3752557|P2|Overall Study|Investigator judgement|2
1142718|NCT01405027|3752558|P1|Overall Study|Investigator judgement|0
1142719|NCT01405027|3752557|P2|Overall Study|Lost to Follow-up|24
1142720|NCT01405027|3752558|P1|Overall Study|Lost to Follow-up|16
1142721|NCT01405027|3752557|P2|Overall Study|Withdrawn consent|0
1142722|NCT01405027|3752558|P1|Overall Study|Withdrawn consent|3
1142723|NCT01404988|3752575|P3|Overall Study|Lost to Follow-up|1
1142724|NCT01404988|3752576|P2|Overall Study|Lost to Follow-up|2
1142725|NCT01404988|3752577|P1|Overall Study|Lost to Follow-up|1
1142726|NCT01404988|3752575|P3|Overall Study|Withdrawal by Subject|0
1142727|NCT01404988|3752576|P2|Overall Study|Withdrawal by Subject|2
1142728|NCT01404988|3752577|P1|Overall Study|Withdrawal by Subject|2
1142729|NCT01404988|3752575|P3|Overall Study|Adverse Event|0
1142730|NCT01404988|3752576|P2|Overall Study|Adverse Event|0
1142731|NCT01404988|3752577|P1|Overall Study|Adverse Event|1
1142732|NCT01404988|3752575|P3|Overall Study|Death|2
1142733|NCT01404988|3752576|P2|Overall Study|Death|0
1142734|NCT01404988|3752577|P1|Overall Study|Death|2
1142735|NCT01404312|3752698|P2|Overall Study|Severe debilitation, unable to continue|2
1142736|NCT01404312|3752699|P1|Overall Study|Severe debilitation, unable to continue|1
1142737|NCT01404312|3752698|P2|Overall Study|Participant not willing to adhere to req|29
1142738|NCT01404312|3752699|P1|Overall Study|Participant not willing to adhere to req|31
1142739|NCT01404312|3752698|P2|Overall Study|Site closed|21
1142740|NCT01404312|3752699|P1|Overall Study|Site closed|22
1142741|NCT01404312|3752698|P2|Overall Study|Lost to Follow-up|111
1142742|NCT01404312|3752699|P1|Overall Study|Lost to Follow-up|115
1142743|NCT01404312|3752698|P2|Overall Study|Participant Unable to get to clinic|103
1142744|NCT01404312|3752699|P1|Overall Study|Participant Unable to get to clinic|93
1142745|NCT01404312|3752698|P2|Overall Study|Withdrawal by Subject|18
1142746|NCT01404312|3752699|P1|Overall Study|Withdrawal by Subject|15
1142747|NCT01404312|3752698|P2|Overall Study|Death|27
1142748|NCT01404312|3752699|P1|Overall Study|Death|21
1142749|NCT01404234|3752728|P1|Overall Study|Withdrawal by Subject|2
1142750|NCT01404208|3752744|P2|Overall Study|Discontinued|0
1142751|NCT01404208|3752745|P1|Overall Study|Discontinued|3
1142752|NCT01403987|3752810|P3|Overall Study|Residents forgot their secret PIN|18
1142753|NCT01403987|3752811|P2|Overall Study|Residents forgot their secret PIN|17
1142754|NCT01403987|3752812|P1|Overall Study|Residents forgot their secret PIN|18
1142755|NCT01403805|3752828|P2|Overall Study|Death|1
1142756|NCT01403805|3752829|P1|Overall Study|Death|0
1142757|NCT01403805|3752828|P2|Overall Study|Lost to Follow-up|2
1142758|NCT01403805|3752829|P1|Overall Study|Lost to Follow-up|0
1142759|NCT01403805|3752828|P2|Overall Study|Withdrawal by Subject|4
1142760|NCT01403805|3752829|P1|Overall Study|Withdrawal by Subject|0
1142761|NCT01403194|3752873|P1|Overall Study|Lost to Follow-up|8
1142762|NCT01403194|3752873|P1|Overall Study|Screen Failure|2
1142763|NCT01403116|3752881|P2|Overall Study|unable to keep appointments|2
1142764|NCT01403116|3752882|P1|Overall Study|unable to keep appointments|0
1142765|NCT01403116|3752881|P2|Overall Study|Hct >54%|0
1142766|NCT01403116|3752882|P1|Overall Study|Hct >54%|2
1142767|NCT01403116|3752881|P2|Overall Study|undisclosed Hx of Prostate Ca|0
1142768|NCT01403116|3752882|P1|Overall Study|undisclosed Hx of Prostate Ca|1
1142769|NCT01403116|3752881|P2|Overall Study|Protocol Violation|1
1142770|NCT01403116|3752882|P1|Overall Study|Protocol Violation|0
1142771|NCT01403116|3752881|P2|Overall Study|Non-compliance of study drug|0
1142772|NCT01403116|3752882|P1|Overall Study|Non-compliance of study drug|3
1142773|NCT01403116|3752881|P2|Overall Study|Withdrawal by Subject|15
1142774|NCT01403116|3752882|P1|Overall Study|Withdrawal by Subject|12
1142775|NCT01403116|3752881|P2|Overall Study|Lost to Follow-up|5
1142776|NCT01403116|3752882|P1|Overall Study|Lost to Follow-up|7
1142777|NCT01403116|3752881|P2|Overall Study|Adverse Event|4
1142778|NCT01403116|3752882|P1|Overall Study|Adverse Event|7
1142779|NCT01403051|3752895|P2|Overall Study|Lost to Follow-up|5
1142780|NCT01403051|3752896|P1|Overall Study|Lost to Follow-up|5
1142781|NCT01403051|3752895|P2|Overall Study|Withdrawal by Subject|1
1142782|NCT01403051|3752896|P1|Overall Study|Withdrawal by Subject|2
1142783|NCT01403051|3752895|P2|Overall Study|Death|0
1142784|NCT01403051|3752896|P1|Overall Study|Death|1
1142785|NCT01403051|3752895|P2|Overall Study|Protocol Violation|0
1142786|NCT01403051|3752896|P1|Overall Study|Protocol Violation|2
1142787|NCT01402986|3752932|P4|Overall Study|Other|6
1142788|NCT01402986|3752933|P3|Overall Study|Other|1
1142789|NCT01402986|3752934|P2|Overall Study|Other|5
1142790|NCT01402986|3752935|P1|Overall Study|Other|2
1142791|NCT01402986|3752932|P4|Overall Study|Lost to Follow-up|1
1142792|NCT01402986|3752933|P3|Overall Study|Lost to Follow-up|0
1142793|NCT01402986|3752934|P2|Overall Study|Lost to Follow-up|0
1142794|NCT01402986|3752935|P1|Overall Study|Lost to Follow-up|0
1142795|NCT01402986|3752932|P4|Overall Study|Death|2
1142796|NCT01402986|3752933|P3|Overall Study|Death|0
1142797|NCT01402986|3752934|P2|Overall Study|Death|0
1142798|NCT01402986|3752935|P1|Overall Study|Death|0
1142799|NCT01402986|3752932|P4|Overall Study|Withdrawal by Subject|13
1142800|NCT01402986|3752933|P3|Overall Study|Withdrawal by Subject|7
1142801|NCT01402986|3752934|P2|Overall Study|Withdrawal by Subject|10
1142802|NCT01402986|3752935|P1|Overall Study|Withdrawal by Subject|7
1142803|NCT01402947|3753070|P2|First Intervention|Adverse Event|1
1142804|NCT01402947|3753071|P1|First Intervention|Adverse Event|0
1142805|NCT01402869|3753082|P3|Overall Study|Required Tooth Extraction|1
1142806|NCT01402869|3753083|P2|Overall Study|Required Tooth Extraction|0
1142807|NCT01402869|3753084|P1|Overall Study|Required Tooth Extraction|0
1142808|NCT01402817|3753098|P1|Overall Study|Study Suspended by FDA|8
1142809|NCT01402817|3753098|P1|Overall Study|Withdrawal by Subject|3
1142810|NCT01402700|3753103|P1|Overall Study|Missed Visit|1
1142811|NCT01402700|3753103|P1|Overall Study|Withdrawal by Subject|3
1142812|NCT01402700|3753103|P1|Overall Study|Death|3
1142813|NCT01402570|3753107|P1|Overall Study|Adverse Event|1
1142814|NCT01402284|3753178|P1|Overall Study|Non compliance|2
1142815|NCT01402284|3753178|P1|Overall Study|Disease progression on study|9
1142816|NCT01402284|3753178|P1|Overall Study|Physician Decision|1
1142817|NCT01402284|3753178|P1|Overall Study|Follows up at Memorial Sloan Kettering|2
1142818|NCT01402284|3753178|P1|Overall Study|Withdrawal consent|1
1142819|NCT01402102|3753260|P2|Overall Study|Withdrawal by Subject|2
1142820|NCT01402102|3753261|P1|Overall Study|Withdrawal by Subject|0
1142821|NCT01402102|3753260|P2|Overall Study|Insufficiency of compliance|1
1142822|NCT01402102|3753261|P1|Overall Study|Insufficiency of compliance|1
1142823|NCT01402102|3753260|P2|Overall Study|Protocol Violation|0
1142824|NCT01402102|3753261|P1|Overall Study|Protocol Violation|1
1142825|NCT01402063|3753281|P2|Overall Study|Withdrawal by Subject|3
1142826|NCT01402063|3753282|P1|Overall Study|Withdrawal by Subject|3
1142827|NCT01402011|3753291|P3|Nine Month Follow-up|Withdrawal by Subject|0
1142828|NCT01402011|3753292|P2|Nine Month Follow-up|Withdrawal by Subject|1
1142829|NCT01402011|3753293|P1|Nine Month Follow-up|Withdrawal by Subject|0
1142830|NCT01402011|3753291|P3|Active Treatment Period|Withdrawal by Subject|0
1142831|NCT01402011|3753292|P2|Active Treatment Period|Withdrawal by Subject|3
1142832|NCT01402011|3753293|P1|Active Treatment Period|Withdrawal by Subject|1
1142833|NCT01402011|3753291|P3|Delayed Treatment Period|Withdrawal by Subject|0
1142834|NCT01402011|3753292|P2|Delayed Treatment Period|Withdrawal by Subject|0
1142835|NCT01402011|3753293|P1|Delayed Treatment Period|Withdrawal by Subject|1
1142836|NCT01401959|3753322|P3|Treated|Protocol Violation|0
1142837|NCT01401959|3753323|P2|Treated|Protocol Violation|1
1142838|NCT01401959|3753324|P1|Treated|Protocol Violation|0
1142839|NCT01401959|3753322|P3|Treated|Withdrawal by Subject|2
1142840|NCT01401959|3753323|P2|Treated|Withdrawal by Subject|2
1142841|NCT01401959|3753324|P1|Treated|Withdrawal by Subject|1
1142842|NCT01401959|3753322|P3|Treated|Adverse Event|2
1142843|NCT01401959|3753323|P2|Treated|Adverse Event|3
1142844|NCT01401959|3753324|P1|Treated|Adverse Event|4
1142845|NCT01401959|3753322|P3|Treated|Disease Progression|1
1142846|NCT01401959|3753323|P2|Treated|Disease Progression|2
1142847|NCT01401959|3753324|P1|Treated|Disease Progression|2
1142848|NCT01401959|3753322|P3|Enrolled|Withdrawal by Subject|0
1142849|NCT01401959|3753323|P2|Enrolled|Withdrawal by Subject|0
1142850|NCT01401959|3753324|P1|Enrolled|Withdrawal by Subject|1
1142851|NCT01401842|3753361|P2|Overall Study|other/unknown|17
1142852|NCT01401842|3753362|P1|Overall Study|other/unknown|28
1142853|NCT01401842|3753361|P2|Overall Study|on profile|5
1142854|NCT01401842|3753362|P1|Overall Study|on profile|9
1142855|NCT01401842|3753361|P2|Overall Study|invalid follow-up strength data|4
1142856|NCT01401842|3753362|P1|Overall Study|invalid follow-up strength data|1
1142857|NCT01401842|3753361|P2|Overall Study|discharged from US Army|4
1142858|NCT01401842|3753362|P1|Overall Study|discharged from US Army|3
1142859|NCT01401842|3753361|P2|Overall Study|changed companies|34
1142860|NCT01401842|3753362|P1|Overall Study|changed companies|20
1142861|NCT01401842|3753361|P2|Overall Study|academic reason|1
1142862|NCT01401842|3753362|P1|Overall Study|academic reason|4
1142863|NCT01401842|3753361|P2|Overall Study|Withdrawal by Subject|2
1142864|NCT01401842|3753362|P1|Overall Study|Withdrawal by Subject|3
1142865|NCT01401647|3753379|P3|Overall Study|Lost to Follow-up|1
1142866|NCT01401647|3753380|P2|Overall Study|Lost to Follow-up|3
1142867|NCT01401647|3753381|P1|Overall Study|Lost to Follow-up|3
1142868|NCT01401647|3753379|P3|Overall Study|Withdrawal by Subject|2
1142869|NCT01401647|3753380|P2|Overall Study|Withdrawal by Subject|5
1142870|NCT01401647|3753381|P1|Overall Study|Withdrawal by Subject|1
1142871|NCT01401530|3753426|P3|Overall Study|Physician Decision|0
1142872|NCT01401530|3753427|P2|Overall Study|Physician Decision|1
1142873|NCT01401530|3753428|P1|Overall Study|Physician Decision|0
1142874|NCT01401530|3753426|P3|Overall Study|Participant Choice|1
1142875|NCT01401530|3753427|P2|Overall Study|Participant Choice|2
1142876|NCT01401530|3753428|P1|Overall Study|Participant Choice|1
1142877|NCT01401530|3753426|P3|Overall Study|Adverse Event|1
1142878|NCT01401530|3753427|P2|Overall Study|Adverse Event|1
1142879|NCT01401530|3753428|P1|Overall Study|Adverse Event|1
1142880|NCT01401530|3753426|P3|Overall Study|Disease Progression|1
1142881|NCT01401530|3753427|P2|Overall Study|Disease Progression|2
1142882|NCT01401530|3753428|P1|Overall Study|Disease Progression|1
1142883|NCT01401478|3753478|P1|Overall Study|Serious adverse event|1
1142884|NCT01401478|3753478|P1|Overall Study|Low intact parathyroid hormone|1
1142885|NCT01401478|3753478|P1|Overall Study|Hyperphosphatemia and adverse event|1
1142886|NCT01401478|3753478|P1|Overall Study|Blood samples not available|1
1142887|NCT01401478|3753478|P1|Overall Study|Withdrawal by Subject|3
1142888|NCT01401478|3753478|P1|Overall Study|Kidney transplantation|3
1142889|NCT01401478|3753478|P1|Overall Study|Lost to Follow-up|5
1142890|NCT01401478|3753478|P1|Overall Study|Hyperphosphatemia|5
1142891|NCT01401478|3753478|P1|Overall Study|Adverse Event|5
1142892|NCT01401478|3753478|P1|Overall Study|Study drug not available|6
1142893|NCT01401465|3753491|P2|Treatment Period 2|Withdrawal by Subject|1
1142894|NCT01401465|3753492|P1|Treatment Period 2|Withdrawal by Subject|0
1142895|NCT01401465|3753491|P2|Treatment Period 2|Lost to Follow-up|1
1142896|NCT01401465|3753492|P1|Treatment Period 2|Lost to Follow-up|0
1142897|NCT01401465|3753491|P2|Treatment Period 1|Scheduling Difficulties|1
1142898|NCT01401465|3753492|P1|Treatment Period 1|Scheduling Difficulties|1
1142899|NCT01401465|3753491|P2|Treatment Period 1|Inability to Meet Continuation Criteria|9
1142900|NCT01401465|3753492|P1|Treatment Period 1|Inability to Meet Continuation Criteria|3
1142901|NCT01401465|3753491|P2|Treatment Period 1|Non-Compliance to Study Drug|0
1142902|NCT01401465|3753492|P1|Treatment Period 1|Non-Compliance to Study Drug|1
1142903|NCT01401465|3753491|P2|Treatment Period 1|Withdrawal by Subject|4
1142904|NCT01401465|3753492|P1|Treatment Period 1|Withdrawal by Subject|1
1142905|NCT01401465|3753491|P2|Treatment Period 1|Protocol Violation|0
1142906|NCT01401465|3753492|P1|Treatment Period 1|Protocol Violation|5
1142907|NCT01401465|3753491|P2|Treatment Period 1|Pregnancy|1
1142908|NCT01401465|3753492|P1|Treatment Period 1|Pregnancy|0
1142909|NCT01401465|3753491|P2|Treatment Period 1|Adverse Event|1
1142910|NCT01401465|3753492|P1|Treatment Period 1|Adverse Event|4
1142911|NCT01401452|3753555|P1|Overall Study|Participant withdrew consent|1
1142912|NCT01401452|3753555|P1|Overall Study|Subject chose to discontinue treatment|1
1142913|NCT01401452|3753555|P1|Overall Study|Subject withdrew because of Tx success|1
1142914|NCT01401452|3753555|P1|Overall Study|Unsatisfactory output|1
1142915|NCT01401452|3753555|P1|Overall Study|Treatment failure|1
1142916|NCT01401452|3753555|P1|Overall Study|Discontinuation for personal reasons|1
1142917|NCT01401452|3753555|P1|Overall Study|Participant stopped Tx|2
1142918|NCT01401452|3753555|P1|Overall Study|Psoriatic arthritis|1
1142919|NCT01401452|3753555|P1|Overall Study|Subject's wife wants to get pregnant|1
1142920|NCT01401452|3753555|P1|Overall Study|Subject moved to another city|1
1142921|NCT01401452|3753555|P1|Overall Study|Subject didn't return for routine visits|1
1142922|NCT01401452|3753555|P1|Overall Study|Subject did not come to follow up visits|2
1142923|NCT01401452|3753555|P1|Overall Study|No more visits within the 36 wk followup|4
1142924|NCT01401452|3753555|P1|Overall Study|Tx stopped by psychiatrist|1
1142925|NCT01401452|3753555|P1|Overall Study|Tx stopped due to financial reasons|1
1142926|NCT01401452|3753555|P1|Overall Study|Participant developed breast cancer|1
1142927|NCT01401452|3753555|P1|Overall Study|Lack of Efficacy|30
1142928|NCT01401452|3753555|P1|Overall Study|Lost to Follow-up|12
1142929|NCT01401452|3753555|P1|Overall Study|Adverse reaction|9
1142930|NCT01401361|3753567|P1|Overall Study|Subject/family decision post procedure|2
1142931|NCT01401361|3753567|P1|Overall Study|Lost to Follow-up|3
1142932|NCT01401361|3753567|P1|Overall Study|Physician Decision|1
1142933|NCT01401361|3753567|P1|Overall Study|Lack of Efficacy|6
1142934|NCT01401361|3753567|P1|Overall Study|Withdrawal by Subject|16
1142935|NCT01401322|3753573|P1|Overall Study|Physician Decision|1
1142936|NCT01401322|3753573|P1|Overall Study|Withdrawal by Subject|1
1142937|NCT01401283|3753579|P2|Overall Study|suspicion of malignant hyperthermia|1
1142938|NCT01401283|3753580|P1|Overall Study|suspicion of malignant hyperthermia|0
1142939|NCT01401283|3753579|P2|Overall Study|no central venous access|1
1142940|NCT01401283|3753580|P1|Overall Study|no central venous access|0
1142941|NCT01401283|3753579|P2|Overall Study|preoperative arrhythmia|0
1142942|NCT01401283|3753580|P1|Overall Study|preoperative arrhythmia|5
1142943|NCT01401283|3753579|P2|Overall Study|surgery cancelled|8
1142944|NCT01401283|3753580|P1|Overall Study|surgery cancelled|5
1142945|NCT01401153|3753646|P2|Second Test Day|illness|5
1142946|NCT01401153|3753647|P1|Second Test Day|illness|0
1142947|NCT01401153|3753646|P2|First Test Day|Learning disabilities; illness|10
1142948|NCT01401153|3753647|P1|First Test Day|Learning disabilities; illness|1
1142949|NCT01401062|3753694|P2|Overall Study|Withdrawal by Subject|1
1142950|NCT01401062|3753695|P1|Overall Study|Withdrawal by Subject|1
1142951|NCT01401062|3753694|P2|Overall Study|Physician Decision|0
1142952|NCT01401062|3753695|P1|Overall Study|Physician Decision|1
1142953|NCT01401062|3753694|P2|Overall Study|Death|7
1142954|NCT01401062|3753695|P1|Overall Study|Death|9
1142955|NCT01401010|3753722|P2|Overall Study|Could not interpret assay results|0
1142956|NCT01401010|3753723|P1|Overall Study|Could not interpret assay results|1
1142957|NCT01400958|3753748|P2|Overall Study|Adverse Event|0
1142958|NCT01400958|3753749|P1|Overall Study|Adverse Event|1
1142959|NCT01400958|3753748|P2|Overall Study|Withdrawal by Subject|1
1142960|NCT01400958|3753749|P1|Overall Study|Withdrawal by Subject|0
1142961|NCT01400958|3753748|P2|Overall Study|Physician Decision|1
1142962|NCT01400958|3753749|P1|Overall Study|Physician Decision|0
1142963|NCT01400932|3753759|P2|Overall Study|Met Protocol-defined Stopping Criteria|0
1142964|NCT01400932|3753760|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
1142965|NCT01400932|3753759|P2|Overall Study|Protocol Deviation|1
1142966|NCT01400932|3753760|P1|Overall Study|Protocol Deviation|0
1142967|NCT01400932|3753759|P2|Overall Study|Lost to Follow-up|0
1142968|NCT01400932|3753760|P1|Overall Study|Lost to Follow-up|1
1142969|NCT01400932|3753759|P2|Overall Study|Withdrawal by Subject|6
1142970|NCT01400932|3753760|P1|Overall Study|Withdrawal by Subject|2
1142971|NCT01400932|3753759|P2|Overall Study|Lack of Efficacy|3
1142972|NCT01400932|3753760|P1|Overall Study|Lack of Efficacy|0
1142973|NCT01400932|3753759|P2|Overall Study|Adverse Event|5
1142974|NCT01400932|3753760|P1|Overall Study|Adverse Event|10
1142975|NCT01400919|3753782|P1|Overall Study|Missed visit|2
1142976|NCT01400919|3753782|P1|Overall Study|Lost to Follow-up|2
1142977|NCT01400919|3753782|P1|Overall Study|Withdrawal by Subject|4
1142978|NCT01400893|3753825|P2|Overall Study|Lost to Follow-up|6
1142979|NCT01400893|3753826|P1|Overall Study|Lost to Follow-up|0
1142980|NCT01400893|3753825|P2|Overall Study|Death|21
1142981|NCT01400893|3753826|P1|Overall Study|Death|27
1142982|NCT01400841|3753838|P1|Extended Study Phase (2 Years)|Adverse Event|2
1142983|NCT01400841|3753838|P1|Initial Study Phase (6 Months)|Death|1
1142984|NCT01400698|3753876|P6|Overall Study|Other|0
1142985|NCT01400698|3753877|P5|Overall Study|Other|1
1142986|NCT01400698|3753878|P4|Overall Study|Other|2
1142987|NCT01400698|3753879|P3|Overall Study|Other|0
1142988|NCT01400698|3753880|P2|Overall Study|Other|2
1142989|NCT01400698|3753881|P1|Overall Study|Other|4
1142990|NCT01400698|3753876|P6|Overall Study|Adverse Event|0
1142991|NCT01400698|3753877|P5|Overall Study|Adverse Event|0
1142992|NCT01400698|3753878|P4|Overall Study|Adverse Event|0
1142993|NCT01400698|3753879|P3|Overall Study|Adverse Event|0
1142994|NCT01400698|3753880|P2|Overall Study|Adverse Event|0
1142995|NCT01400698|3753881|P1|Overall Study|Adverse Event|1
1142996|NCT01400698|3753876|P6|Overall Study|Non-compliance|0
1142997|NCT01400698|3753877|P5|Overall Study|Non-compliance|0
1142998|NCT01400698|3753878|P4|Overall Study|Non-compliance|1
1142999|NCT01400698|3753879|P3|Overall Study|Non-compliance|0
1143000|NCT01400698|3753880|P2|Overall Study|Non-compliance|1
1143001|NCT01400698|3753881|P1|Overall Study|Non-compliance|0
1143002|NCT01400698|3753876|P6|Overall Study|Protocol Violation|0
1143003|NCT01400698|3753877|P5|Overall Study|Protocol Violation|1
1143004|NCT01400698|3753878|P4|Overall Study|Protocol Violation|0
1143005|NCT01400698|3753879|P3|Overall Study|Protocol Violation|0
1143006|NCT01400698|3753880|P2|Overall Study|Protocol Violation|1
1143007|NCT01400698|3753881|P1|Overall Study|Protocol Violation|0
1143008|NCT01400698|3753876|P6|Overall Study|Withdrawal by Subject|3
1143009|NCT01400698|3753877|P5|Overall Study|Withdrawal by Subject|1
1143010|NCT01400698|3753878|P4|Overall Study|Withdrawal by Subject|4
1143011|NCT01400698|3753879|P3|Overall Study|Withdrawal by Subject|0
1143012|NCT01400698|3753880|P2|Overall Study|Withdrawal by Subject|2
1143013|NCT01400698|3753881|P1|Overall Study|Withdrawal by Subject|8
1143014|NCT01400698|3753876|P6|Overall Study|Lost to Follow-up|3
1143015|NCT01400698|3753877|P5|Overall Study|Lost to Follow-up|4
1143016|NCT01400698|3753878|P4|Overall Study|Lost to Follow-up|1
1143017|NCT01400698|3753879|P3|Overall Study|Lost to Follow-up|2
1143018|NCT01400698|3753880|P2|Overall Study|Lost to Follow-up|5
1143019|NCT01400698|3753881|P1|Overall Study|Lost to Follow-up|2
1143020|NCT01400516|3753905|P2|Primary Trial|Withdrawal by Subject|2
1143021|NCT01400516|3753906|P1|Primary Trial|Withdrawal by Subject|0
1143022|NCT01400503|3753916|P1|Overall Study|Other|1
1143023|NCT01400503|3753916|P1|Overall Study|Study Terminated by Sponsor|58
1143024|NCT01400503|3753916|P1|Overall Study|Withdrawal by Subject|1
1143025|NCT01400451|3753928|P3|Combination Treatment (or Intended)|Dose-limiting toxicity|0
1143026|NCT01400451|3753929|P2|Combination Treatment (or Intended)|Dose-limiting toxicity|1
1143027|NCT01400451|3753930|P1|Combination Treatment (or Intended)|Dose-limiting toxicity|0
1143028|NCT01400451|3753928|P3|Combination Treatment (or Intended)|Disease Progression|1
1143029|NCT01400451|3753929|P2|Combination Treatment (or Intended)|Disease Progression|1
1143030|NCT01400451|3753930|P1|Combination Treatment (or Intended)|Disease Progression|3
1143031|NCT01400451|3753928|P3|Combination Treatment (or Intended)|Adverse Event|0
1143032|NCT01400451|3753929|P2|Combination Treatment (or Intended)|Adverse Event|0
1143033|NCT01400451|3753930|P1|Combination Treatment (or Intended)|Adverse Event|1
1143034|NCT01400451|3753928|P3|Combination Treatment (or Intended)|Drug Toxicity|0
1143035|NCT01400451|3753929|P2|Combination Treatment (or Intended)|Drug Toxicity|1
1143036|NCT01400451|3753930|P1|Combination Treatment (or Intended)|Drug Toxicity|0
1143037|NCT01400451|3753928|P3|Combination Treatment (or Intended)|Withdrawal by Subject|1
1143038|NCT01400451|3753929|P2|Combination Treatment (or Intended)|Withdrawal by Subject|1
1143039|NCT01400451|3753930|P1|Combination Treatment (or Intended)|Withdrawal by Subject|2
1143040|NCT01400425|3753944|P1|Overall Study|Withdrawal by Subject|10
1143041|NCT01400412|3753957|P2|Overall Study|Never started study treatment|3
1143042|NCT01400412|3753958|P1|Overall Study|Never started study treatment|0
1143043|NCT01400412|3753957|P2|Overall Study|Unable to complete|3
1143044|NCT01400412|3753958|P1|Overall Study|Unable to complete|3
1143045|NCT01400412|3753957|P2|Overall Study|Withdrawal by Subject|4
1143046|NCT01400412|3753958|P1|Overall Study|Withdrawal by Subject|3
1143047|NCT01400412|3753957|P2|Overall Study|Lost to Follow-up|7
1143048|NCT01400412|3753958|P1|Overall Study|Lost to Follow-up|4
1143049|NCT01400243|3754004|P2|Overall Study|Protocol Violation|11
1143050|NCT01400243|3754005|P1|Overall Study|Protocol Violation|8
1143051|NCT01400139|3754027|P1|HYD Extension Period|Administrative|10
1143052|NCT01400139|3754027|P1|HYD Extension Period|Withdrawal by Subject|5
1143053|NCT01400139|3754027|P1|HYD Extension Period|Adverse Event|8
1143054|NCT01400139|3754027|P1|HYD Core Study|Did not qualify for Maintenance Period|14
1143055|NCT01400139|3754027|P1|HYD Core Study|Administrative|56
1143056|NCT01400139|3754027|P1|HYD Core Study|Confirmed or suspected diversion|20
1143057|NCT01400139|3754027|P1|HYD Core Study|Lost to Follow-up|39
1143058|NCT01400139|3754027|P1|HYD Core Study|Withdrawal by Subject|114
1143059|NCT01400139|3754027|P1|HYD Core Study|Lack of Efficacy|59
1143060|NCT01400139|3754027|P1|HYD Core Study|Adverse Event|210
1143061|NCT01400113|3754037|P2|Overall Study|Withdrawal by Subject|1
1143062|NCT01400113|3754038|P1|Overall Study|Withdrawal by Subject|1
1143063|NCT01399788|3754080|P2|First Intervention Period|Adverse Event|0
1143064|NCT01399788|3754081|P1|First Intervention Period|Adverse Event|1
1143065|NCT01399723|3754103|P2|Overall Study|Lost to Follow-up|1
1143066|NCT01399723|3754104|P1|Overall Study|Lost to Follow-up|0
1143067|NCT01399697|3754117|P3|Overall Study|Sponsor Decision|0
1143068|NCT01399697|3754118|P2|Overall Study|Sponsor Decision|0
1143069|NCT01399697|3754119|P1|Overall Study|Sponsor Decision|1
1143070|NCT01399697|3754117|P3|Overall Study|Clinical RA remission|0
1143071|NCT01399697|3754118|P2|Overall Study|Clinical RA remission|0
1143072|NCT01399697|3754119|P1|Overall Study|Clinical RA remission|1
1143073|NCT01399697|3754117|P3|Overall Study|Positive result for hepatitis B|0
1143074|NCT01399697|3754118|P2|Overall Study|Positive result for hepatitis B|0
1143075|NCT01399697|3754119|P1|Overall Study|Positive result for hepatitis B|1
1143076|NCT01399697|3754117|P3|Overall Study|Inclusion Error|0
1143077|NCT01399697|3754118|P2|Overall Study|Inclusion Error|0
1143078|NCT01399697|3754119|P1|Overall Study|Inclusion Error|2
1143079|NCT01399697|3754117|P3|Overall Study|Non-Compliant|0
1143080|NCT01399697|3754118|P2|Overall Study|Non-Compliant|0
1143081|NCT01399697|3754119|P1|Overall Study|Non-Compliant|1
1143082|NCT01399697|3754117|P3|Overall Study|Protocol Violation|0
1143083|NCT01399697|3754118|P2|Overall Study|Protocol Violation|0
1143084|NCT01399697|3754119|P1|Overall Study|Protocol Violation|2
1143085|NCT01399697|3754117|P3|Overall Study|Lack of Efficacy|1
1143086|NCT01399697|3754118|P2|Overall Study|Lack of Efficacy|0
1143087|NCT01399697|3754119|P1|Overall Study|Lack of Efficacy|9
1143088|NCT01399697|3754117|P3|Overall Study|Investigator Decisión|2
1143089|NCT01399697|3754118|P2|Overall Study|Investigator Decisión|0
1143090|NCT01399697|3754119|P1|Overall Study|Investigator Decisión|1
1143091|NCT01399697|3754117|P3|Overall Study|Withdrawal by Subject|0
1143092|NCT01399697|3754118|P2|Overall Study|Withdrawal by Subject|0
1143093|NCT01399697|3754119|P1|Overall Study|Withdrawal by Subject|8
1143094|NCT01399697|3754117|P3|Overall Study|Lost to Follow-up|0
1143095|NCT01399697|3754118|P2|Overall Study|Lost to Follow-up|0
1143096|NCT01399697|3754119|P1|Overall Study|Lost to Follow-up|2
1143097|NCT01399697|3754117|P3|Overall Study|Adverse Event|1
1143098|NCT01399697|3754118|P2|Overall Study|Adverse Event|3
1143099|NCT01399697|3754119|P1|Overall Study|Adverse Event|13
1143100|NCT01399619|3754146|P4|Overall Study|Not treated|2
1143101|NCT01399619|3754147|P3|Overall Study|Not treated|0
1143102|NCT01399619|3754148|P2|Overall Study|Not treated|0
1143103|NCT01399619|3754149|P1|Overall Study|Not treated|0
1143104|NCT01399619|3754146|P4|Overall Study|Protocol Violation|1
1143105|NCT01399619|3754147|P3|Overall Study|Protocol Violation|0
1143106|NCT01399619|3754148|P2|Overall Study|Protocol Violation|0
1143107|NCT01399619|3754149|P1|Overall Study|Protocol Violation|0
1143108|NCT01399619|3754146|P4|Overall Study|Withdrawal by Subject|4
1143109|NCT01399619|3754147|P3|Overall Study|Withdrawal by Subject|3
1143110|NCT01399619|3754148|P2|Overall Study|Withdrawal by Subject|0
1143111|NCT01399619|3754149|P1|Overall Study|Withdrawal by Subject|6
1143112|NCT01399619|3754146|P4|Overall Study|Lack of Efficacy|0
1143113|NCT01399619|3754147|P3|Overall Study|Lack of Efficacy|5
1143114|NCT01399619|3754148|P2|Overall Study|Lack of Efficacy|0
1143115|NCT01399619|3754149|P1|Overall Study|Lack of Efficacy|9
1143116|NCT01399619|3754146|P4|Overall Study|Adverse Event|10
1143117|NCT01399619|3754147|P3|Overall Study|Adverse Event|4
1143118|NCT01399619|3754148|P2|Overall Study|Adverse Event|0
1143119|NCT01399619|3754149|P1|Overall Study|Adverse Event|10
1143120|NCT01399593|3754212|P2|Overall Study|Transplantectomy|1
1143121|NCT01399593|3754213|P1|Overall Study|Transplantectomy|0
1143122|NCT01399593|3754212|P2|Overall Study|Death|1
1143123|NCT01399593|3754213|P1|Overall Study|Death|1
1143124|NCT01399593|3754212|P2|Overall Study|Adverse Event|0
1143125|NCT01399593|3754213|P1|Overall Study|Adverse Event|1
1143126|NCT01399593|3754212|P2|Overall Study|Physician Decision|0
1143127|NCT01399593|3754213|P1|Overall Study|Physician Decision|1
1143128|NCT01399190|3754246|P1|Overall Study|Physician Decision|2
1143129|NCT01399190|3754246|P1|Overall Study|Participant's Request|5
1143130|NCT01399190|3754246|P1|Overall Study|Adverse Event|8
1143131|NCT01399190|3754246|P1|Overall Study|Not Eligible for Final Analysis|5
1143132|NCT01399125|3754254|P2|Overall Study|Protocol Deviation|2
1143133|NCT01399125|3754255|P1|Overall Study|Protocol Deviation|5
1143134|NCT01399125|3754254|P2|Overall Study|Death|1
1143135|NCT01399125|3754255|P1|Overall Study|Death|0
1143136|NCT01399125|3754254|P2|Overall Study|Administrative Problems|11
1143137|NCT01399125|3754255|P1|Overall Study|Administrative Problems|7
1143138|NCT01399125|3754254|P2|Overall Study|Lost to Follow-up|3
1143139|NCT01399125|3754255|P1|Overall Study|Lost to Follow-up|2
1143140|NCT01399125|3754254|P2|Overall Study|Withdrawal by Subject|8
1143141|NCT01399125|3754255|P1|Overall Study|Withdrawal by Subject|5
1143142|NCT01399125|3754254|P2|Overall Study|Unsatisfactory Therapeutic Effect|4
1143143|NCT01399125|3754255|P1|Overall Study|Unsatisfactory Therapeutic Effect|0
1143144|NCT01399125|3754254|P2|Overall Study|Abnormal Lab values|1
1143145|NCT01399125|3754255|P1|Overall Study|Abnormal Lab values|0
1143146|NCT01399125|3754254|P2|Overall Study|Adverse Event|30
1143147|NCT01399125|3754255|P1|Overall Study|Adverse Event|32
1143148|NCT01399099|3754269|P1|Overall Study|Miscellaneous|4
1143149|NCT01399099|3754269|P1|Overall Study|Infection|1
1143150|NCT01399099|3754269|P1|Overall Study|Skin Irritation|13
1143151|NCT01399099|3754269|P1|Overall Study|Protocol Violation|1
1143152|NCT01399099|3754269|P1|Overall Study|Physician Decision|1
1143153|NCT01399099|3754269|P1|Overall Study|Lost to Follow-up|11
1143154|NCT01399047|3754276|P2|Overall Study|Withdrawal by Subject|1
1143155|NCT01399047|3754277|P1|Overall Study|Withdrawal by Subject|0
1143156|NCT01398956|3754305|P1|Overall Study|Subject moved a long distance|1
1143157|NCT01398956|3754305|P1|Overall Study|Withdrawal Criteria No.3|1
1143158|NCT01398956|3754305|P1|Overall Study|AE, non-serious non-fatal|4
1143159|NCT01398956|3754305|P1|Overall Study|Withdrawal by Subject|4
1143160|NCT01398787|3754337|P1|Overall Study|Adverse Event|1
1143161|NCT01398514|3754355|P2|Overall Study|Failure to show a conditioned response|3
1143162|NCT01398514|3754356|P1|Overall Study|Failure to show a conditioned response|4
1143163|NCT01398514|3754355|P2|Overall Study|Physiologic non-responsiveness|3
1143164|NCT01398514|3754356|P1|Overall Study|Physiologic non-responsiveness|1
1143165|NCT01398514|3754355|P2|Overall Study|Non-compliance with study procedures|0
1143166|NCT01398514|3754356|P1|Overall Study|Non-compliance with study procedures|2
1143167|NCT01398514|3754355|P2|Overall Study|Adverse Event|0
1143168|NCT01398514|3754356|P1|Overall Study|Adverse Event|1
1143169|NCT01398410|3754391|P2|Overall Study|Not Specified|29
1143170|NCT01398410|3754392|P1|Overall Study|Not Specified|36
1143171|NCT01398410|3754391|P2|Overall Study|Inadequate Therapeutic Effect|0
1143172|NCT01398410|3754392|P1|Overall Study|Inadequate Therapeutic Effect|2
1143173|NCT01398410|3754391|P2|Overall Study|Participants Choice|11
1143174|NCT01398410|3754392|P1|Overall Study|Participants Choice|8
1143175|NCT01398410|3754391|P2|Overall Study|Adverse Event|16
1143176|NCT01398410|3754392|P1|Overall Study|Adverse Event|12
1143177|NCT01398358|3754403|P3|Overall Study|no longer eligible|1
1143178|NCT01398358|3754404|P2|Overall Study|no longer eligible|0
1143179|NCT01398358|3754405|P1|Overall Study|no longer eligible|1
1143180|NCT01398358|3754403|P3|Overall Study|Withdrawal by Subject|2
1143181|NCT01398358|3754404|P2|Overall Study|Withdrawal by Subject|2
1143182|NCT01398358|3754405|P1|Overall Study|Withdrawal by Subject|3
1143183|NCT01398358|3754403|P3|Overall Study|Lost to Follow-up|18
1143184|NCT01398358|3754404|P2|Overall Study|Lost to Follow-up|21
1143185|NCT01398358|3754405|P1|Overall Study|Lost to Follow-up|11
1143186|NCT01398176|3754418|P2|Overall Study|Physician Decision|3
1143187|NCT01398176|3754419|P1|Overall Study|Physician Decision|2
1143188|NCT01398176|3754418|P2|Overall Study|Lost to Follow-up|3
1143189|NCT01398176|3754419|P1|Overall Study|Lost to Follow-up|1
1143190|NCT01397890|3754427|P2|Overall Study|Others|1
1143191|NCT01397890|3754428|P1|Overall Study|Others|2
1143192|NCT01397890|3754427|P2|Overall Study|Severe Non-Compliance to Protocol|1
1143193|NCT01397890|3754428|P1|Overall Study|Severe Non-Compliance to Protocol|2
1143194|NCT01397890|3754427|P2|Overall Study|Adverse Event|2
1143195|NCT01397890|3754428|P1|Overall Study|Adverse Event|1
1143196|NCT01397890|3754427|P2|Overall Study|Condition under Investigation Worsened|3
1143197|NCT01397890|3754428|P1|Overall Study|Condition under Investigation Worsened|1
1143198|NCT01397890|3754427|P2|Overall Study|Lost to Follow-up|4
1143199|NCT01397890|3754428|P1|Overall Study|Lost to Follow-up|1
1143200|NCT01397890|3754427|P2|Overall Study|Death|3
1143201|NCT01397890|3754428|P1|Overall Study|Death|2
1143202|NCT01397890|3754427|P2|Overall Study|Eligibility Criteria Not Fulfilled|6
1143203|NCT01397890|3754428|P1|Overall Study|Eligibility Criteria Not Fulfilled|7
1143204|NCT01397890|3754427|P2|Overall Study|Withdrawal by Subject|11
1143205|NCT01397890|3754428|P1|Overall Study|Withdrawal by Subject|7
1143206|NCT01397825|3754499|P5|Overall Study|Withdrawal by Subject|0
1143207|NCT01397825|3754500|P4|Overall Study|Withdrawal by Subject|1
1143208|NCT01397825|3754501|P3|Overall Study|Withdrawal by Subject|5
1143209|NCT01397825|3754502|P2|Overall Study|Withdrawal by Subject|0
1143210|NCT01397825|3754503|P1|Overall Study|Withdrawal by Subject|1
1143211|NCT01397825|3754499|P5|Overall Study|Adverse Event|0
1143212|NCT01397825|3754500|P4|Overall Study|Adverse Event|1
1143213|NCT01397825|3754501|P3|Overall Study|Adverse Event|5
1143214|NCT01397825|3754502|P2|Overall Study|Adverse Event|1
1143215|NCT01397825|3754503|P1|Overall Study|Adverse Event|0
1143216|NCT01397825|3754499|P5|Overall Study|Symptomatic Deterioration|0
1143217|NCT01397825|3754500|P4|Overall Study|Symptomatic Deterioration|0
1143218|NCT01397825|3754501|P3|Overall Study|Symptomatic Deterioration|4
1143219|NCT01397825|3754502|P2|Overall Study|Symptomatic Deterioration|0
1143220|NCT01397825|3754503|P1|Overall Study|Symptomatic Deterioration|2
1143221|NCT01397825|3754499|P5|Overall Study|Progressive Disease|0
1143222|NCT01397825|3754500|P4|Overall Study|Progressive Disease|1
1143223|NCT01397825|3754501|P3|Overall Study|Progressive Disease|11
1143224|NCT01397825|3754502|P2|Overall Study|Progressive Disease|3
1143225|NCT01397825|3754503|P1|Overall Study|Progressive Disease|10
1143226|NCT01397786|3754573|P3|Phase B|Lack of Efficacy|14
1143227|NCT01397786|3754574|P2|Phase B|Lack of Efficacy|7
1143228|NCT01397786|3754575|P1|Phase B|Lack of Efficacy|22
1143229|NCT01397786|3754573|P3|Phase B|Protocol Deviation|4
1143230|NCT01397786|3754574|P2|Phase B|Protocol Deviation|2
1143231|NCT01397786|3754575|P1|Phase B|Protocol Deviation|1
1143232|NCT01397786|3754573|P3|Phase B|Withdrawal by Subject|30
1143233|NCT01397786|3754574|P2|Phase B|Withdrawal by Subject|45
1143234|NCT01397786|3754575|P1|Phase B|Withdrawal by Subject|102
1143235|NCT01397786|3754573|P3|Phase B|Physician Decision|3
1143236|NCT01397786|3754574|P2|Phase B|Physician Decision|1
1143237|NCT01397786|3754575|P1|Phase B|Physician Decision|9
1143238|NCT01397786|3754573|P3|Phase B|Subject Met Withdrawal Criteria|38
1143239|NCT01397786|3754574|P2|Phase B|Subject Met Withdrawal Criteria|5
1143240|NCT01397786|3754575|P1|Phase B|Subject Met Withdrawal Criteria|38
1143241|NCT01397786|3754573|P3|Phase B|Adverse Event|27
1143242|NCT01397786|3754574|P2|Phase B|Adverse Event|23
1143243|NCT01397786|3754575|P1|Phase B|Adverse Event|109
1143244|NCT01397786|3754573|P3|Phase B|Lost to Follow-up|22
1143245|NCT01397786|3754574|P2|Phase B|Lost to Follow-up|12
1143246|NCT01397786|3754575|P1|Phase B|Lost to Follow-up|22
1143247|NCT01397786|3754573|P3|Phase A|Lack of Efficacy|1
1143248|NCT01397786|3754574|P2|Phase A|Lack of Efficacy|0
1143249|NCT01397786|3754575|P1|Phase A|Lack of Efficacy|0
1143250|NCT01397786|3754573|P3|Phase A|Withdrawal by Subject|5
1143251|NCT01397786|3754574|P2|Phase A|Withdrawal by Subject|0
1143252|NCT01397786|3754575|P1|Phase A|Withdrawal by Subject|0
1143253|NCT01397786|3754573|P3|Phase A|Physician Decision|1
1143254|NCT01397786|3754574|P2|Phase A|Physician Decision|0
1143255|NCT01397786|3754575|P1|Phase A|Physician Decision|0
1143256|NCT01397786|3754573|P3|Phase A|Subject Met Withdrawal Criteria|7
1143257|NCT01397786|3754574|P2|Phase A|Subject Met Withdrawal Criteria|0
1143258|NCT01397786|3754575|P1|Phase A|Subject Met Withdrawal Criteria|0
1143259|NCT01397786|3754573|P3|Phase A|Adverse Event|8
1143260|NCT01397786|3754574|P2|Phase A|Adverse Event|0
1143261|NCT01397786|3754575|P1|Phase A|Adverse Event|0
1143262|NCT01397786|3754573|P3|Phase A|Lost to Follow-up|6
1143263|NCT01397786|3754574|P2|Phase A|Lost to Follow-up|0
1143264|NCT01397786|3754575|P1|Phase A|Lost to Follow-up|0
1143265|NCT01397747|3754641|P1|Overall Study|FIT excluded|34
1143266|NCT01397747|3754641|P1|Overall Study|Colonoscopy excluded|304
1143267|NCT01397747|3754641|P1|Overall Study|Multitarget DNA test excluded|689
1143268|NCT01397552|3754687|P2|Overall Study|Withdrawal by Subject|1
1143269|NCT01397552|3754688|P1|Overall Study|Withdrawal by Subject|2
1143270|NCT01397552|3754687|P2|Overall Study|Adverse Event|0
1143271|NCT01397552|3754688|P1|Overall Study|Adverse Event|1
1143272|NCT01397461|3754697|P3|Overall Study|Not treated|1
1143273|NCT01397461|3754698|P2|Overall Study|Not treated|0
1143274|NCT01397461|3754699|P1|Overall Study|Not treated|0
1143275|NCT01397461|3754697|P3|Overall Study|Lack of Efficacy|0
1143276|NCT01397461|3754698|P2|Overall Study|Lack of Efficacy|3
1143277|NCT01397461|3754699|P1|Overall Study|Lack of Efficacy|0
1143278|NCT01397461|3754697|P3|Overall Study|Lost to Follow-up|1
1143279|NCT01397461|3754698|P2|Overall Study|Lost to Follow-up|2
1143280|NCT01397461|3754699|P1|Overall Study|Lost to Follow-up|0
1143281|NCT01397461|3754697|P3|Overall Study|Withdrawal by Subject|0
1143282|NCT01397461|3754698|P2|Overall Study|Withdrawal by Subject|1
1143283|NCT01397461|3754699|P1|Overall Study|Withdrawal by Subject|2
1143284|NCT01397448|3754710|P3|Overall Study|Not specified|4
1143285|NCT01397448|3754711|P2|Overall Study|Not specified|7
1143286|NCT01397448|3754712|P1|Overall Study|Not specified|8
1143287|NCT01397448|3754710|P3|Overall Study|Lack of Efficacy|5
1143288|NCT01397448|3754711|P2|Overall Study|Lack of Efficacy|0
1143289|NCT01397448|3754712|P1|Overall Study|Lack of Efficacy|2
1143290|NCT01397448|3754710|P3|Overall Study|Withdrawal by Subject|3
1143291|NCT01397448|3754711|P2|Overall Study|Withdrawal by Subject|4
1143292|NCT01397448|3754712|P1|Overall Study|Withdrawal by Subject|4
1143293|NCT01397448|3754710|P3|Overall Study|Adverse Event|6
1143294|NCT01397448|3754711|P2|Overall Study|Adverse Event|4
1143295|NCT01397448|3754712|P1|Overall Study|Adverse Event|4
1143296|NCT01397422|3754727|P4|Overall Study|Increased bradykinesia related to PD|0
1143297|NCT01397422|3754728|P3|Overall Study|Increased bradykinesia related to PD|0
1143298|NCT01397422|3754729|P2|Overall Study|Increased bradykinesia related to PD|0
1143299|NCT01397422|3754730|P1|Overall Study|Increased bradykinesia related to PD|1
1143300|NCT01397422|3754727|P4|Overall Study|Withdrawal by Subject|0
1143301|NCT01397422|3754728|P3|Overall Study|Withdrawal by Subject|0
1143302|NCT01397422|3754729|P2|Overall Study|Withdrawal by Subject|0
1143303|NCT01397422|3754730|P1|Overall Study|Withdrawal by Subject|1
1143304|NCT01397422|3754727|P4|Overall Study|Adverse Event|8
1143305|NCT01397422|3754728|P3|Overall Study|Adverse Event|3
1143306|NCT01397422|3754729|P2|Overall Study|Adverse Event|3
1143307|NCT01397422|3754730|P1|Overall Study|Adverse Event|0
1143308|NCT01397409|3754770|P10|Stage 3|Other Miscellaneous Reasons|0
1143309|NCT01397409|3754771|P9|Stage 3|Other Miscellaneous Reasons|0
1143310|NCT01397409|3754772|P8|Stage 3|Other Miscellaneous Reasons|1
1143311|NCT01397409|3754773|P7|Stage 3|Other Miscellaneous Reasons|0
1143312|NCT01397409|3754774|P6|Stage 3|Other Miscellaneous Reasons|0
1143313|NCT01397409|3754775|P5|Stage 3|Other Miscellaneous Reasons|0
1143314|NCT01397409|3754776|P4|Stage 3|Other Miscellaneous Reasons|0
1143315|NCT01397409|3754777|P3|Stage 3|Other Miscellaneous Reasons|0
1143316|NCT01397409|3754778|P2|Stage 3|Other Miscellaneous Reasons|0
1143317|NCT01397409|3754779|P1|Stage 3|Other Miscellaneous Reasons|0
1143318|NCT01397409|3754770|P10|Stage 3|Adverse Event|0
1143319|NCT01397409|3754771|P9|Stage 3|Adverse Event|0
1143320|NCT01397409|3754772|P8|Stage 3|Adverse Event|1
1143321|NCT01397409|3754773|P7|Stage 3|Adverse Event|0
1143322|NCT01397409|3754774|P6|Stage 3|Adverse Event|0
1143323|NCT01397409|3754775|P5|Stage 3|Adverse Event|0
1143324|NCT01397409|3754776|P4|Stage 3|Adverse Event|0
1143325|NCT01397409|3754777|P3|Stage 3|Adverse Event|0
1143326|NCT01397409|3754778|P2|Stage 3|Adverse Event|0
1143327|NCT01397409|3754779|P1|Stage 3|Adverse Event|0
1143328|NCT01397409|3754770|P10|Stage 2|Other Miscellaneous Reasons|0
1143329|NCT01397409|3754771|P9|Stage 2|Other Miscellaneous Reasons|0
1143330|NCT01397409|3754772|P8|Stage 2|Other Miscellaneous Reasons|0
1143331|NCT01397409|3754773|P7|Stage 2|Other Miscellaneous Reasons|0
1143332|NCT01397409|3754774|P6|Stage 2|Other Miscellaneous Reasons|1
1143333|NCT01397409|3754775|P5|Stage 2|Other Miscellaneous Reasons|1
1143334|NCT01397409|3754776|P4|Stage 2|Other Miscellaneous Reasons|0
1143335|NCT01397409|3754777|P3|Stage 2|Other Miscellaneous Reasons|0
1143336|NCT01397409|3754778|P2|Stage 2|Other Miscellaneous Reasons|0
1143337|NCT01397409|3754779|P1|Stage 2|Other Miscellaneous Reasons|0
1143338|NCT01397409|3754770|P10|Stage 2|Personal Reasons|0
1143339|NCT01397409|3754771|P9|Stage 2|Personal Reasons|0
1143340|NCT01397409|3754772|P8|Stage 2|Personal Reasons|0
1143341|NCT01397409|3754773|P7|Stage 2|Personal Reasons|0
1143342|NCT01397409|3754774|P6|Stage 2|Personal Reasons|0
1143343|NCT01397409|3754775|P5|Stage 2|Personal Reasons|1
1143344|NCT01397409|3754776|P4|Stage 2|Personal Reasons|0
1143345|NCT01397409|3754777|P3|Stage 2|Personal Reasons|0
1143346|NCT01397409|3754778|P2|Stage 2|Personal Reasons|0
1143347|NCT01397409|3754779|P1|Stage 2|Personal Reasons|0
1143348|NCT01397409|3754770|P10|Stage 2|Adverse Event|0
1143349|NCT01397409|3754771|P9|Stage 2|Adverse Event|0
1143350|NCT01397409|3754772|P8|Stage 2|Adverse Event|0
1143351|NCT01397409|3754773|P7|Stage 2|Adverse Event|0
1143352|NCT01397409|3754774|P6|Stage 2|Adverse Event|3
1143353|NCT01397409|3754775|P5|Stage 2|Adverse Event|6
1143354|NCT01397409|3754776|P4|Stage 2|Adverse Event|0
1143355|NCT01397409|3754777|P3|Stage 2|Adverse Event|0
1143356|NCT01397409|3754778|P2|Stage 2|Adverse Event|0
1143357|NCT01397409|3754779|P1|Stage 2|Adverse Event|0
1143358|NCT01397253|3754819|P2|Overall Study|Reviewed by only 1 pharmacist|149
1143359|NCT01397253|3754820|P1|Overall Study|Reviewed by only 1 pharmacist|126
1143360|NCT01397084|3754826|P1|Overall Study|Used other proton pump inhibitor|1
1143361|NCT01397084|3754826|P1|Overall Study|Lost to Follow-up|1
1143362|NCT01397084|3754826|P1|Overall Study|Withdrawal by Subject|1
1143363|NCT01397084|3754826|P1|Overall Study|Adverse Event|2
1143364|NCT01397084|3754826|P1|Overall Study|Protocol Violation|2
1143365|NCT01397084|3754826|P1|Overall Study|Severe Non-Compliance to Protocol|1
1143366|NCT01396525|3754833|P1|Overall Study|Lost to Follow-up|4
1143367|NCT01396525|3754833|P1|Overall Study|Death|14
1143368|NCT01396525|3754833|P1|Overall Study|Withdrawal by Subject|8
1143369|NCT01396512|3754933|P2|Overall Study|Withdrawal by Subject|1
1143370|NCT01396512|3754934|P1|Overall Study|Withdrawal by Subject|0
1143371|NCT01396447|3754950|P4|Overall Study|Other Miscellaneous Reasons|0
1143372|NCT01396447|3754951|P3|Overall Study|Other Miscellaneous Reasons|1
1143373|NCT01396447|3754952|P2|Overall Study|Other Miscellaneous Reasons|2
1143374|NCT01396447|3754953|P1|Overall Study|Other Miscellaneous Reasons|0
1143375|NCT01396447|3754950|P4|Overall Study|Lost to Follow-up|9
1143376|NCT01396447|3754951|P3|Overall Study|Lost to Follow-up|7
1143377|NCT01396447|3754952|P2|Overall Study|Lost to Follow-up|8
1143378|NCT01396447|3754953|P1|Overall Study|Lost to Follow-up|4
1143379|NCT01396447|3754950|P4|Overall Study|Withdrawal of Consent|15
1143380|NCT01396447|3754951|P3|Overall Study|Withdrawal of Consent|4
1143381|NCT01396447|3754952|P2|Overall Study|Withdrawal of Consent|9
1143382|NCT01396447|3754953|P1|Overall Study|Withdrawal of Consent|11
1143383|NCT01396447|3754950|P4|Overall Study|Protocol Violation|7
1143384|NCT01396447|3754951|P3|Overall Study|Protocol Violation|3
1143385|NCT01396447|3754952|P2|Overall Study|Protocol Violation|2
1143386|NCT01396447|3754953|P1|Overall Study|Protocol Violation|5
1143387|NCT01396447|3754950|P4|Overall Study|Insufficient Therapeutic Response|4
1143388|NCT01396447|3754951|P3|Overall Study|Insufficient Therapeutic Response|2
1143389|NCT01396447|3754952|P2|Overall Study|Insufficient Therapeutic Response|5
1143390|NCT01396447|3754953|P1|Overall Study|Insufficient Therapeutic Response|5
1143391|NCT01396447|3754950|P4|Overall Study|Adverse Event|17
1143392|NCT01396447|3754951|P3|Overall Study|Adverse Event|12
1143393|NCT01396447|3754952|P2|Overall Study|Adverse Event|12
1143394|NCT01396447|3754953|P1|Overall Study|Adverse Event|15
1143395|NCT01396447|3754950|P4|Overall Study|Did Not Receive Treatment|0
1143396|NCT01396447|3754951|P3|Overall Study|Did Not Receive Treatment|1
1143397|NCT01396447|3754952|P2|Overall Study|Did Not Receive Treatment|2
1143398|NCT01396447|3754953|P1|Overall Study|Did Not Receive Treatment|3
1143399|NCT01396434|3754970|P3|Overall Study|Other|0
1143400|NCT01396434|3754971|P2|Overall Study|Other|0
1143401|NCT01396434|3754972|P1|Overall Study|Other|10
1143402|NCT01396434|3754970|P3|Overall Study|Lost to Follow-up|0
1143403|NCT01396434|3754971|P2|Overall Study|Lost to Follow-up|0
1143404|NCT01396434|3754972|P1|Overall Study|Lost to Follow-up|1
1143405|NCT01396421|3754984|P4|Overall Study|Lack of Efficacy|18
1143406|NCT01396421|3754985|P3|Overall Study|Lack of Efficacy|7
1143407|NCT01396421|3754986|P2|Overall Study|Lack of Efficacy|17
1143408|NCT01396421|3754987|P1|Overall Study|Lack of Efficacy|7
1143409|NCT01396421|3754984|P4|Overall Study|Protocol Deviation|0
1143410|NCT01396421|3754985|P3|Overall Study|Protocol Deviation|1
1143411|NCT01396421|3754986|P2|Overall Study|Protocol Deviation|1
1143412|NCT01396421|3754987|P1|Overall Study|Protocol Deviation|2
1143413|NCT01396421|3754984|P4|Overall Study|Withdrawal by Subject|21
1143414|NCT01396421|3754985|P3|Overall Study|Withdrawal by Subject|13
1143415|NCT01396421|3754986|P2|Overall Study|Withdrawal by Subject|24
1143416|NCT01396421|3754987|P1|Overall Study|Withdrawal by Subject|31
1143417|NCT01396421|3754984|P4|Overall Study|Physician Decision|3
1143418|NCT01396421|3754985|P3|Overall Study|Physician Decision|0
1143419|NCT01396421|3754986|P2|Overall Study|Physician Decision|1
1143420|NCT01396421|3754987|P1|Overall Study|Physician Decision|1
1143421|NCT01396421|3754984|P4|Overall Study|Participant Met Withdrawal Criteria|0
1143422|NCT01396421|3754985|P3|Overall Study|Participant Met Withdrawal Criteria|1
1143423|NCT01396421|3754986|P2|Overall Study|Participant Met Withdrawal Criteria|0
1143424|NCT01396421|3754987|P1|Overall Study|Participant Met Withdrawal Criteria|1
1143425|NCT01396421|3754984|P4|Overall Study|Adverse Event|32
1143426|NCT01396421|3754985|P3|Overall Study|Adverse Event|12
1143427|NCT01396421|3754986|P2|Overall Study|Adverse Event|15
1143428|NCT01396421|3754987|P1|Overall Study|Adverse Event|17
1143429|NCT01396421|3754984|P4|Overall Study|Lost to Follow-up|1
1143430|NCT01396421|3754985|P3|Overall Study|Lost to Follow-up|0
1143431|NCT01396421|3754986|P2|Overall Study|Lost to Follow-up|0
1143432|NCT01396421|3754987|P1|Overall Study|Lost to Follow-up|0
1143433|NCT01396395|3755059|P2|Overall Study|Other|1
1143434|NCT01396395|3755060|P1|Overall Study|Other|0
1143435|NCT01396395|3755059|P2|Overall Study|Lost to Follow-up|11
1143436|NCT01396395|3755060|P1|Overall Study|Lost to Follow-up|17
1143437|NCT01396395|3755059|P2|Overall Study|Adverse Event|2
1143438|NCT01396395|3755060|P1|Overall Study|Adverse Event|10
1143439|NCT01396395|3755059|P2|Overall Study|Protocol Violation|1
1143440|NCT01396395|3755060|P1|Overall Study|Protocol Violation|3
1143441|NCT01396395|3755059|P2|Overall Study|Withdrawal by Subject|12
1143442|NCT01396395|3755060|P1|Overall Study|Withdrawal by Subject|10
1143443|NCT01396317|3755102|P2|Overall Study|Adverse Event|0
1143444|NCT01396317|3755103|P1|Overall Study|Adverse Event|1
1143445|NCT01396265|3755117|P1|Rifa+Afatinib|Withdrawal by Subject|1
1143446|NCT01396187|3755206|P5|Overall Study|Other|1
1143447|NCT01396187|3755207|P4|Overall Study|Other|0
1143448|NCT01396187|3755208|P3|Overall Study|Other|0
1143449|NCT01396187|3755209|P2|Overall Study|Other|1
1143450|NCT01396187|3755210|P1|Overall Study|Other|1
1143451|NCT01396187|3755206|P5|Overall Study|Withdrawal by Subject|0
1143452|NCT01396187|3755207|P4|Overall Study|Withdrawal by Subject|0
1143453|NCT01396187|3755208|P3|Overall Study|Withdrawal by Subject|1
1143454|NCT01396187|3755209|P2|Overall Study|Withdrawal by Subject|1
1143455|NCT01396187|3755210|P1|Overall Study|Withdrawal by Subject|0
1143456|NCT01396187|3755206|P5|Overall Study|Adverse Event|0
1143457|NCT01396187|3755207|P4|Overall Study|Adverse Event|0
1143458|NCT01396187|3755208|P3|Overall Study|Adverse Event|0
1143459|NCT01396187|3755209|P2|Overall Study|Adverse Event|1
1143460|NCT01396187|3755210|P1|Overall Study|Adverse Event|0
1143461|NCT01396161|3755310|P7|Overall Study|Other|1
1143462|NCT01396161|3755311|P6|Overall Study|Other|0
1143463|NCT01396161|3755312|P5|Overall Study|Other|0
1143464|NCT01396161|3755313|P4|Overall Study|Other|0
1143465|NCT01396161|3755314|P3|Overall Study|Other|0
1143466|NCT01396161|3755315|P2|Overall Study|Other|0
1143467|NCT01396161|3755316|P1|Overall Study|Other|0
1143468|NCT01396161|3755310|P7|Overall Study|Withdrawal by Subject|0
1143469|NCT01396161|3755311|P6|Overall Study|Withdrawal by Subject|0
1143470|NCT01396161|3755312|P5|Overall Study|Withdrawal by Subject|1
1143471|NCT01396161|3755313|P4|Overall Study|Withdrawal by Subject|0
1143472|NCT01396161|3755314|P3|Overall Study|Withdrawal by Subject|0
1143473|NCT01396161|3755315|P2|Overall Study|Withdrawal by Subject|0
1143474|NCT01396161|3755316|P1|Overall Study|Withdrawal by Subject|0
1143475|NCT01396148|3755369|P1|Overall Study|Patient Decision|1
1143476|NCT01396083|3755396|P2|Overall Study|Lost to Follow-up|0
1143477|NCT01396083|3755397|P1|Overall Study|Lost to Follow-up|1
1143478|NCT01396083|3755396|P2|Overall Study|Administrative problems|0
1143479|NCT01396083|3755397|P1|Overall Study|Administrative problems|1
1143480|NCT01396083|3755396|P2|Overall Study|Abnormal laboratory value(s)|0
1143481|NCT01396083|3755397|P1|Overall Study|Abnormal laboratory value(s)|1
1143482|NCT01396083|3755396|P2|Overall Study|Protocol deviation(s)|1
1143483|NCT01396083|3755397|P1|Overall Study|Protocol deviation(s)|0
1143484|NCT01396083|3755396|P2|Overall Study|Consent withdrawn|5
1143485|NCT01396083|3755397|P1|Overall Study|Consent withdrawn|4
1143486|NCT01396083|3755396|P2|Overall Study|Unsatisfactory therapeutic effect|13
1143487|NCT01396083|3755397|P1|Overall Study|Unsatisfactory therapeutic effect|2
1143488|NCT01396083|3755396|P2|Overall Study|Adverse Event|28
1143489|NCT01396083|3755397|P1|Overall Study|Adverse Event|2
1143490|NCT01396070|3755421|P1|Overall Study|Lack of Efficacy|4
1143491|NCT01396070|3755421|P1|Overall Study|Physician Decision|3
1143492|NCT01396070|3755421|P1|Overall Study|Adverse Event|8
1143493|NCT01396070|3755421|P1|Overall Study|Death|2
1143494|NCT01396070|3755421|P1|Overall Study|Withdrawal by Subject|2
1143495|NCT01396057|3755430|P2|Overall Study|Consent withdrawn|2
1143496|NCT01396057|3755431|P1|Overall Study|Consent withdrawn|3
1143497|NCT01396057|3755430|P2|Overall Study|Protocol deviation|4
1143498|NCT01396057|3755431|P1|Overall Study|Protocol deviation|4
1143499|NCT01396057|3755430|P2|Overall Study|Unsatisfactory therapeutic effect|6
1143500|NCT01396057|3755431|P1|Overall Study|Unsatisfactory therapeutic effect|2
1143501|NCT01396057|3755430|P2|Overall Study|Adverse Event|6
1143502|NCT01396057|3755431|P1|Overall Study|Adverse Event|2
1143503|NCT01396005|3755480|P2|Overall Study|Non-compliance with protocol|1
1143504|NCT01396005|3755481|P1|Overall Study|Non-compliance with protocol|0
1143505|NCT01396005|3755480|P2|Overall Study|Withdrawal by Subject|1
1143506|NCT01396005|3755481|P1|Overall Study|Withdrawal by Subject|0
1143507|NCT01395914|3755512|P2|Overall Study|Lost to Follow-up|2
1143508|NCT01395914|3755513|P1|Overall Study|Lost to Follow-up|6
1143509|NCT01395914|3755512|P2|Overall Study|Study drug-related AE|0
1143510|NCT01395914|3755513|P1|Overall Study|Study drug-related AE|1
1143511|NCT01395914|3755512|P2|Overall Study|Withdrawal by patient|14
1143512|NCT01395914|3755513|P1|Overall Study|Withdrawal by patient|27
1143513|NCT01395914|3755512|P2|Overall Study|Other|3
1143514|NCT01395914|3755513|P1|Overall Study|Other|9
1143515|NCT01395914|3755512|P2|Overall Study|Death|17
1143516|NCT01395914|3755513|P1|Overall Study|Death|23
1143517|NCT01395914|3755512|P2|Overall Study|Unrelated to study drug AE|1
1143518|NCT01395914|3755513|P1|Overall Study|Unrelated to study drug AE|6
1143519|NCT01395901|3755527|P2|Overall Study|Withdrawal of consent|0
1143520|NCT01395901|3755528|P1|Overall Study|Withdrawal of consent|1
1143521|NCT01395901|3755527|P2|Overall Study|Adverse Event|1
1143522|NCT01395901|3755528|P1|Overall Study|Adverse Event|0
1143523|NCT01395901|3755527|P2|Overall Study|Randomized but not received study drug|4
1143524|NCT01395901|3755528|P1|Overall Study|Randomized but not received study drug|5
1143525|NCT01395901|3755527|P2|Overall Study|Lost to Follow-up|0
1143526|NCT01395901|3755528|P1|Overall Study|Lost to Follow-up|4
1143527|NCT01395888|3755544|P3|Treatment Period (TP)|Withdrawal by Subject|3
1143528|NCT01395888|3755545|P2|Treatment Period (TP)|Withdrawal by Subject|2
1143529|NCT01395888|3755546|P1|Treatment Period (TP)|Withdrawal by Subject|0
1143530|NCT01395888|3755544|P3|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
1143531|NCT01395888|3755545|P2|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1
1143532|NCT01395888|3755546|P1|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
1143533|NCT01395888|3755544|P3|Treatment Period (TP)|Protocol Violation|5
1143534|NCT01395888|3755545|P2|Treatment Period (TP)|Protocol Violation|1
1143535|NCT01395888|3755546|P1|Treatment Period (TP)|Protocol Violation|0
1143536|NCT01395888|3755544|P3|Treatment Period (TP)|Lack of Efficacy|3
1143537|NCT01395888|3755545|P2|Treatment Period (TP)|Lack of Efficacy|4
1143538|NCT01395888|3755546|P1|Treatment Period (TP)|Lack of Efficacy|0
1143539|NCT01395888|3755544|P3|Treatment Period (TP)|Adverse Event|6
1143540|NCT01395888|3755545|P2|Treatment Period (TP)|Adverse Event|7
1143541|NCT01395888|3755546|P1|Treatment Period (TP)|Adverse Event|0
1143542|NCT01395888|3755544|P3|2-week Run-in Period|Withdrawal by Subject|0
1143543|NCT01395888|3755545|P2|2-week Run-in Period|Withdrawal by Subject|0
1143544|NCT01395888|3755546|P1|2-week Run-in Period|Withdrawal by Subject|4
1143545|NCT01395888|3755544|P3|2-week Run-in Period|Protocol Violation|0
1143546|NCT01395888|3755545|P2|2-week Run-in Period|Protocol Violation|0
1143547|NCT01395888|3755546|P1|2-week Run-in Period|Protocol Violation|2
1143548|NCT01395888|3755544|P3|2-week Run-in Period|Lost to Follow-up|0
1143549|NCT01395888|3755545|P2|2-week Run-in Period|Lost to Follow-up|0
1143550|NCT01395888|3755546|P1|2-week Run-in Period|Lost to Follow-up|1
1143551|NCT01395888|3755544|P3|2-week Run-in Period|Continuation Criteria Not Met|0
1143552|NCT01395888|3755545|P2|2-week Run-in Period|Continuation Criteria Not Met|0
1143553|NCT01395888|3755546|P1|2-week Run-in Period|Continuation Criteria Not Met|13
1143554|NCT01395888|3755544|P3|2-week Run-in Period|Adverse Event|0
1143555|NCT01395888|3755545|P2|2-week Run-in Period|Adverse Event|0
1143556|NCT01395888|3755546|P1|2-week Run-in Period|Adverse Event|2
1143557|NCT01395823|3755554|P2|Overall Study|Withdrawal by Subject|4
1143558|NCT01395823|3755555|P1|Overall Study|Withdrawal by Subject|5
1143559|NCT01395823|3755554|P2|Overall Study|GI symptoms|0
1143560|NCT01395823|3755555|P1|Overall Study|GI symptoms|1
1143561|NCT01395823|3755554|P2|Overall Study|Transplant|0
1143562|NCT01395823|3755555|P1|Overall Study|Transplant|1
1143563|NCT01395823|3755554|P2|Overall Study|Lost to Follow-up|0
1143564|NCT01395823|3755555|P1|Overall Study|Lost to Follow-up|1
1143565|NCT01395823|3755554|P2|Overall Study|Physician Decision|1
1143566|NCT01395823|3755555|P1|Overall Study|Physician Decision|3
1143567|NCT01395823|3755554|P2|Overall Study|Death|4
1143568|NCT01395823|3755555|P1|Overall Study|Death|4
1143569|NCT01395810|3755565|P4|Overall Study|Unclassified|0
1143570|NCT01395810|3755566|P3|Overall Study|Unclassified|0
1143571|NCT01395810|3755567|P2|Overall Study|Unclassified|0
1143572|NCT01395810|3755568|P1|Overall Study|Unclassified|2
1143573|NCT01395810|3755565|P4|Overall Study|Withdrawal criteria|0
1143574|NCT01395810|3755566|P3|Overall Study|Withdrawal criteria|0
1143575|NCT01395810|3755567|P2|Overall Study|Withdrawal criteria|2
1143576|NCT01395810|3755568|P1|Overall Study|Withdrawal criteria|0
1143577|NCT01395810|3755565|P4|Overall Study|Lack of Efficacy|0
1143578|NCT01395810|3755566|P3|Overall Study|Lack of Efficacy|0
1143579|NCT01395810|3755567|P2|Overall Study|Lack of Efficacy|1
1143580|NCT01395810|3755568|P1|Overall Study|Lack of Efficacy|0
1143581|NCT01395810|3755565|P4|Overall Study|Adverse Event|0
1143582|NCT01395810|3755566|P3|Overall Study|Adverse Event|0
1143583|NCT01395810|3755567|P2|Overall Study|Adverse Event|1
1143584|NCT01395810|3755568|P1|Overall Study|Adverse Event|0
1143585|NCT01395784|3755627|P1|Overall Study|Physician Decision|5
1143586|NCT01395784|3755627|P1|Overall Study|Withdrawal by Subject|3
1143587|NCT01395784|3755627|P1|Overall Study|Lost to Follow-up|7
1143588|NCT01395758|3755634|P3|Open-label Treatment Period|Withdrawal by Subject|0
1143589|NCT01395758|3755635|P2|Open-label Treatment Period|Withdrawal by Subject|0
1143590|NCT01395758|3755636|P1|Open-label Treatment Period|Withdrawal by Subject|4
1143591|NCT01395524|3755650|P3|Overall Study|Subject had spinal surgery|1
1143592|NCT01395524|3755651|P2|Overall Study|Subject had spinal surgery|0
1143593|NCT01395524|3755652|P1|Overall Study|Subject had spinal surgery|0
1143594|NCT01395524|3755650|P3|Overall Study|Did not receive treatment|3
1143595|NCT01395524|3755651|P2|Overall Study|Did not receive treatment|1
1143596|NCT01395524|3755652|P1|Overall Study|Did not receive treatment|1
1143597|NCT01395524|3755650|P3|Overall Study|Withdrawal by Subject|8
1143598|NCT01395524|3755651|P2|Overall Study|Withdrawal by Subject|8
1143599|NCT01395524|3755652|P1|Overall Study|Withdrawal by Subject|4
1143600|NCT01395524|3755650|P3|Overall Study|Eligibility Criteria Not Fulfilled|0
1143601|NCT01395524|3755651|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
1143602|NCT01395524|3755652|P1|Overall Study|Eligibility Criteria Not Fulfilled|2
1143603|NCT01395524|3755650|P3|Overall Study|Death|0
1143604|NCT01395524|3755651|P2|Overall Study|Death|0
1143605|NCT01395524|3755652|P1|Overall Study|Death|1
1143606|NCT01395524|3755650|P3|Overall Study|Adverse Event|3
1143607|NCT01395524|3755651|P2|Overall Study|Adverse Event|4
1143608|NCT01395524|3755652|P1|Overall Study|Adverse Event|4
1143609|NCT01395524|3755650|P3|Overall Study|Severe noncompliance with protocol|0
1143610|NCT01395524|3755651|P2|Overall Study|Severe noncompliance with protocol|0
1143611|NCT01395524|3755652|P1|Overall Study|Severe noncompliance with protocol|1
1143612|NCT01395524|3755650|P3|Overall Study|Study-Specific Withdrawal Criteria|0
1143613|NCT01395524|3755651|P2|Overall Study|Study-Specific Withdrawal Criteria|2
1143614|NCT01395524|3755652|P1|Overall Study|Study-Specific Withdrawal Criteria|1
1143615|NCT01395524|3755650|P3|Overall Study|Lost to Follow-up|1
1143616|NCT01395524|3755651|P2|Overall Study|Lost to Follow-up|1
1143617|NCT01395524|3755652|P1|Overall Study|Lost to Follow-up|3
1143618|NCT01395524|3755650|P3|Overall Study|Non-compliance with study schedule|1
1143619|NCT01395524|3755651|P2|Overall Study|Non-compliance with study schedule|0
1143620|NCT01395524|3755652|P1|Overall Study|Non-compliance with study schedule|1
1143621|NCT01395394|3755675|P3|Baseline Study Visit|Protocol Violation|0
1143622|NCT01395394|3755676|P2|Baseline Study Visit|Protocol Violation|0
1143623|NCT01395394|3755677|P1|Baseline Study Visit|Protocol Violation|1
1143624|NCT01395368|3755688|P1|Overall Study|Withdrawal by Subject|2
1143625|NCT01395368|3755688|P1|Overall Study|Physician Decision|14
1143626|NCT01395316|3755744|P1|Overall Study|poor MRI quality|1
1143627|NCT01395316|3755744|P1|Overall Study|Lost to Follow-up|2
1143628|NCT01395030|3755764|P1|Overall Study|Did not complete FCH PET/CT|7
1143629|NCT01395017|3755774|P2|Overall Study|Sponsor discontinued study|4
1143630|NCT01395017|3755775|P1|Overall Study|Sponsor discontinued study|1
1143631|NCT01395017|3755774|P2|Overall Study|Disease progression|58
1143632|NCT01395017|3755775|P1|Overall Study|Disease progression|42
1143633|NCT01395017|3755774|P2|Overall Study|Death|3
1143634|NCT01395017|3755775|P1|Overall Study|Death|4
1143635|NCT01395017|3755774|P2|Overall Study|Protocol deviation|2
1143636|NCT01395017|3755775|P1|Overall Study|Protocol deviation|1
1143637|NCT01395017|3755774|P2|Overall Study|Withdrawal by Subject|8
1143638|NCT01395017|3755775|P1|Overall Study|Withdrawal by Subject|14
1143639|NCT01395017|3755774|P2|Overall Study|Physician Decision|15
1143640|NCT01395017|3755775|P1|Overall Study|Physician Decision|11
1143641|NCT01395017|3755774|P2|Overall Study|Adverse Event|12
1143642|NCT01395017|3755775|P1|Overall Study|Adverse Event|26
1143643|NCT01395017|3755774|P2|Overall Study|Lost to Follow-up|0
1143644|NCT01395017|3755775|P1|Overall Study|Lost to Follow-up|1
1143645|NCT01394991|3755785|P2|Overall Study|Prematurely Termination of Trial|10
1143646|NCT01394991|3755786|P1|Overall Study|Prematurely Termination of Trial|9
1143647|NCT01394991|3755785|P2|Overall Study|Disease Progression|7
1143648|NCT01394991|3755786|P1|Overall Study|Disease Progression|7
1143649|NCT01394991|3755785|P2|Overall Study|Chemotherapy Termination|15
1143650|NCT01394991|3755786|P1|Overall Study|Chemotherapy Termination|10
1143651|NCT01394991|3755785|P2|Overall Study|Withdrawal by Subject|17
1143652|NCT01394991|3755786|P1|Overall Study|Withdrawal by Subject|20
1143653|NCT01394991|3755785|P2|Overall Study|Protocol Violation|1
1143654|NCT01394991|3755786|P1|Overall Study|Protocol Violation|1
1143655|NCT01394991|3755785|P2|Overall Study|Physician Decision|3
1143656|NCT01394991|3755786|P1|Overall Study|Physician Decision|1
1143657|NCT01394991|3755785|P2|Overall Study|Lost to Follow-up|8
1143658|NCT01394991|3755786|P1|Overall Study|Lost to Follow-up|6
1143659|NCT01394991|3755785|P2|Overall Study|Lack of Efficacy|7
1143660|NCT01394991|3755786|P1|Overall Study|Lack of Efficacy|5
1143661|NCT01394991|3755785|P2|Overall Study|Adverse Event|4
1143662|NCT01394991|3755786|P1|Overall Study|Adverse Event|0
1143663|NCT01394978|3755808|P2|Overall Study|Death|7
1143664|NCT01394978|3755809|P1|Overall Study|Death|6
1143665|NCT01394978|3755808|P2|Overall Study|Lost to Follow-up|20
1143666|NCT01394978|3755809|P1|Overall Study|Lost to Follow-up|13
1143667|NCT01394978|3755808|P2|Overall Study|Withdrawal by Subject|4
1143668|NCT01394978|3755809|P1|Overall Study|Withdrawal by Subject|2
1143669|NCT01394718|3755826|P2|Overall Study|Met protocol-specific stopping criteria|1
1143670|NCT01394718|3755827|P1|Overall Study|Met protocol-specific stopping criteria|2
1143671|NCT01394627|3755848|P2|Washout (1-3 Months)|concurrent enrollment in another study|0
1143672|NCT01394627|3755849|P1|Washout (1-3 Months)|concurrent enrollment in another study|1
1143673|NCT01394627|3755848|P2|First Intervention (1 Day)|poor intravenous access|1
1143674|NCT01394627|3755849|P1|First Intervention (1 Day)|poor intravenous access|0
1143675|NCT01394523|3755869|P3|Overall Study|Unable to place block|0
1143676|NCT01394523|3755870|P2|Overall Study|Unable to place block|0
1143677|NCT01394523|3755871|P1|Overall Study|Unable to place block|1
1143678|NCT01394276|3755885|P1|Overall Study|Symptoms of concurrent diseases|1
1143679|NCT01394276|3755885|P1|Overall Study|unavailability of drug at the Hospital|2
1143680|NCT01394276|3755885|P1|Overall Study|Pregnancy|1
1143681|NCT01394276|3755885|P1|Overall Study|Participant moved to another site|1
1143682|NCT01394276|3755885|P1|Overall Study|Lost to Follow-up|5
1143683|NCT01394276|3755885|P1|Overall Study|Insufficient compliance|9
1143684|NCT01394276|3755885|P1|Overall Study|Insufficient therapeutic effect|17
1143685|NCT01394276|3755885|P1|Overall Study|Remission of disease|2
1143686|NCT01394276|3755885|P1|Overall Study|Not related AEs|9
1143687|NCT01394276|3755885|P1|Overall Study|Related Adverse event (AEs)|15
1143688|NCT01394250|3755909|P2|Successful IV Placement & Follow-Up|Withdrawal by Subject|11
1143689|NCT01394250|3755910|P1|Successful IV Placement & Follow-Up|Withdrawal by Subject|6
1143690|NCT01394250|3755909|P2|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13
1143691|NCT01394250|3755910|P1|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14
1143692|NCT01394185|3755924|P6|Overall Study|Protocol Violation|1
1143693|NCT01394185|3755925|P5|Overall Study|Protocol Violation|0
1143694|NCT01394185|3755926|P4|Overall Study|Protocol Violation|1
1143695|NCT01394185|3755927|P3|Overall Study|Protocol Violation|0
1143696|NCT01394185|3755928|P2|Overall Study|Protocol Violation|0
1143697|NCT01394185|3755929|P1|Overall Study|Protocol Violation|1
1143698|NCT01394185|3755924|P6|Overall Study|Change in protocol|0
1143699|NCT01394185|3755925|P5|Overall Study|Change in protocol|3
1143700|NCT01394185|3755926|P4|Overall Study|Change in protocol|0
1143701|NCT01394185|3755927|P3|Overall Study|Change in protocol|0
1143702|NCT01394185|3755928|P2|Overall Study|Change in protocol|0
1143703|NCT01394185|3755929|P1|Overall Study|Change in protocol|3
1143704|NCT01394185|3755924|P6|Overall Study|Withdrawal by Subject|0
1143705|NCT01394185|3755925|P5|Overall Study|Withdrawal by Subject|1
1143706|NCT01394185|3755926|P4|Overall Study|Withdrawal by Subject|0
1143707|NCT01394185|3755927|P3|Overall Study|Withdrawal by Subject|0
1143708|NCT01394185|3755928|P2|Overall Study|Withdrawal by Subject|0
1143709|NCT01394185|3755929|P1|Overall Study|Withdrawal by Subject|2
1143710|NCT01393964|3755967|P3|Overall Study|Subject to receive non-protocol therapy|1
1143711|NCT01393964|3755968|P2|Overall Study|Subject to receive non-protocol therapy|0
1143712|NCT01393964|3755969|P1|Overall Study|Subject to receive non-protocol therapy|0
1143713|NCT01393964|3755967|P3|Overall Study|Subject converted to roll-over study|0
1143714|NCT01393964|3755968|P2|Overall Study|Subject converted to roll-over study|1
1143715|NCT01393964|3755969|P1|Overall Study|Subject converted to roll-over study|0
1143716|NCT01393964|3755967|P3|Overall Study|Investigator removed subject from study|0
1143717|NCT01393964|3755968|P2|Overall Study|Investigator removed subject from study|1
1143718|NCT01393964|3755969|P1|Overall Study|Investigator removed subject from study|0
1143719|NCT01393964|3755967|P3|Overall Study|Subject plateaued in terms of effect|0
1143720|NCT01393964|3755968|P2|Overall Study|Subject plateaued in terms of effect|0
1143721|NCT01393964|3755969|P1|Overall Study|Subject plateaued in terms of effect|1
1143722|NCT01393964|3755967|P3|Overall Study|Subject switched to commercial supply|2
1143723|NCT01393964|3755968|P2|Overall Study|Subject switched to commercial supply|0
1143724|NCT01393964|3755969|P1|Overall Study|Subject switched to commercial supply|1
1143725|NCT01393964|3755967|P3|Overall Study|Subject decided to move to transplant|0
1143726|NCT01393964|3755968|P2|Overall Study|Subject decided to move to transplant|0
1143727|NCT01393964|3755969|P1|Overall Study|Subject decided to move to transplant|1
1143728|NCT01393964|3755967|P3|Overall Study|Subject request stop study treatment|0
1143729|NCT01393964|3755968|P2|Overall Study|Subject request stop study treatment|1
1143730|NCT01393964|3755969|P1|Overall Study|Subject request stop study treatment|0
1143731|NCT01393964|3755967|P3|Overall Study|Adverse event unrelated to study drug|0
1143732|NCT01393964|3755968|P2|Overall Study|Adverse event unrelated to study drug|3
1143733|NCT01393964|3755969|P1|Overall Study|Adverse event unrelated to study drug|0
1143734|NCT01393964|3755967|P3|Overall Study|Withdrawal by Subject|1
1143735|NCT01393964|3755968|P2|Overall Study|Withdrawal by Subject|0
1143736|NCT01393964|3755969|P1|Overall Study|Withdrawal by Subject|0
1143737|NCT01393964|3755967|P3|Overall Study|Study drug toxicity|0
1143738|NCT01393964|3755968|P2|Overall Study|Study drug toxicity|0
1143739|NCT01393964|3755969|P1|Overall Study|Study drug toxicity|1
1143740|NCT01393964|3755967|P3|Overall Study|Disease Progression|5
1143741|NCT01393964|3755968|P2|Overall Study|Disease Progression|3
1143742|NCT01393964|3755969|P1|Overall Study|Disease Progression|4
1143743|NCT01393899|3756010|P3|Overall Study|Adverse Event|3
1143744|NCT01393899|3756011|P2|Overall Study|Adverse Event|5
1143745|NCT01393899|3756012|P1|Overall Study|Adverse Event|1
1143746|NCT01393899|3756010|P3|Overall Study|Lack of Efficacy|16
1143747|NCT01393899|3756011|P2|Overall Study|Lack of Efficacy|21
1143748|NCT01393899|3756012|P1|Overall Study|Lack of Efficacy|26
1143749|NCT01393899|3756010|P3|Overall Study|Does not meet entrance criteria|1
1143750|NCT01393899|3756011|P2|Overall Study|Does not meet entrance criteria|0
1143751|NCT01393899|3756012|P1|Overall Study|Does not meet entrance criteria|1
1143752|NCT01393899|3756010|P3|Overall Study|Lost to Follow-up|1
1143753|NCT01393899|3756011|P2|Overall Study|Lost to Follow-up|0
1143754|NCT01393899|3756012|P1|Overall Study|Lost to Follow-up|0
1143755|NCT01393899|3756010|P3|Overall Study|Withdrawal by Subject|1
1143756|NCT01393899|3756011|P2|Overall Study|Withdrawal by Subject|2
1143757|NCT01393899|3756012|P1|Overall Study|Withdrawal by Subject|2
1143758|NCT01393899|3756010|P3|Overall Study|Other|0
1143759|NCT01393899|3756011|P2|Overall Study|Other|0
1143760|NCT01393899|3756012|P1|Overall Study|Other|1
1143761|NCT01393899|3756010|P3|Overall Study|Study terminated by sponsor|1
1143762|NCT01393899|3756011|P2|Overall Study|Study terminated by sponsor|0
1143763|NCT01393899|3756012|P1|Overall Study|Study terminated by sponsor|1
1143764|NCT01393743|3756066|P3|Extension Phase|Not specified|14
1143765|NCT01393743|3756067|P2|Extension Phase|Not specified|0
1143766|NCT01393743|3756068|P1|Extension Phase|Not specified|0
1143767|NCT01393743|3756066|P3|Extension Phase|Pregnancy|1
1143768|NCT01393743|3756067|P2|Extension Phase|Pregnancy|0
1143769|NCT01393743|3756068|P1|Extension Phase|Pregnancy|0
1143770|NCT01393743|3756066|P3|Extension Phase|Withdrawal by Subject|8
1143771|NCT01393743|3756067|P2|Extension Phase|Withdrawal by Subject|0
1143772|NCT01393743|3756068|P1|Extension Phase|Withdrawal by Subject|0
1143773|NCT01393743|3756066|P3|Extension Phase|Inadequate therapeutic effect|7
1143774|NCT01393743|3756067|P2|Extension Phase|Inadequate therapeutic effect|0
1143775|NCT01393743|3756068|P1|Extension Phase|Inadequate therapeutic effect|0
1143776|NCT01393743|3756066|P3|Extension Phase|Participant choice|16
1143777|NCT01393743|3756067|P2|Extension Phase|Participant choice|0
1143778|NCT01393743|3756068|P1|Extension Phase|Participant choice|0
1143779|NCT01393743|3756066|P3|Extension Phase|Lost to Follow-up|2
1143780|NCT01393743|3756067|P2|Extension Phase|Lost to Follow-up|0
1143781|NCT01393743|3756068|P1|Extension Phase|Lost to Follow-up|0
1143782|NCT01393743|3756066|P3|Extension Phase|Adverse Event|12
1143783|NCT01393743|3756067|P2|Extension Phase|Adverse Event|0
1143784|NCT01393743|3756068|P1|Extension Phase|Adverse Event|0
1143785|NCT01393743|3756066|P3|Core Study|Inadequate therapeutic effect|0
1143786|NCT01393743|3756067|P2|Core Study|Inadequate therapeutic effect|0
1143787|NCT01393743|3756068|P1|Core Study|Inadequate therapeutic effect|2
1143788|NCT01393743|3756066|P3|Core Study|Participant's Choice|0
1143789|NCT01393743|3756067|P2|Core Study|Participant's Choice|3
1143790|NCT01393743|3756068|P1|Core Study|Participant's Choice|2
1143791|NCT01393743|3756066|P3|Core Study|Lost to Follow-up|0
1143792|NCT01393743|3756067|P2|Core Study|Lost to Follow-up|1
1143793|NCT01393743|3756068|P1|Core Study|Lost to Follow-up|1
1143794|NCT01393743|3756066|P3|Core Study|Adverse Event|0
1143795|NCT01393743|3756067|P2|Core Study|Adverse Event|9
1143796|NCT01393743|3756068|P1|Core Study|Adverse Event|5
1143797|NCT01393730|3756091|P1|Overall Study|Adverse Event|1
1143798|NCT01393730|3756091|P1|Overall Study|Other|2
1143799|NCT01393730|3756091|P1|Overall Study|Withdrawal by Subject|3
1143800|NCT01393626|3756137|P4|Overall Study|Protocol Violation|0
1143801|NCT01393626|3756138|P3|Overall Study|Protocol Violation|2
1143802|NCT01393626|3756139|P2|Overall Study|Protocol Violation|0
1143803|NCT01393626|3756140|P1|Overall Study|Protocol Violation|1
1143804|NCT01393626|3756137|P4|Overall Study|Other|0
1143805|NCT01393626|3756138|P3|Overall Study|Other|0
1143806|NCT01393626|3756139|P2|Overall Study|Other|0
1143807|NCT01393626|3756140|P1|Overall Study|Other|1
1143808|NCT01393626|3756137|P4|Overall Study|Withdrawal by Subject|0
1143809|NCT01393626|3756138|P3|Overall Study|Withdrawal by Subject|0
1143810|NCT01393626|3756139|P2|Overall Study|Withdrawal by Subject|4
1143811|NCT01393626|3756140|P1|Overall Study|Withdrawal by Subject|6
1143812|NCT01393626|3756137|P4|Overall Study|Lost to Follow-up|0
1143813|NCT01393626|3756138|P3|Overall Study|Lost to Follow-up|1
1143814|NCT01393626|3756139|P2|Overall Study|Lost to Follow-up|1
1143815|NCT01393626|3756140|P1|Overall Study|Lost to Follow-up|1
1143816|NCT01393626|3756137|P4|Overall Study|Lack of Efficacy|1
1143817|NCT01393626|3756138|P3|Overall Study|Lack of Efficacy|4
1143818|NCT01393626|3756139|P2|Overall Study|Lack of Efficacy|6
1143819|NCT01393626|3756140|P1|Overall Study|Lack of Efficacy|6
1143820|NCT01393626|3756137|P4|Overall Study|Did not meet entrance criteria|0
1143821|NCT01393626|3756138|P3|Overall Study|Did not meet entrance criteria|0
1143822|NCT01393626|3756139|P2|Overall Study|Did not meet entrance criteria|0
1143823|NCT01393626|3756140|P1|Overall Study|Did not meet entrance criteria|1
1143824|NCT01393626|3756137|P4|Overall Study|Adverse Event|0
1143825|NCT01393626|3756138|P3|Overall Study|Adverse Event|5
1143826|NCT01393626|3756139|P2|Overall Study|Adverse Event|1
1143827|NCT01393626|3756140|P1|Overall Study|Adverse Event|2
1143828|NCT01393613|3756220|P4|Overall Study|Lack of Efficacy|21
1143829|NCT01393613|3756221|P3|Overall Study|Lack of Efficacy|16
1143830|NCT01393613|3756222|P2|Overall Study|Lack of Efficacy|20
1143831|NCT01393613|3756223|P1|Overall Study|Lack of Efficacy|9
1143832|NCT01393613|3756220|P4|Overall Study|Protocol Deviation|0
1143833|NCT01393613|3756221|P3|Overall Study|Protocol Deviation|0
1143834|NCT01393613|3756222|P2|Overall Study|Protocol Deviation|1
1143835|NCT01393613|3756223|P1|Overall Study|Protocol Deviation|2
1143836|NCT01393613|3756220|P4|Overall Study|Withdrawal by Subject|21
1143837|NCT01393613|3756221|P3|Overall Study|Withdrawal by Subject|23
1143838|NCT01393613|3756222|P2|Overall Study|Withdrawal by Subject|25
1143839|NCT01393613|3756223|P1|Overall Study|Withdrawal by Subject|15
1143840|NCT01393613|3756220|P4|Overall Study|Physician Decision|1
1143841|NCT01393613|3756221|P3|Overall Study|Physician Decision|0
1143842|NCT01393613|3756222|P2|Overall Study|Physician Decision|0
1143843|NCT01393613|3756223|P1|Overall Study|Physician Decision|2
1143844|NCT01393613|3756220|P4|Overall Study|Participant Met Withdrawal Criteria|1
1143845|NCT01393613|3756221|P3|Overall Study|Participant Met Withdrawal Criteria|2
1143846|NCT01393613|3756222|P2|Overall Study|Participant Met Withdrawal Criteria|0
1143847|NCT01393613|3756223|P1|Overall Study|Participant Met Withdrawal Criteria|0
1143848|NCT01393613|3756220|P4|Overall Study|Adverse Event|22
1143849|NCT01393613|3756221|P3|Overall Study|Adverse Event|13
1143850|NCT01393613|3756222|P2|Overall Study|Adverse Event|11
1143851|NCT01393613|3756223|P1|Overall Study|Adverse Event|11
1143852|NCT01393600|3756285|P4|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
1143853|NCT01393600|3756286|P3|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1
1143854|NCT01393600|3756287|P2|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
1143855|NCT01393600|3756288|P1|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
1143856|NCT01393600|3756285|P4|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
1143857|NCT01393600|3756286|P3|Treatment Period 2 (Day 15 to 28)|Physician Decision|1
1143858|NCT01393600|3756287|P2|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
1143859|NCT01393600|3756288|P1|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
1143860|NCT01393600|3756285|P4|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
1143861|NCT01393600|3756286|P3|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1
1143862|NCT01393600|3756287|P2|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
1143863|NCT01393600|3756288|P1|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
1143864|NCT01393600|3756285|P4|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1
1143865|NCT01393600|3756286|P3|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
1143866|NCT01393600|3756287|P2|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
1143867|NCT01393600|3756288|P1|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
1143868|NCT01393600|3756285|P4|Treatment Period 1 (Day 1 to 14)|Adverse Event|1
1143869|NCT01393600|3756286|P3|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
1143870|NCT01393600|3756287|P2|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
1143871|NCT01393600|3756288|P1|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
1143872|NCT01393600|3756285|P4|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
1143873|NCT01393600|3756286|P3|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1
1143874|NCT01393600|3756287|P2|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
1143875|NCT01393600|3756288|P1|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
1143876|NCT01393600|3756285|P4|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
1143877|NCT01393600|3756286|P3|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
1143878|NCT01393600|3756287|P2|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1
1143879|NCT01393600|3756288|P1|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
1143880|NCT01393444|3756324|P1|Overall Study|Determined ineligible during screening.|2
1143881|NCT01393444|3756324|P1|Overall Study|Withdrawal by Subject|1
1143882|NCT01393405|3756329|P3|Maintenance Period Week|Lost to Follow-up|0
1143883|NCT01393405|3756330|P2|Maintenance Period Week|Lost to Follow-up|1
1143884|NCT01393405|3756331|P1|Maintenance Period Week|Lost to Follow-up|0
1143885|NCT01393405|3756329|P3|Maintenance Period Week|Withdrawal by Subject|0
1143886|NCT01393405|3756330|P2|Maintenance Period Week|Withdrawal by Subject|1
1143887|NCT01393405|3756331|P1|Maintenance Period Week|Withdrawal by Subject|0
1143888|NCT01393405|3756329|P3|Maintenance Period Week|Adverse Event|2
1143889|NCT01393405|3756330|P2|Maintenance Period Week|Adverse Event|5
1143890|NCT01393405|3756331|P1|Maintenance Period Week|Adverse Event|0
1143891|NCT01393405|3756329|P3|Maintenance Period Week|Lack of Efficacy|22
1143892|NCT01393405|3756330|P2|Maintenance Period Week|Lack of Efficacy|22
1143893|NCT01393405|3756331|P1|Maintenance Period Week|Lack of Efficacy|0
1143894|NCT01393405|3756329|P3|Induction Period (week1-16)|Withdrawal by Subject|0
1143895|NCT01393405|3756330|P2|Induction Period (week1-16)|Withdrawal by Subject|0
1143896|NCT01393405|3756331|P1|Induction Period (week1-16)|Withdrawal by Subject|9
1143897|NCT01393405|3756329|P3|Induction Period (week1-16)|Adverse Event|0
1143898|NCT01393405|3756330|P2|Induction Period (week1-16)|Adverse Event|0
1143899|NCT01393405|3756331|P1|Induction Period (week1-16)|Adverse Event|16
1143900|NCT01393405|3756329|P3|Induction Period (week1-16)|Lack of Efficacy|0
1143901|NCT01393405|3756330|P2|Induction Period (week1-16)|Lack of Efficacy|0
1143902|NCT01393405|3756331|P1|Induction Period (week1-16)|Lack of Efficacy|70
1143903|NCT01393106|3756382|P1|Overall Study|Lack of Efficacy|1
1143904|NCT01393106|3756382|P1|Overall Study|Withdrawal by Subject|1
1143905|NCT01393106|3756382|P1|Overall Study|Adverse Event|3
1143906|NCT01392963|3756401|P2|Week 24 Follow-up|Lost to Follow-up|0
1143907|NCT01392963|3756402|P1|Week 24 Follow-up|Lost to Follow-up|2
1143908|NCT01392963|3756401|P2|Week 0 (First Intervention)|Withdrawal by Subject|1
1143909|NCT01392963|3756402|P1|Week 0 (First Intervention)|Withdrawal by Subject|0
1143910|NCT01392963|3756401|P2|Week 0 (First Intervention)|Lost to Follow-up|1
1143911|NCT01392963|3756402|P1|Week 0 (First Intervention)|Lost to Follow-up|0
1143912|NCT01392742|3756410|P1|Overall Study|Missing information|13
1143913|NCT01392742|3756410|P1|Overall Study|Other|3
1143914|NCT01392742|3756410|P1|Overall Study|Protocol Violation|14
1143915|NCT01392742|3756410|P1|Overall Study|Adverse event/intercurrent illness|17
1143916|NCT01392742|3756410|P1|Overall Study|ITR and Protocol deviation|1
1143917|NCT01392742|3756410|P1|Overall Study|Insufficient therapeutic response (ITR)|30
1143918|NCT01392742|3756410|P1|Overall Study|Lost to Follow-up|34
1143919|NCT01392742|3756410|P1|Overall Study|No treatment/no cooperation/withdrew|12
1143920|NCT01392742|3756410|P1|Overall Study|Failure to return|35
1143921|NCT01392742|3756410|P1|Overall Study|Premature study termination|42
1143922|NCT01392677|3756456|P2|Overall Study|Other reason|2
1143923|NCT01392677|3756457|P1|Overall Study|Other reason|3
1143924|NCT01392677|3756456|P2|Overall Study|Incorrect enrollment|3
1143925|NCT01392677|3756457|P1|Overall Study|Incorrect enrollment|2
1143926|NCT01392677|3756456|P2|Overall Study|Withdrawal by Subject|2
1143927|NCT01392677|3756457|P1|Overall Study|Withdrawal by Subject|0
1143928|NCT01392677|3756456|P2|Overall Study|Adverse Event|1
1143929|NCT01392677|3756457|P1|Overall Study|Adverse Event|3
1143930|NCT01392573|3756492|P2|Overall Study|Unclassified|6
1143931|NCT01392573|3756493|P1|Overall Study|Unclassified|9
1143932|NCT01392573|3756492|P2|Overall Study|Site closure|7
1143933|NCT01392573|3756493|P1|Overall Study|Site closure|8
1143934|NCT01392573|3756492|P2|Overall Study|Withdrawal Criteria|15
1143935|NCT01392573|3756493|P1|Overall Study|Withdrawal Criteria|13
1143936|NCT01392573|3756492|P2|Overall Study|Protocol Violation|2
1143937|NCT01392573|3756493|P1|Overall Study|Protocol Violation|0
1143938|NCT01392573|3756492|P2|Overall Study|Lack of Efficacy|2
1143939|NCT01392573|3756493|P1|Overall Study|Lack of Efficacy|1
1143940|NCT01392573|3756492|P2|Overall Study|Adverse Event|3
1143941|NCT01392573|3756493|P1|Overall Study|Adverse Event|1
1143942|NCT01392560|3756501|P1|Overall Study|discontinued during placebo run-in|2
1143943|NCT01392560|3756501|P1|Overall Study|not entered|8
1143944|NCT01392560|3756501|P1|Overall Study|Adverse Event|2
1143945|NCT01392547|3756507|P1|Overall Study|Unclassified|1
1143946|NCT01392547|3756507|P1|Overall Study|Withdrawal criteria|3
1143947|NCT01392547|3756507|P1|Overall Study|Non-compliance|2
1143948|NCT01392547|3756507|P1|Overall Study|Adverse Event|2
1143949|NCT01392495|3756521|P1|Overall Study|Adverse Event|3
1143950|NCT01392495|3756521|P1|Overall Study|Withdrawal by Subject|2
1143951|NCT01392495|3756521|P1|Overall Study|Administrative problems|8
1143952|NCT01392495|3756521|P1|Overall Study|Death|3
1143953|NCT01392378|3756538|P5|Toddler Dose|Withdrawal by Parent|1
1143954|NCT01392378|3756539|P4|Toddler Dose|Withdrawal by Parent|1
1143955|NCT01392378|3756540|P3|Toddler Dose|Withdrawal by Parent|0
1143956|NCT01392378|3756541|P2|Toddler Dose|Withdrawal by Parent|1
1143957|NCT01392378|3756542|P1|Toddler Dose|Withdrawal by Parent|0
1143958|NCT01392378|3756538|P5|Toddler Dose|Lost to Follow-up|0
1143959|NCT01392378|3756539|P4|Toddler Dose|Lost to Follow-up|1
1143960|NCT01392378|3756540|P3|Toddler Dose|Lost to Follow-up|0
1143961|NCT01392378|3756541|P2|Toddler Dose|Lost to Follow-up|0
1143962|NCT01392378|3756542|P1|Toddler Dose|Lost to Follow-up|0
1143963|NCT01392378|3756538|P5|After Infant Series|Withdrawal by Parent|1
1143964|NCT01392378|3756539|P4|After Infant Series|Withdrawal by Parent|0
1143965|NCT01392378|3756540|P3|After Infant Series|Withdrawal by Parent|1
1143966|NCT01392378|3756541|P2|After Infant Series|Withdrawal by Parent|1
1143967|NCT01392378|3756542|P1|After Infant Series|Withdrawal by Parent|0
1143968|NCT01392378|3756538|P5|After Infant Series|Lost to Follow-up|0
1143969|NCT01392378|3756539|P4|After Infant Series|Lost to Follow-up|0
1143970|NCT01392378|3756540|P3|After Infant Series|Lost to Follow-up|1
1143971|NCT01392378|3756541|P2|After Infant Series|Lost to Follow-up|0
1143972|NCT01392378|3756542|P1|After Infant Series|Lost to Follow-up|0
1143973|NCT01392378|3756538|P5|Infant Series|Withdrawal by Parent|0
1143974|NCT01392378|3756539|P4|Infant Series|Withdrawal by Parent|0
1143975|NCT01392378|3756540|P3|Infant Series|Withdrawal by Parent|0
1143976|NCT01392378|3756541|P2|Infant Series|Withdrawal by Parent|1
1143977|NCT01392378|3756542|P1|Infant Series|Withdrawal by Parent|4
1143978|NCT01392378|3756538|P5|Infant Series|Protocol Violation|0
1143979|NCT01392378|3756539|P4|Infant Series|Protocol Violation|0
1143980|NCT01392378|3756540|P3|Infant Series|Protocol Violation|0
1143981|NCT01392378|3756541|P2|Infant Series|Protocol Violation|1
1143982|NCT01392378|3756542|P1|Infant Series|Protocol Violation|0
1143983|NCT01392378|3756538|P5|Infant Series|Lost to Follow-up|0
1143984|NCT01392378|3756539|P4|Infant Series|Lost to Follow-up|1
1143985|NCT01392378|3756540|P3|Infant Series|Lost to Follow-up|0
1143986|NCT01392378|3756541|P2|Infant Series|Lost to Follow-up|0
1143987|NCT01392378|3756542|P1|Infant Series|Lost to Follow-up|0
1143988|NCT01392378|3756538|P5|Infant Series|Adverse Event|0
1143989|NCT01392378|3756539|P4|Infant Series|Adverse Event|1
1143990|NCT01392378|3756540|P3|Infant Series|Adverse Event|0
1143991|NCT01392378|3756541|P2|Infant Series|Adverse Event|0
1143992|NCT01392378|3756542|P1|Infant Series|Adverse Event|0
1143993|NCT01392326|3756682|P3|Overall Study|Adverse Event|11
1143994|NCT01392326|3756683|P2|Overall Study|Adverse Event|6
1143995|NCT01392326|3756684|P1|Overall Study|Adverse Event|9
1143996|NCT01392326|3756682|P3|Overall Study|Lack of Efficacy|15
1143997|NCT01392326|3756683|P2|Overall Study|Lack of Efficacy|10
1143998|NCT01392326|3756684|P1|Overall Study|Lack of Efficacy|14
1143999|NCT01392326|3756682|P3|Overall Study|Lost to Follow-up|4
1144000|NCT01392326|3756683|P2|Overall Study|Lost to Follow-up|3
1144001|NCT01392326|3756684|P1|Overall Study|Lost to Follow-up|1
1144002|NCT01392326|3756682|P3|Overall Study|Physician Decision|2
1144003|NCT01392326|3756683|P2|Overall Study|Physician Decision|5
1144004|NCT01392326|3756684|P1|Overall Study|Physician Decision|7
1144005|NCT01392326|3756682|P3|Overall Study|Pregnancy|1
1144006|NCT01392326|3756683|P2|Overall Study|Pregnancy|0
1144007|NCT01392326|3756684|P1|Overall Study|Pregnancy|0
1144008|NCT01392326|3756682|P3|Overall Study|Protocol Violation|0
1144009|NCT01392326|3756683|P2|Overall Study|Protocol Violation|0
1144010|NCT01392326|3756684|P1|Overall Study|Protocol Violation|2
1144011|NCT01392326|3756682|P3|Overall Study|Withdrawal by Subject|15
1144012|NCT01392326|3756683|P2|Overall Study|Withdrawal by Subject|11
1144013|NCT01392326|3756684|P1|Overall Study|Withdrawal by Subject|12
1144014|NCT01392326|3756682|P3|Overall Study|Death|0
1144015|NCT01392326|3756683|P2|Overall Study|Death|0
1144016|NCT01392326|3756684|P1|Overall Study|Death|2
1144017|NCT01392300|3756721|P3|Open Label Extension (OLEX) Period|Lost to Follow-up|6
1144018|NCT01392300|3756722|P2|Open Label Extension (OLEX) Period|Lost to Follow-up|0
1144019|NCT01392300|3756723|P1|Open Label Extension (OLEX) Period|Lost to Follow-up|0
1144020|NCT01392300|3756721|P3|Open Label Extension (OLEX) Period|Withdrawal by Subject|17
1144021|NCT01392300|3756722|P2|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
1144022|NCT01392300|3756723|P1|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
1144023|NCT01392300|3756721|P3|Open Label Extension (OLEX) Period|Adverse Event|7
1144024|NCT01392300|3756722|P2|Open Label Extension (OLEX) Period|Adverse Event|0
1144025|NCT01392300|3756723|P1|Open Label Extension (OLEX) Period|Adverse Event|0
1144026|NCT01392300|3756721|P3|Open Label Extension (OLEX) Period|Death|4
1144027|NCT01392300|3756722|P2|Open Label Extension (OLEX) Period|Death|0
1144028|NCT01392300|3756723|P1|Open Label Extension (OLEX) Period|Death|0
1144029|NCT01392300|3756721|P3|Open Label Extension (OLEX) Period|Non-compliance|1
1144030|NCT01392300|3756722|P2|Open Label Extension (OLEX) Period|Non-compliance|0
1144031|NCT01392300|3756723|P1|Open Label Extension (OLEX) Period|Non-compliance|0
1144032|NCT01392300|3756721|P3|Open Label Extension (OLEX) Period|Lack of Efficacy|3
1144033|NCT01392300|3756722|P2|Open Label Extension (OLEX) Period|Lack of Efficacy|0
1144034|NCT01392300|3756723|P1|Open Label Extension (OLEX) Period|Lack of Efficacy|0
1144035|NCT01392300|3756721|P3|Open Label Extension (OLEX) Period|Protocol Violation|13
1144036|NCT01392300|3756722|P2|Open Label Extension (OLEX) Period|Protocol Violation|0
1144037|NCT01392300|3756723|P1|Open Label Extension (OLEX) Period|Protocol Violation|0
1144038|NCT01392300|3756721|P3|Main Period (MP)|Non-compliance|0
1144039|NCT01392300|3756722|P2|Main Period (MP)|Non-compliance|0
1144040|NCT01392300|3756723|P1|Main Period (MP)|Non-compliance|1
1144041|NCT01392300|3756721|P3|Main Period (MP)|Lost to Follow-up|0
1144042|NCT01392300|3756722|P2|Main Period (MP)|Lost to Follow-up|3
1144043|NCT01392300|3756723|P1|Main Period (MP)|Lost to Follow-up|3
1144044|NCT01392300|3756721|P3|Main Period (MP)|Withdrawal by Subject|0
1144045|NCT01392300|3756722|P2|Main Period (MP)|Withdrawal by Subject|1
1144046|NCT01392300|3756723|P1|Main Period (MP)|Withdrawal by Subject|5
1144047|NCT01392300|3756721|P3|Main Period (MP)|Predefined discontinuation criteria|0
1144048|NCT01392300|3756722|P2|Main Period (MP)|Predefined discontinuation criteria|3
1144049|NCT01392300|3756723|P1|Main Period (MP)|Predefined discontinuation criteria|2
1144050|NCT01392170|3756828|P1|Overall Study|Ineligible|1
1144051|NCT01392170|3756828|P1|Overall Study|Withdrawal by Subject|1
1144052|NCT01391819|3756876|P1|Overall Study|Other|9
1144053|NCT01391819|3756876|P1|Overall Study|Death|3
1144054|NCT01391819|3756876|P1|Overall Study|Lost to Follow-up|252
1144055|NCT01391819|3756876|P1|Overall Study|Migrated/moved from study area|82
1144056|NCT01391819|3756876|P1|Overall Study|Withdrawal by Subject|56
1144057|NCT01391663|3756907|P4|Overall Study|Withdrawal by Subject|0
1144058|NCT01391663|3756908|P3|Overall Study|Withdrawal by Subject|1
1144059|NCT01391663|3756909|P2|Overall Study|Withdrawal by Subject|0
1144060|NCT01391663|3756910|P1|Overall Study|Withdrawal by Subject|0
1144061|NCT01391546|3756954|P2|Overall Study|History of Herpes Zoster (HZ)|0
1144062|NCT01391546|3756955|P1|Overall Study|History of Herpes Zoster (HZ)|1
1144063|NCT01391507|3756977|P4|Overall Study|Protocol Violation|2
1144064|NCT01391507|3756978|P3|Overall Study|Protocol Violation|1
1144065|NCT01391507|3756979|P2|Overall Study|Protocol Violation|1
1144066|NCT01391507|3756980|P1|Overall Study|Protocol Violation|2
1144067|NCT01391507|3756977|P4|Overall Study|Lack of Efficacy|1
1144068|NCT01391507|3756978|P3|Overall Study|Lack of Efficacy|0
1144069|NCT01391507|3756979|P2|Overall Study|Lack of Efficacy|0
1144070|NCT01391507|3756980|P1|Overall Study|Lack of Efficacy|0
1144071|NCT01391507|3756977|P4|Overall Study|Withdrawal by Subject|1
1144072|NCT01391507|3756978|P3|Overall Study|Withdrawal by Subject|1
1144073|NCT01391507|3756979|P2|Overall Study|Withdrawal by Subject|2
1144074|NCT01391507|3756980|P1|Overall Study|Withdrawal by Subject|1
1144075|NCT01391507|3756977|P4|Overall Study|Adverse Event|2
1144076|NCT01391507|3756978|P3|Overall Study|Adverse Event|2
1144077|NCT01391507|3756979|P2|Overall Study|Adverse Event|1
1144078|NCT01391507|3756980|P1|Overall Study|Adverse Event|1
1144079|NCT01391507|3756977|P4|Overall Study|Death|1
1144080|NCT01391507|3756978|P3|Overall Study|Death|0
1144081|NCT01391507|3756979|P2|Overall Study|Death|0
1144082|NCT01391507|3756980|P1|Overall Study|Death|0
1144083|NCT01391000|3757159|P2|Overall Study|Lost to Follow-up|0
1144084|NCT01391000|3757160|P1|Overall Study|Lost to Follow-up|2
1144085|NCT01390948|3757173|P3|Overall Study|Withdrew consent from survival follow-up|0
1144086|NCT01390948|3757174|P2|Overall Study|Withdrew consent from survival follow-up|5
1144087|NCT01390948|3757175|P1|Overall Study|Withdrew consent from survival follow-up|3
1144088|NCT01390948|3757173|P3|Overall Study|Ongoing|0
1144089|NCT01390948|3757174|P2|Overall Study|Ongoing|6
1144090|NCT01390948|3757175|P1|Overall Study|Ongoing|6
1144091|NCT01390948|3757173|P3|Overall Study|Death|2
1144092|NCT01390948|3757174|P2|Overall Study|Death|34
1144093|NCT01390948|3757175|P1|Overall Study|Death|30
1144094|NCT01390948|3757173|P3|Overall Study|Alive in follow-up|1
1144095|NCT01390948|3757174|P2|Overall Study|Alive in follow-up|17
1144096|NCT01390948|3757175|P1|Overall Study|Alive in follow-up|20
1144097|NCT01390857|3757241|P1|Overall Study|No Visit after the First Visit|7
1144098|NCT01390857|3757241|P1|Overall Study|Lost to Follow-up|1
1144099|NCT01390857|3757241|P1|Overall Study|Protocol Violation|2
1144100|NCT01390844|3757252|P4|Follow-Up Phase|Non-Medical Reasons|0
1144101|NCT01390844|3757253|P3|Follow-Up Phase|Non-Medical Reasons|1
1144102|NCT01390844|3757254|P2|Follow-Up Phase|Non-Medical Reasons|1
1144103|NCT01390844|3757255|P1|Follow-Up Phase|Non-Medical Reasons|1
1144104|NCT01390844|3757252|P4|Treatment Phase|Non-GCP Compliant|3
1144105|NCT01390844|3757253|P3|Treatment Phase|Non-GCP Compliant|10
1144106|NCT01390844|3757254|P2|Treatment Phase|Non-GCP Compliant|0
1144107|NCT01390844|3757255|P1|Treatment Phase|Non-GCP Compliant|0
1144108|NCT01390844|3757252|P4|Treatment Phase|Non-Medical Reasons|1
1144109|NCT01390844|3757253|P3|Treatment Phase|Non-Medical Reasons|8
1144110|NCT01390844|3757254|P2|Treatment Phase|Non-Medical Reasons|1
1144111|NCT01390844|3757255|P1|Treatment Phase|Non-Medical Reasons|5
1144112|NCT01390844|3757252|P4|Treatment Phase|Treatment Failure|13
1144113|NCT01390844|3757253|P3|Treatment Phase|Treatment Failure|10
1144114|NCT01390844|3757254|P2|Treatment Phase|Treatment Failure|25
1144115|NCT01390844|3757255|P1|Treatment Phase|Treatment Failure|23
1144116|NCT01390844|3757252|P4|Treatment Phase|Adverse Event|2
1144117|NCT01390844|3757253|P3|Treatment Phase|Adverse Event|3
1144118|NCT01390844|3757254|P2|Treatment Phase|Adverse Event|2
1144119|NCT01390844|3757255|P1|Treatment Phase|Adverse Event|12
1144120|NCT01390779|3757582|P1|Overall Study|Physician Decision|1
1144121|NCT01390649|3757587|P1|Overall Study|Physician Decision|1
1144122|NCT01390441|3757597|P5|Extension Period|Protocol Violation|0
1144123|NCT01390441|3757598|P4|Extension Period|Protocol Violation|1
1144124|NCT01390441|3757599|P3|Extension Period|Protocol Violation|0
1144125|NCT01390441|3757600|P2|Extension Period|Protocol Violation|1
1144126|NCT01390441|3757601|P1|Extension Period|Protocol Violation|3
1144127|NCT01390441|3757597|P5|Treatment Period|Lost to Follow-up|0
1144128|NCT01390441|3757598|P4|Treatment Period|Lost to Follow-up|0
1144129|NCT01390441|3757599|P3|Treatment Period|Lost to Follow-up|0
1144130|NCT01390441|3757600|P2|Treatment Period|Lost to Follow-up|0
1144131|NCT01390441|3757601|P1|Treatment Period|Lost to Follow-up|1
1144132|NCT01390441|3757597|P5|Treatment Period|Withdrawal by Subject|1
1144133|NCT01390441|3757598|P4|Treatment Period|Withdrawal by Subject|0
1144134|NCT01390441|3757599|P3|Treatment Period|Withdrawal by Subject|1
1144135|NCT01390441|3757600|P2|Treatment Period|Withdrawal by Subject|0
1144136|NCT01390441|3757601|P1|Treatment Period|Withdrawal by Subject|0
1144137|NCT01390441|3757597|P5|Treatment Period|Adverse Event|2
1144138|NCT01390441|3757598|P4|Treatment Period|Adverse Event|1
1144139|NCT01390441|3757599|P3|Treatment Period|Adverse Event|1
1144140|NCT01390441|3757600|P2|Treatment Period|Adverse Event|0
1144141|NCT01390441|3757601|P1|Treatment Period|Adverse Event|0
1144142|NCT01390441|3757597|P5|Treatment Period|Unknown due to early stopping of study|7
1144143|NCT01390441|3757598|P4|Treatment Period|Unknown due to early stopping of study|11
1144144|NCT01390441|3757599|P3|Treatment Period|Unknown due to early stopping of study|8
1144145|NCT01390441|3757600|P2|Treatment Period|Unknown due to early stopping of study|0
1144146|NCT01390441|3757601|P1|Treatment Period|Unknown due to early stopping of study|0
1144147|NCT01390441|3757597|P5|Treatment Period|Lack of Efficacy|1
1144148|NCT01390441|3757598|P4|Treatment Period|Lack of Efficacy|0
1144149|NCT01390441|3757599|P3|Treatment Period|Lack of Efficacy|0
1144150|NCT01390441|3757600|P2|Treatment Period|Lack of Efficacy|0
1144151|NCT01390441|3757601|P1|Treatment Period|Lack of Efficacy|0
1144152|NCT01390441|3757597|P5|Treatment Period|Physician Decision|0
1144153|NCT01390441|3757598|P4|Treatment Period|Physician Decision|1
1144154|NCT01390441|3757599|P3|Treatment Period|Physician Decision|0
1144155|NCT01390441|3757600|P2|Treatment Period|Physician Decision|0
1144156|NCT01390441|3757601|P1|Treatment Period|Physician Decision|0
1144157|NCT01390441|3757597|P5|Treatment Period|Protocol Violation|0
1144158|NCT01390441|3757598|P4|Treatment Period|Protocol Violation|0
1144159|NCT01390441|3757599|P3|Treatment Period|Protocol Violation|0
1144160|NCT01390441|3757600|P2|Treatment Period|Protocol Violation|1
1144161|NCT01390441|3757601|P1|Treatment Period|Protocol Violation|0
1144162|NCT01390428|3757666|P6|Overall Study|Withdrawal by Subject|0
1144163|NCT01390428|3757667|P5|Overall Study|Withdrawal by Subject|0
1144164|NCT01390428|3757668|P4|Overall Study|Withdrawal by Subject|0
1144165|NCT01390428|3757669|P3|Overall Study|Withdrawal by Subject|1
1144166|NCT01390428|3757670|P2|Overall Study|Withdrawal by Subject|0
1144167|NCT01390428|3757671|P1|Overall Study|Withdrawal by Subject|0
1144168|NCT01390428|3757666|P6|Overall Study|Elective Surgery|0
1144169|NCT01390428|3757667|P5|Overall Study|Elective Surgery|1
1144170|NCT01390428|3757668|P4|Overall Study|Elective Surgery|0
1144171|NCT01390428|3757669|P3|Overall Study|Elective Surgery|0
1144172|NCT01390428|3757670|P2|Overall Study|Elective Surgery|0
1144173|NCT01390428|3757671|P1|Overall Study|Elective Surgery|0
1144174|NCT01390402|3757734|P1|Overall Study|Disease Progression|4
1144175|NCT01390402|3757734|P1|Overall Study|Death|1
1144176|NCT01390389|3757740|P2|Overall Study|Screen Fail|1
1144177|NCT01390389|3757741|P1|Overall Study|Screen Fail|2
1144178|NCT01390389|3757740|P2|Overall Study|Withdrawal by Subject|0
1144179|NCT01390389|3757741|P1|Overall Study|Withdrawal by Subject|2
1144180|NCT01390181|3757789|P1|Overall Study|Study Terminated due to Low Accrual|3
1144181|NCT01390181|3757789|P1|Overall Study|Lost to Follow-up|1
1144182|NCT01390038|3757793|P1|Overall Study|Simpliciti System Removal|2
1144183|NCT01390038|3757793|P1|Overall Study|Withdrawal by Subject|4
1144184|NCT01390038|3757793|P1|Overall Study|Lost to Follow-up|1
1144185|NCT01390038|3757793|P1|Overall Study|Death|1
1144186|NCT01389973|3757803|P1|Overall Study|Other|10
1144187|NCT01389973|3757803|P1|Overall Study|Trial Stopped by Sponsor|9
1144188|NCT01389973|3757803|P1|Overall Study|Lost to Follow-up|1
1144189|NCT01389882|3757813|P2|Overall Study|Withdrawal by Subject|1
1144190|NCT01389882|3757814|P1|Overall Study|Withdrawal by Subject|0
1144191|NCT01389882|3757813|P2|Overall Study|Respiratory rate > 80/min during study|3
1144192|NCT01389882|3757814|P1|Overall Study|Respiratory rate > 80/min during study|1
1144193|NCT01389817|3757902|P2|Overall Study|Withdrawal by Subject|0
1144194|NCT01389817|3757903|P1|Overall Study|Withdrawal by Subject|2
1144195|NCT01389817|3757902|P2|Overall Study|Lost to Follow-up|0
1144196|NCT01389817|3757903|P1|Overall Study|Lost to Follow-up|1
1144197|NCT01389817|3757902|P2|Overall Study|Physician Decision|0
1144198|NCT01389817|3757903|P1|Overall Study|Physician Decision|1
1144199|NCT01389752|3757920|P2|Study Period 2|Sponsor decision|0
1144200|NCT01389752|3757921|P1|Study Period 2|Sponsor decision|1
1144201|NCT01389752|3757920|P2|Study Period 1|Sponsor decision|2
1144202|NCT01389752|3757921|P1|Study Period 1|Sponsor decision|0
1144203|NCT01389596|3757934|P3|Overall Study|Other Unspecified|0
1144204|NCT01389596|3757935|P2|Overall Study|Other Unspecified|1
1144205|NCT01389596|3757936|P1|Overall Study|Other Unspecified|2
1144206|NCT01389596|3757934|P3|Overall Study|Death|0
1144207|NCT01389596|3757935|P2|Overall Study|Death|1
1144208|NCT01389596|3757936|P1|Overall Study|Death|0
1144209|NCT01389596|3757934|P3|Overall Study|Adverse Event|0
1144210|NCT01389596|3757935|P2|Overall Study|Adverse Event|4
1144211|NCT01389596|3757936|P1|Overall Study|Adverse Event|1
1144212|NCT01389596|3757934|P3|Overall Study|Insufficient Clinical Response|5
1144213|NCT01389596|3757935|P2|Overall Study|Insufficient Clinical Response|4
1144214|NCT01389596|3757936|P1|Overall Study|Insufficient Clinical Response|3
1144215|NCT01389596|3757934|P3|Overall Study|Withdrawal by Subject|2
1144216|NCT01389596|3757935|P2|Overall Study|Withdrawal by Subject|2
1144217|NCT01389596|3757936|P1|Overall Study|Withdrawal by Subject|1
1144218|NCT01389596|3757934|P3|Overall Study|Protocol Violation|3
1144219|NCT01389596|3757935|P2|Overall Study|Protocol Violation|4
1144220|NCT01389596|3757936|P1|Overall Study|Protocol Violation|3
1144221|NCT01389323|3757995|P1|Follow-up Period (up to 48 Weeks)|Other|3
1144222|NCT01389323|3757995|P1|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2
1144223|NCT01389323|3757995|P1|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22
1144224|NCT01389323|3757995|P1|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10
1144225|NCT01389323|3757995|P1|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2
1144226|NCT01389323|3757995|P1|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5
1144227|NCT01389323|3757995|P1|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10
1144228|NCT01389323|3757995|P1|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7
1144229|NCT01389323|3757995|P1|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6
1144230|NCT01389323|3757995|P1|Treatment Period (up to 48 Weeks)|Adverse Event|24
1144231|NCT01389323|3757995|P1|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41
1144232|NCT01389102|3758058|P6|Overall Study|Investigator Judgement|0
1144233|NCT01389102|3758059|P5|Overall Study|Investigator Judgement|0
1144234|NCT01389102|3758060|P4|Overall Study|Investigator Judgement|0
1144235|NCT01389102|3758061|P3|Overall Study|Investigator Judgement|0
1144236|NCT01389102|3758062|P2|Overall Study|Investigator Judgement|1
1144237|NCT01389102|3758063|P1|Overall Study|Investigator Judgement|0
1144238|NCT01389102|3758058|P6|Overall Study|Unavailable due to husband's illness|0
1144239|NCT01389102|3758059|P5|Overall Study|Unavailable due to husband's illness|0
1144240|NCT01389102|3758060|P4|Overall Study|Unavailable due to husband's illness|0
1144241|NCT01389102|3758061|P3|Overall Study|Unavailable due to husband's illness|0
1144242|NCT01389102|3758062|P2|Overall Study|Unavailable due to husband's illness|1
1144243|NCT01389102|3758063|P1|Overall Study|Unavailable due to husband's illness|0
1144244|NCT01389102|3758058|P6|Overall Study|Subject Moved|0
1144245|NCT01389102|3758059|P5|Overall Study|Subject Moved|0
1144246|NCT01389102|3758060|P4|Overall Study|Subject Moved|0
1144247|NCT01389102|3758061|P3|Overall Study|Subject Moved|1
1144248|NCT01389102|3758062|P2|Overall Study|Subject Moved|0
1144249|NCT01389102|3758063|P1|Overall Study|Subject Moved|2
1144250|NCT01389102|3758058|P6|Overall Study|Subject Traveling Out of Country|0
1144251|NCT01389102|3758059|P5|Overall Study|Subject Traveling Out of Country|0
1144252|NCT01389102|3758060|P4|Overall Study|Subject Traveling Out of Country|1
1144253|NCT01389102|3758061|P3|Overall Study|Subject Traveling Out of Country|0
1144254|NCT01389102|3758062|P2|Overall Study|Subject Traveling Out of Country|0
1144255|NCT01389102|3758063|P1|Overall Study|Subject Traveling Out of Country|0
1144256|NCT01389102|3758058|P6|Overall Study|Withdrawal by Subject|3
1144257|NCT01389102|3758059|P5|Overall Study|Withdrawal by Subject|3
1144258|NCT01389102|3758060|P4|Overall Study|Withdrawal by Subject|2
1144259|NCT01389102|3758061|P3|Overall Study|Withdrawal by Subject|9
1144260|NCT01389102|3758062|P2|Overall Study|Withdrawal by Subject|4
1144261|NCT01389102|3758063|P1|Overall Study|Withdrawal by Subject|7
1144262|NCT01389102|3758058|P6|Overall Study|Protocol Violation|1
1144263|NCT01389102|3758059|P5|Overall Study|Protocol Violation|1
1144264|NCT01389102|3758060|P4|Overall Study|Protocol Violation|0
1144265|NCT01389102|3758061|P3|Overall Study|Protocol Violation|3
1144266|NCT01389102|3758062|P2|Overall Study|Protocol Violation|0
1144267|NCT01389102|3758063|P1|Overall Study|Protocol Violation|0
1144268|NCT01389102|3758058|P6|Overall Study|Lost to Follow-up|1
1144269|NCT01389102|3758059|P5|Overall Study|Lost to Follow-up|4
1144270|NCT01389102|3758060|P4|Overall Study|Lost to Follow-up|2
1144271|NCT01389102|3758061|P3|Overall Study|Lost to Follow-up|1
1144272|NCT01389102|3758062|P2|Overall Study|Lost to Follow-up|1
1144273|NCT01389102|3758063|P1|Overall Study|Lost to Follow-up|4
1144274|NCT01389102|3758058|P6|Overall Study|Hurricane Katrina|1
1144275|NCT01389102|3758059|P5|Overall Study|Hurricane Katrina|3
1144276|NCT01389102|3758060|P4|Overall Study|Hurricane Katrina|0
1144277|NCT01389102|3758061|P3|Overall Study|Hurricane Katrina|3
1144278|NCT01389102|3758062|P2|Overall Study|Hurricane Katrina|2
1144279|NCT01389102|3758063|P1|Overall Study|Hurricane Katrina|4
1144280|NCT01389102|3758058|P6|Overall Study|Adverse Event|2
1144281|NCT01389102|3758059|P5|Overall Study|Adverse Event|2
1144282|NCT01389102|3758060|P4|Overall Study|Adverse Event|2
1144283|NCT01389102|3758061|P3|Overall Study|Adverse Event|2
1144284|NCT01389102|3758062|P2|Overall Study|Adverse Event|3
1144285|NCT01389102|3758063|P1|Overall Study|Adverse Event|1
1144286|NCT01388907|3758141|P2|Overall Study|Adverse Event|0
1144287|NCT01388907|3758142|P1|Overall Study|Adverse Event|2
1144288|NCT01388816|3758158|P4|Overall Study|Protocol Violation|0
1144289|NCT01388816|3758159|P3|Overall Study|Protocol Violation|2
1144290|NCT01388816|3758160|P2|Overall Study|Protocol Violation|0
1144291|NCT01388816|3758161|P1|Overall Study|Protocol Violation|0
1144292|NCT01388816|3758158|P4|Overall Study|Withdrawal by Subject|0
1144293|NCT01388816|3758159|P3|Overall Study|Withdrawal by Subject|1
1144294|NCT01388816|3758160|P2|Overall Study|Withdrawal by Subject|1
1144295|NCT01388816|3758161|P1|Overall Study|Withdrawal by Subject|2
1144296|NCT01388816|3758158|P4|Overall Study|Lost to Follow-up|0
1144297|NCT01388816|3758159|P3|Overall Study|Lost to Follow-up|0
1144298|NCT01388816|3758160|P2|Overall Study|Lost to Follow-up|1
1144299|NCT01388816|3758161|P1|Overall Study|Lost to Follow-up|0
1144300|NCT01388816|3758158|P4|Overall Study|Adverse Event|0
1144301|NCT01388816|3758159|P3|Overall Study|Adverse Event|0
1144302|NCT01388816|3758160|P2|Overall Study|Adverse Event|2
1144303|NCT01388816|3758161|P1|Overall Study|Adverse Event|0
1144304|NCT01388790|3758190|P1|Overall Study|Ongoing at data cut−off date|8
1144305|NCT01388647|3758201|P2|Overall Study|Adverse Event|2
1144306|NCT01388647|3758202|P1|Overall Study|Adverse Event|1
1144307|NCT01388530|3758213|P1|Overall Study|Lost to Follow-up|5
1144308|NCT01388491|3758222|P2|Overall Study|Pregnancy|0
1144309|NCT01388491|3758223|P1|Overall Study|Pregnancy|1
1144310|NCT01388491|3758222|P2|Overall Study|Noncompliance|0
1144311|NCT01388491|3758223|P1|Overall Study|Noncompliance|2
1144312|NCT01388491|3758222|P2|Overall Study|Protocol Violation|0
1144313|NCT01388491|3758223|P1|Overall Study|Protocol Violation|2
1144314|NCT01388491|3758222|P2|Overall Study|Lost to Follow-up|3
1144315|NCT01388491|3758223|P1|Overall Study|Lost to Follow-up|4
1144316|NCT01388491|3758222|P2|Overall Study|Withdrawal by Subject|10
1144317|NCT01388491|3758223|P1|Overall Study|Withdrawal by Subject|6
1144318|NCT01388491|3758222|P2|Overall Study|Sponsor Request|7
1144319|NCT01388491|3758223|P1|Overall Study|Sponsor Request|9
1144320|NCT01388491|3758222|P2|Overall Study|Adverse Event|9
1144321|NCT01388491|3758223|P1|Overall Study|Adverse Event|10
1144322|NCT01388361|3758258|P3|Overall Study|Unclassified|1
1144323|NCT01388361|3758259|P2|Overall Study|Unclassified|0
1144324|NCT01388361|3758260|P1|Overall Study|Unclassified|0
1144325|NCT01388361|3758258|P3|Overall Study|Withdrawal criteria|10
1144326|NCT01388361|3758259|P2|Overall Study|Withdrawal criteria|7
1144327|NCT01388361|3758260|P1|Overall Study|Withdrawal criteria|12
1144328|NCT01388361|3758258|P3|Overall Study|Protocol Violation|2
1144329|NCT01388361|3758259|P2|Overall Study|Protocol Violation|0
1144330|NCT01388361|3758260|P1|Overall Study|Protocol Violation|0
1144331|NCT01388361|3758258|P3|Overall Study|Adverse Event|1
1144332|NCT01388361|3758259|P2|Overall Study|Adverse Event|5
1144333|NCT01388361|3758260|P1|Overall Study|Adverse Event|0
1144334|NCT01388166|3758277|P1|Overall Study|Others than specified above|13
1144335|NCT01388166|3758277|P1|Overall Study|Lost to Follow-up|30
1144336|NCT01388166|3758277|P1|Overall Study|Adverse Event|16
1144337|NCT01387789|3758283|P1|Overall Study|Lost to Follow-up|1
1144338|NCT01387789|3758283|P1|Overall Study|Lack of Efficacy|2
1144339|NCT01387789|3758283|P1|Overall Study|Adverse Event|5
1144340|NCT01387737|3758297|P2|Overall Study|Clearly not eligible for the study|3
1144341|NCT01387737|3758298|P1|Overall Study|Clearly not eligible for the study|1
1144342|NCT01387737|3758297|P2|Overall Study|Withdrawal by Subject|31
1144343|NCT01387737|3758298|P1|Overall Study|Withdrawal by Subject|27
1144344|NCT01387737|3758297|P2|Overall Study|Physician Decision|10
1144345|NCT01387737|3758298|P1|Overall Study|Physician Decision|3
1144346|NCT01387737|3758297|P2|Overall Study|Lack of Efficacy|0
1144347|NCT01387737|3758298|P1|Overall Study|Lack of Efficacy|1
1144348|NCT01387737|3758297|P2|Overall Study|Adverse Event|30
1144349|NCT01387737|3758298|P1|Overall Study|Adverse Event|20
1144350|NCT01387607|3758332|P2|Overall Study|Randomized, not treated|6
1144351|NCT01387607|3758333|P1|Overall Study|Randomized, not treated|3
1144352|NCT01387607|3758332|P2|Overall Study|Other|1
1144353|NCT01387607|3758333|P1|Overall Study|Other|1
1144354|NCT01387607|3758332|P2|Overall Study|Withdrawal by Subject|14
1144355|NCT01387607|3758333|P1|Overall Study|Withdrawal by Subject|13
1144356|NCT01387607|3758332|P2|Overall Study|Protocol Violation|5
1144357|NCT01387607|3758333|P1|Overall Study|Protocol Violation|1
1144358|NCT01387607|3758332|P2|Overall Study|No longer meets eligibility criteria|1
1144359|NCT01387607|3758333|P1|Overall Study|No longer meets eligibility criteria|0
1144360|NCT01387607|3758332|P2|Overall Study|Lost to Follow-up|1
1144361|NCT01387607|3758333|P1|Overall Study|Lost to Follow-up|2
1144362|NCT01387607|3758332|P2|Overall Study|Lack of Efficacy|6
1144363|NCT01387607|3758333|P1|Overall Study|Lack of Efficacy|8
1144364|NCT01387607|3758332|P2|Overall Study|Adverse Event|11
1144365|NCT01387607|3758333|P1|Overall Study|Adverse Event|23
1144366|NCT01387594|3758387|P2|Overall Study|Lost to Follow-up|1
1144367|NCT01387594|3758388|P1|Overall Study|Lost to Follow-up|0
1144368|NCT01387594|3758387|P2|Overall Study|Withdrawal by Subject|2
1144369|NCT01387594|3758388|P1|Overall Study|Withdrawal by Subject|0
1144370|NCT01387542|3758416|P1|Overall Study|Lost to Follow-up|1
1144371|NCT01387542|3758416|P1|Overall Study|Non-compliant|1
1144372|NCT01387542|3758416|P1|Overall Study|Insufficient response|1
1144373|NCT01387542|3758416|P1|Overall Study|Changed diagnosis|1
1144374|NCT01387542|3758416|P1|Overall Study|Withdrawal by Subject|1
1144375|NCT01387542|3758416|P1|Overall Study|Adverse Event|3
1144376|NCT01387347|3758434|P2|Overall Study|Lost to Follow-up|1
1144377|NCT01387347|3758435|P1|Overall Study|Lost to Follow-up|2
1144378|NCT01387282|3758447|P2|Overall Study|Lost to Follow-up|1
1144379|NCT01387282|3758448|P1|Overall Study|Lost to Follow-up|4
1144380|NCT01387282|3758447|P2|Overall Study|Study drug-related AE|2
1144381|NCT01387282|3758448|P1|Overall Study|Study drug-related AE|2
1144382|NCT01387282|3758447|P2|Overall Study|Withdrawal by patient|23
1144383|NCT01387282|3758448|P1|Overall Study|Withdrawal by patient|33
1144384|NCT01387282|3758447|P2|Overall Study|Unrelated AE|4
1144385|NCT01387282|3758448|P1|Overall Study|Unrelated AE|6
1144386|NCT01387282|3758447|P2|Overall Study|Other|1
1144387|NCT01387282|3758448|P1|Overall Study|Other|5
1144388|NCT01387282|3758447|P2|Overall Study|Death|16
1144389|NCT01387282|3758448|P1|Overall Study|Death|47
1144390|NCT01387269|3758464|P2|Overall Study|Lost to Follow-up|0
1144391|NCT01387269|3758465|P1|Overall Study|Lost to Follow-up|1
1144392|NCT01387269|3758464|P2|Overall Study|Study drug-related AE|0
1144393|NCT01387269|3758465|P1|Overall Study|Study drug-related AE|1
1144394|NCT01387269|3758464|P2|Overall Study|Withdrawal by patient|10
1144395|NCT01387269|3758465|P1|Overall Study|Withdrawal by patient|32
1144396|NCT01387269|3758464|P2|Overall Study|Unrelated AE|3
1144397|NCT01387269|3758465|P1|Overall Study|Unrelated AE|12
1144398|NCT01387269|3758464|P2|Overall Study|Other|7
1144399|NCT01387269|3758465|P1|Overall Study|Other|8
1144400|NCT01387269|3758464|P2|Overall Study|Death|20
1144401|NCT01387269|3758465|P1|Overall Study|Death|38
1144402|NCT01387230|3758482|P3|Overall Study|Withdrawal by Subject|0
1144403|NCT01387230|3758483|P2|Overall Study|Withdrawal by Subject|1
1144404|NCT01387230|3758484|P1|Overall Study|Withdrawal by Subject|4
1144405|NCT01387230|3758482|P3|Overall Study|Lost to Follow-up|1
1144406|NCT01387230|3758483|P2|Overall Study|Lost to Follow-up|0
1144407|NCT01387230|3758484|P1|Overall Study|Lost to Follow-up|0
1144408|NCT01387230|3758482|P3|Overall Study|Protocol-defined Stopping Criteria|5
1144409|NCT01387230|3758483|P2|Overall Study|Protocol-defined Stopping Criteria|0
1144410|NCT01387230|3758484|P1|Overall Study|Protocol-defined Stopping Criteria|6
1144411|NCT01387230|3758482|P3|Overall Study|Lack of Efficacy|4
1144412|NCT01387230|3758483|P2|Overall Study|Lack of Efficacy|5
1144413|NCT01387230|3758484|P1|Overall Study|Lack of Efficacy|8
1144414|NCT01387230|3758482|P3|Overall Study|Adverse Event|3
1144415|NCT01387230|3758483|P2|Overall Study|Adverse Event|1
1144416|NCT01387230|3758484|P1|Overall Study|Adverse Event|0
1144417|NCT01387074|3758530|P1|Overall Study|Lack of Efficacy|1
1144418|NCT01387074|3758530|P1|Overall Study|Lost to Follow-up|7
1144419|NCT01387022|3758543|P2|Overall Study|Lost to Follow-up|3
1144420|NCT01387022|3758544|P1|Overall Study|Lost to Follow-up|0
1144421|NCT01387022|3758543|P2|Overall Study|Death|1
1144422|NCT01387022|3758544|P1|Overall Study|Death|1
1144423|NCT01386944|3758571|P1|Overall Study|Unspecified reason|8
1144424|NCT01386944|3758571|P1|Overall Study|Lost to Follow-up|8
1144425|NCT01386944|3758571|P1|Overall Study|Lack of Efficacy|14
1144426|NCT01386944|3758571|P1|Overall Study|Adverse Event|26
1144427|NCT01386788|3758581|P1|Overall Study|Lost to Follow-up|2
1144428|NCT01386684|3758586|P1|Overall Study|Missing|3
1144429|NCT01386684|3758586|P1|Overall Study|Protocol Violation|4
1144430|NCT01386684|3758586|P1|Overall Study|Noncompliance|8
1144431|NCT01386684|3758586|P1|Overall Study|Adverse Event|20
1144432|NCT01386684|3758586|P1|Overall Study|Disease Progression|28
1144433|NCT01386684|3758586|P1|Overall Study|Alternative Therapy Required|37
1144434|NCT01386684|3758586|P1|Overall Study|Withdrawal of Consent|44
1144435|NCT01386684|3758586|P1|Overall Study|Death|47
1144436|NCT01386684|3758586|P1|Overall Study|Not Specified|51
1144437|NCT01386684|3758586|P1|Overall Study|Lost to Follow-up|51
1144438|NCT01386606|3758640|P4|Overall Study|T levels too high|0
1144439|NCT01386606|3758641|P3|Overall Study|T levels too high|1
1144440|NCT01386606|3758642|P2|Overall Study|T levels too high|1
1144441|NCT01386606|3758643|P1|Overall Study|T levels too high|0
1144442|NCT01386606|3758640|P4|Overall Study|Unable to draw PK|0
1144443|NCT01386606|3758641|P3|Overall Study|Unable to draw PK|0
1144444|NCT01386606|3758642|P2|Overall Study|Unable to draw PK|0
1144445|NCT01386606|3758643|P1|Overall Study|Unable to draw PK|1
1144446|NCT01386606|3758640|P4|Overall Study|Subject incarcerated|0
1144447|NCT01386606|3758641|P3|Overall Study|Subject incarcerated|0
1144448|NCT01386606|3758642|P2|Overall Study|Subject incarcerated|1
1144449|NCT01386606|3758643|P1|Overall Study|Subject incarcerated|0
1144450|NCT01386606|3758640|P4|Overall Study|Lost to Follow-up|0
1144451|NCT01386606|3758641|P3|Overall Study|Lost to Follow-up|0
1144452|NCT01386606|3758642|P2|Overall Study|Lost to Follow-up|0
1144453|NCT01386606|3758643|P1|Overall Study|Lost to Follow-up|2
1144454|NCT01386606|3758640|P4|Overall Study|Protocol Violation|1
1144455|NCT01386606|3758641|P3|Overall Study|Protocol Violation|1
1144456|NCT01386606|3758642|P2|Overall Study|Protocol Violation|0
1144457|NCT01386606|3758643|P1|Overall Study|Protocol Violation|1
1144458|NCT01386606|3758640|P4|Overall Study|Withdrawal by Subject|0
1144459|NCT01386606|3758641|P3|Overall Study|Withdrawal by Subject|1
1144460|NCT01386606|3758642|P2|Overall Study|Withdrawal by Subject|1
1144461|NCT01386606|3758643|P1|Overall Study|Withdrawal by Subject|0
1144462|NCT01386606|3758640|P4|Overall Study|Adverse Event|0
1144463|NCT01386606|3758641|P3|Overall Study|Adverse Event|0
1144464|NCT01386606|3758642|P2|Overall Study|Adverse Event|1
1144465|NCT01386606|3758643|P1|Overall Study|Adverse Event|0
1144466|NCT01386125|3758702|P2|Overall Study|Participant Leaving Country|0
1144467|NCT01386125|3758703|P1|Overall Study|Participant Leaving Country|1
1144468|NCT01386125|3758702|P2|Overall Study|Lack of Efficacy|1
1144469|NCT01386125|3758703|P1|Overall Study|Lack of Efficacy|0
1144470|NCT01386125|3758702|P2|Overall Study|Adverse Event|5
1144471|NCT01386125|3758703|P1|Overall Study|Adverse Event|2
1144472|NCT01386125|3758702|P2|Overall Study|Withdrawal by Subject|12
1144473|NCT01386125|3758703|P1|Overall Study|Withdrawal by Subject|13
1144474|NCT01386125|3758702|P2|Overall Study|Disease Progress|2
1144475|NCT01386125|3758703|P1|Overall Study|Disease Progress|1
1144476|NCT01386125|3758702|P2|Overall Study|Protocol Violation|7
1144477|NCT01386125|3758703|P1|Overall Study|Protocol Violation|5
1144478|NCT01386125|3758702|P2|Overall Study|Physician Decision|1
1144479|NCT01386125|3758703|P1|Overall Study|Physician Decision|0
1144480|NCT01386125|3758702|P2|Overall Study|Lost to Follow-up|9
1144481|NCT01386125|3758703|P1|Overall Study|Lost to Follow-up|3
1144482|NCT01386008|3758711|P1|Overall Study|Adverse Event|3
1144483|NCT01386008|3758711|P1|Overall Study|exited w/o incident /study discontinued|17
1144484|NCT01385995|3758720|P2|Period 1, 2 Months|Physician Decision|0
1144485|NCT01385995|3758721|P1|Period 1, 2 Months|Physician Decision|1
1144486|NCT01385748|3758738|P3|Overall Study|Adverse Event|1
1144487|NCT01385748|3758739|P2|Overall Study|Adverse Event|2
1144488|NCT01385748|3758740|P1|Overall Study|Adverse Event|4
1144489|NCT01385748|3758738|P3|Overall Study|Not specified|1
1144490|NCT01385748|3758739|P2|Overall Study|Not specified|7
1144491|NCT01385748|3758740|P1|Overall Study|Not specified|1
1144492|NCT01385748|3758738|P3|Overall Study|Noncompliance|6
1144493|NCT01385748|3758739|P2|Overall Study|Noncompliance|1
1144494|NCT01385748|3758740|P1|Overall Study|Noncompliance|3
1144495|NCT01385748|3758738|P3|Overall Study|Withdrawal by Subject|5
1144496|NCT01385748|3758739|P2|Overall Study|Withdrawal by Subject|4
1144497|NCT01385748|3758740|P1|Overall Study|Withdrawal by Subject|7
1144498|NCT01385566|3758825|P6|Overall Study|Withdrawal by Subject|0
1144499|NCT01385566|3758826|P5|Overall Study|Withdrawal by Subject|0
1144500|NCT01385566|3758827|P4|Overall Study|Withdrawal by Subject|1
1144501|NCT01385566|3758828|P3|Overall Study|Withdrawal by Subject|0
1144502|NCT01385566|3758829|P2|Overall Study|Withdrawal by Subject|0
1144503|NCT01385566|3758830|P1|Overall Study|Withdrawal by Subject|0
1144504|NCT01385566|3758825|P6|Overall Study|Lost to Follow-up|0
1144505|NCT01385566|3758826|P5|Overall Study|Lost to Follow-up|0
1144506|NCT01385566|3758827|P4|Overall Study|Lost to Follow-up|0
1144507|NCT01385566|3758828|P3|Overall Study|Lost to Follow-up|0
1144508|NCT01385566|3758829|P2|Overall Study|Lost to Follow-up|0
1144509|NCT01385566|3758830|P1|Overall Study|Lost to Follow-up|1
1144510|NCT01385371|3758884|P2|Overall Study|Administrative|2
1144511|NCT01385371|3758885|P1|Overall Study|Administrative|2
1144512|NCT01385371|3758884|P2|Overall Study|Protocol Violation|21
1144513|NCT01385371|3758885|P1|Overall Study|Protocol Violation|25
1144514|NCT01385371|3758884|P2|Overall Study|Withdrawal by Subject|39
1144515|NCT01385371|3758885|P1|Overall Study|Withdrawal by Subject|52
1144516|NCT01385371|3758884|P2|Overall Study|Lost to Follow-up|16
1144517|NCT01385371|3758885|P1|Overall Study|Lost to Follow-up|16
1144518|NCT01385371|3758884|P2|Overall Study|Adverse Event|19
1144519|NCT01385371|3758885|P1|Overall Study|Adverse Event|54
1144520|NCT01385202|3758933|P1|Overall Study|Withdrawn|1
1144521|NCT01385202|3758933|P1|Overall Study|Not Eligible|11
1144522|NCT01385202|3758933|P1|Overall Study|Lost to Follow-up|6
1144523|NCT01385098|3758985|P1|Overall Study|Lost to Follow-up|4
1144524|NCT01385098|3758985|P1|Overall Study|Adverse Event|10
1144525|NCT01384760|3759007|P2|Overall Study|Protocol Violation|0
1144526|NCT01384760|3759008|P1|Overall Study|Protocol Violation|16
1144527|NCT01384760|3759007|P2|Overall Study|Lost to Follow-up|6
1144528|NCT01384760|3759008|P1|Overall Study|Lost to Follow-up|0
1144529|NCT01384734|3759021|P5|Overall Study|Physician Decision|0
1144530|NCT01384734|3759022|P4|Overall Study|Physician Decision|0
1144531|NCT01384734|3759023|P3|Overall Study|Physician Decision|0
1144532|NCT01384734|3759024|P2|Overall Study|Physician Decision|0
1144533|NCT01384734|3759025|P1|Overall Study|Physician Decision|1
1144534|NCT01384734|3759021|P5|Overall Study|Early termination|1
1144535|NCT01384734|3759022|P4|Overall Study|Early termination|0
1144536|NCT01384734|3759023|P3|Overall Study|Early termination|0
1144537|NCT01384734|3759024|P2|Overall Study|Early termination|0
1144538|NCT01384734|3759025|P1|Overall Study|Early termination|0
1144539|NCT01384734|3759021|P5|Overall Study|Adhesion problem|0
1144540|NCT01384734|3759022|P4|Overall Study|Adhesion problem|1
1144541|NCT01384734|3759023|P3|Overall Study|Adhesion problem|0
1144542|NCT01384734|3759024|P2|Overall Study|Adhesion problem|0
1144543|NCT01384734|3759025|P1|Overall Study|Adhesion problem|0
1144544|NCT01384734|3759021|P5|Overall Study|Missed End of treatment visit|0
1144545|NCT01384734|3759022|P4|Overall Study|Missed End of treatment visit|1
1144546|NCT01384734|3759023|P3|Overall Study|Missed End of treatment visit|0
1144547|NCT01384734|3759024|P2|Overall Study|Missed End of treatment visit|0
1144548|NCT01384734|3759025|P1|Overall Study|Missed End of treatment visit|0
1144549|NCT01384734|3759021|P5|Overall Study|As per Exclusion criteria|0
1144550|NCT01384734|3759022|P4|Overall Study|As per Exclusion criteria|0
1144551|NCT01384734|3759023|P3|Overall Study|As per Exclusion criteria|0
1144552|NCT01384734|3759024|P2|Overall Study|As per Exclusion criteria|1
1144553|NCT01384734|3759025|P1|Overall Study|As per Exclusion criteria|0
1144554|NCT01384734|3759021|P5|Overall Study|Prison|0
1144555|NCT01384734|3759022|P4|Overall Study|Prison|0
1144556|NCT01384734|3759023|P3|Overall Study|Prison|1
1144557|NCT01384734|3759024|P2|Overall Study|Prison|0
1144558|NCT01384734|3759025|P1|Overall Study|Prison|0
1144559|NCT01384734|3759021|P5|Overall Study|Unable to come back for visit|0
1144560|NCT01384734|3759022|P4|Overall Study|Unable to come back for visit|1
1144561|NCT01384734|3759023|P3|Overall Study|Unable to come back for visit|1
1144562|NCT01384734|3759024|P2|Overall Study|Unable to come back for visit|0
1144563|NCT01384734|3759025|P1|Overall Study|Unable to come back for visit|1
1144564|NCT01384734|3759021|P5|Overall Study|Investigator relocating|1
1144565|NCT01384734|3759022|P4|Overall Study|Investigator relocating|3
1144566|NCT01384734|3759023|P3|Overall Study|Investigator relocating|0
1144567|NCT01384734|3759024|P2|Overall Study|Investigator relocating|2
1144568|NCT01384734|3759025|P1|Overall Study|Investigator relocating|0
1144569|NCT01384734|3759021|P5|Overall Study|Withdrawal by Subject|9
1144570|NCT01384734|3759022|P4|Overall Study|Withdrawal by Subject|7
1144571|NCT01384734|3759023|P3|Overall Study|Withdrawal by Subject|6
1144572|NCT01384734|3759024|P2|Overall Study|Withdrawal by Subject|5
1144573|NCT01384734|3759025|P1|Overall Study|Withdrawal by Subject|5
1144574|NCT01384734|3759021|P5|Overall Study|Sponsor terminated|1
1144575|NCT01384734|3759022|P4|Overall Study|Sponsor terminated|0
1144576|NCT01384734|3759023|P3|Overall Study|Sponsor terminated|0
1144577|NCT01384734|3759024|P2|Overall Study|Sponsor terminated|0
1144578|NCT01384734|3759025|P1|Overall Study|Sponsor terminated|0
1144579|NCT01384734|3759021|P5|Overall Study|Pregnancy|1
1144580|NCT01384734|3759022|P4|Overall Study|Pregnancy|0
1144581|NCT01384734|3759023|P3|Overall Study|Pregnancy|0
1144582|NCT01384734|3759024|P2|Overall Study|Pregnancy|1
1144583|NCT01384734|3759025|P1|Overall Study|Pregnancy|0
1144584|NCT01384734|3759021|P5|Overall Study|Non-compliance with study drug|2
1144585|NCT01384734|3759022|P4|Overall Study|Non-compliance with study drug|0
1144586|NCT01384734|3759023|P3|Overall Study|Non-compliance with study drug|6
1144587|NCT01384734|3759024|P2|Overall Study|Non-compliance with study drug|2
1144588|NCT01384734|3759025|P1|Overall Study|Non-compliance with study drug|1
1144589|NCT01384734|3759021|P5|Overall Study|Lost to Follow-up|5
1144590|NCT01384734|3759022|P4|Overall Study|Lost to Follow-up|8
1144591|NCT01384734|3759023|P3|Overall Study|Lost to Follow-up|3
1144592|NCT01384734|3759024|P2|Overall Study|Lost to Follow-up|3
1144593|NCT01384734|3759025|P1|Overall Study|Lost to Follow-up|5
1144594|NCT01384734|3759021|P5|Overall Study|Lack of Efficacy|2
1144595|NCT01384734|3759022|P4|Overall Study|Lack of Efficacy|4
1144596|NCT01384734|3759023|P3|Overall Study|Lack of Efficacy|4
1144597|NCT01384734|3759024|P2|Overall Study|Lack of Efficacy|7
1144598|NCT01384734|3759025|P1|Overall Study|Lack of Efficacy|3
1144599|NCT01384734|3759021|P5|Overall Study|Continuation criteria not met|0
1144600|NCT01384734|3759022|P4|Overall Study|Continuation criteria not met|1
1144601|NCT01384734|3759023|P3|Overall Study|Continuation criteria not met|1
1144602|NCT01384734|3759024|P2|Overall Study|Continuation criteria not met|0
1144603|NCT01384734|3759025|P1|Overall Study|Continuation criteria not met|0
1144604|NCT01384734|3759021|P5|Overall Study|Death|0
1144605|NCT01384734|3759022|P4|Overall Study|Death|0
1144606|NCT01384734|3759023|P3|Overall Study|Death|1
1144607|NCT01384734|3759024|P2|Overall Study|Death|0
1144608|NCT01384734|3759025|P1|Overall Study|Death|1
1144609|NCT01384734|3759021|P5|Overall Study|Adverse Event|7
1144610|NCT01384734|3759022|P4|Overall Study|Adverse Event|2
1144611|NCT01384734|3759023|P3|Overall Study|Adverse Event|0
1144612|NCT01384734|3759024|P2|Overall Study|Adverse Event|3
1144613|NCT01384734|3759025|P1|Overall Study|Adverse Event|0
1144614|NCT01384292|3759254|P3|Part B|Severe non-compliance to protocol|0
1144615|NCT01384292|3759255|P2|Part B|Severe non-compliance to protocol|0
1144616|NCT01384292|3759256|P1|Part B|Severe non-compliance to protocol|1
1144617|NCT01384019|3759268|P2|Overall Study|MRI refusal|6
1144618|NCT01384019|3759269|P1|Overall Study|MRI refusal|6
1144619|NCT01384019|3759268|P2|Overall Study|Death|0
1144620|NCT01384019|3759269|P1|Overall Study|Death|1
1144621|NCT01384019|3759268|P2|Overall Study|Withdrawal by Subject|0
1144622|NCT01384019|3759269|P1|Overall Study|Withdrawal by Subject|3
1144623|NCT01383993|3759278|P3|Overall Study|Marketed voriconazole in post-therapy|0
1144624|NCT01383993|3759279|P2|Overall Study|Marketed voriconazole in post-therapy|0
1144625|NCT01383993|3759280|P1|Overall Study|Marketed voriconazole in post-therapy|2
1144626|NCT01383993|3759278|P3|Overall Study|Withdrawal by Subject|1
1144627|NCT01383993|3759279|P2|Overall Study|Withdrawal by Subject|0
1144628|NCT01383993|3759280|P1|Overall Study|Withdrawal by Subject|0
1144629|NCT01383993|3759278|P3|Overall Study|Adverse Event|0
1144630|NCT01383993|3759279|P2|Overall Study|Adverse Event|1
1144631|NCT01383993|3759280|P1|Overall Study|Adverse Event|1
1144632|NCT01383954|3759327|P1|Overall Study|Reason Not Specified|9
1144633|NCT01383954|3759327|P1|Overall Study|Adverse Event|1
1144634|NCT01383954|3759327|P1|Overall Study|Electronic Diary Too Cumbersome to Use|2
1144635|NCT01383954|3759327|P1|Overall Study|Lack of Efficacy|2
1144636|NCT01383928|3759335|P3|Phase 2|Unsatisfactory therapeutic response|1
1144637|NCT01383928|3759336|P2|Phase 2|Unsatisfactory therapeutic response|0
1144638|NCT01383928|3759337|P1|Phase 2|Unsatisfactory therapeutic response|0
1144639|NCT01383928|3759335|P3|Phase 2|Withdrawal by Subject|4
1144640|NCT01383928|3759336|P2|Phase 2|Withdrawal by Subject|0
1144641|NCT01383928|3759337|P1|Phase 2|Withdrawal by Subject|0
1144642|NCT01383928|3759335|P3|Phase 2|Progressive Disease|5
1144643|NCT01383928|3759336|P2|Phase 2|Progressive Disease|0
1144644|NCT01383928|3759337|P1|Phase 2|Progressive Disease|0
1144645|NCT01383928|3759335|P3|Phase 2|Other|4
1144646|NCT01383928|3759336|P2|Phase 2|Other|0
1144647|NCT01383928|3759337|P1|Phase 2|Other|0
1144648|NCT01383928|3759335|P3|Phase 2|Adverse Event|8
1144649|NCT01383928|3759336|P2|Phase 2|Adverse Event|0
1144650|NCT01383928|3759337|P1|Phase 2|Adverse Event|0
1144651|NCT01383928|3759335|P3|Phase 2|Autologous Stem Cell Transplantation|18
1144652|NCT01383928|3759336|P2|Phase 2|Autologous Stem Cell Transplantation|0
1144653|NCT01383928|3759337|P1|Phase 2|Autologous Stem Cell Transplantation|0
1144654|NCT01383928|3759335|P3|Phase 1|Progressive Disease|0
1144655|NCT01383928|3759336|P2|Phase 1|Progressive Disease|1
1144656|NCT01383928|3759337|P1|Phase 1|Progressive Disease|1
1144657|NCT01383928|3759335|P3|Phase 1|Other|0
1144658|NCT01383928|3759336|P2|Phase 1|Other|3
1144659|NCT01383928|3759337|P1|Phase 1|Other|1
1144660|NCT01383928|3759335|P3|Phase 1|Adverse Event|0
1144661|NCT01383928|3759336|P2|Phase 1|Adverse Event|2
1144662|NCT01383928|3759337|P1|Phase 1|Adverse Event|1
1144663|NCT01383928|3759335|P3|Phase 1|Autologous Stem Cell Transplantation|0
1144664|NCT01383928|3759336|P2|Phase 1|Autologous Stem Cell Transplantation|1
1144665|NCT01383928|3759337|P1|Phase 1|Autologous Stem Cell Transplantation|2
1144666|NCT01383707|3759401|P1|Overall Study|Progressive disease|23
1144667|NCT01383707|3759401|P1|Overall Study|Adverse Event|14
1144668|NCT01383707|3759401|P1|Overall Study|Sponsor's decision|2
1144669|NCT01383707|3759401|P1|Overall Study|Not specified|8
1144670|NCT01383707|3759401|P1|Overall Study|Death|19
1144671|NCT01383707|3759401|P1|Overall Study|Consent withdrawal|6
1144672|NCT01383499|3759441|P4|Period 1 (4 Weeks)|Withdrawal by Subject|0
1144673|NCT01383499|3759442|P3|Period 1 (4 Weeks)|Withdrawal by Subject|0
1144674|NCT01383499|3759443|P2|Period 1 (4 Weeks)|Withdrawal by Subject|0
1144675|NCT01383499|3759444|P1|Period 1 (4 Weeks)|Withdrawal by Subject|1
1144676|NCT01383486|3759494|P1|Overall Study|Did not take any product|6
1144677|NCT01383486|3759494|P1|Overall Study|Incomplete information for analysis|2
1144678|NCT01383486|3759494|P1|Overall Study|Lost to Follow-up|10
1144679|NCT01383356|3759571|P2|Period 1|Personal|2
1144680|NCT01383356|3759572|P1|Period 1|Personal|0
1144681|NCT01383356|3759571|P2|Period 1|Out of Range Mid-study-Test|1
1144682|NCT01383356|3759572|P1|Period 1|Out of Range Mid-study-Test|0
1144683|NCT01383356|3759571|P2|Period 1|Non-compliance|0
1144684|NCT01383356|3759572|P1|Period 1|Non-compliance|3
1144685|NCT01383356|3759571|P2|Period 1|Adverse Event|3
1144686|NCT01383356|3759572|P1|Period 1|Adverse Event|5
1144687|NCT01383317|3759584|P2|Overall Study|Adverse Event|1
1144688|NCT01383317|3759585|P1|Overall Study|Adverse Event|0
1144689|NCT01383317|3759584|P2|Overall Study|Death|0
1144690|NCT01383317|3759585|P1|Overall Study|Death|1
1144691|NCT01383317|3759584|P2|Overall Study|Lost to Follow-up|1
1144692|NCT01383317|3759585|P1|Overall Study|Lost to Follow-up|2
1144693|NCT01383174|3759627|P2|6 Month Assessment|Refused to complete|0
1144694|NCT01383174|3759628|P1|6 Month Assessment|Refused to complete|4
1144695|NCT01383174|3759627|P2|6 Month Assessment|Lost to Follow-up|1
1144696|NCT01383174|3759628|P1|6 Month Assessment|Lost to Follow-up|1
1144697|NCT01383174|3759627|P2|3 Month Assessment|Refused to complete|0
1144698|NCT01383174|3759628|P1|3 Month Assessment|Refused to complete|4
1144699|NCT01383174|3759627|P2|3 Month Assessment|Lost to Follow-up|0
1144700|NCT01383174|3759628|P1|3 Month Assessment|Lost to Follow-up|2
1144701|NCT01383174|3759627|P2|3 Month Assessment|Death|1
1144702|NCT01383174|3759628|P1|3 Month Assessment|Death|0
1144703|NCT01383161|3759654|P2|Overall Study|Lack of Efficacy|1
1144704|NCT01383161|3759655|P1|Overall Study|Lack of Efficacy|0
1144705|NCT01383161|3759654|P2|Overall Study|Withdrawal by Subject|2
1144706|NCT01383161|3759655|P1|Overall Study|Withdrawal by Subject|0
1144707|NCT01383161|3759654|P2|Overall Study|Adverse Event|1
1144708|NCT01383161|3759655|P1|Overall Study|Adverse Event|5
1144709|NCT01383096|3759674|P3|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
1144710|NCT01383096|3759675|P2|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
1144711|NCT01383096|3759676|P1|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1
1144712|NCT01383096|3759674|P3|Fifth Intervention (8 Days)|Withdrawal by Subject|0
1144713|NCT01383096|3759675|P2|Fifth Intervention (8 Days)|Withdrawal by Subject|0
1144714|NCT01383096|3759676|P1|Fifth Intervention (8 Days)|Withdrawal by Subject|1
1144715|NCT01383096|3759674|P3|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
1144716|NCT01383096|3759675|P2|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
1144717|NCT01383096|3759676|P1|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1
1144718|NCT01383096|3759674|P3|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
1144719|NCT01383096|3759675|P2|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
1144720|NCT01383096|3759676|P1|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
1144721|NCT01383096|3759674|P3|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
1144722|NCT01383096|3759675|P2|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
1144723|NCT01383096|3759676|P1|Third Intervention (8 Days)|QTcF was greater than 450 msec|1
1144724|NCT01383096|3759674|P3|Third Intervention (8 Days)|Withdrawal by Subject|0
1144725|NCT01383096|3759675|P2|Third Intervention (8 Days)|Withdrawal by Subject|0
1144726|NCT01383096|3759676|P1|Third Intervention (8 Days)|Withdrawal by Subject|1
1144727|NCT01383096|3759674|P3|Third Intervention (8 Days)|Adverse Event|0
1144728|NCT01383096|3759675|P2|Third Intervention (8 Days)|Adverse Event|0
1144729|NCT01383096|3759676|P1|Third Intervention (8 Days)|Adverse Event|1
1144730|NCT01383096|3759674|P3|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
1144731|NCT01383096|3759675|P2|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3
1144732|NCT01383096|3759676|P1|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
1144733|NCT01383096|3759674|P3|Third Intervention (8 Days)|Elevated AST|0
1144734|NCT01383096|3759675|P2|Third Intervention (8 Days)|Elevated AST|1
1144735|NCT01383096|3759676|P1|Third Intervention (8 Days)|Elevated AST|0
1144736|NCT01383096|3759674|P3|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
1144737|NCT01383096|3759675|P2|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
1144738|NCT01383096|3759676|P1|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
1144739|NCT01383096|3759674|P3|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
1144740|NCT01383096|3759675|P2|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
1144741|NCT01383096|3759676|P1|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
1144742|NCT01382940|3759744|P1|Overall Study|Protocol Violation|20
1144743|NCT01382940|3759744|P1|Overall Study|Withdrawal by Subject|23
1144744|NCT01382940|3759744|P1|Overall Study|Physician Decision|7
1144745|NCT01382940|3759744|P1|Overall Study|Lost to Follow-up|4
1144746|NCT01382940|3759744|P1|Overall Study|Adverse Event|19
1144747|NCT01382602|3759806|P2|Overall Study|Withdrawal by Subject|1
1144748|NCT01382602|3759807|P1|Overall Study|Withdrawal by Subject|0
1144749|NCT01382602|3759806|P2|Overall Study|Protocol Violation|3
1144750|NCT01382602|3759807|P1|Overall Study|Protocol Violation|0
1144751|NCT01382446|3759815|P2|Overall Study|Removal from Mechanical Ventilation|3
1144752|NCT01382446|3759816|P1|Overall Study|Removal from Mechanical Ventilation|3
1144753|NCT01382446|3759815|P2|Overall Study|Withdrawal by Subject|1
1144754|NCT01382446|3759816|P1|Overall Study|Withdrawal by Subject|0
1144755|NCT01382251|3759843|P2|Overall Study|Contacted after study closed|1
1144756|NCT01382251|3759844|P1|Overall Study|Contacted after study closed|1
1144757|NCT01382251|3759843|P2|Overall Study|Lost to Follow-up|4
1144758|NCT01382251|3759844|P1|Overall Study|Lost to Follow-up|4
1144759|NCT01382251|3759843|P2|Overall Study|Surgeries cancelled or delayed|16
1144760|NCT01382251|3759844|P1|Overall Study|Surgeries cancelled or delayed|16
1144761|NCT01382225|3759857|P2|Overall Study|Other|2
1144762|NCT01382225|3759858|P1|Overall Study|Other|4
1144763|NCT01382225|3759857|P2|Overall Study|Subject Withdrew Consent|2
1144764|NCT01382225|3759858|P1|Overall Study|Subject Withdrew Consent|5
1144765|NCT01382225|3759857|P2|Overall Study|Protocol Violation|1
1144766|NCT01382225|3759858|P1|Overall Study|Protocol Violation|2
1144767|NCT01382225|3759857|P2|Overall Study|Adverse Event|2
1144768|NCT01382225|3759858|P1|Overall Study|Adverse Event|3
1144769|NCT01382212|3759880|P1|Overall Study|Withdrew consent|1
1144770|NCT01382212|3759880|P1|Overall Study|Kidney transplant|1
1144771|NCT01381926|3759943|P2|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1
1144772|NCT01381926|3759944|P1|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0
1144773|NCT01381926|3759943|P2|Low/High Dose of 1st Treatment (2months)|Adverse Event|0
1144774|NCT01381926|3759944|P1|Low/High Dose of 1st Treatment (2months)|Adverse Event|2
1144775|NCT01381900|3759957|P3|Overall Study|Early withdraw|1
1144776|NCT01381900|3759958|P2|Overall Study|Early withdraw|1
1144777|NCT01381900|3759959|P1|Overall Study|Early withdraw|3
1144778|NCT01381900|3759957|P3|Overall Study|Withdrawal by Subject|1
1144779|NCT01381900|3759958|P2|Overall Study|Withdrawal by Subject|0
1144780|NCT01381900|3759959|P1|Overall Study|Withdrawal by Subject|0
1144781|NCT01381900|3759957|P3|Overall Study|Protocol Violation|1
1144782|NCT01381900|3759958|P2|Overall Study|Protocol Violation|1
1144783|NCT01381900|3759959|P1|Overall Study|Protocol Violation|0
1144784|NCT01381900|3759957|P3|Overall Study|Physician Decision|1
1144785|NCT01381900|3759958|P2|Overall Study|Physician Decision|1
1144786|NCT01381900|3759959|P1|Overall Study|Physician Decision|0
1144787|NCT01381900|3759957|P3|Overall Study|Noncompliance with study drug|1
1144788|NCT01381900|3759958|P2|Overall Study|Noncompliance with study drug|0
1144789|NCT01381900|3759959|P1|Overall Study|Noncompliance with study drug|0
1144790|NCT01381900|3759957|P3|Overall Study|Adverse Event|7
1144791|NCT01381900|3759958|P2|Overall Study|Adverse Event|6
1144792|NCT01381900|3759959|P1|Overall Study|Adverse Event|4
1144793|NCT01381900|3759957|P3|Overall Study|Subject meets glycemic withdrawal crit.|0
1144794|NCT01381900|3759958|P2|Overall Study|Subject meets glycemic withdrawal crit.|0
1144795|NCT01381900|3759959|P1|Overall Study|Subject meets glycemic withdrawal crit.|2
1144796|NCT01381874|3759982|P3|Overall Study|Other|67
1144797|NCT01381874|3759983|P2|Overall Study|Other|52
1144798|NCT01381874|3759984|P1|Overall Study|Other|67
1144799|NCT01381874|3759982|P3|Overall Study|Withdrawal by Subject|9
1144800|NCT01381874|3759983|P2|Overall Study|Withdrawal by Subject|10
1144801|NCT01381874|3759984|P1|Overall Study|Withdrawal by Subject|9
1144802|NCT01381874|3759982|P3|Overall Study|Lost to Follow-up|0
1144803|NCT01381874|3759983|P2|Overall Study|Lost to Follow-up|1
1144804|NCT01381874|3759984|P1|Overall Study|Lost to Follow-up|1
1144805|NCT01381679|3760010|P1|Overall Study|Lost to Follow-up|885
1144806|NCT01381679|3760010|P1|Overall Study|Adverse Event|3
1144807|NCT01381575|3760025|P3|Overall Study|Withdrawal by Subject|4
1144808|NCT01381575|3760026|P2|Overall Study|Withdrawal by Subject|0
1144809|NCT01381575|3760027|P1|Overall Study|Withdrawal by Subject|0
1144810|NCT01381575|3760025|P3|Overall Study|Protocol Violation|1
1144811|NCT01381575|3760026|P2|Overall Study|Protocol Violation|0
1144812|NCT01381575|3760027|P1|Overall Study|Protocol Violation|0
1144813|NCT01381575|3760025|P3|Overall Study|Lost to Follow-up|1
1144814|NCT01381575|3760026|P2|Overall Study|Lost to Follow-up|0
1144815|NCT01381575|3760027|P1|Overall Study|Lost to Follow-up|0
1144816|NCT01381575|3760025|P3|Overall Study|Adverse Event|1
1144817|NCT01381575|3760026|P2|Overall Study|Adverse Event|0
1144818|NCT01381575|3760027|P1|Overall Study|Adverse Event|0
1144819|NCT01381575|3760025|P3|Overall Study|Other|0
1144820|NCT01381575|3760026|P2|Overall Study|Other|10
1144821|NCT01381575|3760027|P1|Overall Study|Other|2
1144822|NCT01381562|3760084|P3|Overall Study|Adverse Event|0
1144823|NCT01381562|3760085|P2|Overall Study|Adverse Event|1
1144824|NCT01381562|3760086|P1|Overall Study|Adverse Event|0
1144825|NCT01381549|3760154|P3|Overall Study|Ineligible: No organisms isolated|1
1144826|NCT01381549|3760155|P2|Overall Study|Ineligible: No organisms isolated|0
1144827|NCT01381549|3760156|P1|Overall Study|Ineligible: No organisms isolated|0
1144828|NCT01381016|3760282|P2|Overall Study|Physician Decision|2
1144829|NCT01381016|3760283|P1|Overall Study|Physician Decision|0
1144830|NCT01381016|3760282|P2|Overall Study|Withdrawal by Subject|1
1144831|NCT01381016|3760283|P1|Overall Study|Withdrawal by Subject|0
1144832|NCT01381016|3760282|P2|Overall Study|Screen Failure|2
1144833|NCT01381016|3760283|P1|Overall Study|Screen Failure|2
1144834|NCT01381016|3760282|P2|Overall Study|Lost to Follow-up|1
1144835|NCT01381016|3760283|P1|Overall Study|Lost to Follow-up|1
1144836|NCT01380834|3760293|P2|Overall Study|Physician Decision|0
1144837|NCT01380834|3760294|P1|Overall Study|Physician Decision|1
1144838|NCT01380782|3760306|P4|Overall Study|Withdrawal by Subject|1
1144839|NCT01380782|3760307|P3|Overall Study|Withdrawal by Subject|1
1144840|NCT01380782|3760308|P2|Overall Study|Withdrawal by Subject|0
1144841|NCT01380782|3760309|P1|Overall Study|Withdrawal by Subject|0
1144842|NCT01380782|3760306|P4|Overall Study|Physician Decision|0
1144843|NCT01380782|3760307|P3|Overall Study|Physician Decision|0
1144844|NCT01380782|3760308|P2|Overall Study|Physician Decision|0
1144845|NCT01380782|3760309|P1|Overall Study|Physician Decision|1
1144846|NCT01380782|3760306|P4|Overall Study|Lack of Efficacy|3
1144847|NCT01380782|3760307|P3|Overall Study|Lack of Efficacy|10
1144848|NCT01380782|3760308|P2|Overall Study|Lack of Efficacy|9
1144849|NCT01380782|3760309|P1|Overall Study|Lack of Efficacy|10
1144850|NCT01380782|3760306|P4|Overall Study|Death|0
1144851|NCT01380782|3760307|P3|Overall Study|Death|0
1144852|NCT01380782|3760308|P2|Overall Study|Death|0
1144853|NCT01380782|3760309|P1|Overall Study|Death|1
1144854|NCT01380782|3760306|P4|Overall Study|Adverse Event|0
1144855|NCT01380782|3760307|P3|Overall Study|Adverse Event|0
1144856|NCT01380782|3760308|P2|Overall Study|Adverse Event|1
1144857|NCT01380782|3760309|P1|Overall Study|Adverse Event|0
1144858|NCT01380769|3760332|P2|Overall Study|Protocol Violation|1
1144859|NCT01380769|3760333|P1|Overall Study|Protocol Violation|0
1144860|NCT01380769|3760332|P2|Overall Study|Adverse Event|1
1144861|NCT01380769|3760333|P1|Overall Study|Adverse Event|1
1144862|NCT01380769|3760332|P2|Overall Study|Physician Decision|1
1144863|NCT01380769|3760333|P1|Overall Study|Physician Decision|1
1144864|NCT01380769|3760332|P2|Overall Study|Withdrawal by Subject|11
1144865|NCT01380769|3760333|P1|Overall Study|Withdrawal by Subject|7
1144866|NCT01380730|3760394|P8|Overall Study|Death|0
1144867|NCT01380730|3760395|P7|Overall Study|Death|0
1144868|NCT01380730|3760396|P6|Overall Study|Death|0
1144869|NCT01380730|3760397|P5|Overall Study|Death|1
1144870|NCT01380730|3760398|P4|Overall Study|Death|0
1144871|NCT01380730|3760399|P3|Overall Study|Death|0
1144872|NCT01380730|3760400|P2|Overall Study|Death|0
1144873|NCT01380730|3760401|P1|Overall Study|Death|0
1144874|NCT01380379|3760468|P1|Overall Study|Pregnancy|1
1144875|NCT01380327|3760481|P3|Overall Study|Questionable onset of epilepsy|1
1144876|NCT01380327|3760482|P2|Overall Study|Questionable onset of epilepsy|0
1144877|NCT01380327|3760483|P1|Overall Study|Questionable onset of epilepsy|0
1144878|NCT01380327|3760481|P3|Overall Study|Housing situation precluded ability to k|1
1144879|NCT01380327|3760482|P2|Overall Study|Housing situation precluded ability to k|0
1144880|NCT01380327|3760483|P1|Overall Study|Housing situation precluded ability to k|0
1144881|NCT01380327|3760481|P3|Overall Study|Withdrawal by Subject|1
1144882|NCT01380327|3760482|P2|Overall Study|Withdrawal by Subject|0
1144883|NCT01380327|3760483|P1|Overall Study|Withdrawal by Subject|0
1144884|NCT01380327|3760481|P3|Overall Study|Protocol Violation|3
1144885|NCT01380327|3760482|P2|Overall Study|Protocol Violation|2
1144886|NCT01380327|3760483|P1|Overall Study|Protocol Violation|3
1144887|NCT01380327|3760481|P3|Overall Study|Lost to Follow-up|1
1144888|NCT01380327|3760482|P2|Overall Study|Lost to Follow-up|1
1144889|NCT01380327|3760483|P1|Overall Study|Lost to Follow-up|0
1144890|NCT01380145|3760514|P1|Overall Study|Progressive disease|4
1144891|NCT01380093|3760522|P9|Treatment Phase: Third Intervention|Other|1
1144892|NCT01380093|3760523|P8|Treatment Phase: Third Intervention|Other|0
1144893|NCT01380093|3760524|P7|Treatment Phase: Third Intervention|Other|0
1144894|NCT01380093|3760525|P6|Treatment Phase: Third Intervention|Other|0
1144895|NCT01380093|3760526|P5|Treatment Phase: Third Intervention|Other|0
1144896|NCT01380093|3760527|P4|Treatment Phase: Third Intervention|Other|0
1144897|NCT01380093|3760528|P3|Treatment Phase: Third Intervention|Other|0
1144898|NCT01380093|3760529|P2|Treatment Phase: Third Intervention|Other|0
1144899|NCT01380093|3760530|P1|Treatment Phase: Third Intervention|Other|0
1144900|NCT01380093|3760522|P9|Treatment Phase: Third Intervention|Non-compliance|1
1144901|NCT01380093|3760523|P8|Treatment Phase: Third Intervention|Non-compliance|0
1144902|NCT01380093|3760524|P7|Treatment Phase: Third Intervention|Non-compliance|0
1144903|NCT01380093|3760525|P6|Treatment Phase: Third Intervention|Non-compliance|0
1144904|NCT01380093|3760526|P5|Treatment Phase: Third Intervention|Non-compliance|0
1144905|NCT01380093|3760527|P4|Treatment Phase: Third Intervention|Non-compliance|0
1144906|NCT01380093|3760528|P3|Treatment Phase: Third Intervention|Non-compliance|0
1144907|NCT01380093|3760529|P2|Treatment Phase: Third Intervention|Non-compliance|0
1144908|NCT01380093|3760530|P1|Treatment Phase: Third Intervention|Non-compliance|0
1144909|NCT01380093|3760522|P9|Treatment Phase: Second Intervention|Other|0
1144910|NCT01380093|3760523|P8|Treatment Phase: Second Intervention|Other|0
1144911|NCT01380093|3760524|P7|Treatment Phase: Second Intervention|Other|0
1144912|NCT01380093|3760525|P6|Treatment Phase: Second Intervention|Other|0
1144913|NCT01380093|3760526|P5|Treatment Phase: Second Intervention|Other|0
1144914|NCT01380093|3760527|P4|Treatment Phase: Second Intervention|Other|1
1144915|NCT01380093|3760528|P3|Treatment Phase: Second Intervention|Other|0
1144916|NCT01380093|3760529|P2|Treatment Phase: Second Intervention|Other|0
1144917|NCT01380093|3760530|P1|Treatment Phase: Second Intervention|Other|0
1144918|NCT01380093|3760522|P9|Drug Discrimination Phase: Day 2|Sponsor decision|0
1144919|NCT01380093|3760523|P8|Drug Discrimination Phase: Day 2|Sponsor decision|0
1144920|NCT01380093|3760524|P7|Drug Discrimination Phase: Day 2|Sponsor decision|0
1144921|NCT01380093|3760525|P6|Drug Discrimination Phase: Day 2|Sponsor decision|0
1144922|NCT01380093|3760526|P5|Drug Discrimination Phase: Day 2|Sponsor decision|0
1144923|NCT01380093|3760527|P4|Drug Discrimination Phase: Day 2|Sponsor decision|0
1144924|NCT01380093|3760528|P3|Drug Discrimination Phase: Day 2|Sponsor decision|1
1144925|NCT01380093|3760529|P2|Drug Discrimination Phase: Day 2|Sponsor decision|0
1144926|NCT01380093|3760530|P1|Drug Discrimination Phase: Day 2|Sponsor decision|0
1144927|NCT01380093|3760522|P9|Drug Discrimination Phase: Day 2|Backup participant|0
1144928|NCT01380093|3760523|P8|Drug Discrimination Phase: Day 2|Backup participant|0
1144929|NCT01380093|3760524|P7|Drug Discrimination Phase: Day 2|Backup participant|0
1144930|NCT01380093|3760525|P6|Drug Discrimination Phase: Day 2|Backup participant|0
1144931|NCT01380093|3760526|P5|Drug Discrimination Phase: Day 2|Backup participant|0
1144932|NCT01380093|3760527|P4|Drug Discrimination Phase: Day 2|Backup participant|0
1144933|NCT01380093|3760528|P3|Drug Discrimination Phase: Day 2|Backup participant|1
1144934|NCT01380093|3760529|P2|Drug Discrimination Phase: Day 2|Backup participant|0
1144935|NCT01380093|3760530|P1|Drug Discrimination Phase: Day 2|Backup participant|0
1144936|NCT01380093|3760522|P9|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
1144937|NCT01380093|3760523|P8|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
1144938|NCT01380093|3760524|P7|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
1144939|NCT01380093|3760525|P6|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
1144940|NCT01380093|3760526|P5|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
1144941|NCT01380093|3760527|P4|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
1144942|NCT01380093|3760528|P3|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
1144943|NCT01380093|3760529|P2|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
1144944|NCT01380093|3760530|P1|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
1144945|NCT01380093|3760522|P9|Drug Discrimination Phase: Day 2|Discrimination failure|0
1144946|NCT01380093|3760523|P8|Drug Discrimination Phase: Day 2|Discrimination failure|0
1144947|NCT01380093|3760524|P7|Drug Discrimination Phase: Day 2|Discrimination failure|0
1144948|NCT01380093|3760525|P6|Drug Discrimination Phase: Day 2|Discrimination failure|0
1144949|NCT01380093|3760526|P5|Drug Discrimination Phase: Day 2|Discrimination failure|0
1144950|NCT01380093|3760527|P4|Drug Discrimination Phase: Day 2|Discrimination failure|0
1144951|NCT01380093|3760528|P3|Drug Discrimination Phase: Day 2|Discrimination failure|9
1144952|NCT01380093|3760529|P2|Drug Discrimination Phase: Day 2|Discrimination failure|4
1144953|NCT01380093|3760530|P1|Drug Discrimination Phase: Day 2|Discrimination failure|0
1144954|NCT01380093|3760522|P9|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
1144955|NCT01380093|3760523|P8|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
1144956|NCT01380093|3760524|P7|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
1144957|NCT01380093|3760525|P6|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
1144958|NCT01380093|3760526|P5|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
1144959|NCT01380093|3760527|P4|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
1144960|NCT01380093|3760528|P3|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
1144961|NCT01380093|3760529|P2|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1
1144962|NCT01380093|3760530|P1|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
1144963|NCT01380093|3760522|P9|Drug Discrimination Phase: Day 2|Physician Decision|0
1144964|NCT01380093|3760523|P8|Drug Discrimination Phase: Day 2|Physician Decision|0
1144965|NCT01380093|3760524|P7|Drug Discrimination Phase: Day 2|Physician Decision|0
1144966|NCT01380093|3760525|P6|Drug Discrimination Phase: Day 2|Physician Decision|0
1144967|NCT01380093|3760526|P5|Drug Discrimination Phase: Day 2|Physician Decision|0
1144968|NCT01380093|3760527|P4|Drug Discrimination Phase: Day 2|Physician Decision|0
1144969|NCT01380093|3760528|P3|Drug Discrimination Phase: Day 2|Physician Decision|1
1144970|NCT01380093|3760529|P2|Drug Discrimination Phase: Day 2|Physician Decision|3
1144971|NCT01380093|3760530|P1|Drug Discrimination Phase: Day 2|Physician Decision|0
1144972|NCT01380093|3760522|P9|Drug Discrimination Phase: Day 1|Discrimination failure|0
1144973|NCT01380093|3760523|P8|Drug Discrimination Phase: Day 1|Discrimination failure|0
1144974|NCT01380093|3760524|P7|Drug Discrimination Phase: Day 1|Discrimination failure|0
1144975|NCT01380093|3760525|P6|Drug Discrimination Phase: Day 1|Discrimination failure|0
1144976|NCT01380093|3760526|P5|Drug Discrimination Phase: Day 1|Discrimination failure|0
1144977|NCT01380093|3760527|P4|Drug Discrimination Phase: Day 1|Discrimination failure|0
1144978|NCT01380093|3760528|P3|Drug Discrimination Phase: Day 1|Discrimination failure|0
1144979|NCT01380093|3760529|P2|Drug Discrimination Phase: Day 1|Discrimination failure|1
1144980|NCT01380093|3760530|P1|Drug Discrimination Phase: Day 1|Discrimination failure|0
1144981|NCT01380093|3760522|P9|Naloxone Challenge Phase|Screen failures|0
1144982|NCT01380093|3760523|P8|Naloxone Challenge Phase|Screen failures|0
1144983|NCT01380093|3760524|P7|Naloxone Challenge Phase|Screen failures|0
1144984|NCT01380093|3760525|P6|Naloxone Challenge Phase|Screen failures|0
1144985|NCT01380093|3760526|P5|Naloxone Challenge Phase|Screen failures|0
1144986|NCT01380093|3760527|P4|Naloxone Challenge Phase|Screen failures|0
1144987|NCT01380093|3760528|P3|Naloxone Challenge Phase|Screen failures|0
1144988|NCT01380093|3760529|P2|Naloxone Challenge Phase|Screen failures|0
1144989|NCT01380093|3760530|P1|Naloxone Challenge Phase|Screen failures|21
1144990|NCT01380080|3760822|P2|Overall Study|Lost to Follow-up|0
1144991|NCT01380080|3760823|P1|Overall Study|Lost to Follow-up|2
1144992|NCT01380080|3760822|P2|Overall Study|Not willing to adhere to requirements|1
1144993|NCT01380080|3760823|P1|Overall Study|Not willing to adhere to requirements|3
1144994|NCT01380080|3760822|P2|Overall Study|Not able to get to clinic|0
1144995|NCT01380080|3760823|P1|Overall Study|Not able to get to clinic|4
1144996|NCT01380080|3760822|P2|Overall Study|Withdrawal by Subject|0
1144997|NCT01380080|3760823|P1|Overall Study|Withdrawal by Subject|4
1144998|NCT01380080|3760822|P2|Overall Study|Death|22
1144999|NCT01380080|3760823|P1|Overall Study|Death|20
1145000|NCT01379937|3760848|P4|Overall Study|Lost to Follow-up|0
1145001|NCT01379937|3760849|P3|Overall Study|Lost to Follow-up|2
1145002|NCT01379937|3760850|P2|Overall Study|Lost to Follow-up|2
1145003|NCT01379937|3760851|P1|Overall Study|Lost to Follow-up|1
1145004|NCT01379937|3760848|P4|Overall Study|Consent withdrawal|0
1145005|NCT01379937|3760849|P3|Overall Study|Consent withdrawal|0
1145006|NCT01379937|3760850|P2|Overall Study|Consent withdrawal|1
1145007|NCT01379937|3760851|P1|Overall Study|Consent withdrawal|0
1145008|NCT01379937|3760848|P4|Overall Study|Protocol Violation|1
1145009|NCT01379937|3760849|P3|Overall Study|Protocol Violation|0
1145010|NCT01379937|3760850|P2|Overall Study|Protocol Violation|0
1145011|NCT01379937|3760851|P1|Overall Study|Protocol Violation|0
1145012|NCT01379781|3760933|P2|Overall Study|Lost to Follow-up|8
1145013|NCT01379781|3760934|P1|Overall Study|Lost to Follow-up|11
1145014|NCT01379768|3760943|P3|Overall Study|Lost to Follow-up|0
1145015|NCT01379768|3760944|P2|Overall Study|Lost to Follow-up|0
1145016|NCT01379768|3760945|P1|Overall Study|Lost to Follow-up|2
1145017|NCT01379768|3760943|P3|Overall Study|Adverse Event|0
1145018|NCT01379768|3760944|P2|Overall Study|Adverse Event|1
1145019|NCT01379768|3760945|P1|Overall Study|Adverse Event|1
1145020|NCT01379703|3760968|P3|9 Months Through 18 Months|Reason Unknown|0
1145021|NCT01379703|3760969|P2|9 Months Through 18 Months|Reason Unknown|23
1145022|NCT01379703|3760970|P1|9 Months Through 18 Months|Reason Unknown|0
1145023|NCT01379703|3760968|P3|9 Months Through 18 Months|Fatigue|0
1145024|NCT01379703|3760969|P2|9 Months Through 18 Months|Fatigue|1
1145025|NCT01379703|3760970|P1|9 Months Through 18 Months|Fatigue|0
1145026|NCT01379703|3760968|P3|9 Months Through 18 Months|Tuberculosis/TB treatment|0
1145027|NCT01379703|3760969|P2|9 Months Through 18 Months|Tuberculosis/TB treatment|2
1145028|NCT01379703|3760970|P1|9 Months Through 18 Months|Tuberculosis/TB treatment|0
1145029|NCT01379703|3760968|P3|9 Months Through 18 Months|Patient Noncompliance|0
1145030|NCT01379703|3760969|P2|9 Months Through 18 Months|Patient Noncompliance|4
1145031|NCT01379703|3760970|P1|9 Months Through 18 Months|Patient Noncompliance|0
1145032|NCT01379703|3760968|P3|9 Months Through 18 Months|Treatment failure|0
1145033|NCT01379703|3760969|P2|9 Months Through 18 Months|Treatment failure|5
1145034|NCT01379703|3760970|P1|9 Months Through 18 Months|Treatment failure|0
1145035|NCT01379703|3760968|P3|9 Months Through 18 Months|Adverse Event|0
1145036|NCT01379703|3760969|P2|9 Months Through 18 Months|Adverse Event|6
1145037|NCT01379703|3760970|P1|9 Months Through 18 Months|Adverse Event|0
1145038|NCT01379703|3760968|P3|9 Months Through 18 Months|Withdrawal by Subject|0
1145039|NCT01379703|3760969|P2|9 Months Through 18 Months|Withdrawal by Subject|11
1145040|NCT01379703|3760970|P1|9 Months Through 18 Months|Withdrawal by Subject|0
1145041|NCT01379703|3760968|P3|9 Months Through 18 Months|Lost to Follow-up|0
1145042|NCT01379703|3760969|P2|9 Months Through 18 Months|Lost to Follow-up|178
1145043|NCT01379703|3760970|P1|9 Months Through 18 Months|Lost to Follow-up|0
1145044|NCT01379703|3760968|P3|Study Start Through 9 Months|Reason unknown|24
1145045|NCT01379703|3760969|P2|Study Start Through 9 Months|Reason unknown|31
1145046|NCT01379703|3760970|P1|Study Start Through 9 Months|Reason unknown|2
1145047|NCT01379703|3760968|P3|Study Start Through 9 Months|Increased triglycerides|0
1145048|NCT01379703|3760969|P2|Study Start Through 9 Months|Increased triglycerides|1
1145049|NCT01379703|3760970|P1|Study Start Through 9 Months|Increased triglycerides|0
1145050|NCT01379703|3760968|P3|Study Start Through 9 Months|Poor general condition|0
1145051|NCT01379703|3760969|P2|Study Start Through 9 Months|Poor general condition|1
1145052|NCT01379703|3760970|P1|Study Start Through 9 Months|Poor general condition|0
1145053|NCT01379703|3760968|P3|Study Start Through 9 Months|Medication not available|1
1145054|NCT01379703|3760969|P2|Study Start Through 9 Months|Medication not available|2
1145055|NCT01379703|3760970|P1|Study Start Through 9 Months|Medication not available|0
1145056|NCT01379703|3760968|P3|Study Start Through 9 Months|Tuberculosis/TB treatment|0
1145057|NCT01379703|3760969|P2|Study Start Through 9 Months|Tuberculosis/TB treatment|4
1145058|NCT01379703|3760970|P1|Study Start Through 9 Months|Tuberculosis/TB treatment|0
1145059|NCT01379703|3760968|P3|Study Start Through 9 Months|Patient Noncompliance|1
1145060|NCT01379703|3760969|P2|Study Start Through 9 Months|Patient Noncompliance|0
1145061|NCT01379703|3760970|P1|Study Start Through 9 Months|Patient Noncompliance|0
1145062|NCT01379703|3760968|P3|Study Start Through 9 Months|Treatment Failure|2
1145063|NCT01379703|3760969|P2|Study Start Through 9 Months|Treatment Failure|2
1145064|NCT01379703|3760970|P1|Study Start Through 9 Months|Treatment Failure|0
1145065|NCT01379703|3760968|P3|Study Start Through 9 Months|Withdrawal by Subject|1
1145066|NCT01379703|3760969|P2|Study Start Through 9 Months|Withdrawal by Subject|6
1145067|NCT01379703|3760970|P1|Study Start Through 9 Months|Withdrawal by Subject|0
1145068|NCT01379703|3760968|P3|Study Start Through 9 Months|Adverse Event|10
1145069|NCT01379703|3760969|P2|Study Start Through 9 Months|Adverse Event|14
1145070|NCT01379703|3760970|P1|Study Start Through 9 Months|Adverse Event|0
1145071|NCT01379703|3760968|P3|Study Start Through 9 Months|Lost to Follow-up|104
1145072|NCT01379703|3760969|P2|Study Start Through 9 Months|Lost to Follow-up|61
1145073|NCT01379703|3760970|P1|Study Start Through 9 Months|Lost to Follow-up|2
1145074|NCT01379534|3761070|P2|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0
1145075|NCT01379534|3761071|P1|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1
1145076|NCT01379534|3761070|P2|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1
1145077|NCT01379534|3761071|P1|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0
1145078|NCT01379534|3761070|P2|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0
1145079|NCT01379534|3761071|P1|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3
1145080|NCT01379534|3761070|P2|Tumor Assessment Follow-up (f/u) Phase|Death|1
1145081|NCT01379534|3761071|P1|Tumor Assessment Follow-up (f/u) Phase|Death|0
1145082|NCT01379534|3761070|P2|Treatment Phase|Adverse Event|7
1145083|NCT01379534|3761071|P1|Treatment Phase|Adverse Event|7
1145084|NCT01379534|3761070|P2|Treatment Phase|Progressive disease|22
1145085|NCT01379534|3761071|P1|Treatment Phase|Progressive disease|13
1145086|NCT01379534|3761070|P2|Treatment Phase|Withdrawal by Subject|2
1145087|NCT01379534|3761071|P1|Treatment Phase|Withdrawal by Subject|2
1145088|NCT01379521|3761091|P2|Post-Treatment Evaluations|Death|0
1145089|NCT01379521|3761092|P1|Post-Treatment Evaluations|Death|1
1145090|NCT01379521|3761091|P2|Post-Treatment Evaluations|Withdrawal by Subject|1
1145091|NCT01379521|3761092|P1|Post-Treatment Evaluations|Withdrawal by Subject|2
1145092|NCT01379521|3761091|P2|Post-Treatment Evaluations|Disease Progression|20
1145093|NCT01379521|3761092|P1|Post-Treatment Evaluations|Disease Progression|22
1145094|NCT01379521|3761091|P2|Overall Study -Treatment Period|Death|1
1145095|NCT01379521|3761092|P1|Overall Study -Treatment Period|Death|2
1145096|NCT01379521|3761091|P2|Overall Study -Treatment Period|Administrative Problems|0
1145097|NCT01379521|3761092|P1|Overall Study -Treatment Period|Administrative Problems|1
1145098|NCT01379521|3761091|P2|Overall Study -Treatment Period|Withdrawal by Subject|0
1145099|NCT01379521|3761092|P1|Overall Study -Treatment Period|Withdrawal by Subject|3
1145100|NCT01379521|3761091|P2|Overall Study -Treatment Period|Protocol Deviation|2
1145101|NCT01379521|3761092|P1|Overall Study -Treatment Period|Protocol Deviation|0
1145102|NCT01379521|3761091|P2|Overall Study -Treatment Period|New Cancer Therapy|0
1145103|NCT01379521|3761092|P1|Overall Study -Treatment Period|New Cancer Therapy|1
1145104|NCT01379521|3761091|P2|Overall Study -Treatment Period|Disease Progression|22
1145105|NCT01379521|3761092|P1|Overall Study -Treatment Period|Disease Progression|23
1145106|NCT01379521|3761091|P2|Overall Study -Treatment Period|Abnormal test procedure results|1
1145107|NCT01379521|3761092|P1|Overall Study -Treatment Period|Abnormal test procedure results|0
1145108|NCT01379521|3761091|P2|Overall Study -Treatment Period|Adverse Event|0
1145109|NCT01379521|3761092|P1|Overall Study -Treatment Period|Adverse Event|3
1145110|NCT01379508|3761114|P4|Extension Period Weeks 109-156|Protocol Violation|0
1145111|NCT01379508|3761115|P3|Extension Period Weeks 109-156|Protocol Violation|0
1145112|NCT01379508|3761116|P2|Extension Period Weeks 109-156|Protocol Violation|1
1145113|NCT01379508|3761117|P1|Extension Period Weeks 109-156|Protocol Violation|2
1145114|NCT01379508|3761114|P4|Extension Period Weeks 109-156|Administrative problems|0
1145115|NCT01379508|3761115|P3|Extension Period Weeks 109-156|Administrative problems|1
1145116|NCT01379508|3761116|P2|Extension Period Weeks 109-156|Administrative problems|0
1145117|NCT01379508|3761117|P1|Extension Period Weeks 109-156|Administrative problems|3
1145118|NCT01379508|3761114|P4|Extension Period Weeks 109-156|Lost to Follow-up|0
1145119|NCT01379508|3761115|P3|Extension Period Weeks 109-156|Lost to Follow-up|5
1145120|NCT01379508|3761116|P2|Extension Period Weeks 109-156|Lost to Follow-up|1
1145121|NCT01379508|3761117|P1|Extension Period Weeks 109-156|Lost to Follow-up|6
1145122|NCT01379508|3761114|P4|Extension Period Weeks 109-156|Withdrawal by Subject|0
1145123|NCT01379508|3761115|P3|Extension Period Weeks 109-156|Withdrawal by Subject|8
1145124|NCT01379508|3761116|P2|Extension Period Weeks 109-156|Withdrawal by Subject|1
1145125|NCT01379508|3761117|P1|Extension Period Weeks 109-156|Withdrawal by Subject|8
1145126|NCT01379508|3761114|P4|Treatment to Week 104|Protocol Violation|0
1145127|NCT01379508|3761115|P3|Treatment to Week 104|Protocol Violation|1
1145128|NCT01379508|3761116|P2|Treatment to Week 104|Protocol Violation|1
1145129|NCT01379508|3761117|P1|Treatment to Week 104|Protocol Violation|1
1145130|NCT01379508|3761114|P4|Treatment to Week 104|Administrative problems|0
1145131|NCT01379508|3761115|P3|Treatment to Week 104|Administrative problems|0
1145132|NCT01379508|3761116|P2|Treatment to Week 104|Administrative problems|1
1145133|NCT01379508|3761117|P1|Treatment to Week 104|Administrative problems|3
1145134|NCT01379508|3761114|P4|Treatment to Week 104|Lost to Follow-up|0
1145135|NCT01379508|3761115|P3|Treatment to Week 104|Lost to Follow-up|3
1145136|NCT01379508|3761116|P2|Treatment to Week 104|Lost to Follow-up|0
1145137|NCT01379508|3761117|P1|Treatment to Week 104|Lost to Follow-up|5
1145138|NCT01379508|3761114|P4|Treatment to Week 104|Withdrawal by Subject|0
1145139|NCT01379508|3761115|P3|Treatment to Week 104|Withdrawal by Subject|4
1145140|NCT01379508|3761116|P2|Treatment to Week 104|Withdrawal by Subject|1
1145141|NCT01379508|3761117|P1|Treatment to Week 104|Withdrawal by Subject|6
1145142|NCT01379508|3761114|P4|Treatment to Week 104|Abnormal test procedure result(s)|0
1145143|NCT01379508|3761115|P3|Treatment to Week 104|Abnormal test procedure result(s)|0
1145144|NCT01379508|3761116|P2|Treatment to Week 104|Abnormal test procedure result(s)|0
1145145|NCT01379508|3761117|P1|Treatment to Week 104|Abnormal test procedure result(s)|1
1145146|NCT01379508|3761114|P4|Treatment to Week 104|Abnormal lab value|0
1145147|NCT01379508|3761115|P3|Treatment to Week 104|Abnormal lab value|0
1145148|NCT01379508|3761116|P2|Treatment to Week 104|Abnormal lab value|0
1145149|NCT01379508|3761117|P1|Treatment to Week 104|Abnormal lab value|1
1145150|NCT01379508|3761114|P4|Treatment to Week 104|Adverse Event|0
1145151|NCT01379508|3761115|P3|Treatment to Week 104|Adverse Event|5
1145152|NCT01379508|3761116|P2|Treatment to Week 104|Adverse Event|0
1145153|NCT01379508|3761117|P1|Treatment to Week 104|Adverse Event|2
1145154|NCT01378975|3761195|P2|Overall Study|Withdrew Consent|3
1145155|NCT01378975|3761196|P1|Overall Study|Withdrew Consent|4
1145156|NCT01378975|3761195|P2|Overall Study|Lost to Follow-up|1
1145157|NCT01378975|3761196|P1|Overall Study|Lost to Follow-up|4
1145158|NCT01378975|3761195|P2|Overall Study|Investigator Request|0
1145159|NCT01378975|3761196|P1|Overall Study|Investigator Request|1
1145160|NCT01378975|3761195|P2|Overall Study|Death|46
1145161|NCT01378975|3761196|P1|Overall Study|Death|77
1145162|NCT01378962|3761222|P1|Overall Study|Other|2
1145163|NCT01378962|3761222|P1|Overall Study|Lost to Follow-up|1
1145164|NCT01378962|3761222|P1|Overall Study|Death|14
1145165|NCT01378429|3761248|P2|Overall Study|Noncompliance with study drug|0
1145166|NCT01378429|3761249|P1|Overall Study|Noncompliance with study drug|1
1145167|NCT01378325|3761362|P2|Overall Study|Protocol Violation|1
1145168|NCT01378325|3761363|P1|Overall Study|Protocol Violation|0
1145169|NCT01378195|3761380|P2|Overall Study|Lost to Follow-up|18
1145170|NCT01378195|3761381|P1|Overall Study|Lost to Follow-up|29
1145171|NCT01378117|3761394|P3|Overall Study|discharged before med given|1
1145172|NCT01378117|3761395|P2|Overall Study|discharged before med given|0
1145173|NCT01378117|3761396|P1|Overall Study|discharged before med given|2
1145174|NCT01378117|3761394|P3|Overall Study|withdrawal|2
1145175|NCT01378117|3761395|P2|Overall Study|withdrawal|1
1145176|NCT01378117|3761396|P1|Overall Study|withdrawal|2
1145177|NCT01378104|3761430|P2|Overall Study|Withdrawal by Subject|13
1145178|NCT01378104|3761431|P1|Overall Study|Withdrawal by Subject|12
1145179|NCT01378104|3761430|P2|Overall Study|Lack of Efficacy|5
1145180|NCT01378104|3761431|P1|Overall Study|Lack of Efficacy|7
1145181|NCT01378104|3761430|P2|Overall Study|Adverse Event|8
1145182|NCT01378104|3761431|P1|Overall Study|Adverse Event|8
1145183|NCT01377987|3761476|P2|Washout (7 Days)|Withdrawal by Subject|1
1145184|NCT01377987|3761477|P1|Washout (7 Days)|Withdrawal by Subject|1
1145185|NCT01377922|3761495|P2|Overall Study|rescue tx after part 2, entered part 4|0
1145186|NCT01377922|3761496|P1|Overall Study|rescue tx after part 2, entered part 4|1
1145187|NCT01377480|3761581|P4|Overall Study|Not specified|6
1145188|NCT01377480|3761582|P3|Overall Study|Not specified|7
1145189|NCT01377480|3761583|P2|Overall Study|Not specified|0
1145190|NCT01377480|3761584|P1|Overall Study|Not specified|0
1145191|NCT01377480|3761581|P4|Overall Study|Serious adverse event|1
1145192|NCT01377480|3761582|P3|Overall Study|Serious adverse event|1
1145193|NCT01377480|3761583|P2|Overall Study|Serious adverse event|0
1145194|NCT01377480|3761584|P1|Overall Study|Serious adverse event|0
1145195|NCT01377480|3761581|P4|Overall Study|Withdrawal by Subject|0
1145196|NCT01377480|3761582|P3|Overall Study|Withdrawal by Subject|1
1145197|NCT01377480|3761583|P2|Overall Study|Withdrawal by Subject|0
1145198|NCT01377480|3761584|P1|Overall Study|Withdrawal by Subject|0
1145199|NCT01377480|3761581|P4|Overall Study|Evidence of drug-induced hepatotoxicity|0
1145200|NCT01377480|3761582|P3|Overall Study|Evidence of drug-induced hepatotoxicity|1
1145201|NCT01377480|3761583|P2|Overall Study|Evidence of drug-induced hepatotoxicity|1
1145202|NCT01377480|3761584|P1|Overall Study|Evidence of drug-induced hepatotoxicity|0
1145203|NCT01377480|3761581|P4|Overall Study|Protocol Violation|4
1145204|NCT01377480|3761582|P3|Overall Study|Protocol Violation|0
1145205|NCT01377480|3761583|P2|Overall Study|Protocol Violation|0
1145206|NCT01377480|3761584|P1|Overall Study|Protocol Violation|0
1145207|NCT01377233|3761665|P5|Double-blind|Administrative or other|1
1145208|NCT01377233|3761666|P4|Double-blind|Administrative or other|1
1145209|NCT01377233|3761667|P3|Double-blind|Administrative or other|0
1145210|NCT01377233|3761668|P2|Double-blind|Administrative or other|0
1145211|NCT01377233|3761669|P1|Double-blind|Administrative or other|0
1145212|NCT01377233|3761665|P5|Double-blind|Withdrawal by Subject|0
1145213|NCT01377233|3761666|P4|Double-blind|Withdrawal by Subject|1
1145214|NCT01377233|3761667|P3|Double-blind|Withdrawal by Subject|0
1145215|NCT01377233|3761668|P2|Double-blind|Withdrawal by Subject|0
1145216|NCT01377233|3761669|P1|Double-blind|Withdrawal by Subject|0
1145217|NCT01377233|3761665|P5|Double-blind|Protocol Violation|1
1145218|NCT01377233|3761666|P4|Double-blind|Protocol Violation|0
1145219|NCT01377233|3761667|P3|Double-blind|Protocol Violation|0
1145220|NCT01377233|3761668|P2|Double-blind|Protocol Violation|0
1145221|NCT01377233|3761669|P1|Double-blind|Protocol Violation|0
1145222|NCT01377233|3761665|P5|Double-blind|Adverse Event|0
1145223|NCT01377233|3761666|P4|Double-blind|Adverse Event|2
1145224|NCT01377233|3761667|P3|Double-blind|Adverse Event|2
1145225|NCT01377233|3761668|P2|Double-blind|Adverse Event|1
1145226|NCT01377233|3761669|P1|Double-blind|Adverse Event|0
1145227|NCT01377233|3761665|P5|Open-label|Withdrawal by Subject|0
1145228|NCT01377233|3761666|P4|Open-label|Withdrawal by Subject|0
1145229|NCT01377233|3761667|P3|Open-label|Withdrawal by Subject|0
1145230|NCT01377233|3761668|P2|Open-label|Withdrawal by Subject|0
1145231|NCT01377233|3761669|P1|Open-label|Withdrawal by Subject|3
1145232|NCT01377233|3761665|P5|Open-label|Adverse Event|0
1145233|NCT01377233|3761666|P4|Open-label|Adverse Event|0
1145234|NCT01377233|3761667|P3|Open-label|Adverse Event|0
1145235|NCT01377233|3761668|P2|Open-label|Adverse Event|0
1145236|NCT01377233|3761669|P1|Open-label|Adverse Event|1
1145237|NCT01377194|3761696|P3|Overall Study|Lost to Follow-up|11
1145238|NCT01377194|3761697|P2|Overall Study|Lost to Follow-up|8
1145239|NCT01377194|3761698|P1|Overall Study|Lost to Follow-up|14
1145240|NCT01377194|3761696|P3|Overall Study|Withdrawal by Subject|7
1145241|NCT01377194|3761697|P2|Overall Study|Withdrawal by Subject|10
1145242|NCT01377194|3761698|P1|Overall Study|Withdrawal by Subject|8
1145243|NCT01377194|3761696|P3|Overall Study|Protocol Violation|6
1145244|NCT01377194|3761697|P2|Overall Study|Protocol Violation|10
1145245|NCT01377194|3761698|P1|Overall Study|Protocol Violation|4
1145246|NCT01377194|3761696|P3|Overall Study|Lack of Efficacy|3
1145247|NCT01377194|3761697|P2|Overall Study|Lack of Efficacy|3
1145248|NCT01377194|3761698|P1|Overall Study|Lack of Efficacy|3
1145249|NCT01377194|3761696|P3|Overall Study|Adverse Event|19
1145250|NCT01377194|3761697|P2|Overall Study|Adverse Event|12
1145251|NCT01377194|3761698|P1|Overall Study|Adverse Event|3
1145252|NCT01377012|3761712|P3|Extension Study, Weeks 104-260|Adverse Event|1
1145253|NCT01377012|3761713|P2|Extension Study, Weeks 104-260|Adverse Event|2
1145254|NCT01377012|3761714|P1|Extension Study, Weeks 104-260|Adverse Event|0
1145255|NCT01377012|3761712|P3|Extension Study, Weeks 104-260|Lost to Follow-up|1
1145256|NCT01377012|3761713|P2|Extension Study, Weeks 104-260|Lost to Follow-up|0
1145257|NCT01377012|3761714|P1|Extension Study, Weeks 104-260|Lost to Follow-up|0
1145258|NCT01377012|3761712|P3|Extension Study, Weeks 104-260|Physician Decision|0
1145259|NCT01377012|3761713|P2|Extension Study, Weeks 104-260|Physician Decision|0
1145260|NCT01377012|3761714|P1|Extension Study, Weeks 104-260|Physician Decision|1
1145261|NCT01377012|3761712|P3|Extension Study, Weeks 104-260|Withdrawal by Subject|3
1145262|NCT01377012|3761713|P2|Extension Study, Weeks 104-260|Withdrawal by Subject|0
1145263|NCT01377012|3761714|P1|Extension Study, Weeks 104-260|Withdrawal by Subject|1
1145264|NCT01377012|3761712|P3|Extension Study, Weeks 104-260|Study terminated by sponsor|63
1145265|NCT01377012|3761713|P2|Extension Study, Weeks 104-260|Study terminated by sponsor|69
1145266|NCT01377012|3761714|P1|Extension Study, Weeks 104-260|Study terminated by sponsor|52
1145267|NCT01377012|3761712|P3|Extension Study, Weeks 104-260|Lack of Efficacy|0
1145268|NCT01377012|3761713|P2|Extension Study, Weeks 104-260|Lack of Efficacy|0
1145269|NCT01377012|3761714|P1|Extension Study, Weeks 104-260|Lack of Efficacy|3
1145270|NCT01377012|3761712|P3|Core Study|Adverse Event|13
1145271|NCT01377012|3761713|P2|Core Study|Adverse Event|14
1145272|NCT01377012|3761714|P1|Core Study|Adverse Event|10
1145273|NCT01377012|3761712|P3|Core Study|Death|1
1145274|NCT01377012|3761713|P2|Core Study|Death|1
1145275|NCT01377012|3761714|P1|Core Study|Death|1
1145276|NCT01377012|3761712|P3|Core Study|Lack of Efficacy|37
1145277|NCT01377012|3761713|P2|Core Study|Lack of Efficacy|28
1145278|NCT01377012|3761714|P1|Core Study|Lack of Efficacy|41
1145279|NCT01377012|3761712|P3|Core Study|Lost to Follow-up|4
1145280|NCT01377012|3761713|P2|Core Study|Lost to Follow-up|5
1145281|NCT01377012|3761714|P1|Core Study|Lost to Follow-up|7
1145282|NCT01377012|3761712|P3|Core Study|No Longer require treatment|1
1145283|NCT01377012|3761713|P2|Core Study|No Longer require treatment|0
1145284|NCT01377012|3761714|P1|Core Study|No Longer require treatment|0
1145285|NCT01377012|3761712|P3|Core Study|Non-Compliant with study treatment|1
1145286|NCT01377012|3761713|P2|Core Study|Non-Compliant with study treatment|0
1145287|NCT01377012|3761714|P1|Core Study|Non-Compliant with study treatment|0
1145288|NCT01377012|3761712|P3|Core Study|Physician Decision|10
1145289|NCT01377012|3761713|P2|Core Study|Physician Decision|4
1145290|NCT01377012|3761714|P1|Core Study|Physician Decision|5
1145291|NCT01377012|3761712|P3|Core Study|Pregnancy|1
1145292|NCT01377012|3761713|P2|Core Study|Pregnancy|0
1145293|NCT01377012|3761714|P1|Core Study|Pregnancy|0
1145294|NCT01377012|3761712|P3|Core Study|Protocol Violation|2
1145295|NCT01377012|3761713|P2|Core Study|Protocol Violation|3
1145296|NCT01377012|3761714|P1|Core Study|Protocol Violation|7
1145297|NCT01377012|3761712|P3|Core Study|Withdrawal by Subject|18
1145298|NCT01377012|3761713|P2|Core Study|Withdrawal by Subject|23
1145299|NCT01377012|3761714|P1|Core Study|Withdrawal by Subject|15
1145300|NCT01377012|3761712|P3|Core Study|Technical problems|0
1145301|NCT01377012|3761713|P2|Core Study|Technical problems|0
1145302|NCT01377012|3761714|P1|Core Study|Technical problems|1
1145303|NCT01377012|3761712|P3|Core Study|Study terminated by Sponsor|46
1145304|NCT01377012|3761713|P2|Core Study|Study terminated by Sponsor|54
1145305|NCT01377012|3761714|P1|Core Study|Study terminated by Sponsor|47
1145306|NCT01376908|3761751|P2|Overall Study|Withdrawal by Subject|2
1145307|NCT01376908|3761752|P1|Overall Study|Withdrawal by Subject|1
1145308|NCT01376908|3761751|P2|Overall Study|Protocol Violation|1
1145309|NCT01376908|3761752|P1|Overall Study|Protocol Violation|1
1145310|NCT01376804|3761785|P1|Treatment Period|Patient did not receive study drug|1
1145311|NCT01376804|3761785|P1|Treatment Period|Adverse Event|6
1145312|NCT01376804|3761785|P1|Treatment Period|Withdrawal by Subject|1
1145313|NCT01376700|3761796|P1|Overall Study|Low or high titer inhibitor|8
1145314|NCT01376700|3761796|P1|Overall Study|Sponsor terminated study early|8
1145315|NCT01376388|3761858|P1|Overall Study|Withdrawal by Subject|3
1145316|NCT01376388|3761858|P1|Overall Study|Lack of Efficacy|2
1145317|NCT01376388|3761858|P1|Overall Study|Adverse Event|13
1145318|NCT01376349|3761896|P3|Raondomized Treatment|Alternative Treatment|1
1145319|NCT01376349|3761897|P2|Raondomized Treatment|Alternative Treatment|0
1145320|NCT01376349|3761898|P1|Raondomized Treatment|Alternative Treatment|0
1145321|NCT01376349|3761896|P3|Raondomized Treatment|Unkown|1
1145322|NCT01376349|3761897|P2|Raondomized Treatment|Unkown|2
1145323|NCT01376349|3761898|P1|Raondomized Treatment|Unkown|1
1145324|NCT01376349|3761896|P3|Raondomized Treatment|Adverse Event|14
1145325|NCT01376349|3761897|P2|Raondomized Treatment|Adverse Event|17
1145326|NCT01376349|3761898|P1|Raondomized Treatment|Adverse Event|13
1145327|NCT01376349|3761896|P3|Raondomized Treatment|Withdrawal by Subject|13
1145328|NCT01376349|3761897|P2|Raondomized Treatment|Withdrawal by Subject|16
1145329|NCT01376349|3761898|P1|Raondomized Treatment|Withdrawal by Subject|10
1145330|NCT01376323|3761912|P5|Overall Study|Withdrawal by Subject|0
1145331|NCT01376323|3761913|P4|Overall Study|Withdrawal by Subject|0
1145332|NCT01376323|3761914|P3|Overall Study|Withdrawal by Subject|1
1145333|NCT01376323|3761915|P2|Overall Study|Withdrawal by Subject|1
1145334|NCT01376323|3761916|P1|Overall Study|Withdrawal by Subject|0
1145335|NCT01376323|3761912|P5|Overall Study|Physician Decision|1
1145336|NCT01376323|3761913|P4|Overall Study|Physician Decision|1
1145337|NCT01376323|3761914|P3|Overall Study|Physician Decision|2
1145338|NCT01376323|3761915|P2|Overall Study|Physician Decision|0
1145339|NCT01376323|3761916|P1|Overall Study|Physician Decision|1
1145340|NCT01376323|3761912|P5|Overall Study|Lost to Follow-up|0
1145341|NCT01376323|3761913|P4|Overall Study|Lost to Follow-up|2
1145342|NCT01376323|3761914|P3|Overall Study|Lost to Follow-up|0
1145343|NCT01376323|3761915|P2|Overall Study|Lost to Follow-up|0
1145344|NCT01376323|3761916|P1|Overall Study|Lost to Follow-up|0
1145345|NCT01376323|3761912|P5|Overall Study|Adverse Event|0
1145346|NCT01376323|3761913|P4|Overall Study|Adverse Event|2
1145347|NCT01376323|3761914|P3|Overall Study|Adverse Event|0
1145348|NCT01376323|3761915|P2|Overall Study|Adverse Event|0
1145349|NCT01376323|3761916|P1|Overall Study|Adverse Event|1
1145350|NCT01376245|3762011|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
1145351|NCT01376245|3762012|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
1145352|NCT01376245|3762013|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
1145353|NCT01376245|3762014|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
1145354|NCT01376245|3762015|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
1145355|NCT01376245|3762011|P5|24-week, Double-blind Treatment Period|Physician Decision|0
1145356|NCT01376245|3762012|P4|24-week, Double-blind Treatment Period|Physician Decision|1
1145357|NCT01376245|3762013|P3|24-week, Double-blind Treatment Period|Physician Decision|1
1145358|NCT01376245|3762014|P2|24-week, Double-blind Treatment Period|Physician Decision|0
1145359|NCT01376245|3762015|P1|24-week, Double-blind Treatment Period|Physician Decision|0
1145360|NCT01376245|3762011|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|1
1145361|NCT01376245|3762012|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|1
1145362|NCT01376245|3762013|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
1145363|NCT01376245|3762014|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|2
1145364|NCT01376245|3762015|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
1145365|NCT01376245|3762011|P5|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
1145366|NCT01376245|3762012|P4|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1
1145367|NCT01376245|3762013|P3|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3
1145368|NCT01376245|3762014|P2|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2
1145369|NCT01376245|3762015|P1|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
1145370|NCT01376245|3762011|P5|24-week, Double-blind Treatment Period|Protocol Violation|1
1145371|NCT01376245|3762012|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
1145372|NCT01376245|3762013|P3|24-week, Double-blind Treatment Period|Protocol Violation|0
1145373|NCT01376245|3762014|P2|24-week, Double-blind Treatment Period|Protocol Violation|2
1145374|NCT01376245|3762015|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
1145375|NCT01376245|3762011|P5|24-week, Double-blind Treatment Period|Lack of Efficacy|3
1145376|NCT01376245|3762012|P4|24-week, Double-blind Treatment Period|Lack of Efficacy|4
1145377|NCT01376245|3762013|P3|24-week, Double-blind Treatment Period|Lack of Efficacy|5
1145378|NCT01376245|3762014|P2|24-week, Double-blind Treatment Period|Lack of Efficacy|4
1145379|NCT01376245|3762015|P1|24-week, Double-blind Treatment Period|Lack of Efficacy|0
1145380|NCT01376245|3762011|P5|24-week, Double-blind Treatment Period|Adverse Event|18
1145381|NCT01376245|3762012|P4|24-week, Double-blind Treatment Period|Adverse Event|8
1145382|NCT01376245|3762013|P3|24-week, Double-blind Treatment Period|Adverse Event|7
1145383|NCT01376245|3762014|P2|24-week, Double-blind Treatment Period|Adverse Event|16
1145384|NCT01376245|3762015|P1|24-week, Double-blind Treatment Period|Adverse Event|0
1145385|NCT01376245|3762011|P5|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
1145386|NCT01376245|3762012|P4|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
1145387|NCT01376245|3762013|P3|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
1145388|NCT01376245|3762014|P2|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
1145389|NCT01376245|3762015|P1|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28
1145390|NCT01376245|3762011|P5|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
1145391|NCT01376245|3762012|P4|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
1145392|NCT01376245|3762013|P3|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
1145393|NCT01376245|3762014|P2|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
1145394|NCT01376245|3762015|P1|2-wk Single-blind Placebo Run-in Period|Physician Decision|2
1145395|NCT01376245|3762011|P5|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
1145396|NCT01376245|3762012|P4|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
1145397|NCT01376245|3762013|P3|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
1145398|NCT01376245|3762014|P2|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
1145399|NCT01376245|3762015|P1|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1
1145400|NCT01376245|3762011|P5|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
1145401|NCT01376245|3762012|P4|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
1145402|NCT01376245|3762013|P3|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
1145403|NCT01376245|3762014|P2|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
1145404|NCT01376245|3762015|P1|2-wk Single-blind Placebo Run-in Period|Adverse Event|4
1145405|NCT01376245|3762011|P5|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
1145406|NCT01376245|3762012|P4|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
1145407|NCT01376245|3762013|P3|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
1145408|NCT01376245|3762014|P2|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
1145409|NCT01376245|3762015|P1|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66
1145410|NCT01376167|3762032|P3|Overall Study|Withdrawal by Subject|4
1145411|NCT01376167|3762033|P2|Overall Study|Withdrawal by Subject|5
1145412|NCT01376167|3762034|P1|Overall Study|Withdrawal by Subject|1
1145413|NCT01376167|3762032|P3|Overall Study|Physician Decision|0
1145414|NCT01376167|3762033|P2|Overall Study|Physician Decision|1
1145415|NCT01376167|3762034|P1|Overall Study|Physician Decision|1
1145416|NCT01376167|3762032|P3|Overall Study|Lost to Follow-up|2
1145417|NCT01376167|3762033|P2|Overall Study|Lost to Follow-up|4
1145418|NCT01376167|3762034|P1|Overall Study|Lost to Follow-up|2
1145419|NCT01376089|3762105|P2|Overall Study|Patient received no contrast media|4
1145420|NCT01376089|3762106|P1|Overall Study|Patient received no contrast media|3
1145421|NCT01376037|3762129|P2|Overall Study|Lost to Follow-up|2
1145422|NCT01376037|3762130|P1|Overall Study|Lost to Follow-up|0
1145423|NCT01375777|3762158|P9|Overall Study|Other|1
1145424|NCT01375777|3762159|P8|Overall Study|Other|0
1145425|NCT01375777|3762160|P7|Overall Study|Other|0
1145426|NCT01375777|3762161|P6|Overall Study|Other|0
1145427|NCT01375777|3762162|P5|Overall Study|Other|0
1145428|NCT01375777|3762163|P4|Overall Study|Other|0
1145429|NCT01375777|3762164|P3|Overall Study|Other|0
1145430|NCT01375777|3762165|P2|Overall Study|Other|1
1145431|NCT01375777|3762166|P1|Overall Study|Other|1
1145432|NCT01375777|3762158|P9|Overall Study|Lost to Follow-up|0
1145433|NCT01375777|3762159|P8|Overall Study|Lost to Follow-up|0
1145434|NCT01375777|3762160|P7|Overall Study|Lost to Follow-up|1
1145435|NCT01375777|3762161|P6|Overall Study|Lost to Follow-up|0
1145436|NCT01375777|3762162|P5|Overall Study|Lost to Follow-up|0
1145437|NCT01375777|3762163|P4|Overall Study|Lost to Follow-up|0
1145438|NCT01375777|3762164|P3|Overall Study|Lost to Follow-up|0
1145439|NCT01375777|3762165|P2|Overall Study|Lost to Follow-up|0
1145440|NCT01375777|3762166|P1|Overall Study|Lost to Follow-up|1
1145441|NCT01375777|3762158|P9|Overall Study|Withdrawal by Subject|1
1145442|NCT01375777|3762159|P8|Overall Study|Withdrawal by Subject|2
1145443|NCT01375777|3762160|P7|Overall Study|Withdrawal by Subject|1
1145444|NCT01375777|3762161|P6|Overall Study|Withdrawal by Subject|1
1145445|NCT01375777|3762162|P5|Overall Study|Withdrawal by Subject|1
1145446|NCT01375777|3762163|P4|Overall Study|Withdrawal by Subject|0
1145447|NCT01375777|3762164|P3|Overall Study|Withdrawal by Subject|1
1145448|NCT01375777|3762165|P2|Overall Study|Withdrawal by Subject|2
1145449|NCT01375777|3762166|P1|Overall Study|Withdrawal by Subject|0
1145450|NCT01375764|3762236|P5|Overall Study|Other|0
1145451|NCT01375764|3762237|P4|Overall Study|Other|1
1145452|NCT01375764|3762238|P3|Overall Study|Other|0
1145453|NCT01375764|3762239|P2|Overall Study|Other|0
1145454|NCT01375764|3762240|P1|Overall Study|Other|0
1145455|NCT01375764|3762236|P5|Overall Study|Withdrawal by Subject|1
1145456|NCT01375764|3762237|P4|Overall Study|Withdrawal by Subject|0
1145457|NCT01375764|3762238|P3|Overall Study|Withdrawal by Subject|0
1145458|NCT01375764|3762239|P2|Overall Study|Withdrawal by Subject|0
1145459|NCT01375764|3762240|P1|Overall Study|Withdrawal by Subject|2
1145460|NCT01375764|3762236|P5|Overall Study|Lost to Follow-up|0
1145461|NCT01375764|3762237|P4|Overall Study|Lost to Follow-up|0
1145462|NCT01375764|3762238|P3|Overall Study|Lost to Follow-up|0
1145463|NCT01375764|3762239|P2|Overall Study|Lost to Follow-up|1
1145464|NCT01375764|3762240|P1|Overall Study|Lost to Follow-up|0
1145465|NCT01375751|3762286|P3|Overall Study|Other|0
1145466|NCT01375751|3762287|P2|Overall Study|Other|1
1145467|NCT01375751|3762288|P1|Overall Study|Other|0
1145468|NCT01375608|3762332|P1|Overall Study|Withdrawal by Subject|2
1145469|NCT01375374|3762341|P1|Overall Study|Adverse Event|1
1145470|NCT01375075|3762397|P6|Overall Study|Withdrawal by Subject|1
1145471|NCT01375075|3762398|P5|Overall Study|Withdrawal by Subject|0
1145472|NCT01375075|3762399|P4|Overall Study|Withdrawal by Subject|0
1145473|NCT01375075|3762400|P3|Overall Study|Withdrawal by Subject|0
1145474|NCT01375075|3762401|P2|Overall Study|Withdrawal by Subject|1
1145475|NCT01375075|3762402|P1|Overall Study|Withdrawal by Subject|0
1145476|NCT01375075|3762397|P6|Overall Study|Entry Criterion Not Met|1
1145477|NCT01375075|3762398|P5|Overall Study|Entry Criterion Not Met|0
1145478|NCT01375075|3762399|P4|Overall Study|Entry Criterion Not Met|0
1145479|NCT01375075|3762400|P3|Overall Study|Entry Criterion Not Met|0
1145480|NCT01375075|3762401|P2|Overall Study|Entry Criterion Not Met|0
1145481|NCT01375075|3762402|P1|Overall Study|Entry Criterion Not Met|1
1145482|NCT01375075|3762397|P6|Overall Study|Adverse Event|1
1145483|NCT01375075|3762398|P5|Overall Study|Adverse Event|0
1145484|NCT01375075|3762399|P4|Overall Study|Adverse Event|1
1145485|NCT01375075|3762400|P3|Overall Study|Adverse Event|3
1145486|NCT01375075|3762401|P2|Overall Study|Adverse Event|0
1145487|NCT01375075|3762402|P1|Overall Study|Adverse Event|0
1145488|NCT01375049|3762486|P1|Overall Study|Protocol-Specified Withdrawal Criteria|45
1145489|NCT01375049|3762486|P1|Overall Study|Withdrawal by Subject|2
1145490|NCT01375049|3762486|P1|Overall Study|Lost to Follow-up|1
1145491|NCT01375049|3762486|P1|Overall Study|Adverse Event|2
1145492|NCT01374971|3762501|P1|Overall Study|Withdrawal by Subject|1
1145493|NCT01374919|3762506|P1|Overall Study|Withdrawal by Subject|2
1145494|NCT01374906|3762513|P2|Overall Study|Unsatisfactory therapeutic effect|19
1145495|NCT01374906|3762514|P1|Overall Study|Unsatisfactory therapeutic effect|11
1145496|NCT01374906|3762513|P2|Overall Study|Withdrawal by Subject|9
1145497|NCT01374906|3762514|P1|Overall Study|Withdrawal by Subject|15
1145498|NCT01374906|3762513|P2|Overall Study|Protocol Violation|2
1145499|NCT01374906|3762514|P1|Overall Study|Protocol Violation|2
1145500|NCT01374906|3762513|P2|Overall Study|Death|2
1145501|NCT01374906|3762514|P1|Overall Study|Death|0
1145502|NCT01374906|3762513|P2|Overall Study|Adverse Event|11
1145503|NCT01374906|3762514|P1|Overall Study|Adverse Event|10
1145504|NCT01374906|3762513|P2|Overall Study|Administrative problems|2
1145505|NCT01374906|3762514|P1|Overall Study|Administrative problems|2
1145506|NCT01374906|3762513|P2|Overall Study|Abnormal laboratory value(s)|3
1145507|NCT01374906|3762514|P1|Overall Study|Abnormal laboratory value(s)|0
1145508|NCT01374568|3762595|P2|Overall Study|Lab unable to analyze BTM|2
1145509|NCT01374568|3762596|P1|Overall Study|Lab unable to analyze BTM|0
1145510|NCT01374451|3762606|P2|Overall Study|Administrative problems|0
1145511|NCT01374451|3762607|P1|Overall Study|Administrative problems|1
1145512|NCT01374425|3762653|P2|Overall Study|Not Specified|43
1145513|NCT01374425|3762654|P1|Overall Study|Not Specified|41
1145514|NCT01374425|3762653|P2|Overall Study|Lost to Follow-up|1
1145515|NCT01374425|3762654|P1|Overall Study|Lost to Follow-up|2
1145516|NCT01374425|3762653|P2|Overall Study|Sponsor Decision|1
1145517|NCT01374425|3762654|P1|Overall Study|Sponsor Decision|0
1145518|NCT01374425|3762653|P2|Overall Study|Protocol Violation|3
1145519|NCT01374425|3762654|P1|Overall Study|Protocol Violation|2
1145520|NCT01374425|3762653|P2|Overall Study|Refused Treatment|24
1145521|NCT01374425|3762654|P1|Overall Study|Refused Treatment|10
1145522|NCT01374425|3762653|P2|Overall Study|Withdrawal by Subject|7
1145523|NCT01374425|3762654|P1|Overall Study|Withdrawal by Subject|6
1145524|NCT01374425|3762653|P2|Overall Study|Death (Adverse Event)|4
1145525|NCT01374425|3762654|P1|Overall Study|Death (Adverse Event)|2
1145526|NCT01374425|3762653|P2|Overall Study|Death (Progression of Disease)|0
1145527|NCT01374425|3762654|P1|Overall Study|Death (Progression of Disease)|1
1145528|NCT01374425|3762653|P2|Overall Study|Adverse Event|18
1145529|NCT01374425|3762654|P1|Overall Study|Adverse Event|29
1145530|NCT01374425|3762653|P2|Overall Study|Clinical Disease Progression|6
1145531|NCT01374425|3762654|P1|Overall Study|Clinical Disease Progression|9
1145532|NCT01374425|3762653|P2|Overall Study|Radiographic Disease Progression|81
1145533|NCT01374425|3762654|P1|Overall Study|Radiographic Disease Progression|86
1145534|NCT01374269|3762734|P2|Overall Study|closed research|2
1145535|NCT01374269|3762735|P1|Overall Study|closed research|1
1145536|NCT01374269|3762734|P2|Overall Study|Lost to Follow-up|3
1145537|NCT01374269|3762735|P1|Overall Study|Lost to Follow-up|1
1145538|NCT01374269|3762734|P2|Overall Study|Withdrawal by Subject|0
1145539|NCT01374269|3762735|P1|Overall Study|Withdrawal by Subject|4
1145540|NCT01374217|3762863|P1|Overall Study|Lack of Efficacy|13
1145541|NCT01374178|3762871|P2|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0
1145542|NCT01374178|3762872|P1|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2
1145543|NCT01374178|3762871|P2|Washout Period of at Least 7 Days|Withdrawal by Subject|0
1145544|NCT01374178|3762872|P1|Washout Period of at Least 7 Days|Withdrawal by Subject|1
1145545|NCT01374087|3762890|P2|Overall Study|Not provided|13
1145546|NCT01374087|3762891|P1|Overall Study|Not provided|13
1145547|NCT01374087|3762890|P2|Overall Study|Disease progression|2
1145548|NCT01374087|3762891|P1|Overall Study|Disease progression|2
1145549|NCT01374087|3762890|P2|Overall Study|Adverse Event|1
1145550|NCT01374087|3762891|P1|Overall Study|Adverse Event|0
1145551|NCT01373931|3762901|P2|Period 1|Withdrawal by Subject|2
1145552|NCT01373931|3762902|P1|Period 1|Withdrawal by Subject|0
1145553|NCT01373931|3762901|P2|Period 1|Adverse Event|0
1145554|NCT01373931|3762902|P1|Period 1|Adverse Event|2
1145555|NCT01373931|3762901|P2|Lead-in Period|Adverse Event|0
1145556|NCT01373931|3762902|P1|Lead-in Period|Adverse Event|2
1145557|NCT01373918|3762915|P2|Overall Study|Physician Decision|1
1145558|NCT01373918|3762916|P1|Overall Study|Physician Decision|0
1145559|NCT01373346|3762975|P1|Overall Study|Death|1
1145560|NCT01373294|3762998|P2|Overall Study|Adverse Event|0
1145561|NCT01373294|3762999|P1|Overall Study|Adverse Event|1
1145562|NCT01373281|3763008|P2|Surveillance Expansion Period|Serious adverse event|4
1145563|NCT01373281|3763009|P1|Surveillance Expansion Period|Serious adverse event|3
1145564|NCT01373281|3763008|P2|Surveillance Expansion Period|Lost to Follow-up|8
1145565|NCT01373281|3763009|P1|Surveillance Expansion Period|Lost to Follow-up|10
1145566|NCT01373281|3763008|P2|Surveillance Expansion Period|Protocol Violation|1
1145567|NCT01373281|3763009|P1|Surveillance Expansion Period|Protocol Violation|9
1145568|NCT01373281|3763008|P2|Surveillance Expansion Period|Withdrawal by Subject|105
1145569|NCT01373281|3763009|P1|Surveillance Expansion Period|Withdrawal by Subject|180
1145570|NCT01373281|3763008|P2|Vaccination Phase (Up to 25 Months)|Serious adverse event|1
1145571|NCT01373281|3763009|P1|Vaccination Phase (Up to 25 Months)|Serious adverse event|4
1145572|NCT01373281|3763008|P2|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1
1145573|NCT01373281|3763009|P1|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5
1145574|NCT01373281|3763008|P2|Vaccination Phase (Up to 25 Months)|Protocol Violation|2
1145575|NCT01373281|3763009|P1|Vaccination Phase (Up to 25 Months)|Protocol Violation|5
1145576|NCT01373281|3763008|P2|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23
1145577|NCT01373281|3763009|P1|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40
1145578|NCT01373229|3763041|P1|Overall Study|Physician Decision|3
1145579|NCT01373229|3763041|P1|Overall Study|Death|3
1145580|NCT01373164|3763055|P5|Overall Study|Withdrawal by Subject|2
1145581|NCT01373164|3763056|P4|Overall Study|Withdrawal by Subject|10
1145582|NCT01373164|3763057|P3|Overall Study|Withdrawal by Subject|0
1145583|NCT01373164|3763058|P2|Overall Study|Withdrawal by Subject|1
1145584|NCT01373164|3763059|P1|Overall Study|Withdrawal by Subject|0
1145585|NCT01373164|3763055|P5|Overall Study|Lost to Follow-up|0
1145586|NCT01373164|3763056|P4|Overall Study|Lost to Follow-up|2
1145587|NCT01373164|3763057|P3|Overall Study|Lost to Follow-up|1
1145588|NCT01373164|3763058|P2|Overall Study|Lost to Follow-up|0
1145589|NCT01373164|3763059|P1|Overall Study|Lost to Follow-up|0
1145590|NCT01372995|3763093|P3|Overall Study|Physician Decision|1
1145591|NCT01372995|3763094|P2|Overall Study|Physician Decision|0
1145592|NCT01372995|3763095|P1|Overall Study|Physician Decision|0
1145593|NCT01372995|3763093|P3|Overall Study|Spouse withdrew participant from study|0
1145594|NCT01372995|3763094|P2|Overall Study|Spouse withdrew participant from study|1
1145595|NCT01372995|3763095|P1|Overall Study|Spouse withdrew participant from study|0
1145596|NCT01372878|3763142|P1|Overall Study|incomplete study procedure|104
1145597|NCT01372878|3763142|P1|Overall Study|Protocol Violation|17
1145598|NCT01372878|3763142|P1|Overall Study|Withdrawal by Subject|63
1145599|NCT01372774|3763162|P2|Overall Study|Withdrawal prior to treatment|5
1145600|NCT01372774|3763163|P1|Overall Study|Withdrawal prior to treatment|4
1145601|NCT01372748|3763179|P2|Overall Study|Withdrawal by Subject|5
1145602|NCT01372748|3763180|P1|Overall Study|Withdrawal by Subject|7
1145603|NCT01372748|3763179|P2|Overall Study|Lost to Follow-up|34
1145604|NCT01372748|3763180|P1|Overall Study|Lost to Follow-up|16
1145605|NCT01372618|3763188|P1|Overall Study|PI Died. Study Terminated|9
1145606|NCT01372605|3763196|P2|Overall Study|Changed medical home|0
1145607|NCT01372605|3763197|P1|Overall Study|Changed medical home|2
1145608|NCT01372605|3763196|P2|Overall Study|Moved|0
1145609|NCT01372605|3763197|P1|Overall Study|Moved|3
1145610|NCT01372605|3763196|P2|Overall Study|Withdrawal by Subject|7
1145611|NCT01372605|3763197|P1|Overall Study|Withdrawal by Subject|4
1145612|NCT01372605|3763196|P2|Overall Study|Lost to Follow-up|1
1145613|NCT01372605|3763197|P1|Overall Study|Lost to Follow-up|2
1145614|NCT01372605|3763196|P2|Overall Study|Death|2
1145615|NCT01372605|3763197|P1|Overall Study|Death|1
1145616|NCT01372501|3763223|P1|Overall Study|Device migration|1
1145617|NCT01372501|3763223|P1|Overall Study|Adverse Event|4
1145618|NCT01372410|3763246|P8|Treatment Period 3 (7 Days)|Protocol Deviation|0
1145619|NCT01372410|3763247|P7|Treatment Period 3 (7 Days)|Protocol Deviation|0
1145620|NCT01372410|3763248|P6|Treatment Period 3 (7 Days)|Protocol Deviation|1
1145621|NCT01372410|3763249|P5|Treatment Period 3 (7 Days)|Protocol Deviation|0
1145622|NCT01372410|3763250|P4|Treatment Period 3 (7 Days)|Protocol Deviation|0
1145623|NCT01372410|3763251|P3|Treatment Period 3 (7 Days)|Protocol Deviation|0
1145624|NCT01372410|3763252|P2|Treatment Period 3 (7 Days)|Protocol Deviation|0
1145625|NCT01372410|3763253|P1|Treatment Period 3 (7 Days)|Protocol Deviation|0
1145626|NCT01372410|3763246|P8|Treatment Period 3 (7 Days)|Adverse Event|0
1145627|NCT01372410|3763247|P7|Treatment Period 3 (7 Days)|Adverse Event|0
1145628|NCT01372410|3763248|P6|Treatment Period 3 (7 Days)|Adverse Event|0
1145629|NCT01372410|3763249|P5|Treatment Period 3 (7 Days)|Adverse Event|0
1145630|NCT01372410|3763250|P4|Treatment Period 3 (7 Days)|Adverse Event|0
1145631|NCT01372410|3763251|P3|Treatment Period 3 (7 Days)|Adverse Event|1
1145632|NCT01372410|3763252|P2|Treatment Period 3 (7 Days)|Adverse Event|0
1145633|NCT01372410|3763253|P1|Treatment Period 3 (7 Days)|Adverse Event|0
1145634|NCT01372410|3763246|P8|Washout Period 2 (10-14 Days)|Lack of Efficacy|1
1145635|NCT01372410|3763247|P7|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
1145636|NCT01372410|3763248|P6|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
1145637|NCT01372410|3763249|P5|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
1145638|NCT01372410|3763250|P4|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
1145639|NCT01372410|3763251|P3|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
1145640|NCT01372410|3763252|P2|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
1145641|NCT01372410|3763253|P1|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
1145642|NCT01372410|3763246|P8|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
1145643|NCT01372410|3763247|P7|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
1145644|NCT01372410|3763248|P6|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
1145645|NCT01372410|3763249|P5|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
1145646|NCT01372410|3763250|P4|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
1145647|NCT01372410|3763251|P3|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
1145648|NCT01372410|3763252|P2|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
1145649|NCT01372410|3763253|P1|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
1145650|NCT01372410|3763246|P8|Washout Period 2 (10-14 Days)|Adverse Event|0
1145651|NCT01372410|3763247|P7|Washout Period 2 (10-14 Days)|Adverse Event|0
1145652|NCT01372410|3763248|P6|Washout Period 2 (10-14 Days)|Adverse Event|0
1145653|NCT01372410|3763249|P5|Washout Period 2 (10-14 Days)|Adverse Event|1
1145654|NCT01372410|3763250|P4|Washout Period 2 (10-14 Days)|Adverse Event|0
1145655|NCT01372410|3763251|P3|Washout Period 2 (10-14 Days)|Adverse Event|0
1145656|NCT01372410|3763252|P2|Washout Period 2 (10-14 Days)|Adverse Event|0
1145657|NCT01372410|3763253|P1|Washout Period 2 (10-14 Days)|Adverse Event|0
1145658|NCT01372410|3763246|P8|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
1145659|NCT01372410|3763247|P7|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
1145660|NCT01372410|3763248|P6|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
1145661|NCT01372410|3763249|P5|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
1145662|NCT01372410|3763250|P4|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
1145663|NCT01372410|3763251|P3|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
1145664|NCT01372410|3763252|P2|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
1145665|NCT01372410|3763253|P1|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
1145666|NCT01372410|3763246|P8|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
1145667|NCT01372410|3763247|P7|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1
1145668|NCT01372410|3763248|P6|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
1145669|NCT01372410|3763249|P5|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
1145670|NCT01372410|3763250|P4|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
1145671|NCT01372410|3763251|P3|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
1145672|NCT01372410|3763252|P2|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
1145673|NCT01372410|3763253|P1|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
1145674|NCT01372410|3763246|P8|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1145675|NCT01372410|3763247|P7|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1145676|NCT01372410|3763248|P6|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1145677|NCT01372410|3763249|P5|Treatment Period 1 (7 Days)|Lost to Follow-up|1
1145678|NCT01372410|3763250|P4|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1145679|NCT01372410|3763251|P3|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1145680|NCT01372410|3763252|P2|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1145681|NCT01372410|3763253|P1|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1145682|NCT01372410|3763246|P8|Treatment Period 1 (7 Days)|Adverse Event|0
1145683|NCT01372410|3763247|P7|Treatment Period 1 (7 Days)|Adverse Event|1
1145684|NCT01372410|3763248|P6|Treatment Period 1 (7 Days)|Adverse Event|0
1145685|NCT01372410|3763249|P5|Treatment Period 1 (7 Days)|Adverse Event|0
1145686|NCT01372410|3763250|P4|Treatment Period 1 (7 Days)|Adverse Event|0
1145687|NCT01372410|3763251|P3|Treatment Period 1 (7 Days)|Adverse Event|0
1145688|NCT01372410|3763252|P2|Treatment Period 1 (7 Days)|Adverse Event|1
1145689|NCT01372410|3763253|P1|Treatment Period 1 (7 Days)|Adverse Event|0
1145690|NCT01372410|3763246|P8|Treatment Period 1 (7 Days)|Lack of Efficacy|0
1145691|NCT01372410|3763247|P7|Treatment Period 1 (7 Days)|Lack of Efficacy|0
1145692|NCT01372410|3763248|P6|Treatment Period 1 (7 Days)|Lack of Efficacy|0
1145693|NCT01372410|3763249|P5|Treatment Period 1 (7 Days)|Lack of Efficacy|1
1145694|NCT01372410|3763250|P4|Treatment Period 1 (7 Days)|Lack of Efficacy|0
1145695|NCT01372410|3763251|P3|Treatment Period 1 (7 Days)|Lack of Efficacy|0
1145696|NCT01372410|3763252|P2|Treatment Period 1 (7 Days)|Lack of Efficacy|1
1145697|NCT01372410|3763253|P1|Treatment Period 1 (7 Days)|Lack of Efficacy|1
1145698|NCT01372384|3763290|P1|Overall Study|Progression of disease|3
1145699|NCT01372150|3763313|P3|Overall Study|Randomized but not treated|0
1145700|NCT01372150|3763314|P2|Overall Study|Randomized but not treated|1
1145701|NCT01372150|3763315|P1|Overall Study|Randomized but not treated|0
1145702|NCT01372150|3763313|P3|Overall Study|Adverse Event|2
1145703|NCT01372150|3763314|P2|Overall Study|Adverse Event|1
1145704|NCT01372150|3763315|P1|Overall Study|Adverse Event|2
1145705|NCT01372150|3763313|P3|Overall Study|Other|2
1145706|NCT01372150|3763314|P2|Overall Study|Other|0
1145707|NCT01372150|3763315|P1|Overall Study|Other|1
1145708|NCT01372150|3763313|P3|Overall Study|Withdrawal by Subject|2
1145709|NCT01372150|3763314|P2|Overall Study|Withdrawal by Subject|7
1145710|NCT01372150|3763315|P1|Overall Study|Withdrawal by Subject|2
1145711|NCT01372150|3763313|P3|Overall Study|Protocol Violation|3
1145712|NCT01372150|3763314|P2|Overall Study|Protocol Violation|0
1145713|NCT01372150|3763315|P1|Overall Study|Protocol Violation|1
1145714|NCT01372150|3763313|P3|Overall Study|Lost to Follow-up|6
1145715|NCT01372150|3763314|P2|Overall Study|Lost to Follow-up|5
1145716|NCT01372150|3763315|P1|Overall Study|Lost to Follow-up|4
1145717|NCT01372150|3763313|P3|Overall Study|Lack of Efficacy|1
1145718|NCT01372150|3763314|P2|Overall Study|Lack of Efficacy|0
1145719|NCT01372150|3763315|P1|Overall Study|Lack of Efficacy|3
1145720|NCT01371994|3763334|P2|Overall Study|Miscellaneous Reasons|4
1145721|NCT01371994|3763335|P1|Overall Study|Miscellaneous Reasons|6
1145722|NCT01371994|3763334|P2|Overall Study|Physician Decision|1
1145723|NCT01371994|3763335|P1|Overall Study|Physician Decision|1
1145724|NCT01371994|3763334|P2|Overall Study|Randomized but Never Received Study Drug|6
1145725|NCT01371994|3763335|P1|Overall Study|Randomized but Never Received Study Drug|6
1145726|NCT01371994|3763334|P2|Overall Study|Protocol Violation|17
1145727|NCT01371994|3763335|P1|Overall Study|Protocol Violation|24
1145728|NCT01371994|3763334|P2|Overall Study|Lost to Follow-up|1
1145729|NCT01371994|3763335|P1|Overall Study|Lost to Follow-up|1
1145730|NCT01371994|3763334|P2|Overall Study|Withdrawal by Subject|7
1145731|NCT01371994|3763335|P1|Overall Study|Withdrawal by Subject|13
1145732|NCT01371994|3763334|P2|Overall Study|Lack of Efficacy|0
1145733|NCT01371994|3763335|P1|Overall Study|Lack of Efficacy|3
1145734|NCT01371994|3763334|P2|Overall Study|Adverse Event|6
1145735|NCT01371994|3763335|P1|Overall Study|Adverse Event|3
1145736|NCT01371877|3763379|P2|Overall Study|3 for unknown reasons and 1 pregnant|4
1145737|NCT01371877|3763380|P1|Overall Study|3 for unknown reasons and 1 pregnant|0
1145738|NCT01371851|3763392|P2|Overall Study|Blood Pressure outside study parameters|0
1145739|NCT01371851|3763393|P1|Overall Study|Blood Pressure outside study parameters|2
1145740|NCT01371851|3763392|P2|Overall Study|non study related adverse event|0
1145741|NCT01371851|3763393|P1|Overall Study|non study related adverse event|1
1145742|NCT01371851|3763392|P2|Overall Study|was arrested and put in jail|1
1145743|NCT01371851|3763393|P1|Overall Study|was arrested and put in jail|0
1145744|NCT01371851|3763392|P2|Overall Study|Lost to Follow-up|8
1145745|NCT01371851|3763393|P1|Overall Study|Lost to Follow-up|5
1145746|NCT01371838|3763401|P2|Overall Study|Surgery|0
1145747|NCT01371838|3763402|P1|Overall Study|Surgery|1
1145748|NCT01371838|3763401|P2|Overall Study|Lack of therapeutic response|1
1145749|NCT01371838|3763402|P1|Overall Study|Lack of therapeutic response|0
1145750|NCT01371838|3763401|P2|Overall Study|Last follow-up visit not conducted|0
1145751|NCT01371838|3763402|P1|Overall Study|Last follow-up visit not conducted|2
1145752|NCT01371838|3763401|P2|Overall Study|Investigator Decision|8
1145753|NCT01371838|3763402|P1|Overall Study|Investigator Decision|3
1145754|NCT01371838|3763401|P2|Overall Study|Protocol Violation|0
1145755|NCT01371838|3763402|P1|Overall Study|Protocol Violation|3
1145756|NCT01371838|3763401|P2|Overall Study|Death|4
1145757|NCT01371838|3763402|P1|Overall Study|Death|3
1145758|NCT01371838|3763401|P2|Overall Study|Lost to Follow-up|20
1145759|NCT01371838|3763402|P1|Overall Study|Lost to Follow-up|10
1145760|NCT01371838|3763401|P2|Overall Study|Withdrawal by Subject|33
1145761|NCT01371838|3763402|P1|Overall Study|Withdrawal by Subject|27
1145762|NCT01371825|3763438|P1|Primary Efficacy Analysis Period|Death|3
1145763|NCT01371747|3763473|P6|Overall Study|Other Reasons|1
1145764|NCT01371747|3763474|P5|Overall Study|Other Reasons|0
1145765|NCT01371747|3763475|P4|Overall Study|Other Reasons|0
1145766|NCT01371747|3763476|P3|Overall Study|Other Reasons|2
1145767|NCT01371747|3763477|P2|Overall Study|Other Reasons|1
1145768|NCT01371747|3763478|P1|Overall Study|Other Reasons|2
1145769|NCT01371747|3763473|P6|Overall Study|Withdrawal by Subject|4
1145770|NCT01371747|3763474|P5|Overall Study|Withdrawal by Subject|2
1145771|NCT01371747|3763475|P4|Overall Study|Withdrawal by Subject|2
1145772|NCT01371747|3763476|P3|Overall Study|Withdrawal by Subject|5
1145773|NCT01371747|3763477|P2|Overall Study|Withdrawal by Subject|12
1145774|NCT01371747|3763478|P1|Overall Study|Withdrawal by Subject|6
1145775|NCT01371747|3763473|P6|Overall Study|Physician Decision|0
1145776|NCT01371747|3763474|P5|Overall Study|Physician Decision|1
1145777|NCT01371747|3763475|P4|Overall Study|Physician Decision|0
1145778|NCT01371747|3763476|P3|Overall Study|Physician Decision|0
1145779|NCT01371747|3763477|P2|Overall Study|Physician Decision|0
1145780|NCT01371747|3763478|P1|Overall Study|Physician Decision|0
1145781|NCT01371747|3763473|P6|Overall Study|Non-Compliance|1
1145782|NCT01371747|3763474|P5|Overall Study|Non-Compliance|0
1145783|NCT01371747|3763475|P4|Overall Study|Non-Compliance|0
1145784|NCT01371747|3763476|P3|Overall Study|Non-Compliance|3
1145785|NCT01371747|3763477|P2|Overall Study|Non-Compliance|4
1145786|NCT01371747|3763478|P1|Overall Study|Non-Compliance|3
1145787|NCT01371747|3763473|P6|Overall Study|Protocol Violation|0
1145788|NCT01371747|3763474|P5|Overall Study|Protocol Violation|0
1145789|NCT01371747|3763475|P4|Overall Study|Protocol Violation|0
1145790|NCT01371747|3763476|P3|Overall Study|Protocol Violation|1
1145791|NCT01371747|3763477|P2|Overall Study|Protocol Violation|0
1145792|NCT01371747|3763478|P1|Overall Study|Protocol Violation|0
1145793|NCT01371747|3763473|P6|Overall Study|Low Serum Potassium Results|3
1145794|NCT01371747|3763474|P5|Overall Study|Low Serum Potassium Results|0
1145795|NCT01371747|3763475|P4|Overall Study|Low Serum Potassium Results|1
1145796|NCT01371747|3763476|P3|Overall Study|Low Serum Potassium Results|1
1145797|NCT01371747|3763477|P2|Overall Study|Low Serum Potassium Results|1
1145798|NCT01371747|3763478|P1|Overall Study|Low Serum Potassium Results|1
1145799|NCT01371747|3763473|P6|Overall Study|High Serum Potassium Results|2
1145800|NCT01371747|3763474|P5|Overall Study|High Serum Potassium Results|0
1145801|NCT01371747|3763475|P4|Overall Study|High Serum Potassium Results|2
1145802|NCT01371747|3763476|P3|Overall Study|High Serum Potassium Results|1
1145803|NCT01371747|3763477|P2|Overall Study|High Serum Potassium Results|1
1145804|NCT01371747|3763478|P1|Overall Study|High Serum Potassium Results|1
1145805|NCT01371747|3763473|P6|Overall Study|Abnormal Renal Function|1
1145806|NCT01371747|3763474|P5|Overall Study|Abnormal Renal Function|0
1145807|NCT01371747|3763475|P4|Overall Study|Abnormal Renal Function|1
1145808|NCT01371747|3763476|P3|Overall Study|Abnormal Renal Function|0
1145809|NCT01371747|3763477|P2|Overall Study|Abnormal Renal Function|2
1145810|NCT01371747|3763478|P1|Overall Study|Abnormal Renal Function|0
1145811|NCT01371747|3763473|P6|Overall Study|Death|0
1145812|NCT01371747|3763474|P5|Overall Study|Death|2
1145813|NCT01371747|3763475|P4|Overall Study|Death|1
1145814|NCT01371747|3763476|P3|Overall Study|Death|4
1145815|NCT01371747|3763477|P2|Overall Study|Death|0
1145816|NCT01371747|3763478|P1|Overall Study|Death|1
1145817|NCT01371747|3763473|P6|Overall Study|Adverse Event|2
1145818|NCT01371747|3763474|P5|Overall Study|Adverse Event|2
1145819|NCT01371747|3763475|P4|Overall Study|Adverse Event|2
1145820|NCT01371747|3763476|P3|Overall Study|Adverse Event|7
1145821|NCT01371747|3763477|P2|Overall Study|Adverse Event|2
1145822|NCT01371747|3763478|P1|Overall Study|Adverse Event|4
1145823|NCT01371734|3763543|P3|Overall Study|Lack of Efficacy|0
1145824|NCT01371734|3763544|P2|Overall Study|Lack of Efficacy|2
1145825|NCT01371734|3763545|P1|Overall Study|Lack of Efficacy|2
1145826|NCT01371734|3763543|P3|Overall Study|Adverse Event|3
1145827|NCT01371734|3763544|P2|Overall Study|Adverse Event|8
1145828|NCT01371734|3763545|P1|Overall Study|Adverse Event|8
1145829|NCT01371734|3763543|P3|Overall Study|Protocol Violation|2
1145830|NCT01371734|3763544|P2|Overall Study|Protocol Violation|1
1145831|NCT01371734|3763545|P1|Overall Study|Protocol Violation|3
1145832|NCT01371734|3763543|P3|Overall Study|Lost to Follow-up|1
1145833|NCT01371734|3763544|P2|Overall Study|Lost to Follow-up|3
1145834|NCT01371734|3763545|P1|Overall Study|Lost to Follow-up|5
1145835|NCT01371734|3763543|P3|Overall Study|Withdrawal by Subject|9
1145836|NCT01371734|3763544|P2|Overall Study|Withdrawal by Subject|4
1145837|NCT01371734|3763545|P1|Overall Study|Withdrawal by Subject|3
1145838|NCT01371734|3763543|P3|Overall Study|Not specified|2
1145839|NCT01371734|3763544|P2|Overall Study|Not specified|1
1145840|NCT01371734|3763545|P1|Overall Study|Not specified|2
1145841|NCT01371721|3763565|P3|Overall Study|Randomized but not treated|0
1145842|NCT01371721|3763566|P2|Overall Study|Randomized but not treated|0
1145843|NCT01371721|3763567|P1|Overall Study|Randomized but not treated|1
1145844|NCT01371721|3763565|P3|Overall Study|Lack of Efficacy|3
1145845|NCT01371721|3763566|P2|Overall Study|Lack of Efficacy|4
1145846|NCT01371721|3763567|P1|Overall Study|Lack of Efficacy|2
1145847|NCT01371721|3763565|P3|Overall Study|Not specified|0
1145848|NCT01371721|3763566|P2|Overall Study|Not specified|3
1145849|NCT01371721|3763567|P1|Overall Study|Not specified|2
1145850|NCT01371721|3763565|P3|Overall Study|Withdrawal by Subject|11
1145851|NCT01371721|3763566|P2|Overall Study|Withdrawal by Subject|7
1145852|NCT01371721|3763567|P1|Overall Study|Withdrawal by Subject|5
1145853|NCT01371721|3763565|P3|Overall Study|Lost to Follow-up|6
1145854|NCT01371721|3763566|P2|Overall Study|Lost to Follow-up|2
1145855|NCT01371721|3763567|P1|Overall Study|Lost to Follow-up|8
1145856|NCT01371721|3763565|P3|Overall Study|Protocol Violation|5
1145857|NCT01371721|3763566|P2|Overall Study|Protocol Violation|4
1145858|NCT01371721|3763567|P1|Overall Study|Protocol Violation|6
1145859|NCT01371721|3763565|P3|Overall Study|Adverse Event|5
1145860|NCT01371721|3763566|P2|Overall Study|Adverse Event|4
1145861|NCT01371721|3763567|P1|Overall Study|Adverse Event|5
1145862|NCT01371708|3763600|P3|Overall Study|Started but did not receive treatment|1
1145863|NCT01371708|3763601|P2|Overall Study|Started but did not receive treatment|0
1145864|NCT01371708|3763602|P1|Overall Study|Started but did not receive treatment|1
1145865|NCT01371708|3763600|P3|Overall Study|Adverse Event|12
1145866|NCT01371708|3763601|P2|Overall Study|Adverse Event|8
1145867|NCT01371708|3763602|P1|Overall Study|Adverse Event|5
1145868|NCT01371708|3763600|P3|Overall Study|Not specified|4
1145869|NCT01371708|3763601|P2|Overall Study|Not specified|2
1145870|NCT01371708|3763602|P1|Overall Study|Not specified|3
1145871|NCT01371708|3763600|P3|Overall Study|Medication error/not related to AE|0
1145872|NCT01371708|3763601|P2|Overall Study|Medication error/not related to AE|1
1145873|NCT01371708|3763602|P1|Overall Study|Medication error/not related to AE|0
1145874|NCT01371708|3763600|P3|Overall Study|No longer willing to participate|13
1145875|NCT01371708|3763601|P2|Overall Study|No longer willing to participate|7
1145876|NCT01371708|3763602|P1|Overall Study|No longer willing to participate|7
1145877|NCT01371708|3763600|P3|Overall Study|Protocol Violation|2
1145878|NCT01371708|3763601|P2|Overall Study|Protocol Violation|1
1145879|NCT01371708|3763602|P1|Overall Study|Protocol Violation|2
1145880|NCT01371708|3763600|P3|Overall Study|Lost to Follow-up|7
1145881|NCT01371708|3763601|P2|Overall Study|Lost to Follow-up|9
1145882|NCT01371708|3763602|P1|Overall Study|Lost to Follow-up|5
1145883|NCT01371708|3763600|P3|Overall Study|Insufficient clinical response|0
1145884|NCT01371708|3763601|P2|Overall Study|Insufficient clinical response|2
1145885|NCT01371708|3763602|P1|Overall Study|Insufficient clinical response|3
1145886|NCT01371656|3763634|P2|Overall Study|Ineligible|3
1145887|NCT01371656|3763635|P1|Overall Study|Ineligible|4
1145888|NCT01371656|3763634|P2|Overall Study|Withdrawal by Subject|0
1145889|NCT01371656|3763635|P1|Overall Study|Withdrawal by Subject|7
1145890|NCT01371656|3763634|P2|Overall Study|Physician Decision|7
1145891|NCT01371656|3763635|P1|Overall Study|Physician Decision|46
1145892|NCT01371656|3763634|P2|Overall Study|Death|4
1145893|NCT01371656|3763635|P1|Overall Study|Death|7
1145894|NCT01371643|3763655|P2|Overall Study|Withdrawal by Subject|0
1145895|NCT01371643|3763656|P1|Overall Study|Withdrawal by Subject|3
1145896|NCT01371565|3763666|P1|Overall Study|Resection of neuroendocrine tumor|1
1145897|NCT01371565|3763666|P1|Overall Study|Death|1
1145898|NCT01371565|3763666|P1|Overall Study|Withdrawal by Subject|1
1145899|NCT01371552|3763670|P6|Part 1, First 3 Days|Inconvenience|0
1145900|NCT01371552|3763671|P5|Part 1, First 3 Days|Inconvenience|0
1145901|NCT01371552|3763672|P4|Part 1, First 3 Days|Inconvenience|0
1145902|NCT01371552|3763673|P3|Part 1, First 3 Days|Inconvenience|1
1145903|NCT01371552|3763674|P2|Part 1, First 3 Days|Inconvenience|0
1145904|NCT01371552|3763675|P1|Part 1, First 3 Days|Inconvenience|0
1145905|NCT01371539|3763702|P2|Period Two: One Week|Time/job conflict|1
1145906|NCT01371539|3763703|P1|Period Two: One Week|Time/job conflict|0
1145907|NCT01371539|3763702|P2|Period Two: One Week|Unacceptable Objective Visual Acuity|1
1145908|NCT01371539|3763703|P1|Period Two: One Week|Unacceptable Objective Visual Acuity|0
1145909|NCT01371539|3763702|P2|Period Two: One Week|Lost to Follow-up|1
1145910|NCT01371539|3763703|P1|Period Two: One Week|Lost to Follow-up|0
1145911|NCT01371539|3763702|P2|Period One: One Week|Lost to Follow-up|1
1145912|NCT01371539|3763703|P1|Period One: One Week|Lost to Follow-up|0
1145913|NCT01371006|3763724|P2|Overall Study|Adverse Event|0
1145914|NCT01371006|3763725|P1|Overall Study|Adverse Event|1
1145915|NCT01370863|3763766|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
1145916|NCT01370863|3763767|P1|Overall Study|Not meeting inclusion/exclusion criteria|0
1145917|NCT01370863|3763766|P2|Overall Study|Did not want second pH/MII monitoring|1
1145918|NCT01370863|3763767|P1|Overall Study|Did not want second pH/MII monitoring|1
1145919|NCT01370863|3763766|P2|Overall Study|Adverse Event|1
1145920|NCT01370863|3763767|P1|Overall Study|Adverse Event|1
1145921|NCT01370733|3763792|P2|Overall Study|Protocol Violation|3
1145922|NCT01370733|3763793|P1|Overall Study|Protocol Violation|1
1145923|NCT01370733|3763792|P2|Overall Study|Physician Decision|2
1145924|NCT01370733|3763793|P1|Overall Study|Physician Decision|0
1145925|NCT01370733|3763792|P2|Overall Study|Lack of Efficacy|5
1145926|NCT01370733|3763793|P1|Overall Study|Lack of Efficacy|3
1145927|NCT01370733|3763792|P2|Overall Study|Adverse Event|4
1145928|NCT01370733|3763793|P1|Overall Study|Adverse Event|2
1145929|NCT01370733|3763792|P2|Overall Study|Lost to Follow-up|0
1145930|NCT01370733|3763793|P1|Overall Study|Lost to Follow-up|3
1145931|NCT01370733|3763792|P2|Overall Study|Withdrawal by Subject|8
1145932|NCT01370733|3763793|P1|Overall Study|Withdrawal by Subject|8
1145933|NCT01370694|3763815|P1|Overall Study|Progressive disease|2
1145934|NCT01370694|3763815|P1|Overall Study|Switched to rituximab|4
1145935|NCT01370655|3763837|P12|Period 2|Withdrawal by Subject|0
1145936|NCT01370655|3763838|P11|Period 2|Withdrawal by Subject|0
1145937|NCT01370655|3763839|P10|Period 2|Withdrawal by Subject|0
1145938|NCT01370655|3763840|P9|Period 2|Withdrawal by Subject|1
1145939|NCT01370655|3763841|P8|Period 2|Withdrawal by Subject|0
1145940|NCT01370655|3763842|P7|Period 2|Withdrawal by Subject|0
1145941|NCT01370655|3763843|P6|Period 2|Withdrawal by Subject|0
1145942|NCT01370655|3763844|P5|Period 2|Withdrawal by Subject|0
1145943|NCT01370655|3763845|P4|Period 2|Withdrawal by Subject|0
1145944|NCT01370655|3763846|P3|Period 2|Withdrawal by Subject|0
1145945|NCT01370655|3763847|P2|Period 2|Withdrawal by Subject|0
1145946|NCT01370655|3763848|P1|Period 2|Withdrawal by Subject|0
1145947|NCT01370655|3763837|P12|Period 2|met protocol specified stopping criteria|0
1145948|NCT01370655|3763838|P11|Period 2|met protocol specified stopping criteria|1
1145949|NCT01370655|3763839|P10|Period 2|met protocol specified stopping criteria|0
1145950|NCT01370655|3763840|P9|Period 2|met protocol specified stopping criteria|1
1145951|NCT01370655|3763841|P8|Period 2|met protocol specified stopping criteria|0
1145952|NCT01370655|3763842|P7|Period 2|met protocol specified stopping criteria|1
1145953|NCT01370655|3763843|P6|Period 2|met protocol specified stopping criteria|0
1145954|NCT01370655|3763844|P5|Period 2|met protocol specified stopping criteria|0
1145955|NCT01370655|3763845|P4|Period 2|met protocol specified stopping criteria|0
1145956|NCT01370655|3763846|P3|Period 2|met protocol specified stopping criteria|1
1145957|NCT01370655|3763847|P2|Period 2|met protocol specified stopping criteria|0
1145958|NCT01370655|3763848|P1|Period 2|met protocol specified stopping criteria|0
1145959|NCT01370655|3763837|P12|Period 2|Adverse Event|0
1145960|NCT01370655|3763838|P11|Period 2|Adverse Event|0
1145961|NCT01370655|3763839|P10|Period 2|Adverse Event|0
1145962|NCT01370655|3763840|P9|Period 2|Adverse Event|0
1145963|NCT01370655|3763841|P8|Period 2|Adverse Event|1
1145964|NCT01370655|3763842|P7|Period 2|Adverse Event|0
1145965|NCT01370655|3763843|P6|Period 2|Adverse Event|0
1145966|NCT01370655|3763844|P5|Period 2|Adverse Event|1
1145967|NCT01370655|3763845|P4|Period 2|Adverse Event|0
1145968|NCT01370655|3763846|P3|Period 2|Adverse Event|1
1145969|NCT01370655|3763847|P2|Period 2|Adverse Event|0
1145970|NCT01370655|3763848|P1|Period 2|Adverse Event|0
1145971|NCT01370655|3763837|P12|Period 1|Adverse Event|0
1145972|NCT01370655|3763838|P11|Period 1|Adverse Event|0
1145973|NCT01370655|3763839|P10|Period 1|Adverse Event|0
1145974|NCT01370655|3763840|P9|Period 1|Adverse Event|0
1145975|NCT01370655|3763841|P8|Period 1|Adverse Event|0
1145976|NCT01370655|3763842|P7|Period 1|Adverse Event|1
1145977|NCT01370655|3763843|P6|Period 1|Adverse Event|0
1145978|NCT01370655|3763844|P5|Period 1|Adverse Event|0
1145979|NCT01370655|3763845|P4|Period 1|Adverse Event|0
1145980|NCT01370655|3763846|P3|Period 1|Adverse Event|0
1145981|NCT01370655|3763847|P2|Period 1|Adverse Event|0
1145982|NCT01370655|3763848|P1|Period 1|Adverse Event|2
1145983|NCT01370642|3763885|P3|Overall Study|Withdrawal by Subject|3
1145984|NCT01370642|3763886|P2|Overall Study|Withdrawal by Subject|4
1145985|NCT01370642|3763887|P1|Overall Study|Withdrawal by Subject|2
1145986|NCT01370642|3763885|P3|Overall Study|Physician Decision|2
1145987|NCT01370642|3763886|P2|Overall Study|Physician Decision|1
1145988|NCT01370642|3763887|P1|Overall Study|Physician Decision|4
1145989|NCT01370642|3763885|P3|Overall Study|Lost to Follow-up|1
1145990|NCT01370642|3763886|P2|Overall Study|Lost to Follow-up|0
1145991|NCT01370642|3763887|P1|Overall Study|Lost to Follow-up|0
1145992|NCT01370642|3763885|P3|Overall Study|Detectable HCV RNA|22
1145993|NCT01370642|3763886|P2|Overall Study|Detectable HCV RNA|0
1145994|NCT01370642|3763887|P1|Overall Study|Detectable HCV RNA|0
1145995|NCT01370642|3763885|P3|Overall Study|Adverse Event|1
1145996|NCT01370642|3763886|P2|Overall Study|Adverse Event|1
1145997|NCT01370642|3763887|P1|Overall Study|Adverse Event|2
1145998|NCT01370616|3763918|P2|Overall Study|Withdrawal by Subject|34
1145999|NCT01370616|3763919|P1|Overall Study|Withdrawal by Subject|34
1146000|NCT01370616|3763918|P2|Overall Study|Technical Problems|5
1146001|NCT01370616|3763919|P1|Overall Study|Technical Problems|3
1146002|NCT01370616|3763918|P2|Overall Study|Recovery|0
1146003|NCT01370616|3763919|P1|Overall Study|Recovery|1
1146004|NCT01370616|3763918|P2|Overall Study|Progressive Disease|1
1146005|NCT01370616|3763919|P1|Overall Study|Progressive Disease|0
1146006|NCT01370616|3763918|P2|Overall Study|Physician Decision|6
1146007|NCT01370616|3763919|P1|Overall Study|Physician Decision|6
1146008|NCT01370616|3763918|P2|Overall Study|Lost to Follow-up|3
1146009|NCT01370616|3763919|P1|Overall Study|Lost to Follow-up|0
1146010|NCT01370616|3763918|P2|Overall Study|Lack of Efficacy|2
1146011|NCT01370616|3763919|P1|Overall Study|Lack of Efficacy|6
1146012|NCT01370616|3763918|P2|Overall Study|Death|0
1146013|NCT01370616|3763919|P1|Overall Study|Death|1
1146014|NCT01370616|3763918|P2|Overall Study|Adverse Event|16
1146015|NCT01370616|3763919|P1|Overall Study|Adverse Event|11
1146016|NCT01370603|3763943|P2|Period 2|Withdrawal by Subject|0
1146017|NCT01370603|3763944|P1|Period 2|Withdrawal by Subject|1
1146018|NCT01370603|3763943|P2|Period 2|Lost to Follow-up|0
1146019|NCT01370603|3763944|P1|Period 2|Lost to Follow-up|1
1146020|NCT01370603|3763943|P2|Period 2|Adverse Event|4
1146021|NCT01370603|3763944|P1|Period 2|Adverse Event|1
1146022|NCT01370603|3763943|P2|Crossover Washout|Non-compliance with Study Drug|2
1146023|NCT01370603|3763944|P1|Crossover Washout|Non-compliance with Study Drug|0
1146024|NCT01370603|3763943|P2|Crossover Washout|Withdrawal by Subject|1
1146025|NCT01370603|3763944|P1|Crossover Washout|Withdrawal by Subject|4
1146026|NCT01370603|3763943|P2|Crossover Washout|Protocol Violation|0
1146027|NCT01370603|3763944|P1|Crossover Washout|Protocol Violation|1
1146028|NCT01370603|3763943|P2|Crossover Washout|Lost to Follow-up|0
1146029|NCT01370603|3763944|P1|Crossover Washout|Lost to Follow-up|2
1146030|NCT01370603|3763943|P2|Crossover Washout|Adverse Event|1
1146031|NCT01370603|3763944|P1|Crossover Washout|Adverse Event|2
1146032|NCT01370603|3763943|P2|Period 1|Withdrawal by Subject|5
1146033|NCT01370603|3763944|P1|Period 1|Withdrawal by Subject|5
1146034|NCT01370603|3763943|P2|Period 1|Protocol Violation|2
1146035|NCT01370603|3763944|P1|Period 1|Protocol Violation|2
1146036|NCT01370603|3763943|P2|Period 1|Lost to Follow-up|0
1146037|NCT01370603|3763944|P1|Period 1|Lost to Follow-up|2
1146038|NCT01370603|3763943|P2|Period 1|Adverse Event|3
1146039|NCT01370603|3763944|P1|Period 1|Adverse Event|5
1146040|NCT01370590|3763962|P2|Period 2|Withdrawal by Subject|1
1146041|NCT01370590|3763963|P1|Period 2|Withdrawal by Subject|1
1146042|NCT01370590|3763962|P2|Period 2|Adverse Event|1
1146043|NCT01370590|3763963|P1|Period 2|Adverse Event|0
1146044|NCT01370590|3763962|P2|Crossover Washout Period|Withdrawal by Subject|2
1146045|NCT01370590|3763963|P1|Crossover Washout Period|Withdrawal by Subject|2
1146046|NCT01370590|3763962|P2|Crossover Washout Period|Non-compliance with Study Drug|0
1146047|NCT01370590|3763963|P1|Crossover Washout Period|Non-compliance with Study Drug|1
1146048|NCT01370590|3763962|P2|Crossover Washout Period|Lost to Follow-up|0
1146049|NCT01370590|3763963|P1|Crossover Washout Period|Lost to Follow-up|2
1146050|NCT01370590|3763962|P2|Crossover Washout Period|Adverse Event|4
1146051|NCT01370590|3763963|P1|Crossover Washout Period|Adverse Event|1
1146052|NCT01370590|3763962|P2|Period 1|Could not access randomization system|1
1146053|NCT01370590|3763963|P1|Period 1|Could not access randomization system|0
1146054|NCT01370590|3763962|P2|Period 1|Withdrawal by Subject|2
1146055|NCT01370590|3763963|P1|Period 1|Withdrawal by Subject|4
1146056|NCT01370590|3763962|P2|Period 1|Protocol Violation|2
1146057|NCT01370590|3763963|P1|Period 1|Protocol Violation|2
1146058|NCT01370590|3763962|P2|Period 1|Lost to Follow-up|2
1146059|NCT01370590|3763963|P1|Period 1|Lost to Follow-up|2
1146060|NCT01370590|3763962|P2|Period 1|Adverse Event|4
1146061|NCT01370590|3763963|P1|Period 1|Adverse Event|8
1146062|NCT01370538|3763991|P2|Overall Study|Lost to follow up|10
1146063|NCT01370538|3763992|P1|Overall Study|Lost to follow up|6
1146064|NCT01370538|3763991|P2|Overall Study|Development of study specific withdrawal|1
1146065|NCT01370538|3763992|P1|Overall Study|Development of study specific withdrawal|1
1146066|NCT01370538|3763991|P2|Overall Study|Protocol Violation|5
1146067|NCT01370538|3763992|P1|Overall Study|Protocol Violation|8
1146068|NCT01370538|3763991|P2|Overall Study|Adverse Event|0
1146069|NCT01370538|3763992|P1|Overall Study|Adverse Event|1
1146070|NCT01370538|3763991|P2|Overall Study|Eligibility criteria not fulfilled|1
1146071|NCT01370538|3763992|P1|Overall Study|Eligibility criteria not fulfilled|0
1146072|NCT01370538|3763991|P2|Overall Study|Voluntary Discontinuation by Subject|2
1146073|NCT01370538|3763992|P1|Overall Study|Voluntary Discontinuation by Subject|3
1146074|NCT01370525|3764008|P2|Overall Study|Lost to follow up|6
1146075|NCT01370525|3764009|P1|Overall Study|Lost to follow up|2
1146076|NCT01370525|3764008|P2|Overall Study|Protocol Violation|1
1146077|NCT01370525|3764009|P1|Overall Study|Protocol Violation|2
1146078|NCT01370525|3764008|P2|Overall Study|Adverse Event|1
1146079|NCT01370525|3764009|P1|Overall Study|Adverse Event|0
1146080|NCT01370525|3764008|P2|Overall Study|Eligibility criteria not fulfilled|0
1146081|NCT01370525|3764009|P1|Overall Study|Eligibility criteria not fulfilled|2
1146082|NCT01370525|3764008|P2|Overall Study|Voluntary Discontinuation by Subject|3
1146083|NCT01370525|3764009|P1|Overall Study|Voluntary Discontinuation by Subject|2
1146084|NCT01370499|3764025|P2|Overall Study|Sponsor Decision|15
1146085|NCT01370499|3764026|P1|Overall Study|Sponsor Decision|41
1146086|NCT01370499|3764025|P2|Overall Study|Withdrawal by Subject|7
1146087|NCT01370499|3764026|P1|Overall Study|Withdrawal by Subject|18
1146088|NCT01370499|3764025|P2|Overall Study|Protocol Violation|4
1146089|NCT01370499|3764026|P1|Overall Study|Protocol Violation|5
1146090|NCT01370499|3764025|P2|Overall Study|Physician Decision|3
1146091|NCT01370499|3764026|P1|Overall Study|Physician Decision|3
1146092|NCT01370499|3764025|P2|Overall Study|Lost to Follow-up|1
1146093|NCT01370499|3764026|P1|Overall Study|Lost to Follow-up|2
1146094|NCT01370499|3764025|P2|Overall Study|Lack of Efficacy|2
1146095|NCT01370499|3764026|P1|Overall Study|Lack of Efficacy|4
1146096|NCT01370499|3764025|P2|Overall Study|Adverse Event|12
1146097|NCT01370499|3764026|P1|Overall Study|Adverse Event|38
1146098|NCT01370408|3764068|P1|Overall Study|treatment failure|9
1146099|NCT01370356|3764128|P2|Overall Study|AE Not Related to Study Drug|4
1146100|NCT01370356|3764129|P1|Overall Study|AE Not Related to Study Drug|1
1146101|NCT01370356|3764128|P2|Overall Study|Adverse event (AE) Related to Study Drug|9
1146102|NCT01370356|3764129|P1|Overall Study|Adverse event (AE) Related to Study Drug|12
1146103|NCT01370356|3764128|P2|Overall Study|Protocol Violation|3
1146104|NCT01370356|3764129|P1|Overall Study|Protocol Violation|3
1146105|NCT01370356|3764128|P2|Overall Study|Reason not specified|43
1146106|NCT01370356|3764129|P1|Overall Study|Reason not specified|39
1146107|NCT01370356|3764128|P2|Overall Study|Withdrawal by Subject|59
1146108|NCT01370356|3764129|P1|Overall Study|Withdrawal by Subject|54
1146109|NCT01370356|3764128|P2|Overall Study|Lost to Follow-up|81
1146110|NCT01370356|3764129|P1|Overall Study|Lost to Follow-up|76
1146111|NCT01370356|3764128|P2|Overall Study|Lack of Efficacy|28
1146112|NCT01370356|3764129|P1|Overall Study|Lack of Efficacy|6
1146113|NCT01370356|3764128|P2|Overall Study|Death|0
1146114|NCT01370356|3764129|P1|Overall Study|Death|1
1146115|NCT01370265|3764143|P2|First Intervention|Adverse Event|1
1146116|NCT01370265|3764144|P1|First Intervention|Adverse Event|1
1146117|NCT01370083|3764163|P2|Overall Study|Adverse Event|1
1146118|NCT01370083|3764164|P1|Overall Study|Adverse Event|0
1146119|NCT01370083|3764163|P2|Overall Study|Lost to Follow-up|0
1146120|NCT01370083|3764164|P1|Overall Study|Lost to Follow-up|2
1146121|NCT01370005|3764177|P3|Overall Study|Other reason not defined above|2
1146122|NCT01370005|3764178|P2|Overall Study|Other reason not defined above|0
1146123|NCT01370005|3764179|P1|Overall Study|Other reason not defined above|3
1146124|NCT01370005|3764177|P3|Overall Study|Patient refusal to continue,not due toAE|0
1146125|NCT01370005|3764178|P2|Overall Study|Patient refusal to continue,not due toAE|4
1146126|NCT01370005|3764179|P1|Overall Study|Patient refusal to continue,not due toAE|5
1146127|NCT01370005|3764177|P3|Overall Study|Lost to Follow-up|1
1146128|NCT01370005|3764178|P2|Overall Study|Lost to Follow-up|1
1146129|NCT01370005|3764179|P1|Overall Study|Lost to Follow-up|1
1146130|NCT01370005|3764177|P3|Overall Study|Non compliant with protocol|2
1146131|NCT01370005|3764178|P2|Overall Study|Non compliant with protocol|1
1146132|NCT01370005|3764179|P1|Overall Study|Non compliant with protocol|0
1146133|NCT01370005|3764177|P3|Overall Study|Lack of Efficacy|0
1146134|NCT01370005|3764178|P2|Overall Study|Lack of Efficacy|0
1146135|NCT01370005|3764179|P1|Overall Study|Lack of Efficacy|1
1146136|NCT01370005|3764177|P3|Overall Study|Adverse Event|6
1146137|NCT01370005|3764178|P2|Overall Study|Adverse Event|5
1146138|NCT01370005|3764179|P1|Overall Study|Adverse Event|5
1146139|NCT01370005|3764177|P3|Overall Study|Not treated|0
1146140|NCT01370005|3764178|P2|Overall Study|Not treated|0
1146141|NCT01370005|3764179|P1|Overall Study|Not treated|1
1146142|NCT01369849|3764261|P3|Overall Study|Ineligible after receiving treatment|0
1146143|NCT01369849|3764262|P2|Overall Study|Ineligible after receiving treatment|1
1146144|NCT01369849|3764263|P1|Overall Study|Ineligible after receiving treatment|0
1146145|NCT01369849|3764261|P3|Overall Study|Ineligible prior to treatment|1
1146146|NCT01369849|3764262|P2|Overall Study|Ineligible prior to treatment|0
1146147|NCT01369849|3764263|P1|Overall Study|Ineligible prior to treatment|0
1146148|NCT01369784|3764285|P1|Overall Study|Protocol Violation|12
1146149|NCT01369680|3764373|P4|Overall Study|Lost to Follow-up|2
1146150|NCT01369680|3764374|P3|Overall Study|Lost to Follow-up|1
1146151|NCT01369680|3764375|P2|Overall Study|Lost to Follow-up|0
1146152|NCT01369680|3764376|P1|Overall Study|Lost to Follow-up|0
1146153|NCT01369641|3764397|P1|Overall Study|Withdrawal by Subject|1
1146154|NCT01369615|3764403|P2|Overall Study|Lost to Follow-up|1
1146155|NCT01369615|3764404|P1|Overall Study|Lost to Follow-up|0
1146156|NCT01369615|3764403|P2|Overall Study|Withdrawal by Subject|1
1146157|NCT01369615|3764404|P1|Overall Study|Withdrawal by Subject|0
1146158|NCT01369511|3764414|P4|Overall Study|Withdrawal by Subject|6
1146159|NCT01369511|3764415|P3|Overall Study|Withdrawal by Subject|4
1146160|NCT01369511|3764416|P2|Overall Study|Withdrawal by Subject|6
1146161|NCT01369511|3764417|P1|Overall Study|Withdrawal by Subject|5
1146162|NCT01369511|3764414|P4|Overall Study|Sponsor decision|0
1146163|NCT01369511|3764415|P3|Overall Study|Sponsor decision|1
1146164|NCT01369511|3764416|P2|Overall Study|Sponsor decision|0
1146165|NCT01369511|3764417|P1|Overall Study|Sponsor decision|2
1146166|NCT01369511|3764414|P4|Overall Study|Physician Decision|0
1146167|NCT01369511|3764415|P3|Overall Study|Physician Decision|0
1146168|NCT01369511|3764416|P2|Overall Study|Physician Decision|4
1146169|NCT01369511|3764417|P1|Overall Study|Physician Decision|3
1146170|NCT01369511|3764414|P4|Overall Study|Protocol Violation|2
1146171|NCT01369511|3764415|P3|Overall Study|Protocol Violation|0
1146172|NCT01369511|3764416|P2|Overall Study|Protocol Violation|1
1146173|NCT01369511|3764417|P1|Overall Study|Protocol Violation|0
1146174|NCT01369511|3764414|P4|Overall Study|Lost to Follow-up|2
1146175|NCT01369511|3764415|P3|Overall Study|Lost to Follow-up|1
1146176|NCT01369511|3764416|P2|Overall Study|Lost to Follow-up|1
1146177|NCT01369511|3764417|P1|Overall Study|Lost to Follow-up|0
1146178|NCT01369511|3764414|P4|Overall Study|Entry criteria not met|1
1146179|NCT01369511|3764415|P3|Overall Study|Entry criteria not met|0
1146180|NCT01369511|3764416|P2|Overall Study|Entry criteria not met|0
1146181|NCT01369511|3764417|P1|Overall Study|Entry criteria not met|2
1146182|NCT01369511|3764414|P4|Overall Study|Adverse Event|0
1146183|NCT01369511|3764415|P3|Overall Study|Adverse Event|5
1146184|NCT01369511|3764416|P2|Overall Study|Adverse Event|1
1146185|NCT01369511|3764417|P1|Overall Study|Adverse Event|1
1146186|NCT01369485|3764433|P2|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3
1146187|NCT01369485|3764434|P1|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0
1146188|NCT01369485|3764433|P2|Open Label Phase (Week 12 to Month 12)|Death|1
1146189|NCT01369485|3764434|P1|Open Label Phase (Week 12 to Month 12)|Death|0
1146190|NCT01369485|3764433|P2|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20
1146191|NCT01369485|3764434|P1|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17
1146192|NCT01369485|3764433|P2|Open Label Phase (Week 12 to Month 12)|Physician Decision|4
1146193|NCT01369485|3764434|P1|Open Label Phase (Week 12 to Month 12)|Physician Decision|3
1146194|NCT01369485|3764433|P2|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3
1146195|NCT01369485|3764434|P1|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2
1146196|NCT01369485|3764433|P2|Open Label Phase (Week 12 to Month 12)|Adverse Event|9
1146197|NCT01369485|3764434|P1|Open Label Phase (Week 12 to Month 12)|Adverse Event|11
1146198|NCT01369485|3764433|P2|Randomized Phase (Day 0 to Week 12)|expired patches|0
1146199|NCT01369485|3764434|P1|Randomized Phase (Day 0 to Week 12)|expired patches|2
1146200|NCT01369485|3764433|P2|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4
1146201|NCT01369485|3764434|P1|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2
1146202|NCT01369485|3764433|P2|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8
1146203|NCT01369485|3764434|P1|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12
1146204|NCT01369485|3764433|P2|Randomized Phase (Day 0 to Week 12)|Adverse Event|5
1146205|NCT01369485|3764434|P1|Randomized Phase (Day 0 to Week 12)|Adverse Event|7
1146206|NCT01369355|3764480|P6|Overall Study|Not Treated|0
1146207|NCT01369355|3764481|P5|Overall Study|Not Treated|0
1146208|NCT01369355|3764482|P4|Overall Study|Not Treated|0
1146209|NCT01369355|3764483|P3|Overall Study|Not Treated|1
1146210|NCT01369355|3764484|P2|Overall Study|Not Treated|0
1146211|NCT01369355|3764485|P1|Overall Study|Not Treated|0
1146212|NCT01369355|3764480|P6|Overall Study|Other|0
1146213|NCT01369355|3764481|P5|Overall Study|Other|1
1146214|NCT01369355|3764482|P4|Overall Study|Other|0
1146215|NCT01369355|3764483|P3|Overall Study|Other|0
1146216|NCT01369355|3764484|P2|Overall Study|Other|0
1146217|NCT01369355|3764485|P1|Overall Study|Other|0
1146218|NCT01369355|3764480|P6|Overall Study|Withdrawal by Subject|22
1146219|NCT01369355|3764481|P5|Overall Study|Withdrawal by Subject|8
1146220|NCT01369355|3764482|P4|Overall Study|Withdrawal by Subject|6
1146221|NCT01369355|3764483|P3|Overall Study|Withdrawal by Subject|7
1146222|NCT01369355|3764484|P2|Overall Study|Withdrawal by Subject|2
1146223|NCT01369355|3764485|P1|Overall Study|Withdrawal by Subject|6
1146224|NCT01369355|3764480|P6|Overall Study|Lost to Follow-up|6
1146225|NCT01369355|3764481|P5|Overall Study|Lost to Follow-up|5
1146226|NCT01369355|3764482|P4|Overall Study|Lost to Follow-up|2
1146227|NCT01369355|3764483|P3|Overall Study|Lost to Follow-up|1
1146228|NCT01369355|3764484|P2|Overall Study|Lost to Follow-up|0
1146229|NCT01369355|3764485|P1|Overall Study|Lost to Follow-up|1
1146230|NCT01369355|3764480|P6|Overall Study|Protocol Violation|2
1146231|NCT01369355|3764481|P5|Overall Study|Protocol Violation|0
1146232|NCT01369355|3764482|P4|Overall Study|Protocol Violation|0
1146233|NCT01369355|3764483|P3|Overall Study|Protocol Violation|1
1146234|NCT01369355|3764484|P2|Overall Study|Protocol Violation|1
1146235|NCT01369355|3764485|P1|Overall Study|Protocol Violation|0
1146236|NCT01369355|3764480|P6|Overall Study|Lack of Efficacy|217
1146237|NCT01369355|3764481|P5|Overall Study|Lack of Efficacy|126
1146238|NCT01369355|3764482|P4|Overall Study|Lack of Efficacy|15
1146239|NCT01369355|3764483|P3|Overall Study|Lack of Efficacy|15
1146240|NCT01369355|3764484|P2|Overall Study|Lack of Efficacy|14
1146241|NCT01369355|3764485|P1|Overall Study|Lack of Efficacy|15
1146242|NCT01369355|3764480|P6|Overall Study|Adverse Event|25
1146243|NCT01369355|3764481|P5|Overall Study|Adverse Event|14
1146244|NCT01369355|3764482|P4|Overall Study|Adverse Event|7
1146245|NCT01369355|3764483|P3|Overall Study|Adverse Event|6
1146246|NCT01369355|3764484|P2|Overall Study|Adverse Event|12
1146247|NCT01369355|3764485|P1|Overall Study|Adverse Event|9
1146248|NCT01369342|3764514|P3|Overall Study|Not Treated|0
1146249|NCT01369342|3764515|P2|Overall Study|Not Treated|0
1146250|NCT01369342|3764516|P1|Overall Study|Not Treated|1
1146251|NCT01369342|3764514|P3|Overall Study|Lost to Follow-up|1
1146252|NCT01369342|3764515|P2|Overall Study|Lost to Follow-up|2
1146253|NCT01369342|3764516|P1|Overall Study|Lost to Follow-up|5
1146254|NCT01369342|3764514|P3|Overall Study|Withdrawal by Subject|2
1146255|NCT01369342|3764515|P2|Overall Study|Withdrawal by Subject|7
1146256|NCT01369342|3764516|P1|Overall Study|Withdrawal by Subject|7
1146257|NCT01369329|3764539|P3|Overall Study|Other|2
1146258|NCT01369329|3764540|P2|Overall Study|Other|3
1146259|NCT01369329|3764541|P1|Overall Study|Other|2
1146260|NCT01369329|3764539|P3|Overall Study|Lost to Follow-up|2
1146261|NCT01369329|3764540|P2|Overall Study|Lost to Follow-up|2
1146262|NCT01369329|3764541|P1|Overall Study|Lost to Follow-up|2
1146263|NCT01369329|3764539|P3|Overall Study|Withdrawal by Subject|10
1146264|NCT01369329|3764540|P2|Overall Study|Withdrawal by Subject|6
1146265|NCT01369329|3764541|P1|Overall Study|Withdrawal by Subject|8
1146266|NCT01369225|3764567|P6|Overall Study|Adverse Event|0
1146267|NCT01369225|3764568|P5|Overall Study|Adverse Event|1
1146268|NCT01369225|3764569|P4|Overall Study|Adverse Event|1
1146269|NCT01369225|3764570|P3|Overall Study|Adverse Event|0
1146270|NCT01369225|3764571|P2|Overall Study|Adverse Event|0
1146271|NCT01369225|3764572|P1|Overall Study|Adverse Event|0
1146272|NCT01369225|3764567|P6|Overall Study|Other|0
1146273|NCT01369225|3764568|P5|Overall Study|Other|1
1146274|NCT01369225|3764569|P4|Overall Study|Other|0
1146275|NCT01369225|3764570|P3|Overall Study|Other|0
1146276|NCT01369225|3764571|P2|Overall Study|Other|0
1146277|NCT01369225|3764572|P1|Overall Study|Other|1
1146278|NCT01369225|3764567|P6|Overall Study|Does Not Meet Entrance Criteria|0
1146279|NCT01369225|3764568|P5|Overall Study|Does Not Meet Entrance Criteria|0
1146280|NCT01369225|3764569|P4|Overall Study|Does Not Meet Entrance Criteria|0
1146281|NCT01369225|3764570|P3|Overall Study|Does Not Meet Entrance Criteria|1
1146282|NCT01369225|3764571|P2|Overall Study|Does Not Meet Entrance Criteria|0
1146283|NCT01369225|3764572|P1|Overall Study|Does Not Meet Entrance Criteria|0
1146284|NCT01369225|3764567|P6|Overall Study|Withdrawal by Subject|0
1146285|NCT01369225|3764568|P5|Overall Study|Withdrawal by Subject|0
1146286|NCT01369225|3764569|P4|Overall Study|Withdrawal by Subject|1
1146287|NCT01369225|3764570|P3|Overall Study|Withdrawal by Subject|2
1146288|NCT01369225|3764571|P2|Overall Study|Withdrawal by Subject|0
1146289|NCT01369225|3764572|P1|Overall Study|Withdrawal by Subject|1
1146290|NCT01369199|3764664|P1|Overall Study|Lost to Follow-up|2
1146291|NCT01369199|3764664|P1|Overall Study|Withdrawal by Subject|1
1146292|NCT01368965|3764699|P1|Overall Study|Lost to Follow-up|12
1146293|NCT01368900|3764708|P1|Overall Study|Lost to Follow-up|7
1146294|NCT01368835|3764783|P1|Overall Study|Lost to Follow-up|11
1146295|NCT01368835|3764783|P1|Overall Study|Inclusion criteria/photography quality|22
1146296|NCT01368536|3764825|P3|Overall Study|Protocol deviation|1
1146297|NCT01368536|3764826|P2|Overall Study|Protocol deviation|3
1146298|NCT01368536|3764827|P1|Overall Study|Protocol deviation|0
1146299|NCT01368536|3764825|P3|Overall Study|Administrative problems|35
1146300|NCT01368536|3764826|P2|Overall Study|Administrative problems|39
1146301|NCT01368536|3764827|P1|Overall Study|Administrative problems|34
1146302|NCT01368536|3764825|P3|Overall Study|Lost to Follow-up|5
1146303|NCT01368536|3764826|P2|Overall Study|Lost to Follow-up|3
1146304|NCT01368536|3764827|P1|Overall Study|Lost to Follow-up|3
1146305|NCT01368536|3764825|P3|Overall Study|Withdrawal by Subject|4
1146306|NCT01368536|3764826|P2|Overall Study|Withdrawal by Subject|5
1146307|NCT01368536|3764827|P1|Overall Study|Withdrawal by Subject|2
1146308|NCT01368536|3764825|P3|Overall Study|No longer required study medication|1
1146309|NCT01368536|3764826|P2|Overall Study|No longer required study medication|0
1146310|NCT01368536|3764827|P1|Overall Study|No longer required study medication|0
1146311|NCT01368536|3764825|P3|Overall Study|Unsatisfactory therapeutic effect|2
1146312|NCT01368536|3764826|P2|Overall Study|Unsatisfactory therapeutic effect|2
1146313|NCT01368536|3764827|P1|Overall Study|Unsatisfactory therapeutic effect|7
1146314|NCT01368536|3764825|P3|Overall Study|Abnormal test procedure result(s)|1
1146315|NCT01368536|3764826|P2|Overall Study|Abnormal test procedure result(s)|0
1146316|NCT01368536|3764827|P1|Overall Study|Abnormal test procedure result(s)|0
1146317|NCT01368536|3764825|P3|Overall Study|Abnormal laboratory value(s)|2
1146318|NCT01368536|3764826|P2|Overall Study|Abnormal laboratory value(s)|1
1146319|NCT01368536|3764827|P1|Overall Study|Abnormal laboratory value(s)|0
1146320|NCT01368536|3764825|P3|Overall Study|Adverse Event|8
1146321|NCT01368536|3764826|P2|Overall Study|Adverse Event|6
1146322|NCT01368536|3764827|P1|Overall Study|Adverse Event|5
1146323|NCT01368497|3764848|P1|Overall Study|Lost to Follow-up|2
1146324|NCT01368432|3764876|P2|Overall Study|Lost to Follow-up|1
1146325|NCT01368432|3764877|P1|Overall Study|Lost to Follow-up|0
1146326|NCT01368406|3764911|P2|Overall Study|started working|3
1146327|NCT01368406|3764912|P1|Overall Study|started working|2
1146328|NCT01368406|3764911|P2|Overall Study|relapse of the disease|2
1146329|NCT01368406|3764912|P1|Overall Study|relapse of the disease|3
1146330|NCT01368406|3764911|P2|Overall Study|Withdrawal by Subject|4
1146331|NCT01368406|3764912|P1|Overall Study|Withdrawal by Subject|8
1146332|NCT01368406|3764911|P2|Overall Study|Lost to Follow-up|4
1146333|NCT01368406|3764912|P1|Overall Study|Lost to Follow-up|8
1146334|NCT01368276|3764920|P2|Overall Study|Death|10
1146335|NCT01368276|3764921|P1|Overall Study|Death|1
1146336|NCT01368211|3764958|P2|Second Platelets Transfusion|No need for additional transfusion|2
1146337|NCT01368211|3764959|P1|Second Platelets Transfusion|No need for additional transfusion|1
1146338|NCT01368081|3764987|P13|Overall Study|Other reason not defined above|3
1146339|NCT01368081|3764988|P12|Overall Study|Other reason not defined above|0
1146340|NCT01368081|3764989|P11|Overall Study|Other reason not defined above|0
1146341|NCT01368081|3764990|P10|Overall Study|Other reason not defined above|1
1146342|NCT01368081|3764991|P9|Overall Study|Other reason not defined above|0
1146343|NCT01368081|3764992|P8|Overall Study|Other reason not defined above|0
1146344|NCT01368081|3764993|P7|Overall Study|Other reason not defined above|2
1146345|NCT01368081|3764994|P6|Overall Study|Other reason not defined above|1
1146346|NCT01368081|3764995|P5|Overall Study|Other reason not defined above|0
1146347|NCT01368081|3764996|P4|Overall Study|Other reason not defined above|1
1146348|NCT01368081|3764997|P3|Overall Study|Other reason not defined above|0
1146349|NCT01368081|3764998|P2|Overall Study|Other reason not defined above|0
1146350|NCT01368081|3764999|P1|Overall Study|Other reason not defined above|2
1146351|NCT01368081|3764987|P13|Overall Study|Withdrawal by Subject|0
1146352|NCT01368081|3764988|P12|Overall Study|Withdrawal by Subject|2
1146353|NCT01368081|3764989|P11|Overall Study|Withdrawal by Subject|3
1146354|NCT01368081|3764990|P10|Overall Study|Withdrawal by Subject|4
1146355|NCT01368081|3764991|P9|Overall Study|Withdrawal by Subject|5
1146356|NCT01368081|3764992|P8|Overall Study|Withdrawal by Subject|2
1146357|NCT01368081|3764993|P7|Overall Study|Withdrawal by Subject|4
1146358|NCT01368081|3764994|P6|Overall Study|Withdrawal by Subject|3
1146359|NCT01368081|3764995|P5|Overall Study|Withdrawal by Subject|0
1146360|NCT01368081|3764996|P4|Overall Study|Withdrawal by Subject|1
1146361|NCT01368081|3764997|P3|Overall Study|Withdrawal by Subject|1
1146362|NCT01368081|3764998|P2|Overall Study|Withdrawal by Subject|4
1146363|NCT01368081|3764999|P1|Overall Study|Withdrawal by Subject|4
1146364|NCT01368081|3764987|P13|Overall Study|Lost to Follow-up|1
1146365|NCT01368081|3764988|P12|Overall Study|Lost to Follow-up|0
1146366|NCT01368081|3764989|P11|Overall Study|Lost to Follow-up|0
1146367|NCT01368081|3764990|P10|Overall Study|Lost to Follow-up|0
1146368|NCT01368081|3764991|P9|Overall Study|Lost to Follow-up|0
1146369|NCT01368081|3764992|P8|Overall Study|Lost to Follow-up|0
1146370|NCT01368081|3764993|P7|Overall Study|Lost to Follow-up|0
1146371|NCT01368081|3764994|P6|Overall Study|Lost to Follow-up|0
1146372|NCT01368081|3764995|P5|Overall Study|Lost to Follow-up|0
1146373|NCT01368081|3764996|P4|Overall Study|Lost to Follow-up|0
1146374|NCT01368081|3764997|P3|Overall Study|Lost to Follow-up|0
1146375|NCT01368081|3764998|P2|Overall Study|Lost to Follow-up|0
1146376|NCT01368081|3764999|P1|Overall Study|Lost to Follow-up|0
1146377|NCT01368081|3764987|P13|Overall Study|Protocol Violation|0
1146378|NCT01368081|3764988|P12|Overall Study|Protocol Violation|0
1146379|NCT01368081|3764989|P11|Overall Study|Protocol Violation|0
1146380|NCT01368081|3764990|P10|Overall Study|Protocol Violation|0
1146381|NCT01368081|3764991|P9|Overall Study|Protocol Violation|0
1146382|NCT01368081|3764992|P8|Overall Study|Protocol Violation|1
1146383|NCT01368081|3764993|P7|Overall Study|Protocol Violation|0
1146384|NCT01368081|3764994|P6|Overall Study|Protocol Violation|1
1146385|NCT01368081|3764995|P5|Overall Study|Protocol Violation|0
1146386|NCT01368081|3764996|P4|Overall Study|Protocol Violation|0
1146387|NCT01368081|3764997|P3|Overall Study|Protocol Violation|0
1146388|NCT01368081|3764998|P2|Overall Study|Protocol Violation|0
1146389|NCT01368081|3764999|P1|Overall Study|Protocol Violation|0
1146390|NCT01368081|3764987|P13|Overall Study|Lack of Efficacy|0
1146391|NCT01368081|3764988|P12|Overall Study|Lack of Efficacy|0
1146392|NCT01368081|3764989|P11|Overall Study|Lack of Efficacy|0
1146393|NCT01368081|3764990|P10|Overall Study|Lack of Efficacy|0
1146394|NCT01368081|3764991|P9|Overall Study|Lack of Efficacy|0
1146395|NCT01368081|3764992|P8|Overall Study|Lack of Efficacy|2
1146396|NCT01368081|3764993|P7|Overall Study|Lack of Efficacy|0
1146397|NCT01368081|3764994|P6|Overall Study|Lack of Efficacy|0
1146398|NCT01368081|3764995|P5|Overall Study|Lack of Efficacy|0
1146399|NCT01368081|3764996|P4|Overall Study|Lack of Efficacy|1
1146400|NCT01368081|3764997|P3|Overall Study|Lack of Efficacy|0
1146401|NCT01368081|3764998|P2|Overall Study|Lack of Efficacy|1
1146402|NCT01368081|3764999|P1|Overall Study|Lack of Efficacy|0
1146403|NCT01368081|3764987|P13|Overall Study|Adverse Event|3
1146404|NCT01368081|3764988|P12|Overall Study|Adverse Event|1
1146405|NCT01368081|3764989|P11|Overall Study|Adverse Event|6
1146406|NCT01368081|3764990|P10|Overall Study|Adverse Event|5
1146407|NCT01368081|3764991|P9|Overall Study|Adverse Event|3
1146408|NCT01368081|3764992|P8|Overall Study|Adverse Event|2
1146409|NCT01368081|3764993|P7|Overall Study|Adverse Event|6
1146410|NCT01368081|3764994|P6|Overall Study|Adverse Event|5
1146411|NCT01368081|3764995|P5|Overall Study|Adverse Event|2
1146412|NCT01368081|3764996|P4|Overall Study|Adverse Event|2
1146413|NCT01368081|3764997|P3|Overall Study|Adverse Event|3
1146414|NCT01368081|3764998|P2|Overall Study|Adverse Event|4
1146415|NCT01368081|3764999|P1|Overall Study|Adverse Event|4
1146416|NCT01368042|3765053|P1|Overall Study|Transplanted|1
1146417|NCT01368042|3765053|P1|Overall Study|Lost to Follow-up|4
1146418|NCT01368042|3765053|P1|Overall Study|Protocol Violation|11
1146419|NCT01368042|3765053|P1|Overall Study|Death|14
1146420|NCT01367886|3765073|P1|Overall Study|Death|1
1146421|NCT01367886|3765073|P1|Overall Study|Lack of Efficacy|2
1146422|NCT01367886|3765073|P1|Overall Study|Lost to Follow-up|4
1146423|NCT01367847|3765123|P2|Overall Study|Withdrawal by Subject|2
1146424|NCT01367847|3765124|P1|Overall Study|Withdrawal by Subject|2
1146425|NCT01367834|3765140|P2|Overall Study|Study was ended.|1
1146426|NCT01367834|3765141|P1|Overall Study|Study was ended.|0
1146427|NCT01367834|3765140|P2|Overall Study|Withdrawal by Subject|2
1146428|NCT01367834|3765141|P1|Overall Study|Withdrawal by Subject|2
1146429|NCT01367704|3765165|P2|Overall Study|Lost to Follow-up|161
1146430|NCT01367704|3765166|P1|Overall Study|Lost to Follow-up|47
1146431|NCT01367457|3765179|P3|Overall Study|Suspected DP/suspected active infection|0
1146432|NCT01367457|3765180|P2|Overall Study|Suspected DP/suspected active infection|0
1146433|NCT01367457|3765181|P1|Overall Study|Suspected DP/suspected active infection|1
1146434|NCT01367457|3765179|P3|Overall Study|Palliative. Overall decline|0
1146435|NCT01367457|3765180|P2|Overall Study|Palliative. Overall decline|0
1146436|NCT01367457|3765181|P1|Overall Study|Palliative. Overall decline|1
1146437|NCT01367457|3765179|P3|Overall Study|Patient's Wish|0
1146438|NCT01367457|3765180|P2|Overall Study|Patient's Wish|0
1146439|NCT01367457|3765181|P1|Overall Study|Patient's Wish|1
1146440|NCT01367457|3765179|P3|Overall Study|CD, Suspected disease progression (DP)|0
1146441|NCT01367457|3765180|P2|Overall Study|CD, Suspected disease progression (DP)|0
1146442|NCT01367457|3765181|P1|Overall Study|CD, Suspected disease progression (DP)|1
1146443|NCT01367457|3765179|P3|Overall Study|Death from septic shock|0
1146444|NCT01367457|3765180|P2|Overall Study|Death from septic shock|0
1146445|NCT01367457|3765181|P1|Overall Study|Death from septic shock|1
1146446|NCT01367457|3765179|P3|Overall Study|Lost to Follow-up|0
1146447|NCT01367457|3765180|P2|Overall Study|Lost to Follow-up|0
1146448|NCT01367457|3765181|P1|Overall Study|Lost to Follow-up|1
1146449|NCT01367457|3765179|P3|Overall Study|Rejection of treatment|0
1146450|NCT01367457|3765180|P2|Overall Study|Rejection of treatment|0
1146451|NCT01367457|3765181|P1|Overall Study|Rejection of treatment|1
1146452|NCT01367457|3765179|P3|Overall Study|Overall decline|0
1146453|NCT01367457|3765180|P2|Overall Study|Overall decline|0
1146454|NCT01367457|3765181|P1|Overall Study|Overall decline|1
1146455|NCT01367457|3765179|P3|Overall Study|Intestinal obstruction with necrosis|0
1146456|NCT01367457|3765180|P2|Overall Study|Intestinal obstruction with necrosis|0
1146457|NCT01367457|3765181|P1|Overall Study|Intestinal obstruction with necrosis|1
1146458|NCT01367457|3765179|P3|Overall Study|No clinical benefit|0
1146459|NCT01367457|3765180|P2|Overall Study|No clinical benefit|0
1146460|NCT01367457|3765181|P1|Overall Study|No clinical benefit|1
1146461|NCT01367457|3765179|P3|Overall Study|Stabilisation + frequent infections|0
1146462|NCT01367457|3765180|P2|Overall Study|Stabilisation + frequent infections|0
1146463|NCT01367457|3765181|P1|Overall Study|Stabilisation + frequent infections|1
1146464|NCT01367457|3765179|P3|Overall Study|Overall status worsens to grade 4|0
1146465|NCT01367457|3765180|P2|Overall Study|Overall status worsens to grade 4|0
1146466|NCT01367457|3765181|P1|Overall Study|Overall status worsens to grade 4|1
1146467|NCT01367457|3765179|P3|Overall Study|Uncontrolled pain|0
1146468|NCT01367457|3765180|P2|Overall Study|Uncontrolled pain|0
1146469|NCT01367457|3765181|P1|Overall Study|Uncontrolled pain|1
1146470|NCT01367457|3765179|P3|Overall Study|CD, associated leukaemia|0
1146471|NCT01367457|3765180|P2|Overall Study|CD, associated leukaemia|0
1146472|NCT01367457|3765181|P1|Overall Study|CD, associated leukaemia|1
1146473|NCT01367457|3765179|P3|Overall Study|Withdrawal by Subject|0
1146474|NCT01367457|3765180|P2|Overall Study|Withdrawal by Subject|0
1146475|NCT01367457|3765181|P1|Overall Study|Withdrawal by Subject|1
1146476|NCT01367457|3765179|P3|Overall Study|Choledocolithiasis and pancreatitis|0
1146477|NCT01367457|3765180|P2|Overall Study|Choledocolithiasis and pancreatitis|0
1146478|NCT01367457|3765181|P1|Overall Study|Choledocolithiasis and pancreatitis|1
1146479|NCT01367457|3765179|P3|Overall Study|low grade toxicities + stable disease|0
1146480|NCT01367457|3765180|P2|Overall Study|low grade toxicities + stable disease|0
1146481|NCT01367457|3765181|P1|Overall Study|low grade toxicities + stable disease|1
1146482|NCT01367457|3765179|P3|Overall Study|3 yr Temsirolimus treatment (no disease)|0
1146483|NCT01367457|3765180|P2|Overall Study|3 yr Temsirolimus treatment (no disease)|0
1146484|NCT01367457|3765181|P1|Overall Study|3 yr Temsirolimus treatment (no disease)|1
1146485|NCT01367457|3765179|P3|Overall Study|Bleeding from cavernous haemangioma|0
1146486|NCT01367457|3765180|P2|Overall Study|Bleeding from cavernous haemangioma|0
1146487|NCT01367457|3765181|P1|Overall Study|Bleeding from cavernous haemangioma|1
1146488|NCT01367457|3765179|P3|Overall Study|Investigator's opinion, stable disease|0
1146489|NCT01367457|3765180|P2|Overall Study|Investigator's opinion, stable disease|0
1146490|NCT01367457|3765181|P1|Overall Study|Investigator's opinion, stable disease|1
1146491|NCT01367457|3765179|P3|Overall Study|Patient asks for rest + slow progression|0
1146492|NCT01367457|3765180|P2|Overall Study|Patient asks for rest + slow progression|0
1146493|NCT01367457|3765181|P1|Overall Study|Patient asks for rest + slow progression|1
1146494|NCT01367457|3765179|P3|Overall Study|Progression|0
1146495|NCT01367457|3765180|P2|Overall Study|Progression|0
1146496|NCT01367457|3765181|P1|Overall Study|Progression|137
1146497|NCT01367457|3765179|P3|Overall Study|Toxicity|0
1146498|NCT01367457|3765180|P2|Overall Study|Toxicity|0
1146499|NCT01367457|3765181|P1|Overall Study|Toxicity|16
1146500|NCT01367457|3765179|P3|Overall Study|Progression and death|0
1146501|NCT01367457|3765180|P2|Overall Study|Progression and death|0
1146502|NCT01367457|3765181|P1|Overall Study|Progression and death|8
1146503|NCT01367457|3765179|P3|Overall Study|Clinical decline (CD)|0
1146504|NCT01367457|3765180|P2|Overall Study|Clinical decline (CD)|0
1146505|NCT01367457|3765181|P1|Overall Study|Clinical decline (CD)|2
1146506|NCT01367457|3765179|P3|Overall Study|Investigator's decision|0
1146507|NCT01367457|3765180|P2|Overall Study|Investigator's decision|0
1146508|NCT01367457|3765181|P1|Overall Study|Investigator's decision|2
1146509|NCT01367457|3765179|P3|Overall Study|Death|0
1146510|NCT01367457|3765180|P2|Overall Study|Death|0
1146511|NCT01367457|3765181|P1|Overall Study|Death|2
1146512|NCT01367249|3765203|P2|Overall Study|Not Specified|10
1146513|NCT01367249|3765204|P1|Overall Study|Not Specified|3
1146514|NCT01367249|3765203|P2|Overall Study|Withdrawal by Subject|6
1146515|NCT01367249|3765204|P1|Overall Study|Withdrawal by Subject|6
1146516|NCT01367158|3765223|P11|Overall Study|Protocol Violation|0
1146517|NCT01367158|3765224|P10|Overall Study|Protocol Violation|0
1146518|NCT01367158|3765225|P9|Overall Study|Protocol Violation|0
1146519|NCT01367158|3765226|P8|Overall Study|Protocol Violation|0
1146520|NCT01367158|3765227|P7|Overall Study|Protocol Violation|0
1146521|NCT01367158|3765228|P6|Overall Study|Protocol Violation|0
1146522|NCT01367158|3765229|P5|Overall Study|Protocol Violation|0
1146523|NCT01367158|3765230|P4|Overall Study|Protocol Violation|0
1146524|NCT01367158|3765231|P3|Overall Study|Protocol Violation|0
1146525|NCT01367158|3765232|P2|Overall Study|Protocol Violation|1
1146526|NCT01367158|3765233|P1|Overall Study|Protocol Violation|0
1146527|NCT01367158|3765223|P11|Overall Study|Lost to Follow-up|1
1146528|NCT01367158|3765224|P10|Overall Study|Lost to Follow-up|0
1146529|NCT01367158|3765225|P9|Overall Study|Lost to Follow-up|0
1146530|NCT01367158|3765226|P8|Overall Study|Lost to Follow-up|1
1146531|NCT01367158|3765227|P7|Overall Study|Lost to Follow-up|0
1146532|NCT01367158|3765228|P6|Overall Study|Lost to Follow-up|2
1146533|NCT01367158|3765229|P5|Overall Study|Lost to Follow-up|0
1146534|NCT01367158|3765230|P4|Overall Study|Lost to Follow-up|1
1146535|NCT01367158|3765231|P3|Overall Study|Lost to Follow-up|0
1146536|NCT01367158|3765232|P2|Overall Study|Lost to Follow-up|0
1146537|NCT01367158|3765233|P1|Overall Study|Lost to Follow-up|0
1146538|NCT01367158|3765223|P11|Overall Study|Withdrew consent|0
1146539|NCT01367158|3765224|P10|Overall Study|Withdrew consent|0
1146540|NCT01367158|3765225|P9|Overall Study|Withdrew consent|0
1146541|NCT01367158|3765226|P8|Overall Study|Withdrew consent|1
1146542|NCT01367158|3765227|P7|Overall Study|Withdrew consent|0
1146543|NCT01367158|3765228|P6|Overall Study|Withdrew consent|0
1146544|NCT01367158|3765229|P5|Overall Study|Withdrew consent|2
1146545|NCT01367158|3765230|P4|Overall Study|Withdrew consent|0
1146546|NCT01367158|3765231|P3|Overall Study|Withdrew consent|1
1146547|NCT01367158|3765232|P2|Overall Study|Withdrew consent|2
1146548|NCT01367158|3765233|P1|Overall Study|Withdrew consent|0
1146549|NCT01367119|3765377|P2|Overall Study|Withdrawal by Subject|1
1146550|NCT01367119|3765378|P1|Overall Study|Withdrawal by Subject|1
1146551|NCT01367119|3765377|P2|Overall Study|Adverse Event|0
1146552|NCT01367119|3765378|P1|Overall Study|Adverse Event|1
1146553|NCT01366846|3765433|P4|Overall Study|Scheduling Conflicts|0
1146554|NCT01366846|3765434|P3|Overall Study|Scheduling Conflicts|1
1146555|NCT01366846|3765435|P2|Overall Study|Scheduling Conflicts|0
1146556|NCT01366846|3765436|P1|Overall Study|Scheduling Conflicts|0
1146557|NCT01366846|3765433|P4|Overall Study|Communication Difficulties|1
1146558|NCT01366846|3765434|P3|Overall Study|Communication Difficulties|0
1146559|NCT01366846|3765435|P2|Overall Study|Communication Difficulties|4
1146560|NCT01366846|3765436|P1|Overall Study|Communication Difficulties|1
1146561|NCT01366846|3765433|P4|Overall Study|Withdrawal by Subject|0
1146562|NCT01366846|3765434|P3|Overall Study|Withdrawal by Subject|0
1146563|NCT01366846|3765435|P2|Overall Study|Withdrawal by Subject|0
1146564|NCT01366846|3765436|P1|Overall Study|Withdrawal by Subject|2
1146565|NCT01366638|3765459|P3|Overall Study|Not specified|0
1146566|NCT01366638|3765460|P2|Overall Study|Not specified|0
1146567|NCT01366638|3765461|P1|Overall Study|Not specified|1
1146568|NCT01366638|3765459|P3|Overall Study|Withdrawal by Subject|6
1146569|NCT01366638|3765460|P2|Overall Study|Withdrawal by Subject|0
1146570|NCT01366638|3765461|P1|Overall Study|Withdrawal by Subject|0
1146571|NCT01366534|3765498|P3|Overall Study|Declined challenged|0
1146572|NCT01366534|3765499|P2|Overall Study|Declined challenged|1
1146573|NCT01366534|3765500|P1|Overall Study|Declined challenged|0
1146574|NCT01366534|3765498|P3|Overall Study|Migrated|0
1146575|NCT01366534|3765499|P2|Overall Study|Migrated|1
1146576|NCT01366534|3765500|P1|Overall Study|Migrated|1
1146577|NCT01366534|3765498|P3|Overall Study|Lost to Follow-up|0
1146578|NCT01366534|3765499|P2|Overall Study|Lost to Follow-up|0
1146579|NCT01366534|3765500|P1|Overall Study|Lost to Follow-up|1
1146580|NCT01366521|3765550|P4|Overall Study|Withdrawal by Subject|0
1146581|NCT01366521|3765551|P3|Overall Study|Withdrawal by Subject|0
1146582|NCT01366521|3765552|P2|Overall Study|Withdrawal by Subject|1
1146583|NCT01366521|3765553|P1|Overall Study|Withdrawal by Subject|0
1146584|NCT01366521|3765550|P4|Overall Study|Physician Decision|0
1146585|NCT01366521|3765551|P3|Overall Study|Physician Decision|1
1146586|NCT01366521|3765552|P2|Overall Study|Physician Decision|0
1146587|NCT01366521|3765553|P1|Overall Study|Physician Decision|0
1146588|NCT01366521|3765550|P4|Overall Study|Protocol Violation|0
1146589|NCT01366521|3765551|P3|Overall Study|Protocol Violation|1
1146590|NCT01366521|3765552|P2|Overall Study|Protocol Violation|0
1146591|NCT01366521|3765553|P1|Overall Study|Protocol Violation|0
1146592|NCT01366521|3765550|P4|Overall Study|Adverse Event|0
1146593|NCT01366521|3765551|P3|Overall Study|Adverse Event|0
1146594|NCT01366521|3765552|P2|Overall Study|Adverse Event|0
1146595|NCT01366521|3765553|P1|Overall Study|Adverse Event|1
1146596|NCT01366443|3765628|P1|Overall Study|Under 18 yo|1
1146597|NCT01366443|3765628|P1|Overall Study|Lost to Follow-up|2
1146598|NCT01366209|3765642|P2|Overall Study|Withdrew consent|3
1146599|NCT01366209|3765643|P1|Overall Study|Withdrew consent|4
1146600|NCT01366209|3765642|P2|Overall Study|Sponsors decision|1
1146601|NCT01366209|3765643|P1|Overall Study|Sponsors decision|0
1146602|NCT01366209|3765642|P2|Overall Study|Physician Decision|0
1146603|NCT01366209|3765643|P1|Overall Study|Physician Decision|1
1146604|NCT01366209|3765642|P2|Overall Study|Lost to Follow-up|1
1146605|NCT01366209|3765643|P1|Overall Study|Lost to Follow-up|2
1146606|NCT01366209|3765642|P2|Overall Study|Lung transplantation|1
1146607|NCT01366209|3765643|P1|Overall Study|Lung transplantation|6
1146608|NCT01366209|3765642|P2|Overall Study|Death|19
1146609|NCT01366209|3765643|P1|Overall Study|Death|12
1146610|NCT01366209|3765642|P2|Overall Study|Withdrawal by Subject|4
1146611|NCT01366209|3765643|P1|Overall Study|Withdrawal by Subject|4
1146612|NCT01366209|3765642|P2|Overall Study|Adverse Event|7
1146613|NCT01366209|3765643|P1|Overall Study|Adverse Event|6
1146614|NCT01366092|3765666|P1|Overall Study|Withdrawal by Subject|1
1146615|NCT01366092|3765666|P1|Overall Study|Physician Decision|1
1146616|NCT01366092|3765666|P1|Overall Study|Progressive cGVHD|2
1146617|NCT01365910|3765675|P1|Overall Study|pt did not get tx, nausea/vomiting|1
1146618|NCT01365910|3765675|P1|Overall Study|other complicating disease|1
1146619|NCT01365910|3765675|P1|Overall Study|Adverse Event|3
1146620|NCT01365910|3765675|P1|Overall Study|disease progression|18
1146621|NCT01365910|3765675|P1|Overall Study|Withdrawal by Subject|7
1146622|NCT01365546|3765811|P1|Overall Study|Study termination|1
1146623|NCT01365546|3765811|P1|Overall Study|Screen failure|9
1146624|NCT01365546|3765811|P1|Overall Study|Withdrawal by Subject|1
1146625|NCT01365507|3765821|P2|Overall Study|Unclassified|4
1146626|NCT01365507|3765822|P1|Overall Study|Unclassified|1
1146627|NCT01365507|3765821|P2|Overall Study|Withdrawal Criteria|5
1146628|NCT01365507|3765822|P1|Overall Study|Withdrawal Criteria|8
1146629|NCT01365494|3765838|P2|Overall Study|Lost to Follow-up|2
1146630|NCT01365494|3765839|P1|Overall Study|Lost to Follow-up|1
1146631|NCT01365494|3765838|P2|Overall Study|Withdrawal by Subject|1
1146632|NCT01365494|3765839|P1|Overall Study|Withdrawal by Subject|0
1146633|NCT01365494|3765838|P2|Overall Study|Adverse Event|0
1146634|NCT01365494|3765839|P1|Overall Study|Adverse Event|1
1146635|NCT01365481|3765855|P4|Overall Study|Unsatisfactory therapeutic effect|0
1146636|NCT01365481|3765856|P3|Overall Study|Unsatisfactory therapeutic effect|1
1146637|NCT01365481|3765857|P2|Overall Study|Unsatisfactory therapeutic effect|0
1146638|NCT01365481|3765858|P1|Overall Study|Unsatisfactory therapeutic effect|0
1146639|NCT01365481|3765855|P4|Overall Study|Protocol deviation|1
1146640|NCT01365481|3765856|P3|Overall Study|Protocol deviation|0
1146641|NCT01365481|3765857|P2|Overall Study|Protocol deviation|1
1146642|NCT01365481|3765858|P1|Overall Study|Protocol deviation|0
1146643|NCT01365481|3765855|P4|Overall Study|Administrative problems|0
1146644|NCT01365481|3765856|P3|Overall Study|Administrative problems|0
1146645|NCT01365481|3765857|P2|Overall Study|Administrative problems|1
1146646|NCT01365481|3765858|P1|Overall Study|Administrative problems|0
1146647|NCT01365481|3765855|P4|Overall Study|Abnormal laboratory value(s)|0
1146648|NCT01365481|3765856|P3|Overall Study|Abnormal laboratory value(s)|0
1146649|NCT01365481|3765857|P2|Overall Study|Abnormal laboratory value(s)|1
1146650|NCT01365481|3765858|P1|Overall Study|Abnormal laboratory value(s)|0
1146651|NCT01365481|3765855|P4|Overall Study|Lost to Follow-up|3
1146652|NCT01365481|3765856|P3|Overall Study|Lost to Follow-up|2
1146653|NCT01365481|3765857|P2|Overall Study|Lost to Follow-up|1
1146654|NCT01365481|3765858|P1|Overall Study|Lost to Follow-up|1
1146655|NCT01365481|3765855|P4|Overall Study|Withdrawal by Subject|1
1146656|NCT01365481|3765856|P3|Overall Study|Withdrawal by Subject|1
1146657|NCT01365481|3765857|P2|Overall Study|Withdrawal by Subject|2
1146658|NCT01365481|3765858|P1|Overall Study|Withdrawal by Subject|0
1146659|NCT01365481|3765855|P4|Overall Study|Adverse Event|2
1146660|NCT01365481|3765856|P3|Overall Study|Adverse Event|0
1146661|NCT01365481|3765857|P2|Overall Study|Adverse Event|9
1146662|NCT01365481|3765858|P1|Overall Study|Adverse Event|6
1146663|NCT01365468|3765878|P2|Overall Study|Lost to Follow-up|0
1146664|NCT01365468|3765879|P1|Overall Study|Lost to Follow-up|2
1146665|NCT01365468|3765878|P2|Overall Study|Disease progression|0
1146666|NCT01365468|3765879|P1|Overall Study|Disease progression|1
1146667|NCT01365468|3765878|P2|Overall Study|Physician Decision|0
1146668|NCT01365468|3765879|P1|Overall Study|Physician Decision|1
1146669|NCT01365455|3765894|P5|Maintenance Period|Subject/guardian decision|1
1146670|NCT01365455|3765895|P4|Maintenance Period|Subject/guardian decision|4
1146671|NCT01365455|3765896|P3|Maintenance Period|Subject/guardian decision|2
1146672|NCT01365455|3765897|P2|Maintenance Period|Subject/guardian decision|6
1146673|NCT01365455|3765898|P1|Maintenance Period|Subject/guardian decision|4
1146674|NCT01365455|3765894|P5|Maintenance Period|Protocol deviation|0
1146675|NCT01365455|3765895|P4|Maintenance Period|Protocol deviation|0
1146676|NCT01365455|3765896|P3|Maintenance Period|Protocol deviation|0
1146677|NCT01365455|3765897|P2|Maintenance Period|Protocol deviation|1
1146678|NCT01365455|3765898|P1|Maintenance Period|Protocol deviation|1
1146679|NCT01365455|3765894|P5|Maintenance Period|Pregnancy|2
1146680|NCT01365455|3765895|P4|Maintenance Period|Pregnancy|0
1146681|NCT01365455|3765896|P3|Maintenance Period|Pregnancy|0
1146682|NCT01365455|3765897|P2|Maintenance Period|Pregnancy|4
1146683|NCT01365455|3765898|P1|Maintenance Period|Pregnancy|0
1146684|NCT01365455|3765894|P5|Maintenance Period|Physician Decision|1
1146685|NCT01365455|3765895|P4|Maintenance Period|Physician Decision|0
1146686|NCT01365455|3765896|P3|Maintenance Period|Physician Decision|0
1146687|NCT01365455|3765897|P2|Maintenance Period|Physician Decision|1
1146688|NCT01365455|3765898|P1|Maintenance Period|Physician Decision|0
1146689|NCT01365455|3765894|P5|Maintenance Period|Non-compliance with study treatment|0
1146690|NCT01365455|3765895|P4|Maintenance Period|Non-compliance with study treatment|1
1146691|NCT01365455|3765896|P3|Maintenance Period|Non-compliance with study treatment|0
1146692|NCT01365455|3765897|P2|Maintenance Period|Non-compliance with study treatment|0
1146693|NCT01365455|3765898|P1|Maintenance Period|Non-compliance with study treatment|0
1146694|NCT01365455|3765894|P5|Maintenance Period|Lost to Follow-up|3
1146695|NCT01365455|3765895|P4|Maintenance Period|Lost to Follow-up|0
1146696|NCT01365455|3765896|P3|Maintenance Period|Lost to Follow-up|0
1146697|NCT01365455|3765897|P2|Maintenance Period|Lost to Follow-up|4
1146698|NCT01365455|3765898|P1|Maintenance Period|Lost to Follow-up|2
1146699|NCT01365455|3765894|P5|Maintenance Period|Lack of Efficacy|2
1146700|NCT01365455|3765895|P4|Maintenance Period|Lack of Efficacy|2
1146701|NCT01365455|3765896|P3|Maintenance Period|Lack of Efficacy|0
1146702|NCT01365455|3765897|P2|Maintenance Period|Lack of Efficacy|2
1146703|NCT01365455|3765898|P1|Maintenance Period|Lack of Efficacy|10
1146704|NCT01365455|3765894|P5|Maintenance Period|Adverse Event|4
1146705|NCT01365455|3765895|P4|Maintenance Period|Adverse Event|2
1146706|NCT01365455|3765896|P3|Maintenance Period|Adverse Event|1
1146707|NCT01365455|3765897|P2|Maintenance Period|Adverse Event|5
1146708|NCT01365455|3765898|P1|Maintenance Period|Adverse Event|12
1146709|NCT01365455|3765894|P5|Induction Period|Lost to Follow-up|0
1146710|NCT01365455|3765895|P4|Induction Period|Lost to Follow-up|0
1146711|NCT01365455|3765896|P3|Induction Period|Lost to Follow-up|3
1146712|NCT01365455|3765897|P2|Induction Period|Lost to Follow-up|0
1146713|NCT01365455|3765898|P1|Induction Period|Lost to Follow-up|0
1146714|NCT01365455|3765894|P5|Induction Period|Subject/guardian decision|0
1146715|NCT01365455|3765895|P4|Induction Period|Subject/guardian decision|0
1146716|NCT01365455|3765896|P3|Induction Period|Subject/guardian decision|8
1146717|NCT01365455|3765897|P2|Induction Period|Subject/guardian decision|1
1146718|NCT01365455|3765898|P1|Induction Period|Subject/guardian decision|9
1146719|NCT01365455|3765894|P5|Induction Period|Protocol deviation|0
1146720|NCT01365455|3765895|P4|Induction Period|Protocol deviation|0
1146721|NCT01365455|3765896|P3|Induction Period|Protocol deviation|1
1146722|NCT01365455|3765897|P2|Induction Period|Protocol deviation|1
1146723|NCT01365455|3765898|P1|Induction Period|Protocol deviation|0
1146724|NCT01365455|3765894|P5|Induction Period|Pregnancy|0
1146725|NCT01365455|3765895|P4|Induction Period|Pregnancy|0
1146726|NCT01365455|3765896|P3|Induction Period|Pregnancy|0
1146727|NCT01365455|3765897|P2|Induction Period|Pregnancy|1
1146728|NCT01365455|3765898|P1|Induction Period|Pregnancy|0
1146729|NCT01365455|3765894|P5|Induction Period|Lack of Efficacy|0
1146730|NCT01365455|3765895|P4|Induction Period|Lack of Efficacy|0
1146731|NCT01365455|3765896|P3|Induction Period|Lack of Efficacy|0
1146732|NCT01365455|3765897|P2|Induction Period|Lack of Efficacy|1
1146733|NCT01365455|3765898|P1|Induction Period|Lack of Efficacy|1
1146734|NCT01365455|3765894|P5|Induction Period|Adverse Event|0
1146735|NCT01365455|3765895|P4|Induction Period|Adverse Event|0
1146736|NCT01365455|3765896|P3|Induction Period|Adverse Event|4
1146737|NCT01365455|3765897|P2|Induction Period|Adverse Event|3
1146738|NCT01365455|3765898|P1|Induction Period|Adverse Event|5
1146739|NCT01365273|3765988|P2|Overall Study|Physician Decision|0
1146740|NCT01365273|3765989|P1|Overall Study|Physician Decision|1
1146741|NCT01365273|3765988|P2|Overall Study|Protocol Violation|1
1146742|NCT01365273|3765989|P1|Overall Study|Protocol Violation|0
1146743|NCT01365273|3765988|P2|Overall Study|Lost to Follow-up|0
1146744|NCT01365273|3765989|P1|Overall Study|Lost to Follow-up|1
1146745|NCT01365130|3765999|P1|Overall Study|Progression/worsening of Dx prior to txt|2
1146746|NCT01365091|3766008|P4|Period 2|Adverse Event|0
1146747|NCT01365091|3766009|P3|Period 2|Adverse Event|1
1146748|NCT01365091|3766010|P2|Period 2|Adverse Event|0
1146749|NCT01365091|3766011|P1|Period 2|Adverse Event|0
1146750|NCT01365091|3766008|P4|Period 2|Withdrawal by Subject|0
1146751|NCT01365091|3766009|P3|Period 2|Withdrawal by Subject|0
1146752|NCT01365091|3766010|P2|Period 2|Withdrawal by Subject|0
1146753|NCT01365091|3766011|P1|Period 2|Withdrawal by Subject|1
1146754|NCT01365091|3766008|P4|Period 1|Personal reasons|0
1146755|NCT01365091|3766009|P3|Period 1|Personal reasons|1
1146756|NCT01365091|3766010|P2|Period 1|Personal reasons|0
1146757|NCT01365091|3766011|P1|Period 1|Personal reasons|0
1146758|NCT01365091|3766008|P4|Period 1|Withdrawal by Subject|0
1146759|NCT01365091|3766009|P3|Period 1|Withdrawal by Subject|0
1146760|NCT01365091|3766010|P2|Period 1|Withdrawal by Subject|1
1146761|NCT01365091|3766011|P1|Period 1|Withdrawal by Subject|0
1146762|NCT01365091|3766008|P4|Period 1|No longer met study criteria|0
1146763|NCT01365091|3766009|P3|Period 1|No longer met study criteria|0
1146764|NCT01365091|3766010|P2|Period 1|No longer met study criteria|1
1146765|NCT01365091|3766011|P1|Period 1|No longer met study criteria|0
1146766|NCT01365091|3766008|P4|Period 1|Positive test result for drugs of abuse|0
1146767|NCT01365091|3766009|P3|Period 1|Positive test result for drugs of abuse|0
1146768|NCT01365091|3766010|P2|Period 1|Positive test result for drugs of abuse|0
1146769|NCT01365091|3766011|P1|Period 1|Positive test result for drugs of abuse|1
1146770|NCT01365091|3766008|P4|Period 1|Adverse Event|3
1146771|NCT01365091|3766009|P3|Period 1|Adverse Event|2
1146772|NCT01365091|3766010|P2|Period 1|Adverse Event|0
1146773|NCT01365091|3766011|P1|Period 1|Adverse Event|1
1146774|NCT01365052|3766039|P2|Overall Study|Adverse Event|4
1146775|NCT01365052|3766040|P1|Overall Study|Adverse Event|4
1146776|NCT01365039|3766056|P2|Overall Study|Study related symptoms and complaints|0
1146777|NCT01365039|3766057|P1|Overall Study|Study related symptoms and complaints|1
1146778|NCT01364922|3766068|P3|Double-Blind (DB) Period|Other, Unspecified|0
1146779|NCT01364922|3766069|P2|Double-Blind (DB) Period|Other, Unspecified|1
1146780|NCT01364922|3766070|P1|Double-Blind (DB) Period|Other, Unspecified|0
1146781|NCT01364922|3766068|P3|Double-Blind (DB) Period|Adverse Event|1
1146782|NCT01364922|3766069|P2|Double-Blind (DB) Period|Adverse Event|0
1146783|NCT01364922|3766070|P1|Double-Blind (DB) Period|Adverse Event|0
1146784|NCT01364922|3766068|P3|Double-Blind (DB) Period|Subject Noncompliant|0
1146785|NCT01364922|3766069|P2|Double-Blind (DB) Period|Subject Noncompliant|1
1146786|NCT01364922|3766070|P1|Double-Blind (DB) Period|Subject Noncompliant|0
1146787|NCT01364922|3766068|P3|Double-Blind (DB) Period|Lack of Efficacy|4
1146788|NCT01364922|3766069|P2|Double-Blind (DB) Period|Lack of Efficacy|3
1146789|NCT01364922|3766070|P1|Double-Blind (DB) Period|Lack of Efficacy|0
1146790|NCT01364922|3766068|P3|Open-label (OL) Period|Other, Unspecified|0
1146791|NCT01364922|3766069|P2|Open-label (OL) Period|Other, Unspecified|0
1146792|NCT01364922|3766070|P1|Open-label (OL) Period|Other, Unspecified|1
1146793|NCT01364922|3766068|P3|Open-label (OL) Period|Lost to Follow-up|0
1146794|NCT01364922|3766069|P2|Open-label (OL) Period|Lost to Follow-up|0
1146795|NCT01364922|3766070|P1|Open-label (OL) Period|Lost to Follow-up|1
1146796|NCT01364922|3766068|P3|Open-label (OL) Period|Lack of Efficacy|0
1146797|NCT01364922|3766069|P2|Open-label (OL) Period|Lack of Efficacy|0
1146798|NCT01364922|3766070|P1|Open-label (OL) Period|Lack of Efficacy|3
1146799|NCT01364922|3766068|P3|Open-label (OL) Period|Withdrawal by Subject|0
1146800|NCT01364922|3766069|P2|Open-label (OL) Period|Withdrawal by Subject|0
1146801|NCT01364922|3766070|P1|Open-label (OL) Period|Withdrawal by Subject|4
1146802|NCT01364922|3766068|P3|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
1146803|NCT01364922|3766069|P2|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
1146804|NCT01364922|3766070|P1|Open-label (OL) Period|Did Not Meet Randomization Criteria|6
1146805|NCT01364922|3766068|P3|Open-label (OL) Period|Adverse Event|0
1146806|NCT01364922|3766069|P2|Open-label (OL) Period|Adverse Event|0
1146807|NCT01364922|3766070|P1|Open-label (OL) Period|Adverse Event|7
1146808|NCT01364870|3766092|P3|Overall Study|Protocol Violation|0
1146809|NCT01364870|3766093|P2|Overall Study|Protocol Violation|0
1146810|NCT01364870|3766094|P1|Overall Study|Protocol Violation|1
1146811|NCT01364870|3766092|P3|Overall Study|Adverse Event|4
1146812|NCT01364870|3766093|P2|Overall Study|Adverse Event|6
1146813|NCT01364870|3766094|P1|Overall Study|Adverse Event|8
1146814|NCT01364870|3766092|P3|Overall Study|Withdrawal by Subject|10
1146815|NCT01364870|3766093|P2|Overall Study|Withdrawal by Subject|24
1146816|NCT01364870|3766094|P1|Overall Study|Withdrawal by Subject|13
1146817|NCT01364727|3766113|P1|Overall Study|Not Eligible|2
1146818|NCT01364649|3766121|P2|Overall Study|Other|1
1146819|NCT01364649|3766122|P1|Overall Study|Other|4
1146820|NCT01364649|3766121|P2|Overall Study|Lost to Follow-up|13
1146821|NCT01364649|3766122|P1|Overall Study|Lost to Follow-up|12
1146822|NCT01364649|3766121|P2|Overall Study|Withdrawal of Consent|7
1146823|NCT01364649|3766122|P1|Overall Study|Withdrawal of Consent|9
1146824|NCT01364649|3766121|P2|Overall Study|Protocol Deviations|8
1146825|NCT01364649|3766122|P1|Overall Study|Protocol Deviations|4
1146826|NCT01364649|3766121|P2|Overall Study|Non-compliance with Investigational Drug|0
1146827|NCT01364649|3766122|P1|Overall Study|Non-compliance with Investigational Drug|1
1146828|NCT01364649|3766121|P2|Overall Study|Lack of Efficacy|0
1146829|NCT01364649|3766122|P1|Overall Study|Lack of Efficacy|6
1146830|NCT01364649|3766121|P2|Overall Study|Pretreatment Event or Adverse Event|14
1146831|NCT01364649|3766122|P1|Overall Study|Pretreatment Event or Adverse Event|20
1146832|NCT01364428|3766181|P2|Overall Study|Other|3
1146833|NCT01364428|3766182|P1|Overall Study|Other|3
1146834|NCT01364428|3766181|P2|Overall Study|Withdrawal Criteria|10
1146835|NCT01364428|3766182|P1|Overall Study|Withdrawal Criteria|14
1146836|NCT01364428|3766181|P2|Overall Study|Protocol Violation|0
1146837|NCT01364428|3766182|P1|Overall Study|Protocol Violation|2
1146838|NCT01364428|3766181|P2|Overall Study|Adverse Event|2
1146839|NCT01364428|3766182|P1|Overall Study|Adverse Event|1
1146840|NCT01364389|3766199|P3|Overall Study|Adverse Event|0
1146841|NCT01364389|3766200|P2|Overall Study|Adverse Event|0
1146842|NCT01364389|3766201|P1|Overall Study|Adverse Event|1
1146843|NCT01364389|3766199|P3|Overall Study|Administrative problems|0
1146844|NCT01364389|3766200|P2|Overall Study|Administrative problems|0
1146845|NCT01364389|3766201|P1|Overall Study|Administrative problems|1
1146846|NCT01364389|3766199|P3|Overall Study|Protocol deviation|1
1146847|NCT01364389|3766200|P2|Overall Study|Protocol deviation|0
1146848|NCT01364389|3766201|P1|Overall Study|Protocol deviation|0
1146849|NCT01364389|3766199|P3|Overall Study|Withdrawal by Subject|0
1146850|NCT01364389|3766200|P2|Overall Study|Withdrawal by Subject|1
1146851|NCT01364389|3766201|P1|Overall Study|Withdrawal by Subject|0
1146852|NCT01364298|3766220|P2|Overall Study|Other|3
1146853|NCT01364298|3766221|P1|Overall Study|Other|1
1146854|NCT01364298|3766220|P2|Overall Study|Withdrawal by Subject|3
1146855|NCT01364298|3766221|P1|Overall Study|Withdrawal by Subject|3
1146856|NCT01364298|3766220|P2|Overall Study|Lost to Follow-up|10
1146857|NCT01364298|3766221|P1|Overall Study|Lost to Follow-up|5
1146858|NCT01364298|3766220|P2|Overall Study|Lack of Efficacy|0
1146859|NCT01364298|3766221|P1|Overall Study|Lack of Efficacy|1
1146860|NCT01364298|3766220|P2|Overall Study|Lack of adherence to treatment|3
1146861|NCT01364298|3766221|P1|Overall Study|Lack of adherence to treatment|1
1146862|NCT01364298|3766220|P2|Overall Study|Adverse Event|4
1146863|NCT01364298|3766221|P1|Overall Study|Adverse Event|3
1146864|NCT01364233|3766254|P1|Overall Study|Lost to Follow-up|1
1146865|NCT01363986|3766280|P1|Overall Study|Disease progression|1
1146866|NCT01363908|3766290|P2|Chronic Dosing (CD) Phase|Early study termination|3
1146867|NCT01363908|3766291|P1|Chronic Dosing (CD) Phase|Early study termination|9
1146868|NCT01363908|3766290|P2|Chronic Dosing (CD) Phase|Physician Decision|1
1146869|NCT01363908|3766291|P1|Chronic Dosing (CD) Phase|Physician Decision|0
1146870|NCT01363908|3766290|P2|Chronic Dosing (CD) Phase|Patient decision|1
1146871|NCT01363908|3766291|P1|Chronic Dosing (CD) Phase|Patient decision|0
1146872|NCT01363908|3766290|P2|Chronic Dosing (CD) Phase|Adverse Event|1
1146873|NCT01363908|3766291|P1|Chronic Dosing (CD) Phase|Adverse Event|1
1146874|NCT01363765|3766327|P2|Overall Study|smear during intervention|0
1146875|NCT01363765|3766328|P1|Overall Study|smear during intervention|2170
1146876|NCT01363765|3766327|P2|Overall Study|age not recorded (used for cross-linkage|354
1146877|NCT01363765|3766328|P1|Overall Study|age not recorded (used for cross-linkage|117
1146878|NCT01363765|3766327|P2|Overall Study|non-resident|76
1146879|NCT01363765|3766328|P1|Overall Study|non-resident|156
1146880|NCT01363765|3766327|P2|Overall Study|duplicate records|3177
1146881|NCT01363765|3766328|P1|Overall Study|duplicate records|736
1146882|NCT01363765|3766327|P2|Overall Study|non-diagnostic|1124
1146883|NCT01363765|3766328|P1|Overall Study|non-diagnostic|2621
1146884|NCT01363713|3766340|P1|Overall Study|Withdrawal by Subject|2
1146885|NCT01363713|3766340|P1|Overall Study|Protocol Violation|3
1146886|NCT01363713|3766340|P1|Overall Study|Adverse Event|1
1146887|NCT01363700|3766349|P5|Epinastine vs Placebo Period1|Withdrawal by Subject|0
1146888|NCT01363700|3766350|P4|Epinastine vs Placebo Period1|Withdrawal by Subject|0
1146889|NCT01363700|3766351|P3|Epinastine vs Placebo Period1|Withdrawal by Subject|0
1146890|NCT01363700|3766352|P2|Epinastine vs Placebo Period1|Withdrawal by Subject|1
1146891|NCT01363700|3766353|P1|Epinastine vs Placebo Period1|Withdrawal by Subject|0
1146892|NCT01363661|3766372|P2|Overall Study|Lost to Follow-up|1
1146893|NCT01363661|3766373|P1|Overall Study|Lost to Follow-up|3
1146894|NCT01363661|3766372|P2|Overall Study|Protocol Violation|0
1146895|NCT01363661|3766373|P1|Overall Study|Protocol Violation|1
1146896|NCT01363661|3766372|P2|Overall Study|Withdrawal by Subject|1
1146897|NCT01363661|3766373|P1|Overall Study|Withdrawal by Subject|1
1146898|NCT01363661|3766372|P2|Overall Study|Adverse Event|2
1146899|NCT01363661|3766373|P1|Overall Study|Adverse Event|9
1146900|NCT01363440|3766414|P3|Overall Study|Other|2
1146901|NCT01363440|3766415|P2|Overall Study|Other|5
1146902|NCT01363440|3766416|P1|Overall Study|Other|4
1146903|NCT01363440|3766414|P3|Overall Study|Lost to Follow-up|5
1146904|NCT01363440|3766415|P2|Overall Study|Lost to Follow-up|4
1146905|NCT01363440|3766416|P1|Overall Study|Lost to Follow-up|2
1146906|NCT01363440|3766414|P3|Overall Study|Withdrawal by Subject|11
1146907|NCT01363440|3766415|P2|Overall Study|Withdrawal by Subject|11
1146908|NCT01363440|3766416|P1|Overall Study|Withdrawal by Subject|9
1146909|NCT01363440|3766414|P3|Overall Study|Death|5
1146910|NCT01363440|3766415|P2|Overall Study|Death|7
1146911|NCT01363440|3766416|P1|Overall Study|Death|3
1146912|NCT01363440|3766414|P3|Overall Study|Adverse Event|4
1146913|NCT01363440|3766415|P2|Overall Study|Adverse Event|4
1146914|NCT01363440|3766416|P1|Overall Study|Adverse Event|5
1146915|NCT01363349|3766462|P2|Overall Study|missing|2
1146916|NCT01363349|3766463|P1|Overall Study|missing|1
1146917|NCT01363349|3766462|P2|Overall Study|Not reported|37
1146918|NCT01363349|3766463|P1|Overall Study|Not reported|36
1146919|NCT01363349|3766462|P2|Overall Study|Lost to Follow-up|6
1146920|NCT01363349|3766463|P1|Overall Study|Lost to Follow-up|5
1146921|NCT01363349|3766462|P2|Overall Study|Withdrawal by Subject|6
1146922|NCT01363349|3766463|P1|Overall Study|Withdrawal by Subject|14
1146923|NCT01363349|3766462|P2|Overall Study|Non compliance/Protocol deviations|2
1146924|NCT01363349|3766463|P1|Overall Study|Non compliance/Protocol deviations|2
1146925|NCT01363349|3766462|P2|Overall Study|Lack of Efficacy|10
1146926|NCT01363349|3766463|P1|Overall Study|Lack of Efficacy|3
1146927|NCT01363349|3766462|P2|Overall Study|Adverse Event|7
1146928|NCT01363349|3766463|P1|Overall Study|Adverse Event|6
1146929|NCT01363297|3766474|P5|Overall Study|Death|30
1146930|NCT01363297|3766475|P4|Overall Study|Death|10
1146931|NCT01363297|3766476|P3|Overall Study|Death|6
1146932|NCT01363297|3766477|P2|Overall Study|Death|6
1146933|NCT01363297|3766478|P1|Overall Study|Death|3
1146934|NCT01363297|3766474|P5|Overall Study|Not specified|1
1146935|NCT01363297|3766475|P4|Overall Study|Not specified|0
1146936|NCT01363297|3766476|P3|Overall Study|Not specified|0
1146937|NCT01363297|3766477|P2|Overall Study|Not specified|0
1146938|NCT01363297|3766478|P1|Overall Study|Not specified|0
1146939|NCT01363076|3766581|P2|Overall Study|Withdrawal by Subject|1
1146940|NCT01363076|3766582|P1|Overall Study|Withdrawal by Subject|0
1146941|NCT01363011|3766614|P2|Extension Phase|Rolled Over to Another Gilead Study|1
1146942|NCT01363011|3766615|P1|Extension Phase|Rolled Over to Another Gilead Study|2
1146943|NCT01363011|3766614|P2|Extension Phase|Lost to Follow-up|2
1146944|NCT01363011|3766615|P1|Extension Phase|Lost to Follow-up|0
1146945|NCT01363011|3766614|P2|Extension Phase|Withdrew Consent|1
1146946|NCT01363011|3766615|P1|Extension Phase|Withdrew Consent|0
1146947|NCT01363011|3766614|P2|Extension Phase|Investigator's Discretion|2
1146948|NCT01363011|3766615|P1|Extension Phase|Investigator's Discretion|2
1146949|NCT01363011|3766614|P2|Extension Phase|Lack of Efficacy|1
1146950|NCT01363011|3766615|P1|Extension Phase|Lack of Efficacy|0
1146951|NCT01363011|3766614|P2|Extension Phase|Adverse Event|1
1146952|NCT01363011|3766615|P1|Extension Phase|Adverse Event|1
1146953|NCT01363011|3766614|P2|Main Study|Protocol Violation|1
1146954|NCT01363011|3766615|P1|Main Study|Protocol Violation|0
1146955|NCT01363011|3766614|P2|Main Study|Withdrew Consent|4
1146956|NCT01363011|3766615|P1|Main Study|Withdrew Consent|1
1146957|NCT01363011|3766614|P2|Main Study|Investigator's Discretion|1
1146958|NCT01363011|3766615|P1|Main Study|Investigator's Discretion|1
1146959|NCT01363011|3766614|P2|Main Study|Adverse Event|3
1146960|NCT01363011|3766615|P1|Main Study|Adverse Event|2
1146961|NCT01362608|3766757|P2|Overall Study|Adverse Event|2
1146962|NCT01362608|3766758|P1|Overall Study|Adverse Event|0
1146963|NCT01362608|3766757|P2|Overall Study|Lack of Efficacy|2
1146964|NCT01362608|3766758|P1|Overall Study|Lack of Efficacy|0
1146965|NCT01362608|3766757|P2|Overall Study|Withdrawal by Subject|2
1146966|NCT01362608|3766758|P1|Overall Study|Withdrawal by Subject|1
1146967|NCT01362608|3766757|P2|Overall Study|Lost to Follow-up|1
1146968|NCT01362608|3766758|P1|Overall Study|Lost to Follow-up|3
1146969|NCT01362608|3766757|P2|Overall Study|Protocol Violation|1
1146970|NCT01362608|3766758|P1|Overall Study|Protocol Violation|0
1146971|NCT01362530|3766796|P2|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0
1146972|NCT01362530|3766797|P1|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18
1146973|NCT01362530|3766796|P2|Optional Extension (Cycles 2-6)|Protocol Violation|0
1146974|NCT01362530|3766797|P1|Optional Extension (Cycles 2-6)|Protocol Violation|4
1146975|NCT01362530|3766796|P2|Optional Extension (Cycles 2-6)|Physician Decision|0
1146976|NCT01362530|3766797|P1|Optional Extension (Cycles 2-6)|Physician Decision|19
1146977|NCT01362530|3766796|P2|Optional Extension (Cycles 2-6)|Lost to Follow-up|0
1146978|NCT01362530|3766797|P1|Optional Extension (Cycles 2-6)|Lost to Follow-up|1
1146979|NCT01362530|3766796|P2|Optional Extension (Cycles 2-6)|Lack of Efficacy|0
1146980|NCT01362530|3766797|P1|Optional Extension (Cycles 2-6)|Lack of Efficacy|1
1146981|NCT01362530|3766796|P2|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0
1146982|NCT01362530|3766797|P1|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4
1146983|NCT01362530|3766796|P2|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0
1146984|NCT01362530|3766797|P1|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25
1146985|NCT01362530|3766796|P2|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0
1146986|NCT01362530|3766797|P1|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51
1146987|NCT01362530|3766796|P2|Optional Extension (Cycles 2-6)|Adverse Event|0
1146988|NCT01362530|3766797|P1|Optional Extension (Cycles 2-6)|Adverse Event|2
1146989|NCT01362530|3766796|P2|Base Study (Cycle 1)|Withdrawal by Subject|2
1146990|NCT01362530|3766797|P1|Base Study (Cycle 1)|Withdrawal by Subject|1
1146991|NCT01362530|3766796|P2|Base Study (Cycle 1)|Protocol Violation|0
1146992|NCT01362530|3766797|P1|Base Study (Cycle 1)|Protocol Violation|2
1146993|NCT01362530|3766796|P2|Base Study (Cycle 1)|Physician Decision|1
1146994|NCT01362530|3766797|P1|Base Study (Cycle 1)|Physician Decision|0
1146995|NCT01362530|3766796|P2|Base Study (Cycle 1)|Adverse Event|0
1146996|NCT01362530|3766797|P1|Base Study (Cycle 1)|Adverse Event|2
1146997|NCT01362517|3766810|P1|Overall Study|Lost to Follow-up|1
1146998|NCT01362517|3766810|P1|Overall Study|Protocol Violation|1
1146999|NCT01362491|3766821|P3|Overall Study|Ineligible|0
1147000|NCT01362491|3766822|P2|Overall Study|Ineligible|0
1147001|NCT01362491|3766823|P1|Overall Study|Ineligible|1
1147002|NCT01362439|3766871|P1|Overall Study|Participant who withdrew consent|8
1147003|NCT01362439|3766871|P1|Overall Study|Study medication non-compliant|1
1147004|NCT01362439|3766871|P1|Overall Study|Lost to Follow-up|2
1147005|NCT01362439|3766871|P1|Overall Study|Lack of Efficacy|3
1147006|NCT01362439|3766871|P1|Overall Study|Adverse Event|1
1147007|NCT01362348|3766886|P1|Overall Study|Study closed/terminated|5
1147008|NCT01362348|3766886|P1|Overall Study|Protocol-defined stopping criteria|9
1147009|NCT01362322|3766905|P2|Overall Study|Lost to Follow-up|6
1147010|NCT01362322|3766906|P1|Overall Study|Lost to Follow-up|2
1147011|NCT01362322|3766905|P2|Overall Study|Withdrawal by Subject|1
1147012|NCT01362322|3766906|P1|Overall Study|Withdrawal by Subject|3
1147013|NCT01362296|3766938|P4|Crossover Phase|Study Closed/Terminated|0
1147014|NCT01362296|3766939|P3|Crossover Phase|Study Closed/Terminated|1
1147015|NCT01362296|3766940|P2|Crossover Phase|Study Closed/Terminated|0
1147016|NCT01362296|3766941|P1|Crossover Phase|Study Closed/Terminated|0
1147017|NCT01362296|3766938|P4|Crossover Phase|Adverse Event|0
1147018|NCT01362296|3766939|P3|Crossover Phase|Adverse Event|4
1147019|NCT01362296|3766940|P2|Crossover Phase|Adverse Event|0
1147020|NCT01362296|3766941|P1|Crossover Phase|Adverse Event|0
1147021|NCT01362296|3766938|P4|Crossover Phase|Withdrawal by Subject|1
1147022|NCT01362296|3766939|P3|Crossover Phase|Withdrawal by Subject|2
1147023|NCT01362296|3766940|P2|Crossover Phase|Withdrawal by Subject|0
1147024|NCT01362296|3766941|P1|Crossover Phase|Withdrawal by Subject|0
1147025|NCT01362296|3766938|P4|Crossover Phase|PD including Death due to PD|1
1147026|NCT01362296|3766939|P3|Crossover Phase|PD including Death due to PD|16
1147027|NCT01362296|3766940|P2|Crossover Phase|PD including Death due to PD|0
1147028|NCT01362296|3766941|P1|Crossover Phase|PD including Death due to PD|0
1147029|NCT01362296|3766938|P4|Randomized Phase (RP)|Study Closed/Terminated|0
1147030|NCT01362296|3766939|P3|Randomized Phase (RP)|Study Closed/Terminated|0
1147031|NCT01362296|3766940|P2|Randomized Phase (RP)|Study Closed/Terminated|1
1147032|NCT01362296|3766941|P1|Randomized Phase (RP)|Study Closed/Terminated|8
1147033|NCT01362296|3766938|P4|Randomized Phase (RP)|Adverse Event|0
1147034|NCT01362296|3766939|P3|Randomized Phase (RP)|Adverse Event|0
1147035|NCT01362296|3766940|P2|Randomized Phase (RP)|Adverse Event|4
1147036|NCT01362296|3766941|P1|Randomized Phase (RP)|Adverse Event|20
1147037|NCT01362296|3766938|P4|Randomized Phase (RP)|Withdrawal by Subject|0
1147038|NCT01362296|3766939|P3|Randomized Phase (RP)|Withdrawal by Subject|0
1147039|NCT01362296|3766940|P2|Randomized Phase (RP)|Withdrawal by Subject|1
1147040|NCT01362296|3766941|P1|Randomized Phase (RP)|Withdrawal by Subject|2
1147041|NCT01362296|3766938|P4|Randomized Phase (RP)|Physician Decision|0
1147042|NCT01362296|3766939|P3|Randomized Phase (RP)|Physician Decision|0
1147043|NCT01362296|3766940|P2|Randomized Phase (RP)|Physician Decision|9
1147044|NCT01362296|3766941|P1|Randomized Phase (RP)|Physician Decision|1
1147045|NCT01362296|3766938|P4|Randomized Phase (RP)|PD including Death due to PD|0
1147046|NCT01362296|3766939|P3|Randomized Phase (RP)|PD including Death due to PD|0
1147047|NCT01362296|3766940|P2|Randomized Phase (RP)|PD including Death due to PD|28
1147048|NCT01362296|3766941|P1|Randomized Phase (RP)|PD including Death due to PD|56
1147049|NCT01362244|3766989|P2|Overall Study|Protocol Defined Stopping Criteria|1
1147050|NCT01362244|3766990|P1|Overall Study|Protocol Defined Stopping Criteria|0
1147051|NCT01362244|3766989|P2|Overall Study|Did not Meet Continuation Criteria|11
1147052|NCT01362244|3766990|P1|Overall Study|Did not Meet Continuation Criteria|17
1147053|NCT01362244|3766989|P2|Overall Study|Withdrawal by Subject|1
1147054|NCT01362244|3766990|P1|Overall Study|Withdrawal by Subject|2
1147055|NCT01362244|3766989|P2|Overall Study|Protocol Violation|1
1147056|NCT01362244|3766990|P1|Overall Study|Protocol Violation|5
1147057|NCT01362244|3766989|P2|Overall Study|Lost to Follow-up|2
1147058|NCT01362244|3766990|P1|Overall Study|Lost to Follow-up|0
1147059|NCT01362244|3766989|P2|Overall Study|Lack of Efficacy|11
1147060|NCT01362244|3766990|P1|Overall Study|Lack of Efficacy|5
1147061|NCT01362244|3766989|P2|Overall Study|Adverse Event|5
1147062|NCT01362244|3766990|P1|Overall Study|Adverse Event|3
1147063|NCT01362140|3767102|P2|Overall Study|Discontinued Without Receiving Treatment|1
1147064|NCT01362140|3767103|P1|Overall Study|Discontinued Without Receiving Treatment|0
1147065|NCT01362140|3767102|P2|Overall Study|Protocol-specified Criteria|2
1147066|NCT01362140|3767103|P1|Overall Study|Protocol-specified Criteria|1
1147067|NCT01362140|3767102|P2|Overall Study|Other|1
1147068|NCT01362140|3767103|P1|Overall Study|Other|1
1147069|NCT01362140|3767102|P2|Overall Study|Death|1
1147070|NCT01362140|3767103|P1|Overall Study|Death|2
1147071|NCT01362140|3767102|P2|Overall Study|Administrative Decision|1
1147072|NCT01362140|3767103|P1|Overall Study|Administrative Decision|0
1147073|NCT01362140|3767102|P2|Overall Study|Withdrawal by Subject|3
1147074|NCT01362140|3767103|P1|Overall Study|Withdrawal by Subject|3
1147075|NCT01362140|3767102|P2|Overall Study|Adverse Event|2
1147076|NCT01362140|3767103|P1|Overall Study|Adverse Event|2
1147077|NCT01362140|3767102|P2|Overall Study|Noncompliance|0
1147078|NCT01362140|3767103|P1|Overall Study|Noncompliance|1
1147079|NCT01362062|3767127|P2|Overall Study|Had significant improvement|0
1147080|NCT01362062|3767128|P1|Overall Study|Had significant improvement|9
1147081|NCT01362062|3767127|P2|Overall Study|Detected with Spondylo-arthritis|0
1147082|NCT01362062|3767128|P1|Overall Study|Detected with Spondylo-arthritis|1
1147083|NCT01362062|3767127|P2|Overall Study|Non-compliant participant|0
1147084|NCT01362062|3767128|P1|Overall Study|Non-compliant participant|2
1147085|NCT01362062|3767127|P2|Overall Study|Withdrawal by Subject|0
1147086|NCT01362062|3767128|P1|Overall Study|Withdrawal by Subject|2
1147087|NCT01362062|3767127|P2|Overall Study|Lost to Follow-up|0
1147088|NCT01362062|3767128|P1|Overall Study|Lost to Follow-up|11
1147089|NCT01362062|3767127|P2|Overall Study|Adverse Event|0
1147090|NCT01362062|3767128|P1|Overall Study|Adverse Event|1
1147091|NCT01362049|3767149|P4|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
1147092|NCT01362049|3767150|P3|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2
1147093|NCT01362049|3767151|P2|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
1147094|NCT01362049|3767152|P1|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5
1147095|NCT01362049|3767149|P4|Follow-Up at 7 Weeks|Lost to Follow-up|1
1147096|NCT01362049|3767150|P3|Follow-Up at 7 Weeks|Lost to Follow-up|2
1147097|NCT01362049|3767151|P2|Follow-Up at 7 Weeks|Lost to Follow-up|3
1147098|NCT01362049|3767152|P1|Follow-Up at 7 Weeks|Lost to Follow-up|3
1147099|NCT01361607|3767217|P2|Overall Study|Met Withdrawal Criteria|1
1147100|NCT01361607|3767218|P1|Overall Study|Met Withdrawal Criteria|1
1147101|NCT01361607|3767217|P2|Overall Study|Lost to Follow-up|0
1147102|NCT01361607|3767218|P1|Overall Study|Lost to Follow-up|1
1147103|NCT01361607|3767217|P2|Overall Study|Withdrawal by Investigator|3
1147104|NCT01361607|3767218|P1|Overall Study|Withdrawal by Investigator|5
1147105|NCT01361607|3767217|P2|Overall Study|Withdrawal by Subject|8
1147106|NCT01361607|3767218|P1|Overall Study|Withdrawal by Subject|19
1147107|NCT01361607|3767217|P2|Overall Study|Adverse Event|29
1147108|NCT01361607|3767218|P1|Overall Study|Adverse Event|38
1147109|NCT01361594|3767246|P2|Overall Study|Withdrawal by Subject|2
1147110|NCT01361594|3767247|P1|Overall Study|Withdrawal by Subject|1
1147111|NCT01361568|3767261|P6|Overall Study|Withdrawal by Subject|1
1147112|NCT01361568|3767262|P5|Overall Study|Withdrawal by Subject|0
1147113|NCT01361568|3767263|P4|Overall Study|Withdrawal by Subject|0
1147114|NCT01361568|3767264|P3|Overall Study|Withdrawal by Subject|0
1147115|NCT01361568|3767265|P2|Overall Study|Withdrawal by Subject|1
1147116|NCT01361568|3767266|P1|Overall Study|Withdrawal by Subject|2
1147117|NCT01361568|3767261|P6|Overall Study|Physician Decision|1
1147118|NCT01361568|3767262|P5|Overall Study|Physician Decision|0
1147119|NCT01361568|3767263|P4|Overall Study|Physician Decision|0
1147120|NCT01361568|3767264|P3|Overall Study|Physician Decision|0
1147121|NCT01361568|3767265|P2|Overall Study|Physician Decision|0
1147122|NCT01361568|3767266|P1|Overall Study|Physician Decision|0
1147123|NCT01361568|3767261|P6|Overall Study|Adverse Event|0
1147124|NCT01361568|3767262|P5|Overall Study|Adverse Event|1
1147125|NCT01361568|3767263|P4|Overall Study|Adverse Event|0
1147126|NCT01361568|3767264|P3|Overall Study|Adverse Event|0
1147127|NCT01361568|3767265|P2|Overall Study|Adverse Event|0
1147128|NCT01361568|3767266|P1|Overall Study|Adverse Event|0
1147129|NCT01361464|3767296|P1|Overall Study|Withdrawal by Subject|2
1147130|NCT01361464|3767296|P1|Overall Study|Death|1
1147131|NCT01361308|3767305|P2|Overall Study|Not Specified|1
1147132|NCT01361308|3767306|P1|Overall Study|Not Specified|0
1147133|NCT01361308|3767305|P2|Overall Study|Failed C-SSRS|2
1147134|NCT01361308|3767306|P1|Overall Study|Failed C-SSRS|5
1147135|NCT01361308|3767305|P2|Overall Study|Eligibility Criteria Not Met|3
1147136|NCT01361308|3767306|P1|Overall Study|Eligibility Criteria Not Met|2
1147137|NCT01361308|3767305|P2|Overall Study|Adverse Event|4
1147138|NCT01361308|3767306|P1|Overall Study|Adverse Event|8
1147139|NCT01361308|3767305|P2|Overall Study|Lost to Follow-up|4
1147140|NCT01361308|3767306|P1|Overall Study|Lost to Follow-up|5
1147141|NCT01361308|3767305|P2|Overall Study|Protocol Violation|0
1147142|NCT01361308|3767306|P1|Overall Study|Protocol Violation|1
1147143|NCT01361308|3767305|P2|Overall Study|Lack of Efficacy|0
1147144|NCT01361308|3767306|P1|Overall Study|Lack of Efficacy|2
1147145|NCT01361308|3767305|P2|Overall Study|Physician Decision|3
1147146|NCT01361308|3767306|P1|Overall Study|Physician Decision|3
1147147|NCT01361308|3767305|P2|Overall Study|Withdrawal by Subject|13
1147148|NCT01361308|3767306|P1|Overall Study|Withdrawal by Subject|9
1147149|NCT01361178|3767354|P2|Overall Study|Death|0
1147150|NCT01361178|3767355|P1|Overall Study|Death|13
1147151|NCT01361126|3767363|P2|Overall Study|Sponsor decision|2
1147152|NCT01361126|3767364|P1|Overall Study|Sponsor decision|0
1147153|NCT01361009|3767403|P1|Overall Study|Protocol Violation|116
1147154|NCT01360996|3767413|P3|Overall Study|Noncompliant|0
1147155|NCT01360996|3767414|P2|Overall Study|Noncompliant|0
1147156|NCT01360996|3767415|P1|Overall Study|Noncompliant|2
1147157|NCT01360996|3767413|P3|Overall Study|Withdrawal by Subject|2
1147158|NCT01360996|3767414|P2|Overall Study|Withdrawal by Subject|3
1147159|NCT01360996|3767415|P1|Overall Study|Withdrawal by Subject|4
1147160|NCT01360866|3767438|P4|Overall Study|Lack of Efficacy|4
1147161|NCT01360866|3767439|P3|Overall Study|Lack of Efficacy|30
1147162|NCT01360866|3767440|P2|Overall Study|Lack of Efficacy|40
1147163|NCT01360866|3767441|P1|Overall Study|Lack of Efficacy|30
1147164|NCT01360866|3767438|P4|Overall Study|Protocol Deviation|2
1147165|NCT01360866|3767439|P3|Overall Study|Protocol Deviation|61
1147166|NCT01360866|3767440|P2|Overall Study|Protocol Deviation|33
1147167|NCT01360866|3767441|P1|Overall Study|Protocol Deviation|25
1147168|NCT01360866|3767438|P4|Overall Study|Withdrawal by participant|8
1147169|NCT01360866|3767439|P3|Overall Study|Withdrawal by participant|168
1147170|NCT01360866|3767440|P2|Overall Study|Withdrawal by participant|89
1147171|NCT01360866|3767441|P1|Overall Study|Withdrawal by participant|79
1147172|NCT01360866|3767438|P4|Overall Study|Withdrawn by Investigator|2
1147173|NCT01360866|3767439|P3|Overall Study|Withdrawn by Investigator|31
1147174|NCT01360866|3767440|P2|Overall Study|Withdrawn by Investigator|8
1147175|NCT01360866|3767441|P1|Overall Study|Withdrawn by Investigator|9
1147176|NCT01360866|3767438|P4|Overall Study|Paticipant met withdrawal criteria|0
1147177|NCT01360866|3767439|P3|Overall Study|Paticipant met withdrawal criteria|54
1147178|NCT01360866|3767440|P2|Overall Study|Paticipant met withdrawal criteria|28
1147179|NCT01360866|3767441|P1|Overall Study|Paticipant met withdrawal criteria|11
1147180|NCT01360866|3767438|P4|Overall Study|Adverse Event|6
1147181|NCT01360866|3767439|P3|Overall Study|Adverse Event|134
1147182|NCT01360866|3767440|P2|Overall Study|Adverse Event|61
1147183|NCT01360866|3767441|P1|Overall Study|Adverse Event|56
1147184|NCT01360866|3767438|P4|Overall Study|Lost to Follow-up|0
1147185|NCT01360866|3767439|P3|Overall Study|Lost to Follow-up|41
1147186|NCT01360866|3767440|P2|Overall Study|Lost to Follow-up|28
1147187|NCT01360866|3767441|P1|Overall Study|Lost to Follow-up|11
1147188|NCT01360840|3767470|P3|Overall Study|Ongoing at data cut-off|9
1147189|NCT01360840|3767471|P2|Overall Study|Ongoing at data cut-off|10
1147190|NCT01360840|3767472|P1|Overall Study|Ongoing at data cut-off|10
1147191|NCT01360645|3767524|P4|Phase A+|Protocol Deviation|4
1147192|NCT01360645|3767525|P3|Phase A+|Protocol Deviation|0
1147193|NCT01360645|3767526|P2|Phase A+|Protocol Deviation|0
1147194|NCT01360645|3767527|P1|Phase A+|Protocol Deviation|0
1147195|NCT01360645|3767524|P4|Phase A+|Withdrawal by Subject|5
1147196|NCT01360645|3767525|P3|Phase A+|Withdrawal by Subject|0
1147197|NCT01360645|3767526|P2|Phase A+|Withdrawal by Subject|0
1147198|NCT01360645|3767527|P1|Phase A+|Withdrawal by Subject|0
1147199|NCT01360645|3767524|P4|Phase A+|Physician Decision|2
1147200|NCT01360645|3767525|P3|Phase A+|Physician Decision|0
1147201|NCT01360645|3767526|P2|Phase A+|Physician Decision|0
1147202|NCT01360645|3767527|P1|Phase A+|Physician Decision|0
1147203|NCT01360645|3767524|P4|Phase A+|Met Withdrawal Criteria|4
1147204|NCT01360645|3767525|P3|Phase A+|Met Withdrawal Criteria|0
1147205|NCT01360645|3767526|P2|Phase A+|Met Withdrawal Criteria|0
1147206|NCT01360645|3767527|P1|Phase A+|Met Withdrawal Criteria|0
1147207|NCT01360645|3767524|P4|Phase A+|Adverse Event|2
1147208|NCT01360645|3767525|P3|Phase A+|Adverse Event|0
1147209|NCT01360645|3767526|P2|Phase A+|Adverse Event|0
1147210|NCT01360645|3767527|P1|Phase A+|Adverse Event|0
1147211|NCT01360645|3767524|P4|Phase A+|Lost to Follow-up|7
1147212|NCT01360645|3767525|P3|Phase A+|Lost to Follow-up|0
1147213|NCT01360645|3767526|P2|Phase A+|Lost to Follow-up|0
1147214|NCT01360645|3767527|P1|Phase A+|Lost to Follow-up|0
1147215|NCT01360645|3767524|P4|Phase B (6 Weeks)|Protocol Deviation|0
1147216|NCT01360645|3767525|P3|Phase B (6 Weeks)|Protocol Deviation|3
1147217|NCT01360645|3767526|P2|Phase B (6 Weeks)|Protocol Deviation|1
1147218|NCT01360645|3767527|P1|Phase B (6 Weeks)|Protocol Deviation|0
1147219|NCT01360645|3767524|P4|Phase B (6 Weeks)|Withdrawal by Subject|0
1147220|NCT01360645|3767525|P3|Phase B (6 Weeks)|Withdrawal by Subject|8
1147221|NCT01360645|3767526|P2|Phase B (6 Weeks)|Withdrawal by Subject|3
1147222|NCT01360645|3767527|P1|Phase B (6 Weeks)|Withdrawal by Subject|0
1147223|NCT01360645|3767524|P4|Phase B (6 Weeks)|Met Withdrawal Criteria|0
1147224|NCT01360645|3767525|P3|Phase B (6 Weeks)|Met Withdrawal Criteria|2
1147225|NCT01360645|3767526|P2|Phase B (6 Weeks)|Met Withdrawal Criteria|3
1147226|NCT01360645|3767527|P1|Phase B (6 Weeks)|Met Withdrawal Criteria|0
1147227|NCT01360645|3767524|P4|Phase B (6 Weeks)|Adverse Event|0
1147228|NCT01360645|3767525|P3|Phase B (6 Weeks)|Adverse Event|0
1147229|NCT01360645|3767526|P2|Phase B (6 Weeks)|Adverse Event|6
1147230|NCT01360645|3767527|P1|Phase B (6 Weeks)|Adverse Event|0
1147231|NCT01360645|3767524|P4|Phase B (6 Weeks)|Lost to Follow-up|0
1147232|NCT01360645|3767525|P3|Phase B (6 Weeks)|Lost to Follow-up|0
1147233|NCT01360645|3767526|P2|Phase B (6 Weeks)|Lost to Follow-up|1
1147234|NCT01360645|3767527|P1|Phase B (6 Weeks)|Lost to Follow-up|0
1147235|NCT01360645|3767524|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
1147236|NCT01360645|3767525|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
1147237|NCT01360645|3767526|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
1147238|NCT01360645|3767527|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5
1147239|NCT01360645|3767524|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
1147240|NCT01360645|3767525|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
1147241|NCT01360645|3767526|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
1147242|NCT01360645|3767527|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24
1147243|NCT01360645|3767524|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
1147244|NCT01360645|3767525|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
1147245|NCT01360645|3767526|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
1147246|NCT01360645|3767527|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34
1147247|NCT01360645|3767524|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
1147248|NCT01360645|3767525|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
1147249|NCT01360645|3767526|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
1147250|NCT01360645|3767527|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16
1147251|NCT01360645|3767524|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
1147252|NCT01360645|3767525|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
1147253|NCT01360645|3767526|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
1147254|NCT01360645|3767527|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19
1147255|NCT01360645|3767524|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
1147256|NCT01360645|3767525|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
1147257|NCT01360645|3767526|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
1147258|NCT01360645|3767527|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16
1147259|NCT01360632|3767582|P5|Phase A+|Protocol Deviation|3
1147260|NCT01360632|3767583|P4|Phase A+|Protocol Deviation|0
1147261|NCT01360632|3767584|P3|Phase A+|Protocol Deviation|0
1147262|NCT01360632|3767585|P2|Phase A+|Protocol Deviation|0
1147263|NCT01360632|3767586|P1|Phase A+|Protocol Deviation|0
1147264|NCT01360632|3767582|P5|Phase A+|Withdrawal by Subject|8
1147265|NCT01360632|3767583|P4|Phase A+|Withdrawal by Subject|0
1147266|NCT01360632|3767584|P3|Phase A+|Withdrawal by Subject|0
1147267|NCT01360632|3767585|P2|Phase A+|Withdrawal by Subject|0
1147268|NCT01360632|3767586|P1|Phase A+|Withdrawal by Subject|0
1147269|NCT01360632|3767582|P5|Phase A+|Physician Decision|3
1147270|NCT01360632|3767583|P4|Phase A+|Physician Decision|0
1147271|NCT01360632|3767584|P3|Phase A+|Physician Decision|0
1147272|NCT01360632|3767585|P2|Phase A+|Physician Decision|0
1147273|NCT01360632|3767586|P1|Phase A+|Physician Decision|0
1147274|NCT01360632|3767582|P5|Phase A+|Met Withdrawal Criteria|7
1147275|NCT01360632|3767583|P4|Phase A+|Met Withdrawal Criteria|0
1147276|NCT01360632|3767584|P3|Phase A+|Met Withdrawal Criteria|0
1147277|NCT01360632|3767585|P2|Phase A+|Met Withdrawal Criteria|0
1147278|NCT01360632|3767586|P1|Phase A+|Met Withdrawal Criteria|0
1147279|NCT01360632|3767582|P5|Phase A+|Adverse Event|2
1147280|NCT01360632|3767583|P4|Phase A+|Adverse Event|0
1147281|NCT01360632|3767584|P3|Phase A+|Adverse Event|0
1147282|NCT01360632|3767585|P2|Phase A+|Adverse Event|0
1147283|NCT01360632|3767586|P1|Phase A+|Adverse Event|0
1147284|NCT01360632|3767582|P5|Phase A+|Lost to Follow-up|2
1147285|NCT01360632|3767583|P4|Phase A+|Lost to Follow-up|0
1147286|NCT01360632|3767584|P3|Phase A+|Lost to Follow-up|0
1147287|NCT01360632|3767585|P2|Phase A+|Lost to Follow-up|0
1147288|NCT01360632|3767586|P1|Phase A+|Lost to Follow-up|0
1147289|NCT01360632|3767582|P5|Phase B (6 Weeks)|Lack of Efficacy|0
1147290|NCT01360632|3767583|P4|Phase B (6 Weeks)|Lack of Efficacy|0
1147291|NCT01360632|3767584|P3|Phase B (6 Weeks)|Lack of Efficacy|0
1147292|NCT01360632|3767585|P2|Phase B (6 Weeks)|Lack of Efficacy|1
1147293|NCT01360632|3767586|P1|Phase B (6 Weeks)|Lack of Efficacy|0
1147294|NCT01360632|3767582|P5|Phase B (6 Weeks)|Protocol Deviation|0
1147295|NCT01360632|3767583|P4|Phase B (6 Weeks)|Protocol Deviation|1
1147296|NCT01360632|3767584|P3|Phase B (6 Weeks)|Protocol Deviation|4
1147297|NCT01360632|3767585|P2|Phase B (6 Weeks)|Protocol Deviation|1
1147298|NCT01360632|3767586|P1|Phase B (6 Weeks)|Protocol Deviation|0
1147299|NCT01360632|3767582|P5|Phase B (6 Weeks)|Withdrawal by Subject|0
1147300|NCT01360632|3767583|P4|Phase B (6 Weeks)|Withdrawal by Subject|7
1147301|NCT01360632|3767584|P3|Phase B (6 Weeks)|Withdrawal by Subject|4
1147302|NCT01360632|3767585|P2|Phase B (6 Weeks)|Withdrawal by Subject|4
1147303|NCT01360632|3767586|P1|Phase B (6 Weeks)|Withdrawal by Subject|0
1147304|NCT01360632|3767582|P5|Phase B (6 Weeks)|Physician Decision|0
1147305|NCT01360632|3767583|P4|Phase B (6 Weeks)|Physician Decision|1
1147306|NCT01360632|3767584|P3|Phase B (6 Weeks)|Physician Decision|0
1147307|NCT01360632|3767585|P2|Phase B (6 Weeks)|Physician Decision|0
1147308|NCT01360632|3767586|P1|Phase B (6 Weeks)|Physician Decision|0
1147309|NCT01360632|3767582|P5|Phase B (6 Weeks)|Met Withdrawal Criteria|0
1147310|NCT01360632|3767583|P4|Phase B (6 Weeks)|Met Withdrawal Criteria|1
1147311|NCT01360632|3767584|P3|Phase B (6 Weeks)|Met Withdrawal Criteria|2
1147312|NCT01360632|3767585|P2|Phase B (6 Weeks)|Met Withdrawal Criteria|0
1147313|NCT01360632|3767586|P1|Phase B (6 Weeks)|Met Withdrawal Criteria|0
1147314|NCT01360632|3767582|P5|Phase B (6 Weeks)|Adverse Event|0
1147315|NCT01360632|3767583|P4|Phase B (6 Weeks)|Adverse Event|3
1147316|NCT01360632|3767584|P3|Phase B (6 Weeks)|Adverse Event|9
1147317|NCT01360632|3767585|P2|Phase B (6 Weeks)|Adverse Event|3
1147318|NCT01360632|3767586|P1|Phase B (6 Weeks)|Adverse Event|0
1147319|NCT01360632|3767582|P5|Phase B (6 Weeks)|Lost to Follow-up|0
1147320|NCT01360632|3767583|P4|Phase B (6 Weeks)|Lost to Follow-up|0
1147321|NCT01360632|3767584|P3|Phase B (6 Weeks)|Lost to Follow-up|1
1147322|NCT01360632|3767585|P2|Phase B (6 Weeks)|Lost to Follow-up|1
1147323|NCT01360632|3767586|P1|Phase B (6 Weeks)|Lost to Follow-up|0
1147324|NCT01360632|3767582|P5|Phase A (8 Weeks)|Protocol Deviation|0
1147325|NCT01360632|3767583|P4|Phase A (8 Weeks)|Protocol Deviation|0
1147326|NCT01360632|3767584|P3|Phase A (8 Weeks)|Protocol Deviation|0
1147327|NCT01360632|3767585|P2|Phase A (8 Weeks)|Protocol Deviation|0
1147328|NCT01360632|3767586|P1|Phase A (8 Weeks)|Protocol Deviation|39
1147329|NCT01360632|3767582|P5|Phase A (8 Weeks)|Withdrawal by Subject|0
1147330|NCT01360632|3767583|P4|Phase A (8 Weeks)|Withdrawal by Subject|0
1147331|NCT01360632|3767584|P3|Phase A (8 Weeks)|Withdrawal by Subject|0
1147332|NCT01360632|3767585|P2|Phase A (8 Weeks)|Withdrawal by Subject|0
1147333|NCT01360632|3767586|P1|Phase A (8 Weeks)|Withdrawal by Subject|74
1147334|NCT01360632|3767582|P5|Phase A (8 Weeks)|Physician Decision|0
1147335|NCT01360632|3767583|P4|Phase A (8 Weeks)|Physician Decision|0
1147336|NCT01360632|3767584|P3|Phase A (8 Weeks)|Physician Decision|0
1147337|NCT01360632|3767585|P2|Phase A (8 Weeks)|Physician Decision|0
1147338|NCT01360632|3767586|P1|Phase A (8 Weeks)|Physician Decision|10
1147339|NCT01360632|3767582|P5|Phase A (8 Weeks)|Met Withdrawal Criteria|0
1147340|NCT01360632|3767583|P4|Phase A (8 Weeks)|Met Withdrawal Criteria|0
1147341|NCT01360632|3767584|P3|Phase A (8 Weeks)|Met Withdrawal Criteria|0
1147342|NCT01360632|3767585|P2|Phase A (8 Weeks)|Met Withdrawal Criteria|0
1147343|NCT01360632|3767586|P1|Phase A (8 Weeks)|Met Withdrawal Criteria|45
1147344|NCT01360632|3767582|P5|Phase A (8 Weeks)|Adverse Event|0
1147345|NCT01360632|3767583|P4|Phase A (8 Weeks)|Adverse Event|0
1147346|NCT01360632|3767584|P3|Phase A (8 Weeks)|Adverse Event|0
1147347|NCT01360632|3767585|P2|Phase A (8 Weeks)|Adverse Event|0
1147348|NCT01360632|3767586|P1|Phase A (8 Weeks)|Adverse Event|60
1147349|NCT01360632|3767582|P5|Phase A (8 Weeks)|Lost to Follow-up|0
1147350|NCT01360632|3767583|P4|Phase A (8 Weeks)|Lost to Follow-up|0
1147351|NCT01360632|3767584|P3|Phase A (8 Weeks)|Lost to Follow-up|0
1147352|NCT01360632|3767585|P2|Phase A (8 Weeks)|Lost to Follow-up|0
1147353|NCT01360632|3767586|P1|Phase A (8 Weeks)|Lost to Follow-up|27
1147354|NCT01360554|3767665|P2|Overall Study|Randomized but not treated.|3
1147355|NCT01360554|3767666|P1|Overall Study|Randomized but not treated.|3
1147356|NCT01360554|3767665|P2|Overall Study|Other, not specified|0
1147357|NCT01360554|3767666|P1|Overall Study|Other, not specified|1
1147358|NCT01360554|3767665|P2|Overall Study|Study terminated by sponsor|37
1147359|NCT01360554|3767666|P1|Overall Study|Study terminated by sponsor|49
1147360|NCT01360554|3767665|P2|Overall Study|Withdrawal by Subject|24
1147361|NCT01360554|3767666|P1|Overall Study|Withdrawal by Subject|23
1147362|NCT01360554|3767665|P2|Overall Study|Lost to Follow-up|4
1147363|NCT01360554|3767666|P1|Overall Study|Lost to Follow-up|4
1147364|NCT01360554|3767665|P2|Overall Study|Death|371
1147365|NCT01360554|3767666|P1|Overall Study|Death|359
1147366|NCT01360021|3767718|P3|Overall Study|Adverse Event|3
1147367|NCT01360021|3767719|P2|Overall Study|Adverse Event|3
1147368|NCT01360021|3767720|P1|Overall Study|Adverse Event|2
1147369|NCT01360021|3767718|P3|Overall Study|Withdrawal by Subject|2
1147370|NCT01360021|3767719|P2|Overall Study|Withdrawal by Subject|0
1147371|NCT01360021|3767720|P1|Overall Study|Withdrawal by Subject|4
1147372|NCT01360021|3767718|P3|Overall Study|Protocol Violation|1
1147373|NCT01360021|3767719|P2|Overall Study|Protocol Violation|0
1147374|NCT01360021|3767720|P1|Overall Study|Protocol Violation|0
1147375|NCT01360021|3767718|P3|Overall Study|Eligibility criteria + other|1
1147376|NCT01360021|3767719|P2|Overall Study|Eligibility criteria + other|1
1147377|NCT01360021|3767720|P1|Overall Study|Eligibility criteria + other|2
1147378|NCT01359943|3767746|P3|Follow-up (Weeks 52 - 60)|Adverse Event|1
1147379|NCT01359943|3767747|P2|Follow-up (Weeks 52 - 60)|Adverse Event|5
1147380|NCT01359943|3767748|P1|Follow-up (Weeks 52 - 60)|Adverse Event|3
1147381|NCT01359943|3767746|P3|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
1147382|NCT01359943|3767747|P2|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1
1147383|NCT01359943|3767748|P1|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
1147384|NCT01359943|3767746|P3|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
1147385|NCT01359943|3767747|P2|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
1147386|NCT01359943|3767748|P1|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
1147387|NCT01359943|3767746|P3|Follow-up (Weeks 52 - 60)|Protocol deviation|0
1147388|NCT01359943|3767747|P2|Follow-up (Weeks 52 - 60)|Protocol deviation|1
1147389|NCT01359943|3767748|P1|Follow-up (Weeks 52 - 60)|Protocol deviation|0
1147390|NCT01359943|3767746|P3|Follow-up (Weeks 52 - 60)|Administrative problems|0
1147391|NCT01359943|3767747|P2|Follow-up (Weeks 52 - 60)|Administrative problems|0
1147392|NCT01359943|3767748|P1|Follow-up (Weeks 52 - 60)|Administrative problems|1
1147393|NCT01359943|3767746|P3|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4
1147394|NCT01359943|3767747|P2|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5
1147395|NCT01359943|3767748|P1|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1
1147396|NCT01359943|3767746|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1
1147397|NCT01359943|3767747|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5
1147398|NCT01359943|3767748|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3
1147399|NCT01359943|3767746|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
1147400|NCT01359943|3767747|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1
1147401|NCT01359943|3767748|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
1147402|NCT01359943|3767746|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
1147403|NCT01359943|3767747|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
1147404|NCT01359943|3767748|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
1147405|NCT01359943|3767746|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
1147406|NCT01359943|3767747|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1
1147407|NCT01359943|3767748|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
1147408|NCT01359943|3767746|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4
1147409|NCT01359943|3767747|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3
1147410|NCT01359943|3767748|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1
1147411|NCT01359943|3767746|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
1147412|NCT01359943|3767747|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
1147413|NCT01359943|3767748|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1
1147414|NCT01359943|3767746|P3|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
1147415|NCT01359943|3767747|P2|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2
1147416|NCT01359943|3767748|P1|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
1147417|NCT01359943|3767746|P3|Double-blind (Weeks 0 - 16)|Adverse Event|0
1147418|NCT01359943|3767747|P2|Double-blind (Weeks 0 - 16)|Adverse Event|2
1147419|NCT01359943|3767748|P1|Double-blind (Weeks 0 - 16)|Adverse Event|1
1147420|NCT01359943|3767746|P3|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
1147421|NCT01359943|3767747|P2|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
1147422|NCT01359943|3767748|P1|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1
1147423|NCT01359904|3767796|P2|Overall Study|Withdrawal by Subject|0
1147424|NCT01359904|3767797|P1|Overall Study|Withdrawal by Subject|1
1147425|NCT01359644|3767851|P10|Follow-up Period|Lost to Follow-up|0
1147426|NCT01359644|3767852|P9|Follow-up Period|Lost to Follow-up|0
1147427|NCT01359644|3767853|P8|Follow-up Period|Lost to Follow-up|2
1147428|NCT01359644|3767854|P7|Follow-up Period|Lost to Follow-up|1
1147429|NCT01359644|3767855|P6|Follow-up Period|Lost to Follow-up|0
1147430|NCT01359644|3767856|P5|Follow-up Period|Lost to Follow-up|0
1147431|NCT01359644|3767857|P4|Follow-up Period|Lost to Follow-up|0
1147432|NCT01359644|3767858|P3|Follow-up Period|Lost to Follow-up|0
1147433|NCT01359644|3767859|P2|Follow-up Period|Lost to Follow-up|0
1147434|NCT01359644|3767860|P1|Follow-up Period|Lost to Follow-up|0
1147435|NCT01359644|3767851|P10|Follow-up Period|Withdrawal by Subject|0
1147436|NCT01359644|3767852|P9|Follow-up Period|Withdrawal by Subject|0
1147437|NCT01359644|3767853|P8|Follow-up Period|Withdrawal by Subject|0
1147438|NCT01359644|3767854|P7|Follow-up Period|Withdrawal by Subject|0
1147439|NCT01359644|3767855|P6|Follow-up Period|Withdrawal by Subject|1
1147440|NCT01359644|3767856|P5|Follow-up Period|Withdrawal by Subject|0
1147441|NCT01359644|3767857|P4|Follow-up Period|Withdrawal by Subject|0
1147442|NCT01359644|3767858|P3|Follow-up Period|Withdrawal by Subject|0
1147443|NCT01359644|3767859|P2|Follow-up Period|Withdrawal by Subject|0
1147444|NCT01359644|3767860|P1|Follow-up Period|Withdrawal by Subject|0
1147445|NCT01359644|3767851|P10|Treatment Period|Lost to Follow-up|0
1147446|NCT01359644|3767852|P9|Treatment Period|Lost to Follow-up|0
1147447|NCT01359644|3767853|P8|Treatment Period|Lost to Follow-up|0
1147448|NCT01359644|3767854|P7|Treatment Period|Lost to Follow-up|0
1147449|NCT01359644|3767855|P6|Treatment Period|Lost to Follow-up|1
1147450|NCT01359644|3767856|P5|Treatment Period|Lost to Follow-up|0
1147451|NCT01359644|3767857|P4|Treatment Period|Lost to Follow-up|0
1147452|NCT01359644|3767858|P3|Treatment Period|Lost to Follow-up|0
1147453|NCT01359644|3767859|P2|Treatment Period|Lost to Follow-up|0
1147454|NCT01359644|3767860|P1|Treatment Period|Lost to Follow-up|0
1147455|NCT01359644|3767851|P10|Treatment Period|Adverse Event|0
1147456|NCT01359644|3767852|P9|Treatment Period|Adverse Event|0
1147457|NCT01359644|3767853|P8|Treatment Period|Adverse Event|0
1147458|NCT01359644|3767854|P7|Treatment Period|Adverse Event|0
1147459|NCT01359644|3767855|P6|Treatment Period|Adverse Event|1
1147460|NCT01359644|3767856|P5|Treatment Period|Adverse Event|0
1147461|NCT01359644|3767857|P4|Treatment Period|Adverse Event|0
1147462|NCT01359644|3767858|P3|Treatment Period|Adverse Event|1
1147463|NCT01359644|3767859|P2|Treatment Period|Adverse Event|0
1147464|NCT01359644|3767860|P1|Treatment Period|Adverse Event|0
1147465|NCT01359644|3767851|P10|Treatment Period|Lack of Efficacy|0
1147466|NCT01359644|3767852|P9|Treatment Period|Lack of Efficacy|0
1147467|NCT01359644|3767853|P8|Treatment Period|Lack of Efficacy|0
1147468|NCT01359644|3767854|P7|Treatment Period|Lack of Efficacy|0
1147469|NCT01359644|3767855|P6|Treatment Period|Lack of Efficacy|0
1147470|NCT01359644|3767856|P5|Treatment Period|Lack of Efficacy|0
1147471|NCT01359644|3767857|P4|Treatment Period|Lack of Efficacy|0
1147472|NCT01359644|3767858|P3|Treatment Period|Lack of Efficacy|0
1147473|NCT01359644|3767859|P2|Treatment Period|Lack of Efficacy|1
1147474|NCT01359644|3767860|P1|Treatment Period|Lack of Efficacy|0
1147475|NCT01359449|3767904|P2|Overall Study|Withdrawal by Subject|2
1147476|NCT01359449|3767905|P1|Overall Study|Withdrawal by Subject|3
1147477|NCT01359449|3767904|P2|Overall Study|Protocol Violation|2
1147478|NCT01359449|3767905|P1|Overall Study|Protocol Violation|0
1147479|NCT01359449|3767904|P2|Overall Study|Lost to Follow-up|0
1147480|NCT01359449|3767905|P1|Overall Study|Lost to Follow-up|1
1147481|NCT01359254|3767951|P2|Overall Study|Death|0
1147482|NCT01359254|3767952|P1|Overall Study|Death|1
1147483|NCT01359150|3767962|P2|Overall Study|Other|0
1147484|NCT01359150|3767963|P1|Overall Study|Other|1
1147485|NCT01359150|3767962|P2|Overall Study|Adverse Event|3
1147486|NCT01359150|3767963|P1|Overall Study|Adverse Event|4
1147487|NCT01359150|3767962|P2|Overall Study|Withdrawal by Subject|1
1147488|NCT01359150|3767963|P1|Overall Study|Withdrawal by Subject|1
1147489|NCT01359150|3767962|P2|Overall Study|Lack of Efficacy|1
1147490|NCT01359150|3767963|P1|Overall Study|Lack of Efficacy|1
1147491|NCT01358968|3768000|P4|Continued Access Phase|Death|1
1147492|NCT01358968|3768001|P3|Continued Access Phase|Death|1
1147493|NCT01358968|3768002|P2|Continued Access Phase|Death|0
1147494|NCT01358968|3768003|P1|Continued Access Phase|Death|0
1147495|NCT01358968|3768000|P4|Continued Access Phase|Withdrawal by Subject|0
1147496|NCT01358968|3768001|P3|Continued Access Phase|Withdrawal by Subject|3
1147497|NCT01358968|3768002|P2|Continued Access Phase|Withdrawal by Subject|0
1147498|NCT01358968|3768003|P1|Continued Access Phase|Withdrawal by Subject|0
1147499|NCT01358968|3768000|P4|Continued Access Phase|Protocol Violation|2
1147500|NCT01358968|3768001|P3|Continued Access Phase|Protocol Violation|0
1147501|NCT01358968|3768002|P2|Continued Access Phase|Protocol Violation|0
1147502|NCT01358968|3768003|P1|Continued Access Phase|Protocol Violation|0
1147503|NCT01358968|3768000|P4|Continued Access Phase|Progression of Disease|4
1147504|NCT01358968|3768001|P3|Continued Access Phase|Progression of Disease|8
1147505|NCT01358968|3768002|P2|Continued Access Phase|Progression of Disease|0
1147506|NCT01358968|3768003|P1|Continued Access Phase|Progression of Disease|0
1147507|NCT01358968|3768000|P4|Period 2|Adverse Event|0
1147508|NCT01358968|3768001|P3|Period 2|Adverse Event|0
1147509|NCT01358968|3768002|P2|Period 2|Adverse Event|1
1147510|NCT01358968|3768003|P1|Period 2|Adverse Event|0
1147511|NCT01358877|3768019|P2|Overall Study|Other|129
1147512|NCT01358877|3768020|P1|Overall Study|Other|142
1147513|NCT01358877|3768019|P2|Overall Study|Ongoing follow-up for overall survival|5
1147514|NCT01358877|3768020|P1|Overall Study|Ongoing follow-up for overall survival|7
1147515|NCT01358877|3768019|P2|Overall Study|Ongoing follow-up for IDFS event|2073
1147516|NCT01358877|3768020|P1|Overall Study|Ongoing follow-up for IDFS event|2084
1147517|NCT01358877|3768019|P2|Overall Study|Ongoing follow-up for post-recurrence|108
1147518|NCT01358877|3768020|P1|Overall Study|Ongoing follow-up for post-recurrence|87
1147519|NCT01358877|3768019|P2|Overall Study|Death|89
1147520|NCT01358877|3768020|P1|Overall Study|Death|80
1147521|NCT01358864|3768090|P8|Overall Study|Not treated|0
1147522|NCT01358864|3768091|P7|Overall Study|Not treated|1
1147523|NCT01358864|3768092|P6|Overall Study|Not treated|0
1147524|NCT01358864|3768093|P5|Overall Study|Not treated|0
1147525|NCT01358864|3768094|P4|Overall Study|Not treated|0
1147526|NCT01358864|3768095|P3|Overall Study|Not treated|0
1147527|NCT01358864|3768096|P2|Overall Study|Not treated|0
1147528|NCT01358864|3768097|P1|Overall Study|Not treated|0
1147529|NCT01358864|3768090|P8|Overall Study|Other reason not defined above|0
1147530|NCT01358864|3768091|P7|Overall Study|Other reason not defined above|2
1147531|NCT01358864|3768092|P6|Overall Study|Other reason not defined above|0
1147532|NCT01358864|3768093|P5|Overall Study|Other reason not defined above|0
1147533|NCT01358864|3768094|P4|Overall Study|Other reason not defined above|0
1147534|NCT01358864|3768095|P3|Overall Study|Other reason not defined above|0
1147535|NCT01358864|3768096|P2|Overall Study|Other reason not defined above|0
1147536|NCT01358864|3768097|P1|Overall Study|Other reason not defined above|2
1147537|NCT01358864|3768090|P8|Overall Study|Withdrawal by Subject|3
1147538|NCT01358864|3768091|P7|Overall Study|Withdrawal by Subject|1
1147539|NCT01358864|3768092|P6|Overall Study|Withdrawal by Subject|1
1147540|NCT01358864|3768093|P5|Overall Study|Withdrawal by Subject|0
1147541|NCT01358864|3768094|P4|Overall Study|Withdrawal by Subject|0
1147542|NCT01358864|3768095|P3|Overall Study|Withdrawal by Subject|2
1147543|NCT01358864|3768096|P2|Overall Study|Withdrawal by Subject|4
1147544|NCT01358864|3768097|P1|Overall Study|Withdrawal by Subject|3
1147545|NCT01358864|3768090|P8|Overall Study|Lost to Follow-up|1
1147546|NCT01358864|3768091|P7|Overall Study|Lost to Follow-up|0
1147547|NCT01358864|3768092|P6|Overall Study|Lost to Follow-up|0
1147548|NCT01358864|3768093|P5|Overall Study|Lost to Follow-up|0
1147549|NCT01358864|3768094|P4|Overall Study|Lost to Follow-up|0
1147550|NCT01358864|3768095|P3|Overall Study|Lost to Follow-up|1
1147551|NCT01358864|3768096|P2|Overall Study|Lost to Follow-up|0
1147552|NCT01358864|3768097|P1|Overall Study|Lost to Follow-up|0
1147553|NCT01358864|3768090|P8|Overall Study|Lack of Efficacy|44
1147554|NCT01358864|3768091|P7|Overall Study|Lack of Efficacy|49
1147555|NCT01358864|3768092|P6|Overall Study|Lack of Efficacy|4
1147556|NCT01358864|3768093|P5|Overall Study|Lack of Efficacy|7
1147557|NCT01358864|3768094|P4|Overall Study|Lack of Efficacy|19
1147558|NCT01358864|3768095|P3|Overall Study|Lack of Efficacy|4
1147559|NCT01358864|3768096|P2|Overall Study|Lack of Efficacy|3
1147560|NCT01358864|3768097|P1|Overall Study|Lack of Efficacy|26
1147561|NCT01358864|3768090|P8|Overall Study|Adverse Event|7
1147562|NCT01358864|3768091|P7|Overall Study|Adverse Event|12
1147563|NCT01358864|3768092|P6|Overall Study|Adverse Event|8
1147564|NCT01358864|3768093|P5|Overall Study|Adverse Event|4
1147565|NCT01358864|3768094|P4|Overall Study|Adverse Event|0
1147566|NCT01358864|3768095|P3|Overall Study|Adverse Event|9
1147567|NCT01358864|3768096|P2|Overall Study|Adverse Event|6
1147568|NCT01358864|3768097|P1|Overall Study|Adverse Event|0
1147569|NCT01358825|3768188|P2|Overall Study|Blood sample not drawn|1
1147570|NCT01358825|3768189|P1|Overall Study|Blood sample not drawn|0
1147571|NCT01358760|3768213|P3|Overall Study|Entry criteria not met/Non-compliance|16
1147572|NCT01358760|3768214|P2|Overall Study|Entry criteria not met/Non-compliance|12
1147573|NCT01358760|3768215|P1|Overall Study|Entry criteria not met/Non-compliance|12
1147574|NCT01358760|3768213|P3|Overall Study|Physician Decision|1
1147575|NCT01358760|3768214|P2|Overall Study|Physician Decision|0
1147576|NCT01358760|3768215|P1|Overall Study|Physician Decision|1
1147577|NCT01358760|3768213|P3|Overall Study|Withdrawal by Subject|2
1147578|NCT01358760|3768214|P2|Overall Study|Withdrawal by Subject|3
1147579|NCT01358760|3768215|P1|Overall Study|Withdrawal by Subject|5
1147580|NCT01358760|3768213|P3|Overall Study|Lost to Follow-up|3
1147581|NCT01358760|3768214|P2|Overall Study|Lost to Follow-up|1
1147582|NCT01358760|3768215|P1|Overall Study|Lost to Follow-up|1
1147583|NCT01358760|3768213|P3|Overall Study|Adverse Event|3
1147584|NCT01358760|3768214|P2|Overall Study|Adverse Event|4
1147585|NCT01358760|3768215|P1|Overall Study|Adverse Event|3
1147586|NCT01358734|3768250|P3|Overall Study|Not Specified|4
1147587|NCT01358734|3768251|P2|Overall Study|Not Specified|5
1147588|NCT01358734|3768252|P1|Overall Study|Not Specified|2
1147589|NCT01358734|3768250|P3|Overall Study|Non-compliance with study drug|1
1147590|NCT01358734|3768251|P2|Overall Study|Non-compliance with study drug|0
1147591|NCT01358734|3768252|P1|Overall Study|Non-compliance with study drug|0
1147592|NCT01358734|3768250|P3|Overall Study|Progressive Disease|13
1147593|NCT01358734|3768251|P2|Overall Study|Progressive Disease|11
1147594|NCT01358734|3768252|P1|Overall Study|Progressive Disease|5
1147595|NCT01358734|3768250|P3|Overall Study|Death|2
1147596|NCT01358734|3768251|P2|Overall Study|Death|7
1147597|NCT01358734|3768252|P1|Overall Study|Death|3
1147598|NCT01358734|3768250|P3|Overall Study|Withdrawal by Subject|3
1147599|NCT01358734|3768251|P2|Overall Study|Withdrawal by Subject|6
1147600|NCT01358734|3768252|P1|Overall Study|Withdrawal by Subject|1
1147601|NCT01358734|3768250|P3|Overall Study|Lack of Efficacy|3
1147602|NCT01358734|3768251|P2|Overall Study|Lack of Efficacy|1
1147603|NCT01358734|3768252|P1|Overall Study|Lack of Efficacy|0
1147604|NCT01358734|3768250|P3|Overall Study|Adverse Event|3
1147605|NCT01358734|3768251|P2|Overall Study|Adverse Event|7
1147606|NCT01358734|3768252|P1|Overall Study|Adverse Event|4
1147607|NCT01358708|3768271|P2|Double-Blind Treatment Phase|Protocol Violation|0
1147608|NCT01358708|3768272|P1|Double-Blind Treatment Phase|Protocol Violation|1
1147609|NCT01358708|3768271|P2|Double-Blind Treatment Phase|Lost to Follow-up|0
1147610|NCT01358708|3768272|P1|Double-Blind Treatment Phase|Lost to Follow-up|2
1147611|NCT01358578|3768295|P6|Follow-up Period|Physician Decision|0
1147612|NCT01358578|3768296|P5|Follow-up Period|Physician Decision|0
1147613|NCT01358578|3768297|P4|Follow-up Period|Physician Decision|2
1147614|NCT01358578|3768298|P3|Follow-up Period|Physician Decision|0
1147615|NCT01358578|3768299|P2|Follow-up Period|Physician Decision|1
1147616|NCT01358578|3768300|P1|Follow-up Period|Physician Decision|1
1147617|NCT01358578|3768295|P6|Follow-up Period|Withdrawal by Subject|0
1147618|NCT01358578|3768296|P5|Follow-up Period|Withdrawal by Subject|0
1147619|NCT01358578|3768297|P4|Follow-up Period|Withdrawal by Subject|12
1147620|NCT01358578|3768298|P3|Follow-up Period|Withdrawal by Subject|1
1147621|NCT01358578|3768299|P2|Follow-up Period|Withdrawal by Subject|3
1147622|NCT01358578|3768300|P1|Follow-up Period|Withdrawal by Subject|3
1147623|NCT01358578|3768295|P6|Follow-up Period|Pregnancy|0
1147624|NCT01358578|3768296|P5|Follow-up Period|Pregnancy|0
1147625|NCT01358578|3768297|P4|Follow-up Period|Pregnancy|0
1147626|NCT01358578|3768298|P3|Follow-up Period|Pregnancy|0
1147627|NCT01358578|3768299|P2|Follow-up Period|Pregnancy|0
1147628|NCT01358578|3768300|P1|Follow-up Period|Pregnancy|1
1147629|NCT01358578|3768295|P6|Follow-up Period|non- compliance with study treatment|0
1147630|NCT01358578|3768296|P5|Follow-up Period|non- compliance with study treatment|0
1147631|NCT01358578|3768297|P4|Follow-up Period|non- compliance with study treatment|0
1147632|NCT01358578|3768298|P3|Follow-up Period|non- compliance with study treatment|0
1147633|NCT01358578|3768299|P2|Follow-up Period|non- compliance with study treatment|0
1147634|NCT01358578|3768300|P1|Follow-up Period|non- compliance with study treatment|1
1147635|NCT01358578|3768295|P6|Follow-up Period|Lost to Follow-up|0
1147636|NCT01358578|3768296|P5|Follow-up Period|Lost to Follow-up|0
1147637|NCT01358578|3768297|P4|Follow-up Period|Lost to Follow-up|4
1147638|NCT01358578|3768298|P3|Follow-up Period|Lost to Follow-up|0
1147639|NCT01358578|3768299|P2|Follow-up Period|Lost to Follow-up|1
1147640|NCT01358578|3768300|P1|Follow-up Period|Lost to Follow-up|0
1147641|NCT01358578|3768295|P6|Follow-up Period|Lack of Efficacy|0
1147642|NCT01358578|3768296|P5|Follow-up Period|Lack of Efficacy|0
1147643|NCT01358578|3768297|P4|Follow-up Period|Lack of Efficacy|1
1147644|NCT01358578|3768298|P3|Follow-up Period|Lack of Efficacy|4
1147645|NCT01358578|3768299|P2|Follow-up Period|Lack of Efficacy|0
1147646|NCT01358578|3768300|P1|Follow-up Period|Lack of Efficacy|3
1147647|NCT01358578|3768295|P6|Follow-up Period|Adverse Event|0
1147648|NCT01358578|3768296|P5|Follow-up Period|Adverse Event|0
1147649|NCT01358578|3768297|P4|Follow-up Period|Adverse Event|0
1147650|NCT01358578|3768298|P3|Follow-up Period|Adverse Event|0
1147651|NCT01358578|3768299|P2|Follow-up Period|Adverse Event|1
1147652|NCT01358578|3768300|P1|Follow-up Period|Adverse Event|1
1147653|NCT01358578|3768295|P6|Maintenance Period|Withdrawal by Subject|3
1147654|NCT01358578|3768296|P5|Maintenance Period|Withdrawal by Subject|6
1147655|NCT01358578|3768297|P4|Maintenance Period|Withdrawal by Subject|15
1147656|NCT01358578|3768298|P3|Maintenance Period|Withdrawal by Subject|2
1147657|NCT01358578|3768299|P2|Maintenance Period|Withdrawal by Subject|7
1147658|NCT01358578|3768300|P1|Maintenance Period|Withdrawal by Subject|12
1147659|NCT01358578|3768295|P6|Maintenance Period|Protocol deviation|2
1147660|NCT01358578|3768296|P5|Maintenance Period|Protocol deviation|2
1147661|NCT01358578|3768297|P4|Maintenance Period|Protocol deviation|2
1147662|NCT01358578|3768298|P3|Maintenance Period|Protocol deviation|0
1147663|NCT01358578|3768299|P2|Maintenance Period|Protocol deviation|4
1147664|NCT01358578|3768300|P1|Maintenance Period|Protocol deviation|7
1147665|NCT01358578|3768295|P6|Maintenance Period|Pregnancy|0
1147666|NCT01358578|3768296|P5|Maintenance Period|Pregnancy|0
1147667|NCT01358578|3768297|P4|Maintenance Period|Pregnancy|0
1147668|NCT01358578|3768298|P3|Maintenance Period|Pregnancy|0
1147669|NCT01358578|3768299|P2|Maintenance Period|Pregnancy|0
1147670|NCT01358578|3768300|P1|Maintenance Period|Pregnancy|1
1147671|NCT01358578|3768295|P6|Maintenance Period|Physician Decision|0
1147672|NCT01358578|3768296|P5|Maintenance Period|Physician Decision|0
1147673|NCT01358578|3768297|P4|Maintenance Period|Physician Decision|1
1147674|NCT01358578|3768298|P3|Maintenance Period|Physician Decision|0
1147675|NCT01358578|3768299|P2|Maintenance Period|Physician Decision|1
1147676|NCT01358578|3768300|P1|Maintenance Period|Physician Decision|0
1147677|NCT01358578|3768295|P6|Maintenance Period|Non-compliance with study treatment|2
1147678|NCT01358578|3768296|P5|Maintenance Period|Non-compliance with study treatment|1
1147679|NCT01358578|3768297|P4|Maintenance Period|Non-compliance with study treatment|2
1147680|NCT01358578|3768298|P3|Maintenance Period|Non-compliance with study treatment|0
1147681|NCT01358578|3768299|P2|Maintenance Period|Non-compliance with study treatment|1
1147682|NCT01358578|3768300|P1|Maintenance Period|Non-compliance with study treatment|3
1147683|NCT01358578|3768295|P6|Maintenance Period|Lost to Follow-up|1
1147684|NCT01358578|3768296|P5|Maintenance Period|Lost to Follow-up|1
1147685|NCT01358578|3768297|P4|Maintenance Period|Lost to Follow-up|5
1147686|NCT01358578|3768298|P3|Maintenance Period|Lost to Follow-up|0
1147687|NCT01358578|3768299|P2|Maintenance Period|Lost to Follow-up|0
1147688|NCT01358578|3768300|P1|Maintenance Period|Lost to Follow-up|4
1147689|NCT01358578|3768295|P6|Maintenance Period|Lack of Efficacy|0
1147690|NCT01358578|3768296|P5|Maintenance Period|Lack of Efficacy|3
1147691|NCT01358578|3768297|P4|Maintenance Period|Lack of Efficacy|11
1147692|NCT01358578|3768298|P3|Maintenance Period|Lack of Efficacy|0
1147693|NCT01358578|3768299|P2|Maintenance Period|Lack of Efficacy|2
1147694|NCT01358578|3768300|P1|Maintenance Period|Lack of Efficacy|10
1147695|NCT01358578|3768295|P6|Maintenance Period|Adverse Event|3
1147696|NCT01358578|3768296|P5|Maintenance Period|Adverse Event|4
1147697|NCT01358578|3768297|P4|Maintenance Period|Adverse Event|6
1147698|NCT01358578|3768298|P3|Maintenance Period|Adverse Event|0
1147699|NCT01358578|3768299|P2|Maintenance Period|Adverse Event|7
1147700|NCT01358578|3768300|P1|Maintenance Period|Adverse Event|2
1147701|NCT01358578|3768295|P6|Induction Period|Withdrawal by Subject|0
1147702|NCT01358578|3768296|P5|Induction Period|Withdrawal by Subject|0
1147703|NCT01358578|3768297|P4|Induction Period|Withdrawal by Subject|6
1147704|NCT01358578|3768298|P3|Induction Period|Withdrawal by Subject|10
1147705|NCT01358578|3768299|P2|Induction Period|Withdrawal by Subject|5
1147706|NCT01358578|3768300|P1|Induction Period|Withdrawal by Subject|5
1147707|NCT01358578|3768295|P6|Induction Period|technical problems|0
1147708|NCT01358578|3768296|P5|Induction Period|technical problems|0
1147709|NCT01358578|3768297|P4|Induction Period|technical problems|1
1147710|NCT01358578|3768298|P3|Induction Period|technical problems|1
1147711|NCT01358578|3768299|P2|Induction Period|technical problems|0
1147712|NCT01358578|3768300|P1|Induction Period|technical problems|0
1147713|NCT01358578|3768295|P6|Induction Period|Protocol Deviation|0
1147714|NCT01358578|3768296|P5|Induction Period|Protocol Deviation|0
1147715|NCT01358578|3768297|P4|Induction Period|Protocol Deviation|3
1147716|NCT01358578|3768298|P3|Induction Period|Protocol Deviation|0
1147717|NCT01358578|3768299|P2|Induction Period|Protocol Deviation|5
1147718|NCT01358578|3768300|P1|Induction Period|Protocol Deviation|3
1147719|NCT01358578|3768295|P6|Induction Period|Physician Decision|0
1147720|NCT01358578|3768296|P5|Induction Period|Physician Decision|0
1147721|NCT01358578|3768297|P4|Induction Period|Physician Decision|0
1147722|NCT01358578|3768298|P3|Induction Period|Physician Decision|2
1147723|NCT01358578|3768299|P2|Induction Period|Physician Decision|1
1147724|NCT01358578|3768300|P1|Induction Period|Physician Decision|2
1147725|NCT01358578|3768295|P6|Induction Period|Lost to Follow-up|0
1147726|NCT01358578|3768296|P5|Induction Period|Lost to Follow-up|0
1147727|NCT01358578|3768297|P4|Induction Period|Lost to Follow-up|4
1147728|NCT01358578|3768298|P3|Induction Period|Lost to Follow-up|1
1147729|NCT01358578|3768299|P2|Induction Period|Lost to Follow-up|0
1147730|NCT01358578|3768300|P1|Induction Period|Lost to Follow-up|0
1147731|NCT01358578|3768295|P6|Induction Period|Lack of Efficacy|0
1147732|NCT01358578|3768296|P5|Induction Period|Lack of Efficacy|0
1147733|NCT01358578|3768297|P4|Induction Period|Lack of Efficacy|1
1147734|NCT01358578|3768298|P3|Induction Period|Lack of Efficacy|9
1147735|NCT01358578|3768299|P2|Induction Period|Lack of Efficacy|0
1147736|NCT01358578|3768300|P1|Induction Period|Lack of Efficacy|0
1147737|NCT01358578|3768295|P6|Induction Period|Adverse Event|0
1147738|NCT01358578|3768296|P5|Induction Period|Adverse Event|0
1147739|NCT01358578|3768297|P4|Induction Period|Adverse Event|6
1147740|NCT01358578|3768298|P3|Induction Period|Adverse Event|2
1147741|NCT01358578|3768299|P2|Induction Period|Adverse Event|4
1147742|NCT01358578|3768300|P1|Induction Period|Adverse Event|2
1147743|NCT01358526|3768352|P3|Double-blind Phase|Administrative|10
1147744|NCT01358526|3768353|P2|Double-blind Phase|Administrative|6
1147745|NCT01358526|3768354|P1|Double-blind Phase|Administrative|0
1147746|NCT01358526|3768352|P3|Double-blind Phase|Confirmed or suspected diversion|6
1147747|NCT01358526|3768353|P2|Double-blind Phase|Confirmed or suspected diversion|5
1147748|NCT01358526|3768354|P1|Double-blind Phase|Confirmed or suspected diversion|0
1147749|NCT01358526|3768352|P3|Double-blind Phase|Lack of Efficacy|73
1147750|NCT01358526|3768353|P2|Double-blind Phase|Lack of Efficacy|31
1147751|NCT01358526|3768354|P1|Double-blind Phase|Lack of Efficacy|0
1147752|NCT01358526|3768352|P3|Double-blind Phase|Lost to Follow-up|1
1147753|NCT01358526|3768353|P2|Double-blind Phase|Lost to Follow-up|4
1147754|NCT01358526|3768354|P1|Double-blind Phase|Lost to Follow-up|0
1147755|NCT01358526|3768352|P3|Double-blind Phase|Withdrawal by Subject|8
1147756|NCT01358526|3768353|P2|Double-blind Phase|Withdrawal by Subject|10
1147757|NCT01358526|3768354|P1|Double-blind Phase|Withdrawal by Subject|0
1147758|NCT01358526|3768352|P3|Double-blind Phase|Adverse Event|23
1147759|NCT01358526|3768353|P2|Double-blind Phase|Adverse Event|24
1147760|NCT01358526|3768354|P1|Double-blind Phase|Adverse Event|0
1147761|NCT01358526|3768352|P3|Open-label Titration Period|Did not qualify|0
1147762|NCT01358526|3768353|P2|Open-label Titration Period|Did not qualify|0
1147763|NCT01358526|3768354|P1|Open-label Titration Period|Did not qualify|178
1147764|NCT01358526|3768352|P3|Open-label Titration Period|Administrative|0
1147765|NCT01358526|3768353|P2|Open-label Titration Period|Administrative|0
1147766|NCT01358526|3768354|P1|Open-label Titration Period|Administrative|8
1147767|NCT01358526|3768352|P3|Open-label Titration Period|Confirmed or suspected diversion|0
1147768|NCT01358526|3768353|P2|Open-label Titration Period|Confirmed or suspected diversion|0
1147769|NCT01358526|3768354|P1|Open-label Titration Period|Confirmed or suspected diversion|16
1147770|NCT01358526|3768352|P3|Open-label Titration Period|Lack of Efficacy|0
1147771|NCT01358526|3768353|P2|Open-label Titration Period|Lack of Efficacy|0
1147772|NCT01358526|3768354|P1|Open-label Titration Period|Lack of Efficacy|107
1147773|NCT01358526|3768352|P3|Open-label Titration Period|Lost to Follow-up|0
1147774|NCT01358526|3768353|P2|Open-label Titration Period|Lost to Follow-up|0
1147775|NCT01358526|3768354|P1|Open-label Titration Period|Lost to Follow-up|25
1147776|NCT01358526|3768352|P3|Open-label Titration Period|Withdrawal by Subject|0
1147777|NCT01358526|3768353|P2|Open-label Titration Period|Withdrawal by Subject|0
1147778|NCT01358526|3768354|P1|Open-label Titration Period|Withdrawal by Subject|65
1147779|NCT01358526|3768352|P3|Open-label Titration Period|Adverse Event|0
1147780|NCT01358526|3768353|P2|Open-label Titration Period|Adverse Event|0
1147781|NCT01358526|3768354|P1|Open-label Titration Period|Adverse Event|95
1147782|NCT01358357|3768371|P3|Double-Blind Phase|Administrative|0
1147783|NCT01358357|3768372|P2|Double-Blind Phase|Administrative|1
1147784|NCT01358357|3768373|P1|Double-Blind Phase|Administrative|0
1147785|NCT01358357|3768371|P3|Double-Blind Phase|Recurrence of mood event|0
1147786|NCT01358357|3768372|P2|Double-Blind Phase|Recurrence of mood event|64
1147787|NCT01358357|3768373|P1|Double-Blind Phase|Recurrence of mood event|48
1147788|NCT01358357|3768371|P3|Double-Blind Phase|Terminated at study completion|0
1147789|NCT01358357|3768372|P2|Double-Blind Phase|Terminated at study completion|0
1147790|NCT01358357|3768373|P1|Double-Blind Phase|Terminated at study completion|2
1147791|NCT01358357|3768371|P3|Double-Blind Phase|Protocol Violation|0
1147792|NCT01358357|3768372|P2|Double-Blind Phase|Protocol Violation|12
1147793|NCT01358357|3768373|P1|Double-Blind Phase|Protocol Violation|16
1147794|NCT01358357|3768371|P3|Double-Blind Phase|Protocol Violation|0
1147795|NCT01358357|3768372|P2|Double-Blind Phase|Protocol Violation|11
1147796|NCT01358357|3768373|P1|Double-Blind Phase|Protocol Violation|1
1147797|NCT01358357|3768371|P3|Double-Blind Phase|Lost to Follow-up|0
1147798|NCT01358357|3768372|P2|Double-Blind Phase|Lost to Follow-up|7
1147799|NCT01358357|3768373|P1|Double-Blind Phase|Lost to Follow-up|5
1147800|NCT01358357|3768371|P3|Double-Blind Phase|Adverse Event|0
1147801|NCT01358357|3768372|P2|Double-Blind Phase|Adverse Event|5
1147802|NCT01358357|3768373|P1|Double-Blind Phase|Adverse Event|8
1147803|NCT01358357|3768371|P3|Open Label Phase|Mood episode|42
1147804|NCT01358357|3768372|P2|Open Label Phase|Mood episode|0
1147805|NCT01358357|3768373|P1|Open Label Phase|Mood episode|0
1147806|NCT01358357|3768371|P3|Open Label Phase|Terminated at study completion|5
1147807|NCT01358357|3768372|P2|Open Label Phase|Terminated at study completion|0
1147808|NCT01358357|3768373|P1|Open Label Phase|Terminated at study completion|0
1147809|NCT01358357|3768371|P3|Open Label Phase|Did not meet criteria for DB phase|16
1147810|NCT01358357|3768372|P2|Open Label Phase|Did not meet criteria for DB phase|0
1147811|NCT01358357|3768373|P1|Open Label Phase|Did not meet criteria for DB phase|0
1147812|NCT01358357|3768371|P3|Open Label Phase|Withdrawal by Subject|112
1147813|NCT01358357|3768372|P2|Open Label Phase|Withdrawal by Subject|0
1147814|NCT01358357|3768373|P1|Open Label Phase|Withdrawal by Subject|0
1147815|NCT01358357|3768371|P3|Open Label Phase|Protocol Violation|45
1147816|NCT01358357|3768372|P2|Open Label Phase|Protocol Violation|0
1147817|NCT01358357|3768373|P1|Open Label Phase|Protocol Violation|0
1147818|NCT01358357|3768371|P3|Open Label Phase|Lost to Follow-up|76
1147819|NCT01358357|3768372|P2|Open Label Phase|Lost to Follow-up|0
1147820|NCT01358357|3768373|P1|Open Label Phase|Lost to Follow-up|0
1147821|NCT01358357|3768371|P3|Open Label Phase|Lack of Efficacy|107
1147822|NCT01358357|3768372|P2|Open Label Phase|Lack of Efficacy|0
1147823|NCT01358357|3768373|P1|Open Label Phase|Lack of Efficacy|0
1147824|NCT01358357|3768371|P3|Open Label Phase|Adverse Event|59
1147825|NCT01358357|3768372|P2|Open Label Phase|Adverse Event|0
1147826|NCT01358357|3768373|P1|Open Label Phase|Adverse Event|0
1147827|NCT01358175|3768409|P3|Overall Study|Adverse Event|11
1147828|NCT01358175|3768410|P2|Overall Study|Adverse Event|11
1147829|NCT01358175|3768411|P1|Overall Study|Adverse Event|6
1147830|NCT01358175|3768409|P3|Overall Study|Lack of Efficacy|6
1147831|NCT01358175|3768410|P2|Overall Study|Lack of Efficacy|8
1147832|NCT01358175|3768411|P1|Overall Study|Lack of Efficacy|3
1147833|NCT01358175|3768409|P3|Overall Study|Lost to Follow-up|3
1147834|NCT01358175|3768410|P2|Overall Study|Lost to Follow-up|1
1147835|NCT01358175|3768411|P1|Overall Study|Lost to Follow-up|1
1147836|NCT01358175|3768409|P3|Overall Study|Non Compliance with Study Treatment|1
1147837|NCT01358175|3768410|P2|Overall Study|Non Compliance with Study Treatment|1
1147838|NCT01358175|3768411|P1|Overall Study|Non Compliance with Study Treatment|0
1147839|NCT01358175|3768409|P3|Overall Study|Physician Decision|0
1147840|NCT01358175|3768410|P2|Overall Study|Physician Decision|0
1147841|NCT01358175|3768411|P1|Overall Study|Physician Decision|1
1147842|NCT01358175|3768409|P3|Overall Study|Pregnancy|0
1147843|NCT01358175|3768410|P2|Overall Study|Pregnancy|1
1147844|NCT01358175|3768411|P1|Overall Study|Pregnancy|0
1147845|NCT01358175|3768409|P3|Overall Study|Technical issues|0
1147846|NCT01358175|3768410|P2|Overall Study|Technical issues|1
1147847|NCT01358175|3768411|P1|Overall Study|Technical issues|0
1147848|NCT01358175|3768409|P3|Overall Study|Withdrawal by Subject|10
1147849|NCT01358175|3768410|P2|Overall Study|Withdrawal by Subject|5
1147850|NCT01358175|3768411|P1|Overall Study|Withdrawal by Subject|9
1147851|NCT01358175|3768409|P3|Overall Study|Death|1
1147852|NCT01358175|3768410|P2|Overall Study|Death|0
1147853|NCT01358175|3768411|P1|Overall Study|Death|1
1147854|NCT01357980|3768448|P4|Overall Study|Consent withdrawn|0
1147855|NCT01357980|3768449|P3|Overall Study|Consent withdrawn|1
1147856|NCT01357980|3768450|P2|Overall Study|Consent withdrawn|0
1147857|NCT01357980|3768451|P1|Overall Study|Consent withdrawn|0
1147858|NCT01357980|3768448|P4|Overall Study|Lack of Efficacy|0
1147859|NCT01357980|3768449|P3|Overall Study|Lack of Efficacy|0
1147860|NCT01357980|3768450|P2|Overall Study|Lack of Efficacy|1
1147861|NCT01357980|3768451|P1|Overall Study|Lack of Efficacy|0
1147862|NCT01357915|3768495|P2|Overall Study|Lost to Follow-up|0
1147863|NCT01357915|3768496|P1|Overall Study|Lost to Follow-up|3
1147864|NCT01357889|3768511|P2|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0
1147865|NCT01357889|3768512|P1|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1
1147866|NCT01357889|3768511|P2|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0
1147867|NCT01357889|3768512|P1|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1
1147868|NCT01357889|3768511|P2|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4
1147869|NCT01357889|3768512|P1|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0
1147870|NCT01357889|3768511|P2|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0
1147871|NCT01357889|3768512|P1|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1
1147872|NCT01357889|3768511|P2|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
1147873|NCT01357889|3768512|P1|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
1147874|NCT01357889|3768511|P2|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1
1147875|NCT01357889|3768512|P1|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2
1147876|NCT01357889|3768511|P2|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2
1147877|NCT01357889|3768512|P1|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5
1147878|NCT01357889|3768511|P2|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2
1147879|NCT01357889|3768512|P1|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0
1147880|NCT01357889|3768511|P2|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2
1147881|NCT01357889|3768512|P1|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0
1147882|NCT01357889|3768511|P2|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
1147883|NCT01357889|3768512|P1|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
1147884|NCT01357889|3768511|P2|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0
1147885|NCT01357889|3768512|P1|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1
1147886|NCT01357889|3768511|P2|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
1147887|NCT01357889|3768512|P1|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
1147888|NCT01357889|3768511|P2|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1
1147889|NCT01357889|3768512|P1|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2
1147890|NCT01357850|3768556|P4|Overall Study|Lost to Follow-up|0
1147891|NCT01357850|3768557|P3|Overall Study|Lost to Follow-up|0
1147892|NCT01357850|3768558|P2|Overall Study|Lost to Follow-up|0
1147893|NCT01357850|3768559|P1|Overall Study|Lost to Follow-up|1
1147894|NCT01357655|3768650|P2|Overall Study|Subject Withdrew Consent|0
1147895|NCT01357655|3768651|P1|Overall Study|Subject Withdrew Consent|1
1147896|NCT01357655|3768650|P2|Overall Study|Study Drug Toxicity|0
1147897|NCT01357655|3768651|P1|Overall Study|Study Drug Toxicity|11
1147898|NCT01357655|3768650|P2|Overall Study|Reason Unspecified|0
1147899|NCT01357655|3768651|P1|Overall Study|Reason Unspecified|1
1147900|NCT01357655|3768650|P2|Overall Study|Maximum Clinical Benefit|0
1147901|NCT01357655|3768651|P1|Overall Study|Maximum Clinical Benefit|2
1147902|NCT01357655|3768650|P2|Overall Study|Lost to Follow-up|0
1147903|NCT01357655|3768651|P1|Overall Study|Lost to Follow-up|2
1147904|NCT01357655|3768650|P2|Overall Study|Disease Progression|0
1147905|NCT01357655|3768651|P1|Overall Study|Disease Progression|1
1147906|NCT01357655|3768650|P2|Overall Study|Adverse Event Unrelated to Study Drug|0
1147907|NCT01357655|3768651|P1|Overall Study|Adverse Event Unrelated to Study Drug|3
1147908|NCT01357655|3768650|P2|Overall Study|Administrative Reason by Sponsor|0
1147909|NCT01357655|3768651|P1|Overall Study|Administrative Reason by Sponsor|45
1147910|NCT01357616|3768668|P2|Overall Study|Withdrawal by Subject|0
1147911|NCT01357616|3768669|P1|Overall Study|Withdrawal by Subject|1
1147912|NCT01357616|3768668|P2|Overall Study|Decision Unrelated to Adverse Event|1
1147913|NCT01357616|3768669|P1|Overall Study|Decision Unrelated to Adverse Event|3
1147914|NCT01357616|3768668|P2|Overall Study|Inadequate Control of IOP|2
1147915|NCT01357616|3768669|P1|Overall Study|Inadequate Control of IOP|1
1147916|NCT01357616|3768668|P2|Overall Study|Protocol Violation|2
1147917|NCT01357616|3768669|P1|Overall Study|Protocol Violation|0
1147918|NCT01357616|3768668|P2|Overall Study|Lost to Follow-up|3
1147919|NCT01357616|3768669|P1|Overall Study|Lost to Follow-up|4
1147920|NCT01357616|3768668|P2|Overall Study|Adverse Event|1
1147921|NCT01357616|3768669|P1|Overall Study|Adverse Event|1
1147922|NCT01357551|3768683|P2|Overall Study|Lost to Follow-up|6
1147923|NCT01357551|3768684|P1|Overall Study|Lost to Follow-up|16
1147924|NCT01357551|3768683|P2|Overall Study|Death|1
1147925|NCT01357551|3768684|P1|Overall Study|Death|0
1147926|NCT01357551|3768683|P2|Overall Study|Withdrawal by Subject|4
1147927|NCT01357551|3768684|P1|Overall Study|Withdrawal by Subject|6
1147928|NCT01357239|3768711|P4|Stratum II: Partially-Methylated|Subject withdrew consent|1
1147929|NCT01357239|3768712|P3|Stratum II: Partially-Methylated|Subject withdrew consent|1
1147930|NCT01357239|3768713|P2|Stratum II: Partially-Methylated|Subject withdrew consent|0
1147931|NCT01357239|3768714|P1|Stratum II: Partially-Methylated|Subject withdrew consent|0
1147932|NCT01357239|3768711|P4|Stratum II: Partially-Methylated|Adverse Event|1
1147933|NCT01357239|3768712|P3|Stratum II: Partially-Methylated|Adverse Event|0
1147934|NCT01357239|3768713|P2|Stratum II: Partially-Methylated|Adverse Event|0
1147935|NCT01357239|3768714|P1|Stratum II: Partially-Methylated|Adverse Event|0
1147936|NCT01357239|3768711|P4|Stratum I: Fully-Methylated|Adverse Event|0
1147937|NCT01357239|3768712|P3|Stratum I: Fully-Methylated|Adverse Event|1
1147938|NCT01357239|3768713|P2|Stratum I: Fully-Methylated|Adverse Event|0
1147939|NCT01357239|3768714|P1|Stratum I: Fully-Methylated|Adverse Event|0
1147940|NCT01357239|3768711|P4|Stratum: All Patients|Subject withdrew consent|1
1147941|NCT01357239|3768712|P3|Stratum: All Patients|Subject withdrew consent|1
1147942|NCT01357239|3768713|P2|Stratum: All Patients|Subject withdrew consent|0
1147943|NCT01357239|3768714|P1|Stratum: All Patients|Subject withdrew consent|0
1147944|NCT01357239|3768711|P4|Stratum: All Patients|Adverse Event|1
1147945|NCT01357239|3768712|P3|Stratum: All Patients|Adverse Event|1
1147946|NCT01357239|3768713|P2|Stratum: All Patients|Adverse Event|0
1147947|NCT01357239|3768714|P1|Stratum: All Patients|Adverse Event|0
1147948|NCT01357161|3768772|P3|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4
1147949|NCT01357161|3768773|P2|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5
1147950|NCT01357161|3768774|P1|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0
1147951|NCT01357161|3768772|P3|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26
1147952|NCT01357161|3768773|P2|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29
1147953|NCT01357161|3768774|P1|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0
1147954|NCT01357161|3768772|P3|Part 2 (Double-Blind Comparison)|Progressive Disease|3
1147955|NCT01357161|3768773|P2|Part 2 (Double-Blind Comparison)|Progressive Disease|1
1147956|NCT01357161|3768774|P1|Part 2 (Double-Blind Comparison)|Progressive Disease|0
1147957|NCT01357161|3768772|P3|Part 2 (Double-Blind Comparison)|Physician Decision|4
1147958|NCT01357161|3768773|P2|Part 2 (Double-Blind Comparison)|Physician Decision|1
1147959|NCT01357161|3768774|P1|Part 2 (Double-Blind Comparison)|Physician Decision|0
1147960|NCT01357161|3768772|P3|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6
1147961|NCT01357161|3768773|P2|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1
1147962|NCT01357161|3768774|P1|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0
1147963|NCT01357161|3768772|P3|Part 2 (Double-Blind Comparison)|Death|19
1147964|NCT01357161|3768773|P2|Part 2 (Double-Blind Comparison)|Death|22
1147965|NCT01357161|3768774|P1|Part 2 (Double-Blind Comparison)|Death|0
1147966|NCT01357161|3768772|P3|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
1147967|NCT01357161|3768773|P2|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
1147968|NCT01357161|3768774|P1|Part 1 (Open Label Run-in)|Withdrawal by Subject|1
1147969|NCT01357161|3768772|P3|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
1147970|NCT01357161|3768773|P2|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
1147971|NCT01357161|3768774|P1|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5
1147972|NCT01357161|3768772|P3|Part 1 (Open Label Run-in)|Physician Decision|0
1147973|NCT01357161|3768773|P2|Part 1 (Open Label Run-in)|Physician Decision|0
1147974|NCT01357161|3768774|P1|Part 1 (Open Label Run-in)|Physician Decision|1
1147975|NCT01357161|3768772|P3|Part 1 (Open Label Run-in)|Lost to Follow-up|0
1147976|NCT01357161|3768773|P2|Part 1 (Open Label Run-in)|Lost to Follow-up|0
1147977|NCT01357161|3768774|P1|Part 1 (Open Label Run-in)|Lost to Follow-up|3
1147978|NCT01357161|3768772|P3|Part 1 (Open Label Run-in)|Death|0
1147979|NCT01357161|3768773|P2|Part 1 (Open Label Run-in)|Death|0
1147980|NCT01357161|3768774|P1|Part 1 (Open Label Run-in)|Death|5
1147981|NCT01356966|3768826|P2|Overall Study|Physician Decision|0
1147982|NCT01356966|3768827|P1|Overall Study|Physician Decision|1
1147983|NCT01356966|3768826|P2|Overall Study|Withdrawal by Subject|2
1147984|NCT01356966|3768827|P1|Overall Study|Withdrawal by Subject|1
1147985|NCT01356940|3768839|P2|Second Intervention (28 Days)|Withdrawal by Subject|0
1147986|NCT01356940|3768840|P1|Second Intervention (28 Days)|Withdrawal by Subject|1
1147987|NCT01356940|3768839|P2|First Intervention (28 Days)|Adverse Event|0
1147988|NCT01356940|3768840|P1|First Intervention (28 Days)|Adverse Event|1
1147989|NCT01356602|3768869|P3|Overall Study|Adverse Event|1
1147990|NCT01356602|3768870|P2|Overall Study|Adverse Event|1
1147991|NCT01356602|3768871|P1|Overall Study|Adverse Event|0
1147992|NCT01356602|3768869|P3|Overall Study|Lack of Efficacy|4
1147993|NCT01356602|3768870|P2|Overall Study|Lack of Efficacy|1
1147994|NCT01356602|3768871|P1|Overall Study|Lack of Efficacy|0
1147995|NCT01356602|3768869|P3|Overall Study|Withdrawal by Subject|7
1147996|NCT01356602|3768870|P2|Overall Study|Withdrawal by Subject|3
1147997|NCT01356602|3768871|P1|Overall Study|Withdrawal by Subject|4
1147998|NCT01356602|3768869|P3|Overall Study|Lost to Follow-up|6
1147999|NCT01356602|3768870|P2|Overall Study|Lost to Follow-up|5
1148000|NCT01356602|3768871|P1|Overall Study|Lost to Follow-up|4
1148001|NCT01356602|3768869|P3|Overall Study|Administrative Problems|5
1148002|NCT01356602|3768870|P2|Overall Study|Administrative Problems|4
1148003|NCT01356602|3768871|P1|Overall Study|Administrative Problems|1
1148004|NCT01356602|3768869|P3|Overall Study|Protocol Deviation|1
1148005|NCT01356602|3768870|P2|Overall Study|Protocol Deviation|1
1148006|NCT01356602|3768871|P1|Overall Study|Protocol Deviation|0
1148007|NCT01356589|3768930|P1|Overall Study|Dose data not recorded|2
1148008|NCT01356589|3768930|P1|Overall Study|Enrolled, but not treated|3
1148009|NCT01356407|3768987|P2|Overall Study|Not complete Endoscopy|2
1148010|NCT01356407|3768988|P1|Overall Study|Not complete Endoscopy|2
1148011|NCT01356407|3768987|P2|Overall Study|Could not afford IMP administration|1
1148012|NCT01356407|3768988|P1|Overall Study|Could not afford IMP administration|0
1148013|NCT01356407|3768987|P2|Overall Study|Patient Withdrew Consent|1
1148014|NCT01356407|3768988|P1|Overall Study|Patient Withdrew Consent|2
1148015|NCT01356407|3768987|P2|Overall Study|Lost to Follow-up|0
1148016|NCT01356407|3768988|P1|Overall Study|Lost to Follow-up|2
1148017|NCT01355679|3769060|P1|Overall Study|benign tumor types found at biopsy|2
1148018|NCT01355627|3769069|P2|Overall Study|Other|1
1148019|NCT01355627|3769070|P1|Overall Study|Other|1
1148020|NCT01355627|3769069|P2|Overall Study|Fatal Adverse Event|23
1148021|NCT01355627|3769070|P1|Overall Study|Fatal Adverse Event|19
1148022|NCT01355627|3769069|P2|Overall Study|Lost to Follow-up|7
1148023|NCT01355627|3769070|P1|Overall Study|Lost to Follow-up|8
1148024|NCT01355627|3769069|P2|Overall Study|Request By the Patient to Discontinue|7
1148025|NCT01355627|3769070|P1|Overall Study|Request By the Patient to Discontinue|5
1148026|NCT01355523|3769109|P2|Overall Study|Adverse Event|2
1148027|NCT01355523|3769110|P1|Overall Study|Adverse Event|0
1148028|NCT01355523|3769109|P2|Overall Study|Protocol Violation|2
1148029|NCT01355523|3769110|P1|Overall Study|Protocol Violation|0
1148030|NCT01355523|3769109|P2|Overall Study|Lost to Follow-up|2
1148031|NCT01355523|3769110|P1|Overall Study|Lost to Follow-up|0
1148032|NCT01355523|3769109|P2|Overall Study|Withdrawal by Subject|4
1148033|NCT01355523|3769110|P1|Overall Study|Withdrawal by Subject|1
1148034|NCT01355302|3769186|P3|Phase 1b|Study terminated by sponsor|0
1148035|NCT01355302|3769187|P2|Phase 1b|Study terminated by sponsor|0
1148036|NCT01355302|3769188|P1|Phase 1b|Study terminated by sponsor|2
1148037|NCT01355302|3769186|P3|Phase 1b|Death|0
1148038|NCT01355302|3769187|P2|Phase 1b|Death|0
1148039|NCT01355302|3769188|P1|Phase 1b|Death|4
1148040|NCT01355289|3769203|P5|Open Label Extension|Not specified|3
1148041|NCT01355289|3769204|P4|Open Label Extension|Not specified|0
1148042|NCT01355289|3769205|P3|Open Label Extension|Not specified|0
1148043|NCT01355289|3769206|P2|Open Label Extension|Not specified|0
1148044|NCT01355289|3769207|P1|Open Label Extension|Not specified|0
1148045|NCT01355289|3769203|P5|Open Label Extension|Inadequate Therapeutic Effect|29
1148046|NCT01355289|3769204|P4|Open Label Extension|Inadequate Therapeutic Effect|0
1148047|NCT01355289|3769205|P3|Open Label Extension|Inadequate Therapeutic Effect|0
1148048|NCT01355289|3769206|P2|Open Label Extension|Inadequate Therapeutic Effect|0
1148049|NCT01355289|3769207|P1|Open Label Extension|Inadequate Therapeutic Effect|0
1148050|NCT01355289|3769203|P5|Open Label Extension|Lost to Follow-up|1
1148051|NCT01355289|3769204|P4|Open Label Extension|Lost to Follow-up|0
1148052|NCT01355289|3769205|P3|Open Label Extension|Lost to Follow-up|0
1148053|NCT01355289|3769206|P2|Open Label Extension|Lost to Follow-up|0
1148054|NCT01355289|3769207|P1|Open Label Extension|Lost to Follow-up|0
1148055|NCT01355289|3769203|P5|Open Label Extension|Adverse Event, Non-Fatal|1
1148056|NCT01355289|3769204|P4|Open Label Extension|Adverse Event, Non-Fatal|0
1148057|NCT01355289|3769205|P3|Open Label Extension|Adverse Event, Non-Fatal|0
1148058|NCT01355289|3769206|P2|Open Label Extension|Adverse Event, Non-Fatal|0
1148059|NCT01355289|3769207|P1|Open Label Extension|Adverse Event, Non-Fatal|0
1148060|NCT01355289|3769203|P5|Core Study|Not specified|0
1148061|NCT01355289|3769204|P4|Core Study|Not specified|1
1148062|NCT01355289|3769205|P3|Core Study|Not specified|0
1148063|NCT01355289|3769206|P2|Core Study|Not specified|0
1148064|NCT01355289|3769207|P1|Core Study|Not specified|0
1148065|NCT01355289|3769203|P5|Core Study|Inadequate Therapeutic Effect|0
1148066|NCT01355289|3769204|P4|Core Study|Inadequate Therapeutic Effect|1
1148067|NCT01355289|3769205|P3|Core Study|Inadequate Therapeutic Effect|0
1148068|NCT01355289|3769206|P2|Core Study|Inadequate Therapeutic Effect|0
1148069|NCT01355289|3769207|P1|Core Study|Inadequate Therapeutic Effect|0
1148070|NCT01355289|3769203|P5|Core Study|Adverse Event, Non-Fatal|0
1148071|NCT01355289|3769204|P4|Core Study|Adverse Event, Non-Fatal|0
1148072|NCT01355289|3769205|P3|Core Study|Adverse Event, Non-Fatal|0
1148073|NCT01355289|3769206|P2|Core Study|Adverse Event, Non-Fatal|0
1148074|NCT01355289|3769207|P1|Core Study|Adverse Event, Non-Fatal|1
1148075|NCT01355081|3769260|P3|Overall Study|Non Compliance with Study Medication|0
1148076|NCT01355081|3769261|P2|Overall Study|Non Compliance with Study Medication|1
1148077|NCT01355081|3769262|P1|Overall Study|Non Compliance with Study Medication|0
1148078|NCT01355081|3769260|P3|Overall Study|Lack of Efficacy|1
1148079|NCT01355081|3769261|P2|Overall Study|Lack of Efficacy|1
1148080|NCT01355081|3769262|P1|Overall Study|Lack of Efficacy|2
1148081|NCT01355081|3769260|P3|Overall Study|Withdrawal of Consent|3
1148082|NCT01355081|3769261|P2|Overall Study|Withdrawal of Consent|3
1148083|NCT01355081|3769262|P1|Overall Study|Withdrawal of Consent|2
1148084|NCT01355081|3769260|P3|Overall Study|Lost to Follow-up|1
1148085|NCT01355081|3769261|P2|Overall Study|Lost to Follow-up|0
1148086|NCT01355081|3769262|P1|Overall Study|Lost to Follow-up|0
1148087|NCT01355081|3769260|P3|Overall Study|Major Protocol Deviation|0
1148088|NCT01355081|3769261|P2|Overall Study|Major Protocol Deviation|1
1148089|NCT01355081|3769262|P1|Overall Study|Major Protocol Deviation|0
1148090|NCT01355081|3769260|P3|Overall Study|Pretreatment Event or Adverse Event|6
1148091|NCT01355081|3769261|P2|Overall Study|Pretreatment Event or Adverse Event|4
1148092|NCT01355081|3769262|P1|Overall Study|Pretreatment Event or Adverse Event|3
1148093|NCT01355068|3769285|P2|First Intervention Period|Withdrawal by Subject|1
1148094|NCT01355068|3769286|P1|First Intervention Period|Withdrawal by Subject|0
1148095|NCT01355068|3769285|P2|First Intervention Period|Adverse Event|1
1148096|NCT01355068|3769286|P1|First Intervention Period|Adverse Event|0
1148097|NCT01354938|3769316|P1|Overall Study|Lost to Follow-up|1
1148098|NCT01354899|3769322|P1|Overall Study|Protocol Violation|1
1148099|NCT01354899|3769322|P1|Overall Study|discharge from the hospital|2
1148100|NCT01354431|3769371|P3|Participants Treated|Withdrawal by Subject|1
1148101|NCT01354431|3769372|P2|Participants Treated|Withdrawal by Subject|2
1148102|NCT01354431|3769373|P1|Participants Treated|Withdrawal by Subject|1
1148103|NCT01354431|3769371|P3|Participants Treated|Adverse Event|4
1148104|NCT01354431|3769372|P2|Participants Treated|Adverse Event|2
1148105|NCT01354431|3769373|P1|Participants Treated|Adverse Event|1
1148106|NCT01354431|3769371|P3|Participants Treated|Death|0
1148107|NCT01354431|3769372|P2|Participants Treated|Death|1
1148108|NCT01354431|3769373|P1|Participants Treated|Death|0
1148109|NCT01354431|3769371|P3|Participants Treated|Study Drug Toxicity|4
1148110|NCT01354431|3769372|P2|Participants Treated|Study Drug Toxicity|7
1148111|NCT01354431|3769373|P1|Participants Treated|Study Drug Toxicity|2
1148112|NCT01354431|3769371|P3|Participants Treated|Disease Progression|41
1148113|NCT01354431|3769372|P2|Participants Treated|Disease Progression|40
1148114|NCT01354431|3769373|P1|Participants Treated|Disease Progression|49
1148115|NCT01354431|3769371|P3|Participants Treated|Continuing Treatment|4
1148116|NCT01354431|3769372|P2|Participants Treated|Continuing Treatment|2
1148117|NCT01354431|3769373|P1|Participants Treated|Continuing Treatment|6
1148118|NCT01354431|3769371|P3|Randomized to Enter Treatment Period|No longer met criteria|0
1148119|NCT01354431|3769372|P2|Randomized to Enter Treatment Period|No longer met criteria|0
1148120|NCT01354431|3769373|P1|Randomized to Enter Treatment Period|No longer met criteria|1
1148121|NCT01354314|3769397|P4|Overall Study|Less than 90% Adherence|4
1148122|NCT01354314|3769398|P3|Overall Study|Less than 90% Adherence|6
1148123|NCT01354314|3769399|P2|Overall Study|Less than 90% Adherence|2
1148124|NCT01354314|3769400|P1|Overall Study|Less than 90% Adherence|4
1148125|NCT01354314|3769397|P4|Overall Study|Protocol Violation|0
1148126|NCT01354314|3769398|P3|Overall Study|Protocol Violation|0
1148127|NCT01354314|3769399|P2|Overall Study|Protocol Violation|1
1148128|NCT01354314|3769400|P1|Overall Study|Protocol Violation|1
1148129|NCT01354314|3769397|P4|Overall Study|Adverse Event|1
1148130|NCT01354314|3769398|P3|Overall Study|Adverse Event|0
1148131|NCT01354314|3769399|P2|Overall Study|Adverse Event|0
1148132|NCT01354314|3769400|P1|Overall Study|Adverse Event|0
1148133|NCT01354314|3769397|P4|Overall Study|Withdrawal by Subject|0
1148134|NCT01354314|3769398|P3|Overall Study|Withdrawal by Subject|1
1148135|NCT01354314|3769399|P2|Overall Study|Withdrawal by Subject|0
1148136|NCT01354314|3769400|P1|Overall Study|Withdrawal by Subject|0
1148137|NCT01354314|3769397|P4|Overall Study|Lost to Follow-up|1
1148138|NCT01354314|3769398|P3|Overall Study|Lost to Follow-up|1
1148139|NCT01354314|3769399|P2|Overall Study|Lost to Follow-up|0
1148140|NCT01354314|3769400|P1|Overall Study|Lost to Follow-up|1
1148141|NCT01354223|3769536|P2|Overall Study|Withdrawal by Subject|1
1148142|NCT01354223|3769537|P1|Overall Study|Withdrawal by Subject|3
1148143|NCT01354132|3769596|P2|1 Month Post Study Medication|Withdrawal by Subject|3
1148144|NCT01354132|3769597|P1|1 Month Post Study Medication|Withdrawal by Subject|1
1148145|NCT01354132|3769596|P2|Double Blind (Visits 1-7)|Withdrawal by Subject|11
1148146|NCT01354132|3769597|P1|Double Blind (Visits 1-7)|Withdrawal by Subject|8
1148147|NCT01354132|3769596|P2|Double Blind (Visits 1-7)|Adverse Event|0
1148148|NCT01354132|3769597|P1|Double Blind (Visits 1-7)|Adverse Event|1
1148149|NCT01354132|3769596|P2|Randomization|Withdrawal by Subject|1
1148150|NCT01354132|3769597|P1|Randomization|Withdrawal by Subject|0
1148151|NCT01354132|3769596|P2|Randomization|Physician Decision|0
1148152|NCT01354132|3769597|P1|Randomization|Physician Decision|1
1148153|NCT01354106|3769635|P1|Overall Study|Withdrawal by Subject|2
1148154|NCT01354028|3769641|P2|Overall Study|No quiet alert state|1
1148155|NCT01354028|3769642|P1|Overall Study|No quiet alert state|0
1148156|NCT01354028|3769641|P2|Overall Study|Discharged before study start|2
1148157|NCT01354028|3769642|P1|Overall Study|Discharged before study start|2
1148158|NCT01354028|3769641|P2|Overall Study|Physician Decision|2
1148159|NCT01354028|3769642|P1|Overall Study|Physician Decision|0
1148160|NCT01353963|3769678|P1|Overall Study|Adverse Event|2
1148161|NCT01353911|3769696|P8|Overall Study|Status Not Recorded|0
1148162|NCT01353911|3769697|P7|Overall Study|Status Not Recorded|0
1148163|NCT01353911|3769698|P6|Overall Study|Status Not Recorded|0
1148164|NCT01353911|3769699|P5|Overall Study|Status Not Recorded|0
1148165|NCT01353911|3769700|P4|Overall Study|Status Not Recorded|0
1148166|NCT01353911|3769701|P3|Overall Study|Status Not Recorded|1
1148167|NCT01353911|3769702|P2|Overall Study|Status Not Recorded|0
1148168|NCT01353911|3769703|P1|Overall Study|Status Not Recorded|4
1148169|NCT01353911|3769696|P8|Overall Study|Withdrawal by Subject|9
1148170|NCT01353911|3769697|P7|Overall Study|Withdrawal by Subject|3
1148171|NCT01353911|3769698|P6|Overall Study|Withdrawal by Subject|3
1148172|NCT01353911|3769699|P5|Overall Study|Withdrawal by Subject|2
1148173|NCT01353911|3769700|P4|Overall Study|Withdrawal by Subject|2
1148174|NCT01353911|3769701|P3|Overall Study|Withdrawal by Subject|4
1148175|NCT01353911|3769702|P2|Overall Study|Withdrawal by Subject|3
1148176|NCT01353911|3769703|P1|Overall Study|Withdrawal by Subject|2
1148177|NCT01353911|3769696|P8|Overall Study|Lost to Follow-up|6
1148178|NCT01353911|3769697|P7|Overall Study|Lost to Follow-up|3
1148179|NCT01353911|3769698|P6|Overall Study|Lost to Follow-up|4
1148180|NCT01353911|3769699|P5|Overall Study|Lost to Follow-up|4
1148181|NCT01353911|3769700|P4|Overall Study|Lost to Follow-up|0
1148182|NCT01353911|3769701|P3|Overall Study|Lost to Follow-up|4
1148183|NCT01353911|3769702|P2|Overall Study|Lost to Follow-up|6
1148184|NCT01353911|3769703|P1|Overall Study|Lost to Follow-up|2
1148185|NCT01353898|3769783|P6|Overall Study|Study site terminated|1
1148186|NCT01353898|3769784|P5|Overall Study|Study site terminated|0
1148187|NCT01353898|3769785|P4|Overall Study|Study site terminated|0
1148188|NCT01353898|3769786|P3|Overall Study|Study site terminated|0
1148189|NCT01353898|3769787|P2|Overall Study|Study site terminated|0
1148190|NCT01353898|3769788|P1|Overall Study|Study site terminated|0
1148191|NCT01353859|3769814|P1|Overall Study|Lack of Efficacy|1
1148192|NCT01353859|3769814|P1|Overall Study|Adverse Event|3
1148193|NCT01353664|3769827|P1|Overall Study|Disease Progression|16
1148194|NCT01353664|3769827|P1|Overall Study|Other|3
1148195|NCT01353586|3769833|P2|Overall Study|Neurological exam not done|1
1148196|NCT01353586|3769834|P1|Overall Study|Neurological exam not done|0
1148197|NCT01353586|3769833|P2|Overall Study|Never had insertion of study catheter|1
1148198|NCT01353586|3769834|P1|Overall Study|Never had insertion of study catheter|4
1148199|NCT01353586|3769833|P2|Overall Study|Procedure terminated prior to ablation|0
1148200|NCT01353586|3769834|P1|Overall Study|Procedure terminated prior to ablation|3
1148201|NCT01353508|3769852|P4|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
1148202|NCT01353508|3769853|P3|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
1148203|NCT01353508|3769854|P2|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
1148204|NCT01353508|3769855|P1|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1
1148205|NCT01353508|3769852|P4|Period 1 - First Intervention (7 Days)|Adverse Event|1
1148206|NCT01353508|3769853|P3|Period 1 - First Intervention (7 Days)|Adverse Event|0
1148207|NCT01353508|3769854|P2|Period 1 - First Intervention (7 Days)|Adverse Event|0
1148208|NCT01353508|3769855|P1|Period 1 - First Intervention (7 Days)|Adverse Event|0
1148209|NCT01353274|3769933|P1|Overall Study|No case report form (CRF) collected|28
1148210|NCT01353222|3769943|P2|Overall Study|Site closed research department|0
1148211|NCT01353222|3769944|P1|Overall Study|Site closed research department|1
1148212|NCT01353222|3769943|P2|Overall Study|Study Terminated|37
1148213|NCT01353222|3769944|P1|Overall Study|Study Terminated|31
1148214|NCT01353222|3769943|P2|Overall Study|Withdrawal by Subject|5
1148215|NCT01353222|3769944|P1|Overall Study|Withdrawal by Subject|8
1148216|NCT01353222|3769943|P2|Overall Study|Death|30
1148217|NCT01353222|3769944|P1|Overall Study|Death|30
1148218|NCT01352845|3769978|P2|Overall Study|Death|0
1148219|NCT01352845|3769979|P1|Overall Study|Death|3
1148220|NCT01352845|3769978|P2|Overall Study|Protocol Violation|6
1148221|NCT01352845|3769979|P1|Overall Study|Protocol Violation|12
1148222|NCT01352845|3769978|P2|Overall Study|Other|7
1148223|NCT01352845|3769979|P1|Overall Study|Other|17
1148224|NCT01352845|3769978|P2|Overall Study|Adverse Event|6
1148225|NCT01352845|3769979|P1|Overall Study|Adverse Event|22
1148226|NCT01352845|3769978|P2|Overall Study|Pregnancy|7
1148227|NCT01352845|3769979|P1|Overall Study|Pregnancy|27
1148228|NCT01352845|3769978|P2|Overall Study|No Longer Meets Eligibility Criteria|11
1148229|NCT01352845|3769979|P1|Overall Study|No Longer Meets Eligibility Criteria|24
1148230|NCT01352845|3769978|P2|Overall Study|Withdrawal by Subject|16
1148231|NCT01352845|3769979|P1|Overall Study|Withdrawal by Subject|48
1148232|NCT01352845|3769978|P2|Overall Study|No Longer Willing to Participate|58
1148233|NCT01352845|3769979|P1|Overall Study|No Longer Willing to Participate|205
1148234|NCT01352845|3769978|P2|Overall Study|Lost to Follow-up|92
1148235|NCT01352845|3769979|P1|Overall Study|Lost to Follow-up|313
1148236|NCT01352793|3770068|P2|Overall Study|No longer meets eligibility criteria|15
1148237|NCT01352793|3770069|P1|Overall Study|No longer meets eligibility criteria|25
1148238|NCT01352793|3770068|P2|Overall Study|Randomized but not vaccinated|0
1148239|NCT01352793|3770069|P1|Overall Study|Randomized but not vaccinated|8
1148240|NCT01352793|3770068|P2|Overall Study|Death|0
1148241|NCT01352793|3770069|P1|Overall Study|Death|1
1148242|NCT01352793|3770068|P2|Overall Study|Medication error|2
1148243|NCT01352793|3770069|P1|Overall Study|Medication error|2
1148244|NCT01352793|3770068|P2|Overall Study|Other|7
1148245|NCT01352793|3770069|P1|Overall Study|Other|25
1148246|NCT01352793|3770068|P2|Overall Study|Pregnancy|8
1148247|NCT01352793|3770069|P1|Overall Study|Pregnancy|26
1148248|NCT01352793|3770068|P2|Overall Study|Physician Decision|0
1148249|NCT01352793|3770069|P1|Overall Study|Physician Decision|1
1148250|NCT01352793|3770068|P2|Overall Study|Adverse Event|10
1148251|NCT01352793|3770069|P1|Overall Study|Adverse Event|44
1148252|NCT01352793|3770068|P2|Overall Study|Protocol Violation|23
1148253|NCT01352793|3770069|P1|Overall Study|Protocol Violation|44
1148254|NCT01352793|3770068|P2|Overall Study|Withdrawal by Subject|55
1148255|NCT01352793|3770069|P1|Overall Study|Withdrawal by Subject|120
1148256|NCT01352793|3770068|P2|Overall Study|Lost to Follow-up|125
1148257|NCT01352793|3770069|P1|Overall Study|Lost to Follow-up|289
1148258|NCT01352741|3770093|P2|Open-Label Tapentadol Continuation Arm|Protocol Violation|0
1148259|NCT01352741|3770094|P1|Open-Label Tapentadol Continuation Arm|Protocol Violation|1
1148260|NCT01352741|3770093|P2|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0
1148261|NCT01352741|3770094|P1|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2
1148262|NCT01352741|3770093|P2|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0
1148263|NCT01352741|3770094|P1|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1
1148264|NCT01352741|3770093|P2|Open-Label Tapentadol Continuation Arm|Adverse Event|0
1148265|NCT01352741|3770094|P1|Open-Label Tapentadol Continuation Arm|Adverse Event|4
1148266|NCT01352741|3770093|P2|Double-blind Comparative Period|Not Specified|2
1148267|NCT01352741|3770094|P1|Double-blind Comparative Period|Not Specified|1
1148268|NCT01352741|3770093|P2|Double-blind Comparative Period|Withdrawal of consent|3
1148269|NCT01352741|3770094|P1|Double-blind Comparative Period|Withdrawal of consent|8
1148270|NCT01352741|3770093|P2|Double-blind Comparative Period|Death|1
1148271|NCT01352741|3770094|P1|Double-blind Comparative Period|Death|0
1148272|NCT01352741|3770093|P2|Double-blind Comparative Period|Lost to Follow-up|0
1148273|NCT01352741|3770094|P1|Double-blind Comparative Period|Lost to Follow-up|1
1148274|NCT01352741|3770093|P2|Double-blind Comparative Period|Adverse Event|17
1148275|NCT01352741|3770094|P1|Double-blind Comparative Period|Adverse Event|16
1148276|NCT01352741|3770093|P2|Double-blind Comparative Period|Lack of Efficacy|3
1148277|NCT01352741|3770094|P1|Double-blind Comparative Period|Lack of Efficacy|0
1148278|NCT01352741|3770093|P2|Double-blind Comparative Period|Protocol Violation|0
1148279|NCT01352741|3770094|P1|Double-blind Comparative Period|Protocol Violation|2
1148280|NCT01352741|3770093|P2|Open-label Tapentadol Titration Period|Not Specified|0
1148281|NCT01352741|3770094|P1|Open-label Tapentadol Titration Period|Not Specified|4
1148282|NCT01352741|3770093|P2|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0
1148283|NCT01352741|3770094|P1|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5
1148284|NCT01352741|3770093|P2|Open-label Tapentadol Titration Period|Withdrawal of consent|0
1148285|NCT01352741|3770094|P1|Open-label Tapentadol Titration Period|Withdrawal of consent|7
1148286|NCT01352741|3770093|P2|Open-label Tapentadol Titration Period|Adverse Event|0
1148287|NCT01352741|3770094|P1|Open-label Tapentadol Titration Period|Adverse Event|34
1148288|NCT01352741|3770093|P2|Open-label Tapentadol Titration Period|Lack of Efficacy|0
1148289|NCT01352741|3770094|P1|Open-label Tapentadol Titration Period|Lack of Efficacy|19
1148290|NCT01352741|3770093|P2|Open-label Tapentadol Titration Period|Protocol Violation|0
1148291|NCT01352741|3770094|P1|Open-label Tapentadol Titration Period|Protocol Violation|4
1148292|NCT01352715|3770188|P2|Overall Study|major ineligibility|1
1148293|NCT01352715|3770189|P1|Overall Study|major ineligibility|2
1148294|NCT01352715|3770188|P2|Overall Study|no final visit in closeout period|12
1148295|NCT01352715|3770189|P1|Overall Study|no final visit in closeout period|15
1148296|NCT01352715|3770188|P2|Overall Study|site closure|15
1148297|NCT01352715|3770189|P1|Overall Study|site closure|16
1148298|NCT01352715|3770188|P2|Overall Study|Withdrawal by Subject|8
1148299|NCT01352715|3770189|P1|Overall Study|Withdrawal by Subject|4
1148300|NCT01352715|3770188|P2|Overall Study|Lost to Follow-up|7
1148301|NCT01352715|3770189|P1|Overall Study|Lost to Follow-up|5
1148302|NCT01352715|3770188|P2|Overall Study|Death|3
1148303|NCT01352715|3770189|P1|Overall Study|Death|3
1148304|NCT01352585|3770211|P1|Overall Study|Not specified|7
1148305|NCT01352585|3770211|P1|Overall Study|Lost to Follow-up|1
1148306|NCT01352585|3770211|P1|Overall Study|Adverse Event|3
1148307|NCT01352507|3770228|P2|Treatment Period 2|Lack of Efficacy|0
1148308|NCT01352507|3770229|P1|Treatment Period 2|Lack of Efficacy|1
1148309|NCT01352507|3770228|P2|Treatment Period 2|Withdrawal by Subject|3
1148310|NCT01352507|3770229|P1|Treatment Period 2|Withdrawal by Subject|4
1148311|NCT01352507|3770228|P2|Treatment Period 2|Entry Criteria Not Met|0
1148312|NCT01352507|3770229|P1|Treatment Period 2|Entry Criteria Not Met|1
1148313|NCT01352507|3770228|P2|Washout Period|Withdrawal by Subject|1
1148314|NCT01352507|3770229|P1|Washout Period|Withdrawal by Subject|0
1148315|NCT01352507|3770228|P2|Treatment Period 1|Physician Decision|0
1148316|NCT01352507|3770229|P1|Treatment Period 1|Physician Decision|1
1148317|NCT01352507|3770228|P2|Treatment Period 1|Withdrawal by Subject|5
1148318|NCT01352507|3770229|P1|Treatment Period 1|Withdrawal by Subject|7
1148319|NCT01352507|3770228|P2|Treatment Period 1|Lost to Follow-up|4
1148320|NCT01352507|3770229|P1|Treatment Period 1|Lost to Follow-up|3
1148321|NCT01352507|3770228|P2|Treatment Period 1|Adverse Event|0
1148322|NCT01352507|3770229|P1|Treatment Period 1|Adverse Event|3
1148323|NCT01352416|3770282|P4|Overall Study|Physician Decision|1
1148324|NCT01352416|3770283|P3|Overall Study|Physician Decision|2
1148325|NCT01352416|3770284|P2|Overall Study|Physician Decision|2
1148326|NCT01352416|3770285|P1|Overall Study|Physician Decision|1
1148327|NCT01352221|3770297|P4|Open-label Phase|Worsening of IBD|0
1148328|NCT01352221|3770298|P3|Open-label Phase|Worsening of IBD|1
1148329|NCT01352221|3770299|P2|Open-label Phase|Worsening of IBD|0
1148330|NCT01352221|3770300|P1|Open-label Phase|Worsening of IBD|0
1148331|NCT01352221|3770297|P4|Open-label Phase|Withdrawal by Subject|6
1148332|NCT01352221|3770298|P3|Open-label Phase|Withdrawal by Subject|1
1148333|NCT01352221|3770299|P2|Open-label Phase|Withdrawal by Subject|0
1148334|NCT01352221|3770300|P1|Open-label Phase|Withdrawal by Subject|0
1148335|NCT01352221|3770297|P4|Open-label Phase|Adverse Event|4
1148336|NCT01352221|3770298|P3|Open-label Phase|Adverse Event|8
1148337|NCT01352221|3770299|P2|Open-label Phase|Adverse Event|0
1148338|NCT01352221|3770300|P1|Open-label Phase|Adverse Event|0
1148339|NCT01352221|3770297|P4|Open-label Phase|Pregnancy|0
1148340|NCT01352221|3770298|P3|Open-label Phase|Pregnancy|1
1148341|NCT01352221|3770299|P2|Open-label Phase|Pregnancy|0
1148342|NCT01352221|3770300|P1|Open-label Phase|Pregnancy|0
1148343|NCT01352221|3770297|P4|Open-label Phase|Physician Decision|1
1148344|NCT01352221|3770298|P3|Open-label Phase|Physician Decision|2
1148345|NCT01352221|3770299|P2|Open-label Phase|Physician Decision|0
1148346|NCT01352221|3770300|P1|Open-label Phase|Physician Decision|0
1148347|NCT01352221|3770297|P4|Double-blind Phase|Protocol Violation|0
1148348|NCT01352221|3770298|P3|Double-blind Phase|Protocol Violation|0
1148349|NCT01352221|3770299|P2|Double-blind Phase|Protocol Violation|1
1148350|NCT01352221|3770300|P1|Double-blind Phase|Protocol Violation|0
1148351|NCT01352221|3770297|P4|Double-blind Phase|Lost to Follow-up|0
1148352|NCT01352221|3770298|P3|Double-blind Phase|Lost to Follow-up|0
1148353|NCT01352221|3770299|P2|Double-blind Phase|Lost to Follow-up|1
1148354|NCT01352221|3770300|P1|Double-blind Phase|Lost to Follow-up|0
1148355|NCT01352221|3770297|P4|Double-blind Phase|Withdrawal by Subject|0
1148356|NCT01352221|3770298|P3|Double-blind Phase|Withdrawal by Subject|0
1148357|NCT01352221|3770299|P2|Double-blind Phase|Withdrawal by Subject|5
1148358|NCT01352221|3770300|P1|Double-blind Phase|Withdrawal by Subject|3
1148359|NCT01352221|3770297|P4|Double-blind Phase|Adverse Event|0
1148360|NCT01352221|3770298|P3|Double-blind Phase|Adverse Event|0
1148361|NCT01352221|3770299|P2|Double-blind Phase|Adverse Event|4
1148362|NCT01352221|3770300|P1|Double-blind Phase|Adverse Event|6
1148363|NCT01352117|3770360|P2|Overall Study|Ineligible (no KS diagnosis)|0
1148364|NCT01352117|3770361|P1|Overall Study|Ineligible (no KS diagnosis)|1
1148365|NCT01352117|3770360|P2|Overall Study|Did not initiate study treatment|0
1148366|NCT01352117|3770361|P1|Overall Study|Did not initiate study treatment|1
1148367|NCT01352117|3770360|P2|Overall Study|Non-adherent to study requirements|0
1148368|NCT01352117|3770361|P1|Overall Study|Non-adherent to study requirements|1
1148369|NCT01352117|3770360|P2|Overall Study|Lost to Follow-up|4
1148370|NCT01352117|3770361|P1|Overall Study|Lost to Follow-up|2
1148371|NCT01352117|3770360|P2|Overall Study|Withdrawal by Subject|0
1148372|NCT01352117|3770361|P1|Overall Study|Withdrawal by Subject|1
1148373|NCT01352117|3770360|P2|Overall Study|Death|12
1148374|NCT01352117|3770361|P1|Overall Study|Death|13
1148375|NCT01352117|3770360|P2|Overall Study|On study|80
1148376|NCT01352117|3770361|P1|Overall Study|On study|49
1148377|NCT01351623|3770424|P1|Overall Study|Death|2
1148378|NCT01351623|3770424|P1|Overall Study|Withdrawal by Subject|1
1148379|NCT01351623|3770424|P1|Overall Study|Adverse Event|4
1148380|NCT01351623|3770424|P1|Overall Study|Protocol Violation|2
1148381|NCT01351415|3770450|P2|Overall Study|Never Started|5
1148382|NCT01351415|3770451|P1|Overall Study|Never Started|5
1148383|NCT01351415|3770450|P2|Overall Study|Reason unknown|2
1148384|NCT01351415|3770451|P1|Overall Study|Reason unknown|0
1148385|NCT01351415|3770450|P2|Overall Study|Physician Decision|3
1148386|NCT01351415|3770451|P1|Overall Study|Physician Decision|2
1148387|NCT01351415|3770450|P2|Overall Study|Death|187
1148388|NCT01351415|3770451|P1|Overall Study|Death|190
1148389|NCT01351415|3770450|P2|Overall Study|Lost to Follow-up|7
1148390|NCT01351415|3770451|P1|Overall Study|Lost to Follow-up|5
1148391|NCT01351415|3770450|P2|Overall Study|Trial termination by the Sponsor|19
1148392|NCT01351415|3770451|P1|Overall Study|Trial termination by the Sponsor|28
1148393|NCT01351415|3770450|P2|Overall Study|Withdrawal by Subject|17
1148394|NCT01351415|3770451|P1|Overall Study|Withdrawal by Subject|15
1148395|NCT01351025|3770529|P2|Week 24 - 44|unable to get to clinic|1
1148396|NCT01351025|3770530|P1|Week 24 - 44|unable to get to clinic|1
1148397|NCT01351025|3770529|P2|Week 24 - 44|Site closed|1
1148398|NCT01351025|3770530|P1|Week 24 - 44|Site closed|0
1148399|NCT01351025|3770529|P2|Week 24 - 44|Lost to Follow-up|2
1148400|NCT01351025|3770530|P1|Week 24 - 44|Lost to Follow-up|0
1148401|NCT01351025|3770529|P2|Week 0 - 20|Withdrawal by Subject|0
1148402|NCT01351025|3770530|P1|Week 0 - 20|Withdrawal by Subject|1
1148403|NCT01351025|3770529|P2|Week 0 - 20|Lost to Follow-up|1
1148404|NCT01351025|3770530|P1|Week 0 - 20|Lost to Follow-up|2
1148405|NCT01350999|3770563|P3|Overall Study|Difficulty Making it to Study Visit|5
1148406|NCT01350999|3770564|P2|Overall Study|Difficulty Making it to Study Visit|1
1148407|NCT01350999|3770565|P1|Overall Study|Difficulty Making it to Study Visit|1
1148408|NCT01350999|3770563|P3|Overall Study|Voluntary withdrawal|6
1148409|NCT01350999|3770564|P2|Overall Study|Voluntary withdrawal|4
1148410|NCT01350999|3770565|P1|Overall Study|Voluntary withdrawal|3
1148411|NCT01350999|3770563|P3|Overall Study|Adverse Event|10
1148412|NCT01350999|3770564|P2|Overall Study|Adverse Event|9
1148413|NCT01350999|3770565|P1|Overall Study|Adverse Event|4
1148414|NCT01350973|3770603|P3|Overall Study|Voluntary Withdrawal|1
1148415|NCT01350973|3770604|P2|Overall Study|Voluntary Withdrawal|1
1148416|NCT01350973|3770605|P1|Overall Study|Voluntary Withdrawal|2
1148417|NCT01350973|3770603|P3|Overall Study|Adverse Event|7
1148418|NCT01350973|3770604|P2|Overall Study|Adverse Event|7
1148419|NCT01350973|3770605|P1|Overall Study|Adverse Event|4
1148420|NCT01350934|3770646|P2|Extension Study|Withdrawal by Subject|1
1148421|NCT01350934|3770647|P1|Extension Study|Withdrawal by Subject|0
1148422|NCT01350934|3770646|P2|Extension Study|Lack of Efficacy|1
1148423|NCT01350934|3770647|P1|Extension Study|Lack of Efficacy|0
1148424|NCT01350934|3770646|P2|Extension Study|Protocol Violation|1
1148425|NCT01350934|3770647|P1|Extension Study|Protocol Violation|1
1148426|NCT01350934|3770646|P2|Extension Study|Lost to Follow-up|0
1148427|NCT01350934|3770647|P1|Extension Study|Lost to Follow-up|2
1148428|NCT01350934|3770646|P2|Extension Study|Adverse Event|1
1148429|NCT01350934|3770647|P1|Extension Study|Adverse Event|2
1148430|NCT01350934|3770646|P2|Base Study|Non-Compliance With Study Drug|0
1148431|NCT01350934|3770647|P1|Base Study|Non-Compliance With Study Drug|2
1148432|NCT01350934|3770646|P2|Base Study|Withdrawal by Subject|2
1148433|NCT01350934|3770647|P1|Base Study|Withdrawal by Subject|1
1148434|NCT01350934|3770646|P2|Base Study|Protocol Violation|1
1148435|NCT01350934|3770647|P1|Base Study|Protocol Violation|1
1148436|NCT01350934|3770646|P2|Base Study|Lost to Follow-up|0
1148437|NCT01350934|3770647|P1|Base Study|Lost to Follow-up|1
1148438|NCT01350934|3770646|P2|Base Study|Adverse Event|0
1148439|NCT01350934|3770647|P1|Base Study|Adverse Event|6
1148440|NCT01350804|3770669|P4|Extension Study, Weeks 52 - 260|Adverse Event|3
1148441|NCT01350804|3770670|P3|Extension Study, Weeks 52 - 260|Adverse Event|2
1148442|NCT01350804|3770671|P2|Extension Study, Weeks 52 - 260|Adverse Event|1
1148443|NCT01350804|3770672|P1|Extension Study, Weeks 52 - 260|Adverse Event|3
1148444|NCT01350804|3770669|P4|Extension Study, Weeks 52 - 260|Lack of Efficacy|1
1148445|NCT01350804|3770670|P3|Extension Study, Weeks 52 - 260|Lack of Efficacy|0
1148446|NCT01350804|3770671|P2|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
1148447|NCT01350804|3770672|P1|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
1148448|NCT01350804|3770669|P4|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
1148449|NCT01350804|3770670|P3|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
1148450|NCT01350804|3770671|P2|Extension Study, Weeks 52 - 260|Lost to Follow-up|1
1148451|NCT01350804|3770672|P1|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
1148452|NCT01350804|3770669|P4|Extension Study, Weeks 52 - 260|Physician Decision|0
1148453|NCT01350804|3770670|P3|Extension Study, Weeks 52 - 260|Physician Decision|2
1148454|NCT01350804|3770671|P2|Extension Study, Weeks 52 - 260|Physician Decision|0
1148455|NCT01350804|3770672|P1|Extension Study, Weeks 52 - 260|Physician Decision|1
1148456|NCT01350804|3770669|P4|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16
1148457|NCT01350804|3770670|P3|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64
1148458|NCT01350804|3770671|P2|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
1148459|NCT01350804|3770672|P1|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
1148460|NCT01350804|3770669|P4|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3
1148461|NCT01350804|3770670|P3|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4
1148462|NCT01350804|3770671|P2|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6
1148463|NCT01350804|3770672|P1|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5
1148464|NCT01350804|3770669|P4|Core Study|Adverse Event|8
1148465|NCT01350804|3770670|P3|Core Study|Adverse Event|8
1148466|NCT01350804|3770671|P2|Core Study|Adverse Event|10
1148467|NCT01350804|3770672|P1|Core Study|Adverse Event|8
1148468|NCT01350804|3770669|P4|Core Study|Death|0
1148469|NCT01350804|3770670|P3|Core Study|Death|1
1148470|NCT01350804|3770671|P2|Core Study|Death|1
1148471|NCT01350804|3770672|P1|Core Study|Death|1
1148472|NCT01350804|3770669|P4|Core Study|Lack of Efficacy|5
1148473|NCT01350804|3770670|P3|Core Study|Lack of Efficacy|18
1148474|NCT01350804|3770671|P2|Core Study|Lack of Efficacy|19
1148475|NCT01350804|3770672|P1|Core Study|Lack of Efficacy|16
1148476|NCT01350804|3770669|P4|Core Study|Lost to Follow-up|1
1148477|NCT01350804|3770670|P3|Core Study|Lost to Follow-up|2
1148478|NCT01350804|3770671|P2|Core Study|Lost to Follow-up|0
1148479|NCT01350804|3770672|P1|Core Study|Lost to Follow-up|3
1148480|NCT01350804|3770669|P4|Core Study|Physician Decision|3
1148481|NCT01350804|3770670|P3|Core Study|Physician Decision|1
1148482|NCT01350804|3770671|P2|Core Study|Physician Decision|0
1148483|NCT01350804|3770672|P1|Core Study|Physician Decision|1
1148484|NCT01350804|3770669|P4|Core Study|Protocol deviation|0
1148485|NCT01350804|3770670|P3|Core Study|Protocol deviation|1
1148486|NCT01350804|3770671|P2|Core Study|Protocol deviation|0
1148487|NCT01350804|3770672|P1|Core Study|Protocol deviation|1
1148488|NCT01350804|3770669|P4|Core Study|Study terminated by Sponsor|2
1148489|NCT01350804|3770670|P3|Core Study|Study terminated by Sponsor|0
1148490|NCT01350804|3770671|P2|Core Study|Study terminated by Sponsor|0
1148491|NCT01350804|3770672|P1|Core Study|Study terminated by Sponsor|0
1148492|NCT01350804|3770669|P4|Core Study|Withdrawal by Subject|7
1148493|NCT01350804|3770670|P3|Core Study|Withdrawal by Subject|16
1148494|NCT01350804|3770671|P2|Core Study|Withdrawal by Subject|17
1148495|NCT01350804|3770672|P1|Core Study|Withdrawal by Subject|11
1148496|NCT01350544|3770769|P2|Overall Study|Lost to Follow-up|15
1148497|NCT01350544|3770770|P1|Overall Study|Lost to Follow-up|18
1148498|NCT01350544|3770769|P2|Overall Study|Incarceration|0
1148499|NCT01350544|3770770|P1|Overall Study|Incarceration|1
1148500|NCT01350544|3770769|P2|Overall Study|Withdrawal by Subject|1
1148501|NCT01350544|3770770|P1|Overall Study|Withdrawal by Subject|0
1148502|NCT01350544|3770769|P2|Overall Study|Medical Issues|1
1148503|NCT01350544|3770770|P1|Overall Study|Medical Issues|1
1148504|NCT01350544|3770769|P2|Overall Study|Moved out of LA County|2
1148505|NCT01350544|3770770|P1|Overall Study|Moved out of LA County|2
1148506|NCT01350544|3770769|P2|Overall Study|Death|2
1148507|NCT01350544|3770770|P1|Overall Study|Death|1
1148508|NCT01350544|3770769|P2|Overall Study|Administrative Withdrawal|1
1148509|NCT01350544|3770770|P1|Overall Study|Administrative Withdrawal|0
1148510|NCT01350414|3770785|P1|Overall Study|Physician Decision|2
1148511|NCT01350414|3770785|P1|Overall Study|Withdrawal by Subject|4
1148512|NCT01350414|3770785|P1|Overall Study|Lost to Follow-up|13
1148513|NCT01350271|3770834|P3|Overall Study|Lost to Follow-up|26
1148514|NCT01350271|3770835|P2|Overall Study|Lost to Follow-up|17
1148515|NCT01350271|3770836|P1|Overall Study|Lost to Follow-up|21
1148516|NCT01350141|3770878|P3|Overall Study|Randomized but not treated|0
1148517|NCT01350141|3770879|P2|Overall Study|Randomized but not treated|0
1148518|NCT01350141|3770880|P1|Overall Study|Randomized but not treated|1
1148519|NCT01350141|3770878|P3|Overall Study|Withdrawal by Subject|0
1148520|NCT01350141|3770879|P2|Overall Study|Withdrawal by Subject|0
1148521|NCT01350141|3770880|P1|Overall Study|Withdrawal by Subject|1
1148522|NCT01350141|3770878|P3|Overall Study|Lost to Follow-up|1
1148523|NCT01350141|3770879|P2|Overall Study|Lost to Follow-up|0
1148524|NCT01350141|3770880|P1|Overall Study|Lost to Follow-up|1
1148525|NCT01350128|3770914|P1|Overall Study|Lost to Follow-up|2
1148526|NCT01350128|3770914|P1|Overall Study|Physician Decision|1
1148527|NCT01350128|3770914|P1|Overall Study|Protocol discontinuation criteria|8
1148528|NCT01350128|3770914|P1|Overall Study|Withdrawal by Subject|3
1148529|NCT01350115|3770978|P2|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0
1148530|NCT01350115|3770979|P1|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1
1148531|NCT01350115|3770978|P2|Long Term Follow-Up (All Patients)|Adverse Event|1
1148532|NCT01350115|3770979|P1|Long Term Follow-Up (All Patients)|Adverse Event|0
1148533|NCT01350115|3770978|P2|Long Term Follow-Up (All Patients)|Lost to Follow-up|1
1148534|NCT01350115|3770979|P1|Long Term Follow-Up (All Patients)|Lost to Follow-up|0
1148535|NCT01350102|3770995|P4|Overall Study|Adverse Event|0
1148536|NCT01350102|3770996|P3|Overall Study|Adverse Event|1
1148537|NCT01350102|3770997|P2|Overall Study|Adverse Event|0
1148538|NCT01350102|3770998|P1|Overall Study|Adverse Event|0
1148539|NCT01349959|3771035|P1|Overall Study|Patients are followed for survival|7
1148540|NCT01349907|3771071|P2|Overall Study|Administrative|1
1148541|NCT01349907|3771072|P1|Overall Study|Administrative|1
1148542|NCT01349907|3771071|P2|Overall Study|Protocol Violation|13
1148543|NCT01349907|3771072|P1|Overall Study|Protocol Violation|33
1148544|NCT01349907|3771071|P2|Overall Study|Withdrawal by Subject|8
1148545|NCT01349907|3771072|P1|Overall Study|Withdrawal by Subject|30
1148546|NCT01349907|3771071|P2|Overall Study|Lost to Follow-up|6
1148547|NCT01349907|3771072|P1|Overall Study|Lost to Follow-up|25
1148548|NCT01349907|3771071|P2|Overall Study|Treatment failure|4
1148549|NCT01349907|3771072|P1|Overall Study|Treatment failure|13
1148550|NCT01349907|3771071|P2|Overall Study|Adverse Event|11
1148551|NCT01349907|3771072|P1|Overall Study|Adverse Event|37
1148552|NCT01349829|3771110|P2|Overall Study|Migrated/moved|7
1148553|NCT01349829|3771111|P1|Overall Study|Migrated/moved|2
1148554|NCT01349829|3771110|P2|Overall Study|Consent withdrawal|8
1148555|NCT01349829|3771111|P1|Overall Study|Consent withdrawal|3
1148556|NCT01349829|3771110|P2|Overall Study|Lost to Follow-up|8
1148557|NCT01349829|3771111|P1|Overall Study|Lost to Follow-up|4
1148558|NCT01349816|3771129|P1|Overall Study|Protocol-specified criteria|8
1148559|NCT01349816|3771129|P1|Overall Study|Protocol Violation|1
1148560|NCT01349816|3771129|P1|Overall Study|Lost to Follow-up|2
1148561|NCT01349816|3771129|P1|Overall Study|Adverse Event|14
1148562|NCT01349816|3771129|P1|Overall Study|Physician Decision|1
1148563|NCT01349816|3771129|P1|Overall Study|Withdrawal by Subject|4
1148564|NCT01349803|3771195|P4|Overall Study|Protocol-specified criteria|0
1148565|NCT01349803|3771196|P3|Overall Study|Protocol-specified criteria|3
1148566|NCT01349803|3771197|P2|Overall Study|Protocol-specified criteria|1
1148567|NCT01349803|3771198|P1|Overall Study|Protocol-specified criteria|0
1148568|NCT01349803|3771195|P4|Overall Study|Withdrawal by Subject|0
1148569|NCT01349803|3771196|P3|Overall Study|Withdrawal by Subject|0
1148570|NCT01349803|3771197|P2|Overall Study|Withdrawal by Subject|0
1148571|NCT01349803|3771198|P1|Overall Study|Withdrawal by Subject|1
1148572|NCT01349803|3771195|P4|Overall Study|Adverse Event|2
1148573|NCT01349803|3771196|P3|Overall Study|Adverse Event|0
1148574|NCT01349803|3771197|P2|Overall Study|Adverse Event|0
1148575|NCT01349803|3771198|P1|Overall Study|Adverse Event|0
1148576|NCT01349790|3771268|P1|Overall Study|Lost to Follow-up|1
1148577|NCT01349790|3771268|P1|Overall Study|Adverse Event|1
1148578|NCT01349790|3771268|P1|Overall Study|Withdrawal by Patient|2
1148579|NCT01349790|3771268|P1|Overall Study|Death|2
1148580|NCT01349790|3771268|P1|Overall Study|Investigator Judgement|3
1148581|NCT01349660|3771290|P3|Overall Study|Declining Performance Status|1
1148582|NCT01349660|3771291|P2|Overall Study|Declining Performance Status|0
1148583|NCT01349660|3771292|P1|Overall Study|Declining Performance Status|0
1148584|NCT01349660|3771290|P3|Overall Study|Study Compliance|1
1148585|NCT01349660|3771291|P2|Overall Study|Study Compliance|0
1148586|NCT01349660|3771292|P1|Overall Study|Study Compliance|0
1148587|NCT01349660|3771290|P3|Overall Study|Non-Permitted Interventions|2
1148588|NCT01349660|3771291|P2|Overall Study|Non-Permitted Interventions|0
1148589|NCT01349660|3771292|P1|Overall Study|Non-Permitted Interventions|0
1148590|NCT01349660|3771290|P3|Overall Study|Death|0
1148591|NCT01349660|3771291|P2|Overall Study|Death|1
1148592|NCT01349660|3771292|P1|Overall Study|Death|1
1148593|NCT01349660|3771290|P3|Overall Study|Withdrawal by Subject|9
1148594|NCT01349660|3771291|P2|Overall Study|Withdrawal by Subject|0
1148595|NCT01349660|3771292|P1|Overall Study|Withdrawal by Subject|2
1148596|NCT01349660|3771290|P3|Overall Study|Adverse Event|12
1148597|NCT01349660|3771291|P2|Overall Study|Adverse Event|1
1148598|NCT01349660|3771292|P1|Overall Study|Adverse Event|1
1148599|NCT01349660|3771290|P3|Overall Study|Disease Progression|50
1148600|NCT01349660|3771291|P2|Overall Study|Disease Progression|4
1148601|NCT01349660|3771292|P1|Overall Study|Disease Progression|2
1148602|NCT01349660|3771290|P3|Overall Study|Still Receiving Study Treatment|1
1148603|NCT01349660|3771291|P2|Overall Study|Still Receiving Study Treatment|0
1148604|NCT01349660|3771292|P1|Overall Study|Still Receiving Study Treatment|0
1148605|NCT01349595|3771310|P2|Overall Study|Lack of funding|2
1148606|NCT01349595|3771311|P1|Overall Study|Lack of funding|2
1148607|NCT01349465|3771328|P2|Overall Study|Subject Ineligible To Continue The Trial|19
1148608|NCT01349465|3771329|P1|Overall Study|Subject Ineligible To Continue The Trial|0
1148609|NCT01349465|3771328|P2|Overall Study|Withdrawal by Subject|2
1148610|NCT01349465|3771329|P1|Overall Study|Withdrawal by Subject|4
1148611|NCT01349465|3771328|P2|Overall Study|Lost to Follow-up|1
1148612|NCT01349465|3771329|P1|Overall Study|Lost to Follow-up|10
1148613|NCT01349465|3771328|P2|Overall Study|Death|0
1148614|NCT01349465|3771329|P1|Overall Study|Death|3
1148615|NCT01349465|3771328|P2|Overall Study|Adverse Event|0
1148616|NCT01349465|3771329|P1|Overall Study|Adverse Event|1
1148617|NCT01349192|3771350|P2|Overall Study|Failure to adhere to Protocol|0
1148618|NCT01349192|3771351|P1|Overall Study|Failure to adhere to Protocol|2
1148619|NCT01349192|3771350|P2|Overall Study|Lost to Follow-up|3
1148620|NCT01349192|3771351|P1|Overall Study|Lost to Follow-up|1
1148621|NCT01349192|3771350|P2|Overall Study|Withdrawal by Subject|2
1148622|NCT01349192|3771351|P1|Overall Study|Withdrawal by Subject|0
1148623|NCT01349192|3771350|P2|Overall Study|Protocol Violation|1
1148624|NCT01349192|3771351|P1|Overall Study|Protocol Violation|0
1148625|NCT01348854|3771376|P2|Overall Study|Withdrawal by Subject|0
1148626|NCT01348854|3771377|P1|Overall Study|Withdrawal by Subject|1
1148627|NCT01348854|3771376|P2|Overall Study|Lost to Follow-up|1
1148628|NCT01348854|3771377|P1|Overall Study|Lost to Follow-up|2
1148629|NCT01348789|3771385|P1|Overall Study|Withdrawal by Subject|2
1148630|NCT01348789|3771385|P1|Overall Study|Protocol Violation|2
1148631|NCT01348776|3771396|P1|Overall Study|Lost to Follow-up|3
1148632|NCT01348698|3771409|P1|Overall Study|PI decision to close study|68
1148633|NCT01348698|3771409|P1|Overall Study|Death|3
1148634|NCT01348698|3771409|P1|Overall Study|Does not meet lesion size criteria|1
1148635|NCT01348425|3771434|P2|Overall Study|Imaging was not taken.|1
1148636|NCT01348425|3771435|P1|Overall Study|Imaging was not taken.|1
1148637|NCT01348347|3771443|P3|Overall Study|Progressive disease|5
1148638|NCT01348347|3771444|P2|Overall Study|Progressive disease|5
1148639|NCT01348347|3771445|P1|Overall Study|Progressive disease|2
1148640|NCT01348347|3771443|P3|Overall Study|Withdrawal by Subject|1
1148641|NCT01348347|3771444|P2|Overall Study|Withdrawal by Subject|1
1148642|NCT01348347|3771445|P1|Overall Study|Withdrawal by Subject|1
1148643|NCT01348165|3771476|P7|Overall Study|Adverse Event|1
1148644|NCT01348165|3771477|P6|Overall Study|Adverse Event|0
1148645|NCT01348165|3771478|P5|Overall Study|Adverse Event|0
1148646|NCT01348165|3771479|P4|Overall Study|Adverse Event|0
1148647|NCT01348165|3771480|P3|Overall Study|Adverse Event|0
1148648|NCT01348165|3771481|P2|Overall Study|Adverse Event|0
1148649|NCT01348165|3771482|P1|Overall Study|Adverse Event|0
1148650|NCT01348139|3771611|P6|Period 1|Adverse Event|0
1148651|NCT01348139|3771612|P5|Period 1|Adverse Event|0
1148652|NCT01348139|3771613|P4|Period 1|Adverse Event|0
1148653|NCT01348139|3771614|P3|Period 1|Adverse Event|0
1148654|NCT01348139|3771615|P2|Period 1|Adverse Event|0
1148655|NCT01348139|3771616|P1|Period 1|Adverse Event|1
1148656|NCT01348100|3771697|P7|Overall Study|Administrative Problems|1
1148657|NCT01348100|3771698|P6|Overall Study|Administrative Problems|1
1148658|NCT01348100|3771699|P5|Overall Study|Administrative Problems|0
1148659|NCT01348100|3771700|P4|Overall Study|Administrative Problems|0
1148660|NCT01348100|3771701|P3|Overall Study|Administrative Problems|0
1148661|NCT01348100|3771702|P2|Overall Study|Administrative Problems|0
1148662|NCT01348100|3771703|P1|Overall Study|Administrative Problems|0
1148663|NCT01348100|3771697|P7|Overall Study|Lost to Follow-up|1
1148664|NCT01348100|3771698|P6|Overall Study|Lost to Follow-up|0
1148665|NCT01348100|3771699|P5|Overall Study|Lost to Follow-up|0
1148666|NCT01348100|3771700|P4|Overall Study|Lost to Follow-up|0
1148667|NCT01348100|3771701|P3|Overall Study|Lost to Follow-up|0
1148668|NCT01348100|3771702|P2|Overall Study|Lost to Follow-up|0
1148669|NCT01348100|3771703|P1|Overall Study|Lost to Follow-up|0
1148670|NCT01348100|3771697|P7|Overall Study|Unsatisfactory Therapeutic Effect|0
1148671|NCT01348100|3771698|P6|Overall Study|Unsatisfactory Therapeutic Effect|1
1148672|NCT01348100|3771699|P5|Overall Study|Unsatisfactory Therapeutic Effect|0
1148673|NCT01348100|3771700|P4|Overall Study|Unsatisfactory Therapeutic Effect|0
1148674|NCT01348100|3771701|P3|Overall Study|Unsatisfactory Therapeutic Effect|0
1148675|NCT01348100|3771702|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
1148676|NCT01348100|3771703|P1|Overall Study|Unsatisfactory Therapeutic Effect|0
1148677|NCT01348100|3771697|P7|Overall Study|Protocol Deviation|0
1148678|NCT01348100|3771698|P6|Overall Study|Protocol Deviation|0
1148679|NCT01348100|3771699|P5|Overall Study|Protocol Deviation|0
1148680|NCT01348100|3771700|P4|Overall Study|Protocol Deviation|1
1148681|NCT01348100|3771701|P3|Overall Study|Protocol Deviation|0
1148682|NCT01348100|3771702|P2|Overall Study|Protocol Deviation|0
1148683|NCT01348100|3771703|P1|Overall Study|Protocol Deviation|0
1148684|NCT01348100|3771697|P7|Overall Study|Subject Withdrew Consent|1
1148685|NCT01348100|3771698|P6|Overall Study|Subject Withdrew Consent|0
1148686|NCT01348100|3771699|P5|Overall Study|Subject Withdrew Consent|1
1148687|NCT01348100|3771700|P4|Overall Study|Subject Withdrew Consent|0
1148688|NCT01348100|3771701|P3|Overall Study|Subject Withdrew Consent|2
1148689|NCT01348100|3771702|P2|Overall Study|Subject Withdrew Consent|0
1148690|NCT01348100|3771703|P1|Overall Study|Subject Withdrew Consent|0
1148691|NCT01348087|3771748|P1|Overall Study|Adverse Event|25
1148692|NCT01348087|3771748|P1|Overall Study|Subject withdrew consent|7
1148693|NCT01348087|3771748|P1|Overall Study|Lost to Follow-up|1
1148694|NCT01348087|3771748|P1|Overall Study|protocol deviation|1
1148695|NCT01348087|3771748|P1|Overall Study|Administrative problems|79
1148696|NCT01348087|3771748|P1|Overall Study|Unsatisfactory therapeutic effect|35
1148697|NCT01347931|3771762|P1|Standard Oxygen Therapy|Withdrawal by Subject|1
1148698|NCT01347879|3771774|P2|Overall Study|Other|3
1148699|NCT01347879|3771775|P1|Overall Study|Other|2
1148700|NCT01347879|3771774|P2|Overall Study|Withdrawal by Subject|2
1148701|NCT01347879|3771775|P1|Overall Study|Withdrawal by Subject|3
1148702|NCT01347879|3771774|P2|Overall Study|Lost to Follow-up|0
1148703|NCT01347879|3771775|P1|Overall Study|Lost to Follow-up|2
1148704|NCT01347879|3771774|P2|Overall Study|Adverse Event|12
1148705|NCT01347879|3771775|P1|Overall Study|Adverse Event|0
1148706|NCT01347866|3771824|P17|Overall Study|Subject refused further follow-up|2
1148707|NCT01347866|3771825|P16|Overall Study|Subject refused further follow-up|0
1148708|NCT01347866|3771826|P15|Overall Study|Subject refused further follow-up|1
1148709|NCT01347866|3771827|P14|Overall Study|Subject refused further follow-up|3
1148710|NCT01347866|3771828|P13|Overall Study|Subject refused further follow-up|1
1148711|NCT01347866|3771829|P12|Overall Study|Subject refused further follow-up|0
1148712|NCT01347866|3771830|P11|Overall Study|Subject refused further follow-up|0
1148713|NCT01347866|3771831|P10|Overall Study|Subject refused further follow-up|1
1148714|NCT01347866|3771832|P9|Overall Study|Subject refused further follow-up|4
1148715|NCT01347866|3771833|P8|Overall Study|Subject refused further follow-up|0
1148716|NCT01347866|3771834|P7|Overall Study|Subject refused further follow-up|0
1148717|NCT01347866|3771835|P6|Overall Study|Subject refused further follow-up|1
1148718|NCT01347866|3771836|P5|Overall Study|Subject refused further follow-up|0
1148719|NCT01347866|3771837|P4|Overall Study|Subject refused further follow-up|2
1148720|NCT01347866|3771838|P3|Overall Study|Subject refused further follow-up|0
1148721|NCT01347866|3771839|P2|Overall Study|Subject refused further follow-up|0
1148722|NCT01347866|3771840|P1|Overall Study|Subject refused further follow-up|2
1148723|NCT01347866|3771824|P17|Overall Study|Other|0
1148724|NCT01347866|3771825|P16|Overall Study|Other|3
1148725|NCT01347866|3771826|P15|Overall Study|Other|2
1148726|NCT01347866|3771827|P14|Overall Study|Other|4
1148727|NCT01347866|3771828|P13|Overall Study|Other|4
1148728|NCT01347866|3771829|P12|Overall Study|Other|3
1148729|NCT01347866|3771830|P11|Overall Study|Other|0
1148730|NCT01347866|3771831|P10|Overall Study|Other|5
1148731|NCT01347866|3771832|P9|Overall Study|Other|22
1148732|NCT01347866|3771833|P8|Overall Study|Other|3
1148733|NCT01347866|3771834|P7|Overall Study|Other|5
1148734|NCT01347866|3771835|P6|Overall Study|Other|0
1148735|NCT01347866|3771836|P5|Overall Study|Other|5
1148736|NCT01347866|3771837|P4|Overall Study|Other|4
1148737|NCT01347866|3771838|P3|Overall Study|Other|1
1148738|NCT01347866|3771839|P2|Overall Study|Other|1
1148739|NCT01347866|3771840|P1|Overall Study|Other|3
1148740|NCT01347866|3771824|P17|Overall Study|Lost to Follow-up|0
1148741|NCT01347866|3771825|P16|Overall Study|Lost to Follow-up|0
1148742|NCT01347866|3771826|P15|Overall Study|Lost to Follow-up|0
1148743|NCT01347866|3771827|P14|Overall Study|Lost to Follow-up|0
1148744|NCT01347866|3771828|P13|Overall Study|Lost to Follow-up|0
1148745|NCT01347866|3771829|P12|Overall Study|Lost to Follow-up|0
1148746|NCT01347866|3771830|P11|Overall Study|Lost to Follow-up|0
1148747|NCT01347866|3771831|P10|Overall Study|Lost to Follow-up|0
1148748|NCT01347866|3771832|P9|Overall Study|Lost to Follow-up|1
1148749|NCT01347866|3771833|P8|Overall Study|Lost to Follow-up|1
1148750|NCT01347866|3771834|P7|Overall Study|Lost to Follow-up|0
1148751|NCT01347866|3771835|P6|Overall Study|Lost to Follow-up|0
1148752|NCT01347866|3771836|P5|Overall Study|Lost to Follow-up|0
1148753|NCT01347866|3771837|P4|Overall Study|Lost to Follow-up|0
1148754|NCT01347866|3771838|P3|Overall Study|Lost to Follow-up|0
1148755|NCT01347866|3771839|P2|Overall Study|Lost to Follow-up|0
1148756|NCT01347866|3771840|P1|Overall Study|Lost to Follow-up|0
1148757|NCT01347866|3771824|P17|Overall Study|Death|0
1148758|NCT01347866|3771825|P16|Overall Study|Death|1
1148759|NCT01347866|3771826|P15|Overall Study|Death|0
1148760|NCT01347866|3771827|P14|Overall Study|Death|0
1148761|NCT01347866|3771828|P13|Overall Study|Death|2
1148762|NCT01347866|3771829|P12|Overall Study|Death|1
1148763|NCT01347866|3771830|P11|Overall Study|Death|3
1148764|NCT01347866|3771831|P10|Overall Study|Death|1
1148765|NCT01347866|3771832|P9|Overall Study|Death|4
1148766|NCT01347866|3771833|P8|Overall Study|Death|0
1148767|NCT01347866|3771834|P7|Overall Study|Death|1
1148768|NCT01347866|3771835|P6|Overall Study|Death|2
1148769|NCT01347866|3771836|P5|Overall Study|Death|2
1148770|NCT01347866|3771837|P4|Overall Study|Death|1
1148771|NCT01347866|3771838|P3|Overall Study|Death|0
1148772|NCT01347866|3771839|P2|Overall Study|Death|0
1148773|NCT01347866|3771840|P1|Overall Study|Death|0
1148774|NCT01347840|3772214|P1|Overall Study|Withdrawal by Subject|1
1148775|NCT01347762|3772241|P4|Overall Study|Withdrawal by Subject|3
1148776|NCT01347762|3772242|P3|Overall Study|Withdrawal by Subject|3
1148777|NCT01347762|3772243|P2|Overall Study|Withdrawal by Subject|1
1148778|NCT01347762|3772244|P1|Overall Study|Withdrawal by Subject|4
1148779|NCT01347762|3772241|P4|Overall Study|Lost to Follow-up|5
1148780|NCT01347762|3772242|P3|Overall Study|Lost to Follow-up|6
1148781|NCT01347762|3772243|P2|Overall Study|Lost to Follow-up|1
1148782|NCT01347762|3772244|P1|Overall Study|Lost to Follow-up|0
1148783|NCT01347710|3772270|P1|Overall Study|Other|3
1148784|NCT01347710|3772270|P1|Overall Study|Physician Decision|2
1148785|NCT01347710|3772270|P1|Overall Study|Lost to Follow-up|1
1148786|NCT01347710|3772270|P1|Overall Study|issue with vitals prior to dosing|1
1148787|NCT01347710|3772270|P1|Overall Study|Angio or SPECT not completed|18
1148788|NCT01347710|3772270|P1|Overall Study|Adverse Event|4
1148789|NCT01347710|3772270|P1|Overall Study|Withdrawal by Subject|2
1148790|NCT01347580|3772292|P2|Overall Study|Had other reason|6
1148791|NCT01347580|3772293|P1|Overall Study|Had other reason|9
1148792|NCT01347580|3772292|P2|Overall Study|Lost to Follow-up|1
1148793|NCT01347580|3772293|P1|Overall Study|Lost to Follow-up|3
1148794|NCT01347580|3772292|P2|Overall Study|Protocol Violation|7
1148795|NCT01347580|3772293|P1|Overall Study|Protocol Violation|10
1148796|NCT01347580|3772292|P2|Overall Study|Death|19
1148797|NCT01347580|3772293|P1|Overall Study|Death|30
1148798|NCT01347580|3772292|P2|Overall Study|Withdrawal by Subject|23
1148799|NCT01347580|3772293|P1|Overall Study|Withdrawal by Subject|13
1148800|NCT01347554|3772323|P2|Overall Study|Lack of Efficacy|11
1148801|NCT01347554|3772324|P1|Overall Study|Lack of Efficacy|7
1148802|NCT01347112|3772361|P2|Overall Study|Lost to Follow-up|5
1148803|NCT01347112|3772362|P1|Overall Study|Lost to Follow-up|3
1148804|NCT01347112|3772361|P2|Overall Study|Withdrawal by Subject|7
1148805|NCT01347112|3772362|P1|Overall Study|Withdrawal by Subject|1
1148806|NCT01347086|3772382|P10|Overall Study|failed screening visit|1
1148807|NCT01347086|3772383|P9|Overall Study|failed screening visit|0
1148808|NCT01347086|3772384|P8|Overall Study|failed screening visit|1
1148809|NCT01347086|3772385|P7|Overall Study|failed screening visit|1
1148810|NCT01347086|3772386|P6|Overall Study|failed screening visit|0
1148811|NCT01347086|3772387|P5|Overall Study|failed screening visit|0
1148812|NCT01347086|3772388|P4|Overall Study|failed screening visit|0
1148813|NCT01347086|3772389|P3|Overall Study|failed screening visit|1
1148814|NCT01347086|3772390|P2|Overall Study|failed screening visit|0
1148815|NCT01347086|3772391|P1|Overall Study|failed screening visit|0
1148816|NCT01347073|3772490|P1|Overall Study|Liver Transplant|1
1148817|NCT01347073|3772490|P1|Overall Study|Adverse Event|1
1148818|NCT01346774|3772569|P2|Overall Study|Adverse Event|2
1148819|NCT01346774|3772570|P1|Overall Study|Adverse Event|1
1148820|NCT01346774|3772569|P2|Overall Study|Protocol Violation|3
1148821|NCT01346774|3772570|P1|Overall Study|Protocol Violation|2
1148822|NCT01346774|3772569|P2|Overall Study|Withdrawal by Subject|4
1148823|NCT01346774|3772570|P1|Overall Study|Withdrawal by Subject|1
1148824|NCT01346774|3772569|P2|Overall Study|Lost to Follow-up|4
1148825|NCT01346774|3772570|P1|Overall Study|Lost to Follow-up|3
1148826|NCT01346774|3772569|P2|Overall Study|Did not take a single dose|4
1148827|NCT01346774|3772570|P1|Overall Study|Did not take a single dose|6
1148828|NCT01346592|3772579|P3|Overall Study|Unable to Classify|6
1148829|NCT01346592|3772580|P2|Overall Study|Unable to Classify|3
1148830|NCT01346592|3772581|P1|Overall Study|Unable to Classify|7
1148831|NCT01346592|3772579|P3|Overall Study|Administrative reason|0
1148832|NCT01346592|3772580|P2|Overall Study|Administrative reason|0
1148833|NCT01346592|3772581|P1|Overall Study|Administrative reason|1
1148834|NCT01346592|3772579|P3|Overall Study|Inappropriate enrollment|1
1148835|NCT01346592|3772580|P2|Overall Study|Inappropriate enrollment|1
1148836|NCT01346592|3772581|P1|Overall Study|Inappropriate enrollment|3
1148837|NCT01346592|3772579|P3|Overall Study|Withdrawal by Subject|38
1148838|NCT01346592|3772580|P2|Overall Study|Withdrawal by Subject|51
1148839|NCT01346592|3772581|P1|Overall Study|Withdrawal by Subject|77
1148840|NCT01346592|3772579|P3|Overall Study|Adverse Event|0
1148841|NCT01346592|3772580|P2|Overall Study|Adverse Event|1
1148842|NCT01346592|3772581|P1|Overall Study|Adverse Event|0
1148843|NCT01346592|3772579|P3|Overall Study|Death|4
1148844|NCT01346592|3772580|P2|Overall Study|Death|3
1148845|NCT01346592|3772581|P1|Overall Study|Death|1
1148846|NCT01346592|3772579|P3|Overall Study|Protocol Violation|0
1148847|NCT01346592|3772580|P2|Overall Study|Protocol Violation|1
1148848|NCT01346592|3772581|P1|Overall Study|Protocol Violation|2
1148849|NCT01346592|3772579|P3|Overall Study|Lost to Follow-up|29
1148850|NCT01346592|3772580|P2|Overall Study|Lost to Follow-up|29
1148851|NCT01346592|3772581|P1|Overall Study|Lost to Follow-up|62
1148852|NCT01346540|3772673|P2|Overall Study|Adverse Event|4
1148853|NCT01346540|3772674|P1|Overall Study|Adverse Event|0
1148854|NCT01346540|3772673|P2|Overall Study|Progressive disease-RECIST 1.1 criteria|8
1148855|NCT01346540|3772674|P1|Overall Study|Progressive disease-RECIST 1.1 criteria|3
1148856|NCT01346514|3772685|P2|Overall Study|Death|4
1148857|NCT01346514|3772686|P1|Overall Study|Death|3
1148858|NCT01346514|3772685|P2|Overall Study|Withdrawal by Subject|3
1148859|NCT01346514|3772686|P1|Overall Study|Withdrawal by Subject|7
1148860|NCT01346514|3772685|P2|Overall Study|Lost to Follow-up|30
1148861|NCT01346514|3772686|P1|Overall Study|Lost to Follow-up|19
1148862|NCT01346501|3772706|P2|Overall Study|Not Specified|12
1148863|NCT01346501|3772707|P1|Overall Study|Not Specified|8
1148864|NCT01346501|3772706|P2|Overall Study|Initiated Other Biological Agents|1
1148865|NCT01346501|3772707|P1|Overall Study|Initiated Other Biological Agents|3
1148866|NCT01346475|3772740|P2|First Intervention|Lost to Follow-up|3
1148867|NCT01346475|3772741|P1|First Intervention|Lost to Follow-up|4
1148868|NCT01346410|3772753|P1|Overall Study|Death|1
1148869|NCT01346293|3772770|P2|Overall Study|Other|0
1148870|NCT01346293|3772771|P1|Overall Study|Other|1
1148871|NCT01346293|3772770|P2|Overall Study|Withdrawal by Subject|4
1148872|NCT01346293|3772771|P1|Overall Study|Withdrawal by Subject|15
1148873|NCT01346293|3772770|P2|Overall Study|Lost to Follow-up|8
1148874|NCT01346293|3772771|P1|Overall Study|Lost to Follow-up|21
1148875|NCT01346293|3772770|P2|Overall Study|Protocol Violation|9
1148876|NCT01346293|3772771|P1|Overall Study|Protocol Violation|30
1148877|NCT01346189|3772801|P4|Overall Study|Travel|3
1148878|NCT01346189|3772802|P3|Overall Study|Travel|0
1148879|NCT01346189|3772803|P2|Overall Study|Travel|0
1148880|NCT01346189|3772804|P1|Overall Study|Travel|0
1148881|NCT01346189|3772801|P4|Overall Study|Non-health system primary care physician|0
1148882|NCT01346189|3772802|P3|Overall Study|Non-health system primary care physician|0
1148883|NCT01346189|3772803|P2|Overall Study|Non-health system primary care physician|5
1148884|NCT01346189|3772804|P1|Overall Study|Non-health system primary care physician|0
1148885|NCT01346189|3772801|P4|Overall Study|Death|0
1148886|NCT01346189|3772802|P3|Overall Study|Death|0
1148887|NCT01346189|3772803|P2|Overall Study|Death|3
1148888|NCT01346189|3772804|P1|Overall Study|Death|0
1148889|NCT01346189|3772801|P4|Overall Study|Other|3
1148890|NCT01346189|3772802|P3|Overall Study|Other|7
1148891|NCT01346189|3772803|P2|Overall Study|Other|4
1148892|NCT01346189|3772804|P1|Overall Study|Other|2
1148893|NCT01346189|3772801|P4|Overall Study|Moved|0
1148894|NCT01346189|3772802|P3|Overall Study|Moved|4
1148895|NCT01346189|3772803|P2|Overall Study|Moved|0
1148896|NCT01346189|3772804|P1|Overall Study|Moved|3
1148897|NCT01346189|3772801|P4|Overall Study|Physician Decision|0
1148898|NCT01346189|3772802|P3|Overall Study|Physician Decision|0
1148899|NCT01346189|3772803|P2|Overall Study|Physician Decision|0
1148900|NCT01346189|3772804|P1|Overall Study|Physician Decision|4
1148901|NCT01346189|3772801|P4|Overall Study|Withdrawal by Subject|5
1148902|NCT01346189|3772802|P3|Overall Study|Withdrawal by Subject|3
1148903|NCT01346189|3772803|P2|Overall Study|Withdrawal by Subject|5
1148904|NCT01346189|3772804|P1|Overall Study|Withdrawal by Subject|7
1148905|NCT01346176|3772821|P3|Completed Satisfaction Survey|Lost to Follow-up|4
1148906|NCT01346176|3772822|P2|Completed Satisfaction Survey|Lost to Follow-up|4
1148907|NCT01346176|3772823|P1|Completed Satisfaction Survey|Lost to Follow-up|3
1148908|NCT01346176|3772821|P3|Completed Satisfaction Survey|Death|2
1148909|NCT01346176|3772822|P2|Completed Satisfaction Survey|Death|0
1148910|NCT01346176|3772823|P1|Completed Satisfaction Survey|Death|3
1148911|NCT01346176|3772821|P3|Completed Advance Directive|Other reason did not complete AD|7
1148912|NCT01346176|3772822|P2|Completed Advance Directive|Other reason did not complete AD|12
1148913|NCT01346176|3772823|P1|Completed Advance Directive|Other reason did not complete AD|7
1148914|NCT01346176|3772821|P3|Completed Advance Directive|Became Ineligible|1
1148915|NCT01346176|3772822|P2|Completed Advance Directive|Became Ineligible|0
1148916|NCT01346176|3772823|P1|Completed Advance Directive|Became Ineligible|3
1148917|NCT01346176|3772821|P3|Completed Advance Directive|Death|2
1148918|NCT01346176|3772822|P2|Completed Advance Directive|Death|2
1148919|NCT01346176|3772823|P1|Completed Advance Directive|Death|3
1148920|NCT01346176|3772821|P3|Recruited|Protocol Violation|0
1148921|NCT01346176|3772822|P2|Recruited|Protocol Violation|0
1148922|NCT01346176|3772823|P1|Recruited|Protocol Violation|1
1148923|NCT01346059|3772852|P2|Overall Study|Withdrawal by Subject|0
1148924|NCT01346059|3772853|P1|Overall Study|Withdrawal by Subject|1
1148925|NCT01345929|3772865|P2|Overall Study|Patient withdrawal|1
1148926|NCT01345929|3772866|P1|Overall Study|Patient withdrawal|0
1148927|NCT01345929|3772865|P2|Overall Study|40,000 CFU/ML|0
1148928|NCT01345929|3772866|P1|Overall Study|40,000 CFU/ML|1
1148929|NCT01345929|3772865|P2|Overall Study|Didn't meet eligibility criteria|0
1148930|NCT01345929|3772866|P1|Overall Study|Didn't meet eligibility criteria|2
1148931|NCT01345929|3772865|P2|Overall Study|Adverse Event|1
1148932|NCT01345929|3772866|P1|Overall Study|Adverse Event|0
1148933|NCT01345929|3772865|P2|Overall Study|Lost to Follow-up|9
1148934|NCT01345929|3772866|P1|Overall Study|Lost to Follow-up|9
1148935|NCT01345929|3772865|P2|Overall Study|Withdrawal by Subject|8
1148936|NCT01345929|3772866|P1|Overall Study|Withdrawal by Subject|9
1148937|NCT01345786|3772878|P4|Overall Study|Lost to Follow-up|2
1148938|NCT01345786|3772879|P3|Overall Study|Lost to Follow-up|0
1148939|NCT01345786|3772880|P2|Overall Study|Lost to Follow-up|0
1148940|NCT01345786|3772881|P1|Overall Study|Lost to Follow-up|0
1148941|NCT01345786|3772878|P4|Overall Study|Administrative|0
1148942|NCT01345786|3772879|P3|Overall Study|Administrative|0
1148943|NCT01345786|3772880|P2|Overall Study|Administrative|5
1148944|NCT01345786|3772881|P1|Overall Study|Administrative|3
1148945|NCT01345786|3772878|P4|Overall Study|Noncompliance with protocol|0
1148946|NCT01345786|3772879|P3|Overall Study|Noncompliance with protocol|1
1148947|NCT01345786|3772880|P2|Overall Study|Noncompliance with protocol|0
1148948|NCT01345786|3772881|P1|Overall Study|Noncompliance with protocol|1
1148949|NCT01345786|3772878|P4|Overall Study|Subject withdrew consent|0
1148950|NCT01345786|3772879|P3|Overall Study|Subject withdrew consent|1
1148951|NCT01345786|3772880|P2|Overall Study|Subject withdrew consent|2
1148952|NCT01345786|3772881|P1|Overall Study|Subject withdrew consent|2
1148953|NCT01345786|3772878|P4|Overall Study|Adverse Event|1
1148954|NCT01345786|3772879|P3|Overall Study|Adverse Event|3
1148955|NCT01345786|3772880|P2|Overall Study|Adverse Event|1
1148956|NCT01345786|3772881|P1|Overall Study|Adverse Event|0
1148957|NCT01345682|3772961|P2|Overall Study|Reason other than those specified above|3
1148958|NCT01345682|3772962|P1|Overall Study|Reason other than those specified above|4
1148959|NCT01345682|3772961|P2|Overall Study|Not treated|1
1148960|NCT01345682|3772962|P1|Overall Study|Not treated|2
1148961|NCT01345682|3772961|P2|Overall Study|Refused to continue trial medication|9
1148962|NCT01345682|3772962|P1|Overall Study|Refused to continue trial medication|16
1148963|NCT01345682|3772961|P2|Overall Study|Lost to Follow-up|1
1148964|NCT01345682|3772962|P1|Overall Study|Lost to Follow-up|0
1148965|NCT01345682|3772961|P2|Overall Study|Non-compliance with protocol|1
1148966|NCT01345682|3772962|P1|Overall Study|Non-compliance with protocol|0
1148967|NCT01345682|3772961|P2|Overall Study|Adverse Event|41
1148968|NCT01345682|3772962|P1|Overall Study|Adverse Event|51
1148969|NCT01345682|3772961|P2|Overall Study|Worsening of underlying cancer disease|12
1148970|NCT01345682|3772962|P1|Overall Study|Worsening of underlying cancer disease|23
1148971|NCT01345682|3772961|P2|Overall Study|Progressive disease per RECIST|93
1148972|NCT01345682|3772962|P1|Overall Study|Progressive disease per RECIST|226
1148973|NCT01345669|3772996|P2|Overall Study|Other Reasons|60
1148974|NCT01345669|3772997|P1|Overall Study|Other Reasons|111
1148975|NCT01345669|3772996|P2|Overall Study|Withdrawal by Subject|13
1148976|NCT01345669|3772997|P1|Overall Study|Withdrawal by Subject|52
1148977|NCT01345669|3772996|P2|Overall Study|Lost to Follow-up|1
1148978|NCT01345669|3772997|P1|Overall Study|Lost to Follow-up|1
1148979|NCT01345669|3772996|P2|Overall Study|Protocol Violation|1
1148980|NCT01345669|3772997|P1|Overall Study|Protocol Violation|3
1148981|NCT01345669|3772996|P2|Overall Study|Adverse Event|9
1148982|NCT01345669|3772997|P1|Overall Study|Adverse Event|63
1148983|NCT01345669|3772996|P2|Overall Study|Second primary tumour|3
1148984|NCT01345669|3772997|P1|Overall Study|Second primary tumour|4
1148985|NCT01345669|3772996|P2|Overall Study|Primary tumour recurrence|32
1148986|NCT01345669|3772997|P1|Overall Study|Primary tumour recurrence|53
1148987|NCT01345630|3773015|P2|Overall Study|Insufficient clinical response|11
1148988|NCT01345630|3773016|P1|Overall Study|Insufficient clinical response|48
1148989|NCT01345630|3773015|P2|Overall Study|No longer willing to participate|12
1148990|NCT01345630|3773016|P1|Overall Study|No longer willing to participate|9
1148991|NCT01345630|3773015|P2|Overall Study|Withdrawn due to pregnancy|2
1148992|NCT01345630|3773016|P1|Overall Study|Withdrawn due to pregnancy|1
1148993|NCT01345630|3773015|P2|Overall Study|Other reasons|8
1148994|NCT01345630|3773016|P1|Overall Study|Other reasons|6
1148995|NCT01345630|3773015|P2|Overall Study|Study terminated by sponsor|285
1148996|NCT01345630|3773016|P1|Overall Study|Study terminated by sponsor|254
1148997|NCT01345630|3773015|P2|Overall Study|Medication error without associated AE|1
1148998|NCT01345630|3773016|P1|Overall Study|Medication error without associated AE|0
1148999|NCT01345630|3773015|P2|Overall Study|Protocol Violation|1
1149000|NCT01345630|3773016|P1|Overall Study|Protocol Violation|4
1149001|NCT01345630|3773015|P2|Overall Study|Lost to Follow-up|16
1149002|NCT01345630|3773016|P1|Overall Study|Lost to Follow-up|17
1149003|NCT01345630|3773015|P2|Overall Study|Adverse Event|23
1149004|NCT01345630|3773016|P1|Overall Study|Adverse Event|22
1149005|NCT01345591|3773072|P1|Overall Study|Lost to Follow-up|1
1149006|NCT01345318|3773081|P1|Overall Study|Other|3
1149007|NCT01345318|3773081|P1|Overall Study|Withdrawal by Subject|41
1149008|NCT01345318|3773081|P1|Overall Study|Protocol Violation|1
1149009|NCT01345318|3773081|P1|Overall Study|Lost to Follow-up|2
1149010|NCT01345318|3773081|P1|Overall Study|Lack of Efficacy|17
1149011|NCT01345318|3773081|P1|Overall Study|Adverse Event|16
1149012|NCT01345292|3773089|P3|Overall Study|Withdrawal by Subject|1
1149013|NCT01345292|3773090|P2|Overall Study|Withdrawal by Subject|0
1149014|NCT01345292|3773091|P1|Overall Study|Withdrawal by Subject|2
1149015|NCT01345253|3773122|P2|Overall Study|Withdrawal by Subject|19
1149016|NCT01345253|3773123|P1|Overall Study|Withdrawal by Subject|9
1149017|NCT01345253|3773122|P2|Overall Study|Physician Decision|12
1149018|NCT01345253|3773123|P1|Overall Study|Physician Decision|4
1149019|NCT01345253|3773122|P2|Overall Study|Lost to Follow-up|8
1149020|NCT01345253|3773123|P1|Overall Study|Lost to Follow-up|3
1149021|NCT01345253|3773122|P2|Overall Study|Met Protocol Defined Stopping Criteria|1
1149022|NCT01345253|3773123|P1|Overall Study|Met Protocol Defined Stopping Criteria|6
1149023|NCT01345253|3773122|P2|Overall Study|Protocol Violation|5
1149024|NCT01345253|3773123|P1|Overall Study|Protocol Violation|1
1149025|NCT01345253|3773122|P2|Overall Study|Lack of Efficacy|7
1149026|NCT01345253|3773123|P1|Overall Study|Lack of Efficacy|11
1149027|NCT01345253|3773122|P2|Overall Study|Adverse Event|27
1149028|NCT01345253|3773123|P1|Overall Study|Adverse Event|22
1149029|NCT01345240|3773142|P5|Overall Study|Serious Adverse Event|1
1149030|NCT01345240|3773143|P4|Overall Study|Serious Adverse Event|2
1149031|NCT01345240|3773144|P3|Overall Study|Serious Adverse Event|2
1149032|NCT01345240|3773145|P2|Overall Study|Serious Adverse Event|2
1149033|NCT01345240|3773146|P1|Overall Study|Serious Adverse Event|1
1149034|NCT01345240|3773142|P5|Overall Study|Lost to Follow-up|6
1149035|NCT01345240|3773143|P4|Overall Study|Lost to Follow-up|8
1149036|NCT01345240|3773144|P3|Overall Study|Lost to Follow-up|8
1149037|NCT01345240|3773145|P2|Overall Study|Lost to Follow-up|12
1149038|NCT01345240|3773146|P1|Overall Study|Lost to Follow-up|1
1149039|NCT01345188|3773239|P1|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1
1149040|NCT01345188|3773239|P1|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2
1149041|NCT01345162|3773251|P2|Overall Study|Protocol Violation|4
1149042|NCT01345162|3773252|P1|Overall Study|Protocol Violation|2
1149043|NCT01345123|3773261|P3|Overall Study|participants no longer with health plan|88
1149044|NCT01345123|3773262|P2|Overall Study|participants no longer with health plan|85
1149045|NCT01345123|3773263|P1|Overall Study|participants no longer with health plan|79
1149046|NCT01345058|3773285|P2|Overall Study|Participant No-Show at Multiple Visits|0
1149047|NCT01345058|3773286|P1|Overall Study|Participant No-Show at Multiple Visits|1
1149048|NCT01345058|3773285|P2|Overall Study|Participant Stopped Taking Study Drug|0
1149049|NCT01345058|3773286|P1|Overall Study|Participant Stopped Taking Study Drug|1
1149050|NCT01345058|3773285|P2|Overall Study|Side Effects of Hair Loss and Itchiness|0
1149051|NCT01345058|3773286|P1|Overall Study|Side Effects of Hair Loss and Itchiness|1
1149138|NCT01343888|3773580|P1|Overall Study|other than stated above|0
1149052|NCT01345058|3773285|P2|Overall Study|Participant Reported Increase in Events|0
1149053|NCT01345058|3773286|P1|Overall Study|Participant Reported Increase in Events|1
1149054|NCT01345058|3773285|P2|Overall Study|Withdrawal by Subject|0
1149055|NCT01345058|3773286|P1|Overall Study|Withdrawal by Subject|1
1149056|NCT01345019|3773302|P2|Overall Study|Other|3
1149057|NCT01345019|3773303|P1|Overall Study|Other|1
1149058|NCT01345019|3773302|P2|Overall Study|Protocol Deviation|0
1149059|NCT01345019|3773303|P1|Overall Study|Protocol Deviation|5
1149060|NCT01345019|3773302|P2|Overall Study|Lost to Follow-up|2
1149061|NCT01345019|3773303|P1|Overall Study|Lost to Follow-up|4
1149062|NCT01345019|3773302|P2|Overall Study|Ineligibility Determined|6
1149063|NCT01345019|3773303|P1|Overall Study|Ineligibility Determined|1
1149064|NCT01345019|3773302|P2|Overall Study|Noncompliance|4
1149065|NCT01345019|3773303|P1|Overall Study|Noncompliance|4
1149066|NCT01345019|3773302|P2|Overall Study|Administrative Decision|5
1149067|NCT01345019|3773303|P1|Overall Study|Administrative Decision|8
1149068|NCT01345019|3773302|P2|Overall Study|Adverse Event|13
1149069|NCT01345019|3773303|P1|Overall Study|Adverse Event|4
1149070|NCT01345019|3773302|P2|Overall Study|Disease Progression|8
1149071|NCT01345019|3773303|P1|Overall Study|Disease Progression|11
1149072|NCT01345019|3773302|P2|Overall Study|Completed Survival Follow-up|4
1149073|NCT01345019|3773303|P1|Overall Study|Completed Survival Follow-up|16
1149074|NCT01345019|3773302|P2|Overall Study|Withdrawal by Subject|107
1149075|NCT01345019|3773303|P1|Overall Study|Withdrawal by Subject|82
1149076|NCT01345019|3773302|P2|Overall Study|Death|120
1149077|NCT01345019|3773303|P1|Overall Study|Death|127
1149078|NCT01344876|3773323|P5|Overall Study|Definite progression of primary disease|0
1149079|NCT01344876|3773324|P4|Overall Study|Definite progression of primary disease|3
1149080|NCT01344876|3773325|P3|Overall Study|Definite progression of primary disease|0
1149081|NCT01344876|3773326|P2|Overall Study|Definite progression of primary disease|0
1149082|NCT01344876|3773327|P1|Overall Study|Definite progression of primary disease|1
1149083|NCT01344876|3773323|P5|Overall Study|Withdrawal by Subject|0
1149084|NCT01344876|3773324|P4|Overall Study|Withdrawal by Subject|0
1149085|NCT01344876|3773325|P3|Overall Study|Withdrawal by Subject|1
1149086|NCT01344876|3773326|P2|Overall Study|Withdrawal by Subject|0
1149087|NCT01344876|3773327|P1|Overall Study|Withdrawal by Subject|0
1149088|NCT01344876|3773323|P5|Overall Study|Adverse Event|1
1149089|NCT01344876|3773324|P4|Overall Study|Adverse Event|0
1149090|NCT01344876|3773325|P3|Overall Study|Adverse Event|0
1149091|NCT01344876|3773326|P2|Overall Study|Adverse Event|0
1149092|NCT01344876|3773327|P1|Overall Study|Adverse Event|0
1149093|NCT01344824|3773341|P1|Overall Study|Progression|15
1149094|NCT01344824|3773341|P1|Overall Study|Other complicating disease|1
1149095|NCT01344824|3773341|P1|Overall Study|Withdrawal by Subject|6
1149096|NCT01344824|3773341|P1|Overall Study|Adverse Event|15
1149097|NCT01344759|3773349|P2|Overall Study|Patients failed to reach sedation level|2
1149098|NCT01344759|3773350|P1|Overall Study|Patients failed to reach sedation level|0
1149099|NCT01344629|3773382|P2|Crossover Period 2|Withdrawal by Subject|1
1149100|NCT01344629|3773383|P1|Crossover Period 2|Withdrawal by Subject|0
1149101|NCT01344538|3773412|P2|Overall Study|Lost to Follow-up|0
1149102|NCT01344538|3773413|P1|Overall Study|Lost to Follow-up|1
1149103|NCT01344538|3773412|P2|Overall Study|Adverse Event|1
1149104|NCT01344538|3773413|P1|Overall Study|Adverse Event|1
1149105|NCT01344460|3773419|P1|Overall Study|Lost to Follow-up|2
1149106|NCT01344460|3773419|P1|Overall Study|Withdrawal by Subject|1
1149107|NCT01344447|3773464|P1|Overall Study|Error of power injector|1
1149108|NCT01344447|3773464|P1|Overall Study|Bolus tracking failed|1
1149109|NCT01344447|3773464|P1|Overall Study|MRA unsuccessful|1
1149110|NCT01344447|3773464|P1|Overall Study|Physician Decision|1
1149111|NCT01344447|3773464|P1|Overall Study|The contrast was not seen|1
1149112|NCT01344447|3773464|P1|Overall Study|Withdrawal by Subject|1
1149113|NCT01344447|3773464|P1|Overall Study|Protocol Violation|1
1149114|NCT01344447|3773464|P1|Overall Study|Adverse Event|1
1149115|NCT01344369|3773508|P2|Second Intervention|Emesis within 2 x Tmax|1
1149116|NCT01344369|3773509|P1|Second Intervention|Emesis within 2 x Tmax|0
1149117|NCT01344369|3773508|P2|Washout of 28 Days|Physician Decision|1
1149118|NCT01344369|3773509|P1|Washout of 28 Days|Physician Decision|0
1149119|NCT01344369|3773508|P2|Washout of 28 Days|Withdrawal by Subject|0
1149120|NCT01344369|3773509|P1|Washout of 28 Days|Withdrawal by Subject|1
1149121|NCT01344226|3773525|P1|Overall Study|Lack of Efficacy|3
1149122|NCT01344226|3773525|P1|Overall Study|Withdrawal by Subject|3
1149123|NCT01344226|3773525|P1|Overall Study|Protocol Violation|2
1149124|NCT01344161|3773534|P2|Overall Study|Protocol Violation|1
1149125|NCT01344161|3773535|P1|Overall Study|Protocol Violation|1
1149126|NCT01344161|3773534|P2|Overall Study|Pregnancy|1
1149127|NCT01344161|3773535|P1|Overall Study|Pregnancy|0
1149128|NCT01344161|3773534|P2|Overall Study|Lost to Follow-up|1
1149129|NCT01344161|3773535|P1|Overall Study|Lost to Follow-up|4
1149130|NCT01344057|3773547|P1|Overall Study|Premature Withdrawal|1
1149131|NCT01343901|3773554|P1|Overall Study|Participant decision|1
1149132|NCT01343901|3773554|P1|Overall Study|Management by another medical team|11
1149133|NCT01343901|3773554|P1|Overall Study|Lost to Follow-up|12
1149134|NCT01343901|3773554|P1|Overall Study|Physician Decision|4
1149135|NCT01343901|3773554|P1|Overall Study|Death|85
1149136|NCT01343888|3773578|P3|Overall Study|other than stated above|1
1149137|NCT01343888|3773579|P2|Overall Study|other than stated above|0
1149139|NCT01343888|3773578|P3|Overall Study|Withdrawal by Subject|2
1149140|NCT01343888|3773579|P2|Overall Study|Withdrawal by Subject|4
1149141|NCT01343888|3773580|P1|Overall Study|Withdrawal by Subject|4
1149142|NCT01343888|3773578|P3|Overall Study|Protocol Violation|0
1149143|NCT01343888|3773579|P2|Overall Study|Protocol Violation|2
1149144|NCT01343888|3773580|P1|Overall Study|Protocol Violation|0
1149145|NCT01343888|3773578|P3|Overall Study|Lost to Follow-up|1
1149146|NCT01343888|3773579|P2|Overall Study|Lost to Follow-up|2
1149147|NCT01343888|3773580|P1|Overall Study|Lost to Follow-up|0
1149148|NCT01343888|3773578|P3|Overall Study|Lack of Efficacy|13
1149149|NCT01343888|3773579|P2|Overall Study|Lack of Efficacy|9
1149150|NCT01343888|3773580|P1|Overall Study|Lack of Efficacy|9
1149151|NCT01343888|3773578|P3|Overall Study|Adverse Event|5
1149152|NCT01343888|3773579|P2|Overall Study|Adverse Event|22
1149153|NCT01343888|3773580|P1|Overall Study|Adverse Event|12
1149154|NCT01343823|3773622|P4|Overall Study|Withdrawal by Subject|0
1149155|NCT01343823|3773623|P3|Overall Study|Withdrawal by Subject|0
1149156|NCT01343823|3773624|P2|Overall Study|Withdrawal by Subject|0
1149157|NCT01343823|3773625|P1|Overall Study|Withdrawal by Subject|1
1149158|NCT01343823|3773622|P4|Overall Study|Study Terminated|1
1149159|NCT01343823|3773623|P3|Overall Study|Study Terminated|0
1149160|NCT01343823|3773624|P2|Overall Study|Study Terminated|0
1149161|NCT01343823|3773625|P1|Overall Study|Study Terminated|1
1149162|NCT01343368|3773659|P2|Overall Study|Lost to Follow-up|0
1149163|NCT01343368|3773660|P1|Overall Study|Lost to Follow-up|1
1149164|NCT01343368|3773659|P2|Overall Study|Death|0
1149165|NCT01343368|3773660|P1|Overall Study|Death|1
1149166|NCT01343277|3773696|P2|Overall Study|Subsequent anticancer therapy|0
1149167|NCT01343277|3773697|P1|Overall Study|Subsequent anticancer therapy|1
1149168|NCT01343277|3773696|P2|Overall Study|Treatment ongoing|2
1149169|NCT01343277|3773697|P1|Overall Study|Treatment ongoing|8
1149170|NCT01343277|3773696|P2|Overall Study|Randomized not treated|21
1149171|NCT01343277|3773697|P1|Overall Study|Randomized not treated|6
1149172|NCT01343277|3773696|P2|Overall Study|Disease progression|138
1149173|NCT01343277|3773697|P1|Overall Study|Disease progression|270
1149174|NCT01343277|3773696|P2|Overall Study|Adverse Event|13
1149175|NCT01343277|3773697|P1|Overall Study|Adverse Event|67
1149176|NCT01343277|3773696|P2|Overall Study|Death|1
1149177|NCT01343277|3773697|P1|Overall Study|Death|10
1149178|NCT01343277|3773696|P2|Overall Study|Physician Decision|2
1149179|NCT01343277|3773697|P1|Overall Study|Physician Decision|1
1149180|NCT01343277|3773696|P2|Overall Study|Withdrawal by Subject|13
1149181|NCT01343277|3773697|P1|Overall Study|Withdrawal by Subject|18
1149182|NCT01343277|3773696|P2|Overall Study|Other|3
1149183|NCT01343277|3773697|P1|Overall Study|Other|3
1149184|NCT01343082|3773758|P3|Treatment Period , Switched to DE-111|Withdrawal by Subject|5
1149185|NCT01343082|3773759|P2|Treatment Period , Switched to DE-111|Withdrawal by Subject|2
1149186|NCT01343082|3773760|P1|Treatment Period , Switched to DE-111|Withdrawal by Subject|4
1149187|NCT01343082|3773758|P3|Treatment Period , Switched to DE-111|Physician Decision|2
1149188|NCT01343082|3773759|P2|Treatment Period , Switched to DE-111|Physician Decision|2
1149189|NCT01343082|3773760|P1|Treatment Period , Switched to DE-111|Physician Decision|0
1149190|NCT01343082|3773758|P3|Treatment Period , Switched to DE-111|Lack of Efficacy|2
1149191|NCT01343082|3773759|P2|Treatment Period , Switched to DE-111|Lack of Efficacy|1
1149192|NCT01343082|3773760|P1|Treatment Period , Switched to DE-111|Lack of Efficacy|0
1149193|NCT01343082|3773758|P3|Treatment Period , Switched to DE-111|Adverse Event|3
1149194|NCT01343082|3773759|P2|Treatment Period , Switched to DE-111|Adverse Event|4
1149195|NCT01343082|3773760|P1|Treatment Period , Switched to DE-111|Adverse Event|1
1149196|NCT01343082|3773758|P3|The run-in Period|Not meeting criteria|5
1149197|NCT01343082|3773759|P2|The run-in Period|Not meeting criteria|4
1149198|NCT01343082|3773760|P1|The run-in Period|Not meeting criteria|3
1149199|NCT01343056|3773768|P4|Overall Study|Lost to Follow-up|9
1149200|NCT01343056|3773769|P3|Overall Study|Lost to Follow-up|3
1149201|NCT01343056|3773770|P2|Overall Study|Lost to Follow-up|5
1149202|NCT01343056|3773771|P1|Overall Study|Lost to Follow-up|7
1149203|NCT01342965|3773839|P2|Overall Study|Withdrawal by Subject|9
1149204|NCT01342965|3773840|P1|Overall Study|Withdrawal by Subject|2
1149205|NCT01342965|3773839|P2|Overall Study|Other Reasons- Unspecified|38
1149206|NCT01342965|3773840|P1|Overall Study|Other Reasons- Unspecified|44
1149207|NCT01342965|3773839|P2|Overall Study|Lost to Follow-up|3
1149208|NCT01342965|3773840|P1|Overall Study|Lost to Follow-up|5
1149209|NCT01342965|3773839|P2|Overall Study|Death|57
1149210|NCT01342965|3773840|P1|Overall Study|Death|58
1149211|NCT01342926|3773858|P4|Overall Study|Withdrawal by Subject|5
1149212|NCT01342926|3773859|P3|Overall Study|Withdrawal by Subject|3
1149213|NCT01342926|3773860|P2|Overall Study|Withdrawal by Subject|4
1149214|NCT01342926|3773861|P1|Overall Study|Withdrawal by Subject|2
1149215|NCT01342926|3773858|P4|Overall Study|Investigator Discretion|0
1149216|NCT01342926|3773859|P3|Overall Study|Investigator Discretion|0
1149217|NCT01342926|3773860|P2|Overall Study|Investigator Discretion|2
1149218|NCT01342926|3773861|P1|Overall Study|Investigator Discretion|2
1149219|NCT01342926|3773858|P4|Overall Study|Lost to Follow-up|0
1149220|NCT01342926|3773859|P3|Overall Study|Lost to Follow-up|1
1149221|NCT01342926|3773860|P2|Overall Study|Lost to Follow-up|1
1149222|NCT01342926|3773861|P1|Overall Study|Lost to Follow-up|0
1149223|NCT01342926|3773858|P4|Overall Study|Adverse Event|7
1149224|NCT01342926|3773859|P3|Overall Study|Adverse Event|10
1149225|NCT01342926|3773860|P2|Overall Study|Adverse Event|8
1149226|NCT01342926|3773861|P1|Overall Study|Adverse Event|5
1149227|NCT01342913|3773941|P3|Double-Blind Treatment Period|Withdrawal by Subject|2
1149228|NCT01342913|3773942|P2|Double-Blind Treatment Period|Withdrawal by Subject|2
1149229|NCT01342913|3773943|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
1149230|NCT01342913|3773941|P3|Double-Blind Treatment Period|Physician Decision|0
1149231|NCT01342913|3773942|P2|Double-Blind Treatment Period|Physician Decision|2
1149232|NCT01342913|3773943|P1|Double-Blind Treatment Period|Physician Decision|0
1149233|NCT01342913|3773941|P3|Double-Blind Treatment Period|Lost to Follow-up|3
1149234|NCT01342913|3773942|P2|Double-Blind Treatment Period|Lost to Follow-up|1
1149235|NCT01342913|3773943|P1|Double-Blind Treatment Period|Lost to Follow-up|0
1149236|NCT01342913|3773941|P3|Double-Blind Treatment Period|Protocol Violation|9
1149237|NCT01342913|3773942|P2|Double-Blind Treatment Period|Protocol Violation|6
1149238|NCT01342913|3773943|P1|Double-Blind Treatment Period|Protocol Violation|0
1149239|NCT01342913|3773941|P3|Double-Blind Treatment Period|Lack of Efficacy|3
1149240|NCT01342913|3773942|P2|Double-Blind Treatment Period|Lack of Efficacy|2
1149241|NCT01342913|3773943|P1|Double-Blind Treatment Period|Lack of Efficacy|0
1149242|NCT01342913|3773941|P3|Double-Blind Treatment Period|Adverse Event|6
1149243|NCT01342913|3773942|P2|Double-Blind Treatment Period|Adverse Event|3
1149244|NCT01342913|3773943|P1|Double-Blind Treatment Period|Adverse Event|0
1149245|NCT01342913|3773941|P3|2-week Run-in Period|Continuation Criteria Not Met|0
1149246|NCT01342913|3773942|P2|2-week Run-in Period|Continuation Criteria Not Met|0
1149247|NCT01342913|3773943|P1|2-week Run-in Period|Continuation Criteria Not Met|88
1149248|NCT01342913|3773941|P3|2-week Run-in Period|Protocol Violation|0
1149249|NCT01342913|3773942|P2|2-week Run-in Period|Protocol Violation|0
1149250|NCT01342913|3773943|P1|2-week Run-in Period|Protocol Violation|5
1149251|NCT01342913|3773941|P3|2-week Run-in Period|Adverse Event|0
1149252|NCT01342913|3773942|P2|2-week Run-in Period|Adverse Event|0
1149253|NCT01342913|3773943|P1|2-week Run-in Period|Adverse Event|2
1149254|NCT01342913|3773941|P3|2-week Run-in Period|Withdrawal by Subject|0
1149255|NCT01342913|3773942|P2|2-week Run-in Period|Withdrawal by Subject|0
1149256|NCT01342913|3773943|P1|2-week Run-in Period|Withdrawal by Subject|7
1149257|NCT01342913|3773941|P3|2-week Run-in Period|Physician Decision|0
1149258|NCT01342913|3773942|P2|2-week Run-in Period|Physician Decision|0
1149259|NCT01342913|3773943|P1|2-week Run-in Period|Physician Decision|6
1149260|NCT01342913|3773941|P3|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
1149261|NCT01342913|3773942|P2|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
1149262|NCT01342913|3773943|P1|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66
1149263|NCT01342887|3773953|P1|Overall Study|Death|2
1149264|NCT01342640|3773994|P1|Overall Study|Other|1
1149265|NCT01342640|3773994|P1|Overall Study|Lost to Follow-up|21
1149266|NCT01342640|3773994|P1|Overall Study|Protocol Violation|16
1149267|NCT01342640|3773994|P1|Overall Study|Adverse Event|3
1149268|NCT01342510|3774089|P4|Overall Study|Protocol Violation|11
1149269|NCT01342510|3774090|P3|Overall Study|Protocol Violation|13
1149270|NCT01342510|3774091|P2|Overall Study|Protocol Violation|6
1149271|NCT01342510|3774092|P1|Overall Study|Protocol Violation|12
1149272|NCT01342484|3774105|P3|Overall Study|Withdrawal by Subject|0
1149273|NCT01342484|3774106|P2|Overall Study|Withdrawal by Subject|0
1149274|NCT01342484|3774107|P1|Overall Study|Withdrawal by Subject|1
1149275|NCT01342484|3774105|P3|Overall Study|Protocol Violation|1
1149276|NCT01342484|3774106|P2|Overall Study|Protocol Violation|0
1149277|NCT01342484|3774107|P1|Overall Study|Protocol Violation|0
1149278|NCT01342484|3774105|P3|Overall Study|Other Reasons|0
1149279|NCT01342484|3774106|P2|Overall Study|Other Reasons|0
1149280|NCT01342484|3774107|P1|Overall Study|Other Reasons|1
1149281|NCT01342445|3774163|P2|Overall Study|Experienced side effects|2
1149282|NCT01342445|3774164|P1|Overall Study|Experienced side effects|0
1149283|NCT01342341|3774180|P2|Overall Study|Lost to Follow-up|4
1149284|NCT01342341|3774181|P1|Overall Study|Lost to Follow-up|4
1149285|NCT01342211|3774192|P5|Overall Study|Randomized, but not Treated|1
1149286|NCT01342211|3774193|P4|Overall Study|Randomized, but not Treated|0
1149287|NCT01342211|3774194|P3|Overall Study|Randomized, but not Treated|0
1149288|NCT01342211|3774195|P2|Overall Study|Randomized, but not Treated|2
1149289|NCT01342211|3774196|P1|Overall Study|Randomized, but not Treated|0
1149290|NCT01342211|3774192|P5|Overall Study|Withdrawal by Subject|0
1149291|NCT01342211|3774193|P4|Overall Study|Withdrawal by Subject|1
1149292|NCT01342211|3774194|P3|Overall Study|Withdrawal by Subject|0
1149293|NCT01342211|3774195|P2|Overall Study|Withdrawal by Subject|0
1149294|NCT01342211|3774196|P1|Overall Study|Withdrawal by Subject|0
1149295|NCT01342211|3774192|P5|Overall Study|Adverse Event|1
1149296|NCT01342211|3774193|P4|Overall Study|Adverse Event|0
1149297|NCT01342211|3774194|P3|Overall Study|Adverse Event|0
1149298|NCT01342211|3774195|P2|Overall Study|Adverse Event|0
1149299|NCT01342211|3774196|P1|Overall Study|Adverse Event|0
1149300|NCT01342211|3774192|P5|Overall Study|Lost to Follow-up|0
1149301|NCT01342211|3774193|P4|Overall Study|Lost to Follow-up|1
1149302|NCT01342211|3774194|P3|Overall Study|Lost to Follow-up|0
1149303|NCT01342211|3774195|P2|Overall Study|Lost to Follow-up|0
1149304|NCT01342211|3774196|P1|Overall Study|Lost to Follow-up|0
1149305|NCT01342094|3774277|P2|Overall Study|Withdrawal by Subject|2
1149306|NCT01342094|3774278|P1|Overall Study|Withdrawal by Subject|0
1149307|NCT01342094|3774277|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
1149308|NCT01342094|3774278|P1|Overall Study|Not meeting inclusion/exclusion criteria|0
1149309|NCT01342094|3774277|P2|Overall Study|Adverse Event|0
1149310|NCT01342094|3774278|P1|Overall Study|Adverse Event|5
1149311|NCT01342081|3774287|P3|Overall Study|Withdrawal by Subject|0
1149312|NCT01342081|3774288|P2|Overall Study|Withdrawal by Subject|1
1149313|NCT01342081|3774289|P1|Overall Study|Withdrawal by Subject|1
1149314|NCT01342081|3774287|P3|Overall Study|Physician Decision|0
1149315|NCT01342081|3774288|P2|Overall Study|Physician Decision|1
1149316|NCT01342081|3774289|P1|Overall Study|Physician Decision|0
1149317|NCT01342081|3774287|P3|Overall Study|Adverse Event|0
1149318|NCT01342081|3774288|P2|Overall Study|Adverse Event|0
1149319|NCT01342081|3774289|P1|Overall Study|Adverse Event|1
1149320|NCT01342081|3774287|P3|Overall Study|Did not receive allocated intervention|1
1149321|NCT01342081|3774288|P2|Overall Study|Did not receive allocated intervention|0
1149322|NCT01342081|3774289|P1|Overall Study|Did not receive allocated intervention|0
1149323|NCT01341990|3774308|P2|Overall Study|Withdrawal by Subject|0
1149324|NCT01341990|3774309|P1|Overall Study|Withdrawal by Subject|2
1149325|NCT01341990|3774308|P2|Overall Study|Torn Study Lens|0
1149326|NCT01341990|3774309|P1|Overall Study|Torn Study Lens|1
1149327|NCT01341990|3774308|P2|Overall Study|Adverse Event|1
1149328|NCT01341990|3774309|P1|Overall Study|Adverse Event|0
1149329|NCT01341782|3774333|P2|Overall Study|Other|0
1149330|NCT01341782|3774334|P1|Overall Study|Other|5
1149331|NCT01341782|3774333|P2|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
1149332|NCT01341782|3774334|P1|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
1149333|NCT01341782|3774333|P2|Overall Study|2 consecutive calcium values >11.5 mg/dL|1
1149334|NCT01341782|3774334|P1|Overall Study|2 consecutive calcium values >11.5 mg/dL|0
1149335|NCT01341782|3774333|P2|Overall Study|Missed 3 consecutive doses|4
1149336|NCT01341782|3774334|P1|Overall Study|Missed 3 consecutive doses|0
1149337|NCT01341782|3774333|P2|Overall Study|Withdrawal by Subject|5
1149338|NCT01341782|3774334|P1|Overall Study|Withdrawal by Subject|6
1149339|NCT01341782|3774333|P2|Overall Study|Adverse Event|1
1149340|NCT01341782|3774334|P1|Overall Study|Adverse Event|1
1149341|NCT01341587|3774374|P2|Overall Study|stopped using the meters|10
1149342|NCT01341587|3774375|P1|Overall Study|stopped using the meters|2
1149343|NCT01341587|3774374|P2|Overall Study|Lost to Follow-up|0
1149344|NCT01341587|3774375|P1|Overall Study|Lost to Follow-up|2
1149345|NCT01340976|3774410|P6|Overall Study|Adverse Event|0
1149346|NCT01340976|3774411|P5|Overall Study|Adverse Event|0
1149347|NCT01340976|3774412|P4|Overall Study|Adverse Event|0
1149348|NCT01340976|3774413|P3|Overall Study|Adverse Event|0
1149349|NCT01340976|3774414|P2|Overall Study|Adverse Event|1
1149350|NCT01340976|3774415|P1|Overall Study|Adverse Event|0
1149351|NCT01340976|3774410|P6|Overall Study|Other anemia treatment|1
1149352|NCT01340976|3774411|P5|Overall Study|Other anemia treatment|0
1149353|NCT01340976|3774412|P4|Overall Study|Other anemia treatment|1
1149354|NCT01340976|3774413|P3|Overall Study|Other anemia treatment|2
1149355|NCT01340976|3774414|P2|Overall Study|Other anemia treatment|0
1149356|NCT01340976|3774415|P1|Overall Study|Other anemia treatment|1
1149357|NCT01340976|3774410|P6|Overall Study|Withdrawal by Subject|0
1149358|NCT01340976|3774411|P5|Overall Study|Withdrawal by Subject|1
1149359|NCT01340976|3774412|P4|Overall Study|Withdrawal by Subject|1
1149360|NCT01340976|3774413|P3|Overall Study|Withdrawal by Subject|0
1149361|NCT01340976|3774414|P2|Overall Study|Withdrawal by Subject|0
1149362|NCT01340976|3774415|P1|Overall Study|Withdrawal by Subject|0
1149363|NCT01340976|3774410|P6|Overall Study|Dose Limiting Toxicity Stopping Rule|0
1149364|NCT01340976|3774411|P5|Overall Study|Dose Limiting Toxicity Stopping Rule|0
1149365|NCT01340976|3774412|P4|Overall Study|Dose Limiting Toxicity Stopping Rule|0
1149366|NCT01340976|3774413|P3|Overall Study|Dose Limiting Toxicity Stopping Rule|0
1149367|NCT01340976|3774414|P2|Overall Study|Dose Limiting Toxicity Stopping Rule|0
1149368|NCT01340976|3774415|P1|Overall Study|Dose Limiting Toxicity Stopping Rule|1
1149369|NCT01340976|3774410|P6|Overall Study|Death|0
1149370|NCT01340976|3774411|P5|Overall Study|Death|0
1149371|NCT01340976|3774412|P4|Overall Study|Death|0
1149372|NCT01340976|3774413|P3|Overall Study|Death|0
1149373|NCT01340976|3774414|P2|Overall Study|Death|1
1149374|NCT01340976|3774415|P1|Overall Study|Death|0
1149375|NCT01340976|3774410|P6|Overall Study|Physician Decision|0
1149376|NCT01340976|3774411|P5|Overall Study|Physician Decision|1
1149377|NCT01340976|3774412|P4|Overall Study|Physician Decision|1
1149378|NCT01340976|3774413|P3|Overall Study|Physician Decision|1
1149379|NCT01340976|3774414|P2|Overall Study|Physician Decision|0
1149380|NCT01340976|3774415|P1|Overall Study|Physician Decision|2
1149381|NCT01340937|3774453|P4|Period 3: Toddler Vaccinations|Technical problem|0
1149382|NCT01340937|3774454|P3|Period 3: Toddler Vaccinations|Technical problem|1
1149383|NCT01340937|3774455|P2|Period 3: Toddler Vaccinations|Technical problem|1
1149384|NCT01340937|3774456|P1|Period 3: Toddler Vaccinations|Technical problem|1
1149385|NCT01340937|3774453|P4|Period 3: Toddler Vaccinations|Protocol Violation|1
1149386|NCT01340937|3774454|P3|Period 3: Toddler Vaccinations|Protocol Violation|0
1149387|NCT01340937|3774455|P2|Period 3: Toddler Vaccinations|Protocol Violation|0
1149388|NCT01340937|3774456|P1|Period 3: Toddler Vaccinations|Protocol Violation|0
1149389|NCT01340937|3774453|P4|Period 3: Toddler Vaccinations|Lost to Follow-up|8
1149390|NCT01340937|3774454|P3|Period 3: Toddler Vaccinations|Lost to Follow-up|7
1149391|NCT01340937|3774455|P2|Period 3: Toddler Vaccinations|Lost to Follow-up|14
1149392|NCT01340937|3774456|P1|Period 3: Toddler Vaccinations|Lost to Follow-up|6
1149393|NCT01340937|3774453|P4|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
1149394|NCT01340937|3774454|P3|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
1149395|NCT01340937|3774455|P2|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
1149396|NCT01340937|3774456|P1|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
1149397|NCT01340937|3774453|P4|Period 2: Interim Period|Technical problems|3
1149398|NCT01340937|3774454|P3|Period 2: Interim Period|Technical problems|6
1149399|NCT01340937|3774455|P2|Period 2: Interim Period|Technical problems|4
1149400|NCT01340937|3774456|P1|Period 2: Interim Period|Technical problems|4
1149401|NCT01340937|3774453|P4|Period 2: Interim Period|Protocol Violation|3
1149402|NCT01340937|3774454|P3|Period 2: Interim Period|Protocol Violation|6
1149403|NCT01340937|3774455|P2|Period 2: Interim Period|Protocol Violation|3
1149404|NCT01340937|3774456|P1|Period 2: Interim Period|Protocol Violation|5
1149405|NCT01340937|3774453|P4|Period 2: Interim Period|Physician Decision|0
1149406|NCT01340937|3774454|P3|Period 2: Interim Period|Physician Decision|1
1149407|NCT01340937|3774455|P2|Period 2: Interim Period|Physician Decision|1
1149408|NCT01340937|3774456|P1|Period 2: Interim Period|Physician Decision|0
1149409|NCT01340937|3774453|P4|Period 2: Interim Period|Lost to Follow-up|23
1149410|NCT01340937|3774454|P3|Period 2: Interim Period|Lost to Follow-up|53
1149411|NCT01340937|3774455|P2|Period 2: Interim Period|Lost to Follow-up|48
1149412|NCT01340937|3774456|P1|Period 2: Interim Period|Lost to Follow-up|29
1149413|NCT01340937|3774453|P4|Period 2: Interim Period|Adverse Event|0
1149414|NCT01340937|3774454|P3|Period 2: Interim Period|Adverse Event|1
1149415|NCT01340937|3774455|P2|Period 2: Interim Period|Adverse Event|0
1149416|NCT01340937|3774456|P1|Period 2: Interim Period|Adverse Event|1
1149417|NCT01340937|3774453|P4|Period 2: Interim Period|Withdrawal by Subject|12
1149418|NCT01340937|3774454|P3|Period 2: Interim Period|Withdrawal by Subject|17
1149419|NCT01340937|3774455|P2|Period 2: Interim Period|Withdrawal by Subject|23
1149420|NCT01340937|3774456|P1|Period 2: Interim Period|Withdrawal by Subject|28
1149421|NCT01340937|3774453|P4|Period 1: Infant Series|Randomized but not vaccinated|1
1149422|NCT01340937|3774454|P3|Period 1: Infant Series|Randomized but not vaccinated|2
1149423|NCT01340937|3774455|P2|Period 1: Infant Series|Randomized but not vaccinated|5
1149424|NCT01340937|3774456|P1|Period 1: Infant Series|Randomized but not vaccinated|0
1149425|NCT01340937|3774453|P4|Period 1: Infant Series|Withdrawal by Subject|15
1149426|NCT01340937|3774454|P3|Period 1: Infant Series|Withdrawal by Subject|30
1149427|NCT01340937|3774455|P2|Period 1: Infant Series|Withdrawal by Subject|32
1149428|NCT01340937|3774456|P1|Period 1: Infant Series|Withdrawal by Subject|33
1149429|NCT01340937|3774453|P4|Period 1: Infant Series|Protocol Violation|3
1149430|NCT01340937|3774454|P3|Period 1: Infant Series|Protocol Violation|4
1149431|NCT01340937|3774455|P2|Period 1: Infant Series|Protocol Violation|4
1149432|NCT01340937|3774456|P1|Period 1: Infant Series|Protocol Violation|1
1149433|NCT01340937|3774453|P4|Period 1: Infant Series|Physician Decision|0
1149434|NCT01340937|3774454|P3|Period 1: Infant Series|Physician Decision|1
1149435|NCT01340937|3774455|P2|Period 1: Infant Series|Physician Decision|3
1149436|NCT01340937|3774456|P1|Period 1: Infant Series|Physician Decision|2
1149437|NCT01340937|3774453|P4|Period 1: Infant Series|Lost to Follow-up|13
1149438|NCT01340937|3774454|P3|Period 1: Infant Series|Lost to Follow-up|12
1149439|NCT01340937|3774455|P2|Period 1: Infant Series|Lost to Follow-up|14
1149440|NCT01340937|3774456|P1|Period 1: Infant Series|Lost to Follow-up|20
1149441|NCT01340937|3774453|P4|Period 1: Infant Series|Death|0
1149442|NCT01340937|3774454|P3|Period 1: Infant Series|Death|2
1149443|NCT01340937|3774455|P2|Period 1: Infant Series|Death|0
1149444|NCT01340937|3774456|P1|Period 1: Infant Series|Death|2
1149445|NCT01340937|3774453|P4|Period 1: Infant Series|Adverse Event|0
1149446|NCT01340937|3774454|P3|Period 1: Infant Series|Adverse Event|4
1149447|NCT01340937|3774455|P2|Period 1: Infant Series|Adverse Event|1
1149448|NCT01340937|3774456|P1|Period 1: Infant Series|Adverse Event|0
1149449|NCT01340937|3774453|P4|Period 1: Infant Series|Other protocol criterion not met|0
1149450|NCT01340937|3774454|P3|Period 1: Infant Series|Other protocol criterion not met|1
1149451|NCT01340937|3774455|P2|Period 1: Infant Series|Other protocol criterion not met|1
1149452|NCT01340937|3774456|P1|Period 1: Infant Series|Other protocol criterion not met|0
1149453|NCT01340872|3774615|P4|Open-label Phase|Worsening of IBD|0
1149454|NCT01340872|3774616|P3|Open-label Phase|Worsening of IBD|1
1149455|NCT01340872|3774617|P2|Open-label Phase|Worsening of IBD|0
1149456|NCT01340872|3774618|P1|Open-label Phase|Worsening of IBD|0
1149457|NCT01340872|3774615|P4|Open-label Phase|Withdrawal by Subject|6
1149458|NCT01340872|3774616|P3|Open-label Phase|Withdrawal by Subject|1
1149459|NCT01340872|3774617|P2|Open-label Phase|Withdrawal by Subject|0
1149460|NCT01340872|3774618|P1|Open-label Phase|Withdrawal by Subject|0
1149461|NCT01340872|3774615|P4|Open-label Phase|Adverse Event|4
1149462|NCT01340872|3774616|P3|Open-label Phase|Adverse Event|8
1149463|NCT01340872|3774617|P2|Open-label Phase|Adverse Event|0
1149464|NCT01340872|3774618|P1|Open-label Phase|Adverse Event|0
1149465|NCT01340872|3774615|P4|Open-label Phase|Pregnancy|0
1149466|NCT01340872|3774616|P3|Open-label Phase|Pregnancy|1
1149467|NCT01340872|3774617|P2|Open-label Phase|Pregnancy|0
1149468|NCT01340872|3774618|P1|Open-label Phase|Pregnancy|0
1149469|NCT01340872|3774615|P4|Open-label Phase|Physician Decision|1
1149470|NCT01340872|3774616|P3|Open-label Phase|Physician Decision|2
1149471|NCT01340872|3774617|P2|Open-label Phase|Physician Decision|0
1149472|NCT01340872|3774618|P1|Open-label Phase|Physician Decision|0
1149473|NCT01340872|3774615|P4|Double-blind Phase|Protocol Violation|0
1149474|NCT01340872|3774616|P3|Double-blind Phase|Protocol Violation|0
1149475|NCT01340872|3774617|P2|Double-blind Phase|Protocol Violation|1
1149476|NCT01340872|3774618|P1|Double-blind Phase|Protocol Violation|0
1149477|NCT01340872|3774615|P4|Double-blind Phase|Lost to Follow-up|0
1149478|NCT01340872|3774616|P3|Double-blind Phase|Lost to Follow-up|0
1149479|NCT01340872|3774617|P2|Double-blind Phase|Lost to Follow-up|1
1149480|NCT01340872|3774618|P1|Double-blind Phase|Lost to Follow-up|0
1149481|NCT01340872|3774615|P4|Double-blind Phase|Withdrawal by Subject|0
1149482|NCT01340872|3774616|P3|Double-blind Phase|Withdrawal by Subject|0
1149483|NCT01340872|3774617|P2|Double-blind Phase|Withdrawal by Subject|5
1149484|NCT01340872|3774618|P1|Double-blind Phase|Withdrawal by Subject|3
1149485|NCT01340872|3774615|P4|Double-blind Phase|Adverse Event|0
1149486|NCT01340872|3774616|P3|Double-blind Phase|Adverse Event|0
1149487|NCT01340872|3774617|P2|Double-blind Phase|Adverse Event|4
1149488|NCT01340872|3774618|P1|Double-blind Phase|Adverse Event|6
1149489|NCT01340794|3774678|P2|Overall Study|Withdrawal by Subject|1
1149490|NCT01340794|3774679|P1|Overall Study|Withdrawal by Subject|0
1149491|NCT01340768|3774695|P2|Overall Study|Other|0
1149492|NCT01340768|3774696|P1|Overall Study|Other|2
1149493|NCT01340768|3774695|P2|Overall Study|Withdrawal by Subject|1
1149494|NCT01340768|3774696|P1|Overall Study|Withdrawal by Subject|5
1149495|NCT01340768|3774695|P2|Overall Study|Lost to Follow-up|4
1149496|NCT01340768|3774696|P1|Overall Study|Lost to Follow-up|10
1149497|NCT01340664|3774707|P3|Overall Study|Not specified|2
1149498|NCT01340664|3774708|P2|Overall Study|Not specified|2
1149499|NCT01340664|3774709|P1|Overall Study|Not specified|1
1149500|NCT01340664|3774707|P3|Overall Study|Creatinine or eGFR withdrawal criteria|2
1149501|NCT01340664|3774708|P2|Overall Study|Creatinine or eGFR withdrawal criteria|1
1149502|NCT01340664|3774709|P1|Overall Study|Creatinine or eGFR withdrawal criteria|0
1149503|NCT01340664|3774707|P3|Overall Study|Glycemic withdrawal criteria|0
1149504|NCT01340664|3774708|P2|Overall Study|Glycemic withdrawal criteria|0
1149505|NCT01340664|3774709|P1|Overall Study|Glycemic withdrawal criteria|2
1149506|NCT01340664|3774707|P3|Overall Study|Withdrawal by Subject|0
1149507|NCT01340664|3774708|P2|Overall Study|Withdrawal by Subject|4
1149508|NCT01340664|3774709|P1|Overall Study|Withdrawal by Subject|2
1149509|NCT01340664|3774707|P3|Overall Study|Lost to Follow-up|2
1149510|NCT01340664|3774708|P2|Overall Study|Lost to Follow-up|0
1149511|NCT01340664|3774709|P1|Overall Study|Lost to Follow-up|2
1149512|NCT01340664|3774707|P3|Overall Study|Adverse Event|7
1149513|NCT01340664|3774708|P2|Overall Study|Adverse Event|1
1149514|NCT01340664|3774709|P1|Overall Study|Adverse Event|0
1149515|NCT01340651|3774726|P1|Overall Study|Commercial Supply per Sponsor|12
1149516|NCT01340651|3774726|P1|Overall Study|Consent Withdrawn|2
1149517|NCT01340651|3774726|P1|Overall Study|Adverse Event|3
1149518|NCT01340625|3774742|P2|Washout Period of 28 Days|Withdrawal by Subject|0
1149519|NCT01340625|3774743|P1|Washout Period of 28 Days|Withdrawal by Subject|1
1149520|NCT01340625|3774742|P2|First Intervention|Adverse Event|0
1149521|NCT01340625|3774743|P1|First Intervention|Adverse Event|1
1149522|NCT01340495|3774848|P1|Overall Study|Withdrawal by Subject|1
1149523|NCT01340300|3774859|P4|Overall Study|Unrelated sickness|1
1149524|NCT01340300|3774860|P3|Overall Study|Unrelated sickness|0
1149525|NCT01340300|3774861|P2|Overall Study|Unrelated sickness|2
1149526|NCT01340300|3774862|P1|Overall Study|Unrelated sickness|0
1149527|NCT01340300|3774859|P4|Overall Study|Physician Decision|0
1149528|NCT01340300|3774860|P3|Overall Study|Physician Decision|0
1149529|NCT01340300|3774861|P2|Overall Study|Physician Decision|1
1149530|NCT01340300|3774862|P1|Overall Study|Physician Decision|0
1149531|NCT01340300|3774859|P4|Overall Study|Adverse Event|0
1149532|NCT01340300|3774860|P3|Overall Study|Adverse Event|4
1149533|NCT01340300|3774861|P2|Overall Study|Adverse Event|0
1149534|NCT01340300|3774862|P1|Overall Study|Adverse Event|1
1149535|NCT01340300|3774859|P4|Overall Study|Withdrawal by Subject|3
1149536|NCT01340300|3774860|P3|Overall Study|Withdrawal by Subject|6
1149537|NCT01340300|3774861|P2|Overall Study|Withdrawal by Subject|6
1149538|NCT01340300|3774862|P1|Overall Study|Withdrawal by Subject|5
1149539|NCT01340300|3774859|P4|Overall Study|Lost to Follow-up|10
1149540|NCT01340300|3774860|P3|Overall Study|Lost to Follow-up|5
1149541|NCT01340300|3774861|P2|Overall Study|Lost to Follow-up|0
1149542|NCT01340300|3774862|P1|Overall Study|Lost to Follow-up|3
1149543|NCT01340209|3774895|P3|Overall Study|Other reason not defined above|4
1149544|NCT01340209|3774896|P2|Overall Study|Other reason not defined above|5
1149545|NCT01340209|3774897|P1|Overall Study|Other reason not defined above|3
1149546|NCT01340209|3774895|P3|Overall Study|Withdrawal by Subject|1
1149547|NCT01340209|3774896|P2|Overall Study|Withdrawal by Subject|0
1149548|NCT01340209|3774897|P1|Overall Study|Withdrawal by Subject|0
1149549|NCT01340209|3774895|P3|Overall Study|Protocol Violation|1
1149550|NCT01340209|3774896|P2|Overall Study|Protocol Violation|2
1149551|NCT01340209|3774897|P1|Overall Study|Protocol Violation|1
1149552|NCT01340209|3774895|P3|Overall Study|Adverse Event|2
1149553|NCT01340209|3774896|P2|Overall Study|Adverse Event|1
1149554|NCT01340209|3774897|P1|Overall Study|Adverse Event|1
1149555|NCT01340196|3774932|P1|Treat. Period 3 (Faldaprevir)|Adverse Event|2
1149556|NCT01340066|3774972|P3|5 Week Double Blind Randomization Period|Withdrawal by Subject|1
1149557|NCT01340066|3774973|P2|5 Week Double Blind Randomization Period|Withdrawal by Subject|2
1149558|NCT01340066|3774974|P1|5 Week Double Blind Randomization Period|Withdrawal by Subject|0
1149559|NCT01340066|3774972|P3|5 Week Double Blind Randomization Period|Physician Decision|0
1149560|NCT01340066|3774973|P2|5 Week Double Blind Randomization Period|Physician Decision|1
1149561|NCT01340066|3774974|P1|5 Week Double Blind Randomization Period|Physician Decision|0
1149562|NCT01340066|3774972|P3|5 Week Double Blind Randomization Period|Adverse Event|2
1149563|NCT01340066|3774973|P2|5 Week Double Blind Randomization Period|Adverse Event|2
1149564|NCT01340066|3774974|P1|5 Week Double Blind Randomization Period|Adverse Event|0
1149565|NCT01340066|3774972|P3|Placebo Run in Period|Screen Failures|0
1149566|NCT01340066|3774973|P2|Placebo Run in Period|Screen Failures|0
1149567|NCT01340066|3774974|P1|Placebo Run in Period|Screen Failures|27
1149568|NCT01340027|3774993|P12|Overall Study|Miscellaneous|0
1149569|NCT01340027|3774994|P11|Overall Study|Miscellaneous|1
1149570|NCT01340027|3774995|P10|Overall Study|Miscellaneous|0
1149571|NCT01340027|3774996|P9|Overall Study|Miscellaneous|0
1149572|NCT01340027|3774997|P8|Overall Study|Miscellaneous|0
1149573|NCT01340027|3774998|P7|Overall Study|Miscellaneous|0
1149574|NCT01340027|3774999|P6|Overall Study|Miscellaneous|0
1149575|NCT01340027|3775000|P5|Overall Study|Miscellaneous|0
1149576|NCT01340027|3775001|P4|Overall Study|Miscellaneous|1
1149577|NCT01340027|3775002|P3|Overall Study|Miscellaneous|0
1149578|NCT01340027|3775003|P2|Overall Study|Miscellaneous|0
1149579|NCT01340027|3775004|P1|Overall Study|Miscellaneous|0
1149580|NCT01340027|3774993|P12|Overall Study|Withdrawal by Subject|1
1149581|NCT01340027|3774994|P11|Overall Study|Withdrawal by Subject|0
1149582|NCT01340027|3774995|P10|Overall Study|Withdrawal by Subject|2
1149583|NCT01340027|3774996|P9|Overall Study|Withdrawal by Subject|1
1149584|NCT01340027|3774997|P8|Overall Study|Withdrawal by Subject|4
1149585|NCT01340027|3774998|P7|Overall Study|Withdrawal by Subject|3
1149586|NCT01340027|3774999|P6|Overall Study|Withdrawal by Subject|2
1149587|NCT01340027|3775000|P5|Overall Study|Withdrawal by Subject|3
1149588|NCT01340027|3775001|P4|Overall Study|Withdrawal by Subject|3
1149589|NCT01340027|3775002|P3|Overall Study|Withdrawal by Subject|1
1149590|NCT01340027|3775003|P2|Overall Study|Withdrawal by Subject|3
1149591|NCT01340027|3775004|P1|Overall Study|Withdrawal by Subject|4
1149592|NCT01340027|3774993|P12|Overall Study|Protocol Violation|0
1149593|NCT01340027|3774994|P11|Overall Study|Protocol Violation|0
1149594|NCT01340027|3774995|P10|Overall Study|Protocol Violation|2
1149595|NCT01340027|3774996|P9|Overall Study|Protocol Violation|2
1149596|NCT01340027|3774997|P8|Overall Study|Protocol Violation|1
1149597|NCT01340027|3774998|P7|Overall Study|Protocol Violation|0
1149598|NCT01340027|3774999|P6|Overall Study|Protocol Violation|0
1149599|NCT01340027|3775000|P5|Overall Study|Protocol Violation|6
1149600|NCT01340027|3775001|P4|Overall Study|Protocol Violation|0
1149601|NCT01340027|3775002|P3|Overall Study|Protocol Violation|0
1149602|NCT01340027|3775003|P2|Overall Study|Protocol Violation|2
1149603|NCT01340027|3775004|P1|Overall Study|Protocol Violation|1
1149604|NCT01340027|3774993|P12|Overall Study|Lost to Follow-up|0
1149605|NCT01340027|3774994|P11|Overall Study|Lost to Follow-up|0
1149606|NCT01340027|3774995|P10|Overall Study|Lost to Follow-up|1
1149607|NCT01340027|3774996|P9|Overall Study|Lost to Follow-up|0
1149608|NCT01340027|3774997|P8|Overall Study|Lost to Follow-up|0
1149609|NCT01340027|3774998|P7|Overall Study|Lost to Follow-up|1
1149610|NCT01340027|3774999|P6|Overall Study|Lost to Follow-up|0
1149611|NCT01340027|3775000|P5|Overall Study|Lost to Follow-up|0
1149612|NCT01340027|3775001|P4|Overall Study|Lost to Follow-up|0
1149613|NCT01340027|3775002|P3|Overall Study|Lost to Follow-up|0
1149614|NCT01340027|3775003|P2|Overall Study|Lost to Follow-up|1
1149615|NCT01340027|3775004|P1|Overall Study|Lost to Follow-up|0
1149616|NCT01340027|3774993|P12|Overall Study|Lack of Efficacy|0
1149617|NCT01340027|3774994|P11|Overall Study|Lack of Efficacy|0
1149618|NCT01340027|3774995|P10|Overall Study|Lack of Efficacy|0
1149619|NCT01340027|3774996|P9|Overall Study|Lack of Efficacy|1
1149620|NCT01340027|3774997|P8|Overall Study|Lack of Efficacy|1
1149621|NCT01340027|3774998|P7|Overall Study|Lack of Efficacy|1
1149622|NCT01340027|3774999|P6|Overall Study|Lack of Efficacy|0
1149623|NCT01340027|3775000|P5|Overall Study|Lack of Efficacy|0
1149624|NCT01340027|3775001|P4|Overall Study|Lack of Efficacy|0
1149625|NCT01340027|3775002|P3|Overall Study|Lack of Efficacy|0
1149626|NCT01340027|3775003|P2|Overall Study|Lack of Efficacy|0
1149627|NCT01340027|3775004|P1|Overall Study|Lack of Efficacy|0
1149628|NCT01340027|3774993|P12|Overall Study|Adverse Event|3
1149629|NCT01340027|3774994|P11|Overall Study|Adverse Event|1
1149630|NCT01340027|3774995|P10|Overall Study|Adverse Event|1
1149631|NCT01340027|3774996|P9|Overall Study|Adverse Event|4
1149632|NCT01340027|3774997|P8|Overall Study|Adverse Event|1
1149633|NCT01340027|3774998|P7|Overall Study|Adverse Event|2
1149634|NCT01340027|3774999|P6|Overall Study|Adverse Event|2
1149635|NCT01340027|3775000|P5|Overall Study|Adverse Event|1
1149636|NCT01340027|3775001|P4|Overall Study|Adverse Event|0
1149637|NCT01340027|3775002|P3|Overall Study|Adverse Event|2
1149638|NCT01340027|3775003|P2|Overall Study|Adverse Event|1
1149639|NCT01340027|3775004|P1|Overall Study|Adverse Event|0
1149640|NCT01340027|3774993|P12|Overall Study|Randomized but Never Received Study Drug|0
1149641|NCT01340027|3774994|P11|Overall Study|Randomized but Never Received Study Drug|0
1149642|NCT01340027|3774995|P10|Overall Study|Randomized but Never Received Study Drug|0
1149643|NCT01340027|3774996|P9|Overall Study|Randomized but Never Received Study Drug|0
1149644|NCT01340027|3774997|P8|Overall Study|Randomized but Never Received Study Drug|0
1149645|NCT01340027|3774998|P7|Overall Study|Randomized but Never Received Study Drug|0
1149646|NCT01340027|3774999|P6|Overall Study|Randomized but Never Received Study Drug|0
1149647|NCT01340027|3775000|P5|Overall Study|Randomized but Never Received Study Drug|0
1149648|NCT01340027|3775001|P4|Overall Study|Randomized but Never Received Study Drug|0
1149649|NCT01340027|3775002|P3|Overall Study|Randomized but Never Received Study Drug|1
1149650|NCT01340027|3775003|P2|Overall Study|Randomized but Never Received Study Drug|0
1149651|NCT01340027|3775004|P1|Overall Study|Randomized but Never Received Study Drug|0
1149652|NCT01340014|3775380|P2|Period 2, Second 7 Days|Adverse Event|1
1149653|NCT01340014|3775381|P1|Period 2, Second 7 Days|Adverse Event|0
1149654|NCT01340014|3775380|P2|Period 1, First 7 Days|Personal Reasons|0
1149655|NCT01340014|3775381|P1|Period 1, First 7 Days|Personal Reasons|1
1149656|NCT01340014|3775380|P2|Period 1, First 7 Days|Adverse Event|0
1149657|NCT01340014|3775381|P1|Period 1, First 7 Days|Adverse Event|1
1149658|NCT01339923|3775402|P7|Overall Study|Withdrawal by Subject|2
1149659|NCT01339923|3775403|P6|Overall Study|Withdrawal by Subject|3
1149660|NCT01339923|3775404|P5|Overall Study|Withdrawal by Subject|4
1149661|NCT01339923|3775405|P4|Overall Study|Withdrawal by Subject|1
1149662|NCT01339923|3775406|P3|Overall Study|Withdrawal by Subject|6
1149663|NCT01339923|3775407|P2|Overall Study|Withdrawal by Subject|11
1149664|NCT01339923|3775408|P1|Overall Study|Withdrawal by Subject|7
1149665|NCT01339923|3775402|P7|Overall Study|Unable to Classify|5
1149666|NCT01339923|3775403|P6|Overall Study|Unable to Classify|1
1149667|NCT01339923|3775404|P5|Overall Study|Unable to Classify|0
1149668|NCT01339923|3775405|P4|Overall Study|Unable to Classify|0
1149669|NCT01339923|3775406|P3|Overall Study|Unable to Classify|1
1149670|NCT01339923|3775407|P2|Overall Study|Unable to Classify|0
1149671|NCT01339923|3775408|P1|Overall Study|Unable to Classify|1
1149672|NCT01339923|3775402|P7|Overall Study|Protocol Violation|1
1149673|NCT01339923|3775403|P6|Overall Study|Protocol Violation|3
1149674|NCT01339923|3775404|P5|Overall Study|Protocol Violation|0
1149675|NCT01339923|3775405|P4|Overall Study|Protocol Violation|0
1149676|NCT01339923|3775406|P3|Overall Study|Protocol Violation|0
1149677|NCT01339923|3775407|P2|Overall Study|Protocol Violation|0
1149678|NCT01339923|3775408|P1|Overall Study|Protocol Violation|0
1149679|NCT01339923|3775402|P7|Overall Study|Lost to Follow-up|5
1149680|NCT01339923|3775403|P6|Overall Study|Lost to Follow-up|1
1149681|NCT01339923|3775404|P5|Overall Study|Lost to Follow-up|1
1149682|NCT01339923|3775405|P4|Overall Study|Lost to Follow-up|3
1149683|NCT01339923|3775406|P3|Overall Study|Lost to Follow-up|0
1149684|NCT01339923|3775407|P2|Overall Study|Lost to Follow-up|4
1149685|NCT01339923|3775408|P1|Overall Study|Lost to Follow-up|4
1149686|NCT01339923|3775402|P7|Overall Study|Inappropriate Enrollment|0
1149687|NCT01339923|3775403|P6|Overall Study|Inappropriate Enrollment|1
1149688|NCT01339923|3775404|P5|Overall Study|Inappropriate Enrollment|0
1149689|NCT01339923|3775405|P4|Overall Study|Inappropriate Enrollment|0
1149690|NCT01339923|3775406|P3|Overall Study|Inappropriate Enrollment|0
1149691|NCT01339923|3775407|P2|Overall Study|Inappropriate Enrollment|0
1149692|NCT01339923|3775408|P1|Overall Study|Inappropriate Enrollment|1
1149693|NCT01339923|3775402|P7|Overall Study|Adverse Event|1
1149694|NCT01339923|3775403|P6|Overall Study|Adverse Event|0
1149695|NCT01339923|3775404|P5|Overall Study|Adverse Event|0
1149696|NCT01339923|3775405|P4|Overall Study|Adverse Event|0
1149697|NCT01339923|3775406|P3|Overall Study|Adverse Event|1
1149698|NCT01339923|3775407|P2|Overall Study|Adverse Event|1
1149699|NCT01339923|3775408|P1|Overall Study|Adverse Event|1
1149700|NCT01339910|3775479|P2|Overall Study|Disease relapse|4
1149701|NCT01339910|3775480|P1|Overall Study|Disease relapse|1
1149702|NCT01339910|3775479|P2|Overall Study|Physician Decision|0
1149703|NCT01339910|3775480|P1|Overall Study|Physician Decision|1
1149704|NCT01339910|3775479|P2|Overall Study|Withdrawal by Subject|0
1149705|NCT01339910|3775480|P1|Overall Study|Withdrawal by Subject|1
1149706|NCT01339897|3775518|P4|Overall Study|Adverse Event|1
1149707|NCT01339897|3775519|P3|Overall Study|Adverse Event|0
1149708|NCT01339897|3775520|P2|Overall Study|Adverse Event|0
1149709|NCT01339897|3775521|P1|Overall Study|Adverse Event|1
1149710|NCT01339832|3775547|P1|Overall Study|Death|11
1149711|NCT01339832|3775547|P1|Overall Study|Lost to Follow-up|3
1149712|NCT01339429|3775558|P1|Overall Study|Physician Decision|3
1149713|NCT01339429|3775558|P1|Overall Study|Withdrawal by Subject|1
1149714|NCT01339390|3775598|P2|Overall Study|Lost to Follow-up|127
1149715|NCT01339390|3775599|P1|Overall Study|Lost to Follow-up|125
1149716|NCT01339390|3775598|P2|Overall Study|Death|29
1149717|NCT01339390|3775599|P1|Overall Study|Death|32
1149718|NCT01339052|3775657|P2|Overall Study|Physician Decision|0
1149719|NCT01339052|3775658|P1|Overall Study|Physician Decision|1
1149720|NCT01339052|3775657|P2|Overall Study|Withdrawal by Subject|3
1149721|NCT01339052|3775658|P1|Overall Study|Withdrawal by Subject|0
1149722|NCT01339052|3775657|P2|Overall Study|Adverse Event|1
1149723|NCT01339052|3775658|P1|Overall Study|Adverse Event|1
1149724|NCT01339052|3775657|P2|Overall Study|Disease progression|46
1149725|NCT01339052|3775658|P1|Overall Study|Disease progression|13
1149726|NCT01339000|3775684|P2|Overall Study|study closed due to lack of drug supply|0
1149727|NCT01339000|3775685|P1|Overall Study|study closed due to lack of drug supply|1
1149728|NCT01338870|3775705|P6|Overall Study|Adverse Event|1
1149729|NCT01338870|3775706|P5|Overall Study|Adverse Event|4
1149730|NCT01338870|3775707|P4|Overall Study|Adverse Event|5
1149731|NCT01338870|3775708|P3|Overall Study|Adverse Event|1
1149732|NCT01338870|3775709|P2|Overall Study|Adverse Event|4
1149733|NCT01338870|3775710|P1|Overall Study|Adverse Event|4
1149734|NCT01338870|3775705|P6|Overall Study|Protocol Violation|1
1149735|NCT01338870|3775706|P5|Overall Study|Protocol Violation|1
1149736|NCT01338870|3775707|P4|Overall Study|Protocol Violation|2
1149737|NCT01338870|3775708|P3|Overall Study|Protocol Violation|2
1149738|NCT01338870|3775709|P2|Overall Study|Protocol Violation|2
1149739|NCT01338870|3775710|P1|Overall Study|Protocol Violation|0
1149740|NCT01338870|3775705|P6|Overall Study|Other|2
1149741|NCT01338870|3775706|P5|Overall Study|Other|0
1149742|NCT01338870|3775707|P4|Overall Study|Other|2
1149743|NCT01338870|3775708|P3|Overall Study|Other|3
1149744|NCT01338870|3775709|P2|Overall Study|Other|3
1149745|NCT01338870|3775710|P1|Overall Study|Other|3
1149746|NCT01338870|3775705|P6|Overall Study|Withdrawal by Subject|2
1149747|NCT01338870|3775706|P5|Overall Study|Withdrawal by Subject|0
1149748|NCT01338870|3775707|P4|Overall Study|Withdrawal by Subject|0
1149749|NCT01338870|3775708|P3|Overall Study|Withdrawal by Subject|4
1149750|NCT01338870|3775709|P2|Overall Study|Withdrawal by Subject|3
1149751|NCT01338870|3775710|P1|Overall Study|Withdrawal by Subject|2
1149752|NCT01338870|3775705|P6|Overall Study|Lost to Follow-up|0
1149753|NCT01338870|3775706|P5|Overall Study|Lost to Follow-up|1
1149754|NCT01338870|3775707|P4|Overall Study|Lost to Follow-up|0
1149755|NCT01338870|3775708|P3|Overall Study|Lost to Follow-up|1
1149756|NCT01338870|3775709|P2|Overall Study|Lost to Follow-up|0
1149757|NCT01338870|3775710|P1|Overall Study|Lost to Follow-up|0
1149758|NCT01338818|3775765|P1|Overall Study|Protocol Deviation|4
1149759|NCT01338818|3775765|P1|Overall Study|Administrative problems|3
1149760|NCT01338818|3775765|P1|Overall Study|Lost to Follow-up|4
1149761|NCT01338818|3775765|P1|Overall Study|Withdrawal by Subject|11
1149762|NCT01338818|3775765|P1|Overall Study|no longer require study drug|1
1149763|NCT01338818|3775765|P1|Overall Study|Lack of Efficacy|5
1149764|NCT01338818|3775765|P1|Overall Study|Adverse Event|8
1149765|NCT01338792|3775771|P1|Overall Study|Withdrawal by Subject|1
1149766|NCT01338792|3775771|P1|Overall Study|Death|1
1149767|NCT01338792|3775771|P1|Overall Study|Adverse Event|2
1149768|NCT01338636|3775786|P1|Overall Study|Withdrawn due to lack of improvement|8
1149769|NCT01338610|3775800|P3|Overall Study|Adverse Event|0
1149770|NCT01338610|3775801|P2|Overall Study|Adverse Event|0
1149771|NCT01338610|3775802|P1|Overall Study|Adverse Event|3
1149772|NCT01338610|3775800|P3|Overall Study|Protocol Violation|1
1149773|NCT01338610|3775801|P2|Overall Study|Protocol Violation|0
1149774|NCT01338610|3775802|P1|Overall Study|Protocol Violation|1
1149775|NCT01338610|3775800|P3|Overall Study|Patient Decision Unrelated to Advs Event|0
1149776|NCT01338610|3775801|P2|Overall Study|Patient Decision Unrelated to Advs Event|1
1149777|NCT01338610|3775802|P1|Overall Study|Patient Decision Unrelated to Advs Event|1
1149778|NCT01338493|3775809|P1|12 Months Follow up|Lost to Follow-up|9
1149779|NCT01338493|3775809|P1|6 Months Follow up|Missed visit|8
1149780|NCT01338493|3775809|P1|6 Months Follow up|Lost to Follow-up|11
1149781|NCT01338493|3775809|P1|Discharge|Missed visit|1
1149782|NCT01338493|3775809|P1|Discharge|Death|1
1149783|NCT01338493|3775809|P1|Enrolled|Patient not implanted|4
1149784|NCT01338493|3775809|P1|Enrolled|Withdrawal by Subject|1
1149785|NCT01338415|3775816|P2|Overall Study|Other (administrative reason)|0
1149786|NCT01338415|3775817|P1|Overall Study|Other (administrative reason)|1
1149787|NCT01338415|3775816|P2|Overall Study|Other (PAH not the main etiology of PH)|2
1149788|NCT01338415|3775817|P1|Overall Study|Other (PAH not the main etiology of PH)|0
1149789|NCT01338415|3775816|P2|Overall Study|Withdrawal by Subject|1
1149790|NCT01338415|3775817|P1|Overall Study|Withdrawal by Subject|1
1149791|NCT01338415|3775816|P2|Overall Study|Adverse Event|6
1149792|NCT01338415|3775817|P1|Overall Study|Adverse Event|8
1149793|NCT01338298|3775839|P2|Overall Study|Non-adherence|0
1149794|NCT01338298|3775840|P1|Overall Study|Non-adherence|1
1149795|NCT01338298|3775839|P2|Overall Study|Depressive symptoms and nausea|0
1149796|NCT01338298|3775840|P1|Overall Study|Depressive symptoms and nausea|1
1149797|NCT01338298|3775839|P2|Overall Study|Positive symptom worsening|0
1149798|NCT01338298|3775840|P1|Overall Study|Positive symptom worsening|1
1149799|NCT01338298|3775839|P2|Overall Study|Administrative error|1
1149800|NCT01338298|3775840|P1|Overall Study|Administrative error|0
1149801|NCT01338298|3775839|P2|Overall Study|Abdominal Pain and scheduled surgery|1
1149802|NCT01338298|3775840|P1|Overall Study|Abdominal Pain and scheduled surgery|0
1149803|NCT01338298|3775839|P2|Overall Study|Withdrawal by Subject|1
1149804|NCT01338298|3775840|P1|Overall Study|Withdrawal by Subject|1
1149805|NCT01338025|3775850|P2|Overall Study|Found ineligible after starting|0
1149806|NCT01338025|3775851|P1|Overall Study|Found ineligible after starting|1
1149807|NCT01338025|3775850|P2|Overall Study|Withdrawal by Subject|2
1149808|NCT01338025|3775851|P1|Overall Study|Withdrawal by Subject|0
1149809|NCT01338025|3775850|P2|Overall Study|Unexpected closure of study|9
1149810|NCT01338025|3775851|P1|Overall Study|Unexpected closure of study|10
1149811|NCT01338012|3775863|P1|Overall Study|Study terminated|4
1149812|NCT01338012|3775863|P1|Overall Study|Death|4
1149813|NCT01337960|3775870|P3|Overall Study|Withdrawal by Subject|0
1149814|NCT01337960|3775871|P2|Overall Study|Withdrawal by Subject|0
1149815|NCT01337960|3775872|P1|Overall Study|Withdrawal by Subject|1
1149816|NCT01337960|3775870|P3|Overall Study|Lost to Follow-up|0
1149817|NCT01337960|3775871|P2|Overall Study|Lost to Follow-up|0
1149818|NCT01337960|3775872|P1|Overall Study|Lost to Follow-up|1
1149819|NCT01337674|3775905|P4|Treatment Period 2|Withdrawal by Subject|0
1149820|NCT01337674|3775906|P3|Treatment Period 2|Withdrawal by Subject|1
1149821|NCT01337674|3775907|P2|Treatment Period 2|Withdrawal by Subject|0
1149822|NCT01337674|3775908|P1|Treatment Period 2|Withdrawal by Subject|0
1149823|NCT01337674|3775905|P4|Treatment Period 1|Discontinued due to blood draws|1
1149824|NCT01337674|3775906|P3|Treatment Period 1|Discontinued due to blood draws|0
1149825|NCT01337674|3775907|P2|Treatment Period 1|Discontinued due to blood draws|0
1149826|NCT01337674|3775908|P1|Treatment Period 1|Discontinued due to blood draws|0
1149827|NCT01337674|3775905|P4|Treatment Period 1|Adverse Event|0
1149828|NCT01337674|3775906|P3|Treatment Period 1|Adverse Event|0
1149829|NCT01337674|3775907|P2|Treatment Period 1|Adverse Event|1
1149830|NCT01337674|3775908|P1|Treatment Period 1|Adverse Event|0
1149831|NCT01337635|3775926|P2|Overall Study|Lost to Follow-up|1
1149832|NCT01337635|3775927|P1|Overall Study|Lost to Follow-up|0
1149833|NCT01337297|3775977|P2|Overall Study|Lost to Follow-up|3
1149834|NCT01337297|3775978|P1|Overall Study|Lost to Follow-up|1
1149835|NCT01337297|3775977|P2|Overall Study|They entered to single anodal tDCS|3
1149836|NCT01337297|3775978|P1|Overall Study|They entered to single anodal tDCS|4
1149837|NCT01337167|3775986|P2|Toddler Vaccinations|Withdrawal by Subject|0
1149838|NCT01337167|3775987|P1|Toddler Vaccinations|Withdrawal by Subject|3
1149839|NCT01337167|3775986|P2|Toddler Vaccinations|Protocol Violation|1
1149840|NCT01337167|3775987|P1|Toddler Vaccinations|Protocol Violation|0
1149841|NCT01337167|3775986|P2|Toddler Vaccinations|Lost to Follow-up|12
1149842|NCT01337167|3775987|P1|Toddler Vaccinations|Lost to Follow-up|11
1149843|NCT01337167|3775986|P2|Interim Period|Other protocol criterion not met|1
1149844|NCT01337167|3775987|P1|Interim Period|Other protocol criterion not met|0
1149845|NCT01337167|3775986|P2|Interim Period|Withdrawal by Subject|10
1149846|NCT01337167|3775987|P1|Interim Period|Withdrawal by Subject|18
1149847|NCT01337167|3775986|P2|Interim Period|Protocol Violation|3
1149848|NCT01337167|3775987|P1|Interim Period|Protocol Violation|5
1149849|NCT01337167|3775986|P2|Interim Period|Physician Decision|3
1149850|NCT01337167|3775987|P1|Interim Period|Physician Decision|6
1149851|NCT01337167|3775986|P2|Interim Period|Non-compliance with study drug|0
1149852|NCT01337167|3775987|P1|Interim Period|Non-compliance with study drug|1
1149853|NCT01337167|3775986|P2|Interim Period|Lost to Follow-up|23
1149854|NCT01337167|3775987|P1|Interim Period|Lost to Follow-up|51
1149855|NCT01337167|3775986|P2|Infant Series|Randomized but not vaccinated|3
1149856|NCT01337167|3775987|P1|Infant Series|Randomized but not vaccinated|5
1149857|NCT01337167|3775986|P2|Infant Series|Withdrawal by Subject|4
1149858|NCT01337167|3775987|P1|Infant Series|Withdrawal by Subject|15
1149859|NCT01337167|3775986|P2|Infant Series|Protocol Violation|9
1149860|NCT01337167|3775987|P1|Infant Series|Protocol Violation|22
1149861|NCT01337167|3775986|P2|Infant Series|Physician Decision|1
1149862|NCT01337167|3775987|P1|Infant Series|Physician Decision|3
1149863|NCT01337167|3775986|P2|Infant Series|Non-compliance with study drug|1
1149864|NCT01337167|3775987|P1|Infant Series|Non-compliance with study drug|2
1149865|NCT01337167|3775986|P2|Infant Series|Lost to Follow-up|7
1149866|NCT01337167|3775987|P1|Infant Series|Lost to Follow-up|13
1149867|NCT01337167|3775986|P2|Infant Series|Death|1
1149868|NCT01337167|3775987|P1|Infant Series|Death|1
1149869|NCT01337167|3775986|P2|Infant Series|Adverse Event|1
1149870|NCT01337167|3775987|P1|Infant Series|Adverse Event|1
1149871|NCT01337115|3776055|P2|Overall Study|Protocol Violation|0
1149872|NCT01337115|3776056|P1|Overall Study|Protocol Violation|2
1149873|NCT01337089|3776068|P1|Overall Study|Lost to Follow-up|2
1149874|NCT01337089|3776068|P1|Overall Study|Met Withdrawal Criteria|3
1149875|NCT01337089|3776068|P1|Overall Study|Withdrawal by Investigator|33
1149876|NCT01337089|3776068|P1|Overall Study|Withdrawal by Subject|129
1149877|NCT01337089|3776068|P1|Overall Study|Adverse Event|237
1149878|NCT01337050|3776083|P3|Overall Study|Participants refused further follow-up|7
1149879|NCT01337050|3776084|P2|Overall Study|Participants refused further follow-up|7
1149880|NCT01337050|3776085|P1|Overall Study|Participants refused further follow-up|0
1149881|NCT01337050|3776083|P3|Overall Study|Other|8
1149882|NCT01337050|3776084|P2|Overall Study|Other|6
1149883|NCT01337050|3776085|P1|Overall Study|Other|4
1149884|NCT01337050|3776083|P3|Overall Study|Death|4
1149885|NCT01337050|3776084|P2|Overall Study|Death|0
1149886|NCT01337050|3776085|P1|Overall Study|Death|0
1149887|NCT01336972|3776146|P3|Overall Study|Adverse Event|0
1149888|NCT01336972|3776147|P2|Overall Study|Adverse Event|1
1149889|NCT01336972|3776148|P1|Overall Study|Adverse Event|1
1149890|NCT01336894|3776210|P2|Follow-up|Study terminated prematurely|7
1149891|NCT01336894|3776211|P1|Follow-up|Study terminated prematurely|2
1149892|NCT01336764|3776231|P2|Overall Study|Withdrawal by Subject|5
1149893|NCT01336764|3776232|P1|Overall Study|Withdrawal by Subject|5
1149894|NCT01336738|3776243|P5|Overall Study|Other|4
1149895|NCT01336738|3776244|P4|Overall Study|Other|3
1149896|NCT01336738|3776245|P3|Overall Study|Other|2
1149897|NCT01336738|3776246|P2|Overall Study|Other|3
1149898|NCT01336738|3776247|P1|Overall Study|Other|3
1149899|NCT01336738|3776243|P5|Overall Study|Withdrawal by Subject|1
1149900|NCT01336738|3776244|P4|Overall Study|Withdrawal by Subject|1
1149901|NCT01336738|3776245|P3|Overall Study|Withdrawal by Subject|2
1149902|NCT01336738|3776246|P2|Overall Study|Withdrawal by Subject|0
1149903|NCT01336738|3776247|P1|Overall Study|Withdrawal by Subject|2
1149904|NCT01336738|3776243|P5|Overall Study|Protocol Violation|0
1149905|NCT01336738|3776244|P4|Overall Study|Protocol Violation|0
1149906|NCT01336738|3776245|P3|Overall Study|Protocol Violation|0
1149907|NCT01336738|3776246|P2|Overall Study|Protocol Violation|1
1149908|NCT01336738|3776247|P1|Overall Study|Protocol Violation|0
1149909|NCT01336738|3776243|P5|Overall Study|Did not meet entrance criteria|0
1149910|NCT01336738|3776244|P4|Overall Study|Did not meet entrance criteria|0
1149911|NCT01336738|3776245|P3|Overall Study|Did not meet entrance criteria|0
1149912|NCT01336738|3776246|P2|Overall Study|Did not meet entrance criteria|1
1149913|NCT01336738|3776247|P1|Overall Study|Did not meet entrance criteria|0
1149914|NCT01336738|3776243|P5|Overall Study|Lost to Follow-up|2
1149915|NCT01336738|3776244|P4|Overall Study|Lost to Follow-up|2
1149916|NCT01336738|3776245|P3|Overall Study|Lost to Follow-up|2
1149917|NCT01336738|3776246|P2|Overall Study|Lost to Follow-up|1
1149918|NCT01336738|3776247|P1|Overall Study|Lost to Follow-up|2
1149919|NCT01336738|3776243|P5|Overall Study|Adverse Event|3
1149920|NCT01336738|3776244|P4|Overall Study|Adverse Event|1
1149921|NCT01336738|3776245|P3|Overall Study|Adverse Event|2
1149922|NCT01336738|3776246|P2|Overall Study|Adverse Event|3
1149923|NCT01336738|3776247|P1|Overall Study|Adverse Event|0
1149924|NCT01336712|3776289|P1|Overall Study|Lack of Efficacy|1
1149925|NCT01336712|3776289|P1|Overall Study|Death|2
1149926|NCT01336647|3776302|P3|Overall Study|Lost to Follow-up|3
1149927|NCT01336647|3776303|P2|Overall Study|Lost to Follow-up|1
1149928|NCT01336647|3776304|P1|Overall Study|Lost to Follow-up|4
1149929|NCT01336634|3776318|P3|Overall Study|Ongoing|24
1149930|NCT01336634|3776319|P2|Overall Study|Ongoing|22
1149931|NCT01336634|3776320|P1|Overall Study|Ongoing|15
1149932|NCT01336634|3776318|P3|Overall Study|Physician Decision|0
1149933|NCT01336634|3776319|P2|Overall Study|Physician Decision|1
1149934|NCT01336634|3776320|P1|Overall Study|Physician Decision|1
1149935|NCT01336634|3776318|P3|Overall Study|Withdrawal by Subject|1
1149936|NCT01336634|3776319|P2|Overall Study|Withdrawal by Subject|0
1149937|NCT01336634|3776320|P1|Overall Study|Withdrawal by Subject|6
1149938|NCT01336634|3776318|P3|Overall Study|Lost to Follow-up|1
1149939|NCT01336634|3776319|P2|Overall Study|Lost to Follow-up|1
1149940|NCT01336634|3776320|P1|Overall Study|Lost to Follow-up|2
1149941|NCT01336634|3776318|P3|Overall Study|Death|10
1149942|NCT01336634|3776319|P2|Overall Study|Death|33
1149943|NCT01336634|3776320|P1|Overall Study|Death|60
1149944|NCT01336621|3776361|P1|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3
1149945|NCT01336621|3776361|P1|SFUCP (up to 2.6 Years)|Physician Decision|1
1149946|NCT01336621|3776361|P1|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3
1149947|NCT01336621|3776361|P1|SFUCP (up to 2.6 Years)|Adverse Event|1
1149948|NCT01336621|3776361|P1|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1
1149949|NCT01336621|3776361|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9
1149950|NCT01336621|3776361|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2
1149951|NCT01336621|3776361|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22
1149952|NCT01336621|3776361|P1|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2
1149953|NCT01336621|3776361|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11
1149954|NCT01336621|3776361|P1|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27
1149955|NCT01336621|3776361|P1|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12
1149956|NCT01336621|3776361|P1|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2
1149957|NCT01336621|3776361|P1|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11
1149958|NCT01336608|3776411|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|1
1149959|NCT01336608|3776412|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|4
1149960|NCT01336608|3776413|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
1149961|NCT01336608|3776414|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
1149962|NCT01336608|3776411|P4|24-week, Double-blind Treatment Period|Physician Decision|1
1149963|NCT01336608|3776412|P3|24-week, Double-blind Treatment Period|Physician Decision|1
1149964|NCT01336608|3776413|P2|24-week, Double-blind Treatment Period|Physician Decision|3
1149965|NCT01336608|3776414|P1|24-week, Double-blind Treatment Period|Physician Decision|0
1149966|NCT01336608|3776411|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|0
1149967|NCT01336608|3776412|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
1149968|NCT01336608|3776413|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|3
1149969|NCT01336608|3776414|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
1149970|NCT01336608|3776411|P4|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6
1149971|NCT01336608|3776412|P3|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3
1149972|NCT01336608|3776413|P2|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
1149973|NCT01336608|3776414|P1|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
1149974|NCT01336608|3776411|P4|24-week, Double-blind Treatment Period|Protocol Violation|3
1149975|NCT01336608|3776412|P3|24-week, Double-blind Treatment Period|Protocol Violation|3
1149976|NCT01336608|3776413|P2|24-week, Double-blind Treatment Period|Protocol Violation|4
1149977|NCT01336608|3776414|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
1149978|NCT01336608|3776411|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6
1149979|NCT01336608|3776412|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
1149980|NCT01336608|3776413|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
1149981|NCT01336608|3776414|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
1149982|NCT01336608|3776411|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
1149983|NCT01336608|3776412|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
1149984|NCT01336608|3776413|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
1149985|NCT01336608|3776414|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
1149986|NCT01336608|3776411|P4|24-week, Double-blind Treatment Period|Adverse Event|7
1149987|NCT01336608|3776412|P3|24-week, Double-blind Treatment Period|Adverse Event|6
1149988|NCT01336608|3776413|P2|24-week, Double-blind Treatment Period|Adverse Event|8
1149989|NCT01336608|3776414|P1|24-week, Double-blind Treatment Period|Adverse Event|0
1149990|NCT01336608|3776411|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1149991|NCT01336608|3776412|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1149992|NCT01336608|3776413|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1149993|NCT01336608|3776414|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|2
1149994|NCT01336608|3776411|P4|2-week, Single-blind Run-In Period|Physician Decision|0
1149995|NCT01336608|3776412|P3|2-week, Single-blind Run-In Period|Physician Decision|0
1149996|NCT01336608|3776413|P2|2-week, Single-blind Run-In Period|Physician Decision|0
1149997|NCT01336608|3776414|P1|2-week, Single-blind Run-In Period|Physician Decision|1
1149998|NCT01336608|3776411|P4|2-week, Single-blind Run-In Period|Adverse Event|0
1149999|NCT01336608|3776412|P3|2-week, Single-blind Run-In Period|Adverse Event|0
1150000|NCT01336608|3776413|P2|2-week, Single-blind Run-In Period|Adverse Event|0
1150001|NCT01336608|3776414|P1|2-week, Single-blind Run-In Period|Adverse Event|1
1150002|NCT01336608|3776411|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1150003|NCT01336608|3776412|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1150004|NCT01336608|3776413|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1150005|NCT01336608|3776414|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|9
1150006|NCT01336608|3776411|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1150007|NCT01336608|3776412|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1150008|NCT01336608|3776413|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1150009|NCT01336608|3776414|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102
1150010|NCT01336569|3776428|P1|Overall Study|Lost to Follow-up|4
1150011|NCT01336205|3776470|P2|Overall Study|Did not receive treatment|0
1150012|NCT01336205|3776471|P1|Overall Study|Did not receive treatment|4
1150013|NCT01336205|3776470|P2|Overall Study|Withdrawal by Subject|38
1150014|NCT01336205|3776471|P1|Overall Study|Withdrawal by Subject|72
1150015|NCT01336205|3776470|P2|Overall Study|Eligibility Criteria Not Fulfilled|6
1150016|NCT01336205|3776471|P1|Overall Study|Eligibility Criteria Not Fulfilled|9
1150017|NCT01336205|3776470|P2|Overall Study|Death|1
1150018|NCT01336205|3776471|P1|Overall Study|Death|1
1150019|NCT01336205|3776470|P2|Overall Study|Adverse Event|6
1150020|NCT01336205|3776471|P1|Overall Study|Adverse Event|56
1150021|NCT01336205|3776470|P2|Overall Study|Severe noncompliance with protocol|2
1150022|NCT01336205|3776471|P1|Overall Study|Severe noncompliance with protocol|9
1150023|NCT01336205|3776470|P2|Overall Study|Lack of Efficacy|0
1150024|NCT01336205|3776471|P1|Overall Study|Lack of Efficacy|4
1150025|NCT01336205|3776470|P2|Overall Study|Study-Specific Withdrawal Criteria|7
1150026|NCT01336205|3776471|P1|Overall Study|Study-Specific Withdrawal Criteria|16
1150027|NCT01336205|3776470|P2|Overall Study|Lost to Follow-up|20
1150028|NCT01336205|3776471|P1|Overall Study|Lost to Follow-up|40
1150029|NCT01336205|3776470|P2|Overall Study|Other|9
1150030|NCT01336205|3776471|P1|Overall Study|Other|22
1150031|NCT01336023|3776499|P3|Week 27 to 52|Unclassified|9
1150032|NCT01336023|3776500|P2|Week 27 to 52|Unclassified|18
1150033|NCT01336023|3776501|P1|Week 27 to 52|Unclassified|13
1150034|NCT01336023|3776499|P3|Week 27 to 52|Withdrawal Criteria|16
1150035|NCT01336023|3776500|P2|Week 27 to 52|Withdrawal Criteria|19
1150036|NCT01336023|3776501|P1|Week 27 to 52|Withdrawal Criteria|14
1150037|NCT01336023|3776499|P3|Week 27 to 52|Protocol Violation|1
1150038|NCT01336023|3776500|P2|Week 27 to 52|Protocol Violation|2
1150039|NCT01336023|3776501|P1|Week 27 to 52|Protocol Violation|0
1150040|NCT01336023|3776499|P3|Week 27 to 52|Adverse Event|2
1150041|NCT01336023|3776500|P2|Week 27 to 52|Adverse Event|5
1150042|NCT01336023|3776501|P1|Week 27 to 52|Adverse Event|1
1150043|NCT01336023|3776499|P3|Week 0 to Week 26|Unclassified|9
1150044|NCT01336023|3776500|P2|Week 0 to Week 26|Unclassified|16
1150045|NCT01336023|3776501|P1|Week 0 to Week 26|Unclassified|5
1150046|NCT01336023|3776499|P3|Week 0 to Week 26|Withdrawal Criteria|40
1150047|NCT01336023|3776500|P2|Week 0 to Week 26|Withdrawal Criteria|69
1150048|NCT01336023|3776501|P1|Week 0 to Week 26|Withdrawal Criteria|34
1150049|NCT01336023|3776499|P3|Week 0 to Week 26|Protocol Violation|0
1150050|NCT01336023|3776500|P2|Week 0 to Week 26|Protocol Violation|2
1150051|NCT01336023|3776501|P1|Week 0 to Week 26|Protocol Violation|1
1150052|NCT01336023|3776499|P3|Week 0 to Week 26|Lack of Efficacy|0
1150053|NCT01336023|3776500|P2|Week 0 to Week 26|Lack of Efficacy|1
1150054|NCT01336023|3776501|P1|Week 0 to Week 26|Lack of Efficacy|0
1150055|NCT01336023|3776499|P3|Week 0 to Week 26|Adverse Event|24
1150056|NCT01336023|3776500|P2|Week 0 to Week 26|Adverse Event|10
1150057|NCT01336023|3776501|P1|Week 0 to Week 26|Adverse Event|8
1150058|NCT01335997|3776522|P2|Period III|Lost to Follow-up|0
1150059|NCT01335997|3776523|P1|Period III|Lost to Follow-up|1
1150060|NCT01335997|3776522|P2|Period III|Protocol Violation|1
1150061|NCT01335997|3776523|P1|Period III|Protocol Violation|0
1150062|NCT01335997|3776522|P2|Period III|Study Terminated by Sponsor|76
1150063|NCT01335997|3776523|P1|Period III|Study Terminated by Sponsor|77
1150064|NCT01335997|3776522|P2|Period III|Adverse Event|2
1150065|NCT01335997|3776523|P1|Period III|Adverse Event|0
1150066|NCT01335997|3776522|P2|Period I and II|Physician Decision|1
1150067|NCT01335997|3776523|P1|Period I and II|Physician Decision|2
1150068|NCT01335997|3776522|P2|Period I and II|Protocol Violation|10
1150069|NCT01335997|3776523|P1|Period I and II|Protocol Violation|9
1150070|NCT01335997|3776522|P2|Period I and II|Study Terminated by Sponsor|415
1150071|NCT01335997|3776523|P1|Period I and II|Study Terminated by Sponsor|406
1150072|NCT01335997|3776522|P2|Period I and II|Withdrawal by Subject|4
1150073|NCT01335997|3776523|P1|Period I and II|Withdrawal by Subject|9
1150074|NCT01335997|3776522|P2|Period I and II|Lost to Follow-up|5
1150075|NCT01335997|3776523|P1|Period I and II|Lost to Follow-up|3
1150076|NCT01335997|3776522|P2|Period I and II|Noncompliance with Study Drug|1
1150077|NCT01335997|3776523|P1|Period I and II|Noncompliance with Study Drug|1
1150078|NCT01335997|3776522|P2|Period I and II|Adverse Event|43
1150079|NCT01335997|3776523|P1|Period I and II|Adverse Event|63
1150080|NCT01335971|3776536|P3|Overall Study|Did not complete bronchoscopy|1
1150081|NCT01335971|3776537|P2|Overall Study|Did not complete bronchoscopy|1
1150082|NCT01335971|3776538|P1|Overall Study|Did not complete bronchoscopy|1
1150083|NCT01335971|3776536|P3|Overall Study|Withdrawal by Subject|0
1150084|NCT01335971|3776537|P2|Overall Study|Withdrawal by Subject|0
1150085|NCT01335971|3776538|P1|Overall Study|Withdrawal by Subject|1
1150086|NCT01335698|3776775|P5|Treatment Stage 2|Switched to another formulation|0
1150087|NCT01335698|3776776|P4|Treatment Stage 2|Switched to another formulation|0
1150088|NCT01335698|3776777|P3|Treatment Stage 2|Switched to another formulation|0
1150089|NCT01335698|3776778|P2|Treatment Stage 2|Switched to another formulation|1
1150090|NCT01335698|3776779|P1|Treatment Stage 2|Switched to another formulation|1
1150091|NCT01335698|3776775|P5|Treatment Stage 2|Subject no longer meets study criteria|0
1150092|NCT01335698|3776776|P4|Treatment Stage 2|Subject no longer meets study criteria|1
1150093|NCT01335698|3776777|P3|Treatment Stage 2|Subject no longer meets study criteria|0
1150094|NCT01335698|3776778|P2|Treatment Stage 2|Subject no longer meets study criteria|0
1150095|NCT01335698|3776779|P1|Treatment Stage 2|Subject no longer meets study criteria|0
1150096|NCT01335698|3776775|P5|Treatment Stage 2|Capsules received at state hospital|0
1150097|NCT01335698|3776776|P4|Treatment Stage 2|Capsules received at state hospital|0
1150098|NCT01335698|3776777|P3|Treatment Stage 2|Capsules received at state hospital|0
1150099|NCT01335698|3776778|P2|Treatment Stage 2|Capsules received at state hospital|0
1150100|NCT01335698|3776779|P1|Treatment Stage 2|Capsules received at state hospital|1
1150101|NCT01335698|3776775|P5|Treatment Stage 2|Lost to Follow-up|0
1150102|NCT01335698|3776776|P4|Treatment Stage 2|Lost to Follow-up|0
1150103|NCT01335698|3776777|P3|Treatment Stage 2|Lost to Follow-up|0
1150104|NCT01335698|3776778|P2|Treatment Stage 2|Lost to Follow-up|0
1150105|NCT01335698|3776779|P1|Treatment Stage 2|Lost to Follow-up|1
1150106|NCT01335698|3776775|P5|Treatment Stage 2|Poor compliance/noncompliance|1
1150107|NCT01335698|3776776|P4|Treatment Stage 2|Poor compliance/noncompliance|3
1150108|NCT01335698|3776777|P3|Treatment Stage 2|Poor compliance/noncompliance|1
1150109|NCT01335698|3776778|P2|Treatment Stage 2|Poor compliance/noncompliance|0
1150110|NCT01335698|3776779|P1|Treatment Stage 2|Poor compliance/noncompliance|1
1150111|NCT01335698|3776775|P5|Treatment Stage 2|Withdrawal by Subject|0
1150112|NCT01335698|3776776|P4|Treatment Stage 2|Withdrawal by Subject|0
1150113|NCT01335698|3776777|P3|Treatment Stage 2|Withdrawal by Subject|1
1150114|NCT01335698|3776778|P2|Treatment Stage 2|Withdrawal by Subject|1
1150115|NCT01335698|3776779|P1|Treatment Stage 2|Withdrawal by Subject|3
1150116|NCT01335698|3776775|P5|Treatment Stage 2|Adverse Event|0
1150117|NCT01335698|3776776|P4|Treatment Stage 2|Adverse Event|3
1150118|NCT01335698|3776777|P3|Treatment Stage 2|Adverse Event|0
1150119|NCT01335698|3776778|P2|Treatment Stage 2|Adverse Event|0
1150120|NCT01335698|3776779|P1|Treatment Stage 2|Adverse Event|2
1150121|NCT01335698|3776775|P5|Treatment Stage 2|Lack of Efficacy|0
1150122|NCT01335698|3776776|P4|Treatment Stage 2|Lack of Efficacy|1
1150123|NCT01335698|3776777|P3|Treatment Stage 2|Lack of Efficacy|3
1150124|NCT01335698|3776778|P2|Treatment Stage 2|Lack of Efficacy|1
1150125|NCT01335698|3776779|P1|Treatment Stage 2|Lack of Efficacy|2
1150126|NCT01335698|3776775|P5|Treatment Stage 1|Not specified|0
1150127|NCT01335698|3776776|P4|Treatment Stage 1|Not specified|1
1150128|NCT01335698|3776777|P3|Treatment Stage 1|Not specified|0
1150129|NCT01335698|3776778|P2|Treatment Stage 1|Not specified|0
1150130|NCT01335698|3776779|P1|Treatment Stage 1|Not specified|1
1150131|NCT01335698|3776775|P5|Treatment Stage 1|No longer meets study criteria|0
1150132|NCT01335698|3776776|P4|Treatment Stage 1|No longer meets study criteria|1
1150133|NCT01335698|3776777|P3|Treatment Stage 1|No longer meets study criteria|0
1150134|NCT01335698|3776778|P2|Treatment Stage 1|No longer meets study criteria|1
1150135|NCT01335698|3776779|P1|Treatment Stage 1|No longer meets study criteria|1
1150136|NCT01335698|3776775|P5|Treatment Stage 1|Poor compliance/noncompliance|0
1150137|NCT01335698|3776776|P4|Treatment Stage 1|Poor compliance/noncompliance|2
1150138|NCT01335698|3776777|P3|Treatment Stage 1|Poor compliance/noncompliance|0
1150139|NCT01335698|3776778|P2|Treatment Stage 1|Poor compliance/noncompliance|1
1150140|NCT01335698|3776779|P1|Treatment Stage 1|Poor compliance/noncompliance|0
1150141|NCT01335698|3776775|P5|Treatment Stage 1|Lost to Follow-up|0
1150142|NCT01335698|3776776|P4|Treatment Stage 1|Lost to Follow-up|0
1150143|NCT01335698|3776777|P3|Treatment Stage 1|Lost to Follow-up|0
1150144|NCT01335698|3776778|P2|Treatment Stage 1|Lost to Follow-up|1
1150145|NCT01335698|3776779|P1|Treatment Stage 1|Lost to Follow-up|1
1150146|NCT01335698|3776775|P5|Treatment Stage 1|Withdrawal by Subject|0
1150147|NCT01335698|3776776|P4|Treatment Stage 1|Withdrawal by Subject|1
1150148|NCT01335698|3776777|P3|Treatment Stage 1|Withdrawal by Subject|0
1150149|NCT01335698|3776778|P2|Treatment Stage 1|Withdrawal by Subject|2
1150150|NCT01335698|3776779|P1|Treatment Stage 1|Withdrawal by Subject|1
1150151|NCT01335698|3776775|P5|Treatment Stage 1|Adverse Event|1
1150152|NCT01335698|3776776|P4|Treatment Stage 1|Adverse Event|1
1150153|NCT01335698|3776777|P3|Treatment Stage 1|Adverse Event|2
1150154|NCT01335698|3776778|P2|Treatment Stage 1|Adverse Event|2
1150155|NCT01335698|3776779|P1|Treatment Stage 1|Adverse Event|1
1150156|NCT01335698|3776775|P5|Treatment Stage 1|Lack of Efficacy|1
1150157|NCT01335698|3776776|P4|Treatment Stage 1|Lack of Efficacy|3
1150158|NCT01335698|3776777|P3|Treatment Stage 1|Lack of Efficacy|3
1150159|NCT01335698|3776778|P2|Treatment Stage 1|Lack of Efficacy|1
1150160|NCT01335698|3776779|P1|Treatment Stage 1|Lack of Efficacy|3
1150161|NCT01335685|3776844|P8|Overall Study|Reason not Specified|0
1150162|NCT01335685|3776845|P7|Overall Study|Reason not Specified|0
1150163|NCT01335685|3776846|P6|Overall Study|Reason not Specified|1
1150164|NCT01335685|3776847|P5|Overall Study|Reason not Specified|0
1150165|NCT01335685|3776848|P4|Overall Study|Reason not Specified|0
1150166|NCT01335685|3776849|P3|Overall Study|Reason not Specified|1
1150167|NCT01335685|3776850|P2|Overall Study|Reason not Specified|0
1150168|NCT01335685|3776851|P1|Overall Study|Reason not Specified|0
1150169|NCT01335685|3776844|P8|Overall Study|Withdrawal by Subject|0
1150170|NCT01335685|3776845|P7|Overall Study|Withdrawal by Subject|0
1150171|NCT01335685|3776846|P6|Overall Study|Withdrawal by Subject|0
1150172|NCT01335685|3776847|P5|Overall Study|Withdrawal by Subject|0
1150173|NCT01335685|3776848|P4|Overall Study|Withdrawal by Subject|1
1150174|NCT01335685|3776849|P3|Overall Study|Withdrawal by Subject|0
1150175|NCT01335685|3776850|P2|Overall Study|Withdrawal by Subject|0
1150176|NCT01335685|3776851|P1|Overall Study|Withdrawal by Subject|1
1150177|NCT01335685|3776844|P8|Overall Study|Study Terminated by Sponsor|3
1150178|NCT01335685|3776845|P7|Overall Study|Study Terminated by Sponsor|2
1150179|NCT01335685|3776846|P6|Overall Study|Study Terminated by Sponsor|4
1150180|NCT01335685|3776847|P5|Overall Study|Study Terminated by Sponsor|0
1150181|NCT01335685|3776848|P4|Overall Study|Study Terminated by Sponsor|10
1150182|NCT01335685|3776849|P3|Overall Study|Study Terminated by Sponsor|1
1150183|NCT01335685|3776850|P2|Overall Study|Study Terminated by Sponsor|1
1150184|NCT01335685|3776851|P1|Overall Study|Study Terminated by Sponsor|2
1150185|NCT01335477|3776964|P2|Overall Study|Reason other than those stated above|2
1150186|NCT01335477|3776965|P1|Overall Study|Reason other than those stated above|2
1150187|NCT01335477|3776964|P2|Overall Study|Not treated|2
1150188|NCT01335477|3776965|P1|Overall Study|Not treated|1
1150189|NCT01335477|3776964|P2|Overall Study|Consent withdrawn, not due to AE|9
1150190|NCT01335477|3776965|P1|Overall Study|Consent withdrawn, not due to AE|7
1150191|NCT01335477|3776964|P2|Overall Study|Lost to Follow-up|2
1150192|NCT01335477|3776965|P1|Overall Study|Lost to Follow-up|1
1150193|NCT01335477|3776964|P2|Overall Study|Non compliant with protocol|2
1150194|NCT01335477|3776965|P1|Overall Study|Non compliant with protocol|0
1150195|NCT01335477|3776964|P2|Overall Study|Adverse Event|42
1150196|NCT01335477|3776965|P1|Overall Study|Adverse Event|30
1150197|NCT01335464|3777029|P2|Overall Study|Reason other than those stated above|1
1150198|NCT01335464|3777030|P1|Overall Study|Reason other than those stated above|1
1150199|NCT01335464|3777029|P2|Overall Study|Not treated|0
1150200|NCT01335464|3777030|P1|Overall Study|Not treated|2
1150201|NCT01335464|3777029|P2|Overall Study|Consent withdrawn, not due to AE|23
1150202|NCT01335464|3777030|P1|Overall Study|Consent withdrawn, not due to AE|12
1150203|NCT01335464|3777029|P2|Overall Study|Non compliant with protocol|0
1150204|NCT01335464|3777030|P1|Overall Study|Non compliant with protocol|2
1150205|NCT01335464|3777029|P2|Overall Study|Adverse Event|25
1150206|NCT01335464|3777030|P1|Overall Study|Adverse Event|15
1150207|NCT01334918|3777199|P2|Overall Study|Withdrawal by Subject|1
1150208|NCT01334918|3777200|P1|Overall Study|Withdrawal by Subject|0
1150209|NCT01334918|3777199|P2|Overall Study|Adverse Event|0
1150210|NCT01334918|3777200|P1|Overall Study|Adverse Event|2
1150211|NCT01334918|3777199|P2|Overall Study|Did not receive study drug|0
1150212|NCT01334918|3777200|P1|Overall Study|Did not receive study drug|6
1150213|NCT01334866|3777226|P1|Overall Study|medically necessary post-procedure|1
1150214|NCT01334866|3777226|P1|Overall Study|medically necessary prior to procedure|2
1150215|NCT01334866|3777226|P1|Overall Study|Physician Decision|3
1150216|NCT01334866|3777226|P1|Overall Study|Lost to Follow-up|3
1150217|NCT01334866|3777226|P1|Overall Study|Withdrawal by Subject|10
1150218|NCT01334710|3777263|P1|Overall Study|Trial was terminated|3
1150219|NCT01334606|3777268|P1|Overall Study|Study Terminated due to slow enrolment|18
1150220|NCT01334554|3777276|P2|Overall Study|Adverse Event|2
1150221|NCT01334554|3777277|P1|Overall Study|Adverse Event|4
1150222|NCT01334515|3777287|P2|Overall Study|Withdrawal by Subject|1
1150223|NCT01334515|3777288|P1|Overall Study|Withdrawal by Subject|1
1150224|NCT01334515|3777287|P2|Overall Study|Physician Decision|1
1150225|NCT01334515|3777288|P1|Overall Study|Physician Decision|1
1150226|NCT01334515|3777287|P2|Overall Study|Lack of Efficacy|21
1150227|NCT01334515|3777288|P1|Overall Study|Lack of Efficacy|8
1150228|NCT01334515|3777287|P2|Overall Study|Death|0
1150229|NCT01334515|3777288|P1|Overall Study|Death|1
1150230|NCT01334515|3777287|P2|Overall Study|Adverse Event|6
1150231|NCT01334515|3777288|P1|Overall Study|Adverse Event|1
1150232|NCT01334125|3777326|P2|Overall Study|Lost to Follow-up|3
1150233|NCT01334125|3777327|P1|Overall Study|Lost to Follow-up|3
1150234|NCT01333956|3777343|P4|Overall Study|Withdrawal by Subject|0
1150235|NCT01333956|3777344|P3|Overall Study|Withdrawal by Subject|1
1150236|NCT01333956|3777345|P2|Overall Study|Withdrawal by Subject|2
1150237|NCT01333956|3777346|P1|Overall Study|Withdrawal by Subject|0
1150238|NCT01333956|3777343|P4|Overall Study|Unable to complete study procedure|1
1150239|NCT01333956|3777344|P3|Overall Study|Unable to complete study procedure|0
1150240|NCT01333956|3777345|P2|Overall Study|Unable to complete study procedure|0
1150241|NCT01333956|3777346|P1|Overall Study|Unable to complete study procedure|1
1150242|NCT01333956|3777343|P4|Overall Study|Lost to Follow-up|1
1150243|NCT01333956|3777344|P3|Overall Study|Lost to Follow-up|0
1150244|NCT01333956|3777345|P2|Overall Study|Lost to Follow-up|2
1150245|NCT01333956|3777346|P1|Overall Study|Lost to Follow-up|1
1150246|NCT01333943|3777382|P2|Overall Study|Known neuropathy|0
1150247|NCT01333943|3777383|P1|Overall Study|Known neuropathy|1
1150248|NCT01333865|3777399|P1|Overall Study|Adverse Event|2
1150249|NCT01333722|3777419|P2|Overall Study|Withdrawal by Subject|1
1150250|NCT01333722|3777420|P1|Overall Study|Withdrawal by Subject|0
1150251|NCT01333722|3777419|P2|Overall Study|Lack of Efficacy|2
1150252|NCT01333722|3777420|P1|Overall Study|Lack of Efficacy|0
1150253|NCT01333501|3777445|P2|Overall Study|Withdrawn consent|12
1150254|NCT01333501|3777446|P1|Overall Study|Withdrawn consent|3
1150255|NCT01333501|3777445|P2|Overall Study|Unsatisfactory therapeutic effect|7
1150256|NCT01333501|3777446|P1|Overall Study|Unsatisfactory therapeutic effect|1
1150257|NCT01333501|3777445|P2|Overall Study|Abnormal laboratory value|1
1150258|NCT01333501|3777446|P1|Overall Study|Abnormal laboratory value|2
1150259|NCT01333501|3777445|P2|Overall Study|Adverse Event|1
1150260|NCT01333501|3777446|P1|Overall Study|Adverse Event|3
1150261|NCT01333475|3777513|P2|Overall Study|Toxicity|3
1150262|NCT01333475|3777514|P1|Overall Study|Toxicity|1
1150263|NCT01333475|3777513|P2|Overall Study|pt withdrew-need emergent radiation trmt|0
1150264|NCT01333475|3777514|P1|Overall Study|pt withdrew-need emergent radiation trmt|1
1150265|NCT01333397|3777540|P5|Overall Study|Lost to Follow-up|0
1150266|NCT01333397|3777541|P4|Overall Study|Lost to Follow-up|1
1150267|NCT01333397|3777542|P3|Overall Study|Lost to Follow-up|0
1150268|NCT01333397|3777543|P2|Overall Study|Lost to Follow-up|0
1150269|NCT01333397|3777544|P1|Overall Study|Lost to Follow-up|1
1150270|NCT01333189|3777618|P2|Overall Study|Moved from region|1
1150271|NCT01333189|3777619|P1|Overall Study|Moved from region|0
1150272|NCT01333189|3777618|P2|Overall Study|Transportation difficulties|1
1150273|NCT01333189|3777619|P1|Overall Study|Transportation difficulties|0
1150274|NCT01333189|3777618|P2|Overall Study|Adverse Event|0
1150275|NCT01333189|3777619|P1|Overall Study|Adverse Event|1
1150276|NCT01333189|3777618|P2|Overall Study|Time constraints|0
1150277|NCT01333189|3777619|P1|Overall Study|Time constraints|1
1150278|NCT01333111|3777650|P3|Overall Study|Ineffective therapy|1
1150279|NCT01333111|3777651|P2|Overall Study|Ineffective therapy|0
1150280|NCT01333111|3777652|P1|Overall Study|Ineffective therapy|0
1150281|NCT01333111|3777650|P3|Overall Study|Non-compliance|0
1150282|NCT01333111|3777651|P2|Overall Study|Non-compliance|0
1150283|NCT01333111|3777652|P1|Overall Study|Non-compliance|1
1150284|NCT01333111|3777650|P3|Overall Study|withdrawal criteria|0
1150285|NCT01333111|3777651|P2|Overall Study|withdrawal criteria|1
1150286|NCT01333111|3777652|P1|Overall Study|withdrawal criteria|0
1150287|NCT01333111|3777650|P3|Overall Study|unclassified|0
1150288|NCT01333111|3777651|P2|Overall Study|unclassified|0
1150289|NCT01333111|3777652|P1|Overall Study|unclassified|1
1150290|NCT01333111|3777650|P3|Overall Study|personal reasons|1
1150291|NCT01333111|3777651|P2|Overall Study|personal reasons|0
1150292|NCT01333111|3777652|P1|Overall Study|personal reasons|0
1150293|NCT01333111|3777650|P3|Overall Study|patient undergoing major surgery|0
1150294|NCT01333111|3777651|P2|Overall Study|patient undergoing major surgery|2
1150295|NCT01333111|3777652|P1|Overall Study|patient undergoing major surgery|0
1150296|NCT01333072|3777678|P2|Overall Study|Physician Decision|0
1150297|NCT01333072|3777679|P1|Overall Study|Physician Decision|1
1150298|NCT01333072|3777678|P2|Overall Study|Adverse Event|4
1150299|NCT01333072|3777679|P1|Overall Study|Adverse Event|2
1150300|NCT01333072|3777678|P2|Overall Study|Lost to Follow-up|0
1150301|NCT01333072|3777679|P1|Overall Study|Lost to Follow-up|3
1150302|NCT01333059|3777687|P2|Overall Study|Protocol Violation|0
1150303|NCT01333059|3777688|P1|Overall Study|Protocol Violation|3
1150304|NCT01333059|3777687|P2|Overall Study|Physician Decision|3
1150305|NCT01333059|3777688|P1|Overall Study|Physician Decision|3
1150306|NCT01332994|3777698|P1|Overall Study|Not Specified|8
1150307|NCT01332994|3777698|P1|Overall Study|Administrative Problem|2
1150308|NCT01332994|3777698|P1|Overall Study|Withdrawal by Subject|15
1150309|NCT01332994|3777698|P1|Overall Study|Protocol Violation|6
1150310|NCT01332994|3777698|P1|Overall Study|Lost to Follow-up|4
1150311|NCT01332994|3777698|P1|Overall Study|Lack of Efficacy|1
1150312|NCT01332994|3777698|P1|Overall Study|Death|1
1150313|NCT01332994|3777698|P1|Overall Study|Adverse Event|34
1150314|NCT01332968|3777767|P8|Follow-Up Period|Lost to Follow-up|2
1150315|NCT01332968|3777768|P7|Follow-Up Period|Lost to Follow-up|1
1150316|NCT01332968|3777769|P6|Follow-Up Period|Lost to Follow-up|0
1150317|NCT01332968|3777770|P5|Follow-Up Period|Lost to Follow-up|0
1150318|NCT01332968|3777771|P4|Follow-Up Period|Lost to Follow-up|0
1150319|NCT01332968|3777772|P3|Follow-Up Period|Lost to Follow-up|0
1150320|NCT01332968|3777773|P2|Follow-Up Period|Lost to Follow-up|0
1150321|NCT01332968|3777774|P1|Follow-Up Period|Lost to Follow-up|0
1150322|NCT01332968|3777767|P8|Follow-Up Period|Withdrawal by Subject|2
1150323|NCT01332968|3777768|P7|Follow-Up Period|Withdrawal by Subject|1
1150324|NCT01332968|3777769|P6|Follow-Up Period|Withdrawal by Subject|0
1150325|NCT01332968|3777770|P5|Follow-Up Period|Withdrawal by Subject|0
1150326|NCT01332968|3777771|P4|Follow-Up Period|Withdrawal by Subject|0
1150327|NCT01332968|3777772|P3|Follow-Up Period|Withdrawal by Subject|0
1150328|NCT01332968|3777773|P2|Follow-Up Period|Withdrawal by Subject|0
1150329|NCT01332968|3777774|P1|Follow-Up Period|Withdrawal by Subject|0
1150330|NCT01332968|3777767|P8|Follow-Up Period|Follow-up ongoing|505
1150331|NCT01332968|3777768|P7|Follow-Up Period|Follow-up ongoing|502
1150332|NCT01332968|3777769|P6|Follow-Up Period|Follow-up ongoing|0
1150333|NCT01332968|3777770|P5|Follow-Up Period|Follow-up ongoing|0
1150334|NCT01332968|3777771|P4|Follow-Up Period|Follow-up ongoing|0
1150335|NCT01332968|3777772|P3|Follow-Up Period|Follow-up ongoing|0
1150336|NCT01332968|3777773|P2|Follow-Up Period|Follow-up ongoing|0
1150337|NCT01332968|3777774|P1|Follow-Up Period|Follow-up ongoing|0
1150338|NCT01332968|3777767|P8|Follow-Up Period|Death|22
1150339|NCT01332968|3777768|P7|Follow-Up Period|Death|38
1150340|NCT01332968|3777769|P6|Follow-Up Period|Death|0
1150341|NCT01332968|3777770|P5|Follow-Up Period|Death|0
1150342|NCT01332968|3777771|P4|Follow-Up Period|Death|0
1150343|NCT01332968|3777772|P3|Follow-Up Period|Death|0
1150344|NCT01332968|3777773|P2|Follow-Up Period|Death|0
1150345|NCT01332968|3777774|P1|Follow-Up Period|Death|0
1150346|NCT01332968|3777767|P8|Maintenance/Observation Period|Treatment ongoing|0
1150347|NCT01332968|3777768|P7|Maintenance/Observation Period|Treatment ongoing|0
1150348|NCT01332968|3777769|P6|Maintenance/Observation Period|Treatment ongoing|8
1150349|NCT01332968|3777770|P5|Maintenance/Observation Period|Treatment ongoing|10
1150350|NCT01332968|3777771|P4|Maintenance/Observation Period|Treatment ongoing|62
1150351|NCT01332968|3777772|P3|Maintenance/Observation Period|Treatment ongoing|54
1150352|NCT01332968|3777773|P2|Maintenance/Observation Period|Treatment ongoing|0
1150353|NCT01332968|3777774|P1|Maintenance/Observation Period|Treatment ongoing|0
1150354|NCT01332968|3777767|P8|Maintenance/Observation Period|Adverse Event|0
1150355|NCT01332968|3777768|P7|Maintenance/Observation Period|Adverse Event|0
1150356|NCT01332968|3777769|P6|Maintenance/Observation Period|Adverse Event|0
1150357|NCT01332968|3777770|P5|Maintenance/Observation Period|Adverse Event|0
1150358|NCT01332968|3777771|P4|Maintenance/Observation Period|Adverse Event|65
1150359|NCT01332968|3777772|P3|Maintenance/Observation Period|Adverse Event|50
1150360|NCT01332968|3777773|P2|Maintenance/Observation Period|Adverse Event|0
1150361|NCT01332968|3777774|P1|Maintenance/Observation Period|Adverse Event|0
1150362|NCT01332968|3777767|P8|Maintenance/Observation Period|Death|0
1150363|NCT01332968|3777768|P7|Maintenance/Observation Period|Death|0
1150364|NCT01332968|3777769|P6|Maintenance/Observation Period|Death|0
1150365|NCT01332968|3777770|P5|Maintenance/Observation Period|Death|0
1150366|NCT01332968|3777771|P4|Maintenance/Observation Period|Death|6
1150367|NCT01332968|3777772|P3|Maintenance/Observation Period|Death|5
1150368|NCT01332968|3777773|P2|Maintenance/Observation Period|Death|0
1150369|NCT01332968|3777774|P1|Maintenance/Observation Period|Death|0
1150370|NCT01332968|3777767|P8|Maintenance/Observation Period|Lost to Follow-up|0
1150371|NCT01332968|3777768|P7|Maintenance/Observation Period|Lost to Follow-up|0
1150372|NCT01332968|3777769|P6|Maintenance/Observation Period|Lost to Follow-up|0
1150373|NCT01332968|3777770|P5|Maintenance/Observation Period|Lost to Follow-up|0
1150374|NCT01332968|3777771|P4|Maintenance/Observation Period|Lost to Follow-up|2
1150375|NCT01332968|3777772|P3|Maintenance/Observation Period|Lost to Follow-up|1
1150376|NCT01332968|3777773|P2|Maintenance/Observation Period|Lost to Follow-up|0
1150377|NCT01332968|3777774|P1|Maintenance/Observation Period|Lost to Follow-up|0
1150378|NCT01332968|3777767|P8|Maintenance/Observation Period|Non-compliance|0
1150379|NCT01332968|3777768|P7|Maintenance/Observation Period|Non-compliance|0
1150380|NCT01332968|3777769|P6|Maintenance/Observation Period|Non-compliance|1
1150381|NCT01332968|3777770|P5|Maintenance/Observation Period|Non-compliance|0
1150382|NCT01332968|3777771|P4|Maintenance/Observation Period|Non-compliance|3
1150383|NCT01332968|3777772|P3|Maintenance/Observation Period|Non-compliance|2
1150384|NCT01332968|3777773|P2|Maintenance/Observation Period|Non-compliance|0
1150385|NCT01332968|3777774|P1|Maintenance/Observation Period|Non-compliance|0
1150386|NCT01332968|3777767|P8|Maintenance/Observation Period|Other|0
1150387|NCT01332968|3777768|P7|Maintenance/Observation Period|Other|0
1150388|NCT01332968|3777769|P6|Maintenance/Observation Period|Other|0
1150389|NCT01332968|3777770|P5|Maintenance/Observation Period|Other|0
1150390|NCT01332968|3777771|P4|Maintenance/Observation Period|Other|5
1150391|NCT01332968|3777772|P3|Maintenance/Observation Period|Other|4
1150392|NCT01332968|3777773|P2|Maintenance/Observation Period|Other|0
1150393|NCT01332968|3777774|P1|Maintenance/Observation Period|Other|0
1150394|NCT01332968|3777767|P8|Maintenance/Observation Period|Physician Decision|0
1150395|NCT01332968|3777768|P7|Maintenance/Observation Period|Physician Decision|0
1150396|NCT01332968|3777769|P6|Maintenance/Observation Period|Physician Decision|0
1150397|NCT01332968|3777770|P5|Maintenance/Observation Period|Physician Decision|0
1150398|NCT01332968|3777771|P4|Maintenance/Observation Period|Physician Decision|19
1150399|NCT01332968|3777772|P3|Maintenance/Observation Period|Physician Decision|14
1150400|NCT01332968|3777773|P2|Maintenance/Observation Period|Physician Decision|0
1150401|NCT01332968|3777774|P1|Maintenance/Observation Period|Physician Decision|0
1150402|NCT01332968|3777767|P8|Maintenance/Observation Period|Progressive disease|0
1150403|NCT01332968|3777768|P7|Maintenance/Observation Period|Progressive disease|0
1150404|NCT01332968|3777769|P6|Maintenance/Observation Period|Progressive disease|0
1150405|NCT01332968|3777770|P5|Maintenance/Observation Period|Progressive disease|0
1150491|NCT01332968|3777768|P7|Induction Period|Withdrawal by Subject|0
1150406|NCT01332968|3777771|P4|Maintenance/Observation Period|Progressive disease|39
1150407|NCT01332968|3777772|P3|Maintenance/Observation Period|Progressive disease|72
1150408|NCT01332968|3777773|P2|Maintenance/Observation Period|Progressive disease|0
1150409|NCT01332968|3777774|P1|Maintenance/Observation Period|Progressive disease|0
1150410|NCT01332968|3777767|P8|Maintenance/Observation Period|Protocol Violation|0
1150411|NCT01332968|3777768|P7|Maintenance/Observation Period|Protocol Violation|0
1150412|NCT01332968|3777769|P6|Maintenance/Observation Period|Protocol Violation|0
1150413|NCT01332968|3777770|P5|Maintenance/Observation Period|Protocol Violation|0
1150414|NCT01332968|3777771|P4|Maintenance/Observation Period|Protocol Violation|1
1150415|NCT01332968|3777772|P3|Maintenance/Observation Period|Protocol Violation|1
1150416|NCT01332968|3777773|P2|Maintenance/Observation Period|Protocol Violation|0
1150417|NCT01332968|3777774|P1|Maintenance/Observation Period|Protocol Violation|0
1150418|NCT01332968|3777767|P8|Maintenance/Observation Period|Withdrawal by Subject|0
1150419|NCT01332968|3777768|P7|Maintenance/Observation Period|Withdrawal by Subject|0
1150420|NCT01332968|3777769|P6|Maintenance/Observation Period|Withdrawal by Subject|0
1150421|NCT01332968|3777770|P5|Maintenance/Observation Period|Withdrawal by Subject|0
1150422|NCT01332968|3777771|P4|Maintenance/Observation Period|Withdrawal by Subject|5
1150423|NCT01332968|3777772|P3|Maintenance/Observation Period|Withdrawal by Subject|10
1150424|NCT01332968|3777773|P2|Maintenance/Observation Period|Withdrawal by Subject|0
1150425|NCT01332968|3777774|P1|Maintenance/Observation Period|Withdrawal by Subject|0
1150426|NCT01332968|3777767|P8|Induction Period|Randomized, but not treated|0
1150427|NCT01332968|3777768|P7|Induction Period|Randomized, but not treated|0
1150428|NCT01332968|3777769|P6|Induction Period|Randomized, but not treated|0
1150429|NCT01332968|3777770|P5|Induction Period|Randomized, but not treated|0
1150430|NCT01332968|3777771|P4|Induction Period|Randomized, but not treated|0
1150431|NCT01332968|3777772|P3|Induction Period|Randomized, but not treated|0
1150432|NCT01332968|3777773|P2|Induction Period|Randomized, but not treated|7
1150433|NCT01332968|3777774|P1|Induction Period|Randomized, but not treated|4
1150434|NCT01332968|3777767|P8|Induction Period|Adverse Event|0
1150435|NCT01332968|3777768|P7|Induction Period|Adverse Event|0
1150436|NCT01332968|3777769|P6|Induction Period|Adverse Event|0
1150437|NCT01332968|3777770|P5|Induction Period|Adverse Event|0
1150438|NCT01332968|3777771|P4|Induction Period|Adverse Event|0
1150439|NCT01332968|3777772|P3|Induction Period|Adverse Event|0
1150440|NCT01332968|3777773|P2|Induction Period|Adverse Event|26
1150441|NCT01332968|3777774|P1|Induction Period|Adverse Event|23
1150442|NCT01332968|3777767|P8|Induction Period|Death|0
1150443|NCT01332968|3777768|P7|Induction Period|Death|0
1150444|NCT01332968|3777769|P6|Induction Period|Death|0
1150445|NCT01332968|3777770|P5|Induction Period|Death|0
1150446|NCT01332968|3777771|P4|Induction Period|Death|0
1150447|NCT01332968|3777772|P3|Induction Period|Death|0
1150448|NCT01332968|3777773|P2|Induction Period|Death|4
1150449|NCT01332968|3777774|P1|Induction Period|Death|1
1150450|NCT01332968|3777767|P8|Induction Period|Non-compliance|0
1150451|NCT01332968|3777768|P7|Induction Period|Non-compliance|0
1150452|NCT01332968|3777769|P6|Induction Period|Non-compliance|0
1150453|NCT01332968|3777770|P5|Induction Period|Non-compliance|0
1150454|NCT01332968|3777771|P4|Induction Period|Non-compliance|0
1150455|NCT01332968|3777772|P3|Induction Period|Non-compliance|0
1150456|NCT01332968|3777773|P2|Induction Period|Non-compliance|0
1150457|NCT01332968|3777774|P1|Induction Period|Non-compliance|1
1150458|NCT01332968|3777767|P8|Induction Period|Other|0
1150459|NCT01332968|3777768|P7|Induction Period|Other|0
1150460|NCT01332968|3777769|P6|Induction Period|Other|0
1150461|NCT01332968|3777770|P5|Induction Period|Other|0
1150462|NCT01332968|3777771|P4|Induction Period|Other|0
1150463|NCT01332968|3777772|P3|Induction Period|Other|0
1150464|NCT01332968|3777773|P2|Induction Period|Other|2
1150465|NCT01332968|3777774|P1|Induction Period|Other|2
1150466|NCT01332968|3777767|P8|Induction Period|Physician Decision|0
1150467|NCT01332968|3777768|P7|Induction Period|Physician Decision|0
1150468|NCT01332968|3777769|P6|Induction Period|Physician Decision|0
1150469|NCT01332968|3777770|P5|Induction Period|Physician Decision|0
1150470|NCT01332968|3777771|P4|Induction Period|Physician Decision|0
1150471|NCT01332968|3777772|P3|Induction Period|Physician Decision|0
1150472|NCT01332968|3777773|P2|Induction Period|Physician Decision|1
1150473|NCT01332968|3777774|P1|Induction Period|Physician Decision|6
1150474|NCT01332968|3777767|P8|Induction Period|Progressive disease|0
1150475|NCT01332968|3777768|P7|Induction Period|Progressive disease|0
1150476|NCT01332968|3777769|P6|Induction Period|Progressive disease|0
1150477|NCT01332968|3777770|P5|Induction Period|Progressive disease|0
1150478|NCT01332968|3777771|P4|Induction Period|Progressive disease|0
1150479|NCT01332968|3777772|P3|Induction Period|Progressive disease|0
1150480|NCT01332968|3777773|P2|Induction Period|Progressive disease|7
1150481|NCT01332968|3777774|P1|Induction Period|Progressive disease|15
1150482|NCT01332968|3777767|P8|Induction Period|Protocol Violation|0
1150483|NCT01332968|3777768|P7|Induction Period|Protocol Violation|0
1150484|NCT01332968|3777769|P6|Induction Period|Protocol Violation|0
1150485|NCT01332968|3777770|P5|Induction Period|Protocol Violation|0
1150486|NCT01332968|3777771|P4|Induction Period|Protocol Violation|0
1150487|NCT01332968|3777772|P3|Induction Period|Protocol Violation|0
1150488|NCT01332968|3777773|P2|Induction Period|Protocol Violation|4
1150489|NCT01332968|3777774|P1|Induction Period|Protocol Violation|3
1150490|NCT01332968|3777767|P8|Induction Period|Withdrawal by Subject|0
1150492|NCT01332968|3777769|P6|Induction Period|Withdrawal by Subject|0
1150493|NCT01332968|3777770|P5|Induction Period|Withdrawal by Subject|0
1150494|NCT01332968|3777771|P4|Induction Period|Withdrawal by Subject|0
1150495|NCT01332968|3777772|P3|Induction Period|Withdrawal by Subject|0
1150496|NCT01332968|3777773|P2|Induction Period|Withdrawal by Subject|5
1150497|NCT01332968|3777774|P1|Induction Period|Withdrawal by Subject|3
1150498|NCT01332851|3777840|P2|Overall Study|Lost to Follow-up|11
1150499|NCT01332851|3777841|P1|Overall Study|Lost to Follow-up|7
1150500|NCT01332851|3777840|P2|Overall Study|Withdrawal by Subject|2
1150501|NCT01332851|3777841|P1|Overall Study|Withdrawal by Subject|4
1150502|NCT01332630|3777879|P1|Overall Study|Withdrawal by Subject|3
1150503|NCT01332318|3777997|P4|Overall Study|Protocol Violation|1
1150504|NCT01332318|3777998|P3|Overall Study|Protocol Violation|1
1150505|NCT01332318|3777999|P2|Overall Study|Protocol Violation|0
1150506|NCT01332318|3778000|P1|Overall Study|Protocol Violation|1
1150507|NCT01332318|3777997|P4|Overall Study|Withdrawal by Subject|1
1150508|NCT01332318|3777998|P3|Overall Study|Withdrawal by Subject|0
1150509|NCT01332318|3777999|P2|Overall Study|Withdrawal by Subject|1
1150510|NCT01332318|3778000|P1|Overall Study|Withdrawal by Subject|1
1150511|NCT01332318|3777997|P4|Overall Study|Adverse Event|0
1150512|NCT01332318|3777998|P3|Overall Study|Adverse Event|0
1150513|NCT01332318|3777999|P2|Overall Study|Adverse Event|3
1150514|NCT01332318|3778000|P1|Overall Study|Adverse Event|0
1150515|NCT01332305|3778111|P5|Overall Study|Physician Decision|0
1150516|NCT01332305|3778112|P4|Overall Study|Physician Decision|1
1150517|NCT01332305|3778113|P3|Overall Study|Physician Decision|0
1150518|NCT01332305|3778114|P2|Overall Study|Physician Decision|0
1150519|NCT01332305|3778115|P1|Overall Study|Physician Decision|0
1150520|NCT01332305|3778111|P5|Overall Study|Treatment Failure|0
1150521|NCT01332305|3778112|P4|Overall Study|Treatment Failure|0
1150522|NCT01332305|3778113|P3|Overall Study|Treatment Failure|0
1150523|NCT01332305|3778114|P2|Overall Study|Treatment Failure|1
1150524|NCT01332305|3778115|P1|Overall Study|Treatment Failure|1
1150525|NCT01332305|3778111|P5|Overall Study|Withdrawal by Sponsor|1
1150526|NCT01332305|3778112|P4|Overall Study|Withdrawal by Sponsor|1
1150527|NCT01332305|3778113|P3|Overall Study|Withdrawal by Sponsor|0
1150528|NCT01332305|3778114|P2|Overall Study|Withdrawal by Sponsor|0
1150529|NCT01332305|3778115|P1|Overall Study|Withdrawal by Sponsor|1
1150530|NCT01332305|3778111|P5|Overall Study|Protocol Violation|3
1150531|NCT01332305|3778112|P4|Overall Study|Protocol Violation|0
1150532|NCT01332305|3778113|P3|Overall Study|Protocol Violation|1
1150533|NCT01332305|3778114|P2|Overall Study|Protocol Violation|2
1150534|NCT01332305|3778115|P1|Overall Study|Protocol Violation|1
1150535|NCT01332305|3778111|P5|Overall Study|Lost to Follow-up|3
1150536|NCT01332305|3778112|P4|Overall Study|Lost to Follow-up|2
1150537|NCT01332305|3778113|P3|Overall Study|Lost to Follow-up|3
1150538|NCT01332305|3778114|P2|Overall Study|Lost to Follow-up|2
1150539|NCT01332305|3778115|P1|Overall Study|Lost to Follow-up|0
1150540|NCT01332305|3778111|P5|Overall Study|Withdrawal by Subject|0
1150541|NCT01332305|3778112|P4|Overall Study|Withdrawal by Subject|1
1150542|NCT01332305|3778113|P3|Overall Study|Withdrawal by Subject|4
1150543|NCT01332305|3778114|P2|Overall Study|Withdrawal by Subject|5
1150544|NCT01332305|3778115|P1|Overall Study|Withdrawal by Subject|6
1150545|NCT01332305|3778111|P5|Overall Study|Adverse Event|5
1150546|NCT01332305|3778112|P4|Overall Study|Adverse Event|3
1150547|NCT01332305|3778113|P3|Overall Study|Adverse Event|6
1150548|NCT01332305|3778114|P2|Overall Study|Adverse Event|4
1150549|NCT01332305|3778115|P1|Overall Study|Adverse Event|1
1150550|NCT01332292|3778137|P2|Treatment Period 2 (14 Days)|Physician Decision|1
1150551|NCT01332292|3778138|P1|Treatment Period 2 (14 Days)|Physician Decision|1
1150552|NCT01332292|3778137|P2|Treatment Period 1 (14 Days)|Protocol Violation|1
1150553|NCT01332292|3778138|P1|Treatment Period 1 (14 Days)|Protocol Violation|1
1150554|NCT01332292|3778137|P2|Treatment Period 1 (14 Days)|Adverse Event|0
1150555|NCT01332292|3778138|P1|Treatment Period 1 (14 Days)|Adverse Event|1
1150556|NCT01332227|3778229|P2|Overall Study|Patient began prohibited medication|1
1150557|NCT01332227|3778230|P1|Overall Study|Patient began prohibited medication|0
1150558|NCT01332227|3778229|P2|Overall Study|Patient moved from area|0
1150559|NCT01332227|3778230|P1|Overall Study|Patient moved from area|1
1150560|NCT01332227|3778229|P2|Overall Study|Poor compliance/noncompliance|1
1150561|NCT01332227|3778230|P1|Overall Study|Poor compliance/noncompliance|1
1150562|NCT01332227|3778229|P2|Overall Study|Lack of Efficacy|1
1150563|NCT01332227|3778230|P1|Overall Study|Lack of Efficacy|3
1150564|NCT01332227|3778229|P2|Overall Study|Lost to Follow-up|0
1150565|NCT01332227|3778230|P1|Overall Study|Lost to Follow-up|2
1150566|NCT01332227|3778229|P2|Overall Study|Withdrawal by Subject|1
1150567|NCT01332227|3778230|P1|Overall Study|Withdrawal by Subject|5
1150568|NCT01332227|3778229|P2|Overall Study|Adverse Event|1
1150569|NCT01332227|3778230|P1|Overall Study|Adverse Event|4
1150570|NCT01332149|3778411|P2|Overall Study|Randomized but not treated|2
1150571|NCT01332149|3778412|P1|Overall Study|Randomized but not treated|1
1150572|NCT01332149|3778411|P2|Overall Study|Did not meet entrance criteria|4
1150573|NCT01332149|3778412|P1|Overall Study|Did not meet entrance criteria|3
1150574|NCT01332149|3778411|P2|Overall Study|Insufficient clinical response|7
1150575|NCT01332149|3778412|P1|Overall Study|Insufficient clinical response|4
1150576|NCT01332149|3778411|P2|Overall Study|Lost to Follow-up|1
1150577|NCT01332149|3778412|P1|Overall Study|Lost to Follow-up|1
1150578|NCT01332149|3778411|P2|Overall Study|Withdrawal by Subject|5
1150579|NCT01332149|3778412|P1|Overall Study|Withdrawal by Subject|4
1150580|NCT01332149|3778411|P2|Overall Study|Protocol Violation|3
1150581|NCT01332149|3778412|P1|Overall Study|Protocol Violation|1
1150582|NCT01332149|3778411|P2|Overall Study|Other unspecified|7
1150583|NCT01332149|3778412|P1|Overall Study|Other unspecified|5
1150584|NCT01332149|3778411|P2|Overall Study|Adverse Event|9
1150585|NCT01332149|3778412|P1|Overall Study|Adverse Event|11
1150586|NCT01332019|3778490|P2|Overall Study|Adverse Event|22
1150587|NCT01332019|3778491|P1|Overall Study|Adverse Event|13
1150588|NCT01332019|3778490|P2|Overall Study|Lost to Follow-up|7
1150589|NCT01332019|3778491|P1|Overall Study|Lost to Follow-up|4
1150590|NCT01332019|3778490|P2|Overall Study|Withdrawal by Subject|71
1150591|NCT01332019|3778491|P1|Overall Study|Withdrawal by Subject|73
1150592|NCT01332019|3778490|P2|Overall Study|Physician Decision|3
1150593|NCT01332019|3778491|P1|Overall Study|Physician Decision|4
1150594|NCT01332019|3778490|P2|Overall Study|Death|1
1150595|NCT01332019|3778491|P1|Overall Study|Death|2
1150596|NCT01332019|3778490|P2|Overall Study|Not Specified|18
1150597|NCT01332019|3778491|P1|Overall Study|Not Specified|16
1150598|NCT01332019|3778490|P2|Overall Study|Was Not Dosed|0
1150599|NCT01332019|3778491|P1|Overall Study|Was Not Dosed|1
1150600|NCT01331837|3778575|P2|Overall Study|Withdrawal by Subject|16
1150601|NCT01331837|3778576|P1|Overall Study|Withdrawal by Subject|13
1150602|NCT01331837|3778575|P2|Overall Study|Info not recorded|16
1150603|NCT01331837|3778576|P1|Overall Study|Info not recorded|10
1150604|NCT01331837|3778575|P2|Overall Study|Lost to Follow-up|1
1150605|NCT01331837|3778576|P1|Overall Study|Lost to Follow-up|3
1150606|NCT01331837|3778575|P2|Overall Study|Death|34
1150607|NCT01331837|3778576|P1|Overall Study|Death|30
1150608|NCT01331824|3778616|P1|Overall Study|Withdrawal by Subject|1
1150609|NCT01331824|3778616|P1|Overall Study|Disease Progression|9
1150610|NCT01331824|3778616|P1|Overall Study|Death|1
1150611|NCT01331824|3778616|P1|Overall Study|Adverse Event|2
1150612|NCT01331681|3778651|P3|Overall Study|Not Received Study Treatment|2
1150613|NCT01331681|3778652|P2|Overall Study|Not Received Study Treatment|0
1150614|NCT01331681|3778653|P1|Overall Study|Not Received Study Treatment|0
1150615|NCT01331681|3778651|P3|Overall Study|Switching to other therapy|1
1150616|NCT01331681|3778652|P2|Overall Study|Switching to other therapy|0
1150617|NCT01331681|3778653|P1|Overall Study|Switching to other therapy|0
1150618|NCT01331681|3778651|P3|Overall Study|Sponsor decision|0
1150619|NCT01331681|3778652|P2|Overall Study|Sponsor decision|1
1150620|NCT01331681|3778653|P1|Overall Study|Sponsor decision|1
1150621|NCT01331681|3778651|P3|Overall Study|Therapeutic procedure required|0
1150622|NCT01331681|3778652|P2|Overall Study|Therapeutic procedure required|0
1150623|NCT01331681|3778653|P1|Overall Study|Therapeutic procedure required|1
1150624|NCT01331681|3778651|P3|Overall Study|Physician Decision|4
1150625|NCT01331681|3778652|P2|Overall Study|Physician Decision|0
1150626|NCT01331681|3778653|P1|Overall Study|Physician Decision|2
1150627|NCT01331681|3778651|P3|Overall Study|Lost to Follow-up|1
1150628|NCT01331681|3778652|P2|Overall Study|Lost to Follow-up|4
1150629|NCT01331681|3778653|P1|Overall Study|Lost to Follow-up|2
1150630|NCT01331681|3778651|P3|Overall Study|Protocol Violation|0
1150631|NCT01331681|3778652|P2|Overall Study|Protocol Violation|1
1150632|NCT01331681|3778653|P1|Overall Study|Protocol Violation|1
1150633|NCT01331681|3778651|P3|Overall Study|Withdrawal by Subject|15
1150634|NCT01331681|3778652|P2|Overall Study|Withdrawal by Subject|8
1150635|NCT01331681|3778653|P1|Overall Study|Withdrawal by Subject|12
1150636|NCT01331681|3778651|P3|Overall Study|Lack of Efficacy|0
1150637|NCT01331681|3778652|P2|Overall Study|Lack of Efficacy|1
1150638|NCT01331681|3778653|P1|Overall Study|Lack of Efficacy|0
1150639|NCT01331681|3778651|P3|Overall Study|Death|2
1150640|NCT01331681|3778652|P2|Overall Study|Death|6
1150641|NCT01331681|3778653|P1|Overall Study|Death|6
1150642|NCT01331681|3778651|P3|Overall Study|Adverse Event|10
1150643|NCT01331681|3778652|P2|Overall Study|Adverse Event|13
1150644|NCT01331681|3778653|P1|Overall Study|Adverse Event|10
1150645|NCT01331291|3778696|P2|Overall Study|Death|1
1150646|NCT01331291|3778697|P1|Overall Study|Death|0
1150647|NCT01331291|3778696|P2|Overall Study|Lack of Efficacy|8
1150648|NCT01331291|3778697|P1|Overall Study|Lack of Efficacy|2
1150649|NCT01331161|3778731|P2|Overall Study|Pregnancy|1
1150650|NCT01331161|3778732|P1|Overall Study|Pregnancy|0
1150651|NCT01331161|3778731|P2|Overall Study|Lost to Follow-up|1
1150652|NCT01331161|3778732|P1|Overall Study|Lost to Follow-up|0
1150653|NCT01331161|3778731|P2|Overall Study|Physician Decision|0
1150654|NCT01331161|3778732|P1|Overall Study|Physician Decision|1
1150655|NCT01331109|3778740|P1|Overall Study|Study Terminated by Sponsor|38
1150656|NCT01331109|3778740|P1|Overall Study|Lost to Follow-up|1
1150657|NCT01331109|3778740|P1|Overall Study|Withdrawal by Subject|7
1150658|NCT01331109|3778740|P1|Overall Study|Protocol Violation|3
1150659|NCT01331109|3778740|P1|Overall Study|Lack of Efficacy|2
1150660|NCT01331109|3778740|P1|Overall Study|Adverse Event|6
1150661|NCT01331005|3778752|P2|Overall Study|Withdrawal by Subject|3
1150662|NCT01331005|3778753|P1|Overall Study|Withdrawal by Subject|2
1150663|NCT01331005|3778752|P2|Overall Study|Lost to Follow-up|1
1150664|NCT01331005|3778753|P1|Overall Study|Lost to Follow-up|2
1150665|NCT01330914|3778818|P1|Overall Study|No longer eligible (sleeve gastrectomy)|3
1150666|NCT01330914|3778818|P1|Overall Study|Withdrawal by Subject|4
1150667|NCT01330628|3778824|P2|Overall Study|Didn't receive study treatment|0
1150668|NCT01330628|3778825|P1|Overall Study|Didn't receive study treatment|1
1150669|NCT01330628|3778824|P2|Overall Study|Withdrawn|6
1150670|NCT01330628|3778825|P1|Overall Study|Withdrawn|18
1150671|NCT01330628|3778824|P2|Overall Study|Adverse Event|25
1150672|NCT01330628|3778825|P1|Overall Study|Adverse Event|44
1150673|NCT01330628|3778824|P2|Overall Study|Lost to Follow-up|6
1150674|NCT01330628|3778825|P1|Overall Study|Lost to Follow-up|5
1150675|NCT01330628|3778824|P2|Overall Study|Death|3
1150676|NCT01330628|3778825|P1|Overall Study|Death|2
1150677|NCT01330433|3778835|P2|Overall Study|Lost to Follow-up|0
1150678|NCT01330433|3778836|P1|Overall Study|Lost to Follow-up|1
1150679|NCT01330433|3778835|P2|Overall Study|Death|3
1150680|NCT01330433|3778836|P1|Overall Study|Death|1
1150681|NCT01330381|3778875|P3|Open-label Treatment Period (16 Weeks)|Non-compliance|1
1150682|NCT01330381|3778876|P2|Open-label Treatment Period (16 Weeks)|Non-compliance|0
1150683|NCT01330381|3778877|P1|Open-label Treatment Period (16 Weeks)|Non-compliance|0
1150684|NCT01330381|3778875|P3|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
1150685|NCT01330381|3778876|P2|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0
1150686|NCT01330381|3778877|P1|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
1150687|NCT01330381|3778875|P3|Open-label Treatment Period (16 Weeks)|Adverse Event|0
1150688|NCT01330381|3778876|P2|Open-label Treatment Period (16 Weeks)|Adverse Event|0
1150689|NCT01330381|3778877|P1|Open-label Treatment Period (16 Weeks)|Adverse Event|2
1150690|NCT01330381|3778875|P3|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16
1150691|NCT01330381|3778876|P2|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0
1150692|NCT01330381|3778877|P1|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7
1150693|NCT01330381|3778875|P3|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0
1150694|NCT01330381|3778876|P2|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
1150695|NCT01330381|3778877|P1|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
1150696|NCT01330381|3778875|P3|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
1150697|NCT01330381|3778876|P2|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
1150698|NCT01330381|3778877|P1|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1
1150699|NCT01330381|3778875|P3|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
1150700|NCT01330381|3778876|P2|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
1150701|NCT01330381|3778877|P1|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1
1150702|NCT01330381|3778875|P3|Double-blind Treatment Period (8 Weeks)|Adverse Event|0
1150703|NCT01330381|3778876|P2|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
1150704|NCT01330381|3778877|P1|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
1150705|NCT01330381|3778875|P3|Double-blind Treatment Period (8 Weeks)|Non-compliance|0
1150706|NCT01330381|3778876|P2|Double-blind Treatment Period (8 Weeks)|Non-compliance|1
1150707|NCT01330381|3778877|P1|Double-blind Treatment Period (8 Weeks)|Non-compliance|2
1150708|NCT01330381|3778875|P3|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0
1150709|NCT01330381|3778876|P2|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4
1150710|NCT01330381|3778877|P1|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5
1150711|NCT01330316|3778938|P2|Overall Study|other than above|1
1150712|NCT01330316|3778939|P1|Overall Study|other than above|0
1150713|NCT01330316|3778938|P2|Overall Study|Withdrawal by Subject|1
1150714|NCT01330316|3778939|P1|Overall Study|Withdrawal by Subject|0
1150715|NCT01330316|3778938|P2|Overall Study|Lost to Follow-up|1
1150716|NCT01330316|3778939|P1|Overall Study|Lost to Follow-up|0
1150717|NCT01330316|3778938|P2|Overall Study|Lack of Efficacy|10
1150718|NCT01330316|3778939|P1|Overall Study|Lack of Efficacy|0
1150719|NCT01330316|3778938|P2|Overall Study|Adverse Event|2
1150720|NCT01330316|3778939|P1|Overall Study|Adverse Event|2
1150721|NCT01330303|3778975|P2|Period 1|Withdrawal by Subject|1
1150722|NCT01330303|3778976|P1|Period 1|Withdrawal by Subject|0
1150723|NCT01330303|3778975|P2|Period 1|Protocol Violation|1
1150724|NCT01330303|3778976|P1|Period 1|Protocol Violation|0
1150725|NCT01330303|3778975|P2|Period 1|Adverse Event|0
1150726|NCT01330303|3778976|P1|Period 1|Adverse Event|1
1150727|NCT01330108|3779023|P1|Overall Study|Withdrawal by Subject|4
1150728|NCT01330030|3779041|P2|Overall Study|Lost to Follow-up|17
1150729|NCT01330030|3779042|P1|Overall Study|Lost to Follow-up|16
1150730|NCT01330017|3779053|P5|Overall Study|Unknown Reason|2
1150731|NCT01330017|3779054|P4|Overall Study|Unknown Reason|7
1150732|NCT01330017|3779055|P3|Overall Study|Unknown Reason|5
1150733|NCT01330017|3779056|P2|Overall Study|Unknown Reason|3
1150734|NCT01330017|3779057|P1|Overall Study|Unknown Reason|5
1150735|NCT01330017|3779053|P5|Overall Study|Protocol Violation|0
1150736|NCT01330017|3779054|P4|Overall Study|Protocol Violation|1
1150737|NCT01330017|3779055|P3|Overall Study|Protocol Violation|0
1150738|NCT01330017|3779056|P2|Overall Study|Protocol Violation|0
1150739|NCT01330017|3779057|P1|Overall Study|Protocol Violation|0
1150740|NCT01330017|3779053|P5|Overall Study|Lost to Follow-up|0
1150741|NCT01330017|3779054|P4|Overall Study|Lost to Follow-up|0
1150742|NCT01330017|3779055|P3|Overall Study|Lost to Follow-up|1
1150743|NCT01330017|3779056|P2|Overall Study|Lost to Follow-up|0
1150744|NCT01330017|3779057|P1|Overall Study|Lost to Follow-up|0
1150745|NCT01330017|3779053|P5|Overall Study|Withdrawal by Subject|1
1150746|NCT01330017|3779054|P4|Overall Study|Withdrawal by Subject|0
1150747|NCT01330017|3779055|P3|Overall Study|Withdrawal by Subject|1
1150748|NCT01330017|3779056|P2|Overall Study|Withdrawal by Subject|0
1150749|NCT01330017|3779057|P1|Overall Study|Withdrawal by Subject|0
1150750|NCT01330017|3779053|P5|Overall Study|Adverse Event|0
1150751|NCT01330017|3779054|P4|Overall Study|Adverse Event|4
1150752|NCT01330017|3779055|P3|Overall Study|Adverse Event|1
1150753|NCT01330017|3779056|P2|Overall Study|Adverse Event|1
1150754|NCT01330017|3779057|P1|Overall Study|Adverse Event|0
1150755|NCT01329978|3779106|P5|Rerandomization Treatment Period|Withdrawal by Subject|1
1150756|NCT01329978|3779107|P4|Rerandomization Treatment Period|Withdrawal by Subject|0
1150757|NCT01329978|3779108|P3|Rerandomization Treatment Period|Withdrawal by Subject|0
1150758|NCT01329978|3779109|P2|Rerandomization Treatment Period|Withdrawal by Subject|0
1150759|NCT01329978|3779110|P1|Rerandomization Treatment Period|Withdrawal by Subject|0
1150760|NCT01329978|3779106|P5|Rerandomization Treatment Period|Lost to Follow-up|3
1150761|NCT01329978|3779107|P4|Rerandomization Treatment Period|Lost to Follow-up|5
1150762|NCT01329978|3779108|P3|Rerandomization Treatment Period|Lost to Follow-up|0
1150763|NCT01329978|3779109|P2|Rerandomization Treatment Period|Lost to Follow-up|0
1150764|NCT01329978|3779110|P1|Rerandomization Treatment Period|Lost to Follow-up|0
1150765|NCT01329978|3779106|P5|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
1150766|NCT01329978|3779107|P4|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
1150767|NCT01329978|3779108|P3|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
1150768|NCT01329978|3779109|P2|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1
1150769|NCT01329978|3779110|P1|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
1150770|NCT01329978|3779106|P5|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
1150771|NCT01329978|3779107|P4|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
1150772|NCT01329978|3779108|P3|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
1150773|NCT01329978|3779109|P2|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1
1150774|NCT01329978|3779110|P1|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
1150775|NCT01329978|3779106|P5|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
1150776|NCT01329978|3779107|P4|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
1150777|NCT01329978|3779108|P3|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3
1150778|NCT01329978|3779109|P2|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
1150779|NCT01329978|3779110|P1|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
1150780|NCT01329978|3779106|P5|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
1150781|NCT01329978|3779107|P4|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
1150782|NCT01329978|3779108|P3|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
1150783|NCT01329978|3779109|P2|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8
1150784|NCT01329978|3779110|P1|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
1150785|NCT01329978|3779106|P5|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
1150786|NCT01329978|3779107|P4|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
1150787|NCT01329978|3779108|P3|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
1150788|NCT01329978|3779109|P2|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2
1150789|NCT01329978|3779110|P1|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1
1150790|NCT01329939|3779184|P4|Overall Study|Adverse Event|3
1150791|NCT01329939|3779185|P3|Overall Study|Adverse Event|0
1150792|NCT01329939|3779186|P2|Overall Study|Adverse Event|0
1150793|NCT01329939|3779187|P1|Overall Study|Adverse Event|0
1150794|NCT01329939|3779184|P4|Overall Study|Withdrawal by Subject|0
1150795|NCT01329939|3779185|P3|Overall Study|Withdrawal by Subject|0
1150796|NCT01329939|3779186|P2|Overall Study|Withdrawal by Subject|1
1150797|NCT01329939|3779187|P1|Overall Study|Withdrawal by Subject|0
1150798|NCT01329939|3779184|P4|Overall Study|Lost to Follow-up|2
1150799|NCT01329939|3779185|P3|Overall Study|Lost to Follow-up|1
1150800|NCT01329939|3779186|P2|Overall Study|Lost to Follow-up|0
1150801|NCT01329939|3779187|P1|Overall Study|Lost to Follow-up|3
1150802|NCT01329562|3779251|P2|Overall Study|Physician Decision|1
1150803|NCT01329562|3779252|P1|Overall Study|Physician Decision|0
1150804|NCT01329562|3779251|P2|Overall Study|Subject withdrew due to personal issues.|2
1150805|NCT01329562|3779252|P1|Overall Study|Subject withdrew due to personal issues.|3
1150806|NCT01329562|3779251|P2|Overall Study|Lost to Follow-up|1
1150807|NCT01329562|3779252|P1|Overall Study|Lost to Follow-up|1
1150808|NCT01329562|3779251|P2|Overall Study|Protocol Violation|3
1150809|NCT01329562|3779252|P1|Overall Study|Protocol Violation|5
1150810|NCT01329549|3779301|P1|Overall Study|Adverse Event|1
1150811|NCT01329549|3779301|P1|Overall Study|Withdrawal by Subject|1
1150812|NCT01329419|3779312|P1|Overall Study|Protocol Violation|235
1150813|NCT01329263|3779320|P2|Overall Study|Withdrawal by Subject|2
1150814|NCT01329263|3779321|P1|Overall Study|Withdrawal by Subject|1
1150815|NCT01329263|3779320|P2|Overall Study|Lost to Follow-up|21
1150816|NCT01329263|3779321|P1|Overall Study|Lost to Follow-up|4
1150817|NCT01329029|3779358|P2|Overall Study|Met Pre-defined Discontinuation Criteria|1
1150818|NCT01329029|3779359|P1|Overall Study|Met Pre-defined Discontinuation Criteria|5
1150819|NCT01329029|3779358|P2|Overall Study|Lost to Follow-up|5
1150820|NCT01329029|3779359|P1|Overall Study|Lost to Follow-up|8
1150821|NCT01329029|3779358|P2|Overall Study|Physician Decision|13
1150822|NCT01329029|3779359|P1|Overall Study|Physician Decision|16
1150823|NCT01329029|3779358|P2|Overall Study|COPD Exacerbation|18
1150824|NCT01329029|3779359|P1|Overall Study|COPD Exacerbation|11
1150825|NCT01329029|3779358|P2|Overall Study|Other|20
1150826|NCT01329029|3779359|P1|Overall Study|Other|14
1150827|NCT01329029|3779358|P2|Overall Study|Death|19
1150828|NCT01329029|3779359|P1|Overall Study|Death|16
1150829|NCT01329029|3779358|P2|Overall Study|Adverse Event|29
1150830|NCT01329029|3779359|P1|Overall Study|Adverse Event|82
1150831|NCT01329029|3779358|P2|Overall Study|Withdrawal by Subject|87
1150832|NCT01329029|3779359|P1|Overall Study|Withdrawal by Subject|117
1150833|NCT01328951|3779449|P2|Overall Study|Not Specified|6
1150834|NCT01328951|3779450|P1|Overall Study|Not Specified|11
1150835|NCT01328951|3779449|P2|Overall Study|Study Closed by the Sponsor|31
1150836|NCT01328951|3779450|P1|Overall Study|Study Closed by the Sponsor|36
1150837|NCT01328951|3779449|P2|Overall Study|Withdrawal by Subject|6
1150838|NCT01328951|3779450|P1|Overall Study|Withdrawal by Subject|6
1150839|NCT01328951|3779449|P2|Overall Study|Lost to Follow-up|7
1150840|NCT01328951|3779450|P1|Overall Study|Lost to Follow-up|6
1150841|NCT01328951|3779449|P2|Overall Study|Death|258
1150842|NCT01328951|3779450|P1|Overall Study|Death|243
1150843|NCT01328951|3779449|P2|Overall Study|Adverse Event|0
1150844|NCT01328951|3779450|P1|Overall Study|Adverse Event|2
1150845|NCT01328951|3779449|P2|Overall Study|Disease Progression|14
1150846|NCT01328951|3779450|P1|Overall Study|Disease Progression|17
1150847|NCT01328756|3779519|P1|Overall Study|Other|29
1150848|NCT01328756|3779519|P1|Overall Study|Lost to Follow-up|5
1150849|NCT01328756|3779519|P1|Overall Study|Withdrawal by Subject|41
1150850|NCT01328756|3779519|P1|Overall Study|Lack of Efficacy|5
1150851|NCT01328756|3779519|P1|Overall Study|Adverse Event|39
1150852|NCT01328756|3779519|P1|Overall Study|Protocol Violation|4
1150853|NCT01328717|3779536|P1|Overall Study|Adverse Event|1
1150854|NCT01328574|3779541|P1|Overall Study|Refused further treatment|1
1150855|NCT01328548|3779555|P2|Overall Study|Protocol Violation|0
1150856|NCT01328548|3779556|P1|Overall Study|Protocol Violation|1
1150857|NCT01328548|3779555|P2|Overall Study|Death|0
1150858|NCT01328548|3779556|P1|Overall Study|Death|3
1150859|NCT01328535|3779574|P1|Overall Study|Ineligible|1
1150860|NCT01328496|3779585|P2|Overall Study|Significant Change in Health Status|0
1150861|NCT01328496|3779586|P1|Overall Study|Significant Change in Health Status|1
1150862|NCT01328444|3779604|P6|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
1150863|NCT01328444|3779605|P5|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
1150864|NCT01328444|3779606|P4|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
1150865|NCT01328444|3779607|P3|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
1150866|NCT01328444|3779608|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
1150867|NCT01328444|3779609|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
1150868|NCT01328444|3779604|P6|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
1150869|NCT01328444|3779605|P5|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
1150870|NCT01328444|3779606|P4|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
1150871|NCT01328444|3779607|P3|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
1150872|NCT01328444|3779608|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
1150873|NCT01328444|3779609|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
1150874|NCT01328444|3779604|P6|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
1150875|NCT01328444|3779605|P5|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
1150876|NCT01328444|3779606|P4|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
1150877|NCT01328444|3779607|P3|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
1150878|NCT01328444|3779608|P2|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
1150879|NCT01328444|3779609|P1|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
1150880|NCT01328444|3779604|P6|Treatment Period 2 (12 Weeks)|Protocol Violation|0
1150881|NCT01328444|3779605|P5|Treatment Period 2 (12 Weeks)|Protocol Violation|1
1150882|NCT01328444|3779606|P4|Treatment Period 2 (12 Weeks)|Protocol Violation|0
1150883|NCT01328444|3779607|P3|Treatment Period 2 (12 Weeks)|Protocol Violation|0
1150884|NCT01328444|3779608|P2|Treatment Period 2 (12 Weeks)|Protocol Violation|0
1150885|NCT01328444|3779609|P1|Treatment Period 2 (12 Weeks)|Protocol Violation|1
1150886|NCT01328444|3779604|P6|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4
1150887|NCT01328444|3779605|P5|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
1150888|NCT01328444|3779606|P4|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
1150889|NCT01328444|3779607|P3|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
1150890|NCT01328444|3779608|P2|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
1150891|NCT01328444|3779609|P1|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5
1150892|NCT01328444|3779604|P6|Treatment Period 2 (12 Weeks)|Adverse Event|0
1150893|NCT01328444|3779605|P5|Treatment Period 2 (12 Weeks)|Adverse Event|1
1150894|NCT01328444|3779606|P4|Treatment Period 2 (12 Weeks)|Adverse Event|1
1150895|NCT01328444|3779607|P3|Treatment Period 2 (12 Weeks)|Adverse Event|1
1150896|NCT01328444|3779608|P2|Treatment Period 2 (12 Weeks)|Adverse Event|0
1150897|NCT01328444|3779609|P1|Treatment Period 2 (12 Weeks)|Adverse Event|5
1150898|NCT01328444|3779604|P6|Washout Period (14 Days)|Withdrawal by Subject|1
1150899|NCT01328444|3779605|P5|Washout Period (14 Days)|Withdrawal by Subject|0
1150900|NCT01328444|3779606|P4|Washout Period (14 Days)|Withdrawal by Subject|0
1150901|NCT01328444|3779607|P3|Washout Period (14 Days)|Withdrawal by Subject|0
1150902|NCT01328444|3779608|P2|Washout Period (14 Days)|Withdrawal by Subject|0
1150903|NCT01328444|3779609|P1|Washout Period (14 Days)|Withdrawal by Subject|0
1150904|NCT01328444|3779604|P6|Washout Period (14 Days)|Lack of Efficacy|1
1150905|NCT01328444|3779605|P5|Washout Period (14 Days)|Lack of Efficacy|0
1150906|NCT01328444|3779606|P4|Washout Period (14 Days)|Lack of Efficacy|0
1150907|NCT01328444|3779607|P3|Washout Period (14 Days)|Lack of Efficacy|0
1150908|NCT01328444|3779608|P2|Washout Period (14 Days)|Lack of Efficacy|0
1150909|NCT01328444|3779609|P1|Washout Period (14 Days)|Lack of Efficacy|0
1150910|NCT01328444|3779604|P6|Washout Period (14 Days)|Adverse Event|2
1150911|NCT01328444|3779605|P5|Washout Period (14 Days)|Adverse Event|1
1150912|NCT01328444|3779606|P4|Washout Period (14 Days)|Adverse Event|1
1150913|NCT01328444|3779607|P3|Washout Period (14 Days)|Adverse Event|0
1150914|NCT01328444|3779608|P2|Washout Period (14 Days)|Adverse Event|1
1150915|NCT01328444|3779609|P1|Washout Period (14 Days)|Adverse Event|1
1150916|NCT01328444|3779604|P6|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
1150917|NCT01328444|3779605|P5|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
1150918|NCT01328444|3779606|P4|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
1150919|NCT01328444|3779607|P3|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
1150920|NCT01328444|3779608|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
1150921|NCT01328444|3779609|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
1150922|NCT01328444|3779604|P6|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
1150923|NCT01328444|3779605|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1150924|NCT01328444|3779606|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
1150925|NCT01328444|3779607|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1150926|NCT01328444|3779608|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1150927|NCT01328444|3779609|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2
1150928|NCT01328444|3779604|P6|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
1150929|NCT01328444|3779605|P5|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2
1150930|NCT01328444|3779606|P4|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
1150931|NCT01328444|3779607|P3|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
1150932|NCT01328444|3779608|P2|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1
1150933|NCT01328444|3779609|P1|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
1150934|NCT01328444|3779604|P6|Treatment Period 1 (12 Weeks)|Protocol Violation|1
1150935|NCT01328444|3779605|P5|Treatment Period 1 (12 Weeks)|Protocol Violation|0
1150936|NCT01328444|3779606|P4|Treatment Period 1 (12 Weeks)|Protocol Violation|1
1150937|NCT01328444|3779607|P3|Treatment Period 1 (12 Weeks)|Protocol Violation|0
1150938|NCT01328444|3779608|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|0
1150939|NCT01328444|3779609|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|0
1150940|NCT01328444|3779604|P6|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
1150941|NCT01328444|3779605|P5|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
1150942|NCT01328444|3779606|P4|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
1150943|NCT01328444|3779607|P3|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
1150944|NCT01328444|3779608|P2|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
1150945|NCT01328444|3779609|P1|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
1150946|NCT01328444|3779604|P6|Treatment Period 1 (12 Weeks)|Adverse Event|2
1150947|NCT01328444|3779605|P5|Treatment Period 1 (12 Weeks)|Adverse Event|5
1150948|NCT01328444|3779606|P4|Treatment Period 1 (12 Weeks)|Adverse Event|3
1150949|NCT01328444|3779607|P3|Treatment Period 1 (12 Weeks)|Adverse Event|1
1150950|NCT01328444|3779608|P2|Treatment Period 1 (12 Weeks)|Adverse Event|1
1150951|NCT01328444|3779609|P1|Treatment Period 1 (12 Weeks)|Adverse Event|3
1150952|NCT01328431|3779655|P2|12 Month (12M)|Lost to Follow-up|91
1150953|NCT01328431|3779656|P1|12 Month (12M)|Lost to Follow-up|82
1150954|NCT01328431|3779655|P2|12 Month (12M)|Death|6
1150955|NCT01328431|3779656|P1|12 Month (12M)|Death|2
1150956|NCT01328431|3779655|P2|3 Month (3M)|Lost to Follow-up|70
1150957|NCT01328431|3779656|P1|3 Month (3M)|Lost to Follow-up|75
1150958|NCT01328431|3779655|P2|3 Month (3M)|Death|2
1150959|NCT01328431|3779656|P1|3 Month (3M)|Death|2
1150960|NCT01328431|3779655|P2|1 Month (1M)|Lost to Follow-up|58
1150961|NCT01328431|3779656|P1|1 Month (1M)|Lost to Follow-up|55
1150962|NCT01328431|3779655|P2|Baseline|Protocol Violation|2
1150963|NCT01328431|3779656|P1|Baseline|Protocol Violation|0
1150964|NCT01328366|3779712|P1|Overall Study|Lost to Follow-up|7
1150965|NCT01328366|3779712|P1|Overall Study|Withdrawal by Subject|2
1150966|NCT01328366|3779712|P1|Overall Study|Death|1
1150967|NCT01328249|3779732|P2|Overall Study|Protocol Violation|1
1150968|NCT01328249|3779733|P1|Overall Study|Protocol Violation|0
1150969|NCT01328249|3779732|P2|Overall Study|Subject choice|1
1150970|NCT01328249|3779733|P1|Overall Study|Subject choice|1
1150971|NCT01328249|3779732|P2|Overall Study|Moved before end of treatment visit|0
1150972|NCT01328249|3779733|P1|Overall Study|Moved before end of treatment visit|1
1150973|NCT01328249|3779732|P2|Overall Study|Withdrawal by Subject|1
1150974|NCT01328249|3779733|P1|Overall Study|Withdrawal by Subject|1
1150975|NCT01328249|3779732|P2|Overall Study|Disease progression|0
1150976|NCT01328249|3779733|P1|Overall Study|Disease progression|1
1150977|NCT01328249|3779732|P2|Overall Study|Adverse Event|0
1150978|NCT01328249|3779733|P1|Overall Study|Adverse Event|3
1150979|NCT01328080|3779819|P1|Overall Study|Lost to Follow-up|5
1150980|NCT01328054|3779823|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2
1150981|NCT01328054|3779824|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0
1150982|NCT01328054|3779823|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1
1150983|NCT01328054|3779824|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0
1150984|NCT01328054|3779823|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2
1150985|NCT01328054|3779824|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0
1150986|NCT01328041|3779849|P1|Overall Study|Withdrawal by Subject|7
1150987|NCT01328041|3779849|P1|Overall Study|Physician Decision|2
1150988|NCT01328041|3779849|P1|Overall Study|Lost to Follow-up|7
1150989|NCT01328041|3779849|P1|Overall Study|Protocol Violation|7
1150990|NCT01328041|3779849|P1|Overall Study|Lack of Efficacy|27
1150991|NCT01328041|3779849|P1|Overall Study|Adverse Event|7
1150992|NCT01327885|3779898|P2|Overall Study|Ongoing|1
1150993|NCT01327885|3779899|P1|Overall Study|Ongoing|1
1150994|NCT01327885|3779898|P2|Overall Study|Not treated|1
1150995|NCT01327885|3779899|P1|Overall Study|Not treated|1
1150996|NCT01327885|3779898|P2|Overall Study|Withdrawal of consent from study|4
1150997|NCT01327885|3779899|P1|Overall Study|Withdrawal of consent from study|2
1150998|NCT01327885|3779898|P2|Overall Study|Not specified|6
1150999|NCT01327885|3779899|P1|Overall Study|Not specified|8
1151000|NCT01327885|3779898|P2|Overall Study|Subject choice|10
1151001|NCT01327885|3779899|P1|Overall Study|Subject choice|5
1151002|NCT01327885|3779898|P2|Overall Study|Adverse Event|10
1151003|NCT01327885|3779899|P1|Overall Study|Adverse Event|14
1151004|NCT01327885|3779898|P2|Overall Study|Clinical progression|27
1151005|NCT01327885|3779899|P1|Overall Study|Clinical progression|24
1151006|NCT01327885|3779898|P2|Overall Study|Disease progression-according to RECIST|165
1151007|NCT01327885|3779899|P1|Overall Study|Disease progression-according to RECIST|173
1151008|NCT01327703|3779911|P2|Second Treatment Period|Protocol Violation|1
1151009|NCT01327703|3779912|P1|Second Treatment Period|Protocol Violation|0
1151010|NCT01327703|3779911|P2|Second Treatment Period|Adverse Event|1
1151011|NCT01327703|3779912|P1|Second Treatment Period|Adverse Event|1
1151012|NCT01327651|3779968|P9|Post Study Follow-up|Lost to Follow-up|2
1151013|NCT01327651|3779969|P8|Post Study Follow-up|Lost to Follow-up|1
1151014|NCT01327651|3779970|P7|Post Study Follow-up|Lost to Follow-up|4
1151015|NCT01327651|3779971|P6|Post Study Follow-up|Lost to Follow-up|0
1151016|NCT01327651|3779972|P5|Post Study Follow-up|Lost to Follow-up|0
1151017|NCT01327651|3779973|P4|Post Study Follow-up|Lost to Follow-up|0
1151018|NCT01327651|3779974|P3|Post Study Follow-up|Lost to Follow-up|1
1151019|NCT01327651|3779975|P2|Post Study Follow-up|Lost to Follow-up|1
1151020|NCT01327651|3779976|P1|Post Study Follow-up|Lost to Follow-up|0
1151021|NCT01327651|3779968|P9|Self-administered Dosing Period|Withdrawal by Subject|1
1151022|NCT01327651|3779969|P8|Self-administered Dosing Period|Withdrawal by Subject|1
1151023|NCT01327651|3779970|P7|Self-administered Dosing Period|Withdrawal by Subject|2
1151024|NCT01327651|3779971|P6|Self-administered Dosing Period|Withdrawal by Subject|0
1151025|NCT01327651|3779972|P5|Self-administered Dosing Period|Withdrawal by Subject|0
1151026|NCT01327651|3779973|P4|Self-administered Dosing Period|Withdrawal by Subject|1
1151027|NCT01327651|3779974|P3|Self-administered Dosing Period|Withdrawal by Subject|0
1151028|NCT01327651|3779975|P2|Self-administered Dosing Period|Withdrawal by Subject|1
1151029|NCT01327651|3779976|P1|Self-administered Dosing Period|Withdrawal by Subject|0
1151030|NCT01327651|3779968|P9|Self-administered Dosing Period|Ineligible (retrospective result)|0
1151031|NCT01327651|3779969|P8|Self-administered Dosing Period|Ineligible (retrospective result)|0
1151032|NCT01327651|3779970|P7|Self-administered Dosing Period|Ineligible (retrospective result)|0
1151033|NCT01327651|3779971|P6|Self-administered Dosing Period|Ineligible (retrospective result)|0
1151034|NCT01327651|3779972|P5|Self-administered Dosing Period|Ineligible (retrospective result)|0
1151035|NCT01327651|3779973|P4|Self-administered Dosing Period|Ineligible (retrospective result)|0
1151036|NCT01327651|3779974|P3|Self-administered Dosing Period|Ineligible (retrospective result)|0
1151037|NCT01327651|3779975|P2|Self-administered Dosing Period|Ineligible (retrospective result)|0
1151038|NCT01327651|3779976|P1|Self-administered Dosing Period|Ineligible (retrospective result)|1
1151039|NCT01327651|3779968|P9|Self-administered Dosing Period|Lost to Follow-up|10
1151040|NCT01327651|3779969|P8|Self-administered Dosing Period|Lost to Follow-up|9
1151041|NCT01327651|3779970|P7|Self-administered Dosing Period|Lost to Follow-up|8
1151042|NCT01327651|3779971|P6|Self-administered Dosing Period|Lost to Follow-up|0
1151043|NCT01327651|3779972|P5|Self-administered Dosing Period|Lost to Follow-up|3
1151044|NCT01327651|3779973|P4|Self-administered Dosing Period|Lost to Follow-up|2
1151045|NCT01327651|3779974|P3|Self-administered Dosing Period|Lost to Follow-up|4
1151046|NCT01327651|3779975|P2|Self-administered Dosing Period|Lost to Follow-up|2
1151047|NCT01327651|3779976|P1|Self-administered Dosing Period|Lost to Follow-up|3
1151048|NCT01327599|3780095|P1|Overall Study|Withdrawal of Consent|1
1151049|NCT01327599|3780095|P1|Overall Study|Could Not Attend Visit|1
1151050|NCT01327599|3780095|P1|Overall Study|Adverse Event|1
1151051|NCT01327547|3780105|P2|Overall Study|By investigator in subject’s interest|1
1151052|NCT01327547|3780106|P1|Overall Study|By investigator in subject’s interest|0
1151053|NCT01327547|3780105|P2|Overall Study|Non-compliance with study procedures|0
1151054|NCT01327547|3780106|P1|Overall Study|Non-compliance with study procedures|1
1151055|NCT01327547|3780105|P2|Overall Study|Required prohibited medication|0
1151056|NCT01327547|3780106|P1|Overall Study|Required prohibited medication|2
1151057|NCT01327547|3780105|P2|Overall Study|Non-compliance due to alcohol intake|1
1151058|NCT01327547|3780106|P1|Overall Study|Non-compliance due to alcohol intake|0
1151059|NCT01327547|3780105|P2|Overall Study|Protocol Violation|0
1151060|NCT01327547|3780106|P1|Overall Study|Protocol Violation|1
1151061|NCT01327547|3780105|P2|Overall Study|Does Not Meet Entrance Criteria|2
1151062|NCT01327547|3780106|P1|Overall Study|Does Not Meet Entrance Criteria|2
1151063|NCT01327547|3780105|P2|Overall Study|Withdrawal by Subject|7
1151064|NCT01327547|3780106|P1|Overall Study|Withdrawal by Subject|3
1151065|NCT01327547|3780105|P2|Overall Study|Non-Compliance With Study Treatment|2
1151066|NCT01327547|3780106|P1|Overall Study|Non-Compliance With Study Treatment|0
1151067|NCT01327547|3780105|P2|Overall Study|Lost to Follow-up|6
1151068|NCT01327547|3780106|P1|Overall Study|Lost to Follow-up|6
1151069|NCT01327547|3780105|P2|Overall Study|Death|2
1151070|NCT01327547|3780106|P1|Overall Study|Death|1
1151071|NCT01327547|3780105|P2|Overall Study|Adverse Event|1
1151072|NCT01327547|3780106|P1|Overall Study|Adverse Event|4
1151073|NCT01327495|3780174|P6|Overall Study|Physician Decision|0
1151074|NCT01327495|3780175|P5|Overall Study|Physician Decision|2
1151075|NCT01327495|3780176|P4|Overall Study|Physician Decision|0
1151076|NCT01327495|3780177|P3|Overall Study|Physician Decision|0
1151077|NCT01327495|3780178|P2|Overall Study|Physician Decision|0
1151078|NCT01327495|3780179|P1|Overall Study|Physician Decision|0
1151079|NCT01327495|3780174|P6|Overall Study|Withdrawal by Subject|0
1151080|NCT01327495|3780175|P5|Overall Study|Withdrawal by Subject|1
1151081|NCT01327495|3780176|P4|Overall Study|Withdrawal by Subject|0
1151082|NCT01327495|3780177|P3|Overall Study|Withdrawal by Subject|1
1151083|NCT01327495|3780178|P2|Overall Study|Withdrawal by Subject|1
1151084|NCT01327495|3780179|P1|Overall Study|Withdrawal by Subject|0
1151085|NCT01327495|3780174|P6|Overall Study|Adverse Event|2
1151086|NCT01327495|3780175|P5|Overall Study|Adverse Event|0
1151087|NCT01327495|3780176|P4|Overall Study|Adverse Event|0
1151088|NCT01327495|3780177|P3|Overall Study|Adverse Event|1
1151089|NCT01327495|3780178|P2|Overall Study|Adverse Event|1
1151090|NCT01327495|3780179|P1|Overall Study|Adverse Event|2
1151091|NCT01327482|3780271|P1|Overall Study|Adverse Event|1
1151092|NCT01327339|3780276|P1|Overall Study|Protocol Violation|8
1151093|NCT01327300|3780411|P2|Washout (3 Weeks)|Withdrawal by Subject|0
1151094|NCT01327300|3780412|P1|Washout (3 Weeks)|Withdrawal by Subject|1
1151095|NCT01327053|3780452|P2|Overall Study|Untreated|1
1151096|NCT01327053|3780453|P1|Overall Study|Untreated|0
1151097|NCT01327053|3780452|P2|Overall Study|Withdrawal by Subject|28
1151098|NCT01327053|3780453|P1|Overall Study|Withdrawal by Subject|5
1151099|NCT01327053|3780452|P2|Overall Study|Protocol Violation|1
1151100|NCT01327053|3780453|P1|Overall Study|Protocol Violation|0
1151101|NCT01327053|3780452|P2|Overall Study|Progressive Disease|6
1151102|NCT01327053|3780453|P1|Overall Study|Progressive Disease|15
1151103|NCT01327053|3780452|P2|Overall Study|Physician Decision|10
1151104|NCT01327053|3780453|P1|Overall Study|Physician Decision|3
1151105|NCT01327053|3780452|P2|Overall Study|Non-compliance with study treatment|3
1151106|NCT01327053|3780453|P1|Overall Study|Non-compliance with study treatment|0
1151107|NCT01327053|3780452|P2|Overall Study|Lost to Follow-up|4
1151108|NCT01327053|3780453|P1|Overall Study|Lost to Follow-up|1
1151109|NCT01327053|3780452|P2|Overall Study|Death|4
1151110|NCT01327053|3780453|P1|Overall Study|Death|0
1151111|NCT01327053|3780452|P2|Overall Study|Adverse Event|48
1151112|NCT01327053|3780453|P1|Overall Study|Adverse Event|16
1151113|NCT01326962|3780481|P1|Overall Study|Not Specified|2
1151114|NCT01326962|3780481|P1|Overall Study|Lost to Follow-up|3
1151115|NCT01326962|3780481|P1|Overall Study|Withdrawal by Subject|1
1151116|NCT01326962|3780481|P1|Overall Study|Adverse Event|1
1151117|NCT01326910|3780499|P2|Overall Study|Protocol Violation|1
1151118|NCT01326910|3780500|P1|Overall Study|Protocol Violation|1
1151119|NCT01326910|3780499|P2|Overall Study|Withdrawal by Subject|2
1151120|NCT01326910|3780500|P1|Overall Study|Withdrawal by Subject|3
1151121|NCT01326845|3780514|P2|Overall Study|Misisng|3
1151122|NCT01326845|3780515|P1|Overall Study|Misisng|1
1151123|NCT01326845|3780514|P2|Overall Study|Adverse Event|0
1151124|NCT01326845|3780515|P1|Overall Study|Adverse Event|1
1151125|NCT01326845|3780514|P2|Overall Study|Administrative Problems|2
1151126|NCT01326845|3780515|P1|Overall Study|Administrative Problems|5
1151127|NCT01326728|3780576|P2|Overall Study|Early closure of study|9
1151128|NCT01326728|3780577|P1|Overall Study|Early closure of study|34
1151129|NCT01326728|3780576|P2|Overall Study|Death|0
1151130|NCT01326728|3780577|P1|Overall Study|Death|13
1151131|NCT01326533|3780596|P2|Overall Study|Adverse Event|0
1151132|NCT01326533|3780597|P1|Overall Study|Adverse Event|1
1151133|NCT01326533|3780596|P2|Overall Study|Withdrawal by Subject|0
1151134|NCT01326533|3780597|P1|Overall Study|Withdrawal by Subject|1
1151135|NCT01326533|3780596|P2|Overall Study|Lost to Follow-up|0
1151136|NCT01326533|3780597|P1|Overall Study|Lost to Follow-up|2
1151137|NCT01326026|3780607|P2|Overall Study|Other|3
1151138|NCT01326026|3780608|P1|Overall Study|Other|3
1151139|NCT01326026|3780607|P2|Overall Study|Withdrawal Criteria|7
1151140|NCT01326026|3780608|P1|Overall Study|Withdrawal Criteria|5
1151141|NCT01326026|3780607|P2|Overall Study|Adverse Event|3
1151142|NCT01326026|3780608|P1|Overall Study|Adverse Event|4
1151143|NCT01325701|3780673|P2|Overall Study|Rollerover Extension Study|0
1151144|NCT01325701|3780674|P1|Overall Study|Rollerover Extension Study|4
1151145|NCT01325701|3780673|P2|Overall Study|Withdrawal by Subject|1
1151146|NCT01325701|3780674|P1|Overall Study|Withdrawal by Subject|2
1151147|NCT01325701|3780673|P2|Overall Study|Physician Decision|2
1151148|NCT01325701|3780674|P1|Overall Study|Physician Decision|2
1151149|NCT01325701|3780673|P2|Overall Study|Protocol Violation|0
1151150|NCT01325701|3780674|P1|Overall Study|Protocol Violation|1
1151151|NCT01325701|3780673|P2|Overall Study|Adverse Event|0
1151152|NCT01325701|3780674|P1|Overall Study|Adverse Event|12
1151153|NCT01325623|3780684|P1|Overall Study|Withdrawal by Subject|3
1151154|NCT01325584|3780726|P1|Overall Study|Death|1
1151155|NCT01325532|3780736|P2|Overall Study|Withdrawal by Subject|0
1151156|NCT01325532|3780737|P1|Overall Study|Withdrawal by Subject|2
1151157|NCT01325493|3780749|P2|Overall Study|Allergy|0
1151158|NCT01325493|3780750|P1|Overall Study|Allergy|1
1151159|NCT01325493|3780749|P2|Overall Study|loss of neuromonitoring signals|2
1151160|NCT01325493|3780750|P1|Overall Study|loss of neuromonitoring signals|0
1151161|NCT01325493|3780749|P2|Overall Study|Protocol Violation|1
1151162|NCT01325493|3780750|P1|Overall Study|Protocol Violation|0
1151163|NCT01325428|3780762|P1|Part B|Other reason not defined above|1
1151164|NCT01325428|3780762|P1|Part B|Refused continue taking trial medication|2
1151165|NCT01325428|3780762|P1|Part A|Other reason not defined above|2
1151166|NCT01325428|3780762|P1|Part A|Refused continue taking trial medication|2
1151167|NCT01325428|3780762|P1|Part A|Other adverse event|1
1151168|NCT01325428|3780762|P1|Part A|Clinical signs, symptoms of progression|2
1151169|NCT01325428|3780762|P1|Part A|Progressive disease according to RECIST|9
1151170|NCT01325350|3780782|P5|Overall Study|Did Not Receive Treatment|1
1151171|NCT01325350|3780783|P4|Overall Study|Did Not Receive Treatment|0
1151172|NCT01325350|3780784|P3|Overall Study|Did Not Receive Treatment|1
1151173|NCT01325350|3780785|P2|Overall Study|Did Not Receive Treatment|1
1151174|NCT01325350|3780786|P1|Overall Study|Did Not Receive Treatment|0
1151175|NCT01325350|3780782|P5|Overall Study|Withdrawal by Subject|0
1151176|NCT01325350|3780783|P4|Overall Study|Withdrawal by Subject|1
1151177|NCT01325350|3780784|P3|Overall Study|Withdrawal by Subject|1
1151178|NCT01325350|3780785|P2|Overall Study|Withdrawal by Subject|0
1151179|NCT01325350|3780786|P1|Overall Study|Withdrawal by Subject|0
1151180|NCT01325350|3780782|P5|Overall Study|Protocol Violation|0
1151181|NCT01325350|3780783|P4|Overall Study|Protocol Violation|1
1151182|NCT01325350|3780784|P3|Overall Study|Protocol Violation|0
1151183|NCT01325350|3780785|P2|Overall Study|Protocol Violation|0
1151184|NCT01325350|3780786|P1|Overall Study|Protocol Violation|0
1151185|NCT01325350|3780782|P5|Overall Study|Personal Reasons|3
1151186|NCT01325350|3780783|P4|Overall Study|Personal Reasons|5
1151187|NCT01325350|3780784|P3|Overall Study|Personal Reasons|6
1151188|NCT01325350|3780785|P2|Overall Study|Personal Reasons|1
1151189|NCT01325350|3780786|P1|Overall Study|Personal Reasons|2
1151190|NCT01325350|3780782|P5|Overall Study|Lost to Follow-up|5
1151191|NCT01325350|3780783|P4|Overall Study|Lost to Follow-up|1
1151192|NCT01325350|3780784|P3|Overall Study|Lost to Follow-up|5
1151193|NCT01325350|3780785|P2|Overall Study|Lost to Follow-up|0
1151194|NCT01325350|3780786|P1|Overall Study|Lost to Follow-up|1
1151195|NCT01325350|3780782|P5|Overall Study|Pregnancy|1
1151196|NCT01325350|3780783|P4|Overall Study|Pregnancy|0
1151197|NCT01325350|3780784|P3|Overall Study|Pregnancy|1
1151198|NCT01325350|3780785|P2|Overall Study|Pregnancy|0
1151199|NCT01325350|3780786|P1|Overall Study|Pregnancy|0
1151200|NCT01325350|3780782|P5|Overall Study|Adverse Event|2
1151201|NCT01325350|3780783|P4|Overall Study|Adverse Event|1
1151202|NCT01325350|3780784|P3|Overall Study|Adverse Event|3
1151203|NCT01325350|3780785|P2|Overall Study|Adverse Event|3
1151204|NCT01325350|3780786|P1|Overall Study|Adverse Event|3
1151205|NCT01325337|3780828|P5|Overall Study|Withdrawal by Subject|1
1151206|NCT01325337|3780829|P4|Overall Study|Withdrawal by Subject|0
1151207|NCT01325337|3780830|P3|Overall Study|Withdrawal by Subject|1
1151208|NCT01325337|3780831|P2|Overall Study|Withdrawal by Subject|0
1151209|NCT01325337|3780832|P1|Overall Study|Withdrawal by Subject|1
1151210|NCT01325337|3780828|P5|Overall Study|Personal Reasons|3
1151211|NCT01325337|3780829|P4|Overall Study|Personal Reasons|8
1151212|NCT01325337|3780830|P3|Overall Study|Personal Reasons|4
1151213|NCT01325337|3780831|P2|Overall Study|Personal Reasons|5
1151214|NCT01325337|3780832|P1|Overall Study|Personal Reasons|2
1151215|NCT01325337|3780828|P5|Overall Study|Lost to Follow-up|2
1151216|NCT01325337|3780829|P4|Overall Study|Lost to Follow-up|1
1151217|NCT01325337|3780830|P3|Overall Study|Lost to Follow-up|2
1151218|NCT01325337|3780831|P2|Overall Study|Lost to Follow-up|2
1151219|NCT01325337|3780832|P1|Overall Study|Lost to Follow-up|2
1151220|NCT01325337|3780828|P5|Overall Study|Adverse Event|2
1151221|NCT01325337|3780829|P4|Overall Study|Adverse Event|1
1151222|NCT01325337|3780830|P3|Overall Study|Adverse Event|2
1151223|NCT01325337|3780831|P2|Overall Study|Adverse Event|2
1151224|NCT01325337|3780832|P1|Overall Study|Adverse Event|0
1151225|NCT01324999|3780915|P1|Overall Study|Withdrawal by Subject|2
1151226|NCT01324999|3780915|P1|Overall Study|Adverse Event|3
1151227|NCT01324947|3780926|P1|Overall Study|1 discontinued before starting drug|1
1151228|NCT01324947|3780926|P1|Overall Study|Withdrawal by Subject|3
1151229|NCT01324947|3780926|P1|Overall Study|Progressive Disease|50
1151230|NCT01324947|3780926|P1|Overall Study|Other|3
1151231|NCT01324947|3780926|P1|Overall Study|Death|10
1151232|NCT01324947|3780926|P1|Overall Study|Adverse Event|7
1151233|NCT01324830|3780967|P19|Overall Study|Withdrawal by Subject|1
1151234|NCT01324830|3780968|P18|Overall Study|Withdrawal by Subject|0
1151235|NCT01324830|3780969|P17|Overall Study|Withdrawal by Subject|0
1151236|NCT01324830|3780970|P16|Overall Study|Withdrawal by Subject|0
1151237|NCT01324830|3780971|P15|Overall Study|Withdrawal by Subject|0
1151238|NCT01324830|3780972|P14|Overall Study|Withdrawal by Subject|0
1151239|NCT01324830|3780973|P13|Overall Study|Withdrawal by Subject|0
1151240|NCT01324830|3780974|P12|Overall Study|Withdrawal by Subject|0
1151241|NCT01324830|3780975|P11|Overall Study|Withdrawal by Subject|1
1151242|NCT01324830|3780976|P10|Overall Study|Withdrawal by Subject|0
1151243|NCT01324830|3780977|P9|Overall Study|Withdrawal by Subject|0
1151244|NCT01324830|3780978|P8|Overall Study|Withdrawal by Subject|0
1151245|NCT01324830|3780979|P7|Overall Study|Withdrawal by Subject|0
1151246|NCT01324830|3780980|P6|Overall Study|Withdrawal by Subject|1
1151247|NCT01324830|3780981|P5|Overall Study|Withdrawal by Subject|0
1151248|NCT01324830|3780982|P4|Overall Study|Withdrawal by Subject|0
1151249|NCT01324830|3780983|P3|Overall Study|Withdrawal by Subject|0
1151250|NCT01324830|3780984|P2|Overall Study|Withdrawal by Subject|0
1151251|NCT01324830|3780985|P1|Overall Study|Withdrawal by Subject|0
1151252|NCT01324830|3780967|P19|Overall Study|Adverse Event, non-fatal|0
1151253|NCT01324830|3780968|P18|Overall Study|Adverse Event, non-fatal|1
1151254|NCT01324830|3780969|P17|Overall Study|Adverse Event, non-fatal|0
1151255|NCT01324830|3780970|P16|Overall Study|Adverse Event, non-fatal|0
1151256|NCT01324830|3780971|P15|Overall Study|Adverse Event, non-fatal|0
1151257|NCT01324830|3780972|P14|Overall Study|Adverse Event, non-fatal|0
1151258|NCT01324830|3780973|P13|Overall Study|Adverse Event, non-fatal|0
1151259|NCT01324830|3780974|P12|Overall Study|Adverse Event, non-fatal|0
1151260|NCT01324830|3780975|P11|Overall Study|Adverse Event, non-fatal|1
1151261|NCT01324830|3780976|P10|Overall Study|Adverse Event, non-fatal|0
1151262|NCT01324830|3780977|P9|Overall Study|Adverse Event, non-fatal|2
1151263|NCT01324830|3780978|P8|Overall Study|Adverse Event, non-fatal|0
1151264|NCT01324830|3780979|P7|Overall Study|Adverse Event, non-fatal|0
1151265|NCT01324830|3780980|P6|Overall Study|Adverse Event, non-fatal|0
1151266|NCT01324830|3780981|P5|Overall Study|Adverse Event, non-fatal|0
1151267|NCT01324830|3780982|P4|Overall Study|Adverse Event, non-fatal|0
1151268|NCT01324830|3780983|P3|Overall Study|Adverse Event, non-fatal|0
1151269|NCT01324830|3780984|P2|Overall Study|Adverse Event, non-fatal|0
1151270|NCT01324830|3780985|P1|Overall Study|Adverse Event, non-fatal|0
1151271|NCT01324830|3780967|P19|Overall Study|Adverse Event, serious fatal|0
1151272|NCT01324830|3780968|P18|Overall Study|Adverse Event, serious fatal|0
1151273|NCT01324830|3780969|P17|Overall Study|Adverse Event, serious fatal|0
1151274|NCT01324830|3780970|P16|Overall Study|Adverse Event, serious fatal|0
1151275|NCT01324830|3780971|P15|Overall Study|Adverse Event, serious fatal|0
1151276|NCT01324830|3780972|P14|Overall Study|Adverse Event, serious fatal|0
1151277|NCT01324830|3780973|P13|Overall Study|Adverse Event, serious fatal|0
1151278|NCT01324830|3780974|P12|Overall Study|Adverse Event, serious fatal|0
1151279|NCT01324830|3780975|P11|Overall Study|Adverse Event, serious fatal|0
1151280|NCT01324830|3780976|P10|Overall Study|Adverse Event, serious fatal|0
1151281|NCT01324830|3780977|P9|Overall Study|Adverse Event, serious fatal|0
1151282|NCT01324830|3780978|P8|Overall Study|Adverse Event, serious fatal|0
1151283|NCT01324830|3780979|P7|Overall Study|Adverse Event, serious fatal|0
1151284|NCT01324830|3780980|P6|Overall Study|Adverse Event, serious fatal|0
1151285|NCT01324830|3780981|P5|Overall Study|Adverse Event, serious fatal|0
1151286|NCT01324830|3780982|P4|Overall Study|Adverse Event, serious fatal|0
1151287|NCT01324830|3780983|P3|Overall Study|Adverse Event, serious fatal|0
1151288|NCT01324830|3780984|P2|Overall Study|Adverse Event, serious fatal|1
1151289|NCT01324830|3780985|P1|Overall Study|Adverse Event, serious fatal|0
1151290|NCT01324830|3780967|P19|Overall Study|Reason not mentioned above|0
1151291|NCT01324830|3780968|P18|Overall Study|Reason not mentioned above|1
1151292|NCT01324830|3780969|P17|Overall Study|Reason not mentioned above|0
1151293|NCT01324830|3780970|P16|Overall Study|Reason not mentioned above|0
1151294|NCT01324830|3780971|P15|Overall Study|Reason not mentioned above|0
1151295|NCT01324830|3780972|P14|Overall Study|Reason not mentioned above|0
1151296|NCT01324830|3780973|P13|Overall Study|Reason not mentioned above|0
1151297|NCT01324830|3780974|P12|Overall Study|Reason not mentioned above|0
1151298|NCT01324830|3780975|P11|Overall Study|Reason not mentioned above|0
1151299|NCT01324830|3780976|P10|Overall Study|Reason not mentioned above|0
1151300|NCT01324830|3780977|P9|Overall Study|Reason not mentioned above|0
1151301|NCT01324830|3780978|P8|Overall Study|Reason not mentioned above|0
1151302|NCT01324830|3780979|P7|Overall Study|Reason not mentioned above|0
1151303|NCT01324830|3780980|P6|Overall Study|Reason not mentioned above|0
1151304|NCT01324830|3780981|P5|Overall Study|Reason not mentioned above|0
1151305|NCT01324830|3780982|P4|Overall Study|Reason not mentioned above|0
1151306|NCT01324830|3780983|P3|Overall Study|Reason not mentioned above|0
1151307|NCT01324830|3780984|P2|Overall Study|Reason not mentioned above|0
1151308|NCT01324830|3780985|P1|Overall Study|Reason not mentioned above|0
1151309|NCT01324830|3780967|P19|Overall Study|Dose limiting toxicity|1
1151310|NCT01324830|3780968|P18|Overall Study|Dose limiting toxicity|1
1151311|NCT01324830|3780969|P17|Overall Study|Dose limiting toxicity|1
1151312|NCT01324830|3780970|P16|Overall Study|Dose limiting toxicity|0
1151313|NCT01324830|3780971|P15|Overall Study|Dose limiting toxicity|0
1151314|NCT01324830|3780972|P14|Overall Study|Dose limiting toxicity|0
1151315|NCT01324830|3780973|P13|Overall Study|Dose limiting toxicity|0
1151316|NCT01324830|3780974|P12|Overall Study|Dose limiting toxicity|0
1151317|NCT01324830|3780975|P11|Overall Study|Dose limiting toxicity|0
1151318|NCT01324830|3780976|P10|Overall Study|Dose limiting toxicity|0
1151319|NCT01324830|3780977|P9|Overall Study|Dose limiting toxicity|0
1151320|NCT01324830|3780978|P8|Overall Study|Dose limiting toxicity|0
1151321|NCT01324830|3780979|P7|Overall Study|Dose limiting toxicity|0
1151322|NCT01324830|3780980|P6|Overall Study|Dose limiting toxicity|0
1151323|NCT01324830|3780981|P5|Overall Study|Dose limiting toxicity|1
1151324|NCT01324830|3780982|P4|Overall Study|Dose limiting toxicity|0
1151325|NCT01324830|3780983|P3|Overall Study|Dose limiting toxicity|0
1151326|NCT01324830|3780984|P2|Overall Study|Dose limiting toxicity|0
1151327|NCT01324830|3780985|P1|Overall Study|Dose limiting toxicity|0
1151328|NCT01324830|3780967|P19|Overall Study|Progressive Disease|4
1151329|NCT01324830|3780968|P18|Overall Study|Progressive Disease|3
1151330|NCT01324830|3780969|P17|Overall Study|Progressive Disease|2
1151331|NCT01324830|3780970|P16|Overall Study|Progressive Disease|3
1151332|NCT01324830|3780971|P15|Overall Study|Progressive Disease|1
1151333|NCT01324830|3780972|P14|Overall Study|Progressive Disease|1
1151334|NCT01324830|3780973|P13|Overall Study|Progressive Disease|1
1151335|NCT01324830|3780974|P12|Overall Study|Progressive Disease|1
1151336|NCT01324830|3780975|P11|Overall Study|Progressive Disease|2
1151337|NCT01324830|3780976|P10|Overall Study|Progressive Disease|6
1151338|NCT01324830|3780977|P9|Overall Study|Progressive Disease|3
1151339|NCT01324830|3780978|P8|Overall Study|Progressive Disease|3
1151340|NCT01324830|3780979|P7|Overall Study|Progressive Disease|3
1151341|NCT01324830|3780980|P6|Overall Study|Progressive Disease|6
1151342|NCT01324830|3780981|P5|Overall Study|Progressive Disease|6
1151343|NCT01324830|3780982|P4|Overall Study|Progressive Disease|3
1151344|NCT01324830|3780983|P3|Overall Study|Progressive Disease|3
1151345|NCT01324830|3780984|P2|Overall Study|Progressive Disease|2
1151346|NCT01324830|3780985|P1|Overall Study|Progressive Disease|3
1151347|NCT01324622|3781131|P2|Overall Study|Lack of Efficacy|0
1151348|NCT01324622|3781132|P1|Overall Study|Lack of Efficacy|1
1151349|NCT01324622|3781131|P2|Overall Study|Death|0
1151350|NCT01324622|3781132|P1|Overall Study|Death|1
1151351|NCT01324622|3781131|P2|Overall Study|Lost to Follow-up|7
1151352|NCT01324622|3781132|P1|Overall Study|Lost to Follow-up|7
1151353|NCT01324570|3781162|P2|Overall Study|Administrative|2
1151354|NCT01324570|3781163|P1|Overall Study|Administrative|0
1151355|NCT01324570|3781162|P2|Overall Study|Confirmed or suspected diversion|1
1151356|NCT01324570|3781163|P1|Overall Study|Confirmed or suspected diversion|0
1151357|NCT01324570|3781162|P2|Overall Study|Lack of Efficacy|1
1151358|NCT01324570|3781163|P1|Overall Study|Lack of Efficacy|0
1151359|NCT01324570|3781162|P2|Overall Study|Withdrawal by Subject|3
1151360|NCT01324570|3781163|P1|Overall Study|Withdrawal by Subject|0
1151361|NCT01324570|3781162|P2|Overall Study|Adverse Event|7
1151362|NCT01324570|3781163|P1|Overall Study|Adverse Event|4
1151363|NCT01324440|3781200|P2|Overall Study|Subject moved|1
1151364|NCT01324440|3781201|P1|Overall Study|Subject moved|0
1151365|NCT01324401|3781215|P2|Overall Study|Adverse Event|3
1151366|NCT01324401|3781216|P1|Overall Study|Adverse Event|1
1151367|NCT01324401|3781215|P2|Overall Study|Withdrawn before any treatment|3
1151368|NCT01324401|3781216|P1|Overall Study|Withdrawn before any treatment|0
1151369|NCT01324388|3781227|P4|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
1151370|NCT01324388|3781228|P3|Part 2 of Study: Second Intervention|Withdrawal by Subject|1
1151371|NCT01324388|3781229|P2|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
1151372|NCT01324388|3781230|P1|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
1151373|NCT01324388|3781227|P4|Part 2 of Study: First Intervention|Protocol Violation|1
1151374|NCT01324388|3781228|P3|Part 2 of Study: First Intervention|Protocol Violation|0
1151375|NCT01324388|3781229|P2|Part 2 of Study: First Intervention|Protocol Violation|0
1151376|NCT01324388|3781230|P1|Part 2 of Study: First Intervention|Protocol Violation|0
1151377|NCT01324388|3781227|P4|Part 1 of Study|Physician Decision|0
1151378|NCT01324388|3781228|P3|Part 1 of Study|Physician Decision|0
1151379|NCT01324388|3781229|P2|Part 1 of Study|Physician Decision|0
1151380|NCT01324388|3781230|P1|Part 1 of Study|Physician Decision|1
1151381|NCT01324388|3781227|P4|Part 1 of Study|Protocol Violation|0
1151382|NCT01324388|3781228|P3|Part 1 of Study|Protocol Violation|0
1151383|NCT01324388|3781229|P2|Part 1 of Study|Protocol Violation|2
1151384|NCT01324388|3781230|P1|Part 1 of Study|Protocol Violation|1
1151385|NCT01324388|3781227|P4|Part 1 of Study|Adverse Event|0
1151386|NCT01324388|3781228|P3|Part 1 of Study|Adverse Event|0
1151387|NCT01324388|3781229|P2|Part 1 of Study|Adverse Event|0
1151388|NCT01324388|3781230|P1|Part 1 of Study|Adverse Event|2
1151389|NCT01324349|3781251|P2|Overall Study|Withdrawal by Subject|1
1151390|NCT01324349|3781252|P1|Overall Study|Withdrawal by Subject|0
1151391|NCT01324349|3781251|P2|Overall Study|Death|1
1151392|NCT01324349|3781252|P1|Overall Study|Death|1
1151393|NCT01324323|3781262|P1|Overall Study|Withdrawal by Subject|1
1151394|NCT01324310|3781282|P1|Overall Study|Disease Progression|1
1151395|NCT01324310|3781282|P1|Overall Study|Adverse Event|1
1151396|NCT01324271|3781302|P2|Overall Study|Physician Decision|0
1151397|NCT01324271|3781303|P1|Overall Study|Physician Decision|1
1151398|NCT01324271|3781302|P2|Overall Study|Lost to Follow-up|0
1151399|NCT01324271|3781303|P1|Overall Study|Lost to Follow-up|3
1151400|NCT01324102|3781326|P2|Overall Study|illness|6
1151401|NCT01324102|3781327|P1|Overall Study|illness|1
1151402|NCT01324024|3781334|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|1
1151403|NCT01324024|3781335|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|2
1151404|NCT01323972|3781373|P4|Overall Study|Lost to Follow-up|1
1151405|NCT01323972|3781374|P3|Overall Study|Lost to Follow-up|1
1151406|NCT01323972|3781375|P2|Overall Study|Lost to Follow-up|1
1151407|NCT01323972|3781376|P1|Overall Study|Lost to Follow-up|0
1151408|NCT01323972|3781373|P4|Overall Study|Migrated/moved from study area|0
1151409|NCT01323972|3781374|P3|Overall Study|Migrated/moved from study area|0
1151410|NCT01323972|3781375|P2|Overall Study|Migrated/moved from study area|2
1151411|NCT01323972|3781376|P1|Overall Study|Migrated/moved from study area|1
1151412|NCT01323972|3781373|P4|Overall Study|Withdrawal by Subject|0
1151413|NCT01323972|3781374|P3|Overall Study|Withdrawal by Subject|1
1151414|NCT01323972|3781375|P2|Overall Study|Withdrawal by Subject|0
1151415|NCT01323972|3781376|P1|Overall Study|Withdrawal by Subject|1
1151416|NCT01323920|3781469|P1|Overall Study|Withdrawal by Subject|1
1151417|NCT01323920|3781469|P1|Overall Study|Death|5
1151418|NCT01323790|3781510|P3|Overall Study|Severe non-compliance with protocol|2
1151419|NCT01323790|3781511|P2|Overall Study|Severe non-compliance with protocol|2
1151420|NCT01323790|3781512|P1|Overall Study|Severe non-compliance with protocol|2
1151421|NCT01323790|3781510|P3|Overall Study|Did Not Receive Treatment|1
1151422|NCT01323790|3781511|P2|Overall Study|Did Not Receive Treatment|0
1151423|NCT01323790|3781512|P1|Overall Study|Did Not Receive Treatment|2
1151424|NCT01323790|3781510|P3|Overall Study|Withdrawal by Subject|13
1151425|NCT01323790|3781511|P2|Overall Study|Withdrawal by Subject|20
1151426|NCT01323790|3781512|P1|Overall Study|Withdrawal by Subject|23
1151427|NCT01323790|3781510|P3|Overall Study|Eligibility Criteria Not Fulfilled|1
1151428|NCT01323790|3781511|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
1151429|NCT01323790|3781512|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
1151430|NCT01323790|3781510|P3|Overall Study|Adverse Event|12
1151431|NCT01323790|3781511|P2|Overall Study|Adverse Event|24
1151432|NCT01323790|3781512|P1|Overall Study|Adverse Event|11
1151433|NCT01323790|3781510|P3|Overall Study|Lack of Efficacy|3
1151434|NCT01323790|3781511|P2|Overall Study|Lack of Efficacy|0
1151435|NCT01323790|3781512|P1|Overall Study|Lack of Efficacy|3
1151436|NCT01323790|3781510|P3|Overall Study|Study-Specific Withdrawal Criteria|3
1151437|NCT01323790|3781511|P2|Overall Study|Study-Specific Withdrawal Criteria|3
1151438|NCT01323790|3781512|P1|Overall Study|Study-Specific Withdrawal Criteria|0
1151439|NCT01323790|3781510|P3|Overall Study|Lost to Follow-up|9
1151440|NCT01323790|3781511|P2|Overall Study|Lost to Follow-up|9
1151441|NCT01323790|3781512|P1|Overall Study|Lost to Follow-up|11
1151442|NCT01323790|3781510|P3|Overall Study|Other|1
1151443|NCT01323790|3781511|P2|Overall Study|Other|2
1151444|NCT01323790|3781512|P1|Overall Study|Other|3
1151445|NCT01323673|3781563|P2|Overall Study|Withdrawal by Subject|3
1151446|NCT01323673|3781564|P1|Overall Study|Withdrawal by Subject|2
1151447|NCT01323673|3781563|P2|Overall Study|Protocol Violation|0
1151448|NCT01323673|3781564|P1|Overall Study|Protocol Violation|1
1151449|NCT01323673|3781563|P2|Overall Study|Lost to Follow-up|1
1151450|NCT01323673|3781564|P1|Overall Study|Lost to Follow-up|0
1151451|NCT01323673|3781563|P2|Overall Study|Adverse Event|1
1151452|NCT01323673|3781564|P1|Overall Study|Adverse Event|0
1151453|NCT01323660|3781584|P6|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
1151454|NCT01323660|3781585|P5|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
1151455|NCT01323660|3781586|P4|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
1151456|NCT01323660|3781587|P3|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
1151457|NCT01323660|3781588|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
1151458|NCT01323660|3781589|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
1151459|NCT01323660|3781584|P6|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
1151460|NCT01323660|3781585|P5|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
1151461|NCT01323660|3781586|P4|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
1151462|NCT01323660|3781587|P3|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
1151463|NCT01323660|3781588|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
1151464|NCT01323660|3781589|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
1151465|NCT01323660|3781584|P6|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1
1151466|NCT01323660|3781585|P5|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
1151467|NCT01323660|3781586|P4|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
1151468|NCT01323660|3781587|P3|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
1151469|NCT01323660|3781588|P2|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
1151470|NCT01323660|3781589|P1|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
1151471|NCT01323660|3781584|P6|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
1151472|NCT01323660|3781585|P5|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
1151473|NCT01323660|3781586|P4|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
1151474|NCT01323660|3781587|P3|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
1151475|NCT01323660|3781588|P2|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
1151476|NCT01323660|3781589|P1|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9
1151477|NCT01323660|3781584|P6|Treatment Period 2 (12 Weeks)|Adverse Event|2
1151478|NCT01323660|3781585|P5|Treatment Period 2 (12 Weeks)|Adverse Event|1
1151479|NCT01323660|3781586|P4|Treatment Period 2 (12 Weeks)|Adverse Event|1
1151480|NCT01323660|3781587|P3|Treatment Period 2 (12 Weeks)|Adverse Event|0
1151481|NCT01323660|3781588|P2|Treatment Period 2 (12 Weeks)|Adverse Event|0
1151482|NCT01323660|3781589|P1|Treatment Period 2 (12 Weeks)|Adverse Event|1
1151483|NCT01323660|3781584|P6|Washout Period (14 Days)|Lack of Efficacy|2
1151484|NCT01323660|3781585|P5|Washout Period (14 Days)|Lack of Efficacy|2
1151485|NCT01323660|3781586|P4|Washout Period (14 Days)|Lack of Efficacy|3
1151486|NCT01323660|3781587|P3|Washout Period (14 Days)|Lack of Efficacy|1
1151487|NCT01323660|3781588|P2|Washout Period (14 Days)|Lack of Efficacy|0
1151488|NCT01323660|3781589|P1|Washout Period (14 Days)|Lack of Efficacy|0
1151489|NCT01323660|3781584|P6|Washout Period (14 Days)|Adverse Event|0
1151490|NCT01323660|3781585|P5|Washout Period (14 Days)|Adverse Event|1
1151491|NCT01323660|3781586|P4|Washout Period (14 Days)|Adverse Event|0
1151492|NCT01323660|3781587|P3|Washout Period (14 Days)|Adverse Event|0
1151493|NCT01323660|3781588|P2|Washout Period (14 Days)|Adverse Event|0
1151494|NCT01323660|3781589|P1|Washout Period (14 Days)|Adverse Event|0
1151495|NCT01323660|3781584|P6|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
1151496|NCT01323660|3781585|P5|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3
1151497|NCT01323660|3781586|P4|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
1151498|NCT01323660|3781587|P3|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
1151651|NCT01323192|3781761|P2|Overall Study|Withdrawal by Subject|1
1151499|NCT01323660|3781588|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
1151500|NCT01323660|3781589|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5
1151501|NCT01323660|3781584|P6|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1151502|NCT01323660|3781585|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
1151503|NCT01323660|3781586|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1151504|NCT01323660|3781587|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1151505|NCT01323660|3781588|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1151506|NCT01323660|3781589|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1151507|NCT01323660|3781584|P6|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
1151508|NCT01323660|3781585|P5|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1
1151509|NCT01323660|3781586|P4|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
1151510|NCT01323660|3781587|P3|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
1151511|NCT01323660|3781588|P2|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
1151512|NCT01323660|3781589|P1|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
1151513|NCT01323660|3781584|P6|Treatment Period 1 (12 Weeks)|Protocol Violation|2
1151514|NCT01323660|3781585|P5|Treatment Period 1 (12 Weeks)|Protocol Violation|1
1151515|NCT01323660|3781586|P4|Treatment Period 1 (12 Weeks)|Protocol Violation|1
1151516|NCT01323660|3781587|P3|Treatment Period 1 (12 Weeks)|Protocol Violation|1
1151517|NCT01323660|3781588|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|0
1151518|NCT01323660|3781589|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|2
1151519|NCT01323660|3781584|P6|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3
1151520|NCT01323660|3781585|P5|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
1151521|NCT01323660|3781586|P4|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
1151522|NCT01323660|3781587|P3|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
1151523|NCT01323660|3781588|P2|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
1151524|NCT01323660|3781589|P1|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
1151525|NCT01323660|3781584|P6|Treatment Period 1 (12 Weeks)|Adverse Event|4
1151526|NCT01323660|3781585|P5|Treatment Period 1 (12 Weeks)|Adverse Event|3
1151527|NCT01323660|3781586|P4|Treatment Period 1 (12 Weeks)|Adverse Event|3
1151528|NCT01323660|3781587|P3|Treatment Period 1 (12 Weeks)|Adverse Event|1
1151529|NCT01323660|3781588|P2|Treatment Period 1 (12 Weeks)|Adverse Event|1
1151530|NCT01323660|3781589|P1|Treatment Period 1 (12 Weeks)|Adverse Event|6
1151531|NCT01323647|3781635|P2|Overall Study|Lost to Follow-up|0
1151532|NCT01323647|3781636|P1|Overall Study|Lost to Follow-up|2
1151533|NCT01323647|3781635|P2|Overall Study|Withdrawal by Subject|0
1151534|NCT01323647|3781636|P1|Overall Study|Withdrawal by Subject|5
1151535|NCT01323647|3781635|P2|Overall Study|Migrated/moved from study area|0
1151536|NCT01323647|3781636|P1|Overall Study|Migrated/moved from study area|2
1151537|NCT01323634|3781653|P3|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
1151538|NCT01323634|3781654|P2|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
1151539|NCT01323634|3781655|P1|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0
1151540|NCT01323634|3781653|P3|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4
1151541|NCT01323634|3781654|P2|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7
1151542|NCT01323634|3781655|P1|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
1151543|NCT01323634|3781653|P3|Double-Blind (DB) Treatment Period|Physician Decision|3
1151544|NCT01323634|3781654|P2|Double-Blind (DB) Treatment Period|Physician Decision|2
1151545|NCT01323634|3781655|P1|Double-Blind (DB) Treatment Period|Physician Decision|0
1151546|NCT01323634|3781653|P3|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
1151547|NCT01323634|3781654|P2|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
1151548|NCT01323634|3781655|P1|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
1151549|NCT01323634|3781653|P3|Double-Blind (DB) Treatment Period|Protocol Violation|7
1151550|NCT01323634|3781654|P2|Double-Blind (DB) Treatment Period|Protocol Violation|6
1151551|NCT01323634|3781655|P1|Double-Blind (DB) Treatment Period|Protocol Violation|0
1151552|NCT01323634|3781653|P3|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
1151553|NCT01323634|3781654|P2|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
1151554|NCT01323634|3781655|P1|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
1151555|NCT01323634|3781653|P3|Double-Blind (DB) Treatment Period|Adverse Event|4
1151556|NCT01323634|3781654|P2|Double-Blind (DB) Treatment Period|Adverse Event|8
1151557|NCT01323634|3781655|P1|Double-Blind (DB) Treatment Period|Adverse Event|0
1151558|NCT01323634|3781653|P3|2-week Run-in Period|Adverse Event|0
1151559|NCT01323634|3781654|P2|2-week Run-in Period|Adverse Event|0
1151560|NCT01323634|3781655|P1|2-week Run-in Period|Adverse Event|1
1151561|NCT01323634|3781653|P3|2-week Run-in Period|Protocol Violation|0
1151562|NCT01323634|3781654|P2|2-week Run-in Period|Protocol Violation|0
1151563|NCT01323634|3781655|P1|2-week Run-in Period|Protocol Violation|1
1151564|NCT01323634|3781653|P3|2-week Run-in Period|Physician Decision|0
1151565|NCT01323634|3781654|P2|2-week Run-in Period|Physician Decision|0
1151566|NCT01323634|3781655|P1|2-week Run-in Period|Physician Decision|5
1151567|NCT01323634|3781653|P3|2-week Run-in Period|Withdrawal by Subject|0
1151568|NCT01323634|3781654|P2|2-week Run-in Period|Withdrawal by Subject|0
1151569|NCT01323634|3781655|P1|2-week Run-in Period|Withdrawal by Subject|7
1151570|NCT01323634|3781653|P3|2-week Run-in Period|Continuation Criteria not Met|0
1151571|NCT01323634|3781654|P2|2-week Run-in Period|Continuation Criteria not Met|0
1151572|NCT01323634|3781655|P1|2-week Run-in Period|Continuation Criteria not Met|73
1151573|NCT01323634|3781653|P3|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
1151574|NCT01323634|3781654|P2|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
1151575|NCT01323634|3781655|P1|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125
1151576|NCT01323621|3781665|P3|12-week, Double-blind Treatment Period|Withdrawal by Subject|4
1151577|NCT01323621|3781666|P2|12-week, Double-blind Treatment Period|Withdrawal by Subject|5
1151578|NCT01323621|3781667|P1|12-week, Double-blind Treatment Period|Withdrawal by Subject|0
1151579|NCT01323621|3781665|P3|12-week, Double-blind Treatment Period|Physician Decision|1
1151580|NCT01323621|3781666|P2|12-week, Double-blind Treatment Period|Physician Decision|2
1151581|NCT01323621|3781667|P1|12-week, Double-blind Treatment Period|Physician Decision|0
1151582|NCT01323621|3781665|P3|12-week, Double-blind Treatment Period|Lost to Follow-up|0
1151583|NCT01323621|3781666|P2|12-week, Double-blind Treatment Period|Lost to Follow-up|1
1151584|NCT01323621|3781667|P1|12-week, Double-blind Treatment Period|Lost to Follow-up|0
1151585|NCT01323621|3781665|P3|12-week, Double-blind Treatment Period|Protocol Violation|4
1151586|NCT01323621|3781666|P2|12-week, Double-blind Treatment Period|Protocol Violation|4
1151587|NCT01323621|3781667|P1|12-week, Double-blind Treatment Period|Protocol Violation|0
1151588|NCT01323621|3781665|P3|12-week, Double-blind Treatment Period|Lack of Efficacy|6
1151589|NCT01323621|3781666|P2|12-week, Double-blind Treatment Period|Lack of Efficacy|2
1151590|NCT01323621|3781667|P1|12-week, Double-blind Treatment Period|Lack of Efficacy|0
1151591|NCT01323621|3781665|P3|12-week, Double-blind Treatment Period|Adverse Event|5
1151592|NCT01323621|3781666|P2|12-week, Double-blind Treatment Period|Adverse Event|1
1151593|NCT01323621|3781667|P1|12-week, Double-blind Treatment Period|Adverse Event|0
1151594|NCT01323621|3781665|P3|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
1151595|NCT01323621|3781666|P2|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
1151596|NCT01323621|3781667|P1|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86
1151597|NCT01323621|3781665|P3|2-week, Single-blind Run In Period|Lost to Follow-up|0
1151598|NCT01323621|3781666|P2|2-week, Single-blind Run In Period|Lost to Follow-up|0
1151599|NCT01323621|3781667|P1|2-week, Single-blind Run In Period|Lost to Follow-up|1
1151600|NCT01323621|3781665|P3|2-week, Single-blind Run In Period|Protocol Violation|0
1151601|NCT01323621|3781666|P2|2-week, Single-blind Run In Period|Protocol Violation|0
1151602|NCT01323621|3781667|P1|2-week, Single-blind Run In Period|Protocol Violation|1
1151603|NCT01323621|3781665|P3|2-week, Single-blind Run In Period|Withdrawal by Subject|0
1151604|NCT01323621|3781666|P2|2-week, Single-blind Run In Period|Withdrawal by Subject|0
1151605|NCT01323621|3781667|P1|2-week, Single-blind Run In Period|Withdrawal by Subject|12
1151606|NCT01323621|3781665|P3|2-week, Single-blind Run In Period|Physician Decision|0
1151607|NCT01323621|3781666|P2|2-week, Single-blind Run In Period|Physician Decision|0
1151608|NCT01323621|3781667|P1|2-week, Single-blind Run In Period|Physician Decision|7
1151609|NCT01323621|3781665|P3|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
1151610|NCT01323621|3781666|P2|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
1151611|NCT01323621|3781667|P1|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121
1151612|NCT01323582|3781688|P2|Weeks 8-11 (Period 2)|Withdrawal by Subject|1
1151613|NCT01323582|3781689|P1|Weeks 8-11 (Period 2)|Withdrawal by Subject|0
1151614|NCT01323582|3781688|P2|Weeks 5-7 (Washout)|Withdrawal by Subject|1
1151615|NCT01323582|3781689|P1|Weeks 5-7 (Washout)|Withdrawal by Subject|0
1151616|NCT01323582|3781688|P2|Weeks 1-4 (First Period)|Withdrawal by Subject|2
1151617|NCT01323582|3781689|P1|Weeks 1-4 (First Period)|Withdrawal by Subject|2
1151618|NCT01323478|3781712|P1|Overall Study|Administrative or Other Reasons|8
1151619|NCT01323478|3781712|P1|Overall Study|Withdrawal of Consent|1
1151620|NCT01323478|3781712|P1|Overall Study|Protocol Violation|1
1151621|NCT01323478|3781712|P1|Overall Study|Non-compliance With Study Product|3
1151622|NCT01323478|3781712|P1|Overall Study|Lack of Efficacy|4
1151623|NCT01323478|3781712|P1|Overall Study|Adverse Event|7
1151624|NCT01323387|3781725|P1|Overall Study|Randomized but Never Treated|16
1151625|NCT01323387|3781725|P1|Overall Study|Protocol Violation|12
1151626|NCT01323387|3781725|P1|Overall Study|Revision|14
1151627|NCT01323387|3781725|P1|Overall Study|Radiographic Data Unavailable|1
1151628|NCT01323387|3781725|P1|Overall Study|Withdrawal by Subject|41
1151629|NCT01323270|3781738|P2|Overall Study|Randomized, but not vaccinated|0
1151630|NCT01323270|3781739|P1|Overall Study|Randomized, but not vaccinated|1
1151631|NCT01323270|3781738|P2|Overall Study|Death|0
1151632|NCT01323270|3781739|P1|Overall Study|Death|1
1151633|NCT01323270|3781738|P2|Overall Study|Not eligible|1
1151634|NCT01323270|3781739|P1|Overall Study|Not eligible|1
1151635|NCT01323270|3781738|P2|Overall Study|Physician Decision|2
1151636|NCT01323270|3781739|P1|Overall Study|Physician Decision|0
1151637|NCT01323270|3781738|P2|Overall Study|Other|3
1151638|NCT01323270|3781739|P1|Overall Study|Other|0
1151639|NCT01323270|3781738|P2|Overall Study|Adverse Event|0
1151640|NCT01323270|3781739|P1|Overall Study|Adverse Event|8
1151641|NCT01323270|3781738|P2|Overall Study|Lost to Follow-up|6
1151642|NCT01323270|3781739|P1|Overall Study|Lost to Follow-up|4
1151643|NCT01323270|3781738|P2|Overall Study|Protocol Violation|7
1151644|NCT01323270|3781739|P1|Overall Study|Protocol Violation|9
1151645|NCT01323270|3781738|P2|Overall Study|Withdrawal by Subject|10
1151646|NCT01323270|3781739|P1|Overall Study|Withdrawal by Subject|19
1151647|NCT01323192|3781761|P2|Overall Study|Nonmedical reasons|1
1151648|NCT01323192|3781762|P1|Overall Study|Nonmedical reasons|0
1151649|NCT01323192|3781761|P2|Overall Study|Noncompliance with study medication|3
1151650|NCT01323192|3781762|P1|Overall Study|Noncompliance with study medication|0
1151652|NCT01323192|3781762|P1|Overall Study|Withdrawal by Subject|3
1151653|NCT01323192|3781761|P2|Overall Study|Adverse Event|1
1151654|NCT01323192|3781762|P1|Overall Study|Adverse Event|6
1151655|NCT01322386|3782010|P2|Overall Study|Physician Decision|1
1151656|NCT01322386|3782011|P1|Overall Study|Physician Decision|0
1151657|NCT01322386|3782010|P2|Overall Study|Protocol Violation|1
1151658|NCT01322386|3782011|P1|Overall Study|Protocol Violation|0
1151659|NCT01322347|3782026|P2|Overall Study|moved/changed dialysis|4
1151660|NCT01322347|3782027|P1|Overall Study|moved/changed dialysis|2
1151661|NCT01322347|3782026|P2|Overall Study|study drug withheld > 12 wks|1
1151662|NCT01322347|3782027|P1|Overall Study|study drug withheld > 12 wks|0
1151663|NCT01322347|3782026|P2|Overall Study|kidney transplant|1
1151664|NCT01322347|3782027|P1|Overall Study|kidney transplant|3
1151665|NCT01322347|3782026|P2|Overall Study|ineligible|3
1151666|NCT01322347|3782027|P1|Overall Study|ineligible|6
1151667|NCT01322347|3782026|P2|Overall Study|sponsor decision|3
1151668|NCT01322347|3782027|P1|Overall Study|sponsor decision|1
1151669|NCT01322347|3782026|P2|Overall Study|blood transfusion|5
1151670|NCT01322347|3782027|P1|Overall Study|blood transfusion|5
1151671|NCT01322347|3782026|P2|Overall Study|non-protocol change to ESA or IV iron|6
1151672|NCT01322347|3782027|P1|Overall Study|non-protocol change to ESA or IV iron|14
1151673|NCT01322347|3782026|P2|Overall Study|Withdrawal by Subject|4
1151674|NCT01322347|3782027|P1|Overall Study|Withdrawal by Subject|1
1151675|NCT01322347|3782026|P2|Overall Study|Protocol Violation|2
1151676|NCT01322347|3782027|P1|Overall Study|Protocol Violation|5
1151677|NCT01322347|3782026|P2|Overall Study|Physician Decision|1
1151678|NCT01322347|3782027|P1|Overall Study|Physician Decision|2
1151679|NCT01322347|3782026|P2|Overall Study|Death|3
1151680|NCT01322347|3782027|P1|Overall Study|Death|5
1151681|NCT01322347|3782026|P2|Overall Study|Adverse Event|2
1151682|NCT01322347|3782027|P1|Overall Study|Adverse Event|7
1151683|NCT01322009|3782090|P2|Overall Study|ng tube discontinued|1
1151684|NCT01322009|3782091|P1|Overall Study|ng tube discontinued|0
1151685|NCT01322009|3782090|P2|Overall Study|Adverse Event|1
1151686|NCT01322009|3782091|P1|Overall Study|Adverse Event|0
1151687|NCT01322009|3782090|P2|Overall Study|Death|1
1151688|NCT01322009|3782091|P1|Overall Study|Death|0
1151689|NCT01321749|3782101|P2|Overall Study|Withdrawal by Subject|4
1151690|NCT01321749|3782102|P1|Overall Study|Withdrawal by Subject|5
1151691|NCT01321749|3782101|P2|Overall Study|Protocol Violation|7
1151692|NCT01321749|3782102|P1|Overall Study|Protocol Violation|4
1151693|NCT01321749|3782101|P2|Overall Study|Lost to Follow-up|11
1151694|NCT01321749|3782102|P1|Overall Study|Lost to Follow-up|4
1151695|NCT01321723|3782111|P3|Overall Study|Withdrawal by Subject|2
1151696|NCT01321723|3782112|P2|Overall Study|Withdrawal by Subject|0
1151697|NCT01321723|3782113|P1|Overall Study|Withdrawal by Subject|2
1151698|NCT01321723|3782111|P3|Overall Study|Adverse Event|2
1151699|NCT01321723|3782112|P2|Overall Study|Adverse Event|5
1151700|NCT01321723|3782113|P1|Overall Study|Adverse Event|3
1151701|NCT01321710|3782135|P3|Overall Study|Lost to Follow-up|0
1151702|NCT01321710|3782136|P2|Overall Study|Lost to Follow-up|5
1151703|NCT01321710|3782137|P1|Overall Study|Lost to Follow-up|4
1151704|NCT01321697|3782152|P1|Overall Study|Study Terminated|7
1151705|NCT01321606|3782158|P4|Overall Study|Lost to Follow-up|1
1151706|NCT01321606|3782159|P3|Overall Study|Lost to Follow-up|0
1151707|NCT01321606|3782160|P2|Overall Study|Lost to Follow-up|0
1151708|NCT01321606|3782161|P1|Overall Study|Lost to Follow-up|0
1151709|NCT01321554|3782181|P4|OOL Lenvatinib Treatment Period|Death|1
1151710|NCT01321554|3782182|P3|OOL Lenvatinib Treatment Period|Death|1
1151711|NCT01321554|3782183|P2|OOL Lenvatinib Treatment Period|Death|0
1151712|NCT01321554|3782184|P1|OOL Lenvatinib Treatment Period|Death|0
1151713|NCT01321554|3782181|P4|OOL Lenvatinib Treatment Period|Worsening disease|0
1151714|NCT01321554|3782182|P3|OOL Lenvatinib Treatment Period|Worsening disease|1
1151715|NCT01321554|3782183|P2|OOL Lenvatinib Treatment Period|Worsening disease|0
1151716|NCT01321554|3782184|P1|OOL Lenvatinib Treatment Period|Worsening disease|0
1151717|NCT01321554|3782181|P4|OOL Lenvatinib Treatment Period|Lost to Follow-up|0
1151718|NCT01321554|3782182|P3|OOL Lenvatinib Treatment Period|Lost to Follow-up|1
1151719|NCT01321554|3782183|P2|OOL Lenvatinib Treatment Period|Lost to Follow-up|0
1151720|NCT01321554|3782184|P1|OOL Lenvatinib Treatment Period|Lost to Follow-up|0
1151721|NCT01321554|3782181|P4|OOL Lenvatinib Treatment Period|Not specified|0
1151722|NCT01321554|3782182|P3|OOL Lenvatinib Treatment Period|Not specified|5
1151723|NCT01321554|3782183|P2|OOL Lenvatinib Treatment Period|Not specified|0
1151724|NCT01321554|3782184|P1|OOL Lenvatinib Treatment Period|Not specified|0
1151725|NCT01321554|3782181|P4|OOL Lenvatinib Treatment Period|Withdrawal by Subject|0
1151726|NCT01321554|3782182|P3|OOL Lenvatinib Treatment Period|Withdrawal by Subject|1
1151727|NCT01321554|3782183|P2|OOL Lenvatinib Treatment Period|Withdrawal by Subject|0
1151728|NCT01321554|3782184|P1|OOL Lenvatinib Treatment Period|Withdrawal by Subject|0
1151729|NCT01321554|3782181|P4|OOL Lenvatinib Treatment Period|Participant choice|0
1151730|NCT01321554|3782182|P3|OOL Lenvatinib Treatment Period|Participant choice|3
1151731|NCT01321554|3782183|P2|OOL Lenvatinib Treatment Period|Participant choice|0
1151732|NCT01321554|3782184|P1|OOL Lenvatinib Treatment Period|Participant choice|0
1151733|NCT01321554|3782181|P4|OOL Lenvatinib Treatment Period|Adverse Event|1
1151734|NCT01321554|3782182|P3|OOL Lenvatinib Treatment Period|Adverse Event|16
1151735|NCT01321554|3782183|P2|OOL Lenvatinib Treatment Period|Adverse Event|0
1151736|NCT01321554|3782184|P1|OOL Lenvatinib Treatment Period|Adverse Event|0
1151737|NCT01321554|3782181|P4|Randomization Phase|Death|0
1151738|NCT01321554|3782182|P3|Randomization Phase|Death|0
1151739|NCT01321554|3782183|P2|Randomization Phase|Death|1
1151740|NCT01321554|3782184|P1|Randomization Phase|Death|0
1151741|NCT01321554|3782181|P4|Randomization Phase|Withdrawal by Subject|0
1151742|NCT01321554|3782182|P3|Randomization Phase|Withdrawal by Subject|0
1151743|NCT01321554|3782183|P2|Randomization Phase|Withdrawal by Subject|0
1151744|NCT01321554|3782184|P1|Randomization Phase|Withdrawal by Subject|4
1151745|NCT01321554|3782181|P4|Randomization Phase|Participant choice|0
1151746|NCT01321554|3782182|P3|Randomization Phase|Participant choice|0
1151747|NCT01321554|3782183|P2|Randomization Phase|Participant choice|0
1151748|NCT01321554|3782184|P1|Randomization Phase|Participant choice|4
1151749|NCT01321554|3782181|P4|Randomization Phase|Adverse Event|0
1151750|NCT01321554|3782182|P3|Randomization Phase|Adverse Event|0
1151751|NCT01321554|3782183|P2|Randomization Phase|Adverse Event|3
1151752|NCT01321554|3782184|P1|Randomization Phase|Adverse Event|37
1151753|NCT01321073|3782197|P1|Overall Study|Death|3
1151754|NCT01321073|3782197|P1|Overall Study|Did not attempt implant|4
1151755|NCT01321008|3782201|P1|Overall Study|Early Study Termination|1
1151756|NCT01320943|3782207|P2|Overall Study|Randomized but not Treated|1
1151757|NCT01320943|3782208|P1|Overall Study|Randomized but not Treated|0
1151758|NCT01320943|3782207|P2|Overall Study|Physician Decision|1
1151759|NCT01320943|3782208|P1|Overall Study|Physician Decision|0
1151760|NCT01320943|3782207|P2|Overall Study|Lost to Follow-up|0
1151761|NCT01320943|3782208|P1|Overall Study|Lost to Follow-up|1
1151762|NCT01320735|3782242|P1|Overall Study|Investigator Unable to be Contacted|17
1151763|NCT01320735|3782242|P1|Overall Study|No Decrease of Prostate Specific Antigen|7
1151764|NCT01320735|3782242|P1|Overall Study|Not Specified|1
1151765|NCT01320735|3782242|P1|Overall Study|Protocol Violation|1
1151766|NCT01320735|3782242|P1|Overall Study|Progression/Hormone-Refractory Pca|55
1151767|NCT01320735|3782242|P1|Overall Study|Administrative Reason|6
1151768|NCT01320735|3782242|P1|Overall Study|Lost to Follow-up|13
1151769|NCT01320735|3782242|P1|Overall Study|Withdrawal by Subject|3
1151770|NCT01320735|3782242|P1|Overall Study|Adverse Event|3
1151771|NCT01320722|3782264|P5|Overall Study|Withdrew due to Health Condition|1
1151772|NCT01320722|3782265|P4|Overall Study|Withdrew due to Health Condition|0
1151773|NCT01320722|3782266|P3|Overall Study|Withdrew due to Health Condition|0
1151774|NCT01320722|3782267|P2|Overall Study|Withdrew due to Health Condition|0
1151775|NCT01320722|3782268|P1|Overall Study|Withdrew due to Health Condition|0
1151776|NCT01320722|3782264|P5|Overall Study|Started an Exclusionary Medication|1
1151777|NCT01320722|3782265|P4|Overall Study|Started an Exclusionary Medication|0
1151778|NCT01320722|3782266|P3|Overall Study|Started an Exclusionary Medication|0
1151779|NCT01320722|3782267|P2|Overall Study|Started an Exclusionary Medication|0
1151780|NCT01320722|3782268|P1|Overall Study|Started an Exclusionary Medication|0
1151781|NCT01320722|3782264|P5|Overall Study|Pregnancy|0
1151782|NCT01320722|3782265|P4|Overall Study|Pregnancy|1
1151783|NCT01320722|3782266|P3|Overall Study|Pregnancy|0
1151784|NCT01320722|3782267|P2|Overall Study|Pregnancy|0
1151785|NCT01320722|3782268|P1|Overall Study|Pregnancy|0
1151786|NCT01320722|3782264|P5|Overall Study|Not Compliant with Study Procedures|0
1151787|NCT01320722|3782265|P4|Overall Study|Not Compliant with Study Procedures|4
1151788|NCT01320722|3782266|P3|Overall Study|Not Compliant with Study Procedures|0
1151789|NCT01320722|3782267|P2|Overall Study|Not Compliant with Study Procedures|0
1151790|NCT01320722|3782268|P1|Overall Study|Not Compliant with Study Procedures|0
1151791|NCT01320722|3782264|P5|Overall Study|Adverse Event|0
1151792|NCT01320722|3782265|P4|Overall Study|Adverse Event|6
1151793|NCT01320722|3782266|P3|Overall Study|Adverse Event|3
1151794|NCT01320722|3782267|P2|Overall Study|Adverse Event|0
1151795|NCT01320722|3782268|P1|Overall Study|Adverse Event|0
1151796|NCT01320722|3782264|P5|Overall Study|Non-compliant with Medication|0
1151797|NCT01320722|3782265|P4|Overall Study|Non-compliant with Medication|0
1151798|NCT01320722|3782266|P3|Overall Study|Non-compliant with Medication|1
1151799|NCT01320722|3782267|P2|Overall Study|Non-compliant with Medication|0
1151800|NCT01320722|3782268|P1|Overall Study|Non-compliant with Medication|0
1151801|NCT01320722|3782264|P5|Overall Study|Participant Developed a Rash|1
1151802|NCT01320722|3782265|P4|Overall Study|Participant Developed a Rash|1
1151803|NCT01320722|3782266|P3|Overall Study|Participant Developed a Rash|2
1151804|NCT01320722|3782267|P2|Overall Study|Participant Developed a Rash|0
1151805|NCT01320722|3782268|P1|Overall Study|Participant Developed a Rash|0
1151806|NCT01320722|3782264|P5|Overall Study|Not Available for the 8 Week Visit|0
1151807|NCT01320722|3782265|P4|Overall Study|Not Available for the 8 Week Visit|0
1151808|NCT01320722|3782266|P3|Overall Study|Not Available for the 8 Week Visit|0
1151809|NCT01320722|3782267|P2|Overall Study|Not Available for the 8 Week Visit|3
1151810|NCT01320722|3782268|P1|Overall Study|Not Available for the 8 Week Visit|0
1151811|NCT01320722|3782264|P5|Overall Study|Lost to Follow-up|3
1151812|NCT01320722|3782265|P4|Overall Study|Lost to Follow-up|1
1151813|NCT01320722|3782266|P3|Overall Study|Lost to Follow-up|0
1151814|NCT01320722|3782267|P2|Overall Study|Lost to Follow-up|1
1151815|NCT01320722|3782268|P1|Overall Study|Lost to Follow-up|0
1151816|NCT01320722|3782264|P5|Overall Study|Did not Receive Intervention|2
1151817|NCT01320722|3782265|P4|Overall Study|Did not Receive Intervention|1
1151818|NCT01320722|3782266|P3|Overall Study|Did not Receive Intervention|1
1151819|NCT01320722|3782267|P2|Overall Study|Did not Receive Intervention|2
1151820|NCT01320722|3782268|P1|Overall Study|Did not Receive Intervention|3
1151821|NCT01320683|3782305|P1|Overall Study|Positive antibody response|1
1151822|NCT01320293|3782331|P1|Overall Study|Adverse Event|1
1151823|NCT01320293|3782331|P1|Overall Study|Lack of Efficacy|1
1151824|NCT01320202|3782339|P2|Overall Study|regained renal function|0
1151825|NCT01320202|3782340|P1|Overall Study|regained renal function|1
1151826|NCT01320202|3782339|P2|Overall Study|ineligible|0
1151827|NCT01320202|3782340|P1|Overall Study|ineligible|3
1151828|NCT01320202|3782339|P2|Overall Study|sponsor request|0
1151829|NCT01320202|3782340|P1|Overall Study|sponsor request|2
1151830|NCT01320202|3782339|P2|Overall Study|moved/changed dialysis|2
1151831|NCT01320202|3782340|P1|Overall Study|moved/changed dialysis|5
1151832|NCT01320202|3782339|P2|Overall Study|blood transfusion|7
1151833|NCT01320202|3782340|P1|Overall Study|blood transfusion|1
1151834|NCT01320202|3782339|P2|Overall Study|kidney transplant|2
1151835|NCT01320202|3782340|P1|Overall Study|kidney transplant|1
1151836|NCT01320202|3782339|P2|Overall Study|non-protocol change to ESA or IV iron|20
1151837|NCT01320202|3782340|P1|Overall Study|non-protocol change to ESA or IV iron|17
1151838|NCT01320202|3782339|P2|Overall Study|Withdrawal by Subject|3
1151839|NCT01320202|3782340|P1|Overall Study|Withdrawal by Subject|10
1151840|NCT01320202|3782339|P2|Overall Study|Protocol Violation|1
1151841|NCT01320202|3782340|P1|Overall Study|Protocol Violation|2
1151842|NCT01320202|3782339|P2|Overall Study|Physician Decision|1
1151843|NCT01320202|3782340|P1|Overall Study|Physician Decision|3
1151844|NCT01320202|3782339|P2|Overall Study|Lost to Follow-up|0
1151845|NCT01320202|3782340|P1|Overall Study|Lost to Follow-up|1
1151846|NCT01320202|3782339|P2|Overall Study|Death|3
1151847|NCT01320202|3782340|P1|Overall Study|Death|5
1151848|NCT01320202|3782339|P2|Overall Study|Adverse Event|5
1151849|NCT01320202|3782340|P1|Overall Study|Adverse Event|5
1151850|NCT01319877|3782404|P2|Overall Study|Reason Not Specified|5
1151851|NCT01319877|3782405|P1|Overall Study|Reason Not Specified|4
1151852|NCT01319877|3782404|P2|Overall Study|Withdrawal by Subject|1
1151853|NCT01319877|3782405|P1|Overall Study|Withdrawal by Subject|0
1151854|NCT01319877|3782404|P2|Overall Study|Disease Progression|2
1151855|NCT01319877|3782405|P1|Overall Study|Disease Progression|2
1151856|NCT01319877|3782404|P2|Overall Study|Physician Decision|0
1151857|NCT01319877|3782405|P1|Overall Study|Physician Decision|2
1151858|NCT01319877|3782404|P2|Overall Study|Lost to Follow-up|37
1151859|NCT01319877|3782405|P1|Overall Study|Lost to Follow-up|100
1151860|NCT01319721|3782555|P2|Overall Study|Lost to Follow-up|6
1151861|NCT01319721|3782556|P1|Overall Study|Lost to Follow-up|1
1151862|NCT01319422|3782609|P2|Overall Study|Withdrawal by Subject|0
1151863|NCT01319422|3782610|P1|Overall Study|Withdrawal by Subject|1
1151864|NCT01319383|3782628|P2|Overall Study|No in vivo response to interval doses|1
1151865|NCT01319383|3782629|P1|Overall Study|No in vivo response to interval doses|0
1151866|NCT01319383|3782628|P2|Overall Study|Lack of Efficacy|9
1151867|NCT01319383|3782629|P1|Overall Study|Lack of Efficacy|5
1151868|NCT01319383|3782628|P2|Overall Study|Physician Decision|0
1151869|NCT01319383|3782629|P1|Overall Study|Physician Decision|3
1151870|NCT01319383|3782628|P2|Overall Study|No ex vivo or in vivo response|0
1151871|NCT01319383|3782629|P1|Overall Study|No ex vivo or in vivo response|4
1151872|NCT01318993|3782668|P1|Overall Study|Withdrawal by Subject|24
1151873|NCT01318993|3782668|P1|Overall Study|Physician Decision|13
1151874|NCT01318993|3782668|P1|Overall Study|Lost to Follow-up|4
1151875|NCT01318993|3782668|P1|Overall Study|Study closed or terminated|174
1151876|NCT01318993|3782668|P1|Overall Study|Protocol based stopping criteria|6
1151877|NCT01318993|3782668|P1|Overall Study|Protocol Violation|3
1151878|NCT01318993|3782668|P1|Overall Study|Lack of Efficacy|121
1151879|NCT01318993|3782668|P1|Overall Study|Adverse Event|53
1151880|NCT01318915|3782689|P1|Overall Study|Lost to Follow-up|1
1151881|NCT01318876|3782714|P1|Day 29 Survey|survey not completed-don't know why|1825
1151882|NCT01318876|3782714|P1|Day 8 Survey|survey not completed-don't know why|1724
1151883|NCT01318876|3782714|P1|Day 8 Survey|email address invalid|96
1151884|NCT01318512|3782812|P1|Maintenance Period (6 Months)|Protocol Violation|9
1151885|NCT01318512|3782812|P1|Maintenance Period (6 Months)|Death|2
1151886|NCT01318499|3782831|P3|Overall Study|Not Specified|22
1151887|NCT01318499|3782832|P2|Overall Study|Not Specified|10
1151888|NCT01318499|3782833|P1|Overall Study|Not Specified|7
1151889|NCT01318499|3782831|P3|Overall Study|Patient Did Not Use Study Medication|14
1151890|NCT01318499|3782832|P2|Overall Study|Patient Did Not Use Study Medication|28
1151891|NCT01318499|3782833|P1|Overall Study|Patient Did Not Use Study Medication|18
1151892|NCT01318499|3782831|P3|Overall Study|Protocol Violation|2
1151893|NCT01318499|3782832|P2|Overall Study|Protocol Violation|4
1151894|NCT01318499|3782833|P1|Overall Study|Protocol Violation|2
1151895|NCT01318499|3782831|P3|Overall Study|Treatment Failure|101
1151896|NCT01318499|3782832|P2|Overall Study|Treatment Failure|19
1151897|NCT01318499|3782833|P1|Overall Study|Treatment Failure|19
1151898|NCT01318499|3782831|P3|Overall Study|Noncompliance|0
1151899|NCT01318499|3782832|P2|Overall Study|Noncompliance|3
1151900|NCT01318499|3782833|P1|Overall Study|Noncompliance|2
1151901|NCT01318499|3782831|P3|Overall Study|Pt Decision Unrelated to Adverse Event|2
1151902|NCT01318499|3782832|P2|Overall Study|Pt Decision Unrelated to Adverse Event|1
1151903|NCT01318499|3782833|P1|Overall Study|Pt Decision Unrelated to Adverse Event|1
1151904|NCT01318499|3782831|P3|Overall Study|Adverse Event|6
1151905|NCT01318499|3782832|P2|Overall Study|Adverse Event|11
1151906|NCT01318499|3782833|P1|Overall Study|Adverse Event|16
1151907|NCT01318382|3782856|P1|Overall Study|Protocol Violation|1
1151908|NCT01318382|3782856|P1|Overall Study|Device Malfunction|10
1151909|NCT01318382|3782856|P1|Overall Study|Physician Decision|2
1151910|NCT01318135|3782914|P8|Entered - Long-Term Extension Study|Use of Excluded Medications|1
1151911|NCT01318135|3782915|P7|Entered - Long-Term Extension Study|Use of Excluded Medications|0
1151912|NCT01318135|3782916|P6|Entered - Long-Term Extension Study|Use of Excluded Medications|0
1151913|NCT01318135|3782917|P5|Entered - Long-Term Extension Study|Use of Excluded Medications|0
1151914|NCT01318135|3782918|P4|Entered - Long-Term Extension Study|Use of Excluded Medications|0
1151915|NCT01318135|3782919|P3|Entered - Long-Term Extension Study|Use of Excluded Medications|0
1151916|NCT01318135|3782920|P2|Entered - Long-Term Extension Study|Use of Excluded Medications|0
1151917|NCT01318135|3782921|P1|Entered - Long-Term Extension Study|Use of Excluded Medications|0
1151918|NCT01318135|3782914|P8|Entered - Long-Term Extension Study|Lack of Efficacy|1
1151919|NCT01318135|3782915|P7|Entered - Long-Term Extension Study|Lack of Efficacy|1
1151920|NCT01318135|3782916|P6|Entered - Long-Term Extension Study|Lack of Efficacy|2
1151921|NCT01318135|3782917|P5|Entered - Long-Term Extension Study|Lack of Efficacy|2
1151922|NCT01318135|3782918|P4|Entered - Long-Term Extension Study|Lack of Efficacy|3
1151923|NCT01318135|3782919|P3|Entered - Long-Term Extension Study|Lack of Efficacy|2
1151924|NCT01318135|3782920|P2|Entered - Long-Term Extension Study|Lack of Efficacy|7
1151925|NCT01318135|3782921|P1|Entered - Long-Term Extension Study|Lack of Efficacy|5
1151926|NCT01318135|3782914|P8|Entered - Long-Term Extension Study|Withdrawal by Subject|1
1151927|NCT01318135|3782915|P7|Entered - Long-Term Extension Study|Withdrawal by Subject|0
1151928|NCT01318135|3782916|P6|Entered - Long-Term Extension Study|Withdrawal by Subject|0
1151929|NCT01318135|3782917|P5|Entered - Long-Term Extension Study|Withdrawal by Subject|2
1151930|NCT01318135|3782918|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|1
1151931|NCT01318135|3782919|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|2
1151932|NCT01318135|3782920|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
1151933|NCT01318135|3782921|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|2
1151934|NCT01318135|3782914|P8|Entered - Long-Term Extension Study|Protocol Violation|0
1151935|NCT01318135|3782915|P7|Entered - Long-Term Extension Study|Protocol Violation|0
1151936|NCT01318135|3782916|P6|Entered - Long-Term Extension Study|Protocol Violation|0
1151937|NCT01318135|3782917|P5|Entered - Long-Term Extension Study|Protocol Violation|1
1151938|NCT01318135|3782918|P4|Entered - Long-Term Extension Study|Protocol Violation|0
1151939|NCT01318135|3782919|P3|Entered - Long-Term Extension Study|Protocol Violation|0
1151940|NCT01318135|3782920|P2|Entered - Long-Term Extension Study|Protocol Violation|1
1151941|NCT01318135|3782921|P1|Entered - Long-Term Extension Study|Protocol Violation|1
1151942|NCT01318135|3782914|P8|Entered - Long-Term Extension Study|Adverse Event|0
1151943|NCT01318135|3782915|P7|Entered - Long-Term Extension Study|Adverse Event|0
1151944|NCT01318135|3782916|P6|Entered - Long-Term Extension Study|Adverse Event|2
1151945|NCT01318135|3782917|P5|Entered - Long-Term Extension Study|Adverse Event|4
1151946|NCT01318135|3782918|P4|Entered - Long-Term Extension Study|Adverse Event|3
1151947|NCT01318135|3782919|P3|Entered - Long-Term Extension Study|Adverse Event|4
1151948|NCT01318135|3782920|P2|Entered - Long-Term Extension Study|Adverse Event|3
1151949|NCT01318135|3782921|P1|Entered - Long-Term Extension Study|Adverse Event|9
1151950|NCT01318135|3782914|P8|Enrolled - Long-Term Extension Study|Treatment Complications|0
1151951|NCT01318135|3782915|P7|Enrolled - Long-Term Extension Study|Treatment Complications|0
1151952|NCT01318135|3782916|P6|Enrolled - Long-Term Extension Study|Treatment Complications|0
1151953|NCT01318135|3782917|P5|Enrolled - Long-Term Extension Study|Treatment Complications|0
1151954|NCT01318135|3782918|P4|Enrolled - Long-Term Extension Study|Treatment Complications|0
1151955|NCT01318135|3782919|P3|Enrolled - Long-Term Extension Study|Treatment Complications|0
1151956|NCT01318135|3782920|P2|Enrolled - Long-Term Extension Study|Treatment Complications|0
1151957|NCT01318135|3782921|P1|Enrolled - Long-Term Extension Study|Treatment Complications|1
1151958|NCT01318135|3782914|P8|Enrolled - Long-Term Extension Study|Adverse Event|0
1151959|NCT01318135|3782915|P7|Enrolled - Long-Term Extension Study|Adverse Event|0
1151960|NCT01318135|3782916|P6|Enrolled - Long-Term Extension Study|Adverse Event|0
1151961|NCT01318135|3782917|P5|Enrolled - Long-Term Extension Study|Adverse Event|0
1151962|NCT01318135|3782918|P4|Enrolled - Long-Term Extension Study|Adverse Event|0
1151963|NCT01318135|3782919|P3|Enrolled - Long-Term Extension Study|Adverse Event|0
1151964|NCT01318135|3782920|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
1151965|NCT01318135|3782921|P1|Enrolled - Long-Term Extension Study|Adverse Event|1
1151966|NCT01318122|3783053|P4|Entered - Long-Term Extension Study|Lack of Efficacy|0
1151967|NCT01318122|3783054|P3|Entered - Long-Term Extension Study|Lack of Efficacy|3
1151968|NCT01318122|3783055|P2|Entered - Long-Term Extension Study|Lack of Efficacy|2
1151969|NCT01318122|3783056|P1|Entered - Long-Term Extension Study|Lack of Efficacy|0
1151970|NCT01318122|3783053|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|0
1151971|NCT01318122|3783054|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|1
1151972|NCT01318122|3783055|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|3
1151973|NCT01318122|3783056|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|2
1151974|NCT01318122|3783053|P4|Entered - Long-Term Extension Study|Lost to Follow-up|0
1151975|NCT01318122|3783054|P3|Entered - Long-Term Extension Study|Lost to Follow-up|0
1151976|NCT01318122|3783055|P2|Entered - Long-Term Extension Study|Lost to Follow-up|0
1151977|NCT01318122|3783056|P1|Entered - Long-Term Extension Study|Lost to Follow-up|1
1151978|NCT01318122|3783053|P4|Entered - Long-Term Extension Study|Adverse Event|4
1151979|NCT01318122|3783054|P3|Entered - Long-Term Extension Study|Adverse Event|2
1151980|NCT01318122|3783055|P2|Entered - Long-Term Extension Study|Adverse Event|6
1151981|NCT01318122|3783056|P1|Entered - Long-Term Extension Study|Adverse Event|6
1151982|NCT01318122|3783053|P4|Enrolled - Long-Term Extension Study|Other|0
1151983|NCT01318122|3783054|P3|Enrolled - Long-Term Extension Study|Other|0
1151984|NCT01318122|3783055|P2|Enrolled - Long-Term Extension Study|Other|0
1151985|NCT01318122|3783056|P1|Enrolled - Long-Term Extension Study|Other|1
1151986|NCT01318122|3783053|P4|Enrolled - Long-Term Extension Study|Adverse Event|1
1151987|NCT01318122|3783054|P3|Enrolled - Long-Term Extension Study|Adverse Event|2
1151988|NCT01318122|3783055|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
1151989|NCT01318122|3783056|P1|Enrolled - Long-Term Extension Study|Adverse Event|0
1151990|NCT01318109|3783125|P3|Overall Study|Schedule Conflict|0
1151991|NCT01318109|3783126|P2|Overall Study|Schedule Conflict|1
1151992|NCT01318109|3783127|P1|Overall Study|Schedule Conflict|0
1151993|NCT01318109|3783125|P3|Overall Study|Withdrawal by Subject|0
1151994|NCT01318109|3783126|P2|Overall Study|Withdrawal by Subject|0
1151995|NCT01318109|3783127|P1|Overall Study|Withdrawal by Subject|1
1151996|NCT01318109|3783125|P3|Overall Study|Adverse Event|0
1151997|NCT01318109|3783126|P2|Overall Study|Adverse Event|2
1151998|NCT01318109|3783127|P1|Overall Study|Adverse Event|0
1151999|NCT01318083|3783162|P3|Overall Study|Lack of Study Medication Compliance|0
1152000|NCT01318083|3783163|P2|Overall Study|Lack of Study Medication Compliance|1
1152001|NCT01318083|3783164|P1|Overall Study|Lack of Study Medication Compliance|0
1152002|NCT01318083|3783162|P3|Overall Study|Treatment Complications|0
1152003|NCT01318083|3783163|P2|Overall Study|Treatment Complications|0
1152004|NCT01318083|3783164|P1|Overall Study|Treatment Complications|1
1152005|NCT01318083|3783162|P3|Overall Study|Lack of Efficacy|1
1152006|NCT01318083|3783163|P2|Overall Study|Lack of Efficacy|0
1152007|NCT01318083|3783164|P1|Overall Study|Lack of Efficacy|0
1152008|NCT01318083|3783162|P3|Overall Study|Withdrawal by Subject|2
1152009|NCT01318083|3783163|P2|Overall Study|Withdrawal by Subject|0
1152010|NCT01318083|3783164|P1|Overall Study|Withdrawal by Subject|1
1152011|NCT01318083|3783162|P3|Overall Study|Adverse Event|2
1152012|NCT01318083|3783163|P2|Overall Study|Adverse Event|1
1152013|NCT01318083|3783164|P1|Overall Study|Adverse Event|4
1152014|NCT01318070|3783199|P3|Overall Study|Principal Investigator Discretion|0
1152015|NCT01318070|3783200|P2|Overall Study|Principal Investigator Discretion|0
1152016|NCT01318070|3783201|P1|Overall Study|Principal Investigator Discretion|1
1152017|NCT01318070|3783199|P3|Overall Study|Lack of Efficacy|1
1152018|NCT01318070|3783200|P2|Overall Study|Lack of Efficacy|0
1152019|NCT01318070|3783201|P1|Overall Study|Lack of Efficacy|0
1152020|NCT01318070|3783199|P3|Overall Study|Withdrawal by Subject|1
1152021|NCT01318070|3783200|P2|Overall Study|Withdrawal by Subject|1
1152022|NCT01318070|3783201|P1|Overall Study|Withdrawal by Subject|0
1152023|NCT01318070|3783199|P3|Overall Study|Adverse Event|5
1152024|NCT01318070|3783200|P2|Overall Study|Adverse Event|1
1152025|NCT01318070|3783201|P1|Overall Study|Adverse Event|1
1152026|NCT01317797|3783254|P3|Overall Study|Withdrawal of Patient|1
1152027|NCT01317797|3783255|P2|Overall Study|Withdrawal of Patient|0
1152028|NCT01317797|3783256|P1|Overall Study|Withdrawal of Patient|0
1152029|NCT01317797|3783254|P3|Overall Study|Other|0
1152030|NCT01317797|3783255|P2|Overall Study|Other|1
1152031|NCT01317797|3783256|P1|Overall Study|Other|0
1152032|NCT01317641|3783333|P9|Overall Study|Withdrawal by Subject|0
1152033|NCT01317641|3783334|P8|Overall Study|Withdrawal by Subject|0
1152034|NCT01317641|3783335|P7|Overall Study|Withdrawal by Subject|1
1152035|NCT01317641|3783336|P6|Overall Study|Withdrawal by Subject|0
1152036|NCT01317641|3783337|P5|Overall Study|Withdrawal by Subject|0
1152037|NCT01317641|3783338|P4|Overall Study|Withdrawal by Subject|0
1152038|NCT01317641|3783339|P3|Overall Study|Withdrawal by Subject|0
1152039|NCT01317641|3783340|P2|Overall Study|Withdrawal by Subject|0
1152040|NCT01317641|3783341|P1|Overall Study|Withdrawal by Subject|0
1152041|NCT01317641|3783333|P9|Overall Study|Disease progression|4
1152042|NCT01317641|3783334|P8|Overall Study|Disease progression|3
1152043|NCT01317641|3783335|P7|Overall Study|Disease progression|0
1152044|NCT01317641|3783336|P6|Overall Study|Disease progression|0
1152045|NCT01317641|3783337|P5|Overall Study|Disease progression|0
1152046|NCT01317641|3783338|P4|Overall Study|Disease progression|0
1152047|NCT01317641|3783339|P3|Overall Study|Disease progression|0
1152048|NCT01317641|3783340|P2|Overall Study|Disease progression|0
1152049|NCT01317641|3783341|P1|Overall Study|Disease progression|0
1152050|NCT01317641|3783333|P9|Overall Study|Protocol Violation|0
1152051|NCT01317641|3783334|P8|Overall Study|Protocol Violation|0
1152052|NCT01317641|3783335|P7|Overall Study|Protocol Violation|0
1152053|NCT01317641|3783336|P6|Overall Study|Protocol Violation|0
1152054|NCT01317641|3783337|P5|Overall Study|Protocol Violation|0
1152055|NCT01317641|3783338|P4|Overall Study|Protocol Violation|0
1152056|NCT01317641|3783339|P3|Overall Study|Protocol Violation|0
1152057|NCT01317641|3783340|P2|Overall Study|Protocol Violation|0
1152058|NCT01317641|3783341|P1|Overall Study|Protocol Violation|1
1152059|NCT01317641|3783333|P9|Overall Study|Adverse Event|0
1152060|NCT01317641|3783334|P8|Overall Study|Adverse Event|1
1152061|NCT01317641|3783335|P7|Overall Study|Adverse Event|2
1152062|NCT01317641|3783336|P6|Overall Study|Adverse Event|0
1152063|NCT01317641|3783337|P5|Overall Study|Adverse Event|0
1152064|NCT01317641|3783338|P4|Overall Study|Adverse Event|1
1152065|NCT01317641|3783339|P3|Overall Study|Adverse Event|0
1152066|NCT01317641|3783340|P2|Overall Study|Adverse Event|1
1152067|NCT01317641|3783341|P1|Overall Study|Adverse Event|0
1152068|NCT01317641|3783333|P9|Overall Study|Not treated|1
1152069|NCT01317641|3783334|P8|Overall Study|Not treated|1
1152070|NCT01317641|3783335|P7|Overall Study|Not treated|0
1152071|NCT01317641|3783336|P6|Overall Study|Not treated|0
1152072|NCT01317641|3783337|P5|Overall Study|Not treated|0
1152073|NCT01317641|3783338|P4|Overall Study|Not treated|0
1152074|NCT01317641|3783339|P3|Overall Study|Not treated|0
1152075|NCT01317641|3783340|P2|Overall Study|Not treated|0
1152076|NCT01317641|3783341|P1|Overall Study|Not treated|0
1152077|NCT01317615|3783443|P1|Overall Study|Adverse Event|7
1152078|NCT01317615|3783443|P1|Overall Study|Abnormal laboratory value(s)|1
1152079|NCT01317615|3783443|P1|Overall Study|Withdrawal by Subject|5
1152080|NCT01317615|3783443|P1|Overall Study|Death|6
1152081|NCT01317615|3783443|P1|Overall Study|New cancer therapy|5
1152082|NCT01317615|3783443|P1|Overall Study|Disease progression|25
1152083|NCT01317199|3783456|P4|Randomized Phase 2|Patient transferred to other facility|0
1152084|NCT01317199|3783457|P3|Randomized Phase 2|Patient transferred to other facility|1
1152085|NCT01317199|3783458|P2|Randomized Phase 2|Patient transferred to other facility|0
1152086|NCT01317199|3783459|P1|Randomized Phase 2|Patient transferred to other facility|0
1152087|NCT01317199|3783456|P4|Randomized Phase 2|Patient stopped taking study drug|1
1152088|NCT01317199|3783457|P3|Randomized Phase 2|Patient stopped taking study drug|0
1152089|NCT01317199|3783458|P2|Randomized Phase 2|Patient stopped taking study drug|0
1152090|NCT01317199|3783459|P1|Randomized Phase 2|Patient stopped taking study drug|0
1152091|NCT01317199|3783456|P4|Randomized Phase 2|Disenrolled before treatment|2
1152092|NCT01317199|3783457|P3|Randomized Phase 2|Disenrolled before treatment|1
1152093|NCT01317199|3783458|P2|Randomized Phase 2|Disenrolled before treatment|1
1152094|NCT01317199|3783459|P1|Randomized Phase 2|Disenrolled before treatment|0
1152095|NCT01317199|3783456|P4|Randomized Phase 2|Rising PSA, not as defined by protocol|2
1152096|NCT01317199|3783457|P3|Randomized Phase 2|Rising PSA, not as defined by protocol|5
1152097|NCT01317199|3783458|P2|Randomized Phase 2|Rising PSA, not as defined by protocol|2
1152098|NCT01317199|3783459|P1|Randomized Phase 2|Rising PSA, not as defined by protocol|0
1152099|NCT01317199|3783456|P4|Randomized Phase 2|Comorbidities|2
1152100|NCT01317199|3783457|P3|Randomized Phase 2|Comorbidities|2
1152101|NCT01317199|3783458|P2|Randomized Phase 2|Comorbidities|2
1152102|NCT01317199|3783459|P1|Randomized Phase 2|Comorbidities|0
1152103|NCT01317199|3783456|P4|Randomized Phase 2|Adverse Event|1
1152104|NCT01317199|3783457|P3|Randomized Phase 2|Adverse Event|0
1152105|NCT01317199|3783458|P2|Randomized Phase 2|Adverse Event|0
1152106|NCT01317199|3783459|P1|Randomized Phase 2|Adverse Event|0
1152107|NCT01317199|3783456|P4|Randomized Phase 2|Withdrawal by Subject|4
1152108|NCT01317199|3783457|P3|Randomized Phase 2|Withdrawal by Subject|5
1152109|NCT01317199|3783458|P2|Randomized Phase 2|Withdrawal by Subject|3
1152110|NCT01317199|3783459|P1|Randomized Phase 2|Withdrawal by Subject|0
1152111|NCT01317199|3783456|P4|Randomized Phase 2|Disease progression|5
1152112|NCT01317199|3783457|P3|Randomized Phase 2|Disease progression|7
1152113|NCT01317199|3783458|P2|Randomized Phase 2|Disease progression|3
1152114|NCT01317199|3783459|P1|Randomized Phase 2|Disease progression|0
1152115|NCT01317199|3783456|P4|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
1152116|NCT01317199|3783457|P3|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
1152117|NCT01317199|3783458|P2|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
1152118|NCT01317199|3783459|P1|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1
1152119|NCT01317199|3783456|P4|Dose-escalation Phase 1|Disease progression|0
1152120|NCT01317199|3783457|P3|Dose-escalation Phase 1|Disease progression|0
1152121|NCT01317199|3783458|P2|Dose-escalation Phase 1|Disease progression|0
1152122|NCT01317199|3783459|P1|Dose-escalation Phase 1|Disease progression|1
1152123|NCT01317199|3783456|P4|Dose-escalation Phase 1|Physician Decision|0
1152124|NCT01317199|3783457|P3|Dose-escalation Phase 1|Physician Decision|0
1152125|NCT01317199|3783458|P2|Dose-escalation Phase 1|Physician Decision|0
1152126|NCT01317199|3783459|P1|Dose-escalation Phase 1|Physician Decision|5
1152127|NCT01317160|3783488|P2|Overall Study|Withdrawal by Subject|2
1152128|NCT01317160|3783489|P1|Overall Study|Withdrawal by Subject|0
1152129|NCT01317160|3783488|P2|Overall Study|Lost to Follow-up|3
1152130|NCT01317160|3783489|P1|Overall Study|Lost to Follow-up|3
1152131|NCT01317160|3783488|P2|Overall Study|Incorrect inclusion|1
1152132|NCT01317160|3783489|P1|Overall Study|Incorrect inclusion|1
1152133|NCT01317004|3783514|P2|Overall Study|Adverse Event|3
1152134|NCT01317004|3783515|P1|Overall Study|Adverse Event|3
1152135|NCT01317004|3783514|P2|Overall Study|Protocol Violation|2
1152136|NCT01317004|3783515|P1|Overall Study|Protocol Violation|0
1152137|NCT01317004|3783514|P2|Overall Study|Withdrawal by Subject|4
1152138|NCT01317004|3783515|P1|Overall Study|Withdrawal by Subject|1
1152139|NCT01316939|3783536|P3|Overall Study|Protocol Violation|0
1152140|NCT01316939|3783537|P2|Overall Study|Protocol Violation|1
1152141|NCT01316939|3783538|P1|Overall Study|Protocol Violation|0
1152142|NCT01316939|3783536|P3|Overall Study|Met Liver chemistry stopping criteria|1
1152143|NCT01316939|3783537|P2|Overall Study|Met Liver chemistry stopping criteria|0
1152144|NCT01316939|3783538|P1|Overall Study|Met Liver chemistry stopping criteria|1
1152145|NCT01316939|3783536|P3|Overall Study|Lost to Follow-up|2
1152146|NCT01316939|3783537|P2|Overall Study|Lost to Follow-up|0
1152147|NCT01316939|3783538|P1|Overall Study|Lost to Follow-up|0
1152148|NCT01316939|3783536|P3|Overall Study|Physician Decision|1
1152149|NCT01316939|3783537|P2|Overall Study|Physician Decision|2
1152150|NCT01316939|3783538|P1|Overall Study|Physician Decision|2
1152151|NCT01316939|3783536|P3|Overall Study|Withdrawal by Subject|6
1152152|NCT01316939|3783537|P2|Overall Study|Withdrawal by Subject|3
1152153|NCT01316939|3783538|P1|Overall Study|Withdrawal by Subject|1
1152154|NCT01316939|3783536|P3|Overall Study|Adverse Event|11
1152155|NCT01316939|3783537|P2|Overall Study|Adverse Event|12
1152156|NCT01316939|3783538|P1|Overall Study|Adverse Event|9
1152157|NCT01316939|3783536|P3|Overall Study|Lack of Efficacy|25
1152158|NCT01316939|3783537|P2|Overall Study|Lack of Efficacy|25
1152159|NCT01316939|3783538|P1|Overall Study|Lack of Efficacy|24
1152160|NCT01316939|3783536|P3|Overall Study|Study closed/terminated|23
1152161|NCT01316939|3783537|P2|Overall Study|Study closed/terminated|25
1152162|NCT01316939|3783538|P1|Overall Study|Study closed/terminated|26
1152163|NCT01316913|3783633|P4|Overall Study|Withdrawal by Subject|6
1152164|NCT01316913|3783634|P3|Overall Study|Withdrawal by Subject|10
1152165|NCT01316913|3783635|P2|Overall Study|Withdrawal by Subject|9
1152166|NCT01316913|3783636|P1|Overall Study|Withdrawal by Subject|10
1152167|NCT01316913|3783633|P4|Overall Study|Lost to Follow-up|2
1152168|NCT01316913|3783634|P3|Overall Study|Lost to Follow-up|0
1152169|NCT01316913|3783635|P2|Overall Study|Lost to Follow-up|1
1152170|NCT01316913|3783636|P1|Overall Study|Lost to Follow-up|0
1152171|NCT01316913|3783633|P4|Overall Study|Protocol-defined Stopping Criteria|6
1152172|NCT01316913|3783634|P3|Overall Study|Protocol-defined Stopping Criteria|11
1152173|NCT01316913|3783635|P2|Overall Study|Protocol-defined Stopping Criteria|8
1152174|NCT01316913|3783636|P1|Overall Study|Protocol-defined Stopping Criteria|7
1152175|NCT01316913|3783633|P4|Overall Study|Protocol Violation|1
1152176|NCT01316913|3783634|P3|Overall Study|Protocol Violation|4
1152177|NCT01316913|3783635|P2|Overall Study|Protocol Violation|4
1152178|NCT01316913|3783636|P1|Overall Study|Protocol Violation|1
1152179|NCT01316913|3783633|P4|Overall Study|Lack of Efficacy|13
1152180|NCT01316913|3783634|P3|Overall Study|Lack of Efficacy|9
1152181|NCT01316913|3783635|P2|Overall Study|Lack of Efficacy|12
1152182|NCT01316913|3783636|P1|Overall Study|Lack of Efficacy|22
1152183|NCT01316913|3783633|P4|Overall Study|Adverse Event|11
1152184|NCT01316913|3783634|P3|Overall Study|Adverse Event|15
1152185|NCT01316913|3783635|P2|Overall Study|Adverse Event|20
1152186|NCT01316913|3783636|P1|Overall Study|Adverse Event|17
1152187|NCT01316900|3783658|P4|Overall Study|Withdrawal by Subject|9
1152188|NCT01316900|3783659|P3|Overall Study|Withdrawal by Subject|6
1152189|NCT01316900|3783660|P2|Overall Study|Withdrawal by Subject|8
1152190|NCT01316900|3783661|P1|Overall Study|Withdrawal by Subject|7
1152191|NCT01316900|3783658|P4|Overall Study|Lost to Follow-up|1
1152192|NCT01316900|3783659|P3|Overall Study|Lost to Follow-up|1
1152193|NCT01316900|3783660|P2|Overall Study|Lost to Follow-up|0
1152194|NCT01316900|3783661|P1|Overall Study|Lost to Follow-up|1
1152195|NCT01316900|3783658|P4|Overall Study|Protocol-defined Stopping Criteria|5
1152196|NCT01316900|3783659|P3|Overall Study|Protocol-defined Stopping Criteria|10
1152197|NCT01316900|3783660|P2|Overall Study|Protocol-defined Stopping Criteria|3
1152198|NCT01316900|3783661|P1|Overall Study|Protocol-defined Stopping Criteria|2
1152199|NCT01316900|3783658|P4|Overall Study|Protocol Violation|0
1152200|NCT01316900|3783659|P3|Overall Study|Protocol Violation|4
1152201|NCT01316900|3783660|P2|Overall Study|Protocol Violation|1
1152202|NCT01316900|3783661|P1|Overall Study|Protocol Violation|7
1152203|NCT01316900|3783658|P4|Overall Study|Lack of Efficacy|7
1152204|NCT01316900|3783659|P3|Overall Study|Lack of Efficacy|5
1152205|NCT01316900|3783660|P2|Overall Study|Lack of Efficacy|9
1152206|NCT01316900|3783661|P1|Overall Study|Lack of Efficacy|17
1152207|NCT01316900|3783658|P4|Overall Study|Adverse Event|9
1152208|NCT01316900|3783659|P3|Overall Study|Adverse Event|15
1152209|NCT01316900|3783660|P2|Overall Study|Adverse Event|10
1152210|NCT01316900|3783661|P1|Overall Study|Adverse Event|10
1152211|NCT01316887|3783682|P3|Overall Study|Withdrawal by Subject|15
1152212|NCT01316887|3783683|P2|Overall Study|Withdrawal by Subject|16
1152213|NCT01316887|3783684|P1|Overall Study|Withdrawal by Subject|8
1152214|NCT01316887|3783682|P3|Overall Study|Lost to Follow-up|5
1152215|NCT01316887|3783683|P2|Overall Study|Lost to Follow-up|7
1152216|NCT01316887|3783684|P1|Overall Study|Lost to Follow-up|1
1152217|NCT01316887|3783682|P3|Overall Study|Study Closed/Terminated|3
1152218|NCT01316887|3783683|P2|Overall Study|Study Closed/Terminated|4
1152219|NCT01316887|3783684|P1|Overall Study|Study Closed/Terminated|2
1152220|NCT01316887|3783682|P3|Overall Study|Protocol-defined Stopping Criteria|36
1152221|NCT01316887|3783683|P2|Overall Study|Protocol-defined Stopping Criteria|37
1152222|NCT01316887|3783684|P1|Overall Study|Protocol-defined Stopping Criteria|8
1152223|NCT01316887|3783682|P3|Overall Study|Protocol Violation|6
1152224|NCT01316887|3783683|P2|Overall Study|Protocol Violation|6
1152225|NCT01316887|3783684|P1|Overall Study|Protocol Violation|2
1152226|NCT01316887|3783682|P3|Overall Study|Lack of Efficacy|1
1152227|NCT01316887|3783683|P2|Overall Study|Lack of Efficacy|3
1152228|NCT01316887|3783684|P1|Overall Study|Lack of Efficacy|9
1152229|NCT01316887|3783682|P3|Overall Study|Adverse Event|17
1152230|NCT01316887|3783683|P2|Overall Study|Adverse Event|21
1152231|NCT01316887|3783684|P1|Overall Study|Adverse Event|13
1152232|NCT01316692|3783809|P1|Overall Study|Disease Progression|7
1152233|NCT01316692|3783809|P1|Overall Study|Adverse Event|5
1152234|NCT01316614|3783818|P1|Overall Study|Medically unstable|1
1152235|NCT01316614|3783818|P1|Overall Study|Inadequate number of passes|2
1152236|NCT01316614|3783818|P1|Overall Study|Cystic lesion|5
1152237|NCT01316614|3783818|P1|Overall Study|Cytology slides not available for review|4
1152238|NCT01316614|3783818|P1|Overall Study|No solid lesion and FNA not indicated|25
1152239|NCT01316575|3783835|P2|Overall Study|Required alternate treatment|1
1152240|NCT01316575|3783836|P1|Overall Study|Required alternate treatment|0
1152241|NCT01316575|3783835|P2|Overall Study|Withdrawal by Subject|0
1152242|NCT01316575|3783836|P1|Overall Study|Withdrawal by Subject|2
1152243|NCT01316419|3783859|P1|Overall Study|Lost to Follow-up|19
1152244|NCT01316419|3783859|P1|Overall Study|Violated inclusion/exclusion criterion|143
1152245|NCT01316419|3783859|P1|Overall Study|Not treated|103
1152246|NCT01316380|3783885|P3|Overall Study|Not treated|0
1152247|NCT01316380|3783886|P2|Overall Study|Not treated|0
1152248|NCT01316380|3783887|P1|Overall Study|Not treated|1
1152249|NCT01316380|3783885|P3|Overall Study|Other|1
1152250|NCT01316380|3783886|P2|Overall Study|Other|1
1152251|NCT01316380|3783887|P1|Overall Study|Other|0
1152252|NCT01316380|3783885|P3|Overall Study|Withdrawal by Subject|0
1152253|NCT01316380|3783886|P2|Overall Study|Withdrawal by Subject|2
1152254|NCT01316380|3783887|P1|Overall Study|Withdrawal by Subject|1
1152255|NCT01316380|3783885|P3|Overall Study|Protocol Violation|1
1152256|NCT01316380|3783886|P2|Overall Study|Protocol Violation|0
1152257|NCT01316380|3783887|P1|Overall Study|Protocol Violation|0
1152258|NCT01316380|3783885|P3|Overall Study|Adverse Event|1
1152259|NCT01316380|3783886|P2|Overall Study|Adverse Event|2
1152260|NCT01316380|3783887|P1|Overall Study|Adverse Event|0
1152261|NCT01316224|3784053|P1|Overall Study|Not Specified|1
1152262|NCT01316224|3784053|P1|Overall Study|Adverse Event With Treatment Failure|1
1152263|NCT01316224|3784053|P1|Overall Study|Withdrawal by Subject|1
1152264|NCT01316224|3784053|P1|Overall Study|Lack of Efficacy|1
1152265|NCT01316224|3784053|P1|Overall Study|Adverse Event|3
1152266|NCT01316224|3784053|P1|Overall Study|Protocol Violation|3
1152267|NCT01316055|3784070|P3|Overall Study|Lost to Follow-up|0
1152268|NCT01316055|3784071|P2|Overall Study|Lost to Follow-up|0
1152269|NCT01316055|3784072|P1|Overall Study|Lost to Follow-up|1
1152270|NCT01315847|3784103|P2|Part III, Period 1|[11C]MK-4232 synthesis failure|1
1152271|NCT01315847|3784104|P1|Part III, Period 1|[11C]MK-4232 synthesis failure|0
1152272|NCT01315847|3784103|P2|Part I, Period 1|Reached maximum number of arterial lines|0
1152273|NCT01315847|3784104|P1|Part I, Period 1|Reached maximum number of arterial lines|3
1152274|NCT01315353|3784149|P3|Overall Study|Inadvertent randomization/assignment|2
1152275|NCT01315353|3784150|P2|Overall Study|Inadvertent randomization/assignment|0
1152276|NCT01315353|3784151|P1|Overall Study|Inadvertent randomization/assignment|0
1152277|NCT01315353|3784149|P3|Overall Study|Taken off study by site in error|0
1152278|NCT01315353|3784150|P2|Overall Study|Taken off study by site in error|1
1152279|NCT01315353|3784151|P1|Overall Study|Taken off study by site in error|0
1152280|NCT01315353|3784149|P3|Overall Study|Site closing|0
1152281|NCT01315353|3784150|P2|Overall Study|Site closing|4
1152282|NCT01315353|3784151|P1|Overall Study|Site closing|7
1152283|NCT01315353|3784149|P3|Overall Study|Unwilling to adhere to requirements|4
1152284|NCT01315353|3784150|P2|Overall Study|Unwilling to adhere to requirements|5
1152285|NCT01315353|3784151|P1|Overall Study|Unwilling to adhere to requirements|5
1152286|NCT01315353|3784149|P3|Overall Study|Lost to Follow-up|6
1152287|NCT01315353|3784150|P2|Overall Study|Lost to Follow-up|6
1152288|NCT01315353|3784151|P1|Overall Study|Lost to Follow-up|13
1152289|NCT01315353|3784149|P3|Overall Study|Withdrawal by Subject|1
1152290|NCT01315353|3784150|P2|Overall Study|Withdrawal by Subject|6
1152291|NCT01315353|3784151|P1|Overall Study|Withdrawal by Subject|2
1152292|NCT01315353|3784149|P3|Overall Study|Death|0
1152293|NCT01315353|3784150|P2|Overall Study|Death|1
1152294|NCT01315353|3784151|P1|Overall Study|Death|2
1152295|NCT01315249|3784178|P2|Overall Study|Death|1
1152296|NCT01315249|3784179|P1|Overall Study|Death|0
1152297|NCT01315249|3784178|P2|Overall Study|Lost to Follow-up|2
1152298|NCT01315249|3784179|P1|Overall Study|Lost to Follow-up|0
1152299|NCT01315249|3784178|P2|Overall Study|Lack of Efficacy|1
1152300|NCT01315249|3784179|P1|Overall Study|Lack of Efficacy|0
1152301|NCT01315249|3784178|P2|Overall Study|inability to use device|0
1152302|NCT01315249|3784179|P1|Overall Study|inability to use device|1
1152303|NCT01315249|3784178|P2|Overall Study|Administrative problems|0
1152304|NCT01315249|3784179|P1|Overall Study|Administrative problems|1
1152305|NCT01315249|3784178|P2|Overall Study|Abnormal test results|2
1152306|NCT01315249|3784179|P1|Overall Study|Abnormal test results|1
1152307|NCT01315249|3784178|P2|Overall Study|Protocol Violation|5
1152308|NCT01315249|3784179|P1|Overall Study|Protocol Violation|8
1152309|NCT01315249|3784178|P2|Overall Study|Withdrawal by Subject|10
1152310|NCT01315249|3784179|P1|Overall Study|Withdrawal by Subject|11
1152311|NCT01315249|3784178|P2|Overall Study|Adverse Event|26
1152312|NCT01315249|3784179|P1|Overall Study|Adverse Event|22
1152313|NCT01315028|3784241|P2|Overall Study|Death|1
1152314|NCT01315028|3784242|P1|Overall Study|Death|0
1152315|NCT01315028|3784241|P2|Overall Study|Lost to Follow-up|0
1152316|NCT01315028|3784242|P1|Overall Study|Lost to Follow-up|1
1152317|NCT01314872|3784278|P15|Period 2|Lost to Follow-up|6
1152318|NCT01314872|3784279|P14|Period 2|Lost to Follow-up|2
1152319|NCT01314872|3784280|P13|Period 2|Lost to Follow-up|7
1152320|NCT01314872|3784281|P12|Period 2|Lost to Follow-up|6
1152321|NCT01314872|3784282|P11|Period 2|Lost to Follow-up|0
1152322|NCT01314872|3784283|P10|Period 2|Lost to Follow-up|0
1152323|NCT01314872|3784284|P9|Period 2|Lost to Follow-up|0
1152324|NCT01314872|3784285|P8|Period 2|Lost to Follow-up|0
1152325|NCT01314872|3784286|P7|Period 2|Lost to Follow-up|0
1152326|NCT01314872|3784287|P6|Period 2|Lost to Follow-up|0
1152327|NCT01314872|3784288|P5|Period 2|Lost to Follow-up|0
1152328|NCT01314872|3784289|P4|Period 2|Lost to Follow-up|0
1152329|NCT01314872|3784290|P3|Period 2|Lost to Follow-up|0
1152330|NCT01314872|3784291|P2|Period 2|Lost to Follow-up|0
1152331|NCT01314872|3784292|P1|Period 2|Lost to Follow-up|0
1152332|NCT01314872|3784278|P15|Period 2|Withdrawal by Subject|4
1152333|NCT01314872|3784279|P14|Period 2|Withdrawal by Subject|12
1152334|NCT01314872|3784280|P13|Period 2|Withdrawal by Subject|17
1152335|NCT01314872|3784281|P12|Period 2|Withdrawal by Subject|14
1152336|NCT01314872|3784282|P11|Period 2|Withdrawal by Subject|0
1152337|NCT01314872|3784283|P10|Period 2|Withdrawal by Subject|0
1152338|NCT01314872|3784284|P9|Period 2|Withdrawal by Subject|0
1152339|NCT01314872|3784285|P8|Period 2|Withdrawal by Subject|0
1152340|NCT01314872|3784286|P7|Period 2|Withdrawal by Subject|0
1152341|NCT01314872|3784287|P6|Period 2|Withdrawal by Subject|0
1152342|NCT01314872|3784288|P5|Period 2|Withdrawal by Subject|0
1152343|NCT01314872|3784289|P4|Period 2|Withdrawal by Subject|0
1152344|NCT01314872|3784290|P3|Period 2|Withdrawal by Subject|0
1152345|NCT01314872|3784291|P2|Period 2|Withdrawal by Subject|0
1152346|NCT01314872|3784292|P1|Period 2|Withdrawal by Subject|0
1152347|NCT01314872|3784278|P15|Period 2|Adverse event, non-fatal|9
1152348|NCT01314872|3784279|P14|Period 2|Adverse event, non-fatal|24
1152349|NCT01314872|3784280|P13|Period 2|Adverse event, non-fatal|16
1152350|NCT01314872|3784281|P12|Period 2|Adverse event, non-fatal|13
1152351|NCT01314872|3784282|P11|Period 2|Adverse event, non-fatal|0
1152352|NCT01314872|3784283|P10|Period 2|Adverse event, non-fatal|0
1152353|NCT01314872|3784284|P9|Period 2|Adverse event, non-fatal|0
1152354|NCT01314872|3784285|P8|Period 2|Adverse event, non-fatal|0
1152355|NCT01314872|3784286|P7|Period 2|Adverse event, non-fatal|0
1152356|NCT01314872|3784287|P6|Period 2|Adverse event, non-fatal|0
1152357|NCT01314872|3784288|P5|Period 2|Adverse event, non-fatal|0
1152358|NCT01314872|3784289|P4|Period 2|Adverse event, non-fatal|0
1152359|NCT01314872|3784290|P3|Period 2|Adverse event, non-fatal|0
1152360|NCT01314872|3784291|P2|Period 2|Adverse event, non-fatal|0
1152361|NCT01314872|3784292|P1|Period 2|Adverse event, non-fatal|0
1152362|NCT01314872|3784278|P15|Period 2|Study terminated by Sponsor|0
1152363|NCT01314872|3784279|P14|Period 2|Study terminated by Sponsor|3
1152364|NCT01314872|3784280|P13|Period 2|Study terminated by Sponsor|2
1152365|NCT01314872|3784281|P12|Period 2|Study terminated by Sponsor|2
1152366|NCT01314872|3784282|P11|Period 2|Study terminated by Sponsor|0
1152367|NCT01314872|3784283|P10|Period 2|Study terminated by Sponsor|0
1152368|NCT01314872|3784284|P9|Period 2|Study terminated by Sponsor|0
1152369|NCT01314872|3784285|P8|Period 2|Study terminated by Sponsor|0
1152370|NCT01314872|3784286|P7|Period 2|Study terminated by Sponsor|0
1152371|NCT01314872|3784287|P6|Period 2|Study terminated by Sponsor|0
1152372|NCT01314872|3784288|P5|Period 2|Study terminated by Sponsor|0
1152373|NCT01314872|3784289|P4|Period 2|Study terminated by Sponsor|0
1152374|NCT01314872|3784290|P3|Period 2|Study terminated by Sponsor|0
1152375|NCT01314872|3784291|P2|Period 2|Study terminated by Sponsor|0
1152376|NCT01314872|3784292|P1|Period 2|Study terminated by Sponsor|0
1152377|NCT01314872|3784278|P15|Period 2|Pregnancy|1
1152378|NCT01314872|3784279|P14|Period 2|Pregnancy|0
1152379|NCT01314872|3784280|P13|Period 2|Pregnancy|0
1152380|NCT01314872|3784281|P12|Period 2|Pregnancy|0
1152381|NCT01314872|3784282|P11|Period 2|Pregnancy|0
1152382|NCT01314872|3784283|P10|Period 2|Pregnancy|0
1152383|NCT01314872|3784284|P9|Period 2|Pregnancy|0
1152384|NCT01314872|3784285|P8|Period 2|Pregnancy|0
1152385|NCT01314872|3784286|P7|Period 2|Pregnancy|0
1152386|NCT01314872|3784287|P6|Period 2|Pregnancy|0
1152387|NCT01314872|3784288|P5|Period 2|Pregnancy|0
1152388|NCT01314872|3784289|P4|Period 2|Pregnancy|0
1152389|NCT01314872|3784290|P3|Period 2|Pregnancy|0
1152390|NCT01314872|3784291|P2|Period 2|Pregnancy|0
1152391|NCT01314872|3784292|P1|Period 2|Pregnancy|0
1152392|NCT01314872|3784278|P15|Period 2|Lack of Efficacy|2
1152393|NCT01314872|3784279|P14|Period 2|Lack of Efficacy|9
1152394|NCT01314872|3784280|P13|Period 2|Lack of Efficacy|12
1152395|NCT01314872|3784281|P12|Period 2|Lack of Efficacy|7
1152396|NCT01314872|3784282|P11|Period 2|Lack of Efficacy|0
1152397|NCT01314872|3784283|P10|Period 2|Lack of Efficacy|0
1152398|NCT01314872|3784284|P9|Period 2|Lack of Efficacy|0
1152399|NCT01314872|3784285|P8|Period 2|Lack of Efficacy|0
1152400|NCT01314872|3784286|P7|Period 2|Lack of Efficacy|0
1152401|NCT01314872|3784287|P6|Period 2|Lack of Efficacy|0
1152402|NCT01314872|3784288|P5|Period 2|Lack of Efficacy|0
1152403|NCT01314872|3784289|P4|Period 2|Lack of Efficacy|0
1152404|NCT01314872|3784290|P3|Period 2|Lack of Efficacy|0
1152405|NCT01314872|3784291|P2|Period 2|Lack of Efficacy|0
1152406|NCT01314872|3784292|P1|Period 2|Lack of Efficacy|0
1152407|NCT01314872|3784278|P15|Period 2|Non-compliance with study drug|2
1152408|NCT01314872|3784279|P14|Period 2|Non-compliance with study drug|1
1152409|NCT01314872|3784280|P13|Period 2|Non-compliance with study drug|3
1152410|NCT01314872|3784281|P12|Period 2|Non-compliance with study drug|3
1152411|NCT01314872|3784282|P11|Period 2|Non-compliance with study drug|0
1152412|NCT01314872|3784283|P10|Period 2|Non-compliance with study drug|0
1152413|NCT01314872|3784284|P9|Period 2|Non-compliance with study drug|0
1152414|NCT01314872|3784285|P8|Period 2|Non-compliance with study drug|0
1152415|NCT01314872|3784286|P7|Period 2|Non-compliance with study drug|0
1152416|NCT01314872|3784287|P6|Period 2|Non-compliance with study drug|0
1152417|NCT01314872|3784288|P5|Period 2|Non-compliance with study drug|0
1152418|NCT01314872|3784289|P4|Period 2|Non-compliance with study drug|0
1152419|NCT01314872|3784290|P3|Period 2|Non-compliance with study drug|0
1152420|NCT01314872|3784291|P2|Period 2|Non-compliance with study drug|0
1152421|NCT01314872|3784292|P1|Period 2|Non-compliance with study drug|0
1152422|NCT01314872|3784278|P15|Period 2|Protocol Violation|0
1152423|NCT01314872|3784279|P14|Period 2|Protocol Violation|2
1152424|NCT01314872|3784280|P13|Period 2|Protocol Violation|3
1152425|NCT01314872|3784281|P12|Period 2|Protocol Violation|3
1152426|NCT01314872|3784282|P11|Period 2|Protocol Violation|0
1152427|NCT01314872|3784283|P10|Period 2|Protocol Violation|0
1152428|NCT01314872|3784284|P9|Period 2|Protocol Violation|0
1152429|NCT01314872|3784285|P8|Period 2|Protocol Violation|0
1152430|NCT01314872|3784286|P7|Period 2|Protocol Violation|0
1152431|NCT01314872|3784287|P6|Period 2|Protocol Violation|0
1152432|NCT01314872|3784288|P5|Period 2|Protocol Violation|0
1152433|NCT01314872|3784289|P4|Period 2|Protocol Violation|0
1152434|NCT01314872|3784290|P3|Period 2|Protocol Violation|0
1152435|NCT01314872|3784291|P2|Period 2|Protocol Violation|0
1152436|NCT01314872|3784292|P1|Period 2|Protocol Violation|0
1152437|NCT01314872|3784278|P15|Treatment Period 1|Lost to Follow-up|0
1152438|NCT01314872|3784279|P14|Treatment Period 1|Lost to Follow-up|0
1152439|NCT01314872|3784280|P13|Treatment Period 1|Lost to Follow-up|0
1152440|NCT01314872|3784281|P12|Treatment Period 1|Lost to Follow-up|0
1152441|NCT01314872|3784282|P11|Treatment Period 1|Lost to Follow-up|0
1152442|NCT01314872|3784283|P10|Treatment Period 1|Lost to Follow-up|0
1152443|NCT01314872|3784284|P9|Treatment Period 1|Lost to Follow-up|1
1152444|NCT01314872|3784285|P8|Treatment Period 1|Lost to Follow-up|1
1152445|NCT01314872|3784286|P7|Treatment Period 1|Lost to Follow-up|1
1152446|NCT01314872|3784287|P6|Treatment Period 1|Lost to Follow-up|1
1152447|NCT01314872|3784288|P5|Treatment Period 1|Lost to Follow-up|1
1152448|NCT01314872|3784289|P4|Treatment Period 1|Lost to Follow-up|2
1152449|NCT01314872|3784290|P3|Treatment Period 1|Lost to Follow-up|2
1152450|NCT01314872|3784291|P2|Treatment Period 1|Lost to Follow-up|1
1152451|NCT01314872|3784292|P1|Treatment Period 1|Lost to Follow-up|0
1152452|NCT01314872|3784278|P15|Treatment Period 1|Withdrawal by Subject|0
1152453|NCT01314872|3784279|P14|Treatment Period 1|Withdrawal by Subject|0
1152454|NCT01314872|3784280|P13|Treatment Period 1|Withdrawal by Subject|0
1152455|NCT01314872|3784281|P12|Treatment Period 1|Withdrawal by Subject|0
1152456|NCT01314872|3784282|P11|Treatment Period 1|Withdrawal by Subject|1
1152457|NCT01314872|3784283|P10|Treatment Period 1|Withdrawal by Subject|2
1152458|NCT01314872|3784284|P9|Treatment Period 1|Withdrawal by Subject|2
1152459|NCT01314872|3784285|P8|Treatment Period 1|Withdrawal by Subject|2
1152460|NCT01314872|3784286|P7|Treatment Period 1|Withdrawal by Subject|3
1152461|NCT01314872|3784287|P6|Treatment Period 1|Withdrawal by Subject|1
1152462|NCT01314872|3784288|P5|Treatment Period 1|Withdrawal by Subject|3
1152463|NCT01314872|3784289|P4|Treatment Period 1|Withdrawal by Subject|2
1152464|NCT01314872|3784290|P3|Treatment Period 1|Withdrawal by Subject|0
1152465|NCT01314872|3784291|P2|Treatment Period 1|Withdrawal by Subject|1
1152466|NCT01314872|3784292|P1|Treatment Period 1|Withdrawal by Subject|3
1152467|NCT01314872|3784278|P15|Treatment Period 1|Adverse event, non-fatal|0
1152468|NCT01314872|3784279|P14|Treatment Period 1|Adverse event, non-fatal|0
1152469|NCT01314872|3784280|P13|Treatment Period 1|Adverse event, non-fatal|0
1152470|NCT01314872|3784281|P12|Treatment Period 1|Adverse event, non-fatal|0
1152471|NCT01314872|3784282|P11|Treatment Period 1|Adverse event, non-fatal|1
1152472|NCT01314872|3784283|P10|Treatment Period 1|Adverse event, non-fatal|0
1152473|NCT01314872|3784284|P9|Treatment Period 1|Adverse event, non-fatal|3
1152474|NCT01314872|3784285|P8|Treatment Period 1|Adverse event, non-fatal|2
1152475|NCT01314872|3784286|P7|Treatment Period 1|Adverse event, non-fatal|4
1152476|NCT01314872|3784287|P6|Treatment Period 1|Adverse event, non-fatal|4
1152477|NCT01314872|3784288|P5|Treatment Period 1|Adverse event, non-fatal|2
1152478|NCT01314872|3784289|P4|Treatment Period 1|Adverse event, non-fatal|2
1152479|NCT01314872|3784290|P3|Treatment Period 1|Adverse event, non-fatal|3
1152480|NCT01314872|3784291|P2|Treatment Period 1|Adverse event, non-fatal|2
1152481|NCT01314872|3784292|P1|Treatment Period 1|Adverse event, non-fatal|4
1152482|NCT01314872|3784278|P15|Treatment Period 1|Lack of Efficacy|0
1152483|NCT01314872|3784279|P14|Treatment Period 1|Lack of Efficacy|0
1152484|NCT01314872|3784280|P13|Treatment Period 1|Lack of Efficacy|0
1152485|NCT01314872|3784281|P12|Treatment Period 1|Lack of Efficacy|0
1152486|NCT01314872|3784282|P11|Treatment Period 1|Lack of Efficacy|0
1152487|NCT01314872|3784283|P10|Treatment Period 1|Lack of Efficacy|0
1152488|NCT01314872|3784284|P9|Treatment Period 1|Lack of Efficacy|0
1152489|NCT01314872|3784285|P8|Treatment Period 1|Lack of Efficacy|2
1152490|NCT01314872|3784286|P7|Treatment Period 1|Lack of Efficacy|0
1152491|NCT01314872|3784287|P6|Treatment Period 1|Lack of Efficacy|1
1152492|NCT01314872|3784288|P5|Treatment Period 1|Lack of Efficacy|0
1152493|NCT01314872|3784289|P4|Treatment Period 1|Lack of Efficacy|0
1152494|NCT01314872|3784290|P3|Treatment Period 1|Lack of Efficacy|0
1152495|NCT01314872|3784291|P2|Treatment Period 1|Lack of Efficacy|0
1152496|NCT01314872|3784292|P1|Treatment Period 1|Lack of Efficacy|1
1152497|NCT01314872|3784278|P15|Treatment Period 1|Physician Decision|0
1152498|NCT01314872|3784279|P14|Treatment Period 1|Physician Decision|0
1152499|NCT01314872|3784280|P13|Treatment Period 1|Physician Decision|0
1152500|NCT01314872|3784281|P12|Treatment Period 1|Physician Decision|0
1152501|NCT01314872|3784282|P11|Treatment Period 1|Physician Decision|0
1152502|NCT01314872|3784283|P10|Treatment Period 1|Physician Decision|1
1152503|NCT01314872|3784284|P9|Treatment Period 1|Physician Decision|0
1152504|NCT01314872|3784285|P8|Treatment Period 1|Physician Decision|0
1152505|NCT01314872|3784286|P7|Treatment Period 1|Physician Decision|0
1152506|NCT01314872|3784287|P6|Treatment Period 1|Physician Decision|0
1152507|NCT01314872|3784288|P5|Treatment Period 1|Physician Decision|0
1152508|NCT01314872|3784289|P4|Treatment Period 1|Physician Decision|1
1152509|NCT01314872|3784290|P3|Treatment Period 1|Physician Decision|0
1152510|NCT01314872|3784291|P2|Treatment Period 1|Physician Decision|1
1152511|NCT01314872|3784292|P1|Treatment Period 1|Physician Decision|0
1152512|NCT01314872|3784278|P15|Treatment Period 1|Protocol Violation|0
1152513|NCT01314872|3784279|P14|Treatment Period 1|Protocol Violation|0
1152514|NCT01314872|3784280|P13|Treatment Period 1|Protocol Violation|0
1152515|NCT01314872|3784281|P12|Treatment Period 1|Protocol Violation|0
1152516|NCT01314872|3784282|P11|Treatment Period 1|Protocol Violation|1
1152517|NCT01314872|3784283|P10|Treatment Period 1|Protocol Violation|1
1152518|NCT01314872|3784284|P9|Treatment Period 1|Protocol Violation|0
1152519|NCT01314872|3784285|P8|Treatment Period 1|Protocol Violation|0
1152520|NCT01314872|3784286|P7|Treatment Period 1|Protocol Violation|0
1152521|NCT01314872|3784287|P6|Treatment Period 1|Protocol Violation|0
1152522|NCT01314872|3784288|P5|Treatment Period 1|Protocol Violation|1
1152523|NCT01314872|3784289|P4|Treatment Period 1|Protocol Violation|0
1152524|NCT01314872|3784290|P3|Treatment Period 1|Protocol Violation|1
1152525|NCT01314872|3784291|P2|Treatment Period 1|Protocol Violation|1
1152526|NCT01314872|3784292|P1|Treatment Period 1|Protocol Violation|2
1152527|NCT01314716|3784396|P2|Open-Label Phase|Physician Decision|4
1152528|NCT01314716|3784397|P1|Open-Label Phase|Physician Decision|5
1152529|NCT01314716|3784396|P2|Open-Label Phase|Withdrawal by Subject|2
1152530|NCT01314716|3784397|P1|Open-Label Phase|Withdrawal by Subject|1
1152531|NCT01314716|3784396|P2|Open-Label Phase|Adverse Event|6
1152532|NCT01314716|3784397|P1|Open-Label Phase|Adverse Event|4
1152533|NCT01314716|3784396|P2|Double-Blind Phase|Physician Decision|1
1152534|NCT01314716|3784397|P1|Double-Blind Phase|Physician Decision|0
1152535|NCT01314716|3784396|P2|Double-Blind Phase|Sponsor request|2
1152536|NCT01314716|3784397|P1|Double-Blind Phase|Sponsor request|1
1152537|NCT01314716|3784396|P2|Double-Blind Phase|Lost to Follow-up|1
1152538|NCT01314716|3784397|P1|Double-Blind Phase|Lost to Follow-up|0
1152539|NCT01314716|3784396|P2|Double-Blind Phase|Withdrawal by Subject|6
1152540|NCT01314716|3784397|P1|Double-Blind Phase|Withdrawal by Subject|5
1152541|NCT01314716|3784396|P2|Double-Blind Phase|Adverse Event|4
1152542|NCT01314716|3784397|P1|Double-Blind Phase|Adverse Event|10
1152543|NCT01314716|3784396|P2|Double-Blind Phase|Randomized but not treated|1
1152544|NCT01314716|3784397|P1|Double-Blind Phase|Randomized but not treated|1
1152545|NCT01314703|3784409|P1|Overall Study|screen failure and closed enrollment|8
1152546|NCT01314443|3784418|P4|Overall Study|Protocol Violation|1
1152547|NCT01314443|3784419|P3|Overall Study|Protocol Violation|1
1152548|NCT01314443|3784420|P2|Overall Study|Protocol Violation|2
1152549|NCT01314443|3784421|P1|Overall Study|Protocol Violation|2
1152550|NCT01314443|3784418|P4|Overall Study|Withdrawal by Subject|1
1152551|NCT01314443|3784419|P3|Overall Study|Withdrawal by Subject|1
1152552|NCT01314443|3784420|P2|Overall Study|Withdrawal by Subject|1
1152553|NCT01314443|3784421|P1|Overall Study|Withdrawal by Subject|2
1152554|NCT01314261|3784491|P4|Overall Study|Virologic Failure|1
1152555|NCT01314261|3784492|P3|Overall Study|Virologic Failure|0
1152556|NCT01314261|3784493|P2|Overall Study|Virologic Failure|1
1152557|NCT01314261|3784494|P1|Overall Study|Virologic Failure|0
1152558|NCT01314261|3784491|P4|Overall Study|Lost to Follow-up|2
1152559|NCT01314261|3784492|P3|Overall Study|Lost to Follow-up|2
1152560|NCT01314261|3784493|P2|Overall Study|Lost to Follow-up|0
1152561|NCT01314261|3784494|P1|Overall Study|Lost to Follow-up|1
1152562|NCT01314261|3784491|P4|Overall Study|Withdrawal by Subject|0
1152563|NCT01314261|3784492|P3|Overall Study|Withdrawal by Subject|1
1152564|NCT01314261|3784493|P2|Overall Study|Withdrawal by Subject|3
1152565|NCT01314261|3784494|P1|Overall Study|Withdrawal by Subject|0
1152566|NCT01314261|3784491|P4|Overall Study|Adverse Event|0
1152567|NCT01314261|3784492|P3|Overall Study|Adverse Event|0
1152568|NCT01314261|3784493|P2|Overall Study|Adverse Event|0
1152569|NCT01314261|3784494|P1|Overall Study|Adverse Event|1
1152570|NCT01314118|3784545|P1|Overall Study|Ongoing|62
1152571|NCT01314118|3784545|P1|Overall Study|Other|2
1152572|NCT01314118|3784545|P1|Overall Study|Withdrawal by Subject|11
1152573|NCT01314118|3784545|P1|Overall Study|Protocol Violation|5
1152574|NCT01314118|3784545|P1|Overall Study|Death|4
1152575|NCT01314118|3784545|P1|Overall Study|Physician Decision|11
1152576|NCT01314118|3784545|P1|Overall Study|Progressive disease|27
1152577|NCT01314118|3784545|P1|Overall Study|Adverse Event|9
1152578|NCT01314105|3784554|P2|Overall Study|Other Adverse Event|1
1152579|NCT01314105|3784555|P1|Overall Study|Other Adverse Event|1
1152580|NCT01314105|3784554|P2|Overall Study|Refused to continue taking medication|1
1152581|NCT01314105|3784555|P1|Overall Study|Refused to continue taking medication|0
1152582|NCT01314105|3784554|P2|Overall Study|Progressive Disease|10
1152583|NCT01314105|3784555|P1|Overall Study|Progressive Disease|6
1152584|NCT01313923|3784668|P1|Overall Study|Physician Decision|3
1152585|NCT01313884|3784684|P1|Overall Study|Per insurance pvdr, pt can't be on cl tr|1
1152586|NCT01313858|3784692|P3|Overall Study|Lost to Follow-up|47
1152587|NCT01313858|3784693|P2|Overall Study|Lost to Follow-up|51
1152588|NCT01313858|3784694|P1|Overall Study|Lost to Follow-up|35
1152589|NCT01313858|3784692|P3|Overall Study|Premature Treatment Termination|191
1152590|NCT01313858|3784693|P2|Overall Study|Premature Treatment Termination|219
1152591|NCT01313858|3784694|P1|Overall Study|Premature Treatment Termination|251
1152592|NCT01313780|3784717|P2|Overall Study|missing data|3
1152593|NCT01313780|3784718|P1|Overall Study|missing data|3
1152594|NCT01313780|3784717|P2|Overall Study|Protocol Violation|4
1152595|NCT01313780|3784718|P1|Overall Study|Protocol Violation|10
1152596|NCT01313780|3784717|P2|Overall Study|Withdrawal by Subject|8
1152597|NCT01313780|3784718|P1|Overall Study|Withdrawal by Subject|2
1152598|NCT01313780|3784717|P2|Overall Study|Adverse Event|11
1152599|NCT01313780|3784718|P1|Overall Study|Adverse Event|6
1152600|NCT01313780|3784717|P2|Overall Study|Lack of Efficacy|2
1152601|NCT01313780|3784718|P1|Overall Study|Lack of Efficacy|4
1152602|NCT01313728|3784726|P1|Informed Consent to Baseline|Withdrawal by Subject|1
1152603|NCT01313689|3784746|P5|24-Week Randomization 2|Physician Decision|4
1152604|NCT01313689|3784747|P4|24-Week Randomization 2|Physician Decision|0
1152605|NCT01313689|3784748|P3|24-Week Randomization 2|Physician Decision|0
1152606|NCT01313689|3784749|P2|24-Week Randomization 2|Physician Decision|0
1152607|NCT01313689|3784750|P1|24-Week Randomization 2|Physician Decision|0
1152608|NCT01313689|3784746|P5|24-Week Randomization 2|Withdrawal by Subject|3
1152609|NCT01313689|3784747|P4|24-Week Randomization 2|Withdrawal by Subject|1
1152610|NCT01313689|3784748|P3|24-Week Randomization 2|Withdrawal by Subject|1
1152611|NCT01313689|3784749|P2|24-Week Randomization 2|Withdrawal by Subject|0
1152612|NCT01313689|3784750|P1|24-Week Randomization 2|Withdrawal by Subject|0
1152613|NCT01313689|3784746|P5|24-Week Randomization 2|Adverse Event|8
1152614|NCT01313689|3784747|P4|24-Week Randomization 2|Adverse Event|0
1152615|NCT01313689|3784748|P3|24-Week Randomization 2|Adverse Event|2
1152616|NCT01313689|3784749|P2|24-Week Randomization 2|Adverse Event|0
1152617|NCT01313689|3784750|P1|24-Week Randomization 2|Adverse Event|0
1152618|NCT01313689|3784746|P5|24-Week Randomization 1|Withdrawal by Subject|0
1152619|NCT01313689|3784747|P4|24-Week Randomization 1|Withdrawal by Subject|0
1152620|NCT01313689|3784748|P3|24-Week Randomization 1|Withdrawal by Subject|0
1152621|NCT01313689|3784749|P2|24-Week Randomization 1|Withdrawal by Subject|0
1152622|NCT01313689|3784750|P1|24-Week Randomization 1|Withdrawal by Subject|5
1152623|NCT01313689|3784746|P5|24-Week Randomization 1|Physician Decision|0
1152624|NCT01313689|3784747|P4|24-Week Randomization 1|Physician Decision|0
1152625|NCT01313689|3784748|P3|24-Week Randomization 1|Physician Decision|0
1152626|NCT01313689|3784749|P2|24-Week Randomization 1|Physician Decision|5
1152627|NCT01313689|3784750|P1|24-Week Randomization 1|Physician Decision|4
1152628|NCT01313689|3784746|P5|24-Week Randomization 1|Adverse Event|0
1152629|NCT01313689|3784747|P4|24-Week Randomization 1|Adverse Event|0
1152630|NCT01313689|3784748|P3|24-Week Randomization 1|Adverse Event|0
1152631|NCT01313689|3784749|P2|24-Week Randomization 1|Adverse Event|5
1152632|NCT01313689|3784750|P1|24-Week Randomization 1|Adverse Event|10
1152633|NCT01313676|3784829|P4|Overall Study|Missing|0
1152634|NCT01313676|3784830|P3|Overall Study|Missing|1
1152635|NCT01313676|3784831|P2|Overall Study|Missing|1
1152636|NCT01313676|3784832|P1|Overall Study|Missing|1
1152637|NCT01313676|3784829|P4|Overall Study|Investigator Site Closed|10
1152638|NCT01313676|3784830|P3|Overall Study|Investigator Site Closed|15
1152639|NCT01313676|3784831|P2|Overall Study|Investigator Site Closed|11
1152640|NCT01313676|3784832|P1|Overall Study|Investigator Site Closed|12
1152641|NCT01313676|3784829|P4|Overall Study|Sponsor Terminated Study Treatment|1
1152642|NCT01313676|3784830|P3|Overall Study|Sponsor Terminated Study Treatment|0
1152643|NCT01313676|3784831|P2|Overall Study|Sponsor Terminated Study Treatment|1
1152644|NCT01313676|3784832|P1|Overall Study|Sponsor Terminated Study Treatment|1
1152645|NCT01313676|3784829|P4|Overall Study|Decision by Participant or Proxy|492
1152646|NCT01313676|3784830|P3|Overall Study|Decision by Participant or Proxy|515
1152647|NCT01313676|3784831|P2|Overall Study|Decision by Participant or Proxy|527
1152648|NCT01313676|3784832|P1|Overall Study|Decision by Participant or Proxy|643
1152649|NCT01313676|3784829|P4|Overall Study|Physician Decision|48
1152650|NCT01313676|3784830|P3|Overall Study|Physician Decision|62
1152651|NCT01313676|3784831|P2|Overall Study|Physician Decision|64
1152652|NCT01313676|3784832|P1|Overall Study|Physician Decision|53
1152653|NCT01313676|3784829|P4|Overall Study|Lost to Follow-up|0
1152654|NCT01313676|3784830|P3|Overall Study|Lost to Follow-up|1
1152655|NCT01313676|3784831|P2|Overall Study|Lost to Follow-up|0
1152656|NCT01313676|3784832|P1|Overall Study|Lost to Follow-up|0
1152657|NCT01313676|3784829|P4|Overall Study|Study Closed/terminated|9
1152658|NCT01313676|3784830|P3|Overall Study|Study Closed/terminated|9
1152659|NCT01313676|3784831|P2|Overall Study|Study Closed/terminated|6
1152660|NCT01313676|3784832|P1|Overall Study|Study Closed/terminated|7
1152661|NCT01313676|3784829|P4|Overall Study|Met Protocol-Defined Stopping Critera|11
1152662|NCT01313676|3784830|P3|Overall Study|Met Protocol-Defined Stopping Critera|2
1152663|NCT01313676|3784831|P2|Overall Study|Met Protocol-Defined Stopping Critera|4
1152664|NCT01313676|3784832|P1|Overall Study|Met Protocol-Defined Stopping Critera|3
1152665|NCT01313676|3784829|P4|Overall Study|Protocol Violation|44
1152666|NCT01313676|3784830|P3|Overall Study|Protocol Violation|46
1152667|NCT01313676|3784831|P2|Overall Study|Protocol Violation|44
1152668|NCT01313676|3784832|P1|Overall Study|Protocol Violation|37
1152669|NCT01313676|3784829|P4|Overall Study|Lack of Efficacy|46
1152670|NCT01313676|3784830|P3|Overall Study|Lack of Efficacy|65
1152671|NCT01313676|3784831|P2|Overall Study|Lack of Efficacy|90
1152672|NCT01313676|3784832|P1|Overall Study|Lack of Efficacy|98
1152673|NCT01313676|3784829|P4|Overall Study|Adverse Event|333
1152674|NCT01313676|3784830|P3|Overall Study|Adverse Event|372
1152675|NCT01313676|3784831|P2|Overall Study|Adverse Event|365
1152676|NCT01313676|3784832|P1|Overall Study|Adverse Event|395
1152677|NCT01313663|3784852|P2|Overall Study|Withdrawal by Subject|1
1152678|NCT01313663|3784853|P1|Overall Study|Withdrawal by Subject|2
1152679|NCT01313663|3784852|P2|Overall Study|Physician Decision|2
1152680|NCT01313663|3784853|P1|Overall Study|Physician Decision|0
1152681|NCT01313663|3784852|P2|Overall Study|Lost to Follow-up|1
1152682|NCT01313663|3784853|P1|Overall Study|Lost to Follow-up|0
1152683|NCT01313663|3784852|P2|Overall Study|Study Closed/Terminated|4
1152684|NCT01313663|3784853|P1|Overall Study|Study Closed/Terminated|2
1152685|NCT01313650|3784891|P4|Overall Study|Met Protocol-defined Stopping Criteria|15
1152686|NCT01313650|3784892|P3|Overall Study|Met Protocol-defined Stopping Criteria|24
1152687|NCT01313650|3784893|P2|Overall Study|Met Protocol-defined Stopping Criteria|13
1152688|NCT01313650|3784894|P1|Overall Study|Met Protocol-defined Stopping Criteria|9
1152689|NCT01313650|3784891|P4|Overall Study|Protocol Violation|6
1152690|NCT01313650|3784892|P3|Overall Study|Protocol Violation|5
1152691|NCT01313650|3784893|P2|Overall Study|Protocol Violation|7
1152692|NCT01313650|3784894|P1|Overall Study|Protocol Violation|4
1152693|NCT01313650|3784891|P4|Overall Study|Withdrawal by Subject|15
1152694|NCT01313650|3784892|P3|Overall Study|Withdrawal by Subject|15
1152695|NCT01313650|3784893|P2|Overall Study|Withdrawal by Subject|20
1152696|NCT01313650|3784894|P1|Overall Study|Withdrawal by Subject|16
1152697|NCT01313650|3784891|P4|Overall Study|Lost to Follow-up|2
1152698|NCT01313650|3784892|P3|Overall Study|Lost to Follow-up|3
1152699|NCT01313650|3784893|P2|Overall Study|Lost to Follow-up|0
1152700|NCT01313650|3784894|P1|Overall Study|Lost to Follow-up|1
1152701|NCT01313650|3784891|P4|Overall Study|Lack of Efficacy|20
1152702|NCT01313650|3784892|P3|Overall Study|Lack of Efficacy|32
1152703|NCT01313650|3784893|P2|Overall Study|Lack of Efficacy|20
1152704|NCT01313650|3784894|P1|Overall Study|Lack of Efficacy|37
1152705|NCT01313650|3784891|P4|Overall Study|Adverse Event|23
1152706|NCT01313650|3784892|P3|Overall Study|Adverse Event|24
1152707|NCT01313650|3784893|P2|Overall Study|Adverse Event|34
1152708|NCT01313650|3784894|P1|Overall Study|Adverse Event|9
1152709|NCT01313637|3784920|P4|Overall Study|Withdrawal by Subject|15
1152710|NCT01313637|3784921|P3|Overall Study|Withdrawal by Subject|18
1152711|NCT01313637|3784922|P2|Overall Study|Withdrawal by Subject|13
1152712|NCT01313637|3784923|P1|Overall Study|Withdrawal by Subject|11
1152713|NCT01313637|3784920|P4|Overall Study|Lost to Follow-up|3
1152714|NCT01313637|3784921|P3|Overall Study|Lost to Follow-up|1
1152715|NCT01313637|3784922|P2|Overall Study|Lost to Follow-up|2
1152716|NCT01313637|3784923|P1|Overall Study|Lost to Follow-up|0
1152717|NCT01313637|3784920|P4|Overall Study|Met Protocol- Defined Stopping Criteria|13
1152718|NCT01313637|3784921|P3|Overall Study|Met Protocol- Defined Stopping Criteria|14
1152719|NCT01313637|3784922|P2|Overall Study|Met Protocol- Defined Stopping Criteria|15
1152720|NCT01313637|3784923|P1|Overall Study|Met Protocol- Defined Stopping Criteria|16
1152721|NCT01313637|3784920|P4|Overall Study|Protocol Violation|5
1152722|NCT01313637|3784921|P3|Overall Study|Protocol Violation|11
1152723|NCT01313637|3784922|P2|Overall Study|Protocol Violation|3
1152724|NCT01313637|3784923|P1|Overall Study|Protocol Violation|4
1152725|NCT01313637|3784920|P4|Overall Study|Lack of Efficacy|24
1152726|NCT01313637|3784921|P3|Overall Study|Lack of Efficacy|37
1152727|NCT01313637|3784922|P2|Overall Study|Lack of Efficacy|38
1152728|NCT01313637|3784923|P1|Overall Study|Lack of Efficacy|44
1152729|NCT01313637|3784920|P4|Overall Study|Adverse Event|18
1152730|NCT01313637|3784921|P3|Overall Study|Adverse Event|25
1152731|NCT01313637|3784922|P2|Overall Study|Adverse Event|24
1152732|NCT01313637|3784923|P1|Overall Study|Adverse Event|17
1152733|NCT01313624|3784947|P2|Open-Label Phase|Lost to Follow-up|1
1152734|NCT01313624|3784948|P1|Open-Label Phase|Lost to Follow-up|1
1152735|NCT01313624|3784947|P2|Open-Label Phase|Withdrawal by Subject|2
1152736|NCT01313624|3784948|P1|Open-Label Phase|Withdrawal by Subject|2
1152737|NCT01313624|3784947|P2|Open-Label Phase|Adverse Event|10
1152738|NCT01313624|3784948|P1|Open-Label Phase|Adverse Event|1
1152739|NCT01313624|3784947|P2|Double-Blind Phase|Lack of Efficacy|0
1152740|NCT01313624|3784948|P1|Double-Blind Phase|Lack of Efficacy|1
1152741|NCT01313624|3784947|P2|Double-Blind Phase|Physician Decision|0
1152742|NCT01313624|3784948|P1|Double-Blind Phase|Physician Decision|1
1152743|NCT01313624|3784947|P2|Double-Blind Phase|Lost to Follow-up|2
1152744|NCT01313624|3784948|P1|Double-Blind Phase|Lost to Follow-up|0
1152745|NCT01313624|3784947|P2|Double-Blind Phase|Withdrawal by Subject|4
1152746|NCT01313624|3784948|P1|Double-Blind Phase|Withdrawal by Subject|9
1152747|NCT01313624|3784947|P2|Double-Blind Phase|Adverse Event|4
1152748|NCT01313624|3784948|P1|Double-Blind Phase|Adverse Event|27
1152749|NCT01313559|3784962|P2|Overall Study|Rising PSA|0
1152750|NCT01313559|3784963|P1|Overall Study|Rising PSA|2
1152751|NCT01313559|3784962|P2|Overall Study|Disease progression|0
1152752|NCT01313559|3784963|P1|Overall Study|Disease progression|1
1152753|NCT01313559|3784962|P2|Overall Study|Withdrawal by Subject|2
1152754|NCT01313559|3784963|P1|Overall Study|Withdrawal by Subject|1
1152755|NCT01313312|3785059|P1|Overall Study|Did Not Receive Treatment with Dysport®|4
1152756|NCT01313312|3785059|P1|Overall Study|Subject Withdrawn Early in Error|4
1152757|NCT01313312|3785059|P1|Overall Study|Observational Phase|1
1152758|NCT01313312|3785059|P1|Overall Study|Investigator Decision|1
1152759|NCT01313312|3785059|P1|Overall Study|Lack of Efficacy|3
1152760|NCT01313312|3785059|P1|Overall Study|Withdrawal by Subject|18
1152761|NCT01313312|3785059|P1|Overall Study|Adverse Event|5
1152762|NCT01313299|3785106|P3|Overall Study|Lack of subject compliance|1
1152763|NCT01313299|3785107|P2|Overall Study|Lack of subject compliance|0
1152764|NCT01313299|3785108|P1|Overall Study|Lack of subject compliance|0
1152765|NCT01313299|3785106|P3|Overall Study|Family reason and moved out of state|0
1152766|NCT01313299|3785107|P2|Overall Study|Family reason and moved out of state|2
1152767|NCT01313299|3785108|P1|Overall Study|Family reason and moved out of state|0
1152768|NCT01313299|3785106|P3|Overall Study|Withdrawal by Subject|2
1152769|NCT01313299|3785107|P2|Overall Study|Withdrawal by Subject|0
1152770|NCT01313299|3785108|P1|Overall Study|Withdrawal by Subject|1
1152771|NCT01313299|3785106|P3|Overall Study|Protocol Violation|0
1152772|NCT01313299|3785107|P2|Overall Study|Protocol Violation|0
1152773|NCT01313299|3785108|P1|Overall Study|Protocol Violation|2
1152774|NCT01313299|3785106|P3|Overall Study|Lost to Follow-up|0
1152775|NCT01313299|3785107|P2|Overall Study|Lost to Follow-up|0
1152776|NCT01313299|3785108|P1|Overall Study|Lost to Follow-up|1
1152777|NCT01313299|3785106|P3|Overall Study|Adverse Event|1
1152778|NCT01313299|3785107|P2|Overall Study|Adverse Event|1
1152779|NCT01313299|3785108|P1|Overall Study|Adverse Event|3
1152780|NCT01313286|3785122|P2|Period 1|Withdrawal by Subject|0
1152781|NCT01313286|3785123|P1|Period 1|Withdrawal by Subject|2
1152782|NCT01313273|3785133|P2|Overall Study|Screening Chromogranin A-in normal range|1
1152783|NCT01313273|3785134|P1|Overall Study|Screening Chromogranin A-in normal range|0
1152784|NCT01313273|3785133|P2|Overall Study|Withdrawal by Subject|0
1152785|NCT01313273|3785134|P1|Overall Study|Withdrawal by Subject|1
1152786|NCT01313273|3785133|P2|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0
1152787|NCT01313273|3785134|P1|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1
1152788|NCT01313221|3785149|P3|Overall Study|Pregnancy|2
1152789|NCT01313221|3785150|P2|Overall Study|Pregnancy|0
1152790|NCT01313221|3785151|P1|Overall Study|Pregnancy|0
1152791|NCT01313221|3785149|P3|Overall Study|Physician Decision|2
1152792|NCT01313221|3785150|P2|Overall Study|Physician Decision|0
1152793|NCT01313221|3785151|P1|Overall Study|Physician Decision|0
1152794|NCT01313221|3785149|P3|Overall Study|Disease progression|2
1152795|NCT01313221|3785150|P2|Overall Study|Disease progression|0
1152796|NCT01313221|3785151|P1|Overall Study|Disease progression|0
1152797|NCT01313221|3785149|P3|Overall Study|Adverse Event|7
1152798|NCT01313221|3785150|P2|Overall Study|Adverse Event|0
1152799|NCT01313221|3785151|P1|Overall Study|Adverse Event|0
1152800|NCT01313221|3785149|P3|Overall Study|Other|0
1152801|NCT01313221|3785150|P2|Overall Study|Other|0
1152802|NCT01313221|3785151|P1|Overall Study|Other|1
1152803|NCT01313221|3785149|P3|Overall Study|Lost to Follow-up|1
1152804|NCT01313221|3785150|P2|Overall Study|Lost to Follow-up|3
1152805|NCT01313221|3785151|P1|Overall Study|Lost to Follow-up|6
1152806|NCT01313221|3785149|P3|Overall Study|Requirement for alternative therapy|1
1152807|NCT01313221|3785150|P2|Overall Study|Requirement for alternative therapy|1
1152808|NCT01313221|3785151|P1|Overall Study|Requirement for alternative therapy|0
1152809|NCT01313221|3785149|P3|Overall Study|Withdrawal by Subject|5
1152810|NCT01313221|3785150|P2|Overall Study|Withdrawal by Subject|3
1152811|NCT01313221|3785151|P1|Overall Study|Withdrawal by Subject|2
1152812|NCT01313221|3785149|P3|Overall Study|Non-compliance|2
1152813|NCT01313221|3785150|P2|Overall Study|Non-compliance|0
1152814|NCT01313221|3785151|P1|Overall Study|Non-compliance|3
1152815|NCT01313221|3785149|P3|Overall Study|Protocol Violation|1
1152816|NCT01313221|3785150|P2|Overall Study|Protocol Violation|1
1152817|NCT01313221|3785151|P1|Overall Study|Protocol Violation|0
1152818|NCT01313208|3785203|P2|Open-label Phase (Weeks 13 - 24)|Other|0
1152819|NCT01313208|3785204|P1|Open-label Phase (Weeks 13 - 24)|Other|2
1152820|NCT01313208|3785203|P2|Open-label Phase (Weeks 13 - 24)|Adverse Event|0
1152821|NCT01313208|3785204|P1|Open-label Phase (Weeks 13 - 24)|Adverse Event|1
1152822|NCT01313208|3785203|P2|Open-label Phase (Weeks 13 - 24)|Noncompliance|2
1152823|NCT01313208|3785204|P1|Open-label Phase (Weeks 13 - 24)|Noncompliance|0
1152824|NCT01313208|3785203|P2|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1
1152825|NCT01313208|3785204|P1|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3
1152826|NCT01313208|3785203|P2|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0
1152827|NCT01313208|3785204|P1|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1
1152828|NCT01313208|3785203|P2|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0
1152829|NCT01313208|3785204|P1|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1
1152830|NCT01313208|3785203|P2|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1
1152831|NCT01313208|3785204|P1|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0
1152832|NCT01313208|3785203|P2|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2
1152833|NCT01313208|3785204|P1|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1
1152834|NCT01313208|3785203|P2|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2
1152835|NCT01313208|3785204|P1|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3
1152836|NCT01313182|3785294|P2|Overall Study|Protocol Violation|92
1152837|NCT01313182|3785295|P1|Overall Study|Protocol Violation|66
1152838|NCT01313117|3785301|P1|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
1152839|NCT01313117|3785301|P1|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
1152840|NCT01313078|3785308|P1|Overall Study|Withdrawal by Subject|1
1152841|NCT01313078|3785308|P1|Overall Study|Discontinued study drug|1
1152842|NCT01313078|3785308|P1|Overall Study|Death|1
1152843|NCT01313039|3785313|P1|Overall Study|Adverse Event|1
1152844|NCT01313039|3785313|P1|Overall Study|Physician Decision|1
1152845|NCT01312961|3785319|P2|Overall Study|Other than specified above|3
1152846|NCT01312961|3785320|P1|Overall Study|Other than specified above|2
1152847|NCT01312961|3785319|P2|Overall Study|Poor compliance to protocol|0
1152848|NCT01312961|3785320|P1|Overall Study|Poor compliance to protocol|1
1152849|NCT01312961|3785319|P2|Overall Study|Lack of Efficacy|1
1152850|NCT01312961|3785320|P1|Overall Study|Lack of Efficacy|11
1152851|NCT01312961|3785319|P2|Overall Study|Adverse Event|3
1152852|NCT01312961|3785320|P1|Overall Study|Adverse Event|3
1152853|NCT01312909|3785356|P3|Overall Study|Entrance criteria not met|2
1152854|NCT01312909|3785357|P2|Overall Study|Entrance criteria not met|0
1152855|NCT01312909|3785358|P1|Overall Study|Entrance criteria not met|0
1152856|NCT01312909|3785356|P3|Overall Study|Insufficient clinical response|1
1152857|NCT01312909|3785357|P2|Overall Study|Insufficient clinical response|0
1152858|NCT01312909|3785358|P1|Overall Study|Insufficient clinical response|0
1152859|NCT01312909|3785356|P3|Overall Study|Lost to Follow-up|20
1152860|NCT01312909|3785357|P2|Overall Study|Lost to Follow-up|17
1152861|NCT01312909|3785358|P1|Overall Study|Lost to Follow-up|21
1152862|NCT01312909|3785356|P3|Overall Study|Withdrawal by Subject|7
1152863|NCT01312909|3785357|P2|Overall Study|Withdrawal by Subject|10
1152864|NCT01312909|3785358|P1|Overall Study|Withdrawal by Subject|8
1152865|NCT01312909|3785356|P3|Overall Study|Other|11
1152866|NCT01312909|3785357|P2|Overall Study|Other|6
1152867|NCT01312909|3785358|P1|Overall Study|Other|9
1152868|NCT01312909|3785356|P3|Overall Study|Protocol Violation|2
1152869|NCT01312909|3785357|P2|Overall Study|Protocol Violation|0
1152870|NCT01312909|3785358|P1|Overall Study|Protocol Violation|2
1152871|NCT01312909|3785356|P3|Overall Study|Adverse Event|3
1152872|NCT01312909|3785357|P2|Overall Study|Adverse Event|0
1152873|NCT01312909|3785358|P1|Overall Study|Adverse Event|1
1152874|NCT01312909|3785356|P3|Overall Study|Randomized but not treated|1
1152875|NCT01312909|3785357|P2|Overall Study|Randomized but not treated|3
1152876|NCT01312909|3785358|P1|Overall Study|Randomized but not treated|1
1152877|NCT01312467|3785498|P1|Overall Study|Ineligible|4
1152878|NCT01312467|3785498|P1|Overall Study|Another medical condition|1
1152879|NCT01312467|3785498|P1|Overall Study|Deported to country of origin|1
1152880|NCT01312467|3785498|P1|Overall Study|Withdrawal by Subject|2
1152881|NCT01312467|3785498|P1|Overall Study|Lost to Follow-up|1
1152882|NCT01312467|3785498|P1|Overall Study|Adverse Event|4
1152883|NCT01312428|3785507|P2|Overall Study|Study Termination|4
1152884|NCT01312428|3785508|P1|Overall Study|Study Termination|3
1152885|NCT01312129|3785553|P2|Second Intervention (24 Hours)|Lost to Follow-up|1
1152886|NCT01312129|3785554|P1|Second Intervention (24 Hours)|Lost to Follow-up|0
1152887|NCT01311661|3785639|P1|Overall Study|Withdrawal by Subject|2
1152888|NCT01311661|3785639|P1|Overall Study|Protocol Violation|3
1152889|NCT01311661|3785639|P1|Overall Study|Adverse Event|2
1152890|NCT01311557|3785783|P2|Overall Study|Withdrawal by Subject|2
1152891|NCT01311557|3785784|P1|Overall Study|Withdrawal by Subject|1
1152892|NCT01311557|3785783|P2|Overall Study|Lost to Follow-up|1
1152893|NCT01311557|3785784|P1|Overall Study|Lost to Follow-up|0
1152894|NCT01311557|3785783|P2|Overall Study|Protocol Violation|2
1152895|NCT01311557|3785784|P1|Overall Study|Protocol Violation|4
1152896|NCT01311557|3785783|P2|Overall Study|Serious adverse event|1
1152897|NCT01311557|3785784|P1|Overall Study|Serious adverse event|0
1152898|NCT01311505|3785800|P2|First Intervention Period|Protocol Violation|1
1152899|NCT01311505|3785801|P1|First Intervention Period|Protocol Violation|0
1152900|NCT01311024|3785857|P2|Overall Study|Protocol Violation|22
1152901|NCT01311024|3785858|P1|Overall Study|Protocol Violation|35
1152902|NCT01310868|3785864|P1|Overall Study|Do not have histologically confirmed GBM|13
1152903|NCT01310803|3785881|P2|Overall Study|Subject terminated by Sponsor|0
1152904|NCT01310803|3785882|P1|Overall Study|Subject terminated by Sponsor|1
1152905|NCT01310777|3785893|P3|Overall Study|Other|2
1152906|NCT01310777|3785894|P2|Overall Study|Other|1
1152907|NCT01310777|3785895|P1|Overall Study|Other|4
1152908|NCT01310777|3785893|P3|Overall Study|Inadequate Control of IOP|10
1152909|NCT01310777|3785894|P2|Overall Study|Inadequate Control of IOP|7
1152910|NCT01310777|3785895|P1|Overall Study|Inadequate Control of IOP|5
1152911|NCT01310777|3785893|P3|Overall Study|Patient's Decision Unrelated to AE|2
1152912|NCT01310777|3785894|P2|Overall Study|Patient's Decision Unrelated to AE|1
1152913|NCT01310777|3785895|P1|Overall Study|Patient's Decision Unrelated to AE|1
1152914|NCT01310777|3785893|P3|Overall Study|Lost to Follow-up|1
1152915|NCT01310777|3785894|P2|Overall Study|Lost to Follow-up|4
1152916|NCT01310777|3785895|P1|Overall Study|Lost to Follow-up|0
1152917|NCT01310777|3785893|P3|Overall Study|Adverse Event|15
1152918|NCT01310777|3785894|P2|Overall Study|Adverse Event|1
1152919|NCT01310777|3785895|P1|Overall Study|Adverse Event|23
1152920|NCT01310699|3785905|P2|Overall Study|Patients did not complete tandem.|6
1152921|NCT01310699|3785906|P1|Overall Study|Patients did not complete tandem.|4
1152922|NCT01310413|3785933|P7|From Day U0 to Day U385|Lost to Follow-up|2
1152923|NCT01310413|3785934|P6|From Day U0 to Day U385|Lost to Follow-up|0
1152924|NCT01310413|3785935|P5|From Day U0 to Day U385|Lost to Follow-up|0
1152925|NCT01310413|3785936|P4|From Day U0 to Day U385|Lost to Follow-up|0
1152926|NCT01310413|3785937|P3|From Day U0 to Day U385|Lost to Follow-up|0
1152927|NCT01310413|3785938|P2|From Day U0 to Day U385|Lost to Follow-up|0
1152928|NCT01310413|3785939|P1|From Day U0 to Day U385|Lost to Follow-up|0
1152929|NCT01310413|3785933|P7|From Day U0 to Day U385|Withdrawal by Subject|1
1152930|NCT01310413|3785934|P6|From Day U0 to Day U385|Withdrawal by Subject|0
1152931|NCT01310413|3785935|P5|From Day U0 to Day U385|Withdrawal by Subject|0
1152932|NCT01310413|3785936|P4|From Day U0 to Day U385|Withdrawal by Subject|0
1152933|NCT01310413|3785937|P3|From Day U0 to Day U385|Withdrawal by Subject|0
1152934|NCT01310413|3785938|P2|From Day U0 to Day U385|Withdrawal by Subject|0
1152935|NCT01310413|3785939|P1|From Day U0 to Day U385|Withdrawal by Subject|0
1152936|NCT01310413|3785933|P7|Day 0 to Day 385|Other|0
1152937|NCT01310413|3785934|P6|Day 0 to Day 385|Other|0
1152938|NCT01310413|3785935|P5|Day 0 to Day 385|Other|0
1152939|NCT01310413|3785936|P4|Day 0 to Day 385|Other|0
1152940|NCT01310413|3785937|P3|Day 0 to Day 385|Other|3
1152941|NCT01310413|3785938|P2|Day 0 to Day 385|Other|0
1152942|NCT01310413|3785939|P1|Day 0 to Day 385|Other|1
1152943|NCT01310413|3785933|P7|Day 0 to Day 385|Migrated/moved from study area|0
1152944|NCT01310413|3785934|P6|Day 0 to Day 385|Migrated/moved from study area|0
1152945|NCT01310413|3785935|P5|Day 0 to Day 385|Migrated/moved from study area|1
1152946|NCT01310413|3785936|P4|Day 0 to Day 385|Migrated/moved from study area|1
1152947|NCT01310413|3785937|P3|Day 0 to Day 385|Migrated/moved from study area|1
1152948|NCT01310413|3785938|P2|Day 0 to Day 385|Migrated/moved from study area|3
1152949|NCT01310413|3785939|P1|Day 0 to Day 385|Migrated/moved from study area|3
1152950|NCT01310413|3785933|P7|Day 0 to Day 385|Lost to Follow-up|0
1152951|NCT01310413|3785934|P6|Day 0 to Day 385|Lost to Follow-up|2
1152952|NCT01310413|3785935|P5|Day 0 to Day 385|Lost to Follow-up|1
1152953|NCT01310413|3785936|P4|Day 0 to Day 385|Lost to Follow-up|5
1152954|NCT01310413|3785937|P3|Day 0 to Day 385|Lost to Follow-up|3
1152955|NCT01310413|3785938|P2|Day 0 to Day 385|Lost to Follow-up|3
1152956|NCT01310413|3785939|P1|Day 0 to Day 385|Lost to Follow-up|18
1152957|NCT01310413|3785933|P7|Day 0 to Day 385|Withdrawal by Subject|0
1152958|NCT01310413|3785934|P6|Day 0 to Day 385|Withdrawal by Subject|1
1152959|NCT01310413|3785935|P5|Day 0 to Day 385|Withdrawal by Subject|1
1152960|NCT01310413|3785936|P4|Day 0 to Day 385|Withdrawal by Subject|2
1152961|NCT01310413|3785937|P3|Day 0 to Day 385|Withdrawal by Subject|0
1152962|NCT01310413|3785938|P2|Day 0 to Day 385|Withdrawal by Subject|2
1152963|NCT01310413|3785939|P1|Day 0 to Day 385|Withdrawal by Subject|5
1152964|NCT01310127|3786121|P2|Overall Study|advanced psc cataract outlier|0
1152965|NCT01310127|3786122|P1|Overall Study|advanced psc cataract outlier|1
1152966|NCT01310127|3786121|P2|Overall Study|Protocol Violation|1
1152967|NCT01310127|3786122|P1|Overall Study|Protocol Violation|1
1152968|NCT01310036|3786134|P1|Overall Study|Adverse event or intercurrent illness|12
1152969|NCT01310036|3786134|P1|Overall Study|Death|1
1152970|NCT01310036|3786134|P1|Overall Study|Progression of Disease|164
1152971|NCT01310036|3786134|P1|Overall Study|Refused Treatment/Did not Cooperate|4
1152972|NCT01310036|3786134|P1|Overall Study|Withdrew Consent|11
1152973|NCT01310036|3786134|P1|Overall Study|Administrative/other|10
1152974|NCT01309997|3786147|P2|Overall Study|Withdrawal by Subject|1
1152975|NCT01309997|3786148|P1|Overall Study|Withdrawal by Subject|1
1152976|NCT01309997|3786147|P2|Overall Study|Lack of Efficacy|2
1152977|NCT01309997|3786148|P1|Overall Study|Lack of Efficacy|2
1152978|NCT01309997|3786147|P2|Overall Study|Death|3
1152979|NCT01309997|3786148|P1|Overall Study|Death|1
1152980|NCT01309997|3786147|P2|Overall Study|Adverse Event|0
1152981|NCT01309997|3786148|P1|Overall Study|Adverse Event|1
1152982|NCT01309919|3786172|P2|Overall Study|Did not receive a postpartum IUD|48
1152983|NCT01309919|3786173|P1|Overall Study|Did not receive a postpartum IUD|17
1152984|NCT01309893|3786185|P2|Week 2 - Crossover Intervention|Missed crossover visit|1
1152985|NCT01309893|3786186|P1|Week 2 - Crossover Intervention|Missed crossover visit|0
1152986|NCT01309893|3786185|P2|Week 2 - Crossover Intervention|Lost to Follow-up|0
1152987|NCT01309893|3786186|P1|Week 2 - Crossover Intervention|Lost to Follow-up|1
1152988|NCT01309841|3786210|P3|Overall Study|Severe non-compliance with protocol|2
1152989|NCT01309841|3786211|P2|Overall Study|Severe non-compliance with protocol|5
1152990|NCT01309841|3786212|P1|Overall Study|Severe non-compliance with protocol|0
1152991|NCT01309841|3786210|P3|Overall Study|Did Not Receive Treatment|1
1152992|NCT01309841|3786211|P2|Overall Study|Did Not Receive Treatment|0
1152993|NCT01309841|3786212|P1|Overall Study|Did Not Receive Treatment|2
1152994|NCT01309841|3786210|P3|Overall Study|Withdrawal by Subject|13
1152995|NCT01309841|3786211|P2|Overall Study|Withdrawal by Subject|6
1152996|NCT01309841|3786212|P1|Overall Study|Withdrawal by Subject|17
1152997|NCT01309841|3786210|P3|Overall Study|Eligibility Criteria Not Fulfilled|1
1152998|NCT01309841|3786211|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
1152999|NCT01309841|3786212|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
1153000|NCT01309841|3786210|P3|Overall Study|Death|0
1153001|NCT01309841|3786211|P2|Overall Study|Death|0
1153002|NCT01309841|3786212|P1|Overall Study|Death|1
1153003|NCT01309841|3786210|P3|Overall Study|Adverse Event|11
1153004|NCT01309841|3786211|P2|Overall Study|Adverse Event|22
1153005|NCT01309841|3786212|P1|Overall Study|Adverse Event|9
1153006|NCT01309841|3786210|P3|Overall Study|Lack of Efficacy|2
1153007|NCT01309841|3786211|P2|Overall Study|Lack of Efficacy|0
1153008|NCT01309841|3786212|P1|Overall Study|Lack of Efficacy|0
1153009|NCT01309841|3786210|P3|Overall Study|Study-Specific Withdrawal Criteria|2
1153010|NCT01309841|3786211|P2|Overall Study|Study-Specific Withdrawal Criteria|1
1153011|NCT01309841|3786212|P1|Overall Study|Study-Specific Withdrawal Criteria|3
1153012|NCT01309841|3786210|P3|Overall Study|Lost to Follow-up|4
1153013|NCT01309841|3786211|P2|Overall Study|Lost to Follow-up|6
1153014|NCT01309841|3786212|P1|Overall Study|Lost to Follow-up|7
1153015|NCT01309841|3786210|P3|Overall Study|Other|1
1153016|NCT01309841|3786211|P2|Overall Study|Other|1
1153017|NCT01309841|3786212|P1|Overall Study|Other|0
1153018|NCT01309828|3786252|P2|Overall Study|Other|0
1153019|NCT01309828|3786253|P1|Overall Study|Other|1
1153020|NCT01309828|3786252|P2|Overall Study|Major Protocol Deviation|1
1153021|NCT01309828|3786253|P1|Overall Study|Major Protocol Deviation|0
1153022|NCT01309828|3786252|P2|Overall Study|Voluntary Withdrawal|4
1153023|NCT01309828|3786253|P1|Overall Study|Voluntary Withdrawal|5
1153024|NCT01309828|3786252|P2|Overall Study|Adverse Event|11
1153025|NCT01309828|3786253|P1|Overall Study|Adverse Event|10
1153026|NCT01309737|3786287|P5|Week 16 to 52|Other|0
1153027|NCT01309737|3786288|P4|Week 16 to 52|Other|2
1153028|NCT01309737|3786289|P3|Week 16 to 52|Other|0
1153029|NCT01309737|3786290|P2|Week 16 to 52|Other|12
1153030|NCT01309737|3786291|P1|Week 16 to 52|Other|10
1153031|NCT01309737|3786287|P5|Week 16 to 52|Withdrawal by Subject|2
1153032|NCT01309737|3786288|P4|Week 16 to 52|Withdrawal by Subject|0
1153033|NCT01309737|3786289|P3|Week 16 to 52|Withdrawal by Subject|0
1153034|NCT01309737|3786290|P2|Week 16 to 52|Withdrawal by Subject|6
1153035|NCT01309737|3786291|P1|Week 16 to 52|Withdrawal by Subject|5
1153036|NCT01309737|3786287|P5|Week 16 to 52|Lost to Follow-up|4
1153037|NCT01309737|3786288|P4|Week 16 to 52|Lost to Follow-up|1
1153038|NCT01309737|3786289|P3|Week 16 to 52|Lost to Follow-up|0
1153039|NCT01309737|3786290|P2|Week 16 to 52|Lost to Follow-up|2
1153040|NCT01309737|3786291|P1|Week 16 to 52|Lost to Follow-up|4
1153041|NCT01309737|3786287|P5|Week 16 to 52|Lack of Efficacy|21
1153042|NCT01309737|3786288|P4|Week 16 to 52|Lack of Efficacy|25
1153043|NCT01309737|3786289|P3|Week 16 to 52|Lack of Efficacy|0
1153044|NCT01309737|3786290|P2|Week 16 to 52|Lack of Efficacy|76
1153045|NCT01309737|3786291|P1|Week 16 to 52|Lack of Efficacy|107
1153046|NCT01309737|3786287|P5|Week 16 to 52|Adverse Event|5
1153047|NCT01309737|3786288|P4|Week 16 to 52|Adverse Event|6
1153048|NCT01309737|3786289|P3|Week 16 to 52|Adverse Event|0
1153049|NCT01309737|3786290|P2|Week 16 to 52|Adverse Event|7
1153050|NCT01309737|3786291|P1|Week 16 to 52|Adverse Event|7
1153051|NCT01309737|3786287|P5|Week 16 to 52|Death|1
1153052|NCT01309737|3786288|P4|Week 16 to 52|Death|0
1153053|NCT01309737|3786289|P3|Week 16 to 52|Death|0
1153054|NCT01309737|3786290|P2|Week 16 to 52|Death|0
1153055|NCT01309737|3786291|P1|Week 16 to 52|Death|0
1153056|NCT01309737|3786287|P5|Week 0 to 16|Randomized, but not treated|0
1153057|NCT01309737|3786288|P4|Week 0 to 16|Randomized, but not treated|0
1153058|NCT01309737|3786289|P3|Week 0 to 16|Randomized, but not treated|0
1153059|NCT01309737|3786290|P2|Week 0 to 16|Randomized, but not treated|0
1153060|NCT01309737|3786291|P1|Week 0 to 16|Randomized, but not treated|1
1153061|NCT01309737|3786287|P5|Week 0 to 16|Other|0
1153062|NCT01309737|3786288|P4|Week 0 to 16|Other|0
1153063|NCT01309737|3786289|P3|Week 0 to 16|Other|4
1153064|NCT01309737|3786290|P2|Week 0 to 16|Other|14
1153065|NCT01309737|3786291|P1|Week 0 to 16|Other|10
1153066|NCT01309737|3786287|P5|Week 0 to 16|Withdrawal by Subject|0
1153067|NCT01309737|3786288|P4|Week 0 to 16|Withdrawal by Subject|0
1153068|NCT01309737|3786289|P3|Week 0 to 16|Withdrawal by Subject|7
1153069|NCT01309737|3786290|P2|Week 0 to 16|Withdrawal by Subject|6
1153070|NCT01309737|3786291|P1|Week 0 to 16|Withdrawal by Subject|7
1153071|NCT01309737|3786287|P5|Week 0 to 16|Lost to Follow-up|0
1153072|NCT01309737|3786288|P4|Week 0 to 16|Lost to Follow-up|0
1153073|NCT01309737|3786289|P3|Week 0 to 16|Lost to Follow-up|3
1153074|NCT01309737|3786290|P2|Week 0 to 16|Lost to Follow-up|8
1153075|NCT01309737|3786291|P1|Week 0 to 16|Lost to Follow-up|7
1153076|NCT01309737|3786287|P5|Week 0 to 16|Lack of Efficacy|0
1153077|NCT01309737|3786288|P4|Week 0 to 16|Lack of Efficacy|0
1153078|NCT01309737|3786289|P3|Week 0 to 16|Lack of Efficacy|24
1153079|NCT01309737|3786290|P2|Week 0 to 16|Lack of Efficacy|2
1153080|NCT01309737|3786291|P1|Week 0 to 16|Lack of Efficacy|15
1153081|NCT01309737|3786287|P5|Week 0 to 16|Adverse Event|0
1153082|NCT01309737|3786288|P4|Week 0 to 16|Adverse Event|0
1153083|NCT01309737|3786289|P3|Week 0 to 16|Adverse Event|5
1153084|NCT01309737|3786290|P2|Week 0 to 16|Adverse Event|10
1153085|NCT01309737|3786291|P1|Week 0 to 16|Adverse Event|11
1153086|NCT01309737|3786287|P5|Week 0 to 16|Death|0
1153087|NCT01309737|3786288|P4|Week 0 to 16|Death|0
1153088|NCT01309737|3786289|P3|Week 0 to 16|Death|1
1153089|NCT01309737|3786290|P2|Week 0 to 16|Death|0
1153090|NCT01309737|3786291|P1|Week 0 to 16|Death|1
1153091|NCT01309672|3786486|P1|Overall Study|Withdrawal by Subject|3
1153092|NCT01309672|3786486|P1|Overall Study|Adverse Event|5
1153093|NCT01309672|3786486|P1|Overall Study|Other|9
1153094|NCT01309672|3786486|P1|Overall Study|Lack of Efficacy|20
1153095|NCT01309659|3786496|P2|Overall Study|Protocol Violation|1
1153096|NCT01309659|3786497|P1|Overall Study|Protocol Violation|0
1153097|NCT01309386|3786602|P2|Overall Study|Adverse Event|8
1153098|NCT01309386|3786603|P1|Overall Study|Adverse Event|5
1153099|NCT01309386|3786602|P2|Overall Study|Lack of Efficacy|1
1153100|NCT01309386|3786603|P1|Overall Study|Lack of Efficacy|3
1153101|NCT01309386|3786602|P2|Overall Study|Physician Decision|1
1153102|NCT01309386|3786603|P1|Overall Study|Physician Decision|1
1153103|NCT01309386|3786602|P2|Overall Study|Progressive disease|11
1153104|NCT01309386|3786603|P1|Overall Study|Progressive disease|9
1153105|NCT01309386|3786602|P2|Overall Study|Withdrawal by Subject|0
1153106|NCT01309386|3786603|P1|Overall Study|Withdrawal by Subject|2
1153107|NCT01309386|3786602|P2|Overall Study|Other|0
1153108|NCT01309386|3786603|P1|Overall Study|Other|2
1153109|NCT01309308|3786651|P2|Overall Study|Lost to Follow-up|4
1153110|NCT01309308|3786652|P1|Overall Study|Lost to Follow-up|6
1153111|NCT01309282|3786660|P1|Overall Study|Lost to Follow-up|1
1153112|NCT01309269|3786677|P1|Overall Study|Enrolled but not Treated|107
1153113|NCT01309269|3786677|P1|Overall Study|Study Completion Data Not Recorded|95
1153114|NCT01309269|3786677|P1|Overall Study|Other|1
1153115|NCT01309269|3786677|P1|Overall Study|Other|256
1153116|NCT01309269|3786677|P1|Overall Study|Administrative Problems|141
1153117|NCT01309269|3786677|P1|Overall Study|Kidney Transplant|25
1153118|NCT01309269|3786677|P1|Overall Study|Other Erythropoiesis-stimulating Agents|119
1153119|NCT01309269|3786677|P1|Overall Study|Lack of Acceptance|15
1153120|NCT01309269|3786677|P1|Overall Study|Withdrawal by Subject|25
1153121|NCT01309269|3786677|P1|Overall Study|Adverse Event|56
1153122|NCT01309243|3786685|P2|Extension Phase|Lost to Follow-up|0
1153123|NCT01309243|3786686|P1|Extension Phase|Lost to Follow-up|6
1153124|NCT01309243|3786685|P2|Randomized Phase Through Week 96|Protocol Violation|1
1153125|NCT01309243|3786686|P1|Randomized Phase Through Week 96|Protocol Violation|1
1153126|NCT01309243|3786685|P2|Randomized Phase Through Week 96|Subject Non-Compliance|7
1153127|NCT01309243|3786686|P1|Randomized Phase Through Week 96|Subject Non-Compliance|9
1153128|NCT01309243|3786685|P2|Randomized Phase Through Week 96|Lost to Follow-up|22
1153129|NCT01309243|3786686|P1|Randomized Phase Through Week 96|Lost to Follow-up|23
1153130|NCT01309243|3786685|P2|Randomized Phase Through Week 96|Withdrew Consent|18
1153131|NCT01309243|3786686|P1|Randomized Phase Through Week 96|Withdrew Consent|12
1153132|NCT01309243|3786685|P2|Randomized Phase Through Week 96|Investigators Discretion|6
1153133|NCT01309243|3786686|P1|Randomized Phase Through Week 96|Investigators Discretion|3
1153134|NCT01309243|3786685|P2|Randomized Phase Through Week 96|Lack of Efficacy|4
1153135|NCT01309243|3786686|P1|Randomized Phase Through Week 96|Lack of Efficacy|16
1153136|NCT01309243|3786685|P2|Randomized Phase Through Week 96|Pregnancy|0
1153137|NCT01309243|3786686|P1|Randomized Phase Through Week 96|Pregnancy|2
1153138|NCT01309243|3786685|P2|Randomized Phase Through Week 96|Death|1
1153139|NCT01309243|3786686|P1|Randomized Phase Through Week 96|Death|0
1153140|NCT01309243|3786685|P2|Randomized Phase Through Week 96|Adverse Event|43
1153141|NCT01309243|3786686|P1|Randomized Phase Through Week 96|Adverse Event|12
1153142|NCT01309243|3786685|P2|Randomized Phase Through Week 96|Randomized but not treated|7
1153143|NCT01309243|3786686|P1|Randomized Phase Through Week 96|Randomized but not treated|6
1153144|NCT01309204|3786712|P2|Overall Study|Other|1
1153145|NCT01309204|3786713|P1|Overall Study|Other|4
1153146|NCT01309204|3786712|P2|Overall Study|Inadequate control of IOP|4
1153147|NCT01309204|3786713|P1|Overall Study|Inadequate control of IOP|4
1153148|NCT01309204|3786712|P2|Overall Study|Subject's decision unrelated to an AE|10
1153149|NCT01309204|3786713|P1|Overall Study|Subject's decision unrelated to an AE|9
1153150|NCT01309204|3786712|P2|Overall Study|Lost to Follow-up|2
1153151|NCT01309204|3786713|P1|Overall Study|Lost to Follow-up|2
1153152|NCT01309204|3786712|P2|Overall Study|Adverse Event|58
1153153|NCT01309204|3786713|P1|Overall Study|Adverse Event|48
1153154|NCT01309100|3786719|P1|Overall Study|Positive Slit lamp finding|1
1153155|NCT01309100|3786719|P1|Overall Study|Protocol Violation|1
1153156|NCT01308788|3786767|P2|2-year Treatment|medication change by treating physician|11
1153157|NCT01308788|3786768|P1|2-year Treatment|medication change by treating physician|4
1153158|NCT01308762|3786803|P3|Overall Study|Protocol Violation|0
1153159|NCT01308762|3786804|P2|Overall Study|Protocol Violation|1
1153160|NCT01308762|3786805|P1|Overall Study|Protocol Violation|0
1153161|NCT01308749|3786818|P2|Period 2: Open Label Treatment|Lost to Follow-up|1
1153162|NCT01308749|3786819|P1|Period 2: Open Label Treatment|Lost to Follow-up|0
1153163|NCT01308749|3786818|P2|Period 2: Open Label Treatment|Adverse Event|1
1153164|NCT01308749|3786819|P1|Period 2: Open Label Treatment|Adverse Event|0
1153165|NCT01308749|3786818|P2|Period 1: Double Blind Treatment|Adverse Event|0
1153166|NCT01308749|3786819|P1|Period 1: Double Blind Treatment|Adverse Event|1
1153167|NCT01308736|3786849|P2|Overall Study|Did not attend a single session|5
1153168|NCT01308736|3786850|P1|Overall Study|Did not attend a single session|6
1153169|NCT01308580|3786873|P2|Overall Study|Lost to Follow-up|7
1153170|NCT01308580|3786874|P1|Overall Study|Lost to Follow-up|12
1153171|NCT01308567|3786917|P3|Overall Study|Lost to Follow-up|4
1153172|NCT01308567|3786918|P2|Overall Study|Lost to Follow-up|4
1153173|NCT01308567|3786919|P1|Overall Study|Lost to Follow-up|2
1153174|NCT01308476|3786959|P2|Overall Study|Other|0
1153175|NCT01308476|3786960|P1|Overall Study|Other|1
1153176|NCT01308476|3786959|P2|Overall Study|Lost to Follow-up|2
1153177|NCT01308476|3786960|P1|Overall Study|Lost to Follow-up|2
1153178|NCT01308463|3786980|P1|Overall Study|Revision|2
1153179|NCT01308463|3786980|P1|Overall Study|Death|4
1153180|NCT01308463|3786980|P1|Overall Study|Study Discontinued|23
1153181|NCT01308424|3786993|P3|Randomization|Physician Decision|1
1153182|NCT01308424|3786994|P2|Randomization|Physician Decision|1
1153183|NCT01308424|3786995|P1|Randomization|Physician Decision|0
1153184|NCT01308424|3786993|P3|Randomization|Lost to Follow-up|0
1153185|NCT01308424|3786994|P2|Randomization|Lost to Follow-up|1
1153186|NCT01308424|3786995|P1|Randomization|Lost to Follow-up|0
1153187|NCT01308424|3786993|P3|Randomization|Adverse Event|1
1153188|NCT01308424|3786994|P2|Randomization|Adverse Event|1
1153189|NCT01308424|3786995|P1|Randomization|Adverse Event|0
1153190|NCT01308424|3786993|P3|Baseline Eligibility|Screen Failures|0
1153191|NCT01308424|3786994|P2|Baseline Eligibility|Screen Failures|0
1153192|NCT01308424|3786995|P1|Baseline Eligibility|Screen Failures|71
1153193|NCT01308008|3787004|P2|4 Weeks|Illness, disinterest, time|2
1153194|NCT01308008|3787005|P1|4 Weeks|Illness, disinterest, time|9
1153195|NCT01307891|3787021|P2|Overall Study|Progressive Disease|1
1153196|NCT01307891|3787022|P1|Overall Study|Progressive Disease|3
1153197|NCT01307787|3787034|P2|Overall Study|Withdrawal by Subject|0
1153198|NCT01307787|3787035|P1|Overall Study|Withdrawal by Subject|2
1153199|NCT01307449|3787100|P4|Overall Study|Adverse Event|0
1153200|NCT01307449|3787101|P3|Overall Study|Adverse Event|0
1153201|NCT01307449|3787102|P2|Overall Study|Adverse Event|0
1153202|NCT01307449|3787103|P1|Overall Study|Adverse Event|1
1153203|NCT01307423|3787136|P9|Long-term Safety Phase (Year 5)|Miscellaneous|1
1153204|NCT01307423|3787137|P8|Long-term Safety Phase (Year 5)|Miscellaneous|1
1153205|NCT01307423|3787138|P7|Long-term Safety Phase (Year 5)|Miscellaneous|0
1153206|NCT01307423|3787139|P6|Long-term Safety Phase (Year 5)|Miscellaneous|0
1153207|NCT01307423|3787140|P5|Long-term Safety Phase (Year 5)|Miscellaneous|0
1153208|NCT01307423|3787141|P4|Long-term Safety Phase (Year 5)|Miscellaneous|0
1153209|NCT01307423|3787142|P3|Long-term Safety Phase (Year 5)|Miscellaneous|2
1153210|NCT01307423|3787143|P2|Long-term Safety Phase (Year 5)|Miscellaneous|0
1153211|NCT01307423|3787144|P1|Long-term Safety Phase (Year 5)|Miscellaneous|0
1153212|NCT01307423|3787136|P9|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
1153213|NCT01307423|3787137|P8|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
1153214|NCT01307423|3787138|P7|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
1153215|NCT01307423|3787139|P6|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
1153216|NCT01307423|3787140|P5|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
1153217|NCT01307423|3787141|P4|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
1153218|NCT01307423|3787142|P3|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
1153219|NCT01307423|3787143|P2|Long-term Safety Phase (Year 5)|Lost to Follow-up|1
1153220|NCT01307423|3787144|P1|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
1153221|NCT01307423|3787136|P9|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
1153222|NCT01307423|3787137|P8|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
1153223|NCT01307423|3787138|P7|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
1153224|NCT01307423|3787139|P6|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
1153225|NCT01307423|3787140|P5|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
1153226|NCT01307423|3787141|P4|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
1153227|NCT01307423|3787142|P3|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
1153228|NCT01307423|3787143|P2|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6
1153229|NCT01307423|3787144|P1|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
1153230|NCT01307423|3787136|P9|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1153231|NCT01307423|3787137|P8|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1153232|NCT01307423|3787138|P7|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1153233|NCT01307423|3787139|P6|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1153234|NCT01307423|3787140|P5|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1153235|NCT01307423|3787141|P4|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1153236|NCT01307423|3787142|P3|Long-term Safety Phase (Year 5)|Lack of Efficacy|1
1153237|NCT01307423|3787143|P2|Long-term Safety Phase (Year 5)|Lack of Efficacy|2
1153238|NCT01307423|3787144|P1|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1153239|NCT01307423|3787136|P9|Long-term Safety Phase (Year 5)|Adverse Event|1
1153240|NCT01307423|3787137|P8|Long-term Safety Phase (Year 5)|Adverse Event|0
1153241|NCT01307423|3787138|P7|Long-term Safety Phase (Year 5)|Adverse Event|0
1153242|NCT01307423|3787139|P6|Long-term Safety Phase (Year 5)|Adverse Event|0
1153243|NCT01307423|3787140|P5|Long-term Safety Phase (Year 5)|Adverse Event|0
1153244|NCT01307423|3787141|P4|Long-term Safety Phase (Year 5)|Adverse Event|0
1153245|NCT01307423|3787142|P3|Long-term Safety Phase (Year 5)|Adverse Event|1
1153246|NCT01307423|3787143|P2|Long-term Safety Phase (Year 5)|Adverse Event|1
1153247|NCT01307423|3787144|P1|Long-term Safety Phase (Year 5)|Adverse Event|0
1153248|NCT01307423|3787136|P9|Long-term Safety Phase (Year 4)|Miscellaneous|0
1153249|NCT01307423|3787137|P8|Long-term Safety Phase (Year 4)|Miscellaneous|1
1153250|NCT01307423|3787138|P7|Long-term Safety Phase (Year 4)|Miscellaneous|0
1153251|NCT01307423|3787139|P6|Long-term Safety Phase (Year 4)|Miscellaneous|0
1153252|NCT01307423|3787140|P5|Long-term Safety Phase (Year 4)|Miscellaneous|0
1153253|NCT01307423|3787141|P4|Long-term Safety Phase (Year 4)|Miscellaneous|0
1153254|NCT01307423|3787142|P3|Long-term Safety Phase (Year 4)|Miscellaneous|0
1153255|NCT01307423|3787143|P2|Long-term Safety Phase (Year 4)|Miscellaneous|0
1153256|NCT01307423|3787144|P1|Long-term Safety Phase (Year 4)|Miscellaneous|0
1153257|NCT01307423|3787136|P9|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1153258|NCT01307423|3787137|P8|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1153259|NCT01307423|3787138|P7|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1153260|NCT01307423|3787139|P6|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1153261|NCT01307423|3787140|P5|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1153262|NCT01307423|3787141|P4|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1153263|NCT01307423|3787142|P3|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
1153264|NCT01307423|3787143|P2|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1153265|NCT01307423|3787144|P1|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1153266|NCT01307423|3787136|P9|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4
1153267|NCT01307423|3787137|P8|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1
1153268|NCT01307423|3787138|P7|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
1153269|NCT01307423|3787139|P6|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
1153270|NCT01307423|3787140|P5|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
1153271|NCT01307423|3787141|P4|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
1153272|NCT01307423|3787142|P3|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4
1153273|NCT01307423|3787143|P2|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5
1153274|NCT01307423|3787144|P1|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
1153275|NCT01307423|3787136|P9|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
1153276|NCT01307423|3787137|P8|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
1153277|NCT01307423|3787138|P7|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
1153278|NCT01307423|3787139|P6|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
1153279|NCT01307423|3787140|P5|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
1153280|NCT01307423|3787141|P4|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
1153281|NCT01307423|3787142|P3|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
1153282|NCT01307423|3787143|P2|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
1153283|NCT01307423|3787144|P1|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
1153284|NCT01307423|3787136|P9|Long-term Safety Phase (Year 4)|Adverse Event|0
1153285|NCT01307423|3787137|P8|Long-term Safety Phase (Year 4)|Adverse Event|0
1153286|NCT01307423|3787138|P7|Long-term Safety Phase (Year 4)|Adverse Event|0
1153287|NCT01307423|3787139|P6|Long-term Safety Phase (Year 4)|Adverse Event|0
1153288|NCT01307423|3787140|P5|Long-term Safety Phase (Year 4)|Adverse Event|0
1153289|NCT01307423|3787141|P4|Long-term Safety Phase (Year 4)|Adverse Event|0
1153290|NCT01307423|3787142|P3|Long-term Safety Phase (Year 4)|Adverse Event|0
1153291|NCT01307423|3787143|P2|Long-term Safety Phase (Year 4)|Adverse Event|2
1153292|NCT01307423|3787144|P1|Long-term Safety Phase (Year 4)|Adverse Event|0
1153293|NCT01307423|3787136|P9|Long-term Safety Phase (Year 3)|Miscellaneous|0
1153294|NCT01307423|3787137|P8|Long-term Safety Phase (Year 3)|Miscellaneous|1
1153295|NCT01307423|3787138|P7|Long-term Safety Phase (Year 3)|Miscellaneous|0
1153296|NCT01307423|3787139|P6|Long-term Safety Phase (Year 3)|Miscellaneous|0
1153297|NCT01307423|3787140|P5|Long-term Safety Phase (Year 3)|Miscellaneous|0
1153298|NCT01307423|3787141|P4|Long-term Safety Phase (Year 3)|Miscellaneous|0
1153299|NCT01307423|3787142|P3|Long-term Safety Phase (Year 3)|Miscellaneous|0
1153300|NCT01307423|3787143|P2|Long-term Safety Phase (Year 3)|Miscellaneous|1
1153301|NCT01307423|3787144|P1|Long-term Safety Phase (Year 3)|Miscellaneous|0
1153302|NCT01307423|3787136|P9|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
1153303|NCT01307423|3787137|P8|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
1153304|NCT01307423|3787138|P7|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
1153305|NCT01307423|3787139|P6|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
1153306|NCT01307423|3787140|P5|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
1153307|NCT01307423|3787141|P4|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
1153308|NCT01307423|3787142|P3|Long-term Safety Phase (Year 3)|Lost to Follow-up|3
1153309|NCT01307423|3787143|P2|Long-term Safety Phase (Year 3)|Lost to Follow-up|2
1153310|NCT01307423|3787144|P1|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
1153311|NCT01307423|3787136|P9|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
1153312|NCT01307423|3787137|P8|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2
1153313|NCT01307423|3787138|P7|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
1153314|NCT01307423|3787139|P6|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
1153315|NCT01307423|3787140|P5|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
1153316|NCT01307423|3787141|P4|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
1153317|NCT01307423|3787142|P3|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8
1153318|NCT01307423|3787143|P2|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2
1153319|NCT01307423|3787144|P1|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
1153320|NCT01307423|3787136|P9|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
1153321|NCT01307423|3787137|P8|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
1153322|NCT01307423|3787138|P7|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
1153323|NCT01307423|3787139|P6|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
1153324|NCT01307423|3787140|P5|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
1153325|NCT01307423|3787141|P4|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
1153326|NCT01307423|3787142|P3|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1
1153327|NCT01307423|3787143|P2|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1
1153328|NCT01307423|3787144|P1|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
1153329|NCT01307423|3787136|P9|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
1153330|NCT01307423|3787137|P8|Long-term Safety Phase (Year 3)|Lack of Efficacy|1
1153331|NCT01307423|3787138|P7|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
1153332|NCT01307423|3787139|P6|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
1153333|NCT01307423|3787140|P5|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
1153334|NCT01307423|3787141|P4|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
1153335|NCT01307423|3787142|P3|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
1153336|NCT01307423|3787143|P2|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
1153558|NCT01307033|3787403|P4|44-week Open-label Extension|Death|1
1153337|NCT01307423|3787144|P1|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
1153338|NCT01307423|3787136|P9|Long-term Safety Phase (Year 3)|Adverse Event|4
1153339|NCT01307423|3787137|P8|Long-term Safety Phase (Year 3)|Adverse Event|3
1153340|NCT01307423|3787138|P7|Long-term Safety Phase (Year 3)|Adverse Event|0
1153341|NCT01307423|3787139|P6|Long-term Safety Phase (Year 3)|Adverse Event|0
1153342|NCT01307423|3787140|P5|Long-term Safety Phase (Year 3)|Adverse Event|0
1153343|NCT01307423|3787141|P4|Long-term Safety Phase (Year 3)|Adverse Event|0
1153344|NCT01307423|3787142|P3|Long-term Safety Phase (Year 3)|Adverse Event|2
1153345|NCT01307423|3787143|P2|Long-term Safety Phase (Year 3)|Adverse Event|1
1153346|NCT01307423|3787144|P1|Long-term Safety Phase (Year 3)|Adverse Event|0
1153347|NCT01307423|3787136|P9|Long-term Safety Phase (Year 2)|Miscellaneous|1
1153348|NCT01307423|3787137|P8|Long-term Safety Phase (Year 2)|Miscellaneous|1
1153349|NCT01307423|3787138|P7|Long-term Safety Phase (Year 2)|Miscellaneous|0
1153350|NCT01307423|3787139|P6|Long-term Safety Phase (Year 2)|Miscellaneous|0
1153351|NCT01307423|3787140|P5|Long-term Safety Phase (Year 2)|Miscellaneous|0
1153352|NCT01307423|3787141|P4|Long-term Safety Phase (Year 2)|Miscellaneous|0
1153353|NCT01307423|3787142|P3|Long-term Safety Phase (Year 2)|Miscellaneous|0
1153354|NCT01307423|3787143|P2|Long-term Safety Phase (Year 2)|Miscellaneous|1
1153355|NCT01307423|3787144|P1|Long-term Safety Phase (Year 2)|Miscellaneous|0
1153356|NCT01307423|3787136|P9|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2
1153357|NCT01307423|3787137|P8|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
1153358|NCT01307423|3787138|P7|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
1153359|NCT01307423|3787139|P6|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
1153360|NCT01307423|3787140|P5|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
1153361|NCT01307423|3787141|P4|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
1153362|NCT01307423|3787142|P3|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12
1153363|NCT01307423|3787143|P2|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13
1153364|NCT01307423|3787144|P1|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
1153365|NCT01307423|3787136|P9|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
1153366|NCT01307423|3787137|P8|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
1153367|NCT01307423|3787138|P7|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
1153368|NCT01307423|3787139|P6|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
1153369|NCT01307423|3787140|P5|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
1153370|NCT01307423|3787141|P4|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
1153371|NCT01307423|3787142|P3|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1
1153372|NCT01307423|3787143|P2|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
1153373|NCT01307423|3787144|P1|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
1153374|NCT01307423|3787136|P9|Long-term Safety Phase (Year 2)|Lack of Efficacy|3
1153375|NCT01307423|3787137|P8|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
1153376|NCT01307423|3787138|P7|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
1153377|NCT01307423|3787139|P6|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
1153378|NCT01307423|3787140|P5|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
1153379|NCT01307423|3787141|P4|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
1153380|NCT01307423|3787142|P3|Long-term Safety Phase (Year 2)|Lack of Efficacy|5
1153381|NCT01307423|3787143|P2|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
1153382|NCT01307423|3787144|P1|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
1153383|NCT01307423|3787136|P9|Long-term Safety Phase (Year 2)|Adverse Event|1
1153384|NCT01307423|3787137|P8|Long-term Safety Phase (Year 2)|Adverse Event|1
1153385|NCT01307423|3787138|P7|Long-term Safety Phase (Year 2)|Adverse Event|0
1153386|NCT01307423|3787139|P6|Long-term Safety Phase (Year 2)|Adverse Event|0
1153387|NCT01307423|3787140|P5|Long-term Safety Phase (Year 2)|Adverse Event|0
1153388|NCT01307423|3787141|P4|Long-term Safety Phase (Year 2)|Adverse Event|0
1153389|NCT01307423|3787142|P3|Long-term Safety Phase (Year 2)|Adverse Event|7
1153390|NCT01307423|3787143|P2|Long-term Safety Phase (Year 2)|Adverse Event|2
1153391|NCT01307423|3787144|P1|Long-term Safety Phase (Year 2)|Adverse Event|0
1153392|NCT01307423|3787136|P9|Active Treatment Phase (Week 25-52)|Protocol Violation|0
1153393|NCT01307423|3787137|P8|Active Treatment Phase (Week 25-52)|Protocol Violation|0
1153394|NCT01307423|3787138|P7|Active Treatment Phase (Week 25-52)|Protocol Violation|0
1153395|NCT01307423|3787139|P6|Active Treatment Phase (Week 25-52)|Protocol Violation|1
1153396|NCT01307423|3787140|P5|Active Treatment Phase (Week 25-52)|Protocol Violation|0
1153397|NCT01307423|3787141|P4|Active Treatment Phase (Week 25-52)|Protocol Violation|0
1153398|NCT01307423|3787142|P3|Active Treatment Phase (Week 25-52)|Protocol Violation|0
1153399|NCT01307423|3787143|P2|Active Treatment Phase (Week 25-52)|Protocol Violation|0
1153400|NCT01307423|3787144|P1|Active Treatment Phase (Week 25-52)|Protocol Violation|0
1153401|NCT01307423|3787136|P9|Active Treatment Phase (Week 25-52)|Other|0
1153402|NCT01307423|3787137|P8|Active Treatment Phase (Week 25-52)|Other|0
1153403|NCT01307423|3787138|P7|Active Treatment Phase (Week 25-52)|Other|0
1153404|NCT01307423|3787139|P6|Active Treatment Phase (Week 25-52)|Other|0
1153405|NCT01307423|3787140|P5|Active Treatment Phase (Week 25-52)|Other|0
1153406|NCT01307423|3787141|P4|Active Treatment Phase (Week 25-52)|Other|1
1153407|NCT01307423|3787142|P3|Active Treatment Phase (Week 25-52)|Other|0
1153408|NCT01307423|3787143|P2|Active Treatment Phase (Week 25-52)|Other|0
1153409|NCT01307423|3787144|P1|Active Treatment Phase (Week 25-52)|Other|0
1153410|NCT01307423|3787136|P9|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
1153411|NCT01307423|3787137|P8|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
1153412|NCT01307423|3787138|P7|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
1153413|NCT01307423|3787139|P6|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
1153414|NCT01307423|3787140|P5|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
1153415|NCT01307423|3787141|P4|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2
1153416|NCT01307423|3787142|P3|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
1153417|NCT01307423|3787143|P2|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
1153418|NCT01307423|3787144|P1|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
1153419|NCT01307423|3787136|P9|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
1153420|NCT01307423|3787137|P8|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
1153421|NCT01307423|3787138|P7|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
1153422|NCT01307423|3787139|P6|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
1153423|NCT01307423|3787140|P5|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
1153424|NCT01307423|3787141|P4|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
1153425|NCT01307423|3787142|P3|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2
1153426|NCT01307423|3787143|P2|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11
1153427|NCT01307423|3787144|P1|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
1153428|NCT01307423|3787136|P9|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
1153429|NCT01307423|3787137|P8|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
1153430|NCT01307423|3787138|P7|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
1153431|NCT01307423|3787139|P6|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1
1153432|NCT01307423|3787140|P5|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
1153433|NCT01307423|3787141|P4|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
1153434|NCT01307423|3787142|P3|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
1153435|NCT01307423|3787143|P2|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
1153436|NCT01307423|3787144|P1|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
1153437|NCT01307423|3787136|P9|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
1153438|NCT01307423|3787137|P8|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
1153439|NCT01307423|3787138|P7|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
1153440|NCT01307423|3787139|P6|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
1153441|NCT01307423|3787140|P5|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1
1153442|NCT01307423|3787141|P4|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3
1153443|NCT01307423|3787142|P3|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
1153444|NCT01307423|3787143|P2|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
1153445|NCT01307423|3787144|P1|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
1153446|NCT01307423|3787136|P9|Active Treatment Phase (Week 25-52)|Adverse Event|0
1153447|NCT01307423|3787137|P8|Active Treatment Phase (Week 25-52)|Adverse Event|0
1153448|NCT01307423|3787138|P7|Active Treatment Phase (Week 25-52)|Adverse Event|0
1153449|NCT01307423|3787139|P6|Active Treatment Phase (Week 25-52)|Adverse Event|0
1153450|NCT01307423|3787140|P5|Active Treatment Phase (Week 25-52)|Adverse Event|2
1153451|NCT01307423|3787141|P4|Active Treatment Phase (Week 25-52)|Adverse Event|2
1153452|NCT01307423|3787142|P3|Active Treatment Phase (Week 25-52)|Adverse Event|2
1153453|NCT01307423|3787143|P2|Active Treatment Phase (Week 25-52)|Adverse Event|3
1153454|NCT01307423|3787144|P1|Active Treatment Phase (Week 25-52)|Adverse Event|0
1153455|NCT01307423|3787136|P9|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
1153456|NCT01307423|3787137|P8|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
1153457|NCT01307423|3787138|P7|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
1153458|NCT01307423|3787139|P6|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
1153459|NCT01307423|3787140|P5|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
1153460|NCT01307423|3787141|P4|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
1153461|NCT01307423|3787142|P3|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
1153462|NCT01307423|3787143|P2|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
1153463|NCT01307423|3787144|P1|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
1153464|NCT01307423|3787136|P9|Placebo-controlled Phase (Week 0 - 24)|Other|0
1153465|NCT01307423|3787137|P8|Placebo-controlled Phase (Week 0 - 24)|Other|0
1153466|NCT01307423|3787138|P7|Placebo-controlled Phase (Week 0 - 24)|Other|0
1153467|NCT01307423|3787139|P6|Placebo-controlled Phase (Week 0 - 24)|Other|0
1153468|NCT01307423|3787140|P5|Placebo-controlled Phase (Week 0 - 24)|Other|0
1153469|NCT01307423|3787141|P4|Placebo-controlled Phase (Week 0 - 24)|Other|0
1153470|NCT01307423|3787142|P3|Placebo-controlled Phase (Week 0 - 24)|Other|0
1153471|NCT01307423|3787143|P2|Placebo-controlled Phase (Week 0 - 24)|Other|2
1153472|NCT01307423|3787144|P1|Placebo-controlled Phase (Week 0 - 24)|Other|1
1153473|NCT01307423|3787136|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1153474|NCT01307423|3787137|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1153475|NCT01307423|3787138|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1153476|NCT01307423|3787139|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1153477|NCT01307423|3787140|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1153478|NCT01307423|3787141|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1153479|NCT01307423|3787142|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1153480|NCT01307423|3787143|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1153481|NCT01307423|3787144|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
1153482|NCT01307423|3787136|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1153483|NCT01307423|3787137|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1153484|NCT01307423|3787138|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1153485|NCT01307423|3787139|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1153486|NCT01307423|3787140|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1153487|NCT01307423|3787141|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1153488|NCT01307423|3787142|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
1153489|NCT01307423|3787143|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
1153490|NCT01307423|3787144|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5
1153491|NCT01307423|3787136|P9|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1153492|NCT01307423|3787137|P8|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1153493|NCT01307423|3787138|P7|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1153494|NCT01307423|3787139|P6|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1153495|NCT01307423|3787140|P5|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1153496|NCT01307423|3787141|P4|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1153497|NCT01307423|3787142|P3|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
1153498|NCT01307423|3787143|P2|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1153499|NCT01307423|3787144|P1|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1153500|NCT01307423|3787136|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1153501|NCT01307423|3787137|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1153502|NCT01307423|3787138|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1153503|NCT01307423|3787139|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1153504|NCT01307423|3787140|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1153505|NCT01307423|3787141|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1153506|NCT01307423|3787142|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10
1153507|NCT01307423|3787143|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
1153508|NCT01307423|3787144|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8
1153509|NCT01307423|3787136|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1153510|NCT01307423|3787137|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1153511|NCT01307423|3787138|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1153512|NCT01307423|3787139|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1153513|NCT01307423|3787140|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1153514|NCT01307423|3787141|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1153515|NCT01307423|3787142|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
1153516|NCT01307423|3787143|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
1153517|NCT01307423|3787144|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1
1153518|NCT01307423|3787136|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1153519|NCT01307423|3787137|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1153520|NCT01307423|3787138|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1153521|NCT01307423|3787139|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1153522|NCT01307423|3787140|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1153523|NCT01307423|3787141|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1153524|NCT01307423|3787142|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6
1153525|NCT01307423|3787143|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
1153526|NCT01307423|3787144|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
1153527|NCT01307319|3787350|P3|Overall Study|Not specified|3
1153528|NCT01307319|3787351|P2|Overall Study|Not specified|4
1153529|NCT01307319|3787352|P1|Overall Study|Not specified|0
1153530|NCT01307319|3787350|P3|Overall Study|Withdrawal by Subject|2
1153531|NCT01307319|3787351|P2|Overall Study|Withdrawal by Subject|1
1153532|NCT01307319|3787352|P1|Overall Study|Withdrawal by Subject|0
1153533|NCT01307319|3787350|P3|Overall Study|Protocol Violation|0
1153534|NCT01307319|3787351|P2|Overall Study|Protocol Violation|1
1153535|NCT01307319|3787352|P1|Overall Study|Protocol Violation|1
1153536|NCT01307319|3787350|P3|Overall Study|Lost to Follow-up|1
1153537|NCT01307319|3787351|P2|Overall Study|Lost to Follow-up|0
1153538|NCT01307319|3787352|P1|Overall Study|Lost to Follow-up|1
1153539|NCT01307319|3787350|P3|Overall Study|Adverse Event|1
1153540|NCT01307319|3787351|P2|Overall Study|Adverse Event|2
1153541|NCT01307319|3787352|P1|Overall Study|Adverse Event|2
1153542|NCT01307111|3787366|P2|1-2 Week IUD Check up|IUD expulsion/removal|2
1153543|NCT01307111|3787367|P1|1-2 Week IUD Check up|IUD expulsion/removal|2
1153544|NCT01307111|3787366|P2|IUD Insertion|Lost to Follow-up|0
1153545|NCT01307111|3787367|P1|IUD Insertion|Lost to Follow-up|2
1153546|NCT01307046|3787390|P2|Overall Study|Blood Pressure Withdrawal Criteria Met|3
1153547|NCT01307046|3787391|P1|Overall Study|Blood Pressure Withdrawal Criteria Met|2
1153548|NCT01307046|3787390|P2|Overall Study|Serum Potassium Withdrawal Criteria Met|2
1153549|NCT01307046|3787391|P1|Overall Study|Serum Potassium Withdrawal Criteria Met|4
1153550|NCT01307046|3787390|P2|Overall Study|Withdrawal by Subject|1
1153551|NCT01307046|3787391|P1|Overall Study|Withdrawal by Subject|1
1153552|NCT01307046|3787390|P2|Overall Study|Physician Decision|0
1153553|NCT01307046|3787391|P1|Overall Study|Physician Decision|2
1153554|NCT01307046|3787390|P2|Overall Study|Lack of Efficacy|2
1153555|NCT01307046|3787391|P1|Overall Study|Lack of Efficacy|0
1153556|NCT01307046|3787390|P2|Overall Study|Adverse Event|3
1153557|NCT01307046|3787391|P1|Overall Study|Adverse Event|3
1153559|NCT01307033|3787404|P3|44-week Open-label Extension|Death|0
1153560|NCT01307033|3787405|P2|44-week Open-label Extension|Death|0
1153561|NCT01307033|3787406|P1|44-week Open-label Extension|Death|0
1153562|NCT01307033|3787403|P4|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7
1153563|NCT01307033|3787404|P3|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6
1153564|NCT01307033|3787405|P2|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
1153565|NCT01307033|3787406|P1|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
1153566|NCT01307033|3787403|P4|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2
1153567|NCT01307033|3787404|P3|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
1153568|NCT01307033|3787405|P2|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
1153569|NCT01307033|3787406|P1|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
1153570|NCT01307033|3787403|P4|44-week Open-label Extension|Physician Decision|0
1153571|NCT01307033|3787404|P3|44-week Open-label Extension|Physician Decision|1
1153572|NCT01307033|3787405|P2|44-week Open-label Extension|Physician Decision|0
1153573|NCT01307033|3787406|P1|44-week Open-label Extension|Physician Decision|0
1153574|NCT01307033|3787403|P4|44-week Open-label Extension|Withdrawal by Subject|1
1153575|NCT01307033|3787404|P3|44-week Open-label Extension|Withdrawal by Subject|2
1153576|NCT01307033|3787405|P2|44-week Open-label Extension|Withdrawal by Subject|0
1153577|NCT01307033|3787406|P1|44-week Open-label Extension|Withdrawal by Subject|0
1153578|NCT01307033|3787403|P4|44-week Open-label Extension|Adverse Event|1
1153579|NCT01307033|3787404|P3|44-week Open-label Extension|Adverse Event|2
1153580|NCT01307033|3787405|P2|44-week Open-label Extension|Adverse Event|0
1153581|NCT01307033|3787406|P1|44-week Open-label Extension|Adverse Event|0
1153582|NCT01307033|3787403|P4|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
1153583|NCT01307033|3787404|P3|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
1153584|NCT01307033|3787405|P2|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3
1153585|NCT01307033|3787406|P1|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6
1153586|NCT01307033|3787403|P4|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
1153587|NCT01307033|3787404|P3|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
1153588|NCT01307033|3787405|P2|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3
1153589|NCT01307033|3787406|P1|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
1153590|NCT01307033|3787403|P4|8-week Double-blind Period|Lack of Efficacy|0
1153591|NCT01307033|3787404|P3|8-week Double-blind Period|Lack of Efficacy|0
1153592|NCT01307033|3787405|P2|8-week Double-blind Period|Lack of Efficacy|0
1153593|NCT01307033|3787406|P1|8-week Double-blind Period|Lack of Efficacy|1
1153594|NCT01307033|3787403|P4|8-week Double-blind Period|Withdrawal by Subject|0
1153595|NCT01307033|3787404|P3|8-week Double-blind Period|Withdrawal by Subject|0
1153596|NCT01307033|3787405|P2|8-week Double-blind Period|Withdrawal by Subject|1
1153597|NCT01307033|3787406|P1|8-week Double-blind Period|Withdrawal by Subject|4
1153598|NCT01307033|3787403|P4|8-week Double-blind Period|Adverse Event|0
1153599|NCT01307033|3787404|P3|8-week Double-blind Period|Adverse Event|0
1153600|NCT01307033|3787405|P2|8-week Double-blind Period|Adverse Event|0
1153601|NCT01307033|3787406|P1|8-week Double-blind Period|Adverse Event|2
1153602|NCT01307020|3787428|P10|Overall Study|Electronic data capture failure|0
1153603|NCT01307020|3787429|P9|Overall Study|Electronic data capture failure|0
1153604|NCT01307020|3787430|P8|Overall Study|Electronic data capture failure|0
1153605|NCT01307020|3787431|P7|Overall Study|Electronic data capture failure|0
1153606|NCT01307020|3787432|P6|Overall Study|Electronic data capture failure|0
1153607|NCT01307020|3787433|P5|Overall Study|Electronic data capture failure|0
1153608|NCT01307020|3787434|P4|Overall Study|Electronic data capture failure|0
1153609|NCT01307020|3787435|P3|Overall Study|Electronic data capture failure|0
1153610|NCT01307020|3787436|P2|Overall Study|Electronic data capture failure|1
1153611|NCT01307020|3787437|P1|Overall Study|Electronic data capture failure|0
1153612|NCT01307020|3787428|P10|Overall Study|Lost to Follow-up|0
1153613|NCT01307020|3787429|P9|Overall Study|Lost to Follow-up|0
1153614|NCT01307020|3787430|P8|Overall Study|Lost to Follow-up|0
1153615|NCT01307020|3787431|P7|Overall Study|Lost to Follow-up|1
1153616|NCT01307020|3787432|P6|Overall Study|Lost to Follow-up|0
1153617|NCT01307020|3787433|P5|Overall Study|Lost to Follow-up|0
1153618|NCT01307020|3787434|P4|Overall Study|Lost to Follow-up|1
1153619|NCT01307020|3787435|P3|Overall Study|Lost to Follow-up|1
1153620|NCT01307020|3787436|P2|Overall Study|Lost to Follow-up|0
1153621|NCT01307020|3787437|P1|Overall Study|Lost to Follow-up|0
1153622|NCT01306968|3787492|P4|Overall Study|Withdrew over privacy concerns|1
1153623|NCT01306968|3787493|P3|Overall Study|Withdrew over privacy concerns|0
1153624|NCT01306968|3787494|P2|Overall Study|Withdrew over privacy concerns|0
1153625|NCT01306968|3787495|P1|Overall Study|Withdrew over privacy concerns|0
1153626|NCT01306968|3787492|P4|Overall Study|Withdrew - time commitment|2
1153627|NCT01306968|3787493|P3|Overall Study|Withdrew - time commitment|0
1153628|NCT01306968|3787494|P2|Overall Study|Withdrew - time commitment|0
1153629|NCT01306968|3787495|P1|Overall Study|Withdrew - time commitment|0
1153630|NCT01306968|3787492|P4|Overall Study|Relocated and left active duty|1
1153631|NCT01306968|3787493|P3|Overall Study|Relocated and left active duty|1
1153632|NCT01306968|3787494|P2|Overall Study|Relocated and left active duty|1
1153633|NCT01306968|3787495|P1|Overall Study|Relocated and left active duty|0
1153634|NCT01306968|3787492|P4|Overall Study|Physician Decision|0
1153635|NCT01306968|3787493|P3|Overall Study|Physician Decision|0
1153636|NCT01306968|3787494|P2|Overall Study|Physician Decision|1
1153637|NCT01306968|3787495|P1|Overall Study|Physician Decision|0
1153638|NCT01306968|3787492|P4|Overall Study|Lost to Follow-up|0
1153639|NCT01306968|3787493|P3|Overall Study|Lost to Follow-up|0
1153640|NCT01306968|3787494|P2|Overall Study|Lost to Follow-up|1
1153641|NCT01306968|3787495|P1|Overall Study|Lost to Follow-up|1
1153642|NCT01306877|3787519|P2|Overall Study|Physician Decision|1
1153643|NCT01306877|3787520|P1|Overall Study|Physician Decision|0
1153644|NCT01306877|3787519|P2|Overall Study|Lost to Follow-up|3
1153645|NCT01306877|3787520|P1|Overall Study|Lost to Follow-up|3
1153646|NCT01306643|3787538|P1|Overall Study|Other: Change in Eligibility Status|1
1153647|NCT01306643|3787538|P1|Overall Study|Disease Progression|7
1153648|NCT01306643|3787538|P1|Overall Study|Adverse Event|5
1153649|NCT01306617|3787550|P3|Overall Study|Non-compliance|0
1153650|NCT01306617|3787551|P2|Overall Study|Non-compliance|1
1153651|NCT01306617|3787552|P1|Overall Study|Non-compliance|0
1153652|NCT01306617|3787550|P3|Overall Study|Virologic Failure|5
1153653|NCT01306617|3787551|P2|Overall Study|Virologic Failure|0
1153654|NCT01306617|3787552|P1|Overall Study|Virologic Failure|0
1153655|NCT01306617|3787550|P3|Overall Study|Adverse Event|0
1153656|NCT01306617|3787551|P2|Overall Study|Adverse Event|0
1153657|NCT01306617|3787552|P1|Overall Study|Adverse Event|1
1153658|NCT01306305|3787595|P2|Overall Study|Withdrew consent|0
1153659|NCT01306305|3787596|P1|Overall Study|Withdrew consent|1
1153660|NCT01306305|3787595|P2|Overall Study|Lost to Follow-up|0
1153661|NCT01306305|3787596|P1|Overall Study|Lost to Follow-up|1
1153662|NCT01306253|3787633|P2|Overall Study|Lost to Follow-up|1
1153663|NCT01306253|3787634|P1|Overall Study|Lost to Follow-up|1
1153664|NCT01306214|3787651|P3|Overall Study|Not treated|1
1153665|NCT01306214|3787652|P2|Overall Study|Not treated|1
1153666|NCT01306214|3787653|P1|Overall Study|Not treated|1
1153667|NCT01306214|3787651|P3|Overall Study|Withdrawal by Subject|16
1153668|NCT01306214|3787652|P2|Overall Study|Withdrawal by Subject|22
1153669|NCT01306214|3787653|P1|Overall Study|Withdrawal by Subject|24
1153670|NCT01306214|3787651|P3|Overall Study|Lost to Follow-up|4
1153671|NCT01306214|3787652|P2|Overall Study|Lost to Follow-up|5
1153672|NCT01306214|3787653|P1|Overall Study|Lost to Follow-up|3
1153673|NCT01306214|3787651|P3|Overall Study|Death|1
1153674|NCT01306214|3787652|P2|Overall Study|Death|0
1153675|NCT01306214|3787653|P1|Overall Study|Death|0
1153676|NCT01306201|3787670|P1|Overall Study|Files unreadable|3
1153677|NCT01306201|3787670|P1|Overall Study|Files could not be processed|3
1153678|NCT01306201|3787670|P1|Overall Study|Arrhythmia|4
1153679|NCT01306162|3787692|P4|Washout 1|Non-compliance to protocol|0
1153680|NCT01306162|3787693|P3|Washout 1|Non-compliance to protocol|0
1153681|NCT01306162|3787694|P2|Washout 1|Non-compliance to protocol|1
1153682|NCT01306162|3787695|P1|Washout 1|Non-compliance to protocol|0
1153683|NCT01306162|3787692|P4|Period 1|Adverse Event|1
1153684|NCT01306162|3787693|P3|Period 1|Adverse Event|0
1153685|NCT01306162|3787694|P2|Period 1|Adverse Event|0
1153686|NCT01306162|3787695|P1|Period 1|Adverse Event|0
1153687|NCT01306058|3787723|P1|Overall Study|Enrolled but did not get treatment|1
1153688|NCT01306058|3787723|P1|Overall Study|Death|1
1153689|NCT01306032|3787750|P6|Disease Progression/Crossover|other/symptomatic progression|0
1153690|NCT01306032|3787751|P5|Disease Progression/Crossover|other/symptomatic progression|0
1153691|NCT01306032|3787752|P4|Disease Progression/Crossover|other/symptomatic progression|2
1153692|NCT01306032|3787753|P3|Disease Progression/Crossover|other/symptomatic progression|0
1153693|NCT01306032|3787754|P2|Disease Progression/Crossover|other/symptomatic progression|2
1153694|NCT01306032|3787755|P1|Disease Progression/Crossover|other/symptomatic progression|0
1153695|NCT01306032|3787750|P6|Disease Progression/Crossover|Withdrawal by Subject|0
1153696|NCT01306032|3787751|P5|Disease Progression/Crossover|Withdrawal by Subject|0
1153697|NCT01306032|3787752|P4|Disease Progression/Crossover|Withdrawal by Subject|1
1153698|NCT01306032|3787753|P3|Disease Progression/Crossover|Withdrawal by Subject|0
1153699|NCT01306032|3787754|P2|Disease Progression/Crossover|Withdrawal by Subject|0
1153700|NCT01306032|3787755|P1|Disease Progression/Crossover|Withdrawal by Subject|0
1153701|NCT01306032|3787750|P6|First Intervention|Progressive disease|0
1153702|NCT01306032|3787751|P5|First Intervention|Progressive disease|2
1153703|NCT01306032|3787752|P4|First Intervention|Progressive disease|0
1153704|NCT01306032|3787753|P3|First Intervention|Progressive disease|0
1153705|NCT01306032|3787754|P2|First Intervention|Progressive disease|0
1153706|NCT01306032|3787755|P1|First Intervention|Progressive disease|0
1153707|NCT01306032|3787750|P6|First Intervention|Ineligible|1
1153708|NCT01306032|3787751|P5|First Intervention|Ineligible|0
1153709|NCT01306032|3787752|P4|First Intervention|Ineligible|0
1153710|NCT01306032|3787753|P3|First Intervention|Ineligible|0
1153711|NCT01306032|3787754|P2|First Intervention|Ineligible|0
1153712|NCT01306032|3787755|P1|First Intervention|Ineligible|0
1153713|NCT01306032|3787750|P6|First Intervention|Death|0
1153714|NCT01306032|3787751|P5|First Intervention|Death|0
1153715|NCT01306032|3787752|P4|First Intervention|Death|0
1153716|NCT01306032|3787753|P3|First Intervention|Death|1
1153717|NCT01306032|3787754|P2|First Intervention|Death|0
1153718|NCT01306032|3787755|P1|First Intervention|Death|0
1153719|NCT01306032|3787750|P6|First Intervention|Withdrawal by Subject|0
1153720|NCT01306032|3787751|P5|First Intervention|Withdrawal by Subject|0
1153721|NCT01306032|3787752|P4|First Intervention|Withdrawal by Subject|1
1153722|NCT01306032|3787753|P3|First Intervention|Withdrawal by Subject|0
1153723|NCT01306032|3787754|P2|First Intervention|Withdrawal by Subject|2
1153724|NCT01306032|3787755|P1|First Intervention|Withdrawal by Subject|0
1153725|NCT01306032|3787750|P6|First Intervention|Adverse Event|1
1153726|NCT01306032|3787751|P5|First Intervention|Adverse Event|0
1153727|NCT01306032|3787752|P4|First Intervention|Adverse Event|0
1153728|NCT01306032|3787753|P3|First Intervention|Adverse Event|1
1153729|NCT01306032|3787754|P2|First Intervention|Adverse Event|0
1153730|NCT01306032|3787755|P1|First Intervention|Adverse Event|1
1153731|NCT01305941|3787807|P1|Overall Study|Death|1
1153732|NCT01305941|3787807|P1|Overall Study|Withdrawal by Subject|1
1153733|NCT01305941|3787807|P1|Overall Study|Clinical decline|2
1153734|NCT01305941|3787807|P1|Overall Study|Adverse Event|6
1153735|NCT01305577|3787847|P3|Overall Study|Protocol Deviation|1
1153736|NCT01305577|3787848|P2|Overall Study|Protocol Deviation|1
1153737|NCT01305577|3787849|P1|Overall Study|Protocol Deviation|0
1153738|NCT01305577|3787847|P3|Overall Study|Lost to Follow-up|2
1153739|NCT01305577|3787848|P2|Overall Study|Lost to Follow-up|3
1153740|NCT01305577|3787849|P1|Overall Study|Lost to Follow-up|4
1153741|NCT01305577|3787847|P3|Overall Study|Withdrawal by Subject|6
1153742|NCT01305577|3787848|P2|Overall Study|Withdrawal by Subject|5
1153743|NCT01305577|3787849|P1|Overall Study|Withdrawal by Subject|7
1153744|NCT01305577|3787847|P3|Overall Study|Adverse Event|1
1153745|NCT01305577|3787848|P2|Overall Study|Adverse Event|2
1153746|NCT01305577|3787849|P1|Overall Study|Adverse Event|2
1153747|NCT01305564|3787878|P1|Overall Study|Physician Decision|3
1153748|NCT01305564|3787878|P1|Overall Study|Withdrawal by Subject|1
1153749|NCT01305564|3787878|P1|Overall Study|Lost to Follow-up|12
1153750|NCT01305564|3787878|P1|Overall Study|Death|21
1153751|NCT01305408|3787905|P2|Overall Study|Not specified|0
1153752|NCT01305408|3787906|P1|Overall Study|Not specified|1
1153753|NCT01305408|3787905|P2|Overall Study|Noncompliance with study procedures|1
1153754|NCT01305408|3787906|P1|Overall Study|Noncompliance with study procedures|0
1153755|NCT01305408|3787905|P2|Overall Study|Noncompliance with study medication|1
1153756|NCT01305408|3787906|P1|Overall Study|Noncompliance with study medication|0
1153757|NCT01305408|3787905|P2|Overall Study|Lost to Follow-up|3
1153758|NCT01305408|3787906|P1|Overall Study|Lost to Follow-up|5
1153759|NCT01305408|3787905|P2|Overall Study|Protocol Violation|6
1153760|NCT01305408|3787906|P1|Overall Study|Protocol Violation|4
1153761|NCT01305408|3787905|P2|Overall Study|Withdrawal by Subject|9
1153762|NCT01305408|3787906|P1|Overall Study|Withdrawal by Subject|9
1153763|NCT01305408|3787905|P2|Overall Study|Lack of Efficacy|4
1153764|NCT01305408|3787906|P1|Overall Study|Lack of Efficacy|3
1153765|NCT01305408|3787905|P2|Overall Study|Adverse Event|7
1153766|NCT01305408|3787906|P1|Overall Study|Adverse Event|10
1153767|NCT01305239|3787999|P1|Overall Study|Exemestane taken prior to inclusion only|1
1153768|NCT01305239|3787999|P1|Overall Study|Adverse Event|22
1153769|NCT01305200|3788029|P3|Overall Study|Death|0
1153770|NCT01305200|3788030|P2|Overall Study|Death|2
1153771|NCT01305200|3788031|P1|Overall Study|Death|0
1153772|NCT01305200|3788029|P3|Overall Study|Ineligible|1
1153773|NCT01305200|3788030|P2|Overall Study|Ineligible|2
1153774|NCT01305200|3788031|P1|Overall Study|Ineligible|1
1153775|NCT01305200|3788029|P3|Overall Study|Withdrawal by Subject|1
1153776|NCT01305200|3788030|P2|Overall Study|Withdrawal by Subject|21
1153777|NCT01305200|3788031|P1|Overall Study|Withdrawal by Subject|24
1153778|NCT01305200|3788029|P3|Overall Study|Physician Decision|1
1153779|NCT01305200|3788030|P2|Overall Study|Physician Decision|6
1153780|NCT01305200|3788031|P1|Overall Study|Physician Decision|4
1153781|NCT01305044|3788061|P2|Overall Study|Withdrawal by Subject|6
1153782|NCT01305044|3788062|P1|Overall Study|Withdrawal by Subject|3
1153783|NCT01304706|3788092|P1|Overall Study|Discontinued due to failed drug admin.|1
1153784|NCT01304706|3788092|P1|Overall Study|Lost to Follow-up|7
1153785|NCT01304706|3788092|P1|Overall Study|Withdrawal by Subject|3
1153786|NCT01304706|3788092|P1|Overall Study|Death|3
1153787|NCT01304706|3788092|P1|Overall Study|Lack of Efficacy|1
1153788|NCT01304706|3788092|P1|Overall Study|Adverse Event|2
1153789|NCT01304693|3788101|P5|Overall Study|Decision Unrelated to an Adverse Event|0
1153790|NCT01304693|3788102|P4|Overall Study|Decision Unrelated to an Adverse Event|1
1153791|NCT01304693|3788103|P3|Overall Study|Decision Unrelated to an Adverse Event|1
1153792|NCT01304693|3788104|P2|Overall Study|Decision Unrelated to an Adverse Event|0
1153793|NCT01304693|3788105|P1|Overall Study|Decision Unrelated to an Adverse Event|0
1153794|NCT01304693|3788101|P5|Overall Study|Adverse Event|1
1153795|NCT01304693|3788102|P4|Overall Study|Adverse Event|0
1153796|NCT01304693|3788103|P3|Overall Study|Adverse Event|0
1153797|NCT01304693|3788104|P2|Overall Study|Adverse Event|0
1153798|NCT01304693|3788105|P1|Overall Study|Adverse Event|0
1153799|NCT01304498|3788152|P2|Overall Study|Lost to Follow-up|1
1153800|NCT01304498|3788153|P1|Overall Study|Lost to Follow-up|2
1153801|NCT01304498|3788152|P2|Overall Study|Protocol Violation|0
1153802|NCT01304498|3788153|P1|Overall Study|Protocol Violation|1
1153803|NCT01304498|3788152|P2|Overall Study|Withdrawal by Subject|3
1153804|NCT01304498|3788153|P1|Overall Study|Withdrawal by Subject|2
1153805|NCT01304498|3788152|P2|Overall Study|Adverse Event|1
1153806|NCT01304498|3788153|P1|Overall Study|Adverse Event|1
1153807|NCT01304329|3788173|P6|Third Intervention (3 Days)|Adverse Event|0
1153808|NCT01304329|3788174|P5|Third Intervention (3 Days)|Adverse Event|0
1153809|NCT01304329|3788175|P4|Third Intervention (3 Days)|Adverse Event|0
1153810|NCT01304329|3788176|P3|Third Intervention (3 Days)|Adverse Event|0
1153811|NCT01304329|3788177|P2|Third Intervention (3 Days)|Adverse Event|1
1153812|NCT01304329|3788178|P1|Third Intervention (3 Days)|Adverse Event|0
1153813|NCT01304147|3788312|P2|Second Intervention (7days)|Withdrawal by Subject|1
1153814|NCT01304147|3788313|P1|Second Intervention (7days)|Withdrawal by Subject|1
1153815|NCT01303965|3788344|P2|Overall Study|Disease Progression|6
1153816|NCT01303965|3788345|P1|Overall Study|Disease Progression|1
1153817|NCT01303965|3788344|P2|Overall Study|Withdrawal by Subject|0
1153818|NCT01303965|3788345|P1|Overall Study|Withdrawal by Subject|1
1153819|NCT01303965|3788344|P2|Overall Study|Death|3
1153820|NCT01303965|3788345|P1|Overall Study|Death|0
1153821|NCT01303965|3788344|P2|Overall Study|Adverse Event|1
1153822|NCT01303965|3788345|P1|Overall Study|Adverse Event|1
1153823|NCT01303861|3788373|P4|Overall Study|Pregnancy|0
1153824|NCT01303861|3788374|P3|Overall Study|Pregnancy|0
1153825|NCT01303861|3788375|P2|Overall Study|Pregnancy|0
1153826|NCT01303861|3788376|P1|Overall Study|Pregnancy|1
1153827|NCT01303861|3788373|P4|Overall Study|Adverse Event|5
1153828|NCT01303861|3788374|P3|Overall Study|Adverse Event|0
1153829|NCT01303861|3788375|P2|Overall Study|Adverse Event|1
1153830|NCT01303861|3788376|P1|Overall Study|Adverse Event|4
1153831|NCT01303861|3788373|P4|Overall Study|Withdrawal by Subject|23
1153832|NCT01303861|3788374|P3|Overall Study|Withdrawal by Subject|8
1153833|NCT01303861|3788375|P2|Overall Study|Withdrawal by Subject|8
1153834|NCT01303861|3788376|P1|Overall Study|Withdrawal by Subject|16
1153835|NCT01303861|3788373|P4|Overall Study|Lack of Efficacy|0
1153836|NCT01303861|3788374|P3|Overall Study|Lack of Efficacy|1
1153837|NCT01303861|3788375|P2|Overall Study|Lack of Efficacy|2
1153838|NCT01303861|3788376|P1|Overall Study|Lack of Efficacy|3
1153839|NCT01303861|3788373|P4|Overall Study|Lost to Follow-up|31
1153840|NCT01303861|3788374|P3|Overall Study|Lost to Follow-up|27
1153841|NCT01303861|3788375|P2|Overall Study|Lost to Follow-up|14
1153842|NCT01303861|3788376|P1|Overall Study|Lost to Follow-up|34
1153843|NCT01303627|3788435|P2|Overall Study|the failure while performing URS|1
1153844|NCT01303627|3788436|P1|Overall Study|the failure while performing URS|0
1153845|NCT01303510|3788444|P2|Overall Study|Lost to Follow-up|0
1153846|NCT01303510|3788445|P1|Overall Study|Lost to Follow-up|1
1153847|NCT01303445|3788459|P2|Follow-up Period (14 Days)|Withdrawal by Subject|1
1153848|NCT01303445|3788460|P1|Follow-up Period (14 Days)|Withdrawal by Subject|0
1153849|NCT01303445|3788459|P2|Fourth Intervention (7 Days)|Withdrawal by Subject|0
1153850|NCT01303445|3788460|P1|Fourth Intervention (7 Days)|Withdrawal by Subject|1
1153851|NCT01303445|3788459|P2|Washout (14 Days)|Lost to Follow-up|2
1153852|NCT01303445|3788460|P1|Washout (14 Days)|Lost to Follow-up|0
1153853|NCT01303445|3788459|P2|Washout (14 Days)|Protocol Violation|0
1153854|NCT01303445|3788460|P1|Washout (14 Days)|Protocol Violation|1
1153855|NCT01303445|3788459|P2|Second Intervention (7 Days)|Withdrawal by Subject|0
1153856|NCT01303445|3788460|P1|Second Intervention (7 Days)|Withdrawal by Subject|1
1153857|NCT01303445|3788459|P2|Second Intervention (7 Days)|Adverse Event|2
1153858|NCT01303445|3788460|P1|Second Intervention (7 Days)|Adverse Event|0
1153859|NCT01303445|3788459|P2|First Intervention (7 Days)|Withdrawal by Subject|0
1153860|NCT01303445|3788460|P1|First Intervention (7 Days)|Withdrawal by Subject|1
1153861|NCT01303380|3788501|P1|Overall Study|Lack of compliance to study procedures|1
1153862|NCT01303159|3788560|P1|Overall Study|Study Termination|7
1153863|NCT01303159|3788560|P1|Overall Study|Death|16
1153864|NCT01302964|3788578|P2|Overall Study|Adverse Event|0
1153865|NCT01302964|3788579|P1|Overall Study|Adverse Event|1
1153866|NCT01302938|3788589|P2|Overall Study|Adverse Event|0
1153867|NCT01302938|3788590|P1|Overall Study|Adverse Event|1
1153868|NCT01302938|3788589|P2|Overall Study|Withdrawal by Subject|0
1153869|NCT01302938|3788590|P1|Overall Study|Withdrawal by Subject|1
1153870|NCT01302899|3788635|P2|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1
1153871|NCT01302899|3788636|P1|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0
1153872|NCT01302899|3788635|P2|Period 2 (Weeks 7 to 12)|Protocol Deviation|0
1153873|NCT01302899|3788636|P1|Period 2 (Weeks 7 to 12)|Protocol Deviation|1
1153874|NCT01302691|3788716|P2|Overall Study|Protocol Violation|0
1153875|NCT01302691|3788717|P1|Overall Study|Protocol Violation|1
1153876|NCT01302691|3788716|P2|Overall Study|Physician Decision|1
1153877|NCT01302691|3788717|P1|Overall Study|Physician Decision|0
1153878|NCT01302691|3788716|P2|Overall Study|Blood Pressure/Potassium Criteria Met|4
1153879|NCT01302691|3788717|P1|Overall Study|Blood Pressure/Potassium Criteria Met|6
1153880|NCT01302691|3788716|P2|Overall Study|Lost to Follow-up|0
1153881|NCT01302691|3788717|P1|Overall Study|Lost to Follow-up|1
1153882|NCT01302691|3788716|P2|Overall Study|Death|1
1153883|NCT01302691|3788717|P1|Overall Study|Death|0
1153884|NCT01302691|3788716|P2|Overall Study|Adverse Event|0
1153885|NCT01302691|3788717|P1|Overall Study|Adverse Event|2
1153886|NCT01302548|3788737|P2|Overall Study|Lost to Follow-up|1
1153887|NCT01302548|3788738|P1|Overall Study|Lost to Follow-up|2
1153888|NCT01302418|3788788|P1|Overall Study|Non-evaluable|9
1153889|NCT01302418|3788788|P1|Overall Study|Protocol Violation|9
1153890|NCT01302392|3788794|P2|Overall Study|Withdrawal by Subject|1
1153891|NCT01302392|3788795|P1|Overall Study|Withdrawal by Subject|6
1153892|NCT01302392|3788794|P2|Overall Study|Lost to Follow-up|0
1153893|NCT01302392|3788795|P1|Overall Study|Lost to Follow-up|1
1153894|NCT01302366|3788815|P1|Overall Study|patient choice or noncompliance|5
1153895|NCT01302119|3788823|P2|Overall Study|Non-specific|1
1153896|NCT01302119|3788824|P1|Overall Study|Non-specific|4
1153897|NCT01302119|3788823|P2|Overall Study|Non-compliance|2
1153898|NCT01302119|3788824|P1|Overall Study|Non-compliance|4
1153899|NCT01302119|3788823|P2|Overall Study|Adverse Event|1
1153900|NCT01302119|3788824|P1|Overall Study|Adverse Event|2
1153901|NCT01302119|3788823|P2|Overall Study|Lost to Follow-up|4
1153902|NCT01302119|3788824|P1|Overall Study|Lost to Follow-up|10
1153903|NCT01302119|3788823|P2|Overall Study|Withdrawal by Subject|20
1153904|NCT01302119|3788824|P1|Overall Study|Withdrawal by Subject|30
1153905|NCT01302067|3788839|P3|Overall Study|Adverse Event|45
1153906|NCT01302067|3788840|P2|Overall Study|Adverse Event|14
1153907|NCT01302067|3788841|P1|Overall Study|Adverse Event|27
1153908|NCT01302067|3788839|P3|Overall Study|Protocol Violation|8
1153909|NCT01302067|3788840|P2|Overall Study|Protocol Violation|0
1153910|NCT01302067|3788841|P1|Overall Study|Protocol Violation|11
1153911|NCT01302067|3788839|P3|Overall Study|Not specified|3
1153912|NCT01302067|3788840|P2|Overall Study|Not specified|1
1153913|NCT01302067|3788841|P1|Overall Study|Not specified|1
1153914|NCT01302067|3788839|P3|Overall Study|Withdrawal by Subject|10
1153915|NCT01302067|3788840|P2|Overall Study|Withdrawal by Subject|6
1153916|NCT01302067|3788841|P1|Overall Study|Withdrawal by Subject|13
1153917|NCT01302067|3788839|P3|Overall Study|Lost to Follow-up|15
1153918|NCT01302067|3788840|P2|Overall Study|Lost to Follow-up|4
1153919|NCT01302067|3788841|P1|Overall Study|Lost to Follow-up|9
1153920|NCT01302067|3788839|P3|Overall Study|Lack of Efficacy|2
1153921|NCT01302067|3788840|P2|Overall Study|Lack of Efficacy|4
1153922|NCT01302067|3788841|P1|Overall Study|Lack of Efficacy|8
1153923|NCT01302067|3788839|P3|Overall Study|Physician Decision|14
1153924|NCT01302067|3788840|P2|Overall Study|Physician Decision|5
1153925|NCT01302067|3788841|P1|Overall Study|Physician Decision|9
1153926|NCT01302067|3788839|P3|Overall Study|Death|1
1153927|NCT01302067|3788840|P2|Overall Study|Death|0
1153928|NCT01302067|3788841|P1|Overall Study|Death|0
1153929|NCT01302054|3788912|P3|Double-Blind Treatment Phase|Other|9
1153930|NCT01302054|3788913|P2|Double-Blind Treatment Phase|Other|4
1153931|NCT01302054|3788914|P1|Double-Blind Treatment Phase|Other|0
1153932|NCT01302054|3788912|P3|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2
1153933|NCT01302054|3788913|P2|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
1153934|NCT01302054|3788914|P1|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
1153935|NCT01302054|3788912|P3|Double-Blind Treatment Phase|Adverse Event|10
1153936|NCT01302054|3788913|P2|Double-Blind Treatment Phase|Adverse Event|10
1153937|NCT01302054|3788914|P1|Double-Blind Treatment Phase|Adverse Event|0
1153938|NCT01302054|3788912|P3|Double-Blind Treatment Phase|Protocol Violation|6
1153939|NCT01302054|3788913|P2|Double-Blind Treatment Phase|Protocol Violation|3
1153940|NCT01302054|3788914|P1|Double-Blind Treatment Phase|Protocol Violation|0
1153941|NCT01302054|3788912|P3|Double-Blind Treatment Phase|Withdrawal by Subject|14
1153942|NCT01302054|3788913|P2|Double-Blind Treatment Phase|Withdrawal by Subject|6
1153943|NCT01302054|3788914|P1|Double-Blind Treatment Phase|Withdrawal by Subject|0
1153944|NCT01302054|3788912|P3|Double-Blind Treatment Phase|Lost to Follow-up|1
1153945|NCT01302054|3788913|P2|Double-Blind Treatment Phase|Lost to Follow-up|2
1153946|NCT01302054|3788914|P1|Double-Blind Treatment Phase|Lost to Follow-up|0
1153947|NCT01302054|3788912|P3|Double-Blind Treatment Phase|Lack of Efficacy|4
1153948|NCT01302054|3788913|P2|Double-Blind Treatment Phase|Lack of Efficacy|2
1153949|NCT01302054|3788914|P1|Double-Blind Treatment Phase|Lack of Efficacy|0
1153950|NCT01302054|3788912|P3|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
1153951|NCT01302054|3788913|P2|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
1153952|NCT01302054|3788914|P1|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2
1153953|NCT01302054|3788912|P3|Tolterodine Open-Label Run-In Phase|Other|0
1153954|NCT01302054|3788913|P2|Tolterodine Open-Label Run-In Phase|Other|0
1153955|NCT01302054|3788914|P1|Tolterodine Open-Label Run-In Phase|Other|7
1153956|NCT01302054|3788912|P3|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
1153957|NCT01302054|3788913|P2|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
1153958|NCT01302054|3788914|P1|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314
1153959|NCT01302054|3788912|P3|Tolterodine Open-Label Run-In Phase|Adverse Event|0
1153960|NCT01302054|3788913|P2|Tolterodine Open-Label Run-In Phase|Adverse Event|0
1153961|NCT01302054|3788914|P1|Tolterodine Open-Label Run-In Phase|Adverse Event|13
1153962|NCT01302054|3788912|P3|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
1153963|NCT01302054|3788913|P2|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
1153964|NCT01302054|3788914|P1|Tolterodine Open-Label Run-In Phase|Protocol Violation|8
1153965|NCT01302054|3788912|P3|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
1153966|NCT01302054|3788913|P2|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
1153967|NCT01302054|3788914|P1|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16
1153968|NCT01302054|3788912|P3|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
1153969|NCT01302054|3788913|P2|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
1153970|NCT01302054|3788914|P1|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17
1153971|NCT01302054|3788912|P3|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
1153972|NCT01302054|3788913|P2|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
1153973|NCT01302054|3788914|P1|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4
1153974|NCT01302041|3788941|P1|Overall Study|Other-Miscellaneous Reason|2
1153975|NCT01302041|3788941|P1|Overall Study|Other-Transitioned to 9785-CL-0123|29
1153976|NCT01302041|3788941|P1|Overall Study|Withdrawal by Subject|4
1153977|NCT01302041|3788941|P1|Overall Study|Death|5
1154068|NCT01301066|3789520|P2|Overall Study|Protocol Violation|7
1153978|NCT01301950|3788983|P2|Overall Study|Surgery was cancelled by patient|1
1153979|NCT01301950|3788984|P1|Overall Study|Surgery was cancelled by patient|0
1153980|NCT01301833|3789002|P4|Overall Study|Personal matter|0
1153981|NCT01301833|3789003|P3|Overall Study|Personal matter|0
1153982|NCT01301833|3789004|P2|Overall Study|Personal matter|0
1153983|NCT01301833|3789005|P1|Overall Study|Personal matter|1
1153984|NCT01301833|3789002|P4|Overall Study|Withdrawal by Subject|2
1153985|NCT01301833|3789003|P3|Overall Study|Withdrawal by Subject|1
1153986|NCT01301833|3789004|P2|Overall Study|Withdrawal by Subject|1
1153987|NCT01301833|3789005|P1|Overall Study|Withdrawal by Subject|3
1153988|NCT01301833|3789002|P4|Overall Study|Physician Decision|0
1153989|NCT01301833|3789003|P3|Overall Study|Physician Decision|1
1153990|NCT01301833|3789004|P2|Overall Study|Physician Decision|1
1153991|NCT01301833|3789005|P1|Overall Study|Physician Decision|3
1153992|NCT01301833|3789002|P4|Overall Study|Lack of Efficacy|0
1153993|NCT01301833|3789003|P3|Overall Study|Lack of Efficacy|0
1153994|NCT01301833|3789004|P2|Overall Study|Lack of Efficacy|1
1153995|NCT01301833|3789005|P1|Overall Study|Lack of Efficacy|1
1153996|NCT01301833|3789002|P4|Overall Study|Adverse Event|5
1153997|NCT01301833|3789003|P3|Overall Study|Adverse Event|5
1153998|NCT01301833|3789004|P2|Overall Study|Adverse Event|5
1153999|NCT01301833|3789005|P1|Overall Study|Adverse Event|7
1154000|NCT01301729|3789043|P1|Overall Study|Violated Selection Criteria|1
1154001|NCT01301729|3789043|P1|Overall Study|Participant did not Return for Treatment|1
1154002|NCT01301729|3789043|P1|Overall Study|Withdrawal by Subject|2
1154003|NCT01301625|3789054|P1|Overall Study|Lost to Follow-up|1
1154004|NCT01301625|3789054|P1|Overall Study|Expected|8
1154005|NCT01301625|3789054|P1|Overall Study|Not Due|21
1154006|NCT01301625|3789054|P1|Overall Study|Death|5
1154007|NCT01301508|3789126|P2|Overall Study|Lost to Follow-up|1
1154008|NCT01301508|3789127|P1|Overall Study|Lost to Follow-up|0
1154009|NCT01301508|3789126|P2|Overall Study|Withdrawal by Subject|2
1154010|NCT01301508|3789127|P1|Overall Study|Withdrawal by Subject|1
1154011|NCT01301456|3789157|P12|Stage 2|Adverse Event|0
1154012|NCT01301456|3789158|P11|Stage 2|Adverse Event|1
1154013|NCT01301456|3789159|P10|Stage 2|Adverse Event|0
1154014|NCT01301456|3789160|P9|Stage 2|Adverse Event|0
1154015|NCT01301456|3789161|P8|Stage 2|Adverse Event|0
1154016|NCT01301456|3789162|P7|Stage 2|Adverse Event|0
1154017|NCT01301456|3789163|P6|Stage 2|Adverse Event|0
1154018|NCT01301456|3789164|P5|Stage 2|Adverse Event|0
1154019|NCT01301456|3789165|P4|Stage 2|Adverse Event|0
1154020|NCT01301456|3789166|P3|Stage 2|Adverse Event|0
1154021|NCT01301456|3789167|P2|Stage 2|Adverse Event|0
1154022|NCT01301456|3789168|P1|Stage 2|Adverse Event|0
1154023|NCT01301456|3789157|P12|Stage 1|Randomized but not treated|0
1154024|NCT01301456|3789158|P11|Stage 1|Randomized but not treated|0
1154025|NCT01301456|3789159|P10|Stage 1|Randomized but not treated|0
1154026|NCT01301456|3789160|P9|Stage 1|Randomized but not treated|0
1154027|NCT01301456|3789161|P8|Stage 1|Randomized but not treated|0
1154028|NCT01301456|3789162|P7|Stage 1|Randomized but not treated|1
1154029|NCT01301456|3789163|P6|Stage 1|Randomized but not treated|0
1154030|NCT01301456|3789164|P5|Stage 1|Randomized but not treated|0
1154031|NCT01301456|3789165|P4|Stage 1|Randomized but not treated|0
1154032|NCT01301456|3789166|P3|Stage 1|Randomized but not treated|0
1154033|NCT01301456|3789167|P2|Stage 1|Randomized but not treated|0
1154034|NCT01301456|3789168|P1|Stage 1|Randomized but not treated|0
1154035|NCT01301456|3789157|P12|Stage 1|Withdrawal by Subject|0
1154036|NCT01301456|3789158|P11|Stage 1|Withdrawal by Subject|0
1154037|NCT01301456|3789159|P10|Stage 1|Withdrawal by Subject|0
1154038|NCT01301456|3789160|P9|Stage 1|Withdrawal by Subject|0
1154039|NCT01301456|3789161|P8|Stage 1|Withdrawal by Subject|0
1154040|NCT01301456|3789162|P7|Stage 1|Withdrawal by Subject|0
1154041|NCT01301456|3789163|P6|Stage 1|Withdrawal by Subject|0
1154042|NCT01301456|3789164|P5|Stage 1|Withdrawal by Subject|1
1154043|NCT01301456|3789165|P4|Stage 1|Withdrawal by Subject|0
1154044|NCT01301456|3789166|P3|Stage 1|Withdrawal by Subject|1
1154045|NCT01301456|3789167|P2|Stage 1|Withdrawal by Subject|0
1154046|NCT01301456|3789168|P1|Stage 1|Withdrawal by Subject|0
1154047|NCT01301391|3789394|P1|Overall Study|Sponsor's decision|8
1154048|NCT01301391|3789394|P1|Overall Study|Physician Decision|2
1154049|NCT01301391|3789394|P1|Overall Study|Lost to Follow-up|3
1154050|NCT01301391|3789394|P1|Overall Study|Death|13
1154051|NCT01301274|3789406|P2|Overall Study|Physician Decision|1
1154052|NCT01301274|3789407|P1|Overall Study|Physician Decision|2
1154053|NCT01301092|3789422|P3|Overall Study|Lost to Follow-up|1
1154054|NCT01301092|3789423|P2|Overall Study|Lost to Follow-up|0
1154055|NCT01301092|3789424|P1|Overall Study|Lost to Follow-up|0
1154056|NCT01301079|3789441|P2|Overall Study|Lost to Follow-up|2
1154057|NCT01301079|3789442|P1|Overall Study|Lost to Follow-up|2
1154058|NCT01301066|3789520|P2|Overall Study|Other|0
1154059|NCT01301066|3789521|P1|Overall Study|Other|2
1154060|NCT01301066|3789520|P2|Overall Study|Physician Decision|1
1154061|NCT01301066|3789521|P1|Overall Study|Physician Decision|0
1154062|NCT01301066|3789520|P2|Overall Study|Sponsor Decision|1
1154063|NCT01301066|3789521|P1|Overall Study|Sponsor Decision|2
1154064|NCT01301066|3789520|P2|Overall Study|Adverse Event|6
1154065|NCT01301066|3789521|P1|Overall Study|Adverse Event|6
1154066|NCT01301066|3789520|P2|Overall Study|Withdrawal by Subject|9
1154067|NCT01301066|3789521|P1|Overall Study|Withdrawal by Subject|4
1154069|NCT01301066|3789521|P1|Overall Study|Protocol Violation|8
1154070|NCT01301066|3789520|P2|Overall Study|Lost to Follow-up|11
1154071|NCT01301066|3789521|P1|Overall Study|Lost to Follow-up|5
1154072|NCT01301027|3789529|P2|Overall Study|Volume Overload|0
1154073|NCT01301027|3789530|P1|Overall Study|Volume Overload|3
1154074|NCT01301027|3789529|P2|Overall Study|Transplant|2
1154075|NCT01301027|3789530|P1|Overall Study|Transplant|0
1154076|NCT01301027|3789529|P2|Overall Study|Fracture|3
1154077|NCT01301027|3789530|P1|Overall Study|Fracture|1
1154078|NCT01301027|3789529|P2|Overall Study|Adverse Event|2
1154079|NCT01301027|3789530|P1|Overall Study|Adverse Event|0
1154080|NCT01301027|3789529|P2|Overall Study|Withdrawal by Subject|3
1154081|NCT01301027|3789530|P1|Overall Study|Withdrawal by Subject|2
1154082|NCT01301027|3789529|P2|Overall Study|Physician Decision|0
1154083|NCT01301027|3789530|P1|Overall Study|Physician Decision|2
1154084|NCT01301001|3789542|P2|Second Intervention|Withdrawal by Subject|0
1154085|NCT01301001|3789543|P1|Second Intervention|Withdrawal by Subject|2
1154086|NCT01301001|3789542|P2|Second Intervention|Adverse Event|0
1154087|NCT01301001|3789543|P1|Second Intervention|Adverse Event|2
1154088|NCT01301001|3789542|P2|First Intervention|Protocol Violation|1
1154089|NCT01301001|3789543|P1|First Intervention|Protocol Violation|0
1154090|NCT01301001|3789542|P2|First Intervention|Adverse Event|0
1154091|NCT01301001|3789543|P1|First Intervention|Adverse Event|5
1154092|NCT01301001|3789542|P2|First Intervention|Withdrawal by Subject|4
1154093|NCT01301001|3789543|P1|First Intervention|Withdrawal by Subject|1
1154094|NCT01301001|3789542|P2|First Intervention|Lost to Follow-up|4
1154095|NCT01301001|3789543|P1|First Intervention|Lost to Follow-up|4
1154096|NCT01300923|3789566|P2|Overall Study|Physician Decision|2
1154097|NCT01300923|3789567|P1|Overall Study|Physician Decision|0
1154098|NCT01300819|3789580|P2|Overall Study|Follow up call was not done|0
1154099|NCT01300819|3789581|P1|Overall Study|Follow up call was not done|1
1154100|NCT01300819|3789580|P2|Overall Study|Safety follow up not done by mistake|1
1154101|NCT01300819|3789581|P1|Overall Study|Safety follow up not done by mistake|0
1154102|NCT01300819|3789580|P2|Overall Study|Administrative reason|1
1154103|NCT01300819|3789581|P1|Overall Study|Administrative reason|0
1154104|NCT01300819|3789580|P2|Overall Study|Refusal to down titrate study drug|1
1154105|NCT01300819|3789581|P1|Overall Study|Refusal to down titrate study drug|0
1154106|NCT01300819|3789580|P2|Overall Study|Patient was 1 month late for Visit 10|1
1154107|NCT01300819|3789581|P1|Overall Study|Patient was 1 month late for Visit 10|0
1154108|NCT01300819|3789580|P2|Overall Study|Withdrawal by Subject|12
1154109|NCT01300819|3789581|P1|Overall Study|Withdrawal by Subject|10
1154110|NCT01300819|3789580|P2|Overall Study|Lack of Efficacy|1
1154111|NCT01300819|3789581|P1|Overall Study|Lack of Efficacy|2
1154112|NCT01300819|3789580|P2|Overall Study|Adverse Event|27
1154113|NCT01300819|3789581|P1|Overall Study|Adverse Event|9
1154114|NCT01300767|3789609|P1|Overall Study|Unacceptable fit|1
1154115|NCT01300767|3789609|P1|Overall Study|Biomicroscopy|1
1154116|NCT01300767|3789609|P1|Overall Study|Discomfort|2
1154117|NCT01300741|3789637|P1|Overall Study|Discomfort|1
1154118|NCT01300741|3789637|P1|Overall Study|Lost to Follow-up|1
1154119|NCT01300741|3789637|P1|Overall Study|Lens deposits|1
1154120|NCT01300728|3789667|P2|Overall Study|Physician Decision|0
1154121|NCT01300728|3789668|P1|Overall Study|Physician Decision|1
1154122|NCT01300728|3789667|P2|Overall Study|Withdrawal by Subject|1
1154123|NCT01300728|3789668|P1|Overall Study|Withdrawal by Subject|1
1154124|NCT01300650|3789682|P1|Overall Study|Adverse Event|1
1154125|NCT01300546|3789709|P2|Overall Study|Adverse Event|1
1154126|NCT01300546|3789710|P1|Overall Study|Adverse Event|0
1154127|NCT01300546|3789709|P2|Overall Study|Lack of Efficacy|3
1154128|NCT01300546|3789710|P1|Overall Study|Lack of Efficacy|0
1154129|NCT01300546|3789709|P2|Overall Study|Lost to Follow-up|2
1154130|NCT01300546|3789710|P1|Overall Study|Lost to Follow-up|0
1154131|NCT01300546|3789709|P2|Overall Study|Withdrawal by Subject|0
1154132|NCT01300546|3789710|P1|Overall Study|Withdrawal by Subject|1
1154133|NCT01300455|3789740|P2|Washout|Withdrawal by Subject|0
1154134|NCT01300455|3789741|P1|Washout|Withdrawal by Subject|1
1154135|NCT01300351|3789761|P2|Overall Study|Withdrawal by Subject|10
1154136|NCT01300351|3789762|P1|Overall Study|Withdrawal by Subject|7
1154137|NCT01300351|3789761|P2|Overall Study|Adverse Event|4
1154138|NCT01300351|3789762|P1|Overall Study|Adverse Event|0
1154139|NCT01300351|3789761|P2|Overall Study|Lost to Follow-up|1
1154140|NCT01300351|3789762|P1|Overall Study|Lost to Follow-up|0
1154141|NCT01300351|3789761|P2|Overall Study|Ongoing treatment at data cut-off|23
1154142|NCT01300351|3789762|P1|Overall Study|Ongoing treatment at data cut-off|27
1154143|NCT01300351|3789761|P2|Overall Study|Did not receive treatment|0
1154144|NCT01300351|3789762|P1|Overall Study|Did not receive treatment|2
1154145|NCT01300338|3789778|P2|Overall Study|Lost to Follow-up|0
1154146|NCT01300338|3789779|P1|Overall Study|Lost to Follow-up|5
1154147|NCT01300286|3789787|P1|Overall Study|did not get dosed|1
1154148|NCT01300260|3789797|P2|Period 2 of Study: Second Intervention|Adverse Event|1
1154149|NCT01300260|3789798|P1|Period 2 of Study: Second Intervention|Adverse Event|0
1154150|NCT01300260|3789797|P2|Period 1 of Study: First Intervention|Withdrawal by Subject|0
1154151|NCT01300260|3789798|P1|Period 1 of Study: First Intervention|Withdrawal by Subject|1
1154152|NCT01300260|3789797|P2|Period 1 of Study: First Intervention|Adverse Event|1
1154153|NCT01300260|3789798|P1|Period 1 of Study: First Intervention|Adverse Event|0
1154154|NCT01300247|3789830|P2|Overall Study|Non-Compliance|1
1154155|NCT01300247|3789831|P1|Overall Study|Non-Compliance|0
1154156|NCT01300247|3789830|P2|Overall Study|Withdrawal by Subject|0
1154157|NCT01300247|3789831|P1|Overall Study|Withdrawal by Subject|1
1154158|NCT01300247|3789830|P2|Overall Study|Lost to Follow-up|0
1154159|NCT01300247|3789831|P1|Overall Study|Lost to Follow-up|2
1154160|NCT01300247|3789830|P2|Overall Study|Death|1
1154161|NCT01300247|3789831|P1|Overall Study|Death|1
1154162|NCT01300234|3789863|P2|Overall Study|Participant refused return to hospital|0
1154163|NCT01300234|3789864|P1|Overall Study|Participant refused return to hospital|1
1154164|NCT01300234|3789863|P2|Overall Study|Participant stopped medication|1
1154165|NCT01300234|3789864|P1|Overall Study|Participant stopped medication|1
1154166|NCT01300234|3789863|P2|Overall Study|Participant reached stopping critera|0
1154167|NCT01300234|3789864|P1|Overall Study|Participant reached stopping critera|2
1154168|NCT01300234|3789863|P2|Overall Study|Pregnancy|1
1154169|NCT01300234|3789864|P1|Overall Study|Pregnancy|2
1154170|NCT01300234|3789863|P2|Overall Study|Lost to Follow-up|12
1154171|NCT01300234|3789864|P1|Overall Study|Lost to Follow-up|14
1154172|NCT01300234|3789863|P2|Overall Study|Withdrawal by Subject|9
1154173|NCT01300234|3789864|P1|Overall Study|Withdrawal by Subject|5
1154174|NCT01300234|3789863|P2|Overall Study|Protocol Violation|3
1154175|NCT01300234|3789864|P1|Overall Study|Protocol Violation|2
1154176|NCT01300234|3789863|P2|Overall Study|Adverse Event|1
1154177|NCT01300234|3789864|P1|Overall Study|Adverse Event|1
1154178|NCT01300052|3789900|P2|Overall Study|Protocol Violation|1
1154179|NCT01300052|3789901|P1|Overall Study|Protocol Violation|1
1154180|NCT01300052|3789900|P2|Overall Study|Withdrawal by Subject|2
1154181|NCT01300052|3789901|P1|Overall Study|Withdrawal by Subject|2
1154182|NCT01300052|3789900|P2|Overall Study|Adverse Event|0
1154183|NCT01300052|3789901|P1|Overall Study|Adverse Event|3
1154184|NCT01299961|3789919|P1|Overall Study|Lost to Follow-up|1
1154185|NCT01299961|3789919|P1|Overall Study|Lack of Efficacy|2
1154186|NCT01299961|3789919|P1|Overall Study|Adverse Event|3
1154187|NCT01299909|3789928|P3|Overall Study|Lost to Follow-up|17
1154188|NCT01299909|3789929|P2|Overall Study|Lost to Follow-up|18
1154189|NCT01299909|3789930|P1|Overall Study|Lost to Follow-up|22
1154190|NCT01299896|3789945|P2|Overall Study|Lost to Follow-up|11
1154191|NCT01299896|3789946|P1|Overall Study|Lost to Follow-up|0
1154192|NCT01299896|3789945|P2|Overall Study|Withdrawal by Subject|7
1154193|NCT01299896|3789946|P1|Overall Study|Withdrawal by Subject|1
1154194|NCT01299805|3789954|P2|Overall Study|Adverse Event|0
1154195|NCT01299805|3789955|P1|Overall Study|Adverse Event|2
1154196|NCT01299766|3789985|P2|Overall Study|Withdrawal by Subject|19
1154197|NCT01299766|3789986|P1|Overall Study|Withdrawal by Subject|29
1154198|NCT01299766|3789985|P2|Overall Study|Death|4
1154199|NCT01299766|3789986|P1|Overall Study|Death|5
1154200|NCT01299584|3790044|P1|Overall Study|Protocol Violation|9
1154201|NCT01299571|3790051|P1|Overall Study|Protocol Violation|107
1154202|NCT01299480|3790062|P5|Overall Study|Started, but not vaccinated|0
1154203|NCT01299480|3790063|P4|Overall Study|Started, but not vaccinated|1
1154204|NCT01299480|3790064|P3|Overall Study|Started, but not vaccinated|1
1154205|NCT01299480|3790065|P2|Overall Study|Started, but not vaccinated|0
1154206|NCT01299480|3790066|P1|Overall Study|Started, but not vaccinated|0
1154207|NCT01299480|3790062|P5|Overall Study|Other|3
1154208|NCT01299480|3790063|P4|Overall Study|Other|0
1154209|NCT01299480|3790064|P3|Overall Study|Other|3
1154210|NCT01299480|3790065|P2|Overall Study|Other|2
1154211|NCT01299480|3790066|P1|Overall Study|Other|3
1154212|NCT01299480|3790062|P5|Overall Study|Lost to Follow-up|2
1154213|NCT01299480|3790063|P4|Overall Study|Lost to Follow-up|1
1154214|NCT01299480|3790064|P3|Overall Study|Lost to Follow-up|2
1154215|NCT01299480|3790065|P2|Overall Study|Lost to Follow-up|1
1154216|NCT01299480|3790066|P1|Overall Study|Lost to Follow-up|3
1154217|NCT01299480|3790062|P5|Overall Study|Physician Decision|0
1154218|NCT01299480|3790063|P4|Overall Study|Physician Decision|2
1154219|NCT01299480|3790064|P3|Overall Study|Physician Decision|0
1154220|NCT01299480|3790065|P2|Overall Study|Physician Decision|1
1154221|NCT01299480|3790066|P1|Overall Study|Physician Decision|1
1154222|NCT01299480|3790062|P5|Overall Study|Withdrawal due to pregnancy|0
1154223|NCT01299480|3790063|P4|Overall Study|Withdrawal due to pregnancy|0
1154224|NCT01299480|3790064|P3|Overall Study|Withdrawal due to pregnancy|1
1154225|NCT01299480|3790065|P2|Overall Study|Withdrawal due to pregnancy|1
1154226|NCT01299480|3790066|P1|Overall Study|Withdrawal due to pregnancy|0
1154227|NCT01299480|3790062|P5|Overall Study|Adverse Event|0
1154228|NCT01299480|3790063|P4|Overall Study|Adverse Event|4
1154229|NCT01299480|3790064|P3|Overall Study|Adverse Event|5
1154230|NCT01299480|3790065|P2|Overall Study|Adverse Event|4
1154231|NCT01299480|3790066|P1|Overall Study|Adverse Event|6
1154232|NCT01299480|3790062|P5|Overall Study|Withdrawal by Subject|4
1154233|NCT01299480|3790063|P4|Overall Study|Withdrawal by Subject|3
1154234|NCT01299480|3790064|P3|Overall Study|Withdrawal by Subject|7
1154235|NCT01299480|3790065|P2|Overall Study|Withdrawal by Subject|4
1154236|NCT01299480|3790066|P1|Overall Study|Withdrawal by Subject|3
1154237|NCT01299480|3790062|P5|Overall Study|Protocol Violation|1
1154238|NCT01299480|3790063|P4|Overall Study|Protocol Violation|1
1154239|NCT01299480|3790064|P3|Overall Study|Protocol Violation|8
1154240|NCT01299480|3790065|P2|Overall Study|Protocol Violation|5
1154241|NCT01299480|3790066|P1|Overall Study|Protocol Violation|7
1154242|NCT01299480|3790062|P5|Overall Study|No longer willing to participate|10
1154243|NCT01299480|3790063|P4|Overall Study|No longer willing to participate|13
1154244|NCT01299480|3790064|P3|Overall Study|No longer willing to participate|14
1154245|NCT01299480|3790065|P2|Overall Study|No longer willing to participate|17
1154246|NCT01299480|3790066|P1|Overall Study|No longer willing to participate|19
1154247|NCT01299389|3790268|P4|Post-observational|Other|6
1154248|NCT01299389|3790269|P3|Post-observational|Other|12
1154249|NCT01299389|3790270|P2|Post-observational|Other|0
1154250|NCT01299389|3790271|P1|Post-observational|Other|0
1154251|NCT01299389|3790268|P4|Double-blind|fail to meet “study population” criteria|0
1154252|NCT01299389|3790269|P3|Double-blind|fail to meet “study population” criteria|0
1154253|NCT01299389|3790270|P2|Double-blind|fail to meet “study population” criteria|1
1154254|NCT01299389|3790271|P1|Double-blind|fail to meet “study population” criteria|0
1154255|NCT01299389|3790268|P4|Double-blind|Other|0
1154256|NCT01299389|3790269|P3|Double-blind|Other|0
1154257|NCT01299389|3790270|P2|Double-blind|Other|1
1154258|NCT01299389|3790271|P1|Double-blind|Other|1
1154259|NCT01299389|3790268|P4|Double-blind|Withdrawal by Subject|0
1154260|NCT01299389|3790269|P3|Double-blind|Withdrawal by Subject|0
1154261|NCT01299389|3790270|P2|Double-blind|Withdrawal by Subject|13
1154262|NCT01299389|3790271|P1|Double-blind|Withdrawal by Subject|16
1154263|NCT01299389|3790268|P4|Double-blind|Lost to Follow-up|0
1154264|NCT01299389|3790269|P3|Double-blind|Lost to Follow-up|0
1154265|NCT01299389|3790270|P2|Double-blind|Lost to Follow-up|1
1154266|NCT01299389|3790271|P1|Double-blind|Lost to Follow-up|2
1154267|NCT01299389|3790268|P4|Double-blind|Lack of Efficacy|0
1154268|NCT01299389|3790269|P3|Double-blind|Lack of Efficacy|0
1154269|NCT01299389|3790270|P2|Double-blind|Lack of Efficacy|21
1154270|NCT01299389|3790271|P1|Double-blind|Lack of Efficacy|45
1154271|NCT01299389|3790268|P4|Double-blind|Adverse Event|0
1154272|NCT01299389|3790269|P3|Double-blind|Adverse Event|0
1154273|NCT01299389|3790270|P2|Double-blind|Adverse Event|27
1154274|NCT01299389|3790271|P1|Double-blind|Adverse Event|45
1154275|NCT01299376|3790293|P2|Extension (Weeks 9 to 52)|Physician Decision|0
1154276|NCT01299376|3790294|P1|Extension (Weeks 9 to 52)|Physician Decision|1
1154277|NCT01299376|3790293|P2|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9
1154278|NCT01299376|3790294|P1|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4
1154279|NCT01299376|3790293|P2|Extension (Weeks 9 to 52)|Lost to Follow-up|2
1154280|NCT01299376|3790294|P1|Extension (Weeks 9 to 52)|Lost to Follow-up|1
1154281|NCT01299376|3790293|P2|Extension (Weeks 9 to 52)|Adverse Event|3
1154282|NCT01299376|3790294|P1|Extension (Weeks 9 to 52)|Adverse Event|2
1154283|NCT01299376|3790293|P2|Extension (Weeks 9 to 52)|Withdrawal by Subject|1
1154284|NCT01299376|3790294|P1|Extension (Weeks 9 to 52)|Withdrawal by Subject|2
1154285|NCT01299376|3790293|P2|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
1154286|NCT01299376|3790294|P1|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
1154287|NCT01299376|3790293|P2|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0
1154288|NCT01299376|3790294|P1|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1
1154289|NCT01299376|3790293|P2|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7
1154290|NCT01299376|3790294|P1|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4
1154291|NCT01299376|3790293|P2|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1
1154292|NCT01299376|3790294|P1|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0
1154293|NCT01299376|3790293|P2|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1
1154294|NCT01299376|3790294|P1|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0
1154295|NCT01299376|3790293|P2|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2
1154296|NCT01299376|3790294|P1|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1
1154297|NCT01299272|3790337|P4|Double-blind (DB) Randomized Period|Sponsor Decision|1
1154298|NCT01299272|3790338|P3|Double-blind (DB) Randomized Period|Sponsor Decision|1
1154299|NCT01299272|3790339|P2|Double-blind (DB) Randomized Period|Sponsor Decision|0
1154300|NCT01299272|3790340|P1|Double-blind (DB) Randomized Period|Sponsor Decision|0
1154301|NCT01299272|3790337|P4|Double-blind (DB) Randomized Period|Physician Decision|1
1154302|NCT01299272|3790338|P3|Double-blind (DB) Randomized Period|Physician Decision|2
1154303|NCT01299272|3790339|P2|Double-blind (DB) Randomized Period|Physician Decision|0
1154304|NCT01299272|3790340|P1|Double-blind (DB) Randomized Period|Physician Decision|0
1154305|NCT01299272|3790337|P4|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10
1154306|NCT01299272|3790338|P3|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4
1154307|NCT01299272|3790339|P2|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
1154308|NCT01299272|3790340|P1|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
1154309|NCT01299272|3790337|P4|Double-blind (DB) Randomized Period|Lost to Follow-up|5
1154310|NCT01299272|3790338|P3|Double-blind (DB) Randomized Period|Lost to Follow-up|5
1154311|NCT01299272|3790339|P2|Double-blind (DB) Randomized Period|Lost to Follow-up|0
1154312|NCT01299272|3790340|P1|Double-blind (DB) Randomized Period|Lost to Follow-up|0
1154313|NCT01299272|3790337|P4|Double-blind (DB) Randomized Period|Protocol Violation|7
1154314|NCT01299272|3790338|P3|Double-blind (DB) Randomized Period|Protocol Violation|8
1154315|NCT01299272|3790339|P2|Double-blind (DB) Randomized Period|Protocol Violation|0
1154316|NCT01299272|3790340|P1|Double-blind (DB) Randomized Period|Protocol Violation|0
1154317|NCT01299272|3790337|P4|Double-blind (DB) Randomized Period|Adverse Event|9
1154318|NCT01299272|3790338|P3|Double-blind (DB) Randomized Period|Adverse Event|8
1154319|NCT01299272|3790339|P2|Double-blind (DB) Randomized Period|Adverse Event|0
1154320|NCT01299272|3790340|P1|Double-blind (DB) Randomized Period|Adverse Event|0
1154321|NCT01299272|3790337|P4|Double-blind (DB) Randomized Period|Lack of Efficacy|10
1154322|NCT01299272|3790338|P3|Double-blind (DB) Randomized Period|Lack of Efficacy|20
1154323|NCT01299272|3790339|P2|Double-blind (DB) Randomized Period|Lack of Efficacy|0
1154324|NCT01299272|3790340|P1|Double-blind (DB) Randomized Period|Lack of Efficacy|0
1154325|NCT01299272|3790337|P4|Double-blind (DB) Randomized Period|Withdrawal by Subject|15
1154326|NCT01299272|3790338|P3|Double-blind (DB) Randomized Period|Withdrawal by Subject|22
1154327|NCT01299272|3790339|P2|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
1154328|NCT01299272|3790340|P1|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
1154329|NCT01299272|3790337|P4|Stabilization Open-label (OL) Period|Physician Decision|0
1154330|NCT01299272|3790338|P3|Stabilization Open-label (OL) Period|Physician Decision|0
1154331|NCT01299272|3790339|P2|Stabilization Open-label (OL) Period|Physician Decision|3
1154332|NCT01299272|3790340|P1|Stabilization Open-label (OL) Period|Physician Decision|0
1154333|NCT01299272|3790337|P4|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
1154334|NCT01299272|3790338|P3|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
1154335|NCT01299272|3790339|P2|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6
1154336|NCT01299272|3790340|P1|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
1154337|NCT01299272|3790337|P4|Stabilization Open-label (OL) Period|Lost to Follow-up|0
1154338|NCT01299272|3790338|P3|Stabilization Open-label (OL) Period|Lost to Follow-up|0
1154339|NCT01299272|3790339|P2|Stabilization Open-label (OL) Period|Lost to Follow-up|9
1154340|NCT01299272|3790340|P1|Stabilization Open-label (OL) Period|Lost to Follow-up|0
1154341|NCT01299272|3790337|P4|Stabilization Open-label (OL) Period|Lack of Efficacy|0
1154342|NCT01299272|3790338|P3|Stabilization Open-label (OL) Period|Lack of Efficacy|0
1154343|NCT01299272|3790339|P2|Stabilization Open-label (OL) Period|Lack of Efficacy|11
1154344|NCT01299272|3790340|P1|Stabilization Open-label (OL) Period|Lack of Efficacy|0
1154345|NCT01299272|3790337|P4|Stabilization Open-label (OL) Period|Sponsor Decision|0
1154346|NCT01299272|3790338|P3|Stabilization Open-label (OL) Period|Sponsor Decision|0
1154347|NCT01299272|3790339|P2|Stabilization Open-label (OL) Period|Sponsor Decision|12
1154348|NCT01299272|3790340|P1|Stabilization Open-label (OL) Period|Sponsor Decision|0
1154349|NCT01299272|3790337|P4|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
1154350|NCT01299272|3790338|P3|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
1154351|NCT01299272|3790339|P2|Stabilization Open-label (OL) Period|Withdrawal by Subject|42
1154352|NCT01299272|3790340|P1|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
1154353|NCT01299272|3790337|P4|Stabilization Open-label (OL) Period|Adverse Event|0
1154354|NCT01299272|3790338|P3|Stabilization Open-label (OL) Period|Adverse Event|0
1154355|NCT01299272|3790339|P2|Stabilization Open-label (OL) Period|Adverse Event|42
1154356|NCT01299272|3790340|P1|Stabilization Open-label (OL) Period|Adverse Event|0
1154357|NCT01299272|3790337|P4|Stabilization Open-label (OL) Period|Protocol Violation|0
1154358|NCT01299272|3790338|P3|Stabilization Open-label (OL) Period|Protocol Violation|0
1154359|NCT01299272|3790339|P2|Stabilization Open-label (OL) Period|Protocol Violation|44
1154360|NCT01299272|3790340|P1|Stabilization Open-label (OL) Period|Protocol Violation|0
1154361|NCT01299272|3790337|P4|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
1154362|NCT01299272|3790338|P3|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
1154363|NCT01299272|3790339|P2|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80
1154364|NCT01299272|3790340|P1|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
1154365|NCT01299272|3790337|P4|Acute Open-label (OL) Period|Physician Decision|0
1154366|NCT01299272|3790338|P3|Acute Open-label (OL) Period|Physician Decision|0
1154367|NCT01299272|3790339|P2|Acute Open-label (OL) Period|Physician Decision|0
1154368|NCT01299272|3790340|P1|Acute Open-label (OL) Period|Physician Decision|5
1154369|NCT01299272|3790337|P4|Acute Open-label (OL) Period|Lack of Efficacy|0
1154370|NCT01299272|3790338|P3|Acute Open-label (OL) Period|Lack of Efficacy|0
1154371|NCT01299272|3790339|P2|Acute Open-label (OL) Period|Lack of Efficacy|0
1154372|NCT01299272|3790340|P1|Acute Open-label (OL) Period|Lack of Efficacy|10
1154373|NCT01299272|3790337|P4|Acute Open-label (OL) Period|Sponsor Decision|0
1154374|NCT01299272|3790338|P3|Acute Open-label (OL) Period|Sponsor Decision|0
1154375|NCT01299272|3790339|P2|Acute Open-label (OL) Period|Sponsor Decision|0
1154376|NCT01299272|3790340|P1|Acute Open-label (OL) Period|Sponsor Decision|13
1154377|NCT01299272|3790337|P4|Acute Open-label (OL) Period|Lost to Follow-up|0
1154378|NCT01299272|3790338|P3|Acute Open-label (OL) Period|Lost to Follow-up|0
1154379|NCT01299272|3790339|P2|Acute Open-label (OL) Period|Lost to Follow-up|0
1154380|NCT01299272|3790340|P1|Acute Open-label (OL) Period|Lost to Follow-up|14
1154381|NCT01299272|3790337|P4|Acute Open-label (OL) Period|Protocol Violation|0
1154382|NCT01299272|3790338|P3|Acute Open-label (OL) Period|Protocol Violation|0
1154383|NCT01299272|3790339|P2|Acute Open-label (OL) Period|Protocol Violation|0
1154384|NCT01299272|3790340|P1|Acute Open-label (OL) Period|Protocol Violation|36
1154385|NCT01299272|3790337|P4|Acute Open-label (OL) Period|Withdrawal by Subject|0
1154386|NCT01299272|3790338|P3|Acute Open-label (OL) Period|Withdrawal by Subject|0
1154387|NCT01299272|3790339|P2|Acute Open-label (OL) Period|Withdrawal by Subject|0
1154388|NCT01299272|3790340|P1|Acute Open-label (OL) Period|Withdrawal by Subject|56
1154389|NCT01299272|3790337|P4|Acute Open-label (OL) Period|Adverse Event|0
1154390|NCT01299272|3790338|P3|Acute Open-label (OL) Period|Adverse Event|0
1154391|NCT01299272|3790339|P2|Acute Open-label (OL) Period|Adverse Event|0
1154392|NCT01299272|3790340|P1|Acute Open-label (OL) Period|Adverse Event|140
1154393|NCT01299272|3790337|P4|Acute Open-label (OL) Period|Remission Criteria Not Met|0
1154394|NCT01299272|3790338|P3|Acute Open-label (OL) Period|Remission Criteria Not Met|0
1154395|NCT01299272|3790339|P2|Acute Open-label (OL) Period|Remission Criteria Not Met|0
1154396|NCT01299272|3790340|P1|Acute Open-label (OL) Period|Remission Criteria Not Met|140
1154397|NCT01299116|3790395|P3|Overall Study|Lost to Follow-up|11
1154398|NCT01299116|3790396|P2|Overall Study|Lost to Follow-up|9
1154399|NCT01299116|3790397|P1|Overall Study|Lost to Follow-up|65
1154400|NCT01299025|3790442|P2|Overall Study|Lost to Follow-up|0
1154401|NCT01299025|3790443|P1|Overall Study|Lost to Follow-up|1
1154402|NCT01299025|3790442|P2|Overall Study|Withdrawal by Subject|1
1154403|NCT01299025|3790443|P1|Overall Study|Withdrawal by Subject|2
1154404|NCT01298778|3790457|P2|Overall Study|not meet inclusion/exclusion criteria|1
1154405|NCT01298778|3790458|P1|Overall Study|not meet inclusion/exclusion criteria|0
1154406|NCT01298778|3790457|P2|Overall Study|Protocol Violation|1
1154407|NCT01298778|3790458|P1|Overall Study|Protocol Violation|0
1154408|NCT01298778|3790457|P2|Overall Study|Withdrawal by Subject|1
1154409|NCT01298778|3790458|P1|Overall Study|Withdrawal by Subject|0
1154410|NCT01298778|3790457|P2|Overall Study|Incorrect use of VAS|0
1154411|NCT01298778|3790458|P1|Overall Study|Incorrect use of VAS|1
1154412|NCT01298778|3790457|P2|Overall Study|Lost to Follow-up|3
1154413|NCT01298778|3790458|P1|Overall Study|Lost to Follow-up|2
1154414|NCT01298765|3790478|P1|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46
1154415|NCT01298765|3790478|P1|Long-Term Treatment Period|Physician Decision|1
1154416|NCT01298765|3790478|P1|Long-Term Treatment Period|Withdrawal by Subject|19
1154417|NCT01298765|3790478|P1|Long-Term Treatment Period|Lost to Follow-up|8
1154418|NCT01298765|3790478|P1|Long-Term Treatment Period|Lack of Efficacy|6
1154419|NCT01298765|3790478|P1|Long-Term Treatment Period|Adverse Event|19
1154420|NCT01298765|3790478|P1|Titration Period|Other: Not Lack of Analgesic Effect|8
1154421|NCT01298765|3790478|P1|Titration Period|Withdrawal by Subject|10
1154422|NCT01298765|3790478|P1|Titration Period|Physician Decision|1
1154423|NCT01298765|3790478|P1|Titration Period|Lost to Follow-up|9
1154424|NCT01298765|3790478|P1|Titration Period|Lack of Efficacy|21
1154425|NCT01298765|3790478|P1|Titration Period|Death|1
1154426|NCT01298765|3790478|P1|Titration Period|Adverse Event|26
1154427|NCT01298700|3790488|P2|Overall Study|Did not Receive Study Drug|5
1154428|NCT01298700|3790489|P1|Overall Study|Did not Receive Study Drug|3
1154429|NCT01298700|3790488|P2|Overall Study|Other Miscellaneous Reasons|15
1154430|NCT01298700|3790489|P1|Overall Study|Other Miscellaneous Reasons|16
1154431|NCT01298700|3790488|P2|Overall Study|Protocol Violation|4
1154432|NCT01298700|3790489|P1|Overall Study|Protocol Violation|6
1154433|NCT01298700|3790488|P2|Overall Study|Withdrawal by Subject|9
1154434|NCT01298700|3790489|P1|Overall Study|Withdrawal by Subject|12
1154435|NCT01298700|3790488|P2|Overall Study|Lost to Follow-up|2
1154436|NCT01298700|3790489|P1|Overall Study|Lost to Follow-up|5
1154437|NCT01298700|3790488|P2|Overall Study|Lack of Efficacy|14
1154438|NCT01298700|3790489|P1|Overall Study|Lack of Efficacy|9
1154439|NCT01298700|3790488|P2|Overall Study|Adverse Event|51
1154440|NCT01298700|3790489|P1|Overall Study|Adverse Event|50
1154441|NCT01298661|3790500|P3|Overall Study|Withdrawal by Subject|2
1154442|NCT01298661|3790501|P2|Overall Study|Withdrawal by Subject|0
1154443|NCT01298661|3790502|P1|Overall Study|Withdrawal by Subject|2
1154444|NCT01298648|3790580|P1|Overall Study|Lost to Follow-up|21
1154445|NCT01298648|3790580|P1|Overall Study|Withdrawal by Subject|2
1154446|NCT01298570|3790591|P2|Overall Study|Ineligibility|1
1154447|NCT01298570|3790592|P1|Overall Study|Ineligibility|0
1154448|NCT01298570|3790591|P2|Overall Study|Death|1
1154449|NCT01298570|3790592|P1|Overall Study|Death|0
1154450|NCT01298570|3790591|P2|Overall Study|Symptomatic progression/deterioration|2
1154451|NCT01298570|3790592|P1|Overall Study|Symptomatic progression/deterioration|3
1154452|NCT01298570|3790591|P2|Overall Study|Surgery|1
1154453|NCT01298570|3790592|P1|Overall Study|Surgery|2
1154454|NCT01298570|3790591|P2|Overall Study|Other complicating disease|1
1154455|NCT01298570|3790592|P1|Overall Study|Other complicating disease|2
1154456|NCT01298570|3790591|P2|Overall Study|Physician Decision|2
1154457|NCT01298570|3790592|P1|Overall Study|Physician Decision|4
1154458|NCT01298570|3790591|P2|Overall Study|Treatment delay > 4 weeks|5
1154459|NCT01298570|3790592|P1|Overall Study|Treatment delay > 4 weeks|4
1154460|NCT01298570|3790591|P2|Overall Study|Withdrawal by Subject|6
1154461|NCT01298570|3790592|P1|Overall Study|Withdrawal by Subject|21
1154462|NCT01298570|3790591|P2|Overall Study|Adverse Event|2
1154463|NCT01298570|3790592|P1|Overall Study|Adverse Event|20
1154464|NCT01298570|3790591|P2|Overall Study|Disease progression, relapse during acti|40
1154465|NCT01298570|3790592|P1|Overall Study|Disease progression, relapse during acti|64
1154466|NCT01298531|3790619|P2|Overall Study|Not specified|1
1154467|NCT01298531|3790620|P1|Overall Study|Not specified|2
1154468|NCT01298531|3790619|P2|Overall Study|Does not meet entrance criteria|1
1154469|NCT01298531|3790620|P1|Overall Study|Does not meet entrance criteria|0
1154470|NCT01298531|3790619|P2|Overall Study|Adverse Event|3
1154471|NCT01298531|3790620|P1|Overall Study|Adverse Event|4
1154472|NCT01298531|3790619|P2|Overall Study|Protocol Violation|1
1154473|NCT01298531|3790620|P1|Overall Study|Protocol Violation|1
1154474|NCT01298531|3790619|P2|Overall Study|Lost to Follow-up|0
1154475|NCT01298531|3790620|P1|Overall Study|Lost to Follow-up|2
1154476|NCT01298531|3790619|P2|Overall Study|Lack of Efficacy|1
1154477|NCT01298531|3790620|P1|Overall Study|Lack of Efficacy|0
1154478|NCT01298518|3790749|P3|Overall Study|Withdrawal by Subject|1
1154479|NCT01298518|3790750|P2|Overall Study|Withdrawal by Subject|0
1154480|NCT01298518|3790751|P1|Overall Study|Withdrawal by Subject|0
1154481|NCT01298492|3790803|P1|Overall Study|Adverse Event(Not Related to Study Drug)|18
1154482|NCT01298492|3790803|P1|Overall Study|Adverse Event(Related to Study Drug)|8
1154483|NCT01298492|3790803|P1|Overall Study|Protocol Violation|2
1154484|NCT01298492|3790803|P1|Overall Study|Withdrawn Due to Pregnancy|1
1154485|NCT01298492|3790803|P1|Overall Study|Other (Unspecified)|7
1154486|NCT01298492|3790803|P1|Overall Study|Withdrawal by Subject|47
1154487|NCT01298492|3790803|P1|Overall Study|Lost to Follow-up|12
1154488|NCT01298492|3790803|P1|Overall Study|Insufficient Clinical Response|22
1154489|NCT01298492|3790803|P1|Overall Study|Death|2
1154490|NCT01298362|3790811|P2|Overall Study|Did not provide 12month BMD measurements|43
1154491|NCT01298362|3790812|P1|Overall Study|Did not provide 12month BMD measurements|38
1154492|NCT01298323|3790832|P2|Overall Study|Eligibility criteria not fulfilled|1
1154493|NCT01298323|3790833|P1|Overall Study|Eligibility criteria not fulfilled|0
1154494|NCT01298323|3790832|P2|Overall Study|Ongoing|55
1154495|NCT01298323|3790833|P1|Overall Study|Ongoing|55
1154496|NCT01298323|3790832|P2|Overall Study|Other|9
1154497|NCT01298323|3790833|P1|Overall Study|Other|10
1154498|NCT01298323|3790832|P2|Overall Study|Protocol Violation|0
1154499|NCT01298323|3790833|P1|Overall Study|Protocol Violation|1
1154500|NCT01298323|3790832|P2|Overall Study|Withdrawal by Subject|3
1154501|NCT01298323|3790833|P1|Overall Study|Withdrawal by Subject|6
1154502|NCT01298323|3790832|P2|Overall Study|Lost to Follow-up|0
1154503|NCT01298323|3790833|P1|Overall Study|Lost to Follow-up|1
1154504|NCT01298323|3790832|P2|Overall Study|Death|16
1154505|NCT01298323|3790833|P1|Overall Study|Death|11
1154506|NCT01298323|3790832|P2|Overall Study|Adverse Event|4
1154507|NCT01298323|3790833|P1|Overall Study|Adverse Event|2
1154508|NCT01297920|3790896|P3|Overall Study|Patient Did Not Meet Entrance Criteria|0
1154509|NCT01297920|3790897|P2|Overall Study|Patient Did Not Meet Entrance Criteria|0
1154510|NCT01297920|3790898|P1|Overall Study|Patient Did Not Meet Entrance Criteria|1
1154511|NCT01297920|3790896|P3|Overall Study|Inadequate Control of IOP|17
1154512|NCT01297920|3790897|P2|Overall Study|Inadequate Control of IOP|9
1154513|NCT01297920|3790898|P1|Overall Study|Inadequate Control of IOP|7
1154514|NCT01297920|3790896|P3|Overall Study|Protocol Violation|0
1154515|NCT01297920|3790897|P2|Overall Study|Protocol Violation|3
1154516|NCT01297920|3790898|P1|Overall Study|Protocol Violation|1
1154517|NCT01297920|3790896|P3|Overall Study|Noncompliance|0
1154518|NCT01297920|3790897|P2|Overall Study|Noncompliance|0
1154519|NCT01297920|3790898|P1|Overall Study|Noncompliance|1
1154520|NCT01297920|3790896|P3|Overall Study|Patient Decision Unrelated to AE|2
1154521|NCT01297920|3790897|P2|Overall Study|Patient Decision Unrelated to AE|5
1154522|NCT01297920|3790898|P1|Overall Study|Patient Decision Unrelated to AE|6
1154523|NCT01297920|3790896|P3|Overall Study|Adverse Event|38
1154524|NCT01297920|3790897|P2|Overall Study|Adverse Event|10
1154525|NCT01297920|3790898|P1|Overall Study|Adverse Event|42
1154526|NCT01297517|3790942|P3|Overall Study|Inadequate Control of IOP|2
1154527|NCT01297517|3790943|P2|Overall Study|Inadequate Control of IOP|1
1154528|NCT01297517|3790944|P1|Overall Study|Inadequate Control of IOP|1
1154529|NCT01297517|3790942|P3|Overall Study|Protocol Violation|1
1154530|NCT01297517|3790943|P2|Overall Study|Protocol Violation|1
1154531|NCT01297517|3790944|P1|Overall Study|Protocol Violation|1
1154532|NCT01297517|3790942|P3|Overall Study|Noncompliance|0
1154533|NCT01297517|3790943|P2|Overall Study|Noncompliance|0
1154534|NCT01297517|3790944|P1|Overall Study|Noncompliance|1
1154535|NCT01297517|3790942|P3|Overall Study|Patient Decision Unrelated to AE|7
1154536|NCT01297517|3790943|P2|Overall Study|Patient Decision Unrelated to AE|3
1154537|NCT01297517|3790944|P1|Overall Study|Patient Decision Unrelated to AE|2
1154538|NCT01297517|3790942|P3|Overall Study|Lost to Follow-up|1
1154539|NCT01297517|3790943|P2|Overall Study|Lost to Follow-up|0
1154540|NCT01297517|3790944|P1|Overall Study|Lost to Follow-up|1
1154541|NCT01297517|3790942|P3|Overall Study|Adverse Event|16
1154542|NCT01297517|3790943|P2|Overall Study|Adverse Event|7
1154543|NCT01297517|3790944|P1|Overall Study|Adverse Event|21
1154544|NCT01297504|3790952|P1|Overall Study|Protocol Violation|3
1154545|NCT01297504|3790952|P1|Overall Study|Site Closure|3
1154546|NCT01297504|3790952|P1|Overall Study|Withdrawal by Subject|9
1154547|NCT01297504|3790952|P1|Overall Study|Lost to Follow-up|43
1154548|NCT01297504|3790952|P1|Overall Study|Death|3
1154549|NCT01297504|3790952|P1|Overall Study|No Study Visits|4
1154550|NCT01297504|3790952|P1|Overall Study|Received Palivizumab in Previous Season|1
1154551|NCT01297504|3790952|P1|Overall Study|Invalid Consent|1
1154552|NCT01297491|3790966|P2|Overall Study|Death|1
1154553|NCT01297491|3790967|P1|Overall Study|Death|2
1154554|NCT01297491|3790966|P2|Overall Study|Patient/Guardian decision|4
1154555|NCT01297491|3790967|P1|Overall Study|Patient/Guardian decision|3
1154556|NCT01297491|3790966|P2|Overall Study|Progressive disease|20
1154557|NCT01297491|3790967|P1|Overall Study|Progressive disease|11
1154558|NCT01297491|3790966|P2|Overall Study|Physician Decision|2
1154559|NCT01297491|3790967|P1|Overall Study|Physician Decision|3
1154560|NCT01297491|3790966|P2|Overall Study|Adverse Event|6
1154561|NCT01297491|3790967|P1|Overall Study|Adverse Event|11
1154562|NCT01297465|3790985|P2|Overall Study|Intention to Freeze all Embryos|1
1154563|NCT01297465|3790986|P1|Overall Study|Intention to Freeze all Embryos|0
1154564|NCT01297465|3790985|P2|Overall Study|All Embryos Discarded|1
1154565|NCT01297465|3790986|P1|Overall Study|All Embryos Discarded|0
1154566|NCT01297465|3790985|P2|Overall Study|No Fertilization|4
1154567|NCT01297465|3790986|P1|Overall Study|No Fertilization|6
1154568|NCT01297465|3790985|P2|Overall Study|Poor oocyte quality|1
1154569|NCT01297465|3790986|P1|Overall Study|Poor oocyte quality|0
1154570|NCT01297465|3790985|P2|Overall Study|No Oocytes Retrieved|1
1154571|NCT01297465|3790986|P1|Overall Study|No Oocytes Retrieved|1
1154572|NCT01297465|3790985|P2|Overall Study|Ovarian hyperstimulation syndrome risk|1
1154573|NCT01297465|3790986|P1|Overall Study|Ovarian hyperstimulation syndrome risk|0
1154574|NCT01297465|3790985|P2|Overall Study|Lack of Ovarian Response|1
1154575|NCT01297465|3790986|P1|Overall Study|Lack of Ovarian Response|1
1154576|NCT01297322|3791039|P2|Overall Study|Withdrawal by Subject|1
1154577|NCT01297322|3791040|P1|Overall Study|Withdrawal by Subject|0
1154578|NCT01297322|3791039|P2|Overall Study|Lost to Follow-up|0
1154579|NCT01297322|3791040|P1|Overall Study|Lost to Follow-up|1
1154580|NCT01297270|3791068|P3|Overall Study|Not treated|0
1154581|NCT01297270|3791069|P2|Overall Study|Not treated|1
1154582|NCT01297270|3791070|P1|Overall Study|Not treated|0
1154583|NCT01297270|3791068|P3|Overall Study|Other reason not defined above|1
1154584|NCT01297270|3791069|P2|Overall Study|Other reason not defined above|3
1154585|NCT01297270|3791070|P1|Overall Study|Other reason not defined above|3
1154586|NCT01297270|3791068|P3|Overall Study|Withdrawal by Subject|7
1154587|NCT01297270|3791069|P2|Overall Study|Withdrawal by Subject|15
1154588|NCT01297270|3791070|P1|Overall Study|Withdrawal by Subject|7
1154589|NCT01297270|3791068|P3|Overall Study|Protocol Violation|0
1154590|NCT01297270|3791069|P2|Overall Study|Protocol Violation|2
1154591|NCT01297270|3791070|P1|Overall Study|Protocol Violation|0
1154592|NCT01297270|3791068|P3|Overall Study|Lost to Follow-up|1
1154593|NCT01297270|3791069|P2|Overall Study|Lost to Follow-up|2
1154594|NCT01297270|3791070|P1|Overall Study|Lost to Follow-up|1
1154595|NCT01297270|3791068|P3|Overall Study|Lack of Efficacy|15
1154596|NCT01297270|3791069|P2|Overall Study|Lack of Efficacy|17
1154597|NCT01297270|3791070|P1|Overall Study|Lack of Efficacy|15
1154598|NCT01297270|3791068|P3|Overall Study|Adverse Event|5
1154599|NCT01297270|3791069|P2|Overall Study|Adverse Event|32
1154600|NCT01297270|3791070|P1|Overall Study|Adverse Event|19
1154601|NCT01297062|3791119|P7|Overall Study|Subject Decision|2
1154602|NCT01297062|3791120|P6|Overall Study|Subject Decision|1
1154603|NCT01297062|3791121|P5|Overall Study|Subject Decision|1
1154604|NCT01297062|3791122|P4|Overall Study|Subject Decision|1
1154605|NCT01297062|3791123|P3|Overall Study|Subject Decision|0
1154606|NCT01297062|3791124|P2|Overall Study|Subject Decision|1
1154607|NCT01297062|3791125|P1|Overall Study|Subject Decision|1
1154608|NCT01297062|3791119|P7|Overall Study|Protocol Violation|0
1154609|NCT01297062|3791120|P6|Overall Study|Protocol Violation|0
1154610|NCT01297062|3791121|P5|Overall Study|Protocol Violation|1
1154611|NCT01297062|3791122|P4|Overall Study|Protocol Violation|0
1154612|NCT01297062|3791123|P3|Overall Study|Protocol Violation|0
1154613|NCT01297062|3791124|P2|Overall Study|Protocol Violation|0
1154614|NCT01297062|3791125|P1|Overall Study|Protocol Violation|0
1154615|NCT01297062|3791119|P7|Overall Study|Physician Decision|6
1154616|NCT01297062|3791120|P6|Overall Study|Physician Decision|0
1154617|NCT01297062|3791121|P5|Overall Study|Physician Decision|0
1154618|NCT01297062|3791122|P4|Overall Study|Physician Decision|0
1154619|NCT01297062|3791123|P3|Overall Study|Physician Decision|1
1154620|NCT01297062|3791124|P2|Overall Study|Physician Decision|0
1154621|NCT01297062|3791125|P1|Overall Study|Physician Decision|1
1154622|NCT01297062|3791119|P7|Overall Study|Adverse Event|0
1154623|NCT01297062|3791120|P6|Overall Study|Adverse Event|0
1154624|NCT01297062|3791121|P5|Overall Study|Adverse Event|0
1154625|NCT01297062|3791122|P4|Overall Study|Adverse Event|0
1154626|NCT01297062|3791123|P3|Overall Study|Adverse Event|1
1154627|NCT01297062|3791124|P2|Overall Study|Adverse Event|0
1154628|NCT01297062|3791125|P1|Overall Study|Adverse Event|2
1154629|NCT01296698|3791187|P2|Overall Study|Study Terminated by Sponsor|12
1154630|NCT01296698|3791188|P1|Overall Study|Study Terminated by Sponsor|209
1154631|NCT01296698|3791187|P2|Overall Study|Difficulty Contacting Subject|0
1154632|NCT01296698|3791188|P1|Overall Study|Difficulty Contacting Subject|2
1154633|NCT01296698|3791187|P2|Overall Study|Withdrawal by Subject|0
1154634|NCT01296698|3791188|P1|Overall Study|Withdrawal by Subject|12
1154635|NCT01296698|3791187|P2|Overall Study|Lost to Follow-up|1
1154636|NCT01296698|3791188|P1|Overall Study|Lost to Follow-up|19
1154637|NCT01296698|3791187|P2|Overall Study|Death|0
1154638|NCT01296698|3791188|P1|Overall Study|Death|1
1154639|NCT01296698|3791187|P2|Overall Study|Adverse Event|0
1154640|NCT01296698|3791188|P1|Overall Study|Adverse Event|1
1154641|NCT01296672|3791242|P2|Overall Study|Lost to Follow-up|18
1154642|NCT01296672|3791243|P1|Overall Study|Lost to Follow-up|73
1154643|NCT01296568|3791264|P1|Continued Access Phase|Disease Progression|1
1154644|NCT01296568|3791264|P1|Continued Access Phase|Withdrawal by Subject|1
1154645|NCT01296568|3791264|P1|Continued Access Phase|Lost to Follow-up|1
1154646|NCT01296412|3791280|P2|Overall Study|Withdrawal by Subject|13
1154647|NCT01296412|3791281|P1|Overall Study|Withdrawal by Subject|10
1154648|NCT01296412|3791280|P2|Overall Study|Pregnancy|1
1154649|NCT01296412|3791281|P1|Overall Study|Pregnancy|0
1154650|NCT01296412|3791280|P2|Overall Study|Physician Decision|3
1154651|NCT01296412|3791281|P1|Overall Study|Physician Decision|1
1154652|NCT01296412|3791280|P2|Overall Study|Other reason not specified|15
1154653|NCT01296412|3791281|P1|Overall Study|Other reason not specified|20
1154654|NCT01296412|3791280|P2|Overall Study|Non-compliance with study drug|2
1154655|NCT01296412|3791281|P1|Overall Study|Non-compliance with study drug|1
1154656|NCT01296412|3791280|P2|Overall Study|Lost to Follow-up|7
1154657|NCT01296412|3791281|P1|Overall Study|Lost to Follow-up|10
1154658|NCT01296412|3791280|P2|Overall Study|Lack of Efficacy|0
1154659|NCT01296412|3791281|P1|Overall Study|Lack of Efficacy|1
1154660|NCT01296412|3791280|P2|Overall Study|Adverse Event|29
1154661|NCT01296412|3791281|P1|Overall Study|Adverse Event|8
1154662|NCT01296152|3791311|P1|Overall Study|Unwilling to adhere to study requirement|1
1154663|NCT01296035|3791338|P1|Overall Study|Withdrawal by Subject|1
1154664|NCT01295905|3791345|P2|Overall Study|Met exclusion criteria|0
1154665|NCT01295905|3791346|P1|Overall Study|Met exclusion criteria|1
1154666|NCT01295905|3791345|P2|Overall Study|Did not meet inclusion criteria|0
1154667|NCT01295905|3791346|P1|Overall Study|Did not meet inclusion criteria|1
1154668|NCT01295814|3791380|P2|Overall Study|Withdrawal by Subject|0
1154669|NCT01295814|3791381|P1|Overall Study|Withdrawal by Subject|2
1154670|NCT01295814|3791380|P2|Overall Study|Lack of Efficacy|2
1154671|NCT01295814|3791381|P1|Overall Study|Lack of Efficacy|0
1154672|NCT01295671|3791398|P3|Overall Study|Withdrawal by Subject|0
1154673|NCT01295671|3791399|P2|Overall Study|Withdrawal by Subject|1
1154674|NCT01295671|3791400|P1|Overall Study|Withdrawal by Subject|3
1154675|NCT01295671|3791398|P3|Overall Study|Lost to Follow-up|3
1154676|NCT01295671|3791399|P2|Overall Study|Lost to Follow-up|6
1154677|NCT01295671|3791400|P1|Overall Study|Lost to Follow-up|4
1154678|NCT01295320|3791438|P1|Overall Study|Unable to travel|1
1154679|NCT01295320|3791438|P1|Overall Study|Subject was bedridden|1
1154680|NCT01295320|3791438|P1|Overall Study|Withdrawal by Subject|2
1154681|NCT01295320|3791438|P1|Overall Study|Lost to Follow-up|4
1154682|NCT01295320|3791438|P1|Overall Study|Adverse Event|2
1154683|NCT01295281|3791455|P2|First Intervention (7 Days)|Death|1
1154684|NCT01295281|3791456|P1|First Intervention (7 Days)|Death|0
1154685|NCT01295034|3791494|P2|Overall Study|Lost to Follow-up|5
1154686|NCT01295034|3791495|P1|Overall Study|Lost to Follow-up|5
1154687|NCT01294917|3791503|P1|Overall Study|Inconvenience|1
1154688|NCT01294917|3791503|P1|Overall Study|Relocation|5
1154689|NCT01294800|3791513|P4|Overall Study|Did Not Meet Protocol Eligibility|0
1154690|NCT01294800|3791514|P3|Overall Study|Did Not Meet Protocol Eligibility|1
1154691|NCT01294800|3791515|P2|Overall Study|Did Not Meet Protocol Eligibility|1
1154692|NCT01294800|3791516|P1|Overall Study|Did Not Meet Protocol Eligibility|2
1154693|NCT01294800|3791513|P4|Overall Study|Non-compliance With Protocol|0
1154694|NCT01294800|3791514|P3|Overall Study|Non-compliance With Protocol|1
1154695|NCT01294800|3791515|P2|Overall Study|Non-compliance With Protocol|1
1154696|NCT01294800|3791516|P1|Overall Study|Non-compliance With Protocol|0
1154697|NCT01294800|3791513|P4|Overall Study|Lost to Follow-up|0
1154698|NCT01294800|3791514|P3|Overall Study|Lost to Follow-up|1
1154699|NCT01294800|3791515|P2|Overall Study|Lost to Follow-up|0
1154700|NCT01294800|3791516|P1|Overall Study|Lost to Follow-up|0
1154701|NCT01294800|3791513|P4|Overall Study|Subject Withdrew Consent|11
1154702|NCT01294800|3791514|P3|Overall Study|Subject Withdrew Consent|2
1154703|NCT01294800|3791515|P2|Overall Study|Subject Withdrew Consent|2
1154704|NCT01294800|3791516|P1|Overall Study|Subject Withdrew Consent|2
1154705|NCT01294800|3791513|P4|Overall Study|Adverse Event|5
1154706|NCT01294800|3791514|P3|Overall Study|Adverse Event|12
1154707|NCT01294800|3791515|P2|Overall Study|Adverse Event|6
1154708|NCT01294800|3791516|P1|Overall Study|Adverse Event|7
1154709|NCT01294787|3791542|P6|Period 3|Adverse Event|0
1154710|NCT01294787|3791543|P5|Period 3|Adverse Event|1
1154711|NCT01294787|3791544|P4|Period 3|Adverse Event|0
1154712|NCT01294787|3791545|P3|Period 3|Adverse Event|0
1154713|NCT01294787|3791546|P2|Period 3|Adverse Event|0
1154714|NCT01294787|3791547|P1|Period 3|Adverse Event|0
1154715|NCT01294787|3791542|P6|Period 2|No longer needs study drug|0
1154716|NCT01294787|3791543|P5|Period 2|No longer needs study drug|0
1154717|NCT01294787|3791544|P4|Period 2|No longer needs study drug|1
1154718|NCT01294787|3791545|P3|Period 2|No longer needs study drug|0
1154719|NCT01294787|3791546|P2|Period 2|No longer needs study drug|0
1154720|NCT01294787|3791547|P1|Period 2|No longer needs study drug|0
1154721|NCT01294787|3791542|P6|Period 2|Adverse Event|0
1154722|NCT01294787|3791543|P5|Period 2|Adverse Event|0
1154723|NCT01294787|3791544|P4|Period 2|Adverse Event|1
1154724|NCT01294787|3791545|P3|Period 2|Adverse Event|0
1154725|NCT01294787|3791546|P2|Period 2|Adverse Event|3
1154726|NCT01294787|3791547|P1|Period 2|Adverse Event|0
1154727|NCT01294787|3791542|P6|Period 1|Administrative problem|1
1154728|NCT01294787|3791543|P5|Period 1|Administrative problem|0
1154729|NCT01294787|3791544|P4|Period 1|Administrative problem|0
1154730|NCT01294787|3791545|P3|Period 1|Administrative problem|1
1154731|NCT01294787|3791546|P2|Period 1|Administrative problem|0
1154732|NCT01294787|3791547|P1|Period 1|Administrative problem|0
1154733|NCT01294787|3791542|P6|Period 1|Withdrawal by Subject|1
1154734|NCT01294787|3791543|P5|Period 1|Withdrawal by Subject|1
1154735|NCT01294787|3791544|P4|Period 1|Withdrawal by Subject|1
1154736|NCT01294787|3791545|P3|Period 1|Withdrawal by Subject|0
1154737|NCT01294787|3791546|P2|Period 1|Withdrawal by Subject|0
1154738|NCT01294787|3791547|P1|Period 1|Withdrawal by Subject|0
1154739|NCT01294787|3791542|P6|Period 1|Adverse Event|0
1154740|NCT01294787|3791543|P5|Period 1|Adverse Event|1
1154741|NCT01294787|3791544|P4|Period 1|Adverse Event|0
1154742|NCT01294787|3791545|P3|Period 1|Adverse Event|0
1154743|NCT01294787|3791546|P2|Period 1|Adverse Event|0
1154744|NCT01294787|3791547|P1|Period 1|Adverse Event|0
1154745|NCT01294696|3791638|P1|Overall Study|Site closure|52
1154746|NCT01294696|3791638|P1|Overall Study|Missing BPI Response|7
1154747|NCT01294696|3791638|P1|Overall Study|Protocol Violation|8
1154748|NCT01294696|3791638|P1|Overall Study|Screening failures|7
1154749|NCT01294683|3791652|P2|Post Crossover (Period III)|Withdrawal by Subject|2
1154750|NCT01294683|3791653|P1|Post Crossover (Period III)|Withdrawal by Subject|3
1154751|NCT01294683|3791652|P2|Post Crossover (Period III)|Study Terminated by Sponsor|21
1154752|NCT01294683|3791653|P1|Post Crossover (Period III)|Study Terminated by Sponsor|23
1154753|NCT01294683|3791652|P2|Post Crossover (Period III)|Lost to Follow-up|3
1154754|NCT01294683|3791653|P1|Post Crossover (Period III)|Lost to Follow-up|1
1154755|NCT01294683|3791652|P2|Post Crossover (Period III)|Adverse Event|6
1154756|NCT01294683|3791653|P1|Post Crossover (Period III)|Adverse Event|6
1154757|NCT01294683|3791652|P2|Precrossover (Periods I/II)|Withdrawal by Subject|9
1154758|NCT01294683|3791653|P1|Precrossover (Periods I/II)|Withdrawal by Subject|11
1154759|NCT01294683|3791652|P2|Precrossover (Periods I/II)|Technical Problems|1
1154760|NCT01294683|3791653|P1|Precrossover (Periods I/II)|Technical Problems|0
1154761|NCT01294683|3791652|P2|Precrossover (Periods I/II)|Study Terminated by Sponsor|192
1154762|NCT01294683|3791653|P1|Precrossover (Periods I/II)|Study Terminated by Sponsor|187
1154763|NCT01294683|3791652|P2|Precrossover (Periods I/II)|Protocol Violation|5
1154764|NCT01294683|3791653|P1|Precrossover (Periods I/II)|Protocol Violation|5
1154765|NCT01294683|3791652|P2|Precrossover (Periods I/II)|Physician Decision|0
1154766|NCT01294683|3791653|P1|Precrossover (Periods I/II)|Physician Decision|1
1154767|NCT01294683|3791652|P2|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
1154768|NCT01294683|3791653|P1|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
1154769|NCT01294683|3791652|P2|Precrossover (Periods I/II)|Lost to Follow-up|6
1154770|NCT01294683|3791653|P1|Precrossover (Periods I/II)|Lost to Follow-up|3
1154771|NCT01294683|3791652|P2|Precrossover (Periods I/II)|Adverse Event|52
1154772|NCT01294683|3791653|P1|Precrossover (Periods I/II)|Adverse Event|49
1154773|NCT01294644|3791706|P3|Overall Study|Miscellaneous Reason|4
1154774|NCT01294644|3791707|P2|Overall Study|Miscellaneous Reason|1
1154775|NCT01294644|3791708|P1|Overall Study|Miscellaneous Reason|2
1154776|NCT01294644|3791706|P3|Overall Study|Lost to Follow-up|5
1154777|NCT01294644|3791707|P2|Overall Study|Lost to Follow-up|2
1154778|NCT01294644|3791708|P1|Overall Study|Lost to Follow-up|3
1154779|NCT01294644|3791706|P3|Overall Study|Withdrawal by Subject|4
1154780|NCT01294644|3791707|P2|Overall Study|Withdrawal by Subject|7
1154781|NCT01294644|3791708|P1|Overall Study|Withdrawal by Subject|3
1154782|NCT01294644|3791706|P3|Overall Study|Adverse Event|1
1154783|NCT01294644|3791707|P2|Overall Study|Adverse Event|0
1154784|NCT01294644|3791708|P1|Overall Study|Adverse Event|2
1154785|NCT01294592|3791739|P2|Overall Study|Withdrawal by Subject|28
1154786|NCT01294592|3791740|P1|Overall Study|Withdrawal by Subject|28
1154787|NCT01294592|3791739|P2|Overall Study|Physician Decision|11
1154788|NCT01294592|3791740|P1|Overall Study|Physician Decision|6
1154789|NCT01294592|3791739|P2|Overall Study|Lost to Follow-up|9
1154790|NCT01294592|3791740|P1|Overall Study|Lost to Follow-up|7
1154791|NCT01294592|3791739|P2|Overall Study|Protocol Violation|7
1154792|NCT01294592|3791740|P1|Overall Study|Protocol Violation|1
1154793|NCT01294592|3791739|P2|Overall Study|Lack of Efficacy|5
1154794|NCT01294592|3791740|P1|Overall Study|Lack of Efficacy|7
1154795|NCT01294592|3791739|P2|Overall Study|Adverse Event|13
1154796|NCT01294592|3791740|P1|Overall Study|Adverse Event|28
1154797|NCT01294579|3791768|P1|Overall Study|Withdrawal by Subject|5
1154798|NCT01294579|3791768|P1|Overall Study|Physician Decision|3
1154799|NCT01294579|3791768|P1|Overall Study|Lost to Follow-up|1
1154800|NCT01294579|3791768|P1|Overall Study|Study closed/terminated|3
1154801|NCT01294579|3791768|P1|Overall Study|Adverse Event|11
1154802|NCT01294579|3791768|P1|Overall Study|Disease progression|12
1154803|NCT01294553|3791778|P1|Overall Study|Protocol Violation|268
1154804|NCT01294553|3791778|P1|Overall Study|Duplicated Participants|1
1154805|NCT01294514|3791784|P1|Overall Study|Excluded due to Arrhythmia|1
1154806|NCT01294462|3791794|P2|Overall Study|Withdrawal by Subject|63
1154807|NCT01294462|3791795|P1|Overall Study|Withdrawal by Subject|65
1154808|NCT01294462|3791794|P2|Overall Study|Lost to Follow-up|0
1154809|NCT01294462|3791795|P1|Overall Study|Lost to Follow-up|1
1154810|NCT01294449|3791809|P2|Overall Study|Withdrawal by Subject|3
1154811|NCT01294449|3791810|P1|Overall Study|Withdrawal by Subject|1
1154812|NCT01294449|3791809|P2|Overall Study|Death|12
1154813|NCT01294449|3791810|P1|Overall Study|Death|11
1154814|NCT01294436|3791818|P2|Overall Study|poor/non-compliance|5
1154815|NCT01294436|3791819|P1|Overall Study|poor/non-compliance|2
1154816|NCT01294436|3791818|P2|Overall Study|subject no longer meets study criteria|20
1154817|NCT01294436|3791819|P1|Overall Study|subject no longer meets study criteria|5
1154818|NCT01294436|3791818|P2|Overall Study|Withdrawal by Subject|28
1154819|NCT01294436|3791819|P1|Overall Study|Withdrawal by Subject|11
1154820|NCT01294436|3791818|P2|Overall Study|Adverse Event|17
1154821|NCT01294436|3791819|P1|Overall Study|Adverse Event|10
1154822|NCT01294423|3791854|P3|Overall Study|poor/non-compliance|1
1154823|NCT01294423|3791855|P2|Overall Study|poor/non-compliance|0
1154824|NCT01294423|3791856|P1|Overall Study|poor/non-compliance|1
1154825|NCT01294423|3791854|P3|Overall Study|subject no longer meets study criteria|2
1154826|NCT01294423|3791855|P2|Overall Study|subject no longer meets study criteria|5
1154827|NCT01294423|3791856|P1|Overall Study|subject no longer meets study criteria|2
1154828|NCT01294423|3791854|P3|Overall Study|Withdrawal by Subject|2
1154829|NCT01294423|3791855|P2|Overall Study|Withdrawal by Subject|2
1154830|NCT01294423|3791856|P1|Overall Study|Withdrawal by Subject|1
1154831|NCT01294423|3791854|P3|Overall Study|Adverse Event|3
1154832|NCT01294423|3791855|P2|Overall Study|Adverse Event|2
1154833|NCT01294423|3791856|P1|Overall Study|Adverse Event|1
1154834|NCT01294397|3791870|P1|Overall Study|Administrative Decision|1
1154835|NCT01294397|3791870|P1|Overall Study|Withdrawal by Subject|1
1154836|NCT01294371|3791914|P1|Overall Study|Other|14
1154837|NCT01294371|3791914|P1|Overall Study|Administrative Reason|1
1154838|NCT01294371|3791914|P1|Overall Study|Lost to Follow-up|6
1154839|NCT01294371|3791914|P1|Overall Study|Withdrawal by Subject|12
1154840|NCT01294371|3791914|P1|Overall Study|Adverse Event|1
1154841|NCT01294358|3791922|P5|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1
1154842|NCT01294358|3791923|P4|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
1154843|NCT01294358|3791924|P3|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
1154844|NCT01294358|3791925|P2|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
1154845|NCT01294358|3791926|P1|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
1154846|NCT01294358|3791922|P5|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
1154847|NCT01294358|3791923|P4|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1
1154848|NCT01294358|3791924|P3|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
1154849|NCT01294358|3791925|P2|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
1154850|NCT01294358|3791926|P1|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
1154851|NCT01294358|3791922|P5|Cohort 3: 12/1/11-10/6/12|Disease progression|0
1154852|NCT01294358|3791923|P4|Cohort 3: 12/1/11-10/6/12|Disease progression|0
1154853|NCT01294358|3791924|P3|Cohort 3: 12/1/11-10/6/12|Disease progression|2
1154854|NCT01294358|3791925|P2|Cohort 3: 12/1/11-10/6/12|Disease progression|0
1154855|NCT01294358|3791926|P1|Cohort 3: 12/1/11-10/6/12|Disease progression|0
1154856|NCT01294358|3791922|P5|Cohort 2: 6/9/11-9/17/12|Disease progression|0
1154857|NCT01294358|3791923|P4|Cohort 2: 6/9/11-9/17/12|Disease progression|0
1154858|NCT01294358|3791924|P3|Cohort 2: 6/9/11-9/17/12|Disease progression|0
1154859|NCT01294358|3791925|P2|Cohort 2: 6/9/11-9/17/12|Disease progression|2
1154860|NCT01294358|3791926|P1|Cohort 2: 6/9/11-9/17/12|Disease progression|0
1154861|NCT01294150|3792054|P2|Overall Study|Physician Decision|2
1154862|NCT01294150|3792055|P1|Overall Study|Physician Decision|2
1154863|NCT01294046|3792084|P1|Overall Study|Stimulation response inadqequate|1
1154864|NCT01294046|3792084|P1|Overall Study|Eligibility criteria expanded|1
1154865|NCT01294046|3792084|P1|Overall Study|Infection and surgical explant|1
1154866|NCT01293968|3792099|P2|Overall Study|non-cooperation|3
1154867|NCT01293968|3792100|P1|Overall Study|non-cooperation|3
1154868|NCT01293695|3792120|P2|Overall Study|Lost to Follow-up|6
1154869|NCT01293695|3792121|P1|Overall Study|Lost to Follow-up|8
1154870|NCT01293695|3792120|P2|Overall Study|Withdrawal by Subject|1
1154871|NCT01293695|3792121|P1|Overall Study|Withdrawal by Subject|7
1154872|NCT01293539|3792135|P1|Overall Study|Physician Decision|1
1154873|NCT01293240|3792139|P1|Overall Study|Noncompliance|2
1154874|NCT01293084|3792154|P1|Overall Study|Withdrawal by Subject|2
1154875|NCT01293084|3792154|P1|Overall Study|Physician Decision|3
1154876|NCT01293032|3792166|P4|Treatment|Disease Progression, relapse|0
1154877|NCT01293032|3792167|P3|Treatment|Disease Progression, relapse|0
1154878|NCT01293032|3792168|P2|Treatment|Disease Progression, relapse|1
1154879|NCT01293032|3792169|P1|Treatment|Disease Progression, relapse|0
1154880|NCT01293032|3792166|P4|Treatment|Withdrawal by Subject|0
1154881|NCT01293032|3792167|P3|Treatment|Withdrawal by Subject|0
1154882|NCT01293032|3792168|P2|Treatment|Withdrawal by Subject|4
1154883|NCT01293032|3792169|P1|Treatment|Withdrawal by Subject|2
1154884|NCT01293032|3792166|P4|Treatment|Adverse Event|1
1154885|NCT01293032|3792167|P3|Treatment|Adverse Event|1
1154886|NCT01293032|3792168|P2|Treatment|Adverse Event|0
1154887|NCT01293032|3792169|P1|Treatment|Adverse Event|0
1154888|NCT01293032|3792166|P4|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
1154889|NCT01293032|3792167|P3|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5
1154890|NCT01293032|3792168|P2|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
1154891|NCT01293032|3792169|P1|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
1154892|NCT01293006|3792180|P4|Period 2|Lost to Follow-up|0
1154893|NCT01293006|3792181|P3|Period 2|Lost to Follow-up|0
1154894|NCT01293006|3792182|P2|Period 2|Lost to Follow-up|0
1154895|NCT01293006|3792183|P1|Period 2|Lost to Follow-up|1
1154896|NCT01292928|3792204|P1|Overall Study|Physician Decision|2
1154897|NCT01292928|3792204|P1|Overall Study|Lost to Follow-up|6
1154898|NCT01292928|3792204|P1|Overall Study|Withdrawal by Subject|8
1154899|NCT01292928|3792204|P1|Overall Study|Death|8
1154900|NCT01292876|3792221|P1|Overall Study|Physician Decision|4
1154901|NCT01292837|3792227|P1|Overall Study|Further treatment determined|1
1154902|NCT01292837|3792227|P1|Overall Study|Adverse Event|1
1154903|NCT01292603|3792264|P6|Overall Survival Status|Death|10
1154904|NCT01292603|3792265|P5|Overall Survival Status|Death|16
1154905|NCT01292603|3792266|P4|Overall Survival Status|Death|1
1154906|NCT01292603|3792267|P3|Overall Survival Status|Death|3
1154907|NCT01292603|3792268|P2|Overall Survival Status|Death|1
1154908|NCT01292603|3792269|P1|Overall Survival Status|Death|3
1154909|NCT01292603|3792264|P6|Part 2: Regular Follow-Up|Adverse Event|2
1154910|NCT01292603|3792265|P5|Part 2: Regular Follow-Up|Adverse Event|2
1154911|NCT01292603|3792266|P4|Part 2: Regular Follow-Up|Adverse Event|0
1154912|NCT01292603|3792267|P3|Part 2: Regular Follow-Up|Adverse Event|0
1154913|NCT01292603|3792268|P2|Part 2: Regular Follow-Up|Adverse Event|0
1154914|NCT01292603|3792269|P1|Part 2: Regular Follow-Up|Adverse Event|0
1154915|NCT01292603|3792264|P6|Part 2: Regular Follow-Up|Lost to Follow-up|1
1154916|NCT01292603|3792265|P5|Part 2: Regular Follow-Up|Lost to Follow-up|1
1154917|NCT01292603|3792266|P4|Part 2: Regular Follow-Up|Lost to Follow-up|0
1154918|NCT01292603|3792267|P3|Part 2: Regular Follow-Up|Lost to Follow-up|0
1154919|NCT01292603|3792268|P2|Part 2: Regular Follow-Up|Lost to Follow-up|0
1154920|NCT01292603|3792269|P1|Part 2: Regular Follow-Up|Lost to Follow-up|0
1154921|NCT01292603|3792264|P6|Part 2: Regular Follow-Up|Physician Decision|0
1154922|NCT01292603|3792265|P5|Part 2: Regular Follow-Up|Physician Decision|2
1154923|NCT01292603|3792266|P4|Part 2: Regular Follow-Up|Physician Decision|0
1154924|NCT01292603|3792267|P3|Part 2: Regular Follow-Up|Physician Decision|0
1154925|NCT01292603|3792268|P2|Part 2: Regular Follow-Up|Physician Decision|0
1154926|NCT01292603|3792269|P1|Part 2: Regular Follow-Up|Physician Decision|0
1154927|NCT01292603|3792264|P6|Part 2: Regular Follow-Up|Protocol Violation|0
1154928|NCT01292603|3792265|P5|Part 2: Regular Follow-Up|Protocol Violation|2
1154929|NCT01292603|3792266|P4|Part 2: Regular Follow-Up|Protocol Violation|0
1154930|NCT01292603|3792267|P3|Part 2: Regular Follow-Up|Protocol Violation|0
1154931|NCT01292603|3792268|P2|Part 2: Regular Follow-Up|Protocol Violation|0
1154932|NCT01292603|3792269|P1|Part 2: Regular Follow-Up|Protocol Violation|0
1154933|NCT01292603|3792264|P6|Part 2: Regular Follow-Up|Withdrawal by Subject|1
1154934|NCT01292603|3792265|P5|Part 2: Regular Follow-Up|Withdrawal by Subject|0
1154935|NCT01292603|3792266|P4|Part 2: Regular Follow-Up|Withdrawal by Subject|0
1154936|NCT01292603|3792267|P3|Part 2: Regular Follow-Up|Withdrawal by Subject|0
1154937|NCT01292603|3792268|P2|Part 2: Regular Follow-Up|Withdrawal by Subject|0
1154938|NCT01292603|3792269|P1|Part 2: Regular Follow-Up|Withdrawal by Subject|0
1154939|NCT01292603|3792264|P6|Part 2: Regular Follow-Up|Noncompliance|0
1154940|NCT01292603|3792265|P5|Part 2: Regular Follow-Up|Noncompliance|1
1154941|NCT01292603|3792266|P4|Part 2: Regular Follow-Up|Noncompliance|0
1154942|NCT01292603|3792267|P3|Part 2: Regular Follow-Up|Noncompliance|0
1154943|NCT01292603|3792268|P2|Part 2: Regular Follow-Up|Noncompliance|0
1154944|NCT01292603|3792269|P1|Part 2: Regular Follow-Up|Noncompliance|0
1154945|NCT01292603|3792264|P6|Part 2: Regular Follow-Up|Disease Progression|5
1154946|NCT01292603|3792265|P5|Part 2: Regular Follow-Up|Disease Progression|5
1154947|NCT01292603|3792266|P4|Part 2: Regular Follow-Up|Disease Progression|0
1154948|NCT01292603|3792267|P3|Part 2: Regular Follow-Up|Disease Progression|0
1154949|NCT01292603|3792268|P2|Part 2: Regular Follow-Up|Disease Progression|0
1154950|NCT01292603|3792269|P1|Part 2: Regular Follow-Up|Disease Progression|0
1154951|NCT01292603|3792264|P6|Part 2: Regular Follow-Up|Death|3
1154952|NCT01292603|3792265|P5|Part 2: Regular Follow-Up|Death|6
1154953|NCT01292603|3792266|P4|Part 2: Regular Follow-Up|Death|0
1154954|NCT01292603|3792267|P3|Part 2: Regular Follow-Up|Death|0
1154955|NCT01292603|3792268|P2|Part 2: Regular Follow-Up|Death|0
1154956|NCT01292603|3792269|P1|Part 2: Regular Follow-Up|Death|0
1154957|NCT01292603|3792264|P6|Part 2: Dose Confirmation Period|Withdrawal by Subject|2
1154958|NCT01292603|3792265|P5|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
1154959|NCT01292603|3792266|P4|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
1154960|NCT01292603|3792267|P3|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
1154961|NCT01292603|3792268|P2|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
1154962|NCT01292603|3792269|P1|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
1154963|NCT01292603|3792264|P6|Part 2: Dose Confirmation Period|Protocol Violation|3
1154964|NCT01292603|3792265|P5|Part 2: Dose Confirmation Period|Protocol Violation|5
1154965|NCT01292603|3792266|P4|Part 2: Dose Confirmation Period|Protocol Violation|0
1154966|NCT01292603|3792267|P3|Part 2: Dose Confirmation Period|Protocol Violation|0
1154967|NCT01292603|3792268|P2|Part 2: Dose Confirmation Period|Protocol Violation|0
1154968|NCT01292603|3792269|P1|Part 2: Dose Confirmation Period|Protocol Violation|0
1154969|NCT01292603|3792264|P6|Part 2: Dose Confirmation Period|Adverse Event|9
1154970|NCT01292603|3792265|P5|Part 2: Dose Confirmation Period|Adverse Event|7
1154971|NCT01292603|3792266|P4|Part 2: Dose Confirmation Period|Adverse Event|0
1154972|NCT01292603|3792267|P3|Part 2: Dose Confirmation Period|Adverse Event|0
1154973|NCT01292603|3792268|P2|Part 2: Dose Confirmation Period|Adverse Event|0
1154974|NCT01292603|3792269|P1|Part 2: Dose Confirmation Period|Adverse Event|0
1154975|NCT01292603|3792264|P6|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
1154976|NCT01292603|3792265|P5|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
1154977|NCT01292603|3792266|P4|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
1154978|NCT01292603|3792267|P3|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
1154979|NCT01292603|3792268|P2|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
1154980|NCT01292603|3792269|P1|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
1154981|NCT01292603|3792264|P6|Part 2: Dose Confirmation Period|Physician Decision|0
1154982|NCT01292603|3792265|P5|Part 2: Dose Confirmation Period|Physician Decision|2
1154983|NCT01292603|3792266|P4|Part 2: Dose Confirmation Period|Physician Decision|0
1154984|NCT01292603|3792267|P3|Part 2: Dose Confirmation Period|Physician Decision|0
1154985|NCT01292603|3792268|P2|Part 2: Dose Confirmation Period|Physician Decision|0
1154986|NCT01292603|3792269|P1|Part 2: Dose Confirmation Period|Physician Decision|0
1154987|NCT01292603|3792264|P6|Part 2: Dose Confirmation Period|Death|0
1154988|NCT01292603|3792265|P5|Part 2: Dose Confirmation Period|Death|1
1154989|NCT01292603|3792266|P4|Part 2: Dose Confirmation Period|Death|0
1154990|NCT01292603|3792267|P3|Part 2: Dose Confirmation Period|Death|0
1154991|NCT01292603|3792268|P2|Part 2: Dose Confirmation Period|Death|0
1154992|NCT01292603|3792269|P1|Part 2: Dose Confirmation Period|Death|0
1154993|NCT01292603|3792264|P6|Part 1: Regular Follow-Up Period|Disease Progression|0
1154994|NCT01292603|3792265|P5|Part 1: Regular Follow-Up Period|Disease Progression|0
1154995|NCT01292603|3792266|P4|Part 1: Regular Follow-Up Period|Disease Progression|0
1154996|NCT01292603|3792267|P3|Part 1: Regular Follow-Up Period|Disease Progression|3
1154997|NCT01292603|3792268|P2|Part 1: Regular Follow-Up Period|Disease Progression|6
1154998|NCT01292603|3792269|P1|Part 1: Regular Follow-Up Period|Disease Progression|3
1154999|NCT01292603|3792264|P6|Part 1: Regular Follow-Up Period|Death|0
1155000|NCT01292603|3792265|P5|Part 1: Regular Follow-Up Period|Death|0
1155001|NCT01292603|3792266|P4|Part 1: Regular Follow-Up Period|Death|1
1155002|NCT01292603|3792267|P3|Part 1: Regular Follow-Up Period|Death|3
1155003|NCT01292603|3792268|P2|Part 1: Regular Follow-Up Period|Death|1
1155004|NCT01292603|3792269|P1|Part 1: Regular Follow-Up Period|Death|3
1155005|NCT01292603|3792264|P6|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
1155006|NCT01292603|3792265|P5|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
1155007|NCT01292603|3792266|P4|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1
1155008|NCT01292603|3792267|P3|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
1155009|NCT01292603|3792268|P2|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
1155010|NCT01292603|3792269|P1|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
1155011|NCT01292603|3792264|P6|Part 1: Pilot Dose Selection Period|Protocol Violation|0
1155012|NCT01292603|3792265|P5|Part 1: Pilot Dose Selection Period|Protocol Violation|0
1155013|NCT01292603|3792266|P4|Part 1: Pilot Dose Selection Period|Protocol Violation|2
1155014|NCT01292603|3792267|P3|Part 1: Pilot Dose Selection Period|Protocol Violation|0
1155015|NCT01292603|3792268|P2|Part 1: Pilot Dose Selection Period|Protocol Violation|0
1155016|NCT01292603|3792269|P1|Part 1: Pilot Dose Selection Period|Protocol Violation|0
1155017|NCT01292603|3792264|P6|Part 1: Pilot Dose Selection Period|Death|0
1155018|NCT01292603|3792265|P5|Part 1: Pilot Dose Selection Period|Death|0
1155019|NCT01292603|3792266|P4|Part 1: Pilot Dose Selection Period|Death|1
1155020|NCT01292603|3792267|P3|Part 1: Pilot Dose Selection Period|Death|0
1155021|NCT01292603|3792268|P2|Part 1: Pilot Dose Selection Period|Death|0
1155022|NCT01292603|3792269|P1|Part 1: Pilot Dose Selection Period|Death|0
1155023|NCT01292603|3792264|P6|Part 1: Pilot Dose Selection Period|Adverse Event|0
1155024|NCT01292603|3792265|P5|Part 1: Pilot Dose Selection Period|Adverse Event|0
1155025|NCT01292603|3792266|P4|Part 1: Pilot Dose Selection Period|Adverse Event|4
1155026|NCT01292603|3792267|P3|Part 1: Pilot Dose Selection Period|Adverse Event|0
1155027|NCT01292603|3792268|P2|Part 1: Pilot Dose Selection Period|Adverse Event|0
1155028|NCT01292603|3792269|P1|Part 1: Pilot Dose Selection Period|Adverse Event|0
1155029|NCT01292486|3792322|P1|Overall Study|Physician Decision|1
1155030|NCT01292486|3792322|P1|Overall Study|Adverse Event|1
1155031|NCT01292486|3792322|P1|Overall Study|Did not meet screening criteria|2
1155032|NCT01292486|3792322|P1|Overall Study|Protocol Violation|2
1155033|NCT01292473|3792336|P4|Overall Study|Disease Progression|6
1155034|NCT01292473|3792337|P3|Overall Study|Disease Progression|3
1155035|NCT01292473|3792338|P2|Overall Study|Disease Progression|1
1155036|NCT01292473|3792339|P1|Overall Study|Disease Progression|0
1155037|NCT01292473|3792336|P4|Overall Study|Physician Decision|0
1155038|NCT01292473|3792337|P3|Overall Study|Physician Decision|0
1155039|NCT01292473|3792338|P2|Overall Study|Physician Decision|1
1155040|NCT01292473|3792339|P1|Overall Study|Physician Decision|0
1155041|NCT01292473|3792336|P4|Overall Study|Withdrawal by Subject|3
1155042|NCT01292473|3792337|P3|Overall Study|Withdrawal by Subject|3
1155043|NCT01292473|3792338|P2|Overall Study|Withdrawal by Subject|4
1155044|NCT01292473|3792339|P1|Overall Study|Withdrawal by Subject|3
1155045|NCT01292473|3792336|P4|Overall Study|Lost to Follow-up|2
1155046|NCT01292473|3792337|P3|Overall Study|Lost to Follow-up|2
1155047|NCT01292473|3792338|P2|Overall Study|Lost to Follow-up|1
1155048|NCT01292473|3792339|P1|Overall Study|Lost to Follow-up|1
1155049|NCT01292473|3792336|P4|Overall Study|Adverse Event|1
1155050|NCT01292473|3792337|P3|Overall Study|Adverse Event|1
1155051|NCT01292473|3792338|P2|Overall Study|Adverse Event|0
1155052|NCT01292473|3792339|P1|Overall Study|Adverse Event|1
1155053|NCT01292239|3792398|P2|Overall Study|Withdrawal by Subject|6
1155054|NCT01292239|3792399|P1|Overall Study|Withdrawal by Subject|3
1155055|NCT01292239|3792398|P2|Overall Study|Not specified|1
1155056|NCT01292239|3792399|P1|Overall Study|Not specified|1
1155057|NCT01292226|3792420|P1|Overall Study|Not specified|2
1155058|NCT01292226|3792420|P1|Overall Study|Withdrawal by Subject|1
1155059|NCT01292226|3792420|P1|Overall Study|Protocol Violation|3
1155060|NCT01292226|3792420|P1|Overall Study|Graft loss|1
1155061|NCT01292226|3792420|P1|Overall Study|Death|1
1155062|NCT01292226|3792420|P1|Overall Study|Adverse Event|5
1155063|NCT01292187|3792453|P2|Overall Study|All other reasons|3
1155064|NCT01292187|3792454|P1|Overall Study|All other reasons|1
1155065|NCT01292187|3792453|P2|Overall Study|Withdrawal by Subject|5
1155066|NCT01292187|3792454|P1|Overall Study|Withdrawal by Subject|6
1155067|NCT01292187|3792453|P2|Overall Study|Adverse Event|5
1155068|NCT01292187|3792454|P1|Overall Study|Adverse Event|10
1155069|NCT01292057|3792489|P2|Overall Study|Lost to Follow-up|1
1155070|NCT01292057|3792490|P1|Overall Study|Lost to Follow-up|1
1155071|NCT01292057|3792489|P2|Overall Study|Protocol Violation|1
1155072|NCT01292057|3792490|P1|Overall Study|Protocol Violation|1
1155073|NCT01291277|3792562|P2|Overall Study|Lost to Follow-up|1
1155074|NCT01291277|3792563|P1|Overall Study|Lost to Follow-up|3
1155075|NCT01291277|3792562|P2|Overall Study|Death|2
1155076|NCT01291277|3792563|P1|Overall Study|Death|2
1155077|NCT01291225|3792575|P2|Overall Study|Lost to Follow-up|39
1155078|NCT01291225|3792576|P1|Overall Study|Lost to Follow-up|85
1155079|NCT01291173|3792590|P4|Overall Study|Excluded therapy|0
1155080|NCT01291173|3792591|P3|Overall Study|Excluded therapy|1
1155081|NCT01291173|3792592|P2|Overall Study|Excluded therapy|0
1155082|NCT01291173|3792593|P1|Overall Study|Excluded therapy|0
1155083|NCT01291173|3792590|P4|Overall Study|Subject was unblinded|0
1155084|NCT01291173|3792591|P3|Overall Study|Subject was unblinded|1
1155085|NCT01291173|3792592|P2|Overall Study|Subject was unblinded|0
1155086|NCT01291173|3792593|P1|Overall Study|Subject was unblinded|0
1155087|NCT01291173|3792590|P4|Overall Study|Lack of compliance|1
1155088|NCT01291173|3792591|P3|Overall Study|Lack of compliance|0
1155089|NCT01291173|3792592|P2|Overall Study|Lack of compliance|0
1155090|NCT01291173|3792593|P1|Overall Study|Lack of compliance|0
1155091|NCT01291173|3792590|P4|Overall Study|Unable to meet visit schedule|0
1155092|NCT01291173|3792591|P3|Overall Study|Unable to meet visit schedule|1
1155093|NCT01291173|3792592|P2|Overall Study|Unable to meet visit schedule|0
1155094|NCT01291173|3792593|P1|Overall Study|Unable to meet visit schedule|0
1155095|NCT01291173|3792590|P4|Overall Study|Lost to Follow-up|2
1155096|NCT01291173|3792591|P3|Overall Study|Lost to Follow-up|3
1155097|NCT01291173|3792592|P2|Overall Study|Lost to Follow-up|6
1155098|NCT01291173|3792593|P1|Overall Study|Lost to Follow-up|4
1155099|NCT01291173|3792590|P4|Overall Study|Withdrawal by Subject|2
1155100|NCT01291173|3792591|P3|Overall Study|Withdrawal by Subject|4
1155101|NCT01291173|3792592|P2|Overall Study|Withdrawal by Subject|4
1155102|NCT01291173|3792593|P1|Overall Study|Withdrawal by Subject|6
1155103|NCT01291173|3792590|P4|Overall Study|Protocol Violation|5
1155104|NCT01291173|3792591|P3|Overall Study|Protocol Violation|2
1155105|NCT01291173|3792592|P2|Overall Study|Protocol Violation|2
1155106|NCT01291173|3792593|P1|Overall Study|Protocol Violation|7
1155107|NCT01291173|3792590|P4|Overall Study|Adverse Event|3
1155108|NCT01291173|3792591|P3|Overall Study|Adverse Event|1
1155109|NCT01291173|3792592|P2|Overall Study|Adverse Event|3
1155110|NCT01291173|3792593|P1|Overall Study|Adverse Event|0
1155111|NCT01291017|3792702|P1|Overall Study|Withdrawal by Subject|3
1155112|NCT01291017|3792702|P1|Overall Study|Lost to Follow-up|2
1155113|NCT01290887|3792735|P2|Overall Study|Not specified|6
1155114|NCT01290887|3792736|P1|Overall Study|Not specified|3
1155115|NCT01290887|3792735|P2|Overall Study|Sponsor closure of study|476
1155116|NCT01290887|3792736|P1|Overall Study|Sponsor closure of study|420
1155117|NCT01290887|3792735|P2|Overall Study|Non-compliance to study medications|0
1155118|NCT01290887|3792736|P1|Overall Study|Non-compliance to study medications|1
1155119|NCT01290887|3792735|P2|Overall Study|Non-compliance to study procedures|1
1155120|NCT01290887|3792736|P1|Overall Study|Non-compliance to study procedures|0
1155121|NCT01290887|3792735|P2|Overall Study|Lost to Follow-up|4
1155122|NCT01290887|3792736|P1|Overall Study|Lost to Follow-up|4
1155123|NCT01290887|3792735|P2|Overall Study|Protocol Violation|1
1155124|NCT01290887|3792736|P1|Overall Study|Protocol Violation|2
1155125|NCT01290887|3792735|P2|Overall Study|Withdrawal by Subject|32
1155126|NCT01290887|3792736|P1|Overall Study|Withdrawal by Subject|26
1155127|NCT01290887|3792735|P2|Overall Study|Lack of Efficacy|5
1155128|NCT01290887|3792736|P1|Overall Study|Lack of Efficacy|4
1155129|NCT01290887|3792735|P2|Overall Study|Adverse Event|11
1155130|NCT01290887|3792736|P1|Overall Study|Adverse Event|6
1155131|NCT01290822|3792797|P1|Overall Study|Physician Decision|10
1155132|NCT01290822|3792797|P1|Overall Study|Withdrawal by Subject|1
1155133|NCT01290796|3792806|P1|Overall Study|Withdrawal by Sponsor|1
1155134|NCT01290796|3792806|P1|Overall Study|Secondary Surgical Intervention|2
1155135|NCT01290796|3792806|P1|Overall Study|Physician Decision|2
1155136|NCT01290796|3792806|P1|Overall Study|Withdrawal by Subject|4
1155137|NCT01290796|3792806|P1|Overall Study|Lost to Follow-up|21
1155138|NCT01290757|3792822|P2|Overall Study|Other|1
1155139|NCT01290757|3792823|P1|Overall Study|Other|0
1155140|NCT01290757|3792822|P2|Overall Study|Protocol Violation|1
1155141|NCT01290757|3792823|P1|Overall Study|Protocol Violation|1
1155142|NCT01290757|3792822|P2|Overall Study|Adverse Event|0
1155143|NCT01290757|3792823|P1|Overall Study|Adverse Event|1
1155144|NCT01290731|3792839|P1|Overall Study|Withdrawal by Subject|1
1155145|NCT01290718|3792851|P1|Overall Study|Early termination of the study|4
1155146|NCT01290679|3792860|P2|Overall Study|Subject Entered Another Trial|5
1155147|NCT01290679|3792861|P1|Overall Study|Subject Entered Another Trial|0
1155148|NCT01290679|3792860|P2|Overall Study|Withdrawal by Subject|5
1155149|NCT01290679|3792861|P1|Overall Study|Withdrawal by Subject|6
1155150|NCT01290679|3792860|P2|Overall Study|Protocol Violation|1
1155151|NCT01290679|3792861|P1|Overall Study|Protocol Violation|0
1155152|NCT01290679|3792860|P2|Overall Study|Lost to Follow-up|10
1155153|NCT01290679|3792861|P1|Overall Study|Lost to Follow-up|8
1155154|NCT01290679|3792860|P2|Overall Study|Adverse Event|0
1155155|NCT01290679|3792861|P1|Overall Study|Adverse Event|2
1155156|NCT01290666|3792930|P1|Overall Study|Early Termination of Study|4
1155157|NCT01290666|3792930|P1|Overall Study|Withdrawal by Subject|23
1155158|NCT01290666|3792930|P1|Overall Study|Lost to Follow-up|11
1155159|NCT01290601|3792983|P4|Overall Study|Protocol Violation|0
1155160|NCT01290601|3792984|P3|Overall Study|Protocol Violation|0
1155161|NCT01290601|3792985|P2|Overall Study|Protocol Violation|0
1155162|NCT01290601|3792986|P1|Overall Study|Protocol Violation|1
1155163|NCT01290601|3792983|P4|Overall Study|Other|0
1155164|NCT01290601|3792984|P3|Overall Study|Other|0
1155165|NCT01290601|3792985|P2|Overall Study|Other|0
1155166|NCT01290601|3792986|P1|Overall Study|Other|1
1155167|NCT01290601|3792983|P4|Overall Study|Lost to Follow-up|0
1155168|NCT01290601|3792984|P3|Overall Study|Lost to Follow-up|0
1155169|NCT01290601|3792985|P2|Overall Study|Lost to Follow-up|2
1155170|NCT01290601|3792986|P1|Overall Study|Lost to Follow-up|7
1155171|NCT01290601|3792983|P4|Overall Study|Lack of Efficacy|0
1155172|NCT01290601|3792984|P3|Overall Study|Lack of Efficacy|0
1155173|NCT01290601|3792985|P2|Overall Study|Lack of Efficacy|1
1155174|NCT01290601|3792986|P1|Overall Study|Lack of Efficacy|2
1155175|NCT01290601|3792983|P4|Overall Study|Adverse Event|0
1155176|NCT01290601|3792984|P3|Overall Study|Adverse Event|0
1155177|NCT01290601|3792985|P2|Overall Study|Adverse Event|2
1155178|NCT01290601|3792986|P1|Overall Study|Adverse Event|0
1155179|NCT01290341|3793018|P2|Overall Study|Negative baseline culture and others|11
1155180|NCT01290341|3793019|P1|Overall Study|Negative baseline culture and others|44
1155181|NCT01290341|3793018|P2|Overall Study|Withdrawal by Subject|5
1155182|NCT01290341|3793019|P1|Overall Study|Withdrawal by Subject|19
1155183|NCT01290341|3793018|P2|Overall Study|Lost to Follow-up|10
1155184|NCT01290341|3793019|P1|Overall Study|Lost to Follow-up|21
1155185|NCT01290341|3793018|P2|Overall Study|Adverse Event|0
1155186|NCT01290341|3793019|P1|Overall Study|Adverse Event|1
1155187|NCT01290341|3793018|P2|Overall Study|Protocol Violation|3
1155188|NCT01290341|3793019|P1|Overall Study|Protocol Violation|7
1155189|NCT01290315|3793031|P4|Overall Study|Withdrawal by Subject|0
1155190|NCT01290315|3793032|P3|Overall Study|Withdrawal by Subject|0
1155191|NCT01290315|3793033|P2|Overall Study|Withdrawal by Subject|1
1155192|NCT01290315|3793034|P1|Overall Study|Withdrawal by Subject|1
1155193|NCT01290315|3793031|P4|Overall Study|Lost to Follow-up|0
1155194|NCT01290315|3793032|P3|Overall Study|Lost to Follow-up|0
1155195|NCT01290315|3793033|P2|Overall Study|Lost to Follow-up|1
1155196|NCT01290315|3793034|P1|Overall Study|Lost to Follow-up|0
1155197|NCT01290315|3793031|P4|Overall Study|Selection criteria/compliance|2
1155198|NCT01290315|3793032|P3|Overall Study|Selection criteria/compliance|0
1155199|NCT01290315|3793033|P2|Overall Study|Selection criteria/compliance|1
1155200|NCT01290315|3793034|P1|Overall Study|Selection criteria/compliance|2
1155201|NCT01290315|3793031|P4|Overall Study|Adverse Event|3
1155202|NCT01290315|3793032|P3|Overall Study|Adverse Event|0
1155203|NCT01290315|3793033|P2|Overall Study|Adverse Event|0
1155204|NCT01290315|3793034|P1|Overall Study|Adverse Event|0
1155205|NCT01290263|3793056|P5|Overall Study|Participant Non-Compliance|1
1155206|NCT01290263|3793057|P4|Overall Study|Participant Non-Compliance|1
1155207|NCT01290263|3793058|P3|Overall Study|Participant Non-Compliance|0
1155208|NCT01290263|3793059|P2|Overall Study|Participant Non-Compliance|0
1155209|NCT01290263|3793060|P1|Overall Study|Participant Non-Compliance|0
1155210|NCT01290263|3793056|P5|Overall Study|Withdrawal by Subject|2
1155211|NCT01290263|3793057|P4|Overall Study|Withdrawal by Subject|1
1155212|NCT01290263|3793058|P3|Overall Study|Withdrawal by Subject|0
1155213|NCT01290263|3793059|P2|Overall Study|Withdrawal by Subject|1
1155214|NCT01290263|3793060|P1|Overall Study|Withdrawal by Subject|3
1155215|NCT01290263|3793056|P5|Overall Study|Lack of Efficacy|33
1155216|NCT01290263|3793057|P4|Overall Study|Lack of Efficacy|24
1155217|NCT01290263|3793058|P3|Overall Study|Lack of Efficacy|7
1155218|NCT01290263|3793059|P2|Overall Study|Lack of Efficacy|2
1155219|NCT01290263|3793060|P1|Overall Study|Lack of Efficacy|8
1155220|NCT01290263|3793056|P5|Overall Study|Adverse Event|1
1155221|NCT01290263|3793057|P4|Overall Study|Adverse Event|1
1155222|NCT01290263|3793058|P3|Overall Study|Adverse Event|0
1155223|NCT01290263|3793059|P2|Overall Study|Adverse Event|0
1155224|NCT01290263|3793060|P1|Overall Study|Adverse Event|0
1155225|NCT01290224|3793087|P1|Overall Study|Refused Further Treatment|4
1155226|NCT01290224|3793087|P1|Overall Study|Adverse Event|1
1155227|NCT01290094|3793098|P1|Overall Study|Lost to Follow-up|5
1155228|NCT01290094|3793098|P1|Overall Study|Withdrawal by Subject|1
1155229|NCT01290068|3793111|P2|Overall Study|Other|1
1155230|NCT01290068|3793112|P1|Overall Study|Other|3
1155231|NCT01290068|3793111|P2|Overall Study|Withdrawal by subject prior to implant|2
1155232|NCT01290068|3793112|P1|Overall Study|Withdrawal by subject prior to implant|0
1155233|NCT01290068|3793111|P2|Overall Study|Lost to Follow-up|0
1155234|NCT01290068|3793112|P1|Overall Study|Lost to Follow-up|3
1155235|NCT01290068|3793111|P2|Overall Study|Adverse Event|3
1155236|NCT01290068|3793112|P1|Overall Study|Adverse Event|1
1155237|NCT01290029|3793124|P1|Overall Study|Other|2
1155238|NCT01289990|3793150|P13|Overall Study|Not treated|0
1155239|NCT01289990|3793151|P12|Overall Study|Not treated|2
1155240|NCT01289990|3793152|P11|Overall Study|Not treated|1
1155241|NCT01289990|3793153|P10|Overall Study|Not treated|0
1155242|NCT01289990|3793154|P9|Overall Study|Not treated|1
1155243|NCT01289990|3793155|P8|Overall Study|Not treated|0
1155244|NCT01289990|3793156|P7|Overall Study|Not treated|1
1155245|NCT01289990|3793157|P6|Overall Study|Not treated|0
1155246|NCT01289990|3793158|P5|Overall Study|Not treated|0
1155247|NCT01289990|3793159|P4|Overall Study|Not treated|0
1155248|NCT01289990|3793160|P3|Overall Study|Not treated|0
1155249|NCT01289990|3793161|P2|Overall Study|Not treated|0
1155250|NCT01289990|3793162|P1|Overall Study|Not treated|0
1155251|NCT01289990|3793150|P13|Overall Study|did not continue in extension|56
1155252|NCT01289990|3793151|P12|Overall Study|did not continue in extension|34
1155253|NCT01289990|3793152|P11|Overall Study|did not continue in extension|45
1155254|NCT01289990|3793153|P10|Overall Study|did not continue in extension|48
1155255|NCT01289990|3793154|P9|Overall Study|did not continue in extension|44
1155256|NCT01289990|3793155|P8|Overall Study|did not continue in extension|36
1155257|NCT01289990|3793156|P7|Overall Study|did not continue in extension|54
1155258|NCT01289990|3793157|P6|Overall Study|did not continue in extension|50
1155259|NCT01289990|3793158|P5|Overall Study|did not continue in extension|48
1155260|NCT01289990|3793159|P4|Overall Study|did not continue in extension|51
1155261|NCT01289990|3793160|P3|Overall Study|did not continue in extension|51
1155262|NCT01289990|3793161|P2|Overall Study|did not continue in extension|45
1155263|NCT01289990|3793162|P1|Overall Study|did not continue in extension|41
1155264|NCT01289990|3793150|P13|Overall Study|discontinued in preceding trial|24
1155265|NCT01289990|3793151|P12|Overall Study|discontinued in preceding trial|17
1155266|NCT01289990|3793152|P11|Overall Study|discontinued in preceding trial|17
1155267|NCT01289990|3793153|P10|Overall Study|discontinued in preceding trial|21
1155268|NCT01289990|3793154|P9|Overall Study|discontinued in preceding trial|17
1155269|NCT01289990|3793155|P8|Overall Study|discontinued in preceding trial|8
1155270|NCT01289990|3793156|P7|Overall Study|discontinued in preceding trial|18
1155271|NCT01289990|3793157|P6|Overall Study|discontinued in preceding trial|12
1155272|NCT01289990|3793158|P5|Overall Study|discontinued in preceding trial|11
1155273|NCT01289990|3793159|P4|Overall Study|discontinued in preceding trial|17
1155274|NCT01289990|3793160|P3|Overall Study|discontinued in preceding trial|41
1155275|NCT01289990|3793161|P2|Overall Study|discontinued in preceding trial|20
1155276|NCT01289990|3793162|P1|Overall Study|discontinued in preceding trial|18
1155277|NCT01289990|3793150|P13|Overall Study|Withdrawal by Subject|16
1155278|NCT01289990|3793151|P12|Overall Study|Withdrawal by Subject|13
1155279|NCT01289990|3793152|P11|Overall Study|Withdrawal by Subject|11
1155280|NCT01289990|3793153|P10|Overall Study|Withdrawal by Subject|13
1155281|NCT01289990|3793154|P9|Overall Study|Withdrawal by Subject|12
1155282|NCT01289990|3793155|P8|Overall Study|Withdrawal by Subject|9
1155283|NCT01289990|3793156|P7|Overall Study|Withdrawal by Subject|13
1155284|NCT01289990|3793157|P6|Overall Study|Withdrawal by Subject|7
1155285|NCT01289990|3793158|P5|Overall Study|Withdrawal by Subject|8
1155286|NCT01289990|3793159|P4|Overall Study|Withdrawal by Subject|13
1155287|NCT01289990|3793160|P3|Overall Study|Withdrawal by Subject|12
1155288|NCT01289990|3793161|P2|Overall Study|Withdrawal by Subject|14
1155289|NCT01289990|3793162|P1|Overall Study|Withdrawal by Subject|15
1155290|NCT01289990|3793150|P13|Overall Study|Lost to Follow-up|2
1155291|NCT01289990|3793151|P12|Overall Study|Lost to Follow-up|1
1155292|NCT01289990|3793152|P11|Overall Study|Lost to Follow-up|2
1155293|NCT01289990|3793153|P10|Overall Study|Lost to Follow-up|4
1155294|NCT01289990|3793154|P9|Overall Study|Lost to Follow-up|1
1155295|NCT01289990|3793155|P8|Overall Study|Lost to Follow-up|2
1155296|NCT01289990|3793156|P7|Overall Study|Lost to Follow-up|2
1155297|NCT01289990|3793157|P6|Overall Study|Lost to Follow-up|4
1155298|NCT01289990|3793158|P5|Overall Study|Lost to Follow-up|3
1155299|NCT01289990|3793159|P4|Overall Study|Lost to Follow-up|5
1155300|NCT01289990|3793160|P3|Overall Study|Lost to Follow-up|5
1155301|NCT01289990|3793161|P2|Overall Study|Lost to Follow-up|2
1155302|NCT01289990|3793162|P1|Overall Study|Lost to Follow-up|3
1155303|NCT01289990|3793150|P13|Overall Study|Death|0
1155304|NCT01289990|3793151|P12|Overall Study|Death|1
1155305|NCT01289990|3793152|P11|Overall Study|Death|0
1155306|NCT01289990|3793153|P10|Overall Study|Death|0
1155307|NCT01289990|3793154|P9|Overall Study|Death|0
1155308|NCT01289990|3793155|P8|Overall Study|Death|0
1155309|NCT01289990|3793156|P7|Overall Study|Death|0
1155310|NCT01289990|3793157|P6|Overall Study|Death|1
1155311|NCT01289990|3793158|P5|Overall Study|Death|2
1155312|NCT01289990|3793159|P4|Overall Study|Death|1
1155313|NCT01289990|3793160|P3|Overall Study|Death|0
1155314|NCT01289990|3793161|P2|Overall Study|Death|0
1155315|NCT01289990|3793162|P1|Overall Study|Death|0
1155316|NCT01289847|3793379|P1|Overall Study|Patient could not comply with visits|1
1155317|NCT01289821|3793388|P1|Survival Follow-up Period|Clinical endpoint reached|16
1155318|NCT01289821|3793388|P1|Survival Follow-up Period|Lost to Follow-up|1
1155319|NCT01289821|3793388|P1|Survival Follow-up Period|Protocol Violation|1
1155320|NCT01289821|3793388|P1|Safety Follow-up Period|Unspecified reason|1
1155321|NCT01289821|3793388|P1|Safety Follow-up Period|Protocol Violation|3
1155322|NCT01289821|3793388|P1|Safety Follow-up Period|Withdrawal by Subject|1
1155323|NCT01289821|3793388|P1|Treatment Period|Therapeutic procedure required|1
1155324|NCT01289821|3793388|P1|Treatment Period|Clinical Progression|2
1155325|NCT01289821|3793388|P1|Treatment Period|Radiological Progression|43
1155326|NCT01289821|3793388|P1|Treatment Period|Adverse Event|4
1155327|NCT01289821|3793388|P1|Treatment Period|Physician Decision|3
1155328|NCT01289821|3793388|P1|Treatment Period|Withdrawal by Subject|1
1155329|NCT01289782|3793399|P2|Overall Study|Reason not specified|2
1155330|NCT01289782|3793400|P1|Overall Study|Reason not specified|1
1155331|NCT01289782|3793399|P2|Overall Study|Sponsor's Decision|0
1155332|NCT01289782|3793400|P1|Overall Study|Sponsor's Decision|1
1155333|NCT01289782|3793399|P2|Overall Study|Withdrawal by Subject|2
1155334|NCT01289782|3793400|P1|Overall Study|Withdrawal by Subject|8
1155335|NCT01289782|3793399|P2|Overall Study|Protocol Violation|1
1155336|NCT01289782|3793400|P1|Overall Study|Protocol Violation|1
1155337|NCT01289782|3793399|P2|Overall Study|Lost to Follow-up|7
1155338|NCT01289782|3793400|P1|Overall Study|Lost to Follow-up|14
1155339|NCT01289639|3793472|P3|Overall Study|Lost to Follow-up|0
1155340|NCT01289639|3793473|P2|Overall Study|Lost to Follow-up|0
1155341|NCT01289639|3793474|P1|Overall Study|Lost to Follow-up|1
1155342|NCT01289574|3793500|P3|Overall Study|Subject wanted alternate treatment|0
1155343|NCT01289574|3793501|P2|Overall Study|Subject wanted alternate treatment|1
1155344|NCT01289574|3793502|P1|Overall Study|Subject wanted alternate treatment|0
1155345|NCT01289574|3793500|P3|Overall Study|Adverse Event|0
1155346|NCT01289574|3793501|P2|Overall Study|Adverse Event|1
1155347|NCT01289574|3793502|P1|Overall Study|Adverse Event|0
1155348|NCT01289574|3793500|P3|Overall Study|Withdrawal by Subject|1
1155349|NCT01289574|3793501|P2|Overall Study|Withdrawal by Subject|1
1155350|NCT01289574|3793502|P1|Overall Study|Withdrawal by Subject|1
1155351|NCT01289574|3793500|P3|Overall Study|Lost to Follow-up|1
1155352|NCT01289574|3793501|P2|Overall Study|Lost to Follow-up|0
1155353|NCT01289574|3793502|P1|Overall Study|Lost to Follow-up|2
1155354|NCT01289574|3793500|P3|Overall Study|Lack of Efficacy|1
1155355|NCT01289574|3793501|P2|Overall Study|Lack of Efficacy|0
1155356|NCT01289574|3793502|P1|Overall Study|Lack of Efficacy|4
1155357|NCT01289418|3793574|P1|Day 29 Survey|participants did not complete the survey|2185
1155358|NCT01289418|3793574|P1|Day 29 Survey|email address invalid|283
1155359|NCT01289418|3793574|P1|Day 8 Survey|participants did not complete the survey|1935
1155360|NCT01289418|3793574|P1|Day 8 Survey|email address invalid|283
1155361|NCT01289210|3793610|P1|Overall Study|Adverse Event|1
1155362|NCT01289119|3793620|P6|Overall Study|Other|0
1155363|NCT01289119|3793621|P5|Overall Study|Other|0
1155364|NCT01289119|3793622|P4|Overall Study|Other|0
1155365|NCT01289119|3793623|P3|Overall Study|Other|1
1155366|NCT01289119|3793624|P2|Overall Study|Other|0
1155367|NCT01289119|3793625|P1|Overall Study|Other|1
1155368|NCT01289119|3793620|P6|Overall Study|Lack of Efficacy|1
1155369|NCT01289119|3793621|P5|Overall Study|Lack of Efficacy|1
1155370|NCT01289119|3793622|P4|Overall Study|Lack of Efficacy|1
1155371|NCT01289119|3793623|P3|Overall Study|Lack of Efficacy|1
1155372|NCT01289119|3793624|P2|Overall Study|Lack of Efficacy|1
1155373|NCT01289119|3793625|P1|Overall Study|Lack of Efficacy|0
1155374|NCT01289119|3793620|P6|Overall Study|Pregnancy|0
1155375|NCT01289119|3793621|P5|Overall Study|Pregnancy|0
1155376|NCT01289119|3793622|P4|Overall Study|Pregnancy|0
1155377|NCT01289119|3793623|P3|Overall Study|Pregnancy|0
1155378|NCT01289119|3793624|P2|Overall Study|Pregnancy|1
1155379|NCT01289119|3793625|P1|Overall Study|Pregnancy|0
1155380|NCT01289119|3793620|P6|Overall Study|Withdrawal by Subject|1
1155381|NCT01289119|3793621|P5|Overall Study|Withdrawal by Subject|1
1155382|NCT01289119|3793622|P4|Overall Study|Withdrawal by Subject|3
1155383|NCT01289119|3793623|P3|Overall Study|Withdrawal by Subject|4
1155384|NCT01289119|3793624|P2|Overall Study|Withdrawal by Subject|2
1155385|NCT01289119|3793625|P1|Overall Study|Withdrawal by Subject|4
1155386|NCT01289119|3793620|P6|Overall Study|Lost to Follow-up|1
1155387|NCT01289119|3793621|P5|Overall Study|Lost to Follow-up|0
1155388|NCT01289119|3793622|P4|Overall Study|Lost to Follow-up|0
1155389|NCT01289119|3793623|P3|Overall Study|Lost to Follow-up|0
1155390|NCT01289119|3793624|P2|Overall Study|Lost to Follow-up|3
1155391|NCT01289119|3793625|P1|Overall Study|Lost to Follow-up|0
1155392|NCT01289119|3793620|P6|Overall Study|Major Protocol Deviation|1
1155393|NCT01289119|3793621|P5|Overall Study|Major Protocol Deviation|2
1155394|NCT01289119|3793622|P4|Overall Study|Major Protocol Deviation|0
1155395|NCT01289119|3793623|P3|Overall Study|Major Protocol Deviation|3
1155396|NCT01289119|3793624|P2|Overall Study|Major Protocol Deviation|1
1155397|NCT01289119|3793625|P1|Overall Study|Major Protocol Deviation|2
1155398|NCT01289119|3793620|P6|Overall Study|Adverse Event|0
1155399|NCT01289119|3793621|P5|Overall Study|Adverse Event|1
1155400|NCT01289119|3793622|P4|Overall Study|Adverse Event|2
1155401|NCT01289119|3793623|P3|Overall Study|Adverse Event|0
1155402|NCT01289119|3793624|P2|Overall Study|Adverse Event|1
1155403|NCT01289119|3793625|P1|Overall Study|Adverse Event|2
1155404|NCT01289041|3793746|P1|Overall Study|Death|1
1155405|NCT01289041|3793746|P1|Overall Study|Withdrawal by Subject|3
1155406|NCT01289041|3793746|P1|Overall Study|Progressive Disease|41
1155407|NCT01289041|3793746|P1|Overall Study|Physician Decision|1
1155408|NCT01289041|3793746|P1|Overall Study|Adverse Event|24
1155409|NCT01289028|3793758|P1|Overall Study|Missing reason for discon|1
1155410|NCT01289028|3793758|P1|Overall Study|Abnormal Lab Value|1
1155411|NCT01289028|3793758|P1|Overall Study|New Cancer Therapy|2
1155412|NCT01289028|3793758|P1|Overall Study|Lost to Follow-up|2
1155413|NCT01289028|3793758|P1|Overall Study|No longer required|2
1155414|NCT01289028|3793758|P1|Overall Study|Lack of Efficacy|2
1155415|NCT01289028|3793758|P1|Overall Study|Death|4
1155416|NCT01289028|3793758|P1|Overall Study|Withdrawal by Subject|6
1155417|NCT01289028|3793758|P1|Overall Study|Adverse Event|14
1155418|NCT01289028|3793758|P1|Overall Study|Progressive Disease|49
1155419|NCT01289015|3793772|P2|Overall Study|Negative baseline culture and others|20
1155420|NCT01289015|3793773|P1|Overall Study|Negative baseline culture and others|33
1155421|NCT01289015|3793772|P2|Overall Study|Disease progression|0
1155422|NCT01289015|3793773|P1|Overall Study|Disease progression|1
1155423|NCT01289015|3793772|P2|Overall Study|Withdrawal by Subject|8
1155424|NCT01289015|3793773|P1|Overall Study|Withdrawal by Subject|17
1155425|NCT01289015|3793772|P2|Overall Study|Lost to Follow-up|17
1155426|NCT01289015|3793773|P1|Overall Study|Lost to Follow-up|33
1155427|NCT01289015|3793772|P2|Overall Study|Adverse Event|0
1155428|NCT01289015|3793773|P1|Overall Study|Adverse Event|3
1155429|NCT01289015|3793772|P2|Overall Study|Protocol Violation|9
1155430|NCT01289015|3793773|P1|Overall Study|Protocol Violation|12
1155431|NCT01288976|3793784|P3|Overall Study|Data unavailable|7
1155432|NCT01288976|3793785|P2|Overall Study|Data unavailable|9
1155433|NCT01288976|3793786|P1|Overall Study|Data unavailable|22
1155434|NCT01288976|3793784|P3|Overall Study|Death|4
1155435|NCT01288976|3793785|P2|Overall Study|Death|6
1155436|NCT01288976|3793786|P1|Overall Study|Death|98
1155437|NCT01288976|3793784|P3|Overall Study|Withdrawal by Subject|9
1155438|NCT01288976|3793785|P2|Overall Study|Withdrawal by Subject|12
1155439|NCT01288976|3793786|P1|Overall Study|Withdrawal by Subject|58
1155440|NCT01288911|3793815|P2|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5
1155441|NCT01288911|3793816|P1|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17
1155442|NCT01288911|3793815|P2|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0
1155443|NCT01288911|3793816|P1|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5
1155444|NCT01288911|3793815|P2|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0
1155445|NCT01288911|3793816|P1|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1
1155446|NCT01288911|3793815|P2|Open-label Period (All Enzalutamide)|Progressive disease|3
1155447|NCT01288911|3793816|P1|Open-label Period (All Enzalutamide)|Progressive disease|18
1155448|NCT01288911|3793815|P2|Open-label Period (All Enzalutamide)|Lost to Follow-up|0
1155449|NCT01288911|3793816|P1|Open-label Period (All Enzalutamide)|Lost to Follow-up|1
1155450|NCT01288911|3793815|P2|Open-label Period (All Enzalutamide)|Death|1
1155451|NCT01288911|3793816|P1|Open-label Period (All Enzalutamide)|Death|0
1155452|NCT01288911|3793815|P2|Double-blind Period|Randomized but never received study drug|2
1155453|NCT01288911|3793816|P1|Double-blind Period|Randomized but never received study drug|1
1155454|NCT01288911|3793815|P2|Double-blind Period|Miscellaneous Reason|42
1155455|NCT01288911|3793816|P1|Double-blind Period|Miscellaneous Reason|29
1155456|NCT01288911|3793815|P2|Double-blind Period|Withdrawal by Subject|26
1155457|NCT01288911|3793816|P1|Double-blind Period|Withdrawal by Subject|25
1155458|NCT01288911|3793815|P2|Double-blind Period|Protocol Violation|0
1155459|NCT01288911|3793816|P1|Double-blind Period|Protocol Violation|1
1155460|NCT01288911|3793815|P2|Double-blind Period|Progressive Disease|103
1155461|NCT01288911|3793816|P1|Double-blind Period|Progressive Disease|75
1155462|NCT01288911|3793815|P2|Double-blind Period|Lost to Follow-up|2
1155463|NCT01288911|3793816|P1|Double-blind Period|Lost to Follow-up|0
1155464|NCT01288911|3793815|P2|Double-blind Period|Death|7
1155465|NCT01288911|3793816|P1|Double-blind Period|Death|11
1155466|NCT01288729|3793918|P2|Overall Study|Withdrawal by Subject|0
1155467|NCT01288729|3793919|P1|Overall Study|Withdrawal by Subject|1
1155468|NCT01288612|3793928|P3|Overall Study|Unable to intubate|0
1155469|NCT01288612|3793929|P2|Overall Study|Unable to intubate|3
1155470|NCT01288612|3793930|P1|Overall Study|Unable to intubate|0
1155471|NCT01288612|3793928|P3|Overall Study|Declined|62
1155472|NCT01288612|3793929|P2|Overall Study|Declined|63
1155473|NCT01288612|3793930|P1|Overall Study|Declined|78
1155474|NCT01288612|3793928|P3|Overall Study|Unable to contact|20
1155475|NCT01288612|3793929|P2|Overall Study|Unable to contact|16
1155476|NCT01288612|3793930|P1|Overall Study|Unable to contact|11
1155477|NCT01288469|3793979|P3|Overall Study|Exclusion criteria finally met|0
1155478|NCT01288469|3793980|P2|Overall Study|Exclusion criteria finally met|0
1155479|NCT01288469|3793981|P1|Overall Study|Exclusion criteria finally met|1
1155480|NCT01288469|3793979|P3|Overall Study|Consent withdrawn by subject|1
1155481|NCT01288469|3793980|P2|Overall Study|Consent withdrawn by subject|1
1155482|NCT01288469|3793981|P1|Overall Study|Consent withdrawn by subject|1
1155483|NCT01288469|3793979|P3|Overall Study|Participant Moved|0
1155484|NCT01288469|3793980|P2|Overall Study|Participant Moved|0
1155485|NCT01288469|3793981|P1|Overall Study|Participant Moved|1
1155486|NCT01288469|3793979|P3|Overall Study|Poor compliance to protocol|0
1155487|NCT01288469|3793980|P2|Overall Study|Poor compliance to protocol|1
1155488|NCT01288469|3793981|P1|Overall Study|Poor compliance to protocol|0
1155489|NCT01288469|3793979|P3|Overall Study|Adverse Event|1
1155490|NCT01288469|3793980|P2|Overall Study|Adverse Event|1
1155491|NCT01288469|3793981|P1|Overall Study|Adverse Event|4
1155492|NCT01288443|3794013|P6|Overall Study|Other than above|0
1155493|NCT01288443|3794014|P5|Overall Study|Other than above|1
1155494|NCT01288443|3794015|P4|Overall Study|Other than above|2
1155495|NCT01288443|3794016|P3|Overall Study|Other than above|0
1155496|NCT01288443|3794017|P2|Overall Study|Other than above|0
1155497|NCT01288443|3794018|P1|Overall Study|Other than above|0
1155498|NCT01288443|3794013|P6|Overall Study|Study drug auto-injector administration|1
1155499|NCT01288443|3794014|P5|Overall Study|Study drug auto-injector administration|1
1155500|NCT01288443|3794015|P4|Overall Study|Study drug auto-injector administration|0
1155501|NCT01288443|3794016|P3|Overall Study|Study drug auto-injector administration|0
1155502|NCT01288443|3794017|P2|Overall Study|Study drug auto-injector administration|0
1155503|NCT01288443|3794018|P1|Overall Study|Study drug auto-injector administration|0
1155504|NCT01288443|3794013|P6|Overall Study|Lost to Follow-up|0
1155505|NCT01288443|3794014|P5|Overall Study|Lost to Follow-up|0
1155506|NCT01288443|3794015|P4|Overall Study|Lost to Follow-up|0
1155507|NCT01288443|3794016|P3|Overall Study|Lost to Follow-up|0
1155508|NCT01288443|3794017|P2|Overall Study|Lost to Follow-up|1
1155509|NCT01288443|3794018|P1|Overall Study|Lost to Follow-up|0
1155510|NCT01288443|3794013|P6|Overall Study|Consent withdrawn by Participant|1
1155511|NCT01288443|3794014|P5|Overall Study|Consent withdrawn by Participant|0
1155512|NCT01288443|3794015|P4|Overall Study|Consent withdrawn by Participant|0
1155513|NCT01288443|3794016|P3|Overall Study|Consent withdrawn by Participant|0
1155514|NCT01288443|3794017|P2|Overall Study|Consent withdrawn by Participant|0
1155515|NCT01288443|3794018|P1|Overall Study|Consent withdrawn by Participant|0
1155516|NCT01288443|3794013|P6|Overall Study|Participant Moved|1
1155517|NCT01288443|3794014|P5|Overall Study|Participant Moved|2
1155518|NCT01288443|3794015|P4|Overall Study|Participant Moved|1
1155519|NCT01288443|3794016|P3|Overall Study|Participant Moved|0
1155520|NCT01288443|3794017|P2|Overall Study|Participant Moved|0
1155521|NCT01288443|3794018|P1|Overall Study|Participant Moved|0
1155522|NCT01288443|3794013|P6|Overall Study|Poor compliance to protocol|1
1155523|NCT01288443|3794014|P5|Overall Study|Poor compliance to protocol|0
1155524|NCT01288443|3794015|P4|Overall Study|Poor compliance to protocol|0
1155525|NCT01288443|3794016|P3|Overall Study|Poor compliance to protocol|0
1155526|NCT01288443|3794017|P2|Overall Study|Poor compliance to protocol|0
1155527|NCT01288443|3794018|P1|Overall Study|Poor compliance to protocol|0
1155528|NCT01288443|3794013|P6|Overall Study|Adverse Event|1
1155529|NCT01288443|3794014|P5|Overall Study|Adverse Event|3
1155530|NCT01288443|3794015|P4|Overall Study|Adverse Event|1
1155531|NCT01288443|3794016|P3|Overall Study|Adverse Event|1
1155532|NCT01288443|3794017|P2|Overall Study|Adverse Event|0
1155533|NCT01288443|3794018|P1|Overall Study|Adverse Event|0
1155534|NCT01288287|3794068|P1|Overall Study|Unknown Status|7
1155535|NCT01288287|3794068|P1|Overall Study|Unknown Reason|1
1155536|NCT01288287|3794068|P1|Overall Study|Other Reason|13
1155537|NCT01288287|3794068|P1|Overall Study|Lack of Efficacy|13
1155538|NCT01288287|3794068|P1|Overall Study|Withdrawal by Subject|4
1155539|NCT01288287|3794068|P1|Overall Study|Lost to Follow-up|8
1155540|NCT01288209|3794083|P2|Overall Study|Not specified|0
1155541|NCT01288209|3794084|P1|Overall Study|Not specified|1
1155542|NCT01288209|3794083|P2|Overall Study|Withdrawal by Subject|3
1155543|NCT01288209|3794084|P1|Overall Study|Withdrawal by Subject|1
1155544|NCT01288079|3794114|P4|Overall Study|Other or Study Termination|8
1155545|NCT01288079|3794115|P3|Overall Study|Other or Study Termination|14
1155546|NCT01288079|3794116|P2|Overall Study|Other or Study Termination|15
1155547|NCT01288079|3794117|P1|Overall Study|Other or Study Termination|11
1155548|NCT01288079|3794114|P4|Overall Study|Lost to Follow-up|0
1155549|NCT01288079|3794115|P3|Overall Study|Lost to Follow-up|1
1155550|NCT01288079|3794116|P2|Overall Study|Lost to Follow-up|1
1155551|NCT01288079|3794117|P1|Overall Study|Lost to Follow-up|1
1155552|NCT01288079|3794114|P4|Overall Study|Study-Specific Withdrawal Criteria|0
1155553|NCT01288079|3794115|P3|Overall Study|Study-Specific Withdrawal Criteria|0
1155554|NCT01288079|3794116|P2|Overall Study|Study-Specific Withdrawal Criteria|1
1155555|NCT01288079|3794117|P1|Overall Study|Study-Specific Withdrawal Criteria|1
1155556|NCT01288079|3794114|P4|Overall Study|Lack of Efficacy|2
1155557|NCT01288079|3794115|P3|Overall Study|Lack of Efficacy|0
1155558|NCT01288079|3794116|P2|Overall Study|Lack of Efficacy|2
1155559|NCT01288079|3794117|P1|Overall Study|Lack of Efficacy|2
1155560|NCT01288079|3794114|P4|Overall Study|Condition under Investigation Worsened|1
1155561|NCT01288079|3794115|P3|Overall Study|Condition under Investigation Worsened|0
1155562|NCT01288079|3794116|P2|Overall Study|Condition under Investigation Worsened|0
1155563|NCT01288079|3794117|P1|Overall Study|Condition under Investigation Worsened|0
1155564|NCT01288079|3794114|P4|Overall Study|Severe Non-Compliance to Protocol|3
1155565|NCT01288079|3794115|P3|Overall Study|Severe Non-Compliance to Protocol|1
1155566|NCT01288079|3794116|P2|Overall Study|Severe Non-Compliance to Protocol|3
1155567|NCT01288079|3794117|P1|Overall Study|Severe Non-Compliance to Protocol|1
1155568|NCT01288079|3794114|P4|Overall Study|Adverse Event|3
1155569|NCT01288079|3794115|P3|Overall Study|Adverse Event|2
1155570|NCT01288079|3794116|P2|Overall Study|Adverse Event|1
1155571|NCT01288079|3794117|P1|Overall Study|Adverse Event|2
1155572|NCT01288079|3794114|P4|Overall Study|Withdrawal by Subject|0
1155573|NCT01288079|3794115|P3|Overall Study|Withdrawal by Subject|1
1155574|NCT01288079|3794116|P2|Overall Study|Withdrawal by Subject|4
1155575|NCT01288079|3794117|P1|Overall Study|Withdrawal by Subject|2
1155576|NCT01288053|3794127|P1|Overall Study|Death|1
1155577|NCT01287897|3794145|P4|Overall Study|Other|0
1155578|NCT01287897|3794146|P3|Overall Study|Other|1
1155579|NCT01287897|3794147|P2|Overall Study|Other|0
1155580|NCT01287897|3794148|P1|Overall Study|Other|1
1155581|NCT01287897|3794145|P4|Overall Study|Not meeting entrance criteria|0
1155582|NCT01287897|3794146|P3|Overall Study|Not meeting entrance criteria|0
1155583|NCT01287897|3794147|P2|Overall Study|Not meeting entrance criteria|1
1155584|NCT01287897|3794148|P1|Overall Study|Not meeting entrance criteria|1
1155585|NCT01287897|3794145|P4|Overall Study|Not consented properly|0
1155586|NCT01287897|3794146|P3|Overall Study|Not consented properly|0
1155587|NCT01287897|3794147|P2|Overall Study|Not consented properly|1
1155588|NCT01287897|3794148|P1|Overall Study|Not consented properly|0
1155589|NCT01287897|3794145|P4|Overall Study|Withdrawal by Subject|2
1155590|NCT01287897|3794146|P3|Overall Study|Withdrawal by Subject|3
1155591|NCT01287897|3794147|P2|Overall Study|Withdrawal by Subject|5
1155592|NCT01287897|3794148|P1|Overall Study|Withdrawal by Subject|1
1155593|NCT01287897|3794145|P4|Overall Study|Lost to Follow-up|0
1155594|NCT01287897|3794146|P3|Overall Study|Lost to Follow-up|2
1155595|NCT01287897|3794147|P2|Overall Study|Lost to Follow-up|0
1155596|NCT01287897|3794148|P1|Overall Study|Lost to Follow-up|0
1155597|NCT01287897|3794145|P4|Overall Study|Protocol Violation|1
1155598|NCT01287897|3794146|P3|Overall Study|Protocol Violation|0
1155599|NCT01287897|3794147|P2|Overall Study|Protocol Violation|1
1155600|NCT01287897|3794148|P1|Overall Study|Protocol Violation|1
1155601|NCT01287897|3794145|P4|Overall Study|Lack of Efficacy|0
1155602|NCT01287897|3794146|P3|Overall Study|Lack of Efficacy|0
1155603|NCT01287897|3794147|P2|Overall Study|Lack of Efficacy|0
1155604|NCT01287897|3794148|P1|Overall Study|Lack of Efficacy|2
1155605|NCT01287897|3794145|P4|Overall Study|Adverse Event|4
1155606|NCT01287897|3794146|P3|Overall Study|Adverse Event|6
1155607|NCT01287897|3794147|P2|Overall Study|Adverse Event|3
1155608|NCT01287897|3794148|P1|Overall Study|Adverse Event|5
1155609|NCT01287832|3794199|P2|Overall Study|Death|1
1155610|NCT01287832|3794200|P1|Overall Study|Death|0
1155611|NCT01287832|3794199|P2|Overall Study|Adverse Event|0
1155612|NCT01287832|3794200|P1|Overall Study|Adverse Event|1
1155613|NCT01287754|3794208|P2|Overall Study|Protocol Violation|3
1155614|NCT01287754|3794209|P1|Overall Study|Protocol Violation|0
1155615|NCT01287754|3794208|P2|Overall Study|Lost to Follow-up|6
1155616|NCT01287754|3794209|P1|Overall Study|Lost to Follow-up|1
1155617|NCT01287754|3794208|P2|Overall Study|Death|12
1155618|NCT01287754|3794209|P1|Overall Study|Death|2
1155619|NCT01287741|3794221|P2|Overall Study|Reason not specified|9
1155620|NCT01287741|3794222|P1|Overall Study|Reason not specified|14
1155621|NCT01287741|3794221|P2|Overall Study|Progressive disease|148
1155622|NCT01287741|3794222|P1|Overall Study|Progressive disease|173
1155623|NCT01287741|3794221|P2|Overall Study|Continued in the study|455
1155624|NCT01287741|3794222|P1|Overall Study|Continued in the study|446
1155625|NCT01287741|3794221|P2|Overall Study|Adverse Event|4
1155626|NCT01287741|3794222|P1|Overall Study|Adverse Event|3
1155627|NCT01287741|3794221|P2|Overall Study|Death|38
1155628|NCT01287741|3794222|P1|Overall Study|Death|31
1155629|NCT01287741|3794221|P2|Overall Study|Lost to Follow-up|8
1155630|NCT01287741|3794222|P1|Overall Study|Lost to Follow-up|5
1155631|NCT01287741|3794221|P2|Overall Study|Non-compliance|3
1155632|NCT01287741|3794222|P1|Overall Study|Non-compliance|2
1155633|NCT01287741|3794221|P2|Overall Study|Physician Decision|19
1155634|NCT01287741|3794222|P1|Overall Study|Physician Decision|12
1155635|NCT01287741|3794221|P2|Overall Study|Protocol Violation|0
1155636|NCT01287741|3794222|P1|Overall Study|Protocol Violation|1
1155637|NCT01287741|3794221|P2|Overall Study|Withdrawal by Subject|22
1155638|NCT01287741|3794222|P1|Overall Study|Withdrawal by Subject|25
1155639|NCT01287611|3794258|P2|Overall Study|Exclusion due to expanded Kerr incision|3
1155640|NCT01287611|3794259|P1|Overall Study|Exclusion due to expanded Kerr incision|4
1155641|NCT01287611|3794258|P2|Overall Study|Lost to Follow-up|16
1155642|NCT01287611|3794259|P1|Overall Study|Lost to Follow-up|29
1155643|NCT01287416|3794269|P2|6 Month Follow-up|Lost to Follow-up|2
1155644|NCT01287416|3794270|P1|6 Month Follow-up|Lost to Follow-up|3
1155645|NCT01287416|3794269|P2|Pre-post Training|Lost to Follow-up|1
1155646|NCT01287416|3794270|P1|Pre-post Training|Lost to Follow-up|5
1155647|NCT01287416|3794269|P2|Pre-post Training|Withdrawal by Subject|24
1155648|NCT01287416|3794270|P1|Pre-post Training|Withdrawal by Subject|17
1155649|NCT01287403|3794306|P1|1st Intervention (1 Day)|Adverse Event|1
1155650|NCT01287364|3794322|P2|Overall Study|Other Reason|2
1155651|NCT01287364|3794323|P1|Overall Study|Other Reason|4
1155652|NCT01287364|3794322|P2|Overall Study|Protocol Violation|5
1155653|NCT01287364|3794323|P1|Overall Study|Protocol Violation|5
1155654|NCT01287364|3794322|P2|Overall Study|Adverse Event|3
1155655|NCT01287364|3794323|P1|Overall Study|Adverse Event|0
1155656|NCT01287221|3794345|P2|Overall Study|Withdrawal by Subject|1
1155657|NCT01287221|3794346|P1|Overall Study|Withdrawal by Subject|0
1155658|NCT01287221|3794345|P2|Overall Study|Adverse Event|3
1155659|NCT01287221|3794346|P1|Overall Study|Adverse Event|3
1155660|NCT01287221|3794345|P2|Overall Study|Lack of Perceived Benefit|1
1155661|NCT01287221|3794346|P1|Overall Study|Lack of Perceived Benefit|1
1155662|NCT01287195|3794381|P1|Overall Study|Withdrawal by Subject|2
1155663|NCT01287117|3794396|P4|Overall Study|Disease Progression|5
1155664|NCT01287117|3794397|P3|Overall Study|Disease Progression|6
1155665|NCT01287117|3794398|P2|Overall Study|Disease Progression|5
1155666|NCT01287117|3794399|P1|Overall Study|Disease Progression|10
1155667|NCT01287117|3794396|P4|Overall Study|Patient/Legal Guardian's Decision|5
1155668|NCT01287117|3794397|P3|Overall Study|Patient/Legal Guardian's Decision|8
1155669|NCT01287117|3794398|P2|Overall Study|Patient/Legal Guardian's Decision|6
1155670|NCT01287117|3794399|P1|Overall Study|Patient/Legal Guardian's Decision|2
1155671|NCT01287117|3794396|P4|Overall Study|Physician Decision|1
1155672|NCT01287117|3794397|P3|Overall Study|Physician Decision|1
1155673|NCT01287117|3794398|P2|Overall Study|Physician Decision|1
1155674|NCT01287117|3794399|P1|Overall Study|Physician Decision|0
1155675|NCT01287117|3794396|P4|Overall Study|Lost to Follow-up|0
1155676|NCT01287117|3794397|P3|Overall Study|Lost to Follow-up|0
1155677|NCT01287117|3794398|P2|Overall Study|Lost to Follow-up|1
1155678|NCT01287117|3794399|P1|Overall Study|Lost to Follow-up|1
1155679|NCT01287117|3794396|P4|Overall Study|Adverse Event|1
1155680|NCT01287117|3794397|P3|Overall Study|Adverse Event|1
1155681|NCT01287117|3794398|P2|Overall Study|Adverse Event|1
1155682|NCT01287117|3794399|P1|Overall Study|Adverse Event|2
1155683|NCT01287065|3794445|P6|Treatment Period 1|Withdrawal by Subject|1
1155684|NCT01287065|3794446|P5|Treatment Period 1|Withdrawal by Subject|0
1155685|NCT01287065|3794447|P4|Treatment Period 1|Withdrawal by Subject|0
1155686|NCT01287065|3794448|P3|Treatment Period 1|Withdrawal by Subject|0
1155687|NCT01287065|3794449|P2|Treatment Period 1|Withdrawal by Subject|0
1155688|NCT01287065|3794450|P1|Treatment Period 1|Withdrawal by Subject|0
1155689|NCT01287065|3794445|P6|Treatment Period 1|Adverse Event|0
1155690|NCT01287065|3794446|P5|Treatment Period 1|Adverse Event|1
1155691|NCT01287065|3794447|P4|Treatment Period 1|Adverse Event|0
1155692|NCT01287065|3794448|P3|Treatment Period 1|Adverse Event|0
1155693|NCT01287065|3794449|P2|Treatment Period 1|Adverse Event|0
1155694|NCT01287065|3794450|P1|Treatment Period 1|Adverse Event|0
1155695|NCT01287039|3794469|P2|Overall Study|Lost to Follow-up|2
1155696|NCT01287039|3794470|P1|Overall Study|Lost to Follow-up|3
1155697|NCT01287039|3794469|P2|Overall Study|Withdrawal by Subject|11
1155698|NCT01287039|3794470|P1|Overall Study|Withdrawal by Subject|14
1155699|NCT01287039|3794469|P2|Overall Study|Adverse Event|4
1155700|NCT01287039|3794470|P1|Overall Study|Adverse Event|7
1155701|NCT01287039|3794469|P2|Overall Study|Change of residence|0
1155702|NCT01287039|3794470|P1|Overall Study|Change of residence|1
1155703|NCT01287039|3794469|P2|Overall Study|Death|0
1155704|NCT01287039|3794470|P1|Overall Study|Death|1
1155705|NCT01287039|3794469|P2|Overall Study|Problem with travel|1
1155706|NCT01287039|3794470|P1|Overall Study|Problem with travel|0
1155707|NCT01287039|3794469|P2|Overall Study|Noncompliance with study medication|1
1155708|NCT01287039|3794470|P1|Overall Study|Noncompliance with study medication|0
1155709|NCT01287039|3794469|P2|Overall Study|Excluded medication taken|0
1155710|NCT01287039|3794470|P1|Overall Study|Excluded medication taken|1
1155711|NCT01287039|3794469|P2|Overall Study|Protocol Violation|3
1155712|NCT01287039|3794470|P1|Overall Study|Protocol Violation|2
1155713|NCT01287039|3794469|P2|Overall Study|Elective surgery|1
1155714|NCT01287039|3794470|P1|Overall Study|Elective surgery|0
1155715|NCT01287039|3794469|P2|Overall Study|Change of location/residence|3
1155716|NCT01287039|3794470|P1|Overall Study|Change of location/residence|0
1155717|NCT01287039|3794469|P2|Overall Study|Noncompliance with study procedures|1
1155718|NCT01287039|3794470|P1|Overall Study|Noncompliance with study procedures|0
1155719|NCT01287013|3794503|P3|Overall Study|Non-evaluable|21
1155720|NCT01287013|3794504|P2|Overall Study|Non-evaluable|5
1155721|NCT01287013|3794505|P1|Overall Study|Non-evaluable|3
1155722|NCT01286779|3794555|P1|Overall Study|Discontinued by sponsor|1
1155723|NCT01286779|3794555|P1|Overall Study|Participant moved to another country|1
1155724|NCT01286779|3794555|P1|Overall Study|Participant had scheduled surgery|1
1155725|NCT01286779|3794555|P1|Overall Study|Physician Decision|2
1155726|NCT01286779|3794555|P1|Overall Study|Protocol Violation|5
1155727|NCT01286779|3794555|P1|Overall Study|Withdrawal by Subject|9
1155728|NCT01286753|3794607|P2|Overall Study|Participant to Receive Radiotherapy|0
1155729|NCT01286753|3794608|P1|Overall Study|Participant to Receive Radiotherapy|1
1155730|NCT01286753|3794607|P2|Overall Study|Discontinued to Join Extension Study|4
1155731|NCT01286753|3794608|P1|Overall Study|Discontinued to Join Extension Study|6
1155732|NCT01286753|3794607|P2|Overall Study|Withdrawal of Consent|2
1155733|NCT01286753|3794608|P1|Overall Study|Withdrawal of Consent|0
1155734|NCT01286753|3794607|P2|Overall Study|Refused Treatment|0
1155735|NCT01286753|3794608|P1|Overall Study|Refused Treatment|1
1155736|NCT01286753|3794607|P2|Overall Study|Progression|13
1155737|NCT01286753|3794608|P1|Overall Study|Progression|11
1155738|NCT01286753|3794607|P2|Overall Study|Adverse Event|6
1155739|NCT01286753|3794608|P1|Overall Study|Adverse Event|7
1155740|NCT01286740|3794626|P1|Overall Study|Protocol Violation|1
1155741|NCT01286740|3794626|P1|Overall Study|Enrolled but not treated|1
1155742|NCT01286558|3794644|P2|Overall Study|Withdrawal by Subject|1
1155743|NCT01286558|3794645|P1|Overall Study|Withdrawal by Subject|0
1155744|NCT01286558|3794644|P2|Overall Study|Adverse Event|1
1155745|NCT01286558|3794645|P1|Overall Study|Adverse Event|1
1155746|NCT01286480|3794681|P2|Overall Study|Withdrawal by Subject|3
1155747|NCT01286480|3794682|P1|Overall Study|Withdrawal by Subject|5
1155748|NCT01286311|3794768|P2|Overall Study|Physician did not want outreach sent|0
1155749|NCT01286311|3794769|P1|Overall Study|Physician did not want outreach sent|14
1155750|NCT01286207|3794786|P3|Overall Study|Other|13
1155751|NCT01286207|3794787|P2|Overall Study|Other|47
1155752|NCT01286207|3794788|P1|Overall Study|Other|37
1155753|NCT01286207|3794786|P3|Overall Study|Lack of Response|8
1155754|NCT01286207|3794787|P2|Overall Study|Lack of Response|38
1155755|NCT01286207|3794788|P1|Overall Study|Lack of Response|92
1155756|NCT01286207|3794786|P3|Overall Study|Withdrawal by Subject|41
1155757|NCT01286207|3794787|P2|Overall Study|Withdrawal by Subject|79
1155758|NCT01286207|3794788|P1|Overall Study|Withdrawal by Subject|93
1155759|NCT01286207|3794786|P3|Overall Study|Lost to Follow-up|20
1155760|NCT01286207|3794787|P2|Overall Study|Lost to Follow-up|43
1155761|NCT01286207|3794788|P1|Overall Study|Lost to Follow-up|49
1155762|NCT01286207|3794786|P3|Overall Study|Adverse Event|8
1155763|NCT01286207|3794787|P2|Overall Study|Adverse Event|41
1155764|NCT01286207|3794788|P1|Overall Study|Adverse Event|27
1155765|NCT01286168|3794808|P1|Overall Study|Surgical Drains Fell Out at Home|2
1155766|NCT01286168|3794808|P1|Overall Study|Withdrawal by Subject|1
1155767|NCT01286129|3794822|P2|Overall Study|Could not comply with study requirements|4
1155768|NCT01286129|3794823|P1|Overall Study|Could not comply with study requirements|4
1155769|NCT01286129|3794822|P2|Overall Study|Withdrawal by Subject|1
1155770|NCT01286129|3794823|P1|Overall Study|Withdrawal by Subject|4
1155771|NCT01286077|3794833|P2|Overall Study|refill medication not received in time|0
1155772|NCT01286077|3794834|P1|Overall Study|refill medication not received in time|1
1155773|NCT01286077|3794833|P2|Overall Study|Progression of disease|1
1155774|NCT01286077|3794834|P1|Overall Study|Progression of disease|0
1155775|NCT01286077|3794833|P2|Overall Study|Patient's decision to stop treatment|0
1155776|NCT01286077|3794834|P1|Overall Study|Patient's decision to stop treatment|3
1155777|NCT01286077|3794833|P2|Overall Study|The subject starts with alternative MMY|3
1155778|NCT01286077|3794834|P1|Overall Study|The subject starts with alternative MMY|0
1155779|NCT01286077|3794833|P2|Overall Study|Non-compliance|0
1155780|NCT01286077|3794834|P1|Overall Study|Non-compliance|1
1155781|NCT01286077|3794833|P2|Overall Study|Intercurrent illness|0
1155782|NCT01286077|3794834|P1|Overall Study|Intercurrent illness|1
1155783|NCT01286077|3794833|P2|Overall Study|Withdrawal by Subject|2
1155784|NCT01286077|3794834|P1|Overall Study|Withdrawal by Subject|0
1155785|NCT01286077|3794833|P2|Overall Study|Protocol Violation|1
1155786|NCT01286077|3794834|P1|Overall Study|Protocol Violation|1
1155787|NCT01286077|3794833|P2|Overall Study|Death|0
1155788|NCT01286077|3794834|P1|Overall Study|Death|1
1155789|NCT01286077|3794833|P2|Overall Study|Adverse Event|0
1155790|NCT01286077|3794834|P1|Overall Study|Adverse Event|2
1155791|NCT01286012|3794870|P2|Overall Study|peritoneal dialysis, randomized in error|3
1155792|NCT01286012|3794871|P1|Overall Study|peritoneal dialysis, randomized in error|1
1155793|NCT01286012|3794870|P2|Overall Study|Physician Decision|0
1155794|NCT01286012|3794871|P1|Overall Study|Physician Decision|2
1155795|NCT01286012|3794870|P2|Overall Study|Withdrawal by Subject|4
1155796|NCT01286012|3794871|P1|Overall Study|Withdrawal by Subject|4
1155797|NCT01286012|3794870|P2|Overall Study|Protocol Violation|1
1155798|NCT01286012|3794871|P1|Overall Study|Protocol Violation|1
1155799|NCT01286012|3794870|P2|Overall Study|Death|3
1155800|NCT01286012|3794871|P1|Overall Study|Death|2
1155801|NCT01286012|3794870|P2|Overall Study|Adverse Event|3
1155802|NCT01286012|3794871|P1|Overall Study|Adverse Event|3
1155803|NCT01285908|3794894|P3|Baseline Measurement|unable to tolerate procedure|0
1155804|NCT01285908|3794895|P2|Baseline Measurement|unable to tolerate procedure|0
1155805|NCT01285908|3794896|P1|Baseline Measurement|unable to tolerate procedure|1
1155806|NCT01285908|3794894|P3|Baseline Measurement|History of stroke, exclusion criteria|0
1155807|NCT01285908|3794895|P2|Baseline Measurement|History of stroke, exclusion criteria|0
1155808|NCT01285908|3794896|P1|Baseline Measurement|History of stroke, exclusion criteria|1
1155809|NCT01285908|3794894|P3|Baseline Measurement|unable to insert catheter|0
1155810|NCT01285908|3794895|P2|Baseline Measurement|unable to insert catheter|0
1155811|NCT01285908|3794896|P1|Baseline Measurement|unable to insert catheter|1
1155812|NCT01285609|3794990|P2|Treated With Blinded Therapy|Worsening of general condition|1
1155813|NCT01285609|3794991|P1|Treated With Blinded Therapy|Worsening of general condition|0
1155814|NCT01285609|3794990|P2|Treated With Blinded Therapy|PI decision to discontinue|1
1155815|NCT01285609|3794991|P1|Treated With Blinded Therapy|PI decision to discontinue|0
1155816|NCT01285609|3794990|P2|Treated With Blinded Therapy|Investigator's assessment|0
1155817|NCT01285609|3794991|P1|Treated With Blinded Therapy|Investigator's assessment|1
1155818|NCT01285609|3794990|P2|Treated With Blinded Therapy|Participant hospitalized|0
1155819|NCT01285609|3794991|P1|Treated With Blinded Therapy|Participant hospitalized|1
1155820|NCT01285609|3794990|P2|Treated With Blinded Therapy|Participant started radiotherapy|0
1155821|NCT01285609|3794991|P1|Treated With Blinded Therapy|Participant started radiotherapy|1
1155822|NCT01285609|3794990|P2|Treated With Blinded Therapy|Participant refused participation|0
1155823|NCT01285609|3794991|P1|Treated With Blinded Therapy|Participant refused participation|1
1155824|NCT01285609|3794990|P2|Treated With Blinded Therapy|Physician and Patient decision|3
1155825|NCT01285609|3794991|P1|Treated With Blinded Therapy|Physician and Patient decision|1
1155826|NCT01285609|3794990|P2|Treated With Blinded Therapy|Administrative Reason by Sponsor|3
1155827|NCT01285609|3794991|P1|Treated With Blinded Therapy|Administrative Reason by Sponsor|1
1155828|NCT01285609|3794990|P2|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0
1155829|NCT01285609|3794991|P1|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1
1155830|NCT01285609|3794990|P2|Treated With Blinded Therapy|Poor/Non-Compliance|2
1155831|NCT01285609|3794991|P1|Treated With Blinded Therapy|Poor/Non-Compliance|1
1155832|NCT01285609|3794990|P2|Treated With Blinded Therapy|Not Reported|2
1155833|NCT01285609|3794991|P1|Treated With Blinded Therapy|Not Reported|0
1155834|NCT01285609|3794990|P2|Treated With Blinded Therapy|Maximum Clinical Benefit|4
1155835|NCT01285609|3794991|P1|Treated With Blinded Therapy|Maximum Clinical Benefit|2
1155836|NCT01285609|3794990|P2|Treated With Blinded Therapy|Death|3
1155837|NCT01285609|3794991|P1|Treated With Blinded Therapy|Death|11
1155838|NCT01285609|3794990|P2|Treated With Blinded Therapy|Withdrawal by Subject|7
1155839|NCT01285609|3794991|P1|Treated With Blinded Therapy|Withdrawal by Subject|20
1155840|NCT01285609|3794990|P2|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14
1155841|NCT01285609|3794991|P1|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36
1155842|NCT01285609|3794990|P2|Treated With Blinded Therapy|Study Drug Toxicity|14
1155843|NCT01285609|3794991|P1|Treated With Blinded Therapy|Study Drug Toxicity|87
1155844|NCT01285609|3794990|P2|Treated With Blinded Therapy|Progressive Disease|305
1155845|NCT01285609|3794991|P1|Treated With Blinded Therapy|Progressive Disease|223
1155846|NCT01285609|3794990|P2|Randomized|Randomized but not Treated|4
1155847|NCT01285609|3794991|P1|Randomized|Randomized but not Treated|4
1155848|NCT01285609|3794990|P2|Randomized|Undisclosed Reasons|0
1155849|NCT01285609|3794991|P1|Randomized|Undisclosed Reasons|1
1155850|NCT01285609|3794990|P2|Randomized|Subject No Longer Met Study Criteria|1
1155851|NCT01285609|3794991|P1|Randomized|Subject No Longer Met Study Criteria|1
1155852|NCT01285609|3794990|P2|Randomized|Withdrawal by Subject|11
1155853|NCT01285609|3794991|P1|Randomized|Withdrawal by Subject|8
1155854|NCT01285609|3794990|P2|Randomized|Death|7
1155855|NCT01285609|3794991|P1|Randomized|Death|5
1155856|NCT01285609|3794990|P2|Randomized|Study Drug Toxicity|14
1155857|NCT01285609|3794991|P1|Randomized|Study Drug Toxicity|13
1155858|NCT01285609|3794990|P2|Randomized|Adverse Event Unrelated to Study Drug|18
1155859|NCT01285609|3794991|P1|Randomized|Adverse Event Unrelated to Study Drug|18
1155860|NCT01285609|3794990|P2|Randomized|Progressive Disease|61
1155861|NCT01285609|3794991|P1|Randomized|Progressive Disease|41
1155862|NCT01285518|3795009|P8|Overall Study|Lost to Follow-up|0
1155863|NCT01285518|3795010|P7|Overall Study|Lost to Follow-up|0
1155864|NCT01285518|3795011|P6|Overall Study|Lost to Follow-up|1
1155865|NCT01285518|3795012|P5|Overall Study|Lost to Follow-up|0
1155866|NCT01285518|3795013|P4|Overall Study|Lost to Follow-up|0
1155867|NCT01285518|3795014|P3|Overall Study|Lost to Follow-up|0
1155868|NCT01285518|3795015|P2|Overall Study|Lost to Follow-up|0
1155869|NCT01285518|3795016|P1|Overall Study|Lost to Follow-up|0
1155870|NCT01285492|3795276|P2|Overall Study|Death|0
1155871|NCT01285492|3795277|P1|Overall Study|Death|1
1155872|NCT01285492|3795276|P2|Overall Study|Withdrawal by Subject|1
1155873|NCT01285492|3795277|P1|Overall Study|Withdrawal by Subject|2
1155874|NCT01285492|3795276|P2|Overall Study|Protocol Violation|0
1155875|NCT01285492|3795277|P1|Overall Study|Protocol Violation|3
1155876|NCT01285492|3795276|P2|Overall Study|Adverse Event|0
1155877|NCT01285492|3795277|P1|Overall Study|Adverse Event|11
1155878|NCT01285401|3795309|P2|Overall Study|Prematurely withdrawn from the study|29
1155879|NCT01285401|3795310|P1|Overall Study|Prematurely withdrawn from the study|17
1155880|NCT01285323|3795350|P2|Overall Study|Not specified|3
1155881|NCT01285323|3795351|P1|Overall Study|Not specified|1
1155882|NCT01285323|3795350|P2|Overall Study|Lost to Follow-up|1
1155883|NCT01285323|3795351|P1|Overall Study|Lost to Follow-up|1
1155884|NCT01285323|3795350|P2|Overall Study|Non-compliance with study procedures|3
1155885|NCT01285323|3795351|P1|Overall Study|Non-compliance with study procedures|2
1155886|NCT01285323|3795350|P2|Overall Study|Protocol Violation|2
1155887|NCT01285323|3795351|P1|Overall Study|Protocol Violation|1
1155888|NCT01285323|3795350|P2|Overall Study|Withdrawal by Subject|11
1155889|NCT01285323|3795351|P1|Overall Study|Withdrawal by Subject|15
1155890|NCT01285323|3795350|P2|Overall Study|Lack of Efficacy|2
1155891|NCT01285323|3795351|P1|Overall Study|Lack of Efficacy|4
1155892|NCT01285323|3795350|P2|Overall Study|Adverse Event|8
1155893|NCT01285323|3795351|P1|Overall Study|Adverse Event|9
1155894|NCT01285310|3795386|P5|Active Treatment Phase: Weeks 25-52|Non-compliance|0
1155895|NCT01285310|3795387|P4|Active Treatment Phase: Weeks 25-52|Non-compliance|1
1155896|NCT01285310|3795388|P3|Active Treatment Phase: Weeks 25-52|Non-compliance|1
1155897|NCT01285310|3795389|P2|Active Treatment Phase: Weeks 25-52|Non-compliance|1
1155898|NCT01285310|3795390|P1|Active Treatment Phase: Weeks 25-52|Non-compliance|0
1155899|NCT01285310|3795386|P5|Active Treatment Phase: Weeks 25-52|Not Specified|0
1155900|NCT01285310|3795387|P4|Active Treatment Phase: Weeks 25-52|Not Specified|0
1155901|NCT01285310|3795388|P3|Active Treatment Phase: Weeks 25-52|Not Specified|0
1155902|NCT01285310|3795389|P2|Active Treatment Phase: Weeks 25-52|Not Specified|1
1155903|NCT01285310|3795390|P1|Active Treatment Phase: Weeks 25-52|Not Specified|0
1155904|NCT01285310|3795386|P5|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15
1155905|NCT01285310|3795387|P4|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6
1155906|NCT01285310|3795388|P3|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19
1155907|NCT01285310|3795389|P2|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21
1155908|NCT01285310|3795390|P1|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0
1155909|NCT01285310|3795386|P5|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
1155910|NCT01285310|3795387|P4|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
1155911|NCT01285310|3795388|P3|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
1155912|NCT01285310|3795389|P2|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3
1155913|NCT01285310|3795390|P1|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
1155914|NCT01285310|3795386|P5|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
1155915|NCT01285310|3795387|P4|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1
1155916|NCT01285310|3795388|P3|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3
1155917|NCT01285310|3795389|P2|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4
1155918|NCT01285310|3795390|P1|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
1155919|NCT01285310|3795386|P5|Active Treatment Phase: Weeks 25-52|Adverse Event|2
1155920|NCT01285310|3795387|P4|Active Treatment Phase: Weeks 25-52|Adverse Event|0
1155921|NCT01285310|3795388|P3|Active Treatment Phase: Weeks 25-52|Adverse Event|3
1155922|NCT01285310|3795389|P2|Active Treatment Phase: Weeks 25-52|Adverse Event|2
1155923|NCT01285310|3795390|P1|Active Treatment Phase: Weeks 25-52|Adverse Event|0
1155924|NCT01285310|3795386|P5|Placebo Controlled Phase: Weeks 0-24|Not specified|0
1155925|NCT01285310|3795387|P4|Placebo Controlled Phase: Weeks 0-24|Not specified|0
1155926|NCT01285310|3795388|P3|Placebo Controlled Phase: Weeks 0-24|Not specified|1
1155927|NCT01285310|3795389|P2|Placebo Controlled Phase: Weeks 0-24|Not specified|0
1155928|NCT01285310|3795390|P1|Placebo Controlled Phase: Weeks 0-24|Not specified|1
1155929|NCT01285310|3795386|P5|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
1155930|NCT01285310|3795387|P4|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
1155931|NCT01285310|3795388|P3|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
1155932|NCT01285310|3795389|P2|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
1155933|NCT01285310|3795390|P1|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
1155934|NCT01285310|3795386|P5|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
1155935|NCT01285310|3795387|P4|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
1155936|NCT01285310|3795388|P3|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2
1155937|NCT01285310|3795389|P2|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
1155938|NCT01285310|3795390|P1|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
1155939|NCT01285310|3795386|P5|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
1155940|NCT01285310|3795387|P4|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
1155941|NCT01285310|3795388|P3|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2
1155942|NCT01285310|3795389|P2|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
1155943|NCT01285310|3795390|P1|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1
1155944|NCT01285310|3795386|P5|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
1155945|NCT01285310|3795387|P4|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
1155946|NCT01285310|3795388|P3|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3
1155947|NCT01285310|3795389|P2|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7
1155948|NCT01285310|3795390|P1|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1
1155949|NCT01285310|3795386|P5|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
1155950|NCT01285310|3795387|P4|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
1155951|NCT01285310|3795388|P3|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6
1155952|NCT01285310|3795389|P2|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4
1155953|NCT01285310|3795390|P1|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3
1155954|NCT01284959|3795655|P3|Overall Study|Adverse Event|1
1155955|NCT01284959|3795656|P2|Overall Study|Adverse Event|0
1155956|NCT01284959|3795657|P1|Overall Study|Adverse Event|0
1155957|NCT01284959|3795655|P3|Overall Study|Withdrawal by Subject|0
1155958|NCT01284959|3795656|P2|Overall Study|Withdrawal by Subject|0
1155959|NCT01284959|3795657|P1|Overall Study|Withdrawal by Subject|1
1155960|NCT01284634|3795687|P4|Overall Study|Adverse Event|1
1155961|NCT01284634|3795688|P3|Overall Study|Adverse Event|2
1155962|NCT01284634|3795689|P2|Overall Study|Adverse Event|0
1155963|NCT01284634|3795690|P1|Overall Study|Adverse Event|1
1155964|NCT01284621|3795720|P6|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
1155965|NCT01284621|3795721|P5|Washout Period 1 (7 Days)|Required unexpected medical treatment|1
1155966|NCT01284621|3795722|P4|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
1155967|NCT01284621|3795723|P3|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
1155968|NCT01284621|3795724|P2|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
1155969|NCT01284621|3795725|P1|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
1155970|NCT01284491|3795793|P1|Overall Study|Study termination|13
1155971|NCT01284361|3795803|P1|Overall Study|Lost to Follow-up|2
1155972|NCT01284361|3795803|P1|Overall Study|Adverse Event|1
1155973|NCT01284361|3795803|P1|Overall Study|Protocol Violation|5
1155974|NCT01284361|3795803|P1|Overall Study|Withdrawal by Subject|1
1155975|NCT01284140|3795899|P2|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1
1155976|NCT01284140|3795900|P1|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0
1155977|NCT01284140|3795899|P2|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
1155978|NCT01284140|3795900|P1|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
1155979|NCT01284114|3795914|P1|Overall Study|dizziness|1
1155980|NCT01284114|3795914|P1|Overall Study|Symptomatic hypotension|1
1155981|NCT01284114|3795914|P1|Overall Study|From the results of ALLTITUDE study|1
1155982|NCT01284114|3795914|P1|Overall Study|viral infection|1
1155983|NCT01284062|3795926|P4|Overall Study|Site Closed|0
1155984|NCT01284062|3795927|P3|Overall Study|Site Closed|1
1155985|NCT01284062|3795928|P2|Overall Study|Site Closed|0
1155986|NCT01284062|3795929|P1|Overall Study|Site Closed|0
1155987|NCT01284062|3795926|P4|Overall Study|Other|1
1155988|NCT01284062|3795927|P3|Overall Study|Other|0
1155989|NCT01284062|3795928|P2|Overall Study|Other|0
1155990|NCT01284062|3795929|P1|Overall Study|Other|0
1155991|NCT01284062|3795926|P4|Overall Study|Withdrawal by Subject|5
1155992|NCT01284062|3795927|P3|Overall Study|Withdrawal by Subject|2
1155993|NCT01284062|3795928|P2|Overall Study|Withdrawal by Subject|1
1155994|NCT01284062|3795929|P1|Overall Study|Withdrawal by Subject|3
1155995|NCT01284062|3795926|P4|Overall Study|Protocol Violation|2
1155996|NCT01284062|3795927|P3|Overall Study|Protocol Violation|0
1155997|NCT01284062|3795928|P2|Overall Study|Protocol Violation|0
1155998|NCT01284062|3795929|P1|Overall Study|Protocol Violation|1
1155999|NCT01284062|3795926|P4|Overall Study|Medication error without adverse event|0
1156000|NCT01284062|3795927|P3|Overall Study|Medication error without adverse event|1
1156001|NCT01284062|3795928|P2|Overall Study|Medication error without adverse event|0
1156002|NCT01284062|3795929|P1|Overall Study|Medication error without adverse event|0
1156003|NCT01284062|3795926|P4|Overall Study|Lack of Efficacy|1
1156004|NCT01284062|3795927|P3|Overall Study|Lack of Efficacy|2
1156005|NCT01284062|3795928|P2|Overall Study|Lack of Efficacy|2
1156006|NCT01284062|3795929|P1|Overall Study|Lack of Efficacy|3
1156007|NCT01284062|3795926|P4|Overall Study|Adverse Event|5
1156008|NCT01284062|3795927|P3|Overall Study|Adverse Event|0
1156009|NCT01284062|3795928|P2|Overall Study|Adverse Event|5
1156010|NCT01284062|3795929|P1|Overall Study|Adverse Event|4
1156011|NCT01283971|3796003|P2|Overall Study|Administrative reasons|1
1156012|NCT01283971|3796004|P1|Overall Study|Administrative reasons|1
1156013|NCT01283971|3796003|P2|Overall Study|Failure to return|1
1156014|NCT01283971|3796004|P1|Overall Study|Failure to return|0
1156015|NCT01283971|3796003|P2|Overall Study|Refused treatment|1
1156016|NCT01283971|3796004|P1|Overall Study|Refused treatment|3
1156017|NCT01283971|3796003|P2|Overall Study|Protocol Violation|1
1156018|NCT01283971|3796004|P1|Overall Study|Protocol Violation|5
1156019|NCT01283971|3796003|P2|Overall Study|Insufficient therapeutic responses|3
1156020|NCT01283971|3796004|P1|Overall Study|Insufficient therapeutic responses|3
1156021|NCT01283971|3796003|P2|Overall Study|Adverse Event|5
1156022|NCT01283971|3796004|P1|Overall Study|Adverse Event|3
1156023|NCT01283581|3796051|P3|Overall Study|"Early termination"|1
1156024|NCT01283581|3796052|P2|Overall Study|"Early termination"|0
1156025|NCT01283581|3796053|P1|Overall Study|"Early termination"|0
1156026|NCT01283581|3796051|P3|Overall Study|Investigator unblinded|1
1156027|NCT01283581|3796052|P2|Overall Study|Investigator unblinded|0
1156028|NCT01283581|3796053|P1|Overall Study|Investigator unblinded|0
1156029|NCT01283581|3796051|P3|Overall Study|Noncompliance|0
1156030|NCT01283581|3796052|P2|Overall Study|Noncompliance|0
1156031|NCT01283581|3796053|P1|Overall Study|Noncompliance|1
1156032|NCT01283581|3796051|P3|Overall Study|Protocol Violation|2
1156033|NCT01283581|3796052|P2|Overall Study|Protocol Violation|1
1156034|NCT01283581|3796053|P1|Overall Study|Protocol Violation|0
1156035|NCT01283581|3796051|P3|Overall Study|Physician Decision|2
1156036|NCT01283581|3796052|P2|Overall Study|Physician Decision|1
1156037|NCT01283581|3796053|P1|Overall Study|Physician Decision|0
1156038|NCT01283581|3796051|P3|Overall Study|Adverse Event|4
1156039|NCT01283581|3796052|P2|Overall Study|Adverse Event|1
1156040|NCT01283581|3796053|P1|Overall Study|Adverse Event|1
1156041|NCT01283581|3796051|P3|Overall Study|Withdrawal by Subject|2
1156042|NCT01283581|3796052|P2|Overall Study|Withdrawal by Subject|5
1156043|NCT01283581|3796053|P1|Overall Study|Withdrawal by Subject|2
1156044|NCT01283581|3796051|P3|Overall Study|Lost to Follow-up|8
1156045|NCT01283581|3796052|P2|Overall Study|Lost to Follow-up|6
1156046|NCT01283581|3796053|P1|Overall Study|Lost to Follow-up|8
1156047|NCT01283516|3796117|P9|Overall Study|Withdrawal by Subject|11
1156048|NCT01283516|3796118|P8|Overall Study|Withdrawal by Subject|0
1156049|NCT01283516|3796119|P7|Overall Study|Withdrawal by Subject|0
1156050|NCT01283516|3796120|P6|Overall Study|Withdrawal by Subject|0
1156051|NCT01283516|3796121|P5|Overall Study|Withdrawal by Subject|1
1156052|NCT01283516|3796122|P4|Overall Study|Withdrawal by Subject|0
1156053|NCT01283516|3796123|P3|Overall Study|Withdrawal by Subject|0
1156054|NCT01283516|3796124|P2|Overall Study|Withdrawal by Subject|0
1156055|NCT01283516|3796125|P1|Overall Study|Withdrawal by Subject|0
1156056|NCT01283516|3796117|P9|Overall Study|Disease Progression|81
1156057|NCT01283516|3796118|P8|Overall Study|Disease Progression|2
1156058|NCT01283516|3796119|P7|Overall Study|Disease Progression|6
1156059|NCT01283516|3796120|P6|Overall Study|Disease Progression|7
1156060|NCT01283516|3796121|P5|Overall Study|Disease Progression|12
1156061|NCT01283516|3796122|P4|Overall Study|Disease Progression|3
1156062|NCT01283516|3796123|P3|Overall Study|Disease Progression|2
1156063|NCT01283516|3796124|P2|Overall Study|Disease Progression|2
1156064|NCT01283516|3796125|P1|Overall Study|Disease Progression|2
1156065|NCT01283516|3796117|P9|Overall Study|Death|6
1156066|NCT01283516|3796118|P8|Overall Study|Death|1
1156067|NCT01283516|3796119|P7|Overall Study|Death|0
1156068|NCT01283516|3796120|P6|Overall Study|Death|1
1156069|NCT01283516|3796121|P5|Overall Study|Death|0
1156070|NCT01283516|3796122|P4|Overall Study|Death|0
1156071|NCT01283516|3796123|P3|Overall Study|Death|0
1156072|NCT01283516|3796124|P2|Overall Study|Death|0
1156073|NCT01283516|3796125|P1|Overall Study|Death|0
1156074|NCT01283516|3796117|P9|Overall Study|Adverse Event|24
1156075|NCT01283516|3796118|P8|Overall Study|Adverse Event|0
1156076|NCT01283516|3796119|P7|Overall Study|Adverse Event|2
1156077|NCT01283516|3796120|P6|Overall Study|Adverse Event|0
1156078|NCT01283516|3796121|P5|Overall Study|Adverse Event|0
1156079|NCT01283516|3796122|P4|Overall Study|Adverse Event|0
1156080|NCT01283516|3796123|P3|Overall Study|Adverse Event|0
1156081|NCT01283516|3796124|P2|Overall Study|Adverse Event|0
1156082|NCT01283516|3796125|P1|Overall Study|Adverse Event|0
1156083|NCT01283464|3796149|P2|Overall Study|Physician Decision|0
1156084|NCT01283464|3796150|P1|Overall Study|Physician Decision|1
1156085|NCT01283464|3796149|P2|Overall Study|Withdrawal by Subject|0
1156086|NCT01283464|3796150|P1|Overall Study|Withdrawal by Subject|1
1156087|NCT01283464|3796149|P2|Overall Study|Lost to Follow-up|1
1156088|NCT01283464|3796150|P1|Overall Study|Lost to Follow-up|0
1156089|NCT01283334|3796156|P1|Overall Study|Physician Decision|1
1156090|NCT01283334|3796156|P1|Overall Study|Adverse Event|4
1156091|NCT01283334|3796156|P1|Overall Study|Inability to Swallow Everolimus Pills|1
1156092|NCT01283334|3796156|P1|Overall Study|Withdrawal by Subject|1
1156093|NCT01283282|3796179|P2|First Intervention (6 Weeks)|Lost to Follow-up|0
1156094|NCT01283282|3796180|P1|First Intervention (6 Weeks)|Lost to Follow-up|1
1156095|NCT01283282|3796179|P2|First Intervention (6 Weeks)|Withdrawal by Subject|3
1156096|NCT01283282|3796180|P1|First Intervention (6 Weeks)|Withdrawal by Subject|2
1156097|NCT01283282|3796179|P2|First Intervention (6 Weeks)|Physician Decision|1
1156098|NCT01283282|3796180|P1|First Intervention (6 Weeks)|Physician Decision|0
1156099|NCT01283152|3796200|P2|Overall Study|Refused HESA|0
1156100|NCT01283152|3796201|P1|Overall Study|Refused HESA|1
1156101|NCT01283152|3796200|P2|Overall Study|Discharged prior to 24 hr assessment|0
1156102|NCT01283152|3796201|P1|Overall Study|Discharged prior to 24 hr assessment|1
1156103|NCT01283139|3796215|P4|Overall Study|Participant randomized in error|0
1156104|NCT01283139|3796216|P3|Overall Study|Participant randomized in error|1
1156105|NCT01283139|3796217|P2|Overall Study|Participant randomized in error|0
1156106|NCT01283139|3796218|P1|Overall Study|Participant randomized in error|0
1156107|NCT01283139|3796215|P4|Overall Study|Missed follow-up visit|2
1156108|NCT01283139|3796216|P3|Overall Study|Missed follow-up visit|2
1156109|NCT01283139|3796217|P2|Overall Study|Missed follow-up visit|1
1156110|NCT01283139|3796218|P1|Overall Study|Missed follow-up visit|0
1156111|NCT01283139|3796215|P4|Overall Study|Pregnancy|0
1156112|NCT01283139|3796216|P3|Overall Study|Pregnancy|1
1156113|NCT01283139|3796217|P2|Overall Study|Pregnancy|1
1156114|NCT01283139|3796218|P1|Overall Study|Pregnancy|0
1156115|NCT01283139|3796215|P4|Overall Study|Participant's refusal to continue|1
1156116|NCT01283139|3796216|P3|Overall Study|Participant's refusal to continue|1
1156117|NCT01283139|3796217|P2|Overall Study|Participant's refusal to continue|3
1156118|NCT01283139|3796218|P1|Overall Study|Participant's refusal to continue|0
1156119|NCT01283139|3796215|P4|Overall Study|Early termination due to AE/SAE|0
1156120|NCT01283139|3796216|P3|Overall Study|Early termination due to AE/SAE|0
1156121|NCT01283139|3796217|P2|Overall Study|Early termination due to AE/SAE|1
1156122|NCT01283139|3796218|P1|Overall Study|Early termination due to AE/SAE|1
1156123|NCT01283139|3796215|P4|Overall Study|Lack of Efficacy|1
1156124|NCT01283139|3796216|P3|Overall Study|Lack of Efficacy|2
1156125|NCT01283139|3796217|P2|Overall Study|Lack of Efficacy|2
1156126|NCT01283139|3796218|P1|Overall Study|Lack of Efficacy|1
1156127|NCT01283139|3796215|P4|Overall Study|Death|2
1156128|NCT01283139|3796216|P3|Overall Study|Death|2
1156129|NCT01283139|3796217|P2|Overall Study|Death|0
1156130|NCT01283139|3796218|P1|Overall Study|Death|2
1156131|NCT01283139|3796215|P4|Overall Study|Withdrawal by Subject|8
1156132|NCT01283139|3796216|P3|Overall Study|Withdrawal by Subject|6
1156133|NCT01283139|3796217|P2|Overall Study|Withdrawal by Subject|8
1156134|NCT01283139|3796218|P1|Overall Study|Withdrawal by Subject|8
1156135|NCT01283139|3796215|P4|Overall Study|Lost to Follow-up|1
1156136|NCT01283139|3796216|P3|Overall Study|Lost to Follow-up|3
1156137|NCT01283139|3796217|P2|Overall Study|Lost to Follow-up|2
1156138|NCT01283139|3796218|P1|Overall Study|Lost to Follow-up|5
1156139|NCT01283035|3796260|P1|Overall Study|Subject later found ineligible|1
1156140|NCT01282866|3796275|P1|Overall Study|Adverse Event|1
1156141|NCT01282814|3796283|P2|Washout of 7 Days|Withdrawal by Subject|0
1156142|NCT01282814|3796284|P1|Washout of 7 Days|Withdrawal by Subject|2
1156143|NCT01282814|3796283|P2|First Intervention|Emesis During Dosing Interval|3
1156144|NCT01282814|3796284|P1|First Intervention|Emesis During Dosing Interval|0
1156145|NCT01282801|3796296|P2|Second Intervention|Emesis During Critical Breakfast|1
1156146|NCT01282801|3796297|P1|Second Intervention|Emesis During Critical Breakfast|0
1156147|NCT01282476|3796321|P1|Overall Study|Death|11
1156148|NCT01282424|3796327|P1|Overall Study|Investigator Request|7
1156149|NCT01282424|3796327|P1|Overall Study|Withdrew Consent|4
1156150|NCT01282424|3796327|P1|Overall Study|Adverse Event|25
1156151|NCT01282424|3796327|P1|Overall Study|Treatment Ongoing|40
1156152|NCT01282372|3796344|P1|Overall Study|Adverse Event|12
1156153|NCT01282372|3796344|P1|Overall Study|Refer Pre-Assignment Detail for Reason 2|1
1156154|NCT01282372|3796344|P1|Overall Study|Presence of AE, Regression of Symptoms|1
1156155|NCT01282372|3796344|P1|Overall Study|Presence of AE, Lack of Efficacy|1
1156156|NCT01282372|3796344|P1|Overall Study|Death|1
1156157|NCT01282372|3796344|P1|Overall Study|Refer Pre-Assignment Detail for Reason 1|4
1156158|NCT01282372|3796344|P1|Overall Study|Withdrawal by Subject|11
1156159|NCT01282372|3796344|P1|Overall Study|Lost to Follow-up|23
1156160|NCT01282372|3796344|P1|Overall Study|Lack of Efficacy / Exacerbation|25
1156161|NCT01282294|3796372|P1|Overall Study|Physician Decision|1
1156162|NCT01282294|3796372|P1|Overall Study|Patient non-compliance|2
1156163|NCT01282294|3796372|P1|Overall Study|Adverse Event|1
1156164|NCT01282294|3796372|P1|Overall Study|Screening failure|1
1156165|NCT01282294|3796372|P1|Overall Study|Lost to Follow-up|14
1156166|NCT01282229|3796401|P1|Overall Study|Protocol Violation|2
1156167|NCT01282203|3796431|P1|Overall Study|Adverse Event|1
1156168|NCT01282164|3796453|P2|Overall Study|Lack of hypoglycemia during ITT|0
1156169|NCT01282164|3796454|P1|Overall Study|Lack of hypoglycemia during ITT|1
1156170|NCT01281956|3796505|P2|2nd Intervention (3 Months)|Withdrawal by Subject|0
1156171|NCT01281956|3796506|P1|2nd Intervention (3 Months)|Withdrawal by Subject|1
1156172|NCT01281917|3796537|P1|Overall Study|Withdrawal by Subject|1
1156173|NCT01281865|3796549|P2|Overall Study|Lack of Efficacy|0
1156174|NCT01281865|3796550|P1|Overall Study|Lack of Efficacy|1
1156175|NCT01281865|3796549|P2|Overall Study|Withdrawal by Subject|0
1156176|NCT01281865|3796550|P1|Overall Study|Withdrawal by Subject|1
1156177|NCT01281865|3796549|P2|Overall Study|Adverse Event|1
1156178|NCT01281865|3796550|P1|Overall Study|Adverse Event|1
1156179|NCT01281839|3796558|P2|Overall Study|Reason not specified|1
1156180|NCT01281839|3796559|P1|Overall Study|Reason not specified|0
1156181|NCT01281839|3796558|P2|Overall Study|Withdrawal by Subject|10
1156182|NCT01281839|3796559|P1|Overall Study|Withdrawal by Subject|4
1156183|NCT01281839|3796558|P2|Overall Study|Lost to Follow-up|3
1156184|NCT01281839|3796559|P1|Overall Study|Lost to Follow-up|6
1156185|NCT01281644|3796620|P1|Overall Study|Withdrawal by Subject|2
1156186|NCT01281644|3796620|P1|Overall Study|Lost to Follow-up|3
1156187|NCT01281306|3796661|P7|Overall Study|Randomized in error|0
1156188|NCT01281306|3796662|P6|Overall Study|Randomized in error|0
1156189|NCT01281306|3796663|P5|Overall Study|Randomized in error|0
1156190|NCT01281306|3796664|P4|Overall Study|Randomized in error|1
1156191|NCT01281306|3796665|P3|Overall Study|Randomized in error|0
1156192|NCT01281306|3796666|P2|Overall Study|Randomized in error|0
1156193|NCT01281306|3796667|P1|Overall Study|Randomized in error|1
1156194|NCT01281306|3796661|P7|Overall Study|Adverse Event|3
1156195|NCT01281306|3796662|P6|Overall Study|Adverse Event|3
1156196|NCT01281306|3796663|P5|Overall Study|Adverse Event|5
1156197|NCT01281306|3796664|P4|Overall Study|Adverse Event|3
1156198|NCT01281306|3796665|P3|Overall Study|Adverse Event|2
1156199|NCT01281306|3796666|P2|Overall Study|Adverse Event|2
1156200|NCT01281306|3796667|P1|Overall Study|Adverse Event|3
1156201|NCT01281306|3796661|P7|Overall Study|Death|0
1156202|NCT01281306|3796662|P6|Overall Study|Death|0
1156203|NCT01281306|3796663|P5|Overall Study|Death|0
1156204|NCT01281306|3796664|P4|Overall Study|Death|0
1156205|NCT01281306|3796665|P3|Overall Study|Death|0
1156206|NCT01281306|3796666|P2|Overall Study|Death|0
1156207|NCT01281306|3796667|P1|Overall Study|Death|1
1156208|NCT01281306|3796661|P7|Overall Study|Lost to Follow-up|1
1156209|NCT01281306|3796662|P6|Overall Study|Lost to Follow-up|0
1156210|NCT01281306|3796663|P5|Overall Study|Lost to Follow-up|0
1156211|NCT01281306|3796664|P4|Overall Study|Lost to Follow-up|2
1156212|NCT01281306|3796665|P3|Overall Study|Lost to Follow-up|0
1156213|NCT01281306|3796666|P2|Overall Study|Lost to Follow-up|0
1156214|NCT01281306|3796667|P1|Overall Study|Lost to Follow-up|1
1156215|NCT01281306|3796661|P7|Overall Study|Condition no longer requires study drug|1
1156216|NCT01281306|3796662|P6|Overall Study|Condition no longer requires study drug|1
1156217|NCT01281306|3796663|P5|Overall Study|Condition no longer requires study drug|0
1156218|NCT01281306|3796664|P4|Overall Study|Condition no longer requires study drug|0
1156219|NCT01281306|3796665|P3|Overall Study|Condition no longer requires study drug|0
1156220|NCT01281306|3796666|P2|Overall Study|Condition no longer requires study drug|0
1156221|NCT01281306|3796667|P1|Overall Study|Condition no longer requires study drug|1
1156222|NCT01281306|3796661|P7|Overall Study|Protocol deviation|0
1156223|NCT01281306|3796662|P6|Overall Study|Protocol deviation|0
1156224|NCT01281306|3796663|P5|Overall Study|Protocol deviation|1
1156225|NCT01281306|3796664|P4|Overall Study|Protocol deviation|1
1156226|NCT01281306|3796665|P3|Overall Study|Protocol deviation|1
1156227|NCT01281306|3796666|P2|Overall Study|Protocol deviation|1
1156228|NCT01281306|3796667|P1|Overall Study|Protocol deviation|0
1156229|NCT01281306|3796661|P7|Overall Study|Withdrawal by Subject|1
1156230|NCT01281306|3796662|P6|Overall Study|Withdrawal by Subject|3
1156231|NCT01281306|3796663|P5|Overall Study|Withdrawal by Subject|1
1156232|NCT01281306|3796664|P4|Overall Study|Withdrawal by Subject|4
1156233|NCT01281306|3796665|P3|Overall Study|Withdrawal by Subject|2
1156234|NCT01281306|3796666|P2|Overall Study|Withdrawal by Subject|0
1156235|NCT01281306|3796667|P1|Overall Study|Withdrawal by Subject|1
1156236|NCT01281306|3796661|P7|Overall Study|Lack of Efficacy|1
1156237|NCT01281306|3796662|P6|Overall Study|Lack of Efficacy|0
1156238|NCT01281306|3796663|P5|Overall Study|Lack of Efficacy|2
1156239|NCT01281306|3796664|P4|Overall Study|Lack of Efficacy|0
1156240|NCT01281306|3796665|P3|Overall Study|Lack of Efficacy|3
1156241|NCT01281306|3796666|P2|Overall Study|Lack of Efficacy|1
1156242|NCT01281306|3796667|P1|Overall Study|Lack of Efficacy|0
1156243|NCT01281202|3796783|P2|Overall Study|Incarceration|3
1156244|NCT01281202|3796784|P1|Overall Study|Incarceration|0
1156245|NCT01281202|3796783|P2|Overall Study|Lost to Follow-up|13
1156246|NCT01281202|3796784|P1|Overall Study|Lost to Follow-up|11
1156247|NCT01281202|3796783|P2|Overall Study|Administrative|8
1156248|NCT01281202|3796784|P1|Overall Study|Administrative|2
1156249|NCT01281202|3796783|P2|Overall Study|Protocol Violation|10
1156250|NCT01281202|3796784|P1|Overall Study|Protocol Violation|11
1156251|NCT01281202|3796783|P2|Overall Study|Withdrawal by Subject|2
1156252|NCT01281202|3796784|P1|Overall Study|Withdrawal by Subject|2
1156253|NCT01281202|3796783|P2|Overall Study|Adverse Event|0
1156254|NCT01281202|3796784|P1|Overall Study|Adverse Event|2
1156255|NCT01281124|3796792|P1|Overall Study|Death|1
1156256|NCT01280981|3796807|P1|Overall Study|Study site closure|1
1156257|NCT01280981|3796807|P1|Overall Study|Elective surgery|2
1156258|NCT01280981|3796807|P1|Overall Study|Withdrawal of consent|3
1156259|NCT01280981|3796807|P1|Overall Study|Non-compliance with protocol|3
1156260|NCT01280981|3796807|P1|Overall Study|Failed to return|45
1156261|NCT01280981|3796807|P1|Overall Study|Irregular or discontinued menses|3
1156262|NCT01280981|3796807|P1|Overall Study|Adverse Event|6
1156263|NCT01280981|3796807|P1|Overall Study|Lost to Follow-up|3
1156264|NCT01280981|3796807|P1|Overall Study|Lack of Efficacy|13
1156265|NCT01280981|3796807|P1|Overall Study|Protocol Violation|2
1156266|NCT01280981|3796807|P1|Overall Study|Withdrawal by Subject|11
1156267|NCT01280968|3796818|P2|Overall Study|Unable to Smoke in Supine Position|0
1156442|NCT01278030|3797647|P2|Overall Study|Withdrawal by Subject|4
1156268|NCT01280968|3796819|P1|Overall Study|Unable to Smoke in Supine Position|1
1156269|NCT01280968|3796818|P2|Overall Study|Pre-existing Neurological Condition|0
1156270|NCT01280968|3796819|P1|Overall Study|Pre-existing Neurological Condition|1
1156271|NCT01280968|3796818|P2|Overall Study|Scheduling Conflicts|1
1156272|NCT01280968|3796819|P1|Overall Study|Scheduling Conflicts|1
1156273|NCT01280968|3796818|P2|Overall Study|Adverse Event|0
1156274|NCT01280968|3796819|P1|Overall Study|Adverse Event|1
1156275|NCT01280968|3796818|P2|Overall Study|Anxiety|0
1156276|NCT01280968|3796819|P1|Overall Study|Anxiety|2
1156277|NCT01280968|3796818|P2|Overall Study|Commuting Problems|0
1156278|NCT01280968|3796819|P1|Overall Study|Commuting Problems|2
1156279|NCT01280968|3796818|P2|Overall Study|Unable to Follow Experimental Protocol|0
1156280|NCT01280968|3796819|P1|Overall Study|Unable to Follow Experimental Protocol|2
1156281|NCT01280968|3796818|P2|Overall Study|Lost to Follow-up|2
1156282|NCT01280968|3796819|P1|Overall Study|Lost to Follow-up|8
1156283|NCT01280955|3796835|P1|Overall Study|Withdrawal by Subject|1
1156284|NCT01280955|3796835|P1|Overall Study|Death|2
1156285|NCT01280903|3796879|P2|Overall Study|Lost to Follow-up|16
1156286|NCT01280903|3796880|P1|Overall Study|Lost to Follow-up|23
1156287|NCT01280656|3796993|P3|Overall Study|Other|7
1156288|NCT01280656|3796994|P2|Overall Study|Other|7
1156289|NCT01280656|3796995|P1|Overall Study|Other|1
1156290|NCT01280656|3796993|P3|Overall Study|Treatment shortening (RGT)|5
1156291|NCT01280656|3796994|P2|Overall Study|Treatment shortening (RGT)|4
1156292|NCT01280656|3796995|P1|Overall Study|Treatment shortening (RGT)|0
1156293|NCT01280656|3796993|P3|Overall Study|Lack of Efficacy|38
1156294|NCT01280656|3796994|P2|Overall Study|Lack of Efficacy|22
1156295|NCT01280656|3796995|P1|Overall Study|Lack of Efficacy|1
1156296|NCT01280656|3796993|P3|Overall Study|Adverse Event|13
1156297|NCT01280656|3796994|P2|Overall Study|Adverse Event|14
1156298|NCT01280656|3796995|P1|Overall Study|Adverse Event|1
1156299|NCT01280591|3797062|P4|Overall Study|Does not meet exclusion #27 criteria|1
1156300|NCT01280591|3797063|P3|Overall Study|Does not meet exclusion #27 criteria|0
1156301|NCT01280591|3797064|P2|Overall Study|Does not meet exclusion #27 criteria|0
1156302|NCT01280591|3797065|P1|Overall Study|Does not meet exclusion #27 criteria|0
1156303|NCT01280591|3797062|P4|Overall Study|Withdrawal by Subject|2
1156304|NCT01280591|3797063|P3|Overall Study|Withdrawal by Subject|0
1156305|NCT01280591|3797064|P2|Overall Study|Withdrawal by Subject|0
1156306|NCT01280591|3797065|P1|Overall Study|Withdrawal by Subject|0
1156307|NCT01280357|3797203|P1|Overall Study|IInsufficient data/No data supplied|12
1156308|NCT01280357|3797203|P1|Overall Study|Excluded no internal monitoring|14
1156309|NCT01280266|3797212|P2|First Intervention (Week 1-4)|Withdrawal by Subject|2
1156310|NCT01280266|3797213|P1|First Intervention (Week 1-4)|Withdrawal by Subject|0
1156311|NCT01280266|3797212|P2|First Intervention (Week 1-4)|Adverse Event|0
1156312|NCT01280266|3797213|P1|First Intervention (Week 1-4)|Adverse Event|1
1156313|NCT01279681|3797295|P2|Overall Study|Other Reason|2
1156314|NCT01279681|3797296|P1|Overall Study|Other Reason|0
1156315|NCT01279681|3797295|P2|Overall Study|Physician Decision|0
1156316|NCT01279681|3797296|P1|Overall Study|Physician Decision|1
1156317|NCT01279681|3797295|P2|Overall Study|Withdrawal Prior to Beginning Treatment|1
1156318|NCT01279681|3797296|P1|Overall Study|Withdrawal Prior to Beginning Treatment|0
1156319|NCT01279681|3797295|P2|Overall Study|Death|1
1156320|NCT01279681|3797296|P1|Overall Study|Death|0
1156321|NCT01279681|3797295|P2|Overall Study|Adverse Event|3
1156322|NCT01279681|3797296|P1|Overall Study|Adverse Event|2
1156323|NCT01279681|3797295|P2|Overall Study|Withdrawal by Subject|4
1156324|NCT01279681|3797296|P1|Overall Study|Withdrawal by Subject|3
1156325|NCT01279681|3797295|P2|Overall Study|Disease Progression|6
1156326|NCT01279681|3797296|P1|Overall Study|Disease Progression|9
1156327|NCT01279486|3797317|P1|Overall Study|Lost to Follow-up|1
1156328|NCT01279447|3797323|P2|Overall Study|Lost to Follow-up|1
1156329|NCT01279447|3797324|P1|Overall Study|Lost to Follow-up|3
1156330|NCT01279200|3797351|P2|Overall Study|Adverse Event|0
1156331|NCT01279200|3797352|P1|Overall Study|Adverse Event|1
1156332|NCT01279200|3797351|P2|Overall Study|Lost to Follow-up|1
1156333|NCT01279200|3797352|P1|Overall Study|Lost to Follow-up|0
1156334|NCT01279200|3797351|P2|Overall Study|ultrasound screening failure|1
1156335|NCT01279200|3797352|P1|Overall Study|ultrasound screening failure|0
1156336|NCT01279200|3797351|P2|Overall Study|Inconvenience of ultrasound visit|1
1156337|NCT01279200|3797352|P1|Overall Study|Inconvenience of ultrasound visit|0
1156338|NCT01279200|3797351|P2|Overall Study|Patient withdrawal due to high cost|1
1156339|NCT01279200|3797352|P1|Overall Study|Patient withdrawal due to high cost|0
1156340|NCT01279200|3797351|P2|Overall Study|Withdrawal by Subject|3
1156341|NCT01279200|3797352|P1|Overall Study|Withdrawal by Subject|1
1156342|NCT01279070|3797390|P2|Overall Study|Acute exacerbation|1
1156343|NCT01279070|3797391|P1|Overall Study|Acute exacerbation|3
1156344|NCT01279070|3797390|P2|Overall Study|Withdrawal by Subject|3
1156345|NCT01279070|3797391|P1|Overall Study|Withdrawal by Subject|2
1156346|NCT01279044|3797410|P3|PHASE 2 - Randmonized Controlled Trial|Death|1
1156347|NCT01279044|3797411|P2|PHASE 2 - Randmonized Controlled Trial|Death|0
1156348|NCT01279044|3797412|P1|PHASE 2 - Randmonized Controlled Trial|Death|0
1156349|NCT01279044|3797410|P3|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
1156350|NCT01279044|3797411|P2|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8
1156351|NCT01279044|3797412|P1|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
1156352|NCT01279044|3797410|P3|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2
1156353|NCT01279044|3797411|P2|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3
1156354|NCT01279044|3797412|P1|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0
1156355|NCT01278862|3797488|P2|Overall Study|Lost to Follow-up|1
1156356|NCT01278862|3797489|P1|Overall Study|Lost to Follow-up|1
1156357|NCT01278797|3797497|P2|Period 1|Protocol Violation|0
1156358|NCT01278797|3797498|P1|Period 1|Protocol Violation|1
1156359|NCT01278797|3797497|P2|Period 1|Adverse Event|1
1156360|NCT01278797|3797498|P1|Period 1|Adverse Event|0
1156361|NCT01278745|3797510|P4|Overall Study|Moves,enrollment in mx studies, et al.|1
1156362|NCT01278745|3797511|P3|Overall Study|Moves,enrollment in mx studies, et al.|5
1156363|NCT01278745|3797512|P2|Overall Study|Moves,enrollment in mx studies, et al.|0
1156364|NCT01278745|3797513|P1|Overall Study|Moves,enrollment in mx studies, et al.|0
1156365|NCT01278745|3797510|P4|Overall Study|Ineligible|61
1156366|NCT01278745|3797511|P3|Overall Study|Ineligible|42
1156367|NCT01278745|3797512|P2|Overall Study|Ineligible|0
1156368|NCT01278745|3797513|P1|Overall Study|Ineligible|0
1156369|NCT01278745|3797510|P4|Overall Study|Sponsor Decision|6
1156370|NCT01278745|3797511|P3|Overall Study|Sponsor Decision|62
1156371|NCT01278745|3797512|P2|Overall Study|Sponsor Decision|0
1156372|NCT01278745|3797513|P1|Overall Study|Sponsor Decision|1
1156373|NCT01278745|3797510|P4|Overall Study|Withdrawal by Subject|1
1156374|NCT01278745|3797511|P3|Overall Study|Withdrawal by Subject|5
1156375|NCT01278745|3797512|P2|Overall Study|Withdrawal by Subject|1
1156376|NCT01278745|3797513|P1|Overall Study|Withdrawal by Subject|1
1156377|NCT01278745|3797510|P4|Overall Study|Physician Decision|9
1156378|NCT01278745|3797511|P3|Overall Study|Physician Decision|0
1156379|NCT01278745|3797512|P2|Overall Study|Physician Decision|0
1156380|NCT01278745|3797513|P1|Overall Study|Physician Decision|1
1156381|NCT01278745|3797510|P4|Overall Study|Death|0
1156382|NCT01278745|3797511|P3|Overall Study|Death|7
1156383|NCT01278745|3797512|P2|Overall Study|Death|5
1156384|NCT01278745|3797513|P1|Overall Study|Death|2
1156385|NCT01278615|3797545|P1|Overall Study|Withdrawal by Subject|2
1156386|NCT01278407|3797571|P5|Extension Phase|Not Specified|3
1156387|NCT01278407|3797572|P4|Extension Phase|Not Specified|1
1156388|NCT01278407|3797573|P3|Extension Phase|Not Specified|0
1156389|NCT01278407|3797574|P2|Extension Phase|Not Specified|0
1156390|NCT01278407|3797575|P1|Extension Phase|Not Specified|0
1156391|NCT01278407|3797571|P5|Extension Phase|Participant's Choice|11
1156392|NCT01278407|3797572|P4|Extension Phase|Participant's Choice|4
1156393|NCT01278407|3797573|P3|Extension Phase|Participant's Choice|0
1156394|NCT01278407|3797574|P2|Extension Phase|Participant's Choice|0
1156395|NCT01278407|3797575|P1|Extension Phase|Participant's Choice|0
1156396|NCT01278407|3797571|P5|Extension Phase|Adverse Event|16
1156397|NCT01278407|3797572|P4|Extension Phase|Adverse Event|7
1156398|NCT01278407|3797573|P3|Extension Phase|Adverse Event|0
1156399|NCT01278407|3797574|P2|Extension Phase|Adverse Event|0
1156400|NCT01278407|3797575|P1|Extension Phase|Adverse Event|0
1156401|NCT01278407|3797571|P5|Confirmatory Phase|Not Specified|0
1156402|NCT01278407|3797572|P4|Confirmatory Phase|Not Specified|0
1156403|NCT01278407|3797573|P3|Confirmatory Phase|Not Specified|2
1156404|NCT01278407|3797574|P2|Confirmatory Phase|Not Specified|1
1156405|NCT01278407|3797575|P1|Confirmatory Phase|Not Specified|1
1156406|NCT01278407|3797571|P5|Confirmatory Phase|Participant's Choice|0
1156407|NCT01278407|3797572|P4|Confirmatory Phase|Participant's Choice|0
1156408|NCT01278407|3797573|P3|Confirmatory Phase|Participant's Choice|3
1156409|NCT01278407|3797574|P2|Confirmatory Phase|Participant's Choice|5
1156410|NCT01278407|3797575|P1|Confirmatory Phase|Participant's Choice|3
1156411|NCT01278407|3797571|P5|Confirmatory Phase|Adverse Event|0
1156412|NCT01278407|3797572|P4|Confirmatory Phase|Adverse Event|0
1156413|NCT01278407|3797573|P3|Confirmatory Phase|Adverse Event|1
1156414|NCT01278407|3797574|P2|Confirmatory Phase|Adverse Event|10
1156415|NCT01278407|3797575|P1|Confirmatory Phase|Adverse Event|5
1156416|NCT01278394|3797588|P1|Overall Study|Lost to Follow-up|1
1156417|NCT01278342|3797601|P3|Overall Study|Other|0
1156418|NCT01278342|3797602|P2|Overall Study|Other|0
1156419|NCT01278342|3797603|P1|Overall Study|Other|1
1156420|NCT01278342|3797601|P3|Overall Study|Administrative problems|0
1156421|NCT01278342|3797602|P2|Overall Study|Administrative problems|0
1156422|NCT01278342|3797603|P1|Overall Study|Administrative problems|2
1156423|NCT01278342|3797601|P3|Overall Study|Lost to Follow-up|0
1156424|NCT01278342|3797602|P2|Overall Study|Lost to Follow-up|0
1156425|NCT01278342|3797603|P1|Overall Study|Lost to Follow-up|1
1156426|NCT01278342|3797601|P3|Overall Study|Physician Decision|0
1156427|NCT01278342|3797602|P2|Overall Study|Physician Decision|1
1156428|NCT01278342|3797603|P1|Overall Study|Physician Decision|0
1156429|NCT01278173|3797623|P1|Overall Study|Withdrawal by Subject|1
1156430|NCT01278173|3797623|P1|Overall Study|Protocol Violation|1
1156431|NCT01278173|3797623|P1|Overall Study|Administrative or other reason|4
1156432|NCT01278173|3797623|P1|Overall Study|Adverse Event|8
1156433|NCT01278173|3797623|P1|Overall Study|Lack of Efficacy|13
1156434|NCT01278160|3797630|P2|Overall Study|Unclassified|2
1156435|NCT01278160|3797631|P1|Overall Study|Unclassified|1
1156436|NCT01278160|3797630|P2|Overall Study|Withdrawal by Subject|2
1156437|NCT01278160|3797631|P1|Overall Study|Withdrawal by Subject|3
1156438|NCT01278160|3797630|P2|Overall Study|Lost to Follow-up|1
1156439|NCT01278160|3797631|P1|Overall Study|Lost to Follow-up|0
1156440|NCT01278160|3797630|P2|Overall Study|Adverse Event|1
1156441|NCT01278160|3797631|P1|Overall Study|Adverse Event|1
1156443|NCT01278030|3797648|P1|Overall Study|Withdrawal by Subject|8
1156444|NCT01277887|3797656|P2|Post-Quit Treatment Phase|No longer interested in treatment|5
1156445|NCT01277887|3797657|P1|Post-Quit Treatment Phase|No longer interested in treatment|3
1156446|NCT01277887|3797656|P2|Pre-Quit Treatment Phase|Withdrawal by Subject|0
1156447|NCT01277887|3797657|P1|Pre-Quit Treatment Phase|Withdrawal by Subject|2
1156448|NCT01277887|3797656|P2|Pre-Quit Treatment Phase|No longer interested in treatment|0
1156449|NCT01277887|3797657|P1|Pre-Quit Treatment Phase|No longer interested in treatment|1
1156450|NCT01277861|3797669|P2|Overall Study|Physician Decision|2
1156451|NCT01277861|3797670|P1|Overall Study|Physician Decision|2
1156452|NCT01277822|3797682|P2|Overall Study|Participant moved|0
1156453|NCT01277822|3797683|P1|Overall Study|Participant moved|1
1156454|NCT01277822|3797682|P2|Overall Study|Contraindicated medication used|1
1156455|NCT01277822|3797683|P1|Overall Study|Contraindicated medication used|2
1156456|NCT01277822|3797682|P2|Overall Study|Lost to Follow-up|1
1156457|NCT01277822|3797683|P1|Overall Study|Lost to Follow-up|2
1156458|NCT01277822|3797682|P2|Overall Study|Protocol Violation|0
1156459|NCT01277822|3797683|P1|Overall Study|Protocol Violation|1
1156460|NCT01277822|3797682|P2|Overall Study|Physician Decision|1
1156461|NCT01277822|3797683|P1|Overall Study|Physician Decision|1
1156462|NCT01277822|3797682|P2|Overall Study|Withdrawal by Subject|7
1156463|NCT01277822|3797683|P1|Overall Study|Withdrawal by Subject|6
1156464|NCT01277822|3797682|P2|Overall Study|Adverse Event|1
1156465|NCT01277822|3797683|P1|Overall Study|Adverse Event|2
1156466|NCT01277757|3797703|P1|Overall Study|Withdrawal by Subject|1
1156467|NCT01277757|3797703|P1|Overall Study|Disease Progression|1
1156468|NCT01277718|3797710|P2|Period 2 - Second Intervention|Physician Decision|2
1156469|NCT01277718|3797711|P1|Period 2 - Second Intervention|Physician Decision|0
1156470|NCT01277718|3797710|P2|Period 2 - Second Intervention|Protocol Violation|1
1156471|NCT01277718|3797711|P1|Period 2 - Second Intervention|Protocol Violation|0
1156472|NCT01277666|3797725|P3|Overall Study|Death|1
1156473|NCT01277666|3797726|P2|Overall Study|Death|0
1156474|NCT01277666|3797727|P1|Overall Study|Death|0
1156475|NCT01277666|3797725|P3|Overall Study|Withdrawal by Subject|6
1156476|NCT01277666|3797726|P2|Overall Study|Withdrawal by Subject|8
1156477|NCT01277666|3797727|P1|Overall Study|Withdrawal by Subject|7
1156478|NCT01277666|3797725|P3|Overall Study|Lost to Follow-up|2
1156479|NCT01277666|3797726|P2|Overall Study|Lost to Follow-up|1
1156480|NCT01277666|3797727|P1|Overall Study|Lost to Follow-up|1
1156481|NCT01277666|3797725|P3|Overall Study|Protocol Defined Stopping criteria|6
1156482|NCT01277666|3797726|P2|Overall Study|Protocol Defined Stopping criteria|2
1156483|NCT01277666|3797727|P1|Overall Study|Protocol Defined Stopping criteria|1
1156484|NCT01277666|3797725|P3|Overall Study|Protocol Violation|2
1156485|NCT01277666|3797726|P2|Overall Study|Protocol Violation|3
1156486|NCT01277666|3797727|P1|Overall Study|Protocol Violation|2
1156487|NCT01277666|3797725|P3|Overall Study|Lack of Efficacy|12
1156488|NCT01277666|3797726|P2|Overall Study|Lack of Efficacy|20
1156489|NCT01277666|3797727|P1|Overall Study|Lack of Efficacy|8
1156490|NCT01277666|3797725|P3|Overall Study|Adverse Event|20
1156491|NCT01277666|3797726|P2|Overall Study|Adverse Event|25
1156492|NCT01277666|3797727|P1|Overall Study|Adverse Event|26
1156493|NCT01277601|3797760|P4|Overall Study|Subject Terminated from Study by Sponsor|2
1156494|NCT01277601|3797761|P3|Overall Study|Subject Terminated from Study by Sponsor|0
1156495|NCT01277601|3797762|P2|Overall Study|Subject Terminated from Study by Sponsor|1
1156496|NCT01277601|3797763|P1|Overall Study|Subject Terminated from Study by Sponsor|0
1156497|NCT01277601|3797760|P4|Overall Study|Protocol Violation|0
1156498|NCT01277601|3797761|P3|Overall Study|Protocol Violation|5
1156499|NCT01277601|3797762|P2|Overall Study|Protocol Violation|2
1156500|NCT01277601|3797763|P1|Overall Study|Protocol Violation|0
1156501|NCT01277601|3797760|P4|Overall Study|Subject Never Dosed with Study Drug|1
1156502|NCT01277601|3797761|P3|Overall Study|Subject Never Dosed with Study Drug|3
1156503|NCT01277601|3797762|P2|Overall Study|Subject Never Dosed with Study Drug|2
1156504|NCT01277601|3797763|P1|Overall Study|Subject Never Dosed with Study Drug|1
1156505|NCT01277601|3797760|P4|Overall Study|Noncompliance with Study Drug|0
1156506|NCT01277601|3797761|P3|Overall Study|Noncompliance with Study Drug|2
1156507|NCT01277601|3797762|P2|Overall Study|Noncompliance with Study Drug|3
1156508|NCT01277601|3797763|P1|Overall Study|Noncompliance with Study Drug|1
1156509|NCT01277601|3797760|P4|Overall Study|Pregnancy|1
1156510|NCT01277601|3797761|P3|Overall Study|Pregnancy|4
1156511|NCT01277601|3797762|P2|Overall Study|Pregnancy|2
1156512|NCT01277601|3797763|P1|Overall Study|Pregnancy|2
1156513|NCT01277601|3797760|P4|Overall Study|Physician Decision|6
1156514|NCT01277601|3797761|P3|Overall Study|Physician Decision|1
1156515|NCT01277601|3797762|P2|Overall Study|Physician Decision|5
1156516|NCT01277601|3797763|P1|Overall Study|Physician Decision|3
1156517|NCT01277601|3797760|P4|Overall Study|Lost to Follow-up|2
1156518|NCT01277601|3797761|P3|Overall Study|Lost to Follow-up|4
1156519|NCT01277601|3797762|P2|Overall Study|Lost to Follow-up|9
1156520|NCT01277601|3797763|P1|Overall Study|Lost to Follow-up|7
1156521|NCT01277601|3797760|P4|Overall Study|Withdrawal by Subject|17
1156522|NCT01277601|3797761|P3|Overall Study|Withdrawal by Subject|8
1156523|NCT01277601|3797762|P2|Overall Study|Withdrawal by Subject|21
1156524|NCT01277601|3797763|P1|Overall Study|Withdrawal by Subject|18
1156525|NCT01277601|3797760|P4|Overall Study|Adverse Event|7
1156526|NCT01277601|3797761|P3|Overall Study|Adverse Event|0
1156527|NCT01277601|3797762|P2|Overall Study|Adverse Event|3
1156528|NCT01277601|3797763|P1|Overall Study|Adverse Event|5
1156529|NCT01277549|3797854|P2|Overall Study|Physician Decision|1
1156530|NCT01277549|3797855|P1|Overall Study|Physician Decision|2
1156531|NCT01277549|3797854|P2|Overall Study|Protocol Violation|1
1156532|NCT01277549|3797855|P1|Overall Study|Protocol Violation|10
1156533|NCT01277549|3797854|P2|Overall Study|Withdrawal by Subject|3
1156534|NCT01277549|3797855|P1|Overall Study|Withdrawal by Subject|1
1156535|NCT01277549|3797854|P2|Overall Study|Failed to meet eligibility criteria|9
1156536|NCT01277549|3797855|P1|Overall Study|Failed to meet eligibility criteria|13
1156537|NCT01277523|3797872|P3|Overall Study|Other Reason not Defined|0
1156538|NCT01277523|3797873|P2|Overall Study|Other Reason not Defined|1
1156539|NCT01277523|3797874|P1|Overall Study|Other Reason not Defined|0
1156540|NCT01277523|3797872|P3|Overall Study|Protocol Violation|0
1156541|NCT01277523|3797873|P2|Overall Study|Protocol Violation|0
1156542|NCT01277523|3797874|P1|Overall Study|Protocol Violation|2
1156543|NCT01277523|3797872|P3|Overall Study|Adverse Event|0
1156544|NCT01277523|3797873|P2|Overall Study|Adverse Event|0
1156545|NCT01277523|3797874|P1|Overall Study|Adverse Event|1
1156546|NCT01277510|3797926|P2|Open-label Phase|Never received investigational product|0
1156547|NCT01277510|3797927|P1|Open-label Phase|Never received investigational product|2
1156548|NCT01277510|3797926|P2|Open-label Phase|Protocol-specified criteria|0
1156549|NCT01277510|3797927|P1|Open-label Phase|Protocol-specified criteria|1
1156550|NCT01277510|3797926|P2|Open-label Phase|Administrative decision|3
1156551|NCT01277510|3797927|P1|Open-label Phase|Administrative decision|4
1156552|NCT01277510|3797926|P2|Double-blind Phase|Other|1
1156553|NCT01277510|3797927|P1|Double-blind Phase|Other|1
1156554|NCT01277510|3797926|P2|Double-blind Phase|Protocol-specified criteria|6
1156555|NCT01277510|3797927|P1|Double-blind Phase|Protocol-specified criteria|2
1156556|NCT01277510|3797926|P2|Double-blind Phase|Death|1
1156557|NCT01277510|3797927|P1|Double-blind Phase|Death|0
1156558|NCT01277510|3797926|P2|Double-blind Phase|Administrative decision|9
1156559|NCT01277510|3797927|P1|Double-blind Phase|Administrative decision|7
1156560|NCT01277510|3797926|P2|Double-blind Phase|Withdrawal by Subject|0
1156561|NCT01277510|3797927|P1|Double-blind Phase|Withdrawal by Subject|2
1156562|NCT01277510|3797926|P2|Double-blind Phase|Adverse Event|0
1156563|NCT01277510|3797927|P1|Double-blind Phase|Adverse Event|1
1156564|NCT01277510|3797926|P2|Double-blind Phase|Non-compliance|1
1156565|NCT01277510|3797927|P1|Double-blind Phase|Non-compliance|0
1156566|NCT01277302|3797961|P3|8-Month Alternate Dose Regimen Period|Relocation|1
1156567|NCT01277302|3797962|P2|8-Month Alternate Dose Regimen Period|Relocation|0
1156568|NCT01277302|3797963|P1|8-Month Alternate Dose Regimen Period|Relocation|1
1156569|NCT01277302|3797961|P3|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1
1156570|NCT01277302|3797962|P2|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2
1156571|NCT01277302|3797963|P1|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0
1156572|NCT01277302|3797961|P3|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1
1156573|NCT01277302|3797962|P2|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0
1156574|NCT01277302|3797963|P1|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3
1156575|NCT01277302|3797961|P3|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3
1156576|NCT01277302|3797962|P2|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
1156577|NCT01277302|3797963|P1|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
1156578|NCT01277302|3797961|P3|8-Month Alternate Dose Regimen Period|Death|0
1156579|NCT01277302|3797962|P2|8-Month Alternate Dose Regimen Period|Death|1
1156580|NCT01277302|3797963|P1|8-Month Alternate Dose Regimen Period|Death|0
1156581|NCT01277302|3797961|P3|7-Month Fixed Treatment Period|Subject Non-compliance|1
1156582|NCT01277302|3797962|P2|7-Month Fixed Treatment Period|Subject Non-compliance|0
1156583|NCT01277302|3797963|P1|7-Month Fixed Treatment Period|Subject Non-compliance|0
1156584|NCT01277302|3797961|P3|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1
1156585|NCT01277302|3797962|P2|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
1156586|NCT01277302|3797963|P1|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
1156587|NCT01277302|3797961|P3|7-Month Fixed Treatment Period|Lost to Follow-up|2
1156588|NCT01277302|3797962|P2|7-Month Fixed Treatment Period|Lost to Follow-up|0
1156589|NCT01277302|3797963|P1|7-Month Fixed Treatment Period|Lost to Follow-up|0
1156590|NCT01277302|3797961|P3|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8
1156591|NCT01277302|3797962|P2|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
1156592|NCT01277302|3797963|P1|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
1156593|NCT01277211|3797995|P2|Overall Study|Discontinued prior to treatment|13
1156594|NCT01277211|3797996|P1|Overall Study|Discontinued prior to treatment|24
1156595|NCT01277211|3797995|P2|Overall Study|Pregnancy wish|2
1156596|NCT01277211|3797996|P1|Overall Study|Pregnancy wish|0
1156597|NCT01277211|3797995|P2|Overall Study|Administrative|0
1156598|NCT01277211|3797996|P1|Overall Study|Administrative|3
1156599|NCT01277211|3797995|P2|Overall Study|Did not meet protocol eligibility|0
1156600|NCT01277211|3797996|P1|Overall Study|Did not meet protocol eligibility|1
1156601|NCT01277211|3797995|P2|Overall Study|Non-compliance with protocol|4
1156602|NCT01277211|3797996|P1|Overall Study|Non-compliance with protocol|13
1156603|NCT01277211|3797995|P2|Overall Study|Withdrew Consent|9
1156604|NCT01277211|3797996|P1|Overall Study|Withdrew Consent|9
1156605|NCT01277211|3797995|P2|Overall Study|Did not wish to continue|0
1156606|NCT01277211|3797996|P1|Overall Study|Did not wish to continue|17
1156607|NCT01277211|3797995|P2|Overall Study|Lost to Follow-up|9
1156608|NCT01277211|3797996|P1|Overall Study|Lost to Follow-up|14
1156609|NCT01277211|3797995|P2|Overall Study|Pregnancy|4
1156610|NCT01277211|3797996|P1|Overall Study|Pregnancy|9
1156611|NCT01277211|3797995|P2|Overall Study|Adverse Event|22
1156612|NCT01277211|3797996|P1|Overall Study|Adverse Event|60
1156613|NCT01277042|3798048|P2|Overall Study|Withdrawal by Subject|0
1156614|NCT01277042|3798049|P1|Overall Study|Withdrawal by Subject|2
1156615|NCT01277042|3798048|P2|Overall Study|Lost to Follow-up|2
1156616|NCT01277042|3798049|P1|Overall Study|Lost to Follow-up|2
1156617|NCT01277042|3798048|P2|Overall Study|Adverse Event|3
1156618|NCT01277042|3798049|P1|Overall Study|Adverse Event|4
1156619|NCT01276847|3798074|P3|Overall Study|Withdrawal by Subject|0
1156620|NCT01276847|3798075|P2|Overall Study|Withdrawal by Subject|0
1156621|NCT01276847|3798076|P1|Overall Study|Withdrawal by Subject|1
1156622|NCT01276821|3798086|P2|Overall Study|Protocol Violation|1
1156623|NCT01276821|3798087|P1|Overall Study|Protocol Violation|0
1156624|NCT01276756|3798107|P2|Overall Study|Adverse Event|2
1156625|NCT01276756|3798108|P1|Overall Study|Adverse Event|3
1156626|NCT01276756|3798107|P2|Overall Study|Lost to Follow-up|0
1156627|NCT01276756|3798108|P1|Overall Study|Lost to Follow-up|2
1156628|NCT01276639|3798153|P5|Week 16 to 52|Other|3
1156629|NCT01276639|3798154|P4|Week 16 to 52|Other|1
1156630|NCT01276639|3798155|P3|Week 16 to 52|Other|0
1156631|NCT01276639|3798156|P2|Week 16 to 52|Other|12
1156632|NCT01276639|3798157|P1|Week 16 to 52|Other|10
1156633|NCT01276639|3798153|P5|Week 16 to 52|Withdrawal by Subject|1
1156634|NCT01276639|3798154|P4|Week 16 to 52|Withdrawal by Subject|0
1156635|NCT01276639|3798155|P3|Week 16 to 52|Withdrawal by Subject|0
1156636|NCT01276639|3798156|P2|Week 16 to 52|Withdrawal by Subject|4
1156637|NCT01276639|3798157|P1|Week 16 to 52|Withdrawal by Subject|4
1156638|NCT01276639|3798153|P5|Week 16 to 52|Lost to Follow-up|1
1156639|NCT01276639|3798154|P4|Week 16 to 52|Lost to Follow-up|0
1156640|NCT01276639|3798155|P3|Week 16 to 52|Lost to Follow-up|0
1156641|NCT01276639|3798156|P2|Week 16 to 52|Lost to Follow-up|1
1156642|NCT01276639|3798157|P1|Week 16 to 52|Lost to Follow-up|3
1156643|NCT01276639|3798153|P5|Week 16 to 52|Lack of Efficacy|13
1156644|NCT01276639|3798154|P4|Week 16 to 52|Lack of Efficacy|14
1156645|NCT01276639|3798155|P3|Week 16 to 52|Lack of Efficacy|0
1156646|NCT01276639|3798156|P2|Week 16 to 52|Lack of Efficacy|71
1156647|NCT01276639|3798157|P1|Week 16 to 52|Lack of Efficacy|99
1156648|NCT01276639|3798153|P5|Week 16 to 52|Adverse Event|3
1156649|NCT01276639|3798154|P4|Week 16 to 52|Adverse Event|1
1156650|NCT01276639|3798155|P3|Week 16 to 52|Adverse Event|0
1156651|NCT01276639|3798156|P2|Week 16 to 52|Adverse Event|13
1156652|NCT01276639|3798157|P1|Week 16 to 52|Adverse Event|10
1156653|NCT01276639|3798153|P5|Week 16 to 52|Death|0
1156654|NCT01276639|3798154|P4|Week 16 to 52|Death|0
1156655|NCT01276639|3798155|P3|Week 16 to 52|Death|0
1156656|NCT01276639|3798156|P2|Week 16 to 52|Death|0
1156657|NCT01276639|3798157|P1|Week 16 to 52|Death|1
1156658|NCT01276639|3798153|P5|Week 0 to 16|Randomized, But Not Treated|0
1156659|NCT01276639|3798154|P4|Week 0 to 16|Randomized, But Not Treated|0
1156660|NCT01276639|3798155|P3|Week 0 to 16|Randomized, But Not Treated|0
1156661|NCT01276639|3798156|P2|Week 0 to 16|Randomized, But Not Treated|1
1156662|NCT01276639|3798157|P1|Week 0 to 16|Randomized, But Not Treated|0
1156663|NCT01276639|3798153|P5|Week 0 to 16|Other|0
1156664|NCT01276639|3798154|P4|Week 0 to 16|Other|0
1156665|NCT01276639|3798155|P3|Week 0 to 16|Other|2
1156666|NCT01276639|3798156|P2|Week 0 to 16|Other|7
1156667|NCT01276639|3798157|P1|Week 0 to 16|Other|7
1156668|NCT01276639|3798153|P5|Week 0 to 16|Withdrawal by Subject|0
1156669|NCT01276639|3798154|P4|Week 0 to 16|Withdrawal by Subject|0
1156670|NCT01276639|3798155|P3|Week 0 to 16|Withdrawal by Subject|4
1156671|NCT01276639|3798156|P2|Week 0 to 16|Withdrawal by Subject|5
1156672|NCT01276639|3798157|P1|Week 0 to 16|Withdrawal by Subject|8
1156673|NCT01276639|3798153|P5|Week 0 to 16|Lost to Follow-up|0
1156674|NCT01276639|3798154|P4|Week 0 to 16|Lost to Follow-up|0
1156675|NCT01276639|3798155|P3|Week 0 to 16|Lost to Follow-up|3
1156676|NCT01276639|3798156|P2|Week 0 to 16|Lost to Follow-up|5
1156677|NCT01276639|3798157|P1|Week 0 to 16|Lost to Follow-up|3
1156678|NCT01276639|3798153|P5|Week 0 to 16|Lack of Efficacy|0
1156679|NCT01276639|3798154|P4|Week 0 to 16|Lack of Efficacy|0
1156680|NCT01276639|3798155|P3|Week 0 to 16|Lack of Efficacy|25
1156681|NCT01276639|3798156|P2|Week 0 to 16|Lack of Efficacy|15
1156682|NCT01276639|3798157|P1|Week 0 to 16|Lack of Efficacy|20
1156683|NCT01276639|3798153|P5|Week 0 to 16|Adverse Event|0
1156684|NCT01276639|3798154|P4|Week 0 to 16|Adverse Event|0
1156685|NCT01276639|3798155|P3|Week 0 to 16|Adverse Event|11
1156686|NCT01276639|3798156|P2|Week 0 to 16|Adverse Event|8
1156687|NCT01276639|3798157|P1|Week 0 to 16|Adverse Event|11
1156688|NCT01276639|3798153|P5|Week 0 to 16|Death|0
1156689|NCT01276639|3798154|P4|Week 0 to 16|Death|0
1156690|NCT01276639|3798155|P3|Week 0 to 16|Death|0
1156691|NCT01276639|3798156|P2|Week 0 to 16|Death|0
1156692|NCT01276639|3798157|P1|Week 0 to 16|Death|1
1156693|NCT01276509|3798362|P4|Overall Study|Other|0
1156694|NCT01276509|3798363|P3|Overall Study|Other|0
1156695|NCT01276509|3798364|P2|Overall Study|Other|1
1156696|NCT01276509|3798365|P1|Overall Study|Other|0
1156697|NCT01276509|3798362|P4|Overall Study|Withdrawal by Subject|0
1156698|NCT01276509|3798363|P3|Overall Study|Withdrawal by Subject|0
1156699|NCT01276509|3798364|P2|Overall Study|Withdrawal by Subject|2
1156700|NCT01276509|3798365|P1|Overall Study|Withdrawal by Subject|1
1156701|NCT01276509|3798362|P4|Overall Study|Pregnancy|0
1156702|NCT01276509|3798363|P3|Overall Study|Pregnancy|0
1156703|NCT01276509|3798364|P2|Overall Study|Pregnancy|0
1156704|NCT01276509|3798365|P1|Overall Study|Pregnancy|1
1156705|NCT01276509|3798362|P4|Overall Study|Lack of Efficacy|2
1156706|NCT01276509|3798363|P3|Overall Study|Lack of Efficacy|1
1156707|NCT01276509|3798364|P2|Overall Study|Lack of Efficacy|1
1156708|NCT01276509|3798365|P1|Overall Study|Lack of Efficacy|2
1156709|NCT01276509|3798362|P4|Overall Study|Adverse Event|3
1156710|NCT01276509|3798363|P3|Overall Study|Adverse Event|4
1156711|NCT01276509|3798364|P2|Overall Study|Adverse Event|8
1156712|NCT01276509|3798365|P1|Overall Study|Adverse Event|9
1156713|NCT01276457|3798418|P2|Extension Study|Lack of Efficacy|1
1156714|NCT01276457|3798419|P1|Extension Study|Lack of Efficacy|3
1156715|NCT01276457|3798418|P2|Extension Study|Death|1
1156716|NCT01276457|3798419|P1|Extension Study|Death|0
1156717|NCT01276457|3798418|P2|Extension Study|Lost to Follow-up|0
1156718|NCT01276457|3798419|P1|Extension Study|Lost to Follow-up|3
1156719|NCT01276457|3798418|P2|Core Study|Lack of Efficacy|12
1156720|NCT01276457|3798419|P1|Core Study|Lack of Efficacy|3
1156721|NCT01276457|3798418|P2|Core Study|Death|2
1156722|NCT01276457|3798419|P1|Core Study|Death|2
1156723|NCT01276457|3798418|P2|Core Study|Administrative problems|1
1156724|NCT01276457|3798419|P1|Core Study|Administrative problems|1
1156725|NCT01276457|3798418|P2|Core Study|Lost to Follow-up|2
1156726|NCT01276457|3798419|P1|Core Study|Lost to Follow-up|1
1156727|NCT01276457|3798418|P2|Core Study|Adverse Event|3
1156728|NCT01276457|3798419|P1|Core Study|Adverse Event|6
1156729|NCT01276353|3798433|P2|Extension|Prohibited concomitant medications|1
1156730|NCT01276353|3798434|P1|Extension|Prohibited concomitant medications|0
1156731|NCT01276353|3798433|P2|Extension|Physician Decision|0
1156732|NCT01276353|3798434|P1|Extension|Physician Decision|1
1156733|NCT01276353|3798433|P2|Extension|Withdrawal of study drug 4 days in a row|1
1156734|NCT01276353|3798434|P1|Extension|Withdrawal of study drug 4 days in a row|3
1156735|NCT01276353|3798433|P2|Extension|Withdrawal by Subject|2
1156736|NCT01276353|3798434|P1|Extension|Withdrawal by Subject|1
1156737|NCT01276353|3798433|P2|Extension|Adverse Event|5
1156738|NCT01276353|3798434|P1|Extension|Adverse Event|2
1156739|NCT01276353|3798433|P2|Double-blind|Withdrawal by Subject|0
1156740|NCT01276353|3798434|P1|Double-blind|Withdrawal by Subject|1
1156741|NCT01276353|3798433|P2|Double-blind|Adverse Event|0
1156742|NCT01276353|3798434|P1|Double-blind|Adverse Event|2
1156743|NCT01276327|3798446|P2|Overall Study|Withdrawal by Subject|0
1156744|NCT01276327|3798447|P1|Overall Study|Withdrawal by Subject|1
1156745|NCT01276327|3798446|P2|Overall Study|Adverse Event|3
1156746|NCT01276327|3798447|P1|Overall Study|Adverse Event|1
1156747|NCT01276288|3798514|P4|Overall Study|not treated|0
1156748|NCT01276288|3798515|P3|Overall Study|not treated|0
1156749|NCT01276288|3798516|P2|Overall Study|not treated|0
1156750|NCT01276288|3798517|P1|Overall Study|not treated|1
1156751|NCT01276288|3798514|P4|Overall Study|Adverse Event|0
1156752|NCT01276288|3798515|P3|Overall Study|Adverse Event|0
1156753|NCT01276288|3798516|P2|Overall Study|Adverse Event|1
1156754|NCT01276288|3798517|P1|Overall Study|Adverse Event|1
1156755|NCT01276223|3798644|P3|Overall Study|Protocol Violation|0
1156756|NCT01276223|3798645|P2|Overall Study|Protocol Violation|0
1156757|NCT01276223|3798646|P1|Overall Study|Protocol Violation|1
1156758|NCT01276223|3798644|P3|Overall Study|Pt Decision Unrelated to Adverse Event|0
1156759|NCT01276223|3798645|P2|Overall Study|Pt Decision Unrelated to Adverse Event|0
1156760|NCT01276223|3798646|P1|Overall Study|Pt Decision Unrelated to Adverse Event|3
1156761|NCT01276223|3798644|P3|Overall Study|Not specified|1
1156762|NCT01276223|3798645|P2|Overall Study|Not specified|0
1156763|NCT01276223|3798646|P1|Overall Study|Not specified|0
1156764|NCT01276223|3798644|P3|Overall Study|Lost to Follow-up|1
1156765|NCT01276223|3798645|P2|Overall Study|Lost to Follow-up|0
1156766|NCT01276223|3798646|P1|Overall Study|Lost to Follow-up|0
1156767|NCT01276223|3798644|P3|Overall Study|Adverse Event|1
1156768|NCT01276223|3798645|P2|Overall Study|Adverse Event|4
1156769|NCT01276223|3798646|P1|Overall Study|Adverse Event|7
1156770|NCT01276106|3798687|P4|Overall Study|Insufficient therapeutic effects|0
1156771|NCT01276106|3798688|P3|Overall Study|Insufficient therapeutic effects|2
1156772|NCT01276106|3798689|P2|Overall Study|Insufficient therapeutic effects|0
1156773|NCT01276106|3798690|P1|Overall Study|Insufficient therapeutic effects|0
1156774|NCT01276106|3798687|P4|Overall Study|Protocol Violation|2
1156775|NCT01276106|3798688|P3|Overall Study|Protocol Violation|0
1156776|NCT01276106|3798689|P2|Overall Study|Protocol Violation|1
1156777|NCT01276106|3798690|P1|Overall Study|Protocol Violation|1
1156778|NCT01276106|3798687|P4|Overall Study|Physician Decision|1
1156779|NCT01276106|3798688|P3|Overall Study|Physician Decision|1
1156780|NCT01276106|3798689|P2|Overall Study|Physician Decision|0
1156781|NCT01276106|3798690|P1|Overall Study|Physician Decision|0
1156782|NCT01276106|3798687|P4|Overall Study|Lost to Follow-up|0
1156783|NCT01276106|3798688|P3|Overall Study|Lost to Follow-up|1
1156784|NCT01276106|3798689|P2|Overall Study|Lost to Follow-up|1
1156785|NCT01276106|3798690|P1|Overall Study|Lost to Follow-up|2
1156786|NCT01276106|3798687|P4|Overall Study|Lack of Efficacy|1
1156787|NCT01276106|3798688|P3|Overall Study|Lack of Efficacy|0
1156788|NCT01276106|3798689|P2|Overall Study|Lack of Efficacy|1
1156789|NCT01276106|3798690|P1|Overall Study|Lack of Efficacy|0
1156790|NCT01276106|3798687|P4|Overall Study|Withdrawal by Subject|6
1156791|NCT01276106|3798688|P3|Overall Study|Withdrawal by Subject|1
1156792|NCT01276106|3798689|P2|Overall Study|Withdrawal by Subject|3
1156793|NCT01276106|3798690|P1|Overall Study|Withdrawal by Subject|6
1156794|NCT01276106|3798687|P4|Overall Study|Adverse Event|3
1156795|NCT01276106|3798688|P3|Overall Study|Adverse Event|11
1156796|NCT01276106|3798689|P2|Overall Study|Adverse Event|3
1156797|NCT01276106|3798690|P1|Overall Study|Adverse Event|3
1156798|NCT01276054|3798702|P2|Overall Study|No one to oversee trial after P.I. left|2
1156799|NCT01276054|3798703|P1|Overall Study|No one to oversee trial after P.I. left|2
1156800|NCT01275833|3798711|P2|Overall Study|Study terminated|1
1156801|NCT01275833|3798712|P1|Overall Study|Study terminated|1
1156802|NCT01275755|3798720|P2|Run-out Placebo Period|Lost to Follow-up|0
1156803|NCT01275755|3798721|P1|Run-out Placebo Period|Lost to Follow-up|1
1156804|NCT01275755|3798720|P2|Double-blind Treatment Period|Withdrawal by Subject|0
1156805|NCT01275755|3798721|P1|Double-blind Treatment Period|Withdrawal by Subject|1
1156806|NCT01275755|3798720|P2|Double-blind Treatment Period|Lost to Follow-up|1
1156807|NCT01275755|3798721|P1|Double-blind Treatment Period|Lost to Follow-up|1
1156808|NCT01275755|3798720|P2|Double-blind Treatment Period|Adverse Event|2
1156809|NCT01275755|3798721|P1|Double-blind Treatment Period|Adverse Event|0
1156810|NCT01275625|3798735|P1|Overall Study|Not specified|1
1156811|NCT01275625|3798735|P1|Overall Study|Adverse Event|4
1156812|NCT01275625|3798735|P1|Overall Study|Protocol Violation|1
1156813|NCT01275625|3798735|P1|Overall Study|Withdrawal by Subject|3
1156814|NCT01275625|3798735|P1|Overall Study|Lost to Follow-up|1
1156815|NCT01275625|3798735|P1|Overall Study|Lack of Efficacy|2
1156816|NCT01275625|3798735|P1|Overall Study|Death|1
1156817|NCT01275430|3798753|P1|Overall Study|Inability to achieve maximum p-wave|1
1156818|NCT01275430|3798753|P1|Overall Study|Device Malfunction|1
1156819|NCT01275430|3798753|P1|Overall Study|No Contrast Injection|6
1156820|NCT01275430|3798753|P1|Overall Study|Adverse Event|1
1156821|NCT01275196|3798825|P2|Overall Study|Suboptimal response/treatment failure|6
1156822|NCT01275196|3798826|P1|Overall Study|Suboptimal response/treatment failure|5
1156823|NCT01275196|3798825|P2|Overall Study|Protocol Violation|0
1156824|NCT01275196|3798826|P1|Overall Study|Protocol Violation|1
1156825|NCT01275196|3798825|P2|Overall Study|Disease Progression|5
1156826|NCT01275196|3798826|P1|Overall Study|Disease Progression|6
1156827|NCT01275196|3798825|P2|Overall Study|Lost to Follow-up|0
1156828|NCT01275196|3798826|P1|Overall Study|Lost to Follow-up|1
1156829|NCT01275196|3798825|P2|Overall Study|Withdrawal by Subject|5
1156830|NCT01275196|3798826|P1|Overall Study|Withdrawal by Subject|4
1156831|NCT01275196|3798825|P2|Overall Study|Adverse Event|5
1156832|NCT01275196|3798826|P1|Overall Study|Adverse Event|3
1156833|NCT01275131|3798869|P4|Period 2 (Crossover)|Withdrawal by Subject|2
1156834|NCT01275131|3798870|P3|Period 2 (Crossover)|Withdrawal by Subject|1
1156835|NCT01275131|3798871|P2|Period 2 (Crossover)|Withdrawal by Subject|0
1156836|NCT01275131|3798872|P1|Period 2 (Crossover)|Withdrawal by Subject|1
1156837|NCT01275131|3798869|P4|Period 2 (Crossover)|Adverse Event|0
1156838|NCT01275131|3798870|P3|Period 2 (Crossover)|Adverse Event|0
1156839|NCT01275131|3798871|P2|Period 2 (Crossover)|Adverse Event|1
1156840|NCT01275131|3798872|P1|Period 2 (Crossover)|Adverse Event|0
1156841|NCT01275131|3798869|P4|Period 1|Physician Decision|0
1156842|NCT01275131|3798870|P3|Period 1|Physician Decision|0
1156843|NCT01275131|3798871|P2|Period 1|Physician Decision|0
1156844|NCT01275131|3798872|P1|Period 1|Physician Decision|1
1156845|NCT01275131|3798869|P4|Period 1|Withdrawal by Subject|2
1156846|NCT01275131|3798870|P3|Period 1|Withdrawal by Subject|3
1156847|NCT01275131|3798871|P2|Period 1|Withdrawal by Subject|0
1156848|NCT01275131|3798872|P1|Period 1|Withdrawal by Subject|1
1156849|NCT01275066|3798915|P3|Overall Study|Not Diagnosed w/ Disease|0
1156850|NCT01275066|3798916|P2|Overall Study|Not Diagnosed w/ Disease|0
1156851|NCT01275066|3798917|P1|Overall Study|Not Diagnosed w/ Disease|1
1156852|NCT01275066|3798915|P3|Overall Study|Withdrawal by Subject|1
1156853|NCT01275066|3798916|P2|Overall Study|Withdrawal by Subject|0
1156854|NCT01275066|3798917|P1|Overall Study|Withdrawal by Subject|0
1156855|NCT01274715|3798950|P1|Overall Study|After consent, met exclusion criteria.|1
1156856|NCT01274715|3798950|P1|Overall Study|After consent, met exclusion criteria.|1
1156857|NCT01274715|3798950|P1|Overall Study|After consent, met exclusion criteria.|1
1156858|NCT01274715|3798950|P1|Overall Study|Lost to Follow-up|1
1156859|NCT01274637|3798957|P2|Overall Study|Lost to Follow-up|1
1156860|NCT01274637|3798958|P1|Overall Study|Lost to Follow-up|0
1156861|NCT01274637|3798957|P2|Overall Study|Withdrawal by Subject|1
1156862|NCT01274637|3798958|P1|Overall Study|Withdrawal by Subject|0
1156863|NCT01274559|3798997|P2|Overall Study|Withdrawal by Subject|13
1156864|NCT01274559|3798998|P1|Overall Study|Withdrawal by Subject|25
1156865|NCT01274559|3798997|P2|Overall Study|Study Terminated by Sponsor|87
1156866|NCT01274559|3798998|P1|Overall Study|Study Terminated by Sponsor|79
1156867|NCT01274559|3798997|P2|Overall Study|Protocol Violation|23
1156868|NCT01274559|3798998|P1|Overall Study|Protocol Violation|28
1156869|NCT01274559|3798997|P2|Overall Study|Physician Decision|1
1156870|NCT01274559|3798998|P1|Overall Study|Physician Decision|2
1156871|NCT01274559|3798997|P2|Overall Study|Non-compliance with Study Drug|4
1156872|NCT01274559|3798998|P1|Overall Study|Non-compliance with Study Drug|2
1156873|NCT01274559|3798997|P2|Overall Study|Lost to Follow-up|3
1156874|NCT01274559|3798998|P1|Overall Study|Lost to Follow-up|3
1156875|NCT01274559|3798997|P2|Overall Study|Death|1
1156876|NCT01274559|3798998|P1|Overall Study|Death|1
1156877|NCT01274559|3798997|P2|Overall Study|Adverse Event|13
1156878|NCT01274559|3798998|P1|Overall Study|Adverse Event|57
1156879|NCT01274533|3799048|P1|Overall Study|Disease progression|2
1156880|NCT01274533|3799048|P1|Overall Study|Non-compliance|1
1156881|NCT01274533|3799048|P1|Overall Study|Withdrawal by Subject|1
1156882|NCT01274429|3799053|P1|Overall Study|Study closed do to lack of funding|5
1156883|NCT01274182|3799061|P3|Overall Study|Death|1
1156884|NCT01274182|3799062|P2|Overall Study|Death|0
1156885|NCT01274182|3799063|P1|Overall Study|Death|1
1156886|NCT01274182|3799061|P3|Overall Study|Protocol Violation|0
1156887|NCT01274182|3799062|P2|Overall Study|Protocol Violation|2
1156888|NCT01274182|3799063|P1|Overall Study|Protocol Violation|3
1156889|NCT01274182|3799061|P3|Overall Study|Lost to Follow-up|1
1156890|NCT01274182|3799062|P2|Overall Study|Lost to Follow-up|3
1156891|NCT01274182|3799063|P1|Overall Study|Lost to Follow-up|2
1156892|NCT01274182|3799061|P3|Overall Study|Withdrawal by Subject|3
1156893|NCT01274182|3799062|P2|Overall Study|Withdrawal by Subject|5
1156894|NCT01274182|3799063|P1|Overall Study|Withdrawal by Subject|5
1156895|NCT01274182|3799061|P3|Overall Study|Adverse Event|3
1156896|NCT01274182|3799062|P2|Overall Study|Adverse Event|5
1156897|NCT01274182|3799063|P1|Overall Study|Adverse Event|4
1156898|NCT01274182|3799061|P3|Overall Study|Unsatisfactory therapeutic effect|4
1156899|NCT01274182|3799062|P2|Overall Study|Unsatisfactory therapeutic effect|3
1156900|NCT01274182|3799063|P1|Overall Study|Unsatisfactory therapeutic effect|6
1156901|NCT01273883|3799104|P2|Second Intervention|Lack of Efficacy|0
1156902|NCT01273883|3799105|P1|Second Intervention|Lack of Efficacy|1
1156903|NCT01273883|3799104|P2|Second Intervention|Lost to Follow-up|1
1156904|NCT01273883|3799105|P1|Second Intervention|Lost to Follow-up|1
1156905|NCT01273883|3799104|P2|First Intervention|Adverse Event|1
1156906|NCT01273883|3799105|P1|First Intervention|Adverse Event|2
1156907|NCT01273818|3799131|P3|Overall Study|Physician Decision|9
1156908|NCT01273818|3799132|P2|Overall Study|Physician Decision|2
1156909|NCT01273818|3799133|P1|Overall Study|Physician Decision|13
1156910|NCT01273805|3799143|P2|Overall Study|Radiologic PD or Symptom Deterioration|10
1156911|NCT01273805|3799144|P1|Overall Study|Radiologic PD or Symptom Deterioration|10
1156912|NCT01273623|3799175|P1|Overall Study|did not meet IVUS criteria|29
1156913|NCT01273597|3799182|P1|Overall Study|Reason Not Reported|1
1156914|NCT01273597|3799182|P1|Overall Study|Underwent Kidney Transplantation|2
1156915|NCT01273597|3799182|P1|Overall Study|Adverse Event|5
1156916|NCT01273519|3799197|P3|Overall Study|Not Specified|1
1156917|NCT01273519|3799198|P2|Overall Study|Not Specified|1
1156918|NCT01273519|3799199|P1|Overall Study|Not Specified|6
1156919|NCT01273519|3799197|P3|Overall Study|Lack of Efficacy|4
1156920|NCT01273519|3799198|P2|Overall Study|Lack of Efficacy|3
1156921|NCT01273519|3799199|P1|Overall Study|Lack of Efficacy|8
1156922|NCT01273519|3799197|P3|Overall Study|Lost to Follow-up|3
1156923|NCT01273519|3799198|P2|Overall Study|Lost to Follow-up|1
1156924|NCT01273519|3799199|P1|Overall Study|Lost to Follow-up|2
1156925|NCT01273519|3799197|P3|Overall Study|Adverse Event|0
1156926|NCT01273519|3799198|P2|Overall Study|Adverse Event|0
1156927|NCT01273519|3799199|P1|Overall Study|Adverse Event|3
1156928|NCT01273181|3799236|P4|Phase 2, Dose 2|Death during treatment|1
1156929|NCT01273181|3799237|P3|Phase 2, Dose 2|Death during treatment|0
1156930|NCT01273181|3799238|P2|Phase 2, Dose 2|Death during treatment|0
1156931|NCT01273181|3799239|P1|Phase 2, Dose 2|Death during treatment|0
1156932|NCT01273181|3799236|P4|Phase 2, Dose 1|Study termination|0
1156933|NCT01273181|3799237|P3|Phase 2, Dose 1|Study termination|1
1156934|NCT01273181|3799238|P2|Phase 2, Dose 1|Study termination|0
1156935|NCT01273181|3799239|P1|Phase 2, Dose 1|Study termination|0
1156936|NCT01273181|3799236|P4|Phase I, Dose 2|Death during treatment|0
1156937|NCT01273181|3799237|P3|Phase I, Dose 2|Death during treatment|0
1156938|NCT01273181|3799238|P2|Phase I, Dose 2|Death during treatment|1
1156939|NCT01273181|3799239|P1|Phase I, Dose 2|Death during treatment|0
1156940|NCT01273181|3799236|P4|Phase I, Dose 1|Study termination|0
1156941|NCT01273181|3799237|P3|Phase I, Dose 1|Study termination|0
1156942|NCT01273181|3799238|P2|Phase I, Dose 1|Study termination|0
1156943|NCT01273181|3799239|P1|Phase I, Dose 1|Study termination|1
1156944|NCT01273064|3799258|P5|Overall Study|Physician Decision|1
1156945|NCT01273064|3799259|P4|Overall Study|Physician Decision|0
1156946|NCT01273064|3799260|P3|Overall Study|Physician Decision|0
1156947|NCT01273064|3799261|P2|Overall Study|Physician Decision|0
1156948|NCT01273064|3799262|P1|Overall Study|Physician Decision|0
1156949|NCT01273064|3799258|P5|Overall Study|Lost to Follow-up|0
1156950|NCT01273064|3799259|P4|Overall Study|Lost to Follow-up|0
1156951|NCT01273064|3799260|P3|Overall Study|Lost to Follow-up|0
1156952|NCT01273064|3799261|P2|Overall Study|Lost to Follow-up|0
1156953|NCT01273064|3799262|P1|Overall Study|Lost to Follow-up|1
1156954|NCT01273064|3799258|P5|Overall Study|Study Termination|8
1156955|NCT01273064|3799259|P4|Overall Study|Study Termination|16
1156956|NCT01273064|3799260|P3|Overall Study|Study Termination|26
1156957|NCT01273064|3799261|P2|Overall Study|Study Termination|27
1156958|NCT01273064|3799262|P1|Overall Study|Study Termination|13
1156959|NCT01273064|3799258|P5|Overall Study|Withdrawal by Subject|0
1156960|NCT01273064|3799259|P4|Overall Study|Withdrawal by Subject|2
1156961|NCT01273064|3799260|P3|Overall Study|Withdrawal by Subject|2
1156962|NCT01273064|3799261|P2|Overall Study|Withdrawal by Subject|2
1156963|NCT01273064|3799262|P1|Overall Study|Withdrawal by Subject|4
1156964|NCT01273064|3799258|P5|Overall Study|Adverse Event|1
1156965|NCT01273064|3799259|P4|Overall Study|Adverse Event|2
1156966|NCT01273064|3799260|P3|Overall Study|Adverse Event|3
1156967|NCT01273064|3799261|P2|Overall Study|Adverse Event|1
1156968|NCT01273064|3799262|P1|Overall Study|Adverse Event|5
1156969|NCT01273038|3799281|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
1156970|NCT01273038|3799282|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
1156971|NCT01273038|3799281|P2|Second Intervention (14 Days)|Adverse Event|1
1156972|NCT01273038|3799282|P1|Second Intervention (14 Days)|Adverse Event|0
1156973|NCT01272947|3799305|P2|Overall Study|Abnormal Laboratory Value|2
1156974|NCT01272947|3799306|P1|Overall Study|Abnormal Laboratory Value|2
1156975|NCT01272934|3799316|P2|Overall Study|Abnormal Laboratory Value|1
1156976|NCT01272934|3799317|P1|Overall Study|Abnormal Laboratory Value|0
1156977|NCT01272934|3799316|P2|Overall Study|Adverse Event|1
1156978|NCT01272934|3799317|P1|Overall Study|Adverse Event|0
1156979|NCT01272921|3799327|P2|Overall Study|Protocol Violation|1
1156980|NCT01272921|3799328|P1|Overall Study|Protocol Violation|2
1156981|NCT01272908|3799336|P1|Re-Treatment Period|Withdrawal by Subject|1
1156982|NCT01272908|3799336|P1|Re-Treatment Period|Lack of Efficacy|3
1156983|NCT01272908|3799336|P1|Re-Treatment Period|Adverse Event|2
1156984|NCT01272908|3799336|P1|Initial Treatment Period|Withdrawal by Subject|1
1156985|NCT01272908|3799336|P1|Initial Treatment Period|Protocol Violation|1
1156986|NCT01272908|3799336|P1|Initial Treatment Period|Lack of Efficacy|5
1156987|NCT01272908|3799336|P1|Initial Treatment Period|Adverse Event|1
1156988|NCT01272869|3799376|P2|Period 2 (14 Days)|Adverse Event|0
1156989|NCT01272869|3799377|P1|Period 2 (14 Days)|Adverse Event|1
1156990|NCT01272804|3799404|P6|Overall Study|Adverse Event|1
1156991|NCT01272804|3799405|P5|Overall Study|Adverse Event|2
1156992|NCT01272804|3799406|P4|Overall Study|Adverse Event|0
1156993|NCT01272804|3799407|P3|Overall Study|Adverse Event|0
1156994|NCT01272804|3799408|P2|Overall Study|Adverse Event|0
1156995|NCT01272804|3799409|P1|Overall Study|Adverse Event|1
1156996|NCT01272661|3799567|P3|Overall Study|lost to followup/case closed/ no birth|72
1156997|NCT01272661|3799568|P2|Overall Study|lost to followup/case closed/ no birth|209
1156998|NCT01272661|3799569|P1|Overall Study|lost to followup/case closed/ no birth|126
1156999|NCT01272635|3799594|P4|Overall Study|Lost to Follow-up|23
1157000|NCT01272635|3799595|P3|Overall Study|Lost to Follow-up|31
1157001|NCT01272635|3799596|P2|Overall Study|Lost to Follow-up|20
1157002|NCT01272635|3799597|P1|Overall Study|Lost to Follow-up|31
1157003|NCT01272232|3799681|P3|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0
1157004|NCT01272232|3799682|P2|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
1157005|NCT01272232|3799683|P1|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
1157006|NCT01272232|3799681|P3|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4
1157007|NCT01272232|3799682|P2|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7
1157008|NCT01272232|3799683|P1|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9
1157009|NCT01272232|3799681|P3|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
1157010|NCT01272232|3799682|P2|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0
1157011|NCT01272232|3799683|P1|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
1157012|NCT01272232|3799681|P3|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
1157013|NCT01272232|3799682|P2|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
1157014|NCT01272232|3799683|P1|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1
1157015|NCT01272232|3799681|P3|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0
1157016|NCT01272232|3799682|P2|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
1157017|NCT01272232|3799683|P1|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
1157018|NCT01272232|3799681|P3|Weeks 0-56|Unclassified|12
1157019|NCT01272232|3799682|P2|Weeks 0-56|Unclassified|7
1157020|NCT01272232|3799683|P1|Weeks 0-56|Unclassified|16
1157021|NCT01272232|3799681|P3|Weeks 0-56|Withdrawal criteria|37
1157022|NCT01272232|3799682|P2|Weeks 0-56|Withdrawal criteria|14
1157023|NCT01272232|3799683|P1|Weeks 0-56|Withdrawal criteria|32
1157024|NCT01272232|3799681|P3|Weeks 0-56|Protocol Violation|13
1157025|NCT01272232|3799682|P2|Weeks 0-56|Protocol Violation|8
1157026|NCT01272232|3799683|P1|Weeks 0-56|Protocol Violation|12
1157027|NCT01272232|3799681|P3|Weeks 0-56|Lack of Efficacy|3
1157028|NCT01272232|3799682|P2|Weeks 0-56|Lack of Efficacy|0
1157029|NCT01272232|3799683|P1|Weeks 0-56|Lack of Efficacy|0
1157030|NCT01272232|3799681|P3|Weeks 0-56|Adverse Event|7
1157031|NCT01272232|3799682|P2|Weeks 0-56|Adverse Event|18
1157032|NCT01272232|3799683|P1|Weeks 0-56|Adverse Event|39
1157033|NCT01272219|3799728|P6|Main + Extension Period: Week 0-172|Unclassified|51
1157034|NCT01272219|3799729|P5|Main + Extension Period: Week 0-172|Unclassified|61
1157035|NCT01272219|3799730|P4|Main + Extension Period: Week 0-172|Unclassified|0
1157036|NCT01272219|3799731|P3|Main + Extension Period: Week 0-172|Unclassified|0
1157037|NCT01272219|3799732|P2|Main + Extension Period: Week 0-172|Unclassified|0
1157038|NCT01272219|3799733|P1|Main + Extension Period: Week 0-172|Unclassified|0
1157039|NCT01272219|3799728|P6|Main + Extension Period: Week 0-172|Missing reason|0
1157040|NCT01272219|3799729|P5|Main + Extension Period: Week 0-172|Missing reason|1
1157041|NCT01272219|3799730|P4|Main + Extension Period: Week 0-172|Missing reason|0
1157042|NCT01272219|3799731|P3|Main + Extension Period: Week 0-172|Missing reason|0
1157043|NCT01272219|3799732|P2|Main + Extension Period: Week 0-172|Missing reason|0
1157044|NCT01272219|3799733|P1|Main + Extension Period: Week 0-172|Missing reason|0
1157045|NCT01272219|3799728|P6|Main + Extension Period: Week 0-172|Withdrawal criteria|256
1157046|NCT01272219|3799729|P5|Main + Extension Period: Week 0-172|Withdrawal criteria|364
1157047|NCT01272219|3799730|P4|Main + Extension Period: Week 0-172|Withdrawal criteria|0
1157048|NCT01272219|3799731|P3|Main + Extension Period: Week 0-172|Withdrawal criteria|0
1157049|NCT01272219|3799732|P2|Main + Extension Period: Week 0-172|Withdrawal criteria|0
1157050|NCT01272219|3799733|P1|Main + Extension Period: Week 0-172|Withdrawal criteria|0
1157051|NCT01272219|3799728|P6|Main + Extension Period: Week 0-172|Protocol Violation|36
1157052|NCT01272219|3799729|P5|Main + Extension Period: Week 0-172|Protocol Violation|76
1157053|NCT01272219|3799730|P4|Main + Extension Period: Week 0-172|Protocol Violation|0
1157054|NCT01272219|3799731|P3|Main + Extension Period: Week 0-172|Protocol Violation|0
1157055|NCT01272219|3799732|P2|Main + Extension Period: Week 0-172|Protocol Violation|0
1157056|NCT01272219|3799733|P1|Main + Extension Period: Week 0-172|Protocol Violation|0
1157057|NCT01272219|3799728|P6|Main + Extension Period: Week 0-172|Lack of Efficacy|36
1157058|NCT01272219|3799729|P5|Main + Extension Period: Week 0-172|Lack of Efficacy|29
1157059|NCT01272219|3799730|P4|Main + Extension Period: Week 0-172|Lack of Efficacy|0
1157060|NCT01272219|3799731|P3|Main + Extension Period: Week 0-172|Lack of Efficacy|0
1157061|NCT01272219|3799732|P2|Main + Extension Period: Week 0-172|Lack of Efficacy|0
1157062|NCT01272219|3799733|P1|Main + Extension Period: Week 0-172|Lack of Efficacy|0
1157063|NCT01272219|3799728|P6|Main + Extension Period: Week 0-172|Adverse Event|43
1157064|NCT01272219|3799729|P5|Main + Extension Period: Week 0-172|Adverse Event|191
1157065|NCT01272219|3799730|P4|Main + Extension Period: Week 0-172|Adverse Event|0
1157066|NCT01272219|3799731|P3|Main + Extension Period: Week 0-172|Adverse Event|0
1157067|NCT01272219|3799732|P2|Main + Extension Period: Week 0-172|Adverse Event|0
1157068|NCT01272219|3799733|P1|Main + Extension Period: Week 0-172|Adverse Event|0
1157069|NCT01272219|3799728|P6|Re-randomised Period: Week 56 to Week 68|Unclassified|0
1157070|NCT01272219|3799729|P5|Re-randomised Period: Week 56 to Week 68|Unclassified|0
1157071|NCT01272219|3799730|P4|Re-randomised Period: Week 56 to Week 68|Unclassified|2
1157072|NCT01272219|3799731|P3|Re-randomised Period: Week 56 to Week 68|Unclassified|2
1157073|NCT01272219|3799732|P2|Re-randomised Period: Week 56 to Week 68|Unclassified|1
1157074|NCT01272219|3799733|P1|Re-randomised Period: Week 56 to Week 68|Unclassified|0
1157075|NCT01272219|3799728|P6|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
1157076|NCT01272219|3799729|P5|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
1157077|NCT01272219|3799730|P4|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7
1157078|NCT01272219|3799731|P3|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4
1157079|NCT01272219|3799732|P2|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6
1157080|NCT01272219|3799733|P1|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
1157081|NCT01272219|3799728|P6|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
1157082|NCT01272219|3799729|P5|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
1157083|NCT01272219|3799730|P4|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3
1157084|NCT01272219|3799731|P3|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
1157085|NCT01272219|3799732|P2|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1
1157086|NCT01272219|3799733|P1|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
1157087|NCT01272219|3799728|P6|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
1157088|NCT01272219|3799729|P5|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
1157089|NCT01272219|3799730|P4|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1
1157090|NCT01272219|3799731|P3|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
1157091|NCT01272219|3799732|P2|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
1157092|NCT01272219|3799733|P1|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
1157093|NCT01272219|3799728|P6|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
1157094|NCT01272219|3799729|P5|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
1157095|NCT01272219|3799730|P4|Re-randomised Period: Week 56 to Week 68|Adverse Event|2
1157096|NCT01272219|3799731|P3|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
1157097|NCT01272219|3799732|P2|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
1157098|NCT01272219|3799733|P1|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
1157099|NCT01272219|3799728|P6|Main Period: Week 0 to Week 56|Unclassified|34
1157100|NCT01272219|3799729|P5|Main Period: Week 0 to Week 56|Unclassified|42
1157101|NCT01272219|3799730|P4|Main Period: Week 0 to Week 56|Unclassified|29
1157102|NCT01272219|3799731|P3|Main Period: Week 0 to Week 56|Unclassified|0
1157103|NCT01272219|3799732|P2|Main Period: Week 0 to Week 56|Unclassified|0
1157104|NCT01272219|3799733|P1|Main Period: Week 0 to Week 56|Unclassified|36
1157105|NCT01272219|3799728|P6|Main Period: Week 0 to Week 56|Withdrawal criteria|147
1157106|NCT01272219|3799729|P5|Main Period: Week 0 to Week 56|Withdrawal criteria|172
1157107|NCT01272219|3799730|P4|Main Period: Week 0 to Week 56|Withdrawal criteria|114
1157108|NCT01272219|3799731|P3|Main Period: Week 0 to Week 56|Withdrawal criteria|0
1157109|NCT01272219|3799732|P2|Main Period: Week 0 to Week 56|Withdrawal criteria|0
1157110|NCT01272219|3799733|P1|Main Period: Week 0 to Week 56|Withdrawal criteria|122
1157111|NCT01272219|3799728|P6|Main Period: Week 0 to Week 56|Protocol Violation|20
1157112|NCT01272219|3799729|P5|Main Period: Week 0 to Week 56|Protocol Violation|40
1157113|NCT01272219|3799730|P4|Main Period: Week 0 to Week 56|Protocol Violation|18
1157114|NCT01272219|3799731|P3|Main Period: Week 0 to Week 56|Protocol Violation|0
1157115|NCT01272219|3799732|P2|Main Period: Week 0 to Week 56|Protocol Violation|0
1157116|NCT01272219|3799733|P1|Main Period: Week 0 to Week 56|Protocol Violation|25
1157117|NCT01272219|3799728|P6|Main Period: Week 0 to Week 56|Lack of Efficacy|22
1157118|NCT01272219|3799729|P5|Main Period: Week 0 to Week 56|Lack of Efficacy|12
1157119|NCT01272219|3799730|P4|Main Period: Week 0 to Week 56|Lack of Efficacy|14
1157120|NCT01272219|3799731|P3|Main Period: Week 0 to Week 56|Lack of Efficacy|0
1157121|NCT01272219|3799732|P2|Main Period: Week 0 to Week 56|Lack of Efficacy|0
1157122|NCT01272219|3799733|P1|Main Period: Week 0 to Week 56|Lack of Efficacy|11
1157123|NCT01272219|3799728|P6|Main Period: Week 0 to Week 56|Adverse Event|29
1157124|NCT01272219|3799729|P5|Main Period: Week 0 to Week 56|Adverse Event|152
1157125|NCT01272219|3799730|P4|Main Period: Week 0 to Week 56|Adverse Event|16
1157126|NCT01272219|3799731|P3|Main Period: Week 0 to Week 56|Adverse Event|0
1157127|NCT01272219|3799732|P2|Main Period: Week 0 to Week 56|Adverse Event|0
1157128|NCT01272219|3799733|P1|Main Period: Week 0 to Week 56|Adverse Event|86
1157129|NCT01272193|3799767|P2|Overall Study|Unclassified|7
1157130|NCT01272193|3799768|P1|Overall Study|Unclassified|8
1157131|NCT01272193|3799767|P2|Overall Study|Withdrawal Criteria|1
1157132|NCT01272193|3799768|P1|Overall Study|Withdrawal Criteria|1
1157133|NCT01272193|3799767|P2|Overall Study|Lack of Efficacy|3
1157134|NCT01272193|3799768|P1|Overall Study|Lack of Efficacy|0
1157135|NCT01272193|3799767|P2|Overall Study|Adverse Event|1
1157136|NCT01272193|3799768|P1|Overall Study|Adverse Event|1
1157137|NCT01272180|3799788|P4|Overall Study|Protocol Violation|1
1157138|NCT01272180|3799789|P3|Overall Study|Protocol Violation|0
1157139|NCT01272180|3799790|P2|Overall Study|Protocol Violation|1
1157140|NCT01272180|3799791|P1|Overall Study|Protocol Violation|0
1157141|NCT01272180|3799788|P4|Overall Study|Inappropriate enrollment|1
1157142|NCT01272180|3799789|P3|Overall Study|Inappropriate enrollment|1
1157143|NCT01272180|3799790|P2|Overall Study|Inappropriate enrollment|0
1157144|NCT01272180|3799791|P1|Overall Study|Inappropriate enrollment|0
1157145|NCT01272180|3799788|P4|Overall Study|Lost to Follow-up|10
1157146|NCT01272180|3799789|P3|Overall Study|Lost to Follow-up|8
1157147|NCT01272180|3799790|P2|Overall Study|Lost to Follow-up|14
1157148|NCT01272180|3799791|P1|Overall Study|Lost to Follow-up|15
1157149|NCT01272180|3799788|P4|Overall Study|Withdrawal by Subject|2
1157150|NCT01272180|3799789|P3|Overall Study|Withdrawal by Subject|3
1157151|NCT01272180|3799790|P2|Overall Study|Withdrawal by Subject|6
1157152|NCT01272180|3799791|P1|Overall Study|Withdrawal by Subject|2
1157153|NCT01272180|3799788|P4|Overall Study|Adverse Event|0
1157154|NCT01272180|3799789|P3|Overall Study|Adverse Event|1
1157155|NCT01272180|3799790|P2|Overall Study|Adverse Event|0
1157156|NCT01272180|3799791|P1|Overall Study|Adverse Event|0
1157157|NCT01272011|3799840|P3|Overall Study|Withdrawal By Subject or Failed Screen|0
1157158|NCT01272011|3799841|P2|Overall Study|Withdrawal By Subject or Failed Screen|2
1157159|NCT01272011|3799842|P1|Overall Study|Withdrawal By Subject or Failed Screen|0
1157160|NCT01271933|3799878|P3|Double-Blind Phase|Participant request-personal reason|0
1157161|NCT01271933|3799879|P2|Double-Blind Phase|Participant request-personal reason|1
1157162|NCT01271933|3799880|P1|Double-Blind Phase|Participant request-personal reason|0
1157163|NCT01271933|3799878|P3|Double-Blind Phase|Adverse Event|0
1157164|NCT01271933|3799879|P2|Double-Blind Phase|Adverse Event|3
1157165|NCT01271933|3799880|P1|Double-Blind Phase|Adverse Event|0
1157166|NCT01271933|3799878|P3|Double-Blind Phase|Withdrawal by Subject|1
1157167|NCT01271933|3799879|P2|Double-Blind Phase|Withdrawal by Subject|6
1157168|NCT01271933|3799880|P1|Double-Blind Phase|Withdrawal by Subject|0
1157169|NCT01271933|3799878|P3|Double-Blind Phase|Lost to Follow-up|1
1157170|NCT01271933|3799879|P2|Double-Blind Phase|Lost to Follow-up|1
1157171|NCT01271933|3799880|P1|Double-Blind Phase|Lost to Follow-up|0
1157172|NCT01271933|3799878|P3|Double-Blind Phase|Lack of Efficacy|9
1157173|NCT01271933|3799879|P2|Double-Blind Phase|Lack of Efficacy|6
1157174|NCT01271933|3799880|P1|Double-Blind Phase|Lack of Efficacy|0
1157175|NCT01271933|3799878|P3|Double-Blind Phase|Randomized but not treated|1
1157176|NCT01271933|3799879|P2|Double-Blind Phase|Randomized but not treated|0
1157177|NCT01271933|3799880|P1|Double-Blind Phase|Randomized but not treated|0
1157178|NCT01271933|3799878|P3|Single-Blind Phase|(Participant request-personal reason)|0
1157179|NCT01271933|3799879|P2|Single-Blind Phase|(Participant request-personal reason)|0
1157180|NCT01271933|3799880|P1|Single-Blind Phase|(Participant request-personal reason)|1
1157181|NCT01271933|3799878|P3|Single-Blind Phase|(Protocol non-compliance)|0
1157182|NCT01271933|3799879|P2|Single-Blind Phase|(Protocol non-compliance)|0
1157183|NCT01271933|3799880|P1|Single-Blind Phase|(Protocol non-compliance)|2
1157184|NCT01271933|3799878|P3|Single-Blind Phase|(Failed to meet dosing requirement)|0
1157185|NCT01271933|3799879|P2|Single-Blind Phase|(Failed to meet dosing requirement)|0
1157186|NCT01271933|3799880|P1|Single-Blind Phase|(Failed to meet dosing requirement)|1
1157187|NCT01271933|3799878|P3|Single-Blind Phase|Adverse Event|0
1157188|NCT01271933|3799879|P2|Single-Blind Phase|Adverse Event|0
1157189|NCT01271933|3799880|P1|Single-Blind Phase|Adverse Event|52
1157190|NCT01271933|3799878|P3|Single-Blind Phase|Protocol Violation|0
1157191|NCT01271933|3799879|P2|Single-Blind Phase|Protocol Violation|0
1157192|NCT01271933|3799880|P1|Single-Blind Phase|Protocol Violation|3
1157193|NCT01271933|3799878|P3|Single-Blind Phase|Withdrawal by Subject|0
1157194|NCT01271933|3799879|P2|Single-Blind Phase|Withdrawal by Subject|0
1157195|NCT01271933|3799880|P1|Single-Blind Phase|Withdrawal by Subject|15
1157196|NCT01271933|3799878|P3|Single-Blind Phase|Lost to Follow-up|0
1157197|NCT01271933|3799879|P2|Single-Blind Phase|Lost to Follow-up|0
1157198|NCT01271933|3799880|P1|Single-Blind Phase|Lost to Follow-up|10
1157199|NCT01271933|3799878|P3|Single-Blind Phase|Lack of Efficacy|0
1157200|NCT01271933|3799879|P2|Single-Blind Phase|Lack of Efficacy|0
1157201|NCT01271933|3799880|P1|Single-Blind Phase|Lack of Efficacy|37
1157202|NCT01271803|3800021|P12|Stage 2|Ongoing in the Study|14
1157203|NCT01271803|3800022|P11|Stage 2|Ongoing in the Study|6
1157204|NCT01271803|3800023|P10|Stage 2|Ongoing in the Study|0
1157205|NCT01271803|3800024|P9|Stage 2|Ongoing in the Study|0
1157206|NCT01271803|3800025|P8|Stage 2|Ongoing in the Study|0
1157207|NCT01271803|3800026|P7|Stage 2|Ongoing in the Study|0
1157208|NCT01271803|3800027|P6|Stage 2|Ongoing in the Study|0
1157209|NCT01271803|3800028|P5|Stage 2|Ongoing in the Study|0
1157210|NCT01271803|3800029|P4|Stage 2|Ongoing in the Study|0
1157211|NCT01271803|3800030|P3|Stage 2|Ongoing in the Study|0
1157212|NCT01271803|3800031|P2|Stage 2|Ongoing in the Study|0
1157213|NCT01271803|3800032|P1|Stage 2|Ongoing in the Study|0
1157214|NCT01271803|3800021|P12|Stage 2|Other|0
1157215|NCT01271803|3800022|P11|Stage 2|Other|1
1157216|NCT01271803|3800023|P10|Stage 2|Other|0
1157217|NCT01271803|3800024|P9|Stage 2|Other|0
1157218|NCT01271803|3800025|P8|Stage 2|Other|0
1157219|NCT01271803|3800026|P7|Stage 2|Other|0
1157220|NCT01271803|3800027|P6|Stage 2|Other|0
1157221|NCT01271803|3800028|P5|Stage 2|Other|0
1157222|NCT01271803|3800029|P4|Stage 2|Other|0
1157223|NCT01271803|3800030|P3|Stage 2|Other|0
1157224|NCT01271803|3800031|P2|Stage 2|Other|0
1157225|NCT01271803|3800032|P1|Stage 2|Other|0
1157226|NCT01271803|3800021|P12|Stage 2|Physician Decision|1
1157227|NCT01271803|3800022|P11|Stage 2|Physician Decision|0
1157228|NCT01271803|3800023|P10|Stage 2|Physician Decision|0
1157229|NCT01271803|3800024|P9|Stage 2|Physician Decision|0
1157230|NCT01271803|3800025|P8|Stage 2|Physician Decision|0
1157231|NCT01271803|3800026|P7|Stage 2|Physician Decision|0
1157232|NCT01271803|3800027|P6|Stage 2|Physician Decision|0
1157233|NCT01271803|3800028|P5|Stage 2|Physician Decision|0
1157234|NCT01271803|3800029|P4|Stage 2|Physician Decision|0
1157235|NCT01271803|3800030|P3|Stage 2|Physician Decision|0
1157236|NCT01271803|3800031|P2|Stage 2|Physician Decision|0
1157237|NCT01271803|3800032|P1|Stage 2|Physician Decision|0
1157238|NCT01271803|3800021|P12|Stage 2|Withdrawal by Subject|2
1157239|NCT01271803|3800022|P11|Stage 2|Withdrawal by Subject|0
1157240|NCT01271803|3800023|P10|Stage 2|Withdrawal by Subject|0
1157241|NCT01271803|3800024|P9|Stage 2|Withdrawal by Subject|0
1157242|NCT01271803|3800025|P8|Stage 2|Withdrawal by Subject|0
1157243|NCT01271803|3800026|P7|Stage 2|Withdrawal by Subject|0
1157244|NCT01271803|3800027|P6|Stage 2|Withdrawal by Subject|0
1157245|NCT01271803|3800028|P5|Stage 2|Withdrawal by Subject|0
1157246|NCT01271803|3800029|P4|Stage 2|Withdrawal by Subject|0
1157247|NCT01271803|3800030|P3|Stage 2|Withdrawal by Subject|0
1157248|NCT01271803|3800031|P2|Stage 2|Withdrawal by Subject|0
1157249|NCT01271803|3800032|P1|Stage 2|Withdrawal by Subject|0
1157250|NCT01271803|3800021|P12|Stage 2|Death|2
1157251|NCT01271803|3800022|P11|Stage 2|Death|2
1157252|NCT01271803|3800023|P10|Stage 2|Death|0
1157253|NCT01271803|3800024|P9|Stage 2|Death|0
1157254|NCT01271803|3800025|P8|Stage 2|Death|0
1157255|NCT01271803|3800026|P7|Stage 2|Death|0
1157256|NCT01271803|3800027|P6|Stage 2|Death|0
1157257|NCT01271803|3800028|P5|Stage 2|Death|0
1157258|NCT01271803|3800029|P4|Stage 2|Death|0
1157259|NCT01271803|3800030|P3|Stage 2|Death|0
1157260|NCT01271803|3800031|P2|Stage 2|Death|0
1157261|NCT01271803|3800032|P1|Stage 2|Death|0
1157262|NCT01271803|3800021|P12|Stage 2|Adverse Event|3
1157263|NCT01271803|3800022|P11|Stage 2|Adverse Event|1
1157264|NCT01271803|3800023|P10|Stage 2|Adverse Event|0
1157265|NCT01271803|3800024|P9|Stage 2|Adverse Event|0
1157266|NCT01271803|3800025|P8|Stage 2|Adverse Event|0
1157267|NCT01271803|3800026|P7|Stage 2|Adverse Event|0
1157268|NCT01271803|3800027|P6|Stage 2|Adverse Event|0
1157269|NCT01271803|3800028|P5|Stage 2|Adverse Event|0
1157270|NCT01271803|3800029|P4|Stage 2|Adverse Event|0
1157271|NCT01271803|3800030|P3|Stage 2|Adverse Event|0
1157272|NCT01271803|3800031|P2|Stage 2|Adverse Event|0
1157273|NCT01271803|3800032|P1|Stage 2|Adverse Event|0
1157274|NCT01271803|3800021|P12|Stage 2|Progressive disease|17
1157275|NCT01271803|3800022|P11|Stage 2|Progressive disease|17
1157276|NCT01271803|3800023|P10|Stage 2|Progressive disease|0
1157277|NCT01271803|3800024|P9|Stage 2|Progressive disease|0
1157278|NCT01271803|3800025|P8|Stage 2|Progressive disease|0
1157279|NCT01271803|3800026|P7|Stage 2|Progressive disease|0
1157280|NCT01271803|3800027|P6|Stage 2|Progressive disease|0
1157281|NCT01271803|3800028|P5|Stage 2|Progressive disease|0
1157282|NCT01271803|3800029|P4|Stage 2|Progressive disease|0
1157283|NCT01271803|3800030|P3|Stage 2|Progressive disease|0
1157284|NCT01271803|3800031|P2|Stage 2|Progressive disease|0
1157285|NCT01271803|3800032|P1|Stage 2|Progressive disease|0
1157286|NCT01271803|3800021|P12|Stage 1|Ongoing in the Study|0
1157287|NCT01271803|3800022|P11|Stage 1|Ongoing in the Study|0
1157288|NCT01271803|3800023|P10|Stage 1|Ongoing in the Study|0
1157289|NCT01271803|3800024|P9|Stage 1|Ongoing in the Study|1
1157290|NCT01271803|3800025|P8|Stage 1|Ongoing in the Study|1
1157291|NCT01271803|3800026|P7|Stage 1|Ongoing in the Study|1
1157292|NCT01271803|3800027|P6|Stage 1|Ongoing in the Study|0
1157293|NCT01271803|3800028|P5|Stage 1|Ongoing in the Study|3
1157294|NCT01271803|3800029|P4|Stage 1|Ongoing in the Study|1
1157295|NCT01271803|3800030|P3|Stage 1|Ongoing in the Study|11
1157296|NCT01271803|3800031|P2|Stage 1|Ongoing in the Study|1
1157297|NCT01271803|3800032|P1|Stage 1|Ongoing in the Study|0
1157298|NCT01271803|3800021|P12|Stage 1|Other|0
1157299|NCT01271803|3800022|P11|Stage 1|Other|0
1157300|NCT01271803|3800023|P10|Stage 1|Other|0
1157301|NCT01271803|3800024|P9|Stage 1|Other|0
1157302|NCT01271803|3800025|P8|Stage 1|Other|0
1157303|NCT01271803|3800026|P7|Stage 1|Other|0
1157304|NCT01271803|3800027|P6|Stage 1|Other|0
1157305|NCT01271803|3800028|P5|Stage 1|Other|0
1157306|NCT01271803|3800029|P4|Stage 1|Other|0
1157307|NCT01271803|3800030|P3|Stage 1|Other|2
1157308|NCT01271803|3800031|P2|Stage 1|Other|0
1157309|NCT01271803|3800032|P1|Stage 1|Other|0
1157310|NCT01271803|3800021|P12|Stage 1|Withdrawal by Subject|0
1157311|NCT01271803|3800022|P11|Stage 1|Withdrawal by Subject|0
1157312|NCT01271803|3800023|P10|Stage 1|Withdrawal by Subject|0
1157313|NCT01271803|3800024|P9|Stage 1|Withdrawal by Subject|0
1157314|NCT01271803|3800025|P8|Stage 1|Withdrawal by Subject|0
1157315|NCT01271803|3800026|P7|Stage 1|Withdrawal by Subject|0
1157316|NCT01271803|3800027|P6|Stage 1|Withdrawal by Subject|0
1157317|NCT01271803|3800028|P5|Stage 1|Withdrawal by Subject|0
1157318|NCT01271803|3800029|P4|Stage 1|Withdrawal by Subject|0
1157319|NCT01271803|3800030|P3|Stage 1|Withdrawal by Subject|1
1157320|NCT01271803|3800031|P2|Stage 1|Withdrawal by Subject|0
1157321|NCT01271803|3800032|P1|Stage 1|Withdrawal by Subject|0
1157322|NCT01271803|3800021|P12|Stage 1|Physician Decision|0
1157323|NCT01271803|3800022|P11|Stage 1|Physician Decision|0
1157324|NCT01271803|3800023|P10|Stage 1|Physician Decision|0
1157325|NCT01271803|3800024|P9|Stage 1|Physician Decision|0
1157326|NCT01271803|3800025|P8|Stage 1|Physician Decision|0
1157327|NCT01271803|3800026|P7|Stage 1|Physician Decision|1
1157328|NCT01271803|3800027|P6|Stage 1|Physician Decision|0
1157329|NCT01271803|3800028|P5|Stage 1|Physician Decision|0
1157330|NCT01271803|3800029|P4|Stage 1|Physician Decision|0
1157331|NCT01271803|3800030|P3|Stage 1|Physician Decision|0
1157332|NCT01271803|3800031|P2|Stage 1|Physician Decision|0
1157333|NCT01271803|3800032|P1|Stage 1|Physician Decision|1
1157334|NCT01271803|3800021|P12|Stage 1|Death|0
1157335|NCT01271803|3800022|P11|Stage 1|Death|0
1157336|NCT01271803|3800023|P10|Stage 1|Death|0
1157337|NCT01271803|3800024|P9|Stage 1|Death|0
1157338|NCT01271803|3800025|P8|Stage 1|Death|0
1157339|NCT01271803|3800026|P7|Stage 1|Death|0
1157340|NCT01271803|3800027|P6|Stage 1|Death|1
1157341|NCT01271803|3800028|P5|Stage 1|Death|0
1157342|NCT01271803|3800029|P4|Stage 1|Death|0
1157343|NCT01271803|3800030|P3|Stage 1|Death|0
1157344|NCT01271803|3800031|P2|Stage 1|Death|0
1157345|NCT01271803|3800032|P1|Stage 1|Death|1
1157346|NCT01271803|3800021|P12|Stage 1|Adverse Event|0
1157347|NCT01271803|3800022|P11|Stage 1|Adverse Event|0
1157348|NCT01271803|3800023|P10|Stage 1|Adverse Event|0
1157349|NCT01271803|3800024|P9|Stage 1|Adverse Event|0
1157350|NCT01271803|3800025|P8|Stage 1|Adverse Event|0
1157351|NCT01271803|3800026|P7|Stage 1|Adverse Event|0
1157352|NCT01271803|3800027|P6|Stage 1|Adverse Event|0
1157353|NCT01271803|3800028|P5|Stage 1|Adverse Event|0
1157354|NCT01271803|3800029|P4|Stage 1|Adverse Event|0
1157355|NCT01271803|3800030|P3|Stage 1|Adverse Event|1
1157356|NCT01271803|3800031|P2|Stage 1|Adverse Event|0
1157357|NCT01271803|3800032|P1|Stage 1|Adverse Event|0
1157358|NCT01271803|3800021|P12|Stage 1|Progressive disease|0
1157359|NCT01271803|3800022|P11|Stage 1|Progressive disease|0
1157360|NCT01271803|3800023|P10|Stage 1|Progressive disease|2
1157361|NCT01271803|3800024|P9|Stage 1|Progressive disease|4
1157362|NCT01271803|3800025|P8|Stage 1|Progressive disease|2
1157363|NCT01271803|3800026|P7|Stage 1|Progressive disease|2
1157364|NCT01271803|3800027|P6|Stage 1|Progressive disease|3
1157365|NCT01271803|3800028|P5|Stage 1|Progressive disease|1
1157366|NCT01271803|3800029|P4|Stage 1|Progressive disease|2
1157367|NCT01271803|3800030|P3|Stage 1|Progressive disease|12
1157368|NCT01271803|3800031|P2|Stage 1|Progressive disease|7
1157369|NCT01271803|3800032|P1|Stage 1|Progressive disease|3
1157370|NCT01271712|3800205|P2|Survival Follow-up|Ongoing survival follow-up|6
1157371|NCT01271712|3800206|P1|Survival Follow-up|Ongoing survival follow-up|15
1157372|NCT01271712|3800205|P2|Safety Follow-up|Progressive disease|0
1157373|NCT01271712|3800206|P1|Safety Follow-up|Progressive disease|1
1157374|NCT01271712|3800205|P2|Safety Follow-up|No follow-up|1
1157375|NCT01271712|3800206|P1|Safety Follow-up|No follow-up|1
1157376|NCT01271712|3800205|P2|Safety Follow-up|Ongoing safety follow-up|4
1157377|NCT01271712|3800206|P1|Safety Follow-up|Ongoing safety follow-up|3
1157378|NCT01271712|3800205|P2|Safety Follow-up|Protocol Violation|1
1157379|NCT01271712|3800206|P1|Safety Follow-up|Protocol Violation|1
1157380|NCT01271712|3800205|P2|Safety Follow-up|Withdrawal by Subject|2
1157381|NCT01271712|3800206|P1|Safety Follow-up|Withdrawal by Subject|4
1157382|NCT01271712|3800205|P2|Safety Follow-up|Death|7
1157383|NCT01271712|3800206|P1|Safety Follow-up|Death|11
1157384|NCT01271712|3800205|P2|Open Label Treatment|Switching to other therapy|1
1157385|NCT01271712|3800206|P1|Open Label Treatment|Switching to other therapy|2
1157386|NCT01271712|3800205|P2|Open Label Treatment|Protocol Violation|1
1157387|NCT01271712|3800206|P1|Open Label Treatment|Protocol Violation|0
1157388|NCT01271712|3800205|P2|Open Label Treatment|Non-compliance with study drug|0
1157389|NCT01271712|3800206|P1|Open Label Treatment|Non-compliance with study drug|1
1157390|NCT01271712|3800205|P2|Open Label Treatment|Ongoing with open-label treatment|1
1157391|NCT01271712|3800206|P1|Open Label Treatment|Ongoing with open-label treatment|6
1157392|NCT01271712|3800205|P2|Open Label Treatment|Progressive disease|31
1157393|NCT01271712|3800206|P1|Open Label Treatment|Progressive disease|56
1157394|NCT01271712|3800205|P2|Open Label Treatment|Adverse Event|8
1157395|NCT01271712|3800206|P1|Open Label Treatment|Adverse Event|12
1157396|NCT01271712|3800205|P2|Open Label Treatment|Physician Decision|0
1157397|NCT01271712|3800206|P1|Open Label Treatment|Physician Decision|2
1157398|NCT01271712|3800205|P2|Open Label Treatment|Withdrawal by Subject|11
1157399|NCT01271712|3800206|P1|Open Label Treatment|Withdrawal by Subject|6
1157400|NCT01271712|3800205|P2|Open Label Treatment|Death|5
1157401|NCT01271712|3800206|P1|Open Label Treatment|Death|6
1157402|NCT01271712|3800205|P2|Double Blind Treatment|receive no study drug|0
1157403|NCT01271712|3800206|P1|Double Blind Treatment|receive no study drug|1
1157404|NCT01271712|3800205|P2|Double Blind Treatment|Non compliance with study drug|0
1157405|NCT01271712|3800206|P1|Double Blind Treatment|Non compliance with study drug|2
1157406|NCT01271712|3800205|P2|Double Blind Treatment|Withdrawal by Subject|1
1157407|NCT01271712|3800206|P1|Double Blind Treatment|Withdrawal by Subject|4
1157408|NCT01271712|3800205|P2|Double Blind Treatment|Progressive disease|3
1157409|NCT01271712|3800206|P1|Double Blind Treatment|Progressive disease|23
1157410|NCT01271712|3800205|P2|Double Blind Treatment|Adverse Event|4
1157411|NCT01271712|3800206|P1|Double Blind Treatment|Adverse Event|9
1157412|NCT01271712|3800205|P2|Double Blind Treatment|Lack of Efficacy|0
1157413|NCT01271712|3800206|P1|Double Blind Treatment|Lack of Efficacy|1
1157414|NCT01271712|3800205|P2|Double Blind Treatment|Death|0
1157415|NCT01271712|3800206|P1|Double Blind Treatment|Death|2
1157416|NCT01271010|3800300|P1|Overall Study|Disease progression|27
1157417|NCT01271010|3800300|P1|Overall Study|Withdrawal by Subject|18
1157418|NCT01271010|3800300|P1|Overall Study|Progression and relapse of disease|1
1157419|NCT01271010|3800300|P1|Overall Study|Death|2
1157420|NCT01271010|3800300|P1|Overall Study|Protocol Violation|1
1157421|NCT01271010|3800300|P1|Overall Study|Start of new CLL therapy|1
1157422|NCT01271010|3800300|P1|Overall Study|Reason not specified|11
1157423|NCT01270971|3800315|P2|Overall Study|Non-specific|3
1157424|NCT01270971|3800316|P1|Overall Study|Non-specific|7
1157425|NCT01270971|3800315|P2|Overall Study|Non compliance|2
1157426|NCT01270971|3800316|P1|Overall Study|Non compliance|2
1157427|NCT01270971|3800315|P2|Overall Study|Adverse Event|2
1157428|NCT01270971|3800316|P1|Overall Study|Adverse Event|1
1157429|NCT01270971|3800315|P2|Overall Study|Lost to Follow-up|5
1157430|NCT01270971|3800316|P1|Overall Study|Lost to Follow-up|18
1157431|NCT01270971|3800315|P2|Overall Study|Withdrawal by Subject|11
1157432|NCT01270971|3800316|P1|Overall Study|Withdrawal by Subject|24
1157433|NCT01270958|3800328|P1|Overall Study|Did not meet inclusion criteria for age|2
1157434|NCT01270958|3800328|P1|Overall Study|Lost to Follow-up|2
1157435|NCT01270880|3800357|P1|Overall Study|Never rec'd treatment, but registered.|1
1157436|NCT01270841|3800387|P4|Overall Study|Enrolled in error|0
1157437|NCT01270841|3800388|P3|Overall Study|Enrolled in error|0
1157438|NCT01270841|3800389|P2|Overall Study|Enrolled in error|1
1157439|NCT01270841|3800390|P1|Overall Study|Enrolled in error|0
1157440|NCT01270841|3800387|P4|Overall Study|Protocol Violation|0
1157441|NCT01270841|3800388|P3|Overall Study|Protocol Violation|0
1157442|NCT01270841|3800389|P2|Overall Study|Protocol Violation|5
1157443|NCT01270841|3800390|P1|Overall Study|Protocol Violation|1
1157444|NCT01270841|3800387|P4|Overall Study|Did not qualify|5
1157445|NCT01270841|3800388|P3|Overall Study|Did not qualify|4
1157446|NCT01270841|3800389|P2|Overall Study|Did not qualify|3
1157447|NCT01270841|3800390|P1|Overall Study|Did not qualify|6
1157448|NCT01270841|3800387|P4|Overall Study|Physician Decision|0
1157449|NCT01270841|3800388|P3|Overall Study|Physician Decision|0
1157450|NCT01270841|3800389|P2|Overall Study|Physician Decision|1
1157451|NCT01270841|3800390|P1|Overall Study|Physician Decision|0
1157452|NCT01270841|3800387|P4|Overall Study|Lost to Follow-up|2
1157453|NCT01270841|3800388|P3|Overall Study|Lost to Follow-up|4
1157454|NCT01270841|3800389|P2|Overall Study|Lost to Follow-up|1
1157455|NCT01270841|3800390|P1|Overall Study|Lost to Follow-up|3
1157456|NCT01270841|3800387|P4|Overall Study|Withdrawal by Subject|3
1157457|NCT01270841|3800388|P3|Overall Study|Withdrawal by Subject|3
1157458|NCT01270841|3800389|P2|Overall Study|Withdrawal by Subject|2
1157459|NCT01270841|3800390|P1|Overall Study|Withdrawal by Subject|3
1157460|NCT01270841|3800387|P4|Overall Study|Adverse Event|3
1157461|NCT01270841|3800388|P3|Overall Study|Adverse Event|0
1157462|NCT01270841|3800389|P2|Overall Study|Adverse Event|1
1157463|NCT01270841|3800390|P1|Overall Study|Adverse Event|0
1157464|NCT01270828|3800414|P3|Double Blind Phase|Adverse event related to study drug|0
1157465|NCT01270828|3800415|P2|Double Blind Phase|Adverse event related to study drug|7
1157466|NCT01270828|3800416|P1|Double Blind Phase|Adverse event related to study drug|5
1157467|NCT01270828|3800414|P3|Double Blind Phase|Adverse event not related to study drug|0
1157468|NCT01270828|3800415|P2|Double Blind Phase|Adverse event not related to study drug|1
1157469|NCT01270828|3800416|P1|Double Blind Phase|Adverse event not related to study drug|1
1157470|NCT01270828|3800414|P3|Double Blind Phase|Lack of Efficacy|0
1157471|NCT01270828|3800415|P2|Double Blind Phase|Lack of Efficacy|11
1157472|NCT01270828|3800416|P1|Double Blind Phase|Lack of Efficacy|2
1157473|NCT01270828|3800414|P3|Double Blind Phase|Lost to Follow-up|0
1157474|NCT01270828|3800415|P2|Double Blind Phase|Lost to Follow-up|2
1157475|NCT01270828|3800416|P1|Double Blind Phase|Lost to Follow-up|1
1157476|NCT01270828|3800414|P3|Double Blind Phase|Withdrawal by Subject|0
1157477|NCT01270828|3800415|P2|Double Blind Phase|Withdrawal by Subject|15
1157478|NCT01270828|3800416|P1|Double Blind Phase|Withdrawal by Subject|6
1157479|NCT01270828|3800414|P3|Double Blind Phase|Reason Unspecified|0
1157480|NCT01270828|3800415|P2|Double Blind Phase|Reason Unspecified|4
1157481|NCT01270828|3800416|P1|Double Blind Phase|Reason Unspecified|7
1157482|NCT01270828|3800414|P3|Double Blind Phase|Protocol and GCP non-compliance|0
1157483|NCT01270828|3800415|P2|Double Blind Phase|Protocol and GCP non-compliance|3
1157484|NCT01270828|3800416|P1|Double Blind Phase|Protocol and GCP non-compliance|4
1157485|NCT01270828|3800414|P3|Double Blind Phase|Protocol Violation|0
1157486|NCT01270828|3800415|P2|Double Blind Phase|Protocol Violation|1
1157487|NCT01270828|3800416|P1|Double Blind Phase|Protocol Violation|0
1157488|NCT01270828|3800414|P3|Double Blind Phase|Death|0
1157489|NCT01270828|3800415|P2|Double Blind Phase|Death|1
1157490|NCT01270828|3800416|P1|Double Blind Phase|Death|0
1157491|NCT01270828|3800414|P3|Pregabalin CR SB|Protocol Violation|8
1157492|NCT01270828|3800415|P2|Pregabalin CR SB|Protocol Violation|0
1157493|NCT01270828|3800416|P1|Pregabalin CR SB|Protocol Violation|0
1157494|NCT01270828|3800414|P3|Pregabalin CR SB|Unrelated AE|8
1157495|NCT01270828|3800415|P2|Pregabalin CR SB|Unrelated AE|0
1157496|NCT01270828|3800416|P1|Pregabalin CR SB|Unrelated AE|0
1157497|NCT01270828|3800414|P3|Pregabalin CR SB|Lost to Follow-up|10
1157498|NCT01270828|3800415|P2|Pregabalin CR SB|Lost to Follow-up|0
1157499|NCT01270828|3800416|P1|Pregabalin CR SB|Lost to Follow-up|0
1157500|NCT01270828|3800414|P3|Pregabalin CR SB|Withdrawal by Subject|29
1157501|NCT01270828|3800415|P2|Pregabalin CR SB|Withdrawal by Subject|0
1157502|NCT01270828|3800416|P1|Pregabalin CR SB|Withdrawal by Subject|0
1157503|NCT01270828|3800414|P3|Pregabalin CR SB|Lack of Efficacy|32
1157504|NCT01270828|3800415|P2|Pregabalin CR SB|Lack of Efficacy|0
1157505|NCT01270828|3800416|P1|Pregabalin CR SB|Lack of Efficacy|0
1157506|NCT01270828|3800414|P3|Pregabalin CR SB|Related adverse event|46
1157507|NCT01270828|3800415|P2|Pregabalin CR SB|Related adverse event|0
1157508|NCT01270828|3800416|P1|Pregabalin CR SB|Related adverse event|0
1157509|NCT01270828|3800414|P3|Pregabalin CR SB|Enrolled but not treated|5
1157510|NCT01270828|3800415|P2|Pregabalin CR SB|Enrolled but not treated|0
1157511|NCT01270828|3800416|P1|Pregabalin CR SB|Enrolled but not treated|0
1157512|NCT01270828|3800414|P3|Pregabalin CR SB|Reason Unspecified|8
1157513|NCT01270828|3800415|P2|Pregabalin CR SB|Reason Unspecified|0
1157514|NCT01270828|3800416|P1|Pregabalin CR SB|Reason Unspecified|0
1157515|NCT01270802|3800458|P2|Overall Study|Lost to Follow-up|1
1157516|NCT01270802|3800459|P1|Overall Study|Lost to Follow-up|0
1157517|NCT01270802|3800458|P2|Overall Study|Adverse Event|0
1157518|NCT01270802|3800459|P1|Overall Study|Adverse Event|1
1157519|NCT01270802|3800458|P2|Overall Study|Withdrawal by Subject|0
1157520|NCT01270802|3800459|P1|Overall Study|Withdrawal by Subject|1
1157521|NCT01270620|3800606|P2|Overall Study|Withdrawal by Subject|3
1157522|NCT01270620|3800607|P1|Overall Study|Withdrawal by Subject|1
1157523|NCT01270503|3800702|P1|Overall Study|Lost to Follow-up|1
1157524|NCT01270464|3800710|P3|Overall Study|Not Specified|3
1157525|NCT01270464|3800711|P2|Overall Study|Not Specified|1
1157526|NCT01270464|3800712|P1|Overall Study|Not Specified|1
1157527|NCT01270464|3800710|P3|Overall Study|Lost to Follow-up|1
1157528|NCT01270464|3800711|P2|Overall Study|Lost to Follow-up|3
1157529|NCT01270464|3800712|P1|Overall Study|Lost to Follow-up|2
1157530|NCT01270464|3800710|P3|Overall Study|Withdrawal by Subject|4
1157531|NCT01270464|3800711|P2|Overall Study|Withdrawal by Subject|1
1157532|NCT01270464|3800712|P1|Overall Study|Withdrawal by Subject|2
1157533|NCT01270464|3800710|P3|Overall Study|Adverse Event|7
1157534|NCT01270464|3800711|P2|Overall Study|Adverse Event|1
1157535|NCT01270464|3800712|P1|Overall Study|Adverse Event|9
1157536|NCT01270464|3800710|P3|Overall Study|Lack of Efficacy|1
1157537|NCT01270464|3800711|P2|Overall Study|Lack of Efficacy|3
1157538|NCT01270464|3800712|P1|Overall Study|Lack of Efficacy|2
1157539|NCT01270464|3800710|P3|Overall Study|Protocol Violation|2
1157540|NCT01270464|3800711|P2|Overall Study|Protocol Violation|3
1157541|NCT01270464|3800712|P1|Overall Study|Protocol Violation|4
1157542|NCT01270256|3800761|P2|Overall Study|Withdrawal by Subject|0
1157543|NCT01270256|3800762|P1|Overall Study|Withdrawal by Subject|1
1157544|NCT01270139|3800771|P3|Overall Study|Lost to Follow-up|2
1157545|NCT01270139|3800772|P2|Overall Study|Lost to Follow-up|9
1157546|NCT01270139|3800773|P1|Overall Study|Lost to Follow-up|10
1157547|NCT01270139|3800771|P3|Overall Study|Adverse Event|18
1157548|NCT01270139|3800772|P2|Overall Study|Adverse Event|17
1157549|NCT01270139|3800773|P1|Overall Study|Adverse Event|8
1157550|NCT01269918|3800842|P2|Overall Study|Did not receive study drug|3
1157551|NCT01269918|3800843|P1|Overall Study|Did not receive study drug|0
1157552|NCT01269346|3800918|P1|Extension Phase|Started a prohibited con med|1
1157553|NCT01269346|3800918|P1|Extension Phase|Clinical progression|1
1157554|NCT01269346|3800918|P1|Extension Phase|Physician decision or participant choice|9
1157555|NCT01269346|3800918|P1|Extension Phase|Disease progression|22
1157556|NCT01269346|3800918|P1|Extension Phase|Withdrawal by Subject|4
1157557|NCT01269346|3800918|P1|Extension Phase|Adverse Event|6
1157558|NCT01269346|3800918|P1|Treatment Phase|Not specified|2
1157559|NCT01269346|3800918|P1|Treatment Phase|Withdrawal by Subject|1
1157560|NCT01269346|3800918|P1|Treatment Phase|Adverse Event|3
1157561|NCT01269346|3800918|P1|Treatment Phase|Disease progression|3
1157562|NCT01269125|3800929|P3|Overall Study|Lost to Follow-up|0
1157563|NCT01269125|3800930|P2|Overall Study|Lost to Follow-up|0
1157564|NCT01269125|3800931|P1|Overall Study|Lost to Follow-up|4
1157565|NCT01269125|3800929|P3|Overall Study|Adverse Event|0
1157566|NCT01269125|3800930|P2|Overall Study|Adverse Event|5
1157567|NCT01269125|3800931|P1|Overall Study|Adverse Event|3
1157568|NCT01268891|3800990|P2|Overall Study|Administrative or other reason(s)|0
1157569|NCT01268891|3800991|P1|Overall Study|Administrative or other reason(s)|1
1157570|NCT01268891|3800990|P2|Overall Study|Withdrawal of Consent|1
1157571|NCT01268891|3800991|P1|Overall Study|Withdrawal of Consent|3
1157572|NCT01268891|3800990|P2|Overall Study|Lack of Efficacy|0
1157573|NCT01268891|3800991|P1|Overall Study|Lack of Efficacy|1
1157574|NCT01268891|3800990|P2|Overall Study|Adverse Event|7
1157575|NCT01268891|3800991|P1|Overall Study|Adverse Event|3
1157576|NCT01268566|3801010|P1|Overall Study|Death|30
1157577|NCT01268566|3801010|P1|Overall Study|Withdrawal by Subject|12
1157578|NCT01268566|3801010|P1|Overall Study|Lost to Follow-up|1
1157579|NCT01268501|3801037|P1|Overall Study|Handling Difficulties|2
1157580|NCT01268501|3801037|P1|Overall Study|Unacceptable Subjective Vision|3
1157581|NCT01268501|3801037|P1|Overall Study|Withdrawal by Subject|3
1157582|NCT01268501|3801037|P1|Overall Study|Lost to Follow-up|1
1157583|NCT01268488|3801041|P1|Overall Study|Physician Decision|2
1157584|NCT01268488|3801041|P1|Overall Study|Adverse Event|3
1157585|NCT01268306|3801048|P1|Overall Study|Lost to Follow-up|1
1157586|NCT01268293|3801052|P1|Overall Study|Subject choice|1
1157587|NCT01268293|3801052|P1|Overall Study|Adverse Event|1
1157588|NCT01268293|3801052|P1|Overall Study|Disease progression|7
1157589|NCT01268267|3801057|P1|Overall Study|Protocol Violation|1
1157590|NCT01268150|3801078|P1|Extension Phase|Not specified|6
1157591|NCT01268150|3801078|P1|Extension Phase|Disease progression|18
1157592|NCT01268150|3801078|P1|Extension Phase|Adverse Event|3
1157593|NCT01268150|3801078|P1|Treatment Phase|Not specified|4
1157594|NCT01268150|3801078|P1|Treatment Phase|Withdrawal by Subject|3
1157595|NCT01268150|3801078|P1|Treatment Phase|Adverse Event|3
1157596|NCT01268150|3801078|P1|Treatment Phase|Progression of disease|18
1157597|NCT01268098|3801097|P2|Overall Study|Adverse Event|0
1157598|NCT01268098|3801098|P1|Overall Study|Adverse Event|1
1157599|NCT01268046|3801110|P4|Overall Study|Lost to Follow-up|0
1157600|NCT01268046|3801111|P3|Overall Study|Lost to Follow-up|1
1157601|NCT01268046|3801112|P2|Overall Study|Lost to Follow-up|0
1157602|NCT01268046|3801113|P1|Overall Study|Lost to Follow-up|0
1157603|NCT01268046|3801110|P4|Overall Study|Withdrawal by Subject|1
1157604|NCT01268046|3801111|P3|Overall Study|Withdrawal by Subject|0
1157605|NCT01268046|3801112|P2|Overall Study|Withdrawal by Subject|0
1157606|NCT01268046|3801113|P1|Overall Study|Withdrawal by Subject|1
1157607|NCT01267994|3801123|P1|Overall Study|Adverse Event|2
1157608|NCT01267825|3801161|P2|Overall Study|study terminated. no data collected.|0
1157609|NCT01267825|3801162|P1|Overall Study|study terminated. no data collected.|1
1157610|NCT01267266|3801237|P2|Lead-in Phase|Withdrawal by Subject|0
1157611|NCT01267266|3801238|P1|Lead-in Phase|Withdrawal by Subject|1
1157612|NCT01267266|3801237|P2|Lead-in Phase|Adverse Event|0
1157613|NCT01267266|3801238|P1|Lead-in Phase|Adverse Event|2
1157614|NCT01267266|3801237|P2|Lead-in Phase|Lack of Efficacy|0
1157615|NCT01267266|3801238|P1|Lead-in Phase|Lack of Efficacy|20
1157616|NCT01267266|3801237|P2|Enrollment Phase|Withdrawal by Subject|0
1157617|NCT01267266|3801238|P1|Enrollment Phase|Withdrawal by Subject|2
1157618|NCT01267253|3801251|P1|Overall Study|Inevaluable-never received study treatme|2
1157619|NCT01267253|3801251|P1|Overall Study|Ineligible - required test not done|1
1157620|NCT01267201|3801290|P6|Second Intervention Period|Withdrawal by Subject|0
1157621|NCT01267201|3801291|P5|Second Intervention Period|Withdrawal by Subject|0
1157622|NCT01267201|3801292|P4|Second Intervention Period|Withdrawal by Subject|0
1157623|NCT01267201|3801293|P3|Second Intervention Period|Withdrawal by Subject|0
1157624|NCT01267201|3801294|P2|Second Intervention Period|Withdrawal by Subject|1
1157625|NCT01267201|3801295|P1|Second Intervention Period|Withdrawal by Subject|0
1157626|NCT01267201|3801290|P6|First Intervention Period|Withdrawal by Subject|0
1157627|NCT01267201|3801291|P5|First Intervention Period|Withdrawal by Subject|0
1157628|NCT01267201|3801292|P4|First Intervention Period|Withdrawal by Subject|0
1157629|NCT01267201|3801293|P3|First Intervention Period|Withdrawal by Subject|0
1157630|NCT01267201|3801294|P2|First Intervention Period|Withdrawal by Subject|0
1157631|NCT01267201|3801295|P1|First Intervention Period|Withdrawal by Subject|1
1157632|NCT01267175|3801312|P1|Overall Study|Lost to Follow-up|1
1157633|NCT01267175|3801312|P1|Overall Study|Withdrawal by Subject|1
1157634|NCT01266967|3801384|P2|Overall Study|Withdrawal by Subject|3
1157635|NCT01266967|3801385|P1|Overall Study|Withdrawal by Subject|3
1157636|NCT01266967|3801384|P2|Overall Study|Physician Decision|1
1157637|NCT01266967|3801385|P1|Overall Study|Physician Decision|0
1157638|NCT01266967|3801384|P2|Overall Study|Lost to Follow-up|1
1157639|NCT01266967|3801385|P1|Overall Study|Lost to Follow-up|2
1157640|NCT01266967|3801384|P2|Overall Study|Study Closed/Terminated|17
1157641|NCT01266967|3801385|P1|Overall Study|Study Closed/Terminated|15
1157642|NCT01266967|3801384|P2|Overall Study|Death|61
1157643|NCT01266967|3801385|P1|Overall Study|Death|69
1157644|NCT01266876|3801437|P5|Overall Study|Adverse Event|0
1157645|NCT01266876|3801438|P4|Overall Study|Adverse Event|1
1157646|NCT01266876|3801439|P3|Overall Study|Adverse Event|0
1157647|NCT01266876|3801440|P2|Overall Study|Adverse Event|0
1157648|NCT01266876|3801441|P1|Overall Study|Adverse Event|0
1157649|NCT01266850|3801548|P5|Overall Study|Site Closure|0
1157650|NCT01266850|3801549|P4|Overall Study|Site Closure|1
1157651|NCT01266850|3801550|P3|Overall Study|Site Closure|1
1157652|NCT01266850|3801551|P2|Overall Study|Site Closure|1
1157653|NCT01266850|3801552|P1|Overall Study|Site Closure|0
1157654|NCT01266850|3801548|P5|Overall Study|Adverse Event|1
1157655|NCT01266850|3801549|P4|Overall Study|Adverse Event|0
1157656|NCT01266850|3801550|P3|Overall Study|Adverse Event|0
1157657|NCT01266850|3801551|P2|Overall Study|Adverse Event|0
1157658|NCT01266850|3801552|P1|Overall Study|Adverse Event|0
1157659|NCT01266850|3801548|P5|Overall Study|Protocol Violation|2
1157660|NCT01266850|3801549|P4|Overall Study|Protocol Violation|1
1157661|NCT01266850|3801550|P3|Overall Study|Protocol Violation|0
1157662|NCT01266850|3801551|P2|Overall Study|Protocol Violation|1
1157663|NCT01266850|3801552|P1|Overall Study|Protocol Violation|0
1157664|NCT01266850|3801548|P5|Overall Study|Physician Decision|3
1157665|NCT01266850|3801549|P4|Overall Study|Physician Decision|4
1157666|NCT01266850|3801550|P3|Overall Study|Physician Decision|4
1157667|NCT01266850|3801551|P2|Overall Study|Physician Decision|6
1157668|NCT01266850|3801552|P1|Overall Study|Physician Decision|3
1157669|NCT01266850|3801548|P5|Overall Study|Withdrawal by Subject|12
1157670|NCT01266850|3801549|P4|Overall Study|Withdrawal by Subject|9
1157671|NCT01266850|3801550|P3|Overall Study|Withdrawal by Subject|6
1157672|NCT01266850|3801551|P2|Overall Study|Withdrawal by Subject|9
1157673|NCT01266850|3801552|P1|Overall Study|Withdrawal by Subject|8
1157674|NCT01266850|3801548|P5|Overall Study|Lost to Follow-up|12
1157675|NCT01266850|3801549|P4|Overall Study|Lost to Follow-up|13
1157676|NCT01266850|3801550|P3|Overall Study|Lost to Follow-up|13
1157677|NCT01266850|3801551|P2|Overall Study|Lost to Follow-up|19
1157678|NCT01266850|3801552|P1|Overall Study|Lost to Follow-up|19
1157679|NCT01266824|3801606|P2|Overall Study|Study terminated prior to completion|3
1157680|NCT01266824|3801607|P1|Overall Study|Study terminated prior to completion|2
1157681|NCT01266590|3801619|P1|Overall Study|Physician Decision|1
1157682|NCT01266590|3801619|P1|Overall Study|Withdrawal by Subject|1
1157683|NCT01266590|3801619|P1|Overall Study|Lost to Follow-up|1
1157684|NCT01266590|3801619|P1|Overall Study|Adverse Event|3
1157685|NCT01266317|3801639|P1|Overall Study|Withdrawal by Subject|2
1157686|NCT01266291|3801644|P1|Overall Study|Adverse Event|1
1157687|NCT01266265|3801651|P2|Overall Study|Clinical worsening|1
1157688|NCT01266265|3801652|P1|Overall Study|Clinical worsening|1
1157689|NCT01266265|3801651|P2|Overall Study|Site closed early|3
1157690|NCT01266265|3801652|P1|Overall Study|Site closed early|4
1157691|NCT01266265|3801651|P2|Overall Study|Lung transplant|5
1157692|NCT01266265|3801652|P1|Overall Study|Lung transplant|6
1157693|NCT01266265|3801651|P2|Overall Study|Non-compliance|5
1157694|NCT01266265|3801652|P1|Overall Study|Non-compliance|8
1157695|NCT01266265|3801651|P2|Overall Study|Enrolled in another clinical study|26
1157696|NCT01266265|3801652|P1|Overall Study|Enrolled in another clinical study|15
1157697|NCT01266265|3801651|P2|Overall Study|Stopped/changed PAH medication(s)|9
1157698|NCT01266265|3801652|P1|Overall Study|Stopped/changed PAH medication(s)|16
1157699|NCT01266265|3801651|P2|Overall Study|Transferred care to another provider|28
1157700|NCT01266265|3801652|P1|Overall Study|Transferred care to another provider|22
1157701|NCT01266265|3801651|P2|Overall Study|Respiratory-related adverse event|1
1157702|NCT01266265|3801652|P1|Overall Study|Respiratory-related adverse event|2
1157703|NCT01266265|3801651|P2|Overall Study|Withdrawal by Subject|11
1157704|NCT01266265|3801652|P1|Overall Study|Withdrawal by Subject|13
1157705|NCT01266265|3801651|P2|Overall Study|Lost to Follow-up|28
1157706|NCT01266265|3801652|P1|Overall Study|Lost to Follow-up|23
1157707|NCT01266265|3801651|P2|Overall Study|Death|73
1157708|NCT01266265|3801652|P1|Overall Study|Death|95
1157709|NCT01266161|3801660|P2|Overall Study|Vomited within 4 hours of dosing|0
1157710|NCT01266161|3801661|P1|Overall Study|Vomited within 4 hours of dosing|3
1157711|NCT01266161|3801660|P2|Overall Study|Lack of Efficacy|1
1157712|NCT01266161|3801661|P1|Overall Study|Lack of Efficacy|0
1157713|NCT01266161|3801660|P2|Overall Study|Ineligible|0
1157714|NCT01266161|3801661|P1|Overall Study|Ineligible|1
1157715|NCT01266148|3801693|P2|Overall Study|missing mGFR value + AE|0
1157716|NCT01266148|3801694|P1|Overall Study|missing mGFR value + AE|1
1157717|NCT01266148|3801693|P2|Overall Study|Death|3
1157718|NCT01266148|3801694|P1|Overall Study|Death|2
1157719|NCT01266148|3801693|P2|Overall Study|2 2R rejections|0
1157720|NCT01266148|3801694|P1|Overall Study|2 2R rejections|1
1157721|NCT01266148|3801693|P2|Overall Study|Ongoing rejection|0
1157722|NCT01266148|3801694|P1|Overall Study|Ongoing rejection|1
1157723|NCT01266148|3801693|P2|Overall Study|Adverse Event|0
1157724|NCT01266148|3801694|P1|Overall Study|Adverse Event|2
1157725|NCT01266122|3801722|P2|Overall Study|Lost to Follow-up|6
1157726|NCT01266122|3801723|P1|Overall Study|Lost to Follow-up|6
1157727|NCT01266070|3801731|P1|Overall Study|Protocol Violation|1
1157728|NCT01266070|3801731|P1|Overall Study|Adverse Event|3
1157729|NCT01266031|3801739|P3|Overall Study|Not treated|2
1157730|NCT01266031|3801740|P2|Overall Study|Not treated|3
1157731|NCT01266031|3801741|P1|Overall Study|Not treated|0
1157732|NCT01266018|3801768|P2|Overall Study|Progressive disease|1
1157733|NCT01266018|3801769|P1|Overall Study|Progressive disease|0
1157734|NCT01266018|3801768|P2|Overall Study|Physician Decision|0
1157735|NCT01266018|3801769|P1|Overall Study|Physician Decision|1
1157736|NCT01265992|3801780|P1|Overall Study|Did not receive treatment|1
1157737|NCT01265992|3801780|P1|Overall Study|Stopped treatment|3
1157738|NCT01265992|3801780|P1|Overall Study|Administrative reasons|2
1157739|NCT01265992|3801780|P1|Overall Study|Adverse Event|1
1157740|NCT01265992|3801780|P1|Overall Study|Withdrawal by Subject|1
1157741|NCT01265992|3801780|P1|Overall Study|Lost to Follow-up|1
1157742|NCT01265953|3801808|P2|Overall Study|Non compliance|3
1157743|NCT01265953|3801809|P1|Overall Study|Non compliance|5
1157744|NCT01265875|3801821|P1|Overall Study|Uncooperative/unreliable|1
1157745|NCT01265823|3801829|P1|Overall Study|Participant Request|1
1157746|NCT01265823|3801829|P1|Overall Study|Protocol Violation|1
1157747|NCT01265823|3801829|P1|Overall Study|Failure to Return|4
1157748|NCT01265823|3801829|P1|Overall Study|Unsatisfactory Response Efficacy|1
1157749|NCT01265797|3801858|P2|Open Label Month|Lost to Follow-up|1
1157750|NCT01265797|3801859|P1|Open Label Month|Lost to Follow-up|0
1157751|NCT01265797|3801858|P2|Blinded Month|Diary data incomplete|1
1157752|NCT01265797|3801859|P1|Blinded Month|Diary data incomplete|0
1157753|NCT01265797|3801858|P2|Blinded Month|Adverse Event|0
1157754|NCT01265797|3801859|P1|Blinded Month|Adverse Event|2
1157755|NCT01265797|3801858|P2|Blinded Month|Protocol Violation|1
1157756|NCT01265797|3801859|P1|Blinded Month|Protocol Violation|2
1157757|NCT01265797|3801858|P2|Blinded Month|Lost to Follow-up|0
1157758|NCT01265797|3801859|P1|Blinded Month|Lost to Follow-up|1
1157759|NCT01265797|3801858|P2|Blinded Month|Lack of Efficacy|0
1157760|NCT01265797|3801859|P1|Blinded Month|Lack of Efficacy|5
1157761|NCT01265797|3801858|P2|Run-in Month|1st seizure during run-in month|1
1157762|NCT01265797|3801859|P1|Run-in Month|1st seizure during run-in month|0
1157763|NCT01265797|3801858|P2|Run-in Month|Withdrawal by Subject|4
1157764|NCT01265797|3801859|P1|Run-in Month|Withdrawal by Subject|0
1157765|NCT01265784|3801890|P3|Overall Study|Incorrectly Randomized|1
1157766|NCT01265784|3801891|P2|Overall Study|Incorrectly Randomized|0
1157767|NCT01265784|3801892|P1|Overall Study|Incorrectly Randomized|0
1157768|NCT01265784|3801890|P3|Overall Study|Protocol Violation|0
1157769|NCT01265784|3801891|P2|Overall Study|Protocol Violation|0
1157770|NCT01265784|3801892|P1|Overall Study|Protocol Violation|2
1157771|NCT01265784|3801890|P3|Overall Study|Death|0
1157772|NCT01265784|3801891|P2|Overall Study|Death|0
1157773|NCT01265784|3801892|P1|Overall Study|Death|3
1157774|NCT01265784|3801890|P3|Overall Study|Adverse Event|0
1157775|NCT01265784|3801891|P2|Overall Study|Adverse Event|0
1157776|NCT01265784|3801892|P1|Overall Study|Adverse Event|1
1157777|NCT01265784|3801890|P3|Overall Study|Physician Decision|1
1157778|NCT01265784|3801891|P2|Overall Study|Physician Decision|0
1157779|NCT01265784|3801892|P1|Overall Study|Physician Decision|1
1157780|NCT01265784|3801890|P3|Overall Study|Withdrawal by Subject|0
1157781|NCT01265784|3801891|P2|Overall Study|Withdrawal by Subject|5
1157782|NCT01265784|3801892|P1|Overall Study|Withdrawal by Subject|0
1157783|NCT01265784|3801890|P3|Overall Study|Lost to Follow-up|2
1157784|NCT01265784|3801891|P2|Overall Study|Lost to Follow-up|3
1157785|NCT01265784|3801892|P1|Overall Study|Lost to Follow-up|5
1157786|NCT01265719|3801960|P2|Overall Study|Adverse Event|0
1157787|NCT01265719|3801961|P1|Overall Study|Adverse Event|2
1157788|NCT01265719|3801960|P2|Overall Study|Lost to Follow-up|7
1157789|NCT01265719|3801961|P1|Overall Study|Lost to Follow-up|2
1157790|NCT01265719|3801960|P2|Overall Study|Withdrawal by Subject|3
1157791|NCT01265719|3801961|P1|Overall Study|Withdrawal by Subject|8
1157792|NCT01265719|3801960|P2|Overall Study|Other reasons|0
1157793|NCT01265719|3801961|P1|Overall Study|Other reasons|2
1157794|NCT01265719|3801960|P2|Overall Study|Does not meet entrance criteria|3
1157795|NCT01265719|3801961|P1|Overall Study|Does not meet entrance criteria|0
1157796|NCT01265615|3802012|P4|Overall Study|Protocol Violation|3
1157797|NCT01265615|3802013|P3|Overall Study|Protocol Violation|4
1157798|NCT01265615|3802014|P2|Overall Study|Protocol Violation|2
1157799|NCT01265615|3802015|P1|Overall Study|Protocol Violation|2
1157800|NCT01265563|3802066|P5|Overall Study|Withdrawal by Subject|2
1157801|NCT01265563|3802067|P4|Overall Study|Withdrawal by Subject|0
1157802|NCT01265563|3802068|P3|Overall Study|Withdrawal by Subject|1
1157803|NCT01265563|3802069|P2|Overall Study|Withdrawal by Subject|1
1157804|NCT01265563|3802070|P1|Overall Study|Withdrawal by Subject|0
1157805|NCT01265511|3802170|P2|Overall Study|Met stopping rules|2
1157806|NCT01265511|3802171|P1|Overall Study|Met stopping rules|0
1157807|NCT01265511|3802170|P2|Overall Study|Lack of Efficacy|1
1157808|NCT01265511|3802171|P1|Overall Study|Lack of Efficacy|2
1157809|NCT01265498|3802185|P2|Overall Study|Protocol modified to eliminate wk72 bx|33
1157810|NCT01265498|3802186|P1|Overall Study|Protocol modified to eliminate wk72 bx|31
1157811|NCT01265420|3802322|P1|Overall Study|Lost to Follow-up|1
1157812|NCT01265394|3802326|P1|Overall Study|Subjects withdrawn|37
1157813|NCT01265056|3802333|P2|Follow up|Lost to Follow-up|3
1157814|NCT01265056|3802334|P1|Follow up|Lost to Follow-up|7
1157815|NCT01265056|3802333|P2|Initial Study Period|Withdrawal by Subject|1
1157816|NCT01265056|3802334|P1|Initial Study Period|Withdrawal by Subject|1
1157817|NCT01265056|3802333|P2|Initial Study Period|Withdrawal by Subject|1
1157818|NCT01265056|3802334|P1|Initial Study Period|Withdrawal by Subject|1
1157819|NCT01264939|3802365|P2|Overall Study|Disease Progression|11
1157820|NCT01264939|3802366|P1|Overall Study|Disease Progression|8
1157821|NCT01264939|3802365|P2|Overall Study|Patient/Guardian Decision|10
1157822|NCT01264939|3802366|P1|Overall Study|Patient/Guardian Decision|8
1157823|NCT01264939|3802365|P2|Overall Study|Physician Decision|1
1157824|NCT01264939|3802366|P1|Overall Study|Physician Decision|1
1157825|NCT01264939|3802365|P2|Overall Study|Lost to Follow-up|3
1157826|NCT01264939|3802366|P1|Overall Study|Lost to Follow-up|0
1157827|NCT01264939|3802365|P2|Overall Study|Adverse Event|3
1157828|NCT01264939|3802366|P1|Overall Study|Adverse Event|1
1157829|NCT01264887|3802392|P1|Overall Study|Not Specified|2
1157830|NCT01264887|3802392|P1|Overall Study|Sponsor Decision Administrative Reasons|2
1157831|NCT01264887|3802392|P1|Overall Study|Withdrawal by Subject|6
1157832|NCT01264887|3802392|P1|Overall Study|Physician Decision|4
1157833|NCT01264887|3802392|P1|Overall Study|Lack of Efficacy|5
1157834|NCT01264887|3802392|P1|Overall Study|Death|7
1157835|NCT01264887|3802392|P1|Overall Study|Adverse Event|5
1157836|NCT01264835|3802403|P1|Overall Study|Lost to Follow-up|1
1157837|NCT01264770|3802413|P6|Overall Study|Adverse Event|1
1157838|NCT01264770|3802414|P5|Overall Study|Adverse Event|2
1157839|NCT01264770|3802415|P4|Overall Study|Adverse Event|0
1157840|NCT01264770|3802416|P3|Overall Study|Adverse Event|8
1157841|NCT01264770|3802417|P2|Overall Study|Adverse Event|7
1157842|NCT01264770|3802418|P1|Overall Study|Adverse Event|7
1157843|NCT01264770|3802413|P6|Overall Study|Lost to Follow-up|0
1157844|NCT01264770|3802414|P5|Overall Study|Lost to Follow-up|0
1157845|NCT01264770|3802415|P4|Overall Study|Lost to Follow-up|1
1157846|NCT01264770|3802416|P3|Overall Study|Lost to Follow-up|1
1157847|NCT01264770|3802417|P2|Overall Study|Lost to Follow-up|0
1157848|NCT01264770|3802418|P1|Overall Study|Lost to Follow-up|0
1157849|NCT01264770|3802413|P6|Overall Study|Dev. of study specific discont. criteria|1
1157850|NCT01264770|3802414|P5|Overall Study|Dev. of study specific discont. criteria|1
1157851|NCT01264770|3802415|P4|Overall Study|Dev. of study specific discont. criteria|0
1157852|NCT01264770|3802416|P3|Overall Study|Dev. of study specific discont. criteria|0
1157853|NCT01264770|3802417|P2|Overall Study|Dev. of study specific discont. criteria|0
1157854|NCT01264770|3802418|P1|Overall Study|Dev. of study specific discont. criteria|2
1157855|NCT01264770|3802413|P6|Overall Study|Lack of therapeutic response|0
1157856|NCT01264770|3802414|P5|Overall Study|Lack of therapeutic response|1
1157857|NCT01264770|3802415|P4|Overall Study|Lack of therapeutic response|1
1157858|NCT01264770|3802416|P3|Overall Study|Lack of therapeutic response|2
1157859|NCT01264770|3802417|P2|Overall Study|Lack of therapeutic response|0
1157860|NCT01264770|3802418|P1|Overall Study|Lack of therapeutic response|1
1157861|NCT01264770|3802413|P6|Overall Study|Severe non-compliance to protocol|0
1157862|NCT01264770|3802414|P5|Overall Study|Severe non-compliance to protocol|0
1157863|NCT01264770|3802415|P4|Overall Study|Severe non-compliance to protocol|1
1157864|NCT01264770|3802416|P3|Overall Study|Severe non-compliance to protocol|1
1157865|NCT01264770|3802417|P2|Overall Study|Severe non-compliance to protocol|0
1157866|NCT01264770|3802418|P1|Overall Study|Severe non-compliance to protocol|0
1157867|NCT01264770|3802413|P6|Overall Study|e.g., change in circumstances|4
1157868|NCT01264770|3802414|P5|Overall Study|e.g., change in circumstances|4
1157869|NCT01264770|3802415|P4|Overall Study|e.g., change in circumstances|3
1157870|NCT01264770|3802416|P3|Overall Study|e.g., change in circumstances|3
1157871|NCT01264770|3802417|P2|Overall Study|e.g., change in circumstances|3
1157872|NCT01264770|3802418|P1|Overall Study|e.g., change in circumstances|8
1157873|NCT01264770|3802413|P6|Overall Study|Not reported|0
1157874|NCT01264770|3802414|P5|Overall Study|Not reported|0
1157875|NCT01264770|3802415|P4|Overall Study|Not reported|0
1157876|NCT01264770|3802416|P3|Overall Study|Not reported|1
1157877|NCT01264770|3802417|P2|Overall Study|Not reported|0
1157878|NCT01264770|3802418|P1|Overall Study|Not reported|0
1157879|NCT01264679|3802502|P1|Overall Study|Withdrawal by Subject|1
1157880|NCT01264679|3802502|P1|Overall Study|Sponsor's Suspension of Dosing|2
1157881|NCT01264679|3802502|P1|Overall Study|Physician Decision|1
1157882|NCT01264679|3802502|P1|Overall Study|Participation in Another Clinical Trial|1
1157883|NCT01264380|3802536|P3|Period C|Adverse Event|1
1157884|NCT01264380|3802537|P2|Period C|Adverse Event|0
1157885|NCT01264380|3802538|P1|Period C|Adverse Event|0
1157886|NCT01264380|3802536|P3|Period C|Withdrawal by Subject|1
1157887|NCT01264380|3802537|P2|Period C|Withdrawal by Subject|0
1157888|NCT01264380|3802538|P1|Period C|Withdrawal by Subject|0
1157889|NCT01264380|3802536|P3|Period C|Follow-up for survival status|6
1157890|NCT01264380|3802537|P2|Period C|Follow-up for survival status|0
1157891|NCT01264380|3802538|P1|Period C|Follow-up for survival status|0
1157892|NCT01264380|3802536|P3|Period C|Death|2
1157893|NCT01264380|3802537|P2|Period C|Death|0
1157894|NCT01264380|3802538|P1|Period C|Death|0
1157895|NCT01264380|3802536|P3|Period C|Disease Progression|4
1157896|NCT01264380|3802537|P2|Period C|Disease Progression|0
1157897|NCT01264380|3802538|P1|Period C|Disease Progression|0
1157898|NCT01264081|3802559|P1|Started Treatment|Not complete cycle 1 due to death|1
1157899|NCT01264081|3802559|P1|Started Treatment|Withdrawal by Subject|1
1157900|NCT01264081|3802559|P1|Participants Screened|Screening failures|30
1157901|NCT01264016|3802564|P1|Overall Study|Felt faint at sight of blood|1
1157902|NCT01264016|3802564|P1|Overall Study|Withdrawal by Subject|1
1157903|NCT01263925|3802572|P2|Overall Study|Withdrawal/ Not specified|1
1157904|NCT01263925|3802573|P1|Overall Study|Withdrawal/ Not specified|0
1157905|NCT01263925|3802572|P2|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2
1157906|NCT01263925|3802573|P1|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1
1157907|NCT01263925|3802572|P2|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
1157908|NCT01263925|3802573|P1|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
1157909|NCT01263925|3802572|P2|Overall Study|AE/ Withdrawal|4
1157910|NCT01263925|3802573|P1|Overall Study|AE/ Withdrawal|1
1157911|NCT01263925|3802572|P2|Overall Study|AE/ Unsatisfactory Compliance|2
1157912|NCT01263925|3802573|P1|Overall Study|AE/ Unsatisfactory Compliance|2
1157913|NCT01263925|3802572|P2|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
1157914|NCT01263925|3802573|P1|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
1157915|NCT01263925|3802572|P2|Overall Study|Lost to Follow-up|1
1157916|NCT01263925|3802573|P1|Overall Study|Lost to Follow-up|3
1157917|NCT01263925|3802572|P2|Overall Study|Not specified|4
1157918|NCT01263925|3802573|P1|Overall Study|Not specified|4
1157919|NCT01263925|3802572|P2|Overall Study|Withdrawal by Subject|8
1157920|NCT01263925|3802573|P1|Overall Study|Withdrawal by Subject|6
1157921|NCT01263925|3802572|P2|Overall Study|Unsatisfactory Compliance of Subject|5
1157922|NCT01263925|3802573|P1|Overall Study|Unsatisfactory Compliance of Subject|8
1157923|NCT01263925|3802572|P2|Overall Study|Adverse Event|22
1157924|NCT01263925|3802573|P1|Overall Study|Adverse Event|23
1157925|NCT01263925|3802572|P2|Overall Study|Lack of Efficacy|1
1157926|NCT01263925|3802573|P1|Overall Study|Lack of Efficacy|0
1157927|NCT01263925|3802572|P2|Overall Study|Protocol Violation|0
1157928|NCT01263925|3802573|P1|Overall Study|Protocol Violation|1
1157929|NCT01263873|3802607|P2|Overall Study|One provider unable to complete numbers|1
1157930|NCT01263873|3802608|P1|Overall Study|One provider unable to complete numbers|1
1157931|NCT01263704|3802649|P1|Overall Study|Principal Investigator (PI) decision|1
1157932|NCT01263704|3802649|P1|Overall Study|Colon metastases|1
1157933|NCT01263704|3802649|P1|Overall Study|Lost to Follow-up|1
1157934|NCT01263704|3802649|P1|Overall Study|Eligibility criteria not fulfilled|1
1157935|NCT01263704|3802649|P1|Overall Study|Patient withdrew consent|2
1157936|NCT01263704|3802649|P1|Overall Study|Death|2
1157937|NCT01263704|3802649|P1|Overall Study|Adverse Event|3
1157938|NCT01263704|3802649|P1|Overall Study|Progressive disease|18
1157939|NCT01263691|3802664|P6|Overall Study|Adverse Event|0
1157940|NCT01263691|3802665|P5|Overall Study|Adverse Event|0
1157941|NCT01263691|3802666|P4|Overall Study|Adverse Event|0
1157942|NCT01263691|3802667|P3|Overall Study|Adverse Event|0
1157943|NCT01263691|3802668|P2|Overall Study|Adverse Event|0
1157944|NCT01263691|3802669|P1|Overall Study|Adverse Event|1
1157945|NCT01263691|3802664|P6|Overall Study|Withdrawal by Subject|0
1157946|NCT01263691|3802665|P5|Overall Study|Withdrawal by Subject|0
1157947|NCT01263691|3802666|P4|Overall Study|Withdrawal by Subject|0
1157948|NCT01263691|3802667|P3|Overall Study|Withdrawal by Subject|0
1157949|NCT01263691|3802668|P2|Overall Study|Withdrawal by Subject|0
1157950|NCT01263691|3802669|P1|Overall Study|Withdrawal by Subject|1
1157951|NCT01263691|3802664|P6|Overall Study|Lost to Follow-up|0
1157952|NCT01263691|3802665|P5|Overall Study|Lost to Follow-up|0
1157953|NCT01263691|3802666|P4|Overall Study|Lost to Follow-up|1
1157954|NCT01263691|3802667|P3|Overall Study|Lost to Follow-up|1
1157955|NCT01263691|3802668|P2|Overall Study|Lost to Follow-up|0
1157956|NCT01263691|3802669|P1|Overall Study|Lost to Follow-up|1
1157957|NCT01263665|3802779|P1|Overall Study|Surgical Bypass|2
1157958|NCT01263665|3802779|P1|Overall Study|Amputation above the ankle|1
1157959|NCT01263665|3802779|P1|Overall Study|Death|2
1157960|NCT01263665|3802779|P1|Overall Study|Lost to Follow-up|3
1157961|NCT01263665|3802779|P1|Overall Study|Withdrew Consent|1
1157962|NCT01263639|3802786|P2|Overall Study|Exclusion =Admission greater than 7 days|9
1157963|NCT01263639|3802787|P1|Overall Study|Exclusion =Admission greater than 7 days|7
1157964|NCT01263639|3802786|P2|Overall Study|Lost to Follow-up|70
1157965|NCT01263639|3802787|P1|Overall Study|Lost to Follow-up|66
1157966|NCT01263561|3802795|P2|Overall Study|Death|2
1157967|NCT01263561|3802796|P1|Overall Study|Death|1
1157968|NCT01263509|3802808|P4|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1
1157969|NCT01263509|3802809|P3|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
1157970|NCT01263509|3802810|P2|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
1157971|NCT01263509|3802811|P1|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
1157972|NCT01263509|3802808|P4|Entered - Long-Term Extension Study|Participant Unavailability|0
1157973|NCT01263509|3802809|P3|Entered - Long-Term Extension Study|Participant Unavailability|0
1157974|NCT01263509|3802810|P2|Entered - Long-Term Extension Study|Participant Unavailability|1
1157975|NCT01263509|3802811|P1|Entered - Long-Term Extension Study|Participant Unavailability|1
1157976|NCT01263509|3802808|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|0
1157977|NCT01263509|3802809|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|0
1157978|NCT01263509|3802810|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
1157979|NCT01263509|3802811|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|1
1157980|NCT01263509|3802808|P4|Entered - Long-Term Extension Study|Lack of Efficacy|0
1157981|NCT01263509|3802809|P3|Entered - Long-Term Extension Study|Lack of Efficacy|1
1157982|NCT01263509|3802810|P2|Entered - Long-Term Extension Study|Lack of Efficacy|4
1157983|NCT01263509|3802811|P1|Entered - Long-Term Extension Study|Lack of Efficacy|1
1157984|NCT01263509|3802808|P4|Entered - Long-Term Extension Study|Adverse Event|1
1157985|NCT01263509|3802809|P3|Entered - Long-Term Extension Study|Adverse Event|4
1157986|NCT01263509|3802810|P2|Entered - Long-Term Extension Study|Adverse Event|5
1157987|NCT01263509|3802811|P1|Entered - Long-Term Extension Study|Adverse Event|5
1157988|NCT01263496|3802940|P9|Entered - Long-Term Extension Study|Participant Unavailability|0
1157989|NCT01263496|3802941|P8|Entered - Long-Term Extension Study|Participant Unavailability|1
1157990|NCT01263496|3802942|P7|Entered - Long-Term Extension Study|Participant Unavailability|0
1157991|NCT01263496|3802943|P6|Entered - Long-Term Extension Study|Participant Unavailability|0
1157992|NCT01263496|3802944|P5|Entered - Long-Term Extension Study|Participant Unavailability|0
1157993|NCT01263496|3802945|P4|Entered - Long-Term Extension Study|Participant Unavailability|0
1157994|NCT01263496|3802946|P3|Entered - Long-Term Extension Study|Participant Unavailability|0
1157995|NCT01263496|3802947|P2|Entered - Long-Term Extension Study|Participant Unavailability|0
1157996|NCT01263496|3802948|P1|Entered - Long-Term Extension Study|Participant Unavailability|0
1157997|NCT01263496|3802940|P9|Entered - Long-Term Extension Study|Lack of Efficacy|1
1157998|NCT01263496|3802941|P8|Entered - Long-Term Extension Study|Lack of Efficacy|0
1157999|NCT01263496|3802942|P7|Entered - Long-Term Extension Study|Lack of Efficacy|0
1158000|NCT01263496|3802943|P6|Entered - Long-Term Extension Study|Lack of Efficacy|0
1158001|NCT01263496|3802944|P5|Entered - Long-Term Extension Study|Lack of Efficacy|5
1158002|NCT01263496|3802945|P4|Entered - Long-Term Extension Study|Lack of Efficacy|1
1158003|NCT01263496|3802946|P3|Entered - Long-Term Extension Study|Lack of Efficacy|4
1158004|NCT01263496|3802947|P2|Entered - Long-Term Extension Study|Lack of Efficacy|4
1158005|NCT01263496|3802948|P1|Entered - Long-Term Extension Study|Lack of Efficacy|8
1158006|NCT01263496|3802940|P9|Entered - Long-Term Extension Study|Withdrawal by Subject|1
1158007|NCT01263496|3802941|P8|Entered - Long-Term Extension Study|Withdrawal by Subject|0
1158008|NCT01263496|3802942|P7|Entered - Long-Term Extension Study|Withdrawal by Subject|1
1158009|NCT01263496|3802943|P6|Entered - Long-Term Extension Study|Withdrawal by Subject|1
1158010|NCT01263496|3802944|P5|Entered - Long-Term Extension Study|Withdrawal by Subject|4
1158011|NCT01263496|3802945|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|2
1158012|NCT01263496|3802946|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|0
1158013|NCT01263496|3802947|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
1158014|NCT01263496|3802948|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|1
1158015|NCT01263496|3802940|P9|Entered - Long-Term Extension Study|Lost to Follow-up|0
1158016|NCT01263496|3802941|P8|Entered - Long-Term Extension Study|Lost to Follow-up|0
1158017|NCT01263496|3802942|P7|Entered - Long-Term Extension Study|Lost to Follow-up|0
1158018|NCT01263496|3802943|P6|Entered - Long-Term Extension Study|Lost to Follow-up|0
1158019|NCT01263496|3802944|P5|Entered - Long-Term Extension Study|Lost to Follow-up|0
1158020|NCT01263496|3802945|P4|Entered - Long-Term Extension Study|Lost to Follow-up|0
1158021|NCT01263496|3802946|P3|Entered - Long-Term Extension Study|Lost to Follow-up|0
1158022|NCT01263496|3802947|P2|Entered - Long-Term Extension Study|Lost to Follow-up|2
1158023|NCT01263496|3802948|P1|Entered - Long-Term Extension Study|Lost to Follow-up|0
1158024|NCT01263496|3802940|P9|Entered - Long-Term Extension Study|Adverse Event|1
1158025|NCT01263496|3802941|P8|Entered - Long-Term Extension Study|Adverse Event|0
1158026|NCT01263496|3802942|P7|Entered - Long-Term Extension Study|Adverse Event|0
1158027|NCT01263496|3802943|P6|Entered - Long-Term Extension Study|Adverse Event|0
1158028|NCT01263496|3802944|P5|Entered - Long-Term Extension Study|Adverse Event|1
1158029|NCT01263496|3802945|P4|Entered - Long-Term Extension Study|Adverse Event|3
1158030|NCT01263496|3802946|P3|Entered - Long-Term Extension Study|Adverse Event|6
1158031|NCT01263496|3802947|P2|Entered - Long-Term Extension Study|Adverse Event|5
1158032|NCT01263496|3802948|P1|Entered - Long-Term Extension Study|Adverse Event|0
1158033|NCT01263496|3802940|P9|Enrolled - Long-Term Extension Study|Adverse Event|0
1158034|NCT01263496|3802941|P8|Enrolled - Long-Term Extension Study|Adverse Event|0
1158035|NCT01263496|3802942|P7|Enrolled - Long-Term Extension Study|Adverse Event|0
1158036|NCT01263496|3802943|P6|Enrolled - Long-Term Extension Study|Adverse Event|0
1158037|NCT01263496|3802944|P5|Enrolled - Long-Term Extension Study|Adverse Event|2
1158038|NCT01263496|3802945|P4|Enrolled - Long-Term Extension Study|Adverse Event|1
1158039|NCT01263496|3802946|P3|Enrolled - Long-Term Extension Study|Adverse Event|0
1158040|NCT01263496|3802947|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
1158041|NCT01263496|3802948|P1|Enrolled - Long-Term Extension Study|Adverse Event|0
1158042|NCT01263496|3802940|P9|Enrolled - Long-Term Extension Study|Protocol Violation|0
1158043|NCT01263496|3802941|P8|Enrolled - Long-Term Extension Study|Protocol Violation|0
1158044|NCT01263496|3802942|P7|Enrolled - Long-Term Extension Study|Protocol Violation|0
1158045|NCT01263496|3802943|P6|Enrolled - Long-Term Extension Study|Protocol Violation|0
1158046|NCT01263496|3802944|P5|Enrolled - Long-Term Extension Study|Protocol Violation|0
1158047|NCT01263496|3802945|P4|Enrolled - Long-Term Extension Study|Protocol Violation|0
1158048|NCT01263496|3802946|P3|Enrolled - Long-Term Extension Study|Protocol Violation|0
1158049|NCT01263496|3802947|P2|Enrolled - Long-Term Extension Study|Protocol Violation|0
1158050|NCT01263496|3802948|P1|Enrolled - Long-Term Extension Study|Protocol Violation|1
1158051|NCT01263483|3803243|P3|Overall Study|Participant Unavailability|1
1158052|NCT01263483|3803244|P2|Overall Study|Participant Unavailability|1
1158053|NCT01263483|3803245|P1|Overall Study|Participant Unavailability|0
1158054|NCT01263483|3803243|P3|Overall Study|Protocol Violation|1
1158055|NCT01263483|3803244|P2|Overall Study|Protocol Violation|1
1158056|NCT01263483|3803245|P1|Overall Study|Protocol Violation|0
1158057|NCT01263483|3803243|P3|Overall Study|Lack of Efficacy|0
1158058|NCT01263483|3803244|P2|Overall Study|Lack of Efficacy|0
1158059|NCT01263483|3803245|P1|Overall Study|Lack of Efficacy|2
1158060|NCT01263483|3803243|P3|Overall Study|Withdrawal by Subject|0
1158061|NCT01263483|3803244|P2|Overall Study|Withdrawal by Subject|0
1158062|NCT01263483|3803245|P1|Overall Study|Withdrawal by Subject|1
1158063|NCT01263483|3803243|P3|Overall Study|Adverse Event|3
1158064|NCT01263483|3803244|P2|Overall Study|Adverse Event|0
1158065|NCT01263483|3803245|P1|Overall Study|Adverse Event|4
1158066|NCT01263470|3803307|P6|Overall Study|Study Drug Non-compliance|0
1158067|NCT01263470|3803308|P5|Overall Study|Study Drug Non-compliance|1
1158068|NCT01263470|3803309|P4|Overall Study|Study Drug Non-compliance|0
1158069|NCT01263470|3803310|P3|Overall Study|Study Drug Non-compliance|0
1158070|NCT01263470|3803311|P2|Overall Study|Study Drug Non-compliance|0
1158071|NCT01263470|3803312|P1|Overall Study|Study Drug Non-compliance|0
1158072|NCT01263470|3803307|P6|Overall Study|Participant Unavailability|0
1158073|NCT01263470|3803308|P5|Overall Study|Participant Unavailability|0
1158074|NCT01263470|3803309|P4|Overall Study|Participant Unavailability|0
1158075|NCT01263470|3803310|P3|Overall Study|Participant Unavailability|0
1158076|NCT01263470|3803311|P2|Overall Study|Participant Unavailability|1
1158077|NCT01263470|3803312|P1|Overall Study|Participant Unavailability|0
1158078|NCT01263470|3803307|P6|Overall Study|Lack of Efficacy|0
1158079|NCT01263470|3803308|P5|Overall Study|Lack of Efficacy|0
1158080|NCT01263470|3803309|P4|Overall Study|Lack of Efficacy|0
1158081|NCT01263470|3803310|P3|Overall Study|Lack of Efficacy|2
1158082|NCT01263470|3803311|P2|Overall Study|Lack of Efficacy|0
1158083|NCT01263470|3803312|P1|Overall Study|Lack of Efficacy|0
1158084|NCT01263470|3803307|P6|Overall Study|Withdrawal by Subject|2
1158085|NCT01263470|3803308|P5|Overall Study|Withdrawal by Subject|0
1158086|NCT01263470|3803309|P4|Overall Study|Withdrawal by Subject|2
1158087|NCT01263470|3803310|P3|Overall Study|Withdrawal by Subject|1
1158088|NCT01263470|3803311|P2|Overall Study|Withdrawal by Subject|1
1158089|NCT01263470|3803312|P1|Overall Study|Withdrawal by Subject|0
1158090|NCT01263470|3803307|P6|Overall Study|Protocol Violation|1
1158091|NCT01263470|3803308|P5|Overall Study|Protocol Violation|0
1158092|NCT01263470|3803309|P4|Overall Study|Protocol Violation|0
1158093|NCT01263470|3803310|P3|Overall Study|Protocol Violation|0
1158094|NCT01263470|3803311|P2|Overall Study|Protocol Violation|1
1158095|NCT01263470|3803312|P1|Overall Study|Protocol Violation|0
1158096|NCT01263470|3803307|P6|Overall Study|Adverse Event|2
1158097|NCT01263470|3803308|P5|Overall Study|Adverse Event|2
1158098|NCT01263470|3803309|P4|Overall Study|Adverse Event|1
1158099|NCT01263470|3803310|P3|Overall Study|Adverse Event|1
1158100|NCT01263470|3803311|P2|Overall Study|Adverse Event|2
1158101|NCT01263470|3803312|P1|Overall Study|Adverse Event|2
1158102|NCT01263444|3803422|P1|Overall Study|Protocol Violation|1
1158103|NCT01263444|3803422|P1|Overall Study|Withdrawal by Subject|1
1158104|NCT01263444|3803422|P1|Overall Study|Adverse Event|8
1158105|NCT01263223|3803559|P2|7-day Follow-up|Lost to Follow-up|0
1158106|NCT01263223|3803560|P1|7-day Follow-up|Lost to Follow-up|1
1158107|NCT01263223|3803559|P2|7-day Follow-up|Withdrawal by Subject|1
1158108|NCT01263223|3803560|P1|7-day Follow-up|Withdrawal by Subject|0
1158109|NCT01263223|3803559|P2|Period 2|Withdrawal by Subject|1
1158110|NCT01263223|3803560|P1|Period 2|Withdrawal by Subject|0
1158111|NCT01263197|3803583|P6|Third Intervention (Period 3)|Adverse Event|0
1158112|NCT01263197|3803584|P5|Third Intervention (Period 3)|Adverse Event|0
1158113|NCT01263197|3803585|P4|Third Intervention (Period 3)|Adverse Event|0
1158114|NCT01263197|3803586|P3|Third Intervention (Period 3)|Adverse Event|0
1158115|NCT01263197|3803587|P2|Third Intervention (Period 3)|Adverse Event|1
1158116|NCT01263197|3803588|P1|Third Intervention (Period 3)|Adverse Event|0
1158117|NCT01263197|3803583|P6|Washout Period 2|Protocol Violation|0
1158118|NCT01263197|3803584|P5|Washout Period 2|Protocol Violation|0
1158119|NCT01263197|3803585|P4|Washout Period 2|Protocol Violation|1
1158120|NCT01263197|3803586|P3|Washout Period 2|Protocol Violation|0
1158121|NCT01263197|3803587|P2|Washout Period 2|Protocol Violation|0
1158122|NCT01263197|3803588|P1|Washout Period 2|Protocol Violation|0
1158123|NCT01263197|3803583|P6|Washout Period 2|Physician Decision|1
1158124|NCT01263197|3803584|P5|Washout Period 2|Physician Decision|0
1158125|NCT01263197|3803585|P4|Washout Period 2|Physician Decision|0
1158126|NCT01263197|3803586|P3|Washout Period 2|Physician Decision|0
1158127|NCT01263197|3803587|P2|Washout Period 2|Physician Decision|0
1158128|NCT01263197|3803588|P1|Washout Period 2|Physician Decision|0
1158129|NCT01263197|3803583|P6|Washout Period 1|Protocol Violation|0
1158130|NCT01263197|3803584|P5|Washout Period 1|Protocol Violation|1
1158131|NCT01263197|3803585|P4|Washout Period 1|Protocol Violation|0
1158132|NCT01263197|3803586|P3|Washout Period 1|Protocol Violation|0
1158133|NCT01263197|3803587|P2|Washout Period 1|Protocol Violation|0
1158134|NCT01263197|3803588|P1|Washout Period 1|Protocol Violation|0
1158135|NCT01263197|3803583|P6|First Intervention (Period 1)|Adverse Event|1
1158136|NCT01263197|3803584|P5|First Intervention (Period 1)|Adverse Event|0
1158137|NCT01263197|3803585|P4|First Intervention (Period 1)|Adverse Event|0
1158138|NCT01263197|3803586|P3|First Intervention (Period 1)|Adverse Event|0
1158139|NCT01263197|3803587|P2|First Intervention (Period 1)|Adverse Event|0
1158140|NCT01263197|3803588|P1|First Intervention (Period 1)|Adverse Event|0
1158141|NCT01263119|3803631|P1|Overall Study|Adverse Event|2
1158142|NCT01263119|3803631|P1|Overall Study|Protocol Violation|2
1158143|NCT01263093|3803654|P2|Period 2|Adverse Event|0
1158144|NCT01263093|3803655|P1|Period 2|Adverse Event|1
1158145|NCT01263093|3803654|P2|Washout|Physician Decision|0
1158146|NCT01263093|3803655|P1|Washout|Physician Decision|1
1158147|NCT01263054|3803672|P2|Overall Study|Other|1
1158148|NCT01263054|3803673|P1|Overall Study|Other|0
1158149|NCT01263054|3803672|P2|Overall Study|Qualification Violation|0
1158150|NCT01263054|3803673|P1|Overall Study|Qualification Violation|1
1158151|NCT01263054|3803672|P2|Overall Study|Withdrawal by Subject|3
1158152|NCT01263054|3803673|P1|Overall Study|Withdrawal by Subject|1
1158153|NCT01263054|3803672|P2|Overall Study|Lost to Follow-up|2
1158154|NCT01263054|3803673|P1|Overall Study|Lost to Follow-up|2
1158155|NCT01263054|3803672|P2|Overall Study|Death|0
1158156|NCT01263054|3803673|P1|Overall Study|Death|1
1158157|NCT01263028|3803691|P1|Overall Study|Study terminated due to low enrollment.|4
1158158|NCT01263028|3803691|P1|Overall Study|Adverse Event|1
1158159|NCT01263028|3803691|P1|Overall Study|Withdrawal by Subject|1
1158160|NCT01263015|3803701|P2|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7
1158161|NCT01263015|3803702|P1|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3
1158162|NCT01263015|3803701|P2|Open-label Phase: 48 Weeks Duration|Physician Decision|2
1158163|NCT01263015|3803702|P1|Open-label Phase: 48 Weeks Duration|Physician Decision|0
1158164|NCT01263015|3803701|P2|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
1158165|NCT01263015|3803702|P1|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
1158166|NCT01263015|3803701|P2|Open-label Phase: 48 Weeks Duration|Protocol Violation|2
1158167|NCT01263015|3803702|P1|Open-label Phase: 48 Weeks Duration|Protocol Violation|3
1158168|NCT01263015|3803701|P2|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2
1158169|NCT01263015|3803702|P1|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7
1158170|NCT01263015|3803701|P2|Open-label Phase: 48 Weeks Duration|Adverse Event|10
1158171|NCT01263015|3803702|P1|Open-label Phase: 48 Weeks Duration|Adverse Event|3
1158172|NCT01263015|3803701|P2|Double-blind Phase: 96 Weeks Duration|Physician Decision|2
1158173|NCT01263015|3803702|P1|Double-blind Phase: 96 Weeks Duration|Physician Decision|1
1158174|NCT01263015|3803701|P2|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15
1158175|NCT01263015|3803702|P1|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9
1158176|NCT01263015|3803701|P2|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18
1158177|NCT01263015|3803702|P1|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17
1158178|NCT01263015|3803701|P2|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12
1158179|NCT01263015|3803702|P1|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14
1158180|NCT01263015|3803701|P2|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14
1158181|NCT01263015|3803702|P1|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18
1158182|NCT01263015|3803701|P2|Double-blind Phase: 96 Weeks Duration|Adverse Event|48
1158183|NCT01263015|3803702|P1|Double-blind Phase: 96 Weeks Duration|Adverse Event|13
1158184|NCT01262989|3803728|P2|Period 2|Intercurrent disease|1
1158185|NCT01262989|3803729|P1|Period 2|Intercurrent disease|0
1158186|NCT01262989|3803728|P2|Period 1|Positive answer for exclusion criteria|1
1158187|NCT01262989|3803729|P1|Period 1|Positive answer for exclusion criteria|0
1158188|NCT01262989|3803728|P2|Period 1|Intercurrent disease|1
1158189|NCT01262989|3803729|P1|Period 1|Intercurrent disease|0
1158190|NCT01262989|3803728|P2|Period 1|Lost to Follow-up|1
1158191|NCT01262989|3803729|P1|Period 1|Lost to Follow-up|1
1158192|NCT01262976|3803745|P6|Up to Year 3|Other|0
1158193|NCT01262976|3803746|P5|Up to Year 3|Other|0
1158194|NCT01262976|3803747|P4|Up to Year 3|Other|0
1158195|NCT01262976|3803748|P3|Up to Year 3|Other|0
1158196|NCT01262976|3803749|P2|Up to Year 3|Other|0
1158197|NCT01262976|3803750|P1|Up to Year 3|Other|3
1158198|NCT01262976|3803745|P6|Up to Year 3|Subjects with unknown completion status|0
1158199|NCT01262976|3803746|P5|Up to Year 3|Subjects with unknown completion status|0
1158200|NCT01262976|3803747|P4|Up to Year 3|Subjects with unknown completion status|0
1158201|NCT01262976|3803748|P3|Up to Year 3|Subjects with unknown completion status|1
1158202|NCT01262976|3803749|P2|Up to Year 3|Subjects with unknown completion status|0
1158203|NCT01262976|3803750|P1|Up to Year 3|Subjects with unknown completion status|0
1158204|NCT01262976|3803745|P6|Up to Year 3|Lost to Follow-up|3
1158205|NCT01262976|3803746|P5|Up to Year 3|Lost to Follow-up|1
1158206|NCT01262976|3803747|P4|Up to Year 3|Lost to Follow-up|3
1158207|NCT01262976|3803748|P3|Up to Year 3|Lost to Follow-up|4
1158208|NCT01262976|3803749|P2|Up to Year 3|Lost to Follow-up|2
1158209|NCT01262976|3803750|P1|Up to Year 3|Lost to Follow-up|2
1158210|NCT01262976|3803745|P6|Up to Year 3|Migrated/moved from study area|1
1158211|NCT01262976|3803746|P5|Up to Year 3|Migrated/moved from study area|1
1158212|NCT01262976|3803747|P4|Up to Year 3|Migrated/moved from study area|2
1158213|NCT01262976|3803748|P3|Up to Year 3|Migrated/moved from study area|0
1158214|NCT01262976|3803749|P2|Up to Year 3|Migrated/moved from study area|0
1158215|NCT01262976|3803750|P1|Up to Year 3|Migrated/moved from study area|0
1158216|NCT01262976|3803745|P6|Up to Year 3|Withdrawal by Subject|0
1158217|NCT01262976|3803746|P5|Up to Year 3|Withdrawal by Subject|0
1158218|NCT01262976|3803747|P4|Up to Year 3|Withdrawal by Subject|0
1158219|NCT01262976|3803748|P3|Up to Year 3|Withdrawal by Subject|0
1158220|NCT01262976|3803749|P2|Up to Year 3|Withdrawal by Subject|0
1158221|NCT01262976|3803750|P1|Up to Year 3|Withdrawal by Subject|1
1158222|NCT01262976|3803745|P6|Up to Year 3|Serious Adverse Event|0
1158223|NCT01262976|3803746|P5|Up to Year 3|Serious Adverse Event|0
1158224|NCT01262976|3803747|P4|Up to Year 3|Serious Adverse Event|0
1158225|NCT01262976|3803748|P3|Up to Year 3|Serious Adverse Event|2
1158226|NCT01262976|3803749|P2|Up to Year 3|Serious Adverse Event|0
1158227|NCT01262976|3803750|P1|Up to Year 3|Serious Adverse Event|0
1158228|NCT01262976|3803745|P6|Up to Year 2|Other|0
1158229|NCT01262976|3803746|P5|Up to Year 2|Other|0
1158230|NCT01262976|3803747|P4|Up to Year 2|Other|0
1158231|NCT01262976|3803748|P3|Up to Year 2|Other|0
1158232|NCT01262976|3803749|P2|Up to Year 2|Other|0
1158233|NCT01262976|3803750|P1|Up to Year 2|Other|3
1158234|NCT01262976|3803745|P6|Up to Year 2|Subjects with unknown completion status|0
1158235|NCT01262976|3803746|P5|Up to Year 2|Subjects with unknown completion status|0
1158236|NCT01262976|3803747|P4|Up to Year 2|Subjects with unknown completion status|0
1158237|NCT01262976|3803748|P3|Up to Year 2|Subjects with unknown completion status|1
1158238|NCT01262976|3803749|P2|Up to Year 2|Subjects with unknown completion status|0
1158239|NCT01262976|3803750|P1|Up to Year 2|Subjects with unknown completion status|0
1158240|NCT01262976|3803745|P6|Up to Year 2|Lost to Follow-up|3
1158241|NCT01262976|3803746|P5|Up to Year 2|Lost to Follow-up|3
1158242|NCT01262976|3803747|P4|Up to Year 2|Lost to Follow-up|2
1158243|NCT01262976|3803748|P3|Up to Year 2|Lost to Follow-up|2
1158244|NCT01262976|3803749|P2|Up to Year 2|Lost to Follow-up|1
1158245|NCT01262976|3803750|P1|Up to Year 2|Lost to Follow-up|1
1158246|NCT01262976|3803745|P6|Up to Year 2|Migrated/moved from study area|2
1158247|NCT01262976|3803746|P5|Up to Year 2|Migrated/moved from study area|1
1158248|NCT01262976|3803747|P4|Up to Year 2|Migrated/moved from study area|2
1158249|NCT01262976|3803748|P3|Up to Year 2|Migrated/moved from study area|0
1158250|NCT01262976|3803749|P2|Up to Year 2|Migrated/moved from study area|0
1158251|NCT01262976|3803750|P1|Up to Year 2|Migrated/moved from study area|0
1158252|NCT01262976|3803745|P6|Up to Year 2|Withdrawal by Subject|0
1158253|NCT01262976|3803746|P5|Up to Year 2|Withdrawal by Subject|0
1158254|NCT01262976|3803747|P4|Up to Year 2|Withdrawal by Subject|0
1158255|NCT01262976|3803748|P3|Up to Year 2|Withdrawal by Subject|0
1158256|NCT01262976|3803749|P2|Up to Year 2|Withdrawal by Subject|0
1158257|NCT01262976|3803750|P1|Up to Year 2|Withdrawal by Subject|1
1158258|NCT01262976|3803745|P6|Up to Year 2|Serious Adverse Event|0
1158259|NCT01262976|3803746|P5|Up to Year 2|Serious Adverse Event|0
1158260|NCT01262976|3803747|P4|Up to Year 2|Serious Adverse Event|0
1158261|NCT01262976|3803748|P3|Up to Year 2|Serious Adverse Event|2
1158262|NCT01262976|3803749|P2|Up to Year 2|Serious Adverse Event|0
1158263|NCT01262976|3803750|P1|Up to Year 2|Serious Adverse Event|0
1158264|NCT01262976|3803745|P6|Up to Year 1|Subjects with unknown completion status|1
1158265|NCT01262976|3803746|P5|Up to Year 1|Subjects with unknown completion status|0
1158266|NCT01262976|3803747|P4|Up to Year 1|Subjects with unknown completion status|0
1158267|NCT01262976|3803748|P3|Up to Year 1|Subjects with unknown completion status|1
1158268|NCT01262976|3803749|P2|Up to Year 1|Subjects with unknown completion status|0
1158269|NCT01262976|3803750|P1|Up to Year 1|Subjects with unknown completion status|0
1158270|NCT01262976|3803745|P6|Up to Year 1|Other|1
1158271|NCT01262976|3803746|P5|Up to Year 1|Other|2
1158272|NCT01262976|3803747|P4|Up to Year 1|Other|0
1158273|NCT01262976|3803748|P3|Up to Year 1|Other|0
1158274|NCT01262976|3803749|P2|Up to Year 1|Other|1
1158275|NCT01262976|3803750|P1|Up to Year 1|Other|3
1158276|NCT01262976|3803745|P6|Up to Year 1|Lost to Follow-up|5
1158277|NCT01262976|3803746|P5|Up to Year 1|Lost to Follow-up|6
1158278|NCT01262976|3803747|P4|Up to Year 1|Lost to Follow-up|1
1158279|NCT01262976|3803748|P3|Up to Year 1|Lost to Follow-up|0
1158280|NCT01262976|3803749|P2|Up to Year 1|Lost to Follow-up|0
1158281|NCT01262976|3803750|P1|Up to Year 1|Lost to Follow-up|4
1158282|NCT01262976|3803745|P6|Up to Year 1|Migrated/moved from study area|2
1158283|NCT01262976|3803746|P5|Up to Year 1|Migrated/moved from study area|3
1158284|NCT01262976|3803747|P4|Up to Year 1|Migrated/moved from study area|3
1158285|NCT01262976|3803748|P3|Up to Year 1|Migrated/moved from study area|0
1158286|NCT01262976|3803749|P2|Up to Year 1|Migrated/moved from study area|0
1158287|NCT01262976|3803750|P1|Up to Year 1|Migrated/moved from study area|1
1158288|NCT01262976|3803745|P6|Up to Year 1|Withdrawal by Subject|0
1158289|NCT01262976|3803746|P5|Up to Year 1|Withdrawal by Subject|0
1158290|NCT01262976|3803747|P4|Up to Year 1|Withdrawal by Subject|0
1158291|NCT01262976|3803748|P3|Up to Year 1|Withdrawal by Subject|0
1158292|NCT01262976|3803749|P2|Up to Year 1|Withdrawal by Subject|0
1158293|NCT01262976|3803750|P1|Up to Year 1|Withdrawal by Subject|1
1158294|NCT01262976|3803745|P6|Up to Year 1|Serious Adverse Event|0
1158295|NCT01262976|3803746|P5|Up to Year 1|Serious Adverse Event|0
1158296|NCT01262976|3803747|P4|Up to Year 1|Serious Adverse Event|0
1158297|NCT01262976|3803748|P3|Up to Year 1|Serious Adverse Event|2
1158298|NCT01262976|3803749|P2|Up to Year 1|Serious Adverse Event|0
1158299|NCT01262976|3803750|P1|Up to Year 1|Serious Adverse Event|0
1158300|NCT01262976|3803745|P6|Up to Month 7|Other|0
1158301|NCT01262976|3803746|P5|Up to Month 7|Other|0
1158302|NCT01262976|3803747|P4|Up to Month 7|Other|0
1158303|NCT01262976|3803748|P3|Up to Month 7|Other|2
1158304|NCT01262976|3803749|P2|Up to Month 7|Other|0
1158305|NCT01262976|3803750|P1|Up to Month 7|Other|3
1158306|NCT01262976|3803745|P6|Up to Month 7|Lost to Follow-up|3
1158307|NCT01262976|3803746|P5|Up to Month 7|Lost to Follow-up|1
1158308|NCT01262976|3803747|P4|Up to Month 7|Lost to Follow-up|3
1158309|NCT01262976|3803748|P3|Up to Month 7|Lost to Follow-up|1
1158310|NCT01262976|3803749|P2|Up to Month 7|Lost to Follow-up|0
1158311|NCT01262976|3803750|P1|Up to Month 7|Lost to Follow-up|1
1158312|NCT01262976|3803745|P6|Up to Month 7|Migrated/moved from study area|1
1158313|NCT01262976|3803746|P5|Up to Month 7|Migrated/moved from study area|1
1158314|NCT01262976|3803747|P4|Up to Month 7|Migrated/moved from study area|3
1158315|NCT01262976|3803748|P3|Up to Month 7|Migrated/moved from study area|1
1158316|NCT01262976|3803749|P2|Up to Month 7|Migrated/moved from study area|0
1158317|NCT01262976|3803750|P1|Up to Month 7|Migrated/moved from study area|0
1158318|NCT01262976|3803745|P6|Up to Month 7|Withdrawal by Subject|0
1158319|NCT01262976|3803746|P5|Up to Month 7|Withdrawal by Subject|0
1158320|NCT01262976|3803747|P4|Up to Month 7|Withdrawal by Subject|0
1158321|NCT01262976|3803748|P3|Up to Month 7|Withdrawal by Subject|0
1158322|NCT01262976|3803749|P2|Up to Month 7|Withdrawal by Subject|0
1158323|NCT01262976|3803750|P1|Up to Month 7|Withdrawal by Subject|1
1158324|NCT01262976|3803745|P6|Up to Month 7|Serious Adverse Event|0
1158325|NCT01262976|3803746|P5|Up to Month 7|Serious Adverse Event|0
1158326|NCT01262976|3803747|P4|Up to Month 7|Serious Adverse Event|0
1158327|NCT01262976|3803748|P3|Up to Month 7|Serious Adverse Event|2
1158328|NCT01262976|3803749|P2|Up to Month 7|Serious Adverse Event|0
1158329|NCT01262976|3803750|P1|Up to Month 7|Serious Adverse Event|0
1158330|NCT01262976|3803745|P6|Up to Month 2|Other|2
1158331|NCT01262976|3803746|P5|Up to Month 2|Other|0
1158332|NCT01262976|3803747|P4|Up to Month 2|Other|1
1158333|NCT01262976|3803748|P3|Up to Month 2|Other|0
1158334|NCT01262976|3803749|P2|Up to Month 2|Other|0
1158335|NCT01262976|3803750|P1|Up to Month 2|Other|1
1158336|NCT01262976|3803745|P6|Up to Month 2|Lost to Follow-up|1
1158337|NCT01262976|3803746|P5|Up to Month 2|Lost to Follow-up|1
1158338|NCT01262976|3803747|P4|Up to Month 2|Lost to Follow-up|1
1158339|NCT01262976|3803748|P3|Up to Month 2|Lost to Follow-up|0
1158340|NCT01262976|3803749|P2|Up to Month 2|Lost to Follow-up|0
1158341|NCT01262976|3803750|P1|Up to Month 2|Lost to Follow-up|1
1158342|NCT01262976|3803745|P6|Up to Month 2|Migrated/moved from study area|1
1158343|NCT01262976|3803746|P5|Up to Month 2|Migrated/moved from study area|1
1158344|NCT01262976|3803747|P4|Up to Month 2|Migrated/moved from study area|0
1158345|NCT01262976|3803748|P3|Up to Month 2|Migrated/moved from study area|0
1158346|NCT01262976|3803749|P2|Up to Month 2|Migrated/moved from study area|1
1158347|NCT01262976|3803750|P1|Up to Month 2|Migrated/moved from study area|0
1158348|NCT01262976|3803745|P6|Up to Month 2|Withdrawal by Subject|0
1158349|NCT01262976|3803746|P5|Up to Month 2|Withdrawal by Subject|0
1158350|NCT01262976|3803747|P4|Up to Month 2|Withdrawal by Subject|0
1158351|NCT01262976|3803748|P3|Up to Month 2|Withdrawal by Subject|0
1158352|NCT01262976|3803749|P2|Up to Month 2|Withdrawal by Subject|0
1158353|NCT01262976|3803750|P1|Up to Month 2|Withdrawal by Subject|1
1158354|NCT01262976|3803745|P6|Up to Month 2|Serious Adverse Event|0
1158355|NCT01262976|3803746|P5|Up to Month 2|Serious Adverse Event|0
1158356|NCT01262976|3803747|P4|Up to Month 2|Serious Adverse Event|0
1158357|NCT01262976|3803748|P3|Up to Month 2|Serious Adverse Event|1
1158358|NCT01262976|3803749|P2|Up to Month 2|Serious Adverse Event|0
1158359|NCT01262976|3803750|P1|Up to Month 2|Serious Adverse Event|0
1158360|NCT01262898|3803906|P4|Overall Study|Withdrawal by Subject|0
1158361|NCT01262898|3803907|P3|Overall Study|Withdrawal by Subject|0
1158362|NCT01262898|3803908|P2|Overall Study|Withdrawal by Subject|1
1158363|NCT01262898|3803909|P1|Overall Study|Withdrawal by Subject|1
1158364|NCT01262898|3803906|P4|Overall Study|Lost to Follow-up|0
1158365|NCT01262898|3803907|P3|Overall Study|Lost to Follow-up|0
1158366|NCT01262898|3803908|P2|Overall Study|Lost to Follow-up|0
1158367|NCT01262898|3803909|P1|Overall Study|Lost to Follow-up|1
1158368|NCT01262898|3803906|P4|Overall Study|Protocol Violation|0
1158369|NCT01262898|3803907|P3|Overall Study|Protocol Violation|0
1158370|NCT01262898|3803908|P2|Overall Study|Protocol Violation|1
1158371|NCT01262898|3803909|P1|Overall Study|Protocol Violation|1
1158372|NCT01262872|3804037|P8|Step 2|Migrated/moved from study area|3
1158373|NCT01262872|3804038|P7|Step 2|Migrated/moved from study area|2
1158374|NCT01262872|3804039|P6|Step 2|Migrated/moved from study area|6
1158375|NCT01262872|3804040|P5|Step 2|Migrated/moved from study area|2
1158376|NCT01262872|3804041|P4|Step 2|Migrated/moved from study area|3
1158377|NCT01262872|3804042|P3|Step 2|Migrated/moved from study area|4
1158378|NCT01262872|3804043|P2|Step 2|Migrated/moved from study area|0
1158379|NCT01262872|3804044|P1|Step 2|Migrated/moved from study area|0
1158380|NCT01262872|3804037|P8|Step 2|Withdrawal by Subject|1
1158381|NCT01262872|3804038|P7|Step 2|Withdrawal by Subject|2
1158382|NCT01262872|3804039|P6|Step 2|Withdrawal by Subject|1
1158383|NCT01262872|3804040|P5|Step 2|Withdrawal by Subject|3
1158384|NCT01262872|3804041|P4|Step 2|Withdrawal by Subject|6
1158385|NCT01262872|3804042|P3|Step 2|Withdrawal by Subject|4
1158386|NCT01262872|3804043|P2|Step 2|Withdrawal by Subject|0
1158387|NCT01262872|3804044|P1|Step 2|Withdrawal by Subject|0
1158388|NCT01262872|3804037|P8|Step 2|Protocol Violation|1
1158389|NCT01262872|3804038|P7|Step 2|Protocol Violation|3
1158390|NCT01262872|3804039|P6|Step 2|Protocol Violation|0
1158391|NCT01262872|3804040|P5|Step 2|Protocol Violation|0
1158392|NCT01262872|3804041|P4|Step 2|Protocol Violation|0
1158393|NCT01262872|3804042|P3|Step 2|Protocol Violation|1
1158394|NCT01262872|3804043|P2|Step 2|Protocol Violation|0
1158395|NCT01262872|3804044|P1|Step 2|Protocol Violation|0
1158396|NCT01262872|3804037|P8|Step 2|Death|1
1158397|NCT01262872|3804038|P7|Step 2|Death|2
1158398|NCT01262872|3804039|P6|Step 2|Death|2
1158399|NCT01262872|3804040|P5|Step 2|Death|0
1158400|NCT01262872|3804041|P4|Step 2|Death|1
1158401|NCT01262872|3804042|P3|Step 2|Death|0
1158402|NCT01262872|3804043|P2|Step 2|Death|0
1158403|NCT01262872|3804044|P1|Step 2|Death|0
1158404|NCT01262820|3804306|P1|Overall Study|Drug held for 21+ days|1
1158405|NCT01262820|3804306|P1|Overall Study|Lack of Efficacy|9
1158406|NCT01262820|3804306|P1|Overall Study|Adverse Event|5
1158407|NCT01262677|3804320|P3|Overall Study|Adverse Event (AE) related to study drug|3
1158408|NCT01262677|3804321|P2|Overall Study|Adverse Event (AE) related to study drug|8
1158409|NCT01262677|3804322|P1|Overall Study|Adverse Event (AE) related to study drug|3
1158410|NCT01262677|3804320|P3|Overall Study|Protocol Violation|1
1158411|NCT01262677|3804321|P2|Overall Study|Protocol Violation|1
1158412|NCT01262677|3804322|P1|Overall Study|Protocol Violation|0
1158413|NCT01262677|3804320|P3|Overall Study|Reason not provided|3
1158414|NCT01262677|3804321|P2|Overall Study|Reason not provided|1
1158415|NCT01262677|3804322|P1|Overall Study|Reason not provided|2
1158416|NCT01262677|3804320|P3|Overall Study|No longer willing to participate|2
1158417|NCT01262677|3804321|P2|Overall Study|No longer willing to participate|3
1158418|NCT01262677|3804322|P1|Overall Study|No longer willing to participate|3
1158419|NCT01262677|3804320|P3|Overall Study|Lost to Follow-up|2
1158420|NCT01262677|3804321|P2|Overall Study|Lost to Follow-up|0
1158421|NCT01262677|3804322|P1|Overall Study|Lost to Follow-up|1
1158422|NCT01262677|3804320|P3|Overall Study|Insufficient clinical response|1
1158423|NCT01262677|3804321|P2|Overall Study|Insufficient clinical response|0
1158424|NCT01262677|3804322|P1|Overall Study|Insufficient clinical response|0
1158425|NCT01262677|3804320|P3|Overall Study|Does not meet entrance criteria|0
1158426|NCT01262677|3804321|P2|Overall Study|Does not meet entrance criteria|2
1158427|NCT01262677|3804322|P1|Overall Study|Does not meet entrance criteria|0
1158428|NCT01262651|3804413|P2|Overall Study|Met Withdrawal Criteria|0
1158429|NCT01262651|3804414|P1|Overall Study|Met Withdrawal Criteria|1
1158430|NCT01262651|3804413|P2|Overall Study|Withdrawal by Investigator|2
1158431|NCT01262651|3804414|P1|Overall Study|Withdrawal by Investigator|2
1158432|NCT01262651|3804413|P2|Overall Study|Withdrawal by Subject|11
1158433|NCT01262651|3804414|P1|Overall Study|Withdrawal by Subject|15
1158434|NCT01262651|3804413|P2|Overall Study|Adverse Event|35
1158435|NCT01262651|3804414|P1|Overall Study|Adverse Event|40
1158436|NCT01262573|3804455|P2|Overall Study|Withdrawal by Subject|1
1158437|NCT01262573|3804456|P1|Overall Study|Withdrawal by Subject|0
1158438|NCT01262560|3804467|P3|Overall Study|Protocol Violation|2
1158439|NCT01262560|3804468|P2|Overall Study|Protocol Violation|1
1158440|NCT01262560|3804469|P1|Overall Study|Protocol Violation|0
1158441|NCT01262456|3804518|P3|1-Month Open-Label Extension Period|Other Reason|0
1158442|NCT01262456|3804519|P2|1-Month Open-Label Extension Period|Other Reason|1
1158443|NCT01262456|3804520|P1|1-Month Open-Label Extension Period|Other Reason|0
1158444|NCT01262456|3804518|P3|1-Month Open-Label Extension Period|Protocol Violation|2
1158445|NCT01262456|3804519|P2|1-Month Open-Label Extension Period|Protocol Violation|0
1158446|NCT01262456|3804520|P1|1-Month Open-Label Extension Period|Protocol Violation|1
1158447|NCT01262456|3804518|P3|1-Month Open-Label Extension Period|Adverse Event|2
1158448|NCT01262456|3804519|P2|1-Month Open-Label Extension Period|Adverse Event|0
1158449|NCT01262456|3804520|P1|1-Month Open-Label Extension Period|Adverse Event|2
1158450|NCT01262456|3804518|P3|1-Month Open-Label Extension Period|Lost to Follow-up|0
1158451|NCT01262456|3804519|P2|1-Month Open-Label Extension Period|Lost to Follow-up|1
1158452|NCT01262456|3804520|P1|1-Month Open-Label Extension Period|Lost to Follow-up|0
1158453|NCT01262456|3804518|P3|1-Month Open-Label Extension Period|Withdrawal by Subject|1
1158454|NCT01262456|3804519|P2|1-Month Open-Label Extension Period|Withdrawal by Subject|1
1158455|NCT01262456|3804520|P1|1-Month Open-Label Extension Period|Withdrawal by Subject|1
1158456|NCT01262456|3804518|P3|3-Month Double-Blind Period|Protocol Violation|6
1158457|NCT01262456|3804519|P2|3-Month Double-Blind Period|Protocol Violation|6
1158458|NCT01262456|3804520|P1|3-Month Double-Blind Period|Protocol Violation|3
1158459|NCT01262456|3804518|P3|3-Month Double-Blind Period|Adverse Event|8
1158460|NCT01262456|3804519|P2|3-Month Double-Blind Period|Adverse Event|4
1158461|NCT01262456|3804520|P1|3-Month Double-Blind Period|Adverse Event|6
1158462|NCT01262456|3804518|P3|3-Month Double-Blind Period|Lost to Follow-up|3
1158463|NCT01262456|3804519|P2|3-Month Double-Blind Period|Lost to Follow-up|5
1158464|NCT01262456|3804520|P1|3-Month Double-Blind Period|Lost to Follow-up|4
1158465|NCT01262456|3804518|P3|3-Month Double-Blind Period|Withdrawal by Subject|9
1158466|NCT01262456|3804519|P2|3-Month Double-Blind Period|Withdrawal by Subject|8
1158467|NCT01262456|3804520|P1|3-Month Double-Blind Period|Withdrawal by Subject|6
1158468|NCT01262365|3804564|P3|Overall Study|Patient unavailable|1
1158469|NCT01262365|3804565|P2|Overall Study|Patient unavailable|0
1158470|NCT01262365|3804566|P1|Overall Study|Patient unavailable|0
1158471|NCT01262365|3804564|P3|Overall Study|Cannot tolerate the protocol|0
1158472|NCT01262365|3804565|P2|Overall Study|Cannot tolerate the protocol|1
1158473|NCT01262365|3804566|P1|Overall Study|Cannot tolerate the protocol|0
1158474|NCT01262365|3804564|P3|Overall Study|Toxicity related to study drug|0
1158475|NCT01262365|3804565|P2|Overall Study|Toxicity related to study drug|1
1158476|NCT01262365|3804566|P1|Overall Study|Toxicity related to study drug|0
1158477|NCT01262365|3804564|P3|Overall Study|Patient pregnant|1
1158478|NCT01262365|3804565|P2|Overall Study|Patient pregnant|0
1158479|NCT01262365|3804566|P1|Overall Study|Patient pregnant|1
1158480|NCT01262365|3804564|P3|Overall Study|Suspected pregnancy|0
1158481|NCT01262365|3804565|P2|Overall Study|Suspected pregnancy|0
1158482|NCT01262365|3804566|P1|Overall Study|Suspected pregnancy|1
1158483|NCT01262365|3804564|P3|Overall Study|Non-compliance|2
1158484|NCT01262365|3804565|P2|Overall Study|Non-compliance|0
1158485|NCT01262365|3804566|P1|Overall Study|Non-compliance|1
1158486|NCT01262365|3804564|P3|Overall Study|Randomization error|2
1158487|NCT01262365|3804565|P2|Overall Study|Randomization error|0
1158488|NCT01262365|3804566|P1|Overall Study|Randomization error|1
1158489|NCT01262365|3804564|P3|Overall Study|sponsor decision|0
1158490|NCT01262365|3804565|P2|Overall Study|sponsor decision|1
1158491|NCT01262365|3804566|P1|Overall Study|sponsor decision|1
1158492|NCT01262365|3804564|P3|Overall Study|Adverse Event|11
1158493|NCT01262365|3804565|P2|Overall Study|Adverse Event|16
1158494|NCT01262365|3804566|P1|Overall Study|Adverse Event|26
1158495|NCT01262365|3804564|P3|Overall Study|Death|1
1158496|NCT01262365|3804565|P2|Overall Study|Death|2
1158497|NCT01262365|3804566|P1|Overall Study|Death|1
1158498|NCT01262365|3804564|P3|Overall Study|Withdrawal by Subject|22
1158499|NCT01262365|3804565|P2|Overall Study|Withdrawal by Subject|22
1158500|NCT01262365|3804566|P1|Overall Study|Withdrawal by Subject|17
1158501|NCT01262365|3804564|P3|Overall Study|Lost to Follow-up|6
1158502|NCT01262365|3804565|P2|Overall Study|Lost to Follow-up|7
1158503|NCT01262365|3804566|P1|Overall Study|Lost to Follow-up|3
1158504|NCT01262365|3804564|P3|Overall Study|Protocol Violation|1
1158505|NCT01262365|3804565|P2|Overall Study|Protocol Violation|1
1158506|NCT01262365|3804566|P1|Overall Study|Protocol Violation|3
1158507|NCT01262365|3804564|P3|Overall Study|Lack of Efficacy|47
1158508|NCT01262365|3804565|P2|Overall Study|Lack of Efficacy|30
1158509|NCT01262365|3804566|P1|Overall Study|Lack of Efficacy|35
1158510|NCT01262352|3804591|P2|Washout|Extended Washout|1
1158511|NCT01262352|3804592|P1|Washout|Extended Washout|0
1158512|NCT01262352|3804591|P2|Washout|Adverse Event|1
1158513|NCT01262352|3804592|P1|Washout|Adverse Event|1
1158514|NCT01262352|3804591|P2|Period 1|Illness after randomization|0
1158515|NCT01262352|3804592|P1|Period 1|Illness after randomization|1
1158516|NCT01262287|3804610|P2|Overall Study|Lost to Follow-up|1
1158517|NCT01262287|3804611|P1|Overall Study|Lost to Follow-up|2
1158518|NCT01262092|3804672|P2|Gabapentin Taper|noncompliance - missed medications|0
1158519|NCT01262092|3804673|P1|Gabapentin Taper|noncompliance - missed medications|1
1158520|NCT01262092|3804672|P2|Buprenorphine Taper|noncompliance - missed medication|1
1158521|NCT01262092|3804673|P1|Buprenorphine Taper|noncompliance - missed medication|1
1158522|NCT01262092|3804672|P2|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0
1158523|NCT01262092|3804673|P1|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1
1158524|NCT01262092|3804672|P2|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1
1158525|NCT01262092|3804673|P1|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2
1158526|NCT01262027|3804679|P1|Overall Study|Protocol Violation|1
1158527|NCT01262027|3804679|P1|Overall Study|Withdrawal by Subject|3
1158528|NCT01262027|3804679|P1|Overall Study|Adverse Event|1
1158529|NCT01261975|3804684|P1|Overall Study|Surgical complication|1
1158530|NCT01261793|3804706|P3|Overall Study|Patient unable to start IV line|1
1158531|NCT01261793|3804707|P2|Overall Study|Patient unable to start IV line|0
1158532|NCT01261793|3804708|P1|Overall Study|Patient unable to start IV line|0
1158533|NCT01261793|3804706|P3|Overall Study|Randomization error|0
1158534|NCT01261793|3804707|P2|Overall Study|Randomization error|1
1158535|NCT01261793|3804708|P1|Overall Study|Randomization error|0
1158536|NCT01261793|3804706|P3|Overall Study|Patient withdrew after cardiology visit|0
1158537|NCT01261793|3804707|P2|Overall Study|Patient withdrew after cardiology visit|1
1158538|NCT01261793|3804708|P1|Overall Study|Patient withdrew after cardiology visit|0
1158539|NCT01261793|3804706|P3|Overall Study|Lack of efficacy & patient not available|0
1158540|NCT01261793|3804707|P2|Overall Study|Lack of efficacy & patient not available|1
1158541|NCT01261793|3804708|P1|Overall Study|Lack of efficacy & patient not available|0
1158542|NCT01261793|3804706|P3|Overall Study|Outside the study area|1
1158543|NCT01261793|3804707|P2|Overall Study|Outside the study area|2
1158544|NCT01261793|3804708|P1|Overall Study|Outside the study area|0
1158545|NCT01261793|3804706|P3|Overall Study|Patient pregnant|0
1158546|NCT01261793|3804707|P2|Overall Study|Patient pregnant|0
1158547|NCT01261793|3804708|P1|Overall Study|Patient pregnant|1
1158548|NCT01261793|3804706|P3|Overall Study|Patient non-compliance|1
1158549|NCT01261793|3804707|P2|Overall Study|Patient non-compliance|0
1158550|NCT01261793|3804708|P1|Overall Study|Patient non-compliance|1
1158551|NCT01261793|3804706|P3|Overall Study|Suspected pregnancy|0
1158552|NCT01261793|3804707|P2|Overall Study|Suspected pregnancy|1
1158553|NCT01261793|3804708|P1|Overall Study|Suspected pregnancy|1
1158554|NCT01261793|3804706|P3|Overall Study|Patient non-availability|1
1158555|NCT01261793|3804707|P2|Overall Study|Patient non-availability|1
1158556|NCT01261793|3804708|P1|Overall Study|Patient non-availability|1
1158557|NCT01261793|3804706|P3|Overall Study|Adverse Event|19
1158558|NCT01261793|3804707|P2|Overall Study|Adverse Event|24
1158559|NCT01261793|3804708|P1|Overall Study|Adverse Event|9
1158560|NCT01261793|3804706|P3|Overall Study|Death|0
1158561|NCT01261793|3804707|P2|Overall Study|Death|1
1158562|NCT01261793|3804708|P1|Overall Study|Death|3
1158563|NCT01261793|3804706|P3|Overall Study|Withdrawal by Subject|14
1158564|NCT01261793|3804707|P2|Overall Study|Withdrawal by Subject|14
1158565|NCT01261793|3804708|P1|Overall Study|Withdrawal by Subject|12
1158566|NCT01261793|3804706|P3|Overall Study|Lost to Follow-up|7
1158567|NCT01261793|3804707|P2|Overall Study|Lost to Follow-up|3
1158568|NCT01261793|3804708|P1|Overall Study|Lost to Follow-up|10
1158569|NCT01261793|3804706|P3|Overall Study|Protocol Violation|6
1158570|NCT01261793|3804707|P2|Overall Study|Protocol Violation|5
1158571|NCT01261793|3804708|P1|Overall Study|Protocol Violation|3
1158572|NCT01261793|3804706|P3|Overall Study|Lack of Efficacy|32
1158573|NCT01261793|3804707|P2|Overall Study|Lack of Efficacy|37
1158574|NCT01261793|3804708|P1|Overall Study|Lack of Efficacy|44
1158575|NCT01261780|3804733|P2|Overall Study|Event not related to subject|2
1158576|NCT01261780|3804734|P1|Overall Study|Event not related to subject|1
1158577|NCT01261780|3804733|P2|Overall Study|Withdrawal by Subject|0
1158578|NCT01261780|3804734|P1|Overall Study|Withdrawal by Subject|1
1158579|NCT01261624|3804744|P2|Week 13 to Week 24|Insufficient Response|1
1158580|NCT01261624|3804745|P1|Week 13 to Week 24|Insufficient Response|0
1158581|NCT01261624|3804744|P2|Week 0 to Week 12|Insufficient Response|2
1158582|NCT01261624|3804745|P1|Week 0 to Week 12|Insufficient Response|0
1158583|NCT01261624|3804744|P2|Week 0 to Week 12|Disease Progression|1
1158584|NCT01261624|3804745|P1|Week 0 to Week 12|Disease Progression|1
1158585|NCT01261390|3804790|P4|Overall Study|Lost to Follow-up|6
1158586|NCT01261390|3804791|P3|Overall Study|Lost to Follow-up|5
1158587|NCT01261390|3804792|P2|Overall Study|Lost to Follow-up|6
1158588|NCT01261390|3804793|P1|Overall Study|Lost to Follow-up|1
1158589|NCT01261390|3804790|P4|Overall Study|Loss of Interest in the Study|0
1158590|NCT01261390|3804791|P3|Overall Study|Loss of Interest in the Study|0
1158591|NCT01261390|3804792|P2|Overall Study|Loss of Interest in the Study|1
1158592|NCT01261390|3804793|P1|Overall Study|Loss of Interest in the Study|3
1158593|NCT01261390|3804790|P4|Overall Study|Relocation|0
1158594|NCT01261390|3804791|P3|Overall Study|Relocation|0
1158595|NCT01261390|3804792|P2|Overall Study|Relocation|1
1158596|NCT01261390|3804793|P1|Overall Study|Relocation|0
1158597|NCT01261390|3804790|P4|Overall Study|Dissatisfaction with Treatment|2
1158598|NCT01261390|3804791|P3|Overall Study|Dissatisfaction with Treatment|1
1158599|NCT01261390|3804792|P2|Overall Study|Dissatisfaction with Treatment|1
1158600|NCT01261390|3804793|P1|Overall Study|Dissatisfaction with Treatment|2
1158601|NCT01261390|3804790|P4|Overall Study|Significant Concurrent Illness|0
1158602|NCT01261390|3804791|P3|Overall Study|Significant Concurrent Illness|1
1158603|NCT01261390|3804792|P2|Overall Study|Significant Concurrent Illness|0
1158604|NCT01261390|3804793|P1|Overall Study|Significant Concurrent Illness|1
1158605|NCT01261325|3804958|P3|Overall Study|AE, serious fatal|2
1158606|NCT01261325|3804959|P2|Overall Study|AE, serious fatal|0
1158607|NCT01261325|3804960|P1|Overall Study|AE, serious fatal|0
1158608|NCT01261325|3804958|P3|Overall Study|Lost to Follow-up|3
1158609|NCT01261325|3804959|P2|Overall Study|Lost to Follow-up|1
1158610|NCT01261325|3804960|P1|Overall Study|Lost to Follow-up|0
1158611|NCT01261325|3804958|P3|Overall Study|Protocol Violation|1
1158612|NCT01261325|3804959|P2|Overall Study|Protocol Violation|3
1158613|NCT01261325|3804960|P1|Overall Study|Protocol Violation|0
1158614|NCT01261325|3804958|P3|Overall Study|Randomized in Error|1
1158615|NCT01261325|3804959|P2|Overall Study|Randomized in Error|0
1158616|NCT01261325|3804960|P1|Overall Study|Randomized in Error|0
1158617|NCT01261325|3804958|P3|Overall Study|Screen Failure|0
1158618|NCT01261325|3804959|P2|Overall Study|Screen Failure|0
1158619|NCT01261325|3804960|P1|Overall Study|Screen Failure|1
1158620|NCT01261325|3804958|P3|Overall Study|Erroneously Randomized|0
1158621|NCT01261325|3804959|P2|Overall Study|Erroneously Randomized|0
1158622|NCT01261325|3804960|P1|Overall Study|Erroneously Randomized|1
1158623|NCT01261325|3804958|P3|Overall Study|Patient Randomized by Mistake|0
1158624|NCT01261325|3804959|P2|Overall Study|Patient Randomized by Mistake|1
1158625|NCT01261325|3804960|P1|Overall Study|Patient Randomized by Mistake|0
1158626|NCT01261325|3804958|P3|Overall Study|Non Compliance|0
1158627|NCT01261325|3804959|P2|Overall Study|Non Compliance|0
1158628|NCT01261325|3804960|P1|Overall Study|Non Compliance|2
1158629|NCT01261325|3804958|P3|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
1158630|NCT01261325|3804959|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
1158631|NCT01261325|3804960|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
1158632|NCT01261325|3804958|P3|Overall Study|AE, non-serious non-fatal|13
1158633|NCT01261325|3804959|P2|Overall Study|AE, non-serious non-fatal|15
1158634|NCT01261325|3804960|P1|Overall Study|AE, non-serious non-fatal|9
1158635|NCT01261325|3804958|P3|Overall Study|SAE, non-fatal|1
1158636|NCT01261325|3804959|P2|Overall Study|SAE, non-fatal|5
1158637|NCT01261325|3804960|P1|Overall Study|SAE, non-fatal|1
1158638|NCT01261325|3804958|P3|Overall Study|Withdrawal by Subject|4
1158639|NCT01261325|3804959|P2|Overall Study|Withdrawal by Subject|2
1158640|NCT01261325|3804960|P1|Overall Study|Withdrawal by Subject|2
1158641|NCT01261325|3804958|P3|Overall Study|Lack of Efficacy|0
1158642|NCT01261325|3804959|P2|Overall Study|Lack of Efficacy|1
1158643|NCT01261325|3804960|P1|Overall Study|Lack of Efficacy|1
1158644|NCT01261247|3804992|P1|Overall Study|Ineligible|2
1158645|NCT01261000|3805005|P1|Overall Study|Screen failure|1
1158646|NCT01260948|3805011|P2|Second Intervention|Emesis|1
1158647|NCT01260948|3805012|P1|Second Intervention|Emesis|0
1158648|NCT01260948|3805011|P2|Washout of 28 Days|Withdrawal by Subject|3
1158649|NCT01260948|3805012|P1|Washout of 28 Days|Withdrawal by Subject|1
1158650|NCT01260922|3805022|P2|Second Intervention|Emesis|2
1158651|NCT01260922|3805023|P1|Second Intervention|Emesis|0
1158652|NCT01260922|3805022|P2|Washout of 28 Days|Withdrawal by Subject|2
1158653|NCT01260922|3805023|P1|Washout of 28 Days|Withdrawal by Subject|4
1158654|NCT01260922|3805022|P2|First Intervention|Withdrawal by Subject|1
1158655|NCT01260922|3805023|P1|First Intervention|Withdrawal by Subject|0
1158656|NCT01260896|3805033|P2|First Intervention|Withdrawn Due to Emesis|0
1158657|NCT01260896|3805034|P1|First Intervention|Withdrawn Due to Emesis|2
1158658|NCT01260701|3805092|P1|Overall Study|Did not begin protocol therapy|1
1158659|NCT01260701|3805092|P1|Overall Study|Ineligible|4
1158660|NCT01260701|3805092|P1|Overall Study|Under review|1
1158661|NCT01260701|3805092|P1|Overall Study|Not protocol specified|3
1158662|NCT01260701|3805092|P1|Overall Study|Death|2
1158663|NCT01260701|3805092|P1|Overall Study|Progression|53
1158664|NCT01260701|3805092|P1|Overall Study|Withdrawal by Subject|2
1158665|NCT01260701|3805092|P1|Overall Study|Adverse Event|9
1158666|NCT01260584|3805173|P4|Period 2|Withdrawal by Subject|0
1158667|NCT01260584|3805174|P3|Period 2|Withdrawal by Subject|0
1158668|NCT01260584|3805175|P2|Period 2|Withdrawal by Subject|1
1158669|NCT01260584|3805176|P1|Period 2|Withdrawal by Subject|0
1158670|NCT01260584|3805173|P4|Period 2|Adverse Event|0
1158671|NCT01260584|3805174|P3|Period 2|Adverse Event|2
1158672|NCT01260584|3805175|P2|Period 2|Adverse Event|0
1158673|NCT01260584|3805176|P1|Period 2|Adverse Event|1
1158674|NCT01260584|3805173|P4|Period 2|Protocol Violation|1
1158675|NCT01260584|3805174|P3|Period 2|Protocol Violation|3
1158676|NCT01260584|3805175|P2|Period 2|Protocol Violation|2
1158677|NCT01260584|3805176|P1|Period 2|Protocol Violation|0
1158678|NCT01260584|3805173|P4|Period 1|Adverse Event|0
1158679|NCT01260584|3805174|P3|Period 1|Adverse Event|1
1158680|NCT01260584|3805175|P2|Period 1|Adverse Event|0
1158681|NCT01260584|3805176|P1|Period 1|Adverse Event|0
1158682|NCT01260584|3805173|P4|Period 1|Protocol Violation|1
1158683|NCT01260584|3805174|P3|Period 1|Protocol Violation|1
1158684|NCT01260584|3805175|P2|Period 1|Protocol Violation|0
1158685|NCT01260584|3805176|P1|Period 1|Protocol Violation|0
1158686|NCT01260467|3805219|P1|Overall Study|Withdrawal by Subject|2
1158687|NCT01260350|3805251|P22|Overall Study|Did Not Complete Follow-up 12 Visit|0
1158688|NCT01260350|3805252|P21|Overall Study|Did Not Complete Follow-up 12 Visit|0
1158689|NCT01260350|3805253|P20|Overall Study|Did Not Complete Follow-up 12 Visit|0
1158690|NCT01260350|3805254|P19|Overall Study|Did Not Complete Follow-up 12 Visit|0
1158691|NCT01260350|3805255|P18|Overall Study|Did Not Complete Follow-up 12 Visit|0
1158692|NCT01260350|3805256|P17|Overall Study|Did Not Complete Follow-up 12 Visit|0
1158693|NCT01260350|3805257|P16|Overall Study|Did Not Complete Follow-up 12 Visit|0
1158694|NCT01260350|3805258|P15|Overall Study|Did Not Complete Follow-up 12 Visit|0
1158695|NCT01260350|3805259|P14|Overall Study|Did Not Complete Follow-up 12 Visit|0
1158696|NCT01260350|3805260|P13|Overall Study|Did Not Complete Follow-up 12 Visit|0
1158697|NCT01260350|3805261|P12|Overall Study|Did Not Complete Follow-up 12 Visit|0
1158698|NCT01260350|3805262|P11|Overall Study|Did Not Complete Follow-up 12 Visit|0
1158699|NCT01260350|3805263|P10|Overall Study|Did Not Complete Follow-up 12 Visit|0
1158700|NCT01260350|3805264|P9|Overall Study|Did Not Complete Follow-up 12 Visit|1
1158701|NCT01260350|3805265|P8|Overall Study|Did Not Complete Follow-up 12 Visit|0
1158702|NCT01260350|3805266|P7|Overall Study|Did Not Complete Follow-up 12 Visit|0
1158703|NCT01260350|3805267|P6|Overall Study|Did Not Complete Follow-up 12 Visit|0
1158704|NCT01260350|3805268|P5|Overall Study|Did Not Complete Follow-up 12 Visit|0
1158705|NCT01260350|3805269|P4|Overall Study|Did Not Complete Follow-up 12 Visit|0
1158706|NCT01260350|3805270|P3|Overall Study|Did Not Complete Follow-up 12 Visit|0
1158707|NCT01260350|3805271|P2|Overall Study|Did Not Complete Follow-up 12 Visit|0
1158708|NCT01260350|3805272|P1|Overall Study|Did Not Complete Follow-up 12 Visit|0
1158709|NCT01260350|3805251|P22|Overall Study|Lack of Efficacy|0
1158710|NCT01260350|3805252|P21|Overall Study|Lack of Efficacy|3
1158711|NCT01260350|3805253|P20|Overall Study|Lack of Efficacy|0
1158712|NCT01260350|3805254|P19|Overall Study|Lack of Efficacy|0
1158713|NCT01260350|3805255|P18|Overall Study|Lack of Efficacy|1
1158714|NCT01260350|3805256|P17|Overall Study|Lack of Efficacy|0
1158715|NCT01260350|3805257|P16|Overall Study|Lack of Efficacy|0
1158716|NCT01260350|3805258|P15|Overall Study|Lack of Efficacy|0
1158717|NCT01260350|3805259|P14|Overall Study|Lack of Efficacy|0
1158718|NCT01260350|3805260|P13|Overall Study|Lack of Efficacy|0
1158719|NCT01260350|3805261|P12|Overall Study|Lack of Efficacy|0
1158720|NCT01260350|3805262|P11|Overall Study|Lack of Efficacy|0
1158721|NCT01260350|3805263|P10|Overall Study|Lack of Efficacy|0
1158722|NCT01260350|3805264|P9|Overall Study|Lack of Efficacy|0
1158723|NCT01260350|3805265|P8|Overall Study|Lack of Efficacy|0
1158724|NCT01260350|3805266|P7|Overall Study|Lack of Efficacy|0
1158725|NCT01260350|3805267|P6|Overall Study|Lack of Efficacy|0
1158726|NCT01260350|3805268|P5|Overall Study|Lack of Efficacy|0
1158727|NCT01260350|3805269|P4|Overall Study|Lack of Efficacy|0
1158728|NCT01260350|3805270|P3|Overall Study|Lack of Efficacy|0
1158729|NCT01260350|3805271|P2|Overall Study|Lack of Efficacy|0
1158730|NCT01260350|3805272|P1|Overall Study|Lack of Efficacy|0
1158731|NCT01260311|3805479|P1|Overall Study|Fesoterodine Started Before Enrollment|1
1158732|NCT01260311|3805479|P1|Overall Study|Medication Stopped|1
1158733|NCT01260311|3805479|P1|Overall Study|Gone to Province|2
1158734|NCT01260311|3805479|P1|Overall Study|Financial Constraints|77
1158735|NCT01260311|3805479|P1|Overall Study|Withdrawal by Subject|6
1158736|NCT01260311|3805479|P1|Overall Study|Lost to Follow-up|25
1158737|NCT01260311|3805479|P1|Overall Study|Lack of Efficacy|4
1158738|NCT01260311|3805479|P1|Overall Study|Adverse Event|11
1158739|NCT01260194|3805510|P1|Overall Study|Withdrawal of Consent|1
1158740|NCT01260181|3805522|P1|Overall Study|Decision of Investigator|1
1158741|NCT01260142|3805537|P6|Treatment Period 1|Withdrawal by Subject|1
1158742|NCT01260142|3805538|P5|Treatment Period 1|Withdrawal by Subject|0
1158743|NCT01260142|3805539|P4|Treatment Period 1|Withdrawal by Subject|0
1158744|NCT01260142|3805540|P3|Treatment Period 1|Withdrawal by Subject|0
1158745|NCT01260142|3805541|P2|Treatment Period 1|Withdrawal by Subject|0
1158746|NCT01260142|3805542|P1|Treatment Period 1|Withdrawal by Subject|0
1158747|NCT01260142|3805537|P6|Treatment Period 1|Unexplained elevated sys. BP|0
1158748|NCT01260142|3805538|P5|Treatment Period 1|Unexplained elevated sys. BP|1
1158749|NCT01260142|3805539|P4|Treatment Period 1|Unexplained elevated sys. BP|0
1158750|NCT01260142|3805540|P3|Treatment Period 1|Unexplained elevated sys. BP|0
1158751|NCT01260142|3805541|P2|Treatment Period 1|Unexplained elevated sys. BP|0
1158752|NCT01260142|3805542|P1|Treatment Period 1|Unexplained elevated sys. BP|0
1158753|NCT01260142|3805537|P6|Treatment Period 1|Study on hold|2
1158754|NCT01260142|3805538|P5|Treatment Period 1|Study on hold|1
1158755|NCT01260142|3805539|P4|Treatment Period 1|Study on hold|0
1158756|NCT01260142|3805540|P3|Treatment Period 1|Study on hold|0
1158757|NCT01260142|3805541|P2|Treatment Period 1|Study on hold|1
1158758|NCT01260142|3805542|P1|Treatment Period 1|Study on hold|1
1158759|NCT01259856|3805594|P2|Overall Study|Unknown/missing|2
1158760|NCT01259856|3805595|P1|Overall Study|Unknown/missing|2
1158761|NCT01259856|3805594|P2|Overall Study|Transfer to another study|1
1158762|NCT01259856|3805595|P1|Overall Study|Transfer to another study|0
1158763|NCT01259856|3805594|P2|Overall Study|Patient developed other disease|1
1158764|NCT01259856|3805595|P1|Overall Study|Patient developed other disease|0
1158765|NCT01259856|3805594|P2|Overall Study|Study closure by sponsor|41
1158766|NCT01259856|3805595|P1|Overall Study|Study closure by sponsor|40
1158767|NCT01259856|3805594|P2|Overall Study|Treatment never started|6
1158768|NCT01259856|3805595|P1|Overall Study|Treatment never started|0
1158769|NCT01259856|3805594|P2|Overall Study|Withdrawal by Subject|10
1158770|NCT01259856|3805595|P1|Overall Study|Withdrawal by Subject|9
1158771|NCT01259856|3805594|P2|Overall Study|Physician Decision|1
1158772|NCT01259856|3805595|P1|Overall Study|Physician Decision|2
1158773|NCT01259856|3805594|P2|Overall Study|Lost to Follow-up|1
1158774|NCT01259856|3805595|P1|Overall Study|Lost to Follow-up|1
1158775|NCT01259856|3805594|P2|Overall Study|Lack of Efficacy|1
1158776|NCT01259856|3805595|P1|Overall Study|Lack of Efficacy|3
1158777|NCT01259856|3805594|P2|Overall Study|Death|1
1158778|NCT01259856|3805595|P1|Overall Study|Death|0
1158779|NCT01259856|3805594|P2|Overall Study|Adverse Event|9
1158780|NCT01259856|3805595|P1|Overall Study|Adverse Event|12
1158781|NCT01259726|3805619|P4|Overall Study|Lost to Follow-up|3
1158782|NCT01259726|3805620|P3|Overall Study|Lost to Follow-up|1
1158783|NCT01259726|3805621|P2|Overall Study|Lost to Follow-up|1
1158784|NCT01259726|3805622|P1|Overall Study|Lost to Follow-up|1
1158785|NCT01259726|3805619|P4|Overall Study|Withdrawal by Subject|1
1158786|NCT01259726|3805620|P3|Overall Study|Withdrawal by Subject|2
1158787|NCT01259726|3805621|P2|Overall Study|Withdrawal by Subject|3
1158788|NCT01259726|3805622|P1|Overall Study|Withdrawal by Subject|1
1158789|NCT01259726|3805619|P4|Overall Study|Physician Decision|1
1158790|NCT01259726|3805620|P3|Overall Study|Physician Decision|1
1158791|NCT01259726|3805621|P2|Overall Study|Physician Decision|0
1158792|NCT01259726|3805622|P1|Overall Study|Physician Decision|2
1158793|NCT01259726|3805619|P4|Overall Study|Death|0
1158794|NCT01259726|3805620|P3|Overall Study|Death|0
1158795|NCT01259726|3805621|P2|Overall Study|Death|0
1158796|NCT01259726|3805622|P1|Overall Study|Death|1
1158797|NCT01259713|3805654|P2|Overall Study|Subject Withdrew Consent|7
1158798|NCT01259713|3805655|P1|Overall Study|Subject Withdrew Consent|12
1158799|NCT01259713|3805654|P2|Overall Study|Protocol Violation|4
1158800|NCT01259713|3805655|P1|Overall Study|Protocol Violation|5
1158801|NCT01259713|3805654|P2|Overall Study|Lack of Efficacy|0
1158802|NCT01259713|3805655|P1|Overall Study|Lack of Efficacy|2
1158803|NCT01259713|3805654|P2|Overall Study|Investigators Discretion|6
1158804|NCT01259713|3805655|P1|Overall Study|Investigators Discretion|14
1158805|NCT01259713|3805654|P2|Overall Study|Death Not Related to IFI|1
1158806|NCT01259713|3805655|P1|Overall Study|Death Not Related to IFI|8
1158807|NCT01259713|3805654|P2|Overall Study|Adverse Event|23
1158808|NCT01259713|3805655|P1|Overall Study|Adverse Event|54
1158809|NCT01259492|3805702|P4|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7
1158810|NCT01259492|3805703|P3|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3
1158811|NCT01259492|3805704|P2|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6
1158812|NCT01259492|3805705|P1|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5
1158813|NCT01259492|3805702|P4|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
1158814|NCT01259492|3805703|P3|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1
1158815|NCT01259492|3805704|P2|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
1158816|NCT01259492|3805705|P1|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
1158817|NCT01259492|3805702|P4|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
1158818|NCT01259492|3805703|P3|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6
1158819|NCT01259492|3805704|P2|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4
1158820|NCT01259492|3805705|P1|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
1158821|NCT01259492|3805702|P4|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3
1158822|NCT01259492|3805703|P3|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4
1158823|NCT01259492|3805704|P2|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6
1158824|NCT01259492|3805705|P1|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12
1158825|NCT01259492|3805702|P4|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
1158826|NCT01259492|3805703|P3|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
1158827|NCT01259492|3805704|P2|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
1158828|NCT01259492|3805705|P1|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1
1158829|NCT01259492|3805702|P4|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62
1158830|NCT01259492|3805703|P3|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29
1158831|NCT01259492|3805704|P2|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42
1158832|NCT01259492|3805705|P1|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28
1158833|NCT01259492|3805702|P4|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
1158834|NCT01259492|3805703|P3|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1
1158835|NCT01259492|3805704|P2|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
1158836|NCT01259492|3805705|P1|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
1158837|NCT01259492|3805702|P4|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1
1158838|NCT01259492|3805703|P3|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
1158839|NCT01259492|3805704|P2|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
1158840|NCT01259492|3805705|P1|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
1158841|NCT01259492|3805702|P4|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
1158842|NCT01259492|3805703|P3|Period 3 (Week 15 to End of Week 40)|Adverse Event|6
1158843|NCT01259492|3805704|P2|Period 3 (Week 15 to End of Week 40)|Adverse Event|11
1158844|NCT01259492|3805705|P1|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
1158845|NCT01259492|3805702|P4|Period 2 (Week 10 to Week 14)|Protocol Violation|0
1158846|NCT01259492|3805703|P3|Period 2 (Week 10 to Week 14)|Protocol Violation|1
1158847|NCT01259492|3805704|P2|Period 2 (Week 10 to Week 14)|Protocol Violation|2
1158848|NCT01259492|3805705|P1|Period 2 (Week 10 to Week 14)|Protocol Violation|0
1158849|NCT01259492|3805702|P4|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
1158850|NCT01259492|3805703|P3|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1
1158851|NCT01259492|3805704|P2|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
1158852|NCT01259492|3805705|P1|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
1158853|NCT01259492|3805702|P4|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4
1158854|NCT01259492|3805703|P3|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8
1158855|NCT01259492|3805704|P2|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2
1158856|NCT01259492|3805705|P1|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6
1158857|NCT01259492|3805702|P4|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
1158858|NCT01259492|3805703|P3|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
1158859|NCT01259492|3805704|P2|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
1158860|NCT01259492|3805705|P1|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
1158861|NCT01259492|3805702|P4|Period 2 (Week 10 to Week 14)|Adverse Event|8
1158862|NCT01259492|3805703|P3|Period 2 (Week 10 to Week 14)|Adverse Event|7
1158863|NCT01259492|3805704|P2|Period 2 (Week 10 to Week 14)|Adverse Event|4
1158864|NCT01259492|3805705|P1|Period 2 (Week 10 to Week 14)|Adverse Event|3
1158865|NCT01259492|3805702|P4|Period 1 (9 Weeks)|Protocol Violation|1
1158866|NCT01259492|3805703|P3|Period 1 (9 Weeks)|Protocol Violation|3
1158867|NCT01259492|3805704|P2|Period 1 (9 Weeks)|Protocol Violation|6
1158868|NCT01259492|3805705|P1|Period 1 (9 Weeks)|Protocol Violation|5
1158869|NCT01259492|3805702|P4|Period 1 (9 Weeks)|Administrative Problems|2
1158870|NCT01259492|3805703|P3|Period 1 (9 Weeks)|Administrative Problems|1
1158871|NCT01259492|3805704|P2|Period 1 (9 Weeks)|Administrative Problems|1
1158872|NCT01259492|3805705|P1|Period 1 (9 Weeks)|Administrative Problems|0
1158873|NCT01259492|3805702|P4|Period 1 (9 Weeks)|Lost to Follow-up|4
1158874|NCT01259492|3805703|P3|Period 1 (9 Weeks)|Lost to Follow-up|3
1158875|NCT01259492|3805704|P2|Period 1 (9 Weeks)|Lost to Follow-up|6
1158876|NCT01259492|3805705|P1|Period 1 (9 Weeks)|Lost to Follow-up|4
1158877|NCT01259492|3805702|P4|Period 1 (9 Weeks)|Withdrawal by Subject|7
1158878|NCT01259492|3805703|P3|Period 1 (9 Weeks)|Withdrawal by Subject|6
1158879|NCT01259492|3805704|P2|Period 1 (9 Weeks)|Withdrawal by Subject|8
1158880|NCT01259492|3805705|P1|Period 1 (9 Weeks)|Withdrawal by Subject|5
1158881|NCT01259492|3805702|P4|Period 1 (9 Weeks)|Lack of Efficacy|11
1158882|NCT01259492|3805703|P3|Period 1 (9 Weeks)|Lack of Efficacy|4
1158883|NCT01259492|3805704|P2|Period 1 (9 Weeks)|Lack of Efficacy|2
1158884|NCT01259492|3805705|P1|Period 1 (9 Weeks)|Lack of Efficacy|2
1158885|NCT01259492|3805702|P4|Period 1 (9 Weeks)|Adverse Event|3
1158886|NCT01259492|3805703|P3|Period 1 (9 Weeks)|Adverse Event|26
1158887|NCT01259492|3805704|P2|Period 1 (9 Weeks)|Adverse Event|18
1158888|NCT01259492|3805705|P1|Period 1 (9 Weeks)|Adverse Event|13
1158889|NCT01259466|3805754|P2|Overall Study|Withdrawal by Subject|9
1158890|NCT01259466|3805755|P1|Overall Study|Withdrawal by Subject|1
1158891|NCT01259401|3805793|P2|4-month Follow-up|Lost to Follow-up|1
1158892|NCT01259401|3805794|P1|4-month Follow-up|Lost to Follow-up|0
1158893|NCT01259401|3805793|P2|4-month Follow-up|Death|1
1158894|NCT01259401|3805794|P1|4-month Follow-up|Death|0
1158895|NCT01259375|3805802|P1|Overall Study|Adverse Event|1
1158896|NCT01259297|3805819|P8|Double Blind Randomized Period|Other reasons|1
1158897|NCT01259297|3805820|P7|Double Blind Randomized Period|Other reasons|3
1158898|NCT01259297|3805821|P6|Double Blind Randomized Period|Other reasons|2
1158899|NCT01259297|3805822|P5|Double Blind Randomized Period|Other reasons|1
1158900|NCT01259297|3805823|P4|Double Blind Randomized Period|Other reasons|0
1158901|NCT01259297|3805824|P3|Double Blind Randomized Period|Other reasons|0
1158902|NCT01259297|3805825|P2|Double Blind Randomized Period|Other reasons|1
1158903|NCT01259297|3805826|P1|Double Blind Randomized Period|Other reasons|0
1158904|NCT01259297|3805819|P8|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
1158905|NCT01259297|3805820|P7|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
1158906|NCT01259297|3805821|P6|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
1158907|NCT01259297|3805822|P5|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
1158908|NCT01259297|3805823|P4|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
1158909|NCT01259297|3805824|P3|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0
1158910|NCT01259297|3805825|P2|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
1158911|NCT01259297|3805826|P1|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
1158912|NCT01259297|3805819|P8|Double Blind Randomized Period|Death|1
1158913|NCT01259297|3805820|P7|Double Blind Randomized Period|Death|2
1158914|NCT01259297|3805821|P6|Double Blind Randomized Period|Death|5
1158915|NCT01259297|3805822|P5|Double Blind Randomized Period|Death|1
1158916|NCT01259297|3805823|P4|Double Blind Randomized Period|Death|2
1158917|NCT01259297|3805824|P3|Double Blind Randomized Period|Death|1
1158918|NCT01259297|3805825|P2|Double Blind Randomized Period|Death|1
1158919|NCT01259297|3805826|P1|Double Blind Randomized Period|Death|1
1158920|NCT01259284|3805857|P3|Overall Study|Study Termination|0
1158921|NCT01259284|3805858|P2|Overall Study|Study Termination|0
1158922|NCT01259284|3805859|P1|Overall Study|Study Termination|2
1158923|NCT01259245|3805869|P2|Overall Study|Death|2
1158924|NCT01259245|3805870|P1|Overall Study|Death|1
1158925|NCT01259245|3805869|P2|Overall Study|Withdrawal by Subject|24
1158926|NCT01259245|3805870|P1|Overall Study|Withdrawal by Subject|27
1158927|NCT01259115|3805894|P2|Period 2|Adverse Event|0
1158928|NCT01259115|3805895|P1|Period 2|Adverse Event|1
1158929|NCT01259115|3805894|P2|Period 1|Lost to Follow-up|1
1158930|NCT01259115|3805895|P1|Period 1|Lost to Follow-up|0
1158931|NCT01259115|3805894|P2|Period 1|Protocol Violation|0
1158932|NCT01259115|3805895|P1|Period 1|Protocol Violation|2
1158933|NCT01259115|3805894|P2|Period 1|Adverse Event|0
1158934|NCT01259115|3805895|P1|Period 1|Adverse Event|1
1158935|NCT01259102|3805931|P5|Overall Study|Other|1
1158936|NCT01259102|3805932|P4|Overall Study|Other|1
1158937|NCT01259102|3805933|P3|Overall Study|Other|1
1158938|NCT01259102|3805934|P2|Overall Study|Other|0
1158939|NCT01259102|3805935|P1|Overall Study|Other|0
1158940|NCT01259102|3805931|P5|Overall Study|Adverse Event|0
1158941|NCT01259102|3805932|P4|Overall Study|Adverse Event|1
1158942|NCT01259102|3805933|P3|Overall Study|Adverse Event|1
1158943|NCT01259102|3805934|P2|Overall Study|Adverse Event|0
1158944|NCT01259102|3805935|P1|Overall Study|Adverse Event|1
1158945|NCT01259089|3805992|P6|Survival Follow up for Two Years|stopped being followed as study closed|4
1158946|NCT01259089|3805993|P5|Survival Follow up for Two Years|stopped being followed as study closed|0
1158947|NCT01259089|3805994|P4|Survival Follow up for Two Years|stopped being followed as study closed|0
1158948|NCT01259089|3805995|P3|Survival Follow up for Two Years|stopped being followed as study closed|0
1158949|NCT01259089|3805996|P2|Survival Follow up for Two Years|stopped being followed as study closed|0
1158950|NCT01259089|3805997|P1|Survival Follow up for Two Years|stopped being followed as study closed|0
1158951|NCT01259089|3805992|P6|Survival Follow up for Two Years|Lost to Follow-up|2
1158952|NCT01259089|3805993|P5|Survival Follow up for Two Years|Lost to Follow-up|0
1158953|NCT01259089|3805994|P4|Survival Follow up for Two Years|Lost to Follow-up|0
1158954|NCT01259089|3805995|P3|Survival Follow up for Two Years|Lost to Follow-up|0
1158955|NCT01259089|3805996|P2|Survival Follow up for Two Years|Lost to Follow-up|0
1158956|NCT01259089|3805997|P1|Survival Follow up for Two Years|Lost to Follow-up|0
1158957|NCT01259089|3805992|P6|Survival Follow up for Two Years|Death|13
1158958|NCT01259089|3805993|P5|Survival Follow up for Two Years|Death|6
1158959|NCT01259089|3805994|P4|Survival Follow up for Two Years|Death|3
1158960|NCT01259089|3805995|P3|Survival Follow up for Two Years|Death|2
1158961|NCT01259089|3805996|P2|Survival Follow up for Two Years|Death|2
1158962|NCT01259089|3805997|P1|Survival Follow up for Two Years|Death|3
1158963|NCT01259089|3805992|P6|Continued Treatment After 8 Weeks|Progressive disease|0
1158964|NCT01259089|3805993|P5|Continued Treatment After 8 Weeks|Progressive disease|0
1158965|NCT01259089|3805994|P4|Continued Treatment After 8 Weeks|Progressive disease|1
1158966|NCT01259089|3805995|P3|Continued Treatment After 8 Weeks|Progressive disease|1
1158967|NCT01259089|3805996|P2|Continued Treatment After 8 Weeks|Progressive disease|1
1158968|NCT01259089|3805997|P1|Continued Treatment After 8 Weeks|Progressive disease|1
1158969|NCT01259089|3805992|P6|Continued Treatment After 8 Weeks|Adverse Event|1
1158970|NCT01259089|3805993|P5|Continued Treatment After 8 Weeks|Adverse Event|2
1158971|NCT01259089|3805994|P4|Continued Treatment After 8 Weeks|Adverse Event|0
1158972|NCT01259089|3805995|P3|Continued Treatment After 8 Weeks|Adverse Event|0
1158973|NCT01259089|3805996|P2|Continued Treatment After 8 Weeks|Adverse Event|0
1158974|NCT01259089|3805997|P1|Continued Treatment After 8 Weeks|Adverse Event|0
1158975|NCT01259089|3805992|P6|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
1158976|NCT01259089|3805993|P5|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
1158977|NCT01259089|3805994|P4|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
1158978|NCT01259089|3805995|P3|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
1158979|NCT01259089|3805996|P2|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
1158980|NCT01259089|3805997|P1|Continued Treatment After 8 Weeks|Withdrawal by Subject|1
1158981|NCT01259089|3805992|P6|Confirmed Response at 8 Weeks|Progressive disease|7
1158982|NCT01259089|3805993|P5|Confirmed Response at 8 Weeks|Progressive disease|3
1158983|NCT01259089|3805994|P4|Confirmed Response at 8 Weeks|Progressive disease|1
1158984|NCT01259089|3805995|P3|Confirmed Response at 8 Weeks|Progressive disease|1
1158985|NCT01259089|3805996|P2|Confirmed Response at 8 Weeks|Progressive disease|0
1158986|NCT01259089|3805997|P1|Confirmed Response at 8 Weeks|Progressive disease|0
1158987|NCT01259089|3805992|P6|Confirmed Response at 8 Weeks|Adverse Event|2
1158988|NCT01259089|3805993|P5|Confirmed Response at 8 Weeks|Adverse Event|1
1158989|NCT01259089|3805994|P4|Confirmed Response at 8 Weeks|Adverse Event|0
1158990|NCT01259089|3805995|P3|Confirmed Response at 8 Weeks|Adverse Event|0
1158991|NCT01259089|3805996|P2|Confirmed Response at 8 Weeks|Adverse Event|0
1158992|NCT01259089|3805997|P1|Confirmed Response at 8 Weeks|Adverse Event|0
1158993|NCT01259089|3805992|P6|Confirmed Response at 8 Weeks|Withdrawal by Subject|1
1158994|NCT01259089|3805993|P5|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
1158995|NCT01259089|3805994|P4|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
1158996|NCT01259089|3805995|P3|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
1158997|NCT01259089|3805996|P2|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
1158998|NCT01259089|3805997|P1|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
1158999|NCT01259089|3805992|P6|Reached First Response at 4 Weeks|Adverse Event|1
1159000|NCT01259089|3805993|P5|Reached First Response at 4 Weeks|Adverse Event|0
1159001|NCT01259089|3805994|P4|Reached First Response at 4 Weeks|Adverse Event|0
1159002|NCT01259089|3805995|P3|Reached First Response at 4 Weeks|Adverse Event|0
1159003|NCT01259089|3805996|P2|Reached First Response at 4 Weeks|Adverse Event|0
1159004|NCT01259089|3805997|P1|Reached First Response at 4 Weeks|Adverse Event|0
1159005|NCT01259089|3805992|P6|Reached First Response at 4 Weeks|Patient not treated on study|1
1159006|NCT01259089|3805993|P5|Reached First Response at 4 Weeks|Patient not treated on study|0
1159007|NCT01259089|3805994|P4|Reached First Response at 4 Weeks|Patient not treated on study|0
1159008|NCT01259089|3805995|P3|Reached First Response at 4 Weeks|Patient not treated on study|0
1159009|NCT01259089|3805996|P2|Reached First Response at 4 Weeks|Patient not treated on study|0
1159010|NCT01259089|3805997|P1|Reached First Response at 4 Weeks|Patient not treated on study|0
1159011|NCT01259024|3806020|P1|Overall Study|Physician Decision|1
1159012|NCT01258998|3806040|P1|Overall Study|Ineligible|1
1159013|NCT01258803|3806073|P6|Treatment Period 3 (1 Dose)|Protocol Violation|0
1159014|NCT01258803|3806074|P5|Treatment Period 3 (1 Dose)|Protocol Violation|0
1159015|NCT01258803|3806075|P4|Treatment Period 3 (1 Dose)|Protocol Violation|0
1159016|NCT01258803|3806076|P3|Treatment Period 3 (1 Dose)|Protocol Violation|1
1159017|NCT01258803|3806077|P2|Treatment Period 3 (1 Dose)|Protocol Violation|0
1159018|NCT01258803|3806078|P1|Treatment Period 3 (1 Dose)|Protocol Violation|0
1159019|NCT01258803|3806073|P6|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
1159020|NCT01258803|3806074|P5|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
1159021|NCT01258803|3806075|P4|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
1159022|NCT01258803|3806076|P3|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
1159023|NCT01258803|3806077|P2|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1
1159024|NCT01258803|3806078|P1|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
1159025|NCT01258803|3806073|P6|Treatment Period 2 (1 Dose)|Protocol Violation|1
1159026|NCT01258803|3806074|P5|Treatment Period 2 (1 Dose)|Protocol Violation|0
1159027|NCT01258803|3806075|P4|Treatment Period 2 (1 Dose)|Protocol Violation|0
1159028|NCT01258803|3806076|P3|Treatment Period 2 (1 Dose)|Protocol Violation|0
1159029|NCT01258803|3806077|P2|Treatment Period 2 (1 Dose)|Protocol Violation|1
1159030|NCT01258803|3806078|P1|Treatment Period 2 (1 Dose)|Protocol Violation|1
1159031|NCT01258738|3806115|P2|Open-label Period|Withdrawn due to pregnancy|1
1159032|NCT01258738|3806116|P1|Open-label Period|Withdrawn due to pregnancy|1
1159033|NCT01258738|3806115|P2|Open-label Period|Other Reasons|1
1159034|NCT01258738|3806116|P1|Open-label Period|Other Reasons|0
1159035|NCT01258738|3806115|P2|Open-label Period|Adverse Event|5
1159036|NCT01258738|3806116|P1|Open-label Period|Adverse Event|4
1159037|NCT01258738|3806115|P2|Open-label Period|Protocol Violation|2
1159038|NCT01258738|3806116|P1|Open-label Period|Protocol Violation|2
1159039|NCT01258738|3806115|P2|Open-label Period|Withdrawal by Subject|6
1159040|NCT01258738|3806116|P1|Open-label Period|Withdrawal by Subject|5
1159041|NCT01258738|3806115|P2|Open-label Period|Lost to Follow-up|2
1159042|NCT01258738|3806116|P1|Open-label Period|Lost to Follow-up|0
1159043|NCT01258738|3806115|P2|Open-label Period|Insufficient clinical response|3
1159044|NCT01258738|3806116|P1|Open-label Period|Insufficient clinical response|5
1159045|NCT01258738|3806115|P2|Open-label Period|Did not meet inclusion criteria|1
1159046|NCT01258738|3806116|P1|Open-label Period|Did not meet inclusion criteria|0
1159047|NCT01258738|3806115|P2|Double-blind Period|Adverse Event|1
1159048|NCT01258738|3806116|P1|Double-blind Period|Adverse Event|3
1159049|NCT01258738|3806115|P2|Double-blind Period|Protocol Violation|1
1159050|NCT01258738|3806116|P1|Double-blind Period|Protocol Violation|1
1159051|NCT01258738|3806115|P2|Double-blind Period|Withdrawal by Subject|2
1159052|NCT01258738|3806116|P1|Double-blind Period|Withdrawal by Subject|2
1159053|NCT01258738|3806115|P2|Double-blind Period|Did not meet inclusion criteria|3
1159054|NCT01258738|3806116|P1|Double-blind Period|Did not meet inclusion criteria|3
1159055|NCT01258660|3806254|P2|Overall Study|Invalid for primary analysis data set|6
1159056|NCT01258660|3806255|P1|Overall Study|Invalid for primary analysis data set|4
1159057|NCT01258660|3806254|P2|Overall Study|Protocol Violation|1
1159058|NCT01258660|3806255|P1|Overall Study|Protocol Violation|0
1159059|NCT01258660|3806254|P2|Overall Study|due to relocation|0
1159060|NCT01258660|3806255|P1|Overall Study|due to relocation|2
1159061|NCT01258660|3806254|P2|Overall Study|Withdrawal by Subject|0
1159062|NCT01258660|3806255|P1|Overall Study|Withdrawal by Subject|3
1159063|NCT01258660|3806254|P2|Overall Study|Adverse Event|4
1159064|NCT01258660|3806255|P1|Overall Study|Adverse Event|2
1159065|NCT01258608|3806274|P2|Overall Study|Withdrawal by Subject|5
1159066|NCT01258608|3806275|P1|Overall Study|Withdrawal by Subject|6
1159067|NCT01258608|3806274|P2|Overall Study|Adverse Event|10
1159068|NCT01258608|3806275|P1|Overall Study|Adverse Event|6
1159069|NCT01258608|3806274|P2|Overall Study|Lack of Efficacy|1
1159070|NCT01258608|3806275|P1|Overall Study|Lack of Efficacy|0
1159071|NCT01258608|3806274|P2|Overall Study|Lack of compliance|0
1159072|NCT01258608|3806275|P1|Overall Study|Lack of compliance|1
1159073|NCT01258608|3806274|P2|Overall Study|Lost to Follow-up|1
1159074|NCT01258608|3806275|P1|Overall Study|Lost to Follow-up|0
1159075|NCT01258608|3806274|P2|Overall Study|Physician Decision|1
1159076|NCT01258608|3806275|P1|Overall Study|Physician Decision|6
1159077|NCT01258608|3806274|P2|Overall Study|Sponsor decision|1
1159078|NCT01258608|3806275|P1|Overall Study|Sponsor decision|0
1159079|NCT01258608|3806274|P2|Overall Study|Clinical progression|0
1159080|NCT01258608|3806275|P1|Overall Study|Clinical progression|1
1159081|NCT01258608|3806274|P2|Overall Study|Metastatic Hepatocellular Carcinoma|0
1159082|NCT01258608|3806275|P1|Overall Study|Metastatic Hepatocellular Carcinoma|1
1159083|NCT01258595|3806323|P2|Overall Study|Withdrawal by Subject|1
1159084|NCT01258595|3806324|P1|Overall Study|Withdrawal by Subject|0
1159085|NCT01258595|3806323|P2|Overall Study|Lost to Follow-up|0
1159086|NCT01258595|3806324|P1|Overall Study|Lost to Follow-up|1
1159087|NCT01258348|3806414|P5|Overall Study|Withdrawal by Subject|0
1159088|NCT01258348|3806415|P4|Overall Study|Withdrawal by Subject|0
1159089|NCT01258348|3806416|P3|Overall Study|Withdrawal by Subject|0
1159090|NCT01258348|3806417|P2|Overall Study|Withdrawal by Subject|1
1159091|NCT01258348|3806418|P1|Overall Study|Withdrawal by Subject|0
1159092|NCT01258348|3806414|P5|Overall Study|Physician Decision|0
1159093|NCT01258348|3806415|P4|Overall Study|Physician Decision|2
1159094|NCT01258348|3806416|P3|Overall Study|Physician Decision|0
1159095|NCT01258348|3806417|P2|Overall Study|Physician Decision|0
1159096|NCT01258348|3806418|P1|Overall Study|Physician Decision|0
1159097|NCT01258348|3806414|P5|Overall Study|Progressive Disease|2
1159098|NCT01258348|3806415|P4|Overall Study|Progressive Disease|2
1159099|NCT01258348|3806416|P3|Overall Study|Progressive Disease|0
1159100|NCT01258348|3806417|P2|Overall Study|Progressive Disease|3
1159101|NCT01258348|3806418|P1|Overall Study|Progressive Disease|0
1159102|NCT01258348|3806414|P5|Overall Study|Adverse Event|4
1159103|NCT01258348|3806415|P4|Overall Study|Adverse Event|2
1159104|NCT01258348|3806416|P3|Overall Study|Adverse Event|3
1159105|NCT01258348|3806417|P2|Overall Study|Adverse Event|1
1159106|NCT01258348|3806418|P1|Overall Study|Adverse Event|1
1159107|NCT01258101|3806475|P4|Overall Study|Other reason|8
1159108|NCT01258101|3806476|P3|Overall Study|Other reason|1
1159109|NCT01258101|3806477|P2|Overall Study|Other reason|8
1159110|NCT01258101|3806478|P1|Overall Study|Other reason|7
1159111|NCT01258101|3806475|P4|Overall Study|PCR positive at week 24|1
1159112|NCT01258101|3806476|P3|Overall Study|PCR positive at week 24|0
1159113|NCT01258101|3806477|P2|Overall Study|PCR positive at week 24|0
1159114|NCT01258101|3806478|P1|Overall Study|PCR positive at week 24|0
1159115|NCT01258101|3806475|P4|Overall Study|Lost to Follow-up|6
1159116|NCT01258101|3806476|P3|Overall Study|Lost to Follow-up|0
1159117|NCT01258101|3806477|P2|Overall Study|Lost to Follow-up|5
1159118|NCT01258101|3806478|P1|Overall Study|Lost to Follow-up|5
1159119|NCT01258101|3806475|P4|Overall Study|Patient´s compliance|2
1159120|NCT01258101|3806476|P3|Overall Study|Patient´s compliance|1
1159121|NCT01258101|3806477|P2|Overall Study|Patient´s compliance|3
1159122|NCT01258101|3806478|P1|Overall Study|Patient´s compliance|4
1159123|NCT01258101|3806475|P4|Overall Study|Patient is not able to attend visits|6
1159124|NCT01258101|3806476|P3|Overall Study|Patient is not able to attend visits|7
1159125|NCT01258101|3806477|P2|Overall Study|Patient is not able to attend visits|9
1159126|NCT01258101|3806478|P1|Overall Study|Patient is not able to attend visits|8
1159127|NCT01258101|3806475|P4|Overall Study|Informed consent has been withdrawn|1
1159128|NCT01258101|3806476|P3|Overall Study|Informed consent has been withdrawn|1
1159129|NCT01258101|3806477|P2|Overall Study|Informed consent has been withdrawn|2
1159130|NCT01258101|3806478|P1|Overall Study|Informed consent has been withdrawn|2
1159131|NCT01258101|3806475|P4|Overall Study|Extra exclusion criterion amended|1
1159132|NCT01258101|3806476|P3|Overall Study|Extra exclusion criterion amended|1
1159133|NCT01258101|3806477|P2|Overall Study|Extra exclusion criterion amended|1
1159134|NCT01258101|3806478|P1|Overall Study|Extra exclusion criterion amended|2
1159135|NCT01258101|3806475|P4|Overall Study|Adverse Event|0
1159136|NCT01258101|3806476|P3|Overall Study|Adverse Event|0
1159137|NCT01258101|3806477|P2|Overall Study|Adverse Event|6
1159138|NCT01258101|3806478|P1|Overall Study|Adverse Event|5
1159139|NCT01257737|3806608|P2|Overall Study|Withdrew from study|1
1159140|NCT01257737|3806609|P1|Overall Study|Withdrew from study|0
1159141|NCT01257737|3806608|P2|Overall Study|Relocation out of the country|1
1159142|NCT01257737|3806609|P1|Overall Study|Relocation out of the country|0
1159143|NCT01257737|3806608|P2|Overall Study|Liver transplant|0
1159144|NCT01257737|3806609|P1|Overall Study|Liver transplant|1
1159145|NCT01257737|3806608|P2|Overall Study|Lost to Follow-up|2
1159146|NCT01257737|3806609|P1|Overall Study|Lost to Follow-up|1
1159147|NCT01257581|3806630|P3|Overall Study|Death|4
1159148|NCT01257581|3806631|P2|Overall Study|Death|2
1159149|NCT01257581|3806632|P1|Overall Study|Death|2
1159150|NCT01257581|3806630|P3|Overall Study|Early Termination|2
1159151|NCT01257581|3806631|P2|Overall Study|Early Termination|1
1159152|NCT01257581|3806632|P1|Overall Study|Early Termination|3
1159153|NCT01257542|3806672|P2|Overall Study|Withdrawal by Subject|2
1159154|NCT01257542|3806673|P1|Overall Study|Withdrawal by Subject|0
1159155|NCT01257542|3806672|P2|Overall Study|Protocol Violation|5
1159156|NCT01257542|3806673|P1|Overall Study|Protocol Violation|3
1159157|NCT01257503|3806693|P2|Overall Study|strep culture positive at enrollment|0
1159158|NCT01257503|3806694|P1|Overall Study|strep culture positive at enrollment|1
1159159|NCT01257503|3806693|P2|Overall Study|Over 5 years old at enrollment|1
1159160|NCT01257503|3806694|P1|Overall Study|Over 5 years old at enrollment|0
1159161|NCT01257503|3806693|P2|Overall Study|Lost to Follow-up|10
1159162|NCT01257503|3806694|P1|Overall Study|Lost to Follow-up|7
1159163|NCT01257425|3806723|P2|Overall Study|Death|0
1159164|NCT01257425|3806724|P1|Overall Study|Death|1
1159165|NCT01257425|3806723|P2|Overall Study|Withdrawal by Subject|1
1159166|NCT01257425|3806724|P1|Overall Study|Withdrawal by Subject|0
1159167|NCT01257425|3806723|P2|Overall Study|Protocol Violation|1
1159168|NCT01257425|3806724|P1|Overall Study|Protocol Violation|1
1159169|NCT01257425|3806723|P2|Overall Study|Adverse Event|1
1159170|NCT01257425|3806724|P1|Overall Study|Adverse Event|1
1159171|NCT01257425|3806723|P2|Overall Study|Lack of Efficacy|3
1159172|NCT01257425|3806724|P1|Overall Study|Lack of Efficacy|3
1159173|NCT01257230|3806766|P3|Overall Study|Other reason not defined above|3
1159174|NCT01257230|3806767|P2|Overall Study|Other reason not defined above|5
1159175|NCT01257230|3806768|P1|Overall Study|Other reason not defined above|1
1159176|NCT01257230|3806766|P3|Overall Study|Withdrawal by Subject|1
1159177|NCT01257230|3806767|P2|Overall Study|Withdrawal by Subject|4
1159178|NCT01257230|3806768|P1|Overall Study|Withdrawal by Subject|0
1159179|NCT01257230|3806766|P3|Overall Study|Protocol Violation|1
1159180|NCT01257230|3806767|P2|Overall Study|Protocol Violation|0
1159181|NCT01257230|3806768|P1|Overall Study|Protocol Violation|3
1159182|NCT01257230|3806766|P3|Overall Study|Lack of Efficacy|0
1159183|NCT01257230|3806767|P2|Overall Study|Lack of Efficacy|1
1159184|NCT01257230|3806768|P1|Overall Study|Lack of Efficacy|0
1159185|NCT01257230|3806766|P3|Overall Study|Adverse Event|0
1159186|NCT01257230|3806767|P2|Overall Study|Adverse Event|0
1159187|NCT01257230|3806768|P1|Overall Study|Adverse Event|2
1159188|NCT01257230|3806766|P3|Overall Study|Not Treated|1
1159189|NCT01257230|3806767|P2|Overall Study|Not Treated|0
1159190|NCT01257230|3806768|P1|Overall Study|Not Treated|0
1159191|NCT01257204|3806845|P3|Follow-up Period (up to Week 48)|Other|5
1159192|NCT01257204|3806846|P2|Follow-up Period (up to Week 48)|Other|0
1159193|NCT01257204|3806847|P1|Follow-up Period (up to Week 48)|Other|0
1159194|NCT01257204|3806845|P3|Follow-up Period (up to Week 48)|Lost to Follow-up|4
1159195|NCT01257204|3806846|P2|Follow-up Period (up to Week 48)|Lost to Follow-up|4
1159196|NCT01257204|3806847|P1|Follow-up Period (up to Week 48)|Lost to Follow-up|1
1159197|NCT01257204|3806845|P3|Follow-up Period (up to Week 48)|Withdrawal by Subject|1
1159198|NCT01257204|3806846|P2|Follow-up Period (up to Week 48)|Withdrawal by Subject|2
1159199|NCT01257204|3806847|P1|Follow-up Period (up to Week 48)|Withdrawal by Subject|0
1159200|NCT01257204|3806845|P3|Treatment Period (up to Week 24)|Participant's request to discontinue|2
1159201|NCT01257204|3806846|P2|Treatment Period (up to Week 24)|Participant's request to discontinue|2
1159202|NCT01257204|3806847|P1|Treatment Period (up to Week 24)|Participant's request to discontinue|1
1159203|NCT01257204|3806845|P3|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1
1159204|NCT01257204|3806846|P2|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
1159205|NCT01257204|3806847|P1|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
1159206|NCT01257204|3806845|P3|Treatment Period (up to Week 24)|Lost to Follow-up|0
1159207|NCT01257204|3806846|P2|Treatment Period (up to Week 24)|Lost to Follow-up|2
1159208|NCT01257204|3806847|P1|Treatment Period (up to Week 24)|Lost to Follow-up|0
1159209|NCT01257204|3806845|P3|Treatment Period (up to Week 24)|Withdrawal by Subject|1
1159210|NCT01257204|3806846|P2|Treatment Period (up to Week 24)|Withdrawal by Subject|0
1159211|NCT01257204|3806847|P1|Treatment Period (up to Week 24)|Withdrawal by Subject|1
1159212|NCT01257204|3806845|P3|Treatment Period (up to Week 24)|Adverse Event|2
1159213|NCT01257204|3806846|P2|Treatment Period (up to Week 24)|Adverse Event|1
1159214|NCT01257204|3806847|P1|Treatment Period (up to Week 24)|Adverse Event|3
1159215|NCT01257204|3806845|P3|Treatment Period (up to Week 24)|Lack of Efficacy|3
1159216|NCT01257204|3806846|P2|Treatment Period (up to Week 24)|Lack of Efficacy|1
1159217|NCT01257204|3806847|P1|Treatment Period (up to Week 24)|Lack of Efficacy|0
1159218|NCT01256684|3806958|P3|Overall Study|Entry criteria not met/non-compliance|6
1159219|NCT01256684|3806959|P2|Overall Study|Entry criteria not met/non-compliance|7
1159220|NCT01256684|3806960|P1|Overall Study|Entry criteria not met/non-compliance|4
1159221|NCT01256684|3806958|P3|Overall Study|Lack of Efficacy|1
1159222|NCT01256684|3806959|P2|Overall Study|Lack of Efficacy|1
1159223|NCT01256684|3806960|P1|Overall Study|Lack of Efficacy|0
1159224|NCT01256684|3806958|P3|Overall Study|Physician Decision|0
1159225|NCT01256684|3806959|P2|Overall Study|Physician Decision|1
1159226|NCT01256684|3806960|P1|Overall Study|Physician Decision|0
1159227|NCT01256684|3806958|P3|Overall Study|Withdrawal by Subject|2
1159228|NCT01256684|3806959|P2|Overall Study|Withdrawal by Subject|0
1159229|NCT01256684|3806960|P1|Overall Study|Withdrawal by Subject|4
1159230|NCT01256684|3806958|P3|Overall Study|Adverse Event|2
1159231|NCT01256684|3806959|P2|Overall Study|Adverse Event|4
1159232|NCT01256684|3806960|P1|Overall Study|Adverse Event|1
1159233|NCT01256671|3806992|P1|Overall Study|Non-compliance/Sponsor Decision/Other|12
1159234|NCT01256671|3806992|P1|Overall Study|Lack of Efficacy|4
1159235|NCT01256671|3806992|P1|Overall Study|Physician Decision|3
1159236|NCT01256671|3806992|P1|Overall Study|Withdrawal by Subject|31
1159237|NCT01256671|3806992|P1|Overall Study|Lost to Follow-up|16
1159238|NCT01256671|3806992|P1|Overall Study|Adverse Event|29
1159239|NCT01256658|3807005|P2|Period 1|Death|44
1159240|NCT01256658|3807006|P1|Period 1|Death|48
1159241|NCT01256658|3807005|P2|Period 1|Withdrawal by Subject|43
1159242|NCT01256658|3807006|P1|Period 1|Withdrawal by Subject|35
1159243|NCT01256658|3807005|P2|Period 1|Lost to Follow-up|661
1159244|NCT01256658|3807006|P1|Period 1|Lost to Follow-up|837
1159245|NCT01256567|3807056|P1|Overall Study|Withdrawal by Subject|1
1159246|NCT01256502|3807066|P1|Overall Study|Protocol deviation|1
1159247|NCT01256502|3807066|P1|Overall Study|Personal reasons|5
1159248|NCT01256502|3807066|P1|Overall Study|Had scaffold removed|4
1159249|NCT01256476|3807078|P2|Overall Study|LDL-C elevation exceeding 250 mg/dL|1
1159250|NCT01256476|3807079|P1|Overall Study|LDL-C elevation exceeding 250 mg/dL|0
1159251|NCT01256476|3807078|P2|Overall Study|Subject non-compliance|1
1159252|NCT01256476|3807079|P1|Overall Study|Subject non-compliance|0
1159253|NCT01256476|3807078|P2|Overall Study|Physician Decision|1
1159254|NCT01256476|3807079|P1|Overall Study|Physician Decision|0
1159255|NCT01256476|3807078|P2|Overall Study|Persistent ALT or AST elevation|0
1159256|NCT01256476|3807079|P1|Overall Study|Persistent ALT or AST elevation|1
1159257|NCT01256476|3807078|P2|Overall Study|Lost to Follow-up|2
1159258|NCT01256476|3807079|P1|Overall Study|Lost to Follow-up|1
1159259|NCT01256476|3807078|P2|Overall Study|Withdrawal by Subject|1
1159260|NCT01256476|3807079|P1|Overall Study|Withdrawal by Subject|2
1159261|NCT01256476|3807078|P2|Overall Study|Adverse Event|1
1159262|NCT01256476|3807079|P1|Overall Study|Adverse Event|2
1159263|NCT01256450|3807087|P3|Double-blind Treatment|Not specified|12
1159264|NCT01256450|3807088|P2|Double-blind Treatment|Not specified|9
1159265|NCT01256450|3807089|P1|Double-blind Treatment|Not specified|0
1159266|NCT01256450|3807087|P3|Double-blind Treatment|Opioid withdrawal symptoms|1
1159267|NCT01256450|3807088|P2|Double-blind Treatment|Opioid withdrawal symptoms|0
1159268|NCT01256450|3807089|P1|Double-blind Treatment|Opioid withdrawal symptoms|0
1159269|NCT01256450|3807087|P3|Double-blind Treatment|Non-compliance|4
1159270|NCT01256450|3807088|P2|Double-blind Treatment|Non-compliance|5
1159271|NCT01256450|3807089|P1|Double-blind Treatment|Non-compliance|0
1159272|NCT01256450|3807087|P3|Double-blind Treatment|Lack of analgesic effect|6
1159273|NCT01256450|3807088|P2|Double-blind Treatment|Lack of analgesic effect|5
1159274|NCT01256450|3807089|P1|Double-blind Treatment|Lack of analgesic effect|0
1159275|NCT01256450|3807087|P3|Double-blind Treatment|Withdrawal by Subject|1
1159276|NCT01256450|3807088|P2|Double-blind Treatment|Withdrawal by Subject|0
1159277|NCT01256450|3807089|P1|Double-blind Treatment|Withdrawal by Subject|0
1159278|NCT01256450|3807087|P3|Double-blind Treatment|Lost to Follow-up|7
1159279|NCT01256450|3807088|P2|Double-blind Treatment|Lost to Follow-up|1
1159280|NCT01256450|3807089|P1|Double-blind Treatment|Lost to Follow-up|0
1159281|NCT01256450|3807087|P3|Double-blind Treatment|Adverse Event|6
1159282|NCT01256450|3807088|P2|Double-blind Treatment|Adverse Event|8
1159283|NCT01256450|3807089|P1|Double-blind Treatment|Adverse Event|0
1159284|NCT01256450|3807087|P3|Open-label Titration|Not specified|0
1159285|NCT01256450|3807088|P2|Open-label Titration|Not specified|0
1159286|NCT01256450|3807089|P1|Open-label Titration|Not specified|13
1159287|NCT01256450|3807087|P3|Open-label Titration|Screen failure|0
1159288|NCT01256450|3807088|P2|Open-label Titration|Screen failure|0
1159289|NCT01256450|3807089|P1|Open-label Titration|Screen failure|1
1159290|NCT01256450|3807087|P3|Open-label Titration|Non-compliance|0
1159291|NCT01256450|3807088|P2|Open-label Titration|Non-compliance|0
1159292|NCT01256450|3807089|P1|Open-label Titration|Non-compliance|9
1159293|NCT01256450|3807087|P3|Open-label Titration|Lack of analgesic effect|0
1159294|NCT01256450|3807088|P2|Open-label Titration|Lack of analgesic effect|0
1159295|NCT01256450|3807089|P1|Open-label Titration|Lack of analgesic effect|30
1159296|NCT01256450|3807087|P3|Open-label Titration|Lost to Follow-up|0
1159297|NCT01256450|3807088|P2|Open-label Titration|Lost to Follow-up|0
1159298|NCT01256450|3807089|P1|Open-label Titration|Lost to Follow-up|7
1159299|NCT01256450|3807087|P3|Open-label Titration|Adverse Event|0
1159300|NCT01256450|3807088|P2|Open-label Titration|Adverse Event|0
1159301|NCT01256450|3807089|P1|Open-label Titration|Adverse Event|39
1159302|NCT01256411|3807147|P6|Extension by Mono or Combination Therapy|Lack of Efficacy|1
1159303|NCT01256411|3807148|P5|Extension by Mono or Combination Therapy|Lack of Efficacy|1
1159304|NCT01256411|3807149|P4|Extension by Mono or Combination Therapy|Lack of Efficacy|0
1159305|NCT01256411|3807150|P3|Extension by Mono or Combination Therapy|Lack of Efficacy|0
1159306|NCT01256411|3807151|P2|Extension by Mono or Combination Therapy|Lack of Efficacy|0
1159307|NCT01256411|3807152|P1|Extension by Mono or Combination Therapy|Lack of Efficacy|0
1159308|NCT01256411|3807147|P6|Extension by Mono or Combination Therapy|Withdrawal by Subject|1
1159309|NCT01256411|3807148|P5|Extension by Mono or Combination Therapy|Withdrawal by Subject|7
1159310|NCT01256411|3807149|P4|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
1159311|NCT01256411|3807150|P3|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
1159312|NCT01256411|3807151|P2|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
1159313|NCT01256411|3807152|P1|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
1159314|NCT01256411|3807147|P6|Extension by Mono or Combination Therapy|Lost to Follow-up|0
1159315|NCT01256411|3807148|P5|Extension by Mono or Combination Therapy|Lost to Follow-up|3
1159316|NCT01256411|3807149|P4|Extension by Mono or Combination Therapy|Lost to Follow-up|0
1159317|NCT01256411|3807150|P3|Extension by Mono or Combination Therapy|Lost to Follow-up|0
1159318|NCT01256411|3807151|P2|Extension by Mono or Combination Therapy|Lost to Follow-up|0
1159319|NCT01256411|3807152|P1|Extension by Mono or Combination Therapy|Lost to Follow-up|0
1159320|NCT01256411|3807147|P6|Extension by Mono or Combination Therapy|Protocol deviation|1
1159321|NCT01256411|3807148|P5|Extension by Mono or Combination Therapy|Protocol deviation|0
1159322|NCT01256411|3807149|P4|Extension by Mono or Combination Therapy|Protocol deviation|0
1159323|NCT01256411|3807150|P3|Extension by Mono or Combination Therapy|Protocol deviation|0
1159324|NCT01256411|3807151|P2|Extension by Mono or Combination Therapy|Protocol deviation|0
1159325|NCT01256411|3807152|P1|Extension by Mono or Combination Therapy|Protocol deviation|0
1159326|NCT01256411|3807147|P6|Extension by Mono or Combination Therapy|Adverse Event|1
1159327|NCT01256411|3807148|P5|Extension by Mono or Combination Therapy|Adverse Event|6
1159328|NCT01256411|3807149|P4|Extension by Mono or Combination Therapy|Adverse Event|0
1159329|NCT01256411|3807150|P3|Extension by Mono or Combination Therapy|Adverse Event|0
1159330|NCT01256411|3807151|P2|Extension by Mono or Combination Therapy|Adverse Event|0
1159331|NCT01256411|3807152|P1|Extension by Mono or Combination Therapy|Adverse Event|0
1159332|NCT01256411|3807147|P6|Extension by Maximum Treatment|Adverse Event|0
1159333|NCT01256411|3807148|P5|Extension by Maximum Treatment|Adverse Event|0
1159334|NCT01256411|3807149|P4|Extension by Maximum Treatment|Adverse Event|0
1159335|NCT01256411|3807150|P3|Extension by Maximum Treatment|Adverse Event|1
1159336|NCT01256411|3807151|P2|Extension by Maximum Treatment|Adverse Event|2
1159337|NCT01256411|3807152|P1|Extension by Maximum Treatment|Adverse Event|4
1159338|NCT01256411|3807147|P6|Extension by Maximum Treatment|Lack of Efficacy|0
1159339|NCT01256411|3807148|P5|Extension by Maximum Treatment|Lack of Efficacy|0
1159340|NCT01256411|3807149|P4|Extension by Maximum Treatment|Lack of Efficacy|0
1159341|NCT01256411|3807150|P3|Extension by Maximum Treatment|Lack of Efficacy|1
1159342|NCT01256411|3807151|P2|Extension by Maximum Treatment|Lack of Efficacy|0
1159343|NCT01256411|3807152|P1|Extension by Maximum Treatment|Lack of Efficacy|1
1159344|NCT01256411|3807147|P6|Extension by Maximum Treatment|Withdrawal by Subject|0
1159345|NCT01256411|3807148|P5|Extension by Maximum Treatment|Withdrawal by Subject|0
1159346|NCT01256411|3807149|P4|Extension by Maximum Treatment|Withdrawal by Subject|0
1159347|NCT01256411|3807150|P3|Extension by Maximum Treatment|Withdrawal by Subject|1
1159348|NCT01256411|3807151|P2|Extension by Maximum Treatment|Withdrawal by Subject|6
1159349|NCT01256411|3807152|P1|Extension by Maximum Treatment|Withdrawal by Subject|1
1159350|NCT01256411|3807147|P6|Extension by Maximum Treatment|Lost to Follow-up|0
1159351|NCT01256411|3807148|P5|Extension by Maximum Treatment|Lost to Follow-up|0
1159352|NCT01256411|3807149|P4|Extension by Maximum Treatment|Lost to Follow-up|0
1159353|NCT01256411|3807150|P3|Extension by Maximum Treatment|Lost to Follow-up|0
1159354|NCT01256411|3807151|P2|Extension by Maximum Treatment|Lost to Follow-up|2
1159355|NCT01256411|3807152|P1|Extension by Maximum Treatment|Lost to Follow-up|1
1159356|NCT01256411|3807147|P6|Extension by Maximum Treatment|Protocol deviation|0
1159357|NCT01256411|3807148|P5|Extension by Maximum Treatment|Protocol deviation|0
1159358|NCT01256411|3807149|P4|Extension by Maximum Treatment|Protocol deviation|0
1159359|NCT01256411|3807150|P3|Extension by Maximum Treatment|Protocol deviation|1
1159360|NCT01256411|3807151|P2|Extension by Maximum Treatment|Protocol deviation|0
1159361|NCT01256411|3807152|P1|Extension by Maximum Treatment|Protocol deviation|0
1159362|NCT01256385|3807178|P2|Overall Study|Withdrawal by Subject|2
1159363|NCT01256385|3807179|P1|Overall Study|Withdrawal by Subject|2
1159364|NCT01256385|3807178|P2|Overall Study|Physician Decision|1
1159365|NCT01256385|3807179|P1|Overall Study|Physician Decision|1
1159366|NCT01256294|3807199|P2|Overall Study|Protocol deviation|1
1159367|NCT01256294|3807200|P1|Overall Study|Protocol deviation|2
1159368|NCT01256294|3807199|P2|Overall Study|Withdrawal by Subject|1
1159369|NCT01256294|3807200|P1|Overall Study|Withdrawal by Subject|1
1159370|NCT01256294|3807199|P2|Overall Study|Adverse Event|0
1159371|NCT01256294|3807200|P1|Overall Study|Adverse Event|1
1159372|NCT01256190|3807222|P2|Overall Study|Lost to Follow-up|0
1159373|NCT01256190|3807223|P1|Overall Study|Lost to Follow-up|2
1159374|NCT01256177|3807239|P2|Overall Study|TG=593mg/dL, not fit to participate.|0
1159375|NCT01256177|3807240|P1|Overall Study|TG=593mg/dL, not fit to participate.|1
1159376|NCT01256177|3807239|P2|Overall Study|Lack of Efficacy|2
1159377|NCT01256177|3807240|P1|Overall Study|Lack of Efficacy|11
1159378|NCT01256177|3807239|P2|Overall Study|Condition under Investigation Worsened|0
1159379|NCT01256177|3807240|P1|Overall Study|Condition under Investigation Worsened|1
1159380|NCT01256177|3807239|P2|Overall Study|Severe Non-Compliance to Protocol|2
1159381|NCT01256177|3807240|P1|Overall Study|Severe Non-Compliance to Protocol|4
1159382|NCT01256177|3807239|P2|Overall Study|Adverse Event|9
1159383|NCT01256177|3807240|P1|Overall Study|Adverse Event|8
1159384|NCT01256177|3807239|P2|Overall Study|Lost to Follow-up|2
1159385|NCT01256177|3807240|P1|Overall Study|Lost to Follow-up|2
1159386|NCT01256177|3807239|P2|Overall Study|Withdrawal by Subject|22
1159387|NCT01256177|3807240|P1|Overall Study|Withdrawal by Subject|23
1159388|NCT01256060|3807296|P4|Overall Study|Lost to Follow-up|0
1159389|NCT01256060|3807297|P3|Overall Study|Lost to Follow-up|0
1159390|NCT01256060|3807298|P2|Overall Study|Lost to Follow-up|1
1159391|NCT01256060|3807299|P1|Overall Study|Lost to Follow-up|0
1159392|NCT01256008|3807318|P3|Overall Study|Withdrawal by Subject|10
1159393|NCT01256008|3807319|P2|Overall Study|Withdrawal by Subject|3
1159394|NCT01256008|3807320|P1|Overall Study|Withdrawal by Subject|2
1159395|NCT01256008|3807318|P3|Overall Study|Lost to Follow-up|11
1159396|NCT01256008|3807319|P2|Overall Study|Lost to Follow-up|4
1159397|NCT01256008|3807320|P1|Overall Study|Lost to Follow-up|6
1159398|NCT01255904|3807342|P2|Overall Study|Physician Decision|4
1159399|NCT01255904|3807343|P1|Overall Study|Physician Decision|1
1159400|NCT01255787|3807353|P4|Overall Study|Noncompliance with Study Drug|0
1159401|NCT01255787|3807354|P3|Overall Study|Noncompliance with Study Drug|0
1159402|NCT01255787|3807355|P2|Overall Study|Noncompliance with Study Drug|1
1159403|NCT01255787|3807356|P1|Overall Study|Noncompliance with Study Drug|3
1159404|NCT01255787|3807353|P4|Overall Study|Lack of Efficacy|2
1159405|NCT01255787|3807354|P3|Overall Study|Lack of Efficacy|2
1159406|NCT01255787|3807355|P2|Overall Study|Lack of Efficacy|2
1159407|NCT01255787|3807356|P1|Overall Study|Lack of Efficacy|2
1159408|NCT01255787|3807353|P4|Overall Study|Pregnancy|1
1159409|NCT01255787|3807354|P3|Overall Study|Pregnancy|0
1159410|NCT01255787|3807355|P2|Overall Study|Pregnancy|0
1159411|NCT01255787|3807356|P1|Overall Study|Pregnancy|0
1159412|NCT01255787|3807353|P4|Overall Study|Withdrawal of Consent|4
1159413|NCT01255787|3807354|P3|Overall Study|Withdrawal of Consent|3
1159414|NCT01255787|3807355|P2|Overall Study|Withdrawal of Consent|9
1159415|NCT01255787|3807356|P1|Overall Study|Withdrawal of Consent|3
1159416|NCT01255787|3807353|P4|Overall Study|Lost to Follow-up|2
1159417|NCT01255787|3807354|P3|Overall Study|Lost to Follow-up|4
1159418|NCT01255787|3807355|P2|Overall Study|Lost to Follow-up|2
1159419|NCT01255787|3807356|P1|Overall Study|Lost to Follow-up|1
1159420|NCT01255787|3807353|P4|Overall Study|Major Protocol Deviation|4
1159421|NCT01255787|3807354|P3|Overall Study|Major Protocol Deviation|0
1159422|NCT01255787|3807355|P2|Overall Study|Major Protocol Deviation|1
1159423|NCT01255787|3807356|P1|Overall Study|Major Protocol Deviation|1
1159424|NCT01255787|3807353|P4|Overall Study|Pretreatment Event or Adverse Event (AE)|9
1159425|NCT01255787|3807354|P3|Overall Study|Pretreatment Event or Adverse Event (AE)|9
1159426|NCT01255787|3807355|P2|Overall Study|Pretreatment Event or Adverse Event (AE)|2
1159427|NCT01255787|3807356|P1|Overall Study|Pretreatment Event or Adverse Event (AE)|6
1159428|NCT01255761|3807384|P2|Overall Study|Other Reasons|18
1159429|NCT01255761|3807385|P1|Overall Study|Other Reasons|37
1159430|NCT01255761|3807384|P2|Overall Study|Withdrawal by Subject|27
1159431|NCT01255761|3807385|P1|Overall Study|Withdrawal by Subject|11
1159432|NCT01255761|3807384|P2|Overall Study|Lost to Follow-up|8
1159433|NCT01255761|3807385|P1|Overall Study|Lost to Follow-up|10
1159434|NCT01255761|3807384|P2|Overall Study|Protocol Violation|5
1159435|NCT01255761|3807385|P1|Overall Study|Protocol Violation|9
1159436|NCT01255761|3807384|P2|Overall Study|Lack of Efficacy|74
1159437|NCT01255761|3807385|P1|Overall Study|Lack of Efficacy|86
1159438|NCT01255761|3807384|P2|Overall Study|Adverse Event|43
1159439|NCT01255761|3807385|P1|Overall Study|Adverse Event|29
1159440|NCT01255722|3807470|P3|Overall Study|beta-blocker contraindicated|0
1159441|NCT01255722|3807471|P2|Overall Study|beta-blocker contraindicated|0
1159442|NCT01255722|3807472|P1|Overall Study|beta-blocker contraindicated|2
1159443|NCT01255722|3807470|P3|Overall Study|asymptomatic patient|0
1159444|NCT01255722|3807471|P2|Overall Study|asymptomatic patient|0
1159445|NCT01255722|3807472|P1|Overall Study|asymptomatic patient|1
1159446|NCT01255722|3807470|P3|Overall Study|Adverse Event|1
1159447|NCT01255722|3807471|P2|Overall Study|Adverse Event|1
1159448|NCT01255722|3807472|P1|Overall Study|Adverse Event|0
1159449|NCT01255631|3807497|P2|Overall Study|poor enrollment, no data analyzed|6
1159450|NCT01255631|3807498|P1|Overall Study|poor enrollment, no data analyzed|9
1159451|NCT01255592|3807516|P2|Overall Study|Other|1
1159452|NCT01255592|3807517|P1|Overall Study|Other|0
1159453|NCT01255592|3807516|P2|Overall Study|Withdrawal by Subject|0
1159454|NCT01255592|3807517|P1|Overall Study|Withdrawal by Subject|1
1159455|NCT01255592|3807516|P2|Overall Study|Adverse Event|0
1159456|NCT01255592|3807517|P1|Overall Study|Adverse Event|5
1159457|NCT01255436|3807580|P2|Overall Study|Death, stroke, or MI|3
1159458|NCT01255436|3807581|P1|Overall Study|Death, stroke, or MI|4
1159459|NCT01255436|3807580|P2|Overall Study|Lost to Follow-up|191
1159460|NCT01255436|3807581|P1|Overall Study|Lost to Follow-up|178
1159461|NCT01255423|3807595|P2|Overall Study|Use of prohibited medications|1
1159462|NCT01255423|3807596|P1|Overall Study|Use of prohibited medications|0
1159463|NCT01255423|3807595|P2|Overall Study|Abnormal Laboratory value|2
1159464|NCT01255423|3807596|P1|Overall Study|Abnormal Laboratory value|3
1159465|NCT01255306|3807612|P2|Overall Study|Physician Decision|1
1159466|NCT01255306|3807613|P1|Overall Study|Physician Decision|1
1159467|NCT01255163|3807624|P2|Overall Study|AstraZeneca stopped support of the study|3
1159468|NCT01255163|3807625|P1|Overall Study|AstraZeneca stopped support of the study|1
1159469|NCT01255163|3807624|P2|Overall Study|Adverse Event|2
1159470|NCT01255163|3807625|P1|Overall Study|Adverse Event|0
1159471|NCT01255163|3807624|P2|Overall Study|Lost to Follow-up|0
1159472|NCT01255163|3807625|P1|Overall Study|Lost to Follow-up|2
1159473|NCT01255163|3807624|P2|Overall Study|Withdrawal by Subject|0
1159474|NCT01255163|3807625|P1|Overall Study|Withdrawal by Subject|1
1159475|NCT01254890|3807654|P2|Overall Study|Disease Progression|5
1159476|NCT01254890|3807655|P1|Overall Study|Disease Progression|0
1159477|NCT01254890|3807654|P2|Overall Study|Withdrawal by Subject|2
1159478|NCT01254890|3807655|P1|Overall Study|Withdrawal by Subject|1
1159479|NCT01254890|3807654|P2|Overall Study|Ineligible|3
1159480|NCT01254890|3807655|P1|Overall Study|Ineligible|0
1159481|NCT01254747|3807717|P4|Overall Study|Discomfort|0
1159482|NCT01254747|3807718|P3|Overall Study|Discomfort|0
1159483|NCT01254747|3807719|P2|Overall Study|Discomfort|4
1159484|NCT01254747|3807720|P1|Overall Study|Discomfort|0
1159485|NCT01254747|3807717|P4|Overall Study|Biomicroscopy|0
1159486|NCT01254747|3807718|P3|Overall Study|Biomicroscopy|1
1159487|NCT01254747|3807719|P2|Overall Study|Biomicroscopy|0
1159488|NCT01254747|3807720|P1|Overall Study|Biomicroscopy|0
1159489|NCT01254747|3807717|P4|Overall Study|Lost to Follow-up|0
1159490|NCT01254747|3807718|P3|Overall Study|Lost to Follow-up|1
1159491|NCT01254747|3807719|P2|Overall Study|Lost to Follow-up|0
1159492|NCT01254747|3807720|P1|Overall Study|Lost to Follow-up|0
1159493|NCT01254747|3807717|P4|Overall Study|Symptoms and problems|0
1159494|NCT01254747|3807718|P3|Overall Study|Symptoms and problems|1
1159495|NCT01254747|3807719|P2|Overall Study|Symptoms and problems|2
1159496|NCT01254747|3807720|P1|Overall Study|Symptoms and problems|0
1159497|NCT01254747|3807717|P4|Overall Study|Difficult removal handling|0
1159498|NCT01254747|3807718|P3|Overall Study|Difficult removal handling|1
1159499|NCT01254747|3807719|P2|Overall Study|Difficult removal handling|0
1159500|NCT01254747|3807720|P1|Overall Study|Difficult removal handling|0
1159501|NCT01254747|3807717|P4|Overall Study|Unacceptable subjective vision|2
1159502|NCT01254747|3807718|P3|Overall Study|Unacceptable subjective vision|0
1159503|NCT01254747|3807719|P2|Overall Study|Unacceptable subjective vision|0
1159504|NCT01254747|3807720|P1|Overall Study|Unacceptable subjective vision|0
1159505|NCT01254721|3807760|P2|Overall Study|Wrongly randomization|1
1159506|NCT01254721|3807761|P1|Overall Study|Wrongly randomization|0
1159507|NCT01254721|3807760|P2|Overall Study|Withdrawal by Subject|11
1159508|NCT01254721|3807761|P1|Overall Study|Withdrawal by Subject|8
1159509|NCT01254721|3807760|P2|Overall Study|Adverse Event|3
1159510|NCT01254721|3807761|P1|Overall Study|Adverse Event|2
1159511|NCT01254721|3807760|P2|Overall Study|technical problum|0
1159512|NCT01254721|3807761|P1|Overall Study|technical problum|1
1159513|NCT01254721|3807760|P2|Overall Study|Death|1
1159514|NCT01254721|3807761|P1|Overall Study|Death|0
1159515|NCT01254721|3807760|P2|Overall Study|Lack of Efficacy|2
1159516|NCT01254721|3807761|P1|Overall Study|Lack of Efficacy|4
1159517|NCT01254721|3807760|P2|Overall Study|Lost to Follow-up|4
1159518|NCT01254721|3807761|P1|Overall Study|Lost to Follow-up|0
1159519|NCT01254669|3807771|P2|Overall Study|called to clinic during intervention|1
1159520|NCT01254669|3807772|P1|Overall Study|called to clinic during intervention|1
1159521|NCT01254669|3807771|P2|Overall Study|time constraint|2
1159522|NCT01254669|3807772|P1|Overall Study|time constraint|2
1159523|NCT01254669|3807771|P2|Overall Study|Withdrawal by Subject|1
1159524|NCT01254669|3807772|P1|Overall Study|Withdrawal by Subject|0
1159525|NCT01254656|3807783|P3|Overall Study|Death|0
1159526|NCT01254656|3807784|P2|Overall Study|Death|1
1159527|NCT01254656|3807785|P1|Overall Study|Death|0
1159528|NCT01254656|3807783|P3|Overall Study|Adverse Event|0
1159529|NCT01254656|3807784|P2|Overall Study|Adverse Event|1
1159530|NCT01254656|3807785|P1|Overall Study|Adverse Event|1
1159531|NCT01254656|3807783|P3|Overall Study|Pregnancy|2
1159532|NCT01254656|3807784|P2|Overall Study|Pregnancy|0
1159533|NCT01254656|3807785|P1|Overall Study|Pregnancy|0
1159534|NCT01254656|3807783|P3|Overall Study|Withdrawal by Subject|1
1159535|NCT01254656|3807784|P2|Overall Study|Withdrawal by Subject|2
1159536|NCT01254656|3807785|P1|Overall Study|Withdrawal by Subject|2
1159537|NCT01254656|3807783|P3|Overall Study|Lost to Follow-up|2
1159538|NCT01254656|3807784|P2|Overall Study|Lost to Follow-up|0
1159539|NCT01254656|3807785|P1|Overall Study|Lost to Follow-up|1
1159540|NCT01254656|3807783|P3|Overall Study|Lack of Efficacy|0
1159541|NCT01254656|3807784|P2|Overall Study|Lack of Efficacy|0
1159542|NCT01254656|3807785|P1|Overall Study|Lack of Efficacy|3
1159543|NCT01254656|3807783|P3|Overall Study|Discontinued due to termination of study|13
1159544|NCT01254656|3807784|P2|Overall Study|Discontinued due to termination of study|39
1159545|NCT01254656|3807785|P1|Overall Study|Discontinued due to termination of study|40
1159546|NCT01254643|3807811|P1|Overall Study|Withdrawal by Subject|1
1159547|NCT01254630|3807823|P4|Overall Study|Status not recorded|0
1159548|NCT01254630|3807824|P3|Overall Study|Status not recorded|1
1159549|NCT01254630|3807825|P2|Overall Study|Status not recorded|0
1159550|NCT01254630|3807826|P1|Overall Study|Status not recorded|0
1159551|NCT01254630|3807823|P4|Overall Study|Study terminated by sponsor|1010
1159552|NCT01254630|3807824|P3|Overall Study|Study terminated by sponsor|0
1159553|NCT01254630|3807825|P2|Overall Study|Study terminated by sponsor|994
1159554|NCT01254630|3807826|P1|Overall Study|Study terminated by sponsor|0
1159555|NCT01254630|3807823|P4|Overall Study|Withdrawal by Subject|89
1159556|NCT01254630|3807824|P3|Overall Study|Withdrawal by Subject|188
1159557|NCT01254630|3807825|P2|Overall Study|Withdrawal by Subject|94
1159558|NCT01254630|3807826|P1|Overall Study|Withdrawal by Subject|201
1159559|NCT01254630|3807823|P4|Overall Study|Physician Decision|7
1159560|NCT01254630|3807824|P3|Overall Study|Physician Decision|16
1159561|NCT01254630|3807825|P2|Overall Study|Physician Decision|8
1159562|NCT01254630|3807826|P1|Overall Study|Physician Decision|24
1159563|NCT01254630|3807823|P4|Overall Study|Lost to Follow-up|32
1159564|NCT01254630|3807824|P3|Overall Study|Lost to Follow-up|89
1159565|NCT01254630|3807825|P2|Overall Study|Lost to Follow-up|26
1159566|NCT01254630|3807826|P1|Overall Study|Lost to Follow-up|80
1159567|NCT01254630|3807823|P4|Overall Study|Death|139
1159568|NCT01254630|3807824|P3|Overall Study|Death|478
1159569|NCT01254630|3807825|P2|Overall Study|Death|151
1159570|NCT01254630|3807826|P1|Overall Study|Death|461
1159571|NCT01254630|3807823|P4|Overall Study|Adverse Event|8
1159572|NCT01254630|3807824|P3|Overall Study|Adverse Event|40
1159573|NCT01254630|3807825|P2|Overall Study|Adverse Event|15
1159574|NCT01254630|3807826|P1|Overall Study|Adverse Event|36
1159575|NCT01254604|3807846|P2|Overall Study|Adverse Event|2
1159576|NCT01254604|3807847|P1|Overall Study|Adverse Event|3
1159577|NCT01254604|3807846|P2|Overall Study|Withdrawal by Subject|4
1159578|NCT01254604|3807847|P1|Overall Study|Withdrawal by Subject|2
1159579|NCT01254604|3807846|P2|Overall Study|Protocol Violation|2
1159580|NCT01254604|3807847|P1|Overall Study|Protocol Violation|2
1159581|NCT01254604|3807846|P2|Overall Study|Lost to Follow-up|1
1159582|NCT01254604|3807847|P1|Overall Study|Lost to Follow-up|1
1159583|NCT01254565|3807865|P6|Overall Study|Other|0
1159584|NCT01254565|3807866|P5|Overall Study|Other|0
1159585|NCT01254565|3807867|P4|Overall Study|Other|1
1159586|NCT01254565|3807868|P3|Overall Study|Other|0
1159587|NCT01254565|3807869|P2|Overall Study|Other|0
1159588|NCT01254565|3807870|P1|Overall Study|Other|0
1159589|NCT01254565|3807865|P6|Overall Study|Did not Receive Treatment|4
1159590|NCT01254565|3807866|P5|Overall Study|Did not Receive Treatment|3
1159591|NCT01254565|3807867|P4|Overall Study|Did not Receive Treatment|0
1159592|NCT01254565|3807868|P3|Overall Study|Did not Receive Treatment|0
1159593|NCT01254565|3807869|P2|Overall Study|Did not Receive Treatment|1
1159594|NCT01254565|3807870|P1|Overall Study|Did not Receive Treatment|1
1159595|NCT01254565|3807865|P6|Overall Study|Non-compliance to Study Procedures|0
1159596|NCT01254565|3807866|P5|Overall Study|Non-compliance to Study Procedures|1
1159597|NCT01254565|3807867|P4|Overall Study|Non-compliance to Study Procedures|0
1159598|NCT01254565|3807868|P3|Overall Study|Non-compliance to Study Procedures|0
1159599|NCT01254565|3807869|P2|Overall Study|Non-compliance to Study Procedures|0
1159600|NCT01254565|3807870|P1|Overall Study|Non-compliance to Study Procedures|0
1159601|NCT01254409|3807924|P4|Overall Study|Adverse Event|0
1159602|NCT01254409|3807925|P3|Overall Study|Adverse Event|0
1159603|NCT01254409|3807926|P2|Overall Study|Adverse Event|1
1159604|NCT01254409|3807927|P1|Overall Study|Adverse Event|0
1159605|NCT01254344|3807996|P2|Overall Study|Withdrawal by Subject|6
1159606|NCT01254344|3807997|P1|Overall Study|Withdrawal by Subject|3
1159607|NCT01254344|3807996|P2|Overall Study|Protocol Violation|4
1159608|NCT01254344|3807997|P1|Overall Study|Protocol Violation|1
1159609|NCT01254344|3807996|P2|Overall Study|Physician Decision|4
1159610|NCT01254344|3807997|P1|Overall Study|Physician Decision|7
1159611|NCT01254344|3807996|P2|Overall Study|Adverse Event|5
1159612|NCT01254344|3807997|P1|Overall Study|Adverse Event|2
1159613|NCT01254331|3808005|P1|Extension Phase|Lost to Follow-up|3
1159614|NCT01254331|3808005|P1|Extension Phase|Lack of Efficacy|1
1159615|NCT01254331|3808005|P1|Initial Phase|Pregnancy|1
1159616|NCT01254331|3808005|P1|Initial Phase|Withdrawal by Subject|1
1159617|NCT01254331|3808005|P1|Initial Phase|Adverse Event|3
1159618|NCT01254318|3808023|P1|Overall Study|Death|47
1159619|NCT01254318|3808023|P1|Overall Study|Lost to Follow-up|5
1159620|NCT01254305|3808032|P3|Overall Study|Other Reasons|2
1159621|NCT01254305|3808033|P2|Overall Study|Other Reasons|0
1159622|NCT01254305|3808034|P1|Overall Study|Other Reasons|0
1159623|NCT01254305|3808032|P3|Overall Study|Lost to Follow-up|5
1159624|NCT01254305|3808033|P2|Overall Study|Lost to Follow-up|6
1159625|NCT01254305|3808034|P1|Overall Study|Lost to Follow-up|10
1159626|NCT01254305|3808032|P3|Overall Study|Withdrawal by Subject|4
1159627|NCT01254305|3808033|P2|Overall Study|Withdrawal by Subject|2
1159628|NCT01254305|3808034|P1|Overall Study|Withdrawal by Subject|4
1159629|NCT01254305|3808032|P3|Overall Study|Protocol Violation|3
1159630|NCT01254305|3808033|P2|Overall Study|Protocol Violation|7
1159631|NCT01254305|3808034|P1|Overall Study|Protocol Violation|1
1159632|NCT01254305|3808032|P3|Overall Study|Lack of Efficacy|1
1159633|NCT01254305|3808033|P2|Overall Study|Lack of Efficacy|0
1159634|NCT01254305|3808034|P1|Overall Study|Lack of Efficacy|1
1159635|NCT01254305|3808032|P3|Overall Study|Adverse Event|2
1159636|NCT01254305|3808033|P2|Overall Study|Adverse Event|3
1159637|NCT01254305|3808034|P1|Overall Study|Adverse Event|6
1159638|NCT01254292|3808050|P2|LCS12 Extension Phase|Lost to Follow-up|0
1159639|NCT01254292|3808051|P1|LCS12 Extension Phase|Lost to Follow-up|1
1159640|NCT01254292|3808050|P2|LCS12 Extension Phase|Pregnancy|0
1159641|NCT01254292|3808051|P1|LCS12 Extension Phase|Pregnancy|2
1159642|NCT01254292|3808050|P2|LCS12 Extension Phase|Other unknown|0
1159643|NCT01254292|3808051|P1|LCS12 Extension Phase|Other unknown|4
1159644|NCT01254292|3808050|P2|LCS12 Extension Phase|Withdrawal by Subject|0
1159645|NCT01254292|3808051|P1|LCS12 Extension Phase|Withdrawal by Subject|7
1159646|NCT01254292|3808050|P2|LCS12 Extension Phase|Adverse Event|0
1159647|NCT01254292|3808051|P1|LCS12 Extension Phase|Adverse Event|9
1159648|NCT01254292|3808050|P2|LCS12 Extension Phase|Wish for pregnancy|0
1159649|NCT01254292|3808051|P1|LCS12 Extension Phase|Wish for pregnancy|14
1159650|NCT01254292|3808050|P2|Comparative Phase|Wish for pregnancy|6
1159651|NCT01254292|3808051|P1|Comparative Phase|Wish for pregnancy|4
1159652|NCT01254292|3808050|P2|Comparative Phase|Protocol Violation|2
1159653|NCT01254292|3808051|P1|Comparative Phase|Protocol Violation|1
1159654|NCT01254292|3808050|P2|Comparative Phase|Withdrawal by Subject|21
1159655|NCT01254292|3808051|P1|Comparative Phase|Withdrawal by Subject|20
1159656|NCT01254292|3808050|P2|Comparative Phase|Pregnancy|6
1159657|NCT01254292|3808051|P1|Comparative Phase|Pregnancy|2
1159658|NCT01254292|3808050|P2|Comparative Phase|Lost to Follow-up|21
1159659|NCT01254292|3808051|P1|Comparative Phase|Lost to Follow-up|3
1159660|NCT01254292|3808050|P2|Comparative Phase|Adverse Event|25
1159661|NCT01254292|3808051|P1|Comparative Phase|Adverse Event|25
1159662|NCT01254188|3808128|P1|Overall Study|per investigator discretion|20
1159663|NCT01254188|3808128|P1|Overall Study|Adverse Event|43
1159664|NCT01254188|3808128|P1|Overall Study|Withdrawal by Subject|7
1159665|NCT01254188|3808128|P1|Overall Study|Lost to Follow-up|5
1159666|NCT01254188|3808128|P1|Overall Study|Death|4
1159667|NCT01254188|3808128|P1|Overall Study|Pregnancy|2
1159668|NCT01254188|3808128|P1|Overall Study|Protocol Violation|6
1159669|NCT01254188|3808128|P1|Overall Study|Disease Progression|6
1159670|NCT01254045|3808139|P6|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
1159671|NCT01254045|3808140|P5|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
1159672|NCT01254045|3808141|P4|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
1159673|NCT01254045|3808142|P3|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
1159674|NCT01254045|3808143|P2|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
1159675|NCT01254045|3808144|P1|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1
1159676|NCT01253811|3808198|P1|Overall Study|Withdrawal criteria|1
1159677|NCT01253577|3808229|P1|Overall Study|Lost to Follow-up|3
1159678|NCT01253564|3808237|P1|Overall Study|Serious Adverse Event|1
1159679|NCT01253564|3808237|P1|Overall Study|Withdrawal by Subject|1
1159680|NCT01253564|3808237|P1|Overall Study|Disease Progression|22
1159681|NCT01253447|3808281|P1|Overall Study|Adverse Event|2
1159682|NCT01253421|3808291|P5|Drug+Scanning Visit|Physician Decision|1
1159683|NCT01253421|3808292|P4|Drug+Scanning Visit|Physician Decision|0
1159684|NCT01253421|3808293|P3|Drug+Scanning Visit|Physician Decision|0
1159685|NCT01253421|3808294|P2|Drug+Scanning Visit|Physician Decision|0
1159686|NCT01253421|3808295|P1|Drug+Scanning Visit|Physician Decision|0
1159687|NCT01253421|3808291|P5|Assessment and Scheduling|Physician Decision|0
1159688|NCT01253421|3808292|P4|Assessment and Scheduling|Physician Decision|0
1159689|NCT01253421|3808293|P3|Assessment and Scheduling|Physician Decision|0
1159690|NCT01253421|3808294|P2|Assessment and Scheduling|Physician Decision|0
1159691|NCT01253421|3808295|P1|Assessment and Scheduling|Physician Decision|1
1159692|NCT01253421|3808291|P5|Assessment and Scheduling|Withdrawal by Subject|0
1159693|NCT01253421|3808292|P4|Assessment and Scheduling|Withdrawal by Subject|0
1159694|NCT01253421|3808293|P3|Assessment and Scheduling|Withdrawal by Subject|0
1159695|NCT01253421|3808294|P2|Assessment and Scheduling|Withdrawal by Subject|0
1159696|NCT01253421|3808295|P1|Assessment and Scheduling|Withdrawal by Subject|7
1159697|NCT01253421|3808291|P5|Assessment and Scheduling|Lost to Follow-up|0
1159698|NCT01253421|3808292|P4|Assessment and Scheduling|Lost to Follow-up|0
1159699|NCT01253421|3808293|P3|Assessment and Scheduling|Lost to Follow-up|0
1159700|NCT01253421|3808294|P2|Assessment and Scheduling|Lost to Follow-up|0
1159701|NCT01253421|3808295|P1|Assessment and Scheduling|Lost to Follow-up|17
1159702|NCT01253421|3808291|P5|Assessment and Scheduling|Found to be Ineligible|0
1159703|NCT01253421|3808292|P4|Assessment and Scheduling|Found to be Ineligible|0
1159704|NCT01253421|3808293|P3|Assessment and Scheduling|Found to be Ineligible|0
1159705|NCT01253421|3808294|P2|Assessment and Scheduling|Found to be Ineligible|0
1159706|NCT01253421|3808295|P1|Assessment and Scheduling|Found to be Ineligible|74
1159707|NCT01253408|3808344|P3|Overall Study|Adverse Event|0
1159708|NCT01253408|3808345|P2|Overall Study|Adverse Event|1
1159709|NCT01253408|3808346|P1|Overall Study|Adverse Event|0
1159710|NCT01253369|3808369|P1|Overall Study|Not Evaluable|3
1159711|NCT01253369|3808369|P1|Overall Study|Progressive disease|23
1159712|NCT01253369|3808369|P1|Overall Study|Death|1
1159713|NCT01253369|3808369|P1|Overall Study|Withdrawal by Subject|2
1159714|NCT01253369|3808369|P1|Overall Study|Adverse Event|4
1159715|NCT01253317|3808399|P1|Overall Study|Adverse Event|2
1159716|NCT01253304|3808411|P4|Overall Study|Adverse Event|1
1159717|NCT01253304|3808412|P3|Overall Study|Adverse Event|0
1159718|NCT01253304|3808413|P2|Overall Study|Adverse Event|0
1159719|NCT01253304|3808414|P1|Overall Study|Adverse Event|0
1159720|NCT01253265|3808453|P5|Overall Study|Withdrawal by Subject|1
1159721|NCT01253265|3808454|P4|Overall Study|Withdrawal by Subject|0
1159722|NCT01253265|3808455|P3|Overall Study|Withdrawal by Subject|0
1159723|NCT01253265|3808456|P2|Overall Study|Withdrawal by Subject|0
1159724|NCT01253265|3808457|P1|Overall Study|Withdrawal by Subject|0
1159725|NCT01253265|3808453|P5|Overall Study|Met Predefined Discontinuation Criteria|0
1159726|NCT01253265|3808454|P4|Overall Study|Met Predefined Discontinuation Criteria|0
1159727|NCT01253265|3808455|P3|Overall Study|Met Predefined Discontinuation Criteria|0
1159728|NCT01253265|3808456|P2|Overall Study|Met Predefined Discontinuation Criteria|0
1159729|NCT01253265|3808457|P1|Overall Study|Met Predefined Discontinuation Criteria|1
1159730|NCT01253226|3808506|P5|Overall Study|Withdrawal by Subject|0
1159731|NCT01253226|3808507|P4|Overall Study|Withdrawal by Subject|1
1159732|NCT01253226|3808508|P3|Overall Study|Withdrawal by Subject|0
1159733|NCT01253226|3808509|P2|Overall Study|Withdrawal by Subject|0
1159734|NCT01253226|3808510|P1|Overall Study|Withdrawal by Subject|0
1159735|NCT01253226|3808506|P5|Overall Study|Physician Decision|2
1159736|NCT01253226|3808507|P4|Overall Study|Physician Decision|0
1159737|NCT01253226|3808508|P3|Overall Study|Physician Decision|0
1159738|NCT01253226|3808509|P2|Overall Study|Physician Decision|0
1159739|NCT01253226|3808510|P1|Overall Study|Physician Decision|0
1159740|NCT01253226|3808506|P5|Overall Study|Death|0
1159741|NCT01253226|3808507|P4|Overall Study|Death|0
1159742|NCT01253226|3808508|P3|Overall Study|Death|0
1159743|NCT01253226|3808509|P2|Overall Study|Death|1
1159744|NCT01253226|3808510|P1|Overall Study|Death|0
1159745|NCT01253226|3808506|P5|Overall Study|Adverse Event|0
1159746|NCT01253226|3808507|P4|Overall Study|Adverse Event|0
1159747|NCT01253226|3808508|P3|Overall Study|Adverse Event|1
1159748|NCT01253226|3808509|P2|Overall Study|Adverse Event|0
1159749|NCT01253226|3808510|P1|Overall Study|Adverse Event|0
1159750|NCT01253200|3808570|P5|Overall Study|Attempts|0
1159751|NCT01253200|3808571|P4|Overall Study|Attempts|2
1159752|NCT01253200|3808572|P3|Overall Study|Attempts|1
1159753|NCT01253200|3808573|P2|Overall Study|Attempts|4
1159754|NCT01253200|3808574|P1|Overall Study|Attempts|6
1159755|NCT01253200|3808570|P5|Overall Study|intents|0
1159756|NCT01253200|3808571|P4|Overall Study|intents|3
1159757|NCT01253200|3808572|P3|Overall Study|intents|1
1159758|NCT01253200|3808573|P2|Overall Study|intents|10
1159759|NCT01253200|3808574|P1|Overall Study|intents|10
1159760|NCT01253200|3808570|P5|Overall Study|Protocol Violation|5
1159761|NCT01253200|3808571|P4|Overall Study|Protocol Violation|0
1159762|NCT01253200|3808572|P3|Overall Study|Protocol Violation|0
1159763|NCT01253200|3808573|P2|Overall Study|Protocol Violation|4
1159764|NCT01253200|3808574|P1|Overall Study|Protocol Violation|1
1159765|NCT01253200|3808570|P5|Overall Study|Withdrawal by Subject|0
1159766|NCT01253200|3808571|P4|Overall Study|Withdrawal by Subject|0
1159767|NCT01253200|3808572|P3|Overall Study|Withdrawal by Subject|0
1159768|NCT01253200|3808573|P2|Overall Study|Withdrawal by Subject|0
1159769|NCT01253200|3808574|P1|Overall Study|Withdrawal by Subject|2
1159770|NCT01253200|3808570|P5|Overall Study|Lost to Follow-up|0
1159771|NCT01253200|3808571|P4|Overall Study|Lost to Follow-up|0
1159772|NCT01253200|3808572|P3|Overall Study|Lost to Follow-up|0
1159773|NCT01253200|3808573|P2|Overall Study|Lost to Follow-up|1
1159774|NCT01253200|3808574|P1|Overall Study|Lost to Follow-up|1
1159775|NCT01253200|3808570|P5|Overall Study|Death|0
1159776|NCT01253200|3808571|P4|Overall Study|Death|0
1159777|NCT01253200|3808572|P3|Overall Study|Death|0
1159778|NCT01253200|3808573|P2|Overall Study|Death|0
1159779|NCT01253200|3808574|P1|Overall Study|Death|1
1159780|NCT01253187|3808589|P6|Period 3|non-compliance|0
1159781|NCT01253187|3808590|P5|Period 3|non-compliance|1
1159782|NCT01253187|3808591|P4|Period 3|non-compliance|0
1159783|NCT01253187|3808592|P3|Period 3|non-compliance|0
1159784|NCT01253187|3808593|P2|Period 3|non-compliance|0
1159785|NCT01253187|3808594|P1|Period 3|non-compliance|0
1159786|NCT01253187|3808589|P6|Period 3|difficulty with blood sampling|0
1159787|NCT01253187|3808590|P5|Period 3|difficulty with blood sampling|0
1159788|NCT01253187|3808591|P4|Period 3|difficulty with blood sampling|0
1159789|NCT01253187|3808592|P3|Period 3|difficulty with blood sampling|0
1159790|NCT01253187|3808593|P2|Period 3|difficulty with blood sampling|1
1159791|NCT01253187|3808594|P1|Period 3|difficulty with blood sampling|0
1159792|NCT01253187|3808589|P6|Period 3|Pregnancy|0
1159793|NCT01253187|3808590|P5|Period 3|Pregnancy|0
1159794|NCT01253187|3808591|P4|Period 3|Pregnancy|0
1159795|NCT01253187|3808592|P3|Period 3|Pregnancy|0
1159796|NCT01253187|3808593|P2|Period 3|Pregnancy|0
1159797|NCT01253187|3808594|P1|Period 3|Pregnancy|1
1159798|NCT01253187|3808589|P6|Period 2|Withdrawal by Subject|0
1159799|NCT01253187|3808590|P5|Period 2|Withdrawal by Subject|1
1159800|NCT01253187|3808591|P4|Period 2|Withdrawal by Subject|0
1159801|NCT01253187|3808592|P3|Period 2|Withdrawal by Subject|0
1159802|NCT01253187|3808593|P2|Period 2|Withdrawal by Subject|0
1159803|NCT01253187|3808594|P1|Period 2|Withdrawal by Subject|0
1159804|NCT01253174|3808623|P6|Period 3|Pregnancy|0
1159805|NCT01253174|3808624|P5|Period 3|Pregnancy|0
1159806|NCT01253174|3808625|P4|Period 3|Pregnancy|0
1159807|NCT01253174|3808626|P3|Period 3|Pregnancy|1
1159808|NCT01253174|3808627|P2|Period 3|Pregnancy|0
1159809|NCT01253174|3808628|P1|Period 3|Pregnancy|0
1159810|NCT01253174|3808623|P6|Period 3|Withdrawal by Subject|0
1159811|NCT01253174|3808624|P5|Period 3|Withdrawal by Subject|1
1159812|NCT01253174|3808625|P4|Period 3|Withdrawal by Subject|0
1159813|NCT01253174|3808626|P3|Period 3|Withdrawal by Subject|0
1159814|NCT01253174|3808627|P2|Period 3|Withdrawal by Subject|1
1159815|NCT01253174|3808628|P1|Period 3|Withdrawal by Subject|0
1159816|NCT01253174|3808623|P6|Period 2|Adverse Event|0
1159817|NCT01253174|3808624|P5|Period 2|Adverse Event|0
1159818|NCT01253174|3808625|P4|Period 2|Adverse Event|0
1159819|NCT01253174|3808626|P3|Period 2|Adverse Event|1
1159820|NCT01253174|3808627|P2|Period 2|Adverse Event|0
1159821|NCT01253174|3808628|P1|Period 2|Adverse Event|0
1159822|NCT01253174|3808623|P6|Period 1|Randomized but not treated|0
1159823|NCT01253174|3808624|P5|Period 1|Randomized but not treated|1
1159824|NCT01253174|3808625|P4|Period 1|Randomized but not treated|0
1159825|NCT01253174|3808626|P3|Period 1|Randomized but not treated|1
1159826|NCT01253174|3808627|P2|Period 1|Randomized but not treated|1
1159827|NCT01253174|3808628|P1|Period 1|Randomized but not treated|0
1159828|NCT01253135|3808663|P1|Amended Protocol|Non-compliance|1
1159829|NCT01253135|3808663|P1|Original Protocol|Protocol Amendment|15
1159830|NCT01253044|3808682|P2|Overall Study|Lost to Follow-up|29
1159831|NCT01253044|3808683|P1|Overall Study|Lost to Follow-up|38
1159832|NCT01253018|3808693|P2|Overall Study|Withdrawal by Subject|1
1159833|NCT01253018|3808694|P1|Overall Study|Withdrawal by Subject|1
1159834|NCT01253018|3808693|P2|Overall Study|Robot Repair Issues|0
1159835|NCT01253018|3808694|P1|Overall Study|Robot Repair Issues|2
1159836|NCT01253018|3808693|P2|Overall Study|Lost to Follow-up|1
1159837|NCT01253018|3808694|P1|Overall Study|Lost to Follow-up|1
1159838|NCT01252966|3808708|P2|Overall Study|Withdrawal by Subject|3
1159839|NCT01252966|3808709|P1|Overall Study|Withdrawal by Subject|7
1159840|NCT01252966|3808708|P2|Overall Study|Lost to Follow-up|10
1159841|NCT01252966|3808709|P1|Overall Study|Lost to Follow-up|16
1159842|NCT01252953|3808725|P2|Overall Study|Lost to Follow-up|21
1159843|NCT01252953|3808726|P1|Overall Study|Lost to Follow-up|22
1159844|NCT01252953|3808725|P2|Overall Study|Withdrawal by Subject|17
1159845|NCT01252953|3808726|P1|Overall Study|Withdrawal by Subject|16
1159846|NCT01252940|3808740|P2|Extension Phase|Withdrawal by Subject|1
1159847|NCT01252940|3808741|P1|Extension Phase|Withdrawal by Subject|1
1159848|NCT01252940|3808740|P2|Extension Phase|Subject Non-compliance|0
1159849|NCT01252940|3808741|P1|Extension Phase|Subject Non-compliance|1
1159850|NCT01252940|3808740|P2|Extension Phase|Physician Decision|1
1159851|NCT01252940|3808741|P1|Extension Phase|Physician Decision|0
1159852|NCT01252940|3808740|P2|Extension Phase|Lost to Follow-up|0
1159853|NCT01252940|3808741|P1|Extension Phase|Lost to Follow-up|5
1159854|NCT01252940|3808740|P2|Extension Phase|Lack of Efficacy|0
1159855|NCT01252940|3808741|P1|Extension Phase|Lack of Efficacy|1
1159856|NCT01252940|3808740|P2|Extension Phase|Adverse Event|1
1159857|NCT01252940|3808741|P1|Extension Phase|Adverse Event|2
1159858|NCT01252940|3808740|P2|Main Study Phase|Subject Non-compliance|1
1159859|NCT01252940|3808741|P1|Main Study Phase|Subject Non-compliance|1
1159860|NCT01252940|3808740|P2|Main Study Phase|Withdrawal by Subject|5
1159861|NCT01252940|3808741|P1|Main Study Phase|Withdrawal by Subject|6
1159862|NCT01252940|3808740|P2|Main Study Phase|Protocol Violation|2
1159863|NCT01252940|3808741|P1|Main Study Phase|Protocol Violation|4
1159864|NCT01252940|3808740|P2|Main Study Phase|Physician Decision|0
1159865|NCT01252940|3808741|P1|Main Study Phase|Physician Decision|1
1159866|NCT01252940|3808740|P2|Main Study Phase|Lost to Follow-up|1
1159867|NCT01252940|3808741|P1|Main Study Phase|Lost to Follow-up|6
1159868|NCT01252940|3808740|P2|Main Study Phase|Lack of Efficacy|0
1159869|NCT01252940|3808741|P1|Main Study Phase|Lack of Efficacy|1
1159870|NCT01252940|3808740|P2|Main Study Phase|Adverse Event|1
1159871|NCT01252940|3808741|P1|Main Study Phase|Adverse Event|3
1159872|NCT01252940|3808740|P2|Main Study Phase|Randomized but not treated|2
1159873|NCT01252940|3808741|P1|Main Study Phase|Randomized but not treated|4
1159874|NCT01252810|3808772|P2|Overall Study|Various reasons|0
1159875|NCT01252810|3808773|P1|Overall Study|Various reasons|8
1159876|NCT01252810|3808772|P2|Overall Study|Physician Decision|1
1159877|NCT01252810|3808773|P1|Overall Study|Physician Decision|2
1159878|NCT01252810|3808772|P2|Overall Study|Lost to Follow-up|1
1159879|NCT01252810|3808773|P1|Overall Study|Lost to Follow-up|0
1159880|NCT01252810|3808772|P2|Overall Study|Withdrawal by Subject|1
1159881|NCT01252810|3808773|P1|Overall Study|Withdrawal by Subject|4
1159882|NCT01252355|3808805|P3|Overall Study|Other Than Above|7
1159883|NCT01252355|3808806|P2|Overall Study|Other Than Above|7
1159884|NCT01252355|3808807|P1|Overall Study|Other Than Above|8
1159885|NCT01252355|3808805|P3|Overall Study|Randomized but not Treated|0
1159886|NCT01252355|3808806|P2|Overall Study|Randomized but not Treated|0
1159887|NCT01252355|3808807|P1|Overall Study|Randomized but not Treated|2
1159888|NCT01252355|3808805|P3|Overall Study|Sponsor Early Termination of Study|146
1159889|NCT01252355|3808806|P2|Overall Study|Sponsor Early Termination of Study|149
1159890|NCT01252355|3808807|P1|Overall Study|Sponsor Early Termination of Study|149
1159891|NCT01252355|3808805|P3|Overall Study|Progressive Disease|0
1159892|NCT01252355|3808806|P2|Overall Study|Progressive Disease|0
1159893|NCT01252355|3808807|P1|Overall Study|Progressive Disease|2
1159894|NCT01252355|3808805|P3|Overall Study|Poor Compliance to Protocol|1
1159895|NCT01252355|3808806|P2|Overall Study|Poor Compliance to Protocol|1
1159896|NCT01252355|3808807|P1|Overall Study|Poor Compliance to Protocol|1
1159897|NCT01252355|3808805|P3|Overall Study|Lost to Follow-up|1
1159898|NCT01252355|3808806|P2|Overall Study|Lost to Follow-up|0
1159899|NCT01252355|3808807|P1|Overall Study|Lost to Follow-up|0
1159900|NCT01252355|3808805|P3|Overall Study|Lack of Efficacy|2
1159901|NCT01252355|3808806|P2|Overall Study|Lack of Efficacy|4
1159902|NCT01252355|3808807|P1|Overall Study|Lack of Efficacy|6
1159903|NCT01252355|3808805|P3|Overall Study|Adverse Event|22
1159904|NCT01252355|3808806|P2|Overall Study|Adverse Event|17
1159905|NCT01252355|3808807|P1|Overall Study|Adverse Event|9
1159906|NCT01252290|3808845|P1|Overall Study|Withdrawal by Subject|1
1159907|NCT01252251|3808861|P1|Overall Study|Withdrawal by Subject|1
1159908|NCT01252238|3808873|P3|Overall Study|Sponsor terminated study|4
1159909|NCT01252238|3808874|P2|Overall Study|Sponsor terminated study|4
1159910|NCT01252238|3808875|P1|Overall Study|Sponsor terminated study|4
1159911|NCT01252186|3808892|P3|Overall Study|Other - Miscellaneous Reasons|7
1159912|NCT01252186|3808893|P2|Overall Study|Other - Miscellaneous Reasons|5
1159913|NCT01252186|3808894|P1|Overall Study|Other - Miscellaneous Reasons|5
1159914|NCT01252186|3808892|P3|Overall Study|Lost to Follow-up|11
1159915|NCT01252186|3808893|P2|Overall Study|Lost to Follow-up|10
1159916|NCT01252186|3808894|P1|Overall Study|Lost to Follow-up|10
1159917|NCT01252186|3808892|P3|Overall Study|Sponsor Request|0
1159918|NCT01252186|3808893|P2|Overall Study|Sponsor Request|1
1159919|NCT01252186|3808894|P1|Overall Study|Sponsor Request|2
1159920|NCT01252186|3808892|P3|Overall Study|Pregnancy|0
1159921|NCT01252186|3808893|P2|Overall Study|Pregnancy|2
1159922|NCT01252186|3808894|P1|Overall Study|Pregnancy|2
1159923|NCT01252186|3808892|P3|Overall Study|Protocol Violation|1
1159924|NCT01252186|3808893|P2|Overall Study|Protocol Violation|0
1159925|NCT01252186|3808894|P1|Overall Study|Protocol Violation|0
1159926|NCT01252186|3808892|P3|Overall Study|Non-compliance|4
1159927|NCT01252186|3808893|P2|Overall Study|Non-compliance|3
1159928|NCT01252186|3808894|P1|Overall Study|Non-compliance|0
1159929|NCT01252186|3808892|P3|Overall Study|Physician Decision|1
1159930|NCT01252186|3808893|P2|Overall Study|Physician Decision|0
1159931|NCT01252186|3808894|P1|Overall Study|Physician Decision|0
1159932|NCT01252186|3808892|P3|Overall Study|Withdrawal by Subject|2
1159933|NCT01252186|3808893|P2|Overall Study|Withdrawal by Subject|5
1159934|NCT01252186|3808894|P1|Overall Study|Withdrawal by Subject|2
1159935|NCT01252186|3808892|P3|Overall Study|Adverse Event|8
1159936|NCT01252186|3808893|P2|Overall Study|Adverse Event|6
1159937|NCT01252186|3808894|P1|Overall Study|Adverse Event|9
1159938|NCT01252134|3808967|P6|Period 1, 8 Hours|Personal Reasons|0
1159939|NCT01252134|3808968|P5|Period 1, 8 Hours|Personal Reasons|0
1159940|NCT01252134|3808969|P4|Period 1, 8 Hours|Personal Reasons|0
1159941|NCT01252134|3808970|P3|Period 1, 8 Hours|Personal Reasons|1
1159942|NCT01252134|3808971|P2|Period 1, 8 Hours|Personal Reasons|1
1159943|NCT01252134|3808972|P1|Period 1, 8 Hours|Personal Reasons|0
1159944|NCT01252095|3808991|P2|Overall Study|Disease progression|0
1159945|NCT01252095|3808992|P1|Overall Study|Disease progression|1
1159946|NCT01251952|3809010|P1|Overall Study|Adverse Event|1
1159947|NCT01251770|3809016|P2|Overall Study|Protocol Violation|7
1159948|NCT01251770|3809017|P1|Overall Study|Protocol Violation|13
1159949|NCT01251653|3809068|P9|Overall Study|Other reason not mentioned above|0
1159950|NCT01251653|3809069|P8|Overall Study|Other reason not mentioned above|2
1159951|NCT01251653|3809070|P7|Overall Study|Other reason not mentioned above|0
1159952|NCT01251653|3809071|P6|Overall Study|Other reason not mentioned above|0
1159953|NCT01251653|3809072|P5|Overall Study|Other reason not mentioned above|0
1159954|NCT01251653|3809073|P4|Overall Study|Other reason not mentioned above|0
1159955|NCT01251653|3809074|P3|Overall Study|Other reason not mentioned above|0
1159956|NCT01251653|3809075|P2|Overall Study|Other reason not mentioned above|0
1159957|NCT01251653|3809076|P1|Overall Study|Other reason not mentioned above|0
1159958|NCT01251653|3809068|P9|Overall Study|Withdrawal by Subject|0
1159959|NCT01251653|3809069|P8|Overall Study|Withdrawal by Subject|1
1159960|NCT01251653|3809070|P7|Overall Study|Withdrawal by Subject|0
1159961|NCT01251653|3809071|P6|Overall Study|Withdrawal by Subject|1
1159962|NCT01251653|3809072|P5|Overall Study|Withdrawal by Subject|1
1159963|NCT01251653|3809073|P4|Overall Study|Withdrawal by Subject|0
1159964|NCT01251653|3809074|P3|Overall Study|Withdrawal by Subject|1
1159965|NCT01251653|3809075|P2|Overall Study|Withdrawal by Subject|0
1159966|NCT01251653|3809076|P1|Overall Study|Withdrawal by Subject|1
1159967|NCT01251653|3809068|P9|Overall Study|Adverse Event|1
1159968|NCT01251653|3809069|P8|Overall Study|Adverse Event|2
1159969|NCT01251653|3809070|P7|Overall Study|Adverse Event|2
1159970|NCT01251653|3809071|P6|Overall Study|Adverse Event|0
1159971|NCT01251653|3809072|P5|Overall Study|Adverse Event|1
1159972|NCT01251653|3809073|P4|Overall Study|Adverse Event|1
1159973|NCT01251653|3809074|P3|Overall Study|Adverse Event|2
1159974|NCT01251653|3809075|P2|Overall Study|Adverse Event|0
1159975|NCT01251653|3809076|P1|Overall Study|Adverse Event|1
1159976|NCT01251653|3809068|P9|Overall Study|Dose-limiting toxicity|0
1159977|NCT01251653|3809069|P8|Overall Study|Dose-limiting toxicity|0
1159978|NCT01251653|3809070|P7|Overall Study|Dose-limiting toxicity|2
1159979|NCT01251653|3809071|P6|Overall Study|Dose-limiting toxicity|0
1159980|NCT01251653|3809072|P5|Overall Study|Dose-limiting toxicity|0
1159981|NCT01251653|3809073|P4|Overall Study|Dose-limiting toxicity|1
1159982|NCT01251653|3809074|P3|Overall Study|Dose-limiting toxicity|1
1159983|NCT01251653|3809075|P2|Overall Study|Dose-limiting toxicity|1
1159984|NCT01251653|3809076|P1|Overall Study|Dose-limiting toxicity|0
1159985|NCT01251653|3809068|P9|Overall Study|Progressive Disease|5
1159986|NCT01251653|3809069|P8|Overall Study|Progressive Disease|7
1159987|NCT01251653|3809070|P7|Overall Study|Progressive Disease|14
1159988|NCT01251653|3809071|P6|Overall Study|Progressive Disease|17
1159989|NCT01251653|3809072|P5|Overall Study|Progressive Disease|0
1159990|NCT01251653|3809073|P4|Overall Study|Progressive Disease|4
1159991|NCT01251653|3809074|P3|Overall Study|Progressive Disease|16
1159992|NCT01251653|3809075|P2|Overall Study|Progressive Disease|7
1159993|NCT01251653|3809076|P1|Overall Study|Progressive Disease|1
1159994|NCT01251614|3809204|P3|Overall Study|Lost to Follow-up|0
1159995|NCT01251614|3809205|P2|Overall Study|Lost to Follow-up|1
1159996|NCT01251614|3809206|P1|Overall Study|Lost to Follow-up|0
1159997|NCT01251614|3809204|P3|Overall Study|Withdrawal by Subject|1
1159998|NCT01251614|3809205|P2|Overall Study|Withdrawal by Subject|2
1159999|NCT01251614|3809206|P1|Overall Study|Withdrawal by Subject|0
1160000|NCT01251614|3809204|P3|Overall Study|Loss of Disease Control|0
1160001|NCT01251614|3809205|P2|Overall Study|Loss of Disease Control|1
1160002|NCT01251614|3809206|P1|Overall Study|Loss of Disease Control|0
1160003|NCT01251614|3809204|P3|Overall Study|Pregnancy|2
1160004|NCT01251614|3809205|P2|Overall Study|Pregnancy|0
1160005|NCT01251614|3809206|P1|Overall Study|Pregnancy|0
1160006|NCT01251614|3809204|P3|Overall Study|Clearing of Psoriatic Lesions|0
1160007|NCT01251614|3809205|P2|Overall Study|Clearing of Psoriatic Lesions|0
1160008|NCT01251614|3809206|P1|Overall Study|Clearing of Psoriatic Lesions|1
1160009|NCT01251614|3809204|P3|Overall Study|Lack of Efficacy|4
1160010|NCT01251614|3809205|P2|Overall Study|Lack of Efficacy|9
1160011|NCT01251614|3809206|P1|Overall Study|Lack of Efficacy|1
1160012|NCT01251614|3809204|P3|Overall Study|Adverse Event|1
1160013|NCT01251614|3809205|P2|Overall Study|Adverse Event|0
1160014|NCT01251614|3809206|P1|Overall Study|Adverse Event|1
1160015|NCT01251380|3809313|P1|Overall Study|Lost to Follow-up|2
1160016|NCT01251380|3809313|P1|Overall Study|Adverse Event|1
1160017|NCT01251380|3809313|P1|Overall Study|Lack of Efficacy|1
1160018|NCT01251380|3809313|P1|Overall Study|Withdrawal by Subject|6
1160019|NCT01251380|3809313|P1|Overall Study|Other (Not otherwise specified)|12
1160020|NCT01251367|3809337|P1|Overall Study|End of Study Visit Performed in Error|1
1160111|NCT01250119|3809939|P2|Treatment Phase|Withdrawal by Subject|1
1160021|NCT01251367|3809337|P1|Overall Study|Subject had Personal or Medical Issues|4
1160022|NCT01251367|3809337|P1|Overall Study|No Study Drug Available|1
1160023|NCT01251367|3809337|P1|Overall Study|Subject Required Alternative Treatment|7
1160024|NCT01251367|3809337|P1|Overall Study|Lost to Follow-up|5
1160025|NCT01251367|3809337|P1|Overall Study|Withdrawal by Subject|36
1160026|NCT01251367|3809337|P1|Overall Study|Adverse Event|19
1160027|NCT01251367|3809337|P1|Overall Study|Lack of Efficacy|2
1160028|NCT01251367|3809337|P1|Overall Study|Protocol Violation|1
1160029|NCT01251354|3809372|P1|Overall Study|Disease Progression|4
1160030|NCT01251354|3809372|P1|Overall Study|Investigator's Decision|1
1160031|NCT01251354|3809372|P1|Overall Study|Adverse Event|1
1160032|NCT01251276|3809415|P2|Overall Study|Lost to Follow-up|1
1160033|NCT01251276|3809416|P1|Overall Study|Lost to Follow-up|0
1160034|NCT01251276|3809415|P2|Overall Study|Protocol Violation|0
1160035|NCT01251276|3809416|P1|Overall Study|Protocol Violation|1
1160036|NCT01251146|3809434|P2|Overall Study|Lost to Follow-up|10
1160037|NCT01251146|3809435|P1|Overall Study|Lost to Follow-up|3
1160038|NCT01251120|3809457|P2|Overall Study|Lack of Efficacy|1
1160039|NCT01251120|3809458|P1|Overall Study|Lack of Efficacy|0
1160040|NCT01250925|3809523|P3|Overall Study|Adverse Event|1
1160041|NCT01250925|3809524|P2|Overall Study|Adverse Event|0
1160042|NCT01250925|3809525|P1|Overall Study|Adverse Event|0
1160043|NCT01250925|3809523|P3|Overall Study|Physician Decision|1
1160044|NCT01250925|3809524|P2|Overall Study|Physician Decision|2
1160045|NCT01250925|3809525|P1|Overall Study|Physician Decision|0
1160046|NCT01250925|3809523|P3|Overall Study|Protocol Violation|0
1160047|NCT01250925|3809524|P2|Overall Study|Protocol Violation|0
1160048|NCT01250925|3809525|P1|Overall Study|Protocol Violation|2
1160049|NCT01250925|3809523|P3|Overall Study|Withdrawal by Subject|0
1160050|NCT01250925|3809524|P2|Overall Study|Withdrawal by Subject|0
1160051|NCT01250925|3809525|P1|Overall Study|Withdrawal by Subject|2
1160052|NCT01250925|3809523|P3|Overall Study|Lost to Follow-up|0
1160053|NCT01250925|3809524|P2|Overall Study|Lost to Follow-up|1
1160054|NCT01250925|3809525|P1|Overall Study|Lost to Follow-up|1
1160055|NCT01250873|3809570|P1|Overall Study|Adverse Event|3
1160056|NCT01250769|3809602|P4|Overall Study|Adverse Event|0
1160057|NCT01250769|3809603|P3|Overall Study|Adverse Event|1
1160058|NCT01250769|3809604|P2|Overall Study|Adverse Event|0
1160059|NCT01250769|3809605|P1|Overall Study|Adverse Event|0
1160060|NCT01250769|3809602|P4|Overall Study|Withdrawal by Subject|0
1160061|NCT01250769|3809603|P3|Overall Study|Withdrawal by Subject|1
1160062|NCT01250769|3809604|P2|Overall Study|Withdrawal by Subject|1
1160063|NCT01250769|3809605|P1|Overall Study|Withdrawal by Subject|0
1160064|NCT01250756|3809637|P2|After Toddler Dose|Adverse Event|1
1160065|NCT01250756|3809638|P1|After Toddler Dose|Adverse Event|0
1160066|NCT01250756|3809637|P2|Toddler Dose|Adverse Event|1
1160067|NCT01250756|3809638|P1|Toddler Dose|Adverse Event|0
1160068|NCT01250756|3809637|P2|After Infant Series|Other|1
1160069|NCT01250756|3809638|P1|After Infant Series|Other|2
1160070|NCT01250756|3809637|P2|After Infant Series|Withdrawal by Subject|1
1160071|NCT01250756|3809638|P1|After Infant Series|Withdrawal by Subject|4
1160072|NCT01250756|3809637|P2|After Infant Series|Adverse Event|2
1160073|NCT01250756|3809638|P1|After Infant Series|Adverse Event|5
1160074|NCT01250756|3809637|P2|Infant Series|Other|0
1160075|NCT01250756|3809638|P1|Infant Series|Other|22
1160076|NCT01250756|3809637|P2|Infant Series|Randomized, Not Vaccinated|2
1160077|NCT01250756|3809638|P1|Infant Series|Randomized, Not Vaccinated|2
1160078|NCT01250756|3809637|P2|Infant Series|Withdrawal by Subject|5
1160079|NCT01250756|3809638|P1|Infant Series|Withdrawal by Subject|4
1160080|NCT01250509|3809755|P2|Overall Study|Lost to Follow-up|2
1160081|NCT01250509|3809756|P1|Overall Study|Lost to Follow-up|5
1160082|NCT01250418|3809770|P2|Overall Study|monitor data failure|1
1160083|NCT01250418|3809771|P1|Overall Study|monitor data failure|1
1160084|NCT01250379|3809779|P2|Overall Study|Participant noncompliance|0
1160085|NCT01250379|3809780|P1|Overall Study|Participant noncompliance|2
1160086|NCT01250379|3809779|P2|Overall Study|Not specified|4
1160087|NCT01250379|3809780|P1|Overall Study|Not specified|0
1160088|NCT01250379|3809779|P2|Overall Study|Adverse Event|4
1160089|NCT01250379|3809780|P1|Overall Study|Adverse Event|5
1160090|NCT01250379|3809779|P2|Overall Study|Lost to Follow-up|6
1160091|NCT01250379|3809780|P1|Overall Study|Lost to Follow-up|9
1160092|NCT01250379|3809779|P2|Overall Study|Protocol Violation|8
1160093|NCT01250379|3809780|P1|Overall Study|Protocol Violation|2
1160094|NCT01250379|3809779|P2|Overall Study|Physician Decision|3
1160095|NCT01250379|3809780|P1|Overall Study|Physician Decision|11
1160096|NCT01250379|3809779|P2|Overall Study|Withdrawal by Subject|20
1160097|NCT01250379|3809780|P1|Overall Study|Withdrawal by Subject|32
1160098|NCT01250379|3809779|P2|Overall Study|Death|148
1160099|NCT01250379|3809780|P1|Overall Study|Death|141
1160100|NCT01250171|3809885|P3|Overall Study|Administrative reasons|0
1160101|NCT01250171|3809886|P2|Overall Study|Administrative reasons|0
1160102|NCT01250171|3809887|P1|Overall Study|Administrative reasons|1
1160103|NCT01250145|3809918|P2|Overall Study|Withdrawal by Subject|4
1160104|NCT01250145|3809919|P1|Overall Study|Withdrawal by Subject|0
1160105|NCT01250145|3809918|P2|Overall Study|Adverse Event|1
1160106|NCT01250145|3809919|P1|Overall Study|Adverse Event|2
1160107|NCT01250119|3809939|P2|Treatment Phase|Unknown reason|4
1160108|NCT01250119|3809940|P1|Treatment Phase|Unknown reason|0
1160109|NCT01250119|3809939|P2|Treatment Phase|Adverse Event|2
1160110|NCT01250119|3809940|P1|Treatment Phase|Adverse Event|0
1160112|NCT01250119|3809940|P1|Treatment Phase|Withdrawal by Subject|0
1160113|NCT01250119|3809939|P2|Treatment Phase|Death|2
1160114|NCT01250119|3809940|P1|Treatment Phase|Death|0
1160115|NCT01250119|3809939|P2|Treatment Phase|Progressive Disease|32
1160116|NCT01250119|3809940|P1|Treatment Phase|Progressive Disease|0
1160117|NCT01250119|3809939|P2|Diagnostic Phase|Participants Not Tested|0
1160118|NCT01250119|3809940|P1|Diagnostic Phase|Participants Not Tested|44
1160119|NCT01250119|3809939|P2|Diagnostic Phase|Failed to Produce a Test Results|0
1160120|NCT01250119|3809940|P1|Diagnostic Phase|Failed to Produce a Test Results|69
1160121|NCT01250054|3809955|P2|Period 2, One Week of Wear|Unacceptable subjective vision|0
1160122|NCT01250054|3809956|P1|Period 2, One Week of Wear|Unacceptable subjective vision|1
1160123|NCT01250002|3809964|P2|Overall Study|Change to open surgical procedure|3
1160124|NCT01250002|3809965|P1|Overall Study|Change to open surgical procedure|4
1160125|NCT01249833|3810030|P2|Overall Study|Lost to Follow-up|1
1160126|NCT01249833|3810031|P1|Overall Study|Lost to Follow-up|0
1160127|NCT01249664|3810045|P2|Overall Study|Adverse Event|0
1160128|NCT01249664|3810046|P1|Overall Study|Adverse Event|1
1160129|NCT01249664|3810045|P2|Overall Study|Withdrawal by Subject|0
1160130|NCT01249664|3810046|P1|Overall Study|Withdrawal by Subject|5
1160131|NCT01249651|3810096|P1|Overall Study|Sponsor Decision|1
1160132|NCT01249651|3810096|P1|Overall Study|Protocol Violation|1
1160133|NCT01249651|3810096|P1|Overall Study|Adverse Event|1
1160134|NCT01249651|3810096|P1|Overall Study|Withdrawal by Subject|4
1160135|NCT01249417|3810106|P3|Treatment Phase - ITT Population|Lost to Follow-up|1
1160136|NCT01249417|3810107|P2|Treatment Phase - ITT Population|Lost to Follow-up|1
1160137|NCT01249417|3810108|P1|Treatment Phase - ITT Population|Lost to Follow-up|0
1160138|NCT01249417|3810106|P3|Treatment Phase - ITT Population|Withdrawal by Subject|1
1160139|NCT01249417|3810107|P2|Treatment Phase - ITT Population|Withdrawal by Subject|3
1160140|NCT01249417|3810108|P1|Treatment Phase - ITT Population|Withdrawal by Subject|1
1160141|NCT01249417|3810106|P3|Treatment Phase - ITT Population|Adverse Event|1
1160142|NCT01249417|3810107|P2|Treatment Phase - ITT Population|Adverse Event|0
1160143|NCT01249417|3810108|P1|Treatment Phase - ITT Population|Adverse Event|0
1160144|NCT01249417|3810106|P3|Treatment Phase - ITT Population|Not specified|1
1160145|NCT01249417|3810107|P2|Treatment Phase - ITT Population|Not specified|0
1160146|NCT01249417|3810108|P1|Treatment Phase - ITT Population|Not specified|0
1160147|NCT01249417|3810106|P3|Randomised Population|No MAS score at baseline and/or Week 4|2
1160148|NCT01249417|3810107|P2|Randomised Population|No MAS score at baseline and/or Week 4|1
1160149|NCT01249417|3810108|P1|Randomised Population|No MAS score at baseline and/or Week 4|1
1160150|NCT01249417|3810106|P3|Randomised Population|Study treatment not received|2
1160151|NCT01249417|3810107|P2|Randomised Population|Study treatment not received|0
1160152|NCT01249417|3810108|P1|Randomised Population|Study treatment not received|0
1160153|NCT01249404|3810125|P3|Overall Study|Non compliance to visit schedule|0
1160154|NCT01249404|3810126|P2|Overall Study|Non compliance to visit schedule|1
1160155|NCT01249404|3810127|P1|Overall Study|Non compliance to visit schedule|0
1160156|NCT01249404|3810125|P3|Overall Study|Botulinum toxin (BTX) in upper limb|1
1160157|NCT01249404|3810126|P2|Overall Study|Botulinum toxin (BTX) in upper limb|2
1160158|NCT01249404|3810127|P1|Overall Study|Botulinum toxin (BTX) in upper limb|1
1160159|NCT01249404|3810125|P3|Overall Study|Withdrawal by Subject|0
1160160|NCT01249404|3810126|P2|Overall Study|Withdrawal by Subject|2
1160161|NCT01249404|3810127|P1|Overall Study|Withdrawal by Subject|2
1160162|NCT01249404|3810125|P3|Overall Study|Adverse Event|2
1160163|NCT01249404|3810126|P2|Overall Study|Adverse Event|2
1160164|NCT01249404|3810127|P1|Overall Study|Adverse Event|2
1160165|NCT01249404|3810125|P3|Overall Study|No MAS Score at baseline and/or Week 4|2
1160166|NCT01249404|3810126|P2|Overall Study|No MAS Score at baseline and/or Week 4|0
1160167|NCT01249404|3810127|P1|Overall Study|No MAS Score at baseline and/or Week 4|2
1160168|NCT01249404|3810125|P3|Overall Study|Study treatment not received|2
1160169|NCT01249404|3810126|P2|Overall Study|Study treatment not received|1
1160170|NCT01249404|3810127|P1|Overall Study|Study treatment not received|0
1160171|NCT01249365|3810204|P1|Overall Study|Lost to Follow-up|1
1160172|NCT01249274|3810212|P2|Overall Study|Received inpatient substance treatment|2
1160173|NCT01249274|3810213|P1|Overall Study|Received inpatient substance treatment|1
1160174|NCT01249274|3810212|P2|Overall Study|Lost to Follow-up|4
1160175|NCT01249274|3810213|P1|Overall Study|Lost to Follow-up|3
1160176|NCT01249261|3810239|P2|Overall Study|Withdrawal by Subject|0
1160177|NCT01249261|3810240|P1|Overall Study|Withdrawal by Subject|1
1160178|NCT01249157|3810268|P1|Overall Study|Withdrawal by Subject|1
1160179|NCT01249131|3810272|P6|Washout Period of 10 Days|Adverse Event|0
1160180|NCT01249131|3810273|P5|Washout Period of 10 Days|Adverse Event|1
1160181|NCT01249131|3810274|P4|Washout Period of 10 Days|Adverse Event|0
1160182|NCT01249131|3810275|P3|Washout Period of 10 Days|Adverse Event|0
1160183|NCT01249131|3810276|P2|Washout Period of 10 Days|Adverse Event|0
1160184|NCT01249131|3810277|P1|Washout Period of 10 Days|Adverse Event|0
1160185|NCT01249118|3810297|P3|First Washout Period|Physician Decision|0
1160186|NCT01249118|3810298|P2|First Washout Period|Physician Decision|1
1160187|NCT01249118|3810299|P1|First Washout Period|Physician Decision|0
1160188|NCT01249092|3810333|P1|Overall Study|Unable to tolerate expected SE -nausea|1
1160189|NCT01249092|3810333|P1|Overall Study|Expected side effect of nausea/dyspepsia|1
1160190|NCT01248949|3810344|P5|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
1160191|NCT01248949|3810345|P4|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
1160192|NCT01248949|3810346|P3|Overall Study|Lesion In ThoracicSpine Requires Therapy|1
1160193|NCT01248949|3810347|P2|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
1160194|NCT01248949|3810348|P1|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
1160195|NCT01248949|3810344|P5|Overall Study|Pi Discretion Due To Hospitalisation|0
1160196|NCT01248949|3810345|P4|Overall Study|Pi Discretion Due To Hospitalisation|0
1160197|NCT01248949|3810346|P3|Overall Study|Pi Discretion Due To Hospitalisation|0
1160198|NCT01248949|3810347|P2|Overall Study|Pi Discretion Due To Hospitalisation|1
1160199|NCT01248949|3810348|P1|Overall Study|Pi Discretion Due To Hospitalisation|0
1160200|NCT01248949|3810344|P5|Overall Study|Pi Decision Due To Declining Status|0
1160201|NCT01248949|3810345|P4|Overall Study|Pi Decision Due To Declining Status|0
1160202|NCT01248949|3810346|P3|Overall Study|Pi Decision Due To Declining Status|1
1160203|NCT01248949|3810347|P2|Overall Study|Pi Decision Due To Declining Status|0
1160204|NCT01248949|3810348|P1|Overall Study|Pi Decision Due To Declining Status|0
1160205|NCT01248949|3810344|P5|Overall Study|Per Sponsor Request o Discontinue Drug|0
1160206|NCT01248949|3810345|P4|Overall Study|Per Sponsor Request o Discontinue Drug|0
1160207|NCT01248949|3810346|P3|Overall Study|Per Sponsor Request o Discontinue Drug|0
1160208|NCT01248949|3810347|P2|Overall Study|Per Sponsor Request o Discontinue Drug|0
1160209|NCT01248949|3810348|P1|Overall Study|Per Sponsor Request o Discontinue Drug|1
1160210|NCT01248949|3810344|P5|Overall Study|Participant Went To Hospice|0
1160211|NCT01248949|3810345|P4|Overall Study|Participant Went To Hospice|0
1160212|NCT01248949|3810346|P3|Overall Study|Participant Went To Hospice|1
1160213|NCT01248949|3810347|P2|Overall Study|Participant Went To Hospice|0
1160214|NCT01248949|3810348|P1|Overall Study|Participant Went To Hospice|0
1160215|NCT01248949|3810344|P5|Overall Study|Entered Hospice And Refused Follow Up|1
1160216|NCT01248949|3810345|P4|Overall Study|Entered Hospice And Refused Follow Up|0
1160217|NCT01248949|3810346|P3|Overall Study|Entered Hospice And Refused Follow Up|0
1160218|NCT01248949|3810347|P2|Overall Study|Entered Hospice And Refused Follow Up|0
1160219|NCT01248949|3810348|P1|Overall Study|Entered Hospice And Refused Follow Up|0
1160220|NCT01248949|3810344|P5|Overall Study|Palliative Radiation To Brain Metastases|0
1160221|NCT01248949|3810345|P4|Overall Study|Palliative Radiation To Brain Metastases|0
1160222|NCT01248949|3810346|P3|Overall Study|Palliative Radiation To Brain Metastases|0
1160223|NCT01248949|3810347|P2|Overall Study|Palliative Radiation To Brain Metastases|0
1160224|NCT01248949|3810348|P1|Overall Study|Palliative Radiation To Brain Metastases|1
1160225|NCT01248949|3810344|P5|Overall Study|Alternative Therapy.|0
1160226|NCT01248949|3810345|P4|Overall Study|Alternative Therapy.|0
1160227|NCT01248949|3810346|P3|Overall Study|Alternative Therapy.|0
1160228|NCT01248949|3810347|P2|Overall Study|Alternative Therapy.|0
1160229|NCT01248949|3810348|P1|Overall Study|Alternative Therapy.|1
1160230|NCT01248949|3810344|P5|Overall Study|Alternative Therapy|0
1160231|NCT01248949|3810345|P4|Overall Study|Alternative Therapy|0
1160232|NCT01248949|3810346|P3|Overall Study|Alternative Therapy|0
1160233|NCT01248949|3810347|P2|Overall Study|Alternative Therapy|0
1160234|NCT01248949|3810348|P1|Overall Study|Alternative Therapy|1
1160235|NCT01248949|3810344|P5|Overall Study|Death|2
1160236|NCT01248949|3810345|P4|Overall Study|Death|6
1160237|NCT01248949|3810346|P3|Overall Study|Death|21
1160238|NCT01248949|3810347|P2|Overall Study|Death|7
1160239|NCT01248949|3810348|P1|Overall Study|Death|22
1160240|NCT01248949|3810344|P5|Overall Study|Withdrawal by Subject|1
1160241|NCT01248949|3810345|P4|Overall Study|Withdrawal by Subject|3
1160242|NCT01248949|3810346|P3|Overall Study|Withdrawal by Subject|11
1160243|NCT01248949|3810347|P2|Overall Study|Withdrawal by Subject|3
1160244|NCT01248949|3810348|P1|Overall Study|Withdrawal by Subject|5
1160245|NCT01248949|3810344|P5|Overall Study|Lost to Follow-up|0
1160246|NCT01248949|3810345|P4|Overall Study|Lost to Follow-up|1
1160247|NCT01248949|3810346|P3|Overall Study|Lost to Follow-up|2
1160248|NCT01248949|3810347|P2|Overall Study|Lost to Follow-up|2
1160249|NCT01248949|3810348|P1|Overall Study|Lost to Follow-up|2
1160250|NCT01248936|3810460|P1|Overall Study|Other reason|3
1160251|NCT01248936|3810460|P1|Overall Study|Refused Treatment|1
1160252|NCT01248936|3810460|P1|Overall Study|Lost to Follow-up|7
1160253|NCT01248936|3810460|P1|Overall Study|Adverse Event|8
1160254|NCT01248936|3810460|P1|Overall Study|Withdrawal of Consent|20
1160255|NCT01248936|3810460|P1|Overall Study|Death|26
1160256|NCT01248936|3810460|P1|Overall Study|Progression of Disease|50
1160257|NCT01248936|3810460|P1|Overall Study|Sponsor Decision|259
1160258|NCT01248884|3810473|P3|Overall Study|Adverse Event|0
1160259|NCT01248884|3810474|P2|Overall Study|Adverse Event|0
1160260|NCT01248884|3810475|P1|Overall Study|Adverse Event|1
1160261|NCT01248884|3810473|P3|Overall Study|Withdrawal by Subject|1
1160262|NCT01248884|3810474|P2|Overall Study|Withdrawal by Subject|3
1160263|NCT01248884|3810475|P1|Overall Study|Withdrawal by Subject|1
1160264|NCT01248793|3810533|P2|Overall Study|Withdrawal by Subject|3
1160265|NCT01248793|3810534|P1|Overall Study|Withdrawal by Subject|3
1160266|NCT01248793|3810533|P2|Overall Study|Protocol Violation|1
1160267|NCT01248793|3810534|P1|Overall Study|Protocol Violation|0
1160268|NCT01248793|3810533|P2|Overall Study|Adverse Event|1
1160269|NCT01248793|3810534|P1|Overall Study|Adverse Event|1
1160270|NCT01248793|3810533|P2|Overall Study|Lost to Follow-up|1
1160271|NCT01248793|3810534|P1|Overall Study|Lost to Follow-up|0
1160272|NCT01248780|3810548|P2|Overall Study|Not treated|1
1160273|NCT01248780|3810549|P1|Overall Study|Not treated|0
1160274|NCT01248780|3810548|P2|Overall Study|Withdrawal by Subject|4
1160275|NCT01248780|3810549|P1|Overall Study|Withdrawal by Subject|4
1160276|NCT01248780|3810548|P2|Overall Study|Protocol Violation|1
1160277|NCT01248780|3810549|P1|Overall Study|Protocol Violation|1
1160278|NCT01248780|3810548|P2|Overall Study|Adverse Event|7
1160279|NCT01248780|3810549|P1|Overall Study|Adverse Event|2
1160280|NCT01248780|3810548|P2|Overall Study|Death|1
1160281|NCT01248780|3810549|P1|Overall Study|Death|0
1160282|NCT01248780|3810548|P2|Overall Study|Lost to Follow-up|1
1160283|NCT01248780|3810549|P1|Overall Study|Lost to Follow-up|0
1160284|NCT01248780|3810548|P2|Overall Study|Lack of Efficacy|0
1160285|NCT01248780|3810549|P1|Overall Study|Lack of Efficacy|2
1160286|NCT01248728|3810563|P2|Overall Study|Lack of Efficacy|0
1160287|NCT01248728|3810564|P1|Overall Study|Lack of Efficacy|1
1160288|NCT01248728|3810563|P2|Overall Study|Withdrawal by Subject|1
1160289|NCT01248728|3810564|P1|Overall Study|Withdrawal by Subject|2
1160290|NCT01248728|3810563|P2|Overall Study|Adverse Event|1
1160291|NCT01248728|3810564|P1|Overall Study|Adverse Event|1
1160292|NCT01248715|3810580|P2|Overall Study|Not influenza positive|510
1160293|NCT01248715|3810581|P1|Overall Study|Not influenza positive|501
1160294|NCT01248468|3810602|P3|Overall Study|Withdrawal by Subject|0
1160295|NCT01248468|3810603|P2|Overall Study|Withdrawal by Subject|2
1160296|NCT01248468|3810604|P1|Overall Study|Withdrawal by Subject|4
1160297|NCT01248468|3810602|P3|Overall Study|Pregnancy|0
1160298|NCT01248468|3810603|P2|Overall Study|Pregnancy|0
1160299|NCT01248468|3810604|P1|Overall Study|Pregnancy|1
1160300|NCT01248468|3810602|P3|Overall Study|Lost to Follow-up|4
1160301|NCT01248468|3810603|P2|Overall Study|Lost to Follow-up|12
1160302|NCT01248468|3810604|P1|Overall Study|Lost to Follow-up|9
1160303|NCT01248468|3810602|P3|Overall Study|Administrative problem|0
1160304|NCT01248468|3810603|P2|Overall Study|Administrative problem|0
1160305|NCT01248468|3810604|P1|Overall Study|Administrative problem|1
1160306|NCT01248455|3810621|P1|Overall Study|switched to alternate treatment|1
1160307|NCT01248364|3810666|P4|Overall Study|Adverse Event|0
1160308|NCT01248364|3810667|P3|Overall Study|Adverse Event|0
1160309|NCT01248364|3810668|P2|Overall Study|Adverse Event|1
1160310|NCT01248364|3810669|P1|Overall Study|Adverse Event|0
1160311|NCT01248130|3810732|P2|Overall Study|Ineligible|0
1160312|NCT01248130|3810733|P1|Overall Study|Ineligible|1
1160313|NCT01248130|3810732|P2|Overall Study|Protocol Violation|0
1160314|NCT01248130|3810733|P1|Overall Study|Protocol Violation|1
1160315|NCT01248065|3810743|P2|Overall Study|Other|5
1160316|NCT01248065|3810744|P1|Overall Study|Other|3
1160317|NCT01248065|3810743|P2|Overall Study|Third treatment failure event|1
1160318|NCT01248065|3810744|P1|Overall Study|Third treatment failure event|3
1160319|NCT01248065|3810743|P2|Overall Study|Adverse Event|0
1160320|NCT01248065|3810744|P1|Overall Study|Adverse Event|3
1160321|NCT01248065|3810743|P2|Overall Study|Withdrawal by Subject|11
1160322|NCT01248065|3810744|P1|Overall Study|Withdrawal by Subject|14
1160323|NCT01248065|3810743|P2|Overall Study|Lost to Follow-up|5
1160324|NCT01248065|3810744|P1|Overall Study|Lost to Follow-up|3
1160325|NCT01248013|3810754|P1|Overall Study|Withdrawal by Subject|14
1160326|NCT01247922|3810769|P1|Overall Study|Disease progression|4
1160327|NCT01247350|3810867|P5|Overall Study|Entry criteria not met|1
1160328|NCT01247350|3810868|P4|Overall Study|Entry criteria not met|0
1160329|NCT01247350|3810869|P3|Overall Study|Entry criteria not met|0
1160330|NCT01247350|3810870|P2|Overall Study|Entry criteria not met|0
1160331|NCT01247350|3810871|P1|Overall Study|Entry criteria not met|0
1160332|NCT01247350|3810867|P5|Overall Study|Withdrawal by Subject|0
1160333|NCT01247350|3810868|P4|Overall Study|Withdrawal by Subject|1
1160334|NCT01247350|3810869|P3|Overall Study|Withdrawal by Subject|0
1160335|NCT01247350|3810870|P2|Overall Study|Withdrawal by Subject|0
1160336|NCT01247350|3810871|P1|Overall Study|Withdrawal by Subject|0
1160337|NCT01247350|3810867|P5|Overall Study|Adverse Event|0
1160338|NCT01247350|3810868|P4|Overall Study|Adverse Event|0
1160339|NCT01247350|3810869|P3|Overall Study|Adverse Event|1
1160340|NCT01247350|3810870|P2|Overall Study|Adverse Event|0
1160341|NCT01247350|3810871|P1|Overall Study|Adverse Event|0
1160342|NCT01247324|3810929|P2|Overall Study|Lost to Follow-up|1
1160343|NCT01247324|3810930|P1|Overall Study|Lost to Follow-up|1
1160344|NCT01247324|3810929|P2|Overall Study|Adverse Event|13
1160345|NCT01247324|3810930|P1|Overall Study|Adverse Event|25
1160346|NCT01247324|3810929|P2|Overall Study|Consent withdrawn by participant|8
1160347|NCT01247324|3810930|P1|Overall Study|Consent withdrawn by participant|13
1160348|NCT01247324|3810929|P2|Overall Study|Reason not specified|8
1160349|NCT01247324|3810930|P1|Overall Study|Reason not specified|11
1160350|NCT01247324|3810929|P2|Overall Study|Protocol Violation|2
1160351|NCT01247324|3810930|P1|Overall Study|Protocol Violation|1
1160352|NCT01247324|3810929|P2|Overall Study|Pregnancy|3
1160353|NCT01247324|3810930|P1|Overall Study|Pregnancy|2
1160354|NCT01247324|3810929|P2|Overall Study|Non-compliance|0
1160355|NCT01247324|3810930|P1|Overall Study|Non-compliance|2
1160356|NCT01247324|3810929|P2|Overall Study|Lack of Efficacy|8
1160357|NCT01247324|3810930|P1|Overall Study|Lack of Efficacy|12
1160358|NCT01247324|3810929|P2|Overall Study|Non-compliance with study drug|0
1160359|NCT01247324|3810930|P1|Overall Study|Non-compliance with study drug|3
1160360|NCT01247324|3810929|P2|Overall Study|Physician Decision|1
1160361|NCT01247324|3810930|P1|Overall Study|Physician Decision|0
1160362|NCT01247324|3810929|P2|Overall Study|Death|0
1160363|NCT01247324|3810930|P1|Overall Study|Death|1
1160364|NCT01247090|3811023|P3|Overall Study|Withdrawal by Subject|0
1160365|NCT01247090|3811024|P2|Overall Study|Withdrawal by Subject|1
1160366|NCT01247090|3811025|P1|Overall Study|Withdrawal by Subject|0
1160367|NCT01247090|3811023|P3|Overall Study|Physician Decision|0
1160368|NCT01247090|3811024|P2|Overall Study|Physician Decision|0
1160369|NCT01247090|3811025|P1|Overall Study|Physician Decision|1
1160370|NCT01246999|3811054|P4|Overall Study|Withdrawal by Subject|2
1160371|NCT01246999|3811055|P3|Overall Study|Withdrawal by Subject|0
1160372|NCT01246999|3811056|P2|Overall Study|Withdrawal by Subject|0
1160373|NCT01246999|3811057|P1|Overall Study|Withdrawal by Subject|0
1160374|NCT01246999|3811054|P4|Overall Study|Lost to Follow-up|0
1160375|NCT01246999|3811055|P3|Overall Study|Lost to Follow-up|0
1160376|NCT01246999|3811056|P2|Overall Study|Lost to Follow-up|1
1160377|NCT01246999|3811057|P1|Overall Study|Lost to Follow-up|0
1160378|NCT01246973|3811092|P2|Overall Study|Withdrawal by Subject|13
1160379|NCT01246973|3811093|P1|Overall Study|Withdrawal by Subject|7
1160380|NCT01246973|3811092|P2|Overall Study|Adverse Event|9
1160381|NCT01246973|3811093|P1|Overall Study|Adverse Event|16
1160382|NCT01246973|3811092|P2|Overall Study|Other|25
1160383|NCT01246973|3811093|P1|Overall Study|Other|38
1160384|NCT01246960|3811103|P2|Overall Study|Withdrawal (by participant or physician)|3
1160385|NCT01246960|3811104|P1|Overall Study|Withdrawal (by participant or physician)|3
1160386|NCT01246960|3811103|P2|Overall Study|Lost to Follow-up|1
1160387|NCT01246960|3811104|P1|Overall Study|Lost to Follow-up|3
1160388|NCT01246206|3811212|P1|Overall Study|Patient did not receive study regiments.|1
1160389|NCT01246011|3811235|P3|Overall Study|Withdrawal by Subject|1
1160390|NCT01246011|3811236|P2|Overall Study|Withdrawal by Subject|0
1160391|NCT01246011|3811237|P1|Overall Study|Withdrawal by Subject|0
1160392|NCT01246011|3811235|P3|Overall Study|If needed warfarin clinically, withdrawn|3
1160393|NCT01246011|3811236|P2|Overall Study|If needed warfarin clinically, withdrawn|0
1160394|NCT01246011|3811237|P1|Overall Study|If needed warfarin clinically, withdrawn|0
1160395|NCT01245764|3811252|P4|Study Phase A|Lost to Follow-up|0
1160396|NCT01245764|3811253|P3|Study Phase A|Lost to Follow-up|5
1160397|NCT01245764|3811254|P2|Study Phase A|Lost to Follow-up|0
1160398|NCT01245764|3811255|P1|Study Phase A|Lost to Follow-up|0
1160399|NCT01245764|3811252|P4|Study Phase A|Protocol Violation|2
1160400|NCT01245764|3811253|P3|Study Phase A|Protocol Violation|2
1160401|NCT01245764|3811254|P2|Study Phase A|Protocol Violation|3
1160402|NCT01245764|3811255|P1|Study Phase A|Protocol Violation|6
1160403|NCT01245764|3811252|P4|Study Phase A|Other|1
1160404|NCT01245764|3811253|P3|Study Phase A|Other|3
1160405|NCT01245764|3811254|P2|Study Phase A|Other|2
1160406|NCT01245764|3811255|P1|Study Phase A|Other|3
1160407|NCT01245751|3811293|P4|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
1160408|NCT01245751|3811294|P3|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
1160409|NCT01245751|3811295|P2|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4
1160410|NCT01245751|3811296|P1|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
1160411|NCT01245751|3811293|P4|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2
1160412|NCT01245751|3811294|P3|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
1160413|NCT01245751|3811295|P2|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
1160414|NCT01245751|3811296|P1|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
1160415|NCT01245751|3811293|P4|Part 1: Day 1 to Week 52 (1 Year)|Death|0
1160416|NCT01245751|3811294|P3|Part 1: Day 1 to Week 52 (1 Year)|Death|0
1160417|NCT01245751|3811295|P2|Part 1: Day 1 to Week 52 (1 Year)|Death|1
1160418|NCT01245751|3811296|P1|Part 1: Day 1 to Week 52 (1 Year)|Death|2
1160419|NCT01245387|3811390|P1|Overall Study|Missing discontinuation status|369
1160420|NCT01245387|3811390|P1|Overall Study|Other|131
1160421|NCT01245387|3811390|P1|Overall Study|Death|3
1160422|NCT01245387|3811390|P1|Overall Study|Adverse Event|9
1160423|NCT01245387|3811390|P1|Overall Study|Lack of Efficacy|195
1160424|NCT01245387|3811390|P1|Overall Study|Lost to Follow-up|106
1160425|NCT01245374|3811439|P1|Overall Study|Withdrawal by Subject|3
1160426|NCT01245374|3811439|P1|Overall Study|Protocol Violation|1
1160427|NCT01245283|3811462|P3|Overall Study|Lost to Follow-up|11
1160428|NCT01245283|3811463|P2|Overall Study|Lost to Follow-up|11
1160429|NCT01245283|3811464|P1|Overall Study|Lost to Follow-up|14
1160430|NCT01245140|3811509|P2|Overall Study|Refused Treatment/Did Not Coopera|1
1160431|NCT01245140|3811510|P1|Overall Study|Refused Treatment/Did Not Coopera|0
1160432|NCT01245140|3811509|P2|Overall Study|Withdrawal by Subject|1
1160433|NCT01245140|3811510|P1|Overall Study|Withdrawal by Subject|0
1160434|NCT01245140|3811509|P2|Overall Study|Protocol Violation|1
1160435|NCT01245140|3811510|P1|Overall Study|Protocol Violation|0
1160436|NCT01245140|3811509|P2|Overall Study|Lack of Efficacy|4
1160437|NCT01245140|3811510|P1|Overall Study|Lack of Efficacy|2
1160438|NCT01245140|3811509|P2|Overall Study|Adverse Event|3
1160439|NCT01245140|3811510|P1|Overall Study|Adverse Event|1
1160440|NCT01245101|3811566|P2|Period 3 (Treatment)|Withdrawal by Subject|0
1160441|NCT01245101|3811567|P1|Period 3 (Treatment)|Withdrawal by Subject|1
1160442|NCT01245101|3811566|P2|Period 2 (Washout)|Withdrawal by Subject|0
1160443|NCT01245101|3811567|P1|Period 2 (Washout)|Withdrawal by Subject|1
1160444|NCT01245101|3811566|P2|Period 1 (Treatment)|Withdrawal by Subject|0
1160445|NCT01245101|3811567|P1|Period 1 (Treatment)|Withdrawal by Subject|2
1160446|NCT01245062|3811577|P3|Cross-over Phase|Study closed/ terminated|11
1160447|NCT01245062|3811578|P2|Cross-over Phase|Study closed/ terminated|0
1160448|NCT01245062|3811579|P1|Cross-over Phase|Study closed/ terminated|0
1160449|NCT01245062|3811577|P3|Cross-over Phase|Withdrew Consent|4
1160450|NCT01245062|3811578|P2|Cross-over Phase|Withdrew Consent|0
1160451|NCT01245062|3811579|P1|Cross-over Phase|Withdrew Consent|0
1160452|NCT01245062|3811577|P3|Cross-over Phase|Physician Decision|1
1160453|NCT01245062|3811578|P2|Cross-over Phase|Physician Decision|0
1160454|NCT01245062|3811579|P1|Cross-over Phase|Physician Decision|0
1160455|NCT01245062|3811577|P3|Cross-over Phase|Lost to Follow-up|1
1160456|NCT01245062|3811578|P2|Cross-over Phase|Lost to Follow-up|0
1160457|NCT01245062|3811579|P1|Cross-over Phase|Lost to Follow-up|0
1160458|NCT01245062|3811577|P3|Randomization and Crossover Phase|Study closed/ terminated|0
1160459|NCT01245062|3811578|P2|Randomization and Crossover Phase|Study closed/ terminated|14
1160460|NCT01245062|3811579|P1|Randomization and Crossover Phase|Study closed/ terminated|23
1160461|NCT01245062|3811577|P3|Randomization and Crossover Phase|Withdrew Consent|0
1160462|NCT01245062|3811578|P2|Randomization and Crossover Phase|Withdrew Consent|11
1160463|NCT01245062|3811579|P1|Randomization and Crossover Phase|Withdrew Consent|12
1160464|NCT01245062|3811577|P3|Randomization and Crossover Phase|Physician Decision|0
1160465|NCT01245062|3811578|P2|Randomization and Crossover Phase|Physician Decision|4
1160466|NCT01245062|3811579|P1|Randomization and Crossover Phase|Physician Decision|2
1160467|NCT01245062|3811577|P3|Randomization and Crossover Phase|Lost to Follow-up|0
1160468|NCT01245062|3811578|P2|Randomization and Crossover Phase|Lost to Follow-up|2
1160469|NCT01245062|3811579|P1|Randomization and Crossover Phase|Lost to Follow-up|4
1160470|NCT01245049|3811617|P2|Overall Study|Lost to Follow-up|2
1160471|NCT01245049|3811618|P1|Overall Study|Lost to Follow-up|1
1160472|NCT01245049|3811617|P2|Overall Study|Withdrawal by Subject|1
1160473|NCT01245049|3811618|P1|Overall Study|Withdrawal by Subject|0
1160474|NCT01245049|3811617|P2|Overall Study|Migrated/moved from study area|1
1160475|NCT01245049|3811618|P1|Overall Study|Migrated/moved from study area|0
1160476|NCT01244984|3811671|P3|Overall Study|Withdrawal by Subject|2
1160477|NCT01244984|3811672|P2|Overall Study|Withdrawal by Subject|2
1160478|NCT01244984|3811673|P1|Overall Study|Withdrawal by Subject|1
1160479|NCT01244984|3811671|P3|Overall Study|Protocol Defined Stopping Criteria|0
1160480|NCT01244984|3811672|P2|Overall Study|Protocol Defined Stopping Criteria|1
1160481|NCT01244984|3811673|P1|Overall Study|Protocol Defined Stopping Criteria|1
1160482|NCT01244984|3811671|P3|Overall Study|Protocol Violation|0
1160483|NCT01244984|3811672|P2|Overall Study|Protocol Violation|0
1160484|NCT01244984|3811673|P1|Overall Study|Protocol Violation|1
1160485|NCT01244984|3811671|P3|Overall Study|Adverse Event|2
1160486|NCT01244984|3811672|P2|Overall Study|Adverse Event|11
1160487|NCT01244984|3811673|P1|Overall Study|Adverse Event|2
1160488|NCT01244906|3811747|P1|Overall Study|Progression of disease post treatment|6
1160489|NCT01244906|3811747|P1|Overall Study|Death|2
1160490|NCT01244893|3811756|P2|1-Week Follow Up|Lost to Follow-up|0
1160491|NCT01244893|3811757|P1|1-Week Follow Up|Lost to Follow-up|1
1160492|NCT01244893|3811756|P2|Baseline|Protocol Violation|1
1160493|NCT01244893|3811757|P1|Baseline|Protocol Violation|0
1160494|NCT01244828|3811769|P1|Overall Study|Other reason (not specified)|1
1160495|NCT01244828|3811769|P1|Overall Study|Lost to Follow-up|2
1160496|NCT01244828|3811769|P1|Overall Study|Lack of Efficacy|7
1160497|NCT01244828|3811769|P1|Overall Study|Withdrawal by Subject|31
1160498|NCT01244828|3811769|P1|Overall Study|Adverse Event|37
1160499|NCT01244815|3811785|P4|Overall Study|Did Not Meet Protocol Eligibility|0
1160500|NCT01244815|3811786|P3|Overall Study|Did Not Meet Protocol Eligibility|0
1160501|NCT01244815|3811787|P2|Overall Study|Did Not Meet Protocol Eligibility|1
1160502|NCT01244815|3811788|P1|Overall Study|Did Not Meet Protocol Eligibility|0
1160503|NCT01244815|3811785|P4|Overall Study|Protocol Violation|1
1160504|NCT01244815|3811786|P3|Overall Study|Protocol Violation|3
1160505|NCT01244815|3811787|P2|Overall Study|Protocol Violation|4
1160506|NCT01244815|3811788|P1|Overall Study|Protocol Violation|7
1160507|NCT01244815|3811785|P4|Overall Study|Withdrawal by Subject|3
1160508|NCT01244815|3811786|P3|Overall Study|Withdrawal by Subject|0
1160509|NCT01244815|3811787|P2|Overall Study|Withdrawal by Subject|2
1160510|NCT01244815|3811788|P1|Overall Study|Withdrawal by Subject|0
1160511|NCT01244815|3811785|P4|Overall Study|Lost to Follow-up|2
1160512|NCT01244815|3811786|P3|Overall Study|Lost to Follow-up|3
1160513|NCT01244815|3811787|P2|Overall Study|Lost to Follow-up|2
1160514|NCT01244815|3811788|P1|Overall Study|Lost to Follow-up|3
1160515|NCT01244815|3811785|P4|Overall Study|Treatment Failure|1
1160516|NCT01244815|3811786|P3|Overall Study|Treatment Failure|0
1160517|NCT01244815|3811787|P2|Overall Study|Treatment Failure|0
1160518|NCT01244815|3811788|P1|Overall Study|Treatment Failure|0
1160519|NCT01244815|3811785|P4|Overall Study|Adverse Event|5
1160520|NCT01244815|3811786|P3|Overall Study|Adverse Event|5
1160521|NCT01244815|3811787|P2|Overall Study|Adverse Event|7
1160522|NCT01244815|3811788|P1|Overall Study|Adverse Event|4
1160523|NCT01244815|3811785|P4|Overall Study|Not Treated|0
1160524|NCT01244815|3811786|P3|Overall Study|Not Treated|0
1160525|NCT01244815|3811787|P2|Overall Study|Not Treated|1
1160526|NCT01244815|3811788|P1|Overall Study|Not Treated|0
1160527|NCT01244620|3811875|P4|Overall Study|Study terminated|4
1160528|NCT01244620|3811876|P3|Overall Study|Study terminated|4
1160529|NCT01244620|3811877|P2|Overall Study|Study terminated|4
1160530|NCT01244620|3811878|P1|Overall Study|Study terminated|4
1160531|NCT01244516|3811937|P3|Period 2 (1-week to 2-week Visit)|Poor Comfort|1
1160532|NCT01244516|3811938|P2|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
1160533|NCT01244516|3811939|P1|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
1160534|NCT01244516|3811937|P3|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
1160535|NCT01244516|3811938|P2|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1
1160536|NCT01244516|3811939|P1|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
1160537|NCT01244516|3811937|P3|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
1160538|NCT01244516|3811938|P2|Period 2 (1-week to 2-week Visit)|Protocol Violation|0
1160539|NCT01244516|3811939|P1|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
1160540|NCT01244516|3811937|P3|Period 2 (1-week to 2-week Visit)|Adverse Event|0
1160541|NCT01244516|3811938|P2|Period 2 (1-week to 2-week Visit)|Adverse Event|0
1160542|NCT01244516|3811939|P1|Period 2 (1-week to 2-week Visit)|Adverse Event|2
1160543|NCT01244516|3811937|P3|Period 1 (Baseline to 1-week Visit)|Poor comfort|1
1160544|NCT01244516|3811938|P2|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
1160545|NCT01244516|3811939|P1|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
1160546|NCT01244516|3811937|P3|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
1160547|NCT01244516|3811938|P2|Period 1 (Baseline to 1-week Visit)|Poor Vision|1
1160548|NCT01244516|3811939|P1|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
1160549|NCT01244516|3811937|P3|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2
1160550|NCT01244516|3811938|P2|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5
1160551|NCT01244516|3811939|P1|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4
1160552|NCT01244490|3811960|P3|Overall Study|Not specified|1
1160553|NCT01244490|3811961|P2|Overall Study|Not specified|0
1160554|NCT01244490|3811962|P1|Overall Study|Not specified|0
1160555|NCT01244490|3811960|P3|Overall Study|Lost to Follow-up|3
1160556|NCT01244490|3811961|P2|Overall Study|Lost to Follow-up|6
1160557|NCT01244490|3811962|P1|Overall Study|Lost to Follow-up|0
1160558|NCT01244490|3811960|P3|Overall Study|Adverse Event|5
1160559|NCT01244490|3811961|P2|Overall Study|Adverse Event|9
1160560|NCT01244490|3811962|P1|Overall Study|Adverse Event|1
1160561|NCT01244490|3811960|P3|Overall Study|Withdrawal by Subject|9
1160562|NCT01244490|3811961|P2|Overall Study|Withdrawal by Subject|4
1160563|NCT01244490|3811962|P1|Overall Study|Withdrawal by Subject|4
1160564|NCT01244490|3811960|P3|Overall Study|Lack of Efficacy|5
1160565|NCT01244490|3811961|P2|Overall Study|Lack of Efficacy|5
1160566|NCT01244490|3811962|P1|Overall Study|Lack of Efficacy|14
1160567|NCT01244425|3812030|P2|Overall Study|Adverse Event|1
1160568|NCT01244425|3812031|P1|Overall Study|Adverse Event|1
1160569|NCT01244425|3812030|P2|Overall Study|Withdrawal by Subject|2
1160570|NCT01244425|3812031|P1|Overall Study|Withdrawal by Subject|2
1160571|NCT01244126|3812063|P3|Overall Study|Protocol Violation|9
1160572|NCT01244126|3812064|P2|Overall Study|Protocol Violation|3
1160573|NCT01244126|3812065|P1|Overall Study|Protocol Violation|3
1160574|NCT01244061|3812078|P2|Overall Study|Randomized but not treated|2
1160575|NCT01244061|3812079|P1|Overall Study|Randomized but not treated|2
1160576|NCT01244061|3812078|P2|Overall Study|Adverse Event|2
1160577|NCT01244061|3812079|P1|Overall Study|Adverse Event|5
1160578|NCT01244061|3812078|P2|Overall Study|Protocol Violation|1
1160579|NCT01244061|3812079|P1|Overall Study|Protocol Violation|1
1160580|NCT01244061|3812078|P2|Overall Study|Not specified|19
1160581|NCT01244061|3812079|P1|Overall Study|Not specified|8
1160582|NCT01244061|3812078|P2|Overall Study|Withdrawal by Subject|46
1160583|NCT01244061|3812079|P1|Overall Study|Withdrawal by Subject|29
1160584|NCT01244061|3812078|P2|Overall Study|Lost to Follow-up|30
1160585|NCT01244061|3812079|P1|Overall Study|Lost to Follow-up|34
1160586|NCT01244061|3812078|P2|Overall Study|Lack of Efficacy|3
1160587|NCT01244061|3812079|P1|Overall Study|Lack of Efficacy|1
1160588|NCT01244061|3812078|P2|Overall Study|Did not meet entrance criteria|0
1160589|NCT01244061|3812079|P1|Overall Study|Did not meet entrance criteria|1
1160590|NCT01244061|3812078|P2|Overall Study|Death|0
1160591|NCT01244061|3812079|P1|Overall Study|Death|1
1160592|NCT01243944|3812104|P2|Overall Study|Physician Decision|2
1160593|NCT01243944|3812105|P1|Overall Study|Physician Decision|2
1160594|NCT01243944|3812104|P2|Overall Study|Patient decision|5
1160595|NCT01243944|3812105|P1|Overall Study|Patient decision|6
1160596|NCT01243944|3812104|P2|Overall Study|Disease progression|1
1160597|NCT01243944|3812105|P1|Overall Study|Disease progression|5
1160598|NCT01243944|3812104|P2|Overall Study|Lack of Efficacy|98
1160599|NCT01243944|3812105|P1|Overall Study|Lack of Efficacy|0
1160600|NCT01243944|3812104|P2|Overall Study|Adverse Event|2
1160601|NCT01243944|3812105|P1|Overall Study|Adverse Event|4
1160602|NCT01243892|3812129|P2|Overall Study|Did not meet eligibility criteria|0
1160603|NCT01243892|3812130|P1|Overall Study|Did not meet eligibility criteria|2
1160604|NCT01243775|3812140|P1|Overall Study|Withdrawal by Subject|2
1160605|NCT01243762|3812154|P7|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
1160606|NCT01243762|3812155|P6|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
1160607|NCT01243762|3812156|P5|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
1160608|NCT01243762|3812157|P4|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
1160609|NCT01243762|3812158|P3|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
1160610|NCT01243762|3812159|P2|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
1160611|NCT01243762|3812160|P1|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
1160612|NCT01243762|3812154|P7|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
1160613|NCT01243762|3812155|P6|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
1160614|NCT01243762|3812156|P5|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
1160615|NCT01243762|3812157|P4|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
1160616|NCT01243762|3812158|P3|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
1160617|NCT01243762|3812159|P2|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
1160618|NCT01243762|3812160|P1|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
1160700|NCT01243177|3812386|P2|Overall Study|Lack of Efficacy|31
1160619|NCT01243762|3812154|P7|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
1160620|NCT01243762|3812155|P6|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
1160621|NCT01243762|3812156|P5|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2
1160622|NCT01243762|3812157|P4|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
1160623|NCT01243762|3812158|P3|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
1160624|NCT01243762|3812159|P2|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
1160625|NCT01243762|3812160|P1|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
1160626|NCT01243762|3812154|P7|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3
1160627|NCT01243762|3812155|P6|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
1160628|NCT01243762|3812156|P5|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
1160629|NCT01243762|3812157|P4|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
1160630|NCT01243762|3812158|P3|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
1160631|NCT01243762|3812159|P2|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1
1160632|NCT01243762|3812160|P1|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
1160633|NCT01243762|3812154|P7|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
1160634|NCT01243762|3812155|P6|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
1160635|NCT01243762|3812156|P5|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
1160636|NCT01243762|3812157|P4|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
1160637|NCT01243762|3812158|P3|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
1160638|NCT01243762|3812159|P2|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3
1160639|NCT01243762|3812160|P1|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
1160640|NCT01243762|3812154|P7|Part 1 (Dose Escalation/MTD)|Progressive Disease|0
1160641|NCT01243762|3812155|P6|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
1160642|NCT01243762|3812156|P5|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
1160643|NCT01243762|3812157|P4|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
1160644|NCT01243762|3812158|P3|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
1160645|NCT01243762|3812159|P2|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
1160646|NCT01243762|3812160|P1|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
1160647|NCT01243762|3812154|P7|Part 1 (Dose Escalation/MTD)|Physician Decision|0
1160648|NCT01243762|3812155|P6|Part 1 (Dose Escalation/MTD)|Physician Decision|0
1160649|NCT01243762|3812156|P5|Part 1 (Dose Escalation/MTD)|Physician Decision|0
1160650|NCT01243762|3812157|P4|Part 1 (Dose Escalation/MTD)|Physician Decision|1
1160651|NCT01243762|3812158|P3|Part 1 (Dose Escalation/MTD)|Physician Decision|0
1160652|NCT01243762|3812159|P2|Part 1 (Dose Escalation/MTD)|Physician Decision|1
1160653|NCT01243762|3812160|P1|Part 1 (Dose Escalation/MTD)|Physician Decision|0
1160654|NCT01243762|3812154|P7|Part 1 (Dose Escalation/MTD)|Adverse Event|0
1160655|NCT01243762|3812155|P6|Part 1 (Dose Escalation/MTD)|Adverse Event|1
1160656|NCT01243762|3812156|P5|Part 1 (Dose Escalation/MTD)|Adverse Event|1
1160657|NCT01243762|3812157|P4|Part 1 (Dose Escalation/MTD)|Adverse Event|0
1160658|NCT01243762|3812158|P3|Part 1 (Dose Escalation/MTD)|Adverse Event|0
1160659|NCT01243762|3812159|P2|Part 1 (Dose Escalation/MTD)|Adverse Event|2
1160660|NCT01243762|3812160|P1|Part 1 (Dose Escalation/MTD)|Adverse Event|0
1160661|NCT01243671|3812179|P1|Overall Study|Not Specified|1
1160662|NCT01243671|3812179|P1|Overall Study|Anti-adalimumab antibody positive|1
1160663|NCT01243671|3812179|P1|Overall Study|Adverse Event|3
1160664|NCT01243411|3812256|P1|Overall Study|Other|8
1160665|NCT01243411|3812256|P1|Overall Study|Adverse Event|5
1160666|NCT01243411|3812256|P1|Overall Study|Lost to Follow-up|10
1160667|NCT01243411|3812256|P1|Overall Study|Withdrawal by Subject|18
1160668|NCT01243268|3812361|P1|Overall Study|Duplicate subject|2
1160669|NCT01243268|3812361|P1|Overall Study|Deviation with contract date|7
1160670|NCT01243268|3812361|P1|Overall Study|Protocol Violation|51
1160671|NCT01243268|3812361|P1|Overall Study|Lost to Follow-up|4
1160672|NCT01243242|3812371|P2|Overall Study|non compliance|0
1160673|NCT01243242|3812372|P1|Overall Study|non compliance|1
1160674|NCT01243242|3812371|P2|Overall Study|sponsor decision|1
1160675|NCT01243242|3812372|P1|Overall Study|sponsor decision|0
1160676|NCT01243242|3812371|P2|Overall Study|Physician Decision|1
1160677|NCT01243242|3812372|P1|Overall Study|Physician Decision|0
1160678|NCT01243242|3812371|P2|Overall Study|Withdrawal by Subject|1
1160679|NCT01243242|3812372|P1|Overall Study|Withdrawal by Subject|1
1160680|NCT01243242|3812371|P2|Overall Study|Adverse Event|1
1160681|NCT01243242|3812372|P1|Overall Study|Adverse Event|1
1160682|NCT01243177|3812386|P2|Overall Study|Other Reason|12
1160683|NCT01243177|3812387|P1|Overall Study|Other Reason|11
1160684|NCT01243177|3812386|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
1160685|NCT01243177|3812387|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
1160686|NCT01243177|3812386|P2|Overall Study|SAE, fatal + SAE, non-fatal|0
1160687|NCT01243177|3812387|P1|Overall Study|SAE, fatal + SAE, non-fatal|1
1160688|NCT01243177|3812386|P2|Overall Study|AE, non-serious non-fatal|58
1160689|NCT01243177|3812387|P1|Overall Study|AE, non-serious non-fatal|40
1160690|NCT01243177|3812386|P2|Overall Study|SAE, non-fatal|9
1160691|NCT01243177|3812387|P1|Overall Study|SAE, non-fatal|7
1160692|NCT01243177|3812386|P2|Overall Study|AE, serious fatal|1
1160693|NCT01243177|3812387|P1|Overall Study|AE, serious fatal|0
1160694|NCT01243177|3812386|P2|Overall Study|Withdrawal by Subject|38
1160695|NCT01243177|3812387|P1|Overall Study|Withdrawal by Subject|46
1160696|NCT01243177|3812386|P2|Overall Study|Lost to Follow-up|18
1160697|NCT01243177|3812387|P1|Overall Study|Lost to Follow-up|15
1160698|NCT01243177|3812386|P2|Overall Study|Protocol Violation|10
1160699|NCT01243177|3812387|P1|Overall Study|Protocol Violation|11
1160701|NCT01243177|3812387|P1|Overall Study|Lack of Efficacy|47
1160702|NCT01242813|3812408|P1|Overall Study|Lost to Follow-up|2
1160703|NCT01242748|3812430|P2|Overall Study|Miscellaneous reasons|3
1160704|NCT01242748|3812431|P1|Overall Study|Miscellaneous reasons|8
1160705|NCT01242748|3812430|P2|Overall Study|Withdrawal by Subject|2
1160706|NCT01242748|3812431|P1|Overall Study|Withdrawal by Subject|10
1160707|NCT01242748|3812430|P2|Overall Study|Protocol Violation|0
1160708|NCT01242748|3812431|P1|Overall Study|Protocol Violation|1
1160709|NCT01242748|3812430|P2|Overall Study|Physician Decision|2
1160710|NCT01242748|3812431|P1|Overall Study|Physician Decision|3
1160711|NCT01242748|3812430|P2|Overall Study|Lost to Follow-up|2
1160712|NCT01242748|3812431|P1|Overall Study|Lost to Follow-up|6
1160713|NCT01242748|3812430|P2|Overall Study|Adverse Event|5
1160714|NCT01242748|3812431|P1|Overall Study|Adverse Event|10
1160715|NCT01242514|3812471|P3|Overall Study|Adverse Event|19
1160716|NCT01242514|3812472|P2|Overall Study|Adverse Event|18
1160717|NCT01242514|3812473|P1|Overall Study|Adverse Event|129
1160718|NCT01242514|3812471|P3|Overall Study|Lost to Follow-up|4
1160719|NCT01242514|3812472|P2|Overall Study|Lost to Follow-up|5
1160720|NCT01242514|3812473|P1|Overall Study|Lost to Follow-up|14
1160721|NCT01242514|3812471|P3|Overall Study|Dev. of study specific discont. criteria|5
1160722|NCT01242514|3812472|P2|Overall Study|Dev. of study specific discont. criteria|3
1160723|NCT01242514|3812473|P1|Overall Study|Dev. of study specific discont. criteria|21
1160724|NCT01242514|3812471|P3|Overall Study|Lack of therapeutic response|10
1160725|NCT01242514|3812472|P2|Overall Study|Lack of therapeutic response|16
1160726|NCT01242514|3812473|P1|Overall Study|Lack of therapeutic response|99
1160727|NCT01242514|3812471|P3|Overall Study|Severe non-compliance to protocol|1
1160728|NCT01242514|3812472|P2|Overall Study|Severe non-compliance to protocol|2
1160729|NCT01242514|3812473|P1|Overall Study|Severe non-compliance to protocol|5
1160730|NCT01242514|3812471|P3|Overall Study|Subject decision|2
1160731|NCT01242514|3812472|P2|Overall Study|Subject decision|8
1160732|NCT01242514|3812473|P1|Overall Study|Subject decision|33
1160733|NCT01242514|3812471|P3|Overall Study|e.g., project closure|171
1160734|NCT01242514|3812472|P2|Overall Study|e.g., project closure|305
1160735|NCT01242514|3812473|P1|Overall Study|e.g., project closure|1042
1160736|NCT01242371|3812492|P2|Overall Study|Protocol Violation|3
1160737|NCT01242371|3812493|P1|Overall Study|Protocol Violation|0
1160738|NCT01242371|3812492|P2|Overall Study|Withdrawal by Subject|2
1160739|NCT01242371|3812493|P1|Overall Study|Withdrawal by Subject|2
1160740|NCT01242176|3812499|P2|Washout Period of 7 Days|Non-compliant with protocol|0
1160741|NCT01242176|3812500|P1|Washout Period of 7 Days|Non-compliant with protocol|1
1160742|NCT01242176|3812499|P2|Washout Period of 7 Days|Adverse Event|2
1160743|NCT01242176|3812500|P1|Washout Period of 7 Days|Adverse Event|0
1160744|NCT01242111|3812510|P1|Overall Study|Did not consent to MOR-100 follow-up|1
1160745|NCT01242111|3812510|P1|Overall Study|Withdrawal by Subject|1
1160746|NCT01242111|3812510|P1|Overall Study|Adverse Event|1
1160747|NCT01242085|3812522|P3|Overall Study|medically unable to have surgery|0
1160748|NCT01242085|3812523|P2|Overall Study|medically unable to have surgery|5
1160749|NCT01242085|3812524|P1|Overall Study|medically unable to have surgery|4
1160750|NCT01242085|3812522|P3|Overall Study|Withdrawal by Subject|0
1160751|NCT01242085|3812523|P2|Overall Study|Withdrawal by Subject|2
1160752|NCT01242085|3812524|P1|Overall Study|Withdrawal by Subject|4
1160753|NCT01242020|3812534|P2|Overall Study|Failed screening|0
1160754|NCT01242020|3812535|P1|Overall Study|Failed screening|1
1160755|NCT01242020|3812534|P2|Overall Study|Withdrawal by Subject|0
1160756|NCT01242020|3812535|P1|Overall Study|Withdrawal by Subject|2
1160757|NCT01241760|3812565|P2|Overall Study|Not specified|1
1160758|NCT01241760|3812566|P1|Overall Study|Not specified|1
1160759|NCT01241760|3812565|P2|Overall Study|Switch To Commercially Available Medicat|4
1160760|NCT01241760|3812566|P1|Overall Study|Switch To Commercially Available Medicat|1
1160761|NCT01241760|3812565|P2|Overall Study|Withdrawal by Subject|13
1160762|NCT01241760|3812566|P1|Overall Study|Withdrawal by Subject|13
1160763|NCT01241760|3812565|P2|Overall Study|Lost to Follow-up|22
1160764|NCT01241760|3812566|P1|Overall Study|Lost to Follow-up|18
1160765|NCT01241760|3812565|P2|Overall Study|Adverse Event|0
1160766|NCT01241760|3812566|P1|Overall Study|Adverse Event|1
1160767|NCT01241591|3812589|P4|Overall Study|Adverse Event|4
1160768|NCT01241591|3812590|P3|Overall Study|Adverse Event|12
1160769|NCT01241591|3812591|P2|Overall Study|Adverse Event|11
1160770|NCT01241591|3812592|P1|Overall Study|Adverse Event|3
1160771|NCT01241591|3812589|P4|Overall Study|Not specified|1
1160772|NCT01241591|3812590|P3|Overall Study|Not specified|0
1160773|NCT01241591|3812591|P2|Overall Study|Not specified|1
1160774|NCT01241591|3812592|P1|Overall Study|Not specified|0
1160775|NCT01241591|3812589|P4|Overall Study|Withdrawal by Subject|2
1160776|NCT01241591|3812590|P3|Overall Study|Withdrawal by Subject|2
1160777|NCT01241591|3812591|P2|Overall Study|Withdrawal by Subject|4
1160778|NCT01241591|3812592|P1|Overall Study|Withdrawal by Subject|6
1160779|NCT01241591|3812589|P4|Overall Study|Screen Failure|0
1160780|NCT01241591|3812590|P3|Overall Study|Screen Failure|1
1160781|NCT01241591|3812591|P2|Overall Study|Screen Failure|2
1160782|NCT01241591|3812592|P1|Overall Study|Screen Failure|3
1160783|NCT01241591|3812589|P4|Overall Study|Lost to Follow-up|2
1160784|NCT01241591|3812590|P3|Overall Study|Lost to Follow-up|2
1160785|NCT01241591|3812591|P2|Overall Study|Lost to Follow-up|2
1160786|NCT01241591|3812592|P1|Overall Study|Lost to Follow-up|1
1160787|NCT01241591|3812589|P4|Overall Study|Protocol Violation|0
1160788|NCT01241591|3812590|P3|Overall Study|Protocol Violation|3
1160789|NCT01241591|3812591|P2|Overall Study|Protocol Violation|2
1160790|NCT01241591|3812592|P1|Overall Study|Protocol Violation|5
1160791|NCT01241591|3812589|P4|Overall Study|Lack of Efficacy|3
1160792|NCT01241591|3812590|P3|Overall Study|Lack of Efficacy|2
1160793|NCT01241591|3812591|P2|Overall Study|Lack of Efficacy|2
1160794|NCT01241591|3812592|P1|Overall Study|Lack of Efficacy|5
1160795|NCT01241552|3812795|P4|Overall Study|Lost to Follow-up|16
1160796|NCT01241552|3812796|P3|Overall Study|Lost to Follow-up|15
1160797|NCT01241552|3812797|P2|Overall Study|Lost to Follow-up|11
1160798|NCT01241552|3812798|P1|Overall Study|Lost to Follow-up|2
1160799|NCT01241552|3812795|P4|Overall Study|Physician Decision|3
1160800|NCT01241552|3812796|P3|Overall Study|Physician Decision|2
1160801|NCT01241552|3812797|P2|Overall Study|Physician Decision|4
1160802|NCT01241552|3812798|P1|Overall Study|Physician Decision|2
1160803|NCT01241552|3812795|P4|Overall Study|Withdrawal by Subject|15
1160804|NCT01241552|3812796|P3|Overall Study|Withdrawal by Subject|14
1160805|NCT01241552|3812797|P2|Overall Study|Withdrawal by Subject|15
1160806|NCT01241552|3812798|P1|Overall Study|Withdrawal by Subject|7
1160807|NCT01241552|3812795|P4|Overall Study|Protocol Violation|1
1160808|NCT01241552|3812796|P3|Overall Study|Protocol Violation|6
1160809|NCT01241552|3812797|P2|Overall Study|Protocol Violation|2
1160810|NCT01241552|3812798|P1|Overall Study|Protocol Violation|0
1160811|NCT01241552|3812795|P4|Overall Study|Progressive Disease|2
1160812|NCT01241552|3812796|P3|Overall Study|Progressive Disease|1
1160813|NCT01241552|3812797|P2|Overall Study|Progressive Disease|0
1160814|NCT01241552|3812798|P1|Overall Study|Progressive Disease|0
1160815|NCT01241552|3812795|P4|Overall Study|Technical Problems|2
1160816|NCT01241552|3812796|P3|Overall Study|Technical Problems|2
1160817|NCT01241552|3812797|P2|Overall Study|Technical Problems|0
1160818|NCT01241552|3812798|P1|Overall Study|Technical Problems|2
1160819|NCT01241552|3812795|P4|Overall Study|Adverse Event|0
1160820|NCT01241552|3812796|P3|Overall Study|Adverse Event|0
1160821|NCT01241552|3812797|P2|Overall Study|Adverse Event|1
1160822|NCT01241552|3812798|P1|Overall Study|Adverse Event|1
1160823|NCT01241552|3812795|P4|Overall Study|Death|25
1160824|NCT01241552|3812796|P3|Overall Study|Death|20
1160825|NCT01241552|3812797|P2|Overall Study|Death|30
1160826|NCT01241552|3812798|P1|Overall Study|Death|26
1160827|NCT01241552|3812795|P4|Overall Study|Lack of Efficacy|0
1160828|NCT01241552|3812796|P3|Overall Study|Lack of Efficacy|0
1160829|NCT01241552|3812797|P2|Overall Study|Lack of Efficacy|0
1160830|NCT01241552|3812798|P1|Overall Study|Lack of Efficacy|1
1160831|NCT01241461|3812893|P2|Overall Study|Progressive Disease|6
1160832|NCT01241461|3812894|P1|Overall Study|Progressive Disease|3
1160833|NCT01241448|3812914|P4|Overall Study|Excluded due to data integrity issues|2
1160834|NCT01241448|3812915|P3|Overall Study|Excluded due to data integrity issues|2
1160835|NCT01241448|3812916|P2|Overall Study|Excluded due to data integrity issues|2
1160836|NCT01241448|3812917|P1|Overall Study|Excluded due to data integrity issues|3
1160837|NCT01241448|3812914|P4|Overall Study|Withdrawal by Subject|6
1160838|NCT01241448|3812915|P3|Overall Study|Withdrawal by Subject|3
1160839|NCT01241448|3812916|P2|Overall Study|Withdrawal by Subject|5
1160840|NCT01241448|3812917|P1|Overall Study|Withdrawal by Subject|4
1160841|NCT01241448|3812914|P4|Overall Study|Sponsor Decision|6
1160842|NCT01241448|3812915|P3|Overall Study|Sponsor Decision|12
1160843|NCT01241448|3812916|P2|Overall Study|Sponsor Decision|14
1160844|NCT01241448|3812917|P1|Overall Study|Sponsor Decision|17
1160845|NCT01241448|3812914|P4|Overall Study|Protocol Violation|6
1160846|NCT01241448|3812915|P3|Overall Study|Protocol Violation|3
1160847|NCT01241448|3812916|P2|Overall Study|Protocol Violation|5
1160848|NCT01241448|3812917|P1|Overall Study|Protocol Violation|10
1160849|NCT01241448|3812914|P4|Overall Study|Physician Decision|0
1160850|NCT01241448|3812915|P3|Overall Study|Physician Decision|0
1160851|NCT01241448|3812916|P2|Overall Study|Physician Decision|2
1160852|NCT01241448|3812917|P1|Overall Study|Physician Decision|0
1160853|NCT01241448|3812914|P4|Overall Study|Lost to Follow-up|1
1160854|NCT01241448|3812915|P3|Overall Study|Lost to Follow-up|1
1160855|NCT01241448|3812916|P2|Overall Study|Lost to Follow-up|1
1160856|NCT01241448|3812917|P1|Overall Study|Lost to Follow-up|2
1160857|NCT01241448|3812914|P4|Overall Study|Adverse Event|2
1160858|NCT01241448|3812915|P3|Overall Study|Adverse Event|2
1160859|NCT01241448|3812916|P2|Overall Study|Adverse Event|0
1160860|NCT01241448|3812917|P1|Overall Study|Adverse Event|1
1160861|NCT01241292|3813008|P2|Overall Study|Participant Discontinued Treatment|2
1160862|NCT01241292|3813009|P1|Overall Study|Participant Discontinued Treatment|0
1160863|NCT01241292|3813008|P2|Overall Study|Study Drug Toxicity|1
1160864|NCT01241292|3813009|P1|Overall Study|Study Drug Toxicity|0
1160865|NCT01241292|3813008|P2|Overall Study|Disease Progression|0
1160866|NCT01241292|3813009|P1|Overall Study|Disease Progression|2
1160867|NCT01241292|3813008|P2|Overall Study|Administrative Reason by Sponsor|0
1160868|NCT01241292|3813009|P1|Overall Study|Administrative Reason by Sponsor|1
1160869|NCT01241279|3813033|P2|Overall Study|Lost to Follow-up|1
1160870|NCT01241279|3813034|P1|Overall Study|Lost to Follow-up|0
1160871|NCT01241240|3813044|P2|Overall Study|Personal Reasons|1
1160872|NCT01241240|3813045|P1|Overall Study|Personal Reasons|1
1160873|NCT01241240|3813044|P2|Overall Study|Lost to Follow-up|4
1160874|NCT01241240|3813045|P1|Overall Study|Lost to Follow-up|2
1160875|NCT01241240|3813044|P2|Overall Study|Adverse Event|4
1160876|NCT01241240|3813045|P1|Overall Study|Adverse Event|5
1160877|NCT01240915|3813063|P9|Overall Study|Insufficient Clinical Response|3
1160878|NCT01240915|3813064|P8|Overall Study|Insufficient Clinical Response|0
1160879|NCT01240915|3813065|P7|Overall Study|Insufficient Clinical Response|6
1160880|NCT01240915|3813066|P6|Overall Study|Insufficient Clinical Response|3
1160881|NCT01240915|3813067|P5|Overall Study|Insufficient Clinical Response|1
1160882|NCT01240915|3813068|P4|Overall Study|Insufficient Clinical Response|0
1160883|NCT01240915|3813069|P3|Overall Study|Insufficient Clinical Response|0
1160884|NCT01240915|3813070|P2|Overall Study|Insufficient Clinical Response|0
1160885|NCT01240915|3813071|P1|Overall Study|Insufficient Clinical Response|0
1160886|NCT01240915|3813063|P9|Overall Study|Other|0
1160887|NCT01240915|3813064|P8|Overall Study|Other|0
1160888|NCT01240915|3813065|P7|Overall Study|Other|0
1160889|NCT01240915|3813066|P6|Overall Study|Other|0
1160890|NCT01240915|3813067|P5|Overall Study|Other|2
1160891|NCT01240915|3813068|P4|Overall Study|Other|0
1160892|NCT01240915|3813069|P3|Overall Study|Other|0
1160893|NCT01240915|3813070|P2|Overall Study|Other|0
1160894|NCT01240915|3813071|P1|Overall Study|Other|0
1160895|NCT01240915|3813063|P9|Overall Study|Withdrawal by Subject|3
1160896|NCT01240915|3813064|P8|Overall Study|Withdrawal by Subject|3
1160897|NCT01240915|3813065|P7|Overall Study|Withdrawal by Subject|2
1160898|NCT01240915|3813066|P6|Overall Study|Withdrawal by Subject|4
1160899|NCT01240915|3813067|P5|Overall Study|Withdrawal by Subject|0
1160900|NCT01240915|3813068|P4|Overall Study|Withdrawal by Subject|2
1160901|NCT01240915|3813069|P3|Overall Study|Withdrawal by Subject|0
1160902|NCT01240915|3813070|P2|Overall Study|Withdrawal by Subject|1
1160903|NCT01240915|3813071|P1|Overall Study|Withdrawal by Subject|2
1160904|NCT01240915|3813063|P9|Overall Study|Lost to Follow-up|1
1160905|NCT01240915|3813064|P8|Overall Study|Lost to Follow-up|1
1160906|NCT01240915|3813065|P7|Overall Study|Lost to Follow-up|0
1160907|NCT01240915|3813066|P6|Overall Study|Lost to Follow-up|1
1160908|NCT01240915|3813067|P5|Overall Study|Lost to Follow-up|1
1160909|NCT01240915|3813068|P4|Overall Study|Lost to Follow-up|0
1160910|NCT01240915|3813069|P3|Overall Study|Lost to Follow-up|0
1160911|NCT01240915|3813070|P2|Overall Study|Lost to Follow-up|0
1160912|NCT01240915|3813071|P1|Overall Study|Lost to Follow-up|0
1160913|NCT01240915|3813063|P9|Overall Study|Adverse Event|1
1160914|NCT01240915|3813064|P8|Overall Study|Adverse Event|0
1160915|NCT01240915|3813065|P7|Overall Study|Adverse Event|0
1160916|NCT01240915|3813066|P6|Overall Study|Adverse Event|2
1160917|NCT01240915|3813067|P5|Overall Study|Adverse Event|0
1160918|NCT01240915|3813068|P4|Overall Study|Adverse Event|1
1160919|NCT01240915|3813069|P3|Overall Study|Adverse Event|0
1160920|NCT01240915|3813070|P2|Overall Study|Adverse Event|0
1160921|NCT01240915|3813071|P1|Overall Study|Adverse Event|0
1160922|NCT01240863|3813345|P3|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
1160923|NCT01240863|3813346|P2|Double-blind Treatment Period (12 Weeks)|Physician Decision|1
1160924|NCT01240863|3813347|P1|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
1160925|NCT01240863|3813345|P3|Double-blind Treatment Period (12 Weeks)|Not specified|5
1160926|NCT01240863|3813346|P2|Double-blind Treatment Period (12 Weeks)|Not specified|1
1160927|NCT01240863|3813347|P1|Double-blind Treatment Period (12 Weeks)|Not specified|0
1160928|NCT01240863|3813345|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
1160929|NCT01240863|3813346|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
1160930|NCT01240863|3813347|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0
1160931|NCT01240863|3813345|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11
1160932|NCT01240863|3813346|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9
1160933|NCT01240863|3813347|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
1160934|NCT01240863|3813345|P3|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14
1160935|NCT01240863|3813346|P2|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
1160936|NCT01240863|3813347|P1|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
1160937|NCT01240863|3813345|P3|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5
1160938|NCT01240863|3813346|P2|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3
1160939|NCT01240863|3813347|P1|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
1160940|NCT01240863|3813345|P3|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
1160941|NCT01240863|3813346|P2|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
1160942|NCT01240863|3813347|P1|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
1160943|NCT01240863|3813345|P3|Double-blind Treatment Period (12 Weeks)|Adverse Event|10
1160944|NCT01240863|3813346|P2|Double-blind Treatment Period (12 Weeks)|Adverse Event|4
1160945|NCT01240863|3813347|P1|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
1160946|NCT01240863|3813345|P3|Open-label Titration Period|Not specified|0
1160947|NCT01240863|3813346|P2|Open-label Titration Period|Not specified|0
1160948|NCT01240863|3813347|P1|Open-label Titration Period|Not specified|7
1160949|NCT01240863|3813345|P3|Open-label Titration Period|Dropped out prior to dosing|0
1160950|NCT01240863|3813346|P2|Open-label Titration Period|Dropped out prior to dosing|0
1160951|NCT01240863|3813347|P1|Open-label Titration Period|Dropped out prior to dosing|2
1160952|NCT01240863|3813345|P3|Open-label Titration Period|Noncompliance to study procedures|0
1160953|NCT01240863|3813346|P2|Open-label Titration Period|Noncompliance to study procedures|0
1160954|NCT01240863|3813347|P1|Open-label Titration Period|Noncompliance to study procedures|3
1160955|NCT01240863|3813345|P3|Open-label Titration Period|Noncompliance to study drug admin|0
1160956|NCT01240863|3813346|P2|Open-label Titration Period|Noncompliance to study drug admin|0
1160957|NCT01240863|3813347|P1|Open-label Titration Period|Noncompliance to study drug admin|3
1160958|NCT01240863|3813345|P3|Open-label Titration Period|Protocol Violation|0
1160959|NCT01240863|3813346|P2|Open-label Titration Period|Protocol Violation|0
1160960|NCT01240863|3813347|P1|Open-label Titration Period|Protocol Violation|7
1160961|NCT01240863|3813345|P3|Open-label Titration Period|Withdrawal by Subject|0
1160962|NCT01240863|3813346|P2|Open-label Titration Period|Withdrawal by Subject|0
1160963|NCT01240863|3813347|P1|Open-label Titration Period|Withdrawal by Subject|9
1160964|NCT01240863|3813345|P3|Open-label Titration Period|Lack of Efficacy|0
1160965|NCT01240863|3813346|P2|Open-label Titration Period|Lack of Efficacy|0
1160966|NCT01240863|3813347|P1|Open-label Titration Period|Lack of Efficacy|19
1160967|NCT01240863|3813345|P3|Open-label Titration Period|Adverse Event|0
1160968|NCT01240863|3813346|P2|Open-label Titration Period|Adverse Event|0
1160969|NCT01240863|3813347|P1|Open-label Titration Period|Adverse Event|47
1160970|NCT01240811|3813409|P3|Overall Study|Withdrawal by Subject|1
1160971|NCT01240811|3813410|P2|Overall Study|Withdrawal by Subject|0
1160972|NCT01240811|3813411|P1|Overall Study|Withdrawal by Subject|0
1160973|NCT01240811|3813409|P3|Overall Study|Physician Decision|0
1160974|NCT01240811|3813410|P2|Overall Study|Physician Decision|1
1160975|NCT01240811|3813411|P1|Overall Study|Physician Decision|0
1160976|NCT01240785|3813427|P2|Overall Study|Protocol Violation|3
1160977|NCT01240785|3813428|P1|Overall Study|Protocol Violation|0
1160978|NCT01240785|3813427|P2|Overall Study|Lost to Follow-up|0
1160979|NCT01240785|3813428|P1|Overall Study|Lost to Follow-up|1
1160980|NCT01240746|3813459|P3|Overall Study|Withdrawal by Subject|59
1160981|NCT01240746|3813460|P2|Overall Study|Withdrawal by Subject|13
1160982|NCT01240746|3813461|P1|Overall Study|Withdrawal by Subject|10
1160983|NCT01240746|3813459|P3|Overall Study|Protocol Violation|72
1160984|NCT01240746|3813460|P2|Overall Study|Protocol Violation|15
1160985|NCT01240746|3813461|P1|Overall Study|Protocol Violation|24
1160986|NCT01240746|3813459|P3|Overall Study|Lost to Follow-up|102
1160987|NCT01240746|3813460|P2|Overall Study|Lost to Follow-up|20
1160988|NCT01240746|3813461|P1|Overall Study|Lost to Follow-up|23
1160989|NCT01240746|3813459|P3|Overall Study|Adverse Event|10
1160990|NCT01240746|3813460|P2|Overall Study|Adverse Event|0
1160991|NCT01240746|3813461|P1|Overall Study|Adverse Event|2
1160992|NCT01240590|3813516|P5|Phase II|Refused further treatment|1
1160993|NCT01240590|3813517|P4|Phase II|Refused further treatment|2
1160994|NCT01240590|3813518|P3|Phase II|Refused further treatment|0
1160995|NCT01240590|3813519|P2|Phase II|Refused further treatment|0
1160996|NCT01240590|3813520|P1|Phase II|Refused further treatment|0
1160997|NCT01240590|3813516|P5|Phase I|Refused further treatment|0
1160998|NCT01240590|3813517|P4|Phase I|Refused further treatment|0
1160999|NCT01240590|3813518|P3|Phase I|Refused further treatment|3
1161000|NCT01240590|3813519|P2|Phase I|Refused further treatment|0
1161001|NCT01240590|3813520|P1|Phase I|Refused further treatment|0
1161002|NCT01240551|3813548|P2|Overall Study|Lost to Follow-up|1
1161003|NCT01240551|3813549|P1|Overall Study|Lost to Follow-up|1
1161004|NCT01240551|3813548|P2|Overall Study|Refused further treatment|2
1161005|NCT01240551|3813549|P1|Overall Study|Refused further treatment|3
1161006|NCT01240382|3813559|P2|Overall Study|Fear of adverse events|1
1161007|NCT01240382|3813560|P1|Overall Study|Fear of adverse events|0
1161008|NCT01240382|3813559|P2|Overall Study|Lack of Efficacy|2
1161009|NCT01240382|3813560|P1|Overall Study|Lack of Efficacy|0
1161010|NCT01240382|3813559|P2|Overall Study|Adverse Event|1
1161011|NCT01240382|3813560|P1|Overall Study|Adverse Event|2
1161012|NCT01240356|3813570|P2|Overall Study|MRI contraindication|0
1161013|NCT01240356|3813571|P1|Overall Study|MRI contraindication|1
1161014|NCT01240356|3813570|P2|Overall Study|Withdrawal by Subject|0
1161015|NCT01240356|3813571|P1|Overall Study|Withdrawal by Subject|2
1161016|NCT01240200|3813590|P2|12-week Crossover Phase - Period 1|Withdrawal by Subject|1
1161017|NCT01240200|3813591|P1|12-week Crossover Phase - Period 1|Withdrawal by Subject|2
1161018|NCT01240135|3813609|P2|Period Two, 14 Days of Wear|Adverse Event|1
1161019|NCT01240135|3813610|P1|Period Two, 14 Days of Wear|Adverse Event|0
1161020|NCT01240135|3813609|P2|Period Two, 14 Days of Wear|Withdrawal by Subject|1
1161021|NCT01240135|3813610|P1|Period Two, 14 Days of Wear|Withdrawal by Subject|1
1161022|NCT01239992|3813627|P1|Overall Study|Withdrawal by Subject|2
1161023|NCT01239797|3813636|P2|Treated Participants|Poor/Non-compliance|1
1161024|NCT01239797|3813637|P1|Treated Participants|Poor/Non-compliance|0
1161025|NCT01239797|3813636|P2|Treated Participants|Subject No Longer Meets Study Criteria|1
1161026|NCT01239797|3813637|P1|Treated Participants|Subject No Longer Meets Study Criteria|1
1161027|NCT01239797|3813636|P2|Treated Participants|Death|1
1161028|NCT01239797|3813637|P1|Treated Participants|Death|1
1161029|NCT01239797|3813636|P2|Treated Participants|Non-specified|11
1161030|NCT01239797|3813637|P1|Treated Participants|Non-specified|1
1161031|NCT01239797|3813636|P2|Treated Participants|Withdrawal by Subject|23
1161032|NCT01239797|3813637|P1|Treated Participants|Withdrawal by Subject|27
1161033|NCT01239797|3813636|P2|Treated Participants|Adverse Event Unrelated to Study Drug|32
1161034|NCT01239797|3813637|P1|Treated Participants|Adverse Event Unrelated to Study Drug|22
1161035|NCT01239797|3813636|P2|Treated Participants|Study Drug Toxicity|44
1161036|NCT01239797|3813637|P1|Treated Participants|Study Drug Toxicity|30
1161037|NCT01239797|3813636|P2|Treated Participants|Disease Progression|161
1161038|NCT01239797|3813637|P1|Treated Participants|Disease Progression|153
1161039|NCT01239745|3813645|P1|Overall Study|Adverse Event|1
1161040|NCT01239745|3813645|P1|Overall Study|Study terminated by sponsor|45
1161041|NCT01239732|3813656|P1|Overall Study|Other|19
1161042|NCT01239732|3813656|P1|Overall Study|Treatment failure|2
1161043|NCT01239732|3813656|P1|Overall Study|Investigator's decision|4
1161044|NCT01239732|3813656|P1|Overall Study|Study termination by sponsor|2
1161045|NCT01239732|3813656|P1|Overall Study|Participant non compliance|5
1161046|NCT01239732|3813656|P1|Overall Study|Protocol Violation|3
1161047|NCT01239732|3813656|P1|Overall Study|Adverse Event|6
1161048|NCT01239732|3813656|P1|Overall Study|Withdrawal by Subject|87
1161049|NCT01239732|3813656|P1|Overall Study|Death|226
1161050|NCT01239732|3813656|P1|Overall Study|Termination of study per protocol|667
1161051|NCT01239680|3813669|P2|Overall Study|Withdrawal by Subject|0
1161052|NCT01239680|3813670|P1|Overall Study|Withdrawal by Subject|2
1161053|NCT01239394|3813693|P1|Overall Study|Adverse Event|1
1161054|NCT01239381|3813700|P1|Overall Study|Withdrawal by Subject|1
1161055|NCT01239381|3813700|P1|Overall Study|Protocol Violation|1
1161056|NCT01239368|3813720|P10|Overall Study|Death|0
1161057|NCT01239368|3813721|P9|Overall Study|Death|0
1161058|NCT01239368|3813722|P8|Overall Study|Death|0
1161059|NCT01239368|3813723|P7|Overall Study|Death|1
1161060|NCT01239368|3813724|P6|Overall Study|Death|0
1161061|NCT01239368|3813725|P5|Overall Study|Death|0
1161062|NCT01239368|3813726|P4|Overall Study|Death|0
1161063|NCT01239368|3813727|P3|Overall Study|Death|0
1161064|NCT01239368|3813728|P2|Overall Study|Death|0
1161065|NCT01239368|3813729|P1|Overall Study|Death|0
1161066|NCT01239368|3813720|P10|Overall Study|Refused further treatment|1
1161067|NCT01239368|3813721|P9|Overall Study|Refused further treatment|0
1161068|NCT01239368|3813722|P8|Overall Study|Refused further treatment|0
1161069|NCT01239368|3813723|P7|Overall Study|Refused further treatment|0
1161070|NCT01239368|3813724|P6|Overall Study|Refused further treatment|0
1161071|NCT01239368|3813725|P5|Overall Study|Refused further treatment|0
1161072|NCT01239368|3813726|P4|Overall Study|Refused further treatment|0
1161073|NCT01239368|3813727|P3|Overall Study|Refused further treatment|0
1161074|NCT01239368|3813728|P2|Overall Study|Refused further treatment|0
1161075|NCT01239368|3813729|P1|Overall Study|Refused further treatment|0
1161076|NCT01239368|3813720|P10|Overall Study|Disease progression on study|2
1161077|NCT01239368|3813721|P9|Overall Study|Disease progression on study|0
1161078|NCT01239368|3813722|P8|Overall Study|Disease progression on study|0
1161079|NCT01239368|3813723|P7|Overall Study|Disease progression on study|5
1161080|NCT01239368|3813724|P6|Overall Study|Disease progression on study|2
1161081|NCT01239368|3813725|P5|Overall Study|Disease progression on study|4
1161082|NCT01239368|3813726|P4|Overall Study|Disease progression on study|1
1161083|NCT01239368|3813727|P3|Overall Study|Disease progression on study|1
1161084|NCT01239368|3813728|P2|Overall Study|Disease progression on study|1
1161085|NCT01239368|3813729|P1|Overall Study|Disease progression on study|1
1161086|NCT01239368|3813720|P10|Overall Study|Principal investigator discretion|1
1161087|NCT01239368|3813721|P9|Overall Study|Principal investigator discretion|0
1161088|NCT01239368|3813722|P8|Overall Study|Principal investigator discretion|0
1161089|NCT01239368|3813723|P7|Overall Study|Principal investigator discretion|0
1161090|NCT01239368|3813724|P6|Overall Study|Principal investigator discretion|2
1161091|NCT01239368|3813725|P5|Overall Study|Principal investigator discretion|1
1161092|NCT01239368|3813726|P4|Overall Study|Principal investigator discretion|0
1161093|NCT01239368|3813727|P3|Overall Study|Principal investigator discretion|0
1161094|NCT01239368|3813728|P2|Overall Study|Principal investigator discretion|0
1161095|NCT01239368|3813729|P1|Overall Study|Principal investigator discretion|1
1161096|NCT01239342|3813781|P2|Overall Study|Reason Unknown|1
1161097|NCT01239342|3813782|P1|Overall Study|Reason Unknown|1
1161098|NCT01239342|3813781|P2|Overall Study|Withdrawal by Subject|5
1161099|NCT01239342|3813782|P1|Overall Study|Withdrawal by Subject|1
1161100|NCT01239342|3813781|P2|Overall Study|Adverse Event|0
1161101|NCT01239342|3813782|P1|Overall Study|Adverse Event|1
1161102|NCT01239316|3813798|P1|Overall Study|Adverse Event|1
1161103|NCT01239316|3813798|P1|Overall Study|Progression/Relapse|11
1161104|NCT01239121|3813813|P3|Overall Study|Withdrawal by Subject|0
1161105|NCT01239121|3813814|P2|Overall Study|Withdrawal by Subject|4
1161106|NCT01239121|3813815|P1|Overall Study|Withdrawal by Subject|2
1161107|NCT01239043|3813837|P2|Overall Study|Protocol Violation|1
1161108|NCT01239043|3813838|P1|Overall Study|Protocol Violation|2
1161109|NCT01238991|3813866|P10|Overall Study|Admission to a nursing home|0
1161110|NCT01238991|3813867|P9|Overall Study|Admission to a nursing home|0
1161111|NCT01238991|3813868|P8|Overall Study|Admission to a nursing home|0
1161112|NCT01238991|3813869|P7|Overall Study|Admission to a nursing home|0
1161113|NCT01238991|3813870|P6|Overall Study|Admission to a nursing home|0
1161114|NCT01238991|3813871|P5|Overall Study|Admission to a nursing home|0
1161115|NCT01238991|3813872|P4|Overall Study|Admission to a nursing home|0
1161116|NCT01238991|3813873|P3|Overall Study|Admission to a nursing home|1
1161117|NCT01238991|3813874|P2|Overall Study|Admission to a nursing home|0
1161118|NCT01238991|3813875|P1|Overall Study|Admission to a nursing home|1
1161119|NCT01238991|3813866|P10|Overall Study|Caregiver's request|0
1161120|NCT01238991|3813867|P9|Overall Study|Caregiver's request|1
1161121|NCT01238991|3813868|P8|Overall Study|Caregiver's request|0
1161122|NCT01238991|3813869|P7|Overall Study|Caregiver's request|0
1161123|NCT01238991|3813870|P6|Overall Study|Caregiver's request|0
1161124|NCT01238991|3813871|P5|Overall Study|Caregiver's request|0
1161125|NCT01238991|3813872|P4|Overall Study|Caregiver's request|0
1161126|NCT01238991|3813873|P3|Overall Study|Caregiver's request|0
1161127|NCT01238991|3813874|P2|Overall Study|Caregiver's request|0
1161128|NCT01238991|3813875|P1|Overall Study|Caregiver's request|0
1161129|NCT01238991|3813866|P10|Overall Study|Study Terminated by Sponsor|2
1161130|NCT01238991|3813867|P9|Overall Study|Study Terminated by Sponsor|2
1161131|NCT01238991|3813868|P8|Overall Study|Study Terminated by Sponsor|4
1161132|NCT01238991|3813869|P7|Overall Study|Study Terminated by Sponsor|7
1161133|NCT01238991|3813870|P6|Overall Study|Study Terminated by Sponsor|0
1161134|NCT01238991|3813871|P5|Overall Study|Study Terminated by Sponsor|1
1161135|NCT01238991|3813872|P4|Overall Study|Study Terminated by Sponsor|0
1161136|NCT01238991|3813873|P3|Overall Study|Study Terminated by Sponsor|0
1161137|NCT01238991|3813874|P2|Overall Study|Study Terminated by Sponsor|0
1161138|NCT01238991|3813875|P1|Overall Study|Study Terminated by Sponsor|0
1161139|NCT01238991|3813866|P10|Overall Study|Withdrawal by Subject|0
1161140|NCT01238991|3813867|P9|Overall Study|Withdrawal by Subject|0
1161141|NCT01238991|3813868|P8|Overall Study|Withdrawal by Subject|0
1161142|NCT01238991|3813869|P7|Overall Study|Withdrawal by Subject|0
1161143|NCT01238991|3813870|P6|Overall Study|Withdrawal by Subject|0
1161144|NCT01238991|3813871|P5|Overall Study|Withdrawal by Subject|0
1161145|NCT01238991|3813872|P4|Overall Study|Withdrawal by Subject|0
1161146|NCT01238991|3813873|P3|Overall Study|Withdrawal by Subject|1
1161147|NCT01238991|3813874|P2|Overall Study|Withdrawal by Subject|0
1161148|NCT01238991|3813875|P1|Overall Study|Withdrawal by Subject|0
1161149|NCT01238991|3813866|P10|Overall Study|Lack of Efficacy|0
1161150|NCT01238991|3813867|P9|Overall Study|Lack of Efficacy|1
1161151|NCT01238991|3813868|P8|Overall Study|Lack of Efficacy|0
1161152|NCT01238991|3813869|P7|Overall Study|Lack of Efficacy|0
1161153|NCT01238991|3813870|P6|Overall Study|Lack of Efficacy|0
1161154|NCT01238991|3813871|P5|Overall Study|Lack of Efficacy|0
1161155|NCT01238991|3813872|P4|Overall Study|Lack of Efficacy|0
1161156|NCT01238991|3813873|P3|Overall Study|Lack of Efficacy|1
1161157|NCT01238991|3813874|P2|Overall Study|Lack of Efficacy|0
1161158|NCT01238991|3813875|P1|Overall Study|Lack of Efficacy|0
1161159|NCT01238991|3813866|P10|Overall Study|Death|0
1161160|NCT01238991|3813867|P9|Overall Study|Death|0
1161161|NCT01238991|3813868|P8|Overall Study|Death|0
1161162|NCT01238991|3813869|P7|Overall Study|Death|0
1161163|NCT01238991|3813870|P6|Overall Study|Death|0
1161164|NCT01238991|3813871|P5|Overall Study|Death|0
1161165|NCT01238991|3813872|P4|Overall Study|Death|1
1161166|NCT01238991|3813873|P3|Overall Study|Death|0
1161167|NCT01238991|3813874|P2|Overall Study|Death|0
1161168|NCT01238991|3813875|P1|Overall Study|Death|0
1161169|NCT01238991|3813866|P10|Overall Study|Adverse Event|0
1161170|NCT01238991|3813867|P9|Overall Study|Adverse Event|0
1161171|NCT01238991|3813868|P8|Overall Study|Adverse Event|1
1161172|NCT01238991|3813869|P7|Overall Study|Adverse Event|1
1161173|NCT01238991|3813870|P6|Overall Study|Adverse Event|0
1161174|NCT01238991|3813871|P5|Overall Study|Adverse Event|1
1161175|NCT01238991|3813872|P4|Overall Study|Adverse Event|1
1161176|NCT01238991|3813873|P3|Overall Study|Adverse Event|3
1161177|NCT01238991|3813874|P2|Overall Study|Adverse Event|0
1161178|NCT01238991|3813875|P1|Overall Study|Adverse Event|1
1161179|NCT01238900|3813962|P1|<12 Months Post Stent Removal|persistent stricture after stenting|1
1161180|NCT01238900|3813962|P1|<12 Months Post Stent Removal|Lost to Follow-up|4
1161181|NCT01238861|3813976|P6|Overall Study|Withdrawal by Subject|9
1161182|NCT01238861|3813977|P5|Overall Study|Withdrawal by Subject|10
1161183|NCT01238861|3813978|P4|Overall Study|Withdrawal by Subject|8
1161184|NCT01238861|3813979|P3|Overall Study|Withdrawal by Subject|4
1161185|NCT01238861|3813980|P2|Overall Study|Withdrawal by Subject|5
1161186|NCT01238861|3813981|P1|Overall Study|Withdrawal by Subject|6
1161187|NCT01238861|3813976|P6|Overall Study|Adverse Event|0
1161188|NCT01238861|3813977|P5|Overall Study|Adverse Event|0
1161189|NCT01238861|3813978|P4|Overall Study|Adverse Event|0
1161190|NCT01238861|3813979|P3|Overall Study|Adverse Event|0
1161191|NCT01238861|3813980|P2|Overall Study|Adverse Event|1
1161192|NCT01238861|3813981|P1|Overall Study|Adverse Event|0
1161193|NCT01238861|3813976|P6|Overall Study|Lack of compliance|1
1161194|NCT01238861|3813977|P5|Overall Study|Lack of compliance|0
1161195|NCT01238861|3813978|P4|Overall Study|Lack of compliance|0
1161196|NCT01238861|3813979|P3|Overall Study|Lack of compliance|0
1161197|NCT01238861|3813980|P2|Overall Study|Lack of compliance|0
1161198|NCT01238861|3813981|P1|Overall Study|Lack of compliance|0
1161199|NCT01238861|3813976|P6|Overall Study|Serious adverse event|1
1161200|NCT01238861|3813977|P5|Overall Study|Serious adverse event|0
1161201|NCT01238861|3813978|P4|Overall Study|Serious adverse event|0
1161202|NCT01238861|3813979|P3|Overall Study|Serious adverse event|0
1161203|NCT01238861|3813980|P2|Overall Study|Serious adverse event|0
1161204|NCT01238861|3813981|P1|Overall Study|Serious adverse event|0
1161205|NCT01238861|3813976|P6|Overall Study|Unable to continue visits|1
1161206|NCT01238861|3813977|P5|Overall Study|Unable to continue visits|0
1161207|NCT01238861|3813978|P4|Overall Study|Unable to continue visits|1
1161208|NCT01238861|3813979|P3|Overall Study|Unable to continue visits|0
1161209|NCT01238861|3813980|P2|Overall Study|Unable to continue visits|0
1161210|NCT01238861|3813981|P1|Overall Study|Unable to continue visits|0
1161211|NCT01238861|3813976|P6|Overall Study|Personal problems|0
1161212|NCT01238861|3813977|P5|Overall Study|Personal problems|0
1161213|NCT01238861|3813978|P4|Overall Study|Personal problems|1
1161214|NCT01238861|3813979|P3|Overall Study|Personal problems|0
1161215|NCT01238861|3813980|P2|Overall Study|Personal problems|0
1161216|NCT01238861|3813981|P1|Overall Study|Personal problems|0
1161217|NCT01238861|3813976|P6|Overall Study|Strongyloides stercoralis antibodies +|0
1161218|NCT01238861|3813977|P5|Overall Study|Strongyloides stercoralis antibodies +|0
1161219|NCT01238861|3813978|P4|Overall Study|Strongyloides stercoralis antibodies +|1
1161220|NCT01238861|3813979|P3|Overall Study|Strongyloides stercoralis antibodies +|0
1161221|NCT01238861|3813980|P2|Overall Study|Strongyloides stercoralis antibodies +|0
1161222|NCT01238861|3813981|P1|Overall Study|Strongyloides stercoralis antibodies +|0
1161223|NCT01238861|3813976|P6|Overall Study|Subject moved out of state/area|0
1161224|NCT01238861|3813977|P5|Overall Study|Subject moved out of state/area|0
1161225|NCT01238861|3813978|P4|Overall Study|Subject moved out of state/area|1
1161226|NCT01238861|3813979|P3|Overall Study|Subject moved out of state/area|1
1161227|NCT01238861|3813980|P2|Overall Study|Subject moved out of state/area|0
1161228|NCT01238861|3813981|P1|Overall Study|Subject moved out of state/area|0
1161229|NCT01238861|3813976|P6|Overall Study|Subject traveled to Argentina by 1 year|0
1161230|NCT01238861|3813977|P5|Overall Study|Subject traveled to Argentina by 1 year|0
1161231|NCT01238861|3813978|P4|Overall Study|Subject traveled to Argentina by 1 year|0
1161232|NCT01238861|3813979|P3|Overall Study|Subject traveled to Argentina by 1 year|1
1161233|NCT01238861|3813980|P2|Overall Study|Subject traveled to Argentina by 1 year|0
1161234|NCT01238861|3813981|P1|Overall Study|Subject traveled to Argentina by 1 year|0
1161235|NCT01238861|3813976|P6|Overall Study|Incorrect enrollment/randomization|0
1161236|NCT01238861|3813977|P5|Overall Study|Incorrect enrollment/randomization|1
1161237|NCT01238861|3813978|P4|Overall Study|Incorrect enrollment/randomization|0
1161238|NCT01238861|3813979|P3|Overall Study|Incorrect enrollment/randomization|1
1161239|NCT01238861|3813980|P2|Overall Study|Incorrect enrollment/randomization|0
1161240|NCT01238861|3813981|P1|Overall Study|Incorrect enrollment/randomization|0
1161241|NCT01238861|3813976|P6|Overall Study|Did not meet entry ACQ-6 criteria|1
1161242|NCT01238861|3813977|P5|Overall Study|Did not meet entry ACQ-6 criteria|1
1161243|NCT01238861|3813978|P4|Overall Study|Did not meet entry ACQ-6 criteria|0
1161244|NCT01238861|3813979|P3|Overall Study|Did not meet entry ACQ-6 criteria|1
1161245|NCT01238861|3813980|P2|Overall Study|Did not meet entry ACQ-6 criteria|0
1161246|NCT01238861|3813981|P1|Overall Study|Did not meet entry ACQ-6 criteria|0
1161247|NCT01238861|3813976|P6|Overall Study|Unplanned surgery|0
1161248|NCT01238861|3813977|P5|Overall Study|Unplanned surgery|0
1161249|NCT01238861|3813978|P4|Overall Study|Unplanned surgery|0
1161250|NCT01238861|3813979|P3|Overall Study|Unplanned surgery|0
1161251|NCT01238861|3813980|P2|Overall Study|Unplanned surgery|0
1161252|NCT01238861|3813981|P1|Overall Study|Unplanned surgery|1
1161253|NCT01238861|3813976|P6|Overall Study|Lost to Follow-up|2
1161254|NCT01238861|3813977|P5|Overall Study|Lost to Follow-up|1
1161255|NCT01238861|3813978|P4|Overall Study|Lost to Follow-up|1
1161256|NCT01238861|3813979|P3|Overall Study|Lost to Follow-up|3
1161257|NCT01238861|3813980|P2|Overall Study|Lost to Follow-up|2
1161258|NCT01238861|3813981|P1|Overall Study|Lost to Follow-up|4
1161259|NCT01238848|3814061|P2|Overall Study|Physician Decision|5
1161260|NCT01238848|3814062|P1|Overall Study|Physician Decision|13
1161261|NCT01238822|3814070|P1|Overall Study|COULD NOT SWALLOW PILLS|3
1161262|NCT01238588|3814097|P1|Overall Study|Physician Decision|2
1161263|NCT01238588|3814097|P1|Overall Study|Withdrawal by Subject|1
1161264|NCT01238575|3814110|P2|Overall Study|Adverse Event|0
1161265|NCT01238575|3814111|P1|Overall Study|Adverse Event|2
1161266|NCT01238575|3814110|P2|Overall Study|Lack of Efficacy|4
1161267|NCT01238575|3814111|P1|Overall Study|Lack of Efficacy|2
1161268|NCT01238211|3814195|P1|Overall Study|Investigator/Patient Decision|3
1161269|NCT01238211|3814195|P1|Overall Study|Non-protocol treatment|4
1161270|NCT01238211|3814195|P1|Overall Study|Withdrawal by Subject|7
1161271|NCT01238211|3814195|P1|Overall Study|Relapse/Progression|2
1161272|NCT01238211|3814195|P1|Overall Study|Death|4
1161273|NCT01238211|3814195|P1|Overall Study|Adverse Event|7
1161274|NCT01238211|3814195|P1|Overall Study|Continues active treatment|31
1161275|NCT01237678|3814202|P3|Phase II|Randomized but were not treated|3
1161276|NCT01237678|3814203|P2|Phase II|Randomized but were not treated|4
1161277|NCT01237678|3814204|P1|Phase II|Randomized but were not treated|0
1161278|NCT01237678|3814202|P3|Phase II|Sponsor Decision/Study Closed|7
1161279|NCT01237678|3814203|P2|Phase II|Sponsor Decision/Study Closed|18
1161280|NCT01237678|3814204|P1|Phase II|Sponsor Decision/Study Closed|0
1161281|NCT01237678|3814202|P3|Phase II|Completed Cycles 4-6|21
1161282|NCT01237678|3814203|P2|Phase II|Completed Cycles 4-6|11
1161283|NCT01237678|3814204|P1|Phase II|Completed Cycles 4-6|0
1161284|NCT01237678|3814202|P3|Phase II|Withdrawal by Subject|5
1161285|NCT01237678|3814203|P2|Phase II|Withdrawal by Subject|1
1161286|NCT01237678|3814204|P1|Phase II|Withdrawal by Subject|0
1161287|NCT01237678|3814202|P3|Phase II|Lack of Efficacy|3
1161288|NCT01237678|3814203|P2|Phase II|Lack of Efficacy|25
1161289|NCT01237678|3814204|P1|Phase II|Lack of Efficacy|0
1161290|NCT01237678|3814202|P3|Phase II|Death|2
1161291|NCT01237678|3814203|P2|Phase II|Death|0
1161292|NCT01237678|3814204|P1|Phase II|Death|0
1161293|NCT01237678|3814202|P3|Phase II|Adverse Event|9
1161294|NCT01237678|3814203|P2|Phase II|Adverse Event|39
1161295|NCT01237678|3814204|P1|Phase II|Adverse Event|0
1161296|NCT01237678|3814202|P3|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
1161297|NCT01237678|3814203|P2|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
1161298|NCT01237678|3814204|P1|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1
1161299|NCT01237678|3814202|P3|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
1161300|NCT01237678|3814203|P2|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
1161301|NCT01237678|3814204|P1|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3
1161302|NCT01237678|3814202|P3|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
1161303|NCT01237678|3814203|P2|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
1161304|NCT01237678|3814204|P1|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24
1161305|NCT01237678|3814202|P3|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
1161306|NCT01237678|3814203|P2|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
1161307|NCT01237678|3814204|P1|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5
1161308|NCT01237587|3814249|P2|Taper Phase|Withdrawal by Subject|1
1161309|NCT01237587|3814250|P1|Taper Phase|Withdrawal by Subject|0
1161310|NCT01237587|3814249|P2|Taper Phase|Sponsor Decision|0
1161311|NCT01237587|3814250|P1|Taper Phase|Sponsor Decision|1
1161312|NCT01237587|3814249|P2|Taper Phase|Parent/Guardian Decision|2
1161313|NCT01237587|3814250|P1|Taper Phase|Parent/Guardian Decision|0
1161314|NCT01237587|3814249|P2|Taper Phase|Lack of Efficacy|5
1161315|NCT01237587|3814250|P1|Taper Phase|Lack of Efficacy|2
1161316|NCT01237587|3814249|P2|Taper Phase|Protocol Violation|0
1161317|NCT01237587|3814250|P1|Taper Phase|Protocol Violation|2
1161318|NCT01237587|3814249|P2|Taper Phase|Adverse Event|2
1161319|NCT01237587|3814250|P1|Taper Phase|Adverse Event|0
1161320|NCT01237587|3814249|P2|Open Label Treatment (Extension Phase)|Physician Decision|4
1161321|NCT01237587|3814250|P1|Open Label Treatment (Extension Phase)|Physician Decision|4
1161322|NCT01237587|3814249|P2|Open Label Treatment (Extension Phase)|Sponsor Decision|0
1161323|NCT01237587|3814250|P1|Open Label Treatment (Extension Phase)|Sponsor Decision|1
1161324|NCT01237587|3814249|P2|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5
1161325|NCT01237587|3814250|P1|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0
1161326|NCT01237587|3814249|P2|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4
1161327|NCT01237587|3814250|P1|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2
1161328|NCT01237587|3814249|P2|Open Label Treatment (Extension Phase)|Lack of Efficacy|4
1161329|NCT01237587|3814250|P1|Open Label Treatment (Extension Phase)|Lack of Efficacy|2
1161330|NCT01237587|3814249|P2|Open Label Treatment (Extension Phase)|Adverse Event|5
1161331|NCT01237587|3814250|P1|Open Label Treatment (Extension Phase)|Adverse Event|5
1161332|NCT01237587|3814249|P2|Open Label Treatment (Extension Phase)|Lost to Follow-up|3
1161333|NCT01237587|3814250|P1|Open Label Treatment (Extension Phase)|Lost to Follow-up|4
1161334|NCT01237587|3814249|P2|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4
1161335|NCT01237587|3814250|P1|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3
1161336|NCT01237587|3814249|P2|Double Blind Treatment (Acute Phase)|Protocol Violation|3
1161337|NCT01237587|3814250|P1|Double Blind Treatment (Acute Phase)|Protocol Violation|4
1161338|NCT01237587|3814249|P2|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4
1161339|NCT01237587|3814250|P1|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2
1161340|NCT01237587|3814249|P2|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3
1161341|NCT01237587|3814250|P1|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2
1161342|NCT01237587|3814249|P2|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3
1161343|NCT01237587|3814250|P1|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1
1161344|NCT01237587|3814249|P2|Double Blind Treatment (Acute Phase)|Adverse Event|1
1161345|NCT01237587|3814250|P1|Double Blind Treatment (Acute Phase)|Adverse Event|5
1161346|NCT01237340|3814302|P1|Overall Study|Early termination of the trial|36
1161347|NCT01237340|3814302|P1|Overall Study|Withdrawal by Subject|1
1161348|NCT01237340|3814302|P1|Overall Study|Adverse Event|3
1161349|NCT01237327|3814316|P2|Overall Study|Lost to Follow-up|0
1161350|NCT01237327|3814317|P1|Overall Study|Lost to Follow-up|3
1161351|NCT01237327|3814316|P2|Overall Study|Withdrawal by Subject|3
1161352|NCT01237327|3814317|P1|Overall Study|Withdrawal by Subject|1
1161353|NCT01237327|3814316|P2|Overall Study|Protocol Specific Withdrawal Criteria|0
1161354|NCT01237327|3814317|P1|Overall Study|Protocol Specific Withdrawal Criteria|1
1161355|NCT01237327|3814316|P2|Overall Study|Progression of Disease: Extension Study|13
1161356|NCT01237327|3814317|P1|Overall Study|Progression of Disease: Extension Study|15
1161357|NCT01237327|3814316|P2|Overall Study|Progression of Disease: Core Study|22
1161358|NCT01237327|3814317|P1|Overall Study|Progression of Disease: Core Study|18
1161359|NCT01237327|3814316|P2|Overall Study|Completed 26 weeks treatment:Core Study|2
1161360|NCT01237327|3814317|P1|Overall Study|Completed 26 weeks treatment:Core Study|3
1161361|NCT01237327|3814316|P2|Overall Study|Protocol Violation: Core Study|0
1161362|NCT01237327|3814317|P1|Overall Study|Protocol Violation: Core Study|1
1161363|NCT01237223|3814352|P6|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
1161364|NCT01237223|3814353|P5|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
1161365|NCT01237223|3814354|P4|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2
1161366|NCT01237223|3814355|P3|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
1161367|NCT01237223|3814356|P2|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
1161368|NCT01237223|3814357|P1|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0
1161369|NCT01237223|3814352|P6|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1
1161370|NCT01237223|3814353|P5|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
1161371|NCT01237223|3814354|P4|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
1161372|NCT01237223|3814355|P3|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
1161373|NCT01237223|3814356|P2|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
1161374|NCT01237223|3814357|P1|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
1161375|NCT01237223|3814352|P6|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
1161376|NCT01237223|3814353|P5|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
1161377|NCT01237223|3814354|P4|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0
1161378|NCT01237223|3814355|P3|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
1161379|NCT01237223|3814356|P2|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
1161380|NCT01237223|3814357|P1|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
1161381|NCT01237223|3814352|P6|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
1161382|NCT01237223|3814353|P5|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0
1161383|NCT01237223|3814354|P4|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
1161384|NCT01237223|3814355|P3|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7
1161385|NCT01237223|3814356|P2|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6
1161386|NCT01237223|3814357|P1|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20
1161387|NCT01237223|3814352|P6|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1
1161388|NCT01237223|3814353|P5|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
1161389|NCT01237223|3814354|P4|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
1161390|NCT01237223|3814355|P3|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3
1161391|NCT01237223|3814356|P2|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4
1161392|NCT01237223|3814357|P1|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12
1161393|NCT01237223|3814352|P6|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
1161394|NCT01237223|3814353|P5|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
1161395|NCT01237223|3814354|P4|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
1161396|NCT01237223|3814355|P3|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
1161397|NCT01237223|3814356|P2|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
1161398|NCT01237223|3814357|P1|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8
1161399|NCT01237223|3814352|P6|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
1161400|NCT01237223|3814353|P5|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
1161401|NCT01237223|3814354|P4|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
1161402|NCT01237223|3814355|P3|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
1161403|NCT01237223|3814356|P2|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
1161404|NCT01237223|3814357|P1|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28
1161405|NCT01237223|3814352|P6|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
1161406|NCT01237223|3814353|P5|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
1161407|NCT01237223|3814354|P4|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
1161408|NCT01237223|3814355|P3|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
1161409|NCT01237223|3814356|P2|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
1161410|NCT01237223|3814357|P1|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308
1161411|NCT01237223|3814352|P6|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
1161412|NCT01237223|3814353|P5|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
1161413|NCT01237223|3814354|P4|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
1161414|NCT01237223|3814355|P3|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
1161415|NCT01237223|3814356|P2|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
1161416|NCT01237223|3814357|P1|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25
1161417|NCT01237223|3814352|P6|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
1161418|NCT01237223|3814353|P5|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
1161419|NCT01237223|3814354|P4|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
1161420|NCT01237223|3814355|P3|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
1161421|NCT01237223|3814356|P2|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
1161422|NCT01237223|3814357|P1|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29
1161423|NCT01237054|3814416|P1|Overall Study|imaging 10C0096|1
1161424|NCT01236573|3814512|P11|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1
1161425|NCT01236573|3814513|P10|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
1161426|NCT01236573|3814514|P9|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
1161427|NCT01236573|3814515|P8|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
1161428|NCT01236573|3814516|P7|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
1161429|NCT01236573|3814517|P6|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
1161430|NCT01236573|3814518|P5|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
1161431|NCT01236573|3814519|P4|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
1161432|NCT01236573|3814520|P3|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
1161433|NCT01236573|3814521|P2|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
1161434|NCT01236573|3814522|P1|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
1161435|NCT01236573|3814512|P11|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
1161436|NCT01236573|3814513|P10|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
1161437|NCT01236573|3814514|P9|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1
1161438|NCT01236573|3814515|P8|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
1161439|NCT01236573|3814516|P7|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
1161440|NCT01236573|3814517|P6|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
1161441|NCT01236573|3814518|P5|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
1161442|NCT01236573|3814519|P4|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
1161443|NCT01236573|3814520|P3|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
1161444|NCT01236573|3814521|P2|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
1161445|NCT01236573|3814522|P1|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
1161446|NCT01236573|3814512|P11|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
1161447|NCT01236573|3814513|P10|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
1161448|NCT01236573|3814514|P9|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
1161449|NCT01236573|3814515|P8|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
1161450|NCT01236573|3814516|P7|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
1161451|NCT01236573|3814517|P6|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
1161452|NCT01236573|3814518|P5|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
1161453|NCT01236573|3814519|P4|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
1161454|NCT01236573|3814520|P3|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
1161455|NCT01236573|3814521|P2|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
1161456|NCT01236573|3814522|P1|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
1161457|NCT01236534|3814560|P2|Overall Study|Adverse Event|0
1161458|NCT01236534|3814561|P1|Overall Study|Adverse Event|3
1161459|NCT01236521|3814571|P2|Overall Study|Lost to Follow-up|7
1161460|NCT01236521|3814572|P1|Overall Study|Lost to Follow-up|7
1161461|NCT01236521|3814571|P2|Overall Study|Death|1
1161462|NCT01236521|3814572|P1|Overall Study|Death|2
1161463|NCT01236521|3814571|P2|Overall Study|Withdrawal by Subject|17
1161464|NCT01236521|3814572|P1|Overall Study|Withdrawal by Subject|12
1161465|NCT01236365|3814622|P2|Overall Study|Dropped at Randomization due to high LFT|0
1161466|NCT01236365|3814623|P1|Overall Study|Dropped at Randomization due to high LFT|1
1161467|NCT01236365|3814622|P2|Overall Study|Moved Out of State|0
1161468|NCT01236365|3814623|P1|Overall Study|Moved Out of State|1
1161469|NCT01236365|3814622|P2|Overall Study|Lost to Follow-up|2
1161470|NCT01236365|3814623|P1|Overall Study|Lost to Follow-up|0
1161471|NCT01236339|3814637|P2|Overall Study|Termination of study by sponsor|13
1161472|NCT01236339|3814638|P1|Overall Study|Termination of study by sponsor|11
1161473|NCT01236118|3814706|P3|Overall Study|Withdrawal by Subject|1
1161474|NCT01236118|3814707|P2|Overall Study|Withdrawal by Subject|0
1161475|NCT01236118|3814708|P1|Overall Study|Withdrawal by Subject|0
1161476|NCT01236118|3814706|P3|Overall Study|Physician Decision|0
1161477|NCT01236118|3814707|P2|Overall Study|Physician Decision|1
1161478|NCT01236118|3814708|P1|Overall Study|Physician Decision|0
1161479|NCT01236118|3814706|P3|Overall Study|Adverse Event|2
1161480|NCT01236118|3814707|P2|Overall Study|Adverse Event|0
1161481|NCT01236118|3814708|P1|Overall Study|Adverse Event|2
1161482|NCT01236001|3814909|P2|Overall Study|Planned Visit After End of Study|1
1161483|NCT01236001|3814910|P1|Overall Study|Planned Visit After End of Study|0
1161484|NCT01236001|3814909|P2|Overall Study|Incompliance|0
1161485|NCT01236001|3814910|P1|Overall Study|Incompliance|1
1161486|NCT01236001|3814909|P2|Overall Study|Lost to Follow-up|1
1161487|NCT01236001|3814910|P1|Overall Study|Lost to Follow-up|6
1161488|NCT01236001|3814909|P2|Overall Study|Lack of Efficacy|6
1161489|NCT01236001|3814910|P1|Overall Study|Lack of Efficacy|6
1161490|NCT01236001|3814909|P2|Overall Study|Adverse Event|14
1161491|NCT01236001|3814910|P1|Overall Study|Adverse Event|5
1161492|NCT01235975|3814942|P2|Overall Study|Lost to Follow-up|3
1161493|NCT01235975|3814943|P1|Overall Study|Lost to Follow-up|7
1161494|NCT01235975|3814942|P2|Overall Study|Migrated/moved from study area|1
1161495|NCT01235975|3814943|P1|Overall Study|Migrated/moved from study area|2
1161496|NCT01235975|3814942|P2|Overall Study|Withdrawal by Subject|2
1161497|NCT01235975|3814943|P1|Overall Study|Withdrawal by Subject|8
1161498|NCT01235975|3814942|P2|Overall Study|Serious Adverse Event|1
1161499|NCT01235975|3814943|P1|Overall Study|Serious Adverse Event|0
1161500|NCT01235793|3814997|P1|Overall Study|Death|6
1161501|NCT01235741|3815005|P3|Follow-Up Post Treatment up to Month 6|not specified|0
1161502|NCT01235741|3815006|P2|Follow-Up Post Treatment up to Month 6|not specified|1
1161503|NCT01235741|3815007|P1|Follow-Up Post Treatment up to Month 6|not specified|0
1161504|NCT01235741|3815005|P3|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1
1161505|NCT01235741|3815006|P2|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5
1161506|NCT01235741|3815007|P1|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0
1161507|NCT01235741|3815005|P3|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6
1161508|NCT01235741|3815006|P2|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3
1161509|NCT01235741|3815007|P1|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0
1161510|NCT01235741|3815005|P3|Randomized to Treatment|Sponsor terminated study|34
1161511|NCT01235741|3815006|P2|Randomized to Treatment|Sponsor terminated study|35
1161512|NCT01235741|3815007|P1|Randomized to Treatment|Sponsor terminated study|0
1161513|NCT01235741|3815005|P3|Randomized to Treatment|Adverse Event|1
1161514|NCT01235741|3815006|P2|Randomized to Treatment|Adverse Event|1
1161515|NCT01235741|3815007|P1|Randomized to Treatment|Adverse Event|0
1161516|NCT01235741|3815005|P3|Randomized to Treatment|Withdrawal by Subject|1
1161517|NCT01235741|3815006|P2|Randomized to Treatment|Withdrawal by Subject|0
1161518|NCT01235741|3815007|P1|Randomized to Treatment|Withdrawal by Subject|0
1161602|NCT01235338|3815286|P2|Overall Study|Withdrawal by Subject|0
1161519|NCT01235741|3815005|P3|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
1161520|NCT01235741|3815006|P2|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
1161521|NCT01235741|3815007|P1|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4
1161522|NCT01235741|3815005|P3|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
1161523|NCT01235741|3815006|P2|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
1161524|NCT01235741|3815007|P1|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5
1161525|NCT01235741|3815005|P3|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
1161526|NCT01235741|3815006|P2|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
1161527|NCT01235741|3815007|P1|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1
1161528|NCT01235741|3815005|P3|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
1161529|NCT01235741|3815006|P2|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
1161530|NCT01235741|3815007|P1|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1
1161531|NCT01235741|3815005|P3|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
1161532|NCT01235741|3815006|P2|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
1161533|NCT01235741|3815007|P1|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121
1161534|NCT01235741|3815005|P3|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
1161535|NCT01235741|3815006|P2|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
1161536|NCT01235741|3815007|P1|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9
1161537|NCT01235728|3815034|P8|Overall Study|Protocol Violation|0
1161538|NCT01235728|3815035|P7|Overall Study|Protocol Violation|0
1161539|NCT01235728|3815036|P6|Overall Study|Protocol Violation|0
1161540|NCT01235728|3815037|P5|Overall Study|Protocol Violation|0
1161541|NCT01235728|3815038|P4|Overall Study|Protocol Violation|1
1161542|NCT01235728|3815039|P3|Overall Study|Protocol Violation|0
1161543|NCT01235728|3815040|P2|Overall Study|Protocol Violation|0
1161544|NCT01235728|3815041|P1|Overall Study|Protocol Violation|0
1161545|NCT01235715|3815051|P2|Overall Study|Physician Decision|2
1161546|NCT01235715|3815052|P1|Overall Study|Physician Decision|0
1161547|NCT01235689|3815092|P2|Overall Study|Miscellaneous|5
1161548|NCT01235689|3815093|P1|Overall Study|Miscellaneous|1
1161549|NCT01235689|3815092|P2|Overall Study|Lost to Follow-up|2
1161550|NCT01235689|3815093|P1|Overall Study|Lost to Follow-up|1
1161551|NCT01235689|3815092|P2|Overall Study|Withdrawal by Subject|4
1161552|NCT01235689|3815093|P1|Overall Study|Withdrawal by Subject|3
1161553|NCT01235689|3815092|P2|Overall Study|Lack of Efficacy|5
1161554|NCT01235689|3815093|P1|Overall Study|Lack of Efficacy|12
1161555|NCT01235689|3815092|P2|Overall Study|Adverse Event|16
1161556|NCT01235689|3815093|P1|Overall Study|Adverse Event|12
1161557|NCT01235598|3815165|P2|Overall Study|Withdrawal by Subject|0
1161558|NCT01235598|3815166|P1|Overall Study|Withdrawal by Subject|1
1161559|NCT01235598|3815165|P2|Overall Study|Lack of Efficacy|1
1161560|NCT01235598|3815166|P1|Overall Study|Lack of Efficacy|0
1161561|NCT01235598|3815165|P2|Overall Study|Adverse Event|3
1161562|NCT01235598|3815166|P1|Overall Study|Adverse Event|0
1161563|NCT01235546|3815211|P2|Overall Study|Protocol Violation|1
1161564|NCT01235546|3815212|P1|Overall Study|Protocol Violation|1
1161565|NCT01235546|3815211|P2|Overall Study|Staff error, medication not administered|0
1161566|NCT01235546|3815212|P1|Overall Study|Staff error, medication not administered|1
1161567|NCT01235507|3815236|P1|Overall Study|Withdrawal by Subject|1
1161568|NCT01235507|3815236|P1|Overall Study|Adverse Event|1
1161569|NCT01235442|3815250|P2|Overall Study|Other unspecified|2
1161570|NCT01235442|3815251|P1|Overall Study|Other unspecified|1
1161571|NCT01235442|3815250|P2|Overall Study|Administrative decision|2
1161572|NCT01235442|3815251|P1|Overall Study|Administrative decision|1
1161573|NCT01235442|3815250|P2|Overall Study|Noncompliance|2
1161574|NCT01235442|3815251|P1|Overall Study|Noncompliance|1
1161575|NCT01235442|3815250|P2|Overall Study|Lack of Efficacy|3
1161576|NCT01235442|3815251|P1|Overall Study|Lack of Efficacy|1
1161577|NCT01235442|3815250|P2|Overall Study|Withdrawal by Subject|9
1161578|NCT01235442|3815251|P1|Overall Study|Withdrawal by Subject|15
1161579|NCT01235442|3815250|P2|Overall Study|Adverse Event|6
1161580|NCT01235442|3815251|P1|Overall Study|Adverse Event|4
1161581|NCT01235442|3815250|P2|Overall Study|Protocol Violation|3
1161582|NCT01235442|3815251|P1|Overall Study|Protocol Violation|3
1161583|NCT01235442|3815250|P2|Overall Study|Ineligibility determined|4
1161584|NCT01235442|3815251|P1|Overall Study|Ineligibility determined|5
1161585|NCT01235442|3815250|P2|Overall Study|Pregnancy|1
1161586|NCT01235442|3815251|P1|Overall Study|Pregnancy|1
1161587|NCT01235442|3815250|P2|Overall Study|Death|2
1161588|NCT01235442|3815251|P1|Overall Study|Death|0
1161589|NCT01235442|3815250|P2|Overall Study|Lost to Follow-up|10
1161590|NCT01235442|3815251|P1|Overall Study|Lost to Follow-up|12
1161591|NCT01235403|3815269|P1|Overall Study|Other reasons for premature termination|4
1161592|NCT01235403|3815269|P1|Overall Study|Lack of Efficacy|2
1161593|NCT01235403|3815269|P1|Overall Study|Withdrawal by Subject|4
1161594|NCT01235403|3815269|P1|Overall Study|Lost to Follow-up|2
1161595|NCT01235403|3815269|P1|Overall Study|Adverse Event|14
1161596|NCT01235338|3815286|P2|Overall Study|Prohibited meds|0
1161597|NCT01235338|3815287|P1|Overall Study|Prohibited meds|1
1161598|NCT01235338|3815286|P2|Overall Study|Positive drug screen|1
1161599|NCT01235338|3815287|P1|Overall Study|Positive drug screen|0
1161600|NCT01235338|3815286|P2|Overall Study|Exclusion criteria violations|1
1161601|NCT01235338|3815287|P1|Overall Study|Exclusion criteria violations|1
1161603|NCT01235338|3815287|P1|Overall Study|Withdrawal by Subject|5
1161604|NCT01235338|3815286|P2|Overall Study|Protocol Violation|1
1161605|NCT01235338|3815287|P1|Overall Study|Protocol Violation|1
1161606|NCT01235338|3815286|P2|Overall Study|Adverse Event|2
1161607|NCT01235338|3815287|P1|Overall Study|Adverse Event|3
1161608|NCT01235234|3815332|P3|Overall Study|Adverse Event|1
1161609|NCT01235234|3815333|P2|Overall Study|Adverse Event|2
1161610|NCT01235234|3815334|P1|Overall Study|Adverse Event|2
1161611|NCT01234883|3815382|P2|Overall Study|Inclusion/exclusion failure|0
1161612|NCT01234883|3815383|P1|Overall Study|Inclusion/exclusion failure|1
1161613|NCT01234883|3815382|P2|Overall Study|Technical difficulties with IV infusion|1
1161614|NCT01234883|3815383|P1|Overall Study|Technical difficulties with IV infusion|0
1161615|NCT01234883|3815382|P2|Overall Study|Parent/guardian withdrew consent|2
1161616|NCT01234883|3815383|P1|Overall Study|Parent/guardian withdrew consent|1
1161617|NCT01234883|3815382|P2|Overall Study|Early treatment release|10
1161618|NCT01234883|3815383|P1|Overall Study|Early treatment release|8
1161619|NCT01234675|3815430|P2|First Intervention (6 Weeks)|Withdrawal by Subject|0
1161620|NCT01234675|3815431|P1|First Intervention (6 Weeks)|Withdrawal by Subject|1
1161621|NCT01234675|3815430|P2|First Intervention (6 Weeks)|Adverse Event|1
1161622|NCT01234675|3815431|P1|First Intervention (6 Weeks)|Adverse Event|0
1161623|NCT01234467|3815445|P1|Overall Study|Other complicating disease (stroke)|1
1161624|NCT01234467|3815445|P1|Overall Study|Physician Decision|1
1161625|NCT01234467|3815445|P1|Overall Study|Clinical deterioration|1
1161626|NCT01234467|3815445|P1|Overall Study|Disease Progression|2
1161627|NCT01234467|3815445|P1|Overall Study|Withdrawal by Subject|2
1161628|NCT01234467|3815445|P1|Overall Study|Death|2
1161629|NCT01234467|3815445|P1|Overall Study|Adverse Event|3
1161630|NCT01234337|3815456|P2|Overall Study|Switch to commercial drug|1
1161631|NCT01234337|3815457|P1|Overall Study|Switch to commercial drug|0
1161632|NCT01234337|3815456|P2|Overall Study|Death|1
1161633|NCT01234337|3815457|P1|Overall Study|Death|0
1161634|NCT01234337|3815456|P2|Overall Study|Withdrawal by Subject|9
1161635|NCT01234337|3815457|P1|Overall Study|Withdrawal by Subject|11
1161636|NCT01234337|3815456|P2|Overall Study|Protocol Violation|3
1161637|NCT01234337|3815457|P1|Overall Study|Protocol Violation|2
1161638|NCT01234337|3815456|P2|Overall Study|Lost to Follow-up|1
1161639|NCT01234337|3815457|P1|Overall Study|Lost to Follow-up|0
1161640|NCT01234337|3815456|P2|Overall Study|Randomized but not treated|4
1161641|NCT01234337|3815457|P1|Overall Study|Randomized but not treated|6
1161642|NCT01234337|3815456|P2|Overall Study|Non-compliant with study medication|2
1161643|NCT01234337|3815457|P1|Overall Study|Non-compliant with study medication|3
1161644|NCT01234337|3815456|P2|Overall Study|Investi. decision not protocol driven|6
1161645|NCT01234337|3815457|P1|Overall Study|Investi. decision not protocol driven|5
1161646|NCT01234337|3815456|P2|Overall Study|Disease progression/recurrence/relapse|223
1161647|NCT01234337|3815457|P1|Overall Study|Disease progression/recurrence/relapse|181
1161648|NCT01234337|3815456|P2|Overall Study|Adverse Event|21
1161649|NCT01234337|3815457|P1|Overall Study|Adverse Event|58
1161650|NCT01233999|3815517|P1|Overall Study|Lost to Follow-up|1
1161651|NCT01233999|3815517|P1|Overall Study|Withdrawal by Subject|1
1161652|NCT01233869|3815536|P4|Extended Treatment Period (46 Months)|Adverse Event|1
1161653|NCT01233869|3815537|P3|Extended Treatment Period (46 Months)|Adverse Event|0
1161654|NCT01233869|3815538|P2|Extended Treatment Period (46 Months)|Adverse Event|0
1161655|NCT01233869|3815539|P1|Extended Treatment Period (46 Months)|Adverse Event|1
1161656|NCT01233869|3815536|P4|Extended Treatment Period (46 Months)|Other|3
1161657|NCT01233869|3815537|P3|Extended Treatment Period (46 Months)|Other|0
1161658|NCT01233869|3815538|P2|Extended Treatment Period (46 Months)|Other|0
1161659|NCT01233869|3815539|P1|Extended Treatment Period (46 Months)|Other|3
1161660|NCT01233869|3815536|P4|Extended Treatment Period (46 Months)|Withdrawal by Subject|11
1161661|NCT01233869|3815537|P3|Extended Treatment Period (46 Months)|Withdrawal by Subject|5
1161662|NCT01233869|3815538|P2|Extended Treatment Period (46 Months)|Withdrawal by Subject|3
1161663|NCT01233869|3815539|P1|Extended Treatment Period (46 Months)|Withdrawal by Subject|10
1161664|NCT01233869|3815536|P4|Extended Treatment Period (46 Months)|Lost to Follow-up|1
1161665|NCT01233869|3815537|P3|Extended Treatment Period (46 Months)|Lost to Follow-up|0
1161666|NCT01233869|3815538|P2|Extended Treatment Period (46 Months)|Lost to Follow-up|0
1161667|NCT01233869|3815539|P1|Extended Treatment Period (46 Months)|Lost to Follow-up|0
1161668|NCT01233869|3815536|P4|Initial Treatment Period (24 Months)|Not Related to Study Drug|19
1161669|NCT01233869|3815537|P3|Initial Treatment Period (24 Months)|Not Related to Study Drug|2
1161670|NCT01233869|3815538|P2|Initial Treatment Period (24 Months)|Not Related to Study Drug|11
1161671|NCT01233869|3815539|P1|Initial Treatment Period (24 Months)|Not Related to Study Drug|14
1161672|NCT01233869|3815536|P4|Initial Treatment Period (24 Months)|Adverse Event|3
1161673|NCT01233869|3815537|P3|Initial Treatment Period (24 Months)|Adverse Event|0
1161674|NCT01233869|3815538|P2|Initial Treatment Period (24 Months)|Adverse Event|17
1161675|NCT01233869|3815539|P1|Initial Treatment Period (24 Months)|Adverse Event|9
1161676|NCT01233869|3815536|P4|Initial Treatment Period (24 Months)|Death|0
1161677|NCT01233869|3815537|P3|Initial Treatment Period (24 Months)|Death|0
1161678|NCT01233869|3815538|P2|Initial Treatment Period (24 Months)|Death|0
1161679|NCT01233869|3815539|P1|Initial Treatment Period (24 Months)|Death|1
1161680|NCT01233817|3815625|P1|Overall Study|Withdrawal by Subject|2
1161681|NCT01233817|3815625|P1|Overall Study|Lost to Follow-up|1
1161682|NCT01233687|3815672|P1|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1
1161683|NCT01233687|3815672|P1|Phase II AMG 102 + Erlotinib|Physician Decision|2
1161684|NCT01233687|3815672|P1|Phase II AMG 102 + Erlotinib|Death|1
1161685|NCT01233609|3815682|P2|Overall Study|Withdrawal by Subject|0
1161686|NCT01233609|3815683|P1|Overall Study|Withdrawal by Subject|3
1161687|NCT01233609|3815682|P2|Overall Study|Adverse Event|1
1161688|NCT01233609|3815683|P1|Overall Study|Adverse Event|2
1161689|NCT01233609|3815682|P2|Overall Study|Lost to Follow-up|1
1161690|NCT01233609|3815683|P1|Overall Study|Lost to Follow-up|3
1161691|NCT01233609|3815682|P2|Overall Study|Death|0
1161692|NCT01233609|3815683|P1|Overall Study|Death|1
1161693|NCT01233284|3815707|P5|Period 4 (4 Weeks)|Lost to Follow-up|0
1161694|NCT01233284|3815708|P4|Period 4 (4 Weeks)|Lost to Follow-up|1
1161695|NCT01233284|3815709|P3|Period 4 (4 Weeks)|Lost to Follow-up|0
1161696|NCT01233284|3815710|P2|Period 4 (4 Weeks)|Lost to Follow-up|0
1161697|NCT01233284|3815711|P1|Period 4 (4 Weeks)|Lost to Follow-up|0
1161698|NCT01233284|3815707|P5|Period 4 (4 Weeks)|Adverse Event|0
1161699|NCT01233284|3815708|P4|Period 4 (4 Weeks)|Adverse Event|0
1161700|NCT01233284|3815709|P3|Period 4 (4 Weeks)|Adverse Event|0
1161701|NCT01233284|3815710|P2|Period 4 (4 Weeks)|Adverse Event|1
1161702|NCT01233284|3815711|P1|Period 4 (4 Weeks)|Adverse Event|0
1161703|NCT01233284|3815707|P5|Period 3 (4 Weeks)|Other|0
1161704|NCT01233284|3815708|P4|Period 3 (4 Weeks)|Other|1
1161705|NCT01233284|3815709|P3|Period 3 (4 Weeks)|Other|0
1161706|NCT01233284|3815710|P2|Period 3 (4 Weeks)|Other|0
1161707|NCT01233284|3815711|P1|Period 3 (4 Weeks)|Other|0
1161708|NCT01233284|3815707|P5|Period 3 (4 Weeks)|Withdrawal by Subject|0
1161709|NCT01233284|3815708|P4|Period 3 (4 Weeks)|Withdrawal by Subject|0
1161710|NCT01233284|3815709|P3|Period 3 (4 Weeks)|Withdrawal by Subject|1
1161711|NCT01233284|3815710|P2|Period 3 (4 Weeks)|Withdrawal by Subject|0
1161712|NCT01233284|3815711|P1|Period 3 (4 Weeks)|Withdrawal by Subject|0
1161713|NCT01233284|3815707|P5|Period 2 (4 Weeks)|Withdrawal by Subject|0
1161714|NCT01233284|3815708|P4|Period 2 (4 Weeks)|Withdrawal by Subject|0
1161715|NCT01233284|3815709|P3|Period 2 (4 Weeks)|Withdrawal by Subject|1
1161716|NCT01233284|3815710|P2|Period 2 (4 Weeks)|Withdrawal by Subject|0
1161717|NCT01233284|3815711|P1|Period 2 (4 Weeks)|Withdrawal by Subject|0
1161718|NCT01233284|3815707|P5|Period 1 (4 Weeks)|Other|0
1161719|NCT01233284|3815708|P4|Period 1 (4 Weeks)|Other|0
1161720|NCT01233284|3815709|P3|Period 1 (4 Weeks)|Other|1
1161721|NCT01233284|3815710|P2|Period 1 (4 Weeks)|Other|0
1161722|NCT01233284|3815711|P1|Period 1 (4 Weeks)|Other|0
1161723|NCT01233284|3815707|P5|Period 1 (4 Weeks)|Withdrawal by Subject|0
1161724|NCT01233284|3815708|P4|Period 1 (4 Weeks)|Withdrawal by Subject|0
1161725|NCT01233284|3815709|P3|Period 1 (4 Weeks)|Withdrawal by Subject|0
1161726|NCT01233284|3815710|P2|Period 1 (4 Weeks)|Withdrawal by Subject|1
1161727|NCT01233284|3815711|P1|Period 1 (4 Weeks)|Withdrawal by Subject|0
1161728|NCT01233284|3815707|P5|Period 1 (4 Weeks)|Lost to Follow-up|0
1161729|NCT01233284|3815708|P4|Period 1 (4 Weeks)|Lost to Follow-up|0
1161730|NCT01233284|3815709|P3|Period 1 (4 Weeks)|Lost to Follow-up|0
1161731|NCT01233284|3815710|P2|Period 1 (4 Weeks)|Lost to Follow-up|0
1161732|NCT01233284|3815711|P1|Period 1 (4 Weeks)|Lost to Follow-up|1
1161733|NCT01233258|3815792|P6|First Intervention (6 Months)|Non-compliance with study medication|0
1161734|NCT01233258|3815793|P5|First Intervention (6 Months)|Non-compliance with study medication|0
1161735|NCT01233258|3815794|P4|First Intervention (6 Months)|Non-compliance with study medication|0
1161736|NCT01233258|3815795|P3|First Intervention (6 Months)|Non-compliance with study medication|0
1161737|NCT01233258|3815796|P2|First Intervention (6 Months)|Non-compliance with study medication|0
1161738|NCT01233258|3815797|P1|First Intervention (6 Months)|Non-compliance with study medication|1
1161739|NCT01233258|3815792|P6|First Intervention (6 Months)|Protocol Violation|0
1161740|NCT01233258|3815793|P5|First Intervention (6 Months)|Protocol Violation|0
1161741|NCT01233258|3815794|P4|First Intervention (6 Months)|Protocol Violation|0
1161742|NCT01233258|3815795|P3|First Intervention (6 Months)|Protocol Violation|1
1161743|NCT01233258|3815796|P2|First Intervention (6 Months)|Protocol Violation|0
1161744|NCT01233258|3815797|P1|First Intervention (6 Months)|Protocol Violation|0
1161745|NCT01233258|3815792|P6|First Intervention (6 Months)|Withdrawal by Subject|1
1161746|NCT01233258|3815793|P5|First Intervention (6 Months)|Withdrawal by Subject|0
1161747|NCT01233258|3815794|P4|First Intervention (6 Months)|Withdrawal by Subject|1
1161748|NCT01233258|3815795|P3|First Intervention (6 Months)|Withdrawal by Subject|0
1161749|NCT01233258|3815796|P2|First Intervention (6 Months)|Withdrawal by Subject|0
1161750|NCT01233258|3815797|P1|First Intervention (6 Months)|Withdrawal by Subject|0
1161751|NCT01233232|3815817|P3|Overall Study|Voluntary Discontinuation by Subject|0
1161752|NCT01233232|3815818|P2|Overall Study|Voluntary Discontinuation by Subject|0
1161753|NCT01233232|3815819|P1|Overall Study|Voluntary Discontinuation by Subject|1
1161754|NCT01233076|3815872|P2|Period 2, One Week|Lost to Follow-up|0
1161755|NCT01233076|3815873|P1|Period 2, One Week|Lost to Follow-up|1
1161756|NCT01233050|3815881|P2|Overall Study|protocol deviation (inclusion/exclusion)|6
1161757|NCT01233050|3815882|P1|Overall Study|protocol deviation (inclusion/exclusion)|8
1161758|NCT01232894|3815915|P2|Overall Study|Physician Decision|1
1161759|NCT01232894|3815916|P1|Overall Study|Physician Decision|2
1161760|NCT01232894|3815915|P2|Overall Study|Withdrawal by Subject|5
1161761|NCT01232894|3815916|P1|Overall Study|Withdrawal by Subject|8
1161762|NCT01232894|3815915|P2|Overall Study|Protocol Violation|1
1161763|NCT01232894|3815916|P1|Overall Study|Protocol Violation|1
1161764|NCT01232894|3815915|P2|Overall Study|Death|0
1161765|NCT01232894|3815916|P1|Overall Study|Death|1
1161766|NCT01232894|3815915|P2|Overall Study|Lost to Follow-up|1
1161767|NCT01232894|3815916|P1|Overall Study|Lost to Follow-up|0
1161768|NCT01232868|3815924|P2|Overall Study|Lost to Follow-up|4
1161769|NCT01232868|3815925|P1|Overall Study|Lost to Follow-up|2
1161770|NCT01232790|3815939|P2|Second Crossover|Withdrawal by Subject|2
1161771|NCT01232790|3815940|P1|Second Crossover|Withdrawal by Subject|1
1161772|NCT01232790|3815939|P2|First Crossover|Withdrawal by Subject|0
1161773|NCT01232790|3815940|P1|First Crossover|Withdrawal by Subject|1
1161774|NCT01232790|3815939|P2|Initial Assessment|Withdrawal by Subject|1
1161775|NCT01232790|3815940|P1|Initial Assessment|Withdrawal by Subject|0
1161776|NCT01232790|3815939|P2|Randomization|Physician Decision|1
1161777|NCT01232790|3815940|P1|Randomization|Physician Decision|0
1161778|NCT01232790|3815939|P2|Randomization|Protocol Violation|1
1161779|NCT01232790|3815940|P1|Randomization|Protocol Violation|0
1161780|NCT01232790|3815939|P2|Randomization|Withdrawal by Subject|0
1161781|NCT01232790|3815940|P1|Randomization|Withdrawal by Subject|2
1161782|NCT01232738|3815994|P1|Overall Study|Adverse Event|5
1161783|NCT01232738|3815994|P1|Overall Study|Withdrawal by Subject|2
1161784|NCT01232738|3815994|P1|Overall Study|Lost to Follow-up|1
1161785|NCT01232738|3815994|P1|Overall Study|Physician Decision|2
1161786|NCT01232738|3815994|P1|Overall Study|Death|3
1161787|NCT01232569|3816010|P4|Double-blind Treatment Period|Death|0
1161788|NCT01232569|3816011|P3|Double-blind Treatment Period|Death|0
1161789|NCT01232569|3816012|P2|Double-blind Treatment Period|Death|0
1161790|NCT01232569|3816013|P1|Double-blind Treatment Period|Death|2
1161791|NCT01232569|3816010|P4|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
1161792|NCT01232569|3816011|P3|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
1161793|NCT01232569|3816012|P2|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3
1161794|NCT01232569|3816013|P1|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9
1161795|NCT01232569|3816010|P4|Double-blind Treatment Period|Physician Decision|0
1161796|NCT01232569|3816011|P3|Double-blind Treatment Period|Physician Decision|0
1161797|NCT01232569|3816012|P2|Double-blind Treatment Period|Physician Decision|0
1161798|NCT01232569|3816013|P1|Double-blind Treatment Period|Physician Decision|1
1161799|NCT01232569|3816010|P4|Double-blind Treatment Period|Lack of Efficacy|0
1161800|NCT01232569|3816011|P3|Double-blind Treatment Period|Lack of Efficacy|0
1161801|NCT01232569|3816012|P2|Double-blind Treatment Period|Lack of Efficacy|2
1161802|NCT01232569|3816013|P1|Double-blind Treatment Period|Lack of Efficacy|1
1161803|NCT01232569|3816010|P4|Double-blind Treatment Period|Lost to Follow-up|0
1161804|NCT01232569|3816011|P3|Double-blind Treatment Period|Lost to Follow-up|0
1161805|NCT01232569|3816012|P2|Double-blind Treatment Period|Lost to Follow-up|0
1161806|NCT01232569|3816013|P1|Double-blind Treatment Period|Lost to Follow-up|4
1161807|NCT01232569|3816010|P4|Double-blind Treatment Period|Escape|0
1161808|NCT01232569|3816011|P3|Double-blind Treatment Period|Escape|0
1161809|NCT01232569|3816012|P2|Double-blind Treatment Period|Escape|2
1161810|NCT01232569|3816013|P1|Double-blind Treatment Period|Escape|2
1161811|NCT01232569|3816010|P4|Double-blind Treatment Period|Withdrawal by Subject|0
1161812|NCT01232569|3816011|P3|Double-blind Treatment Period|Withdrawal by Subject|0
1161813|NCT01232569|3816012|P2|Double-blind Treatment Period|Withdrawal by Subject|2
1161814|NCT01232569|3816013|P1|Double-blind Treatment Period|Withdrawal by Subject|9
1161815|NCT01232556|3816056|P2|Overall Study|Other|4
1161816|NCT01232556|3816057|P1|Overall Study|Other|6
1161817|NCT01232556|3816056|P2|Overall Study|Terminated by Sponsor|51
1161818|NCT01232556|3816057|P1|Overall Study|Terminated by Sponsor|35
1161819|NCT01232556|3816056|P2|Overall Study|Lost to Follow-up|2
1161820|NCT01232556|3816057|P1|Overall Study|Lost to Follow-up|0
1161821|NCT01232556|3816056|P2|Overall Study|Death|97
1161822|NCT01232556|3816057|P1|Overall Study|Death|97
1161823|NCT01232556|3816056|P2|Overall Study|Withdrawal by Subject|17
1161824|NCT01232556|3816057|P1|Overall Study|Withdrawal by Subject|21
1161825|NCT01232491|3816116|P2|Overall Study|Other|18
1161826|NCT01232491|3816117|P1|Overall Study|Other|21
1161827|NCT01232491|3816116|P2|Overall Study|Withdrawal Criteria|21
1161828|NCT01232491|3816117|P1|Overall Study|Withdrawal Criteria|12
1161829|NCT01232491|3816116|P2|Overall Study|Protocol Violation|11
1161830|NCT01232491|3816117|P1|Overall Study|Protocol Violation|13
1161831|NCT01232491|3816116|P2|Overall Study|Lack of Efficacy|5
1161832|NCT01232491|3816117|P1|Overall Study|Lack of Efficacy|1
1161833|NCT01232491|3816116|P2|Overall Study|Adverse Event|8
1161834|NCT01232491|3816117|P1|Overall Study|Adverse Event|13
1161835|NCT01232452|3816146|P2|Overall Study|Protocol Violation|1
1161836|NCT01232452|3816147|P1|Overall Study|Protocol Violation|0
1161837|NCT01232452|3816146|P2|Overall Study|Sponsor Decision|1
1161838|NCT01232452|3816147|P1|Overall Study|Sponsor Decision|3
1161839|NCT01232452|3816146|P2|Overall Study|Protocol entry criterion not met|2
1161840|NCT01232452|3816147|P1|Overall Study|Protocol entry criterion not met|0
1161841|NCT01232452|3816146|P2|Overall Study|Physician Decision|12
1161842|NCT01232452|3816147|P1|Overall Study|Physician Decision|8
1161843|NCT01232452|3816146|P2|Overall Study|Withdrawal by Subject|8
1161844|NCT01232452|3816147|P1|Overall Study|Withdrawal by Subject|11
1161845|NCT01232452|3816146|P2|Overall Study|Adverse Event|15
1161846|NCT01232452|3816147|P1|Overall Study|Adverse Event|17
1161847|NCT01232296|3816173|P2|Overall Study|Death|6
1161848|NCT01232296|3816174|P1|Overall Study|Death|1
1161849|NCT01232296|3816173|P2|Overall Study|Subject/guardian decision|2
1161850|NCT01232296|3816174|P1|Overall Study|Subject/guardian decision|10
1161851|NCT01232296|3816173|P2|Overall Study|Technical problems|0
1161852|NCT01232296|3816174|P1|Overall Study|Technical problems|3
1161853|NCT01232296|3816173|P2|Overall Study|Study terminated by sponsor|1
1161854|NCT01232296|3816174|P1|Overall Study|Study terminated by sponsor|0
1161855|NCT01232296|3816173|P2|Overall Study|Progressive disease|61
1161856|NCT01232296|3816174|P1|Overall Study|Progressive disease|43
1161857|NCT01232296|3816173|P2|Overall Study|Physician Decision|1
1161858|NCT01232296|3816174|P1|Overall Study|Physician Decision|1
1161859|NCT01232296|3816173|P2|Overall Study|Adverse Event|12
1161860|NCT01232296|3816174|P1|Overall Study|Adverse Event|24
1161861|NCT01232283|3816191|P10|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3
1161862|NCT01232283|3816192|P9|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7
1161863|NCT01232283|3816193|P8|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
1161864|NCT01232283|3816194|P7|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
1161865|NCT01232283|3816195|P6|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
1161866|NCT01232283|3816196|P5|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
1161867|NCT01232283|3816197|P4|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
1161868|NCT01232283|3816198|P3|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
1161869|NCT01232283|3816199|P2|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
1161870|NCT01232283|3816200|P1|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
1161871|NCT01232283|3816191|P10|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
1161872|NCT01232283|3816192|P9|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1
1161873|NCT01232283|3816193|P8|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
1161874|NCT01232283|3816194|P7|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
1161875|NCT01232283|3816195|P6|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
1161876|NCT01232283|3816196|P5|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
1161877|NCT01232283|3816197|P4|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
1161878|NCT01232283|3816198|P3|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
1161879|NCT01232283|3816199|P2|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
1161880|NCT01232283|3816200|P1|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
1161881|NCT01232283|3816191|P10|Long-Term Extension Phase (Weeks 52-260)|Death|0
1161882|NCT01232283|3816192|P9|Long-Term Extension Phase (Weeks 52-260)|Death|1
1161883|NCT01232283|3816193|P8|Long-Term Extension Phase (Weeks 52-260)|Death|0
1161884|NCT01232283|3816194|P7|Long-Term Extension Phase (Weeks 52-260)|Death|0
1161885|NCT01232283|3816195|P6|Long-Term Extension Phase (Weeks 52-260)|Death|0
1161886|NCT01232283|3816196|P5|Long-Term Extension Phase (Weeks 52-260)|Death|0
1161887|NCT01232283|3816197|P4|Long-Term Extension Phase (Weeks 52-260)|Death|0
1161888|NCT01232283|3816198|P3|Long-Term Extension Phase (Weeks 52-260)|Death|0
1161889|NCT01232283|3816199|P2|Long-Term Extension Phase (Weeks 52-260)|Death|0
1161890|NCT01232283|3816200|P1|Long-Term Extension Phase (Weeks 52-260)|Death|0
1161891|NCT01232283|3816191|P10|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6
1161892|NCT01232283|3816192|P9|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9
1161893|NCT01232283|3816193|P8|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
1161894|NCT01232283|3816194|P7|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
1161895|NCT01232283|3816195|P6|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
1161896|NCT01232283|3816196|P5|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
1161897|NCT01232283|3816197|P4|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
1161898|NCT01232283|3816198|P3|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
1161899|NCT01232283|3816199|P2|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
1161900|NCT01232283|3816200|P1|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
1161901|NCT01232283|3816191|P10|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14
1161902|NCT01232283|3816192|P9|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30
1161903|NCT01232283|3816193|P8|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
1161904|NCT01232283|3816194|P7|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
1161905|NCT01232283|3816195|P6|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
1161906|NCT01232283|3816196|P5|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
1161907|NCT01232283|3816197|P4|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
1161908|NCT01232283|3816198|P3|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
1161909|NCT01232283|3816199|P2|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
1161910|NCT01232283|3816200|P1|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
1161911|NCT01232283|3816191|P10|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2
1161912|NCT01232283|3816192|P9|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3
1161913|NCT01232283|3816193|P8|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
1161914|NCT01232283|3816194|P7|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
1161915|NCT01232283|3816195|P6|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
1161916|NCT01232283|3816196|P5|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
1161917|NCT01232283|3816197|P4|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
1161918|NCT01232283|3816198|P3|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
1161919|NCT01232283|3816199|P2|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
1161920|NCT01232283|3816200|P1|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
1161921|NCT01232283|3816191|P10|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30
1161922|NCT01232283|3816192|P9|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46
1161923|NCT01232283|3816193|P8|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
1161924|NCT01232283|3816194|P7|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
1161925|NCT01232283|3816195|P6|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
1161926|NCT01232283|3816196|P5|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
1161927|NCT01232283|3816197|P4|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
1161928|NCT01232283|3816198|P3|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
1161929|NCT01232283|3816199|P2|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
1161930|NCT01232283|3816200|P1|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
1161931|NCT01232283|3816191|P10|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6
1161932|NCT01232283|3816192|P9|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11
1161933|NCT01232283|3816193|P8|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
1161934|NCT01232283|3816194|P7|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
1161935|NCT01232283|3816195|P6|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
1161936|NCT01232283|3816196|P5|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
1161937|NCT01232283|3816197|P4|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
1161938|NCT01232283|3816198|P3|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
1161939|NCT01232283|3816199|P2|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
1161940|NCT01232283|3816200|P1|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
1161941|NCT01232283|3816191|P10|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
1161942|NCT01232283|3816192|P9|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
1161943|NCT01232283|3816193|P8|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
1161944|NCT01232283|3816194|P7|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
1161945|NCT01232283|3816195|P6|Randomized Withdrawal Phase(Weeks 32-52)|Other|1
1161946|NCT01232283|3816196|P5|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
1161947|NCT01232283|3816197|P4|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
1161948|NCT01232283|3816198|P3|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
1161949|NCT01232283|3816199|P2|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
1161950|NCT01232283|3816200|P1|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
1161951|NCT01232283|3816191|P10|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
1161952|NCT01232283|3816192|P9|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
1161953|NCT01232283|3816193|P8|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1
1161954|NCT01232283|3816194|P7|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
1161955|NCT01232283|3816195|P6|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
1161956|NCT01232283|3816196|P5|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
1161957|NCT01232283|3816197|P4|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
1161958|NCT01232283|3816198|P3|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
1161959|NCT01232283|3816199|P2|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
1161960|NCT01232283|3816200|P1|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
1161961|NCT01232283|3816191|P10|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
1161962|NCT01232283|3816192|P9|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
1161963|NCT01232283|3816193|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
1161964|NCT01232283|3816194|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
1161965|NCT01232283|3816195|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
1161966|NCT01232283|3816196|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2
1161967|NCT01232283|3816197|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
1161968|NCT01232283|3816198|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
1161969|NCT01232283|3816199|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
1161970|NCT01232283|3816200|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
1161971|NCT01232283|3816191|P10|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
1161972|NCT01232283|3816192|P9|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
1161973|NCT01232283|3816193|P8|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
1161974|NCT01232283|3816194|P7|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
1161975|NCT01232283|3816195|P6|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
1161976|NCT01232283|3816196|P5|Randomized Withdrawal Phase(Weeks 32-52)|Death|1
1161977|NCT01232283|3816197|P4|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
1161978|NCT01232283|3816198|P3|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
1161979|NCT01232283|3816199|P2|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
1161980|NCT01232283|3816200|P1|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
1161981|NCT01232283|3816191|P10|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
1161982|NCT01232283|3816192|P9|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
1161983|NCT01232283|3816193|P8|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4
1161984|NCT01232283|3816194|P7|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
1161985|NCT01232283|3816195|P6|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
1161986|NCT01232283|3816196|P5|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
1161987|NCT01232283|3816197|P4|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
1161988|NCT01232283|3816198|P3|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
1161989|NCT01232283|3816199|P2|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
1161990|NCT01232283|3816200|P1|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
1161991|NCT01232283|3816191|P10|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
1161992|NCT01232283|3816192|P9|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
1161993|NCT01232283|3816193|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5
1161994|NCT01232283|3816194|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13
1161995|NCT01232283|3816195|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
1161996|NCT01232283|3816196|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4
1161997|NCT01232283|3816197|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
1161998|NCT01232283|3816198|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
1161999|NCT01232283|3816199|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
1162000|NCT01232283|3816200|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
1162001|NCT01232283|3816191|P10|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
1162002|NCT01232283|3816192|P9|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
1162003|NCT01232283|3816193|P8|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
1162004|NCT01232283|3816194|P7|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
1162005|NCT01232283|3816195|P6|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
1162006|NCT01232283|3816196|P5|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2
1162007|NCT01232283|3816197|P4|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
1162008|NCT01232283|3816198|P3|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
1162009|NCT01232283|3816199|P2|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
1162010|NCT01232283|3816200|P1|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
1162011|NCT01232283|3816191|P10|Maintenance Phase (Weeks16-32)|Other|0
1162012|NCT01232283|3816192|P9|Maintenance Phase (Weeks16-32)|Other|0
1162013|NCT01232283|3816193|P8|Maintenance Phase (Weeks16-32)|Other|0
1162014|NCT01232283|3816194|P7|Maintenance Phase (Weeks16-32)|Other|0
1162015|NCT01232283|3816195|P6|Maintenance Phase (Weeks16-32)|Other|0
1162016|NCT01232283|3816196|P5|Maintenance Phase (Weeks16-32)|Other|0
1162017|NCT01232283|3816197|P4|Maintenance Phase (Weeks16-32)|Other|0
1162018|NCT01232283|3816198|P3|Maintenance Phase (Weeks16-32)|Other|2
1162019|NCT01232283|3816199|P2|Maintenance Phase (Weeks16-32)|Other|0
1162020|NCT01232283|3816200|P1|Maintenance Phase (Weeks16-32)|Other|0
1162021|NCT01232283|3816191|P10|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
1162022|NCT01232283|3816192|P9|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
1162023|NCT01232283|3816193|P8|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
1162024|NCT01232283|3816194|P7|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
1162025|NCT01232283|3816195|P6|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
1162026|NCT01232283|3816196|P5|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
1162027|NCT01232283|3816197|P4|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2
1162028|NCT01232283|3816198|P3|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3
1162029|NCT01232283|3816199|P2|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
1162030|NCT01232283|3816200|P1|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
1162031|NCT01232283|3816191|P10|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
1162032|NCT01232283|3816192|P9|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
1162033|NCT01232283|3816193|P8|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
1162034|NCT01232283|3816194|P7|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
1162035|NCT01232283|3816195|P6|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
1162036|NCT01232283|3816196|P5|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
1162037|NCT01232283|3816197|P4|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1
1162038|NCT01232283|3816198|P3|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7
1162039|NCT01232283|3816199|P2|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
1162040|NCT01232283|3816200|P1|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
1162041|NCT01232283|3816191|P10|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
1162042|NCT01232283|3816192|P9|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
1162043|NCT01232283|3816193|P8|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
1162044|NCT01232283|3816194|P7|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
1162045|NCT01232283|3816195|P6|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
1162046|NCT01232283|3816196|P5|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
1162047|NCT01232283|3816197|P4|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
1162048|NCT01232283|3816198|P3|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1
1162049|NCT01232283|3816199|P2|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
1162050|NCT01232283|3816200|P1|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
1162051|NCT01232283|3816191|P10|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
1162052|NCT01232283|3816192|P9|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
1162053|NCT01232283|3816193|P8|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
1162054|NCT01232283|3816194|P7|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
1162055|NCT01232283|3816195|P6|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
1162056|NCT01232283|3816196|P5|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
1162057|NCT01232283|3816197|P4|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3
1162058|NCT01232283|3816198|P3|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19
1162059|NCT01232283|3816199|P2|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
1162060|NCT01232283|3816200|P1|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
1162061|NCT01232283|3816191|P10|Maintenance Phase (Weeks16-32)|Adverse Event|0
1162062|NCT01232283|3816192|P9|Maintenance Phase (Weeks16-32)|Adverse Event|0
1162063|NCT01232283|3816193|P8|Maintenance Phase (Weeks16-32)|Adverse Event|0
1162064|NCT01232283|3816194|P7|Maintenance Phase (Weeks16-32)|Adverse Event|0
1162065|NCT01232283|3816195|P6|Maintenance Phase (Weeks16-32)|Adverse Event|0
1162066|NCT01232283|3816196|P5|Maintenance Phase (Weeks16-32)|Adverse Event|0
1162067|NCT01232283|3816197|P4|Maintenance Phase (Weeks16-32)|Adverse Event|2
1162068|NCT01232283|3816198|P3|Maintenance Phase (Weeks16-32)|Adverse Event|8
1162069|NCT01232283|3816199|P2|Maintenance Phase (Weeks16-32)|Adverse Event|0
1162070|NCT01232283|3816200|P1|Maintenance Phase (Weeks16-32)|Adverse Event|0
1162071|NCT01232283|3816191|P10|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
1162072|NCT01232283|3816192|P9|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
1162073|NCT01232283|3816193|P8|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
1162074|NCT01232283|3816194|P7|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
1162075|NCT01232283|3816195|P6|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
1162076|NCT01232283|3816196|P5|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
1162077|NCT01232283|3816197|P4|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
1162078|NCT01232283|3816198|P3|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
1162079|NCT01232283|3816199|P2|Placebo Controlled Phase (Weeks 0-16)|Not specified|1
1162080|NCT01232283|3816200|P1|Placebo Controlled Phase (Weeks 0-16)|Not specified|2
1162081|NCT01232283|3816191|P10|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
1162082|NCT01232283|3816192|P9|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
1162083|NCT01232283|3816193|P8|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
1162084|NCT01232283|3816194|P7|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
1162085|NCT01232283|3816195|P6|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
1162086|NCT01232283|3816196|P5|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
1162087|NCT01232283|3816197|P4|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
1162088|NCT01232283|3816198|P3|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
1162089|NCT01232283|3816199|P2|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2
1162090|NCT01232283|3816200|P1|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3
1162091|NCT01232283|3816191|P10|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
1162092|NCT01232283|3816192|P9|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
1162093|NCT01232283|3816193|P8|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
1162094|NCT01232283|3816194|P7|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
1162095|NCT01232283|3816195|P6|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
1162096|NCT01232283|3816196|P5|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
1162097|NCT01232283|3816197|P4|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
1162098|NCT01232283|3816198|P3|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
1162099|NCT01232283|3816199|P2|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
1162100|NCT01232283|3816200|P1|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
1162101|NCT01232283|3816191|P10|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1162102|NCT01232283|3816192|P9|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1162103|NCT01232283|3816193|P8|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1162104|NCT01232283|3816194|P7|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1162105|NCT01232283|3816195|P6|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1162106|NCT01232283|3816196|P5|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1162107|NCT01232283|3816197|P4|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1162108|NCT01232283|3816198|P3|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1162109|NCT01232283|3816199|P2|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7
1162110|NCT01232283|3816200|P1|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9
1162111|NCT01232283|3816191|P10|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
1162112|NCT01232283|3816192|P9|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
1162113|NCT01232283|3816193|P8|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
1162114|NCT01232283|3816194|P7|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
1162115|NCT01232283|3816195|P6|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
1162116|NCT01232283|3816196|P5|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
1162117|NCT01232283|3816197|P4|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
1162118|NCT01232283|3816198|P3|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
1162119|NCT01232283|3816199|P2|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
1162120|NCT01232283|3816200|P1|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1
1162121|NCT01232283|3816191|P10|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1162122|NCT01232283|3816192|P9|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1162123|NCT01232283|3816193|P8|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1162124|NCT01232283|3816194|P7|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1162125|NCT01232283|3816195|P6|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1162126|NCT01232283|3816196|P5|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1162127|NCT01232283|3816197|P4|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1162128|NCT01232283|3816198|P3|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1162129|NCT01232283|3816199|P2|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2
1162130|NCT01232283|3816200|P1|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3
1162131|NCT01232283|3816191|P10|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
1162132|NCT01232283|3816192|P9|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
1162133|NCT01232283|3816193|P8|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
1162134|NCT01232283|3816194|P7|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
1162135|NCT01232283|3816195|P6|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
1162136|NCT01232283|3816196|P5|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
1162137|NCT01232283|3816197|P4|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
1162138|NCT01232283|3816198|P3|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
1162139|NCT01232283|3816199|P2|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8
1162140|NCT01232283|3816200|P1|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12
1162141|NCT01232127|3816241|P3|Period 1: Days 1-10|Discontinued due to dosing error|0
1162142|NCT01232127|3816242|P2|Period 1: Days 1-10|Discontinued due to dosing error|0
1162143|NCT01232127|3816243|P1|Period 1: Days 1-10|Discontinued due to dosing error|1
1162144|NCT01231984|3816267|P4|Study Period 2|Did not continue to meet I/E Criteria|1
1162145|NCT01231984|3816268|P3|Study Period 2|Did not continue to meet I/E Criteria|0
1162146|NCT01231984|3816269|P2|Study Period 2|Did not continue to meet I/E Criteria|1
1162147|NCT01231984|3816270|P1|Study Period 2|Did not continue to meet I/E Criteria|1
1162148|NCT01231984|3816267|P4|Study Period 2|Lost to Follow-up|3
1162149|NCT01231984|3816268|P3|Study Period 2|Lost to Follow-up|0
1162150|NCT01231984|3816269|P2|Study Period 2|Lost to Follow-up|0
1162151|NCT01231984|3816270|P1|Study Period 2|Lost to Follow-up|1
1162152|NCT01231984|3816267|P4|Study Period 2|Withdrawal by Subject|0
1162153|NCT01231984|3816268|P3|Study Period 2|Withdrawal by Subject|0
1162154|NCT01231984|3816269|P2|Study Period 2|Withdrawal by Subject|1
1162155|NCT01231984|3816270|P1|Study Period 2|Withdrawal by Subject|1
1162156|NCT01231984|3816267|P4|Study Period 1|Not Specified|1
1162157|NCT01231984|3816268|P3|Study Period 1|Not Specified|0
1162158|NCT01231984|3816269|P2|Study Period 1|Not Specified|0
1162159|NCT01231984|3816270|P1|Study Period 1|Not Specified|0
1162160|NCT01231984|3816267|P4|Study Period 1|Adverse Event|0
1162161|NCT01231984|3816268|P3|Study Period 1|Adverse Event|0
1162162|NCT01231984|3816269|P2|Study Period 1|Adverse Event|0
1162163|NCT01231984|3816270|P1|Study Period 1|Adverse Event|1
1162164|NCT01231984|3816267|P4|Study Period 1|Protocol Violation|3
1162165|NCT01231984|3816268|P3|Study Period 1|Protocol Violation|2
1162166|NCT01231984|3816269|P2|Study Period 1|Protocol Violation|4
1162167|NCT01231984|3816270|P1|Study Period 1|Protocol Violation|3
1162168|NCT01231984|3816267|P4|Study Period 1|Non-compliance with study requirements|1
1162169|NCT01231984|3816268|P3|Study Period 1|Non-compliance with study requirements|2
1162170|NCT01231984|3816269|P2|Study Period 1|Non-compliance with study requirements|0
1162171|NCT01231984|3816270|P1|Study Period 1|Non-compliance with study requirements|5
1162172|NCT01231984|3816267|P4|Study Period 1|Screen Failure|1
1162173|NCT01231984|3816268|P3|Study Period 1|Screen Failure|0
1162174|NCT01231984|3816269|P2|Study Period 1|Screen Failure|0
1162175|NCT01231984|3816270|P1|Study Period 1|Screen Failure|0
1162176|NCT01231984|3816267|P4|Study Period 1|Did not continue to meet I/E Criteria|2
1162177|NCT01231984|3816268|P3|Study Period 1|Did not continue to meet I/E Criteria|2
1162178|NCT01231984|3816269|P2|Study Period 1|Did not continue to meet I/E Criteria|2
1162179|NCT01231984|3816270|P1|Study Period 1|Did not continue to meet I/E Criteria|2
1162180|NCT01231984|3816267|P4|Study Period 1|Lost to Follow-up|0
1162181|NCT01231984|3816268|P3|Study Period 1|Lost to Follow-up|1
1162182|NCT01231984|3816269|P2|Study Period 1|Lost to Follow-up|1
1162183|NCT01231984|3816270|P1|Study Period 1|Lost to Follow-up|1
1162184|NCT01231984|3816267|P4|Study Period 1|Withdrawal by Subject|1
1162185|NCT01231984|3816268|P3|Study Period 1|Withdrawal by Subject|0
1162186|NCT01231984|3816269|P2|Study Period 1|Withdrawal by Subject|0
1162187|NCT01231984|3816270|P1|Study Period 1|Withdrawal by Subject|0
1162188|NCT01231620|3816339|P3|Overall Study|Lost to Follow-up|9
1162189|NCT01231620|3816340|P2|Overall Study|Lost to Follow-up|4
1162190|NCT01231620|3816341|P1|Overall Study|Lost to Follow-up|3
1162191|NCT01231620|3816339|P3|Overall Study|Withdrawal by Subject|8
1162192|NCT01231620|3816340|P2|Overall Study|Withdrawal by Subject|6
1162193|NCT01231620|3816341|P1|Overall Study|Withdrawal by Subject|6
1162194|NCT01231620|3816339|P3|Overall Study|Adverse Event|1
1162195|NCT01231620|3816340|P2|Overall Study|Adverse Event|2
1162196|NCT01231620|3816341|P1|Overall Study|Adverse Event|2
1162197|NCT01231620|3816339|P3|Overall Study|Death|11
1162198|NCT01231620|3816340|P2|Overall Study|Death|14
1162199|NCT01231620|3816341|P1|Overall Study|Death|12
1162200|NCT01231620|3816339|P3|Overall Study|Physician Decision|10
1162201|NCT01231620|3816340|P2|Overall Study|Physician Decision|5
1162202|NCT01231620|3816341|P1|Overall Study|Physician Decision|3
1162203|NCT01231607|3816447|P5|Overall Study|Withdrawal by Subject|9
1162204|NCT01231607|3816448|P4|Overall Study|Withdrawal by Subject|17
1162205|NCT01231607|3816449|P3|Overall Study|Withdrawal by Subject|14
1162206|NCT01231607|3816450|P2|Overall Study|Withdrawal by Subject|9
1162207|NCT01231607|3816451|P1|Overall Study|Withdrawal by Subject|9
1162208|NCT01231607|3816447|P5|Overall Study|Protocol Violation|2
1162209|NCT01231607|3816448|P4|Overall Study|Protocol Violation|2
1162210|NCT01231607|3816449|P3|Overall Study|Protocol Violation|0
1162211|NCT01231607|3816450|P2|Overall Study|Protocol Violation|2
1162212|NCT01231607|3816451|P1|Overall Study|Protocol Violation|3
1162213|NCT01231607|3816447|P5|Overall Study|Physician Decision|4
1162214|NCT01231607|3816448|P4|Overall Study|Physician Decision|5
1162215|NCT01231607|3816449|P3|Overall Study|Physician Decision|3
1162216|NCT01231607|3816450|P2|Overall Study|Physician Decision|4
1162217|NCT01231607|3816451|P1|Overall Study|Physician Decision|4
1162218|NCT01231607|3816447|P5|Overall Study|Lost to Follow-up|4
1162219|NCT01231607|3816448|P4|Overall Study|Lost to Follow-up|10
1162220|NCT01231607|3816449|P3|Overall Study|Lost to Follow-up|10
1162221|NCT01231607|3816450|P2|Overall Study|Lost to Follow-up|11
1162222|NCT01231607|3816451|P1|Overall Study|Lost to Follow-up|13
1162223|NCT01231607|3816447|P5|Overall Study|Adverse Event|5
1162224|NCT01231607|3816448|P4|Overall Study|Adverse Event|4
1162225|NCT01231607|3816449|P3|Overall Study|Adverse Event|4
1162226|NCT01231607|3816450|P2|Overall Study|Adverse Event|8
1162227|NCT01231607|3816451|P1|Overall Study|Adverse Event|0
1162228|NCT01231581|3816543|P2|Overall Study|Ongoing|0
1162229|NCT01231581|3816544|P1|Overall Study|Ongoing|1
1162230|NCT01231581|3816543|P2|Overall Study|Death|64
1162231|NCT01231581|3816544|P1|Overall Study|Death|65
1162232|NCT01231581|3816543|P2|Overall Study|Study Closed/Terminated|5
1162233|NCT01231581|3816544|P1|Overall Study|Study Closed/Terminated|6
1162234|NCT01231581|3816543|P2|Overall Study|Withdrawal by Subject|9
1162235|NCT01231581|3816544|P1|Overall Study|Withdrawal by Subject|6
1162236|NCT01231581|3816543|P2|Overall Study|Lost to Follow-up|2
1162237|NCT01231581|3816544|P1|Overall Study|Lost to Follow-up|2
1162238|NCT01231555|3816565|P3|Overall Study|Withdrawal by Subject|0
1162239|NCT01231555|3816566|P2|Overall Study|Withdrawal by Subject|2
1162240|NCT01231555|3816567|P1|Overall Study|Withdrawal by Subject|0
1162241|NCT01231555|3816565|P3|Overall Study|Study terminated|8
1162242|NCT01231555|3816566|P2|Overall Study|Study terminated|5
1162243|NCT01231555|3816567|P1|Overall Study|Study terminated|8
1162244|NCT01231516|3816598|P2|Open-label Phase|Ongoing at the time of analysis|23
1162245|NCT01231516|3816599|P1|Open-label Phase|Ongoing at the time of analysis|282
1162246|NCT01231516|3816598|P2|Open-label Phase|Withdrawal by Subject|0
1162247|NCT01231516|3816599|P1|Open-label Phase|Withdrawal by Subject|1
1162248|NCT01231516|3816598|P2|Open-label Phase|Lost to Follow-up|0
1162249|NCT01231516|3816599|P1|Open-label Phase|Lost to Follow-up|3
1162250|NCT01231516|3816598|P2|Open-label Phase|Protocol Violation|0
1162251|NCT01231516|3816599|P1|Open-label Phase|Protocol Violation|2
1162252|NCT01231516|3816598|P2|Open-label Phase|Lack of Efficacy|3
1162253|NCT01231516|3816599|P1|Open-label Phase|Lack of Efficacy|7
1162254|NCT01231516|3816598|P2|48 Week Double-blind Phase|Site Closed|1
1162255|NCT01231516|3816599|P1|48 Week Double-blind Phase|Site Closed|3
1162256|NCT01231516|3816598|P2|48 Week Double-blind Phase|Withdrawal by Subject|5
1162257|NCT01231516|3816599|P1|48 Week Double-blind Phase|Withdrawal by Subject|11
1162258|NCT01231516|3816598|P2|48 Week Double-blind Phase|Physician Decision|1
1162259|NCT01231516|3816599|P1|48 Week Double-blind Phase|Physician Decision|1
1162260|NCT01231516|3816598|P2|48 Week Double-blind Phase|Lost to Follow-up|10
1162261|NCT01231516|3816599|P1|48 Week Double-blind Phase|Lost to Follow-up|5
1162262|NCT01231516|3816598|P2|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|3
1162263|NCT01231516|3816599|P1|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|5
1162264|NCT01231516|3816598|P2|48 Week Double-blind Phase|Protocol Violation|6
1162265|NCT01231516|3816599|P1|48 Week Double-blind Phase|Protocol Violation|9
1162266|NCT01231516|3816598|P2|48 Week Double-blind Phase|Lack of Efficacy|42
1162267|NCT01231516|3816599|P1|48 Week Double-blind Phase|Lack of Efficacy|20
1162268|NCT01231516|3816598|P2|48 Week Double-blind Phase|Adverse Event|11
1162269|NCT01231516|3816599|P1|48 Week Double-blind Phase|Adverse Event|4
1162270|NCT01231503|3816629|P8|Overall Study|Protocol Violation|0
1162271|NCT01231503|3816630|P7|Overall Study|Protocol Violation|0
1162272|NCT01231503|3816631|P6|Overall Study|Protocol Violation|0
1162273|NCT01231503|3816632|P5|Overall Study|Protocol Violation|0
1162274|NCT01231503|3816633|P4|Overall Study|Protocol Violation|1
1162275|NCT01231503|3816634|P3|Overall Study|Protocol Violation|0
1162276|NCT01231503|3816635|P2|Overall Study|Protocol Violation|0
1162277|NCT01231503|3816636|P1|Overall Study|Protocol Violation|0
1162278|NCT01231503|3816629|P8|Overall Study|Lost to Follow-up|6
1162279|NCT01231503|3816630|P7|Overall Study|Lost to Follow-up|6
1162280|NCT01231503|3816631|P6|Overall Study|Lost to Follow-up|9
1162281|NCT01231503|3816632|P5|Overall Study|Lost to Follow-up|7
1162282|NCT01231503|3816633|P4|Overall Study|Lost to Follow-up|5
1162283|NCT01231503|3816634|P3|Overall Study|Lost to Follow-up|8
1162284|NCT01231503|3816635|P2|Overall Study|Lost to Follow-up|10
1162285|NCT01231503|3816636|P1|Overall Study|Lost to Follow-up|8
1162286|NCT01231503|3816629|P8|Overall Study|Withdrawal by Subject|2
1162287|NCT01231503|3816630|P7|Overall Study|Withdrawal by Subject|1
1162288|NCT01231503|3816631|P6|Overall Study|Withdrawal by Subject|5
1162289|NCT01231503|3816632|P5|Overall Study|Withdrawal by Subject|3
1162290|NCT01231503|3816633|P4|Overall Study|Withdrawal by Subject|1
1162291|NCT01231503|3816634|P3|Overall Study|Withdrawal by Subject|3
1162292|NCT01231503|3816635|P2|Overall Study|Withdrawal by Subject|3
1162293|NCT01231503|3816636|P1|Overall Study|Withdrawal by Subject|6
1162294|NCT01231503|3816629|P8|Overall Study|Adverse event, serious fatal|0
1162295|NCT01231503|3816630|P7|Overall Study|Adverse event, serious fatal|0
1162296|NCT01231503|3816631|P6|Overall Study|Adverse event, serious fatal|1
1162297|NCT01231503|3816632|P5|Overall Study|Adverse event, serious fatal|0
1162298|NCT01231503|3816633|P4|Overall Study|Adverse event, serious fatal|1
1162299|NCT01231503|3816634|P3|Overall Study|Adverse event, serious fatal|1
1162300|NCT01231503|3816635|P2|Overall Study|Adverse event, serious fatal|0
1162301|NCT01231503|3816636|P1|Overall Study|Adverse event, serious fatal|0
1162302|NCT01231503|3816629|P8|Overall Study|Adverse Event|0
1162303|NCT01231503|3816630|P7|Overall Study|Adverse Event|0
1162304|NCT01231503|3816631|P6|Overall Study|Adverse Event|1
1162305|NCT01231503|3816632|P5|Overall Study|Adverse Event|0
1162306|NCT01231503|3816633|P4|Overall Study|Adverse Event|0
1162307|NCT01231503|3816634|P3|Overall Study|Adverse Event|0
1162308|NCT01231503|3816635|P2|Overall Study|Adverse Event|0
1162309|NCT01231503|3816636|P1|Overall Study|Adverse Event|0
1162310|NCT01231464|3816876|P2|Overall Study|Withdrawal by Subject|2
1162311|NCT01231464|3816877|P1|Overall Study|Withdrawal by Subject|3
1162312|NCT01231464|3816876|P2|Overall Study|Lost to Follow-up|2
1162313|NCT01231464|3816877|P1|Overall Study|Lost to Follow-up|1
1162314|NCT01231464|3816876|P2|Overall Study|Protocol Violation|2
1162315|NCT01231464|3816877|P1|Overall Study|Protocol Violation|1
1162316|NCT01231464|3816876|P2|Overall Study|Adverse Event|1
1162317|NCT01231464|3816877|P1|Overall Study|Adverse Event|0
1162318|NCT01231373|3816926|P4|Overall Study|Withdrew Consent|0
1162319|NCT01231373|3816927|P3|Overall Study|Withdrew Consent|0
1162320|NCT01231373|3816928|P2|Overall Study|Withdrew Consent|0
1162321|NCT01231373|3816929|P1|Overall Study|Withdrew Consent|1
1162322|NCT01231373|3816926|P4|Overall Study|Lost to Follow-up|1
1162323|NCT01231373|3816927|P3|Overall Study|Lost to Follow-up|0
1162324|NCT01231373|3816928|P2|Overall Study|Lost to Follow-up|0
1162325|NCT01231373|3816929|P1|Overall Study|Lost to Follow-up|0
1162326|NCT01231373|3816926|P4|Overall Study|Withdrew consent prior to randomization|0
1162327|NCT01231373|3816927|P3|Overall Study|Withdrew consent prior to randomization|0
1162328|NCT01231373|3816928|P2|Overall Study|Withdrew consent prior to randomization|1
1162329|NCT01231373|3816929|P1|Overall Study|Withdrew consent prior to randomization|2
1162330|NCT01231321|3816968|P1|Overall Study|Lack of Efficacy|2
1162331|NCT01231321|3816968|P1|Overall Study|Adverse Event|3
1162332|NCT01230892|3817016|P2|Overall Study|Lost to Follow-up|0
1162333|NCT01230892|3817017|P1|Overall Study|Lost to Follow-up|2
1162334|NCT01230892|3817016|P2|Overall Study|Withdrawal by Subject|1
1162335|NCT01230892|3817017|P1|Overall Study|Withdrawal by Subject|1
1162336|NCT01230827|3817027|P4|Overall Study|Study terminated by Sponsor|63
1162337|NCT01230827|3817028|P3|Overall Study|Study terminated by Sponsor|56
1162338|NCT01230827|3817029|P2|Overall Study|Study terminated by Sponsor|2
1162339|NCT01230827|3817030|P1|Overall Study|Study terminated by Sponsor|0
1162340|NCT01230827|3817027|P4|Overall Study|Recovery|0
1162341|NCT01230827|3817028|P3|Overall Study|Recovery|0
1162342|NCT01230827|3817029|P2|Overall Study|Recovery|6
1162343|NCT01230827|3817030|P1|Overall Study|Recovery|0
1162344|NCT01230827|3817027|P4|Overall Study|Adverse Event|7
1162345|NCT01230827|3817028|P3|Overall Study|Adverse Event|3
1162346|NCT01230827|3817029|P2|Overall Study|Adverse Event|2
1162347|NCT01230827|3817030|P1|Overall Study|Adverse Event|4
1162348|NCT01230827|3817027|P4|Overall Study|Lack of Efficacy|3
1162349|NCT01230827|3817028|P3|Overall Study|Lack of Efficacy|2
1162350|NCT01230827|3817029|P2|Overall Study|Lack of Efficacy|1
1162351|NCT01230827|3817030|P1|Overall Study|Lack of Efficacy|14
1162352|NCT01230827|3817027|P4|Overall Study|Withdrawal by Subject|2
1162353|NCT01230827|3817028|P3|Overall Study|Withdrawal by Subject|3
1162354|NCT01230827|3817029|P2|Overall Study|Withdrawal by Subject|0
1162355|NCT01230827|3817030|P1|Overall Study|Withdrawal by Subject|1
1162356|NCT01230827|3817027|P4|Overall Study|Lost to Follow-up|3
1162357|NCT01230827|3817028|P3|Overall Study|Lost to Follow-up|1
1162358|NCT01230827|3817029|P2|Overall Study|Lost to Follow-up|0
1162359|NCT01230827|3817030|P1|Overall Study|Lost to Follow-up|0
1162360|NCT01230814|3817046|P2|Overall Study|Discontinued (not due to adverse event)|1
1162361|NCT01230814|3817047|P1|Overall Study|Discontinued (not due to adverse event)|2
1162362|NCT01230814|3817046|P2|Overall Study|Lost to Follow-up|3
1162363|NCT01230814|3817047|P1|Overall Study|Lost to Follow-up|11
1162364|NCT01230788|3817097|P1|Overall Study|Prescribed exclusion drug|1
1162365|NCT01230749|3817109|P4|Overall Study|Fasting glucose more than 270 mg/dL|1
1162366|NCT01230749|3817110|P3|Overall Study|Fasting glucose more than 270 mg/dL|1
1162367|NCT01230749|3817111|P2|Overall Study|Fasting glucose more than 270 mg/dL|1
1162368|NCT01230749|3817112|P1|Overall Study|Fasting glucose more than 270 mg/dL|0
1162369|NCT01230749|3817109|P4|Overall Study|Withdrawal by Subject|0
1162370|NCT01230749|3817110|P3|Overall Study|Withdrawal by Subject|0
1162371|NCT01230749|3817111|P2|Overall Study|Withdrawal by Subject|1
1162372|NCT01230749|3817112|P1|Overall Study|Withdrawal by Subject|0
1162373|NCT01230749|3817109|P4|Overall Study|Physician Decision|0
1162374|NCT01230749|3817110|P3|Overall Study|Physician Decision|1
1162375|NCT01230749|3817111|P2|Overall Study|Physician Decision|0
1162376|NCT01230749|3817112|P1|Overall Study|Physician Decision|0
1162377|NCT01230749|3817109|P4|Overall Study|Adverse Event|1
1162378|NCT01230749|3817110|P3|Overall Study|Adverse Event|0
1162379|NCT01230749|3817111|P2|Overall Study|Adverse Event|0
1162380|NCT01230749|3817112|P1|Overall Study|Adverse Event|0
1162381|NCT01230710|3817147|P1|Overall Study|Withdrawal of Consent|1
1162382|NCT01230710|3817147|P1|Overall Study|Death|4
1162383|NCT01230710|3817147|P1|Overall Study|Lost to Follow-up|3
1162384|NCT01230710|3817147|P1|Overall Study|Disease Progression|41
1162385|NCT01230489|3817187|P1|Overall Study|Treatment modality changed|1
1162386|NCT01230489|3817187|P1|Overall Study|Adverse Event|2
1162387|NCT01230489|3817187|P1|Overall Study|Death|2
1162388|NCT01230307|3817222|P2|Overall Study|LVAD Placement|2
1162389|NCT01230307|3817223|P1|Overall Study|LVAD Placement|0
1162390|NCT01230060|3817243|P1|Overall Study|Withdrawal by Subject|1
1162391|NCT01229735|3817316|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
1162392|NCT01229735|3817317|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
1162393|NCT01229735|3817316|P2|Overall Study|AE, non-serious non-fatal|17
1162394|NCT01229735|3817317|P1|Overall Study|AE, non-serious non-fatal|13
1162395|NCT01229735|3817316|P2|Overall Study|SAE, non-fatal|4
1162396|NCT01229735|3817317|P1|Overall Study|SAE, non-fatal|0
1162397|NCT01229735|3817316|P2|Overall Study|Other Reason|10
1162398|NCT01229735|3817317|P1|Overall Study|Other Reason|13
1162399|NCT01229735|3817316|P2|Overall Study|Withdrawal by Subject|17
1162400|NCT01229735|3817317|P1|Overall Study|Withdrawal by Subject|18
1162401|NCT01229735|3817316|P2|Overall Study|Lost to Follow-up|2
1162402|NCT01229735|3817317|P1|Overall Study|Lost to Follow-up|0
1162403|NCT01229735|3817316|P2|Overall Study|Protocol Violation|8
1162404|NCT01229735|3817317|P1|Overall Study|Protocol Violation|13
1162405|NCT01229735|3817316|P2|Overall Study|Lack of Efficacy|8
1162406|NCT01229735|3817317|P1|Overall Study|Lack of Efficacy|8
1162407|NCT01229449|3817370|P5|Overall Study|Physician Decision|0
1162408|NCT01229449|3817371|P4|Overall Study|Physician Decision|0
1162409|NCT01229449|3817372|P3|Overall Study|Physician Decision|1
1162410|NCT01229449|3817373|P2|Overall Study|Physician Decision|0
1162411|NCT01229449|3817374|P1|Overall Study|Physician Decision|0
1162412|NCT01229449|3817370|P5|Overall Study|Lost to Follow-up|0
1162413|NCT01229449|3817371|P4|Overall Study|Lost to Follow-up|0
1162414|NCT01229449|3817372|P3|Overall Study|Lost to Follow-up|1
1162415|NCT01229449|3817373|P2|Overall Study|Lost to Follow-up|1
1162416|NCT01229449|3817374|P1|Overall Study|Lost to Follow-up|1
1162417|NCT01229449|3817370|P5|Overall Study|Withdrawal by Subject|1
1162418|NCT01229449|3817371|P4|Overall Study|Withdrawal by Subject|1
1162419|NCT01229449|3817372|P3|Overall Study|Withdrawal by Subject|0
1162420|NCT01229449|3817373|P2|Overall Study|Withdrawal by Subject|3
1162421|NCT01229449|3817374|P1|Overall Study|Withdrawal by Subject|0
1162422|NCT01229436|3817431|P1|Overall Study|Lost to Follow-up|3
1162423|NCT01229436|3817431|P1|Overall Study|Withdrawal by Subject|2
1162424|NCT01229397|3817493|P2|Overall Study|Migrated/moved from study area|0
1162425|NCT01229397|3817494|P1|Overall Study|Migrated/moved from study area|1
1162426|NCT01229397|3817493|P2|Overall Study|Lost to Follow-up|6
1162427|NCT01229397|3817494|P1|Overall Study|Lost to Follow-up|7
1162428|NCT01229397|3817493|P2|Overall Study|Withdrawal by Subject|3
1162429|NCT01229397|3817494|P1|Overall Study|Withdrawal by Subject|3
1162430|NCT01229371|3817512|P4|Overall Study|Withdrawal by Subject|0
1162431|NCT01229371|3817513|P3|Overall Study|Withdrawal by Subject|0
1162432|NCT01229371|3817514|P2|Overall Study|Withdrawal by Subject|1
1162433|NCT01229371|3817515|P1|Overall Study|Withdrawal by Subject|0
1162434|NCT01229267|3817542|P5|Overall Study|Lost to Follow-up|22
1162435|NCT01229267|3817543|P4|Overall Study|Lost to Follow-up|3
1162436|NCT01229267|3817544|P3|Overall Study|Lost to Follow-up|8
1162437|NCT01229267|3817545|P2|Overall Study|Lost to Follow-up|5
1162438|NCT01229267|3817546|P1|Overall Study|Lost to Follow-up|6
1162439|NCT01229267|3817542|P5|Overall Study|Physician Decision|25
1162440|NCT01229267|3817543|P4|Overall Study|Physician Decision|3
1162441|NCT01229267|3817544|P3|Overall Study|Physician Decision|8
1162442|NCT01229267|3817545|P2|Overall Study|Physician Decision|11
1162443|NCT01229267|3817546|P1|Overall Study|Physician Decision|8
1162444|NCT01229267|3817542|P5|Overall Study|Progressive disease|1
1162445|NCT01229267|3817543|P4|Overall Study|Progressive disease|0
1162446|NCT01229267|3817544|P3|Overall Study|Progressive disease|0
1162447|NCT01229267|3817545|P2|Overall Study|Progressive disease|0
1162448|NCT01229267|3817546|P1|Overall Study|Progressive disease|0
1162449|NCT01229267|3817542|P5|Overall Study|Protocol Violation|0
1162450|NCT01229267|3817543|P4|Overall Study|Protocol Violation|0
1162451|NCT01229267|3817544|P3|Overall Study|Protocol Violation|0
1162452|NCT01229267|3817545|P2|Overall Study|Protocol Violation|1
1162453|NCT01229267|3817546|P1|Overall Study|Protocol Violation|0
1162454|NCT01229267|3817542|P5|Overall Study|Withdrawal by Subject|59
1162455|NCT01229267|3817543|P4|Overall Study|Withdrawal by Subject|14
1162456|NCT01229267|3817544|P3|Overall Study|Withdrawal by Subject|32
1162457|NCT01229267|3817545|P2|Overall Study|Withdrawal by Subject|22
1162458|NCT01229267|3817546|P1|Overall Study|Withdrawal by Subject|23
1162459|NCT01229267|3817542|P5|Overall Study|Death|103
1162460|NCT01229267|3817543|P4|Overall Study|Death|13
1162461|NCT01229267|3817544|P3|Overall Study|Death|35
1162462|NCT01229267|3817545|P2|Overall Study|Death|37
1162463|NCT01229267|3817546|P1|Overall Study|Death|40
1162464|NCT01229267|3817542|P5|Overall Study|Adverse Event|10
1162465|NCT01229267|3817543|P4|Overall Study|Adverse Event|2
1162466|NCT01229267|3817544|P3|Overall Study|Adverse Event|3
1162467|NCT01229267|3817545|P2|Overall Study|Adverse Event|6
1162468|NCT01229267|3817546|P1|Overall Study|Adverse Event|4
1162469|NCT01229254|3817565|P3|Overall Study|Non-compliance with Study Drug|1
1162470|NCT01229254|3817566|P2|Overall Study|Non-compliance with Study Drug|1
1162471|NCT01229254|3817567|P1|Overall Study|Non-compliance with Study Drug|0
1162472|NCT01229254|3817565|P3|Overall Study|Withdrawal by Subject|1
1162473|NCT01229254|3817566|P2|Overall Study|Withdrawal by Subject|0
1162474|NCT01229254|3817567|P1|Overall Study|Withdrawal by Subject|1
1162475|NCT01229254|3817565|P3|Overall Study|Protocol Violation|5
1162476|NCT01229254|3817566|P2|Overall Study|Protocol Violation|6
1162477|NCT01229254|3817567|P1|Overall Study|Protocol Violation|4
1162478|NCT01229254|3817565|P3|Overall Study|Physician Decision|0
1162479|NCT01229254|3817566|P2|Overall Study|Physician Decision|3
1162480|NCT01229254|3817567|P1|Overall Study|Physician Decision|0
1162481|NCT01229254|3817565|P3|Overall Study|Lost to Follow-up|1
1162482|NCT01229254|3817566|P2|Overall Study|Lost to Follow-up|0
1162483|NCT01229254|3817567|P1|Overall Study|Lost to Follow-up|3
1162484|NCT01229254|3817565|P3|Overall Study|Adverse Event|3
1162485|NCT01229254|3817566|P2|Overall Study|Adverse Event|5
1162486|NCT01229254|3817567|P1|Overall Study|Adverse Event|4
1162487|NCT01229254|3817565|P3|Overall Study|Not Continuing Into Safety Extension|1
1162488|NCT01229254|3817566|P2|Overall Study|Not Continuing Into Safety Extension|1
1162489|NCT01229254|3817567|P1|Overall Study|Not Continuing Into Safety Extension|3
1162490|NCT01229176|3817605|P8|Overall Study|Lost to Follow-up|2
1162491|NCT01229176|3817606|P7|Overall Study|Lost to Follow-up|0
1162492|NCT01229176|3817607|P6|Overall Study|Lost to Follow-up|1
1162493|NCT01229176|3817608|P5|Overall Study|Lost to Follow-up|1
1162494|NCT01229176|3817609|P4|Overall Study|Lost to Follow-up|0
1162495|NCT01229176|3817610|P3|Overall Study|Lost to Follow-up|0
1162496|NCT01229176|3817611|P2|Overall Study|Lost to Follow-up|3
1162497|NCT01229176|3817612|P1|Overall Study|Lost to Follow-up|0
1162498|NCT01229176|3817605|P8|Overall Study|Withdrawal by Subject|1
1162499|NCT01229176|3817606|P7|Overall Study|Withdrawal by Subject|0
1162500|NCT01229176|3817607|P6|Overall Study|Withdrawal by Subject|1
1162501|NCT01229176|3817608|P5|Overall Study|Withdrawal by Subject|1
1162502|NCT01229176|3817609|P4|Overall Study|Withdrawal by Subject|1
1162503|NCT01229176|3817610|P3|Overall Study|Withdrawal by Subject|0
1162504|NCT01229176|3817611|P2|Overall Study|Withdrawal by Subject|0
1162505|NCT01229176|3817612|P1|Overall Study|Withdrawal by Subject|0
1162506|NCT01229150|3817666|P4|Overall Study|Toxicity|0
1162507|NCT01229150|3817667|P3|Overall Study|Toxicity|0
1162508|NCT01229150|3817668|P2|Overall Study|Toxicity|2
1162509|NCT01229150|3817669|P1|Overall Study|Toxicity|2
1162510|NCT01229111|3817726|P1|Overall Study|Death|1
1162511|NCT01228747|3817775|P2|Overall Study|Other Reason|5
1162512|NCT01228747|3817776|P1|Overall Study|Other Reason|2
1162513|NCT01228747|3817775|P2|Overall Study|Withdrawal by Subject|1
1162514|NCT01228747|3817776|P1|Overall Study|Withdrawal by Subject|5
1162515|NCT01228747|3817775|P2|Overall Study|Lost to Follow-up|3
1162516|NCT01228747|3817776|P1|Overall Study|Lost to Follow-up|4
1162517|NCT01228747|3817775|P2|Overall Study|Protocol Violation|5
1162518|NCT01228747|3817776|P1|Overall Study|Protocol Violation|6
1162519|NCT01228747|3817775|P2|Overall Study|Lack of Efficacy|27
1162520|NCT01228747|3817776|P1|Overall Study|Lack of Efficacy|40
1162521|NCT01228747|3817775|P2|Overall Study|Adverse Event|4
1162522|NCT01228747|3817776|P1|Overall Study|Adverse Event|8
1162523|NCT01228734|3817792|P2|Overall Study|Randomized, but not treated|4
1162524|NCT01228734|3817793|P1|Overall Study|Randomized, but not treated|0
1162525|NCT01228734|3817792|P2|Overall Study|Ongoing at clinical cut-off date|4
1162526|NCT01228734|3817793|P1|Overall Study|Ongoing at clinical cut-off date|16
1162527|NCT01228591|3817807|P2|Baseline|Lack of Efficacy|2
1162528|NCT01228591|3817808|P1|Baseline|Lack of Efficacy|1
1162529|NCT01228318|3817837|P2|Overall Study|Incarcerated|0
1162530|NCT01228318|3817838|P1|Overall Study|Incarcerated|1
1162531|NCT01228318|3817837|P2|Overall Study|Moved|2
1162532|NCT01228318|3817838|P1|Overall Study|Moved|0
1162533|NCT01228318|3817837|P2|Overall Study|Unable to contact|5
1162534|NCT01228318|3817838|P1|Overall Study|Unable to contact|2
1162535|NCT01228318|3817837|P2|Overall Study|Clinic no show to receive intervention|0
1162536|NCT01228318|3817838|P1|Overall Study|Clinic no show to receive intervention|1
1162537|NCT01228175|3817854|P2|Overall Study|Physician Decision|1
1162538|NCT01228175|3817855|P1|Overall Study|Physician Decision|1
1162539|NCT01228175|3817854|P2|Overall Study|Withdrawal by Subject|2
1162540|NCT01228175|3817855|P1|Overall Study|Withdrawal by Subject|1
1162541|NCT01228175|3817854|P2|Overall Study|Lost to Follow-up|50
1162542|NCT01228175|3817855|P1|Overall Study|Lost to Follow-up|64
1162543|NCT01228071|3817897|P1|Overall Study|Withdrawal by Subject|1
1162544|NCT01228071|3817897|P1|Overall Study|Protocol Violation|1
1162545|NCT01228019|3817903|P1|Overall Study|Violation of Entry Criterion|9
1162546|NCT01228019|3817903|P1|Overall Study|Triglyceride Entry Criteria Not Met|152
1162547|NCT01228019|3817903|P1|Overall Study|Missing pre-treatment data|72
1162548|NCT01228019|3817903|P1|Overall Study|Duplicate enrollment|1
1162549|NCT01228019|3817903|P1|Overall Study|Dose Violation|70
1162550|NCT01227967|3817969|P2|Overall Study|Taking Additional Antiviral Drug|0
1162551|NCT01227967|3817970|P1|Overall Study|Taking Additional Antiviral Drug|1
1162552|NCT01227967|3817969|P2|Overall Study|Never Started Treatment|4
1162553|NCT01227967|3817970|P1|Overall Study|Never Started Treatment|0
1162554|NCT01227967|3817969|P2|Overall Study|Physician Decision|1
1162555|NCT01227967|3817970|P1|Overall Study|Physician Decision|0
1162556|NCT01227967|3817969|P2|Overall Study|Withdrawal by Subject|3
1162557|NCT01227967|3817970|P1|Overall Study|Withdrawal by Subject|4
1162558|NCT01227967|3817969|P2|Overall Study|Lost to Follow-up|3
1162559|NCT01227967|3817970|P1|Overall Study|Lost to Follow-up|8
1162560|NCT01227967|3817969|P2|Overall Study|Death|1
1162561|NCT01227967|3817970|P1|Overall Study|Death|0
1162562|NCT01227967|3817969|P2|Overall Study|Protocol Violation|1
1162563|NCT01227967|3817970|P1|Overall Study|Protocol Violation|3
1162564|NCT01227954|3818004|P1|Overall Study|No protocol treatment|7
1162565|NCT01227954|3818004|P1|Overall Study|Protocol Violation|6
1162566|NCT01227928|3818018|P2|Overall Study|Death|12
1162567|NCT01227928|3818019|P1|Overall Study|Death|14
1162568|NCT01227928|3818018|P2|Overall Study|Withdrawal by Subject|3
1162569|NCT01227928|3818019|P1|Overall Study|Withdrawal by Subject|4
1162570|NCT01227928|3818018|P2|Overall Study|Lost to Follow-up|2
1162571|NCT01227928|3818019|P1|Overall Study|Lost to Follow-up|4
1162572|NCT01227902|3818057|P4|Overall Study|Withdrawal by Subject|3
1162573|NCT01227902|3818058|P3|Overall Study|Withdrawal by Subject|4
1162574|NCT01227902|3818059|P2|Overall Study|Withdrawal by Subject|2
1162575|NCT01227902|3818060|P1|Overall Study|Withdrawal by Subject|4
1162576|NCT01227902|3818057|P4|Overall Study|Physician Decision|0
1162577|NCT01227902|3818058|P3|Overall Study|Physician Decision|1
1162578|NCT01227902|3818059|P2|Overall Study|Physician Decision|1
1162579|NCT01227902|3818060|P1|Overall Study|Physician Decision|0
1162580|NCT01227902|3818057|P4|Overall Study|Lost to Follow-up|2
1162581|NCT01227902|3818058|P3|Overall Study|Lost to Follow-up|1
1162582|NCT01227902|3818059|P2|Overall Study|Lost to Follow-up|0
1162583|NCT01227902|3818060|P1|Overall Study|Lost to Follow-up|0
1162584|NCT01227902|3818057|P4|Overall Study|Protocol Violation|0
1162585|NCT01227902|3818058|P3|Overall Study|Protocol Violation|0
1162586|NCT01227902|3818059|P2|Overall Study|Protocol Violation|0
1162587|NCT01227902|3818060|P1|Overall Study|Protocol Violation|1
1162588|NCT01227902|3818057|P4|Overall Study|Lack of Efficacy|1
1162589|NCT01227902|3818058|P3|Overall Study|Lack of Efficacy|2
1162590|NCT01227902|3818059|P2|Overall Study|Lack of Efficacy|2
1162591|NCT01227902|3818060|P1|Overall Study|Lack of Efficacy|1
1162592|NCT01227902|3818057|P4|Overall Study|Adverse Event|4
1162593|NCT01227902|3818058|P3|Overall Study|Adverse Event|11
1162594|NCT01227902|3818059|P2|Overall Study|Adverse Event|8
1162595|NCT01227902|3818060|P1|Overall Study|Adverse Event|12
1162596|NCT01227889|3818153|P2|Crossover Phase|Withdrawal by Subject|1
1162597|NCT01227889|3818154|P1|Crossover Phase|Withdrawal by Subject|0
1162598|NCT01227889|3818153|P2|Crossover Phase|Study Terminated By Sponsor|1
1162599|NCT01227889|3818154|P1|Crossover Phase|Study Terminated By Sponsor|0
1162600|NCT01227889|3818153|P2|Crossover Phase|Progressive Disease|31
1162601|NCT01227889|3818154|P1|Crossover Phase|Progressive Disease|0
1162602|NCT01227889|3818153|P2|Crossover Phase|Physician Decision|3
1162603|NCT01227889|3818154|P1|Crossover Phase|Physician Decision|0
1162604|NCT01227889|3818153|P2|Crossover Phase|Adverse Event|1
1162605|NCT01227889|3818154|P1|Crossover Phase|Adverse Event|0
1162606|NCT01227889|3818153|P2|Randomized Phase (RP)|Withdrawal by Subject|3
1162607|NCT01227889|3818154|P1|Randomized Phase (RP)|Withdrawal by Subject|15
1162608|NCT01227889|3818153|P2|Randomized Phase (RP)|Missing|3
1162609|NCT01227889|3818154|P1|Randomized Phase (RP)|Missing|1
1162610|NCT01227889|3818153|P2|Randomized Phase (RP)|Study terminated by sponsor|0
1162611|NCT01227889|3818154|P1|Randomized Phase (RP)|Study terminated by sponsor|10
1162612|NCT01227889|3818153|P2|Randomized Phase (RP)|Progressive Disease|52
1162613|NCT01227889|3818154|P1|Randomized Phase (RP)|Progressive Disease|135
1162614|NCT01227889|3818153|P2|Randomized Phase (RP)|Physician Decision|5
1162615|NCT01227889|3818154|P1|Randomized Phase (RP)|Physician Decision|13
1162616|NCT01227889|3818153|P2|Randomized Phase (RP)|Adverse Event|0
1162617|NCT01227889|3818154|P1|Randomized Phase (RP)|Adverse Event|13
1162618|NCT01227824|3818181|P3|Open-label Phase: Median of 1267 Days|Physician Decision|3
1162619|NCT01227824|3818182|P2|Open-label Phase: Median of 1267 Days|Physician Decision|0
1162620|NCT01227824|3818183|P1|Open-label Phase: Median of 1267 Days|Physician Decision|0
1162621|NCT01227824|3818181|P3|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8
1162622|NCT01227824|3818182|P2|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
1162623|NCT01227824|3818183|P1|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
1162624|NCT01227824|3818181|P3|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15
1162625|NCT01227824|3818182|P2|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
1162626|NCT01227824|3818183|P1|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
1162627|NCT01227824|3818181|P3|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4
1162628|NCT01227824|3818182|P2|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
1162629|NCT01227824|3818183|P1|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
1162630|NCT01227824|3818181|P3|Open-label Phase: Median of 1267 Days|Protocol Violation|5
1162631|NCT01227824|3818182|P2|Open-label Phase: Median of 1267 Days|Protocol Violation|0
1162632|NCT01227824|3818183|P1|Open-label Phase: Median of 1267 Days|Protocol Violation|0
1162633|NCT01227824|3818181|P3|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5
1162634|NCT01227824|3818182|P2|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
1162635|NCT01227824|3818183|P1|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
1162636|NCT01227824|3818181|P3|Open-label Phase: Median of 1267 Days|Adverse Event|4
1162637|NCT01227824|3818182|P2|Open-label Phase: Median of 1267 Days|Adverse Event|0
1162638|NCT01227824|3818183|P1|Open-label Phase: Median of 1267 Days|Adverse Event|0
1162639|NCT01227824|3818181|P3|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
1162640|NCT01227824|3818182|P2|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
1162641|NCT01227824|3818183|P1|Double-blind Phase: 96 Weeks Duration|Physician Decision|3
1162642|NCT01227824|3818181|P3|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0
1162643|NCT01227824|3818182|P2|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14
1162644|NCT01227824|3818183|P1|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18
1162645|NCT01227824|3818181|P3|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0
1162646|NCT01227824|3818182|P2|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10
1162647|NCT01227824|3818183|P1|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22
1162648|NCT01227824|3818181|P3|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0
1162649|NCT01227824|3818182|P2|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4
1162650|NCT01227824|3818183|P1|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6
1162651|NCT01227824|3818181|P3|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0
1162652|NCT01227824|3818182|P2|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3
1162653|NCT01227824|3818183|P1|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6
1162654|NCT01227824|3818181|P3|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0
1162655|NCT01227824|3818182|P2|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16
1162656|NCT01227824|3818183|P1|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18
1162657|NCT01227824|3818181|P3|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0
1162658|NCT01227824|3818182|P2|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25
1162659|NCT01227824|3818183|P1|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22
1162660|NCT01227824|3818181|P3|Double-blind Phase: 96 Weeks Duration|Adverse Event|0
1162661|NCT01227824|3818182|P2|Double-blind Phase: 96 Weeks Duration|Adverse Event|7
1162662|NCT01227824|3818183|P1|Double-blind Phase: 96 Weeks Duration|Adverse Event|12
1162663|NCT01227707|3818278|P1|Overall Study|Death|1
1162664|NCT01227707|3818278|P1|Overall Study|Medical decision|6
1162665|NCT01227707|3818278|P1|Overall Study|Patient non-compliance|3
1162666|NCT01227707|3818278|P1|Overall Study|Withdrawal by Subject|1
1162667|NCT01227707|3818278|P1|Overall Study|Progression of disease|3
1162668|NCT01227707|3818278|P1|Overall Study|Adverse Event|10
1162669|NCT01227668|3818305|P2|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1
1162670|NCT01227668|3818306|P1|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0
1162671|NCT01227668|3818305|P2|Phase 2 (Randomization Phase)|Lack of Efficacy|23
1162672|NCT01227668|3818306|P1|Phase 2 (Randomization Phase)|Lack of Efficacy|13
1162673|NCT01227668|3818305|P2|Phase 2 (Randomization Phase)|Lost to Follow-up|0
1162674|NCT01227668|3818306|P1|Phase 2 (Randomization Phase)|Lost to Follow-up|1
1162675|NCT01227668|3818305|P2|Phase 2 (Randomization Phase)|Withdrawal by Subject|0
1162676|NCT01227668|3818306|P1|Phase 2 (Randomization Phase)|Withdrawal by Subject|5
1162677|NCT01227668|3818305|P2|Phase 2 (Randomization Phase)|Adverse Event|1
1162678|NCT01227668|3818306|P1|Phase 2 (Randomization Phase)|Adverse Event|0
1162679|NCT01227668|3818305|P2|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0
1162680|NCT01227668|3818306|P1|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2
1162681|NCT01227668|3818305|P2|Phase 1 (Stabilization Phase)|Lack of Efficacy|0
1162682|NCT01227668|3818306|P1|Phase 1 (Stabilization Phase)|Lack of Efficacy|25
1162683|NCT01227668|3818305|P2|Phase 1 (Stabilization Phase)|No longer meets study criteria|0
1162684|NCT01227668|3818306|P1|Phase 1 (Stabilization Phase)|No longer meets study criteria|7
1162685|NCT01227668|3818305|P2|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0
1162686|NCT01227668|3818306|P1|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11
1162687|NCT01227668|3818305|P2|Phase 1 (Stabilization Phase)|Lost to Follow-up|0
1162688|NCT01227668|3818306|P1|Phase 1 (Stabilization Phase)|Lost to Follow-up|8
1162689|NCT01227668|3818305|P2|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0
1162690|NCT01227668|3818306|P1|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7
1162691|NCT01227668|3818305|P2|Phase 1 (Stabilization Phase)|Adverse Event|0
1162692|NCT01227668|3818306|P1|Phase 1 (Stabilization Phase)|Adverse Event|12
1162693|NCT01227629|3818352|P10|Overall Study|Not Specified|1
1162694|NCT01227629|3818353|P9|Overall Study|Not Specified|2
1162695|NCT01227629|3818354|P8|Overall Study|Not Specified|0
1162696|NCT01227629|3818355|P7|Overall Study|Not Specified|0
1162697|NCT01227629|3818356|P6|Overall Study|Not Specified|0
1162698|NCT01227629|3818357|P5|Overall Study|Not Specified|0
1162699|NCT01227629|3818358|P4|Overall Study|Not Specified|1
1162700|NCT01227629|3818359|P3|Overall Study|Not Specified|0
1162701|NCT01227629|3818360|P2|Overall Study|Not Specified|0
1162702|NCT01227629|3818361|P1|Overall Study|Not Specified|0
1162703|NCT01227629|3818352|P10|Overall Study|Withdrawal by Subject|1
1162704|NCT01227629|3818353|P9|Overall Study|Withdrawal by Subject|0
1162705|NCT01227629|3818354|P8|Overall Study|Withdrawal by Subject|0
1162706|NCT01227629|3818355|P7|Overall Study|Withdrawal by Subject|2
1162707|NCT01227629|3818356|P6|Overall Study|Withdrawal by Subject|0
1162708|NCT01227629|3818357|P5|Overall Study|Withdrawal by Subject|0
1162709|NCT01227629|3818358|P4|Overall Study|Withdrawal by Subject|0
1162710|NCT01227629|3818359|P3|Overall Study|Withdrawal by Subject|0
1162711|NCT01227629|3818360|P2|Overall Study|Withdrawal by Subject|0
1162712|NCT01227629|3818361|P1|Overall Study|Withdrawal by Subject|0
1162713|NCT01227629|3818352|P10|Overall Study|Lost to Follow-up|0
1162714|NCT01227629|3818353|P9|Overall Study|Lost to Follow-up|0
1162715|NCT01227629|3818354|P8|Overall Study|Lost to Follow-up|0
1162716|NCT01227629|3818355|P7|Overall Study|Lost to Follow-up|0
1162717|NCT01227629|3818356|P6|Overall Study|Lost to Follow-up|0
1162718|NCT01227629|3818357|P5|Overall Study|Lost to Follow-up|1
1162719|NCT01227629|3818358|P4|Overall Study|Lost to Follow-up|0
1162720|NCT01227629|3818359|P3|Overall Study|Lost to Follow-up|0
1162721|NCT01227629|3818360|P2|Overall Study|Lost to Follow-up|0
1162722|NCT01227629|3818361|P1|Overall Study|Lost to Follow-up|0
1162723|NCT01227629|3818352|P10|Overall Study|Protocol Violation|0
1162724|NCT01227629|3818353|P9|Overall Study|Protocol Violation|0
1162725|NCT01227629|3818354|P8|Overall Study|Protocol Violation|0
1162726|NCT01227629|3818355|P7|Overall Study|Protocol Violation|0
1162727|NCT01227629|3818356|P6|Overall Study|Protocol Violation|0
1162728|NCT01227629|3818357|P5|Overall Study|Protocol Violation|0
1162729|NCT01227629|3818358|P4|Overall Study|Protocol Violation|1
1162730|NCT01227629|3818359|P3|Overall Study|Protocol Violation|0
1162731|NCT01227629|3818360|P2|Overall Study|Protocol Violation|0
1162732|NCT01227629|3818361|P1|Overall Study|Protocol Violation|0
1162733|NCT01227629|3818352|P10|Overall Study|Adverse Event|0
1162734|NCT01227629|3818353|P9|Overall Study|Adverse Event|4
1162735|NCT01227629|3818354|P8|Overall Study|Adverse Event|6
1162736|NCT01227629|3818355|P7|Overall Study|Adverse Event|6
1162737|NCT01227629|3818356|P6|Overall Study|Adverse Event|1
1162738|NCT01227629|3818357|P5|Overall Study|Adverse Event|1
1162739|NCT01227629|3818358|P4|Overall Study|Adverse Event|6
1162740|NCT01227629|3818359|P3|Overall Study|Adverse Event|1
1162741|NCT01227629|3818360|P2|Overall Study|Adverse Event|2
1162742|NCT01227629|3818361|P1|Overall Study|Adverse Event|2
1162743|NCT01227577|3818597|P1|Overall Study|Adverse Event|17
1162744|NCT01227577|3818597|P1|Overall Study|Lack of Efficacy|5
1162745|NCT01227577|3818597|P1|Overall Study|Withdrawal by Subject|4
1162746|NCT01227577|3818597|P1|Overall Study|Lost to Follow-up|1
1162747|NCT01227577|3818597|P1|Overall Study|Administrative problems|2
1162748|NCT01227577|3818597|P1|Overall Study|Death|3
1162749|NCT01227577|3818597|P1|Overall Study|Protocol deviation|3
1162750|NCT01227564|3818612|P3|Overall Study|Participant moved to another town|1
1162751|NCT01227564|3818613|P2|Overall Study|Participant moved to another town|0
1162752|NCT01227564|3818614|P1|Overall Study|Participant moved to another town|0
1162753|NCT01227564|3818612|P3|Overall Study|No Longer Willing to Participate|5
1162754|NCT01227564|3818613|P2|Overall Study|No Longer Willing to Participate|2
1162755|NCT01227564|3818614|P1|Overall Study|No Longer Willing to Participate|4
1162756|NCT01227512|3818752|P2|Overall Study|Participant met withdrawal criteria|1
1162757|NCT01227512|3818753|P1|Overall Study|Participant met withdrawal criteria|0
1162758|NCT01227512|3818752|P2|Overall Study|Withdrawal by Subject|0
1162759|NCT01227512|3818753|P1|Overall Study|Withdrawal by Subject|3
1162760|NCT01227512|3818752|P2|Overall Study|Adverse Event|3
1162761|NCT01227512|3818753|P1|Overall Study|Adverse Event|4
1162762|NCT01227512|3818752|P2|Overall Study|Physician Decision|6
1162763|NCT01227512|3818753|P1|Overall Study|Physician Decision|6
1162764|NCT01227421|3818787|P3|Overall Study|Randomized in error|0
1162765|NCT01227421|3818788|P2|Overall Study|Randomized in error|1
1162766|NCT01227421|3818789|P1|Overall Study|Randomized in error|1
1162767|NCT01227421|3818787|P3|Overall Study|Protocol Violation|2
1162768|NCT01227421|3818788|P2|Overall Study|Protocol Violation|1
1162769|NCT01227421|3818789|P1|Overall Study|Protocol Violation|1
1162770|NCT01227421|3818787|P3|Overall Study|Withdrawal by Subject|1
1162771|NCT01227421|3818788|P2|Overall Study|Withdrawal by Subject|2
1162772|NCT01227421|3818789|P1|Overall Study|Withdrawal by Subject|1
1162773|NCT01227421|3818787|P3|Overall Study|Adverse Event|2
1162774|NCT01227421|3818788|P2|Overall Study|Adverse Event|7
1162775|NCT01227421|3818789|P1|Overall Study|Adverse Event|2
1162776|NCT01227421|3818787|P3|Overall Study|Lost to Follow-up|5
1162777|NCT01227421|3818788|P2|Overall Study|Lost to Follow-up|7
1162778|NCT01227421|3818789|P1|Overall Study|Lost to Follow-up|6
1162779|NCT01227395|3818841|P2|Overall Study|Protocol Violation|1
1162780|NCT01227395|3818842|P1|Overall Study|Protocol Violation|0
1162781|NCT01227278|3818882|P2|Overall Study|Other|2
1162782|NCT01227278|3818883|P1|Overall Study|Other|1
1162783|NCT01227278|3818882|P2|Overall Study|Death|2
1162784|NCT01227278|3818883|P1|Overall Study|Death|0
1162785|NCT01227278|3818882|P2|Overall Study|Withdrawal by Subject|4
1162786|NCT01227278|3818883|P1|Overall Study|Withdrawal by Subject|4
1162787|NCT01227265|3818910|P3|Overall Study|Adverse Event|5
1162788|NCT01227265|3818911|P2|Overall Study|Adverse Event|10
1162789|NCT01227265|3818912|P1|Overall Study|Adverse Event|6
1162790|NCT01227265|3818910|P3|Overall Study|Lost to Follow-up|3
1162791|NCT01227265|3818911|P2|Overall Study|Lost to Follow-up|0
1162792|NCT01227265|3818912|P1|Overall Study|Lost to Follow-up|2
1162793|NCT01227265|3818910|P3|Overall Study|Withdrawal by Subject|3
1162794|NCT01227265|3818911|P2|Overall Study|Withdrawal by Subject|7
1162795|NCT01227265|3818912|P1|Overall Study|Withdrawal by Subject|7
1162796|NCT01227265|3818910|P3|Overall Study|Protocol Violation|0
1162797|NCT01227265|3818911|P2|Overall Study|Protocol Violation|1
1162798|NCT01227265|3818912|P1|Overall Study|Protocol Violation|2
1162799|NCT01227265|3818910|P3|Overall Study|Did Not Meet Protocol Eligibility|1
1162800|NCT01227265|3818911|P2|Overall Study|Did Not Meet Protocol Eligibility|0
1162801|NCT01227265|3818912|P1|Overall Study|Did Not Meet Protocol Eligibility|0
1162802|NCT01227265|3818910|P3|Overall Study|Administrative|2
1162803|NCT01227265|3818911|P2|Overall Study|Administrative|0
1162804|NCT01227265|3818912|P1|Overall Study|Administrative|1
1162805|NCT01227265|3818910|P3|Overall Study|Did Not Receive Treatment|0
1162806|NCT01227265|3818911|P2|Overall Study|Did Not Receive Treatment|2
1162807|NCT01227265|3818912|P1|Overall Study|Did Not Receive Treatment|1
1162808|NCT01227018|3818951|P1|Overall Study|Withdrew after beginning treatment|4
1162809|NCT01227018|3818951|P1|Overall Study|Toxicity|2
1162810|NCT01227018|3818951|P1|Overall Study|Disease progression|9
1162811|NCT01226745|3818978|P6|Overall Study|Other|1
1162812|NCT01226745|3818979|P5|Overall Study|Other|3
1162813|NCT01226745|3818980|P4|Overall Study|Other|4
1162814|NCT01226745|3818981|P3|Overall Study|Other|8
1162815|NCT01226745|3818982|P2|Overall Study|Other|7
1162816|NCT01226745|3818983|P1|Overall Study|Other|6
1162817|NCT01226745|3818978|P6|Overall Study|Death|1
1162818|NCT01226745|3818979|P5|Overall Study|Death|0
1162819|NCT01226745|3818980|P4|Overall Study|Death|0
1162820|NCT01226745|3818981|P3|Overall Study|Death|0
1162821|NCT01226745|3818982|P2|Overall Study|Death|0
1162822|NCT01226745|3818983|P1|Overall Study|Death|1
1162823|NCT01226745|3818978|P6|Overall Study|Lost to Follow-up|2
1162824|NCT01226745|3818979|P5|Overall Study|Lost to Follow-up|1
1162825|NCT01226745|3818980|P4|Overall Study|Lost to Follow-up|1
1162826|NCT01226745|3818981|P3|Overall Study|Lost to Follow-up|6
1162827|NCT01226745|3818982|P2|Overall Study|Lost to Follow-up|6
1162828|NCT01226745|3818983|P1|Overall Study|Lost to Follow-up|2
1162829|NCT01226745|3818978|P6|Overall Study|Did not complete schedule of assessments|1
1162830|NCT01226745|3818979|P5|Overall Study|Did not complete schedule of assessments|0
1162831|NCT01226745|3818980|P4|Overall Study|Did not complete schedule of assessments|0
1162832|NCT01226745|3818981|P3|Overall Study|Did not complete schedule of assessments|6
1162833|NCT01226745|3818982|P2|Overall Study|Did not complete schedule of assessments|3
1162834|NCT01226745|3818983|P1|Overall Study|Did not complete schedule of assessments|8
1162835|NCT01226511|3819179|P2|Taper Period|Parent/Caregiver Decision|1
1162836|NCT01226511|3819180|P1|Taper Period|Parent/Caregiver Decision|1
1162837|NCT01226511|3819179|P2|Taper Period|Protocol Violation|0
1162838|NCT01226511|3819180|P1|Taper Period|Protocol Violation|1
1162839|NCT01226511|3819179|P2|Taper Period|Lost to Follow-up|2
1162840|NCT01226511|3819180|P1|Taper Period|Lost to Follow-up|2
1162841|NCT01226511|3819179|P2|Taper Period|Adverse Event|0
1162842|NCT01226511|3819180|P1|Taper Period|Adverse Event|1
1162843|NCT01226511|3819179|P2|Extension Treatment Period|Sponsor Decision|1
1162844|NCT01226511|3819180|P1|Extension Treatment Period|Sponsor Decision|1
1162845|NCT01226511|3819179|P2|Extension Treatment Period|Parent/Caregiver Decision|8
1162846|NCT01226511|3819180|P1|Extension Treatment Period|Parent/Caregiver Decision|8
1162847|NCT01226511|3819179|P2|Extension Treatment Period|Withdrawal by Subject|3
1162848|NCT01226511|3819180|P1|Extension Treatment Period|Withdrawal by Subject|1
1162849|NCT01226511|3819179|P2|Extension Treatment Period|Protocol Violation|2
1162850|NCT01226511|3819180|P1|Extension Treatment Period|Protocol Violation|2
1162851|NCT01226511|3819179|P2|Extension Treatment Period|Lost to Follow-up|3
1162852|NCT01226511|3819180|P1|Extension Treatment Period|Lost to Follow-up|4
1162853|NCT01226511|3819179|P2|Extension Treatment Period|Lack of Efficacy|2
1162854|NCT01226511|3819180|P1|Extension Treatment Period|Lack of Efficacy|3
1162855|NCT01226511|3819179|P2|Extension Treatment Period|Adverse Event|8
1162856|NCT01226511|3819180|P1|Extension Treatment Period|Adverse Event|8
1162857|NCT01226511|3819179|P2|Acute Treatment Period|Withdrawal by Subject|6
1162858|NCT01226511|3819180|P1|Acute Treatment Period|Withdrawal by Subject|10
1162859|NCT01226511|3819179|P2|Acute Treatment Period|Protocol Violation|5
1162860|NCT01226511|3819180|P1|Acute Treatment Period|Protocol Violation|5
1162861|NCT01226511|3819179|P2|Acute Treatment Period|Parent/caregiver decision|7
1162862|NCT01226511|3819180|P1|Acute Treatment Period|Parent/caregiver decision|5
1162863|NCT01226511|3819179|P2|Acute Treatment Period|Lost to Follow-up|6
1162864|NCT01226511|3819180|P1|Acute Treatment Period|Lost to Follow-up|3
1162865|NCT01226511|3819179|P2|Acute Treatment Period|Lack of Efficacy|1
1162866|NCT01226511|3819180|P1|Acute Treatment Period|Lack of Efficacy|2
1162867|NCT01226511|3819179|P2|Acute Treatment Period|Adverse Event|6
1162868|NCT01226511|3819180|P1|Acute Treatment Period|Adverse Event|7
1162869|NCT01226459|3819218|P2|Overall Study|Pregnancy|0
1162870|NCT01226459|3819219|P1|Overall Study|Pregnancy|1
1162871|NCT01226459|3819218|P2|Overall Study|Lost to Follow-up|8
1162872|NCT01226459|3819219|P1|Overall Study|Lost to Follow-up|4
1162873|NCT01226459|3819218|P2|Overall Study|Withdrawal by Subject|13
1162874|NCT01226459|3819219|P1|Overall Study|Withdrawal by Subject|10
1162875|NCT01226459|3819218|P2|Overall Study|Protocol Violation|3
1162876|NCT01226459|3819219|P1|Overall Study|Protocol Violation|4
1162877|NCT01226459|3819218|P2|Overall Study|Adverse Event|8
1162878|NCT01226459|3819219|P1|Overall Study|Adverse Event|2
1162879|NCT01226121|3819237|P3|Overall Study|Lost to Follow-up|1
1162880|NCT01226121|3819238|P2|Overall Study|Lost to Follow-up|0
1162881|NCT01226121|3819239|P1|Overall Study|Lost to Follow-up|2
1162882|NCT01226095|3819250|P1|Overall Study|Poor compliance|1
1162883|NCT01226043|3819275|P4|30-week Observational Phase|Physician Decision|2
1162884|NCT01226043|3819276|P3|30-week Observational Phase|Physician Decision|2
1162885|NCT01226043|3819277|P2|30-week Observational Phase|Physician Decision|0
1162886|NCT01226043|3819278|P1|30-week Observational Phase|Physician Decision|0
1162887|NCT01226043|3819275|P4|30-week Observational Phase|Withdrawal by Subject|7
1162888|NCT01226043|3819276|P3|30-week Observational Phase|Withdrawal by Subject|1
1162889|NCT01226043|3819277|P2|30-week Observational Phase|Withdrawal by Subject|0
1162890|NCT01226043|3819278|P1|30-week Observational Phase|Withdrawal by Subject|0
1162891|NCT01226043|3819275|P4|30-week Observational Phase|Lost to Follow-up|2
1162892|NCT01226043|3819276|P3|30-week Observational Phase|Lost to Follow-up|2
1162893|NCT01226043|3819277|P2|30-week Observational Phase|Lost to Follow-up|0
1162894|NCT01226043|3819278|P1|30-week Observational Phase|Lost to Follow-up|0
1162895|NCT01226043|3819275|P4|30-week Observational Phase|Protocol Violation|1
1162896|NCT01226043|3819276|P3|30-week Observational Phase|Protocol Violation|0
1162897|NCT01226043|3819277|P2|30-week Observational Phase|Protocol Violation|0
1162898|NCT01226043|3819278|P1|30-week Observational Phase|Protocol Violation|0
1162899|NCT01226043|3819275|P4|30-week Observational Phase|Adverse Event|1
1162900|NCT01226043|3819276|P3|30-week Observational Phase|Adverse Event|1
1162901|NCT01226043|3819277|P2|30-week Observational Phase|Adverse Event|0
1162902|NCT01226043|3819278|P1|30-week Observational Phase|Adverse Event|0
1162903|NCT01226043|3819275|P4|6-week Re-randomization Phase|completed in error|1
1162904|NCT01226043|3819276|P3|6-week Re-randomization Phase|completed in error|0
1162905|NCT01226043|3819277|P2|6-week Re-randomization Phase|completed in error|0
1162906|NCT01226043|3819278|P1|6-week Re-randomization Phase|completed in error|0
1162907|NCT01226043|3819275|P4|6-week Re-randomization Phase|Physician Decision|2
1162908|NCT01226043|3819276|P3|6-week Re-randomization Phase|Physician Decision|3
1162909|NCT01226043|3819277|P2|6-week Re-randomization Phase|Physician Decision|0
1162910|NCT01226043|3819278|P1|6-week Re-randomization Phase|Physician Decision|0
1162911|NCT01226043|3819275|P4|6-week Re-randomization Phase|Withdrawal by Subject|3
1162912|NCT01226043|3819276|P3|6-week Re-randomization Phase|Withdrawal by Subject|1
1162913|NCT01226043|3819277|P2|6-week Re-randomization Phase|Withdrawal by Subject|0
1162914|NCT01226043|3819278|P1|6-week Re-randomization Phase|Withdrawal by Subject|0
1162915|NCT01226043|3819275|P4|6-week Re-randomization Phase|Lost to Follow-up|3
1162916|NCT01226043|3819276|P3|6-week Re-randomization Phase|Lost to Follow-up|1
1162917|NCT01226043|3819277|P2|6-week Re-randomization Phase|Lost to Follow-up|0
1162918|NCT01226043|3819278|P1|6-week Re-randomization Phase|Lost to Follow-up|0
1162919|NCT01226043|3819275|P4|6-week Re-randomization Phase|Protocol Violation|1
1162920|NCT01226043|3819276|P3|6-week Re-randomization Phase|Protocol Violation|1
1162921|NCT01226043|3819277|P2|6-week Re-randomization Phase|Protocol Violation|0
1162922|NCT01226043|3819278|P1|6-week Re-randomization Phase|Protocol Violation|0
1162923|NCT01226043|3819275|P4|6-week Re-randomization Phase|Adverse Event|1
1162924|NCT01226043|3819276|P3|6-week Re-randomization Phase|Adverse Event|1
1162925|NCT01226043|3819277|P2|6-week Re-randomization Phase|Adverse Event|0
1162926|NCT01226043|3819278|P1|6-week Re-randomization Phase|Adverse Event|0
1162927|NCT01226043|3819275|P4|4-week Crossover Phase - Period 2|Physician Decision|0
1162928|NCT01226043|3819276|P3|4-week Crossover Phase - Period 2|Physician Decision|0
1162929|NCT01226043|3819277|P2|4-week Crossover Phase - Period 2|Physician Decision|5
1162930|NCT01226043|3819278|P1|4-week Crossover Phase - Period 2|Physician Decision|4
1162931|NCT01226043|3819275|P4|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
1162932|NCT01226043|3819276|P3|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
1162933|NCT01226043|3819277|P2|4-week Crossover Phase - Period 2|Withdrawal by Subject|1
1162934|NCT01226043|3819278|P1|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
1162935|NCT01226043|3819275|P4|4-week Crossover Phase - Period 1|Physician Decision|0
1162936|NCT01226043|3819276|P3|4-week Crossover Phase - Period 1|Physician Decision|0
1162937|NCT01226043|3819277|P2|4-week Crossover Phase - Period 1|Physician Decision|6
1162938|NCT01226043|3819278|P1|4-week Crossover Phase - Period 1|Physician Decision|0
1162939|NCT01226043|3819275|P4|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
1162940|NCT01226043|3819276|P3|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
1162941|NCT01226043|3819277|P2|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
1162942|NCT01226043|3819278|P1|4-week Crossover Phase - Period 1|Withdrawal by Subject|2
1162943|NCT01226043|3819275|P4|4-week Crossover Phase - Period 1|Lost to Follow-up|0
1162944|NCT01226043|3819276|P3|4-week Crossover Phase - Period 1|Lost to Follow-up|0
1162945|NCT01226043|3819277|P2|4-week Crossover Phase - Period 1|Lost to Follow-up|1
1162946|NCT01226043|3819278|P1|4-week Crossover Phase - Period 1|Lost to Follow-up|0
1162947|NCT01226043|3819275|P4|4-week Crossover Phase - Period 1|Protocol Violation|0
1162948|NCT01226043|3819276|P3|4-week Crossover Phase - Period 1|Protocol Violation|0
1162949|NCT01226043|3819277|P2|4-week Crossover Phase - Period 1|Protocol Violation|2
1162950|NCT01226043|3819278|P1|4-week Crossover Phase - Period 1|Protocol Violation|1
1162951|NCT01225991|3819316|P1|Overall Study|Withdrawal by Subject|6
1162952|NCT01225952|3819327|P3|Overall Study|Surgical complications|0
1162953|NCT01225952|3819328|P2|Overall Study|Surgical complications|0
1162954|NCT01225952|3819329|P1|Overall Study|Surgical complications|1
1162955|NCT01225952|3819327|P3|Overall Study|Withdrawal by Subject|5
1162956|NCT01225952|3819328|P2|Overall Study|Withdrawal by Subject|4
1162957|NCT01225952|3819329|P1|Overall Study|Withdrawal by Subject|4
1162958|NCT01225952|3819327|P3|Overall Study|Study Eye Explanted|1
1162959|NCT01225952|3819328|P2|Overall Study|Study Eye Explanted|0
1162960|NCT01225952|3819329|P1|Overall Study|Study Eye Explanted|0
1162961|NCT01225952|3819327|P3|Overall Study|Lost to Follow-up|0
1162962|NCT01225952|3819328|P2|Overall Study|Lost to Follow-up|0
1162963|NCT01225952|3819329|P1|Overall Study|Lost to Follow-up|1
1162964|NCT01225887|3819421|P1|Overall Study|Ineligible:inadequate pathology|2
1162965|NCT01225887|3819421|P1|Overall Study|Ineligible;improper pre-protocol therapy|1
1162966|NCT01225887|3819421|P1|Overall Study|Ineligible:required test not done|2
1162967|NCT01225835|3819431|P2|Overall Study|not specified|1
1162968|NCT01225835|3819432|P1|Overall Study|not specified|1
1162969|NCT01225835|3819431|P2|Overall Study|Adverse Event|1
1162970|NCT01225835|3819432|P1|Overall Study|Adverse Event|2
1162971|NCT01225835|3819431|P2|Overall Study|Did not meet hCG criterion|0
1162972|NCT01225835|3819432|P1|Overall Study|Did not meet hCG criterion|2
1162973|NCT01225835|3819431|P2|Overall Study|Completed protocol|1
1162974|NCT01225835|3819432|P1|Overall Study|Completed protocol|2
1162975|NCT01225822|3819480|P5|Overall Study|Not Specified|7
1162976|NCT01225822|3819481|P4|Overall Study|Not Specified|10
1162977|NCT01225822|3819482|P3|Overall Study|Not Specified|7
1162978|NCT01225822|3819483|P2|Overall Study|Not Specified|10
1162979|NCT01225822|3819484|P1|Overall Study|Not Specified|13
1162980|NCT01225822|3819480|P5|Overall Study|Withdrawal by Subject|6
1162981|NCT01225822|3819481|P4|Overall Study|Withdrawal by Subject|11
1162982|NCT01225822|3819482|P3|Overall Study|Withdrawal by Subject|7
1162983|NCT01225822|3819483|P2|Overall Study|Withdrawal by Subject|7
1162984|NCT01225822|3819484|P1|Overall Study|Withdrawal by Subject|6
1162985|NCT01225822|3819480|P5|Overall Study|Lost to Follow-up|0
1162986|NCT01225822|3819481|P4|Overall Study|Lost to Follow-up|1
1162987|NCT01225822|3819482|P3|Overall Study|Lost to Follow-up|0
1162988|NCT01225822|3819483|P2|Overall Study|Lost to Follow-up|0
1162989|NCT01225822|3819484|P1|Overall Study|Lost to Follow-up|0
1162990|NCT01225822|3819480|P5|Overall Study|Protocol Violation|4
1162991|NCT01225822|3819481|P4|Overall Study|Protocol Violation|7
1162992|NCT01225822|3819482|P3|Overall Study|Protocol Violation|6
1162993|NCT01225822|3819483|P2|Overall Study|Protocol Violation|8
1162994|NCT01225822|3819484|P1|Overall Study|Protocol Violation|6
1162995|NCT01225822|3819480|P5|Overall Study|Adverse Event|14
1162996|NCT01225822|3819481|P4|Overall Study|Adverse Event|23
1162997|NCT01225822|3819482|P3|Overall Study|Adverse Event|18
1162998|NCT01225822|3819483|P2|Overall Study|Adverse Event|31
1162999|NCT01225822|3819484|P1|Overall Study|Adverse Event|13
1163000|NCT01225731|3819551|P13|Part 3|Withdrawal by Subject|4
1163001|NCT01225731|3819552|P12|Part 3|Withdrawal by Subject|6
1163002|NCT01225731|3819553|P11|Part 3|Withdrawal by Subject|4
1163003|NCT01225731|3819554|P10|Part 3|Withdrawal by Subject|0
1163004|NCT01225731|3819555|P9|Part 3|Withdrawal by Subject|0
1163005|NCT01225731|3819556|P8|Part 3|Withdrawal by Subject|0
1163006|NCT01225731|3819557|P7|Part 3|Withdrawal by Subject|0
1163007|NCT01225731|3819558|P6|Part 3|Withdrawal by Subject|0
1163008|NCT01225731|3819559|P5|Part 3|Withdrawal by Subject|0
1163009|NCT01225731|3819560|P4|Part 3|Withdrawal by Subject|0
1163010|NCT01225731|3819561|P3|Part 3|Withdrawal by Subject|0
1163011|NCT01225731|3819562|P2|Part 3|Withdrawal by Subject|0
1163012|NCT01225731|3819563|P1|Part 3|Withdrawal by Subject|0
1163013|NCT01225731|3819551|P13|Part 3|Physician Decision|2
1163014|NCT01225731|3819552|P12|Part 3|Physician Decision|1
1163015|NCT01225731|3819553|P11|Part 3|Physician Decision|0
1163016|NCT01225731|3819554|P10|Part 3|Physician Decision|0
1163017|NCT01225731|3819555|P9|Part 3|Physician Decision|0
1163018|NCT01225731|3819556|P8|Part 3|Physician Decision|0
1163019|NCT01225731|3819557|P7|Part 3|Physician Decision|0
1163020|NCT01225731|3819558|P6|Part 3|Physician Decision|0
1163021|NCT01225731|3819559|P5|Part 3|Physician Decision|0
1163022|NCT01225731|3819560|P4|Part 3|Physician Decision|0
1163023|NCT01225731|3819561|P3|Part 3|Physician Decision|0
1163024|NCT01225731|3819562|P2|Part 3|Physician Decision|0
1163025|NCT01225731|3819563|P1|Part 3|Physician Decision|0
1163026|NCT01225731|3819551|P13|Part 3|Lost to Follow-up|1
1163027|NCT01225731|3819552|P12|Part 3|Lost to Follow-up|2
1163028|NCT01225731|3819553|P11|Part 3|Lost to Follow-up|1
1163029|NCT01225731|3819554|P10|Part 3|Lost to Follow-up|0
1163030|NCT01225731|3819555|P9|Part 3|Lost to Follow-up|0
1163031|NCT01225731|3819556|P8|Part 3|Lost to Follow-up|0
1163032|NCT01225731|3819557|P7|Part 3|Lost to Follow-up|0
1163033|NCT01225731|3819558|P6|Part 3|Lost to Follow-up|0
1163034|NCT01225731|3819559|P5|Part 3|Lost to Follow-up|0
1163035|NCT01225731|3819560|P4|Part 3|Lost to Follow-up|0
1163036|NCT01225731|3819561|P3|Part 3|Lost to Follow-up|0
1163037|NCT01225731|3819562|P2|Part 3|Lost to Follow-up|0
1163038|NCT01225731|3819563|P1|Part 3|Lost to Follow-up|0
1163039|NCT01225731|3819551|P13|Part 3|Adverse Event|0
1163040|NCT01225731|3819552|P12|Part 3|Adverse Event|1
1163041|NCT01225731|3819553|P11|Part 3|Adverse Event|1
1163042|NCT01225731|3819554|P10|Part 3|Adverse Event|0
1163043|NCT01225731|3819555|P9|Part 3|Adverse Event|0
1163044|NCT01225731|3819556|P8|Part 3|Adverse Event|0
1163045|NCT01225731|3819557|P7|Part 3|Adverse Event|0
1163046|NCT01225731|3819558|P6|Part 3|Adverse Event|0
1163047|NCT01225731|3819559|P5|Part 3|Adverse Event|0
1163048|NCT01225731|3819560|P4|Part 3|Adverse Event|0
1163049|NCT01225731|3819561|P3|Part 3|Adverse Event|0
1163050|NCT01225731|3819562|P2|Part 3|Adverse Event|0
1163051|NCT01225731|3819563|P1|Part 3|Adverse Event|0
1163052|NCT01225731|3819551|P13|Part 2|Withdrawal by Subject|0
1163053|NCT01225731|3819552|P12|Part 2|Withdrawal by Subject|0
1163054|NCT01225731|3819553|P11|Part 2|Withdrawal by Subject|0
1163055|NCT01225731|3819554|P10|Part 2|Withdrawal by Subject|0
1163056|NCT01225731|3819555|P9|Part 2|Withdrawal by Subject|1
1163057|NCT01225731|3819556|P8|Part 2|Withdrawal by Subject|4
1163058|NCT01225731|3819557|P7|Part 2|Withdrawal by Subject|3
1163059|NCT01225731|3819558|P6|Part 2|Withdrawal by Subject|1
1163060|NCT01225731|3819559|P5|Part 2|Withdrawal by Subject|0
1163061|NCT01225731|3819560|P4|Part 2|Withdrawal by Subject|0
1163062|NCT01225731|3819561|P3|Part 2|Withdrawal by Subject|0
1163063|NCT01225731|3819562|P2|Part 2|Withdrawal by Subject|0
1163064|NCT01225731|3819563|P1|Part 2|Withdrawal by Subject|0
1163065|NCT01225731|3819551|P13|Part 2|Physician Decision|0
1163066|NCT01225731|3819552|P12|Part 2|Physician Decision|0
1163067|NCT01225731|3819553|P11|Part 2|Physician Decision|0
1163068|NCT01225731|3819554|P10|Part 2|Physician Decision|0
1163069|NCT01225731|3819555|P9|Part 2|Physician Decision|2
1163070|NCT01225731|3819556|P8|Part 2|Physician Decision|2
1163071|NCT01225731|3819557|P7|Part 2|Physician Decision|0
1163072|NCT01225731|3819558|P6|Part 2|Physician Decision|0
1163073|NCT01225731|3819559|P5|Part 2|Physician Decision|0
1163074|NCT01225731|3819560|P4|Part 2|Physician Decision|0
1163075|NCT01225731|3819561|P3|Part 2|Physician Decision|0
1163076|NCT01225731|3819562|P2|Part 2|Physician Decision|0
1163077|NCT01225731|3819563|P1|Part 2|Physician Decision|0
1163078|NCT01225731|3819551|P13|Part 2|Lost to Follow-up|0
1163079|NCT01225731|3819552|P12|Part 2|Lost to Follow-up|0
1163080|NCT01225731|3819553|P11|Part 2|Lost to Follow-up|0
1163081|NCT01225731|3819554|P10|Part 2|Lost to Follow-up|0
1163082|NCT01225731|3819555|P9|Part 2|Lost to Follow-up|1
1163083|NCT01225731|3819556|P8|Part 2|Lost to Follow-up|3
1163084|NCT01225731|3819557|P7|Part 2|Lost to Follow-up|0
1163085|NCT01225731|3819558|P6|Part 2|Lost to Follow-up|0
1163086|NCT01225731|3819559|P5|Part 2|Lost to Follow-up|0
1163087|NCT01225731|3819560|P4|Part 2|Lost to Follow-up|0
1163088|NCT01225731|3819561|P3|Part 2|Lost to Follow-up|0
1163089|NCT01225731|3819562|P2|Part 2|Lost to Follow-up|0
1163090|NCT01225731|3819563|P1|Part 2|Lost to Follow-up|0
1163091|NCT01225731|3819551|P13|Part 2|Pregnancy|0
1163092|NCT01225731|3819552|P12|Part 2|Pregnancy|0
1163093|NCT01225731|3819553|P11|Part 2|Pregnancy|0
1163094|NCT01225731|3819554|P10|Part 2|Pregnancy|0
1163095|NCT01225731|3819555|P9|Part 2|Pregnancy|1
1163096|NCT01225731|3819556|P8|Part 2|Pregnancy|0
1163097|NCT01225731|3819557|P7|Part 2|Pregnancy|1
1163098|NCT01225731|3819558|P6|Part 2|Pregnancy|0
1163099|NCT01225731|3819559|P5|Part 2|Pregnancy|0
1163100|NCT01225731|3819560|P4|Part 2|Pregnancy|0
1163101|NCT01225731|3819561|P3|Part 2|Pregnancy|0
1163102|NCT01225731|3819562|P2|Part 2|Pregnancy|0
1163103|NCT01225731|3819563|P1|Part 2|Pregnancy|0
1163104|NCT01225731|3819551|P13|Part 2|Lack of Efficacy|0
1163105|NCT01225731|3819552|P12|Part 2|Lack of Efficacy|0
1163106|NCT01225731|3819553|P11|Part 2|Lack of Efficacy|0
1163107|NCT01225731|3819554|P10|Part 2|Lack of Efficacy|0
1163108|NCT01225731|3819555|P9|Part 2|Lack of Efficacy|3
1163109|NCT01225731|3819556|P8|Part 2|Lack of Efficacy|12
1163110|NCT01225731|3819557|P7|Part 2|Lack of Efficacy|0
1163111|NCT01225731|3819558|P6|Part 2|Lack of Efficacy|1
1163112|NCT01225731|3819559|P5|Part 2|Lack of Efficacy|0
1163113|NCT01225731|3819560|P4|Part 2|Lack of Efficacy|0
1163114|NCT01225731|3819561|P3|Part 2|Lack of Efficacy|0
1163115|NCT01225731|3819562|P2|Part 2|Lack of Efficacy|0
1163116|NCT01225731|3819563|P1|Part 2|Lack of Efficacy|0
1163117|NCT01225731|3819551|P13|Part 2|Adverse Event|0
1163118|NCT01225731|3819552|P12|Part 2|Adverse Event|0
1163119|NCT01225731|3819553|P11|Part 2|Adverse Event|0
1163120|NCT01225731|3819554|P10|Part 2|Adverse Event|0
1163121|NCT01225731|3819555|P9|Part 2|Adverse Event|2
1163122|NCT01225731|3819556|P8|Part 2|Adverse Event|4
1163123|NCT01225731|3819557|P7|Part 2|Adverse Event|4
1163124|NCT01225731|3819558|P6|Part 2|Adverse Event|0
1163125|NCT01225731|3819559|P5|Part 2|Adverse Event|0
1163126|NCT01225731|3819560|P4|Part 2|Adverse Event|0
1163127|NCT01225731|3819561|P3|Part 2|Adverse Event|0
1163128|NCT01225731|3819562|P2|Part 2|Adverse Event|0
1163129|NCT01225731|3819563|P1|Part 2|Adverse Event|0
1163130|NCT01225731|3819551|P13|Part 2|Protocol Violation|0
1163131|NCT01225731|3819552|P12|Part 2|Protocol Violation|0
1163132|NCT01225731|3819553|P11|Part 2|Protocol Violation|0
1163133|NCT01225731|3819554|P10|Part 2|Protocol Violation|0
1163134|NCT01225731|3819555|P9|Part 2|Protocol Violation|1
1163135|NCT01225731|3819556|P8|Part 2|Protocol Violation|0
1163136|NCT01225731|3819557|P7|Part 2|Protocol Violation|0
1163137|NCT01225731|3819558|P6|Part 2|Protocol Violation|1
1163138|NCT01225731|3819559|P5|Part 2|Protocol Violation|0
1163139|NCT01225731|3819560|P4|Part 2|Protocol Violation|0
1163140|NCT01225731|3819561|P3|Part 2|Protocol Violation|0
1163141|NCT01225731|3819562|P2|Part 2|Protocol Violation|0
1163142|NCT01225731|3819563|P1|Part 2|Protocol Violation|0
1163143|NCT01225731|3819551|P13|Part 1|Protocol Violation|0
1163144|NCT01225731|3819552|P12|Part 1|Protocol Violation|0
1163145|NCT01225731|3819553|P11|Part 1|Protocol Violation|0
1163146|NCT01225731|3819554|P10|Part 1|Protocol Violation|0
1163147|NCT01225731|3819555|P9|Part 1|Protocol Violation|0
1163148|NCT01225731|3819556|P8|Part 1|Protocol Violation|0
1163149|NCT01225731|3819557|P7|Part 1|Protocol Violation|0
1163150|NCT01225731|3819558|P6|Part 1|Protocol Violation|0
1163151|NCT01225731|3819559|P5|Part 1|Protocol Violation|0
1163152|NCT01225731|3819560|P4|Part 1|Protocol Violation|1
1163153|NCT01225731|3819561|P3|Part 1|Protocol Violation|0
1163154|NCT01225731|3819562|P2|Part 1|Protocol Violation|0
1163155|NCT01225731|3819563|P1|Part 1|Protocol Violation|0
1163156|NCT01225731|3819551|P13|Part 1|Withdrawal by Subject|0
1163157|NCT01225731|3819552|P12|Part 1|Withdrawal by Subject|0
1163158|NCT01225731|3819553|P11|Part 1|Withdrawal by Subject|0
1163159|NCT01225731|3819554|P10|Part 1|Withdrawal by Subject|0
1163160|NCT01225731|3819555|P9|Part 1|Withdrawal by Subject|0
1163161|NCT01225731|3819556|P8|Part 1|Withdrawal by Subject|0
1163162|NCT01225731|3819557|P7|Part 1|Withdrawal by Subject|0
1163163|NCT01225731|3819558|P6|Part 1|Withdrawal by Subject|0
1163164|NCT01225731|3819559|P5|Part 1|Withdrawal by Subject|4
1163165|NCT01225731|3819560|P4|Part 1|Withdrawal by Subject|0
1163166|NCT01225731|3819561|P3|Part 1|Withdrawal by Subject|0
1163167|NCT01225731|3819562|P2|Part 1|Withdrawal by Subject|3
1163168|NCT01225731|3819563|P1|Part 1|Withdrawal by Subject|0
1163169|NCT01225731|3819551|P13|Part 1|Adverse Event|0
1163170|NCT01225731|3819552|P12|Part 1|Adverse Event|0
1163171|NCT01225731|3819553|P11|Part 1|Adverse Event|0
1163172|NCT01225731|3819554|P10|Part 1|Adverse Event|0
1163173|NCT01225731|3819555|P9|Part 1|Adverse Event|0
1163174|NCT01225731|3819556|P8|Part 1|Adverse Event|0
1163175|NCT01225731|3819557|P7|Part 1|Adverse Event|0
1163176|NCT01225731|3819558|P6|Part 1|Adverse Event|0
1163177|NCT01225731|3819559|P5|Part 1|Adverse Event|1
1163178|NCT01225731|3819560|P4|Part 1|Adverse Event|1
1163179|NCT01225731|3819561|P3|Part 1|Adverse Event|1
1163180|NCT01225731|3819562|P2|Part 1|Adverse Event|2
1163181|NCT01225731|3819563|P1|Part 1|Adverse Event|1
1163182|NCT01225731|3819551|P13|Part 1|Did not meet eligibility criteria|0
1163183|NCT01225731|3819552|P12|Part 1|Did not meet eligibility criteria|0
1163184|NCT01225731|3819553|P11|Part 1|Did not meet eligibility criteria|0
1163185|NCT01225731|3819554|P10|Part 1|Did not meet eligibility criteria|0
1163186|NCT01225731|3819555|P9|Part 1|Did not meet eligibility criteria|0
1163187|NCT01225731|3819556|P8|Part 1|Did not meet eligibility criteria|0
1163188|NCT01225731|3819557|P7|Part 1|Did not meet eligibility criteria|0
1163189|NCT01225731|3819558|P6|Part 1|Did not meet eligibility criteria|0
1163190|NCT01225731|3819559|P5|Part 1|Did not meet eligibility criteria|1
1163191|NCT01225731|3819560|P4|Part 1|Did not meet eligibility criteria|0
1163192|NCT01225731|3819561|P3|Part 1|Did not meet eligibility criteria|0
1163193|NCT01225731|3819562|P2|Part 1|Did not meet eligibility criteria|0
1163194|NCT01225731|3819563|P1|Part 1|Did not meet eligibility criteria|1
1163195|NCT01225562|3819658|P3|Overall Study|Lost to Follow-up|1
1163196|NCT01225562|3819659|P2|Overall Study|Lost to Follow-up|6
1163197|NCT01225562|3819660|P1|Overall Study|Lost to Follow-up|3
1163198|NCT01225562|3819658|P3|Overall Study|Withdrawal by Subject|52
1163199|NCT01225562|3819659|P2|Overall Study|Withdrawal by Subject|50
1163200|NCT01225562|3819660|P1|Overall Study|Withdrawal by Subject|52
1163201|NCT01225549|3819677|P10|Period 6 - Washout|Disallowed medication|0
1163202|NCT01225549|3819678|P9|Period 6 - Washout|Disallowed medication|0
1163203|NCT01225549|3819679|P8|Period 6 - Washout|Disallowed medication|0
1163204|NCT01225549|3819680|P7|Period 6 - Washout|Disallowed medication|0
1163205|NCT01225549|3819681|P6|Period 6 - Washout|Disallowed medication|0
1163206|NCT01225549|3819682|P5|Period 6 - Washout|Disallowed medication|0
1163207|NCT01225549|3819683|P4|Period 6 - Washout|Disallowed medication|1
1163208|NCT01225549|3819684|P3|Period 6 - Washout|Disallowed medication|0
1163209|NCT01225549|3819685|P2|Period 6 - Washout|Disallowed medication|0
1163210|NCT01225549|3819686|P1|Period 6 - Washout|Disallowed medication|0
1163211|NCT01225549|3819677|P10|Period 4 - Washout|Disallowed medication|0
1163212|NCT01225549|3819678|P9|Period 4 - Washout|Disallowed medication|0
1163213|NCT01225549|3819679|P8|Period 4 - Washout|Disallowed medication|0
1163214|NCT01225549|3819680|P7|Period 4 - Washout|Disallowed medication|0
1163215|NCT01225549|3819681|P6|Period 4 - Washout|Disallowed medication|0
1163216|NCT01225549|3819682|P5|Period 4 - Washout|Disallowed medication|0
1163217|NCT01225549|3819683|P4|Period 4 - Washout|Disallowed medication|0
1163218|NCT01225549|3819684|P3|Period 4 - Washout|Disallowed medication|0
1163219|NCT01225549|3819685|P2|Period 4 - Washout|Disallowed medication|1
1163220|NCT01225549|3819686|P1|Period 4 - Washout|Disallowed medication|0
1163221|NCT01225211|3819769|P10|Overall Study|Other|1
1163222|NCT01225211|3819770|P9|Overall Study|Other|0
1163223|NCT01225211|3819771|P8|Overall Study|Other|0
1163224|NCT01225211|3819772|P7|Overall Study|Other|0
1163225|NCT01225211|3819773|P6|Overall Study|Other|0
1163226|NCT01225211|3819774|P5|Overall Study|Other|0
1163227|NCT01225211|3819775|P4|Overall Study|Other|0
1163228|NCT01225211|3819776|P3|Overall Study|Other|0
1163229|NCT01225211|3819777|P2|Overall Study|Other|0
1163230|NCT01225211|3819778|P1|Overall Study|Other|0
1163231|NCT01225211|3819769|P10|Overall Study|Withdrawal by Subject|3
1163232|NCT01225211|3819770|P9|Overall Study|Withdrawal by Subject|1
1163233|NCT01225211|3819771|P8|Overall Study|Withdrawal by Subject|0
1163234|NCT01225211|3819772|P7|Overall Study|Withdrawal by Subject|1
1163235|NCT01225211|3819773|P6|Overall Study|Withdrawal by Subject|0
1163236|NCT01225211|3819774|P5|Overall Study|Withdrawal by Subject|0
1163237|NCT01225211|3819775|P4|Overall Study|Withdrawal by Subject|0
1163238|NCT01225211|3819776|P3|Overall Study|Withdrawal by Subject|0
1163239|NCT01225211|3819777|P2|Overall Study|Withdrawal by Subject|0
1163240|NCT01225211|3819778|P1|Overall Study|Withdrawal by Subject|0
1163241|NCT01225211|3819769|P10|Overall Study|Adverse Event|1
1163242|NCT01225211|3819770|P9|Overall Study|Adverse Event|0
1163243|NCT01225211|3819771|P8|Overall Study|Adverse Event|0
1163244|NCT01225211|3819772|P7|Overall Study|Adverse Event|0
1163245|NCT01225211|3819773|P6|Overall Study|Adverse Event|0
1163246|NCT01225211|3819774|P5|Overall Study|Adverse Event|0
1163247|NCT01225211|3819775|P4|Overall Study|Adverse Event|0
1163248|NCT01225211|3819776|P3|Overall Study|Adverse Event|1
1163249|NCT01225211|3819777|P2|Overall Study|Adverse Event|0
1163250|NCT01225211|3819778|P1|Overall Study|Adverse Event|0
1163251|NCT01225159|3819881|P2|Overall Study|Change operation|0
1163252|NCT01225159|3819882|P1|Overall Study|Change operation|1
1163253|NCT01225146|3819892|P2|Overall Study|Sponsor discontinued making 2mg drug|2
1163254|NCT01225146|3819893|P1|Overall Study|Sponsor discontinued making 2mg drug|0
1163255|NCT01224821|3819959|P1|Long-Term Follow-Up|Completion of 10 Year Follow-up|9
1163256|NCT01224821|3819959|P1|Long-Term Follow-Up|Death|2
1163257|NCT01224821|3819959|P1|Dosimetric and Therapeutic Treatment|Started Other Treatment|1
1163258|NCT01224821|3819959|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1
1163259|NCT01224821|3819959|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
1163260|NCT01224821|3819959|P1|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3
1163261|NCT01224821|3819959|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|38
1163262|NCT01224821|3819959|P1|Dosimetric and Therapeutic Treatment|Adverse Event|1
1163263|NCT01224782|3819978|P1|Overall Study|Transplantation|1
1163264|NCT01224782|3819978|P1|Overall Study|Deterioration|1
1163265|NCT01224782|3819978|P1|Overall Study|Financial Reasons|1
1163266|NCT01224782|3819978|P1|Overall Study|Change of Treatment|1
1163267|NCT01224782|3819978|P1|Overall Study|Start of Dialysis|3
1163268|NCT01224782|3819978|P1|Overall Study|Not Specified|4
1163269|NCT01224782|3819978|P1|Overall Study|Noncompliance|10
1163270|NCT01224782|3819978|P1|Overall Study|Adverse Reaction|11
1163271|NCT01224782|3819978|P1|Overall Study|Adverse Event|12
1163272|NCT01224782|3819978|P1|Overall Study|Improvement|13
1163273|NCT01224782|3819978|P1|Overall Study|Death|14
1163274|NCT01224782|3819978|P1|Overall Study|Withdrawal by Subject|16
1163275|NCT01224782|3819978|P1|Overall Study|Lost to Follow-up|177
1163276|NCT01224639|3820004|P8|Overall Study|Adverse Event|1
1163277|NCT01224639|3820005|P7|Overall Study|Adverse Event|0
1163278|NCT01224639|3820006|P6|Overall Study|Adverse Event|0
1163279|NCT01224639|3820007|P5|Overall Study|Adverse Event|0
1163280|NCT01224639|3820008|P4|Overall Study|Adverse Event|0
1163281|NCT01224639|3820009|P3|Overall Study|Adverse Event|0
1163282|NCT01224639|3820010|P2|Overall Study|Adverse Event|0
1163283|NCT01224639|3820011|P1|Overall Study|Adverse Event|0
1163284|NCT01224639|3820004|P8|Overall Study|Withdrawal by Subject|1
1163285|NCT01224639|3820005|P7|Overall Study|Withdrawal by Subject|1
1163286|NCT01224639|3820006|P6|Overall Study|Withdrawal by Subject|0
1163287|NCT01224639|3820007|P5|Overall Study|Withdrawal by Subject|2
1163288|NCT01224639|3820008|P4|Overall Study|Withdrawal by Subject|0
1163289|NCT01224639|3820009|P3|Overall Study|Withdrawal by Subject|0
1163290|NCT01224639|3820010|P2|Overall Study|Withdrawal by Subject|0
1163291|NCT01224639|3820011|P1|Overall Study|Withdrawal by Subject|0
1163292|NCT01224431|3820129|P2|Overall Study|no video record|1
1163293|NCT01224431|3820130|P1|Overall Study|no video record|0
1163294|NCT01224431|3820129|P2|Overall Study|not randomized|4
1163295|NCT01224431|3820130|P1|Overall Study|not randomized|0
1163296|NCT01224171|3820151|P2|Overall Study|Lost to Follow-up|3
1163297|NCT01224171|3820152|P1|Overall Study|Lost to Follow-up|0
1163298|NCT01224171|3820151|P2|Overall Study|Withdrawal of Consent|4
1163299|NCT01224171|3820152|P1|Overall Study|Withdrawal of Consent|2
1163300|NCT01224171|3820151|P2|Overall Study|Lack of Efficacy|1
1163301|NCT01224171|3820152|P1|Overall Study|Lack of Efficacy|5
1163302|NCT01224171|3820151|P2|Overall Study|Protocol Violation|1
1163303|NCT01224171|3820152|P1|Overall Study|Protocol Violation|0
1163304|NCT01224171|3820151|P2|Overall Study|Adverse Event|4
1163305|NCT01224171|3820152|P1|Overall Study|Adverse Event|8
1163306|NCT01223937|3820192|P2|Overall Study|Not specified|1
1163307|NCT01223937|3820193|P1|Overall Study|Not specified|4
1163308|NCT01223937|3820192|P2|Overall Study|Protocol Violation|7
1163309|NCT01223937|3820193|P1|Overall Study|Protocol Violation|8
1163310|NCT01223937|3820192|P2|Overall Study|Adverse Event|4
1163311|NCT01223937|3820193|P1|Overall Study|Adverse Event|1
1163312|NCT01223937|3820192|P2|Overall Study|Lost to Follow-up|4
1163313|NCT01223937|3820193|P1|Overall Study|Lost to Follow-up|1
1163314|NCT01223937|3820192|P2|Overall Study|Withdrawal by Subject|2
1163315|NCT01223937|3820193|P1|Overall Study|Withdrawal by Subject|3
1163316|NCT01223404|3820239|P6|Third Intervention (1 Day)|Non-compliance (slept)|0
1163317|NCT01223404|3820240|P5|Third Intervention (1 Day)|Non-compliance (slept)|0
1163318|NCT01223404|3820241|P4|Third Intervention (1 Day)|Non-compliance (slept)|1
1163319|NCT01223404|3820242|P3|Third Intervention (1 Day)|Non-compliance (slept)|0
1163320|NCT01223404|3820243|P2|Third Intervention (1 Day)|Non-compliance (slept)|0
1163321|NCT01223404|3820244|P1|Third Intervention (1 Day)|Non-compliance (slept)|0
1163322|NCT01223404|3820239|P6|Second Intervention (1 Day)|Adverse Event|0
1163323|NCT01223404|3820240|P5|Second Intervention (1 Day)|Adverse Event|0
1163324|NCT01223404|3820241|P4|Second Intervention (1 Day)|Adverse Event|0
1163325|NCT01223404|3820242|P3|Second Intervention (1 Day)|Adverse Event|0
1163326|NCT01223404|3820243|P2|Second Intervention (1 Day)|Adverse Event|0
1163327|NCT01223404|3820244|P1|Second Intervention (1 Day)|Adverse Event|1
1163328|NCT01223404|3820239|P6|First Intervention (1 Day)|Adverse Event|0
1163329|NCT01223404|3820240|P5|First Intervention (1 Day)|Adverse Event|0
1163330|NCT01223404|3820241|P4|First Intervention (1 Day)|Adverse Event|1
1163331|NCT01223404|3820242|P3|First Intervention (1 Day)|Adverse Event|0
1163332|NCT01223404|3820243|P2|First Intervention (1 Day)|Adverse Event|0
1163333|NCT01223404|3820244|P1|First Intervention (1 Day)|Adverse Event|0
1163334|NCT01223365|3820308|P1|Open-label Treatment Period|Physician Decision|2
1163335|NCT01223365|3820308|P1|Open-label Treatment Period|Starting physical therapy|1
1163336|NCT01223365|3820308|P1|Open-label Treatment Period|"Out of window"|1
1163337|NCT01223365|3820308|P1|Open-label Treatment Period|Negative urine drug screen when on treat|1
1163338|NCT01223365|3820308|P1|Open-label Treatment Period|Moved out of area|2
1163339|NCT01223365|3820308|P1|Open-label Treatment Period|Noncompliance with study procedures|6
1163340|NCT01223365|3820308|P1|Open-label Treatment Period|Noncompliance with study drug admin|7
1163341|NCT01223365|3820308|P1|Open-label Treatment Period|Lost to Follow-up|7
1163342|NCT01223365|3820308|P1|Open-label Treatment Period|Protocol Violation|15
1163343|NCT01223365|3820308|P1|Open-label Treatment Period|Withdrawal by Subject|19
1163344|NCT01223365|3820308|P1|Open-label Treatment Period|Lack of Efficacy|2
1163345|NCT01223365|3820308|P1|Open-label Treatment Period|Adverse Event|39
1163346|NCT01223365|3820308|P1|Open-label Titration Period|Starting physical therapy|1
1163347|NCT01223365|3820308|P1|Open-label Titration Period|Noncompliance with study procedures|2
1163348|NCT01223365|3820308|P1|Open-label Titration Period|Noncompliance with study drug admin|1
1163349|NCT01223365|3820308|P1|Open-label Titration Period|Lost to Follow-up|2
1163350|NCT01223365|3820308|P1|Open-label Titration Period|Protocol Violation|1
1163351|NCT01223365|3820308|P1|Open-label Titration Period|Withdrawal by Subject|5
1163352|NCT01223365|3820308|P1|Open-label Titration Period|Lack of Efficacy|3
1163353|NCT01223365|3820308|P1|Open-label Titration Period|Adverse Event|23
1163354|NCT01223365|3820308|P1|Open-label Titration Period|Enrolled but not treated|1
1163355|NCT01223235|3820372|P1|Overall Study|Withdrawal by Subject|1
1163356|NCT01223196|3820380|P2|Overall Study|Withdrawal by Subject|0
1163357|NCT01223196|3820381|P1|Overall Study|Withdrawal by Subject|1
1163358|NCT01223196|3820380|P2|Overall Study|Physician Decision|0
1163359|NCT01223196|3820381|P1|Overall Study|Physician Decision|1
1163360|NCT01223196|3820380|P2|Overall Study|Lost to Follow-up|0
1163361|NCT01223196|3820381|P1|Overall Study|Lost to Follow-up|2
1163362|NCT01223183|3820393|P2|Washout Period (5-24 Days)|Physician Decision|0
1163363|NCT01223183|3820394|P1|Washout Period (5-24 Days)|Physician Decision|1
1163364|NCT01223183|3820393|P2|Washout Period (5-24 Days)|Lost to Follow-up|0
1163365|NCT01223183|3820394|P1|Washout Period (5-24 Days)|Lost to Follow-up|1
1163366|NCT01223183|3820393|P2|Imaging Day 1|Physician Decision|1
1163367|NCT01223183|3820394|P1|Imaging Day 1|Physician Decision|0
1163368|NCT01223027|3820404|P2|Overall Study|Study terminated by sponsor|8
1163369|NCT01223027|3820405|P1|Overall Study|Study terminated by sponsor|2
1163370|NCT01223027|3820404|P2|Overall Study|New therapy for study indication|8
1163371|NCT01223027|3820405|P1|Overall Study|New therapy for study indication|17
1163372|NCT01223027|3820404|P2|Overall Study|Subject/guardian decicion|16
1163373|NCT01223027|3820405|P1|Overall Study|Subject/guardian decicion|18
1163374|NCT01223027|3820404|P2|Overall Study|Protocol Violation|1
1163375|NCT01223027|3820405|P1|Overall Study|Protocol Violation|2
1163376|NCT01223027|3820404|P2|Overall Study|Progressive Disease|183
1163377|NCT01223027|3820405|P1|Overall Study|Progressive Disease|167
1163378|NCT01223027|3820404|P2|Overall Study|Physician Decision|8
1163379|NCT01223027|3820405|P1|Overall Study|Physician Decision|4
1163380|NCT01223027|3820404|P2|Overall Study|Lost to Follow-up|1
1163381|NCT01223027|3820405|P1|Overall Study|Lost to Follow-up|2
1163382|NCT01223027|3820404|P2|Overall Study|Death|42
1163383|NCT01223027|3820405|P1|Overall Study|Death|42
1163384|NCT01223027|3820404|P2|Overall Study|Adverse Event|10
1163385|NCT01223027|3820405|P1|Overall Study|Adverse Event|20
1163386|NCT01222715|3820467|P2|Overall Study|Surgery or radiation therapy in 1st 6 wk|0
1163387|NCT01222715|3820468|P1|Overall Study|Surgery or radiation therapy in 1st 6 wk|1
1163388|NCT01222715|3820467|P2|Overall Study|Ineligible|1
1163389|NCT01222715|3820468|P1|Overall Study|Ineligible|0
1163390|NCT01222715|3820467|P2|Overall Study|Pt cannot receive treatment for >9 wks|1
1163391|NCT01222715|3820468|P1|Overall Study|Pt cannot receive treatment for >9 wks|1
1163392|NCT01222715|3820467|P2|Overall Study|Refusal of further protocol therapy|4
1163393|NCT01222715|3820468|P1|Overall Study|Refusal of further protocol therapy|0
1163394|NCT01222715|3820467|P2|Overall Study|Physician Decision|2
1163395|NCT01222715|3820468|P1|Overall Study|Physician Decision|12
1163396|NCT01222715|3820467|P2|Overall Study|Lack of Efficacy|14
1163397|NCT01222715|3820468|P1|Overall Study|Lack of Efficacy|22
1163398|NCT01222715|3820467|P2|Overall Study|Death|1
1163399|NCT01222715|3820468|P1|Overall Study|Death|0
1163400|NCT01222715|3820467|P2|Overall Study|Adverse Event|4
1163401|NCT01222715|3820468|P1|Overall Study|Adverse Event|0
1163402|NCT01222533|3820507|P1|Overall Study|Other|4
1163403|NCT01222533|3820507|P1|Overall Study|Withdrawal by Subject|5
1163404|NCT01222533|3820507|P1|Overall Study|Adverse Event|5
1163405|NCT01222520|3820646|P2|Double-blind Period|Study medication stolen|0
1163406|NCT01222520|3820647|P1|Double-blind Period|Study medication stolen|1
1163407|NCT01222520|3820646|P2|Double-blind Period|Lack of Efficacy|1
1163408|NCT01222520|3820647|P1|Double-blind Period|Lack of Efficacy|0
1163409|NCT01222520|3820646|P2|Double-blind Period|Adverse Event|1
1163410|NCT01222520|3820647|P1|Double-blind Period|Adverse Event|0
1163411|NCT01222520|3820646|P2|Open-label run-in Period|Number of patients fulfilled|3
1163412|NCT01222520|3820647|P1|Open-label run-in Period|Number of patients fulfilled|0
1163413|NCT01222520|3820646|P2|Open-label run-in Period|Blood pressure criteria not met|18
1163414|NCT01222520|3820647|P1|Open-label run-in Period|Blood pressure criteria not met|0
1163415|NCT01222520|3820646|P2|Open-label run-in Period|Withdrawal by Subject|2
1163416|NCT01222520|3820647|P1|Open-label run-in Period|Withdrawal by Subject|0
1163417|NCT01222507|3820665|P1|Overall Study|Withdrawal by Subject|1
1163418|NCT01222507|3820665|P1|Overall Study|Physician Decision|1
1163419|NCT01222416|3820693|P2|Overall Study|Death|0
1163420|NCT01222416|3820694|P1|Overall Study|Death|1
1163421|NCT01222416|3820693|P2|Overall Study|missed view/scan|0
1163422|NCT01222416|3820694|P1|Overall Study|missed view/scan|1
1163423|NCT01222416|3820693|P2|Overall Study|scheduling|0
1163424|NCT01222416|3820694|P1|Overall Study|scheduling|6
1163425|NCT01222416|3820693|P2|Overall Study|Withdrawal by Subject|0
1163426|NCT01222416|3820694|P1|Overall Study|Withdrawal by Subject|5
1163427|NCT01222416|3820693|P2|Overall Study|Adverse Event|0
1163428|NCT01222416|3820694|P1|Overall Study|Adverse Event|4
1163429|NCT01222416|3820693|P2|Overall Study|ineligible;metastasis|0
1163430|NCT01222416|3820694|P1|Overall Study|ineligible;metastasis|3
1163431|NCT01222403|3820704|P2|Overall Study|Inappropriate enrollment|2
1163432|NCT01222403|3820705|P1|Overall Study|Inappropriate enrollment|0
1163433|NCT01222104|3820814|P1|Overall Study|Death|10
1163434|NCT01222104|3820814|P1|Overall Study|Lost to Follow-up|37
1163435|NCT01222078|3820837|P1|Overall Study|Early termination of the study|1
1163436|NCT01221948|3820871|P1|Overall Study|Protocol Violation|4
1163437|NCT01221948|3820871|P1|Overall Study|Death|1
1163438|NCT01221948|3820871|P1|Overall Study|not disclosed|2
1163439|NCT01221948|3820871|P1|Overall Study|Withdrawal by Subject|2
1163440|NCT01221948|3820871|P1|Overall Study|Physician Decision|5
1163441|NCT01221753|3820882|P1|Overall Study|Adverse Event|1
1163442|NCT01221727|3820889|P2|Overall Study|Withdrawal by Subject|1
1163443|NCT01221727|3820890|P1|Overall Study|Withdrawal by Subject|1
1163444|NCT01221727|3820889|P2|Overall Study|Physician Decision|0
1163445|NCT01221727|3820890|P1|Overall Study|Physician Decision|2
1163446|NCT01221623|3820911|P2|Overall Study|Other|2
1163447|NCT01221623|3820912|P1|Overall Study|Other|5
1163448|NCT01221623|3820911|P2|Overall Study|Death|0
1163449|NCT01221623|3820912|P1|Overall Study|Death|1
1163450|NCT01221623|3820911|P2|Overall Study|Adverse Event|3
1163451|NCT01221623|3820912|P1|Overall Study|Adverse Event|6
1163452|NCT01221623|3820911|P2|Overall Study|Lost to Follow-up|1
1163453|NCT01221623|3820912|P1|Overall Study|Lost to Follow-up|7
1163454|NCT01221623|3820911|P2|Overall Study|Withdrawal by Subject|8
1163455|NCT01221623|3820912|P1|Overall Study|Withdrawal by Subject|19
1163456|NCT01221597|3820936|P2|Overall Study|Death|0
1163457|NCT01221597|3820937|P1|Overall Study|Death|2
1163458|NCT01221597|3820936|P2|Overall Study|Other|4
1163459|NCT01221597|3820937|P1|Overall Study|Other|3
1163460|NCT01221597|3820936|P2|Overall Study|Protocol Violation|0
1163461|NCT01221597|3820937|P1|Overall Study|Protocol Violation|1
1163462|NCT01221597|3820936|P2|Overall Study|Lost to Follow-up|5
1163463|NCT01221597|3820937|P1|Overall Study|Lost to Follow-up|6
1163464|NCT01221597|3820936|P2|Overall Study|Withdrawal by Subject|6
1163465|NCT01221597|3820937|P1|Overall Study|Withdrawal by Subject|20
1163466|NCT01221597|3820936|P2|Overall Study|Adverse Event|1
1163467|NCT01221597|3820937|P1|Overall Study|Adverse Event|4
1163468|NCT01221363|3820994|P2|Overall Study|Withdrawal by Subject|5
1163469|NCT01221363|3820995|P1|Overall Study|Withdrawal by Subject|11
1163470|NCT01221363|3820994|P2|Overall Study|Pregnancy|0
1163471|NCT01221363|3820995|P1|Overall Study|Pregnancy|1
1163472|NCT01221350|3821005|P2|Overall Study|Withdrawal by Subject|2
1163473|NCT01221350|3821006|P1|Overall Study|Withdrawal by Subject|4
1163474|NCT01221350|3821005|P2|Overall Study|Exclusion criteria, asthma exacerbation|1
1163475|NCT01221350|3821006|P1|Overall Study|Exclusion criteria, asthma exacerbation|0
1163476|NCT01221350|3821005|P2|Overall Study|Discontinued intervention (GERD)|0
1163477|NCT01221350|3821006|P1|Overall Study|Discontinued intervention (GERD)|1
1163478|NCT01221285|3821065|P1|Overall Study|Withdrawal by Subject|1
1163479|NCT01221272|3821074|P2|Period 2|Adverse Event|2
1163480|NCT01221272|3821075|P1|Period 2|Adverse Event|0
1163481|NCT01221272|3821074|P2|Period 1|Significant Dosing Noncompliance|1
1163482|NCT01221272|3821075|P1|Period 1|Significant Dosing Noncompliance|0
1163483|NCT01221272|3821074|P2|Period 1|Consent Withdrawal|1
1163484|NCT01221272|3821075|P1|Period 1|Consent Withdrawal|0
1163485|NCT01221272|3821074|P2|Period 1|Adverse Event|0
1163486|NCT01221272|3821075|P1|Period 1|Adverse Event|2
1163487|NCT01221090|3821094|P4|Overall Study|Withdrawal by Subject|2
1163488|NCT01221090|3821095|P3|Overall Study|Withdrawal by Subject|27
1163489|NCT01221090|3821096|P2|Overall Study|Withdrawal by Subject|22
1163490|NCT01221090|3821097|P1|Overall Study|Withdrawal by Subject|0
1163491|NCT01221090|3821094|P4|Overall Study|Non-Compliant or Unable to Contact|20
1163492|NCT01221090|3821095|P3|Overall Study|Non-Compliant or Unable to Contact|15
1163493|NCT01221090|3821096|P2|Overall Study|Non-Compliant or Unable to Contact|12
1163494|NCT01221090|3821097|P1|Overall Study|Non-Compliant or Unable to Contact|15
1163495|NCT01220609|3821146|P1|Overall Study|Ineligible-Never treated|1
1163496|NCT01220609|3821146|P1|Overall Study|Ineligible- Wrong cell type|1
1163497|NCT01220609|3821146|P1|Overall Study|Ineligible-Wrong primary cancer site|1
1163498|NCT01220557|3821160|P2|Overall Study|attended less than 6 lessons|2
1163499|NCT01220557|3821161|P1|Overall Study|attended less than 6 lessons|1
1163500|NCT01220557|3821160|P2|Overall Study|Lost to Follow-up|3
1163501|NCT01220557|3821161|P1|Overall Study|Lost to Follow-up|5
1163502|NCT01220414|3821194|P4|Overall Study|Withdrawal by Subject|1
1163503|NCT01220414|3821195|P3|Overall Study|Withdrawal by Subject|0
1163504|NCT01220414|3821196|P2|Overall Study|Withdrawal by Subject|0
1163505|NCT01220414|3821197|P1|Overall Study|Withdrawal by Subject|1
1163506|NCT01220401|3821204|P1|Overall Study|Protocol Violation|1
1163507|NCT01220401|3821204|P1|Overall Study|Withdrawal by Subject|2
1163508|NCT01220297|3821213|P1|Overall Study|Lost to Follow-up|1
1163509|NCT01220297|3821213|P1|Overall Study|Death|2
1163510|NCT01220180|3821230|P1|Overall Study|Randomized but not treated|1
1163511|NCT01220180|3821230|P1|Overall Study|Death|1
1163512|NCT01220180|3821230|P1|Overall Study|Lack of Efficacy|22
1163513|NCT01220180|3821230|P1|Overall Study|Adverse Event|35
1163514|NCT01220180|3821230|P1|Overall Study|Other|72
1163515|NCT01220180|3821230|P1|Overall Study|Lost to Follow-up|76
1163516|NCT01220128|3821260|P7|Overall Study|Consent withdrawn by subject|0
1163517|NCT01220128|3821261|P6|Overall Study|Consent withdrawn by subject|0
1163518|NCT01220128|3821262|P5|Overall Study|Consent withdrawn by subject|0
1163519|NCT01220128|3821263|P4|Overall Study|Consent withdrawn by subject|0
1163520|NCT01220128|3821264|P3|Overall Study|Consent withdrawn by subject|0
1163521|NCT01220128|3821265|P2|Overall Study|Consent withdrawn by subject|0
1163522|NCT01220128|3821266|P1|Overall Study|Consent withdrawn by subject|1
1163523|NCT01220128|3821260|P7|Overall Study|Other|0
1163524|NCT01220128|3821261|P6|Overall Study|Other|0
1163525|NCT01220128|3821262|P5|Overall Study|Other|0
1163526|NCT01220128|3821263|P4|Overall Study|Other|0
1163527|NCT01220128|3821264|P3|Overall Study|Other|1
1163528|NCT01220128|3821265|P2|Overall Study|Other|0
1163529|NCT01220128|3821266|P1|Overall Study|Other|0
1163530|NCT01220128|3821260|P7|Overall Study|Adverse event, non-fatal|3
1163531|NCT01220128|3821261|P6|Overall Study|Adverse event, non-fatal|0
1163532|NCT01220128|3821262|P5|Overall Study|Adverse event, non-fatal|0
1163533|NCT01220128|3821263|P4|Overall Study|Adverse event, non-fatal|0
1163534|NCT01220128|3821264|P3|Overall Study|Adverse event, non-fatal|0
1163535|NCT01220128|3821265|P2|Overall Study|Adverse event, non-fatal|0
1163536|NCT01220128|3821266|P1|Overall Study|Adverse event, non-fatal|1
1163537|NCT01220128|3821260|P7|Overall Study|Adverse event, serious fatal|1
1163538|NCT01220128|3821261|P6|Overall Study|Adverse event, serious fatal|0
1163539|NCT01220128|3821262|P5|Overall Study|Adverse event, serious fatal|0
1163540|NCT01220128|3821263|P4|Overall Study|Adverse event, serious fatal|0
1163541|NCT01220128|3821264|P3|Overall Study|Adverse event, serious fatal|0
1163542|NCT01220128|3821265|P2|Overall Study|Adverse event, serious fatal|0
1163543|NCT01220128|3821266|P1|Overall Study|Adverse event, serious fatal|2
1163544|NCT01220128|3821260|P7|Overall Study|Sponsor study termination|1
1163545|NCT01220128|3821261|P6|Overall Study|Sponsor study termination|0
1163546|NCT01220128|3821262|P5|Overall Study|Sponsor study termination|0
1163547|NCT01220128|3821263|P4|Overall Study|Sponsor study termination|0
1163548|NCT01220128|3821264|P3|Overall Study|Sponsor study termination|0
1163549|NCT01220128|3821265|P2|Overall Study|Sponsor study termination|1
1163550|NCT01220128|3821266|P1|Overall Study|Sponsor study termination|0
1163551|NCT01220128|3821260|P7|Overall Study|Progressive disease|0
1163552|NCT01220128|3821261|P6|Overall Study|Progressive disease|0
1163553|NCT01220128|3821262|P5|Overall Study|Progressive disease|0
1163554|NCT01220128|3821263|P4|Overall Study|Progressive disease|0
1163555|NCT01220128|3821264|P3|Overall Study|Progressive disease|2
1163556|NCT01220128|3821265|P2|Overall Study|Progressive disease|0
1163557|NCT01220128|3821266|P1|Overall Study|Progressive disease|0
1163558|NCT01219985|3821471|P1|Overall Study|Physician Decision|20
1163559|NCT01219933|3821477|P1|Overall Study|Lack of Efficacy|1
1163560|NCT01219933|3821477|P1|Overall Study|Protocol Violation|8
1163561|NCT01219933|3821477|P1|Overall Study|Withdrawal by Subject|5
1163562|NCT01219933|3821477|P1|Overall Study|GC free|1
1163563|NCT01219933|3821477|P1|Overall Study|Lost to Follow-up|3
1163564|NCT01219933|3821477|P1|Overall Study|No LDA maintained|7
1163565|NCT01219933|3821477|P1|Overall Study|No LDA reached|5
1163566|NCT01219933|3821477|P1|Overall Study|Adverse Event|8
1163567|NCT01218867|3821687|P11|Overall Study|Death during treatment|0
1163568|NCT01218867|3821688|P10|Overall Study|Death during treatment|0
1163569|NCT01218867|3821689|P9|Overall Study|Death during treatment|0
1163570|NCT01218867|3821690|P8|Overall Study|Death during treatment|0
1163571|NCT01218867|3821691|P7|Overall Study|Death during treatment|1
1163572|NCT01218867|3821692|P6|Overall Study|Death during treatment|0
1163573|NCT01218867|3821693|P5|Overall Study|Death during treatment|0
1163574|NCT01218867|3821694|P4|Overall Study|Death during treatment|0
1163575|NCT01218867|3821695|P3|Overall Study|Death during treatment|0
1163576|NCT01218867|3821696|P2|Overall Study|Death during treatment|0
1163577|NCT01218867|3821697|P1|Overall Study|Death during treatment|0
1163578|NCT01218802|3821745|P2|Overall Study|Incarcerated|0
1163579|NCT01218802|3821746|P1|Overall Study|Incarcerated|2
1163580|NCT01218802|3821745|P2|Overall Study|Adverse Event|2
1163581|NCT01218802|3821746|P1|Overall Study|Adverse Event|0
1163582|NCT01218802|3821745|P2|Overall Study|Withdrawal by Subject|10
1163583|NCT01218802|3821746|P1|Overall Study|Withdrawal by Subject|3
1163584|NCT01218802|3821745|P2|Overall Study|Lost to Follow-up|6
1163585|NCT01218802|3821746|P1|Overall Study|Lost to Follow-up|5
1163586|NCT01218659|3821756|P3|12-Month OLE|Declined to participate in the OLE|4
1163587|NCT01218659|3821757|P2|12-Month OLE|Declined to participate in the OLE|0
1163588|NCT01218659|3821758|P1|12-Month OLE|Declined to participate in the OLE|0
1163589|NCT01218659|3821756|P3|12-Month OLE|Lack of Efficacy|1
1163590|NCT01218659|3821757|P2|12-Month OLE|Lack of Efficacy|0
1163591|NCT01218659|3821758|P1|12-Month OLE|Lack of Efficacy|0
1163592|NCT01218659|3821756|P3|12-Month OLE|Pregnancy|1
1163593|NCT01218659|3821757|P2|12-Month OLE|Pregnancy|0
1163594|NCT01218659|3821758|P1|12-Month OLE|Pregnancy|0
1163595|NCT01218659|3821756|P3|12-Month OLE|Lost to Follow-up|1
1163596|NCT01218659|3821757|P2|12-Month OLE|Lost to Follow-up|0
1163597|NCT01218659|3821758|P1|12-Month OLE|Lost to Follow-up|0
1163598|NCT01218659|3821756|P3|12-Month OLE|Physician Decision|1
1163599|NCT01218659|3821757|P2|12-Month OLE|Physician Decision|0
1163600|NCT01218659|3821758|P1|12-Month OLE|Physician Decision|0
1163601|NCT01218659|3821756|P3|12-Month OLE|Withdrawal by Subject|2
1163602|NCT01218659|3821757|P2|12-Month OLE|Withdrawal by Subject|0
1163603|NCT01218659|3821758|P1|12-Month OLE|Withdrawal by Subject|0
1163604|NCT01218659|3821756|P3|18-Month Randomized Period|Did not receive study drug|0
1163605|NCT01218659|3821757|P2|18-Month Randomized Period|Did not receive study drug|3
1163606|NCT01218659|3821758|P1|18-Month Randomized Period|Did not receive study drug|0
1163607|NCT01218659|3821756|P3|18-Month Randomized Period|Withdrawal by Subject|0
1163608|NCT01218659|3821757|P2|18-Month Randomized Period|Withdrawal by Subject|3
1163609|NCT01218659|3821758|P1|18-Month Randomized Period|Withdrawal by Subject|2
1163610|NCT01218646|3821773|P4|Overall Study|Protocol Violation|1
1163611|NCT01218646|3821774|P3|Overall Study|Protocol Violation|1
1163612|NCT01218646|3821775|P2|Overall Study|Protocol Violation|0
1163613|NCT01218646|3821776|P1|Overall Study|Protocol Violation|0
1163614|NCT01218646|3821773|P4|Overall Study|Lost to Follow-up|0
1163615|NCT01218646|3821774|P3|Overall Study|Lost to Follow-up|0
1163616|NCT01218646|3821775|P2|Overall Study|Lost to Follow-up|0
1163617|NCT01218646|3821776|P1|Overall Study|Lost to Follow-up|1
1163618|NCT01218646|3821773|P4|Overall Study|Adverse Event|0
1163619|NCT01218646|3821774|P3|Overall Study|Adverse Event|1
1163620|NCT01218646|3821775|P2|Overall Study|Adverse Event|0
1163621|NCT01218646|3821776|P1|Overall Study|Adverse Event|0
1163622|NCT01218594|3821814|P1|Overall Study|Physician Decision|6
1163623|NCT01218594|3821814|P1|Overall Study|Adverse Event|2
1163624|NCT01218594|3821814|P1|Overall Study|Withdrawal by Subject|3
1163625|NCT01218594|3821814|P1|Overall Study|Death|1
1163626|NCT01218477|3821822|P4|Overall Study|Maximum clinical benefit|0
1163627|NCT01218477|3821823|P3|Overall Study|Maximum clinical benefit|0
1163628|NCT01218477|3821824|P2|Overall Study|Maximum clinical benefit|2
1163629|NCT01218477|3821825|P1|Overall Study|Maximum clinical benefit|0
1163630|NCT01218477|3821822|P4|Overall Study|Administrative reason by sponsor|0
1163631|NCT01218477|3821823|P3|Overall Study|Administrative reason by sponsor|1
1163632|NCT01218477|3821824|P2|Overall Study|Administrative reason by sponsor|0
1163633|NCT01218477|3821825|P1|Overall Study|Administrative reason by sponsor|0
1163634|NCT01218477|3821822|P4|Overall Study|Prepared for cell transplantation|0
1163635|NCT01218477|3821823|P3|Overall Study|Prepared for cell transplantation|1
1163636|NCT01218477|3821824|P2|Overall Study|Prepared for cell transplantation|1
1163637|NCT01218477|3821825|P1|Overall Study|Prepared for cell transplantation|0
1163638|NCT01218477|3821822|P4|Overall Study|Withdrawal by Subject|0
1163639|NCT01218477|3821823|P3|Overall Study|Withdrawal by Subject|1
1163640|NCT01218477|3821824|P2|Overall Study|Withdrawal by Subject|0
1163641|NCT01218477|3821825|P1|Overall Study|Withdrawal by Subject|0
1163642|NCT01218477|3821822|P4|Overall Study|No longer meets study criteria|0
1163643|NCT01218477|3821823|P3|Overall Study|No longer meets study criteria|0
1163644|NCT01218477|3821824|P2|Overall Study|No longer meets study criteria|0
1163645|NCT01218477|3821825|P1|Overall Study|No longer meets study criteria|1
1163646|NCT01218477|3821822|P4|Overall Study|Study drug toxicity|0
1163647|NCT01218477|3821823|P3|Overall Study|Study drug toxicity|5
1163648|NCT01218477|3821824|P2|Overall Study|Study drug toxicity|2
1163649|NCT01218477|3821825|P1|Overall Study|Study drug toxicity|0
1163650|NCT01218477|3821822|P4|Overall Study|Disease progression|2
1163651|NCT01218477|3821823|P3|Overall Study|Disease progression|6
1163652|NCT01218477|3821824|P2|Overall Study|Disease progression|3
1163653|NCT01218477|3821825|P1|Overall Study|Disease progression|2
1163654|NCT01218438|3821842|P1|Epoch 4|Withdrawal by Subject|2
1163655|NCT01218438|3821842|P1|Epoch 4|Physician Decision|1
1163656|NCT01218438|3821842|P1|Epoch 3|Adverse Event|1
1163657|NCT01218438|3821842|P1|Epoch 3|Withdrawal by Subject|3
1163658|NCT01218438|3821842|P1|Epoch 1|Adverse Event|1
1163659|NCT01218438|3821842|P1|Epoch 1|Physician Decision|2
1163660|NCT01218308|3822008|P2|Overall Study|Other|21
1163661|NCT01218308|3822009|P1|Overall Study|Other|14
1163662|NCT01218308|3822008|P2|Overall Study|Lost to Follow-up|31
1163663|NCT01218308|3822009|P1|Overall Study|Lost to Follow-up|27
1163664|NCT01218308|3822008|P2|Overall Study|Withdrawal by Subject|64
1163665|NCT01218308|3822009|P1|Overall Study|Withdrawal by Subject|61
1163666|NCT01218308|3822008|P2|Overall Study|Protocol Violation|2
1163667|NCT01218308|3822009|P1|Overall Study|Protocol Violation|0
1163668|NCT01218308|3822008|P2|Overall Study|Adverse Event|2
1163669|NCT01218308|3822009|P1|Overall Study|Adverse Event|1
1163670|NCT01218243|3822053|P2|Overall Study|Protocol Violation|10
1163671|NCT01218243|3822054|P1|Overall Study|Protocol Violation|5
1163672|NCT01218243|3822053|P2|Overall Study|Lost to Follow-up|3
1163673|NCT01218243|3822054|P1|Overall Study|Lost to Follow-up|3
1163674|NCT01218243|3822053|P2|Overall Study|Lack of Efficacy|1
1163675|NCT01218243|3822054|P1|Overall Study|Lack of Efficacy|1
1163676|NCT01218204|3822070|P4|Part B Pooled Treatment Arm|Protocol Violation|1
1163677|NCT01218204|3822071|P3|Part B Pooled Treatment Arm|Protocol Violation|0
1163678|NCT01218204|3822072|P2|Part B Pooled Treatment Arm|Protocol Violation|0
1163679|NCT01218204|3822073|P1|Part B Pooled Treatment Arm|Protocol Violation|0
1163680|NCT01218204|3822070|P4|Part B Pooled Treatment Arm|Adverse Event|2
1163681|NCT01218204|3822071|P3|Part B Pooled Treatment Arm|Adverse Event|0
1163682|NCT01218204|3822072|P2|Part B Pooled Treatment Arm|Adverse Event|0
1163683|NCT01218204|3822073|P1|Part B Pooled Treatment Arm|Adverse Event|0
1163684|NCT01218204|3822070|P4|Part B Run-in|Withdrawal by Subject|0
1163685|NCT01218204|3822071|P3|Part B Run-in|Withdrawal by Subject|3
1163686|NCT01218204|3822072|P2|Part B Run-in|Withdrawal by Subject|0
1163687|NCT01218204|3822073|P1|Part B Run-in|Withdrawal by Subject|0
1163688|NCT01218204|3822070|P4|Part B Run-in|Protocol Violation|0
1163689|NCT01218204|3822071|P3|Part B Run-in|Protocol Violation|2
1163690|NCT01218204|3822072|P2|Part B Run-in|Protocol Violation|0
1163691|NCT01218204|3822073|P1|Part B Run-in|Protocol Violation|0
1163692|NCT01218204|3822070|P4|Part B Run-in|Adverse Event|0
1163693|NCT01218204|3822071|P3|Part B Run-in|Adverse Event|1
1163694|NCT01218204|3822072|P2|Part B Run-in|Adverse Event|0
1163695|NCT01218204|3822073|P1|Part B Run-in|Adverse Event|0
1163696|NCT01218204|3822070|P4|Part B Washout|Did not meet continuation criteria|0
1163697|NCT01218204|3822071|P3|Part B Washout|Did not meet continuation criteria|0
1163698|NCT01218204|3822072|P2|Part B Washout|Did not meet continuation criteria|112
1163699|NCT01218204|3822073|P1|Part B Washout|Did not meet continuation criteria|0
1163700|NCT01218204|3822070|P4|Part B Washout|Reached defined stopping criteria|0
1163701|NCT01218204|3822071|P3|Part B Washout|Reached defined stopping criteria|0
1163702|NCT01218204|3822072|P2|Part B Washout|Reached defined stopping criteria|2
1163703|NCT01218204|3822073|P1|Part B Washout|Reached defined stopping criteria|0
1163704|NCT01218204|3822070|P4|Part B Washout|Withdrawal by Subject|0
1163705|NCT01218204|3822071|P3|Part B Washout|Withdrawal by Subject|0
1163706|NCT01218204|3822072|P2|Part B Washout|Withdrawal by Subject|14
1163707|NCT01218204|3822073|P1|Part B Washout|Withdrawal by Subject|0
1163708|NCT01218204|3822070|P4|Part B Washout|Physician Decision|0
1163709|NCT01218204|3822071|P3|Part B Washout|Physician Decision|0
1163710|NCT01218204|3822072|P2|Part B Washout|Physician Decision|14
1163711|NCT01218204|3822073|P1|Part B Washout|Physician Decision|0
1163712|NCT01218204|3822070|P4|Part B Washout|Lost to Follow-up|0
1163713|NCT01218204|3822071|P3|Part B Washout|Lost to Follow-up|0
1163714|NCT01218204|3822072|P2|Part B Washout|Lost to Follow-up|2
1163715|NCT01218204|3822073|P1|Part B Washout|Lost to Follow-up|0
1163716|NCT01218204|3822070|P4|Part B Washout|Adverse Event|0
1163717|NCT01218204|3822071|P3|Part B Washout|Adverse Event|0
1163718|NCT01218204|3822072|P2|Part B Washout|Adverse Event|1
1163719|NCT01218204|3822073|P1|Part B Washout|Adverse Event|0
1163720|NCT01218126|3822337|P4|Overall Study|Withdrawal by Subject|6
1163721|NCT01218126|3822338|P3|Overall Study|Withdrawal by Subject|4
1163722|NCT01218126|3822339|P2|Overall Study|Withdrawal by Subject|5
1163723|NCT01218126|3822340|P1|Overall Study|Withdrawal by Subject|2
1163724|NCT01218126|3822337|P4|Overall Study|Physician Decision|2
1163725|NCT01218126|3822338|P3|Overall Study|Physician Decision|4
1163726|NCT01218126|3822339|P2|Overall Study|Physician Decision|2
1163727|NCT01218126|3822340|P1|Overall Study|Physician Decision|1
1163728|NCT01218126|3822337|P4|Overall Study|Lost to Follow-up|2
1163729|NCT01218126|3822338|P3|Overall Study|Lost to Follow-up|0
1163730|NCT01218126|3822339|P2|Overall Study|Lost to Follow-up|0
1163731|NCT01218126|3822340|P1|Overall Study|Lost to Follow-up|0
1163732|NCT01218126|3822337|P4|Overall Study|Protocol-defined stopping criteria|0
1163733|NCT01218126|3822338|P3|Overall Study|Protocol-defined stopping criteria|0
1163734|NCT01218126|3822339|P2|Overall Study|Protocol-defined stopping criteria|1
1163735|NCT01218126|3822340|P1|Overall Study|Protocol-defined stopping criteria|1
1163736|NCT01218126|3822337|P4|Overall Study|Protocol Violation|3
1163737|NCT01218126|3822338|P3|Overall Study|Protocol Violation|2
1163738|NCT01218126|3822339|P2|Overall Study|Protocol Violation|2
1163739|NCT01218126|3822340|P1|Overall Study|Protocol Violation|5
1163740|NCT01218126|3822337|P4|Overall Study|Lack of Efficacy|6
1163741|NCT01218126|3822338|P3|Overall Study|Lack of Efficacy|2
1163742|NCT01218126|3822339|P2|Overall Study|Lack of Efficacy|2
1163743|NCT01218126|3822340|P1|Overall Study|Lack of Efficacy|7
1163744|NCT01218126|3822337|P4|Overall Study|Adverse Event|16
1163745|NCT01218126|3822338|P3|Overall Study|Adverse Event|12
1163746|NCT01218126|3822339|P2|Overall Study|Adverse Event|10
1163747|NCT01218126|3822340|P1|Overall Study|Adverse Event|8
1163748|NCT01218113|3822381|P3|Overall Study|Protocol Deviation Eligibility Criteria|1
1163749|NCT01218113|3822382|P2|Overall Study|Protocol Deviation Eligibility Criteria|0
1163750|NCT01218113|3822383|P1|Overall Study|Protocol Deviation Eligibility Criteria|0
1163751|NCT01218113|3822381|P3|Overall Study|Lost to Follow-up|4
1163752|NCT01218113|3822382|P2|Overall Study|Lost to Follow-up|1
1163753|NCT01218113|3822383|P1|Overall Study|Lost to Follow-up|4
1163754|NCT01218113|3822381|P3|Overall Study|Withdrawal by Subject|1
1163755|NCT01218113|3822382|P2|Overall Study|Withdrawal by Subject|0
1163756|NCT01218113|3822383|P1|Overall Study|Withdrawal by Subject|1
1163757|NCT01218100|3822564|P4|Overall Study|Other Reason|4
1163758|NCT01218100|3822565|P3|Overall Study|Other Reason|6
1163759|NCT01218100|3822566|P2|Overall Study|Other Reason|2
1163760|NCT01218100|3822567|P1|Overall Study|Other Reason|2
1163761|NCT01218100|3822564|P4|Overall Study|Lost to Follow-up|1
1163762|NCT01218100|3822565|P3|Overall Study|Lost to Follow-up|2
1163763|NCT01218100|3822566|P2|Overall Study|Lost to Follow-up|8
1163764|NCT01218100|3822567|P1|Overall Study|Lost to Follow-up|3
1163765|NCT01218100|3822564|P4|Overall Study|Withdrawal by Subject|7
1163766|NCT01218100|3822565|P3|Overall Study|Withdrawal by Subject|6
1163767|NCT01218100|3822566|P2|Overall Study|Withdrawal by Subject|2
1163768|NCT01218100|3822567|P1|Overall Study|Withdrawal by Subject|5
1163769|NCT01218100|3822564|P4|Overall Study|Protocol Violation|1
1163770|NCT01218100|3822565|P3|Overall Study|Protocol Violation|1
1163771|NCT01218100|3822566|P2|Overall Study|Protocol Violation|0
1163772|NCT01218100|3822567|P1|Overall Study|Protocol Violation|0
1163773|NCT01218100|3822564|P4|Overall Study|Lack of Efficacy|12
1163774|NCT01218100|3822565|P3|Overall Study|Lack of Efficacy|5
1163775|NCT01218100|3822566|P2|Overall Study|Lack of Efficacy|6
1163776|NCT01218100|3822567|P1|Overall Study|Lack of Efficacy|9
1163777|NCT01218100|3822564|P4|Overall Study|Adverse Event|7
1163778|NCT01218100|3822565|P3|Overall Study|Adverse Event|6
1163779|NCT01218100|3822566|P2|Overall Study|Adverse Event|6
1163780|NCT01218100|3822567|P1|Overall Study|Adverse Event|4
1163781|NCT01218100|3822564|P4|Overall Study|Did not meet InclusionExclusion criteria|2
1163782|NCT01218100|3822565|P3|Overall Study|Did not meet InclusionExclusion criteria|1
1163783|NCT01218100|3822566|P2|Overall Study|Did not meet InclusionExclusion criteria|1
1163784|NCT01218100|3822567|P1|Overall Study|Did not meet InclusionExclusion criteria|1
1163785|NCT01218087|3822583|P2|Overall Study|Transferred|5
1163786|NCT01218087|3822584|P1|Overall Study|Transferred|8
1163787|NCT01218087|3822583|P2|Overall Study|Withdrawal by Subject|0
1163788|NCT01218087|3822584|P1|Overall Study|Withdrawal by Subject|5
1163789|NCT01218087|3822583|P2|Overall Study|Death|1
1163790|NCT01218087|3822584|P1|Overall Study|Death|2
1163791|NCT01218009|3822606|P2|Overall Study|Sponsor terminated study|163
1163792|NCT01218009|3822607|P1|Overall Study|Sponsor terminated study|161
1163793|NCT01218009|3822606|P2|Overall Study|Withdrawal by Subject|1
1163794|NCT01218009|3822607|P1|Overall Study|Withdrawal by Subject|3
1163795|NCT01218009|3822606|P2|Overall Study|Protocol Violation|1
1163796|NCT01218009|3822607|P1|Overall Study|Protocol Violation|2
1163797|NCT01217957|3822630|P5|Phase 2|Withdrawal by Patient|1
1163798|NCT01217957|3822631|P4|Phase 2|Withdrawal by Patient|0
1163799|NCT01217957|3822632|P3|Phase 2|Withdrawal by Patient|0
1163800|NCT01217957|3822633|P2|Phase 2|Withdrawal by Patient|0
1163801|NCT01217957|3822634|P1|Phase 2|Withdrawal by Patient|0
1163802|NCT01217957|3822630|P5|Phase 1|Withdrawal by Patient|0
1163803|NCT01217957|3822631|P4|Phase 1|Withdrawal by Patient|1
1163804|NCT01217957|3822632|P3|Phase 1|Withdrawal by Patient|1
1163805|NCT01217957|3822633|P2|Phase 1|Withdrawal by Patient|0
1163806|NCT01217957|3822634|P1|Phase 1|Withdrawal by Patient|1
1163807|NCT01217944|3822693|P3|Overall Study|Lack of Efficacy|0
1163808|NCT01217944|3822694|P2|Overall Study|Lack of Efficacy|0
1163809|NCT01217944|3822695|P1|Overall Study|Lack of Efficacy|1
1163810|NCT01217944|3822693|P3|Overall Study|Withdrawal by Subject|0
1163811|NCT01217944|3822694|P2|Overall Study|Withdrawal by Subject|2
1163812|NCT01217944|3822695|P1|Overall Study|Withdrawal by Subject|1
1163813|NCT01217944|3822693|P3|Overall Study|Lost to Follow-up|0
1163814|NCT01217944|3822694|P2|Overall Study|Lost to Follow-up|1
1163815|NCT01217944|3822695|P1|Overall Study|Lost to Follow-up|3
1163816|NCT01217944|3822693|P3|Overall Study|Protocol Violation|0
1163817|NCT01217944|3822694|P2|Overall Study|Protocol Violation|1
1163818|NCT01217944|3822695|P1|Overall Study|Protocol Violation|1
1163819|NCT01217892|3822738|P4|Overall Study|Poor/Non-Compliance|0
1163820|NCT01217892|3822739|P3|Overall Study|Poor/Non-Compliance|1
1163821|NCT01217892|3822740|P2|Overall Study|Poor/Non-Compliance|0
1163822|NCT01217892|3822741|P1|Overall Study|Poor/Non-Compliance|0
1163823|NCT01217892|3822738|P4|Overall Study|Incorrect enrollment|0
1163824|NCT01217892|3822739|P3|Overall Study|Incorrect enrollment|1
1163825|NCT01217892|3822740|P2|Overall Study|Incorrect enrollment|1
1163826|NCT01217892|3822741|P1|Overall Study|Incorrect enrollment|0
1163827|NCT01217892|3822738|P4|Overall Study|Subject no longer meets study criteria|8
1163828|NCT01217892|3822739|P3|Overall Study|Subject no longer meets study criteria|4
1163829|NCT01217892|3822740|P2|Overall Study|Subject no longer meets study criteria|2
1163830|NCT01217892|3822741|P1|Overall Study|Subject no longer meets study criteria|5
1163831|NCT01217892|3822738|P4|Overall Study|Lab value|0
1163832|NCT01217892|3822739|P3|Overall Study|Lab value|1
1163833|NCT01217892|3822740|P2|Overall Study|Lab value|0
1163834|NCT01217892|3822741|P1|Overall Study|Lab value|1
1163835|NCT01217892|3822738|P4|Overall Study|Withdrawal by Subject|0
1163836|NCT01217892|3822739|P3|Overall Study|Withdrawal by Subject|1
1163837|NCT01217892|3822740|P2|Overall Study|Withdrawal by Subject|2
1163838|NCT01217892|3822741|P1|Overall Study|Withdrawal by Subject|0
1163839|NCT01217892|3822738|P4|Overall Study|Adverse Event|0
1163840|NCT01217892|3822739|P3|Overall Study|Adverse Event|1
1163841|NCT01217892|3822740|P2|Overall Study|Adverse Event|1
1163842|NCT01217892|3822741|P1|Overall Study|Adverse Event|1
1163843|NCT01217814|3822804|P3|Overall Study|Lack of Efficacy|1
1163844|NCT01217814|3822805|P2|Overall Study|Lack of Efficacy|0
1163845|NCT01217814|3822806|P1|Overall Study|Lack of Efficacy|0
1163846|NCT01217814|3822804|P3|Overall Study|Adverse Event|0
1163847|NCT01217814|3822805|P2|Overall Study|Adverse Event|1
1163848|NCT01217814|3822806|P1|Overall Study|Adverse Event|1
1163849|NCT01217801|3822832|P2|Period 1|Withdrawal by Subject|1
1163850|NCT01217801|3822833|P1|Period 1|Withdrawal by Subject|0
1163851|NCT01217801|3822832|P2|Period 1|Protocol Violation|1
1163852|NCT01217801|3822833|P1|Period 1|Protocol Violation|1
1163853|NCT01217606|3822862|P2|9-Month Masked Extension|Lack of Efficacy|0
1163854|NCT01217606|3822863|P1|9-Month Masked Extension|Lack of Efficacy|2
1163855|NCT01217606|3822862|P2|9-Month Masked Extension|Pregnancy|0
1163856|NCT01217606|3822863|P1|9-Month Masked Extension|Pregnancy|1
1163857|NCT01217606|3822862|P2|9-Month Masked Extension|Lost to Follow-up|0
1163858|NCT01217606|3822863|P1|9-Month Masked Extension|Lost to Follow-up|1
1163859|NCT01217606|3822862|P2|9-Month Masked Extension|Personal Reasons|1
1163860|NCT01217606|3822863|P1|9-Month Masked Extension|Personal Reasons|2
1163861|NCT01217606|3822862|P2|9-Month Masked Extension|Other Reasons|4
1163862|NCT01217606|3822863|P1|9-Month Masked Extension|Other Reasons|4
1163863|NCT01217606|3822862|P2|9-Month Masked Extension|Adverse Event|6
1163864|NCT01217606|3822863|P1|9-Month Masked Extension|Adverse Event|3
1163865|NCT01217606|3822862|P2|Initial Treatment Phase|Adverse Event|6
1163866|NCT01217606|3822863|P1|Initial Treatment Phase|Adverse Event|10
1163867|NCT01217606|3822862|P2|Initial Treatment Phase|Lack of Efficacy|0
1163868|NCT01217606|3822863|P1|Initial Treatment Phase|Lack of Efficacy|1
1163869|NCT01217606|3822862|P2|Initial Treatment Phase|Personal Reasons|2
1163870|NCT01217606|3822863|P1|Initial Treatment Phase|Personal Reasons|0
1163871|NCT01217606|3822862|P2|Initial Treatment Phase|Protocol Violation|2
1163872|NCT01217606|3822863|P1|Initial Treatment Phase|Protocol Violation|3
1163873|NCT01217606|3822862|P2|Initial Treatment Phase|Other Reasons|2
1163874|NCT01217606|3822863|P1|Initial Treatment Phase|Other Reasons|0
1163875|NCT01217476|3822894|P2|Overall Study|Other|0
1163876|NCT01217476|3822895|P1|Overall Study|Other|2
1163877|NCT01217476|3822894|P2|Overall Study|Protocol Deviation|0
1163878|NCT01217476|3822895|P1|Overall Study|Protocol Deviation|1
1163879|NCT01217476|3822894|P2|Overall Study|Surgery on the Target Limb|2
1163880|NCT01217476|3822895|P1|Overall Study|Surgery on the Target Limb|0
1163881|NCT01217476|3822894|P2|Overall Study|Withdrawal by Subject|3
1163882|NCT01217476|3822895|P1|Overall Study|Withdrawal by Subject|3
1163883|NCT01217476|3822894|P2|Overall Study|Physician Decision|1
1163884|NCT01217476|3822895|P1|Overall Study|Physician Decision|0
1163885|NCT01217476|3822894|P2|Overall Study|Adverse Event|1
1163886|NCT01217476|3822895|P1|Overall Study|Adverse Event|6
1163887|NCT01217463|3822905|P2|Overall Study|Other|1
1163888|NCT01217463|3822906|P1|Overall Study|Other|1
1163889|NCT01217463|3822905|P2|Overall Study|Patient Non-compliant|0
1163890|NCT01217463|3822906|P1|Overall Study|Patient Non-compliant|1
1163891|NCT01217463|3822905|P2|Overall Study|Surgery on the Target Limb|1
1163892|NCT01217463|3822906|P1|Overall Study|Surgery on the Target Limb|0
1163893|NCT01217463|3822905|P2|Overall Study|Withdrawal by Subject|0
1163894|NCT01217463|3822906|P1|Overall Study|Withdrawal by Subject|3
1163895|NCT01217463|3822905|P2|Overall Study|Physician Decision|1
1163896|NCT01217463|3822906|P1|Overall Study|Physician Decision|0
1163897|NCT01217463|3822905|P2|Overall Study|Adverse Event|5
1163898|NCT01217463|3822906|P1|Overall Study|Adverse Event|8
1163899|NCT01217307|3822926|P2|Overall Study|Withdrawal by Subject|1
1163900|NCT01217307|3822927|P1|Overall Study|Withdrawal by Subject|0
1163901|NCT01217112|3822942|P5|Overall Study|Physician Decision|1
1163902|NCT01217112|3822943|P4|Overall Study|Physician Decision|0
1163903|NCT01217112|3822944|P3|Overall Study|Physician Decision|0
1163904|NCT01217112|3822945|P2|Overall Study|Physician Decision|0
1163905|NCT01217112|3822946|P1|Overall Study|Physician Decision|0
1163906|NCT01217112|3822942|P5|Overall Study|Withdrawal by Subject|0
1163907|NCT01217112|3822943|P4|Overall Study|Withdrawal by Subject|0
1163908|NCT01217112|3822944|P3|Overall Study|Withdrawal by Subject|1
1163909|NCT01217112|3822945|P2|Overall Study|Withdrawal by Subject|0
1163910|NCT01217112|3822946|P1|Overall Study|Withdrawal by Subject|0
1163911|NCT01217112|3822942|P5|Overall Study|Adverse Event|0
1163912|NCT01217112|3822943|P4|Overall Study|Adverse Event|2
1163913|NCT01217112|3822944|P3|Overall Study|Adverse Event|0
1163914|NCT01217112|3822945|P2|Overall Study|Adverse Event|2
1163915|NCT01217112|3822946|P1|Overall Study|Adverse Event|0
1163916|NCT01217073|3823179|P8|Extension Period|Withdrawal by Subject|8
1163917|NCT01217073|3823180|P7|Extension Period|Withdrawal by Subject|30
1163918|NCT01217073|3823181|P6|Extension Period|Withdrawal by Subject|0
1163919|NCT01217073|3823182|P5|Extension Period|Withdrawal by Subject|0
1163920|NCT01217073|3823183|P4|Extension Period|Withdrawal by Subject|0
1163921|NCT01217073|3823184|P3|Extension Period|Withdrawal by Subject|0
1163922|NCT01217073|3823185|P2|Extension Period|Withdrawal by Subject|0
1163923|NCT01217073|3823186|P1|Extension Period|Withdrawal by Subject|0
1163924|NCT01217073|3823179|P8|Extension Period|Site discontinued study participation|2
1163925|NCT01217073|3823180|P7|Extension Period|Site discontinued study participation|7
1163926|NCT01217073|3823181|P6|Extension Period|Site discontinued study participation|0
1163927|NCT01217073|3823182|P5|Extension Period|Site discontinued study participation|0
1163928|NCT01217073|3823183|P4|Extension Period|Site discontinued study participation|0
1163929|NCT01217073|3823184|P3|Extension Period|Site discontinued study participation|0
1163930|NCT01217073|3823185|P2|Extension Period|Site discontinued study participation|0
1163931|NCT01217073|3823186|P1|Extension Period|Site discontinued study participation|0
1163932|NCT01217073|3823179|P8|Extension Period|Protocol Violation|1
1163933|NCT01217073|3823180|P7|Extension Period|Protocol Violation|2
1163934|NCT01217073|3823181|P6|Extension Period|Protocol Violation|0
1163935|NCT01217073|3823182|P5|Extension Period|Protocol Violation|0
1163936|NCT01217073|3823183|P4|Extension Period|Protocol Violation|0
1163937|NCT01217073|3823184|P3|Extension Period|Protocol Violation|0
1163938|NCT01217073|3823185|P2|Extension Period|Protocol Violation|0
1163939|NCT01217073|3823186|P1|Extension Period|Protocol Violation|0
1163940|NCT01217073|3823179|P8|Extension Period|Physician Decision|1
1163941|NCT01217073|3823180|P7|Extension Period|Physician Decision|4
1163942|NCT01217073|3823181|P6|Extension Period|Physician Decision|0
1163943|NCT01217073|3823182|P5|Extension Period|Physician Decision|0
1163944|NCT01217073|3823183|P4|Extension Period|Physician Decision|0
1163945|NCT01217073|3823184|P3|Extension Period|Physician Decision|0
1163946|NCT01217073|3823185|P2|Extension Period|Physician Decision|0
1163947|NCT01217073|3823186|P1|Extension Period|Physician Decision|0
1163948|NCT01217073|3823179|P8|Extension Period|Non-compliance with study drug|1
1163949|NCT01217073|3823180|P7|Extension Period|Non-compliance with study drug|0
1163950|NCT01217073|3823181|P6|Extension Period|Non-compliance with study drug|0
1163951|NCT01217073|3823182|P5|Extension Period|Non-compliance with study drug|0
1163952|NCT01217073|3823183|P4|Extension Period|Non-compliance with study drug|0
1163953|NCT01217073|3823184|P3|Extension Period|Non-compliance with study drug|0
1163954|NCT01217073|3823185|P2|Extension Period|Non-compliance with study drug|0
1163955|NCT01217073|3823186|P1|Extension Period|Non-compliance with study drug|0
1163956|NCT01217073|3823179|P8|Extension Period|Lost to Follow-up|1
1163957|NCT01217073|3823180|P7|Extension Period|Lost to Follow-up|9
1163958|NCT01217073|3823181|P6|Extension Period|Lost to Follow-up|0
1163959|NCT01217073|3823182|P5|Extension Period|Lost to Follow-up|0
1163960|NCT01217073|3823183|P4|Extension Period|Lost to Follow-up|0
1163961|NCT01217073|3823184|P3|Extension Period|Lost to Follow-up|0
1163962|NCT01217073|3823185|P2|Extension Period|Lost to Follow-up|0
1163963|NCT01217073|3823186|P1|Extension Period|Lost to Follow-up|0
1163964|NCT01217073|3823179|P8|Extension Period|Lack of Efficacy|0
1163965|NCT01217073|3823180|P7|Extension Period|Lack of Efficacy|3
1163966|NCT01217073|3823181|P6|Extension Period|Lack of Efficacy|0
1163967|NCT01217073|3823182|P5|Extension Period|Lack of Efficacy|0
1163968|NCT01217073|3823183|P4|Extension Period|Lack of Efficacy|0
1163969|NCT01217073|3823184|P3|Extension Period|Lack of Efficacy|0
1163970|NCT01217073|3823185|P2|Extension Period|Lack of Efficacy|0
1163971|NCT01217073|3823186|P1|Extension Period|Lack of Efficacy|0
1163972|NCT01217073|3823179|P8|Extension Period|Excluded medication|0
1163973|NCT01217073|3823180|P7|Extension Period|Excluded medication|2
1163974|NCT01217073|3823181|P6|Extension Period|Excluded medication|0
1163975|NCT01217073|3823182|P5|Extension Period|Excluded medication|0
1163976|NCT01217073|3823183|P4|Extension Period|Excluded medication|0
1163977|NCT01217073|3823184|P3|Extension Period|Excluded medication|0
1163978|NCT01217073|3823185|P2|Extension Period|Excluded medication|0
1163979|NCT01217073|3823186|P1|Extension Period|Excluded medication|0
1163980|NCT01217073|3823179|P8|Extension Period|Death|0
1163981|NCT01217073|3823180|P7|Extension Period|Death|1
1163982|NCT01217073|3823181|P6|Extension Period|Death|0
1163983|NCT01217073|3823182|P5|Extension Period|Death|0
1163984|NCT01217073|3823183|P4|Extension Period|Death|0
1163985|NCT01217073|3823184|P3|Extension Period|Death|0
1163986|NCT01217073|3823185|P2|Extension Period|Death|0
1163987|NCT01217073|3823186|P1|Extension Period|Death|0
1163988|NCT01217073|3823179|P8|Extension Period|Creatinine/eGFR|1
1163989|NCT01217073|3823180|P7|Extension Period|Creatinine/eGFR|11
1163990|NCT01217073|3823181|P6|Extension Period|Creatinine/eGFR|0
1163991|NCT01217073|3823182|P5|Extension Period|Creatinine/eGFR|0
1163992|NCT01217073|3823183|P4|Extension Period|Creatinine/eGFR|0
1163993|NCT01217073|3823184|P3|Extension Period|Creatinine/eGFR|0
1163994|NCT01217073|3823185|P2|Extension Period|Creatinine/eGFR|0
1163995|NCT01217073|3823186|P1|Extension Period|Creatinine/eGFR|0
1163996|NCT01217073|3823179|P8|Extension Period|Contraindication to study medication|0
1163997|NCT01217073|3823180|P7|Extension Period|Contraindication to study medication|1
1163998|NCT01217073|3823181|P6|Extension Period|Contraindication to study medication|0
1163999|NCT01217073|3823182|P5|Extension Period|Contraindication to study medication|0
1164000|NCT01217073|3823183|P4|Extension Period|Contraindication to study medication|0
1164001|NCT01217073|3823184|P3|Extension Period|Contraindication to study medication|0
1164002|NCT01217073|3823185|P2|Extension Period|Contraindication to study medication|0
1164003|NCT01217073|3823186|P1|Extension Period|Contraindication to study medication|0
1164004|NCT01217073|3823179|P8|Extension Period|ALT/AST|0
1164005|NCT01217073|3823180|P7|Extension Period|ALT/AST|2
1164006|NCT01217073|3823181|P6|Extension Period|ALT/AST|0
1164007|NCT01217073|3823182|P5|Extension Period|ALT/AST|0
1164008|NCT01217073|3823183|P4|Extension Period|ALT/AST|0
1164009|NCT01217073|3823184|P3|Extension Period|ALT/AST|0
1164010|NCT01217073|3823185|P2|Extension Period|ALT/AST|0
1164011|NCT01217073|3823186|P1|Extension Period|ALT/AST|0
1164012|NCT01217073|3823179|P8|Extension Period|Adverse Event|5
1164013|NCT01217073|3823180|P7|Extension Period|Adverse Event|19
1164014|NCT01217073|3823181|P6|Extension Period|Adverse Event|0
1164015|NCT01217073|3823182|P5|Extension Period|Adverse Event|0
1164016|NCT01217073|3823183|P4|Extension Period|Adverse Event|0
1164017|NCT01217073|3823184|P3|Extension Period|Adverse Event|0
1164018|NCT01217073|3823185|P2|Extension Period|Adverse Event|0
1164019|NCT01217073|3823186|P1|Extension Period|Adverse Event|0
1164020|NCT01217073|3823179|P8|Base Period|Withdrawal by Subject|0
1164021|NCT01217073|3823180|P7|Base Period|Withdrawal by Subject|0
1164022|NCT01217073|3823181|P6|Base Period|Withdrawal by Subject|5
1164023|NCT01217073|3823182|P5|Base Period|Withdrawal by Subject|5
1164024|NCT01217073|3823183|P4|Base Period|Withdrawal by Subject|1
1164025|NCT01217073|3823184|P3|Base Period|Withdrawal by Subject|5
1164026|NCT01217073|3823185|P2|Base Period|Withdrawal by Subject|5
1164027|NCT01217073|3823186|P1|Base Period|Withdrawal by Subject|4
1164028|NCT01217073|3823179|P8|Base Period|Protocol Violation|0
1164029|NCT01217073|3823180|P7|Base Period|Protocol Violation|0
1164030|NCT01217073|3823181|P6|Base Period|Protocol Violation|2
1164031|NCT01217073|3823182|P5|Base Period|Protocol Violation|1
1164032|NCT01217073|3823183|P4|Base Period|Protocol Violation|0
1164033|NCT01217073|3823184|P3|Base Period|Protocol Violation|0
1164034|NCT01217073|3823185|P2|Base Period|Protocol Violation|0
1164035|NCT01217073|3823186|P1|Base Period|Protocol Violation|1
1164036|NCT01217073|3823179|P8|Base Period|Physician Decision|0
1164037|NCT01217073|3823180|P7|Base Period|Physician Decision|0
1164038|NCT01217073|3823181|P6|Base Period|Physician Decision|0
1164039|NCT01217073|3823182|P5|Base Period|Physician Decision|1
1164040|NCT01217073|3823183|P4|Base Period|Physician Decision|0
1164041|NCT01217073|3823184|P3|Base Period|Physician Decision|0
1164042|NCT01217073|3823185|P2|Base Period|Physician Decision|0
1164043|NCT01217073|3823186|P1|Base Period|Physician Decision|0
1164044|NCT01217073|3823179|P8|Base Period|Lost to Follow-up|0
1164045|NCT01217073|3823180|P7|Base Period|Lost to Follow-up|0
1164046|NCT01217073|3823181|P6|Base Period|Lost to Follow-up|0
1164047|NCT01217073|3823182|P5|Base Period|Lost to Follow-up|3
1164048|NCT01217073|3823183|P4|Base Period|Lost to Follow-up|1
1164049|NCT01217073|3823184|P3|Base Period|Lost to Follow-up|1
1164050|NCT01217073|3823185|P2|Base Period|Lost to Follow-up|0
1164051|NCT01217073|3823186|P1|Base Period|Lost to Follow-up|0
1164052|NCT01217073|3823179|P8|Base Period|Lack of Efficacy|0
1164053|NCT01217073|3823180|P7|Base Period|Lack of Efficacy|0
1164054|NCT01217073|3823181|P6|Base Period|Lack of Efficacy|1
1164055|NCT01217073|3823182|P5|Base Period|Lack of Efficacy|0
1164056|NCT01217073|3823183|P4|Base Period|Lack of Efficacy|0
1164057|NCT01217073|3823184|P3|Base Period|Lack of Efficacy|0
1164058|NCT01217073|3823185|P2|Base Period|Lack of Efficacy|0
1164059|NCT01217073|3823186|P1|Base Period|Lack of Efficacy|0
1164060|NCT01217073|3823179|P8|Base Period|Excluded medication|0
1164061|NCT01217073|3823180|P7|Base Period|Excluded medication|0
1164062|NCT01217073|3823181|P6|Base Period|Excluded medication|0
1164063|NCT01217073|3823182|P5|Base Period|Excluded medication|1
1164064|NCT01217073|3823183|P4|Base Period|Excluded medication|0
1164065|NCT01217073|3823184|P3|Base Period|Excluded medication|0
1164066|NCT01217073|3823185|P2|Base Period|Excluded medication|0
1164067|NCT01217073|3823186|P1|Base Period|Excluded medication|0
1164068|NCT01217073|3823179|P8|Base Period|Alanine aminotransferase (ALT)/AST|0
1164069|NCT01217073|3823180|P7|Base Period|Alanine aminotransferase (ALT)/AST|0
1164070|NCT01217073|3823181|P6|Base Period|Alanine aminotransferase (ALT)/AST|0
1164071|NCT01217073|3823182|P5|Base Period|Alanine aminotransferase (ALT)/AST|0
1164072|NCT01217073|3823183|P4|Base Period|Alanine aminotransferase (ALT)/AST|0
1164073|NCT01217073|3823184|P3|Base Period|Alanine aminotransferase (ALT)/AST|0
1164074|NCT01217073|3823185|P2|Base Period|Alanine aminotransferase (ALT)/AST|0
1164075|NCT01217073|3823186|P1|Base Period|Alanine aminotransferase (ALT)/AST|1
1164076|NCT01217073|3823179|P8|Base Period|Adverse Event|0
1164077|NCT01217073|3823180|P7|Base Period|Adverse Event|0
1164078|NCT01217073|3823181|P6|Base Period|Adverse Event|1
1164079|NCT01217073|3823182|P5|Base Period|Adverse Event|4
1164080|NCT01217073|3823183|P4|Base Period|Adverse Event|0
1164081|NCT01217073|3823184|P3|Base Period|Adverse Event|1
1164082|NCT01217073|3823185|P2|Base Period|Adverse Event|0
1164083|NCT01217073|3823186|P1|Base Period|Adverse Event|1
1164084|NCT01216319|3823375|P1|Overall Study|Unanticipated chemo for breast cancer|2
1164085|NCT01216319|3823375|P1|Overall Study|Lost to Follow-up|2
1164086|NCT01216163|3823392|P3|Overall Study|Withdrawal by Subject|0
1164087|NCT01216163|3823393|P2|Overall Study|Withdrawal by Subject|1
1164088|NCT01216163|3823394|P1|Overall Study|Withdrawal by Subject|1
1164089|NCT01216072|3823446|P2|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3
1164090|NCT01216072|3823447|P1|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0
1164091|NCT01216072|3823446|P2|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1
1164092|NCT01216072|3823447|P1|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0
1164093|NCT01216072|3823446|P2|Open-Label Extension Period (3 Months)|Adverse Event|10
1164094|NCT01216072|3823447|P1|Open-Label Extension Period (3 Months)|Adverse Event|0
1164095|NCT01216072|3823446|P2|Open-Label Core Period ( 6 Months)|Protocol Deviation|4
1164096|NCT01216072|3823447|P1|Open-Label Core Period ( 6 Months)|Protocol Deviation|11
1164097|NCT01216072|3823446|P2|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0
1164098|NCT01216072|3823447|P1|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5
1164099|NCT01216072|3823446|P2|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22
1164100|NCT01216072|3823447|P1|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12
1164101|NCT01216072|3823446|P2|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4
1164102|NCT01216072|3823447|P1|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3
1164103|NCT01216072|3823446|P2|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0
1164104|NCT01216072|3823447|P1|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3
1164105|NCT01216072|3823446|P2|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0
1164106|NCT01216072|3823447|P1|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2
1164107|NCT01216072|3823446|P2|Open-Label Core Period ( 6 Months)|Adverse Event|4
1164108|NCT01216072|3823447|P1|Open-Label Core Period ( 6 Months)|Adverse Event|40
1164109|NCT01215981|3823475|P2|Overall Study|Withdrawal by Subject|0
1164110|NCT01215981|3823476|P1|Overall Study|Withdrawal by Subject|1
1164111|NCT01215981|3823475|P2|Overall Study|Protocol Violation|0
1164112|NCT01215981|3823476|P1|Overall Study|Protocol Violation|1
1164113|NCT01215981|3823475|P2|Overall Study|Physician Decision|1
1164114|NCT01215981|3823476|P1|Overall Study|Physician Decision|0
1164115|NCT01215968|3823486|P2|Overall Study|Not received study drug|1
1164116|NCT01215968|3823487|P1|Overall Study|Not received study drug|0
1164117|NCT01215968|3823486|P2|Overall Study|Protocol Violation|4
1164118|NCT01215968|3823487|P1|Overall Study|Protocol Violation|2
1164119|NCT01215968|3823486|P2|Overall Study|Adverse Event|2
1164120|NCT01215968|3823487|P1|Overall Study|Adverse Event|0
1164121|NCT01215955|3823507|P4|Overall Study|Quality Issues|2
1164122|NCT01215955|3823508|P3|Overall Study|Quality Issues|3
1164123|NCT01215955|3823509|P2|Overall Study|Quality Issues|0
1164124|NCT01215955|3823510|P1|Overall Study|Quality Issues|0
1164125|NCT01215955|3823507|P4|Overall Study|Withdrawal by Subject|9
1164126|NCT01215955|3823508|P3|Overall Study|Withdrawal by Subject|13
1164127|NCT01215955|3823509|P2|Overall Study|Withdrawal by Subject|15
1164128|NCT01215955|3823510|P1|Overall Study|Withdrawal by Subject|14
1164129|NCT01215955|3823507|P4|Overall Study|Sponsor Decision|1
1164130|NCT01215955|3823508|P3|Overall Study|Sponsor Decision|0
1164131|NCT01215955|3823509|P2|Overall Study|Sponsor Decision|2
1164132|NCT01215955|3823510|P1|Overall Study|Sponsor Decision|1
1164133|NCT01215955|3823507|P4|Overall Study|Protocol Violation|8
1164134|NCT01215955|3823508|P3|Overall Study|Protocol Violation|8
1164135|NCT01215955|3823509|P2|Overall Study|Protocol Violation|13
1164136|NCT01215955|3823510|P1|Overall Study|Protocol Violation|17
1164137|NCT01215955|3823507|P4|Overall Study|Physician Decision|11
1164138|NCT01215955|3823508|P3|Overall Study|Physician Decision|8
1164139|NCT01215955|3823509|P2|Overall Study|Physician Decision|10
1164140|NCT01215955|3823510|P1|Overall Study|Physician Decision|4
1164141|NCT01215955|3823507|P4|Overall Study|Lost to Follow-up|9
1164142|NCT01215955|3823508|P3|Overall Study|Lost to Follow-up|8
1164143|NCT01215955|3823509|P2|Overall Study|Lost to Follow-up|4
1164144|NCT01215955|3823510|P1|Overall Study|Lost to Follow-up|4
1164145|NCT01215955|3823507|P4|Overall Study|Lack of Efficacy|0
1164146|NCT01215955|3823508|P3|Overall Study|Lack of Efficacy|1
1164147|NCT01215955|3823509|P2|Overall Study|Lack of Efficacy|2
1164148|NCT01215955|3823510|P1|Overall Study|Lack of Efficacy|1
1164149|NCT01215955|3823507|P4|Overall Study|Entry Criteria Not Met|7
1164150|NCT01215955|3823508|P3|Overall Study|Entry Criteria Not Met|4
1164151|NCT01215955|3823509|P2|Overall Study|Entry Criteria Not Met|3
1164152|NCT01215955|3823510|P1|Overall Study|Entry Criteria Not Met|1
1164153|NCT01215955|3823507|P4|Overall Study|Death|3
1164154|NCT01215955|3823508|P3|Overall Study|Death|1
1164155|NCT01215955|3823509|P2|Overall Study|Death|0
1164156|NCT01215955|3823510|P1|Overall Study|Death|2
1164157|NCT01215955|3823507|P4|Overall Study|Adverse Event|3
1164158|NCT01215955|3823508|P3|Overall Study|Adverse Event|2
1164159|NCT01215955|3823509|P2|Overall Study|Adverse Event|4
1164160|NCT01215955|3823510|P1|Overall Study|Adverse Event|1
1164161|NCT01215942|3823578|P2|Post-Treatment Follow-Up Period|Sponsor Decision|61
1164162|NCT01215942|3823579|P1|Post-Treatment Follow-Up Period|Sponsor Decision|28
1164163|NCT01215942|3823578|P2|Post-Treatment Follow-Up Period|Physician Decision|2
1164164|NCT01215942|3823579|P1|Post-Treatment Follow-Up Period|Physician Decision|1
1164165|NCT01215942|3823578|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|69
1164166|NCT01215942|3823579|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|43
1164167|NCT01215942|3823578|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|13
1164168|NCT01215942|3823579|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|13
1164169|NCT01215942|3823578|P2|Post-Treatment Follow-Up Period|Death|1
1164170|NCT01215942|3823579|P1|Post-Treatment Follow-Up Period|Death|0
1164171|NCT01215942|3823578|P2|Treatment Period|Sponsor Decision|530
1164172|NCT01215942|3823579|P1|Treatment Period|Sponsor Decision|349
1164173|NCT01215942|3823578|P2|Treatment Period|Protocol Violation|1
1164174|NCT01215942|3823579|P1|Treatment Period|Protocol Violation|0
1164175|NCT01215942|3823578|P2|Treatment Period|Physician Decision|5
1164176|NCT01215942|3823579|P1|Treatment Period|Physician Decision|5
1164177|NCT01215942|3823578|P2|Treatment Period|Withdrawal by Subject|40
1164178|NCT01215942|3823579|P1|Treatment Period|Withdrawal by Subject|17
1164179|NCT01215942|3823578|P2|Treatment Period|Lost to Follow-up|4
1164180|NCT01215942|3823579|P1|Treatment Period|Lost to Follow-up|3
1164181|NCT01215942|3823578|P2|Treatment Period|Lack of Efficacy|62
1164182|NCT01215942|3823579|P1|Treatment Period|Lack of Efficacy|23
1164183|NCT01215942|3823578|P2|Treatment Period|Death|4
1164184|NCT01215942|3823579|P1|Treatment Period|Death|2
1164185|NCT01215942|3823578|P2|Treatment Period|Adverse Event|26
1164186|NCT01215942|3823579|P1|Treatment Period|Adverse Event|15
1164187|NCT01215851|3823709|P6|Follow up Period|Lost to Follow-up|1
1164188|NCT01215851|3823710|P5|Follow up Period|Lost to Follow-up|0
1164189|NCT01215851|3823711|P4|Follow up Period|Lost to Follow-up|0
1164190|NCT01215851|3823712|P3|Follow up Period|Lost to Follow-up|0
1164191|NCT01215851|3823713|P2|Follow up Period|Lost to Follow-up|0
1164192|NCT01215851|3823714|P1|Follow up Period|Lost to Follow-up|0
1164193|NCT01215851|3823709|P6|Treatment Period|Adverse Event|1
1164194|NCT01215851|3823710|P5|Treatment Period|Adverse Event|0
1164195|NCT01215851|3823711|P4|Treatment Period|Adverse Event|3
1164196|NCT01215851|3823712|P3|Treatment Period|Adverse Event|1
1164197|NCT01215851|3823713|P2|Treatment Period|Adverse Event|1
1164198|NCT01215851|3823714|P1|Treatment Period|Adverse Event|1
1164199|NCT01215734|3823773|P2|Overall Study|Death|1
1164200|NCT01215734|3823774|P1|Overall Study|Death|0
1164201|NCT01215721|3823782|P1|Overall Study|Adverse Event|2
1164202|NCT01215513|3823914|P1|Overall Study|Miscellaneous reasons (CS42A)|2
1164203|NCT01215513|3823914|P1|Overall Study|Withdrawal by subject (CS42A)|5
1164204|NCT01215513|3823914|P1|Overall Study|Physician decision (CS42A)|6
1164205|NCT01215513|3823914|P1|Overall Study|Adverse event (CS42A)|2
1164206|NCT01215513|3823914|P1|Overall Study|Not enrolled from CS42 to CS42A|21
1164207|NCT01215513|3823914|P1|Overall Study|Not completed CS42|9
1164208|NCT01215435|3823923|P2|Overall Study|Unclassified|5
1164209|NCT01215435|3823924|P1|Overall Study|Unclassified|5
1164210|NCT01215435|3823923|P2|Overall Study|Lost to Follow-up|0
1164211|NCT01215435|3823924|P1|Overall Study|Lost to Follow-up|3
1164212|NCT01215435|3823923|P2|Overall Study|Withdrawal Criteria|11
1164213|NCT01215435|3823924|P1|Overall Study|Withdrawal Criteria|8
1164214|NCT01215435|3823923|P2|Overall Study|Protocol Violation|0
1164215|NCT01215435|3823924|P1|Overall Study|Protocol Violation|2
1164216|NCT01215435|3823923|P2|Overall Study|Adverse Event|0
1164217|NCT01215435|3823924|P1|Overall Study|Adverse Event|1
1164218|NCT01215422|3823938|P4|Overall Study|Did not complete all intubations|0
1164219|NCT01215422|3823939|P3|Overall Study|Did not complete all intubations|0
1164220|NCT01215422|3823940|P2|Overall Study|Did not complete all intubations|0
1164221|NCT01215422|3823941|P1|Overall Study|Did not complete all intubations|7
1164222|NCT01215422|3823938|P4|Overall Study|Failed intubations|8
1164223|NCT01215422|3823939|P3|Overall Study|Failed intubations|3
1164224|NCT01215422|3823940|P2|Overall Study|Failed intubations|0
1164225|NCT01215422|3823941|P1|Overall Study|Failed intubations|0
1164226|NCT01215422|3823938|P4|Overall Study|Relocation|0
1164227|NCT01215422|3823939|P3|Overall Study|Relocation|0
1164228|NCT01215422|3823940|P2|Overall Study|Relocation|0
1164229|NCT01215422|3823941|P1|Overall Study|Relocation|1
1164230|NCT01215357|3823963|P1|Overall Study|Protocol Violation|9
1164231|NCT01215357|3823963|P1|Overall Study|Withdrawal by Subject|3
1164232|NCT01215253|3824078|P2|Overall Study|Other|12
1164233|NCT01215253|3824079|P1|Overall Study|Other|14
1164234|NCT01215253|3824078|P2|Overall Study|Lost to Follow-up|4
1164235|NCT01215253|3824079|P1|Overall Study|Lost to Follow-up|6
1164236|NCT01215253|3824078|P2|Overall Study|Physician Decision|12
1164237|NCT01215253|3824079|P1|Overall Study|Physician Decision|9
1164238|NCT01215253|3824078|P2|Overall Study|Withdrawal by Subject|35
1164239|NCT01215253|3824079|P1|Overall Study|Withdrawal by Subject|57
1164240|NCT01215227|3824113|P6|Overall Study|Randomized but not treated|1
1164241|NCT01215227|3824114|P5|Overall Study|Randomized but not treated|0
1164242|NCT01215227|3824115|P4|Overall Study|Randomized but not treated|1
1164243|NCT01215227|3824116|P3|Overall Study|Randomized but not treated|1
1164244|NCT01215227|3824117|P2|Overall Study|Randomized but not treated|0
1164245|NCT01215227|3824118|P1|Overall Study|Randomized but not treated|0
1164246|NCT01215227|3824113|P6|Overall Study|Missing Status|0
1164247|NCT01215227|3824114|P5|Overall Study|Missing Status|0
1164248|NCT01215227|3824115|P4|Overall Study|Missing Status|0
1164249|NCT01215227|3824116|P3|Overall Study|Missing Status|0
1164250|NCT01215227|3824117|P2|Overall Study|Missing Status|1
1164251|NCT01215227|3824118|P1|Overall Study|Missing Status|0
1164252|NCT01215227|3824113|P6|Overall Study|Administrative|40
1164253|NCT01215227|3824114|P5|Overall Study|Administrative|28
1164254|NCT01215227|3824115|P4|Overall Study|Administrative|24
1164255|NCT01215227|3824116|P3|Overall Study|Administrative|42
1164256|NCT01215227|3824117|P2|Overall Study|Administrative|73
1164257|NCT01215227|3824118|P1|Overall Study|Administrative|83
1164258|NCT01215227|3824113|P6|Overall Study|Non-Compliance With Protocol|0
1164259|NCT01215227|3824114|P5|Overall Study|Non-Compliance With Protocol|0
1164260|NCT01215227|3824115|P4|Overall Study|Non-Compliance With Protocol|0
1164261|NCT01215227|3824116|P3|Overall Study|Non-Compliance With Protocol|1
1164262|NCT01215227|3824117|P2|Overall Study|Non-Compliance With Protocol|6
1164263|NCT01215227|3824118|P1|Overall Study|Non-Compliance With Protocol|2
1164264|NCT01215227|3824113|P6|Overall Study|Subject Withdrew Consent|8
1164265|NCT01215227|3824114|P5|Overall Study|Subject Withdrew Consent|11
1164266|NCT01215227|3824115|P4|Overall Study|Subject Withdrew Consent|10
1164267|NCT01215227|3824116|P3|Overall Study|Subject Withdrew Consent|7
1164268|NCT01215227|3824117|P2|Overall Study|Subject Withdrew Consent|20
1164269|NCT01215227|3824118|P1|Overall Study|Subject Withdrew Consent|16
1164270|NCT01215227|3824113|P6|Overall Study|Lost to Follow-up|2
1164271|NCT01215227|3824114|P5|Overall Study|Lost to Follow-up|1
1164272|NCT01215227|3824115|P4|Overall Study|Lost to Follow-up|1
1164273|NCT01215227|3824116|P3|Overall Study|Lost to Follow-up|1
1164274|NCT01215227|3824117|P2|Overall Study|Lost to Follow-up|4
1164275|NCT01215227|3824118|P1|Overall Study|Lost to Follow-up|1
1164276|NCT01215227|3824113|P6|Overall Study|Treatment Failure|1
1164277|NCT01215227|3824114|P5|Overall Study|Treatment Failure|1
1164278|NCT01215227|3824115|P4|Overall Study|Treatment Failure|5
1164279|NCT01215227|3824116|P3|Overall Study|Treatment Failure|1
1164280|NCT01215227|3824117|P2|Overall Study|Treatment Failure|4
1164281|NCT01215227|3824118|P1|Overall Study|Treatment Failure|8
1164282|NCT01215227|3824113|P6|Overall Study|Adverse Event|6
1164283|NCT01215227|3824114|P5|Overall Study|Adverse Event|7
1164284|NCT01215227|3824115|P4|Overall Study|Adverse Event|8
1164285|NCT01215227|3824116|P3|Overall Study|Adverse Event|4
1164286|NCT01215227|3824117|P2|Overall Study|Adverse Event|11
1164287|NCT01215227|3824118|P1|Overall Study|Adverse Event|11
1164288|NCT01215097|3824237|P2|Overall Study|patient's private reason|1
1164289|NCT01215097|3824238|P1|Overall Study|patient's private reason|1
1164290|NCT01215097|3824237|P2|Overall Study|patient's refusal to come|2
1164291|NCT01215097|3824238|P1|Overall Study|patient's refusal to come|2
1164292|NCT01215097|3824237|P2|Overall Study|Lack of Efficacy|3
1164293|NCT01215097|3824238|P1|Overall Study|Lack of Efficacy|0
1164294|NCT01215097|3824237|P2|Overall Study|Withdrawal by Subject|3
1164295|NCT01215097|3824238|P1|Overall Study|Withdrawal by Subject|6
1164296|NCT01215097|3824237|P2|Overall Study|Lost to Follow-up|0
1164297|NCT01215097|3824238|P1|Overall Study|Lost to Follow-up|2
1164298|NCT01215097|3824237|P2|Overall Study|Protocol Violation|2
1164299|NCT01215097|3824238|P1|Overall Study|Protocol Violation|0
1164300|NCT01215097|3824237|P2|Overall Study|Adverse Event|3
1164301|NCT01215097|3824238|P1|Overall Study|Adverse Event|1
1164302|NCT01215032|3824270|P1|Overall Study|Lack of Efficacy|17
1164303|NCT01215032|3824270|P1|Overall Study|Adverse Event|3
1164304|NCT01214915|3824295|P1|Overall Study|Lack of Efficacy|3
1164305|NCT01214915|3824295|P1|Overall Study|Adverse Event|8
1164306|NCT01214850|3824306|P3|Overall Study|Unable to classify|1
1164307|NCT01214850|3824307|P2|Overall Study|Unable to classify|1
1164308|NCT01214850|3824308|P1|Overall Study|Unable to classify|2
1164309|NCT01214850|3824306|P3|Overall Study|Administrative reason|0
1164310|NCT01214850|3824307|P2|Overall Study|Administrative reason|0
1164311|NCT01214850|3824308|P1|Overall Study|Administrative reason|1
1164312|NCT01214850|3824306|P3|Overall Study|Inappropriate enrollment|0
1164313|NCT01214850|3824307|P2|Overall Study|Inappropriate enrollment|1
1164314|NCT01214850|3824308|P1|Overall Study|Inappropriate enrollment|2
1164315|NCT01214850|3824306|P3|Overall Study|Adverse event or death|3
1164316|NCT01214850|3824307|P2|Overall Study|Adverse event or death|8
1164317|NCT01214850|3824308|P1|Overall Study|Adverse event or death|11
1164318|NCT01214850|3824306|P3|Overall Study|Protocol Violation|6
1164319|NCT01214850|3824307|P2|Overall Study|Protocol Violation|5
1164320|NCT01214850|3824308|P1|Overall Study|Protocol Violation|5
1164321|NCT01214850|3824306|P3|Overall Study|Lost to Follow-up|123
1164322|NCT01214850|3824307|P2|Overall Study|Lost to Follow-up|98
1164323|NCT01214850|3824308|P1|Overall Study|Lost to Follow-up|124
1164324|NCT01214850|3824306|P3|Overall Study|Withdrawal by Subject|28
1164325|NCT01214850|3824307|P2|Overall Study|Withdrawal by Subject|31
1164326|NCT01214850|3824308|P1|Overall Study|Withdrawal by Subject|38
1164327|NCT01214837|3824392|P3|Overall Study|Unable to Classify|0
1164328|NCT01214837|3824393|P2|Overall Study|Unable to Classify|3
1164329|NCT01214837|3824394|P1|Overall Study|Unable to Classify|1
1164330|NCT01214837|3824392|P3|Overall Study|Protocol Violation|5
1164331|NCT01214837|3824393|P2|Overall Study|Protocol Violation|1
1164332|NCT01214837|3824394|P1|Overall Study|Protocol Violation|3
1164333|NCT01214837|3824392|P3|Overall Study|Administrative Reason|4
1164334|NCT01214837|3824393|P2|Overall Study|Administrative Reason|6
1164335|NCT01214837|3824394|P1|Overall Study|Administrative Reason|2
1164336|NCT01214837|3824392|P3|Overall Study|Inappropriate Enrolment|2
1164337|NCT01214837|3824393|P2|Overall Study|Inappropriate Enrolment|1
1164338|NCT01214837|3824394|P1|Overall Study|Inappropriate Enrolment|0
1164339|NCT01214837|3824392|P3|Overall Study|Lost to Follow-up|21
1164340|NCT01214837|3824393|P2|Overall Study|Lost to Follow-up|15
1164341|NCT01214837|3824394|P1|Overall Study|Lost to Follow-up|20
1164342|NCT01214837|3824392|P3|Overall Study|Withdrawal by Subject|28
1164343|NCT01214837|3824393|P2|Overall Study|Withdrawal by Subject|36
1164344|NCT01214837|3824394|P1|Overall Study|Withdrawal by Subject|27
1164345|NCT01214837|3824392|P3|Overall Study|Adverse Event|1
1164346|NCT01214837|3824393|P2|Overall Study|Adverse Event|2
1164347|NCT01214837|3824394|P1|Overall Study|Adverse Event|1
1164348|NCT01214837|3824392|P3|Overall Study|Death|1
1164349|NCT01214837|3824393|P2|Overall Study|Death|0
1164350|NCT01214837|3824394|P1|Overall Study|Death|0
1164351|NCT01214720|3824450|P2|Overall Study|Lost to Follow-up|2
1164352|NCT01214720|3824451|P1|Overall Study|Lost to Follow-up|6
1164353|NCT01214720|3824450|P2|Overall Study|Alive and in follow-up|48
1164354|NCT01214720|3824451|P1|Overall Study|Alive and in follow-up|45
1164355|NCT01214720|3824450|P2|Overall Study|Alive and still on treatment|18
1164356|NCT01214720|3824451|P1|Overall Study|Alive and still on treatment|34
1164357|NCT01214668|3824474|P6|Overall Study|Withdrawal by Subject|0
1164358|NCT01214668|3824475|P5|Overall Study|Withdrawal by Subject|1
1164359|NCT01214668|3824476|P4|Overall Study|Withdrawal by Subject|0
1164360|NCT01214668|3824477|P3|Overall Study|Withdrawal by Subject|0
1164361|NCT01214668|3824478|P2|Overall Study|Withdrawal by Subject|0
1164362|NCT01214668|3824479|P1|Overall Study|Withdrawal by Subject|0
1164363|NCT01214668|3824474|P6|Overall Study|Progressive Disease|5
1164364|NCT01214668|3824475|P5|Overall Study|Progressive Disease|4
1164365|NCT01214668|3824476|P4|Overall Study|Progressive Disease|4
1164366|NCT01214668|3824477|P3|Overall Study|Progressive Disease|5
1164367|NCT01214668|3824478|P2|Overall Study|Progressive Disease|2
1164368|NCT01214668|3824479|P1|Overall Study|Progressive Disease|4
1164369|NCT01214668|3824474|P6|Overall Study|Death|0
1164370|NCT01214668|3824475|P5|Overall Study|Death|0
1164371|NCT01214668|3824476|P4|Overall Study|Death|0
1164372|NCT01214668|3824477|P3|Overall Study|Death|1
1164373|NCT01214668|3824478|P2|Overall Study|Death|0
1164374|NCT01214668|3824479|P1|Overall Study|Death|0
1164375|NCT01214668|3824474|P6|Overall Study|Adverse Event|1
1164376|NCT01214668|3824475|P5|Overall Study|Adverse Event|1
1164377|NCT01214668|3824476|P4|Overall Study|Adverse Event|2
1164378|NCT01214668|3824477|P3|Overall Study|Adverse Event|0
1164379|NCT01214668|3824478|P2|Overall Study|Adverse Event|1
1164380|NCT01214668|3824479|P1|Overall Study|Adverse Event|0
1164381|NCT01214642|3824525|P12|Overall Study|Physician Decision|2
1164382|NCT01214642|3824526|P11|Overall Study|Physician Decision|0
1164383|NCT01214642|3824527|P10|Overall Study|Physician Decision|0
1164384|NCT01214642|3824528|P9|Overall Study|Physician Decision|0
1164385|NCT01214642|3824529|P8|Overall Study|Physician Decision|0
1164386|NCT01214642|3824530|P7|Overall Study|Physician Decision|0
1164387|NCT01214642|3824531|P6|Overall Study|Physician Decision|0
1164388|NCT01214642|3824532|P5|Overall Study|Physician Decision|1
1164389|NCT01214642|3824533|P4|Overall Study|Physician Decision|1
1164390|NCT01214642|3824534|P3|Overall Study|Physician Decision|1
1164391|NCT01214642|3824535|P2|Overall Study|Physician Decision|0
1164392|NCT01214642|3824536|P1|Overall Study|Physician Decision|0
1164393|NCT01214642|3824525|P12|Overall Study|Withdrawal by Subject|0
1164394|NCT01214642|3824526|P11|Overall Study|Withdrawal by Subject|1
1164395|NCT01214642|3824527|P10|Overall Study|Withdrawal by Subject|1
1164396|NCT01214642|3824528|P9|Overall Study|Withdrawal by Subject|3
1164397|NCT01214642|3824529|P8|Overall Study|Withdrawal by Subject|0
1164398|NCT01214642|3824530|P7|Overall Study|Withdrawal by Subject|0
1164399|NCT01214642|3824531|P6|Overall Study|Withdrawal by Subject|0
1164400|NCT01214642|3824532|P5|Overall Study|Withdrawal by Subject|0
1164401|NCT01214642|3824533|P4|Overall Study|Withdrawal by Subject|0
1164402|NCT01214642|3824534|P3|Overall Study|Withdrawal by Subject|1
1164403|NCT01214642|3824535|P2|Overall Study|Withdrawal by Subject|0
1164404|NCT01214642|3824536|P1|Overall Study|Withdrawal by Subject|0
1164405|NCT01214642|3824525|P12|Overall Study|Death|0
1164406|NCT01214642|3824526|P11|Overall Study|Death|1
1164407|NCT01214642|3824527|P10|Overall Study|Death|0
1164408|NCT01214642|3824528|P9|Overall Study|Death|0
1164409|NCT01214642|3824529|P8|Overall Study|Death|0
1164410|NCT01214642|3824530|P7|Overall Study|Death|0
1164411|NCT01214642|3824531|P6|Overall Study|Death|0
1164412|NCT01214642|3824532|P5|Overall Study|Death|0
1164413|NCT01214642|3824533|P4|Overall Study|Death|0
1164414|NCT01214642|3824534|P3|Overall Study|Death|1
1164415|NCT01214642|3824535|P2|Overall Study|Death|0
1164416|NCT01214642|3824536|P1|Overall Study|Death|0
1164417|NCT01214642|3824525|P12|Overall Study|Adverse Event|0
1164418|NCT01214642|3824526|P11|Overall Study|Adverse Event|1
1164419|NCT01214642|3824527|P10|Overall Study|Adverse Event|1
1164420|NCT01214642|3824528|P9|Overall Study|Adverse Event|0
1164421|NCT01214642|3824529|P8|Overall Study|Adverse Event|0
1164422|NCT01214642|3824530|P7|Overall Study|Adverse Event|1
1164423|NCT01214642|3824531|P6|Overall Study|Adverse Event|0
1164424|NCT01214642|3824532|P5|Overall Study|Adverse Event|0
1164425|NCT01214642|3824533|P4|Overall Study|Adverse Event|0
1164426|NCT01214642|3824534|P3|Overall Study|Adverse Event|0
1164427|NCT01214642|3824535|P2|Overall Study|Adverse Event|1
1164428|NCT01214642|3824536|P1|Overall Study|Adverse Event|0
1164429|NCT01214642|3824525|P12|Overall Study|Progressive Disease|4
1164430|NCT01214642|3824526|P11|Overall Study|Progressive Disease|1
1164431|NCT01214642|3824527|P10|Overall Study|Progressive Disease|2
1164432|NCT01214642|3824528|P9|Overall Study|Progressive Disease|10
1164433|NCT01214642|3824529|P8|Overall Study|Progressive Disease|3
1164434|NCT01214642|3824530|P7|Overall Study|Progressive Disease|5
1164435|NCT01214642|3824531|P6|Overall Study|Progressive Disease|3
1164436|NCT01214642|3824532|P5|Overall Study|Progressive Disease|5
1164437|NCT01214642|3824533|P4|Overall Study|Progressive Disease|5
1164438|NCT01214642|3824534|P3|Overall Study|Progressive Disease|3
1164439|NCT01214642|3824535|P2|Overall Study|Progressive Disease|2
1164440|NCT01214642|3824536|P1|Overall Study|Progressive Disease|3
1164441|NCT01214629|3824616|P11|Overall Study|Withdrawal by Subject|0
1164442|NCT01214629|3824617|P10|Overall Study|Withdrawal by Subject|1
1164443|NCT01214629|3824618|P9|Overall Study|Withdrawal by Subject|0
1164444|NCT01214629|3824619|P8|Overall Study|Withdrawal by Subject|0
1164445|NCT01214629|3824620|P7|Overall Study|Withdrawal by Subject|0
1164446|NCT01214629|3824621|P6|Overall Study|Withdrawal by Subject|0
1164447|NCT01214629|3824622|P5|Overall Study|Withdrawal by Subject|0
1164448|NCT01214629|3824623|P4|Overall Study|Withdrawal by Subject|0
1164449|NCT01214629|3824624|P3|Overall Study|Withdrawal by Subject|0
1164450|NCT01214629|3824625|P2|Overall Study|Withdrawal by Subject|0
1164451|NCT01214629|3824626|P1|Overall Study|Withdrawal by Subject|0
1164452|NCT01214629|3824616|P11|Overall Study|Physician Decision|1
1164453|NCT01214629|3824617|P10|Overall Study|Physician Decision|0
1164454|NCT01214629|3824618|P9|Overall Study|Physician Decision|0
1164455|NCT01214629|3824619|P8|Overall Study|Physician Decision|0
1164456|NCT01214629|3824620|P7|Overall Study|Physician Decision|0
1164457|NCT01214629|3824621|P6|Overall Study|Physician Decision|0
1164458|NCT01214629|3824622|P5|Overall Study|Physician Decision|0
1164459|NCT01214629|3824623|P4|Overall Study|Physician Decision|0
1164460|NCT01214629|3824624|P3|Overall Study|Physician Decision|0
1164461|NCT01214629|3824625|P2|Overall Study|Physician Decision|0
1164462|NCT01214629|3824626|P1|Overall Study|Physician Decision|0
1164463|NCT01214629|3824616|P11|Overall Study|Adverse Event|0
1164464|NCT01214629|3824617|P10|Overall Study|Adverse Event|1
1164465|NCT01214629|3824618|P9|Overall Study|Adverse Event|0
1164466|NCT01214629|3824619|P8|Overall Study|Adverse Event|0
1164467|NCT01214629|3824620|P7|Overall Study|Adverse Event|0
1164468|NCT01214629|3824621|P6|Overall Study|Adverse Event|1
1164469|NCT01214629|3824622|P5|Overall Study|Adverse Event|0
1164470|NCT01214629|3824623|P4|Overall Study|Adverse Event|1
1164471|NCT01214629|3824624|P3|Overall Study|Adverse Event|0
1164472|NCT01214629|3824625|P2|Overall Study|Adverse Event|0
1164473|NCT01214629|3824626|P1|Overall Study|Adverse Event|0
1164474|NCT01214629|3824616|P11|Overall Study|Progressive Disease|1
1164475|NCT01214629|3824617|P10|Overall Study|Progressive Disease|5
1164476|NCT01214629|3824618|P9|Overall Study|Progressive Disease|1
1164477|NCT01214629|3824619|P8|Overall Study|Progressive Disease|1
1164478|NCT01214629|3824620|P7|Overall Study|Progressive Disease|1
1164479|NCT01214629|3824621|P6|Overall Study|Progressive Disease|3
1164480|NCT01214629|3824622|P5|Overall Study|Progressive Disease|2
1164481|NCT01214629|3824623|P4|Overall Study|Progressive Disease|1
1164482|NCT01214629|3824624|P3|Overall Study|Progressive Disease|0
1164483|NCT01214629|3824625|P2|Overall Study|Progressive Disease|1
1164484|NCT01214629|3824626|P1|Overall Study|Progressive Disease|1
1164485|NCT01214616|3824691|P4|Overall Study|Withdrawal by Subject|1
1164486|NCT01214616|3824692|P3|Overall Study|Withdrawal by Subject|0
1164487|NCT01214616|3824693|P2|Overall Study|Withdrawal by Subject|0
1164488|NCT01214616|3824694|P1|Overall Study|Withdrawal by Subject|1
1164489|NCT01214616|3824691|P4|Overall Study|Other adverse events|1
1164490|NCT01214616|3824692|P3|Overall Study|Other adverse events|1
1164491|NCT01214616|3824693|P2|Overall Study|Other adverse events|1
1164492|NCT01214616|3824694|P1|Overall Study|Other adverse events|0
1164493|NCT01214616|3824691|P4|Overall Study|Dose limiting toxicity|0
1164494|NCT01214616|3824692|P3|Overall Study|Dose limiting toxicity|0
1164495|NCT01214616|3824693|P2|Overall Study|Dose limiting toxicity|2
1164496|NCT01214616|3824694|P1|Overall Study|Dose limiting toxicity|0
1164497|NCT01214616|3824691|P4|Overall Study|Progressive disease|4
1164498|NCT01214616|3824692|P3|Overall Study|Progressive disease|2
1164499|NCT01214616|3824693|P2|Overall Study|Progressive disease|2
1164500|NCT01214616|3824694|P1|Overall Study|Progressive disease|2
1164501|NCT01214603|3824731|P3|Overall Study|Progressive Disease|3
1164502|NCT01214603|3824732|P2|Overall Study|Progressive Disease|1
1164503|NCT01214603|3824733|P1|Overall Study|Progressive Disease|4
1164504|NCT01214603|3824731|P3|Overall Study|Death|0
1164505|NCT01214603|3824732|P2|Overall Study|Death|0
1164506|NCT01214603|3824733|P1|Overall Study|Death|1
1164507|NCT01214603|3824731|P3|Overall Study|Adverse Event|1
1164508|NCT01214603|3824732|P2|Overall Study|Adverse Event|0
1164509|NCT01214603|3824733|P1|Overall Study|Adverse Event|0
1164510|NCT01214434|3824756|P2|Overall Study|Site error|0
1164511|NCT01214434|3824757|P1|Overall Study|Site error|1
1164512|NCT01214434|3824756|P2|Overall Study|Lost to Follow-up|2
1164513|NCT01214434|3824757|P1|Overall Study|Lost to Follow-up|2
1164514|NCT01214434|3824756|P2|Overall Study|Withdrawal by Subject|0
1164515|NCT01214434|3824757|P1|Overall Study|Withdrawal by Subject|1
1164516|NCT01214395|3824773|P1|Overall Study|All patients had infection|5
1164517|NCT01214252|3824791|P1|Overall Study|Not eligible per protocol|82
1164518|NCT01214239|3824799|P2|Overall Study|patient's private reason|1
1164519|NCT01214239|3824800|P1|Overall Study|patient's private reason|1
1164520|NCT01214239|3824799|P2|Overall Study|Lack of Efficacy|2
1164521|NCT01214239|3824800|P1|Overall Study|Lack of Efficacy|1
1164522|NCT01214239|3824799|P2|Overall Study|Withdrawal by Subject|9
1164523|NCT01214239|3824800|P1|Overall Study|Withdrawal by Subject|4
1164524|NCT01214239|3824799|P2|Overall Study|Lost to Follow-up|1
1164525|NCT01214239|3824800|P1|Overall Study|Lost to Follow-up|1
1164526|NCT01214239|3824799|P2|Overall Study|Protocol Violation|1
1164527|NCT01214239|3824800|P1|Overall Study|Protocol Violation|2
1164528|NCT01214239|3824799|P2|Overall Study|Adverse Event|4
1164529|NCT01214239|3824800|P1|Overall Study|Adverse Event|3
1164530|NCT01214187|3824834|P2|Overall Study|Withdrawal by Subject|3
1164531|NCT01214187|3824835|P1|Overall Study|Withdrawal by Subject|0
1164532|NCT01214187|3824834|P2|Overall Study|Death|1
1164533|NCT01214187|3824835|P1|Overall Study|Death|1
1164534|NCT01214187|3824834|P2|Overall Study|Adverse Event|2
1164535|NCT01214187|3824835|P1|Overall Study|Adverse Event|6
1164536|NCT01214174|3824852|P3|Overall Study|Withdrawal by Subject|1
1164537|NCT01214174|3824853|P2|Overall Study|Withdrawal by Subject|0
1164538|NCT01214174|3824854|P1|Overall Study|Withdrawal by Subject|0
1164539|NCT01213966|3825008|P4|Overall Study|Protocol Violation|1
1164540|NCT01213966|3825009|P3|Overall Study|Protocol Violation|3
1164541|NCT01213966|3825010|P2|Overall Study|Protocol Violation|0
1164542|NCT01213966|3825011|P1|Overall Study|Protocol Violation|1
1164543|NCT01213836|3825023|P2|Period 1, First Intervention|Withdrawal by Subject|1
1164544|NCT01213836|3825024|P1|Period 1, First Intervention|Withdrawal by Subject|1
1164545|NCT01213836|3825023|P2|Period 1, First Intervention|Protocol Violation|1
1164546|NCT01213836|3825024|P1|Period 1, First Intervention|Protocol Violation|0
1164547|NCT01213836|3825023|P2|Period 1, First Intervention|Adverse Event|1
1164548|NCT01213836|3825024|P1|Period 1, First Intervention|Adverse Event|2
1164549|NCT01213264|3825137|P3|Overall Study|Lost to Follow-up|6
1164550|NCT01213264|3825138|P2|Overall Study|Lost to Follow-up|2
1164551|NCT01213264|3825139|P1|Overall Study|Lost to Follow-up|1
1164552|NCT01213264|3825137|P3|Overall Study|Adverse Event|0
1164553|NCT01213264|3825138|P2|Overall Study|Adverse Event|0
1164554|NCT01213264|3825139|P1|Overall Study|Adverse Event|1
1164555|NCT01213251|3825159|P3|Overall Study|Missed 18-Month Follow-up|1
1164556|NCT01213251|3825160|P2|Overall Study|Missed 18-Month Follow-up|0
1164557|NCT01213251|3825161|P1|Overall Study|Missed 18-Month Follow-up|0
1164558|NCT01213251|3825159|P3|Overall Study|Protocol Violation|0
1164559|NCT01213251|3825160|P2|Overall Study|Protocol Violation|1
1164560|NCT01213251|3825161|P1|Overall Study|Protocol Violation|1
1164561|NCT01213251|3825159|P3|Overall Study|Exit|8
1164562|NCT01213251|3825160|P2|Overall Study|Exit|2
1164563|NCT01213251|3825161|P1|Overall Study|Exit|3
1164564|NCT01213251|3825159|P3|Overall Study|Death|2
1164565|NCT01213251|3825160|P2|Overall Study|Death|1
1164566|NCT01213251|3825161|P1|Overall Study|Death|2
1164567|NCT01213173|3825188|P2|Overall Study|Incorrect Enrollment|3
1164568|NCT01213173|3825189|P1|Overall Study|Incorrect Enrollment|1
1164569|NCT01213173|3825188|P2|Overall Study|Withdrawal by Subject|5
1164570|NCT01213173|3825189|P1|Overall Study|Withdrawal by Subject|5
1164571|NCT01213173|3825188|P2|Overall Study|Adverse Event|8
1164572|NCT01213173|3825189|P1|Overall Study|Adverse Event|4
1164573|NCT01213173|3825188|P2|Overall Study|Protocol Violation|0
1164574|NCT01213173|3825189|P1|Overall Study|Protocol Violation|2
1164575|NCT01213082|3825222|P3|Overall Study|Physician Decision|1
1164576|NCT01213082|3825223|P2|Overall Study|Physician Decision|0
1164577|NCT01213082|3825224|P1|Overall Study|Physician Decision|0
1164578|NCT01213082|3825222|P3|Overall Study|Lost to Follow-up|4
1164579|NCT01213082|3825223|P2|Overall Study|Lost to Follow-up|7
1164580|NCT01213082|3825224|P1|Overall Study|Lost to Follow-up|6
1164581|NCT01212991|3825266|P2|Overall Study|Continuing Treatment|61
1164582|NCT01212991|3825267|P1|Overall Study|Continuing Treatment|367
1164583|NCT01212991|3825266|P2|Overall Study|Withdrawal by Subject|14
1164584|NCT01212991|3825267|P1|Overall Study|Withdrawal by Subject|4
1164585|NCT01212991|3825266|P2|Overall Study|Death|299
1164586|NCT01212991|3825267|P1|Overall Study|Death|241
1164587|NCT01212991|3825266|P2|Overall Study|Lost to Follow-up|0
1164588|NCT01212991|3825267|P1|Overall Study|Lost to Follow-up|1
1164589|NCT01212770|3825308|P9|Long-term Safety Phase (Year 5)|Death|0
1164590|NCT01212770|3825309|P8|Long-term Safety Phase (Year 5)|Death|1
1164591|NCT01212770|3825310|P7|Long-term Safety Phase (Year 5)|Death|0
1164592|NCT01212770|3825311|P6|Long-term Safety Phase (Year 5)|Death|0
1164593|NCT01212770|3825312|P5|Long-term Safety Phase (Year 5)|Death|0
1164594|NCT01212770|3825313|P4|Long-term Safety Phase (Year 5)|Death|0
1164595|NCT01212770|3825314|P3|Long-term Safety Phase (Year 5)|Death|0
1164596|NCT01212770|3825315|P2|Long-term Safety Phase (Year 5)|Death|0
1164597|NCT01212770|3825316|P1|Long-term Safety Phase (Year 5)|Death|0
1164598|NCT01212770|3825308|P9|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
1164599|NCT01212770|3825309|P8|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
1164600|NCT01212770|3825310|P7|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
1164601|NCT01212770|3825311|P6|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
1164602|NCT01212770|3825312|P5|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
1164603|NCT01212770|3825313|P4|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
1164604|NCT01212770|3825314|P3|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
1164605|NCT01212770|3825315|P2|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
1164606|NCT01212770|3825316|P1|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
1164607|NCT01212770|3825308|P9|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1164608|NCT01212770|3825309|P8|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1164609|NCT01212770|3825310|P7|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1164610|NCT01212770|3825311|P6|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1164611|NCT01212770|3825312|P5|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1164612|NCT01212770|3825313|P4|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1164613|NCT01212770|3825314|P3|Long-term Safety Phase (Year 5)|Lack of Efficacy|4
1164614|NCT01212770|3825315|P2|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1164615|NCT01212770|3825316|P1|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1164616|NCT01212770|3825308|P9|Long-term Safety Phase (Year 5)|Adverse Event|1
1164617|NCT01212770|3825309|P8|Long-term Safety Phase (Year 5)|Adverse Event|0
1164618|NCT01212770|3825310|P7|Long-term Safety Phase (Year 5)|Adverse Event|0
1164619|NCT01212770|3825311|P6|Long-term Safety Phase (Year 5)|Adverse Event|0
1164620|NCT01212770|3825312|P5|Long-term Safety Phase (Year 5)|Adverse Event|0
1164621|NCT01212770|3825313|P4|Long-term Safety Phase (Year 5)|Adverse Event|0
1164622|NCT01212770|3825314|P3|Long-term Safety Phase (Year 5)|Adverse Event|2
1164623|NCT01212770|3825315|P2|Long-term Safety Phase (Year 5)|Adverse Event|0
1164624|NCT01212770|3825316|P1|Long-term Safety Phase (Year 5)|Adverse Event|0
1164625|NCT01212770|3825308|P9|Long-term Safety Phase (Year 5)|Miscellaneous|0
1164626|NCT01212770|3825309|P8|Long-term Safety Phase (Year 5)|Miscellaneous|0
1164627|NCT01212770|3825310|P7|Long-term Safety Phase (Year 5)|Miscellaneous|0
1164628|NCT01212770|3825311|P6|Long-term Safety Phase (Year 5)|Miscellaneous|0
1164629|NCT01212770|3825312|P5|Long-term Safety Phase (Year 5)|Miscellaneous|0
1164630|NCT01212770|3825313|P4|Long-term Safety Phase (Year 5)|Miscellaneous|0
1164631|NCT01212770|3825314|P3|Long-term Safety Phase (Year 5)|Miscellaneous|3
1164632|NCT01212770|3825315|P2|Long-term Safety Phase (Year 5)|Miscellaneous|0
1164633|NCT01212770|3825316|P1|Long-term Safety Phase (Year 5)|Miscellaneous|0
1164634|NCT01212770|3825308|P9|Long-term Safety Phase (Year 5)|Missing|0
1164635|NCT01212770|3825309|P8|Long-term Safety Phase (Year 5)|Missing|0
1164636|NCT01212770|3825310|P7|Long-term Safety Phase (Year 5)|Missing|0
1164637|NCT01212770|3825311|P6|Long-term Safety Phase (Year 5)|Missing|0
1164638|NCT01212770|3825312|P5|Long-term Safety Phase (Year 5)|Missing|0
1164639|NCT01212770|3825313|P4|Long-term Safety Phase (Year 5)|Missing|0
1164640|NCT01212770|3825314|P3|Long-term Safety Phase (Year 5)|Missing|1
1164641|NCT01212770|3825315|P2|Long-term Safety Phase (Year 5)|Missing|0
1164642|NCT01212770|3825316|P1|Long-term Safety Phase (Year 5)|Missing|0
1164643|NCT01212770|3825308|P9|Long-term Safety Phase (Year 4)|Miscellaneous|1
1164644|NCT01212770|3825309|P8|Long-term Safety Phase (Year 4)|Miscellaneous|0
1164645|NCT01212770|3825310|P7|Long-term Safety Phase (Year 4)|Miscellaneous|0
1164646|NCT01212770|3825311|P6|Long-term Safety Phase (Year 4)|Miscellaneous|0
1164647|NCT01212770|3825312|P5|Long-term Safety Phase (Year 4)|Miscellaneous|0
1164648|NCT01212770|3825313|P4|Long-term Safety Phase (Year 4)|Miscellaneous|0
1164649|NCT01212770|3825314|P3|Long-term Safety Phase (Year 4)|Miscellaneous|0
1164650|NCT01212770|3825315|P2|Long-term Safety Phase (Year 4)|Miscellaneous|1
1164651|NCT01212770|3825316|P1|Long-term Safety Phase (Year 4)|Miscellaneous|0
1164652|NCT01212770|3825308|P9|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1164653|NCT01212770|3825309|P8|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1164654|NCT01212770|3825310|P7|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1164655|NCT01212770|3825311|P6|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1164656|NCT01212770|3825312|P5|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1164657|NCT01212770|3825313|P4|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1164658|NCT01212770|3825314|P3|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
1164659|NCT01212770|3825315|P2|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1164660|NCT01212770|3825316|P1|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1164661|NCT01212770|3825308|P9|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
1164662|NCT01212770|3825309|P8|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
1164663|NCT01212770|3825310|P7|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
1164664|NCT01212770|3825311|P6|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
1164665|NCT01212770|3825312|P5|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
1164666|NCT01212770|3825313|P4|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
1164667|NCT01212770|3825314|P3|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3
1164668|NCT01212770|3825315|P2|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2
1164669|NCT01212770|3825316|P1|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
1164670|NCT01212770|3825308|P9|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
1164671|NCT01212770|3825309|P8|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
1164672|NCT01212770|3825310|P7|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
1164673|NCT01212770|3825311|P6|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
1164674|NCT01212770|3825312|P5|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
1164675|NCT01212770|3825313|P4|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
1164676|NCT01212770|3825314|P3|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
1164677|NCT01212770|3825315|P2|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
1164678|NCT01212770|3825316|P1|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
1164679|NCT01212770|3825308|P9|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
1164680|NCT01212770|3825309|P8|Long-term Safety Phase (Year 4)|Lack of Efficacy|2
1164681|NCT01212770|3825310|P7|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
1164682|NCT01212770|3825311|P6|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
1164683|NCT01212770|3825312|P5|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
1164684|NCT01212770|3825313|P4|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
1164685|NCT01212770|3825314|P3|Long-term Safety Phase (Year 4)|Lack of Efficacy|5
1164686|NCT01212770|3825315|P2|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
1164687|NCT01212770|3825316|P1|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
1164688|NCT01212770|3825308|P9|Long-term Safety Phase (Year 4)|Adverse Event|1
1164689|NCT01212770|3825309|P8|Long-term Safety Phase (Year 4)|Adverse Event|0
1164690|NCT01212770|3825310|P7|Long-term Safety Phase (Year 4)|Adverse Event|0
1164691|NCT01212770|3825311|P6|Long-term Safety Phase (Year 4)|Adverse Event|0
1164692|NCT01212770|3825312|P5|Long-term Safety Phase (Year 4)|Adverse Event|0
1164693|NCT01212770|3825313|P4|Long-term Safety Phase (Year 4)|Adverse Event|0
1164694|NCT01212770|3825314|P3|Long-term Safety Phase (Year 4)|Adverse Event|1
1164695|NCT01212770|3825315|P2|Long-term Safety Phase (Year 4)|Adverse Event|1
1164696|NCT01212770|3825316|P1|Long-term Safety Phase (Year 4)|Adverse Event|0
1164697|NCT01212770|3825308|P9|Long-term Safety Phase (Year 3)|Miscellaneous|1
1164698|NCT01212770|3825309|P8|Long-term Safety Phase (Year 3)|Miscellaneous|1
1164699|NCT01212770|3825310|P7|Long-term Safety Phase (Year 3)|Miscellaneous|0
1164700|NCT01212770|3825311|P6|Long-term Safety Phase (Year 3)|Miscellaneous|0
1164701|NCT01212770|3825312|P5|Long-term Safety Phase (Year 3)|Miscellaneous|0
1164702|NCT01212770|3825313|P4|Long-term Safety Phase (Year 3)|Miscellaneous|0
1164703|NCT01212770|3825314|P3|Long-term Safety Phase (Year 3)|Miscellaneous|1
1164704|NCT01212770|3825315|P2|Long-term Safety Phase (Year 3)|Miscellaneous|2
1164705|NCT01212770|3825316|P1|Long-term Safety Phase (Year 3)|Miscellaneous|0
1164706|NCT01212770|3825308|P9|Long-term Safety Phase (Year 3)|Protocol Violation|0
1164707|NCT01212770|3825309|P8|Long-term Safety Phase (Year 3)|Protocol Violation|1
1164708|NCT01212770|3825310|P7|Long-term Safety Phase (Year 3)|Protocol Violation|0
1164709|NCT01212770|3825311|P6|Long-term Safety Phase (Year 3)|Protocol Violation|0
1164710|NCT01212770|3825312|P5|Long-term Safety Phase (Year 3)|Protocol Violation|0
1164711|NCT01212770|3825313|P4|Long-term Safety Phase (Year 3)|Protocol Violation|0
1164712|NCT01212770|3825314|P3|Long-term Safety Phase (Year 3)|Protocol Violation|0
1164713|NCT01212770|3825315|P2|Long-term Safety Phase (Year 3)|Protocol Violation|0
1164714|NCT01212770|3825316|P1|Long-term Safety Phase (Year 3)|Protocol Violation|0
1164715|NCT01212770|3825308|P9|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
1164716|NCT01212770|3825309|P8|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
1164717|NCT01212770|3825310|P7|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
1164718|NCT01212770|3825311|P6|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
1164719|NCT01212770|3825312|P5|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
1164720|NCT01212770|3825313|P4|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
1164721|NCT01212770|3825314|P3|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
1164722|NCT01212770|3825315|P2|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
1164723|NCT01212770|3825316|P1|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
1164724|NCT01212770|3825308|P9|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
1164725|NCT01212770|3825309|P8|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
1164726|NCT01212770|3825310|P7|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
1164727|NCT01212770|3825311|P6|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
1164728|NCT01212770|3825312|P5|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
1164729|NCT01212770|3825313|P4|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
1164730|NCT01212770|3825314|P3|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
1164731|NCT01212770|3825315|P2|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3
1164732|NCT01212770|3825316|P1|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
1164733|NCT01212770|3825308|P9|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
1164734|NCT01212770|3825309|P8|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
1164735|NCT01212770|3825310|P7|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
1164736|NCT01212770|3825311|P6|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
1164737|NCT01212770|3825312|P5|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
1164738|NCT01212770|3825313|P4|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
1164739|NCT01212770|3825314|P3|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
1164740|NCT01212770|3825315|P2|Long-term Safety Phase (Year 3)|Lack of Efficacy|3
1164741|NCT01212770|3825316|P1|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
1164742|NCT01212770|3825308|P9|Long-term Safety Phase (Year 3)|Adverse Event|1
1164743|NCT01212770|3825309|P8|Long-term Safety Phase (Year 3)|Adverse Event|2
1164744|NCT01212770|3825310|P7|Long-term Safety Phase (Year 3)|Adverse Event|0
1164745|NCT01212770|3825311|P6|Long-term Safety Phase (Year 3)|Adverse Event|0
1164746|NCT01212770|3825312|P5|Long-term Safety Phase (Year 3)|Adverse Event|0
1164747|NCT01212770|3825313|P4|Long-term Safety Phase (Year 3)|Adverse Event|0
1164748|NCT01212770|3825314|P3|Long-term Safety Phase (Year 3)|Adverse Event|2
1164749|NCT01212770|3825315|P2|Long-term Safety Phase (Year 3)|Adverse Event|2
1164750|NCT01212770|3825316|P1|Long-term Safety Phase (Year 3)|Adverse Event|0
1164751|NCT01212770|3825308|P9|Long-term Safety Phase (Year 2)|Miscellaneous|1
1164752|NCT01212770|3825309|P8|Long-term Safety Phase (Year 2)|Miscellaneous|0
1164753|NCT01212770|3825310|P7|Long-term Safety Phase (Year 2)|Miscellaneous|0
1164754|NCT01212770|3825311|P6|Long-term Safety Phase (Year 2)|Miscellaneous|0
1164755|NCT01212770|3825312|P5|Long-term Safety Phase (Year 2)|Miscellaneous|0
1164756|NCT01212770|3825313|P4|Long-term Safety Phase (Year 2)|Miscellaneous|0
1164757|NCT01212770|3825314|P3|Long-term Safety Phase (Year 2)|Miscellaneous|1
1164758|NCT01212770|3825315|P2|Long-term Safety Phase (Year 2)|Miscellaneous|2
1164759|NCT01212770|3825316|P1|Long-term Safety Phase (Year 2)|Miscellaneous|0
1164760|NCT01212770|3825308|P9|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
1164761|NCT01212770|3825309|P8|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
1164762|NCT01212770|3825310|P7|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
1164763|NCT01212770|3825311|P6|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
1164764|NCT01212770|3825312|P5|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
1164765|NCT01212770|3825313|P4|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
1164766|NCT01212770|3825314|P3|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
1164767|NCT01212770|3825315|P2|Long-term Safety Phase (Year 2)|Lost to Follow-up|2
1164768|NCT01212770|3825316|P1|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
1164769|NCT01212770|3825308|P9|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
1164770|NCT01212770|3825309|P8|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
1164771|NCT01212770|3825310|P7|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
1164772|NCT01212770|3825311|P6|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
1164773|NCT01212770|3825312|P5|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
1164774|NCT01212770|3825313|P4|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
1164775|NCT01212770|3825314|P3|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
1164776|NCT01212770|3825315|P2|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9
1164777|NCT01212770|3825316|P1|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
1164778|NCT01212770|3825308|P9|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
1164779|NCT01212770|3825309|P8|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
1164780|NCT01212770|3825310|P7|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
1164781|NCT01212770|3825311|P6|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
1164782|NCT01212770|3825312|P5|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
1164783|NCT01212770|3825313|P4|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
1164784|NCT01212770|3825314|P3|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
1164785|NCT01212770|3825315|P2|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1
1164786|NCT01212770|3825316|P1|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
1164787|NCT01212770|3825308|P9|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
1164788|NCT01212770|3825309|P8|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
1164789|NCT01212770|3825310|P7|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
1164790|NCT01212770|3825311|P6|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
1164791|NCT01212770|3825312|P5|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
1164792|NCT01212770|3825313|P4|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
1164793|NCT01212770|3825314|P3|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
1164794|NCT01212770|3825315|P2|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
1164795|NCT01212770|3825316|P1|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
1164796|NCT01212770|3825308|P9|Long-term Safety Phase (Year 2)|Adverse Event|2
1164797|NCT01212770|3825309|P8|Long-term Safety Phase (Year 2)|Adverse Event|0
1164798|NCT01212770|3825310|P7|Long-term Safety Phase (Year 2)|Adverse Event|0
1164799|NCT01212770|3825311|P6|Long-term Safety Phase (Year 2)|Adverse Event|0
1164800|NCT01212770|3825312|P5|Long-term Safety Phase (Year 2)|Adverse Event|0
1165318|NCT01211145|3826017|P4|Overall Study|Reason not specified|1
1164801|NCT01212770|3825313|P4|Long-term Safety Phase (Year 2)|Adverse Event|0
1164802|NCT01212770|3825314|P3|Long-term Safety Phase (Year 2)|Adverse Event|3
1164803|NCT01212770|3825315|P2|Long-term Safety Phase (Year 2)|Adverse Event|3
1164804|NCT01212770|3825316|P1|Long-term Safety Phase (Year 2)|Adverse Event|0
1164805|NCT01212770|3825308|P9|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
1164806|NCT01212770|3825309|P8|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
1164807|NCT01212770|3825310|P7|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
1164808|NCT01212770|3825311|P6|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
1164809|NCT01212770|3825312|P5|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
1164810|NCT01212770|3825313|P4|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
1164811|NCT01212770|3825314|P3|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
1164812|NCT01212770|3825315|P2|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
1164813|NCT01212770|3825316|P1|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
1164814|NCT01212770|3825308|P9|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
1164815|NCT01212770|3825309|P8|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
1164816|NCT01212770|3825310|P7|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
1164817|NCT01212770|3825311|P6|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
1164818|NCT01212770|3825312|P5|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
1164819|NCT01212770|3825313|P4|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1
1164820|NCT01212770|3825314|P3|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
1164821|NCT01212770|3825315|P2|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
1164822|NCT01212770|3825316|P1|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
1164823|NCT01212770|3825308|P9|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
1164824|NCT01212770|3825309|P8|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
1164825|NCT01212770|3825310|P7|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
1164826|NCT01212770|3825311|P6|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
1164827|NCT01212770|3825312|P5|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
1164828|NCT01212770|3825313|P4|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
1164829|NCT01212770|3825314|P3|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
1164830|NCT01212770|3825315|P2|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
1164831|NCT01212770|3825316|P1|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
1164832|NCT01212770|3825308|P9|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
1164833|NCT01212770|3825309|P8|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
1164834|NCT01212770|3825310|P7|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
1164835|NCT01212770|3825311|P6|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
1164836|NCT01212770|3825312|P5|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
1164837|NCT01212770|3825313|P4|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
1164838|NCT01212770|3825314|P3|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
1164839|NCT01212770|3825315|P2|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6
1164840|NCT01212770|3825316|P1|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
1164841|NCT01212770|3825308|P9|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
1164842|NCT01212770|3825309|P8|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
1164843|NCT01212770|3825310|P7|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
1164844|NCT01212770|3825311|P6|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2
1164845|NCT01212770|3825312|P5|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1
1164846|NCT01212770|3825313|P4|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4
1164847|NCT01212770|3825314|P3|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5
1164848|NCT01212770|3825315|P2|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7
1164849|NCT01212770|3825316|P1|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
1164850|NCT01212770|3825308|P9|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
1164851|NCT01212770|3825309|P8|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
1164852|NCT01212770|3825310|P7|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1
1164853|NCT01212770|3825311|P6|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
1164854|NCT01212770|3825312|P5|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
1164855|NCT01212770|3825313|P4|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
1164856|NCT01212770|3825314|P3|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
1164857|NCT01212770|3825315|P2|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6
1164858|NCT01212770|3825316|P1|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
1164859|NCT01212770|3825308|P9|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
1164860|NCT01212770|3825309|P8|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
1164861|NCT01212770|3825310|P7|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
1164862|NCT01212770|3825311|P6|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
1164863|NCT01212770|3825312|P5|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
1164864|NCT01212770|3825313|P4|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
1164865|NCT01212770|3825314|P3|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2
1164866|NCT01212770|3825315|P2|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1
1164867|NCT01212770|3825316|P1|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3
1164868|NCT01212770|3825308|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1164869|NCT01212770|3825309|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1164870|NCT01212770|3825310|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1164871|NCT01212770|3825311|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1164872|NCT01212770|3825312|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1164873|NCT01212770|3825313|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1164874|NCT01212770|3825314|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
1164875|NCT01212770|3825315|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1164876|NCT01212770|3825316|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1164877|NCT01212770|3825308|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1164878|NCT01212770|3825309|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1164879|NCT01212770|3825310|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1164880|NCT01212770|3825311|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1164881|NCT01212770|3825312|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1164882|NCT01212770|3825313|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1164883|NCT01212770|3825314|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3
1164884|NCT01212770|3825315|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1164885|NCT01212770|3825316|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
1164886|NCT01212770|3825308|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1164887|NCT01212770|3825309|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1164888|NCT01212770|3825310|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1164889|NCT01212770|3825311|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1164890|NCT01212770|3825312|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1164891|NCT01212770|3825313|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1164892|NCT01212770|3825314|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
1164893|NCT01212770|3825315|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
1164894|NCT01212770|3825316|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
1164895|NCT01212770|3825308|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1164896|NCT01212770|3825309|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1164897|NCT01212770|3825310|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1164898|NCT01212770|3825311|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1164899|NCT01212770|3825312|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1164900|NCT01212770|3825313|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1164901|NCT01212770|3825314|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7
1164902|NCT01212770|3825315|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5
1164903|NCT01212770|3825316|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
1164904|NCT01212770|3825308|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1164905|NCT01212770|3825309|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1164906|NCT01212770|3825310|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1164907|NCT01212770|3825311|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1164908|NCT01212770|3825312|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1164909|NCT01212770|3825313|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1164910|NCT01212770|3825314|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8
1164911|NCT01212770|3825315|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
1164912|NCT01212770|3825316|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
1164913|NCT01212757|3825513|P9|Long-Term Safety Phase (Year 5)|Miscellaneous|0
1164914|NCT01212757|3825514|P8|Long-Term Safety Phase (Year 5)|Miscellaneous|0
1164915|NCT01212757|3825515|P7|Long-Term Safety Phase (Year 5)|Miscellaneous|0
1164916|NCT01212757|3825516|P6|Long-Term Safety Phase (Year 5)|Miscellaneous|0
1164917|NCT01212757|3825517|P5|Long-Term Safety Phase (Year 5)|Miscellaneous|0
1164918|NCT01212757|3825518|P4|Long-Term Safety Phase (Year 5)|Miscellaneous|0
1164919|NCT01212757|3825519|P3|Long-Term Safety Phase (Year 5)|Miscellaneous|1
1164920|NCT01212757|3825520|P2|Long-Term Safety Phase (Year 5)|Miscellaneous|1
1164921|NCT01212757|3825521|P1|Long-Term Safety Phase (Year 5)|Miscellaneous|0
1164922|NCT01212757|3825513|P9|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
1164923|NCT01212757|3825514|P8|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
1164924|NCT01212757|3825515|P7|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
1164925|NCT01212757|3825516|P6|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
1164926|NCT01212757|3825517|P5|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
1164927|NCT01212757|3825518|P4|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
1164928|NCT01212757|3825519|P3|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
1164929|NCT01212757|3825520|P2|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1
1164930|NCT01212757|3825521|P1|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
1164931|NCT01212757|3825513|P9|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
1164932|NCT01212757|3825514|P8|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
1164933|NCT01212757|3825515|P7|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
1164934|NCT01212757|3825516|P6|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
1164935|NCT01212757|3825517|P5|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
1164936|NCT01212757|3825518|P4|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
1164937|NCT01212757|3825519|P3|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
1164938|NCT01212757|3825520|P2|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
1164939|NCT01212757|3825521|P1|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
1164940|NCT01212757|3825513|P9|Long-Term Safety Phase (Year 5)|Adverse Event|0
1164941|NCT01212757|3825514|P8|Long-Term Safety Phase (Year 5)|Adverse Event|2
1164942|NCT01212757|3825515|P7|Long-Term Safety Phase (Year 5)|Adverse Event|0
1164943|NCT01212757|3825516|P6|Long-Term Safety Phase (Year 5)|Adverse Event|0
1164944|NCT01212757|3825517|P5|Long-Term Safety Phase (Year 5)|Adverse Event|0
1164945|NCT01212757|3825518|P4|Long-Term Safety Phase (Year 5)|Adverse Event|0
1164946|NCT01212757|3825519|P3|Long-Term Safety Phase (Year 5)|Adverse Event|2
1164947|NCT01212757|3825520|P2|Long-Term Safety Phase (Year 5)|Adverse Event|2
1164948|NCT01212757|3825521|P1|Long-Term Safety Phase (Year 5)|Adverse Event|0
1164949|NCT01212757|3825513|P9|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
1164950|NCT01212757|3825514|P8|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
1164951|NCT01212757|3825515|P7|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
1164952|NCT01212757|3825516|P6|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
1164953|NCT01212757|3825517|P5|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
1164954|NCT01212757|3825518|P4|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
1164955|NCT01212757|3825519|P3|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
1164956|NCT01212757|3825520|P2|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
1164957|NCT01212757|3825521|P1|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
1164958|NCT01212757|3825513|P9|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
1164959|NCT01212757|3825514|P8|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1
1164960|NCT01212757|3825515|P7|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
1164961|NCT01212757|3825516|P6|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
1164962|NCT01212757|3825517|P5|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
1164963|NCT01212757|3825518|P4|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
1164964|NCT01212757|3825519|P3|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
1164965|NCT01212757|3825520|P2|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
1164966|NCT01212757|3825521|P1|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
1164967|NCT01212757|3825513|P9|Long-Term Safety Phase (Year 4)|Death|1
1164968|NCT01212757|3825514|P8|Long-Term Safety Phase (Year 4)|Death|0
1164969|NCT01212757|3825515|P7|Long-Term Safety Phase (Year 4)|Death|0
1164970|NCT01212757|3825516|P6|Long-Term Safety Phase (Year 4)|Death|0
1164971|NCT01212757|3825517|P5|Long-Term Safety Phase (Year 4)|Death|0
1164972|NCT01212757|3825518|P4|Long-Term Safety Phase (Year 4)|Death|0
1164973|NCT01212757|3825519|P3|Long-Term Safety Phase (Year 4)|Death|1
1164974|NCT01212757|3825520|P2|Long-Term Safety Phase (Year 4)|Death|0
1164975|NCT01212757|3825521|P1|Long-Term Safety Phase (Year 4)|Death|0
1164976|NCT01212757|3825513|P9|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3
1164977|NCT01212757|3825514|P8|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1
1164978|NCT01212757|3825515|P7|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
1164979|NCT01212757|3825516|P6|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
1164980|NCT01212757|3825517|P5|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
1164981|NCT01212757|3825518|P4|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
1164982|NCT01212757|3825519|P3|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2
1164983|NCT01212757|3825520|P2|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4
1164984|NCT01212757|3825521|P1|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
1164985|NCT01212757|3825513|P9|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
1164986|NCT01212757|3825514|P8|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
1164987|NCT01212757|3825515|P7|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
1164988|NCT01212757|3825516|P6|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
1164989|NCT01212757|3825517|P5|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
1164990|NCT01212757|3825518|P4|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
1164991|NCT01212757|3825519|P3|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
1164992|NCT01212757|3825520|P2|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
1164993|NCT01212757|3825521|P1|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
1164994|NCT01212757|3825513|P9|Long-Term Safety Phase (Year 4)|Adverse Event|1
1164995|NCT01212757|3825514|P8|Long-Term Safety Phase (Year 4)|Adverse Event|1
1164996|NCT01212757|3825515|P7|Long-Term Safety Phase (Year 4)|Adverse Event|0
1164997|NCT01212757|3825516|P6|Long-Term Safety Phase (Year 4)|Adverse Event|0
1164998|NCT01212757|3825517|P5|Long-Term Safety Phase (Year 4)|Adverse Event|0
1164999|NCT01212757|3825518|P4|Long-Term Safety Phase (Year 4)|Adverse Event|0
1165000|NCT01212757|3825519|P3|Long-Term Safety Phase (Year 4)|Adverse Event|2
1165001|NCT01212757|3825520|P2|Long-Term Safety Phase (Year 4)|Adverse Event|1
1165002|NCT01212757|3825521|P1|Long-Term Safety Phase (Year 4)|Adverse Event|0
1165003|NCT01212757|3825513|P9|Long-Term Safety Phase (Year 4)|Miscellaneous|1
1165004|NCT01212757|3825514|P8|Long-Term Safety Phase (Year 4)|Miscellaneous|0
1165005|NCT01212757|3825515|P7|Long-Term Safety Phase (Year 4)|Miscellaneous|0
1165006|NCT01212757|3825516|P6|Long-Term Safety Phase (Year 4)|Miscellaneous|0
1165007|NCT01212757|3825517|P5|Long-Term Safety Phase (Year 4)|Miscellaneous|0
1165008|NCT01212757|3825518|P4|Long-Term Safety Phase (Year 4)|Miscellaneous|0
1165009|NCT01212757|3825519|P3|Long-Term Safety Phase (Year 4)|Miscellaneous|0
1165010|NCT01212757|3825520|P2|Long-Term Safety Phase (Year 4)|Miscellaneous|2
1165011|NCT01212757|3825521|P1|Long-Term Safety Phase (Year 4)|Miscellaneous|0
1165012|NCT01212757|3825513|P9|Long-Term Safety Phase (Year 3)|Miscellaneous|2
1165013|NCT01212757|3825514|P8|Long-Term Safety Phase (Year 3)|Miscellaneous|0
1165014|NCT01212757|3825515|P7|Long-Term Safety Phase (Year 3)|Miscellaneous|0
1165015|NCT01212757|3825516|P6|Long-Term Safety Phase (Year 3)|Miscellaneous|0
1165016|NCT01212757|3825517|P5|Long-Term Safety Phase (Year 3)|Miscellaneous|0
1165017|NCT01212757|3825518|P4|Long-Term Safety Phase (Year 3)|Miscellaneous|0
1165018|NCT01212757|3825519|P3|Long-Term Safety Phase (Year 3)|Miscellaneous|3
1165319|NCT01211145|3826018|P3|Overall Study|Reason not specified|2
1165019|NCT01212757|3825520|P2|Long-Term Safety Phase (Year 3)|Miscellaneous|0
1165020|NCT01212757|3825521|P1|Long-Term Safety Phase (Year 3)|Miscellaneous|0
1165021|NCT01212757|3825513|P9|Long-Term Safety Phase (Year 3)|Protocol Violation|0
1165022|NCT01212757|3825514|P8|Long-Term Safety Phase (Year 3)|Protocol Violation|0
1165023|NCT01212757|3825515|P7|Long-Term Safety Phase (Year 3)|Protocol Violation|0
1165024|NCT01212757|3825516|P6|Long-Term Safety Phase (Year 3)|Protocol Violation|0
1165025|NCT01212757|3825517|P5|Long-Term Safety Phase (Year 3)|Protocol Violation|0
1165026|NCT01212757|3825518|P4|Long-Term Safety Phase (Year 3)|Protocol Violation|0
1165027|NCT01212757|3825519|P3|Long-Term Safety Phase (Year 3)|Protocol Violation|0
1165028|NCT01212757|3825520|P2|Long-Term Safety Phase (Year 3)|Protocol Violation|1
1165029|NCT01212757|3825521|P1|Long-Term Safety Phase (Year 3)|Protocol Violation|0
1165030|NCT01212757|3825513|P9|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1
1165031|NCT01212757|3825514|P8|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
1165032|NCT01212757|3825515|P7|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
1165033|NCT01212757|3825516|P6|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
1165034|NCT01212757|3825517|P5|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
1165035|NCT01212757|3825518|P4|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
1165036|NCT01212757|3825519|P3|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
1165037|NCT01212757|3825520|P2|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
1165038|NCT01212757|3825521|P1|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
1165039|NCT01212757|3825513|P9|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
1165040|NCT01212757|3825514|P8|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
1165041|NCT01212757|3825515|P7|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
1165042|NCT01212757|3825516|P6|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
1165043|NCT01212757|3825517|P5|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
1165044|NCT01212757|3825518|P4|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
1165045|NCT01212757|3825519|P3|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
1165046|NCT01212757|3825520|P2|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5
1165047|NCT01212757|3825521|P1|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
1165048|NCT01212757|3825513|P9|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
1165049|NCT01212757|3825514|P8|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
1165050|NCT01212757|3825515|P7|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
1165051|NCT01212757|3825516|P6|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
1165052|NCT01212757|3825517|P5|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
1165053|NCT01212757|3825518|P4|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
1165054|NCT01212757|3825519|P3|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1
1165055|NCT01212757|3825520|P2|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
1165056|NCT01212757|3825521|P1|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
1165057|NCT01212757|3825513|P9|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1
1165058|NCT01212757|3825514|P8|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3
1165059|NCT01212757|3825515|P7|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
1165060|NCT01212757|3825516|P6|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
1165061|NCT01212757|3825517|P5|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
1165062|NCT01212757|3825518|P4|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
1165063|NCT01212757|3825519|P3|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5
1165064|NCT01212757|3825520|P2|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8
1165065|NCT01212757|3825521|P1|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
1165066|NCT01212757|3825513|P9|Long-Term Safety Phase (Year 3)|Adverse Event|0
1165067|NCT01212757|3825514|P8|Long-Term Safety Phase (Year 3)|Adverse Event|2
1165068|NCT01212757|3825515|P7|Long-Term Safety Phase (Year 3)|Adverse Event|0
1165069|NCT01212757|3825516|P6|Long-Term Safety Phase (Year 3)|Adverse Event|0
1165070|NCT01212757|3825517|P5|Long-Term Safety Phase (Year 3)|Adverse Event|0
1165071|NCT01212757|3825518|P4|Long-Term Safety Phase (Year 3)|Adverse Event|0
1165072|NCT01212757|3825519|P3|Long-Term Safety Phase (Year 3)|Adverse Event|1
1165073|NCT01212757|3825520|P2|Long-Term Safety Phase (Year 3)|Adverse Event|4
1165074|NCT01212757|3825521|P1|Long-Term Safety Phase (Year 3)|Adverse Event|0
1165075|NCT01212757|3825513|P9|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
1165076|NCT01212757|3825514|P8|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
1165077|NCT01212757|3825515|P7|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
1165078|NCT01212757|3825516|P6|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
1165079|NCT01212757|3825517|P5|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
1165080|NCT01212757|3825518|P4|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
1165081|NCT01212757|3825519|P3|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2
1165082|NCT01212757|3825520|P2|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
1165083|NCT01212757|3825521|P1|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
1165084|NCT01212757|3825513|P9|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6
1165085|NCT01212757|3825514|P8|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4
1165086|NCT01212757|3825515|P7|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
1165087|NCT01212757|3825516|P6|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
1165088|NCT01212757|3825517|P5|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
1165089|NCT01212757|3825518|P4|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
1165090|NCT01212757|3825519|P3|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9
1165091|NCT01212757|3825520|P2|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7
1165092|NCT01212757|3825521|P1|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
1165093|NCT01212757|3825513|P9|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
1165094|NCT01212757|3825514|P8|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
1165095|NCT01212757|3825515|P7|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
1165096|NCT01212757|3825516|P6|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
1165097|NCT01212757|3825517|P5|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
1165098|NCT01212757|3825518|P4|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
1165099|NCT01212757|3825519|P3|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2
1165100|NCT01212757|3825520|P2|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
1165101|NCT01212757|3825521|P1|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
1165102|NCT01212757|3825513|P9|Long-Term Safety Phase (Year 2)|Adverse Event|2
1165103|NCT01212757|3825514|P8|Long-Term Safety Phase (Year 2)|Adverse Event|2
1165104|NCT01212757|3825515|P7|Long-Term Safety Phase (Year 2)|Adverse Event|0
1165105|NCT01212757|3825516|P6|Long-Term Safety Phase (Year 2)|Adverse Event|0
1165106|NCT01212757|3825517|P5|Long-Term Safety Phase (Year 2)|Adverse Event|0
1165107|NCT01212757|3825518|P4|Long-Term Safety Phase (Year 2)|Adverse Event|0
1165108|NCT01212757|3825519|P3|Long-Term Safety Phase (Year 2)|Adverse Event|1
1165109|NCT01212757|3825520|P2|Long-Term Safety Phase (Year 2)|Adverse Event|1
1165110|NCT01212757|3825521|P1|Long-Term Safety Phase (Year 2)|Adverse Event|0
1165111|NCT01212757|3825513|P9|Long-Term Safety Phase (Year 2)|Miscellaneous|1
1165112|NCT01212757|3825514|P8|Long-Term Safety Phase (Year 2)|Miscellaneous|0
1165113|NCT01212757|3825515|P7|Long-Term Safety Phase (Year 2)|Miscellaneous|0
1165114|NCT01212757|3825516|P6|Long-Term Safety Phase (Year 2)|Miscellaneous|0
1165115|NCT01212757|3825517|P5|Long-Term Safety Phase (Year 2)|Miscellaneous|0
1165116|NCT01212757|3825518|P4|Long-Term Safety Phase (Year 2)|Miscellaneous|0
1165117|NCT01212757|3825519|P3|Long-Term Safety Phase (Year 2)|Miscellaneous|0
1165118|NCT01212757|3825520|P2|Long-Term Safety Phase (Year 2)|Miscellaneous|0
1165119|NCT01212757|3825521|P1|Long-Term Safety Phase (Year 2)|Miscellaneous|0
1165120|NCT01212757|3825513|P9|Active Treatment Phase (Weeks 24 - 52)|Other|0
1165121|NCT01212757|3825514|P8|Active Treatment Phase (Weeks 24 - 52)|Other|0
1165122|NCT01212757|3825515|P7|Active Treatment Phase (Weeks 24 - 52)|Other|0
1165123|NCT01212757|3825516|P6|Active Treatment Phase (Weeks 24 - 52)|Other|0
1165124|NCT01212757|3825517|P5|Active Treatment Phase (Weeks 24 - 52)|Other|0
1165125|NCT01212757|3825518|P4|Active Treatment Phase (Weeks 24 - 52)|Other|0
1165126|NCT01212757|3825519|P3|Active Treatment Phase (Weeks 24 - 52)|Other|1
1165127|NCT01212757|3825520|P2|Active Treatment Phase (Weeks 24 - 52)|Other|1
1165128|NCT01212757|3825521|P1|Active Treatment Phase (Weeks 24 - 52)|Other|0
1165129|NCT01212757|3825513|P9|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
1165130|NCT01212757|3825514|P8|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
1165131|NCT01212757|3825515|P7|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
1165132|NCT01212757|3825516|P6|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
1165133|NCT01212757|3825517|P5|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
1165134|NCT01212757|3825518|P4|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
1165135|NCT01212757|3825519|P3|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
1165136|NCT01212757|3825520|P2|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
1165137|NCT01212757|3825521|P1|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
1165138|NCT01212757|3825513|P9|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
1165139|NCT01212757|3825514|P8|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
1165140|NCT01212757|3825515|P7|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
1165141|NCT01212757|3825516|P6|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
1165142|NCT01212757|3825517|P5|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1
1165143|NCT01212757|3825518|P4|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
1165144|NCT01212757|3825519|P3|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7
1165145|NCT01212757|3825520|P2|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
1165146|NCT01212757|3825521|P1|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
1165147|NCT01212757|3825513|P9|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
1165148|NCT01212757|3825514|P8|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
1165149|NCT01212757|3825515|P7|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
1165150|NCT01212757|3825516|P6|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
1165151|NCT01212757|3825517|P5|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
1165152|NCT01212757|3825518|P4|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
1165153|NCT01212757|3825519|P3|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2
1165154|NCT01212757|3825520|P2|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
1165155|NCT01212757|3825521|P1|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
1165156|NCT01212757|3825513|P9|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
1165157|NCT01212757|3825514|P8|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
1165158|NCT01212757|3825515|P7|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
1165159|NCT01212757|3825516|P6|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2
1165160|NCT01212757|3825517|P5|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
1165161|NCT01212757|3825518|P4|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4
1165162|NCT01212757|3825519|P3|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7
1165163|NCT01212757|3825520|P2|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5
1165164|NCT01212757|3825521|P1|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
1165165|NCT01212757|3825513|P9|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
1165166|NCT01212757|3825514|P8|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
1165167|NCT01212757|3825515|P7|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
1165168|NCT01212757|3825516|P6|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
1165169|NCT01212757|3825517|P5|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
1165170|NCT01212757|3825518|P4|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1
1165171|NCT01212757|3825519|P3|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3
1165172|NCT01212757|3825520|P2|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
1165173|NCT01212757|3825521|P1|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
1165174|NCT01212757|3825513|P9|Placebo-controlled Phase (Week 0 - 24)|Other|0
1165175|NCT01212757|3825514|P8|Placebo-controlled Phase (Week 0 - 24)|Other|0
1165176|NCT01212757|3825515|P7|Placebo-controlled Phase (Week 0 - 24)|Other|0
1165177|NCT01212757|3825516|P6|Placebo-controlled Phase (Week 0 - 24)|Other|0
1165178|NCT01212757|3825517|P5|Placebo-controlled Phase (Week 0 - 24)|Other|0
1165179|NCT01212757|3825518|P4|Placebo-controlled Phase (Week 0 - 24)|Other|0
1165180|NCT01212757|3825519|P3|Placebo-controlled Phase (Week 0 - 24)|Other|0
1165181|NCT01212757|3825520|P2|Placebo-controlled Phase (Week 0 - 24)|Other|2
1165182|NCT01212757|3825521|P1|Placebo-controlled Phase (Week 0 - 24)|Other|1
1165183|NCT01212757|3825513|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1165184|NCT01212757|3825514|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1165185|NCT01212757|3825515|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1165186|NCT01212757|3825516|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1165187|NCT01212757|3825517|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1165188|NCT01212757|3825518|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1165189|NCT01212757|3825519|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
1165190|NCT01212757|3825520|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
1165191|NCT01212757|3825521|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1165192|NCT01212757|3825513|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1165193|NCT01212757|3825514|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1165194|NCT01212757|3825515|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1165195|NCT01212757|3825516|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1165196|NCT01212757|3825517|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1165197|NCT01212757|3825518|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1165198|NCT01212757|3825519|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
1165199|NCT01212757|3825520|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
1165200|NCT01212757|3825521|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
1165201|NCT01212757|3825513|P9|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1165202|NCT01212757|3825514|P8|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1165203|NCT01212757|3825515|P7|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1165204|NCT01212757|3825516|P6|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1165205|NCT01212757|3825517|P5|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1165206|NCT01212757|3825518|P4|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1165207|NCT01212757|3825519|P3|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
1165208|NCT01212757|3825520|P2|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1165209|NCT01212757|3825521|P1|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3
1165210|NCT01212757|3825513|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1165211|NCT01212757|3825514|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1165212|NCT01212757|3825515|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1165213|NCT01212757|3825516|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1165214|NCT01212757|3825517|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1165215|NCT01212757|3825518|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1165216|NCT01212757|3825519|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
1165217|NCT01212757|3825520|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9
1165218|NCT01212757|3825521|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7
1165219|NCT01212757|3825513|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1165220|NCT01212757|3825514|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1165221|NCT01212757|3825515|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1165222|NCT01212757|3825516|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1165223|NCT01212757|3825517|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1165224|NCT01212757|3825518|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1165225|NCT01212757|3825519|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
1165226|NCT01212757|3825520|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
1165227|NCT01212757|3825521|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
1165228|NCT01212757|3825513|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1165229|NCT01212757|3825514|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1165230|NCT01212757|3825515|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1165231|NCT01212757|3825516|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1165232|NCT01212757|3825517|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1165233|NCT01212757|3825518|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1165234|NCT01212757|3825519|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
1165235|NCT01212757|3825520|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
1165236|NCT01212757|3825521|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
1165237|NCT01212185|3825760|P2|Overall Study|Protocol Violation|1
1165238|NCT01212185|3825761|P1|Overall Study|Protocol Violation|2
1165239|NCT01212159|3825780|P2|Overall Study|Withdrawal by Subject|12
1165240|NCT01212159|3825781|P1|Overall Study|Withdrawal by Subject|12
1165241|NCT01212094|3825794|P3|Years 2 & 3: Treatment Randomization|Adverse Event|1
1165242|NCT01212094|3825795|P2|Years 2 & 3: Treatment Randomization|Adverse Event|0
1165243|NCT01212094|3825796|P1|Years 2 & 3: Treatment Randomization|Adverse Event|0
1165244|NCT01212094|3825794|P3|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3
1165245|NCT01212094|3825795|P2|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
1165246|NCT01212094|3825796|P1|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
1165247|NCT01212094|3825794|P3|Years 2 & 3: Treatment Randomization|Study terminated|7
1165248|NCT01212094|3825795|P2|Years 2 & 3: Treatment Randomization|Study terminated|4
1165249|NCT01212094|3825796|P1|Years 2 & 3: Treatment Randomization|Study terminated|0
1165250|NCT01212094|3825794|P3|Year 1: Baseline Monitoring|Started on DMT|0
1165251|NCT01212094|3825795|P2|Year 1: Baseline Monitoring|Started on DMT|0
1165252|NCT01212094|3825796|P1|Year 1: Baseline Monitoring|Started on DMT|2
1165253|NCT01212094|3825794|P3|Year 1: Baseline Monitoring|Withdrawal by Subject|0
1165254|NCT01212094|3825795|P2|Year 1: Baseline Monitoring|Withdrawal by Subject|0
1165255|NCT01212094|3825796|P1|Year 1: Baseline Monitoring|Withdrawal by Subject|7
1165256|NCT01212094|3825794|P3|Year 1: Baseline Monitoring|Study terminated|0
1165257|NCT01212094|3825795|P2|Year 1: Baseline Monitoring|Study terminated|0
1165258|NCT01212094|3825796|P1|Year 1: Baseline Monitoring|Study terminated|7
1165259|NCT01211769|3825843|P4|Overall Study|Adverse Event|1
1165260|NCT01211769|3825844|P3|Overall Study|Adverse Event|1
1165261|NCT01211769|3825845|P2|Overall Study|Adverse Event|1
1165262|NCT01211769|3825846|P1|Overall Study|Adverse Event|0
1165263|NCT01211769|3825843|P4|Overall Study|Physician Decision|1
1165264|NCT01211769|3825844|P3|Overall Study|Physician Decision|2
1165265|NCT01211769|3825845|P2|Overall Study|Physician Decision|0
1165266|NCT01211769|3825846|P1|Overall Study|Physician Decision|2
1165267|NCT01211769|3825843|P4|Overall Study|Lost to Follow-up|9
1165268|NCT01211769|3825844|P3|Overall Study|Lost to Follow-up|5
1165269|NCT01211769|3825845|P2|Overall Study|Lost to Follow-up|9
1165270|NCT01211769|3825846|P1|Overall Study|Lost to Follow-up|7
1165271|NCT01211665|3825885|P2|Overall Study|Death|0
1165272|NCT01211665|3825886|P1|Overall Study|Death|1
1165273|NCT01211665|3825885|P2|Overall Study|Withdrawal by Subject|0
1165274|NCT01211665|3825886|P1|Overall Study|Withdrawal by Subject|1
1165275|NCT01211613|3825913|P3|Overall Study|Withdrawal by Subject|0
1165276|NCT01211613|3825914|P2|Overall Study|Withdrawal by Subject|0
1165277|NCT01211613|3825915|P1|Overall Study|Withdrawal by Subject|1
1165278|NCT01211613|3825913|P3|Overall Study|Lost to Follow-up|2
1165279|NCT01211613|3825914|P2|Overall Study|Lost to Follow-up|2
1165280|NCT01211613|3825915|P1|Overall Study|Lost to Follow-up|2
1165281|NCT01211535|3825928|P2|Overall Study|Adverse Event|1
1165282|NCT01211535|3825929|P1|Overall Study|Adverse Event|0
1165283|NCT01211197|3825948|P6|Washout Period 2 (7 Days)|Adverse Event|0
1165284|NCT01211197|3825949|P5|Washout Period 2 (7 Days)|Adverse Event|0
1165285|NCT01211197|3825950|P4|Washout Period 2 (7 Days)|Adverse Event|0
1165286|NCT01211197|3825951|P3|Washout Period 2 (7 Days)|Adverse Event|0
1165287|NCT01211197|3825952|P2|Washout Period 2 (7 Days)|Adverse Event|0
1165288|NCT01211197|3825953|P1|Washout Period 2 (7 Days)|Adverse Event|1
1165289|NCT01211197|3825948|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1165290|NCT01211197|3825949|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1165291|NCT01211197|3825950|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1165292|NCT01211197|3825951|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|1
1165293|NCT01211197|3825952|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1165294|NCT01211197|3825953|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1165295|NCT01211184|3826000|P3|Overall Study|Withdrawal by Subject|1
1165296|NCT01211184|3826001|P2|Overall Study|Withdrawal by Subject|2
1165297|NCT01211184|3826002|P1|Overall Study|Withdrawal by Subject|0
1165298|NCT01211145|3826017|P4|Overall Study|Patient decision|2
1165299|NCT01211145|3826018|P3|Overall Study|Patient decision|0
1165300|NCT01211145|3826019|P2|Overall Study|Patient decision|1
1165301|NCT01211145|3826020|P1|Overall Study|Patient decision|2
1165302|NCT01211145|3826017|P4|Overall Study|Eligibility criteria not fulfilled|15
1165303|NCT01211145|3826018|P3|Overall Study|Eligibility criteria not fulfilled|10
1165304|NCT01211145|3826019|P2|Overall Study|Eligibility criteria not fulfilled|12
1165305|NCT01211145|3826020|P1|Overall Study|Eligibility criteria not fulfilled|16
1165306|NCT01211145|3826017|P4|Overall Study|Severe noncompliance to protocol|0
1165307|NCT01211145|3826018|P3|Overall Study|Severe noncompliance to protocol|0
1165308|NCT01211145|3826019|P2|Overall Study|Severe noncompliance to protocol|0
1165309|NCT01211145|3826020|P1|Overall Study|Severe noncompliance to protocol|1
1165310|NCT01211145|3826017|P4|Overall Study|Study-specific withdrawal criteria|0
1165311|NCT01211145|3826018|P3|Overall Study|Study-specific withdrawal criteria|0
1165312|NCT01211145|3826019|P2|Overall Study|Study-specific withdrawal criteria|0
1165313|NCT01211145|3826020|P1|Overall Study|Study-specific withdrawal criteria|1
1165314|NCT01211145|3826017|P4|Overall Study|Lost to Follow-up|2
1165315|NCT01211145|3826018|P3|Overall Study|Lost to Follow-up|1
1165316|NCT01211145|3826019|P2|Overall Study|Lost to Follow-up|2
1165317|NCT01211145|3826020|P1|Overall Study|Lost to Follow-up|3
1165320|NCT01211145|3826019|P2|Overall Study|Reason not specified|2
1165321|NCT01211145|3826020|P1|Overall Study|Reason not specified|3
1165322|NCT01210807|3826074|P2|Overall Study|Not implanted bilaterally|1
1165323|NCT01210807|3826075|P1|Overall Study|Not implanted bilaterally|2
1165324|NCT01210807|3826074|P2|Overall Study|Lost to Follow-up|2
1165325|NCT01210807|3826075|P1|Overall Study|Lost to Follow-up|1
1165326|NCT01210690|3826090|P1|Overall Study|Patient could not take glucose|1
1165327|NCT01210690|3826090|P1|Overall Study|Patient refused to swallow|1
1165328|NCT01210690|3826090|P1|Overall Study|Withdrawal by Subject|1
1165329|NCT01210690|3826090|P1|Overall Study|Disease Remission|1
1165330|NCT01210690|3826090|P1|Overall Study|Lost to Follow-up|3
1165331|NCT01210690|3826090|P1|Overall Study|Lack of Efficacy|12
1165332|NCT01210690|3826090|P1|Overall Study|Adverse Event|7
1165333|NCT01210664|3826103|P4|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1
1165334|NCT01210664|3826104|P3|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
1165335|NCT01210664|3826105|P2|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
1165336|NCT01210664|3826106|P1|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
1165337|NCT01210664|3826103|P4|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
1165338|NCT01210664|3826104|P3|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1
1165339|NCT01210664|3826105|P2|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
1165340|NCT01210664|3826106|P1|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
1165341|NCT01210664|3826103|P4|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
1165342|NCT01210664|3826104|P3|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1
1165343|NCT01210664|3826105|P2|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
1165344|NCT01210664|3826106|P1|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
1165345|NCT01210651|3826134|P2|Overall Study|Injury outside study|0
1165346|NCT01210651|3826135|P1|Overall Study|Injury outside study|2
1165347|NCT01210651|3826134|P2|Overall Study|Withdrawal by Subject|1
1165348|NCT01210651|3826135|P1|Overall Study|Withdrawal by Subject|1
1165349|NCT01210651|3826134|P2|Overall Study|Withdrawn by PI for disruptive behavior|1
1165350|NCT01210651|3826135|P1|Overall Study|Withdrawn by PI for disruptive behavior|0
1165351|NCT01210651|3826134|P2|Overall Study|schedule conflicts|5
1165352|NCT01210651|3826135|P1|Overall Study|schedule conflicts|1
1165353|NCT01210651|3826134|P2|Overall Study|Lost to Follow-up|1
1165354|NCT01210651|3826135|P1|Overall Study|Lost to Follow-up|1
1165355|NCT01210495|3826255|P4|Overall Study|Other unspecified|0
1165356|NCT01210495|3826256|P3|Overall Study|Other unspecified|6
1165357|NCT01210495|3826257|P2|Overall Study|Other unspecified|0
1165358|NCT01210495|3826258|P1|Overall Study|Other unspecified|0
1165359|NCT01210495|3826255|P4|Overall Study|Lost to Follow-up|1
1165360|NCT01210495|3826256|P3|Overall Study|Lost to Follow-up|1
1165361|NCT01210495|3826257|P2|Overall Study|Lost to Follow-up|0
1165362|NCT01210495|3826258|P1|Overall Study|Lost to Follow-up|0
1165363|NCT01210495|3826255|P4|Overall Study|Study Terminated by Sponsor|11
1165364|NCT01210495|3826256|P3|Overall Study|Study Terminated by Sponsor|4
1165365|NCT01210495|3826257|P2|Overall Study|Study Terminated by Sponsor|0
1165366|NCT01210495|3826258|P1|Overall Study|Study Terminated by Sponsor|0
1165367|NCT01210495|3826255|P4|Overall Study|Death|54
1165368|NCT01210495|3826256|P3|Overall Study|Death|112
1165369|NCT01210495|3826257|P2|Overall Study|Death|7
1165370|NCT01210495|3826258|P1|Overall Study|Death|14
1165371|NCT01210495|3826255|P4|Overall Study|Participant Refused Further Follow-Up|2
1165372|NCT01210495|3826256|P3|Overall Study|Participant Refused Further Follow-Up|11
1165373|NCT01210495|3826257|P2|Overall Study|Participant Refused Further Follow-Up|0
1165374|NCT01210495|3826258|P1|Overall Study|Participant Refused Further Follow-Up|1
1165375|NCT01210443|3826320|P1|Overall Study|Study terminated by sponsor|2
1165376|NCT01210222|3826328|P1|Overall Study|Never treated|1
1165377|NCT01210222|3826328|P1|Overall Study|Ineligible|2
1165378|NCT01210144|3826364|P2|Overall Study|No transfer|0
1165379|NCT01210144|3826365|P1|Overall Study|No transfer|1
1165380|NCT01210144|3826364|P2|Overall Study|No fertilization|0
1165381|NCT01210144|3826365|P1|Overall Study|No fertilization|1
1165382|NCT01210144|3826364|P2|Overall Study|Lack of ovarian response|0
1165383|NCT01210144|3826365|P1|Overall Study|Lack of ovarian response|1
1165384|NCT01210118|3826387|P2|Overall Study|Spontaneous abortion|3
1165385|NCT01210118|3826388|P1|Overall Study|Spontaneous abortion|1
1165386|NCT01210118|3826387|P2|Overall Study|Protocol Violation|1
1165387|NCT01210118|3826388|P1|Overall Study|Protocol Violation|1
1165388|NCT01210118|3826387|P2|Overall Study|Lost to Follow-up|1
1165389|NCT01210118|3826388|P1|Overall Study|Lost to Follow-up|1
1165390|NCT01210001|3826412|P3|Overall Study|Other reason not defined above|1
1165391|NCT01210001|3826413|P2|Overall Study|Other reason not defined above|2
1165392|NCT01210001|3826414|P1|Overall Study|Other reason not defined above|2
1165393|NCT01210001|3826412|P3|Overall Study|Patient refusal to continue,not due toAE|1
1165394|NCT01210001|3826413|P2|Overall Study|Patient refusal to continue,not due toAE|2
1165395|NCT01210001|3826414|P1|Overall Study|Patient refusal to continue,not due toAE|6
1165396|NCT01210001|3826412|P3|Overall Study|Lost to Follow-up|2
1165397|NCT01210001|3826413|P2|Overall Study|Lost to Follow-up|3
1165398|NCT01210001|3826414|P1|Overall Study|Lost to Follow-up|4
1165399|NCT01210001|3826412|P3|Overall Study|Non compliant with protocol|3
1165400|NCT01210001|3826413|P2|Overall Study|Non compliant with protocol|2
1165401|NCT01210001|3826414|P1|Overall Study|Non compliant with protocol|2
1165402|NCT01210001|3826412|P3|Overall Study|Adverse Event|5
1165403|NCT01210001|3826413|P2|Overall Study|Adverse Event|2
1165404|NCT01210001|3826414|P1|Overall Study|Adverse Event|4
1165405|NCT01210001|3826412|P3|Overall Study|Not treated|0
1165406|NCT01210001|3826413|P2|Overall Study|Not treated|0
1165407|NCT01210001|3826414|P1|Overall Study|Not treated|1
1165408|NCT01209949|3826434|P1|Overall Study|Lost to Follow-up|3
1165409|NCT01209780|3826444|P5|Overall Study|Inappropriate enrollment|1
1165410|NCT01209780|3826445|P4|Overall Study|Inappropriate enrollment|0
1165411|NCT01209780|3826446|P3|Overall Study|Inappropriate enrollment|0
1165412|NCT01209780|3826447|P2|Overall Study|Inappropriate enrollment|2
1165413|NCT01209780|3826448|P1|Overall Study|Inappropriate enrollment|0
1165414|NCT01209780|3826444|P5|Overall Study|Protocol Violation|0
1165415|NCT01209780|3826445|P4|Overall Study|Protocol Violation|0
1165416|NCT01209780|3826446|P3|Overall Study|Protocol Violation|0
1165417|NCT01209780|3826447|P2|Overall Study|Protocol Violation|1
1165418|NCT01209780|3826448|P1|Overall Study|Protocol Violation|0
1165419|NCT01209780|3826444|P5|Overall Study|Lost to Follow-up|4
1165420|NCT01209780|3826445|P4|Overall Study|Lost to Follow-up|9
1165421|NCT01209780|3826446|P3|Overall Study|Lost to Follow-up|3
1165422|NCT01209780|3826447|P2|Overall Study|Lost to Follow-up|12
1165423|NCT01209780|3826448|P1|Overall Study|Lost to Follow-up|17
1165424|NCT01209780|3826444|P5|Overall Study|Withdrawal by Subject|0
1165425|NCT01209780|3826445|P4|Overall Study|Withdrawal by Subject|1
1165426|NCT01209780|3826446|P3|Overall Study|Withdrawal by Subject|1
1165427|NCT01209780|3826447|P2|Overall Study|Withdrawal by Subject|2
1165428|NCT01209780|3826448|P1|Overall Study|Withdrawal by Subject|9
1165429|NCT01209780|3826444|P5|Overall Study|Adverse Event|0
1165430|NCT01209780|3826445|P4|Overall Study|Adverse Event|0
1165431|NCT01209780|3826446|P3|Overall Study|Adverse Event|0
1165432|NCT01209780|3826447|P2|Overall Study|Adverse Event|1
1165433|NCT01209780|3826448|P1|Overall Study|Adverse Event|0
1165434|NCT01209767|3826474|P1|Overall Study|Lost to Follow-up|3
1165435|NCT01209767|3826474|P1|Overall Study|Withdrawal by Subject|1
1165436|NCT01209689|3826543|P2|Overall Study|Sponsor's Decision to Stop the Study|17
1165437|NCT01209689|3826544|P1|Overall Study|Sponsor's Decision to Stop the Study|68
1165438|NCT01209689|3826543|P2|Overall Study|Failure to Return|0
1165439|NCT01209689|3826544|P1|Overall Study|Failure to Return|3
1165440|NCT01209689|3826543|P2|Overall Study|Violation of Selection Criteria at Entry|0
1165441|NCT01209689|3826544|P1|Overall Study|Violation of Selection Criteria at Entry|1
1165442|NCT01209689|3826543|P2|Overall Study|Adverse Event|0
1165443|NCT01209689|3826544|P1|Overall Study|Adverse Event|4
1165444|NCT01209689|3826543|P2|Overall Study|Refused Treatment|3
1165445|NCT01209689|3826544|P1|Overall Study|Refused Treatment|8
1165446|NCT01209689|3826543|P2|Overall Study|Insufficient Therapeutic Response|2
1165447|NCT01209689|3826544|P1|Overall Study|Insufficient Therapeutic Response|7
1165448|NCT01209624|3826550|P1|Overall Study|Other|4
1165449|NCT01209624|3826550|P1|Overall Study|Lost to Follow-up|290
1165450|NCT01209624|3826550|P1|Overall Study|Lack of Efficacy|17
1165451|NCT01209624|3826550|P1|Overall Study|Adverse Event|13
1165452|NCT01209624|3826550|P1|Overall Study|Death|2
1165453|NCT01209598|3826583|P2|Overall Study|Withdrawal by Subject|0
1165454|NCT01209598|3826584|P1|Overall Study|Withdrawal by Subject|1
1165455|NCT01209520|3826592|P1|Overall Study|Withdrawal by Subject|3
1165456|NCT01209286|3826600|P3|Overall Study|Other|0
1165457|NCT01209286|3826601|P2|Overall Study|Other|1
1165458|NCT01209286|3826602|P1|Overall Study|Other|0
1165459|NCT01209286|3826600|P3|Overall Study|Physician Decision|0
1165460|NCT01209286|3826601|P2|Overall Study|Physician Decision|2
1165461|NCT01209286|3826602|P1|Overall Study|Physician Decision|0
1165462|NCT01209286|3826600|P3|Overall Study|Remission Not Achieved in 2 Cycles|1
1165463|NCT01209286|3826601|P2|Overall Study|Remission Not Achieved in 2 Cycles|3
1165464|NCT01209286|3826602|P1|Overall Study|Remission Not Achieved in 2 Cycles|1
1165465|NCT01209286|3826600|P3|Overall Study|Hematological Relapse After Remission|1
1165466|NCT01209286|3826601|P2|Overall Study|Hematological Relapse After Remission|1
1165467|NCT01209286|3826602|P1|Overall Study|Hematological Relapse After Remission|0
1165468|NCT01209286|3826600|P3|Overall Study|Adverse Event|1
1165469|NCT01209286|3826601|P2|Overall Study|Adverse Event|3
1165470|NCT01209286|3826602|P1|Overall Study|Adverse Event|4
1165471|NCT01209143|3826711|P2|Overall Study|Disease progression|16
1165472|NCT01209143|3826712|P1|Overall Study|Disease progression|11
1165473|NCT01209143|3826711|P2|Overall Study|Withdrawal by Subject|1
1165474|NCT01209143|3826712|P1|Overall Study|Withdrawal by Subject|2
1165475|NCT01209143|3826711|P2|Overall Study|Lost to Follow-up|0
1165476|NCT01209143|3826712|P1|Overall Study|Lost to Follow-up|1
1165477|NCT01209143|3826711|P2|Overall Study|Physician Decision|1
1165478|NCT01209143|3826712|P1|Overall Study|Physician Decision|3
1165479|NCT01209143|3826711|P2|Overall Study|Death|1
1165480|NCT01209143|3826712|P1|Overall Study|Death|0
1165481|NCT01209143|3826711|P2|Overall Study|Adverse Event|1
1165482|NCT01209143|3826712|P1|Overall Study|Adverse Event|2
1165483|NCT01209078|3826722|P2|Overall Study|Withdrawal by Subject|1
1165484|NCT01209078|3826723|P1|Overall Study|Withdrawal by Subject|2
1165485|NCT01209078|3826722|P2|Overall Study|Physician Decision|2
1165486|NCT01209078|3826723|P1|Overall Study|Physician Decision|5
1165487|NCT01209078|3826722|P2|Overall Study|Lost to Follow-up|0
1165488|NCT01209078|3826723|P1|Overall Study|Lost to Follow-up|4
1165489|NCT01209078|3826722|P2|Overall Study|Adverse Event|0
1165490|NCT01209078|3826723|P1|Overall Study|Adverse Event|5
1165491|NCT01208961|3826798|P2|High-Fat Period III|Protocol Violation|0
1165492|NCT01208961|3826799|P1|High-Fat Period III|Protocol Violation|1
1165493|NCT01208870|3826810|P2|Overall Study|Lost to Follow-up|8
1165494|NCT01208870|3826811|P1|Overall Study|Lost to Follow-up|2
1165495|NCT01208415|3826827|P1|Overall Study|Still be eligible for follow-up|33
1165496|NCT01208415|3826827|P1|Overall Study|Device not placed|1
1165497|NCT01208415|3826827|P1|Overall Study|Withdrawal by Subject|3
1165498|NCT01208415|3826827|P1|Overall Study|Lost to Follow-up|2
1165499|NCT01208415|3826827|P1|Overall Study|Death|1
1165500|NCT01208402|3826833|P2|Overall Study|Withdrawal by Subject|0
1165501|NCT01208402|3826834|P1|Overall Study|Withdrawal by Subject|1
1165502|NCT01208337|3826850|P1|Overall Study|Death|3
1165503|NCT01208233|3826864|P6|Overall Study|Withdrawal by Subject|2
1165504|NCT01208233|3826865|P5|Overall Study|Withdrawal by Subject|4
1165505|NCT01208233|3826866|P4|Overall Study|Withdrawal by Subject|1
1165506|NCT01208233|3826867|P3|Overall Study|Withdrawal by Subject|1
1165507|NCT01208233|3826868|P2|Overall Study|Withdrawal by Subject|0
1165508|NCT01208233|3826869|P1|Overall Study|Withdrawal by Subject|1
1165509|NCT01208233|3826864|P6|Overall Study|Other|1
1165510|NCT01208233|3826865|P5|Overall Study|Other|0
1165511|NCT01208233|3826866|P4|Overall Study|Other|0
1165512|NCT01208233|3826867|P3|Overall Study|Other|0
1165513|NCT01208233|3826868|P2|Overall Study|Other|1
1165514|NCT01208233|3826869|P1|Overall Study|Other|2
1165515|NCT01208233|3826864|P6|Overall Study|Protocol Violation|0
1165516|NCT01208233|3826865|P5|Overall Study|Protocol Violation|3
1165517|NCT01208233|3826866|P4|Overall Study|Protocol Violation|0
1165518|NCT01208233|3826867|P3|Overall Study|Protocol Violation|0
1165519|NCT01208233|3826868|P2|Overall Study|Protocol Violation|0
1165520|NCT01208233|3826869|P1|Overall Study|Protocol Violation|0
1165521|NCT01208233|3826864|P6|Overall Study|Study terminated by sponsor|7
1165522|NCT01208233|3826865|P5|Overall Study|Study terminated by sponsor|10
1165523|NCT01208233|3826866|P4|Overall Study|Study terminated by sponsor|0
1165524|NCT01208233|3826867|P3|Overall Study|Study terminated by sponsor|0
1165525|NCT01208233|3826868|P2|Overall Study|Study terminated by sponsor|0
1165526|NCT01208233|3826869|P1|Overall Study|Study terminated by sponsor|0
1165527|NCT01208233|3826864|P6|Overall Study|Medication error without adverse event|1
1165528|NCT01208233|3826865|P5|Overall Study|Medication error without adverse event|0
1165529|NCT01208233|3826866|P4|Overall Study|Medication error without adverse event|0
1165530|NCT01208233|3826867|P3|Overall Study|Medication error without adverse event|0
1165531|NCT01208233|3826868|P2|Overall Study|Medication error without adverse event|0
1165532|NCT01208233|3826869|P1|Overall Study|Medication error without adverse event|0
1165533|NCT01208233|3826864|P6|Overall Study|Did not meet entrance criteria|0
1165534|NCT01208233|3826865|P5|Overall Study|Did not meet entrance criteria|1
1165535|NCT01208233|3826866|P4|Overall Study|Did not meet entrance criteria|0
1165536|NCT01208233|3826867|P3|Overall Study|Did not meet entrance criteria|1
1165537|NCT01208233|3826868|P2|Overall Study|Did not meet entrance criteria|1
1165538|NCT01208233|3826869|P1|Overall Study|Did not meet entrance criteria|2
1165539|NCT01208233|3826864|P6|Overall Study|Death|5
1165540|NCT01208233|3826865|P5|Overall Study|Death|3
1165541|NCT01208233|3826866|P4|Overall Study|Death|0
1165542|NCT01208233|3826867|P3|Overall Study|Death|0
1165543|NCT01208233|3826868|P2|Overall Study|Death|0
1165544|NCT01208233|3826869|P1|Overall Study|Death|0
1165545|NCT01208233|3826864|P6|Overall Study|Adverse Event|5
1165546|NCT01208233|3826865|P5|Overall Study|Adverse Event|3
1165547|NCT01208233|3826866|P4|Overall Study|Adverse Event|0
1165548|NCT01208233|3826867|P3|Overall Study|Adverse Event|2
1165549|NCT01208233|3826868|P2|Overall Study|Adverse Event|1
1165550|NCT01208233|3826869|P1|Overall Study|Adverse Event|0
1165551|NCT01208207|3826994|P7|Part II|Technical Problems|0
1165552|NCT01208207|3826995|P6|Part II|Technical Problems|1
1165553|NCT01208207|3826996|P5|Part II|Technical Problems|0
1165554|NCT01208207|3826997|P4|Part II|Technical Problems|1
1165555|NCT01208207|3826998|P3|Part II|Technical Problems|0
1165556|NCT01208207|3826999|P2|Part II|Technical Problems|0
1165557|NCT01208207|3827000|P1|Part II|Technical Problems|0
1165558|NCT01208207|3826994|P7|Part II|Protocol Violation|0
1165559|NCT01208207|3826995|P6|Part II|Protocol Violation|0
1165560|NCT01208207|3826996|P5|Part II|Protocol Violation|0
1165561|NCT01208207|3826997|P4|Part II|Protocol Violation|1
1165562|NCT01208207|3826998|P3|Part II|Protocol Violation|0
1165563|NCT01208207|3826999|P2|Part II|Protocol Violation|0
1165564|NCT01208207|3827000|P1|Part II|Protocol Violation|0
1165565|NCT01208207|3826994|P7|Part II|Physician Decision|0
1165566|NCT01208207|3826995|P6|Part II|Physician Decision|2
1165567|NCT01208207|3826996|P5|Part II|Physician Decision|0
1165568|NCT01208207|3826997|P4|Part II|Physician Decision|1
1165569|NCT01208207|3826998|P3|Part II|Physician Decision|0
1165570|NCT01208207|3826999|P2|Part II|Physician Decision|0
1165571|NCT01208207|3827000|P1|Part II|Physician Decision|0
1165572|NCT01208207|3826994|P7|Part II|Non-Compliance With Study Drug|0
1165573|NCT01208207|3826995|P6|Part II|Non-Compliance With Study Drug|1
1165574|NCT01208207|3826996|P5|Part II|Non-Compliance With Study Drug|1
1165575|NCT01208207|3826997|P4|Part II|Non-Compliance With Study Drug|4
1165576|NCT01208207|3826998|P3|Part II|Non-Compliance With Study Drug|0
1165577|NCT01208207|3826999|P2|Part II|Non-Compliance With Study Drug|0
1165578|NCT01208207|3827000|P1|Part II|Non-Compliance With Study Drug|0
1165579|NCT01208207|3826994|P7|Part II|Lost to Follow-up|1
1165580|NCT01208207|3826995|P6|Part II|Lost to Follow-up|2
1165581|NCT01208207|3826996|P5|Part II|Lost to Follow-up|0
1165582|NCT01208207|3826997|P4|Part II|Lost to Follow-up|4
1165583|NCT01208207|3826998|P3|Part II|Lost to Follow-up|0
1165584|NCT01208207|3826999|P2|Part II|Lost to Follow-up|0
1165585|NCT01208207|3827000|P1|Part II|Lost to Follow-up|0
1165586|NCT01208207|3826994|P7|Part II|Lack of Efficacy|3
1165587|NCT01208207|3826995|P6|Part II|Lack of Efficacy|3
1165588|NCT01208207|3826996|P5|Part II|Lack of Efficacy|4
1165589|NCT01208207|3826997|P4|Part II|Lack of Efficacy|6
1165590|NCT01208207|3826998|P3|Part II|Lack of Efficacy|0
1165591|NCT01208207|3826999|P2|Part II|Lack of Efficacy|0
1165592|NCT01208207|3827000|P1|Part II|Lack of Efficacy|0
1165593|NCT01208207|3826994|P7|Part II|Adverse Event|2
1165594|NCT01208207|3826995|P6|Part II|Adverse Event|4
1165595|NCT01208207|3826996|P5|Part II|Adverse Event|9
1165596|NCT01208207|3826997|P4|Part II|Adverse Event|5
1165597|NCT01208207|3826998|P3|Part II|Adverse Event|0
1165598|NCT01208207|3826999|P2|Part II|Adverse Event|0
1165599|NCT01208207|3827000|P1|Part II|Adverse Event|0
1165600|NCT01208207|3826994|P7|Part II|Withdrawal by Subject|5
1165601|NCT01208207|3826995|P6|Part II|Withdrawal by Subject|3
1165602|NCT01208207|3826996|P5|Part II|Withdrawal by Subject|9
1165603|NCT01208207|3826997|P4|Part II|Withdrawal by Subject|10
1165604|NCT01208207|3826998|P3|Part II|Withdrawal by Subject|0
1165605|NCT01208207|3826999|P2|Part II|Withdrawal by Subject|0
1165606|NCT01208207|3827000|P1|Part II|Withdrawal by Subject|0
1165607|NCT01208207|3826994|P7|Part I|Withdrawal by Subject|0
1165608|NCT01208207|3826995|P6|Part I|Withdrawal by Subject|0
1165609|NCT01208207|3826996|P5|Part I|Withdrawal by Subject|0
1165610|NCT01208207|3826997|P4|Part I|Withdrawal by Subject|0
1165611|NCT01208207|3826998|P3|Part I|Withdrawal by Subject|4
1165612|NCT01208207|3826999|P2|Part I|Withdrawal by Subject|4
1165613|NCT01208207|3827000|P1|Part I|Withdrawal by Subject|14
1165614|NCT01208207|3826994|P7|Part I|Protocol Violation|0
1165615|NCT01208207|3826995|P6|Part I|Protocol Violation|0
1165616|NCT01208207|3826996|P5|Part I|Protocol Violation|0
1165617|NCT01208207|3826997|P4|Part I|Protocol Violation|0
1165618|NCT01208207|3826998|P3|Part I|Protocol Violation|2
1165619|NCT01208207|3826999|P2|Part I|Protocol Violation|0
1165620|NCT01208207|3827000|P1|Part I|Protocol Violation|8
1165621|NCT01208207|3826994|P7|Part I|Progressive Disease|0
1165622|NCT01208207|3826995|P6|Part I|Progressive Disease|0
1165623|NCT01208207|3826996|P5|Part I|Progressive Disease|0
1165624|NCT01208207|3826997|P4|Part I|Progressive Disease|0
1165625|NCT01208207|3826998|P3|Part I|Progressive Disease|0
1165626|NCT01208207|3826999|P2|Part I|Progressive Disease|0
1165627|NCT01208207|3827000|P1|Part I|Progressive Disease|1
1165628|NCT01208207|3826994|P7|Part I|Physician Decision|0
1165629|NCT01208207|3826995|P6|Part I|Physician Decision|0
1165630|NCT01208207|3826996|P5|Part I|Physician Decision|0
1165631|NCT01208207|3826997|P4|Part I|Physician Decision|0
1165632|NCT01208207|3826998|P3|Part I|Physician Decision|0
1165633|NCT01208207|3826999|P2|Part I|Physician Decision|1
1165634|NCT01208207|3827000|P1|Part I|Physician Decision|0
1165635|NCT01208207|3826994|P7|Part I|Non-Compliance With Study Drug|0
1165636|NCT01208207|3826995|P6|Part I|Non-Compliance With Study Drug|0
1165637|NCT01208207|3826996|P5|Part I|Non-Compliance With Study Drug|0
1165638|NCT01208207|3826997|P4|Part I|Non-Compliance With Study Drug|0
1165639|NCT01208207|3826998|P3|Part I|Non-Compliance With Study Drug|1
1165640|NCT01208207|3826999|P2|Part I|Non-Compliance With Study Drug|0
1165641|NCT01208207|3827000|P1|Part I|Non-Compliance With Study Drug|1
1165642|NCT01208207|3826994|P7|Part I|Lost to Follow-up|0
1165643|NCT01208207|3826995|P6|Part I|Lost to Follow-up|0
1165644|NCT01208207|3826996|P5|Part I|Lost to Follow-up|0
1165645|NCT01208207|3826997|P4|Part I|Lost to Follow-up|0
1165646|NCT01208207|3826998|P3|Part I|Lost to Follow-up|0
1165647|NCT01208207|3826999|P2|Part I|Lost to Follow-up|1
1165648|NCT01208207|3827000|P1|Part I|Lost to Follow-up|6
1165649|NCT01208207|3826994|P7|Part I|Lack of Efficacy|0
1165650|NCT01208207|3826995|P6|Part I|Lack of Efficacy|0
1165651|NCT01208207|3826996|P5|Part I|Lack of Efficacy|0
1165652|NCT01208207|3826997|P4|Part I|Lack of Efficacy|0
1165653|NCT01208207|3826998|P3|Part I|Lack of Efficacy|2
1165654|NCT01208207|3826999|P2|Part I|Lack of Efficacy|3
1165655|NCT01208207|3827000|P1|Part I|Lack of Efficacy|21
1165656|NCT01208207|3826994|P7|Part I|Adverse Event|0
1165657|NCT01208207|3826995|P6|Part I|Adverse Event|0
1165658|NCT01208207|3826996|P5|Part I|Adverse Event|0
1165659|NCT01208207|3826997|P4|Part I|Adverse Event|0
1165660|NCT01208207|3826998|P3|Part I|Adverse Event|6
1165661|NCT01208207|3826999|P2|Part I|Adverse Event|2
1165662|NCT01208207|3827000|P1|Part I|Adverse Event|19
1165663|NCT01208181|3827027|P5|Part 2|Lack of Efficacy|0
1165664|NCT01208181|3827028|P4|Part 2|Lack of Efficacy|7
1165665|NCT01208181|3827029|P3|Part 2|Lack of Efficacy|5
1165666|NCT01208181|3827030|P2|Part 2|Lack of Efficacy|0
1165667|NCT01208181|3827031|P1|Part 2|Lack of Efficacy|0
1165668|NCT01208181|3827027|P5|Part 2|Lost to Follow-up|0
1165669|NCT01208181|3827028|P4|Part 2|Lost to Follow-up|2
1165670|NCT01208181|3827029|P3|Part 2|Lost to Follow-up|1
1165671|NCT01208181|3827030|P2|Part 2|Lost to Follow-up|0
1165672|NCT01208181|3827031|P1|Part 2|Lost to Follow-up|0
1165673|NCT01208181|3827027|P5|Part 2|Non-compliance with study drug|0
1165674|NCT01208181|3827028|P4|Part 2|Non-compliance with study drug|1
1165675|NCT01208181|3827029|P3|Part 2|Non-compliance with study drug|1
1165676|NCT01208181|3827030|P2|Part 2|Non-compliance with study drug|0
1165677|NCT01208181|3827031|P1|Part 2|Non-compliance with study drug|0
1165678|NCT01208181|3827027|P5|Part 2|Physician Decision|0
1165679|NCT01208181|3827028|P4|Part 2|Physician Decision|2
1165680|NCT01208181|3827029|P3|Part 2|Physician Decision|1
1165681|NCT01208181|3827030|P2|Part 2|Physician Decision|0
1165682|NCT01208181|3827031|P1|Part 2|Physician Decision|0
1165683|NCT01208181|3827027|P5|Part 2|Protocol Violation|0
1165684|NCT01208181|3827028|P4|Part 2|Protocol Violation|0
1165685|NCT01208181|3827029|P3|Part 2|Protocol Violation|1
1165686|NCT01208181|3827030|P2|Part 2|Protocol Violation|0
1165687|NCT01208181|3827031|P1|Part 2|Protocol Violation|0
1165688|NCT01208181|3827027|P5|Part 2|Withdrawal by Subject|0
1165689|NCT01208181|3827028|P4|Part 2|Withdrawal by Subject|1
1165690|NCT01208181|3827029|P3|Part 2|Withdrawal by Subject|1
1165691|NCT01208181|3827030|P2|Part 2|Withdrawal by Subject|0
1165692|NCT01208181|3827031|P1|Part 2|Withdrawal by Subject|0
1165693|NCT01208181|3827027|P5|Part 2|Adverse Event|0
1165694|NCT01208181|3827028|P4|Part 2|Adverse Event|7
1165695|NCT01208181|3827029|P3|Part 2|Adverse Event|6
1165696|NCT01208181|3827030|P2|Part 2|Adverse Event|0
1165697|NCT01208181|3827031|P1|Part 2|Adverse Event|0
1165698|NCT01208181|3827027|P5|Part 1|Adverse Event|4
1165699|NCT01208181|3827028|P4|Part 1|Adverse Event|0
1165700|NCT01208181|3827029|P3|Part 1|Adverse Event|0
1165701|NCT01208181|3827030|P2|Part 1|Adverse Event|24
1165702|NCT01208181|3827031|P1|Part 1|Adverse Event|26
1165703|NCT01208181|3827027|P5|Part 1|Lack of Efficacy|17
1165704|NCT01208181|3827028|P4|Part 1|Lack of Efficacy|0
1165705|NCT01208181|3827029|P3|Part 1|Lack of Efficacy|0
1165706|NCT01208181|3827030|P2|Part 1|Lack of Efficacy|12
1165707|NCT01208181|3827031|P1|Part 1|Lack of Efficacy|37
1165708|NCT01208181|3827027|P5|Part 1|Lost to Follow-up|1
1165709|NCT01208181|3827028|P4|Part 1|Lost to Follow-up|0
1165710|NCT01208181|3827029|P3|Part 1|Lost to Follow-up|0
1165711|NCT01208181|3827030|P2|Part 1|Lost to Follow-up|3
1165712|NCT01208181|3827031|P1|Part 1|Lost to Follow-up|5
1165713|NCT01208181|3827027|P5|Part 1|Non-compliance with study drug|0
1165714|NCT01208181|3827028|P4|Part 1|Non-compliance with study drug|0
1165715|NCT01208181|3827029|P3|Part 1|Non-compliance with study drug|0
1165716|NCT01208181|3827030|P2|Part 1|Non-compliance with study drug|1
1165717|NCT01208181|3827031|P1|Part 1|Non-compliance with study drug|1
1165718|NCT01208181|3827027|P5|Part 1|Physician Decision|0
1165719|NCT01208181|3827028|P4|Part 1|Physician Decision|0
1165720|NCT01208181|3827029|P3|Part 1|Physician Decision|0
1165721|NCT01208181|3827030|P2|Part 1|Physician Decision|0
1165722|NCT01208181|3827031|P1|Part 1|Physician Decision|4
1165723|NCT01208181|3827027|P5|Part 1|Protocol Violation|0
1165724|NCT01208181|3827028|P4|Part 1|Protocol Violation|0
1165725|NCT01208181|3827029|P3|Part 1|Protocol Violation|0
1165726|NCT01208181|3827030|P2|Part 1|Protocol Violation|5
1165727|NCT01208181|3827031|P1|Part 1|Protocol Violation|10
1165728|NCT01208181|3827027|P5|Part 1|Technical problem|0
1165729|NCT01208181|3827028|P4|Part 1|Technical problem|0
1165730|NCT01208181|3827029|P3|Part 1|Technical problem|0
1165731|NCT01208181|3827030|P2|Part 1|Technical problem|0
1165732|NCT01208181|3827031|P1|Part 1|Technical problem|5
1165733|NCT01208181|3827027|P5|Part 1|Withdrawal by Subject|0
1165734|NCT01208181|3827028|P4|Part 1|Withdrawal by Subject|0
1165735|NCT01208181|3827029|P3|Part 1|Withdrawal by Subject|0
1165736|NCT01208181|3827030|P2|Part 1|Withdrawal by Subject|10
1165737|NCT01208181|3827031|P1|Part 1|Withdrawal by Subject|11
1165738|NCT01207687|3827088|P1|Overall Study|Withdrawal by Subject|1
1165739|NCT01207687|3827088|P1|Overall Study|Adverse Event|1
1165740|NCT01207596|3827126|P1|Overall Study|Withdrawal by Subject|1
1165741|NCT01207596|3827126|P1|Overall Study|Adverse Event|3
1165742|NCT01207596|3827126|P1|Overall Study|Lack of Efficacy|1
1165743|NCT01207596|3827126|P1|Overall Study|Physician Decision|4
1165744|NCT01207583|3827139|P3|Overall Study|Lost to Follow-up|0
1165745|NCT01207583|3827140|P2|Overall Study|Lost to Follow-up|2
1165746|NCT01207583|3827141|P1|Overall Study|Lost to Follow-up|0
1165747|NCT01207583|3827139|P3|Overall Study|Participant failed to return|0
1165748|NCT01207583|3827140|P2|Overall Study|Participant failed to return|0
1165749|NCT01207583|3827141|P1|Overall Study|Participant failed to return|1
1165750|NCT01207583|3827139|P3|Overall Study|Withdrawal by Subject|1
1165751|NCT01207583|3827140|P2|Overall Study|Withdrawal by Subject|3
1165752|NCT01207583|3827141|P1|Overall Study|Withdrawal by Subject|0
1165753|NCT01207492|3827194|P1|Overall Study|Toxicity|1
1165754|NCT01207492|3827194|P1|Overall Study|Progressive disease|3
1165755|NCT01207492|3827194|P1|Overall Study|Physician Decision|1
1165756|NCT01207492|3827194|P1|Overall Study|Withdrawal by Subject|9
1165757|NCT01207492|3827194|P1|Overall Study|Still on study|1
1165758|NCT01207453|3827209|P2|2nd Intervention|Lost to Follow-up|0
1165759|NCT01207453|3827210|P1|2nd Intervention|Lost to Follow-up|1
1165760|NCT01207453|3827209|P2|2nd Intervention|Adverse Event|2
1165761|NCT01207453|3827210|P1|2nd Intervention|Adverse Event|1
1165762|NCT01207453|3827209|P2|Washout|Lost to Follow-up|0
1165763|NCT01207453|3827210|P1|Washout|Lost to Follow-up|1
1165764|NCT01207453|3827209|P2|Washout|Adverse Event|0
1165765|NCT01207453|3827210|P1|Washout|Adverse Event|1
1165766|NCT01207453|3827209|P2|First Intervention|Adverse Event|1
1165767|NCT01207453|3827210|P1|First Intervention|Adverse Event|2
1165768|NCT01207427|3827232|P3|Double-blind Treatment Period|Withdrawal by Subject|0
1165853|NCT01205581|3827756|P2|Overall Study|Withdrawal by Subject|0
1165769|NCT01207427|3827233|P2|Double-blind Treatment Period|Withdrawal by Subject|0
1165770|NCT01207427|3827234|P1|Double-blind Treatment Period|Withdrawal by Subject|1
1165771|NCT01207427|3827232|P3|Double-blind Treatment Period|Protocol Violation|1
1165772|NCT01207427|3827233|P2|Double-blind Treatment Period|Protocol Violation|1
1165773|NCT01207427|3827234|P1|Double-blind Treatment Period|Protocol Violation|2
1165774|NCT01207427|3827232|P3|Double-blind Treatment Period|Lost to Follow-up|1
1165775|NCT01207427|3827233|P2|Double-blind Treatment Period|Lost to Follow-up|0
1165776|NCT01207427|3827234|P1|Double-blind Treatment Period|Lost to Follow-up|0
1165777|NCT01207427|3827232|P3|Double-blind Treatment Period|Adverse Event|0
1165778|NCT01207427|3827233|P2|Double-blind Treatment Period|Adverse Event|1
1165779|NCT01207427|3827234|P1|Double-blind Treatment Period|Adverse Event|0
1165780|NCT01207414|3827244|P2|Overall Study|Randomized in error|0
1165781|NCT01207414|3827245|P1|Overall Study|Randomized in error|1
1165782|NCT01207414|3827244|P2|Overall Study|Protocol deviation|9
1165783|NCT01207414|3827245|P1|Overall Study|Protocol deviation|12
1165784|NCT01207414|3827244|P2|Overall Study|Administrative problems|1
1165785|NCT01207414|3827245|P1|Overall Study|Administrative problems|1
1165786|NCT01207414|3827244|P2|Overall Study|Lost to Follow-up|17
1165787|NCT01207414|3827245|P1|Overall Study|Lost to Follow-up|15
1165788|NCT01207414|3827244|P2|Overall Study|Patient withdrew consent|11
1165789|NCT01207414|3827245|P1|Overall Study|Patient withdrew consent|14
1165790|NCT01207414|3827244|P2|Overall Study|Unsatisfactory therapeutic effect|4
1165791|NCT01207414|3827245|P1|Overall Study|Unsatisfactory therapeutic effect|5
1165792|NCT01207414|3827244|P2|Overall Study|Abnormal test procedure results|1
1165793|NCT01207414|3827245|P1|Overall Study|Abnormal test procedure results|0
1165794|NCT01207414|3827244|P2|Overall Study|Adverse Event|39
1165795|NCT01207414|3827245|P1|Overall Study|Adverse Event|25
1165796|NCT01207388|3827270|P1|Overall Study|Other|1
1165797|NCT01207388|3827270|P1|Overall Study|Physician Decision|2
1165798|NCT01207388|3827270|P1|Overall Study|Disease Relapse|10
1165799|NCT01207388|3827270|P1|Overall Study|Adverse Event|20
1165800|NCT01207219|3827293|P3|Overall Study|Lost to Follow-up|6
1165801|NCT01207219|3827294|P2|Overall Study|Lost to Follow-up|8
1165802|NCT01207219|3827295|P1|Overall Study|Lost to Follow-up|6
1165803|NCT01207219|3827293|P3|Overall Study|changed diagnosis during study period|1
1165804|NCT01207219|3827294|P2|Overall Study|changed diagnosis during study period|3
1165805|NCT01207219|3827295|P1|Overall Study|changed diagnosis during study period|5
1165806|NCT01207102|3827315|P1|Overall Study|Withdrawal by Treating Physician|1
1165807|NCT01207102|3827315|P1|Overall Study|progression|2
1165808|NCT01207102|3827315|P1|Overall Study|Adverse Event|2
1165809|NCT01207102|3827315|P1|Overall Study|Withdrawal by Subject|5
1165810|NCT01206777|3827320|P1|Overall Study|Adverse Event|1
1165811|NCT01206777|3827320|P1|Overall Study|Death|1
1165812|NCT01206582|3827376|P2|Overall Study|Discontinued intervention before week 8|2
1165813|NCT01206582|3827377|P1|Overall Study|Discontinued intervention before week 8|1
1165814|NCT01206582|3827376|P2|Overall Study|Withdrew prior to study|0
1165815|NCT01206582|3827377|P1|Overall Study|Withdrew prior to study|1
1165816|NCT01206517|3827409|P6|Overall Study|Withdrawal by Subject|0
1165817|NCT01206517|3827410|P5|Overall Study|Withdrawal by Subject|1
1165818|NCT01206517|3827411|P4|Overall Study|Withdrawal by Subject|0
1165819|NCT01206517|3827412|P3|Overall Study|Withdrawal by Subject|2
1165820|NCT01206517|3827413|P2|Overall Study|Withdrawal by Subject|0
1165821|NCT01206517|3827414|P1|Overall Study|Withdrawal by Subject|0
1165822|NCT01206439|3827494|P1|Overall Study|subject did not meet inclusion criteria|1
1165823|NCT01206322|3827517|P4|Overall Study|Adverse Event|1
1165824|NCT01206322|3827518|P3|Overall Study|Adverse Event|0
1165825|NCT01206322|3827519|P2|Overall Study|Adverse Event|0
1165826|NCT01206322|3827520|P1|Overall Study|Adverse Event|0
1165827|NCT01206140|3827536|P2|Overall Study|Deemed ineligible due to incorrect diag.|0
1165828|NCT01206140|3827537|P1|Overall Study|Deemed ineligible due to incorrect diag.|1
1165829|NCT01206101|3827549|P2|Overall Study|Unclassified|0
1165830|NCT01206101|3827550|P1|Overall Study|Unclassified|1
1165831|NCT01206101|3827549|P2|Overall Study|Physician Decision|1
1165832|NCT01206101|3827550|P1|Overall Study|Physician Decision|0
1165833|NCT01206101|3827549|P2|Overall Study|Adverse Event|0
1165834|NCT01206101|3827550|P1|Overall Study|Adverse Event|1
1165835|NCT01205776|3827591|P2|3 Years Follow-up|Withdrawal by Subject|2
1165836|NCT01205776|3827592|P1|3 Years Follow-up|Withdrawal by Subject|1
1165837|NCT01205776|3827591|P2|3 Years Follow-up|Lost to Follow-up|22
1165838|NCT01205776|3827592|P1|3 Years Follow-up|Lost to Follow-up|15
1165839|NCT01205776|3827591|P2|2 Years Follow-up|Withdrawal by Subject|19
1165840|NCT01205776|3827592|P1|2 Years Follow-up|Withdrawal by Subject|4
1165841|NCT01205776|3827591|P2|2 Years Follow-up|Lost to Follow-up|13
1165842|NCT01205776|3827592|P1|2 Years Follow-up|Lost to Follow-up|12
1165843|NCT01205776|3827591|P2|1 Month Follow-up|Withdrawal by Subject|10
1165844|NCT01205776|3827592|P1|1 Month Follow-up|Withdrawal by Subject|5
1165845|NCT01205776|3827591|P2|1 Month Follow-up|Lost to Follow-up|2
1165846|NCT01205776|3827592|P1|1 Month Follow-up|Lost to Follow-up|0
1165847|NCT01205685|3827732|P1|Overall Study|Withdrawal by Subject|1
1165848|NCT01205685|3827732|P1|Overall Study|Disease Progression|10
1165849|NCT01205581|3827752|P6|Overall Study|Withdrawal by Subject|0
1165850|NCT01205581|3827753|P5|Overall Study|Withdrawal by Subject|0
1165851|NCT01205581|3827754|P4|Overall Study|Withdrawal by Subject|0
1165852|NCT01205581|3827755|P3|Overall Study|Withdrawal by Subject|0
1165854|NCT01205581|3827757|P1|Overall Study|Withdrawal by Subject|1
1165855|NCT01205529|3827827|P1|Overall Study|No longer met criteria|30
1165856|NCT01205529|3827827|P1|Overall Study|Unstable post op|15
1165857|NCT01205529|3827827|P1|Overall Study|Physician Decision|4
1165858|NCT01205529|3827827|P1|Overall Study|Withdrawal by Subject|2
1165859|NCT01205529|3827827|P1|Overall Study|Procedure Cancelled|4
1165860|NCT01205451|3827850|P2|Overall Study|Withdrawal by Subject|9
1165861|NCT01205451|3827851|P1|Overall Study|Withdrawal by Subject|5
1165862|NCT01205451|3827850|P2|Overall Study|Lost to Follow-up|1
1165863|NCT01205451|3827851|P1|Overall Study|Lost to Follow-up|1
1165864|NCT01205438|3827896|P3|Overall Study|Sponsor Decision|1
1165865|NCT01205438|3827897|P2|Overall Study|Sponsor Decision|1
1165866|NCT01205438|3827898|P1|Overall Study|Sponsor Decision|0
1165867|NCT01205438|3827896|P3|Overall Study|Protocol Violation|4
1165868|NCT01205438|3827897|P2|Overall Study|Protocol Violation|7
1165869|NCT01205438|3827898|P1|Overall Study|Protocol Violation|2
1165870|NCT01205438|3827896|P3|Overall Study|Physician Decision|2
1165871|NCT01205438|3827897|P2|Overall Study|Physician Decision|3
1165872|NCT01205438|3827898|P1|Overall Study|Physician Decision|0
1165873|NCT01205438|3827896|P3|Overall Study|Withdrawal by Subject|19
1165874|NCT01205438|3827897|P2|Overall Study|Withdrawal by Subject|25
1165875|NCT01205438|3827898|P1|Overall Study|Withdrawal by Subject|19
1165876|NCT01205438|3827896|P3|Overall Study|Lost to Follow-up|8
1165877|NCT01205438|3827897|P2|Overall Study|Lost to Follow-up|7
1165878|NCT01205438|3827898|P1|Overall Study|Lost to Follow-up|6
1165879|NCT01205438|3827896|P3|Overall Study|Lack of Efficacy|14
1165880|NCT01205438|3827897|P2|Overall Study|Lack of Efficacy|11
1165881|NCT01205438|3827898|P1|Overall Study|Lack of Efficacy|14
1165882|NCT01205438|3827896|P3|Overall Study|Entry Criteria Not Met|13
1165883|NCT01205438|3827897|P2|Overall Study|Entry Criteria Not Met|15
1165884|NCT01205438|3827898|P1|Overall Study|Entry Criteria Not Met|16
1165885|NCT01205438|3827896|P3|Overall Study|Death|3
1165886|NCT01205438|3827897|P2|Overall Study|Death|1
1165887|NCT01205438|3827898|P1|Overall Study|Death|1
1165888|NCT01205438|3827896|P3|Overall Study|Adverse Event|24
1165889|NCT01205438|3827897|P2|Overall Study|Adverse Event|17
1165890|NCT01205438|3827898|P1|Overall Study|Adverse Event|19
1165891|NCT01205269|3827954|P6|Period 4 - Washout|Eligibility criteria not fulfilled|0
1165892|NCT01205269|3827955|P5|Period 4 - Washout|Eligibility criteria not fulfilled|0
1165893|NCT01205269|3827956|P4|Period 4 - Washout|Eligibility criteria not fulfilled|1
1165894|NCT01205269|3827957|P3|Period 4 - Washout|Eligibility criteria not fulfilled|0
1165895|NCT01205269|3827958|P2|Period 4 - Washout|Eligibility criteria not fulfilled|0
1165896|NCT01205269|3827959|P1|Period 4 - Washout|Eligibility criteria not fulfilled|0
1165897|NCT01205230|3827999|P2|Overall Study|Physician Decision|0
1165898|NCT01205230|3828000|P1|Overall Study|Physician Decision|1
1165899|NCT01205230|3827999|P2|Overall Study|Adverse Event|0
1165900|NCT01205230|3828000|P1|Overall Study|Adverse Event|4
1165901|NCT01205165|3828043|P1|Overall Study|Lost to Follow-up|2
1165902|NCT01205152|3828056|P1|Overall Study|Death|1
1165903|NCT01205126|3828069|P2|Maintenance Phase|Withdrawal by Subject|11
1165904|NCT01205126|3828070|P1|Maintenance Phase|Withdrawal by Subject|8
1165905|NCT01205126|3828069|P2|Maintenance Phase|Lost to Follow-up|5
1165906|NCT01205126|3828070|P1|Maintenance Phase|Lost to Follow-up|5
1165907|NCT01205126|3828069|P2|Maintenance Phase|Other|8
1165908|NCT01205126|3828070|P1|Maintenance Phase|Other|11
1165909|NCT01205126|3828069|P2|Maintenance Phase|Prohibited drugs used|0
1165910|NCT01205126|3828070|P1|Maintenance Phase|Prohibited drugs used|1
1165911|NCT01205126|3828069|P2|Maintenance Phase|More than the maximum dosage required|5
1165912|NCT01205126|3828070|P1|Maintenance Phase|More than the maximum dosage required|5
1165913|NCT01205126|3828069|P2|Maintenance Phase|Death|4
1165914|NCT01205126|3828070|P1|Maintenance Phase|Death|4
1165915|NCT01205126|3828069|P2|Maintenance Phase|Adverse Event|7
1165916|NCT01205126|3828070|P1|Maintenance Phase|Adverse Event|3
1165917|NCT01205126|3828069|P2|Between Titration & Maintenance Phase|Other|4
1165918|NCT01205126|3828070|P1|Between Titration & Maintenance Phase|Other|0
1165919|NCT01205126|3828069|P2|Titration Phase|Other|6
1165920|NCT01205126|3828070|P1|Titration Phase|Other|8
1165921|NCT01205126|3828069|P2|Titration Phase|More than maximum dosage required|3
1165922|NCT01205126|3828070|P1|Titration Phase|More than maximum dosage required|2
1165923|NCT01205126|3828069|P2|Titration Phase|No stable titration dose|0
1165924|NCT01205126|3828070|P1|Titration Phase|No stable titration dose|1
1165925|NCT01205126|3828069|P2|Titration Phase|Lost to Follow-up|2
1165926|NCT01205126|3828070|P1|Titration Phase|Lost to Follow-up|2
1165927|NCT01205126|3828069|P2|Titration Phase|Withdrawal by Subject|5
1165928|NCT01205126|3828070|P1|Titration Phase|Withdrawal by Subject|5
1165929|NCT01205126|3828069|P2|Titration Phase|Adverse Event|3
1165930|NCT01205126|3828070|P1|Titration Phase|Adverse Event|5
1165931|NCT01205035|3828088|P2|Overall Study|Physician Decision|0
1165932|NCT01205035|3828089|P1|Overall Study|Physician Decision|1
1165933|NCT01205035|3828088|P2|Overall Study|Withdrawal by Subject|0
1165934|NCT01205035|3828089|P1|Overall Study|Withdrawal by Subject|1
1165935|NCT01204918|3828106|P3|Overall Study|Withdrawal by Subject|5
1165936|NCT01204918|3828107|P2|Overall Study|Withdrawal by Subject|10
1165937|NCT01204918|3828108|P1|Overall Study|Withdrawal by Subject|4
1165938|NCT01204775|3828151|P2|Overall Study|Withdrawal by Subject|0
1165939|NCT01204775|3828152|P1|Overall Study|Withdrawal by Subject|1
1165940|NCT01204775|3828151|P2|Overall Study|Poor/non-compliance|1
1165941|NCT01204775|3828152|P1|Overall Study|Poor/non-compliance|0
1165942|NCT01204710|3828177|P2|Optional Olaratumab Monotherapy|Withdrawal by Subject|1
1165943|NCT01204710|3828178|P1|Optional Olaratumab Monotherapy|Withdrawal by Subject|0
1165944|NCT01204710|3828177|P2|Optional Olaratumab Monotherapy|Physician Decision|1
1165945|NCT01204710|3828178|P1|Optional Olaratumab Monotherapy|Physician Decision|0
1165946|NCT01204710|3828177|P2|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1
1165947|NCT01204710|3828178|P1|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0
1165948|NCT01204710|3828177|P2|Randomization Treatment|Moved and Followed for Survival|1
1165949|NCT01204710|3828178|P1|Randomization Treatment|Moved and Followed for Survival|0
1165950|NCT01204710|3828177|P2|Randomization Treatment|Worsening of General condition|1
1165951|NCT01204710|3828178|P1|Randomization Treatment|Worsening of General condition|0
1165952|NCT01204710|3828177|P2|Randomization Treatment|Sponsor Decision|1
1165953|NCT01204710|3828178|P1|Randomization Treatment|Sponsor Decision|0
1165954|NCT01204710|3828177|P2|Randomization Treatment|Adverse Event|2
1165955|NCT01204710|3828178|P1|Randomization Treatment|Adverse Event|4
1165956|NCT01204710|3828177|P2|Randomization Treatment|Entry criteria not met|1
1165957|NCT01204710|3828178|P1|Randomization Treatment|Entry criteria not met|0
1165958|NCT01204710|3828177|P2|Randomization Treatment|Physician Decision|2
1165959|NCT01204710|3828178|P1|Randomization Treatment|Physician Decision|3
1165960|NCT01204710|3828177|P2|Randomization Treatment|Withdrawal by Subject|5
1165961|NCT01204710|3828178|P1|Randomization Treatment|Withdrawal by Subject|6
1165962|NCT01204710|3828177|P2|Randomization Treatment|Lost to Follow-up|0
1165963|NCT01204710|3828178|P1|Randomization Treatment|Lost to Follow-up|1
1165964|NCT01204697|3828214|P2|Overall Study|Randomized, but not treated|1
1165965|NCT01204697|3828215|P1|Overall Study|Randomized, but not treated|0
1165966|NCT01204697|3828214|P2|Overall Study|Withdrawal by Subject|4
1165967|NCT01204697|3828215|P1|Overall Study|Withdrawal by Subject|2
1165968|NCT01204697|3828214|P2|Overall Study|Lost to Follow-up|4
1165969|NCT01204697|3828215|P1|Overall Study|Lost to Follow-up|3
1165970|NCT01204697|3828214|P2|Overall Study|Death|27
1165971|NCT01204697|3828215|P1|Overall Study|Death|26
1165972|NCT01204671|3828236|P5|Overall Study|Physician Decision|0
1165973|NCT01204671|3828237|P4|Overall Study|Physician Decision|1
1165974|NCT01204671|3828238|P3|Overall Study|Physician Decision|0
1165975|NCT01204671|3828239|P2|Overall Study|Physician Decision|0
1165976|NCT01204671|3828240|P1|Overall Study|Physician Decision|0
1165977|NCT01204671|3828236|P5|Overall Study|Unknown Completion Status|0
1165978|NCT01204671|3828237|P4|Overall Study|Unknown Completion Status|0
1165979|NCT01204671|3828238|P3|Overall Study|Unknown Completion Status|0
1165980|NCT01204671|3828239|P2|Overall Study|Unknown Completion Status|1
1165981|NCT01204671|3828240|P1|Overall Study|Unknown Completion Status|1
1165982|NCT01204671|3828236|P5|Overall Study|Lost to Follow-up|0
1165983|NCT01204671|3828237|P4|Overall Study|Lost to Follow-up|4
1165984|NCT01204671|3828238|P3|Overall Study|Lost to Follow-up|6
1165985|NCT01204671|3828239|P2|Overall Study|Lost to Follow-up|8
1165986|NCT01204671|3828240|P1|Overall Study|Lost to Follow-up|7
1165987|NCT01204671|3828236|P5|Overall Study|Withdrawal by Subject|3
1165988|NCT01204671|3828237|P4|Overall Study|Withdrawal by Subject|5
1165989|NCT01204671|3828238|P3|Overall Study|Withdrawal by Subject|4
1165990|NCT01204671|3828239|P2|Overall Study|Withdrawal by Subject|3
1165991|NCT01204671|3828240|P1|Overall Study|Withdrawal by Subject|2
1165992|NCT01204671|3828236|P5|Overall Study|Adverse Event|1
1165993|NCT01204671|3828237|P4|Overall Study|Adverse Event|3
1165994|NCT01204671|3828238|P3|Overall Study|Adverse Event|3
1165995|NCT01204671|3828239|P2|Overall Study|Adverse Event|3
1165996|NCT01204671|3828240|P1|Overall Study|Adverse Event|4
1165997|NCT01204658|3828302|P4|Primary Phase|Adverse Event|0
1165998|NCT01204658|3828303|P3|Primary Phase|Adverse Event|1
1165999|NCT01204658|3828304|P2|Primary Phase|Adverse Event|0
1166000|NCT01204658|3828305|P1|Primary Phase|Adverse Event|0
1166001|NCT01204398|3828423|P1|Overall Study|Adverse Event|1
1166002|NCT01204294|3828440|P7|Overall Study|Other (house moving)|0
1166003|NCT01204294|3828441|P6|Overall Study|Other (house moving)|0
1166004|NCT01204294|3828442|P5|Overall Study|Other (house moving)|0
1166005|NCT01204294|3828443|P4|Overall Study|Other (house moving)|0
1166006|NCT01204294|3828444|P3|Overall Study|Other (house moving)|1
1166007|NCT01204294|3828445|P2|Overall Study|Other (house moving)|0
1166008|NCT01204294|3828446|P1|Overall Study|Other (house moving)|0
1166009|NCT01204294|3828440|P7|Overall Study|Lack of Efficacy|0
1166010|NCT01204294|3828441|P6|Overall Study|Lack of Efficacy|0
1166011|NCT01204294|3828442|P5|Overall Study|Lack of Efficacy|0
1166012|NCT01204294|3828443|P4|Overall Study|Lack of Efficacy|2
1166013|NCT01204294|3828444|P3|Overall Study|Lack of Efficacy|0
1166014|NCT01204294|3828445|P2|Overall Study|Lack of Efficacy|0
1166015|NCT01204294|3828446|P1|Overall Study|Lack of Efficacy|0
1166016|NCT01204294|3828440|P7|Overall Study|Withdrawal by Subject|2
1166017|NCT01204294|3828441|P6|Overall Study|Withdrawal by Subject|1
1166018|NCT01204294|3828442|P5|Overall Study|Withdrawal by Subject|1
1166019|NCT01204294|3828443|P4|Overall Study|Withdrawal by Subject|1
1166020|NCT01204294|3828444|P3|Overall Study|Withdrawal by Subject|2
1166021|NCT01204294|3828445|P2|Overall Study|Withdrawal by Subject|2
1166022|NCT01204294|3828446|P1|Overall Study|Withdrawal by Subject|0
1166023|NCT01204294|3828440|P7|Overall Study|Protocol Violation|0
1166024|NCT01204294|3828441|P6|Overall Study|Protocol Violation|0
1166025|NCT01204294|3828442|P5|Overall Study|Protocol Violation|0
1166026|NCT01204294|3828443|P4|Overall Study|Protocol Violation|1
1166027|NCT01204294|3828444|P3|Overall Study|Protocol Violation|2
1166028|NCT01204294|3828445|P2|Overall Study|Protocol Violation|0
1166029|NCT01204294|3828446|P1|Overall Study|Protocol Violation|1
1166030|NCT01204294|3828440|P7|Overall Study|Adverse Event|0
1166031|NCT01204294|3828441|P6|Overall Study|Adverse Event|4
1166032|NCT01204294|3828442|P5|Overall Study|Adverse Event|1
1166033|NCT01204294|3828443|P4|Overall Study|Adverse Event|7
1166034|NCT01204294|3828444|P3|Overall Study|Adverse Event|0
1166035|NCT01204294|3828445|P2|Overall Study|Adverse Event|6
1166036|NCT01204294|3828446|P1|Overall Study|Adverse Event|2
1166037|NCT01203956|3828480|P2|Second Two-week Period|Non-compliant: no evaluable results|6
1166038|NCT01203956|3828481|P1|Second Two-week Period|Non-compliant: no evaluable results|5
1166039|NCT01203930|3828490|P2|Overall Study|Adverse Event|5
1166040|NCT01203930|3828491|P1|Overall Study|Adverse Event|17
1166041|NCT01203930|3828490|P2|Overall Study|Poor tolerance of study drug|1
1166042|NCT01203930|3828491|P1|Overall Study|Poor tolerance of study drug|0
1166043|NCT01203930|3828490|P2|Overall Study|Study Terminated by Sponsor|12
1166044|NCT01203930|3828491|P1|Overall Study|Study Terminated by Sponsor|0
1166045|NCT01203930|3828490|P2|Overall Study|Investigator Request|8
1166046|NCT01203930|3828491|P1|Overall Study|Investigator Request|0
1166047|NCT01203930|3828490|P2|Overall Study|Withdrew Consent|10
1166048|NCT01203930|3828491|P1|Overall Study|Withdrew Consent|1
1166049|NCT01203930|3828490|P2|Overall Study|Death|1
1166050|NCT01203930|3828491|P1|Overall Study|Death|3
1166051|NCT01203930|3828490|P2|Overall Study|Disease Progression|4
1166052|NCT01203930|3828491|P1|Overall Study|Disease Progression|0
1166053|NCT01203917|3828513|P1|Overall Study|Due to EGFR M+I patient|1
1166054|NCT01203917|3828513|P1|Overall Study|Due to objective disease progression|1
1166055|NCT01203917|3828513|P1|Overall Study|Withdrawal by Subject|3
1166056|NCT01203917|3828513|P1|Overall Study|Lost to Follow-up|2
1166057|NCT01203917|3828513|P1|Overall Study|Death|29
1166058|NCT01203878|3828526|P3|Overall Study|Adverse Event|2
1166059|NCT01203878|3828527|P2|Overall Study|Adverse Event|0
1166060|NCT01203878|3828528|P1|Overall Study|Adverse Event|0
1166061|NCT01203878|3828526|P3|Overall Study|Withdrawal by Subject|1
1166062|NCT01203878|3828527|P2|Overall Study|Withdrawal by Subject|0
1166063|NCT01203878|3828528|P1|Overall Study|Withdrawal by Subject|0
1166064|NCT01203852|3828539|P1|Washout 2 Weeks|Physician Decision|46
1166065|NCT01203852|3828539|P1|Metoprolol 8 Weeks|Physician Decision|470
1166066|NCT01203787|3828557|P2|Overall Study|Adverse Event|15
1166067|NCT01203787|3828558|P1|Overall Study|Adverse Event|11
1166068|NCT01203787|3828557|P2|Overall Study|Lost to Follow-up|0
1166069|NCT01203787|3828558|P1|Overall Study|Lost to Follow-up|2
1166070|NCT01203787|3828557|P2|Overall Study|Withdrawal by Subject|2
1166071|NCT01203787|3828558|P1|Overall Study|Withdrawal by Subject|6
1166072|NCT01203787|3828557|P2|Overall Study|Death|10
1166073|NCT01203787|3828558|P1|Overall Study|Death|12
1166074|NCT01203098|3828629|P3|Overall Study|Withdrawal by Subject|3
1166075|NCT01203098|3828630|P2|Overall Study|Withdrawal by Subject|1
1166076|NCT01203098|3828631|P1|Overall Study|Withdrawal by Subject|1
1166077|NCT01203098|3828629|P3|Overall Study|Physician Decision|0
1166078|NCT01203098|3828630|P2|Overall Study|Physician Decision|2
1166079|NCT01203098|3828631|P1|Overall Study|Physician Decision|2
1166080|NCT01203098|3828629|P3|Overall Study|Lost to Follow-up|1
1166081|NCT01203098|3828630|P2|Overall Study|Lost to Follow-up|0
1166082|NCT01203098|3828631|P1|Overall Study|Lost to Follow-up|0
1166083|NCT01203098|3828629|P3|Overall Study|Adverse Event|7
1166084|NCT01203098|3828630|P2|Overall Study|Adverse Event|1
1166085|NCT01203098|3828631|P1|Overall Study|Adverse Event|3
1166086|NCT01203072|3828647|P5|Overall Study|Withdrawal by Subject|3
1166087|NCT01203072|3828648|P4|Overall Study|Withdrawal by Subject|2
1166088|NCT01203072|3828649|P3|Overall Study|Withdrawal by Subject|1
1166089|NCT01203072|3828650|P2|Overall Study|Withdrawal by Subject|2
1166090|NCT01203072|3828651|P1|Overall Study|Withdrawal by Subject|2
1166091|NCT01203072|3828647|P5|Overall Study|Protocol Violation|1
1166092|NCT01203072|3828648|P4|Overall Study|Protocol Violation|0
1166093|NCT01203072|3828649|P3|Overall Study|Protocol Violation|0
1166094|NCT01203072|3828650|P2|Overall Study|Protocol Violation|0
1166095|NCT01203072|3828651|P1|Overall Study|Protocol Violation|2
1166096|NCT01203072|3828647|P5|Overall Study|Lost to Follow-up|0
1166097|NCT01203072|3828648|P4|Overall Study|Lost to Follow-up|0
1166098|NCT01203072|3828649|P3|Overall Study|Lost to Follow-up|0
1166099|NCT01203072|3828650|P2|Overall Study|Lost to Follow-up|1
1166100|NCT01203072|3828651|P1|Overall Study|Lost to Follow-up|0
1166101|NCT01203072|3828647|P5|Overall Study|Lack of Efficacy|0
1166102|NCT01203072|3828648|P4|Overall Study|Lack of Efficacy|0
1166103|NCT01203072|3828649|P3|Overall Study|Lack of Efficacy|0
1166104|NCT01203072|3828650|P2|Overall Study|Lack of Efficacy|0
1166105|NCT01203072|3828651|P1|Overall Study|Lack of Efficacy|1
1166106|NCT01203072|3828647|P5|Overall Study|Adverse Event|2
1166107|NCT01203072|3828648|P4|Overall Study|Adverse Event|4
1166108|NCT01203072|3828649|P3|Overall Study|Adverse Event|2
1166109|NCT01203072|3828650|P2|Overall Study|Adverse Event|3
1166110|NCT01203072|3828651|P1|Overall Study|Adverse Event|5
1166111|NCT01202955|3828686|P2|Period 1: 10 Days|Withdrawal by Subject|2
1166112|NCT01202955|3828687|P1|Period 1: 10 Days|Withdrawal by Subject|0
1166113|NCT01202903|3828699|P2|Overall Study|Withdrawal by Subject|4
1166114|NCT01202903|3828700|P1|Overall Study|Withdrawal by Subject|4
1166115|NCT01202903|3828699|P2|Overall Study|Adverse Event|3
1166116|NCT01202903|3828700|P1|Overall Study|Adverse Event|3
1166117|NCT01202903|3828699|P2|Overall Study|Lack of Efficacy|3
1166118|NCT01202903|3828700|P1|Overall Study|Lack of Efficacy|1
1166119|NCT01202903|3828699|P2|Overall Study|Lost to Follow-up|1
1166120|NCT01202903|3828700|P1|Overall Study|Lost to Follow-up|1
1166121|NCT01202903|3828699|P2|Overall Study|Death|0
1166122|NCT01202903|3828700|P1|Overall Study|Death|1
1166123|NCT01202903|3828699|P2|Overall Study|Protocol Violation|1
1166124|NCT01202903|3828700|P1|Overall Study|Protocol Violation|0
1166125|NCT01202903|3828699|P2|Overall Study|Administrative Probelms|4
1166126|NCT01202903|3828700|P1|Overall Study|Administrative Probelms|1
1166127|NCT01202877|3828727|P3|Overall Study|Death|1
1166128|NCT01202877|3828728|P2|Overall Study|Death|0
1166129|NCT01202877|3828729|P1|Overall Study|Death|0
1166130|NCT01202877|3828727|P3|Overall Study|Withdrawal by Subject|1
1166131|NCT01202877|3828728|P2|Overall Study|Withdrawal by Subject|0
1166132|NCT01202877|3828729|P1|Overall Study|Withdrawal by Subject|0
1166133|NCT01202877|3828727|P3|Overall Study|Adverse Event|2
1166134|NCT01202877|3828728|P2|Overall Study|Adverse Event|0
1166135|NCT01202877|3828729|P1|Overall Study|Adverse Event|0
1166136|NCT01202877|3828727|P3|Overall Study|Disease Progression|2
1166137|NCT01202877|3828728|P2|Overall Study|Disease Progression|1
1166138|NCT01202877|3828729|P1|Overall Study|Disease Progression|0
1166139|NCT01202773|3828743|P3|Overall Study|Sponsor Decision|23
1166140|NCT01202773|3828744|P2|Overall Study|Sponsor Decision|20
1166141|NCT01202773|3828745|P1|Overall Study|Sponsor Decision|19
1166142|NCT01202773|3828743|P3|Overall Study|Protocol Violation|10
1166143|NCT01202773|3828744|P2|Overall Study|Protocol Violation|6
1166144|NCT01202773|3828745|P1|Overall Study|Protocol Violation|11
1166145|NCT01202773|3828743|P3|Overall Study|Physician Decision|0
1166146|NCT01202773|3828744|P2|Overall Study|Physician Decision|0
1166147|NCT01202773|3828745|P1|Overall Study|Physician Decision|2
1166148|NCT01202773|3828743|P3|Overall Study|Withdrawal by Subject|5
1166149|NCT01202773|3828744|P2|Overall Study|Withdrawal by Subject|6
1166150|NCT01202773|3828745|P1|Overall Study|Withdrawal by Subject|13
1166151|NCT01202773|3828743|P3|Overall Study|Lost to Follow-up|2
1166152|NCT01202773|3828744|P2|Overall Study|Lost to Follow-up|2
1166153|NCT01202773|3828745|P1|Overall Study|Lost to Follow-up|1
1166154|NCT01202773|3828743|P3|Overall Study|Entry Criteria Not Met|1
1166155|NCT01202773|3828744|P2|Overall Study|Entry Criteria Not Met|0
1166156|NCT01202773|3828745|P1|Overall Study|Entry Criteria Not Met|2
1166157|NCT01202773|3828743|P3|Overall Study|Lack of Efficacy|9
1166158|NCT01202773|3828744|P2|Overall Study|Lack of Efficacy|4
1166159|NCT01202773|3828745|P1|Overall Study|Lack of Efficacy|5
1166160|NCT01202773|3828743|P3|Overall Study|Adverse Event|5
1166161|NCT01202773|3828744|P2|Overall Study|Adverse Event|5
1166162|NCT01202773|3828745|P1|Overall Study|Adverse Event|4
1166163|NCT01202760|3828822|P3|Overall Study|Sponsor Decision|0
1166164|NCT01202760|3828823|P2|Overall Study|Sponsor Decision|4
1166165|NCT01202760|3828824|P1|Overall Study|Sponsor Decision|4
1166166|NCT01202760|3828822|P3|Overall Study|Protocol Violation|2
1166167|NCT01202760|3828823|P2|Overall Study|Protocol Violation|5
1166168|NCT01202760|3828824|P1|Overall Study|Protocol Violation|7
1166169|NCT01202760|3828822|P3|Overall Study|Physician Decision|0
1166170|NCT01202760|3828823|P2|Overall Study|Physician Decision|1
1166171|NCT01202760|3828824|P1|Overall Study|Physician Decision|0
1166172|NCT01202760|3828822|P3|Overall Study|Withdrawal by Subject|14
1166173|NCT01202760|3828823|P2|Overall Study|Withdrawal by Subject|18
1166174|NCT01202760|3828824|P1|Overall Study|Withdrawal by Subject|17
1166175|NCT01202760|3828822|P3|Overall Study|Parent / Caregiver Decision|0
1166176|NCT01202760|3828823|P2|Overall Study|Parent / Caregiver Decision|1
1166177|NCT01202760|3828824|P1|Overall Study|Parent / Caregiver Decision|0
1166178|NCT01202760|3828822|P3|Overall Study|Lost to Follow-up|1
1166179|NCT01202760|3828823|P2|Overall Study|Lost to Follow-up|2
1166180|NCT01202760|3828824|P1|Overall Study|Lost to Follow-up|0
1166181|NCT01202760|3828822|P3|Overall Study|Lack of Efficacy|7
1166182|NCT01202760|3828823|P2|Overall Study|Lack of Efficacy|8
1166183|NCT01202760|3828824|P1|Overall Study|Lack of Efficacy|6
1166184|NCT01202760|3828822|P3|Overall Study|Death|0
1166185|NCT01202760|3828823|P2|Overall Study|Death|1
1166186|NCT01202760|3828824|P1|Overall Study|Death|2
1166187|NCT01202760|3828822|P3|Overall Study|Adverse Event|10
1166188|NCT01202760|3828823|P2|Overall Study|Adverse Event|9
1166189|NCT01202760|3828824|P1|Overall Study|Adverse Event|11
1166190|NCT01202760|3828822|P3|Overall Study|Entry Criteria Not Met|1
1166191|NCT01202760|3828823|P2|Overall Study|Entry Criteria Not Met|3
1166192|NCT01202760|3828824|P1|Overall Study|Entry Criteria Not Met|0
1166193|NCT01202747|3828892|P1|Overall Study|Withdrawal by Subject|1
1166194|NCT01202591|3828924|P6|Overall Study|Objective Disease Progression|0
1166195|NCT01202591|3828925|P5|Overall Study|Objective Disease Progression|2
1166196|NCT01202591|3828926|P4|Overall Study|Objective Disease Progression|0
1166197|NCT01202591|3828927|P3|Overall Study|Objective Disease Progression|0
1166198|NCT01202591|3828928|P2|Overall Study|Objective Disease Progression|0
1166199|NCT01202591|3828929|P1|Overall Study|Objective Disease Progression|0
1166200|NCT01202591|3828924|P6|Overall Study|Withdrawal by Subject|1
1166201|NCT01202591|3828925|P5|Overall Study|Withdrawal by Subject|2
1166202|NCT01202591|3828926|P4|Overall Study|Withdrawal by Subject|0
1166203|NCT01202591|3828927|P3|Overall Study|Withdrawal by Subject|0
1166204|NCT01202591|3828928|P2|Overall Study|Withdrawal by Subject|0
1166205|NCT01202591|3828929|P1|Overall Study|Withdrawal by Subject|0
1166206|NCT01202591|3828924|P6|Overall Study|Other reason as per investigator|3
1166207|NCT01202591|3828925|P5|Overall Study|Other reason as per investigator|1
1166208|NCT01202591|3828926|P4|Overall Study|Other reason as per investigator|3
1166209|NCT01202591|3828927|P3|Overall Study|Other reason as per investigator|7
1166210|NCT01202591|3828928|P2|Overall Study|Other reason as per investigator|4
1166211|NCT01202591|3828929|P1|Overall Study|Other reason as per investigator|3
1166212|NCT01202591|3828924|P6|Overall Study|Adverse Event|0
1166213|NCT01202591|3828925|P5|Overall Study|Adverse Event|0
1166214|NCT01202591|3828926|P4|Overall Study|Adverse Event|4
1166215|NCT01202591|3828927|P3|Overall Study|Adverse Event|4
1166216|NCT01202591|3828928|P2|Overall Study|Adverse Event|1
1166217|NCT01202591|3828929|P1|Overall Study|Adverse Event|2
1166218|NCT01202279|3828975|P2|Overall Study|study compliance|2
1166219|NCT01202279|3828976|P1|Overall Study|study compliance|5
1166220|NCT01202279|3828975|P2|Overall Study|Protocol Violation|1
1166221|NCT01202279|3828976|P1|Overall Study|Protocol Violation|1
1166222|NCT01202279|3828975|P2|Overall Study|Lost to Follow-up|7
1166223|NCT01202279|3828976|P1|Overall Study|Lost to Follow-up|10
1166224|NCT01202279|3828975|P2|Overall Study|Physician Decision|1
1166225|NCT01202279|3828976|P1|Overall Study|Physician Decision|0
1166226|NCT01202279|3828975|P2|Overall Study|Withdrawal by Subject|10
1166227|NCT01202279|3828976|P1|Overall Study|Withdrawal by Subject|13
1166228|NCT01202279|3828975|P2|Overall Study|Adverse Event|6
1166229|NCT01202279|3828976|P1|Overall Study|Adverse Event|8
1166230|NCT01202227|3829028|P1|Overall Study|Lack of Efficacy|1
1166231|NCT01202227|3829028|P1|Overall Study|Withdrawal by Subject|2
1166232|NCT01202227|3829028|P1|Overall Study|Adverse Event|16
1166233|NCT01202188|3829052|P5|Overall Study|Abnormal test procedure result (s)|0
1166234|NCT01202188|3829053|P4|Overall Study|Abnormal test procedure result (s)|0
1166235|NCT01202188|3829054|P3|Overall Study|Abnormal test procedure result (s)|2
1166236|NCT01202188|3829055|P2|Overall Study|Abnormal test procedure result (s)|0
1166237|NCT01202188|3829056|P1|Overall Study|Abnormal test procedure result (s)|0
1166238|NCT01202188|3829052|P5|Overall Study|Death|0
1166239|NCT01202188|3829053|P4|Overall Study|Death|1
1166240|NCT01202188|3829054|P3|Overall Study|Death|1
1166241|NCT01202188|3829055|P2|Overall Study|Death|1
1166242|NCT01202188|3829056|P1|Overall Study|Death|1
1166243|NCT01202188|3829052|P5|Overall Study|Lost to Follow-up|1
1166244|NCT01202188|3829053|P4|Overall Study|Lost to Follow-up|4
1166245|NCT01202188|3829054|P3|Overall Study|Lost to Follow-up|0
1166246|NCT01202188|3829055|P2|Overall Study|Lost to Follow-up|1
1166247|NCT01202188|3829056|P1|Overall Study|Lost to Follow-up|1
1166248|NCT01202188|3829052|P5|Overall Study|Unsatisfactory therapeutic effect|8
1166249|NCT01202188|3829053|P4|Overall Study|Unsatisfactory therapeutic effect|5
1166250|NCT01202188|3829054|P3|Overall Study|Unsatisfactory therapeutic effect|2
1166251|NCT01202188|3829055|P2|Overall Study|Unsatisfactory therapeutic effect|8
1166252|NCT01202188|3829056|P1|Overall Study|Unsatisfactory therapeutic effect|2
1166253|NCT01202188|3829052|P5|Overall Study|Administrative problems|2
1166254|NCT01202188|3829053|P4|Overall Study|Administrative problems|1
1166255|NCT01202188|3829054|P3|Overall Study|Administrative problems|1
1166256|NCT01202188|3829055|P2|Overall Study|Administrative problems|2
1166257|NCT01202188|3829056|P1|Overall Study|Administrative problems|3
1166258|NCT01202188|3829052|P5|Overall Study|Adverse Event|10
1166259|NCT01202188|3829053|P4|Overall Study|Adverse Event|10
1166260|NCT01202188|3829054|P3|Overall Study|Adverse Event|13
1166261|NCT01202188|3829055|P2|Overall Study|Adverse Event|23
1166262|NCT01202188|3829056|P1|Overall Study|Adverse Event|5
1166263|NCT01202188|3829052|P5|Overall Study|Subject withdrew consent|13
1166264|NCT01202188|3829053|P4|Overall Study|Subject withdrew consent|11
1166265|NCT01202188|3829054|P3|Overall Study|Subject withdrew consent|22
1166266|NCT01202188|3829055|P2|Overall Study|Subject withdrew consent|13
1166267|NCT01202188|3829056|P1|Overall Study|Subject withdrew consent|12
1166268|NCT01202188|3829052|P5|Overall Study|Protocol deviation|11
1166269|NCT01202188|3829053|P4|Overall Study|Protocol deviation|10
1166270|NCT01202188|3829054|P3|Overall Study|Protocol deviation|12
1166271|NCT01202188|3829055|P2|Overall Study|Protocol deviation|8
1166272|NCT01202188|3829056|P1|Overall Study|Protocol deviation|14
1166273|NCT01201967|3829203|P2|Overall Study|Lost to Follow-up|5
1166274|NCT01201967|3829204|P1|Overall Study|Lost to Follow-up|6
1166275|NCT01201915|3829229|P3|Overall Study|Target Lesion Progression|0
1166276|NCT01201915|3829230|P2|Overall Study|Target Lesion Progression|3
1166277|NCT01201915|3829231|P1|Overall Study|Target Lesion Progression|0
1166278|NCT01201915|3829229|P3|Overall Study|Subject Decision|5
1166279|NCT01201915|3829230|P2|Overall Study|Subject Decision|3
1166280|NCT01201915|3829231|P1|Overall Study|Subject Decision|3
1166281|NCT01201915|3829229|P3|Overall Study|Physician Decision|0
1166282|NCT01201915|3829230|P2|Overall Study|Physician Decision|0
1166283|NCT01201915|3829231|P1|Overall Study|Physician Decision|3
1166284|NCT01201915|3829229|P3|Overall Study|Lost to Follow-up|0
1166285|NCT01201915|3829230|P2|Overall Study|Lost to Follow-up|4
1166286|NCT01201915|3829231|P1|Overall Study|Lost to Follow-up|0
1166287|NCT01201915|3829229|P3|Overall Study|Adverse Event|1
1166288|NCT01201915|3829230|P2|Overall Study|Adverse Event|1
1166289|NCT01201915|3829231|P1|Overall Study|Adverse Event|2
1166290|NCT01201811|3829242|P1|Overall Study|Physician Decision|1
1166291|NCT01201811|3829242|P1|Overall Study|Treatment Failure|2
1166292|NCT01201811|3829242|P1|Overall Study|Death|4
1166293|NCT01201811|3829242|P1|Overall Study|Withdrawal by Subject|3
1166294|NCT01201811|3829242|P1|Overall Study|Disease progression|3
1166295|NCT01201811|3829242|P1|Overall Study|Adverse Event|6
1166296|NCT01201798|3829264|P2|Overall Study|Treatment Failure|8
1166297|NCT01201798|3829265|P1|Overall Study|Treatment Failure|1
1166298|NCT01201798|3829264|P2|Overall Study|Protocol Violation|1
1166299|NCT01201798|3829265|P1|Overall Study|Protocol Violation|1
1166300|NCT01201798|3829264|P2|Overall Study|Noncompliance|0
1166301|NCT01201798|3829265|P1|Overall Study|Noncompliance|1
1166302|NCT01201798|3829264|P2|Overall Study|Decision Unrelated to an Adverse Event|1
1166303|NCT01201798|3829265|P1|Overall Study|Decision Unrelated to an Adverse Event|1
1166304|NCT01201798|3829264|P2|Overall Study|Lost to Follow-up|5
1166305|NCT01201798|3829265|P1|Overall Study|Lost to Follow-up|3
1166306|NCT01201798|3829264|P2|Overall Study|Adverse Event|0
1166307|NCT01201798|3829265|P1|Overall Study|Adverse Event|2
1166308|NCT01201785|3829289|P1|Overall Study|Lost to Follow-up|16
1166309|NCT01201759|3829306|P2|Visit 4 Crossover|Lost to Follow-up|1
1166310|NCT01201759|3829307|P1|Visit 4 Crossover|Lost to Follow-up|0
1166311|NCT01201759|3829306|P2|Visit 3 - Washout|Lost to Follow-up|0
1166312|NCT01201759|3829307|P1|Visit 3 - Washout|Lost to Follow-up|1
1166313|NCT01201759|3829306|P2|Visit 3 - Washout|Adverse Event|3
1166314|NCT01201759|3829307|P1|Visit 3 - Washout|Adverse Event|0
1166315|NCT01201759|3829306|P2|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1
1166316|NCT01201759|3829307|P1|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2
1166317|NCT01201343|3829336|P1|Overall Study|Randomized, not treated|3
1166318|NCT01201343|3829336|P1|Overall Study|Participant wrongly included in trial|1
1166319|NCT01201343|3829336|P1|Overall Study|Lack of Efficacy|2
1166320|NCT01201343|3829336|P1|Overall Study|Lost to Follow-up|2
1166321|NCT01201343|3829336|P1|Overall Study|Withdrawal by Subject|5
1166322|NCT01201343|3829336|P1|Overall Study|Adverse Event|6
1166323|NCT01201317|3829350|P3|Overall Study|Safety, possible history of tuberculosis|1
1166324|NCT01201317|3829351|P2|Overall Study|Safety, possible history of tuberculosis|0
1166325|NCT01201317|3829352|P1|Overall Study|Safety, possible history of tuberculosis|0
1166326|NCT01201317|3829350|P3|Overall Study|Lack of Efficacy|0
1166327|NCT01201317|3829351|P2|Overall Study|Lack of Efficacy|0
1166328|NCT01201317|3829352|P1|Overall Study|Lack of Efficacy|1
1166329|NCT01201317|3829350|P3|Overall Study|Decrease in renal function|0
1166330|NCT01201317|3829351|P2|Overall Study|Decrease in renal function|1
1166331|NCT01201317|3829352|P1|Overall Study|Decrease in renal function|0
1166332|NCT01201317|3829350|P3|Overall Study|Painful Diabetic Neuropathy worsening|0
1166333|NCT01201317|3829351|P2|Overall Study|Painful Diabetic Neuropathy worsening|1
1166334|NCT01201317|3829352|P1|Overall Study|Painful Diabetic Neuropathy worsening|0
1166335|NCT01201317|3829350|P3|Overall Study|Study-specific withdrawal criteria|1
1166336|NCT01201317|3829351|P2|Overall Study|Study-specific withdrawal criteria|0
1166337|NCT01201317|3829352|P1|Overall Study|Study-specific withdrawal criteria|0
1166338|NCT01201317|3829350|P3|Overall Study|Death|0
1166339|NCT01201317|3829351|P2|Overall Study|Death|1
1166340|NCT01201317|3829352|P1|Overall Study|Death|0
1166341|NCT01201317|3829350|P3|Overall Study|Protocol Violation|1
1166342|NCT01201317|3829351|P2|Overall Study|Protocol Violation|1
1166343|NCT01201317|3829352|P1|Overall Study|Protocol Violation|0
1166344|NCT01201317|3829350|P3|Overall Study|Screen failure|0
1166345|NCT01201317|3829351|P2|Overall Study|Screen failure|1
1166346|NCT01201317|3829352|P1|Overall Study|Screen failure|1
1166347|NCT01201317|3829350|P3|Overall Study|Adverse Event|2
1166348|NCT01201317|3829351|P2|Overall Study|Adverse Event|2
1166349|NCT01201317|3829352|P1|Overall Study|Adverse Event|2
1166350|NCT01201317|3829350|P3|Overall Study|Withdrawal by Subject|3
1166351|NCT01201317|3829351|P2|Overall Study|Withdrawal by Subject|0
1166352|NCT01201317|3829352|P1|Overall Study|Withdrawal by Subject|5
1166353|NCT01201265|3829372|P1|Overall Study|Disease Progression|4
1166354|NCT01201265|3829372|P1|Overall Study|Withdrawal by Subject|7
1166355|NCT01201265|3829372|P1|Overall Study|Lost to Follow-up|10
1166356|NCT01201265|3829372|P1|Overall Study|Insufficient Therapeutic Response|3
1166357|NCT01201265|3829372|P1|Overall Study|Death|14
1166358|NCT01200992|3829386|P2|Overall Study|Randomized but not treated|0
1166359|NCT01200992|3829387|P1|Overall Study|Randomized but not treated|2
1166360|NCT01200992|3829386|P2|Overall Study|Study terminated early|41
1166361|NCT01200992|3829387|P1|Overall Study|Study terminated early|35
1166362|NCT01200810|3829401|P2|Overall Study|Sponsor stopped making study drug|3
1166363|NCT01200810|3829402|P1|Overall Study|Sponsor stopped making study drug|3
1166364|NCT01200810|3829401|P2|Overall Study|Withdrawal by Subject|2
1166365|NCT01200810|3829402|P1|Overall Study|Withdrawal by Subject|1
1166366|NCT01200810|3829401|P2|Overall Study|Physician Decision|0
1166367|NCT01200810|3829402|P1|Overall Study|Physician Decision|1
1166368|NCT01200797|3829422|P1|Overall Study|Disease Progression|13
1166369|NCT01200797|3829422|P1|Overall Study|Adverse Event|4
1166370|NCT01200797|3829422|P1|Overall Study|symptomatic deterioration|2
1166371|NCT01200758|3829432|P4|Stage 2|Death|5
1166372|NCT01200758|3829433|P3|Stage 2|Death|3
1166373|NCT01200758|3829434|P2|Stage 2|Death|0
1166374|NCT01200758|3829435|P1|Stage 2|Death|0
1166375|NCT01200758|3829432|P4|Stage 2|Protocol Violation|4
1166376|NCT01200758|3829433|P3|Stage 2|Protocol Violation|1
1166377|NCT01200758|3829434|P2|Stage 2|Protocol Violation|0
1166378|NCT01200758|3829435|P1|Stage 2|Protocol Violation|0
1166379|NCT01200758|3829432|P4|Stage 2|Lost to Follow-up|1
1166380|NCT01200758|3829433|P3|Stage 2|Lost to Follow-up|3
1166381|NCT01200758|3829434|P2|Stage 2|Lost to Follow-up|0
1166382|NCT01200758|3829435|P1|Stage 2|Lost to Follow-up|0
1166383|NCT01200758|3829432|P4|Stage 2|Withdrawal by Subject|1
1166384|NCT01200758|3829433|P3|Stage 2|Withdrawal by Subject|4
1166385|NCT01200758|3829434|P2|Stage 2|Withdrawal by Subject|0
1166386|NCT01200758|3829435|P1|Stage 2|Withdrawal by Subject|0
1166387|NCT01200758|3829432|P4|Stage 2|Adverse Event|9
1166388|NCT01200758|3829433|P3|Stage 2|Adverse Event|5
1166389|NCT01200758|3829434|P2|Stage 2|Adverse Event|0
1166390|NCT01200758|3829435|P1|Stage 2|Adverse Event|0
1166391|NCT01200758|3829432|P4|Stage 2|Physician Decision|7
1166392|NCT01200758|3829433|P3|Stage 2|Physician Decision|5
1166393|NCT01200758|3829434|P2|Stage 2|Physician Decision|0
1166394|NCT01200758|3829435|P1|Stage 2|Physician Decision|0
1166395|NCT01200758|3829432|P4|Stage 2|Lack of Efficacy|2
1166396|NCT01200758|3829433|P3|Stage 2|Lack of Efficacy|4
1166397|NCT01200758|3829434|P2|Stage 2|Lack of Efficacy|0
1166398|NCT01200758|3829435|P1|Stage 2|Lack of Efficacy|0
1166399|NCT01200758|3829432|P4|Stage 2|Disease Progression|21
1166400|NCT01200758|3829433|P3|Stage 2|Disease Progression|16
1166401|NCT01200758|3829434|P2|Stage 2|Disease Progression|0
1166402|NCT01200758|3829435|P1|Stage 2|Disease Progression|0
1166403|NCT01200758|3829432|P4|Stage I|Disease Progression|0
1166404|NCT01200758|3829433|P3|Stage I|Disease Progression|0
1166405|NCT01200758|3829434|P2|Stage I|Disease Progression|7
1166406|NCT01200758|3829435|P1|Stage I|Disease Progression|9
1166407|NCT01200758|3829432|P4|Stage I|Withdrawal by Subject|0
1166408|NCT01200758|3829433|P3|Stage I|Withdrawal by Subject|0
1166409|NCT01200758|3829434|P2|Stage I|Withdrawal by Subject|2
1166410|NCT01200758|3829435|P1|Stage I|Withdrawal by Subject|1
1166411|NCT01200758|3829432|P4|Stage I|Adverse Event|0
1166412|NCT01200758|3829433|P3|Stage I|Adverse Event|0
1166413|NCT01200758|3829434|P2|Stage I|Adverse Event|5
1166414|NCT01200758|3829435|P1|Stage I|Adverse Event|5
1166415|NCT01200758|3829432|P4|Stage I|Lack of Efficacy|0
1166416|NCT01200758|3829433|P3|Stage I|Lack of Efficacy|0
1166417|NCT01200758|3829434|P2|Stage I|Lack of Efficacy|1
1166418|NCT01200758|3829435|P1|Stage I|Lack of Efficacy|2
1166419|NCT01200758|3829432|P4|Stage I|Physician Decision|0
1166420|NCT01200758|3829433|P3|Stage I|Physician Decision|0
1166421|NCT01200758|3829434|P2|Stage I|Physician Decision|1
1166422|NCT01200758|3829435|P1|Stage I|Physician Decision|1
1166423|NCT01200758|3829432|P4|Stage I|Death|0
1166424|NCT01200758|3829433|P3|Stage I|Death|0
1166425|NCT01200758|3829434|P2|Stage I|Death|1
1166426|NCT01200758|3829435|P1|Stage I|Death|0
1166427|NCT01200589|3829508|P2|Overall Study|Study terminated|172
1166428|NCT01200589|3829509|P1|Overall Study|Study terminated|170
1166429|NCT01200589|3829508|P2|Overall Study|Lost to Follow-up|4
1166430|NCT01200589|3829509|P1|Overall Study|Lost to Follow-up|5
1166431|NCT01200589|3829508|P2|Overall Study|Physician Decision|2
1166432|NCT01200589|3829509|P1|Overall Study|Physician Decision|2
1166433|NCT01200589|3829508|P2|Overall Study|Withdrawal by Subject|11
1166434|NCT01200589|3829509|P1|Overall Study|Withdrawal by Subject|13
1166435|NCT01200524|3829536|P3|Overall Study|Non availability of study nurse|1
1166436|NCT01200524|3829537|P2|Overall Study|Non availability of study nurse|0
1166437|NCT01200524|3829538|P1|Overall Study|Non availability of study nurse|0
1166438|NCT01200524|3829536|P3|Overall Study|Adverse Event|0
1166439|NCT01200524|3829537|P2|Overall Study|Adverse Event|0
1166440|NCT01200524|3829538|P1|Overall Study|Adverse Event|1
1166441|NCT01200524|3829536|P3|Overall Study|Withdrawal by Subject|3
1166442|NCT01200524|3829537|P2|Overall Study|Withdrawal by Subject|1
1166443|NCT01200524|3829538|P1|Overall Study|Withdrawal by Subject|1
1166444|NCT01200511|3829558|P1|Overall Study|Adverse Event|1
1166445|NCT01200511|3829558|P1|Overall Study|Withdrawal by Subject|1
1166446|NCT01200511|3829558|P1|Overall Study|Lost to Follow-up|3
1166447|NCT01200368|3829596|P3|Toddler Dose|Adverse Event|1
1166448|NCT01200368|3829597|P2|Toddler Dose|Adverse Event|3
1166449|NCT01200368|3829598|P1|Toddler Dose|Adverse Event|0
1166450|NCT01200368|3829596|P3|After Infant Series|Other|2
1166451|NCT01200368|3829597|P2|After Infant Series|Other|2
1166452|NCT01200368|3829598|P1|After Infant Series|Other|1
1166453|NCT01200368|3829596|P3|After Infant Series|Lost to Follow-up|0
1166454|NCT01200368|3829597|P2|After Infant Series|Lost to Follow-up|0
1166455|NCT01200368|3829598|P1|After Infant Series|Lost to Follow-up|1
1166456|NCT01200368|3829596|P3|After Infant Series|Withdrawal by Subject|4
1166457|NCT01200368|3829597|P2|After Infant Series|Withdrawal by Subject|8
1166458|NCT01200368|3829598|P1|After Infant Series|Withdrawal by Subject|10
1166459|NCT01200368|3829596|P3|After Infant Series|Adverse Event|3
1166460|NCT01200368|3829597|P2|After Infant Series|Adverse Event|6
1166461|NCT01200368|3829598|P1|After Infant Series|Adverse Event|6
1166462|NCT01200368|3829596|P3|Infant Series|Other|0
1166463|NCT01200368|3829597|P2|Infant Series|Other|0
1166464|NCT01200368|3829598|P1|Infant Series|Other|1
1166465|NCT01200368|3829596|P3|Infant Series|Randomized, not vaccinated|1
1166466|NCT01200368|3829597|P2|Infant Series|Randomized, not vaccinated|1
1166467|NCT01200368|3829598|P1|Infant Series|Randomized, not vaccinated|0
1166468|NCT01200368|3829596|P3|Infant Series|Did not meet entrance criteria|0
1166469|NCT01200368|3829597|P2|Infant Series|Did not meet entrance criteria|1
1166470|NCT01200368|3829598|P1|Infant Series|Did not meet entrance criteria|0
1166471|NCT01200368|3829596|P3|Infant Series|Withdrawal by Subject|2
1166472|NCT01200368|3829597|P2|Infant Series|Withdrawal by Subject|2
1166473|NCT01200368|3829598|P1|Infant Series|Withdrawal by Subject|0
1166474|NCT01200368|3829596|P3|Infant Series|Adverse Event|3
1166475|NCT01200368|3829597|P2|Infant Series|Adverse Event|2
1166476|NCT01200368|3829598|P1|Infant Series|Adverse Event|2
1166477|NCT01200355|3829664|P2|Overall Study|Death|2
1166478|NCT01200355|3829665|P1|Overall Study|Death|7
1166479|NCT01200342|3829679|P1|Overall Study|Disease Progression|1
1166480|NCT01200290|3829684|P1|Post-Treatment Follow-Up Period|Death|2
1166481|NCT01200290|3829684|P1|Treatment Period|Adverse Event|1
1166482|NCT01200238|3829697|P2|Overall Study|Withdrawal by Subject|1
1166483|NCT01200238|3829698|P1|Overall Study|Withdrawal by Subject|0
1166484|NCT01200238|3829697|P2|Overall Study|Progressive Disease|8
1166485|NCT01200238|3829698|P1|Overall Study|Progressive Disease|5
1166486|NCT01200238|3829697|P2|Overall Study|Adverse Event|1
1166487|NCT01200238|3829698|P1|Overall Study|Adverse Event|2
1166488|NCT01200069|3829722|P2|Overall Study|Withdrawal by Subject|1
1166489|NCT01200069|3829723|P1|Overall Study|Withdrawal by Subject|0
1166490|NCT01199939|3829792|P1|Overall Study|Reached a virologic endpoint|4
1166491|NCT01199939|3829792|P1|Overall Study|Lost to Follow-up|2
1166492|NCT01199939|3829792|P1|Overall Study|Protocol Violation|3
1166493|NCT01199939|3829792|P1|Overall Study|Adverse Event|4
1166494|NCT01199861|3829824|P2|Overall Study|Adverse Event|0
1166495|NCT01199861|3829825|P1|Overall Study|Adverse Event|1
1166496|NCT01199861|3829824|P2|Overall Study|Administrative problems|0
1166497|NCT01199861|3829825|P1|Overall Study|Administrative problems|1
1166498|NCT01199822|3829846|P3|Overall Study|Investigator discontinued therapy|0
1166499|NCT01199822|3829847|P2|Overall Study|Investigator discontinued therapy|1
1166500|NCT01199822|3829848|P1|Overall Study|Investigator discontinued therapy|0
1166501|NCT01199731|3829897|P3|Overall Study|Withdrawal by Subject|0
1166502|NCT01199731|3829898|P2|Overall Study|Withdrawal by Subject|0
1166503|NCT01199731|3829899|P1|Overall Study|Withdrawal by Subject|2
1166504|NCT01199731|3829897|P3|Overall Study|Physician Decision|1
1166505|NCT01199731|3829898|P2|Overall Study|Physician Decision|1
1166506|NCT01199731|3829899|P1|Overall Study|Physician Decision|0
1166507|NCT01199731|3829897|P3|Overall Study|Lost to Follow-up|2
1166508|NCT01199731|3829898|P2|Overall Study|Lost to Follow-up|0
1166509|NCT01199731|3829899|P1|Overall Study|Lost to Follow-up|0
1166510|NCT01199731|3829897|P3|Overall Study|Study closed/terminated|7
1166511|NCT01199731|3829898|P2|Overall Study|Study closed/terminated|9
1166512|NCT01199731|3829899|P1|Overall Study|Study closed/terminated|7
1166513|NCT01199731|3829897|P3|Overall Study|Adverse Event|0
1166514|NCT01199731|3829898|P2|Overall Study|Adverse Event|1
1166515|NCT01199731|3829899|P1|Overall Study|Adverse Event|0
1166516|NCT01199705|3829937|P1|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1
1166517|NCT01199601|3829969|P2|Overall Study|Insecurity prevented staff interviewing.|9
1166518|NCT01199601|3829970|P1|Overall Study|Insecurity prevented staff interviewing.|7
1166519|NCT01199601|3829969|P2|Overall Study|Withdrawal by Subject|3
1166520|NCT01199601|3829970|P1|Overall Study|Withdrawal by Subject|15
1166521|NCT01199601|3829969|P2|Overall Study|Lost to Follow-up|66
1166522|NCT01199601|3829970|P1|Overall Study|Lost to Follow-up|47
1166523|NCT01199575|3829980|P1|Overall Study|Withdrawal by Subject|5
1166524|NCT01199471|3829985|P1|Overall Study|Physician Decision|1
1166525|NCT01199471|3829985|P1|Overall Study|Withdrawal by Subject|1
1166526|NCT01199471|3829985|P1|Overall Study|Protocol Violation|4
1166527|NCT01199042|3830017|P1|At Home (3 Months)|Lost to Follow-up|1
1166528|NCT01199042|3830017|P1|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2
1166529|NCT01199016|3830026|P1|Overall Study|Lost to Follow-up|25
1166530|NCT01199016|3830026|P1|Overall Study|Withdrawal by Subject|21
1166531|NCT01199016|3830026|P1|Overall Study|Other|13
1166532|NCT01199016|3830026|P1|Overall Study|Protocol Violation|9
1166533|NCT01199016|3830026|P1|Overall Study|Entrance criteria|5
1166534|NCT01199016|3830026|P1|Overall Study|No longer meets eligibility criteria|4
1166535|NCT01198977|3830035|P2|Overall Study|Lost to Follow-up|0
1166536|NCT01198977|3830036|P1|Overall Study|Lost to Follow-up|1
1166537|NCT01198873|3830048|P2|Overall Study|Other than above|2
1166538|NCT01198873|3830049|P1|Overall Study|Other than above|4
1166539|NCT01198873|3830048|P2|Overall Study|Study closure|23
1166540|NCT01198873|3830049|P1|Overall Study|Study closure|29
1166541|NCT01198873|3830048|P2|Overall Study|Adverse Event|7
1166542|NCT01198873|3830049|P1|Overall Study|Adverse Event|4
1166543|NCT01198795|3830063|P1|Overall Study|Other Reason|4
1166544|NCT01198795|3830063|P1|Overall Study|Protocol Violation|2
1166545|NCT01198795|3830063|P1|Overall Study|Lack of Efficacy|5
1166546|NCT01198795|3830063|P1|Overall Study|Adverse Event|9
1166547|NCT01198795|3830063|P1|Overall Study|Lost to Follow-up|15
1166548|NCT01198795|3830063|P1|Overall Study|Withdrawal by Subject|17
1166549|NCT01198795|3830063|P1|Overall Study|Did not meet InclusionExclusion criteria|30
1166550|NCT01198756|3830080|P4|Overall Study|Lost to Follow-up|18
1166551|NCT01198756|3830081|P3|Overall Study|Lost to Follow-up|23
1166552|NCT01198756|3830082|P2|Overall Study|Lost to Follow-up|36
1166553|NCT01198756|3830083|P1|Overall Study|Lost to Follow-up|29
1166554|NCT01198756|3830080|P4|Overall Study|Withdrawal by Subject|5
1166555|NCT01198756|3830081|P3|Overall Study|Withdrawal by Subject|7
1166556|NCT01198756|3830082|P2|Overall Study|Withdrawal by Subject|4
1166557|NCT01198756|3830083|P1|Overall Study|Withdrawal by Subject|9
1166558|NCT01198756|3830080|P4|Overall Study|Protocol Violation|2
1166559|NCT01198756|3830081|P3|Overall Study|Protocol Violation|0
1166560|NCT01198756|3830082|P2|Overall Study|Protocol Violation|0
1166561|NCT01198756|3830083|P1|Overall Study|Protocol Violation|0
1166562|NCT01198756|3830080|P4|Overall Study|Adverse Event|1
1166563|NCT01198756|3830081|P3|Overall Study|Adverse Event|0
1166564|NCT01198756|3830082|P2|Overall Study|Adverse Event|0
1166565|NCT01198756|3830083|P1|Overall Study|Adverse Event|0
1166566|NCT01198600|3830194|P4|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
1166567|NCT01198600|3830195|P3|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1
1166568|NCT01198600|3830196|P2|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
1166569|NCT01198600|3830197|P1|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
1166570|NCT01198600|3830194|P4|Phase 2: 56 Days of Wear|Relocation|0
1166571|NCT01198600|3830195|P3|Phase 2: 56 Days of Wear|Relocation|2
1166572|NCT01198600|3830196|P2|Phase 2: 56 Days of Wear|Relocation|0
1166573|NCT01198600|3830197|P1|Phase 2: 56 Days of Wear|Relocation|0
1166574|NCT01198600|3830194|P4|Phase 2: 56 Days of Wear|Inconvenience|0
1166575|NCT01198600|3830195|P3|Phase 2: 56 Days of Wear|Inconvenience|2
1166576|NCT01198600|3830196|P2|Phase 2: 56 Days of Wear|Inconvenience|0
1166577|NCT01198600|3830197|P1|Phase 2: 56 Days of Wear|Inconvenience|0
1166578|NCT01198600|3830194|P4|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
1166579|NCT01198600|3830195|P3|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
1166580|NCT01198600|3830196|P2|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1
1166581|NCT01198600|3830197|P1|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
1166582|NCT01198600|3830194|P4|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
1166583|NCT01198600|3830195|P3|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
1166584|NCT01198600|3830196|P2|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1
1166585|NCT01198600|3830197|P1|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
1166586|NCT01198600|3830194|P4|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
1166587|NCT01198600|3830195|P3|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
1166588|NCT01198600|3830196|P2|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
1166589|NCT01198600|3830197|P1|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1
1166590|NCT01198600|3830194|P4|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
1166591|NCT01198600|3830195|P3|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
1166592|NCT01198600|3830196|P2|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
1166593|NCT01198600|3830197|P1|Phase 1: Period One, 30 Days of Wear|Inconvenience|1
1166594|NCT01198587|3830223|P4|Overall Study|Lost to Follow-up|0
1166595|NCT01198587|3830224|P3|Overall Study|Lost to Follow-up|9
1166596|NCT01198587|3830225|P2|Overall Study|Lost to Follow-up|0
1166597|NCT01198587|3830226|P1|Overall Study|Lost to Follow-up|8
1166598|NCT01198574|3830248|P4|Overall Study|Resigned from schools|4
1166599|NCT01198574|3830249|P3|Overall Study|Resigned from schools|1
1166600|NCT01198574|3830250|P2|Overall Study|Resigned from schools|1
1166601|NCT01198574|3830251|P1|Overall Study|Resigned from schools|4
1166602|NCT01198548|3830269|P1|Overall Study|Administrative Decision|1
1166603|NCT01198548|3830269|P1|Overall Study|Disease Progression|9
1166604|NCT01198509|3830284|P6|Overall Study|Withdrawal by Subject|0
1166605|NCT01198509|3830285|P5|Overall Study|Withdrawal by Subject|0
1166606|NCT01198509|3830286|P4|Overall Study|Withdrawal by Subject|0
1166607|NCT01198509|3830287|P3|Overall Study|Withdrawal by Subject|0
1166608|NCT01198509|3830288|P2|Overall Study|Withdrawal by Subject|0
1166609|NCT01198509|3830289|P1|Overall Study|Withdrawal by Subject|1
1166610|NCT01198470|3830306|P1|Overall Study|Adverse Event|2
1166611|NCT01198275|3830372|P2|Overall Study|spontaneous return to sinus rhythm|2
1166612|NCT01198275|3830373|P1|Overall Study|spontaneous return to sinus rhythm|4
1166613|NCT01198275|3830372|P2|Overall Study|Adverse Event|3
1166614|NCT01198275|3830373|P1|Overall Study|Adverse Event|2
1166615|NCT01198145|3830381|P2|Overall Study|Withdrawal by Subject|1
1166616|NCT01198145|3830382|P1|Overall Study|Withdrawal by Subject|1
1166617|NCT01198132|3830404|P2|Overall Study|Protocol Violation|0
1166618|NCT01198132|3830405|P1|Overall Study|Protocol Violation|1
1166619|NCT01198132|3830404|P2|Overall Study|Adverse Event|1
1166620|NCT01198132|3830405|P1|Overall Study|Adverse Event|0
1166621|NCT01198132|3830404|P2|Overall Study|Abnormal/clinically significant biologic|1
1166622|NCT01198132|3830405|P1|Overall Study|Abnormal/clinically significant biologic|1
1166623|NCT01198132|3830404|P2|Overall Study|Sign/symptoms of underlying disease|1
1166624|NCT01198132|3830405|P1|Overall Study|Sign/symptoms of underlying disease|2
1166625|NCT01198132|3830404|P2|Overall Study|Lack of Efficacy|3
1166626|NCT01198132|3830405|P1|Overall Study|Lack of Efficacy|2
1166627|NCT01198132|3830404|P2|Overall Study|Other Unspecified|6
1166628|NCT01198132|3830405|P1|Overall Study|Other Unspecified|3
1166629|NCT01198132|3830404|P2|Overall Study|Physician Decision|4
1166630|NCT01198132|3830405|P1|Overall Study|Physician Decision|5
1166631|NCT01198132|3830404|P2|Overall Study|Withdrawal by Subject|5
1166632|NCT01198132|3830405|P1|Overall Study|Withdrawal by Subject|4
1166633|NCT01198002|3830432|P3|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75
1166634|NCT01198002|3830433|P2|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70
1166635|NCT01198002|3830434|P1|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62
1166636|NCT01198002|3830432|P3|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
1166637|NCT01198002|3830433|P2|Treatment Period 2 (Weeks 52-100)|Physician Decision|0
1166638|NCT01198002|3830434|P1|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
1166639|NCT01198002|3830432|P3|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
1166640|NCT01198002|3830433|P2|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2
1166641|NCT01198002|3830434|P1|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
1166642|NCT01198002|3830432|P3|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
1166643|NCT01198002|3830433|P2|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
1166644|NCT01198002|3830434|P1|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1
1166645|NCT01198002|3830432|P3|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
1166646|NCT01198002|3830433|P2|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
1166647|NCT01198002|3830434|P1|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3
1166648|NCT01198002|3830432|P3|Treatment Period 2 (Weeks 52-100)|Adverse Event|1
1166649|NCT01198002|3830433|P2|Treatment Period 2 (Weeks 52-100)|Adverse Event|0
1166650|NCT01198002|3830434|P1|Treatment Period 2 (Weeks 52-100)|Adverse Event|2
1166651|NCT01198002|3830432|P3|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224
1166652|NCT01198002|3830433|P2|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216
1166653|NCT01198002|3830434|P1|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213
1166654|NCT01198002|3830432|P3|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
1166655|NCT01198002|3830433|P2|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
1166656|NCT01198002|3830434|P1|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14
1166657|NCT01198002|3830432|P3|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
1166658|NCT01198002|3830433|P2|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
1166659|NCT01198002|3830434|P1|Treatment Period 1 (Weeks 0-52)|Physician Decision|1
1166660|NCT01198002|3830432|P3|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12
1166661|NCT01198002|3830433|P2|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21
1166662|NCT01198002|3830434|P1|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16
1166663|NCT01198002|3830432|P3|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
1166664|NCT01198002|3830433|P2|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2
1166665|NCT01198002|3830434|P1|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
1166666|NCT01198002|3830432|P3|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
1166667|NCT01198002|3830433|P2|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
1166668|NCT01198002|3830434|P1|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1
1166669|NCT01198002|3830432|P3|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6
1166670|NCT01198002|3830433|P2|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9
1166671|NCT01198002|3830434|P1|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10
1166672|NCT01198002|3830432|P3|Treatment Period 1 (Weeks 0-52)|Death|1
1166673|NCT01198002|3830433|P2|Treatment Period 1 (Weeks 0-52)|Death|0
1166674|NCT01198002|3830434|P1|Treatment Period 1 (Weeks 0-52)|Death|2
1166675|NCT01198002|3830432|P3|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
1166676|NCT01198002|3830433|P2|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
1166677|NCT01198002|3830434|P1|Treatment Period 1 (Weeks 0-52)|Adverse Event|18
1166678|NCT01197911|3830549|P3|Overall Study|Adverse Event|1
1166679|NCT01197911|3830550|P2|Overall Study|Adverse Event|0
1166680|NCT01197911|3830551|P1|Overall Study|Adverse Event|0
1166681|NCT01197794|3830666|P7|Overall Study|Other|4
1166682|NCT01197794|3830667|P6|Overall Study|Other|2
1166683|NCT01197794|3830668|P5|Overall Study|Other|2
1166684|NCT01197794|3830669|P4|Overall Study|Other|0
1166685|NCT01197794|3830670|P3|Overall Study|Other|3
1166686|NCT01197794|3830671|P2|Overall Study|Other|1
1166687|NCT01197794|3830672|P1|Overall Study|Other|1
1166688|NCT01197794|3830666|P7|Overall Study|Lost to Follow-up|0
1166689|NCT01197794|3830667|P6|Overall Study|Lost to Follow-up|1
1166690|NCT01197794|3830668|P5|Overall Study|Lost to Follow-up|0
1166691|NCT01197794|3830669|P4|Overall Study|Lost to Follow-up|1
1166692|NCT01197794|3830670|P3|Overall Study|Lost to Follow-up|0
1166693|NCT01197794|3830671|P2|Overall Study|Lost to Follow-up|1
1166694|NCT01197794|3830672|P1|Overall Study|Lost to Follow-up|1
1166695|NCT01197794|3830666|P7|Overall Study|Withdrawal by Subject|6
1166696|NCT01197794|3830667|P6|Overall Study|Withdrawal by Subject|5
1166697|NCT01197794|3830668|P5|Overall Study|Withdrawal by Subject|1
1166698|NCT01197794|3830669|P4|Overall Study|Withdrawal by Subject|1
1166699|NCT01197794|3830670|P3|Overall Study|Withdrawal by Subject|4
1166700|NCT01197794|3830671|P2|Overall Study|Withdrawal by Subject|3
1166701|NCT01197794|3830672|P1|Overall Study|Withdrawal by Subject|3
1166702|NCT01197794|3830666|P7|Overall Study|Eligibility criteria not fulfilled|6
1166703|NCT01197794|3830667|P6|Overall Study|Eligibility criteria not fulfilled|9
1166704|NCT01197794|3830668|P5|Overall Study|Eligibility criteria not fulfilled|5
1166705|NCT01197794|3830669|P4|Overall Study|Eligibility criteria not fulfilled|5
1166706|NCT01197794|3830670|P3|Overall Study|Eligibility criteria not fulfilled|2
1166707|NCT01197794|3830671|P2|Overall Study|Eligibility criteria not fulfilled|8
1166708|NCT01197794|3830672|P1|Overall Study|Eligibility criteria not fulfilled|5
1166709|NCT01197794|3830666|P7|Overall Study|Development of study withdrawal criteria|1
1166710|NCT01197794|3830667|P6|Overall Study|Development of study withdrawal criteria|0
1166711|NCT01197794|3830668|P5|Overall Study|Development of study withdrawal criteria|0
1166712|NCT01197794|3830669|P4|Overall Study|Development of study withdrawal criteria|1
1166713|NCT01197794|3830670|P3|Overall Study|Development of study withdrawal criteria|0
1166714|NCT01197794|3830671|P2|Overall Study|Development of study withdrawal criteria|0
1166715|NCT01197794|3830672|P1|Overall Study|Development of study withdrawal criteria|3
1166716|NCT01197794|3830666|P7|Overall Study|Protocol Violation|1
1166717|NCT01197794|3830667|P6|Overall Study|Protocol Violation|0
1166718|NCT01197794|3830668|P5|Overall Study|Protocol Violation|2
1166719|NCT01197794|3830669|P4|Overall Study|Protocol Violation|0
1166720|NCT01197794|3830670|P3|Overall Study|Protocol Violation|0
1166721|NCT01197794|3830671|P2|Overall Study|Protocol Violation|0
1166722|NCT01197794|3830672|P1|Overall Study|Protocol Violation|0
1166723|NCT01197794|3830666|P7|Overall Study|Adverse Event|3
1166724|NCT01197794|3830667|P6|Overall Study|Adverse Event|2
1166725|NCT01197794|3830668|P5|Overall Study|Adverse Event|4
1166726|NCT01197794|3830669|P4|Overall Study|Adverse Event|4
1166727|NCT01197794|3830670|P3|Overall Study|Adverse Event|4
1166728|NCT01197794|3830671|P2|Overall Study|Adverse Event|2
1166729|NCT01197794|3830672|P1|Overall Study|Adverse Event|3
1166730|NCT01197755|3830754|P3|Overall Study|eg, change in circumstances|2
1166731|NCT01197755|3830755|P2|Overall Study|eg, change in circumstances|3
1166732|NCT01197755|3830756|P1|Overall Study|eg, change in circumstances|7
1166733|NCT01197755|3830754|P3|Overall Study|Lost to Follow-up|1
1166734|NCT01197755|3830755|P2|Overall Study|Lost to Follow-up|0
1166735|NCT01197755|3830756|P1|Overall Study|Lost to Follow-up|0
1166736|NCT01197755|3830754|P3|Overall Study|Withdrawal by Subject|0
1166737|NCT01197755|3830755|P2|Overall Study|Withdrawal by Subject|0
1166738|NCT01197755|3830756|P1|Overall Study|Withdrawal by Subject|1
1166739|NCT01197755|3830754|P3|Overall Study|Severe non-compliance to the protocol|2
1166740|NCT01197755|3830755|P2|Overall Study|Severe non-compliance to the protocol|1
1166741|NCT01197755|3830756|P1|Overall Study|Severe non-compliance to the protocol|2
1166742|NCT01197755|3830754|P3|Overall Study|Lack of therapeutic response|4
1166743|NCT01197755|3830755|P2|Overall Study|Lack of therapeutic response|7
1166744|NCT01197755|3830756|P1|Overall Study|Lack of therapeutic response|0
1166745|NCT01197755|3830754|P3|Overall Study|Entered the long-term extension study|35
1166746|NCT01197755|3830755|P2|Overall Study|Entered the long-term extension study|21
1166747|NCT01197755|3830756|P1|Overall Study|Entered the long-term extension study|18
1166748|NCT01197755|3830754|P3|Overall Study|Study-specific discontinuation criteria|0
1166749|NCT01197755|3830755|P2|Overall Study|Study-specific discontinuation criteria|1
1166750|NCT01197755|3830756|P1|Overall Study|Study-specific discontinuation criteria|2
1166751|NCT01197755|3830754|P3|Overall Study|Adverse Event|10
1166752|NCT01197755|3830755|P2|Overall Study|Adverse Event|10
1166753|NCT01197755|3830756|P1|Overall Study|Adverse Event|8
1166754|NCT01197560|3830828|P2|Overall Study|Missing|1
1166755|NCT01197560|3830829|P1|Overall Study|Missing|0
1166756|NCT01197560|3830828|P2|Overall Study|Elected to discontinue before cycle end|2
1166757|NCT01197560|3830829|P1|Overall Study|Elected to discontinue before cycle end|0
1166758|NCT01197560|3830828|P2|Overall Study|Proceeded to transplant|1
1166759|NCT01197560|3830829|P1|Overall Study|Proceeded to transplant|1
1166760|NCT01197560|3830828|P2|Overall Study|Disease progression|35
1166761|NCT01197560|3830829|P1|Overall Study|Disease progression|39
1166762|NCT01197560|3830828|P2|Overall Study|Withdrawal by Subject|1
1166763|NCT01197560|3830829|P1|Overall Study|Withdrawal by Subject|1
1166764|NCT01197560|3830828|P2|Overall Study|Death|5
1166765|NCT01197560|3830829|P1|Overall Study|Death|1
1166766|NCT01197560|3830828|P2|Overall Study|Adverse Event|8
1166767|NCT01197560|3830829|P1|Overall Study|Adverse Event|4
1166768|NCT01197534|3830862|P3|Overall Study|Adverse Event|24
1166769|NCT01197534|3830863|P2|Overall Study|Adverse Event|36
1166770|NCT01197534|3830864|P1|Overall Study|Adverse Event|35
1166771|NCT01197534|3830862|P3|Overall Study|Lost to Follow-up|2
1166772|NCT01197534|3830863|P2|Overall Study|Lost to Follow-up|4
1166773|NCT01197534|3830864|P1|Overall Study|Lost to Follow-up|1
1166774|NCT01197534|3830862|P3|Overall Study|Dev. of study specific discont. criteria|2
1166775|NCT01197534|3830863|P2|Overall Study|Dev. of study specific discont. criteria|6
1166776|NCT01197534|3830864|P1|Overall Study|Dev. of study specific discont. criteria|13
1166777|NCT01197534|3830862|P3|Overall Study|Lack of therapeutic response|9
1166778|NCT01197534|3830863|P2|Overall Study|Lack of therapeutic response|4
1166779|NCT01197534|3830864|P1|Overall Study|Lack of therapeutic response|9
1166780|NCT01197534|3830862|P3|Overall Study|Severe non-compliance to protocol|1
1166781|NCT01197534|3830863|P2|Overall Study|Severe non-compliance to protocol|4
1166782|NCT01197534|3830864|P1|Overall Study|Severe non-compliance to protocol|3
1166783|NCT01197534|3830862|P3|Overall Study|Enrolment in long term extension|119
1166784|NCT01197534|3830863|P2|Overall Study|Enrolment in long term extension|66
1166785|NCT01197534|3830864|P1|Overall Study|Enrolment in long term extension|57
1166786|NCT01197534|3830862|P3|Overall Study|Not reported|16
1166787|NCT01197534|3830863|P2|Overall Study|Not reported|10
1166788|NCT01197534|3830864|P1|Overall Study|Not reported|16
1166789|NCT01197521|3830908|P3|Overall Study|Adverse Event|24
1166790|NCT01197521|3830909|P2|Overall Study|Adverse Event|28
1166791|NCT01197521|3830910|P1|Overall Study|Adverse Event|25
1166792|NCT01197521|3830908|P3|Overall Study|Lost to Follow-up|2
1166793|NCT01197521|3830909|P2|Overall Study|Lost to Follow-up|2
1166794|NCT01197521|3830910|P1|Overall Study|Lost to Follow-up|3
1166795|NCT01197521|3830908|P3|Overall Study|Dev. of study specific discont. criteria|2
1166796|NCT01197521|3830909|P2|Overall Study|Dev. of study specific discont. criteria|16
1166797|NCT01197521|3830910|P1|Overall Study|Dev. of study specific discont. criteria|6
1166798|NCT01197521|3830908|P3|Overall Study|Lack of therapeutic response|4
1166799|NCT01197521|3830909|P2|Overall Study|Lack of therapeutic response|3
1166800|NCT01197521|3830910|P1|Overall Study|Lack of therapeutic response|2
1166801|NCT01197521|3830908|P3|Overall Study|Severe non-compliance to protocol|3
1166802|NCT01197521|3830909|P2|Overall Study|Severe non-compliance to protocol|3
1166803|NCT01197521|3830910|P1|Overall Study|Severe non-compliance to protocol|1
1166804|NCT01197521|3830908|P3|Overall Study|Enrolment in long term extension|87
1166805|NCT01197521|3830909|P2|Overall Study|Enrolment in long term extension|36
1166806|NCT01197521|3830910|P1|Overall Study|Enrolment in long term extension|42
1166807|NCT01197521|3830908|P3|Overall Study|Not reported|21
1166808|NCT01197521|3830909|P2|Overall Study|Not reported|25
1166809|NCT01197521|3830910|P1|Overall Study|Not reported|24
1166810|NCT01197508|3830955|P4|Overall Study|Not specified|2
1166811|NCT01197508|3830956|P3|Overall Study|Not specified|2
1166812|NCT01197508|3830957|P2|Overall Study|Not specified|3
1166813|NCT01197508|3830958|P1|Overall Study|Not specified|2
1166814|NCT01197508|3830955|P4|Overall Study|Lost to Follow-up|0
1166815|NCT01197508|3830956|P3|Overall Study|Lost to Follow-up|2
1166816|NCT01197508|3830957|P2|Overall Study|Lost to Follow-up|1
1166817|NCT01197508|3830958|P1|Overall Study|Lost to Follow-up|1
1166818|NCT01197508|3830955|P4|Overall Study|Study-specific withdrawal criteria|2
1166819|NCT01197508|3830956|P3|Overall Study|Study-specific withdrawal criteria|1
1166820|NCT01197508|3830957|P2|Overall Study|Study-specific withdrawal criteria|0
1166821|NCT01197508|3830958|P1|Overall Study|Study-specific withdrawal criteria|0
1166822|NCT01197508|3830955|P4|Overall Study|Lack of Efficacy|1
1166823|NCT01197508|3830956|P3|Overall Study|Lack of Efficacy|2
1166824|NCT01197508|3830957|P2|Overall Study|Lack of Efficacy|2
1166825|NCT01197508|3830958|P1|Overall Study|Lack of Efficacy|1
1166826|NCT01197508|3830955|P4|Overall Study|Condition under investigation worsened|1
1166827|NCT01197508|3830956|P3|Overall Study|Condition under investigation worsened|1
1166828|NCT01197508|3830957|P2|Overall Study|Condition under investigation worsened|1
1166829|NCT01197508|3830958|P1|Overall Study|Condition under investigation worsened|1
1166830|NCT01197508|3830955|P4|Overall Study|Severe non-compliance to protocol|3
1166831|NCT01197508|3830956|P3|Overall Study|Severe non-compliance to protocol|1
1166832|NCT01197508|3830957|P2|Overall Study|Severe non-compliance to protocol|3
1166833|NCT01197508|3830958|P1|Overall Study|Severe non-compliance to protocol|0
1166834|NCT01197508|3830955|P4|Overall Study|Adverse Event|3
1166835|NCT01197508|3830956|P3|Overall Study|Adverse Event|23
1166836|NCT01197508|3830957|P2|Overall Study|Adverse Event|13
1166837|NCT01197508|3830958|P1|Overall Study|Adverse Event|10
1166838|NCT01197508|3830955|P4|Overall Study|Eligiblity criteria not fulfilled|0
1166839|NCT01197508|3830956|P3|Overall Study|Eligiblity criteria not fulfilled|2
1166840|NCT01197508|3830957|P2|Overall Study|Eligiblity criteria not fulfilled|0
1166841|NCT01197508|3830958|P1|Overall Study|Eligiblity criteria not fulfilled|0
1166842|NCT01197508|3830955|P4|Overall Study|Withdrawal by Subject|4
1166843|NCT01197508|3830956|P3|Overall Study|Withdrawal by Subject|15
1166844|NCT01197508|3830957|P2|Overall Study|Withdrawal by Subject|7
1166845|NCT01197508|3830958|P1|Overall Study|Withdrawal by Subject|8
1166846|NCT01197417|3831068|P2|Overall Study|No 25-hour magnesium level|2
1166847|NCT01197417|3831069|P1|Overall Study|No 25-hour magnesium level|0
1166848|NCT01197417|3831068|P2|Overall Study|Found to be ineligible|5
1166849|NCT01197417|3831069|P1|Overall Study|Found to be ineligible|2
1166850|NCT01197417|3831068|P2|Overall Study|Hypotension|2
1166851|NCT01197417|3831069|P1|Overall Study|Hypotension|1
1166852|NCT01197417|3831068|P2|Overall Study|Not consented in time to receive drug|1
1166853|NCT01197417|3831069|P1|Overall Study|Not consented in time to receive drug|0
1166854|NCT01197417|3831068|P2|Overall Study|Subject transferred to intensive care|1
1166855|NCT01197417|3831069|P1|Overall Study|Subject transferred to intensive care|0
1166856|NCT01197417|3831068|P2|Overall Study|Site miscommunication|1
1166857|NCT01197417|3831069|P1|Overall Study|Site miscommunication|0
1166858|NCT01197417|3831068|P2|Overall Study|Withdrawal by Subject|4
1166859|NCT01197417|3831069|P1|Overall Study|Withdrawal by Subject|2
1166860|NCT01197417|3831068|P2|Overall Study|Physician Decision|2
1166861|NCT01197417|3831069|P1|Overall Study|Physician Decision|3
1166862|NCT01197378|3831087|P1|Overall Study|Other|2
1166863|NCT01197378|3831087|P1|Overall Study|Physician Decision|1
1166864|NCT01197378|3831087|P1|Overall Study|Withdrawal by Subject|1
1166865|NCT01197378|3831087|P1|Overall Study|Adverse Event|3
1166866|NCT01196988|3831108|P4|Overall Study|Other|0
1166867|NCT01196988|3831109|P3|Overall Study|Other|0
1166868|NCT01196988|3831110|P2|Overall Study|Other|0
1166869|NCT01196988|3831111|P1|Overall Study|Other|2
1166870|NCT01196988|3831108|P4|Overall Study|Lost to Follow-up|1
1166871|NCT01196988|3831109|P3|Overall Study|Lost to Follow-up|21
1166872|NCT01196988|3831110|P2|Overall Study|Lost to Follow-up|29
1166873|NCT01196988|3831111|P1|Overall Study|Lost to Follow-up|16
1166874|NCT01196988|3831108|P4|Overall Study|Withdrawal by Subject|0
1166875|NCT01196988|3831109|P3|Overall Study|Withdrawal by Subject|4
1166876|NCT01196988|3831110|P2|Overall Study|Withdrawal by Subject|1
1166877|NCT01196988|3831111|P1|Overall Study|Withdrawal by Subject|5
1166878|NCT01196988|3831108|P4|Overall Study|Adverse Event|0
1166879|NCT01196988|3831109|P3|Overall Study|Adverse Event|0
1166880|NCT01196988|3831110|P2|Overall Study|Adverse Event|2
1166881|NCT01196988|3831111|P1|Overall Study|Adverse Event|1
1166882|NCT01196975|3831205|P5|Overall Study|Lost to Follow-up|11
1166883|NCT01196975|3831206|P4|Overall Study|Lost to Follow-up|5
1166884|NCT01196975|3831207|P3|Overall Study|Lost to Follow-up|5
1166885|NCT01196975|3831208|P2|Overall Study|Lost to Follow-up|6
1166886|NCT01196975|3831209|P1|Overall Study|Lost to Follow-up|11
1166887|NCT01196975|3831205|P5|Overall Study|Withdrawal by Subject|0
1166888|NCT01196975|3831206|P4|Overall Study|Withdrawal by Subject|1
1166889|NCT01196975|3831207|P3|Overall Study|Withdrawal by Subject|0
1166890|NCT01196975|3831208|P2|Overall Study|Withdrawal by Subject|1
1166891|NCT01196975|3831209|P1|Overall Study|Withdrawal by Subject|2
1166892|NCT01196975|3831205|P5|Overall Study|Adverse Event|2
1166893|NCT01196975|3831206|P4|Overall Study|Adverse Event|0
1166894|NCT01196975|3831207|P3|Overall Study|Adverse Event|0
1166895|NCT01196975|3831208|P2|Overall Study|Adverse Event|2
1166896|NCT01196975|3831209|P1|Overall Study|Adverse Event|2
1166897|NCT01196741|3831464|P2|Overall Study|Protocol Violation|1
1166898|NCT01196741|3831465|P1|Overall Study|Protocol Violation|2
1166899|NCT01196741|3831464|P2|Overall Study|Other|2
1166900|NCT01196741|3831465|P1|Overall Study|Other|3
1166901|NCT01196741|3831464|P2|Overall Study|Other reason|3
1166902|NCT01196741|3831465|P1|Overall Study|Other reason|3
1166903|NCT01196741|3831464|P2|Overall Study|Withdrawal by Subject|0
1166904|NCT01196741|3831465|P1|Overall Study|Withdrawal by Subject|3
1166905|NCT01196741|3831464|P2|Overall Study|Dose limiting Adverse Event|1
1166906|NCT01196741|3831465|P1|Overall Study|Dose limiting Adverse Event|2
1166907|NCT01196741|3831464|P2|Overall Study|Serious Adverse Event|1
1166908|NCT01196741|3831465|P1|Overall Study|Serious Adverse Event|3
1166909|NCT01196741|3831464|P2|Overall Study|Adverse Event|6
1166910|NCT01196741|3831465|P1|Overall Study|Adverse Event|10
1166911|NCT01196741|3831464|P2|Overall Study|Disease progression|14
1166912|NCT01196741|3831465|P1|Overall Study|Disease progression|34
1166913|NCT01196429|3831491|P2|Overall Study|Refused – Never Treated|0
1166914|NCT01196429|3831492|P1|Overall Study|Refused – Never Treated|1
1166915|NCT01196429|3831491|P2|Overall Study|Ineligible - wrong cell type|0
1166916|NCT01196429|3831492|P1|Overall Study|Ineligible - wrong cell type|1
1166917|NCT01196429|3831491|P2|Overall Study|Ineligible - inadequate pathology|0
1166918|NCT01196429|3831492|P1|Overall Study|Ineligible - inadequate pathology|1
1166919|NCT01196416|3831508|P1|Overall Study|Withdrawal by Subject|2
1166920|NCT01196104|3831534|P2|Overall Study|Various|1
1166921|NCT01196104|3831535|P1|Overall Study|Various|0
1166922|NCT01196104|3831534|P2|Overall Study|Withdrawal by Subject|3
1166923|NCT01196104|3831535|P1|Overall Study|Withdrawal by Subject|3
1166924|NCT01196104|3831534|P2|Overall Study|Physician Decision|1
1166925|NCT01196104|3831535|P1|Overall Study|Physician Decision|0
1166926|NCT01196104|3831534|P2|Overall Study|Lost to Follow-up|0
1166927|NCT01196104|3831535|P1|Overall Study|Lost to Follow-up|1
1166928|NCT01196091|3831578|P3|Overall Study|Randomized, No Study Drug Received|1
1166929|NCT01196091|3831579|P2|Overall Study|Randomized, No Study Drug Received|0
1166930|NCT01196091|3831580|P1|Overall Study|Randomized, No Study Drug Received|1
1166931|NCT01196091|3831578|P3|Overall Study|Excluded Site|8
1166932|NCT01196091|3831579|P2|Overall Study|Excluded Site|11
1166933|NCT01196091|3831580|P1|Overall Study|Excluded Site|5
1166934|NCT01196091|3831578|P3|Overall Study|Sponsor Decision|4
1166935|NCT01196091|3831579|P2|Overall Study|Sponsor Decision|5
1166936|NCT01196091|3831580|P1|Overall Study|Sponsor Decision|6
1166937|NCT01196091|3831578|P3|Overall Study|Protocol Violation|3
1166938|NCT01196091|3831579|P2|Overall Study|Protocol Violation|3
1166939|NCT01196091|3831580|P1|Overall Study|Protocol Violation|1
1166940|NCT01196091|3831578|P3|Overall Study|Physician Decision|4
1166941|NCT01196091|3831579|P2|Overall Study|Physician Decision|3
1166942|NCT01196091|3831580|P1|Overall Study|Physician Decision|3
1166943|NCT01196091|3831578|P3|Overall Study|Withdrawal by Subject|22
1166944|NCT01196091|3831579|P2|Overall Study|Withdrawal by Subject|19
1166945|NCT01196091|3831580|P1|Overall Study|Withdrawal by Subject|16
1166946|NCT01196091|3831578|P3|Overall Study|Parent/Caregiver Decision|1
1166947|NCT01196091|3831579|P2|Overall Study|Parent/Caregiver Decision|0
1166948|NCT01196091|3831580|P1|Overall Study|Parent/Caregiver Decision|0
1166949|NCT01196091|3831578|P3|Overall Study|Lost to Follow-up|6
1166950|NCT01196091|3831579|P2|Overall Study|Lost to Follow-up|5
1166951|NCT01196091|3831580|P1|Overall Study|Lost to Follow-up|5
1166952|NCT01196091|3831578|P3|Overall Study|Lack of Efficacy|17
1166953|NCT01196091|3831579|P2|Overall Study|Lack of Efficacy|12
1166954|NCT01196091|3831580|P1|Overall Study|Lack of Efficacy|15
1166955|NCT01196091|3831578|P3|Overall Study|Entry Criteria Not Met|10
1166956|NCT01196091|3831579|P2|Overall Study|Entry Criteria Not Met|11
1166957|NCT01196091|3831580|P1|Overall Study|Entry Criteria Not Met|11
1166958|NCT01196091|3831578|P3|Overall Study|Death|2
1166959|NCT01196091|3831579|P2|Overall Study|Death|2
1166960|NCT01196091|3831580|P1|Overall Study|Death|3
1166961|NCT01196091|3831578|P3|Overall Study|Adverse Event|26
1166962|NCT01196091|3831579|P2|Overall Study|Adverse Event|27
1166963|NCT01196091|3831580|P1|Overall Study|Adverse Event|22
1166964|NCT01196078|3831632|P2|Overall Study|Death|4
1166965|NCT01196078|3831633|P1|Overall Study|Death|6
1166966|NCT01196078|3831632|P2|Overall Study|Lost to Follow-up|0
1166967|NCT01196078|3831633|P1|Overall Study|Lost to Follow-up|1
1166968|NCT01196078|3831632|P2|Overall Study|Lack of Efficacy|23
1166969|NCT01196078|3831633|P1|Overall Study|Lack of Efficacy|17
1166970|NCT01196078|3831632|P2|Overall Study|Protocol Violation|1
1166971|NCT01196078|3831633|P1|Overall Study|Protocol Violation|2
1166972|NCT01196078|3831632|P2|Overall Study|Adverse Event|4
1166973|NCT01196078|3831633|P1|Overall Study|Adverse Event|4
1166974|NCT01196078|3831632|P2|Overall Study|Withdrawal by Subject|5
1166975|NCT01196078|3831633|P1|Overall Study|Withdrawal by Subject|3
1166976|NCT01196052|3831661|P1|Overall Study|Withdrawal by Subject|6
1166977|NCT01196052|3831661|P1|Overall Study|Reason not Specified|5
1166978|NCT01196052|3831661|P1|Overall Study|Noncompliance to Protocol Requirements|2
1166979|NCT01196052|3831661|P1|Overall Study|Lost to Follow-up|1
1166980|NCT01196052|3831661|P1|Overall Study|Adverse Event|9
1166981|NCT01196026|3831678|P6|Overall Study|Other|0
1166982|NCT01196026|3831679|P5|Overall Study|Other|0
1166983|NCT01196026|3831680|P4|Overall Study|Other|0
1166984|NCT01196026|3831681|P3|Overall Study|Other|0
1166985|NCT01196026|3831682|P2|Overall Study|Other|1
1166986|NCT01196026|3831683|P1|Overall Study|Other|0
1166987|NCT01196026|3831678|P6|Overall Study|Lost to Follow-up|0
1166988|NCT01196026|3831679|P5|Overall Study|Lost to Follow-up|1
1166989|NCT01196026|3831680|P4|Overall Study|Lost to Follow-up|0
1166990|NCT01196026|3831681|P3|Overall Study|Lost to Follow-up|0
1166991|NCT01196026|3831682|P2|Overall Study|Lost to Follow-up|3
1166992|NCT01196026|3831683|P1|Overall Study|Lost to Follow-up|0
1166993|NCT01196026|3831678|P6|Overall Study|Withdrawal by Subject|0
1166994|NCT01196026|3831679|P5|Overall Study|Withdrawal by Subject|0
1166995|NCT01196026|3831680|P4|Overall Study|Withdrawal by Subject|0
1166996|NCT01196026|3831681|P3|Overall Study|Withdrawal by Subject|0
1166997|NCT01196026|3831682|P2|Overall Study|Withdrawal by Subject|4
1166998|NCT01196026|3831683|P1|Overall Study|Withdrawal by Subject|1
1166999|NCT01195948|3831917|P3|Overall Study|Lost to Follow-up|2
1167000|NCT01195948|3831918|P2|Overall Study|Lost to Follow-up|1
1167001|NCT01195948|3831919|P1|Overall Study|Lost to Follow-up|0
1167002|NCT01195844|3831972|P1|Overall Study|Fecal sample not collected|40
1167003|NCT01195831|3831989|P2|Overall Study|Protocol Violation|2
1167004|NCT01195831|3831990|P1|Overall Study|Protocol Violation|0
1167005|NCT01195831|3831989|P2|Overall Study|Adverse Event|2
1167006|NCT01195831|3831990|P1|Overall Study|Adverse Event|4
1167007|NCT01195831|3831989|P2|Overall Study|Withdrawal by Subject|2
1167008|NCT01195831|3831990|P1|Overall Study|Withdrawal by Subject|2
1167009|NCT01195831|3831989|P2|Overall Study|Lost to Follow-up|4
1167010|NCT01195831|3831990|P1|Overall Study|Lost to Follow-up|2
1167011|NCT01195675|3832230|P1|Overall Study|Withdrawal by Subject|2
1167012|NCT01195675|3832230|P1|Overall Study|Adverse Event|1
1167013|NCT01195662|3832263|P3|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
1167014|NCT01195662|3832264|P2|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
1167015|NCT01195662|3832265|P1|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1
1167016|NCT01195662|3832263|P3|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1
1167017|NCT01195662|3832264|P2|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0
1167018|NCT01195662|3832265|P1|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2
1167019|NCT01195662|3832263|P3|Double Blind Treatment Period|Missing disposition information|1
1167020|NCT01195662|3832264|P2|Double Blind Treatment Period|Missing disposition information|1
1167021|NCT01195662|3832265|P1|Double Blind Treatment Period|Missing disposition information|0
1167022|NCT01195662|3832263|P3|Double Blind Treatment Period|Non-specified|0
1167023|NCT01195662|3832264|P2|Double Blind Treatment Period|Non-specified|0
1167024|NCT01195662|3832265|P1|Double Blind Treatment Period|Non-specified|3
1167025|NCT01195662|3832263|P3|Double Blind Treatment Period|Lack of Efficacy|0
1167026|NCT01195662|3832264|P2|Double Blind Treatment Period|Lack of Efficacy|0
1167027|NCT01195662|3832265|P1|Double Blind Treatment Period|Lack of Efficacy|2
1167028|NCT01195662|3832263|P3|Double Blind Treatment Period|No Longer Meets Criteria|2
1167029|NCT01195662|3832264|P2|Double Blind Treatment Period|No Longer Meets Criteria|5
1167030|NCT01195662|3832265|P1|Double Blind Treatment Period|No Longer Meets Criteria|1
1167031|NCT01195662|3832263|P3|Double Blind Treatment Period|Requested discontinue treatment|1
1167032|NCT01195662|3832264|P2|Double Blind Treatment Period|Requested discontinue treatment|0
1167033|NCT01195662|3832265|P1|Double Blind Treatment Period|Requested discontinue treatment|1
1167034|NCT01195662|3832263|P3|Double Blind Treatment Period|Administrative reason|1
1167035|NCT01195662|3832264|P2|Double Blind Treatment Period|Administrative reason|1
1167036|NCT01195662|3832265|P1|Double Blind Treatment Period|Administrative reason|2
1167037|NCT01195662|3832263|P3|Double Blind Treatment Period|Lost to Follow-up|3
1167038|NCT01195662|3832264|P2|Double Blind Treatment Period|Lost to Follow-up|2
1167039|NCT01195662|3832265|P1|Double Blind Treatment Period|Lost to Follow-up|3
1167040|NCT01195662|3832263|P3|Double Blind Treatment Period|Withdrawal by Subject|4
1167041|NCT01195662|3832264|P2|Double Blind Treatment Period|Withdrawal by Subject|4
1167042|NCT01195662|3832265|P1|Double Blind Treatment Period|Withdrawal by Subject|6
1167043|NCT01195662|3832263|P3|Double Blind Treatment Period|Adverse Event|2
1167044|NCT01195662|3832264|P2|Double Blind Treatment Period|Adverse Event|1
1167045|NCT01195662|3832265|P1|Double Blind Treatment Period|Adverse Event|4
1167046|NCT01195636|3832295|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|1
1167047|NCT01195636|3832296|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|0
1167048|NCT01195636|3832295|P2|Second Intervention (3 Weeks)|Adverse Event|1
1167049|NCT01195636|3832296|P1|Second Intervention (3 Weeks)|Adverse Event|1
1167050|NCT01195636|3832295|P2|Washout Period (2 Weeks)|Withdrawal by Subject|2
1167051|NCT01195636|3832296|P1|Washout Period (2 Weeks)|Withdrawal by Subject|1
1167052|NCT01195636|3832295|P2|Washout Period (2 Weeks)|Adverse Event|1
1167053|NCT01195636|3832296|P1|Washout Period (2 Weeks)|Adverse Event|1
1167054|NCT01195636|3832295|P2|First Intervention (3 Weeks)|Lost to Follow-up|0
1167055|NCT01195636|3832296|P1|First Intervention (3 Weeks)|Lost to Follow-up|1
1167056|NCT01195636|3832295|P2|First Intervention (3 Weeks)|Withdrawal by Subject|0
1167057|NCT01195636|3832296|P1|First Intervention (3 Weeks)|Withdrawal by Subject|1
1167058|NCT01195636|3832295|P2|First Intervention (3 Weeks)|Protocol Violation|0
1167059|NCT01195636|3832296|P1|First Intervention (3 Weeks)|Protocol Violation|1
1167060|NCT01195636|3832295|P2|First Intervention (3 Weeks)|Adverse Event|3
1167061|NCT01195636|3832296|P1|First Intervention (3 Weeks)|Adverse Event|2
1167062|NCT01195623|3832322|P2|Overall Study|Lost to Follow-up|37
1167063|NCT01195623|3832323|P1|Overall Study|Lost to Follow-up|35
1167064|NCT01195545|3832352|P1|Overall Study|Protocol Violation|4
1167065|NCT01195415|3832364|P1|Overall Study|No repeat biopsy due to progression|2
1167066|NCT01195363|3832373|P2|Overall Study|incarceration|0
1167067|NCT01195363|3832374|P1|Overall Study|incarceration|1
1167068|NCT01195363|3832373|P2|Overall Study|Lack of Efficacy|4
1167069|NCT01195363|3832374|P1|Overall Study|Lack of Efficacy|0
1167070|NCT01195363|3832373|P2|Overall Study|Adverse Event|1
1167071|NCT01195363|3832374|P1|Overall Study|Adverse Event|3
1167072|NCT01195363|3832373|P2|Overall Study|Lost to Follow-up|4
1167073|NCT01195363|3832374|P1|Overall Study|Lost to Follow-up|7
1167074|NCT01195272|3832380|P1|Overall Study|Lack of Efficacy|3
1167075|NCT01195272|3832380|P1|Overall Study|Adverse Event|1
1167076|NCT01195103|3832409|P3|Overall Study|Withdrawal by Subject|0
1167077|NCT01195103|3832410|P2|Overall Study|Withdrawal by Subject|0
1167078|NCT01195103|3832411|P1|Overall Study|Withdrawal by Subject|1
1167079|NCT01195090|3832421|P2|Overall Study|Protocol Violation|4
1167080|NCT01195090|3832422|P1|Overall Study|Protocol Violation|3
1167081|NCT01195090|3832421|P2|Overall Study|Lost to Follow-up|2
1167082|NCT01195090|3832422|P1|Overall Study|Lost to Follow-up|2
1167083|NCT01195090|3832421|P2|Overall Study|Adverse Event|2
1167084|NCT01195090|3832422|P1|Overall Study|Adverse Event|1
1167085|NCT01194999|3832491|P1|Overall Study|Lost to Follow-up|17
1167086|NCT01194973|3832495|P1|26 Week Treatment Period|Pregnancy|1
1167087|NCT01194973|3832495|P1|26 Week Treatment Period|Lack of Efficacy|1
1167088|NCT01194973|3832495|P1|26 Week Treatment Period|Adverse Event|1
1167089|NCT01194973|3832495|P1|Screening Period|Screen Failure|3
1167090|NCT01194869|3832515|P1|Overall Study|Toxicity|2
1167091|NCT01194869|3832515|P1|Overall Study|Disease Progression|2
1167092|NCT01194830|3832546|P2|Overall Study|Other Reason|8
1167093|NCT01194830|3832547|P1|Overall Study|Other Reason|12
1167094|NCT01194830|3832546|P2|Overall Study|Non-compliance issues|4
1167095|NCT01194830|3832547|P1|Overall Study|Non-compliance issues|4
1167096|NCT01194830|3832546|P2|Overall Study|Lack of Efficacy|1
1167097|NCT01194830|3832547|P1|Overall Study|Lack of Efficacy|1
1167098|NCT01194830|3832546|P2|Overall Study|Withdrawal by Subject|1
1167099|NCT01194830|3832547|P1|Overall Study|Withdrawal by Subject|2
1167100|NCT01194830|3832546|P2|Overall Study|Lost to Follow-up|7
1167101|NCT01194830|3832547|P1|Overall Study|Lost to Follow-up|9
1167102|NCT01194830|3832546|P2|Overall Study|Protocol Violation|4
1167103|NCT01194830|3832547|P1|Overall Study|Protocol Violation|5
1167104|NCT01194830|3832546|P2|Overall Study|Adverse Event|2
1167105|NCT01194830|3832547|P1|Overall Study|Adverse Event|3
1167106|NCT01194570|3832583|P2|Overall Study|Lost to Follow-up|4
1167107|NCT01194570|3832584|P1|Overall Study|Lost to Follow-up|1
1167108|NCT01194570|3832583|P2|Overall Study|Pregnancy|1
1167109|NCT01194570|3832584|P1|Overall Study|Pregnancy|1
1167110|NCT01194570|3832583|P2|Overall Study|Withdrawal by Subject|22
1167111|NCT01194570|3832584|P1|Overall Study|Withdrawal by Subject|21
1167112|NCT01194570|3832583|P2|Overall Study|Lack of Efficacy|21
1167113|NCT01194570|3832584|P1|Overall Study|Lack of Efficacy|27
1167114|NCT01194570|3832583|P2|Overall Study|Non-compliance|2
1167115|NCT01194570|3832584|P1|Overall Study|Non-compliance|2
1167116|NCT01194570|3832583|P2|Overall Study|Adverse Event|18
1167117|NCT01194570|3832584|P1|Overall Study|Adverse Event|12
1167118|NCT01194570|3832583|P2|Overall Study|Non-compliance with study drug|2
1167119|NCT01194570|3832584|P1|Overall Study|Non-compliance with study drug|2
1167120|NCT01194570|3832583|P2|Overall Study|Protocol Violation|2
1167121|NCT01194570|3832584|P1|Overall Study|Protocol Violation|0
1167122|NCT01194570|3832583|P2|Overall Study|Reason not specified|20
1167123|NCT01194570|3832584|P1|Overall Study|Reason not specified|13
1167124|NCT01194570|3832583|P2|Overall Study|Physician Decision|6
1167125|NCT01194570|3832584|P1|Overall Study|Physician Decision|2
1167126|NCT01194570|3832583|P2|Overall Study|Ongoing at CCOD|387
1167127|NCT01194570|3832584|P1|Overall Study|Ongoing at CCOD|162
1167128|NCT01194570|3832583|P2|Overall Study|Death|3
1167129|NCT01194570|3832584|P1|Overall Study|Death|1
1167130|NCT01194531|3832604|P2|Overall Study|Physician Decision|2
1167131|NCT01194531|3832605|P1|Overall Study|Physician Decision|0
1167132|NCT01194531|3832604|P2|Overall Study|Protocol Violation|1
1167133|NCT01194531|3832605|P1|Overall Study|Protocol Violation|4
1167134|NCT01194531|3832604|P2|Overall Study|Withdrawal by Subject|0
1167135|NCT01194531|3832605|P1|Overall Study|Withdrawal by Subject|1
1167136|NCT01194440|3832649|P1|6-months (2nd Dose)|Change in therapy|4
1167137|NCT01194440|3832649|P1|Baseline (First Dose)|Adverse Event|1
1167138|NCT01194440|3832649|P1|Baseline (First Dose)|Change in therapy|1
1167139|NCT01194440|3832649|P1|Baseline (First Dose)|Lack of Efficacy|1
1167140|NCT01194440|3832649|P1|Baseline (First Dose)|Reason not specified|4
1167141|NCT01194414|3832662|P4|72 Weeks Open Label Extension|Death|2
1167142|NCT01194414|3832663|P3|72 Weeks Open Label Extension|Death|0
1167143|NCT01194414|3832664|P2|72 Weeks Open Label Extension|Death|2
1167144|NCT01194414|3832665|P1|72 Weeks Open Label Extension|Death|1
1167145|NCT01194414|3832662|P4|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
1167146|NCT01194414|3832663|P3|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
1167147|NCT01194414|3832664|P2|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
1167148|NCT01194414|3832665|P1|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
1167149|NCT01194414|3832662|P4|72 Weeks Open Label Extension|Adverse Event|12
1167150|NCT01194414|3832663|P3|72 Weeks Open Label Extension|Adverse Event|2
1167151|NCT01194414|3832664|P2|72 Weeks Open Label Extension|Adverse Event|21
1167152|NCT01194414|3832665|P1|72 Weeks Open Label Extension|Adverse Event|35
1167153|NCT01194414|3832662|P4|72 Weeks Open Label Extension|Protocol Violation|1
1167154|NCT01194414|3832663|P3|72 Weeks Open Label Extension|Protocol Violation|0
1167155|NCT01194414|3832664|P2|72 Weeks Open Label Extension|Protocol Violation|0
1167156|NCT01194414|3832665|P1|72 Weeks Open Label Extension|Protocol Violation|0
1167157|NCT01194414|3832662|P4|72 Weeks Open Label Extension|Other|0
1167158|NCT01194414|3832663|P3|72 Weeks Open Label Extension|Other|0
1167159|NCT01194414|3832664|P2|72 Weeks Open Label Extension|Other|1
1167160|NCT01194414|3832665|P1|72 Weeks Open Label Extension|Other|2
1167161|NCT01194414|3832662|P4|72 Weeks Open Label Extension|Pregnancy|1
1167162|NCT01194414|3832663|P3|72 Weeks Open Label Extension|Pregnancy|1
1167163|NCT01194414|3832664|P2|72 Weeks Open Label Extension|Pregnancy|3
1167164|NCT01194414|3832665|P1|72 Weeks Open Label Extension|Pregnancy|1
1167165|NCT01194414|3832662|P4|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
1167166|NCT01194414|3832663|P3|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
1167167|NCT01194414|3832664|P2|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5
1167168|NCT01194414|3832665|P1|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3
1167169|NCT01194414|3832662|P4|72 Weeks Open Label Extension|Lost to Follow-up|1
1167170|NCT01194414|3832663|P3|72 Weeks Open Label Extension|Lost to Follow-up|2
1167171|NCT01194414|3832664|P2|72 Weeks Open Label Extension|Lost to Follow-up|3
1167172|NCT01194414|3832665|P1|72 Weeks Open Label Extension|Lost to Follow-up|4
1167173|NCT01194414|3832662|P4|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3
1167174|NCT01194414|3832663|P3|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2
1167175|NCT01194414|3832664|P2|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11
1167176|NCT01194414|3832665|P1|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9
1167177|NCT01194414|3832662|P4|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6
1167178|NCT01194414|3832663|P3|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1
1167179|NCT01194414|3832664|P2|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14
1167180|NCT01194414|3832665|P1|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20
1167181|NCT01194414|3832662|P4|72 Weeks Open Label Extension|Randomized but not Treated|0
1167182|NCT01194414|3832663|P3|72 Weeks Open Label Extension|Randomized but not Treated|0
1167183|NCT01194414|3832664|P2|72 Weeks Open Label Extension|Randomized but not Treated|5
1167184|NCT01194414|3832665|P1|72 Weeks Open Label Extension|Randomized but not Treated|3
1167185|NCT01194414|3832662|P4|24 Weeks Double Blind Period|Death|0
1167186|NCT01194414|3832663|P3|24 Weeks Double Blind Period|Death|0
1167187|NCT01194414|3832664|P2|24 Weeks Double Blind Period|Death|1
1167188|NCT01194414|3832665|P1|24 Weeks Double Blind Period|Death|0
1167189|NCT01194414|3832662|P4|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
1167190|NCT01194414|3832663|P3|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
1167191|NCT01194414|3832664|P2|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1
1167192|NCT01194414|3832665|P1|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2
1167193|NCT01194414|3832662|P4|24 Weeks Double Blind Period|Adverse Event|0
1167194|NCT01194414|3832663|P3|24 Weeks Double Blind Period|Adverse Event|0
1167195|NCT01194414|3832664|P2|24 Weeks Double Blind Period|Adverse Event|40
1167196|NCT01194414|3832665|P1|24 Weeks Double Blind Period|Adverse Event|28
1167197|NCT01194414|3832662|P4|24 Weeks Double Blind Period|Other|0
1167198|NCT01194414|3832663|P3|24 Weeks Double Blind Period|Other|0
1167199|NCT01194414|3832664|P2|24 Weeks Double Blind Period|Other|1
1167200|NCT01194414|3832665|P1|24 Weeks Double Blind Period|Other|0
1167201|NCT01194414|3832662|P4|24 Weeks Double Blind Period|Lost to Follow-up|0
1167202|NCT01194414|3832663|P3|24 Weeks Double Blind Period|Lost to Follow-up|0
1167203|NCT01194414|3832664|P2|24 Weeks Double Blind Period|Lost to Follow-up|1
1167204|NCT01194414|3832665|P1|24 Weeks Double Blind Period|Lost to Follow-up|2
1167205|NCT01194414|3832662|P4|24 Weeks Double Blind Period|Pregnancy|0
1167206|NCT01194414|3832663|P3|24 Weeks Double Blind Period|Pregnancy|0
1167207|NCT01194414|3832664|P2|24 Weeks Double Blind Period|Pregnancy|2
1167208|NCT01194414|3832665|P1|24 Weeks Double Blind Period|Pregnancy|2
1167209|NCT01194414|3832662|P4|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
1167210|NCT01194414|3832663|P3|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
1167211|NCT01194414|3832664|P2|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5
1167212|NCT01194414|3832665|P1|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
1167213|NCT01194414|3832662|P4|24 Weeks Double Blind Period|Protocol Violation|0
1167214|NCT01194414|3832663|P3|24 Weeks Double Blind Period|Protocol Violation|0
1167215|NCT01194414|3832664|P2|24 Weeks Double Blind Period|Protocol Violation|3
1167216|NCT01194414|3832665|P1|24 Weeks Double Blind Period|Protocol Violation|5
1167217|NCT01194414|3832662|P4|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
1167218|NCT01194414|3832663|P3|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
1167219|NCT01194414|3832664|P2|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5
1167220|NCT01194414|3832665|P1|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9
1167221|NCT01194414|3832662|P4|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
1167222|NCT01194414|3832663|P3|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
1167223|NCT01194414|3832664|P2|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8
1167224|NCT01194414|3832665|P1|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11
1167225|NCT01194258|3832736|P5|Period 2 (12 Weeks)|Withdrawal by Subject|0
1167226|NCT01194258|3832737|P4|Period 2 (12 Weeks)|Withdrawal by Subject|0
1167227|NCT01194258|3832738|P3|Period 2 (12 Weeks)|Withdrawal by Subject|1
1167228|NCT01194258|3832739|P2|Period 2 (12 Weeks)|Withdrawal by Subject|1
1167229|NCT01194258|3832740|P1|Period 2 (12 Weeks)|Withdrawal by Subject|0
1167230|NCT01194258|3832736|P5|Period 2 (12 Weeks)|Adverse Event|0
1167231|NCT01194258|3832737|P4|Period 2 (12 Weeks)|Adverse Event|0
1167232|NCT01194258|3832738|P3|Period 2 (12 Weeks)|Adverse Event|0
1167233|NCT01194258|3832739|P2|Period 2 (12 Weeks)|Adverse Event|1
1167234|NCT01194258|3832740|P1|Period 2 (12 Weeks)|Adverse Event|0
1167235|NCT01194258|3832736|P5|Period 2 (12 Weeks)|Lost to Follow-up|2
1167236|NCT01194258|3832737|P4|Period 2 (12 Weeks)|Lost to Follow-up|0
1167237|NCT01194258|3832738|P3|Period 2 (12 Weeks)|Lost to Follow-up|0
1167238|NCT01194258|3832739|P2|Period 2 (12 Weeks)|Lost to Follow-up|0
1167239|NCT01194258|3832740|P1|Period 2 (12 Weeks)|Lost to Follow-up|0
1167240|NCT01194258|3832736|P5|Period 1 (12 Weeks)|Death|1
1167241|NCT01194258|3832737|P4|Period 1 (12 Weeks)|Death|0
1167242|NCT01194258|3832738|P3|Period 1 (12 Weeks)|Death|0
1167243|NCT01194258|3832739|P2|Period 1 (12 Weeks)|Death|0
1167244|NCT01194258|3832740|P1|Period 1 (12 Weeks)|Death|0
1167245|NCT01194258|3832736|P5|Titration Period|Titration failure|0
1167246|NCT01194258|3832737|P4|Titration Period|Titration failure|0
1167247|NCT01194258|3832738|P3|Titration Period|Titration failure|0
1167248|NCT01194258|3832739|P2|Titration Period|Titration failure|0
1167249|NCT01194258|3832740|P1|Titration Period|Titration failure|3
1167250|NCT01194258|3832736|P5|Titration Period|Lost to Follow-up|0
1167251|NCT01194258|3832737|P4|Titration Period|Lost to Follow-up|0
1167252|NCT01194258|3832738|P3|Titration Period|Lost to Follow-up|0
1167253|NCT01194258|3832739|P2|Titration Period|Lost to Follow-up|0
1167254|NCT01194258|3832740|P1|Titration Period|Lost to Follow-up|2
1167255|NCT01194258|3832736|P5|Titration Period|Withdrawal by Subject|0
1167256|NCT01194258|3832737|P4|Titration Period|Withdrawal by Subject|0
1167257|NCT01194258|3832738|P3|Titration Period|Withdrawal by Subject|0
1167258|NCT01194258|3832739|P2|Titration Period|Withdrawal by Subject|0
1167259|NCT01194258|3832740|P1|Titration Period|Withdrawal by Subject|6
1167260|NCT01194245|3832764|P5|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
1167261|NCT01194245|3832765|P4|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
1167262|NCT01194245|3832766|P3|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
1167263|NCT01194245|3832767|P2|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
1167264|NCT01194245|3832768|P1|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
1167265|NCT01194245|3832764|P5|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1
1167266|NCT01194245|3832765|P4|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
1167267|NCT01194245|3832766|P3|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
1167268|NCT01194245|3832767|P2|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
1167269|NCT01194245|3832768|P1|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
1167270|NCT01194245|3832764|P5|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
1167271|NCT01194245|3832765|P4|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
1167272|NCT01194245|3832766|P3|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
1167273|NCT01194245|3832767|P2|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
1167274|NCT01194245|3832768|P1|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7
1167275|NCT01194245|3832764|P5|Titration Period (4 to 6 Weeks)|Titration Failure|0
1167276|NCT01194245|3832765|P4|Titration Period (4 to 6 Weeks)|Titration Failure|0
1167277|NCT01194245|3832766|P3|Titration Period (4 to 6 Weeks)|Titration Failure|0
1167278|NCT01194245|3832767|P2|Titration Period (4 to 6 Weeks)|Titration Failure|0
1167279|NCT01194245|3832768|P1|Titration Period (4 to 6 Weeks)|Titration Failure|3
1167280|NCT01194245|3832764|P5|Titration Period (4 to 6 Weeks)|Physician Decision|0
1167281|NCT01194245|3832765|P4|Titration Period (4 to 6 Weeks)|Physician Decision|0
1167282|NCT01194245|3832766|P3|Titration Period (4 to 6 Weeks)|Physician Decision|0
1167283|NCT01194245|3832767|P2|Titration Period (4 to 6 Weeks)|Physician Decision|0
1167284|NCT01194245|3832768|P1|Titration Period (4 to 6 Weeks)|Physician Decision|3
1167285|NCT01194245|3832764|P5|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
1167286|NCT01194245|3832765|P4|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
1167287|NCT01194245|3832766|P3|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
1167288|NCT01194245|3832767|P2|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
1167289|NCT01194245|3832768|P1|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5
1167290|NCT01194219|3832789|P10|Long-Term Extension Weeks 52 to 260|Miscellaneous|2
1167291|NCT01194219|3832790|P9|Long-Term Extension Weeks 52 to 260|Miscellaneous|11
1167292|NCT01194219|3832791|P8|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
1167293|NCT01194219|3832792|P7|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
1167294|NCT01194219|3832793|P6|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
1167295|NCT01194219|3832794|P5|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
1167296|NCT01194219|3832795|P4|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
1167297|NCT01194219|3832796|P3|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
1167298|NCT01194219|3832797|P2|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
1167299|NCT01194219|3832798|P1|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
1167300|NCT01194219|3832789|P10|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
1167301|NCT01194219|3832790|P9|Long-Term Extension Weeks 52 to 260|Protocol Violation|3
1167302|NCT01194219|3832791|P8|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
1167303|NCT01194219|3832792|P7|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
1167304|NCT01194219|3832793|P6|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
1167305|NCT01194219|3832794|P5|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
1167306|NCT01194219|3832795|P4|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
1167307|NCT01194219|3832796|P3|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
1167308|NCT01194219|3832797|P2|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
1167309|NCT01194219|3832798|P1|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
1167310|NCT01194219|3832789|P10|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10
1167311|NCT01194219|3832790|P9|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24
1167312|NCT01194219|3832791|P8|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
1167313|NCT01194219|3832792|P7|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
1167314|NCT01194219|3832793|P6|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
1167315|NCT01194219|3832794|P5|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
1167316|NCT01194219|3832795|P4|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
1167317|NCT01194219|3832796|P3|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
1167318|NCT01194219|3832797|P2|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
1167319|NCT01194219|3832798|P1|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
1167320|NCT01194219|3832789|P10|Long-Term Extension Weeks 52 to 260|Death|1
1167321|NCT01194219|3832790|P9|Long-Term Extension Weeks 52 to 260|Death|1
1167322|NCT01194219|3832791|P8|Long-Term Extension Weeks 52 to 260|Death|0
1167323|NCT01194219|3832792|P7|Long-Term Extension Weeks 52 to 260|Death|0
1167324|NCT01194219|3832793|P6|Long-Term Extension Weeks 52 to 260|Death|0
1167325|NCT01194219|3832794|P5|Long-Term Extension Weeks 52 to 260|Death|0
1167326|NCT01194219|3832795|P4|Long-Term Extension Weeks 52 to 260|Death|0
1167327|NCT01194219|3832796|P3|Long-Term Extension Weeks 52 to 260|Death|0
1167328|NCT01194219|3832797|P2|Long-Term Extension Weeks 52 to 260|Death|0
1167329|NCT01194219|3832798|P1|Long-Term Extension Weeks 52 to 260|Death|0
1167330|NCT01194219|3832789|P10|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32
1167331|NCT01194219|3832790|P9|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66
1167332|NCT01194219|3832791|P8|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
1167333|NCT01194219|3832792|P7|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
1167334|NCT01194219|3832793|P6|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
1167335|NCT01194219|3832794|P5|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
1167336|NCT01194219|3832795|P4|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
1167337|NCT01194219|3832796|P3|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
1167338|NCT01194219|3832797|P2|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
1167339|NCT01194219|3832798|P1|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
1167340|NCT01194219|3832789|P10|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4
1167341|NCT01194219|3832790|P9|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9
1167342|NCT01194219|3832791|P8|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
1167343|NCT01194219|3832792|P7|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
1167344|NCT01194219|3832793|P6|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
1167345|NCT01194219|3832794|P5|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
1167346|NCT01194219|3832795|P4|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
1167347|NCT01194219|3832796|P3|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
1167348|NCT01194219|3832797|P2|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
1167349|NCT01194219|3832798|P1|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
1167350|NCT01194219|3832789|P10|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49
1167351|NCT01194219|3832790|P9|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81
1167352|NCT01194219|3832791|P8|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
1167353|NCT01194219|3832792|P7|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
1167354|NCT01194219|3832793|P6|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
1167355|NCT01194219|3832794|P5|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
1167356|NCT01194219|3832795|P4|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
1167357|NCT01194219|3832796|P3|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
1167358|NCT01194219|3832797|P2|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
1167359|NCT01194219|3832798|P1|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
1167360|NCT01194219|3832789|P10|Long-Term Extension Weeks 52 to 260|Adverse Event|14
1167361|NCT01194219|3832790|P9|Long-Term Extension Weeks 52 to 260|Adverse Event|25
1167362|NCT01194219|3832791|P8|Long-Term Extension Weeks 52 to 260|Adverse Event|0
1167363|NCT01194219|3832792|P7|Long-Term Extension Weeks 52 to 260|Adverse Event|0
1167364|NCT01194219|3832793|P6|Long-Term Extension Weeks 52 to 260|Adverse Event|0
1167365|NCT01194219|3832794|P5|Long-Term Extension Weeks 52 to 260|Adverse Event|0
1167366|NCT01194219|3832795|P4|Long-Term Extension Weeks 52 to 260|Adverse Event|0
1167367|NCT01194219|3832796|P3|Long-Term Extension Weeks 52 to 260|Adverse Event|0
1167368|NCT01194219|3832797|P2|Long-Term Extension Weeks 52 to 260|Adverse Event|0
1167369|NCT01194219|3832798|P1|Long-Term Extension Weeks 52 to 260|Adverse Event|0
1167370|NCT01194219|3832789|P10|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
1167371|NCT01194219|3832790|P9|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
1167372|NCT01194219|3832791|P8|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
1167373|NCT01194219|3832792|P7|Randomized Withdrawal Phase-Weeks 32-52|Not specified|1
1167374|NCT01194219|3832793|P6|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
1167375|NCT01194219|3832794|P5|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
1167376|NCT01194219|3832795|P4|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
1167377|NCT01194219|3832796|P3|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
1167378|NCT01194219|3832797|P2|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
1167379|NCT01194219|3832798|P1|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
1167380|NCT01194219|3832789|P10|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
1167381|NCT01194219|3832790|P9|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
1167382|NCT01194219|3832791|P8|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1
1167383|NCT01194219|3832792|P7|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
1167384|NCT01194219|3832793|P6|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
1167385|NCT01194219|3832794|P5|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
1167386|NCT01194219|3832795|P4|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
1167387|NCT01194219|3832796|P3|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
1167388|NCT01194219|3832797|P2|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
1167389|NCT01194219|3832798|P1|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
1167390|NCT01194219|3832789|P10|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
1167391|NCT01194219|3832790|P9|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
1167392|NCT01194219|3832791|P8|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
1167393|NCT01194219|3832792|P7|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5
1167394|NCT01194219|3832793|P6|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2
1167395|NCT01194219|3832794|P5|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1
1167396|NCT01194219|3832795|P4|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
1167397|NCT01194219|3832796|P3|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
1167398|NCT01194219|3832797|P2|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
1167399|NCT01194219|3832798|P1|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
1167400|NCT01194219|3832789|P10|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
1167401|NCT01194219|3832790|P9|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
1167402|NCT01194219|3832791|P8|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6
1167403|NCT01194219|3832792|P7|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12
1167404|NCT01194219|3832793|P6|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
1167405|NCT01194219|3832794|P5|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1
1167406|NCT01194219|3832795|P4|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
1167407|NCT01194219|3832796|P3|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
1167408|NCT01194219|3832797|P2|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
1167409|NCT01194219|3832798|P1|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
1167410|NCT01194219|3832789|P10|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
1167411|NCT01194219|3832790|P9|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
1167412|NCT01194219|3832791|P8|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
1167413|NCT01194219|3832792|P7|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2
1167414|NCT01194219|3832793|P6|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
1167415|NCT01194219|3832794|P5|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1
1167416|NCT01194219|3832795|P4|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
1167417|NCT01194219|3832796|P3|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
1167418|NCT01194219|3832797|P2|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
1167419|NCT01194219|3832798|P1|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
1167420|NCT01194219|3832789|P10|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
1167421|NCT01194219|3832790|P9|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
1167422|NCT01194219|3832791|P8|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33
1167423|NCT01194219|3832792|P7|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35
1167424|NCT01194219|3832793|P6|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
1167425|NCT01194219|3832794|P5|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
1167426|NCT01194219|3832795|P4|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
1167427|NCT01194219|3832796|P3|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
1167428|NCT01194219|3832797|P2|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
1167429|NCT01194219|3832798|P1|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
1167430|NCT01194219|3832789|P10|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
1167431|NCT01194219|3832790|P9|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
1167432|NCT01194219|3832791|P8|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5
1167433|NCT01194219|3832792|P7|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6
1167434|NCT01194219|3832793|P6|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1
1167435|NCT01194219|3832794|P5|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
1167436|NCT01194219|3832795|P4|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
1167437|NCT01194219|3832796|P3|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
1167438|NCT01194219|3832797|P2|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
1167439|NCT01194219|3832798|P1|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
1167440|NCT01194219|3832789|P10|Maintenance Phase Weeks16-32|Other|0
1167441|NCT01194219|3832790|P9|Maintenance Phase Weeks16-32|Other|0
1167442|NCT01194219|3832791|P8|Maintenance Phase Weeks16-32|Other|0
1167443|NCT01194219|3832792|P7|Maintenance Phase Weeks16-32|Other|0
1167444|NCT01194219|3832793|P6|Maintenance Phase Weeks16-32|Other|0
1167445|NCT01194219|3832794|P5|Maintenance Phase Weeks16-32|Other|0
1167446|NCT01194219|3832795|P4|Maintenance Phase Weeks16-32|Other|1
1167447|NCT01194219|3832796|P3|Maintenance Phase Weeks16-32|Other|2
1167448|NCT01194219|3832797|P2|Maintenance Phase Weeks16-32|Other|0
1167449|NCT01194219|3832798|P1|Maintenance Phase Weeks16-32|Other|0
1167450|NCT01194219|3832789|P10|Maintenance Phase Weeks16-32|Protocol Violation|0
1167451|NCT01194219|3832790|P9|Maintenance Phase Weeks16-32|Protocol Violation|0
1167452|NCT01194219|3832791|P8|Maintenance Phase Weeks16-32|Protocol Violation|0
1167453|NCT01194219|3832792|P7|Maintenance Phase Weeks16-32|Protocol Violation|0
1167454|NCT01194219|3832793|P6|Maintenance Phase Weeks16-32|Protocol Violation|0
1167455|NCT01194219|3832794|P5|Maintenance Phase Weeks16-32|Protocol Violation|0
1167456|NCT01194219|3832795|P4|Maintenance Phase Weeks16-32|Protocol Violation|1
1167457|NCT01194219|3832796|P3|Maintenance Phase Weeks16-32|Protocol Violation|0
1167458|NCT01194219|3832797|P2|Maintenance Phase Weeks16-32|Protocol Violation|0
1167459|NCT01194219|3832798|P1|Maintenance Phase Weeks16-32|Protocol Violation|0
1167460|NCT01194219|3832789|P10|Maintenance Phase Weeks16-32|Lost to Follow-up|0
1167461|NCT01194219|3832790|P9|Maintenance Phase Weeks16-32|Lost to Follow-up|0
1167462|NCT01194219|3832791|P8|Maintenance Phase Weeks16-32|Lost to Follow-up|0
1167463|NCT01194219|3832792|P7|Maintenance Phase Weeks16-32|Lost to Follow-up|0
1167464|NCT01194219|3832793|P6|Maintenance Phase Weeks16-32|Lost to Follow-up|0
1167465|NCT01194219|3832794|P5|Maintenance Phase Weeks16-32|Lost to Follow-up|0
1167466|NCT01194219|3832795|P4|Maintenance Phase Weeks16-32|Lost to Follow-up|0
1167467|NCT01194219|3832796|P3|Maintenance Phase Weeks16-32|Lost to Follow-up|9
1167468|NCT01194219|3832797|P2|Maintenance Phase Weeks16-32|Lost to Follow-up|0
1167469|NCT01194219|3832798|P1|Maintenance Phase Weeks16-32|Lost to Follow-up|0
1167470|NCT01194219|3832789|P10|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
1167471|NCT01194219|3832790|P9|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
1167472|NCT01194219|3832791|P8|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
1167473|NCT01194219|3832792|P7|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
1167474|NCT01194219|3832793|P6|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
1167475|NCT01194219|3832794|P5|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
1167476|NCT01194219|3832795|P4|Maintenance Phase Weeks16-32|Withdrawal by Subject|3
1167477|NCT01194219|3832796|P3|Maintenance Phase Weeks16-32|Withdrawal by Subject|12
1167478|NCT01194219|3832797|P2|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
1167479|NCT01194219|3832798|P1|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
1167480|NCT01194219|3832789|P10|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
1167481|NCT01194219|3832790|P9|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
1167482|NCT01194219|3832791|P8|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
1167483|NCT01194219|3832792|P7|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
1167484|NCT01194219|3832793|P6|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
1167485|NCT01194219|3832794|P5|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
1167486|NCT01194219|3832795|P4|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1
1167487|NCT01194219|3832796|P3|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2
1167488|NCT01194219|3832797|P2|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
1167489|NCT01194219|3832798|P1|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
1167490|NCT01194219|3832789|P10|Maintenance Phase Weeks16-32|Lack of Efficacy|0
1167491|NCT01194219|3832790|P9|Maintenance Phase Weeks16-32|Lack of Efficacy|0
1167492|NCT01194219|3832791|P8|Maintenance Phase Weeks16-32|Lack of Efficacy|0
1167493|NCT01194219|3832792|P7|Maintenance Phase Weeks16-32|Lack of Efficacy|0
1167494|NCT01194219|3832793|P6|Maintenance Phase Weeks16-32|Lack of Efficacy|0
1167495|NCT01194219|3832794|P5|Maintenance Phase Weeks16-32|Lack of Efficacy|0
1167496|NCT01194219|3832795|P4|Maintenance Phase Weeks16-32|Lack of Efficacy|15
1167497|NCT01194219|3832796|P3|Maintenance Phase Weeks16-32|Lack of Efficacy|37
1167498|NCT01194219|3832797|P2|Maintenance Phase Weeks16-32|Lack of Efficacy|0
1167499|NCT01194219|3832798|P1|Maintenance Phase Weeks16-32|Lack of Efficacy|0
1167500|NCT01194219|3832789|P10|Maintenance Phase Weeks16-32|Adverse Event|0
1167501|NCT01194219|3832790|P9|Maintenance Phase Weeks16-32|Adverse Event|0
1167502|NCT01194219|3832791|P8|Maintenance Phase Weeks16-32|Adverse Event|0
1167503|NCT01194219|3832792|P7|Maintenance Phase Weeks16-32|Adverse Event|0
1167504|NCT01194219|3832793|P6|Maintenance Phase Weeks16-32|Adverse Event|0
1167505|NCT01194219|3832794|P5|Maintenance Phase Weeks16-32|Adverse Event|0
1167506|NCT01194219|3832795|P4|Maintenance Phase Weeks16-32|Adverse Event|9
1167507|NCT01194219|3832796|P3|Maintenance Phase Weeks16-32|Adverse Event|8
1167508|NCT01194219|3832797|P2|Maintenance Phase Weeks16-32|Adverse Event|0
1167509|NCT01194219|3832798|P1|Maintenance Phase Weeks16-32|Adverse Event|0
1167510|NCT01194219|3832789|P10|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
1167511|NCT01194219|3832790|P9|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
1167512|NCT01194219|3832791|P8|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
1167513|NCT01194219|3832792|P7|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
1167514|NCT01194219|3832793|P6|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
1167515|NCT01194219|3832794|P5|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
1167516|NCT01194219|3832795|P4|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
1167517|NCT01194219|3832796|P3|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
1167518|NCT01194219|3832797|P2|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
1167519|NCT01194219|3832798|P1|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
1167520|NCT01194219|3832789|P10|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
1167521|NCT01194219|3832790|P9|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
1167522|NCT01194219|3832791|P8|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
1167523|NCT01194219|3832792|P7|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
1167524|NCT01194219|3832793|P6|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
1167525|NCT01194219|3832794|P5|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
1167526|NCT01194219|3832795|P4|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
1167527|NCT01194219|3832796|P3|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
1167528|NCT01194219|3832797|P2|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1
1167529|NCT01194219|3832798|P1|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7
1167530|NCT01194219|3832789|P10|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
1167531|NCT01194219|3832790|P9|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
1167532|NCT01194219|3832791|P8|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
1167533|NCT01194219|3832792|P7|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
1167534|NCT01194219|3832793|P6|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
1167535|NCT01194219|3832794|P5|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
1167536|NCT01194219|3832795|P4|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
1167537|NCT01194219|3832796|P3|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
1167538|NCT01194219|3832797|P2|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9
1167539|NCT01194219|3832798|P1|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7
1167540|NCT01194219|3832789|P10|Placebo-Controlled Phase Weeks 0-16|Death|0
1167541|NCT01194219|3832790|P9|Placebo-Controlled Phase Weeks 0-16|Death|0
1167542|NCT01194219|3832791|P8|Placebo-Controlled Phase Weeks 0-16|Death|0
1167543|NCT01194219|3832792|P7|Placebo-Controlled Phase Weeks 0-16|Death|0
1167544|NCT01194219|3832793|P6|Placebo-Controlled Phase Weeks 0-16|Death|0
1167545|NCT01194219|3832794|P5|Placebo-Controlled Phase Weeks 0-16|Death|0
1167546|NCT01194219|3832795|P4|Placebo-Controlled Phase Weeks 0-16|Death|0
1167547|NCT01194219|3832796|P3|Placebo-Controlled Phase Weeks 0-16|Death|0
1167548|NCT01194219|3832797|P2|Placebo-Controlled Phase Weeks 0-16|Death|1
1167549|NCT01194219|3832798|P1|Placebo-Controlled Phase Weeks 0-16|Death|0
1167550|NCT01194219|3832789|P10|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
1167551|NCT01194219|3832790|P9|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
1167552|NCT01194219|3832791|P8|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
1167553|NCT01194219|3832792|P7|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
1167554|NCT01194219|3832793|P6|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
1167555|NCT01194219|3832794|P5|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
1167556|NCT01194219|3832795|P4|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
1167557|NCT01194219|3832796|P3|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
1167558|NCT01194219|3832797|P2|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9
1167559|NCT01194219|3832798|P1|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12
1167560|NCT01194219|3832789|P10|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
1167561|NCT01194219|3832790|P9|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
1167562|NCT01194219|3832791|P8|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
1167563|NCT01194219|3832792|P7|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
1167564|NCT01194219|3832793|P6|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
1167565|NCT01194219|3832794|P5|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
1167566|NCT01194219|3832795|P4|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
1167567|NCT01194219|3832796|P3|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
1167568|NCT01194219|3832797|P2|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
1167569|NCT01194219|3832798|P1|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7
1167570|NCT01194219|3832789|P10|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
1167571|NCT01194219|3832790|P9|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
1167572|NCT01194219|3832791|P8|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
1167573|NCT01194219|3832792|P7|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
1167574|NCT01194219|3832793|P6|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
1167575|NCT01194219|3832794|P5|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
1167576|NCT01194219|3832795|P4|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
1167577|NCT01194219|3832796|P3|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
1167578|NCT01194219|3832797|P2|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7
1167579|NCT01194219|3832798|P1|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2
1167580|NCT01194219|3832789|P10|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
1167581|NCT01194219|3832790|P9|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
1167582|NCT01194219|3832791|P8|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
1167583|NCT01194219|3832792|P7|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
1167584|NCT01194219|3832793|P6|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
1167585|NCT01194219|3832794|P5|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
1167586|NCT01194219|3832795|P4|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
1167587|NCT01194219|3832796|P3|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
1167588|NCT01194219|3832797|P2|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5
1167589|NCT01194219|3832798|P1|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23
1167590|NCT01194154|3832832|P2|Overall Study|Did not receive study medication|4
1167591|NCT01194154|3832833|P1|Overall Study|Did not receive study medication|2
1167592|NCT01194154|3832832|P2|Overall Study|Other|0
1167593|NCT01194154|3832833|P1|Overall Study|Other|4
1167594|NCT01194154|3832832|P2|Overall Study|Treatment with prohibited medication|5
1167595|NCT01194154|3832833|P1|Overall Study|Treatment with prohibited medication|4
1167596|NCT01194154|3832832|P2|Overall Study|Skipping of CERA treatment at two visits|0
1167597|NCT01194154|3832833|P1|Overall Study|Skipping of CERA treatment at two visits|3
1167598|NCT01194154|3832832|P2|Overall Study|Hemoglobin increase|3
1167599|NCT01194154|3832833|P1|Overall Study|Hemoglobin increase|12
1167600|NCT01194154|3832832|P2|Overall Study|Hemoglobin decrease|1
1167601|NCT01194154|3832833|P1|Overall Study|Hemoglobin decrease|0
1167602|NCT01194154|3832832|P2|Overall Study|Blood pressure increase|3
1167603|NCT01194154|3832833|P1|Overall Study|Blood pressure increase|5
1167604|NCT01194154|3832832|P2|Overall Study|Withdrawal by Subject|6
1167605|NCT01194154|3832833|P1|Overall Study|Withdrawal by Subject|5
1167606|NCT01194154|3832832|P2|Overall Study|Protocol Violation|1
1167607|NCT01194154|3832833|P1|Overall Study|Protocol Violation|0
1167608|NCT01194154|3832832|P2|Overall Study|Lost to Follow-up|3
1167609|NCT01194154|3832833|P1|Overall Study|Lost to Follow-up|2
1167610|NCT01194154|3832832|P2|Overall Study|Adverse Event|7
1167611|NCT01194154|3832833|P1|Overall Study|Adverse Event|12
1167612|NCT01193920|3832874|P10|Overall Study|Unable to classify|0
1167613|NCT01193920|3832875|P9|Overall Study|Unable to classify|0
1167614|NCT01193920|3832876|P8|Overall Study|Unable to classify|1
1167615|NCT01193920|3832877|P7|Overall Study|Unable to classify|0
1167616|NCT01193920|3832878|P6|Overall Study|Unable to classify|0
1167617|NCT01193920|3832879|P5|Overall Study|Unable to classify|0
1167618|NCT01193920|3832880|P4|Overall Study|Unable to classify|1
1167619|NCT01193920|3832881|P3|Overall Study|Unable to classify|0
1167620|NCT01193920|3832882|P2|Overall Study|Unable to classify|0
1167621|NCT01193920|3832883|P1|Overall Study|Unable to classify|0
1167622|NCT01193920|3832874|P10|Overall Study|Death|4
1167623|NCT01193920|3832875|P9|Overall Study|Death|2
1167624|NCT01193920|3832876|P8|Overall Study|Death|3
1167625|NCT01193920|3832877|P7|Overall Study|Death|2
1167626|NCT01193920|3832878|P6|Overall Study|Death|0
1167627|NCT01193920|3832879|P5|Overall Study|Death|0
1167628|NCT01193920|3832880|P4|Overall Study|Death|1
1167629|NCT01193920|3832881|P3|Overall Study|Death|0
1167630|NCT01193920|3832882|P2|Overall Study|Death|0
1167631|NCT01193920|3832883|P1|Overall Study|Death|0
1167632|NCT01193920|3832874|P10|Overall Study|Protocol Violation|0
1167633|NCT01193920|3832875|P9|Overall Study|Protocol Violation|0
1167634|NCT01193920|3832876|P8|Overall Study|Protocol Violation|0
1167635|NCT01193920|3832877|P7|Overall Study|Protocol Violation|0
1167636|NCT01193920|3832878|P6|Overall Study|Protocol Violation|0
1167637|NCT01193920|3832879|P5|Overall Study|Protocol Violation|0
1167638|NCT01193920|3832880|P4|Overall Study|Protocol Violation|0
1167639|NCT01193920|3832881|P3|Overall Study|Protocol Violation|0
1167640|NCT01193920|3832882|P2|Overall Study|Protocol Violation|0
1167641|NCT01193920|3832883|P1|Overall Study|Protocol Violation|1
1167642|NCT01193920|3832874|P10|Overall Study|Lost to Follow-up|3
1167643|NCT01193920|3832875|P9|Overall Study|Lost to Follow-up|2
1167644|NCT01193920|3832876|P8|Overall Study|Lost to Follow-up|0
1167645|NCT01193920|3832877|P7|Overall Study|Lost to Follow-up|1
1167646|NCT01193920|3832878|P6|Overall Study|Lost to Follow-up|3
1167647|NCT01193920|3832879|P5|Overall Study|Lost to Follow-up|3
1167648|NCT01193920|3832880|P4|Overall Study|Lost to Follow-up|1
1167649|NCT01193920|3832881|P3|Overall Study|Lost to Follow-up|1
1167650|NCT01193920|3832882|P2|Overall Study|Lost to Follow-up|0
1167651|NCT01193920|3832883|P1|Overall Study|Lost to Follow-up|1
1167652|NCT01193920|3832874|P10|Overall Study|Withdrawal by Subject|0
1167653|NCT01193920|3832875|P9|Overall Study|Withdrawal by Subject|1
1167654|NCT01193920|3832876|P8|Overall Study|Withdrawal by Subject|0
1167655|NCT01193920|3832877|P7|Overall Study|Withdrawal by Subject|3
1167656|NCT01193920|3832878|P6|Overall Study|Withdrawal by Subject|1
1167657|NCT01193920|3832879|P5|Overall Study|Withdrawal by Subject|3
1167658|NCT01193920|3832880|P4|Overall Study|Withdrawal by Subject|1
1167659|NCT01193920|3832881|P3|Overall Study|Withdrawal by Subject|5
1167660|NCT01193920|3832882|P2|Overall Study|Withdrawal by Subject|0
1167661|NCT01193920|3832883|P1|Overall Study|Withdrawal by Subject|1
1167662|NCT01193842|3832979|P5|Phase II: Randomized Groups|Disease progression/relapse on treatment|3
1167663|NCT01193842|3832980|P4|Phase II: Randomized Groups|Disease progression/relapse on treatment|5
1167664|NCT01193842|3832981|P3|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
1167665|NCT01193842|3832982|P2|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
1167666|NCT01193842|3832983|P1|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
1167667|NCT01193842|3832979|P5|Phase II: Randomized Groups|Ineligible|1
1167668|NCT01193842|3832980|P4|Phase II: Randomized Groups|Ineligible|0
1167669|NCT01193842|3832981|P3|Phase II: Randomized Groups|Ineligible|0
1167670|NCT01193842|3832982|P2|Phase II: Randomized Groups|Ineligible|0
1167671|NCT01193842|3832983|P1|Phase II: Randomized Groups|Ineligible|0
1167672|NCT01193842|3832979|P5|Phase II: Randomized Groups|Withdrawal by Subject|2
1167673|NCT01193842|3832980|P4|Phase II: Randomized Groups|Withdrawal by Subject|1
1167674|NCT01193842|3832981|P3|Phase II: Randomized Groups|Withdrawal by Subject|0
1167675|NCT01193842|3832982|P2|Phase II: Randomized Groups|Withdrawal by Subject|0
1167676|NCT01193842|3832983|P1|Phase II: Randomized Groups|Withdrawal by Subject|0
1167677|NCT01193842|3832979|P5|Phase II: Randomized Groups|Adverse Event|3
1167678|NCT01193842|3832980|P4|Phase II: Randomized Groups|Adverse Event|5
1167679|NCT01193842|3832981|P3|Phase II: Randomized Groups|Adverse Event|0
1167680|NCT01193842|3832982|P2|Phase II: Randomized Groups|Adverse Event|0
1167681|NCT01193842|3832983|P1|Phase II: Randomized Groups|Adverse Event|0
1167682|NCT01193842|3832979|P5|Phase II: Randomized Groups|Death|1
1167683|NCT01193842|3832980|P4|Phase II: Randomized Groups|Death|1
1167684|NCT01193842|3832981|P3|Phase II: Randomized Groups|Death|0
1167685|NCT01193842|3832982|P2|Phase II: Randomized Groups|Death|0
1167686|NCT01193842|3832983|P1|Phase II: Randomized Groups|Death|0
1167687|NCT01193842|3832979|P5|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
1167688|NCT01193842|3832980|P4|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
1167689|NCT01193842|3832981|P3|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1
1167690|NCT01193842|3832982|P2|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
1167691|NCT01193842|3832983|P1|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
1167692|NCT01193842|3832979|P5|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
1167693|NCT01193842|3832980|P4|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
1167694|NCT01193842|3832981|P3|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
1167695|NCT01193842|3832982|P2|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
1167696|NCT01193842|3832983|P1|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1
1167697|NCT01193842|3832979|P5|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
1167698|NCT01193842|3832980|P4|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
1167699|NCT01193842|3832981|P3|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
1167700|NCT01193842|3832982|P2|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1
1167701|NCT01193842|3832983|P1|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
1167702|NCT01193686|3833018|P2|Overall Study|Removed by Investigators; unable to matc|0
1167703|NCT01193686|3833019|P1|Overall Study|Removed by Investigators; unable to matc|3
1167704|NCT01193686|3833018|P2|Overall Study|Withdrawal by Subject|1
1167705|NCT01193686|3833019|P1|Overall Study|Withdrawal by Subject|4
1167706|NCT01193660|3833036|P3|Overall Study|Physician Decision|1
1167707|NCT01193660|3833037|P2|Overall Study|Physician Decision|0
1167708|NCT01193660|3833038|P1|Overall Study|Physician Decision|1
1167709|NCT01193660|3833036|P3|Overall Study|Death|0
1167710|NCT01193660|3833037|P2|Overall Study|Death|0
1167711|NCT01193660|3833038|P1|Overall Study|Death|1
1167712|NCT01193660|3833036|P3|Overall Study|Withdrawal by Subject|1
1167713|NCT01193660|3833037|P2|Overall Study|Withdrawal by Subject|3
1167714|NCT01193660|3833038|P1|Overall Study|Withdrawal by Subject|2
1167715|NCT01193608|3833082|P6|Overall Study|Adverse Event|0
1167716|NCT01193608|3833083|P5|Overall Study|Adverse Event|1
1167717|NCT01193608|3833084|P4|Overall Study|Adverse Event|0
1167718|NCT01193608|3833085|P3|Overall Study|Adverse Event|0
1167719|NCT01193608|3833086|P2|Overall Study|Adverse Event|0
1167720|NCT01193608|3833087|P1|Overall Study|Adverse Event|0
1167721|NCT01193608|3833082|P6|Overall Study|Lost to Follow-up|2
1167722|NCT01193608|3833083|P5|Overall Study|Lost to Follow-up|1
1167723|NCT01193608|3833084|P4|Overall Study|Lost to Follow-up|0
1167724|NCT01193608|3833085|P3|Overall Study|Lost to Follow-up|0
1167725|NCT01193608|3833086|P2|Overall Study|Lost to Follow-up|0
1167726|NCT01193608|3833087|P1|Overall Study|Lost to Follow-up|0
1167727|NCT01193608|3833082|P6|Overall Study|Withdrawal by Subject|0
1167728|NCT01193608|3833083|P5|Overall Study|Withdrawal by Subject|3
1167729|NCT01193608|3833084|P4|Overall Study|Withdrawal by Subject|3
1167730|NCT01193608|3833085|P3|Overall Study|Withdrawal by Subject|2
1167731|NCT01193608|3833086|P2|Overall Study|Withdrawal by Subject|1
1167732|NCT01193608|3833087|P1|Overall Study|Withdrawal by Subject|0
1167733|NCT01193608|3833082|P6|Overall Study|Other|0
1167734|NCT01193608|3833083|P5|Overall Study|Other|0
1167735|NCT01193608|3833084|P4|Overall Study|Other|0
1167736|NCT01193608|3833085|P3|Overall Study|Other|0
1167737|NCT01193608|3833086|P2|Overall Study|Other|1
1167738|NCT01193608|3833087|P1|Overall Study|Other|0
1167739|NCT01193582|3833324|P4|12 Month Follow-up|Withdrawal by Subject|11
1167740|NCT01193582|3833325|P3|12 Month Follow-up|Withdrawal by Subject|3
1167741|NCT01193582|3833326|P2|12 Month Follow-up|Withdrawal by Subject|0
1167742|NCT01193582|3833327|P1|12 Month Follow-up|Withdrawal by Subject|6
1167743|NCT01193582|3833324|P4|12 Month Follow-up|Death|0
1167744|NCT01193582|3833325|P3|12 Month Follow-up|Death|1
1167745|NCT01193582|3833326|P2|12 Month Follow-up|Death|0
1167746|NCT01193582|3833327|P1|12 Month Follow-up|Death|0
1167747|NCT01193582|3833324|P4|Vaccination Series|Withdrawal by Subject|3
1167748|NCT01193582|3833325|P3|Vaccination Series|Withdrawal by Subject|8
1167749|NCT01193582|3833326|P2|Vaccination Series|Withdrawal by Subject|13
1167750|NCT01193582|3833327|P1|Vaccination Series|Withdrawal by Subject|11
1167751|NCT01193556|3833357|P2|Overall Study|Study termination|25
1167752|NCT01193556|3833358|P1|Overall Study|Study termination|26
1167753|NCT01193348|3833366|P1|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2
1167754|NCT01193348|3833366|P1|Extension Treatment Period|Physician Decision|1
1167755|NCT01193348|3833366|P1|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1
1167756|NCT01193348|3833366|P1|Treatment Period (26 Weeks)|Serious Adverse Event|1
1167757|NCT01193348|3833366|P1|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1
1167758|NCT01193348|3833366|P1|Screening Period|Screen Failure|5
1167759|NCT01193335|3833386|P2|2-Year Follow-up|No Longer Met Eligibility Criteria|2
1167760|NCT01193335|3833387|P1|2-Year Follow-up|No Longer Met Eligibility Criteria|2
1167761|NCT01193335|3833386|P2|2-Year Follow-up|No Longer Willing to Participate|6
1167931|NCT01192516|3834183|P3|Overall Study|started new treatment|0
1167762|NCT01193335|3833387|P1|2-Year Follow-up|No Longer Willing to Participate|5
1167763|NCT01193335|3833386|P2|1-Year Follow-up|Lost to Follow-up|0
1167764|NCT01193335|3833387|P1|1-Year Follow-up|Lost to Follow-up|4
1167765|NCT01193335|3833386|P2|1-Year Follow-up|No Longer Willing to Participate|9
1167766|NCT01193335|3833387|P1|1-Year Follow-up|No Longer Willing to Participate|7
1167767|NCT01193335|3833386|P2|After Infant Series|No Longer Met Eligibility Criteria|1
1167768|NCT01193335|3833387|P1|After Infant Series|No Longer Met Eligibility Criteria|0
1167769|NCT01193335|3833386|P2|After Infant Series|Lost to Follow-up|2
1167770|NCT01193335|3833387|P1|After Infant Series|Lost to Follow-up|1
1167771|NCT01193283|3833482|P1|Overall Study|Death|1
1167772|NCT01193257|3833488|P2|Overall Study|Unblinded due to futility|251
1167773|NCT01193257|3833489|P1|Overall Study|Unblinded due to futility|135
1167774|NCT01193257|3833488|P2|Overall Study|Lost to Follow-up|3
1167775|NCT01193257|3833489|P1|Overall Study|Lost to Follow-up|2
1167776|NCT01193257|3833488|P2|Overall Study|Withdrawal by Subject|86
1167777|NCT01193257|3833489|P1|Overall Study|Withdrawal by Subject|26
1167778|NCT01193257|3833488|P2|Overall Study|Study termination by sponsor|3
1167779|NCT01193257|3833489|P1|Overall Study|Study termination by sponsor|0
1167780|NCT01193257|3833488|P2|Overall Study|Death|391
1167781|NCT01193257|3833489|P1|Overall Study|Death|202
1167782|NCT01193244|3833539|P2|Overall Study|Lost to Follow-up|15
1167783|NCT01193244|3833540|P1|Overall Study|Lost to Follow-up|6
1167784|NCT01193244|3833539|P2|Overall Study|Other|278
1167785|NCT01193244|3833540|P1|Overall Study|Other|303
1167786|NCT01193244|3833539|P2|Overall Study|Withdrawal by Subject|97
1167787|NCT01193244|3833540|P1|Overall Study|Withdrawal by Subject|79
1167788|NCT01193218|3833595|P8|12-52 Weeks|Other reason than above|0
1167789|NCT01193218|3833596|P7|12-52 Weeks|Other reason than above|0
1167790|NCT01193218|3833597|P6|12-52 Weeks|Other reason than above|0
1167791|NCT01193218|3833598|P5|12-52 Weeks|Other reason than above|1
1167792|NCT01193218|3833599|P4|12-52 Weeks|Other reason than above|1
1167793|NCT01193218|3833600|P3|12-52 Weeks|Other reason than above|0
1167794|NCT01193218|3833601|P2|12-52 Weeks|Other reason than above|0
1167795|NCT01193218|3833602|P1|12-52 Weeks|Other reason than above|1
1167796|NCT01193218|3833595|P8|12-52 Weeks|Withdrawal by Subject|2
1167797|NCT01193218|3833596|P7|12-52 Weeks|Withdrawal by Subject|1
1167798|NCT01193218|3833597|P6|12-52 Weeks|Withdrawal by Subject|2
1167799|NCT01193218|3833598|P5|12-52 Weeks|Withdrawal by Subject|0
1167800|NCT01193218|3833599|P4|12-52 Weeks|Withdrawal by Subject|0
1167801|NCT01193218|3833600|P3|12-52 Weeks|Withdrawal by Subject|3
1167802|NCT01193218|3833601|P2|12-52 Weeks|Withdrawal by Subject|0
1167803|NCT01193218|3833602|P1|12-52 Weeks|Withdrawal by Subject|3
1167804|NCT01193218|3833595|P8|12-52 Weeks|Lack of Efficacy|0
1167805|NCT01193218|3833596|P7|12-52 Weeks|Lack of Efficacy|1
1167806|NCT01193218|3833597|P6|12-52 Weeks|Lack of Efficacy|0
1167807|NCT01193218|3833598|P5|12-52 Weeks|Lack of Efficacy|0
1167808|NCT01193218|3833599|P4|12-52 Weeks|Lack of Efficacy|0
1167809|NCT01193218|3833600|P3|12-52 Weeks|Lack of Efficacy|0
1167810|NCT01193218|3833601|P2|12-52 Weeks|Lack of Efficacy|0
1167811|NCT01193218|3833602|P1|12-52 Weeks|Lack of Efficacy|0
1167812|NCT01193218|3833595|P8|12-52 Weeks|Adverse Event|2
1167813|NCT01193218|3833596|P7|12-52 Weeks|Adverse Event|1
1167814|NCT01193218|3833597|P6|12-52 Weeks|Adverse Event|3
1167815|NCT01193218|3833598|P5|12-52 Weeks|Adverse Event|3
1167816|NCT01193218|3833599|P4|12-52 Weeks|Adverse Event|2
1167817|NCT01193218|3833600|P3|12-52 Weeks|Adverse Event|1
1167818|NCT01193218|3833601|P2|12-52 Weeks|Adverse Event|0
1167819|NCT01193218|3833602|P1|12-52 Weeks|Adverse Event|1
1167820|NCT01193218|3833595|P8|0-12 Weeks|Withdrawal by Subject|0
1167821|NCT01193218|3833596|P7|0-12 Weeks|Withdrawal by Subject|1
1167822|NCT01193218|3833597|P6|0-12 Weeks|Withdrawal by Subject|0
1167823|NCT01193218|3833598|P5|0-12 Weeks|Withdrawal by Subject|0
1167824|NCT01193218|3833599|P4|0-12 Weeks|Withdrawal by Subject|0
1167825|NCT01193218|3833600|P3|0-12 Weeks|Withdrawal by Subject|2
1167826|NCT01193218|3833601|P2|0-12 Weeks|Withdrawal by Subject|0
1167827|NCT01193218|3833602|P1|0-12 Weeks|Withdrawal by Subject|3
1167828|NCT01193218|3833595|P8|0-12 Weeks|Protocol Violation|0
1167829|NCT01193218|3833596|P7|0-12 Weeks|Protocol Violation|0
1167830|NCT01193218|3833597|P6|0-12 Weeks|Protocol Violation|1
1167831|NCT01193218|3833598|P5|0-12 Weeks|Protocol Violation|1
1167832|NCT01193218|3833599|P4|0-12 Weeks|Protocol Violation|0
1167833|NCT01193218|3833600|P3|0-12 Weeks|Protocol Violation|0
1167834|NCT01193218|3833601|P2|0-12 Weeks|Protocol Violation|0
1167835|NCT01193218|3833602|P1|0-12 Weeks|Protocol Violation|0
1167836|NCT01193218|3833595|P8|0-12 Weeks|Adverse Event|0
1167837|NCT01193218|3833596|P7|0-12 Weeks|Adverse Event|2
1167838|NCT01193218|3833597|P6|0-12 Weeks|Adverse Event|2
1167839|NCT01193218|3833598|P5|0-12 Weeks|Adverse Event|0
1167840|NCT01193218|3833599|P4|0-12 Weeks|Adverse Event|0
1167841|NCT01193218|3833600|P3|0-12 Weeks|Adverse Event|1
1167842|NCT01193218|3833601|P2|0-12 Weeks|Adverse Event|0
1167843|NCT01193218|3833602|P1|0-12 Weeks|Adverse Event|6
1167844|NCT01193153|3833633|P2|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3
1167845|NCT01193153|3833634|P1|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1
1167846|NCT01193153|3833633|P2|Double Blind Relapse Prevention Period|Experienced Relapse|57
1167847|NCT01193153|3833634|P1|Double Blind Relapse Prevention Period|Experienced Relapse|25
1167848|NCT01193153|3833633|P2|Double Blind Relapse Prevention Period|Withdrawal by Subject|30
1167849|NCT01193153|3833634|P1|Double Blind Relapse Prevention Period|Withdrawal by Subject|19
1167850|NCT01193153|3833633|P2|Double Blind Relapse Prevention Period|Pregnancy|0
1167851|NCT01193153|3833634|P1|Double Blind Relapse Prevention Period|Pregnancy|1
1167852|NCT01193153|3833633|P2|Double Blind Relapse Prevention Period|Lost to Follow-up|9
1167853|NCT01193153|3833634|P1|Double Blind Relapse Prevention Period|Lost to Follow-up|2
1167854|NCT01193153|3833633|P2|Double Blind Relapse Prevention Period|Death|0
1167855|NCT01193153|3833634|P1|Double Blind Relapse Prevention Period|Death|2
1167856|NCT01193153|3833633|P2|Double Blind Relapse Prevention Period|Adverse Event|3
1167857|NCT01193153|3833634|P1|Double Blind Relapse Prevention Period|Adverse Event|12
1167858|NCT01193153|3833633|P2|Double Blind Relapse Prevention Period|Other|3
1167859|NCT01193153|3833634|P1|Double Blind Relapse Prevention Period|Other|2
1167860|NCT01193153|3833633|P2|Open-label Stabilization Period|Other|0
1167861|NCT01193153|3833634|P1|Open-label Stabilization Period|Other|8
1167862|NCT01193153|3833633|P2|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0
1167863|NCT01193153|3833634|P1|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35
1167864|NCT01193153|3833633|P2|Open-label Stabilization Period|Withdrawal by Subject|0
1167865|NCT01193153|3833634|P1|Open-label Stabilization Period|Withdrawal by Subject|29
1167866|NCT01193153|3833633|P2|Open-label Stabilization Period|Lack of Efficacy|0
1167867|NCT01193153|3833634|P1|Open-label Stabilization Period|Lack of Efficacy|5
1167868|NCT01193153|3833633|P2|Open-label Stabilization Period|Lost to Follow-up|0
1167869|NCT01193153|3833634|P1|Open-label Stabilization Period|Lost to Follow-up|10
1167870|NCT01193153|3833633|P2|Open-label Stabilization Period|Death|0
1167871|NCT01193153|3833634|P1|Open-label Stabilization Period|Death|2
1167872|NCT01193153|3833633|P2|Open-label Stabilization Period|Adverse Event|0
1167873|NCT01193153|3833634|P1|Open-label Stabilization Period|Adverse Event|9
1167874|NCT01193153|3833633|P2|Open-label Lead in Period|Lack of Efficacy|0
1167875|NCT01193153|3833634|P1|Open-label Lead in Period|Lack of Efficacy|26
1167876|NCT01193153|3833633|P2|Open-label Lead in Period|Death|0
1167877|NCT01193153|3833634|P1|Open-label Lead in Period|Death|1
1167878|NCT01193153|3833633|P2|Open-label Lead in Period|Adverse Event|0
1167879|NCT01193153|3833634|P1|Open-label Lead in Period|Adverse Event|41
1167880|NCT01193153|3833633|P2|Open-label Lead in Period|Subject Failed Stabilization Criteria|0
1167881|NCT01193153|3833634|P1|Open-label Lead in Period|Subject Failed Stabilization Criteria|47
1167882|NCT01193153|3833633|P2|Open-label Lead in Period|Other|0
1167883|NCT01193153|3833634|P1|Open-label Lead in Period|Other|14
1167884|NCT01193153|3833633|P2|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0
1167885|NCT01193153|3833634|P1|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4
1167886|NCT01193153|3833633|P2|Open-label Lead in Period|Withdrawal by Subject|0
1167887|NCT01193153|3833634|P1|Open-label Lead in Period|Withdrawal by Subject|69
1167888|NCT01193153|3833633|P2|Open-label Lead in Period|Pregnancy|0
1167889|NCT01193153|3833634|P1|Open-label Lead in Period|Pregnancy|1
1167890|NCT01193153|3833633|P2|Open-label Lead in Period|Lost to Follow-up|0
1167891|NCT01193153|3833634|P1|Open-label Lead in Period|Lost to Follow-up|32
1167892|NCT01193127|3833669|P4|Treated|Withdrawal by Subject|1
1167893|NCT01193127|3833670|P3|Treated|Withdrawal by Subject|0
1167894|NCT01193127|3833671|P2|Treated|Withdrawal by Subject|0
1167895|NCT01193127|3833672|P1|Treated|Withdrawal by Subject|0
1167896|NCT01193127|3833669|P4|Randomized|Surgery Cancelled|1
1167897|NCT01193127|3833670|P3|Randomized|Surgery Cancelled|0
1167898|NCT01193127|3833671|P2|Randomized|Surgery Cancelled|0
1167899|NCT01193127|3833672|P1|Randomized|Surgery Cancelled|0
1167900|NCT01193101|3833997|P4|Overall Study|Abnormal test procedure results|0
1167901|NCT01193101|3833998|P3|Overall Study|Abnormal test procedure results|0
1167902|NCT01193101|3833999|P2|Overall Study|Abnormal test procedure results|1
1167903|NCT01193101|3834000|P1|Overall Study|Abnormal test procedure results|0
1167904|NCT01193101|3833997|P4|Overall Study|Administrative problems|0
1167905|NCT01193101|3833998|P3|Overall Study|Administrative problems|1
1167906|NCT01193101|3833999|P2|Overall Study|Administrative problems|0
1167907|NCT01193101|3834000|P1|Overall Study|Administrative problems|0
1167908|NCT01193101|3833997|P4|Overall Study|Withdrawal by Subject|1
1167909|NCT01193101|3833998|P3|Overall Study|Withdrawal by Subject|1
1167910|NCT01193101|3833999|P2|Overall Study|Withdrawal by Subject|4
1167911|NCT01193101|3834000|P1|Overall Study|Withdrawal by Subject|2
1167912|NCT01193101|3833997|P4|Overall Study|Lack of Efficacy|8
1167913|NCT01193101|3833998|P3|Overall Study|Lack of Efficacy|0
1167914|NCT01193101|3833999|P2|Overall Study|Lack of Efficacy|1
1167915|NCT01193101|3834000|P1|Overall Study|Lack of Efficacy|3
1167916|NCT01193101|3833997|P4|Overall Study|Adverse Event|3
1167917|NCT01193101|3833998|P3|Overall Study|Adverse Event|1
1167918|NCT01193101|3833999|P2|Overall Study|Adverse Event|1
1167919|NCT01193101|3834000|P1|Overall Study|Adverse Event|0
1167920|NCT01192776|3834106|P4|Overall Study|Lost to Follow-up|5
1167921|NCT01192776|3834107|P3|Overall Study|Lost to Follow-up|3
1167922|NCT01192776|3834108|P2|Overall Study|Lost to Follow-up|6
1167923|NCT01192776|3834109|P1|Overall Study|Lost to Follow-up|3
1167924|NCT01192776|3834106|P4|Overall Study|Death|15
1167925|NCT01192776|3834107|P3|Overall Study|Death|18
1167926|NCT01192776|3834108|P2|Overall Study|Death|15
1167927|NCT01192776|3834109|P1|Overall Study|Death|8
1167928|NCT01192516|3834183|P3|Overall Study|Unable to follow Actiwatch instructions|0
1167929|NCT01192516|3834184|P2|Overall Study|Unable to follow Actiwatch instructions|2
1167930|NCT01192516|3834185|P1|Overall Study|Unable to follow Actiwatch instructions|4
1167932|NCT01192516|3834184|P2|Overall Study|started new treatment|1
1167933|NCT01192516|3834185|P1|Overall Study|started new treatment|5
1167934|NCT01192516|3834183|P3|Overall Study|Withdrawal by Subject|1
1167935|NCT01192516|3834184|P2|Overall Study|Withdrawal by Subject|4
1167936|NCT01192516|3834185|P1|Overall Study|Withdrawal by Subject|4
1167937|NCT01192516|3834183|P3|Overall Study|Lost to Follow-up|7
1167938|NCT01192516|3834184|P2|Overall Study|Lost to Follow-up|10
1167939|NCT01192516|3834185|P1|Overall Study|Lost to Follow-up|7
1167940|NCT01192412|3834219|P2|Overall Study|Withdrawal by Subject|1
1167941|NCT01192412|3834220|P1|Overall Study|Withdrawal by Subject|2
1167942|NCT01192412|3834219|P2|Overall Study|Lost to Follow-up|1
1167943|NCT01192412|3834220|P1|Overall Study|Lost to Follow-up|2
1167944|NCT01192399|3834228|P1|Overall Study|Lack of Efficacy|2
1167945|NCT01192347|3834238|P1|Overall Study|Patient did not show up for visits|1
1167946|NCT01192347|3834238|P1|Overall Study|Patient not visiting hospital regularly|1
1167947|NCT01192347|3834238|P1|Overall Study|Patient seen in different hospital|1
1167948|NCT01192347|3834238|P1|Overall Study|Suspected serious adverse drug reaction|1
1167949|NCT01192347|3834238|P1|Overall Study|Adverse Event|1
1167950|NCT01192347|3834238|P1|Overall Study|Withdrawal by Subject|1
1167951|NCT01192347|3834238|P1|Overall Study|Lost to Follow-up|3
1167952|NCT01192347|3834238|P1|Overall Study|Death|3
1167953|NCT01192295|3834261|P2|Overall Study|Administrative|6
1167954|NCT01192295|3834262|P1|Overall Study|Administrative|4
1167955|NCT01192295|3834261|P2|Overall Study|Lack of Efficacy|5
1167956|NCT01192295|3834262|P1|Overall Study|Lack of Efficacy|0
1167957|NCT01192295|3834261|P2|Overall Study|Lost to Follow-up|1
1167958|NCT01192295|3834262|P1|Overall Study|Lost to Follow-up|0
1167959|NCT01192295|3834261|P2|Overall Study|Withdrawal by Subject|4
1167960|NCT01192295|3834262|P1|Overall Study|Withdrawal by Subject|3
1167961|NCT01192295|3834261|P2|Overall Study|Adverse Event|7
1167962|NCT01192295|3834262|P1|Overall Study|Adverse Event|3
1167963|NCT01192204|3834296|P2|Overall Study|could not keep recall appointments|0
1167964|NCT01192204|3834297|P1|Overall Study|could not keep recall appointments|1
1167965|NCT01192191|3834309|P2|Overall Study|Withdrawal by Subject|6
1167966|NCT01192191|3834310|P1|Overall Study|Withdrawal by Subject|1
1167967|NCT01192191|3834309|P2|Overall Study|Lost to Follow-up|1
1167968|NCT01192191|3834310|P1|Overall Study|Lost to Follow-up|0
1167969|NCT01192191|3834309|P2|Overall Study|Participants Reached Stopping Criteria|2
1167970|NCT01192191|3834310|P1|Overall Study|Participants Reached Stopping Criteria|3
1167971|NCT01192191|3834309|P2|Overall Study|Adverse Event|12
1167972|NCT01192191|3834310|P1|Overall Study|Adverse Event|7
1167973|NCT01192178|3834336|P2|Overall Study|Lack of Efficacy|2
1167974|NCT01192178|3834337|P1|Overall Study|Lack of Efficacy|1
1167975|NCT01192178|3834336|P2|Overall Study|Adverse Event|1
1167976|NCT01192178|3834337|P1|Overall Study|Adverse Event|2
1167977|NCT01192178|3834336|P2|Overall Study|Lost to Follow-up|3
1167978|NCT01192178|3834337|P1|Overall Study|Lost to Follow-up|3
1167979|NCT01192178|3834336|P2|Overall Study|Physician Decision|4
1167980|NCT01192178|3834337|P1|Overall Study|Physician Decision|2
1167981|NCT01192178|3834336|P2|Overall Study|Protocol Violation|3
1167982|NCT01192178|3834337|P1|Overall Study|Protocol Violation|10
1167983|NCT01192178|3834336|P2|Overall Study|Withdrawal by Subject|10
1167984|NCT01192178|3834337|P1|Overall Study|Withdrawal by Subject|6
1167985|NCT01192152|3834357|P2|Period 3|family emergency|0
1167986|NCT01192152|3834358|P1|Period 3|family emergency|1
1167987|NCT01192152|3834357|P2|Period 1|left prematurely (while on treatment B)|1
1167988|NCT01192152|3834358|P1|Period 1|left prematurely (while on treatment B)|0
1167989|NCT01192126|3834529|P2|First Intervention (1 Week)|Lost to Follow-up|1
1167990|NCT01192126|3834530|P1|First Intervention (1 Week)|Lost to Follow-up|1
1167991|NCT01192126|3834529|P2|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0
1167992|NCT01192126|3834530|P1|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1
1167993|NCT01192022|3834542|P5|Overall Study|Parents did not allow all follow up|0
1167994|NCT01192022|3834543|P4|Overall Study|Parents did not allow all follow up|1
1167995|NCT01192022|3834544|P3|Overall Study|Parents did not allow all follow up|0
1167996|NCT01192022|3834545|P2|Overall Study|Parents did not allow all follow up|0
1167997|NCT01192022|3834546|P1|Overall Study|Parents did not allow all follow up|0
1167998|NCT01192022|3834542|P5|Overall Study|Patient needed surgery|0
1167999|NCT01192022|3834543|P4|Overall Study|Patient needed surgery|0
1168000|NCT01192022|3834544|P3|Overall Study|Patient needed surgery|0
1168001|NCT01192022|3834545|P2|Overall Study|Patient needed surgery|1
1168002|NCT01192022|3834546|P1|Overall Study|Patient needed surgery|0
1168003|NCT01192022|3834542|P5|Overall Study|Patient too sick from chemotherapy|0
1168004|NCT01192022|3834543|P4|Overall Study|Patient too sick from chemotherapy|0
1168005|NCT01192022|3834544|P3|Overall Study|Patient too sick from chemotherapy|0
1168006|NCT01192022|3834545|P2|Overall Study|Patient too sick from chemotherapy|1
1168007|NCT01192022|3834546|P1|Overall Study|Patient too sick from chemotherapy|0
1168008|NCT01192022|3834542|P5|Overall Study|Physician withdrew-patient hardship|0
1168009|NCT01192022|3834543|P4|Overall Study|Physician withdrew-patient hardship|0
1168010|NCT01192022|3834544|P3|Overall Study|Physician withdrew-patient hardship|0
1168011|NCT01192022|3834545|P2|Overall Study|Physician withdrew-patient hardship|0
1168012|NCT01192022|3834546|P1|Overall Study|Physician withdrew-patient hardship|1
1168013|NCT01192022|3834542|P5|Overall Study|Fatal Adverse Event|1
1168014|NCT01192022|3834543|P4|Overall Study|Fatal Adverse Event|0
1168015|NCT01192022|3834544|P3|Overall Study|Fatal Adverse Event|0
1168016|NCT01192022|3834545|P2|Overall Study|Fatal Adverse Event|6
1168017|NCT01192022|3834546|P1|Overall Study|Fatal Adverse Event|4
1168018|NCT01192022|3834542|P5|Overall Study|Adverse Event|0
1168019|NCT01192022|3834543|P4|Overall Study|Adverse Event|0
1168020|NCT01192022|3834544|P3|Overall Study|Adverse Event|0
1168021|NCT01192022|3834545|P2|Overall Study|Adverse Event|0
1168022|NCT01192022|3834546|P1|Overall Study|Adverse Event|1
1168023|NCT01192022|3834542|P5|Overall Study|Lost to Follow-up|0
1168024|NCT01192022|3834543|P4|Overall Study|Lost to Follow-up|1
1168025|NCT01192022|3834544|P3|Overall Study|Lost to Follow-up|1
1168026|NCT01192022|3834545|P2|Overall Study|Lost to Follow-up|2
1168027|NCT01192022|3834546|P1|Overall Study|Lost to Follow-up|4
1168028|NCT01192022|3834542|P5|Overall Study|Withdrawal of Consent|0
1168029|NCT01192022|3834543|P4|Overall Study|Withdrawal of Consent|0
1168030|NCT01192022|3834544|P3|Overall Study|Withdrawal of Consent|0
1168031|NCT01192022|3834545|P2|Overall Study|Withdrawal of Consent|1
1168032|NCT01192022|3834546|P1|Overall Study|Withdrawal of Consent|3
1168033|NCT01191944|3834569|P2|Overall Study|Other|3
1168034|NCT01191944|3834570|P1|Overall Study|Other|1
1168035|NCT01191944|3834569|P2|Overall Study|Withdrawal by Subject|2
1168036|NCT01191944|3834570|P1|Overall Study|Withdrawal by Subject|4
1168037|NCT01191944|3834569|P2|Overall Study|Protocol Violation|2
1168038|NCT01191944|3834570|P1|Overall Study|Protocol Violation|1
1168039|NCT01191944|3834569|P2|Overall Study|Adverse Event|12
1168040|NCT01191944|3834570|P1|Overall Study|Adverse Event|11
1168041|NCT01191840|3834616|P2|Overall Study|Withdrawal by Subject|0
1168042|NCT01191840|3834617|P1|Overall Study|Withdrawal by Subject|2
1168043|NCT01191840|3834616|P2|Overall Study|lab error speciation - non Staph infecti|1
1168044|NCT01191840|3834617|P1|Overall Study|lab error speciation - non Staph infecti|0
1168045|NCT01191840|3834616|P2|Overall Study|IRB approval lapse|2
1168046|NCT01191840|3834617|P1|Overall Study|IRB approval lapse|0
1168047|NCT01191840|3834616|P2|Overall Study|ineligible at enrollment|0
1168048|NCT01191840|3834617|P1|Overall Study|ineligible at enrollment|1
1168049|NCT01191840|3834616|P2|Overall Study|Non Staph Infection|3
1168050|NCT01191840|3834617|P1|Overall Study|Non Staph Infection|4
1168051|NCT01191840|3834616|P2|Overall Study|Lost to Follow-up|6
1168052|NCT01191840|3834617|P1|Overall Study|Lost to Follow-up|4
1168053|NCT01191840|3834616|P2|Overall Study|Subject discontinued treatment|2
1168054|NCT01191840|3834617|P1|Overall Study|Subject discontinued treatment|1
1168055|NCT01191840|3834616|P2|Overall Study|withdrew consent|1
1168056|NCT01191840|3834617|P1|Overall Study|withdrew consent|2
1168057|NCT01191801|3834642|P2|Overall Study|Not Provided|27
1168058|NCT01191801|3834643|P1|Overall Study|Not Provided|45
1168059|NCT01191801|3834642|P2|Overall Study|Withdrawal by Subject|4
1168060|NCT01191801|3834643|P1|Overall Study|Withdrawal by Subject|1
1168061|NCT01191801|3834642|P2|Overall Study|Physician Decision|24
1168062|NCT01191801|3834643|P1|Overall Study|Physician Decision|47
1168063|NCT01191801|3834642|P2|Overall Study|Protocol Violation|4
1168064|NCT01191801|3834643|P1|Overall Study|Protocol Violation|2
1168065|NCT01191801|3834642|P2|Overall Study|Adverse Event|8
1168066|NCT01191801|3834643|P1|Overall Study|Adverse Event|9
1168067|NCT01191801|3834642|P2|Overall Study|Lack of Efficacy|258
1168068|NCT01191801|3834643|P1|Overall Study|Lack of Efficacy|176
1168069|NCT01191801|3834642|P2|Overall Study|Death|12
1168070|NCT01191801|3834643|P1|Overall Study|Death|36
1168071|NCT01191788|3834663|P2|Overall Study|Lost to Follow-up|22
1168072|NCT01191788|3834664|P1|Overall Study|Lost to Follow-up|21
1168073|NCT01191762|3834674|P2|Overall Study|Adverse Event|0
1168074|NCT01191762|3834675|P1|Overall Study|Adverse Event|1
1168075|NCT01191268|3834833|P3|Overall Study|Sponsor Decision|0
1168076|NCT01191268|3834834|P2|Overall Study|Sponsor Decision|2
1168077|NCT01191268|3834835|P1|Overall Study|Sponsor Decision|0
1168078|NCT01191268|3834833|P3|Overall Study|Protocol Violation|1
1168079|NCT01191268|3834834|P2|Overall Study|Protocol Violation|0
1168080|NCT01191268|3834835|P1|Overall Study|Protocol Violation|1
1168081|NCT01191268|3834833|P3|Overall Study|Death|3
1168082|NCT01191268|3834834|P2|Overall Study|Death|1
1168083|NCT01191268|3834835|P1|Overall Study|Death|0
1168084|NCT01191268|3834833|P3|Overall Study|Entry Criteria Not Met|1
1168085|NCT01191268|3834834|P2|Overall Study|Entry Criteria Not Met|1
1168086|NCT01191268|3834835|P1|Overall Study|Entry Criteria Not Met|3
1168087|NCT01191268|3834833|P3|Overall Study|Lost to Follow-up|9
1168088|NCT01191268|3834834|P2|Overall Study|Lost to Follow-up|5
1168089|NCT01191268|3834835|P1|Overall Study|Lost to Follow-up|8
1168090|NCT01191268|3834833|P3|Overall Study|Physician Decision|9
1168091|NCT01191268|3834834|P2|Overall Study|Physician Decision|8
1168092|NCT01191268|3834835|P1|Overall Study|Physician Decision|6
1168093|NCT01191268|3834833|P3|Overall Study|Adverse Event|8
1168094|NCT01191268|3834834|P2|Overall Study|Adverse Event|13
1168095|NCT01191268|3834835|P1|Overall Study|Adverse Event|21
1168096|NCT01191268|3834833|P3|Overall Study|Withdrawal by Subject|21
1168097|NCT01191268|3834834|P2|Overall Study|Withdrawal by Subject|25
1168098|NCT01191268|3834835|P1|Overall Study|Withdrawal by Subject|19
1168099|NCT01191190|3834976|P1|Overall Study|Withdrawal by Subject|1
1168100|NCT01191086|3834989|P1|Overall Study|Other|1
1168101|NCT01191086|3834989|P1|Overall Study|Discontinuation criterion met|1
1168102|NCT01191086|3834989|P1|Overall Study|Withdrawal by Subject|24
1168103|NCT01191086|3834989|P1|Overall Study|Physician Decision|2
1168104|NCT01191086|3834989|P1|Overall Study|Lost to Follow-up|4
1168105|NCT01191086|3834989|P1|Overall Study|Lack of Efficacy|10
1168106|NCT01191086|3834989|P1|Overall Study|Adverse Event|20
1168107|NCT01191008|3834993|P1|Overall Study|Lost to Follow-up|8
1168108|NCT01191008|3834993|P1|Overall Study|Protocol Violation|7
1168109|NCT01190891|3835001|P2|Overall Study|Withdrawal by Subject|0
1168110|NCT01190891|3835002|P1|Overall Study|Withdrawal by Subject|5
1168111|NCT01190891|3835001|P2|Overall Study|Protocol Violation|0
1168112|NCT01190891|3835002|P1|Overall Study|Protocol Violation|1
1168113|NCT01190865|3835027|P1|Overall Study|Non-compliance|2
1168114|NCT01190865|3835027|P1|Overall Study|Withdrawal by Subject|1
1168115|NCT01190839|3835034|P2|Overall Study|Randomized but not treated|4
1168116|NCT01190839|3835035|P1|Overall Study|Randomized but not treated|2
1168117|NCT01190839|3835034|P2|Overall Study|Undefined|31
1168118|NCT01190839|3835035|P1|Overall Study|Undefined|35
1168119|NCT01190839|3835034|P2|Overall Study|Trial stopped by Sponsor|68
1168120|NCT01190839|3835035|P1|Overall Study|Trial stopped by Sponsor|71
1168121|NCT01190839|3835034|P2|Overall Study|Death|0
1168122|NCT01190839|3835035|P1|Overall Study|Death|1
1168123|NCT01190839|3835034|P2|Overall Study|Lost to Follow-up|1
1168124|NCT01190839|3835035|P1|Overall Study|Lost to Follow-up|7
1168125|NCT01190839|3835034|P2|Overall Study|Protocol Violation|2
1168126|NCT01190839|3835035|P1|Overall Study|Protocol Violation|2
1168127|NCT01190839|3835034|P2|Overall Study|Adverse Event|41
1168128|NCT01190839|3835035|P1|Overall Study|Adverse Event|32
1168129|NCT01190813|3835049|P2|Overall Study|Adverse Event|1
1168130|NCT01190813|3835050|P1|Overall Study|Adverse Event|0
1168131|NCT01190813|3835049|P2|Overall Study|Refused study treatment after randomized|0
1168132|NCT01190813|3835050|P1|Overall Study|Refused study treatment after randomized|1
1168133|NCT01190813|3835049|P2|Overall Study|Withdrawal by Subject|1
1168134|NCT01190813|3835050|P1|Overall Study|Withdrawal by Subject|2
1168135|NCT01190813|3835049|P2|Overall Study|Lost to Follow-up|2
1168136|NCT01190813|3835050|P1|Overall Study|Lost to Follow-up|1
1168137|NCT01190514|3835171|P4|Third Intervention (Period 3)|Adverse Event|0
1168138|NCT01190514|3835172|P3|Third Intervention (Period 3)|Adverse Event|0
1168139|NCT01190514|3835173|P2|Third Intervention (Period 3)|Adverse Event|0
1168140|NCT01190514|3835174|P1|Third Intervention (Period 3)|Adverse Event|1
1168141|NCT01190514|3835171|P4|First Intervention (Period 1)|Adverse Event|0
1168142|NCT01190514|3835172|P3|First Intervention (Period 1)|Adverse Event|0
1168143|NCT01190514|3835173|P2|First Intervention (Period 1)|Adverse Event|0
1168144|NCT01190514|3835174|P1|First Intervention (Period 1)|Adverse Event|1
1168145|NCT01190449|3835219|P2|Overall Study|Ineligible|4
1168146|NCT01190449|3835220|P1|Overall Study|Ineligible|0
1168147|NCT01190436|3835228|P1|Overall Study|Other|4
1168148|NCT01190436|3835228|P1|Overall Study|Lost to Follow-up|35
1168149|NCT01190267|3835253|P2|Overall Study|Protocol Violation|1
1168150|NCT01190267|3835254|P1|Overall Study|Protocol Violation|8
1168151|NCT01190267|3835253|P2|Overall Study|Withdrawal by Subject|1
1168152|NCT01190267|3835254|P1|Overall Study|Withdrawal by Subject|13
1168153|NCT01190267|3835253|P2|Overall Study|Lost to Follow-up|0
1168154|NCT01190267|3835254|P1|Overall Study|Lost to Follow-up|2
1168155|NCT01190267|3835253|P2|Overall Study|Treatment Failure|2
1168156|NCT01190267|3835254|P1|Overall Study|Treatment Failure|8
1168157|NCT01190267|3835253|P2|Overall Study|Adverse Event|0
1168158|NCT01190267|3835254|P1|Overall Study|Adverse Event|10
1168159|NCT01190254|3835265|P3|Overall Study|Did not meet protocol eligibility|0
1168160|NCT01190254|3835266|P2|Overall Study|Did not meet protocol eligibility|0
1168161|NCT01190254|3835267|P1|Overall Study|Did not meet protocol eligibility|1
1168162|NCT01190254|3835265|P3|Overall Study|Protocol Violation|2
1168163|NCT01190254|3835266|P2|Overall Study|Protocol Violation|0
1168164|NCT01190254|3835267|P1|Overall Study|Protocol Violation|2
1168165|NCT01190254|3835265|P3|Overall Study|Withdrawal by Subject|7
1168166|NCT01190254|3835266|P2|Overall Study|Withdrawal by Subject|5
1168167|NCT01190254|3835267|P1|Overall Study|Withdrawal by Subject|4
1168168|NCT01190254|3835265|P3|Overall Study|Lost to Follow-up|0
1168169|NCT01190254|3835266|P2|Overall Study|Lost to Follow-up|2
1168170|NCT01190254|3835267|P1|Overall Study|Lost to Follow-up|4
1168171|NCT01190254|3835265|P3|Overall Study|Lack of Efficacy|5
1168172|NCT01190254|3835266|P2|Overall Study|Lack of Efficacy|4
1168173|NCT01190254|3835267|P1|Overall Study|Lack of Efficacy|7
1168174|NCT01190254|3835265|P3|Overall Study|Adverse Event|8
1168175|NCT01190254|3835266|P2|Overall Study|Adverse Event|6
1168176|NCT01190254|3835267|P1|Overall Study|Adverse Event|3
1168177|NCT01190228|3835332|P3|Overall Study|Withdrawal by Subject|0
1168178|NCT01190228|3835333|P2|Overall Study|Withdrawal by Subject|0
1168179|NCT01190228|3835334|P1|Overall Study|Withdrawal by Subject|1
1168180|NCT01190228|3835332|P3|Overall Study|Protocol Violation|0
1168181|NCT01190228|3835333|P2|Overall Study|Protocol Violation|0
1168182|NCT01190228|3835334|P1|Overall Study|Protocol Violation|4
1168183|NCT01190215|3835357|P2|Up to Month 6|Lost to Follow-up|0
1168184|NCT01190215|3835358|P1|Up to Month 6|Lost to Follow-up|2
1168185|NCT01190189|3835426|P1|Overall Study|Migrated/moved from study area|1
1168186|NCT01190189|3835426|P1|Overall Study|Withdrawal by Subject|1
1168187|NCT01190189|3835426|P1|Overall Study|Lost to Follow-up|4
1168188|NCT01190176|3835433|P1|Overall Study|Lost to Follow-up|1
1168189|NCT01190176|3835433|P1|Overall Study|Withdrawal by Subject|1
1168190|NCT01190150|3835454|P2|Washout|Difficulty in adherence|1
1168191|NCT01190150|3835455|P1|Washout|Difficulty in adherence|0
1168192|NCT01190150|3835454|P2|Washout|Withdrawal by Subject|1
1168193|NCT01190150|3835455|P1|Washout|Withdrawal by Subject|0
1168194|NCT01190150|3835454|P2|First Treatment|Withdrawal by Subject|0
1168195|NCT01190150|3835455|P1|First Treatment|Withdrawal by Subject|1
1168196|NCT01190124|3835482|P3|Overall Study|Lost to Follow-up|0
1168197|NCT01190124|3835483|P2|Overall Study|Lost to Follow-up|0
1168198|NCT01190124|3835484|P1|Overall Study|Lost to Follow-up|2
1168199|NCT01190124|3835482|P3|Overall Study|Therapeutic Failure|1
1168200|NCT01190124|3835483|P2|Overall Study|Therapeutic Failure|0
1168201|NCT01190124|3835484|P1|Overall Study|Therapeutic Failure|12
1168202|NCT01190124|3835482|P3|Overall Study|Death|0
1168203|NCT01190124|3835483|P2|Overall Study|Death|0
1168204|NCT01190124|3835484|P1|Overall Study|Death|3
1168205|NCT01190098|3835522|P2|Overall Study|Other|1
1168206|NCT01190098|3835523|P1|Overall Study|Other|0
1168207|NCT01190098|3835522|P2|Overall Study|Lack of transportation|0
1168208|NCT01190098|3835523|P1|Overall Study|Lack of transportation|1
1168209|NCT01190098|3835522|P2|Overall Study|Patient coomorbidity|1
1168210|NCT01190098|3835523|P1|Overall Study|Patient coomorbidity|0
1168211|NCT01190098|3835522|P2|Overall Study|Adverse Event|0
1168212|NCT01190098|3835523|P1|Overall Study|Adverse Event|2
1168213|NCT01190007|3835562|P1|Overall Study|Participant was arrested|1
1168214|NCT01190007|3835562|P1|Overall Study|Difficulty of visit for complications|1
1168215|NCT01190007|3835562|P1|Overall Study|Adverse Event|8
1168216|NCT01190007|3835562|P1|Overall Study|Withdrawal by Subject|4
1168217|NCT01189890|3835579|P2|Overall Study|Hyperglycemia Discontinuation Criteria|5
1168218|NCT01189890|3835580|P1|Overall Study|Hyperglycemia Discontinuation Criteria|5
1168219|NCT01189890|3835579|P2|Overall Study|Physician Decision|4
1168220|NCT01189890|3835580|P1|Overall Study|Physician Decision|5
1168221|NCT01189890|3835579|P2|Overall Study|Non Compliance|1
1168222|NCT01189890|3835580|P1|Overall Study|Non Compliance|0
1168223|NCT01189890|3835579|P2|Overall Study|Withdrawal by Subject|11
1168224|NCT01189890|3835580|P1|Overall Study|Withdrawal by Subject|15
1168225|NCT01189890|3835579|P2|Overall Study|Protocol Violation|5
1168226|NCT01189890|3835580|P1|Overall Study|Protocol Violation|1
1168227|NCT01189890|3835579|P2|Overall Study|Lost to Follow-up|7
1168228|NCT01189890|3835580|P1|Overall Study|Lost to Follow-up|1
1168229|NCT01189890|3835579|P2|Overall Study|Lack of Efficacy|2
1168230|NCT01189890|3835580|P1|Overall Study|Lack of Efficacy|7
1168231|NCT01189890|3835579|P2|Overall Study|Adverse Event|4
1168232|NCT01189890|3835580|P1|Overall Study|Adverse Event|3
1168233|NCT01189812|3835602|P2|Overall Study|Moved out of State|2
1168234|NCT01189812|3835603|P1|Overall Study|Moved out of State|1
1168235|NCT01189812|3835602|P2|Overall Study|Out of Window|3
1168236|NCT01189812|3835603|P1|Overall Study|Out of Window|4
1168237|NCT01189812|3835602|P2|Overall Study|Adverse Event|0
1168238|NCT01189812|3835603|P1|Overall Study|Adverse Event|1
1168239|NCT01189812|3835602|P2|Overall Study|Withdrawal by Subject|3
1168240|NCT01189812|3835603|P1|Overall Study|Withdrawal by Subject|2
1168241|NCT01189604|3835687|P7|Overall Study|Withdrawal by Subject|0
1168242|NCT01189604|3835688|P6|Overall Study|Withdrawal by Subject|0
1168243|NCT01189604|3835689|P5|Overall Study|Withdrawal by Subject|0
1168244|NCT01189604|3835690|P4|Overall Study|Withdrawal by Subject|0
1168245|NCT01189604|3835691|P3|Overall Study|Withdrawal by Subject|0
1168246|NCT01189604|3835692|P2|Overall Study|Withdrawal by Subject|0
1168247|NCT01189604|3835693|P1|Overall Study|Withdrawal by Subject|1
1168248|NCT01189604|3835687|P7|Overall Study|Adverse Event|1
1168249|NCT01189604|3835688|P6|Overall Study|Adverse Event|0
1168250|NCT01189604|3835689|P5|Overall Study|Adverse Event|2
1168251|NCT01189604|3835690|P4|Overall Study|Adverse Event|0
1168252|NCT01189604|3835691|P3|Overall Study|Adverse Event|0
1168253|NCT01189604|3835692|P2|Overall Study|Adverse Event|1
1168254|NCT01189604|3835693|P1|Overall Study|Adverse Event|0
1168255|NCT01189604|3835687|P7|Overall Study|Impossible to visit|0
1168256|NCT01189604|3835688|P6|Overall Study|Impossible to visit|1
1168257|NCT01189604|3835689|P5|Overall Study|Impossible to visit|0
1168258|NCT01189604|3835690|P4|Overall Study|Impossible to visit|0
1168259|NCT01189604|3835691|P3|Overall Study|Impossible to visit|0
1168260|NCT01189604|3835692|P2|Overall Study|Impossible to visit|0
1168261|NCT01189604|3835693|P1|Overall Study|Impossible to visit|0
1168262|NCT01189500|3835737|P1|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1
1168263|NCT01189500|3835737|P1|Period 1: TAMOX Alone|Adverse Event|1
1168264|NCT01189487|3835798|P1|Overall Study|Adverse Event|1
1168265|NCT01189487|3835798|P1|Overall Study|Lack of Efficacy|2
1168266|NCT01189461|3835806|P1|Overall Study|Other|8
1168267|NCT01189461|3835806|P1|Overall Study|Did not meet entrance criteria|3
1168268|NCT01189461|3835806|P1|Overall Study|Adverse Event|2
1168269|NCT01189461|3835806|P1|Overall Study|Protocol Violation|1
1168270|NCT01189461|3835806|P1|Overall Study|Withdrawal by Subject|6
1168271|NCT01189461|3835806|P1|Overall Study|Lost to Follow-up|1
1168272|NCT01189461|3835806|P1|Overall Study|Lack of Efficacy|13
1168273|NCT01189435|3835813|P1|Overall Study|Physician Decision|1
1168274|NCT01189435|3835813|P1|Overall Study|Withdrawal by Subject|1
1168275|NCT01189227|3835913|P2|Overall Study|Study terminated due to low accrual|3
1168276|NCT01189227|3835914|P1|Overall Study|Study terminated due to low accrual|6
1168277|NCT01189201|3835920|P1|Overall Study|Adverse Event|1
1168278|NCT01189032|3836023|P3|Overall Study|Protocol Violation|1
1168279|NCT01189032|3836024|P2|Overall Study|Protocol Violation|1
1168280|NCT01189032|3836025|P1|Overall Study|Protocol Violation|1
1168281|NCT01189032|3836023|P3|Overall Study|Withdrawal by Subject|1
1168282|NCT01189032|3836024|P2|Overall Study|Withdrawal by Subject|0
1168283|NCT01189032|3836025|P1|Overall Study|Withdrawal by Subject|1
1168284|NCT01189032|3836023|P3|Overall Study|Lack of Efficacy|0
1168285|NCT01189032|3836024|P2|Overall Study|Lack of Efficacy|3
1168286|NCT01189032|3836025|P1|Overall Study|Lack of Efficacy|2
1168287|NCT01189032|3836023|P3|Overall Study|Adverse Event|4
1168288|NCT01189032|3836024|P2|Overall Study|Adverse Event|3
1168289|NCT01189032|3836025|P1|Overall Study|Adverse Event|1
1168290|NCT01188967|3836035|P2|Overall Study|Lost to Follow-up|2
1168291|NCT01188967|3836036|P1|Overall Study|Lost to Follow-up|3
1168292|NCT01188967|3836035|P2|Overall Study|Physician Decision|1
1168293|NCT01188967|3836036|P1|Overall Study|Physician Decision|1
1168294|NCT01188967|3836035|P2|Overall Study|Withdrawal by Subject|1
1168295|NCT01188967|3836036|P1|Overall Study|Withdrawal by Subject|1
1168296|NCT01188811|3836089|P2|Overall Study|Adverse Event|0
1168297|NCT01188811|3836090|P1|Overall Study|Adverse Event|6
1168298|NCT01188811|3836089|P2|Overall Study|Withdrawal by Subject|2
1168299|NCT01188811|3836090|P1|Overall Study|Withdrawal by Subject|0
1168300|NCT01188798|3836102|P2|Overall Study|Protocol closure|1
1168301|NCT01188798|3836103|P1|Overall Study|Protocol closure|1
1168302|NCT01188798|3836102|P2|Overall Study|Required additional transplant|1
1168303|NCT01188798|3836103|P1|Overall Study|Required additional transplant|1
1168304|NCT01188798|3836102|P2|Overall Study|Death|1
1168305|NCT01188798|3836103|P1|Overall Study|Death|0
1168306|NCT01188772|3836115|P4|Overall Study|Withdrawal by Subject|0
1168307|NCT01188772|3836116|P3|Overall Study|Withdrawal by Subject|2
1168308|NCT01188772|3836117|P2|Overall Study|Withdrawal by Subject|0
1168309|NCT01188772|3836118|P1|Overall Study|Withdrawal by Subject|0
1168310|NCT01188772|3836115|P4|Overall Study|Virologic Failure|0
1168311|NCT01188772|3836116|P3|Overall Study|Virologic Failure|0
1168312|NCT01188772|3836117|P2|Overall Study|Virologic Failure|0
1168313|NCT01188772|3836118|P1|Overall Study|Virologic Failure|1
1168314|NCT01188772|3836115|P4|Overall Study|Treatment Failure|0
1168315|NCT01188772|3836116|P3|Overall Study|Treatment Failure|1
1168316|NCT01188772|3836117|P2|Overall Study|Treatment Failure|0
1168317|NCT01188772|3836118|P1|Overall Study|Treatment Failure|0
1168318|NCT01188772|3836115|P4|Overall Study|Terminated by Sponsor|0
1168319|NCT01188772|3836116|P3|Overall Study|Terminated by Sponsor|1
1168320|NCT01188772|3836117|P2|Overall Study|Terminated by Sponsor|0
1168321|NCT01188772|3836118|P1|Overall Study|Terminated by Sponsor|0
1168322|NCT01188772|3836115|P4|Overall Study|Physician Decision|0
1168323|NCT01188772|3836116|P3|Overall Study|Physician Decision|1
1168324|NCT01188772|3836117|P2|Overall Study|Physician Decision|0
1168325|NCT01188772|3836118|P1|Overall Study|Physician Decision|0
1168326|NCT01188772|3836115|P4|Overall Study|Non-responder|0
1168327|NCT01188772|3836116|P3|Overall Study|Non-responder|3
1168328|NCT01188772|3836117|P2|Overall Study|Non-responder|0
1168329|NCT01188772|3836118|P1|Overall Study|Non-responder|0
1168330|NCT01188772|3836115|P4|Overall Study|Lost to Follow-up|1
1168331|NCT01188772|3836116|P3|Overall Study|Lost to Follow-up|1
1168332|NCT01188772|3836117|P2|Overall Study|Lost to Follow-up|1
1168333|NCT01188772|3836118|P1|Overall Study|Lost to Follow-up|4
1168334|NCT01188772|3836115|P4|Overall Study|Adverse Event|0
1168335|NCT01188772|3836116|P3|Overall Study|Adverse Event|2
1168336|NCT01188772|3836117|P2|Overall Study|Adverse Event|1
1168337|NCT01188772|3836118|P1|Overall Study|Adverse Event|0
1168338|NCT01188772|3836115|P4|Overall Study|Randomized but Not Treated|0
1168339|NCT01188772|3836116|P3|Overall Study|Randomized but Not Treated|0
1168340|NCT01188772|3836117|P2|Overall Study|Randomized but Not Treated|1
1168341|NCT01188772|3836118|P1|Overall Study|Randomized but Not Treated|0
1168342|NCT01188681|3836190|P4|Overall Study|Withdrawal by Subject|1
1168343|NCT01188681|3836191|P3|Overall Study|Withdrawal by Subject|0
1168344|NCT01188681|3836192|P2|Overall Study|Withdrawal by Subject|0
1168345|NCT01188681|3836193|P1|Overall Study|Withdrawal by Subject|0
1168346|NCT01188681|3836190|P4|Overall Study|bladder cancer|0
1168347|NCT01188681|3836191|P3|Overall Study|bladder cancer|1
1168348|NCT01188681|3836192|P2|Overall Study|bladder cancer|0
1168349|NCT01188681|3836193|P1|Overall Study|bladder cancer|0
1168350|NCT01188668|3836207|P1|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1
1168351|NCT01188668|3836207|P1|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2
1168352|NCT01188668|3836207|P1|Period 1: ARIP Alone|Protocol Violation|2
1168353|NCT01188655|3836240|P1|Overall Study|Other|11
1168354|NCT01188655|3836240|P1|Overall Study|Lost to Follow-up|1
1168355|NCT01188655|3836240|P1|Overall Study|Lack of Efficacy|1
1168356|NCT01188564|3836284|P2|Double-blind Phase|randomized not treated|0
1168357|NCT01188564|3836285|P1|Double-blind Phase|randomized not treated|1
1168358|NCT01188551|3836297|P4|Overall Study|Pharmacy issues|0
1168359|NCT01188551|3836298|P3|Overall Study|Pharmacy issues|0
1168360|NCT01188551|3836299|P2|Overall Study|Pharmacy issues|0
1168361|NCT01188551|3836300|P1|Overall Study|Pharmacy issues|1
1168362|NCT01188538|3836316|P2|Overall Study|Lost to Follow-up|1
1168363|NCT01188538|3836317|P1|Overall Study|Lost to Follow-up|0
1168364|NCT01188343|3836413|P3|Overall Study|Withdrawal by Subject|0
1168365|NCT01188343|3836414|P2|Overall Study|Withdrawal by Subject|24
1168366|NCT01188343|3836415|P1|Overall Study|Withdrawal by Subject|1
1168367|NCT01188343|3836413|P3|Overall Study|Not vaccinated|1
1168368|NCT01188343|3836414|P2|Overall Study|Not vaccinated|2
1168369|NCT01188343|3836415|P1|Overall Study|Not vaccinated|0
1168370|NCT01188226|3836441|P1|Overall Study|Withdrawal by Subject|4
1168371|NCT01187953|3836487|P2|Overall Study|Withdrawal by Subject|3
1168372|NCT01187953|3836488|P1|Overall Study|Withdrawal by Subject|3
1168373|NCT01187953|3836487|P2|Overall Study|Lost to Follow-up|3
1168374|NCT01187953|3836488|P1|Overall Study|Lost to Follow-up|0
1168375|NCT01187953|3836487|P2|Overall Study|Adverse Event|2
1168376|NCT01187953|3836488|P1|Overall Study|Adverse Event|1
1168377|NCT01187953|3836487|P2|Overall Study|Death|13
1168378|NCT01187953|3836488|P1|Overall Study|Death|11
1168379|NCT01187901|3836502|P2|Overall Study|Pregnancy|2
1168380|NCT01187901|3836503|P1|Overall Study|Pregnancy|0
1168381|NCT01187901|3836502|P2|Overall Study|No Endpoint due to Early Study Halt|3
1168382|NCT01187901|3836503|P1|Overall Study|No Endpoint due to Early Study Halt|2
1168383|NCT01187901|3836502|P2|Overall Study|Adverse Event|0
1168384|NCT01187901|3836503|P1|Overall Study|Adverse Event|3
1168385|NCT01187901|3836502|P2|Overall Study|Suspected Allergic Reaction|1
1168386|NCT01187901|3836503|P1|Overall Study|Suspected Allergic Reaction|1
1168387|NCT01187901|3836502|P2|Overall Study|Unrelated Health Reasons|2
1168388|NCT01187901|3836503|P1|Overall Study|Unrelated Health Reasons|1
1168389|NCT01187901|3836502|P2|Overall Study|Lost to Follow-up|2
1168390|NCT01187901|3836503|P1|Overall Study|Lost to Follow-up|1
1168391|NCT01187901|3836502|P2|Overall Study|Protocol Violation|0
1168392|NCT01187901|3836503|P1|Overall Study|Protocol Violation|1
1168393|NCT01187550|3836544|P2|Overall Study|Randomized but not treated|0
1168394|NCT01187550|3836545|P1|Overall Study|Randomized but not treated|8
1168395|NCT01187550|3836544|P2|Overall Study|Other|0
1168396|NCT01187550|3836545|P1|Overall Study|Other|3
1168397|NCT01187550|3836544|P2|Overall Study|Protocol Violation|1
1168398|NCT01187550|3836545|P1|Overall Study|Protocol Violation|3
1168399|NCT01187446|3836701|P2|Overall Study|Patient started non-protocol therapy|1
1168400|NCT01187446|3836702|P1|Overall Study|Patient started non-protocol therapy|0
1168401|NCT01187433|3836718|P2|Overall Study|Withdrawal by Subject|2
1168402|NCT01187433|3836719|P1|Overall Study|Withdrawal by Subject|5
1168403|NCT01187433|3836718|P2|Overall Study|Protocol Violation|2
1168404|NCT01187433|3836719|P1|Overall Study|Protocol Violation|6
1168405|NCT01187407|3836749|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
1168406|NCT01187407|3836750|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
1168407|NCT01187407|3836751|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
1168408|NCT01187407|3836752|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
1168409|NCT01187407|3836753|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
1168410|NCT01187407|3836749|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22
1168411|NCT01187407|3836750|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11
1168412|NCT01187407|3836751|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
1168413|NCT01187407|3836752|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
1168414|NCT01187407|3836753|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
1168415|NCT01187407|3836749|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10
1168416|NCT01187407|3836750|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3
1168417|NCT01187407|3836751|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
1168418|NCT01187407|3836752|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6
1168419|NCT01187407|3836753|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
1168420|NCT01187407|3836749|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
1168421|NCT01187407|3836750|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
1168422|NCT01187407|3836751|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
1168423|NCT01187407|3836752|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
1168424|NCT01187407|3836753|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
1168425|NCT01187407|3836749|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
1168426|NCT01187407|3836750|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
1168427|NCT01187407|3836751|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
1168428|NCT01187407|3836752|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
1168429|NCT01187407|3836753|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
1168430|NCT01187407|3836749|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13
1168431|NCT01187407|3836750|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5
1168432|NCT01187407|3836751|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
1168433|NCT01187407|3836752|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3
1168434|NCT01187407|3836753|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
1168435|NCT01187407|3836749|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12
1168436|NCT01187407|3836750|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5
1168437|NCT01187407|3836751|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6
1168438|NCT01187407|3836752|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
1168439|NCT01187407|3836753|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
1168440|NCT01187407|3836749|P5|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
1168441|NCT01187407|3836750|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
1168442|NCT01187407|3836751|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
1168443|NCT01187407|3836752|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
1168444|NCT01187407|3836753|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4
1168445|NCT01187407|3836749|P5|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
1168446|NCT01187407|3836750|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
1168447|NCT01187407|3836751|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
1168448|NCT01187407|3836752|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
1168449|NCT01187407|3836753|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29
1168450|NCT01187407|3836749|P5|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
1168451|NCT01187407|3836750|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
1168452|NCT01187407|3836751|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
1168453|NCT01187407|3836752|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
1168454|NCT01187407|3836753|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13
1168455|NCT01187407|3836749|P5|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
1168456|NCT01187407|3836750|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
1168457|NCT01187407|3836751|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
1168458|NCT01187407|3836752|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
1168459|NCT01187407|3836753|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
1168460|NCT01187407|3836749|P5|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
1168461|NCT01187407|3836750|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
1168462|NCT01187407|3836751|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
1168463|NCT01187407|3836752|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
1168464|NCT01187407|3836753|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9
1168465|NCT01187407|3836749|P5|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
1168466|NCT01187407|3836750|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
1168467|NCT01187407|3836751|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
1168468|NCT01187407|3836752|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
1168469|NCT01187407|3836753|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4
1168470|NCT01187407|3836749|P5|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
1168471|NCT01187407|3836750|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
1168472|NCT01187407|3836751|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
1168473|NCT01187407|3836752|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
1168474|NCT01187407|3836753|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29
1168475|NCT01187043|3836866|P5|Overall Study|Unable to make scheduled visits|1
1168476|NCT01187043|3836867|P4|Overall Study|Unable to make scheduled visits|0
1168477|NCT01187043|3836868|P3|Overall Study|Unable to make scheduled visits|4
1168478|NCT01187043|3836869|P2|Overall Study|Unable to make scheduled visits|0
1168479|NCT01187043|3836870|P1|Overall Study|Unable to make scheduled visits|1
1168480|NCT01187043|3836866|P5|Overall Study|Adverse Event|1
1168481|NCT01187043|3836867|P4|Overall Study|Adverse Event|0
1168482|NCT01187043|3836868|P3|Overall Study|Adverse Event|0
1168483|NCT01187043|3836869|P2|Overall Study|Adverse Event|0
1168484|NCT01187043|3836870|P1|Overall Study|Adverse Event|0
1168485|NCT01186939|3836896|P1|Overall Study|Transformation to AML|1
1168486|NCT01186939|3836896|P1|Overall Study|Bone marrow transplant|1
1168487|NCT01186939|3836896|P1|Overall Study|Myocardial infarction|1
1168488|NCT01186939|3836896|P1|Overall Study|NCI CTC Grade 3 or 4 toxicity|1
1168489|NCT01186939|3836896|P1|Overall Study|Started additional treatment|1
1168490|NCT01186939|3836896|P1|Overall Study|Sponsor decision|4
1168491|NCT01186939|3836896|P1|Overall Study|Program closed|5
1168492|NCT01186939|3836896|P1|Overall Study|No longer receiving clinical benefit|17
1168493|NCT01186939|3836896|P1|Overall Study|Withdrawal by Subject|2
1168494|NCT01186939|3836896|P1|Overall Study|Death|7
1168495|NCT01186848|3836900|P1|Overall Study|Adverse Event|2
1168496|NCT01186848|3836900|P1|Overall Study|Withdrawal by Subject|2
1168497|NCT01186848|3836900|P1|Overall Study|Lost to Follow-up|4
1168498|NCT01186796|3836908|P2|Overall Study|Protocol Violation|1
1168499|NCT01186796|3836909|P1|Overall Study|Protocol Violation|0
1168500|NCT01186796|3836908|P2|Overall Study|Withdrawal by Subject|1
1168501|NCT01186796|3836909|P1|Overall Study|Withdrawal by Subject|1
1168502|NCT01186796|3836908|P2|Overall Study|Adverse Event|0
1168503|NCT01186796|3836909|P1|Overall Study|Adverse Event|3
1168504|NCT01186744|3836929|P6|Overall Study|Death|0
1168505|NCT01186744|3836930|P5|Overall Study|Death|0
1168506|NCT01186744|3836931|P4|Overall Study|Death|0
1168507|NCT01186744|3836932|P3|Overall Study|Death|0
1168508|NCT01186744|3836933|P2|Overall Study|Death|0
1168509|NCT01186744|3836934|P1|Overall Study|Death|1
1168510|NCT01186744|3836929|P6|Overall Study|Adverse Event|4
1168511|NCT01186744|3836930|P5|Overall Study|Adverse Event|1
1168512|NCT01186744|3836931|P4|Overall Study|Adverse Event|0
1168513|NCT01186744|3836932|P3|Overall Study|Adverse Event|1
1168514|NCT01186744|3836933|P2|Overall Study|Adverse Event|14
1168515|NCT01186744|3836934|P1|Overall Study|Adverse Event|10
1168516|NCT01186744|3836929|P6|Overall Study|Not specified|5
1168517|NCT01186744|3836930|P5|Overall Study|Not specified|1
1168518|NCT01186744|3836931|P4|Overall Study|Not specified|2
1168519|NCT01186744|3836932|P3|Overall Study|Not specified|1
1168520|NCT01186744|3836933|P2|Overall Study|Not specified|10
1168521|NCT01186744|3836934|P1|Overall Study|Not specified|9
1168522|NCT01186744|3836929|P6|Overall Study|Study terminated by Sponsor|0
1168523|NCT01186744|3836930|P5|Overall Study|Study terminated by Sponsor|0
1168524|NCT01186744|3836931|P4|Overall Study|Study terminated by Sponsor|0
1168525|NCT01186744|3836932|P3|Overall Study|Study terminated by Sponsor|0
1168526|NCT01186744|3836933|P2|Overall Study|Study terminated by Sponsor|0
1168527|NCT01186744|3836934|P1|Overall Study|Study terminated by Sponsor|1
1168528|NCT01186744|3836929|P6|Overall Study|Withdrawal by Subject|6
1168529|NCT01186744|3836930|P5|Overall Study|Withdrawal by Subject|0
1168530|NCT01186744|3836931|P4|Overall Study|Withdrawal by Subject|5
1168531|NCT01186744|3836932|P3|Overall Study|Withdrawal by Subject|2
1168532|NCT01186744|3836933|P2|Overall Study|Withdrawal by Subject|10
1168533|NCT01186744|3836934|P1|Overall Study|Withdrawal by Subject|14
1168534|NCT01186744|3836929|P6|Overall Study|Screen failure|0
1168535|NCT01186744|3836930|P5|Overall Study|Screen failure|0
1168536|NCT01186744|3836931|P4|Overall Study|Screen failure|1
1168537|NCT01186744|3836932|P3|Overall Study|Screen failure|0
1168538|NCT01186744|3836933|P2|Overall Study|Screen failure|1
1168539|NCT01186744|3836934|P1|Overall Study|Screen failure|1
1168540|NCT01186744|3836929|P6|Overall Study|Lost to Follow-up|4
1168541|NCT01186744|3836930|P5|Overall Study|Lost to Follow-up|1
1168542|NCT01186744|3836931|P4|Overall Study|Lost to Follow-up|1
1168543|NCT01186744|3836932|P3|Overall Study|Lost to Follow-up|2
1168544|NCT01186744|3836933|P2|Overall Study|Lost to Follow-up|16
1168545|NCT01186744|3836934|P1|Overall Study|Lost to Follow-up|15
1168546|NCT01186744|3836929|P6|Overall Study|Protocol Violation|2
1168547|NCT01186744|3836930|P5|Overall Study|Protocol Violation|1
1168548|NCT01186744|3836931|P4|Overall Study|Protocol Violation|1
1168549|NCT01186744|3836932|P3|Overall Study|Protocol Violation|0
1168550|NCT01186744|3836933|P2|Overall Study|Protocol Violation|2
1168551|NCT01186744|3836934|P1|Overall Study|Protocol Violation|1
1168552|NCT01186744|3836929|P6|Overall Study|Lack of Efficacy|5
1168553|NCT01186744|3836930|P5|Overall Study|Lack of Efficacy|2
1168554|NCT01186744|3836931|P4|Overall Study|Lack of Efficacy|2
1168555|NCT01186744|3836932|P3|Overall Study|Lack of Efficacy|0
1168556|NCT01186744|3836933|P2|Overall Study|Lack of Efficacy|99
1168557|NCT01186744|3836934|P1|Overall Study|Lack of Efficacy|156
1168558|NCT01186692|3837354|P1|Overall Study|Adverse Event|2
1168559|NCT01186692|3837354|P1|Overall Study|Futher testing contraindicated implant|19
1168560|NCT01186692|3837354|P1|Overall Study|Not Catheterized|11
1168561|NCT01186458|3837381|P1|Overall Study|Adverse Event|1
1168562|NCT01186419|3837390|P2|Overall Study|Not specified|1
1168563|NCT01186419|3837391|P1|Overall Study|Not specified|1
1168564|NCT01186419|3837390|P2|Overall Study|Physician Decision|3
1168565|NCT01186419|3837391|P1|Overall Study|Physician Decision|0
1168566|NCT01186419|3837390|P2|Overall Study|Adverse Event|2
1168567|NCT01186419|3837391|P1|Overall Study|Adverse Event|1
1168568|NCT01186419|3837390|P2|Overall Study|Withdrawal by Subject|3
1168569|NCT01186419|3837391|P1|Overall Study|Withdrawal by Subject|5
1168570|NCT01185964|3837429|P4|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2
1168571|NCT01185964|3837430|P3|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
1168572|NCT01185964|3837431|P2|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
1168573|NCT01185964|3837432|P1|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
1168574|NCT01185964|3837429|P4|Optional Olaratumab Monotherapy on Dox|Adverse Event|1
1168575|NCT01185964|3837430|P3|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
1168576|NCT01185964|3837431|P2|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
1168577|NCT01185964|3837432|P1|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
1168578|NCT01185964|3837429|P4|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2
1168579|NCT01185964|3837430|P3|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
1168580|NCT01185964|3837431|P2|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
1168581|NCT01185964|3837432|P1|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
1168582|NCT01185964|3837429|P4|Phase 1b and Phase 2|Off Treatment but alive and on study|0
1168583|NCT01185964|3837430|P3|Phase 1b and Phase 2|Off Treatment but alive and on study|1
1168584|NCT01185964|3837431|P2|Phase 1b and Phase 2|Off Treatment but alive and on study|1
1168585|NCT01185964|3837432|P1|Phase 1b and Phase 2|Off Treatment but alive and on study|0
1168586|NCT01185964|3837429|P4|Phase 1b and Phase 2|Adverse Event|0
1168587|NCT01185964|3837430|P3|Phase 1b and Phase 2|Adverse Event|2
1168588|NCT01185964|3837431|P2|Phase 1b and Phase 2|Adverse Event|0
1168589|NCT01185964|3837432|P1|Phase 1b and Phase 2|Adverse Event|1
1168590|NCT01185964|3837429|P4|Phase 1b and Phase 2|Participant was beyond maximum weight|0
1168591|NCT01185964|3837430|P3|Phase 1b and Phase 2|Participant was beyond maximum weight|1
1168592|NCT01185964|3837431|P2|Phase 1b and Phase 2|Participant was beyond maximum weight|0
1168593|NCT01185964|3837432|P1|Phase 1b and Phase 2|Participant was beyond maximum weight|0
1168594|NCT01185964|3837429|P4|Phase 1b and Phase 2|Other Therapy Started|0
1168595|NCT01185964|3837430|P3|Phase 1b and Phase 2|Other Therapy Started|3
1168596|NCT01185964|3837431|P2|Phase 1b and Phase 2|Other Therapy Started|3
1168597|NCT01185964|3837432|P1|Phase 1b and Phase 2|Other Therapy Started|0
1168598|NCT01185964|3837429|P4|Phase 1b and Phase 2|Withdrawal by Subject|0
1168599|NCT01185964|3837430|P3|Phase 1b and Phase 2|Withdrawal by Subject|2
1168600|NCT01185964|3837431|P2|Phase 1b and Phase 2|Withdrawal by Subject|6
1168601|NCT01185964|3837432|P1|Phase 1b and Phase 2|Withdrawal by Subject|1
1168602|NCT01185834|3837458|P1|Overall Study|Early exit - Site error|2
1168603|NCT01185834|3837458|P1|Overall Study|Time/Job Conflict|2
1168604|NCT01185834|3837458|P1|Overall Study|Biomicroscopy|4
1168605|NCT01185834|3837458|P1|Overall Study|Discomfort|4
1168606|NCT01185834|3837458|P1|Overall Study|Lost to Follow-up|2
1168607|NCT01185821|3837468|P5|Overall Study|Administrative problems|2
1168608|NCT01185821|3837469|P4|Overall Study|Administrative problems|1
1168609|NCT01185821|3837470|P3|Overall Study|Administrative problems|1
1168610|NCT01185821|3837471|P2|Overall Study|Administrative problems|0
1168611|NCT01185821|3837472|P1|Overall Study|Administrative problems|0
1168612|NCT01185821|3837468|P5|Overall Study|Lost to Follow-up|2
1168613|NCT01185821|3837469|P4|Overall Study|Lost to Follow-up|1
1168614|NCT01185821|3837470|P3|Overall Study|Lost to Follow-up|2
1168615|NCT01185821|3837471|P2|Overall Study|Lost to Follow-up|1
1168616|NCT01185821|3837472|P1|Overall Study|Lost to Follow-up|1
1168617|NCT01185821|3837468|P5|Overall Study|Withdrawal by Subject|3
1168618|NCT01185821|3837469|P4|Overall Study|Withdrawal by Subject|1
1168619|NCT01185821|3837470|P3|Overall Study|Withdrawal by Subject|2
1168620|NCT01185821|3837471|P2|Overall Study|Withdrawal by Subject|2
1168621|NCT01185821|3837472|P1|Overall Study|Withdrawal by Subject|3
1168622|NCT01185821|3837468|P5|Overall Study|Lack of Efficacy|9
1168623|NCT01185821|3837469|P4|Overall Study|Lack of Efficacy|0
1168624|NCT01185821|3837470|P3|Overall Study|Lack of Efficacy|3
1168625|NCT01185821|3837471|P2|Overall Study|Lack of Efficacy|0
1168626|NCT01185821|3837472|P1|Overall Study|Lack of Efficacy|0
1168627|NCT01185821|3837468|P5|Overall Study|Adverse Event|5
1168628|NCT01185821|3837469|P4|Overall Study|Adverse Event|2
1168629|NCT01185821|3837470|P3|Overall Study|Adverse Event|1
1168630|NCT01185821|3837471|P2|Overall Study|Adverse Event|3
1168631|NCT01185821|3837472|P1|Overall Study|Adverse Event|2
1168632|NCT01185821|3837468|P5|Overall Study|Condition no longer required study drug|1
1168633|NCT01185821|3837469|P4|Overall Study|Condition no longer required study drug|0
1168634|NCT01185821|3837470|P3|Overall Study|Condition no longer required study drug|0
1168635|NCT01185821|3837471|P2|Overall Study|Condition no longer required study drug|0
1168636|NCT01185821|3837472|P1|Overall Study|Condition no longer required study drug|0
1168637|NCT01185821|3837468|P5|Overall Study|Death|0
1168638|NCT01185821|3837469|P4|Overall Study|Death|0
1168639|NCT01185821|3837470|P3|Overall Study|Death|0
1168640|NCT01185821|3837471|P2|Overall Study|Death|1
1168641|NCT01185821|3837472|P1|Overall Study|Death|0
1168642|NCT01185821|3837468|P5|Overall Study|Abnormal test procedure result|1
1168643|NCT01185821|3837469|P4|Overall Study|Abnormal test procedure result|0
1168644|NCT01185821|3837470|P3|Overall Study|Abnormal test procedure result|0
1168645|NCT01185821|3837471|P2|Overall Study|Abnormal test procedure result|0
1168646|NCT01185821|3837472|P1|Overall Study|Abnormal test procedure result|0
1168647|NCT01185821|3837468|P5|Overall Study|Protocol Violation|1
1168648|NCT01185821|3837469|P4|Overall Study|Protocol Violation|1
1168649|NCT01185821|3837470|P3|Overall Study|Protocol Violation|0
1168650|NCT01185821|3837471|P2|Overall Study|Protocol Violation|0
1168651|NCT01185821|3837472|P1|Overall Study|Protocol Violation|0
1168652|NCT01185821|3837468|P5|Overall Study|Abnormal laboratory value(s)|0
1168653|NCT01185821|3837469|P4|Overall Study|Abnormal laboratory value(s)|0
1168654|NCT01185821|3837470|P3|Overall Study|Abnormal laboratory value(s)|1
1168655|NCT01185821|3837471|P2|Overall Study|Abnormal laboratory value(s)|2
1168656|NCT01185821|3837472|P1|Overall Study|Abnormal laboratory value(s)|1
1168657|NCT01185782|3837523|P2|Overall Study|Randomized but not treated|4
1168658|NCT01185782|3837524|P1|Overall Study|Randomized but not treated|0
1168659|NCT01185782|3837523|P2|Overall Study|Other|5
1168660|NCT01185782|3837524|P1|Overall Study|Other|2
1168661|NCT01185782|3837523|P2|Overall Study|Poor Response to Treatment|1
1168662|NCT01185782|3837524|P1|Overall Study|Poor Response to Treatment|3
1168663|NCT01185782|3837523|P2|Overall Study|Protocol Violation|0
1168664|NCT01185782|3837524|P1|Overall Study|Protocol Violation|1
1168665|NCT01185782|3837523|P2|Overall Study|Adverse Event|1
1168666|NCT01185782|3837524|P1|Overall Study|Adverse Event|0
1168667|NCT01185704|3837552|P2|Overall Study|Ectopic pregnancy|1
1168668|NCT01185704|3837553|P1|Overall Study|Ectopic pregnancy|0
1168669|NCT01185704|3837552|P2|Overall Study|Ovarian hyperstimulation syndrome risk|3
1168670|NCT01185704|3837553|P1|Overall Study|Ovarian hyperstimulation syndrome risk|5
1168671|NCT01185704|3837552|P2|Overall Study|Lack of ovarian response|1
1168672|NCT01185704|3837553|P1|Overall Study|Lack of ovarian response|5
1168673|NCT01185704|3837552|P2|Overall Study|Randomized but not treated|3
1168674|NCT01185704|3837553|P1|Overall Study|Randomized but not treated|3
1168675|NCT01185600|3837589|P2|Overall Study|Hold by DSMB|2
1168676|NCT01185600|3837590|P1|Overall Study|Hold by DSMB|1
1168677|NCT01185600|3837589|P2|Overall Study|Withdrawal by Subject|1
1168678|NCT01185600|3837590|P1|Overall Study|Withdrawal by Subject|1
1168679|NCT01185600|3837589|P2|Overall Study|Physician Decision|35
1168680|NCT01185600|3837590|P1|Overall Study|Physician Decision|29
1168681|NCT01185600|3837589|P2|Overall Study|Lost to Follow-up|5
1168682|NCT01185600|3837590|P1|Overall Study|Lost to Follow-up|0
1168683|NCT01185600|3837589|P2|Overall Study|Death|1
1168684|NCT01185600|3837590|P1|Overall Study|Death|0
1168685|NCT01185600|3837589|P2|Overall Study|Adverse Event|1
1168686|NCT01185600|3837590|P1|Overall Study|Adverse Event|1
1168687|NCT01185561|3837612|P2|Overall Study|Withdrawal by Subject|8
1168688|NCT01185561|3837613|P1|Overall Study|Withdrawal by Subject|2
1168689|NCT01185561|3837612|P2|Overall Study|Lost to Follow-up|4
1168690|NCT01185561|3837613|P1|Overall Study|Lost to Follow-up|0
1168691|NCT01185548|3837625|P1|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2
1168692|NCT01185522|3837638|P1|Overall Study|Other reasons|12
1168693|NCT01185522|3837638|P1|Overall Study|Poor tolerance|39
1168694|NCT01185522|3837638|P1|Overall Study|Withdrawal by Subject|10
1168695|NCT01185522|3837638|P1|Overall Study|Lost to Follow-up|19
1168696|NCT01185522|3837638|P1|Overall Study|Lack of Efficacy|28
1168697|NCT01185509|3837664|P2|Overall Study|Intercurrent Illness|1
1168698|NCT01185509|3837665|P1|Overall Study|Intercurrent Illness|0
1168699|NCT01185509|3837664|P2|Overall Study|Death|1
1168700|NCT01185509|3837665|P1|Overall Study|Death|0
1168701|NCT01185509|3837664|P2|Overall Study|Withdrawal by Subject|1
1168702|NCT01185509|3837665|P1|Overall Study|Withdrawal by Subject|0
1168703|NCT01185509|3837664|P2|Overall Study|Physician Decision|2
1168704|NCT01185509|3837665|P1|Overall Study|Physician Decision|2
1168705|NCT01185509|3837664|P2|Overall Study|Progression/Relapse|15
1168706|NCT01185509|3837665|P1|Overall Study|Progression/Relapse|9
1168707|NCT01185353|3837680|P10|Part D (Weeks 76 Through 128)|Adverse Event|0
1168708|NCT01185353|3837681|P9|Part D (Weeks 76 Through 128)|Adverse Event|2
1168709|NCT01185353|3837682|P8|Part D (Weeks 76 Through 128)|Adverse Event|1
1168710|NCT01185353|3837683|P7|Part D (Weeks 76 Through 128)|Adverse Event|0
1168711|NCT01185353|3837684|P6|Part D (Weeks 76 Through 128)|Adverse Event|0
1168712|NCT01185353|3837685|P5|Part D (Weeks 76 Through 128)|Adverse Event|0
1168713|NCT01185353|3837686|P4|Part D (Weeks 76 Through 128)|Adverse Event|0
1168714|NCT01185353|3837687|P3|Part D (Weeks 76 Through 128)|Adverse Event|0
1168715|NCT01185353|3837688|P2|Part D (Weeks 76 Through 128)|Adverse Event|0
1168716|NCT01185353|3837689|P1|Part D (Weeks 76 Through 128)|Adverse Event|0
1168717|NCT01185353|3837680|P10|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
1168718|NCT01185353|3837681|P9|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2
1168719|NCT01185353|3837682|P8|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
1168720|NCT01185353|3837683|P7|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
1168721|NCT01185353|3837684|P6|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
1168722|NCT01185353|3837685|P5|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
1168723|NCT01185353|3837686|P4|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
1168724|NCT01185353|3837687|P3|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
1168725|NCT01185353|3837688|P2|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
1168726|NCT01185353|3837689|P1|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
1168727|NCT01185353|3837680|P10|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
1168728|NCT01185353|3837681|P9|Part D (Weeks 76 Through 128)|Lost to Follow-up|3
1168729|NCT01185353|3837682|P8|Part D (Weeks 76 Through 128)|Lost to Follow-up|1
1168730|NCT01185353|3837683|P7|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
1168731|NCT01185353|3837684|P6|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
1168732|NCT01185353|3837685|P5|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
1168733|NCT01185353|3837686|P4|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
1168734|NCT01185353|3837687|P3|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
1168735|NCT01185353|3837688|P2|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
1168736|NCT01185353|3837689|P1|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
1168737|NCT01185353|3837680|P10|Part C (Weeks 24 Through 76)|Reason missing|0
1168738|NCT01185353|3837681|P9|Part C (Weeks 24 Through 76)|Reason missing|1
1168739|NCT01185353|3837682|P8|Part C (Weeks 24 Through 76)|Reason missing|0
1168740|NCT01185353|3837683|P7|Part C (Weeks 24 Through 76)|Reason missing|0
1168741|NCT01185353|3837684|P6|Part C (Weeks 24 Through 76)|Reason missing|0
1168742|NCT01185353|3837685|P5|Part C (Weeks 24 Through 76)|Reason missing|0
1168743|NCT01185353|3837686|P4|Part C (Weeks 24 Through 76)|Reason missing|0
1168744|NCT01185353|3837687|P3|Part C (Weeks 24 Through 76)|Reason missing|0
1168745|NCT01185353|3837688|P2|Part C (Weeks 24 Through 76)|Reason missing|0
1168746|NCT01185353|3837689|P1|Part C (Weeks 24 Through 76)|Reason missing|0
1168747|NCT01185353|3837680|P10|Part C (Weeks 24 Through 76)|Physician Decision|1
1168748|NCT01185353|3837681|P9|Part C (Weeks 24 Through 76)|Physician Decision|0
1168749|NCT01185353|3837682|P8|Part C (Weeks 24 Through 76)|Physician Decision|0
1168750|NCT01185353|3837683|P7|Part C (Weeks 24 Through 76)|Physician Decision|0
1168751|NCT01185353|3837684|P6|Part C (Weeks 24 Through 76)|Physician Decision|0
1168752|NCT01185353|3837685|P5|Part C (Weeks 24 Through 76)|Physician Decision|0
1168753|NCT01185353|3837686|P4|Part C (Weeks 24 Through 76)|Physician Decision|0
1168754|NCT01185353|3837687|P3|Part C (Weeks 24 Through 76)|Physician Decision|0
1168755|NCT01185353|3837688|P2|Part C (Weeks 24 Through 76)|Physician Decision|0
1168756|NCT01185353|3837689|P1|Part C (Weeks 24 Through 76)|Physician Decision|0
1168757|NCT01185353|3837680|P10|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1
1168758|NCT01185353|3837681|P9|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
1168759|NCT01185353|3837682|P8|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
1168760|NCT01185353|3837683|P7|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
1168761|NCT01185353|3837684|P6|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
1168762|NCT01185353|3837685|P5|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
1168763|NCT01185353|3837686|P4|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
1168764|NCT01185353|3837687|P3|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
1168765|NCT01185353|3837688|P2|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
1168766|NCT01185353|3837689|P1|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
1168767|NCT01185353|3837680|P10|Part C (Weeks 24 Through 76)|Death|1
1168768|NCT01185353|3837681|P9|Part C (Weeks 24 Through 76)|Death|0
1168769|NCT01185353|3837682|P8|Part C (Weeks 24 Through 76)|Death|0
1168770|NCT01185353|3837683|P7|Part C (Weeks 24 Through 76)|Death|0
1168771|NCT01185353|3837684|P6|Part C (Weeks 24 Through 76)|Death|0
1168772|NCT01185353|3837685|P5|Part C (Weeks 24 Through 76)|Death|0
1168773|NCT01185353|3837686|P4|Part C (Weeks 24 Through 76)|Death|0
1168774|NCT01185353|3837687|P3|Part C (Weeks 24 Through 76)|Death|0
1168775|NCT01185353|3837688|P2|Part C (Weeks 24 Through 76)|Death|0
1168776|NCT01185353|3837689|P1|Part C (Weeks 24 Through 76)|Death|0
1168777|NCT01185353|3837680|P10|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
1168778|NCT01185353|3837681|P9|Part C (Weeks 24 Through 76)|Lack of Efficacy|2
1168779|NCT01185353|3837682|P8|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
1168780|NCT01185353|3837683|P7|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
1168781|NCT01185353|3837684|P6|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
1168782|NCT01185353|3837685|P5|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
1168783|NCT01185353|3837686|P4|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
1168784|NCT01185353|3837687|P3|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
1168785|NCT01185353|3837688|P2|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
1168786|NCT01185353|3837689|P1|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
1168787|NCT01185353|3837680|P10|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
1168788|NCT01185353|3837681|P9|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
1168789|NCT01185353|3837682|P8|Part C (Weeks 24 Through 76)|Lost to Follow-up|2
1168790|NCT01185353|3837683|P7|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
1168791|NCT01185353|3837684|P6|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
1168792|NCT01185353|3837685|P5|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
1168793|NCT01185353|3837686|P4|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
1168794|NCT01185353|3837687|P3|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
1168795|NCT01185353|3837688|P2|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
1168796|NCT01185353|3837689|P1|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
1168797|NCT01185353|3837680|P10|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
1168798|NCT01185353|3837681|P9|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
1168799|NCT01185353|3837682|P8|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6
1168800|NCT01185353|3837683|P7|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
1168801|NCT01185353|3837684|P6|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
1168802|NCT01185353|3837685|P5|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
1168803|NCT01185353|3837686|P4|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
1168804|NCT01185353|3837687|P3|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
1168805|NCT01185353|3837688|P2|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
1168806|NCT01185353|3837689|P1|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
1168807|NCT01185353|3837680|P10|Part C (Weeks 24 Through 76)|Adverse Event|2
1168808|NCT01185353|3837681|P9|Part C (Weeks 24 Through 76)|Adverse Event|2
1168809|NCT01185353|3837682|P8|Part C (Weeks 24 Through 76)|Adverse Event|8
1168810|NCT01185353|3837683|P7|Part C (Weeks 24 Through 76)|Adverse Event|0
1168811|NCT01185353|3837684|P6|Part C (Weeks 24 Through 76)|Adverse Event|0
1168812|NCT01185353|3837685|P5|Part C (Weeks 24 Through 76)|Adverse Event|0
1168813|NCT01185353|3837686|P4|Part C (Weeks 24 Through 76)|Adverse Event|0
1168814|NCT01185353|3837687|P3|Part C (Weeks 24 Through 76)|Adverse Event|0
1168815|NCT01185353|3837688|P2|Part C (Weeks 24 Through 76)|Adverse Event|0
1168816|NCT01185353|3837689|P1|Part C (Weeks 24 Through 76)|Adverse Event|0
1168817|NCT01185353|3837680|P10|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
1168818|NCT01185353|3837681|P9|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
1168819|NCT01185353|3837682|P8|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
1168820|NCT01185353|3837683|P7|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1
1168821|NCT01185353|3837684|P6|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
1168822|NCT01185353|3837685|P5|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
1168823|NCT01185353|3837686|P4|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
1168824|NCT01185353|3837687|P3|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
1168825|NCT01185353|3837688|P2|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
1168826|NCT01185353|3837689|P1|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
1168827|NCT01185353|3837680|P10|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
1168828|NCT01185353|3837681|P9|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
1168829|NCT01185353|3837682|P8|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
1168830|NCT01185353|3837683|P7|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4
1168831|NCT01185353|3837684|P6|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3
1168832|NCT01185353|3837685|P5|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
1168833|NCT01185353|3837686|P4|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2
1168834|NCT01185353|3837687|P3|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1
1168835|NCT01185353|3837688|P2|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
1168836|NCT01185353|3837689|P1|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
1168837|NCT01185353|3837680|P10|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
1168838|NCT01185353|3837681|P9|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
1168839|NCT01185353|3837682|P8|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
1168840|NCT01185353|3837683|P7|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
1168841|NCT01185353|3837684|P6|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
1168842|NCT01185353|3837685|P5|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
1168843|NCT01185353|3837686|P4|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
1168844|NCT01185353|3837687|P3|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
1168845|NCT01185353|3837688|P2|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
1168846|NCT01185353|3837689|P1|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
1168847|NCT01185353|3837680|P10|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
1168848|NCT01185353|3837681|P9|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
1168849|NCT01185353|3837682|P8|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
1168850|NCT01185353|3837683|P7|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
1168851|NCT01185353|3837684|P6|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
1168852|NCT01185353|3837685|P5|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
1168853|NCT01185353|3837686|P4|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
1168854|NCT01185353|3837687|P3|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
1168855|NCT01185353|3837688|P2|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
1168856|NCT01185353|3837689|P1|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
1168857|NCT01185353|3837680|P10|Part B (Weeks 12 Through 24)|Adverse Event|0
1168858|NCT01185353|3837681|P9|Part B (Weeks 12 Through 24)|Adverse Event|0
1168859|NCT01185353|3837682|P8|Part B (Weeks 12 Through 24)|Adverse Event|0
1168860|NCT01185353|3837683|P7|Part B (Weeks 12 Through 24)|Adverse Event|0
1168861|NCT01185353|3837684|P6|Part B (Weeks 12 Through 24)|Adverse Event|1
1168862|NCT01185353|3837685|P5|Part B (Weeks 12 Through 24)|Adverse Event|0
1168863|NCT01185353|3837686|P4|Part B (Weeks 12 Through 24)|Adverse Event|0
1168864|NCT01185353|3837687|P3|Part B (Weeks 12 Through 24)|Adverse Event|1
1168865|NCT01185353|3837688|P2|Part B (Weeks 12 Through 24)|Adverse Event|0
1168866|NCT01185353|3837689|P1|Part B (Weeks 12 Through 24)|Adverse Event|0
1168867|NCT01185353|3837680|P10|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
1168868|NCT01185353|3837681|P9|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
1168869|NCT01185353|3837682|P8|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
1168870|NCT01185353|3837683|P7|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
1168871|NCT01185353|3837684|P6|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
1168872|NCT01185353|3837685|P5|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3
1168873|NCT01185353|3837686|P4|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
1168874|NCT01185353|3837687|P3|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
1168875|NCT01185353|3837688|P2|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
1168876|NCT01185353|3837689|P1|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2
1168877|NCT01185353|3837680|P10|Part A (Weeks 0 Through 12)|Protocol Violation|0
1168878|NCT01185353|3837681|P9|Part A (Weeks 0 Through 12)|Protocol Violation|0
1168879|NCT01185353|3837682|P8|Part A (Weeks 0 Through 12)|Protocol Violation|0
1168880|NCT01185353|3837683|P7|Part A (Weeks 0 Through 12)|Protocol Violation|0
1168881|NCT01185353|3837684|P6|Part A (Weeks 0 Through 12)|Protocol Violation|0
1168882|NCT01185353|3837685|P5|Part A (Weeks 0 Through 12)|Protocol Violation|1
1168883|NCT01185353|3837686|P4|Part A (Weeks 0 Through 12)|Protocol Violation|0
1168884|NCT01185353|3837687|P3|Part A (Weeks 0 Through 12)|Protocol Violation|0
1168885|NCT01185353|3837688|P2|Part A (Weeks 0 Through 12)|Protocol Violation|0
1168886|NCT01185353|3837689|P1|Part A (Weeks 0 Through 12)|Protocol Violation|0
1168887|NCT01185353|3837680|P10|Part A (Weeks 0 Through 12)|Physician Decision|0
1168888|NCT01185353|3837681|P9|Part A (Weeks 0 Through 12)|Physician Decision|0
1168889|NCT01185353|3837682|P8|Part A (Weeks 0 Through 12)|Physician Decision|0
1168890|NCT01185353|3837683|P7|Part A (Weeks 0 Through 12)|Physician Decision|0
1168891|NCT01185353|3837684|P6|Part A (Weeks 0 Through 12)|Physician Decision|0
1168892|NCT01185353|3837685|P5|Part A (Weeks 0 Through 12)|Physician Decision|2
1168893|NCT01185353|3837686|P4|Part A (Weeks 0 Through 12)|Physician Decision|0
1168894|NCT01185353|3837687|P3|Part A (Weeks 0 Through 12)|Physician Decision|1
1168895|NCT01185353|3837688|P2|Part A (Weeks 0 Through 12)|Physician Decision|0
1168896|NCT01185353|3837689|P1|Part A (Weeks 0 Through 12)|Physician Decision|0
1168897|NCT01185353|3837680|P10|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
1168898|NCT01185353|3837681|P9|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
1168899|NCT01185353|3837682|P8|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
1168900|NCT01185353|3837683|P7|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
1168901|NCT01185353|3837684|P6|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
1168902|NCT01185353|3837685|P5|Part A (Weeks 0 Through 12)|Lack of Efficacy|1
1168903|NCT01185353|3837686|P4|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
1168904|NCT01185353|3837687|P3|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
1168905|NCT01185353|3837688|P2|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
1168906|NCT01185353|3837689|P1|Part A (Weeks 0 Through 12)|Lack of Efficacy|2
1168907|NCT01185353|3837680|P10|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
1168908|NCT01185353|3837681|P9|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
1168909|NCT01185353|3837682|P8|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
1168910|NCT01185353|3837683|P7|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
1168911|NCT01185353|3837684|P6|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
1168912|NCT01185353|3837685|P5|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4
1168913|NCT01185353|3837686|P4|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
1168914|NCT01185353|3837687|P3|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
1168915|NCT01185353|3837688|P2|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
1168916|NCT01185353|3837689|P1|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
1168917|NCT01185353|3837680|P10|Part A (Weeks 0 Through 12)|Adverse Event|0
1168918|NCT01185353|3837681|P9|Part A (Weeks 0 Through 12)|Adverse Event|0
1168919|NCT01185353|3837682|P8|Part A (Weeks 0 Through 12)|Adverse Event|0
1168920|NCT01185353|3837683|P7|Part A (Weeks 0 Through 12)|Adverse Event|0
1168921|NCT01185353|3837684|P6|Part A (Weeks 0 Through 12)|Adverse Event|0
1168922|NCT01185353|3837685|P5|Part A (Weeks 0 Through 12)|Adverse Event|5
1168923|NCT01185353|3837686|P4|Part A (Weeks 0 Through 12)|Adverse Event|1
1168924|NCT01185353|3837687|P3|Part A (Weeks 0 Through 12)|Adverse Event|1
1168925|NCT01185353|3837688|P2|Part A (Weeks 0 Through 12)|Adverse Event|1
1168926|NCT01185353|3837689|P1|Part A (Weeks 0 Through 12)|Adverse Event|1
1168927|NCT01185340|3837850|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
1168928|NCT01185340|3837851|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3
1168929|NCT01185340|3837852|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
1168930|NCT01185340|3837853|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
1168931|NCT01185340|3837850|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
1168932|NCT01185340|3837851|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
1168933|NCT01185340|3837852|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
1168934|NCT01185340|3837853|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
1168935|NCT01185340|3837850|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
1168936|NCT01185340|3837851|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2
1168937|NCT01185340|3837852|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
1168938|NCT01185340|3837853|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
1168939|NCT01185340|3837850|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
1168940|NCT01185340|3837851|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
1168941|NCT01185340|3837852|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
1168942|NCT01185340|3837853|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
1168943|NCT01185340|3837850|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7
1168944|NCT01185340|3837851|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
1168945|NCT01185340|3837852|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4
1168946|NCT01185340|3837853|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
1168947|NCT01185340|3837850|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
1168948|NCT01185340|3837851|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7
1168949|NCT01185340|3837852|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
1168950|NCT01185340|3837853|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
1168951|NCT01185340|3837850|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
1168952|NCT01185340|3837851|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8
1168953|NCT01185340|3837852|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
1168954|NCT01185340|3837853|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
1168955|NCT01185340|3837850|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
1168956|NCT01185340|3837851|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
1168957|NCT01185340|3837852|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
1168958|NCT01185340|3837853|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3
1168959|NCT01185340|3837850|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
1168960|NCT01185340|3837851|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
1168961|NCT01185340|3837852|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
1168962|NCT01185340|3837853|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32
1168963|NCT01185340|3837850|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
1168964|NCT01185340|3837851|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
1168965|NCT01185340|3837852|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
1168966|NCT01185340|3837853|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16
1168967|NCT01185340|3837850|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
1168968|NCT01185340|3837851|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
1168969|NCT01185340|3837852|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
1168970|NCT01185340|3837853|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
1168971|NCT01185340|3837850|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
1168972|NCT01185340|3837851|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
1168973|NCT01185340|3837852|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
1168974|NCT01185340|3837853|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5
1168975|NCT01185340|3837850|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
1168976|NCT01185340|3837851|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
1168977|NCT01185340|3837852|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
1168978|NCT01185340|3837853|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6
1168979|NCT01185340|3837850|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
1168980|NCT01185340|3837851|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
1168981|NCT01185340|3837852|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
1168982|NCT01185340|3837853|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24
1168983|NCT01185301|3837905|P4|Overall Study|Other Reason|2
1168984|NCT01185301|3837906|P3|Overall Study|Other Reason|2
1168985|NCT01185301|3837907|P2|Overall Study|Other Reason|2
1168986|NCT01185301|3837908|P1|Overall Study|Other Reason|3
1168987|NCT01185301|3837905|P4|Overall Study|Lost to Follow-up|1
1168988|NCT01185301|3837906|P3|Overall Study|Lost to Follow-up|0
1168989|NCT01185301|3837907|P2|Overall Study|Lost to Follow-up|0
1168990|NCT01185301|3837908|P1|Overall Study|Lost to Follow-up|2
1168991|NCT01185301|3837905|P4|Overall Study|Withdrawal by Subject|3
1168992|NCT01185301|3837906|P3|Overall Study|Withdrawal by Subject|2
1168993|NCT01185301|3837907|P2|Overall Study|Withdrawal by Subject|5
1168994|NCT01185301|3837908|P1|Overall Study|Withdrawal by Subject|7
1168995|NCT01185301|3837905|P4|Overall Study|Adverse Event|3
1168996|NCT01185301|3837906|P3|Overall Study|Adverse Event|2
1168997|NCT01185301|3837907|P2|Overall Study|Adverse Event|0
1168998|NCT01185301|3837908|P1|Overall Study|Adverse Event|3
1168999|NCT01185288|3837968|P2|Overall Study|Noncompliance|1
1169000|NCT01185288|3837969|P1|Overall Study|Noncompliance|0
1169001|NCT01185288|3837968|P2|Overall Study|Did not meet inclusion criteria|0
1169002|NCT01185288|3837969|P1|Overall Study|Did not meet inclusion criteria|1
1169003|NCT01185288|3837968|P2|Overall Study|Investigator discretion|0
1169004|NCT01185288|3837969|P1|Overall Study|Investigator discretion|1
1169005|NCT01185288|3837968|P2|Overall Study|Lack of Efficacy|0
1169006|NCT01185288|3837969|P1|Overall Study|Lack of Efficacy|2
1169007|NCT01185288|3837968|P2|Overall Study|Lost to Follow-up|5
1169008|NCT01185288|3837969|P1|Overall Study|Lost to Follow-up|2
1169009|NCT01185288|3837968|P2|Overall Study|Withdrawal by Subject|4
1169010|NCT01185288|3837969|P1|Overall Study|Withdrawal by Subject|6
1169011|NCT01185288|3837968|P2|Overall Study|Adverse Event|6
1169012|NCT01185288|3837969|P1|Overall Study|Adverse Event|7
1169013|NCT01185249|3837987|P1|Overall Study|Patients discharged or change in status|42
1169014|NCT01185080|3837995|P3|Overall Study|Personal reasons|1
1169015|NCT01185080|3837996|P2|Overall Study|Personal reasons|0
1169016|NCT01185080|3837997|P1|Overall Study|Personal reasons|0
1169017|NCT01185080|3837995|P3|Overall Study|Adverse Event|0
1169018|NCT01185080|3837996|P2|Overall Study|Adverse Event|1
1169019|NCT01185080|3837997|P1|Overall Study|Adverse Event|1
1169020|NCT01184989|3838049|P1|Overall Study|Withdrawal by Subject|1
1169021|NCT01184989|3838049|P1|Overall Study|Adverse Event|11
1169022|NCT01184872|3838069|P2|Overall Study|Protocol deviation|0
1169023|NCT01184872|3838070|P1|Overall Study|Protocol deviation|1
1169024|NCT01184872|3838069|P2|Overall Study|Administrative problems|1
1169025|NCT01184872|3838070|P1|Overall Study|Administrative problems|1
1169026|NCT01184872|3838069|P2|Overall Study|Lost to Follow-up|1
1169027|NCT01184872|3838070|P1|Overall Study|Lost to Follow-up|0
1169028|NCT01184872|3838069|P2|Overall Study|Withdrawal by Subject|0
1169029|NCT01184872|3838070|P1|Overall Study|Withdrawal by Subject|2
1169030|NCT01184872|3838069|P2|Overall Study|Unsatisfactory therapeutic effect|2
1169031|NCT01184872|3838070|P1|Overall Study|Unsatisfactory therapeutic effect|3
1169032|NCT01184872|3838069|P2|Overall Study|Adverse Event|4
1169033|NCT01184872|3838070|P1|Overall Study|Adverse Event|3
1169034|NCT01184859|3838089|P5|Period 2: Daily Dose for 28 Days|Adverse Event|0
1169035|NCT01184859|3838090|P4|Period 2: Daily Dose for 28 Days|Adverse Event|0
1169036|NCT01184859|3838091|P3|Period 2: Daily Dose for 28 Days|Adverse Event|0
1169037|NCT01184859|3838092|P2|Period 2: Daily Dose for 28 Days|Adverse Event|0
1169038|NCT01184859|3838093|P1|Period 2: Daily Dose for 28 Days|Adverse Event|1
1169039|NCT01184859|3838089|P5|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1
1169040|NCT01184859|3838090|P4|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
1169041|NCT01184859|3838091|P3|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
1169042|NCT01184859|3838092|P2|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
1169043|NCT01184859|3838093|P1|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
1169044|NCT01184859|3838089|P5|Period 1: Single Dose|Adverse Event|1
1169045|NCT01184859|3838090|P4|Period 1: Single Dose|Adverse Event|0
1169046|NCT01184859|3838091|P3|Period 1: Single Dose|Adverse Event|0
1169047|NCT01184859|3838092|P2|Period 1: Single Dose|Adverse Event|0
1169048|NCT01184859|3838093|P1|Period 1: Single Dose|Adverse Event|0
1169049|NCT01184859|3838089|P5|Period 1: Single Dose|Protocol Violation|0
1169050|NCT01184859|3838090|P4|Period 1: Single Dose|Protocol Violation|0
1169051|NCT01184859|3838091|P3|Period 1: Single Dose|Protocol Violation|0
1169052|NCT01184859|3838092|P2|Period 1: Single Dose|Protocol Violation|1
1169053|NCT01184859|3838093|P1|Period 1: Single Dose|Protocol Violation|0
1169054|NCT01184859|3838089|P5|Period 1: Single Dose|Insufficient urine production|0
1169055|NCT01184859|3838090|P4|Period 1: Single Dose|Insufficient urine production|0
1169056|NCT01184859|3838091|P3|Period 1: Single Dose|Insufficient urine production|0
1169057|NCT01184859|3838092|P2|Period 1: Single Dose|Insufficient urine production|1
1169058|NCT01184859|3838093|P1|Period 1: Single Dose|Insufficient urine production|0
1169059|NCT01184846|3838185|P1|Overall Study|Insufficient response|1
1169060|NCT01184846|3838185|P1|Overall Study|Adverse Event|2
1169061|NCT01184508|3838218|P2|Overall Study|Randomized, Not Treated|1
1169062|NCT01184508|3838219|P1|Overall Study|Randomized, Not Treated|0
1169063|NCT01184508|3838218|P2|Overall Study|Withdrawal by Subject|3
1169064|NCT01184508|3838219|P1|Overall Study|Withdrawal by Subject|1
1169065|NCT01184508|3838218|P2|Overall Study|Sponsor Decision|2
1169066|NCT01184508|3838219|P1|Overall Study|Sponsor Decision|5
1169067|NCT01184508|3838218|P2|Overall Study|Protocol Violation|1
1169068|NCT01184508|3838219|P1|Overall Study|Protocol Violation|3
1169069|NCT01184508|3838218|P2|Overall Study|Physician Decision|0
1169070|NCT01184508|3838219|P1|Overall Study|Physician Decision|1
1169071|NCT01184508|3838218|P2|Overall Study|Lost to Follow-up|1
1169072|NCT01184508|3838219|P1|Overall Study|Lost to Follow-up|1
1169073|NCT01184508|3838218|P2|Overall Study|Lack of Efficacy|1
1169074|NCT01184508|3838219|P1|Overall Study|Lack of Efficacy|1
1169075|NCT01184508|3838218|P2|Overall Study|Adverse Event|6
1169076|NCT01184508|3838219|P1|Overall Study|Adverse Event|4
1169077|NCT01184326|3838267|P1|Overall Study|Withdrawal by Subject|1
1169078|NCT01184326|3838267|P1|Overall Study|Death|1
1169079|NCT01184326|3838267|P1|Overall Study|Adverse Event|3
1169080|NCT01184118|3838275|P1|Overall Study|Withdrawal by Subject|5
1169081|NCT01184118|3838275|P1|Overall Study|Exclusionary medical condition|2
1169082|NCT01184118|3838275|P1|Overall Study|FEV1 <60% predicted|2
1169083|NCT01184118|3838275|P1|Overall Study|No physiologic confirmation of asthma|8
1169084|NCT01184118|3838275|P1|Overall Study|Only asthma step 1 - screen fail|1
1169085|NCT01184079|3838283|P2|Overall Study|Lost to Follow-up|2
1169086|NCT01184079|3838284|P1|Overall Study|Lost to Follow-up|14
1169087|NCT01184053|3838294|P1|Overall Study|progression while on treatment|3
1169088|NCT01183975|3838310|P1|Overall Study|Lost to Follow-up|73
1169089|NCT01183858|3838317|P2|Overall Study|Lost to Follow-up|1
1169090|NCT01183858|3838318|P1|Overall Study|Lost to Follow-up|1
1169091|NCT01183858|3838317|P2|Overall Study|Death related to Progressive Disease|5
1169092|NCT01183858|3838318|P1|Overall Study|Death related to Progressive Disease|4
1169093|NCT01183858|3838317|P2|Overall Study|Progressive Disease|115
1169094|NCT01183858|3838318|P1|Overall Study|Progressive Disease|112
1169095|NCT01183858|3838317|P2|Overall Study|Administrative/Other|6
1169096|NCT01183858|3838318|P1|Overall Study|Administrative/Other|6
1169097|NCT01183858|3838317|P2|Overall Study|Protocol Violation|0
1169098|NCT01183858|3838318|P1|Overall Study|Protocol Violation|1
1169099|NCT01183858|3838317|P2|Overall Study|Discontinued Smoking|1
1169100|NCT01183858|3838318|P1|Overall Study|Discontinued Smoking|3
1169101|NCT01183858|3838317|P2|Overall Study|Withdrew Consent|4
1169102|NCT01183858|3838318|P1|Overall Study|Withdrew Consent|4
1169103|NCT01183858|3838317|P2|Overall Study|Refused Treatment|4
1169104|NCT01183858|3838318|P1|Overall Study|Refused Treatment|1
1169105|NCT01183858|3838317|P2|Overall Study|Insufficient Therapeutic Response|0
1169106|NCT01183858|3838318|P1|Overall Study|Insufficient Therapeutic Response|2
1169107|NCT01183858|3838317|P2|Overall Study|Investigator's Decision|3
1169108|NCT01183858|3838318|P1|Overall Study|Investigator's Decision|0
1169109|NCT01183858|3838317|P2|Overall Study|Adverse Event|11
1169110|NCT01183858|3838318|P1|Overall Study|Adverse Event|14
1169111|NCT01183858|3838317|P2|Overall Study|Death not related to Progressive Disease|6
1169112|NCT01183858|3838318|P1|Overall Study|Death not related to Progressive Disease|5
1169113|NCT01183780|3838340|P2|Overall Study|Lost to Follow-up|11
1169114|NCT01183780|3838341|P1|Overall Study|Lost to Follow-up|6
1169115|NCT01183780|3838340|P2|Overall Study|Withdrawal by Subject|14
1169116|NCT01183780|3838341|P1|Overall Study|Withdrawal by Subject|25
1169117|NCT01183468|3838474|P4|Overall Study|Withdrawal by Subject|0
1169118|NCT01183468|3838475|P3|Overall Study|Withdrawal by Subject|0
1169119|NCT01183468|3838476|P2|Overall Study|Withdrawal by Subject|1
1169120|NCT01183468|3838477|P1|Overall Study|Withdrawal by Subject|0
1169121|NCT01183468|3838474|P4|Overall Study|Physician Decision|0
1169122|NCT01183468|3838475|P3|Overall Study|Physician Decision|0
1169123|NCT01183468|3838476|P2|Overall Study|Physician Decision|0
1169124|NCT01183468|3838477|P1|Overall Study|Physician Decision|1
1169125|NCT01183468|3838474|P4|Overall Study|Lost to Follow-up|0
1169126|NCT01183468|3838475|P3|Overall Study|Lost to Follow-up|0
1169127|NCT01183468|3838476|P2|Overall Study|Lost to Follow-up|1
1169128|NCT01183468|3838477|P1|Overall Study|Lost to Follow-up|2
1169129|NCT01183390|3838487|P2|First Intervention|Adverse Event|1
1169130|NCT01183390|3838488|P1|First Intervention|Adverse Event|0
1169131|NCT01183260|3838521|P2|Overall Study|Death|0
1169132|NCT01183260|3838522|P1|Overall Study|Death|1
1169133|NCT01183260|3838521|P2|Overall Study|Revised within 30 days|1
1169134|NCT01183260|3838522|P1|Overall Study|Revised within 30 days|0
1169135|NCT01183260|3838521|P2|Overall Study|Withdrawal by Subject|1
1169136|NCT01183260|3838522|P1|Overall Study|Withdrawal by Subject|1
1169137|NCT01183260|3838521|P2|Overall Study|Intraop screen failure|0
1169138|NCT01183260|3838522|P1|Overall Study|Intraop screen failure|2
1169139|NCT01183234|3838532|P2|First Intervention|Adverse Event|0
1169140|NCT01183234|3838533|P1|First Intervention|Adverse Event|1
1169141|NCT01183143|3838625|P1|Overall Study|Subjects enrolled, but not treated|11
1169142|NCT01183143|3838625|P1|Overall Study|Subject Questionnaires not returned|5
1169143|NCT01183143|3838625|P1|Overall Study|Withdrawal by Subject|19
1169144|NCT01183143|3838625|P1|Overall Study|Protocol Violation|115
1169145|NCT01183104|3838641|P2|Overall Study|Did not receive study drug|9
1169146|NCT01183104|3838642|P1|Overall Study|Did not receive study drug|5
1169147|NCT01183104|3838641|P2|Overall Study|Nonparticipation in Extension Study|50
1169148|NCT01183104|3838642|P1|Overall Study|Nonparticipation in Extension Study|39
1169149|NCT01183104|3838641|P2|Overall Study|Withdrawal by Subject|11
1169150|NCT01183104|3838642|P1|Overall Study|Withdrawal by Subject|6
1169151|NCT01183104|3838641|P2|Overall Study|Physician Decision|8
1169152|NCT01183104|3838642|P1|Overall Study|Physician Decision|5
1169153|NCT01183104|3838641|P2|Overall Study|Lost to Follow-up|7
1169154|NCT01183104|3838642|P1|Overall Study|Lost to Follow-up|14
1169155|NCT01183104|3838641|P2|Overall Study|Death|1
1169156|NCT01183104|3838642|P1|Overall Study|Death|0
1169157|NCT01183104|3838641|P2|Overall Study|Adverse Event|6
1169158|NCT01183104|3838642|P1|Overall Study|Adverse Event|8
1169159|NCT01183065|3838658|P1|Overall Study|Patient no longer fits eligibility crite|1
1169160|NCT01183013|3838669|P7|Overall Study|Reasons other than stated above|13
1169161|NCT01183013|3838670|P6|Overall Study|Reasons other than stated above|15
1169162|NCT01183013|3838671|P5|Overall Study|Reasons other than stated above|12
1169163|NCT01183013|3838672|P4|Overall Study|Reasons other than stated above|12
1169164|NCT01183013|3838673|P3|Overall Study|Reasons other than stated above|17
1169165|NCT01183013|3838674|P2|Overall Study|Reasons other than stated above|11
1169166|NCT01183013|3838675|P1|Overall Study|Reasons other than stated above|15
1169167|NCT01183013|3838669|P7|Overall Study|Withdrawal by Subject|10
1169168|NCT01183013|3838670|P6|Overall Study|Withdrawal by Subject|9
1169169|NCT01183013|3838671|P5|Overall Study|Withdrawal by Subject|7
1169170|NCT01183013|3838672|P4|Overall Study|Withdrawal by Subject|8
1169171|NCT01183013|3838673|P3|Overall Study|Withdrawal by Subject|10
1169172|NCT01183013|3838674|P2|Overall Study|Withdrawal by Subject|13
1169173|NCT01183013|3838675|P1|Overall Study|Withdrawal by Subject|9
1169174|NCT01183013|3838669|P7|Overall Study|Lost to Follow-up|5
1169175|NCT01183013|3838670|P6|Overall Study|Lost to Follow-up|6
1169176|NCT01183013|3838671|P5|Overall Study|Lost to Follow-up|2
1169177|NCT01183013|3838672|P4|Overall Study|Lost to Follow-up|3
1169178|NCT01183013|3838673|P3|Overall Study|Lost to Follow-up|4
1169179|NCT01183013|3838674|P2|Overall Study|Lost to Follow-up|3
1169180|NCT01183013|3838675|P1|Overall Study|Lost to Follow-up|7
1169181|NCT01183013|3838669|P7|Overall Study|Protocol Violation|3
1169182|NCT01183013|3838670|P6|Overall Study|Protocol Violation|3
1169183|NCT01183013|3838671|P5|Overall Study|Protocol Violation|4
1169184|NCT01183013|3838672|P4|Overall Study|Protocol Violation|0
1169185|NCT01183013|3838673|P3|Overall Study|Protocol Violation|4
1169186|NCT01183013|3838674|P2|Overall Study|Protocol Violation|2
1169187|NCT01183013|3838675|P1|Overall Study|Protocol Violation|5
1169188|NCT01183013|3838669|P7|Overall Study|Lack of Efficacy|0
1169189|NCT01183013|3838670|P6|Overall Study|Lack of Efficacy|2
1169190|NCT01183013|3838671|P5|Overall Study|Lack of Efficacy|1
1169191|NCT01183013|3838672|P4|Overall Study|Lack of Efficacy|2
1169192|NCT01183013|3838673|P3|Overall Study|Lack of Efficacy|1
1169193|NCT01183013|3838674|P2|Overall Study|Lack of Efficacy|2
1169194|NCT01183013|3838675|P1|Overall Study|Lack of Efficacy|3
1169195|NCT01183013|3838669|P7|Overall Study|Adverse Event|6
1169196|NCT01183013|3838670|P6|Overall Study|Adverse Event|10
1169197|NCT01183013|3838671|P5|Overall Study|Adverse Event|10
1169198|NCT01183013|3838672|P4|Overall Study|Adverse Event|5
1169199|NCT01183013|3838673|P3|Overall Study|Adverse Event|5
1169200|NCT01183013|3838674|P2|Overall Study|Adverse Event|8
1169201|NCT01183013|3838675|P1|Overall Study|Adverse Event|6
1169202|NCT01182441|3838821|P2|Overall Study|Physician Decision|1
1169203|NCT01182441|3838822|P1|Overall Study|Physician Decision|1
1169204|NCT01182441|3838821|P2|Overall Study|Adverse Event|0
1169205|NCT01182441|3838822|P1|Overall Study|Adverse Event|2
1169206|NCT01182441|3838821|P2|Overall Study|Implant Not Attempted|0
1169207|NCT01182441|3838822|P1|Overall Study|Implant Not Attempted|4
1169208|NCT01182441|3838821|P2|Overall Study|Withdrawal by Subject|13
1169209|NCT01182441|3838822|P1|Overall Study|Withdrawal by Subject|6
1169210|NCT01182441|3838821|P2|Overall Study|Lost to Follow-up|8
1169211|NCT01182441|3838822|P1|Overall Study|Lost to Follow-up|5
1169212|NCT01182441|3838821|P2|Overall Study|Implant Attempt Unsuccessful|0
1169213|NCT01182441|3838822|P1|Overall Study|Implant Attempt Unsuccessful|13
1169214|NCT01182441|3838821|P2|Overall Study|Death|25
1169215|NCT01182441|3838822|P1|Overall Study|Death|37
1169216|NCT01182441|3838821|P2|Overall Study|Patient Still in Follow-up|72
1169217|NCT01182441|3838822|P1|Overall Study|Patient Still in Follow-up|152
1169218|NCT01182428|3838833|P2|Overall Study|Withdrawal by Subject|0
1169219|NCT01182428|3838834|P1|Overall Study|Withdrawal by Subject|1
1169220|NCT01182428|3838833|P2|Overall Study|Lost to Follow-up|1
1169221|NCT01182428|3838834|P1|Overall Study|Lost to Follow-up|9
1169222|NCT01182428|3838833|P2|Overall Study|Physician Decision|0
1169223|NCT01182428|3838834|P1|Overall Study|Physician Decision|1
1169224|NCT01182415|3838898|P1|Overall Study|Lost to Follow-up|1
1169225|NCT01182337|3838916|P2|Overall Study|Lost to Follow-up|1
1169226|NCT01182337|3838917|P1|Overall Study|Lost to Follow-up|0
1169227|NCT01182337|3838916|P2|Overall Study|Withdrawal by Subject|1
1169228|NCT01182337|3838917|P1|Overall Study|Withdrawal by Subject|3
1169229|NCT01182298|3838935|P1|Overall Study|Withdrawal by Subject|2
1169230|NCT01182298|3838935|P1|Overall Study|Lack of Efficacy|4
1169231|NCT01182285|3838939|P3|Third Intervention Week 11-52|Other|2
1169232|NCT01182285|3838940|P2|Third Intervention Week 11-52|Other|0
1169233|NCT01182285|3838941|P1|Third Intervention Week 11-52|Other|0
1169234|NCT01182285|3838939|P3|Third Intervention Week 11-52|Disease Progression|6
1169235|NCT01182285|3838940|P2|Third Intervention Week 11-52|Disease Progression|0
1169236|NCT01182285|3838941|P1|Third Intervention Week 11-52|Disease Progression|0
1169237|NCT01182285|3838939|P3|First Intervention Week 1-10|Non-compliance|0
1169238|NCT01182285|3838940|P2|First Intervention Week 1-10|Non-compliance|0
1169239|NCT01182285|3838941|P1|First Intervention Week 1-10|Non-compliance|1
1169240|NCT01182285|3838939|P3|First Intervention Week 1-10|Adverse Event|0
1169241|NCT01182285|3838940|P2|First Intervention Week 1-10|Adverse Event|0
1169242|NCT01182285|3838941|P1|First Intervention Week 1-10|Adverse Event|1
1169243|NCT01182285|3838939|P3|First Intervention Week 1-10|Disease progression|0
1169244|NCT01182285|3838940|P2|First Intervention Week 1-10|Disease progression|0
1169245|NCT01182285|3838941|P1|First Intervention Week 1-10|Disease progression|1
1169246|NCT01182207|3838951|P2|Second Intervention|Emeses within 1 hour of dosing|0
1169247|NCT01182207|3838952|P1|Second Intervention|Emeses within 1 hour of dosing|1
1169248|NCT01182207|3838951|P2|First Intervention|Positive Hepatitis Results|1
1169249|NCT01182207|3838952|P1|First Intervention|Positive Hepatitis Results|0
1169250|NCT01182194|3838970|P2|Washout of 28 Days|Withdrawal by Subject|0
1169251|NCT01182194|3838971|P1|Washout of 28 Days|Withdrawal by Subject|1
1169252|NCT01182181|3838989|P2|Washout of 21 Days|Withdrawal by Subject|1
1169253|NCT01182181|3838990|P1|Washout of 21 Days|Withdrawal by Subject|0
1169254|NCT01182181|3838989|P2|First Intervention|Adverse Event|0
1169255|NCT01182181|3838990|P1|First Intervention|Adverse Event|1
1169256|NCT01181986|3839015|P3|Phase 2|Medical condition|0
1169257|NCT01181986|3839016|P2|Phase 2|Medical condition|1
1169258|NCT01181986|3839017|P1|Phase 2|Medical condition|0
1169259|NCT01181986|3839015|P3|Phase 2|Adverse Event|0
1169260|NCT01181986|3839016|P2|Phase 2|Adverse Event|3
1169261|NCT01181986|3839017|P1|Phase 2|Adverse Event|0
1169262|NCT01181986|3839015|P3|Phase 1|Protocol Violation|0
1169263|NCT01181986|3839016|P2|Phase 1|Protocol Violation|0
1169264|NCT01181986|3839017|P1|Phase 1|Protocol Violation|1
1169265|NCT01181986|3839015|P3|Phase 1|Adverse Event|1
1169266|NCT01181986|3839016|P2|Phase 1|Adverse Event|0
1169267|NCT01181986|3839017|P1|Phase 1|Adverse Event|0
1169268|NCT01181986|3839015|P3|Phase 1|Lost to Follow-up|1
1169269|NCT01181986|3839016|P2|Phase 1|Lost to Follow-up|1
1169270|NCT01181986|3839017|P1|Phase 1|Lost to Follow-up|0
1169271|NCT01181921|3839038|P1|Overall Study|Lost to Follow-up|1
1169272|NCT01181895|3839045|P3|Overall Study|Withdrawal by Subject|5
1169273|NCT01181895|3839046|P2|Overall Study|Withdrawal by Subject|0
1169274|NCT01181895|3839047|P1|Overall Study|Withdrawal by Subject|3
1169275|NCT01181895|3839045|P3|Overall Study|Investigator Discretion|1
1169276|NCT01181895|3839046|P2|Overall Study|Investigator Discretion|2
1169277|NCT01181895|3839047|P1|Overall Study|Investigator Discretion|1
1169278|NCT01181895|3839045|P3|Overall Study|Lost to Follow-up|2
1169279|NCT01181895|3839046|P2|Overall Study|Lost to Follow-up|1
1169280|NCT01181895|3839047|P1|Overall Study|Lost to Follow-up|0
1169281|NCT01181895|3839045|P3|Overall Study|Protocol Violation|0
1169282|NCT01181895|3839046|P2|Overall Study|Protocol Violation|1
1169283|NCT01181895|3839047|P1|Overall Study|Protocol Violation|2
1169284|NCT01181895|3839045|P3|Overall Study|Lack of Efficacy|9
1169285|NCT01181895|3839046|P2|Overall Study|Lack of Efficacy|9
1169286|NCT01181895|3839047|P1|Overall Study|Lack of Efficacy|8
1169287|NCT01181895|3839045|P3|Overall Study|Adverse Event|1
1169288|NCT01181895|3839046|P2|Overall Study|Adverse Event|1
1169289|NCT01181895|3839047|P1|Overall Study|Adverse Event|3
1169290|NCT01181778|3839105|P1|Overall Study|Physician Decision|48
1169291|NCT01181726|3839113|P2|First Intervention|Adverse Event|0
1169292|NCT01181726|3839114|P1|First Intervention|Adverse Event|1
1169293|NCT01181609|3839160|P1|Overall Study|Death|50
1169294|NCT01181609|3839160|P1|Overall Study|Lost to Follow-up|1
1169295|NCT01181609|3839160|P1|Overall Study|Withdrawal by Subject|1
1169296|NCT01181609|3839160|P1|Overall Study|Adverse Event|1
1169297|NCT01181531|3839173|P2|Overall Study|Adverse Event|1
1169298|NCT01181531|3839174|P1|Overall Study|Adverse Event|0
1169299|NCT01181531|3839173|P2|Overall Study|Death|12
1169300|NCT01181531|3839174|P1|Overall Study|Death|9
1169301|NCT01181531|3839173|P2|Overall Study|Protocol Violation|6
1169302|NCT01181531|3839174|P1|Overall Study|Protocol Violation|6
1169303|NCT01181531|3839173|P2|Overall Study|Withdrawal by Subject|7
1169304|NCT01181531|3839174|P1|Overall Study|Withdrawal by Subject|8
1169305|NCT01181531|3839173|P2|Overall Study|Pregnancy|1
1169306|NCT01181531|3839174|P1|Overall Study|Pregnancy|0
1169307|NCT01181531|3839173|P2|Overall Study|Protocol Specified Criteria|8
1169308|NCT01181531|3839174|P1|Overall Study|Protocol Specified Criteria|15
1169309|NCT01181531|3839173|P2|Overall Study|Ineligibility determined|2
1169310|NCT01181531|3839174|P1|Overall Study|Ineligibility determined|1
1169311|NCT01181531|3839173|P2|Overall Study|Noncompliance|2
1169312|NCT01181531|3839174|P1|Overall Study|Noncompliance|2
1169313|NCT01181531|3839173|P2|Overall Study|Physician Decision|1
1169314|NCT01181531|3839174|P1|Overall Study|Physician Decision|3
1169315|NCT01181531|3839173|P2|Overall Study|Partial consent by subject withdrawn|1
1169316|NCT01181531|3839174|P1|Overall Study|Partial consent by subject withdrawn|0
1169317|NCT01181531|3839173|P2|Overall Study|Other|12
1169318|NCT01181531|3839174|P1|Overall Study|Other|17
1169319|NCT01181271|3839316|P1|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1
1169320|NCT01181271|3839316|P1|Evaluation for Allogeneic Transplant|No suitable donor|2
1169321|NCT01181271|3839316|P1|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4
1169322|NCT01181271|3839316|P1|Evaluation for Allogeneic Transplant|Lack of Efficacy|6
1169323|NCT01181167|3839340|P2|Overall Study|Withdrawal by Subject|8
1169324|NCT01181167|3839341|P1|Overall Study|Withdrawal by Subject|6
1169325|NCT01181167|3839340|P2|Overall Study|Protocol Violation|0
1169326|NCT01181167|3839341|P1|Overall Study|Protocol Violation|3
1169327|NCT01181167|3839340|P2|Overall Study|Physician Decision|3
1169328|NCT01181167|3839341|P1|Overall Study|Physician Decision|2
1169329|NCT01181167|3839340|P2|Overall Study|Lost to Follow-up|0
1169330|NCT01181167|3839341|P1|Overall Study|Lost to Follow-up|1
1169331|NCT01181167|3839340|P2|Overall Study|Adverse Event|21
1169332|NCT01181167|3839341|P1|Overall Study|Adverse Event|11
1169333|NCT01181141|3839351|P2|Overall Study|Withdrawal by Subject|1
1169334|NCT01181141|3839352|P1|Overall Study|Withdrawal by Subject|3
1169335|NCT01181141|3839351|P2|Overall Study|Protocol Violation|1
1169336|NCT01181141|3839352|P1|Overall Study|Protocol Violation|3
1169337|NCT01181141|3839351|P2|Overall Study|Physician Decision|0
1169338|NCT01181141|3839352|P1|Overall Study|Physician Decision|2
1169339|NCT01181141|3839351|P2|Overall Study|Lost to Follow-up|1
1169340|NCT01181141|3839352|P1|Overall Study|Lost to Follow-up|1
1169341|NCT01181141|3839351|P2|Overall Study|Lack of Efficacy|0
1169342|NCT01181141|3839352|P1|Overall Study|Lack of Efficacy|1
1169343|NCT01181141|3839351|P2|Overall Study|Adverse Event|1
1169344|NCT01181141|3839352|P1|Overall Study|Adverse Event|2
1169345|NCT01181128|3839361|P3|Overall Study|Not Specified|1
1169346|NCT01181128|3839362|P2|Overall Study|Not Specified|1
1169347|NCT01181128|3839363|P1|Overall Study|Not Specified|1
1169348|NCT01181128|3839361|P3|Overall Study|Adverse Event|0
1169349|NCT01181128|3839362|P2|Overall Study|Adverse Event|2
1169350|NCT01181128|3839363|P1|Overall Study|Adverse Event|0
1169351|NCT01181128|3839361|P3|Overall Study|Physician Decision|0
1169352|NCT01181128|3839362|P2|Overall Study|Physician Decision|0
1169353|NCT01181128|3839363|P1|Overall Study|Physician Decision|2
1169354|NCT01181128|3839361|P3|Overall Study|Death|0
1169355|NCT01181128|3839362|P2|Overall Study|Death|0
1169356|NCT01181128|3839363|P1|Overall Study|Death|1
1169357|NCT01181128|3839361|P3|Overall Study|Withdrawal by Subject|0
1169358|NCT01181128|3839362|P2|Overall Study|Withdrawal by Subject|2
1169359|NCT01181128|3839363|P1|Overall Study|Withdrawal by Subject|2
1169360|NCT01181102|3839451|P2|Overall Study|Withdrawal by Subject|12
1169361|NCT01181102|3839452|P1|Overall Study|Withdrawal by Subject|10
1169362|NCT01181102|3839451|P2|Overall Study|Protocol Violation|6
1169363|NCT01181102|3839452|P1|Overall Study|Protocol Violation|5
1169364|NCT01181102|3839451|P2|Overall Study|Physician Decision|1
1169365|NCT01181102|3839452|P1|Overall Study|Physician Decision|3
1169366|NCT01181102|3839451|P2|Overall Study|Lost to Follow-up|0
1169367|NCT01181102|3839452|P1|Overall Study|Lost to Follow-up|2
1169368|NCT01181102|3839451|P2|Overall Study|Lack of Efficacy|1
1169369|NCT01181102|3839452|P1|Overall Study|Lack of Efficacy|3
1169370|NCT01181102|3839451|P2|Overall Study|Adverse Event|26
1169371|NCT01181102|3839452|P1|Overall Study|Adverse Event|28
1169372|NCT01181011|3839473|P1|Overall Study|Lost to Follow-up|1
1169373|NCT01181011|3839473|P1|Overall Study|Adverse Event|2
1169374|NCT01180998|3839523|P3|Overall Study|Poor lens handling|2
1169375|NCT01180998|3839524|P2|Overall Study|Poor lens handling|0
1169376|NCT01180998|3839525|P1|Overall Study|Poor lens handling|0
1169377|NCT01180998|3839523|P3|Overall Study|Poor comfort|4
1169378|NCT01180998|3839524|P2|Overall Study|Poor comfort|0
1169379|NCT01180998|3839525|P1|Overall Study|Poor comfort|3
1169380|NCT01180998|3839523|P3|Overall Study|Withdrawal by Subject|1
1169381|NCT01180998|3839524|P2|Overall Study|Withdrawal by Subject|0
1169382|NCT01180998|3839525|P1|Overall Study|Withdrawal by Subject|0
1169383|NCT01180998|3839523|P3|Overall Study|Protocol Violation|0
1169384|NCT01180998|3839524|P2|Overall Study|Protocol Violation|2
1169385|NCT01180998|3839525|P1|Overall Study|Protocol Violation|1
1169386|NCT01180998|3839523|P3|Overall Study|Lost to Follow-up|1
1169387|NCT01180998|3839524|P2|Overall Study|Lost to Follow-up|0
1169388|NCT01180998|3839525|P1|Overall Study|Lost to Follow-up|0
1169389|NCT01180998|3839523|P3|Overall Study|Poor Vision|2
1169390|NCT01180998|3839524|P2|Overall Study|Poor Vision|2
1169391|NCT01180998|3839525|P1|Overall Study|Poor Vision|0
1169392|NCT01180985|3839539|P2|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0
1169393|NCT01180985|3839540|P1|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1
1169394|NCT01180790|3839579|P7|Overall Study|Severe coronary atherosclerosis (death)|0
1169395|NCT01180790|3839580|P6|Overall Study|Severe coronary atherosclerosis (death)|0
1169396|NCT01180790|3839581|P5|Overall Study|Severe coronary atherosclerosis (death)|0
1169397|NCT01180790|3839582|P4|Overall Study|Severe coronary atherosclerosis (death)|0
1169398|NCT01180790|3839583|P3|Overall Study|Severe coronary atherosclerosis (death)|1
1169399|NCT01180790|3839584|P2|Overall Study|Severe coronary atherosclerosis (death)|0
1169400|NCT01180790|3839585|P1|Overall Study|Severe coronary atherosclerosis (death)|0
1169401|NCT01180790|3839579|P7|Overall Study|compliance|0
1169402|NCT01180790|3839580|P6|Overall Study|compliance|0
1169403|NCT01180790|3839581|P5|Overall Study|compliance|0
1169404|NCT01180790|3839582|P4|Overall Study|compliance|0
1169405|NCT01180790|3839583|P3|Overall Study|compliance|0
1169406|NCT01180790|3839584|P2|Overall Study|compliance|1
1169407|NCT01180790|3839585|P1|Overall Study|compliance|0
1169408|NCT01180790|3839579|P7|Overall Study|Lack of Efficacy|0
1169409|NCT01180790|3839580|P6|Overall Study|Lack of Efficacy|3
1169410|NCT01180790|3839581|P5|Overall Study|Lack of Efficacy|1
1169411|NCT01180790|3839582|P4|Overall Study|Lack of Efficacy|6
1169412|NCT01180790|3839583|P3|Overall Study|Lack of Efficacy|5
1169413|NCT01180790|3839584|P2|Overall Study|Lack of Efficacy|2
1169414|NCT01180790|3839585|P1|Overall Study|Lack of Efficacy|1
1169415|NCT01180790|3839579|P7|Overall Study|Physician Decision|0
1169416|NCT01180790|3839580|P6|Overall Study|Physician Decision|0
1169417|NCT01180790|3839581|P5|Overall Study|Physician Decision|0
1169418|NCT01180790|3839582|P4|Overall Study|Physician Decision|1
1169419|NCT01180790|3839583|P3|Overall Study|Physician Decision|0
1169420|NCT01180790|3839584|P2|Overall Study|Physician Decision|0
1169421|NCT01180790|3839585|P1|Overall Study|Physician Decision|1
1169422|NCT01180790|3839579|P7|Overall Study|Lost to Follow-up|1
1169423|NCT01180790|3839580|P6|Overall Study|Lost to Follow-up|0
1169424|NCT01180790|3839581|P5|Overall Study|Lost to Follow-up|1
1169425|NCT01180790|3839582|P4|Overall Study|Lost to Follow-up|2
1169426|NCT01180790|3839583|P3|Overall Study|Lost to Follow-up|0
1169427|NCT01180790|3839584|P2|Overall Study|Lost to Follow-up|1
1169428|NCT01180790|3839585|P1|Overall Study|Lost to Follow-up|3
1169429|NCT01180790|3839579|P7|Overall Study|Withdrawal by Subject|0
1169430|NCT01180790|3839580|P6|Overall Study|Withdrawal by Subject|1
1169431|NCT01180790|3839581|P5|Overall Study|Withdrawal by Subject|2
1169432|NCT01180790|3839582|P4|Overall Study|Withdrawal by Subject|0
1169433|NCT01180790|3839583|P3|Overall Study|Withdrawal by Subject|5
1169434|NCT01180790|3839584|P2|Overall Study|Withdrawal by Subject|0
1169435|NCT01180790|3839585|P1|Overall Study|Withdrawal by Subject|3
1169436|NCT01180790|3839579|P7|Overall Study|Adverse Event|0
1169437|NCT01180790|3839580|P6|Overall Study|Adverse Event|3
1169438|NCT01180790|3839581|P5|Overall Study|Adverse Event|1
1169439|NCT01180790|3839582|P4|Overall Study|Adverse Event|0
1169440|NCT01180790|3839583|P3|Overall Study|Adverse Event|2
1169441|NCT01180790|3839584|P2|Overall Study|Adverse Event|1
1169442|NCT01180790|3839585|P1|Overall Study|Adverse Event|1
1169443|NCT01180777|3839650|P1|Overall Study|Adverse Event|1
1169444|NCT01180777|3839650|P1|Overall Study|Lost to Follow-up|1
1169445|NCT01180777|3839650|P1|Overall Study|Poor lens fit|4
1169446|NCT01180777|3839650|P1|Overall Study|Protocol Violation|6
1169447|NCT01180660|3839664|P2|Overall Study|Changed to open surgery|0
1169448|NCT01180660|3839665|P1|Overall Study|Changed to open surgery|1
1169449|NCT01180647|3839675|P2|Overall Study|Lost to Follow-up|6
1169450|NCT01180647|3839676|P1|Overall Study|Lost to Follow-up|5
1169451|NCT01180400|3839711|P2|Overall Study|Not specified|1
1169452|NCT01180400|3839712|P1|Overall Study|Not specified|0
1169453|NCT01180400|3839711|P2|Overall Study|Lost to Follow-up|3
1169454|NCT01180400|3839712|P1|Overall Study|Lost to Follow-up|2
1169455|NCT01180400|3839711|P2|Overall Study|Study-specific withdrawal criteria|2
1169456|NCT01180400|3839712|P1|Overall Study|Study-specific withdrawal criteria|1
1169457|NCT01180400|3839711|P2|Overall Study|Lack of Efficacy|0
1169458|NCT01180400|3839712|P1|Overall Study|Lack of Efficacy|2
1169459|NCT01180400|3839711|P2|Overall Study|Condition under investigation worsened|1
1169460|NCT01180400|3839712|P1|Overall Study|Condition under investigation worsened|2
1169461|NCT01180400|3839711|P2|Overall Study|Severe non-compliance to protocol|2
1169462|NCT01180400|3839712|P1|Overall Study|Severe non-compliance to protocol|1
1169463|NCT01180400|3839711|P2|Overall Study|Adverse Event|10
1169464|NCT01180400|3839712|P1|Overall Study|Adverse Event|12
1169465|NCT01180400|3839711|P2|Overall Study|Eligibility criteria not fulfilled|2
1169466|NCT01180400|3839712|P1|Overall Study|Eligibility criteria not fulfilled|0
1169467|NCT01180400|3839711|P2|Overall Study|Withdrawal by Subject|6
1169468|NCT01180400|3839712|P1|Overall Study|Withdrawal by Subject|5
1169469|NCT01180296|3839760|P2|Overall Study|Protocol Violation|2
1169470|NCT01180296|3839761|P1|Overall Study|Protocol Violation|1
1169471|NCT01180244|3839769|P2|Overall Study|Lost to Follow-up|0
1169472|NCT01180244|3839770|P1|Overall Study|Lost to Follow-up|1
1169473|NCT01180244|3839769|P2|Overall Study|Protocol Violation|0
1169474|NCT01180244|3839770|P1|Overall Study|Protocol Violation|1
1169475|NCT01180244|3839769|P2|Overall Study|Withdrawal by Subject|1
1169476|NCT01180244|3839770|P1|Overall Study|Withdrawal by Subject|0
1169477|NCT01180244|3839769|P2|Overall Study|Adverse Event|0
1169478|NCT01180244|3839770|P1|Overall Study|Adverse Event|1
1169479|NCT01180244|3839769|P2|Overall Study|Physician Decision|0
1169480|NCT01180244|3839770|P1|Overall Study|Physician Decision|3
1169481|NCT01180244|3839769|P2|Overall Study|Lack of Efficacy|7
1169482|NCT01180244|3839770|P1|Overall Study|Lack of Efficacy|0
1169483|NCT01180049|3839815|P2|Overall Study|Ongoing on treatment|10
1169484|NCT01180049|3839816|P1|Overall Study|Ongoing on treatment|18
1169485|NCT01180049|3839815|P2|Overall Study|Death|28
1169486|NCT01180049|3839816|P1|Overall Study|Death|23
1169487|NCT01180049|3839815|P2|Overall Study|Lost to Follow-up|1
1169488|NCT01180049|3839816|P1|Overall Study|Lost to Follow-up|0
1169489|NCT01180049|3839815|P2|Overall Study|Participant Refused Follow Up|3
1169490|NCT01180049|3839816|P1|Overall Study|Participant Refused Follow Up|5
1169491|NCT01180049|3839815|P2|Overall Study|Enrolled to Another Clinical Trial|1
1169492|NCT01180049|3839816|P1|Overall Study|Enrolled to Another Clinical Trial|1
1169493|NCT01179919|3839842|P1|Overall Study|Adverse Event|1
1169494|NCT01179919|3839842|P1|Overall Study|Protocol Violation|1
1169495|NCT01179737|3839851|P4|Extension|The study was terminated|0
1169496|NCT01179737|3839852|P3|Extension|The study was terminated|0
1169497|NCT01179737|3839853|P2|Extension|The study was terminated|0
1169498|NCT01179737|3839854|P1|Extension|The study was terminated|3
1169499|NCT01179737|3839851|P4|Cohort 1 & Cohort 2 Expansion|Death|0
1169500|NCT01179737|3839852|P3|Cohort 1 & Cohort 2 Expansion|Death|0
1169501|NCT01179737|3839853|P2|Cohort 1 & Cohort 2 Expansion|Death|0
1169502|NCT01179737|3839854|P1|Cohort 1 & Cohort 2 Expansion|Death|1
1169503|NCT01179737|3839851|P4|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
1169504|NCT01179737|3839852|P3|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
1169505|NCT01179737|3839853|P2|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1
1169506|NCT01179737|3839854|P1|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
1169507|NCT01179737|3839851|P4|Cohort 1 & Cohort 2|Death|0
1169508|NCT01179737|3839852|P3|Cohort 1 & Cohort 2|Death|1
1169509|NCT01179737|3839853|P2|Cohort 1 & Cohort 2|Death|0
1169510|NCT01179737|3839854|P1|Cohort 1 & Cohort 2|Death|0
1169511|NCT01179737|3839851|P4|Cohort 1 & Cohort 2|Administrative problems|4
1169512|NCT01179737|3839852|P3|Cohort 1 & Cohort 2|Administrative problems|2
1169513|NCT01179737|3839853|P2|Cohort 1 & Cohort 2|Administrative problems|0
1169514|NCT01179737|3839854|P1|Cohort 1 & Cohort 2|Administrative problems|0
1169515|NCT01179737|3839851|P4|Cohort 1 & Cohort 2|Withdrew consent|0
1169516|NCT01179737|3839852|P3|Cohort 1 & Cohort 2|Withdrew consent|0
1169517|NCT01179737|3839853|P2|Cohort 1 & Cohort 2|Withdrew consent|0
1169518|NCT01179737|3839854|P1|Cohort 1 & Cohort 2|Withdrew consent|2
1169519|NCT01179737|3839851|P4|Cohort 1 & Cohort 2|Adverse Event|0
1169520|NCT01179737|3839852|P3|Cohort 1 & Cohort 2|Adverse Event|1
1169521|NCT01179737|3839853|P2|Cohort 1 & Cohort 2|Adverse Event|1
1169522|NCT01179737|3839854|P1|Cohort 1 & Cohort 2|Adverse Event|3
1169523|NCT01179672|3839865|P2|Overall Study|Physician Decision|1
1169524|NCT01179672|3839866|P1|Overall Study|Physician Decision|1
1169525|NCT01179672|3839865|P2|Overall Study|Protocol Violation|2
1169526|NCT01179672|3839866|P1|Overall Study|Protocol Violation|2
1169527|NCT01179672|3839865|P2|Overall Study|Lost to Follow-up|1
1169528|NCT01179672|3839866|P1|Overall Study|Lost to Follow-up|0
1169529|NCT01179672|3839865|P2|Overall Study|Entry Criteria Not Met|2
1169530|NCT01179672|3839866|P1|Overall Study|Entry Criteria Not Met|0
1169531|NCT01179672|3839865|P2|Overall Study|Withdrawal by Subject|12
1169532|NCT01179672|3839866|P1|Overall Study|Withdrawal by Subject|10
1169533|NCT01179672|3839865|P2|Overall Study|Adverse Event|8
1169534|NCT01179672|3839866|P1|Overall Study|Adverse Event|17
1169535|NCT01179516|3839922|P3|Overall Study|Other|2
1169536|NCT01179516|3839923|P2|Overall Study|Other|0
1169537|NCT01179516|3839924|P1|Overall Study|Other|2
1169538|NCT01179516|3839922|P3|Overall Study|Lost to Follow-up|3
1169539|NCT01179516|3839923|P2|Overall Study|Lost to Follow-up|7
1169540|NCT01179516|3839924|P1|Overall Study|Lost to Follow-up|7
1169541|NCT01179516|3839922|P3|Overall Study|Withdrawal of Consent|10
1169542|NCT01179516|3839923|P2|Overall Study|Withdrawal of Consent|6
1169543|NCT01179516|3839924|P1|Overall Study|Withdrawal of Consent|2
1169544|NCT01179516|3839922|P3|Overall Study|Protocol Deviations|3
1169545|NCT01179516|3839923|P2|Overall Study|Protocol Deviations|3
1169546|NCT01179516|3839924|P1|Overall Study|Protocol Deviations|4
1169547|NCT01179516|3839922|P3|Overall Study|Noncompliance with Study Drug|1
1169548|NCT01179516|3839923|P2|Overall Study|Noncompliance with Study Drug|0
1169549|NCT01179516|3839924|P1|Overall Study|Noncompliance with Study Drug|2
1169550|NCT01179516|3839922|P3|Overall Study|Lack of Efficacy|0
1169551|NCT01179516|3839923|P2|Overall Study|Lack of Efficacy|2
1169552|NCT01179516|3839924|P1|Overall Study|Lack of Efficacy|4
1169553|NCT01179516|3839922|P3|Overall Study|Pretreatment Event or Adverse Event|12
1169554|NCT01179516|3839923|P2|Overall Study|Pretreatment Event or Adverse Event|8
1169555|NCT01179516|3839924|P1|Overall Study|Pretreatment Event or Adverse Event|6
1169556|NCT01179399|3839968|P1|Overall Study|Withdrawal by Subject|1
1169557|NCT01179399|3839968|P1|Overall Study|Lack of Efficacy|30
1169558|NCT01179399|3839968|P1|Overall Study|Adverse Event|1
1169559|NCT01179347|3839974|P2|Open-label Period (12 Weeks)|Other|4
1169560|NCT01179347|3839975|P1|Open-label Period (12 Weeks)|Other|7
1169561|NCT01179347|3839974|P2|Open-label Period (12 Weeks)|Protocol Violation|0
1169562|NCT01179347|3839975|P1|Open-label Period (12 Weeks)|Protocol Violation|1
1169563|NCT01179347|3839974|P2|Open-label Period (12 Weeks)|Withdrawal by Subject|1
1169564|NCT01179347|3839975|P1|Open-label Period (12 Weeks)|Withdrawal by Subject|1
1169565|NCT01179347|3839974|P2|Open-label Period (12 Weeks)|Lost to Follow-up|0
1169566|NCT01179347|3839975|P1|Open-label Period (12 Weeks)|Lost to Follow-up|1
1169567|NCT01179347|3839974|P2|Open-label Period (12 Weeks)|Lack of Efficacy|2
1169568|NCT01179347|3839975|P1|Open-label Period (12 Weeks)|Lack of Efficacy|0
1169569|NCT01179347|3839974|P2|Open-label Period (12 Weeks)|Adverse Event|9
1169570|NCT01179347|3839975|P1|Open-label Period (12 Weeks)|Adverse Event|5
1169571|NCT01179347|3839974|P2|Double-blind Period (12 Weeks)|Other|4
1169572|NCT01179347|3839975|P1|Double-blind Period (12 Weeks)|Other|2
1169573|NCT01179347|3839974|P2|Double-blind Period (12 Weeks)|Withdrawal by Subject|2
1169574|NCT01179347|3839975|P1|Double-blind Period (12 Weeks)|Withdrawal by Subject|1
1169575|NCT01179347|3839974|P2|Double-blind Period (12 Weeks)|Lost to Follow-up|2
1169576|NCT01179347|3839975|P1|Double-blind Period (12 Weeks)|Lost to Follow-up|1
1169577|NCT01179347|3839974|P2|Double-blind Period (12 Weeks)|Protocol Violation|0
1169578|NCT01179347|3839975|P1|Double-blind Period (12 Weeks)|Protocol Violation|2
1169579|NCT01179347|3839974|P2|Double-blind Period (12 Weeks)|Adverse Event|6
1169580|NCT01179347|3839975|P1|Double-blind Period (12 Weeks)|Adverse Event|2
1169581|NCT01179334|3839997|P2|Long-term Extension (LTE) Period|Adverse Event|4
1169582|NCT01179334|3839998|P1|Long-term Extension (LTE) Period|Adverse Event|2
1169583|NCT01179334|3839997|P2|Long-term Extension (LTE) Period|Death|0
1169584|NCT01179334|3839998|P1|Long-term Extension (LTE) Period|Death|3
1169585|NCT01179334|3839997|P2|Long-term Extension (LTE) Period|Study terminated by sponsor|2
1169586|NCT01179334|3839998|P1|Long-term Extension (LTE) Period|Study terminated by sponsor|6
1169587|NCT01179334|3839997|P2|Treatment Period|Adverse Event|0
1169588|NCT01179334|3839998|P1|Treatment Period|Adverse Event|1
1169589|NCT01179191|3840053|P1|Maintenance Phase (8 Weeks)|Other|66
1169590|NCT01179191|3840053|P1|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29
1169591|NCT01179191|3840053|P1|Maintenance Phase (8 Weeks)|Physician Decision|3
1169592|NCT01179191|3840053|P1|Maintenance Phase (8 Weeks)|Lost to Follow-up|9
1169593|NCT01179191|3840053|P1|Maintenance Phase (8 Weeks)|Adverse Event|10
1169594|NCT01179191|3840053|P1|Titration Phase (up to 6 Weeks)|Other|62
1169595|NCT01179191|3840053|P1|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13
1169596|NCT01179191|3840053|P1|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162
1169597|NCT01179191|3840053|P1|Titration Phase (up to 6 Weeks)|Physician Decision|30
1169598|NCT01179191|3840053|P1|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19
1169599|NCT01179191|3840053|P1|Titration Phase (up to 6 Weeks)|Adverse Event|47
1169600|NCT01179048|3840085|P2|Overall Study|Alive|142
1169601|NCT01179048|3840086|P1|Overall Study|Alive|127
1169602|NCT01179048|3840085|P2|Overall Study|Lost to Follow-up|9
1169603|NCT01179048|3840086|P1|Overall Study|Lost to Follow-up|8
1169604|NCT01179048|3840085|P2|Overall Study|Withdrawn - does not allow contact|8
1169605|NCT01179048|3840086|P1|Overall Study|Withdrawn - does not allow contact|4
1169606|NCT01178853|3840113|P2|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1
1169607|NCT01178853|3840114|P1|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0
1169608|NCT01178853|3840113|P2|Period 4 (Warfarin + Study Drug)|Adverse Event|2
1169609|NCT01178853|3840114|P1|Period 4 (Warfarin + Study Drug)|Adverse Event|0
1169610|NCT01178853|3840113|P2|Period 3 (Warfarin Titration)|Adverse Event|0
1169611|NCT01178853|3840114|P1|Period 3 (Warfarin Titration)|Adverse Event|1
1169612|NCT01178853|3840113|P2|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0
1169613|NCT01178853|3840114|P1|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1
1169614|NCT01178853|3840113|P2|Period 1 (Warfarin Titration)|INR Out of Range|2
1169615|NCT01178853|3840114|P1|Period 1 (Warfarin Titration)|INR Out of Range|1
1169616|NCT01178762|3840154|P1|Overall Study|Lost to Follow-up|15
1169617|NCT01178671|3840160|P2|Overall Study|Physician Decision|6
1169618|NCT01178671|3840161|P1|Overall Study|Physician Decision|4
1169619|NCT01178671|3840160|P2|Overall Study|Lost to Follow-up|1
1169620|NCT01178671|3840161|P1|Overall Study|Lost to Follow-up|3
1169621|NCT01178671|3840160|P2|Overall Study|Lack of Efficacy|1
1169622|NCT01178671|3840161|P1|Overall Study|Lack of Efficacy|0
1169623|NCT01178671|3840160|P2|Overall Study|Protocol Violation|1
1169624|NCT01178671|3840161|P1|Overall Study|Protocol Violation|1
1169625|NCT01178671|3840160|P2|Overall Study|Adverse Event|6
1169626|NCT01178671|3840161|P1|Overall Study|Adverse Event|4
1169627|NCT01178385|3840209|P2|Overall Study|Withdrawal by Subject|0
1169628|NCT01178385|3840210|P1|Overall Study|Withdrawal by Subject|2
1169629|NCT01178294|3840279|P1|Overall Study|Completion status could not be verified|1
1169630|NCT01178294|3840279|P1|Overall Study|Subject status is terminal|1
1169631|NCT01178294|3840279|P1|Overall Study|Development of inhibitors to OBI-1|1
1169632|NCT01178294|3840279|P1|Overall Study|Death|1
1169633|NCT01178294|3840279|P1|Overall Study|Lack of Efficacy|1
1169634|NCT01178294|3840279|P1|Overall Study|Lost to Follow-up|2
1169635|NCT01178294|3840279|P1|Overall Study|Adverse Event|4
1169636|NCT01178281|3840302|P2|Overall Study|Prohibited Medications|2
1169637|NCT01178281|3840303|P1|Overall Study|Prohibited Medications|0
1169638|NCT01178281|3840302|P2|Overall Study|Adverse Event|9
1169639|NCT01178281|3840303|P1|Overall Study|Adverse Event|39
1169640|NCT01178281|3840302|P2|Overall Study|Withdrawal by Subject|7
1169641|NCT01178281|3840303|P1|Overall Study|Withdrawal by Subject|18
1169642|NCT01178281|3840302|P2|Overall Study|Death|5
1169643|NCT01178281|3840303|P1|Overall Study|Death|4
1169644|NCT01178281|3840302|P2|Overall Study|Disease Progression|6
1169645|NCT01178281|3840303|P1|Overall Study|Disease Progression|18
1169646|NCT01178281|3840302|P2|Overall Study|Non-compliance to study drug|0
1169647|NCT01178281|3840303|P1|Overall Study|Non-compliance to study drug|1
1169648|NCT01178281|3840302|P2|Overall Study|Lack of Efficacy|38
1169649|NCT01178281|3840303|P1|Overall Study|Lack of Efficacy|60
1169650|NCT01178281|3840302|P2|Overall Study|Loss of Clinical Benefit|7
1169651|NCT01178281|3840303|P1|Overall Study|Loss of Clinical Benefit|5
1169652|NCT01178281|3840302|P2|Overall Study|Physician Decision|3
1169653|NCT01178281|3840303|P1|Overall Study|Physician Decision|4
1169654|NCT01178138|3840538|P1|Overall Study|Physician Decision|8
1169655|NCT01178138|3840538|P1|Overall Study|Withdrawal by Subject|7
1169656|NCT01178138|3840538|P1|Overall Study|Lost to Follow-up|8
1169657|NCT01178125|3840559|P1|Overall Study|Investigator Decision|5
1169658|NCT01178125|3840559|P1|Overall Study|Protocol Violation|17
1169659|NCT01178125|3840559|P1|Overall Study|Sponsor Decision|28
1169660|NCT01178125|3840559|P1|Overall Study|Other Reason|39
1169661|NCT01178125|3840559|P1|Overall Study|Pregnancy|55
1169662|NCT01178125|3840559|P1|Overall Study|Noncompliance|184
1169663|NCT01178125|3840559|P1|Overall Study|Withdrawal by Subject|209
1169664|NCT01178125|3840559|P1|Overall Study|Adverse Event|244
1169665|NCT01178125|3840559|P1|Overall Study|Lost to Follow-up|397
1169666|NCT01178099|3840590|P2|Overall Study|Physician Decision|1
1169667|NCT01178099|3840591|P1|Overall Study|Physician Decision|0
1169668|NCT01178086|3840631|P1|Overall Study|Excluded from EAS|20
1169669|NCT01178086|3840631|P1|Overall Study|Other unspecified|89
1169670|NCT01178086|3840631|P1|Overall Study|Death|59
1169671|NCT01178086|3840631|P1|Overall Study|Switch to other CLL therapy|113
1169672|NCT01178086|3840631|P1|Overall Study|Physician Decision|44
1169673|NCT01178086|3840631|P1|Overall Study|Participant refusal|7
1169674|NCT01178073|3840658|P3|Overall Study|Missing Completion Status|0
1169675|NCT01178073|3840659|P2|Overall Study|Missing Completion Status|0
1169676|NCT01178073|3840660|P1|Overall Study|Missing Completion Status|1
1169677|NCT01178073|3840658|P3|Overall Study|Withdrawal by Subject|8
1169678|NCT01178073|3840659|P2|Overall Study|Withdrawal by Subject|6
1169679|NCT01178073|3840660|P1|Overall Study|Withdrawal by Subject|10
1169680|NCT01178073|3840658|P3|Overall Study|Physician Decision|10
1169681|NCT01178073|3840659|P2|Overall Study|Physician Decision|10
1169682|NCT01178073|3840660|P1|Overall Study|Physician Decision|14
1169683|NCT01178073|3840658|P3|Overall Study|Lost to Follow-up|3
1169684|NCT01178073|3840659|P2|Overall Study|Lost to Follow-up|0
1169685|NCT01178073|3840660|P1|Overall Study|Lost to Follow-up|2
1169686|NCT01178073|3840658|P3|Overall Study|Protocol Violation|1
1169687|NCT01178073|3840659|P2|Overall Study|Protocol Violation|1
1169688|NCT01178073|3840660|P1|Overall Study|Protocol Violation|1
1169689|NCT01178073|3840658|P3|Overall Study|Adverse Event|24
1169690|NCT01178073|3840659|P2|Overall Study|Adverse Event|27
1169691|NCT01178073|3840660|P1|Overall Study|Adverse Event|34
1169692|NCT01177969|3840691|P2|Overall Study|Withdrawal by Subject|2
1169693|NCT01177969|3840692|P1|Overall Study|Withdrawal by Subject|1
1169694|NCT01177969|3840691|P2|Overall Study|Protocol Violation|1
1169695|NCT01177969|3840692|P1|Overall Study|Protocol Violation|2
1169696|NCT01177943|3840715|P2|First Intervention|Withdrawal by Subject|0
1169697|NCT01177943|3840716|P1|First Intervention|Withdrawal by Subject|2
1169698|NCT01177813|3840729|P5|Overall Study|Other reason not defined above|2
1169699|NCT01177813|3840730|P4|Overall Study|Other reason not defined above|3
1169700|NCT01177813|3840731|P3|Overall Study|Other reason not defined above|2
1169701|NCT01177813|3840732|P2|Overall Study|Other reason not defined above|2
1169702|NCT01177813|3840733|P1|Overall Study|Other reason not defined above|5
1169703|NCT01177813|3840729|P5|Overall Study|Withdrawal by Subject|3
1169704|NCT01177813|3840730|P4|Overall Study|Withdrawal by Subject|5
1169705|NCT01177813|3840731|P3|Overall Study|Withdrawal by Subject|6
1169706|NCT01177813|3840732|P2|Overall Study|Withdrawal by Subject|7
1169707|NCT01177813|3840733|P1|Overall Study|Withdrawal by Subject|12
1169708|NCT01177813|3840729|P5|Overall Study|Lost to Follow-up|0
1169709|NCT01177813|3840730|P4|Overall Study|Lost to Follow-up|3
1169710|NCT01177813|3840731|P3|Overall Study|Lost to Follow-up|6
1169711|NCT01177813|3840732|P2|Overall Study|Lost to Follow-up|5
1169712|NCT01177813|3840733|P1|Overall Study|Lost to Follow-up|12
1169713|NCT01177813|3840729|P5|Overall Study|Protocol Violation|1
1169714|NCT01177813|3840730|P4|Overall Study|Protocol Violation|0
1169715|NCT01177813|3840731|P3|Overall Study|Protocol Violation|2
1169716|NCT01177813|3840732|P2|Overall Study|Protocol Violation|2
1169717|NCT01177813|3840733|P1|Overall Study|Protocol Violation|3
1169718|NCT01177813|3840729|P5|Overall Study|Lack of Efficacy|0
1169719|NCT01177813|3840730|P4|Overall Study|Lack of Efficacy|0
1169720|NCT01177813|3840731|P3|Overall Study|Lack of Efficacy|0
1169721|NCT01177813|3840732|P2|Overall Study|Lack of Efficacy|0
1169722|NCT01177813|3840733|P1|Overall Study|Lack of Efficacy|1
1169723|NCT01177813|3840729|P5|Overall Study|Adverse Event|3
1169724|NCT01177813|3840730|P4|Overall Study|Adverse Event|6
1169725|NCT01177813|3840731|P3|Overall Study|Adverse Event|4
1169726|NCT01177813|3840732|P2|Overall Study|Adverse Event|2
1169727|NCT01177813|3840733|P1|Overall Study|Adverse Event|8
1169728|NCT01177800|3840762|P2|Overall Study|Withdrawal of informed consent|1
1169729|NCT01177800|3840763|P1|Overall Study|Withdrawal of informed consent|0
1169730|NCT01177800|3840762|P2|Overall Study|Physician Decision|0
1169731|NCT01177800|3840763|P1|Overall Study|Physician Decision|1
1169732|NCT01177800|3840762|P2|Overall Study|Protocol Violation|1
1169733|NCT01177800|3840763|P1|Overall Study|Protocol Violation|0
1169734|NCT01177800|3840762|P2|Overall Study|Adverse Event|3
1169735|NCT01177800|3840763|P1|Overall Study|Adverse Event|9
1169736|NCT01177722|3840785|P4|Overall Study|Withdrawal by Subject|6
1169737|NCT01177722|3840786|P3|Overall Study|Withdrawal by Subject|4
1169738|NCT01177722|3840787|P2|Overall Study|Withdrawal by Subject|6
1169739|NCT01177722|3840788|P1|Overall Study|Withdrawal by Subject|10
1169740|NCT01177722|3840785|P4|Overall Study|Lost to Follow-up|1
1169741|NCT01177722|3840786|P3|Overall Study|Lost to Follow-up|3
1169742|NCT01177722|3840787|P2|Overall Study|Lost to Follow-up|4
1169743|NCT01177722|3840788|P1|Overall Study|Lost to Follow-up|3
1169744|NCT01177722|3840785|P4|Overall Study|Protocol Violation|0
1169745|NCT01177722|3840786|P3|Overall Study|Protocol Violation|1
1169746|NCT01177722|3840787|P2|Overall Study|Protocol Violation|0
1169747|NCT01177722|3840788|P1|Overall Study|Protocol Violation|0
1169748|NCT01177722|3840785|P4|Overall Study|Serious Adverse Event|0
1169749|NCT01177722|3840786|P3|Overall Study|Serious Adverse Event|1
1169750|NCT01177722|3840787|P2|Overall Study|Serious Adverse Event|0
1169751|NCT01177722|3840788|P1|Overall Study|Serious Adverse Event|0
1169752|NCT01177670|3840820|P1|Overall Study|Withdrawal by Subject|4
1169753|NCT01177670|3840820|P1|Overall Study|Physician Decision|50
1169754|NCT01177670|3840820|P1|Overall Study|Study Terminated|115
1169755|NCT01177553|3840827|P2|Overall Study|babies not yet 6 months of age|0
1169756|NCT01177553|3840828|P1|Overall Study|babies not yet 6 months of age|1
1169757|NCT01177410|3840837|P3|Overall Study|Lost to Follow-up|0
1169758|NCT01177410|3840838|P2|Overall Study|Lost to Follow-up|1
1169759|NCT01177410|3840839|P1|Overall Study|Lost to Follow-up|0
1169760|NCT01177410|3840837|P3|Overall Study|Withdrawal by Subject|3
1169761|NCT01177410|3840838|P2|Overall Study|Withdrawal by Subject|4
1169762|NCT01177410|3840839|P1|Overall Study|Withdrawal by Subject|1
1169763|NCT01177410|3840837|P3|Overall Study|Adverse Event|2
1169764|NCT01177410|3840838|P2|Overall Study|Adverse Event|2
1169765|NCT01177410|3840839|P1|Overall Study|Adverse Event|0
1169766|NCT01177384|3840852|P2|Overall Study|Withdrawal by Subject|12
1169767|NCT01177384|3840853|P1|Overall Study|Withdrawal by Subject|5
1169768|NCT01177384|3840852|P2|Overall Study|Protocol Violation|2
1169769|NCT01177384|3840853|P1|Overall Study|Protocol Violation|0
1169770|NCT01177384|3840852|P2|Overall Study|Physician Decision|3
1169771|NCT01177384|3840853|P1|Overall Study|Physician Decision|0
1169772|NCT01177384|3840852|P2|Overall Study|Lost to Follow-up|4
1169773|NCT01177384|3840853|P1|Overall Study|Lost to Follow-up|3
1169774|NCT01177384|3840852|P2|Overall Study|Lack of Efficacy|1
1169775|NCT01177384|3840853|P1|Overall Study|Lack of Efficacy|0
1169776|NCT01177384|3840852|P2|Overall Study|Adverse Event|4
1169777|NCT01177384|3840853|P1|Overall Study|Adverse Event|6
1169778|NCT01177293|3840865|P2|Washout Period (of 14 Days)|Lost to Follow-up|1
1169779|NCT01177293|3840866|P1|Washout Period (of 14 Days)|Lost to Follow-up|0
1169780|NCT01177228|3840884|P4|Overall Study|Withdrawal by Subject|0
1169781|NCT01177228|3840885|P3|Overall Study|Withdrawal by Subject|0
1169782|NCT01177228|3840886|P2|Overall Study|Withdrawal by Subject|1
1169783|NCT01177228|3840887|P1|Overall Study|Withdrawal by Subject|0
1169784|NCT01177228|3840884|P4|Overall Study|Worsening disease activity|0
1169785|NCT01177228|3840885|P3|Overall Study|Worsening disease activity|0
1169786|NCT01177228|3840886|P2|Overall Study|Worsening disease activity|0
1169787|NCT01177228|3840887|P1|Overall Study|Worsening disease activity|1
1169788|NCT01177228|3840884|P4|Overall Study|Positive tuberculosis test|0
1169789|NCT01177228|3840885|P3|Overall Study|Positive tuberculosis test|0
1169790|NCT01177228|3840886|P2|Overall Study|Positive tuberculosis test|1
1169791|NCT01177228|3840887|P1|Overall Study|Positive tuberculosis test|0
1169792|NCT01177137|3840928|P3|Overall Study|Withdrawal by Subject|2
1169793|NCT01177137|3840929|P2|Overall Study|Withdrawal by Subject|10
1169794|NCT01177137|3840930|P1|Overall Study|Withdrawal by Subject|10
1169795|NCT01177059|3841014|P1|Overall Study|Lost to Follow-up|18
1169796|NCT01177059|3841014|P1|Overall Study|Withdrew consent|2
1169797|NCT01177059|3841014|P1|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30
1169798|NCT01177007|3841020|P1|Overall Study|Change in treatment modality|21
1169799|NCT01177007|3841020|P1|Overall Study|Required additional Y90 treatment|6
1169800|NCT01177007|3841020|P1|Overall Study|Entered hospice care|5
1169801|NCT01177007|3841020|P1|Overall Study|Death|4
1169802|NCT01177007|3841020|P1|Overall Study|Lost to Follow-up|2
1169803|NCT01176968|3841034|P2|Overall Study|Reason not defined|3
1169804|NCT01176968|3841035|P1|Overall Study|Reason not defined|5
1169805|NCT01176968|3841034|P2|Overall Study|Study terminated by sponsor|1
1169806|NCT01176968|3841035|P1|Overall Study|Study terminated by sponsor|0
1169807|NCT01176968|3841034|P2|Overall Study|Did Not Meet Entrance Criteria|0
1169808|NCT01176968|3841035|P1|Overall Study|Did Not Meet Entrance Criteria|1
1169809|NCT01176968|3841034|P2|Overall Study|Protocol Violation|1
1169810|NCT01176968|3841035|P1|Overall Study|Protocol Violation|2
1169811|NCT01176968|3841034|P2|Overall Study|Withdrawal by Subject|48
1169812|NCT01176968|3841035|P1|Overall Study|Withdrawal by Subject|48
1169813|NCT01176968|3841034|P2|Overall Study|Lost to Follow-up|14
1169814|NCT01176968|3841035|P1|Overall Study|Lost to Follow-up|16
1169815|NCT01176968|3841034|P2|Overall Study|Lack of Efficacy|1
1169816|NCT01176968|3841035|P1|Overall Study|Lack of Efficacy|0
1169817|NCT01176968|3841034|P2|Overall Study|Death|3
1169818|NCT01176968|3841035|P1|Overall Study|Death|2
1169819|NCT01176968|3841034|P2|Overall Study|Adverse Event|11
1169820|NCT01176968|3841035|P1|Overall Study|Adverse Event|10
1169821|NCT01176773|3841086|P1|Overall Study|Withdrew consent|1
1169822|NCT01176773|3841086|P1|Overall Study|Screen Failure|2
1169823|NCT01176565|3841110|P2|Overall Study|Not Analyzed (any other reason)|2
1169824|NCT01176565|3841111|P1|Overall Study|Not Analyzed (any other reason)|1
1169825|NCT01176565|3841110|P2|Overall Study|Withdrawal by Subject|1
1169826|NCT01176565|3841111|P1|Overall Study|Withdrawal by Subject|7
1169827|NCT01176565|3841110|P2|Overall Study|Lost to Follow-up|16
1169828|NCT01176565|3841111|P1|Overall Study|Lost to Follow-up|12
1169829|NCT01176513|3841129|P1|Overall Study|Withdrew subjects prior to dosing|3
1169830|NCT01176292|3841157|P2|Overall Study|Has not scheduled one-year visit yet|2
1169831|NCT01176292|3841158|P1|Overall Study|Has not scheduled one-year visit yet|2
1169832|NCT01176292|3841157|P2|Overall Study|Physician Decision|2
1169833|NCT01176292|3841158|P1|Overall Study|Physician Decision|0
1169834|NCT01176292|3841157|P2|Overall Study|Adverse Event|1
1169835|NCT01176292|3841158|P1|Overall Study|Adverse Event|1
1169836|NCT01176292|3841157|P2|Overall Study|Lost to Follow-up|4
1169837|NCT01176292|3841158|P1|Overall Study|Lost to Follow-up|2
1169838|NCT01176266|3841176|P1|Overall Study|Withdrawal by Subject|3
1169839|NCT01176266|3841176|P1|Overall Study|Death|6
1169840|NCT01176240|3841200|P2|Study 306B|withdrew prior to dosing|1
1169841|NCT01176240|3841201|P1|Study 306B|withdrew prior to dosing|2
1169842|NCT01176240|3841200|P2|Study 306B|Lost to Follow-up|1
1169843|NCT01176240|3841201|P1|Study 306B|Lost to Follow-up|0
1169844|NCT01176240|3841200|P2|Study 306B|Supine Hypertension|2
1169845|NCT01176240|3841201|P1|Study 306B|Supine Hypertension|1
1169846|NCT01176240|3841200|P2|Study 306B|Physician Decision|1
1169847|NCT01176240|3841201|P1|Study 306B|Physician Decision|2
1169848|NCT01176240|3841200|P2|Study 306B|Withdrawal by Subject|1
1169849|NCT01176240|3841201|P1|Study 306B|Withdrawal by Subject|4
1169850|NCT01176240|3841200|P2|Study 306B|Protocol Violation|3
1169851|NCT01176240|3841201|P1|Study 306B|Protocol Violation|2
1169852|NCT01176240|3841200|P2|Study 306B|Adverse Event|5
1169853|NCT01176240|3841201|P1|Study 306B|Adverse Event|10
1169854|NCT01176240|3841200|P2|Study 306B|Lack of Efficacy|3
1169855|NCT01176240|3841201|P1|Study 306B|Lack of Efficacy|5
1169856|NCT01176240|3841200|P2|Study 306A|Stop due to diverse problems|0
1169857|NCT01176240|3841201|P1|Study 306A|Stop due to diverse problems|1
1169858|NCT01176240|3841200|P2|Study 306A|Withdrawal by Subject|1
1169859|NCT01176240|3841201|P1|Study 306A|Withdrawal by Subject|0
1169860|NCT01176240|3841200|P2|Study 306A|Protocol Violation|1
1169861|NCT01176240|3841201|P1|Study 306A|Protocol Violation|0
1169862|NCT01176240|3841200|P2|Study 306A|Lack of Efficacy|1
1169863|NCT01176240|3841201|P1|Study 306A|Lack of Efficacy|2
1169864|NCT01176058|3841227|P2|Overall Study|Withdrawal by Subject|0
1169865|NCT01176058|3841228|P1|Overall Study|Withdrawal by Subject|1
1169866|NCT01176058|3841227|P2|Overall Study|Insufficient mycological response|1
1169867|NCT01176058|3841228|P1|Overall Study|Insufficient mycological response|0
1169868|NCT01176058|3841227|P2|Overall Study|Insufficient clinical response|2
1169869|NCT01176058|3841228|P1|Overall Study|Insufficient clinical response|2
1169870|NCT01176058|3841227|P2|Overall Study|Adverse Event|0
1169871|NCT01176058|3841228|P1|Overall Study|Adverse Event|1
1169872|NCT01176032|3841252|P2|Overall Study|Not available|0
1169873|NCT01176032|3841253|P1|Overall Study|Not available|1
1169874|NCT01176032|3841252|P2|Overall Study|Informed consent withdrawn|0
1169875|NCT01176032|3841253|P1|Overall Study|Informed consent withdrawn|3
1169876|NCT01176032|3841252|P2|Overall Study|Protocol Violation|0
1169877|NCT01176032|3841253|P1|Overall Study|Protocol Violation|1
1169878|NCT01176032|3841252|P2|Overall Study|Unsatisfactory therapeutic effect|1
1169879|NCT01176032|3841253|P1|Overall Study|Unsatisfactory therapeutic effect|0
1169880|NCT01176032|3841252|P2|Overall Study|Adverse Event|0
1169881|NCT01176032|3841253|P1|Overall Study|Adverse Event|1
1169882|NCT01175824|3841377|P2|Overall Study|Entry Criteria Not Met|4
1169883|NCT01175824|3841378|P1|Overall Study|Entry Criteria Not Met|6
1169884|NCT01175824|3841377|P2|Overall Study|Sponsor Decision|0
1169885|NCT01175824|3841378|P1|Overall Study|Sponsor Decision|1
1169886|NCT01175824|3841377|P2|Overall Study|Withdrawal by Subject|7
1169887|NCT01175824|3841378|P1|Overall Study|Withdrawal by Subject|3
1169888|NCT01175824|3841377|P2|Overall Study|Protocol Violation|5
1169889|NCT01175824|3841378|P1|Overall Study|Protocol Violation|2
1169890|NCT01175824|3841377|P2|Overall Study|Physician Decision|4
1169891|NCT01175824|3841378|P1|Overall Study|Physician Decision|0
1169892|NCT01175824|3841377|P2|Overall Study|Lost to Follow-up|1
1169893|NCT01175824|3841378|P1|Overall Study|Lost to Follow-up|0
1169894|NCT01175824|3841377|P2|Overall Study|Lack of Efficacy|0
1169895|NCT01175824|3841378|P1|Overall Study|Lack of Efficacy|2
1169896|NCT01175824|3841377|P2|Overall Study|Adverse Event|1
1169897|NCT01175824|3841378|P1|Overall Study|Adverse Event|2
1169898|NCT01175811|3841412|P2|Overall Study|Withdrawal by Subject|7
1169899|NCT01175811|3841413|P1|Overall Study|Withdrawal by Subject|6
1169900|NCT01175811|3841412|P2|Overall Study|Protocol Violation|2
1169901|NCT01175811|3841413|P1|Overall Study|Protocol Violation|1
1169902|NCT01175811|3841412|P2|Overall Study|Physician Decision|1
1169903|NCT01175811|3841413|P1|Overall Study|Physician Decision|1
1169904|NCT01175811|3841412|P2|Overall Study|Lost to Follow-up|2
1169905|NCT01175811|3841413|P1|Overall Study|Lost to Follow-up|3
1169906|NCT01175811|3841412|P2|Overall Study|Lack of Efficacy|0
1169907|NCT01175811|3841413|P1|Overall Study|Lack of Efficacy|1
1169908|NCT01175811|3841412|P2|Overall Study|Entry criteria not met|1
1169909|NCT01175811|3841413|P1|Overall Study|Entry criteria not met|3
1169910|NCT01175811|3841412|P2|Overall Study|Adverse Event|1
1169911|NCT01175811|3841413|P1|Overall Study|Adverse Event|1
1169912|NCT01175707|3841448|P2|Overall Study|Adverse Event|6
1169913|NCT01175707|3841449|P1|Overall Study|Adverse Event|4
1169914|NCT01175668|3841485|P2|Overall Study|Withdrawal by Subject|0
1169915|NCT01175668|3841486|P1|Overall Study|Withdrawal by Subject|2
1169916|NCT01175590|3841496|P2|Overall Study|Protocol Violation|1
1169917|NCT01175590|3841497|P1|Overall Study|Protocol Violation|0
1169918|NCT01175590|3841496|P2|Overall Study|Herpes Simplex Dermatitis|0
1169919|NCT01175590|3841497|P1|Overall Study|Herpes Simplex Dermatitis|1
1169920|NCT01175590|3841496|P2|Overall Study|Treated not as randomized|2
1169921|NCT01175590|3841497|P1|Overall Study|Treated not as randomized|3
1169922|NCT01175590|3841496|P2|Overall Study|Residual Bacterial Conjunctivitis|0
1169923|NCT01175590|3841497|P1|Overall Study|Residual Bacterial Conjunctivitis|1
1169924|NCT01175590|3841496|P2|Overall Study|Lack of Efficacy|1
1169925|NCT01175590|3841497|P1|Overall Study|Lack of Efficacy|1
1169926|NCT01175590|3841496|P2|Overall Study|Physician Decision|4
1169927|NCT01175590|3841497|P1|Overall Study|Physician Decision|1
1169928|NCT01175590|3841496|P2|Overall Study|Adverse Event|0
1169929|NCT01175590|3841497|P1|Overall Study|Adverse Event|4
1169930|NCT01175590|3841496|P2|Overall Study|Withdrawal by Subject|2
1169931|NCT01175590|3841497|P1|Overall Study|Withdrawal by Subject|0
1169932|NCT01175590|3841496|P2|Overall Study|Lost to Follow-up|0
1169933|NCT01175590|3841497|P1|Overall Study|Lost to Follow-up|1
1169934|NCT01175473|3841531|P2|Overall Study|Adverse Event|2
1169935|NCT01175473|3841532|P1|Overall Study|Adverse Event|2
1169936|NCT01175382|3841573|P3|Overall Study|Unable to tolerate study meds|1
1169937|NCT01175382|3841574|P2|Overall Study|Unable to tolerate study meds|1
1169938|NCT01175382|3841575|P1|Overall Study|Unable to tolerate study meds|0
1169939|NCT01175382|3841573|P3|Overall Study|Unwilling to follow protocol|0
1169940|NCT01175382|3841574|P2|Overall Study|Unwilling to follow protocol|1
1169941|NCT01175382|3841575|P1|Overall Study|Unwilling to follow protocol|0
1169942|NCT01175382|3841573|P3|Overall Study|Unable/unwilling to attend visits|2
1169943|NCT01175382|3841574|P2|Overall Study|Unable/unwilling to attend visits|1
1169944|NCT01175382|3841575|P1|Overall Study|Unable/unwilling to attend visits|3
1169945|NCT01175382|3841573|P3|Overall Study|No longer having problem|1
1169946|NCT01175382|3841574|P2|Overall Study|No longer having problem|0
1169947|NCT01175382|3841575|P1|Overall Study|No longer having problem|1
1169948|NCT01175382|3841573|P3|Overall Study|Withdrawal by Subject|1
1169949|NCT01175382|3841574|P2|Overall Study|Withdrawal by Subject|0
1169950|NCT01175382|3841575|P1|Overall Study|Withdrawal by Subject|0
1169951|NCT01175382|3841573|P3|Overall Study|Physician Decision|0
1169952|NCT01175382|3841574|P2|Overall Study|Physician Decision|1
1169953|NCT01175382|3841575|P1|Overall Study|Physician Decision|0
1169954|NCT01175382|3841573|P3|Overall Study|Lost to Follow-up|1
1169955|NCT01175382|3841574|P2|Overall Study|Lost to Follow-up|3
1169956|NCT01175382|3841575|P1|Overall Study|Lost to Follow-up|4
1169957|NCT01175356|3841661|P1|Overall Study|Initiation other tx prior to completion|9
1169958|NCT01175356|3841661|P1|Overall Study|Inadequate stem cell for transplant|1
1169959|NCT01175356|3841661|P1|Overall Study|On other COG study w/tumor tx intent|7
1169960|NCT01175356|3841661|P1|Overall Study|Pts MIBG non-avid after enrollment|2
1169961|NCT01175356|3841661|P1|Overall Study|Refusal by patient/parent/guardian|6
1169962|NCT01175356|3841661|P1|Overall Study|Treatment Slot Not Available|18
1169963|NCT01175356|3841661|P1|Overall Study|Ineligible|1
1169964|NCT01175356|3841661|P1|Overall Study|Physician Decision|23
1169965|NCT01175356|3841661|P1|Overall Study|Lost to Follow-up|1
1169966|NCT01175356|3841661|P1|Overall Study|Lack of Efficacy|12
1169967|NCT01175356|3841661|P1|Overall Study|Death|1
1169968|NCT01175213|3841701|P2|Safety Follow-up|Adverse Event|0
1169969|NCT01175213|3841702|P1|Safety Follow-up|Adverse Event|1
1169970|NCT01175213|3841701|P2|IGSC, 10%/rHuPH20|site elected to exit study|0
1169971|NCT01175213|3841702|P1|IGSC, 10%/rHuPH20|site elected to exit study|3
1169972|NCT01175213|3841701|P2|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0
1169973|NCT01175213|3841702|P1|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6
1169974|NCT01175213|3841701|P2|IGSC, 10%/rHuPH20|bone marrow transplant|0
1169975|NCT01175213|3841702|P1|IGSC, 10%/rHuPH20|bone marrow transplant|1
1169976|NCT01175213|3841701|P2|IGSC, 10%/rHuPH20|Death|0
1169977|NCT01175213|3841702|P1|IGSC, 10%/rHuPH20|Death|1
1169978|NCT01175213|3841701|P2|IGSC, 10%/rHuPH20|Withdrawal by Subject|0
1169979|NCT01175213|3841702|P1|IGSC, 10%/rHuPH20|Withdrawal by Subject|4
1169980|NCT01175135|3841759|P4|Overall Study|Randomized But Not Treated|0
1169981|NCT01175135|3841760|P3|Overall Study|Randomized But Not Treated|1
1169982|NCT01175135|3841761|P2|Overall Study|Randomized But Not Treated|0
1169983|NCT01175135|3841762|P1|Overall Study|Randomized But Not Treated|0
1169984|NCT01175135|3841759|P4|Overall Study|Other|0
1169985|NCT01175135|3841760|P3|Overall Study|Other|3
1169986|NCT01175135|3841761|P2|Overall Study|Other|1
1169987|NCT01175135|3841762|P1|Overall Study|Other|3
1169988|NCT01175135|3841759|P4|Overall Study|Withdrawal by Subject|5
1169989|NCT01175135|3841760|P3|Overall Study|Withdrawal by Subject|5
1169990|NCT01175135|3841761|P2|Overall Study|Withdrawal by Subject|8
1169991|NCT01175135|3841762|P1|Overall Study|Withdrawal by Subject|4
1169992|NCT01175135|3841759|P4|Overall Study|Protocol Violation|0
1169993|NCT01175135|3841760|P3|Overall Study|Protocol Violation|0
1169994|NCT01175135|3841761|P2|Overall Study|Protocol Violation|1
1169995|NCT01175135|3841762|P1|Overall Study|Protocol Violation|1
1169996|NCT01175135|3841759|P4|Overall Study|Lost to Follow-up|0
1169997|NCT01175135|3841760|P3|Overall Study|Lost to Follow-up|0
1169998|NCT01175135|3841761|P2|Overall Study|Lost to Follow-up|2
1169999|NCT01175135|3841762|P1|Overall Study|Lost to Follow-up|1
1170000|NCT01175135|3841759|P4|Overall Study|Lack of Efficacy|5
1170001|NCT01175135|3841760|P3|Overall Study|Lack of Efficacy|0
1170002|NCT01175135|3841761|P2|Overall Study|Lack of Efficacy|5
1170003|NCT01175135|3841762|P1|Overall Study|Lack of Efficacy|4
1170004|NCT01175135|3841759|P4|Overall Study|Death|0
1170005|NCT01175135|3841760|P3|Overall Study|Death|0
1170006|NCT01175135|3841761|P2|Overall Study|Death|0
1170007|NCT01175135|3841762|P1|Overall Study|Death|1
1170008|NCT01175135|3841759|P4|Overall Study|Adverse Event|4
1170009|NCT01175135|3841760|P3|Overall Study|Adverse Event|3
1170010|NCT01175135|3841761|P2|Overall Study|Adverse Event|5
1170011|NCT01175135|3841762|P1|Overall Study|Adverse Event|2
1170012|NCT01175018|3841854|P2|Overall Study|Adverse Event|1
1170013|NCT01175018|3841855|P1|Overall Study|Adverse Event|3
1170014|NCT01174563|3841942|P1|Overall Study|Sponsor's decision|1
1170015|NCT01174563|3841942|P1|Overall Study|Rash Adverse Event|1
1170016|NCT01174563|3841942|P1|Overall Study|Participant Withdrew Consent|3
1170017|NCT01174563|3841942|P1|Overall Study|Investigator's Discretion|5
1170018|NCT01174563|3841942|P1|Overall Study|Death|5
1170019|NCT01174563|3841942|P1|Overall Study|Progressive Disease|45
1170020|NCT01174550|3841950|P2|Overall Study|Withdrawal by Subject|289
1170021|NCT01174550|3841951|P1|Overall Study|Withdrawal by Subject|543
1170022|NCT01174550|3841950|P2|Overall Study|Lost to Follow-up|510
1170023|NCT01174550|3841951|P1|Overall Study|Lost to Follow-up|652
1170024|NCT01174550|3841950|P2|Overall Study|Death|74
1170025|NCT01174550|3841951|P1|Overall Study|Death|75
1170026|NCT01174459|3841979|P1|Overall Study|case report form (CRF) not collected|5
1170027|NCT01174446|3841984|P4|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
1170028|NCT01174446|3841985|P3|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
1170029|NCT01174446|3841986|P2|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1
1170030|NCT01174446|3841987|P1|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
1170031|NCT01174446|3841984|P4|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
1170032|NCT01174446|3841985|P3|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
1170033|NCT01174446|3841986|P2|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
1170034|NCT01174446|3841987|P1|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1
1170035|NCT01174446|3841984|P4|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
1170036|NCT01174446|3841985|P3|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1
1170037|NCT01174446|3841986|P2|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
1170038|NCT01174446|3841987|P1|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
1170039|NCT01174446|3841984|P4|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
1170040|NCT01174446|3841985|P3|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1
1170041|NCT01174446|3841986|P2|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
1170042|NCT01174446|3841987|P1|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
1170043|NCT01174368|3842174|P1|Overall Study|Withdrawal by Subject|1
1170044|NCT01174342|3842180|P1|Overall Study|Conversion to cesarean section|4
1170045|NCT01174264|3842187|P3|Steady-state Pharmacokinetics|Not evaluable|2
1170046|NCT01174264|3842188|P2|Steady-state Pharmacokinetics|Not evaluable|0
1170047|NCT01174264|3842189|P1|Steady-state Pharmacokinetics|Not evaluable|6
1170048|NCT01174264|3842187|P3|Single Dose Pharmacokinetics|Patient entered hospice care|1
1170049|NCT01174264|3842188|P2|Single Dose Pharmacokinetics|Patient entered hospice care|0
1170050|NCT01174264|3842189|P1|Single Dose Pharmacokinetics|Patient entered hospice care|0
1170051|NCT01174264|3842187|P3|Single Dose Pharmacokinetics|Early progressive disease|1
1170052|NCT01174264|3842188|P2|Single Dose Pharmacokinetics|Early progressive disease|0
1170053|NCT01174264|3842189|P1|Single Dose Pharmacokinetics|Early progressive disease|1
1170054|NCT01174238|3842221|P1|Overall Study|Lost to Follow-up|2
1170055|NCT01174186|3842232|P2|Overall Study|Withdrawal by Subject|2
1170056|NCT01174186|3842233|P1|Overall Study|Withdrawal by Subject|0
1170057|NCT01174186|3842232|P2|Overall Study|Lost to Follow-up|1
1170058|NCT01174186|3842233|P1|Overall Study|Lost to Follow-up|0
1170059|NCT01174173|3842240|P1|Overall Study|drug-drug interaction|1
1170060|NCT01174160|3842251|P2|Overall Study|Withdrawal by Subject|0
1170061|NCT01174160|3842252|P1|Overall Study|Withdrawal by Subject|1
1170062|NCT01174160|3842251|P2|Overall Study|Protocol Violation|6
1170063|NCT01174160|3842252|P1|Overall Study|Protocol Violation|4
1170064|NCT01174160|3842251|P2|Overall Study|Physician Decision|0
1170065|NCT01174160|3842252|P1|Overall Study|Physician Decision|1
1170066|NCT01174160|3842251|P2|Overall Study|Lost to Follow-up|0
1170067|NCT01174160|3842252|P1|Overall Study|Lost to Follow-up|1
1170068|NCT01174160|3842251|P2|Overall Study|Adverse Event|0
1170069|NCT01174160|3842252|P1|Overall Study|Adverse Event|1
1170070|NCT01174043|3842267|P1|Overall Study|Withdrawal by Subject|2
1170071|NCT01174043|3842267|P1|Overall Study|Death|1
1170072|NCT01174043|3842267|P1|Overall Study|Adverse Event|3
1170073|NCT01174043|3842267|P1|Overall Study|Disease progression|5
1170074|NCT01174004|3842306|P2|Overall Study|Physician Decision|0
1170075|NCT01174004|3842307|P1|Overall Study|Physician Decision|1
1170076|NCT01174004|3842306|P2|Overall Study|Protocol Violation|1
1170077|NCT01174004|3842307|P1|Overall Study|Protocol Violation|0
1170078|NCT01174004|3842306|P2|Overall Study|At Discretion of Sponsor|2
1170079|NCT01174004|3842307|P1|Overall Study|At Discretion of Sponsor|2
1170080|NCT01174004|3842306|P2|Overall Study|Withdrawal by Subject|3
1170081|NCT01174004|3842307|P1|Overall Study|Withdrawal by Subject|2
1170082|NCT01174004|3842306|P2|Overall Study|Adverse Event|10
1170083|NCT01174004|3842307|P1|Overall Study|Adverse Event|2
1170084|NCT01173718|3842338|P1|Overall Study|Abandonment of study graft|27
1170085|NCT01173718|3842338|P1|Overall Study|Death|17
1170086|NCT01173679|3842347|P1|Overall Study|Death|1
1170087|NCT01173653|3842355|P2|Overall Study|Pts unwilling to provide follow-up|41
1170088|NCT01173653|3842356|P1|Overall Study|Pts unwilling to provide follow-up|53
1170089|NCT01173601|3842366|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6
1170090|NCT01173601|3842367|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
1170091|NCT01173601|3842368|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
1170092|NCT01173601|3842369|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
1170093|NCT01173601|3842370|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
1170094|NCT01173601|3842366|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
1170095|NCT01173601|3842367|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5
1170096|NCT01173601|3842368|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7
1170097|NCT01173601|3842369|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
1170098|NCT01173601|3842370|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
1170099|NCT01173601|3842366|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
1170100|NCT01173601|3842367|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4
1170101|NCT01173601|3842368|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
1170102|NCT01173601|3842369|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1
1170103|NCT01173601|3842370|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
1170104|NCT01173601|3842366|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
1170105|NCT01173601|3842367|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
1170106|NCT01173601|3842368|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
1170107|NCT01173601|3842369|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
1170108|NCT01173601|3842370|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
1170109|NCT01173601|3842366|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
1170110|NCT01173601|3842367|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
1170111|NCT01173601|3842368|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
1170112|NCT01173601|3842369|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
1170113|NCT01173601|3842370|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
1170114|NCT01173601|3842366|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9
1170115|NCT01173601|3842367|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
1170116|NCT01173601|3842368|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6
1170117|NCT01173601|3842369|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10
1170118|NCT01173601|3842370|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
1170119|NCT01173601|3842366|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14
1170120|NCT01173601|3842367|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7
1170121|NCT01173601|3842368|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15
1170122|NCT01173601|3842369|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10
1170123|NCT01173601|3842370|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
1170124|NCT01173601|3842366|P5|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
1170125|NCT01173601|3842367|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
1170126|NCT01173601|3842368|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
1170127|NCT01173601|3842369|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
1170128|NCT01173601|3842370|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6
1170129|NCT01173601|3842366|P5|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
1170130|NCT01173601|3842367|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
1170131|NCT01173601|3842368|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
1170132|NCT01173601|3842369|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
1170133|NCT01173601|3842370|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25
1170134|NCT01173601|3842366|P5|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
1170135|NCT01173601|3842367|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
1170136|NCT01173601|3842368|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
1170137|NCT01173601|3842369|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
1170138|NCT01173601|3842370|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15
1170139|NCT01173601|3842366|P5|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
1170140|NCT01173601|3842367|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
1170141|NCT01173601|3842368|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
1170142|NCT01173601|3842369|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
1170143|NCT01173601|3842370|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3
1170144|NCT01173601|3842366|P5|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
1170145|NCT01173601|3842367|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
1170146|NCT01173601|3842368|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
1170147|NCT01173601|3842369|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
1170148|NCT01173601|3842370|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7
1170149|NCT01173601|3842366|P5|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
1170150|NCT01173601|3842367|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
1170151|NCT01173601|3842368|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
1170152|NCT01173601|3842369|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
1170153|NCT01173601|3842370|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9
1170154|NCT01173601|3842366|P5|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
1170155|NCT01173601|3842367|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
1170156|NCT01173601|3842368|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
1170157|NCT01173601|3842369|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
1170158|NCT01173601|3842370|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23
1170159|NCT01173523|3842447|P2|Overall Study|Other|3
1170160|NCT01173523|3842448|P1|Overall Study|Other|2
1170161|NCT01173523|3842447|P2|Overall Study|Progressive Disease|8
1170162|NCT01173523|3842448|P1|Overall Study|Progressive Disease|10
1170163|NCT01173523|3842447|P2|Overall Study|Clinical Progression|1
1170164|NCT01173523|3842448|P1|Overall Study|Clinical Progression|1
1170165|NCT01173471|3842464|P4|Overall Study|Reason given as Other|0
1170166|NCT01173471|3842465|P3|Overall Study|Reason given as Other|1
1170167|NCT01173471|3842466|P2|Overall Study|Reason given as Other|0
1170168|NCT01173471|3842467|P1|Overall Study|Reason given as Other|0
1170169|NCT01173471|3842464|P4|Overall Study|Lost to Follow-up|0
1170170|NCT01173471|3842465|P3|Overall Study|Lost to Follow-up|1
1170171|NCT01173471|3842466|P2|Overall Study|Lost to Follow-up|0
1170172|NCT01173471|3842467|P1|Overall Study|Lost to Follow-up|0
1170173|NCT01173471|3842464|P4|Overall Study|Condition under investigation worsened|0
1170174|NCT01173471|3842465|P3|Overall Study|Condition under investigation worsened|0
1170175|NCT01173471|3842466|P2|Overall Study|Condition under investigation worsened|0
1170176|NCT01173471|3842467|P1|Overall Study|Condition under investigation worsened|2
1170177|NCT01173471|3842464|P4|Overall Study|Eligibility criteria not fulfilled|1
1170178|NCT01173471|3842465|P3|Overall Study|Eligibility criteria not fulfilled|1
1170179|NCT01173471|3842466|P2|Overall Study|Eligibility criteria not fulfilled|0
1170180|NCT01173471|3842467|P1|Overall Study|Eligibility criteria not fulfilled|0
1170181|NCT01173120|3842597|P1|Overall Study|Switch-Difficulty With Device|12
1170182|NCT01173120|3842597|P1|Overall Study|Switch-Participant Decision|12
1170183|NCT01173120|3842597|P1|Overall Study|Switch-Administrative Reason By Sponsor|33
1170184|NCT01173120|3842597|P1|Overall Study|Participant Decision|2
1170185|NCT01173120|3842597|P1|Overall Study|Lost to Follow-up|1
1170186|NCT01173120|3842597|P1|Overall Study|Lack of Efficacy|2
1170187|NCT01173055|3842615|P2|Period 2 - Day 64 to 112|Adverse Event|1
1170188|NCT01173055|3842616|P1|Period 2 - Day 64 to 112|Adverse Event|0
1170189|NCT01173055|3842615|P2|Period 1 - Day 1 to 49|Withdrawal by Subject|2
1170190|NCT01173055|3842616|P1|Period 1 - Day 1 to 49|Withdrawal by Subject|2
1170191|NCT01172938|3842655|P9|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1
1170192|NCT01172938|3842656|P8|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
1170193|NCT01172938|3842657|P7|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
1170194|NCT01172938|3842658|P6|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
1170195|NCT01172938|3842659|P5|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
1170196|NCT01172938|3842660|P4|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
1170197|NCT01172938|3842661|P3|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
1170198|NCT01172938|3842662|P2|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
1170199|NCT01172938|3842663|P1|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
1170200|NCT01172938|3842655|P9|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
1170201|NCT01172938|3842656|P8|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
1170202|NCT01172938|3842657|P7|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
1170203|NCT01172938|3842658|P6|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
1170204|NCT01172938|3842659|P5|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
1170205|NCT01172938|3842660|P4|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
1170206|NCT01172938|3842661|P3|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1
1170207|NCT01172938|3842662|P2|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
1170208|NCT01172938|3842663|P1|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
1170209|NCT01172938|3842655|P9|Active-Treatment Phase (Weeks 208-260)|Death|0
1170210|NCT01172938|3842656|P8|Active-Treatment Phase (Weeks 208-260)|Death|0
1170211|NCT01172938|3842657|P7|Active-Treatment Phase (Weeks 208-260)|Death|0
1170212|NCT01172938|3842658|P6|Active-Treatment Phase (Weeks 208-260)|Death|0
1170213|NCT01172938|3842659|P5|Active-Treatment Phase (Weeks 208-260)|Death|0
1170214|NCT01172938|3842660|P4|Active-Treatment Phase (Weeks 208-260)|Death|0
1170215|NCT01172938|3842661|P3|Active-Treatment Phase (Weeks 208-260)|Death|1
1170216|NCT01172938|3842662|P2|Active-Treatment Phase (Weeks 208-260)|Death|0
1170217|NCT01172938|3842663|P1|Active-Treatment Phase (Weeks 208-260)|Death|0
1170218|NCT01172938|3842655|P9|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
1170219|NCT01172938|3842656|P8|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1
1170220|NCT01172938|3842657|P7|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
1170221|NCT01172938|3842658|P6|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
1170222|NCT01172938|3842659|P5|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
1170223|NCT01172938|3842660|P4|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
1170224|NCT01172938|3842661|P3|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3
1170225|NCT01172938|3842662|P2|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2
1170226|NCT01172938|3842663|P1|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
1170227|NCT01172938|3842655|P9|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
1170228|NCT01172938|3842656|P8|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
1170229|NCT01172938|3842657|P7|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
1170230|NCT01172938|3842658|P6|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
1170231|NCT01172938|3842659|P5|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
1170232|NCT01172938|3842660|P4|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
1170233|NCT01172938|3842661|P3|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
1170234|NCT01172938|3842662|P2|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
1170235|NCT01172938|3842663|P1|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
1170236|NCT01172938|3842655|P9|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
1170237|NCT01172938|3842656|P8|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
1170238|NCT01172938|3842657|P7|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
1170239|NCT01172938|3842658|P6|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
1170240|NCT01172938|3842659|P5|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
1170241|NCT01172938|3842660|P4|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
1170242|NCT01172938|3842661|P3|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2
1170243|NCT01172938|3842662|P2|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
1170244|NCT01172938|3842663|P1|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
1170245|NCT01172938|3842655|P9|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
1170246|NCT01172938|3842656|P8|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
1170247|NCT01172938|3842657|P7|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
1170248|NCT01172938|3842658|P6|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
1170249|NCT01172938|3842659|P5|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
1170250|NCT01172938|3842660|P4|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
1170251|NCT01172938|3842661|P3|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
1170252|NCT01172938|3842662|P2|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
1170253|NCT01172938|3842663|P1|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
1170254|NCT01172938|3842655|P9|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
1170255|NCT01172938|3842656|P8|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1
1170256|NCT01172938|3842657|P7|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
1170257|NCT01172938|3842658|P6|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
1170258|NCT01172938|3842659|P5|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
1170259|NCT01172938|3842660|P4|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
1170260|NCT01172938|3842661|P3|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
1170261|NCT01172938|3842662|P2|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
1170262|NCT01172938|3842663|P1|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
1170263|NCT01172938|3842655|P9|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
1170264|NCT01172938|3842656|P8|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
1170265|NCT01172938|3842657|P7|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
1170266|NCT01172938|3842658|P6|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
1170267|NCT01172938|3842659|P5|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
1170268|NCT01172938|3842660|P4|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
1170269|NCT01172938|3842661|P3|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
1170270|NCT01172938|3842662|P2|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
1170271|NCT01172938|3842663|P1|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
1170272|NCT01172938|3842655|P9|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
1170273|NCT01172938|3842656|P8|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
1170274|NCT01172938|3842657|P7|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
1170275|NCT01172938|3842658|P6|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
1170276|NCT01172938|3842659|P5|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
1170277|NCT01172938|3842660|P4|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
1170278|NCT01172938|3842661|P3|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
1170279|NCT01172938|3842662|P2|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
1170280|NCT01172938|3842663|P1|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
1170281|NCT01172938|3842655|P9|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2
1170282|NCT01172938|3842656|P8|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3
1170283|NCT01172938|3842657|P7|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
1170284|NCT01172938|3842658|P6|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
1170285|NCT01172938|3842659|P5|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
1170286|NCT01172938|3842660|P4|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
1170287|NCT01172938|3842661|P3|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
1170288|NCT01172938|3842662|P2|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
1170289|NCT01172938|3842663|P1|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
1170290|NCT01172938|3842655|P9|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
1170291|NCT01172938|3842656|P8|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3
1170292|NCT01172938|3842657|P7|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
1170293|NCT01172938|3842658|P6|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
1170294|NCT01172938|3842659|P5|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
1170295|NCT01172938|3842660|P4|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
1170296|NCT01172938|3842661|P3|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1
1170297|NCT01172938|3842662|P2|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4
1170298|NCT01172938|3842663|P1|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
1170299|NCT01172938|3842655|P9|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
1170300|NCT01172938|3842656|P8|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
1170301|NCT01172938|3842657|P7|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
1170302|NCT01172938|3842658|P6|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
1170303|NCT01172938|3842659|P5|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
1170304|NCT01172938|3842660|P4|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
1170305|NCT01172938|3842661|P3|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2
1170306|NCT01172938|3842662|P2|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
1170307|NCT01172938|3842663|P1|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
1170308|NCT01172938|3842655|P9|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
1170309|NCT01172938|3842656|P8|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
1170310|NCT01172938|3842657|P7|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
1170311|NCT01172938|3842658|P6|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
1170312|NCT01172938|3842659|P5|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
1170313|NCT01172938|3842660|P4|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
1170314|NCT01172938|3842661|P3|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
1170315|NCT01172938|3842662|P2|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1
1170316|NCT01172938|3842663|P1|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
1170317|NCT01172938|3842655|P9|Active-Treatment Phase Weeks (104-156)|Death|0
1170318|NCT01172938|3842656|P8|Active-Treatment Phase Weeks (104-156)|Death|1
1170319|NCT01172938|3842657|P7|Active-Treatment Phase Weeks (104-156)|Death|0
1170320|NCT01172938|3842658|P6|Active-Treatment Phase Weeks (104-156)|Death|0
1170321|NCT01172938|3842659|P5|Active-Treatment Phase Weeks (104-156)|Death|0
1170322|NCT01172938|3842660|P4|Active-Treatment Phase Weeks (104-156)|Death|0
1170323|NCT01172938|3842661|P3|Active-Treatment Phase Weeks (104-156)|Death|0
1170324|NCT01172938|3842662|P2|Active-Treatment Phase Weeks (104-156)|Death|0
1170325|NCT01172938|3842663|P1|Active-Treatment Phase Weeks (104-156)|Death|0
1170326|NCT01172938|3842655|P9|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1
1170327|NCT01172938|3842656|P8|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2
1170328|NCT01172938|3842657|P7|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
1170329|NCT01172938|3842658|P6|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
1170330|NCT01172938|3842659|P5|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
1170331|NCT01172938|3842660|P4|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
1170332|NCT01172938|3842661|P3|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3
1170333|NCT01172938|3842662|P2|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6
1170334|NCT01172938|3842663|P1|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
1170335|NCT01172938|3842655|P9|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
1170336|NCT01172938|3842656|P8|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
1170337|NCT01172938|3842657|P7|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
1170338|NCT01172938|3842658|P6|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
1170339|NCT01172938|3842659|P5|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
1170340|NCT01172938|3842660|P4|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
1170341|NCT01172938|3842661|P3|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
1170342|NCT01172938|3842662|P2|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4
1170343|NCT01172938|3842663|P1|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
1170344|NCT01172938|3842655|P9|Active-Treatment Phase Weeks (104-156)|Adverse Event|1
1170345|NCT01172938|3842656|P8|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
1170346|NCT01172938|3842657|P7|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
1170347|NCT01172938|3842658|P6|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
1170348|NCT01172938|3842659|P5|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
1170349|NCT01172938|3842660|P4|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
1170350|NCT01172938|3842661|P3|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
1170351|NCT01172938|3842662|P2|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
1170352|NCT01172938|3842663|P1|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
1170353|NCT01172938|3842655|P9|Active-Treatment Phase (Weeks 52-104)|Missing|0
1170354|NCT01172938|3842656|P8|Active-Treatment Phase (Weeks 52-104)|Missing|0
1170355|NCT01172938|3842657|P7|Active-Treatment Phase (Weeks 52-104)|Missing|0
1170356|NCT01172938|3842658|P6|Active-Treatment Phase (Weeks 52-104)|Missing|0
1170357|NCT01172938|3842659|P5|Active-Treatment Phase (Weeks 52-104)|Missing|0
1170358|NCT01172938|3842660|P4|Active-Treatment Phase (Weeks 52-104)|Missing|0
1170359|NCT01172938|3842661|P3|Active-Treatment Phase (Weeks 52-104)|Missing|0
1170360|NCT01172938|3842662|P2|Active-Treatment Phase (Weeks 52-104)|Missing|1
1170361|NCT01172938|3842663|P1|Active-Treatment Phase (Weeks 52-104)|Missing|0
1170362|NCT01172938|3842655|P9|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1
1170363|NCT01172938|3842656|P8|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
1170364|NCT01172938|3842657|P7|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
1170365|NCT01172938|3842658|P6|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
1170366|NCT01172938|3842659|P5|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
1170367|NCT01172938|3842660|P4|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
1170368|NCT01172938|3842661|P3|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
1170369|NCT01172938|3842662|P2|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2
1170370|NCT01172938|3842663|P1|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
1170371|NCT01172938|3842655|P9|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
1170372|NCT01172938|3842656|P8|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3
1170373|NCT01172938|3842657|P7|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
1170374|NCT01172938|3842658|P6|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
1170375|NCT01172938|3842659|P5|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
1170376|NCT01172938|3842660|P4|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
1170377|NCT01172938|3842661|P3|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
1170378|NCT01172938|3842662|P2|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
1170379|NCT01172938|3842663|P1|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
1170380|NCT01172938|3842655|P9|Active-Treatment Phase (Weeks 52-104)|Death|0
1170381|NCT01172938|3842656|P8|Active-Treatment Phase (Weeks 52-104)|Death|0
1170382|NCT01172938|3842657|P7|Active-Treatment Phase (Weeks 52-104)|Death|0
1170383|NCT01172938|3842658|P6|Active-Treatment Phase (Weeks 52-104)|Death|0
1170384|NCT01172938|3842659|P5|Active-Treatment Phase (Weeks 52-104)|Death|0
1170385|NCT01172938|3842660|P4|Active-Treatment Phase (Weeks 52-104)|Death|0
1170386|NCT01172938|3842661|P3|Active-Treatment Phase (Weeks 52-104)|Death|1
1170387|NCT01172938|3842662|P2|Active-Treatment Phase (Weeks 52-104)|Death|0
1170388|NCT01172938|3842663|P1|Active-Treatment Phase (Weeks 52-104)|Death|0
1170389|NCT01172938|3842655|P9|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2
1170390|NCT01172938|3842656|P8|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5
1170391|NCT01172938|3842657|P7|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
1170392|NCT01172938|3842658|P6|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
1170393|NCT01172938|3842659|P5|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
1170394|NCT01172938|3842660|P4|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
1170395|NCT01172938|3842661|P3|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8
1170396|NCT01172938|3842662|P2|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10
1170397|NCT01172938|3842663|P1|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
1170398|NCT01172938|3842655|P9|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
1170399|NCT01172938|3842656|P8|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
1170400|NCT01172938|3842657|P7|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
1170401|NCT01172938|3842658|P6|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
1170402|NCT01172938|3842659|P5|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
1170403|NCT01172938|3842660|P4|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
1170404|NCT01172938|3842661|P3|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2
1170405|NCT01172938|3842662|P2|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
1170406|NCT01172938|3842663|P1|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
1170407|NCT01172938|3842655|P9|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
1170408|NCT01172938|3842656|P8|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4
1170409|NCT01172938|3842657|P7|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
1170410|NCT01172938|3842658|P6|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
1170411|NCT01172938|3842659|P5|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
1170412|NCT01172938|3842660|P4|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
1170413|NCT01172938|3842661|P3|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8
1170414|NCT01172938|3842662|P2|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7
1170415|NCT01172938|3842663|P1|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
1170416|NCT01172938|3842655|P9|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
1170417|NCT01172938|3842656|P8|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3
1170418|NCT01172938|3842657|P7|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
1170569|NCT01172808|3842982|P4|Overall Study|Withdrawal by Subject|2
1170419|NCT01172938|3842658|P6|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
1170420|NCT01172938|3842659|P5|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
1170421|NCT01172938|3842660|P4|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
1170422|NCT01172938|3842661|P3|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
1170423|NCT01172938|3842662|P2|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2
1170424|NCT01172938|3842663|P1|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
1170425|NCT01172938|3842655|P9|Active Treatment Phase (Weeks 25-52)|Not specified|0
1170426|NCT01172938|3842656|P8|Active Treatment Phase (Weeks 25-52)|Not specified|0
1170427|NCT01172938|3842657|P7|Active Treatment Phase (Weeks 25-52)|Not specified|1
1170428|NCT01172938|3842658|P6|Active Treatment Phase (Weeks 25-52)|Not specified|1
1170429|NCT01172938|3842659|P5|Active Treatment Phase (Weeks 25-52)|Not specified|0
1170430|NCT01172938|3842660|P4|Active Treatment Phase (Weeks 25-52)|Not specified|0
1170431|NCT01172938|3842661|P3|Active Treatment Phase (Weeks 25-52)|Not specified|0
1170432|NCT01172938|3842662|P2|Active Treatment Phase (Weeks 25-52)|Not specified|0
1170433|NCT01172938|3842663|P1|Active Treatment Phase (Weeks 25-52)|Not specified|0
1170434|NCT01172938|3842655|P9|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
1170435|NCT01172938|3842656|P8|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
1170436|NCT01172938|3842657|P7|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
1170437|NCT01172938|3842658|P6|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
1170438|NCT01172938|3842659|P5|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
1170439|NCT01172938|3842660|P4|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
1170440|NCT01172938|3842661|P3|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
1170441|NCT01172938|3842662|P2|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
1170442|NCT01172938|3842663|P1|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
1170443|NCT01172938|3842655|P9|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
1170444|NCT01172938|3842656|P8|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
1170445|NCT01172938|3842657|P7|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
1170446|NCT01172938|3842658|P6|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9
1170447|NCT01172938|3842659|P5|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
1170448|NCT01172938|3842660|P4|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
1170449|NCT01172938|3842661|P3|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
1170450|NCT01172938|3842662|P2|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5
1170451|NCT01172938|3842663|P1|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
1170452|NCT01172938|3842655|P9|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
1170453|NCT01172938|3842656|P8|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
1170454|NCT01172938|3842657|P7|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
1170455|NCT01172938|3842658|P6|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
1170456|NCT01172938|3842659|P5|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
1170457|NCT01172938|3842660|P4|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
1170458|NCT01172938|3842661|P3|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1
1170459|NCT01172938|3842662|P2|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
1170460|NCT01172938|3842663|P1|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
1170461|NCT01172938|3842655|P9|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
1170462|NCT01172938|3842656|P8|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
1170463|NCT01172938|3842657|P7|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
1170464|NCT01172938|3842658|P6|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
1170465|NCT01172938|3842659|P5|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1
1170466|NCT01172938|3842660|P4|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
1170467|NCT01172938|3842661|P3|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7
1170468|NCT01172938|3842662|P2|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4
1170469|NCT01172938|3842663|P1|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
1170470|NCT01172938|3842655|P9|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
1170471|NCT01172938|3842656|P8|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
1170472|NCT01172938|3842657|P7|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
1170473|NCT01172938|3842658|P6|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
1170474|NCT01172938|3842659|P5|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
1170475|NCT01172938|3842660|P4|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
1170476|NCT01172938|3842661|P3|Active Treatment Phase (Weeks 25-52)|Adverse Event|5
1170477|NCT01172938|3842662|P2|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
1170478|NCT01172938|3842663|P1|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
1170479|NCT01172938|3842655|P9|Placebo-controlled Phase (Week 0-24)|Not specified|0
1170480|NCT01172938|3842656|P8|Placebo-controlled Phase (Week 0-24)|Not specified|0
1170481|NCT01172938|3842657|P7|Placebo-controlled Phase (Week 0-24)|Not specified|0
1170482|NCT01172938|3842658|P6|Placebo-controlled Phase (Week 0-24)|Not specified|0
1170483|NCT01172938|3842659|P5|Placebo-controlled Phase (Week 0-24)|Not specified|0
1170484|NCT01172938|3842660|P4|Placebo-controlled Phase (Week 0-24)|Not specified|0
1170485|NCT01172938|3842661|P3|Placebo-controlled Phase (Week 0-24)|Not specified|1
1170486|NCT01172938|3842662|P2|Placebo-controlled Phase (Week 0-24)|Not specified|2
1170487|NCT01172938|3842663|P1|Placebo-controlled Phase (Week 0-24)|Not specified|0
1170488|NCT01172938|3842655|P9|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1170489|NCT01172938|3842656|P8|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1170490|NCT01172938|3842657|P7|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1170491|NCT01172938|3842658|P6|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1170492|NCT01172938|3842659|P5|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1170493|NCT01172938|3842660|P4|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1170494|NCT01172938|3842661|P3|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1170495|NCT01172938|3842662|P2|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1170496|NCT01172938|3842663|P1|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1
1170497|NCT01172938|3842655|P9|Placebo-controlled Phase (Week 0-24)|Death|0
1170498|NCT01172938|3842656|P8|Placebo-controlled Phase (Week 0-24)|Death|0
1170499|NCT01172938|3842657|P7|Placebo-controlled Phase (Week 0-24)|Death|0
1170500|NCT01172938|3842658|P6|Placebo-controlled Phase (Week 0-24)|Death|0
1170501|NCT01172938|3842659|P5|Placebo-controlled Phase (Week 0-24)|Death|0
1170502|NCT01172938|3842660|P4|Placebo-controlled Phase (Week 0-24)|Death|0
1170503|NCT01172938|3842661|P3|Placebo-controlled Phase (Week 0-24)|Death|0
1170504|NCT01172938|3842662|P2|Placebo-controlled Phase (Week 0-24)|Death|1
1170505|NCT01172938|3842663|P1|Placebo-controlled Phase (Week 0-24)|Death|0
1170506|NCT01172938|3842655|P9|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
1170507|NCT01172938|3842656|P8|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
1170508|NCT01172938|3842657|P7|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
1170509|NCT01172938|3842658|P6|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
1170510|NCT01172938|3842659|P5|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
1170511|NCT01172938|3842660|P4|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
1170512|NCT01172938|3842661|P3|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3
1170513|NCT01172938|3842662|P2|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5
1170514|NCT01172938|3842663|P1|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2
1170515|NCT01172938|3842655|P9|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
1170516|NCT01172938|3842656|P8|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
1170517|NCT01172938|3842657|P7|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
1170518|NCT01172938|3842658|P6|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
1170519|NCT01172938|3842659|P5|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
1170520|NCT01172938|3842660|P4|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
1170521|NCT01172938|3842661|P3|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2
1170522|NCT01172938|3842662|P2|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
1170523|NCT01172938|3842663|P1|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
1170524|NCT01172938|3842655|P9|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
1170525|NCT01172938|3842656|P8|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
1170526|NCT01172938|3842657|P7|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
1170527|NCT01172938|3842658|P6|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
1170528|NCT01172938|3842659|P5|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
1170529|NCT01172938|3842660|P4|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
1170530|NCT01172938|3842661|P3|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
1170531|NCT01172938|3842662|P2|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5
1170532|NCT01172938|3842663|P1|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
1170533|NCT01172938|3842655|P9|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
1170534|NCT01172938|3842656|P8|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
1170535|NCT01172938|3842657|P7|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
1170536|NCT01172938|3842658|P6|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
1170537|NCT01172938|3842659|P5|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
1170538|NCT01172938|3842660|P4|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
1170539|NCT01172938|3842661|P3|Placebo-controlled Phase (Week 0-24)|Adverse Event|10
1170540|NCT01172938|3842662|P2|Placebo-controlled Phase (Week 0-24)|Adverse Event|8
1170541|NCT01172938|3842663|P1|Placebo-controlled Phase (Week 0-24)|Adverse Event|11
1170542|NCT01172873|3842849|P2|Overall Study|Withdrawal by Subject|2
1170543|NCT01172873|3842850|P1|Overall Study|Withdrawal by Subject|3
1170544|NCT01172847|3842860|P1|Overall Study|Withdrawal by Subject|3
1170545|NCT01172821|3842889|P4|Overall Study|Other|3
1170546|NCT01172821|3842890|P3|Overall Study|Other|5
1170547|NCT01172821|3842891|P2|Overall Study|Other|4
1170548|NCT01172821|3842892|P1|Overall Study|Other|3
1170549|NCT01172821|3842889|P4|Overall Study|Withdrawal by Subject|3
1170550|NCT01172821|3842890|P3|Overall Study|Withdrawal by Subject|3
1170551|NCT01172821|3842891|P2|Overall Study|Withdrawal by Subject|3
1170552|NCT01172821|3842892|P1|Overall Study|Withdrawal by Subject|2
1170553|NCT01172821|3842889|P4|Overall Study|Lost to Follow-up|2
1170554|NCT01172821|3842890|P3|Overall Study|Lost to Follow-up|2
1170555|NCT01172821|3842891|P2|Overall Study|Lost to Follow-up|1
1170556|NCT01172821|3842892|P1|Overall Study|Lost to Follow-up|4
1170557|NCT01172821|3842889|P4|Overall Study|Protocol Violation|2
1170558|NCT01172821|3842890|P3|Overall Study|Protocol Violation|1
1170559|NCT01172821|3842891|P2|Overall Study|Protocol Violation|2
1170560|NCT01172821|3842892|P1|Overall Study|Protocol Violation|0
1170561|NCT01172821|3842889|P4|Overall Study|Adverse Event|7
1170562|NCT01172821|3842890|P3|Overall Study|Adverse Event|2
1170563|NCT01172821|3842891|P2|Overall Study|Adverse Event|2
1170564|NCT01172821|3842892|P1|Overall Study|Adverse Event|5
1170565|NCT01172808|3842982|P4|Overall Study|Other|7
1170566|NCT01172808|3842983|P3|Overall Study|Other|9
1170567|NCT01172808|3842984|P2|Overall Study|Other|5
1170568|NCT01172808|3842985|P1|Overall Study|Other|6
1170570|NCT01172808|3842983|P3|Overall Study|Withdrawal by Subject|3
1170571|NCT01172808|3842984|P2|Overall Study|Withdrawal by Subject|1
1170572|NCT01172808|3842985|P1|Overall Study|Withdrawal by Subject|4
1170573|NCT01172808|3842982|P4|Overall Study|Lost to Follow-up|3
1170574|NCT01172808|3842983|P3|Overall Study|Lost to Follow-up|1
1170575|NCT01172808|3842984|P2|Overall Study|Lost to Follow-up|1
1170576|NCT01172808|3842985|P1|Overall Study|Lost to Follow-up|0
1170577|NCT01172808|3842982|P4|Overall Study|Protocol Violation|0
1170578|NCT01172808|3842983|P3|Overall Study|Protocol Violation|2
1170579|NCT01172808|3842984|P2|Overall Study|Protocol Violation|2
1170580|NCT01172808|3842985|P1|Overall Study|Protocol Violation|2
1170581|NCT01172808|3842982|P4|Overall Study|Lack of Efficacy|0
1170582|NCT01172808|3842983|P3|Overall Study|Lack of Efficacy|0
1170583|NCT01172808|3842984|P2|Overall Study|Lack of Efficacy|0
1170584|NCT01172808|3842985|P1|Overall Study|Lack of Efficacy|1
1170585|NCT01172808|3842982|P4|Overall Study|Adverse Event|3
1170586|NCT01172808|3842983|P3|Overall Study|Adverse Event|8
1170587|NCT01172808|3842984|P2|Overall Study|Adverse Event|4
1170588|NCT01172808|3842985|P1|Overall Study|Adverse Event|8
1170589|NCT01172639|3843076|P5|Overall Study|Withdrawal by Subject|0
1170590|NCT01172639|3843077|P4|Overall Study|Withdrawal by Subject|5
1170591|NCT01172639|3843078|P3|Overall Study|Withdrawal by Subject|5
1170592|NCT01172639|3843079|P2|Overall Study|Withdrawal by Subject|3
1170593|NCT01172639|3843080|P1|Overall Study|Withdrawal by Subject|3
1170594|NCT01172639|3843076|P5|Overall Study|Lost to Follow-up|6
1170595|NCT01172639|3843077|P4|Overall Study|Lost to Follow-up|6
1170596|NCT01172639|3843078|P3|Overall Study|Lost to Follow-up|11
1170597|NCT01172639|3843079|P2|Overall Study|Lost to Follow-up|7
1170598|NCT01172639|3843080|P1|Overall Study|Lost to Follow-up|9
1170599|NCT01172639|3843076|P5|Overall Study|Death|0
1170600|NCT01172639|3843077|P4|Overall Study|Death|0
1170601|NCT01172639|3843078|P3|Overall Study|Death|0
1170602|NCT01172639|3843079|P2|Overall Study|Death|1
1170603|NCT01172639|3843080|P1|Overall Study|Death|1
1170604|NCT01172535|3843155|P1|Overall Study|Unwilling to adhere to study requirement|1
1170605|NCT01172535|3843155|P1|Overall Study|Ineligible at study entry|1
1170606|NCT01172535|3843155|P1|Overall Study|Lost to Follow-up|1
1170607|NCT01172535|3843155|P1|Overall Study|Withdrawal by Subject|2
1170608|NCT01172535|3843155|P1|Overall Study|Death|3
1170609|NCT01172288|3843208|P2|Overall Study|Protocol Violation|1
1170610|NCT01172288|3843209|P1|Overall Study|Protocol Violation|0
1170611|NCT01172288|3843208|P2|Overall Study|Adverse Event|0
1170612|NCT01172288|3843209|P1|Overall Study|Adverse Event|1
1170613|NCT01171989|3843264|P3|Overall Study|Lost to Follow-up|1
1170614|NCT01171989|3843265|P2|Overall Study|Lost to Follow-up|0
1170615|NCT01171989|3843266|P1|Overall Study|Lost to Follow-up|0
1170616|NCT01171976|3843340|P3|Overall Study|Adverse Event|5
1170617|NCT01171976|3843341|P2|Overall Study|Adverse Event|2
1170618|NCT01171976|3843342|P1|Overall Study|Adverse Event|6
1170619|NCT01171976|3843340|P3|Overall Study|Abnormal test result|0
1170620|NCT01171976|3843341|P2|Overall Study|Abnormal test result|0
1170621|NCT01171976|3843342|P1|Overall Study|Abnormal test result|1
1170622|NCT01171976|3843340|P3|Overall Study|Withdrawal by Subject|6
1170623|NCT01171976|3843341|P2|Overall Study|Withdrawal by Subject|5
1170624|NCT01171976|3843342|P1|Overall Study|Withdrawal by Subject|1
1170625|NCT01171976|3843340|P3|Overall Study|Lost to Follow-up|2
1170626|NCT01171976|3843341|P2|Overall Study|Lost to Follow-up|0
1170627|NCT01171976|3843342|P1|Overall Study|Lost to Follow-up|4
1170628|NCT01171976|3843340|P3|Overall Study|Death|1
1170629|NCT01171976|3843341|P2|Overall Study|Death|4
1170630|NCT01171976|3843342|P1|Overall Study|Death|2
1170631|NCT01171976|3843340|P3|Overall Study|Protocol Violation|1
1170632|NCT01171976|3843341|P2|Overall Study|Protocol Violation|0
1170633|NCT01171976|3843342|P1|Overall Study|Protocol Violation|0
1170634|NCT01171963|3843379|P2|Overall Study|Withdrawal by Subject|129
1170635|NCT01171963|3843380|P1|Overall Study|Withdrawal by Subject|114
1170636|NCT01171963|3843379|P2|Overall Study|Other - diarrhoea|0
1170637|NCT01171963|3843380|P1|Overall Study|Other - diarrhoea|1
1170638|NCT01171963|3843379|P2|Overall Study|Lost to Follow-up|24
1170639|NCT01171963|3843380|P1|Overall Study|Lost to Follow-up|23
1170640|NCT01171963|3843379|P2|Overall Study|Adverse Event|15
1170641|NCT01171963|3843380|P1|Overall Study|Adverse Event|10
1170642|NCT01171898|3843449|P4|Overall Study|Other|2
1170643|NCT01171898|3843450|P3|Overall Study|Other|0
1170644|NCT01171898|3843451|P2|Overall Study|Other|5
1170645|NCT01171898|3843452|P1|Overall Study|Other|1
1170646|NCT01171898|3843449|P4|Overall Study|Ongoing|0
1170647|NCT01171898|3843450|P3|Overall Study|Ongoing|3
1170648|NCT01171898|3843451|P2|Overall Study|Ongoing|9
1170649|NCT01171898|3843452|P1|Overall Study|Ongoing|1
1170650|NCT01171898|3843449|P4|Overall Study|Terminated by Sponsor|0
1170651|NCT01171898|3843450|P3|Overall Study|Terminated by Sponsor|0
1170652|NCT01171898|3843451|P2|Overall Study|Terminated by Sponsor|0
1170653|NCT01171898|3843452|P1|Overall Study|Terminated by Sponsor|1
1170654|NCT01171898|3843449|P4|Overall Study|Withdrawal by Subject|3
1170655|NCT01171898|3843450|P3|Overall Study|Withdrawal by Subject|6
1170656|NCT01171898|3843451|P2|Overall Study|Withdrawal by Subject|4
1170657|NCT01171898|3843452|P1|Overall Study|Withdrawal by Subject|1
1170658|NCT01171898|3843449|P4|Overall Study|Lost to Follow-up|1
1170659|NCT01171898|3843450|P3|Overall Study|Lost to Follow-up|1
1170660|NCT01171898|3843451|P2|Overall Study|Lost to Follow-up|1
1170661|NCT01171898|3843452|P1|Overall Study|Lost to Follow-up|0
1170662|NCT01171898|3843449|P4|Overall Study|Death|0
1170663|NCT01171898|3843450|P3|Overall Study|Death|2
1170664|NCT01171898|3843451|P2|Overall Study|Death|0
1170665|NCT01171898|3843452|P1|Overall Study|Death|0
1170666|NCT01171820|3843476|P2|Overall Study|1-Year Missed Visit|1
1170667|NCT01171820|3843477|P1|Overall Study|1-Year Missed Visit|1
1170668|NCT01171820|3843476|P2|Overall Study|Physician Decision|1
1170669|NCT01171820|3843477|P1|Overall Study|Physician Decision|0
1170670|NCT01171820|3843476|P2|Overall Study|Withdrawal by Subject|0
1170671|NCT01171820|3843477|P1|Overall Study|Withdrawal by Subject|2
1170672|NCT01171820|3843476|P2|Overall Study|Lost to Follow-up|1
1170673|NCT01171820|3843477|P1|Overall Study|Lost to Follow-up|0
1170674|NCT01171820|3843476|P2|Overall Study|Death|3
1170675|NCT01171820|3843477|P1|Overall Study|Death|3
1170676|NCT01171677|3843555|P2|Overall Study|completed <70% IntenSati classes|0
1170677|NCT01171677|3843556|P1|Overall Study|completed <70% IntenSati classes|5
1170678|NCT01171677|3843555|P2|Overall Study|Adverse Event|0
1170679|NCT01171677|3843556|P1|Overall Study|Adverse Event|1
1170680|NCT01171677|3843555|P2|Overall Study|Withdrawal by Subject|3
1170681|NCT01171677|3843556|P1|Overall Study|Withdrawal by Subject|0
1170682|NCT01171612|3843588|P1|Overall Study|Lost to Follow-up|51
1170683|NCT01171534|3843598|P2|Overall Study|screen failure|1
1170684|NCT01171534|3843599|P1|Overall Study|screen failure|0
1170685|NCT01171534|3843598|P2|Overall Study|Lost to Follow-up|2
1170686|NCT01171534|3843599|P1|Overall Study|Lost to Follow-up|0
1170687|NCT01171521|3843611|P1|Overall Study|screen failure|1
1170688|NCT01171521|3843611|P1|Overall Study|Lost to Follow-up|5
1170689|NCT01171183|3843618|P2|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0
1170690|NCT01171183|3843619|P1|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1
1170691|NCT01171183|3843618|P2|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3
1170692|NCT01171183|3843619|P1|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7
1170693|NCT01171183|3843618|P2|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
1170694|NCT01171183|3843619|P1|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
1170695|NCT01171183|3843618|P2|Residential Facility (Weeks 1-2)|BP outside of study parameters|3
1170696|NCT01171183|3843619|P1|Residential Facility (Weeks 1-2)|BP outside of study parameters|0
1170697|NCT01171183|3843618|P2|Residential Facility (Weeks 1-2)|Protocol Violation|1
1170698|NCT01171183|3843619|P1|Residential Facility (Weeks 1-2)|Protocol Violation|0
1170699|NCT01171183|3843618|P2|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
1170700|NCT01171183|3843619|P1|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
1170701|NCT01170962|3843640|P3|Follow up Period|Others|3
1170702|NCT01170962|3843641|P2|Follow up Period|Others|7
1170703|NCT01170962|3843642|P1|Follow up Period|Others|10
1170704|NCT01170962|3843640|P3|Follow up Period|Death|0
1170705|NCT01170962|3843641|P2|Follow up Period|Death|2
1170706|NCT01170962|3843642|P1|Follow up Period|Death|2
1170707|NCT01170962|3843640|P3|Follow up Period|Lost to Follow-up|1
1170708|NCT01170962|3843641|P2|Follow up Period|Lost to Follow-up|8
1170709|NCT01170962|3843642|P1|Follow up Period|Lost to Follow-up|13
1170710|NCT01170962|3843640|P3|Follow up Period|Withdrawal by Subject|2
1170711|NCT01170962|3843641|P2|Follow up Period|Withdrawal by Subject|10
1170712|NCT01170962|3843642|P1|Follow up Period|Withdrawal by Subject|14
1170713|NCT01170962|3843640|P3|Treatment Period|Completed 24 Week treatment period only|0
1170714|NCT01170962|3843641|P2|Treatment Period|Completed 24 Week treatment period only|2
1170715|NCT01170962|3843642|P1|Treatment Period|Completed 24 Week treatment period only|10
1170716|NCT01170962|3843640|P3|Treatment Period|Request to discontinue treatment|1
1170717|NCT01170962|3843641|P2|Treatment Period|Request to discontinue treatment|3
1170718|NCT01170962|3843642|P1|Treatment Period|Request to discontinue treatment|7
1170719|NCT01170962|3843640|P3|Treatment Period|Participant no longer meets criteria|0
1170720|NCT01170962|3843641|P2|Treatment Period|Participant no longer meets criteria|1
1170721|NCT01170962|3843642|P1|Treatment Period|Participant no longer meets criteria|0
1170722|NCT01170962|3843640|P3|Treatment Period|Lost to Follow-up|1
1170723|NCT01170962|3843641|P2|Treatment Period|Lost to Follow-up|1
1170724|NCT01170962|3843642|P1|Treatment Period|Lost to Follow-up|1
1170725|NCT01170962|3843640|P3|Treatment Period|Withdrawal by Subject|0
1170726|NCT01170962|3843641|P2|Treatment Period|Withdrawal by Subject|1
1170727|NCT01170962|3843642|P1|Treatment Period|Withdrawal by Subject|2
1170728|NCT01170962|3843640|P3|Treatment Period|Adverse Event|3
1170729|NCT01170962|3843641|P2|Treatment Period|Adverse Event|12
1170730|NCT01170962|3843642|P1|Treatment Period|Adverse Event|11
1170731|NCT01170962|3843640|P3|Treatment Period|Lack of Efficacy|7
1170732|NCT01170962|3843641|P2|Treatment Period|Lack of Efficacy|91
1170733|NCT01170962|3843642|P1|Treatment Period|Lack of Efficacy|96
1170734|NCT01170663|3843737|P2|Overall Study|Withdrawal of consent without follow-up|11
1170735|NCT01170663|3843738|P1|Overall Study|Withdrawal of consent without follow-up|11
1170736|NCT01170663|3843737|P2|Overall Study|Lost to Follow-up|9
1170737|NCT01170663|3843738|P1|Overall Study|Lost to Follow-up|3
1170738|NCT01170598|3843766|P1|Overall Study|Refused|1
1170739|NCT01170598|3843766|P1|Overall Study|Lost to Follow-up|1
1170740|NCT01170598|3843766|P1|Overall Study|Death|3
1170741|NCT01170598|3843766|P1|Overall Study|Withdrawal by Subject|1
1170742|NCT01170364|3843829|P2|Overall Study|Protocol Violation|1
1170743|NCT01170364|3843830|P1|Overall Study|Protocol Violation|4
1170744|NCT01170273|3843838|P2|Overall Study|Adverse Event|1
1170745|NCT01170273|3843839|P1|Overall Study|Adverse Event|0
1170746|NCT01170273|3843838|P2|Overall Study|Death|0
1170747|NCT01170273|3843839|P1|Overall Study|Death|1
1170748|NCT01170273|3843838|P2|Overall Study|Protocol Violation|0
1170749|NCT01170273|3843839|P1|Overall Study|Protocol Violation|1
1170750|NCT01170273|3843838|P2|Overall Study|Lost to Follow-up|8
1170751|NCT01170273|3843839|P1|Overall Study|Lost to Follow-up|6
1170752|NCT01170221|3843856|P2|Overall Study|Randomized but not treated|0
1170753|NCT01170221|3843857|P1|Overall Study|Randomized but not treated|1
1170754|NCT01170221|3843856|P2|Overall Study|Subject completed only screening and LFU|0
1170755|NCT01170221|3843857|P1|Overall Study|Subject completed only screening and LFU|1
1170756|NCT01170221|3843856|P2|Overall Study|Withdrawal by Subject|7
1170757|NCT01170221|3843857|P1|Overall Study|Withdrawal by Subject|9
1170758|NCT01170221|3843856|P2|Overall Study|Lost to Follow-up|21
1170759|NCT01170221|3843857|P1|Overall Study|Lost to Follow-up|22
1170760|NCT01170208|3843880|P3|Overall Study|Protocol Violation|1
1170761|NCT01170208|3843881|P2|Overall Study|Protocol Violation|0
1170762|NCT01170208|3843882|P1|Overall Study|Protocol Violation|1
1170763|NCT01170208|3843880|P3|Overall Study|Withdrawal by Subject|1
1170764|NCT01170208|3843881|P2|Overall Study|Withdrawal by Subject|0
1170765|NCT01170208|3843882|P1|Overall Study|Withdrawal by Subject|5
1170766|NCT01170091|3843901|P1|Overall Study|Treatment duration is less than 4 weeks|21
1170767|NCT01170091|3843901|P1|Overall Study|Missing efficacy evaluation|3
1170768|NCT01170039|3843910|P2|Overall Study|Lack of funding, drug not available|3
1170769|NCT01170039|3843911|P1|Overall Study|Lack of funding, drug not available|3
1170770|NCT01170039|3843910|P2|Overall Study|Withdrawal by Subject|3
1170771|NCT01170039|3843911|P1|Overall Study|Withdrawal by Subject|5
1170772|NCT01169987|3843923|P1|Overall Study|Not Specified|4
1170773|NCT01169987|3843923|P1|Overall Study|Lost to Follow-up|24
1170774|NCT01169987|3843923|P1|Overall Study|Withdrawal by Subject|3
1170775|NCT01169779|3843989|P2|Overall Study|Familial and personal reasons|3
1170776|NCT01169779|3843990|P1|Overall Study|Familial and personal reasons|3
1170777|NCT01169779|3843989|P2|Overall Study|Withdrawal by Subject|2
1170778|NCT01169779|3843990|P1|Overall Study|Withdrawal by Subject|3
1170779|NCT01169779|3843989|P2|Overall Study|Protocol Violation|1
1170780|NCT01169779|3843990|P1|Overall Study|Protocol Violation|1
1170781|NCT01169779|3843989|P2|Overall Study|Lack of Efficacy|0
1170782|NCT01169779|3843990|P1|Overall Study|Lack of Efficacy|1
1170783|NCT01169779|3843989|P2|Overall Study|Adverse Event|11
1170784|NCT01169779|3843990|P1|Overall Study|Adverse Event|3
1170785|NCT01169701|3844025|P2|Overall Study|Sponsor decision|1
1170786|NCT01169701|3844026|P1|Overall Study|Sponsor decision|0
1170787|NCT01169701|3844025|P2|Overall Study|Serious adverse event|1
1170788|NCT01169701|3844026|P1|Overall Study|Serious adverse event|0
1170789|NCT01169701|3844025|P2|Overall Study|Administrative problems|1
1170790|NCT01169701|3844026|P1|Overall Study|Administrative problems|0
1170791|NCT01169701|3844025|P2|Overall Study|Death|1
1170792|NCT01169701|3844026|P1|Overall Study|Death|0
1170793|NCT01169701|3844025|P2|Overall Study|Exclusion criteria|0
1170794|NCT01169701|3844026|P1|Overall Study|Exclusion criteria|2
1170795|NCT01169701|3844025|P2|Overall Study|Adverse Event|2
1170796|NCT01169701|3844026|P1|Overall Study|Adverse Event|1
1170797|NCT01169701|3844025|P2|Overall Study|Withdrawal by Subject|3
1170798|NCT01169701|3844026|P1|Overall Study|Withdrawal by Subject|1
1170799|NCT01169701|3844025|P2|Overall Study|Lost to Follow-up|1
1170800|NCT01169701|3844026|P1|Overall Study|Lost to Follow-up|1
1170801|NCT01169675|3844063|P5|Overall Study|Other Reason Not Defined Above|1
1170802|NCT01169675|3844064|P4|Overall Study|Other Reason Not Defined Above|1
1170803|NCT01169675|3844065|P3|Overall Study|Other Reason Not Defined Above|0
1170804|NCT01169675|3844066|P2|Overall Study|Other Reason Not Defined Above|0
1170805|NCT01169675|3844067|P1|Overall Study|Other Reason Not Defined Above|0
1170806|NCT01169675|3844063|P5|Overall Study|Withdrawal by Subject|2
1170807|NCT01169675|3844064|P4|Overall Study|Withdrawal by Subject|1
1170808|NCT01169675|3844065|P3|Overall Study|Withdrawal by Subject|0
1170809|NCT01169675|3844066|P2|Overall Study|Withdrawal by Subject|0
1170810|NCT01169675|3844067|P1|Overall Study|Withdrawal by Subject|1
1170811|NCT01169675|3844063|P5|Overall Study|Adverse Event|0
1170812|NCT01169675|3844064|P4|Overall Study|Adverse Event|0
1170813|NCT01169675|3844065|P3|Overall Study|Adverse Event|2
1170814|NCT01169675|3844066|P2|Overall Study|Adverse Event|1
1170815|NCT01169675|3844067|P1|Overall Study|Adverse Event|5
1170816|NCT01169675|3844063|P5|Overall Study|Dose Limiting Toxicity (DLT)|2
1170817|NCT01169675|3844064|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
1170818|NCT01169675|3844065|P3|Overall Study|Dose Limiting Toxicity (DLT)|0
1170819|NCT01169675|3844066|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
1170820|NCT01169675|3844067|P1|Overall Study|Dose Limiting Toxicity (DLT)|1
1170821|NCT01169675|3844063|P5|Overall Study|Progressive disease|1
1170822|NCT01169675|3844064|P4|Overall Study|Progressive disease|15
1170823|NCT01169675|3844065|P3|Overall Study|Progressive disease|5
1170824|NCT01169675|3844066|P2|Overall Study|Progressive disease|2
1170825|NCT01169675|3844067|P1|Overall Study|Progressive disease|13
1170826|NCT01169649|3844104|P1|Overall Study|Patient Not Treated|3
1170827|NCT01169558|3844116|P1|Overall Study|Partial response|2
1170828|NCT01169558|3844116|P1|Overall Study|Protocol Violation|2
1170829|NCT01169558|3844116|P1|Overall Study|Non-compliance|2
1170830|NCT01169558|3844116|P1|Overall Study|Need for Surgery|4
1170831|NCT01169558|3844116|P1|Overall Study|Lost to Follow-up|4
1170832|NCT01169558|3844116|P1|Overall Study|Stable Disease|4
1170833|NCT01169558|3844116|P1|Overall Study|Medical Decision|7
1170834|NCT01169558|3844116|P1|Overall Study|Withdrawal of Consent|8
1170835|NCT01169558|3844116|P1|Overall Study|Adverse Event|25
1170836|NCT01169558|3844116|P1|Overall Study|Disease progression|98
1170837|NCT01169493|3844141|P6|Period 3 (6 Months)|Physician Decision|0
1170838|NCT01169493|3844142|P5|Period 3 (6 Months)|Physician Decision|0
1170839|NCT01169493|3844143|P4|Period 3 (6 Months)|Physician Decision|0
1170840|NCT01169493|3844144|P3|Period 3 (6 Months)|Physician Decision|1
1170841|NCT01169493|3844145|P2|Period 3 (6 Months)|Physician Decision|1
1170842|NCT01169493|3844146|P1|Period 3 (6 Months)|Physician Decision|0
1170843|NCT01169493|3844141|P6|Period 3 (6 Months)|Adverse Event|0
1170844|NCT01169493|3844142|P5|Period 3 (6 Months)|Adverse Event|0
1170845|NCT01169493|3844143|P4|Period 3 (6 Months)|Adverse Event|0
1170846|NCT01169493|3844144|P3|Period 3 (6 Months)|Adverse Event|0
1170847|NCT01169493|3844145|P2|Period 3 (6 Months)|Adverse Event|1
1170848|NCT01169493|3844146|P1|Period 3 (6 Months)|Adverse Event|0
1170849|NCT01169493|3844141|P6|Period 1 (6 Months)|Withdrawal by Subject|3
1170850|NCT01169493|3844142|P5|Period 1 (6 Months)|Withdrawal by Subject|0
1170851|NCT01169493|3844143|P4|Period 1 (6 Months)|Withdrawal by Subject|0
1170852|NCT01169493|3844144|P3|Period 1 (6 Months)|Withdrawal by Subject|2
1170853|NCT01169493|3844145|P2|Period 1 (6 Months)|Withdrawal by Subject|1
1170854|NCT01169493|3844146|P1|Period 1 (6 Months)|Withdrawal by Subject|0
1170855|NCT01169350|3844192|P1|Overall Study|Lost to Follow-up|2
1170856|NCT01169350|3844192|P1|Overall Study|Physician Decision|3
1170857|NCT01169103|3844213|P2|Overall Study|Withdrawal by Subject|1
1170858|NCT01169103|3844214|P1|Overall Study|Withdrawal by Subject|3
1170859|NCT01169103|3844213|P2|Overall Study|Lost to Follow-up|3
1170860|NCT01169103|3844214|P1|Overall Study|Lost to Follow-up|3
1170861|NCT01169038|3844241|P1|Overall Study|Required antibiotic administration|1
1170862|NCT01169038|3844241|P1|Overall Study|Adverse Event|5
1170863|NCT01169038|3844241|P1|Overall Study|Death|1
1170864|NCT01168999|3844249|P4|Overall Study|Lost to Follow-up|0
1170865|NCT01168999|3844250|P3|Overall Study|Lost to Follow-up|0
1170866|NCT01168999|3844251|P2|Overall Study|Lost to Follow-up|1
1170867|NCT01168999|3844252|P1|Overall Study|Lost to Follow-up|2
1170868|NCT01168973|3844318|P2|Overall Study|Protocol Criterion Not Met and Deviation|9
1170869|NCT01168973|3844319|P1|Overall Study|Protocol Criterion Not Met and Deviation|7
1170870|NCT01168973|3844318|P2|Overall Study|Sponsor Decision|1
1170871|NCT01168973|3844319|P1|Overall Study|Sponsor Decision|2
1170872|NCT01168973|3844318|P2|Overall Study|Physician Decision|19
1170873|NCT01168973|3844319|P1|Overall Study|Physician Decision|37
1170874|NCT01168973|3844318|P2|Overall Study|Death|45
1170875|NCT01168973|3844319|P1|Overall Study|Death|42
1170876|NCT01168973|3844318|P2|Overall Study|Withdrawal by Subject|53
1170877|NCT01168973|3844319|P1|Overall Study|Withdrawal by Subject|90
1170878|NCT01168973|3844318|P2|Overall Study|Adverse Event|55
1170879|NCT01168973|3844319|P1|Overall Study|Adverse Event|94
1170880|NCT01168973|3844318|P2|Overall Study|Progressive Disease|429
1170881|NCT01168973|3844319|P1|Overall Study|Progressive Disease|341
1170882|NCT01168856|3844392|P2|Overall Study|Protocol Violation|6
1170883|NCT01168856|3844393|P1|Overall Study|Protocol Violation|4
1170884|NCT01168856|3844392|P2|Overall Study|Other|291
1170885|NCT01168856|3844393|P1|Overall Study|Other|1
1170886|NCT01168856|3844392|P2|Overall Study|Death|2
1170887|NCT01168856|3844393|P1|Overall Study|Death|0
1170888|NCT01168856|3844392|P2|Overall Study|Participant received anti-HCV treatment|0
1170889|NCT01168856|3844393|P1|Overall Study|Participant received anti-HCV treatment|1
1170890|NCT01168856|3844392|P2|Overall Study|Confirmed Quantifiable HCV RNA|1
1170891|NCT01168856|3844393|P1|Overall Study|Confirmed Quantifiable HCV RNA|0
1170892|NCT01168856|3844392|P2|Overall Study|Physician Decision|1
1170893|NCT01168856|3844393|P1|Overall Study|Physician Decision|2
1170894|NCT01168856|3844392|P2|Overall Study|Withdrawal by Subject|8
1170895|NCT01168856|3844393|P1|Overall Study|Withdrawal by Subject|6
1170896|NCT01168856|3844392|P2|Overall Study|Lost to Follow-up|34
1170897|NCT01168856|3844393|P1|Overall Study|Lost to Follow-up|4
1170898|NCT01168596|3844491|P2|Overall Study|Withdrawal by Subject|1
1170899|NCT01168596|3844492|P1|Overall Study|Withdrawal by Subject|3
1170900|NCT01168427|3844536|P1|Overall Study|Patient exited prior to implant|1
1170901|NCT01168401|3844552|P11|Overall Study|Withdrawal by Subject|0
1170902|NCT01168401|3844553|P10|Overall Study|Withdrawal by Subject|0
1170903|NCT01168401|3844554|P9|Overall Study|Withdrawal by Subject|0
1170904|NCT01168401|3844555|P8|Overall Study|Withdrawal by Subject|0
1170905|NCT01168401|3844556|P7|Overall Study|Withdrawal by Subject|0
1170906|NCT01168401|3844557|P6|Overall Study|Withdrawal by Subject|0
1170907|NCT01168401|3844558|P5|Overall Study|Withdrawal by Subject|0
1170908|NCT01168401|3844559|P4|Overall Study|Withdrawal by Subject|1
1170909|NCT01168401|3844560|P3|Overall Study|Withdrawal by Subject|0
1170910|NCT01168401|3844561|P2|Overall Study|Withdrawal by Subject|0
1170911|NCT01168401|3844562|P1|Overall Study|Withdrawal by Subject|0
1170912|NCT01168401|3844552|P11|Overall Study|Lost to Follow-up|0
1170913|NCT01168401|3844553|P10|Overall Study|Lost to Follow-up|0
1170914|NCT01168401|3844554|P9|Overall Study|Lost to Follow-up|0
1170915|NCT01168401|3844555|P8|Overall Study|Lost to Follow-up|0
1170916|NCT01168401|3844556|P7|Overall Study|Lost to Follow-up|0
1170917|NCT01168401|3844557|P6|Overall Study|Lost to Follow-up|0
1170918|NCT01168401|3844558|P5|Overall Study|Lost to Follow-up|0
1170919|NCT01168401|3844559|P4|Overall Study|Lost to Follow-up|1
1170920|NCT01168401|3844560|P3|Overall Study|Lost to Follow-up|2
1170921|NCT01168401|3844561|P2|Overall Study|Lost to Follow-up|1
1170922|NCT01168401|3844562|P1|Overall Study|Lost to Follow-up|1
1170923|NCT01168349|3844795|P1|Overall Study|Protocol Violation|76
1170924|NCT01168349|3844795|P1|Overall Study|Other|22
1170925|NCT01168349|3844795|P1|Overall Study|Kidney transplantation|3
1170926|NCT01168349|3844795|P1|Overall Study|Withdrawal by Subject|9
1170927|NCT01168349|3844795|P1|Overall Study|Lost to Follow-up|34
1170928|NCT01168349|3844795|P1|Overall Study|Death|157
1170929|NCT01168232|3844901|P1|Overall Study|Ineligible-Inadequate pathology|1
1170930|NCT01168232|3844901|P1|Overall Study|Ineligible- Wrong cell type|6
1170931|NCT01168232|3844901|P1|Overall Study|Ineligible-Second primary cancer site|1
1170932|NCT01167907|3844929|P2|Overall Study|saphenous catheter dislodged before comp|1
1170933|NCT01167907|3844930|P1|Overall Study|saphenous catheter dislodged before comp|1
1170934|NCT01167907|3844929|P2|Overall Study|Protocol Violation|0
1170935|NCT01167907|3844930|P1|Overall Study|Protocol Violation|1
1170936|NCT01167881|3844948|P2|Overall Study|Other not defined above|55
1170937|NCT01167881|3844949|P1|Overall Study|Other not defined above|31
1170938|NCT01167881|3844948|P2|Overall Study|Not treated|0
1170939|NCT01167881|3844949|P1|Overall Study|Not treated|4
1170940|NCT01167881|3844948|P2|Overall Study|Patient refusal to cont., not due to AE|40
1170941|NCT01167881|3844949|P1|Overall Study|Patient refusal to cont., not due to AE|45
1170942|NCT01167881|3844948|P2|Overall Study|Lost to Follow-up|20
1170943|NCT01167881|3844949|P1|Overall Study|Lost to Follow-up|19
1170944|NCT01167881|3844948|P2|Overall Study|Non compliant with protocol|18
1170945|NCT01167881|3844949|P1|Overall Study|Non compliant with protocol|9
1170946|NCT01167881|3844948|P2|Overall Study|Lack of Efficacy|7
1170947|NCT01167881|3844949|P1|Overall Study|Lack of Efficacy|4
1170948|NCT01167881|3844948|P2|Overall Study|Adverse Event|51
1170949|NCT01167881|3844949|P1|Overall Study|Adverse Event|47
1170950|NCT01167634|3845003|P4|Overall Study|Withdrawal by Subject|0
1170951|NCT01167634|3845004|P3|Overall Study|Withdrawal by Subject|0
1170952|NCT01167634|3845005|P2|Overall Study|Withdrawal by Subject|1
1170953|NCT01167634|3845006|P1|Overall Study|Withdrawal by Subject|1
1170954|NCT01167634|3845003|P4|Overall Study|Lost to Follow-up|4
1170955|NCT01167634|3845004|P3|Overall Study|Lost to Follow-up|3
1170956|NCT01167634|3845005|P2|Overall Study|Lost to Follow-up|3
1170957|NCT01167634|3845006|P1|Overall Study|Lost to Follow-up|1
1170958|NCT01167582|3845027|P2|Overall Study|Lost to Follow-up|1
1170959|NCT01167582|3845028|P1|Overall Study|Lost to Follow-up|0
1170960|NCT01167426|3845068|P1|Overall Study|Sponsor Decision|1
1170961|NCT01167426|3845068|P1|Overall Study|Withdrawal by Subject|2
1170962|NCT01167426|3845068|P1|Overall Study|Protocol Violation|1
1170963|NCT01167426|3845068|P1|Overall Study|Lost to Follow-up|6
1170964|NCT01167257|3845076|P2|Overall Study|Withdrew consent|1
1170965|NCT01167257|3845077|P1|Overall Study|Withdrew consent|1
1170966|NCT01167257|3845076|P2|Overall Study|Lost to Follow-up|2
1170967|NCT01167257|3845077|P1|Overall Study|Lost to Follow-up|2
1170968|NCT01167192|3845099|P1|Overall Study|Insurance denial|1
1170969|NCT01167192|3845099|P1|Overall Study|Withdrawal by Subject|1
1170970|NCT01167192|3845099|P1|Overall Study|Death|1
1170971|NCT01167192|3845099|P1|Overall Study|Adverse Event|1
1170972|NCT01167179|3845116|P2|Overall Study|diverse|5
1170973|NCT01167179|3845117|P1|Overall Study|diverse|6
1170974|NCT01167179|3845116|P2|Overall Study|Withdrawal by Subject|2
1170975|NCT01167179|3845117|P1|Overall Study|Withdrawal by Subject|1
1170976|NCT01167179|3845116|P2|Overall Study|Death|10
1170977|NCT01167179|3845117|P1|Overall Study|Death|4
1170978|NCT01167179|3845116|P2|Overall Study|disease recurrence|4
1170979|NCT01167179|3845117|P1|Overall Study|disease recurrence|4
1170980|NCT01167153|3845127|P2|Overall Study|Subject initiation withdrawal, Other|8
1170981|NCT01167153|3845128|P1|Overall Study|Subject initiation withdrawal, Other|5
1170982|NCT01167153|3845127|P2|Overall Study|Withdrawal consent|1
1170983|NCT01167153|3845128|P1|Overall Study|Withdrawal consent|1
1170984|NCT01167153|3845127|P2|Overall Study|Investigator initiation withdrawal,Other|1
1170985|NCT01167153|3845128|P1|Overall Study|Investigator initiation withdrawal,Other|1
1170986|NCT01167153|3845127|P2|Overall Study|Non-compliance to concomitant medication|2
1170987|NCT01167153|3845128|P1|Overall Study|Non-compliance to concomitant medication|0
1170988|NCT01167153|3845127|P2|Overall Study|Lost to Follow-up|9
1170989|NCT01167153|3845128|P1|Overall Study|Lost to Follow-up|7
1170990|NCT01167153|3845127|P2|Overall Study|Hypotension|0
1170991|NCT01167153|3845128|P1|Overall Study|Hypotension|1
1170992|NCT01167153|3845127|P2|Overall Study|AE including clinical laboratory AE|8
1170993|NCT01167153|3845128|P1|Overall Study|AE including clinical laboratory AE|2
1170994|NCT01167153|3845127|P2|Overall Study|Non-effective therapy|4
1170995|NCT01167153|3845128|P1|Overall Study|Non-effective therapy|1
1170996|NCT01167140|3845146|P1|Overall Study|Withdrawal by Subject|1
1170997|NCT01167023|3845154|P3|Overall Study|Withdrawal by Subject|1
1170998|NCT01167023|3845155|P2|Overall Study|Withdrawal by Subject|0
1170999|NCT01167023|3845156|P1|Overall Study|Withdrawal by Subject|0
1171000|NCT01167023|3845154|P3|Overall Study|Sponsor Decision|0
1171001|NCT01167023|3845155|P2|Overall Study|Sponsor Decision|1
1171002|NCT01167023|3845156|P1|Overall Study|Sponsor Decision|0
1171003|NCT01167023|3845154|P3|Overall Study|Screen Failure|0
1171004|NCT01167023|3845155|P2|Overall Study|Screen Failure|1
1171005|NCT01167023|3845156|P1|Overall Study|Screen Failure|0
1171006|NCT01167023|3845154|P3|Overall Study|Lost to Follow-up|1
1171007|NCT01167023|3845155|P2|Overall Study|Lost to Follow-up|1
1171008|NCT01167023|3845156|P1|Overall Study|Lost to Follow-up|0
1171009|NCT01166958|3845196|P2|Overall Study|Withdrawal by Subject|0
1171010|NCT01166958|3845197|P1|Overall Study|Withdrawal by Subject|1
1171011|NCT01166763|3845211|P1|Overall Study|Withdrawal by Subject|3
1171012|NCT01166750|3845219|P2|Overall Study|Lost to Follow-up|0
1171013|NCT01166750|3845220|P1|Overall Study|Lost to Follow-up|1
1171014|NCT01166659|3845237|P1|Overall Study|Study Closed at Site|1
1171015|NCT01166659|3845237|P1|Overall Study|Lost to Follow-up|1
1171016|NCT01166659|3845237|P1|Overall Study|Death|1
1171017|NCT01166659|3845237|P1|Overall Study|Investigator Decision|2
1171018|NCT01166659|3845237|P1|Overall Study|Subject Decision|8
1171019|NCT01166646|3845246|P2|Overall Study|Adverse Event|0
1171020|NCT01166646|3845247|P1|Overall Study|Adverse Event|1
1171021|NCT01166646|3845246|P2|Overall Study|Protocol Violation|1
1171022|NCT01166646|3845247|P1|Overall Study|Protocol Violation|0
1171023|NCT01166568|3845266|P3|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1
1171024|NCT01166568|3845267|P2|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
1171025|NCT01166568|3845268|P1|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7
1171026|NCT01166568|3845266|P3|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0
1171027|NCT01166568|3845267|P2|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1
1171028|NCT01166568|3845268|P1|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7
1171029|NCT01166568|3845266|P3|Deferred Implantation- Randomized|Withdrawal by Subject|1
1171030|NCT01166568|3845267|P2|Deferred Implantation- Randomized|Withdrawal by Subject|0
1171031|NCT01166568|3845268|P1|Deferred Implantation- Randomized|Withdrawal by Subject|0
1171032|NCT01166438|3845281|P2|Off Treatment Follow-up Phase|Lack of Efficacy|52
1171033|NCT01166438|3845282|P1|Off Treatment Follow-up Phase|Lack of Efficacy|29
1171034|NCT01166438|3845281|P2|Off Treatment Follow-up Phase|Lost to Follow-up|2
1171035|NCT01166438|3845282|P1|Off Treatment Follow-up Phase|Lost to Follow-up|4
1171036|NCT01166438|3845281|P2|Off Treatment Follow-up Phase|Withdrawal by Subject|2
1171037|NCT01166438|3845282|P1|Off Treatment Follow-up Phase|Withdrawal by Subject|1
1171038|NCT01166438|3845281|P2|Double-blind Phase: 1st 6 Months|Not treated|1
1171039|NCT01166438|3845282|P1|Double-blind Phase: 1st 6 Months|Not treated|1
1171040|NCT01166438|3845281|P2|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4
1171041|NCT01166438|3845282|P1|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0
1171042|NCT01166438|3845281|P2|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4
1171043|NCT01166438|3845282|P1|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8
1171044|NCT01166282|3845331|P3|Open-label Period|Irregular Compliance|1
1171045|NCT01166282|3845332|P2|Open-label Period|Irregular Compliance|0
1171046|NCT01166282|3845333|P1|Open-label Period|Irregular Compliance|0
1171047|NCT01166282|3845331|P3|Open-label Period|Remission|4
1171048|NCT01166282|3845332|P2|Open-label Period|Remission|0
1171049|NCT01166282|3845333|P1|Open-label Period|Remission|0
1171050|NCT01166282|3845331|P3|Open-label Period|Lack of Efficacy|2
1171051|NCT01166282|3845332|P2|Open-label Period|Lack of Efficacy|0
1171052|NCT01166282|3845333|P1|Open-label Period|Lack of Efficacy|0
1171053|NCT01166282|3845331|P3|Open-label Period|Withdrawal by Subject|4
1171054|NCT01166282|3845332|P2|Open-label Period|Withdrawal by Subject|0
1171055|NCT01166282|3845333|P1|Open-label Period|Withdrawal by Subject|0
1171056|NCT01166282|3845331|P3|Open-label Period|Adverse Event|6
1171057|NCT01166282|3845332|P2|Open-label Period|Adverse Event|0
1171058|NCT01166282|3845333|P1|Open-label Period|Adverse Event|0
1171059|NCT01166178|3845372|P2|Overall Study|Study was terminated|8
1171060|NCT01166178|3845373|P1|Overall Study|Study was terminated|20
1171061|NCT01166178|3845372|P2|Overall Study|Withdrawal by Subject|0
1171062|NCT01166178|3845373|P1|Overall Study|Withdrawal by Subject|1
1171063|NCT01165996|3845412|P1|Overall Study|Physician Decision|1
1171064|NCT01165996|3845412|P1|Overall Study|Death|1
1171065|NCT01165684|3845479|P2|Overall Study|Unclassified|22
1171066|NCT01165684|3845480|P1|Overall Study|Unclassified|16
1171067|NCT01165684|3845479|P2|Overall Study|Withdrawal Criteria|13
1171068|NCT01165684|3845480|P1|Overall Study|Withdrawal Criteria|2
1171069|NCT01165684|3845479|P2|Overall Study|Protocol Violation|15
1171070|NCT01165684|3845480|P1|Overall Study|Protocol Violation|7
1171071|NCT01165684|3845479|P2|Overall Study|Lack of Efficacy|1
1171072|NCT01165684|3845480|P1|Overall Study|Lack of Efficacy|2
1171073|NCT01165684|3845479|P2|Overall Study|Adverse Event|1
1171074|NCT01165684|3845480|P1|Overall Study|Adverse Event|1
1171075|NCT01165554|3845514|P1|Overall Study|Withdrawal by Subject|23
1171076|NCT01165424|3845537|P1|Overall Study|Participant moved (relocated)|1
1171077|NCT01165424|3845537|P1|Overall Study|Did not meet entry criteria|1
1171078|NCT01165424|3845537|P1|Overall Study|Laboratory adverse experiences|1
1171079|NCT01165424|3845537|P1|Overall Study|Clinical adverse experiences|1
1171080|NCT01165320|3845544|P3|Overall Study|Reason unknown|0
1171081|NCT01165320|3845545|P2|Overall Study|Reason unknown|1
1171082|NCT01165320|3845546|P1|Overall Study|Reason unknown|0
1171083|NCT01165320|3845544|P3|Overall Study|Lack of Efficacy|0
1171084|NCT01165320|3845545|P2|Overall Study|Lack of Efficacy|2
1171085|NCT01165320|3845546|P1|Overall Study|Lack of Efficacy|0
1171086|NCT01165320|3845544|P3|Overall Study|Laboratory adverse experience|0
1171087|NCT01165320|3845545|P2|Overall Study|Laboratory adverse experience|0
1171088|NCT01165320|3845546|P1|Overall Study|Laboratory adverse experience|1
1171089|NCT01165320|3845544|P3|Overall Study|Clinical adverse experience|0
1171090|NCT01165320|3845545|P2|Overall Study|Clinical adverse experience|1
1171091|NCT01165320|3845546|P1|Overall Study|Clinical adverse experience|2
1171092|NCT01165307|3845556|P2|Overall Study|Subject not available for contact|0
1171093|NCT01165307|3845557|P1|Overall Study|Subject not available for contact|1
1171094|NCT01165307|3845556|P2|Overall Study|Withdrawal by Subject|0
1171095|NCT01165307|3845557|P1|Overall Study|Withdrawal by Subject|2
1171096|NCT01165307|3845556|P2|Overall Study|Lost to Follow-up|3
1171097|NCT01165307|3845557|P1|Overall Study|Lost to Follow-up|11
1171098|NCT01165281|3845587|P2|Overall Study|Other|0
1171099|NCT01165281|3845588|P1|Overall Study|Other|6
1171100|NCT01165281|3845587|P2|Overall Study|Progressive Disease|14
1171101|NCT01165281|3845588|P1|Overall Study|Progressive Disease|10
1171102|NCT01165281|3845587|P2|Overall Study|Noncompliance with Study Drug|4
1171103|NCT01165281|3845588|P1|Overall Study|Noncompliance with Study Drug|1
1171104|NCT01165281|3845587|P2|Overall Study|Withdrawal by Subject|7
1171105|NCT01165281|3845588|P1|Overall Study|Withdrawal by Subject|8
1171106|NCT01165281|3845587|P2|Overall Study|Protocol Violation|5
1171107|NCT01165281|3845588|P1|Overall Study|Protocol Violation|6
1171108|NCT01165281|3845587|P2|Overall Study|Physician Decision|1
1171109|NCT01165281|3845588|P1|Overall Study|Physician Decision|8
1171110|NCT01165281|3845587|P2|Overall Study|Lost to Follow-up|1
1171111|NCT01165281|3845588|P1|Overall Study|Lost to Follow-up|0
1171112|NCT01165281|3845587|P2|Overall Study|Lack of Efficacy|1
1171113|NCT01165281|3845588|P1|Overall Study|Lack of Efficacy|4
1171114|NCT01165281|3845587|P2|Overall Study|Death|4
1171115|NCT01165281|3845588|P1|Overall Study|Death|3
1171116|NCT01165281|3845587|P2|Overall Study|Adverse Event|14
1171117|NCT01165281|3845588|P1|Overall Study|Adverse Event|12
1171118|NCT01165242|3845609|P3|Overall Study|Lost to Follow-up|10
1171119|NCT01165242|3845610|P2|Overall Study|Lost to Follow-up|7
1171120|NCT01165242|3845611|P1|Overall Study|Lost to Follow-up|9
1171121|NCT01165242|3845609|P3|Overall Study|Extended Holiday|1
1171122|NCT01165242|3845610|P2|Overall Study|Extended Holiday|0
1171123|NCT01165242|3845611|P1|Overall Study|Extended Holiday|0
1171124|NCT01165242|3845609|P3|Overall Study|Withdrawal by Subject|2
1171125|NCT01165242|3845610|P2|Overall Study|Withdrawal by Subject|2
1171126|NCT01165242|3845611|P1|Overall Study|Withdrawal by Subject|0
1171127|NCT01165242|3845609|P3|Overall Study|Visit 2 Declined by Subject|1
1171128|NCT01165242|3845610|P2|Overall Study|Visit 2 Declined by Subject|0
1171129|NCT01165242|3845611|P1|Overall Study|Visit 2 Declined by Subject|0
1171130|NCT01165242|3845609|P3|Overall Study|Incarcerated Subjects|0
1171131|NCT01165242|3845610|P2|Overall Study|Incarcerated Subjects|1
1171132|NCT01165242|3845611|P1|Overall Study|Incarcerated Subjects|0
1171133|NCT01165242|3845609|P3|Overall Study|Unreachable Subjects|0
1171134|NCT01165242|3845610|P2|Overall Study|Unreachable Subjects|0
1171135|NCT01165242|3845611|P1|Overall Study|Unreachable Subjects|1
1171136|NCT01165229|3845645|P2|Overall Study|Screening criteria unmet|0
1171137|NCT01165229|3845646|P1|Overall Study|Screening criteria unmet|1
1171138|NCT01165229|3845645|P2|Overall Study|Lack of time|0
1171139|NCT01165229|3845646|P1|Overall Study|Lack of time|1
1171140|NCT01165229|3845645|P2|Overall Study|Missed visit|0
1171141|NCT01165229|3845646|P1|Overall Study|Missed visit|1
1171142|NCT01165229|3845645|P2|Overall Study|Sponsor study termination|0
1171143|NCT01165229|3845646|P1|Overall Study|Sponsor study termination|1
1171144|NCT01165229|3845645|P2|Overall Study|Investigator decision|2
1171145|NCT01165229|3845646|P1|Overall Study|Investigator decision|0
1171146|NCT01165229|3845645|P2|Overall Study|Personal reason|4
1171147|NCT01165229|3845646|P1|Overall Study|Personal reason|10
1171148|NCT01165229|3845645|P2|Overall Study|Site closure|20
1171149|NCT01165229|3845646|P1|Overall Study|Site closure|18
1171150|NCT01165229|3845645|P2|Overall Study|Health issues|56
1171151|NCT01165229|3845646|P1|Overall Study|Health issues|61
1171152|NCT01165229|3845645|P2|Overall Study|Patient not eligible|1
1171153|NCT01165229|3845646|P1|Overall Study|Patient not eligible|0
1171154|NCT01165229|3845645|P2|Overall Study|Page entered in error|1
1171155|NCT01165229|3845646|P1|Overall Study|Page entered in error|0
1171156|NCT01165229|3845645|P2|Overall Study|No reason from the subject|1
1171157|NCT01165229|3845646|P1|Overall Study|No reason from the subject|0
1171158|NCT01165229|3845645|P2|Overall Study|Suspected HZ Episode|2
1171159|NCT01165229|3845646|P1|Overall Study|Suspected HZ Episode|0
1171160|NCT01165229|3845645|P2|Overall Study|Lost to Follow-up|138
1171161|NCT01165229|3845646|P1|Overall Study|Lost to Follow-up|124
1171162|NCT01165229|3845645|P2|Overall Study|Migrated/moved from study area|46
1171163|NCT01165229|3845646|P1|Overall Study|Migrated/moved from study area|51
1171164|NCT01165229|3845645|P2|Overall Study|Withdrawal by Subject|403
1171165|NCT01165229|3845646|P1|Overall Study|Withdrawal by Subject|396
1171166|NCT01165229|3845645|P2|Overall Study|Protocol Violation|12
1171167|NCT01165229|3845646|P1|Overall Study|Protocol Violation|10
1171168|NCT01165229|3845645|P2|Overall Study|Non-Serious Adverse Event|15
1171169|NCT01165229|3845646|P1|Overall Study|Non-Serious Adverse Event|47
1171170|NCT01165229|3845645|P2|Overall Study|Serious Adverse Event|487
1171171|NCT01165229|3845646|P1|Overall Study|Serious Adverse Event|459
1171172|NCT01165229|3845645|P2|Overall Study|Unknown completion status|1
1171173|NCT01165229|3845646|P1|Overall Study|Unknown completion status|0
1171174|NCT01165216|3845774|P2|Overall Study|Disease progression|3
1171175|NCT01165216|3845775|P1|Overall Study|Disease progression|1
1171176|NCT01165216|3845774|P2|Overall Study|Withdrawal by Subject|1
1171177|NCT01165216|3845775|P1|Overall Study|Withdrawal by Subject|1
1171178|NCT01165216|3845774|P2|Overall Study|Adverse Event|3
1171179|NCT01165216|3845775|P1|Overall Study|Adverse Event|6
1171180|NCT01165203|3845797|P2|Extended Safety Follow-up Phase|Other-subjects business reasons|1
1171181|NCT01165203|3845798|P1|Extended Safety Follow-up Phase|Other-subjects business reasons|0
1171182|NCT01165203|3845797|P2|Extended Safety Follow-up Phase|Lost to Follow-up|0
1171183|NCT01165203|3845798|P1|Extended Safety Follow-up Phase|Lost to Follow-up|2
1171184|NCT01165203|3845797|P2|Extended Safety Follow-up Phase|Migrated/moved from study area|1
1171185|NCT01165203|3845798|P1|Extended Safety Follow-up Phase|Migrated/moved from study area|2
1171186|NCT01165203|3845797|P2|Extended Safety Follow-up Phase|Withdrawal by Subject|2
1171187|NCT01165203|3845798|P1|Extended Safety Follow-up Phase|Withdrawal by Subject|2
1171188|NCT01165203|3845797|P2|Extended Safety Follow-up Phase|Serious Adverse Event|0
1171189|NCT01165203|3845798|P1|Extended Safety Follow-up Phase|Serious Adverse Event|1
1171190|NCT01165203|3845797|P2|Active Phase|Lost to Follow-up|0
1171191|NCT01165203|3845798|P1|Active Phase|Lost to Follow-up|2
1171192|NCT01165203|3845797|P2|Active Phase|Migrated/moved from study area|1
1171193|NCT01165203|3845798|P1|Active Phase|Migrated/moved from study area|0
1171194|NCT01165203|3845797|P2|Active Phase|Withdrawal by Subject|1
1171195|NCT01165203|3845798|P1|Active Phase|Withdrawal by Subject|2
1171196|NCT01165203|3845797|P2|Active Phase|Serious Adverse Event|0
1171197|NCT01165203|3845798|P1|Active Phase|Serious Adverse Event|1
1171198|NCT01165177|3845888|P2|Overall Study|Death|1
1171199|NCT01165177|3845889|P1|Overall Study|Death|0
1171200|NCT01165177|3845888|P2|Overall Study|Personal Reasons|4
1171201|NCT01165177|3845889|P1|Overall Study|Personal Reasons|1
1171202|NCT01165177|3845888|P2|Overall Study|Physician Decision|1
1171203|NCT01165177|3845889|P1|Overall Study|Physician Decision|0
1171204|NCT01165177|3845888|P2|Overall Study|Non-serious Adverse Event|20
1171205|NCT01165177|3845889|P1|Overall Study|Non-serious Adverse Event|32
1171206|NCT01165177|3845888|P2|Overall Study|Migrated/moved from study area|43
1171207|NCT01165177|3845889|P1|Overall Study|Migrated/moved from study area|48
1171208|NCT01165177|3845888|P2|Overall Study|Subject missed visit|2
1171209|NCT01165177|3845889|P1|Overall Study|Subject missed visit|5
1171210|NCT01165177|3845888|P2|Overall Study|Previous health issues worsening|11
1171211|NCT01165177|3845889|P1|Overall Study|Previous health issues worsening|9
1171212|NCT01165177|3845888|P2|Overall Study|Subject non-compliant with procedures|2
1171213|NCT01165177|3845889|P1|Overall Study|Subject non-compliant with procedures|12
1171214|NCT01165177|3845888|P2|Overall Study|Site closure|5
1171215|NCT01165177|3845889|P1|Overall Study|Site closure|7
1171216|NCT01165177|3845888|P2|Overall Study|Protocol Violation|22
1171217|NCT01165177|3845889|P1|Overall Study|Protocol Violation|19
1171218|NCT01165177|3845888|P2|Overall Study|Lost to Follow-up|195
1171219|NCT01165177|3845889|P1|Overall Study|Lost to Follow-up|188
1171220|NCT01165177|3845888|P2|Overall Study|Serious Adverse Event|240
1171221|NCT01165177|3845889|P1|Overall Study|Serious Adverse Event|229
1171222|NCT01165177|3845888|P2|Overall Study|Withdrawal by Subject|356
1171223|NCT01165177|3845889|P1|Overall Study|Withdrawal by Subject|372
1171224|NCT01165138|3846014|P4|Overall Study|Withdrawal by Subject|3
1171225|NCT01165138|3846015|P3|Overall Study|Withdrawal by Subject|6
1171226|NCT01165138|3846016|P2|Overall Study|Withdrawal by Subject|6
1171227|NCT01165138|3846017|P1|Overall Study|Withdrawal by Subject|0
1171228|NCT01165138|3846014|P4|Overall Study|Physician Decision|6
1171229|NCT01165138|3846015|P3|Overall Study|Physician Decision|7
1171230|NCT01165138|3846016|P2|Overall Study|Physician Decision|6
1171231|NCT01165138|3846017|P1|Overall Study|Physician Decision|0
1171232|NCT01165138|3846014|P4|Overall Study|Lost to Follow-up|2
1171233|NCT01165138|3846015|P3|Overall Study|Lost to Follow-up|1
1171234|NCT01165138|3846016|P2|Overall Study|Lost to Follow-up|0
1171235|NCT01165138|3846017|P1|Overall Study|Lost to Follow-up|0
1171236|NCT01165138|3846014|P4|Overall Study|Protocol Violation|2
1171237|NCT01165138|3846015|P3|Overall Study|Protocol Violation|0
1171238|NCT01165138|3846016|P2|Overall Study|Protocol Violation|7
1171239|NCT01165138|3846017|P1|Overall Study|Protocol Violation|0
1171240|NCT01165138|3846014|P4|Overall Study|Lack of Efficacy|7
1171241|NCT01165138|3846015|P3|Overall Study|Lack of Efficacy|6
1171242|NCT01165138|3846016|P2|Overall Study|Lack of Efficacy|32
1171243|NCT01165138|3846017|P1|Overall Study|Lack of Efficacy|0
1171244|NCT01165138|3846014|P4|Overall Study|Adverse Event|2
1171245|NCT01165138|3846015|P3|Overall Study|Adverse Event|0
1171246|NCT01165138|3846016|P2|Overall Study|Adverse Event|1
1171247|NCT01165138|3846017|P1|Overall Study|Adverse Event|0
1171248|NCT01165021|3846087|P1|Overall Study|Death|1
1171249|NCT01164891|3846095|P1|Overall Study|Adverse Event|1
1171250|NCT01164891|3846095|P1|Overall Study|Disease Progression|5
1171251|NCT01164865|3846115|P2|Overall Study|Lost to Follow-up|1
1171252|NCT01164865|3846116|P1|Overall Study|Lost to Follow-up|2
1171253|NCT01164722|3846126|P2|Overall Study|enrolled on other study, concomitant med|3
1171254|NCT01164722|3846127|P1|Overall Study|enrolled on other study, concomitant med|1
1171255|NCT01164722|3846126|P2|Overall Study|met protocol criteria for non-treatment|1
1171256|NCT01164722|3846127|P1|Overall Study|met protocol criteria for non-treatment|11
1171257|NCT01164722|3846126|P2|Overall Study|Lost to Follow-up|6
1171258|NCT01164722|3846127|P1|Overall Study|Lost to Follow-up|3
1171259|NCT01164722|3846126|P2|Overall Study|Withdrawal by Subject|4
1171260|NCT01164722|3846127|P1|Overall Study|Withdrawal by Subject|3
1171261|NCT01164722|3846126|P2|Overall Study|Adverse Event|1
1171262|NCT01164722|3846127|P1|Overall Study|Adverse Event|0
1171263|NCT01164579|3846157|P3|Overall Study|Reason not specified|0
1171264|NCT01164579|3846158|P2|Overall Study|Reason not specified|0
1171265|NCT01164579|3846159|P1|Overall Study|Reason not specified|1
1171266|NCT01164579|3846157|P3|Overall Study|Adverse Event|5
1171267|NCT01164579|3846158|P2|Overall Study|Adverse Event|2
1171268|NCT01164579|3846159|P1|Overall Study|Adverse Event|4
1171269|NCT01164579|3846157|P3|Overall Study|Protocol Violation|2
1171270|NCT01164579|3846158|P2|Overall Study|Protocol Violation|1
1171271|NCT01164579|3846159|P1|Overall Study|Protocol Violation|0
1171272|NCT01164579|3846157|P3|Overall Study|Withdrawal by Subject|3
1171273|NCT01164579|3846158|P2|Overall Study|Withdrawal by Subject|5
1171274|NCT01164579|3846159|P1|Overall Study|Withdrawal by Subject|2
1171275|NCT01164579|3846157|P3|Overall Study|Lost to Follow-up|0
1171276|NCT01164579|3846158|P2|Overall Study|Lost to Follow-up|1
1171277|NCT01164579|3846159|P1|Overall Study|Lost to Follow-up|1
1171278|NCT01164579|3846157|P3|Overall Study|Lack of Efficacy|6
1171279|NCT01164579|3846158|P2|Overall Study|Lack of Efficacy|0
1171280|NCT01164579|3846159|P1|Overall Study|Lack of Efficacy|0
1171281|NCT01164501|3846239|P3|Overall Study|Other reason not defined above|4
1171282|NCT01164501|3846240|P2|Overall Study|Other reason not defined above|1
1171283|NCT01164501|3846241|P1|Overall Study|Other reason not defined above|9
1171284|NCT01164501|3846239|P3|Overall Study|Patient refusal to continue,not due toAE|8
1171285|NCT01164501|3846240|P2|Overall Study|Patient refusal to continue,not due toAE|4
1171286|NCT01164501|3846241|P1|Overall Study|Patient refusal to continue,not due toAE|10
1171287|NCT01164501|3846239|P3|Overall Study|Lost to Follow-up|3
1171288|NCT01164501|3846240|P2|Overall Study|Lost to Follow-up|0
1171289|NCT01164501|3846241|P1|Overall Study|Lost to Follow-up|3
1171290|NCT01164501|3846239|P3|Overall Study|Non compliant with protocol|4
1171291|NCT01164501|3846240|P2|Overall Study|Non compliant with protocol|1
1171292|NCT01164501|3846241|P1|Overall Study|Non compliant with protocol|1
1171293|NCT01164501|3846239|P3|Overall Study|Lack of Efficacy|1
1171294|NCT01164501|3846240|P2|Overall Study|Lack of Efficacy|0
1171295|NCT01164501|3846241|P1|Overall Study|Lack of Efficacy|0
1171296|NCT01164501|3846239|P3|Overall Study|Adverse Event|21
1171297|NCT01164501|3846240|P2|Overall Study|Adverse Event|4
1171298|NCT01164501|3846241|P1|Overall Study|Adverse Event|18
1171299|NCT01164501|3846239|P3|Overall Study|Not treated|1
1171300|NCT01164501|3846240|P2|Overall Study|Not treated|0
1171301|NCT01164501|3846241|P1|Overall Study|Not treated|2
1171302|NCT01164475|3846258|P2|Overall Study|Protocol Violation|0
1171303|NCT01164475|3846259|P1|Overall Study|Protocol Violation|1
1171304|NCT01164475|3846258|P2|Overall Study|Progressive disease|1
1171305|NCT01164475|3846259|P1|Overall Study|Progressive disease|0
1171306|NCT01164475|3846258|P2|Overall Study|Other|1
1171307|NCT01164475|3846259|P1|Overall Study|Other|0
1171308|NCT01164475|3846258|P2|Overall Study|Lack of Efficacy|0
1171309|NCT01164475|3846259|P1|Overall Study|Lack of Efficacy|1
1171310|NCT01164007|3846313|P1|Overall Study|Medical Decision|3
1171311|NCT01164007|3846313|P1|Overall Study|Withdrawal by Subject|1
1171312|NCT01164007|3846313|P1|Overall Study|Protocol Violation|1
1171313|NCT01164007|3846313|P1|Overall Study|Progression of Disease|30
1171314|NCT01164007|3846313|P1|Overall Study|Adverse Event|5
1171315|NCT01163916|3846339|P3|Overall Study|Other|16
1171316|NCT01163916|3846340|P2|Overall Study|Other|4
1171317|NCT01163916|3846341|P1|Overall Study|Other|24
1171318|NCT01163916|3846339|P3|Overall Study|Lack of Efficacy|1
1171319|NCT01163916|3846340|P2|Overall Study|Lack of Efficacy|0
1171320|NCT01163916|3846341|P1|Overall Study|Lack of Efficacy|2
1171321|NCT01163916|3846339|P3|Overall Study|Adverse Event|1
1171322|NCT01163916|3846340|P2|Overall Study|Adverse Event|0
1171323|NCT01163916|3846341|P1|Overall Study|Adverse Event|2
1171324|NCT01163916|3846339|P3|Overall Study|Withdrawal by Subject|2
1171325|NCT01163916|3846340|P2|Overall Study|Withdrawal by Subject|0
1171326|NCT01163916|3846341|P1|Overall Study|Withdrawal by Subject|2
1171327|NCT01163851|3846379|P2|Overall Study|Enrolled but not treated|0
1171328|NCT01163851|3846380|P1|Overall Study|Enrolled but not treated|1
1171329|NCT01163851|3846379|P2|Overall Study|Site Closure|1
1171330|NCT01163851|3846380|P1|Overall Study|Site Closure|0
1171331|NCT01163747|3846475|P2|Overall Study|Refused Treatment|4
1171332|NCT01163747|3846476|P1|Overall Study|Refused Treatment|6
1171333|NCT01163747|3846475|P2|Overall Study|Protocol Violation|1
1171334|NCT01163747|3846476|P1|Overall Study|Protocol Violation|0
1171335|NCT01163747|3846475|P2|Overall Study|Insufficient Therapeutic Response|1
1171336|NCT01163747|3846476|P1|Overall Study|Insufficient Therapeutic Response|0
1171337|NCT01163747|3846475|P2|Overall Study|Adverse Event|5
1171338|NCT01163747|3846476|P1|Overall Study|Adverse Event|0
1171339|NCT01163721|3846496|P2|Overall Study|Physician Decision|1
1171340|NCT01163721|3846497|P1|Overall Study|Physician Decision|0
1171341|NCT01163721|3846496|P2|Overall Study|Lost to Follow-up|1
1171342|NCT01163721|3846497|P1|Overall Study|Lost to Follow-up|0
1171343|NCT01163721|3846496|P2|Overall Study|Withdrawal by Subject|4
1171344|NCT01163721|3846497|P1|Overall Study|Withdrawal by Subject|3
1171345|NCT01163721|3846496|P2|Overall Study|Adverse Event|6
1171346|NCT01163721|3846497|P1|Overall Study|Adverse Event|5
1171347|NCT01163617|3846516|P8|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
1171348|NCT01163617|3846517|P7|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
1171349|NCT01163617|3846518|P6|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
1171350|NCT01163617|3846519|P5|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
1171351|NCT01163617|3846520|P4|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
1171352|NCT01163617|3846521|P3|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1
1171353|NCT01163617|3846522|P2|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
1171354|NCT01163617|3846523|P1|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
1171355|NCT01163617|3846516|P8|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
1171356|NCT01163617|3846517|P7|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
1171357|NCT01163617|3846518|P6|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
1171358|NCT01163617|3846519|P5|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
1171359|NCT01163617|3846520|P4|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
1171360|NCT01163617|3846521|P3|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
1171361|NCT01163617|3846522|P2|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1
1171362|NCT01163617|3846523|P1|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
1171363|NCT01163617|3846516|P8|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
1171364|NCT01163617|3846517|P7|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
1171365|NCT01163617|3846518|P6|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
1171366|NCT01163617|3846519|P5|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
1171367|NCT01163617|3846520|P4|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
1171368|NCT01163617|3846521|P3|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
1171369|NCT01163617|3846522|P2|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1
1171370|NCT01163617|3846523|P1|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
1171371|NCT01163474|3846552|P1|Overall Study|Lost to Follow-up|3
1171372|NCT01163474|3846552|P1|Overall Study|Tech barriers to videoteleconference vis|12
1171373|NCT01163474|3846552|P1|Overall Study|Withdrawal by Subject|1
1171374|NCT01163318|3846563|P1|Overall Study|Multiple Reasons Per Participant|224
1171375|NCT01163318|3846563|P1|Overall Study|Participants Without Case Report Form|7
1171376|NCT01163318|3846563|P1|Overall Study|History/comorbidity of malignant tumor|3
1171377|NCT01163318|3846563|P1|Overall Study|Did Not Continue Use of Adalimumab|26
1171378|NCT01163318|3846563|P1|Overall Study|Off-Label Use of Adalimumab|8
1171379|NCT01163292|3846572|P2|Overall Study|No further visits|7
1171380|NCT01163292|3846573|P1|Overall Study|No further visits|5
1171381|NCT01163292|3846572|P2|Overall Study|Economic reasons|0
1171382|NCT01163292|3846573|P1|Overall Study|Economic reasons|6
1171383|NCT01163292|3846572|P2|Overall Study|Refusal to receive adalimumab|0
1171384|NCT01163292|3846573|P1|Overall Study|Refusal to receive adalimumab|7
1171385|NCT01163292|3846572|P2|Overall Study|Sufficient response to adalimumab|0
1171386|NCT01163292|3846573|P1|Overall Study|Sufficient response to adalimumab|8
1171387|NCT01163292|3846572|P2|Overall Study|Initiation of biological therapy|15
1171388|NCT01163292|3846573|P1|Overall Study|Initiation of biological therapy|0
1171389|NCT01163292|3846572|P2|Overall Study|Adverse Event|0
1171390|NCT01163292|3846573|P1|Overall Study|Adverse Event|6
1171391|NCT01163292|3846572|P2|Overall Study|Lack of Efficacy|0
1171392|NCT01163292|3846573|P1|Overall Study|Lack of Efficacy|9
1171393|NCT01163279|3846589|P2|Overall Study|Withdrawal by Subject|0
1171394|NCT01163279|3846590|P1|Overall Study|Withdrawal by Subject|2
1171395|NCT01163266|3846619|P3|Overall Study|Other|2
1171396|NCT01163266|3846620|P2|Overall Study|Other|1
1171397|NCT01163266|3846621|P1|Overall Study|Other|1
1171398|NCT01163266|3846619|P3|Overall Study|Lost to Follow-up|10
1171399|NCT01163266|3846620|P2|Overall Study|Lost to Follow-up|7
1171400|NCT01163266|3846621|P1|Overall Study|Lost to Follow-up|7
1171401|NCT01163266|3846619|P3|Overall Study|Withdrawal of Consent|3
1171402|NCT01163266|3846620|P2|Overall Study|Withdrawal of Consent|7
1171403|NCT01163266|3846621|P1|Overall Study|Withdrawal of Consent|5
1171404|NCT01163266|3846619|P3|Overall Study|Protocol Deviations|5
1171405|NCT01163266|3846620|P2|Overall Study|Protocol Deviations|2
1171406|NCT01163266|3846621|P1|Overall Study|Protocol Deviations|2
1171407|NCT01163266|3846619|P3|Overall Study|Noncompliance with Study Drug|0
1171408|NCT01163266|3846620|P2|Overall Study|Noncompliance with Study Drug|2
1171409|NCT01163266|3846621|P1|Overall Study|Noncompliance with Study Drug|0
1171410|NCT01163266|3846619|P3|Overall Study|Lack of Efficacy|1
1171411|NCT01163266|3846620|P2|Overall Study|Lack of Efficacy|3
1171412|NCT01163266|3846621|P1|Overall Study|Lack of Efficacy|1
1171413|NCT01163266|3846619|P3|Overall Study|Pretreatment Event or Adverse Event|7
1171414|NCT01163266|3846620|P2|Overall Study|Pretreatment Event or Adverse Event|9
1171415|NCT01163266|3846621|P1|Overall Study|Pretreatment Event or Adverse Event|2
1171416|NCT01163253|3846646|P2|Overall Study|Other Unspecified|34
1171417|NCT01163253|3846647|P1|Overall Study|Other Unspecified|170
1171418|NCT01163253|3846646|P2|Overall Study|Ongoing|4
1171419|NCT01163253|3846647|P1|Overall Study|Ongoing|13
1171420|NCT01163253|3846646|P2|Overall Study|Death|5
1171421|NCT01163253|3846647|P1|Overall Study|Death|17
1171422|NCT01163253|3846646|P2|Overall Study|Adverse Event|78
1171423|NCT01163253|3846647|P1|Overall Study|Adverse Event|300
1171424|NCT01163253|3846646|P2|Overall Study|Insufficient Clinical Response|29
1171425|NCT01163253|3846647|P1|Overall Study|Insufficient Clinical Response|423
1171426|NCT01163253|3846646|P2|Overall Study|Lost to Follow-up|23
1171427|NCT01163253|3846647|P1|Overall Study|Lost to Follow-up|125
1171428|NCT01163253|3846646|P2|Overall Study|Medication Error|0
1171429|NCT01163253|3846647|P1|Overall Study|Medication Error|1
1171430|NCT01163253|3846646|P2|Overall Study|Withdrawal by Subject|50
1171431|NCT01163253|3846647|P1|Overall Study|Withdrawal by Subject|199
1171432|NCT01163253|3846646|P2|Overall Study|Protocol Violation|12
1171433|NCT01163253|3846647|P1|Overall Study|Protocol Violation|43
1171434|NCT01163253|3846646|P2|Overall Study|Study Terminated by Sponsor|349
1171435|NCT01163253|3846647|P1|Overall Study|Study Terminated by Sponsor|978
1171436|NCT01163253|3846646|P2|Overall Study|Withdrawn Due to Pregnancy|2
1171437|NCT01163253|3846647|P1|Overall Study|Withdrawn Due to Pregnancy|12
1171438|NCT01163149|3846835|P3|Extension Treatment Period|Noncompliance|1
1171439|NCT01163149|3846836|P2|Extension Treatment Period|Noncompliance|0
1171440|NCT01163149|3846837|P1|Extension Treatment Period|Noncompliance|0
1171441|NCT01163149|3846835|P3|Extension Treatment Period|Adverse Event|0
1171442|NCT01163149|3846836|P2|Extension Treatment Period|Adverse Event|1
1171443|NCT01163149|3846837|P1|Extension Treatment Period|Adverse Event|0
1171444|NCT01163149|3846835|P3|Extension Treatment Period|Withdrawal by Subject|1
1171445|NCT01163149|3846836|P2|Extension Treatment Period|Withdrawal by Subject|0
1171446|NCT01163149|3846837|P1|Extension Treatment Period|Withdrawal by Subject|2
1171447|NCT01163032|3846937|P3|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2
1171448|NCT01163032|3846938|P2|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
1171449|NCT01163032|3846939|P1|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
1171450|NCT01163032|3846937|P3|Open Label Extension Phase|Study Termination|7
1171451|NCT01163032|3846938|P2|Open Label Extension Phase|Study Termination|0
1171452|NCT01163032|3846939|P1|Open Label Extension Phase|Study Termination|0
1171453|NCT01163032|3846937|P3|Open Label Extension Phase|Protocol Violation|1
1171454|NCT01163032|3846938|P2|Open Label Extension Phase|Protocol Violation|0
1171455|NCT01163032|3846939|P1|Open Label Extension Phase|Protocol Violation|0
1171456|NCT01163032|3846937|P3|Open Label Extension Phase|Withdrawal by Subject|3
1171457|NCT01163032|3846938|P2|Open Label Extension Phase|Withdrawal by Subject|0
1171458|NCT01163032|3846939|P1|Open Label Extension Phase|Withdrawal by Subject|0
1171459|NCT01163032|3846937|P3|Open Label Extension Phase|Adverse Event|3
1171460|NCT01163032|3846938|P2|Open Label Extension Phase|Adverse Event|0
1171461|NCT01163032|3846939|P1|Open Label Extension Phase|Adverse Event|0
1171462|NCT01163032|3846937|P3|Randomization Phase|Unsatisfactory Therapeutic Effect|0
1171463|NCT01163032|3846938|P2|Randomization Phase|Unsatisfactory Therapeutic Effect|1
1171464|NCT01163032|3846939|P1|Randomization Phase|Unsatisfactory Therapeutic Effect|0
1171465|NCT01163032|3846937|P3|Randomization Phase|Various*|0
1171466|NCT01163032|3846938|P2|Randomization Phase|Various*|4
1171467|NCT01163032|3846939|P1|Randomization Phase|Various*|5
1171468|NCT01163032|3846937|P3|Randomization Phase|Protocol Violation|0
1171469|NCT01163032|3846938|P2|Randomization Phase|Protocol Violation|1
1171470|NCT01163032|3846939|P1|Randomization Phase|Protocol Violation|0
1171471|NCT01163032|3846937|P3|Randomization Phase|Adverse Event|0
1171472|NCT01163032|3846938|P2|Randomization Phase|Adverse Event|3
1171473|NCT01163032|3846939|P1|Randomization Phase|Adverse Event|3
1171474|NCT01163032|3846937|P3|Randomization Phase|Withdrawal by Subject|0
1171475|NCT01163032|3846938|P2|Randomization Phase|Withdrawal by Subject|3
1171476|NCT01163032|3846939|P1|Randomization Phase|Withdrawal by Subject|2
1171477|NCT01162863|3846972|P3|Overall Study|Adverse Event|0
1171478|NCT01162863|3846973|P2|Overall Study|Adverse Event|1
1171479|NCT01162863|3846974|P1|Overall Study|Adverse Event|0
1171480|NCT01162863|3846972|P3|Overall Study|Lack of Efficacy|0
1171481|NCT01162863|3846973|P2|Overall Study|Lack of Efficacy|0
1171482|NCT01162863|3846974|P1|Overall Study|Lack of Efficacy|1
1171483|NCT01162499|3846999|P2|Intervention 1 (4 Hours)|Unable to establish IV access|1
1171484|NCT01162499|3847000|P1|Intervention 1 (4 Hours)|Unable to establish IV access|0
1171485|NCT01162473|3847022|P2|Overall Study|Withdrawal by Subject|4
1171486|NCT01162473|3847023|P1|Overall Study|Withdrawal by Subject|0
1171487|NCT01162473|3847022|P2|Overall Study|Adverse Event|1
1171488|NCT01162473|3847023|P1|Overall Study|Adverse Event|2
1171489|NCT01162421|3847031|P2|Overall Study|Not specified|3
1171490|NCT01162421|3847032|P1|Overall Study|Not specified|2
1171491|NCT01162421|3847031|P2|Overall Study|Lack of Efficacy|2
1171492|NCT01162421|3847032|P1|Overall Study|Lack of Efficacy|2
1171493|NCT01162421|3847031|P2|Overall Study|Lost to Follow-up|2
1171494|NCT01162421|3847032|P1|Overall Study|Lost to Follow-up|0
1171495|NCT01162421|3847031|P2|Overall Study|Adverse Event|5
1171496|NCT01162421|3847032|P1|Overall Study|Adverse Event|2
1171497|NCT01162421|3847031|P2|Overall Study|Did not receive study drug|1
1171498|NCT01162421|3847032|P1|Overall Study|Did not receive study drug|2
1171499|NCT01162343|3847110|P1|Overall Study|Refused psychiatrist assessment|12
1171500|NCT01162343|3847110|P1|Overall Study|Left ED prior to psychiatrist assessment|80
1171501|NCT01162304|3847125|P1|Overall Study|Beck scale to high|11
1171502|NCT01162135|3847139|P1|Overall Study|Ineligible|1
1171503|NCT01162135|3847139|P1|Overall Study|Severe back pain|1
1171504|NCT01162135|3847139|P1|Overall Study|Withdrawal by Subject|1
1171505|NCT01162122|3847145|P2|Overall Study|Missing primary reason|0
1171506|NCT01162122|3847146|P1|Overall Study|Missing primary reason|1
1171507|NCT01162122|3847145|P2|Overall Study|Unable to classify|7
1171508|NCT01162122|3847146|P1|Overall Study|Unable to classify|3
1171509|NCT01162122|3847145|P2|Overall Study|Administrative reason|1
1171510|NCT01162122|3847146|P1|Overall Study|Administrative reason|1
1171511|NCT01162122|3847145|P2|Overall Study|Inappropriate enrollment|4
1171512|NCT01162122|3847146|P1|Overall Study|Inappropriate enrollment|5
1171513|NCT01162122|3847145|P2|Overall Study|Protocol Violation|2
1171514|NCT01162122|3847146|P1|Overall Study|Protocol Violation|2
1171515|NCT01162122|3847145|P2|Overall Study|Death|46
1171516|NCT01162122|3847146|P1|Overall Study|Death|51
1171517|NCT01162122|3847145|P2|Overall Study|Adverse Event|2
1171518|NCT01162122|3847146|P1|Overall Study|Adverse Event|3
1171519|NCT01162122|3847145|P2|Overall Study|Lost to Follow-up|91
1171520|NCT01162122|3847146|P1|Overall Study|Lost to Follow-up|73
1171521|NCT01162122|3847145|P2|Overall Study|Withdrawal by Subject|43
1171522|NCT01162122|3847146|P1|Overall Study|Withdrawal by Subject|52
1171523|NCT01161628|3847241|P1|Overall Study|Lack of Efficacy|2
1171524|NCT01161628|3847241|P1|Overall Study|Death|6
1171525|NCT01161537|3847264|P1|Part B|Withdrawal by Subject|2
1171526|NCT01161498|3847282|P2|Overall Study|Disease Progression|1
1171527|NCT01161498|3847283|P1|Overall Study|Disease Progression|0
1171528|NCT01161472|3847307|P4|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
1171529|NCT01161472|3847308|P3|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
1171530|NCT01161472|3847309|P2|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
1171531|NCT01161472|3847310|P1|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1
1171532|NCT01161446|3847366|P2|Overall Study|Withdrawal by Subject|1
1171533|NCT01161446|3847367|P1|Overall Study|Withdrawal by Subject|0
1171534|NCT01161446|3847366|P2|Overall Study|Lost to Follow-up|14
1171535|NCT01161446|3847367|P1|Overall Study|Lost to Follow-up|18
1171536|NCT01161407|3847393|P2|Overall Study|Protocol Violation|1
1171537|NCT01161407|3847394|P1|Overall Study|Protocol Violation|3
1171538|NCT01161173|3847449|P1|Overall Study|Reasons Not Specified|23
1171539|NCT01161173|3847449|P1|Overall Study|End of Study|2
1171540|NCT01161173|3847449|P1|Overall Study|Death|194
1171541|NCT01161173|3847449|P1|Overall Study|Unacceptable Toxicity|21
1171542|NCT01161173|3847449|P1|Overall Study|Withdrawal of Consent|5
1171543|NCT01161173|3847449|P1|Overall Study|Progressive Disease|82
1171544|NCT01161173|3847449|P1|Overall Study|Lost to Follow-up|7
1171545|NCT01161173|3847449|P1|Overall Study|Protocol Violation|13
1171546|NCT01160822|3847576|P7|Overall Study|Protocol deviation|0
1171547|NCT01160822|3847577|P6|Overall Study|Protocol deviation|0
1171548|NCT01160822|3847578|P5|Overall Study|Protocol deviation|2
1171549|NCT01160822|3847579|P4|Overall Study|Protocol deviation|0
1171550|NCT01160822|3847580|P3|Overall Study|Protocol deviation|0
1171551|NCT01160822|3847581|P2|Overall Study|Protocol deviation|0
1171552|NCT01160822|3847582|P1|Overall Study|Protocol deviation|0
1171553|NCT01160822|3847576|P7|Overall Study|Administrative problems|0
1171554|NCT01160822|3847577|P6|Overall Study|Administrative problems|0
1171555|NCT01160822|3847578|P5|Overall Study|Administrative problems|1
1171556|NCT01160822|3847579|P4|Overall Study|Administrative problems|0
1171557|NCT01160822|3847580|P3|Overall Study|Administrative problems|0
1171558|NCT01160822|3847581|P2|Overall Study|Administrative problems|0
1171559|NCT01160822|3847582|P1|Overall Study|Administrative problems|0
1171560|NCT01160822|3847576|P7|Overall Study|Lost to Follow-up|0
1171561|NCT01160822|3847577|P6|Overall Study|Lost to Follow-up|0
1171562|NCT01160822|3847578|P5|Overall Study|Lost to Follow-up|1
1171563|NCT01160822|3847579|P4|Overall Study|Lost to Follow-up|0
1171564|NCT01160822|3847580|P3|Overall Study|Lost to Follow-up|0
1171565|NCT01160822|3847581|P2|Overall Study|Lost to Follow-up|0
1171566|NCT01160822|3847582|P1|Overall Study|Lost to Follow-up|0
1171567|NCT01160822|3847576|P7|Overall Study|Withdrawal by Subject|1
1171568|NCT01160822|3847577|P6|Overall Study|Withdrawal by Subject|0
1171569|NCT01160822|3847578|P5|Overall Study|Withdrawal by Subject|0
1171570|NCT01160822|3847579|P4|Overall Study|Withdrawal by Subject|0
1171571|NCT01160822|3847580|P3|Overall Study|Withdrawal by Subject|0
1171572|NCT01160822|3847581|P2|Overall Study|Withdrawal by Subject|0
1171573|NCT01160822|3847582|P1|Overall Study|Withdrawal by Subject|0
1171574|NCT01160822|3847576|P7|Overall Study|Unsatisfactory therapeutic effect|3
1171575|NCT01160822|3847577|P6|Overall Study|Unsatisfactory therapeutic effect|5
1171576|NCT01160822|3847578|P5|Overall Study|Unsatisfactory therapeutic effect|4
1171577|NCT01160822|3847579|P4|Overall Study|Unsatisfactory therapeutic effect|0
1171578|NCT01160822|3847580|P3|Overall Study|Unsatisfactory therapeutic effect|0
1171579|NCT01160822|3847581|P2|Overall Study|Unsatisfactory therapeutic effect|0
1171580|NCT01160822|3847582|P1|Overall Study|Unsatisfactory therapeutic effect|0
1171581|NCT01160822|3847576|P7|Overall Study|Adverse Event|5
1171582|NCT01160822|3847577|P6|Overall Study|Adverse Event|2
1171583|NCT01160822|3847578|P5|Overall Study|Adverse Event|1
1171584|NCT01160822|3847579|P4|Overall Study|Adverse Event|0
1171585|NCT01160822|3847580|P3|Overall Study|Adverse Event|0
1171586|NCT01160822|3847581|P2|Overall Study|Adverse Event|0
1171587|NCT01160822|3847582|P1|Overall Study|Adverse Event|0
1171588|NCT01160770|3847671|P1|Overall Study|Other Reasons|1
1171589|NCT01160770|3847671|P1|Overall Study|Lack of Efficacy|15
1171590|NCT01160770|3847671|P1|Overall Study|Death|9
1171591|NCT01160770|3847671|P1|Overall Study|Study termination or sponsor request|1
1171592|NCT01160770|3847671|P1|Overall Study|Lost to Follow-up|7
1171593|NCT01160770|3847671|P1|Overall Study|Physician Decision|1
1171594|NCT01160770|3847671|P1|Overall Study|Subject/parent/caregiver request|33
1171595|NCT01160770|3847671|P1|Overall Study|Protocol Violation|2
1171596|NCT01160770|3847671|P1|Overall Study|Adverse Event|10
1171597|NCT01160744|3847684|P4|Overall Study|Alive and Still on Treatment|14
1171598|NCT01160744|3847685|P3|Overall Study|Alive and Still on Treatment|8
1171599|NCT01160744|3847686|P2|Overall Study|Alive and Still on Treatment|11
1171600|NCT01160744|3847687|P1|Overall Study|Alive and Still on Treatment|9
1171601|NCT01160744|3847684|P4|Overall Study|Not Specified|4
1171602|NCT01160744|3847685|P3|Overall Study|Not Specified|5
1171603|NCT01160744|3847686|P2|Overall Study|Not Specified|9
1171604|NCT01160744|3847687|P1|Overall Study|Not Specified|5
1171605|NCT01160744|3847684|P4|Overall Study|Not meet inclusion/exclusion criteria|0
1171606|NCT01160744|3847685|P3|Overall Study|Not meet inclusion/exclusion criteria|1
1171607|NCT01160744|3847686|P2|Overall Study|Not meet inclusion/exclusion criteria|0
1171608|NCT01160744|3847687|P1|Overall Study|Not meet inclusion/exclusion criteria|0
1171609|NCT01160744|3847684|P4|Overall Study|Withdrawal by Subject|4
1171610|NCT01160744|3847685|P3|Overall Study|Withdrawal by Subject|6
1171611|NCT01160744|3847686|P2|Overall Study|Withdrawal by Subject|5
1171612|NCT01160744|3847687|P1|Overall Study|Withdrawal by Subject|6
1171613|NCT01160640|3847723|P2|Overall Study|Withdrawal by Subject|3
1171614|NCT01160640|3847724|P1|Overall Study|Withdrawal by Subject|0
1171615|NCT01160640|3847723|P2|Overall Study|Incarceration|0
1171616|NCT01160640|3847724|P1|Overall Study|Incarceration|1
1171617|NCT01160640|3847723|P2|Overall Study|Physician Decision|3
1171618|NCT01160640|3847724|P1|Overall Study|Physician Decision|3
1171619|NCT01160614|3847740|P2|Overall Study|Withdrawal by Subject|2
1171620|NCT01160614|3847741|P1|Overall Study|Withdrawal by Subject|0
1171621|NCT01160484|3847789|P1|Overall Study|inclusion/exclusion criteria failure|1
1171622|NCT01160484|3847789|P1|Overall Study|Withdrawal by Subject|2
1171623|NCT01160484|3847789|P1|Overall Study|Adverse Event|6
1171624|NCT01160484|3847789|P1|Overall Study|Lack of Efficacy|9
1171625|NCT01160198|3847870|P3|Overall Study|Participant lost drug; withdrew consent|1
1171626|NCT01160198|3847871|P2|Overall Study|Participant lost drug; withdrew consent|0
1171627|NCT01160198|3847872|P1|Overall Study|Participant lost drug; withdrew consent|0
1171628|NCT01160198|3847870|P3|Overall Study|Lost to Follow-up|0
1171629|NCT01160198|3847871|P2|Overall Study|Lost to Follow-up|1
1171630|NCT01160198|3847872|P1|Overall Study|Lost to Follow-up|0
1171631|NCT01160198|3847870|P3|Overall Study|Adverse Event|0
1171632|NCT01160198|3847871|P2|Overall Study|Adverse Event|1
1171633|NCT01160198|3847872|P1|Overall Study|Adverse Event|0
1171634|NCT01160198|3847870|P3|Overall Study|Withdrawal by Subject|0
1171635|NCT01160198|3847871|P2|Overall Study|Withdrawal by Subject|1
1171636|NCT01160198|3847872|P1|Overall Study|Withdrawal by Subject|2
1171637|NCT01159938|3847894|P5|First Study Period|Protocol Violation (Microalbuminuria)|0
1171638|NCT01159938|3847895|P4|First Study Period|Protocol Violation (Microalbuminuria)|0
1171639|NCT01159938|3847896|P3|First Study Period|Protocol Violation (Microalbuminuria)|1
1171640|NCT01159938|3847897|P2|First Study Period|Protocol Violation (Microalbuminuria)|0
1171641|NCT01159938|3847898|P1|First Study Period|Protocol Violation (Microalbuminuria)|0
1171642|NCT01159912|3847961|P3|Overall Study|Withdrawal by Subject|3
1171643|NCT01159912|3847962|P2|Overall Study|Withdrawal by Subject|3
1171644|NCT01159912|3847963|P1|Overall Study|Withdrawal by Subject|10
1171645|NCT01159912|3847961|P3|Overall Study|Physician Decision|3
1171646|NCT01159912|3847962|P2|Overall Study|Physician Decision|0
1171647|NCT01159912|3847963|P1|Overall Study|Physician Decision|0
1171648|NCT01159912|3847961|P3|Overall Study|Lost to Follow-up|0
1171649|NCT01159912|3847962|P2|Overall Study|Lost to Follow-up|0
1171650|NCT01159912|3847963|P1|Overall Study|Lost to Follow-up|4
1171651|NCT01159912|3847961|P3|Overall Study|Protocol Violation|3
1171652|NCT01159912|3847962|P2|Overall Study|Protocol Violation|2
1171653|NCT01159912|3847963|P1|Overall Study|Protocol Violation|1
1171654|NCT01159912|3847961|P3|Overall Study|Lack of Efficacy|14
1171655|NCT01159912|3847962|P2|Overall Study|Lack of Efficacy|15
1171656|NCT01159912|3847963|P1|Overall Study|Lack of Efficacy|23
1171657|NCT01159912|3847961|P3|Overall Study|Adverse Event|3
1171658|NCT01159912|3847962|P2|Overall Study|Adverse Event|2
1171659|NCT01159912|3847963|P1|Overall Study|Adverse Event|2
1171660|NCT01159769|3847986|P1|Overall Study|Adverse Event|1
1171661|NCT01159691|3848006|P1|Overall Study|Disc. Neupro lack of efficacy & unknown|1
1171662|NCT01159691|3848006|P1|Overall Study|Disc. Neupro due to AE & unknown reasons|2
1171663|NCT01159691|3848006|P1|Overall Study|Disc. Neupro other & unknown reasons|7
1171664|NCT01159691|3848006|P1|Overall Study|Disc. Neupro other & lost to follow-up|2
1171665|NCT01159691|3848006|P1|Overall Study|Discontinued Neupro due to other reasons|1
1171666|NCT01159691|3848006|P1|Overall Study|Discontinued Neupro due to Adverse Event|6
1171667|NCT01159691|3848006|P1|Overall Study|Unknown reasons|1
1171668|NCT01159691|3848006|P1|Overall Study|Lost to Follow-up|2
1171669|NCT01159665|3848019|P6|Overall Study|Withdrawal by Subject|0
1171670|NCT01159665|3848020|P5|Overall Study|Withdrawal by Subject|0
1171671|NCT01159665|3848021|P4|Overall Study|Withdrawal by Subject|0
1171672|NCT01159665|3848022|P3|Overall Study|Withdrawal by Subject|0
1171673|NCT01159665|3848023|P2|Overall Study|Withdrawal by Subject|1
1171674|NCT01159665|3848024|P1|Overall Study|Withdrawal by Subject|0
1171675|NCT01159600|3848052|P8|Overall Study|Other reason not defined above|3
1171676|NCT01159600|3848053|P7|Overall Study|Other reason not defined above|3
1171677|NCT01159600|3848054|P6|Overall Study|Other reason not defined above|7
1171678|NCT01159600|3848055|P5|Overall Study|Other reason not defined above|5
1171679|NCT01159600|3848056|P4|Overall Study|Other reason not defined above|2
1171680|NCT01159600|3848057|P3|Overall Study|Other reason not defined above|4
1171681|NCT01159600|3848058|P2|Overall Study|Other reason not defined above|0
1171682|NCT01159600|3848059|P1|Overall Study|Other reason not defined above|3
1171683|NCT01159600|3848052|P8|Overall Study|Patient refusal to continue,not due toAE|5
1171684|NCT01159600|3848053|P7|Overall Study|Patient refusal to continue,not due toAE|2
1171685|NCT01159600|3848054|P6|Overall Study|Patient refusal to continue,not due toAE|4
1171686|NCT01159600|3848055|P5|Overall Study|Patient refusal to continue,not due toAE|4
1171687|NCT01159600|3848056|P4|Overall Study|Patient refusal to continue,not due toAE|5
1171688|NCT01159600|3848057|P3|Overall Study|Patient refusal to continue,not due toAE|4
1171689|NCT01159600|3848058|P2|Overall Study|Patient refusal to continue,not due toAE|2
1171690|NCT01159600|3848059|P1|Overall Study|Patient refusal to continue,not due toAE|7
1171691|NCT01159600|3848052|P8|Overall Study|Lost to Follow-up|2
1171692|NCT01159600|3848053|P7|Overall Study|Lost to Follow-up|3
1171693|NCT01159600|3848054|P6|Overall Study|Lost to Follow-up|0
1171694|NCT01159600|3848055|P5|Overall Study|Lost to Follow-up|3
1171695|NCT01159600|3848056|P4|Overall Study|Lost to Follow-up|3
1171696|NCT01159600|3848057|P3|Overall Study|Lost to Follow-up|4
1171697|NCT01159600|3848058|P2|Overall Study|Lost to Follow-up|3
1171698|NCT01159600|3848059|P1|Overall Study|Lost to Follow-up|2
1171699|NCT01159600|3848052|P8|Overall Study|Non compliant with protocol|0
1171700|NCT01159600|3848053|P7|Overall Study|Non compliant with protocol|2
1171701|NCT01159600|3848054|P6|Overall Study|Non compliant with protocol|0
1171702|NCT01159600|3848055|P5|Overall Study|Non compliant with protocol|2
1171703|NCT01159600|3848056|P4|Overall Study|Non compliant with protocol|0
1171704|NCT01159600|3848057|P3|Overall Study|Non compliant with protocol|0
1171705|NCT01159600|3848058|P2|Overall Study|Non compliant with protocol|1
1171706|NCT01159600|3848059|P1|Overall Study|Non compliant with protocol|2
1171707|NCT01159600|3848052|P8|Overall Study|Lack of Efficacy|1
1171708|NCT01159600|3848053|P7|Overall Study|Lack of Efficacy|0
1171709|NCT01159600|3848054|P6|Overall Study|Lack of Efficacy|0
1171710|NCT01159600|3848055|P5|Overall Study|Lack of Efficacy|2
1171711|NCT01159600|3848056|P4|Overall Study|Lack of Efficacy|0
1171712|NCT01159600|3848057|P3|Overall Study|Lack of Efficacy|0
1171713|NCT01159600|3848058|P2|Overall Study|Lack of Efficacy|0
1171714|NCT01159600|3848059|P1|Overall Study|Lack of Efficacy|0
1171715|NCT01159600|3848052|P8|Overall Study|Adverse Event|5
1171716|NCT01159600|3848053|P7|Overall Study|Adverse Event|7
1171717|NCT01159600|3848054|P6|Overall Study|Adverse Event|6
1171718|NCT01159600|3848055|P5|Overall Study|Adverse Event|8
1171719|NCT01159600|3848056|P4|Overall Study|Adverse Event|1
1171720|NCT01159600|3848057|P3|Overall Study|Adverse Event|5
1171721|NCT01159600|3848058|P2|Overall Study|Adverse Event|2
1171722|NCT01159600|3848059|P1|Overall Study|Adverse Event|7
1171723|NCT01159600|3848052|P8|Overall Study|Not treated|2
1171724|NCT01159600|3848053|P7|Overall Study|Not treated|2
1171725|NCT01159600|3848054|P6|Overall Study|Not treated|1
1171726|NCT01159600|3848055|P5|Overall Study|Not treated|0
1171727|NCT01159600|3848056|P4|Overall Study|Not treated|0
1171728|NCT01159600|3848057|P3|Overall Study|Not treated|1
1171729|NCT01159600|3848058|P2|Overall Study|Not treated|0
1171730|NCT01159600|3848059|P1|Overall Study|Not treated|0
1171731|NCT01159574|3848101|P1|Follow Up Phase|still being followed for overall surviva|18
1171732|NCT01159574|3848101|P1|Follow Up Phase|Lost to Follow-up|2
1171733|NCT01159574|3848101|P1|Treatment Phase|still on treatment|2
1171734|NCT01159574|3848101|P1|Treatment Phase|Withdrawal by Subject|7
1171735|NCT01159574|3848101|P1|Treatment Phase|Physician Decision|2
1171736|NCT01159574|3848101|P1|Treatment Phase|Death|6
1171737|NCT01159574|3848101|P1|Treatment Phase|Adverse Event|3
1171738|NCT01159574|3848101|P1|Treatment Phase|non-evaluable/not included in analysis|1
1171739|NCT01159431|3848122|P2|Overall Study|Lack of Efficacy|3
1171740|NCT01159431|3848123|P1|Overall Study|Lack of Efficacy|0
1171741|NCT01159431|3848122|P2|Overall Study|non-compliance|1
1171742|NCT01159431|3848123|P1|Overall Study|non-compliance|1
1171743|NCT01159431|3848122|P2|Overall Study|Adverse Event|2
1171744|NCT01159431|3848123|P1|Overall Study|Adverse Event|1
1171745|NCT01159171|3848176|P1|Overall Study|Death|1
1171746|NCT01159171|3848176|P1|Overall Study|Medical Decision|4
1171747|NCT01159171|3848176|P1|Overall Study|Need for Surgery|5
1171748|NCT01159171|3848176|P1|Overall Study|Protocol Violation|1
1171749|NCT01159171|3848176|P1|Overall Study|Progression of Disease|28
1171750|NCT01159171|3848176|P1|Overall Study|Adverse Event|11
1171751|NCT01158924|3848250|P2|Overall Study|Lost to Follow-up|1
1171752|NCT01158924|3848251|P1|Overall Study|Lost to Follow-up|0
1171753|NCT01158924|3848250|P2|Overall Study|Withdrawal by Subject|2
1171754|NCT01158924|3848251|P1|Overall Study|Withdrawal by Subject|1
1171755|NCT01158534|3848345|P1|Overall Study|Other|1
1171756|NCT01158534|3848345|P1|Overall Study|Death|1
1171757|NCT01158534|3848345|P1|Overall Study|Withdrawal by Subject|1
1171758|NCT01158378|3848364|P2|Overall Study|Withdrawal by Subject|0
1171759|NCT01158378|3848365|P1|Overall Study|Withdrawal by Subject|4
1171760|NCT01158378|3848364|P2|Overall Study|Lost to Follow-up|4
1171761|NCT01158378|3848365|P1|Overall Study|Lost to Follow-up|2
1171762|NCT01158378|3848364|P2|Overall Study|Death|5
1171763|NCT01158378|3848365|P1|Overall Study|Death|4
1171764|NCT01158261|3848377|P1|Overall Study|Withdrawal by Subject|1
1171765|NCT01158261|3848377|P1|Overall Study|Death|7
1171766|NCT01158261|3848377|P1|Overall Study|Lost to Follow-up|9
1171767|NCT01158222|3848381|P1|Overall Study|Not eligible for intermediate phase|17
1171768|NCT01158118|3848389|P2|Overall Study|Death|1
1171769|NCT01158118|3848390|P1|Overall Study|Death|0
1171770|NCT01158118|3848389|P2|Overall Study|Suffered stroke prior to transplant|1
1171771|NCT01158118|3848390|P1|Overall Study|Suffered stroke prior to transplant|0
1171772|NCT01158118|3848389|P2|Overall Study|Donor match was a screen failure|1
1171773|NCT01158118|3848390|P1|Overall Study|Donor match was a screen failure|0
1171774|NCT01158118|3848389|P2|Overall Study|Screen failure|0
1171775|NCT01158118|3848390|P1|Overall Study|Screen failure|1
1171776|NCT01157845|3848406|P1|Overall Study|Device malfunction|1
1171777|NCT01157845|3848406|P1|Overall Study|Study was ended|1
1171778|NCT01157845|3848406|P1|Overall Study|Protocol Violation|13
1171779|NCT01157845|3848406|P1|Overall Study|Physician Decision|3
1171780|NCT01157845|3848406|P1|Overall Study|Withdrawal by Subject|12
1171781|NCT01157845|3848406|P1|Overall Study|Lost to Follow-up|5
1171782|NCT01157377|3848440|P7|Overall Study|Other Miscellaneous Reasons|1
1171783|NCT01157377|3848441|P6|Overall Study|Other Miscellaneous Reasons|1
1171784|NCT01157377|3848442|P5|Overall Study|Other Miscellaneous Reasons|1
1171785|NCT01157377|3848443|P4|Overall Study|Other Miscellaneous Reasons|0
1171786|NCT01157377|3848444|P3|Overall Study|Other Miscellaneous Reasons|0
1171787|NCT01157377|3848445|P2|Overall Study|Other Miscellaneous Reasons|2
1171788|NCT01157377|3848446|P1|Overall Study|Other Miscellaneous Reasons|0
1171789|NCT01157377|3848440|P7|Overall Study|Lack of Efficacy|1
1171790|NCT01157377|3848441|P6|Overall Study|Lack of Efficacy|0
1171791|NCT01157377|3848442|P5|Overall Study|Lack of Efficacy|0
1171792|NCT01157377|3848443|P4|Overall Study|Lack of Efficacy|0
1171793|NCT01157377|3848444|P3|Overall Study|Lack of Efficacy|0
1171794|NCT01157377|3848445|P2|Overall Study|Lack of Efficacy|0
1171795|NCT01157377|3848446|P1|Overall Study|Lack of Efficacy|0
1171796|NCT01157377|3848440|P7|Overall Study|Protocol Violation|0
1171797|NCT01157377|3848441|P6|Overall Study|Protocol Violation|1
1171798|NCT01157377|3848442|P5|Overall Study|Protocol Violation|0
1171799|NCT01157377|3848443|P4|Overall Study|Protocol Violation|0
1171800|NCT01157377|3848444|P3|Overall Study|Protocol Violation|0
1171801|NCT01157377|3848445|P2|Overall Study|Protocol Violation|0
1171802|NCT01157377|3848446|P1|Overall Study|Protocol Violation|0
1171803|NCT01157377|3848440|P7|Overall Study|Personal Reasons|0
1171804|NCT01157377|3848441|P6|Overall Study|Personal Reasons|0
1171805|NCT01157377|3848442|P5|Overall Study|Personal Reasons|0
1171806|NCT01157377|3848443|P4|Overall Study|Personal Reasons|1
1171807|NCT01157377|3848444|P3|Overall Study|Personal Reasons|0
1171808|NCT01157377|3848445|P2|Overall Study|Personal Reasons|1
1171809|NCT01157377|3848446|P1|Overall Study|Personal Reasons|2
1171810|NCT01157377|3848440|P7|Overall Study|Lost to Follow-up|0
1171811|NCT01157377|3848441|P6|Overall Study|Lost to Follow-up|1
1171812|NCT01157377|3848442|P5|Overall Study|Lost to Follow-up|1
1171813|NCT01157377|3848443|P4|Overall Study|Lost to Follow-up|0
1171814|NCT01157377|3848444|P3|Overall Study|Lost to Follow-up|1
1171815|NCT01157377|3848445|P2|Overall Study|Lost to Follow-up|0
1171816|NCT01157377|3848446|P1|Overall Study|Lost to Follow-up|0
1171817|NCT01157351|3848464|P2|Overall Study|Randomized but not Treated|2
1171818|NCT01157351|3848465|P1|Overall Study|Randomized but not Treated|4
1171819|NCT01157351|3848464|P2|Overall Study|Noncompliance with Study Drug|3
1171820|NCT01157351|3848465|P1|Overall Study|Noncompliance with Study Drug|0
1171821|NCT01157351|3848464|P2|Overall Study|Other|36
1171822|NCT01157351|3848465|P1|Overall Study|Other|32
1171823|NCT01157351|3848464|P2|Overall Study|Protocol Violation|1
1171824|NCT01157351|3848465|P1|Overall Study|Protocol Violation|0
1171825|NCT01157351|3848464|P2|Overall Study|Physician Decision|4
1171826|NCT01157351|3848465|P1|Overall Study|Physician Decision|5
1171827|NCT01157351|3848464|P2|Overall Study|Withdrawal by Subject|27
1171828|NCT01157351|3848465|P1|Overall Study|Withdrawal by Subject|37
1171829|NCT01157351|3848464|P2|Overall Study|Lost to Follow-up|55
1171830|NCT01157351|3848465|P1|Overall Study|Lost to Follow-up|53
1171831|NCT01157351|3848464|P2|Overall Study|Death|0
1171832|NCT01157351|3848465|P1|Overall Study|Death|1
1171833|NCT01157351|3848464|P2|Overall Study|Adverse Event|4
1171834|NCT01157351|3848465|P1|Overall Study|Adverse Event|5
1171835|NCT01157234|3848483|P2|Overall Study|Withdrawal by Subject|0
1171836|NCT01157234|3848484|P1|Overall Study|Withdrawal by Subject|1
1171837|NCT01157182|3848516|P2|Washout of 28 Days|Adverse Event|0
1171838|NCT01157182|3848517|P1|Washout of 28 Days|Adverse Event|2
1171839|NCT01157169|3848565|P2|Second Intervention|Emesis Within 4 hrs of Administration|1
1171840|NCT01157169|3848566|P1|Second Intervention|Emesis Within 4 hrs of Administration|0
1171841|NCT01157169|3848565|P2|First Intervention|Emesis Within 4 hrs of Administration|2
1171842|NCT01157169|3848566|P1|First Intervention|Emesis Within 4 hrs of Administration|4
1171843|NCT01157169|3848565|P2|First Intervention|Protocol Violation|0
1171844|NCT01157169|3848566|P1|First Intervention|Protocol Violation|0
1171845|NCT01157117|3848585|P3|Overall Study|Unknown (Pending Final Form Submission)|13
1171846|NCT01157117|3848586|P2|Overall Study|Unknown (Pending Final Form Submission)|5
1171847|NCT01157117|3848587|P1|Overall Study|Unknown (Pending Final Form Submission)|4
1171848|NCT01157117|3848585|P3|Overall Study|Lost to Follow-up|1
1171849|NCT01157117|3848586|P2|Overall Study|Lost to Follow-up|0
1171850|NCT01157117|3848587|P1|Overall Study|Lost to Follow-up|0
1171851|NCT01157117|3848585|P3|Overall Study|Lack of Efficacy|0
1171852|NCT01157117|3848586|P2|Overall Study|Lack of Efficacy|1
1171853|NCT01157117|3848587|P1|Overall Study|Lack of Efficacy|1
1171854|NCT01157117|3848585|P3|Overall Study|Withdrawal by Subject|1
1171855|NCT01157117|3848586|P2|Overall Study|Withdrawal by Subject|1
1171856|NCT01157117|3848587|P1|Overall Study|Withdrawal by Subject|4
1171857|NCT01157117|3848585|P3|Overall Study|Dosing Symptoms|0
1171858|NCT01157117|3848586|P2|Overall Study|Dosing Symptoms|4
1171859|NCT01157117|3848587|P1|Overall Study|Dosing Symptoms|0
1171860|NCT01157078|3848628|P2|Overall Study|Not specified|4
1171861|NCT01157078|3848629|P1|Overall Study|Not specified|2
1171862|NCT01157078|3848628|P2|Overall Study|Lost to Follow-up|5
1171863|NCT01157078|3848629|P1|Overall Study|Lost to Follow-up|7
1171864|NCT01157078|3848628|P2|Overall Study|Study-specific withdrawal criteria|2
1171865|NCT01157078|3848629|P1|Overall Study|Study-specific withdrawal criteria|2
1171866|NCT01157078|3848628|P2|Overall Study|Lack of Efficacy|0
1171867|NCT01157078|3848629|P1|Overall Study|Lack of Efficacy|2
1171868|NCT01157078|3848628|P2|Overall Study|Condition under investigation worsened|1
1171869|NCT01157078|3848629|P1|Overall Study|Condition under investigation worsened|0
1171870|NCT01157078|3848628|P2|Overall Study|Severe non-compliance to protocol|4
1171871|NCT01157078|3848629|P1|Overall Study|Severe non-compliance to protocol|2
1171872|NCT01157078|3848628|P2|Overall Study|Adverse Event|6
1171873|NCT01157078|3848629|P1|Overall Study|Adverse Event|6
1171874|NCT01157078|3848628|P2|Overall Study|Eligibility criteria not fulfilled|0
1171875|NCT01157078|3848629|P1|Overall Study|Eligibility criteria not fulfilled|2
1171876|NCT01157078|3848628|P2|Overall Study|Withdrawal by Subject|14
1171877|NCT01157078|3848629|P1|Overall Study|Withdrawal by Subject|12
1171878|NCT01157065|3848679|P2|Overall Study|Death|1
1171879|NCT01157065|3848680|P1|Overall Study|Death|0
1171880|NCT01156844|3848701|P4|Overall Study|Protocol deviation|0
1171881|NCT01156844|3848702|P3|Overall Study|Protocol deviation|0
1171882|NCT01156844|3848703|P2|Overall Study|Protocol deviation|0
1171883|NCT01156844|3848704|P1|Overall Study|Protocol deviation|2
1171884|NCT01156844|3848701|P4|Overall Study|Administrative problems|1
1171885|NCT01156844|3848702|P3|Overall Study|Administrative problems|0
1171886|NCT01156844|3848703|P2|Overall Study|Administrative problems|1
1171887|NCT01156844|3848704|P1|Overall Study|Administrative problems|0
1171888|NCT01156844|3848701|P4|Overall Study|Lost to Follow-up|0
1171889|NCT01156844|3848702|P3|Overall Study|Lost to Follow-up|1
1171890|NCT01156844|3848703|P2|Overall Study|Lost to Follow-up|0
1171891|NCT01156844|3848704|P1|Overall Study|Lost to Follow-up|0
1171892|NCT01156844|3848701|P4|Overall Study|Withdrawal by Subject|2
1171893|NCT01156844|3848702|P3|Overall Study|Withdrawal by Subject|2
1171894|NCT01156844|3848703|P2|Overall Study|Withdrawal by Subject|0
1171895|NCT01156844|3848704|P1|Overall Study|Withdrawal by Subject|0
1171896|NCT01156844|3848701|P4|Overall Study|Abnormal test procedure result(s)|2
1171897|NCT01156844|3848702|P3|Overall Study|Abnormal test procedure result(s)|2
1171898|NCT01156844|3848703|P2|Overall Study|Abnormal test procedure result(s)|1
1171899|NCT01156844|3848704|P1|Overall Study|Abnormal test procedure result(s)|0
1171900|NCT01156844|3848701|P4|Overall Study|Adverse Event|1
1171901|NCT01156844|3848702|P3|Overall Study|Adverse Event|1
1171902|NCT01156844|3848703|P2|Overall Study|Adverse Event|0
1171903|NCT01156844|3848704|P1|Overall Study|Adverse Event|0
1171904|NCT01156792|3848723|P1|Overall Study|other Sponsor Decision (Protocol Amendme|11
1171905|NCT01156792|3848723|P1|Overall Study|Withdrawal by Subject|9
1171906|NCT01156792|3848723|P1|Overall Study|Physician Decision|3
1171907|NCT01156792|3848723|P1|Overall Study|Lost to Follow-up|3
1171908|NCT01156792|3848723|P1|Overall Study|Protocol Violation|6
1171909|NCT01156792|3848723|P1|Overall Study|Lack of Efficacy|36
1171910|NCT01156792|3848723|P1|Overall Study|Adverse Event|1
1171911|NCT01156675|3848828|P3|Overall Study|No data|2
1171912|NCT01156675|3848829|P2|Overall Study|No data|22
1171913|NCT01156675|3848830|P1|Overall Study|No data|29
1171914|NCT01156675|3848828|P3|Overall Study|Death|0
1171915|NCT01156675|3848829|P2|Overall Study|Death|3
1171916|NCT01156675|3848830|P1|Overall Study|Death|5
1171917|NCT01156532|3848888|P1|Overall Study|Lost to Follow-up|1
1171918|NCT01156532|3848888|P1|Overall Study|Family Reasons|1
1171919|NCT01156480|3848900|P2|Overall Study|change in diagnosis|1
1171920|NCT01156480|3848901|P1|Overall Study|change in diagnosis|0
1171921|NCT01156376|3848912|P3|Overall Study|Withdrawal by Subject|3
1171922|NCT01156376|3848913|P2|Overall Study|Withdrawal by Subject|0
1171923|NCT01156376|3848914|P1|Overall Study|Withdrawal by Subject|0
1171924|NCT01156376|3848912|P3|Overall Study|Adverse Event|1
1171925|NCT01156376|3848913|P2|Overall Study|Adverse Event|0
1171926|NCT01156376|3848914|P1|Overall Study|Adverse Event|1
1171927|NCT01156363|3849135|P1|Overall Study|Other|6
1171928|NCT01156363|3849135|P1|Overall Study|Refused Treatment|4
1171929|NCT01156363|3849135|P1|Overall Study|Failure to Return|1
1171930|NCT01156363|3849135|P1|Overall Study|Insufficient Therapeutic Response|5
1171931|NCT01156363|3849135|P1|Overall Study|Adverse Event|6
1171932|NCT01156311|3849157|P4|6-month Add-on Therapy Period|Not Specified|2
1171933|NCT01156311|3849158|P3|6-month Add-on Therapy Period|Not Specified|1
1171934|NCT01156311|3849159|P2|6-month Add-on Therapy Period|Not Specified|0
1171935|NCT01156311|3849160|P1|6-month Add-on Therapy Period|Not Specified|0
1171936|NCT01156311|3849157|P4|6-month Add-on Therapy Period|Physician Decision|0
1171937|NCT01156311|3849158|P3|6-month Add-on Therapy Period|Physician Decision|1
1171938|NCT01156311|3849159|P2|6-month Add-on Therapy Period|Physician Decision|0
1171939|NCT01156311|3849160|P1|6-month Add-on Therapy Period|Physician Decision|0
1171940|NCT01156311|3849157|P4|6-month Add-on Therapy Period|Disease Activity|2
1171941|NCT01156311|3849158|P3|6-month Add-on Therapy Period|Disease Activity|1
1171942|NCT01156311|3849159|P2|6-month Add-on Therapy Period|Disease Activity|0
1171943|NCT01156311|3849160|P1|6-month Add-on Therapy Period|Disease Activity|0
1171944|NCT01156311|3849157|P4|6-month Add-on Therapy Period|Lost to Follow-up|0
1171945|NCT01156311|3849158|P3|6-month Add-on Therapy Period|Lost to Follow-up|2
1171946|NCT01156311|3849159|P2|6-month Add-on Therapy Period|Lost to Follow-up|0
1171947|NCT01156311|3849160|P1|6-month Add-on Therapy Period|Lost to Follow-up|0
1171948|NCT01156311|3849157|P4|6-month Add-on Therapy Period|Adverse Event|6
1171949|NCT01156311|3849158|P3|6-month Add-on Therapy Period|Adverse Event|7
1171950|NCT01156311|3849159|P2|6-month Add-on Therapy Period|Adverse Event|0
1171951|NCT01156311|3849160|P1|6-month Add-on Therapy Period|Adverse Event|0
1171952|NCT01156311|3849157|P4|2-Month Monotherapy Period|Not specified|0
1171953|NCT01156311|3849158|P3|2-Month Monotherapy Period|Not specified|0
1171954|NCT01156311|3849159|P2|2-Month Monotherapy Period|Not specified|0
1171955|NCT01156311|3849160|P1|2-Month Monotherapy Period|Not specified|1
1171956|NCT01156311|3849157|P4|2-Month Monotherapy Period|Physician Decision|0
1171957|NCT01156311|3849158|P3|2-Month Monotherapy Period|Physician Decision|0
1171958|NCT01156311|3849159|P2|2-Month Monotherapy Period|Physician Decision|1
1171959|NCT01156311|3849160|P1|2-Month Monotherapy Period|Physician Decision|0
1171960|NCT01156311|3849157|P4|2-Month Monotherapy Period|Withdrawal by Subject|0
1171961|NCT01156311|3849158|P3|2-Month Monotherapy Period|Withdrawal by Subject|0
1171962|NCT01156311|3849159|P2|2-Month Monotherapy Period|Withdrawal by Subject|1
1171963|NCT01156311|3849160|P1|2-Month Monotherapy Period|Withdrawal by Subject|1
1171964|NCT01156142|3849184|P2|Overall Study|Ineligible|1
1171965|NCT01156142|3849185|P1|Overall Study|Ineligible|0
1171966|NCT01156142|3849184|P2|Overall Study|Withdrawal by Subject|6
1171967|NCT01156142|3849185|P1|Overall Study|Withdrawal by Subject|8
1171968|NCT01156116|3849203|P2|Overall Study|CPAP intolerance|0
1171969|NCT01156116|3849204|P1|Overall Study|CPAP intolerance|2
1171970|NCT01156116|3849203|P2|Overall Study|Withdrawal by Subject|1
1171971|NCT01156116|3849204|P1|Overall Study|Withdrawal by Subject|3
1171972|NCT01156051|3849218|P2|Overall Study|patient not compliant with protocol|1
1171973|NCT01156051|3849219|P1|Overall Study|patient not compliant with protocol|0
1171974|NCT01156051|3849218|P2|Overall Study|Lost to Follow-up|0
1171975|NCT01156051|3849219|P1|Overall Study|Lost to Follow-up|1
1171976|NCT01156012|3849233|P2|Overall Study|Non respect of one of inclusion criteria|1
1171977|NCT01156012|3849234|P1|Overall Study|Non respect of one of inclusion criteria|2
1171978|NCT01156012|3849233|P2|Overall Study|use of commercial drug instead of study|1
1171979|NCT01156012|3849234|P1|Overall Study|use of commercial drug instead of study|0
1171980|NCT01156012|3849233|P2|Overall Study|Withdrawal by Subject|0
1171981|NCT01156012|3849234|P1|Overall Study|Withdrawal by Subject|1
1171982|NCT01156012|3849233|P2|Overall Study|Lost to Follow-up|0
1171983|NCT01156012|3849234|P1|Overall Study|Lost to Follow-up|1
1171984|NCT01156012|3849233|P2|Overall Study|Adverse Event|1
1171985|NCT01156012|3849234|P1|Overall Study|Adverse Event|3
1171986|NCT01155869|3849251|P2|Overall Study|Lost to Follow-up|1
1171987|NCT01155869|3849252|P1|Overall Study|Lost to Follow-up|3
1171988|NCT01155726|3849361|P4|Period 1, 3 Days (Masked)|Inconvenience|0
1171989|NCT01155726|3849362|P3|Period 1, 3 Days (Masked)|Inconvenience|2
1171990|NCT01155726|3849363|P2|Period 1, 3 Days (Masked)|Inconvenience|0
1171991|NCT01155726|3849364|P1|Period 1, 3 Days (Masked)|Inconvenience|1
1171992|NCT01155661|3849386|P1|Overall Study|Sponsor Decision|13
1171993|NCT01155661|3849386|P1|Overall Study|Withdrawal by Subject|73
1171994|NCT01155661|3849386|P1|Overall Study|Protocol Violation|35
1171995|NCT01155661|3849386|P1|Overall Study|Physician Decision|3
1171996|NCT01155661|3849386|P1|Overall Study|Lost to Follow-up|22
1171997|NCT01155661|3849386|P1|Overall Study|Lack of Efficacy|32
1171998|NCT01155661|3849386|P1|Overall Study|Death|1
1171999|NCT01155661|3849386|P1|Overall Study|Adverse Event|101
1172000|NCT01155570|3849412|P1|Overall Study|Other Reasons|23
1172001|NCT01155570|3849412|P1|Overall Study|Participant's Economic Reasons + Other|1
1172002|NCT01155570|3849412|P1|Overall Study|Adverse Event + Other Reasons|7
1172003|NCT01155570|3849412|P1|Overall Study|Adverse Event + Lack of Efficacy|2
1172004|NCT01155570|3849412|P1|Overall Study|No Hospital Visits|7
1172005|NCT01155570|3849412|P1|Overall Study|Participant's Economic Reasons|17
1172006|NCT01155570|3849412|P1|Overall Study|Lack of Efficacy|46
1172007|NCT01155570|3849412|P1|Overall Study|Adverse Event|39
1172008|NCT01155531|3849446|P4|Overall Study|Withdrawal by Subject|0
1172009|NCT01155531|3849447|P3|Overall Study|Withdrawal by Subject|1
1172010|NCT01155531|3849448|P2|Overall Study|Withdrawal by Subject|0
1172011|NCT01155531|3849449|P1|Overall Study|Withdrawal by Subject|1
1172012|NCT01155531|3849446|P4|Overall Study|Lost to Follow-up|1
1172013|NCT01155531|3849447|P3|Overall Study|Lost to Follow-up|0
1172014|NCT01155531|3849448|P2|Overall Study|Lost to Follow-up|0
1172015|NCT01155531|3849449|P1|Overall Study|Lost to Follow-up|0
1172016|NCT01155531|3849446|P4|Overall Study|Adverse Event|0
1172017|NCT01155531|3849447|P3|Overall Study|Adverse Event|1
1172018|NCT01155531|3849448|P2|Overall Study|Adverse Event|0
1172019|NCT01155531|3849449|P1|Overall Study|Adverse Event|0
1172020|NCT01155479|3849472|P5|Part II|Non-Compliance with Protocol|0
1172021|NCT01155479|3849473|P4|Part II|Non-Compliance with Protocol|2
1172022|NCT01155479|3849474|P3|Part II|Non-Compliance with Protocol|0
1172023|NCT01155479|3849475|P2|Part II|Non-Compliance with Protocol|1
1172024|NCT01155479|3849476|P1|Part II|Non-Compliance with Protocol|0
1172025|NCT01155479|3849472|P5|Part II|Treatment Failure|1
1172026|NCT01155479|3849473|P4|Part II|Treatment Failure|0
1172027|NCT01155479|3849474|P3|Part II|Treatment Failure|2
1172028|NCT01155479|3849475|P2|Part II|Treatment Failure|1
1172029|NCT01155479|3849476|P1|Part II|Treatment Failure|0
1172030|NCT01155479|3849472|P5|Part II|Lost to Follow-up|1
1172031|NCT01155479|3849473|P4|Part II|Lost to Follow-up|0
1172032|NCT01155479|3849474|P3|Part II|Lost to Follow-up|0
1172033|NCT01155479|3849475|P2|Part II|Lost to Follow-up|0
1172034|NCT01155479|3849476|P1|Part II|Lost to Follow-up|1
1172035|NCT01155479|3849472|P5|Part II|Withdrawal by Subject|3
1172036|NCT01155479|3849473|P4|Part II|Withdrawal by Subject|7
1172037|NCT01155479|3849474|P3|Part II|Withdrawal by Subject|12
1172038|NCT01155479|3849475|P2|Part II|Withdrawal by Subject|4
1172039|NCT01155479|3849476|P1|Part II|Withdrawal by Subject|8
1172040|NCT01155479|3849472|P5|Part II|Administrative|46
1172041|NCT01155479|3849473|P4|Part II|Administrative|38
1172042|NCT01155479|3849474|P3|Part II|Administrative|36
1172043|NCT01155479|3849475|P2|Part II|Administrative|49
1172044|NCT01155479|3849476|P1|Part II|Administrative|43
1172045|NCT01155479|3849472|P5|Part II|Adverse Event|4
1172046|NCT01155479|3849473|P4|Part II|Adverse Event|3
1172047|NCT01155479|3849474|P3|Part II|Adverse Event|8
1172048|NCT01155479|3849475|P2|Part II|Adverse Event|6
1172049|NCT01155479|3849476|P1|Part II|Adverse Event|7
1172050|NCT01155479|3849472|P5|Part I|Non-Compliance with Protocol|2
1172051|NCT01155479|3849473|P4|Part I|Non-Compliance with Protocol|3
1172052|NCT01155479|3849474|P3|Part I|Non-Compliance with Protocol|3
1172053|NCT01155479|3849475|P2|Part I|Non-Compliance with Protocol|1
1172054|NCT01155479|3849476|P1|Part I|Non-Compliance with Protocol|2
1172055|NCT01155479|3849472|P5|Part I|Did Not Receive Treatment|1
1172056|NCT01155479|3849473|P4|Part I|Did Not Receive Treatment|6
1172057|NCT01155479|3849474|P3|Part I|Did Not Receive Treatment|2
1172058|NCT01155479|3849475|P2|Part I|Did Not Receive Treatment|2
1172059|NCT01155479|3849476|P1|Part I|Did Not Receive Treatment|4
1172060|NCT01155479|3849472|P5|Part I|Treatment Failure|2
1172061|NCT01155479|3849473|P4|Part I|Treatment Failure|1
1172062|NCT01155479|3849474|P3|Part I|Treatment Failure|3
1172063|NCT01155479|3849475|P2|Part I|Treatment Failure|0
1172064|NCT01155479|3849476|P1|Part I|Treatment Failure|3
1172065|NCT01155479|3849472|P5|Part I|Lost to Follow-up|0
1172066|NCT01155479|3849473|P4|Part I|Lost to Follow-up|1
1172067|NCT01155479|3849474|P3|Part I|Lost to Follow-up|1
1172068|NCT01155479|3849475|P2|Part I|Lost to Follow-up|0
1172069|NCT01155479|3849476|P1|Part I|Lost to Follow-up|0
1172070|NCT01155479|3849472|P5|Part I|Withdrawal by Subject|9
1172071|NCT01155479|3849473|P4|Part I|Withdrawal by Subject|8
1172072|NCT01155479|3849474|P3|Part I|Withdrawal by Subject|8
1172073|NCT01155479|3849475|P2|Part I|Withdrawal by Subject|13
1172074|NCT01155479|3849476|P1|Part I|Withdrawal by Subject|11
1172075|NCT01155479|3849472|P5|Part I|Did Not Meet Protocol Eligibility|3
1172076|NCT01155479|3849473|P4|Part I|Did Not Meet Protocol Eligibility|1
1172077|NCT01155479|3849474|P3|Part I|Did Not Meet Protocol Eligibility|2
1172078|NCT01155479|3849475|P2|Part I|Did Not Meet Protocol Eligibility|1
1172079|NCT01155479|3849476|P1|Part I|Did Not Meet Protocol Eligibility|3
1172080|NCT01155479|3849472|P5|Part I|Administrative|0
1172081|NCT01155479|3849473|P4|Part I|Administrative|0
1172082|NCT01155479|3849474|P3|Part I|Administrative|2
1172083|NCT01155479|3849475|P2|Part I|Administrative|2
1172084|NCT01155479|3849476|P1|Part I|Administrative|2
1172085|NCT01155479|3849472|P5|Part I|Adverse Event|6
1172086|NCT01155479|3849473|P4|Part I|Adverse Event|7
1172087|NCT01155479|3849474|P3|Part I|Adverse Event|18
1172088|NCT01155479|3849475|P2|Part I|Adverse Event|8
1172089|NCT01155479|3849476|P1|Part I|Adverse Event|13
1172090|NCT01155466|3849528|P5|Overall Study|Randomized not treated|2
1172091|NCT01155466|3849529|P4|Overall Study|Randomized not treated|0
1172092|NCT01155466|3849530|P3|Overall Study|Randomized not treated|3
1172093|NCT01155466|3849531|P2|Overall Study|Randomized not treated|2
1172094|NCT01155466|3849532|P1|Overall Study|Randomized not treated|2
1172095|NCT01155466|3849528|P5|Overall Study|Administrative|0
1172096|NCT01155466|3849529|P4|Overall Study|Administrative|0
1172097|NCT01155466|3849530|P3|Overall Study|Administrative|0
1172098|NCT01155466|3849531|P2|Overall Study|Administrative|3
1172099|NCT01155466|3849532|P1|Overall Study|Administrative|0
1172100|NCT01155466|3849528|P5|Overall Study|Protocol Violation|1
1172101|NCT01155466|3849529|P4|Overall Study|Protocol Violation|0
1172102|NCT01155466|3849530|P3|Overall Study|Protocol Violation|2
1172103|NCT01155466|3849531|P2|Overall Study|Protocol Violation|0
1172104|NCT01155466|3849532|P1|Overall Study|Protocol Violation|0
1172105|NCT01155466|3849528|P5|Overall Study|Withdrawal by Subject|4
1172106|NCT01155466|3849529|P4|Overall Study|Withdrawal by Subject|4
1172107|NCT01155466|3849530|P3|Overall Study|Withdrawal by Subject|9
1172108|NCT01155466|3849531|P2|Overall Study|Withdrawal by Subject|5
1172109|NCT01155466|3849532|P1|Overall Study|Withdrawal by Subject|7
1172110|NCT01155466|3849528|P5|Overall Study|Lost to Follow-up|2
1172111|NCT01155466|3849529|P4|Overall Study|Lost to Follow-up|0
1172112|NCT01155466|3849530|P3|Overall Study|Lost to Follow-up|0
1172113|NCT01155466|3849531|P2|Overall Study|Lost to Follow-up|0
1172114|NCT01155466|3849532|P1|Overall Study|Lost to Follow-up|0
1172115|NCT01155466|3849528|P5|Overall Study|Adverse Event|18
1172116|NCT01155466|3849529|P4|Overall Study|Adverse Event|17
1172117|NCT01155466|3849530|P3|Overall Study|Adverse Event|6
1172118|NCT01155466|3849531|P2|Overall Study|Adverse Event|15
1172119|NCT01155466|3849532|P1|Overall Study|Adverse Event|13
1172120|NCT01155388|3849586|P2|Overall Study|Adverse Event|0
1172121|NCT01155388|3849587|P1|Overall Study|Adverse Event|1
1172122|NCT01155375|3849597|P2|Overall Study|Adverse Event|0
1172123|NCT01155375|3849598|P1|Overall Study|Adverse Event|1
1172124|NCT01155323|3849617|P2|Second Intervention|Lost to Follow-up|1
1172125|NCT01155323|3849618|P1|Second Intervention|Lost to Follow-up|1
1172126|NCT01155323|3849617|P2|First Intervention|exclusion criteria|1
1172127|NCT01155323|3849618|P1|First Intervention|exclusion criteria|1
1172128|NCT01155284|3849636|P2|Overall Study|Adverse Event|0
1172129|NCT01155284|3849637|P1|Overall Study|Adverse Event|1
1172130|NCT01155284|3849636|P2|Overall Study|Physician Decision|0
1172131|NCT01155284|3849637|P1|Overall Study|Physician Decision|1
1172132|NCT01155284|3849636|P2|Overall Study|Lost to Follow-up|2
1172133|NCT01155284|3849637|P1|Overall Study|Lost to Follow-up|1
1172134|NCT01155284|3849636|P2|Overall Study|Withdrawal by Subject|3
1172135|NCT01155284|3849637|P1|Overall Study|Withdrawal by Subject|4
1172136|NCT01155219|3849647|P2|Overall Study|non-medical reason|2
1172137|NCT01155219|3849648|P1|Overall Study|non-medical reason|1
1172138|NCT01155219|3849647|P2|Overall Study|Adverse Event|1
1172139|NCT01155219|3849648|P1|Overall Study|Adverse Event|3
1172140|NCT01155167|3849697|P2|Overall Study|Access site changed to femoral artery|0
1172141|NCT01155167|3849698|P1|Overall Study|Access site changed to femoral artery|1
1172142|NCT01155167|3849697|P2|Overall Study|Insufficient ultrasound data|0
1172143|NCT01155167|3849698|P1|Overall Study|Insufficient ultrasound data|2
1172144|NCT01155141|3849721|P1|Overall Study|Screen Failure|1
1172145|NCT01155141|3849721|P1|Overall Study|Withdrawal by Subject|1
1172146|NCT01155063|3849733|P1|Overall Study|Study terminated by sponsor|87
1172147|NCT01155063|3849733|P1|Overall Study|Withdrawal by Subject|1
1172148|NCT01155063|3849733|P1|Overall Study|Adverse Event|1
1172149|NCT01155024|3849743|P2|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2
1172150|NCT01155024|3849744|P1|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0
1172151|NCT01155024|3849743|P2|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2
1172152|NCT01155024|3849744|P1|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0
1172153|NCT01155024|3849743|P2|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2
1172154|NCT01155024|3849744|P1|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0
1172155|NCT01155011|3849754|P2|6 to 12 Months|Death|5
1172156|NCT01155011|3849755|P1|6 to 12 Months|Death|1
1172157|NCT01155011|3849754|P2|6 to 12 Months|Withdrawal by Subject|5
1172158|NCT01155011|3849755|P1|6 to 12 Months|Withdrawal by Subject|8
1172159|NCT01155011|3849754|P2|Baseline to 6 Months|Death|1
1172160|NCT01155011|3849755|P1|Baseline to 6 Months|Death|0
1172161|NCT01155011|3849754|P2|Baseline to 6 Months|investigator decision, moved|5
1172162|NCT01155011|3849755|P1|Baseline to 6 Months|investigator decision, moved|4
1172163|NCT01155011|3849754|P2|Baseline to 6 Months|Withdrawal by Subject|19
1172164|NCT01155011|3849755|P1|Baseline to 6 Months|Withdrawal by Subject|18
1172165|NCT01154816|3849796|P12|Overall Study|Adverse Event|0
1172166|NCT01154816|3849797|P11|Overall Study|Adverse Event|0
1172167|NCT01154816|3849798|P10|Overall Study|Adverse Event|0
1172168|NCT01154816|3849799|P9|Overall Study|Adverse Event|0
1172169|NCT01154816|3849800|P8|Overall Study|Adverse Event|1
1172170|NCT01154816|3849801|P7|Overall Study|Adverse Event|1
1172171|NCT01154816|3849802|P6|Overall Study|Adverse Event|0
1172172|NCT01154816|3849803|P5|Overall Study|Adverse Event|0
1172173|NCT01154816|3849804|P4|Overall Study|Adverse Event|0
1172174|NCT01154816|3849805|P3|Overall Study|Adverse Event|0
1172175|NCT01154816|3849806|P2|Overall Study|Adverse Event|2
1172176|NCT01154816|3849807|P1|Overall Study|Adverse Event|5
1172177|NCT01154816|3849796|P12|Overall Study|Physician Decision|1
1172178|NCT01154816|3849797|P11|Overall Study|Physician Decision|1
1172179|NCT01154816|3849798|P10|Overall Study|Physician Decision|1
1172180|NCT01154816|3849799|P9|Overall Study|Physician Decision|0
1172181|NCT01154816|3849800|P8|Overall Study|Physician Decision|0
1172182|NCT01154816|3849801|P7|Overall Study|Physician Decision|0
1172183|NCT01154816|3849802|P6|Overall Study|Physician Decision|0
1172184|NCT01154816|3849803|P5|Overall Study|Physician Decision|2
1172185|NCT01154816|3849804|P4|Overall Study|Physician Decision|0
1172186|NCT01154816|3849805|P3|Overall Study|Physician Decision|1
1172187|NCT01154816|3849806|P2|Overall Study|Physician Decision|0
1172188|NCT01154816|3849807|P1|Overall Study|Physician Decision|1
1172189|NCT01154816|3849796|P12|Overall Study|Progressive Disease|3
1172190|NCT01154816|3849797|P11|Overall Study|Progressive Disease|10
1172191|NCT01154816|3849798|P10|Overall Study|Progressive Disease|6
1172192|NCT01154816|3849799|P9|Overall Study|Progressive Disease|8
1172193|NCT01154816|3849800|P8|Overall Study|Progressive Disease|6
1172194|NCT01154816|3849801|P7|Overall Study|Progressive Disease|5
1172195|NCT01154816|3849802|P6|Overall Study|Progressive Disease|8
1172196|NCT01154816|3849803|P5|Overall Study|Progressive Disease|8
1172197|NCT01154816|3849804|P4|Overall Study|Progressive Disease|9
1172198|NCT01154816|3849805|P3|Overall Study|Progressive Disease|9
1172199|NCT01154816|3849806|P2|Overall Study|Progressive Disease|8
1172200|NCT01154816|3849807|P1|Overall Study|Progressive Disease|13
1172201|NCT01154816|3849796|P12|Overall Study|Withdrawal by Subject|0
1172202|NCT01154816|3849797|P11|Overall Study|Withdrawal by Subject|0
1172203|NCT01154816|3849798|P10|Overall Study|Withdrawal by Subject|3
1172204|NCT01154816|3849799|P9|Overall Study|Withdrawal by Subject|1
1172205|NCT01154816|3849800|P8|Overall Study|Withdrawal by Subject|0
1172206|NCT01154816|3849801|P7|Overall Study|Withdrawal by Subject|0
1172207|NCT01154816|3849802|P6|Overall Study|Withdrawal by Subject|0
1172208|NCT01154816|3849803|P5|Overall Study|Withdrawal by Subject|0
1172209|NCT01154816|3849804|P4|Overall Study|Withdrawal by Subject|1
1172210|NCT01154816|3849805|P3|Overall Study|Withdrawal by Subject|0
1172211|NCT01154816|3849806|P2|Overall Study|Withdrawal by Subject|0
1172212|NCT01154816|3849807|P1|Overall Study|Withdrawal by Subject|1
1172213|NCT01154673|3849884|P2|Overall Study|moved out of province|0
1172214|NCT01154673|3849885|P1|Overall Study|moved out of province|1
1172215|NCT01154673|3849884|P2|Overall Study|Lost to Follow-up|0
1172216|NCT01154673|3849885|P1|Overall Study|Lost to Follow-up|1
1172217|NCT01154452|3849940|P4|Phase II|Adverse Event|4
1172218|NCT01154452|3849941|P3|Phase II|Adverse Event|4
1172219|NCT01154452|3849942|P2|Phase II|Adverse Event|0
1172220|NCT01154452|3849943|P1|Phase II|Adverse Event|0
1172221|NCT01154452|3849940|P4|Phase II|Withdrawal by Subject|2
1172222|NCT01154452|3849941|P3|Phase II|Withdrawal by Subject|1
1172223|NCT01154452|3849942|P2|Phase II|Withdrawal by Subject|0
1172224|NCT01154452|3849943|P1|Phase II|Withdrawal by Subject|0
1172225|NCT01154452|3849940|P4|Phase Ib|Adverse Event|0
1172226|NCT01154452|3849941|P3|Phase Ib|Adverse Event|0
1172227|NCT01154452|3849942|P2|Phase Ib|Adverse Event|1
1172228|NCT01154452|3849943|P1|Phase Ib|Adverse Event|2
1172229|NCT01154452|3849940|P4|Phase Ib|Not Treated|0
1172230|NCT01154452|3849941|P3|Phase Ib|Not Treated|0
1172231|NCT01154452|3849942|P2|Phase Ib|Not Treated|0
1172232|NCT01154452|3849943|P1|Phase Ib|Not Treated|1
1172233|NCT01154296|3849975|P2|6-month Follow-up|Declined by Study Coordinator|4
1172234|NCT01154296|3849976|P1|6-month Follow-up|Declined by Study Coordinator|5
1172235|NCT01154296|3849975|P2|6-month Follow-up|Death|2
1172236|NCT01154296|3849976|P1|6-month Follow-up|Death|3
1172237|NCT01154296|3849975|P2|6-month Follow-up|Withdrew consent|15
1172238|NCT01154296|3849976|P1|6-month Follow-up|Withdrew consent|14
1172239|NCT01154296|3849975|P2|6-month Follow-up|Incarcerated|32
1172240|NCT01154296|3849976|P1|6-month Follow-up|Incarcerated|37
1172241|NCT01154296|3849975|P2|6-month Follow-up|Lost contact|275
1172242|NCT01154296|3849976|P1|6-month Follow-up|Lost contact|269
1172243|NCT01154296|3849975|P2|Randomization and Intervention|Left clinic early|0
1172244|NCT01154296|3849976|P1|Randomization and Intervention|Left clinic early|2
1172245|NCT01154296|3849975|P2|Randomization and Intervention|Left before test|1
1172246|NCT01154296|3849976|P1|Randomization and Intervention|Left before test|0
1172247|NCT01154296|3849975|P2|Randomization and Intervention|Did not return|0
1172248|NCT01154296|3849976|P1|Randomization and Intervention|Did not return|1
1172249|NCT01154296|3849975|P2|Randomization and Intervention|Declined by staff|0
1172250|NCT01154296|3849976|P1|Randomization and Intervention|Declined by staff|1
1172251|NCT01154296|3849975|P2|Randomization and Intervention|Decided to decline|1
1172252|NCT01154296|3849976|P1|Randomization and Intervention|Decided to decline|1
1172253|NCT01154283|3849994|P2|7-12 Weeks|Withdrawal by Subject|1
1172254|NCT01154283|3849995|P1|7-12 Weeks|Withdrawal by Subject|0
1172255|NCT01154283|3849994|P2|7-12 Weeks|Death|0
1172256|NCT01154283|3849995|P1|7-12 Weeks|Death|1
1172257|NCT01154283|3849994|P2|0-6 Weeks|Death|1
1172258|NCT01154283|3849995|P1|0-6 Weeks|Death|0
1172259|NCT01154283|3849994|P2|0-6 Weeks|Withdrawal by Subject|2
1172260|NCT01154283|3849995|P1|0-6 Weeks|Withdrawal by Subject|7
1172261|NCT01154231|3850007|P1|Overall Study|No Info. After 1st Day, No Drug Admin.|1
1172262|NCT01154231|3850007|P1|Overall Study|Safety Unassessable, No Drug Admin.|1
1172263|NCT01154218|3850013|P4|Fourth Intervention Period|Withdrawal by Subject|0
1172264|NCT01154218|3850014|P3|Fourth Intervention Period|Withdrawal by Subject|0
1172265|NCT01154218|3850015|P2|Fourth Intervention Period|Withdrawal by Subject|0
1172266|NCT01154218|3850016|P1|Fourth Intervention Period|Withdrawal by Subject|1
1172267|NCT01154218|3850013|P4|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
1172268|NCT01154218|3850014|P3|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
1172269|NCT01154218|3850015|P2|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
1172270|NCT01154218|3850016|P1|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
1172271|NCT01154218|3850013|P4|Third Intervention Period|Adverse Event|0
1172272|NCT01154218|3850014|P3|Third Intervention Period|Adverse Event|0
1172273|NCT01154218|3850015|P2|Third Intervention Period|Adverse Event|1
1172274|NCT01154218|3850016|P1|Third Intervention Period|Adverse Event|0
1172275|NCT01154166|3850068|P2|Overall Study|Poor Compliance|0
1172276|NCT01154166|3850069|P1|Overall Study|Poor Compliance|1
1172277|NCT01154166|3850068|P2|Overall Study|Disease Progression|0
1172278|NCT01154166|3850069|P1|Overall Study|Disease Progression|1
1172279|NCT01154166|3850068|P2|Overall Study|Lack of Efficacy|0
1172280|NCT01154166|3850069|P1|Overall Study|Lack of Efficacy|3
1172281|NCT01154166|3850068|P2|Overall Study|Withdrawal by Subject|1
1172282|NCT01154166|3850069|P1|Overall Study|Withdrawal by Subject|10
1172283|NCT01154166|3850068|P2|Overall Study|Protocol Violation|1
1172284|NCT01154166|3850069|P1|Overall Study|Protocol Violation|4
1172285|NCT01154166|3850068|P2|Overall Study|Lost to Follow-up|1
1172286|NCT01154166|3850069|P1|Overall Study|Lost to Follow-up|1
1172287|NCT01154166|3850068|P2|Overall Study|Adverse Event|9
1172288|NCT01154166|3850069|P1|Overall Study|Adverse Event|14
1172289|NCT01154153|3850101|P2|Overall Study|Withdrew consent|0
1172290|NCT01154153|3850102|P1|Overall Study|Withdrew consent|1
1172291|NCT01154153|3850101|P2|Overall Study|Unable to use labs|3
1172292|NCT01154153|3850102|P1|Overall Study|Unable to use labs|2
1172293|NCT01154153|3850101|P2|Overall Study|Poor compliance to protocol|0
1172294|NCT01154153|3850102|P1|Overall Study|Poor compliance to protocol|2
1172295|NCT01154140|3850120|P2|Overall Study|Randomized but not treated|2
1172296|NCT01154140|3850121|P1|Overall Study|Randomized but not treated|1
1172297|NCT01154140|3850120|P2|Overall Study|Other|1
1172298|NCT01154140|3850121|P1|Overall Study|Other|3
1172299|NCT01154140|3850120|P2|Overall Study|Withdrawal by Subject|13
1172300|NCT01154140|3850121|P1|Overall Study|Withdrawal by Subject|12
1172301|NCT01154140|3850120|P2|Overall Study|Lost to Follow-up|5
1172302|NCT01154140|3850121|P1|Overall Study|Lost to Follow-up|4
1172303|NCT01154140|3850120|P2|Overall Study|Death|81
1172304|NCT01154140|3850121|P1|Overall Study|Death|71
1172305|NCT01154127|3850174|P2|Period 2 (21 Days)|Protocol Deviation|1
1172306|NCT01154127|3850175|P1|Period 2 (21 Days)|Protocol Deviation|0
1172307|NCT01154127|3850174|P2|Washout (14 - 28 Days)|Abnormal Test Procedure|0
1172308|NCT01154127|3850175|P1|Washout (14 - 28 Days)|Abnormal Test Procedure|1
1172309|NCT01154127|3850174|P2|Washout (14 - 28 Days)|Adverse Event|0
1172310|NCT01154127|3850175|P1|Washout (14 - 28 Days)|Adverse Event|2
1172311|NCT01154127|3850174|P2|Period 1 (21 Days)|Withdrawal by Subject|2
1172312|NCT01154127|3850175|P1|Period 1 (21 Days)|Withdrawal by Subject|0
1172313|NCT01154127|3850174|P2|Period 1 (21 Days)|Adverse Event|4
1172314|NCT01154127|3850175|P1|Period 1 (21 Days)|Adverse Event|3
1172315|NCT01154101|3850202|P5|Overall Study|Withdrawal by Subject|1
1172316|NCT01154101|3850203|P4|Overall Study|Withdrawal by Subject|0
1172317|NCT01154101|3850204|P3|Overall Study|Withdrawal by Subject|2
1172318|NCT01154101|3850205|P2|Overall Study|Withdrawal by Subject|1
1172319|NCT01154101|3850206|P1|Overall Study|Withdrawal by Subject|0
1172320|NCT01154101|3850202|P5|Overall Study|Lost to Follow-up|0
1172321|NCT01154101|3850203|P4|Overall Study|Lost to Follow-up|1
1172322|NCT01154101|3850204|P3|Overall Study|Lost to Follow-up|0
1172323|NCT01154101|3850205|P2|Overall Study|Lost to Follow-up|1
1172324|NCT01154101|3850206|P1|Overall Study|Lost to Follow-up|0
1172325|NCT01154101|3850202|P5|Overall Study|Adverse Event|0
1172326|NCT01154101|3850203|P4|Overall Study|Adverse Event|1
1172327|NCT01154101|3850204|P3|Overall Study|Adverse Event|1
1172328|NCT01154101|3850205|P2|Overall Study|Adverse Event|2
1172329|NCT01154101|3850206|P1|Overall Study|Adverse Event|0
1172330|NCT01154088|3850261|P3|Overall Study|Lost to Follow-up|7
1172331|NCT01154088|3850262|P2|Overall Study|Lost to Follow-up|6
1172332|NCT01154088|3850263|P1|Overall Study|Lost to Follow-up|4
1172333|NCT01154036|3850303|P8|Phase II|Withdrawal by Subject|4
1172334|NCT01154036|3850304|P7|Phase II|Withdrawal by Subject|5
1172335|NCT01154036|3850305|P6|Phase II|Withdrawal by Subject|2
1172336|NCT01154036|3850306|P5|Phase II|Withdrawal by Subject|4
1172337|NCT01154036|3850307|P4|Phase II|Withdrawal by Subject|0
1172338|NCT01154036|3850308|P3|Phase II|Withdrawal by Subject|0
1172339|NCT01154036|3850309|P2|Phase II|Withdrawal by Subject|0
1172340|NCT01154036|3850310|P1|Phase II|Withdrawal by Subject|0
1172341|NCT01154036|3850303|P8|Phase II|Protocol Violation|0
1172342|NCT01154036|3850304|P7|Phase II|Protocol Violation|0
1172343|NCT01154036|3850305|P6|Phase II|Protocol Violation|2
1172344|NCT01154036|3850306|P5|Phase II|Protocol Violation|1
1172345|NCT01154036|3850307|P4|Phase II|Protocol Violation|0
1172346|NCT01154036|3850308|P3|Phase II|Protocol Violation|0
1172347|NCT01154036|3850309|P2|Phase II|Protocol Violation|0
1172348|NCT01154036|3850310|P1|Phase II|Protocol Violation|0
1172349|NCT01154036|3850303|P8|Phase II|Lost to Follow-up|1
1172350|NCT01154036|3850304|P7|Phase II|Lost to Follow-up|2
1172351|NCT01154036|3850305|P6|Phase II|Lost to Follow-up|0
1172352|NCT01154036|3850306|P5|Phase II|Lost to Follow-up|2
1172353|NCT01154036|3850307|P4|Phase II|Lost to Follow-up|1
1172354|NCT01154036|3850308|P3|Phase II|Lost to Follow-up|0
1172355|NCT01154036|3850309|P2|Phase II|Lost to Follow-up|0
1172356|NCT01154036|3850310|P1|Phase II|Lost to Follow-up|0
1172357|NCT01154036|3850303|P8|Phase II|Physician Decision|0
1172358|NCT01154036|3850304|P7|Phase II|Physician Decision|1
1172359|NCT01154036|3850305|P6|Phase II|Physician Decision|0
1172360|NCT01154036|3850306|P5|Phase II|Physician Decision|0
1172361|NCT01154036|3850307|P4|Phase II|Physician Decision|0
1172362|NCT01154036|3850308|P3|Phase II|Physician Decision|0
1172363|NCT01154036|3850309|P2|Phase II|Physician Decision|0
1172364|NCT01154036|3850310|P1|Phase II|Physician Decision|0
1172365|NCT01154036|3850303|P8|Phase II|Adverse Event|1
1172366|NCT01154036|3850304|P7|Phase II|Adverse Event|1
1172367|NCT01154036|3850305|P6|Phase II|Adverse Event|1
1172368|NCT01154036|3850306|P5|Phase II|Adverse Event|1
1172369|NCT01154036|3850307|P4|Phase II|Adverse Event|0
1172370|NCT01154036|3850308|P3|Phase II|Adverse Event|0
1172371|NCT01154036|3850309|P2|Phase II|Adverse Event|0
1172372|NCT01154036|3850310|P1|Phase II|Adverse Event|0
1172373|NCT01154036|3850303|P8|Phase I|Adverse Event|0
1172374|NCT01154036|3850304|P7|Phase I|Adverse Event|0
1172375|NCT01154036|3850305|P6|Phase I|Adverse Event|0
1172376|NCT01154036|3850306|P5|Phase I|Adverse Event|0
1172377|NCT01154036|3850307|P4|Phase I|Adverse Event|0
1172378|NCT01154036|3850308|P3|Phase I|Adverse Event|12
1172379|NCT01154036|3850309|P2|Phase I|Adverse Event|11
1172380|NCT01154036|3850310|P1|Phase I|Adverse Event|1
1172381|NCT01154036|3850303|P8|Phase I|Withdrawal by Subject|0
1172382|NCT01154036|3850304|P7|Phase I|Withdrawal by Subject|0
1172383|NCT01154036|3850305|P6|Phase I|Withdrawal by Subject|0
1172384|NCT01154036|3850306|P5|Phase I|Withdrawal by Subject|0
1172385|NCT01154036|3850307|P4|Phase I|Withdrawal by Subject|0
1172386|NCT01154036|3850308|P3|Phase I|Withdrawal by Subject|29
1172387|NCT01154036|3850309|P2|Phase I|Withdrawal by Subject|10
1172388|NCT01154036|3850310|P1|Phase I|Withdrawal by Subject|2
1172389|NCT01154036|3850303|P8|Phase I|Protocol Violation|0
1172390|NCT01154036|3850304|P7|Phase I|Protocol Violation|0
1172391|NCT01154036|3850305|P6|Phase I|Protocol Violation|0
1172392|NCT01154036|3850306|P5|Phase I|Protocol Violation|0
1172393|NCT01154036|3850307|P4|Phase I|Protocol Violation|0
1172394|NCT01154036|3850308|P3|Phase I|Protocol Violation|9
1172395|NCT01154036|3850309|P2|Phase I|Protocol Violation|3
1172396|NCT01154036|3850310|P1|Phase I|Protocol Violation|0
1172397|NCT01154036|3850303|P8|Phase I|Lost to Follow-up|0
1172398|NCT01154036|3850304|P7|Phase I|Lost to Follow-up|0
1172399|NCT01154036|3850305|P6|Phase I|Lost to Follow-up|0
1172400|NCT01154036|3850306|P5|Phase I|Lost to Follow-up|0
1172401|NCT01154036|3850307|P4|Phase I|Lost to Follow-up|0
1172402|NCT01154036|3850308|P3|Phase I|Lost to Follow-up|6
1172403|NCT01154036|3850309|P2|Phase I|Lost to Follow-up|3
1172404|NCT01154036|3850310|P1|Phase I|Lost to Follow-up|0
1172405|NCT01154036|3850303|P8|Phase I|Physician Decision|0
1172406|NCT01154036|3850304|P7|Phase I|Physician Decision|0
1172407|NCT01154036|3850305|P6|Phase I|Physician Decision|0
1172408|NCT01154036|3850306|P5|Phase I|Physician Decision|0
1172409|NCT01154036|3850307|P4|Phase I|Physician Decision|0
1172410|NCT01154036|3850308|P3|Phase I|Physician Decision|0
1172411|NCT01154036|3850309|P2|Phase I|Physician Decision|1
1172412|NCT01154036|3850310|P1|Phase I|Physician Decision|0
1172413|NCT01154010|3850434|P2|Overall Study|Lost to Follow-up|1
1172414|NCT01154010|3850435|P1|Overall Study|Lost to Follow-up|0
1172415|NCT01153984|3850441|P1|Overall Study|Adverse Event|1
1172416|NCT01153984|3850441|P1|Overall Study|Withdrawal by Subject|1
1172417|NCT01153971|3850452|P1|Follow-up (Months 17-40 of Study)|Disease progression|2
1172418|NCT01153971|3850452|P1|Follow-up (Months 17-40 of Study)|Protocol Violation|1
1172419|NCT01153971|3850452|P1|Follow-up (Months 17-40 of Study)|Adverse Event|1
1172420|NCT01153971|3850452|P1|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1
1172421|NCT01153971|3850452|P1|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2
1172422|NCT01153971|3850452|P1|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1
1172423|NCT01153971|3850452|P1|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2
1172424|NCT01153958|3850475|P2|Overall Study|Study Terminated|32
1172425|NCT01153958|3850476|P1|Overall Study|Study Terminated|36
1172426|NCT01153893|3850494|P2|Overall Study|Adverse Event|0
1172427|NCT01153893|3850495|P1|Overall Study|Adverse Event|1
1172428|NCT01153841|3850521|P2|Overall Study|Lost to Follow-up|0
1172429|NCT01153841|3850522|P1|Overall Study|Lost to Follow-up|2
1172430|NCT01153841|3850521|P2|Overall Study|Protocol Violation|0
1172431|NCT01153841|3850522|P1|Overall Study|Protocol Violation|2
1172432|NCT01153841|3850521|P2|Overall Study|Withdrawal by Subject|0
1172433|NCT01153841|3850522|P1|Overall Study|Withdrawal by Subject|1
1172434|NCT01153841|3850521|P2|Overall Study|Adverse Event|0
1172435|NCT01153841|3850522|P1|Overall Study|Adverse Event|1
1172436|NCT01153815|3850538|P2|Overall Study|Withdrawal by Subject|4
1172437|NCT01153815|3850539|P1|Overall Study|Withdrawal by Subject|6
1172438|NCT01153815|3850538|P2|Overall Study|Adverse Event|1
1172439|NCT01153815|3850539|P1|Overall Study|Adverse Event|3
1172440|NCT01153763|3850561|P1|Overall Study|Withdrawal by Subject|2
1172441|NCT01153763|3850561|P1|Overall Study|Physician Decision|2
1172442|NCT01153763|3850561|P1|Overall Study|Lost to Follow-up|1
1172443|NCT01153763|3850561|P1|Overall Study|Study Closed|16
1172444|NCT01153724|3850577|P1|Treatment Period 2|Other reason not defined above|1
1172445|NCT01153724|3850577|P1|Treatment Period 2|Adverse Event|1
1172446|NCT01153724|3850577|P1|Treatment Period 1|Withdrawal by Subject|1
1172447|NCT01153698|3850617|P1|Overall Study|Not treated with Pradaxa|5
1172448|NCT01153698|3850617|P1|Overall Study|Other|2
1172449|NCT01153698|3850617|P1|Overall Study|Switch to other anticoagulants|4
1172450|NCT01153698|3850617|P1|Overall Study|Withdrawal by Subject|2
1172451|NCT01153698|3850617|P1|Overall Study|Lost to Follow-up|4
1172452|NCT01153698|3850617|P1|Overall Study|Adverse Event|12
1172453|NCT01153633|3850668|P2|Overall Study|Therapeutic failure|3
1172454|NCT01153633|3850669|P1|Overall Study|Therapeutic failure|3
1172455|NCT01153633|3850668|P2|Overall Study|Protocol Violation|1
1172456|NCT01153633|3850669|P1|Overall Study|Protocol Violation|1
1172457|NCT01153425|3850719|P2|Overall Study|Withdrawal by Subject|3
1172458|NCT01153425|3850720|P1|Overall Study|Withdrawal by Subject|3
1172459|NCT01153347|3850732|P4|Overall Study|Death|0
1172460|NCT01153347|3850733|P3|Overall Study|Death|0
1172461|NCT01153347|3850734|P2|Overall Study|Death|0
1172462|NCT01153347|3850735|P1|Overall Study|Death|1
1172463|NCT01153347|3850732|P4|Overall Study|Not specified|0
1172464|NCT01153347|3850733|P3|Overall Study|Not specified|4
1172465|NCT01153347|3850734|P2|Overall Study|Not specified|5
1172466|NCT01153347|3850735|P1|Overall Study|Not specified|5
1172467|NCT01153347|3850732|P4|Overall Study|Lost to Follow-up|8
1172468|NCT01153347|3850733|P3|Overall Study|Lost to Follow-up|11
1172469|NCT01153347|3850734|P2|Overall Study|Lost to Follow-up|9
1172470|NCT01153347|3850735|P1|Overall Study|Lost to Follow-up|4
1172471|NCT01153347|3850732|P4|Overall Study|Study-specific withdrawal criteria|2
1172472|NCT01153347|3850733|P3|Overall Study|Study-specific withdrawal criteria|1
1172473|NCT01153347|3850734|P2|Overall Study|Study-specific withdrawal criteria|3
1172474|NCT01153347|3850735|P1|Overall Study|Study-specific withdrawal criteria|4
1172475|NCT01153347|3850732|P4|Overall Study|Lack of Efficacy|4
1172476|NCT01153347|3850733|P3|Overall Study|Lack of Efficacy|0
1172477|NCT01153347|3850734|P2|Overall Study|Lack of Efficacy|2
1172478|NCT01153347|3850735|P1|Overall Study|Lack of Efficacy|2
1172479|NCT01153347|3850732|P4|Overall Study|Condition under investigation worsened|0
1172480|NCT01153347|3850733|P3|Overall Study|Condition under investigation worsened|0
1172481|NCT01153347|3850734|P2|Overall Study|Condition under investigation worsened|1
1172482|NCT01153347|3850735|P1|Overall Study|Condition under investigation worsened|1
1172483|NCT01153347|3850732|P4|Overall Study|Severe non-compliance to protocol|3
1172484|NCT01153347|3850733|P3|Overall Study|Severe non-compliance to protocol|4
1172485|NCT01153347|3850734|P2|Overall Study|Severe non-compliance to protocol|7
1172486|NCT01153347|3850735|P1|Overall Study|Severe non-compliance to protocol|6
1172487|NCT01153347|3850732|P4|Overall Study|Adverse Event|7
1172488|NCT01153347|3850733|P3|Overall Study|Adverse Event|21
1172489|NCT01153347|3850734|P2|Overall Study|Adverse Event|9
1172490|NCT01153347|3850735|P1|Overall Study|Adverse Event|3
1172491|NCT01153347|3850732|P4|Overall Study|Eligibility criteria not fulfilled|1
1172492|NCT01153347|3850733|P3|Overall Study|Eligibility criteria not fulfilled|2
1172493|NCT01153347|3850734|P2|Overall Study|Eligibility criteria not fulfilled|1
1172494|NCT01153347|3850735|P1|Overall Study|Eligibility criteria not fulfilled|0
1172495|NCT01153347|3850732|P4|Overall Study|Withdrawal by Subject|7
1172496|NCT01153347|3850733|P3|Overall Study|Withdrawal by Subject|7
1172497|NCT01153347|3850734|P2|Overall Study|Withdrawal by Subject|7
1172498|NCT01153347|3850735|P1|Overall Study|Withdrawal by Subject|7
1172499|NCT01153321|3850835|P2|Overall Study|Adverse Event|1
1172500|NCT01153321|3850836|P1|Overall Study|Adverse Event|1
1172501|NCT01153321|3850835|P2|Overall Study|Withdrawal by Subject|1
1172502|NCT01153321|3850836|P1|Overall Study|Withdrawal by Subject|0
1172503|NCT01153321|3850835|P2|Overall Study|Development of study withdrawal criteria|1
1172504|NCT01153321|3850836|P1|Overall Study|Development of study withdrawal criteria|0
1172505|NCT01153269|3850948|P1|Overall Study|Antiretroviral therapy break|1
1172506|NCT01153269|3850948|P1|Overall Study|Withdrawal by Subject|1
1172507|NCT01153009|3851011|P4|Overall Study|Other|2
1172508|NCT01153009|3851012|P3|Overall Study|Other|3
1172509|NCT01153009|3851013|P2|Overall Study|Other|1
1172510|NCT01153009|3851014|P1|Overall Study|Other|1
1172511|NCT01153009|3851011|P4|Overall Study|Lost to Follow-up|15
1172512|NCT01153009|3851012|P3|Overall Study|Lost to Follow-up|11
1172513|NCT01153009|3851013|P2|Overall Study|Lost to Follow-up|8
1172514|NCT01153009|3851014|P1|Overall Study|Lost to Follow-up|8
1172515|NCT01153009|3851011|P4|Overall Study|Withdrawal of Consent|6
1172516|NCT01153009|3851012|P3|Overall Study|Withdrawal of Consent|4
1172517|NCT01153009|3851013|P2|Overall Study|Withdrawal of Consent|5
1172518|NCT01153009|3851014|P1|Overall Study|Withdrawal of Consent|5
1172519|NCT01153009|3851011|P4|Overall Study|Protocol Deviations|2
1172520|NCT01153009|3851012|P3|Overall Study|Protocol Deviations|3
1172521|NCT01153009|3851013|P2|Overall Study|Protocol Deviations|3
1172522|NCT01153009|3851014|P1|Overall Study|Protocol Deviations|4
1172523|NCT01153009|3851011|P4|Overall Study|Noncompliance with Study Medication|1
1172524|NCT01153009|3851012|P3|Overall Study|Noncompliance with Study Medication|4
1172525|NCT01153009|3851013|P2|Overall Study|Noncompliance with Study Medication|3
1172526|NCT01153009|3851014|P1|Overall Study|Noncompliance with Study Medication|1
1172527|NCT01153009|3851011|P4|Overall Study|Lack of Efficacy|1
1172528|NCT01153009|3851012|P3|Overall Study|Lack of Efficacy|2
1172529|NCT01153009|3851013|P2|Overall Study|Lack of Efficacy|0
1172530|NCT01153009|3851014|P1|Overall Study|Lack of Efficacy|9
1172531|NCT01153009|3851011|P4|Overall Study|Adverse Event|10
1172532|NCT01153009|3851012|P3|Overall Study|Adverse Event|14
1172533|NCT01153009|3851013|P2|Overall Study|Adverse Event|14
1172534|NCT01153009|3851014|P1|Overall Study|Adverse Event|4
1172535|NCT01152996|3851044|P1|Overall Study|Elevated liver enzymes|1
1172536|NCT01152996|3851044|P1|Overall Study|Protocol Violation|22
1172537|NCT01152996|3851044|P1|Overall Study|Other|36
1172538|NCT01152996|3851044|P1|Overall Study|Noncompliance|41
1172539|NCT01152996|3851044|P1|Overall Study|Lack of Efficacy|68
1172540|NCT01152996|3851044|P1|Overall Study|Lost to Follow-up|112
1172541|NCT01152996|3851044|P1|Overall Study|Adverse Event|115
1172542|NCT01152996|3851044|P1|Overall Study|Withdrawal by Subject|142
1172543|NCT01152814|3851057|P1|Overall Study|Lost to Follow-up|2
1172544|NCT01152788|3851066|P2|Overall Study|No treatment|1
1172545|NCT01152788|3851067|P1|Overall Study|No treatment|0
1172546|NCT01152788|3851066|P2|Overall Study|Withdrawal by Subject|3
1172547|NCT01152788|3851067|P1|Overall Study|Withdrawal by Subject|0
1172548|NCT01152580|3851104|P2|Overall Study|Withdrawal by Subject|1
1172549|NCT01152580|3851105|P1|Overall Study|Withdrawal by Subject|0
1172550|NCT01152554|3851127|P2|Overall Study|Death|1
1172551|NCT01152554|3851128|P1|Overall Study|Death|1
1172552|NCT01152554|3851127|P2|Overall Study|Not specified|8
1172553|NCT01152554|3851128|P1|Overall Study|Not specified|28
1172554|NCT01152554|3851127|P2|Overall Study|Lost to Follow-up|32
1172555|NCT01152554|3851128|P1|Overall Study|Lost to Follow-up|87
1172556|NCT01152554|3851127|P2|Overall Study|Study-specific withdrawal criteria|8
1172557|NCT01152554|3851128|P1|Overall Study|Study-specific withdrawal criteria|17
1172558|NCT01152554|3851127|P2|Overall Study|Lack of Efficacy|3
1172559|NCT01152554|3851128|P1|Overall Study|Lack of Efficacy|20
1172560|NCT01152554|3851127|P2|Overall Study|Condition under investigation worsened|2
1172561|NCT01152554|3851128|P1|Overall Study|Condition under investigation worsened|5
1172562|NCT01152554|3851127|P2|Overall Study|Severe non-compliance to protocol|14
1172650|NCT01151280|3851493|P1|Overall Study|Lack of Efficacy|3
1172563|NCT01152554|3851128|P1|Overall Study|Severe non-compliance to protocol|36
1172564|NCT01152554|3851127|P2|Overall Study|Adverse Event|14
1172565|NCT01152554|3851128|P1|Overall Study|Adverse Event|67
1172566|NCT01152554|3851127|P2|Overall Study|Eligiblity criteria not fulfilled|1
1172567|NCT01152554|3851128|P1|Overall Study|Eligiblity criteria not fulfilled|0
1172568|NCT01152554|3851127|P2|Overall Study|Withdrawal by Subject|28
1172569|NCT01152554|3851128|P1|Overall Study|Withdrawal by Subject|73
1172570|NCT01152450|3851150|P6|Period 1 (4 Weeks)|Lost to Follow-up|0
1172571|NCT01152450|3851151|P5|Period 1 (4 Weeks)|Lost to Follow-up|0
1172572|NCT01152450|3851152|P4|Period 1 (4 Weeks)|Lost to Follow-up|0
1172573|NCT01152450|3851153|P3|Period 1 (4 Weeks)|Lost to Follow-up|1
1172574|NCT01152450|3851154|P2|Period 1 (4 Weeks)|Lost to Follow-up|1
1172575|NCT01152450|3851155|P1|Period 1 (4 Weeks)|Lost to Follow-up|0
1172576|NCT01152450|3851150|P6|Period 1 (4 Weeks)|Protocol Violation|0
1172577|NCT01152450|3851151|P5|Period 1 (4 Weeks)|Protocol Violation|1
1172578|NCT01152450|3851152|P4|Period 1 (4 Weeks)|Protocol Violation|0
1172579|NCT01152450|3851153|P3|Period 1 (4 Weeks)|Protocol Violation|0
1172580|NCT01152450|3851154|P2|Period 1 (4 Weeks)|Protocol Violation|0
1172581|NCT01152450|3851155|P1|Period 1 (4 Weeks)|Protocol Violation|0
1172582|NCT01152450|3851150|P6|Period 1 (4 Weeks)|Adverse Event|1
1172583|NCT01152450|3851151|P5|Period 1 (4 Weeks)|Adverse Event|1
1172584|NCT01152450|3851152|P4|Period 1 (4 Weeks)|Adverse Event|0
1172585|NCT01152450|3851153|P3|Period 1 (4 Weeks)|Adverse Event|0
1172586|NCT01152450|3851154|P2|Period 1 (4 Weeks)|Adverse Event|0
1172587|NCT01152450|3851155|P1|Period 1 (4 Weeks)|Adverse Event|0
1172588|NCT01152437|3851226|P3|Overall Study|Refusal to continue taking trial medicat|2
1172589|NCT01152437|3851227|P2|Overall Study|Refusal to continue taking trial medicat|0
1172590|NCT01152437|3851228|P1|Overall Study|Refusal to continue taking trial medicat|1
1172591|NCT01152437|3851226|P3|Overall Study|Progressive disease|32
1172592|NCT01152437|3851227|P2|Overall Study|Progressive disease|13
1172593|NCT01152437|3851228|P1|Overall Study|Progressive disease|27
1172594|NCT01152437|3851226|P3|Overall Study|Not treated|2
1172595|NCT01152437|3851227|P2|Overall Study|Not treated|1
1172596|NCT01152437|3851228|P1|Overall Study|Not treated|0
1172597|NCT01152437|3851226|P3|Overall Study|Other Adverse Event|7
1172598|NCT01152437|3851227|P2|Overall Study|Other Adverse Event|1
1172599|NCT01152437|3851228|P1|Overall Study|Other Adverse Event|8
1172600|NCT01152385|3851248|P4|Overall Study|Other|3
1172601|NCT01152385|3851249|P3|Overall Study|Other|2
1172602|NCT01152385|3851250|P2|Overall Study|Other|3
1172603|NCT01152385|3851251|P1|Overall Study|Other|4
1172604|NCT01152385|3851248|P4|Overall Study|Study-specific withdrawal criteria|0
1172605|NCT01152385|3851249|P3|Overall Study|Study-specific withdrawal criteria|2
1172606|NCT01152385|3851250|P2|Overall Study|Study-specific withdrawal criteria|1
1172607|NCT01152385|3851251|P1|Overall Study|Study-specific withdrawal criteria|1
1172608|NCT01152385|3851248|P4|Overall Study|Adverse Event|0
1172609|NCT01152385|3851249|P3|Overall Study|Adverse Event|0
1172610|NCT01152385|3851250|P2|Overall Study|Adverse Event|1
1172611|NCT01152385|3851251|P1|Overall Study|Adverse Event|1
1172612|NCT01152385|3851248|P4|Overall Study|Protocol Violation|1
1172613|NCT01152385|3851249|P3|Overall Study|Protocol Violation|0
1172614|NCT01152385|3851250|P2|Overall Study|Protocol Violation|0
1172615|NCT01152385|3851251|P1|Overall Study|Protocol Violation|0
1172616|NCT01152385|3851248|P4|Overall Study|Withdrawal by Subject|1
1172617|NCT01152385|3851249|P3|Overall Study|Withdrawal by Subject|1
1172618|NCT01152385|3851250|P2|Overall Study|Withdrawal by Subject|1
1172619|NCT01152385|3851251|P1|Overall Study|Withdrawal by Subject|3
1172620|NCT01152190|3851318|P2|Overall Study|Withdrawal by Subject|3
1172621|NCT01152190|3851319|P1|Overall Study|Withdrawal by Subject|1
1172622|NCT01152190|3851318|P2|Overall Study|Protocol Violation|1
1172623|NCT01152190|3851319|P1|Overall Study|Protocol Violation|1
1172624|NCT01152190|3851318|P2|Overall Study|Death|0
1172625|NCT01152190|3851319|P1|Overall Study|Death|1
1172626|NCT01152190|3851318|P2|Overall Study|Adverse Event|4
1172627|NCT01152190|3851319|P1|Overall Study|Adverse Event|2
1172628|NCT01151579|3851378|P2|Overall Study|Not meet inclusion criteria|4
1172629|NCT01151579|3851379|P1|Overall Study|Not meet inclusion criteria|6
1172630|NCT01151579|3851378|P2|Overall Study|Withdrawal by Subject|2
1172631|NCT01151579|3851379|P1|Overall Study|Withdrawal by Subject|3
1172632|NCT01151579|3851378|P2|Overall Study|Physician Decision|1
1172633|NCT01151579|3851379|P1|Overall Study|Physician Decision|3
1172634|NCT01151410|3851433|P2|Overall Study|Abnormal laboratory value(s)|1
1172635|NCT01151410|3851434|P1|Overall Study|Abnormal laboratory value(s)|0
1172636|NCT01151410|3851433|P2|Overall Study|Unsatisfactory therapeutic effect|1
1172637|NCT01151410|3851434|P1|Overall Study|Unsatisfactory therapeutic effect|1
1172638|NCT01151410|3851433|P2|Overall Study|Administrative problems|1
1172639|NCT01151410|3851434|P1|Overall Study|Administrative problems|1
1172640|NCT01151410|3851433|P2|Overall Study|Protocol deviation|1
1172641|NCT01151410|3851434|P1|Overall Study|Protocol deviation|2
1172642|NCT01151410|3851433|P2|Overall Study|Adverse Event|2
1172643|NCT01151410|3851434|P1|Overall Study|Adverse Event|1
1172644|NCT01151410|3851433|P2|Overall Study|Lost to Follow-up|4
1172645|NCT01151410|3851434|P1|Overall Study|Lost to Follow-up|3
1172646|NCT01151410|3851433|P2|Overall Study|Withdrawal by Subject|5
1172647|NCT01151410|3851434|P1|Overall Study|Withdrawal by Subject|3
1172648|NCT01151345|3851478|P2|First Intervention Period|Protocol Violation|1
1172649|NCT01151345|3851479|P1|First Intervention Period|Protocol Violation|0
1172651|NCT01151280|3851493|P1|Overall Study|Adverse Event|1
1172652|NCT01151215|3851506|P3|Overall Study|Safety as judged by the investigator|1
1172653|NCT01151215|3851507|P2|Overall Study|Safety as judged by the investigator|0
1172654|NCT01151215|3851508|P1|Overall Study|Safety as judged by the investigator|0
1172655|NCT01151215|3851506|P3|Overall Study|Disease progression|1
1172656|NCT01151215|3851507|P2|Overall Study|Disease progression|1
1172657|NCT01151215|3851508|P1|Overall Study|Disease progression|0
1172658|NCT01151215|3851506|P3|Overall Study|Withdrawal by Subject|2
1172659|NCT01151215|3851507|P2|Overall Study|Withdrawal by Subject|1
1172660|NCT01151215|3851508|P1|Overall Study|Withdrawal by Subject|3
1172661|NCT01151215|3851506|P3|Overall Study|Lost to Follow-up|3
1172662|NCT01151215|3851507|P2|Overall Study|Lost to Follow-up|0
1172663|NCT01151215|3851508|P1|Overall Study|Lost to Follow-up|0
1172664|NCT01151215|3851506|P3|Overall Study|Death|11
1172665|NCT01151215|3851507|P2|Overall Study|Death|20
1172666|NCT01151215|3851508|P1|Overall Study|Death|16
1172667|NCT01151215|3851506|P3|Overall Study|Worsening of condition under study|1
1172668|NCT01151215|3851507|P2|Overall Study|Worsening of condition under study|1
1172669|NCT01151215|3851508|P1|Overall Study|Worsening of condition under study|1
1172670|NCT01151137|3851546|P2|Overall Study|Lost to Follow-up|1
1172671|NCT01151137|3851547|P1|Overall Study|Lost to Follow-up|1
1172672|NCT01151137|3851546|P2|Overall Study|Death|27
1172673|NCT01151137|3851547|P1|Overall Study|Death|15
1172674|NCT01151098|3851565|P1|Overall Study|Miscellaneous|13
1172675|NCT01151098|3851565|P1|Overall Study|Protocol Violation|1
1172676|NCT01151098|3851565|P1|Overall Study|Lack of Efficacy|15
1172677|NCT01151098|3851565|P1|Overall Study|Lost to Follow-up|6
1172678|NCT01151098|3851565|P1|Overall Study|Adverse Event|82
1172679|NCT01151085|3851569|P1|Overall Study|Protocol Violation|25
1172680|NCT01151085|3851569|P1|Overall Study|Lost to Follow-up|31
1172681|NCT01151020|3851600|P1|Overall Study|Still be eligible for follow-up|79
1172682|NCT01151020|3851600|P1|Overall Study|Patients did not receive the device|2
1172683|NCT01151020|3851600|P1|Overall Study|Withdrawal by Subject|12
1172684|NCT01151020|3851600|P1|Overall Study|Lost to Follow-up|1
1172685|NCT01151020|3851600|P1|Overall Study|Conversion to open repair|1
1172686|NCT01151020|3851600|P1|Overall Study|Death|15
1172687|NCT01150474|3851679|P2|Overall Study|Surgery Changed|0
1172688|NCT01150474|3851680|P1|Overall Study|Surgery Changed|1
1172689|NCT01150474|3851679|P2|Overall Study|Drug not administered|0
1172690|NCT01150474|3851680|P1|Overall Study|Drug not administered|1
1172691|NCT01150474|3851679|P2|Overall Study|Drug did not arrive in time|0
1172692|NCT01150474|3851680|P1|Overall Study|Drug did not arrive in time|1
1172693|NCT01150474|3851679|P2|Overall Study|Rectotomy|0
1172694|NCT01150474|3851680|P1|Overall Study|Rectotomy|1
1172695|NCT01150474|3851679|P2|Overall Study|Multiple Studies|1
1172696|NCT01150474|3851680|P1|Overall Study|Multiple Studies|0
1172697|NCT01150474|3851679|P2|Overall Study|Cancer found|0
1172698|NCT01150474|3851680|P1|Overall Study|Cancer found|1
1172699|NCT01150474|3851679|P2|Overall Study|Withdrawal by Subject|2
1172700|NCT01150474|3851680|P1|Overall Study|Withdrawal by Subject|5
1172701|NCT01150357|3851725|P3|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
1172702|NCT01150357|3851726|P2|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
1172703|NCT01150357|3851727|P1|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1
1172704|NCT01150357|3851725|P3|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
1172705|NCT01150357|3851726|P2|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
1172706|NCT01150357|3851727|P1|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2
1172707|NCT01150357|3851725|P3|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2
1172708|NCT01150357|3851726|P2|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
1172709|NCT01150357|3851727|P1|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
1172710|NCT01150357|3851725|P3|Dose Response Phase (Phase 1)|Withdrawal by Participants|1
1172711|NCT01150357|3851726|P2|Dose Response Phase (Phase 1)|Withdrawal by Participants|2
1172712|NCT01150357|3851727|P1|Dose Response Phase (Phase 1)|Withdrawal by Participants|0
1172713|NCT01150357|3851725|P3|Dose Response Phase (Phase 1)|Adverse Event|1
1172714|NCT01150357|3851726|P2|Dose Response Phase (Phase 1)|Adverse Event|0
1172715|NCT01150357|3851727|P1|Dose Response Phase (Phase 1)|Adverse Event|0
1172716|NCT01150357|3851725|P3|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
1172717|NCT01150357|3851726|P2|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
1172718|NCT01150357|3851727|P1|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1
1172719|NCT01150357|3851725|P3|Dose Response Phase (Phase 1)|Protocol Violation|1
1172720|NCT01150357|3851726|P2|Dose Response Phase (Phase 1)|Protocol Violation|1
1172721|NCT01150357|3851727|P1|Dose Response Phase (Phase 1)|Protocol Violation|0
1172722|NCT01150123|3851807|P18|Overall Study|Lost to Follow-up|0
1172723|NCT01150123|3851808|P17|Overall Study|Lost to Follow-up|0
1172724|NCT01150123|3851809|P16|Overall Study|Lost to Follow-up|0
1172725|NCT01150123|3851810|P15|Overall Study|Lost to Follow-up|0
1172726|NCT01150123|3851811|P14|Overall Study|Lost to Follow-up|0
1172727|NCT01150123|3851812|P13|Overall Study|Lost to Follow-up|2
1172728|NCT01150123|3851813|P12|Overall Study|Lost to Follow-up|1
1172729|NCT01150123|3851814|P11|Overall Study|Lost to Follow-up|1
1172730|NCT01150123|3851815|P10|Overall Study|Lost to Follow-up|1
1172731|NCT01150123|3851816|P9|Overall Study|Lost to Follow-up|3
1172732|NCT01150123|3851817|P8|Overall Study|Lost to Follow-up|0
1172733|NCT01150123|3851818|P7|Overall Study|Lost to Follow-up|0
1172734|NCT01150123|3851819|P6|Overall Study|Lost to Follow-up|5
1172735|NCT01150123|3851820|P5|Overall Study|Lost to Follow-up|2
1172736|NCT01150123|3851821|P4|Overall Study|Lost to Follow-up|2
1172737|NCT01150123|3851822|P3|Overall Study|Lost to Follow-up|2
1172738|NCT01150123|3851823|P2|Overall Study|Lost to Follow-up|1
1172739|NCT01150123|3851824|P1|Overall Study|Lost to Follow-up|2
1172740|NCT01150123|3851807|P18|Overall Study|Withdrawal by Subject|1
1172741|NCT01150123|3851808|P17|Overall Study|Withdrawal by Subject|0
1172742|NCT01150123|3851809|P16|Overall Study|Withdrawal by Subject|1
1172743|NCT01150123|3851810|P15|Overall Study|Withdrawal by Subject|0
1172744|NCT01150123|3851811|P14|Overall Study|Withdrawal by Subject|0
1172745|NCT01150123|3851812|P13|Overall Study|Withdrawal by Subject|1
1172746|NCT01150123|3851813|P12|Overall Study|Withdrawal by Subject|0
1172747|NCT01150123|3851814|P11|Overall Study|Withdrawal by Subject|1
1172748|NCT01150123|3851815|P10|Overall Study|Withdrawal by Subject|0
1172749|NCT01150123|3851816|P9|Overall Study|Withdrawal by Subject|2
1172750|NCT01150123|3851817|P8|Overall Study|Withdrawal by Subject|3
1172751|NCT01150123|3851818|P7|Overall Study|Withdrawal by Subject|0
1172752|NCT01150123|3851819|P6|Overall Study|Withdrawal by Subject|1
1172753|NCT01150123|3851820|P5|Overall Study|Withdrawal by Subject|1
1172754|NCT01150123|3851821|P4|Overall Study|Withdrawal by Subject|1
1172755|NCT01150123|3851822|P3|Overall Study|Withdrawal by Subject|2
1172756|NCT01150123|3851823|P2|Overall Study|Withdrawal by Subject|1
1172757|NCT01150123|3851824|P1|Overall Study|Withdrawal by Subject|1
1172758|NCT01150097|3852000|P3|Months 24 to 48 Post-transplantation|Death|0
1172759|NCT01150097|3852001|P2|Months 24 to 48 Post-transplantation|Death|0
1172760|NCT01150097|3852002|P1|Months 24 to 48 Post-transplantation|Death|2
1172761|NCT01150097|3852000|P3|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
1172762|NCT01150097|3852001|P2|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
1172763|NCT01150097|3852002|P1|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4
1172764|NCT01150097|3852000|P3|Months 24 to 48 Post-transplantation|Administrative problems|0
1172765|NCT01150097|3852001|P2|Months 24 to 48 Post-transplantation|Administrative problems|4
1172766|NCT01150097|3852002|P1|Months 24 to 48 Post-transplantation|Administrative problems|5
1172767|NCT01150097|3852000|P3|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
1172768|NCT01150097|3852001|P2|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0
1172769|NCT01150097|3852002|P1|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
1172770|NCT01150097|3852000|P3|Months 24 to 36 Post-transplantation|Lost to Follow-up|3
1172771|NCT01150097|3852001|P2|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
1172772|NCT01150097|3852002|P1|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
1172773|NCT01150097|3852000|P3|Months 24 to 36 Post-transplantation|Administrative problems|2
1172774|NCT01150097|3852001|P2|Months 24 to 36 Post-transplantation|Administrative problems|2
1172775|NCT01150097|3852002|P1|Months 24 to 36 Post-transplantation|Administrative problems|5
1172776|NCT01150097|3852000|P3|Months 24 to 36 Post-transplantation|Death|0
1172777|NCT01150097|3852001|P2|Months 24 to 36 Post-transplantation|Death|0
1172778|NCT01150097|3852002|P1|Months 24 to 36 Post-transplantation|Death|2
1172779|NCT01149863|3852046|P1|Overall Study|Missing data or Not receiveing studydrug|3
1172780|NCT01149655|3852123|P4|Period 3-DB Maintenance Phase|Relapse With AE|18
1172781|NCT01149655|3852124|P3|Period 3-DB Maintenance Phase|Relapse With AE|19
1172782|NCT01149655|3852125|P2|Period 3-DB Maintenance Phase|Relapse With AE|0
1172783|NCT01149655|3852126|P1|Period 3-DB Maintenance Phase|Relapse With AE|0
1172784|NCT01149655|3852123|P4|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
1172785|NCT01149655|3852124|P3|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
1172786|NCT01149655|3852125|P2|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
1172787|NCT01149655|3852126|P1|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
1172788|NCT01149655|3852123|P4|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
1172789|NCT01149655|3852124|P3|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
1172790|NCT01149655|3852125|P2|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
1172791|NCT01149655|3852126|P1|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
1172792|NCT01149655|3852123|P4|Period 3-DB Maintenance Phase|Physician Decision|0
1172793|NCT01149655|3852124|P3|Period 3-DB Maintenance Phase|Physician Decision|1
1172794|NCT01149655|3852125|P2|Period 3-DB Maintenance Phase|Physician Decision|0
1172795|NCT01149655|3852126|P1|Period 3-DB Maintenance Phase|Physician Decision|0
1172796|NCT01149655|3852123|P4|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19
1172797|NCT01149655|3852124|P3|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58
1172798|NCT01149655|3852125|P2|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
1172799|NCT01149655|3852126|P1|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
1172800|NCT01149655|3852123|P4|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
1172801|NCT01149655|3852124|P3|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
1172802|NCT01149655|3852125|P2|Period 2-Stabilization Phase|Adverse Event Without Relapse|6
1172803|NCT01149655|3852126|P1|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
1172804|NCT01149655|3852123|P4|Period 2-Stabilization Phase|Withdrawal by Subject|0
1172805|NCT01149655|3852124|P3|Period 2-Stabilization Phase|Withdrawal by Subject|0
1172806|NCT01149655|3852125|P2|Period 2-Stabilization Phase|Withdrawal by Subject|5
1172807|NCT01149655|3852126|P1|Period 2-Stabilization Phase|Withdrawal by Subject|0
1172808|NCT01149655|3852123|P4|Period 2-Stabilization Phase|Physician Decision|0
1172809|NCT01149655|3852124|P3|Period 2-Stabilization Phase|Physician Decision|0
1172810|NCT01149655|3852125|P2|Period 2-Stabilization Phase|Physician Decision|3
1172811|NCT01149655|3852126|P1|Period 2-Stabilization Phase|Physician Decision|0
1172812|NCT01149655|3852123|P4|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
1172813|NCT01149655|3852124|P3|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
1172814|NCT01149655|3852125|P2|Period 2-Stabilization Phase|Met Withdrawal Criteria|7
1172815|NCT01149655|3852126|P1|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
1172816|NCT01149655|3852123|P4|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
1172817|NCT01149655|3852124|P3|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
1172818|NCT01149655|3852125|P2|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16
1172819|NCT01149655|3852126|P1|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
1172820|NCT01149655|3852123|P4|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
1172821|NCT01149655|3852124|P3|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
1172822|NCT01149655|3852125|P2|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
1172823|NCT01149655|3852126|P1|Period 1 - Conversion Phase|Adverse Event Without Relapse|3
1172824|NCT01149655|3852123|P4|Period 1 - Conversion Phase|Withdrawal by Subject|0
1172825|NCT01149655|3852124|P3|Period 1 - Conversion Phase|Withdrawal by Subject|0
1172826|NCT01149655|3852125|P2|Period 1 - Conversion Phase|Withdrawal by Subject|0
1172827|NCT01149655|3852126|P1|Period 1 - Conversion Phase|Withdrawal by Subject|7
1172828|NCT01149655|3852123|P4|Period 1 - Conversion Phase|Physician Decision|0
1172829|NCT01149655|3852124|P3|Period 1 - Conversion Phase|Physician Decision|0
1172830|NCT01149655|3852125|P2|Period 1 - Conversion Phase|Physician Decision|0
1172831|NCT01149655|3852126|P1|Period 1 - Conversion Phase|Physician Decision|2
1172832|NCT01149655|3852123|P4|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
1172833|NCT01149655|3852124|P3|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
1172834|NCT01149655|3852125|P2|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
1172835|NCT01149655|3852126|P1|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
1172836|NCT01149655|3852123|P4|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
1172837|NCT01149655|3852124|P3|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
1172838|NCT01149655|3852125|P2|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
1172839|NCT01149655|3852126|P1|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4
1172840|NCT01149655|3852123|P4|Period 1 - Conversion Phase|Lost to Follow-up|0
1172841|NCT01149655|3852124|P3|Period 1 - Conversion Phase|Lost to Follow-up|0
1172842|NCT01149655|3852125|P2|Period 1 - Conversion Phase|Lost to Follow-up|0
1172843|NCT01149655|3852126|P1|Period 1 - Conversion Phase|Lost to Follow-up|1
1172844|NCT01149538|3852169|P2|Overall Study|Withdrawal by Subject|3
1172845|NCT01149538|3852170|P1|Overall Study|Withdrawal by Subject|5
1172846|NCT01149538|3852169|P2|Overall Study|Lost to Follow-up|1
1172847|NCT01149538|3852170|P1|Overall Study|Lost to Follow-up|0
1172848|NCT01149486|3852191|P2|First Intervention|Adverse Event|1
1172849|NCT01149486|3852192|P1|First Intervention|Adverse Event|0
1172850|NCT01149473|3852216|P2|Washout of 7 Days|Withdrawal by Subject|1
1172851|NCT01149473|3852217|P1|Washout of 7 Days|Withdrawal by Subject|1
1172852|NCT01149473|3852216|P2|First Intervention|Adverse Event|1
1172853|NCT01149473|3852217|P1|First Intervention|Adverse Event|1
1172854|NCT01149460|3852235|P2|Overall Study|Withdrawal by Subject|2
1172855|NCT01149460|3852236|P1|Overall Study|Withdrawal by Subject|0
1172856|NCT01149421|3852269|P3|Overall Study|Protocol Violation|6
1172857|NCT01149421|3852270|P2|Overall Study|Protocol Violation|2
1172858|NCT01149421|3852271|P1|Overall Study|Protocol Violation|2
1172859|NCT01149421|3852269|P3|Overall Study|Entry Criteria Not Met|2
1172860|NCT01149421|3852270|P2|Overall Study|Entry Criteria Not Met|1
1172861|NCT01149421|3852271|P1|Overall Study|Entry Criteria Not Met|1
1172862|NCT01149421|3852269|P3|Overall Study|Physician Decision|6
1172863|NCT01149421|3852270|P2|Overall Study|Physician Decision|3
1172864|NCT01149421|3852271|P1|Overall Study|Physician Decision|5
1172865|NCT01149421|3852269|P3|Overall Study|Lost to Follow-up|5
1172866|NCT01149421|3852270|P2|Overall Study|Lost to Follow-up|4
1172867|NCT01149421|3852271|P1|Overall Study|Lost to Follow-up|2
1172868|NCT01149421|3852269|P3|Overall Study|Sponsor Decision|1
1172869|NCT01149421|3852270|P2|Overall Study|Sponsor Decision|1
1172870|NCT01149421|3852271|P1|Overall Study|Sponsor Decision|0
1172871|NCT01149421|3852269|P3|Overall Study|Withdrawal by Subject|13
1172872|NCT01149421|3852270|P2|Overall Study|Withdrawal by Subject|12
1172873|NCT01149421|3852271|P1|Overall Study|Withdrawal by Subject|20
1172874|NCT01149421|3852269|P3|Overall Study|Adverse Event|11
1172875|NCT01149421|3852270|P2|Overall Study|Adverse Event|6
1172876|NCT01149421|3852271|P1|Overall Study|Adverse Event|22
1172877|NCT01149343|3852354|P4|Overall Study|Recurrence / Progressive disease|0
1172878|NCT01149343|3852355|P3|Overall Study|Recurrence / Progressive disease|1
1172879|NCT01149343|3852356|P2|Overall Study|Recurrence / Progressive disease|0
1172880|NCT01149343|3852357|P1|Overall Study|Recurrence / Progressive disease|0
1172881|NCT01149343|3852354|P4|Overall Study|Sponsor study termination|2
1172882|NCT01149343|3852355|P3|Overall Study|Sponsor study termination|0
1172883|NCT01149343|3852356|P2|Overall Study|Sponsor study termination|0
1172884|NCT01149343|3852357|P1|Overall Study|Sponsor study termination|0
1172885|NCT01149343|3852354|P4|Overall Study|Other|14
1172886|NCT01149343|3852355|P3|Overall Study|Other|2
1172887|NCT01149343|3852356|P2|Overall Study|Other|10
1172888|NCT01149343|3852357|P1|Overall Study|Other|8
1172889|NCT01149343|3852354|P4|Overall Study|Lost to Follow-up|1
1172890|NCT01149343|3852355|P3|Overall Study|Lost to Follow-up|0
1172891|NCT01149343|3852356|P2|Overall Study|Lost to Follow-up|0
1172892|NCT01149343|3852357|P1|Overall Study|Lost to Follow-up|1
1172893|NCT01149343|3852354|P4|Overall Study|Death|18
1172894|NCT01149343|3852355|P3|Overall Study|Death|18
1172895|NCT01149343|3852356|P2|Overall Study|Death|13
1172896|NCT01149343|3852357|P1|Overall Study|Death|10
1172897|NCT01149343|3852354|P4|Overall Study|Withdrawal by Subject|5
1172898|NCT01149343|3852355|P3|Overall Study|Withdrawal by Subject|1
1172899|NCT01149343|3852356|P2|Overall Study|Withdrawal by Subject|1
1172900|NCT01149343|3852357|P1|Overall Study|Withdrawal by Subject|1
1172901|NCT01149148|3852442|P2|Overall Study|Death|0
1172902|NCT01149148|3852443|P1|Overall Study|Death|1
1172903|NCT01149148|3852442|P2|Overall Study|Lost to Follow-up|2
1172904|NCT01149148|3852443|P1|Overall Study|Lost to Follow-up|1
1172905|NCT01149057|3852451|P1|Overall Study|Other|6
1172906|NCT01149057|3852451|P1|Overall Study|High Parathyroid Hormone Value|1
1172907|NCT01149057|3852451|P1|Overall Study|Lost to Follow-up|1
1172908|NCT01149057|3852451|P1|Overall Study|Participant Non-Compliance|2
1172909|NCT01149057|3852451|P1|Overall Study|B Cell Depletion|4
1172910|NCT01149057|3852451|P1|Overall Study|Positive Hepatitis B Core Antibody|5
1172911|NCT01149057|3852451|P1|Overall Study|Withdrawal by Subject|9
1172912|NCT01149057|3852451|P1|Overall Study|Adverse Event|13
1172913|NCT01149057|3852451|P1|Overall Study|Lack of Efficacy|16
1172914|NCT01148979|3852478|P2|Overall Study|Lost to Follow-up|1
1172915|NCT01148979|3852479|P1|Overall Study|Lost to Follow-up|0
1172916|NCT01148862|3852485|P2|Second Intervention|Withdrawal by Subject|2
1172917|NCT01148862|3852486|P1|Second Intervention|Withdrawal by Subject|0
1172918|NCT01148771|3852518|P2|Washout Period|Withdrawal by Subject|1
1172919|NCT01148771|3852519|P1|Washout Period|Withdrawal by Subject|0
1172920|NCT01148693|3852539|P2|Overall Study|Attempts for cannulation were failed|10
1172921|NCT01148693|3852540|P1|Overall Study|Attempts for cannulation were failed|13
1172922|NCT01148537|3852560|P3|Overall Study|Adverse Event|1
1172923|NCT01148537|3852561|P2|Overall Study|Adverse Event|0
1172924|NCT01148537|3852562|P1|Overall Study|Adverse Event|2
1172925|NCT01148537|3852560|P3|Overall Study|Withdrawal by Subject|2
1172926|NCT01148537|3852561|P2|Overall Study|Withdrawal by Subject|0
1172927|NCT01148537|3852562|P1|Overall Study|Withdrawal by Subject|1
1172928|NCT01148511|3852648|P3|Randomized|Not Specified|1
1172929|NCT01148511|3852649|P2|Randomized|Not Specified|1
1172930|NCT01148511|3852650|P1|Randomized|Not Specified|0
1172931|NCT01148511|3852648|P3|Randomized|Consent withdrawal|3
1172932|NCT01148511|3852649|P2|Randomized|Consent withdrawal|5
1172933|NCT01148511|3852650|P1|Randomized|Consent withdrawal|0
1172934|NCT01148511|3852648|P3|Randomized|Lost to Follow-up|1
1172935|NCT01148511|3852649|P2|Randomized|Lost to Follow-up|1
1172936|NCT01148511|3852650|P1|Randomized|Lost to Follow-up|0
1172937|NCT01148511|3852648|P3|Randomized|Protocol Violation|1
1172938|NCT01148511|3852649|P2|Randomized|Protocol Violation|2
1172939|NCT01148511|3852650|P1|Randomized|Protocol Violation|0
1172940|NCT01148511|3852648|P3|Randomized|Adverse Event|0
1172941|NCT01148511|3852649|P2|Randomized|Adverse Event|1
1172942|NCT01148511|3852650|P1|Randomized|Adverse Event|0
1172943|NCT01148511|3852648|P3|Exposed to Study Drug|Lost to Follow-up|0
1172944|NCT01148511|3852649|P2|Exposed to Study Drug|Lost to Follow-up|0
1172945|NCT01148511|3852650|P1|Exposed to Study Drug|Lost to Follow-up|4
1172946|NCT01148511|3852648|P3|Exposed to Study Drug|Protocol Violation|0
1172947|NCT01148511|3852649|P2|Exposed to Study Drug|Protocol Violation|0
1172948|NCT01148511|3852650|P1|Exposed to Study Drug|Protocol Violation|2
1172949|NCT01148017|3852688|P4|Overall Study|Unable to classify|0
1172950|NCT01148017|3852689|P3|Overall Study|Unable to classify|0
1172951|NCT01148017|3852690|P2|Overall Study|Unable to classify|1
1172952|NCT01148017|3852691|P1|Overall Study|Unable to classify|3
1172953|NCT01148017|3852688|P4|Overall Study|Administrative reason|0
1172954|NCT01148017|3852689|P3|Overall Study|Administrative reason|0
1172955|NCT01148017|3852690|P2|Overall Study|Administrative reason|9
1172956|NCT01148017|3852691|P1|Overall Study|Administrative reason|22
1172957|NCT01148017|3852688|P4|Overall Study|Inappropriate enrollment|0
1172958|NCT01148017|3852689|P3|Overall Study|Inappropriate enrollment|0
1172959|NCT01148017|3852690|P2|Overall Study|Inappropriate enrollment|0
1172960|NCT01148017|3852691|P1|Overall Study|Inappropriate enrollment|1
1172961|NCT01148017|3852688|P4|Overall Study|Lost to Follow-up|0
1172962|NCT01148017|3852689|P3|Overall Study|Lost to Follow-up|0
1172963|NCT01148017|3852690|P2|Overall Study|Lost to Follow-up|10
1172964|NCT01148017|3852691|P1|Overall Study|Lost to Follow-up|23
1172965|NCT01148017|3852688|P4|Overall Study|Withdrawal by Subject|0
1172966|NCT01148017|3852689|P3|Overall Study|Withdrawal by Subject|0
1172967|NCT01148017|3852690|P2|Overall Study|Withdrawal by Subject|14
1172968|NCT01148017|3852691|P1|Overall Study|Withdrawal by Subject|31
1172969|NCT01147926|3852730|P2|Overall Study|Colonoscopy result|1
1172970|NCT01147926|3852731|P1|Overall Study|Colonoscopy result|0
1172971|NCT01147926|3852730|P2|Overall Study|Went on holiday|1
1172972|NCT01147926|3852731|P1|Overall Study|Went on holiday|0
1172973|NCT01147926|3852730|P2|Overall Study|Too busy, no time for study|0
1172974|NCT01147926|3852731|P1|Overall Study|Too busy, no time for study|1
1172975|NCT01147926|3852730|P2|Overall Study|Lack of Efficacy|0
1172976|NCT01147926|3852731|P1|Overall Study|Lack of Efficacy|1
1172977|NCT01147926|3852730|P2|Overall Study|Sponsor's Decision|1
1172978|NCT01147926|3852731|P1|Overall Study|Sponsor's Decision|0
1172979|NCT01147926|3852730|P2|Overall Study|Lost to Follow-up|2
1172980|NCT01147926|3852731|P1|Overall Study|Lost to Follow-up|0
1172981|NCT01147926|3852730|P2|Overall Study|Selection criteria not met|1
1172982|NCT01147926|3852731|P1|Overall Study|Selection criteria not met|3
1172983|NCT01147926|3852730|P2|Overall Study|Principal investigator left hospital|3
1172984|NCT01147926|3852731|P1|Overall Study|Principal investigator left hospital|1
1172985|NCT01147926|3852730|P2|Overall Study|Subject Non-Compliant|4
1172986|NCT01147926|3852731|P1|Overall Study|Subject Non-Compliant|5
1172987|NCT01147926|3852730|P2|Overall Study|Adverse Event|6
1172988|NCT01147926|3852731|P1|Overall Study|Adverse Event|7
1172989|NCT01147926|3852730|P2|Overall Study|Subject Withdrew Consent|10
1172990|NCT01147926|3852731|P1|Overall Study|Subject Withdrew Consent|9
1172991|NCT01147900|3852766|P3|At Year 10|Lost to Follow-up|0
1172992|NCT01147900|3852767|P2|At Year 10|Lost to Follow-up|1
1172993|NCT01147900|3852768|P1|At Year 10|Lost to Follow-up|0
1172994|NCT01147874|3852827|P1|Overall Study|Withdrawal by Subject|24
1172995|NCT01147874|3852827|P1|Overall Study|Sponsor's Decision|2
1172996|NCT01147874|3852827|P1|Overall Study|Protocol Violation|5
1172997|NCT01147874|3852827|P1|Overall Study|Other|5
1172998|NCT01147874|3852827|P1|Overall Study|Lost to Follow-up|25
1172999|NCT01147874|3852827|P1|Overall Study|Investigator’s Request|1
1173000|NCT01147874|3852827|P1|Overall Study|Adverse Event|5
1173001|NCT01147848|3852835|P3|Randomized Phase|Withdrawal by Subject|9
1173002|NCT01147848|3852836|P2|Randomized Phase|Withdrawal by Subject|7
1173003|NCT01147848|3852837|P1|Randomized Phase|Withdrawal by Subject|0
1173004|NCT01147848|3852835|P3|Randomized Phase|Physician Decision|1
1173005|NCT01147848|3852836|P2|Randomized Phase|Physician Decision|0
1173006|NCT01147848|3852837|P1|Randomized Phase|Physician Decision|0
1173007|NCT01147848|3852835|P3|Randomized Phase|Lost to Follow-up|7
1173008|NCT01147848|3852836|P2|Randomized Phase|Lost to Follow-up|5
1173009|NCT01147848|3852837|P1|Randomized Phase|Lost to Follow-up|0
1173010|NCT01147848|3852835|P3|Randomized Phase|Protocol Violation|10
1173011|NCT01147848|3852836|P2|Randomized Phase|Protocol Violation|7
1173012|NCT01147848|3852837|P1|Randomized Phase|Protocol Violation|0
1173013|NCT01147848|3852835|P3|Randomized Phase|Lack of Efficacy|11
1173014|NCT01147848|3852836|P2|Randomized Phase|Lack of Efficacy|20
1173015|NCT01147848|3852837|P1|Randomized Phase|Lack of Efficacy|0
1173016|NCT01147848|3852835|P3|Randomized Phase|Adverse Event|8
1173017|NCT01147848|3852836|P2|Randomized Phase|Adverse Event|6
1173018|NCT01147848|3852837|P1|Randomized Phase|Adverse Event|0
1173019|NCT01147848|3852835|P3|Run-in Period|Run-in Failure|0
1173020|NCT01147848|3852836|P2|Run-in Period|Run-in Failure|0
1173021|NCT01147848|3852837|P1|Run-in Period|Run-in Failure|135
1173022|NCT01147848|3852835|P3|Run-in Period|Screen Failure|0
1173023|NCT01147848|3852836|P2|Run-in Period|Screen Failure|0
1173024|NCT01147848|3852837|P1|Run-in Period|Screen Failure|623
1173025|NCT01147822|3852869|P2|Overall Study|Not Completed/Ongoing|102
1173026|NCT01147822|3852870|P1|Overall Study|Not Completed/Ongoing|111
1173027|NCT01147822|3852869|P2|Overall Study|Withdrawal by Subject|13
1173028|NCT01147822|3852870|P1|Overall Study|Withdrawal by Subject|8
1173029|NCT01147822|3852869|P2|Overall Study|Physician Decision|2
1173030|NCT01147822|3852870|P1|Overall Study|Physician Decision|0
1173031|NCT01147822|3852869|P2|Overall Study|Lost to Follow-up|2
1173032|NCT01147822|3852870|P1|Overall Study|Lost to Follow-up|3
1173033|NCT01147822|3852869|P2|Overall Study|Protocol Violation|1
1173034|NCT01147822|3852870|P1|Overall Study|Protocol Violation|0
1173035|NCT01147822|3852869|P2|Overall Study|Death|59
1173036|NCT01147822|3852870|P1|Overall Study|Death|66
1173037|NCT01147809|3852890|P6|Phase II (168 Days)|Ongoing|0
1173038|NCT01147809|3852891|P5|Phase II (168 Days)|Ongoing|1
1173039|NCT01147809|3852892|P4|Phase II (168 Days)|Ongoing|0
1173040|NCT01147809|3852893|P3|Phase II (168 Days)|Ongoing|0
1173041|NCT01147809|3852894|P2|Phase II (168 Days)|Ongoing|0
1173042|NCT01147809|3852895|P1|Phase II (168 Days)|Ongoing|0
1173043|NCT01147809|3852890|P6|Phase II (168 Days)|Withdrawal by Subject|15
1173044|NCT01147809|3852891|P5|Phase II (168 Days)|Withdrawal by Subject|7
1173045|NCT01147809|3852892|P4|Phase II (168 Days)|Withdrawal by Subject|0
1173046|NCT01147809|3852893|P3|Phase II (168 Days)|Withdrawal by Subject|0
1173047|NCT01147809|3852894|P2|Phase II (168 Days)|Withdrawal by Subject|0
1173048|NCT01147809|3852895|P1|Phase II (168 Days)|Withdrawal by Subject|0
1173049|NCT01147809|3852890|P6|Phase II (168 Days)|Physician Decision|11
1173050|NCT01147809|3852891|P5|Phase II (168 Days)|Physician Decision|5
1173051|NCT01147809|3852892|P4|Phase II (168 Days)|Physician Decision|0
1173052|NCT01147809|3852893|P3|Phase II (168 Days)|Physician Decision|0
1173053|NCT01147809|3852894|P2|Phase II (168 Days)|Physician Decision|0
1173054|NCT01147809|3852895|P1|Phase II (168 Days)|Physician Decision|0
1173055|NCT01147809|3852890|P6|Phase II (168 Days)|Protocol Violation|1
1173056|NCT01147809|3852891|P5|Phase II (168 Days)|Protocol Violation|0
1173057|NCT01147809|3852892|P4|Phase II (168 Days)|Protocol Violation|0
1173058|NCT01147809|3852893|P3|Phase II (168 Days)|Protocol Violation|0
1173059|NCT01147809|3852894|P2|Phase II (168 Days)|Protocol Violation|0
1173060|NCT01147809|3852895|P1|Phase II (168 Days)|Protocol Violation|0
1173061|NCT01147809|3852890|P6|Phase II (168 Days)|Adverse Event|6
1173062|NCT01147809|3852891|P5|Phase II (168 Days)|Adverse Event|3
1173063|NCT01147809|3852892|P4|Phase II (168 Days)|Adverse Event|0
1173064|NCT01147809|3852893|P3|Phase II (168 Days)|Adverse Event|0
1173065|NCT01147809|3852894|P2|Phase II (168 Days)|Adverse Event|0
1173066|NCT01147809|3852895|P1|Phase II (168 Days)|Adverse Event|0
1173067|NCT01147809|3852890|P6|Phase I (168 Days)|Withdrawal by Subject|0
1173068|NCT01147809|3852891|P5|Phase I (168 Days)|Withdrawal by Subject|0
1173069|NCT01147809|3852892|P4|Phase I (168 Days)|Withdrawal by Subject|3
1173070|NCT01147809|3852893|P3|Phase I (168 Days)|Withdrawal by Subject|0
1173071|NCT01147809|3852894|P2|Phase I (168 Days)|Withdrawal by Subject|0
1173072|NCT01147809|3852895|P1|Phase I (168 Days)|Withdrawal by Subject|0
1173073|NCT01147809|3852890|P6|Phase I (168 Days)|Physician Decision|0
1173074|NCT01147809|3852891|P5|Phase I (168 Days)|Physician Decision|0
1173075|NCT01147809|3852892|P4|Phase I (168 Days)|Physician Decision|0
1173076|NCT01147809|3852893|P3|Phase I (168 Days)|Physician Decision|2
1173077|NCT01147809|3852894|P2|Phase I (168 Days)|Physician Decision|1
1173078|NCT01147809|3852895|P1|Phase I (168 Days)|Physician Decision|0
1173079|NCT01147809|3852890|P6|Phase I (168 Days)|Lost to Follow-up|0
1173080|NCT01147809|3852891|P5|Phase I (168 Days)|Lost to Follow-up|0
1173081|NCT01147809|3852892|P4|Phase I (168 Days)|Lost to Follow-up|1
1173082|NCT01147809|3852893|P3|Phase I (168 Days)|Lost to Follow-up|0
1173083|NCT01147809|3852894|P2|Phase I (168 Days)|Lost to Follow-up|0
1173084|NCT01147809|3852895|P1|Phase I (168 Days)|Lost to Follow-up|1
1173085|NCT01147809|3852890|P6|Phase I (168 Days)|Adverse Event|0
1173086|NCT01147809|3852891|P5|Phase I (168 Days)|Adverse Event|0
1173087|NCT01147809|3852892|P4|Phase I (168 Days)|Adverse Event|1
1173088|NCT01147809|3852893|P3|Phase I (168 Days)|Adverse Event|0
1173089|NCT01147809|3852894|P2|Phase I (168 Days)|Adverse Event|0
1173090|NCT01147809|3852895|P1|Phase I (168 Days)|Adverse Event|0
1173091|NCT01147744|3853016|P7|Overall Study|Met Protocol-defined Stopping Criteria|0
1173092|NCT01147744|3853017|P6|Overall Study|Met Protocol-defined Stopping Criteria|1
1173093|NCT01147744|3853018|P5|Overall Study|Met Protocol-defined Stopping Criteria|0
1173094|NCT01147744|3853019|P4|Overall Study|Met Protocol-defined Stopping Criteria|0
1173095|NCT01147744|3853020|P3|Overall Study|Met Protocol-defined Stopping Criteria|0
1173096|NCT01147744|3853021|P2|Overall Study|Met Protocol-defined Stopping Criteria|0
1173097|NCT01147744|3853022|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
1173098|NCT01147744|3853016|P7|Overall Study|Sponsor decision to amend protocol|6
1173099|NCT01147744|3853017|P6|Overall Study|Sponsor decision to amend protocol|2
1173100|NCT01147744|3853018|P5|Overall Study|Sponsor decision to amend protocol|7
1173101|NCT01147744|3853019|P4|Overall Study|Sponsor decision to amend protocol|5
1173102|NCT01147744|3853020|P3|Overall Study|Sponsor decision to amend protocol|2
1173103|NCT01147744|3853021|P2|Overall Study|Sponsor decision to amend protocol|4
1173104|NCT01147744|3853022|P1|Overall Study|Sponsor decision to amend protocol|7
1173105|NCT01147744|3853016|P7|Overall Study|Lost to Follow-up|0
1173106|NCT01147744|3853017|P6|Overall Study|Lost to Follow-up|0
1173107|NCT01147744|3853018|P5|Overall Study|Lost to Follow-up|0
1173108|NCT01147744|3853019|P4|Overall Study|Lost to Follow-up|0
1173109|NCT01147744|3853020|P3|Overall Study|Lost to Follow-up|0
1173110|NCT01147744|3853021|P2|Overall Study|Lost to Follow-up|1
1173111|NCT01147744|3853022|P1|Overall Study|Lost to Follow-up|0
1173112|NCT01147744|3853016|P7|Overall Study|Withdrawal by Subject|2
1173113|NCT01147744|3853017|P6|Overall Study|Withdrawal by Subject|5
1173114|NCT01147744|3853018|P5|Overall Study|Withdrawal by Subject|2
1173115|NCT01147744|3853019|P4|Overall Study|Withdrawal by Subject|2
1173116|NCT01147744|3853020|P3|Overall Study|Withdrawal by Subject|2
1173117|NCT01147744|3853021|P2|Overall Study|Withdrawal by Subject|4
1173118|NCT01147744|3853022|P1|Overall Study|Withdrawal by Subject|8
1173119|NCT01147744|3853016|P7|Overall Study|Adverse Event|2
1173120|NCT01147744|3853017|P6|Overall Study|Adverse Event|1
1173121|NCT01147744|3853018|P5|Overall Study|Adverse Event|2
1173122|NCT01147744|3853019|P4|Overall Study|Adverse Event|0
1173123|NCT01147744|3853020|P3|Overall Study|Adverse Event|3
1173124|NCT01147744|3853021|P2|Overall Study|Adverse Event|2
1173125|NCT01147744|3853022|P1|Overall Study|Adverse Event|1
1173126|NCT01147744|3853016|P7|Overall Study|Lack of Efficacy|7
1173127|NCT01147744|3853017|P6|Overall Study|Lack of Efficacy|8
1173128|NCT01147744|3853018|P5|Overall Study|Lack of Efficacy|13
1173129|NCT01147744|3853019|P4|Overall Study|Lack of Efficacy|11
1173130|NCT01147744|3853020|P3|Overall Study|Lack of Efficacy|9
1173131|NCT01147744|3853021|P2|Overall Study|Lack of Efficacy|11
1173132|NCT01147744|3853022|P1|Overall Study|Lack of Efficacy|11
1173133|NCT01147744|3853016|P7|Overall Study|Physician Decision|1
1173134|NCT01147744|3853017|P6|Overall Study|Physician Decision|0
1173135|NCT01147744|3853018|P5|Overall Study|Physician Decision|0
1173136|NCT01147744|3853019|P4|Overall Study|Physician Decision|0
1173137|NCT01147744|3853020|P3|Overall Study|Physician Decision|1
1173138|NCT01147744|3853021|P2|Overall Study|Physician Decision|1
1173139|NCT01147744|3853022|P1|Overall Study|Physician Decision|0
1173140|NCT01147744|3853016|P7|Overall Study|Protocol Violation|1
1173141|NCT01147744|3853017|P6|Overall Study|Protocol Violation|3
1173142|NCT01147744|3853018|P5|Overall Study|Protocol Violation|1
1173143|NCT01147744|3853019|P4|Overall Study|Protocol Violation|0
1173144|NCT01147744|3853020|P3|Overall Study|Protocol Violation|1
1173145|NCT01147744|3853021|P2|Overall Study|Protocol Violation|0
1173146|NCT01147744|3853022|P1|Overall Study|Protocol Violation|1
1173147|NCT01147653|3853117|P2|Year 2|Withdrawal by Subject|3
1173148|NCT01147653|3853118|P1|Year 2|Withdrawal by Subject|2
1173149|NCT01147640|3853179|P2|Overall Study|Didn't meet eligibility criteria|0
1173150|NCT01147640|3853180|P1|Overall Study|Didn't meet eligibility criteria|1
1173151|NCT01147640|3853179|P2|Overall Study|Lost to Follow-up|1
1173152|NCT01147640|3853180|P1|Overall Study|Lost to Follow-up|0
1173153|NCT01147640|3853179|P2|Overall Study|Withdrawal by Subject|0
1173154|NCT01147640|3853180|P1|Overall Study|Withdrawal by Subject|1
1173155|NCT01147640|3853179|P2|Overall Study|Physician Decision|0
1173156|NCT01147640|3853180|P1|Overall Study|Physician Decision|1
1173157|NCT01147640|3853179|P2|Overall Study|Adverse Event|0
1173158|NCT01147640|3853180|P1|Overall Study|Adverse Event|2
1173159|NCT01147497|3853212|P2|Overall Study|failed insertion|0
1173160|NCT01147497|3853213|P1|Overall Study|failed insertion|2
1173161|NCT01147471|3853233|P2|6 Month Follow Up|Lost to Follow-up|2
1173162|NCT01147471|3853234|P1|6 Month Follow Up|Lost to Follow-up|4
1173163|NCT01147471|3853233|P2|3 Month Follow Up|Physician Decision|1
1173164|NCT01147471|3853234|P1|3 Month Follow Up|Physician Decision|0
1173165|NCT01147471|3853233|P2|3 Month Follow Up|Lost to Follow-up|1
1173166|NCT01147471|3853234|P1|3 Month Follow Up|Lost to Follow-up|1
1173167|NCT01147471|3853233|P2|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1
1173168|NCT01147471|3853234|P1|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0
1173169|NCT01147471|3853233|P2|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1
1173170|NCT01147471|3853234|P1|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0
1173171|NCT01147471|3853233|P2|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1
1173172|NCT01147471|3853234|P1|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0
1173173|NCT01147458|3853248|P4|Second Intervention|Other|0
1173174|NCT01147458|3853249|P3|Second Intervention|Other|1
1173175|NCT01147458|3853250|P2|Second Intervention|Other|0
1173176|NCT01147458|3853251|P1|Second Intervention|Other|0
1173177|NCT01147458|3853248|P4|Second Intervention|Adverse Event|1
1173178|NCT01147458|3853249|P3|Second Intervention|Adverse Event|1
1173179|NCT01147458|3853250|P2|Second Intervention|Adverse Event|0
1173180|NCT01147458|3853251|P1|Second Intervention|Adverse Event|2
1173181|NCT01147458|3853248|P4|Second Intervention|Withdrawal by Subject|0
1173182|NCT01147458|3853249|P3|Second Intervention|Withdrawal by Subject|0
1173183|NCT01147458|3853250|P2|Second Intervention|Withdrawal by Subject|1
1173184|NCT01147458|3853251|P1|Second Intervention|Withdrawal by Subject|0
1173185|NCT01147458|3853248|P4|Second Intervention|Protocol Violation|0
1173186|NCT01147458|3853249|P3|Second Intervention|Protocol Violation|1
1173187|NCT01147458|3853250|P2|Second Intervention|Protocol Violation|1
1173188|NCT01147458|3853251|P1|Second Intervention|Protocol Violation|0
1173189|NCT01147458|3853248|P4|Second Intervention|Study terminated by sponsor|3
1173190|NCT01147458|3853249|P3|Second Intervention|Study terminated by sponsor|5
1173191|NCT01147458|3853250|P2|Second Intervention|Study terminated by sponsor|5
1173192|NCT01147458|3853251|P1|Second Intervention|Study terminated by sponsor|7
1173193|NCT01147458|3853248|P4|First Intervention|Other|0
1173194|NCT01147458|3853249|P3|First Intervention|Other|0
1173195|NCT01147458|3853250|P2|First Intervention|Other|2
1173196|NCT01147458|3853251|P1|First Intervention|Other|1
1173197|NCT01147458|3853248|P4|First Intervention|Adverse Event|3
1173198|NCT01147458|3853249|P3|First Intervention|Adverse Event|2
1173199|NCT01147458|3853250|P2|First Intervention|Adverse Event|3
1173200|NCT01147458|3853251|P1|First Intervention|Adverse Event|0
1173201|NCT01147458|3853248|P4|First Intervention|Withdrawal by Subject|0
1173202|NCT01147458|3853249|P3|First Intervention|Withdrawal by Subject|1
1173203|NCT01147458|3853250|P2|First Intervention|Withdrawal by Subject|0
1173204|NCT01147458|3853251|P1|First Intervention|Withdrawal by Subject|3
1173205|NCT01147458|3853248|P4|First Intervention|Protocol Violation|3
1173206|NCT01147458|3853249|P3|First Intervention|Protocol Violation|2
1173207|NCT01147458|3853250|P2|First Intervention|Protocol Violation|3
1173208|NCT01147458|3853251|P1|First Intervention|Protocol Violation|2
1173209|NCT01147458|3853248|P4|First Intervention|Study terminated by sponsor|8
1173210|NCT01147458|3853249|P3|First Intervention|Study terminated by sponsor|7
1173211|NCT01147458|3853250|P2|First Intervention|Study terminated by sponsor|8
1173212|NCT01147458|3853251|P1|First Intervention|Study terminated by sponsor|8
1173213|NCT01147393|3853330|P1|Dose Level -1|Dose Limited Toxicity|1
1173214|NCT01147393|3853330|P1|Dose Level 1|Dose limiting Toxicity|2
1173215|NCT01147341|3853351|P2|Open Label Period|Subject moved|0
1173216|NCT01147341|3853352|P1|Open Label Period|Subject moved|1
1173217|NCT01147341|3853351|P2|Open Label Period|Lack of Efficacy|0
1173218|NCT01147341|3853352|P1|Open Label Period|Lack of Efficacy|3
1173219|NCT01147341|3853351|P2|Double Blind Period|Withdrawal by Subject|1
1173220|NCT01147341|3853352|P1|Double Blind Period|Withdrawal by Subject|0
1173221|NCT01147341|3853351|P2|Double Blind Period|Lack of Efficacy|1
1173222|NCT01147341|3853352|P1|Double Blind Period|Lack of Efficacy|1
1173223|NCT01147250|3853415|P2|Overall Study|Other than specified|1
1173224|NCT01147250|3853416|P1|Overall Study|Other than specified|0
1173225|NCT01147250|3853415|P2|Overall Study|Site termination by sponsor|5
1173226|NCT01147250|3853416|P1|Overall Study|Site termination by sponsor|13
1173227|NCT01147250|3853415|P2|Overall Study|Withdrawal by Subject|88
1173228|NCT01147250|3853416|P1|Overall Study|Withdrawal by Subject|83
1173229|NCT01147250|3853415|P2|Overall Study|Lost to Follow-up|11
1173230|NCT01147250|3853416|P1|Overall Study|Lost to Follow-up|14
1173231|NCT01147172|3853428|P1|Overall Study|Lost to Follow-up|2
1173232|NCT01147172|3853428|P1|Overall Study|Withdrawal by Subject|2
1173233|NCT01147068|3853446|P7|Subjects That Completed Safety Follow-up|Ineligible|0
1173234|NCT01147068|3853447|P6|Subjects That Completed Safety Follow-up|Ineligible|0
1173235|NCT01147068|3853448|P5|Subjects That Completed Safety Follow-up|Ineligible|0
1173236|NCT01147068|3853449|P4|Subjects That Completed Safety Follow-up|Ineligible|0
1173237|NCT01147068|3853450|P3|Subjects That Completed Safety Follow-up|Ineligible|0
1173238|NCT01147068|3853451|P2|Subjects That Completed Safety Follow-up|Ineligible|1
1173239|NCT01147068|3853452|P1|Subjects That Completed Safety Follow-up|Ineligible|0
1173240|NCT01147068|3853446|P7|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
1173241|NCT01147068|3853447|P6|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
1173242|NCT01147068|3853448|P5|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
1173243|NCT01147068|3853449|P4|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2
1173244|NCT01147068|3853450|P3|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
1173245|NCT01147068|3853451|P2|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
1173246|NCT01147068|3853452|P1|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
1173247|NCT01147068|3853446|P7|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
1173248|NCT01147068|3853447|P6|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
1173249|NCT01147068|3853448|P5|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
1173250|NCT01147068|3853449|P4|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
1173251|NCT01147068|3853450|P3|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
1173252|NCT01147068|3853451|P2|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
1173253|NCT01147068|3853452|P1|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
1173254|NCT01147068|3853446|P7|Subjects That Received 2nd Dose|Other|0
1173255|NCT01147068|3853447|P6|Subjects That Received 2nd Dose|Other|0
1173256|NCT01147068|3853448|P5|Subjects That Received 2nd Dose|Other|1
1173257|NCT01147068|3853449|P4|Subjects That Received 2nd Dose|Other|0
1173258|NCT01147068|3853450|P3|Subjects That Received 2nd Dose|Other|3
1173259|NCT01147068|3853451|P2|Subjects That Received 2nd Dose|Other|3
1173260|NCT01147068|3853452|P1|Subjects That Received 2nd Dose|Other|0
1173261|NCT01147068|3853446|P7|Subjects That Received 2nd Dose|Did not complete the study|0
1173262|NCT01147068|3853447|P6|Subjects That Received 2nd Dose|Did not complete the study|1
1173263|NCT01147068|3853448|P5|Subjects That Received 2nd Dose|Did not complete the study|0
1173264|NCT01147068|3853449|P4|Subjects That Received 2nd Dose|Did not complete the study|0
1173265|NCT01147068|3853450|P3|Subjects That Received 2nd Dose|Did not complete the study|0
1173266|NCT01147068|3853451|P2|Subjects That Received 2nd Dose|Did not complete the study|1
1173267|NCT01147068|3853452|P1|Subjects That Received 2nd Dose|Did not complete the study|0
1173268|NCT01147068|3853446|P7|Subjects That Received 2nd Dose|Ineligible|0
1173269|NCT01147068|3853447|P6|Subjects That Received 2nd Dose|Ineligible|0
1173270|NCT01147068|3853448|P5|Subjects That Received 2nd Dose|Ineligible|0
1173271|NCT01147068|3853449|P4|Subjects That Received 2nd Dose|Ineligible|0
1173272|NCT01147068|3853450|P3|Subjects That Received 2nd Dose|Ineligible|0
1173273|NCT01147068|3853451|P2|Subjects That Received 2nd Dose|Ineligible|1
1173274|NCT01147068|3853452|P1|Subjects That Received 2nd Dose|Ineligible|0
1173275|NCT01147068|3853446|P7|Subjects That Received 2nd Dose|Lost to Follow-up|0
1173276|NCT01147068|3853447|P6|Subjects That Received 2nd Dose|Lost to Follow-up|1
1173277|NCT01147068|3853448|P5|Subjects That Received 2nd Dose|Lost to Follow-up|0
1173278|NCT01147068|3853449|P4|Subjects That Received 2nd Dose|Lost to Follow-up|0
1173279|NCT01147068|3853450|P3|Subjects That Received 2nd Dose|Lost to Follow-up|0
1173280|NCT01147068|3853451|P2|Subjects That Received 2nd Dose|Lost to Follow-up|0
1173281|NCT01147068|3853452|P1|Subjects That Received 2nd Dose|Lost to Follow-up|1
1173282|NCT01147055|3853482|P2|First Intervention Period|Lost to Follow-up|0
1173283|NCT01147055|3853483|P1|First Intervention Period|Lost to Follow-up|1
1173284|NCT01146951|3853525|P2|Overall Study|Adverse Event|1
1173285|NCT01146951|3853526|P1|Overall Study|Adverse Event|4
1173286|NCT01146912|3853547|P8|Overall Study|Duplicate patient|0
1173287|NCT01146912|3853548|P7|Overall Study|Duplicate patient|0
1173288|NCT01146912|3853549|P6|Overall Study|Duplicate patient|0
1173289|NCT01146912|3853550|P5|Overall Study|Duplicate patient|0
1173290|NCT01146912|3853551|P4|Overall Study|Duplicate patient|0
1173291|NCT01146912|3853552|P3|Overall Study|Duplicate patient|1
1173292|NCT01146912|3853553|P2|Overall Study|Duplicate patient|0
1173293|NCT01146912|3853554|P1|Overall Study|Duplicate patient|0
1173294|NCT01146912|3853547|P8|Overall Study|< 14 weeks gestational age|0
1173295|NCT01146912|3853548|P7|Overall Study|< 14 weeks gestational age|0
1173296|NCT01146912|3853549|P6|Overall Study|< 14 weeks gestational age|0
1173297|NCT01146912|3853550|P5|Overall Study|< 14 weeks gestational age|0
1173298|NCT01146912|3853551|P4|Overall Study|< 14 weeks gestational age|2
1173299|NCT01146912|3853552|P3|Overall Study|< 14 weeks gestational age|3
1173300|NCT01146912|3853553|P2|Overall Study|< 14 weeks gestational age|0
1173301|NCT01146912|3853554|P1|Overall Study|< 14 weeks gestational age|0
1173302|NCT01146912|3853547|P8|Overall Study|Already received influenza vaccination|0
1173303|NCT01146912|3853548|P7|Overall Study|Already received influenza vaccination|56
1173304|NCT01146912|3853549|P6|Overall Study|Already received influenza vaccination|61
1173305|NCT01146912|3853550|P5|Overall Study|Already received influenza vaccination|41
1173306|NCT01146912|3853551|P4|Overall Study|Already received influenza vaccination|15
1173307|NCT01146912|3853552|P3|Overall Study|Already received influenza vaccination|13
1173308|NCT01146912|3853553|P2|Overall Study|Already received influenza vaccination|822
1173309|NCT01146912|3853554|P1|Overall Study|Already received influenza vaccination|817
1173310|NCT01146873|3853576|P2|Overall Study|Transfer out|6
1173311|NCT01146873|3853577|P1|Overall Study|Transfer out|0
1173312|NCT01146860|3853593|P2|Overall Study|Withdrawal by Subject|1
1173313|NCT01146860|3853594|P1|Overall Study|Withdrawal by Subject|0
1173314|NCT01146782|3853614|P1|Primary Endpoint Cohort|Physician Decision|1
1173315|NCT01146782|3853614|P1|Primary Endpoint Cohort|Withdrawal by Subject|5
1173316|NCT01146782|3853614|P1|Safety Cohort|TST <4 hrs|14
1173317|NCT01146782|3853614|P1|Safety Cohort|Control AHI <5|4
1173318|NCT01146782|3853614|P1|Safety Cohort|Withdrawal by Subject|4
1173319|NCT01146782|3853614|P1|Safety Cohort|Screen Failure|61
1173320|NCT01146782|3853614|P1|Screening Cohort|Withdrawal by Subject|29
1173321|NCT01146782|3853614|P1|Screening Cohort|Physician Decision|1
1173322|NCT01146782|3853614|P1|Screening Cohort|Lost to Follow-up|4
1173323|NCT01146782|3853614|P1|Screening Cohort|Screen Failure|187
1173324|NCT01146665|3853623|P2|Overall Study|Withdrawal by Subject|16
1173325|NCT01146665|3853624|P1|Overall Study|Withdrawal by Subject|10
1173326|NCT01146613|3853656|P2|Overall Study|Outpatient detox|0
1173327|NCT01146613|3853657|P1|Overall Study|Outpatient detox|1
1173328|NCT01146613|3853656|P2|Overall Study|schedule conflict|0
1173329|NCT01146613|3853657|P1|Overall Study|schedule conflict|1
1173330|NCT01146613|3853656|P2|Overall Study|Withdrawal by Subject|3
1173331|NCT01146613|3853657|P1|Overall Study|Withdrawal by Subject|0
1173332|NCT01146613|3853656|P2|Overall Study|Physician Decision|0
1173333|NCT01146613|3853657|P1|Overall Study|Physician Decision|1
1173334|NCT01146613|3853656|P2|Overall Study|Death|0
1173335|NCT01146613|3853657|P1|Overall Study|Death|1
1173336|NCT01146613|3853656|P2|Overall Study|Lack of Efficacy|1
1173337|NCT01146613|3853657|P1|Overall Study|Lack of Efficacy|0
1173338|NCT01146613|3853656|P2|Overall Study|Lost to Follow-up|8
1173339|NCT01146613|3853657|P1|Overall Study|Lost to Follow-up|3
1173340|NCT01146288|3853748|P2|First Intervention(1 Day)|Adverse Event|1
1173341|NCT01146288|3853749|P1|First Intervention(1 Day)|Adverse Event|0
1173342|NCT01146054|3853763|P1|Overall Study|Lost to Follow-up|1
1173343|NCT01146054|3853763|P1|Overall Study|Other illness precluded treatment|2
1173344|NCT01146054|3853763|P1|Overall Study|Rapid tumor progression|2
1173345|NCT01146054|3853763|P1|Overall Study|Did not meet dose constraints for SBRT|5
1173346|NCT01145898|3853773|P2|3-year Treatment|medication change by treating physician|16
1173347|NCT01145898|3853774|P1|3-year Treatment|medication change by treating physician|3
1173348|NCT01145755|3853808|P3|Overall Study|Positive urine ethanol|0
1173349|NCT01145755|3853809|P2|Overall Study|Positive urine ethanol|1
1173350|NCT01145755|3853810|P1|Overall Study|Positive urine ethanol|0
1173351|NCT01145755|3853808|P3|Overall Study|Withdrawal by Subject|1
1173352|NCT01145755|3853809|P2|Overall Study|Withdrawal by Subject|0
1173353|NCT01145755|3853810|P1|Overall Study|Withdrawal by Subject|0
1173354|NCT01145755|3853808|P3|Overall Study|Patient could not swollow medication|1
1173355|NCT01145755|3853809|P2|Overall Study|Patient could not swollow medication|0
1173356|NCT01145755|3853810|P1|Overall Study|Patient could not swollow medication|0
1173357|NCT01145755|3853808|P3|Overall Study|Lack of Efficacy|0
1173358|NCT01145755|3853809|P2|Overall Study|Lack of Efficacy|1
1173359|NCT01145755|3853810|P1|Overall Study|Lack of Efficacy|0
1173360|NCT01145755|3853808|P3|Overall Study|Study Closure|17
1173361|NCT01145755|3853809|P2|Overall Study|Study Closure|14
1173362|NCT01145755|3853810|P1|Overall Study|Study Closure|14
1173363|NCT01145755|3853808|P3|Overall Study|Protocol Violation|1
1173364|NCT01145755|3853809|P2|Overall Study|Protocol Violation|3
1173365|NCT01145755|3853810|P1|Overall Study|Protocol Violation|0
1173366|NCT01145755|3853808|P3|Overall Study|Lost to Follow-up|1
1173367|NCT01145755|3853809|P2|Overall Study|Lost to Follow-up|3
1173368|NCT01145755|3853810|P1|Overall Study|Lost to Follow-up|2
1173369|NCT01145755|3853808|P3|Overall Study|Withdrawal by Subject|2
1173370|NCT01145755|3853809|P2|Overall Study|Withdrawal by Subject|2
1173371|NCT01145755|3853810|P1|Overall Study|Withdrawal by Subject|2
1173372|NCT01145755|3853808|P3|Overall Study|Adverse Event|2
1173373|NCT01145755|3853809|P2|Overall Study|Adverse Event|4
1173374|NCT01145755|3853810|P1|Overall Study|Adverse Event|2
1173375|NCT01145625|3853837|P2|Overall Study|Pregnancy|1
1173376|NCT01145625|3853838|P1|Overall Study|Pregnancy|0
1173377|NCT01145625|3853837|P2|Overall Study|Withdrawal by Subject|16
1173378|NCT01145625|3853838|P1|Overall Study|Withdrawal by Subject|7
1173379|NCT01145625|3853837|P2|Overall Study|Protocol Violation|1
1173380|NCT01145625|3853838|P1|Overall Study|Protocol Violation|3
1173381|NCT01145625|3853837|P2|Overall Study|Adverse Event|4
1173382|NCT01145625|3853838|P1|Overall Study|Adverse Event|6
1173383|NCT01145625|3853837|P2|Overall Study|Lost to Follow-up|9
1173384|NCT01145625|3853838|P1|Overall Study|Lost to Follow-up|8
1173385|NCT01145560|3853851|P3|Overall Study|Withdrawal of therapy|1
1173386|NCT01145560|3853852|P2|Overall Study|Withdrawal of therapy|0
1173387|NCT01145560|3853853|P1|Overall Study|Withdrawal of therapy|0
1173388|NCT01145560|3853851|P3|Overall Study|False insurance information|0
1173389|NCT01145560|3853852|P2|Overall Study|False insurance information|1
1173390|NCT01145560|3853853|P1|Overall Study|False insurance information|0
1173391|NCT01145560|3853851|P3|Overall Study|Accidental unblinding of study treatment|0
1173392|NCT01145560|3853852|P2|Overall Study|Accidental unblinding of study treatment|1
1173393|NCT01145560|3853853|P1|Overall Study|Accidental unblinding of study treatment|0
1173394|NCT01145560|3853851|P3|Overall Study|No study drug by 24h after organ failure|0
1173395|NCT01145560|3853852|P2|Overall Study|No study drug by 24h after organ failure|0
1173396|NCT01145560|3853853|P1|Overall Study|No study drug by 24h after organ failure|1
1173397|NCT01145560|3853851|P3|Overall Study|Lost to Follow-up|1
1173398|NCT01145560|3853852|P2|Overall Study|Lost to Follow-up|1
1173399|NCT01145560|3853853|P1|Overall Study|Lost to Follow-up|1
1173400|NCT01145560|3853851|P3|Overall Study|Withdrawal by Subject|0
1173401|NCT01145560|3853852|P2|Overall Study|Withdrawal by Subject|1
1173402|NCT01145560|3853853|P1|Overall Study|Withdrawal by Subject|2
1173403|NCT01145508|3853879|P2|Overall Study|Never started treatment|1
1173404|NCT01145508|3853880|P1|Overall Study|Never started treatment|1
1173405|NCT01145508|3853879|P2|Overall Study|Physician Decision|1
1173406|NCT01145508|3853880|P1|Overall Study|Physician Decision|2
1173407|NCT01145508|3853879|P2|Overall Study|Death|0
1173408|NCT01145508|3853880|P1|Overall Study|Death|1
1173409|NCT01145508|3853879|P2|Overall Study|Adverse Event|0
1173410|NCT01145508|3853880|P1|Overall Study|Adverse Event|1
1173411|NCT01145495|3853886|P1|Overall Study|Disease progression after respone|1
1173412|NCT01145495|3853886|P1|Overall Study|Withdrawal by Subject|5
1173413|NCT01145495|3853886|P1|Overall Study|Adverse Event|6
1173414|NCT01145482|3853892|P2|First Intervention (1 Day)|Withdrawal by Subject|1
1173415|NCT01145482|3853893|P1|First Intervention (1 Day)|Withdrawal by Subject|0
1173416|NCT01145417|3853903|P2|Overall Study|Other|0
1173417|NCT01145417|3853904|P1|Overall Study|Other|1
1173418|NCT01145417|3853903|P2|Overall Study|Study terminated by sponsor|43
1173419|NCT01145417|3853904|P1|Overall Study|Study terminated by sponsor|35
1173420|NCT01145417|3853903|P2|Overall Study|Adverse Event|1
1173421|NCT01145417|3853904|P1|Overall Study|Adverse Event|0
1173422|NCT01145417|3853903|P2|Overall Study|Pregnancy|0
1173423|NCT01145417|3853904|P1|Overall Study|Pregnancy|1
1173424|NCT01145417|3853903|P2|Overall Study|Withdrawal by Subject|2
1173425|NCT01145417|3853904|P1|Overall Study|Withdrawal by Subject|1
1173426|NCT01145417|3853903|P2|Overall Study|Lost to Follow-up|1
1173427|NCT01145417|3853904|P1|Overall Study|Lost to Follow-up|2
1173428|NCT01145417|3853903|P2|Overall Study|Death|0
1173429|NCT01145417|3853904|P1|Overall Study|Death|1
1173430|NCT01145352|3853937|P1|Overall Study|Syringe formulation was used|1
1173431|NCT01145352|3853937|P1|Overall Study|Treated before marketing approval|4
1173432|NCT01145352|3853937|P1|Overall Study|Found to have been registered twice|6
1173433|NCT01145066|3853948|P3|Overall Study|Low platelet count|0
1173434|NCT01145066|3853949|P2|Overall Study|Low platelet count|1
1173435|NCT01145066|3853950|P1|Overall Study|Low platelet count|0
1173436|NCT01145066|3853948|P3|Overall Study|Abdominal discomfort|0
1173437|NCT01145066|3853949|P2|Overall Study|Abdominal discomfort|1
1173438|NCT01145066|3853950|P1|Overall Study|Abdominal discomfort|0
1173439|NCT01145066|3853948|P3|Overall Study|problems swallowing capsule|0
1173440|NCT01145066|3853949|P2|Overall Study|problems swallowing capsule|0
1173441|NCT01145066|3853950|P1|Overall Study|problems swallowing capsule|1
1173442|NCT01145066|3853948|P3|Overall Study|To start new med|0
1173443|NCT01145066|3853949|P2|Overall Study|To start new med|0
1173444|NCT01145066|3853950|P1|Overall Study|To start new med|1
1173445|NCT01145066|3853948|P3|Overall Study|Withdrawal by Subject|2
1173446|NCT01145066|3853949|P2|Overall Study|Withdrawal by Subject|0
1173447|NCT01145066|3853950|P1|Overall Study|Withdrawal by Subject|0
1173448|NCT01145066|3853948|P3|Overall Study|Non-related surgery|1
1173449|NCT01145066|3853949|P2|Overall Study|Non-related surgery|0
1173450|NCT01145066|3853950|P1|Overall Study|Non-related surgery|0
1173451|NCT01145066|3853948|P3|Overall Study|To resume NSAIDs|1
1173452|NCT01145066|3853949|P2|Overall Study|To resume NSAIDs|2
1173453|NCT01145066|3853950|P1|Overall Study|To resume NSAIDs|2
1173454|NCT01145053|3854018|P1|Overall Study|Other|18
1173455|NCT01145053|3854018|P1|Overall Study|Withdrawal by Subject|25
1173456|NCT01145053|3854018|P1|Overall Study|Lost to Follow-up|28
1173457|NCT01145053|3854018|P1|Overall Study|Adverse Event|22
1173458|NCT01144715|3854070|P2|Overall Study|Adverse Event|1
1173459|NCT01144715|3854071|P1|Overall Study|Adverse Event|0
1173460|NCT01144715|3854070|P2|Overall Study|Withdrawal by Subject|1
1173461|NCT01144715|3854071|P1|Overall Study|Withdrawal by Subject|2
1173462|NCT01144715|3854070|P2|Overall Study|Lost to Follow-up|1
1173463|NCT01144715|3854071|P1|Overall Study|Lost to Follow-up|2
1173464|NCT01144416|3854140|P2|Intervention Period|Other|5
1173465|NCT01144416|3854141|P1|Intervention Period|Other|7
1173466|NCT01144416|3854140|P2|Intervention Period|No/too few/bad quality embryos|3
1173467|NCT01144416|3854141|P1|Intervention Period|No/too few/bad quality embryos|3
1173468|NCT01144416|3854140|P2|Intervention Period|No or abnormal fertilization|10
1173469|NCT01144416|3854141|P1|Intervention Period|No or abnormal fertilization|25
1173470|NCT01144416|3854140|P2|Intervention Period|No/too few/bad oocytes|5
1173471|NCT01144416|3854141|P1|Intervention Period|No/too few/bad oocytes|7
1173472|NCT01144416|3854140|P2|Intervention Period|Too high ovarian response|2
1173473|NCT01144416|3854141|P1|Intervention Period|Too high ovarian response|4
1173474|NCT01144416|3854140|P2|Intervention Period|Risk of OHSS|1
1173475|NCT01144416|3854141|P1|Intervention Period|Risk of OHSS|0
1173476|NCT01144416|3854140|P2|Intervention Period|Insufficient ovarian response|17
1173477|NCT01144416|3854141|P1|Intervention Period|Insufficient ovarian response|11
1173478|NCT01144416|3854140|P2|Intervention Period|Adverse Event|6
1173479|NCT01144416|3854141|P1|Intervention Period|Adverse Event|5
1173480|NCT01144403|3854157|P1|Overall Study|Adverse Event|1
1173481|NCT01144403|3854157|P1|Overall Study|Death|1
1173482|NCT01144403|3854157|P1|Overall Study|Lost to Follow-up|3
1173483|NCT01144377|3854169|P5|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
1173484|NCT01144377|3854170|P4|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
1173485|NCT01144377|3854171|P3|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
1173486|NCT01144377|3854172|P2|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
1173566|NCT01144364|3854224|P1|Induction Phase|Withdrawal by Subject|1
1173487|NCT01144377|3854173|P1|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1
1173488|NCT01144377|3854169|P5|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1
1173489|NCT01144377|3854170|P4|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
1173490|NCT01144377|3854171|P3|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
1173491|NCT01144377|3854172|P2|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
1173492|NCT01144377|3854173|P1|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
1173493|NCT01144377|3854169|P5|Optional 40 Week Safety Follow-up Period|Adverse Event|1
1173494|NCT01144377|3854170|P4|Optional 40 Week Safety Follow-up Period|Adverse Event|0
1173495|NCT01144377|3854171|P3|Optional 40 Week Safety Follow-up Period|Adverse Event|0
1173496|NCT01144377|3854172|P2|Optional 40 Week Safety Follow-up Period|Adverse Event|1
1173497|NCT01144377|3854173|P1|Optional 40 Week Safety Follow-up Period|Adverse Event|0
1173498|NCT01144377|3854169|P5|52 Week Treatment Period|Sponsor Decision|1
1173499|NCT01144377|3854170|P4|52 Week Treatment Period|Sponsor Decision|0
1173500|NCT01144377|3854171|P3|52 Week Treatment Period|Sponsor Decision|0
1173501|NCT01144377|3854172|P2|52 Week Treatment Period|Sponsor Decision|0
1173502|NCT01144377|3854173|P1|52 Week Treatment Period|Sponsor Decision|0
1173503|NCT01144377|3854169|P5|52 Week Treatment Period|Withdrawal by Subject|0
1173504|NCT01144377|3854170|P4|52 Week Treatment Period|Withdrawal by Subject|1
1173505|NCT01144377|3854171|P3|52 Week Treatment Period|Withdrawal by Subject|1
1173506|NCT01144377|3854172|P2|52 Week Treatment Period|Withdrawal by Subject|1
1173507|NCT01144377|3854173|P1|52 Week Treatment Period|Withdrawal by Subject|4
1173508|NCT01144377|3854169|P5|52 Week Treatment Period|Lost to Follow-up|0
1173509|NCT01144377|3854170|P4|52 Week Treatment Period|Lost to Follow-up|0
1173510|NCT01144377|3854171|P3|52 Week Treatment Period|Lost to Follow-up|0
1173511|NCT01144377|3854172|P2|52 Week Treatment Period|Lost to Follow-up|0
1173512|NCT01144377|3854173|P1|52 Week Treatment Period|Lost to Follow-up|1
1173513|NCT01144377|3854169|P5|52 Week Treatment Period|Protocol Violation|1
1173514|NCT01144377|3854170|P4|52 Week Treatment Period|Protocol Violation|0
1173515|NCT01144377|3854171|P3|52 Week Treatment Period|Protocol Violation|0
1173516|NCT01144377|3854172|P2|52 Week Treatment Period|Protocol Violation|0
1173517|NCT01144377|3854173|P1|52 Week Treatment Period|Protocol Violation|0
1173518|NCT01144377|3854169|P5|52 Week Treatment Period|Entry Criteria Not Met|0
1173519|NCT01144377|3854170|P4|52 Week Treatment Period|Entry Criteria Not Met|1
1173520|NCT01144377|3854171|P3|52 Week Treatment Period|Entry Criteria Not Met|1
1173521|NCT01144377|3854172|P2|52 Week Treatment Period|Entry Criteria Not Met|0
1173522|NCT01144377|3854173|P1|52 Week Treatment Period|Entry Criteria Not Met|0
1173523|NCT01144377|3854169|P5|52 Week Treatment Period|Adverse Event|1
1173524|NCT01144377|3854170|P4|52 Week Treatment Period|Adverse Event|2
1173525|NCT01144377|3854171|P3|52 Week Treatment Period|Adverse Event|3
1173526|NCT01144377|3854172|P2|52 Week Treatment Period|Adverse Event|0
1173527|NCT01144377|3854173|P1|52 Week Treatment Period|Adverse Event|0
1173528|NCT01144364|3854222|P3|Follow-Up/Maintenance Phase|Physician Decision|1
1173529|NCT01144364|3854223|P2|Follow-Up/Maintenance Phase|Physician Decision|0
1173530|NCT01144364|3854224|P1|Follow-Up/Maintenance Phase|Physician Decision|0
1173531|NCT01144364|3854222|P3|Follow-Up/Maintenance Phase|Relapse|5
1173532|NCT01144364|3854223|P2|Follow-Up/Maintenance Phase|Relapse|5
1173533|NCT01144364|3854224|P1|Follow-Up/Maintenance Phase|Relapse|0
1173534|NCT01144364|3854222|P3|Follow-Up/Maintenance Phase|Lost to Follow-up|4
1173535|NCT01144364|3854223|P2|Follow-Up/Maintenance Phase|Lost to Follow-up|1
1173536|NCT01144364|3854224|P1|Follow-Up/Maintenance Phase|Lost to Follow-up|0
1173537|NCT01144364|3854222|P3|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
1173538|NCT01144364|3854223|P2|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
1173539|NCT01144364|3854224|P1|Follow-Up/Maintenance Phase|Withdrawal by Subject|0
1173540|NCT01144364|3854222|P3|Follow-Up/Maintenance Phase|Death|0
1173541|NCT01144364|3854223|P2|Follow-Up/Maintenance Phase|Death|2
1173542|NCT01144364|3854224|P1|Follow-Up/Maintenance Phase|Death|0
1173543|NCT01144364|3854222|P3|Follow-Up/Maintenance Phase|Adverse Event|1
1173544|NCT01144364|3854223|P2|Follow-Up/Maintenance Phase|Adverse Event|3
1173545|NCT01144364|3854224|P1|Follow-Up/Maintenance Phase|Adverse Event|0
1173546|NCT01144364|3854222|P3|Follow-Up/Maintenance Phase|Disease progression|29
1173547|NCT01144364|3854223|P2|Follow-Up/Maintenance Phase|Disease progression|23
1173548|NCT01144364|3854224|P1|Follow-Up/Maintenance Phase|Disease progression|0
1173549|NCT01144364|3854222|P3|Induction Phase|Protocol Violation|0
1173550|NCT01144364|3854223|P2|Induction Phase|Protocol Violation|0
1173551|NCT01144364|3854224|P1|Induction Phase|Protocol Violation|1
1173552|NCT01144364|3854222|P3|Induction Phase|Secondary neoplasia|0
1173553|NCT01144364|3854223|P2|Induction Phase|Secondary neoplasia|0
1173554|NCT01144364|3854224|P1|Induction Phase|Secondary neoplasia|1
1173555|NCT01144364|3854222|P3|Induction Phase|Stable disease|0
1173556|NCT01144364|3854223|P2|Induction Phase|Stable disease|0
1173557|NCT01144364|3854224|P1|Induction Phase|Stable disease|2
1173558|NCT01144364|3854222|P3|Induction Phase|Physician Decision|0
1173559|NCT01144364|3854223|P2|Induction Phase|Physician Decision|0
1173560|NCT01144364|3854224|P1|Induction Phase|Physician Decision|1
1173561|NCT01144364|3854222|P3|Induction Phase|Lost to Follow-up|0
1173562|NCT01144364|3854223|P2|Induction Phase|Lost to Follow-up|0
1173563|NCT01144364|3854224|P1|Induction Phase|Lost to Follow-up|2
1173564|NCT01144364|3854222|P3|Induction Phase|Withdrawal by Subject|0
1173565|NCT01144364|3854223|P2|Induction Phase|Withdrawal by Subject|0
1173567|NCT01144364|3854222|P3|Induction Phase|Death|0
1173568|NCT01144364|3854223|P2|Induction Phase|Death|0
1173569|NCT01144364|3854224|P1|Induction Phase|Death|1
1173570|NCT01144364|3854222|P3|Induction Phase|Adverse Event|0
1173571|NCT01144364|3854223|P2|Induction Phase|Adverse Event|0
1173572|NCT01144364|3854224|P1|Induction Phase|Adverse Event|9
1173573|NCT01144364|3854222|P3|Induction Phase|Disease progression|0
1173574|NCT01144364|3854223|P2|Induction Phase|Disease progression|0
1173575|NCT01144364|3854224|P1|Induction Phase|Disease progression|14
1173576|NCT01144299|3854273|P2|Overall Study|Withdrawal by Subject|0
1173577|NCT01144299|3854274|P1|Overall Study|Withdrawal by Subject|1
1173578|NCT01144299|3854273|P2|Overall Study|Lost to Follow-up|0
1173579|NCT01144299|3854274|P1|Overall Study|Lost to Follow-up|1
1173580|NCT01144182|3854319|P2|Overall Study|Lost to Follow-up|9
1173581|NCT01144182|3854320|P1|Overall Study|Lost to Follow-up|9
1173582|NCT01144182|3854319|P2|Overall Study|Withdrawal by Subject|6
1173583|NCT01144182|3854320|P1|Overall Study|Withdrawal by Subject|3
1173584|NCT01144182|3854319|P2|Overall Study|Death|6
1173585|NCT01144182|3854320|P1|Overall Study|Death|5
1173586|NCT01144052|3854380|P2|Overall Study|Withdrawal by Subject|1
1173587|NCT01144052|3854381|P1|Overall Study|Withdrawal by Subject|1
1173588|NCT01143896|3854412|P2|Overall Study|Death|3
1173589|NCT01143896|3854413|P1|Overall Study|Death|6
1173590|NCT01143896|3854412|P2|Overall Study|Withdrawal by Subject|5
1173591|NCT01143896|3854413|P1|Overall Study|Withdrawal by Subject|13
1173592|NCT01143896|3854412|P2|Overall Study|Lost to Follow-up|13
1173593|NCT01143896|3854413|P1|Overall Study|Lost to Follow-up|18
1173594|NCT01143896|3854412|P2|Overall Study|Did not complete Baseline Interview|4
1173595|NCT01143896|3854413|P1|Overall Study|Did not complete Baseline Interview|5
1173596|NCT01143714|3854525|P2|Overall Study|wound size increased|0
1173597|NCT01143714|3854526|P1|Overall Study|wound size increased|1
1173598|NCT01143714|3854525|P2|Overall Study|wound closed = deemed healed|0
1173599|NCT01143714|3854526|P1|Overall Study|wound closed = deemed healed|1
1173600|NCT01143714|3854525|P2|Overall Study|Subject non-compliance|1
1173601|NCT01143714|3854526|P1|Overall Study|Subject non-compliance|0
1173602|NCT01143714|3854525|P2|Overall Study|Withdrawal by Subject|0
1173603|NCT01143714|3854526|P1|Overall Study|Withdrawal by Subject|1
1173604|NCT01143714|3854525|P2|Overall Study|Adverse Event|2
1173605|NCT01143714|3854526|P1|Overall Study|Adverse Event|4
1173606|NCT01143402|3854631|P3|Overall Study|Not Treated|1
1173607|NCT01143402|3854632|P2|Overall Study|Not Treated|0
1173608|NCT01143402|3854633|P1|Overall Study|Not Treated|0
1173609|NCT01143402|3854631|P3|Overall Study|Rapid clinical decline|0
1173610|NCT01143402|3854632|P2|Overall Study|Rapid clinical decline|1
1173611|NCT01143402|3854633|P1|Overall Study|Rapid clinical decline|1
1173612|NCT01143389|3854644|P2|Overall Study|Lost to Follow-up|25
1173613|NCT01143389|3854645|P1|Overall Study|Lost to Follow-up|26
1173614|NCT01143337|3854659|P3|Overall Study|Other reason|5
1173615|NCT01143337|3854660|P2|Overall Study|Other reason|0
1173616|NCT01143337|3854661|P1|Overall Study|Other reason|0
1173617|NCT01143337|3854659|P3|Overall Study|Withdrawal by Subject|1
1173618|NCT01143337|3854660|P2|Overall Study|Withdrawal by Subject|0
1173619|NCT01143337|3854661|P1|Overall Study|Withdrawal by Subject|0
1173620|NCT01143337|3854659|P3|Overall Study|Protocol Violation|0
1173621|NCT01143337|3854660|P2|Overall Study|Protocol Violation|0
1173622|NCT01143337|3854661|P1|Overall Study|Protocol Violation|1
1173623|NCT01143337|3854659|P3|Overall Study|Lack of Efficacy|1
1173624|NCT01143337|3854660|P2|Overall Study|Lack of Efficacy|2
1173625|NCT01143337|3854661|P1|Overall Study|Lack of Efficacy|6
1173626|NCT01143337|3854659|P3|Overall Study|Adverse Event|5
1173627|NCT01143337|3854660|P2|Overall Study|Adverse Event|9
1173628|NCT01143337|3854661|P1|Overall Study|Adverse Event|3
1173629|NCT01143324|3854675|P1|Overall Study|Explant of the device|4
1173630|NCT01143324|3854675|P1|Overall Study|Withdrawal by Subject|4
1173631|NCT01143324|3854675|P1|Overall Study|Lost to Follow-up|11
1173632|NCT01143259|3854714|P2|Overall Study|Screen Failure|9
1173633|NCT01143259|3854715|P1|Overall Study|Screen Failure|7
1173634|NCT01143259|3854714|P2|Overall Study|Protocol Violation|9
1173635|NCT01143259|3854715|P1|Overall Study|Protocol Violation|13
1173636|NCT01143259|3854714|P2|Overall Study|Withdrawal by Subject|2
1173637|NCT01143259|3854715|P1|Overall Study|Withdrawal by Subject|3
1173638|NCT01143207|3854723|P1|Overall Study|Lost to Follow-up|2
1173639|NCT01143090|3854743|P1|Overall Study|Administrative|1
1173640|NCT01143090|3854743|P1|Overall Study|Failure to meet eligibility criteria|1
1173641|NCT01143090|3854743|P1|Overall Study|Non-compliance with study drug|1
1173642|NCT01143090|3854743|P1|Overall Study|Withdrawal by Subject|18
1173643|NCT01143090|3854743|P1|Overall Study|Protocol Violation|2
1173644|NCT01143090|3854743|P1|Overall Study|Lost to Follow-up|9
1173645|NCT01143090|3854743|P1|Overall Study|Adverse Event|17
1173646|NCT01143090|3854743|P1|Overall Study|Lack of Efficacy|2
1173647|NCT01143077|3854750|P3|Overall Study|Principal Investigator Decision|1
1173648|NCT01143077|3854751|P2|Overall Study|Principal Investigator Decision|0
1173649|NCT01143077|3854752|P1|Overall Study|Principal Investigator Decision|2
1173650|NCT01143077|3854750|P3|Overall Study|Administrative|0
1173651|NCT01143077|3854751|P2|Overall Study|Administrative|0
1173652|NCT01143077|3854752|P1|Overall Study|Administrative|1
1173653|NCT01143077|3854750|P3|Overall Study|Non-compliance with study drug|1
1173654|NCT01143077|3854751|P2|Overall Study|Non-compliance with study drug|1
1173655|NCT01143077|3854752|P1|Overall Study|Non-compliance with study drug|0
1173656|NCT01143077|3854750|P3|Overall Study|Withdrawal by Subject|3
1173657|NCT01143077|3854751|P2|Overall Study|Withdrawal by Subject|3
1173658|NCT01143077|3854752|P1|Overall Study|Withdrawal by Subject|4
1173659|NCT01143077|3854750|P3|Overall Study|Protocol Violation|0
1173660|NCT01143077|3854751|P2|Overall Study|Protocol Violation|0
1173661|NCT01143077|3854752|P1|Overall Study|Protocol Violation|2
1173662|NCT01143077|3854750|P3|Overall Study|Lost to Follow-up|4
1173663|NCT01143077|3854751|P2|Overall Study|Lost to Follow-up|3
1173664|NCT01143077|3854752|P1|Overall Study|Lost to Follow-up|2
1173665|NCT01143077|3854750|P3|Overall Study|Adverse Event|5
1173666|NCT01143077|3854751|P2|Overall Study|Adverse Event|6
1173667|NCT01143077|3854752|P1|Overall Study|Adverse Event|5
1173668|NCT01143077|3854750|P3|Overall Study|Lack of Efficacy|1
1173669|NCT01143077|3854751|P2|Overall Study|Lack of Efficacy|2
1173670|NCT01143077|3854752|P1|Overall Study|Lack of Efficacy|0
1173671|NCT01143051|3854769|P6|3-14 Day Washout|Withdrawal by Subject|1
1173672|NCT01143051|3854770|P5|3-14 Day Washout|Withdrawal by Subject|0
1173673|NCT01143051|3854771|P4|3-14 Day Washout|Withdrawal by Subject|0
1173674|NCT01143051|3854772|P3|3-14 Day Washout|Withdrawal by Subject|0
1173675|NCT01143051|3854773|P2|3-14 Day Washout|Withdrawal by Subject|0
1173676|NCT01143051|3854774|P1|3-14 Day Washout|Withdrawal by Subject|0
1173677|NCT01143051|3854769|P6|3-14 Day Washout|Withdrawal by Subject|0
1173678|NCT01143051|3854770|P5|3-14 Day Washout|Withdrawal by Subject|0
1173679|NCT01143051|3854771|P4|3-14 Day Washout|Withdrawal by Subject|0
1173680|NCT01143051|3854772|P3|3-14 Day Washout|Withdrawal by Subject|1
1173681|NCT01143051|3854773|P2|3-14 Day Washout|Withdrawal by Subject|0
1173682|NCT01143051|3854774|P1|3-14 Day Washout|Withdrawal by Subject|0
1173683|NCT01143038|3854823|P1|Overall Study|Death|1
1173684|NCT01143038|3854823|P1|Overall Study|Protocol Deviation|1
1173685|NCT01143038|3854823|P1|Overall Study|Lost to Follow-up|2
1173686|NCT01143038|3854823|P1|Overall Study|Adverse Event|3
1173687|NCT01143038|3854823|P1|Overall Study|Requirement for alternative therapy|5
1173688|NCT01143038|3854823|P1|Overall Study|Withdrawal by Subject|4
1173689|NCT01142908|3854833|P2|Overall Study|Withdrawal by Subject|0
1173690|NCT01142908|3854834|P1|Overall Study|Withdrawal by Subject|3
1173691|NCT01142908|3854833|P2|Overall Study|Excluded - did not meet criteria|5
1173692|NCT01142908|3854834|P1|Overall Study|Excluded - did not meet criteria|9
1173693|NCT01142908|3854833|P2|Overall Study|Death|4
1173694|NCT01142908|3854834|P1|Overall Study|Death|1
1173695|NCT01142908|3854833|P2|Overall Study|Lost to Follow-up|13
1173696|NCT01142908|3854834|P1|Overall Study|Lost to Follow-up|19
1173697|NCT01142726|3854883|P3|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
1173698|NCT01142726|3854884|P2|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1
1173699|NCT01142726|3854885|P1|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
1173700|NCT01142726|3854883|P3|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1
1173701|NCT01142726|3854884|P2|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
1173702|NCT01142726|3854885|P1|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
1173703|NCT01142726|3854883|P3|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
1173704|NCT01142726|3854884|P2|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
1173705|NCT01142726|3854885|P1|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
1173706|NCT01142726|3854883|P3|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1
1173707|NCT01142726|3854884|P2|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
1173708|NCT01142726|3854885|P1|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
1173709|NCT01142726|3854883|P3|Withdrawal Phase: Months 12 up to 24|non-specified|1
1173710|NCT01142726|3854884|P2|Withdrawal Phase: Months 12 up to 24|non-specified|1
1173711|NCT01142726|3854885|P1|Withdrawal Phase: Months 12 up to 24|non-specified|0
1173712|NCT01142726|3854883|P3|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53
1173713|NCT01142726|3854884|P2|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54
1173714|NCT01142726|3854885|P1|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65
1173715|NCT01142726|3854883|P3|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
1173716|NCT01142726|3854884|P2|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
1173717|NCT01142726|3854885|P1|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1
1173718|NCT01142726|3854883|P3|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
1173719|NCT01142726|3854884|P2|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
1173720|NCT01142726|3854885|P1|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2
1173721|NCT01142726|3854883|P3|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
1173722|NCT01142726|3854884|P2|Withdrawal Phase: Months 12 up to 24|Pregnancy|0
1173723|NCT01142726|3854885|P1|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
1173724|NCT01142726|3854883|P3|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2
1173725|NCT01142726|3854884|P2|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
1173726|NCT01142726|3854885|P1|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
1173727|NCT01142726|3854883|P3|Withdrawal Phase: Months 12 up to 24|Adverse Event|1
1173728|NCT01142726|3854884|P2|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
1173729|NCT01142726|3854885|P1|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
1173730|NCT01142726|3854883|P3|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11
1173731|NCT01142726|3854884|P2|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6
1173732|NCT01142726|3854885|P1|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5
1173733|NCT01142726|3854883|P3|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
1173820|NCT01141205|3855254|P1|Overall Study|Withdrawal by Subject|1
1173734|NCT01142726|3854884|P2|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
1173735|NCT01142726|3854885|P1|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1
1173736|NCT01142726|3854883|P3|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
1173737|NCT01142726|3854884|P2|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2
1173738|NCT01142726|3854885|P1|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
1173739|NCT01142726|3854883|P3|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3
1173740|NCT01142726|3854884|P2|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9
1173741|NCT01142726|3854885|P1|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4
1173742|NCT01142726|3854883|P3|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
1173743|NCT01142726|3854884|P2|Treatment Phase: Day 1 Through Month 12|Adverse Event|8
1173744|NCT01142726|3854885|P1|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
1173745|NCT01142661|3854948|P1|Overall Study|Physician Decision|1
1173746|NCT01142661|3854948|P1|Overall Study|Withdrawal by Subject|1
1173747|NCT01142661|3854948|P1|Overall Study|Adverse Event|2
1173748|NCT01142596|3854955|P2|Overall Study|Other reason (not specified)|4
1173749|NCT01142596|3854956|P1|Overall Study|Other reason (not specified)|5
1173750|NCT01142596|3854955|P2|Overall Study|Lost to Follow-up|3
1173751|NCT01142596|3854956|P1|Overall Study|Lost to Follow-up|2
1173752|NCT01142596|3854955|P2|Overall Study|Lack of Efficacy|9
1173753|NCT01142596|3854956|P1|Overall Study|Lack of Efficacy|5
1173754|NCT01142596|3854955|P2|Overall Study|Adverse Event|35
1173755|NCT01142596|3854956|P1|Overall Study|Adverse Event|8
1173756|NCT01142596|3854955|P2|Overall Study|Withdrawal by Subject|35
1173757|NCT01142596|3854956|P1|Overall Study|Withdrawal by Subject|9
1173758|NCT01142466|3855008|P2|Overall Study|Withdrawal by Subject|1
1173759|NCT01142466|3855009|P1|Overall Study|Withdrawal by Subject|1
1173760|NCT01142466|3855008|P2|Overall Study|Adverse Event|1
1173761|NCT01142466|3855009|P1|Overall Study|Adverse Event|2
1173762|NCT01142388|3855029|P2|Overall Study|Never started therapy|3
1173763|NCT01142388|3855030|P1|Overall Study|Never started therapy|7
1173764|NCT01142388|3855029|P2|Overall Study|Other|1
1173765|NCT01142388|3855030|P1|Overall Study|Other|1
1173766|NCT01142388|3855029|P2|Overall Study|Other complications|2
1173767|NCT01142388|3855030|P1|Overall Study|Other complications|0
1173768|NCT01142388|3855029|P2|Overall Study|Alternative therapy|0
1173769|NCT01142388|3855030|P1|Overall Study|Alternative therapy|1
1173770|NCT01142388|3855029|P2|Overall Study|Withdrawal by Subject|3
1173771|NCT01142388|3855030|P1|Overall Study|Withdrawal by Subject|5
1173772|NCT01142388|3855029|P2|Overall Study|Death|2
1173773|NCT01142388|3855030|P1|Overall Study|Death|3
1173774|NCT01142388|3855029|P2|Overall Study|Adverse Event|5
1173775|NCT01142388|3855030|P1|Overall Study|Adverse Event|9
1173776|NCT01142388|3855029|P2|Overall Study|Lack of Efficacy|31
1173777|NCT01142388|3855030|P1|Overall Study|Lack of Efficacy|21
1173778|NCT01142336|3855042|P2|Overall Study|Lost to Follow-up|1
1173779|NCT01142336|3855043|P1|Overall Study|Lost to Follow-up|0
1173780|NCT01142336|3855042|P2|Overall Study|Adverse Event|1
1173781|NCT01142336|3855043|P1|Overall Study|Adverse Event|1
1173782|NCT01142193|3855077|P2|Overall Study|Other|2
1173783|NCT01142193|3855078|P1|Overall Study|Other|1
1173784|NCT01142193|3855077|P2|Overall Study|Protocol Discontinuation Criterion Met|0
1173785|NCT01142193|3855078|P1|Overall Study|Protocol Discontinuation Criterion Met|1
1173786|NCT01142193|3855077|P2|Overall Study|Withdrawal by Subject|3
1173787|NCT01142193|3855078|P1|Overall Study|Withdrawal by Subject|4
1173788|NCT01142193|3855077|P2|Overall Study|Physician Decision|1
1173789|NCT01142193|3855078|P1|Overall Study|Physician Decision|1
1173790|NCT01142193|3855077|P2|Overall Study|Lack of Efficacy|1
1173791|NCT01142193|3855078|P1|Overall Study|Lack of Efficacy|2
1173792|NCT01142193|3855077|P2|Overall Study|Adverse Event|4
1173793|NCT01142193|3855078|P1|Overall Study|Adverse Event|12
1173794|NCT01142128|3855106|P1|Overall Study|Withdrawal by Subject|2
1173795|NCT01142128|3855106|P1|Overall Study|Lost to Follow-up|1
1173796|NCT01142128|3855106|P1|Overall Study|Physician Decision|1
1173797|NCT01142115|3855116|P2|First Intervention|Adverse Event|0
1173798|NCT01142115|3855117|P1|First Intervention|Adverse Event|1
1173799|NCT01142115|3855116|P2|First Intervention|Lack of Efficacy|1
1173800|NCT01142115|3855117|P1|First Intervention|Lack of Efficacy|1
1173801|NCT01142089|3855134|P2|Overall Study|Patient required rescue medication|17
1173802|NCT01142089|3855135|P1|Overall Study|Patient required rescue medication|8
1173803|NCT01142089|3855134|P2|Overall Study|Noncompliance with study procedures|1
1173804|NCT01142089|3855135|P1|Overall Study|Noncompliance with study procedures|2
1173805|NCT01142089|3855134|P2|Overall Study|Use of prohibited medications|1
1173806|NCT01142089|3855135|P1|Overall Study|Use of prohibited medications|0
1173807|NCT01142089|3855134|P2|Overall Study|Withdrawal by Subject|2
1173808|NCT01142089|3855135|P1|Overall Study|Withdrawal by Subject|1
1173809|NCT01142089|3855134|P2|Overall Study|Physician Decision|0
1173810|NCT01142089|3855135|P1|Overall Study|Physician Decision|1
1173811|NCT01141712|3855157|P1|Overall Study|Disease progression|3
1173812|NCT01141660|3855178|P2|Overall Study|Physician Decision|12
1173813|NCT01141660|3855179|P1|Overall Study|Physician Decision|0
1173814|NCT01141283|3855247|P1|Overall Study|Lack of Efficacy|10
1173815|NCT01141283|3855247|P1|Overall Study|Administrative|4
1173816|NCT01141283|3855247|P1|Overall Study|Withdrawal by Subject|14
1173817|NCT01141283|3855247|P1|Overall Study|Lost to Follow-up|4
1173818|NCT01141283|3855247|P1|Overall Study|Adverse Event|56
1173819|NCT01141205|3855253|P2|Overall Study|Withdrawal by Subject|1
1173821|NCT01141205|3855253|P2|Overall Study|Lost to Follow-up|0
1173822|NCT01141205|3855254|P1|Overall Study|Lost to Follow-up|1
1173823|NCT01141205|3855253|P2|Overall Study|Physician Decision|1
1173824|NCT01141205|3855254|P1|Overall Study|Physician Decision|1
1173825|NCT01140906|3855281|P4|Overall Study|Administrative or other reason|2
1173826|NCT01140906|3855282|P3|Overall Study|Administrative or other reason|3
1173827|NCT01140906|3855283|P2|Overall Study|Administrative or other reason|5
1173828|NCT01140906|3855284|P1|Overall Study|Administrative or other reason|0
1173829|NCT01140906|3855281|P4|Overall Study|Lost to Follow-up|2
1173830|NCT01140906|3855282|P3|Overall Study|Lost to Follow-up|0
1173831|NCT01140906|3855283|P2|Overall Study|Lost to Follow-up|1
1173832|NCT01140906|3855284|P1|Overall Study|Lost to Follow-up|1
1173833|NCT01140906|3855281|P4|Overall Study|Withdrawal of consent|2
1173834|NCT01140906|3855282|P3|Overall Study|Withdrawal of consent|2
1173835|NCT01140906|3855283|P2|Overall Study|Withdrawal of consent|6
1173836|NCT01140906|3855284|P1|Overall Study|Withdrawal of consent|6
1173837|NCT01140906|3855281|P4|Overall Study|Protocol Violation|1
1173838|NCT01140906|3855282|P3|Overall Study|Protocol Violation|2
1173839|NCT01140906|3855283|P2|Overall Study|Protocol Violation|3
1173840|NCT01140906|3855284|P1|Overall Study|Protocol Violation|5
1173841|NCT01140906|3855281|P4|Overall Study|Non-compliance|1
1173842|NCT01140906|3855282|P3|Overall Study|Non-compliance|0
1173843|NCT01140906|3855283|P2|Overall Study|Non-compliance|1
1173844|NCT01140906|3855284|P1|Overall Study|Non-compliance|0
1173845|NCT01140906|3855281|P4|Overall Study|Lack of Efficacy|1
1173846|NCT01140906|3855282|P3|Overall Study|Lack of Efficacy|2
1173847|NCT01140906|3855283|P2|Overall Study|Lack of Efficacy|8
1173848|NCT01140906|3855284|P1|Overall Study|Lack of Efficacy|6
1173849|NCT01140906|3855281|P4|Overall Study|Adverse Event|7
1173850|NCT01140906|3855282|P3|Overall Study|Adverse Event|17
1173851|NCT01140906|3855283|P2|Overall Study|Adverse Event|10
1173852|NCT01140906|3855284|P1|Overall Study|Adverse Event|7
1173853|NCT01140880|3855324|P2|Overall Study|Protocol Violation|30
1173854|NCT01140880|3855325|P1|Overall Study|Protocol Violation|0
1173855|NCT01140880|3855324|P2|Overall Study|Lost to Follow-up|10
1173856|NCT01140880|3855325|P1|Overall Study|Lost to Follow-up|8
1173857|NCT01140880|3855324|P2|Overall Study|Withdrawal by Subject|3
1173858|NCT01140880|3855325|P1|Overall Study|Withdrawal by Subject|6
1173859|NCT01140880|3855324|P2|Overall Study|Death|1
1173860|NCT01140880|3855325|P1|Overall Study|Death|0
1173861|NCT01140867|3855337|P1|Overall Study|Medication Noncompliance|2
1173862|NCT01140867|3855337|P1|Overall Study|Uncooperative patient|2
1173863|NCT01140867|3855337|P1|Overall Study|Protocol Violation|1
1173864|NCT01140867|3855337|P1|Overall Study|Withdrawal by Subject|1
1173865|NCT01140867|3855337|P1|Overall Study|Lost to Follow-up|2
1173866|NCT01140867|3855337|P1|Overall Study|Lack of Efficacy|3
1173867|NCT01140867|3855337|P1|Overall Study|Adverse Event|22
1173868|NCT01140646|3855377|P1|Overall Study|Refused Further Treatment|5
1173869|NCT01140646|3855377|P1|Overall Study|Adverse Event|4
1173870|NCT01140503|3855381|P1|Overall Study|Withdrawal by Subject|1
1173871|NCT01140477|3855389|P2|Overall Study|Subject explanted|1
1173872|NCT01140477|3855390|P1|Overall Study|Subject explanted|0
1173873|NCT01140477|3855389|P2|Overall Study|Death|1
1173874|NCT01140477|3855390|P1|Overall Study|Death|1
1173875|NCT01140477|3855389|P2|Overall Study|Surgical complication preventing implant|0
1173876|NCT01140477|3855390|P1|Overall Study|Surgical complication preventing implant|2
1173877|NCT01140477|3855389|P2|Overall Study|Withdrawal by Subject|4
1173878|NCT01140477|3855390|P1|Overall Study|Withdrawal by Subject|1
1173879|NCT01140477|3855389|P2|Overall Study|Lost to Follow-up|0
1173880|NCT01140477|3855390|P1|Overall Study|Lost to Follow-up|4
1173881|NCT01140347|3855405|P2|Overall Study|Withdrawal by Subject|8
1173882|NCT01140347|3855406|P1|Overall Study|Withdrawal by Subject|13
1173883|NCT01140347|3855405|P2|Overall Study|Lost to Follow-up|6
1173884|NCT01140347|3855406|P1|Overall Study|Lost to Follow-up|5
1173885|NCT01140061|3855459|P10|Extension|Laboratory Adverse Event|1
1173886|NCT01140061|3855460|P9|Extension|Laboratory Adverse Event|0
1173887|NCT01140061|3855461|P8|Extension|Laboratory Adverse Event|0
1173888|NCT01140061|3855462|P7|Extension|Laboratory Adverse Event|0
1173889|NCT01140061|3855463|P6|Extension|Laboratory Adverse Event|0
1173890|NCT01140061|3855464|P5|Extension|Laboratory Adverse Event|0
1173891|NCT01140061|3855465|P4|Extension|Laboratory Adverse Event|0
1173892|NCT01140061|3855466|P3|Extension|Laboratory Adverse Event|0
1173893|NCT01140061|3855467|P2|Extension|Laboratory Adverse Event|0
1173894|NCT01140061|3855468|P1|Extension|Laboratory Adverse Event|0
1173895|NCT01140061|3855459|P10|Part I|Adverse Event|0
1173896|NCT01140061|3855460|P9|Part I|Adverse Event|0
1173897|NCT01140061|3855461|P8|Part I|Adverse Event|0
1173898|NCT01140061|3855462|P7|Part I|Adverse Event|0
1173899|NCT01140061|3855463|P6|Part I|Adverse Event|0
1173900|NCT01140061|3855464|P5|Part I|Adverse Event|0
1173901|NCT01140061|3855465|P4|Part I|Adverse Event|0
1173902|NCT01140061|3855466|P3|Part I|Adverse Event|0
1173903|NCT01140061|3855467|P2|Part I|Adverse Event|0
1173904|NCT01140061|3855468|P1|Part I|Adverse Event|1
1173905|NCT01140048|3855495|P1|Overall Study|Lost to Follow-up|31
1173906|NCT01140048|3855495|P1|Overall Study|Withdrawal by Subject|13
1173907|NCT01140048|3855495|P1|Overall Study|Physician Decision|1
1173908|NCT01139775|3855535|P3|Overall Study|Physician Decision|2
1173909|NCT01139775|3855536|P2|Overall Study|Physician Decision|2
1173910|NCT01139775|3855537|P1|Overall Study|Physician Decision|0
1173911|NCT01139775|3855535|P3|Overall Study|Withdrawal by Subject|2
1173912|NCT01139775|3855536|P2|Overall Study|Withdrawal by Subject|0
1173913|NCT01139775|3855537|P1|Overall Study|Withdrawal by Subject|1
1173914|NCT01139775|3855535|P3|Overall Study|Protocol Violation|0
1173915|NCT01139775|3855536|P2|Overall Study|Protocol Violation|5
1173916|NCT01139775|3855537|P1|Overall Study|Protocol Violation|0
1173917|NCT01139775|3855535|P3|Overall Study|Adverse Event|2
1173918|NCT01139775|3855536|P2|Overall Study|Adverse Event|6
1173919|NCT01139775|3855537|P1|Overall Study|Adverse Event|0
1173920|NCT01139762|3855569|P3|Double-Blind Randomized Active Treatment|Lost to Follow-up|4
1173921|NCT01139762|3855570|P2|Double-Blind Randomized Active Treatment|Lost to Follow-up|3
1173922|NCT01139762|3855571|P1|Double-Blind Randomized Active Treatment|Lost to Follow-up|0
1173923|NCT01139762|3855569|P3|Double-Blind Randomized Active Treatment|Lack of Efficacy|5
1173924|NCT01139762|3855570|P2|Double-Blind Randomized Active Treatment|Lack of Efficacy|3
1173925|NCT01139762|3855571|P1|Double-Blind Randomized Active Treatment|Lack of Efficacy|0
1173926|NCT01139762|3855569|P3|Double-Blind Randomized Active Treatment|Sponsor Decision|6
1173927|NCT01139762|3855570|P2|Double-Blind Randomized Active Treatment|Sponsor Decision|5
1173928|NCT01139762|3855571|P1|Double-Blind Randomized Active Treatment|Sponsor Decision|0
1173929|NCT01139762|3855569|P3|Double-Blind Randomized Active Treatment|Physician Decision|0
1173930|NCT01139762|3855570|P2|Double-Blind Randomized Active Treatment|Physician Decision|2
1173931|NCT01139762|3855571|P1|Double-Blind Randomized Active Treatment|Physician Decision|0
1173932|NCT01139762|3855569|P3|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13
1173933|NCT01139762|3855570|P2|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6
1173934|NCT01139762|3855571|P1|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0
1173935|NCT01139762|3855569|P3|Double-Blind Randomized Active Treatment|Protocol Violation|8
1173936|NCT01139762|3855570|P2|Double-Blind Randomized Active Treatment|Protocol Violation|2
1173937|NCT01139762|3855571|P1|Double-Blind Randomized Active Treatment|Protocol Violation|0
1173938|NCT01139762|3855569|P3|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17
1173939|NCT01139762|3855570|P2|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14
1173940|NCT01139762|3855571|P1|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0
1173941|NCT01139762|3855569|P3|Double-Blind Randomized Active Treatment|Death|1
1173942|NCT01139762|3855570|P2|Double-Blind Randomized Active Treatment|Death|1
1173943|NCT01139762|3855571|P1|Double-Blind Randomized Active Treatment|Death|0
1173944|NCT01139762|3855569|P3|Double-Blind Randomized Active Treatment|Adverse Event|10
1173945|NCT01139762|3855570|P2|Double-Blind Randomized Active Treatment|Adverse Event|4
1173946|NCT01139762|3855571|P1|Double-Blind Randomized Active Treatment|Adverse Event|0
1173947|NCT01139762|3855569|P3|Washout and Placebo Lead-In Period|Lost to Follow-up|0
1173948|NCT01139762|3855570|P2|Washout and Placebo Lead-In Period|Lost to Follow-up|0
1173949|NCT01139762|3855571|P1|Washout and Placebo Lead-In Period|Lost to Follow-up|10
1173950|NCT01139762|3855569|P3|Washout and Placebo Lead-In Period|Sponsor Decision|0
1173951|NCT01139762|3855570|P2|Washout and Placebo Lead-In Period|Sponsor Decision|0
1173952|NCT01139762|3855571|P1|Washout and Placebo Lead-In Period|Sponsor Decision|10
1173953|NCT01139762|3855569|P3|Washout and Placebo Lead-In Period|Physician Decision|0
1173954|NCT01139762|3855570|P2|Washout and Placebo Lead-In Period|Physician Decision|0
1173955|NCT01139762|3855571|P1|Washout and Placebo Lead-In Period|Physician Decision|12
1173956|NCT01139762|3855569|P3|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
1173957|NCT01139762|3855570|P2|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
1173958|NCT01139762|3855571|P1|Washout and Placebo Lead-In Period|Withdrawal by Subject|83
1173959|NCT01139762|3855569|P3|Washout and Placebo Lead-In Period|Adverse Event|0
1173960|NCT01139762|3855570|P2|Washout and Placebo Lead-In Period|Adverse Event|0
1173961|NCT01139762|3855571|P1|Washout and Placebo Lead-In Period|Adverse Event|1
1173962|NCT01139762|3855569|P3|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
1173963|NCT01139762|3855570|P2|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
1173964|NCT01139762|3855571|P1|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258
1173965|NCT01139658|3855606|P2|Overall Study|Not specified|75
1173966|NCT01139658|3855607|P1|Overall Study|Not specified|28
1173967|NCT01139658|3855606|P2|Overall Study|No documentation of treatment|0
1173968|NCT01139658|3855607|P1|Overall Study|No documentation of treatment|1
1173969|NCT01139658|3855606|P2|Overall Study|Withdrawal by Subject|4
1173970|NCT01139658|3855607|P1|Overall Study|Withdrawal by Subject|2
1173971|NCT01139658|3855606|P2|Overall Study|Lack of Efficacy|7
1173972|NCT01139658|3855607|P1|Overall Study|Lack of Efficacy|15
1173973|NCT01139658|3855606|P2|Overall Study|Adverse Event|27
1173974|NCT01139658|3855607|P1|Overall Study|Adverse Event|10
1173975|NCT01139580|3855645|P2|Overall Study|Participant Randomization in Error|1
1173976|NCT01139580|3855646|P1|Overall Study|Participant Randomization in Error|0
1173977|NCT01139580|3855645|P2|Overall Study|Beginning Study Exclusion Treatment|1
1173978|NCT01139580|3855646|P1|Overall Study|Beginning Study Exclusion Treatment|0
1173979|NCT01139580|3855645|P2|Overall Study|Misrandomized|0
1173980|NCT01139580|3855646|P1|Overall Study|Misrandomized|1
1173981|NCT01139580|3855645|P2|Overall Study|Did Not Meet Exclusion Criteria|0
1173982|NCT01139580|3855646|P1|Overall Study|Did Not Meet Exclusion Criteria|1
1173983|NCT01139580|3855645|P2|Overall Study|Used Excluded Medicine After Enrollment|0
1173984|NCT01139580|3855646|P1|Overall Study|Used Excluded Medicine After Enrollment|1
1173985|NCT01139580|3855645|P2|Overall Study|Withdrawal by Subject|9
1173986|NCT01139580|3855646|P1|Overall Study|Withdrawal by Subject|6
1173987|NCT01139580|3855645|P2|Overall Study|Lack of Efficacy|2
1173988|NCT01139580|3855646|P1|Overall Study|Lack of Efficacy|0
1173989|NCT01139580|3855645|P2|Overall Study|Lost to Follow-up|1
1173990|NCT01139580|3855646|P1|Overall Study|Lost to Follow-up|9
1173991|NCT01139580|3855645|P2|Overall Study|Adverse Event|4
1173992|NCT01139580|3855646|P1|Overall Study|Adverse Event|5
1173993|NCT01139450|3855694|P3|Overall Study|Adverse Event|3
1173994|NCT01139450|3855695|P2|Overall Study|Adverse Event|2
1173995|NCT01139450|3855696|P1|Overall Study|Adverse Event|2
1173996|NCT01139450|3855694|P3|Overall Study|Administrative|1
1173997|NCT01139450|3855695|P2|Overall Study|Administrative|0
1173998|NCT01139450|3855696|P1|Overall Study|Administrative|0
1173999|NCT01139450|3855694|P3|Overall Study|Lost to Follow-up|11
1174000|NCT01139450|3855695|P2|Overall Study|Lost to Follow-up|7
1174001|NCT01139450|3855696|P1|Overall Study|Lost to Follow-up|9
1174002|NCT01139450|3855694|P3|Overall Study|Protocol Violation|2
1174003|NCT01139450|3855695|P2|Overall Study|Protocol Violation|5
1174004|NCT01139450|3855696|P1|Overall Study|Protocol Violation|6
1174005|NCT01139450|3855694|P3|Overall Study|Lack of Efficacy|8
1174006|NCT01139450|3855695|P2|Overall Study|Lack of Efficacy|1
1174007|NCT01139450|3855696|P1|Overall Study|Lack of Efficacy|3
1174008|NCT01139450|3855694|P3|Overall Study|Withdrawal by Subject|13
1174009|NCT01139450|3855695|P2|Overall Study|Withdrawal by Subject|10
1174010|NCT01139450|3855696|P1|Overall Study|Withdrawal by Subject|7
1174011|NCT01139164|3855748|P3|Overall Study|Withdrawn prior to study start|0
1174012|NCT01139164|3855749|P2|Overall Study|Withdrawn prior to study start|2
1174013|NCT01139164|3855750|P1|Overall Study|Withdrawn prior to study start|0
1174014|NCT01139125|3855764|P1|Overall Study|Withdrawal by Subject|1
1174015|NCT01139047|3855768|P1|Overall Study|Withdrawal by Subject|1
1174016|NCT01139021|3855783|P6|Overall Study|Withdrawal by Subject|0
1174017|NCT01139021|3855784|P5|Overall Study|Withdrawal by Subject|4
1174018|NCT01139021|3855785|P4|Overall Study|Withdrawal by Subject|1
1174019|NCT01139021|3855786|P3|Overall Study|Withdrawal by Subject|0
1174020|NCT01139021|3855787|P2|Overall Study|Withdrawal by Subject|0
1174021|NCT01139021|3855788|P1|Overall Study|Withdrawal by Subject|0
1174022|NCT01139021|3855783|P6|Overall Study|Protocol Violation|0
1174023|NCT01139021|3855784|P5|Overall Study|Protocol Violation|2
1174024|NCT01139021|3855785|P4|Overall Study|Protocol Violation|0
1174025|NCT01139021|3855786|P3|Overall Study|Protocol Violation|0
1174026|NCT01139021|3855787|P2|Overall Study|Protocol Violation|0
1174027|NCT01139021|3855788|P1|Overall Study|Protocol Violation|1
1174028|NCT01139021|3855783|P6|Overall Study|Lost to Follow-up|0
1174029|NCT01139021|3855784|P5|Overall Study|Lost to Follow-up|2
1174030|NCT01139021|3855785|P4|Overall Study|Lost to Follow-up|0
1174031|NCT01139021|3855786|P3|Overall Study|Lost to Follow-up|0
1174032|NCT01139021|3855787|P2|Overall Study|Lost to Follow-up|0
1174033|NCT01139021|3855788|P1|Overall Study|Lost to Follow-up|0
1174034|NCT01139021|3855783|P6|Overall Study|Adverse Event|0
1174035|NCT01139021|3855784|P5|Overall Study|Adverse Event|1
1174036|NCT01139021|3855785|P4|Overall Study|Adverse Event|0
1174037|NCT01139021|3855786|P3|Overall Study|Adverse Event|0
1174038|NCT01139021|3855787|P2|Overall Study|Adverse Event|0
1174039|NCT01139021|3855788|P1|Overall Study|Adverse Event|0
1174040|NCT01139008|3855824|P1|Overall Study|Non-compliant, lost product|1
1174041|NCT01139008|3855824|P1|Overall Study|Withdrawal by Subject|5
1174042|NCT01138826|3855857|P6|Washout Period I (of 16 Days)|Lost to Follow-up|0
1174043|NCT01138826|3855858|P5|Washout Period I (of 16 Days)|Lost to Follow-up|1
1174044|NCT01138826|3855859|P4|Washout Period I (of 16 Days)|Lost to Follow-up|0
1174045|NCT01138826|3855860|P3|Washout Period I (of 16 Days)|Lost to Follow-up|0
1174046|NCT01138826|3855861|P2|Washout Period I (of 16 Days)|Lost to Follow-up|1
1174047|NCT01138826|3855862|P1|Washout Period I (of 16 Days)|Lost to Follow-up|1
1174048|NCT01138657|3855899|P2|Overall Study|Miscellaneous Reasons|4
1174049|NCT01138657|3855900|P1|Overall Study|Miscellaneous Reasons|3
1174050|NCT01138657|3855899|P2|Overall Study|Lost to Follow-up|3
1174051|NCT01138657|3855900|P1|Overall Study|Lost to Follow-up|0
1174052|NCT01138657|3855899|P2|Overall Study|Lack of Efficacy|1
1174053|NCT01138657|3855900|P1|Overall Study|Lack of Efficacy|2
1174054|NCT01138657|3855899|P2|Overall Study|Adverse Event|10
1174055|NCT01138657|3855900|P1|Overall Study|Adverse Event|3
1174056|NCT01138501|3855963|P1|Overall Study|Withdrawal by Subject|3
1174057|NCT01138501|3855963|P1|Overall Study|Protocol Violation|2
1174058|NCT01138150|3856007|P2|Overall Study|Physician Decision|0
1174059|NCT01138150|3856008|P1|Overall Study|Physician Decision|1
1174060|NCT01138150|3856007|P2|Overall Study|blood unable to be processed|1
1174061|NCT01138150|3856008|P1|Overall Study|blood unable to be processed|0
1174062|NCT01138111|3856089|P1|Overall Study|Lost to Follow-up|2
1174063|NCT01138111|3856089|P1|Overall Study|Death|1
1174064|NCT01138111|3856089|P1|Overall Study|Adverse Event|1
1174065|NCT01138111|3856089|P1|Overall Study|Withdrawal by Subject|5
1174066|NCT01138046|3856143|P1|Overall Study|Withdrawal due to death|6
1174067|NCT01138007|3856163|P3|Overall Study|Withdrawal by Subject|15
1174068|NCT01138007|3856164|P2|Overall Study|Withdrawal by Subject|6
1174069|NCT01138007|3856165|P1|Overall Study|Withdrawal by Subject|5
1174070|NCT01138007|3856163|P3|Overall Study|Physician Decision|3
1174071|NCT01138007|3856164|P2|Overall Study|Physician Decision|5
1174072|NCT01138007|3856165|P1|Overall Study|Physician Decision|0
1174073|NCT01138007|3856163|P3|Overall Study|Lost to Follow-up|5
1174074|NCT01138007|3856164|P2|Overall Study|Lost to Follow-up|3
1174075|NCT01138007|3856165|P1|Overall Study|Lost to Follow-up|3
1174076|NCT01138007|3856163|P3|Overall Study|Protocol-Defined Stopping Criteria|8
1174077|NCT01138007|3856164|P2|Overall Study|Protocol-Defined Stopping Criteria|1
1174078|NCT01138007|3856165|P1|Overall Study|Protocol-Defined Stopping Criteria|6
1174079|NCT01138007|3856163|P3|Overall Study|Protocol Violation|2
1174080|NCT01138007|3856164|P2|Overall Study|Protocol Violation|3
1174081|NCT01138007|3856165|P1|Overall Study|Protocol Violation|2
1174082|NCT01138007|3856163|P3|Overall Study|Lack of Efficacy|6
1174083|NCT01138007|3856164|P2|Overall Study|Lack of Efficacy|0
1174084|NCT01138007|3856165|P1|Overall Study|Lack of Efficacy|2
1174085|NCT01138007|3856163|P3|Overall Study|Adverse Event|9
1174086|NCT01138007|3856164|P2|Overall Study|Adverse Event|12
1174087|NCT01138007|3856165|P1|Overall Study|Adverse Event|4
1174088|NCT01137812|3856272|P2|Overall Study|Not specified|27
1174089|NCT01137812|3856273|P1|Overall Study|Not specified|19
1174090|NCT01137812|3856272|P2|Overall Study|Patient met glycemic withdrawal criteria|85
1174091|NCT01137812|3856273|P1|Overall Study|Patient met glycemic withdrawal criteria|40
1174092|NCT01137812|3856272|P2|Overall Study|Death|0
1174093|NCT01137812|3856273|P1|Overall Study|Death|2
1174094|NCT01137812|3856272|P2|Overall Study|Withdrawal by Subject|13
1174095|NCT01137812|3856273|P1|Overall Study|Withdrawal by Subject|5
1174096|NCT01137812|3856272|P2|Overall Study|Protocol Violation|4
1174097|NCT01137812|3856273|P1|Overall Study|Protocol Violation|5
1174098|NCT01137812|3856272|P2|Overall Study|Physician Decision|17
1174099|NCT01137812|3856273|P1|Overall Study|Physician Decision|25
1174100|NCT01137812|3856272|P2|Overall Study|Lost to Follow-up|8
1174101|NCT01137812|3856273|P1|Overall Study|Lost to Follow-up|6
1174102|NCT01137812|3856272|P2|Overall Study|Adverse Event|14
1174103|NCT01137812|3856273|P1|Overall Study|Adverse Event|21
1174104|NCT01137786|3856293|P2|Overall Study|Withdrawal by Subject|1
1174105|NCT01137786|3856294|P1|Overall Study|Withdrawal by Subject|1
1174106|NCT01137786|3856293|P2|Overall Study|Lost to Follow-up|2
1174107|NCT01137786|3856294|P1|Overall Study|Lost to Follow-up|0
1174108|NCT01137773|3856304|P2|Overall Study|Lost to Follow-up|0
1174109|NCT01137773|3856305|P1|Overall Study|Lost to Follow-up|6
1174110|NCT01137773|3856304|P2|Overall Study|Death|3
1174111|NCT01137773|3856305|P1|Overall Study|Death|3
1174112|NCT01137682|3856316|P3|Overall Study|Did not receive treatment in extension|1
1174113|NCT01137682|3856317|P2|Overall Study|Did not receive treatment in extension|0
1174114|NCT01137682|3856318|P1|Overall Study|Did not receive treatment in extension|0
1174115|NCT01137682|3856316|P3|Overall Study|Did not enter extension|2
1174116|NCT01137682|3856317|P2|Overall Study|Did not enter extension|3
1174117|NCT01137682|3856318|P1|Overall Study|Did not enter extension|2
1174118|NCT01137682|3856316|P3|Overall Study|Protocol Violation-Extension|0
1174119|NCT01137682|3856317|P2|Overall Study|Protocol Violation-Extension|1
1174120|NCT01137682|3856318|P1|Overall Study|Protocol Violation-Extension|2
1174121|NCT01137682|3856316|P3|Overall Study|Death-Extension|0
1174122|NCT01137682|3856317|P2|Overall Study|Death-Extension|0
1174123|NCT01137682|3856318|P1|Overall Study|Death-Extension|2
1174124|NCT01137682|3856316|P3|Overall Study|Administrative problems-Extension|0
1174125|NCT01137682|3856317|P2|Overall Study|Administrative problems-Extension|2
1174126|NCT01137682|3856318|P1|Overall Study|Administrative problems-Extension|0
1174127|NCT01137682|3856316|P3|Overall Study|Lost to Follow Up-Extension|0
1174128|NCT01137682|3856317|P2|Overall Study|Lost to Follow Up-Extension|1
1174129|NCT01137682|3856318|P1|Overall Study|Lost to Follow Up-Extension|0
1174130|NCT01137682|3856316|P3|Overall Study|Withdrawal by Subject-Extension|8
1174131|NCT01137682|3856317|P2|Overall Study|Withdrawal by Subject-Extension|8
1174132|NCT01137682|3856318|P1|Overall Study|Withdrawal by Subject-Extension|6
1174133|NCT01137682|3856316|P3|Overall Study|Lack of Efficacy-Extension|13
1174134|NCT01137682|3856317|P2|Overall Study|Lack of Efficacy-Extension|9
1174135|NCT01137682|3856318|P1|Overall Study|Lack of Efficacy-Extension|15
1174136|NCT01137682|3856316|P3|Overall Study|Adverse Event-Extension|7
1174137|NCT01137682|3856317|P2|Overall Study|Adverse Event-Extension|8
1174138|NCT01137682|3856318|P1|Overall Study|Adverse Event-Extension|4
1174139|NCT01137682|3856316|P3|Overall Study|Protocol Violation-CORE|1
1174140|NCT01137682|3856317|P2|Overall Study|Protocol Violation-CORE|1
1174141|NCT01137682|3856318|P1|Overall Study|Protocol Violation-CORE|0
1174142|NCT01137682|3856316|P3|Overall Study|Administrative problems-CORE|0
1174143|NCT01137682|3856317|P2|Overall Study|Administrative problems-CORE|1
1174144|NCT01137682|3856318|P1|Overall Study|Administrative problems-CORE|2
1174145|NCT01137682|3856316|P3|Overall Study|Withdrawal by Subject-CORE|2
1174146|NCT01137682|3856317|P2|Overall Study|Withdrawal by Subject-CORE|2
1174147|NCT01137682|3856318|P1|Overall Study|Withdrawal by Subject-CORE|2
1174148|NCT01137682|3856316|P3|Overall Study|Adverse Event-CORE|0
1174149|NCT01137682|3856317|P2|Overall Study|Adverse Event-CORE|4
1174150|NCT01137682|3856318|P1|Overall Study|Adverse Event-CORE|2
1174151|NCT01137604|3856368|P4|Overall Study|Clinical Decline|1
1174152|NCT01137604|3856369|P3|Overall Study|Clinical Decline|1
1174153|NCT01137604|3856370|P2|Overall Study|Clinical Decline|0
1174154|NCT01137604|3856371|P1|Overall Study|Clinical Decline|0
1174155|NCT01137604|3856368|P4|Overall Study|Participant's Decision|0
1174156|NCT01137604|3856369|P3|Overall Study|Participant's Decision|0
1174157|NCT01137604|3856370|P2|Overall Study|Participant's Decision|0
1174158|NCT01137604|3856371|P1|Overall Study|Participant's Decision|1
1174159|NCT01137604|3856368|P4|Overall Study|Clinical Progression|0
1174160|NCT01137604|3856369|P3|Overall Study|Clinical Progression|1
1174161|NCT01137604|3856370|P2|Overall Study|Clinical Progression|2
1174162|NCT01137604|3856371|P1|Overall Study|Clinical Progression|0
1174163|NCT01137604|3856368|P4|Overall Study|Withdrawal by Subject|1
1174164|NCT01137604|3856369|P3|Overall Study|Withdrawal by Subject|2
1174165|NCT01137604|3856370|P2|Overall Study|Withdrawal by Subject|2
1174166|NCT01137604|3856371|P1|Overall Study|Withdrawal by Subject|0
1174167|NCT01137604|3856368|P4|Overall Study|Adverse Event|9
1174168|NCT01137604|3856369|P3|Overall Study|Adverse Event|9
1174169|NCT01137604|3856370|P2|Overall Study|Adverse Event|6
1174170|NCT01137604|3856371|P1|Overall Study|Adverse Event|1
1174171|NCT01137578|3856405|P3|Overall Study|Not Specified|6
1174172|NCT01137578|3856406|P2|Overall Study|Not Specified|2
1174173|NCT01137578|3856407|P1|Overall Study|Not Specified|12
1174174|NCT01137578|3856405|P3|Overall Study|Withdrawal by Subject|0
1174175|NCT01137578|3856406|P2|Overall Study|Withdrawal by Subject|0
1174176|NCT01137578|3856407|P1|Overall Study|Withdrawal by Subject|1
1174177|NCT01137578|3856405|P3|Overall Study|Participant requested to Discontinue|0
1174178|NCT01137578|3856406|P2|Overall Study|Participant requested to Discontinue|0
1174179|NCT01137578|3856407|P1|Overall Study|Participant requested to Discontinue|3
1174180|NCT01137474|3856456|P4|Overall Study|Administrative reason by sponsor|0
1174181|NCT01137474|3856457|P3|Overall Study|Administrative reason by sponsor|0
1174182|NCT01137474|3856458|P2|Overall Study|Administrative reason by sponsor|1
1174183|NCT01137474|3856459|P1|Overall Study|Administrative reason by sponsor|0
1174184|NCT01137474|3856456|P4|Overall Study|Pregnancy|0
1174185|NCT01137474|3856457|P3|Overall Study|Pregnancy|0
1174186|NCT01137474|3856458|P2|Overall Study|Pregnancy|1
1174187|NCT01137474|3856459|P1|Overall Study|Pregnancy|0
1174188|NCT01137474|3856456|P4|Overall Study|Not specified|0
1174189|NCT01137474|3856457|P3|Overall Study|Not specified|0
1174190|NCT01137474|3856458|P2|Overall Study|Not specified|1
1174191|NCT01137474|3856459|P1|Overall Study|Not specified|3
1174192|NCT01137474|3856456|P4|Overall Study|Lack of Efficacy|2
1174193|NCT01137474|3856457|P3|Overall Study|Lack of Efficacy|0
1174194|NCT01137474|3856458|P2|Overall Study|Lack of Efficacy|0
1174195|NCT01137474|3856459|P1|Overall Study|Lack of Efficacy|0
1174196|NCT01137474|3856456|P4|Overall Study|Lost to Follow-up|2
1174197|NCT01137474|3856457|P3|Overall Study|Lost to Follow-up|0
1174198|NCT01137474|3856458|P2|Overall Study|Lost to Follow-up|1
1174199|NCT01137474|3856459|P1|Overall Study|Lost to Follow-up|5
1174200|NCT01137474|3856456|P4|Overall Study|No longer met study criteria|5
1174201|NCT01137474|3856457|P3|Overall Study|No longer met study criteria|0
1174202|NCT01137474|3856458|P2|Overall Study|No longer met study criteria|1
1174203|NCT01137474|3856459|P1|Overall Study|No longer met study criteria|6
1174204|NCT01137474|3856456|P4|Overall Study|Withdrawal by Subject|9
1174205|NCT01137474|3856457|P3|Overall Study|Withdrawal by Subject|6
1174206|NCT01137474|3856458|P2|Overall Study|Withdrawal by Subject|2
1174207|NCT01137474|3856459|P1|Overall Study|Withdrawal by Subject|7
1174208|NCT01137474|3856456|P4|Overall Study|Adverse Event|3
1174209|NCT01137474|3856457|P3|Overall Study|Adverse Event|1
1174210|NCT01137474|3856458|P2|Overall Study|Adverse Event|5
1174211|NCT01137474|3856459|P1|Overall Study|Adverse Event|3
1174212|NCT01137435|3856477|P1|Overall Study|Off label usage|4
1174213|NCT01137435|3856477|P1|Overall Study|Lost to Follow-up|24
1174214|NCT01137292|3856504|P1|Overall Study|Other|7
1174215|NCT01137292|3856504|P1|Overall Study|Lost to Follow-up|1
1174216|NCT01137292|3856504|P1|Overall Study|Lack of Efficacy|13
1174217|NCT01137292|3856504|P1|Overall Study|Adverse Event|3
1174218|NCT01137292|3856504|P1|Overall Study|Death|30
1174219|NCT01137071|3856511|P1|Overall Study|Wrongly Included|1
1174220|NCT01137071|3856511|P1|Overall Study|Withdrawal by Subject|2
1174221|NCT01137071|3856511|P1|Overall Study|Disease Progression|11
1174222|NCT01136967|3856580|P2|Overall Study|Diagnosis of Second Primary Cancer|1
1174223|NCT01136967|3856581|P1|Overall Study|Diagnosis of Second Primary Cancer|0
1174224|NCT01136967|3856580|P2|Overall Study|Increase in Lesion Size|2
1174225|NCT01136967|3856581|P1|Overall Study|Increase in Lesion Size|0
1174226|NCT01136967|3856580|P2|Overall Study|Investigator's Choice|1
1174227|NCT01136967|3856581|P1|Overall Study|Investigator's Choice|1
1174228|NCT01136967|3856580|P2|Overall Study|Non Compliance|0
1174229|NCT01136967|3856581|P1|Overall Study|Non Compliance|1
1174230|NCT01136967|3856580|P2|Overall Study|Radiation|0
1174231|NCT01136967|3856581|P1|Overall Study|Radiation|1
1174232|NCT01136967|3856580|P2|Overall Study|Clinical Progression|5
1174233|NCT01136967|3856581|P1|Overall Study|Clinical Progression|3
1174234|NCT01136967|3856580|P2|Overall Study|Withdrawal by Subject|2
1174235|NCT01136967|3856581|P1|Overall Study|Withdrawal by Subject|1
1174236|NCT01136967|3856580|P2|Overall Study|Lost to Follow-up|1
1174237|NCT01136967|3856581|P1|Overall Study|Lost to Follow-up|0
1174238|NCT01136967|3856580|P2|Overall Study|Participant Choice|3
1174239|NCT01136967|3856581|P1|Overall Study|Participant Choice|8
1174240|NCT01136967|3856580|P2|Overall Study|Adverse Event|12
1174241|NCT01136967|3856581|P1|Overall Study|Adverse Event|9
1174242|NCT01136954|3856599|P2|Overall Study|Not Specified|3
1174243|NCT01136954|3856600|P1|Overall Study|Not Specified|1
1174244|NCT01136954|3856599|P2|Overall Study|Physician Decision|1
1174245|NCT01136954|3856600|P1|Overall Study|Physician Decision|0
1174246|NCT01136954|3856599|P2|Overall Study|Lack of Efficacy|13
1174247|NCT01136954|3856600|P1|Overall Study|Lack of Efficacy|14
1174248|NCT01136954|3856599|P2|Overall Study|Withdrawal by Subject|2
1174249|NCT01136954|3856600|P1|Overall Study|Withdrawal by Subject|6
1174250|NCT01136954|3856599|P2|Overall Study|Adverse Event|2
1174251|NCT01136954|3856600|P1|Overall Study|Adverse Event|3
1174252|NCT01136915|3856614|P2|Overall Study|Exclusion criterion met|1
1174253|NCT01136915|3856615|P1|Overall Study|Exclusion criterion met|0
1174254|NCT01136915|3856614|P2|Overall Study|Lost to Follow-up|0
1174255|NCT01136915|3856615|P1|Overall Study|Lost to Follow-up|2
1174256|NCT01136876|3856625|P2|Overall Study|Physician Decision|5
1174257|NCT01136876|3856626|P1|Overall Study|Physician Decision|3
1174258|NCT01136876|3856625|P2|Overall Study|Lost to Follow-up|1
1174259|NCT01136876|3856626|P1|Overall Study|Lost to Follow-up|0
1174260|NCT01136785|3856655|P2|Overall Study|Protocol Violation|1
1174261|NCT01136785|3856656|P1|Overall Study|Protocol Violation|2
1174262|NCT01136772|3856671|P2|Overall Study|Did not follow up after first injection|2
1174263|NCT01136772|3856672|P1|Overall Study|Did not follow up after first injection|2
1174264|NCT01136772|3856671|P2|Overall Study|Did not receive injection|7
1174265|NCT01136772|3856672|P1|Overall Study|Did not receive injection|10
1174266|NCT01136772|3856671|P2|Overall Study|Withdrawal by Subject|36
1174267|NCT01136772|3856672|P1|Overall Study|Withdrawal by Subject|33
1174268|NCT01136772|3856671|P2|Overall Study|Administrative|12
1174269|NCT01136772|3856672|P1|Overall Study|Administrative|14
1174270|NCT01136772|3856671|P2|Overall Study|Lack of Efficacy|39
1174271|NCT01136772|3856672|P1|Overall Study|Lack of Efficacy|42
1174272|NCT01136772|3856671|P2|Overall Study|Adverse Event|14
1174273|NCT01136772|3856672|P1|Overall Study|Adverse Event|15
1174274|NCT01136746|3856682|P2|Overall Study|Death|0
1174275|NCT01136746|3856683|P1|Overall Study|Death|1
1174276|NCT01136746|3856682|P2|Overall Study|Protocol Violation|1
1174277|NCT01136746|3856683|P1|Overall Study|Protocol Violation|2
1174278|NCT01136746|3856682|P2|Overall Study|Lost to Follow-up|2
1174279|NCT01136746|3856683|P1|Overall Study|Lost to Follow-up|0
1174280|NCT01136655|3856743|P1|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1
1174281|NCT01136655|3856743|P1|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1
1174282|NCT01136655|3856743|P1|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1
1174283|NCT01136655|3856743|P1|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1
1174284|NCT01136408|3856776|P3|Overall Study|Protocol Violation|1
1174285|NCT01136408|3856777|P2|Overall Study|Protocol Violation|1
1174286|NCT01136408|3856778|P1|Overall Study|Protocol Violation|1
1174287|NCT01136408|3856776|P3|Overall Study|Adverse Event|4
1174288|NCT01136408|3856777|P2|Overall Study|Adverse Event|8
1174289|NCT01136408|3856778|P1|Overall Study|Adverse Event|4
1174290|NCT01136382|3856835|P2|Overall Study|Withdrawal by Subject|1
1174291|NCT01136382|3856836|P1|Overall Study|Withdrawal by Subject|4
1174292|NCT01136382|3856835|P2|Overall Study|Severe Non-Compliance to Protocol|2
1174293|NCT01136382|3856836|P1|Overall Study|Severe Non-Compliance to Protocol|0
1174294|NCT01136382|3856835|P2|Overall Study|Study-Specific Withdrawal Criteria|25
1174295|NCT01136382|3856836|P1|Overall Study|Study-Specific Withdrawal Criteria|48
1174296|NCT01136382|3856835|P2|Overall Study|Not Specified|3
1174297|NCT01136382|3856836|P1|Overall Study|Not Specified|8
1174298|NCT01136356|3856862|P2|Second 18-day Withdrawal|Withdrawal by Subject|1
1174299|NCT01136356|3856863|P1|Second 18-day Withdrawal|Withdrawal by Subject|0
1174300|NCT01136356|3856862|P2|First 18-day Withdrawal|Physician Decision|0
1174301|NCT01136356|3856863|P1|First 18-day Withdrawal|Physician Decision|1
1174302|NCT01136356|3856862|P2|First 18-day Withdrawal|Withdrawal by Subject|0
1174303|NCT01136356|3856863|P1|First 18-day Withdrawal|Withdrawal by Subject|3
1174304|NCT01136291|3856874|P2|Overall Study|Lost to Follow-up|1
1174305|NCT01136291|3856875|P1|Overall Study|Lost to Follow-up|1
1174306|NCT01136174|3856894|P4|Overall Study|Adverse Event|4
1174307|NCT01136174|3856895|P3|Overall Study|Adverse Event|0
1174308|NCT01136174|3856896|P2|Overall Study|Adverse Event|0
1174309|NCT01136174|3856897|P1|Overall Study|Adverse Event|0
1174310|NCT01135992|3856977|P1|Overall Study|Unclassified|7
1174311|NCT01135992|3856977|P1|Overall Study|Withdrawal criteria|10
1174312|NCT01135992|3856977|P1|Overall Study|Protocol Violation|2
1174313|NCT01135992|3856977|P1|Overall Study|Lack of Efficacy|1
1174314|NCT01135992|3856977|P1|Overall Study|Adverse Event|1
1174315|NCT01135914|3856989|P3|Overall Study|Adverse Event|2
1174316|NCT01135914|3856990|P2|Overall Study|Adverse Event|1
1174317|NCT01135914|3856991|P1|Overall Study|Adverse Event|0
1174318|NCT01135914|3856989|P3|Overall Study|Lack of Efficacy|10
1174319|NCT01135914|3856990|P2|Overall Study|Lack of Efficacy|1
1174320|NCT01135914|3856991|P1|Overall Study|Lack of Efficacy|2
1174321|NCT01135914|3856989|P3|Overall Study|Protocol Violation|3
1174322|NCT01135914|3856990|P2|Overall Study|Protocol Violation|0
1174323|NCT01135914|3856991|P1|Overall Study|Protocol Violation|0
1174324|NCT01135914|3856989|P3|Overall Study|Lost to Follow-up|1
1174325|NCT01135914|3856990|P2|Overall Study|Lost to Follow-up|0
1174326|NCT01135914|3856991|P1|Overall Study|Lost to Follow-up|1
1174327|NCT01135914|3856989|P3|Overall Study|Withdrawal by Subject|6
1174328|NCT01135914|3856990|P2|Overall Study|Withdrawal by Subject|3
1174329|NCT01135914|3856991|P1|Overall Study|Withdrawal by Subject|1
1174330|NCT01135524|3857020|P1|Overall Study|Lack of Efficacy|8
1174331|NCT01135524|3857020|P1|Overall Study|Administrative|151
1174332|NCT01135524|3857020|P1|Overall Study|Lost to Follow-up|3
1174333|NCT01135524|3857020|P1|Overall Study|Adverse Event|20
1174334|NCT01135524|3857020|P1|Overall Study|Withdrawal by Subject|14
1174335|NCT01135511|3857033|P9|Overall Study|Withdrawal by Subject|1
1174336|NCT01135511|3857034|P8|Overall Study|Withdrawal by Subject|0
1174337|NCT01135511|3857035|P7|Overall Study|Withdrawal by Subject|1
1174338|NCT01135511|3857036|P6|Overall Study|Withdrawal by Subject|0
1174339|NCT01135511|3857037|P5|Overall Study|Withdrawal by Subject|0
1174340|NCT01135511|3857038|P4|Overall Study|Withdrawal by Subject|0
1174341|NCT01135511|3857039|P3|Overall Study|Withdrawal by Subject|0
1174342|NCT01135511|3857040|P2|Overall Study|Withdrawal by Subject|0
1174343|NCT01135511|3857041|P1|Overall Study|Withdrawal by Subject|0
1174344|NCT01135511|3857033|P9|Overall Study|noncompliance with study drug taken|0
1174345|NCT01135511|3857034|P8|Overall Study|noncompliance with study drug taken|0
1174346|NCT01135511|3857035|P7|Overall Study|noncompliance with study drug taken|0
1174347|NCT01135511|3857036|P6|Overall Study|noncompliance with study drug taken|0
1174348|NCT01135511|3857037|P5|Overall Study|noncompliance with study drug taken|1
1174349|NCT01135511|3857038|P4|Overall Study|noncompliance with study drug taken|0
1174350|NCT01135511|3857039|P3|Overall Study|noncompliance with study drug taken|0
1174351|NCT01135511|3857040|P2|Overall Study|noncompliance with study drug taken|0
1174352|NCT01135511|3857041|P1|Overall Study|noncompliance with study drug taken|0
1174353|NCT01135511|3857033|P9|Overall Study|could not visit the clinic|0
1174354|NCT01135511|3857034|P8|Overall Study|could not visit the clinic|0
1174355|NCT01135511|3857035|P7|Overall Study|could not visit the clinic|0
1174356|NCT01135511|3857036|P6|Overall Study|could not visit the clinic|0
1174357|NCT01135511|3857037|P5|Overall Study|could not visit the clinic|0
1174358|NCT01135511|3857038|P4|Overall Study|could not visit the clinic|0
1174359|NCT01135511|3857039|P3|Overall Study|could not visit the clinic|2
1174360|NCT01135511|3857040|P2|Overall Study|could not visit the clinic|1
1174361|NCT01135511|3857041|P1|Overall Study|could not visit the clinic|0
1174362|NCT01135511|3857033|P9|Overall Study|Pregnancy|0
1174363|NCT01135511|3857034|P8|Overall Study|Pregnancy|0
1174364|NCT01135511|3857035|P7|Overall Study|Pregnancy|0
1174365|NCT01135511|3857036|P6|Overall Study|Pregnancy|0
1174366|NCT01135511|3857037|P5|Overall Study|Pregnancy|0
1174367|NCT01135511|3857038|P4|Overall Study|Pregnancy|1
1174368|NCT01135511|3857039|P3|Overall Study|Pregnancy|0
1174369|NCT01135511|3857040|P2|Overall Study|Pregnancy|0
1174370|NCT01135511|3857041|P1|Overall Study|Pregnancy|0
1174371|NCT01135511|3857033|P9|Overall Study|Protocol Violation|0
1174372|NCT01135511|3857034|P8|Overall Study|Protocol Violation|0
1174373|NCT01135511|3857035|P7|Overall Study|Protocol Violation|0
1174374|NCT01135511|3857036|P6|Overall Study|Protocol Violation|0
1174375|NCT01135511|3857037|P5|Overall Study|Protocol Violation|0
1174376|NCT01135511|3857038|P4|Overall Study|Protocol Violation|0
1174377|NCT01135511|3857039|P3|Overall Study|Protocol Violation|3
1174378|NCT01135511|3857040|P2|Overall Study|Protocol Violation|0
1174379|NCT01135511|3857041|P1|Overall Study|Protocol Violation|0
1174380|NCT01135511|3857033|P9|Overall Study|Lack of Efficacy|0
1174381|NCT01135511|3857034|P8|Overall Study|Lack of Efficacy|0
1174382|NCT01135511|3857035|P7|Overall Study|Lack of Efficacy|0
1174383|NCT01135511|3857036|P6|Overall Study|Lack of Efficacy|0
1174384|NCT01135511|3857037|P5|Overall Study|Lack of Efficacy|0
1174385|NCT01135511|3857038|P4|Overall Study|Lack of Efficacy|2
1174386|NCT01135511|3857039|P3|Overall Study|Lack of Efficacy|1
1174387|NCT01135511|3857040|P2|Overall Study|Lack of Efficacy|1
1174388|NCT01135511|3857041|P1|Overall Study|Lack of Efficacy|0
1174389|NCT01135511|3857033|P9|Overall Study|Adverse Event|0
1174390|NCT01135511|3857034|P8|Overall Study|Adverse Event|1
1174391|NCT01135511|3857035|P7|Overall Study|Adverse Event|0
1174392|NCT01135511|3857036|P6|Overall Study|Adverse Event|1
1174393|NCT01135511|3857037|P5|Overall Study|Adverse Event|0
1174394|NCT01135511|3857038|P4|Overall Study|Adverse Event|0
1174395|NCT01135511|3857039|P3|Overall Study|Adverse Event|2
1174396|NCT01135511|3857040|P2|Overall Study|Adverse Event|1
1174397|NCT01135511|3857041|P1|Overall Study|Adverse Event|0
1174398|NCT01135498|3857323|P1|Overall Study|Ongoing at time of analysis|2
1174399|NCT01135498|3857323|P1|Overall Study|Death|1
1174400|NCT01135498|3857323|P1|Overall Study|Withdrawal by Subject|4
1174401|NCT01135498|3857323|P1|Overall Study|Investigator judgement|25
1174402|NCT01135498|3857323|P1|Overall Study|Progressive disease|38
1174403|NCT01135498|3857323|P1|Overall Study|Adverse Event|20
1174404|NCT01135134|3857502|P2|Overall Study|Did not meet protocol eligibility|0
1174405|NCT01135134|3857503|P1|Overall Study|Did not meet protocol eligibility|1
1174406|NCT01135134|3857502|P2|Overall Study|Adverse Event|1
1174407|NCT01135134|3857503|P1|Overall Study|Adverse Event|1
1174408|NCT01135017|3857526|P2|Overall Study|Other than above|4
1174409|NCT01135017|3857527|P1|Overall Study|Other than above|3
1174410|NCT01135017|3857526|P2|Overall Study|Adverse Event|8
1174411|NCT01135017|3857527|P1|Overall Study|Adverse Event|3
1174412|NCT01134939|3857565|P8|Overall Study|Termination page not available|0
1174413|NCT01134939|3857566|P7|Overall Study|Termination page not available|7
1174414|NCT01134939|3857567|P6|Overall Study|Termination page not available|3
1174415|NCT01134939|3857568|P5|Overall Study|Termination page not available|0
1174416|NCT01134939|3857569|P4|Overall Study|Termination page not available|8
1174417|NCT01134939|3857570|P3|Overall Study|Termination page not available|5
1174418|NCT01134939|3857571|P2|Overall Study|Termination page not available|6
1174419|NCT01134939|3857572|P1|Overall Study|Termination page not available|4
1174420|NCT01134939|3857565|P8|Overall Study|Death|0
1174421|NCT01134939|3857566|P7|Overall Study|Death|0
1174422|NCT01134939|3857567|P6|Overall Study|Death|0
1174423|NCT01134939|3857568|P5|Overall Study|Death|0
1174424|NCT01134939|3857569|P4|Overall Study|Death|0
1174425|NCT01134939|3857570|P3|Overall Study|Death|0
1174426|NCT01134939|3857571|P2|Overall Study|Death|1
1174427|NCT01134939|3857572|P1|Overall Study|Death|0
1174428|NCT01134939|3857565|P8|Overall Study|Lost to Follow-up|0
1174429|NCT01134939|3857566|P7|Overall Study|Lost to Follow-up|0
1174430|NCT01134939|3857567|P6|Overall Study|Lost to Follow-up|1
1174431|NCT01134939|3857568|P5|Overall Study|Lost to Follow-up|2
1174432|NCT01134939|3857569|P4|Overall Study|Lost to Follow-up|1
1174433|NCT01134939|3857570|P3|Overall Study|Lost to Follow-up|0
1174434|NCT01134939|3857571|P2|Overall Study|Lost to Follow-up|3
1174435|NCT01134939|3857572|P1|Overall Study|Lost to Follow-up|2
1174436|NCT01134939|3857565|P8|Overall Study|Lack of Efficacy|0
1174437|NCT01134939|3857566|P7|Overall Study|Lack of Efficacy|1
1174438|NCT01134939|3857567|P6|Overall Study|Lack of Efficacy|0
1174439|NCT01134939|3857568|P5|Overall Study|Lack of Efficacy|3
1174440|NCT01134939|3857569|P4|Overall Study|Lack of Efficacy|0
1174441|NCT01134939|3857570|P3|Overall Study|Lack of Efficacy|1
1174442|NCT01134939|3857571|P2|Overall Study|Lack of Efficacy|5
1174443|NCT01134939|3857572|P1|Overall Study|Lack of Efficacy|2
1174444|NCT01134939|3857565|P8|Overall Study|Adverse Event|0
1174445|NCT01134939|3857566|P7|Overall Study|Adverse Event|1
1174446|NCT01134939|3857567|P6|Overall Study|Adverse Event|5
1174447|NCT01134939|3857568|P5|Overall Study|Adverse Event|5
1174448|NCT01134939|3857569|P4|Overall Study|Adverse Event|5
1174449|NCT01134939|3857570|P3|Overall Study|Adverse Event|4
1174450|NCT01134939|3857571|P2|Overall Study|Adverse Event|3
1174451|NCT01134939|3857572|P1|Overall Study|Adverse Event|9
1174452|NCT01134783|3857710|P2|Overall Study|Lost to Follow-up|20
1174453|NCT01134783|3857711|P1|Overall Study|Lost to Follow-up|5
1174454|NCT01134783|3857710|P2|Overall Study|Withdrawal by Subject|9
1174455|NCT01134783|3857711|P1|Overall Study|Withdrawal by Subject|15
1174456|NCT01134783|3857710|P2|Overall Study|Pregnancy|8
1174457|NCT01134783|3857711|P1|Overall Study|Pregnancy|16
1174458|NCT01134731|3857730|P3|Overall Study|Lost to Follow-up|3
1174459|NCT01134731|3857731|P2|Overall Study|Lost to Follow-up|4
1174460|NCT01134731|3857732|P1|Overall Study|Lost to Follow-up|5
1174461|NCT01134731|3857730|P3|Overall Study|Withdrawal by Subject|1
1174462|NCT01134731|3857731|P2|Overall Study|Withdrawal by Subject|3
1174463|NCT01134731|3857732|P1|Overall Study|Withdrawal by Subject|3
1174464|NCT01134731|3857730|P3|Overall Study|Lack of Efficacy|1
1174465|NCT01134731|3857731|P2|Overall Study|Lack of Efficacy|0
1174466|NCT01134731|3857732|P1|Overall Study|Lack of Efficacy|0
1174467|NCT01134731|3857730|P3|Overall Study|Physician Decision|2
1174468|NCT01134731|3857731|P2|Overall Study|Physician Decision|2
1174469|NCT01134731|3857732|P1|Overall Study|Physician Decision|2
1174470|NCT01134731|3857730|P3|Overall Study|Adverse Event|1
1174471|NCT01134731|3857731|P2|Overall Study|Adverse Event|2
1174472|NCT01134731|3857732|P1|Overall Study|Adverse Event|3
1174473|NCT01134705|3857745|P2|Overall Study|Other|6
1174474|NCT01134705|3857746|P1|Overall Study|Other|1
1174475|NCT01134705|3857745|P2|Overall Study|Protocol Violation|1
1174476|NCT01134705|3857746|P1|Overall Study|Protocol Violation|1
1174477|NCT01134705|3857745|P2|Overall Study|Lost to Follow-up|2
1174478|NCT01134705|3857746|P1|Overall Study|Lost to Follow-up|5
1174479|NCT01134705|3857745|P2|Overall Study|Pregnancy|0
1174480|NCT01134705|3857746|P1|Overall Study|Pregnancy|1
1174481|NCT01134705|3857745|P2|Overall Study|Withdrawal by Subject|6
1174482|NCT01134705|3857746|P1|Overall Study|Withdrawal by Subject|6
1174483|NCT01134705|3857745|P2|Overall Study|Adverse Event|7
1174484|NCT01134705|3857746|P1|Overall Study|Adverse Event|1
1174485|NCT01134627|3857758|P2|Overall Study|Other|14
1174486|NCT01134627|3857759|P1|Overall Study|Other|11
1174487|NCT01134627|3857758|P2|Overall Study|Planning to become pregnant/pregnancy|0
1174488|NCT01134627|3857759|P1|Overall Study|Planning to become pregnant/pregnancy|1
1174489|NCT01134627|3857758|P2|Overall Study|Withdrawal by Subject|3
1174490|NCT01134627|3857759|P1|Overall Study|Withdrawal by Subject|4
1174491|NCT01134627|3857758|P2|Overall Study|Lack of Efficacy|12
1174492|NCT01134627|3857759|P1|Overall Study|Lack of Efficacy|2
1174493|NCT01134627|3857758|P2|Overall Study|Protocol Violation|5
1174494|NCT01134627|3857759|P1|Overall Study|Protocol Violation|3
1174495|NCT01134627|3857758|P2|Overall Study|Lost to Follow-up|2
1174496|NCT01134627|3857759|P1|Overall Study|Lost to Follow-up|1
1174497|NCT01134627|3857758|P2|Overall Study|Adverse Event|31
1174498|NCT01134627|3857759|P1|Overall Study|Adverse Event|47
1174499|NCT01134614|3857789|P2|Overall Study|Patient in hospice care|1
1174500|NCT01134614|3857790|P1|Overall Study|Patient in hospice care|0
1174501|NCT01134614|3857789|P2|Overall Study|Symptomatic deterioration|1
1174502|NCT01134614|3857790|P1|Overall Study|Symptomatic deterioration|0
1174503|NCT01134614|3857789|P2|Overall Study|Pt received tx not allowed on study|1
1174504|NCT01134614|3857790|P1|Overall Study|Pt received tx not allowed on study|0
1174505|NCT01134614|3857789|P2|Overall Study|Never started treatment|1
1174506|NCT01134614|3857790|P1|Overall Study|Never started treatment|4
1174507|NCT01134614|3857789|P2|Overall Study|Physician's decision|1
1174508|NCT01134614|3857790|P1|Overall Study|Physician's decision|0
1174509|NCT01134614|3857789|P2|Overall Study|Complicating disease|1
1174510|NCT01134614|3857790|P1|Overall Study|Complicating disease|2
1174511|NCT01134614|3857789|P2|Overall Study|Alternative therapy|0
1174512|NCT01134614|3857790|P1|Overall Study|Alternative therapy|2
1174513|NCT01134614|3857789|P2|Overall Study|Withdrawal by Subject|2
1174514|NCT01134614|3857790|P1|Overall Study|Withdrawal by Subject|3
1174515|NCT01134614|3857789|P2|Overall Study|Death|8
1174516|NCT01134614|3857790|P1|Overall Study|Death|5
1174517|NCT01134614|3857789|P2|Overall Study|Adverse Event|39
1174518|NCT01134614|3857790|P1|Overall Study|Adverse Event|26
1174519|NCT01134614|3857789|P2|Overall Study|Progressive disease|54
1174520|NCT01134614|3857790|P1|Overall Study|Progressive disease|60
1174521|NCT01134614|3857789|P2|Overall Study|Still on treatment as of March 2013|13
1174522|NCT01134614|3857790|P1|Overall Study|Still on treatment as of March 2013|21
1174523|NCT01134562|3857805|P5|Overall Study|Adverse Event|0
1174524|NCT01134562|3857806|P4|Overall Study|Adverse Event|0
1174525|NCT01134562|3857807|P3|Overall Study|Adverse Event|0
1174526|NCT01134562|3857808|P2|Overall Study|Adverse Event|1
1174527|NCT01134562|3857809|P1|Overall Study|Adverse Event|0
1174528|NCT01134393|3857981|P1|Overall Study|Other|6
1174529|NCT01134393|3857981|P1|Overall Study|Withdrawal by Subject|11
1174530|NCT01134393|3857981|P1|Overall Study|Lost to Follow-up|3
1174531|NCT01134393|3857981|P1|Overall Study|Protocol Violation|12
1174532|NCT01134393|3857981|P1|Overall Study|Lack of Efficacy|2
1174533|NCT01134393|3857981|P1|Overall Study|Adverse Event|18
1174534|NCT01134315|3858102|P2|Overall Study|Other Reason|17
1174535|NCT01134315|3858103|P1|Overall Study|Other Reason|8
1174536|NCT01134315|3858102|P2|Overall Study|Adverse Event|2
1174537|NCT01134315|3858103|P1|Overall Study|Adverse Event|1
1174538|NCT01134107|3858147|P2|Period 2-Second Treatment Intervention|Sponsor Decision|0
1174539|NCT01134107|3858148|P1|Period 2-Second Treatment Intervention|Sponsor Decision|1
1174540|NCT01134107|3858147|P2|Period 2-Second Treatment Intervention|Physician Decision|0
1174541|NCT01134107|3858148|P1|Period 2-Second Treatment Intervention|Physician Decision|1
1174542|NCT01134107|3858147|P2|Period 2-Second Treatment Intervention|Withdrawal by Subject|0
1174543|NCT01134107|3858148|P1|Period 2-Second Treatment Intervention|Withdrawal by Subject|2
1174544|NCT01134107|3858147|P2|Period 1-First Treatment Intervention|Physician Decision|0
1174545|NCT01134107|3858148|P1|Period 1-First Treatment Intervention|Physician Decision|1
1174546|NCT01134107|3858147|P2|Period 1-First Treatment Intervention|Withdrawal by Subject|4
1174547|NCT01134107|3858148|P1|Period 1-First Treatment Intervention|Withdrawal by Subject|3
1174548|NCT01134107|3858147|P2|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
1174549|NCT01134107|3858148|P1|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
1174550|NCT01134107|3858147|P2|Period 1-First Treatment Intervention|Adverse Event|0
1174551|NCT01134107|3858148|P1|Period 1-First Treatment Intervention|Adverse Event|1
1174552|NCT01134055|3858195|P7|Overall Study|Physician Decision|1
1174553|NCT01134055|3858196|P6|Overall Study|Physician Decision|0
1174554|NCT01134055|3858197|P5|Overall Study|Physician Decision|0
1174555|NCT01134055|3858198|P4|Overall Study|Physician Decision|0
1174556|NCT01134055|3858199|P3|Overall Study|Physician Decision|0
1174557|NCT01134055|3858200|P2|Overall Study|Physician Decision|0
1174558|NCT01134055|3858201|P1|Overall Study|Physician Decision|0
1174559|NCT01134055|3858195|P7|Overall Study|Protocol Violation|0
1174560|NCT01134055|3858196|P6|Overall Study|Protocol Violation|0
1174561|NCT01134055|3858197|P5|Overall Study|Protocol Violation|1
1174562|NCT01134055|3858198|P4|Overall Study|Protocol Violation|1
1174563|NCT01134055|3858199|P3|Overall Study|Protocol Violation|0
1174564|NCT01134055|3858200|P2|Overall Study|Protocol Violation|0
1174565|NCT01134055|3858201|P1|Overall Study|Protocol Violation|0
1174566|NCT01134055|3858195|P7|Overall Study|Withdrawal by Subject|8
1174567|NCT01134055|3858196|P6|Overall Study|Withdrawal by Subject|0
1174568|NCT01134055|3858197|P5|Overall Study|Withdrawal by Subject|0
1174569|NCT01134055|3858198|P4|Overall Study|Withdrawal by Subject|2
1174570|NCT01134055|3858199|P3|Overall Study|Withdrawal by Subject|1
1174571|NCT01134055|3858200|P2|Overall Study|Withdrawal by Subject|3
1174572|NCT01134055|3858201|P1|Overall Study|Withdrawal by Subject|3
1174573|NCT01134055|3858195|P7|Overall Study|Lost to Follow-up|0
1174574|NCT01134055|3858196|P6|Overall Study|Lost to Follow-up|0
1174575|NCT01134055|3858197|P5|Overall Study|Lost to Follow-up|0
1174576|NCT01134055|3858198|P4|Overall Study|Lost to Follow-up|1
1174577|NCT01134055|3858199|P3|Overall Study|Lost to Follow-up|0
1174578|NCT01134055|3858200|P2|Overall Study|Lost to Follow-up|1
1174579|NCT01134055|3858201|P1|Overall Study|Lost to Follow-up|0
1174580|NCT01134055|3858195|P7|Overall Study|Adverse Event|2
1174581|NCT01134055|3858196|P6|Overall Study|Adverse Event|7
1174582|NCT01134055|3858197|P5|Overall Study|Adverse Event|5
1174583|NCT01134055|3858198|P4|Overall Study|Adverse Event|2
1174584|NCT01134055|3858199|P3|Overall Study|Adverse Event|2
1174585|NCT01134055|3858200|P2|Overall Study|Adverse Event|2
1174586|NCT01134055|3858201|P1|Overall Study|Adverse Event|5
1174587|NCT01134042|3858335|P3|Overall Study|Withdrawal by Subject|7
1174588|NCT01134042|3858336|P2|Overall Study|Withdrawal by Subject|4
1174589|NCT01134042|3858337|P1|Overall Study|Withdrawal by Subject|13
1174590|NCT01134042|3858335|P3|Overall Study|Physician Decision|1
1174591|NCT01134042|3858336|P2|Overall Study|Physician Decision|8
1174592|NCT01134042|3858337|P1|Overall Study|Physician Decision|4
1174593|NCT01134042|3858335|P3|Overall Study|Lost to Follow-up|1
1174594|NCT01134042|3858336|P2|Overall Study|Lost to Follow-up|0
1174595|NCT01134042|3858337|P1|Overall Study|Lost to Follow-up|2
1174596|NCT01134042|3858335|P3|Overall Study|Protocol Violation|5
1174597|NCT01134042|3858336|P2|Overall Study|Protocol Violation|3
1174598|NCT01134042|3858337|P1|Overall Study|Protocol Violation|5
1174599|NCT01134042|3858335|P3|Overall Study|Lack of Efficacy|18
1174600|NCT01134042|3858336|P2|Overall Study|Lack of Efficacy|6
1174601|NCT01134042|3858337|P1|Overall Study|Lack of Efficacy|21
1174602|NCT01134042|3858335|P3|Overall Study|Adverse Event|2
1174603|NCT01134042|3858336|P2|Overall Study|Adverse Event|7
1174604|NCT01134042|3858337|P1|Overall Study|Adverse Event|3
1174605|NCT01133977|3858413|P5|Overall Study|Withdrawal by Subject|1
1174606|NCT01133977|3858414|P4|Overall Study|Withdrawal by Subject|5
1174607|NCT01133977|3858415|P3|Overall Study|Withdrawal by Subject|0
1174608|NCT01133977|3858416|P2|Overall Study|Withdrawal by Subject|0
1174609|NCT01133977|3858417|P1|Overall Study|Withdrawal by Subject|0
1174610|NCT01133977|3858413|P5|Overall Study|Lost to Follow-up|1
1174611|NCT01133977|3858414|P4|Overall Study|Lost to Follow-up|2
1174612|NCT01133977|3858415|P3|Overall Study|Lost to Follow-up|0
1174613|NCT01133977|3858416|P2|Overall Study|Lost to Follow-up|0
1174614|NCT01133977|3858417|P1|Overall Study|Lost to Follow-up|0
1174615|NCT01133977|3858413|P5|Overall Study|Started a New Line of Therapy|33
1174616|NCT01133977|3858414|P4|Overall Study|Started a New Line of Therapy|25
1174617|NCT01133977|3858415|P3|Overall Study|Started a New Line of Therapy|4
1174618|NCT01133977|3858416|P2|Overall Study|Started a New Line of Therapy|6
1174619|NCT01133977|3858417|P1|Overall Study|Started a New Line of Therapy|2
1174620|NCT01133977|3858413|P5|Overall Study|Death|3
1174621|NCT01133977|3858414|P4|Overall Study|Death|7
1174622|NCT01133977|3858415|P3|Overall Study|Death|1
1174623|NCT01133977|3858416|P2|Overall Study|Death|1
1174624|NCT01133977|3858417|P1|Overall Study|Death|1
1174625|NCT01133977|3858413|P5|Overall Study|Adverse Event|0
1174626|NCT01133977|3858414|P4|Overall Study|Adverse Event|0
1174627|NCT01133977|3858415|P3|Overall Study|Adverse Event|1
1174628|NCT01133977|3858416|P2|Overall Study|Adverse Event|0
1174629|NCT01133977|3858417|P1|Overall Study|Adverse Event|0
1174630|NCT01133847|3858444|P3|Follow-Up Phase|Lost to Follow-up|7
1174631|NCT01133847|3858445|P2|Follow-Up Phase|Lost to Follow-up|3
1174632|NCT01133847|3858446|P1|Follow-Up Phase|Lost to Follow-up|1
1174633|NCT01133847|3858444|P3|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3
1174634|NCT01133847|3858445|P2|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1
1174635|NCT01133847|3858446|P1|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5
1174636|NCT01133821|3858486|P2|Overall Study|Refused participation|3
1174637|NCT01133821|3858487|P1|Overall Study|Refused participation|1
1174638|NCT01133821|3858486|P2|Overall Study|Protocol Violation|1
1174639|NCT01133821|3858487|P1|Overall Study|Protocol Violation|0
1174640|NCT01133821|3858486|P2|Overall Study|preferred other treatment|1
1174641|NCT01133821|3858487|P1|Overall Study|preferred other treatment|1
1174642|NCT01133821|3858486|P2|Overall Study|Withdrawal by Subject|3
1174643|NCT01133821|3858487|P1|Overall Study|Withdrawal by Subject|8
1174644|NCT01133821|3858486|P2|Overall Study|Lost to Follow-up|11
1174645|NCT01133821|3858487|P1|Overall Study|Lost to Follow-up|8
1174646|NCT01133756|3858498|P3|Overall Study|Progression of Disease|1
1174647|NCT01133756|3858499|P2|Overall Study|Progression of Disease|0
1174648|NCT01133756|3858500|P1|Overall Study|Progression of Disease|0
1174649|NCT01133756|3858498|P3|Overall Study|Withdrawal by Subject|0
1174650|NCT01133756|3858499|P2|Overall Study|Withdrawal by Subject|1
1174651|NCT01133756|3858500|P1|Overall Study|Withdrawal by Subject|0
1174652|NCT01133756|3858498|P3|Overall Study|Investigator Decision|0
1174653|NCT01133756|3858499|P2|Overall Study|Investigator Decision|0
1174654|NCT01133756|3858500|P1|Overall Study|Investigator Decision|1
1174655|NCT01133756|3858498|P3|Overall Study|Adverse Event|1
1174656|NCT01133756|3858499|P2|Overall Study|Adverse Event|2
1174657|NCT01133756|3858500|P1|Overall Study|Adverse Event|1
1174658|NCT01133704|3858516|P2|Overall Study|Study Closure|0
1174659|NCT01133704|3858517|P1|Overall Study|Study Closure|1
1174660|NCT01133704|3858516|P2|Overall Study|Patient refused to continue|0
1174661|NCT01133704|3858517|P1|Overall Study|Patient refused to continue|4
1174662|NCT01133704|3858516|P2|Overall Study|Death|26
1174663|NCT01133704|3858517|P1|Overall Study|Death|44
1174664|NCT01133665|3858525|P1|Overall Study|Physician Decision|2
1174665|NCT01133626|3858586|P3|Overall Study|Not specified|0
1174666|NCT01133626|3858587|P2|Overall Study|Not specified|2
1174667|NCT01133626|3858588|P1|Overall Study|Not specified|0
1174668|NCT01133626|3858586|P3|Overall Study|Withdrawal by Subject|2
1174669|NCT01133626|3858587|P2|Overall Study|Withdrawal by Subject|2
1174670|NCT01133626|3858588|P1|Overall Study|Withdrawal by Subject|1
1174671|NCT01133626|3858586|P3|Overall Study|Adverse Event|0
1174672|NCT01133626|3858587|P2|Overall Study|Adverse Event|1
1174673|NCT01133626|3858588|P1|Overall Study|Adverse Event|0
1174674|NCT01133522|3858606|P10|Overall Study|Physician Decision|0
1174675|NCT01133522|3858607|P9|Overall Study|Physician Decision|0
1174676|NCT01133522|3858608|P8|Overall Study|Physician Decision|0
1174677|NCT01133522|3858609|P7|Overall Study|Physician Decision|0
1174678|NCT01133522|3858610|P6|Overall Study|Physician Decision|0
1174679|NCT01133522|3858611|P5|Overall Study|Physician Decision|1
1174680|NCT01133522|3858612|P4|Overall Study|Physician Decision|0
1174681|NCT01133522|3858613|P3|Overall Study|Physician Decision|0
1174682|NCT01133522|3858614|P2|Overall Study|Physician Decision|0
1174683|NCT01133522|3858615|P1|Overall Study|Physician Decision|0
1174684|NCT01133522|3858606|P10|Overall Study|Withdrawal by Subject|0
1174685|NCT01133522|3858607|P9|Overall Study|Withdrawal by Subject|0
1174686|NCT01133522|3858608|P8|Overall Study|Withdrawal by Subject|0
1174687|NCT01133522|3858609|P7|Overall Study|Withdrawal by Subject|0
1174688|NCT01133522|3858610|P6|Overall Study|Withdrawal by Subject|0
1174689|NCT01133522|3858611|P5|Overall Study|Withdrawal by Subject|0
1174690|NCT01133522|3858612|P4|Overall Study|Withdrawal by Subject|1
1174691|NCT01133522|3858613|P3|Overall Study|Withdrawal by Subject|0
1174692|NCT01133522|3858614|P2|Overall Study|Withdrawal by Subject|1
1174693|NCT01133522|3858615|P1|Overall Study|Withdrawal by Subject|0
1174694|NCT01133418|3858683|P2|Overall Study|Lost to Follow-up|6
1174695|NCT01133418|3858684|P1|Overall Study|Lost to Follow-up|5
1174696|NCT01133392|3858698|P2|Interval Between Dosing (4-7 Days)|Protocol Violation|1
1174697|NCT01133392|3858699|P1|Interval Between Dosing (4-7 Days)|Protocol Violation|0
1174698|NCT01133392|3858698|P2|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1
1174699|NCT01133392|3858699|P1|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0
1174700|NCT01133379|3858716|P3|Overall Study|Lost to Follow-up|1
1174701|NCT01133379|3858717|P2|Overall Study|Lost to Follow-up|1
1174702|NCT01133379|3858718|P1|Overall Study|Lost to Follow-up|1
1174703|NCT01133379|3858716|P3|Overall Study|Withdrawal by Subject|1
1174704|NCT01133379|3858717|P2|Overall Study|Withdrawal by Subject|1
1174705|NCT01133379|3858718|P1|Overall Study|Withdrawal by Subject|0
1174706|NCT01133288|3858771|P1|Intervention Allocation|study terminated|2
1174707|NCT01133288|3858771|P1|Eligibility Assessment|met exclusion criteria|5
1174708|NCT01133275|3858776|P1|Overall Study|Cerebrovascular accident (CVA)|1
1174709|NCT01133275|3858776|P1|Overall Study|Withdrawal by Subject|1
1174710|NCT01133171|3858784|P3|Overall Study|Withdrawal by Subject|0
1174711|NCT01133171|3858785|P2|Overall Study|Withdrawal by Subject|2
1174712|NCT01133171|3858786|P1|Overall Study|Withdrawal by Subject|1
1174713|NCT01133067|3858802|P1|Overall Study|Lost to Follow-up|3
1174714|NCT01133067|3858802|P1|Overall Study|Death|136
1174715|NCT01132820|3858862|P1|Overall Study|Inadequate data|1
1174716|NCT01132820|3858862|P1|Overall Study|Never treated|1
1174717|NCT01132820|3858862|P1|Overall Study|Ineligible:Inadequate pathology|1
1174718|NCT01132820|3858862|P1|Overall Study|Ineligible:Improper pre-protocol therapy|1
1174719|NCT01132820|3858862|P1|Overall Study|Ineligible: wrong cell type|1
1174720|NCT01132664|3858895|P5|BM Cohort|Withdrawal by Subject|1
1174721|NCT01132664|3858896|P4|BM Cohort|Withdrawal by Subject|0
1174722|NCT01132664|3858897|P3|BM Cohort|Withdrawal by Subject|0
1174723|NCT01132664|3858898|P2|BM Cohort|Withdrawal by Subject|0
1174724|NCT01132664|3858899|P1|BM Cohort|Withdrawal by Subject|0
1174725|NCT01132664|3858895|P5|BM Cohort|Adverse Event|1
1174726|NCT01132664|3858896|P4|BM Cohort|Adverse Event|0
1174727|NCT01132664|3858897|P3|BM Cohort|Adverse Event|0
1174728|NCT01132664|3858898|P2|BM Cohort|Adverse Event|0
1174729|NCT01132664|3858899|P1|BM Cohort|Adverse Event|0
1174730|NCT01132664|3858895|P5|BM Cohort|Disease progression|4
1174731|NCT01132664|3858896|P4|BM Cohort|Disease progression|3
1174732|NCT01132664|3858897|P3|BM Cohort|Disease progression|0
1174733|NCT01132664|3858898|P2|BM Cohort|Disease progression|0
1174734|NCT01132664|3858899|P1|BM Cohort|Disease progression|0
1174735|NCT01132664|3858895|P5|Phase ll|Disease progression|0
1174736|NCT01132664|3858896|P4|Phase ll|Disease progression|0
1174737|NCT01132664|3858897|P3|Phase ll|Disease progression|35
1174738|NCT01132664|3858898|P2|Phase ll|Disease progression|0
1174739|NCT01132664|3858899|P1|Phase ll|Disease progression|0
1174740|NCT01132664|3858895|P5|Phase ll|Withdrawal by Subject|0
1174741|NCT01132664|3858896|P4|Phase ll|Withdrawal by Subject|0
1174742|NCT01132664|3858897|P3|Phase ll|Withdrawal by Subject|3
1174743|NCT01132664|3858898|P2|Phase ll|Withdrawal by Subject|0
1174744|NCT01132664|3858899|P1|Phase ll|Withdrawal by Subject|0
1174745|NCT01132664|3858895|P5|Phase ll|Adverse Event|0
1174746|NCT01132664|3858896|P4|Phase ll|Adverse Event|0
1174747|NCT01132664|3858897|P3|Phase ll|Adverse Event|10
1174748|NCT01132664|3858898|P2|Phase ll|Adverse Event|0
1174749|NCT01132664|3858899|P1|Phase ll|Adverse Event|0
1174750|NCT01132664|3858895|P5|Phase ll|Death|0
1174751|NCT01132664|3858896|P4|Phase ll|Death|0
1174752|NCT01132664|3858897|P3|Phase ll|Death|2
1174753|NCT01132664|3858898|P2|Phase ll|Death|0
1174754|NCT01132664|3858899|P1|Phase ll|Death|0
1174755|NCT01132664|3858895|P5|Phase lb|Disease Progression|0
1174756|NCT01132664|3858896|P4|Phase lb|Disease Progression|0
1174757|NCT01132664|3858897|P3|Phase lb|Disease Progression|0
1174758|NCT01132664|3858898|P2|Phase lb|Disease Progression|9
1174759|NCT01132664|3858899|P1|Phase lb|Disease Progression|4
1174760|NCT01132664|3858895|P5|Phase lb|Withdrawal by Subject|0
1174761|NCT01132664|3858896|P4|Phase lb|Withdrawal by Subject|0
1174762|NCT01132664|3858897|P3|Phase lb|Withdrawal by Subject|0
1174763|NCT01132664|3858898|P2|Phase lb|Withdrawal by Subject|2
1174764|NCT01132664|3858899|P1|Phase lb|Withdrawal by Subject|1
1174765|NCT01132664|3858895|P5|Phase lb|Adverse Event|0
1174766|NCT01132664|3858896|P4|Phase lb|Adverse Event|0
1174767|NCT01132664|3858897|P3|Phase lb|Adverse Event|0
1174768|NCT01132664|3858898|P2|Phase lb|Adverse Event|1
1174769|NCT01132664|3858899|P1|Phase lb|Adverse Event|0
1174770|NCT01132651|3858933|P2|Overall Study|Lost to Follow-up|1
1174771|NCT01132651|3858934|P1|Overall Study|Lost to Follow-up|1
1174772|NCT01132612|3858945|P3|Overall Study|Lack of Efficacy|73
1174773|NCT01132612|3858946|P2|Overall Study|Lack of Efficacy|22
1174774|NCT01132612|3858947|P1|Overall Study|Lack of Efficacy|23
1174775|NCT01132612|3858945|P3|Overall Study|Administrative problems|52
1174776|NCT01132612|3858946|P2|Overall Study|Administrative problems|1
1174777|NCT01132612|3858947|P1|Overall Study|Administrative problems|5
1174778|NCT01132612|3858945|P3|Overall Study|Withdrawal by Subject|19
1174779|NCT01132612|3858946|P2|Overall Study|Withdrawal by Subject|8
1174780|NCT01132612|3858947|P1|Overall Study|Withdrawal by Subject|5
1174781|NCT01132612|3858945|P3|Overall Study|Adverse Event|15
1174782|NCT01132612|3858946|P2|Overall Study|Adverse Event|2
1174783|NCT01132612|3858947|P1|Overall Study|Adverse Event|5
1174784|NCT01132612|3858945|P3|Overall Study|Lost to Follow-up|7
1174785|NCT01132612|3858946|P2|Overall Study|Lost to Follow-up|2
1174786|NCT01132612|3858947|P1|Overall Study|Lost to Follow-up|2
1174787|NCT01132612|3858945|P3|Overall Study|Protocol deviation|3
1174788|NCT01132612|3858946|P2|Overall Study|Protocol deviation|0
1174789|NCT01132612|3858947|P1|Overall Study|Protocol deviation|0
1174790|NCT01132612|3858945|P3|Overall Study|Death|1
1174791|NCT01132612|3858946|P2|Overall Study|Death|0
1174792|NCT01132612|3858947|P1|Overall Study|Death|0
1174793|NCT01132547|3858963|P2|Overall Study|Death|0
1174794|NCT01132547|3858964|P1|Overall Study|Death|1
1174795|NCT01132547|3858963|P2|Overall Study|Withdrawal by Subject|1
1174796|NCT01132547|3858964|P1|Overall Study|Withdrawal by Subject|3
1174797|NCT01132495|3859034|P4|Overall Study|Various reasons|12
1174798|NCT01132495|3859035|P3|Overall Study|Various reasons|20
1174799|NCT01132495|3859036|P2|Overall Study|Various reasons|38
1174800|NCT01132495|3859037|P1|Overall Study|Various reasons|40
1174801|NCT01132326|3859050|P1|Overall Study|Subject Unable to Come To Visits|1
1174802|NCT01132326|3859050|P1|Overall Study|Death|5
1174803|NCT01132326|3859050|P1|Overall Study|Caregiver Withdrew Consent|1
1174804|NCT01132326|3859050|P1|Overall Study|Pregnancy|1
1174805|NCT01132326|3859050|P1|Overall Study|Declining Health|1
1174806|NCT01132326|3859050|P1|Overall Study|Study Termination|80
1174807|NCT01132326|3859050|P1|Overall Study|Physician Decision|10
1174808|NCT01132326|3859050|P1|Overall Study|Withdrawal by Subject|40
1174809|NCT01132326|3859050|P1|Overall Study|Lost to Follow-up|16
1174810|NCT01132326|3859050|P1|Overall Study|Protocol Violation|1
1174811|NCT01132326|3859050|P1|Overall Study|Adverse Event|37
1174812|NCT01132326|3859050|P1|Overall Study|Lack of Efficacy|25
1174813|NCT01132313|3859066|P12|Overall Study|Other reason not defined above|0
1174814|NCT01132313|3859067|P11|Overall Study|Other reason not defined above|0
1174815|NCT01132313|3859068|P10|Overall Study|Other reason not defined above|0
1174816|NCT01132313|3859069|P9|Overall Study|Other reason not defined above|0
1174817|NCT01132313|3859070|P8|Overall Study|Other reason not defined above|1
1174818|NCT01132313|3859071|P7|Overall Study|Other reason not defined above|0
1174819|NCT01132313|3859072|P6|Overall Study|Other reason not defined above|0
1174820|NCT01132313|3859073|P5|Overall Study|Other reason not defined above|0
1174821|NCT01132313|3859074|P4|Overall Study|Other reason not defined above|0
1174822|NCT01132313|3859075|P3|Overall Study|Other reason not defined above|0
1174823|NCT01132313|3859076|P2|Overall Study|Other reason not defined above|0
1174824|NCT01132313|3859077|P1|Overall Study|Other reason not defined above|0
1174825|NCT01132313|3859066|P12|Overall Study|Lack of antiviral response|0
1174826|NCT01132313|3859067|P11|Overall Study|Lack of antiviral response|1
1174827|NCT01132313|3859068|P10|Overall Study|Lack of antiviral response|0
1174828|NCT01132313|3859069|P9|Overall Study|Lack of antiviral response|0
1174829|NCT01132313|3859070|P8|Overall Study|Lack of antiviral response|0
1174830|NCT01132313|3859071|P7|Overall Study|Lack of antiviral response|21
1174831|NCT01132313|3859072|P6|Overall Study|Lack of antiviral response|18
1174832|NCT01132313|3859073|P5|Overall Study|Lack of antiviral response|18
1174833|NCT01132313|3859074|P4|Overall Study|Lack of antiviral response|18
1174834|NCT01132313|3859075|P3|Overall Study|Lack of antiviral response|12
1174835|NCT01132313|3859076|P2|Overall Study|Lack of antiviral response|0
1174836|NCT01132313|3859077|P1|Overall Study|Lack of antiviral response|0
1174837|NCT01132313|3859066|P12|Overall Study|Withdrawal by Subject|0
1174838|NCT01132313|3859067|P11|Overall Study|Withdrawal by Subject|0
1174839|NCT01132313|3859068|P10|Overall Study|Withdrawal by Subject|2
1174840|NCT01132313|3859069|P9|Overall Study|Withdrawal by Subject|0
1174841|NCT01132313|3859070|P8|Overall Study|Withdrawal by Subject|0
1174842|NCT01132313|3859071|P7|Overall Study|Withdrawal by Subject|1
1174843|NCT01132313|3859072|P6|Overall Study|Withdrawal by Subject|0
1174844|NCT01132313|3859073|P5|Overall Study|Withdrawal by Subject|6
1174845|NCT01132313|3859074|P4|Overall Study|Withdrawal by Subject|3
1174846|NCT01132313|3859075|P3|Overall Study|Withdrawal by Subject|3
1174847|NCT01132313|3859076|P2|Overall Study|Withdrawal by Subject|0
1174848|NCT01132313|3859077|P1|Overall Study|Withdrawal by Subject|0
1174849|NCT01132313|3859066|P12|Overall Study|Lost to Follow-up|0
1174850|NCT01132313|3859067|P11|Overall Study|Lost to Follow-up|0
1174851|NCT01132313|3859068|P10|Overall Study|Lost to Follow-up|0
1174852|NCT01132313|3859069|P9|Overall Study|Lost to Follow-up|0
1174853|NCT01132313|3859070|P8|Overall Study|Lost to Follow-up|1
1174854|NCT01132313|3859071|P7|Overall Study|Lost to Follow-up|0
1174855|NCT01132313|3859072|P6|Overall Study|Lost to Follow-up|0
1174856|NCT01132313|3859073|P5|Overall Study|Lost to Follow-up|0
1174857|NCT01132313|3859074|P4|Overall Study|Lost to Follow-up|0
1174858|NCT01132313|3859075|P3|Overall Study|Lost to Follow-up|1
1174859|NCT01132313|3859076|P2|Overall Study|Lost to Follow-up|0
1174860|NCT01132313|3859077|P1|Overall Study|Lost to Follow-up|0
1174861|NCT01132313|3859066|P12|Overall Study|Protocol Violation|0
1174862|NCT01132313|3859067|P11|Overall Study|Protocol Violation|0
1174863|NCT01132313|3859068|P10|Overall Study|Protocol Violation|0
1174864|NCT01132313|3859069|P9|Overall Study|Protocol Violation|0
1174865|NCT01132313|3859070|P8|Overall Study|Protocol Violation|0
1174866|NCT01132313|3859071|P7|Overall Study|Protocol Violation|0
1174867|NCT01132313|3859072|P6|Overall Study|Protocol Violation|0
1174868|NCT01132313|3859073|P5|Overall Study|Protocol Violation|0
1174869|NCT01132313|3859074|P4|Overall Study|Protocol Violation|1
1174870|NCT01132313|3859075|P3|Overall Study|Protocol Violation|0
1174871|NCT01132313|3859076|P2|Overall Study|Protocol Violation|0
1174872|NCT01132313|3859077|P1|Overall Study|Protocol Violation|0
1174873|NCT01132313|3859066|P12|Overall Study|Adverse Event|0
1174874|NCT01132313|3859067|P11|Overall Study|Adverse Event|0
1174875|NCT01132313|3859068|P10|Overall Study|Adverse Event|2
1174876|NCT01132313|3859069|P9|Overall Study|Adverse Event|7
1174877|NCT01132313|3859070|P8|Overall Study|Adverse Event|3
1174878|NCT01132313|3859071|P7|Overall Study|Adverse Event|5
1174879|NCT01132313|3859072|P6|Overall Study|Adverse Event|6
1174880|NCT01132313|3859073|P5|Overall Study|Adverse Event|19
1174881|NCT01132313|3859074|P4|Overall Study|Adverse Event|10
1174882|NCT01132313|3859075|P3|Overall Study|Adverse Event|4
1174883|NCT01132313|3859076|P2|Overall Study|Adverse Event|0
1174884|NCT01132313|3859077|P1|Overall Study|Adverse Event|0
1174885|NCT01132313|3859066|P12|Overall Study|Not treated|0
1174886|NCT01132313|3859067|P11|Overall Study|Not treated|0
1174887|NCT01132313|3859068|P10|Overall Study|Not treated|0
1174888|NCT01132313|3859069|P9|Overall Study|Not treated|0
1174889|NCT01132313|3859070|P8|Overall Study|Not treated|0
1174890|NCT01132313|3859071|P7|Overall Study|Not treated|3
1174891|NCT01132313|3859072|P6|Overall Study|Not treated|1
1174892|NCT01132313|3859073|P5|Overall Study|Not treated|2
1174893|NCT01132313|3859074|P4|Overall Study|Not treated|0
1174894|NCT01132313|3859075|P3|Overall Study|Not treated|0
1174895|NCT01132313|3859076|P2|Overall Study|Not treated|0
1174896|NCT01132313|3859077|P1|Overall Study|Not treated|2
1174897|NCT01132313|3859066|P12|Overall Study|Lack of Efficacy|0
1174898|NCT01132313|3859067|P11|Overall Study|Lack of Efficacy|0
1174899|NCT01132313|3859068|P10|Overall Study|Lack of Efficacy|16
1174900|NCT01132313|3859069|P9|Overall Study|Lack of Efficacy|14
1174901|NCT01132313|3859070|P8|Overall Study|Lack of Efficacy|3
1174902|NCT01132313|3859071|P7|Overall Study|Lack of Efficacy|0
1174903|NCT01132313|3859072|P6|Overall Study|Lack of Efficacy|0
1174904|NCT01132313|3859073|P5|Overall Study|Lack of Efficacy|0
1174905|NCT01132313|3859074|P4|Overall Study|Lack of Efficacy|0
1174906|NCT01132313|3859075|P3|Overall Study|Lack of Efficacy|0
1174907|NCT01132313|3859076|P2|Overall Study|Lack of Efficacy|0
1174908|NCT01132313|3859077|P1|Overall Study|Lack of Efficacy|1
1174909|NCT01132118|3859157|P2|Second Intervention (8 Weeks)|Adverse Event|1
1174910|NCT01132118|3859158|P1|Second Intervention (8 Weeks)|Adverse Event|0
1174911|NCT01132118|3859157|P2|First Intervention (8 Weeks)|Withdrawal by Subject|3
1174912|NCT01132118|3859158|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
1174913|NCT01132118|3859157|P2|First Intervention (8 Weeks)|Adverse Event|0
1174914|NCT01132118|3859158|P1|First Intervention (8 Weeks)|Adverse Event|1
1174915|NCT01131676|3859188|P3|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2
1174916|NCT01131676|3859189|P2|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
1174917|NCT01131676|3859190|P1|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
1174918|NCT01131676|3859188|P3|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5
1174919|NCT01131676|3859189|P2|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6
1174920|NCT01131676|3859190|P1|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7
1174921|NCT01131676|3859188|P3|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7
1174922|NCT01131676|3859189|P2|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9
1174923|NCT01131676|3859190|P1|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5
1174924|NCT01131676|3859188|P3|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19
1174925|NCT01131676|3859189|P2|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21
1174926|NCT01131676|3859190|P1|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20
1174927|NCT01131676|3859188|P3|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5
1174928|NCT01131676|3859189|P2|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6
1174929|NCT01131676|3859190|P1|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8
1174930|NCT01131676|3859188|P3|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25
1174931|NCT01131676|3859189|P2|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35
1174932|NCT01131676|3859190|P1|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23
1174933|NCT01131676|3859188|P3|Discontinuation From Treatment|Adverse Event|273
1174934|NCT01131676|3859189|P2|Discontinuation From Treatment|Adverse Event|267
1174935|NCT01131676|3859190|P1|Discontinuation From Treatment|Adverse Event|303
1174936|NCT01131676|3859188|P3|Discontinuation From Treatment|Other than those specified|125
1174937|NCT01131676|3859189|P2|Discontinuation From Treatment|Other than those specified|142
1174938|NCT01131676|3859190|P1|Discontinuation From Treatment|Other than those specified|162
1174939|NCT01131676|3859188|P3|Discontinuation From Treatment|Refusal to continue, not due to AE|122
1174940|NCT01131676|3859189|P2|Discontinuation From Treatment|Refusal to continue, not due to AE|118
1174941|NCT01131676|3859190|P1|Discontinuation From Treatment|Refusal to continue, not due to AE|172
1174942|NCT01131676|3859188|P3|Discontinuation From Treatment|Lost to Follow-up|6
1174943|NCT01131676|3859189|P2|Discontinuation From Treatment|Lost to Follow-up|9
1174944|NCT01131676|3859190|P1|Discontinuation From Treatment|Lost to Follow-up|15
1174945|NCT01131676|3859188|P3|Discontinuation From Treatment|Non compliant with protocol|12
1174946|NCT01131676|3859189|P2|Discontinuation From Treatment|Non compliant with protocol|15
1174947|NCT01131676|3859190|P1|Discontinuation From Treatment|Non compliant with protocol|15
1174948|NCT01131676|3859188|P3|Discontinuation From Treatment|Lack of Efficacy|0
1174949|NCT01131676|3859189|P2|Discontinuation From Treatment|Lack of Efficacy|1
1174950|NCT01131676|3859190|P1|Discontinuation From Treatment|Lack of Efficacy|11
1174951|NCT01131676|3859188|P3|Discontinuation From Treatment|Not treated|2
1174952|NCT01131676|3859189|P2|Discontinuation From Treatment|Not treated|2
1174953|NCT01131676|3859190|P1|Discontinuation From Treatment|Not treated|4
1174954|NCT01131676|3859188|P3|Discontinuation From Treatment|Study drug stopped, reason missing|4
1174955|NCT01131676|3859189|P2|Discontinuation From Treatment|Study drug stopped, reason missing|3
1174956|NCT01131676|3859190|P1|Discontinuation From Treatment|Study drug stopped, reason missing|5
1174957|NCT01131585|3859225|P2|Overall Study|Study termination|32
1174958|NCT01131585|3859226|P1|Overall Study|Study termination|78
1174959|NCT01131585|3859225|P2|Overall Study|Administrative problems|1
1174960|NCT01131585|3859226|P1|Overall Study|Administrative problems|1
1174961|NCT01131585|3859225|P2|Overall Study|Lost to Follow-up|1
1174962|NCT01131585|3859226|P1|Overall Study|Lost to Follow-up|0
1174963|NCT01131585|3859225|P2|Overall Study|Withdrawal by Subject|3
1174964|NCT01131585|3859226|P1|Overall Study|Withdrawal by Subject|3
1174965|NCT01131585|3859225|P2|Overall Study|Protocol Violation|1
1174966|NCT01131585|3859226|P1|Overall Study|Protocol Violation|2
1174967|NCT01131585|3859225|P2|Overall Study|Unsatisfactory therapeutic effect|3
1174968|NCT01131585|3859226|P1|Overall Study|Unsatisfactory therapeutic effect|0
1174969|NCT01131585|3859225|P2|Overall Study|Abnormal laboratory value|0
1174970|NCT01131585|3859226|P1|Overall Study|Abnormal laboratory value|1
1174971|NCT01131585|3859225|P2|Overall Study|Adverse Event|2
1174972|NCT01131585|3859226|P1|Overall Study|Adverse Event|0
1174973|NCT01131520|3859234|P2|Overall Study|Subject changed history after enrollment|1
1174974|NCT01131520|3859235|P1|Overall Study|Subject changed history after enrollment|0
1174975|NCT01131520|3859234|P2|Overall Study|Counselor not available|3
1174976|NCT01131520|3859235|P1|Overall Study|Counselor not available|0
1174977|NCT01131520|3859234|P2|Overall Study|Computer problem|0
1174978|NCT01131520|3859235|P1|Overall Study|Computer problem|1
1174979|NCT01131507|3859257|P1|Overall Study|Withdrawal by Subject|1
1174980|NCT01131507|3859257|P1|Overall Study|Lost to Follow-up|1
1174981|NCT01131507|3859257|P1|Overall Study|Adverse Event|1
1174982|NCT01131494|3859262|P1|Overall Study|Withdrawal by Subject|2
1174983|NCT01131455|3859272|P3|Overall Study|Death of PI|0
1174984|NCT01131455|3859273|P2|Overall Study|Death of PI|4
1174985|NCT01131455|3859274|P1|Overall Study|Death of PI|6
1174986|NCT01131312|3859285|P3|Overall Study|Lost to Follow-up|351
1174987|NCT01131312|3859286|P2|Overall Study|Lost to Follow-up|229
1174988|NCT01131312|3859287|P1|Overall Study|Lost to Follow-up|425
1174989|NCT01131299|3859298|P2|Overall Study|Withdrawal by Subject|7
1174990|NCT01131299|3859299|P1|Overall Study|Withdrawal by Subject|4
1174991|NCT01131182|3859312|P2|Overall Study|Other Reason|0
1174992|NCT01131182|3859313|P1|Overall Study|Other Reason|1
1174993|NCT01131182|3859312|P2|Overall Study|Lost to Follow-up|15
1174994|NCT01131182|3859313|P1|Overall Study|Lost to Follow-up|14
1174995|NCT01131182|3859312|P2|Overall Study|Withdrawal by Subject|1
1174996|NCT01131182|3859313|P1|Overall Study|Withdrawal by Subject|1
1174997|NCT01131130|3859321|P1|Period 3- Crossover|+ Slit lamp finding|1
1174998|NCT01131130|3859321|P1|Period 1 - Baseline|Pregnancy|1
1174999|NCT01131104|3859334|P1|Overall Study|No Information on Index Date of Onset|1
1175000|NCT01131104|3859334|P1|Overall Study|Information Not Available|5
1175001|NCT01131104|3859334|P1|Overall Study|Physician Decision|4
1175002|NCT01131104|3859334|P1|Overall Study|Withdrawal by Subject|3
1175003|NCT01131078|3859341|P3|Overall Study|Other|0
1175004|NCT01131078|3859342|P2|Overall Study|Other|1
1175005|NCT01131078|3859343|P1|Overall Study|Other|0
1175006|NCT01131078|3859341|P3|Overall Study|Death|2
1175007|NCT01131078|3859342|P2|Overall Study|Death|0
1175008|NCT01131078|3859343|P1|Overall Study|Death|4
1175009|NCT01131078|3859341|P3|Overall Study|Physician Decision|8
1175010|NCT01131078|3859342|P2|Overall Study|Physician Decision|6
1175011|NCT01131078|3859343|P1|Overall Study|Physician Decision|10
1175012|NCT01131078|3859341|P3|Overall Study|Non-compliance|0
1175013|NCT01131078|3859342|P2|Overall Study|Non-compliance|0
1175014|NCT01131078|3859343|P1|Overall Study|Non-compliance|3
1175015|NCT01131078|3859341|P3|Overall Study|Withdrawal by Subject|3
1175016|NCT01131078|3859342|P2|Overall Study|Withdrawal by Subject|4
1175017|NCT01131078|3859343|P1|Overall Study|Withdrawal by Subject|2
1175018|NCT01131078|3859341|P3|Overall Study|Lost to Follow-up|1
1175019|NCT01131078|3859342|P2|Overall Study|Lost to Follow-up|1
1175020|NCT01131078|3859343|P1|Overall Study|Lost to Follow-up|1
1175021|NCT01131078|3859341|P3|Overall Study|Protocol Violation|0
1175022|NCT01131078|3859342|P2|Overall Study|Protocol Violation|0
1175023|NCT01131078|3859343|P1|Overall Study|Protocol Violation|1
1175024|NCT01131078|3859341|P3|Overall Study|Progressive Disease|71
1175025|NCT01131078|3859342|P2|Overall Study|Progressive Disease|77
1175026|NCT01131078|3859343|P1|Overall Study|Progressive Disease|58
1175027|NCT01131078|3859341|P3|Overall Study|Adverse Event|17
1175028|NCT01131078|3859342|P2|Overall Study|Adverse Event|12
1175029|NCT01131078|3859343|P1|Overall Study|Adverse Event|22
1175030|NCT01130974|3859430|P2|Overall Study|Ineligibility criteria|2
1175031|NCT01130974|3859431|P1|Overall Study|Ineligibility criteria|5
1175032|NCT01130974|3859430|P2|Overall Study|Withdrawal by Subject|1
1175033|NCT01130974|3859431|P1|Overall Study|Withdrawal by Subject|0
1175034|NCT01130974|3859430|P2|Overall Study|Protocol Violation|10
1175035|NCT01130974|3859431|P1|Overall Study|Protocol Violation|10
1175036|NCT01130883|3859457|P1|Overall Study|Adverse Event|3
1175037|NCT01130883|3859457|P1|Overall Study|Reason Unknown|1
1175038|NCT01130883|3859457|P1|Overall Study|Patient Noncompliance|6
1175039|NCT01130831|3859514|P1|Overall Study|Information was missing|3
1175040|NCT01130831|3859514|P1|Overall Study|Death|4
1175041|NCT01130831|3859514|P1|Overall Study|Withdrawal by Subject|7
1175042|NCT01130597|3859553|P1|Overall Study|Protocol Violation|1
1175043|NCT01130597|3859553|P1|Overall Study|Death|1
1175044|NCT01130597|3859553|P1|Overall Study|Adverse Event|4
1175045|NCT01130597|3859553|P1|Overall Study|Protocol-specified (High K+)|1
1175046|NCT01130532|3859578|P4|Period IV (Weeks 13-16)|Withdrawal by Subject|3
1175047|NCT01130532|3859579|P3|Period IV (Weeks 13-16)|Withdrawal by Subject|0
1175048|NCT01130532|3859580|P2|Period IV (Weeks 13-16)|Withdrawal by Subject|0
1175049|NCT01130532|3859581|P1|Period IV (Weeks 13-16)|Withdrawal by Subject|0
1175050|NCT01130532|3859578|P4|Period IV (Weeks 13-16)|Lost to Follow-up|5
1175051|NCT01130532|3859579|P3|Period IV (Weeks 13-16)|Lost to Follow-up|0
1175052|NCT01130532|3859580|P2|Period IV (Weeks 13-16)|Lost to Follow-up|0
1175053|NCT01130532|3859581|P1|Period IV (Weeks 13-16)|Lost to Follow-up|0
1175054|NCT01130532|3859578|P4|Period IV (Weeks 13-16)|Entry Criteria Not Met|1
1175055|NCT01130532|3859579|P3|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
1175056|NCT01130532|3859580|P2|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
1175057|NCT01130532|3859581|P1|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
1175058|NCT01130532|3859578|P4|Period IV (Weeks 13-16)|Adverse Event|1
1175059|NCT01130532|3859579|P3|Period IV (Weeks 13-16)|Adverse Event|0
1175060|NCT01130532|3859580|P2|Period IV (Weeks 13-16)|Adverse Event|0
1175061|NCT01130532|3859581|P1|Period IV (Weeks 13-16)|Adverse Event|0
1175062|NCT01130532|3859578|P4|Period III (Weeks 0-12)|Withdrawal by Subject|0
1175063|NCT01130532|3859579|P3|Period III (Weeks 0-12)|Withdrawal by Subject|6
1175064|NCT01130532|3859580|P2|Period III (Weeks 0-12)|Withdrawal by Subject|7
1175065|NCT01130532|3859581|P1|Period III (Weeks 0-12)|Withdrawal by Subject|7
1175066|NCT01130532|3859578|P4|Period III (Weeks 0-12)|Sponsor Decision|0
1175067|NCT01130532|3859579|P3|Period III (Weeks 0-12)|Sponsor Decision|2
1175068|NCT01130532|3859580|P2|Period III (Weeks 0-12)|Sponsor Decision|4
1175069|NCT01130532|3859581|P1|Period III (Weeks 0-12)|Sponsor Decision|3
1175070|NCT01130532|3859578|P4|Period III (Weeks 0-12)|Protocol Violation|0
1175071|NCT01130532|3859579|P3|Period III (Weeks 0-12)|Protocol Violation|1
1175072|NCT01130532|3859580|P2|Period III (Weeks 0-12)|Protocol Violation|0
1175073|NCT01130532|3859581|P1|Period III (Weeks 0-12)|Protocol Violation|0
1175074|NCT01130532|3859578|P4|Period III (Weeks 0-12)|Lost to Follow-up|0
1175075|NCT01130532|3859579|P3|Period III (Weeks 0-12)|Lost to Follow-up|3
1175076|NCT01130532|3859580|P2|Period III (Weeks 0-12)|Lost to Follow-up|2
1175077|NCT01130532|3859581|P1|Period III (Weeks 0-12)|Lost to Follow-up|2
1175078|NCT01130532|3859578|P4|Period III (Weeks 0-12)|Lack of Efficacy|0
1175079|NCT01130532|3859579|P3|Period III (Weeks 0-12)|Lack of Efficacy|1
1175080|NCT01130532|3859580|P2|Period III (Weeks 0-12)|Lack of Efficacy|0
1175081|NCT01130532|3859581|P1|Period III (Weeks 0-12)|Lack of Efficacy|2
1175082|NCT01130532|3859578|P4|Period III (Weeks 0-12)|Entry Criteria Not Met|0
1175083|NCT01130532|3859579|P3|Period III (Weeks 0-12)|Entry Criteria Not Met|4
1175084|NCT01130532|3859580|P2|Period III (Weeks 0-12)|Entry Criteria Not Met|2
1175085|NCT01130532|3859581|P1|Period III (Weeks 0-12)|Entry Criteria Not Met|4
1175086|NCT01130532|3859578|P4|Period III (Weeks 0-12)|Adverse Event|0
1175087|NCT01130532|3859579|P3|Period III (Weeks 0-12)|Adverse Event|2
1175088|NCT01130532|3859580|P2|Period III (Weeks 0-12)|Adverse Event|3
1175089|NCT01130532|3859581|P1|Period III (Weeks 0-12)|Adverse Event|3
1175090|NCT01130493|3859626|P3|Part 2: OLE|Withdrawal by Subject|4
1175091|NCT01130493|3859627|P2|Part 2: OLE|Withdrawal by Subject|1
1175092|NCT01130493|3859628|P1|Part 2: OLE|Withdrawal by Subject|0
1175093|NCT01130493|3859626|P3|Part 2: OLE|Adverse Event|1
1175094|NCT01130493|3859627|P2|Part 2: OLE|Adverse Event|2
1175095|NCT01130493|3859628|P1|Part 2: OLE|Adverse Event|0
1175096|NCT01130493|3859626|P3|Part 1: Double-blind Treatment Period 2|Noncompliance|1
1175097|NCT01130493|3859627|P2|Part 1: Double-blind Treatment Period 2|Noncompliance|0
1175098|NCT01130493|3859628|P1|Part 1: Double-blind Treatment Period 2|Noncompliance|0
1175099|NCT01130493|3859626|P3|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1
1175100|NCT01130493|3859627|P2|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
1175101|NCT01130493|3859628|P1|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
1175102|NCT01130493|3859626|P3|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1
1175103|NCT01130493|3859627|P2|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
1175104|NCT01130493|3859628|P1|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
1175105|NCT01130493|3859626|P3|Part 1: Open-Label IPX066 Washout|Adverse Event|1
1175106|NCT01130493|3859627|P2|Part 1: Open-Label IPX066 Washout|Adverse Event|0
1175107|NCT01130493|3859628|P1|Part 1: Open-Label IPX066 Washout|Adverse Event|0
1175108|NCT01130493|3859626|P3|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
1175109|NCT01130493|3859627|P2|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1
1175110|NCT01130493|3859628|P1|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
1175111|NCT01130493|3859626|P3|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
1175112|NCT01130493|3859627|P2|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1
1175113|NCT01130493|3859628|P1|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
1175114|NCT01130493|3859626|P3|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
1175115|NCT01130493|3859627|P2|Part 1: Double-blind Treatment Period 1|Protocol Violation|1
1175116|NCT01130493|3859628|P1|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
1175117|NCT01130493|3859626|P3|Open-label Dose Conversion to IPX066|Diary imcomplete|0
1175118|NCT01130493|3859627|P2|Open-label Dose Conversion to IPX066|Diary imcomplete|0
1175119|NCT01130493|3859628|P1|Open-label Dose Conversion to IPX066|Diary imcomplete|1
1175120|NCT01130493|3859626|P3|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
1175121|NCT01130493|3859627|P2|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
1175122|NCT01130493|3859628|P1|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7
1175123|NCT01130493|3859626|P3|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
1175124|NCT01130493|3859627|P2|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
1175125|NCT01130493|3859628|P1|Open-label Dose Conversion to IPX066|Lack of Efficacy|7
1175126|NCT01130493|3859626|P3|Open-label Dose Conversion to IPX066|Protocol Violation|0
1175127|NCT01130493|3859627|P2|Open-label Dose Conversion to IPX066|Protocol Violation|0
1175128|NCT01130493|3859628|P1|Open-label Dose Conversion to IPX066|Protocol Violation|3
1175129|NCT01130493|3859626|P3|Open-label Dose Conversion to IPX066|Adverse Event|0
1175130|NCT01130493|3859627|P2|Open-label Dose Conversion to IPX066|Adverse Event|0
1175131|NCT01130493|3859628|P1|Open-label Dose Conversion to IPX066|Adverse Event|1
1175132|NCT01130337|3859645|P1|Overall Study|Surgical resection (R2)|1
1175133|NCT01130337|3859645|P1|Overall Study|Toxicity, AE/intercurrent disease|7
1175134|NCT01130337|3859645|P1|Overall Study|Disease progression|1
1175135|NCT01130337|3859645|P1|Overall Study|Death|1
1175136|NCT01130337|3859645|P1|Overall Study|Principal investigator decision|1
1175137|NCT01130337|3859645|P1|Overall Study|Withdrawal by Subject|3
1175138|NCT01130168|3859652|P6|Period 1|Adverse Event|0
1175139|NCT01130168|3859653|P5|Period 1|Adverse Event|0
1175140|NCT01130168|3859654|P4|Period 1|Adverse Event|1
1175141|NCT01130168|3859655|P3|Period 1|Adverse Event|0
1175142|NCT01130168|3859656|P2|Period 1|Adverse Event|0
1175143|NCT01130168|3859657|P1|Period 1|Adverse Event|0
1175144|NCT01130168|3859652|P6|Period 1|Discontinued For Other Reason|0
1175145|NCT01130168|3859653|P5|Period 1|Discontinued For Other Reason|0
1175146|NCT01130168|3859654|P4|Period 1|Discontinued For Other Reason|1
1175147|NCT01130168|3859655|P3|Period 1|Discontinued For Other Reason|1
1175148|NCT01130168|3859656|P2|Period 1|Discontinued For Other Reason|0
1175149|NCT01130168|3859657|P1|Period 1|Discontinued For Other Reason|0
1175150|NCT01130168|3859652|P6|Period 1|Withdrawal by Subject|0
1175151|NCT01130168|3859653|P5|Period 1|Withdrawal by Subject|0
1175152|NCT01130168|3859654|P4|Period 1|Withdrawal by Subject|1
1175153|NCT01130168|3859655|P3|Period 1|Withdrawal by Subject|0
1175154|NCT01130168|3859656|P2|Period 1|Withdrawal by Subject|1
1175155|NCT01130168|3859657|P1|Period 1|Withdrawal by Subject|0
1175156|NCT01130103|3859694|P2|Maintenance Treatment|Withdrawal by Subject|0
1175157|NCT01130103|3859695|P1|Maintenance Treatment|Withdrawal by Subject|1
1175158|NCT01130103|3859694|P2|Maintenance Treatment|Lost to Follow-up|1
1175159|NCT01130103|3859695|P1|Maintenance Treatment|Lost to Follow-up|1
1175160|NCT01130103|3859694|P2|Maintenance Treatment|Lack of Efficacy|1
1175161|NCT01130103|3859695|P1|Maintenance Treatment|Lack of Efficacy|0
1175162|NCT01130103|3859694|P2|Randomized Treatment|Withdrawal by Subject|2
1175163|NCT01130103|3859695|P1|Randomized Treatment|Withdrawal by Subject|1
1175164|NCT01130103|3859694|P2|Randomized Treatment|Protocol Violation|2
1175165|NCT01130103|3859695|P1|Randomized Treatment|Protocol Violation|3
1175166|NCT01130103|3859694|P2|Randomized Treatment|Lost to Follow-up|0
1175167|NCT01130103|3859695|P1|Randomized Treatment|Lost to Follow-up|1
1175168|NCT01130103|3859694|P2|Randomized Treatment|Adverse Event|1
1175169|NCT01130103|3859695|P1|Randomized Treatment|Adverse Event|1
1175170|NCT01130051|3859709|P2|Washout Period of 14 Days|Protocol Violation|1
1175171|NCT01130051|3859710|P1|Washout Period of 14 Days|Protocol Violation|1
1175172|NCT01130051|3859709|P2|Washout Period of 14 Days|Withdrawal by Subject|1
1175173|NCT01130051|3859710|P1|Washout Period of 14 Days|Withdrawal by Subject|0
1175174|NCT01129960|3859724|P4|Overall Study|Pregnancy|0
1175175|NCT01129960|3859725|P3|Overall Study|Pregnancy|0
1175176|NCT01129960|3859726|P2|Overall Study|Pregnancy|0
1175177|NCT01129960|3859727|P1|Overall Study|Pregnancy|1
1175178|NCT01129960|3859724|P4|Overall Study|Physician Decision|0
1175179|NCT01129960|3859725|P3|Overall Study|Physician Decision|0
1175180|NCT01129960|3859726|P2|Overall Study|Physician Decision|0
1175181|NCT01129960|3859727|P1|Overall Study|Physician Decision|1
1175182|NCT01129960|3859724|P4|Overall Study|Discontinuation of the study by Sponsor|0
1175183|NCT01129960|3859725|P3|Overall Study|Discontinuation of the study by Sponsor|0
1175184|NCT01129960|3859726|P2|Overall Study|Discontinuation of the study by Sponsor|1
1175185|NCT01129960|3859727|P1|Overall Study|Discontinuation of the study by Sponsor|0
1175186|NCT01129960|3859724|P4|Overall Study|Lost to Follow-up|3
1175187|NCT01129960|3859725|P3|Overall Study|Lost to Follow-up|3
1175188|NCT01129960|3859726|P2|Overall Study|Lost to Follow-up|2
1175189|NCT01129960|3859727|P1|Overall Study|Lost to Follow-up|0
1175190|NCT01129960|3859724|P4|Overall Study|Protocol Violation|0
1175191|NCT01129960|3859725|P3|Overall Study|Protocol Violation|3
1175192|NCT01129960|3859726|P2|Overall Study|Protocol Violation|2
1175193|NCT01129960|3859727|P1|Overall Study|Protocol Violation|1
1175194|NCT01129960|3859724|P4|Overall Study|Adverse Event|7
1175195|NCT01129960|3859725|P3|Overall Study|Adverse Event|16
1175196|NCT01129960|3859726|P2|Overall Study|Adverse Event|16
1175197|NCT01129960|3859727|P1|Overall Study|Adverse Event|23
1175198|NCT01129960|3859724|P4|Overall Study|Lack of Efficacy|1
1175199|NCT01129960|3859725|P3|Overall Study|Lack of Efficacy|1
1175200|NCT01129960|3859726|P2|Overall Study|Lack of Efficacy|1
1175201|NCT01129960|3859727|P1|Overall Study|Lack of Efficacy|1
1175202|NCT01129960|3859724|P4|Overall Study|Withdrawal by Subject|2
1175203|NCT01129960|3859725|P3|Overall Study|Withdrawal by Subject|3
1175204|NCT01129960|3859726|P2|Overall Study|Withdrawal by Subject|0
1175205|NCT01129960|3859727|P1|Overall Study|Withdrawal by Subject|3
1175206|NCT01129921|3859739|P2|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1
1175207|NCT01129921|3859740|P1|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0
1175208|NCT01129921|3859739|P2|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4
1175209|NCT01129921|3859740|P1|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0
1175210|NCT01129921|3859739|P2|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1
1175211|NCT01129921|3859740|P1|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0
1175212|NCT01129921|3859739|P2|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1
1175213|NCT01129921|3859740|P1|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2
1175214|NCT01129622|3859764|P1|Overall Study|Withdrawal by Subject|2
1175215|NCT01129583|3859771|P2|Overall Study|Ipsilateral Upper Extremity Injury|1
1175216|NCT01129583|3859772|P1|Overall Study|Ipsilateral Upper Extremity Injury|1
1175217|NCT01129583|3859771|P2|Overall Study|Lost to Follow-up|1
1175218|NCT01129583|3859772|P1|Overall Study|Lost to Follow-up|1
1175219|NCT01129583|3859771|P2|Overall Study|Death|0
1175220|NCT01129583|3859772|P1|Overall Study|Death|1
1175221|NCT01129557|3859785|P3|Overall Study|Novartis terminated study early|2
1175222|NCT01129557|3859786|P2|Overall Study|Novartis terminated study early|3
1175223|NCT01129557|3859787|P1|Overall Study|Novartis terminated study early|3
1175224|NCT01129557|3859785|P3|Overall Study|Adverse Event|2
1175225|NCT01129557|3859786|P2|Overall Study|Adverse Event|2
1175226|NCT01129557|3859787|P1|Overall Study|Adverse Event|1
1175227|NCT01129336|3859882|P2|Overall Study|Death|4
1175228|NCT01129336|3859883|P1|Overall Study|Death|0
1175229|NCT01129336|3859882|P2|Overall Study|Missing Study Completion Status|3
1175230|NCT01129336|3859883|P1|Overall Study|Missing Study Completion Status|2
1175231|NCT01129336|3859882|P2|Overall Study|Adverse Event|1
1175232|NCT01129336|3859883|P1|Overall Study|Adverse Event|0
1175233|NCT01129336|3859882|P2|Overall Study|Withdrawal by Subject|4
1175234|NCT01129336|3859883|P1|Overall Study|Withdrawal by Subject|7
1175235|NCT01129336|3859882|P2|Overall Study|Lost to Follow-up|0
1175236|NCT01129336|3859883|P1|Overall Study|Lost to Follow-up|1
1175237|NCT01129336|3859882|P2|Overall Study|Disease Progression|4
1175238|NCT01129336|3859883|P1|Overall Study|Disease Progression|1
1175239|NCT01129336|3859882|P2|Overall Study|Protocol Violation|0
1175240|NCT01129336|3859883|P1|Overall Study|Protocol Violation|1
1175241|NCT01129284|3859898|P3|Overall Study|Adverse Event|1
1175242|NCT01129284|3859899|P2|Overall Study|Adverse Event|0
1175243|NCT01129284|3859900|P1|Overall Study|Adverse Event|2
1175244|NCT01129128|3859940|P3|Overall Study|Physician Decision|0
1175245|NCT01129128|3859941|P2|Overall Study|Physician Decision|0
1175246|NCT01129128|3859942|P1|Overall Study|Physician Decision|1
1175247|NCT01129128|3859940|P3|Overall Study|Withdrawal by Subject|3
1175248|NCT01129128|3859941|P2|Overall Study|Withdrawal by Subject|1
1175249|NCT01129128|3859942|P1|Overall Study|Withdrawal by Subject|0
1175250|NCT01129128|3859940|P3|Overall Study|Protocol Violation|0
1175251|NCT01129128|3859941|P2|Overall Study|Protocol Violation|1
1175252|NCT01129128|3859942|P1|Overall Study|Protocol Violation|0
1175253|NCT01129128|3859940|P3|Overall Study|Lost to Follow-up|1
1175254|NCT01129128|3859941|P2|Overall Study|Lost to Follow-up|2
1175255|NCT01129128|3859942|P1|Overall Study|Lost to Follow-up|2
1175256|NCT01129115|3859966|P4|Overall Study|Protocol Violation|2
1175257|NCT01129115|3859967|P3|Overall Study|Protocol Violation|2
1175258|NCT01129115|3859968|P2|Overall Study|Protocol Violation|2
1175259|NCT01129115|3859969|P1|Overall Study|Protocol Violation|0
1175260|NCT01129115|3859966|P4|Overall Study|Withdrawal by Subject|4
1175261|NCT01129115|3859967|P3|Overall Study|Withdrawal by Subject|1
1175262|NCT01129115|3859968|P2|Overall Study|Withdrawal by Subject|3
1175263|NCT01129115|3859969|P1|Overall Study|Withdrawal by Subject|1
1175264|NCT01129115|3859966|P4|Overall Study|Adverse Event|3
1175265|NCT01129115|3859967|P3|Overall Study|Adverse Event|3
1175266|NCT01129115|3859968|P2|Overall Study|Adverse Event|2
1175267|NCT01129115|3859969|P1|Overall Study|Adverse Event|1
1175268|NCT01129102|3860006|P3|Overall Study|Lost to Follow-up|0
1175269|NCT01129102|3860007|P2|Overall Study|Lost to Follow-up|0
1175270|NCT01129102|3860008|P1|Overall Study|Lost to Follow-up|2
1175271|NCT01129102|3860006|P3|Overall Study|Adverse Event|1
1175272|NCT01129102|3860007|P2|Overall Study|Adverse Event|2
1175273|NCT01129102|3860008|P1|Overall Study|Adverse Event|2
1175274|NCT01129102|3860006|P3|Overall Study|Pregnancy|1
1175275|NCT01129102|3860007|P2|Overall Study|Pregnancy|0
1175276|NCT01129102|3860008|P1|Overall Study|Pregnancy|0
1175277|NCT01129102|3860006|P3|Overall Study|Protocol Violation|1
1175278|NCT01129102|3860007|P2|Overall Study|Protocol Violation|1
1175279|NCT01129102|3860008|P1|Overall Study|Protocol Violation|0
1175280|NCT01129102|3860006|P3|Overall Study|Withdrawal by Subject|3
1175281|NCT01129102|3860007|P2|Overall Study|Withdrawal by Subject|0
1175282|NCT01129102|3860008|P1|Overall Study|Withdrawal by Subject|2
1175283|NCT01129102|3860006|P3|Overall Study|No study drug treatment|1
1175284|NCT01129102|3860007|P2|Overall Study|No study drug treatment|3
1175285|NCT01129102|3860008|P1|Overall Study|No study drug treatment|2
1175286|NCT01129011|3860019|P2|Overall Study|misc|4
1175287|NCT01129011|3860020|P1|Overall Study|misc|7
1175288|NCT01129011|3860019|P2|Overall Study|Duodenal Ulcer|8
1175289|NCT01129011|3860020|P1|Overall Study|Duodenal Ulcer|2
1175290|NCT01129011|3860019|P2|Overall Study|Lost to Follow-up|7
1175291|NCT01129011|3860020|P1|Overall Study|Lost to Follow-up|6
1175292|NCT01129011|3860019|P2|Overall Study|Withdrawal by Subject|8
1175293|NCT01129011|3860020|P1|Overall Study|Withdrawal by Subject|24
1175294|NCT01129011|3860019|P2|Overall Study|Adverse Event|30
1175295|NCT01129011|3860020|P1|Overall Study|Adverse Event|20
1175296|NCT01128959|3860075|P1|Treatment Period|Withdrawal by Subject|1
1175297|NCT01128959|3860075|P1|Treatment Period|Adverse Event|3
1175298|NCT01128959|3860075|P1|Lead in Period|Adverse Event|3
1175299|NCT01128946|3860081|P4|Period III|Protocol Violation|0
1175300|NCT01128946|3860082|P3|Period III|Protocol Violation|0
1175301|NCT01128946|3860083|P2|Period III|Protocol Violation|0
1175302|NCT01128946|3860084|P1|Period III|Protocol Violation|1
1175303|NCT01128946|3860081|P4|Period II|Withdrawal by Subject|1
1175304|NCT01128946|3860082|P3|Period II|Withdrawal by Subject|0
1175305|NCT01128946|3860083|P2|Period II|Withdrawal by Subject|0
1175306|NCT01128946|3860084|P1|Period II|Withdrawal by Subject|0
1175307|NCT01128946|3860081|P4|Period II|Protocol Violation|0
1175308|NCT01128946|3860082|P3|Period II|Protocol Violation|0
1175309|NCT01128946|3860083|P2|Period II|Protocol Violation|1
1175310|NCT01128946|3860084|P1|Period II|Protocol Violation|0
1175311|NCT01128946|3860081|P4|Period I|Withdrawal by Subject|1
1175312|NCT01128946|3860082|P3|Period I|Withdrawal by Subject|1
1175313|NCT01128946|3860083|P2|Period I|Withdrawal by Subject|0
1175314|NCT01128946|3860084|P1|Period I|Withdrawal by Subject|0
1175315|NCT01128946|3860081|P4|Period I|Protocol Violation|0
1175316|NCT01128946|3860082|P3|Period I|Protocol Violation|0
1175317|NCT01128946|3860083|P2|Period I|Protocol Violation|1
1175318|NCT01128946|3860084|P1|Period I|Protocol Violation|0
1175319|NCT01128894|3860102|P2|Overall Study|Conflicting HbA1c Results at Screening|0
1175320|NCT01128894|3860103|P1|Overall Study|Conflicting HbA1c Results at Screening|1
1175321|NCT01128894|3860102|P2|Overall Study|Physician Decision|1
1175322|NCT01128894|3860103|P1|Overall Study|Physician Decision|2
1175323|NCT01128894|3860102|P2|Overall Study|Withdrawal by Subject|12
1175324|NCT01128894|3860103|P1|Overall Study|Withdrawal by Subject|10
1175325|NCT01128894|3860102|P2|Overall Study|Lost to Follow-up|8
1175326|NCT01128894|3860103|P1|Overall Study|Lost to Follow-up|8
1175327|NCT01128894|3860102|P2|Overall Study|Noncompliance|5
1175328|NCT01128894|3860103|P1|Overall Study|Noncompliance|4
1175329|NCT01128894|3860102|P2|Overall Study|Protocol Violation|1
1175330|NCT01128894|3860103|P1|Overall Study|Protocol Violation|2
1175331|NCT01128894|3860102|P2|Overall Study|Adverse Event|41
1175332|NCT01128894|3860103|P1|Overall Study|Adverse Event|31
1175333|NCT01128842|3860121|P1|Overall Study|Disease Progression|6
1175334|NCT01128842|3860121|P1|Overall Study|Adverse Event|1
1175335|NCT01128738|3860138|P2|Second TP|Withdrawal by Subject|2
1175336|NCT01128738|3860139|P1|Second TP|Withdrawal by Subject|0
1175337|NCT01128738|3860138|P2|Second TP|Lost to Follow-up|1
1175338|NCT01128738|3860139|P1|Second TP|Lost to Follow-up|0
1175339|NCT01128738|3860138|P2|First Treatment Phase (TP)|Withdrawal by Subject|1
1175340|NCT01128738|3860139|P1|First Treatment Phase (TP)|Withdrawal by Subject|3
1175341|NCT01128738|3860138|P2|First Treatment Phase (TP)|Lost to Follow-up|0
1175342|NCT01128738|3860139|P1|First Treatment Phase (TP)|Lost to Follow-up|1
1175343|NCT01128621|3860264|P2|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2
1175344|NCT01128621|3860265|P1|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0
1175345|NCT01128595|3860386|P4|Treatment Period 3|Withdrawal by Subject|0
1175346|NCT01128595|3860387|P3|Treatment Period 3|Withdrawal by Subject|0
1175347|NCT01128595|3860388|P2|Treatment Period 3|Withdrawal by Subject|1
1175348|NCT01128595|3860389|P1|Treatment Period 3|Withdrawal by Subject|0
1175349|NCT01128569|3860419|P6|Treatment Period 2|Withdrawal by Subject|0
1175350|NCT01128569|3860420|P5|Treatment Period 2|Withdrawal by Subject|0
1175351|NCT01128569|3860421|P4|Treatment Period 2|Withdrawal by Subject|0
1175352|NCT01128569|3860422|P3|Treatment Period 2|Withdrawal by Subject|0
1175353|NCT01128569|3860423|P2|Treatment Period 2|Withdrawal by Subject|1
1175354|NCT01128569|3860424|P1|Treatment Period 2|Withdrawal by Subject|0
1175355|NCT01128569|3860419|P6|Washout Period 1|Adverse Event|0
1175356|NCT01128569|3860420|P5|Washout Period 1|Adverse Event|0
1175357|NCT01128569|3860421|P4|Washout Period 1|Adverse Event|0
1175358|NCT01128569|3860422|P3|Washout Period 1|Adverse Event|1
1175359|NCT01128569|3860423|P2|Washout Period 1|Adverse Event|0
1175360|NCT01128569|3860424|P1|Washout Period 1|Adverse Event|0
1175361|NCT01128543|3860441|P1|Overall Study|Protocol Violation|1
1175362|NCT01128543|3860441|P1|Overall Study|Withdrawal by Subject|3
1175363|NCT01128413|3860467|P2|Overall Study|Pt made DNR|0
1175364|NCT01128413|3860468|P1|Overall Study|Pt made DNR|1
1175365|NCT01128413|3860467|P2|Overall Study|NICOM Monitor Problems|1
1175366|NCT01128413|3860468|P1|Overall Study|NICOM Monitor Problems|2
1175367|NCT01128413|3860467|P2|Overall Study|Withdrawal by Subject|0
1175368|NCT01128413|3860468|P1|Overall Study|Withdrawal by Subject|1
1175369|NCT01128400|3860477|P3|Overall Study|Excluded due to sinus problems|0
1175370|NCT01128400|3860478|P2|Overall Study|Excluded due to sinus problems|1
1175371|NCT01128400|3860479|P1|Overall Study|Excluded due to sinus problems|0
1175372|NCT01128400|3860477|P3|Overall Study|were not invited to participate on taste|15
1175373|NCT01128400|3860478|P2|Overall Study|were not invited to participate on taste|0
1175374|NCT01128400|3860479|P1|Overall Study|were not invited to participate on taste|0
1175375|NCT01128400|3860477|P3|Overall Study|Screening failure|0
1175376|NCT01128400|3860478|P2|Overall Study|Screening failure|0
1175377|NCT01128400|3860479|P1|Overall Study|Screening failure|1
1175378|NCT01128400|3860477|P3|Overall Study|Lost to Follow-up|1
1175379|NCT01128400|3860478|P2|Overall Study|Lost to Follow-up|0
1175380|NCT01128400|3860479|P1|Overall Study|Lost to Follow-up|1
1175381|NCT01128387|3860492|P2|Overall Study|Physician Decision|1
1175382|NCT01128387|3860493|P1|Overall Study|Physician Decision|0
1175383|NCT01128361|3860503|P2|Overall Study|Withdrawal by Subject|2
1175384|NCT01128361|3860504|P1|Overall Study|Withdrawal by Subject|5
1175385|NCT01128361|3860503|P2|Overall Study|Lost to Follow-up|1
1175386|NCT01128361|3860504|P1|Overall Study|Lost to Follow-up|0
1175387|NCT01128296|3860516|P6|Overall Study|Withdrawal by Subject|2
1175388|NCT01128296|3860517|P5|Overall Study|Withdrawal by Subject|0
1175389|NCT01128296|3860518|P4|Overall Study|Withdrawal by Subject|0
1175390|NCT01128296|3860519|P3|Overall Study|Withdrawal by Subject|0
1175391|NCT01128296|3860520|P2|Overall Study|Withdrawal by Subject|0
1175392|NCT01128296|3860521|P1|Overall Study|Withdrawal by Subject|0
1175393|NCT01128296|3860516|P6|Overall Study|Physician Decision|3
1175394|NCT01128296|3860517|P5|Overall Study|Physician Decision|0
1175395|NCT01128296|3860518|P4|Overall Study|Physician Decision|0
1175396|NCT01128296|3860519|P3|Overall Study|Physician Decision|0
1175397|NCT01128296|3860520|P2|Overall Study|Physician Decision|0
1175398|NCT01128296|3860521|P1|Overall Study|Physician Decision|0
1175399|NCT01128244|3860552|P1|Overall Study|Scheduling conflict|2
1175400|NCT01128244|3860552|P1|Overall Study|Adverse Event|1
1175401|NCT01128179|3860593|P2|Overall Study|Protocol Violation|0
1175402|NCT01128179|3860594|P1|Overall Study|Protocol Violation|1
1175403|NCT01128179|3860593|P2|Overall Study|Death|0
1175404|NCT01128179|3860594|P1|Overall Study|Death|1
1175405|NCT01128153|3860614|P2|Overall Study|Developed discontinuation criteria|1
1175406|NCT01128153|3860615|P1|Overall Study|Developed discontinuation criteria|1
1175407|NCT01128153|3860614|P2|Overall Study|Protocol Violation|0
1175408|NCT01128153|3860615|P1|Overall Study|Protocol Violation|2
1175409|NCT01128153|3860614|P2|Overall Study|Incorrect enrolment to study|1
1175410|NCT01128153|3860615|P1|Overall Study|Incorrect enrolment to study|2
1175411|NCT01128153|3860614|P2|Overall Study|Withdrawal by Subject|3
1175412|NCT01128153|3860615|P1|Overall Study|Withdrawal by Subject|2
1175413|NCT01128153|3860614|P2|Overall Study|Condition under investigation worsened|7
1175414|NCT01128153|3860615|P1|Overall Study|Condition under investigation worsened|8
1175415|NCT01128153|3860614|P2|Overall Study|Adverse Event|3
1175416|NCT01128153|3860615|P1|Overall Study|Adverse Event|1
1175417|NCT01128114|3860631|P1|Overall Study|Screening Failed|2
1175418|NCT01128114|3860631|P1|Overall Study|Treatment Withdrawn|6
1175419|NCT01127763|3860648|P1|Overall Study|Physician Decision|2
1175420|NCT01127763|3860648|P1|Overall Study|Withdrawal by Subject|1
1175421|NCT01127763|3860648|P1|Overall Study|Adverse Event|2
1175422|NCT01127646|3860693|P2|Overall Study|Protocol Violation|1
1175423|NCT01127646|3860694|P1|Overall Study|Protocol Violation|0
1175424|NCT01127646|3860693|P2|Overall Study|Entry Criteria Not Met|0
1175425|NCT01127646|3860694|P1|Overall Study|Entry Criteria Not Met|1
1175426|NCT01127633|3860728|P2|Overall Study|Not treated|0
1175427|NCT01127633|3860729|P1|Overall Study|Not treated|1
1175428|NCT01127633|3860728|P2|Overall Study|Abnormal Lab/ECG Result|1
1175429|NCT01127633|3860729|P1|Overall Study|Abnormal Lab/ECG Result|0
1175430|NCT01127633|3860728|P2|Overall Study|Protocol Violation|16
1175431|NCT01127633|3860729|P1|Overall Study|Protocol Violation|8
1175432|NCT01127633|3860728|P2|Overall Study|Sponsor Decision|195
1175433|NCT01127633|3860729|P1|Overall Study|Sponsor Decision|163
1175434|NCT01127633|3860728|P2|Overall Study|Withdrawal by Subject|72
1175435|NCT01127633|3860729|P1|Overall Study|Withdrawal by Subject|57
1175436|NCT01127633|3860728|P2|Overall Study|Physician Decision|45
1175437|NCT01127633|3860729|P1|Overall Study|Physician Decision|60
1175438|NCT01127633|3860728|P2|Overall Study|Parent/Caregiver Decision|228
1175439|NCT01127633|3860729|P1|Overall Study|Parent/Caregiver Decision|246
1175440|NCT01127633|3860728|P2|Overall Study|Lost to Follow-up|0
1175441|NCT01127633|3860729|P1|Overall Study|Lost to Follow-up|4
1175442|NCT01127633|3860728|P2|Overall Study|Death|43
1175443|NCT01127633|3860729|P1|Overall Study|Death|40
1175444|NCT01127633|3860728|P2|Overall Study|Adverse Event|73
1175445|NCT01127633|3860729|P1|Overall Study|Adverse Event|74
1175446|NCT01127607|3860761|P2|Phase II (Between Subjects)|Withdrawal by Subject|0
1175447|NCT01127607|3860762|P1|Phase II (Between Subjects)|Withdrawal by Subject|1
1175448|NCT01127607|3860761|P2|Phase II (Between Subjects)|Lost to Follow-up|2
1175449|NCT01127607|3860762|P1|Phase II (Between Subjects)|Lost to Follow-up|0
1175450|NCT01127256|3860937|P2|Overall Study|Protocol Violation|0
1175451|NCT01127256|3860938|P1|Overall Study|Protocol Violation|1
1175452|NCT01127256|3860937|P2|Overall Study|Withdrawal by Subject|9
1175453|NCT01127256|3860938|P1|Overall Study|Withdrawal by Subject|5
1175454|NCT01127256|3860937|P2|Overall Study|Lost to Follow-up|17
1175455|NCT01127256|3860938|P1|Overall Study|Lost to Follow-up|16
1175456|NCT01127256|3860937|P2|Overall Study|Lack of Efficacy|0
1175457|NCT01127256|3860938|P1|Overall Study|Lack of Efficacy|4
1175458|NCT01127256|3860937|P2|Overall Study|Adverse Event|13
1175459|NCT01127256|3860938|P1|Overall Study|Adverse Event|13
1175460|NCT01127165|3860950|P2|Overall Study|Protocol Violation|1
1175461|NCT01127165|3860951|P1|Overall Study|Protocol Violation|0
1175462|NCT01127165|3860950|P2|Overall Study|Withdrawal by Subject|3
1175463|NCT01127165|3860951|P1|Overall Study|Withdrawal by Subject|1
1175464|NCT01127165|3860950|P2|Overall Study|Lost to Follow-up|5
1175465|NCT01127165|3860951|P1|Overall Study|Lost to Follow-up|3
1175466|NCT01127165|3860950|P2|Overall Study|Lack of Efficacy|8
1175467|NCT01127165|3860951|P1|Overall Study|Lack of Efficacy|10
1175468|NCT01127165|3860950|P2|Overall Study|Adverse Event|2
1175469|NCT01127165|3860951|P1|Overall Study|Adverse Event|2
1175470|NCT01127139|3860963|P1|Overall Study|Reason not specified|1
1175471|NCT01127139|3860963|P1|Overall Study|Lack of Efficacy|4
1175472|NCT01127139|3860963|P1|Overall Study|Incompliance|12
1175473|NCT01127139|3860963|P1|Overall Study|Adverse Event|40
1175474|NCT01126619|3861029|P1|Overall Study|Non-compliance|1
1175475|NCT01126619|3861029|P1|Overall Study|Withdrawal by Subject|9
1175476|NCT01126619|3861029|P1|Overall Study|Serious adverse event|1
1175477|NCT01126619|3861029|P1|Overall Study|Investigator decision|4
1175478|NCT01126619|3861029|P1|Overall Study|Not eligible for the study|2
1175479|NCT01126580|3861057|P3|Overall Study|Treatment Non-compliance|3
1175480|NCT01126580|3861058|P2|Overall Study|Treatment Non-compliance|2
1175481|NCT01126580|3861059|P1|Overall Study|Treatment Non-compliance|0
1175482|NCT01126580|3861057|P3|Overall Study|Lost to Follow-up|9
1175483|NCT01126580|3861058|P2|Overall Study|Lost to Follow-up|13
1175484|NCT01126580|3861059|P1|Overall Study|Lost to Follow-up|15
1175485|NCT01126580|3861057|P3|Overall Study|Protocol Violation|2
1175486|NCT01126580|3861058|P2|Overall Study|Protocol Violation|1
1175487|NCT01126580|3861059|P1|Overall Study|Protocol Violation|0
1175488|NCT01126580|3861057|P3|Overall Study|Lack of Efficacy|4
1175489|NCT01126580|3861058|P2|Overall Study|Lack of Efficacy|3
1175490|NCT01126580|3861059|P1|Overall Study|Lack of Efficacy|2
1175491|NCT01126580|3861057|P3|Overall Study|Entry Criteria Not Met|2
1175492|NCT01126580|3861058|P2|Overall Study|Entry Criteria Not Met|1
1175493|NCT01126580|3861059|P1|Overall Study|Entry Criteria Not Met|1
1175494|NCT01126580|3861057|P3|Overall Study|Physician Decision|2
1175495|NCT01126580|3861058|P2|Overall Study|Physician Decision|1
1175496|NCT01126580|3861059|P1|Overall Study|Physician Decision|1
1175497|NCT01126580|3861057|P3|Overall Study|Sponsor Decision|7
1175498|NCT01126580|3861058|P2|Overall Study|Sponsor Decision|4
1175499|NCT01126580|3861059|P1|Overall Study|Sponsor Decision|5
1175500|NCT01126580|3861057|P3|Overall Study|Withdrawal by Subject|14
1175501|NCT01126580|3861058|P2|Overall Study|Withdrawal by Subject|19
1175502|NCT01126580|3861059|P1|Overall Study|Withdrawal by Subject|11
1175503|NCT01126580|3861057|P3|Overall Study|Adverse Event|12
1175504|NCT01126580|3861058|P2|Overall Study|Adverse Event|8
1175505|NCT01126580|3861059|P1|Overall Study|Adverse Event|14
1175506|NCT01126541|3861154|P3|Overall Study|Administrative reason or other|2
1175507|NCT01126541|3861155|P2|Overall Study|Administrative reason or other|1
1175508|NCT01126541|3861156|P1|Overall Study|Administrative reason or other|1
1175509|NCT01126541|3861154|P3|Overall Study|Protocol Violation|1
1175510|NCT01126541|3861155|P2|Overall Study|Protocol Violation|0
1175511|NCT01126541|3861156|P1|Overall Study|Protocol Violation|0
1175512|NCT01126541|3861154|P3|Overall Study|Withdrawal by Subject|6
1175513|NCT01126541|3861155|P2|Overall Study|Withdrawal by Subject|5
1175514|NCT01126541|3861156|P1|Overall Study|Withdrawal by Subject|2
1175515|NCT01126541|3861154|P3|Overall Study|Lost to Follow-up|2
1175516|NCT01126541|3861155|P2|Overall Study|Lost to Follow-up|2
1175517|NCT01126541|3861156|P1|Overall Study|Lost to Follow-up|1
1175518|NCT01126541|3861154|P3|Overall Study|Lack of Efficacy|11
1175519|NCT01126541|3861155|P2|Overall Study|Lack of Efficacy|1
1175520|NCT01126541|3861156|P1|Overall Study|Lack of Efficacy|6
1175521|NCT01126541|3861154|P3|Overall Study|Death|0
1175522|NCT01126541|3861155|P2|Overall Study|Death|1
1175523|NCT01126541|3861156|P1|Overall Study|Death|0
1175524|NCT01126541|3861154|P3|Overall Study|Adverse Event|4
1175525|NCT01126541|3861155|P2|Overall Study|Adverse Event|2
1175526|NCT01126541|3861156|P1|Overall Study|Adverse Event|0
1175527|NCT01126437|3861240|P3|Overall Study|Other reason not specified|178
1175528|NCT01126437|3861241|P2|Overall Study|Other reason not specified|176
1175529|NCT01126437|3861242|P1|Overall Study|Other reason not specified|210
1175530|NCT01126437|3861240|P3|Overall Study|Withdrawal by Subject|319
1175531|NCT01126437|3861241|P2|Overall Study|Withdrawal by Subject|335
1175532|NCT01126437|3861242|P1|Overall Study|Withdrawal by Subject|331
1175533|NCT01126437|3861240|P3|Overall Study|Lost to Follow-up|55
1175534|NCT01126437|3861241|P2|Overall Study|Lost to Follow-up|63
1175535|NCT01126437|3861242|P1|Overall Study|Lost to Follow-up|52
1175536|NCT01126437|3861240|P3|Overall Study|Protocol Violation|41
1175537|NCT01126437|3861241|P2|Overall Study|Protocol Violation|66
1175538|NCT01126437|3861242|P1|Overall Study|Protocol Violation|64
1175539|NCT01126437|3861240|P3|Overall Study|Lack of Efficacy|59
1175540|NCT01126437|3861241|P2|Overall Study|Lack of Efficacy|60
1175541|NCT01126437|3861242|P1|Overall Study|Lack of Efficacy|65
1175542|NCT01126437|3861240|P3|Overall Study|Adverse Event|635
1175543|NCT01126437|3861241|P2|Overall Study|Adverse Event|606
1175544|NCT01126437|3861242|P1|Overall Study|Adverse Event|602
1175545|NCT01126437|3861240|P3|Overall Study|Sites with data irregularities/fraud|7
1175546|NCT01126437|3861241|P2|Overall Study|Sites with data irregularities/fraud|6
1175547|NCT01126437|3861242|P1|Overall Study|Sites with data irregularities/fraud|6
1175548|NCT01126437|3861240|P3|Overall Study|Not treated|19
1175549|NCT01126437|3861241|P2|Overall Study|Not treated|18
1175550|NCT01126437|3861242|P1|Overall Study|Not treated|11
1175551|NCT01126424|3861280|P6|Overall Study|Withdrawal by Subject|0
1175552|NCT01126424|3861281|P5|Overall Study|Withdrawal by Subject|1
1175553|NCT01126424|3861282|P4|Overall Study|Withdrawal by Subject|3
1175554|NCT01126424|3861283|P3|Overall Study|Withdrawal by Subject|1
1175555|NCT01126424|3861284|P2|Overall Study|Withdrawal by Subject|0
1175556|NCT01126424|3861285|P1|Overall Study|Withdrawal by Subject|0
1175557|NCT01126424|3861280|P6|Overall Study|Adverse Event|0
1175558|NCT01126424|3861281|P5|Overall Study|Adverse Event|1
1175559|NCT01126424|3861282|P4|Overall Study|Adverse Event|0
1175560|NCT01126424|3861283|P3|Overall Study|Adverse Event|0
1175561|NCT01126424|3861284|P2|Overall Study|Adverse Event|0
1175562|NCT01126424|3861285|P1|Overall Study|Adverse Event|0
1175563|NCT01126359|3861308|P2|First Intervention (20-minutes)|Physician Decision|1
1175564|NCT01126359|3861309|P1|First Intervention (20-minutes)|Physician Decision|0
1175565|NCT01126268|3861321|P1|Overall Study|Adverse Event|1
1175566|NCT01126060|3861360|P2|Overall Study|Protocol Violation|2
1175567|NCT01126060|3861361|P1|Overall Study|Protocol Violation|0
1175568|NCT01125930|3861369|P2|Overall Study|Lost to Follow-up|2
1175569|NCT01125930|3861370|P1|Overall Study|Lost to Follow-up|0
1175570|NCT01125930|3861369|P2|Overall Study|Protocol Violation|1
1175571|NCT01125930|3861370|P1|Overall Study|Protocol Violation|0
1175572|NCT01125930|3861369|P2|Overall Study|Withdrawal by Subject|6
1175573|NCT01125930|3861370|P1|Overall Study|Withdrawal by Subject|1
1175574|NCT01125930|3861369|P2|Overall Study|Adverse Event|1
1175575|NCT01125930|3861370|P1|Overall Study|Adverse Event|0
1175576|NCT01125917|3861524|P1|Overall Study|Lack of Efficacy|19
1175577|NCT01125917|3861524|P1|Overall Study|Administrative|223
1175578|NCT01125917|3861524|P1|Overall Study|Withdrawal by Subject|31
1175579|NCT01125917|3861524|P1|Overall Study|Lost to Follow-up|23
1175580|NCT01125917|3861524|P1|Overall Study|Adverse Event|43
1175581|NCT01125813|3861528|P1|Overall Study|Screen Failures|4
1175582|NCT01125813|3861528|P1|Overall Study|Withdrawal by Subject|1
1175583|NCT01125813|3861528|P1|Overall Study|Death|1
1175584|NCT01125800|3861538|P5|Phase II|Disease progression|8
1175585|NCT01125800|3861539|P4|Phase II|Disease progression|1
1175586|NCT01125800|3861540|P3|Phase II|Disease progression|0
1175587|NCT01125800|3861541|P2|Phase II|Disease progression|0
1175588|NCT01125800|3861542|P1|Phase II|Disease progression|0
1175589|NCT01125800|3861538|P5|Phase II|Adverse Event|2
1175590|NCT01125800|3861539|P4|Phase II|Adverse Event|0
1175591|NCT01125800|3861540|P3|Phase II|Adverse Event|0
1175592|NCT01125800|3861541|P2|Phase II|Adverse Event|0
1175593|NCT01125800|3861542|P1|Phase II|Adverse Event|0
1175594|NCT01125800|3861538|P5|Phase II|Protocol Violation|1
1175595|NCT01125800|3861539|P4|Phase II|Protocol Violation|0
1175596|NCT01125800|3861540|P3|Phase II|Protocol Violation|0
1175597|NCT01125800|3861541|P2|Phase II|Protocol Violation|0
1175598|NCT01125800|3861542|P1|Phase II|Protocol Violation|0
1175599|NCT01125800|3861538|P5|Phase I|Disease progression|0
1175600|NCT01125800|3861539|P4|Phase I|Disease progression|3
1175601|NCT01125800|3861540|P3|Phase I|Disease progression|1
1175602|NCT01125800|3861541|P2|Phase I|Disease progression|4
1175603|NCT01125800|3861542|P1|Phase I|Disease progression|5
1175604|NCT01125800|3861538|P5|Phase I|Withdrawal by Subject|0
1175605|NCT01125800|3861539|P4|Phase I|Withdrawal by Subject|0
1175606|NCT01125800|3861540|P3|Phase I|Withdrawal by Subject|1
1175607|NCT01125800|3861541|P2|Phase I|Withdrawal by Subject|0
1175608|NCT01125800|3861542|P1|Phase I|Withdrawal by Subject|0
1175609|NCT01125800|3861538|P5|Phase I|Administrative problems|0
1175610|NCT01125800|3861539|P4|Phase I|Administrative problems|0
1175611|NCT01125800|3861540|P3|Phase I|Administrative problems|0
1175612|NCT01125800|3861541|P2|Phase I|Administrative problems|0
1175613|NCT01125800|3861542|P1|Phase I|Administrative problems|1
1175614|NCT01125800|3861538|P5|Phase I|Adverse Event|0
1175615|NCT01125800|3861539|P4|Phase I|Adverse Event|7
1175616|NCT01125800|3861540|P3|Phase I|Adverse Event|1
1175617|NCT01125800|3861541|P2|Phase I|Adverse Event|2
1175618|NCT01125800|3861542|P1|Phase I|Adverse Event|2
1175619|NCT01125800|3861538|P5|Phase I|Protocol Violation|0
1175620|NCT01125800|3861539|P4|Phase I|Protocol Violation|1
1175621|NCT01125800|3861540|P3|Phase I|Protocol Violation|1
1175622|NCT01125800|3861541|P2|Phase I|Protocol Violation|3
1175623|NCT01125800|3861542|P1|Phase I|Protocol Violation|0
1175624|NCT01125748|3861608|P2|Overall Study|Patient Decision to Withdraw|4
1175625|NCT01125748|3861609|P1|Overall Study|Patient Decision to Withdraw|2
1175626|NCT01125748|3861608|P2|Overall Study|Physician Decision|7
1175627|NCT01125748|3861609|P1|Overall Study|Physician Decision|8
1175628|NCT01125748|3861608|P2|Overall Study|Lost to Follow-up|1
1175629|NCT01125748|3861609|P1|Overall Study|Lost to Follow-up|0
1175630|NCT01125748|3861608|P2|Overall Study|Adverse Event|2
1175631|NCT01125748|3861609|P1|Overall Study|Adverse Event|0
1175632|NCT01125722|3861619|P2|Overall Study|Lost to Follow-up|0
1175633|NCT01125722|3861620|P1|Overall Study|Lost to Follow-up|1
1175634|NCT01125722|3861619|P2|Overall Study|Withdrawal by Subject|1
1175635|NCT01125722|3861620|P1|Overall Study|Withdrawal by Subject|2
1175636|NCT01125566|3861667|P3|Patients Who Switched From AV to TV|Refused to continue taking medication|4
1175637|NCT01125566|3861668|P2|Patients Who Switched From AV to TV|Refused to continue taking medication|0
1175638|NCT01125566|3861669|P1|Patients Who Switched From AV to TV|Refused to continue taking medication|0
1175639|NCT01125566|3861667|P3|Patients Who Switched From AV to TV|Progressive disease according to RECIST|20
1175640|NCT01125566|3861668|P2|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
1175641|NCT01125566|3861669|P1|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
1175642|NCT01125566|3861667|P3|Patients Before the Switch (26Apr2013)|Other than those stated above|0
1175643|NCT01125566|3861668|P2|Patients Before the Switch (26Apr2013)|Other than those stated above|5
1175644|NCT01125566|3861669|P1|Patients Before the Switch (26Apr2013)|Other than those stated above|23
1175645|NCT01125566|3861667|P3|Patients Before the Switch (26Apr2013)|Not treated|0
1175646|NCT01125566|3861668|P2|Patients Before the Switch (26Apr2013)|Not treated|0
1175647|NCT01125566|3861669|P1|Patients Before the Switch (26Apr2013)|Not treated|2
1175648|NCT01125566|3861667|P3|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0
1175649|NCT01125566|3861668|P2|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|21
1175650|NCT01125566|3861669|P1|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|25
1175651|NCT01125566|3861667|P3|Patients Before the Switch (26Apr2013)|Protocol Violation|0
1175652|NCT01125566|3861668|P2|Patients Before the Switch (26Apr2013)|Protocol Violation|1
1175653|NCT01125566|3861669|P1|Patients Before the Switch (26Apr2013)|Protocol Violation|0
1175654|NCT01125566|3861667|P3|Patients Before the Switch (26Apr2013)|Adverse Event|0
1175655|NCT01125566|3861668|P2|Patients Before the Switch (26Apr2013)|Adverse Event|5
1175656|NCT01125566|3861669|P1|Patients Before the Switch (26Apr2013)|Adverse Event|24
1175657|NCT01125566|3861667|P3|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0
1175658|NCT01125566|3861668|P2|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|4
1175659|NCT01125566|3861669|P1|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|5
1175660|NCT01125566|3861667|P3|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0
1175661|NCT01125566|3861668|P2|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|100
1175662|NCT01125566|3861669|P1|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|181
1175663|NCT01125514|3861682|P1|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1
1175664|NCT01125514|3861682|P1|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1
1175665|NCT01125514|3861682|P1|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2
1175666|NCT01125514|3861682|P1|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3
1175667|NCT01125514|3861682|P1|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1
1175668|NCT01125514|3861682|P1|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1
1175669|NCT01125189|3861782|P3|Follow up Period|Other reasons|5
1175670|NCT01125189|3861783|P2|Follow up Period|Other reasons|4
1175671|NCT01125189|3861784|P1|Follow up Period|Other reasons|4
1175672|NCT01125189|3861782|P3|Follow up Period|Lost to Follow-up|6
1175673|NCT01125189|3861783|P2|Follow up Period|Lost to Follow-up|9
1175674|NCT01125189|3861784|P1|Follow up Period|Lost to Follow-up|12
1175675|NCT01125189|3861782|P3|Follow up Period|Death|0
1175676|NCT01125189|3861783|P2|Follow up Period|Death|0
1175677|NCT01125189|3861784|P1|Follow up Period|Death|1
1175678|NCT01125189|3861782|P3|Follow up Period|Withdrawal by Subject|5
1175679|NCT01125189|3861783|P2|Follow up Period|Withdrawal by Subject|2
1175680|NCT01125189|3861784|P1|Follow up Period|Withdrawal by Subject|3
1175681|NCT01125189|3861782|P3|Treatment Period|Completed 24 week treatment period only|2
1175682|NCT01125189|3861783|P2|Treatment Period|Completed 24 week treatment period only|1
1175683|NCT01125189|3861784|P1|Treatment Period|Completed 24 week treatment period only|2
1175684|NCT01125189|3861782|P3|Treatment Period|Other reasons|0
1175685|NCT01125189|3861783|P2|Treatment Period|Other reasons|1
1175686|NCT01125189|3861784|P1|Treatment Period|Other reasons|1
1175687|NCT01125189|3861782|P3|Treatment Period|Participants requested to discontinue|4
1175688|NCT01125189|3861783|P2|Treatment Period|Participants requested to discontinue|3
1175689|NCT01125189|3861784|P1|Treatment Period|Participants requested to discontinue|1
1175690|NCT01125189|3861782|P3|Treatment Period|Poor compliance/noncompliance|0
1175691|NCT01125189|3861783|P2|Treatment Period|Poor compliance/noncompliance|1
1175692|NCT01125189|3861784|P1|Treatment Period|Poor compliance/noncompliance|0
1175693|NCT01125189|3861782|P3|Treatment Period|Lost to Follow-up|1
1175694|NCT01125189|3861783|P2|Treatment Period|Lost to Follow-up|2
1175695|NCT01125189|3861784|P1|Treatment Period|Lost to Follow-up|1
1175696|NCT01125189|3861782|P3|Treatment Period|Death|0
1175697|NCT01125189|3861783|P2|Treatment Period|Death|0
1175698|NCT01125189|3861784|P1|Treatment Period|Death|1
1175699|NCT01125189|3861782|P3|Treatment Period|Withdrawal by Subject|1
1175700|NCT01125189|3861783|P2|Treatment Period|Withdrawal by Subject|1
1175701|NCT01125189|3861784|P1|Treatment Period|Withdrawal by Subject|3
1175702|NCT01125189|3861782|P3|Treatment Period|Adverse Event|8
1175703|NCT01125189|3861783|P2|Treatment Period|Adverse Event|8
1175704|NCT01125189|3861784|P1|Treatment Period|Adverse Event|7
1175705|NCT01125189|3861782|P3|Treatment Period|Lack of Efficacy|25
1175706|NCT01125189|3861783|P2|Treatment Period|Lack of Efficacy|18
1175707|NCT01125189|3861784|P1|Treatment Period|Lack of Efficacy|15
1175708|NCT01124916|3861838|P2|Overall Study|Lost to Follow-up|2
1175709|NCT01124916|3861839|P1|Overall Study|Lost to Follow-up|3
1175710|NCT01124864|3861853|P6|Overall Study|Protocol Violation|0
1175711|NCT01124864|3861854|P5|Overall Study|Protocol Violation|1
1175712|NCT01124864|3861855|P4|Overall Study|Protocol Violation|0
1175713|NCT01124864|3861856|P3|Overall Study|Protocol Violation|0
1175714|NCT01124864|3861857|P2|Overall Study|Protocol Violation|0
1175715|NCT01124864|3861858|P1|Overall Study|Protocol Violation|1
1175716|NCT01124864|3861853|P6|Overall Study|Lost to Follow-up|0
1175717|NCT01124864|3861854|P5|Overall Study|Lost to Follow-up|0
1175718|NCT01124864|3861855|P4|Overall Study|Lost to Follow-up|1
1175719|NCT01124864|3861856|P3|Overall Study|Lost to Follow-up|0
1175720|NCT01124864|3861857|P2|Overall Study|Lost to Follow-up|1
1175721|NCT01124864|3861858|P1|Overall Study|Lost to Follow-up|1
1175722|NCT01124864|3861853|P6|Overall Study|Withdrawal by Subject|1
1175723|NCT01124864|3861854|P5|Overall Study|Withdrawal by Subject|2
1175724|NCT01124864|3861855|P4|Overall Study|Withdrawal by Subject|0
1175725|NCT01124864|3861856|P3|Overall Study|Withdrawal by Subject|4
1175726|NCT01124864|3861857|P2|Overall Study|Withdrawal by Subject|3
1175727|NCT01124864|3861858|P1|Overall Study|Withdrawal by Subject|2
1175728|NCT01124864|3861853|P6|Overall Study|Death|0
1175729|NCT01124864|3861854|P5|Overall Study|Death|1
1175730|NCT01124864|3861855|P4|Overall Study|Death|2
1175731|NCT01124864|3861856|P3|Overall Study|Death|6
1175732|NCT01124864|3861857|P2|Overall Study|Death|9
1175733|NCT01124864|3861858|P1|Overall Study|Death|6
1175734|NCT01124864|3861853|P6|Overall Study|Follow up phase competed as per protocol|2
1175735|NCT01124864|3861854|P5|Overall Study|Follow up phase competed as per protocol|26
1175736|NCT01124864|3861855|P4|Overall Study|Follow up phase competed as per protocol|18
1175737|NCT01124864|3861856|P3|Overall Study|Follow up phase competed as per protocol|24
1175738|NCT01124864|3861857|P2|Overall Study|Follow up phase competed as per protocol|22
1175739|NCT01124864|3861858|P1|Overall Study|Follow up phase competed as per protocol|18
1175740|NCT01124838|3861892|P2|Overall Study|Lost to Follow-up|0
1175741|NCT01124838|3861893|P1|Overall Study|Lost to Follow-up|2
1175742|NCT01124838|3861892|P2|Overall Study|Withdrawal by Subject|2
1175743|NCT01124838|3861893|P1|Overall Study|Withdrawal by Subject|3
1175744|NCT01124838|3861892|P2|Overall Study|Lack of Efficacy|0
1175745|NCT01124838|3861893|P1|Overall Study|Lack of Efficacy|2
1175746|NCT01124838|3861892|P2|Overall Study|Adverse Event|11
1175747|NCT01124838|3861893|P1|Overall Study|Adverse Event|7
1175748|NCT01124838|3861892|P2|Overall Study|Miscellaneous|2
1175749|NCT01124838|3861893|P1|Overall Study|Miscellaneous|4
1175750|NCT01124643|3861960|P1|Overall Study|Death|1
1175751|NCT01124617|3861974|P2|Overall Study|Other|1
1175752|NCT01124617|3861975|P1|Overall Study|Other|2
1175753|NCT01124617|3861974|P2|Overall Study|Withdrawal by Subject|1
1175754|NCT01124617|3861975|P1|Overall Study|Withdrawal by Subject|9
1175755|NCT01124617|3861974|P2|Overall Study|Protocol Violation|1
1175756|NCT01124617|3861975|P1|Overall Study|Protocol Violation|1
1175757|NCT01124617|3861974|P2|Overall Study|Lack of Efficacy|1
1175758|NCT01124617|3861975|P1|Overall Study|Lack of Efficacy|2
1175759|NCT01124617|3861974|P2|Overall Study|Adverse Event|2
1175760|NCT01124617|3861975|P1|Overall Study|Adverse Event|5
1175761|NCT01124604|3862007|P2|Overall Study|Disease Progression|1
1175762|NCT01124604|3862008|P1|Overall Study|Disease Progression|0
1175763|NCT01124604|3862007|P2|Overall Study|Withdrawal by Subject|0
1175764|NCT01124604|3862008|P1|Overall Study|Withdrawal by Subject|4
1175765|NCT01124604|3862007|P2|Overall Study|Lack of Efficacy|0
1175766|NCT01124604|3862008|P1|Overall Study|Lack of Efficacy|1
1175767|NCT01124604|3862007|P2|Overall Study|Adverse Event|1
1175768|NCT01124604|3862008|P1|Overall Study|Adverse Event|10
1175769|NCT01124448|3862047|P2|Overall Study|Protocol Violation|0
1175770|NCT01124448|3862048|P1|Overall Study|Protocol Violation|2
1175771|NCT01124448|3862047|P2|Overall Study|Lost to Follow-up|3
1175772|NCT01124448|3862048|P1|Overall Study|Lost to Follow-up|0
1175773|NCT01124422|3862056|P3|4-Week Double-blind Treatment Phase|Lost to Follow-up|1
1175774|NCT01124422|3862057|P2|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
1175775|NCT01124422|3862058|P1|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
1175776|NCT01124422|3862056|P3|4-Week Double-blind Treatment Phase|Physician Decision|2
1175777|NCT01124422|3862057|P2|4-Week Double-blind Treatment Phase|Physician Decision|5
1175778|NCT01124422|3862058|P1|4-Week Double-blind Treatment Phase|Physician Decision|0
1175779|NCT01124422|3862056|P3|4-Week Double-blind Treatment Phase|Adverse Event|3
1175780|NCT01124422|3862057|P2|4-Week Double-blind Treatment Phase|Adverse Event|6
1175781|NCT01124422|3862058|P1|4-Week Double-blind Treatment Phase|Adverse Event|0
1175782|NCT01124422|3862056|P3|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3
1175783|NCT01124422|3862057|P2|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
1175784|NCT01124422|3862058|P1|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
1175785|NCT01124422|3862056|P3|4-Week Open-label Run-in Phase|Protocol Violation|0
1175786|NCT01124422|3862057|P2|4-Week Open-label Run-in Phase|Protocol Violation|0
1175787|NCT01124422|3862058|P1|4-Week Open-label Run-in Phase|Protocol Violation|5
1175788|NCT01124422|3862056|P3|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
1175789|NCT01124422|3862057|P2|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
1175790|NCT01124422|3862058|P1|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61
1175791|NCT01124422|3862056|P3|4-Week Open-label Run-in Phase|Lost to Follow-up|0
1175792|NCT01124422|3862057|P2|4-Week Open-label Run-in Phase|Lost to Follow-up|0
1175793|NCT01124422|3862058|P1|4-Week Open-label Run-in Phase|Lost to Follow-up|1
1175794|NCT01124422|3862056|P3|4-Week Open-label Run-in Phase|Physician Decision|0
1175795|NCT01124422|3862057|P2|4-Week Open-label Run-in Phase|Physician Decision|0
1175796|NCT01124422|3862058|P1|4-Week Open-label Run-in Phase|Physician Decision|4
1175797|NCT01124422|3862056|P3|4-Week Open-label Run-in Phase|Adverse Event|0
1175798|NCT01124422|3862057|P2|4-Week Open-label Run-in Phase|Adverse Event|0
1175799|NCT01124422|3862058|P1|4-Week Open-label Run-in Phase|Adverse Event|7
1175800|NCT01124422|3862056|P3|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
1175801|NCT01124422|3862057|P2|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
1175802|NCT01124422|3862058|P1|4-Week Open-label Run-in Phase|Withdrawal by Subject|5
1175803|NCT01124292|3862128|P3|Overall Study|piercing track closed|1
1175804|NCT01124292|3862129|P2|Overall Study|piercing track closed|2
1175805|NCT01124292|3862130|P1|Overall Study|piercing track closed|0
1175806|NCT01124292|3862128|P3|Overall Study|medical issue unrelated to the study|2
1175807|NCT01124292|3862129|P2|Overall Study|medical issue unrelated to the study|0
1175808|NCT01124292|3862130|P1|Overall Study|medical issue unrelated to the study|0
1175809|NCT01124292|3862128|P3|Overall Study|Withdrawal by Subject|2
1175810|NCT01124292|3862129|P2|Overall Study|Withdrawal by Subject|6
1175811|NCT01124292|3862130|P1|Overall Study|Withdrawal by Subject|0
1175812|NCT01124292|3862128|P3|Overall Study|Physician Decision|2
1175813|NCT01124292|3862129|P2|Overall Study|Physician Decision|3
1175814|NCT01124292|3862130|P1|Overall Study|Physician Decision|0
1175815|NCT01124292|3862128|P3|Overall Study|Lost to Follow-up|3
1175816|NCT01124292|3862129|P2|Overall Study|Lost to Follow-up|4
1175817|NCT01124292|3862130|P1|Overall Study|Lost to Follow-up|2
1175818|NCT01124175|3862201|P2|Washout of 7 Days|Withdrawal by Subject|2
1175819|NCT01124175|3862202|P1|Washout of 7 Days|Withdrawal by Subject|0
1175820|NCT01124162|3862220|P2|Washout of 7 Days|Withdrawal by Subject|0
1175821|NCT01124162|3862221|P1|Washout of 7 Days|Withdrawal by Subject|1
1175822|NCT01124162|3862220|P2|First Intervention|Adverse Event|0
1175823|NCT01124162|3862221|P1|First Intervention|Adverse Event|2
1175824|NCT01124149|3862237|P1|Maintenance Phase|Non-compliance|1
1175825|NCT01124149|3862237|P1|Maintenance Phase|Coordinator error|1
1175826|NCT01124149|3862237|P1|Maintenance Phase|Protocol Violation|5
1175827|NCT01124149|3862237|P1|Maintenance Phase|Withdrawal by Subject|10
1175828|NCT01124149|3862237|P1|Maintenance Phase|Lost to Follow-up|15
1175829|NCT01124149|3862237|P1|Maintenance Phase|Adverse Event|24
1175830|NCT01124149|3862237|P1|Maintenance Phase|Lack of Efficacy|40
1175831|NCT01124149|3862237|P1|Acute Phase|Sponsor decision|1
1175832|NCT01124149|3862237|P1|Acute Phase|Travelling to another country|1
1175833|NCT01124149|3862237|P1|Acute Phase|Low hemoglobin|1
1175834|NCT01124149|3862237|P1|Acute Phase|Non-compliance|1
1175835|NCT01124149|3862237|P1|Acute Phase|UC symptoms not ameliorated|1
1175836|NCT01124149|3862237|P1|Acute Phase|Sponsor request|1
1175837|NCT01124149|3862237|P1|Acute Phase|Prolonged antibiotic therapy|1
1175838|NCT01124149|3862237|P1|Acute Phase|Lost to Follow-up|2
1175839|NCT01124149|3862237|P1|Acute Phase|Protocol Violation|14
1175840|NCT01124149|3862237|P1|Acute Phase|Lack of Efficacy|17
1175841|NCT01124149|3862237|P1|Acute Phase|Adverse Event|21
1175842|NCT01124149|3862237|P1|Acute Phase|Withdrawal by Subject|22
1175843|NCT01124097|3862257|P4|Overall Study|Physician Decision|0
1175844|NCT01124097|3862258|P3|Overall Study|Physician Decision|0
1175845|NCT01124097|3862259|P2|Overall Study|Physician Decision|1
1175846|NCT01124097|3862260|P1|Overall Study|Physician Decision|2
1175847|NCT01124097|3862257|P4|Overall Study|Protocol Violation|1
1175848|NCT01124097|3862258|P3|Overall Study|Protocol Violation|2
1175849|NCT01124097|3862259|P2|Overall Study|Protocol Violation|0
1175850|NCT01124097|3862260|P1|Overall Study|Protocol Violation|2
1175851|NCT01124097|3862257|P4|Overall Study|Adverse Event|7
1175852|NCT01124097|3862258|P3|Overall Study|Adverse Event|15
1175853|NCT01124097|3862259|P2|Overall Study|Adverse Event|15
1175854|NCT01124097|3862260|P1|Overall Study|Adverse Event|24
1175855|NCT01124097|3862257|P4|Overall Study|Lack of Efficacy|3
1175856|NCT01124097|3862258|P3|Overall Study|Lack of Efficacy|1
1175857|NCT01124097|3862259|P2|Overall Study|Lack of Efficacy|3
1175858|NCT01124097|3862260|P1|Overall Study|Lack of Efficacy|2
1175859|NCT01124097|3862257|P4|Overall Study|Withdrawal by Subject|3
1175860|NCT01124097|3862258|P3|Overall Study|Withdrawal by Subject|2
1175861|NCT01124097|3862259|P2|Overall Study|Withdrawal by Subject|3
1175862|NCT01124097|3862260|P1|Overall Study|Withdrawal by Subject|4
1175863|NCT01124045|3862272|P2|Overall Study|Physician Decision|2
1175864|NCT01124045|3862273|P1|Overall Study|Physician Decision|0
1175865|NCT01124045|3862272|P2|Overall Study|Lost to Follow-up|1
1175866|NCT01124045|3862273|P1|Overall Study|Lost to Follow-up|0
1175867|NCT01124006|3862306|P3|Overall Study|Other|1
1175868|NCT01124006|3862307|P2|Overall Study|Other|0
1175869|NCT01124006|3862308|P1|Overall Study|Other|0
1175870|NCT01124006|3862306|P3|Overall Study|Lost to Follow-up|1
1175871|NCT01124006|3862307|P2|Overall Study|Lost to Follow-up|0
1175872|NCT01124006|3862308|P1|Overall Study|Lost to Follow-up|1
1175873|NCT01124006|3862306|P3|Overall Study|Withdrawal by Subject|0
1175874|NCT01124006|3862307|P2|Overall Study|Withdrawal by Subject|2
1175875|NCT01124006|3862308|P1|Overall Study|Withdrawal by Subject|2
1175876|NCT01123980|3862336|P2|Overall Study|Unclassified|7
1175877|NCT01123980|3862337|P1|Overall Study|Unclassified|6
1175878|NCT01123980|3862336|P2|Overall Study|Withdrawal by Subject|3
1175879|NCT01123980|3862337|P1|Overall Study|Withdrawal by Subject|5
1175880|NCT01123980|3862336|P2|Overall Study|Protocol Violation|6
1175881|NCT01123980|3862337|P1|Overall Study|Protocol Violation|6
1175882|NCT01123980|3862336|P2|Overall Study|Lost to Follow-up|6
1175883|NCT01123980|3862337|P1|Overall Study|Lost to Follow-up|0
1175884|NCT01123980|3862336|P2|Overall Study|Physician Decision|1
1175885|NCT01123980|3862337|P1|Overall Study|Physician Decision|0
1175886|NCT01123980|3862336|P2|Overall Study|Lack of Efficacy|0
1175887|NCT01123980|3862337|P1|Overall Study|Lack of Efficacy|1
1175888|NCT01123980|3862336|P2|Overall Study|Adverse Event|1
1175889|NCT01123980|3862337|P1|Overall Study|Adverse Event|1
1175890|NCT01123941|3862357|P2|Overall Study|Lost to Follow-up|1
1175891|NCT01123941|3862358|P1|Overall Study|Lost to Follow-up|2
1175892|NCT01123889|3862393|P2|Overall Study|Lost to Follow-up|1
1175893|NCT01123889|3862394|P1|Overall Study|Lost to Follow-up|3
1175894|NCT01123850|3862404|P1|Overall Study|Slow enrollment|45
1175895|NCT01123642|3862409|P1|Overall Study|ineligible at baseline assessment|36
1175896|NCT01123642|3862409|P1|Overall Study|Withdrawal by Subject|9
1175897|NCT01123642|3862409|P1|Overall Study|Lost to Follow-up|23
1175898|NCT01123395|3862425|P2|Washout Period of 14 Days|Withdrawal by Subject|1
1175899|NCT01123395|3862426|P1|Washout Period of 14 Days|Withdrawal by Subject|0
1175900|NCT01123382|3862438|P2|Overall Study|Lost to Follow-up|2
1175901|NCT01123382|3862439|P1|Overall Study|Lost to Follow-up|1
1175902|NCT01123382|3862438|P2|Overall Study|Withdrawal by Subject|4
1175903|NCT01123382|3862439|P1|Overall Study|Withdrawal by Subject|1
1175904|NCT01123356|3862461|P1|Overall Study|Withdrawal by Subject|1
1175905|NCT01123356|3862461|P1|Overall Study|Lack of Efficacy|4
1175906|NCT01123356|3862461|P1|Overall Study|Adverse Event|2
1175907|NCT01123200|3862469|P1|Overall Study|Withdrawal by Subject|1
1175908|NCT01123161|3862476|P2|Overall Study|Withdrawal by Subject|0
1175909|NCT01123161|3862477|P1|Overall Study|Withdrawal by Subject|1
1175910|NCT01123161|3862476|P2|Overall Study|Lost to Follow-up|0
1175911|NCT01123161|3862477|P1|Overall Study|Lost to Follow-up|1
1175912|NCT01123148|3862495|P1|Overall Study|Didn't meet milestone criteria|1
1175913|NCT01123148|3862495|P1|Overall Study|Coughing caused unacceptable EEG quality|1
1175914|NCT01123083|3862501|P2|Overall Study|Participant/legal representative request|3
1175915|NCT01123083|3862502|P1|Overall Study|Participant/legal representative request|7
1175916|NCT01123083|3862501|P2|Overall Study|Withdrew for another reason not covered|1
1175917|NCT01123083|3862502|P1|Overall Study|Withdrew for another reason not covered|0
1175918|NCT01123083|3862501|P2|Overall Study|Adverse Event|0
1175919|NCT01123083|3862502|P1|Overall Study|Adverse Event|1
1175920|NCT01123083|3862501|P2|Overall Study|Lost to Follow-up|6
1175921|NCT01123083|3862502|P1|Overall Study|Lost to Follow-up|2
1175922|NCT01123083|3862501|P2|Overall Study|Administrative reasons|4
1175923|NCT01123083|3862502|P1|Overall Study|Administrative reasons|0
1175924|NCT01123083|3862501|P2|Overall Study|Investigator recommendation|1
1175925|NCT01123083|3862502|P1|Overall Study|Investigator recommendation|1
1175926|NCT01122927|3862526|P2|Period 2- Open-label Treatment Phase|Lack of Efficacy|7
1175927|NCT01122927|3862527|P1|Period 2- Open-label Treatment Phase|Lack of Efficacy|0
1175928|NCT01122927|3862526|P2|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65
1175929|NCT01122927|3862527|P1|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0
1175930|NCT01122927|3862526|P2|Period 2- Open-label Treatment Phase|Physician Decision|12
1175931|NCT01122927|3862527|P1|Period 2- Open-label Treatment Phase|Physician Decision|0
1175932|NCT01122927|3862526|P2|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9
1175933|NCT01122927|3862527|P1|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0
1175934|NCT01122927|3862526|P2|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165
1175935|NCT01122927|3862527|P1|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0
1175936|NCT01122927|3862526|P2|Period 2- Open-label Treatment Phase|Adverse Event|33
1175937|NCT01122927|3862527|P1|Period 2- Open-label Treatment Phase|Adverse Event|0
1175938|NCT01122927|3862526|P2|Period 2- Open-label Treatment Phase|Lost to Follow-up|21
1175939|NCT01122927|3862527|P1|Period 2- Open-label Treatment Phase|Lost to Follow-up|0
1175940|NCT01122927|3862526|P2|Period 1 - Conversion Phase|Protocol Deviation|0
1175941|NCT01122927|3862527|P1|Period 1 - Conversion Phase|Protocol Deviation|1
1175942|NCT01122927|3862526|P2|Period 1 - Conversion Phase|Withdrawal by Subject|0
1175943|NCT01122927|3862527|P1|Period 1 - Conversion Phase|Withdrawal by Subject|7
1175944|NCT01122927|3862526|P2|Period 1 - Conversion Phase|Physician Decision|0
1175945|NCT01122927|3862527|P1|Period 1 - Conversion Phase|Physician Decision|2
1175946|NCT01122927|3862526|P2|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
1175947|NCT01122927|3862527|P1|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
1175948|NCT01122927|3862526|P2|Period 1 - Conversion Phase|Adverse Event|0
1175949|NCT01122927|3862527|P1|Period 1 - Conversion Phase|Adverse Event|3
1175950|NCT01122862|3862579|P3|Period 2|Adverse Event|1
1175951|NCT01122862|3862580|P2|Period 2|Adverse Event|0
1175952|NCT01122862|3862581|P1|Period 2|Adverse Event|0
1175953|NCT01122862|3862579|P3|Period 1|Protocol Violation|0
1175954|NCT01122862|3862580|P2|Period 1|Protocol Violation|1
1175955|NCT01122862|3862581|P1|Period 1|Protocol Violation|0
1175956|NCT01122680|3862687|P4|Period 3 (4 Weeks)|Withdrawal by Subject|0
1175957|NCT01122680|3862688|P3|Period 3 (4 Weeks)|Withdrawal by Subject|0
1175958|NCT01122680|3862689|P2|Period 3 (4 Weeks)|Withdrawal by Subject|1
1175959|NCT01122680|3862690|P1|Period 3 (4 Weeks)|Withdrawal by Subject|0
1175960|NCT01122680|3862687|P4|Period 3 (4 Weeks)|Adverse Event|0
1175961|NCT01122680|3862688|P3|Period 3 (4 Weeks)|Adverse Event|0
1175962|NCT01122680|3862689|P2|Period 3 (4 Weeks)|Adverse Event|0
1175963|NCT01122680|3862690|P1|Period 3 (4 Weeks)|Adverse Event|1
1175964|NCT01122680|3862687|P4|Period 2 (4 Weeks)|Other|0
1175965|NCT01122680|3862688|P3|Period 2 (4 Weeks)|Other|0
1175966|NCT01122680|3862689|P2|Period 2 (4 Weeks)|Other|0
1175967|NCT01122680|3862690|P1|Period 2 (4 Weeks)|Other|1
1175968|NCT01122680|3862687|P4|Period 2 (4 Weeks)|Protocol Violation|1
1175969|NCT01122680|3862688|P3|Period 2 (4 Weeks)|Protocol Violation|0
1175970|NCT01122680|3862689|P2|Period 2 (4 Weeks)|Protocol Violation|0
1175971|NCT01122680|3862690|P1|Period 2 (4 Weeks)|Protocol Violation|0
1175972|NCT01122680|3862687|P4|Period 1 (4 Weeks)|Other|0
1175973|NCT01122680|3862688|P3|Period 1 (4 Weeks)|Other|0
1175974|NCT01122680|3862689|P2|Period 1 (4 Weeks)|Other|1
1175975|NCT01122680|3862690|P1|Period 1 (4 Weeks)|Other|1
1175976|NCT01122680|3862687|P4|Period 1 (4 Weeks)|Protocol Violation|0
1175977|NCT01122680|3862688|P3|Period 1 (4 Weeks)|Protocol Violation|0
1175978|NCT01122680|3862689|P2|Period 1 (4 Weeks)|Protocol Violation|0
1175979|NCT01122680|3862690|P1|Period 1 (4 Weeks)|Protocol Violation|1
1175980|NCT01122680|3862687|P4|Period 1 (4 Weeks)|Adverse Event|0
1175981|NCT01122680|3862688|P3|Period 1 (4 Weeks)|Adverse Event|0
1175982|NCT01122680|3862689|P2|Period 1 (4 Weeks)|Adverse Event|0
1175983|NCT01122680|3862690|P1|Period 1 (4 Weeks)|Adverse Event|1
1175984|NCT01122576|3862755|P3|Post-Cataract Surgery|Fellow Eye Explanted|1
1175985|NCT01122576|3862756|P2|Post-Cataract Surgery|Fellow Eye Explanted|0
1175986|NCT01122576|3862757|P1|Post-Cataract Surgery|Fellow Eye Explanted|0
1175987|NCT01122576|3862755|P3|Post-Cataract Surgery|Central Macular Edema|1
1175988|NCT01122576|3862756|P2|Post-Cataract Surgery|Central Macular Edema|0
1175989|NCT01122576|3862757|P1|Post-Cataract Surgery|Central Macular Edema|0
1175990|NCT01122576|3862755|P3|Pre-Cataract Surgery|Withdrawal by Subject|2
1175991|NCT01122576|3862756|P2|Pre-Cataract Surgery|Withdrawal by Subject|1
1175992|NCT01122576|3862757|P1|Pre-Cataract Surgery|Withdrawal by Subject|0
1175993|NCT01122394|3862911|P2|Overall Study|Adverse Event|1
1175994|NCT01122394|3862912|P1|Overall Study|Adverse Event|0
1175995|NCT01122394|3862911|P2|Overall Study|Lost to Follow-up|2
1175996|NCT01122394|3862912|P1|Overall Study|Lost to Follow-up|2
1175997|NCT01122394|3862911|P2|Overall Study|Withdrawal by Subject|1
1175998|NCT01122394|3862912|P1|Overall Study|Withdrawal by Subject|1
1175999|NCT01122381|3862928|P2|Overall Study|study terminated early|1
1176000|NCT01122381|3862929|P1|Overall Study|study terminated early|0
1176001|NCT01122264|3862938|P3|Overall Study|Lack of Efficacy|1
1176002|NCT01122264|3862939|P2|Overall Study|Lack of Efficacy|1
1176003|NCT01122264|3862940|P1|Overall Study|Lack of Efficacy|3
1176004|NCT01122264|3862938|P3|Overall Study|Physician Decision|1
1176005|NCT01122264|3862939|P2|Overall Study|Physician Decision|1
1176006|NCT01122264|3862940|P1|Overall Study|Physician Decision|3
1176007|NCT01122264|3862938|P3|Overall Study|Withdrawal by Subject|16
1176008|NCT01122264|3862939|P2|Overall Study|Withdrawal by Subject|6
1176009|NCT01122264|3862940|P1|Overall Study|Withdrawal by Subject|6
1176010|NCT01122264|3862938|P3|Overall Study|Protocol Violation|9
1176011|NCT01122264|3862939|P2|Overall Study|Protocol Violation|7
1176012|NCT01122264|3862940|P1|Overall Study|Protocol Violation|7
1176013|NCT01122264|3862938|P3|Overall Study|Entry Criteria Not Met|0
1176014|NCT01122264|3862939|P2|Overall Study|Entry Criteria Not Met|0
1176015|NCT01122264|3862940|P1|Overall Study|Entry Criteria Not Met|1
1176016|NCT01122264|3862938|P3|Overall Study|Lost to Follow-up|13
1176017|NCT01122264|3862939|P2|Overall Study|Lost to Follow-up|9
1176018|NCT01122264|3862940|P1|Overall Study|Lost to Follow-up|5
1176019|NCT01122264|3862938|P3|Overall Study|Death|0
1176020|NCT01122264|3862939|P2|Overall Study|Death|0
1176021|NCT01122264|3862940|P1|Overall Study|Death|1
1176022|NCT01122264|3862938|P3|Overall Study|Adverse Event|7
1176023|NCT01122264|3862939|P2|Overall Study|Adverse Event|5
1176024|NCT01122264|3862940|P1|Overall Study|Adverse Event|6
1176025|NCT01122173|3863050|P1|Overall Study|Left study for other reasons|3
1176026|NCT01122173|3863050|P1|Overall Study|Withdrawal by Subject|3
1176027|NCT01122173|3863050|P1|Overall Study|Lost to Follow-up|3
1176028|NCT01121991|3863273|P1|Overall Study|No Fertilization|1
1176029|NCT01121991|3863273|P1|Overall Study|No Oocytes Retrieved|3
1176030|NCT01121991|3863273|P1|Overall Study|Lack of Ovarian Response|2
1176031|NCT01121926|3863298|P2|Washout Period|Positive pregnancy test|1
1176032|NCT01121926|3863299|P1|Washout Period|Positive pregnancy test|0
1176033|NCT01121926|3863298|P2|Washout Period|Adverse Event|1
1176034|NCT01121926|3863299|P1|Washout Period|Adverse Event|0
1176035|NCT01121926|3863298|P2|First Intervention Period|Adverse Event|0
1176036|NCT01121926|3863299|P1|First Intervention Period|Adverse Event|1
1176037|NCT01121913|3863317|P4|Third Washout Period|Adverse Event|0
1176038|NCT01121913|3863318|P3|Third Washout Period|Adverse Event|0
1176039|NCT01121913|3863319|P2|Third Washout Period|Adverse Event|0
1176040|NCT01121913|3863320|P1|Third Washout Period|Adverse Event|1
1176041|NCT01121913|3863317|P4|Second Washout Period|Withdrawal by Subject|0
1176042|NCT01121913|3863318|P3|Second Washout Period|Withdrawal by Subject|1
1176043|NCT01121913|3863319|P2|Second Washout Period|Withdrawal by Subject|0
1176044|NCT01121913|3863320|P1|Second Washout Period|Withdrawal by Subject|0
1176045|NCT01121913|3863317|P4|Second Intervention Period|Adverse Event|0
1176046|NCT01121913|3863318|P3|Second Intervention Period|Adverse Event|1
1176047|NCT01121913|3863319|P2|Second Intervention Period|Adverse Event|0
1176048|NCT01121913|3863320|P1|Second Intervention Period|Adverse Event|0
1176049|NCT01121913|3863317|P4|First Washout Period|Withdrawal by Subject|0
1176050|NCT01121913|3863318|P3|First Washout Period|Withdrawal by Subject|0
1176051|NCT01121913|3863319|P2|First Washout Period|Withdrawal by Subject|0
1176052|NCT01121913|3863320|P1|First Washout Period|Withdrawal by Subject|1
1176053|NCT01121913|3863317|P4|First Intervention Period|Adverse Event|0
1176054|NCT01121913|3863318|P3|First Intervention Period|Adverse Event|1
1176055|NCT01121913|3863319|P2|First Intervention Period|Adverse Event|0
1176056|NCT01121913|3863320|P1|First Intervention Period|Adverse Event|0
1176057|NCT01121900|3863350|P2|Washout Period of 7 Days|Withdrawal by Subject|1
1176058|NCT01121900|3863351|P1|Washout Period of 7 Days|Withdrawal by Subject|0
1176059|NCT01121900|3863350|P2|First Intervention Period|Adverse Event|1
1176060|NCT01121900|3863351|P1|First Intervention Period|Adverse Event|1
1176061|NCT01121757|3863371|P2|Combination|Disease Progression|0
1176062|NCT01121757|3863372|P1|Combination|Disease Progression|2
1176063|NCT01121757|3863371|P2|Combination|Physician Decision|1
1176064|NCT01121757|3863372|P1|Combination|Physician Decision|0
1176065|NCT01121757|3863371|P2|First Drug|Disease Progression|2
1176066|NCT01121757|3863372|P1|First Drug|Disease Progression|0
1176067|NCT01121757|3863371|P2|First Drug|Death|0
1176068|NCT01121757|3863372|P1|First Drug|Death|1
1176069|NCT01121666|3863388|P2|Overall Study|Protocol Violation|10
1176070|NCT01121666|3863389|P1|Overall Study|Protocol Violation|29
1176071|NCT01121575|3863445|P6|Overall Study|Death|1
1176072|NCT01121575|3863446|P5|Overall Study|Death|7
1176073|NCT01121575|3863447|P4|Overall Study|Death|1
1176074|NCT01121575|3863448|P3|Overall Study|Death|0
1176075|NCT01121575|3863449|P2|Overall Study|Death|0
1176076|NCT01121575|3863450|P1|Overall Study|Death|6
1176077|NCT01121575|3863445|P6|Overall Study|Unspecified Reasons|10
1176078|NCT01121575|3863446|P5|Overall Study|Unspecified Reasons|13
1176079|NCT01121575|3863447|P4|Overall Study|Unspecified Reasons|5
1176080|NCT01121575|3863448|P3|Overall Study|Unspecified Reasons|7
1176081|NCT01121575|3863449|P2|Overall Study|Unspecified Reasons|6
1176082|NCT01121575|3863450|P1|Overall Study|Unspecified Reasons|8
1176083|NCT01121575|3863445|P6|Overall Study|Participant Refused Further Follow-Up|1
1176084|NCT01121575|3863446|P5|Overall Study|Participant Refused Further Follow-Up|5
1176085|NCT01121575|3863447|P4|Overall Study|Participant Refused Further Follow-Up|0
1176086|NCT01121575|3863448|P3|Overall Study|Participant Refused Further Follow-Up|0
1176087|NCT01121575|3863449|P2|Overall Study|Participant Refused Further Follow-Up|0
1176088|NCT01121575|3863450|P1|Overall Study|Participant Refused Further Follow-Up|0
1176089|NCT01121562|3863574|P1|Overall Study|Met study discontinuation criteria|1
1176090|NCT01121562|3863574|P1|Overall Study|Sponsor Decision|1
1176091|NCT01121562|3863574|P1|Overall Study|Adverse Event|1
1176092|NCT01121562|3863574|P1|Overall Study|Withdrawal by Subject|1
1176093|NCT01121562|3863574|P1|Overall Study|Objective progression or relapse|8
1176094|NCT01121549|3863583|P1|Overall Study|Other|58
1176095|NCT01121549|3863583|P1|Overall Study|Withdrawal by Subject|16
1176096|NCT01121549|3863583|P1|Overall Study|Protocol Violation|33
1176097|NCT01121549|3863583|P1|Overall Study|Pregnancy|1
1176098|NCT01121549|3863583|P1|Overall Study|Study terminated by sponsor|197
1176099|NCT01121549|3863583|P1|Overall Study|Did not meet entrance criteria|9
1176100|NCT01121549|3863583|P1|Overall Study|Lost to Follow-up|12
1176101|NCT01121549|3863583|P1|Overall Study|Lack of Efficacy|11
1176102|NCT01121549|3863583|P1|Overall Study|Adverse Event|10
1176103|NCT01121536|3863594|P1|Overall Study|Not specified|118
1176104|NCT01121536|3863594|P1|Overall Study|Lost to Follow-up|39
1176105|NCT01121536|3863594|P1|Overall Study|Noncompliance with study procedures|9
1176106|NCT01121536|3863594|P1|Overall Study|Noncompliance with study medication|12
1176107|NCT01121536|3863594|P1|Overall Study|Protocol Violation|20
1176108|NCT01121536|3863594|P1|Overall Study|Withdrawal by Subject|65
1176109|NCT01121536|3863594|P1|Overall Study|Lack of Efficacy|35
1176110|NCT01121536|3863594|P1|Overall Study|Adverse Event|63
1176111|NCT01121484|3863615|P2|Overall Study|Randomized, not treated|4
1176112|NCT01121484|3863616|P1|Overall Study|Randomized, not treated|1
1176113|NCT01121484|3863615|P2|Overall Study|Other|3
1176114|NCT01121484|3863616|P1|Overall Study|Other|3
1176115|NCT01121484|3863615|P2|Overall Study|Discontinuation of study by sponsor|1
1176116|NCT01121484|3863616|P1|Overall Study|Discontinuation of study by sponsor|0
1176117|NCT01121484|3863615|P2|Overall Study|Withdrawal by Subject|7
1176118|NCT01121484|3863616|P1|Overall Study|Withdrawal by Subject|8
1176119|NCT01121484|3863615|P2|Overall Study|Protocol Violation|0
1176120|NCT01121484|3863616|P1|Overall Study|Protocol Violation|1
1176121|NCT01121484|3863615|P2|Overall Study|Physician Decision|3
1176122|NCT01121484|3863616|P1|Overall Study|Physician Decision|0
1176123|NCT01121484|3863615|P2|Overall Study|Lost to Follow-up|9
1176124|NCT01121484|3863616|P1|Overall Study|Lost to Follow-up|5
1176125|NCT01121484|3863615|P2|Overall Study|Lack of Efficacy|11
1176126|NCT01121484|3863616|P1|Overall Study|Lack of Efficacy|3
1176127|NCT01121484|3863615|P2|Overall Study|Adverse Event|5
1176128|NCT01121484|3863616|P1|Overall Study|Adverse Event|12
1176129|NCT01121406|3863634|P2|Overall Study|Not treated|0
1176130|NCT01121406|3863635|P1|Overall Study|Not treated|1
1176131|NCT01121406|3863634|P2|Overall Study|Reason other than specified above|6
1176132|NCT01121406|3863635|P1|Overall Study|Reason other than specified above|2
1176133|NCT01121406|3863634|P2|Overall Study|Refused continuation of study med.|2
1176134|NCT01121406|3863635|P1|Overall Study|Refused continuation of study med.|1
1176135|NCT01121406|3863634|P2|Overall Study|Lost to Follow-up|1
1176136|NCT01121406|3863635|P1|Overall Study|Lost to Follow-up|0
1176137|NCT01121406|3863634|P2|Overall Study|Non−compliant with protocol|2
1176138|NCT01121406|3863635|P1|Overall Study|Non−compliant with protocol|0
1176139|NCT01121406|3863634|P2|Overall Study|Other AE|10
1176140|NCT01121406|3863635|P1|Overall Study|Other AE|3
1176141|NCT01121406|3863634|P2|Overall Study|Wors. or AE of underlying cancer disease|6
1176142|NCT01121406|3863635|P1|Overall Study|Wors. or AE of underlying cancer disease|4
1176143|NCT01121406|3863634|P2|Overall Study|Progressive disease RECIST|28
1176144|NCT01121406|3863635|P1|Overall Study|Progressive disease RECIST|44
1176145|NCT01121393|3863685|P2|Overall Study|Other than listed|0
1176146|NCT01121393|3863686|P1|Overall Study|Other than listed|6
1176147|NCT01121393|3863685|P2|Overall Study|Not treated|9
1176148|NCT01121393|3863686|P1|Overall Study|Not treated|3
1176149|NCT01121393|3863685|P2|Overall Study|Refused cont. medication|7
1176150|NCT01121393|3863686|P1|Overall Study|Refused cont. medication|7
1176151|NCT01121393|3863685|P2|Overall Study|Lost to Follow-up|0
1176152|NCT01121393|3863686|P1|Overall Study|Lost to Follow-up|1
1176153|NCT01121393|3863685|P2|Overall Study|Non-compliant with protocol|3
1176154|NCT01121393|3863686|P1|Overall Study|Non-compliant with protocol|0
1176155|NCT01121393|3863685|P2|Overall Study|Other Adverse events|45
1176156|NCT01121393|3863686|P1|Overall Study|Other Adverse events|24
1176157|NCT01121393|3863685|P2|Overall Study|Progressive disease|20
1176158|NCT01121393|3863686|P1|Overall Study|Progressive disease|201
1176159|NCT01121263|3863731|P2|Overall Study|Withdrawal by Subject|1
1176160|NCT01121263|3863732|P1|Overall Study|Withdrawal by Subject|0
1176161|NCT01121263|3863731|P2|Overall Study|Lost to Follow-up|12
1176162|NCT01121263|3863732|P1|Overall Study|Lost to Follow-up|22
1176163|NCT01121263|3863731|P2|Overall Study|Death|2
1176164|NCT01121263|3863732|P1|Overall Study|Death|3
1176165|NCT01121185|3863797|P2|Overall Study|Not transplanted|0
1176166|NCT01121185|3863798|P1|Overall Study|Not transplanted|1
1176167|NCT01121185|3863797|P2|Overall Study|Not infused|1
1176168|NCT01121185|3863798|P1|Overall Study|Not infused|0
1176169|NCT01121146|3863832|P2|Overall Study|Lost to Follow-up|16
1176170|NCT01121146|3863833|P1|Overall Study|Lost to Follow-up|7
1176171|NCT01121146|3863832|P2|Overall Study|Adverse Event|11
1176172|NCT01121146|3863833|P1|Overall Study|Adverse Event|2
1176173|NCT01121146|3863832|P2|Overall Study|Death|15
1176174|NCT01121146|3863833|P1|Overall Study|Death|17
1176175|NCT01120899|3863854|P1|Overall Study|Withdrawal by Subject|3
1176176|NCT01120782|3863882|P1|Overall Study|Test article shipping error|11
1176177|NCT01120717|3863888|P2|Overall Study|Abnormal Test Procedure Result(s)|0
1176178|NCT01120717|3863889|P1|Overall Study|Abnormal Test Procedure Result(s)|1
1176179|NCT01120717|3863888|P2|Overall Study|Death|1
1176180|NCT01120717|3863889|P1|Overall Study|Death|3
1176181|NCT01120717|3863888|P2|Overall Study|Lost to Follow-up|3
1176182|NCT01120717|3863889|P1|Overall Study|Lost to Follow-up|2
1176183|NCT01120717|3863888|P2|Overall Study|Unsatisfactory Therapeutic Effect|3
1176184|NCT01120717|3863889|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
1176185|NCT01120717|3863888|P2|Overall Study|Protocol Deviation|5
1176186|NCT01120717|3863889|P1|Overall Study|Protocol Deviation|2
1176187|NCT01120717|3863888|P2|Overall Study|Adverse Event|6
1176188|NCT01120717|3863889|P1|Overall Study|Adverse Event|10
1176189|NCT01120717|3863888|P2|Overall Study|Withdrawal by Subject|6
1176190|NCT01120717|3863889|P1|Overall Study|Withdrawal by Subject|11
1176191|NCT01120691|3863995|P3|Overall Study|Abnormal laboratory value(s)|4
1176192|NCT01120691|3863996|P2|Overall Study|Abnormal laboratory value(s)|3
1176193|NCT01120691|3863997|P1|Overall Study|Abnormal laboratory value(s)|1
1176194|NCT01120691|3863995|P3|Overall Study|Patient's inability to use the device|0
1176195|NCT01120691|3863996|P2|Overall Study|Patient's inability to use the device|1
1176196|NCT01120691|3863997|P1|Overall Study|Patient's inability to use the device|3
1176197|NCT01120691|3863995|P3|Overall Study|Abnormal test procedure result(s)|1
1176198|NCT01120691|3863996|P2|Overall Study|Abnormal test procedure result(s)|2
1176199|NCT01120691|3863997|P1|Overall Study|Abnormal test procedure result(s)|3
1176200|NCT01120691|3863995|P3|Overall Study|Lost to Follow-up|4
1176201|NCT01120691|3863996|P2|Overall Study|Lost to Follow-up|6
1176202|NCT01120691|3863997|P1|Overall Study|Lost to Follow-up|5
1176203|NCT01120691|3863995|P3|Overall Study|Protocol deviation|12
1176204|NCT01120691|3863996|P2|Overall Study|Protocol deviation|12
1176205|NCT01120691|3863997|P1|Overall Study|Protocol deviation|13
1176206|NCT01120691|3863995|P3|Overall Study|Administrative problems|9
1176207|NCT01120691|3863996|P2|Overall Study|Administrative problems|8
1176208|NCT01120691|3863997|P1|Overall Study|Administrative problems|15
1176209|NCT01120691|3863995|P3|Overall Study|Unsatisfactory therapeutic effect|38
1176210|NCT01120691|3863996|P2|Overall Study|Unsatisfactory therapeutic effect|32
1176211|NCT01120691|3863997|P1|Overall Study|Unsatisfactory therapeutic effect|18
1176212|NCT01120691|3863995|P3|Overall Study|Death|24
1176213|NCT01120691|3863996|P2|Overall Study|Death|22
1176214|NCT01120691|3863997|P1|Overall Study|Death|21
1176215|NCT01120691|3863995|P3|Overall Study|Subject withdrew consent|44
1176216|NCT01120691|3863996|P2|Overall Study|Subject withdrew consent|50
1176217|NCT01120691|3863997|P1|Overall Study|Subject withdrew consent|33
1176218|NCT01120691|3863995|P3|Overall Study|Adverse Event|47
1176219|NCT01120691|3863996|P2|Overall Study|Adverse Event|67
1176220|NCT01120691|3863997|P1|Overall Study|Adverse Event|59
1176221|NCT01120626|3864041|P2|Overall Study|Withdrawal by Subject|0
1176222|NCT01120626|3864042|P1|Overall Study|Withdrawal by Subject|1
1176223|NCT01120600|3864052|P2|Overall Study|Withdrawal by Subject|11
1176224|NCT01120600|3864053|P1|Overall Study|Withdrawal by Subject|10
1176225|NCT01120600|3864052|P2|Overall Study|Protocol Violation|4
1176226|NCT01120600|3864053|P1|Overall Study|Protocol Violation|0
1176227|NCT01120600|3864052|P2|Overall Study|Physician Decision|3
1176228|NCT01120600|3864053|P1|Overall Study|Physician Decision|1
1176229|NCT01120600|3864052|P2|Overall Study|Lost to Follow-up|3
1176230|NCT01120600|3864053|P1|Overall Study|Lost to Follow-up|1
1176231|NCT01120600|3864052|P2|Overall Study|Excessive Bone Loss|4
1176232|NCT01120600|3864053|P1|Overall Study|Excessive Bone Loss|0
1176233|NCT01120600|3864052|P2|Overall Study|Adverse Event|7
1176234|NCT01120600|3864053|P1|Overall Study|Adverse Event|7
1176235|NCT01120379|3864108|P1|Four Year Timepoint|Any other reason for early termination|217
1176236|NCT01120379|3864108|P1|Four Year Timepoint|Physician Decision|5
1176237|NCT01120379|3864108|P1|Four Year Timepoint|Death|131
1176238|NCT01120379|3864108|P1|Four Year Timepoint|Lost to Follow-up|10
1176239|NCT01120379|3864108|P1|Four Year Timepoint|Withdrawal by Subject|5
1176240|NCT01120379|3864108|P1|Three Year Timepoint|Any other reason for early termination|17
1176241|NCT01120379|3864108|P1|Three Year Timepoint|Physician Decision|9
1176242|NCT01120379|3864108|P1|Three Year Timepoint|Death|120
1176243|NCT01120379|3864108|P1|Three Year Timepoint|Lost to Follow-up|43
1176244|NCT01120379|3864108|P1|Three Year Timepoint|Withdrawal by Subject|25
1176245|NCT01120379|3864108|P1|Two Year Timepoint|Any other reason for early termination|4
1176246|NCT01120379|3864108|P1|Two Year Timepoint|Physician Decision|12
1176247|NCT01120379|3864108|P1|Two Year Timepoint|Death|123
1176248|NCT01120379|3864108|P1|Two Year Timepoint|Lost to Follow-up|87
1176249|NCT01120379|3864108|P1|Two Year Timepoint|Withdrawal by Subject|11
1176250|NCT01120379|3864108|P1|One Year Timepoint|Any other reason for early termination|5
1176251|NCT01120379|3864108|P1|One Year Timepoint|Physician Decision|9
1176252|NCT01120379|3864108|P1|One Year Timepoint|Death|108
1176253|NCT01120379|3864108|P1|One Year Timepoint|Lost to Follow-up|115
1176254|NCT01120379|3864108|P1|One Year Timepoint|Withdrawal by Subject|41
1176255|NCT01120275|3864144|P1|Overall Study|Not specific|1
1176256|NCT01120275|3864144|P1|Overall Study|Refusal|1
1176257|NCT01120275|3864144|P1|Overall Study|Withdrawal by Subject|1
1176258|NCT01120275|3864144|P1|Overall Study|Ineligible|3
1176259|NCT01120275|3864144|P1|Overall Study|Progression|27
1176260|NCT01120275|3864144|P1|Overall Study|Adverse Event|3
1176261|NCT01120210|3864211|P2|MAIN INFUSION|Withdrawal by Subject|1
1176262|NCT01120210|3864212|P1|MAIN INFUSION|Withdrawal by Subject|0
1176263|NCT01120210|3864211|P2|MAIN INFUSION|Adverse Event|0
1176264|NCT01120210|3864212|P1|MAIN INFUSION|Adverse Event|1
1176265|NCT01120184|3864262|P3|Overall Study|Death|169
1176266|NCT01120184|3864263|P2|Overall Study|Death|176
1176267|NCT01120184|3864264|P1|Overall Study|Death|170
1176268|NCT01120184|3864262|P3|Overall Study|Subject/ Guardian Decision to Withdraw|25
1176269|NCT01120184|3864263|P2|Overall Study|Subject/ Guardian Decision to Withdraw|29
1176270|NCT01120184|3864264|P1|Overall Study|Subject/ Guardian Decision to Withdraw|32
1176271|NCT01120184|3864262|P3|Overall Study|Sponsor Decision to Terminate Study|143
1176272|NCT01120184|3864263|P2|Overall Study|Sponsor Decision to Terminate Study|144
1176273|NCT01120184|3864264|P1|Overall Study|Sponsor Decision to Terminate Study|133
1176274|NCT01120184|3864262|P3|Overall Study|Reason not Specified|12
1176275|NCT01120184|3864263|P2|Overall Study|Reason not Specified|3
1176276|NCT01120184|3864264|P1|Overall Study|Reason not Specified|8
1176277|NCT01120184|3864262|P3|Overall Study|Physician Decision|3
1176278|NCT01120184|3864263|P2|Overall Study|Physician Decision|1
1176279|NCT01120184|3864264|P1|Overall Study|Physician Decision|9
1176280|NCT01120184|3864262|P3|Overall Study|Lost to Follow-up|11
1176281|NCT01120184|3864263|P2|Overall Study|Lost to Follow-up|13
1176282|NCT01120184|3864264|P1|Overall Study|Lost to Follow-up|13
1176283|NCT01120184|3864262|P3|Overall Study|Adverse Event|0
1176284|NCT01120184|3864263|P2|Overall Study|Adverse Event|1
1176285|NCT01120184|3864264|P1|Overall Study|Adverse Event|0
1176286|NCT01120093|3864386|P5|Treatment Period 5|Adverse Event|0
1176287|NCT01120093|3864387|P4|Treatment Period 5|Adverse Event|1
1176288|NCT01120093|3864388|P3|Treatment Period 5|Adverse Event|0
1176289|NCT01120093|3864389|P2|Treatment Period 5|Adverse Event|1
1176290|NCT01120093|3864390|P1|Treatment Period 5|Adverse Event|0
1176291|NCT01120093|3864386|P5|Treatment Period 4|Adverse Event|0
1176292|NCT01120093|3864387|P4|Treatment Period 4|Adverse Event|0
1176293|NCT01120093|3864388|P3|Treatment Period 4|Adverse Event|0
1176294|NCT01120093|3864389|P2|Treatment Period 4|Adverse Event|0
1176295|NCT01120093|3864390|P1|Treatment Period 4|Adverse Event|1
1176296|NCT01120093|3864386|P5|Treatment Period 3|Withdrawal by Subject|0
1176297|NCT01120093|3864387|P4|Treatment Period 3|Withdrawal by Subject|0
1176298|NCT01120093|3864388|P3|Treatment Period 3|Withdrawal by Subject|1
1176299|NCT01120093|3864389|P2|Treatment Period 3|Withdrawal by Subject|0
1176300|NCT01120093|3864390|P1|Treatment Period 3|Withdrawal by Subject|0
1176301|NCT01120093|3864386|P5|Treatment Period 3|Adverse Event|1
1176302|NCT01120093|3864387|P4|Treatment Period 3|Adverse Event|0
1176303|NCT01120093|3864388|P3|Treatment Period 3|Adverse Event|0
1176304|NCT01120093|3864389|P2|Treatment Period 3|Adverse Event|0
1176305|NCT01120093|3864390|P1|Treatment Period 3|Adverse Event|0
1176306|NCT01120093|3864386|P5|Treatment Period 3|Lack of Efficacy|0
1176307|NCT01120093|3864387|P4|Treatment Period 3|Lack of Efficacy|1
1176308|NCT01120093|3864388|P3|Treatment Period 3|Lack of Efficacy|0
1176309|NCT01120093|3864389|P2|Treatment Period 3|Lack of Efficacy|0
1176310|NCT01120093|3864390|P1|Treatment Period 3|Lack of Efficacy|0
1176311|NCT01120093|3864386|P5|Treatment Period 2|Withdrawal by Subject|1
1176312|NCT01120093|3864387|P4|Treatment Period 2|Withdrawal by Subject|0
1176313|NCT01120093|3864388|P3|Treatment Period 2|Withdrawal by Subject|0
1176314|NCT01120093|3864389|P2|Treatment Period 2|Withdrawal by Subject|0
1176315|NCT01120093|3864390|P1|Treatment Period 2|Withdrawal by Subject|0
1176316|NCT01120093|3864386|P5|Treatment Period 2|Adverse Event|0
1176317|NCT01120093|3864387|P4|Treatment Period 2|Adverse Event|1
1176318|NCT01120093|3864388|P3|Treatment Period 2|Adverse Event|0
1176319|NCT01120093|3864389|P2|Treatment Period 2|Adverse Event|0
1176320|NCT01120093|3864390|P1|Treatment Period 2|Adverse Event|0
1176321|NCT01120093|3864386|P5|Treatment Period 1|Withdrawal by Subject|0
1176322|NCT01120093|3864387|P4|Treatment Period 1|Withdrawal by Subject|0
1176323|NCT01120093|3864388|P3|Treatment Period 1|Withdrawal by Subject|0
1176324|NCT01120093|3864389|P2|Treatment Period 1|Withdrawal by Subject|1
1176325|NCT01120093|3864390|P1|Treatment Period 1|Withdrawal by Subject|0
1176326|NCT01120093|3864386|P5|Treatment Period 1|Adverse Event|1
1176327|NCT01120093|3864387|P4|Treatment Period 1|Adverse Event|0
1176328|NCT01120093|3864388|P3|Treatment Period 1|Adverse Event|1
1176329|NCT01120093|3864389|P2|Treatment Period 1|Adverse Event|0
1176330|NCT01120093|3864390|P1|Treatment Period 1|Adverse Event|0
1176331|NCT01120067|3864419|P2|Overall Study|fail to engage >3 sessions|0
1176332|NCT01120067|3864420|P1|Overall Study|fail to engage >3 sessions|2
1176333|NCT01120067|3864419|P2|Overall Study|Lost to Follow-up|1
1176334|NCT01120067|3864420|P1|Overall Study|Lost to Follow-up|3
1176335|NCT01119963|3864428|P2|Overall Study|Lost to Follow-up|1
1176336|NCT01119963|3864429|P1|Overall Study|Lost to Follow-up|1
1176337|NCT01119950|3864439|P1|Overall Study|Death|1
1176338|NCT01119950|3864439|P1|Overall Study|Abnormal lab value|1
1176339|NCT01119950|3864439|P1|Overall Study|Administrative|2
1176340|NCT01119950|3864439|P1|Overall Study|Lost to Follow-up|4
1176341|NCT01119950|3864439|P1|Overall Study|Protocol Violation|5
1176342|NCT01119950|3864439|P1|Overall Study|Withdrawal by Subject|9
1176343|NCT01119950|3864439|P1|Overall Study|Adverse Event|25
1176344|NCT01119937|3864686|P2|Overall Study|Withdrawal by Subject|1
1176345|NCT01119937|3864687|P1|Overall Study|Withdrawal by Subject|2
1176346|NCT01119937|3864686|P2|Overall Study|Unsatisfactory therapeutic effect|0
1176347|NCT01119937|3864687|P1|Overall Study|Unsatisfactory therapeutic effect|3
1176348|NCT01119937|3864686|P2|Overall Study|Protocol deviation|1
1176349|NCT01119937|3864687|P1|Overall Study|Protocol deviation|3
1176350|NCT01119937|3864686|P2|Overall Study|Adverse Event|5
1176351|NCT01119937|3864687|P1|Overall Study|Adverse Event|11
1176352|NCT01119859|3864715|P2|Overall Study|Failure to return|0
1176353|NCT01119859|3864716|P1|Overall Study|Failure to return|3
1176354|NCT01119859|3864715|P2|Overall Study|Refused treatment|6
1176355|NCT01119859|3864716|P1|Overall Study|Refused treatment|3
1176356|NCT01119859|3864715|P2|Overall Study|Insufficient therapeutic response|14
1176357|NCT01119859|3864716|P1|Overall Study|Insufficient therapeutic response|7
1176358|NCT01119859|3864715|P2|Overall Study|Death|0
1176359|NCT01119859|3864716|P1|Overall Study|Death|2
1176360|NCT01119859|3864715|P2|Overall Study|Adverse Event|10
1176361|NCT01119859|3864716|P1|Overall Study|Adverse Event|9
1176362|NCT01119846|3864735|P3|Overall Study|Withdrawal by Subject|4
1176363|NCT01119846|3864736|P2|Overall Study|Withdrawal by Subject|0
1176364|NCT01119846|3864737|P1|Overall Study|Withdrawal by Subject|0
1176365|NCT01119846|3864735|P3|Overall Study|Protocol Violation|1
1176366|NCT01119846|3864736|P2|Overall Study|Protocol Violation|0
1176367|NCT01119846|3864737|P1|Overall Study|Protocol Violation|0
1176368|NCT01119846|3864735|P3|Overall Study|Physician Decision|0
1176369|NCT01119846|3864736|P2|Overall Study|Physician Decision|0
1176370|NCT01119846|3864737|P1|Overall Study|Physician Decision|1
1176371|NCT01119846|3864735|P3|Overall Study|Adverse Event|6
1176372|NCT01119846|3864736|P2|Overall Study|Adverse Event|0
1176373|NCT01119846|3864737|P1|Overall Study|Adverse Event|1
1176374|NCT01119768|3864951|P2|Treatment Period|Lack of Efficacy|25
1176375|NCT01119768|3864952|P1|Treatment Period|Lack of Efficacy|18
1176376|NCT01119703|3865008|P2|Overall Study|Adverse Event|1
1176377|NCT01119703|3865009|P1|Overall Study|Adverse Event|0
1176378|NCT01119625|3865023|P2|Overall Study|Other|1
1176379|NCT01119625|3865024|P1|Overall Study|Other|0
1176380|NCT01119625|3865023|P2|Overall Study|Withdrawal by Subject|1
1176381|NCT01119625|3865024|P1|Overall Study|Withdrawal by Subject|2
1176382|NCT01119625|3865023|P2|Overall Study|Lost to Follow-up|2
1176383|NCT01119625|3865024|P1|Overall Study|Lost to Follow-up|1
1176384|NCT01119443|3865066|P2|Crossover Period 1 (5 Days)|Adverse Event|1
1176385|NCT01119443|3865067|P1|Crossover Period 1 (5 Days)|Adverse Event|0
1176386|NCT01119287|3865110|P6|Overall Study|Patient Decision, not related to AE|0
1176387|NCT01119287|3865111|P5|Overall Study|Patient Decision, not related to AE|1
1176388|NCT01119287|3865112|P4|Overall Study|Patient Decision, not related to AE|2
1176389|NCT01119287|3865113|P3|Overall Study|Patient Decision, not related to AE|2
1176390|NCT01119287|3865114|P2|Overall Study|Patient Decision, not related to AE|0
1176391|NCT01119287|3865115|P1|Overall Study|Patient Decision, not related to AE|0
1176392|NCT01119248|3865128|P1|Overall Study|Physician Decision|5
1176393|NCT01119131|3865178|P3|Overall Study|Physician Decision|1
1176394|NCT01119131|3865179|P2|Overall Study|Physician Decision|0
1176395|NCT01119131|3865180|P1|Overall Study|Physician Decision|0
1176396|NCT01119131|3865178|P3|Overall Study|Non-Compliance|4
1176397|NCT01119131|3865179|P2|Overall Study|Non-Compliance|0
1176398|NCT01119131|3865180|P1|Overall Study|Non-Compliance|1
1176399|NCT01119131|3865178|P3|Overall Study|Adverse Event|1
1176400|NCT01119131|3865179|P2|Overall Study|Adverse Event|1
1176401|NCT01119131|3865180|P1|Overall Study|Adverse Event|1
1176402|NCT01119118|3865209|P1|Overall Study|Adverse Event|1
1176403|NCT01119001|3865221|P1|Overall Study|Withdrawal by Subject|2
1176404|NCT01118975|3865265|P2|Overall Study|Adverse Event|1
1176405|NCT01118975|3865266|P1|Overall Study|Adverse Event|0
1176406|NCT01118962|3865272|P1|Overall Study|Non-compliance with Medicinal Product|1
1176407|NCT01118962|3865272|P1|Overall Study|Pregnancy|1
1176408|NCT01118962|3865272|P1|Overall Study|Withdrawal by Subject|4
1176409|NCT01118962|3865272|P1|Overall Study|Protocol Violation|1
1176410|NCT01118962|3865272|P1|Overall Study|Lack of Efficacy|1
1176411|NCT01118962|3865272|P1|Overall Study|Adverse Event|2
1176412|NCT01118949|3865277|P1|Overall Study|Withdrawal by Subject|4
1176413|NCT01118949|3865277|P1|Overall Study|Adverse Event|5
1176414|NCT01118780|3865307|P2|Overall Study|Withdrawal by Subject|8
1176415|NCT01118780|3865308|P1|Overall Study|Withdrawal by Subject|13
1176416|NCT01118780|3865307|P2|Overall Study|Protocol Violation|6
1176417|NCT01118780|3865308|P1|Overall Study|Protocol Violation|3
1176418|NCT01118780|3865307|P2|Overall Study|Physician Decision|0
1176419|NCT01118780|3865308|P1|Overall Study|Physician Decision|2
1176420|NCT01118780|3865307|P2|Overall Study|Lack of Efficacy|6
1176421|NCT01118780|3865308|P1|Overall Study|Lack of Efficacy|2
1176422|NCT01118780|3865307|P2|Overall Study|Death|0
1176423|NCT01118780|3865308|P1|Overall Study|Death|1
1176424|NCT01118780|3865307|P2|Overall Study|Adverse Event|15
1176425|NCT01118780|3865308|P1|Overall Study|Adverse Event|15
1176426|NCT01118728|3865366|P1|Overall Study|Lost to Follow-up|4
1176427|NCT01118728|3865366|P1|Overall Study|Withdrawal by Subject|3
1176428|NCT01118728|3865366|P1|Overall Study|Sponsor's decision to discontinue study|172
1176429|NCT01118728|3865366|P1|Overall Study|Lack of Efficacy|27
1176430|NCT01118728|3865366|P1|Overall Study|Adverse Event|17
1176431|NCT01118663|3865373|P2|Overall Study|Withdrawal by Subject|1
1176432|NCT01118663|3865374|P1|Overall Study|Withdrawal by Subject|0
1176433|NCT01118663|3865373|P2|Overall Study|Adverse Event|1
1176434|NCT01118663|3865374|P1|Overall Study|Adverse Event|2
1176435|NCT01118455|3865397|P2|Baseline [Visits 1 & 2]|Adverse Event|0
1176436|NCT01118455|3865398|P1|Baseline [Visits 1 & 2]|Adverse Event|1
1176437|NCT01118377|3865426|P1|Overall Study|Failure to Return|3
1176438|NCT01118377|3865426|P1|Overall Study|Death|38
1176439|NCT01118377|3865426|P1|Overall Study|Did Not Receive Study Medication|1
1176440|NCT01118325|3865435|P3|Overall Study|Adverse Event|1
1176441|NCT01118325|3865436|P2|Overall Study|Adverse Event|0
1176442|NCT01118325|3865437|P1|Overall Study|Adverse Event|1
1176443|NCT01118312|3865483|P2|Overall Study|Withdrawal by Subject|3
1176444|NCT01118312|3865484|P1|Overall Study|Withdrawal by Subject|1
1176445|NCT01118312|3865483|P2|Overall Study|Lost to Follow-up|32
1176446|NCT01118312|3865484|P1|Overall Study|Lost to Follow-up|33
1176447|NCT01118143|3865682|P2|Overall Study|Withdrawal by Subject|5
1176448|NCT01118143|3865683|P1|Overall Study|Withdrawal by Subject|2
1176449|NCT01118117|3865693|P2|Overall Study|Missed 12 Month Visit|0
1176450|NCT01118117|3865694|P1|Overall Study|Missed 12 Month Visit|7
1176451|NCT01118117|3865693|P2|Overall Study|Lost to Follow-up|0
1176452|NCT01118117|3865694|P1|Overall Study|Lost to Follow-up|6
1176453|NCT01118117|3865693|P2|Overall Study|Death|0
1176454|NCT01118117|3865694|P1|Overall Study|Death|8
1176455|NCT01118052|3865726|P1|Overall Study|Never treated|2
1176456|NCT01117987|3865749|P2|Overall Study|Administrative problems|22
1176457|NCT01117987|3865750|P1|Overall Study|Administrative problems|25
1176458|NCT01117987|3865749|P2|Overall Study|Adverse Event|26
1176459|NCT01117987|3865750|P1|Overall Study|Adverse Event|19
1176460|NCT01117987|3865749|P2|Overall Study|Withdrawal by Subject|10
1176461|NCT01117987|3865750|P1|Overall Study|Withdrawal by Subject|5
1176462|NCT01117987|3865749|P2|Overall Study|Death|10
1176463|NCT01117987|3865750|P1|Overall Study|Death|5
1176464|NCT01117987|3865749|P2|Overall Study|Lack of Efficacy|4
1176465|NCT01117987|3865750|P1|Overall Study|Lack of Efficacy|3
1176466|NCT01117987|3865749|P2|Overall Study|Abnormal test procedure result|0
1176467|NCT01117987|3865750|P1|Overall Study|Abnormal test procedure result|2
1176468|NCT01117987|3865749|P2|Overall Study|Lost to Follow-up|1
1176469|NCT01117987|3865750|P1|Overall Study|Lost to Follow-up|1
1176470|NCT01117987|3865749|P2|Overall Study|Subject no longer requires study drug|0
1176471|NCT01117987|3865750|P1|Overall Study|Subject no longer requires study drug|1
1176472|NCT01117987|3865749|P2|Overall Study|Protocol deviation|1
1176473|NCT01117987|3865750|P1|Overall Study|Protocol deviation|0
1176474|NCT01117870|3865771|P2|Overall Study|Inability to place needle|0
1176475|NCT01117870|3865772|P1|Overall Study|Inability to place needle|1
1176476|NCT01117857|3865786|P1|Overall Study|Physician Decision|1
1176477|NCT01117857|3865786|P1|Overall Study|Withdrawal by Subject|4
1176478|NCT01117857|3865786|P1|Overall Study|Lost to Follow-up|4
1176479|NCT01117766|3865794|P2|Second Intervention|Withdrawal by Subject|1
1176480|NCT01117766|3865795|P1|Second Intervention|Withdrawal by Subject|0
1176481|NCT01117766|3865794|P2|Second Intervention|Adverse Event|2
1176482|NCT01117766|3865795|P1|Second Intervention|Adverse Event|0
1176483|NCT01117766|3865794|P2|Second Intervention|Other|2
1176484|NCT01117766|3865795|P1|Second Intervention|Other|1
1176485|NCT01117766|3865794|P2|Second Intervention|Lost to Follow-up|0
1176486|NCT01117766|3865795|P1|Second Intervention|Lost to Follow-up|1
1176487|NCT01117766|3865794|P2|Washout Period|Protocol Violation|2
1176488|NCT01117766|3865795|P1|Washout Period|Protocol Violation|0
1176489|NCT01117766|3865794|P2|First Intervention|Protocol Violation|0
1176490|NCT01117766|3865795|P1|First Intervention|Protocol Violation|1
1176491|NCT01117766|3865794|P2|First Intervention|Other|0
1176492|NCT01117766|3865795|P1|First Intervention|Other|0
1176493|NCT01117766|3865794|P2|First Intervention|Adverse Event|1
1176494|NCT01117766|3865795|P1|First Intervention|Adverse Event|0
1176495|NCT01117623|3865832|P8|Overall Study|Invest. text: completed all planned txs|0
1176496|NCT01117623|3865833|P7|Overall Study|Invest. text: completed all planned txs|0
1176497|NCT01117623|3865834|P6|Overall Study|Invest. text: completed all planned txs|1
1176498|NCT01117623|3865835|P5|Overall Study|Invest. text: completed all planned txs|0
1176499|NCT01117623|3865836|P4|Overall Study|Invest. text: completed all planned txs|0
1176500|NCT01117623|3865837|P3|Overall Study|Invest. text: completed all planned txs|0
1176501|NCT01117623|3865838|P2|Overall Study|Invest. text: completed all planned txs|0
1176502|NCT01117623|3865839|P1|Overall Study|Invest. text: completed all planned txs|0
1176503|NCT01117623|3865832|P8|Overall Study|Non-compliance with study medication|1
1176504|NCT01117623|3865833|P7|Overall Study|Non-compliance with study medication|0
1176505|NCT01117623|3865834|P6|Overall Study|Non-compliance with study medication|0
1176506|NCT01117623|3865835|P5|Overall Study|Non-compliance with study medication|0
1176507|NCT01117623|3865836|P4|Overall Study|Non-compliance with study medication|0
1176508|NCT01117623|3865837|P3|Overall Study|Non-compliance with study medication|0
1176509|NCT01117623|3865838|P2|Overall Study|Non-compliance with study medication|0
1176510|NCT01117623|3865839|P1|Overall Study|Non-compliance with study medication|0
1176511|NCT01117623|3865832|P8|Overall Study|Withdrawal by Subject|1
1176512|NCT01117623|3865833|P7|Overall Study|Withdrawal by Subject|1
1176513|NCT01117623|3865834|P6|Overall Study|Withdrawal by Subject|1
1176514|NCT01117623|3865835|P5|Overall Study|Withdrawal by Subject|0
1176515|NCT01117623|3865836|P4|Overall Study|Withdrawal by Subject|0
1176516|NCT01117623|3865837|P3|Overall Study|Withdrawal by Subject|2
1176517|NCT01117623|3865838|P2|Overall Study|Withdrawal by Subject|0
1176518|NCT01117623|3865839|P1|Overall Study|Withdrawal by Subject|0
1176519|NCT01117623|3865832|P8|Overall Study|Disease progression, recurrence, relapse|22
1176520|NCT01117623|3865833|P7|Overall Study|Disease progression, recurrence, relapse|5
1176521|NCT01117623|3865834|P6|Overall Study|Disease progression, recurrence, relapse|14
1176522|NCT01117623|3865835|P5|Overall Study|Disease progression, recurrence, relapse|8
1176523|NCT01117623|3865836|P4|Overall Study|Disease progression, recurrence, relapse|6
1176524|NCT01117623|3865837|P3|Overall Study|Disease progression, recurrence, relapse|5
1176525|NCT01117623|3865838|P2|Overall Study|Disease progression, recurrence, relapse|6
1176526|NCT01117623|3865839|P1|Overall Study|Disease progression, recurrence, relapse|3
1176527|NCT01117623|3865832|P8|Overall Study|Adverse Event|2
1176528|NCT01117623|3865833|P7|Overall Study|Adverse Event|0
1176529|NCT01117623|3865834|P6|Overall Study|Adverse Event|0
1176530|NCT01117623|3865835|P5|Overall Study|Adverse Event|2
1176531|NCT01117623|3865836|P4|Overall Study|Adverse Event|0
1176532|NCT01117623|3865837|P3|Overall Study|Adverse Event|4
1176533|NCT01117623|3865838|P2|Overall Study|Adverse Event|2
1176534|NCT01117623|3865839|P1|Overall Study|Adverse Event|0
1176535|NCT01117480|3865991|P1|Overall Study|Did Not Start Adalimumab Therapy|20
1176536|NCT01117480|3865991|P1|Overall Study|Protocol Violation|8
1176537|NCT01117454|3865999|P2|Overall Study|Pregnancy|1
1176538|NCT01117454|3866000|P1|Overall Study|Pregnancy|0
1176539|NCT01117428|3866012|P6|Overall Study|Progressive disease|17
1176540|NCT01117428|3866013|P5|Overall Study|Progressive disease|16
1176541|NCT01117428|3866014|P4|Overall Study|Progressive disease|12
1176542|NCT01117428|3866015|P3|Overall Study|Progressive disease|10
1176543|NCT01117428|3866016|P2|Overall Study|Progressive disease|27
1176544|NCT01117428|3866017|P1|Overall Study|Progressive disease|15
1176545|NCT01117428|3866012|P6|Overall Study|Withdrawal by Subject|0
1176546|NCT01117428|3866013|P5|Overall Study|Withdrawal by Subject|0
1176547|NCT01117428|3866014|P4|Overall Study|Withdrawal by Subject|0
1176548|NCT01117428|3866015|P3|Overall Study|Withdrawal by Subject|1
1176549|NCT01117428|3866016|P2|Overall Study|Withdrawal by Subject|0
1176550|NCT01117428|3866017|P1|Overall Study|Withdrawal by Subject|0
1176551|NCT01117428|3866012|P6|Overall Study|Physician Decision|0
1176552|NCT01117428|3866013|P5|Overall Study|Physician Decision|0
1176553|NCT01117428|3866014|P4|Overall Study|Physician Decision|0
1176554|NCT01117428|3866015|P3|Overall Study|Physician Decision|0
1176555|NCT01117428|3866016|P2|Overall Study|Physician Decision|1
1176556|NCT01117428|3866017|P1|Overall Study|Physician Decision|0
1176557|NCT01117428|3866012|P6|Overall Study|Death|1
1176558|NCT01117428|3866013|P5|Overall Study|Death|0
1176559|NCT01117428|3866014|P4|Overall Study|Death|0
1176560|NCT01117428|3866015|P3|Overall Study|Death|2
1176561|NCT01117428|3866016|P2|Overall Study|Death|1
1176562|NCT01117428|3866017|P1|Overall Study|Death|0
1176563|NCT01117428|3866012|P6|Overall Study|Adverse Event|2
1176564|NCT01117428|3866013|P5|Overall Study|Adverse Event|1
1176565|NCT01117428|3866014|P4|Overall Study|Adverse Event|0
1176566|NCT01117428|3866015|P3|Overall Study|Adverse Event|0
1176567|NCT01117428|3866016|P2|Overall Study|Adverse Event|0
1176568|NCT01117428|3866017|P1|Overall Study|Adverse Event|4
1176569|NCT01117428|3866012|P6|Overall Study|Lack of Efficacy|0
1176570|NCT01117428|3866013|P5|Overall Study|Lack of Efficacy|0
1176571|NCT01117428|3866014|P4|Overall Study|Lack of Efficacy|0
1176572|NCT01117428|3866015|P3|Overall Study|Lack of Efficacy|0
1176573|NCT01117428|3866016|P2|Overall Study|Lack of Efficacy|0
1176574|NCT01117428|3866017|P1|Overall Study|Lack of Efficacy|1
1176575|NCT01117350|3866051|P2|Extension Period|Prohibited medication|1
1176576|NCT01117350|3866052|P1|Extension Period|Prohibited medication|0
1176577|NCT01117350|3866051|P2|Extension Period|Inclusion criteria not respected|1
1176578|NCT01117350|3866052|P1|Extension Period|Inclusion criteria not respected|0
1176579|NCT01117350|3866051|P2|Extension Period|Lack of Efficacy|2
1176580|NCT01117350|3866052|P1|Extension Period|Lack of Efficacy|0
1176581|NCT01117350|3866051|P2|Extension Period|Withdrawal by Subject|3
1176582|NCT01117350|3866052|P1|Extension Period|Withdrawal by Subject|0
1176583|NCT01117350|3866051|P2|Extension Period|Lost to Follow-up|2
1176584|NCT01117350|3866052|P1|Extension Period|Lost to Follow-up|0
1176585|NCT01117350|3866051|P2|Extension Period|Protocol Violation|2
1176586|NCT01117350|3866052|P1|Extension Period|Protocol Violation|0
1176587|NCT01117350|3866051|P2|Extension Period|Adverse Event|2
1176588|NCT01117350|3866052|P1|Extension Period|Adverse Event|0
1176589|NCT01117350|3866051|P2|Extension Period|Not included in extension, not treated|50
1176590|NCT01117350|3866052|P1|Extension Period|Not included in extension, not treated|0
1176591|NCT01117350|3866051|P2|Comparative Period|Move to another city/country|1
1176592|NCT01117350|3866052|P1|Comparative Period|Move to another city/country|2
1176593|NCT01117350|3866051|P2|Comparative Period|Physician Decision|1
1176594|NCT01117350|3866052|P1|Comparative Period|Physician Decision|0
1176595|NCT01117350|3866051|P2|Comparative Period|Lack of Efficacy|0
1176596|NCT01117350|3866052|P1|Comparative Period|Lack of Efficacy|1
1176597|NCT01117350|3866051|P2|Comparative Period|Protocol Violation|12
1176598|NCT01117350|3866052|P1|Comparative Period|Protocol Violation|8
1176599|NCT01117350|3866051|P2|Comparative Period|Withdrawal by Subject|13
1176600|NCT01117350|3866052|P1|Comparative Period|Withdrawal by Subject|9
1176601|NCT01117350|3866051|P2|Comparative Period|Lost to Follow-up|7
1176602|NCT01117350|3866052|P1|Comparative Period|Lost to Follow-up|11
1176603|NCT01117350|3866051|P2|Comparative Period|Adverse Event|33
1176604|NCT01117350|3866052|P1|Comparative Period|Adverse Event|6
1176605|NCT01117350|3866051|P2|Comparative Period|Not Treated|8
1176606|NCT01117350|3866052|P1|Comparative Period|Not Treated|5
1176607|NCT01117337|3866084|P2|Overall Study|Lost to Follow-up|0
1176608|NCT01117337|3866085|P1|Overall Study|Lost to Follow-up|4
1176609|NCT01117181|3866106|P2|Overall Study|Withdrawal by Subject|2
1176610|NCT01117181|3866107|P1|Overall Study|Withdrawal by Subject|0
1176611|NCT01117181|3866106|P2|Overall Study|Lost to Follow-up|0
1176612|NCT01117181|3866107|P1|Overall Study|Lost to Follow-up|1
1176613|NCT01117051|3866140|P2|Overall Study|Convenience issue|0
1176614|NCT01117051|3866141|P1|Overall Study|Convenience issue|1
1176615|NCT01117051|3866140|P2|Overall Study|Randomized by mistake|1
1176616|NCT01117051|3866141|P1|Overall Study|Randomized by mistake|0
1176617|NCT01117051|3866140|P2|Overall Study|Surgical procedure|1
1176618|NCT01117051|3866141|P1|Overall Study|Surgical procedure|0
1176619|NCT01117051|3866140|P2|Overall Study|Sponsor's decision|1
1176620|NCT01117051|3866141|P1|Overall Study|Sponsor's decision|3
1176621|NCT01117051|3866140|P2|Overall Study|Did not meet in-/exclusion criteria|1
1176622|NCT01117051|3866141|P1|Overall Study|Did not meet in-/exclusion criteria|0
1176623|NCT01117051|3866140|P2|Overall Study|Lost to Follow-up|1
1176624|NCT01117051|3866141|P1|Overall Study|Lost to Follow-up|0
1176625|NCT01117051|3866140|P2|Overall Study|Adverse Event|3
1176626|NCT01117051|3866141|P1|Overall Study|Adverse Event|4
1176627|NCT01117051|3866140|P2|Overall Study|Withdrawal by Subject|3
1176628|NCT01117051|3866141|P1|Overall Study|Withdrawal by Subject|5
1176629|NCT01117012|3866151|P2|Overall Study|Undefined|3
1176630|NCT01117012|3866152|P1|Overall Study|Undefined|4
1176631|NCT01117012|3866151|P2|Overall Study|Withdrawal by Subject|0
1176632|NCT01117012|3866152|P1|Overall Study|Withdrawal by Subject|3
1176633|NCT01117012|3866151|P2|Overall Study|Death|1
1176634|NCT01117012|3866152|P1|Overall Study|Death|1
1176635|NCT01117012|3866151|P2|Overall Study|Adverse Event|1
1176636|NCT01117012|3866152|P1|Overall Study|Adverse Event|0
1176637|NCT01116882|3866326|P2|12-month|Withdrawal by Subject|8
1176638|NCT01116882|3866327|P1|12-month|Withdrawal by Subject|5
1176639|NCT01116882|3866326|P2|12-month|Other Reasons|49
1176640|NCT01116882|3866327|P1|12-month|Other Reasons|151
1176641|NCT01116882|3866326|P2|12-month|Lost to Follow-up|42
1176642|NCT01116882|3866327|P1|12-month|Lost to Follow-up|111
1176643|NCT01116882|3866326|P2|30-day|Other Reasons|6
1176644|NCT01116882|3866327|P1|30-day|Other Reasons|16
1176645|NCT01116882|3866326|P2|30-day|Withdrawal by Subject|4
1176646|NCT01116882|3866327|P1|30-day|Withdrawal by Subject|2
1176647|NCT01116882|3866326|P2|30-day|Lost to Follow-up|21
1176648|NCT01116882|3866327|P1|30-day|Lost to Follow-up|50
1176649|NCT01116687|3866365|P1|Overall Study|Withdrawal by Subject|4
1176650|NCT01116427|3866382|P2|Extension Phase|Not using appropriate birth control|0
1176651|NCT01116427|3866383|P1|Extension Phase|Not using appropriate birth control|1
1176652|NCT01116427|3866382|P2|Extension Phase|Withdrawal by Subject|1
1176653|NCT01116427|3866383|P1|Extension Phase|Withdrawal by Subject|5
1176654|NCT01116427|3866382|P2|Extension Phase|Lost to Follow-up|0
1176655|NCT01116427|3866383|P1|Extension Phase|Lost to Follow-up|2
1176656|NCT01116427|3866382|P2|Extension Phase|Adverse Event|1
1176657|NCT01116427|3866383|P1|Extension Phase|Adverse Event|1
1176658|NCT01116427|3866382|P2|Core Phase|Worsening Multiple Sclerosis|0
1176659|NCT01116427|3866383|P1|Core Phase|Worsening Multiple Sclerosis|1
1176660|NCT01116427|3866382|P2|Core Phase|Withdrawal by Subject|0
1176661|NCT01116427|3866383|P1|Core Phase|Withdrawal by Subject|3
1176662|NCT01116427|3866382|P2|Core Phase|Lost to Follow-up|0
1176663|NCT01116427|3866383|P1|Core Phase|Lost to Follow-up|1
1176664|NCT01116427|3866382|P2|Core Phase|Adverse Event|1
1176665|NCT01116427|3866383|P1|Core Phase|Adverse Event|0
1176666|NCT01116232|3866424|P1|Overall Study|Progressive diease|4
1176667|NCT01115998|3866532|P2|Overall Study|Lost to Follow-up|6
1176668|NCT01115998|3866533|P1|Overall Study|Lost to Follow-up|6
1176669|NCT01115933|3866543|P1|Overall Study|Did not receive XIENCE PRIME SV|1
1176670|NCT01115855|3866640|P2|Overall Study|Other|6
1176671|NCT01115855|3866641|P1|Overall Study|Other|8
1176672|NCT01115855|3866640|P2|Overall Study|Withdrawal by Subject|5
1176673|NCT01115855|3866641|P1|Overall Study|Withdrawal by Subject|5
1176674|NCT01115855|3866640|P2|Overall Study|Protocol Violation|1
1176675|NCT01115855|3866641|P1|Overall Study|Protocol Violation|0
1176676|NCT01115855|3866640|P2|Overall Study|Lab Abnormality|1
1176677|NCT01115855|3866641|P1|Overall Study|Lab Abnormality|1
1176678|NCT01115855|3866640|P2|Overall Study|Death|5
1176679|NCT01115855|3866641|P1|Overall Study|Death|6
1176680|NCT01115855|3866640|P2|Overall Study|Adverse Event|18
1176681|NCT01115855|3866641|P1|Overall Study|Adverse Event|16
1176682|NCT01115738|3866692|P3|Overall Study|Withdrawal by Subject|9
1176683|NCT01115738|3866693|P2|Overall Study|Withdrawal by Subject|6
1176684|NCT01115738|3866694|P1|Overall Study|Withdrawal by Subject|6
1176685|NCT01115738|3866692|P3|Overall Study|Physician Decision|17
1176686|NCT01115738|3866693|P2|Overall Study|Physician Decision|15
1176687|NCT01115738|3866694|P1|Overall Study|Physician Decision|18
1176688|NCT01115738|3866692|P3|Overall Study|Lost to Follow-up|1
1176689|NCT01115738|3866693|P2|Overall Study|Lost to Follow-up|0
1176690|NCT01115738|3866694|P1|Overall Study|Lost to Follow-up|0
1176691|NCT01115738|3866692|P3|Overall Study|Death|0
1176692|NCT01115738|3866693|P2|Overall Study|Death|0
1176693|NCT01115738|3866694|P1|Overall Study|Death|1
1176694|NCT01115569|3866892|P2|Maintenance Phase|Administrative|1
1176695|NCT01115569|3866893|P1|Maintenance Phase|Administrative|0
1176696|NCT01115569|3866892|P2|Maintenance Phase|Non-Compliance with Study Drug|48
1176697|NCT01115569|3866893|P1|Maintenance Phase|Non-Compliance with Study Drug|0
1176698|NCT01115569|3866892|P2|Maintenance Phase|Withdrawal by Subject|27
1176699|NCT01115569|3866893|P1|Maintenance Phase|Withdrawal by Subject|0
1176700|NCT01115569|3866892|P2|Maintenance Phase|Protocol Violation|9
1176701|NCT01115569|3866893|P1|Maintenance Phase|Protocol Violation|0
1176702|NCT01115569|3866892|P2|Maintenance Phase|Physician Decision|3
1176703|NCT01115569|3866893|P1|Maintenance Phase|Physician Decision|0
1176704|NCT01115569|3866892|P2|Maintenance Phase|Lost to Follow-up|8
1176705|NCT01115569|3866893|P1|Maintenance Phase|Lost to Follow-up|0
1176706|NCT01115569|3866892|P2|Maintenance Phase|Adverse Event|43
1176707|NCT01115569|3866893|P1|Maintenance Phase|Adverse Event|0
1176708|NCT01115569|3866892|P2|Conversion/Titration Phase|Non-Compliance with Study Drug|0
1176709|NCT01115569|3866893|P1|Conversion/Titration Phase|Non-Compliance with Study Drug|53
1176710|NCT01115569|3866892|P2|Conversion/Titration Phase|Withdrawal by Subject|0
1176711|NCT01115569|3866893|P1|Conversion/Titration Phase|Withdrawal by Subject|26
1176712|NCT01115569|3866892|P2|Conversion/Titration Phase|Protocol Violation|0
1176713|NCT01115569|3866893|P1|Conversion/Titration Phase|Protocol Violation|68
1176714|NCT01115569|3866892|P2|Conversion/Titration Phase|Physician Decision|0
1176715|NCT01115569|3866893|P1|Conversion/Titration Phase|Physician Decision|5
1176716|NCT01115569|3866892|P2|Conversion/Titration Phase|Lost to Follow-up|0
1176717|NCT01115569|3866893|P1|Conversion/Titration Phase|Lost to Follow-up|3
1176718|NCT01115569|3866892|P2|Conversion/Titration Phase|Adverse Event|0
1176719|NCT01115569|3866893|P1|Conversion/Titration Phase|Adverse Event|59
1176720|NCT01115491|3866922|P1|Overall Study|Physician Decision|1
1176721|NCT01115491|3866922|P1|Overall Study|Withdrawal by Subject|1
1176722|NCT01115491|3866922|P1|Overall Study|Lost to Follow-up|3
1176723|NCT01115491|3866922|P1|Overall Study|Adverse Event|3
1176724|NCT01115491|3866922|P1|Overall Study|Death|22
1176725|NCT01114880|3867097|P2|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2
1176726|NCT01114880|3867098|P1|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0
1176727|NCT01114880|3867097|P2|Period 2 (Week 12 to Week 24)|Adverse Event|0
1176728|NCT01114880|3867098|P1|Period 2 (Week 12 to Week 24)|Adverse Event|3
1176729|NCT01114880|3867097|P2|Period 1 (Week 0 to Week 12)|Poor subject compliance|1
1176730|NCT01114880|3867098|P1|Period 1 (Week 0 to Week 12)|Poor subject compliance|0
1176731|NCT01114880|3867097|P2|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1
1176732|NCT01114880|3867098|P1|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0
1176733|NCT01114880|3867097|P2|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0
1176734|NCT01114880|3867098|P1|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1
1176735|NCT01114880|3867097|P2|Period 1 (Week 0 to Week 12)|Adverse Event|0
1176736|NCT01114880|3867098|P1|Period 1 (Week 0 to Week 12)|Adverse Event|4
1176737|NCT01114828|3867150|P2|Overall Study|Withdrawal by Subject|1
1176738|NCT01114828|3867151|P1|Overall Study|Withdrawal by Subject|0
1176739|NCT01114828|3867150|P2|Overall Study|Protocol Violation|0
1176740|NCT01114828|3867151|P1|Overall Study|Protocol Violation|2
1176741|NCT01114828|3867150|P2|Overall Study|Lack of Efficacy|2
1176742|NCT01114828|3867151|P1|Overall Study|Lack of Efficacy|0
1176743|NCT01114828|3867150|P2|Overall Study|Adverse Event|1
1176744|NCT01114828|3867151|P1|Overall Study|Adverse Event|1
1176745|NCT01114737|3867161|P2|Open-Label Treatment Period|Difficult Personal Events|0
1176746|NCT01114737|3867162|P1|Open-Label Treatment Period|Difficult Personal Events|1
1176747|NCT01114737|3867161|P2|Open-Label Treatment Period|Lost to Follow-up|1
1176748|NCT01114737|3867162|P1|Open-Label Treatment Period|Lost to Follow-up|3
1176749|NCT01114737|3867161|P2|Open-Label Treatment Period|Withdrawal by Subject|1
1176750|NCT01114737|3867162|P1|Open-Label Treatment Period|Withdrawal by Subject|1
1176751|NCT01114737|3867161|P2|Randomized Treatment Period|Pregnancy|0
1176752|NCT01114737|3867162|P1|Randomized Treatment Period|Pregnancy|1
1176753|NCT01114737|3867161|P2|Randomized Treatment Period|Lost to Follow-up|1
1176754|NCT01114737|3867162|P1|Randomized Treatment Period|Lost to Follow-up|1
1176755|NCT01114737|3867161|P2|Randomized Treatment Period|Withdrawal by Subject|0
1176756|NCT01114737|3867162|P1|Randomized Treatment Period|Withdrawal by Subject|1
1176757|NCT01114724|3867210|P1|Overall Study|Withdrawal by Subject|1
1176758|NCT01114724|3867210|P1|Overall Study|Lost to Follow-up|1
1176759|NCT01114724|3867210|P1|Overall Study|Death|8
1176760|NCT01114672|3867230|P2|Overall Study|transplanted|0
1176761|NCT01114672|3867231|P1|Overall Study|transplanted|1
1176762|NCT01114672|3867230|P2|Overall Study|Lost to Follow-up|0
1176763|NCT01114672|3867231|P1|Overall Study|Lost to Follow-up|1
1176764|NCT01114672|3867230|P2|Overall Study|Withdrawal by Subject|1
1176765|NCT01114672|3867231|P1|Overall Study|Withdrawal by Subject|2
1176766|NCT01114672|3867230|P2|Overall Study|Death|1
1176767|NCT01114672|3867231|P1|Overall Study|Death|0
1176768|NCT01114646|3867239|P2|Overall Study|Withdrawal by Subject|2
1176769|NCT01114646|3867240|P1|Overall Study|Withdrawal by Subject|3
1176770|NCT01114529|3867293|P3|Completed Study Phase at Month 24|Missing|0
1176771|NCT01114529|3867294|P2|Completed Study Phase at Month 24|Missing|0
1176772|NCT01114529|3867295|P1|Completed Study Phase at Month 24|Missing|2
1176773|NCT01114529|3867293|P3|Completed Study Phase at Month 24|Other|0
1176774|NCT01114529|3867294|P2|Completed Study Phase at Month 24|Other|0
1176775|NCT01114529|3867295|P1|Completed Study Phase at Month 24|Other|2
1176776|NCT01114529|3867293|P3|Completed Study Phase at Month 24|Death|4
1176777|NCT01114529|3867294|P2|Completed Study Phase at Month 24|Death|5
1176778|NCT01114529|3867295|P1|Completed Study Phase at Month 24|Death|8
1176779|NCT01114529|3867293|P3|Completed Study Phase at Month 24|Lost to Follow-up|7
1176780|NCT01114529|3867294|P2|Completed Study Phase at Month 24|Lost to Follow-up|5
1176781|NCT01114529|3867295|P1|Completed Study Phase at Month 24|Lost to Follow-up|10
1176782|NCT01114529|3867293|P3|Completed Study Phase at Month 24|Withdrawal by Subject|3
1176783|NCT01114529|3867294|P2|Completed Study Phase at Month 24|Withdrawal by Subject|6
1176784|NCT01114529|3867295|P1|Completed Study Phase at Month 24|Withdrawal by Subject|18
1176785|NCT01114529|3867293|P3|Completed Study Medication at Month 24|Missing|0
1176786|NCT01114529|3867294|P2|Completed Study Medication at Month 24|Missing|0
1176787|NCT01114529|3867295|P1|Completed Study Medication at Month 24|Missing|2
1176788|NCT01114529|3867293|P3|Completed Study Medication at Month 24|Protocol Violation|2
1176789|NCT01114529|3867294|P2|Completed Study Medication at Month 24|Protocol Violation|5
1176790|NCT01114529|3867295|P1|Completed Study Medication at Month 24|Protocol Violation|0
1176791|NCT01114529|3867293|P3|Completed Study Medication at Month 24|Graft loss|0
1176792|NCT01114529|3867294|P2|Completed Study Medication at Month 24|Graft loss|2
1176793|NCT01114529|3867295|P1|Completed Study Medication at Month 24|Graft loss|0
1176794|NCT01114529|3867293|P3|Completed Study Medication at Month 24|Death|2
1176795|NCT01114529|3867294|P2|Completed Study Medication at Month 24|Death|1
1176796|NCT01114529|3867295|P1|Completed Study Medication at Month 24|Death|2
1176797|NCT01114529|3867293|P3|Completed Study Medication at Month 24|Administrative problems|2
1176798|NCT01114529|3867294|P2|Completed Study Medication at Month 24|Administrative problems|1
1176799|NCT01114529|3867295|P1|Completed Study Medication at Month 24|Administrative problems|2
1176800|NCT01114529|3867293|P3|Completed Study Medication at Month 24|Lost to Follow-up|2
1176801|NCT01114529|3867294|P2|Completed Study Medication at Month 24|Lost to Follow-up|4
1176802|NCT01114529|3867295|P1|Completed Study Medication at Month 24|Lost to Follow-up|1
1176803|NCT01114529|3867293|P3|Completed Study Medication at Month 24|Withdrawal by Subject|2
1176804|NCT01114529|3867294|P2|Completed Study Medication at Month 24|Withdrawal by Subject|8
1176805|NCT01114529|3867295|P1|Completed Study Medication at Month 24|Withdrawal by Subject|18
1176806|NCT01114529|3867293|P3|Completed Study Medication at Month 24|Subject's no longer required drug|1
1176807|NCT01114529|3867294|P2|Completed Study Medication at Month 24|Subject's no longer required drug|1
1176808|NCT01114529|3867295|P1|Completed Study Medication at Month 24|Subject's no longer required drug|1
1176809|NCT01114529|3867293|P3|Completed Study Medication at Month 24|Lack of Efficacy|2
1176810|NCT01114529|3867294|P2|Completed Study Medication at Month 24|Lack of Efficacy|1
1176811|NCT01114529|3867295|P1|Completed Study Medication at Month 24|Lack of Efficacy|2
1176812|NCT01114529|3867293|P3|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1
1176813|NCT01114529|3867294|P2|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0
1176814|NCT01114529|3867295|P1|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3
1176815|NCT01114529|3867293|P3|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1
1176816|NCT01114529|3867294|P2|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0
1176817|NCT01114529|3867295|P1|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6
1176818|NCT01114529|3867293|P3|Completed Study Medication at Month 24|Adverse Event|17
1176819|NCT01114529|3867294|P2|Completed Study Medication at Month 24|Adverse Event|18
1176820|NCT01114529|3867295|P1|Completed Study Medication at Month 24|Adverse Event|87
1176821|NCT01114516|3867314|P2|Overall Study|Lost to Follow-up|1
1176822|NCT01114516|3867315|P1|Overall Study|Lost to Follow-up|2
1176823|NCT01114438|3867350|P1|Overall Study|Withdrawal by Subject|2
1176824|NCT01114438|3867350|P1|Overall Study|Physician Decision|1
1176825|NCT01114438|3867350|P1|Overall Study|concomitant medication|1
1176826|NCT01114438|3867350|P1|Overall Study|Adverse Event|10
1176827|NCT01114373|3867360|P2|Intervention 2 (4 Weeks)|Lost to Follow-up|1
1176828|NCT01114373|3867361|P1|Intervention 2 (4 Weeks)|Lost to Follow-up|0
1176829|NCT01114373|3867360|P2|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0
1176830|NCT01114373|3867361|P1|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1
1176831|NCT01114373|3867360|P2|Intervention 1 (4 Weeks)|Incarceration|0
1176832|NCT01114373|3867361|P1|Intervention 1 (4 Weeks)|Incarceration|1
1176833|NCT01114373|3867360|P2|Intervention 1 (4 Weeks)|Lost to Follow-up|0
1176834|NCT01114373|3867361|P1|Intervention 1 (4 Weeks)|Lost to Follow-up|1
1176835|NCT01114360|3867393|P2|Intervention 1 (4 Weeks)|Physician Decision|1
1176836|NCT01114360|3867394|P1|Intervention 1 (4 Weeks)|Physician Decision|0
1176837|NCT01114217|3867445|P2|Overall Study|Other-Withdrawal by Subject|1
1176838|NCT01114217|3867446|P1|Overall Study|Other-Withdrawal by Subject|1
1176839|NCT01114217|3867445|P2|Overall Study|Other-Lost to Follow-up|0
1176840|NCT01114217|3867446|P1|Overall Study|Other-Lost to Follow-up|1
1176841|NCT01114217|3867445|P2|Overall Study|Other-Site Stopped Communicating|0
1176842|NCT01114217|3867446|P1|Overall Study|Other-Site Stopped Communicating|2
1176843|NCT01114217|3867445|P2|Overall Study|Other-Study Withdrawn|1
1176844|NCT01114217|3867446|P1|Overall Study|Other-Study Withdrawn|1
1176845|NCT01114217|3867445|P2|Overall Study|Other-Study Termination|1
1176846|NCT01114217|3867446|P1|Overall Study|Other-Study Termination|0
1176847|NCT01114217|3867445|P2|Overall Study|Other-Sponsor Decision|12
1176848|NCT01114217|3867446|P1|Overall Study|Other-Sponsor Decision|10
1176849|NCT01114217|3867445|P2|Overall Study|Other-Physician Decision|1
1176850|NCT01114217|3867446|P1|Overall Study|Other-Physician Decision|1
1176851|NCT01114217|3867445|P2|Overall Study|Other-Non Compliance|0
1176852|NCT01114217|3867446|P1|Overall Study|Other-Non Compliance|2
1176853|NCT01114217|3867445|P2|Overall Study|Other-Lack of Efficacy|0
1176854|NCT01114217|3867446|P1|Overall Study|Other-Lack of Efficacy|1
1176855|NCT01114217|3867445|P2|Overall Study|Other-Protocol Violation|3
1176856|NCT01114217|3867446|P1|Overall Study|Other-Protocol Violation|1
1176857|NCT01114217|3867445|P2|Overall Study|Other-Pregnancy|4
1176858|NCT01114217|3867446|P1|Overall Study|Other-Pregnancy|2
1176859|NCT01114217|3867445|P2|Overall Study|Other-Procedure|1
1176860|NCT01114217|3867446|P1|Overall Study|Other-Procedure|1
1176861|NCT01114217|3867445|P2|Overall Study|Other-Early termination|10
1176862|NCT01114217|3867446|P1|Overall Study|Other-Early termination|6
1176863|NCT01114217|3867445|P2|Overall Study|Other-Clerical Error|0
1176864|NCT01114217|3867446|P1|Overall Study|Other-Clerical Error|3
1176865|NCT01114217|3867445|P2|Overall Study|Withdrawal by Subject|28
1176866|NCT01114217|3867446|P1|Overall Study|Withdrawal by Subject|21
1176867|NCT01114217|3867445|P2|Overall Study|Lost to Follow-up|33
1176868|NCT01114217|3867446|P1|Overall Study|Lost to Follow-up|17
1176869|NCT01114217|3867445|P2|Overall Study|Adverse Event|3
1176870|NCT01114217|3867446|P1|Overall Study|Adverse Event|5
1176871|NCT01114204|3867458|P2|Overall Study|Other-Protocol Violation|0
1176872|NCT01114204|3867459|P1|Overall Study|Other-Protocol Violation|1
1176873|NCT01114204|3867458|P2|Overall Study|Other-Participant request|0
1176874|NCT01114204|3867459|P1|Overall Study|Other-Participant request|2
1176875|NCT01114204|3867458|P2|Overall Study|Other-Medical monitor request|0
1176876|NCT01114204|3867459|P1|Overall Study|Other-Medical monitor request|1
1176877|NCT01114204|3867458|P2|Overall Study|Other-Personal reasons|0
1176878|NCT01114204|3867459|P1|Overall Study|Other-Personal reasons|2
1176879|NCT01114204|3867458|P2|Overall Study|Death|0
1176880|NCT01114204|3867459|P1|Overall Study|Death|1
1176881|NCT01114204|3867458|P2|Overall Study|Withdrawal by Subject|6
1176882|NCT01114204|3867459|P1|Overall Study|Withdrawal by Subject|10
1176883|NCT01114204|3867458|P2|Overall Study|Lost to Follow-up|0
1176884|NCT01114204|3867459|P1|Overall Study|Lost to Follow-up|1
1176885|NCT01114204|3867458|P2|Overall Study|Adverse Event|2
1176886|NCT01114204|3867459|P1|Overall Study|Adverse Event|3
1176887|NCT01114139|3867477|P2|Overall Study|Other-Withdrew prior to receiving dose|3
1176888|NCT01114139|3867478|P1|Overall Study|Other-Withdrew prior to receiving dose|1
1176889|NCT01114139|3867477|P2|Overall Study|Other-Physician changed treatment|0
1176890|NCT01114139|3867478|P1|Overall Study|Other-Physician changed treatment|1
1176891|NCT01114139|3867477|P2|Overall Study|Other-Participant went on hospice|1
1176892|NCT01114139|3867478|P1|Overall Study|Other-Participant went on hospice|0
1176893|NCT01114139|3867477|P2|Overall Study|Other-Participant falsified records|1
1176894|NCT01114139|3867478|P1|Overall Study|Other-Participant falsified records|0
1176895|NCT01114139|3867477|P2|Overall Study|Other-Out of window for study drug dose|0
1176896|NCT01114139|3867478|P1|Overall Study|Other-Out of window for study drug dose|1
1176897|NCT01114139|3867477|P2|Overall Study|Other-Protocol Violation|0
1176898|NCT01114139|3867478|P1|Overall Study|Other-Protocol Violation|1
1176899|NCT01114139|3867477|P2|Overall Study|Other-Missed 1 visit|0
1176900|NCT01114139|3867478|P1|Overall Study|Other-Missed 1 visit|1
1176901|NCT01114139|3867477|P2|Overall Study|Withdrawal by Subject|6
1176902|NCT01114139|3867478|P1|Overall Study|Withdrawal by Subject|17
1176903|NCT01114139|3867477|P2|Overall Study|Lost to Follow-up|3
1176904|NCT01114139|3867478|P1|Overall Study|Lost to Follow-up|15
1176905|NCT01114139|3867477|P2|Overall Study|Adverse Event|2
1176906|NCT01114139|3867478|P1|Overall Study|Adverse Event|3
1176907|NCT01113931|3867496|P2|Overall Study|Withdrawal by Subject|0
1176908|NCT01113931|3867497|P1|Overall Study|Withdrawal by Subject|3
1176909|NCT01113931|3867496|P2|Overall Study|Various|4
1176910|NCT01113931|3867497|P1|Overall Study|Various|2
1176911|NCT01113931|3867496|P2|Overall Study|Lost to Follow-up|9
1176912|NCT01113931|3867497|P1|Overall Study|Lost to Follow-up|12
1176913|NCT01113931|3867496|P2|Overall Study|Physician Decision|2
1176914|NCT01113931|3867497|P1|Overall Study|Physician Decision|0
1176915|NCT01113931|3867496|P2|Overall Study|Adverse Event|2
1176916|NCT01113931|3867497|P1|Overall Study|Adverse Event|2
1176917|NCT01113801|3867513|P4|Overall Study|Clinical Endpoint (ESRD)|5
1176918|NCT01113801|3867514|P3|Overall Study|Clinical Endpoint (ESRD)|2
1176919|NCT01113801|3867515|P2|Overall Study|Clinical Endpoint (ESRD)|4
1176920|NCT01113801|3867516|P1|Overall Study|Clinical Endpoint (ESRD)|7
1176921|NCT01113801|3867513|P4|Overall Study|Sponsor Decision|15
1176922|NCT01113801|3867514|P3|Overall Study|Sponsor Decision|20
1176923|NCT01113801|3867515|P2|Overall Study|Sponsor Decision|21
1176924|NCT01113801|3867516|P1|Overall Study|Sponsor Decision|15
1176925|NCT01113801|3867513|P4|Overall Study|Physician Decision|3
1176926|NCT01113801|3867514|P3|Overall Study|Physician Decision|3
1176927|NCT01113801|3867515|P2|Overall Study|Physician Decision|2
1176928|NCT01113801|3867516|P1|Overall Study|Physician Decision|2
1176929|NCT01113801|3867513|P4|Overall Study|Withdrawal by Subject|8
1176930|NCT01113801|3867514|P3|Overall Study|Withdrawal by Subject|7
1176931|NCT01113801|3867515|P2|Overall Study|Withdrawal by Subject|7
1176932|NCT01113801|3867516|P1|Overall Study|Withdrawal by Subject|9
1176933|NCT01113801|3867513|P4|Overall Study|Protocol Violation|0
1176934|NCT01113801|3867514|P3|Overall Study|Protocol Violation|0
1176935|NCT01113801|3867515|P2|Overall Study|Protocol Violation|1
1176936|NCT01113801|3867516|P1|Overall Study|Protocol Violation|0
1176937|NCT01113801|3867513|P4|Overall Study|Death|4
1176938|NCT01113801|3867514|P3|Overall Study|Death|3
1176939|NCT01113801|3867515|P2|Overall Study|Death|5
1176940|NCT01113801|3867516|P1|Overall Study|Death|4
1176941|NCT01113801|3867513|P4|Overall Study|Adverse Event|6
1176942|NCT01113801|3867514|P3|Overall Study|Adverse Event|2
1176943|NCT01113801|3867515|P2|Overall Study|Adverse Event|0
1176944|NCT01113801|3867516|P1|Overall Study|Adverse Event|4
1176945|NCT01113749|3867544|P2|Overall Study|Lost to Follow-up|2
1176946|NCT01113749|3867545|P1|Overall Study|Lost to Follow-up|1
1176947|NCT01113710|3867568|P1|Overall Study|Subject Did Not Receive Neupro|3
1176948|NCT01113710|3867568|P1|Overall Study|Compliance/Subject Withdrawal/AE|1
1176949|NCT01113710|3867568|P1|Overall Study|Lack of Patient's Compliance/Other|1
1176950|NCT01113710|3867568|P1|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1
1176951|NCT01113710|3867568|P1|Overall Study|Compliance/Efficacy/Subject Withdrawal|1
1176952|NCT01113710|3867568|P1|Overall Study|Compliance/Efficacy/AE/Other|1
1176953|NCT01113710|3867568|P1|Overall Study|Compliance/Efficacy/Adverse Event|1
1176954|NCT01113710|3867568|P1|Overall Study|Efficacy/Withdrawal by Subject/Other|1
1176955|NCT01113710|3867568|P1|Overall Study|Lost to Follow up/Withdrawal by Subject|2
1176956|NCT01113710|3867568|P1|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2
1176957|NCT01113710|3867568|P1|Overall Study|Efficacy/Subject Withdrawal/AE|2
1176958|NCT01113710|3867568|P1|Overall Study|Lack of Efficacy/Adverse Event|3
1176959|NCT01113710|3867568|P1|Overall Study|Patient Compliance/Withdrawal by Subject|4
1176960|NCT01113710|3867568|P1|Overall Study|Lack of Efficacy/Other|4
1176961|NCT01113710|3867568|P1|Overall Study|Patient's Compliance/Lost to Follow up|5
1176962|NCT01113710|3867568|P1|Overall Study|Adverse Event/Other|5
1176963|NCT01113710|3867568|P1|Overall Study|Other|7
1176964|NCT01113710|3867568|P1|Overall Study|Lack of Patient's Compliance|8
1176965|NCT01113710|3867568|P1|Overall Study|Withdrawal by Subject/Adverse Event|11
1176966|NCT01113710|3867568|P1|Overall Study|Lack of Efficacy/Withdrawal by Subject|13
1176967|NCT01113710|3867568|P1|Overall Study|Lost to Follow-up|20
1176968|NCT01113710|3867568|P1|Overall Study|Withdrawal by Subject|28
1176969|NCT01113710|3867568|P1|Overall Study|No Information Available|40
1176970|NCT01113710|3867568|P1|Overall Study|Lack of Efficacy|41
1176971|NCT01113710|3867568|P1|Overall Study|Adverse Event|64
1176972|NCT01113580|3867596|P2|Overall Study|Protocol Violation|0
1176973|NCT01113580|3867597|P1|Overall Study|Protocol Violation|1
1176974|NCT01113541|3867611|P1|Overall Study|Adverse Event|4
1176975|NCT01113541|3867611|P1|Overall Study|Study Terminated by Sponsor|7
1176976|NCT01113541|3867611|P1|Overall Study|Protocol Violation|1
1176977|NCT01113541|3867611|P1|Overall Study|Withdrawal by Subject|1
1176978|NCT01113463|3867644|P1|Overall Study|Physician Decision|5
1176979|NCT01112917|3867674|P2|Overall Study|Unable to Convert Filter|0
1176980|NCT01112917|3867675|P1|Overall Study|Unable to Convert Filter|3
1176981|NCT01112917|3867674|P2|Overall Study|Withdrawal by Subject|3
1176982|NCT01112917|3867675|P1|Overall Study|Withdrawal by Subject|1
1176983|NCT01112917|3867674|P2|Overall Study|Lost to Follow-up|1
1176984|NCT01112917|3867675|P1|Overall Study|Lost to Follow-up|1
1176985|NCT01112917|3867674|P2|Overall Study|Death|11
1176986|NCT01112917|3867675|P1|Overall Study|Death|2
1176987|NCT01112579|3867779|P2|Overall Study|Death|2
1176988|NCT01112579|3867780|P1|Overall Study|Death|0
1176989|NCT01112579|3867779|P2|Overall Study|Missed Visit|1
1176990|NCT01112579|3867780|P1|Overall Study|Missed Visit|1
1176991|NCT01112514|3867790|P1|Overall Study|Lost to Follow-up|1
1176992|NCT01112267|3867835|P2|Overall Study|Participants not receive any study drug|2
1176993|NCT01112267|3867836|P1|Overall Study|Participants not receive any study drug|1
1176994|NCT01112267|3867835|P2|Overall Study|Participants not compliant|2
1176995|NCT01112267|3867836|P1|Overall Study|Participants not compliant|1
1176996|NCT01112267|3867835|P2|Overall Study|Protocol Violation|3
1176997|NCT01112267|3867836|P1|Overall Study|Protocol Violation|5
1176998|NCT01112267|3867835|P2|Overall Study|Withdrawal by Subject|5
1176999|NCT01112267|3867836|P1|Overall Study|Withdrawal by Subject|3
1177000|NCT01112267|3867835|P2|Overall Study|Adverse Event|6
1177001|NCT01112267|3867836|P1|Overall Study|Adverse Event|24
1177002|NCT01112059|3867869|P2|Overall Study|Withdrawal by Subject|0
1177003|NCT01112059|3867870|P1|Overall Study|Withdrawal by Subject|1
1177004|NCT01111851|3867884|P2|Overall Study|All planned PET scans were not obtained.|0
1177005|NCT01111851|3867885|P1|Overall Study|All planned PET scans were not obtained.|2
1177006|NCT01111838|3867897|P1|Overall Study|Other Complicating Disease|1
1177007|NCT01111838|3867897|P1|Overall Study|Clinical deterioration|1
1177008|NCT01111838|3867897|P1|Overall Study|Not Treated|3
1177009|NCT01111838|3867897|P1|Overall Study|Patient Ineligible|2
1177010|NCT01111825|3867905|P4|Overall Study|Discontinuation by Sponsor|20
1177011|NCT01111825|3867906|P3|Overall Study|Discontinuation by Sponsor|0
1177012|NCT01111825|3867907|P2|Overall Study|Discontinuation by Sponsor|0
1177013|NCT01111825|3867908|P1|Overall Study|Discontinuation by Sponsor|0
1177014|NCT01111825|3867905|P4|Overall Study|Disease Progression|0
1177015|NCT01111825|3867906|P3|Overall Study|Disease Progression|0
1177016|NCT01111825|3867907|P2|Overall Study|Disease Progression|0
1177017|NCT01111825|3867908|P1|Overall Study|Disease Progression|1
1177018|NCT01111825|3867905|P4|Overall Study|Adverse Event|0
1177019|NCT01111825|3867906|P3|Overall Study|Adverse Event|4
1177020|NCT01111825|3867907|P2|Overall Study|Adverse Event|1
1177021|NCT01111825|3867908|P1|Overall Study|Adverse Event|2
1177022|NCT01111825|3867905|P4|Overall Study|Lost to Follow-up|1
1177023|NCT01111825|3867906|P3|Overall Study|Lost to Follow-up|3
1177024|NCT01111825|3867907|P2|Overall Study|Lost to Follow-up|0
1177025|NCT01111825|3867908|P1|Overall Study|Lost to Follow-up|0
1177026|NCT01111825|3867905|P4|Overall Study|Withdrawal by Subject|0
1177027|NCT01111825|3867906|P3|Overall Study|Withdrawal by Subject|1
1177028|NCT01111825|3867907|P2|Overall Study|Withdrawal by Subject|0
1177029|NCT01111825|3867908|P1|Overall Study|Withdrawal by Subject|0
1177030|NCT01111526|3867927|P3|Overall Study|GVHD Disease Progression|2
1177031|NCT01111526|3867928|P2|Overall Study|GVHD Disease Progression|1
1177032|NCT01111526|3867929|P1|Overall Study|GVHD Disease Progression|0
1177033|NCT01111461|3867941|P1|Overall Study|Not specified|6
1177034|NCT01111461|3867941|P1|Overall Study|Withdrawal by Subject|1
1177035|NCT01111461|3867941|P1|Overall Study|Lost to Follow-up|1
1177036|NCT01111461|3867941|P1|Overall Study|Participant choice|11
1177037|NCT01111461|3867941|P1|Overall Study|Adverse Event|32
1177038|NCT01111292|3868121|P2|Treatment|Physician Decision|1
1177039|NCT01111292|3868122|P1|Treatment|Physician Decision|1
1177040|NCT01111240|3868128|P1|Overall Study|Not Specified|312
1177041|NCT01111240|3868128|P1|Overall Study|Lack of Efficacy and Adverse Event|19
1177042|NCT01111240|3868128|P1|Overall Study|Lack of Efficacy|545
1177043|NCT01111240|3868128|P1|Overall Study|Adverse Event|190
1177044|NCT01111149|3868158|P3|Overall Study|Withdrawal by Subject|2
1177045|NCT01111149|3868159|P2|Overall Study|Withdrawal by Subject|0
1177046|NCT01111149|3868160|P1|Overall Study|Withdrawal by Subject|1
1177047|NCT01111149|3868158|P3|Overall Study|Protocol Violation|2
1177048|NCT01111149|3868159|P2|Overall Study|Protocol Violation|1
1177049|NCT01111149|3868160|P1|Overall Study|Protocol Violation|1
1177050|NCT01111123|3868236|P2|Maintenance Phase|Lost to Follow-up|2
1177051|NCT01111123|3868237|P1|Maintenance Phase|Lost to Follow-up|0
1177052|NCT01111123|3868236|P2|Open- Label Phase|Failed to be clear or almost cleared|0
1177053|NCT01111123|3868237|P1|Open- Label Phase|Failed to be clear or almost cleared|14
1177054|NCT01110915|3868271|P2|Overall Study|Withdrawal by Subject|1
1177055|NCT01110915|3868272|P1|Overall Study|Withdrawal by Subject|7
1177056|NCT01110915|3868271|P2|Overall Study|Lost to Follow-up|0
1177057|NCT01110915|3868272|P1|Overall Study|Lost to Follow-up|1
1177058|NCT01110915|3868271|P2|Overall Study|Death|1
1177059|NCT01110915|3868272|P1|Overall Study|Death|2
1177060|NCT01110707|3868289|P2|Overall Study|Protocol Violation|3
1177061|NCT01110707|3868290|P1|Overall Study|Protocol Violation|0
1177062|NCT01110408|3868370|P2|Overall Study|Protocol Violation|0
1177063|NCT01110408|3868371|P1|Overall Study|Protocol Violation|1
1177064|NCT01110382|3868391|P2|Overall Study|Protocol Violation|1
1177065|NCT01110382|3868392|P1|Overall Study|Protocol Violation|0
1177066|NCT01110382|3868391|P2|Overall Study|Withdrawal by Subject|1
1177067|NCT01110382|3868392|P1|Overall Study|Withdrawal by Subject|0
1177068|NCT01110330|3868413|P3|Overall Study|Not specified|1
1177069|NCT01110330|3868414|P2|Overall Study|Not specified|1
1177070|NCT01110330|3868415|P1|Overall Study|Not specified|1
1177071|NCT01110330|3868413|P3|Overall Study|Withdrawal by Subject|2
1177072|NCT01110330|3868414|P2|Overall Study|Withdrawal by Subject|6
1177073|NCT01110330|3868415|P1|Overall Study|Withdrawal by Subject|0
1177074|NCT01110330|3868413|P3|Overall Study|Protocol Violation|4
1177075|NCT01110330|3868414|P2|Overall Study|Protocol Violation|0
1177076|NCT01110330|3868415|P1|Overall Study|Protocol Violation|2
1177077|NCT01110330|3868413|P3|Overall Study|Physician Decision|0
1177078|NCT01110330|3868414|P2|Overall Study|Physician Decision|1
1177079|NCT01110330|3868415|P1|Overall Study|Physician Decision|0
1177080|NCT01110330|3868413|P3|Overall Study|Lost to Follow-up|15
1177081|NCT01110330|3868414|P2|Overall Study|Lost to Follow-up|10
1177082|NCT01110330|3868415|P1|Overall Study|Lost to Follow-up|9
1177083|NCT01110330|3868413|P3|Overall Study|Lack of Efficacy|1
1177084|NCT01110330|3868414|P2|Overall Study|Lack of Efficacy|1
1177085|NCT01110330|3868415|P1|Overall Study|Lack of Efficacy|3
1177086|NCT01110330|3868413|P3|Overall Study|Adverse Event|3
1177087|NCT01110330|3868414|P2|Overall Study|Adverse Event|4
1177088|NCT01110330|3868415|P1|Overall Study|Adverse Event|0
1177089|NCT01110239|3868443|P4|7.5 Min Ischemia|Withdrawal by Subject|0
1177090|NCT01110239|3868444|P3|7.5 Min Ischemia|Withdrawal by Subject|1
1177091|NCT01110239|3868445|P2|7.5 Min Ischemia|Withdrawal by Subject|0
1177092|NCT01110239|3868446|P1|7.5 Min Ischemia|Withdrawal by Subject|0
1177093|NCT01110239|3868443|P4|Sham Preconditioning|Withdrawal by Subject|0
1177094|NCT01110239|3868444|P3|Sham Preconditioning|Withdrawal by Subject|1
1177095|NCT01110239|3868445|P2|Sham Preconditioning|Withdrawal by Subject|0
1177096|NCT01110239|3868446|P1|Sham Preconditioning|Withdrawal by Subject|0
1177097|NCT01110200|3868462|P2|Overall Study|Lost to Follow-up|7
1177098|NCT01110200|3868463|P1|Overall Study|Lost to Follow-up|10
1177099|NCT01110200|3868462|P2|Overall Study|Physician Decision|17
1177100|NCT01110200|3868463|P1|Overall Study|Physician Decision|13
1177101|NCT01110200|3868462|P2|Overall Study|Protocol Violation|12
1177102|NCT01110200|3868463|P1|Overall Study|Protocol Violation|14
1177103|NCT01110200|3868462|P2|Overall Study|Lack of Efficacy|25
1177104|NCT01110200|3868463|P1|Overall Study|Lack of Efficacy|16
1177105|NCT01110200|3868462|P2|Overall Study|Withdrawal by Subject|32
1177106|NCT01110200|3868463|P1|Overall Study|Withdrawal by Subject|25
1177107|NCT01110200|3868462|P2|Overall Study|Adverse Event|28
1177108|NCT01110200|3868463|P1|Overall Study|Adverse Event|28
1177109|NCT01110005|3868494|P2|Overall Study|Withdrawal by Subject|1
1177110|NCT01110005|3868495|P1|Overall Study|Withdrawal by Subject|0
1177111|NCT01110005|3868494|P2|Overall Study|missing consent|2
1177112|NCT01110005|3868495|P1|Overall Study|missing consent|3
1177113|NCT01110005|3868494|P2|Overall Study|ineligible|2
1177114|NCT01110005|3868495|P1|Overall Study|ineligible|1
1177115|NCT01109992|3868507|P2|Overall Study|Movement during rest scan.|1
1177116|NCT01109992|3868508|P1|Overall Study|Movement during rest scan.|0
1177117|NCT01109992|3868507|P2|Overall Study|Withdrawal by Subject|1
1177118|NCT01109992|3868508|P1|Overall Study|Withdrawal by Subject|0
1177119|NCT01109979|3868522|P2|Overall Study|Withdrawal by Subject|1
1177120|NCT01109979|3868523|P1|Overall Study|Withdrawal by Subject|0
1177121|NCT01109979|3868522|P2|Overall Study|Physician Decision|0
1177122|NCT01109979|3868523|P1|Overall Study|Physician Decision|2
1177123|NCT01109849|3868531|P5|Adaptive Randomization: Weight Recovery|moved away|0
1177124|NCT01109849|3868532|P4|Adaptive Randomization: Weight Recovery|moved away|2
1177125|NCT01109849|3868533|P3|Adaptive Randomization: Weight Recovery|moved away|0
1177126|NCT01109849|3868534|P2|Adaptive Randomization: Weight Recovery|moved away|0
1177127|NCT01109849|3868535|P1|Adaptive Randomization: Weight Recovery|moved away|0
1177128|NCT01109849|3868531|P5|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
1177129|NCT01109849|3868532|P4|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
1177130|NCT01109849|3868533|P3|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
1177131|NCT01109849|3868534|P2|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
1177132|NCT01109849|3868535|P1|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
1177133|NCT01109849|3868531|P5|Initial Randomization: ADHD Treatment|move away|0
1177134|NCT01109849|3868532|P4|Initial Randomization: ADHD Treatment|move away|0
1177135|NCT01109849|3868533|P3|Initial Randomization: ADHD Treatment|move away|0
1177136|NCT01109849|3868534|P2|Initial Randomization: ADHD Treatment|move away|7
1177137|NCT01109849|3868535|P1|Initial Randomization: ADHD Treatment|move away|2
1177138|NCT01109849|3868531|P5|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
1177139|NCT01109849|3868532|P4|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
1177140|NCT01109849|3868533|P3|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
1177141|NCT01109849|3868534|P2|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7
1177142|NCT01109849|3868535|P1|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6
1177143|NCT01109849|3868531|P5|Initial Randomization: ADHD Treatment|Protocol Violation|0
1177144|NCT01109849|3868532|P4|Initial Randomization: ADHD Treatment|Protocol Violation|0
1177145|NCT01109849|3868533|P3|Initial Randomization: ADHD Treatment|Protocol Violation|0
1177146|NCT01109849|3868534|P2|Initial Randomization: ADHD Treatment|Protocol Violation|0
1177147|NCT01109849|3868535|P1|Initial Randomization: ADHD Treatment|Protocol Violation|1
1177148|NCT01109849|3868531|P5|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
1177149|NCT01109849|3868532|P4|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
1177150|NCT01109849|3868533|P3|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
1177151|NCT01109849|3868534|P2|Initial Randomization: ADHD Treatment|Lost to Follow-up|35
1177152|NCT01109849|3868535|P1|Initial Randomization: ADHD Treatment|Lost to Follow-up|9
1177153|NCT01109524|3868604|P1|Overall Study|Not specified|5
1177154|NCT01109524|3868604|P1|Overall Study|Participant requested to end treatment|4
1177155|NCT01109524|3868604|P1|Overall Study|No longer meets criteria|2
1177156|NCT01109524|3868604|P1|Overall Study|Death|2
1177157|NCT01109524|3868604|P1|Overall Study|Maximum clinical benefit|3
1177158|NCT01109524|3868604|P1|Overall Study|Withdrawal by Subject|2
1177159|NCT01109524|3868604|P1|Overall Study|Adverse Event|4
1177160|NCT01109524|3868604|P1|Overall Study|Study Drug toxicity|6
1177161|NCT01109524|3868604|P1|Overall Study|Disease Progression|29
1177162|NCT01109316|3868626|P3|Study Period 3|Withdrawal by Subject|1
1177163|NCT01109316|3868627|P2|Study Period 3|Withdrawal by Subject|1
1177164|NCT01109316|3868628|P1|Study Period 3|Withdrawal by Subject|0
1177165|NCT01109316|3868626|P3|Study Period 3|Lost to Follow-up|0
1177166|NCT01109316|3868627|P2|Study Period 3|Lost to Follow-up|1
1177167|NCT01109316|3868628|P1|Study Period 3|Lost to Follow-up|0
1177168|NCT01109316|3868626|P3|Study Period 2|Withdrawal by Subject|0
1177169|NCT01109316|3868627|P2|Study Period 2|Withdrawal by Subject|1
1177170|NCT01109316|3868628|P1|Study Period 2|Withdrawal by Subject|1
1177171|NCT01109316|3868626|P3|Study Period 2|Protocol Violation|0
1177172|NCT01109316|3868627|P2|Study Period 2|Protocol Violation|1
1177173|NCT01109316|3868628|P1|Study Period 2|Protocol Violation|0
1177174|NCT01109316|3868626|P3|Study Period 2|Physician Decision|1
1177175|NCT01109316|3868627|P2|Study Period 2|Physician Decision|0
1177176|NCT01109316|3868628|P1|Study Period 2|Physician Decision|0
1177177|NCT01109316|3868626|P3|Study Period 2|Entry Criteria Not Met|1
1177178|NCT01109316|3868627|P2|Study Period 2|Entry Criteria Not Met|0
1177179|NCT01109316|3868628|P1|Study Period 2|Entry Criteria Not Met|0
1177180|NCT01109316|3868626|P3|Study Period 1|Sponsor Decision|2
1177181|NCT01109316|3868627|P2|Study Period 1|Sponsor Decision|0
1177182|NCT01109316|3868628|P1|Study Period 1|Sponsor Decision|0
1177183|NCT01109316|3868626|P3|Study Period 1|Withdrawal by Subject|2
1177184|NCT01109316|3868627|P2|Study Period 1|Withdrawal by Subject|1
1177185|NCT01109316|3868628|P1|Study Period 1|Withdrawal by Subject|0
1177186|NCT01109316|3868626|P3|Study Period 1|Lost to Follow-up|0
1177187|NCT01109316|3868627|P2|Study Period 1|Lost to Follow-up|2
1177188|NCT01109316|3868628|P1|Study Period 1|Lost to Follow-up|0
1177189|NCT01109316|3868626|P3|Study Period 1|Adverse Event|0
1177190|NCT01109316|3868627|P2|Study Period 1|Adverse Event|1
1177191|NCT01109316|3868628|P1|Study Period 1|Adverse Event|0
1177192|NCT01109173|3868676|P4|Overall Study|Not Specifiied|14
1177193|NCT01109173|3868677|P3|Overall Study|Not Specifiied|9
1177194|NCT01109173|3868678|P2|Overall Study|Not Specifiied|4
1177195|NCT01109173|3868679|P1|Overall Study|Not Specifiied|5
1177196|NCT01109173|3868676|P4|Overall Study|Patient Did Not Use Study Medication|7
1177197|NCT01109173|3868677|P3|Overall Study|Patient Did Not Use Study Medication|11
1177198|NCT01109173|3868678|P2|Overall Study|Patient Did Not Use Study Medication|26
1177199|NCT01109173|3868679|P1|Overall Study|Patient Did Not Use Study Medication|34
1177200|NCT01109173|3868676|P4|Overall Study|Protocol Violation|2
1177201|NCT01109173|3868677|P3|Overall Study|Protocol Violation|1
1177202|NCT01109173|3868678|P2|Overall Study|Protocol Violation|5
1177203|NCT01109173|3868679|P1|Overall Study|Protocol Violation|4
1177204|NCT01109173|3868676|P4|Overall Study|Treatment Failure|64
1177205|NCT01109173|3868677|P3|Overall Study|Treatment Failure|69
1177206|NCT01109173|3868678|P2|Overall Study|Treatment Failure|32
1177207|NCT01109173|3868679|P1|Overall Study|Treatment Failure|25
1177208|NCT01109173|3868676|P4|Overall Study|Noncompliance|0
1177209|NCT01109173|3868677|P3|Overall Study|Noncompliance|0
1177210|NCT01109173|3868678|P2|Overall Study|Noncompliance|1
1177211|NCT01109173|3868679|P1|Overall Study|Noncompliance|0
1177212|NCT01109173|3868676|P4|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
1177213|NCT01109173|3868677|P3|Overall Study|Patient Decision Unrelated to Advrs Evnt|2
1177214|NCT01109173|3868678|P2|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
1177215|NCT01109173|3868679|P1|Overall Study|Patient Decision Unrelated to Advrs Evnt|5
1177216|NCT01109173|3868676|P4|Overall Study|Lost to Follow-up|0
1177217|NCT01109173|3868677|P3|Overall Study|Lost to Follow-up|0
1177218|NCT01109173|3868678|P2|Overall Study|Lost to Follow-up|1
1177219|NCT01109173|3868679|P1|Overall Study|Lost to Follow-up|0
1177220|NCT01109173|3868676|P4|Overall Study|Adverse Event|6
1177221|NCT01109173|3868677|P3|Overall Study|Adverse Event|9
1177222|NCT01109173|3868678|P2|Overall Study|Adverse Event|17
1177223|NCT01109173|3868679|P1|Overall Study|Adverse Event|15
1177224|NCT01108809|3868785|P1|Overall Study|Lost to Follow-up|1
1177225|NCT01108809|3868785|P1|Overall Study|Adverse Event|3
1177226|NCT01108796|3868802|P2|Overall Study|Lost to Follow-up|6
1177227|NCT01108796|3868803|P1|Overall Study|Lost to Follow-up|7
1177228|NCT01108796|3868802|P2|Overall Study|Adverse Event|1
1177229|NCT01108796|3868803|P1|Overall Study|Adverse Event|0
1177230|NCT01108731|3868846|P2|Overall Study|Adverse Event|3
1177231|NCT01108731|3868847|P1|Overall Study|Adverse Event|3
1177232|NCT01108731|3868846|P2|Overall Study|Withdrawal by Subject|1
1177233|NCT01108731|3868847|P1|Overall Study|Withdrawal by Subject|1
1177234|NCT01108718|3868859|P2|Received Second Intervention (2 Months)|Withdrawal by Subject|0
1177235|NCT01108718|3868860|P1|Received Second Intervention (2 Months)|Withdrawal by Subject|1
1177236|NCT01108523|3868865|P1|Overall Study|Protocol Violation|4
1177237|NCT01108510|3868872|P2|Overall Study|Death|1
1177238|NCT01108510|3868873|P1|Overall Study|Death|1
1177239|NCT01108510|3868872|P2|Overall Study|Pregnancy|3
1177240|NCT01108510|3868873|P1|Overall Study|Pregnancy|0
1177241|NCT01108510|3868872|P2|Overall Study|Lack of Efficacy|0
1177242|NCT01108510|3868873|P1|Overall Study|Lack of Efficacy|3
1177243|NCT01108510|3868872|P2|Overall Study|Participant Noncompliance|7
1177244|NCT01108510|3868873|P1|Overall Study|Participant Noncompliance|5
1177245|NCT01108510|3868872|P2|Overall Study|Investigator’s Discretion|10
1177246|NCT01108510|3868873|P1|Overall Study|Investigator’s Discretion|12
1177247|NCT01108510|3868872|P2|Overall Study|Withdrew Consent|15
1177248|NCT01108510|3868873|P1|Overall Study|Withdrew Consent|21
1177249|NCT01108510|3868872|P2|Overall Study|Lost to Follow-up|17
1177250|NCT01108510|3868873|P1|Overall Study|Lost to Follow-up|20
1177251|NCT01108510|3868872|P2|Overall Study|Adverse Event|19
1177252|NCT01108510|3868873|P1|Overall Study|Adverse Event|26
1177253|NCT01108510|3868872|P2|Overall Study|Joined Another Gilead-sponsored Study|195
1177254|NCT01108510|3868873|P1|Overall Study|Joined Another Gilead-sponsored Study|186
1177255|NCT01108510|3868872|P2|Overall Study|Randomized but Not Treated|1
1177256|NCT01108510|3868873|P1|Overall Study|Randomized but Not Treated|5
1177257|NCT01108458|3868893|P1|Overall Study|Withdrawal by Subject|1
1177258|NCT01108341|3868945|P1|Overall Study|not specified|1
1177259|NCT01108341|3868945|P1|Overall Study|Lost to Follow-up|1
1177260|NCT01108341|3868945|P1|Overall Study|Withdrawal by Subject|1
1177261|NCT01108341|3868945|P1|Overall Study|Death|2
1177262|NCT01108263|3868952|P2|Overall Study|Adverse Event|1
1177263|NCT01108263|3868953|P1|Overall Study|Adverse Event|0
1177264|NCT01108237|3868963|P2|Overall Study|Did not meet criteria for analysis|0
1177265|NCT01108237|3868964|P1|Overall Study|Did not meet criteria for analysis|7
1177266|NCT01108237|3868963|P2|Overall Study|No alignment data|17
1177267|NCT01108237|3868964|P1|Overall Study|No alignment data|2
1177268|NCT01108185|3868970|P1|Overall Study|Lost to Follow-up|12
1177269|NCT01108185|3868970|P1|Overall Study|Non-compliance|15
1177270|NCT01108094|3868987|P4|Overall Study|Withdrawal by Subject|0
1177271|NCT01108094|3868988|P3|Overall Study|Withdrawal by Subject|0
1177272|NCT01108094|3868989|P2|Overall Study|Withdrawal by Subject|0
1177273|NCT01108094|3868990|P1|Overall Study|Withdrawal by Subject|1
1177274|NCT01108094|3868987|P4|Overall Study|Adverse Event|0
1177275|NCT01108094|3868988|P3|Overall Study|Adverse Event|0
1177276|NCT01108094|3868989|P2|Overall Study|Adverse Event|0
1177277|NCT01108094|3868990|P1|Overall Study|Adverse Event|2
1177278|NCT01108068|3869034|P2|Overall Study|5 not started, 1 stop due to side effect|0
1177279|NCT01108068|3869035|P1|Overall Study|5 not started, 1 stop due to side effect|6
1177280|NCT01108055|3869042|P1|Overall Study|Not evaluable- didn't complete treatment|4
1177281|NCT01108055|3869042|P1|Overall Study|Ineligible|11
1177282|NCT01107925|3869080|P6|Period 2|Withdrawal by Subject|1
1177283|NCT01107925|3869081|P5|Period 2|Withdrawal by Subject|0
1177284|NCT01107925|3869082|P4|Period 2|Withdrawal by Subject|0
1177285|NCT01107925|3869083|P3|Period 2|Withdrawal by Subject|0
1177286|NCT01107925|3869084|P2|Period 2|Withdrawal by Subject|1
1177287|NCT01107925|3869085|P1|Period 2|Withdrawal by Subject|0
1177288|NCT01107925|3869080|P6|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
1177289|NCT01107925|3869081|P5|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
1177290|NCT01107925|3869082|P4|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
1177291|NCT01107925|3869083|P3|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
1177292|NCT01107925|3869084|P2|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
1177293|NCT01107925|3869085|P1|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
1177294|NCT01107912|3869123|P6|Period 3|Withdrawal by Subject|0
1177295|NCT01107912|3869124|P5|Period 3|Withdrawal by Subject|0
1177296|NCT01107912|3869125|P4|Period 3|Withdrawal by Subject|1
1177297|NCT01107912|3869126|P3|Period 3|Withdrawal by Subject|0
1177298|NCT01107912|3869127|P2|Period 3|Withdrawal by Subject|0
1177299|NCT01107912|3869128|P1|Period 3|Withdrawal by Subject|0
1177300|NCT01107912|3869123|P6|Period 3|Adverse Event|0
1177301|NCT01107912|3869124|P5|Period 3|Adverse Event|0
1177302|NCT01107912|3869125|P4|Period 3|Adverse Event|0
1177303|NCT01107912|3869126|P3|Period 3|Adverse Event|1
1177304|NCT01107912|3869127|P2|Period 3|Adverse Event|1
1177305|NCT01107912|3869128|P1|Period 3|Adverse Event|0
1177306|NCT01107912|3869123|P6|Period 2|Physician Decision|0
1177307|NCT01107912|3869124|P5|Period 2|Physician Decision|0
1177308|NCT01107912|3869125|P4|Period 2|Physician Decision|0
1177309|NCT01107912|3869126|P3|Period 2|Physician Decision|1
1177310|NCT01107912|3869127|P2|Period 2|Physician Decision|0
1177311|NCT01107912|3869128|P1|Period 2|Physician Decision|0
1177312|NCT01107912|3869123|P6|Period 1|Withdrawal by Subject|0
1177313|NCT01107912|3869124|P5|Period 1|Withdrawal by Subject|0
1177314|NCT01107912|3869125|P4|Period 1|Withdrawal by Subject|0
1177315|NCT01107912|3869126|P3|Period 1|Withdrawal by Subject|0
1177316|NCT01107912|3869127|P2|Period 1|Withdrawal by Subject|0
1177317|NCT01107912|3869128|P1|Period 1|Withdrawal by Subject|1
1177318|NCT01107912|3869123|P6|Period 1|Physician Decision|0
1177319|NCT01107912|3869124|P5|Period 1|Physician Decision|1
1177320|NCT01107912|3869125|P4|Period 1|Physician Decision|0
1177321|NCT01107912|3869126|P3|Period 1|Physician Decision|0
1177322|NCT01107912|3869127|P2|Period 1|Physician Decision|0
1177323|NCT01107912|3869128|P1|Period 1|Physician Decision|0
1177324|NCT01107912|3869123|P6|Period 1|Adverse Event|0
1177325|NCT01107912|3869124|P5|Period 1|Adverse Event|2
1177326|NCT01107912|3869125|P4|Period 1|Adverse Event|0
1177327|NCT01107912|3869126|P3|Period 1|Adverse Event|0
1177328|NCT01107912|3869127|P2|Period 1|Adverse Event|0
1177329|NCT01107912|3869128|P1|Period 1|Adverse Event|0
1177330|NCT01107899|3869165|P3|Overall Study|Withdrawal by Subject|1
1177331|NCT01107899|3869166|P2|Overall Study|Withdrawal by Subject|0
1177332|NCT01107899|3869167|P1|Overall Study|Withdrawal by Subject|0
1177333|NCT01107899|3869165|P3|Overall Study|Physician Decision|3
1177334|NCT01107899|3869166|P2|Overall Study|Physician Decision|0
1177335|NCT01107899|3869167|P1|Overall Study|Physician Decision|5
1177336|NCT01107886|3869213|P2|Overall Study|Administrative withdrawal of consent|5
1177337|NCT01107886|3869214|P1|Overall Study|Administrative withdrawal of consent|7
1177338|NCT01107886|3869213|P2|Overall Study|Withdrawal by Subject|196
1177339|NCT01107886|3869214|P1|Overall Study|Withdrawal by Subject|180
1177340|NCT01107886|3869213|P2|Overall Study|Lost to Follow-up|13
1177341|NCT01107886|3869214|P1|Overall Study|Lost to Follow-up|15
1177342|NCT01107743|3869243|P1|Overall Study|Protocol Violation|46
1177343|NCT01107535|3869342|P1|Overall Study|Death|5
1177344|NCT01107457|3869355|P6|Part B and C|Clinical Relapse|4
1177345|NCT01107457|3869356|P5|Part B and C|Clinical Relapse|0
1177346|NCT01107457|3869357|P4|Part B and C|Clinical Relapse|0
1177347|NCT01107457|3869358|P3|Part B and C|Clinical Relapse|0
1177348|NCT01107457|3869359|P2|Part B and C|Clinical Relapse|0
1177349|NCT01107457|3869360|P1|Part B and C|Clinical Relapse|0
1177350|NCT01107457|3869355|P6|Part B and C|Withdrawal by Subject|16
1177351|NCT01107457|3869356|P5|Part B and C|Withdrawal by Subject|0
1177352|NCT01107457|3869357|P4|Part B and C|Withdrawal by Subject|0
1177353|NCT01107457|3869358|P3|Part B and C|Withdrawal by Subject|0
1177354|NCT01107457|3869359|P2|Part B and C|Withdrawal by Subject|0
1177355|NCT01107457|3869360|P1|Part B and C|Withdrawal by Subject|0
1177356|NCT01107457|3869355|P6|Part B and C|Sponsor Decision|66
1177357|NCT01107457|3869356|P5|Part B and C|Sponsor Decision|0
1177358|NCT01107457|3869357|P4|Part B and C|Sponsor Decision|0
1177359|NCT01107457|3869358|P3|Part B and C|Sponsor Decision|0
1177360|NCT01107457|3869359|P2|Part B and C|Sponsor Decision|0
1177361|NCT01107457|3869360|P1|Part B and C|Sponsor Decision|0
1177362|NCT01107457|3869355|P6|Part B and C|Protocol Violation|1
1177363|NCT01107457|3869356|P5|Part B and C|Protocol Violation|0
1177364|NCT01107457|3869357|P4|Part B and C|Protocol Violation|0
1177365|NCT01107457|3869358|P3|Part B and C|Protocol Violation|0
1177366|NCT01107457|3869359|P2|Part B and C|Protocol Violation|0
1177367|NCT01107457|3869360|P1|Part B and C|Protocol Violation|0
1177368|NCT01107457|3869355|P6|Part B and C|Lost to Follow-up|10
1177369|NCT01107457|3869356|P5|Part B and C|Lost to Follow-up|0
1177370|NCT01107457|3869357|P4|Part B and C|Lost to Follow-up|0
1177371|NCT01107457|3869358|P3|Part B and C|Lost to Follow-up|0
1177372|NCT01107457|3869359|P2|Part B and C|Lost to Follow-up|0
1177373|NCT01107457|3869360|P1|Part B and C|Lost to Follow-up|0
1177374|NCT01107457|3869355|P6|Part B and C|Lack of Efficacy|7
1177375|NCT01107457|3869356|P5|Part B and C|Lack of Efficacy|0
1177376|NCT01107457|3869357|P4|Part B and C|Lack of Efficacy|0
1177377|NCT01107457|3869358|P3|Part B and C|Lack of Efficacy|0
1177378|NCT01107457|3869359|P2|Part B and C|Lack of Efficacy|0
1177379|NCT01107457|3869360|P1|Part B and C|Lack of Efficacy|0
1177380|NCT01107457|3869355|P6|Part B and C|Physician Decision|3
1177381|NCT01107457|3869356|P5|Part B and C|Physician Decision|0
1177382|NCT01107457|3869357|P4|Part B and C|Physician Decision|0
1177383|NCT01107457|3869358|P3|Part B and C|Physician Decision|0
1177384|NCT01107457|3869359|P2|Part B and C|Physician Decision|0
1177385|NCT01107457|3869360|P1|Part B and C|Physician Decision|0
1177386|NCT01107457|3869355|P6|Part B and C|Inclusion/Exclusion Criteria Not Met|1
1177387|NCT01107457|3869356|P5|Part B and C|Inclusion/Exclusion Criteria Not Met|0
1177388|NCT01107457|3869357|P4|Part B and C|Inclusion/Exclusion Criteria Not Met|0
1177389|NCT01107457|3869358|P3|Part B and C|Inclusion/Exclusion Criteria Not Met|0
1177390|NCT01107457|3869359|P2|Part B and C|Inclusion/Exclusion Criteria Not Met|0
1177391|NCT01107457|3869360|P1|Part B and C|Inclusion/Exclusion Criteria Not Met|0
1177392|NCT01107457|3869355|P6|Part B and C|Adverse Event|12
1177393|NCT01107457|3869356|P5|Part B and C|Adverse Event|0
1177394|NCT01107457|3869357|P4|Part B and C|Adverse Event|0
1177395|NCT01107457|3869358|P3|Part B and C|Adverse Event|0
1177396|NCT01107457|3869359|P2|Part B and C|Adverse Event|0
1177397|NCT01107457|3869360|P1|Part B and C|Adverse Event|0
1177398|NCT01107457|3869355|P6|Part A|Protocol Violation|0
1177399|NCT01107457|3869356|P5|Part A|Protocol Violation|0
1177400|NCT01107457|3869357|P4|Part A|Protocol Violation|0
1177401|NCT01107457|3869358|P3|Part A|Protocol Violation|0
1177402|NCT01107457|3869359|P2|Part A|Protocol Violation|1
1177403|NCT01107457|3869360|P1|Part A|Protocol Violation|0
1177404|NCT01107457|3869355|P6|Part A|Lack of Efficacy|0
1177405|NCT01107457|3869356|P5|Part A|Lack of Efficacy|0
1177406|NCT01107457|3869357|P4|Part A|Lack of Efficacy|0
1177407|NCT01107457|3869358|P3|Part A|Lack of Efficacy|0
1177408|NCT01107457|3869359|P2|Part A|Lack of Efficacy|0
1177409|NCT01107457|3869360|P1|Part A|Lack of Efficacy|1
1177410|NCT01107457|3869355|P6|Part A|Lost to Follow-up|0
1177411|NCT01107457|3869356|P5|Part A|Lost to Follow-up|0
1177412|NCT01107457|3869357|P4|Part A|Lost to Follow-up|0
1177413|NCT01107457|3869358|P3|Part A|Lost to Follow-up|0
1177414|NCT01107457|3869359|P2|Part A|Lost to Follow-up|1
1177415|NCT01107457|3869360|P1|Part A|Lost to Follow-up|0
1177416|NCT01107457|3869355|P6|Part A|Withdrawal by Subject|0
1177417|NCT01107457|3869356|P5|Part A|Withdrawal by Subject|1
1177418|NCT01107457|3869357|P4|Part A|Withdrawal by Subject|3
1177419|NCT01107457|3869358|P3|Part A|Withdrawal by Subject|0
1177420|NCT01107457|3869359|P2|Part A|Withdrawal by Subject|3
1177421|NCT01107457|3869360|P1|Part A|Withdrawal by Subject|3
1177422|NCT01107457|3869355|P6|Part A|Adverse Event|0
1177423|NCT01107457|3869356|P5|Part A|Adverse Event|0
1177424|NCT01107457|3869357|P4|Part A|Adverse Event|0
1177425|NCT01107457|3869358|P3|Part A|Adverse Event|1
1177426|NCT01107457|3869359|P2|Part A|Adverse Event|2
1177427|NCT01107457|3869360|P1|Part A|Adverse Event|1
1177428|NCT01107418|3869490|P1|Overall Study|Entered Extension Study|1
1177429|NCT01107418|3869490|P1|Overall Study|Started Other Therapy|1
1177430|NCT01107418|3869490|P1|Overall Study|Study Closing|1
1177431|NCT01107418|3869490|P1|Overall Study|Withdrawal by Subject|1
1177432|NCT01107418|3869490|P1|Overall Study|Adverse Event|3
1177433|NCT01107418|3869490|P1|Overall Study|Disease Progression|45
1177434|NCT01107405|3869563|P5|Overall Study|Protocol Violation|0
1177435|NCT01107405|3869564|P4|Overall Study|Protocol Violation|1
1177436|NCT01107405|3869565|P3|Overall Study|Protocol Violation|1
1177437|NCT01107405|3869566|P2|Overall Study|Protocol Violation|0
1177438|NCT01107405|3869567|P1|Overall Study|Protocol Violation|0
1177439|NCT01107405|3869563|P5|Overall Study|Withdrawal by Subject|1
1177440|NCT01107405|3869564|P4|Overall Study|Withdrawal by Subject|2
1177441|NCT01107405|3869565|P3|Overall Study|Withdrawal by Subject|1
1177442|NCT01107405|3869566|P2|Overall Study|Withdrawal by Subject|0
1177443|NCT01107405|3869567|P1|Overall Study|Withdrawal by Subject|1
1177444|NCT01107405|3869563|P5|Overall Study|Adverse Event|2
1177445|NCT01107405|3869564|P4|Overall Study|Adverse Event|0
1177446|NCT01107405|3869565|P3|Overall Study|Adverse Event|0
1177447|NCT01107405|3869566|P2|Overall Study|Adverse Event|1
1177448|NCT01107405|3869567|P1|Overall Study|Adverse Event|1
1177449|NCT01107392|3869606|P2|Overall Study|Administrative decision|0
1177450|NCT01107392|3869607|P1|Overall Study|Administrative decision|1
1177451|NCT01107392|3869606|P2|Overall Study|Personal Reasons|3
1177452|NCT01107392|3869607|P1|Overall Study|Personal Reasons|2
1177453|NCT01107392|3869606|P2|Overall Study|Adverse Event|0
1177454|NCT01107392|3869607|P1|Overall Study|Adverse Event|2
1177455|NCT01107379|3869619|P1|Overall Study|Lost to Follow-up|3
1177456|NCT01107379|3869619|P1|Overall Study|Withdrawal by Subject|18
1177457|NCT01107353|3869630|P2|Overall Study|Positive Drug Screen|0
1177458|NCT01107353|3869631|P1|Overall Study|Positive Drug Screen|1
1177459|NCT01107197|3869639|P2|Overall Study|Withdrawal by Subject|5
1177460|NCT01107197|3869640|P1|Overall Study|Withdrawal by Subject|3
1177461|NCT01107197|3869639|P2|Overall Study|Lost to Follow-up|8
1177462|NCT01107197|3869640|P1|Overall Study|Lost to Follow-up|5
1177463|NCT01107197|3869639|P2|Overall Study|Death|10
1177464|NCT01107197|3869640|P1|Overall Study|Death|12
1177465|NCT01106976|3869675|P1|Overall Study|Lost to Follow-up|8
1177466|NCT01106911|3869689|P1|Overall Study|deemed ineligible after screening|3
1177467|NCT01106911|3869689|P1|Overall Study|Physician Decision|2
1177468|NCT01106898|3869693|P1|Overall Study|Adverse Event|6
1177469|NCT01106846|3869738|P2|Overall Study|Change in surgical procedure|1
1177470|NCT01106846|3869739|P1|Overall Study|Change in surgical procedure|0
1177471|NCT01106690|3869789|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
1177472|NCT01106690|3869790|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
1177473|NCT01106690|3869791|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
1177474|NCT01106690|3869789|P3|Extension Period: Week 26 to Week 52|Not specified|4
1177475|NCT01106690|3869790|P2|Extension Period: Week 26 to Week 52|Not specified|3
1177476|NCT01106690|3869791|P1|Extension Period: Week 26 to Week 52|Not specified|8
1177477|NCT01106690|3869789|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
1177478|NCT01106690|3869790|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
1177479|NCT01106690|3869791|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
1177480|NCT01106690|3869789|P3|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
1177481|NCT01106690|3869790|P2|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
1177482|NCT01106690|3869791|P1|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
1177483|NCT01106690|3869789|P3|Extension Period: Week 26 to Week 52|Physician Decision|2
1177484|NCT01106690|3869790|P2|Extension Period: Week 26 to Week 52|Physician Decision|2
1177485|NCT01106690|3869791|P1|Extension Period: Week 26 to Week 52|Physician Decision|0
1177486|NCT01106690|3869789|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
1177487|NCT01106690|3869790|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
1177488|NCT01106690|3869791|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
1177489|NCT01106690|3869789|P3|Extension Period: Week 26 to Week 52|Adverse Event|0
1177490|NCT01106690|3869790|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
1177491|NCT01106690|3869791|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
1177492|NCT01106690|3869789|P3|Core Period: Baseline to Week 26|Not specified|6
1177493|NCT01106690|3869790|P2|Core Period: Baseline to Week 26|Not specified|2
1177494|NCT01106690|3869791|P1|Core Period: Baseline to Week 26|Not specified|10
1177495|NCT01106690|3869789|P3|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
1177496|NCT01106690|3869790|P2|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
1177497|NCT01106690|3869791|P1|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
1177498|NCT01106690|3869789|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
1177499|NCT01106690|3869790|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
1177500|NCT01106690|3869791|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
1177501|NCT01106690|3869789|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
1177502|NCT01106690|3869790|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
1177503|NCT01106690|3869791|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|0
1177504|NCT01106690|3869789|P3|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
1177505|NCT01106690|3869790|P2|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
1177506|NCT01106690|3869791|P1|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0
1177507|NCT01106690|3869789|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|0
1177508|NCT01106690|3869790|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|1
1177509|NCT01106690|3869791|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|4
1177510|NCT01106690|3869789|P3|Core Period: Baseline to Week 26|Protocol Violation|0
1177511|NCT01106690|3869790|P2|Core Period: Baseline to Week 26|Protocol Violation|0
1177512|NCT01106690|3869791|P1|Core Period: Baseline to Week 26|Protocol Violation|1
1177513|NCT01106690|3869789|P3|Core Period: Baseline to Week 26|Lost to Follow-up|2
1177514|NCT01106690|3869790|P2|Core Period: Baseline to Week 26|Lost to Follow-up|1
1177515|NCT01106690|3869791|P1|Core Period: Baseline to Week 26|Lost to Follow-up|1
1177516|NCT01106690|3869789|P3|Core Period: Baseline to Week 26|Adverse Event|4
1177517|NCT01106690|3869790|P2|Core Period: Baseline to Week 26|Adverse Event|1
1177518|NCT01106690|3869791|P1|Core Period: Baseline to Week 26|Adverse Event|6
1177519|NCT01106677|3869827|P4|Extension Period: Week 26 to Week 52|Not specified|5
1177520|NCT01106677|3869828|P3|Extension Period: Week 26 to Week 52|Not specified|8
1177521|NCT01106677|3869829|P2|Extension Period: Week 26 to Week 52|Not specified|5
1177522|NCT01106677|3869830|P1|Extension Period: Week 26 to Week 52|Not specified|6
1177523|NCT01106677|3869827|P4|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
1177524|NCT01106677|3869828|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
1177525|NCT01106677|3869829|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
1177526|NCT01106677|3869830|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
1177527|NCT01106677|3869827|P4|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
1177528|NCT01106677|3869828|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3
1177529|NCT01106677|3869829|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
1177530|NCT01106677|3869830|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
1177531|NCT01106677|3869827|P4|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
1177532|NCT01106677|3869828|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
1177533|NCT01106677|3869829|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3
1177534|NCT01106677|3869830|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
1177535|NCT01106677|3869827|P4|Extension Period: Week 26 to Week 52|Protocol Violation|0
1177536|NCT01106677|3869828|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
1177537|NCT01106677|3869829|P2|Extension Period: Week 26 to Week 52|Protocol Violation|0
1177538|NCT01106677|3869830|P1|Extension Period: Week 26 to Week 52|Protocol Violation|1
1177539|NCT01106677|3869827|P4|Extension Period: Week 26 to Week 52|Physician Decision|3
1177540|NCT01106677|3869828|P3|Extension Period: Week 26 to Week 52|Physician Decision|2
1177541|NCT01106677|3869829|P2|Extension Period: Week 26 to Week 52|Physician Decision|3
1177542|NCT01106677|3869830|P1|Extension Period: Week 26 to Week 52|Physician Decision|2
1177543|NCT01106677|3869827|P4|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
1177544|NCT01106677|3869828|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
1177545|NCT01106677|3869829|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
1177546|NCT01106677|3869830|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
1177547|NCT01106677|3869827|P4|Extension Period: Week 26 to Week 52|Lack of Efficacy|4
1177548|NCT01106677|3869828|P3|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
1177549|NCT01106677|3869829|P2|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
1177550|NCT01106677|3869830|P1|Extension Period: Week 26 to Week 52|Lack of Efficacy|2
1177551|NCT01106677|3869827|P4|Extension Period: Week 26 to Week 52|Death|1
1177552|NCT01106677|3869828|P3|Extension Period: Week 26 to Week 52|Death|0
1177553|NCT01106677|3869829|P2|Extension Period: Week 26 to Week 52|Death|0
1177554|NCT01106677|3869830|P1|Extension Period: Week 26 to Week 52|Death|0
1177555|NCT01106677|3869827|P4|Extension Period: Week 26 to Week 52|Adverse Event|9
1177556|NCT01106677|3869828|P3|Extension Period: Week 26 to Week 52|Adverse Event|5
1177557|NCT01106677|3869829|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
1177558|NCT01106677|3869830|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
1177559|NCT01106677|3869827|P4|Core Period: Baseline to Week 26|Pregnancy|0
1177560|NCT01106677|3869828|P3|Core Period: Baseline to Week 26|Pregnancy|0
1177561|NCT01106677|3869829|P2|Core Period: Baseline to Week 26|Pregnancy|1
1177562|NCT01106677|3869830|P1|Core Period: Baseline to Week 26|Pregnancy|0
1177563|NCT01106677|3869827|P4|Core Period: Baseline to Week 26|Not specified|23
1177564|NCT01106677|3869828|P3|Core Period: Baseline to Week 26|Not specified|8
1177565|NCT01106677|3869829|P2|Core Period: Baseline to Week 26|Not specified|14
1177566|NCT01106677|3869830|P1|Core Period: Baseline to Week 26|Not specified|8
1177567|NCT01106677|3869827|P4|Core Period: Baseline to Week 26|Product quality complaint|0
1177568|NCT01106677|3869828|P3|Core Period: Baseline to Week 26|Product quality complaint|1
1177569|NCT01106677|3869829|P2|Core Period: Baseline to Week 26|Product quality complaint|1
1177570|NCT01106677|3869830|P1|Core Period: Baseline to Week 26|Product quality complaint|0
1177571|NCT01106677|3869827|P4|Core Period: Baseline to Week 26|Study terminated by sponsor|0
1177572|NCT01106677|3869828|P3|Core Period: Baseline to Week 26|Study terminated by sponsor|2
1177573|NCT01106677|3869829|P2|Core Period: Baseline to Week 26|Study terminated by sponsor|1
1177574|NCT01106677|3869830|P1|Core Period: Baseline to Week 26|Study terminated by sponsor|0
1177575|NCT01106677|3869827|P4|Core Period: Baseline to Week 26|Noncompliance with study drug|0
1177576|NCT01106677|3869828|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
1177733|NCT01106404|3870056|P1|Period I (First 6 Weeks)|Lack of Efficacy|0
1177577|NCT01106677|3869829|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|3
1177578|NCT01106677|3869830|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|1
1177579|NCT01106677|3869827|P4|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
1177580|NCT01106677|3869828|P3|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
1177581|NCT01106677|3869829|P2|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
1177582|NCT01106677|3869830|P1|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
1177583|NCT01106677|3869827|P4|Core Period: Baseline to Week 26|Withdrawal by Subject|6
1177584|NCT01106677|3869828|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|15
1177585|NCT01106677|3869829|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|3
1177586|NCT01106677|3869830|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|5
1177587|NCT01106677|3869827|P4|Core Period: Baseline to Week 26|Protocol Violation|3
1177588|NCT01106677|3869828|P3|Core Period: Baseline to Week 26|Protocol Violation|0
1177589|NCT01106677|3869829|P2|Core Period: Baseline to Week 26|Protocol Violation|1
1177590|NCT01106677|3869830|P1|Core Period: Baseline to Week 26|Protocol Violation|0
1177591|NCT01106677|3869827|P4|Core Period: Baseline to Week 26|Physician Decision|1
1177592|NCT01106677|3869828|P3|Core Period: Baseline to Week 26|Physician Decision|3
1177593|NCT01106677|3869829|P2|Core Period: Baseline to Week 26|Physician Decision|1
1177594|NCT01106677|3869830|P1|Core Period: Baseline to Week 26|Physician Decision|2
1177595|NCT01106677|3869827|P4|Core Period: Baseline to Week 26|Lost to Follow-up|3
1177596|NCT01106677|3869828|P3|Core Period: Baseline to Week 26|Lost to Follow-up|6
1177597|NCT01106677|3869829|P2|Core Period: Baseline to Week 26|Lost to Follow-up|1
1177598|NCT01106677|3869830|P1|Core Period: Baseline to Week 26|Lost to Follow-up|3
1177599|NCT01106677|3869827|P4|Core Period: Baseline to Week 26|Lack of Efficacy|0
1177600|NCT01106677|3869828|P3|Core Period: Baseline to Week 26|Lack of Efficacy|0
1177601|NCT01106677|3869829|P2|Core Period: Baseline to Week 26|Lack of Efficacy|0
1177602|NCT01106677|3869830|P1|Core Period: Baseline to Week 26|Lack of Efficacy|1
1177603|NCT01106677|3869827|P4|Core Period: Baseline to Week 26|Death|0
1177604|NCT01106677|3869828|P3|Core Period: Baseline to Week 26|Death|1
1177605|NCT01106677|3869829|P2|Core Period: Baseline to Week 26|Death|0
1177606|NCT01106677|3869830|P1|Core Period: Baseline to Week 26|Death|0
1177607|NCT01106677|3869827|P4|Core Period: Baseline to Week 26|Adverse Event|8
1177608|NCT01106677|3869828|P3|Core Period: Baseline to Week 26|Adverse Event|6
1177609|NCT01106677|3869829|P2|Core Period: Baseline to Week 26|Adverse Event|18
1177610|NCT01106677|3869830|P1|Core Period: Baseline to Week 26|Adverse Event|7
1177611|NCT01106651|3869893|P3|Overall Study|Death|0
1177612|NCT01106651|3869894|P2|Overall Study|Death|3
1177613|NCT01106651|3869895|P1|Overall Study|Death|0
1177614|NCT01106651|3869893|P3|Overall Study|Not specified|21
1177615|NCT01106651|3869894|P2|Overall Study|Not specified|31
1177616|NCT01106651|3869895|P1|Overall Study|Not specified|34
1177617|NCT01106651|3869893|P3|Overall Study|Noncompliance with study drug|2
1177618|NCT01106651|3869894|P2|Overall Study|Noncompliance with study drug|0
1177619|NCT01106651|3869895|P1|Overall Study|Noncompliance with study drug|1
1177620|NCT01106651|3869893|P3|Overall Study|Withdrawal by Subject|4
1177621|NCT01106651|3869894|P2|Overall Study|Withdrawal by Subject|7
1177622|NCT01106651|3869895|P1|Overall Study|Withdrawal by Subject|14
1177623|NCT01106651|3869893|P3|Overall Study|Protocol Violation|1
1177624|NCT01106651|3869894|P2|Overall Study|Protocol Violation|2
1177625|NCT01106651|3869895|P1|Overall Study|Protocol Violation|1
1177626|NCT01106651|3869893|P3|Overall Study|Physician Decision|1
1177627|NCT01106651|3869894|P2|Overall Study|Physician Decision|3
1177628|NCT01106651|3869895|P1|Overall Study|Physician Decision|4
1177629|NCT01106651|3869893|P3|Overall Study|Lost to Follow-up|6
1177630|NCT01106651|3869894|P2|Overall Study|Lost to Follow-up|2
1177631|NCT01106651|3869895|P1|Overall Study|Lost to Follow-up|8
1177632|NCT01106651|3869893|P3|Overall Study|Adverse Event|23
1177633|NCT01106651|3869894|P2|Overall Study|Adverse Event|9
1177634|NCT01106651|3869895|P1|Overall Study|Adverse Event|17
1177635|NCT01106625|3869948|P3|Extension Period: Week 26 to Week 52|Not specified|4
1177636|NCT01106625|3869949|P2|Extension Period: Week 26 to Week 52|Not specified|5
1177637|NCT01106625|3869950|P1|Extension Period: Week 26 to Week 52|Not specified|5
1177638|NCT01106625|3869948|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
1177639|NCT01106625|3869949|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
1177640|NCT01106625|3869950|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
1177641|NCT01106625|3869948|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4
1177642|NCT01106625|3869949|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5
1177643|NCT01106625|3869950|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14
1177644|NCT01106625|3869948|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
1177645|NCT01106625|3869949|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
1177646|NCT01106625|3869950|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4
1177647|NCT01106625|3869948|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
1177648|NCT01106625|3869949|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
1177649|NCT01106625|3869950|P1|Extension Period: Week 26 to Week 52|Protocol Violation|0
1177650|NCT01106625|3869948|P3|Extension Period: Week 26 to Week 52|Physician Decision|1
1177651|NCT01106625|3869949|P2|Extension Period: Week 26 to Week 52|Physician Decision|0
1177652|NCT01106625|3869950|P1|Extension Period: Week 26 to Week 52|Physician Decision|2
1177653|NCT01106625|3869948|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
1177654|NCT01106625|3869949|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|3
1177655|NCT01106625|3869950|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
1177656|NCT01106625|3869948|P3|Extension Period: Week 26 to Week 52|Adverse Event|3
1177657|NCT01106625|3869949|P2|Extension Period: Week 26 to Week 52|Adverse Event|2
1177658|NCT01106625|3869950|P1|Extension Period: Week 26 to Week 52|Adverse Event|2
1177659|NCT01106625|3869948|P3|Core Period: Baseline to Week 26|Not specified|4
1177660|NCT01106625|3869949|P2|Core Period: Baseline to Week 26|Not specified|7
1177661|NCT01106625|3869950|P1|Core Period: Baseline to Week 26|Not specified|8
1177662|NCT01106625|3869948|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
1177663|NCT01106625|3869949|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
1177664|NCT01106625|3869950|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|1
1177665|NCT01106625|3869948|P3|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
1177666|NCT01106625|3869949|P2|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
1177667|NCT01106625|3869950|P1|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0
1177668|NCT01106625|3869948|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
1177669|NCT01106625|3869949|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
1177670|NCT01106625|3869950|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|4
1177671|NCT01106625|3869948|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|7
1177672|NCT01106625|3869949|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|9
1177673|NCT01106625|3869950|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|6
1177674|NCT01106625|3869948|P3|Core Period: Baseline to Week 26|Protocol Violation|3
1177675|NCT01106625|3869949|P2|Core Period: Baseline to Week 26|Protocol Violation|1
1177676|NCT01106625|3869950|P1|Core Period: Baseline to Week 26|Protocol Violation|2
1177677|NCT01106625|3869948|P3|Core Period: Baseline to Week 26|Physician Decision|0
1177678|NCT01106625|3869949|P2|Core Period: Baseline to Week 26|Physician Decision|0
1177679|NCT01106625|3869950|P1|Core Period: Baseline to Week 26|Physician Decision|1
1177680|NCT01106625|3869948|P3|Core Period: Baseline to Week 26|Lost to Follow-up|4
1177681|NCT01106625|3869949|P2|Core Period: Baseline to Week 26|Lost to Follow-up|0
1177682|NCT01106625|3869950|P1|Core Period: Baseline to Week 26|Lost to Follow-up|5
1177683|NCT01106625|3869948|P3|Core Period: Baseline to Week 26|Adverse Event|8
1177684|NCT01106625|3869949|P2|Core Period: Baseline to Week 26|Adverse Event|8
1177685|NCT01106625|3869950|P1|Core Period: Baseline to Week 26|Adverse Event|6
1177686|NCT01106586|3869981|P2|Overall Study|Participant Transferred to Another Study|197
1177687|NCT01106586|3869982|P1|Overall Study|Participant Transferred to Another Study|212
1177688|NCT01106586|3869981|P2|Overall Study|Protocol Violation|0
1177689|NCT01106586|3869982|P1|Overall Study|Protocol Violation|1
1177690|NCT01106586|3869981|P2|Overall Study|Participant Noncompliance|10
1177691|NCT01106586|3869982|P1|Overall Study|Participant Noncompliance|12
1177692|NCT01106586|3869981|P2|Overall Study|Lost to Follow-up|20
1177693|NCT01106586|3869982|P1|Overall Study|Lost to Follow-up|24
1177694|NCT01106586|3869981|P2|Overall Study|Withdrew Consent|30
1177695|NCT01106586|3869982|P1|Overall Study|Withdrew Consent|18
1177696|NCT01106586|3869981|P2|Overall Study|Investigator's Discretion|8
1177697|NCT01106586|3869982|P1|Overall Study|Investigator's Discretion|5
1177698|NCT01106586|3869981|P2|Overall Study|Lack of Efficacy|0
1177699|NCT01106586|3869982|P1|Overall Study|Lack of Efficacy|1
1177700|NCT01106586|3869981|P2|Overall Study|Pregnancy|2
1177701|NCT01106586|3869982|P1|Overall Study|Pregnancy|2
1177702|NCT01106586|3869981|P2|Overall Study|Death|3
1177703|NCT01106586|3869982|P1|Overall Study|Death|1
1177704|NCT01106586|3869981|P2|Overall Study|Adverse Event|15
1177705|NCT01106586|3869982|P1|Overall Study|Adverse Event|9
1177706|NCT01106534|3870000|P1|Overall Study|Physician Decision|1
1177707|NCT01106534|3870000|P1|Overall Study|Death|16
1177708|NCT01106534|3870000|P1|Overall Study|Lost to Follow-up|2
1177709|NCT01106534|3870000|P1|Overall Study|Withdrawal by Subject|18
1177710|NCT01106430|3870032|P2|Overall Study|Withdrawal by Subject|4
1177711|NCT01106430|3870033|P1|Overall Study|Withdrawal by Subject|8
1177712|NCT01106430|3870032|P2|Overall Study|Protocol Violation|2
1177713|NCT01106430|3870033|P1|Overall Study|Protocol Violation|7
1177714|NCT01106430|3870032|P2|Overall Study|Previous Use Of Marijuana|0
1177715|NCT01106430|3870033|P1|Overall Study|Previous Use Of Marijuana|1
1177716|NCT01106430|3870032|P2|Overall Study|Hard Time Swallowing The Pills|0
1177717|NCT01106430|3870033|P1|Overall Study|Hard Time Swallowing The Pills|1
1177718|NCT01106430|3870032|P2|Overall Study|Noncompliance|1
1177719|NCT01106430|3870033|P1|Overall Study|Noncompliance|0
1177720|NCT01106430|3870032|P2|Overall Study|Refused To Take Medication|1
1177721|NCT01106430|3870033|P1|Overall Study|Refused To Take Medication|0
1177722|NCT01106430|3870032|P2|Overall Study|Moved Out Of State|1
1177723|NCT01106430|3870033|P1|Overall Study|Moved Out Of State|0
1177724|NCT01106430|3870032|P2|Overall Study|Early Termination Requested By Sponsor|0
1177725|NCT01106430|3870033|P1|Overall Study|Early Termination Requested By Sponsor|1
1177726|NCT01106430|3870032|P2|Overall Study|Lost to Follow-up|1
1177727|NCT01106430|3870033|P1|Overall Study|Lost to Follow-up|5
1177728|NCT01106430|3870032|P2|Overall Study|Lack of Efficacy|13
1177729|NCT01106430|3870033|P1|Overall Study|Lack of Efficacy|2
1177730|NCT01106430|3870032|P2|Overall Study|Adverse Event|10
1177731|NCT01106430|3870033|P1|Overall Study|Adverse Event|8
1177732|NCT01106404|3870055|P2|Period I (First 6 Weeks)|Lack of Efficacy|1
1177734|NCT01106404|3870055|P2|Period I (First 6 Weeks)|Lost to Follow-up|1
1177735|NCT01106404|3870056|P1|Period I (First 6 Weeks)|Lost to Follow-up|0
1177736|NCT01106404|3870055|P2|Period I (First 6 Weeks)|Physician Decision|0
1177737|NCT01106404|3870056|P1|Period I (First 6 Weeks)|Physician Decision|1
1177738|NCT01106404|3870055|P2|Period I (First 6 Weeks)|Adverse Event|0
1177739|NCT01106404|3870056|P1|Period I (First 6 Weeks)|Adverse Event|2
1177740|NCT01106352|3870079|P5|Overall Study|Home hospice since July 2013|0
1177741|NCT01106352|3870080|P4|Overall Study|Home hospice since July 2013|1
1177742|NCT01106352|3870081|P3|Overall Study|Home hospice since July 2013|0
1177743|NCT01106352|3870082|P2|Overall Study|Home hospice since July 2013|0
1177744|NCT01106352|3870083|P1|Overall Study|Home hospice since July 2013|0
1177745|NCT01106352|3870079|P5|Overall Study|Subject entered hospice|0
1177746|NCT01106352|3870080|P4|Overall Study|Subject entered hospice|1
1177747|NCT01106352|3870081|P3|Overall Study|Subject entered hospice|0
1177748|NCT01106352|3870082|P2|Overall Study|Subject entered hospice|0
1177749|NCT01106352|3870083|P1|Overall Study|Subject entered hospice|0
1177750|NCT01106352|3870079|P5|Overall Study|Went on hospice|0
1177751|NCT01106352|3870080|P4|Overall Study|Went on hospice|1
1177752|NCT01106352|3870081|P3|Overall Study|Went on hospice|0
1177753|NCT01106352|3870082|P2|Overall Study|Went on hospice|0
1177754|NCT01106352|3870083|P1|Overall Study|Went on hospice|0
1177755|NCT01106352|3870079|P5|Overall Study|Withdrawal by Subject|2
1177756|NCT01106352|3870080|P4|Overall Study|Withdrawal by Subject|3
1177757|NCT01106352|3870081|P3|Overall Study|Withdrawal by Subject|0
1177758|NCT01106352|3870082|P2|Overall Study|Withdrawal by Subject|0
1177759|NCT01106352|3870083|P1|Overall Study|Withdrawal by Subject|0
1177760|NCT01106352|3870079|P5|Overall Study|Disease progression|0
1177761|NCT01106352|3870080|P4|Overall Study|Disease progression|1
1177762|NCT01106352|3870081|P3|Overall Study|Disease progression|0
1177763|NCT01106352|3870082|P2|Overall Study|Disease progression|0
1177764|NCT01106352|3870083|P1|Overall Study|Disease progression|0
1177765|NCT01106352|3870079|P5|Overall Study|Death|1
1177766|NCT01106352|3870080|P4|Overall Study|Death|3
1177767|NCT01106352|3870081|P3|Overall Study|Death|1
1177768|NCT01106352|3870082|P2|Overall Study|Death|0
1177769|NCT01106352|3870083|P1|Overall Study|Death|0
1177770|NCT01106352|3870079|P5|Overall Study|Lost to Follow-up|1
1177771|NCT01106352|3870080|P4|Overall Study|Lost to Follow-up|0
1177772|NCT01106352|3870081|P3|Overall Study|Lost to Follow-up|0
1177773|NCT01106352|3870082|P2|Overall Study|Lost to Follow-up|0
1177774|NCT01106352|3870083|P1|Overall Study|Lost to Follow-up|0
1177775|NCT01106352|3870079|P5|Overall Study|Too ill to come in for the visit|0
1177776|NCT01106352|3870080|P4|Overall Study|Too ill to come in for the visit|0
1177777|NCT01106352|3870081|P3|Overall Study|Too ill to come in for the visit|1
1177778|NCT01106352|3870082|P2|Overall Study|Too ill to come in for the visit|0
1177779|NCT01106352|3870083|P1|Overall Study|Too ill to come in for the visit|0
1177780|NCT01106352|3870079|P5|Overall Study|Sponsor Decision|0
1177781|NCT01106352|3870080|P4|Overall Study|Sponsor Decision|0
1177782|NCT01106352|3870081|P3|Overall Study|Sponsor Decision|0
1177783|NCT01106352|3870082|P2|Overall Study|Sponsor Decision|0
1177784|NCT01106352|3870083|P1|Overall Study|Sponsor Decision|1
1177785|NCT01106352|3870079|P5|Overall Study|Subjects untreated|4
1177786|NCT01106352|3870080|P4|Overall Study|Subjects untreated|3
1177787|NCT01106352|3870081|P3|Overall Study|Subjects untreated|0
1177788|NCT01106352|3870082|P2|Overall Study|Subjects untreated|0
1177789|NCT01106352|3870083|P1|Overall Study|Subjects untreated|0
1177790|NCT01106287|3870179|P4|Overall Study|Adverse Event|0
1177791|NCT01106287|3870180|P3|Overall Study|Adverse Event|0
1177792|NCT01106287|3870181|P2|Overall Study|Adverse Event|0
1177793|NCT01106287|3870182|P1|Overall Study|Adverse Event|1
1177794|NCT01106248|3870202|P1|Overall Study|Administrative|2
1177795|NCT01106248|3870202|P1|Overall Study|Adverse Event|1
1177796|NCT01106157|3870210|P2|Overall Study|Withdrawal by Subject|0
1177797|NCT01106157|3870211|P1|Overall Study|Withdrawal by Subject|1
1177798|NCT01106092|3870239|P4|Overall Study|Withdrawal by Subject|1
1177799|NCT01106092|3870240|P3|Overall Study|Withdrawal by Subject|0
1177800|NCT01106092|3870241|P2|Overall Study|Withdrawal by Subject|0
1177801|NCT01106092|3870242|P1|Overall Study|Withdrawal by Subject|0
1177802|NCT01106027|3870325|P1|Overall Study|Lost graft early, discontinued|1
1177803|NCT01106014|3870331|P2|Overall Study|Lost to Follow-up|3
1177804|NCT01106014|3870332|P1|Overall Study|Lost to Follow-up|2
1177805|NCT01106014|3870331|P2|Overall Study|Administrative reason|6
1177806|NCT01106014|3870332|P1|Overall Study|Administrative reason|7
1177807|NCT01106014|3870331|P2|Overall Study|Withdrawal by Subject|37
1177808|NCT01106014|3870332|P1|Overall Study|Withdrawal by Subject|43
1177809|NCT01106014|3870331|P2|Overall Study|Adverse Event|42
1177810|NCT01106014|3870332|P1|Overall Study|Adverse Event|78
1177811|NCT01106014|3870331|P2|Overall Study|Morbidity or Mortality primary endpoint|242
1177812|NCT01106014|3870332|P1|Overall Study|Morbidity or Mortality primary endpoint|155
1177813|NCT01105975|3870352|P10|Overall Study|Abnormal Lab/Electrocardiogram Result|0
1177814|NCT01105975|3870353|P9|Overall Study|Abnormal Lab/Electrocardiogram Result|2
1177815|NCT01105975|3870354|P8|Overall Study|Abnormal Lab/Electrocardiogram Result|1
1177816|NCT01105975|3870355|P7|Overall Study|Abnormal Lab/Electrocardiogram Result|1
1177817|NCT01105975|3870356|P6|Overall Study|Abnormal Lab/Electrocardiogram Result|2
1177818|NCT01105975|3870357|P5|Overall Study|Abnormal Lab/Electrocardiogram Result|0
1177819|NCT01105975|3870358|P4|Overall Study|Abnormal Lab/Electrocardiogram Result|0
1177820|NCT01105975|3870359|P3|Overall Study|Abnormal Lab/Electrocardiogram Result|1
1177821|NCT01105975|3870360|P2|Overall Study|Abnormal Lab/Electrocardiogram Result|0
1177822|NCT01105975|3870361|P1|Overall Study|Abnormal Lab/Electrocardiogram Result|0
1177823|NCT01105975|3870352|P10|Overall Study|Protocol Violation|2
1177824|NCT01105975|3870353|P9|Overall Study|Protocol Violation|2
1177825|NCT01105975|3870354|P8|Overall Study|Protocol Violation|1
1177826|NCT01105975|3870355|P7|Overall Study|Protocol Violation|1
1177827|NCT01105975|3870356|P6|Overall Study|Protocol Violation|1
1177828|NCT01105975|3870357|P5|Overall Study|Protocol Violation|1
1177829|NCT01105975|3870358|P4|Overall Study|Protocol Violation|0
1177830|NCT01105975|3870359|P3|Overall Study|Protocol Violation|2
1177831|NCT01105975|3870360|P2|Overall Study|Protocol Violation|2
1177832|NCT01105975|3870361|P1|Overall Study|Protocol Violation|0
1177833|NCT01105975|3870352|P10|Overall Study|Physician Decision|0
1177834|NCT01105975|3870353|P9|Overall Study|Physician Decision|0
1177835|NCT01105975|3870354|P8|Overall Study|Physician Decision|0
1177836|NCT01105975|3870355|P7|Overall Study|Physician Decision|2
1177837|NCT01105975|3870356|P6|Overall Study|Physician Decision|0
1177838|NCT01105975|3870357|P5|Overall Study|Physician Decision|0
1177839|NCT01105975|3870358|P4|Overall Study|Physician Decision|0
1177840|NCT01105975|3870359|P3|Overall Study|Physician Decision|0
1177841|NCT01105975|3870360|P2|Overall Study|Physician Decision|0
1177842|NCT01105975|3870361|P1|Overall Study|Physician Decision|0
1177843|NCT01105975|3870352|P10|Overall Study|Lost to Follow-up|0
1177844|NCT01105975|3870353|P9|Overall Study|Lost to Follow-up|1
1177845|NCT01105975|3870354|P8|Overall Study|Lost to Follow-up|0
1177846|NCT01105975|3870355|P7|Overall Study|Lost to Follow-up|0
1177847|NCT01105975|3870356|P6|Overall Study|Lost to Follow-up|0
1177848|NCT01105975|3870357|P5|Overall Study|Lost to Follow-up|1
1177849|NCT01105975|3870358|P4|Overall Study|Lost to Follow-up|1
1177850|NCT01105975|3870359|P3|Overall Study|Lost to Follow-up|0
1177851|NCT01105975|3870360|P2|Overall Study|Lost to Follow-up|0
1177852|NCT01105975|3870361|P1|Overall Study|Lost to Follow-up|1
1177853|NCT01105975|3870352|P10|Overall Study|Withdrawal by Subject|3
1177854|NCT01105975|3870353|P9|Overall Study|Withdrawal by Subject|0
1177855|NCT01105975|3870354|P8|Overall Study|Withdrawal by Subject|1
1177856|NCT01105975|3870355|P7|Overall Study|Withdrawal by Subject|2
1177857|NCT01105975|3870356|P6|Overall Study|Withdrawal by Subject|1
1177858|NCT01105975|3870357|P5|Overall Study|Withdrawal by Subject|4
1177859|NCT01105975|3870358|P4|Overall Study|Withdrawal by Subject|0
1177860|NCT01105975|3870359|P3|Overall Study|Withdrawal by Subject|2
1177861|NCT01105975|3870360|P2|Overall Study|Withdrawal by Subject|2
1177862|NCT01105975|3870361|P1|Overall Study|Withdrawal by Subject|2
1177863|NCT01105975|3870352|P10|Overall Study|Adverse Event|4
1177864|NCT01105975|3870353|P9|Overall Study|Adverse Event|1
1177865|NCT01105975|3870354|P8|Overall Study|Adverse Event|4
1177866|NCT01105975|3870355|P7|Overall Study|Adverse Event|2
1177867|NCT01105975|3870356|P6|Overall Study|Adverse Event|1
1177868|NCT01105975|3870357|P5|Overall Study|Adverse Event|0
1177869|NCT01105975|3870358|P4|Overall Study|Adverse Event|1
1177870|NCT01105975|3870359|P3|Overall Study|Adverse Event|5
1177871|NCT01105975|3870360|P2|Overall Study|Adverse Event|1
1177872|NCT01105975|3870361|P1|Overall Study|Adverse Event|2
1177873|NCT01105936|3870509|P4|Period 3|Protocol Violation|0
1177874|NCT01105936|3870510|P3|Period 3|Protocol Violation|0
1177875|NCT01105936|3870511|P2|Period 3|Protocol Violation|2
1177876|NCT01105936|3870512|P1|Period 3|Protocol Violation|0
1177877|NCT01105936|3870509|P4|Period 2|Adverse Event|0
1177878|NCT01105936|3870510|P3|Period 2|Adverse Event|0
1177879|NCT01105936|3870511|P2|Period 2|Adverse Event|0
1177880|NCT01105936|3870512|P1|Period 2|Adverse Event|1
1177881|NCT01105936|3870509|P4|Period 1|Adverse Event|1
1177882|NCT01105936|3870510|P3|Period 1|Adverse Event|0
1177883|NCT01105936|3870511|P2|Period 1|Adverse Event|0
1177884|NCT01105936|3870512|P1|Period 1|Adverse Event|0
1177885|NCT01105767|3870541|P3|Overall Study|Lost to Follow-up|1184
1177886|NCT01105767|3870542|P2|Overall Study|Lost to Follow-up|1614
1177887|NCT01105767|3870543|P1|Overall Study|Lost to Follow-up|1160
1177888|NCT01105533|3870595|P9|Overall Study|Physician Decision|0
1177889|NCT01105533|3870596|P8|Overall Study|Physician Decision|1
1177890|NCT01105533|3870597|P7|Overall Study|Physician Decision|0
1177891|NCT01105533|3870598|P6|Overall Study|Physician Decision|0
1177892|NCT01105533|3870599|P5|Overall Study|Physician Decision|0
1177893|NCT01105533|3870600|P4|Overall Study|Physician Decision|0
1177894|NCT01105533|3870601|P3|Overall Study|Physician Decision|0
1177895|NCT01105533|3870602|P2|Overall Study|Physician Decision|0
1177896|NCT01105533|3870603|P1|Overall Study|Physician Decision|0
1177897|NCT01105533|3870595|P9|Overall Study|Other|2
1177898|NCT01105533|3870596|P8|Overall Study|Other|1
1177899|NCT01105533|3870597|P7|Overall Study|Other|3
1177900|NCT01105533|3870598|P6|Overall Study|Other|0
1177901|NCT01105533|3870599|P5|Overall Study|Other|1
1177902|NCT01105533|3870600|P4|Overall Study|Other|0
1177903|NCT01105533|3870601|P3|Overall Study|Other|0
1177904|NCT01105533|3870602|P2|Overall Study|Other|0
1177905|NCT01105533|3870603|P1|Overall Study|Other|0
1177906|NCT01105533|3870595|P9|Overall Study|Adverse Event|1
1177907|NCT01105533|3870596|P8|Overall Study|Adverse Event|0
1177908|NCT01105533|3870597|P7|Overall Study|Adverse Event|2
1177909|NCT01105533|3870598|P6|Overall Study|Adverse Event|2
1177910|NCT01105533|3870599|P5|Overall Study|Adverse Event|1
1177911|NCT01105533|3870600|P4|Overall Study|Adverse Event|0
1177912|NCT01105533|3870601|P3|Overall Study|Adverse Event|0
1177913|NCT01105533|3870602|P2|Overall Study|Adverse Event|0
1177914|NCT01105533|3870603|P1|Overall Study|Adverse Event|0
1177915|NCT01105533|3870595|P9|Overall Study|Lack of Efficacy|9
1177916|NCT01105533|3870596|P8|Overall Study|Lack of Efficacy|2
1177917|NCT01105533|3870597|P7|Overall Study|Lack of Efficacy|3
1177918|NCT01105533|3870598|P6|Overall Study|Lack of Efficacy|5
1177919|NCT01105533|3870599|P5|Overall Study|Lack of Efficacy|4
1177920|NCT01105533|3870600|P4|Overall Study|Lack of Efficacy|3
1177921|NCT01105533|3870601|P3|Overall Study|Lack of Efficacy|3
1177922|NCT01105533|3870602|P2|Overall Study|Lack of Efficacy|1
1177923|NCT01105533|3870603|P1|Overall Study|Lack of Efficacy|1
1177924|NCT01105533|3870595|P9|Overall Study|Death|0
1177925|NCT01105533|3870596|P8|Overall Study|Death|0
1177926|NCT01105533|3870597|P7|Overall Study|Death|0
1177927|NCT01105533|3870598|P6|Overall Study|Death|0
1177928|NCT01105533|3870599|P5|Overall Study|Death|1
1177929|NCT01105533|3870600|P4|Overall Study|Death|0
1177930|NCT01105533|3870601|P3|Overall Study|Death|0
1177931|NCT01105533|3870602|P2|Overall Study|Death|0
1177932|NCT01105533|3870603|P1|Overall Study|Death|0
1177933|NCT01105377|3870693|P2|Overall Study|Withdrawal by Subject|1
1177934|NCT01105377|3870694|P1|Overall Study|Withdrawal by Subject|0
1177935|NCT01105130|3870742|P3|Overall Study|Multiple Reasons|2
1177936|NCT01105130|3870743|P2|Overall Study|Multiple Reasons|0
1177937|NCT01105130|3870744|P1|Overall Study|Multiple Reasons|3
1177938|NCT01105130|3870742|P3|Overall Study|Toxicity|2
1177939|NCT01105130|3870743|P2|Overall Study|Toxicity|3
1177940|NCT01105130|3870744|P1|Overall Study|Toxicity|1
1177941|NCT01105130|3870742|P3|Overall Study|Never Started|4
1177942|NCT01105130|3870743|P2|Overall Study|Never Started|2
1177943|NCT01105130|3870744|P1|Overall Study|Never Started|2
1177944|NCT01105130|3870742|P3|Overall Study|Withdrawal by Subject|2
1177945|NCT01105130|3870743|P2|Overall Study|Withdrawal by Subject|6
1177946|NCT01105130|3870744|P1|Overall Study|Withdrawal by Subject|4
1177947|NCT01105091|3870774|P2|Overall Study|Death|0
1177948|NCT01105091|3870775|P1|Overall Study|Death|2
1177949|NCT01105065|3870799|P1|Overall Study|Technical Problems|1
1177950|NCT01105065|3870799|P1|Overall Study|Adverse Event|5
1177951|NCT01104870|3870808|P3|Overall Study|Withdrawal by Subject|1
1177952|NCT01104870|3870809|P2|Overall Study|Withdrawal by Subject|0
1177953|NCT01104870|3870810|P1|Overall Study|Withdrawal by Subject|0
1177954|NCT01104870|3870808|P3|Overall Study|Death|1
1177955|NCT01104870|3870809|P2|Overall Study|Death|0
1177956|NCT01104870|3870810|P1|Overall Study|Death|0
1177957|NCT01104870|3870808|P3|Overall Study|Adverse Event|0
1177958|NCT01104870|3870809|P2|Overall Study|Adverse Event|1
1177959|NCT01104870|3870810|P1|Overall Study|Adverse Event|1
1177960|NCT01104779|3870842|P3|Overall Study|Withdrawal by Subject|32
1177961|NCT01104779|3870843|P2|Overall Study|Withdrawal by Subject|25
1177962|NCT01104779|3870844|P1|Overall Study|Withdrawal by Subject|16
1177963|NCT01104779|3870842|P3|Overall Study|Lost to Follow-up|1
1177964|NCT01104779|3870843|P2|Overall Study|Lost to Follow-up|0
1177965|NCT01104779|3870844|P1|Overall Study|Lost to Follow-up|2
1177966|NCT01104779|3870842|P3|Overall Study|Other reasons|0
1177967|NCT01104779|3870843|P2|Overall Study|Other reasons|1
1177968|NCT01104779|3870844|P1|Overall Study|Other reasons|0
1177969|NCT01104779|3870842|P3|Overall Study|Did not meet inc/exc criteria|1
1177970|NCT01104779|3870843|P2|Overall Study|Did not meet inc/exc criteria|1
1177971|NCT01104779|3870844|P1|Overall Study|Did not meet inc/exc criteria|1
1177972|NCT01104779|3870842|P3|Overall Study|Adverse Event|13
1177973|NCT01104779|3870843|P2|Overall Study|Adverse Event|14
1177974|NCT01104779|3870844|P1|Overall Study|Adverse Event|13
1177975|NCT01104779|3870842|P3|Overall Study|Lack of Efficacy|13
1177976|NCT01104779|3870843|P2|Overall Study|Lack of Efficacy|12
1177977|NCT01104779|3870844|P1|Overall Study|Lack of Efficacy|26
1177978|NCT01104779|3870842|P3|Overall Study|Protocol Violation|2
1177979|NCT01104779|3870843|P2|Overall Study|Protocol Violation|2
1177980|NCT01104779|3870844|P1|Overall Study|Protocol Violation|1
1177981|NCT01104766|3870859|P4|Overall Study|Lost to Follow-up|1
1177982|NCT01104766|3870860|P3|Overall Study|Lost to Follow-up|1
1177983|NCT01104766|3870861|P2|Overall Study|Lost to Follow-up|2
1177984|NCT01104766|3870862|P1|Overall Study|Lost to Follow-up|1
1177985|NCT01104766|3870859|P4|Overall Study|Withdrawal by Subject|15
1177986|NCT01104766|3870860|P3|Overall Study|Withdrawal by Subject|25
1177987|NCT01104766|3870861|P2|Overall Study|Withdrawal by Subject|19
1177988|NCT01104766|3870862|P1|Overall Study|Withdrawal by Subject|17
1177989|NCT01104766|3870859|P4|Overall Study|Protocol Violation|0
1177990|NCT01104766|3870860|P3|Overall Study|Protocol Violation|0
1177991|NCT01104766|3870861|P2|Overall Study|Protocol Violation|0
1177992|NCT01104766|3870862|P1|Overall Study|Protocol Violation|2
1177993|NCT01104766|3870859|P4|Overall Study|Lack of Efficacy|8
1177994|NCT01104766|3870860|P3|Overall Study|Lack of Efficacy|14
1177995|NCT01104766|3870861|P2|Overall Study|Lack of Efficacy|15
1177996|NCT01104766|3870862|P1|Overall Study|Lack of Efficacy|20
1177997|NCT01104766|3870859|P4|Overall Study|Adverse Event|14
1177998|NCT01104766|3870860|P3|Overall Study|Adverse Event|20
1177999|NCT01104766|3870861|P2|Overall Study|Adverse Event|15
1178000|NCT01104766|3870862|P1|Overall Study|Adverse Event|17
1178001|NCT01104766|3870859|P4|Overall Study|Did not meet inc/exc criteria|0
1178002|NCT01104766|3870860|P3|Overall Study|Did not meet inc/exc criteria|0
1178003|NCT01104766|3870861|P2|Overall Study|Did not meet inc/exc criteria|0
1178004|NCT01104766|3870862|P1|Overall Study|Did not meet inc/exc criteria|1
1178005|NCT01104701|3870880|P4|Overall Study|Physician Decision|0
1178006|NCT01104701|3870881|P3|Overall Study|Physician Decision|0
1178007|NCT01104701|3870882|P2|Overall Study|Physician Decision|2
1178008|NCT01104701|3870883|P1|Overall Study|Physician Decision|0
1178009|NCT01104701|3870880|P4|Overall Study|Adverse Event|1
1178010|NCT01104701|3870881|P3|Overall Study|Adverse Event|0
1178011|NCT01104701|3870882|P2|Overall Study|Adverse Event|0
1178012|NCT01104701|3870883|P1|Overall Study|Adverse Event|0
1178013|NCT01104701|3870880|P4|Overall Study|Withdrawal by Subject|1
1178014|NCT01104701|3870881|P3|Overall Study|Withdrawal by Subject|2
1178015|NCT01104701|3870882|P2|Overall Study|Withdrawal by Subject|1
1178016|NCT01104701|3870883|P1|Overall Study|Withdrawal by Subject|0
1178017|NCT01104662|3870945|P8|Overall Study|Randomized but not treated|0
1178018|NCT01104662|3870946|P7|Overall Study|Randomized but not treated|0
1178019|NCT01104662|3870947|P6|Overall Study|Randomized but not treated|1
1178020|NCT01104662|3870948|P5|Overall Study|Randomized but not treated|0
1178021|NCT01104662|3870949|P4|Overall Study|Randomized but not treated|0
1178022|NCT01104662|3870950|P3|Overall Study|Randomized but not treated|1
1178023|NCT01104662|3870951|P2|Overall Study|Randomized but not treated|4
1178024|NCT01104662|3870952|P1|Overall Study|Randomized but not treated|3
1178025|NCT01104662|3870945|P8|Overall Study|Reason not specified|0
1178026|NCT01104662|3870946|P7|Overall Study|Reason not specified|0
1178027|NCT01104662|3870947|P6|Overall Study|Reason not specified|1
1178028|NCT01104662|3870948|P5|Overall Study|Reason not specified|0
1178029|NCT01104662|3870949|P4|Overall Study|Reason not specified|0
1178030|NCT01104662|3870950|P3|Overall Study|Reason not specified|0
1178031|NCT01104662|3870951|P2|Overall Study|Reason not specified|3
1178032|NCT01104662|3870952|P1|Overall Study|Reason not specified|3
1178033|NCT01104662|3870945|P8|Overall Study|Participant left investigator’s care|0
1178034|NCT01104662|3870946|P7|Overall Study|Participant left investigator’s care|0
1178035|NCT01104662|3870947|P6|Overall Study|Participant left investigator’s care|0
1178036|NCT01104662|3870948|P5|Overall Study|Participant left investigator’s care|0
1178037|NCT01104662|3870949|P4|Overall Study|Participant left investigator’s care|0
1178038|NCT01104662|3870950|P3|Overall Study|Participant left investigator’s care|0
1178039|NCT01104662|3870951|P2|Overall Study|Participant left investigator’s care|1
1178040|NCT01104662|3870952|P1|Overall Study|Participant left investigator’s care|1
1178041|NCT01104662|3870945|P8|Overall Study|Clinical Failure|0
1178042|NCT01104662|3870946|P7|Overall Study|Clinical Failure|0
1178043|NCT01104662|3870947|P6|Overall Study|Clinical Failure|1
1178044|NCT01104662|3870948|P5|Overall Study|Clinical Failure|0
1178045|NCT01104662|3870949|P4|Overall Study|Clinical Failure|0
1178046|NCT01104662|3870950|P3|Overall Study|Clinical Failure|0
1178047|NCT01104662|3870951|P2|Overall Study|Clinical Failure|0
1178048|NCT01104662|3870952|P1|Overall Study|Clinical Failure|1
1178049|NCT01104662|3870945|P8|Overall Study|Adverse Event|0
1178050|NCT01104662|3870946|P7|Overall Study|Adverse Event|0
1178051|NCT01104662|3870947|P6|Overall Study|Adverse Event|1
1178052|NCT01104662|3870948|P5|Overall Study|Adverse Event|1
1178053|NCT01104662|3870949|P4|Overall Study|Adverse Event|1
1178054|NCT01104662|3870950|P3|Overall Study|Adverse Event|0
1178055|NCT01104662|3870951|P2|Overall Study|Adverse Event|2
1178056|NCT01104662|3870952|P1|Overall Study|Adverse Event|2
1178057|NCT01104636|3870978|P1|Overall Study|Ongoing|21
1178058|NCT01104636|3870978|P1|Overall Study|Adverse Event|40
1178059|NCT01104636|3870978|P1|Overall Study|Pregnancy|2
1178060|NCT01104636|3870978|P1|Overall Study|Study terminated by sponsor|1
1178061|NCT01104636|3870978|P1|Overall Study|Other|43
1178062|NCT01104636|3870978|P1|Overall Study|Withdrawal by Subject|4
1178063|NCT01104636|3870978|P1|Overall Study|Lost to Follow-up|24
1178064|NCT01104636|3870978|P1|Overall Study|Lack of Efficacy|43
1178065|NCT01104584|3870983|P1|Overall Study|Study prematurely discontinued|2
1178066|NCT01104584|3870983|P1|Overall Study|Study drug never administered|21
1178067|NCT01104558|3871053|P1|Overall Study|Missing of genetic analysis results|1
1178068|NCT01104558|3871053|P1|Overall Study|Missing of primary efficacy assessment|10
1178069|NCT01104558|3871053|P1|Overall Study|Protocol Violation|6
1178070|NCT01104493|3871096|P2|Overall Study|Lost to Follow-up|2
1178071|NCT01104493|3871097|P1|Overall Study|Lost to Follow-up|0
1178072|NCT01104415|3871115|P1|Overall Study|Withdrawal by Subject|1
1178073|NCT01104376|3871158|P1|Overall Study|Consented but excluded after labs|13
1178074|NCT01104376|3871158|P1|Overall Study|Withdrawal by Subject|15
1178075|NCT01104311|3871164|P2|Overall Study|Adverse Event|2
1178076|NCT01104311|3871165|P1|Overall Study|Adverse Event|1
1178077|NCT01104311|3871164|P2|Overall Study|low compliance|1
1178078|NCT01104311|3871165|P1|Overall Study|low compliance|1
1178079|NCT01104311|3871164|P2|Overall Study|Physician Decision|2
1178080|NCT01104311|3871165|P1|Overall Study|Physician Decision|2
1178081|NCT01104311|3871164|P2|Overall Study|Protocol Violation|1
1178082|NCT01104311|3871165|P1|Overall Study|Protocol Violation|0
1178083|NCT01104311|3871164|P2|Overall Study|Withdrawal by Subject|6
1178084|NCT01104311|3871165|P1|Overall Study|Withdrawal by Subject|6
1178085|NCT01104246|3871192|P1|Overall Study|did not meet inclusion criteria|4
1178086|NCT01104246|3871192|P1|Overall Study|Withdrawal by Subject|1
1178087|NCT01104155|3871207|P2|Overall Study|Not specified|4
1178088|NCT01104155|3871208|P1|Overall Study|Not specified|3
1178089|NCT01104155|3871207|P2|Overall Study|Withdrawal of consent|1
1178090|NCT01104155|3871208|P1|Overall Study|Withdrawal of consent|1
1178091|NCT01104155|3871207|P2|Overall Study|Participant choice|5
1178092|NCT01104155|3871208|P1|Overall Study|Participant choice|6
1178093|NCT01104155|3871207|P2|Overall Study|Adverse Event|8
1178094|NCT01104155|3871208|P1|Overall Study|Adverse Event|15
1178095|NCT01103960|3871251|P2|Overall Study|Other|0
1178096|NCT01103960|3871252|P1|Overall Study|Other|1
1178097|NCT01103960|3871251|P2|Overall Study|Withdrawal by Subject|1
1178098|NCT01103960|3871252|P1|Overall Study|Withdrawal by Subject|2
1178099|NCT01103960|3871251|P2|Overall Study|Adverse Event|1
1178100|NCT01103960|3871252|P1|Overall Study|Adverse Event|2
1178101|NCT01103778|3871287|P1|Overall Study|Screen failure|1
1178102|NCT01103778|3871287|P1|Overall Study|Proteinuria improved prior to enrollment|1
1178103|NCT01103778|3871287|P1|Overall Study|Lost to Follow-up|1
1178104|NCT01103713|3871294|P1|Overall Study|Not specified|1
1178105|NCT01103713|3871294|P1|Overall Study|Study terminated by sponsor|2
1178106|NCT01103713|3871294|P1|Overall Study|Withdrawal by Subject|8
1178107|NCT01103713|3871294|P1|Overall Study|Lost to Follow-up|2
1178108|NCT01103479|3871327|P3|Overall Study|Saw non-study physician|0
1178109|NCT01103479|3871328|P2|Overall Study|Saw non-study physician|0
1178110|NCT01103479|3871329|P1|Overall Study|Saw non-study physician|2
1178111|NCT01103479|3871327|P3|Overall Study|Active cancer|0
1178112|NCT01103479|3871328|P2|Overall Study|Active cancer|0
1178113|NCT01103479|3871329|P1|Overall Study|Active cancer|1
1178114|NCT01103479|3871327|P3|Overall Study|Family history of CRC|2
1178115|NCT01103479|3871328|P2|Overall Study|Family history of CRC|0
1178116|NCT01103479|3871329|P1|Overall Study|Family history of CRC|1
1178117|NCT01103479|3871327|P3|Overall Study|Up to date with CRC screening|12
1178118|NCT01103479|3871328|P2|Overall Study|Up to date with CRC screening|9
1178119|NCT01103479|3871329|P1|Overall Study|Up to date with CRC screening|1
1178120|NCT01103466|3871342|P3|Third Period (14 +/- 3 Days)|not satisfied with product|1
1178121|NCT01103466|3871343|P2|Third Period (14 +/- 3 Days)|not satisfied with product|0
1178122|NCT01103466|3871344|P1|Third Period (14 +/- 3 Days)|not satisfied with product|0
1178123|NCT01103466|3871342|P3|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
1178124|NCT01103466|3871343|P2|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
1178125|NCT01103466|3871344|P1|Third Period (14 +/- 3 Days)|Lack of Efficacy|1
1178126|NCT01103466|3871342|P3|Third Period (14 +/- 3 Days)|Adverse Event|0
1178127|NCT01103466|3871343|P2|Third Period (14 +/- 3 Days)|Adverse Event|0
1178128|NCT01103466|3871344|P1|Third Period (14 +/- 3 Days)|Adverse Event|1
1178129|NCT01103466|3871342|P3|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
1178130|NCT01103466|3871343|P2|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
1178131|NCT01103466|3871344|P1|Second Period (14 +/- 3 Days)|Lack of Efficacy|0
1178132|NCT01103466|3871342|P3|Second Period (14 +/- 3 Days)|Adverse Event|0
1178133|NCT01103466|3871343|P2|Second Period (14 +/- 3 Days)|Adverse Event|1
1178134|NCT01103466|3871344|P1|Second Period (14 +/- 3 Days)|Adverse Event|2
1178135|NCT01103466|3871342|P3|First Period (14 +/- 3 Days)|Protocol Violation|0
1178136|NCT01103466|3871343|P2|First Period (14 +/- 3 Days)|Protocol Violation|0
1178137|NCT01103466|3871344|P1|First Period (14 +/- 3 Days)|Protocol Violation|2
1178138|NCT01103362|3871434|P1|Overall Study|study terminated|596
1178139|NCT01103323|3871440|P2|Switched From Placebo to Regorafenib|Adverse Event|1
1178140|NCT01103323|3871441|P1|Switched From Placebo to Regorafenib|Adverse Event|0
1178141|NCT01103323|3871440|P2|Without/Before Drug Switch|Switch to Regorafenib|4
1178142|NCT01103323|3871441|P1|Without/Before Drug Switch|Switch to Regorafenib|0
1178143|NCT01103323|3871440|P2|Without/Before Drug Switch|did not receive study treatment|2
1178144|NCT01103323|3871441|P1|Without/Before Drug Switch|did not receive study treatment|5
1178145|NCT01103323|3871440|P2|Without/Before Drug Switch|Physician Decision|0
1178146|NCT01103323|3871441|P1|Without/Before Drug Switch|Physician Decision|2
1178147|NCT01103323|3871440|P2|Without/Before Drug Switch|Protocol Violation|0
1178148|NCT01103323|3871441|P1|Without/Before Drug Switch|Protocol Violation|2
1178149|NCT01103323|3871440|P2|Without/Before Drug Switch|Withdrawal by Subject|5
1178150|NCT01103323|3871441|P1|Without/Before Drug Switch|Withdrawal by Subject|17
1178151|NCT01103323|3871440|P2|Without/Before Drug Switch|Adverse Event|7
1178152|NCT01103323|3871441|P1|Without/Before Drug Switch|Adverse Event|50
1178153|NCT01103284|3871458|P2|Overall Study|Missing CRF entries for study completion|2
1178154|NCT01103284|3871459|P1|Overall Study|Missing CRF entries for study completion|0
1178155|NCT01103284|3871458|P2|Overall Study|Not described|1
1178156|NCT01103284|3871459|P1|Overall Study|Not described|2
1178157|NCT01103284|3871458|P2|Overall Study|Termination by the Sponsor|1
1178158|NCT01103284|3871459|P1|Overall Study|Termination by the Sponsor|0
1178159|NCT01103284|3871458|P2|Overall Study|Dermal Hypersensitivity|1
1178160|NCT01103284|3871459|P1|Overall Study|Dermal Hypersensitivity|0
1178161|NCT01103284|3871458|P2|Overall Study|Withdrawal by Subject|18
1178162|NCT01103284|3871459|P1|Overall Study|Withdrawal by Subject|14
1178163|NCT01103284|3871458|P2|Overall Study|Adverse Event|5
1178164|NCT01103284|3871459|P1|Overall Study|Adverse Event|0
1178165|NCT01103284|3871458|P2|Overall Study|Protocol Violation|5
1178166|NCT01103284|3871459|P1|Overall Study|Protocol Violation|12
1178167|NCT01103284|3871458|P2|Overall Study|Pregnancy|1
1178168|NCT01103284|3871459|P1|Overall Study|Pregnancy|3
1178169|NCT01103284|3871458|P2|Overall Study|Lost to Follow-up|10
1178170|NCT01103284|3871459|P1|Overall Study|Lost to Follow-up|9
1178171|NCT01103284|3871458|P2|Overall Study|Death|0
1178172|NCT01103284|3871459|P1|Overall Study|Death|2
1178173|NCT01103245|3871487|P4|Overall Study|Physician Decision|0
1178174|NCT01103245|3871488|P3|Overall Study|Physician Decision|0
1178175|NCT01103245|3871489|P2|Overall Study|Physician Decision|0
1178176|NCT01103245|3871490|P1|Overall Study|Physician Decision|1
1178177|NCT01103245|3871487|P4|Overall Study|Adverse Event|0
1178178|NCT01103245|3871488|P3|Overall Study|Adverse Event|1
1178179|NCT01103245|3871489|P2|Overall Study|Adverse Event|2
1178180|NCT01103245|3871490|P1|Overall Study|Adverse Event|0
1178181|NCT01103245|3871487|P4|Overall Study|Inadequate IV access|0
1178182|NCT01103245|3871488|P3|Overall Study|Inadequate IV access|0
1178183|NCT01103245|3871489|P2|Overall Study|Inadequate IV access|0
1178184|NCT01103245|3871490|P1|Overall Study|Inadequate IV access|1
1178185|NCT01103245|3871487|P4|Overall Study|Withdrawal by Subject|0
1178186|NCT01103245|3871488|P3|Overall Study|Withdrawal by Subject|3
1178187|NCT01103245|3871489|P2|Overall Study|Withdrawal by Subject|0
1178188|NCT01103245|3871490|P1|Overall Study|Withdrawal by Subject|1
1178189|NCT01103232|3871506|P2|Overall Study|Protocol Violation|1
1178190|NCT01103232|3871507|P1|Overall Study|Protocol Violation|0
1178191|NCT01103232|3871506|P2|Overall Study|Withdrawal by Subject|1
1178192|NCT01103232|3871507|P1|Overall Study|Withdrawal by Subject|1
1178193|NCT01103141|3871515|P2|Overall Study|Lost to Follow-up|1
1178194|NCT01103141|3871516|P1|Overall Study|Lost to Follow-up|2
1178195|NCT01103141|3871515|P2|Overall Study|Death|1
1178196|NCT01103141|3871516|P1|Overall Study|Death|0
1178197|NCT01103063|3871524|P2|Overall Study|Death|1
1178198|NCT01103063|3871525|P1|Overall Study|Death|3
1178199|NCT01103063|3871524|P2|Overall Study|Study terminated by Sponsor|342
1178200|NCT01103063|3871525|P1|Overall Study|Study terminated by Sponsor|326
1178201|NCT01103063|3871524|P2|Overall Study|Protocol Violation|0
1178202|NCT01103063|3871525|P1|Overall Study|Protocol Violation|1
1178203|NCT01103063|3871524|P2|Overall Study|Not specified|11
1178204|NCT01103063|3871525|P1|Overall Study|Not specified|16
1178205|NCT01103063|3871524|P2|Overall Study|Withdrawal by Subject|15
1178206|NCT01103063|3871525|P1|Overall Study|Withdrawal by Subject|60
1178207|NCT01103063|3871524|P2|Overall Study|Lost to Follow-up|51
1178208|NCT01103063|3871525|P1|Overall Study|Lost to Follow-up|68
1178209|NCT01103063|3871524|P2|Overall Study|Adverse Event|1
1178210|NCT01103063|3871525|P1|Overall Study|Adverse Event|3
1178211|NCT01102972|3871593|P2|Overall Study|Withdrawal by Subject|6
1178212|NCT01102972|3871594|P1|Overall Study|Withdrawal by Subject|6
1178213|NCT01102972|3871593|P2|Overall Study|Investigator Discretion|0
1178214|NCT01102972|3871594|P1|Overall Study|Investigator Discretion|2
1178215|NCT01102972|3871593|P2|Overall Study|Lost to Follow-up|5
1178216|NCT01102972|3871594|P1|Overall Study|Lost to Follow-up|10
1178217|NCT01102972|3871593|P2|Overall Study|Protocol Violation|0
1178218|NCT01102972|3871594|P1|Overall Study|Protocol Violation|1
1178219|NCT01102972|3871593|P2|Overall Study|Lack of Efficacy|1
1178220|NCT01102972|3871594|P1|Overall Study|Lack of Efficacy|2
1178221|NCT01102972|3871593|P2|Overall Study|Adverse Event|2
1178222|NCT01102972|3871594|P1|Overall Study|Adverse Event|8
1178223|NCT01102803|3871658|P2|Post to Follow-Up|Lost to Follow-up|3
1178224|NCT01102803|3871659|P1|Post to Follow-Up|Lost to Follow-up|1
1178225|NCT01102803|3871658|P2|Baseline to Post-Treatment|Lost to Follow-up|0
1178226|NCT01102803|3871659|P1|Baseline to Post-Treatment|Lost to Follow-up|3
1178227|NCT01102777|3871673|P2|Overall Study|Lost to Follow-up|10
1178228|NCT01102777|3871674|P1|Overall Study|Lost to Follow-up|7
1178229|NCT01102777|3871673|P2|Overall Study|Death|6
1178230|NCT01102777|3871674|P1|Overall Study|Death|2
1178231|NCT01102491|3871713|P2|Overall Study|Protocol Violation|12
1178232|NCT01102491|3871714|P1|Overall Study|Protocol Violation|11
1178233|NCT01102374|3871733|P2|Overall Study|Lost to Follow-up|6
1178234|NCT01102374|3871734|P1|Overall Study|Lost to Follow-up|7
1178235|NCT01102374|3871733|P2|Overall Study|Death|13
1178236|NCT01102374|3871734|P1|Overall Study|Death|9
1178237|NCT01102257|3871783|P2|Overall Study|Adverse Event|0
1178238|NCT01102257|3871784|P1|Overall Study|Adverse Event|1
1178239|NCT01102257|3871783|P2|Overall Study|Adverse Event|0
1178240|NCT01102257|3871784|P1|Overall Study|Adverse Event|1
1178241|NCT01102140|3871801|P2|Overall Study|Investigator terminated study|2
1178242|NCT01102140|3871802|P1|Overall Study|Investigator terminated study|2
1178243|NCT01102140|3871801|P2|Overall Study|Lost to Follow-up|0
1178244|NCT01102140|3871802|P1|Overall Study|Lost to Follow-up|1
1178245|NCT01101841|3871857|P2|Overall Study|Eligibility Criteria|2
1178246|NCT01101841|3871858|P1|Overall Study|Eligibility Criteria|1
1178247|NCT01101841|3871857|P2|Overall Study|Suicidality Tracking Scale|1
1178248|NCT01101841|3871858|P1|Overall Study|Suicidality Tracking Scale|3
1178249|NCT01101841|3871857|P2|Overall Study|Not Specified|1
1178250|NCT01101841|3871858|P1|Overall Study|Not Specified|0
1178251|NCT01101841|3871857|P2|Overall Study|Lack of Efficacy|2
1178252|NCT01101841|3871858|P1|Overall Study|Lack of Efficacy|0
1178253|NCT01101841|3871857|P2|Overall Study|Physician Decision|2
1178254|NCT01101841|3871858|P1|Overall Study|Physician Decision|0
1178255|NCT01101841|3871857|P2|Overall Study|Protocol Violation|1
1178256|NCT01101841|3871858|P1|Overall Study|Protocol Violation|1
1178257|NCT01101841|3871857|P2|Overall Study|Withdrawal by Subject|40
1178258|NCT01101841|3871858|P1|Overall Study|Withdrawal by Subject|21
1178259|NCT01101841|3871857|P2|Overall Study|Lost to Follow-up|3
1178260|NCT01101841|3871858|P1|Overall Study|Lost to Follow-up|9
1178261|NCT01101841|3871857|P2|Overall Study|Adverse Event|15
1178262|NCT01101841|3871858|P1|Overall Study|Adverse Event|15
1178263|NCT01101542|3871896|P1|Year 6 Surveillance Period|Withdrawal by Subject|4
1178264|NCT01101542|3871896|P1|Year 6 Surveillance Period|Pregnancy|1
1178265|NCT01101542|3871896|P1|Year 6 Surveillance Period|Lost to Follow-up|986
1178266|NCT01101542|3871896|P1|Year 5 Surveillance Period|Pregnancy|1
1178267|NCT01101542|3871896|P1|Year 5 Surveillance Period|Lost to Follow-up|140
1178268|NCT01101542|3871896|P1|Year 4 Surveillance Period|Other|287
1178269|NCT01101542|3871896|P1|Year 3 Surveillance Period|Withdrawal by Subject|4
1178270|NCT01101542|3871896|P1|Year 3 Surveillance Period|Lost to Follow-up|7
1178271|NCT01101477|3871912|P3|Overall Study|Protocol Violation|1
1178272|NCT01101477|3871913|P2|Overall Study|Protocol Violation|3
1178273|NCT01101477|3871914|P1|Overall Study|Protocol Violation|5
1178274|NCT01101321|3871935|P2|Period 1|Adverse Event|3
1178275|NCT01101321|3871936|P1|Period 1|Adverse Event|3
1178276|NCT01101321|3871935|P2|Period 1|Withdrawal by Subject|1
1178277|NCT01101321|3871936|P1|Period 1|Withdrawal by Subject|1
1178278|NCT01101308|3871946|P2|Period 1|Positive for cotinine|0
1178279|NCT01101308|3871947|P1|Period 1|Positive for cotinine|1
1178280|NCT01101308|3871946|P2|Period 1|Adverse Event|1
1178281|NCT01101308|3871947|P1|Period 1|Adverse Event|2
1178282|NCT01101191|3871958|P2|Period 1|Adverse Event|2
1178283|NCT01101191|3871959|P1|Period 1|Adverse Event|1
1178284|NCT01101191|3871958|P2|Period 1|Withdrawal by Subject|0
1178285|NCT01101191|3871959|P1|Period 1|Withdrawal by Subject|1
1178286|NCT01101178|3871970|P2|Period 2|Withdrawal by Subject|1
1178287|NCT01101178|3871971|P1|Period 2|Withdrawal by Subject|0
1178288|NCT01101178|3871970|P2|Period 1|Adverse Event|1
1178289|NCT01101178|3871971|P1|Period 1|Adverse Event|2
1178290|NCT01101178|3871970|P2|Period 1|Positive drug screen|1
1178291|NCT01101178|3871971|P1|Period 1|Positive drug screen|1
1178292|NCT01101178|3871970|P2|Period 1|Withdrawal by Subject|2
1178293|NCT01101178|3871971|P1|Period 1|Withdrawal by Subject|1
1178294|NCT01101165|3871982|P2|Period 2|Adverse Event|0
1178295|NCT01101165|3871983|P1|Period 2|Adverse Event|1
1178296|NCT01101165|3871982|P2|Period 2|Withdrawal by Subject|1
1178297|NCT01101165|3871983|P1|Period 2|Withdrawal by Subject|3
1178298|NCT01101165|3871982|P2|Period 1|Lost to Follow-up|0
1178299|NCT01101165|3871983|P1|Period 1|Lost to Follow-up|1
1178300|NCT01101165|3871982|P2|Period 1|Positive Drug Screen|1
1178301|NCT01101165|3871983|P1|Period 1|Positive Drug Screen|0
1178302|NCT01101165|3871982|P2|Period 1|Withdrawal by Subject|2
1178303|NCT01101165|3871983|P1|Period 1|Withdrawal by Subject|0
1178304|NCT01101165|3871982|P2|Period 1|Adverse Event|2
1178305|NCT01101165|3871983|P1|Period 1|Adverse Event|1
1178306|NCT01101035|3871995|P2|Overall Study|Reason not Specified|363
1178307|NCT01101035|3871996|P1|Overall Study|Reason not Specified|333
1178308|NCT01101035|3871995|P2|Overall Study|Voluntary Withdrawal|587
1178309|NCT01101035|3871996|P1|Overall Study|Voluntary Withdrawal|595
1178310|NCT01101035|3871995|P2|Overall Study|Lost to Follow-up|223
1178311|NCT01101035|3871996|P1|Overall Study|Lost to Follow-up|226
1178312|NCT01101035|3871995|P2|Overall Study|Major Protocol Deviation|46
1178313|NCT01101035|3871996|P1|Overall Study|Major Protocol Deviation|52
1178314|NCT01101035|3871995|P2|Overall Study|Adverse Event|172
1178315|NCT01101035|3871996|P1|Overall Study|Adverse Event|191
1178316|NCT01101022|3872016|P2|Overall Study|Vacation|1
1178317|NCT01101022|3872017|P1|Overall Study|Vacation|0
1178318|NCT01101022|3872016|P2|Overall Study|Work schedule|1
1178319|NCT01101022|3872017|P1|Overall Study|Work schedule|1
1178320|NCT01101022|3872016|P2|Overall Study|Non-compliance|0
1178321|NCT01101022|3872017|P1|Overall Study|Non-compliance|1
1178322|NCT01101022|3872016|P2|Overall Study|Sponsor decision|1
1178323|NCT01101022|3872017|P1|Overall Study|Sponsor decision|1
1178324|NCT01101022|3872016|P2|Overall Study|Lack of Efficacy|7
1178325|NCT01101022|3872017|P1|Overall Study|Lack of Efficacy|0
1178326|NCT01101022|3872016|P2|Overall Study|Lost to Follow-up|4
1178327|NCT01101022|3872017|P1|Overall Study|Lost to Follow-up|1
1178328|NCT01101022|3872016|P2|Overall Study|Withdrawal by Subject|8
1178329|NCT01101022|3872017|P1|Overall Study|Withdrawal by Subject|3
1178330|NCT01101022|3872016|P2|Overall Study|Protocol Violation|3
1178331|NCT01101022|3872017|P1|Overall Study|Protocol Violation|4
1178332|NCT01101022|3872016|P2|Overall Study|Adverse Event|2
1178333|NCT01101022|3872017|P1|Overall Study|Adverse Event|6
1178334|NCT01100944|3872051|P3|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
1178335|NCT01100944|3872052|P2|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2
1178336|NCT01100944|3872053|P1|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
1178337|NCT01100944|3872051|P3|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
1178338|NCT01100944|3872052|P2|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
1178339|NCT01100944|3872053|P1|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1
1178340|NCT01100944|3872051|P3|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
1178341|NCT01100944|3872052|P2|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
1178342|NCT01100944|3872053|P1|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1
1178343|NCT01100944|3872051|P3|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
1178344|NCT01100944|3872052|P2|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
1178345|NCT01100944|3872053|P1|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2
1178346|NCT01100853|3872111|P2|Overall Study|Withdrawal by Subject|4
1178347|NCT01100853|3872112|P1|Overall Study|Withdrawal by Subject|6
1178348|NCT01100853|3872111|P2|Overall Study|Received <4 study injections|13
1178349|NCT01100853|3872112|P1|Overall Study|Received <4 study injections|10
1178350|NCT01100853|3872111|P2|Overall Study|Lost to Follow-up|6
1178351|NCT01100853|3872112|P1|Overall Study|Lost to Follow-up|11
1178352|NCT01100658|3872158|P1|Overall Study|Withdrawal by Subject|1
1178353|NCT01100567|3872190|P2|Overall Study|Deemed ineligible after consent|1
1178354|NCT01100567|3872191|P1|Overall Study|Deemed ineligible after consent|0
1178355|NCT01100567|3872190|P2|Overall Study|Physician Decision|1
1178356|NCT01100567|3872191|P1|Overall Study|Physician Decision|0
1178357|NCT01100567|3872190|P2|Overall Study|Lost to Follow-up|2
1178358|NCT01100567|3872191|P1|Overall Study|Lost to Follow-up|1
1178359|NCT01100567|3872190|P2|Overall Study|Early Hospital Discharge|4
1178360|NCT01100567|3872191|P1|Overall Study|Early Hospital Discharge|6
1178361|NCT01100567|3872190|P2|Overall Study|Withdrawal by Subject|8
1178362|NCT01100567|3872191|P1|Overall Study|Withdrawal by Subject|5
1178363|NCT01100528|3872199|P1|Overall Study|Withdrawal by Subject|2
1178364|NCT01100528|3872199|P1|Overall Study|Death|1
1178365|NCT01100502|3872207|P2|Long-Term Follow-up|Continuing in long-term follow-up|129
1178366|NCT01100502|3872208|P1|Long-Term Follow-up|Continuing in long-term follow-up|122
1178367|NCT01100502|3872207|P2|Long-Term Follow-up|Lost to Follow-up|2
1178368|NCT01100502|3872208|P1|Long-Term Follow-up|Lost to Follow-up|5
1178369|NCT01100502|3872207|P2|Long-Term Follow-up|Withdrawal by Subject|8
1178370|NCT01100502|3872208|P1|Long-Term Follow-up|Withdrawal by Subject|10
1178371|NCT01100502|3872207|P2|Treatment Period|Progressive Disease|69
1178372|NCT01100502|3872208|P1|Treatment Period|Progressive Disease|24
1178373|NCT01100502|3872207|P2|Treatment Period|Withdrawal by Subject|4
1178374|NCT01100502|3872208|P1|Treatment Period|Withdrawal by Subject|9
1178375|NCT01100502|3872207|P2|Treatment Period|Adverse Event|10
1178376|NCT01100502|3872208|P1|Treatment Period|Adverse Event|54
1178377|NCT01100437|3872218|P3|Maintenance|Sponsor termination of study|1
1178378|NCT01100437|3872219|P2|Maintenance|Sponsor termination of study|0
1178379|NCT01100437|3872220|P1|Maintenance|Sponsor termination of study|0
1178380|NCT01100437|3872218|P3|Maintenance|Withdrawal by Subject|1
1178381|NCT01100437|3872219|P2|Maintenance|Withdrawal by Subject|0
1178382|NCT01100437|3872220|P1|Maintenance|Withdrawal by Subject|0
1178383|NCT01100437|3872218|P3|Titration/Stabilization|Sponsor canceled study|1
1178384|NCT01100437|3872219|P2|Titration/Stabilization|Sponsor canceled study|0
1178385|NCT01100437|3872220|P1|Titration/Stabilization|Sponsor canceled study|0
1178386|NCT01100437|3872218|P3|Titration/Stabilization|Non-compliance|1
1178387|NCT01100437|3872219|P2|Titration/Stabilization|Non-compliance|0
1178388|NCT01100437|3872220|P1|Titration/Stabilization|Non-compliance|0
1178389|NCT01100437|3872218|P3|Titration/Stabilization|Adverse Event|4
1178390|NCT01100437|3872219|P2|Titration/Stabilization|Adverse Event|0
1178391|NCT01100437|3872220|P1|Titration/Stabilization|Adverse Event|0
1178392|NCT01100320|3872257|P2|Period 2|Withdrawal by Subject|1
1178393|NCT01100320|3872258|P1|Period 2|Withdrawal by Subject|1
1178394|NCT01100320|3872257|P2|Period 1|Adverse Event|2
1178395|NCT01100320|3872258|P1|Period 1|Adverse Event|2
1178396|NCT01100320|3872257|P2|Period 1|Positive Drug Screen|1
1178397|NCT01100320|3872258|P1|Period 1|Positive Drug Screen|1
1178398|NCT01100320|3872257|P2|Period 1|Withdrawal by Subject|4
1178399|NCT01100320|3872258|P1|Period 1|Withdrawal by Subject|2
1178400|NCT01100307|3872270|P2|Open Phase (Week 24 up to Week 54)|Adverse Event|8
1178401|NCT01100307|3872271|P1|Open Phase (Week 24 up to Week 54)|Adverse Event|3
1178402|NCT01100307|3872270|P2|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3
1178403|NCT01100307|3872271|P1|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2
1178404|NCT01100307|3872270|P2|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2
1178405|NCT01100307|3872271|P1|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1
1178406|NCT01100307|3872270|P2|Double Masked Phase (Up to Week 24)|Adverse Event|2
1178407|NCT01100307|3872271|P1|Double Masked Phase (Up to Week 24)|Adverse Event|5
1178408|NCT01100307|3872270|P2|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1
1178409|NCT01100307|3872271|P1|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0
1178410|NCT01100307|3872270|P2|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
1178411|NCT01100307|3872271|P1|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
1178412|NCT01100086|3872340|P2|Period 1|Withdrawal by Subject|0
1178413|NCT01100086|3872341|P1|Period 1|Withdrawal by Subject|1
1178414|NCT01100073|3872351|P1|Overall Study|Missing|5
1178415|NCT01100073|3872351|P1|Overall Study|Other|8
1178416|NCT01100073|3872351|P1|Overall Study|Insufficient tolerability +patients wish|8
1178417|NCT01100073|3872351|P1|Overall Study|Lack of effect + patient's wish|2
1178418|NCT01100073|3872351|P1|Overall Study|Lost to Follow-up|39
1178419|NCT01100073|3872351|P1|Overall Study|Withdrawal by Subject|13
1178420|NCT01100073|3872351|P1|Overall Study|Insufficient Tolerability|21
1178421|NCT01100073|3872351|P1|Overall Study|Lack of Efficacy|4
1178422|NCT01099917|3872395|P1|Overall Study|Not Treated|24
1178423|NCT01099917|3872395|P1|Overall Study|Adverse Event|3
1178424|NCT01099709|3872457|P2|Period 1|Adverse Event|0
1178425|NCT01099709|3872458|P1|Period 1|Adverse Event|1
1178426|NCT01099709|3872457|P2|Period 1|Positive cotinine test|1
1178427|NCT01099709|3872458|P1|Period 1|Positive cotinine test|0
1178428|NCT01099709|3872457|P2|Period 1|Withdrawal by Subject|1
1178429|NCT01099709|3872458|P1|Period 1|Withdrawal by Subject|0
1178430|NCT01099579|3872484|P3|Stage 2 (ATV Capsule)|Adverse Event|0
1178431|NCT01099579|3872485|P2|Stage 2 (ATV Capsule)|Adverse Event|1
1178432|NCT01099579|3872486|P1|Stage 2 (ATV Capsule)|Adverse Event|0
1178433|NCT01099579|3872484|P3|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1
1178434|NCT01099579|3872485|P2|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0
1178435|NCT01099579|3872486|P1|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2
1178436|NCT01099579|3872484|P3|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
1178437|NCT01099579|3872485|P2|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
1178438|NCT01099579|3872486|P1|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
1178439|NCT01099579|3872484|P3|Stage 2 (ATV Capsule)|Lack of Efficacy|2
1178440|NCT01099579|3872485|P2|Stage 2 (ATV Capsule)|Lack of Efficacy|0
1178441|NCT01099579|3872486|P1|Stage 2 (ATV Capsule)|Lack of Efficacy|0
1178442|NCT01099579|3872484|P3|Stage 2 (ATV Capsule)|Lost to Follow-up|1
1178443|NCT01099579|3872485|P2|Stage 2 (ATV Capsule)|Lost to Follow-up|1
1178444|NCT01099579|3872486|P1|Stage 2 (ATV Capsule)|Lost to Follow-up|1
1178445|NCT01099579|3872484|P3|Stage 2 (ATV Capsule)|No longer met study criteria|1
1178446|NCT01099579|3872485|P2|Stage 2 (ATV Capsule)|No longer met study criteria|2
1178447|NCT01099579|3872486|P1|Stage 2 (ATV Capsule)|No longer met study criteria|2
1178448|NCT01099579|3872484|P3|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
1178449|NCT01099579|3872485|P2|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2
1178450|NCT01099579|3872486|P1|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
1178451|NCT01099579|3872484|P3|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
1178452|NCT01099579|3872485|P2|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2
1178453|NCT01099579|3872486|P1|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
1178454|NCT01099579|3872484|P3|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1
1178455|NCT01099579|3872485|P2|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
1178456|NCT01099579|3872486|P1|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
1178457|NCT01099579|3872484|P3|Stage 1 (ATV Powder Formulation)|Adverse Event|0
1178458|NCT01099579|3872485|P2|Stage 1 (ATV Powder Formulation)|Adverse Event|1
1178459|NCT01099579|3872486|P1|Stage 1 (ATV Powder Formulation)|Adverse Event|4
1178460|NCT01099397|3872555|P1|Overall Study|Withdrawal by Subject|5
1178461|NCT01099397|3872555|P1|Overall Study|Protocol Violation|4
1178462|NCT01099397|3872555|P1|Overall Study|Lost to Follow-up|4
1178463|NCT01099267|3872582|P1|MDS-003 Study|Secondary Malign Disease|1
1178464|NCT01099267|3872582|P1|MDS-003 Study|Loss of Response|1
1178465|NCT01099267|3872582|P1|MDS-003 Study|Non-Compliance|2
1178466|NCT01099267|3872582|P1|MDS-003 Study|Investigator Decision|2
1178467|NCT01099267|3872582|P1|MDS-003 Study|Disease Progression|7
1178468|NCT01099267|3872582|P1|MDS-003 Study|Study Closed by Sponsor|2
1178469|NCT01099267|3872582|P1|MDS-003 Study|Death|11
1178470|NCT01099267|3872582|P1|MDS-003 Study|Lost to Follow-up|1
1178471|NCT01099267|3872582|P1|MDS-003 Study|Withdrawal by Subject|8
1178472|NCT01099267|3872582|P1|MDS-003 Study|Lack of Efficacy|52
1178473|NCT01099267|3872582|P1|MDS-003 Study|Adverse Event|37
1178474|NCT01099215|3872592|P2|Overall Study|Adverse Event|1
1178475|NCT01099215|3872593|P1|Overall Study|Adverse Event|0
1178476|NCT01099215|3872592|P2|Overall Study|Withdrawal by Subject|0
1178477|NCT01099215|3872593|P1|Overall Study|Withdrawal by Subject|1
1178478|NCT01098851|3872663|P2|Overall Study|Equipment failure|0
1178479|NCT01098851|3872664|P1|Overall Study|Equipment failure|1
1178480|NCT01098812|3872675|P3|Overall Study|Lost to Follow-up|0
1178481|NCT01098812|3872676|P2|Overall Study|Lost to Follow-up|1
1178482|NCT01098812|3872677|P1|Overall Study|Lost to Follow-up|0
1178483|NCT01098812|3872675|P3|Overall Study|Death|1
1178484|NCT01098812|3872676|P2|Overall Study|Death|0
1178485|NCT01098812|3872677|P1|Overall Study|Death|2
1178486|NCT01098539|3872753|P2|Overall Study|Physician Decision|3
1178487|NCT01098539|3872754|P1|Overall Study|Physician Decision|5
1178488|NCT01098539|3872753|P2|Overall Study|Withdrawal by Subject|26
1178489|NCT01098539|3872754|P1|Overall Study|Withdrawal by Subject|12
1178490|NCT01098539|3872753|P2|Overall Study|Lost to Follow-up|4
1178491|NCT01098539|3872754|P1|Overall Study|Lost to Follow-up|4
1178492|NCT01098539|3872753|P2|Overall Study|Noncompliance|5
1178493|NCT01098539|3872754|P1|Overall Study|Noncompliance|3
1178494|NCT01098539|3872753|P2|Overall Study|Protocol Violation|4
1178495|NCT01098539|3872754|P1|Overall Study|Protocol Violation|1
1178496|NCT01098539|3872753|P2|Overall Study|Adverse Event|26
1178497|NCT01098539|3872754|P1|Overall Study|Adverse Event|26
1178498|NCT01098487|3872805|P1|Overall Study|Physician Decision|1
1178499|NCT01098487|3872805|P1|Overall Study|Lost to Follow-up|3
1178500|NCT01098487|3872805|P1|Overall Study|Withdrawal by Subject|7
1178501|NCT01098487|3872805|P1|Overall Study|Lack of Efficacy|11
1178502|NCT01098487|3872805|P1|Overall Study|Adverse Event|22
1178503|NCT01098474|3872823|P6|Follow Up Phase|Lost to Follow-up|0
1178504|NCT01098474|3872824|P5|Follow Up Phase|Lost to Follow-up|1
1178505|NCT01098474|3872825|P4|Follow Up Phase|Lost to Follow-up|0
1178506|NCT01098474|3872826|P3|Follow Up Phase|Lost to Follow-up|0
1178507|NCT01098474|3872827|P2|Follow Up Phase|Lost to Follow-up|0
1178508|NCT01098474|3872828|P1|Follow Up Phase|Lost to Follow-up|0
1178509|NCT01098474|3872823|P6|Follow Up Phase|Withdrawal by Subject|1
1178510|NCT01098474|3872824|P5|Follow Up Phase|Withdrawal by Subject|0
1178511|NCT01098474|3872825|P4|Follow Up Phase|Withdrawal by Subject|2
1178512|NCT01098474|3872826|P3|Follow Up Phase|Withdrawal by Subject|0
1178513|NCT01098474|3872827|P2|Follow Up Phase|Withdrawal by Subject|0
1178514|NCT01098474|3872828|P1|Follow Up Phase|Withdrawal by Subject|0
1178515|NCT01098474|3872823|P6|Follow Up Phase|Other|4
1178516|NCT01098474|3872824|P5|Follow Up Phase|Other|0
1178517|NCT01098474|3872825|P4|Follow Up Phase|Other|0
1178518|NCT01098474|3872826|P3|Follow Up Phase|Other|0
1178519|NCT01098474|3872827|P2|Follow Up Phase|Other|0
1178520|NCT01098474|3872828|P1|Follow Up Phase|Other|0
1178521|NCT01098474|3872823|P6|Follow Up Phase|Travelled out of study area|0
1178522|NCT01098474|3872824|P5|Follow Up Phase|Travelled out of study area|1
1178523|NCT01098474|3872825|P4|Follow Up Phase|Travelled out of study area|0
1178524|NCT01098474|3872826|P3|Follow Up Phase|Travelled out of study area|0
1178525|NCT01098474|3872827|P2|Follow Up Phase|Travelled out of study area|0
1178526|NCT01098474|3872828|P1|Follow Up Phase|Travelled out of study area|0
1178527|NCT01098474|3872823|P6|Active Phase|Lost to Follow-up|0
1178528|NCT01098474|3872824|P5|Active Phase|Lost to Follow-up|0
1178529|NCT01098474|3872825|P4|Active Phase|Lost to Follow-up|0
1178530|NCT01098474|3872826|P3|Active Phase|Lost to Follow-up|0
1178531|NCT01098474|3872827|P2|Active Phase|Lost to Follow-up|0
1178532|NCT01098474|3872828|P1|Active Phase|Lost to Follow-up|1
1178533|NCT01098474|3872823|P6|Active Phase|Withdrawal by Subject|0
1178534|NCT01098474|3872824|P5|Active Phase|Withdrawal by Subject|0
1178535|NCT01098474|3872825|P4|Active Phase|Withdrawal by Subject|0
1178536|NCT01098474|3872826|P3|Active Phase|Withdrawal by Subject|2
1178537|NCT01098474|3872827|P2|Active Phase|Withdrawal by Subject|1
1178538|NCT01098474|3872828|P1|Active Phase|Withdrawal by Subject|1
1178539|NCT01098474|3872823|P6|Active Phase|Other|0
1178540|NCT01098474|3872824|P5|Active Phase|Other|0
1178541|NCT01098474|3872825|P4|Active Phase|Other|0
1178542|NCT01098474|3872826|P3|Active Phase|Other|3
1178543|NCT01098474|3872827|P2|Active Phase|Other|0
1178544|NCT01098474|3872828|P1|Active Phase|Other|0
1178545|NCT01098461|3873062|P4|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
1178546|NCT01098461|3873063|P3|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
1178547|NCT01098461|3873064|P2|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
1178548|NCT01098461|3873065|P1|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
1178549|NCT01098461|3873062|P4|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
1178550|NCT01098461|3873063|P3|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
1178551|NCT01098461|3873064|P2|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1
1178552|NCT01098461|3873065|P1|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
1178553|NCT01098461|3873062|P4|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
1178554|NCT01098461|3873063|P3|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
1178555|NCT01098461|3873064|P2|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1
1178556|NCT01098461|3873065|P1|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
1178557|NCT01098461|3873062|P4|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
1178558|NCT01098461|3873063|P3|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
1178559|NCT01098461|3873064|P2|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1
1178560|NCT01098461|3873065|P1|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
1178561|NCT01098461|3873062|P4|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
1178562|NCT01098461|3873063|P3|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
1178563|NCT01098461|3873064|P2|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2
1178564|NCT01098461|3873065|P1|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1
1178565|NCT01098461|3873062|P4|Treatment Period (TP) (16 Weeks)|Adverse Event|3
1178566|NCT01098461|3873063|P3|Treatment Period (TP) (16 Weeks)|Adverse Event|1
1178567|NCT01098461|3873064|P2|Treatment Period (TP) (16 Weeks)|Adverse Event|2
1178568|NCT01098461|3873065|P1|Treatment Period (TP) (16 Weeks)|Adverse Event|1
1178569|NCT01098461|3873062|P4|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
1178570|NCT01098461|3873063|P3|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
1178571|NCT01098461|3873064|P2|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2
1178572|NCT01098461|3873065|P1|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10
1178573|NCT01098305|3873125|P2|Overall Study|Lost to Follow-up|33
1178574|NCT01098305|3873126|P1|Overall Study|Lost to Follow-up|31
1178575|NCT01098240|3873145|P3|Double-Blind Phase|Adverse Event|3
1178576|NCT01098240|3873146|P2|Double-Blind Phase|Adverse Event|3
1178577|NCT01098240|3873147|P1|Double-Blind Phase|Adverse Event|0
1178578|NCT01098240|3873145|P3|Double-Blind Phase|Withdrawal by Subject|3
1178579|NCT01098240|3873146|P2|Double-Blind Phase|Withdrawal by Subject|1
1178580|NCT01098240|3873147|P1|Double-Blind Phase|Withdrawal by Subject|0
1178581|NCT01098240|3873145|P3|Double-Blind Phase|Insufficient Clinical Response|2
1178582|NCT01098240|3873146|P2|Double-Blind Phase|Insufficient Clinical Response|1
1178583|NCT01098240|3873147|P1|Double-Blind Phase|Insufficient Clinical Response|0
1178584|NCT01098240|3873145|P3|Double-Blind Phase|Did Not Meet Entrance Criteria|0
1178585|NCT01098240|3873146|P2|Double-Blind Phase|Did Not Meet Entrance Criteria|1
1178586|NCT01098240|3873147|P1|Double-Blind Phase|Did Not Meet Entrance Criteria|0
1178587|NCT01098240|3873145|P3|Double-Blind Phase|Other|2
1178588|NCT01098240|3873146|P2|Double-Blind Phase|Other|2
1178589|NCT01098240|3873147|P1|Double-Blind Phase|Other|0
1178590|NCT01098240|3873145|P3|Double-Blind Phase|Lost to Follow-up|0
1178591|NCT01098240|3873146|P2|Double-Blind Phase|Lost to Follow-up|2
1178592|NCT01098240|3873147|P1|Double-Blind Phase|Lost to Follow-up|0
1178593|NCT01098240|3873145|P3|Double-Blind Phase|Protocol Violation|4
1178594|NCT01098240|3873146|P2|Double-Blind Phase|Protocol Violation|2
1178595|NCT01098240|3873147|P1|Double-Blind Phase|Protocol Violation|0
1178596|NCT01098240|3873145|P3|Double-Blind Phase|Study Terminated by Sponsor|8
1178597|NCT01098240|3873146|P2|Double-Blind Phase|Study Terminated by Sponsor|5
1178598|NCT01098240|3873147|P1|Double-Blind Phase|Study Terminated by Sponsor|0
1178599|NCT01098240|3873145|P3|Open-Label Phase|Adverse Event|0
1178600|NCT01098240|3873146|P2|Open-Label Phase|Adverse Event|0
1178601|NCT01098240|3873147|P1|Open-Label Phase|Adverse Event|12
1178602|NCT01098240|3873145|P3|Open-Label Phase|Withdrawal by Subject|0
1178603|NCT01098240|3873146|P2|Open-Label Phase|Withdrawal by Subject|0
1178604|NCT01098240|3873147|P1|Open-Label Phase|Withdrawal by Subject|9
1178605|NCT01098240|3873145|P3|Open-Label Phase|Pregnancy|0
1178606|NCT01098240|3873146|P2|Open-Label Phase|Pregnancy|0
1178607|NCT01098240|3873147|P1|Open-Label Phase|Pregnancy|1
1178608|NCT01098240|3873145|P3|Open-Label Phase|Did Not Meet Entrance Criteria|0
1178609|NCT01098240|3873146|P2|Open-Label Phase|Did Not Meet Entrance Criteria|0
1178610|NCT01098240|3873147|P1|Open-Label Phase|Did Not Meet Entrance Criteria|50
1178611|NCT01098240|3873145|P3|Open-Label Phase|Other|0
1178612|NCT01098240|3873146|P2|Open-Label Phase|Other|0
1178613|NCT01098240|3873147|P1|Open-Label Phase|Other|19
1178614|NCT01098240|3873145|P3|Open-Label Phase|Lost to Follow-up|0
1178615|NCT01098240|3873146|P2|Open-Label Phase|Lost to Follow-up|0
1178616|NCT01098240|3873147|P1|Open-Label Phase|Lost to Follow-up|13
1178617|NCT01098240|3873145|P3|Open-Label Phase|Protocol Violation|0
1178618|NCT01098240|3873146|P2|Open-Label Phase|Protocol Violation|0
1178619|NCT01098240|3873147|P1|Open-Label Phase|Protocol Violation|4
1178620|NCT01098240|3873145|P3|Open-Label Phase|Study Terminated by Sponsor|0
1178621|NCT01098240|3873146|P2|Open-Label Phase|Study Terminated by Sponsor|0
1178622|NCT01098240|3873147|P1|Open-Label Phase|Study Terminated by Sponsor|27
1178623|NCT01098162|3873177|P1|Overall Study|Reason Unknown|26
1178624|NCT01098162|3873177|P1|Overall Study|Other Reason|1
1178625|NCT01098162|3873177|P1|Overall Study|Wish of Patient & Lost to Follow-up|1
1178626|NCT01098162|3873177|P1|Overall Study|AE & Lack of Efficacy & Wish of Patient|1
1178627|NCT01098162|3873177|P1|Overall Study|Adverse Event & Lost to Follow-up|2
1178628|NCT01098162|3873177|P1|Overall Study|Adverse Event & Wish of Patient|13
1178629|NCT01098162|3873177|P1|Overall Study|Adverse Event & Lack of Efficacy|6
1178630|NCT01098162|3873177|P1|Overall Study|Lack of Efficacy & Wish of Patient|5
1178631|NCT01098162|3873177|P1|Overall Study|Lost to Follow-up|9
1178632|NCT01098162|3873177|P1|Overall Study|Wish of Patient|7
1178633|NCT01098162|3873177|P1|Overall Study|Lack of Efficacy|4
1178634|NCT01098162|3873177|P1|Overall Study|Adverse Event|37
1178635|NCT01098110|3873189|P3|Overall Study|Untreated|0
1178636|NCT01098110|3873190|P2|Overall Study|Untreated|1
1178637|NCT01098110|3873191|P1|Overall Study|Untreated|1
1178638|NCT01098110|3873189|P3|Overall Study|Not Specified|5
1178639|NCT01098110|3873190|P2|Overall Study|Not Specified|7
1178640|NCT01098110|3873191|P1|Overall Study|Not Specified|4
1178641|NCT01098110|3873189|P3|Overall Study|Lack of Efficacy|27
1178642|NCT01098110|3873190|P2|Overall Study|Lack of Efficacy|9
1178643|NCT01098110|3873191|P1|Overall Study|Lack of Efficacy|13
1178644|NCT01098110|3873189|P3|Overall Study|Adverse Event|43
1178645|NCT01098110|3873190|P2|Overall Study|Adverse Event|32
1178646|NCT01098110|3873191|P1|Overall Study|Adverse Event|30
1178647|NCT01098110|3873189|P3|Overall Study|Withdrawal by Subject|19
1178648|NCT01098110|3873190|P2|Overall Study|Withdrawal by Subject|24
1178649|NCT01098110|3873191|P1|Overall Study|Withdrawal by Subject|14
1178650|NCT01098097|3873232|P1|Overall Study|No reason reported|31
1178651|NCT01098097|3873232|P1|Overall Study|Status unknown|16
1178652|NCT01098097|3873232|P1|Overall Study|Lost to Follow-up|18
1178653|NCT01098097|3873232|P1|Overall Study|Adverse Event|17
1178654|NCT01098071|3873241|P1|Overall Study|Lost to Follow-up|13
1178655|NCT01098071|3873241|P1|Overall Study|Surgery (adenoidectomy)|2
1178656|NCT01098032|3873254|P2|Overall Study|Withdrawal by Subject|1
1178657|NCT01098032|3873255|P1|Overall Study|Withdrawal by Subject|1
1178658|NCT01097863|3873372|P3|Overall Study|Did not return for final visit|1
1178659|NCT01097863|3873373|P2|Overall Study|Did not return for final visit|0
1178660|NCT01097863|3873374|P1|Overall Study|Did not return for final visit|0
1178661|NCT01097863|3873372|P3|Overall Study|Discomfort|1
1178662|NCT01097863|3873373|P2|Overall Study|Discomfort|0
1178663|NCT01097863|3873374|P1|Overall Study|Discomfort|1
1178664|NCT01097694|3873395|P2|Overall Study|Withdrawal by Subject|1
1178665|NCT01097694|3873396|P1|Overall Study|Withdrawal by Subject|3
1178666|NCT01097694|3873395|P2|Overall Study|Lost to Follow-up|3
1178667|NCT01097694|3873396|P1|Overall Study|Lost to Follow-up|0
1178668|NCT01097694|3873395|P2|Overall Study|Adverse Event|0
1178669|NCT01097694|3873396|P1|Overall Study|Adverse Event|5
1178670|NCT01097668|3873458|P2|Overall Study|Lost to Follow-up|0
1178671|NCT01097668|3873459|P1|Overall Study|Lost to Follow-up|1
1178672|NCT01097668|3873458|P2|Overall Study|Withdrawal by Subject|2
1178673|NCT01097668|3873459|P1|Overall Study|Withdrawal by Subject|1
1178674|NCT01097655|3873469|P1|Overall Study|Did Not Meet Inclusion Criteria|8
1178675|NCT01097655|3873469|P1|Overall Study|Subject Documented Twice|1
1178676|NCT01097655|3873469|P1|Overall Study|Withdrawal by Subject|1
1178677|NCT01097629|3873479|P8|DB RO Phase|Lost to Follow-up|0
1178678|NCT01097629|3873480|P7|DB RO Phase|Lost to Follow-up|2
1178679|NCT01097629|3873481|P6|DB RO Phase|Lost to Follow-up|0
1178680|NCT01097629|3873482|P5|DB RO Phase|Lost to Follow-up|0
1178681|NCT01097629|3873483|P4|DB RO Phase|Lost to Follow-up|0
1178682|NCT01097629|3873484|P3|DB RO Phase|Lost to Follow-up|0
1178683|NCT01097629|3873485|P2|DB RO Phase|Lost to Follow-up|0
1178684|NCT01097629|3873486|P1|DB RO Phase|Lost to Follow-up|0
1178685|NCT01097629|3873479|P8|DB RO Phase|Protocol Violation|0
1178686|NCT01097629|3873480|P7|DB RO Phase|Protocol Violation|1
1178687|NCT01097629|3873481|P6|DB RO Phase|Protocol Violation|1
1178688|NCT01097629|3873482|P5|DB RO Phase|Protocol Violation|0
1178689|NCT01097629|3873483|P4|DB RO Phase|Protocol Violation|1
1178690|NCT01097629|3873484|P3|DB RO Phase|Protocol Violation|0
1178691|NCT01097629|3873485|P2|DB RO Phase|Protocol Violation|0
1178692|NCT01097629|3873486|P1|DB RO Phase|Protocol Violation|0
1178693|NCT01097629|3873479|P8|DB RO Phase|Withdrawal by Subject|1
1178694|NCT01097629|3873480|P7|DB RO Phase|Withdrawal by Subject|0
1178695|NCT01097629|3873481|P6|DB RO Phase|Withdrawal by Subject|0
1178696|NCT01097629|3873482|P5|DB RO Phase|Withdrawal by Subject|0
1178697|NCT01097629|3873483|P4|DB RO Phase|Withdrawal by Subject|0
1178698|NCT01097629|3873484|P3|DB RO Phase|Withdrawal by Subject|0
1178699|NCT01097629|3873485|P2|DB RO Phase|Withdrawal by Subject|0
1178700|NCT01097629|3873486|P1|DB RO Phase|Withdrawal by Subject|0
1178701|NCT01097629|3873479|P8|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
1178702|NCT01097629|3873480|P7|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
1178703|NCT01097629|3873481|P6|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
1178704|NCT01097629|3873482|P5|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
1178705|NCT01097629|3873483|P4|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
1178706|NCT01097629|3873484|P3|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4
1178707|NCT01097629|3873485|P2|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5
1178708|NCT01097629|3873486|P1|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
1178709|NCT01097629|3873479|P8|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
1178710|NCT01097629|3873480|P7|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
1178711|NCT01097629|3873481|P6|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
1178712|NCT01097629|3873482|P5|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
1178713|NCT01097629|3873483|P4|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
1178714|NCT01097629|3873484|P3|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
1178715|NCT01097629|3873485|P2|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1
1178716|NCT01097629|3873486|P1|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2
1178717|NCT01097629|3873479|P8|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
1178718|NCT01097629|3873480|P7|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
1178719|NCT01097629|3873481|P6|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
1178720|NCT01097629|3873482|P5|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
1178721|NCT01097629|3873483|P4|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
1178722|NCT01097629|3873484|P3|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8
1178723|NCT01097629|3873485|P2|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4
1178724|NCT01097629|3873486|P1|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
1178725|NCT01097629|3873479|P8|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
1178726|NCT01097629|3873480|P7|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
1178727|NCT01097629|3873481|P6|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
1178728|NCT01097629|3873482|P5|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
1178729|NCT01097629|3873483|P4|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
1178730|NCT01097629|3873484|P3|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
1178731|NCT01097629|3873485|P2|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4
1178732|NCT01097629|3873486|P1|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2
1178733|NCT01097629|3873479|P8|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
1178734|NCT01097629|3873480|P7|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
1178735|NCT01097629|3873481|P6|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
1178736|NCT01097629|3873482|P5|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
1178737|NCT01097629|3873483|P4|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
1178738|NCT01097629|3873484|P3|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8
1178739|NCT01097629|3873485|P2|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4
1178740|NCT01097629|3873486|P1|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
1178741|NCT01097629|3873479|P8|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
1178742|NCT01097629|3873480|P7|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
1178743|NCT01097629|3873481|P6|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
1178744|NCT01097629|3873482|P5|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
1178745|NCT01097629|3873483|P4|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
1178746|NCT01097629|3873484|P3|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19
1178747|NCT01097629|3873485|P2|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9
1178748|NCT01097629|3873486|P1|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
1178749|NCT01097629|3873479|P8|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
1178750|NCT01097629|3873480|P7|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
1178751|NCT01097629|3873481|P6|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
1178752|NCT01097629|3873482|P5|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
1178753|NCT01097629|3873483|P4|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
1178754|NCT01097629|3873484|P3|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17
1178755|NCT01097629|3873485|P2|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19
1178756|NCT01097629|3873486|P1|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10
1178757|NCT01097616|3873537|P8|DB RO Phase|Not Treated in RO|0
1178758|NCT01097616|3873538|P7|DB RO Phase|Not Treated in RO|0
1178759|NCT01097616|3873539|P6|DB RO Phase|Not Treated in RO|1
1178760|NCT01097616|3873540|P5|DB RO Phase|Not Treated in RO|0
1178761|NCT01097616|3873541|P4|DB RO Phase|Not Treated in RO|0
1178762|NCT01097616|3873542|P3|DB RO Phase|Not Treated in RO|0
1178763|NCT01097616|3873543|P2|DB RO Phase|Not Treated in RO|0
1178764|NCT01097616|3873544|P1|DB RO Phase|Not Treated in RO|0
1178765|NCT01097616|3873537|P8|DB RO Phase|Lost to Follow-up|1
1178766|NCT01097616|3873538|P7|DB RO Phase|Lost to Follow-up|0
1178767|NCT01097616|3873539|P6|DB RO Phase|Lost to Follow-up|0
1178768|NCT01097616|3873540|P5|DB RO Phase|Lost to Follow-up|1
1178769|NCT01097616|3873541|P4|DB RO Phase|Lost to Follow-up|1
1178770|NCT01097616|3873542|P3|DB RO Phase|Lost to Follow-up|0
1178771|NCT01097616|3873543|P2|DB RO Phase|Lost to Follow-up|0
1178772|NCT01097616|3873544|P1|DB RO Phase|Lost to Follow-up|0
1178773|NCT01097616|3873537|P8|DB RO Phase|Withdrawal by Subject|0
1178774|NCT01097616|3873538|P7|DB RO Phase|Withdrawal by Subject|0
1178775|NCT01097616|3873539|P6|DB RO Phase|Withdrawal by Subject|1
1178776|NCT01097616|3873540|P5|DB RO Phase|Withdrawal by Subject|0
1178777|NCT01097616|3873541|P4|DB RO Phase|Withdrawal by Subject|0
1178778|NCT01097616|3873542|P3|DB RO Phase|Withdrawal by Subject|0
1178779|NCT01097616|3873543|P2|DB RO Phase|Withdrawal by Subject|0
1178780|NCT01097616|3873544|P1|DB RO Phase|Withdrawal by Subject|0
1178781|NCT01097616|3873537|P8|DB RO Phase|Adverse Event|0
1178782|NCT01097616|3873538|P7|DB RO Phase|Adverse Event|1
1178783|NCT01097616|3873539|P6|DB RO Phase|Adverse Event|0
1178784|NCT01097616|3873540|P5|DB RO Phase|Adverse Event|0
1178785|NCT01097616|3873541|P4|DB RO Phase|Adverse Event|0
1178786|NCT01097616|3873542|P3|DB RO Phase|Adverse Event|0
1178787|NCT01097616|3873543|P2|DB RO Phase|Adverse Event|0
1178788|NCT01097616|3873544|P1|DB RO Phase|Adverse Event|0
1178789|NCT01097616|3873537|P8|Optional DB EXT Phase|Physician Decision|0
1178790|NCT01097616|3873538|P7|Optional DB EXT Phase|Physician Decision|0
1178791|NCT01097616|3873539|P6|Optional DB EXT Phase|Physician Decision|0
1178792|NCT01097616|3873540|P5|Optional DB EXT Phase|Physician Decision|0
1178793|NCT01097616|3873541|P4|Optional DB EXT Phase|Physician Decision|0
1178794|NCT01097616|3873542|P3|Optional DB EXT Phase|Physician Decision|0
1178795|NCT01097616|3873543|P2|Optional DB EXT Phase|Physician Decision|0
1178796|NCT01097616|3873544|P1|Optional DB EXT Phase|Physician Decision|1
1178797|NCT01097616|3873537|P8|Optional DB EXT Phase|Lack of Efficacy|0
1178798|NCT01097616|3873538|P7|Optional DB EXT Phase|Lack of Efficacy|0
1178799|NCT01097616|3873539|P6|Optional DB EXT Phase|Lack of Efficacy|0
1178800|NCT01097616|3873540|P5|Optional DB EXT Phase|Lack of Efficacy|0
1178801|NCT01097616|3873541|P4|Optional DB EXT Phase|Lack of Efficacy|0
1178802|NCT01097616|3873542|P3|Optional DB EXT Phase|Lack of Efficacy|1
1178803|NCT01097616|3873543|P2|Optional DB EXT Phase|Lack of Efficacy|1
1178804|NCT01097616|3873544|P1|Optional DB EXT Phase|Lack of Efficacy|1
1178805|NCT01097616|3873537|P8|Optional DB EXT Phase|Lost to Follow-up|0
1178806|NCT01097616|3873538|P7|Optional DB EXT Phase|Lost to Follow-up|0
1178807|NCT01097616|3873539|P6|Optional DB EXT Phase|Lost to Follow-up|0
1178808|NCT01097616|3873540|P5|Optional DB EXT Phase|Lost to Follow-up|0
1178809|NCT01097616|3873541|P4|Optional DB EXT Phase|Lost to Follow-up|0
1178810|NCT01097616|3873542|P3|Optional DB EXT Phase|Lost to Follow-up|1
1178811|NCT01097616|3873543|P2|Optional DB EXT Phase|Lost to Follow-up|5
1178812|NCT01097616|3873544|P1|Optional DB EXT Phase|Lost to Follow-up|1
1178813|NCT01097616|3873537|P8|Optional DB EXT Phase|Protocol Violation|0
1178814|NCT01097616|3873538|P7|Optional DB EXT Phase|Protocol Violation|0
1178815|NCT01097616|3873539|P6|Optional DB EXT Phase|Protocol Violation|0
1178816|NCT01097616|3873540|P5|Optional DB EXT Phase|Protocol Violation|0
1178817|NCT01097616|3873541|P4|Optional DB EXT Phase|Protocol Violation|0
1178818|NCT01097616|3873542|P3|Optional DB EXT Phase|Protocol Violation|3
1178819|NCT01097616|3873543|P2|Optional DB EXT Phase|Protocol Violation|2
1178820|NCT01097616|3873544|P1|Optional DB EXT Phase|Protocol Violation|0
1178821|NCT01097616|3873537|P8|Optional DB EXT Phase|Withdrawal by Subject|0
1178822|NCT01097616|3873538|P7|Optional DB EXT Phase|Withdrawal by Subject|0
1178823|NCT01097616|3873539|P6|Optional DB EXT Phase|Withdrawal by Subject|0
1178824|NCT01097616|3873540|P5|Optional DB EXT Phase|Withdrawal by Subject|0
1178825|NCT01097616|3873541|P4|Optional DB EXT Phase|Withdrawal by Subject|0
1178826|NCT01097616|3873542|P3|Optional DB EXT Phase|Withdrawal by Subject|3
1178827|NCT01097616|3873543|P2|Optional DB EXT Phase|Withdrawal by Subject|6
1178828|NCT01097616|3873544|P1|Optional DB EXT Phase|Withdrawal by Subject|12
1178829|NCT01097616|3873537|P8|Optional DB EXT Phase|Adverse Event|0
1178830|NCT01097616|3873538|P7|Optional DB EXT Phase|Adverse Event|0
1178831|NCT01097616|3873539|P6|Optional DB EXT Phase|Adverse Event|0
1178832|NCT01097616|3873540|P5|Optional DB EXT Phase|Adverse Event|0
1178833|NCT01097616|3873541|P4|Optional DB EXT Phase|Adverse Event|0
1178834|NCT01097616|3873542|P3|Optional DB EXT Phase|Adverse Event|2
1178835|NCT01097616|3873543|P2|Optional DB EXT Phase|Adverse Event|7
1178836|NCT01097616|3873544|P1|Optional DB EXT Phase|Adverse Event|0
1178837|NCT01097616|3873537|P8|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
1178838|NCT01097616|3873538|P7|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
1178839|NCT01097616|3873539|P6|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
1178840|NCT01097616|3873540|P5|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
1178841|NCT01097616|3873541|P4|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
1178842|NCT01097616|3873542|P3|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
1178843|NCT01097616|3873543|P2|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
1178844|NCT01097616|3873544|P1|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
1178845|NCT01097616|3873537|P8|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
1178846|NCT01097616|3873538|P7|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
1178847|NCT01097616|3873539|P6|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
1178848|NCT01097616|3873540|P5|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
1178849|NCT01097616|3873541|P4|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
1178850|NCT01097616|3873542|P3|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
1178851|NCT01097616|3873543|P2|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3
1178852|NCT01097616|3873544|P1|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4
1178853|NCT01097616|3873537|P8|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
1178854|NCT01097616|3873538|P7|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
1178855|NCT01097616|3873539|P6|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
1178856|NCT01097616|3873540|P5|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
1178857|NCT01097616|3873541|P4|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
1178858|NCT01097616|3873542|P3|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
1178859|NCT01097616|3873543|P2|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
1178860|NCT01097616|3873544|P1|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
1178861|NCT01097616|3873537|P8|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
1178862|NCT01097616|3873538|P7|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
1178863|NCT01097616|3873539|P6|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
1178864|NCT01097616|3873540|P5|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
1178865|NCT01097616|3873541|P4|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
1178866|NCT01097616|3873542|P3|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9
1178867|NCT01097616|3873543|P2|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
1178868|NCT01097616|3873544|P1|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1
1178869|NCT01097616|3873537|P8|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
1178870|NCT01097616|3873538|P7|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
1178871|NCT01097616|3873539|P6|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
1178872|NCT01097616|3873540|P5|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
1178873|NCT01097616|3873541|P4|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
1178874|NCT01097616|3873542|P3|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
1178875|NCT01097616|3873543|P2|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
1178876|NCT01097616|3873544|P1|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
1178877|NCT01097616|3873537|P8|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
1178878|NCT01097616|3873538|P7|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
1178879|NCT01097616|3873539|P6|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
1178880|NCT01097616|3873540|P5|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
1178881|NCT01097616|3873541|P4|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
1178882|NCT01097616|3873542|P3|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1
1178883|NCT01097616|3873543|P2|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3
1178884|NCT01097616|3873544|P1|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
1178885|NCT01097616|3873537|P8|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
1178886|NCT01097616|3873538|P7|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
1178887|NCT01097616|3873539|P6|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
1178888|NCT01097616|3873540|P5|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
1178889|NCT01097616|3873541|P4|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
1178890|NCT01097616|3873542|P3|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12
1178891|NCT01097616|3873543|P2|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
1178892|NCT01097616|3873544|P1|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6
1178893|NCT01097616|3873537|P8|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
1178894|NCT01097616|3873538|P7|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
1178895|NCT01097616|3873539|P6|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
1178896|NCT01097616|3873540|P5|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
1178897|NCT01097616|3873541|P4|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
1178898|NCT01097616|3873542|P3|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21
1178899|NCT01097616|3873543|P2|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15
1178900|NCT01097616|3873544|P1|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6
1178901|NCT01097421|3873619|P1|Overall Study|Withdrawal by Subject|3
1178902|NCT01097421|3873619|P1|Overall Study|Lost to Follow-up|1
1178903|NCT01097421|3873619|P1|Overall Study|Protocol Violation|2
1178904|NCT01097421|3873619|P1|Overall Study|Adverse Event|8
1178905|NCT01097057|3873643|P1|Overall Study|Physician Decision|3
1178906|NCT01097005|3873650|P1|Overall Study|Discontinuance by complication|50
1178907|NCT01097005|3873650|P1|Overall Study|Adverse Event|14
1178908|NCT01097005|3873650|P1|Overall Study|Deviation from exclusion criteria|37
1178909|NCT01097005|3873650|P1|Overall Study|No examination data available|244
1178910|NCT01097005|3873650|P1|Overall Study|Poor medication compliance|1
1178911|NCT01097005|3873650|P1|Overall Study|Subjects cannot visit the hospital|1
1178912|NCT01097005|3873650|P1|Overall Study|Case Report Form not collected|18
1178913|NCT01096849|3873674|P3|Overall Study|Lost to Follow-up|1
1178914|NCT01096849|3873675|P2|Overall Study|Lost to Follow-up|3
1178915|NCT01096849|3873676|P1|Overall Study|Lost to Follow-up|1
1178916|NCT01096849|3873674|P3|Overall Study|Administrative Reasons|2
1178917|NCT01096849|3873675|P2|Overall Study|Administrative Reasons|1
1178918|NCT01096849|3873676|P1|Overall Study|Administrative Reasons|0
1178919|NCT01096849|3873674|P3|Overall Study|Investigator or Medical Monitor Decision|0
1178920|NCT01096849|3873675|P2|Overall Study|Investigator or Medical Monitor Decision|1
1178921|NCT01096849|3873676|P1|Overall Study|Investigator or Medical Monitor Decision|0
1178922|NCT01096849|3873674|P3|Overall Study|Unacceptable/ Intolerable AE(s)|1
1178923|NCT01096849|3873675|P2|Overall Study|Unacceptable/ Intolerable AE(s)|1
1178924|NCT01096849|3873676|P1|Overall Study|Unacceptable/ Intolerable AE(s)|0
1178925|NCT01096849|3873674|P3|Overall Study|Lack of Efficacy|0
1178926|NCT01096849|3873675|P2|Overall Study|Lack of Efficacy|2
1178927|NCT01096849|3873676|P1|Overall Study|Lack of Efficacy|0
1178928|NCT01096849|3873674|P3|Overall Study|Consent Withdrawn|2
1178929|NCT01096849|3873675|P2|Overall Study|Consent Withdrawn|4
1178930|NCT01096849|3873676|P1|Overall Study|Consent Withdrawn|1
1178931|NCT01096784|3873752|P2|Overall Study|Other Unspecified|1
1178932|NCT01096784|3873753|P1|Overall Study|Other Unspecified|0
1178933|NCT01096784|3873752|P2|Overall Study|Administrative Decision|1
1178934|NCT01096784|3873753|P1|Overall Study|Administrative Decision|0
1178935|NCT01096784|3873752|P2|Overall Study|Protocol Deviation|2
1178936|NCT01096784|3873753|P1|Overall Study|Protocol Deviation|2
1178937|NCT01096784|3873752|P2|Overall Study|Adverse Event|9
1178938|NCT01096784|3873753|P1|Overall Study|Adverse Event|11
1178939|NCT01096784|3873752|P2|Overall Study|Withdrawal by Subject|1
1178940|NCT01096784|3873753|P1|Overall Study|Withdrawal by Subject|2
1178941|NCT01096667|3873858|P5|Overall Study|Not treated|0
1178942|NCT01096667|3873859|P4|Overall Study|Not treated|0
1178943|NCT01096667|3873860|P3|Overall Study|Not treated|0
1178944|NCT01096667|3873861|P2|Overall Study|Not treated|0
1178945|NCT01096667|3873862|P1|Overall Study|Not treated|1
1178946|NCT01096667|3873858|P5|Overall Study|Protocol Violation|0
1178947|NCT01096667|3873859|P4|Overall Study|Protocol Violation|1
1178948|NCT01096667|3873860|P3|Overall Study|Protocol Violation|0
1178949|NCT01096667|3873861|P2|Overall Study|Protocol Violation|0
1178950|NCT01096667|3873862|P1|Overall Study|Protocol Violation|0
1178951|NCT01096667|3873858|P5|Overall Study|Reason not available|0
1178952|NCT01096667|3873859|P4|Overall Study|Reason not available|1
1178953|NCT01096667|3873860|P3|Overall Study|Reason not available|1
1178954|NCT01096667|3873861|P2|Overall Study|Reason not available|1
1178955|NCT01096667|3873862|P1|Overall Study|Reason not available|0
1178956|NCT01096667|3873858|P5|Overall Study|Withdrawal by Subject|0
1178957|NCT01096667|3873859|P4|Overall Study|Withdrawal by Subject|1
1178958|NCT01096667|3873860|P3|Overall Study|Withdrawal by Subject|0
1178959|NCT01096667|3873861|P2|Overall Study|Withdrawal by Subject|0
1178960|NCT01096667|3873862|P1|Overall Study|Withdrawal by Subject|1
1178961|NCT01096667|3873858|P5|Overall Study|Lost to Follow-up|0
1178962|NCT01096667|3873859|P4|Overall Study|Lost to Follow-up|0
1178963|NCT01096667|3873860|P3|Overall Study|Lost to Follow-up|1
1178964|NCT01096667|3873861|P2|Overall Study|Lost to Follow-up|1
1178965|NCT01096667|3873862|P1|Overall Study|Lost to Follow-up|1
1178966|NCT01096589|3874004|P4|Overall Study|found treatment exhausting|1
1178967|NCT01096589|3874005|P3|Overall Study|found treatment exhausting|0
1178968|NCT01096589|3874006|P2|Overall Study|found treatment exhausting|0
1178969|NCT01096589|3874007|P1|Overall Study|found treatment exhausting|0
1178970|NCT01096589|3874004|P4|Overall Study|Compliance with protocol|0
1178971|NCT01096589|3874005|P3|Overall Study|Compliance with protocol|1
1178972|NCT01096589|3874006|P2|Overall Study|Compliance with protocol|0
1178973|NCT01096589|3874007|P1|Overall Study|Compliance with protocol|0
1178974|NCT01096589|3874004|P4|Overall Study|Withdrawal by Subject|1
1178975|NCT01096589|3874005|P3|Overall Study|Withdrawal by Subject|1
1178976|NCT01096589|3874006|P2|Overall Study|Withdrawal by Subject|1
1178977|NCT01096589|3874007|P1|Overall Study|Withdrawal by Subject|2
1178978|NCT01096589|3874004|P4|Overall Study|Adverse Event|1
1178979|NCT01096589|3874005|P3|Overall Study|Adverse Event|2
1178980|NCT01096589|3874006|P2|Overall Study|Adverse Event|1
1178981|NCT01096589|3874007|P1|Overall Study|Adverse Event|2
1178982|NCT01096550|3874023|P2|Overall Study|Lost to Follow-up|9
1178983|NCT01096550|3874024|P1|Overall Study|Lost to Follow-up|12
1178984|NCT01096550|3874023|P2|Overall Study|non-African American participant|6
1178985|NCT01096550|3874024|P1|Overall Study|non-African American participant|13
1178986|NCT01096550|3874023|P2|Overall Study|Withdrawal by Subject|1
1178987|NCT01096550|3874024|P1|Overall Study|Withdrawal by Subject|0
1178988|NCT01096550|3874023|P2|Overall Study|clinic readmission|1
1178989|NCT01096550|3874024|P1|Overall Study|clinic readmission|1
1178990|NCT01096550|3874023|P2|Overall Study|non-regular treatment track at clinic|1
1178991|NCT01096550|3874024|P1|Overall Study|non-regular treatment track at clinic|1
1178992|NCT01096550|3874023|P2|Overall Study|discontinued site|11
1178993|NCT01096550|3874024|P1|Overall Study|discontinued site|10
1178994|NCT01096446|3874032|P2|Overall Study|Protocol Violation|0
1178995|NCT01096446|3874033|P1|Overall Study|Protocol Violation|2
1178996|NCT01096446|3874032|P2|Overall Study|Death|0
1178997|NCT01096446|3874033|P1|Overall Study|Death|1
1178998|NCT01096342|3874038|P1|Overall Study|Protocol Violation|1
1178999|NCT01096316|3874046|P2|Overall Study|Lost to Follow-up|9
1179000|NCT01096316|3874047|P1|Overall Study|Lost to Follow-up|15
1179001|NCT01096186|3874057|P1|Overall Study|Noncompliance with study drug|1
1179002|NCT01096186|3874057|P1|Overall Study|Physician Decision|1
1179003|NCT01096186|3874057|P1|Overall Study|Withdrawal by Subject|22
1179004|NCT01096186|3874057|P1|Overall Study|Lost to Follow-up|2
1179005|NCT01096186|3874057|P1|Overall Study|Lack of Efficacy|4
1179006|NCT01096186|3874057|P1|Overall Study|Death|4
1179007|NCT01096186|3874057|P1|Overall Study|Adverse Event|16
1179008|NCT01096056|3874065|P2|Overall Study|Lost to Follow-up|1
1179009|NCT01096056|3874066|P1|Overall Study|Lost to Follow-up|0
1179010|NCT01096017|3874098|P2|Treatment Period 2|Eligibility criteria not fulfilled|1
1179011|NCT01096017|3874099|P1|Treatment Period 2|Eligibility criteria not fulfilled|1
1179012|NCT01095978|3874127|P1|Overall Study|Adverse Event|1
1179013|NCT01095978|3874127|P1|Overall Study|Did not take Klacid SR|2
1179014|NCT01095835|3874161|P3|Overall Study|Protocol Violation|0
1179015|NCT01095835|3874162|P2|Overall Study|Protocol Violation|2
1179016|NCT01095835|3874163|P1|Overall Study|Protocol Violation|1
1179017|NCT01095835|3874161|P3|Overall Study|Non study compliance|1
1179018|NCT01095835|3874162|P2|Overall Study|Non study compliance|0
1179019|NCT01095835|3874163|P1|Overall Study|Non study compliance|0
1179020|NCT01095835|3874161|P3|Overall Study|Withdrawal by Subject|0
1179021|NCT01095835|3874162|P2|Overall Study|Withdrawal by Subject|3
1179022|NCT01095835|3874163|P1|Overall Study|Withdrawal by Subject|1
1179023|NCT01095835|3874161|P3|Overall Study|Physician Decision|1
1179024|NCT01095835|3874162|P2|Overall Study|Physician Decision|0
1179025|NCT01095835|3874163|P1|Overall Study|Physician Decision|0
1179026|NCT01095835|3874161|P3|Overall Study|Lack of Efficacy|0
1179027|NCT01095835|3874162|P2|Overall Study|Lack of Efficacy|1
1179028|NCT01095835|3874163|P1|Overall Study|Lack of Efficacy|0
1179029|NCT01095835|3874161|P3|Overall Study|Adverse Event|6
1179030|NCT01095835|3874162|P2|Overall Study|Adverse Event|6
1179031|NCT01095835|3874163|P1|Overall Study|Adverse Event|8
1179032|NCT01095796|3874201|P2|Overall Study|Participant Transferred to Another Study|200
1179033|NCT01095796|3874202|P1|Overall Study|Participant Transferred to Another Study|215
1179034|NCT01095796|3874201|P2|Overall Study|Protocol Violation|0
1179035|NCT01095796|3874202|P1|Overall Study|Protocol Violation|1
1179036|NCT01095796|3874201|P2|Overall Study|Participant Noncompliance|10
1179037|NCT01095796|3874202|P1|Overall Study|Participant Noncompliance|5
1179038|NCT01095796|3874201|P2|Overall Study|Lost to Follow-up|29
1179039|NCT01095796|3874202|P1|Overall Study|Lost to Follow-up|27
1179040|NCT01095796|3874201|P2|Overall Study|Withdrew Consent|22
1179041|NCT01095796|3874202|P1|Overall Study|Withdrew Consent|16
1179042|NCT01095796|3874201|P2|Overall Study|Investigator's Discretion|2
1179043|NCT01095796|3874202|P1|Overall Study|Investigator's Discretion|7
1179044|NCT01095796|3874201|P2|Overall Study|Lack of Efficacy|3
1179045|NCT01095796|3874202|P1|Overall Study|Lack of Efficacy|5
1179046|NCT01095796|3874201|P2|Overall Study|Pregnancy|0
1179047|NCT01095796|3874202|P1|Overall Study|Pregnancy|2
1179048|NCT01095796|3874201|P2|Overall Study|Death|2
1179049|NCT01095796|3874202|P1|Overall Study|Death|3
1179050|NCT01095796|3874201|P2|Overall Study|Adverse Event|19
1179051|NCT01095796|3874202|P1|Overall Study|Adverse Event|9
1179052|NCT01095796|3874201|P2|Overall Study|Randomized but Not Treated|2
1179053|NCT01095796|3874202|P1|Overall Study|Randomized but Not Treated|5
1179054|NCT01095666|3874232|P3|Overall Study|Non-compliance, not met criteria etc.|2
1179055|NCT01095666|3874233|P2|Overall Study|Non-compliance, not met criteria etc.|2
1179056|NCT01095666|3874234|P1|Overall Study|Non-compliance, not met criteria etc.|7
1179057|NCT01095666|3874232|P3|Overall Study|Withdrawal by Subject|1
1179058|NCT01095666|3874233|P2|Overall Study|Withdrawal by Subject|6
1179059|NCT01095666|3874234|P1|Overall Study|Withdrawal by Subject|6
1179060|NCT01095666|3874232|P3|Overall Study|Lost to Follow-up|0
1179061|NCT01095666|3874233|P2|Overall Study|Lost to Follow-up|2
1179062|NCT01095666|3874234|P1|Overall Study|Lost to Follow-up|2
1179063|NCT01095666|3874232|P3|Overall Study|Adverse Event|3
1179064|NCT01095666|3874233|P2|Overall Study|Adverse Event|1
1179065|NCT01095666|3874234|P1|Overall Study|Adverse Event|2
1179066|NCT01095666|3874232|P3|Overall Study|Lack of Efficacy|1
1179067|NCT01095666|3874233|P2|Overall Study|Lack of Efficacy|0
1179068|NCT01095666|3874234|P1|Overall Study|Lack of Efficacy|0
1179069|NCT01095653|3874257|P3|Overall Study|non-compliance, not met criteria, etc.|5
1179070|NCT01095653|3874258|P2|Overall Study|non-compliance, not met criteria, etc.|6
1179071|NCT01095653|3874259|P1|Overall Study|non-compliance, not met criteria, etc.|10
1179072|NCT01095653|3874257|P3|Overall Study|Withdrawal by Subject|3
1179073|NCT01095653|3874258|P2|Overall Study|Withdrawal by Subject|5
1179074|NCT01095653|3874259|P1|Overall Study|Withdrawal by Subject|4
1179075|NCT01095653|3874257|P3|Overall Study|Lost to Follow-up|4
1179076|NCT01095653|3874258|P2|Overall Study|Lost to Follow-up|0
1179077|NCT01095653|3874259|P1|Overall Study|Lost to Follow-up|1
1179078|NCT01095653|3874257|P3|Overall Study|Adverse Event|4
1179079|NCT01095653|3874258|P2|Overall Study|Adverse Event|4
1179080|NCT01095653|3874259|P1|Overall Study|Adverse Event|1
1179081|NCT01095653|3874257|P3|Overall Study|Lack of Efficacy|0
1179082|NCT01095653|3874258|P2|Overall Study|Lack of Efficacy|0
1179083|NCT01095653|3874259|P1|Overall Study|Lack of Efficacy|3
1179084|NCT01095250|3874317|P4|Overall Study|Withdrawal by Subject|0
1179085|NCT01095250|3874318|P3|Overall Study|Withdrawal by Subject|1
1179086|NCT01095250|3874319|P2|Overall Study|Withdrawal by Subject|0
1179087|NCT01095250|3874320|P1|Overall Study|Withdrawal by Subject|0
1179088|NCT01095250|3874317|P4|Overall Study|administrative reasons|5
1179089|NCT01095250|3874318|P3|Overall Study|administrative reasons|7
1179090|NCT01095250|3874319|P2|Overall Study|administrative reasons|10
1179091|NCT01095250|3874320|P1|Overall Study|administrative reasons|8
1179092|NCT01095094|3874350|P1|Overall Study|Physician Decision|1
1179093|NCT01095094|3874350|P1|Overall Study|Death|1
1179094|NCT01095094|3874350|P1|Overall Study|Withdrawal by Subject|1
1179095|NCT01094886|3874355|P1|Overall Study|Withdrawal by Subject|5
1179096|NCT01094886|3874355|P1|Overall Study|Adverse Event|2
1179097|NCT01094808|3874365|P3|Overall Study|Withdrawal by Subject|0
1179098|NCT01094808|3874366|P2|Overall Study|Withdrawal by Subject|1
1179099|NCT01094808|3874367|P1|Overall Study|Withdrawal by Subject|1
1179100|NCT01094782|3874408|P6|Overall Study|Noncompliance With Study Schedule|0
1179101|NCT01094782|3874409|P5|Overall Study|Noncompliance With Study Schedule|0
1179102|NCT01094782|3874410|P4|Overall Study|Noncompliance With Study Schedule|1
1179103|NCT01094782|3874411|P3|Overall Study|Noncompliance With Study Schedule|0
1179104|NCT01094782|3874412|P2|Overall Study|Noncompliance With Study Schedule|0
1179105|NCT01094782|3874413|P1|Overall Study|Noncompliance With Study Schedule|0
1179106|NCT01094782|3874408|P6|Overall Study|Low Visual Analog Scale (VAS) Score|0
1179107|NCT01094782|3874409|P5|Overall Study|Low Visual Analog Scale (VAS) Score|1
1179108|NCT01094782|3874410|P4|Overall Study|Low Visual Analog Scale (VAS) Score|0
1179109|NCT01094782|3874411|P3|Overall Study|Low Visual Analog Scale (VAS) Score|0
1179110|NCT01094782|3874412|P2|Overall Study|Low Visual Analog Scale (VAS) Score|0
1179111|NCT01094782|3874413|P1|Overall Study|Low Visual Analog Scale (VAS) Score|0
1179112|NCT01094782|3874408|P6|Overall Study|Recent Interventional Injection|1
1179113|NCT01094782|3874409|P5|Overall Study|Recent Interventional Injection|0
1179114|NCT01094782|3874410|P4|Overall Study|Recent Interventional Injection|0
1179115|NCT01094782|3874411|P3|Overall Study|Recent Interventional Injection|0
1179116|NCT01094782|3874412|P2|Overall Study|Recent Interventional Injection|0
1179117|NCT01094782|3874413|P1|Overall Study|Recent Interventional Injection|0
1179118|NCT01094782|3874408|P6|Overall Study|Wrong Pain Condition|1
1179119|NCT01094782|3874409|P5|Overall Study|Wrong Pain Condition|1
1179120|NCT01094782|3874410|P4|Overall Study|Wrong Pain Condition|2
1179121|NCT01094782|3874411|P3|Overall Study|Wrong Pain Condition|0
1179122|NCT01094782|3874412|P2|Overall Study|Wrong Pain Condition|0
1179123|NCT01094782|3874413|P1|Overall Study|Wrong Pain Condition|0
1179124|NCT01094782|3874408|P6|Overall Study|Hypertension|0
1179125|NCT01094782|3874409|P5|Overall Study|Hypertension|0
1179126|NCT01094782|3874410|P4|Overall Study|Hypertension|0
1179127|NCT01094782|3874411|P3|Overall Study|Hypertension|1
1179128|NCT01094782|3874412|P2|Overall Study|Hypertension|0
1179129|NCT01094782|3874413|P1|Overall Study|Hypertension|0
1179130|NCT01094782|3874408|P6|Overall Study|Healthy Subject Had Pain|0
1179131|NCT01094782|3874409|P5|Overall Study|Healthy Subject Had Pain|0
1179132|NCT01094782|3874410|P4|Overall Study|Healthy Subject Had Pain|0
1179133|NCT01094782|3874411|P3|Overall Study|Healthy Subject Had Pain|0
1179134|NCT01094782|3874412|P2|Overall Study|Healthy Subject Had Pain|1
1179135|NCT01094782|3874413|P1|Overall Study|Healthy Subject Had Pain|0
1179136|NCT01094782|3874408|P6|Overall Study|Unable to Complete Questionnaires|0
1179137|NCT01094782|3874409|P5|Overall Study|Unable to Complete Questionnaires|0
1179138|NCT01094782|3874410|P4|Overall Study|Unable to Complete Questionnaires|0
1179139|NCT01094782|3874411|P3|Overall Study|Unable to Complete Questionnaires|0
1179140|NCT01094782|3874412|P2|Overall Study|Unable to Complete Questionnaires|1
1179141|NCT01094782|3874413|P1|Overall Study|Unable to Complete Questionnaires|0
1179142|NCT01094782|3874408|P6|Overall Study|Sensory Deficit at Site of QST|0
1179143|NCT01094782|3874409|P5|Overall Study|Sensory Deficit at Site of QST|0
1179144|NCT01094782|3874410|P4|Overall Study|Sensory Deficit at Site of QST|0
1179145|NCT01094782|3874411|P3|Overall Study|Sensory Deficit at Site of QST|0
1179146|NCT01094782|3874412|P2|Overall Study|Sensory Deficit at Site of QST|1
1179147|NCT01094782|3874413|P1|Overall Study|Sensory Deficit at Site of QST|0
1179148|NCT01094782|3874408|P6|Overall Study|Positive Drug Screen|2
1179149|NCT01094782|3874409|P5|Overall Study|Positive Drug Screen|3
1179150|NCT01094782|3874410|P4|Overall Study|Positive Drug Screen|1
1179151|NCT01094782|3874411|P3|Overall Study|Positive Drug Screen|1
1179152|NCT01094782|3874412|P2|Overall Study|Positive Drug Screen|2
1179153|NCT01094782|3874413|P1|Overall Study|Positive Drug Screen|2
1179154|NCT01094782|3874408|P6|Overall Study|Lost to Follow-up|4
1179155|NCT01094782|3874409|P5|Overall Study|Lost to Follow-up|1
1179156|NCT01094782|3874410|P4|Overall Study|Lost to Follow-up|2
1179157|NCT01094782|3874411|P3|Overall Study|Lost to Follow-up|0
1179158|NCT01094782|3874412|P2|Overall Study|Lost to Follow-up|0
1179159|NCT01094782|3874413|P1|Overall Study|Lost to Follow-up|1
1179160|NCT01094782|3874408|P6|Overall Study|Withdrawal by Subject|0
1179161|NCT01094782|3874409|P5|Overall Study|Withdrawal by Subject|5
1179162|NCT01094782|3874410|P4|Overall Study|Withdrawal by Subject|5
1179163|NCT01094782|3874411|P3|Overall Study|Withdrawal by Subject|1
1179164|NCT01094782|3874412|P2|Overall Study|Withdrawal by Subject|5
1179165|NCT01094782|3874413|P1|Overall Study|Withdrawal by Subject|5
1179166|NCT01094743|3874457|P1|Period 1|Unsatisfactory comfort at lens fitting|2
1179167|NCT01094730|3874474|P2|Period 2 (14 Days)|Unsatisfactory lens fitting|1
1179168|NCT01094730|3874475|P1|Period 2 (14 Days)|Unsatisfactory lens fitting|0
1179169|NCT01094730|3874474|P2|Period 2 (14 Days)|Adverse Event|1
1179170|NCT01094730|3874475|P1|Period 2 (14 Days)|Adverse Event|0
1179171|NCT01094730|3874474|P2|Period 2 (14 Days)|No time for the follow-up visit|0
1179172|NCT01094730|3874475|P1|Period 2 (14 Days)|No time for the follow-up visit|1
1179173|NCT01094730|3874474|P2|Period 2 (14 Days)|Protocol Violation|0
1179174|NCT01094730|3874475|P1|Period 2 (14 Days)|Protocol Violation|2
1179175|NCT01094730|3874474|P2|Period 1 (14 Days)|Unsatisfactory visual response|0
1179176|NCT01094730|3874475|P1|Period 1 (14 Days)|Unsatisfactory visual response|1
1179177|NCT01094730|3874474|P2|Period 1 (14 Days)|No time for the follow-up visit|0
1179178|NCT01094730|3874475|P1|Period 1 (14 Days)|No time for the follow-up visit|1
1179179|NCT01094730|3874474|P2|Period 1 (14 Days)|Withdrawal by Subject|1
1179180|NCT01094730|3874475|P1|Period 1 (14 Days)|Withdrawal by Subject|0
1179181|NCT01094730|3874474|P2|Period 1 (14 Days)|Lost to Follow-up|1
1179182|NCT01094730|3874475|P1|Period 1 (14 Days)|Lost to Follow-up|0
1179183|NCT01094301|3874592|P1|Implant Stage|No return of pain|4
1179184|NCT01094301|3874592|P1|Implant Stage|Withdrawal by Subject|2
1179185|NCT01094301|3874592|P1|Implant Stage|Protocol Violation|1
1179186|NCT01094301|3874592|P1|Implant Stage|Adverse Event|1
1179187|NCT01094301|3874592|P1|Trial Stage|Withdrawal by Subject|1
1179188|NCT01094184|3874616|P2|Overall Study|Death|11
1179189|NCT01094184|3874617|P1|Overall Study|Death|35
1179190|NCT01094171|3874851|P1|Overall Study|Other|1
1179191|NCT01094171|3874851|P1|Overall Study|Migration from the study area|3
1179192|NCT01094171|3874851|P1|Overall Study|Informed consent withdrawal|4
1179193|NCT01094171|3874851|P1|Overall Study|Lost to Follow-up|2
1179194|NCT01094119|3874860|P2|Overall Study|Lack of Efficacy|4
1179195|NCT01094119|3874861|P1|Overall Study|Lack of Efficacy|2
1179196|NCT01093885|3874873|P1|Overall Study|Lost to Follow-up|1
1179197|NCT01093885|3874873|P1|Overall Study|Adverse Event|4
1179198|NCT01093846|3874881|P3|Overall Study|Administrative Problems|15
1179199|NCT01093846|3874882|P2|Overall Study|Administrative Problems|17
1179200|NCT01093846|3874883|P1|Overall Study|Administrative Problems|18
1179201|NCT01093846|3874881|P3|Overall Study|Condition no longer required study drug|1
1179202|NCT01093846|3874882|P2|Overall Study|Condition no longer required study drug|1
1179203|NCT01093846|3874883|P1|Overall Study|Condition no longer required study drug|1
1179204|NCT01093846|3874881|P3|Overall Study|Lack of Efficacy|4
1179205|NCT01093846|3874882|P2|Overall Study|Lack of Efficacy|0
1179206|NCT01093846|3874883|P1|Overall Study|Lack of Efficacy|0
1179207|NCT01093846|3874881|P3|Overall Study|Adverse Event|1
1179208|NCT01093846|3874882|P2|Overall Study|Adverse Event|0
1179209|NCT01093846|3874883|P1|Overall Study|Adverse Event|0
1179210|NCT01093755|3874908|P2|Overall Study|Withdrawal by Subject|4
1179211|NCT01093755|3874909|P1|Overall Study|Withdrawal by Subject|3
1179212|NCT01093625|3874949|P2|1-Year Visit|Lost to Follow-up|3
1179213|NCT01093625|3874950|P1|1-Year Visit|Lost to Follow-up|5
1179214|NCT01093625|3874949|P2|6-Month Visit|Lost to Follow-up|2
1179215|NCT01093625|3874950|P1|6-Month Visit|Lost to Follow-up|2
1179216|NCT01093625|3874949|P2|6-Month Visit|Withdrawal by Subject|7
1179217|NCT01093625|3874950|P1|6-Month Visit|Withdrawal by Subject|6
1179218|NCT01093625|3874949|P2|3-Month Visit|Lost to Follow-up|0
1179219|NCT01093625|3874950|P1|3-Month Visit|Lost to Follow-up|2
1179220|NCT01093625|3874949|P2|1-Month Visit|Lost to Follow-up|0
1179221|NCT01093625|3874950|P1|1-Month Visit|Lost to Follow-up|2
1179222|NCT01093625|3874949|P2|2-Week Visit|Withdrawal by Subject|0
1179223|NCT01093625|3874950|P1|2-Week Visit|Withdrawal by Subject|1
1179224|NCT01093625|3874949|P2|Baseline and Dispensed|Withdrawal by Subject|0
1179225|NCT01093625|3874950|P1|Baseline and Dispensed|Withdrawal by Subject|2
1179226|NCT01093599|3874970|P2|Overall Study|Lost to Follow-up|46
1179227|NCT01093599|3874971|P1|Overall Study|Lost to Follow-up|32
1179228|NCT01093534|3874980|P3|Overall Study|Other|4
1179229|NCT01093534|3874981|P2|Overall Study|Other|3
1179230|NCT01093534|3874982|P1|Overall Study|Other|1
1179231|NCT01093534|3874980|P3|Overall Study|Withdrawal by Subject|2
1179232|NCT01093534|3874981|P2|Overall Study|Withdrawal by Subject|7
1179233|NCT01093534|3874982|P1|Overall Study|Withdrawal by Subject|5
1179234|NCT01093534|3874980|P3|Overall Study|Lack of Efficacy|1
1179235|NCT01093534|3874981|P2|Overall Study|Lack of Efficacy|1
1179236|NCT01093534|3874982|P1|Overall Study|Lack of Efficacy|2
1179237|NCT01093534|3874980|P3|Overall Study|Adverse Event|2
1179238|NCT01093534|3874981|P2|Overall Study|Adverse Event|5
1179239|NCT01093534|3874982|P1|Overall Study|Adverse Event|2
1179240|NCT01093222|3875130|P1|Overall Study|Not protocol specified|1
1179241|NCT01093222|3875130|P1|Overall Study|Death|2
1179242|NCT01093222|3875130|P1|Overall Study|Progression/relapse|24
1179243|NCT01093222|3875130|P1|Overall Study|Adverse Event|7
1179244|NCT01093222|3875130|P1|Overall Study|Ineligible|6
1179245|NCT01092832|3875203|P2|Overall Study|Not specified|0
1179246|NCT01092832|3875204|P1|Overall Study|Not specified|1
1179247|NCT01092780|3875216|P4|Washout Period 2|Adverse Event|0
1179248|NCT01092780|3875217|P3|Washout Period 2|Adverse Event|1
1179249|NCT01092780|3875218|P2|Washout Period 2|Adverse Event|1
1179250|NCT01092780|3875219|P1|Washout Period 2|Adverse Event|0
1179251|NCT01092780|3875216|P4|Washout Period 1|Noncompliance with nCPAP|0
1179252|NCT01092780|3875217|P3|Washout Period 1|Noncompliance with nCPAP|0
1179253|NCT01092780|3875218|P2|Washout Period 1|Noncompliance with nCPAP|0
1179254|NCT01092780|3875219|P1|Washout Period 1|Noncompliance with nCPAP|1
1179255|NCT01092780|3875216|P4|Washout Period 1|Adverse Event|0
1179256|NCT01092780|3875217|P3|Washout Period 1|Adverse Event|0
1179257|NCT01092780|3875218|P2|Washout Period 1|Adverse Event|1
1179258|NCT01092780|3875219|P1|Washout Period 1|Adverse Event|0
1179259|NCT01092728|3875255|P2|Overall Study|Prohibited Concomitant Medications|0
1179260|NCT01092728|3875256|P1|Overall Study|Prohibited Concomitant Medications|1
1179261|NCT01092728|3875255|P2|Overall Study|Disease Progression|13
1179262|NCT01092728|3875256|P1|Overall Study|Disease Progression|1
1179263|NCT01092728|3875255|P2|Overall Study|Adverse Event|1
1179264|NCT01092728|3875256|P1|Overall Study|Adverse Event|0
1179265|NCT01092728|3875255|P2|Overall Study|Withdrawal by Subject|0
1179266|NCT01092728|3875256|P1|Overall Study|Withdrawal by Subject|2
1179267|NCT01092702|3875264|P1|Overall Study|Lost to Follow-up|2
1179268|NCT01092702|3875264|P1|Overall Study|Withdrawal by Subject|7
1179269|NCT01092663|3875270|P2|Overall Study|Protocol Violation|1
1179270|NCT01092663|3875271|P1|Overall Study|Protocol Violation|0
1179271|NCT01092663|3875270|P2|Overall Study|Adverse Event|1
1179272|NCT01092663|3875271|P1|Overall Study|Adverse Event|1
1179273|NCT01092663|3875270|P2|Overall Study|High fasting triglyceride|0
1179274|NCT01092663|3875271|P1|Overall Study|High fasting triglyceride|2
1179275|NCT01092663|3875270|P2|Overall Study|Glucose >300mg/dL|0
1179276|NCT01092663|3875271|P1|Overall Study|Glucose >300mg/dL|1
1179277|NCT01092663|3875270|P2|Overall Study|Withdrawal by Subject|2
1179278|NCT01092663|3875271|P1|Overall Study|Withdrawal by Subject|3
1179279|NCT01092637|3875319|P2|Overall Study|Death|49
1179280|NCT01092637|3875320|P1|Overall Study|Death|47
1179281|NCT01092546|3875335|P1|Overall Study|Subjects withdrawn prior to dosing|4
1179282|NCT01092507|3875342|P2|Overall Study|Withdrawal by Subject|0
1179283|NCT01092507|3875343|P1|Overall Study|Withdrawal by Subject|2
1179284|NCT01092416|3875378|P1|12-Month Follow-up|Data collected after close of 1Y window|2
1179285|NCT01092416|3875378|P1|12-Month Follow-up|Missed 1-year follow-up|1
1179286|NCT01092416|3875378|P1|12-Month Follow-up|Withdrawal by Subject|2
1179287|NCT01092416|3875378|P1|12-Month Follow-up|Lost to Follow-up|4
1179288|NCT01092416|3875378|P1|12-Month Follow-up|Death|16
1179289|NCT01092416|3875378|P1|30-Day Follow-up|Data collected after close of 30D window|5
1179290|NCT01092416|3875378|P1|30-Day Follow-up|Missed 30-day follow-up|3
1179291|NCT01092416|3875378|P1|30-Day Follow-up|Death|2
1179292|NCT01092416|3875378|P1|Enrollment|Atherectomy device not inserted|3
1179293|NCT01091974|3875415|P4|Overall Study|side-effects|2
1179294|NCT01091974|3875416|P3|Overall Study|side-effects|0
1179295|NCT01091974|3875417|P2|Overall Study|side-effects|1
1179296|NCT01091974|3875418|P1|Overall Study|side-effects|1
1179297|NCT01091974|3875415|P4|Overall Study|Withdrawal by Subject|2
1179298|NCT01091974|3875416|P3|Overall Study|Withdrawal by Subject|2
1179299|NCT01091974|3875417|P2|Overall Study|Withdrawal by Subject|3
1179300|NCT01091974|3875418|P1|Overall Study|Withdrawal by Subject|1
1179301|NCT01091974|3875415|P4|Overall Study|resumed sleep medication|2
1179302|NCT01091974|3875416|P3|Overall Study|resumed sleep medication|1
1179303|NCT01091974|3875417|P2|Overall Study|resumed sleep medication|0
1179304|NCT01091974|3875418|P1|Overall Study|resumed sleep medication|0
1179305|NCT01091974|3875415|P4|Overall Study|Did not start intervention|1
1179306|NCT01091974|3875416|P3|Overall Study|Did not start intervention|3
1179307|NCT01091974|3875417|P2|Overall Study|Did not start intervention|1
1179308|NCT01091974|3875418|P1|Overall Study|Did not start intervention|3
1179309|NCT01091675|3875453|P1|Overall Study|Lack of Efficacy|27
1179310|NCT01091675|3875453|P1|Overall Study|Adverse Event|7
1179311|NCT01091662|3875459|P2|Overall Study|unable to swallow capsule|1
1179312|NCT01091662|3875460|P1|Overall Study|unable to swallow capsule|0
1179313|NCT01091662|3875459|P2|Overall Study|Protocol Violation|2
1179314|NCT01091662|3875460|P1|Overall Study|Protocol Violation|0
1179315|NCT01091662|3875459|P2|Overall Study|Pregnancy|1
1179316|NCT01091662|3875460|P1|Overall Study|Pregnancy|0
1179317|NCT01091662|3875459|P2|Overall Study|Lost to Follow-up|1
1179318|NCT01091662|3875460|P1|Overall Study|Lost to Follow-up|0
1179319|NCT01091662|3875459|P2|Overall Study|met exclusion criteria|0
1179320|NCT01091662|3875460|P1|Overall Study|met exclusion criteria|1
1179321|NCT01091662|3875459|P2|Overall Study|met exit criteria|13
1179322|NCT01091662|3875460|P1|Overall Study|met exit criteria|7
1179323|NCT01091662|3875459|P2|Overall Study|Withdrawal by Subject|6
1179324|NCT01091662|3875460|P1|Overall Study|Withdrawal by Subject|7
1179325|NCT01091662|3875459|P2|Overall Study|Physician Decision|1
1179326|NCT01091662|3875460|P1|Overall Study|Physician Decision|1
1179327|NCT01091662|3875459|P2|Overall Study|Adverse Event|9
1179328|NCT01091662|3875460|P1|Overall Study|Adverse Event|1
1179329|NCT01091519|3875498|P2|Overall Study|Randomized not treated|4
1179330|NCT01091519|3875499|P1|Overall Study|Randomized not treated|4
1179331|NCT01091519|3875498|P2|Overall Study|Other|8
1179332|NCT01091519|3875499|P1|Overall Study|Other|6
1179333|NCT01091519|3875498|P2|Overall Study|Withdrawal by Subject|2
1179334|NCT01091519|3875499|P1|Overall Study|Withdrawal by Subject|2
1179335|NCT01091519|3875498|P2|Overall Study|Lost to Follow-up|24
1179336|NCT01091519|3875499|P1|Overall Study|Lost to Follow-up|14
1179337|NCT01091519|3875498|P2|Overall Study|Lack of Efficacy|19
1179338|NCT01091519|3875499|P1|Overall Study|Lack of Efficacy|16
1179339|NCT01091519|3875498|P2|Overall Study|Death|0
1179340|NCT01091519|3875499|P1|Overall Study|Death|1
1179341|NCT01091519|3875498|P2|Overall Study|Adverse Event|16
1179342|NCT01091519|3875499|P1|Overall Study|Adverse Event|12
1179343|NCT01091454|3875511|P1|Overall Study|Ineligible|1
1179344|NCT01091428|3875524|P4|Phase 2|Physician Decision|0
1179345|NCT01091428|3875525|P3|Phase 2|Physician Decision|2
1179346|NCT01091428|3875526|P2|Phase 2|Physician Decision|0
1179347|NCT01091428|3875527|P1|Phase 2|Physician Decision|0
1179348|NCT01091428|3875524|P4|Phase 2|Reason not specified|3
1179349|NCT01091428|3875525|P3|Phase 2|Reason not specified|4
1179350|NCT01091428|3875526|P2|Phase 2|Reason not specified|0
1179351|NCT01091428|3875527|P1|Phase 2|Reason not specified|0
1179352|NCT01091428|3875524|P4|Phase 2|Unsatisfactory Therapeutic Response|1
1179353|NCT01091428|3875525|P3|Phase 2|Unsatisfactory Therapeutic Response|1
1179354|NCT01091428|3875526|P2|Phase 2|Unsatisfactory Therapeutic Response|0
1179355|NCT01091428|3875527|P1|Phase 2|Unsatisfactory Therapeutic Response|0
1179356|NCT01091428|3875524|P4|Phase 2|Withdrawal by Subject|8
1179357|NCT01091428|3875525|P3|Phase 2|Withdrawal by Subject|9
1179358|NCT01091428|3875526|P2|Phase 2|Withdrawal by Subject|0
1179359|NCT01091428|3875527|P1|Phase 2|Withdrawal by Subject|0
1179360|NCT01091428|3875524|P4|Phase 2|Adverse Event|5
1179361|NCT01091428|3875525|P3|Phase 2|Adverse Event|12
1179362|NCT01091428|3875526|P2|Phase 2|Adverse Event|0
1179363|NCT01091428|3875527|P1|Phase 2|Adverse Event|0
1179364|NCT01091428|3875524|P4|Phase 2|Symptomatic Deterioration|6
1179365|NCT01091428|3875525|P3|Phase 2|Symptomatic Deterioration|1
1179366|NCT01091428|3875526|P2|Phase 2|Symptomatic Deterioration|0
1179367|NCT01091428|3875527|P1|Phase 2|Symptomatic Deterioration|0
1179368|NCT01091428|3875524|P4|Phase 2|Progressive Disease|46
1179369|NCT01091428|3875525|P3|Phase 2|Progressive Disease|44
1179370|NCT01091428|3875526|P2|Phase 2|Progressive Disease|0
1179371|NCT01091428|3875527|P1|Phase 2|Progressive Disease|0
1179372|NCT01091428|3875524|P4|Phase 1|Single-Patient IND|0
1179373|NCT01091428|3875525|P3|Phase 1|Single-Patient IND|0
1179374|NCT01091428|3875526|P2|Phase 1|Single-Patient IND|0
1179375|NCT01091428|3875527|P1|Phase 1|Single-Patient IND|2
1179376|NCT01091428|3875524|P4|Phase 1|Reason not specified|0
1179377|NCT01091428|3875525|P3|Phase 1|Reason not specified|0
1179378|NCT01091428|3875526|P2|Phase 1|Reason not specified|1
1179379|NCT01091428|3875527|P1|Phase 1|Reason not specified|0
1179380|NCT01091428|3875524|P4|Phase 1|Withdrawal by Subject|0
1179381|NCT01091428|3875525|P3|Phase 1|Withdrawal by Subject|0
1179382|NCT01091428|3875526|P2|Phase 1|Withdrawal by Subject|0
1179383|NCT01091428|3875527|P1|Phase 1|Withdrawal by Subject|7
1179384|NCT01091428|3875524|P4|Phase 1|Adverse Event|0
1179385|NCT01091428|3875525|P3|Phase 1|Adverse Event|0
1179386|NCT01091428|3875526|P2|Phase 1|Adverse Event|0
1179387|NCT01091428|3875527|P1|Phase 1|Adverse Event|2
1179388|NCT01091428|3875524|P4|Phase 1|Symptomatic Deterioration|0
1179389|NCT01091428|3875525|P3|Phase 1|Symptomatic Deterioration|0
1179390|NCT01091428|3875526|P2|Phase 1|Symptomatic Deterioration|2
1179391|NCT01091428|3875527|P1|Phase 1|Symptomatic Deterioration|3
1179392|NCT01091428|3875524|P4|Phase 1|Progressive Disease|0
1179393|NCT01091428|3875525|P3|Phase 1|Progressive Disease|0
1179394|NCT01091428|3875526|P2|Phase 1|Progressive Disease|8
1179395|NCT01091428|3875527|P1|Phase 1|Progressive Disease|24
1179396|NCT01091259|3875628|P1|Overall Study|Lack of Efficacy|2
1179397|NCT01091259|3875628|P1|Overall Study|Adverse Event|3
1179398|NCT01091246|3875639|P3|Overall Study|Subject not dosed|1
1179399|NCT01091246|3875640|P2|Overall Study|Subject not dosed|0
1179400|NCT01091246|3875641|P1|Overall Study|Subject not dosed|2
1179401|NCT01091246|3875639|P3|Overall Study|Withdrawal by Subject|4
1179402|NCT01091246|3875640|P2|Overall Study|Withdrawal by Subject|5
1179403|NCT01091246|3875641|P1|Overall Study|Withdrawal by Subject|9
1179404|NCT01091246|3875639|P3|Overall Study|Adverse Event|1
1179405|NCT01091246|3875640|P2|Overall Study|Adverse Event|0
1179406|NCT01091246|3875641|P1|Overall Study|Adverse Event|1
1179407|NCT01091246|3875639|P3|Overall Study|Lost to Follow-up|7
1179408|NCT01091246|3875640|P2|Overall Study|Lost to Follow-up|11
1179409|NCT01091246|3875641|P1|Overall Study|Lost to Follow-up|23
1179410|NCT01091103|3875780|P1|Overall Study|Progressive Disease|3
1179411|NCT01091103|3875780|P1|Overall Study|Adverse Event|1
1179412|NCT01090973|3875800|P1|Overall Study|Disease progression|1
1179413|NCT01090765|3875816|P6|Overall Study|Vasovagal reaction with first infusion|0
1179414|NCT01090765|3875817|P5|Overall Study|Vasovagal reaction with first infusion|1
1179415|NCT01090765|3875818|P4|Overall Study|Vasovagal reaction with first infusion|0
1179416|NCT01090765|3875819|P3|Overall Study|Vasovagal reaction with first infusion|0
1179417|NCT01090765|3875820|P2|Overall Study|Vasovagal reaction with first infusion|0
1179418|NCT01090765|3875821|P1|Overall Study|Vasovagal reaction with first infusion|0
1179419|NCT01090765|3875816|P6|Overall Study|Developed a DVT, needed anticoagulation|0
1179420|NCT01090765|3875817|P5|Overall Study|Developed a DVT, needed anticoagulation|0
1179421|NCT01090765|3875818|P4|Overall Study|Developed a DVT, needed anticoagulation|1
1179422|NCT01090765|3875819|P3|Overall Study|Developed a DVT, needed anticoagulation|0
1179423|NCT01090765|3875820|P2|Overall Study|Developed a DVT, needed anticoagulation|0
1179424|NCT01090765|3875821|P1|Overall Study|Developed a DVT, needed anticoagulation|0
1179425|NCT01090765|3875816|P6|Overall Study|Patient withdrew consent|1
1179426|NCT01090765|3875817|P5|Overall Study|Patient withdrew consent|1
1179427|NCT01090765|3875818|P4|Overall Study|Patient withdrew consent|0
1179428|NCT01090765|3875819|P3|Overall Study|Patient withdrew consent|0
1179429|NCT01090765|3875820|P2|Overall Study|Patient withdrew consent|0
1179430|NCT01090765|3875821|P1|Overall Study|Patient withdrew consent|0
1179431|NCT01090739|3875867|P1|36 Month Follow-up|Visit still pending|17
1179432|NCT01090739|3875867|P1|36 Month Follow-up|Withdrawal by Subject|6
1179433|NCT01090739|3875867|P1|24 Month Follow-up|Death|1
1179434|NCT01090739|3875867|P1|24 Month Follow-up|Lost to Follow-up|1
1179435|NCT01090739|3875867|P1|24 Month Follow-up|Withdrawal by Subject|7
1179436|NCT01090739|3875867|P1|12 Month Follow-up|Death|1
1179437|NCT01090739|3875867|P1|12 Month Follow-up|Physician Decision|1
1179438|NCT01090739|3875867|P1|12 Month Follow-up|Lost to Follow-up|1
1179439|NCT01090739|3875867|P1|12 Month Follow-up|Withdrawal by Subject|2
1179440|NCT01090739|3875867|P1|Enrollment|Adverse Event|1
1179441|NCT01090739|3875867|P1|Enrollment|Study implant limit reached|2
1179442|NCT01090739|3875867|P1|Enrollment|Sponsor termination of site|4
1179443|NCT01090739|3875867|P1|Enrollment|Physician Decision|5
1179444|NCT01090739|3875867|P1|Enrollment|Lost to Follow-up|5
1179445|NCT01090739|3875867|P1|Enrollment|Protocol Violation|14
1179446|NCT01090739|3875867|P1|Enrollment|Withdrawal by Subject|24
1179447|NCT01090492|3875892|P8|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
1179448|NCT01090492|3875893|P7|Second Intervention Period (4 Weeks)|Lost to Follow-up|1
1179449|NCT01090492|3875894|P6|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
1179450|NCT01090492|3875895|P5|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
1179451|NCT01090492|3875896|P4|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
1179452|NCT01090492|3875897|P3|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
1179453|NCT01090492|3875898|P2|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
1179454|NCT01090492|3875899|P1|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
1179455|NCT01090492|3875892|P8|Second Intervention Period (4 Weeks)|Adverse Event|1
1179456|NCT01090492|3875893|P7|Second Intervention Period (4 Weeks)|Adverse Event|7
1179457|NCT01090492|3875894|P6|Second Intervention Period (4 Weeks)|Adverse Event|1
1179458|NCT01090492|3875895|P5|Second Intervention Period (4 Weeks)|Adverse Event|1
1179459|NCT01090492|3875896|P4|Second Intervention Period (4 Weeks)|Adverse Event|0
1179460|NCT01090492|3875897|P3|Second Intervention Period (4 Weeks)|Adverse Event|1
1179461|NCT01090492|3875898|P2|Second Intervention Period (4 Weeks)|Adverse Event|0
1179462|NCT01090492|3875899|P1|Second Intervention Period (4 Weeks)|Adverse Event|0
1179463|NCT01090492|3875892|P8|Second Intervention Period (4 Weeks)|Other|0
1179464|NCT01090492|3875893|P7|Second Intervention Period (4 Weeks)|Other|0
1179465|NCT01090492|3875894|P6|Second Intervention Period (4 Weeks)|Other|0
1179466|NCT01090492|3875895|P5|Second Intervention Period (4 Weeks)|Other|0
1179467|NCT01090492|3875896|P4|Second Intervention Period (4 Weeks)|Other|0
1179468|NCT01090492|3875897|P3|Second Intervention Period (4 Weeks)|Other|1
1179469|NCT01090492|3875898|P2|Second Intervention Period (4 Weeks)|Other|1
1179470|NCT01090492|3875899|P1|Second Intervention Period (4 Weeks)|Other|0
1179471|NCT01090492|3875892|P8|Second Intervention Period (4 Weeks)|Non-compliance|0
1179472|NCT01090492|3875893|P7|Second Intervention Period (4 Weeks)|Non-compliance|0
1179473|NCT01090492|3875894|P6|Second Intervention Period (4 Weeks)|Non-compliance|0
1179474|NCT01090492|3875895|P5|Second Intervention Period (4 Weeks)|Non-compliance|0
1179475|NCT01090492|3875896|P4|Second Intervention Period (4 Weeks)|Non-compliance|0
1179476|NCT01090492|3875897|P3|Second Intervention Period (4 Weeks)|Non-compliance|0
1179477|NCT01090492|3875898|P2|Second Intervention Period (4 Weeks)|Non-compliance|1
1179478|NCT01090492|3875899|P1|Second Intervention Period (4 Weeks)|Non-compliance|0
1179479|NCT01090492|3875892|P8|Second Intervention Period (4 Weeks)|Protocol Violation|1
1179480|NCT01090492|3875893|P7|Second Intervention Period (4 Weeks)|Protocol Violation|1
1179481|NCT01090492|3875894|P6|Second Intervention Period (4 Weeks)|Protocol Violation|0
1179482|NCT01090492|3875895|P5|Second Intervention Period (4 Weeks)|Protocol Violation|1
1179483|NCT01090492|3875896|P4|Second Intervention Period (4 Weeks)|Protocol Violation|0
1179484|NCT01090492|3875897|P3|Second Intervention Period (4 Weeks)|Protocol Violation|0
1179485|NCT01090492|3875898|P2|Second Intervention Period (4 Weeks)|Protocol Violation|0
1179486|NCT01090492|3875899|P1|Second Intervention Period (4 Weeks)|Protocol Violation|1
1179487|NCT01090492|3875892|P8|First Intervention Period (4 Weeks)|Adverse Event|5
1179488|NCT01090492|3875893|P7|First Intervention Period (4 Weeks)|Adverse Event|0
1179489|NCT01090492|3875894|P6|First Intervention Period (4 Weeks)|Adverse Event|2
1179490|NCT01090492|3875895|P5|First Intervention Period (4 Weeks)|Adverse Event|1
1179491|NCT01090492|3875896|P4|First Intervention Period (4 Weeks)|Adverse Event|3
1179492|NCT01090492|3875897|P3|First Intervention Period (4 Weeks)|Adverse Event|0
1179493|NCT01090492|3875898|P2|First Intervention Period (4 Weeks)|Adverse Event|2
1179494|NCT01090492|3875899|P1|First Intervention Period (4 Weeks)|Adverse Event|0
1179495|NCT01090492|3875892|P8|First Intervention Period (4 Weeks)|Pregnancy|0
1179496|NCT01090492|3875893|P7|First Intervention Period (4 Weeks)|Pregnancy|0
1179497|NCT01090492|3875894|P6|First Intervention Period (4 Weeks)|Pregnancy|0
1179498|NCT01090492|3875895|P5|First Intervention Period (4 Weeks)|Pregnancy|1
1179499|NCT01090492|3875896|P4|First Intervention Period (4 Weeks)|Pregnancy|0
1179500|NCT01090492|3875897|P3|First Intervention Period (4 Weeks)|Pregnancy|0
1179501|NCT01090492|3875898|P2|First Intervention Period (4 Weeks)|Pregnancy|0
1179502|NCT01090492|3875899|P1|First Intervention Period (4 Weeks)|Pregnancy|0
1179503|NCT01090492|3875892|P8|First Intervention Period (4 Weeks)|Other|0
1179504|NCT01090492|3875893|P7|First Intervention Period (4 Weeks)|Other|0
1179505|NCT01090492|3875894|P6|First Intervention Period (4 Weeks)|Other|0
1179506|NCT01090492|3875895|P5|First Intervention Period (4 Weeks)|Other|2
1179507|NCT01090492|3875896|P4|First Intervention Period (4 Weeks)|Other|1
1179508|NCT01090492|3875897|P3|First Intervention Period (4 Weeks)|Other|1
1179509|NCT01090492|3875898|P2|First Intervention Period (4 Weeks)|Other|0
1179510|NCT01090492|3875899|P1|First Intervention Period (4 Weeks)|Other|0
1179511|NCT01090492|3875892|P8|First Intervention Period (4 Weeks)|Lost to Follow-up|0
1179512|NCT01090492|3875893|P7|First Intervention Period (4 Weeks)|Lost to Follow-up|0
1179513|NCT01090492|3875894|P6|First Intervention Period (4 Weeks)|Lost to Follow-up|0
1179514|NCT01090492|3875895|P5|First Intervention Period (4 Weeks)|Lost to Follow-up|0
1179515|NCT01090492|3875896|P4|First Intervention Period (4 Weeks)|Lost to Follow-up|0
1179516|NCT01090492|3875897|P3|First Intervention Period (4 Weeks)|Lost to Follow-up|1
1179517|NCT01090492|3875898|P2|First Intervention Period (4 Weeks)|Lost to Follow-up|0
1179518|NCT01090492|3875899|P1|First Intervention Period (4 Weeks)|Lost to Follow-up|0
1179519|NCT01090492|3875892|P8|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1
1179520|NCT01090492|3875893|P7|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
1179521|NCT01090492|3875894|P6|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
1179522|NCT01090492|3875895|P5|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
1179523|NCT01090492|3875896|P4|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
1179524|NCT01090492|3875897|P3|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
1179525|NCT01090492|3875898|P2|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2
1179526|NCT01090492|3875899|P1|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
1179527|NCT01090492|3875892|P8|First Intervention Period (4 Weeks)|Protocol Violation|0
1179528|NCT01090492|3875893|P7|First Intervention Period (4 Weeks)|Protocol Violation|1
1179529|NCT01090492|3875894|P6|First Intervention Period (4 Weeks)|Protocol Violation|0
1179530|NCT01090492|3875895|P5|First Intervention Period (4 Weeks)|Protocol Violation|0
1179531|NCT01090492|3875896|P4|First Intervention Period (4 Weeks)|Protocol Violation|2
1179532|NCT01090492|3875897|P3|First Intervention Period (4 Weeks)|Protocol Violation|1
1179533|NCT01090492|3875898|P2|First Intervention Period (4 Weeks)|Protocol Violation|1
1179534|NCT01090492|3875899|P1|First Intervention Period (4 Weeks)|Protocol Violation|1
1179535|NCT01090453|3875967|P2|Overall Study|Eligibility Criteria|1
1179536|NCT01090453|3875968|P1|Overall Study|Eligibility Criteria|0
1179537|NCT01090453|3875967|P2|Overall Study|Other|4
1179538|NCT01090453|3875968|P1|Overall Study|Other|2
1179539|NCT01090453|3875967|P2|Overall Study|Protocol Violation|0
1179540|NCT01090453|3875968|P1|Overall Study|Protocol Violation|2
1179541|NCT01090453|3875967|P2|Overall Study|Non serious AEs|0
1179542|NCT01090453|3875968|P1|Overall Study|Non serious AEs|1
1179543|NCT01090453|3875967|P2|Overall Study|Lost to Follow-up|7
1179544|NCT01090453|3875968|P1|Overall Study|Lost to Follow-up|7
1179545|NCT01090453|3875967|P2|Overall Study|Withdrawal by Subject|2
1179546|NCT01090453|3875968|P1|Overall Study|Withdrawal by Subject|1
1179547|NCT01090427|3876019|P7|After Controlled Period|Adverse Event|0
1179548|NCT01090427|3876020|P6|After Controlled Period|Adverse Event|1
1179549|NCT01090427|3876021|P5|After Controlled Period|Adverse Event|0
1179550|NCT01090427|3876022|P4|After Controlled Period|Adverse Event|2
1179551|NCT01090427|3876023|P3|After Controlled Period|Adverse Event|0
1179552|NCT01090427|3876024|P2|After Controlled Period|Adverse Event|0
1179553|NCT01090427|3876025|P1|After Controlled Period|Adverse Event|0
1179554|NCT01090427|3876019|P7|After Controlled Period|Lack of Efficacy|2
1179555|NCT01090427|3876020|P6|After Controlled Period|Lack of Efficacy|3
1179556|NCT01090427|3876021|P5|After Controlled Period|Lack of Efficacy|0
1179557|NCT01090427|3876022|P4|After Controlled Period|Lack of Efficacy|0
1179558|NCT01090427|3876023|P3|After Controlled Period|Lack of Efficacy|0
1179559|NCT01090427|3876024|P2|After Controlled Period|Lack of Efficacy|0
1179560|NCT01090427|3876025|P1|After Controlled Period|Lack of Efficacy|0
1179561|NCT01090427|3876019|P7|After Controlled Period|Death|0
1179562|NCT01090427|3876020|P6|After Controlled Period|Death|1
1179563|NCT01090427|3876021|P5|After Controlled Period|Death|0
1179564|NCT01090427|3876022|P4|After Controlled Period|Death|0
1179565|NCT01090427|3876023|P3|After Controlled Period|Death|0
1179566|NCT01090427|3876024|P2|After Controlled Period|Death|0
1179567|NCT01090427|3876025|P1|After Controlled Period|Death|0
1179568|NCT01090323|3876060|P2|Overall Study|Stopped end of extension 1#|1
1179569|NCT01090323|3876061|P1|Overall Study|Stopped end of extension 1#|3
1179570|NCT01090323|3876060|P2|Overall Study|Stopped end of core|0
1179571|NCT01090323|3876061|P1|Overall Study|Stopped end of core|7
1179572|NCT01090323|3876060|P2|Overall Study|Death|2
1179573|NCT01090323|3876061|P1|Overall Study|Death|1
1179574|NCT01090323|3876060|P2|Overall Study|Administrative problems|4
1179575|NCT01090323|3876061|P1|Overall Study|Administrative problems|6
1179576|NCT01090323|3876060|P2|Overall Study|Lost to Follow-up|6
1179577|NCT01090323|3876061|P1|Overall Study|Lost to Follow-up|11
1179578|NCT01090323|3876060|P2|Overall Study|Withdrew consent|11
1179579|NCT01090323|3876061|P1|Overall Study|Withdrew consent|33
1179580|NCT01090323|3876060|P2|Overall Study|Protocol Violation|1
1179581|NCT01090323|3876061|P1|Overall Study|Protocol Violation|2
1179582|NCT01090323|3876060|P2|Overall Study|Condition no longer requires drug|4
1179583|NCT01090323|3876061|P1|Overall Study|Condition no longer requires drug|5
1179584|NCT01090323|3876060|P2|Overall Study|Unsatisfactory therapeutic effect|2
1179585|NCT01090323|3876061|P1|Overall Study|Unsatisfactory therapeutic effect|4
1179586|NCT01090323|3876060|P2|Overall Study|Abnormal Test Procedure Results|0
1179587|NCT01090323|3876061|P1|Overall Study|Abnormal Test Procedure Results|2
1179588|NCT01090323|3876060|P2|Overall Study|Abnormal Lab Values|1
1179589|NCT01090323|3876061|P1|Overall Study|Abnormal Lab Values|3
1179590|NCT01090323|3876060|P2|Overall Study|Adverse Event|2
1179591|NCT01090323|3876061|P1|Overall Study|Adverse Event|12
1179592|NCT01090310|3876073|P4|Extension Study|Subject withdrew consent|0
1179593|NCT01090310|3876074|P3|Extension Study|Subject withdrew consent|0
1179594|NCT01090310|3876075|P2|Extension Study|Subject withdrew consent|1
1179595|NCT01090310|3876076|P1|Extension Study|Subject withdrew consent|0
1179596|NCT01090310|3876073|P4|Extension Study|Unsatisfactory therapeutic effect|1
1179597|NCT01090310|3876074|P3|Extension Study|Unsatisfactory therapeutic effect|1
1179598|NCT01090310|3876075|P2|Extension Study|Unsatisfactory therapeutic effect|0
1179599|NCT01090310|3876076|P1|Extension Study|Unsatisfactory therapeutic effect|1
1179600|NCT01090310|3876073|P4|Extension Study|Adverse Event|1
1179601|NCT01090310|3876074|P3|Extension Study|Adverse Event|0
1179602|NCT01090310|3876075|P2|Extension Study|Adverse Event|0
1179603|NCT01090310|3876076|P1|Extension Study|Adverse Event|0
1179604|NCT01090310|3876073|P4|Extension Study|Aministrative problems|18
1179605|NCT01090310|3876074|P3|Extension Study|Aministrative problems|14
1179606|NCT01090310|3876075|P2|Extension Study|Aministrative problems|15
1179607|NCT01090310|3876076|P1|Extension Study|Aministrative problems|13
1179608|NCT01090310|3876073|P4|Core Study|Protocol deviation|1
1179609|NCT01090310|3876074|P3|Core Study|Protocol deviation|0
1179610|NCT01090310|3876075|P2|Core Study|Protocol deviation|0
1179611|NCT01090310|3876076|P1|Core Study|Protocol deviation|1
1179612|NCT01090310|3876073|P4|Core Study|Administrative reasons|4
1179613|NCT01090310|3876074|P3|Core Study|Administrative reasons|4
1179614|NCT01090310|3876075|P2|Core Study|Administrative reasons|6
1179615|NCT01090310|3876076|P1|Core Study|Administrative reasons|5
1179616|NCT01090310|3876073|P4|Core Study|Abnormal test procedure result|0
1179617|NCT01090310|3876074|P3|Core Study|Abnormal test procedure result|1
1179618|NCT01090310|3876075|P2|Core Study|Abnormal test procedure result|0
1179619|NCT01090310|3876076|P1|Core Study|Abnormal test procedure result|0
1179620|NCT01090310|3876073|P4|Core Study|Subject withdrew consent|1
1179621|NCT01090310|3876074|P3|Core Study|Subject withdrew consent|1
1179622|NCT01090310|3876075|P2|Core Study|Subject withdrew consent|3
1179623|NCT01090310|3876076|P1|Core Study|Subject withdrew consent|0
1179624|NCT01090310|3876073|P4|Core Study|Adverse Event|1
1179625|NCT01090310|3876074|P3|Core Study|Adverse Event|1
1179626|NCT01090310|3876075|P2|Core Study|Adverse Event|2
1179627|NCT01090310|3876076|P1|Core Study|Adverse Event|2
1179628|NCT01090102|3876115|P2|Second 12 Weeks|Withdrawal by Subject|1
1179629|NCT01090102|3876116|P1|Second 12 Weeks|Withdrawal by Subject|0
1179630|NCT01090102|3876115|P2|First 12 Weeks|Death|1
1179631|NCT01090102|3876116|P1|First 12 Weeks|Death|1
1179632|NCT01090102|3876115|P2|First 12 Weeks|Adverse Event|0
1179633|NCT01090102|3876116|P1|First 12 Weeks|Adverse Event|2
1179634|NCT01090102|3876115|P2|First 12 Weeks|Withdrawal by Subject|1
1179635|NCT01090102|3876116|P1|First 12 Weeks|Withdrawal by Subject|1
1179636|NCT01090076|3876126|P2|Overall Study|Withdrawal by Subject|1
1179637|NCT01090076|3876127|P1|Overall Study|Withdrawal by Subject|0
1179638|NCT01090076|3876126|P2|Overall Study|Death|1
1179639|NCT01090076|3876127|P1|Overall Study|Death|1
1179640|NCT01090063|3876137|P1|Treatment|Withdrawal by Subject|4
1179641|NCT01090063|3876137|P1|Screen|Screen Failed|4
1179642|NCT01090050|3876153|P2|Overall Study|Physician Decision|1
1179643|NCT01090050|3876154|P1|Overall Study|Physician Decision|0
1179644|NCT01090050|3876153|P2|Overall Study|Lack of Efficacy|5
1179645|NCT01090050|3876154|P1|Overall Study|Lack of Efficacy|1
1179646|NCT01090050|3876153|P2|Overall Study|Lost to Follow-up|1
1179647|NCT01090050|3876154|P1|Overall Study|Lost to Follow-up|0
1179648|NCT01090011|3876174|P1|Overall Study|Other reason not defined above|5
1179649|NCT01090011|3876174|P1|Overall Study|Refusal to start/continue medication|5
1179650|NCT01090011|3876174|P1|Overall Study|Protocol Violation|1
1179651|NCT01090011|3876174|P1|Overall Study|Adverse Event|32
1179652|NCT01090011|3876174|P1|Overall Study|Progressive disease|128
1179653|NCT01089647|3876267|P2|Overall Study|Adverse Event|1
1179654|NCT01089647|3876268|P1|Overall Study|Adverse Event|0
1179655|NCT01089647|3876267|P2|Overall Study|Withdrawal by Subject|1
1179656|NCT01089647|3876268|P1|Overall Study|Withdrawal by Subject|2
1179657|NCT01089647|3876267|P2|Overall Study|Lost to Follow-up|2
1179658|NCT01089647|3876268|P1|Overall Study|Lost to Follow-up|2
1179659|NCT01089608|3876276|P2|Overall Study|Lost to Follow-up|2
1179660|NCT01089608|3876277|P1|Overall Study|Lost to Follow-up|0
1179661|NCT01089608|3876276|P2|Overall Study|Adverse Event|4
1179662|NCT01089608|3876277|P1|Overall Study|Adverse Event|0
1179663|NCT01089582|3876294|P1|Overall Study|Withdrawal by Subject|1
1179664|NCT01089582|3876294|P1|Overall Study|Other|4
1179665|NCT01089582|3876294|P1|Overall Study|Lost to Follow-up|8
1179666|NCT01089582|3876294|P1|Overall Study|Adverse Event|15
1179667|NCT01089582|3876294|P1|Overall Study|Death|2
1179668|NCT01089556|3876337|P6|Study Period III (Weeks 9-16)|Withdrawal by Subject|2
1179669|NCT01089556|3876338|P5|Study Period III (Weeks 9-16)|Withdrawal by Subject|1
1179670|NCT01089556|3876339|P4|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
1179671|NCT01089556|3876340|P3|Study Period III (Weeks 9-16)|Withdrawal by Subject|3
1179672|NCT01089556|3876341|P2|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
1179673|NCT01089556|3876342|P1|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
1179674|NCT01089556|3876337|P6|Study Period III (Weeks 9-16)|Satisfactory Response|1
1179675|NCT01089556|3876338|P5|Study Period III (Weeks 9-16)|Satisfactory Response|4
1179676|NCT01089556|3876339|P4|Study Period III (Weeks 9-16)|Satisfactory Response|3
1179677|NCT01089556|3876340|P3|Study Period III (Weeks 9-16)|Satisfactory Response|4
1179678|NCT01089556|3876341|P2|Study Period III (Weeks 9-16)|Satisfactory Response|0
1179679|NCT01089556|3876342|P1|Study Period III (Weeks 9-16)|Satisfactory Response|0
1179680|NCT01089556|3876337|P6|Study Period III (Weeks 9-16)|Protocol Violation|0
1179681|NCT01089556|3876338|P5|Study Period III (Weeks 9-16)|Protocol Violation|1
1179682|NCT01089556|3876339|P4|Study Period III (Weeks 9-16)|Protocol Violation|1
1179683|NCT01089556|3876340|P3|Study Period III (Weeks 9-16)|Protocol Violation|1
1179684|NCT01089556|3876341|P2|Study Period III (Weeks 9-16)|Protocol Violation|0
1179685|NCT01089556|3876342|P1|Study Period III (Weeks 9-16)|Protocol Violation|0
1179686|NCT01089556|3876337|P6|Study Period III (Weeks 9-16)|Lost to Follow-up|0
1179687|NCT01089556|3876338|P5|Study Period III (Weeks 9-16)|Lost to Follow-up|0
1179688|NCT01089556|3876339|P4|Study Period III (Weeks 9-16)|Lost to Follow-up|0
1179689|NCT01089556|3876340|P3|Study Period III (Weeks 9-16)|Lost to Follow-up|1
1179690|NCT01089556|3876341|P2|Study Period III (Weeks 9-16)|Lost to Follow-up|0
1179691|NCT01089556|3876342|P1|Study Period III (Weeks 9-16)|Lost to Follow-up|0
1179692|NCT01089556|3876337|P6|Study Period III (Weeks 9-16)|Lack of Efficacy|0
1179693|NCT01089556|3876338|P5|Study Period III (Weeks 9-16)|Lack of Efficacy|1
1179694|NCT01089556|3876339|P4|Study Period III (Weeks 9-16)|Lack of Efficacy|2
1179695|NCT01089556|3876340|P3|Study Period III (Weeks 9-16)|Lack of Efficacy|0
1179696|NCT01089556|3876341|P2|Study Period III (Weeks 9-16)|Lack of Efficacy|0
1179697|NCT01089556|3876342|P1|Study Period III (Weeks 9-16)|Lack of Efficacy|0
1179698|NCT01089556|3876337|P6|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
1179699|NCT01089556|3876338|P5|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
1179700|NCT01089556|3876339|P4|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
1179701|NCT01089556|3876340|P3|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
1179702|NCT01089556|3876341|P2|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
1179703|NCT01089556|3876342|P1|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
1179704|NCT01089556|3876337|P6|Study Period III (Weeks 9-16)|Adverse Event|3
1179705|NCT01089556|3876338|P5|Study Period III (Weeks 9-16)|Adverse Event|4
1179706|NCT01089556|3876339|P4|Study Period III (Weeks 9-16)|Adverse Event|2
1179707|NCT01089556|3876340|P3|Study Period III (Weeks 9-16)|Adverse Event|4
1179708|NCT01089556|3876341|P2|Study Period III (Weeks 9-16)|Adverse Event|0
1179709|NCT01089556|3876342|P1|Study Period III (Weeks 9-16)|Adverse Event|0
1179710|NCT01089556|3876337|P6|Study Period II (Weeks 1-8)|Not received any study drug|0
1179711|NCT01089556|3876338|P5|Study Period II (Weeks 1-8)|Not received any study drug|0
1179712|NCT01089556|3876339|P4|Study Period II (Weeks 1-8)|Not received any study drug|0
1179713|NCT01089556|3876340|P3|Study Period II (Weeks 1-8)|Not received any study drug|0
1179714|NCT01089556|3876341|P2|Study Period II (Weeks 1-8)|Not received any study drug|4
1179715|NCT01089556|3876342|P1|Study Period II (Weeks 1-8)|Not received any study drug|3
1179716|NCT01089556|3876337|P6|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
1179717|NCT01089556|3876338|P5|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
1179718|NCT01089556|3876339|P4|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
1179719|NCT01089556|3876340|P3|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
1179720|NCT01089556|3876341|P2|Study Period II (Weeks 1-8)|Withdrawal by Subject|14
1179721|NCT01089556|3876342|P1|Study Period II (Weeks 1-8)|Withdrawal by Subject|12
1179722|NCT01089556|3876337|P6|Study Period II (Weeks 1-8)|Protocol Violation|0
1179723|NCT01089556|3876338|P5|Study Period II (Weeks 1-8)|Protocol Violation|0
1179724|NCT01089556|3876339|P4|Study Period II (Weeks 1-8)|Protocol Violation|0
1179725|NCT01089556|3876340|P3|Study Period II (Weeks 1-8)|Protocol Violation|0
1179726|NCT01089556|3876341|P2|Study Period II (Weeks 1-8)|Protocol Violation|4
1179727|NCT01089556|3876342|P1|Study Period II (Weeks 1-8)|Protocol Violation|4
1179728|NCT01089556|3876337|P6|Study Period II (Weeks 1-8)|Physician Decision|0
1179729|NCT01089556|3876338|P5|Study Period II (Weeks 1-8)|Physician Decision|0
1179730|NCT01089556|3876339|P4|Study Period II (Weeks 1-8)|Physician Decision|0
1179731|NCT01089556|3876340|P3|Study Period II (Weeks 1-8)|Physician Decision|0
1179732|NCT01089556|3876341|P2|Study Period II (Weeks 1-8)|Physician Decision|0
1179733|NCT01089556|3876342|P1|Study Period II (Weeks 1-8)|Physician Decision|4
1179734|NCT01089556|3876337|P6|Study Period II (Weeks 1-8)|Lost to Follow-up|0
1179735|NCT01089556|3876338|P5|Study Period II (Weeks 1-8)|Lost to Follow-up|0
1179736|NCT01089556|3876339|P4|Study Period II (Weeks 1-8)|Lost to Follow-up|0
1179737|NCT01089556|3876340|P3|Study Period II (Weeks 1-8)|Lost to Follow-up|0
1179738|NCT01089556|3876341|P2|Study Period II (Weeks 1-8)|Lost to Follow-up|3
1179739|NCT01089556|3876342|P1|Study Period II (Weeks 1-8)|Lost to Follow-up|0
1179740|NCT01089556|3876337|P6|Study Period II (Weeks 1-8)|Lack of Efficacy|0
1179741|NCT01089556|3876338|P5|Study Period II (Weeks 1-8)|Lack of Efficacy|0
1179742|NCT01089556|3876339|P4|Study Period II (Weeks 1-8)|Lack of Efficacy|0
1179743|NCT01089556|3876340|P3|Study Period II (Weeks 1-8)|Lack of Efficacy|0
1179744|NCT01089556|3876341|P2|Study Period II (Weeks 1-8)|Lack of Efficacy|2
1179745|NCT01089556|3876342|P1|Study Period II (Weeks 1-8)|Lack of Efficacy|1
1179746|NCT01089556|3876337|P6|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
1179747|NCT01089556|3876338|P5|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
1179748|NCT01089556|3876339|P4|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
1179749|NCT01089556|3876340|P3|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
1179750|NCT01089556|3876341|P2|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8
1179751|NCT01089556|3876342|P1|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12
1179752|NCT01089556|3876337|P6|Study Period II (Weeks 1-8)|Adverse Event|0
1179753|NCT01089556|3876338|P5|Study Period II (Weeks 1-8)|Adverse Event|0
1179754|NCT01089556|3876339|P4|Study Period II (Weeks 1-8)|Adverse Event|0
1179755|NCT01089556|3876340|P3|Study Period II (Weeks 1-8)|Adverse Event|0
1179756|NCT01089556|3876341|P2|Study Period II (Weeks 1-8)|Adverse Event|39
1179757|NCT01089556|3876342|P1|Study Period II (Weeks 1-8)|Adverse Event|35
1179758|NCT01089543|3876416|P4|Overall Study|Adverse Event|0
1179759|NCT01089543|3876417|P3|Overall Study|Adverse Event|0
1179760|NCT01089543|3876418|P2|Overall Study|Adverse Event|1
1179761|NCT01089543|3876419|P1|Overall Study|Adverse Event|0
1179762|NCT01089543|3876416|P4|Overall Study|Physician Decision|1
1179763|NCT01089543|3876417|P3|Overall Study|Physician Decision|0
1179764|NCT01089543|3876418|P2|Overall Study|Physician Decision|0
1179765|NCT01089543|3876419|P1|Overall Study|Physician Decision|1
1179766|NCT01089543|3876416|P4|Overall Study|Withdrawal by Subject|1
1179767|NCT01089543|3876417|P3|Overall Study|Withdrawal by Subject|3
1179768|NCT01089543|3876418|P2|Overall Study|Withdrawal by Subject|3
1179769|NCT01089543|3876419|P1|Overall Study|Withdrawal by Subject|2
1179770|NCT01089504|3876454|P2|Overall Study|Withdrawal by Subject|0
1179771|NCT01089504|3876455|P1|Overall Study|Withdrawal by Subject|2
1179772|NCT01089504|3876454|P2|Overall Study|Lost to Follow-up|1
1179773|NCT01089504|3876455|P1|Overall Study|Lost to Follow-up|1
1179774|NCT01089413|3876468|P1|Overall Study|Other|71
1179775|NCT01089413|3876468|P1|Overall Study|Metastasectomy|13
1179776|NCT01089413|3876468|P1|Overall Study|Death|10
1179777|NCT01089413|3876468|P1|Overall Study|Unacceptable Toxicity|12
1179778|NCT01089413|3876468|P1|Overall Study|Participant Withdrew Consent|1
1179779|NCT01089413|3876468|P1|Overall Study|Progressive Disease|93
1179780|NCT01089413|3876468|P1|Overall Study|Lost to Follow-up|1
1179781|NCT01089361|3876487|P2|Overall Study|Death|0
1179782|NCT01089361|3876488|P1|Overall Study|Death|1
1179783|NCT01089127|3876537|P6|Overall Study|Protocol deviation|0
1179784|NCT01089127|3876538|P5|Overall Study|Protocol deviation|1
1179785|NCT01089127|3876539|P4|Overall Study|Protocol deviation|0
1179786|NCT01089127|3876540|P3|Overall Study|Protocol deviation|0
1179787|NCT01089127|3876541|P2|Overall Study|Protocol deviation|1
1179788|NCT01089127|3876542|P1|Overall Study|Protocol deviation|0
1179789|NCT01089127|3876537|P6|Overall Study|Lost to Follow-up|0
1179790|NCT01089127|3876538|P5|Overall Study|Lost to Follow-up|1
1179791|NCT01089127|3876539|P4|Overall Study|Lost to Follow-up|0
1179792|NCT01089127|3876540|P3|Overall Study|Lost to Follow-up|0
1179793|NCT01089127|3876541|P2|Overall Study|Lost to Follow-up|1
1179794|NCT01089127|3876542|P1|Overall Study|Lost to Follow-up|1
1179795|NCT01089127|3876537|P6|Overall Study|Abnormal test procedure result(s)|0
1179796|NCT01089127|3876538|P5|Overall Study|Abnormal test procedure result(s)|0
1179797|NCT01089127|3876539|P4|Overall Study|Abnormal test procedure result(s)|0
1179798|NCT01089127|3876540|P3|Overall Study|Abnormal test procedure result(s)|0
1179799|NCT01089127|3876541|P2|Overall Study|Abnormal test procedure result(s)|1
1179800|NCT01089127|3876542|P1|Overall Study|Abnormal test procedure result(s)|2
1179801|NCT01089127|3876537|P6|Overall Study|Subject withdrew consent|2
1179802|NCT01089127|3876538|P5|Overall Study|Subject withdrew consent|0
1179803|NCT01089127|3876539|P4|Overall Study|Subject withdrew consent|1
1179804|NCT01089127|3876540|P3|Overall Study|Subject withdrew consent|1
1179805|NCT01089127|3876541|P2|Overall Study|Subject withdrew consent|1
1179806|NCT01089127|3876542|P1|Overall Study|Subject withdrew consent|0
1179807|NCT01089127|3876537|P6|Overall Study|Adverse Event|1
1179808|NCT01089127|3876538|P5|Overall Study|Adverse Event|0
1179809|NCT01089127|3876539|P4|Overall Study|Adverse Event|0
1179810|NCT01089127|3876540|P3|Overall Study|Adverse Event|1
1179811|NCT01089127|3876541|P2|Overall Study|Adverse Event|1
1179812|NCT01089127|3876542|P1|Overall Study|Adverse Event|5
1179813|NCT01089023|3876596|P1|Overall Study|Lack of Efficacy|1
1179814|NCT01089023|3876596|P1|Overall Study|Protocol Violation|1
1179815|NCT01089023|3876596|P1|Overall Study|Withdrawal by Subject|1
1179816|NCT01089023|3876596|P1|Overall Study|Adverse Event|1
1179817|NCT01089023|3876596|P1|Overall Study|Lost to Follow-up|3
1179818|NCT01088997|3876610|P2|Overall Study|Excluded prior to receiving drug|1
1179819|NCT01088997|3876611|P1|Overall Study|Excluded prior to receiving drug|1
1179820|NCT01088997|3876610|P2|Overall Study|Req. Extracorporeal membrane oxygenation|1
1179821|NCT01088997|3876611|P1|Overall Study|Req. Extracorporeal membrane oxygenation|1
1179822|NCT01088997|3876610|P2|Overall Study|Physician Decision|1
1179823|NCT01088997|3876611|P1|Overall Study|Physician Decision|1
1179824|NCT01088984|3876622|P2|Phase 2|Not Specified|1
1179825|NCT01088984|3876623|P1|Phase 2|Not Specified|0
1179826|NCT01088984|3876622|P2|Phase 2|DIsease Progression|25
1179827|NCT01088984|3876623|P1|Phase 2|DIsease Progression|0
1179828|NCT01088984|3876622|P2|Phase 2|Withdrawal by Subject|1
1179829|NCT01088984|3876623|P1|Phase 2|Withdrawal by Subject|0
1179830|NCT01088984|3876622|P2|Phase 2|Death|5
1179831|NCT01088984|3876623|P1|Phase 2|Death|0
1179832|NCT01088984|3876622|P2|Phase 1|Not Specified|1
1179833|NCT01088984|3876623|P1|Phase 1|Not Specified|1
1179834|NCT01088984|3876622|P2|Phase 1|Disease Progression|4
1179835|NCT01088984|3876623|P1|Phase 1|Disease Progression|2
1179836|NCT01088984|3876622|P2|Phase 1|Death|1
1179837|NCT01088984|3876623|P1|Phase 1|Death|2
1179838|NCT01088529|3876684|P2|Overall Study|Did not receive study treatment|1
1179839|NCT01088529|3876685|P1|Overall Study|Did not receive study treatment|0
1179840|NCT01088503|3876698|P3|Overall Study|Death|7
1179841|NCT01088503|3876699|P2|Overall Study|Death|358
1179842|NCT01088503|3876700|P1|Overall Study|Death|64
1179843|NCT01088503|3876698|P3|Overall Study|Withdrawal by Subject|10
1179844|NCT01088503|3876699|P2|Overall Study|Withdrawal by Subject|327
1179845|NCT01088503|3876700|P1|Overall Study|Withdrawal by Subject|118
1179846|NCT01088438|3876778|P2|Overall Study|Lost to Follow-up|30
1179847|NCT01088438|3876779|P1|Overall Study|Lost to Follow-up|18
1179848|NCT01088438|3876778|P2|Overall Study|Withdrawal by Subject|6
1179849|NCT01088438|3876779|P1|Overall Study|Withdrawal by Subject|11
1179850|NCT01088399|3876792|P3|Overall Study|Study summary visit not completed|80
1179851|NCT01088399|3876793|P2|Overall Study|Study summary visit not completed|283
1179852|NCT01088399|3876794|P1|Overall Study|Study summary visit not completed|2398
1179853|NCT01088399|3876792|P3|Overall Study|Enrollment criteria not met|70
1179854|NCT01088399|3876793|P2|Overall Study|Enrollment criteria not met|119
1179855|NCT01088399|3876794|P1|Overall Study|Enrollment criteria not met|48
1179856|NCT01088399|3876792|P3|Overall Study|Protocol Violation|0
1179857|NCT01088399|3876793|P2|Overall Study|Protocol Violation|1
1179858|NCT01088399|3876794|P1|Overall Study|Protocol Violation|10
1179859|NCT01088399|3876792|P3|Overall Study|Sponsor decision|7
1179860|NCT01088399|3876793|P2|Overall Study|Sponsor decision|298
1179861|NCT01088399|3876794|P1|Overall Study|Sponsor decision|1573
1179862|NCT01088399|3876792|P3|Overall Study|Change to or start of somatropin therapy|12
1179863|NCT01088399|3876793|P2|Overall Study|Change to or start of somatropin therapy|17
1179864|NCT01088399|3876794|P1|Overall Study|Change to or start of somatropin therapy|234
1179865|NCT01088399|3876792|P3|Overall Study|Withdrawal by Subject|33
1179866|NCT01088399|3876793|P2|Overall Study|Withdrawal by Subject|195
1179867|NCT01088399|3876794|P1|Overall Study|Withdrawal by Subject|544
1179868|NCT01088399|3876792|P3|Overall Study|Physician Decision|16
1179869|NCT01088399|3876793|P2|Overall Study|Physician Decision|88
1179870|NCT01088399|3876794|P1|Overall Study|Physician Decision|531
1179871|NCT01088399|3876792|P3|Overall Study|Lost to Follow-up|58
1179872|NCT01088399|3876793|P2|Overall Study|Lost to Follow-up|278
1179873|NCT01088399|3876794|P1|Overall Study|Lost to Follow-up|1070
1179874|NCT01088399|3876792|P3|Overall Study|Lack of Efficacy|5
1179875|NCT01088399|3876793|P2|Overall Study|Lack of Efficacy|7
1179876|NCT01088399|3876794|P1|Overall Study|Lack of Efficacy|298
1179877|NCT01088399|3876792|P3|Overall Study|Death|0
1179878|NCT01088399|3876793|P2|Overall Study|Death|45
1179879|NCT01088399|3876794|P1|Overall Study|Death|204
1179880|NCT01088399|3876792|P3|Overall Study|Adverse Event|0
1179881|NCT01088399|3876793|P2|Overall Study|Adverse Event|16
1179882|NCT01088399|3876794|P1|Overall Study|Adverse Event|211
1179883|NCT01088243|3876823|P2|Overall Study|Adverse Event|0
1179884|NCT01088243|3876824|P1|Overall Study|Adverse Event|1
1179885|NCT01087970|3876865|P1|Overall Study|Protocol Violation|2
1179886|NCT01087957|3876877|P2|Overall Study|Physician Decision|9
1179887|NCT01087957|3876878|P1|Overall Study|Physician Decision|5
1179888|NCT01087957|3876877|P2|Overall Study|Withdrawal by Subject|15
1179889|NCT01087957|3876878|P1|Overall Study|Withdrawal by Subject|18
1179890|NCT01087957|3876877|P2|Overall Study|Protocol Violation|25
1179891|NCT01087957|3876878|P1|Overall Study|Protocol Violation|13
1179892|NCT01087957|3876877|P2|Overall Study|Lost to Follow-up|4
1179893|NCT01087957|3876878|P1|Overall Study|Lost to Follow-up|3
1179894|NCT01087957|3876877|P2|Overall Study|Death|2
1179895|NCT01087957|3876878|P1|Overall Study|Death|2
1179896|NCT01087944|3876904|P2|Period 2 (Week 4-6)|Adverse Event|2
1179897|NCT01087944|3876905|P1|Period 2 (Week 4-6)|Adverse Event|0
1179898|NCT01087944|3876904|P2|Period 1 (Week 1-3)|Adverse Event|0
1179899|NCT01087944|3876905|P1|Period 1 (Week 1-3)|Adverse Event|1
1179900|NCT01087905|3876985|P8|Overall Study|Withdrawal by Subject|5
1179901|NCT01087905|3876986|P7|Overall Study|Withdrawal by Subject|3
1179902|NCT01087905|3876987|P6|Overall Study|Withdrawal by Subject|3
1179903|NCT01087905|3876988|P5|Overall Study|Withdrawal by Subject|4
1179904|NCT01087905|3876989|P4|Overall Study|Withdrawal by Subject|5
1179905|NCT01087905|3876990|P3|Overall Study|Withdrawal by Subject|4
1179906|NCT01087905|3876991|P2|Overall Study|Withdrawal by Subject|4
1179907|NCT01087905|3876992|P1|Overall Study|Withdrawal by Subject|5
1179908|NCT01087905|3876985|P8|Overall Study|Lost to Follow-up|24
1179909|NCT01087905|3876986|P7|Overall Study|Lost to Follow-up|20
1179910|NCT01087905|3876987|P6|Overall Study|Lost to Follow-up|25
1179911|NCT01087905|3876988|P5|Overall Study|Lost to Follow-up|27
1179912|NCT01087905|3876989|P4|Overall Study|Lost to Follow-up|31
1179913|NCT01087905|3876990|P3|Overall Study|Lost to Follow-up|18
1179914|NCT01087905|3876991|P2|Overall Study|Lost to Follow-up|28
1179915|NCT01087905|3876992|P1|Overall Study|Lost to Follow-up|24
1179916|NCT01087814|3877014|P2|Second Intervention (5 Days)|Physician Decision|0
1179917|NCT01087814|3877015|P1|Second Intervention (5 Days)|Physician Decision|1
1179918|NCT01087814|3877014|P2|First Intervention (5 Days)|Withdrawal by Subject|1
1179919|NCT01087814|3877015|P1|First Intervention (5 Days)|Withdrawal by Subject|3
1179920|NCT01087788|3877033|P3|Open-Label Period (OL-P)|Personal reasons|1
1179921|NCT01087788|3877034|P2|Open-Label Period (OL-P)|Personal reasons|0
1179922|NCT01087788|3877035|P1|Open-Label Period (OL-P)|Personal reasons|0
1179923|NCT01087788|3877033|P3|Open-Label Period (OL-P)|No participation in study extension|1
1179924|NCT01087788|3877034|P2|Open-Label Period (OL-P)|No participation in study extension|0
1179925|NCT01087788|3877035|P1|Open-Label Period (OL-P)|No participation in study extension|0
1179926|NCT01087788|3877033|P3|Open-Label Period (OL-P)|Principal investigator decision|2
1179927|NCT01087788|3877034|P2|Open-Label Period (OL-P)|Principal investigator decision|1
1179928|NCT01087788|3877035|P1|Open-Label Period (OL-P)|Principal investigator decision|0
1179929|NCT01087788|3877033|P3|Open-Label Period (OL-P)|Sponsor request|0
1179930|NCT01087788|3877034|P2|Open-Label Period (OL-P)|Sponsor request|0
1179931|NCT01087788|3877035|P1|Open-Label Period (OL-P)|Sponsor request|1
1179932|NCT01087788|3877033|P3|Open-Label Period (OL-P)|AE, non-serious unknown|0
1179933|NCT01087788|3877034|P2|Open-Label Period (OL-P)|AE, non-serious unknown|0
1179934|NCT01087788|3877035|P1|Open-Label Period (OL-P)|AE, non-serious unknown|1
1179935|NCT01087788|3877033|P3|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
1179936|NCT01087788|3877034|P2|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1
1179937|NCT01087788|3877035|P1|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
1179938|NCT01087788|3877033|P3|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
1179939|NCT01087788|3877034|P2|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
1179940|NCT01087788|3877035|P1|Open-Label Period (OL-P)|AE, non-serious non-fatal|6
1179941|NCT01087788|3877033|P3|Open-Label Period (OL-P)|AE, serious non-fatal|4
1179942|NCT01087788|3877034|P2|Open-Label Period (OL-P)|AE, serious non-fatal|3
1179943|NCT01087788|3877035|P1|Open-Label Period (OL-P)|AE, serious non-fatal|1
1179944|NCT01087788|3877033|P3|Open-Label Period (OL-P)|AE, serious fatal|1
1179945|NCT01087788|3877034|P2|Open-Label Period (OL-P)|AE, serious fatal|0
1179946|NCT01087788|3877035|P1|Open-Label Period (OL-P)|AE, serious fatal|2
1179947|NCT01087788|3877033|P3|Open-Label Period (OL-P)|Withdrawal by Subject|10
1179948|NCT01087788|3877034|P2|Open-Label Period (OL-P)|Withdrawal by Subject|8
1179949|NCT01087788|3877035|P1|Open-Label Period (OL-P)|Withdrawal by Subject|13
1179950|NCT01087788|3877033|P3|Open-Label Period (OL-P)|Lost to Follow-up|2
1179951|NCT01087788|3877034|P2|Open-Label Period (OL-P)|Lost to Follow-up|4
1179952|NCT01087788|3877035|P1|Open-Label Period (OL-P)|Lost to Follow-up|0
1179953|NCT01087788|3877033|P3|Open-Label Period (OL-P)|Protocol Violation|0
1179954|NCT01087788|3877034|P2|Open-Label Period (OL-P)|Protocol Violation|1
1179955|NCT01087788|3877035|P1|Open-Label Period (OL-P)|Protocol Violation|2
1179956|NCT01087788|3877033|P3|Open-Label Period (OL-P)|Lack of Efficacy|3
1179957|NCT01087788|3877034|P2|Open-Label Period (OL-P)|Lack of Efficacy|2
1179958|NCT01087788|3877035|P1|Open-Label Period (OL-P)|Lack of Efficacy|4
1179959|NCT01087788|3877033|P3|24-weeks Dose-blind Period|Patient moved|1
1179960|NCT01087788|3877034|P2|24-weeks Dose-blind Period|Patient moved|0
1179961|NCT01087788|3877035|P1|24-weeks Dose-blind Period|Patient moved|0
1179962|NCT01087788|3877033|P3|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
1179963|NCT01087788|3877034|P2|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
1179964|NCT01087788|3877035|P1|24-weeks Dose-blind Period|Sponsor decision following missed visits|1
1179965|NCT01087788|3877033|P3|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
1179966|NCT01087788|3877034|P2|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
1179967|NCT01087788|3877035|P1|24-weeks Dose-blind Period|AE, non-serious non-fatal|2
1179968|NCT01087788|3877033|P3|24-weeks Dose-blind Period|AE, serious non-fatal|2
1179969|NCT01087788|3877034|P2|24-weeks Dose-blind Period|AE, serious non-fatal|1
1179970|NCT01087788|3877035|P1|24-weeks Dose-blind Period|AE, serious non-fatal|2
1179971|NCT01087788|3877033|P3|24-weeks Dose-blind Period|AE, serious fatal|0
1179972|NCT01087788|3877034|P2|24-weeks Dose-blind Period|AE, serious fatal|1
1179973|NCT01087788|3877035|P1|24-weeks Dose-blind Period|AE, serious fatal|0
1179974|NCT01087788|3877033|P3|24-weeks Dose-blind Period|Withdrawal by Subject|0
1179975|NCT01087788|3877034|P2|24-weeks Dose-blind Period|Withdrawal by Subject|0
1179976|NCT01087788|3877035|P1|24-weeks Dose-blind Period|Withdrawal by Subject|1
1179977|NCT01087788|3877033|P3|24-weeks Dose-blind Period|Lost to Follow-up|1
1179978|NCT01087788|3877034|P2|24-weeks Dose-blind Period|Lost to Follow-up|0
1179979|NCT01087788|3877035|P1|24-weeks Dose-blind Period|Lost to Follow-up|1
1179980|NCT01087788|3877033|P3|24-weeks Dose-blind Period|Lack of Efficacy|1
1179981|NCT01087788|3877034|P2|24-weeks Dose-blind Period|Lack of Efficacy|2
1179982|NCT01087788|3877035|P1|24-weeks Dose-blind Period|Lack of Efficacy|0
1179983|NCT01087788|3877033|P3|24-weeks Double-blind Period|P cannot comply with scheduled visits|1
1179984|NCT01087788|3877034|P2|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
1179985|NCT01087788|3877035|P1|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
1179986|NCT01087788|3877033|P3|24-weeks Double-blind Period|Exclusion criteria were not met|0
1179987|NCT01087788|3877034|P2|24-weeks Double-blind Period|Exclusion criteria were not met|1
1179988|NCT01087788|3877035|P1|24-weeks Double-blind Period|Exclusion criteria were not met|0
1179989|NCT01087788|3877033|P3|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
1179990|NCT01087788|3877034|P2|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1
1179991|NCT01087788|3877035|P1|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
1179992|NCT01087788|3877033|P3|24-weeks Double-blind Period|Patient (P) does not want to attend|0
1179993|NCT01087788|3877034|P2|24-weeks Double-blind Period|Patient (P) does not want to attend|0
1179994|NCT01087788|3877035|P1|24-weeks Double-blind Period|Patient (P) does not want to attend|1
1179995|NCT01087788|3877033|P3|24-weeks Double-blind Period|AE, unknown type|1
1179996|NCT01087788|3877034|P2|24-weeks Double-blind Period|AE, unknown type|0
1179997|NCT01087788|3877035|P1|24-weeks Double-blind Period|AE, unknown type|0
1179998|NCT01087788|3877033|P3|24-weeks Double-blind Period|AE, non-serious non-fatal|2
1179999|NCT01087788|3877034|P2|24-weeks Double-blind Period|AE, non-serious non-fatal|1
1180000|NCT01087788|3877035|P1|24-weeks Double-blind Period|AE, non-serious non-fatal|2
1180001|NCT01087788|3877033|P3|24-weeks Double-blind Period|AE, serious non-fatal|3
1180002|NCT01087788|3877034|P2|24-weeks Double-blind Period|AE, serious non-fatal|2
1180003|NCT01087788|3877035|P1|24-weeks Double-blind Period|AE, serious non-fatal|0
1180004|NCT01087788|3877033|P3|24-weeks Double-blind Period|AE, serious fatal|1
1180005|NCT01087788|3877034|P2|24-weeks Double-blind Period|AE, serious fatal|1
1180006|NCT01087788|3877035|P1|24-weeks Double-blind Period|AE, serious fatal|0
1180007|NCT01087788|3877033|P3|24-weeks Double-blind Period|Withdrawal by Subject|5
1180008|NCT01087788|3877034|P2|24-weeks Double-blind Period|Withdrawal by Subject|2
1180009|NCT01087788|3877035|P1|24-weeks Double-blind Period|Withdrawal by Subject|7
1180010|NCT01087788|3877033|P3|24-weeks Double-blind Period|Lost to Follow-up|1
1180011|NCT01087788|3877034|P2|24-weeks Double-blind Period|Lost to Follow-up|1
1180012|NCT01087788|3877035|P1|24-weeks Double-blind Period|Lost to Follow-up|4
1180013|NCT01087788|3877033|P3|24-weeks Double-blind Period|Protocol Violation|0
1180014|NCT01087788|3877034|P2|24-weeks Double-blind Period|Protocol Violation|1
1180015|NCT01087788|3877035|P1|24-weeks Double-blind Period|Protocol Violation|0
1180016|NCT01087788|3877033|P3|24-weeks Double-blind Period|Lack of Efficacy|1
1180017|NCT01087788|3877034|P2|24-weeks Double-blind Period|Lack of Efficacy|0
1180018|NCT01087788|3877035|P1|24-weeks Double-blind Period|Lack of Efficacy|2
1180019|NCT01087762|3877065|P5|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4
1180020|NCT01087762|3877066|P4|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2
1180021|NCT01087762|3877067|P3|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
1180022|NCT01087762|3877068|P2|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
1180023|NCT01087762|3877069|P1|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
1180024|NCT01087762|3877065|P5|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13
1180025|NCT01087762|3877066|P4|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16
1180026|NCT01087762|3877067|P3|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
1180027|NCT01087762|3877068|P2|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
1180028|NCT01087762|3877069|P1|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
1180029|NCT01087762|3877065|P5|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4
1180030|NCT01087762|3877066|P4|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7
1180031|NCT01087762|3877067|P3|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
1180032|NCT01087762|3877068|P2|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
1180033|NCT01087762|3877069|P1|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
1180034|NCT01087762|3877065|P5|Open-Label Period (Weeks 48-204)|Other|4
1180035|NCT01087762|3877066|P4|Open-Label Period (Weeks 48-204)|Other|2
1180036|NCT01087762|3877067|P3|Open-Label Period (Weeks 48-204)|Other|0
1180037|NCT01087762|3877068|P2|Open-Label Period (Weeks 48-204)|Other|0
1180038|NCT01087762|3877069|P1|Open-Label Period (Weeks 48-204)|Other|0
1180039|NCT01087762|3877065|P5|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15
1180040|NCT01087762|3877066|P4|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22
1180041|NCT01087762|3877067|P3|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
1180042|NCT01087762|3877068|P2|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
1180043|NCT01087762|3877069|P1|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
1180044|NCT01087762|3877065|P5|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2
1180045|NCT01087762|3877066|P4|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5
1180046|NCT01087762|3877067|P3|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
1180047|NCT01087762|3877068|P2|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
1180048|NCT01087762|3877069|P1|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
1180049|NCT01087762|3877065|P5|Open-Label Period (Weeks 48-204)|Protocol Violation|1
1180050|NCT01087762|3877066|P4|Open-Label Period (Weeks 48-204)|Protocol Violation|1
1180051|NCT01087762|3877067|P3|Open-Label Period (Weeks 48-204)|Protocol Violation|0
1180052|NCT01087762|3877068|P2|Open-Label Period (Weeks 48-204)|Protocol Violation|0
1180053|NCT01087762|3877069|P1|Open-Label Period (Weeks 48-204)|Protocol Violation|0
1180054|NCT01087762|3877065|P5|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14
1180055|NCT01087762|3877066|P4|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4
1180056|NCT01087762|3877067|P3|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
1180057|NCT01087762|3877068|P2|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
1180058|NCT01087762|3877069|P1|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
1180059|NCT01087762|3877065|P5|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
1180060|NCT01087762|3877066|P4|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
1180061|NCT01087762|3877067|P3|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3
1180062|NCT01087762|3877068|P2|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
1180063|NCT01087762|3877069|P1|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
1180064|NCT01087762|3877065|P5|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
1180065|NCT01087762|3877066|P4|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
1180066|NCT01087762|3877067|P3|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
1180067|NCT01087762|3877068|P2|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2
1180068|NCT01087762|3877069|P1|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
1180069|NCT01087762|3877065|P5|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
1180070|NCT01087762|3877066|P4|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
1180071|NCT01087762|3877067|P3|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
1180072|NCT01087762|3877068|P2|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2
1180073|NCT01087762|3877069|P1|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
1180074|NCT01087762|3877065|P5|Double Blind Period (Weeks 0-24)|Protocol Violation|0
1180075|NCT01087762|3877066|P4|Double Blind Period (Weeks 0-24)|Protocol Violation|0
1180076|NCT01087762|3877067|P3|Double Blind Period (Weeks 0-24)|Protocol Violation|1
1180077|NCT01087762|3877068|P2|Double Blind Period (Weeks 0-24)|Protocol Violation|0
1180078|NCT01087762|3877069|P1|Double Blind Period (Weeks 0-24)|Protocol Violation|6
1180079|NCT01087762|3877065|P5|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
1180080|NCT01087762|3877066|P4|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
1180081|NCT01087762|3877067|P3|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3
1180082|NCT01087762|3877068|P2|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
1180083|NCT01087762|3877069|P1|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2
1180084|NCT01087736|3877117|P2|Overall Study|Withdrawal by Subject|1
1180085|NCT01087736|3877118|P1|Overall Study|Withdrawal by Subject|0
1180086|NCT01087736|3877117|P2|Overall Study|Death|1
1180087|NCT01087736|3877118|P1|Overall Study|Death|0
1180088|NCT01087736|3877117|P2|Overall Study|Lost to Follow-up|0
1180089|NCT01087736|3877118|P1|Overall Study|Lost to Follow-up|1
1180090|NCT01087723|3877128|P2|Overall Study|Reason Not Specified|2
1180091|NCT01087723|3877129|P1|Overall Study|Reason Not Specified|1
1180092|NCT01087723|3877128|P2|Overall Study|Lost to Follow-up|4
1180093|NCT01087723|3877129|P1|Overall Study|Lost to Follow-up|1
1180094|NCT01087723|3877128|P2|Overall Study|Physician Decision|0
1180095|NCT01087723|3877129|P1|Overall Study|Physician Decision|2
1180096|NCT01087723|3877128|P2|Overall Study|Withdrawal by Subject|13
1180097|NCT01087723|3877129|P1|Overall Study|Withdrawal by Subject|10
1180098|NCT01087723|3877128|P2|Overall Study|1 Year Visit Too Early (<335 days)|1
1180099|NCT01087723|3877129|P1|Overall Study|1 Year Visit Too Early (<335 days)|0
1180100|NCT01087528|3877170|P1|Overall Study|Incomplete CE procedure|6
1180101|NCT01087528|3877170|P1|Overall Study|Withdrawal by Subject|1
1180102|NCT01087502|3877176|P2|Up to Final Analysis (Week 52)|Other reason not described above|4
1180103|NCT01087502|3877177|P1|Up to Final Analysis (Week 52)|Other reason not described above|5
1180104|NCT01087502|3877176|P2|Up to Final Analysis (Week 52)|Study site excluded from analysis|5
1180105|NCT01087502|3877177|P1|Up to Final Analysis (Week 52)|Study site excluded from analysis|1
1180106|NCT01087502|3877176|P2|Up to Final Analysis (Week 52)|Withdrawal by Subject|2
1180107|NCT01087502|3877177|P1|Up to Final Analysis (Week 52)|Withdrawal by Subject|3
1180108|NCT01087502|3877176|P2|Up to Final Analysis (Week 52)|Lost to Follow-up|0
1180109|NCT01087502|3877177|P1|Up to Final Analysis (Week 52)|Lost to Follow-up|2
1180110|NCT01087502|3877176|P2|Up to Final Analysis (Week 52)|Protocol Violation|0
1180111|NCT01087502|3877177|P1|Up to Final Analysis (Week 52)|Protocol Violation|4
1180112|NCT01087502|3877176|P2|Up to Final Analysis (Week 52)|Lack of Efficacy|2
1180113|NCT01087502|3877177|P1|Up to Final Analysis (Week 52)|Lack of Efficacy|1
1180114|NCT01087502|3877176|P2|Up to Final Analysis (Week 52)|Adverse Event|10
1180115|NCT01087502|3877177|P1|Up to Final Analysis (Week 52)|Adverse Event|17
1180116|NCT01087502|3877176|P2|Up to Interim Analysis (Week 12)|Other reason not described above|2
1180117|NCT01087502|3877177|P1|Up to Interim Analysis (Week 12)|Other reason not described above|1
1180118|NCT01087502|3877176|P2|Up to Interim Analysis (Week 12)|Lack of Efficacy|0
1180119|NCT01087502|3877177|P1|Up to Interim Analysis (Week 12)|Lack of Efficacy|1
1180120|NCT01087502|3877176|P2|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
1180121|NCT01087502|3877177|P1|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
1180122|NCT01087502|3877176|P2|Up to Interim Analysis (Week 12)|Protocol Violation|1
1180123|NCT01087502|3877177|P1|Up to Interim Analysis (Week 12)|Protocol Violation|1
1180124|NCT01087502|3877176|P2|Up to Interim Analysis (Week 12)|Adverse Event|4
1180125|NCT01087502|3877177|P1|Up to Interim Analysis (Week 12)|Adverse Event|5
1180126|NCT01087489|3877196|P2|Overall Study|unable to survey by telephone|1
1180127|NCT01087489|3877197|P1|Overall Study|unable to survey by telephone|0
1180128|NCT01087489|3877196|P2|Overall Study|Death|1
1180129|NCT01087489|3877197|P1|Overall Study|Death|0
1180130|NCT01087489|3877196|P2|Overall Study|enrolled in another VA study|1
1180131|NCT01087489|3877197|P1|Overall Study|enrolled in another VA study|0
1180132|NCT01086969|3877210|P3|Overall Study|Withdrawal by Subject|0
1180133|NCT01086969|3877211|P2|Overall Study|Withdrawal by Subject|2
1180134|NCT01086969|3877212|P1|Overall Study|Withdrawal by Subject|1
1180135|NCT01086423|3877322|P3|Overall Study|Lost to Follow-up|1
1180136|NCT01086423|3877323|P2|Overall Study|Lost to Follow-up|0
1180137|NCT01086423|3877324|P1|Overall Study|Lost to Follow-up|0
1180138|NCT01086423|3877322|P3|Overall Study|Withdrawal by Subject|3
1180139|NCT01086423|3877323|P2|Overall Study|Withdrawal by Subject|1
1180140|NCT01086423|3877324|P1|Overall Study|Withdrawal by Subject|5
1180141|NCT01086423|3877322|P3|Overall Study|Adverse event, non-fatal|0
1180142|NCT01086423|3877323|P2|Overall Study|Adverse event, non-fatal|1
1180143|NCT01086423|3877324|P1|Overall Study|Adverse event, non-fatal|2
1180144|NCT01086423|3877322|P3|Overall Study|Adverse event, fatal|0
1180145|NCT01086423|3877323|P2|Overall Study|Adverse event, fatal|1
1180146|NCT01086423|3877324|P1|Overall Study|Adverse event, fatal|1
1180147|NCT01086423|3877322|P3|Overall Study|Migrated/moved from study area|4
1180148|NCT01086423|3877323|P2|Overall Study|Migrated/moved from study area|0
1180149|NCT01086423|3877324|P1|Overall Study|Migrated/moved from study area|2
1180150|NCT01086423|3877322|P3|Overall Study|Protocol Violation|1
1180151|NCT01086423|3877323|P2|Overall Study|Protocol Violation|0
1180152|NCT01086423|3877324|P1|Overall Study|Protocol Violation|0
1180153|NCT01086410|3877369|P4|Overall Study|Lost to Follow-up|0
1180154|NCT01086410|3877370|P3|Overall Study|Lost to Follow-up|1
1180155|NCT01086410|3877371|P2|Overall Study|Lost to Follow-up|0
1180156|NCT01086410|3877372|P1|Overall Study|Lost to Follow-up|0
1180157|NCT01086410|3877369|P4|Overall Study|Protocol Violation|0
1180158|NCT01086410|3877370|P3|Overall Study|Protocol Violation|0
1180159|NCT01086410|3877371|P2|Overall Study|Protocol Violation|1
1180160|NCT01086410|3877372|P1|Overall Study|Protocol Violation|1
1180161|NCT01086410|3877369|P4|Overall Study|Lack of Efficacy|0
1180162|NCT01086410|3877370|P3|Overall Study|Lack of Efficacy|0
1180163|NCT01086410|3877371|P2|Overall Study|Lack of Efficacy|1
1180164|NCT01086410|3877372|P1|Overall Study|Lack of Efficacy|1
1180165|NCT01086410|3877369|P4|Overall Study|Adverse Event|2
1180166|NCT01086410|3877370|P3|Overall Study|Adverse Event|0
1180167|NCT01086410|3877371|P2|Overall Study|Adverse Event|0
1180168|NCT01086410|3877372|P1|Overall Study|Adverse Event|1
1180169|NCT01086384|3877468|P3|Treatment Period|Received Treatment in Error|0
1180170|NCT01086384|3877469|P2|Treatment Period|Received Treatment in Error|1
1180171|NCT01086384|3877470|P1|Treatment Period|Received Treatment in Error|0
1180172|NCT01086384|3877468|P3|Treatment Period|Protocol-Defined Stopping Criteria|1
1180173|NCT01086384|3877469|P2|Treatment Period|Protocol-Defined Stopping Criteria|0
1180174|NCT01086384|3877470|P1|Treatment Period|Protocol-Defined Stopping Criteria|0
1180175|NCT01086384|3877468|P3|Treatment Period|Study Closed/Terminated|8
1180176|NCT01086384|3877469|P2|Treatment Period|Study Closed/Terminated|7
1180177|NCT01086384|3877470|P1|Treatment Period|Study Closed/Terminated|0
1180178|NCT01086384|3877468|P3|Treatment Period|Physician Decision|6
1180179|NCT01086384|3877469|P2|Treatment Period|Physician Decision|9
1180180|NCT01086384|3877470|P1|Treatment Period|Physician Decision|0
1180181|NCT01086384|3877468|P3|Treatment Period|Lost to Follow-up|9
1180182|NCT01086384|3877469|P2|Treatment Period|Lost to Follow-up|11
1180183|NCT01086384|3877470|P1|Treatment Period|Lost to Follow-up|0
1180184|NCT01086384|3877468|P3|Treatment Period|Adverse Event|15
1180185|NCT01086384|3877469|P2|Treatment Period|Adverse Event|19
1180186|NCT01086384|3877470|P1|Treatment Period|Adverse Event|0
1180187|NCT01086384|3877468|P3|Treatment Period|Lack of Efficacy|13
1180188|NCT01086384|3877469|P2|Treatment Period|Lack of Efficacy|22
1180189|NCT01086384|3877470|P1|Treatment Period|Lack of Efficacy|0
1180190|NCT01086384|3877468|P3|Treatment Period|Protocol Violation|17
1180191|NCT01086384|3877469|P2|Treatment Period|Protocol Violation|26
1180192|NCT01086384|3877470|P1|Treatment Period|Protocol Violation|0
1180193|NCT01086384|3877468|P3|Treatment Period|Withdrawal by Subject|55
1180194|NCT01086384|3877469|P2|Treatment Period|Withdrawal by Subject|53
1180195|NCT01086384|3877470|P1|Treatment Period|Withdrawal by Subject|0
1180196|NCT01086384|3877468|P3|2-week Run-in Period|Randomized in Error|0
1180197|NCT01086384|3877469|P2|2-week Run-in Period|Randomized in Error|0
1180198|NCT01086384|3877470|P1|2-week Run-in Period|Randomized in Error|1
1180199|NCT01086384|3877468|P3|2-week Run-in Period|Continuation Criteria Not Met|0
1180200|NCT01086384|3877469|P2|2-week Run-in Period|Continuation Criteria Not Met|0
1180201|NCT01086384|3877470|P1|2-week Run-in Period|Continuation Criteria Not Met|92
1180202|NCT01086384|3877468|P3|2-week Run-in Period|Study Closed/Terminated|0
1180203|NCT01086384|3877469|P2|2-week Run-in Period|Study Closed/Terminated|0
1180204|NCT01086384|3877470|P1|2-week Run-in Period|Study Closed/Terminated|42
1180205|NCT01086384|3877468|P3|2-week Run-in Period|Withdrawal by Subject|0
1180206|NCT01086384|3877469|P2|2-week Run-in Period|Withdrawal by Subject|0
1180207|NCT01086384|3877470|P1|2-week Run-in Period|Withdrawal by Subject|19
1180208|NCT01086384|3877468|P3|2-week Run-in Period|Physician Decision|0
1180209|NCT01086384|3877469|P2|2-week Run-in Period|Physician Decision|0
1180210|NCT01086384|3877470|P1|2-week Run-in Period|Physician Decision|6
1180211|NCT01086384|3877468|P3|2-week Run-in Period|Lost to Follow-up|0
1180212|NCT01086384|3877469|P2|2-week Run-in Period|Lost to Follow-up|0
1180213|NCT01086384|3877470|P1|2-week Run-in Period|Lost to Follow-up|1
1180214|NCT01086384|3877468|P3|2-week Run-in Period|Protocol Violation|0
1180215|NCT01086384|3877469|P2|2-week Run-in Period|Protocol Violation|0
1180216|NCT01086384|3877470|P1|2-week Run-in Period|Protocol Violation|1
1180217|NCT01086384|3877468|P3|2-week Run-in Period|Adverse Event|0
1180218|NCT01086384|3877469|P2|2-week Run-in Period|Adverse Event|0
1180219|NCT01086384|3877470|P1|2-week Run-in Period|Adverse Event|1
1180220|NCT01086358|3877480|P2|Second Intervention|Lost to Follow-up|4
1180221|NCT01086358|3877481|P1|Second Intervention|Lost to Follow-up|4
1180222|NCT01086358|3877480|P2|First Intervention|Withdrawal by Subject|1
1180223|NCT01086358|3877481|P1|First Intervention|Withdrawal by Subject|0
1180224|NCT01086358|3877480|P2|First Intervention|Lost to Follow-up|4
1180225|NCT01086358|3877481|P1|First Intervention|Lost to Follow-up|9
1180226|NCT01086215|3877551|P4|Overall Study|Lost to Follow-up|2
1180227|NCT01086215|3877552|P3|Overall Study|Lost to Follow-up|18
1180228|NCT01086215|3877553|P2|Overall Study|Lost to Follow-up|39
1180229|NCT01086215|3877554|P1|Overall Study|Lost to Follow-up|22
1180230|NCT01086215|3877551|P4|Overall Study|Death|1
1180231|NCT01086215|3877552|P3|Overall Study|Death|8
1180232|NCT01086215|3877553|P2|Overall Study|Death|8
1180233|NCT01086215|3877554|P1|Overall Study|Death|14
1180234|NCT01086033|3877572|P1|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1
1180235|NCT01086033|3877572|P1|Overall Study|AE and Other Reason|1
1180236|NCT01086033|3877572|P1|Overall Study|AE and Lost to Follow-up|1
1180237|NCT01086033|3877572|P1|Overall Study|Death|1
1180238|NCT01086033|3877572|P1|Overall Study|AE and Lack of Efficacy|4
1180239|NCT01086033|3877572|P1|Overall Study|Withdrew consent and Other Reason|4
1180240|NCT01086033|3877572|P1|Overall Study|Withdrew Consent and Lack of Efficacy|5
1180241|NCT01086033|3877572|P1|Overall Study|AE and Withdrew Consent|5
1180242|NCT01086033|3877572|P1|Overall Study|Other|13
1180243|NCT01086033|3877572|P1|Overall Study|Other|14
1180244|NCT01086033|3877572|P1|Overall Study|Withdrawal by Subject|41
1180245|NCT01086033|3877572|P1|Overall Study|Adverse Event|42
1180246|NCT01086033|3877572|P1|Overall Study|Lost to Follow-up|86
1180247|NCT01086033|3877572|P1|Overall Study|Lack of efficacy/Exacerbation of RA|86
1180248|NCT01085734|3877678|P2|Overall Study|Withdrawal by Subject|1
1180249|NCT01085734|3877679|P1|Overall Study|Withdrawal by Subject|0
1180250|NCT01085734|3877678|P2|Overall Study|Lost to Follow-up|1
1180251|NCT01085734|3877679|P1|Overall Study|Lost to Follow-up|0
1180252|NCT01085734|3877678|P2|Overall Study|Death|0
1180253|NCT01085734|3877679|P1|Overall Study|Death|1
1180254|NCT01085734|3877678|P2|Overall Study|Adverse Event|2
1180255|NCT01085734|3877679|P1|Overall Study|Adverse Event|0
1180256|NCT01085682|3877691|P2|Overall Study|Withdrawal by Subject|25
1180257|NCT01085682|3877692|P1|Overall Study|Withdrawal by Subject|25
1180258|NCT01085591|3877710|P3|Overall Study|Not Properly Consented|0
1180259|NCT01085591|3877711|P2|Overall Study|Not Properly Consented|0
1180260|NCT01085591|3877712|P1|Overall Study|Not Properly Consented|1
1180261|NCT01085591|3877710|P3|Overall Study|Other|0
1180262|NCT01085591|3877711|P2|Overall Study|Other|1
1180263|NCT01085591|3877712|P1|Overall Study|Other|0
1180264|NCT01085591|3877710|P3|Overall Study|Protocol Violation|1
1180265|NCT01085591|3877711|P2|Overall Study|Protocol Violation|1
1180266|NCT01085591|3877712|P1|Overall Study|Protocol Violation|1
1180267|NCT01085591|3877710|P3|Overall Study|Lost to Follow-up|1
1180268|NCT01085591|3877711|P2|Overall Study|Lost to Follow-up|1
1180269|NCT01085591|3877712|P1|Overall Study|Lost to Follow-up|0
1180270|NCT01085591|3877710|P3|Overall Study|Withdrawal by Subject|1
1180271|NCT01085591|3877711|P2|Overall Study|Withdrawal by Subject|2
1180272|NCT01085591|3877712|P1|Overall Study|Withdrawal by Subject|0
1180273|NCT01085591|3877710|P3|Overall Study|Physician Decision|1
1180274|NCT01085591|3877711|P2|Overall Study|Physician Decision|0
1180275|NCT01085591|3877712|P1|Overall Study|Physician Decision|1
1180276|NCT01085591|3877710|P3|Overall Study|Adverse Event|3
1180277|NCT01085591|3877711|P2|Overall Study|Adverse Event|1
1180278|NCT01085591|3877712|P1|Overall Study|Adverse Event|0
1180279|NCT01085357|3877763|P2|Overall Study|Lost to Follow-up|0
1180280|NCT01085357|3877764|P1|Overall Study|Lost to Follow-up|2
1180281|NCT01085357|3877763|P2|Overall Study|Death|1
1180282|NCT01085357|3877764|P1|Overall Study|Death|11
1180283|NCT01085357|3877763|P2|Overall Study|Investigator Decision|1
1180284|NCT01085357|3877764|P1|Overall Study|Investigator Decision|1
1180285|NCT01085357|3877763|P2|Overall Study|Subject Decision|3
1180286|NCT01085357|3877764|P1|Overall Study|Subject Decision|4
1180287|NCT01085357|3877763|P2|Overall Study|Adverse Event|1
1180288|NCT01085357|3877764|P1|Overall Study|Adverse Event|1
1180289|NCT01085214|3877827|P1|Overall Study|Alternate treatment required|1
1180290|NCT01085201|3877839|P5|Overall Study|Fond ineligible after consent|0
1180291|NCT01085201|3877840|P4|Overall Study|Fond ineligible after consent|0
1180292|NCT01085201|3877841|P3|Overall Study|Fond ineligible after consent|1
1180293|NCT01085201|3877842|P2|Overall Study|Fond ineligible after consent|1
1180294|NCT01085201|3877843|P1|Overall Study|Fond ineligible after consent|0
1180295|NCT01085201|3877839|P5|Overall Study|Unknown- no study drug|0
1180296|NCT01085201|3877840|P4|Overall Study|Unknown- no study drug|0
1180297|NCT01085201|3877841|P3|Overall Study|Unknown- no study drug|0
1180298|NCT01085201|3877842|P2|Overall Study|Unknown- no study drug|0
1180299|NCT01085201|3877843|P1|Overall Study|Unknown- no study drug|2
1180300|NCT01085201|3877839|P5|Overall Study|Scheduling conflict|0
1180301|NCT01085201|3877840|P4|Overall Study|Scheduling conflict|0
1180302|NCT01085201|3877841|P3|Overall Study|Scheduling conflict|1
1180303|NCT01085201|3877842|P2|Overall Study|Scheduling conflict|0
1180304|NCT01085201|3877843|P1|Overall Study|Scheduling conflict|1
1180305|NCT01085136|3877865|P3|Part B|Other reason not defined above|3
1180306|NCT01085136|3877866|P2|Part B|Other reason not defined above|6
1180307|NCT01085136|3877867|P1|Part B|Other reason not defined above|0
1180308|NCT01085136|3877865|P3|Part B|Not treated|8
1180309|NCT01085136|3877866|P2|Part B|Not treated|4
1180310|NCT01085136|3877867|P1|Part B|Not treated|0
1180311|NCT01085136|3877865|P3|Part B|Refusal to continue trial medication|7
1180312|NCT01085136|3877866|P2|Part B|Refusal to continue trial medication|12
1180313|NCT01085136|3877867|P1|Part B|Refusal to continue trial medication|0
1180314|NCT01085136|3877865|P3|Part B|Other AE|8
1180315|NCT01085136|3877866|P2|Part B|Other AE|29
1180316|NCT01085136|3877867|P1|Part B|Other AE|0
1180317|NCT01085136|3877865|P3|Part A|Other reason not defined above|0
1180318|NCT01085136|3877866|P2|Part A|Other reason not defined above|0
1180319|NCT01085136|3877867|P1|Part A|Other reason not defined above|30
1180320|NCT01085136|3877865|P3|Part A|Refusal to continue trial medication|0
1180321|NCT01085136|3877866|P2|Part A|Refusal to continue trial medication|0
1180322|NCT01085136|3877867|P1|Part A|Refusal to continue trial medication|64
1180323|NCT01085136|3877865|P3|Part A|Lost to Follow-up|0
1180324|NCT01085136|3877866|P2|Part A|Lost to Follow-up|0
1180325|NCT01085136|3877867|P1|Part A|Lost to Follow-up|3
1180326|NCT01085136|3877865|P3|Part A|Protocol Violation|0
1180327|NCT01085136|3877866|P2|Part A|Protocol Violation|0
1180328|NCT01085136|3877867|P1|Part A|Protocol Violation|3
1180329|NCT01085136|3877865|P3|Part A|Other Adverse event|0
1180330|NCT01085136|3877866|P2|Part A|Other Adverse event|0
1180331|NCT01085136|3877867|P1|Part A|Other Adverse event|223
1180332|NCT01085045|3877883|P1|Part B|Adverse Event|6
1180333|NCT01085045|3877883|P1|Part B|Lost to Follow-up|1
1180334|NCT01085045|3877883|P1|Part B|Protocol Specified Criteria|6
1180335|NCT01085045|3877883|P1|Part B|Withdrawal by Subject|2
1180336|NCT01085045|3877883|P1|Part A|Protocol Specified Criteria|7
1180337|NCT01085045|3877883|P1|Part A|Protocol Violation|1
1180338|NCT01085045|3877883|P1|Part A|Adverse Event|6
1180339|NCT01085045|3877883|P1|Part A|Withdrawal by Subject|4
1180340|NCT01084707|3877998|P1|Overall Study|Withdrawal by Subject|6
1180341|NCT01084668|3878032|P1|Overall Study|Non-compliance|1
1180342|NCT01084668|3878032|P1|Overall Study|Pregnancy|1
1180343|NCT01084668|3878032|P1|Overall Study|Withdrawal by Subject|2
1180344|NCT01084668|3878032|P1|Overall Study|Lack of Efficacy|5
1180345|NCT01084603|3878041|P1|Washout Period 4|Adverse Event|1
1180346|NCT01084603|3878041|P1|Oral Nicotine 1|Withdrawal by Subject|1
1180347|NCT01084603|3878041|P1|Nicorette® Gum|Withdrawal by Subject|1
1180348|NCT01084603|3878041|P1|NiQuitinTM Lozenge|Withdrawal by Subject|1
1180349|NCT01084603|3878041|P1|Baseline|Withdrawal by Subject|2
1180350|NCT01084551|3878077|P3|Overall Study|Physician Decision|0
1180351|NCT01084551|3878078|P2|Overall Study|Physician Decision|0
1180352|NCT01084551|3878079|P1|Overall Study|Physician Decision|1
1180353|NCT01084551|3878077|P3|Overall Study|Lost to Follow-up|3
1180354|NCT01084551|3878078|P2|Overall Study|Lost to Follow-up|0
1180355|NCT01084551|3878079|P1|Overall Study|Lost to Follow-up|0
1180356|NCT01084551|3878077|P3|Overall Study|Protocol Violation|0
1180357|NCT01084551|3878078|P2|Overall Study|Protocol Violation|4
1180358|NCT01084551|3878079|P1|Overall Study|Protocol Violation|2
1180359|NCT01084551|3878077|P3|Overall Study|Withdrawal by Subject|0
1180360|NCT01084551|3878078|P2|Overall Study|Withdrawal by Subject|1
1180361|NCT01084551|3878079|P1|Overall Study|Withdrawal by Subject|2
1180362|NCT01084551|3878077|P3|Overall Study|Lack of Efficacy|1
1180363|NCT01084551|3878078|P2|Overall Study|Lack of Efficacy|0
1180364|NCT01084551|3878079|P1|Overall Study|Lack of Efficacy|2
1180365|NCT01084551|3878077|P3|Overall Study|Adverse Event|4
1180366|NCT01084551|3878078|P2|Overall Study|Adverse Event|9
1180367|NCT01084551|3878079|P1|Overall Study|Adverse Event|2
1180368|NCT01084538|3878117|P1|Overall Study|Reason unknown|8
1180369|NCT01084538|3878117|P1|Overall Study|Over-suppression of parathyroid gland|2
1180370|NCT01084538|3878117|P1|Overall Study|Change of residence|2
1180371|NCT01084538|3878117|P1|Overall Study|Nodular hyperplasia of parathyroid gland|2
1180372|NCT01084538|3878117|P1|Overall Study|Hyperphosphatemia|2
1180373|NCT01084538|3878117|P1|Overall Study|Patient noncompliance|2
1180374|NCT01084538|3878117|P1|Overall Study|Lack of effectiveness|2
1180375|NCT01084538|3878117|P1|Overall Study|Serious Adverse Event|3
1180376|NCT01084538|3878117|P1|Overall Study|Kidney transplant|6
1180377|NCT01084538|3878117|P1|Overall Study|Adverse Event|9
1180378|NCT01084538|3878117|P1|Overall Study|Drug not available|30
1180379|NCT01084239|3878228|P2|28-Day Follow-up|Lost to Follow-up|9
1180380|NCT01084239|3878229|P1|28-Day Follow-up|Lost to Follow-up|4
1180381|NCT01084174|3878247|P2|Overall Study|Participant noncompliance|1
1180382|NCT01084174|3878248|P1|Overall Study|Participant noncompliance|0
1180383|NCT01084174|3878247|P2|Overall Study|Anaphylaxis|1
1180384|NCT01084174|3878248|P1|Overall Study|Anaphylaxis|0
1180385|NCT01084174|3878247|P2|Overall Study|Eosinophilic esophagitis|1
1180386|NCT01084174|3878248|P1|Overall Study|Eosinophilic esophagitis|0
1180387|NCT01084174|3878247|P2|Overall Study|gastrointestinal symptoms|1
1180388|NCT01084174|3878248|P1|Overall Study|gastrointestinal symptoms|1
1180389|NCT01084135|3878281|P2|20 Week|Physician Decision|1
1180390|NCT01084135|3878282|P1|20 Week|Physician Decision|0
1180391|NCT01084083|3878292|P1|Overall Study|Never started assigned therapy|1
1180392|NCT01084083|3878292|P1|Overall Study|Other|2
1180393|NCT01084083|3878292|P1|Overall Study|Complicating disease|1
1180394|NCT01084083|3878292|P1|Overall Study|Withdrawal by Subject|2
1180395|NCT01084083|3878292|P1|Overall Study|Death|1
1180396|NCT01084083|3878292|P1|Overall Study|Adverse Event|5
1180397|NCT01084005|3878300|P2|Overall Study|Withdrawal by Subject|1
1180398|NCT01084005|3878301|P1|Overall Study|Withdrawal by Subject|1
1180399|NCT01084005|3878300|P2|Overall Study|Protocol Violation|7
1180400|NCT01084005|3878301|P1|Overall Study|Protocol Violation|3
1180401|NCT01084005|3878300|P2|Overall Study|Adverse Event|8
1180402|NCT01084005|3878301|P1|Overall Study|Adverse Event|1
1180403|NCT01083810|3878382|P3|Overall Study|Virologic failure|0
1180404|NCT01083810|3878383|P2|Overall Study|Virologic failure|8
1180405|NCT01083810|3878384|P1|Overall Study|Virologic failure|1
1180406|NCT01083810|3878382|P3|Overall Study|Therapy break|2
1180407|NCT01083810|3878383|P2|Overall Study|Therapy break|2
1180408|NCT01083810|3878384|P1|Overall Study|Therapy break|1
1180409|NCT01083810|3878382|P3|Overall Study|Participation in study|0
1180410|NCT01083810|3878383|P2|Overall Study|Participation in study|0
1180411|NCT01083810|3878384|P1|Overall Study|Participation in study|1
1180412|NCT01083810|3878382|P3|Overall Study|Co-morbidities|0
1180413|NCT01083810|3878383|P2|Overall Study|Co-morbidities|0
1180414|NCT01083810|3878384|P1|Overall Study|Co-morbidities|1
1180415|NCT01083810|3878382|P3|Overall Study|Death|3
1180416|NCT01083810|3878383|P2|Overall Study|Death|2
1180417|NCT01083810|3878384|P1|Overall Study|Death|2
1180418|NCT01083810|3878382|P3|Overall Study|Simplification|0
1180419|NCT01083810|3878383|P2|Overall Study|Simplification|1
1180420|NCT01083810|3878384|P1|Overall Study|Simplification|4
1180421|NCT01083810|3878382|P3|Overall Study|Non-compliance|2
1180422|NCT01083810|3878383|P2|Overall Study|Non-compliance|7
1180423|NCT01083810|3878384|P1|Overall Study|Non-compliance|4
1180424|NCT01083810|3878382|P3|Overall Study|Reason not reported|1
1180425|NCT01083810|3878383|P2|Overall Study|Reason not reported|1
1180426|NCT01083810|3878384|P1|Overall Study|Reason not reported|6
1180427|NCT01083810|3878382|P3|Overall Study|Withdrawal by Subject|4
1180428|NCT01083810|3878383|P2|Overall Study|Withdrawal by Subject|2
1180429|NCT01083810|3878384|P1|Overall Study|Withdrawal by Subject|7
1180430|NCT01083810|3878382|P3|Overall Study|Adverse Event|4
1180431|NCT01083810|3878383|P2|Overall Study|Adverse Event|11
1180432|NCT01083810|3878384|P1|Overall Study|Adverse Event|15
1180433|NCT01083810|3878382|P3|Overall Study|Lost to Follow-up|4
1180434|NCT01083810|3878383|P2|Overall Study|Lost to Follow-up|11
1180435|NCT01083810|3878384|P1|Overall Study|Lost to Follow-up|23
1180436|NCT01083771|3878405|P1|Overall Study|Withdrawal by Subject|3
1180437|NCT01083771|3878405|P1|Overall Study|non-compliant|2
1180438|NCT01083693|3878506|P3|Overall Study|Reason unknown|1
1180439|NCT01083693|3878507|P2|Overall Study|Reason unknown|0
1180440|NCT01083693|3878508|P1|Overall Study|Reason unknown|0
1180441|NCT01083693|3878506|P3|Overall Study|Withdrawal by Subject|2
1180442|NCT01083693|3878507|P2|Overall Study|Withdrawal by Subject|0
1180443|NCT01083693|3878508|P1|Overall Study|Withdrawal by Subject|3
1180444|NCT01083693|3878506|P3|Overall Study|Other medical condition/surgery|0
1180445|NCT01083693|3878507|P2|Overall Study|Other medical condition/surgery|1
1180446|NCT01083693|3878508|P1|Overall Study|Other medical condition/surgery|1
1180447|NCT01083693|3878506|P3|Overall Study|Complete remission|0
1180448|NCT01083693|3878507|P2|Overall Study|Complete remission|1
1180449|NCT01083693|3878508|P1|Overall Study|Complete remission|0
1180450|NCT01083693|3878506|P3|Overall Study|Patient Moved|0
1180451|NCT01083693|3878507|P2|Overall Study|Patient Moved|1
1180452|NCT01083693|3878508|P1|Overall Study|Patient Moved|0
1180453|NCT01083693|3878506|P3|Overall Study|Lack of effectiveness|2
1180454|NCT01083693|3878507|P2|Overall Study|Lack of effectiveness|2
1180455|NCT01083693|3878508|P1|Overall Study|Lack of effectiveness|13
1180456|NCT01083693|3878506|P3|Overall Study|Lost to Follow-up|2
1180457|NCT01083693|3878507|P2|Overall Study|Lost to Follow-up|0
1180458|NCT01083693|3878508|P1|Overall Study|Lost to Follow-up|2
1180459|NCT01083693|3878506|P3|Overall Study|Adverse Event|0
1180460|NCT01083693|3878507|P2|Overall Study|Adverse Event|1
1180461|NCT01083693|3878508|P1|Overall Study|Adverse Event|1
1180462|NCT01083680|3878543|P1|Overall Study|Withdrawal by Subject|1086
1180463|NCT01083680|3878543|P1|Overall Study|Lost to Follow-up|2758
1180464|NCT01083641|3878566|P1|Overall Study|Withdrawal by Subject|2
1180465|NCT01083602|3878573|P1|Overall Study|Lack of Efficacy|36
1180466|NCT01083602|3878573|P1|Overall Study|Withdrawal by Subject|5
1180467|NCT01083602|3878573|P1|Overall Study|Death|1
1180468|NCT01083602|3878573|P1|Overall Study|New Cancer Therapy|2
1180469|NCT01083602|3878573|P1|Overall Study|Adverse Event|11
1180470|NCT01083576|3878584|P2|Overall Study|Treatment Failure|1
1180471|NCT01083576|3878585|P1|Overall Study|Treatment Failure|6
1180472|NCT01083485|3878615|P2|Overall Study|Other|0
1180473|NCT01083485|3878616|P1|Overall Study|Other|1
1180474|NCT01083485|3878615|P2|Overall Study|Withdrawal by Subject|2
1180475|NCT01083485|3878616|P1|Overall Study|Withdrawal by Subject|5
1180476|NCT01083485|3878615|P2|Overall Study|Protocol Violation|0
1180477|NCT01083485|3878616|P1|Overall Study|Protocol Violation|1
1180478|NCT01083485|3878615|P2|Overall Study|Adverse Event|1
1180479|NCT01083485|3878616|P1|Overall Study|Adverse Event|0
1180480|NCT01083316|3878633|P1|Overall Study|Withdrawal by Subject|1
1180481|NCT01083316|3878633|P1|Overall Study|Adverse Event|2
1180482|NCT01083186|3878644|P1|Overall Study|Non-compliance to Study Treatment|1
1180483|NCT01083186|3878644|P1|Overall Study|Administrative Reasons|2
1180484|NCT01083186|3878644|P1|Overall Study|Hemodialysis Initiation|28
1180485|NCT01083186|3878644|P1|Overall Study|Lack of Efficacy|2
1180486|NCT01083186|3878644|P1|Overall Study|Adverse Event|3
1180487|NCT01083186|3878644|P1|Overall Study|Death|3
1180488|NCT01083186|3878644|P1|Overall Study|Consent Withdrawal|7
1180489|NCT01083186|3878644|P1|Overall Study|Lost to Follow-up|48
1180490|NCT01083173|3878685|P2|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46
1180491|NCT01083173|3878686|P1|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0
1180492|NCT01083173|3878685|P2|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136
1180493|NCT01083173|3878686|P1|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0
1180494|NCT01083173|3878685|P2|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195
1180495|NCT01083173|3878686|P1|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0
1180496|NCT01083173|3878685|P2|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101
1180497|NCT01083173|3878686|P1|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0
1180498|NCT01083173|3878685|P2|Long-term Surveillance: Safety Group|Violation of the dosage|1
1180499|NCT01083173|3878686|P1|Long-term Surveillance: Safety Group|Violation of the dosage|0
1180500|NCT01083173|3878685|P2|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
1180501|NCT01083173|3878686|P1|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
1180502|NCT01083173|3878685|P2|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0
1180503|NCT01083173|3878686|P1|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13
1180504|NCT01083173|3878685|P2|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0
1180505|NCT01083173|3878686|P1|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168
1180506|NCT01083173|3878685|P2|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0
1180507|NCT01083173|3878686|P1|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201
1180594|NCT01081912|3878981|P3|Maintenance Treatment|Lost to Follow-up|0
1180508|NCT01083173|3878685|P2|Main Surveillance: Safety Group|Violation of the use/dosage|0
1180509|NCT01083173|3878686|P1|Main Surveillance: Safety Group|Violation of the use/dosage|1
1180510|NCT01083173|3878685|P2|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
1180511|NCT01083173|3878686|P1|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
1180512|NCT01083160|3878704|P1|Overall Study|Adverse Event|1
1180513|NCT01083121|3878711|P1|Overall Study|Use of Humira outside the approved label|81
1180514|NCT01082965|3878721|P2|Overall Study|Other|1
1180515|NCT01082965|3878722|P1|Overall Study|Other|1
1180516|NCT01082965|3878721|P2|Overall Study|Protocol Violation|1
1180517|NCT01082965|3878722|P1|Overall Study|Protocol Violation|0
1180518|NCT01082874|3878759|P4|Overall Study|Withdrawal by Subject|3
1180519|NCT01082874|3878760|P3|Overall Study|Withdrawal by Subject|5
1180520|NCT01082874|3878761|P2|Overall Study|Withdrawal by Subject|2
1180521|NCT01082874|3878762|P1|Overall Study|Withdrawal by Subject|1
1180522|NCT01082874|3878759|P4|Overall Study|Lost to Follow-up|10
1180523|NCT01082874|3878760|P3|Overall Study|Lost to Follow-up|6
1180524|NCT01082874|3878761|P2|Overall Study|Lost to Follow-up|10
1180525|NCT01082874|3878762|P1|Overall Study|Lost to Follow-up|10
1180526|NCT01082640|3878775|P3|Overall Study|Other|3
1180527|NCT01082640|3878776|P2|Overall Study|Other|1
1180528|NCT01082640|3878777|P1|Overall Study|Other|2
1180529|NCT01082640|3878775|P3|Overall Study|Lost to Follow-up|0
1180530|NCT01082640|3878776|P2|Overall Study|Lost to Follow-up|3
1180531|NCT01082640|3878777|P1|Overall Study|Lost to Follow-up|0
1180532|NCT01082640|3878775|P3|Overall Study|Major protocol deviation|0
1180533|NCT01082640|3878776|P2|Overall Study|Major protocol deviation|3
1180534|NCT01082640|3878777|P1|Overall Study|Major protocol deviation|3
1180535|NCT01082640|3878775|P3|Overall Study|Withdrawal by Subject|2
1180536|NCT01082640|3878776|P2|Overall Study|Withdrawal by Subject|3
1180537|NCT01082640|3878777|P1|Overall Study|Withdrawal by Subject|3
1180538|NCT01082640|3878775|P3|Overall Study|Adverse Event|3
1180539|NCT01082640|3878776|P2|Overall Study|Adverse Event|5
1180540|NCT01082640|3878777|P1|Overall Study|Adverse Event|9
1180541|NCT01082614|3878799|P2|Overall Study|Physician Decision|0
1180542|NCT01082614|3878800|P1|Overall Study|Physician Decision|2
1180543|NCT01082614|3878799|P2|Overall Study|Equipment Malfunction|1
1180544|NCT01082614|3878800|P1|Overall Study|Equipment Malfunction|0
1180545|NCT01082614|3878799|P2|Overall Study|Adverse Event|4
1180546|NCT01082614|3878800|P1|Overall Study|Adverse Event|1
1180547|NCT01082367|3878871|P2|Follow-up (F-U) Period|Adverse Event|1
1180548|NCT01082367|3878872|P1|Follow-up (F-U) Period|Adverse Event|0
1180549|NCT01082367|3878871|P2|Follow-up (F-U) Period|Abnormal lab values|0
1180550|NCT01082367|3878872|P1|Follow-up (F-U) Period|Abnormal lab values|1
1180551|NCT01082367|3878871|P2|Follow-up (F-U) Period|Administrative problems|0
1180552|NCT01082367|3878872|P1|Follow-up (F-U) Period|Administrative problems|1
1180553|NCT01082367|3878871|P2|Double-blind Period|Adverse Event|1
1180554|NCT01082367|3878872|P1|Double-blind Period|Adverse Event|0
1180555|NCT01082367|3878871|P2|Double-blind Period|Lack of Efficacy|11
1180556|NCT01082367|3878872|P1|Double-blind Period|Lack of Efficacy|5
1180557|NCT01082367|3878871|P2|Double-blind Period|Administrative problems|1
1180558|NCT01082367|3878872|P1|Double-blind Period|Administrative problems|0
1180559|NCT01082328|3878886|P1|Overall Study|Adverse Event|1
1180560|NCT01082211|3878895|P1|Overall Study|No protocol treatment received|3
1180561|NCT01082211|3878895|P1|Overall Study|Protocol Violation|4
1180562|NCT01082081|3878916|P3|Overall Study|Other Reason|0
1180563|NCT01082081|3878917|P2|Overall Study|Other Reason|1
1180564|NCT01082081|3878918|P1|Overall Study|Other Reason|0
1180565|NCT01082081|3878916|P3|Overall Study|Withdrawal by Subject|1
1180566|NCT01082081|3878917|P2|Overall Study|Withdrawal by Subject|0
1180567|NCT01082081|3878918|P1|Overall Study|Withdrawal by Subject|0
1180568|NCT01082081|3878916|P3|Overall Study|Lost to Follow-up|1
1180569|NCT01082081|3878917|P2|Overall Study|Lost to Follow-up|0
1180570|NCT01082081|3878918|P1|Overall Study|Lost to Follow-up|0
1180571|NCT01081951|3878970|P2|Overall Study|Lost to Follow-up|1
1180572|NCT01081951|3878971|P1|Overall Study|Lost to Follow-up|0
1180573|NCT01081951|3878970|P2|Overall Study|Allocated treatment but did not take it|1
1180574|NCT01081951|3878971|P1|Overall Study|Allocated treatment but did not take it|0
1180575|NCT01081951|3878970|P2|Overall Study|Withdrawal by Subject|6
1180576|NCT01081951|3878971|P1|Overall Study|Withdrawal by Subject|2
1180577|NCT01081951|3878970|P2|Overall Study|Death|47
1180578|NCT01081951|3878971|P1|Overall Study|Death|54
1180579|NCT01081912|3878981|P3|Maintenance Treatment|Withdrawal by Medical Monitor|1
1180580|NCT01081912|3878982|P2|Maintenance Treatment|Withdrawal by Medical Monitor|0
1180581|NCT01081912|3878983|P1|Maintenance Treatment|Withdrawal by Medical Monitor|0
1180582|NCT01081912|3878981|P3|Maintenance Treatment|Non-Compliance|7
1180583|NCT01081912|3878982|P2|Maintenance Treatment|Non-Compliance|4
1180584|NCT01081912|3878983|P1|Maintenance Treatment|Non-Compliance|0
1180585|NCT01081912|3878981|P3|Maintenance Treatment|Withdrawal by Subject|5
1180586|NCT01081912|3878982|P2|Maintenance Treatment|Withdrawal by Subject|5
1180587|NCT01081912|3878983|P1|Maintenance Treatment|Withdrawal by Subject|0
1180588|NCT01081912|3878981|P3|Maintenance Treatment|Protocol Violation|2
1180589|NCT01081912|3878982|P2|Maintenance Treatment|Protocol Violation|1
1180590|NCT01081912|3878983|P1|Maintenance Treatment|Protocol Violation|0
1180591|NCT01081912|3878981|P3|Maintenance Treatment|Physician Decision|1
1180592|NCT01081912|3878982|P2|Maintenance Treatment|Physician Decision|0
1180593|NCT01081912|3878983|P1|Maintenance Treatment|Physician Decision|0
1180595|NCT01081912|3878982|P2|Maintenance Treatment|Lost to Follow-up|1
1180596|NCT01081912|3878983|P1|Maintenance Treatment|Lost to Follow-up|0
1180597|NCT01081912|3878981|P3|Maintenance Treatment|Lack of Efficacy|64
1180598|NCT01081912|3878982|P2|Maintenance Treatment|Lack of Efficacy|14
1180599|NCT01081912|3878983|P1|Maintenance Treatment|Lack of Efficacy|0
1180600|NCT01081912|3878981|P3|Maintenance Treatment|Adverse Event|12
1180601|NCT01081912|3878982|P2|Maintenance Treatment|Adverse Event|2
1180602|NCT01081912|3878983|P1|Maintenance Treatment|Adverse Event|0
1180603|NCT01081912|3878981|P3|Conversion/Titration|Non-Compliance|0
1180604|NCT01081912|3878982|P2|Conversion/Titration|Non-Compliance|0
1180605|NCT01081912|3878983|P1|Conversion/Titration|Non-Compliance|47
1180606|NCT01081912|3878981|P3|Conversion/Titration|Withdrawal by Subject|0
1180607|NCT01081912|3878982|P2|Conversion/Titration|Withdrawal by Subject|0
1180608|NCT01081912|3878983|P1|Conversion/Titration|Withdrawal by Subject|23
1180609|NCT01081912|3878981|P3|Conversion/Titration|Protocol Violation|0
1180610|NCT01081912|3878982|P2|Conversion/Titration|Protocol Violation|0
1180611|NCT01081912|3878983|P1|Conversion/Titration|Protocol Violation|67
1180612|NCT01081912|3878981|P3|Conversion/Titration|Physician Decision|0
1180613|NCT01081912|3878982|P2|Conversion/Titration|Physician Decision|0
1180614|NCT01081912|3878983|P1|Conversion/Titration|Physician Decision|2
1180615|NCT01081912|3878981|P3|Conversion/Titration|Lost to Follow-up|0
1180616|NCT01081912|3878982|P2|Conversion/Titration|Lost to Follow-up|0
1180617|NCT01081912|3878983|P1|Conversion/Titration|Lost to Follow-up|5
1180618|NCT01081912|3878981|P3|Conversion/Titration|Lack of Efficacy|0
1180619|NCT01081912|3878982|P2|Conversion/Titration|Lack of Efficacy|0
1180620|NCT01081912|3878983|P1|Conversion/Titration|Lack of Efficacy|17
1180621|NCT01081912|3878981|P3|Conversion/Titration|Adverse Event|0
1180622|NCT01081912|3878982|P2|Conversion/Titration|Adverse Event|0
1180623|NCT01081912|3878983|P1|Conversion/Titration|Adverse Event|47
1180624|NCT01081886|3878992|P2|Overall Study|Study termination|13
1180625|NCT01081886|3878993|P1|Overall Study|Study termination|11
1180626|NCT01081873|3879001|P1|Overall Study|Other|47
1180627|NCT01081873|3879001|P1|Overall Study|Progression of prostate cancer|13
1180628|NCT01081873|3879001|P1|Overall Study|Lost to Follow-up|142
1180629|NCT01081873|3879001|P1|Overall Study|Withdrawal by Subject|10
1180630|NCT01081873|3879001|P1|Overall Study|Death|86
1180631|NCT01081834|3879073|P5|Extension Period: Week 26 to Week 52|Physician Decision|0
1180632|NCT01081834|3879074|P4|Extension Period: Week 26 to Week 52|Physician Decision|0
1180633|NCT01081834|3879075|P3|Extension Period: Week 26 to Week 52|Physician Decision|0
1180634|NCT01081834|3879076|P2|Extension Period: Week 26 to Week 52|Physician Decision|1
1180635|NCT01081834|3879077|P1|Extension Period: Week 26 to Week 52|Physician Decision|0
1180636|NCT01081834|3879073|P5|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
1180637|NCT01081834|3879074|P4|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
1180638|NCT01081834|3879075|P3|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
1180639|NCT01081834|3879076|P2|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1
1180640|NCT01081834|3879077|P1|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7
1180641|NCT01081834|3879073|P5|Extension Period: Week 26 to Week 52|Not specified|0
1180642|NCT01081834|3879074|P4|Extension Period: Week 26 to Week 52|Not specified|0
1180643|NCT01081834|3879075|P3|Extension Period: Week 26 to Week 52|Not specified|4
1180644|NCT01081834|3879076|P2|Extension Period: Week 26 to Week 52|Not specified|5
1180645|NCT01081834|3879077|P1|Extension Period: Week 26 to Week 52|Not specified|4
1180646|NCT01081834|3879073|P5|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
1180647|NCT01081834|3879074|P4|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
1180648|NCT01081834|3879075|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
1180649|NCT01081834|3879076|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
1180650|NCT01081834|3879077|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
1180651|NCT01081834|3879073|P5|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
1180652|NCT01081834|3879074|P4|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
1180653|NCT01081834|3879075|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
1180654|NCT01081834|3879076|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
1180655|NCT01081834|3879077|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
1180656|NCT01081834|3879073|P5|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
1180657|NCT01081834|3879074|P4|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
1180658|NCT01081834|3879075|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
1180659|NCT01081834|3879076|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
1180660|NCT01081834|3879077|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
1180661|NCT01081834|3879073|P5|Extension Period: Week 26 to Week 52|Protocol Violation|0
1180662|NCT01081834|3879074|P4|Extension Period: Week 26 to Week 52|Protocol Violation|0
1180663|NCT01081834|3879075|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
1180664|NCT01081834|3879076|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
1180665|NCT01081834|3879077|P1|Extension Period: Week 26 to Week 52|Protocol Violation|0
1180666|NCT01081834|3879073|P5|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
1180667|NCT01081834|3879074|P4|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
1180668|NCT01081834|3879075|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
1180669|NCT01081834|3879076|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
1180670|NCT01081834|3879077|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
1180671|NCT01081834|3879073|P5|Extension Period: Week 26 to Week 52|Death|0
1180672|NCT01081834|3879074|P4|Extension Period: Week 26 to Week 52|Death|0
1180673|NCT01081834|3879075|P3|Extension Period: Week 26 to Week 52|Death|0
1180674|NCT01081834|3879076|P2|Extension Period: Week 26 to Week 52|Death|0
1180675|NCT01081834|3879077|P1|Extension Period: Week 26 to Week 52|Death|1
1180676|NCT01081834|3879073|P5|Extension Period: Week 26 to Week 52|Adverse Event|0
1180677|NCT01081834|3879074|P4|Extension Period: Week 26 to Week 52|Adverse Event|0
1180678|NCT01081834|3879075|P3|Extension Period: Week 26 to Week 52|Adverse Event|0
1180679|NCT01081834|3879076|P2|Extension Period: Week 26 to Week 52|Adverse Event|0
1180680|NCT01081834|3879077|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
1180681|NCT01081834|3879073|P5|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
1180682|NCT01081834|3879074|P4|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
1180683|NCT01081834|3879075|P3|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
1180684|NCT01081834|3879076|P2|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
1180685|NCT01081834|3879077|P1|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3
1180686|NCT01081834|3879073|P5|Core Period: Baseline to Week 26|Not specified|0
1180687|NCT01081834|3879074|P4|Core Period: Baseline to Week 26|Not specified|1
1180688|NCT01081834|3879075|P3|Core Period: Baseline to Week 26|Not specified|3
1180689|NCT01081834|3879076|P2|Core Period: Baseline to Week 26|Not specified|4
1180690|NCT01081834|3879077|P1|Core Period: Baseline to Week 26|Not specified|4
1180691|NCT01081834|3879073|P5|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
1180692|NCT01081834|3879074|P4|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
1180693|NCT01081834|3879075|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
1180694|NCT01081834|3879076|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
1180695|NCT01081834|3879077|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
1180696|NCT01081834|3879073|P5|Core Period: Baseline to Week 26|Noncompliance with study drug|0
1180697|NCT01081834|3879074|P4|Core Period: Baseline to Week 26|Noncompliance with study drug|2
1180698|NCT01081834|3879075|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|2
1180699|NCT01081834|3879076|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|4
1180700|NCT01081834|3879077|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|3
1180701|NCT01081834|3879073|P5|Core Period: Baseline to Week 26|Withdrawal by Subject|1
1180702|NCT01081834|3879074|P4|Core Period: Baseline to Week 26|Withdrawal by Subject|3
1180703|NCT01081834|3879075|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|9
1180704|NCT01081834|3879076|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|3
1180705|NCT01081834|3879077|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|15
1180706|NCT01081834|3879073|P5|Core Period: Baseline to Week 26|Protocol Violation|2
1180707|NCT01081834|3879074|P4|Core Period: Baseline to Week 26|Protocol Violation|0
1180708|NCT01081834|3879075|P3|Core Period: Baseline to Week 26|Protocol Violation|0
1180709|NCT01081834|3879076|P2|Core Period: Baseline to Week 26|Protocol Violation|4
1180710|NCT01081834|3879077|P1|Core Period: Baseline to Week 26|Protocol Violation|0
1180711|NCT01081834|3879073|P5|Core Period: Baseline to Week 26|Lost to Follow-up|0
1180712|NCT01081834|3879074|P4|Core Period: Baseline to Week 26|Lost to Follow-up|0
1180713|NCT01081834|3879075|P3|Core Period: Baseline to Week 26|Lost to Follow-up|5
1180714|NCT01081834|3879076|P2|Core Period: Baseline to Week 26|Lost to Follow-up|2
1180715|NCT01081834|3879077|P1|Core Period: Baseline to Week 26|Lost to Follow-up|2
1180716|NCT01081834|3879073|P5|Core Period: Baseline to Week 26|Death|0
1180717|NCT01081834|3879074|P4|Core Period: Baseline to Week 26|Death|0
1180718|NCT01081834|3879075|P3|Core Period: Baseline to Week 26|Death|0
1180719|NCT01081834|3879076|P2|Core Period: Baseline to Week 26|Death|0
1180720|NCT01081834|3879077|P1|Core Period: Baseline to Week 26|Death|1
1180721|NCT01081834|3879073|P5|Core Period: Baseline to Week 26|Adverse Event|1
1180722|NCT01081834|3879074|P4|Core Period: Baseline to Week 26|Adverse Event|1
1180723|NCT01081834|3879075|P3|Core Period: Baseline to Week 26|Adverse Event|3
1180724|NCT01081834|3879076|P2|Core Period: Baseline to Week 26|Adverse Event|5
1180725|NCT01081834|3879077|P1|Core Period: Baseline to Week 26|Adverse Event|2
1180726|NCT01081834|3879073|P5|Core Period: Baseline to Week 26|Pregnancy|0
1180727|NCT01081834|3879074|P4|Core Period: Baseline to Week 26|Pregnancy|0
1180728|NCT01081834|3879075|P3|Core Period: Baseline to Week 26|Pregnancy|0
1180729|NCT01081834|3879076|P2|Core Period: Baseline to Week 26|Pregnancy|0
1180730|NCT01081834|3879077|P1|Core Period: Baseline to Week 26|Pregnancy|1
1180731|NCT01081795|3879138|P3|Overall Study|Other|0
1180732|NCT01081795|3879139|P2|Overall Study|Other|2
1180733|NCT01081795|3879140|P1|Overall Study|Other|1
1180734|NCT01081795|3879138|P3|Overall Study|Using drug with restricted days of use|2
1180735|NCT01081795|3879139|P2|Overall Study|Using drug with restricted days of use|3
1180736|NCT01081795|3879140|P1|Overall Study|Using drug with restricted days of use|2
1180737|NCT01081795|3879138|P3|Overall Study|Use of a prohibited concomitant drug|1
1180738|NCT01081795|3879139|P2|Overall Study|Use of a prohibited concomitant drug|1
1180739|NCT01081795|3879140|P1|Overall Study|Use of a prohibited concomitant drug|1
1180740|NCT01081795|3879138|P3|Overall Study|Ineligible for participation|0
1180741|NCT01081795|3879139|P2|Overall Study|Ineligible for participation|0
1180742|NCT01081795|3879140|P1|Overall Study|Ineligible for participation|1
1180743|NCT01081795|3879138|P3|Overall Study|Revocation of informed consent|0
1180744|NCT01081795|3879139|P2|Overall Study|Revocation of informed consent|0
1180745|NCT01081795|3879140|P1|Overall Study|Revocation of informed consent|2
1180746|NCT01081795|3879138|P3|Overall Study|Subject’s schedule|2
1180747|NCT01081795|3879139|P2|Overall Study|Subject’s schedule|1
1180748|NCT01081795|3879140|P1|Overall Study|Subject’s schedule|1
1180749|NCT01081795|3879138|P3|Overall Study|Lack of Efficacy|19
1180750|NCT01081795|3879139|P2|Overall Study|Lack of Efficacy|5
1180751|NCT01081795|3879140|P1|Overall Study|Lack of Efficacy|7
1180752|NCT01081795|3879138|P3|Overall Study|Adverse Event|6
1180753|NCT01081795|3879139|P2|Overall Study|Adverse Event|23
1180754|NCT01081795|3879140|P1|Overall Study|Adverse Event|18
1180755|NCT01081769|3879177|P2|CORE Intent-To-Treat|Patient Moved|2
1180756|NCT01081769|3879178|P1|CORE Intent-To-Treat|Patient Moved|2
1180757|NCT01081769|3879177|P2|CORE Intent-To-Treat|Visit Schedule Issues|2
1180758|NCT01081769|3879178|P1|CORE Intent-To-Treat|Visit Schedule Issues|1
1180759|NCT01081769|3879177|P2|CORE Intent-To-Treat|Ineligibility|4
1180760|NCT01081769|3879178|P1|CORE Intent-To-Treat|Ineligibility|3
1180761|NCT01081769|3879177|P2|CORE Intent-To-Treat|Other|1
1180762|NCT01081769|3879178|P1|CORE Intent-To-Treat|Other|0
1180763|NCT01081769|3879177|P2|CORE Intent-To-Treat|Noncompliance With Study Drug|5
1180764|NCT01081769|3879178|P1|CORE Intent-To-Treat|Noncompliance With Study Drug|0
1180765|NCT01081769|3879177|P2|CORE Intent-To-Treat|Withdrawal by Subject|60
1180766|NCT01081769|3879178|P1|CORE Intent-To-Treat|Withdrawal by Subject|52
1180767|NCT01081769|3879177|P2|CORE Intent-To-Treat|Pregnancy|0
1180768|NCT01081769|3879178|P1|CORE Intent-To-Treat|Pregnancy|1
1180769|NCT01081769|3879177|P2|CORE Intent-To-Treat|Lost to Follow-up|5
1180770|NCT01081769|3879178|P1|CORE Intent-To-Treat|Lost to Follow-up|4
1180771|NCT01081769|3879177|P2|CORE Intent-To-Treat|Lack of Efficacy|6
1180772|NCT01081769|3879178|P1|CORE Intent-To-Treat|Lack of Efficacy|2
1180773|NCT01081769|3879177|P2|CORE Intent-To-Treat|Death|1
1180774|NCT01081769|3879178|P1|CORE Intent-To-Treat|Death|1
1180775|NCT01081769|3879177|P2|CORE Intent-To-Treat|Adverse Event|11
1180776|NCT01081769|3879178|P1|CORE Intent-To-Treat|Adverse Event|14
1180777|NCT01081769|3879177|P2|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0
1180778|NCT01081769|3879178|P1|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2
1180779|NCT01081769|3879177|P2|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7
1180780|NCT01081769|3879178|P1|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6
1180781|NCT01081769|3879177|P2|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
1180782|NCT01081769|3879178|P1|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
1180783|NCT01081769|3879177|P2|Whole Intent-to-Treat|Missing Responder Assessment|12
1180784|NCT01081769|3879178|P1|Whole Intent-to-Treat|Missing Responder Assessment|10
1180785|NCT01081665|3879212|P1|Overall Study|Lack of Efficacy|1
1180786|NCT01081665|3879212|P1|Overall Study|Adverse Event|1
1180787|NCT01081665|3879212|P1|Overall Study|Change in renal replacement therapy|2
1180788|NCT01081665|3879212|P1|Overall Study|Regulation of iPTH|5
1180789|NCT01081665|3879212|P1|Overall Study|Change of dialysis unit|10
1180790|NCT01081665|3879212|P1|Overall Study|Withdrawal by Subject|17
1180791|NCT01081665|3879212|P1|Overall Study|Lost to Follow-up|18
1180792|NCT01081665|3879212|P1|Overall Study|Death|41
1180793|NCT01081626|3879224|P2|Overall Study|Other|30
1180794|NCT01081626|3879225|P1|Overall Study|Other|33
1180795|NCT01081626|3879224|P2|Overall Study|Lost to Follow-up|1
1180796|NCT01081626|3879225|P1|Overall Study|Lost to Follow-up|0
1180797|NCT01081626|3879224|P2|Overall Study|Overstimulation|1
1180798|NCT01081626|3879225|P1|Overall Study|Overstimulation|0
1180799|NCT01081626|3879224|P2|Overall Study|Low antral follicle count|0
1180800|NCT01081626|3879225|P1|Overall Study|Low antral follicle count|1
1180801|NCT01081626|3879224|P2|Overall Study|Missing Estradiol|28
1180802|NCT01081626|3879225|P1|Overall Study|Missing Estradiol|25
1180803|NCT01081626|3879224|P2|Overall Study|Dosing error|1
1180804|NCT01081626|3879225|P1|Overall Study|Dosing error|1
1180805|NCT01081301|3879251|P1|Overall Study|Lost to Follow-up|4
1180806|NCT01081301|3879251|P1|Overall Study|Patient too ill|2
1180807|NCT01081301|3879251|P1|Overall Study|Too busy|5
1180808|NCT01081301|3879251|P1|Overall Study|Bereaved|3
1180809|NCT01081249|3879289|P2|Overall Study|Diagnosed with Bipolar Disorder|1
1180810|NCT01081249|3879290|P1|Overall Study|Diagnosed with Bipolar Disorder|0
1180811|NCT01081145|3879296|P2|Double-Blind Randomized-Withdrawal Phase|Not specified|3
1180812|NCT01081145|3879297|P1|Double-Blind Randomized-Withdrawal Phase|Not specified|4
1180813|NCT01081145|3879296|P2|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71
1180814|NCT01081145|3879297|P1|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47
1180815|NCT01081145|3879296|P2|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20
1180816|NCT01081145|3879297|P1|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13
1180817|NCT01081145|3879296|P2|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2
1180818|NCT01081145|3879297|P1|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3
1180819|NCT01081145|3879296|P2|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8
1180820|NCT01081145|3879297|P1|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10
1180821|NCT01081145|3879296|P2|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0
1180822|NCT01081145|3879297|P1|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1
1180823|NCT01081145|3879296|P2|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2
1180824|NCT01081145|3879297|P1|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3
1180825|NCT01081145|3879296|P2|Open-Label Phase|Protocol Violation|0
1180826|NCT01081145|3879297|P1|Open-Label Phase|Protocol Violation|4
1180827|NCT01081145|3879296|P2|Open-Label Phase|Lost to Follow-up|0
1180828|NCT01081145|3879297|P1|Open-Label Phase|Lost to Follow-up|11
1180829|NCT01081145|3879296|P2|Open-Label Phase|Not specified|0
1180830|NCT01081145|3879297|P1|Open-Label Phase|Not specified|12
1180831|NCT01081145|3879296|P2|Open-Label Phase|Withdrawal by Subject|0
1180832|NCT01081145|3879297|P1|Open-Label Phase|Withdrawal by Subject|41
1180833|NCT01081145|3879296|P2|Open-Label Phase|Adverse Event|0
1180834|NCT01081145|3879297|P1|Open-Label Phase|Adverse Event|42
1180835|NCT01081145|3879296|P2|Open-Label Phase|Response criteria not met|0
1180836|NCT01081145|3879297|P1|Open-Label Phase|Response criteria not met|46
1180837|NCT01081145|3879296|P2|Open-Label Phase|Lack of Efficacy|0
1180838|NCT01081145|3879297|P1|Open-Label Phase|Lack of Efficacy|56
1180839|NCT01081132|3879325|P2|Overall Study|Protocol Violation|1
1180840|NCT01081132|3879326|P1|Overall Study|Protocol Violation|3
1180841|NCT01081132|3879325|P2|Overall Study|Declined Taper Phase|1
1180842|NCT01081132|3879326|P1|Overall Study|Declined Taper Phase|0
1180843|NCT01081132|3879325|P2|Overall Study|Patient Did Not Complete Wk14 and 15|1
1180844|NCT01081132|3879326|P1|Overall Study|Patient Did Not Complete Wk14 and 15|0
1180845|NCT01081132|3879325|P2|Overall Study|Stopped Taking Meds|0
1180846|NCT01081132|3879326|P1|Overall Study|Stopped Taking Meds|2
1180847|NCT01081132|3879325|P2|Overall Study|Missed Visits|1
1180848|NCT01081132|3879326|P1|Overall Study|Missed Visits|1
1180849|NCT01081132|3879325|P2|Overall Study|Lack Of Compliance|1
1180850|NCT01081132|3879326|P1|Overall Study|Lack Of Compliance|0
1180851|NCT01081132|3879325|P2|Overall Study|Non Compliance|2
1180852|NCT01081132|3879326|P1|Overall Study|Non Compliance|4
1180853|NCT01081132|3879325|P2|Overall Study|Adverse Event|9
1180854|NCT01081132|3879326|P1|Overall Study|Adverse Event|3
1180855|NCT01081132|3879325|P2|Overall Study|Lost to Follow-up|11
1180856|NCT01081132|3879326|P1|Overall Study|Lost to Follow-up|4
1180857|NCT01081132|3879325|P2|Overall Study|Withdrawal by Subject|16
1180858|NCT01081132|3879326|P1|Overall Study|Withdrawal by Subject|13
1180859|NCT01081132|3879325|P2|Overall Study|Lack of Efficacy|9
1180860|NCT01081132|3879326|P1|Overall Study|Lack of Efficacy|25
1180861|NCT01080807|3879410|P2|Overall Study|Moved away without notifying center|0
1180862|NCT01080807|3879411|P1|Overall Study|Moved away without notifying center|1
1180863|NCT01080807|3879410|P2|Overall Study|Switched to first shift|0
1180864|NCT01080807|3879411|P1|Overall Study|Switched to first shift|1
1180865|NCT01080807|3879410|P2|Overall Study|Work schedule and travel|1
1180866|NCT01080807|3879411|P1|Overall Study|Work schedule and travel|0
1180867|NCT01080807|3879410|P2|Overall Study|Work schedule changing|1
1180868|NCT01080807|3879411|P1|Overall Study|Work schedule changing|1
1180869|NCT01080807|3879410|P2|Overall Study|Stopped working consistent night shifts|1
1180870|NCT01080807|3879411|P1|Overall Study|Stopped working consistent night shifts|0
1180871|NCT01080807|3879410|P2|Overall Study|Laid off or terminated from job|2
1180872|NCT01080807|3879411|P1|Overall Study|Laid off or terminated from job|1
1180873|NCT01080807|3879410|P2|Overall Study|Began working day shift|2
1180874|NCT01080807|3879411|P1|Overall Study|Began working day shift|0
1180875|NCT01080807|3879410|P2|Overall Study|Noncompliance to study procedures|1
1180876|NCT01080807|3879411|P1|Overall Study|Noncompliance to study procedures|1
1180877|NCT01080807|3879410|P2|Overall Study|Noncompliance with drug administration|1
1180878|NCT01080807|3879411|P1|Overall Study|Noncompliance with drug administration|1
1180879|NCT01080807|3879410|P2|Overall Study|Lost to Follow-up|4
1180880|NCT01080807|3879411|P1|Overall Study|Lost to Follow-up|6
1180881|NCT01080807|3879410|P2|Overall Study|Protocol Violation|6
1180882|NCT01080807|3879411|P1|Overall Study|Protocol Violation|7
1180883|NCT01080807|3879410|P2|Overall Study|Withdrawal by Subject|2
1180884|NCT01080807|3879411|P1|Overall Study|Withdrawal by Subject|7
1180885|NCT01080807|3879410|P2|Overall Study|Lack of Efficacy|1
1180886|NCT01080807|3879411|P1|Overall Study|Lack of Efficacy|0
1180887|NCT01080807|3879410|P2|Overall Study|Adverse Event|1
1180888|NCT01080807|3879411|P1|Overall Study|Adverse Event|9
1180889|NCT01080768|3879520|P2|Overall Study|Protocol Deviation|1
1180890|NCT01080768|3879521|P1|Overall Study|Protocol Deviation|2
1180891|NCT01080716|3879531|P4|Part 1|Physician Decision|0
1180892|NCT01080716|3879532|P3|Part 1|Physician Decision|0
1180893|NCT01080716|3879533|P2|Part 1|Physician Decision|0
1180894|NCT01080716|3879534|P1|Part 1|Physician Decision|1
1180895|NCT01080625|3879573|P3|Overall Study|Physician Decision|1
1180896|NCT01080625|3879574|P2|Overall Study|Physician Decision|2
1180897|NCT01080625|3879575|P1|Overall Study|Physician Decision|0
1180898|NCT01080391|3879585|P2|Overall Study|Randomized but not treated|4
1180899|NCT01080391|3879586|P1|Overall Study|Randomized but not treated|7
1180900|NCT01080326|3879604|P1|Overall Study|Surgeon decision|1
1180901|NCT01080326|3879604|P1|Overall Study|Patient deterioration prior to procedure|3
1180902|NCT01080300|3879610|P2|Overall Study|Reasons not specified|6
1180903|NCT01080300|3879611|P1|Overall Study|Reasons not specified|4
1180904|NCT01080300|3879610|P2|Overall Study|Withdrawal by Subject|28
1180905|NCT01080300|3879611|P1|Overall Study|Withdrawal by Subject|12
1180906|NCT01080300|3879610|P2|Overall Study|Death|1
1180907|NCT01080300|3879611|P1|Overall Study|Death|0
1180908|NCT01080300|3879610|P2|Overall Study|Lost to Follow-up|6
1180909|NCT01080300|3879611|P1|Overall Study|Lost to Follow-up|10
1180910|NCT01080300|3879610|P2|Overall Study|Protocol Violation|13
1180911|NCT01080300|3879611|P1|Overall Study|Protocol Violation|7
1180912|NCT01080300|3879610|P2|Overall Study|Lack of Efficacy|15
1180913|NCT01080300|3879611|P1|Overall Study|Lack of Efficacy|12
1180914|NCT01080300|3879610|P2|Overall Study|Adverse Event|35
1180915|NCT01080300|3879611|P1|Overall Study|Adverse Event|49
1180916|NCT01080131|3879696|P2|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5
1180917|NCT01080131|3879697|P1|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4
1180918|NCT01080131|3879696|P2|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4
1180919|NCT01080131|3879697|P1|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3
1180920|NCT01080131|3879696|P2|Extension Study 2 (25-72 Weeks)|Adverse Event|2
1180921|NCT01080131|3879697|P1|Extension Study 2 (25-72 Weeks)|Adverse Event|1
1180922|NCT01080131|3879696|P2|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0
1180923|NCT01080131|3879697|P1|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1
1180924|NCT01080131|3879696|P2|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3
1180925|NCT01080131|3879697|P1|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4
1180926|NCT01080131|3879696|P2|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1
1180927|NCT01080131|3879697|P1|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0
1180928|NCT01080131|3879696|P2|Extension Study 1 (12 -24 Weeks)|Adverse Event|0
1180929|NCT01080131|3879697|P1|Extension Study 1 (12 -24 Weeks)|Adverse Event|1
1180930|NCT01080131|3879696|P2|Core Study (0- 12 Weeks)|Protocol deviation|2
1180931|NCT01080131|3879697|P1|Core Study (0- 12 Weeks)|Protocol deviation|0
1180932|NCT01080131|3879696|P2|Core Study (0- 12 Weeks)|Death|0
1180933|NCT01080131|3879697|P1|Core Study (0- 12 Weeks)|Death|1
1180934|NCT01080131|3879696|P2|Core Study (0- 12 Weeks)|Administrative problems|1
1180935|NCT01080131|3879697|P1|Core Study (0- 12 Weeks)|Administrative problems|0
1180936|NCT01080131|3879696|P2|Core Study (0- 12 Weeks)|Lost to Follow-up|3
1180937|NCT01080131|3879697|P1|Core Study (0- 12 Weeks)|Lost to Follow-up|5
1180938|NCT01080131|3879696|P2|Core Study (0- 12 Weeks)|Patient withdrew consent|4
1180939|NCT01080131|3879697|P1|Core Study (0- 12 Weeks)|Patient withdrew consent|6
1180940|NCT01080131|3879696|P2|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
1180941|NCT01080131|3879697|P1|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
1180942|NCT01079988|3879792|P5|Overall Study|Other|1
1180943|NCT01079988|3879793|P4|Overall Study|Other|2
1180944|NCT01079988|3879794|P3|Overall Study|Other|0
1180945|NCT01079988|3879795|P2|Overall Study|Other|0
1180946|NCT01079988|3879796|P1|Overall Study|Other|0
1180947|NCT01079988|3879792|P5|Overall Study|Lack of Efficacy|0
1180948|NCT01079988|3879793|P4|Overall Study|Lack of Efficacy|0
1180949|NCT01079988|3879794|P3|Overall Study|Lack of Efficacy|0
1180950|NCT01079988|3879795|P2|Overall Study|Lack of Efficacy|0
1180951|NCT01079988|3879796|P1|Overall Study|Lack of Efficacy|1
1180952|NCT01079988|3879792|P5|Overall Study|Lost to Follow-up|0
1180953|NCT01079988|3879793|P4|Overall Study|Lost to Follow-up|1
1180954|NCT01079988|3879794|P3|Overall Study|Lost to Follow-up|0
1180955|NCT01079988|3879795|P2|Overall Study|Lost to Follow-up|0
1180956|NCT01079988|3879796|P1|Overall Study|Lost to Follow-up|0
1180957|NCT01079962|3879815|P2|Overall Study|Due to arrhythmia/bradycardia|1
1180958|NCT01079962|3879816|P1|Overall Study|Due to arrhythmia/bradycardia|1
1180959|NCT01079962|3879815|P2|Overall Study|Participant not returning for next visit|0
1180960|NCT01079962|3879816|P1|Overall Study|Participant not returning for next visit|1
1180961|NCT01079962|3879815|P2|Overall Study|Inclusion/exclusion criteria|3
1180962|NCT01079962|3879816|P1|Overall Study|Inclusion/exclusion criteria|1
1180963|NCT01079962|3879815|P2|Overall Study|No blood pressure (BP) control|0
1180964|NCT01079962|3879816|P1|Overall Study|No blood pressure (BP) control|3
1180965|NCT01079962|3879815|P2|Overall Study|Protocol Violation|2
1180966|NCT01079962|3879816|P1|Overall Study|Protocol Violation|2
1180967|NCT01079962|3879815|P2|Overall Study|Withdrawal by Subject|7
1180968|NCT01079962|3879816|P1|Overall Study|Withdrawal by Subject|5
1180969|NCT01079962|3879815|P2|Overall Study|Adverse Event|2
1180970|NCT01079962|3879816|P1|Overall Study|Adverse Event|2
1180971|NCT01079949|3879844|P2|Overall Study|Randomized but not treated|0
1180972|NCT01079949|3879845|P1|Overall Study|Randomized but not treated|1
1180973|NCT01079949|3879844|P2|Overall Study|Withdrawal between OPU - embryo transfer|2
1180974|NCT01079949|3879845|P1|Overall Study|Withdrawal between OPU - embryo transfer|8
1180975|NCT01079949|3879844|P2|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8
1180976|NCT01079949|3879845|P1|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4
1180977|NCT01079949|3879844|P2|Overall Study|Withdrawal before r-hCG administration|3
1180978|NCT01079949|3879845|P1|Overall Study|Withdrawal before r-hCG administration|2
1180979|NCT01079936|3879891|P5|Phase II|Insurance Issue|1
1180980|NCT01079936|3879892|P4|Phase II|Insurance Issue|0
1180981|NCT01079936|3879893|P3|Phase II|Insurance Issue|0
1180982|NCT01079936|3879894|P2|Phase II|Insurance Issue|0
1180983|NCT01079936|3879895|P1|Phase II|Insurance Issue|0
1180984|NCT01079936|3879891|P5|Phase II|Adverse Event|0
1180985|NCT01079936|3879892|P4|Phase II|Adverse Event|0
1180986|NCT01079936|3879893|P3|Phase II|Adverse Event|1
1180987|NCT01079936|3879894|P2|Phase II|Adverse Event|0
1180988|NCT01079936|3879895|P1|Phase II|Adverse Event|0
1180989|NCT01079936|3879891|P5|Phase I: MTD|No Stem Cell Transplantation|0
1180990|NCT01079936|3879892|P4|Phase I: MTD|No Stem Cell Transplantation|0
1180991|NCT01079936|3879893|P3|Phase I: MTD|No Stem Cell Transplantation|0
1180992|NCT01079936|3879894|P2|Phase I: MTD|No Stem Cell Transplantation|0
1180993|NCT01079936|3879895|P1|Phase I: MTD|No Stem Cell Transplantation|2
1180994|NCT01079936|3879891|P5|Phase I: MTD|First Remission Status|0
1180995|NCT01079936|3879892|P4|Phase I: MTD|First Remission Status|0
1180996|NCT01079936|3879893|P3|Phase I: MTD|First Remission Status|0
1180997|NCT01079936|3879894|P2|Phase I: MTD|First Remission Status|0
1180998|NCT01079936|3879895|P1|Phase I: MTD|First Remission Status|2
1180999|NCT01079832|3879914|P1|Overall Study|Withdrawal by Subject|1
1181000|NCT01079806|3879924|P2|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|2
1181001|NCT01079806|3879925|P1|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|0
1181002|NCT01079806|3879924|P2|Day 1 to Week 96|Poor compliance or noncompliance|0
1181003|NCT01079806|3879925|P1|Day 1 to Week 96|Poor compliance or noncompliance|1
1181004|NCT01079806|3879924|P2|Day 1 to Week 96|Pregnancy|1
1181005|NCT01079806|3879925|P1|Day 1 to Week 96|Pregnancy|0
1181006|NCT01079806|3879924|P2|Day 1 to Week 96|Withdrawal by Subject|1
1181007|NCT01079806|3879925|P1|Day 1 to Week 96|Withdrawal by Subject|3
1181008|NCT01079806|3879924|P2|Day 1 to Week 96|Adverse Event|2
1181009|NCT01079806|3879925|P1|Day 1 to Week 96|Adverse Event|0
1181010|NCT01079741|3879950|P5|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3
1181011|NCT01079741|3879951|P4|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
1181012|NCT01079741|3879952|P3|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
1181013|NCT01079741|3879953|P2|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
1181014|NCT01079741|3879954|P1|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
1181015|NCT01079741|3879950|P5|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
1181016|NCT01079741|3879951|P4|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
1181017|NCT01079741|3879952|P3|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
1181018|NCT01079741|3879953|P2|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1
1181019|NCT01079741|3879954|P1|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
1181020|NCT01079234|3880002|P4|Extension: Week 27 to 52|Unclassified|7
1181021|NCT01079234|3880003|P3|Extension: Week 27 to 52|Unclassified|4
1181022|NCT01079234|3880004|P2|Extension: Week 27 to 52|Unclassified|0
1181023|NCT01079234|3880005|P1|Extension: Week 27 to 52|Unclassified|0
1181024|NCT01079234|3880002|P4|Extension: Week 27 to 52|Withdrawal criteria|2
1181025|NCT01079234|3880003|P3|Extension: Week 27 to 52|Withdrawal criteria|4
1181026|NCT01079234|3880004|P2|Extension: Week 27 to 52|Withdrawal criteria|0
1181027|NCT01079234|3880005|P1|Extension: Week 27 to 52|Withdrawal criteria|0
1181028|NCT01079234|3880002|P4|Extension: Week 27 to 52|Protocol Violation|5
1181029|NCT01079234|3880003|P3|Extension: Week 27 to 52|Protocol Violation|2
1181030|NCT01079234|3880004|P2|Extension: Week 27 to 52|Protocol Violation|0
1181031|NCT01079234|3880005|P1|Extension: Week 27 to 52|Protocol Violation|0
1181032|NCT01079234|3880002|P4|Extension: Week 27 to 52|Lack of Efficacy|2
1181033|NCT01079234|3880003|P3|Extension: Week 27 to 52|Lack of Efficacy|0
1181034|NCT01079234|3880004|P2|Extension: Week 27 to 52|Lack of Efficacy|0
1181035|NCT01079234|3880005|P1|Extension: Week 27 to 52|Lack of Efficacy|0
1181036|NCT01079234|3880002|P4|Extension: Week 27 to 52|Adverse Event|0
1181037|NCT01079234|3880003|P3|Extension: Week 27 to 52|Adverse Event|1
1181038|NCT01079234|3880004|P2|Extension: Week 27 to 52|Adverse Event|0
1181039|NCT01079234|3880005|P1|Extension: Week 27 to 52|Adverse Event|0
1181040|NCT01079234|3880002|P4|Main: Week 0 to 26|Unclassified|0
1181041|NCT01079234|3880003|P3|Main: Week 0 to 26|Unclassified|4
1181042|NCT01079234|3880004|P2|Main: Week 0 to 26|Unclassified|13
1181043|NCT01079234|3880005|P1|Main: Week 0 to 26|Unclassified|7
1181044|NCT01079234|3880002|P4|Main: Week 0 to 26|Withdrawal criteria|0
1181045|NCT01079234|3880003|P3|Main: Week 0 to 26|Withdrawal criteria|2
1181046|NCT01079234|3880004|P2|Main: Week 0 to 26|Withdrawal criteria|6
1181047|NCT01079234|3880005|P1|Main: Week 0 to 26|Withdrawal criteria|6
1181048|NCT01079234|3880002|P4|Main: Week 0 to 26|Protocol Violation|0
1181049|NCT01079234|3880003|P3|Main: Week 0 to 26|Protocol Violation|4
1181050|NCT01079234|3880004|P2|Main: Week 0 to 26|Protocol Violation|2
1181051|NCT01079234|3880005|P1|Main: Week 0 to 26|Protocol Violation|6
1181052|NCT01079234|3880002|P4|Main: Week 0 to 26|Lack of Efficacy|0
1181053|NCT01079234|3880003|P3|Main: Week 0 to 26|Lack of Efficacy|1
1181054|NCT01079234|3880004|P2|Main: Week 0 to 26|Lack of Efficacy|1
1181055|NCT01079234|3880005|P1|Main: Week 0 to 26|Lack of Efficacy|2
1181056|NCT01079234|3880002|P4|Main: Week 0 to 26|Adverse Event|0
1181057|NCT01079234|3880003|P3|Main: Week 0 to 26|Adverse Event|1
1181058|NCT01079234|3880004|P2|Main: Week 0 to 26|Adverse Event|4
1181059|NCT01079234|3880005|P1|Main: Week 0 to 26|Adverse Event|5
1181060|NCT01079195|3880023|P1|Overall Study|Non-compliance|2
1181061|NCT01079195|3880023|P1|Overall Study|No Follow-up Documentation Available|4
1181062|NCT01079195|3880023|P1|Overall Study|Improved Status of Participant|4
1181063|NCT01079195|3880023|P1|Overall Study|Physician Decision|4
1181064|NCT01079195|3880023|P1|Overall Study|Lack of Effectiveness|12
1181065|NCT01079195|3880023|P1|Overall Study|Financial Reasons|15
1181066|NCT01079195|3880023|P1|Overall Study|Withdrawal by Subject|18
1181067|NCT01079195|3880023|P1|Overall Study|Reason Unknown|39
1181068|NCT01079195|3880023|P1|Overall Study|Adverse Event|157
1181069|NCT01079195|3880023|P1|Overall Study|No Documentation Available|437
1181070|NCT01079195|3880023|P1|Overall Study|No Documentation of Tarka Therapy|739
1181071|NCT01079182|3880029|P1|Overall Study|Reasons not Evaluated|271
1181072|NCT01079182|3880029|P1|Overall Study|ADR and Lack of Effectiveness|39
1181073|NCT01079182|3880029|P1|Overall Study|Lack of Efficacy|514
1181074|NCT01079182|3880029|P1|Overall Study|Adverse Drug Reaction (ADR)|261
1181075|NCT01079182|3880029|P1|Overall Study|Lost to Follow-up|1634
1181076|NCT01079130|3880137|P6|Overall Study|Lost to Follow-up|0
1181077|NCT01079130|3880138|P5|Overall Study|Lost to Follow-up|1
1181078|NCT01079130|3880139|P4|Overall Study|Lost to Follow-up|0
1181079|NCT01079130|3880140|P3|Overall Study|Lost to Follow-up|0
1181080|NCT01079130|3880141|P2|Overall Study|Lost to Follow-up|0
1181081|NCT01079130|3880142|P1|Overall Study|Lost to Follow-up|0
1181082|NCT01079130|3880137|P6|Overall Study|Unsatisfactory therapeutic effect|0
1181083|NCT01079130|3880138|P5|Overall Study|Unsatisfactory therapeutic effect|0
1181084|NCT01079130|3880139|P4|Overall Study|Unsatisfactory therapeutic effect|2
1181085|NCT01079130|3880140|P3|Overall Study|Unsatisfactory therapeutic effect|0
1181086|NCT01079130|3880141|P2|Overall Study|Unsatisfactory therapeutic effect|0
1181087|NCT01079130|3880142|P1|Overall Study|Unsatisfactory therapeutic effect|0
1181088|NCT01079130|3880137|P6|Overall Study|Abnormal test procedure result(s)|0
1181089|NCT01079130|3880138|P5|Overall Study|Abnormal test procedure result(s)|1
1181090|NCT01079130|3880139|P4|Overall Study|Abnormal test procedure result(s)|0
1181091|NCT01079130|3880140|P3|Overall Study|Abnormal test procedure result(s)|0
1181092|NCT01079130|3880141|P2|Overall Study|Abnormal test procedure result(s)|0
1181093|NCT01079130|3880142|P1|Overall Study|Abnormal test procedure result(s)|0
1181094|NCT01079130|3880137|P6|Overall Study|Protocol deviation|0
1181095|NCT01079130|3880138|P5|Overall Study|Protocol deviation|0
1181096|NCT01079130|3880139|P4|Overall Study|Protocol deviation|2
1181097|NCT01079130|3880140|P3|Overall Study|Protocol deviation|1
1181098|NCT01079130|3880141|P2|Overall Study|Protocol deviation|2
1181099|NCT01079130|3880142|P1|Overall Study|Protocol deviation|0
1181100|NCT01079130|3880137|P6|Overall Study|Withdrawal by Subject|3
1181101|NCT01079130|3880138|P5|Overall Study|Withdrawal by Subject|1
1181102|NCT01079130|3880139|P4|Overall Study|Withdrawal by Subject|0
1181103|NCT01079130|3880140|P3|Overall Study|Withdrawal by Subject|0
1181104|NCT01079130|3880141|P2|Overall Study|Withdrawal by Subject|1
1181105|NCT01079130|3880142|P1|Overall Study|Withdrawal by Subject|0
1181106|NCT01079130|3880137|P6|Overall Study|Administrative problems|1
1181107|NCT01079130|3880138|P5|Overall Study|Administrative problems|0
1181108|NCT01079130|3880139|P4|Overall Study|Administrative problems|0
1181109|NCT01079130|3880140|P3|Overall Study|Administrative problems|0
1181110|NCT01079130|3880141|P2|Overall Study|Administrative problems|3
1181111|NCT01079130|3880142|P1|Overall Study|Administrative problems|1
1181112|NCT01079130|3880137|P6|Overall Study|Adverse Event|1
1181113|NCT01079130|3880138|P5|Overall Study|Adverse Event|5
1181114|NCT01079130|3880139|P4|Overall Study|Adverse Event|1
1181115|NCT01079130|3880140|P3|Overall Study|Adverse Event|0
1181116|NCT01079130|3880141|P2|Overall Study|Adverse Event|1
1181117|NCT01079130|3880142|P1|Overall Study|Adverse Event|1
1181118|NCT01078974|3880162|P1|Overall Study|Adverse Event|3
1181119|NCT01078922|3880167|P1|Overall Study|Adverse Event|1
1181120|NCT01078805|3880208|P1|Overall Study|Didn't take study drug|82
1181121|NCT01078805|3880208|P1|Overall Study|Other|173
1181122|NCT01078805|3880208|P1|Overall Study|Withdrawal by Subject|739
1181123|NCT01078805|3880208|P1|Overall Study|Sponsor decision|46
1181124|NCT01078805|3880208|P1|Overall Study|Serious adverse event|26
1181125|NCT01078805|3880208|P1|Overall Study|Physician Decision|169
1181126|NCT01078805|3880208|P1|Overall Study|Lost to Follow-up|676
1181127|NCT01078805|3880208|P1|Overall Study|Death|134
1181128|NCT01078805|3880208|P1|Overall Study|Clinically significant abnormal lab|5
1181129|NCT01078675|3880235|P2|Overall Study|Adverse Event|0
1181130|NCT01078675|3880236|P1|Overall Study|Adverse Event|3
1181131|NCT01078675|3880235|P2|Overall Study|Provided in CRF for specific reasons|3
1181132|NCT01078675|3880236|P1|Overall Study|Provided in CRF for specific reasons|2
1181133|NCT01078675|3880235|P2|Overall Study|Protocol Violation|0
1181134|NCT01078675|3880236|P1|Overall Study|Protocol Violation|56
1181135|NCT01078675|3880235|P2|Overall Study|Withdrawal by Subject|3
1181136|NCT01078675|3880236|P1|Overall Study|Withdrawal by Subject|7
1181137|NCT01078662|3880258|P5|Overall Study|Lost to Follow-up|0
1181138|NCT01078662|3880259|P4|Overall Study|Lost to Follow-up|0
1181139|NCT01078662|3880260|P3|Overall Study|Lost to Follow-up|0
1181140|NCT01078662|3880261|P2|Overall Study|Lost to Follow-up|0
1181141|NCT01078662|3880262|P1|Overall Study|Lost to Follow-up|1
1181142|NCT01078662|3880258|P5|Overall Study|Protocol Violation|0
1181143|NCT01078662|3880259|P4|Overall Study|Protocol Violation|0
1181144|NCT01078662|3880260|P3|Overall Study|Protocol Violation|0
1181145|NCT01078662|3880261|P2|Overall Study|Protocol Violation|1
1181146|NCT01078662|3880262|P1|Overall Study|Protocol Violation|0
1181147|NCT01078662|3880258|P5|Overall Study|Withdrawal by Subject|0
1181148|NCT01078662|3880259|P4|Overall Study|Withdrawal by Subject|0
1181149|NCT01078662|3880260|P3|Overall Study|Withdrawal by Subject|1
1181150|NCT01078662|3880261|P2|Overall Study|Withdrawal by Subject|11
1181151|NCT01078662|3880262|P1|Overall Study|Withdrawal by Subject|4
1181152|NCT01078662|3880258|P5|Overall Study|Patients reached data cut-off|3
1181153|NCT01078662|3880259|P4|Overall Study|Patients reached data cut-off|2
1181154|NCT01078662|3880260|P3|Overall Study|Patients reached data cut-off|2
1181155|NCT01078662|3880261|P2|Overall Study|Patients reached data cut-off|53
1181156|NCT01078662|3880262|P1|Overall Study|Patients reached data cut-off|12
1181157|NCT01078662|3880258|P5|Overall Study|Death|8
1181158|NCT01078662|3880259|P4|Overall Study|Death|5
1181159|NCT01078662|3880260|P3|Overall Study|Death|18
1181160|NCT01078662|3880261|P2|Overall Study|Death|103
1181161|NCT01078662|3880262|P1|Overall Study|Death|41
1181162|NCT01078623|3880301|P20|Treatment Period 4|Withdrawal by Subject|0
1181163|NCT01078623|3880302|P19|Treatment Period 4|Withdrawal by Subject|0
1181164|NCT01078623|3880303|P18|Treatment Period 4|Withdrawal by Subject|0
1181165|NCT01078623|3880304|P17|Treatment Period 4|Withdrawal by Subject|0
1181166|NCT01078623|3880305|P16|Treatment Period 4|Withdrawal by Subject|1
1181167|NCT01078623|3880306|P15|Treatment Period 4|Withdrawal by Subject|0
1181168|NCT01078623|3880307|P14|Treatment Period 4|Withdrawal by Subject|0
1181169|NCT01078623|3880308|P13|Treatment Period 4|Withdrawal by Subject|0
1181170|NCT01078623|3880309|P12|Treatment Period 4|Withdrawal by Subject|0
1181171|NCT01078623|3880310|P11|Treatment Period 4|Withdrawal by Subject|0
1181172|NCT01078623|3880311|P10|Treatment Period 4|Withdrawal by Subject|0
1181173|NCT01078623|3880312|P9|Treatment Period 4|Withdrawal by Subject|0
1181174|NCT01078623|3880313|P8|Treatment Period 4|Withdrawal by Subject|0
1181175|NCT01078623|3880314|P7|Treatment Period 4|Withdrawal by Subject|0
1181176|NCT01078623|3880315|P6|Treatment Period 4|Withdrawal by Subject|0
1181177|NCT01078623|3880316|P5|Treatment Period 4|Withdrawal by Subject|0
1181178|NCT01078623|3880317|P4|Treatment Period 4|Withdrawal by Subject|0
1181179|NCT01078623|3880318|P3|Treatment Period 4|Withdrawal by Subject|0
1181180|NCT01078623|3880319|P2|Treatment Period 4|Withdrawal by Subject|0
1181181|NCT01078623|3880320|P1|Treatment Period 4|Withdrawal by Subject|0
1181182|NCT01078623|3880301|P20|Treatment Period 4|Adverse Event|0
1181183|NCT01078623|3880302|P19|Treatment Period 4|Adverse Event|0
1181184|NCT01078623|3880303|P18|Treatment Period 4|Adverse Event|0
1181185|NCT01078623|3880304|P17|Treatment Period 4|Adverse Event|0
1181186|NCT01078623|3880305|P16|Treatment Period 4|Adverse Event|0
1181187|NCT01078623|3880306|P15|Treatment Period 4|Adverse Event|0
1181188|NCT01078623|3880307|P14|Treatment Period 4|Adverse Event|0
1181189|NCT01078623|3880308|P13|Treatment Period 4|Adverse Event|0
1181190|NCT01078623|3880309|P12|Treatment Period 4|Adverse Event|0
1181191|NCT01078623|3880310|P11|Treatment Period 4|Adverse Event|0
1181192|NCT01078623|3880311|P10|Treatment Period 4|Adverse Event|0
1181193|NCT01078623|3880312|P9|Treatment Period 4|Adverse Event|0
1181194|NCT01078623|3880313|P8|Treatment Period 4|Adverse Event|0
1181195|NCT01078623|3880314|P7|Treatment Period 4|Adverse Event|0
1181196|NCT01078623|3880315|P6|Treatment Period 4|Adverse Event|0
1181197|NCT01078623|3880316|P5|Treatment Period 4|Adverse Event|0
1181198|NCT01078623|3880317|P4|Treatment Period 4|Adverse Event|0
1181199|NCT01078623|3880318|P3|Treatment Period 4|Adverse Event|1
1181200|NCT01078623|3880319|P2|Treatment Period 4|Adverse Event|0
1181201|NCT01078623|3880320|P1|Treatment Period 4|Adverse Event|0
1181202|NCT01078623|3880301|P20|Treatment Period 3|Adverse Event|0
1181203|NCT01078623|3880302|P19|Treatment Period 3|Adverse Event|0
1181204|NCT01078623|3880303|P18|Treatment Period 3|Adverse Event|0
1181205|NCT01078623|3880304|P17|Treatment Period 3|Adverse Event|0
1181206|NCT01078623|3880305|P16|Treatment Period 3|Adverse Event|0
1181207|NCT01078623|3880306|P15|Treatment Period 3|Adverse Event|0
1181208|NCT01078623|3880307|P14|Treatment Period 3|Adverse Event|1
1181209|NCT01078623|3880308|P13|Treatment Period 3|Adverse Event|0
1181210|NCT01078623|3880309|P12|Treatment Period 3|Adverse Event|0
1181211|NCT01078623|3880310|P11|Treatment Period 3|Adverse Event|0
1181212|NCT01078623|3880311|P10|Treatment Period 3|Adverse Event|0
1181213|NCT01078623|3880312|P9|Treatment Period 3|Adverse Event|0
1181214|NCT01078623|3880313|P8|Treatment Period 3|Adverse Event|0
1181215|NCT01078623|3880314|P7|Treatment Period 3|Adverse Event|0
1181216|NCT01078623|3880315|P6|Treatment Period 3|Adverse Event|0
1181217|NCT01078623|3880316|P5|Treatment Period 3|Adverse Event|1
1181218|NCT01078623|3880317|P4|Treatment Period 3|Adverse Event|0
1181219|NCT01078623|3880318|P3|Treatment Period 3|Adverse Event|0
1181220|NCT01078623|3880319|P2|Treatment Period 3|Adverse Event|0
1181221|NCT01078623|3880320|P1|Treatment Period 3|Adverse Event|0
1181222|NCT01078623|3880301|P20|Treatment Period 2|Withdrawal by Subject|0
1181223|NCT01078623|3880302|P19|Treatment Period 2|Withdrawal by Subject|0
1181224|NCT01078623|3880303|P18|Treatment Period 2|Withdrawal by Subject|0
1181225|NCT01078623|3880304|P17|Treatment Period 2|Withdrawal by Subject|0
1181226|NCT01078623|3880305|P16|Treatment Period 2|Withdrawal by Subject|0
1181227|NCT01078623|3880306|P15|Treatment Period 2|Withdrawal by Subject|0
1181228|NCT01078623|3880307|P14|Treatment Period 2|Withdrawal by Subject|0
1181229|NCT01078623|3880308|P13|Treatment Period 2|Withdrawal by Subject|0
1181230|NCT01078623|3880309|P12|Treatment Period 2|Withdrawal by Subject|0
1181231|NCT01078623|3880310|P11|Treatment Period 2|Withdrawal by Subject|0
1181232|NCT01078623|3880311|P10|Treatment Period 2|Withdrawal by Subject|0
1181233|NCT01078623|3880312|P9|Treatment Period 2|Withdrawal by Subject|0
1181234|NCT01078623|3880313|P8|Treatment Period 2|Withdrawal by Subject|0
1181235|NCT01078623|3880314|P7|Treatment Period 2|Withdrawal by Subject|0
1181236|NCT01078623|3880315|P6|Treatment Period 2|Withdrawal by Subject|1
1181237|NCT01078623|3880316|P5|Treatment Period 2|Withdrawal by Subject|0
1181238|NCT01078623|3880317|P4|Treatment Period 2|Withdrawal by Subject|0
1181239|NCT01078623|3880318|P3|Treatment Period 2|Withdrawal by Subject|0
1181240|NCT01078623|3880319|P2|Treatment Period 2|Withdrawal by Subject|0
1181241|NCT01078623|3880320|P1|Treatment Period 2|Withdrawal by Subject|0
1181242|NCT01078623|3880301|P20|Treatment Period 2|Adverse Event|0
1181243|NCT01078623|3880302|P19|Treatment Period 2|Adverse Event|1
1181244|NCT01078623|3880303|P18|Treatment Period 2|Adverse Event|0
1181245|NCT01078623|3880304|P17|Treatment Period 2|Adverse Event|0
1181246|NCT01078623|3880305|P16|Treatment Period 2|Adverse Event|0
1181247|NCT01078623|3880306|P15|Treatment Period 2|Adverse Event|0
1181248|NCT01078623|3880307|P14|Treatment Period 2|Adverse Event|0
1181249|NCT01078623|3880308|P13|Treatment Period 2|Adverse Event|0
1181250|NCT01078623|3880309|P12|Treatment Period 2|Adverse Event|0
1181251|NCT01078623|3880310|P11|Treatment Period 2|Adverse Event|0
1181252|NCT01078623|3880311|P10|Treatment Period 2|Adverse Event|0
1181253|NCT01078623|3880312|P9|Treatment Period 2|Adverse Event|0
1181254|NCT01078623|3880313|P8|Treatment Period 2|Adverse Event|0
1181255|NCT01078623|3880314|P7|Treatment Period 2|Adverse Event|1
1181256|NCT01078623|3880315|P6|Treatment Period 2|Adverse Event|0
1181257|NCT01078623|3880316|P5|Treatment Period 2|Adverse Event|0
1181258|NCT01078623|3880317|P4|Treatment Period 2|Adverse Event|0
1181259|NCT01078623|3880318|P3|Treatment Period 2|Adverse Event|0
1181260|NCT01078623|3880319|P2|Treatment Period 2|Adverse Event|0
1181261|NCT01078623|3880320|P1|Treatment Period 2|Adverse Event|0
1181262|NCT01078623|3880301|P20|Treatment Period 1|Protocol Violation|0
1181263|NCT01078623|3880302|P19|Treatment Period 1|Protocol Violation|0
1181264|NCT01078623|3880303|P18|Treatment Period 1|Protocol Violation|0
1181265|NCT01078623|3880304|P17|Treatment Period 1|Protocol Violation|0
1181266|NCT01078623|3880305|P16|Treatment Period 1|Protocol Violation|0
1181267|NCT01078623|3880306|P15|Treatment Period 1|Protocol Violation|0
1181268|NCT01078623|3880307|P14|Treatment Period 1|Protocol Violation|0
1181269|NCT01078623|3880308|P13|Treatment Period 1|Protocol Violation|0
1181270|NCT01078623|3880309|P12|Treatment Period 1|Protocol Violation|0
1181271|NCT01078623|3880310|P11|Treatment Period 1|Protocol Violation|0
1181272|NCT01078623|3880311|P10|Treatment Period 1|Protocol Violation|0
1181273|NCT01078623|3880312|P9|Treatment Period 1|Protocol Violation|0
1181274|NCT01078623|3880313|P8|Treatment Period 1|Protocol Violation|0
1181275|NCT01078623|3880314|P7|Treatment Period 1|Protocol Violation|0
1181276|NCT01078623|3880315|P6|Treatment Period 1|Protocol Violation|1
1181277|NCT01078623|3880316|P5|Treatment Period 1|Protocol Violation|0
1181278|NCT01078623|3880317|P4|Treatment Period 1|Protocol Violation|0
1181279|NCT01078623|3880318|P3|Treatment Period 1|Protocol Violation|0
1181280|NCT01078623|3880319|P2|Treatment Period 1|Protocol Violation|0
1181281|NCT01078623|3880320|P1|Treatment Period 1|Protocol Violation|0
1181282|NCT01078623|3880301|P20|Treatment Period 1|Withdrawal by Subject|0
1181283|NCT01078623|3880302|P19|Treatment Period 1|Withdrawal by Subject|0
1181284|NCT01078623|3880303|P18|Treatment Period 1|Withdrawal by Subject|0
1181285|NCT01078623|3880304|P17|Treatment Period 1|Withdrawal by Subject|0
1181286|NCT01078623|3880305|P16|Treatment Period 1|Withdrawal by Subject|0
1181287|NCT01078623|3880306|P15|Treatment Period 1|Withdrawal by Subject|0
1181288|NCT01078623|3880307|P14|Treatment Period 1|Withdrawal by Subject|0
1181289|NCT01078623|3880308|P13|Treatment Period 1|Withdrawal by Subject|0
1181290|NCT01078623|3880309|P12|Treatment Period 1|Withdrawal by Subject|0
1181291|NCT01078623|3880310|P11|Treatment Period 1|Withdrawal by Subject|1
1181292|NCT01078623|3880311|P10|Treatment Period 1|Withdrawal by Subject|0
1181293|NCT01078623|3880312|P9|Treatment Period 1|Withdrawal by Subject|0
1181294|NCT01078623|3880313|P8|Treatment Period 1|Withdrawal by Subject|1
1181295|NCT01078623|3880314|P7|Treatment Period 1|Withdrawal by Subject|0
1181296|NCT01078623|3880315|P6|Treatment Period 1|Withdrawal by Subject|0
1181297|NCT01078623|3880316|P5|Treatment Period 1|Withdrawal by Subject|0
1181298|NCT01078623|3880317|P4|Treatment Period 1|Withdrawal by Subject|0
1181299|NCT01078623|3880318|P3|Treatment Period 1|Withdrawal by Subject|0
1181300|NCT01078623|3880319|P2|Treatment Period 1|Withdrawal by Subject|0
1181301|NCT01078623|3880320|P1|Treatment Period 1|Withdrawal by Subject|0
1181302|NCT01078623|3880301|P20|Treatment Period 1|Adverse Event|0
1181303|NCT01078623|3880302|P19|Treatment Period 1|Adverse Event|0
1181304|NCT01078623|3880303|P18|Treatment Period 1|Adverse Event|0
1181305|NCT01078623|3880304|P17|Treatment Period 1|Adverse Event|0
1181306|NCT01078623|3880305|P16|Treatment Period 1|Adverse Event|0
1181307|NCT01078623|3880306|P15|Treatment Period 1|Adverse Event|0
1181308|NCT01078623|3880307|P14|Treatment Period 1|Adverse Event|0
1181309|NCT01078623|3880308|P13|Treatment Period 1|Adverse Event|0
1181310|NCT01078623|3880309|P12|Treatment Period 1|Adverse Event|0
1181311|NCT01078623|3880310|P11|Treatment Period 1|Adverse Event|0
1181312|NCT01078623|3880311|P10|Treatment Period 1|Adverse Event|1
1181313|NCT01078623|3880312|P9|Treatment Period 1|Adverse Event|1
1181314|NCT01078623|3880313|P8|Treatment Period 1|Adverse Event|0
1181315|NCT01078623|3880314|P7|Treatment Period 1|Adverse Event|1
1181316|NCT01078623|3880315|P6|Treatment Period 1|Adverse Event|0
1181317|NCT01078623|3880316|P5|Treatment Period 1|Adverse Event|0
1181318|NCT01078623|3880317|P4|Treatment Period 1|Adverse Event|0
1181319|NCT01078623|3880318|P3|Treatment Period 1|Adverse Event|1
1181320|NCT01078623|3880319|P2|Treatment Period 1|Adverse Event|1
1181321|NCT01078623|3880320|P1|Treatment Period 1|Adverse Event|1
1181322|NCT01078584|3880342|P1|Overall Study|Multiple Reasons|2
1181323|NCT01078584|3880342|P1|Overall Study|Serious Adverse Event|27
1181324|NCT01078584|3880342|P1|Overall Study|Protocol Violation|75
1181325|NCT01078584|3880342|P1|Overall Study|Lack of Efficacy|98
1181326|NCT01078584|3880342|P1|Overall Study|Physician Discontinued Patient|12
1181327|NCT01078584|3880342|P1|Overall Study|Physician Switched Medication|26
1181328|NCT01078584|3880342|P1|Overall Study|Blood Pressure Controlled|49
1181329|NCT01078584|3880342|P1|Overall Study|Non-compliance|67
1181330|NCT01078584|3880342|P1|Overall Study|Physician Withdrew from Study|90
1181331|NCT01078584|3880342|P1|Overall Study|Withdrawal of Consent|244
1181332|NCT01078584|3880342|P1|Overall Study|Non-serious Adverse Event|577
1181333|NCT01078584|3880342|P1|Overall Study|Lost to Follow-up|670
1181334|NCT01078584|3880342|P1|Overall Study|Final Status Unknown|1073
1181335|NCT01078571|3880423|P1|Overall Study|Protocol Violation|2
1181336|NCT01078571|3880423|P1|Overall Study|Lost to Follow-up|8
1181337|NCT01078571|3880423|P1|Overall Study|Withdrawal by Subject|12
1181338|NCT01078571|3880423|P1|Overall Study|Reason not reported|21
1181339|NCT01078571|3880423|P1|Overall Study|Lack of effectiveness|36
1181340|NCT01078571|3880423|P1|Overall Study|Adverse Event|36
1181341|NCT01078545|3880439|P1|Overall Study|Participant moved to another physician|1
1181342|NCT01078545|3880439|P1|Overall Study|Death|3
1181343|NCT01078545|3880439|P1|Overall Study|Withdrawal by Subject|3
1181344|NCT01078545|3880439|P1|Overall Study|Physician Decision|6
1181345|NCT01078545|3880439|P1|Overall Study|Lost to Follow-up|13
1181346|NCT01078454|3880449|P2|Overall Study|Death|1
1181347|NCT01078454|3880450|P1|Overall Study|Death|0
1181348|NCT01078454|3880449|P2|Overall Study|Adverse Event|1
1181349|NCT01078454|3880450|P1|Overall Study|Adverse Event|1
1181350|NCT01078441|3880456|P1|Overall Study|Withdrawal by Subject|1
1181351|NCT01078389|3880496|P2|Overall Study|Other|2
1181352|NCT01078389|3880497|P1|Overall Study|Other|9
1181353|NCT01078389|3880496|P2|Overall Study|Voluntary Withdrawal|36
1181354|NCT01078389|3880497|P1|Overall Study|Voluntary Withdrawal|20
1181355|NCT01078389|3880496|P2|Overall Study|Lost to Follow-up|23
1181356|NCT01078389|3880497|P1|Overall Study|Lost to Follow-up|23
1181357|NCT01078389|3880496|P2|Overall Study|Major Protocol Deviation|0
1181358|NCT01078389|3880497|P1|Overall Study|Major Protocol Deviation|2
1181359|NCT01078389|3880496|P2|Overall Study|Adverse Event|6
1181360|NCT01078389|3880497|P1|Overall Study|Adverse Event|10
1181361|NCT01078298|3880658|P2|Overall Study|Other|32
1181362|NCT01078298|3880659|P1|Overall Study|Other|24
1181363|NCT01078298|3880658|P2|Overall Study|Did not meet entrance criteria|1
1181364|NCT01078298|3880659|P1|Overall Study|Did not meet entrance criteria|0
1181365|NCT01078298|3880658|P2|Overall Study|Death|0
1181366|NCT01078298|3880659|P1|Overall Study|Death|2
1181367|NCT01078298|3880658|P2|Overall Study|Adverse Event|5
1181368|NCT01078298|3880659|P1|Overall Study|Adverse Event|6
1181369|NCT01078298|3880658|P2|Overall Study|Protocol Violation|6
1181370|NCT01078298|3880659|P1|Overall Study|Protocol Violation|6
1181371|NCT01078298|3880658|P2|Overall Study|Withdrawal by Subject|33
1181372|NCT01078298|3880659|P1|Overall Study|Withdrawal by Subject|31
1181373|NCT01078298|3880658|P2|Overall Study|Lost to Follow-up|13
1181374|NCT01078298|3880659|P1|Overall Study|Lost to Follow-up|12
1181375|NCT01078168|3880769|P2|Overall Study|Physician Decision|1
1181376|NCT01078168|3880770|P1|Overall Study|Physician Decision|0
1181377|NCT01078155|3880776|P1|Overall Study|Lost to Follow-up|15
1181378|NCT01078155|3880776|P1|Overall Study|Participant's Decision|6
1181379|NCT01078155|3880776|P1|Overall Study|Lack of Efficacy|16
1181380|NCT01078155|3880776|P1|Overall Study|Adverse Event|7
1181381|NCT01078116|3880792|P1|Overall Study|Case report form not completed|3
1181382|NCT01078116|3880792|P1|Overall Study|Lack of effectiveness|15
1181383|NCT01078116|3880792|P1|Overall Study|Withdrawal by Subject|8
1181384|NCT01078116|3880792|P1|Overall Study|Adverse Event|5
1181385|NCT01078116|3880792|P1|Overall Study|Lost to Follow-up|17
1181386|NCT01078090|3880800|P1|Overall Study|Other|523
1181387|NCT01078090|3880800|P1|Overall Study|ADR and lack of efficacy|61
1181388|NCT01078090|3880800|P1|Overall Study|Lack of Efficacy|1193
1181389|NCT01078090|3880800|P1|Overall Study|Adverse drug reaction (ADR)|453
1181390|NCT01078090|3880800|P1|Overall Study|Lost to Follow-up|2363
1181391|NCT01077960|3880894|P1|Overall Study|Reason unspecified|1
1181392|NCT01077960|3880894|P1|Overall Study|Subject decision|1
1181393|NCT01077960|3880894|P1|Overall Study|Lost to Follow-up|5
1181394|NCT01077960|3880894|P1|Overall Study|Protocol Violation|3
1181395|NCT01077960|3880894|P1|Overall Study|Adverse Event|6
1181396|NCT01077804|3881144|P1|Overall Study|Other|18
1181397|NCT01077804|3881144|P1|Overall Study|Refused to continue|79
1181398|NCT01077804|3881144|P1|Overall Study|Unreachable|102
1181399|NCT01077739|3881153|P2|Overall Study|Not specified|2
1181400|NCT01077739|3881154|P1|Overall Study|Not specified|2
1181401|NCT01077739|3881153|P2|Overall Study|Unacceptable toxicity|2
1181402|NCT01077739|3881154|P1|Overall Study|Unacceptable toxicity|1
1181403|NCT01077739|3881153|P2|Overall Study|Death|3
1181404|NCT01077739|3881154|P1|Overall Study|Death|0
1181405|NCT01077739|3881153|P2|Overall Study|Withdrawal by Subject|0
1181406|NCT01077739|3881154|P1|Overall Study|Withdrawal by Subject|1
1181407|NCT01077739|3881153|P2|Overall Study|Premature withdrawal|3
1181408|NCT01077739|3881154|P1|Overall Study|Premature withdrawal|1
1181409|NCT01077713|3881168|P2|Overall Study|Other|2
1181410|NCT01077713|3881169|P1|Overall Study|Other|4
1181411|NCT01077713|3881168|P2|Overall Study|Adverse Event|1
1181412|NCT01077713|3881169|P1|Overall Study|Adverse Event|2
1181413|NCT01077713|3881168|P2|Overall Study|Lost to Follow-up|1
1181414|NCT01077713|3881169|P1|Overall Study|Lost to Follow-up|1
1181415|NCT01077713|3881168|P2|Overall Study|Death|29
1181416|NCT01077713|3881169|P1|Overall Study|Death|28
1181417|NCT01077713|3881168|P2|Overall Study|Progressive Disease (PD)|1
1181418|NCT01077713|3881169|P1|Overall Study|Progressive Disease (PD)|0
1181419|NCT01077713|3881168|P2|Overall Study|Withdrawal by Subject|2
1181420|NCT01077713|3881169|P1|Overall Study|Withdrawal by Subject|1
1181421|NCT01077622|3881193|P1|Overall Study|Withdrawal by Subject|1
1181422|NCT01077622|3881193|P1|Overall Study|Physician Decision|2
1181423|NCT01077544|3881313|P2|Overall Study|Disease Progression|1
1181424|NCT01077544|3881314|P1|Overall Study|Disease Progression|0
1181425|NCT01077544|3881313|P2|Overall Study|Adverse Event|1
1181426|NCT01077544|3881314|P1|Overall Study|Adverse Event|0
1181427|NCT01077544|3881313|P2|Overall Study|New Cancer Therapy|3
1181428|NCT01077544|3881314|P1|Overall Study|New Cancer Therapy|3
1181429|NCT01077375|3881355|P2|Overall Study|Other Reason|1
1181430|NCT01077375|3881356|P1|Overall Study|Other Reason|0
1181431|NCT01077375|3881355|P2|Overall Study|Lost to Follow-up|5
1181432|NCT01077375|3881356|P1|Overall Study|Lost to Follow-up|2
1181433|NCT01077375|3881355|P2|Overall Study|Withdrawal by Subject|6
1181434|NCT01077375|3881356|P1|Overall Study|Withdrawal by Subject|0
1181435|NCT01077375|3881355|P2|Overall Study|Lack of Efficacy|8
1181436|NCT01077375|3881356|P1|Overall Study|Lack of Efficacy|6
1181437|NCT01077375|3881355|P2|Overall Study|Adverse Event|15
1181438|NCT01077375|3881356|P1|Overall Study|Adverse Event|2
1181439|NCT01077362|3881367|P3|Overall Study|Not Specified|2
1181440|NCT01077362|3881368|P2|Overall Study|Not Specified|1
1181441|NCT01077362|3881369|P1|Overall Study|Not Specified|0
1181442|NCT01077362|3881367|P3|Overall Study|Withdrawal by Subject|5
1181443|NCT01077362|3881368|P2|Overall Study|Withdrawal by Subject|3
1181444|NCT01077362|3881369|P1|Overall Study|Withdrawal by Subject|5
1181445|NCT01077362|3881367|P3|Overall Study|Adverse Event|4
1181446|NCT01077362|3881368|P2|Overall Study|Adverse Event|7
1181447|NCT01077362|3881369|P1|Overall Study|Adverse Event|12
1181448|NCT01077362|3881367|P3|Overall Study|Lost to Follow-up|3
1181449|NCT01077362|3881368|P2|Overall Study|Lost to Follow-up|0
1181450|NCT01077362|3881369|P1|Overall Study|Lost to Follow-up|1
1181451|NCT01077362|3881367|P3|Overall Study|Lack of Efficacy|10
1181452|NCT01077362|3881368|P2|Overall Study|Lack of Efficacy|8
1181453|NCT01077362|3881369|P1|Overall Study|Lack of Efficacy|13
1181454|NCT01077323|3881405|P3|Overall Study|Baseline diagnosis of pancreatic disease|120
1181455|NCT01077323|3881406|P2|Overall Study|Baseline diagnosis of pancreatic disease|2080
1181456|NCT01077323|3881407|P1|Overall Study|Baseline diagnosis of pancreatic disease|152
1181457|NCT01077323|3881405|P3|Overall Study|Dispensing of drug in baseline period|256446
1181458|NCT01077323|3881406|P2|Overall Study|Dispensing of drug in baseline period|120229
1181459|NCT01077323|3881407|P1|Overall Study|Dispensing of drug in baseline period|0
1181460|NCT01077323|3881405|P3|Overall Study|<9 months enroll before drug dispensed|11655523
1181461|NCT01077323|3881406|P2|Overall Study|<9 months enroll before drug dispensed|263954
1181462|NCT01077323|3881407|P1|Overall Study|<9 months enroll before drug dispensed|11226
1181463|NCT01077284|3881450|P3|Overall Study|Other|1
1181464|NCT01077284|3881451|P2|Overall Study|Other|0
1181465|NCT01077284|3881452|P1|Overall Study|Other|0
1181466|NCT01077284|3881450|P3|Overall Study|Withdrawal by Subject|1
1181467|NCT01077284|3881451|P2|Overall Study|Withdrawal by Subject|3
1181468|NCT01077284|3881452|P1|Overall Study|Withdrawal by Subject|2
1181469|NCT01077284|3881450|P3|Overall Study|Lost to Follow-up|0
1181470|NCT01077284|3881451|P2|Overall Study|Lost to Follow-up|2
1181471|NCT01077284|3881452|P1|Overall Study|Lost to Follow-up|1
1181472|NCT01077284|3881450|P3|Overall Study|Adverse Event|1
1181473|NCT01077284|3881451|P2|Overall Study|Adverse Event|0
1181474|NCT01077284|3881452|P1|Overall Study|Adverse Event|2
1181475|NCT01077271|3881473|P1|Overall Study|Mother unconvinced of the necessity|1
1181476|NCT01077271|3881473|P1|Overall Study|End of RSV season nearly reached|1
1181477|NCT01077271|3881473|P1|Overall Study|Parents thought too many injections|2
1181478|NCT01077271|3881473|P1|Overall Study|Changed doctors|2
1181479|NCT01077271|3881473|P1|Overall Study|Quota used up (insurance reimb issue)|2
1181480|NCT01077271|3881473|P1|Overall Study|Noncompliance|2
1181481|NCT01077271|3881473|P1|Overall Study|Screen failure, did not take palivizumab|4
1181482|NCT01077271|3881473|P1|Overall Study|Parental desire|8
1181483|NCT01077258|3881511|P1|Overall Study|Other reasons|260
1181484|NCT01077258|3881511|P1|Overall Study|Clinical remission|37
1181485|NCT01077258|3881511|P1|Overall Study|Lack of Efficacy|663
1181486|NCT01077258|3881511|P1|Overall Study|Adverse drug reaction|218
1181487|NCT01077258|3881511|P1|Overall Study|Lost to Follow-up|1390
1181488|NCT01077193|3881547|P1|Overall Study|Study Terminated by Sponsor|40
1181489|NCT01077193|3881547|P1|Overall Study|Lack of Efficacy|1
1181490|NCT01077193|3881547|P1|Overall Study|Withdrawal by Subject|2
1181491|NCT01077193|3881547|P1|Overall Study|Lost to Follow-up|1
1181492|NCT01077154|3881553|P2|Overall Study|Protocol Deviation|0
1181493|NCT01077154|3881554|P1|Overall Study|Protocol Deviation|1
1181494|NCT01077154|3881553|P2|Overall Study|Administrative Decision|6
1181495|NCT01077154|3881554|P1|Overall Study|Administrative Decision|1
1181496|NCT01077154|3881553|P2|Overall Study|Adverse Event|8
1181497|NCT01077154|3881554|P1|Overall Study|Adverse Event|8
1181498|NCT01077154|3881553|P2|Overall Study|Other|11
1181499|NCT01077154|3881554|P1|Overall Study|Other|13
1181500|NCT01077154|3881553|P2|Overall Study|Ineligibility Determined|14
1181501|NCT01077154|3881554|P1|Overall Study|Ineligibility Determined|10
1181502|NCT01077154|3881553|P2|Overall Study|Disease Progression|20
1181503|NCT01077154|3881554|P1|Overall Study|Disease Progression|17
1181504|NCT01077154|3881553|P2|Overall Study|Noncompliance|20
1181505|NCT01077154|3881554|P1|Overall Study|Noncompliance|22
1181506|NCT01077154|3881553|P2|Overall Study|Lost to Follow-up|32
1181507|NCT01077154|3881554|P1|Overall Study|Lost to Follow-up|39
1181508|NCT01077154|3881553|P2|Overall Study|Death|207
1181509|NCT01077154|3881554|P1|Overall Study|Death|204
1181510|NCT01077154|3881553|P2|Overall Study|Withdrawal by Subject|368
1181511|NCT01077154|3881554|P1|Overall Study|Withdrawal by Subject|355
1181512|NCT01077154|3881553|P2|Overall Study|On-study as of Analysis Cutoff Date|1555
1181513|NCT01077154|3881554|P1|Overall Study|On-study as of Analysis Cutoff Date|1571
1181514|NCT01077128|3881568|P1|Overall Study|Not available|54
1181515|NCT01077128|3881568|P1|Overall Study|Lack of efficacy/disease exacerbation|1
1181516|NCT01077128|3881568|P1|Overall Study|Adverse event and disease exacerbation|1
1181517|NCT01077128|3881568|P1|Overall Study|Adverse event and consent withdrawal|1
1181518|NCT01077128|3881568|P1|Overall Study|Disease exacerbation|1
1181519|NCT01077128|3881568|P1|Overall Study|Lack of Efficacy|1
1181520|NCT01077128|3881568|P1|Overall Study|Adverse Event|8
1181521|NCT01077076|3881626|P6|Third Intervention|Death in the participant's family|1
1181522|NCT01077076|3881627|P5|Third Intervention|Death in the participant's family|0
1181523|NCT01077076|3881628|P4|Third Intervention|Death in the participant's family|0
1181524|NCT01077076|3881629|P3|Third Intervention|Death in the participant's family|0
1181525|NCT01077076|3881630|P2|Third Intervention|Death in the participant's family|0
1181526|NCT01077076|3881631|P1|Third Intervention|Death in the participant's family|0
1181527|NCT01077076|3881626|P6|First Intervention|Withdrawal by Subject|0
1181528|NCT01077076|3881627|P5|First Intervention|Withdrawal by Subject|0
1181529|NCT01077076|3881628|P4|First Intervention|Withdrawal by Subject|0
1181530|NCT01077076|3881629|P3|First Intervention|Withdrawal by Subject|0
1181531|NCT01077076|3881630|P2|First Intervention|Withdrawal by Subject|0
1181532|NCT01077076|3881631|P1|First Intervention|Withdrawal by Subject|1
1181533|NCT01077063|3881641|P2|Overall Study|Withdrawal by Subject|2
1181534|NCT01077063|3881642|P1|Overall Study|Withdrawal by Subject|0
1181535|NCT01077063|3881641|P2|Overall Study|Death|1
1181536|NCT01077063|3881642|P1|Overall Study|Death|1
1181537|NCT01077063|3881641|P2|Overall Study|Adverse Event|0
1181538|NCT01077063|3881642|P1|Overall Study|Adverse Event|3
1181539|NCT01077050|3881648|P1|Overall Study|Screen failure|8
1181540|NCT01077050|3881648|P1|Overall Study|Subjects signed ICF could not be located|1
1181541|NCT01077024|3881654|P2|Overall Study|Other|4
1181542|NCT01077024|3881655|P1|Overall Study|Other|4
1181543|NCT01077024|3881654|P2|Overall Study|Incarcerated|8
1181544|NCT01077024|3881655|P1|Overall Study|Incarcerated|7
1181545|NCT01077024|3881654|P2|Overall Study|Withdrawal by Subject|2
1181546|NCT01077024|3881655|P1|Overall Study|Withdrawal by Subject|0
1181547|NCT01077024|3881654|P2|Overall Study|Lost to Follow-up|14
1181548|NCT01077024|3881655|P1|Overall Study|Lost to Follow-up|20
1181549|NCT01076959|3881694|P1|Overall Study|Other|119
1181550|NCT01076959|3881694|P1|Overall Study|Lost to Follow-up|241
1181551|NCT01076959|3881694|P1|Overall Study|Non-compliance|274
1181552|NCT01076959|3881694|P1|Overall Study|Lack of Efficacy|849
1181553|NCT01076959|3881694|P1|Overall Study|Adverse Event|767
1181554|NCT01076647|3881730|P2|Overall Study|Unclassified|12
1181555|NCT01076647|3881731|P1|Overall Study|Unclassified|12
1181556|NCT01076647|3881730|P2|Overall Study|Withdrawal criteria|2
1181557|NCT01076647|3881731|P1|Overall Study|Withdrawal criteria|2
1181558|NCT01076647|3881730|P2|Overall Study|Protocol Violation|9
1181559|NCT01076647|3881731|P1|Overall Study|Protocol Violation|7
1181560|NCT01076647|3881730|P2|Overall Study|Lack of Efficacy|1
1181561|NCT01076647|3881731|P1|Overall Study|Lack of Efficacy|0
1181562|NCT01076647|3881730|P2|Overall Study|Adverse Event|1
1181563|NCT01076647|3881731|P1|Overall Study|Adverse Event|4
1181564|NCT01076400|3881762|P3|Overall Study|Progressive Disease|0
1181565|NCT01076400|3881763|P2|Overall Study|Progressive Disease|0
1181566|NCT01076400|3881764|P1|Overall Study|Progressive Disease|5
1181567|NCT01076400|3881762|P3|Overall Study|Adverse Event|0
1181568|NCT01076400|3881763|P2|Overall Study|Adverse Event|0
1181569|NCT01076400|3881764|P1|Overall Study|Adverse Event|2
1181570|NCT01076361|3881770|P1|Overall Study|22 leads were excluded from analysis|21
1181571|NCT01076335|3881778|P1|Overall Study|Withdrawal without treatment|1
1181572|NCT01076335|3881778|P1|Overall Study|Withdrawal by Subject|3
1181573|NCT01076192|3881830|P1|Overall Study|Not specified|197
1181574|NCT01076179|3881845|P1|Overall Study|Withdrawal by Subject|1
1181575|NCT01076166|3881868|P1|Overall Study|Symptoms improved/resolved|6
1181576|NCT01076166|3881868|P1|Overall Study|Adverse Event|3
1181577|NCT01076153|3881875|P1|Overall Study|Adverse Event|1
1181578|NCT01076153|3881875|P1|Overall Study|Symptoms improved/resolved|10
1181579|NCT01076088|3881889|P6|Overall Study|Other protocol specified criteria|1
1181580|NCT01076088|3881890|P5|Overall Study|Other protocol specified criteria|0
1181581|NCT01076088|3881891|P4|Overall Study|Other protocol specified criteria|0
1181582|NCT01076088|3881892|P3|Overall Study|Other protocol specified criteria|0
1181583|NCT01076088|3881893|P2|Overall Study|Other protocol specified criteria|0
1181584|NCT01076088|3881894|P1|Overall Study|Other protocol specified criteria|0
1181585|NCT01076088|3881889|P6|Overall Study|Withdrawal by Subject|17
1181586|NCT01076088|3881890|P5|Overall Study|Withdrawal by Subject|11
1181587|NCT01076088|3881891|P4|Overall Study|Withdrawal by Subject|10
1181588|NCT01076088|3881892|P3|Overall Study|Withdrawal by Subject|14
1181589|NCT01076088|3881893|P2|Overall Study|Withdrawal by Subject|8
1181590|NCT01076088|3881894|P1|Overall Study|Withdrawal by Subject|8
1181591|NCT01076088|3881889|P6|Overall Study|Physician Decision|0
1181592|NCT01076088|3881890|P5|Overall Study|Physician Decision|1
1181593|NCT01076088|3881891|P4|Overall Study|Physician Decision|1
1181594|NCT01076088|3881892|P3|Overall Study|Physician Decision|0
1181595|NCT01076088|3881893|P2|Overall Study|Physician Decision|3
1181596|NCT01076088|3881894|P1|Overall Study|Physician Decision|1
1181597|NCT01076088|3881889|P6|Overall Study|Non-compliance with study drug|0
1181598|NCT01076088|3881890|P5|Overall Study|Non-compliance with study drug|0
1181599|NCT01076088|3881891|P4|Overall Study|Non-compliance with study drug|1
1181600|NCT01076088|3881892|P3|Overall Study|Non-compliance with study drug|0
1181601|NCT01076088|3881893|P2|Overall Study|Non-compliance with study drug|0
1181602|NCT01076088|3881894|P1|Overall Study|Non-compliance with study drug|0
1181603|NCT01076088|3881889|P6|Overall Study|Lost to Follow-up|2
1181604|NCT01076088|3881890|P5|Overall Study|Lost to Follow-up|1
1181605|NCT01076088|3881891|P4|Overall Study|Lost to Follow-up|1
1181606|NCT01076088|3881892|P3|Overall Study|Lost to Follow-up|0
1181607|NCT01076088|3881893|P2|Overall Study|Lost to Follow-up|1
1181608|NCT01076088|3881894|P1|Overall Study|Lost to Follow-up|1
1181609|NCT01076088|3881889|P6|Overall Study|Adverse Event|3
1181610|NCT01076088|3881890|P5|Overall Study|Adverse Event|3
1181611|NCT01076088|3881891|P4|Overall Study|Adverse Event|2
1181612|NCT01076088|3881892|P3|Overall Study|Adverse Event|3
1181613|NCT01076088|3881893|P2|Overall Study|Adverse Event|6
1181614|NCT01076088|3881894|P1|Overall Study|Adverse Event|1
1181615|NCT01076075|3881922|P2|Overall Study|Withdrawal by Subject|19
1181616|NCT01076075|3881923|P1|Overall Study|Withdrawal by Subject|8
1181617|NCT01076075|3881922|P2|Overall Study|Protocol Violation|1
1181618|NCT01076075|3881923|P1|Overall Study|Protocol Violation|0
1181619|NCT01076075|3881922|P2|Overall Study|other|9
1181620|NCT01076075|3881923|P1|Overall Study|other|19
1181621|NCT01076075|3881922|P2|Overall Study|Lost to Follow-up|5
1181622|NCT01076075|3881923|P1|Overall Study|Lost to Follow-up|6
1181623|NCT01076075|3881922|P2|Overall Study|Lack of Efficacy|4
1181624|NCT01076075|3881923|P1|Overall Study|Lack of Efficacy|5
1181625|NCT01076075|3881922|P2|Overall Study|Adverse Event|9
1181626|NCT01076075|3881923|P1|Overall Study|Adverse Event|3
1181627|NCT01076036|3881937|P1|Overall Study|Didn't meet inclusion/exclusion criteria|2
1181628|NCT01075984|3881947|P5|Follow-up Phase|Treatment failure|4
1181629|NCT01075984|3881948|P4|Follow-up Phase|Treatment failure|0
1181630|NCT01075984|3881949|P3|Follow-up Phase|Treatment failure|0
1181631|NCT01075984|3881950|P2|Follow-up Phase|Treatment failure|0
1181632|NCT01075984|3881951|P1|Follow-up Phase|Treatment failure|0
1181633|NCT01075984|3881947|P5|Follow-up Phase|Progression of disease|2
1181634|NCT01075984|3881948|P4|Follow-up Phase|Progression of disease|0
1181635|NCT01075984|3881949|P3|Follow-up Phase|Progression of disease|0
1181636|NCT01075984|3881950|P2|Follow-up Phase|Progression of disease|0
1181637|NCT01075984|3881951|P1|Follow-up Phase|Progression of disease|0
1181638|NCT01075984|3881947|P5|Follow-up Phase|Withdrawal by Subject|10
1181639|NCT01075984|3881948|P4|Follow-up Phase|Withdrawal by Subject|0
1181640|NCT01075984|3881949|P3|Follow-up Phase|Withdrawal by Subject|0
1181641|NCT01075984|3881950|P2|Follow-up Phase|Withdrawal by Subject|0
1181642|NCT01075984|3881951|P1|Follow-up Phase|Withdrawal by Subject|0
1181643|NCT01075984|3881947|P5|Follow-up Phase|Administrative|1
1181644|NCT01075984|3881948|P4|Follow-up Phase|Administrative|0
1181645|NCT01075984|3881949|P3|Follow-up Phase|Administrative|0
1181646|NCT01075984|3881950|P2|Follow-up Phase|Administrative|0
1181647|NCT01075984|3881951|P1|Follow-up Phase|Administrative|0
1181648|NCT01075984|3881947|P5|Follow-up Phase|Adverse Event|27
1181649|NCT01075984|3881948|P4|Follow-up Phase|Adverse Event|2
1181650|NCT01075984|3881949|P3|Follow-up Phase|Adverse Event|0
1181651|NCT01075984|3881950|P2|Follow-up Phase|Adverse Event|0
1181652|NCT01075984|3881951|P1|Follow-up Phase|Adverse Event|0
1181653|NCT01075984|3881947|P5|Follow-up Phase|Protocol Violation|3
1181654|NCT01075984|3881948|P4|Follow-up Phase|Protocol Violation|0
1181655|NCT01075984|3881949|P3|Follow-up Phase|Protocol Violation|1
1181656|NCT01075984|3881950|P2|Follow-up Phase|Protocol Violation|0
1181657|NCT01075984|3881951|P1|Follow-up Phase|Protocol Violation|0
1181658|NCT01075984|3881947|P5|Treatment Phase|Progression of disease|2
1181659|NCT01075984|3881948|P4|Treatment Phase|Progression of disease|0
1181660|NCT01075984|3881949|P3|Treatment Phase|Progression of disease|0
1181661|NCT01075984|3881950|P2|Treatment Phase|Progression of disease|0
1181662|NCT01075984|3881951|P1|Treatment Phase|Progression of disease|0
1181663|NCT01075984|3881947|P5|Treatment Phase|Treatment Failure|5
1181664|NCT01075984|3881948|P4|Treatment Phase|Treatment Failure|0
1181665|NCT01075984|3881949|P3|Treatment Phase|Treatment Failure|1
1181666|NCT01075984|3881950|P2|Treatment Phase|Treatment Failure|0
1181667|NCT01075984|3881951|P1|Treatment Phase|Treatment Failure|0
1181668|NCT01075984|3881947|P5|Treatment Phase|Withdrawal by Subject|15
1181669|NCT01075984|3881948|P4|Treatment Phase|Withdrawal by Subject|0
1181670|NCT01075984|3881949|P3|Treatment Phase|Withdrawal by Subject|2
1181671|NCT01075984|3881950|P2|Treatment Phase|Withdrawal by Subject|0
1181672|NCT01075984|3881951|P1|Treatment Phase|Withdrawal by Subject|0
1181673|NCT01075984|3881947|P5|Treatment Phase|Protocol Violation|3
1181674|NCT01075984|3881948|P4|Treatment Phase|Protocol Violation|0
1181675|NCT01075984|3881949|P3|Treatment Phase|Protocol Violation|1
1181676|NCT01075984|3881950|P2|Treatment Phase|Protocol Violation|0
1181677|NCT01075984|3881951|P1|Treatment Phase|Protocol Violation|0
1181678|NCT01075984|3881947|P5|Treatment Phase|Adverse Event|35
1181679|NCT01075984|3881948|P4|Treatment Phase|Adverse Event|7
1181680|NCT01075984|3881949|P3|Treatment Phase|Adverse Event|3
1181681|NCT01075984|3881950|P2|Treatment Phase|Adverse Event|1
1181682|NCT01075984|3881951|P1|Treatment Phase|Adverse Event|0
1181683|NCT01075958|3882009|P1|Overall Study|Blood sample could not be obtained|44
1181684|NCT01075815|3882025|P2|Overall Study|Withdrawal between OPU - embryo transfer|2
1181685|NCT01075815|3882026|P1|Overall Study|Withdrawal between OPU - embryo transfer|3
1181686|NCT01075815|3882025|P2|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
1181687|NCT01075815|3882026|P1|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
1181688|NCT01075815|3882025|P2|Overall Study|Withdrawal before r-hCG administration|1
1181689|NCT01075815|3882026|P1|Overall Study|Withdrawal before r-hCG administration|6
1181690|NCT01075763|3882064|P2|Overall Study|Withdrawal by Subject|2
1181691|NCT01075763|3882065|P1|Overall Study|Withdrawal by Subject|2
1181692|NCT01075763|3882064|P2|Overall Study|Lack of Efficacy|1
1181693|NCT01075763|3882065|P1|Overall Study|Lack of Efficacy|0
1181694|NCT01075763|3882064|P2|Overall Study|Lost to Follow-up|1
1181695|NCT01075763|3882065|P1|Overall Study|Lost to Follow-up|2
1181696|NCT01075685|3882089|P2|Overall Study|Lost to Follow-up|220
1181697|NCT01075685|3882090|P1|Overall Study|Lost to Follow-up|563
1181698|NCT01075685|3882089|P2|Overall Study|Withdrawal by Subject|5
1181699|NCT01075685|3882090|P1|Overall Study|Withdrawal by Subject|20
1181700|NCT01075685|3882089|P2|Overall Study|Protocol Violation|1
1181701|NCT01075685|3882090|P1|Overall Study|Protocol Violation|9
1181702|NCT01075646|3882106|P4|Overall Study|Lost to Follow-up|2
1181703|NCT01075646|3882107|P3|Overall Study|Lost to Follow-up|1
1181704|NCT01075646|3882108|P2|Overall Study|Lost to Follow-up|3
1181705|NCT01075646|3882109|P1|Overall Study|Lost to Follow-up|4
1181706|NCT01075412|3882141|P2|Overall Study|Withdrawal by Subject|1
1181707|NCT01075412|3882142|P1|Overall Study|Withdrawal by Subject|0
1181708|NCT01075282|3882170|P3|Overall Study|Death|2
1181709|NCT01075282|3882171|P2|Overall Study|Death|1
1181710|NCT01075282|3882172|P1|Overall Study|Death|0
1181711|NCT01075282|3882170|P3|Overall Study|Protocol Violation|1
1181712|NCT01075282|3882171|P2|Overall Study|Protocol Violation|2
1181713|NCT01075282|3882172|P1|Overall Study|Protocol Violation|0
1181714|NCT01075282|3882170|P3|Overall Study|Treatment Non-compliance|2
1181715|NCT01075282|3882171|P2|Overall Study|Treatment Non-compliance|2
1181716|NCT01075282|3882172|P1|Overall Study|Treatment Non-compliance|1
1181717|NCT01075282|3882170|P3|Overall Study|Lack of Efficacy|0
1181718|NCT01075282|3882171|P2|Overall Study|Lack of Efficacy|1
1181719|NCT01075282|3882172|P1|Overall Study|Lack of Efficacy|1
1181720|NCT01075282|3882170|P3|Overall Study|Physician Decision|3
1181721|NCT01075282|3882171|P2|Overall Study|Physician Decision|3
1181722|NCT01075282|3882172|P1|Overall Study|Physician Decision|3
1181723|NCT01075282|3882170|P3|Overall Study|Lost to Follow-up|3
1181724|NCT01075282|3882171|P2|Overall Study|Lost to Follow-up|3
1181725|NCT01075282|3882172|P1|Overall Study|Lost to Follow-up|3
1181726|NCT01075282|3882170|P3|Overall Study|Entry Criteria Not Met|0
1181727|NCT01075282|3882171|P2|Overall Study|Entry Criteria Not Met|2
1181728|NCT01075282|3882172|P1|Overall Study|Entry Criteria Not Met|3
1181729|NCT01075282|3882170|P3|Overall Study|Adverse Event|5
1181730|NCT01075282|3882171|P2|Overall Study|Adverse Event|8
1181731|NCT01075282|3882172|P1|Overall Study|Adverse Event|9
1181732|NCT01075282|3882170|P3|Overall Study|Withdrawal by Subject|11
1181733|NCT01075282|3882171|P2|Overall Study|Withdrawal by Subject|7
1181734|NCT01075282|3882172|P1|Overall Study|Withdrawal by Subject|11
1181735|NCT01075256|3882255|P3|Overall Study|Withdrawal by Subject|0
1181736|NCT01075256|3882256|P2|Overall Study|Withdrawal by Subject|0
1181737|NCT01075256|3882257|P1|Overall Study|Withdrawal by Subject|1
1181738|NCT01075243|3882289|P3|Overall Study|Withdrawal by Subject|0
1181739|NCT01075243|3882290|P2|Overall Study|Withdrawal by Subject|1
1181740|NCT01075243|3882291|P1|Overall Study|Withdrawal by Subject|1
1181741|NCT01075243|3882289|P3|Overall Study|Lost to Follow-up|0
1181742|NCT01075243|3882290|P2|Overall Study|Lost to Follow-up|2
1181743|NCT01075243|3882291|P1|Overall Study|Lost to Follow-up|5
1181744|NCT01075217|3882343|P2|Overall Study|Physician Decision|0
1181745|NCT01075217|3882344|P1|Overall Study|Physician Decision|1
1181746|NCT01075217|3882343|P2|Overall Study|Adverse Event|1
1181747|NCT01075217|3882344|P1|Overall Study|Adverse Event|1
1181748|NCT01075191|3882377|P1|Overall Study|Unknown Reasons|1
1181749|NCT01075191|3882377|P1|Overall Study|Patient's Wish|2
1181750|NCT01075191|3882377|P1|Overall Study|Therapy Break|3
1181751|NCT01075191|3882377|P1|Overall Study|Noncompliance|3
1181752|NCT01075191|3882377|P1|Overall Study|Adverse Event|4
1181753|NCT01075191|3882377|P1|Overall Study|Co-morbidities|1
1181754|NCT01075191|3882377|P1|Overall Study|Intensification|3
1181755|NCT01075191|3882377|P1|Overall Study|Death|1
1181756|NCT01075178|3882388|P2|Subject Chart Review|matched partner excluded (reasons above)|3
1181757|NCT01075178|3882389|P1|Subject Chart Review|matched partner excluded (reasons above)|6
1181758|NCT01075178|3882388|P2|Subject Chart Review|no data collected due to site closure|4
1181759|NCT01075178|3882389|P1|Subject Chart Review|no data collected due to site closure|3
1181760|NCT01075178|3882388|P2|Subject Chart Review|died before chart review period|2
1181761|NCT01075178|3882389|P1|Subject Chart Review|died before chart review period|0
1181762|NCT01075178|3882388|P2|Subject Matching|eligible but not matched|403
1181763|NCT01075178|3882389|P1|Subject Matching|eligible but not matched|130
1181764|NCT01075152|3882403|P2|Overall Study|Withdrawal by Subject|0
1181765|NCT01075152|3882404|P1|Overall Study|Withdrawal by Subject|1
1181766|NCT01075100|3882430|P2|Overall Study|Other|1
1181767|NCT01075100|3882431|P1|Overall Study|Other|3
1181768|NCT01075100|3882430|P2|Overall Study|Disease Progression|29
1181769|NCT01075100|3882431|P1|Overall Study|Disease Progression|25
1181770|NCT01075100|3882430|P2|Overall Study|Investigator Request|1
1181771|NCT01075100|3882431|P1|Overall Study|Investigator Request|2
1181772|NCT01075100|3882430|P2|Overall Study|Patient Request|4
1181773|NCT01075100|3882431|P1|Overall Study|Patient Request|4
1181774|NCT01075100|3882430|P2|Overall Study|Adverse Event|18
1181775|NCT01075100|3882431|P1|Overall Study|Adverse Event|15
1181776|NCT01075074|3882461|P3|Overall Study|Surgeon changed to open incisional case|2
1181777|NCT01075074|3882462|P2|Overall Study|Surgeon changed to open incisional case|2
1181778|NCT01075074|3882463|P1|Overall Study|Surgeon changed to open incisional case|1
1181779|NCT01074944|3882480|P5|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3
1181780|NCT01074944|3882481|P4|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
1181781|NCT01074944|3882482|P3|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
1181782|NCT01074944|3882483|P2|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
1181783|NCT01074944|3882484|P1|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
1181784|NCT01074944|3882480|P5|Extended Treatment (up to 42 Months)|Pregnancy|2
1181785|NCT01074944|3882481|P4|Extended Treatment (up to 42 Months)|Pregnancy|0
1181786|NCT01074944|3882482|P3|Extended Treatment (up to 42 Months)|Pregnancy|0
1181787|NCT01074944|3882483|P2|Extended Treatment (up to 42 Months)|Pregnancy|0
1181788|NCT01074944|3882484|P1|Extended Treatment (up to 42 Months)|Pregnancy|0
1181789|NCT01074944|3882480|P5|Long Term Treatment|Withdrawal by Subject|0
1181790|NCT01074944|3882481|P4|Long Term Treatment|Withdrawal by Subject|2
1181791|NCT01074944|3882482|P3|Long Term Treatment|Withdrawal by Subject|0
1181792|NCT01074944|3882483|P2|Long Term Treatment|Withdrawal by Subject|0
1181793|NCT01074944|3882484|P1|Long Term Treatment|Withdrawal by Subject|0
1181794|NCT01074944|3882480|P5|Long Term Treatment|Entered in Period, But Not Treated|0
1181795|NCT01074944|3882481|P4|Long Term Treatment|Entered in Period, But Not Treated|1
1181796|NCT01074944|3882482|P3|Long Term Treatment|Entered in Period, But Not Treated|0
1181797|NCT01074944|3882483|P2|Long Term Treatment|Entered in Period, But Not Treated|0
1181798|NCT01074944|3882484|P1|Long Term Treatment|Entered in Period, But Not Treated|0
1181799|NCT01074944|3882480|P5|Long Term Treatment|Transitioned to Commercial Eliglustat|0
1181800|NCT01074944|3882481|P4|Long Term Treatment|Transitioned to Commercial Eliglustat|18
1181801|NCT01074944|3882482|P3|Long Term Treatment|Transitioned to Commercial Eliglustat|0
1181802|NCT01074944|3882483|P2|Long Term Treatment|Transitioned to Commercial Eliglustat|0
1181803|NCT01074944|3882484|P1|Long Term Treatment|Transitioned to Commercial Eliglustat|0
1181804|NCT01074944|3882480|P5|Long Term Treatment|Lost to Follow-up|0
1181805|NCT01074944|3882481|P4|Long Term Treatment|Lost to Follow-up|2
1181806|NCT01074944|3882482|P3|Long Term Treatment|Lost to Follow-up|0
1181807|NCT01074944|3882483|P2|Long Term Treatment|Lost to Follow-up|0
1181808|NCT01074944|3882484|P1|Long Term Treatment|Lost to Follow-up|0
1181809|NCT01074944|3882480|P5|Long Term Treatment|Adverse Event|0
1181810|NCT01074944|3882481|P4|Long Term Treatment|Adverse Event|3
1181811|NCT01074944|3882482|P3|Long Term Treatment|Adverse Event|0
1181812|NCT01074944|3882483|P2|Long Term Treatment|Adverse Event|0
1181813|NCT01074944|3882484|P1|Long Term Treatment|Adverse Event|0
1181814|NCT01074944|3882480|P5|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
1181815|NCT01074944|3882481|P4|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
1181816|NCT01074944|3882482|P3|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
1181817|NCT01074944|3882483|P2|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
1181818|NCT01074944|3882484|P1|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
1181819|NCT01074944|3882480|P5|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
1181820|NCT01074944|3882481|P4|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
1181821|NCT01074944|3882482|P3|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
1181822|NCT01074944|3882483|P2|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1
1181823|NCT01074944|3882484|P1|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
1181824|NCT01074944|3882480|P5|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
1181825|NCT01074944|3882481|P4|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
1181826|NCT01074944|3882482|P3|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
1181827|NCT01074944|3882483|P2|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
1181828|NCT01074944|3882484|P1|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
1181829|NCT01074944|3882480|P5|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
1181830|NCT01074944|3882481|P4|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
1181831|NCT01074944|3882482|P3|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1
1181832|NCT01074944|3882483|P2|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6
1181833|NCT01074944|3882484|P1|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
1181834|NCT01074944|3882480|P5|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
1181835|NCT01074944|3882481|P4|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
1181836|NCT01074944|3882482|P3|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3
1181837|NCT01074944|3882483|P2|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2
1181838|NCT01074944|3882484|P1|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
1181839|NCT01074944|3882480|P5|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
1181840|NCT01074944|3882481|P4|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
1181841|NCT01074944|3882482|P3|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
1181842|NCT01074944|3882483|P2|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
1181843|NCT01074944|3882484|P1|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6
1181844|NCT01074944|3882480|P5|Lead-in Period (up to 78 Weeks)|Pregnancy|0
1181845|NCT01074944|3882481|P4|Lead-in Period (up to 78 Weeks)|Pregnancy|0
1181846|NCT01074944|3882482|P3|Lead-in Period (up to 78 Weeks)|Pregnancy|0
1181847|NCT01074944|3882483|P2|Lead-in Period (up to 78 Weeks)|Pregnancy|0
1181848|NCT01074944|3882484|P1|Lead-in Period (up to 78 Weeks)|Pregnancy|4
1181849|NCT01074944|3882480|P5|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
1181850|NCT01074944|3882481|P4|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
1181851|NCT01074944|3882482|P3|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
1181852|NCT01074944|3882483|P2|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
1181853|NCT01074944|3882484|P1|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1
1181854|NCT01074944|3882480|P5|Lead-in Period (up to 78 Weeks)|Adverse Event|0
1181855|NCT01074944|3882481|P4|Lead-in Period (up to 78 Weeks)|Adverse Event|0
1181856|NCT01074944|3882482|P3|Lead-in Period (up to 78 Weeks)|Adverse Event|0
1181857|NCT01074944|3882483|P2|Lead-in Period (up to 78 Weeks)|Adverse Event|0
1181858|NCT01074944|3882484|P1|Lead-in Period (up to 78 Weeks)|Adverse Event|2
1181859|NCT01074931|3882538|P1|Overall Study|Death|5
1181860|NCT01074931|3882538|P1|Overall Study|Economic reasons|1
1181861|NCT01074658|3882550|P1|Overall Study|No implant attempted|19
1181862|NCT01074554|3882558|P2|Overall Study|Lost to Follow-up|1
1181863|NCT01074554|3882559|P1|Overall Study|Lost to Follow-up|0
1181864|NCT01074554|3882558|P2|Overall Study|Adverse Event|3
1181865|NCT01074554|3882559|P1|Overall Study|Adverse Event|3
1181866|NCT01074502|3882569|P1|Overall Study|Withdrawal by Subject|1
1181867|NCT01074450|3882593|P2|Second Intervention|Physician Decision|1
1181868|NCT01074450|3882594|P1|Second Intervention|Physician Decision|0
1181869|NCT01074450|3882593|P2|Second Intervention|Protocol Violation|0
1181870|NCT01074450|3882594|P1|Second Intervention|Protocol Violation|1
1181871|NCT01074450|3882593|P2|First Intervention|Emesis in Dosing Interval|2
1181872|NCT01074450|3882594|P1|First Intervention|Emesis in Dosing Interval|0
1181873|NCT01074307|3882623|P2|Overall Study|Protocol Violation|5
1181874|NCT01074307|3882624|P1|Overall Study|Protocol Violation|8
1181875|NCT01074307|3882623|P2|Overall Study|Exclusion criterion|1
1181876|NCT01074307|3882624|P1|Overall Study|Exclusion criterion|0
1181877|NCT01074307|3882623|P2|Overall Study|No primary endpoint evaluation|6
1181878|NCT01074307|3882624|P1|Overall Study|No primary endpoint evaluation|14
1181879|NCT01074268|3882646|P2|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2
1181880|NCT01074268|3882647|P1|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3
1181881|NCT01074268|3882646|P2|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
1181882|NCT01074268|3882647|P1|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
1181883|NCT01074268|3882646|P2|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2
1181884|NCT01074268|3882647|P1|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0
1181885|NCT01074268|3882646|P2|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
1181886|NCT01074268|3882647|P1|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
1181887|NCT01074268|3882646|P2|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5
1181888|NCT01074268|3882647|P1|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8
1181889|NCT01074268|3882646|P2|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3
1181890|NCT01074268|3882647|P1|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6
1181891|NCT01074268|3882646|P2|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4
1181892|NCT01074268|3882647|P1|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3
1181893|NCT01074268|3882646|P2|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2
1181894|NCT01074268|3882647|P1|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0
1181895|NCT01074268|3882646|P2|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1
1181896|NCT01074268|3882647|P1|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3
1181897|NCT01074255|3882673|P1|Overall Study|Did not receive EMEND|2
1181898|NCT01074242|3882677|P1|Overall Study|Duplicate Case Report Form|5
1181899|NCT01074242|3882677|P1|Overall Study|Violation of vaccine dose or dosage|351
1181900|NCT01074242|3882677|P1|Overall Study|Case report unclear|6
1181901|NCT01074242|3882677|P1|Overall Study|Lost to Follow-up|1
1181902|NCT01074242|3882677|P1|Overall Study|Case report before date of contract|40
1181903|NCT01074229|3882685|P3|Overall Study|Change to open surgical procedure|4
1181904|NCT01074229|3882686|P2|Overall Study|Change to open surgical procedure|3
1181905|NCT01074229|3882687|P1|Overall Study|Change to open surgical procedure|1
1181906|NCT01074229|3882685|P3|Overall Study|Lost to Follow-up|0
1181907|NCT01074229|3882686|P2|Overall Study|Lost to Follow-up|0
1181908|NCT01074229|3882687|P1|Overall Study|Lost to Follow-up|1
1181909|NCT01074216|3882698|P1|Overall Study|Not Treated|12
1181910|NCT01074216|3882698|P1|Overall Study|Physician Decision|1
1181911|NCT01074047|3882762|P2|Extension Phase|Death|0
1181912|NCT01074047|3882763|P1|Extension Phase|Death|5
1181913|NCT01074047|3882762|P2|Extension Phase|Withdrawal by Subject|0
1181914|NCT01074047|3882763|P1|Extension Phase|Withdrawal by Subject|2
1181915|NCT01074047|3882762|P2|Extension Phase|Disease Progression|0
1181916|NCT01074047|3882763|P1|Extension Phase|Disease Progression|9
1181917|NCT01074047|3882762|P2|Extension Phase|Adverse Event|0
1181918|NCT01074047|3882763|P1|Extension Phase|Adverse Event|5
1181919|NCT01074047|3882762|P2|Extension Phase|Physician Decision|0
1181920|NCT01074047|3882763|P1|Extension Phase|Physician Decision|1
1181921|NCT01074047|3882762|P2|Survival Follow-Up Phase|Alive at study closure|3
1181922|NCT01074047|3882763|P1|Survival Follow-Up Phase|Alive at study closure|1
1181923|NCT01074047|3882762|P2|Survival Follow-Up Phase|Death|124
1181924|NCT01074047|3882763|P1|Survival Follow-Up Phase|Death|116
1181925|NCT01074047|3882762|P2|Survival Follow-Up Phase|Lost to Follow-up|1
1181926|NCT01074047|3882763|P1|Survival Follow-Up Phase|Lost to Follow-up|2
1181927|NCT01074047|3882762|P2|Survival Follow-Up Phase|Withdrawal by Subject|8
1181928|NCT01074047|3882763|P1|Survival Follow-Up Phase|Withdrawal by Subject|5
1181929|NCT01074047|3882762|P2|Treatment Phase|Miscellaneous|39
1181930|NCT01074047|3882763|P1|Treatment Phase|Miscellaneous|32
1181931|NCT01074047|3882762|P2|Treatment Phase|Protocol Violation|1
1181932|NCT01074047|3882763|P1|Treatment Phase|Protocol Violation|0
1181933|NCT01074047|3882762|P2|Treatment Phase|Lost to Follow-up|1
1181934|NCT01074047|3882763|P1|Treatment Phase|Lost to Follow-up|0
1181935|NCT01074047|3882762|P2|Treatment Phase|Death|58
1181936|NCT01074047|3882763|P1|Treatment Phase|Death|53
1181937|NCT01074047|3882762|P2|Treatment Phase|Withdrawal by Subject|48
1181938|NCT01074047|3882763|P1|Treatment Phase|Withdrawal by Subject|27
1181939|NCT01074047|3882762|P2|Treatment Phase|Disease Progression|21
1181940|NCT01074047|3882763|P1|Treatment Phase|Disease Progression|16
1181941|NCT01074047|3882762|P2|Treatment Phase|Adverse Event|66
1181942|NCT01074047|3882763|P1|Treatment Phase|Adverse Event|89
1181943|NCT01074008|3882851|P9|Overall Study|Lost to Follow-up|4
1181944|NCT01074008|3882852|P8|Overall Study|Lost to Follow-up|0
1181945|NCT01074008|3882853|P7|Overall Study|Lost to Follow-up|1
1181946|NCT01074008|3882854|P6|Overall Study|Lost to Follow-up|0
1181947|NCT01074008|3882855|P5|Overall Study|Lost to Follow-up|1
1181948|NCT01074008|3882856|P4|Overall Study|Lost to Follow-up|1
1181949|NCT01074008|3882857|P3|Overall Study|Lost to Follow-up|1
1181950|NCT01074008|3882858|P2|Overall Study|Lost to Follow-up|1
1181951|NCT01074008|3882859|P1|Overall Study|Lost to Follow-up|0
1181952|NCT01074008|3882851|P9|Overall Study|Withdrawal by Subject|0
1181953|NCT01074008|3882852|P8|Overall Study|Withdrawal by Subject|0
1181954|NCT01074008|3882853|P7|Overall Study|Withdrawal by Subject|0
1181955|NCT01074008|3882854|P6|Overall Study|Withdrawal by Subject|0
1181956|NCT01074008|3882855|P5|Overall Study|Withdrawal by Subject|1
1181957|NCT01074008|3882856|P4|Overall Study|Withdrawal by Subject|0
1181958|NCT01074008|3882857|P3|Overall Study|Withdrawal by Subject|1
1181959|NCT01074008|3882858|P2|Overall Study|Withdrawal by Subject|1
1181960|NCT01074008|3882859|P1|Overall Study|Withdrawal by Subject|1
1181961|NCT01074008|3882851|P9|Overall Study|Adverse Event|0
1181962|NCT01074008|3882852|P8|Overall Study|Adverse Event|0
1181963|NCT01074008|3882853|P7|Overall Study|Adverse Event|0
1181964|NCT01074008|3882854|P6|Overall Study|Adverse Event|0
1181965|NCT01074008|3882855|P5|Overall Study|Adverse Event|0
1181966|NCT01074008|3882856|P4|Overall Study|Adverse Event|0
1181967|NCT01074008|3882857|P3|Overall Study|Adverse Event|0
1181968|NCT01074008|3882858|P2|Overall Study|Adverse Event|1
1181969|NCT01074008|3882859|P1|Overall Study|Adverse Event|0
1181970|NCT01073943|3882969|P2|Overall Study|Could not tolerate prep|0
1181971|NCT01073943|3882970|P1|Overall Study|Could not tolerate prep|1
1181972|NCT01073943|3882969|P2|Overall Study|Unable to return for follow-up|1
1181973|NCT01073943|3882970|P1|Overall Study|Unable to return for follow-up|0
1181974|NCT01073943|3882969|P2|Overall Study|Subject forgot|1
1181975|NCT01073943|3882970|P1|Overall Study|Subject forgot|0
1181976|NCT01073943|3882969|P2|Overall Study|Power outage; colonoscopy not done|0
1181977|NCT01073943|3882970|P1|Overall Study|Power outage; colonoscopy not done|1
1181978|NCT01073943|3882969|P2|Overall Study|Lost to Follow-up|2
1181979|NCT01073943|3882970|P1|Overall Study|Lost to Follow-up|0
1181980|NCT01073943|3882969|P2|Overall Study|Adverse Event|1
1181981|NCT01073943|3882970|P1|Overall Study|Adverse Event|1
1181982|NCT01073943|3882969|P2|Overall Study|Protocol Violation|1
1181983|NCT01073943|3882970|P1|Overall Study|Protocol Violation|2
1181984|NCT01073943|3882969|P2|Overall Study|Withdrawal by Subject|2
1181985|NCT01073943|3882970|P1|Overall Study|Withdrawal by Subject|8
1181986|NCT01073930|3882996|P2|Overall Study|Inadequate prep; unable to do procedure|1
1181987|NCT01073930|3882997|P1|Overall Study|Inadequate prep; unable to do procedure|0
1181988|NCT01073930|3882996|P2|Overall Study|Noncompliance with study drug|1
1181989|NCT01073930|3882997|P1|Overall Study|Noncompliance with study drug|0
1181990|NCT01073930|3882996|P2|Overall Study|Adverse Event|1
1181991|NCT01073930|3882997|P1|Overall Study|Adverse Event|0
1181992|NCT01073930|3882996|P2|Overall Study|Lost to Follow-up|1
1181993|NCT01073930|3882997|P1|Overall Study|Lost to Follow-up|0
1181994|NCT01073930|3882996|P2|Overall Study|Withdrawal by Subject|2
1181995|NCT01073930|3882997|P1|Overall Study|Withdrawal by Subject|3
1181996|NCT01073865|3883021|P2|Overall Study|Withdrawal by Subject|5
1181997|NCT01073865|3883022|P1|Overall Study|Withdrawal by Subject|5
1181998|NCT01073865|3883021|P2|Overall Study|Death|2
1181999|NCT01073865|3883022|P1|Overall Study|Death|3
1182000|NCT01073865|3883021|P2|Overall Study|Lost to Follow-up|1
1182001|NCT01073865|3883022|P1|Overall Study|Lost to Follow-up|1
1182002|NCT01073865|3883021|P2|Overall Study|Reasons other than below|31
1182003|NCT01073865|3883022|P1|Overall Study|Reasons other than below|19
1182004|NCT01073631|3883041|P1|Overall Study|Other|63
1182005|NCT01073631|3883041|P1|Overall Study|Adverse Event|24
1182006|NCT01073631|3883041|P1|Overall Study|Death|82
1182007|NCT01073618|3883046|P1|Overall Study|Other|80
1182008|NCT01073618|3883046|P1|Overall Study|Adverse Event|19
1182009|NCT01073618|3883046|P1|Overall Study|Death|208
1182010|NCT01073605|3883054|P3|Overall Study|Randomized But Not Treated|1
1182011|NCT01073605|3883055|P2|Overall Study|Randomized But Not Treated|1
1182012|NCT01073605|3883056|P1|Overall Study|Randomized But Not Treated|0
1182013|NCT01073605|3883054|P3|Overall Study|Withdrawal by Subject|22
1182014|NCT01073605|3883055|P2|Overall Study|Withdrawal by Subject|39
1182015|NCT01073605|3883056|P1|Overall Study|Withdrawal by Subject|31
1182016|NCT01073605|3883054|P3|Overall Study|Other|29
1182017|NCT01073605|3883055|P2|Overall Study|Other|21
1182018|NCT01073605|3883056|P1|Overall Study|Other|25
1182019|NCT01073605|3883054|P3|Overall Study|Lost to Follow-up|9
1182020|NCT01073605|3883055|P2|Overall Study|Lost to Follow-up|4
1182021|NCT01073605|3883056|P1|Overall Study|Lost to Follow-up|3
1182022|NCT01073605|3883054|P3|Overall Study|Adverse Event|0
1182023|NCT01073605|3883055|P2|Overall Study|Adverse Event|1
1182024|NCT01073605|3883056|P1|Overall Study|Adverse Event|2
1182025|NCT01073605|3883054|P3|Overall Study|Ongoing at Cutoff Date|0
1182026|NCT01073605|3883055|P2|Overall Study|Ongoing at Cutoff Date|1
1182027|NCT01073605|3883056|P1|Overall Study|Ongoing at Cutoff Date|1
1182028|NCT01073566|3883102|P2|Period 2 (6 Weeks)|Adverse Event|0
1182029|NCT01073566|3883103|P1|Period 2 (6 Weeks)|Adverse Event|1
1182030|NCT01073462|3883115|P1|Overall Study|Lost to Follow-up|7
1182031|NCT01073462|3883115|P1|Overall Study|Serious adverse event|2
1182032|NCT01073462|3883115|P1|Overall Study|Low parathyroid hormone levels|8
1182033|NCT01073462|3883115|P1|Overall Study|Kidney transplant|10
1182034|NCT01073462|3883115|P1|Overall Study|Death|14
1182035|NCT01073293|3883134|P2|Overall Study|Withdrawal by Subject|10
1182036|NCT01073293|3883135|P1|Overall Study|Withdrawal by Subject|5
1182037|NCT01073293|3883134|P2|Overall Study|Lost to Follow-up|1
1182038|NCT01073293|3883135|P1|Overall Study|Lost to Follow-up|0
1182039|NCT01073267|3883157|P1|Overall Study|Disease Progression|3
1182040|NCT01073163|3883161|P1|Overall Study|Early termination|1
1182041|NCT01073163|3883161|P1|Overall Study|Disease Progression|1
1182042|NCT01073163|3883161|P1|Overall Study|Adverse Event|1
1182043|NCT01072929|3883184|P3|Overall Study|Not specified|0
1182044|NCT01072929|3883185|P2|Overall Study|Not specified|3
1182045|NCT01072929|3883186|P1|Overall Study|Not specified|0
1182046|NCT01072929|3883184|P3|Overall Study|Noncompliance with study procedures|1
1182047|NCT01072929|3883185|P2|Overall Study|Noncompliance with study procedures|0
1182048|NCT01072929|3883186|P1|Overall Study|Noncompliance with study procedures|1
1182049|NCT01072929|3883184|P3|Overall Study|Noncompliance with study medication|0
1182050|NCT01072929|3883185|P2|Overall Study|Noncompliance with study medication|3
1182051|NCT01072929|3883186|P1|Overall Study|Noncompliance with study medication|0
1182052|NCT01072929|3883184|P3|Overall Study|Lost to Follow-up|1
1182053|NCT01072929|3883185|P2|Overall Study|Lost to Follow-up|4
1182054|NCT01072929|3883186|P1|Overall Study|Lost to Follow-up|8
1182055|NCT01072929|3883184|P3|Overall Study|Protocol Violation|2
1182056|NCT01072929|3883185|P2|Overall Study|Protocol Violation|11
1182057|NCT01072929|3883186|P1|Overall Study|Protocol Violation|13
1182058|NCT01072929|3883184|P3|Overall Study|Withdrawal by Subject|3
1182059|NCT01072929|3883185|P2|Overall Study|Withdrawal by Subject|15
1182060|NCT01072929|3883186|P1|Overall Study|Withdrawal by Subject|7
1182061|NCT01072929|3883184|P3|Overall Study|Lack of Efficacy|0
1182062|NCT01072929|3883185|P2|Overall Study|Lack of Efficacy|4
1182063|NCT01072929|3883186|P1|Overall Study|Lack of Efficacy|7
1182064|NCT01072929|3883184|P3|Overall Study|Adverse Event|2
1182065|NCT01072929|3883185|P2|Overall Study|Adverse Event|11
1182066|NCT01072929|3883186|P1|Overall Study|Adverse Event|8
1182067|NCT01072877|3883265|P5|Overall Study|Lost to Follow-up|0
1182068|NCT01072877|3883266|P4|Overall Study|Lost to Follow-up|2
1182069|NCT01072877|3883267|P3|Overall Study|Lost to Follow-up|0
1182070|NCT01072877|3883268|P2|Overall Study|Lost to Follow-up|1
1182071|NCT01072877|3883269|P1|Overall Study|Lost to Follow-up|1
1182072|NCT01072630|3883332|P3|Overall Study|Not specified|1
1182073|NCT01072630|3883333|P2|Overall Study|Not specified|2
1182074|NCT01072630|3883334|P1|Overall Study|Not specified|3
1182075|NCT01072630|3883332|P3|Overall Study|Noncompliance with study procedures|1
1182076|NCT01072630|3883333|P2|Overall Study|Noncompliance with study procedures|2
1182077|NCT01072630|3883334|P1|Overall Study|Noncompliance with study procedures|1
1182078|NCT01072630|3883332|P3|Overall Study|Noncompliance with study medication|1
1182079|NCT01072630|3883333|P2|Overall Study|Noncompliance with study medication|1
1182080|NCT01072630|3883334|P1|Overall Study|Noncompliance with study medication|1
1182081|NCT01072630|3883332|P3|Overall Study|Lost to Follow-up|1
1182082|NCT01072630|3883333|P2|Overall Study|Lost to Follow-up|11
1182083|NCT01072630|3883334|P1|Overall Study|Lost to Follow-up|11
1182084|NCT01072630|3883332|P3|Overall Study|Protocol Violation|4
1182085|NCT01072630|3883333|P2|Overall Study|Protocol Violation|8
1182086|NCT01072630|3883334|P1|Overall Study|Protocol Violation|10
1182087|NCT01072630|3883332|P3|Overall Study|Withdrawal by Subject|2
1182088|NCT01072630|3883333|P2|Overall Study|Withdrawal by Subject|7
1182089|NCT01072630|3883334|P1|Overall Study|Withdrawal by Subject|8
1182090|NCT01072630|3883332|P3|Overall Study|Lack of Efficacy|1
1182091|NCT01072630|3883333|P2|Overall Study|Lack of Efficacy|10
1182092|NCT01072630|3883334|P1|Overall Study|Lack of Efficacy|10
1182093|NCT01072630|3883332|P3|Overall Study|Adverse Event|2
1182094|NCT01072630|3883333|P2|Overall Study|Adverse Event|19
1182095|NCT01072630|3883334|P1|Overall Study|Adverse Event|11
1182096|NCT01072539|3883415|P1|Overall Study|Protocol Violation|2
1182097|NCT01072539|3883415|P1|Overall Study|Treated prior to the Site Initiation|1
1182098|NCT01072500|3883439|P2|Overall Study|Withdrawal by Subject|10
1182099|NCT01072500|3883440|P1|Overall Study|Withdrawal by Subject|17
1182100|NCT01072500|3883439|P2|Overall Study|Lost to Follow-up|2
1182101|NCT01072500|3883440|P1|Overall Study|Lost to Follow-up|5
1182102|NCT01072500|3883439|P2|Overall Study|Death|2
1182103|NCT01072500|3883440|P1|Overall Study|Death|2
1182104|NCT01072448|3883450|P2|Overall Study|Death|2
1182105|NCT01072448|3883451|P1|Overall Study|Death|0
1182106|NCT01072448|3883450|P2|Overall Study|Abnormal laboratory value(s)|1
1182107|NCT01072448|3883451|P1|Overall Study|Abnormal laboratory value(s)|0
1182108|NCT01072448|3883450|P2|Overall Study|Lost to Follow-up|1
1182109|NCT01072448|3883451|P1|Overall Study|Lost to Follow-up|1
1182110|NCT01072448|3883450|P2|Overall Study|Unsatisfactory therapeutic effect|3
1182111|NCT01072448|3883451|P1|Overall Study|Unsatisfactory therapeutic effect|1
1182112|NCT01072448|3883450|P2|Overall Study|Abnormal test procedure result(s)|0
1182113|NCT01072448|3883451|P1|Overall Study|Abnormal test procedure result(s)|1
1182114|NCT01072448|3883450|P2|Overall Study|Protocol deviation|4
1182115|NCT01072448|3883451|P1|Overall Study|Protocol deviation|3
1182116|NCT01072448|3883450|P2|Overall Study|Subject withdrew consent|9
1182117|NCT01072448|3883451|P1|Overall Study|Subject withdrew consent|4
1182118|NCT01072448|3883450|P2|Overall Study|Adverse Event|10
1182119|NCT01072448|3883451|P1|Overall Study|Adverse Event|9
1182120|NCT01072396|3883465|P2|Period Two|Lost to Follow-up|0
1182121|NCT01072396|3883466|P1|Period Two|Lost to Follow-up|1
1182122|NCT01072396|3883465|P2|Period Two|Adverse Event|3
1182123|NCT01072396|3883466|P1|Period Two|Adverse Event|0
1182124|NCT01072396|3883465|P2|Washout Period|Missing termination information|1
1182125|NCT01072396|3883466|P1|Washout Period|Missing termination information|0
1182126|NCT01072396|3883465|P2|Period One|Withdrawal by Subject|0
1182127|NCT01072396|3883466|P1|Period One|Withdrawal by Subject|2
1182128|NCT01072396|3883465|P2|Period One|Protocol Violation|1
1182129|NCT01072396|3883466|P1|Period One|Protocol Violation|2
1182130|NCT01072396|3883465|P2|Period One|Adverse Event|1
1182131|NCT01072396|3883466|P1|Period One|Adverse Event|1
1182132|NCT01072357|3883478|P2|Overall Study|Lost to Follow-up|1
1182133|NCT01072357|3883479|P1|Overall Study|Lost to Follow-up|0
1182134|NCT01072344|3883489|P2|Overall Study|Lost to Follow-up|4
1182135|NCT01072344|3883490|P1|Overall Study|Lost to Follow-up|3
1182136|NCT01072344|3883489|P2|Overall Study|Protocol Violation|2
1182137|NCT01072344|3883490|P1|Overall Study|Protocol Violation|1
1182138|NCT01072344|3883489|P2|Overall Study|Relasped-reached end point|12
1182139|NCT01072344|3883490|P1|Overall Study|Relasped-reached end point|7
1182140|NCT01072201|3883528|P2|Overall Study|Lost to Follow-up|1
1182141|NCT01072201|3883529|P1|Overall Study|Lost to Follow-up|0
1182142|NCT01072175|3883562|P13|Part D (HPMC Capsules)|Ongoing|34
1182143|NCT01072175|3883563|P12|Part D (HPMC Capsules)|Ongoing|34
1182144|NCT01072175|3883564|P11|Part D (HPMC Capsules)|Ongoing|12
1182145|NCT01072175|3883565|P10|Part D (HPMC Capsules)|Ongoing|10
1182146|NCT01072175|3883566|P9|Part D (HPMC Capsules)|Ongoing|0
1182147|NCT01072175|3883567|P8|Part D (HPMC Capsules)|Ongoing|0
1182148|NCT01072175|3883568|P7|Part D (HPMC Capsules)|Ongoing|0
1182149|NCT01072175|3883569|P6|Part D (HPMC Capsules)|Ongoing|0
1182150|NCT01072175|3883570|P5|Part D (HPMC Capsules)|Ongoing|0
1182151|NCT01072175|3883571|P4|Part D (HPMC Capsules)|Ongoing|0
1182152|NCT01072175|3883572|P3|Part D (HPMC Capsules)|Ongoing|0
1182153|NCT01072175|3883573|P2|Part D (HPMC Capsules)|Ongoing|0
1182154|NCT01072175|3883574|P1|Part D (HPMC Capsules)|Ongoing|0
1182155|NCT01072175|3883562|P13|Part D (HPMC Capsules)|Death|5
1182156|NCT01072175|3883563|P12|Part D (HPMC Capsules)|Death|6
1182157|NCT01072175|3883564|P11|Part D (HPMC Capsules)|Death|4
1182158|NCT01072175|3883565|P10|Part D (HPMC Capsules)|Death|2
1182159|NCT01072175|3883566|P9|Part D (HPMC Capsules)|Death|0
1182160|NCT01072175|3883567|P8|Part D (HPMC Capsules)|Death|0
1182161|NCT01072175|3883568|P7|Part D (HPMC Capsules)|Death|0
1182162|NCT01072175|3883569|P6|Part D (HPMC Capsules)|Death|0
1182163|NCT01072175|3883570|P5|Part D (HPMC Capsules)|Death|0
1182164|NCT01072175|3883571|P4|Part D (HPMC Capsules)|Death|0
1182165|NCT01072175|3883572|P3|Part D (HPMC Capsules)|Death|0
1182166|NCT01072175|3883573|P2|Part D (HPMC Capsules)|Death|0
1182167|NCT01072175|3883574|P1|Part D (HPMC Capsules)|Death|0
1182168|NCT01072175|3883562|P13|Part D (HPMC Capsules)|Withdrawal by Subject|0
1182169|NCT01072175|3883563|P12|Part D (HPMC Capsules)|Withdrawal by Subject|1
1182170|NCT01072175|3883564|P11|Part D (HPMC Capsules)|Withdrawal by Subject|0
1182171|NCT01072175|3883565|P10|Part D (HPMC Capsules)|Withdrawal by Subject|0
1182172|NCT01072175|3883566|P9|Part D (HPMC Capsules)|Withdrawal by Subject|0
1182173|NCT01072175|3883567|P8|Part D (HPMC Capsules)|Withdrawal by Subject|0
1182174|NCT01072175|3883568|P7|Part D (HPMC Capsules)|Withdrawal by Subject|0
1182175|NCT01072175|3883569|P6|Part D (HPMC Capsules)|Withdrawal by Subject|0
1182176|NCT01072175|3883570|P5|Part D (HPMC Capsules)|Withdrawal by Subject|0
1182177|NCT01072175|3883571|P4|Part D (HPMC Capsules)|Withdrawal by Subject|0
1182178|NCT01072175|3883572|P3|Part D (HPMC Capsules)|Withdrawal by Subject|0
1182179|NCT01072175|3883573|P2|Part D (HPMC Capsules)|Withdrawal by Subject|0
1182180|NCT01072175|3883574|P1|Part D (HPMC Capsules)|Withdrawal by Subject|0
1182181|NCT01072175|3883562|P13|Part D (HPMC Capsules)|Lost to Follow-up|0
1182182|NCT01072175|3883563|P12|Part D (HPMC Capsules)|Lost to Follow-up|2
1182183|NCT01072175|3883564|P11|Part D (HPMC Capsules)|Lost to Follow-up|0
1182184|NCT01072175|3883565|P10|Part D (HPMC Capsules)|Lost to Follow-up|0
1182185|NCT01072175|3883566|P9|Part D (HPMC Capsules)|Lost to Follow-up|0
1182186|NCT01072175|3883567|P8|Part D (HPMC Capsules)|Lost to Follow-up|0
1182187|NCT01072175|3883568|P7|Part D (HPMC Capsules)|Lost to Follow-up|0
1182188|NCT01072175|3883569|P6|Part D (HPMC Capsules)|Lost to Follow-up|0
1182189|NCT01072175|3883570|P5|Part D (HPMC Capsules)|Lost to Follow-up|0
1182190|NCT01072175|3883571|P4|Part D (HPMC Capsules)|Lost to Follow-up|0
1182191|NCT01072175|3883572|P3|Part D (HPMC Capsules)|Lost to Follow-up|0
1182192|NCT01072175|3883573|P2|Part D (HPMC Capsules)|Lost to Follow-up|0
1182193|NCT01072175|3883574|P1|Part D (HPMC Capsules)|Lost to Follow-up|0
1182194|NCT01072175|3883562|P13|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
1182195|NCT01072175|3883563|P12|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
1182196|NCT01072175|3883564|P11|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
1182197|NCT01072175|3883565|P10|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
1182198|NCT01072175|3883566|P9|Part C (Phase II: Crossover Phase [CP])|Ongoing|28
1182199|NCT01072175|3883567|P8|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
1182200|NCT01072175|3883568|P7|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
1182201|NCT01072175|3883569|P6|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
1182202|NCT01072175|3883570|P5|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
1182203|NCT01072175|3883571|P4|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
1182204|NCT01072175|3883572|P3|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
1182205|NCT01072175|3883573|P2|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
1182206|NCT01072175|3883574|P1|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
1182207|NCT01072175|3883562|P13|Part C (Phase II: Crossover Phase [CP])|Death|0
1182208|NCT01072175|3883563|P12|Part C (Phase II: Crossover Phase [CP])|Death|0
1182209|NCT01072175|3883564|P11|Part C (Phase II: Crossover Phase [CP])|Death|0
1182210|NCT01072175|3883565|P10|Part C (Phase II: Crossover Phase [CP])|Death|0
1182211|NCT01072175|3883566|P9|Part C (Phase II: Crossover Phase [CP])|Death|15
1182212|NCT01072175|3883567|P8|Part C (Phase II: Crossover Phase [CP])|Death|0
1182213|NCT01072175|3883568|P7|Part C (Phase II: Crossover Phase [CP])|Death|0
1182214|NCT01072175|3883569|P6|Part C (Phase II: Crossover Phase [CP])|Death|0
1182215|NCT01072175|3883570|P5|Part C (Phase II: Crossover Phase [CP])|Death|0
1182216|NCT01072175|3883571|P4|Part C (Phase II: Crossover Phase [CP])|Death|0
1182217|NCT01072175|3883572|P3|Part C (Phase II: Crossover Phase [CP])|Death|0
1182218|NCT01072175|3883573|P2|Part C (Phase II: Crossover Phase [CP])|Death|0
1182219|NCT01072175|3883574|P1|Part C (Phase II: Crossover Phase [CP])|Death|0
1182220|NCT01072175|3883562|P13|Part C (Phase II: Randomized Phase)|Ongoing|0
1182221|NCT01072175|3883563|P12|Part C (Phase II: Randomized Phase)|Ongoing|0
1182222|NCT01072175|3883564|P11|Part C (Phase II: Randomized Phase)|Ongoing|0
1182223|NCT01072175|3883565|P10|Part C (Phase II: Randomized Phase)|Ongoing|0
1182224|NCT01072175|3883566|P9|Part C (Phase II: Randomized Phase)|Ongoing|0
1182225|NCT01072175|3883567|P8|Part C (Phase II: Randomized Phase)|Ongoing|40
1182226|NCT01072175|3883568|P7|Part C (Phase II: Randomized Phase)|Ongoing|32
1182227|NCT01072175|3883569|P6|Part C (Phase II: Randomized Phase)|Ongoing|35
1182228|NCT01072175|3883570|P5|Part C (Phase II: Randomized Phase)|Ongoing|0
1182229|NCT01072175|3883571|P4|Part C (Phase II: Randomized Phase)|Ongoing|0
1182230|NCT01072175|3883572|P3|Part C (Phase II: Randomized Phase)|Ongoing|0
1182231|NCT01072175|3883573|P2|Part C (Phase II: Randomized Phase)|Ongoing|0
1182232|NCT01072175|3883574|P1|Part C (Phase II: Randomized Phase)|Ongoing|0
1182233|NCT01072175|3883562|P13|Part C (Phase II: Randomized Phase)|Death|0
1182234|NCT01072175|3883563|P12|Part C (Phase II: Randomized Phase)|Death|0
1182235|NCT01072175|3883564|P11|Part C (Phase II: Randomized Phase)|Death|0
1182236|NCT01072175|3883565|P10|Part C (Phase II: Randomized Phase)|Death|0
1182237|NCT01072175|3883566|P9|Part C (Phase II: Randomized Phase)|Death|0
1182238|NCT01072175|3883567|P8|Part C (Phase II: Randomized Phase)|Death|14
1182239|NCT01072175|3883568|P7|Part C (Phase II: Randomized Phase)|Death|18
1182240|NCT01072175|3883569|P6|Part C (Phase II: Randomized Phase)|Death|19
1182241|NCT01072175|3883570|P5|Part C (Phase II: Randomized Phase)|Death|0
1182242|NCT01072175|3883571|P4|Part C (Phase II: Randomized Phase)|Death|0
1182243|NCT01072175|3883572|P3|Part C (Phase II: Randomized Phase)|Death|0
1182244|NCT01072175|3883573|P2|Part C (Phase II: Randomized Phase)|Death|0
1182245|NCT01072175|3883574|P1|Part C (Phase II: Randomized Phase)|Death|0
1182246|NCT01072175|3883562|P13|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
1182247|NCT01072175|3883563|P12|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
1182248|NCT01072175|3883564|P11|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
1182249|NCT01072175|3883565|P10|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
1182250|NCT01072175|3883566|P9|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
1182251|NCT01072175|3883567|P8|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
1182252|NCT01072175|3883568|P7|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|4
1182253|NCT01072175|3883569|P6|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
1182254|NCT01072175|3883570|P5|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
1182255|NCT01072175|3883571|P4|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
1182256|NCT01072175|3883572|P3|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
1182257|NCT01072175|3883573|P2|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
1182258|NCT01072175|3883574|P1|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
1182259|NCT01072175|3883562|P13|Part B (Dose Escalation and Expansion)|Ongoing|0
1182260|NCT01072175|3883563|P12|Part B (Dose Escalation and Expansion)|Ongoing|0
1182261|NCT01072175|3883564|P11|Part B (Dose Escalation and Expansion)|Ongoing|0
1182262|NCT01072175|3883565|P10|Part B (Dose Escalation and Expansion)|Ongoing|0
1182263|NCT01072175|3883566|P9|Part B (Dose Escalation and Expansion)|Ongoing|0
1182264|NCT01072175|3883567|P8|Part B (Dose Escalation and Expansion)|Ongoing|0
1182265|NCT01072175|3883568|P7|Part B (Dose Escalation and Expansion)|Ongoing|0
1182266|NCT01072175|3883569|P6|Part B (Dose Escalation and Expansion)|Ongoing|0
1182267|NCT01072175|3883570|P5|Part B (Dose Escalation and Expansion)|Ongoing|28
1182268|NCT01072175|3883571|P4|Part B (Dose Escalation and Expansion)|Ongoing|9
1182269|NCT01072175|3883572|P3|Part B (Dose Escalation and Expansion)|Ongoing|10
1182270|NCT01072175|3883573|P2|Part B (Dose Escalation and Expansion)|Ongoing|2
1182271|NCT01072175|3883574|P1|Part B (Dose Escalation and Expansion)|Ongoing|0
1182272|NCT01072175|3883562|P13|Part B (Dose Escalation and Expansion)|Death|0
1182273|NCT01072175|3883563|P12|Part B (Dose Escalation and Expansion)|Death|0
1182274|NCT01072175|3883564|P11|Part B (Dose Escalation and Expansion)|Death|0
1182275|NCT01072175|3883565|P10|Part B (Dose Escalation and Expansion)|Death|0
1182276|NCT01072175|3883566|P9|Part B (Dose Escalation and Expansion)|Death|0
1182277|NCT01072175|3883567|P8|Part B (Dose Escalation and Expansion)|Death|0
1182278|NCT01072175|3883568|P7|Part B (Dose Escalation and Expansion)|Death|0
1182279|NCT01072175|3883569|P6|Part B (Dose Escalation and Expansion)|Death|0
1182280|NCT01072175|3883570|P5|Part B (Dose Escalation and Expansion)|Death|36
1182281|NCT01072175|3883571|P4|Part B (Dose Escalation and Expansion)|Death|12
1182282|NCT01072175|3883572|P3|Part B (Dose Escalation and Expansion)|Death|10
1182283|NCT01072175|3883573|P2|Part B (Dose Escalation and Expansion)|Death|3
1182284|NCT01072175|3883574|P1|Part B (Dose Escalation and Expansion)|Death|0
1182285|NCT01072175|3883562|P13|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
1182286|NCT01072175|3883563|P12|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
1182287|NCT01072175|3883564|P11|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
1182288|NCT01072175|3883565|P10|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
1182289|NCT01072175|3883566|P9|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
1182290|NCT01072175|3883567|P8|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
1182291|NCT01072175|3883568|P7|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
1182292|NCT01072175|3883569|P6|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
1182293|NCT01072175|3883570|P5|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|2
1182294|NCT01072175|3883571|P4|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|2
1182295|NCT01072175|3883572|P3|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
1182296|NCT01072175|3883573|P2|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
1182297|NCT01072175|3883574|P1|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
1182298|NCT01072175|3883562|P13|Part B (Dose Escalation and Expansion)|Physician Decision|0
1182299|NCT01072175|3883563|P12|Part B (Dose Escalation and Expansion)|Physician Decision|0
1182300|NCT01072175|3883564|P11|Part B (Dose Escalation and Expansion)|Physician Decision|0
1182301|NCT01072175|3883565|P10|Part B (Dose Escalation and Expansion)|Physician Decision|0
1182302|NCT01072175|3883566|P9|Part B (Dose Escalation and Expansion)|Physician Decision|0
1182303|NCT01072175|3883567|P8|Part B (Dose Escalation and Expansion)|Physician Decision|0
1182304|NCT01072175|3883568|P7|Part B (Dose Escalation and Expansion)|Physician Decision|0
1182305|NCT01072175|3883569|P6|Part B (Dose Escalation and Expansion)|Physician Decision|0
1182306|NCT01072175|3883570|P5|Part B (Dose Escalation and Expansion)|Physician Decision|13
1182307|NCT01072175|3883571|P4|Part B (Dose Escalation and Expansion)|Physician Decision|4
1182308|NCT01072175|3883572|P3|Part B (Dose Escalation and Expansion)|Physician Decision|3
1182309|NCT01072175|3883573|P2|Part B (Dose Escalation and Expansion)|Physician Decision|1
1182310|NCT01072175|3883574|P1|Part B (Dose Escalation and Expansion)|Physician Decision|0
1182311|NCT01072175|3883562|P13|Part A (Drug-Drug Interaction)|Death|0
1182312|NCT01072175|3883563|P12|Part A (Drug-Drug Interaction)|Death|0
1182313|NCT01072175|3883564|P11|Part A (Drug-Drug Interaction)|Death|0
1182314|NCT01072175|3883565|P10|Part A (Drug-Drug Interaction)|Death|0
1182315|NCT01072175|3883566|P9|Part A (Drug-Drug Interaction)|Death|0
1182316|NCT01072175|3883567|P8|Part A (Drug-Drug Interaction)|Death|0
1182317|NCT01072175|3883568|P7|Part A (Drug-Drug Interaction)|Death|0
1182318|NCT01072175|3883569|P6|Part A (Drug-Drug Interaction)|Death|0
1182319|NCT01072175|3883570|P5|Part A (Drug-Drug Interaction)|Death|0
1182320|NCT01072175|3883571|P4|Part A (Drug-Drug Interaction)|Death|0
1182321|NCT01072175|3883572|P3|Part A (Drug-Drug Interaction)|Death|0
1182322|NCT01072175|3883573|P2|Part A (Drug-Drug Interaction)|Death|0
1182323|NCT01072175|3883574|P1|Part A (Drug-Drug Interaction)|Death|1
1182324|NCT01072175|3883562|P13|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
1182325|NCT01072175|3883563|P12|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
1182326|NCT01072175|3883564|P11|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
1182327|NCT01072175|3883565|P10|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
1182328|NCT01072175|3883566|P9|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
1182329|NCT01072175|3883567|P8|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
1182330|NCT01072175|3883568|P7|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
1182331|NCT01072175|3883569|P6|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
1182332|NCT01072175|3883570|P5|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
1182333|NCT01072175|3883571|P4|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
1182334|NCT01072175|3883572|P3|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
1182335|NCT01072175|3883573|P2|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
1182336|NCT01072175|3883574|P1|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1
1182337|NCT01072175|3883562|P13|Part A (Drug-Drug Interaction)|Physician Decision|0
1182338|NCT01072175|3883563|P12|Part A (Drug-Drug Interaction)|Physician Decision|0
1182339|NCT01072175|3883564|P11|Part A (Drug-Drug Interaction)|Physician Decision|0
1182340|NCT01072175|3883565|P10|Part A (Drug-Drug Interaction)|Physician Decision|0
1182341|NCT01072175|3883566|P9|Part A (Drug-Drug Interaction)|Physician Decision|0
1182342|NCT01072175|3883567|P8|Part A (Drug-Drug Interaction)|Physician Decision|0
1182343|NCT01072175|3883568|P7|Part A (Drug-Drug Interaction)|Physician Decision|0
1182344|NCT01072175|3883569|P6|Part A (Drug-Drug Interaction)|Physician Decision|0
1182345|NCT01072175|3883570|P5|Part A (Drug-Drug Interaction)|Physician Decision|0
1182346|NCT01072175|3883571|P4|Part A (Drug-Drug Interaction)|Physician Decision|0
1182347|NCT01072175|3883572|P3|Part A (Drug-Drug Interaction)|Physician Decision|0
1182348|NCT01072175|3883573|P2|Part A (Drug-Drug Interaction)|Physician Decision|0
1182349|NCT01072175|3883574|P1|Part A (Drug-Drug Interaction)|Physician Decision|6
1182350|NCT01072149|3883757|P18|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1182351|NCT01072149|3883758|P17|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1182352|NCT01072149|3883759|P16|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1182353|NCT01072149|3883760|P15|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1182354|NCT01072149|3883761|P14|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
1182355|NCT01072149|3883762|P13|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1182356|NCT01072149|3883763|P12|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1182357|NCT01072149|3883764|P11|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1182358|NCT01072149|3883765|P10|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1182359|NCT01072149|3883766|P9|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1182360|NCT01072149|3883767|P8|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1182361|NCT01072149|3883768|P7|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1182362|NCT01072149|3883769|P6|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1182363|NCT01072149|3883770|P5|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1182364|NCT01072149|3883771|P4|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1182365|NCT01072149|3883772|P3|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
1182366|NCT01072149|3883773|P2|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1182367|NCT01072149|3883774|P1|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1182368|NCT01072149|3883757|P18|Washout Period 2 (14 Days)|Lack of Efficacy|0
1182369|NCT01072149|3883758|P17|Washout Period 2 (14 Days)|Lack of Efficacy|0
1182370|NCT01072149|3883759|P16|Washout Period 2 (14 Days)|Lack of Efficacy|0
1182371|NCT01072149|3883760|P15|Washout Period 2 (14 Days)|Lack of Efficacy|0
1182372|NCT01072149|3883761|P14|Washout Period 2 (14 Days)|Lack of Efficacy|0
1182373|NCT01072149|3883762|P13|Washout Period 2 (14 Days)|Lack of Efficacy|1
1182374|NCT01072149|3883763|P12|Washout Period 2 (14 Days)|Lack of Efficacy|0
1182375|NCT01072149|3883764|P11|Washout Period 2 (14 Days)|Lack of Efficacy|0
1182376|NCT01072149|3883765|P10|Washout Period 2 (14 Days)|Lack of Efficacy|0
1182377|NCT01072149|3883766|P9|Washout Period 2 (14 Days)|Lack of Efficacy|0
1182378|NCT01072149|3883767|P8|Washout Period 2 (14 Days)|Lack of Efficacy|0
1182379|NCT01072149|3883768|P7|Washout Period 2 (14 Days)|Lack of Efficacy|0
1182380|NCT01072149|3883769|P6|Washout Period 2 (14 Days)|Lack of Efficacy|0
1182381|NCT01072149|3883770|P5|Washout Period 2 (14 Days)|Lack of Efficacy|0
1182382|NCT01072149|3883771|P4|Washout Period 2 (14 Days)|Lack of Efficacy|0
1182383|NCT01072149|3883772|P3|Washout Period 2 (14 Days)|Lack of Efficacy|0
1182384|NCT01072149|3883773|P2|Washout Period 2 (14 Days)|Lack of Efficacy|0
1182385|NCT01072149|3883774|P1|Washout Period 2 (14 Days)|Lack of Efficacy|0
1182386|NCT01072149|3883757|P18|Washout Period 2 (14 Days)|Adverse Event|0
1182387|NCT01072149|3883758|P17|Washout Period 2 (14 Days)|Adverse Event|0
1182388|NCT01072149|3883759|P16|Washout Period 2 (14 Days)|Adverse Event|1
1182389|NCT01072149|3883760|P15|Washout Period 2 (14 Days)|Adverse Event|0
1182390|NCT01072149|3883761|P14|Washout Period 2 (14 Days)|Adverse Event|0
1182391|NCT01072149|3883762|P13|Washout Period 2 (14 Days)|Adverse Event|0
1182392|NCT01072149|3883763|P12|Washout Period 2 (14 Days)|Adverse Event|0
1182393|NCT01072149|3883764|P11|Washout Period 2 (14 Days)|Adverse Event|0
1182394|NCT01072149|3883765|P10|Washout Period 2 (14 Days)|Adverse Event|0
1182395|NCT01072149|3883766|P9|Washout Period 2 (14 Days)|Adverse Event|0
1182396|NCT01072149|3883767|P8|Washout Period 2 (14 Days)|Adverse Event|0
1182397|NCT01072149|3883768|P7|Washout Period 2 (14 Days)|Adverse Event|0
1182398|NCT01072149|3883769|P6|Washout Period 2 (14 Days)|Adverse Event|0
1182399|NCT01072149|3883770|P5|Washout Period 2 (14 Days)|Adverse Event|0
1182400|NCT01072149|3883771|P4|Washout Period 2 (14 Days)|Adverse Event|0
1182401|NCT01072149|3883772|P3|Washout Period 2 (14 Days)|Adverse Event|0
1182402|NCT01072149|3883773|P2|Washout Period 2 (14 Days)|Adverse Event|0
1182403|NCT01072149|3883774|P1|Washout Period 2 (14 Days)|Adverse Event|0
1182404|NCT01072149|3883757|P18|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1182405|NCT01072149|3883758|P17|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1182406|NCT01072149|3883759|P16|Washout Period 2 (14 Days)|Withdrawal by Subject|1
1182407|NCT01072149|3883760|P15|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1182408|NCT01072149|3883761|P14|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1182409|NCT01072149|3883762|P13|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1182410|NCT01072149|3883763|P12|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1182411|NCT01072149|3883764|P11|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1182412|NCT01072149|3883765|P10|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1182413|NCT01072149|3883766|P9|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1182414|NCT01072149|3883767|P8|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1182415|NCT01072149|3883768|P7|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1182416|NCT01072149|3883769|P6|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1182417|NCT01072149|3883770|P5|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1182418|NCT01072149|3883771|P4|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1182419|NCT01072149|3883772|P3|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1182420|NCT01072149|3883773|P2|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1182421|NCT01072149|3883774|P1|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1182422|NCT01072149|3883757|P18|Washout Period 2 (14 Days)|Physician Decision|0
1182423|NCT01072149|3883758|P17|Washout Period 2 (14 Days)|Physician Decision|0
1182424|NCT01072149|3883759|P16|Washout Period 2 (14 Days)|Physician Decision|0
1182425|NCT01072149|3883760|P15|Washout Period 2 (14 Days)|Physician Decision|0
1182426|NCT01072149|3883761|P14|Washout Period 2 (14 Days)|Physician Decision|0
1182427|NCT01072149|3883762|P13|Washout Period 2 (14 Days)|Physician Decision|0
1182428|NCT01072149|3883763|P12|Washout Period 2 (14 Days)|Physician Decision|0
1182429|NCT01072149|3883764|P11|Washout Period 2 (14 Days)|Physician Decision|0
1182430|NCT01072149|3883765|P10|Washout Period 2 (14 Days)|Physician Decision|0
1182431|NCT01072149|3883766|P9|Washout Period 2 (14 Days)|Physician Decision|0
1182432|NCT01072149|3883767|P8|Washout Period 2 (14 Days)|Physician Decision|0
1182433|NCT01072149|3883768|P7|Washout Period 2 (14 Days)|Physician Decision|0
1182434|NCT01072149|3883769|P6|Washout Period 2 (14 Days)|Physician Decision|0
1182435|NCT01072149|3883770|P5|Washout Period 2 (14 Days)|Physician Decision|0
1182436|NCT01072149|3883771|P4|Washout Period 2 (14 Days)|Physician Decision|0
1182437|NCT01072149|3883772|P3|Washout Period 2 (14 Days)|Physician Decision|0
1182438|NCT01072149|3883773|P2|Washout Period 2 (14 Days)|Physician Decision|0
1182439|NCT01072149|3883774|P1|Washout Period 2 (14 Days)|Physician Decision|1
1182440|NCT01072149|3883757|P18|Treatment Period 2 (28 Days)|Physician Decision|0
1182441|NCT01072149|3883758|P17|Treatment Period 2 (28 Days)|Physician Decision|0
1182442|NCT01072149|3883759|P16|Treatment Period 2 (28 Days)|Physician Decision|0
1182443|NCT01072149|3883760|P15|Treatment Period 2 (28 Days)|Physician Decision|0
1182444|NCT01072149|3883761|P14|Treatment Period 2 (28 Days)|Physician Decision|0
1182445|NCT01072149|3883762|P13|Treatment Period 2 (28 Days)|Physician Decision|0
1182446|NCT01072149|3883763|P12|Treatment Period 2 (28 Days)|Physician Decision|0
1182447|NCT01072149|3883764|P11|Treatment Period 2 (28 Days)|Physician Decision|0
1182448|NCT01072149|3883765|P10|Treatment Period 2 (28 Days)|Physician Decision|0
1182449|NCT01072149|3883766|P9|Treatment Period 2 (28 Days)|Physician Decision|0
1182450|NCT01072149|3883767|P8|Treatment Period 2 (28 Days)|Physician Decision|1
1182451|NCT01072149|3883768|P7|Treatment Period 2 (28 Days)|Physician Decision|0
1182452|NCT01072149|3883769|P6|Treatment Period 2 (28 Days)|Physician Decision|0
1182453|NCT01072149|3883770|P5|Treatment Period 2 (28 Days)|Physician Decision|0
1182454|NCT01072149|3883771|P4|Treatment Period 2 (28 Days)|Physician Decision|0
1182455|NCT01072149|3883772|P3|Treatment Period 2 (28 Days)|Physician Decision|0
1182456|NCT01072149|3883773|P2|Treatment Period 2 (28 Days)|Physician Decision|0
1182457|NCT01072149|3883774|P1|Treatment Period 2 (28 Days)|Physician Decision|0
1182458|NCT01072149|3883757|P18|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1182459|NCT01072149|3883758|P17|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1182460|NCT01072149|3883759|P16|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1182461|NCT01072149|3883760|P15|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1182462|NCT01072149|3883761|P14|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1182463|NCT01072149|3883762|P13|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1182464|NCT01072149|3883763|P12|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1182465|NCT01072149|3883764|P11|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1182466|NCT01072149|3883765|P10|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1182467|NCT01072149|3883766|P9|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1182468|NCT01072149|3883767|P8|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1182469|NCT01072149|3883768|P7|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1182470|NCT01072149|3883769|P6|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1182471|NCT01072149|3883770|P5|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1182472|NCT01072149|3883771|P4|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1182473|NCT01072149|3883772|P3|Treatment Period 2 (28 Days)|Withdrawal by Subject|1
1182474|NCT01072149|3883773|P2|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1182475|NCT01072149|3883774|P1|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1182476|NCT01072149|3883757|P18|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1182477|NCT01072149|3883758|P17|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1182478|NCT01072149|3883759|P16|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1182479|NCT01072149|3883760|P15|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1182480|NCT01072149|3883761|P14|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1182481|NCT01072149|3883762|P13|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1182482|NCT01072149|3883763|P12|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1182483|NCT01072149|3883764|P11|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1182484|NCT01072149|3883765|P10|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1182485|NCT01072149|3883766|P9|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1182486|NCT01072149|3883767|P8|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1182487|NCT01072149|3883768|P7|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1182488|NCT01072149|3883769|P6|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1182489|NCT01072149|3883770|P5|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1182490|NCT01072149|3883771|P4|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1182491|NCT01072149|3883772|P3|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1182492|NCT01072149|3883773|P2|Treatment Period 2 (28 Days)|Lost to Follow-up|1
1182493|NCT01072149|3883774|P1|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1182494|NCT01072149|3883757|P18|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1182495|NCT01072149|3883758|P17|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1182496|NCT01072149|3883759|P16|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1182497|NCT01072149|3883760|P15|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1182498|NCT01072149|3883761|P14|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1182499|NCT01072149|3883762|P13|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1182500|NCT01072149|3883763|P12|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1182501|NCT01072149|3883764|P11|Treatment Period 1 (28 Days)|Lost to Follow-up|1
1182502|NCT01072149|3883765|P10|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1182503|NCT01072149|3883766|P9|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1182504|NCT01072149|3883767|P8|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1182505|NCT01072149|3883768|P7|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1182506|NCT01072149|3883769|P6|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1182507|NCT01072149|3883770|P5|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1182508|NCT01072149|3883771|P4|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1182509|NCT01072149|3883772|P3|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1182510|NCT01072149|3883773|P2|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1182511|NCT01072149|3883774|P1|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1182512|NCT01072149|3883757|P18|Treatment Period 1 (28 Days)|Protocol Violation|1
1182513|NCT01072149|3883758|P17|Treatment Period 1 (28 Days)|Protocol Violation|0
1182514|NCT01072149|3883759|P16|Treatment Period 1 (28 Days)|Protocol Violation|0
1182515|NCT01072149|3883760|P15|Treatment Period 1 (28 Days)|Protocol Violation|0
1182516|NCT01072149|3883761|P14|Treatment Period 1 (28 Days)|Protocol Violation|0
1182517|NCT01072149|3883762|P13|Treatment Period 1 (28 Days)|Protocol Violation|0
1182518|NCT01072149|3883763|P12|Treatment Period 1 (28 Days)|Protocol Violation|0
1182519|NCT01072149|3883764|P11|Treatment Period 1 (28 Days)|Protocol Violation|0
1182520|NCT01072149|3883765|P10|Treatment Period 1 (28 Days)|Protocol Violation|0
1182521|NCT01072149|3883766|P9|Treatment Period 1 (28 Days)|Protocol Violation|0
1182522|NCT01072149|3883767|P8|Treatment Period 1 (28 Days)|Protocol Violation|0
1182523|NCT01072149|3883768|P7|Treatment Period 1 (28 Days)|Protocol Violation|0
1182524|NCT01072149|3883769|P6|Treatment Period 1 (28 Days)|Protocol Violation|0
1182525|NCT01072149|3883770|P5|Treatment Period 1 (28 Days)|Protocol Violation|0
1182526|NCT01072149|3883771|P4|Treatment Period 1 (28 Days)|Protocol Violation|0
1182527|NCT01072149|3883772|P3|Treatment Period 1 (28 Days)|Protocol Violation|0
1182528|NCT01072149|3883773|P2|Treatment Period 1 (28 Days)|Protocol Violation|0
1182529|NCT01072149|3883774|P1|Treatment Period 1 (28 Days)|Protocol Violation|0
1182530|NCT01072149|3883757|P18|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1182531|NCT01072149|3883758|P17|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1182532|NCT01072149|3883759|P16|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1182533|NCT01072149|3883760|P15|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1182534|NCT01072149|3883761|P14|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1182535|NCT01072149|3883762|P13|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1182536|NCT01072149|3883763|P12|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1182537|NCT01072149|3883764|P11|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1182538|NCT01072149|3883765|P10|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1182539|NCT01072149|3883766|P9|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1182540|NCT01072149|3883767|P8|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1182541|NCT01072149|3883768|P7|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1182542|NCT01072149|3883769|P6|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1182543|NCT01072149|3883770|P5|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1182544|NCT01072149|3883771|P4|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1182545|NCT01072149|3883772|P3|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
1182546|NCT01072149|3883773|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1182547|NCT01072149|3883774|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1182548|NCT01071915|3883863|P1|Overall Study|Miscellaneous Reasons|2
1182549|NCT01071915|3883863|P1|Overall Study|Withdrawal by Subject|2
1182550|NCT01071915|3883863|P1|Overall Study|Physician Decision|2
1182551|NCT01071915|3883863|P1|Overall Study|Adverse Event|3
1182552|NCT01071798|3883873|P1|Subpopulation Who Received Two Cycles|Patient Requirement|7
1182553|NCT01071798|3883873|P1|Subpopulation Who Received Two Cycles|Lack of Tolerability|4
1182554|NCT01071798|3883873|P1|Subpopulation Who Received Two Cycles|Lack of Efficacy|3
1182555|NCT01071798|3883873|P1|Subpopulation Who Received Two Cycles|Remission|1
1182556|NCT01071798|3883873|P1|Participants Who Received One Cycle|Severe concomitant disease|2
1182557|NCT01071798|3883873|P1|Participants Who Received One Cycle|Change of therapy|6
1182558|NCT01071798|3883873|P1|Participants Who Received One Cycle|Death|5
1182559|NCT01071798|3883873|P1|Participants Who Received One Cycle|Patient requirement|20
1182560|NCT01071798|3883873|P1|Participants Who Received One Cycle|Lack of tolerability|14
1182561|NCT01071798|3883873|P1|Participants Who Received One Cycle|Lack of Efficacy|18
1182562|NCT01071512|3883903|P1|Overall Study|positive anti-JC virus antibody test|2
1182563|NCT01071512|3883903|P1|Overall Study|Development of antibodies to drug|2
1182564|NCT01071512|3883903|P1|Overall Study|Adverse Event|1
1182565|NCT01071395|3883913|P2|Overall Study|Adverse Event|1
1182566|NCT01071395|3883914|P1|Overall Study|Adverse Event|3
1182567|NCT01071395|3883913|P2|Overall Study|Withdrawal by Subject|1
1182568|NCT01071395|3883914|P1|Overall Study|Withdrawal by Subject|2
1182569|NCT01071317|3883933|P2|Overall Study|Lost to Follow-up|2
1182570|NCT01071317|3883934|P1|Overall Study|Lost to Follow-up|2
1182571|NCT01071278|3883946|P1|Overall Study|Completion Status Unknown|459
1182572|NCT01071278|3883946|P1|Overall Study|Premature Discontinuation|254
1182573|NCT01071252|3883957|P5|Overall Study|Death|1
1182574|NCT01071252|3883958|P4|Overall Study|Death|0
1182575|NCT01071252|3883959|P3|Overall Study|Death|0
1182576|NCT01071252|3883960|P2|Overall Study|Death|0
1182577|NCT01071252|3883961|P1|Overall Study|Death|0
1182578|NCT01071252|3883957|P5|Overall Study|Adverse Event|0
1182579|NCT01071252|3883958|P4|Overall Study|Adverse Event|1
1182580|NCT01071252|3883959|P3|Overall Study|Adverse Event|0
1182581|NCT01071252|3883960|P2|Overall Study|Adverse Event|1
1182582|NCT01071252|3883961|P1|Overall Study|Adverse Event|1
1182583|NCT01071252|3883957|P5|Overall Study|Lost to Follow-up|0
1182584|NCT01071252|3883958|P4|Overall Study|Lost to Follow-up|2
1182585|NCT01071252|3883959|P3|Overall Study|Lost to Follow-up|1
1182586|NCT01071252|3883960|P2|Overall Study|Lost to Follow-up|0
1182587|NCT01071252|3883961|P1|Overall Study|Lost to Follow-up|1
1182588|NCT01071252|3883957|P5|Overall Study|administrative problems|1
1182589|NCT01071252|3883958|P4|Overall Study|administrative problems|2
1182590|NCT01071252|3883959|P3|Overall Study|administrative problems|0
1182591|NCT01071252|3883960|P2|Overall Study|administrative problems|1
1182592|NCT01071252|3883961|P1|Overall Study|administrative problems|1
1182593|NCT01071252|3883957|P5|Overall Study|Withdrawal by Subject|3
1182594|NCT01071252|3883958|P4|Overall Study|Withdrawal by Subject|2
1182595|NCT01071252|3883959|P3|Overall Study|Withdrawal by Subject|1
1182596|NCT01071252|3883960|P2|Overall Study|Withdrawal by Subject|2
1182597|NCT01071252|3883961|P1|Overall Study|Withdrawal by Subject|8
1182598|NCT01071252|3883957|P5|Overall Study|unsatisfactory therapeutic effect|6
1182599|NCT01071252|3883958|P4|Overall Study|unsatisfactory therapeutic effect|0
1182600|NCT01071252|3883959|P3|Overall Study|unsatisfactory therapeutic effect|2
1182601|NCT01071252|3883960|P2|Overall Study|unsatisfactory therapeutic effect|6
1182602|NCT01071252|3883961|P1|Overall Study|unsatisfactory therapeutic effect|4
1182603|NCT01071200|3883989|P2|Overall Study|No viable embryos|1
1182604|NCT01071200|3883990|P1|Overall Study|No viable embryos|0
1182605|NCT01071200|3883989|P2|Overall Study|Ovarian Hyper Stimulation Syndrome|0
1182606|NCT01071200|3883990|P1|Overall Study|Ovarian Hyper Stimulation Syndrome|1
1182607|NCT01071200|3883989|P2|Overall Study|No oocytes retrieved|1
1182608|NCT01071200|3883990|P1|Overall Study|No oocytes retrieved|1
1182609|NCT01071200|3883989|P2|Overall Study|No fertilization|0
1182610|NCT01071200|3883990|P1|Overall Study|No fertilization|4
1182611|NCT01071200|3883989|P2|Overall Study|Lack of ovarian response|1
1182612|NCT01071200|3883990|P1|Overall Study|Lack of ovarian response|1
1182613|NCT01071096|3884022|P2|First Intervention (90 Days)|Lost to Follow-up|0
1182614|NCT01071096|3884023|P1|First Intervention (90 Days)|Lost to Follow-up|1
1182615|NCT01071083|3884047|P5|Overall Study|Subject Refused to Continue|0
1182616|NCT01071083|3884048|P4|Overall Study|Subject Refused to Continue|0
1182617|NCT01071083|3884049|P3|Overall Study|Subject Refused to Continue|0
1182618|NCT01071083|3884050|P2|Overall Study|Subject Refused to Continue|0
1182619|NCT01071083|3884051|P1|Overall Study|Subject Refused to Continue|1
1182620|NCT01071083|3884047|P5|Overall Study|Did Not Want Per Protocol Treatment|1
1182621|NCT01071083|3884048|P4|Overall Study|Did Not Want Per Protocol Treatment|0
1182622|NCT01071083|3884049|P3|Overall Study|Did Not Want Per Protocol Treatment|1
1182623|NCT01071083|3884050|P2|Overall Study|Did Not Want Per Protocol Treatment|0
1182624|NCT01071083|3884051|P1|Overall Study|Did Not Want Per Protocol Treatment|0
1182625|NCT01071083|3884047|P5|Overall Study|Did Not Meet Eligibility Criteria|1
1182626|NCT01071083|3884048|P4|Overall Study|Did Not Meet Eligibility Criteria|1
1182627|NCT01071083|3884049|P3|Overall Study|Did Not Meet Eligibility Criteria|1
1182628|NCT01071083|3884050|P2|Overall Study|Did Not Meet Eligibility Criteria|0
1182629|NCT01071083|3884051|P1|Overall Study|Did Not Meet Eligibility Criteria|0
1182630|NCT01071083|3884047|P5|Overall Study|Images Not Usable (Motion)|0
1182631|NCT01071083|3884048|P4|Overall Study|Images Not Usable (Motion)|0
1182632|NCT01071083|3884049|P3|Overall Study|Images Not Usable (Motion)|0
1182633|NCT01071083|3884050|P2|Overall Study|Images Not Usable (Motion)|1
1182634|NCT01071083|3884051|P1|Overall Study|Images Not Usable (Motion)|0
1182635|NCT01071083|3884047|P5|Overall Study|Subject Moved|0
1182636|NCT01071083|3884048|P4|Overall Study|Subject Moved|0
1182637|NCT01071083|3884049|P3|Overall Study|Subject Moved|0
1182638|NCT01071083|3884050|P2|Overall Study|Subject Moved|1
1182639|NCT01071083|3884051|P1|Overall Study|Subject Moved|0
1182640|NCT01071083|3884047|P5|Overall Study|Early Rescue|1
1182641|NCT01071083|3884048|P4|Overall Study|Early Rescue|0
1182642|NCT01071083|3884049|P3|Overall Study|Early Rescue|0
1182643|NCT01071083|3884050|P2|Overall Study|Early Rescue|0
1182644|NCT01071083|3884051|P1|Overall Study|Early Rescue|1
1182645|NCT01071083|3884047|P5|Overall Study|Physician Decision|1
1182646|NCT01071083|3884048|P4|Overall Study|Physician Decision|1
1182647|NCT01071083|3884049|P3|Overall Study|Physician Decision|0
1182648|NCT01071083|3884050|P2|Overall Study|Physician Decision|0
1182649|NCT01071083|3884051|P1|Overall Study|Physician Decision|1
1182650|NCT01071083|3884047|P5|Overall Study|Withdrawal by Subject|3
1182651|NCT01071083|3884048|P4|Overall Study|Withdrawal by Subject|0
1182652|NCT01071083|3884049|P3|Overall Study|Withdrawal by Subject|2
1182653|NCT01071083|3884050|P2|Overall Study|Withdrawal by Subject|0
1182654|NCT01071083|3884051|P1|Overall Study|Withdrawal by Subject|3
1182655|NCT01071083|3884047|P5|Overall Study|Adverse Event|1
1182656|NCT01071083|3884048|P4|Overall Study|Adverse Event|0
1182657|NCT01071083|3884049|P3|Overall Study|Adverse Event|1
1182658|NCT01071083|3884050|P2|Overall Study|Adverse Event|0
1182659|NCT01071083|3884051|P1|Overall Study|Adverse Event|1
1182660|NCT01071070|3884070|P2|Overall Study|Hypercalcemia|0
1182661|NCT01071070|3884071|P1|Overall Study|Hypercalcemia|1
1182662|NCT01071070|3884070|P2|Overall Study|Missed 3 consecutive doses of study drug|0
1182663|NCT01071070|3884071|P1|Overall Study|Missed 3 consecutive doses of study drug|2
1182664|NCT01071070|3884070|P2|Overall Study|Withdrawal by Subject|0
1182665|NCT01071070|3884071|P1|Overall Study|Withdrawal by Subject|1
1182666|NCT01071070|3884070|P2|Overall Study|Adverse Event|3
1182667|NCT01071070|3884071|P1|Overall Study|Adverse Event|0
1182668|NCT01070979|3884117|P3|Overall Study|No study drug taken|0
1182669|NCT01070979|3884118|P2|Overall Study|No study drug taken|1
1182670|NCT01070979|3884119|P1|Overall Study|No study drug taken|0
1182671|NCT01070979|3884117|P3|Overall Study|Withdrawal by Subject|1
1182672|NCT01070979|3884118|P2|Overall Study|Withdrawal by Subject|1
1182673|NCT01070979|3884119|P1|Overall Study|Withdrawal by Subject|3
1182674|NCT01070979|3884117|P3|Overall Study|Surgery, moving, personal, abn. labs|2
1182675|NCT01070979|3884118|P2|Overall Study|Surgery, moving, personal, abn. labs|4
1182676|NCT01070979|3884119|P1|Overall Study|Surgery, moving, personal, abn. labs|4
1182677|NCT01070979|3884117|P3|Overall Study|Protocol Violation|6
1182678|NCT01070979|3884118|P2|Overall Study|Protocol Violation|2
1182679|NCT01070979|3884119|P1|Overall Study|Protocol Violation|0
1182680|NCT01070979|3884117|P3|Overall Study|Lost to Follow-up|1
1182681|NCT01070979|3884118|P2|Overall Study|Lost to Follow-up|1
1182682|NCT01070979|3884119|P1|Overall Study|Lost to Follow-up|2
1182683|NCT01070979|3884117|P3|Overall Study|Adverse Event|3
1182684|NCT01070979|3884118|P2|Overall Study|Adverse Event|3
1182685|NCT01070979|3884119|P1|Overall Study|Adverse Event|2
1182686|NCT01070966|3884145|P1|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2
1182687|NCT01070966|3884145|P1|Participants for Efficacy Evaluation|No efficacy evaluation|19
1182688|NCT01070966|3884145|P1|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61
1182689|NCT01070966|3884145|P1|Participants for Safety Evaluation|TMT given before date of contract|3
1182690|NCT01070966|3884145|P1|Participants for Safety Evaluation|Violation inclusion criteria/off label|3
1182691|NCT01070966|3884145|P1|Participants for Safety Evaluation|Duplicate Participants|4
1182692|NCT01070966|3884145|P1|Participants for Safety Evaluation|Off-label use|9
1182693|NCT01070966|3884145|P1|Participants for Safety Evaluation|Violation of inclusion criteria|59
1182694|NCT01070953|3884156|P1|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2
1182695|NCT01070953|3884156|P1|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106
1182696|NCT01070953|3884156|P1|Participants for Efficacy Evaluation|No efficacy evaluation|119
1182697|NCT01070953|3884156|P1|Participants for Safety Evaluation|Duplicated participants & off-label use|1
1182698|NCT01070953|3884156|P1|Participants for Safety Evaluation|Violation of inclusions & off label use|1
1182699|NCT01070953|3884156|P1|Participants for Safety Evaluation|Uncontracted participants|4
1182700|NCT01070953|3884156|P1|Participants for Safety Evaluation|Treatment prior to date of contract|8
1182701|NCT01070953|3884156|P1|Participants for Safety Evaluation|Duplicated participants|22
1182702|NCT01070953|3884156|P1|Participants for Safety Evaluation|Off-label use|283
1182703|NCT01070953|3884156|P1|Participants for Safety Evaluation|Violation of inclusion criteria|612
1182704|NCT01070888|3884169|P2|Washout (14 Days)|Physician Decision|0
1182705|NCT01070888|3884170|P1|Washout (14 Days)|Physician Decision|1
1182706|NCT01070888|3884169|P2|First Intervention (14 Days)|Lost to Follow-up|1
1182707|NCT01070888|3884170|P1|First Intervention (14 Days)|Lost to Follow-up|0
1182708|NCT01070888|3884169|P2|First Intervention (14 Days)|Adverse Event|1
1182709|NCT01070888|3884170|P1|First Intervention (14 Days)|Adverse Event|0
1182710|NCT01070784|3884195|P2|Overall Study|Adverse Event|9
1182711|NCT01070784|3884196|P1|Overall Study|Adverse Event|14
1182712|NCT01070784|3884195|P2|Overall Study|Withdrawal by Subject|9
1182713|NCT01070784|3884196|P1|Overall Study|Withdrawal by Subject|6
1182714|NCT01070771|3884284|P1|Overall Study|Protocol Violation|1
1182715|NCT01070771|3884284|P1|Overall Study|Adverse Event|2
1182716|NCT01070550|3884304|P6|Overall Study|Withdrawal by Subject|0
1182717|NCT01070550|3884305|P5|Overall Study|Withdrawal by Subject|0
1182718|NCT01070550|3884306|P4|Overall Study|Withdrawal by Subject|0
1182719|NCT01070550|3884307|P3|Overall Study|Withdrawal by Subject|3
1182720|NCT01070550|3884308|P2|Overall Study|Withdrawal by Subject|0
1182721|NCT01070550|3884309|P1|Overall Study|Withdrawal by Subject|35
1182722|NCT01070550|3884304|P6|Overall Study|Other|0
1182723|NCT01070550|3884305|P5|Overall Study|Other|0
1182724|NCT01070550|3884306|P4|Overall Study|Other|1
1182725|NCT01070550|3884307|P3|Overall Study|Other|0
1182726|NCT01070550|3884308|P2|Overall Study|Other|0
1182727|NCT01070550|3884309|P1|Overall Study|Other|5
1182728|NCT01070550|3884304|P6|Overall Study|Treatment was stopped early|0
1182729|NCT01070550|3884305|P5|Overall Study|Treatment was stopped early|0
1182730|NCT01070550|3884306|P4|Overall Study|Treatment was stopped early|0
1182731|NCT01070550|3884307|P3|Overall Study|Treatment was stopped early|0
1182732|NCT01070550|3884308|P2|Overall Study|Treatment was stopped early|0
1182733|NCT01070550|3884309|P1|Overall Study|Treatment was stopped early|7
1182734|NCT01070550|3884304|P6|Overall Study|Treatment unavailable|0
1182735|NCT01070550|3884305|P5|Overall Study|Treatment unavailable|0
1182736|NCT01070550|3884306|P4|Overall Study|Treatment unavailable|0
1182737|NCT01070550|3884307|P3|Overall Study|Treatment unavailable|0
1182738|NCT01070550|3884308|P2|Overall Study|Treatment unavailable|0
1182739|NCT01070550|3884309|P1|Overall Study|Treatment unavailable|1
1182740|NCT01070550|3884304|P6|Overall Study|Treatment stopped|0
1182741|NCT01070550|3884305|P5|Overall Study|Treatment stopped|0
1182742|NCT01070550|3884306|P4|Overall Study|Treatment stopped|0
1182743|NCT01070550|3884307|P3|Overall Study|Treatment stopped|0
1182744|NCT01070550|3884308|P2|Overall Study|Treatment stopped|0
1182745|NCT01070550|3884309|P1|Overall Study|Treatment stopped|3
1182746|NCT01070550|3884304|P6|Overall Study|Treatment restarted|0
1182747|NCT01070550|3884305|P5|Overall Study|Treatment restarted|0
1182748|NCT01070550|3884306|P4|Overall Study|Treatment restarted|0
1182749|NCT01070550|3884307|P3|Overall Study|Treatment restarted|0
1182750|NCT01070550|3884308|P2|Overall Study|Treatment restarted|1
1182751|NCT01070550|3884309|P1|Overall Study|Treatment restarted|0
1182752|NCT01070550|3884304|P6|Overall Study|Treatment not started|0
1182753|NCT01070550|3884305|P5|Overall Study|Treatment not started|0
1182754|NCT01070550|3884306|P4|Overall Study|Treatment not started|0
1182755|NCT01070550|3884307|P3|Overall Study|Treatment not started|4
1182756|NCT01070550|3884308|P2|Overall Study|Treatment not started|2
1182757|NCT01070550|3884309|P1|Overall Study|Treatment not started|14
1182758|NCT01070550|3884304|P6|Overall Study|Treatment interrupted|0
1182759|NCT01070550|3884305|P5|Overall Study|Treatment interrupted|0
1182760|NCT01070550|3884306|P4|Overall Study|Treatment interrupted|1
1182761|NCT01070550|3884307|P3|Overall Study|Treatment interrupted|1
1182762|NCT01070550|3884308|P2|Overall Study|Treatment interrupted|0
1182763|NCT01070550|3884309|P1|Overall Study|Treatment interrupted|7
1182764|NCT01070550|3884304|P6|Overall Study|Treatment duration shortened|0
1182765|NCT01070550|3884305|P5|Overall Study|Treatment duration shortened|0
1182766|NCT01070550|3884306|P4|Overall Study|Treatment duration shortened|0
1182767|NCT01070550|3884307|P3|Overall Study|Treatment duration shortened|0
1182768|NCT01070550|3884308|P2|Overall Study|Treatment duration shortened|0
1182769|NCT01070550|3884309|P1|Overall Study|Treatment duration shortened|1
1182770|NCT01070550|3884304|P6|Overall Study|Sponsor decision|0
1182771|NCT01070550|3884305|P5|Overall Study|Sponsor decision|0
1182772|NCT01070550|3884306|P4|Overall Study|Sponsor decision|0
1182773|NCT01070550|3884307|P3|Overall Study|Sponsor decision|0
1182774|NCT01070550|3884308|P2|Overall Study|Sponsor decision|0
1182775|NCT01070550|3884309|P1|Overall Study|Sponsor decision|1
1182776|NCT01070550|3884304|P6|Overall Study|Screen failure|0
1182777|NCT01070550|3884305|P5|Overall Study|Screen failure|0
1182778|NCT01070550|3884306|P4|Overall Study|Screen failure|0
1182779|NCT01070550|3884307|P3|Overall Study|Screen failure|0
1182780|NCT01070550|3884308|P2|Overall Study|Screen failure|0
1182781|NCT01070550|3884309|P1|Overall Study|Screen failure|1
1182782|NCT01070550|3884304|P6|Overall Study|Result not available|0
1182783|NCT01070550|3884305|P5|Overall Study|Result not available|0
1182784|NCT01070550|3884306|P4|Overall Study|Result not available|0
1182785|NCT01070550|3884307|P3|Overall Study|Result not available|3
1182786|NCT01070550|3884308|P2|Overall Study|Result not available|1
1182787|NCT01070550|3884309|P1|Overall Study|Result not available|3
1182788|NCT01070550|3884304|P6|Overall Study|Relapse|0
1182789|NCT01070550|3884305|P5|Overall Study|Relapse|0
1182790|NCT01070550|3884306|P4|Overall Study|Relapse|4
1182791|NCT01070550|3884307|P3|Overall Study|Relapse|14
1182792|NCT01070550|3884308|P2|Overall Study|Relapse|5
1182793|NCT01070550|3884309|P1|Overall Study|Relapse|44
1182794|NCT01070550|3884304|P6|Overall Study|Protocol Violation|0
1182795|NCT01070550|3884305|P5|Overall Study|Protocol Violation|0
1182796|NCT01070550|3884306|P4|Overall Study|Protocol Violation|1
1182797|NCT01070550|3884307|P3|Overall Study|Protocol Violation|1
1182798|NCT01070550|3884308|P2|Overall Study|Protocol Violation|1
1182799|NCT01070550|3884309|P1|Overall Study|Protocol Violation|15
1182800|NCT01070550|3884304|P6|Overall Study|Not categorized|1
1182801|NCT01070550|3884305|P5|Overall Study|Not categorized|0
1182802|NCT01070550|3884306|P4|Overall Study|Not categorized|1
1182803|NCT01070550|3884307|P3|Overall Study|Not categorized|6
1182804|NCT01070550|3884308|P2|Overall Study|Not categorized|2
1182805|NCT01070550|3884309|P1|Overall Study|Not categorized|33
1182806|NCT01070550|3884304|P6|Overall Study|Non-responders|2
1182807|NCT01070550|3884305|P5|Overall Study|Non-responders|0
1182808|NCT01070550|3884306|P4|Overall Study|Non-responders|20
1182809|NCT01070550|3884307|P3|Overall Study|Non-responders|21
1182810|NCT01070550|3884308|P2|Overall Study|Non-responders|4
1182811|NCT01070550|3884309|P1|Overall Study|Non-responders|493
1182812|NCT01070550|3884304|P6|Overall Study|New treatment started|0
1182813|NCT01070550|3884305|P5|Overall Study|New treatment started|0
1182814|NCT01070550|3884306|P4|Overall Study|New treatment started|2
1182815|NCT01070550|3884307|P3|Overall Study|New treatment started|0
1182816|NCT01070550|3884308|P2|Overall Study|New treatment started|1
1182817|NCT01070550|3884309|P1|Overall Study|New treatment started|3
1182818|NCT01070550|3884304|P6|Overall Study|Miscellaneous|0
1182819|NCT01070550|3884305|P5|Overall Study|Miscellaneous|0
1182820|NCT01070550|3884306|P4|Overall Study|Miscellaneous|1
1182821|NCT01070550|3884307|P3|Overall Study|Miscellaneous|3
1182822|NCT01070550|3884308|P2|Overall Study|Miscellaneous|2
1182823|NCT01070550|3884309|P1|Overall Study|Miscellaneous|12
1182824|NCT01070550|3884304|P6|Overall Study|Lack of Efficacy|1
1182825|NCT01070550|3884305|P5|Overall Study|Lack of Efficacy|0
1182826|NCT01070550|3884306|P4|Overall Study|Lack of Efficacy|5
1182827|NCT01070550|3884307|P3|Overall Study|Lack of Efficacy|5
1182828|NCT01070550|3884308|P2|Overall Study|Lack of Efficacy|1
1182829|NCT01070550|3884309|P1|Overall Study|Lack of Efficacy|65
1182830|NCT01070550|3884304|P6|Overall Study|Lab test not done|1
1182831|NCT01070550|3884305|P5|Overall Study|Lab test not done|0
1182832|NCT01070550|3884306|P4|Overall Study|Lab test not done|1
1182833|NCT01070550|3884307|P3|Overall Study|Lab test not done|4
1182834|NCT01070550|3884308|P2|Overall Study|Lab test not done|3
1182835|NCT01070550|3884309|P1|Overall Study|Lab test not done|22
1182836|NCT01070550|3884304|P6|Overall Study|Incomplete treatment|0
1182837|NCT01070550|3884305|P5|Overall Study|Incomplete treatment|0
1182838|NCT01070550|3884306|P4|Overall Study|Incomplete treatment|0
1182839|NCT01070550|3884307|P3|Overall Study|Incomplete treatment|0
1182840|NCT01070550|3884308|P2|Overall Study|Incomplete treatment|0
1182841|NCT01070550|3884309|P1|Overall Study|Incomplete treatment|2
1182842|NCT01070550|3884304|P6|Overall Study|Failed to return|2
1182843|NCT01070550|3884305|P5|Overall Study|Failed to return|1
1182844|NCT01070550|3884306|P4|Overall Study|Failed to return|40
1182845|NCT01070550|3884307|P3|Overall Study|Failed to return|144
1182846|NCT01070550|3884308|P2|Overall Study|Failed to return|33
1182847|NCT01070550|3884309|P1|Overall Study|Failed to return|450
1182848|NCT01070550|3884304|P6|Overall Study|Early termination|0
1182849|NCT01070550|3884305|P5|Overall Study|Early termination|0
1182850|NCT01070550|3884306|P4|Overall Study|Early termination|0
1182851|NCT01070550|3884307|P3|Overall Study|Early termination|0
1182852|NCT01070550|3884308|P2|Overall Study|Early termination|0
1182853|NCT01070550|3884309|P1|Overall Study|Early termination|3
1182854|NCT01070550|3884304|P6|Overall Study|Not meeting inclusion/exclusion criteria|0
1182855|NCT01070550|3884305|P5|Overall Study|Not meeting inclusion/exclusion criteria|0
1182856|NCT01070550|3884306|P4|Overall Study|Not meeting inclusion/exclusion criteria|0
1182857|NCT01070550|3884307|P3|Overall Study|Not meeting inclusion/exclusion criteria|1
1182858|NCT01070550|3884308|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
1182859|NCT01070550|3884309|P1|Overall Study|Not meeting inclusion/exclusion criteria|2
1182860|NCT01070550|3884304|P6|Overall Study|Death|0
1182861|NCT01070550|3884305|P5|Overall Study|Death|0
1182862|NCT01070550|3884306|P4|Overall Study|Death|0
1182863|NCT01070550|3884307|P3|Overall Study|Death|3
1182864|NCT01070550|3884308|P2|Overall Study|Death|4
1182865|NCT01070550|3884309|P1|Overall Study|Death|20
1182866|NCT01070550|3884304|P6|Overall Study|Adverse Event|0
1182867|NCT01070550|3884305|P5|Overall Study|Adverse Event|0
1182868|NCT01070550|3884306|P4|Overall Study|Adverse Event|0
1182869|NCT01070550|3884307|P3|Overall Study|Adverse Event|3
1182870|NCT01070550|3884308|P2|Overall Study|Adverse Event|1
1182871|NCT01070550|3884309|P1|Overall Study|Adverse Event|43
1182872|NCT01070394|3884449|P1|Overall Study|Withdrawal by Subject|1
1182873|NCT01070394|3884449|P1|Overall Study|Adverse Event|6
1182874|NCT01070381|3884460|P2|Period 2, 1 Week of Wear|Unacceptable Vision|0
1182875|NCT01070381|3884461|P1|Period 2, 1 Week of Wear|Unacceptable Vision|1
1182876|NCT01070381|3884460|P2|Period 2, 1 Week of Wear|Handling|1
1182877|NCT01070381|3884461|P1|Period 2, 1 Week of Wear|Handling|0
1182878|NCT01070329|3884469|P2|Overall Study|Sponsor Decision|1
1182879|NCT01070329|3884470|P1|Overall Study|Sponsor Decision|0
1182880|NCT01070329|3884469|P2|Overall Study|Entry Criteria Not Met|0
1182881|NCT01070329|3884470|P1|Overall Study|Entry Criteria Not Met|1
1182882|NCT01070329|3884469|P2|Overall Study|Physician Decision|1
1182883|NCT01070329|3884470|P1|Overall Study|Physician Decision|2
1182884|NCT01070329|3884469|P2|Overall Study|Lack of Efficacy|6
1182885|NCT01070329|3884470|P1|Overall Study|Lack of Efficacy|2
1182886|NCT01070329|3884469|P2|Overall Study|Protocol Violation|8
1182887|NCT01070329|3884470|P1|Overall Study|Protocol Violation|3
1182888|NCT01070329|3884469|P2|Overall Study|Withdrawal by Subject|11
1182889|NCT01070329|3884470|P1|Overall Study|Withdrawal by Subject|9
1182890|NCT01070329|3884469|P2|Overall Study|Lost to Follow-up|12
1182891|NCT01070329|3884470|P1|Overall Study|Lost to Follow-up|22
1182892|NCT01070329|3884469|P2|Overall Study|Adverse Event|10
1182893|NCT01070329|3884470|P1|Overall Study|Adverse Event|13
1182894|NCT01070316|3884502|P1|Extension Phase|Withdrawal by Subject|1
1182895|NCT01070316|3884502|P1|Extension Phase|Lack of Efficacy|3
1182896|NCT01070303|3884509|P1|Overall Study|Other|18
1182897|NCT01070303|3884509|P1|Overall Study|Administrative Reason|1
1182898|NCT01070303|3884509|P1|Overall Study|Lack of Efficacy|2
1182899|NCT01070303|3884509|P1|Overall Study|Protocol Violation|0
1182900|NCT01070303|3884509|P1|Overall Study|Lost to Follow-up|9
1182901|NCT01070303|3884509|P1|Overall Study|Withdrawal by Subject|20
1182902|NCT01070303|3884509|P1|Overall Study|Adverse Event|39
1182903|NCT01070043|3884583|P3|Double-Blind Treatment|Adverse Event|2
1182904|NCT01070043|3884584|P2|Double-Blind Treatment|Adverse Event|0
1182905|NCT01070043|3884585|P1|Double-Blind Treatment|Adverse Event|0
1182906|NCT01070043|3884583|P3|Run-In Phase|Did not Meet Inclusion Criteria|0
1182907|NCT01070043|3884584|P2|Run-In Phase|Did not Meet Inclusion Criteria|0
1182908|NCT01070043|3884585|P1|Run-In Phase|Did not Meet Inclusion Criteria|18
1182909|NCT01069939|3884601|P2|Randomised and Included in the Analyses|Removal|0
1182910|NCT01069939|3884602|P1|Randomised and Included in the Analyses|Removal|1
1182911|NCT01069939|3884601|P2|Randomised and Included in the Analyses|Physician Decision|2
1182912|NCT01069939|3884602|P1|Randomised and Included in the Analyses|Physician Decision|0
1182913|NCT01069939|3884601|P2|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2
1182914|NCT01069939|3884602|P1|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4
1182915|NCT01069939|3884601|P2|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3
1182916|NCT01069939|3884602|P1|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4
1182917|NCT01069939|3884601|P2|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33
1182918|NCT01069939|3884602|P1|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7
1182919|NCT01069939|3884601|P2|Randomised and Included in the Analyses|Lack of Efficacy|1
1182920|NCT01069939|3884602|P1|Randomised and Included in the Analyses|Lack of Efficacy|0
1182921|NCT01069939|3884601|P2|Randomised and Included in the Analyses|Protocol Violation|1
1182922|NCT01069939|3884602|P1|Randomised and Included in the Analyses|Protocol Violation|0
1182923|NCT01069939|3884601|P2|Randomised and Included in the Analyses|Lost to Follow-up|1
1182924|NCT01069939|3884602|P1|Randomised and Included in the Analyses|Lost to Follow-up|1
1182925|NCT01069939|3884601|P2|Randomised and Included in the Analyses|Withdrawal by Subject|12
1182926|NCT01069939|3884602|P1|Randomised and Included in the Analyses|Withdrawal by Subject|15
1182927|NCT01069939|3884601|P2|Randomised and Included in the Analyses|Adverse Event|22
1182928|NCT01069939|3884602|P1|Randomised and Included in the Analyses|Adverse Event|17
1182929|NCT01069900|3884628|P2|Overall Study|Insufficient Therapeutic effect|0
1182930|NCT01069900|3884629|P1|Overall Study|Insufficient Therapeutic effect|1
1182931|NCT01069900|3884628|P2|Overall Study|Protocol Violation|1
1182932|NCT01069900|3884629|P1|Overall Study|Protocol Violation|4
1182933|NCT01069900|3884628|P2|Overall Study|Withdrawal by Subject|1
1182934|NCT01069900|3884629|P1|Overall Study|Withdrawal by Subject|6
1182935|NCT01069900|3884628|P2|Overall Study|Lost to Follow-up|1
1182936|NCT01069900|3884629|P1|Overall Study|Lost to Follow-up|7
1182937|NCT01069900|3884628|P2|Overall Study|Technical problems|1
1182938|NCT01069900|3884629|P1|Overall Study|Technical problems|0
1182939|NCT01069861|3884673|P1|Overall Study|Did not meet entrance criteria|1
1182940|NCT01069861|3884673|P1|Overall Study|Adverse Event|1
1182941|NCT01069861|3884673|P1|Overall Study|Death|1
1182942|NCT01069627|3884686|P1|Overall Study|Protocol Violation|1
1182943|NCT01069627|3884686|P1|Overall Study|Adverse Event|12
1182944|NCT01069627|3884686|P1|Overall Study|Disease progression|7
1182945|NCT01069523|3884736|P2|Overall Study|Withdrawal by Subject|7
1182946|NCT01069523|3884737|P1|Overall Study|Withdrawal by Subject|4
1182947|NCT01069484|3884747|P2|Overall Study|Illness mother or child|1
1182948|NCT01069484|3884748|P1|Overall Study|Illness mother or child|3
1182949|NCT01069484|3884747|P2|Overall Study|No specific reason|2
1182950|NCT01069484|3884748|P1|Overall Study|No specific reason|8
1182951|NCT01069484|3884747|P2|Overall Study|Death-in-near-family|0
1182952|NCT01069484|3884748|P1|Overall Study|Death-in-near-family|1
1182953|NCT01069419|3884756|P1|Overall Study|Missing termination information|13
1182954|NCT01069419|3884756|P1|Overall Study|Other Reason|43
1182955|NCT01069419|3884756|P1|Overall Study|Withdrawal by Subject|34
1182956|NCT01069419|3884756|P1|Overall Study|Remission of disease|11
1182957|NCT01069419|3884756|P1|Overall Study|Lost to Follow-up|49
1182958|NCT01069419|3884756|P1|Overall Study|Lack of Efficacy|332
1182959|NCT01069419|3884756|P1|Overall Study|Adverse Event|233
1182960|NCT01069341|3884785|P1|Overall Study|Lost to Follow-up|1
1182961|NCT01069289|3884798|P2|Overall Study|Due to deteriorating health condition|0
1182962|NCT01069289|3884799|P1|Overall Study|Due to deteriorating health condition|1
1182963|NCT01069289|3884798|P2|Overall Study|Severe non-compliance to protocol|2
1182964|NCT01069289|3884799|P1|Overall Study|Severe non-compliance to protocol|3
1182965|NCT01069289|3884798|P2|Overall Study|Eligibility criteria not fulfilled|0
1182966|NCT01069289|3884799|P1|Overall Study|Eligibility criteria not fulfilled|2
1182967|NCT01069289|3884798|P2|Overall Study|Adverse Event|28
1182968|NCT01069289|3884799|P1|Overall Study|Adverse Event|21
1182969|NCT01069289|3884798|P2|Overall Study|Withdrawal by Subject|26
1182970|NCT01069289|3884799|P1|Overall Study|Withdrawal by Subject|15
1182971|NCT01069172|3884848|P2|Overall Study|Withdrawal by Subject|0
1182972|NCT01069172|3884849|P1|Overall Study|Withdrawal by Subject|1
1182973|NCT01069120|3884859|P1|Overall Study|Study prematurely terminated|27
1182974|NCT01068912|3884896|P3|Overall Study|other underlying illness|3
1182975|NCT01068912|3884897|P2|Overall Study|other underlying illness|3
1182976|NCT01068912|3884898|P1|Overall Study|other underlying illness|0
1182977|NCT01068912|3884896|P3|Overall Study|aggravation influenza|1
1182978|NCT01068912|3884897|P2|Overall Study|aggravation influenza|1
1182979|NCT01068912|3884898|P1|Overall Study|aggravation influenza|1
1182980|NCT01068912|3884896|P3|Overall Study|Protocol Violation|0
1182981|NCT01068912|3884897|P2|Overall Study|Protocol Violation|2
1182982|NCT01068912|3884898|P1|Overall Study|Protocol Violation|0
1182983|NCT01068912|3884896|P3|Overall Study|Lost to Follow-up|3
1182984|NCT01068912|3884897|P2|Overall Study|Lost to Follow-up|7
1182985|NCT01068912|3884898|P1|Overall Study|Lost to Follow-up|3
1182986|NCT01068912|3884896|P3|Overall Study|Withdrawal by Subject|6
1182987|NCT01068912|3884897|P2|Overall Study|Withdrawal by Subject|6
1182988|NCT01068912|3884898|P1|Overall Study|Withdrawal by Subject|5
1182989|NCT01068912|3884896|P3|Overall Study|Adverse Event|2
1182990|NCT01068912|3884897|P2|Overall Study|Adverse Event|3
1182991|NCT01068912|3884898|P1|Overall Study|Adverse Event|2
1182992|NCT01068860|3884916|P10|Overall Study|Lost to Follow-up|0
1182993|NCT01068860|3884917|P9|Overall Study|Lost to Follow-up|0
1182994|NCT01068860|3884918|P8|Overall Study|Lost to Follow-up|0
1182995|NCT01068860|3884919|P7|Overall Study|Lost to Follow-up|0
1182996|NCT01068860|3884920|P6|Overall Study|Lost to Follow-up|0
1182997|NCT01068860|3884921|P5|Overall Study|Lost to Follow-up|0
1182998|NCT01068860|3884922|P4|Overall Study|Lost to Follow-up|0
1182999|NCT01068860|3884923|P3|Overall Study|Lost to Follow-up|0
1183000|NCT01068860|3884924|P2|Overall Study|Lost to Follow-up|1
1183001|NCT01068860|3884925|P1|Overall Study|Lost to Follow-up|0
1183002|NCT01068860|3884916|P10|Overall Study|Administrative problems; misrandomized|1
1183003|NCT01068860|3884917|P9|Overall Study|Administrative problems; misrandomized|0
1183004|NCT01068860|3884918|P8|Overall Study|Administrative problems; misrandomized|0
1183005|NCT01068860|3884919|P7|Overall Study|Administrative problems; misrandomized|0
1183006|NCT01068860|3884920|P6|Overall Study|Administrative problems; misrandomized|0
1183007|NCT01068860|3884921|P5|Overall Study|Administrative problems; misrandomized|0
1183008|NCT01068860|3884922|P4|Overall Study|Administrative problems; misrandomized|1
1183009|NCT01068860|3884923|P3|Overall Study|Administrative problems; misrandomized|0
1183010|NCT01068860|3884924|P2|Overall Study|Administrative problems; misrandomized|0
1183011|NCT01068860|3884925|P1|Overall Study|Administrative problems; misrandomized|0
1183012|NCT01068860|3884916|P10|Overall Study|Withdrawal by Subject|3
1183013|NCT01068860|3884917|P9|Overall Study|Withdrawal by Subject|0
1183014|NCT01068860|3884918|P8|Overall Study|Withdrawal by Subject|0
1183015|NCT01068860|3884919|P7|Overall Study|Withdrawal by Subject|0
1183016|NCT01068860|3884920|P6|Overall Study|Withdrawal by Subject|2
1183017|NCT01068860|3884921|P5|Overall Study|Withdrawal by Subject|0
1183018|NCT01068860|3884922|P4|Overall Study|Withdrawal by Subject|0
1183019|NCT01068860|3884923|P3|Overall Study|Withdrawal by Subject|0
1183020|NCT01068860|3884924|P2|Overall Study|Withdrawal by Subject|0
1183021|NCT01068860|3884925|P1|Overall Study|Withdrawal by Subject|0
1183022|NCT01068769|3885108|P1|Overall Study|Ineligible|1
1183023|NCT01068743|3885113|P4|Period 3|Adverse Event|0
1183024|NCT01068743|3885114|P3|Period 3|Adverse Event|0
1183025|NCT01068743|3885115|P2|Period 3|Adverse Event|1
1183026|NCT01068743|3885116|P1|Period 3|Adverse Event|0
1183027|NCT01068730|3885190|P4|Period 4|Family emergency|0
1183028|NCT01068730|3885191|P3|Period 4|Family emergency|0
1183029|NCT01068730|3885192|P2|Period 4|Family emergency|1
1183030|NCT01068730|3885193|P1|Period 4|Family emergency|0
1183031|NCT01068730|3885190|P4|Period 3|Personal reason|0
1183032|NCT01068730|3885191|P3|Period 3|Personal reason|0
1183033|NCT01068730|3885192|P2|Period 3|Personal reason|0
1183034|NCT01068730|3885193|P1|Period 3|Personal reason|1
1183035|NCT01068717|3885247|P4|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
1183036|NCT01068717|3885248|P3|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
1183037|NCT01068717|3885249|P2|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
1183038|NCT01068717|3885250|P1|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1
1183039|NCT01068678|3885306|P2|Overall Study|Unclassified|15
1183040|NCT01068678|3885307|P1|Overall Study|Unclassified|18
1183041|NCT01068678|3885306|P2|Overall Study|Withdrawal criteria|6
1183042|NCT01068678|3885307|P1|Overall Study|Withdrawal criteria|12
1183043|NCT01068678|3885306|P2|Overall Study|Protocol Violation|1
1183044|NCT01068678|3885307|P1|Overall Study|Protocol Violation|5
1183045|NCT01068678|3885306|P2|Overall Study|Lack of Efficacy|2
1183046|NCT01068678|3885307|P1|Overall Study|Lack of Efficacy|3
1183047|NCT01068665|3885317|P2|Overall Study|Other|12
1183048|NCT01068665|3885318|P1|Overall Study|Other|17
1183049|NCT01068665|3885317|P2|Overall Study|Withdrawal Criteria|9
1183050|NCT01068665|3885318|P1|Overall Study|Withdrawal Criteria|3
1183051|NCT01068665|3885317|P2|Overall Study|Protocol Violation|2
1183052|NCT01068665|3885318|P1|Overall Study|Protocol Violation|5
1183053|NCT01068665|3885317|P2|Overall Study|Lack of Efficacy|2
1183054|NCT01068665|3885318|P1|Overall Study|Lack of Efficacy|0
1183055|NCT01068665|3885317|P2|Overall Study|Adverse Event|4
1183056|NCT01068665|3885318|P1|Overall Study|Adverse Event|5
1183057|NCT01068652|3885328|P2|Overall Study|Unclassified|4
1183058|NCT01068652|3885329|P1|Overall Study|Unclassified|7
1183059|NCT01068652|3885328|P2|Overall Study|Patient was not eligible|0
1183060|NCT01068652|3885329|P1|Overall Study|Patient was not eligible|1
1183061|NCT01068652|3885328|P2|Overall Study|Withdrawal criteria|2
1183062|NCT01068652|3885329|P1|Overall Study|Withdrawal criteria|1
1183063|NCT01068652|3885328|P2|Overall Study|Protocol Violation|6
1183064|NCT01068652|3885329|P1|Overall Study|Protocol Violation|3
1183065|NCT01068652|3885328|P2|Overall Study|Lost to Follow-up|1
1183066|NCT01068652|3885329|P1|Overall Study|Lost to Follow-up|2
1183067|NCT01068652|3885328|P2|Overall Study|Lack of Efficacy|2
1183068|NCT01068652|3885329|P1|Overall Study|Lack of Efficacy|0
1183069|NCT01068652|3885328|P2|Overall Study|Adverse Event|0
1183070|NCT01068652|3885329|P1|Overall Study|Adverse Event|4
1183071|NCT01068626|3885369|P2|Overall Study|Withdrawal by Subject|2
1183072|NCT01068626|3885370|P1|Overall Study|Withdrawal by Subject|0
1183073|NCT01068626|3885369|P2|Overall Study|Adverse Event|0
1183074|NCT01068626|3885370|P1|Overall Study|Adverse Event|3
1183075|NCT01068600|3885388|P2|Overall Study|Administrative problems|1
1183076|NCT01068600|3885389|P1|Overall Study|Administrative problems|0
1183077|NCT01068600|3885388|P2|Overall Study|Unsatisfactory therapeutic effect|4
1183078|NCT01068600|3885389|P1|Overall Study|Unsatisfactory therapeutic effect|0
1183079|NCT01068600|3885388|P2|Overall Study|Protocol deviation|1
1183080|NCT01068600|3885389|P1|Overall Study|Protocol deviation|1
1183081|NCT01068600|3885388|P2|Overall Study|Lost to Follow-up|2
1183082|NCT01068600|3885389|P1|Overall Study|Lost to Follow-up|1
1183083|NCT01068600|3885388|P2|Overall Study|Abnormal laboratory value(s)|0
1183084|NCT01068600|3885389|P1|Overall Study|Abnormal laboratory value(s)|1
1183085|NCT01068600|3885388|P2|Overall Study|Adverse Event|3
1183086|NCT01068600|3885389|P1|Overall Study|Adverse Event|3
1183087|NCT01068600|3885388|P2|Overall Study|Withdrawal by Subject|6
1183088|NCT01068600|3885389|P1|Overall Study|Withdrawal by Subject|5
1183089|NCT01068509|3885409|P3|Overall Study|Reason Not Specified|0
1183090|NCT01068509|3885410|P2|Overall Study|Reason Not Specified|1
1183091|NCT01068509|3885411|P1|Overall Study|Reason Not Specified|0
1183092|NCT01068509|3885409|P3|Overall Study|Withdrew Consent|2
1183093|NCT01068509|3885410|P2|Overall Study|Withdrew Consent|1
1183094|NCT01068509|3885411|P1|Overall Study|Withdrew Consent|0
1183095|NCT01068509|3885409|P3|Overall Study|Lost to Follow-up|0
1183096|NCT01068509|3885410|P2|Overall Study|Lost to Follow-up|0
1183097|NCT01068509|3885411|P1|Overall Study|Lost to Follow-up|1
1183098|NCT01068509|3885409|P3|Overall Study|Disease Progression|18
1183099|NCT01068509|3885410|P2|Overall Study|Disease Progression|20
1183100|NCT01068509|3885411|P1|Overall Study|Disease Progression|5
1183101|NCT01068509|3885409|P3|Overall Study|Death|1
1183102|NCT01068509|3885410|P2|Overall Study|Death|0
1183103|NCT01068509|3885411|P1|Overall Study|Death|0
1183104|NCT01068418|3885424|P1|Overall Study|Physician Decision|12
1183105|NCT01068262|3885433|P4|Overall Study|Withdrawal by Subject|0
1183106|NCT01068262|3885434|P3|Overall Study|Withdrawal by Subject|0
1183107|NCT01068262|3885435|P2|Overall Study|Withdrawal by Subject|1
1183108|NCT01068262|3885436|P1|Overall Study|Withdrawal by Subject|0
1183109|NCT01068262|3885433|P4|Overall Study|Protocol Violation|0
1183110|NCT01068262|3885434|P3|Overall Study|Protocol Violation|0
1183111|NCT01068262|3885435|P2|Overall Study|Protocol Violation|0
1183112|NCT01068262|3885436|P1|Overall Study|Protocol Violation|1
1183113|NCT01068262|3885433|P4|Overall Study|Adverse Event|0
1183114|NCT01068262|3885434|P3|Overall Study|Adverse Event|1
1183115|NCT01068262|3885435|P2|Overall Study|Adverse Event|0
1183116|NCT01068262|3885436|P1|Overall Study|Adverse Event|2
1183117|NCT01068158|3885466|P2|Overall Study|Protocol Violation|2
1183118|NCT01068158|3885467|P1|Overall Study|Protocol Violation|0
1183119|NCT01068158|3885466|P2|Overall Study|Lost to Follow-up|0
1183120|NCT01068158|3885467|P1|Overall Study|Lost to Follow-up|7
1183121|NCT01068158|3885466|P2|Overall Study|Withdrawal by Subject|2
1183122|NCT01068158|3885467|P1|Overall Study|Withdrawal by Subject|1
1183123|NCT01067976|3885479|P1|Overall Study|Study prematurely discontinued|2
1183124|NCT01067976|3885479|P1|Overall Study|Study drug never administered|20
1183125|NCT01067846|3885540|P2|Overall Study|participation in other tx study|0
1183126|NCT01067846|3885541|P1|Overall Study|participation in other tx study|1
1183127|NCT01067846|3885540|P2|Overall Study|Withdrawal by Subject|0
1183128|NCT01067846|3885541|P1|Overall Study|Withdrawal by Subject|1
1183129|NCT01067846|3885540|P2|Overall Study|Lost to Follow-up|19
1183130|NCT01067846|3885541|P1|Overall Study|Lost to Follow-up|17
1183131|NCT01067521|3885599|P2|Open-Label Period|Lost to Follow-up|20
1183132|NCT01067521|3885600|P1|Open-Label Period|Lost to Follow-up|21
1183133|NCT01067521|3885599|P2|Open-Label Period|Teva requested subject to be withdrawn|2
1183134|NCT01067521|3885600|P1|Open-Label Period|Teva requested subject to be withdrawn|5
1183135|NCT01067521|3885599|P2|Open-Label Period|Pregnancy|8
1183136|NCT01067521|3885600|P1|Open-Label Period|Pregnancy|14
1183137|NCT01067521|3885599|P2|Open-Label Period|Protocol Violation|0
1183138|NCT01067521|3885600|P1|Open-Label Period|Protocol Violation|3
1183139|NCT01067521|3885599|P2|Open-Label Period|Non-compliance with study drug|0
1183140|NCT01067521|3885600|P1|Open-Label Period|Non-compliance with study drug|5
1183141|NCT01067521|3885599|P2|Open-Label Period|Physician Decision|11
1183142|NCT01067521|3885600|P1|Open-Label Period|Physician Decision|13
1183143|NCT01067521|3885599|P2|Open-Label Period|Withdrawal by Subject|88
1183144|NCT01067521|3885600|P1|Open-Label Period|Withdrawal by Subject|160
1183145|NCT01067521|3885599|P2|Open-Label Period|Adverse Event|28
1183146|NCT01067521|3885600|P1|Open-Label Period|Adverse Event|30
1183147|NCT01067521|3885599|P2|Open-Label Period|Death|1
1183148|NCT01067521|3885600|P1|Open-Label Period|Death|3
1183149|NCT01067521|3885599|P2|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1
1183150|NCT01067521|3885600|P1|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5
1183151|NCT01067521|3885599|P2|Double-Blind Placebo-Controlled Period|Pregnancy|4
1183152|NCT01067521|3885600|P1|Double-Blind Placebo-Controlled Period|Pregnancy|7
1183153|NCT01067521|3885599|P2|Double-Blind Placebo-Controlled Period|Protocol Violation|0
1183154|NCT01067521|3885600|P1|Double-Blind Placebo-Controlled Period|Protocol Violation|2
1183155|NCT01067521|3885599|P2|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0
1183156|NCT01067521|3885600|P1|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2
1183157|NCT01067521|3885599|P2|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1
1183158|NCT01067521|3885600|P1|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4
1183159|NCT01067521|3885599|P2|Double-Blind Placebo-Controlled Period|Physician Decision|1
1183160|NCT01067521|3885600|P1|Double-Blind Placebo-Controlled Period|Physician Decision|1
1183161|NCT01067521|3885599|P2|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17
1183162|NCT01067521|3885600|P1|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34
1183163|NCT01067521|3885599|P2|Double-Blind Placebo-Controlled Period|Adverse Event|6
1183164|NCT01067521|3885600|P1|Double-Blind Placebo-Controlled Period|Adverse Event|29
1183165|NCT01067521|3885599|P2|Double-Blind Placebo-Controlled Period|Death|1
1183166|NCT01067521|3885600|P1|Double-Blind Placebo-Controlled Period|Death|0
1183167|NCT01067352|3885640|P3|Overall Study|Physician Decision|0
1183168|NCT01067352|3885641|P2|Overall Study|Physician Decision|1
1183169|NCT01067352|3885642|P1|Overall Study|Physician Decision|0
1183170|NCT01067352|3885640|P3|Overall Study|Withdrawal by Subject|1
1183171|NCT01067352|3885641|P2|Overall Study|Withdrawal by Subject|2
1183172|NCT01067352|3885642|P1|Overall Study|Withdrawal by Subject|1
1183173|NCT01067339|3885658|P2|Overall Study|Withdrawal by Subject|5
1183174|NCT01067339|3885659|P1|Overall Study|Withdrawal by Subject|6
1183175|NCT01067326|3885669|P2|Overall Study|Early Study Termination|1
1183176|NCT01067326|3885670|P1|Overall Study|Early Study Termination|1
1183177|NCT01067326|3885669|P2|Overall Study|Withdrawal by Subject|0
1183178|NCT01067326|3885670|P1|Overall Study|Withdrawal by Subject|1
1183179|NCT01067326|3885669|P2|Overall Study|Adverse Event|2
1183180|NCT01067326|3885670|P1|Overall Study|Adverse Event|0
1183181|NCT01067144|3885684|P2|Follow-up|Death|1
1183182|NCT01067144|3885685|P1|Follow-up|Death|0
1183183|NCT01067144|3885684|P2|Follow-up|Surgery cancelled|1
1183184|NCT01067144|3885685|P1|Follow-up|Surgery cancelled|0
1183185|NCT01067144|3885684|P2|Follow-up|Withdrawal by Subject|14
1183186|NCT01067144|3885685|P1|Follow-up|Withdrawal by Subject|18
1183187|NCT01067144|3885684|P2|Follow-up|Censored owing to second surgery|28
1183188|NCT01067144|3885685|P1|Follow-up|Censored owing to second surgery|19
1183189|NCT01067144|3885684|P2|Follow-up|Lost to Follow-up|12
1183190|NCT01067144|3885685|P1|Follow-up|Lost to Follow-up|22
1183191|NCT01067144|3885684|P2|Treatment|Did not receive allocated intervention|7
1183192|NCT01067144|3885685|P1|Treatment|Did not receive allocated intervention|4
1183193|NCT01067105|3885701|P1|Overall Study|Other|31
1183194|NCT01067105|3885701|P1|Overall Study|Physician Decision|6
1183195|NCT01067105|3885701|P1|Overall Study|Lost to Follow-up|6
1183196|NCT01067105|3885701|P1|Overall Study|Withdrawal by Subject|36
1183197|NCT01067105|3885701|P1|Overall Study|Protocol Violation|48
1183198|NCT01067105|3885701|P1|Overall Study|Adverse Event|14
1183199|NCT01066923|3885722|P4|Overall Study|Withdrawal by Subject|8
1183200|NCT01066923|3885723|P3|Overall Study|Withdrawal by Subject|8
1183201|NCT01066923|3885724|P2|Overall Study|Withdrawal by Subject|3
1183202|NCT01066923|3885725|P1|Overall Study|Withdrawal by Subject|3
1183203|NCT01066897|3885749|P2|Overall Study|stopped study after developing the flu.|0
1183204|NCT01066897|3885750|P1|Overall Study|stopped study after developing the flu.|1
1183205|NCT01066897|3885749|P2|Overall Study|Withdrawal by Subject|0
1183206|NCT01066897|3885750|P1|Overall Study|Withdrawal by Subject|1
1183207|NCT01066871|3885764|P4|Overall Study|Other|2
1183208|NCT01066871|3885765|P3|Overall Study|Other|1
1183209|NCT01066871|3885766|P2|Overall Study|Other|2
1183210|NCT01066871|3885767|P1|Overall Study|Other|0
1183211|NCT01066871|3885764|P4|Overall Study|Withdrawal by Subject|0
1183212|NCT01066871|3885765|P3|Overall Study|Withdrawal by Subject|0
1183213|NCT01066871|3885766|P2|Overall Study|Withdrawal by Subject|1
1183214|NCT01066871|3885767|P1|Overall Study|Withdrawal by Subject|3
1183215|NCT01066871|3885764|P4|Overall Study|Lack of Efficacy|1
1183216|NCT01066871|3885765|P3|Overall Study|Lack of Efficacy|0
1183217|NCT01066871|3885766|P2|Overall Study|Lack of Efficacy|0
1183218|NCT01066871|3885767|P1|Overall Study|Lack of Efficacy|0
1183219|NCT01066871|3885764|P4|Overall Study|Protocol Violation|2
1183220|NCT01066871|3885765|P3|Overall Study|Protocol Violation|3
1183221|NCT01066871|3885766|P2|Overall Study|Protocol Violation|0
1183222|NCT01066871|3885767|P1|Overall Study|Protocol Violation|1
1183223|NCT01066871|3885764|P4|Overall Study|Lost to Follow-up|0
1183224|NCT01066871|3885765|P3|Overall Study|Lost to Follow-up|2
1183225|NCT01066871|3885766|P2|Overall Study|Lost to Follow-up|2
1183226|NCT01066871|3885767|P1|Overall Study|Lost to Follow-up|0
1183227|NCT01066819|3885831|P6|Overall Study|Other|0
1183228|NCT01066819|3885832|P5|Overall Study|Other|0
1183229|NCT01066819|3885833|P4|Overall Study|Other|0
1183230|NCT01066819|3885834|P3|Overall Study|Other|1
1183231|NCT01066819|3885835|P2|Overall Study|Other|1
1183232|NCT01066819|3885836|P1|Overall Study|Other|5
1183233|NCT01066819|3885831|P6|Overall Study|Treatment stopped|0
1183234|NCT01066819|3885832|P5|Overall Study|Treatment stopped|0
1183235|NCT01066819|3885833|P4|Overall Study|Treatment stopped|1
1183236|NCT01066819|3885834|P3|Overall Study|Treatment stopped|2
1183237|NCT01066819|3885835|P2|Overall Study|Treatment stopped|1
1183238|NCT01066819|3885836|P1|Overall Study|Treatment stopped|12
1183239|NCT01066819|3885831|P6|Overall Study|Treatment never started|2
1183240|NCT01066819|3885832|P5|Overall Study|Treatment never started|2
1183241|NCT01066819|3885833|P4|Overall Study|Treatment never started|3
1183242|NCT01066819|3885834|P3|Overall Study|Treatment never started|19
1183243|NCT01066819|3885835|P2|Overall Study|Treatment never started|19
1183244|NCT01066819|3885836|P1|Overall Study|Treatment never started|85
1183245|NCT01066819|3885831|P6|Overall Study|Spontaneous cure|0
1183246|NCT01066819|3885832|P5|Overall Study|Spontaneous cure|0
1183247|NCT01066819|3885833|P4|Overall Study|Spontaneous cure|0
1183248|NCT01066819|3885834|P3|Overall Study|Spontaneous cure|0
1183249|NCT01066819|3885835|P2|Overall Study|Spontaneous cure|0
1183250|NCT01066819|3885836|P1|Overall Study|Spontaneous cure|1
1183251|NCT01066819|3885831|P6|Overall Study|Screen failure|0
1183252|NCT01066819|3885832|P5|Overall Study|Screen failure|0
1183253|NCT01066819|3885833|P4|Overall Study|Screen failure|0
1183254|NCT01066819|3885834|P3|Overall Study|Screen failure|0
1183255|NCT01066819|3885835|P2|Overall Study|Screen failure|0
1183256|NCT01066819|3885836|P1|Overall Study|Screen failure|1
1183257|NCT01066819|3885831|P6|Overall Study|Results not available|0
1183258|NCT01066819|3885832|P5|Overall Study|Results not available|0
1183259|NCT01066819|3885833|P4|Overall Study|Results not available|0
1183260|NCT01066819|3885834|P3|Overall Study|Results not available|0
1183261|NCT01066819|3885835|P2|Overall Study|Results not available|0
1183262|NCT01066819|3885836|P1|Overall Study|Results not available|1
1183263|NCT01066819|3885831|P6|Overall Study|Relapse|0
1183264|NCT01066819|3885832|P5|Overall Study|Relapse|0
1183265|NCT01066819|3885833|P4|Overall Study|Relapse|0
1183266|NCT01066819|3885834|P3|Overall Study|Relapse|3
1183267|NCT01066819|3885835|P2|Overall Study|Relapse|4
1183268|NCT01066819|3885836|P1|Overall Study|Relapse|16
1183269|NCT01066819|3885831|P6|Overall Study|Not categorised|0
1183270|NCT01066819|3885832|P5|Overall Study|Not categorised|0
1183271|NCT01066819|3885833|P4|Overall Study|Not categorised|1
1183272|NCT01066819|3885834|P3|Overall Study|Not categorised|6
1183273|NCT01066819|3885835|P2|Overall Study|Not categorised|2
1183274|NCT01066819|3885836|P1|Overall Study|Not categorised|9
1183275|NCT01066819|3885831|P6|Overall Study|Non responders|1
1183276|NCT01066819|3885832|P5|Overall Study|Non responders|0
1183277|NCT01066819|3885833|P4|Overall Study|Non responders|2
1183278|NCT01066819|3885834|P3|Overall Study|Non responders|7
1183279|NCT01066819|3885835|P2|Overall Study|Non responders|2
1183280|NCT01066819|3885836|P1|Overall Study|Non responders|123
1183281|NCT01066819|3885831|P6|Overall Study|Miscellaneous|0
1183282|NCT01066819|3885832|P5|Overall Study|Miscellaneous|0
1183283|NCT01066819|3885833|P4|Overall Study|Miscellaneous|1
1183284|NCT01066819|3885834|P3|Overall Study|Miscellaneous|18
1183285|NCT01066819|3885835|P2|Overall Study|Miscellaneous|10
1183286|NCT01066819|3885836|P1|Overall Study|Miscellaneous|28
1183287|NCT01066819|3885831|P6|Overall Study|Lab test not done|0
1183288|NCT01066819|3885832|P5|Overall Study|Lab test not done|0
1183289|NCT01066819|3885833|P4|Overall Study|Lab test not done|1
1183290|NCT01066819|3885834|P3|Overall Study|Lab test not done|2
1183291|NCT01066819|3885835|P2|Overall Study|Lab test not done|0
1183292|NCT01066819|3885836|P1|Overall Study|Lab test not done|9
1183293|NCT01066819|3885831|P6|Overall Study|Failed to return|3
1183294|NCT01066819|3885832|P5|Overall Study|Failed to return|2
1183295|NCT01066819|3885833|P4|Overall Study|Failed to return|7
1183296|NCT01066819|3885834|P3|Overall Study|Failed to return|68
1183297|NCT01066819|3885835|P2|Overall Study|Failed to return|107
1183298|NCT01066819|3885836|P1|Overall Study|Failed to return|298
1183299|NCT01066819|3885831|P6|Overall Study|Early termination|0
1183300|NCT01066819|3885832|P5|Overall Study|Early termination|0
1183301|NCT01066819|3885833|P4|Overall Study|Early termination|0
1183302|NCT01066819|3885834|P3|Overall Study|Early termination|0
1183303|NCT01066819|3885835|P2|Overall Study|Early termination|0
1183304|NCT01066819|3885836|P1|Overall Study|Early termination|2
1183305|NCT01066819|3885831|P6|Overall Study|Not met inclusion/exclusion criteria|0
1183306|NCT01066819|3885832|P5|Overall Study|Not met inclusion/exclusion criteria|0
1183307|NCT01066819|3885833|P4|Overall Study|Not met inclusion/exclusion criteria|0
1183308|NCT01066819|3885834|P3|Overall Study|Not met inclusion/exclusion criteria|0
1183309|NCT01066819|3885835|P2|Overall Study|Not met inclusion/exclusion criteria|0
1183310|NCT01066819|3885836|P1|Overall Study|Not met inclusion/exclusion criteria|1
1183311|NCT01066819|3885831|P6|Overall Study|Administrative|0
1183312|NCT01066819|3885832|P5|Overall Study|Administrative|0
1183313|NCT01066819|3885833|P4|Overall Study|Administrative|0
1183314|NCT01066819|3885834|P3|Overall Study|Administrative|2
1183315|NCT01066819|3885835|P2|Overall Study|Administrative|4
1183316|NCT01066819|3885836|P1|Overall Study|Administrative|6
1183317|NCT01066819|3885831|P6|Overall Study|Withdrawal by Subject|0
1183318|NCT01066819|3885832|P5|Overall Study|Withdrawal by Subject|0
1183319|NCT01066819|3885833|P4|Overall Study|Withdrawal by Subject|0
1183320|NCT01066819|3885834|P3|Overall Study|Withdrawal by Subject|6
1183321|NCT01066819|3885835|P2|Overall Study|Withdrawal by Subject|11
1183322|NCT01066819|3885836|P1|Overall Study|Withdrawal by Subject|29
1183323|NCT01066819|3885831|P6|Overall Study|Protocol Violation|0
1183324|NCT01066819|3885832|P5|Overall Study|Protocol Violation|0
1183325|NCT01066819|3885833|P4|Overall Study|Protocol Violation|0
1183326|NCT01066819|3885834|P3|Overall Study|Protocol Violation|0
1183327|NCT01066819|3885835|P2|Overall Study|Protocol Violation|6
1183328|NCT01066819|3885836|P1|Overall Study|Protocol Violation|12
1183329|NCT01066819|3885831|P6|Overall Study|Physician Decision|0
1183330|NCT01066819|3885832|P5|Overall Study|Physician Decision|0
1183331|NCT01066819|3885833|P4|Overall Study|Physician Decision|0
1183332|NCT01066819|3885834|P3|Overall Study|Physician Decision|3
1183333|NCT01066819|3885835|P2|Overall Study|Physician Decision|2
1183334|NCT01066819|3885836|P1|Overall Study|Physician Decision|6
1183335|NCT01066819|3885831|P6|Overall Study|Lack of Efficacy|0
1183336|NCT01066819|3885832|P5|Overall Study|Lack of Efficacy|0
1183337|NCT01066819|3885833|P4|Overall Study|Lack of Efficacy|1
1183338|NCT01066819|3885834|P3|Overall Study|Lack of Efficacy|2
1183339|NCT01066819|3885835|P2|Overall Study|Lack of Efficacy|1
1183340|NCT01066819|3885836|P1|Overall Study|Lack of Efficacy|22
1183341|NCT01066819|3885831|P6|Overall Study|Death|0
1183342|NCT01066819|3885832|P5|Overall Study|Death|0
1183343|NCT01066819|3885833|P4|Overall Study|Death|0
1183344|NCT01066819|3885834|P3|Overall Study|Death|1
1183345|NCT01066819|3885835|P2|Overall Study|Death|0
1183346|NCT01066819|3885836|P1|Overall Study|Death|5
1183347|NCT01066819|3885831|P6|Overall Study|Adverse Event|0
1183348|NCT01066819|3885832|P5|Overall Study|Adverse Event|0
1183349|NCT01066819|3885833|P4|Overall Study|Adverse Event|0
1183350|NCT01066819|3885834|P3|Overall Study|Adverse Event|6
1183351|NCT01066819|3885835|P2|Overall Study|Adverse Event|1
1183352|NCT01066819|3885836|P1|Overall Study|Adverse Event|18
1183353|NCT01066793|3885977|P6|Overall Study|Treatment Stopped|0
1183354|NCT01066793|3885978|P5|Overall Study|Treatment Stopped|0
1183355|NCT01066793|3885979|P4|Overall Study|Treatment Stopped|1
1183356|NCT01066793|3885980|P3|Overall Study|Treatment Stopped|0
1183357|NCT01066793|3885981|P2|Overall Study|Treatment Stopped|1
1183358|NCT01066793|3885982|P1|Overall Study|Treatment Stopped|2
1183359|NCT01066793|3885977|P6|Overall Study|Treatment Never Started|0
1183360|NCT01066793|3885978|P5|Overall Study|Treatment Never Started|0
1183361|NCT01066793|3885979|P4|Overall Study|Treatment Never Started|1
1183362|NCT01066793|3885980|P3|Overall Study|Treatment Never Started|4
1183363|NCT01066793|3885981|P2|Overall Study|Treatment Never Started|5
1183364|NCT01066793|3885982|P1|Overall Study|Treatment Never Started|18
1183365|NCT01066793|3885977|P6|Overall Study|Treatment Interrupted|0
1183366|NCT01066793|3885978|P5|Overall Study|Treatment Interrupted|0
1183367|NCT01066793|3885979|P4|Overall Study|Treatment Interrupted|0
1183368|NCT01066793|3885980|P3|Overall Study|Treatment Interrupted|0
1183369|NCT01066793|3885981|P2|Overall Study|Treatment Interrupted|1
1183370|NCT01066793|3885982|P1|Overall Study|Treatment Interrupted|1
1183371|NCT01066793|3885977|P6|Overall Study|Result Not Available|0
1183372|NCT01066793|3885978|P5|Overall Study|Result Not Available|0
1183373|NCT01066793|3885979|P4|Overall Study|Result Not Available|0
1183374|NCT01066793|3885980|P3|Overall Study|Result Not Available|0
1183375|NCT01066793|3885981|P2|Overall Study|Result Not Available|0
1183376|NCT01066793|3885982|P1|Overall Study|Result Not Available|1
1183377|NCT01066793|3885977|P6|Overall Study|Relapse|0
1183378|NCT01066793|3885978|P5|Overall Study|Relapse|0
1183379|NCT01066793|3885979|P4|Overall Study|Relapse|3
1183380|NCT01066793|3885980|P3|Overall Study|Relapse|2
1183381|NCT01066793|3885981|P2|Overall Study|Relapse|8
1183382|NCT01066793|3885982|P1|Overall Study|Relapse|20
1183383|NCT01066793|3885977|P6|Overall Study|Other|0
1183384|NCT01066793|3885978|P5|Overall Study|Other|0
1183385|NCT01066793|3885979|P4|Overall Study|Other|2
1183386|NCT01066793|3885980|P3|Overall Study|Other|6
1183387|NCT01066793|3885981|P2|Overall Study|Other|5
1183388|NCT01066793|3885982|P1|Overall Study|Other|15
1183389|NCT01066793|3885977|P6|Overall Study|Non-responders|0
1183390|NCT01066793|3885978|P5|Overall Study|Non-responders|0
1183391|NCT01066793|3885979|P4|Overall Study|Non-responders|25
1183392|NCT01066793|3885980|P3|Overall Study|Non-responders|11
1183393|NCT01066793|3885981|P2|Overall Study|Non-responders|5
1183394|NCT01066793|3885982|P1|Overall Study|Non-responders|104
1183395|NCT01066793|3885977|P6|Overall Study|Miscellaneous|0
1183396|NCT01066793|3885978|P5|Overall Study|Miscellaneous|0
1183397|NCT01066793|3885979|P4|Overall Study|Miscellaneous|0
1183398|NCT01066793|3885980|P3|Overall Study|Miscellaneous|6
1183399|NCT01066793|3885981|P2|Overall Study|Miscellaneous|5
1183400|NCT01066793|3885982|P1|Overall Study|Miscellaneous|4
1183401|NCT01066793|3885977|P6|Overall Study|Lab test not done|0
1183402|NCT01066793|3885978|P5|Overall Study|Lab test not done|0
1183403|NCT01066793|3885979|P4|Overall Study|Lab test not done|1
1183404|NCT01066793|3885980|P3|Overall Study|Lab test not done|0
1183405|NCT01066793|3885981|P2|Overall Study|Lab test not done|0
1183406|NCT01066793|3885982|P1|Overall Study|Lab test not done|7
1183407|NCT01066793|3885977|P6|Overall Study|Early Termination|0
1183408|NCT01066793|3885978|P5|Overall Study|Early Termination|0
1183409|NCT01066793|3885979|P4|Overall Study|Early Termination|0
1183410|NCT01066793|3885980|P3|Overall Study|Early Termination|0
1183411|NCT01066793|3885981|P2|Overall Study|Early Termination|0
1183412|NCT01066793|3885982|P1|Overall Study|Early Termination|3
1183413|NCT01066793|3885977|P6|Overall Study|Withdrawal by Subject|0
1183414|NCT01066793|3885978|P5|Overall Study|Withdrawal by Subject|0
1183415|NCT01066793|3885979|P4|Overall Study|Withdrawal by Subject|0
1183416|NCT01066793|3885980|P3|Overall Study|Withdrawal by Subject|1
1183417|NCT01066793|3885981|P2|Overall Study|Withdrawal by Subject|4
1183418|NCT01066793|3885982|P1|Overall Study|Withdrawal by Subject|7
1183419|NCT01066793|3885977|P6|Overall Study|Protocol Violation|0
1183420|NCT01066793|3885978|P5|Overall Study|Protocol Violation|0
1183421|NCT01066793|3885979|P4|Overall Study|Protocol Violation|0
1183422|NCT01066793|3885980|P3|Overall Study|Protocol Violation|2
1183423|NCT01066793|3885981|P2|Overall Study|Protocol Violation|2
1183424|NCT01066793|3885982|P1|Overall Study|Protocol Violation|3
1183425|NCT01066793|3885977|P6|Overall Study|Physician Decision|0
1183426|NCT01066793|3885978|P5|Overall Study|Physician Decision|0
1183427|NCT01066793|3885979|P4|Overall Study|Physician Decision|0
1183428|NCT01066793|3885980|P3|Overall Study|Physician Decision|0
1183429|NCT01066793|3885981|P2|Overall Study|Physician Decision|0
1183430|NCT01066793|3885982|P1|Overall Study|Physician Decision|3
1183431|NCT01066793|3885977|P6|Overall Study|Lost to Follow-up|1
1183432|NCT01066793|3885978|P5|Overall Study|Lost to Follow-up|0
1183433|NCT01066793|3885979|P4|Overall Study|Lost to Follow-up|16
1183434|NCT01066793|3885980|P3|Overall Study|Lost to Follow-up|82
1183435|NCT01066793|3885981|P2|Overall Study|Lost to Follow-up|39
1183436|NCT01066793|3885982|P1|Overall Study|Lost to Follow-up|180
1183437|NCT01066793|3885977|P6|Overall Study|Lack of Efficacy|0
1183438|NCT01066793|3885978|P5|Overall Study|Lack of Efficacy|0
1183439|NCT01066793|3885979|P4|Overall Study|Lack of Efficacy|0
1183440|NCT01066793|3885980|P3|Overall Study|Lack of Efficacy|0
1183441|NCT01066793|3885981|P2|Overall Study|Lack of Efficacy|1
1183442|NCT01066793|3885982|P1|Overall Study|Lack of Efficacy|2
1183443|NCT01066793|3885977|P6|Overall Study|Death|0
1183444|NCT01066793|3885978|P5|Overall Study|Death|0
1183445|NCT01066793|3885979|P4|Overall Study|Death|0
1183446|NCT01066793|3885980|P3|Overall Study|Death|1
1183447|NCT01066793|3885981|P2|Overall Study|Death|1
1183448|NCT01066793|3885982|P1|Overall Study|Death|4
1183449|NCT01066780|3886122|P2|Overall Study|Withdrawn prior to ClearVoice exposure.|1
1183450|NCT01066780|3886123|P1|Overall Study|Withdrawn prior to ClearVoice exposure.|1
1183451|NCT01066585|3886142|P2|Overall Study|Withdrawal by Subject|3
1183452|NCT01066585|3886143|P1|Overall Study|Withdrawal by Subject|0
1183453|NCT01066585|3886142|P2|Overall Study|Protocol Violation|0
1183454|NCT01066585|3886143|P1|Overall Study|Protocol Violation|1
1183455|NCT01066546|3886155|P1|Overall Study|Study terminated by sponsor|5
1183456|NCT01066156|3886185|P1|Overall Study|Withdrawal by Subject|1
1183457|NCT01066156|3886185|P1|Overall Study|Lost to Follow-up|7
1183458|NCT01066156|3886185|P1|Overall Study|ineligible|2
1183459|NCT01066143|3886189|P1|Overall Study|ineligible for the study|8
1183460|NCT01066104|3886195|P2|Overall Study|Protocol Violation|0
1183461|NCT01066104|3886196|P1|Overall Study|Protocol Violation|1
1183462|NCT01066104|3886195|P2|Overall Study|Adverse Event|1
1183463|NCT01066104|3886196|P1|Overall Study|Adverse Event|1
1183464|NCT01066052|3886206|P2|Overall Study|Enrolled But Not Treated|0
1183465|NCT01066052|3886207|P1|Overall Study|Enrolled But Not Treated|3
1183466|NCT01066039|3886218|P1|Overall Study|Drug/Dose Adjustment Required|1
1183467|NCT01066039|3886218|P1|Overall Study|Failure to Control Blood Pressure|1
1183468|NCT01066039|3886218|P1|Overall Study|Volunteer Failed to Make the Next Visit|2
1183469|NCT01066039|3886218|P1|Overall Study|Additional Antihypertensive Required|4
1183470|NCT01066039|3886218|P1|Overall Study|Dropout due to Insulin Administration|1
1183471|NCT01066039|3886218|P1|Overall Study|Investigator’s Request|1
1183472|NCT01066039|3886218|P1|Overall Study|Inclusion/Exclusion Criteria Violation|9
1183473|NCT01066039|3886218|P1|Overall Study|Protocol Violation|2
1183474|NCT01066039|3886218|P1|Overall Study|Withdrawal by Subject|17
1183475|NCT01066039|3886218|P1|Overall Study|Adverse Event|6
1183476|NCT01066000|3886231|P1|Overall Study|Adverse Event|1
1183477|NCT01066000|3886231|P1|Overall Study|Withdrawal by Subject|1
1183478|NCT01066000|3886231|P1|Overall Study|Death|3
1183479|NCT01066000|3886231|P1|Overall Study|Protocol Violation|4
1183480|NCT01065844|3886242|P1|Overall Study|Adverse Event|5
1183481|NCT01065818|3886246|P1|Overall Study|Not a candidate for surgery|1
1183482|NCT01065818|3886246|P1|Overall Study|Withdrawal by Subject|1
1183483|NCT01065779|3886250|P1|Overall Study|Inclusion Criteria Violation|7
1183484|NCT01065779|3886250|P1|Overall Study|Failed to Follow-up|10
1183485|NCT01065779|3886250|P1|Overall Study|Not Administered With Study Drug|17
1183486|NCT01065779|3886250|P1|Overall Study|Non-enrollment Period Administration|10
1183487|NCT01065779|3886250|P1|Overall Study|Investigation Before Contract Date|37
1183488|NCT01065779|3886250|P1|Overall Study|Duplicate Investigation|1
1183489|NCT01065766|3886261|P1|Overall Study|Violated dosage/administration|25
1183490|NCT01065766|3886261|P1|Overall Study|Contraindication to administration|6
1183491|NCT01065766|3886261|P1|Overall Study|Assessed before the contracted date|1
1183492|NCT01065597|3886280|P1|Overall Study|Adverse Event|1
1183493|NCT01065454|3886314|P4|Follow up|study ongoing|41
1183494|NCT01065454|3886315|P3|Follow up|study ongoing|15
1183495|NCT01065454|3886316|P2|Follow up|study ongoing|22
1183496|NCT01065454|3886317|P1|Follow up|study ongoing|37
1183497|NCT01065454|3886314|P4|Follow up|Withdrawal by Subject|0
1183498|NCT01065454|3886315|P3|Follow up|Withdrawal by Subject|1
1183499|NCT01065454|3886316|P2|Follow up|Withdrawal by Subject|1
1183500|NCT01065454|3886317|P1|Follow up|Withdrawal by Subject|1
1183501|NCT01065454|3886314|P4|Follow up|Progressive disease|1
1183502|NCT01065454|3886315|P3|Follow up|Progressive disease|0
1183503|NCT01065454|3886316|P2|Follow up|Progressive disease|0
1183504|NCT01065454|3886317|P1|Follow up|Progressive disease|0
1183505|NCT01065454|3886314|P4|Follow up|Lost to Follow-up|1
1183506|NCT01065454|3886315|P3|Follow up|Lost to Follow-up|0
1183507|NCT01065454|3886316|P2|Follow up|Lost to Follow-up|0
1183508|NCT01065454|3886317|P1|Follow up|Lost to Follow-up|0
1183509|NCT01065454|3886314|P4|Follow up|Death|0
1183510|NCT01065454|3886315|P3|Follow up|Death|1
1183511|NCT01065454|3886316|P2|Follow up|Death|1
1183512|NCT01065454|3886317|P1|Follow up|Death|0
1183513|NCT01065454|3886314|P4|Follow up|Adverse Event|1
1183514|NCT01065454|3886315|P3|Follow up|Adverse Event|0
1183515|NCT01065454|3886316|P2|Follow up|Adverse Event|0
1183516|NCT01065454|3886317|P1|Follow up|Adverse Event|1
1183517|NCT01065454|3886314|P4|Treatment|Withdrawal by Subject|3
1183518|NCT01065454|3886315|P3|Treatment|Withdrawal by Subject|2
1183519|NCT01065454|3886316|P2|Treatment|Withdrawal by Subject|1
1183520|NCT01065454|3886317|P1|Treatment|Withdrawal by Subject|3
1183521|NCT01065454|3886314|P4|Treatment|Protocol Violation|0
1183522|NCT01065454|3886315|P3|Treatment|Protocol Violation|1
1183523|NCT01065454|3886316|P2|Treatment|Protocol Violation|0
1183524|NCT01065454|3886317|P1|Treatment|Protocol Violation|1
1183525|NCT01065454|3886314|P4|Treatment|Protocol Decision|2
1183526|NCT01065454|3886315|P3|Treatment|Protocol Decision|3
1183527|NCT01065454|3886316|P2|Treatment|Protocol Decision|0
1183528|NCT01065454|3886317|P1|Treatment|Protocol Decision|0
1183529|NCT01065454|3886314|P4|Treatment|Non-compliance|1
1183530|NCT01065454|3886315|P3|Treatment|Non-compliance|0
1183531|NCT01065454|3886316|P2|Treatment|Non-compliance|0
1183532|NCT01065454|3886317|P1|Treatment|Non-compliance|1
1183533|NCT01065454|3886314|P4|Treatment|Death|0
1183534|NCT01065454|3886315|P3|Treatment|Death|0
1183535|NCT01065454|3886316|P2|Treatment|Death|0
1183536|NCT01065454|3886317|P1|Treatment|Death|1
1183537|NCT01065454|3886314|P4|Treatment|Adverse Event|6
1183538|NCT01065454|3886315|P3|Treatment|Adverse Event|3
1183539|NCT01065454|3886316|P2|Treatment|Adverse Event|4
1183540|NCT01065454|3886317|P1|Treatment|Adverse Event|7
1183541|NCT01065350|3886440|P2|Overall Study|Received incorrect drug allocation|1
1183542|NCT01065350|3886441|P1|Overall Study|Received incorrect drug allocation|0
1183543|NCT01064947|3886502|P1|Overall Study|negative culture|41
1183544|NCT01064856|3886543|P4|Open-label (OL) Period|Not specified|7
1183545|NCT01064856|3886544|P3|Open-label (OL) Period|Not specified|7
1183546|NCT01064856|3886545|P2|Open-label (OL) Period|Not specified|0
1183547|NCT01064856|3886546|P1|Open-label (OL) Period|Not specified|0
1183548|NCT01064856|3886543|P4|Open-label (OL) Period|Lost to Follow-up|1
1183549|NCT01064856|3886544|P3|Open-label (OL) Period|Lost to Follow-up|2
1183550|NCT01064856|3886545|P2|Open-label (OL) Period|Lost to Follow-up|0
1183551|NCT01064856|3886546|P1|Open-label (OL) Period|Lost to Follow-up|0
1183552|NCT01064856|3886543|P4|Open-label (OL) Period|Consent withdrawn by participant|6
1183553|NCT01064856|3886544|P3|Open-label (OL) Period|Consent withdrawn by participant|5
1183554|NCT01064856|3886545|P2|Open-label (OL) Period|Consent withdrawn by participant|0
1183555|NCT01064856|3886546|P1|Open-label (OL) Period|Consent withdrawn by participant|0
1183556|NCT01064856|3886543|P4|Open-label (OL) Period|Adverse Event|6
1183557|NCT01064856|3886544|P3|Open-label (OL) Period|Adverse Event|12
1183558|NCT01064856|3886545|P2|Open-label (OL) Period|Adverse Event|0
1183559|NCT01064856|3886546|P1|Open-label (OL) Period|Adverse Event|0
1183560|NCT01064856|3886543|P4|Double-blind (DB) Period|Consent withdrawn by participant|0
1183561|NCT01064856|3886544|P3|Double-blind (DB) Period|Consent withdrawn by participant|0
1183562|NCT01064856|3886545|P2|Double-blind (DB) Period|Consent withdrawn by participant|0
1183563|NCT01064856|3886546|P1|Double-blind (DB) Period|Consent withdrawn by participant|1
1183564|NCT01064856|3886543|P4|Double-blind (DB) Period|Adverse Event|0
1183565|NCT01064856|3886544|P3|Double-blind (DB) Period|Adverse Event|0
1183566|NCT01064856|3886545|P2|Double-blind (DB) Period|Adverse Event|0
1183567|NCT01064856|3886546|P1|Double-blind (DB) Period|Adverse Event|1
1183568|NCT01064817|3886590|P2|Study Completion|Withdrawal by Subject|0
1183569|NCT01064817|3886591|P1|Study Completion|Withdrawal by Subject|1
1183570|NCT01064817|3886590|P2|Study Completion|Physician Decision|0
1183571|NCT01064817|3886591|P1|Study Completion|Physician Decision|1
1183572|NCT01064739|3886603|P1|Fixed Sodium Diet + Fava Beans|Adverse Event|1
1183573|NCT01064687|3886674|P4|Overall Study|Treatment Noncompliance|0
1183574|NCT01064687|3886675|P3|Overall Study|Treatment Noncompliance|1
1183575|NCT01064687|3886676|P2|Overall Study|Treatment Noncompliance|1
1183576|NCT01064687|3886677|P1|Overall Study|Treatment Noncompliance|1
1183577|NCT01064687|3886674|P4|Overall Study|Withdrawal by Subject|5
1183578|NCT01064687|3886675|P3|Overall Study|Withdrawal by Subject|12
1183579|NCT01064687|3886676|P2|Overall Study|Withdrawal by Subject|7
1183580|NCT01064687|3886677|P1|Overall Study|Withdrawal by Subject|9
1183581|NCT01064687|3886674|P4|Overall Study|Sponsor Decision|0
1183582|NCT01064687|3886675|P3|Overall Study|Sponsor Decision|3
1183583|NCT01064687|3886676|P2|Overall Study|Sponsor Decision|0
1183584|NCT01064687|3886677|P1|Overall Study|Sponsor Decision|0
1183585|NCT01064687|3886674|P4|Overall Study|Protocol Violation|1
1183586|NCT01064687|3886675|P3|Overall Study|Protocol Violation|0
1183587|NCT01064687|3886676|P2|Overall Study|Protocol Violation|1
1183588|NCT01064687|3886677|P1|Overall Study|Protocol Violation|1
1183589|NCT01064687|3886674|P4|Overall Study|Physician Decision|0
1183590|NCT01064687|3886675|P3|Overall Study|Physician Decision|0
1183591|NCT01064687|3886676|P2|Overall Study|Physician Decision|2
1183592|NCT01064687|3886677|P1|Overall Study|Physician Decision|2
1183593|NCT01064687|3886674|P4|Overall Study|Lost to Follow-up|5
1183594|NCT01064687|3886675|P3|Overall Study|Lost to Follow-up|13
1183595|NCT01064687|3886676|P2|Overall Study|Lost to Follow-up|10
1183596|NCT01064687|3886677|P1|Overall Study|Lost to Follow-up|7
1183597|NCT01064687|3886674|P4|Overall Study|Lack of Efficacy|3
1183598|NCT01064687|3886675|P3|Overall Study|Lack of Efficacy|2
1183599|NCT01064687|3886676|P2|Overall Study|Lack of Efficacy|0
1183600|NCT01064687|3886677|P1|Overall Study|Lack of Efficacy|1
1183601|NCT01064687|3886674|P4|Overall Study|Entry Criteria Not Met|0
1183602|NCT01064687|3886675|P3|Overall Study|Entry Criteria Not Met|0
1183603|NCT01064687|3886676|P2|Overall Study|Entry Criteria Not Met|0
1183604|NCT01064687|3886677|P1|Overall Study|Entry Criteria Not Met|3
1183605|NCT01064687|3886674|P4|Overall Study|Death|0
1183606|NCT01064687|3886675|P3|Overall Study|Death|0
1183607|NCT01064687|3886676|P2|Overall Study|Death|1
1183608|NCT01064687|3886677|P1|Overall Study|Death|1
1183609|NCT01064687|3886674|P4|Overall Study|Adverse Event|3
1183610|NCT01064687|3886675|P3|Overall Study|Adverse Event|10
1183611|NCT01064687|3886676|P2|Overall Study|Adverse Event|4
1183612|NCT01064687|3886677|P1|Overall Study|Adverse Event|9
1183613|NCT01064622|3886857|P2|Randomized Phase II|Protocol Violation|1
1183614|NCT01064622|3886858|P1|Randomized Phase II|Protocol Violation|0
1183615|NCT01064622|3886857|P2|Randomized Phase II|Withdrawal by Subject|2
1183616|NCT01064622|3886858|P1|Randomized Phase II|Withdrawal by Subject|2
1183617|NCT01064414|3886882|P3|Extension Period: Week 26 to Week 52|Not specified|1
1183618|NCT01064414|3886883|P2|Extension Period: Week 26 to Week 52|Not specified|2
1183619|NCT01064414|3886884|P1|Extension Period: Week 26 to Week 52|Not specified|5
1183620|NCT01064414|3886882|P3|Extension Period: Week 26 to Week 52|Protocol Violation|1
1183621|NCT01064414|3886883|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
1183622|NCT01064414|3886884|P1|Extension Period: Week 26 to Week 52|Protocol Violation|1
1183623|NCT01064414|3886882|P3|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
1183624|NCT01064414|3886883|P2|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
1183625|NCT01064414|3886884|P1|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
1183626|NCT01064414|3886882|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
1183627|NCT01064414|3886883|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
1183628|NCT01064414|3886884|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
1183629|NCT01064414|3886882|P3|Extension Period: Week 26 to Week 52|Physician Decision|0
1183630|NCT01064414|3886883|P2|Extension Period: Week 26 to Week 52|Physician Decision|0
1183631|NCT01064414|3886884|P1|Extension Period: Week 26 to Week 52|Physician Decision|1
1183632|NCT01064414|3886882|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
1183633|NCT01064414|3886883|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
1183634|NCT01064414|3886884|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
1183635|NCT01064414|3886882|P3|Extension Period: Week 26 to Week 52|Death|0
1183636|NCT01064414|3886883|P2|Extension Period: Week 26 to Week 52|Death|1
1183637|NCT01064414|3886884|P1|Extension Period: Week 26 to Week 52|Death|0
1183638|NCT01064414|3886882|P3|Extension Period: Week 26 to Week 52|Adverse Event|2
1183639|NCT01064414|3886883|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
1183640|NCT01064414|3886884|P1|Extension Period: Week 26 to Week 52|Adverse Event|2
1183641|NCT01064414|3886882|P3|Core Period: Baseline to Week 26|Not specified|2
1183642|NCT01064414|3886883|P2|Core Period: Baseline to Week 26|Not specified|7
1183643|NCT01064414|3886884|P1|Core Period: Baseline to Week 26|Not specified|4
1183644|NCT01064414|3886882|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
1183645|NCT01064414|3886883|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
1183646|NCT01064414|3886884|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|0
1183647|NCT01064414|3886882|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|2
1183648|NCT01064414|3886883|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|2
1183649|NCT01064414|3886884|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|4
1183650|NCT01064414|3886882|P3|Core Period: Baseline to Week 26|Protocol Violation|1
1183651|NCT01064414|3886883|P2|Core Period: Baseline to Week 26|Protocol Violation|0
1183652|NCT01064414|3886884|P1|Core Period: Baseline to Week 26|Protocol Violation|1
1183653|NCT01064414|3886882|P3|Core Period: Baseline to Week 26|Death|0
1183654|NCT01064414|3886883|P2|Core Period: Baseline to Week 26|Death|1
1183655|NCT01064414|3886884|P1|Core Period: Baseline to Week 26|Death|0
1183656|NCT01064414|3886882|P3|Core Period: Baseline to Week 26|Adverse Event|2
1183657|NCT01064414|3886883|P2|Core Period: Baseline to Week 26|Adverse Event|4
1183658|NCT01064414|3886884|P1|Core Period: Baseline to Week 26|Adverse Event|4
1183659|NCT01064401|3886903|P2|Overall Study|Not Specified|1
1183660|NCT01064401|3886904|P1|Overall Study|Not Specified|2
1183661|NCT01064401|3886903|P2|Overall Study|Site Closure|5
1183662|NCT01064401|3886904|P1|Overall Study|Site Closure|4
1183663|NCT01064401|3886903|P2|Overall Study|Noncompliance|8
1183664|NCT01064401|3886904|P1|Overall Study|Noncompliance|7
1183665|NCT01064401|3886903|P2|Overall Study|Pregnancy|7
1183666|NCT01064401|3886904|P1|Overall Study|Pregnancy|4
1183667|NCT01064401|3886903|P2|Overall Study|Death|0
1183668|NCT01064401|3886904|P1|Overall Study|Death|4
1183669|NCT01064401|3886903|P2|Overall Study|Investigator Decision|6
1183670|NCT01064401|3886904|P1|Overall Study|Investigator Decision|4
1183671|NCT01064401|3886903|P2|Overall Study|Consent Withdrawn|80
1183672|NCT01064401|3886904|P1|Overall Study|Consent Withdrawn|98
1183673|NCT01064401|3886903|P2|Overall Study|Lost to Follow-up|9
1183674|NCT01064401|3886904|P1|Overall Study|Lost to Follow-up|12
1183675|NCT01064401|3886903|P2|Overall Study|Lack of Efficacy|23
1183676|NCT01064401|3886904|P1|Overall Study|Lack of Efficacy|46
1183677|NCT01064401|3886903|P2|Overall Study|Adverse Event|56
1183678|NCT01064401|3886904|P1|Overall Study|Adverse Event|47
1183679|NCT01064310|3886953|P3|Open Label Pazopinib|Physician Decision|20
1183680|NCT01064310|3886954|P2|Open Label Pazopinib|Physician Decision|0
1183681|NCT01064310|3886955|P1|Open Label Pazopinib|Physician Decision|0
1183682|NCT01064310|3886953|P3|Open Label Pazopinib|Lack of Efficacy|51
1183683|NCT01064310|3886954|P2|Open Label Pazopinib|Lack of Efficacy|0
1183684|NCT01064310|3886955|P1|Open Label Pazopinib|Lack of Efficacy|0
1183685|NCT01064310|3886953|P3|Open Label Pazopinib|Adverse Event|12
1183686|NCT01064310|3886954|P2|Open Label Pazopinib|Adverse Event|0
1183687|NCT01064310|3886955|P1|Open Label Pazopinib|Adverse Event|0
1183688|NCT01064310|3886953|P3|Open Label Pazopinib|Withdrawal by Subject|1
1183689|NCT01064310|3886954|P2|Open Label Pazopinib|Withdrawal by Subject|0
1183690|NCT01064310|3886955|P1|Open Label Pazopinib|Withdrawal by Subject|0
1183691|NCT01064310|3886953|P3|Period 2|Lack of Efficacy|0
1183692|NCT01064310|3886954|P2|Period 2|Lack of Efficacy|4
1183693|NCT01064310|3886955|P1|Period 2|Lack of Efficacy|1
1183694|NCT01064310|3886953|P3|Period 2|Entered Open-label Period|0
1183695|NCT01064310|3886954|P2|Period 2|Entered Open-label Period|0
1183696|NCT01064310|3886955|P1|Period 2|Entered Open-label Period|1
1183697|NCT01064310|3886953|P3|Period 2|Physician Decision|0
1183698|NCT01064310|3886954|P2|Period 2|Physician Decision|1
1183699|NCT01064310|3886955|P1|Period 2|Physician Decision|0
1183700|NCT01064310|3886953|P3|Period 2|Adverse Event|0
1183701|NCT01064310|3886954|P2|Period 2|Adverse Event|1
1183702|NCT01064310|3886955|P1|Period 2|Adverse Event|2
1183703|NCT01064310|3886953|P3|Period 1|Entered Open-label Period|0
1183704|NCT01064310|3886954|P2|Period 1|Entered Open-label Period|1
1183705|NCT01064310|3886955|P1|Period 1|Entered Open-label Period|1
1183706|NCT01064310|3886953|P3|Period 1|Lack of Efficacy|0
1183707|NCT01064310|3886954|P2|Period 1|Lack of Efficacy|5
1183708|NCT01064310|3886955|P1|Period 1|Lack of Efficacy|3
1183709|NCT01064310|3886953|P3|Period 1|Withdrawal by Subject|0
1183710|NCT01064310|3886954|P2|Period 1|Withdrawal by Subject|2
1183711|NCT01064310|3886955|P1|Period 1|Withdrawal by Subject|2
1183712|NCT01064310|3886953|P3|Period 1|Physician Decision|0
1183713|NCT01064310|3886954|P2|Period 1|Physician Decision|0
1183714|NCT01064310|3886955|P1|Period 1|Physician Decision|1
1183715|NCT01064310|3886953|P3|Period 1|Adverse Event|0
1183716|NCT01064310|3886954|P2|Period 1|Adverse Event|10
1183717|NCT01064310|3886955|P1|Period 1|Adverse Event|7
1183718|NCT01064297|3886985|P3|Overall Study|Lost to Follow-up|133
1183719|NCT01064297|3886986|P2|Overall Study|Lost to Follow-up|48
1183720|NCT01064297|3886987|P1|Overall Study|Lost to Follow-up|791
1183721|NCT01064167|3887056|P2|Overall Study|Protocol Violation|15
1183722|NCT01064167|3887057|P1|Overall Study|Protocol Violation|14
1183723|NCT01063881|3887104|P3|Overall Study|Reason for not completed not specified|0
1183724|NCT01063881|3887105|P2|Overall Study|Reason for not completed not specified|1
1183725|NCT01063881|3887106|P1|Overall Study|Reason for not completed not specified|5
1183726|NCT01063881|3887104|P3|Overall Study|Withdrawal by Subject|0
1183727|NCT01063881|3887105|P2|Overall Study|Withdrawal by Subject|1
1183728|NCT01063881|3887106|P1|Overall Study|Withdrawal by Subject|25
1183729|NCT01063881|3887104|P3|Overall Study|Lost to Follow-up|1
1183730|NCT01063881|3887105|P2|Overall Study|Lost to Follow-up|7
1183731|NCT01063881|3887106|P1|Overall Study|Lost to Follow-up|13
1183732|NCT01063881|3887104|P3|Overall Study|Adverse Event|0
1183733|NCT01063881|3887105|P2|Overall Study|Adverse Event|2
1183734|NCT01063881|3887106|P1|Overall Study|Adverse Event|12
1183735|NCT01063868|3887130|P2|Overall Study|Study Terminated By Sponsor|4
1183736|NCT01063868|3887131|P1|Overall Study|Study Terminated By Sponsor|23
1183737|NCT01063868|3887130|P2|Overall Study|Withdrawal by Subject|1
1183738|NCT01063868|3887131|P1|Overall Study|Withdrawal by Subject|3
1183739|NCT01063868|3887130|P2|Overall Study|Adverse Event|7
1183740|NCT01063868|3887131|P1|Overall Study|Adverse Event|9
1183741|NCT01063855|3887139|P2|Overall Study|Reason not specified|11
1183742|NCT01063855|3887140|P1|Overall Study|Reason not specified|13
1183743|NCT01063855|3887139|P2|Overall Study|Withdrawal by Subject|8
1183744|NCT01063855|3887140|P1|Overall Study|Withdrawal by Subject|11
1183745|NCT01063855|3887139|P2|Overall Study|Lack of Efficacy|1
1183746|NCT01063855|3887140|P1|Overall Study|Lack of Efficacy|0
1183747|NCT01063855|3887139|P2|Overall Study|Pregnancy|0
1183748|NCT01063855|3887140|P1|Overall Study|Pregnancy|1
1183749|NCT01063855|3887139|P2|Overall Study|Lost to Follow-up|4
1183750|NCT01063855|3887140|P1|Overall Study|Lost to Follow-up|8
1183751|NCT01063855|3887139|P2|Overall Study|Death|1
1183752|NCT01063855|3887140|P1|Overall Study|Death|0
1183753|NCT01063855|3887139|P2|Overall Study|Adverse Event|4
1183754|NCT01063855|3887140|P1|Overall Study|Adverse Event|4
1183755|NCT01063764|3887187|P1|2nd Period (Week 22 to the End of Study)|Protocol Violation|1
1183756|NCT01063764|3887187|P1|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7
1183757|NCT01063764|3887187|P1|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9
1183758|NCT01063764|3887187|P1|2nd Period (Week 22 to the End of Study)|Adverse Event|3
1183759|NCT01063764|3887187|P1|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1
1183760|NCT01063764|3887187|P1|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6
1183761|NCT01063764|3887187|P1|1st Period (From Week 8 to Week 22)|Adverse Event|4
1183762|NCT01063595|3887206|P2|First Intervention|Reason not Specified|1
1183763|NCT01063595|3887207|P1|First Intervention|Reason not Specified|0
1183764|NCT01063595|3887206|P2|First Intervention|Withdrawal by Subject|0
1183765|NCT01063595|3887207|P1|First Intervention|Withdrawal by Subject|1
1183766|NCT01063595|3887206|P2|First Intervention|Adverse Event|4
1183767|NCT01063595|3887207|P1|First Intervention|Adverse Event|1
1183768|NCT01063595|3887206|P2|Enrolled in Study and Randomized|Withdrawn by the Investigator|1
1183769|NCT01063595|3887207|P1|Enrolled in Study and Randomized|Withdrawn by the Investigator|0
1183770|NCT01063595|3887206|P2|Enrolled in Study and Randomized|Adverse Event|1
1183771|NCT01063595|3887207|P1|Enrolled in Study and Randomized|Adverse Event|0
1183772|NCT01063595|3887206|P2|Enrolled in Study and Randomized|Reason not Specified|0
1183773|NCT01063595|3887207|P1|Enrolled in Study and Randomized|Reason not Specified|1
1183774|NCT01063517|3887219|P2|Overall Study|Death|48
1183775|NCT01063517|3887220|P1|Overall Study|Death|33
1183776|NCT01063517|3887219|P2|Overall Study|Withdrawal by Subject|2
1183777|NCT01063517|3887220|P1|Overall Study|Withdrawal by Subject|1
1183778|NCT01063517|3887219|P2|Overall Study|Lost to Follow-up|3
1183779|NCT01063517|3887220|P1|Overall Study|Lost to Follow-up|4
1183780|NCT01063517|3887219|P2|Overall Study|Study reached data cut-off|7
1183781|NCT01063517|3887220|P1|Overall Study|Study reached data cut-off|19
1183782|NCT01063517|3887219|P2|Overall Study|Consent withdrawal|0
1183783|NCT01063517|3887220|P1|Overall Study|Consent withdrawal|1
1183784|NCT01063348|3887260|P2|Overall Study|Lost to Follow-up|10
1183785|NCT01063348|3887261|P1|Overall Study|Lost to Follow-up|3
1183786|NCT01063153|3887271|P2|Overall Study|Physician Decision|4
1183787|NCT01063153|3887272|P1|Overall Study|Physician Decision|0
1183788|NCT01063153|3887271|P2|Overall Study|Withdrawal by Subject|1
1183789|NCT01063153|3887272|P1|Overall Study|Withdrawal by Subject|0
1183790|NCT01063153|3887271|P2|Overall Study|Lost to Follow-up|7
1183791|NCT01063153|3887272|P1|Overall Study|Lost to Follow-up|0
1183792|NCT01063153|3887271|P2|Overall Study|Found Ineligible During Screening|0
1183793|NCT01063153|3887272|P1|Overall Study|Found Ineligible During Screening|2
1183794|NCT01063062|3887303|P2|Overall Study|Miscellaneous reason|1
1183795|NCT01063062|3887304|P1|Overall Study|Miscellaneous reason|0
1183796|NCT01063062|3887303|P2|Overall Study|Lost to Follow-up|2
1183797|NCT01063062|3887304|P1|Overall Study|Lost to Follow-up|0
1183798|NCT01063062|3887303|P2|Overall Study|Investigator's request|0
1183799|NCT01063062|3887304|P1|Overall Study|Investigator's request|1
1183800|NCT01063062|3887303|P2|Overall Study|Protocol Violation|4
1183801|NCT01063062|3887304|P1|Overall Study|Protocol Violation|5
1183802|NCT01063062|3887303|P2|Overall Study|Adverse Event|4
1183803|NCT01063062|3887304|P1|Overall Study|Adverse Event|2
1183804|NCT01063062|3887303|P2|Overall Study|Patient withdrew consent|1
1183805|NCT01063062|3887304|P1|Overall Study|Patient withdrew consent|0
1183806|NCT01063036|3887358|P1|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32
1183807|NCT01063036|3887358|P1|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6
1183808|NCT01063036|3887358|P1|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1
1183809|NCT01063036|3887358|P1|Participants Treated With Study Drug|Pregnancy|1
1183810|NCT01063036|3887358|P1|Participants Treated With Study Drug|Lost to Follow-up|1
1183811|NCT01063036|3887358|P1|Participants Treated With Study Drug|Withdrawal by Subject|2
1183812|NCT01063036|3887358|P1|Participants Treated With Study Drug|Protocol Violation|1
1183813|NCT01063036|3887358|P1|Participants Treated With Study Drug|Adverse Event|1
1183814|NCT01062841|3887403|P2|Overall Study|Withdrawal by Study|0
1183815|NCT01062841|3887404|P1|Overall Study|Withdrawal by Study|3
1183816|NCT01062841|3887403|P2|Overall Study|Withdrawal by Subject|0
1183817|NCT01062841|3887404|P1|Overall Study|Withdrawal by Subject|2
1183818|NCT01062841|3887403|P2|Overall Study|Death|5
1183819|NCT01062841|3887404|P1|Overall Study|Death|3
1183820|NCT01062841|3887403|P2|Overall Study|Indwelling Device Removed|48
1183821|NCT01062841|3887404|P1|Overall Study|Indwelling Device Removed|41
1183822|NCT01062763|3887434|P2|Overall Study|Adverse Event|4
1183823|NCT01062763|3887435|P1|Overall Study|Adverse Event|3
1183824|NCT01062425|3887447|P2|Overall Study|Protocol Violation|6
1183825|NCT01062425|3887448|P1|Overall Study|Protocol Violation|3
1183826|NCT01062399|3887465|P5|Overall Study|Protocol Violation|4
1183827|NCT01062399|3887466|P4|Overall Study|Protocol Violation|6
1183828|NCT01062399|3887467|P3|Overall Study|Protocol Violation|0
1183829|NCT01062399|3887468|P2|Overall Study|Protocol Violation|1
1183830|NCT01062399|3887469|P1|Overall Study|Protocol Violation|0
1183831|NCT01062256|3887513|P3|Overall Study|Administrative|0
1183832|NCT01062256|3887514|P2|Overall Study|Administrative|2
1183833|NCT01062256|3887515|P1|Overall Study|Administrative|0
1183834|NCT01062256|3887513|P3|Overall Study|Ineligible|3
1183835|NCT01062256|3887514|P2|Overall Study|Ineligible|4
1183836|NCT01062256|3887515|P1|Overall Study|Ineligible|1
1183837|NCT01062256|3887513|P3|Overall Study|Withdrawal by Subject|1
1183838|NCT01062256|3887514|P2|Overall Study|Withdrawal by Subject|1
1183839|NCT01062256|3887515|P1|Overall Study|Withdrawal by Subject|1
1183840|NCT01062256|3887513|P3|Overall Study|Adverse Event|0
1183841|NCT01062256|3887514|P2|Overall Study|Adverse Event|0
1183842|NCT01062256|3887515|P1|Overall Study|Adverse Event|1
1183843|NCT01062113|3887549|P3|Overall Study|Withdrawal by Subject|0
1183844|NCT01062113|3887550|P2|Overall Study|Withdrawal by Subject|0
1183845|NCT01062113|3887551|P1|Overall Study|Withdrawal by Subject|1
1183846|NCT01062113|3887549|P3|Overall Study|Lack of Efficacy|31
1183847|NCT01062113|3887550|P2|Overall Study|Lack of Efficacy|22
1183848|NCT01062113|3887551|P1|Overall Study|Lack of Efficacy|38
1183849|NCT01062113|3887549|P3|Overall Study|Adverse Event|0
1183850|NCT01062113|3887550|P2|Overall Study|Adverse Event|0
1183851|NCT01062113|3887551|P1|Overall Study|Adverse Event|1
1183852|NCT01062061|3887569|P1|Overall Study|Failed to meet inclusion criteria|2
1183853|NCT01062061|3887569|P1|Overall Study|Outside chief indications|10
1183854|NCT01062061|3887569|P1|Overall Study|Investigated before study start|13
1183855|NCT01062061|3887569|P1|Overall Study|Enrolled more than once|2
1183856|NCT01061866|3887583|P1|Overall Study|Adverse Event|2
1183857|NCT01061775|3887587|P1|Overall Study|Lost to Follow-up|1
1183858|NCT01061775|3887587|P1|Overall Study|Physician Decision|2
1183859|NCT01061736|3887604|P10|Overall Study|Other than specified above|21
1183860|NCT01061736|3887605|P9|Overall Study|Other than specified above|15
1183861|NCT01061736|3887606|P8|Overall Study|Other than specified above|18
1183862|NCT01061736|3887607|P7|Overall Study|Other than specified above|0
1183863|NCT01061736|3887608|P6|Overall Study|Other than specified above|0
1183864|NCT01061736|3887609|P5|Overall Study|Other than specified above|1
1183865|NCT01061736|3887610|P4|Overall Study|Other than specified above|0
1183866|NCT01061736|3887611|P3|Overall Study|Other than specified above|2
1183867|NCT01061736|3887612|P2|Overall Study|Other than specified above|1
1183868|NCT01061736|3887613|P1|Overall Study|Other than specified above|0
1183869|NCT01061736|3887604|P10|Overall Study|Not treated|0
1183870|NCT01061736|3887605|P9|Overall Study|Not treated|1
1183871|NCT01061736|3887606|P8|Overall Study|Not treated|2
1183872|NCT01061736|3887607|P7|Overall Study|Not treated|0
1183873|NCT01061736|3887608|P6|Overall Study|Not treated|0
1183874|NCT01061736|3887609|P5|Overall Study|Not treated|1
1183875|NCT01061736|3887610|P4|Overall Study|Not treated|0
1183876|NCT01061736|3887611|P3|Overall Study|Not treated|0
1183877|NCT01061736|3887612|P2|Overall Study|Not treated|0
1183878|NCT01061736|3887613|P1|Overall Study|Not treated|0
1183879|NCT01061736|3887604|P10|Overall Study|Poor compliance to protocol|9
1183880|NCT01061736|3887605|P9|Overall Study|Poor compliance to protocol|5
1183881|NCT01061736|3887606|P8|Overall Study|Poor compliance to protocol|2
1183882|NCT01061736|3887607|P7|Overall Study|Poor compliance to protocol|0
1183883|NCT01061736|3887608|P6|Overall Study|Poor compliance to protocol|0
1183884|NCT01061736|3887609|P5|Overall Study|Poor compliance to protocol|0
1183885|NCT01061736|3887610|P4|Overall Study|Poor compliance to protocol|0
1183886|NCT01061736|3887611|P3|Overall Study|Poor compliance to protocol|0
1183887|NCT01061736|3887612|P2|Overall Study|Poor compliance to protocol|0
1183888|NCT01061736|3887613|P1|Overall Study|Poor compliance to protocol|0
1183889|NCT01061736|3887604|P10|Overall Study|Lack of Efficacy|10
1183890|NCT01061736|3887605|P9|Overall Study|Lack of Efficacy|9
1183891|NCT01061736|3887606|P8|Overall Study|Lack of Efficacy|9
1183892|NCT01061736|3887607|P7|Overall Study|Lack of Efficacy|1
1183893|NCT01061736|3887608|P6|Overall Study|Lack of Efficacy|2
1183894|NCT01061736|3887609|P5|Overall Study|Lack of Efficacy|1
1183895|NCT01061736|3887610|P4|Overall Study|Lack of Efficacy|1
1183896|NCT01061736|3887611|P3|Overall Study|Lack of Efficacy|1
1183897|NCT01061736|3887612|P2|Overall Study|Lack of Efficacy|2
1183898|NCT01061736|3887613|P1|Overall Study|Lack of Efficacy|0
1183899|NCT01061736|3887604|P10|Overall Study|Adverse Event|34
1183900|NCT01061736|3887605|P9|Overall Study|Adverse Event|67
1183901|NCT01061736|3887606|P8|Overall Study|Adverse Event|63
1183902|NCT01061736|3887607|P7|Overall Study|Adverse Event|4
1183903|NCT01061736|3887608|P6|Overall Study|Adverse Event|1
1183904|NCT01061736|3887609|P5|Overall Study|Adverse Event|4
1183905|NCT01061736|3887610|P4|Overall Study|Adverse Event|2
1183906|NCT01061736|3887611|P3|Overall Study|Adverse Event|3
1183907|NCT01061736|3887612|P2|Overall Study|Adverse Event|1
1183908|NCT01061736|3887613|P1|Overall Study|Adverse Event|13
1183909|NCT01061736|3887604|P10|Overall Study|Dose regimen not selected|0
1183910|NCT01061736|3887605|P9|Overall Study|Dose regimen not selected|0
1183911|NCT01061736|3887606|P8|Overall Study|Dose regimen not selected|0
1183912|NCT01061736|3887607|P7|Overall Study|Dose regimen not selected|79
1183913|NCT01061736|3887608|P6|Overall Study|Dose regimen not selected|0
1183914|NCT01061736|3887609|P5|Overall Study|Dose regimen not selected|0
1183915|NCT01061736|3887610|P4|Overall Study|Dose regimen not selected|0
1183916|NCT01061736|3887611|P3|Overall Study|Dose regimen not selected|0
1183917|NCT01061736|3887612|P2|Overall Study|Dose regimen not selected|0
1183918|NCT01061736|3887613|P1|Overall Study|Dose regimen not selected|0
1183919|NCT01061723|3887652|P6|Overall Study|Other than specified above|1
1183920|NCT01061723|3887653|P5|Overall Study|Other than specified above|0
1183921|NCT01061723|3887654|P4|Overall Study|Other than specified above|1
1183922|NCT01061723|3887655|P3|Overall Study|Other than specified above|1
1183923|NCT01061723|3887656|P2|Overall Study|Other than specified above|1
1183924|NCT01061723|3887657|P1|Overall Study|Other than specified above|2
1183925|NCT01061723|3887652|P6|Overall Study|Randomized but not treated|1
1183926|NCT01061723|3887653|P5|Overall Study|Randomized but not treated|0
1183927|NCT01061723|3887654|P4|Overall Study|Randomized but not treated|0
1183928|NCT01061723|3887655|P3|Overall Study|Randomized but not treated|0
1183929|NCT01061723|3887656|P2|Overall Study|Randomized but not treated|0
1183930|NCT01061723|3887657|P1|Overall Study|Randomized but not treated|0
1183931|NCT01061723|3887652|P6|Overall Study|Lack of Efficacy|1
1183932|NCT01061723|3887653|P5|Overall Study|Lack of Efficacy|1
1183933|NCT01061723|3887654|P4|Overall Study|Lack of Efficacy|2
1183934|NCT01061723|3887655|P3|Overall Study|Lack of Efficacy|4
1183935|NCT01061723|3887656|P2|Overall Study|Lack of Efficacy|3
1183936|NCT01061723|3887657|P1|Overall Study|Lack of Efficacy|2
1183937|NCT01061723|3887652|P6|Overall Study|Adverse Event|6
1183938|NCT01061723|3887653|P5|Overall Study|Adverse Event|2
1183939|NCT01061723|3887654|P4|Overall Study|Adverse Event|5
1183940|NCT01061723|3887655|P3|Overall Study|Adverse Event|5
1183941|NCT01061723|3887656|P2|Overall Study|Adverse Event|2
1183942|NCT01061723|3887657|P1|Overall Study|Adverse Event|0
1183943|NCT01061710|3887737|P1|Overall Study|Protocol Violation|14
1183944|NCT01061671|3887747|P2|Overall Study|Death|30
1183945|NCT01061671|3887748|P1|Overall Study|Death|28
1183946|NCT01061671|3887747|P2|Overall Study|Lost to Follow-up|5
1183947|NCT01061671|3887748|P1|Overall Study|Lost to Follow-up|3
1183948|NCT01061671|3887747|P2|Overall Study|Withdrawal by Subject|20
1183949|NCT01061671|3887748|P1|Overall Study|Withdrawal by Subject|16
1183950|NCT01061606|3887760|P1|Overall Study|alternative therapy|2
1183951|NCT01061606|3887760|P1|Overall Study|Disease Progression|4
1183952|NCT01061606|3887760|P1|Overall Study|Death|1
1183953|NCT01061606|3887760|P1|Overall Study|Adverse Event|1
1183954|NCT01061567|3887769|P1|Overall Study|Other reason than stated above|3
1183955|NCT01061567|3887769|P1|Overall Study|Withdrawal by Subject|11
1183956|NCT01061567|3887769|P1|Overall Study|Protocol Violation|1
1183957|NCT01061567|3887769|P1|Overall Study|Lost to Follow-up|24
1183958|NCT01061567|3887769|P1|Overall Study|Lack of Efficacy|3
1183959|NCT01061567|3887769|P1|Overall Study|Death|2
1183960|NCT01061567|3887769|P1|Overall Study|Adverse Event|32
1183961|NCT01061385|3887793|P2|Overall Study|subject decision not related to AE|1
1183962|NCT01061385|3887794|P1|Overall Study|subject decision not related to AE|0
1183963|NCT01061385|3887793|P2|Overall Study|Lost to Follow-up|0
1183964|NCT01061385|3887794|P1|Overall Study|Lost to Follow-up|1
1183965|NCT01061359|3887802|P1|Overall Study|Secondary neoplasm|11
1183966|NCT01061359|3887802|P1|Overall Study|Relapse|187
1183967|NCT01061359|3887802|P1|Overall Study|Lost to Follow-up|1072
1183968|NCT01061359|3887802|P1|Overall Study|Death|32
1183969|NCT01061333|3887808|P2|Period 4: 20-day Washout|Discontinued by Study Team|1
1183970|NCT01061333|3887809|P1|Period 4: 20-day Washout|Discontinued by Study Team|0
1183971|NCT01061177|3887847|P1|Overall Study|Death|4
1183972|NCT01061177|3887847|P1|Overall Study|Administratie problems|4
1183973|NCT01061177|3887847|P1|Overall Study|Abnormal test procedure results|4
1183974|NCT01061177|3887847|P1|Overall Study|Abnormal laboratory values|6
1183975|NCT01061177|3887847|P1|Overall Study|New cancer therapy|9
1183976|NCT01061177|3887847|P1|Overall Study|Lost to Follow-up|9
1183977|NCT01061177|3887847|P1|Overall Study|Protocol Violation|11
1183978|NCT01061177|3887847|P1|Overall Study|Disease progression|17
1183979|NCT01061177|3887847|P1|Overall Study|Withdrawal by Subject|27
1183980|NCT01061177|3887847|P1|Overall Study|Adverse Event|117
1183981|NCT01061151|3887870|P4|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3
1183982|NCT01061151|3887871|P3|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1
1183983|NCT01061151|3887872|P2|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8
1183984|NCT01061151|3887873|P1|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5
1183985|NCT01061151|3887870|P4|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5
1183986|NCT01061151|3887871|P3|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15
1183987|NCT01061151|3887872|P2|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26
1183988|NCT01061151|3887873|P1|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28
1183989|NCT01061151|3887870|P4|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0
1183990|NCT01061151|3887871|P3|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2
1183991|NCT01061151|3887872|P2|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11
1183992|NCT01061151|3887873|P1|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12
1183993|NCT01061151|3887870|P4|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4
1183994|NCT01061151|3887871|P3|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25
1183995|NCT01061151|3887872|P2|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36
1183996|NCT01061151|3887873|P1|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49
1183997|NCT01061151|3887870|P4|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3
1183998|NCT01061151|3887871|P3|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31
1183999|NCT01061151|3887872|P2|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52
1184000|NCT01061151|3887873|P1|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54
1184001|NCT01061151|3887870|P4|Protocol Version 3.0: 10/2012-10/2014|Death|1
1184002|NCT01061151|3887871|P3|Protocol Version 3.0: 10/2012-10/2014|Death|1
1184003|NCT01061151|3887872|P2|Protocol Version 3.0: 10/2012-10/2014|Death|5
1184004|NCT01061151|3887873|P1|Protocol Version 3.0: 10/2012-10/2014|Death|3
1184005|NCT01061151|3887870|P4|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
1184006|NCT01061151|3887871|P3|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
1184007|NCT01061151|3887872|P2|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
1184008|NCT01061151|3887873|P1|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1
1184009|NCT01061151|3887870|P4|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4
1184010|NCT01061151|3887871|P3|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2
1184011|NCT01061151|3887872|P2|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
1184012|NCT01061151|3887873|P1|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
1184013|NCT01061151|3887870|P4|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0
1184014|NCT01061151|3887871|P3|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1
1184015|NCT01061151|3887872|P2|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5
1184016|NCT01061151|3887873|P1|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3
1184017|NCT01061151|3887870|P4|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5
1184018|NCT01061151|3887871|P3|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2
1184019|NCT01061151|3887872|P2|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61
1184020|NCT01061151|3887873|P1|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44
1184021|NCT01061151|3887870|P4|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0
1184022|NCT01061151|3887871|P3|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1
1184023|NCT01061151|3887872|P2|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19
1184024|NCT01061151|3887873|P1|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15
1184025|NCT01061151|3887870|P4|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10
1184026|NCT01061151|3887871|P3|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2
1184027|NCT01061151|3887872|P2|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65
1184028|NCT01061151|3887873|P1|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73
1184029|NCT01061151|3887870|P4|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10
1184030|NCT01061151|3887871|P3|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2
1184031|NCT01061151|3887872|P2|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82
1184032|NCT01061151|3887873|P1|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89
1184033|NCT01061151|3887870|P4|Protocol Version 2.0: 04/2011-09/2012|Death|2
1184034|NCT01061151|3887871|P3|Protocol Version 2.0: 04/2011-09/2012|Death|1
1184035|NCT01061151|3887872|P2|Protocol Version 2.0: 04/2011-09/2012|Death|9
1184036|NCT01061151|3887873|P1|Protocol Version 2.0: 04/2011-09/2012|Death|6
1184037|NCT01061151|3887870|P4|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1
1184038|NCT01061151|3887871|P3|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
1184039|NCT01061151|3887872|P2|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
1184040|NCT01061151|3887873|P1|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2
1184041|NCT01061008|3887932|P2|Overall Study|Adverse Event|1
1184042|NCT01061008|3887933|P1|Overall Study|Adverse Event|0
1184043|NCT01061008|3887932|P2|Overall Study|Unable to exercise following surgery|0
1184044|NCT01061008|3887933|P1|Overall Study|Unable to exercise following surgery|1
1184045|NCT01061008|3887932|P2|Overall Study|Withdrawal by Subject|3
1184046|NCT01061008|3887933|P1|Overall Study|Withdrawal by Subject|1
1184047|NCT01061008|3887932|P2|Overall Study|Death|0
1184048|NCT01061008|3887933|P1|Overall Study|Death|1
1184049|NCT01061008|3887932|P2|Overall Study|Badiocephalic fistula failed|2
1184050|NCT01061008|3887933|P1|Overall Study|Badiocephalic fistula failed|3
1184051|NCT01060670|3887941|P2|Run In|screen failure|238
1184052|NCT01060670|3887942|P1|Run In|screen failure|0
1184053|NCT01060553|3887977|P2|Overall Study|Lack of Efficacy|0
1184054|NCT01060553|3887978|P1|Overall Study|Lack of Efficacy|1
1184055|NCT01060553|3887977|P2|Overall Study|Withdrawal by Subject|5
1184056|NCT01060553|3887978|P1|Overall Study|Withdrawal by Subject|5
1184057|NCT01060553|3887977|P2|Overall Study|Lost to Follow-up|5
1184058|NCT01060553|3887978|P1|Overall Study|Lost to Follow-up|3
1184059|NCT01060540|3887985|P2|Overall Study|Physician Decision|1
1184060|NCT01060540|3887986|P1|Overall Study|Physician Decision|0
1184061|NCT01060540|3887985|P2|Overall Study|Death|1
1184062|NCT01060540|3887986|P1|Overall Study|Death|2
1184063|NCT01060540|3887985|P2|Overall Study|Lost to Follow-up|43
1184064|NCT01060540|3887986|P1|Overall Study|Lost to Follow-up|52
1184065|NCT01060540|3887985|P2|Overall Study|Withdrawal by Subject|20
1184066|NCT01060540|3887986|P1|Overall Study|Withdrawal by Subject|10
1184067|NCT01060384|3888000|P5|Overall Study|Intercurrent illness|1
1184068|NCT01060384|3888001|P4|Overall Study|Intercurrent illness|0
1184069|NCT01060384|3888002|P3|Overall Study|Intercurrent illness|0
1184070|NCT01060384|3888003|P2|Overall Study|Intercurrent illness|0
1184071|NCT01060384|3888004|P1|Overall Study|Intercurrent illness|0
1184072|NCT01060384|3888000|P5|Overall Study|Death|1
1184073|NCT01060384|3888001|P4|Overall Study|Death|0
1184074|NCT01060384|3888002|P3|Overall Study|Death|0
1184075|NCT01060384|3888003|P2|Overall Study|Death|0
1184076|NCT01060384|3888004|P1|Overall Study|Death|0
1184077|NCT01060384|3888000|P5|Overall Study|Withdrawal by Subject|0
1184078|NCT01060384|3888001|P4|Overall Study|Withdrawal by Subject|0
1184079|NCT01060384|3888002|P3|Overall Study|Withdrawal by Subject|0
1184080|NCT01060384|3888003|P2|Overall Study|Withdrawal by Subject|1
1184081|NCT01060384|3888004|P1|Overall Study|Withdrawal by Subject|0
1184082|NCT01060150|3888013|P1|Overall Study|Enrolled, but not treated|2
1184083|NCT01060150|3888013|P1|Overall Study|Withdrawal by Subject|8
1184084|NCT01060150|3888013|P1|Overall Study|Protocol Violation|6
1184085|NCT01060150|3888013|P1|Overall Study|Lost to Follow-up|1
1184086|NCT01060150|3888013|P1|Overall Study|Adverse Event|6
1184087|NCT01060124|3888028|P1|Overall Study|Withdrawal by Subject|7
1184088|NCT01060124|3888028|P1|Overall Study|Adverse Event|14
1184089|NCT01060124|3888028|P1|Overall Study|Other|16
1184090|NCT01060111|3888039|P3|Overall Study|Other|4
1184091|NCT01060111|3888040|P2|Overall Study|Other|3
1184092|NCT01060111|3888041|P1|Overall Study|Other|2
1184093|NCT01060111|3888039|P3|Overall Study|Participants' non-cooperation|0
1184094|NCT01060111|3888040|P2|Overall Study|Participants' non-cooperation|0
1184095|NCT01060111|3888041|P1|Overall Study|Participants' non-cooperation|1
1184096|NCT01060111|3888039|P3|Overall Study|Adverse event and insufficient effect|0
1184097|NCT01060111|3888040|P2|Overall Study|Adverse event and insufficient effect|1
1184098|NCT01060111|3888041|P1|Overall Study|Adverse event and insufficient effect|0
1184099|NCT01060111|3888039|P3|Overall Study|Participants' non-cooperation|6
1184100|NCT01060111|3888040|P2|Overall Study|Participants' non-cooperation|6
1184101|NCT01060111|3888041|P1|Overall Study|Participants' non-cooperation|8
1184102|NCT01060111|3888039|P3|Overall Study|Participants' evasion for hospital visit|2
1184103|NCT01060111|3888040|P2|Overall Study|Participants' evasion for hospital visit|3
1184104|NCT01060111|3888041|P1|Overall Study|Participants' evasion for hospital visit|0
1184105|NCT01060111|3888039|P3|Overall Study|Inappropriate participant|5
1184106|NCT01060111|3888040|P2|Overall Study|Inappropriate participant|4
1184107|NCT01060111|3888041|P1|Overall Study|Inappropriate participant|5
1184108|NCT01060111|3888039|P3|Overall Study|Lack of Efficacy|0
1184109|NCT01060111|3888040|P2|Overall Study|Lack of Efficacy|1
1184110|NCT01060111|3888041|P1|Overall Study|Lack of Efficacy|2
1184111|NCT01060111|3888039|P3|Overall Study|Adverse Event|18
1184112|NCT01060111|3888040|P2|Overall Study|Adverse Event|5
1184113|NCT01060111|3888041|P1|Overall Study|Adverse Event|9
1184114|NCT01060072|3888060|P2|Overall Study|Excluded Medications|1
1184115|NCT01060072|3888061|P1|Overall Study|Excluded Medications|0
1184116|NCT01060072|3888060|P2|Overall Study|Acute cholecystitis|0
1184117|NCT01060072|3888061|P1|Overall Study|Acute cholecystitis|1
1184118|NCT01060072|3888060|P2|Overall Study|Protocol Violation|1
1184119|NCT01060072|3888061|P1|Overall Study|Protocol Violation|0
1184120|NCT01060072|3888060|P2|Overall Study|Physician Decision|2
1184121|NCT01060072|3888061|P1|Overall Study|Physician Decision|0
1184122|NCT01060072|3888060|P2|Overall Study|Adverse Event|1
1184123|NCT01060072|3888061|P1|Overall Study|Adverse Event|1
1184124|NCT01060059|3888077|P2|Overall Study|lack of compliance|2
1184125|NCT01060059|3888078|P1|Overall Study|lack of compliance|5
1184126|NCT01060059|3888077|P2|Overall Study|lack of glycemic control|1
1184127|NCT01060059|3888078|P1|Overall Study|lack of glycemic control|2
1184128|NCT01060059|3888077|P2|Overall Study|Withdrawal by Subject|23
1184129|NCT01060059|3888078|P1|Overall Study|Withdrawal by Subject|35
1184130|NCT01060059|3888077|P2|Overall Study|entry criteria not met|3
1184131|NCT01060059|3888078|P1|Overall Study|entry criteria not met|4
1184132|NCT01060059|3888077|P2|Overall Study|Lost to Follow-up|34
1184133|NCT01060059|3888078|P1|Overall Study|Lost to Follow-up|18
1184134|NCT01060059|3888077|P2|Overall Study|Death|3
1184135|NCT01060059|3888078|P1|Overall Study|Death|2
1184136|NCT01060059|3888077|P2|Overall Study|Adverse Event|1
1184137|NCT01060059|3888078|P1|Overall Study|Adverse Event|1
1184138|NCT01060007|3888136|P1|Overall Study|Inevaluable for response at surgery|3
1184139|NCT01060007|3888136|P1|Overall Study|Withdrawal by Subject|1
1184140|NCT01059903|3888204|P2|Period 1: First Intervention- 24 Hours|Adverse Event|1
1184141|NCT01059903|3888205|P1|Period 1: First Intervention- 24 Hours|Adverse Event|1
1184142|NCT01059864|3888248|P3|Double-Blind Treatment Phase|Adverse Event|3
1184143|NCT01059864|3888249|P2|Double-Blind Treatment Phase|Adverse Event|3
1184144|NCT01059864|3888250|P1|Double-Blind Treatment Phase|Adverse Event|0
1184145|NCT01059864|3888248|P3|Open-Label Run-In Phase|Protocol Violation|0
1184146|NCT01059864|3888249|P2|Open-Label Run-In Phase|Protocol Violation|0
1184147|NCT01059864|3888250|P1|Open-Label Run-In Phase|Protocol Violation|2
1184148|NCT01059864|3888248|P3|Open-Label Run-In Phase|Withdrawal by Subject|0
1184149|NCT01059864|3888249|P2|Open-Label Run-In Phase|Withdrawal by Subject|0
1184150|NCT01059864|3888250|P1|Open-Label Run-In Phase|Withdrawal by Subject|1
1184151|NCT01059864|3888248|P3|Open-Label Run-In Phase|Lost to Follow-up|0
1184152|NCT01059864|3888249|P2|Open-Label Run-In Phase|Lost to Follow-up|0
1184153|NCT01059864|3888250|P1|Open-Label Run-In Phase|Lost to Follow-up|2
1184154|NCT01059864|3888248|P3|Open-Label Run-In Phase|Lack of Efficacy|0
1184155|NCT01059864|3888249|P2|Open-Label Run-In Phase|Lack of Efficacy|0
1184156|NCT01059864|3888250|P1|Open-Label Run-In Phase|Lack of Efficacy|1
1184157|NCT01059864|3888248|P3|Open-Label Run-In Phase|Adverse Event|0
1184158|NCT01059864|3888249|P2|Open-Label Run-In Phase|Adverse Event|0
1184159|NCT01059864|3888250|P1|Open-Label Run-In Phase|Adverse Event|7
1184160|NCT01059825|3888324|P7|Treatment Period|Adverse event not related to study drug|0
1184161|NCT01059825|3888325|P6|Treatment Period|Adverse event not related to study drug|1
1184162|NCT01059825|3888326|P5|Treatment Period|Adverse event not related to study drug|1
1184163|NCT01059825|3888327|P4|Treatment Period|Adverse event not related to study drug|1
1184164|NCT01059825|3888328|P3|Treatment Period|Adverse event not related to study drug|2
1184165|NCT01059825|3888329|P2|Treatment Period|Adverse event not related to study drug|1
1184166|NCT01059825|3888330|P1|Treatment Period|Adverse event not related to study drug|0
1184167|NCT01059825|3888324|P7|Treatment Period|Insufficient clinical response|0
1184168|NCT01059825|3888325|P6|Treatment Period|Insufficient clinical response|0
1184169|NCT01059825|3888326|P5|Treatment Period|Insufficient clinical response|0
1184170|NCT01059825|3888327|P4|Treatment Period|Insufficient clinical response|0
1184171|NCT01059825|3888328|P3|Treatment Period|Insufficient clinical response|0
1184172|NCT01059825|3888329|P2|Treatment Period|Insufficient clinical response|0
1184173|NCT01059825|3888330|P1|Treatment Period|Insufficient clinical response|3
1184174|NCT01059825|3888324|P7|Treatment Period|Adverse event related to study drug|0
1184175|NCT01059825|3888325|P6|Treatment Period|Adverse event related to study drug|0
1184176|NCT01059825|3888326|P5|Treatment Period|Adverse event related to study drug|0
1184177|NCT01059825|3888327|P4|Treatment Period|Adverse event related to study drug|1
1184178|NCT01059825|3888328|P3|Treatment Period|Adverse event related to study drug|1
1184179|NCT01059825|3888329|P2|Treatment Period|Adverse event related to study drug|0
1184180|NCT01059825|3888330|P1|Treatment Period|Adverse event related to study drug|1
1184181|NCT01059825|3888324|P7|Treatment Period|Protocol Violation|0
1184182|NCT01059825|3888325|P6|Treatment Period|Protocol Violation|1
1184183|NCT01059825|3888326|P5|Treatment Period|Protocol Violation|1
1184184|NCT01059825|3888327|P4|Treatment Period|Protocol Violation|1
1184185|NCT01059825|3888328|P3|Treatment Period|Protocol Violation|1
1184186|NCT01059825|3888329|P2|Treatment Period|Protocol Violation|0
1184187|NCT01059825|3888330|P1|Treatment Period|Protocol Violation|0
1184188|NCT01059825|3888324|P7|Treatment Period|Other reason not specified|0
1184189|NCT01059825|3888325|P6|Treatment Period|Other reason not specified|0
1184190|NCT01059825|3888326|P5|Treatment Period|Other reason not specified|0
1184191|NCT01059825|3888327|P4|Treatment Period|Other reason not specified|2
1184192|NCT01059825|3888328|P3|Treatment Period|Other reason not specified|1
1184193|NCT01059825|3888329|P2|Treatment Period|Other reason not specified|2
1184194|NCT01059825|3888330|P1|Treatment Period|Other reason not specified|1
1184195|NCT01059825|3888324|P7|Treatment Period|Withdrawal by Subject|0
1184196|NCT01059825|3888325|P6|Treatment Period|Withdrawal by Subject|1
1184197|NCT01059825|3888326|P5|Treatment Period|Withdrawal by Subject|4
1184198|NCT01059825|3888327|P4|Treatment Period|Withdrawal by Subject|5
1184199|NCT01059825|3888328|P3|Treatment Period|Withdrawal by Subject|1
1184200|NCT01059825|3888329|P2|Treatment Period|Withdrawal by Subject|0
1184201|NCT01059825|3888330|P1|Treatment Period|Withdrawal by Subject|3
1184202|NCT01059825|3888324|P7|Treatment Period|Lost to Follow-up|0
1184203|NCT01059825|3888325|P6|Treatment Period|Lost to Follow-up|0
1184204|NCT01059825|3888326|P5|Treatment Period|Lost to Follow-up|2
1184205|NCT01059825|3888327|P4|Treatment Period|Lost to Follow-up|1
1184206|NCT01059825|3888328|P3|Treatment Period|Lost to Follow-up|0
1184207|NCT01059825|3888329|P2|Treatment Period|Lost to Follow-up|1
1184208|NCT01059825|3888330|P1|Treatment Period|Lost to Follow-up|2
1184209|NCT01059825|3888324|P7|Enrolled, Run-in Period|Protocol Violation|5
1184210|NCT01059825|3888325|P6|Enrolled, Run-in Period|Protocol Violation|0
1184211|NCT01059825|3888326|P5|Enrolled, Run-in Period|Protocol Violation|0
1184212|NCT01059825|3888327|P4|Enrolled, Run-in Period|Protocol Violation|0
1184213|NCT01059825|3888328|P3|Enrolled, Run-in Period|Protocol Violation|0
1184214|NCT01059825|3888329|P2|Enrolled, Run-in Period|Protocol Violation|0
1184215|NCT01059825|3888330|P1|Enrolled, Run-in Period|Protocol Violation|0
1184216|NCT01059825|3888324|P7|Enrolled, Run-in Period|Other reason not specified|7
1184217|NCT01059825|3888325|P6|Enrolled, Run-in Period|Other reason not specified|0
1184218|NCT01059825|3888326|P5|Enrolled, Run-in Period|Other reason not specified|0
1184219|NCT01059825|3888327|P4|Enrolled, Run-in Period|Other reason not specified|0
1184220|NCT01059825|3888328|P3|Enrolled, Run-in Period|Other reason not specified|0
1184221|NCT01059825|3888329|P2|Enrolled, Run-in Period|Other reason not specified|0
1184222|NCT01059825|3888330|P1|Enrolled, Run-in Period|Other reason not specified|0
1184223|NCT01059825|3888324|P7|Enrolled, Run-in Period|Withdrawal by Subject|13
1184224|NCT01059825|3888325|P6|Enrolled, Run-in Period|Withdrawal by Subject|0
1184225|NCT01059825|3888326|P5|Enrolled, Run-in Period|Withdrawal by Subject|0
1184226|NCT01059825|3888327|P4|Enrolled, Run-in Period|Withdrawal by Subject|0
1184227|NCT01059825|3888328|P3|Enrolled, Run-in Period|Withdrawal by Subject|0
1184228|NCT01059825|3888329|P2|Enrolled, Run-in Period|Withdrawal by Subject|0
1184229|NCT01059825|3888330|P1|Enrolled, Run-in Period|Withdrawal by Subject|0
1184230|NCT01059825|3888324|P7|Enrolled, Run-in Period|Lost to Follow-up|5
1184231|NCT01059825|3888325|P6|Enrolled, Run-in Period|Lost to Follow-up|0
1184232|NCT01059825|3888326|P5|Enrolled, Run-in Period|Lost to Follow-up|0
1184233|NCT01059825|3888327|P4|Enrolled, Run-in Period|Lost to Follow-up|0
1184234|NCT01059825|3888328|P3|Enrolled, Run-in Period|Lost to Follow-up|0
1184235|NCT01059825|3888329|P2|Enrolled, Run-in Period|Lost to Follow-up|0
1184236|NCT01059825|3888330|P1|Enrolled, Run-in Period|Lost to Follow-up|0
1184237|NCT01059825|3888324|P7|Enrolled, Run-in Period|Did not meet entrance criteria|14
1184238|NCT01059825|3888325|P6|Enrolled, Run-in Period|Did not meet entrance criteria|0
1184239|NCT01059825|3888326|P5|Enrolled, Run-in Period|Did not meet entrance criteria|0
1184240|NCT01059825|3888327|P4|Enrolled, Run-in Period|Did not meet entrance criteria|0
1184241|NCT01059825|3888328|P3|Enrolled, Run-in Period|Did not meet entrance criteria|0
1184242|NCT01059825|3888329|P2|Enrolled, Run-in Period|Did not meet entrance criteria|0
1184243|NCT01059825|3888330|P1|Enrolled, Run-in Period|Did not meet entrance criteria|0
1184244|NCT01059825|3888324|P7|Enrolled, Run-in Period|Adverse event not related to study drug|3
1184245|NCT01059825|3888325|P6|Enrolled, Run-in Period|Adverse event not related to study drug|0
1184246|NCT01059825|3888326|P5|Enrolled, Run-in Period|Adverse event not related to study drug|0
1184247|NCT01059825|3888327|P4|Enrolled, Run-in Period|Adverse event not related to study drug|0
1184248|NCT01059825|3888328|P3|Enrolled, Run-in Period|Adverse event not related to study drug|0
1184249|NCT01059825|3888329|P2|Enrolled, Run-in Period|Adverse event not related to study drug|0
1184250|NCT01059825|3888330|P1|Enrolled, Run-in Period|Adverse event not related to study drug|0
1184251|NCT01059812|3888517|P2|Overall Study|Unclassified|4
1184252|NCT01059812|3888518|P1|Overall Study|Unclassified|14
1184253|NCT01059812|3888517|P2|Overall Study|Withdrawal Criteria|4
1184254|NCT01059812|3888518|P1|Overall Study|Withdrawal Criteria|9
1184255|NCT01059812|3888517|P2|Overall Study|Protocol Violation|1
1184256|NCT01059812|3888518|P1|Overall Study|Protocol Violation|3
1184257|NCT01059812|3888517|P2|Overall Study|Lack of Efficacy|2
1184258|NCT01059812|3888518|P1|Overall Study|Lack of Efficacy|2
1184259|NCT01059812|3888517|P2|Overall Study|Adverse Event|5
1184260|NCT01059812|3888518|P1|Overall Study|Adverse Event|9
1184261|NCT01059799|3888534|P2|Overall Study|Other|3
1184262|NCT01059799|3888535|P1|Overall Study|Other|12
1184263|NCT01059799|3888534|P2|Overall Study|Withdrawal criteria|2
1184264|NCT01059799|3888535|P1|Overall Study|Withdrawal criteria|13
1184265|NCT01059799|3888534|P2|Overall Study|Protocol Violation|2
1184266|NCT01059799|3888535|P1|Overall Study|Protocol Violation|3
1184267|NCT01059799|3888534|P2|Overall Study|Lack of Efficacy|0
1184268|NCT01059799|3888535|P1|Overall Study|Lack of Efficacy|1
1184269|NCT01059799|3888534|P2|Overall Study|Adverse Event|3
1184270|NCT01059799|3888535|P1|Overall Study|Adverse Event|2
1184271|NCT01059773|3888549|P2|Overall Study|Other|3
1184272|NCT01059773|3888550|P1|Overall Study|Other|1
1184273|NCT01059773|3888549|P2|Overall Study|Ineligible follow TB screening criteria|1
1184274|NCT01059773|3888550|P1|Overall Study|Ineligible follow TB screening criteria|0
1184275|NCT01059773|3888549|P2|Overall Study|Malignancy including squamous cell skin|1
1184276|NCT01059773|3888550|P1|Overall Study|Malignancy including squamous cell skin|0
1184277|NCT01059773|3888549|P2|Overall Study|Death|1
1184278|NCT01059773|3888550|P1|Overall Study|Death|0
1184279|NCT01059773|3888549|P2|Overall Study|Lack of Efficacy|3
1184280|NCT01059773|3888550|P1|Overall Study|Lack of Efficacy|3
1184281|NCT01059773|3888549|P2|Overall Study|Physician Decision|4
1184282|NCT01059773|3888550|P1|Overall Study|Physician Decision|5
1184283|NCT01059773|3888549|P2|Overall Study|Protocol Violation|2
1184284|NCT01059773|3888550|P1|Overall Study|Protocol Violation|6
1184285|NCT01059773|3888549|P2|Overall Study|Pregnancy|1
1184286|NCT01059773|3888550|P1|Overall Study|Pregnancy|1
1184287|NCT01059773|3888549|P2|Overall Study|Lost to Follow-up|1
1184288|NCT01059773|3888550|P1|Overall Study|Lost to Follow-up|1
1184289|NCT01059773|3888549|P2|Overall Study|Withdrawal by Subject|5
1184290|NCT01059773|3888550|P1|Overall Study|Withdrawal by Subject|1
1184291|NCT01059773|3888549|P2|Overall Study|Adverse Event|2
1184292|NCT01059773|3888550|P1|Overall Study|Adverse Event|2
1184293|NCT01059643|3888689|P1|Overall Study|Physician Decision|1
1184294|NCT01059643|3888689|P1|Overall Study|Withdrawal by Subject|2
1184295|NCT01059643|3888689|P1|Overall Study|Adverse Event|3
1184296|NCT01059630|3888704|P2|Maintenance Period (up to 2 Years)|Other|3
1184297|NCT01059630|3888705|P1|Maintenance Period (up to 2 Years)|Other|0
1184298|NCT01059630|3888704|P2|Maintenance Period (up to 2 Years)|Physician Decision|2
1184299|NCT01059630|3888705|P1|Maintenance Period (up to 2 Years)|Physician Decision|0
1184300|NCT01059630|3888704|P2|Maintenance Period (up to 2 Years)|Death|2
1184301|NCT01059630|3888705|P1|Maintenance Period (up to 2 Years)|Death|0
1184302|NCT01059630|3888704|P2|Maintenance Period (up to 2 Years)|Withdrawal by Subject|3
1184303|NCT01059630|3888705|P1|Maintenance Period (up to 2 Years)|Withdrawal by Subject|0
1184304|NCT01059630|3888704|P2|Maintenance Period (up to 2 Years)|Progressive Disease|44
1184305|NCT01059630|3888705|P1|Maintenance Period (up to 2 Years)|Progressive Disease|0
1184306|NCT01059630|3888704|P2|Maintenance Period (up to 2 Years)|Adverse Event|8
1184307|NCT01059630|3888705|P1|Maintenance Period (up to 2 Years)|Adverse Event|0
1184308|NCT01059630|3888704|P2|Maintenance Period (up to 2 Years)|Maintenance ongoing|46
1184309|NCT01059630|3888705|P1|Maintenance Period (up to 2 Years)|Maintenance ongoing|0
1184310|NCT01059630|3888704|P2|Induction Period (6 Months)|Randomized but not Treated|0
1184311|NCT01059630|3888705|P1|Induction Period (6 Months)|Randomized but not Treated|4
1184312|NCT01059630|3888704|P2|Induction Period (6 Months)|Other|0
1184313|NCT01059630|3888705|P1|Induction Period (6 Months)|Other|1
1184314|NCT01059630|3888704|P2|Induction Period (6 Months)|Physician Decision|4
1184315|NCT01059630|3888705|P1|Induction Period (6 Months)|Physician Decision|2
1184316|NCT01059630|3888704|P2|Induction Period (6 Months)|Death|2
1184317|NCT01059630|3888705|P1|Induction Period (6 Months)|Death|2
1184318|NCT01059630|3888704|P2|Induction Period (6 Months)|Withdrawal by Subject|2
1184319|NCT01059630|3888705|P1|Induction Period (6 Months)|Withdrawal by Subject|7
1184320|NCT01059630|3888704|P2|Induction Period (6 Months)|Progressive Disease|9
1184321|NCT01059630|3888705|P1|Induction Period (6 Months)|Progressive Disease|14
1184322|NCT01059630|3888704|P2|Induction Period (6 Months)|Adverse Event|15
1184323|NCT01059630|3888705|P1|Induction Period (6 Months)|Adverse Event|30
1184324|NCT01059630|3888704|P2|Induction Period (6 Months)|Induction ongoing|6
1184325|NCT01059630|3888705|P1|Induction Period (6 Months)|Induction ongoing|13
1184326|NCT01059617|3888765|P4|Overall Study|Other|6
1184327|NCT01059617|3888766|P3|Overall Study|Other|8
1184328|NCT01059617|3888767|P2|Overall Study|Other|1
1184329|NCT01059617|3888768|P1|Overall Study|Other|7
1184330|NCT01059565|3888938|P2|24-Week Open-Label Phase|Pulmonologist/participant decision|1
1184331|NCT01059565|3888939|P1|24-Week Open-Label Phase|Pulmonologist/participant decision|0
1184332|NCT01059565|3888938|P2|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1
1184333|NCT01059565|3888939|P1|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0
1184334|NCT01059565|3888938|P2|24-Week Open-Label Phase|Subject noncompliance|0
1184335|NCT01059565|3888939|P1|24-Week Open-Label Phase|Subject noncompliance|1
1184336|NCT01059565|3888938|P2|24-Week Open-Label Phase|Withdrawal by Subject|0
1184337|NCT01059565|3888939|P1|24-Week Open-Label Phase|Withdrawal by Subject|1
1184338|NCT01059565|3888938|P2|24-Week Open-Label Phase|Worsening health (physician decision)|1
1184339|NCT01059565|3888939|P1|24-Week Open-Label Phase|Worsening health (physician decision)|1
1184340|NCT01059565|3888938|P2|24-Week Open-Label Phase|Adverse Event|0
1184341|NCT01059565|3888939|P1|24-Week Open-Label Phase|Adverse Event|2
1184342|NCT01059565|3888938|P2|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5
1184343|NCT01059565|3888939|P1|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1
1184344|NCT01059565|3888938|P2|24-Week Randomized Phase|Lost to Follow-up|1
1184345|NCT01059565|3888939|P1|24-Week Randomized Phase|Lost to Follow-up|0
1184346|NCT01059565|3888938|P2|24-Week Randomized Phase|Withdrawal by Subject|1
1184347|NCT01059565|3888939|P1|24-Week Randomized Phase|Withdrawal by Subject|3
1184348|NCT01059565|3888938|P2|24-Week Randomized Phase|Adverse Event|0
1184349|NCT01059565|3888939|P1|24-Week Randomized Phase|Adverse Event|5
1184350|NCT01059565|3888938|P2|24-Week Randomized Phase|Randomized but not treated|0
1184351|NCT01059565|3888939|P1|24-Week Randomized Phase|Randomized but not treated|1
1184352|NCT01059526|3888975|P2|Overall Study|Patient found to be dermatographic|0
1184353|NCT01059526|3888976|P1|Overall Study|Patient found to be dermatographic|1
1184354|NCT01059526|3888975|P2|Overall Study|Lost to Follow-up|1
1184355|NCT01059526|3888976|P1|Overall Study|Lost to Follow-up|4
1184356|NCT01059526|3888975|P2|Overall Study|Withdrawal by Subject|1
1184357|NCT01059526|3888976|P1|Overall Study|Withdrawal by Subject|3
1184358|NCT01059526|3888975|P2|Overall Study|Protocol Violation|1
1184359|NCT01059526|3888976|P1|Overall Study|Protocol Violation|0
1184360|NCT01059526|3888975|P2|Overall Study|Adverse Event|2
1184361|NCT01059526|3888976|P1|Overall Study|Adverse Event|2
1184362|NCT01059526|3888975|P2|Overall Study|Patient enrolled but not treated|17
1184363|NCT01059526|3888976|P1|Overall Study|Patient enrolled but not treated|20
1184364|NCT01059344|3888995|P2|Overall Study|Other|6
1184365|NCT01059344|3888996|P1|Overall Study|Other|3
1184366|NCT01059344|3888995|P2|Overall Study|Lost to Follow-up|1
1184367|NCT01059344|3888996|P1|Overall Study|Lost to Follow-up|1
1184368|NCT01059344|3888995|P2|Overall Study|Withdrawal by Subject|9
1184369|NCT01059344|3888996|P1|Overall Study|Withdrawal by Subject|6
1184370|NCT01059344|3888995|P2|Overall Study|Adverse Event|30
1184371|NCT01059344|3888996|P1|Overall Study|Adverse Event|12
1184372|NCT01059175|3889020|P2|Overall Study|Lost to Follow-up|1
1184373|NCT01059175|3889021|P1|Overall Study|Lost to Follow-up|0
1184374|NCT01059175|3889020|P2|Overall Study|Adverse Event|2
1184375|NCT01059175|3889021|P1|Overall Study|Adverse Event|4
1184376|NCT01059175|3889020|P2|Overall Study|Death|17
1184377|NCT01059175|3889021|P1|Overall Study|Death|17
1184378|NCT01059071|3889043|P4|Overall Study|Physician Decision|1
1184379|NCT01059071|3889044|P3|Overall Study|Physician Decision|0
1184380|NCT01059071|3889045|P2|Overall Study|Physician Decision|0
1184381|NCT01059071|3889046|P1|Overall Study|Physician Decision|0
1184382|NCT01059071|3889043|P4|Overall Study|Withdrawal by Subject|2
1184383|NCT01059071|3889044|P3|Overall Study|Withdrawal by Subject|0
1184384|NCT01059071|3889045|P2|Overall Study|Withdrawal by Subject|0
1184385|NCT01059071|3889046|P1|Overall Study|Withdrawal by Subject|1
1184386|NCT01059071|3889043|P4|Overall Study|Lack of Efficacy|3
1184387|NCT01059071|3889044|P3|Overall Study|Lack of Efficacy|2
1184388|NCT01059071|3889045|P2|Overall Study|Lack of Efficacy|4
1184389|NCT01059071|3889046|P1|Overall Study|Lack of Efficacy|1
1184390|NCT01058863|3889073|P1|Overall Study|Randomized in error|1
1184391|NCT01058863|3889073|P1|Overall Study|Sponsor requested withdrawal|1
1184392|NCT01058863|3889073|P1|Overall Study|Withdrawal by Subject|1
1184393|NCT01058863|3889073|P1|Overall Study|Lost to Follow-up|1
1184394|NCT01058668|3889094|P3|Double-blind Treatment Phase|Other Unspecified|0
1184395|NCT01058668|3889095|P2|Double-blind Treatment Phase|Other Unspecified|1
1184396|NCT01058668|3889096|P1|Double-blind Treatment Phase|Other Unspecified|1
1184397|NCT01058668|3889094|P3|Double-blind Treatment Phase|Lost to Follow-up|1
1184398|NCT01058668|3889095|P2|Double-blind Treatment Phase|Lost to Follow-up|1
1184399|NCT01058668|3889096|P1|Double-blind Treatment Phase|Lost to Follow-up|0
1184400|NCT01058668|3889094|P3|Double-blind Treatment Phase|Withdrawal of Consent|17
1184401|NCT01058668|3889095|P2|Double-blind Treatment Phase|Withdrawal of Consent|18
1184402|NCT01058668|3889096|P1|Double-blind Treatment Phase|Withdrawal of Consent|14
1184403|NCT01058668|3889094|P3|Double-blind Treatment Phase|Protocol Violation|2
1184404|NCT01058668|3889095|P2|Double-blind Treatment Phase|Protocol Violation|1
1184405|NCT01058668|3889096|P1|Double-blind Treatment Phase|Protocol Violation|1
1184406|NCT01058668|3889094|P3|Double-blind Treatment Phase|Insufficient Therapeutic Response|5
1184407|NCT01058668|3889095|P2|Double-blind Treatment Phase|Insufficient Therapeutic Response|2
1184408|NCT01058668|3889096|P1|Double-blind Treatment Phase|Insufficient Therapeutic Response|15
1184409|NCT01058668|3889094|P3|Double-blind Treatment Phase|Adverse Event|25
1184410|NCT01058668|3889095|P2|Double-blind Treatment Phase|Adverse Event|15
1184411|NCT01058668|3889096|P1|Double-blind Treatment Phase|Adverse Event|8
1184412|NCT01058655|3889111|P4|Overall Study|Other|4
1184413|NCT01058655|3889112|P3|Overall Study|Other|0
1184414|NCT01058655|3889113|P2|Overall Study|Other|0
1184415|NCT01058655|3889114|P1|Overall Study|Other|0
1184416|NCT01058655|3889111|P4|Overall Study|Disease Progression|24
1184417|NCT01058655|3889112|P3|Overall Study|Disease Progression|4
1184418|NCT01058655|3889113|P2|Overall Study|Disease Progression|2
1184419|NCT01058655|3889114|P1|Overall Study|Disease Progression|1
1184420|NCT01058655|3889111|P4|Overall Study|Death|0
1184421|NCT01058655|3889112|P3|Overall Study|Death|1
1184422|NCT01058655|3889113|P2|Overall Study|Death|1
1184423|NCT01058655|3889114|P1|Overall Study|Death|0
1184424|NCT01058655|3889111|P4|Overall Study|Clinical Progression (non-RECIST)|7
1184425|NCT01058655|3889112|P3|Overall Study|Clinical Progression (non-RECIST)|0
1184426|NCT01058655|3889113|P2|Overall Study|Clinical Progression (non-RECIST)|0
1184427|NCT01058655|3889114|P1|Overall Study|Clinical Progression (non-RECIST)|1
1184428|NCT01058655|3889111|P4|Overall Study|Symptomatic Deterioration|1
1184429|NCT01058655|3889112|P3|Overall Study|Symptomatic Deterioration|0
1184430|NCT01058655|3889113|P2|Overall Study|Symptomatic Deterioration|0
1184431|NCT01058655|3889114|P1|Overall Study|Symptomatic Deterioration|0
1184432|NCT01058655|3889111|P4|Overall Study|Prolonged Treatment Delay|2
1184433|NCT01058655|3889112|P3|Overall Study|Prolonged Treatment Delay|0
1184434|NCT01058655|3889113|P2|Overall Study|Prolonged Treatment Delay|0
1184435|NCT01058655|3889114|P1|Overall Study|Prolonged Treatment Delay|0
1184436|NCT01058655|3889111|P4|Overall Study|Withdrawal by Subject|4
1184437|NCT01058655|3889112|P3|Overall Study|Withdrawal by Subject|3
1184438|NCT01058655|3889113|P2|Overall Study|Withdrawal by Subject|0
1184439|NCT01058655|3889114|P1|Overall Study|Withdrawal by Subject|1
1184440|NCT01058642|3889132|P4|Treatment Period 1|Lack of Compliance with Study Drug|0
1184441|NCT01058642|3889133|P3|Treatment Period 1|Lack of Compliance with Study Drug|0
1184442|NCT01058642|3889134|P2|Treatment Period 1|Lack of Compliance with Study Drug|0
1184443|NCT01058642|3889135|P1|Treatment Period 1|Lack of Compliance with Study Drug|1
1184444|NCT01058642|3889132|P4|Treatment Period 1|Protocol Violation|1
1184445|NCT01058642|3889133|P3|Treatment Period 1|Protocol Violation|0
1184446|NCT01058642|3889134|P2|Treatment Period 1|Protocol Violation|0
1184447|NCT01058642|3889135|P1|Treatment Period 1|Protocol Violation|0
1184448|NCT01058642|3889132|P4|Treatment Period 1|Lack of Efficacy|1
1184449|NCT01058642|3889133|P3|Treatment Period 1|Lack of Efficacy|0
1184450|NCT01058642|3889134|P2|Treatment Period 1|Lack of Efficacy|0
1184451|NCT01058642|3889135|P1|Treatment Period 1|Lack of Efficacy|0
1184452|NCT01058642|3889132|P4|Treatment Period 1|Withdrawal by Subject|0
1184453|NCT01058642|3889133|P3|Treatment Period 1|Withdrawal by Subject|0
1184454|NCT01058642|3889134|P2|Treatment Period 1|Withdrawal by Subject|0
1184455|NCT01058642|3889135|P1|Treatment Period 1|Withdrawal by Subject|1
1184456|NCT01058642|3889132|P4|Treatment Period 1|Physician Decision|0
1184457|NCT01058642|3889133|P3|Treatment Period 1|Physician Decision|1
1184458|NCT01058642|3889134|P2|Treatment Period 1|Physician Decision|0
1184459|NCT01058642|3889135|P1|Treatment Period 1|Physician Decision|0
1184460|NCT01058642|3889132|P4|Treatment Period 1|Adverse Event|0
1184461|NCT01058642|3889133|P3|Treatment Period 1|Adverse Event|1
1184462|NCT01058642|3889134|P2|Treatment Period 1|Adverse Event|1
1184463|NCT01058642|3889135|P1|Treatment Period 1|Adverse Event|0
1184464|NCT01058421|3889145|P2|6 Month Outcomes|Remained in Other Facility|3
1184465|NCT01058421|3889146|P1|6 Month Outcomes|Remained in Other Facility|1
1184466|NCT01058421|3889145|P2|6 Month Outcomes|Lost to Follow-up|21
1184467|NCT01058421|3889146|P1|6 Month Outcomes|Lost to Follow-up|16
1184468|NCT01058421|3889145|P2|6 Month Outcomes|Death|2
1184469|NCT01058421|3889146|P1|6 Month Outcomes|Death|2
1184470|NCT01058421|3889145|P2|3 Month Outcomes|Remained in Other Facility|8
1184471|NCT01058421|3889146|P1|3 Month Outcomes|Remained in Other Facility|5
1184472|NCT01058421|3889145|P2|3 Month Outcomes|Remained in Hospital|2
1184473|NCT01058421|3889146|P1|3 Month Outcomes|Remained in Hospital|0
1184474|NCT01058421|3889145|P2|3 Month Outcomes|Lost to Follow-up|11
1184475|NCT01058421|3889146|P1|3 Month Outcomes|Lost to Follow-up|12
1184476|NCT01058421|3889145|P2|3 Month Outcomes|Death|5
1184477|NCT01058421|3889146|P1|3 Month Outcomes|Death|3
1184478|NCT01058421|3889145|P2|1 Month Outcomes|Remained in Other Facility|17
1184479|NCT01058421|3889146|P1|1 Month Outcomes|Remained in Other Facility|16
1184480|NCT01058421|3889145|P2|1 Month Outcomes|Remained in Hospital|12
1184481|NCT01058421|3889146|P1|1 Month Outcomes|Remained in Hospital|5
1184482|NCT01058421|3889145|P2|1 Month Outcomes|Lost to Follow-up|7
1184483|NCT01058421|3889146|P1|1 Month Outcomes|Lost to Follow-up|8
1184484|NCT01058421|3889145|P2|1 Month Outcomes|Death|6
1184485|NCT01058421|3889146|P1|1 Month Outcomes|Death|10
1184486|NCT01058395|3889170|P2|Overall Study|Lost to Follow-up|0
1184487|NCT01058395|3889171|P1|Overall Study|Lost to Follow-up|1
1184488|NCT01058395|3889170|P2|Overall Study|Death|1
1184489|NCT01058395|3889171|P1|Overall Study|Death|2
1184490|NCT01058356|3889180|P1|Overall Study|Lost to Follow-up|4
1184491|NCT01058356|3889180|P1|Overall Study|Withdrawal by Subject|21
1184492|NCT01058356|3889180|P1|Overall Study|Administration of contraindicated drugs|12
1184493|NCT01058356|3889180|P1|Overall Study|Adverse Event|5
1184494|NCT01058304|3889187|P2|Overall Study|Developed exclusion criterion|12
1184495|NCT01058304|3889188|P1|Overall Study|Developed exclusion criterion|6
1184496|NCT01058304|3889187|P2|Overall Study|Lost to Follow-up|16
1184497|NCT01058304|3889188|P1|Overall Study|Lost to Follow-up|13
1184498|NCT01058304|3889187|P2|Overall Study|Withdrawal by Subject|5
1184499|NCT01058304|3889188|P1|Overall Study|Withdrawal by Subject|8
1184500|NCT01058265|3889198|P2|Overall Study|Lost to Follow-up|12
1184501|NCT01058265|3889199|P1|Overall Study|Lost to Follow-up|11
1184502|NCT01058096|3889218|P2|Double-blind Treatment Phase|Other Unspecified|0
1184503|NCT01058096|3889219|P1|Double-blind Treatment Phase|Other Unspecified|2
1184504|NCT01058096|3889218|P2|Double-blind Treatment Phase|Lost to Follow-up|1
1184505|NCT01058096|3889219|P1|Double-blind Treatment Phase|Lost to Follow-up|0
1184506|NCT01058096|3889218|P2|Double-blind Treatment Phase|Withdrawal of Consent|26
1184507|NCT01058096|3889219|P1|Double-blind Treatment Phase|Withdrawal of Consent|17
1184508|NCT01058096|3889218|P2|Double-blind Treatment Phase|Protocol Violation|1
1184509|NCT01058096|3889219|P1|Double-blind Treatment Phase|Protocol Violation|2
1184510|NCT01058096|3889218|P2|Double-blind Treatment Phase|Insufficient Therapeutic Response|7
1184511|NCT01058096|3889219|P1|Double-blind Treatment Phase|Insufficient Therapeutic Response|16
1184512|NCT01058096|3889218|P2|Double-blind Treatment Phase|Adverse Event|15
1184513|NCT01058096|3889219|P1|Double-blind Treatment Phase|Adverse Event|11
1184514|NCT01058005|3889235|P3|Overall Study|Reason Missing|1
1184515|NCT01058005|3889236|P2|Overall Study|Reason Missing|3
1184516|NCT01058005|3889237|P1|Overall Study|Reason Missing|5
1184517|NCT01058005|3889235|P3|Overall Study|Withdrawn Due to Study Termination|7
1184518|NCT01058005|3889236|P2|Overall Study|Withdrawn Due to Study Termination|13
1184519|NCT01058005|3889237|P1|Overall Study|Withdrawn Due to Study Termination|27
1184520|NCT01058005|3889235|P3|Overall Study|Withdrawal by Subject|11
1184521|NCT01058005|3889236|P2|Overall Study|Withdrawal by Subject|5
1184522|NCT01058005|3889237|P1|Overall Study|Withdrawal by Subject|4
1184523|NCT01058005|3889235|P3|Overall Study|Physician Decision|0
1184524|NCT01058005|3889236|P2|Overall Study|Physician Decision|2
1184525|NCT01058005|3889237|P1|Overall Study|Physician Decision|2
1184526|NCT01058005|3889235|P3|Overall Study|Adverse Event|1
1184527|NCT01058005|3889236|P2|Overall Study|Adverse Event|2
1184528|NCT01058005|3889237|P1|Overall Study|Adverse Event|0
1184529|NCT01057862|3889272|P2|Overall Study|Withdrawal by Subject|2
1184530|NCT01057862|3889273|P1|Overall Study|Withdrawal by Subject|1
1184531|NCT01057810|3889283|P2|Overall Study|Other|14
1184532|NCT01057810|3889284|P1|Overall Study|Other|7
1184533|NCT01057810|3889283|P2|Overall Study|No longer met study criteria|1
1184534|NCT01057810|3889284|P1|Overall Study|No longer met study criteria|0
1184535|NCT01057810|3889283|P2|Overall Study|Poor/non-compliance|1
1184536|NCT01057810|3889284|P1|Overall Study|Poor/non-compliance|0
1184537|NCT01057810|3889283|P2|Overall Study|Maximum clinical benefit|5
1184538|NCT01057810|3889284|P1|Overall Study|Maximum clinical benefit|5
1184539|NCT01057810|3889283|P2|Overall Study|Death|12
1184540|NCT01057810|3889284|P1|Overall Study|Death|2
1184541|NCT01057810|3889283|P2|Overall Study|Withdrawal by Subject|25
1184542|NCT01057810|3889284|P1|Overall Study|Withdrawal by Subject|10
1184543|NCT01057810|3889283|P2|Overall Study|Adverse event unrelated to study drug|29
1184544|NCT01057810|3889284|P1|Overall Study|Adverse event unrelated to study drug|13
1184545|NCT01057810|3889283|P2|Overall Study|Study drug toxicity|114
1184546|NCT01057810|3889284|P1|Overall Study|Study drug toxicity|5
1184547|NCT01057810|3889283|P2|Overall Study|Disease progression|197
1184548|NCT01057810|3889284|P1|Overall Study|Disease progression|156
1184549|NCT01057693|3889300|P3|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2
1184550|NCT01057693|3889301|P2|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
1184551|NCT01057693|3889302|P1|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
1184552|NCT01057693|3889300|P3|Double-Blind Phase (Week 7 to Week 19)|Other|0
1184553|NCT01057693|3889301|P2|Double-Blind Phase (Week 7 to Week 19)|Other|1
1184554|NCT01057693|3889302|P1|Double-Blind Phase (Week 7 to Week 19)|Other|0
1184555|NCT01057693|3889300|P3|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6
1184556|NCT01057693|3889301|P2|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8
1184557|NCT01057693|3889302|P1|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0
1184558|NCT01057693|3889300|P3|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4
1184559|NCT01057693|3889301|P2|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
1184560|NCT01057693|3889302|P1|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
1184561|NCT01057693|3889300|P3|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5
1184562|NCT01057693|3889301|P2|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2
1184563|NCT01057693|3889302|P1|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0
1184564|NCT01057693|3889300|P3|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8
1184565|NCT01057693|3889301|P2|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3
1184566|NCT01057693|3889302|P1|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0
1184567|NCT01057693|3889300|P3|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11
1184568|NCT01057693|3889301|P2|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8
1184569|NCT01057693|3889302|P1|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0
1184570|NCT01057693|3889300|P3|Between Single-Blind and Double-Blind|Other|0
1184571|NCT01057693|3889301|P2|Between Single-Blind and Double-Blind|Other|0
1184572|NCT01057693|3889302|P1|Between Single-Blind and Double-Blind|Other|6
1184573|NCT01057693|3889300|P3|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
1184574|NCT01057693|3889301|P2|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
1184575|NCT01057693|3889302|P1|Between Single-Blind and Double-Blind|Withdrawal by Subject|4
1184576|NCT01057693|3889300|P3|Between Single-Blind and Double-Blind|Protocol Violation|0
1184577|NCT01057693|3889301|P2|Between Single-Blind and Double-Blind|Protocol Violation|0
1184578|NCT01057693|3889302|P1|Between Single-Blind and Double-Blind|Protocol Violation|7
1184579|NCT01057693|3889300|P3|Between Single-Blind and Double-Blind|Lost to Follow-up|0
1184580|NCT01057693|3889301|P2|Between Single-Blind and Double-Blind|Lost to Follow-up|0
1184581|NCT01057693|3889302|P1|Between Single-Blind and Double-Blind|Lost to Follow-up|1
1184582|NCT01057693|3889300|P3|Between Single-Blind and Double-Blind|Lack of Efficacy|0
1184583|NCT01057693|3889301|P2|Between Single-Blind and Double-Blind|Lack of Efficacy|0
1184584|NCT01057693|3889302|P1|Between Single-Blind and Double-Blind|Lack of Efficacy|247
1184585|NCT01057693|3889300|P3|Between Single-Blind and Double-Blind|Adverse Event|0
1184586|NCT01057693|3889301|P2|Between Single-Blind and Double-Blind|Adverse Event|0
1184587|NCT01057693|3889302|P1|Between Single-Blind and Double-Blind|Adverse Event|5
1184588|NCT01057693|3889300|P3|Single-Blind Phase (Up to Week 6)|Other|0
1184589|NCT01057693|3889301|P2|Single-Blind Phase (Up to Week 6)|Other|0
1184590|NCT01057693|3889302|P1|Single-Blind Phase (Up to Week 6)|Other|2
1184591|NCT01057693|3889300|P3|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
1184592|NCT01057693|3889301|P2|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
1184593|NCT01057693|3889302|P1|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22
1184594|NCT01057693|3889300|P3|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
1184595|NCT01057693|3889301|P2|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
1184596|NCT01057693|3889302|P1|Single-Blind Phase (Up to Week 6)|Protocol Violation|9
1184597|NCT01057693|3889300|P3|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
1184598|NCT01057693|3889301|P2|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
1184599|NCT01057693|3889302|P1|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14
1184600|NCT01057693|3889300|P3|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
1184601|NCT01057693|3889301|P2|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
1184602|NCT01057693|3889302|P1|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7
1184603|NCT01057693|3889300|P3|Single-Blind Phase (Up to Week 6)|Adverse Event|0
1184604|NCT01057693|3889301|P2|Single-Blind Phase (Up to Week 6)|Adverse Event|0
1184605|NCT01057693|3889302|P1|Single-Blind Phase (Up to Week 6)|Adverse Event|45
1184606|NCT01057589|3889348|P1|Overall Study|Lost to Follow-up|1
1184607|NCT01057589|3889348|P1|Overall Study|Death|8
1184608|NCT01057589|3889348|P1|Overall Study|Sponsor Decision|1
1184609|NCT01057589|3889348|P1|Overall Study|Withdrawal by Subject|3
1184610|NCT01057589|3889348|P1|Overall Study|Physician Decision|8
1184611|NCT01057589|3889348|P1|Overall Study|Adverse Event|10
1184612|NCT01057589|3889348|P1|Overall Study|Disease Progression|35
1184613|NCT01057433|3889357|P1|Overall Study|Adverse Event|1
1184614|NCT01057394|3889361|P2|Overall Study|Not eligible|2
1184615|NCT01057394|3889362|P1|Overall Study|Not eligible|0
1184616|NCT01057251|3889372|P2|Overall Study|Other Reason|1
1184617|NCT01057251|3889373|P1|Overall Study|Other Reason|1
1184618|NCT01057251|3889372|P2|Overall Study|Lost to Follow-up|6
1184619|NCT01057251|3889373|P1|Overall Study|Lost to Follow-up|7
1184620|NCT01057251|3889372|P2|Overall Study|Withdrawal by Subject|5
1184621|NCT01057251|3889373|P1|Overall Study|Withdrawal by Subject|4
1184622|NCT01057251|3889372|P2|Overall Study|Protocol Violation|2
1184623|NCT01057251|3889373|P1|Overall Study|Protocol Violation|6
1184624|NCT01057251|3889372|P2|Overall Study|Lack of Efficacy|11
1184625|NCT01057251|3889373|P1|Overall Study|Lack of Efficacy|2
1184626|NCT01057251|3889372|P2|Overall Study|Adverse Event|2
1184627|NCT01057251|3889373|P1|Overall Study|Adverse Event|4
1184628|NCT01057251|3889372|P2|Overall Study|Did not meet InclusionExclusion criteria|2
1184629|NCT01057251|3889373|P1|Overall Study|Did not meet InclusionExclusion criteria|4
1184630|NCT01056822|3889451|P2|Overall Study|Lost to Follow-up|0
1184631|NCT01056822|3889452|P1|Overall Study|Lost to Follow-up|1
1184632|NCT01056822|3889451|P2|Overall Study|Withdrawal by Subject|1
1184633|NCT01056822|3889452|P1|Overall Study|Withdrawal by Subject|1
1184634|NCT01056822|3889451|P2|Overall Study|Protocol Violation|5
1184635|NCT01056822|3889452|P1|Overall Study|Protocol Violation|6
1184636|NCT01056822|3889451|P2|Overall Study|Adverse Event|1
1184637|NCT01056822|3889452|P1|Overall Study|Adverse Event|0
1184638|NCT01056718|3889501|P1|Overall Study|Ischemia on baseline stress test|1
1184639|NCT01056718|3889501|P1|Overall Study|Withdrawal by Subject|2
1184640|NCT01056653|3889534|P3|Overall Study|Lost to Follow-up|2
1184641|NCT01056653|3889535|P2|Overall Study|Lost to Follow-up|0
1184642|NCT01056653|3889536|P1|Overall Study|Lost to Follow-up|0
1184643|NCT01056640|3889552|P2|Overall Study|Death|4
1184644|NCT01056640|3889553|P1|Overall Study|Death|15
1184645|NCT01056640|3889552|P2|Overall Study|Withdrawal by Subject|8
1184646|NCT01056640|3889553|P1|Overall Study|Withdrawal by Subject|11
1184647|NCT01056523|3889565|P7|Overall Study|Death|1
1184648|NCT01056523|3889566|P6|Overall Study|Death|0
1184649|NCT01056523|3889567|P5|Overall Study|Death|0
1184650|NCT01056523|3889568|P4|Overall Study|Death|3
1184651|NCT01056523|3889569|P3|Overall Study|Death|2
1184652|NCT01056523|3889570|P2|Overall Study|Death|0
1184653|NCT01056523|3889571|P1|Overall Study|Death|1
1184654|NCT01056510|3889581|P2|Overall Study|Missing|1
1184655|NCT01056510|3889582|P1|Overall Study|Missing|0
1184656|NCT01056510|3889581|P2|Overall Study|Not Specified|12
1184657|NCT01056510|3889582|P1|Overall Study|Not Specified|10
1184658|NCT01056510|3889581|P2|Overall Study|Lost to Follow-up|6
1184659|NCT01056510|3889582|P1|Overall Study|Lost to Follow-up|5
1184660|NCT01056510|3889581|P2|Overall Study|Physician Decision|5
1184661|NCT01056510|3889582|P1|Overall Study|Physician Decision|4
1184662|NCT01056510|3889581|P2|Overall Study|Noncompliance|3
1184663|NCT01056510|3889582|P1|Overall Study|Noncompliance|1
1184664|NCT01056510|3889581|P2|Overall Study|Death|34
1184665|NCT01056510|3889582|P1|Overall Study|Death|29
1184666|NCT01056510|3889581|P2|Overall Study|Withdrawal by Subject|2
1184667|NCT01056510|3889582|P1|Overall Study|Withdrawal by Subject|4
1184668|NCT01056510|3889581|P2|Overall Study|Dropout Before Start of Treatment|1
1184669|NCT01056510|3889582|P1|Overall Study|Dropout Before Start of Treatment|1
1184670|NCT01056484|3889628|P2|Follow up - Non-randomized|Withdrawal by Subject|2
1184671|NCT01056484|3889629|P1|Follow up - Non-randomized|Withdrawal by Subject|0
1184672|NCT01056484|3889628|P2|Randomized Controlled Trial|Physician Decision|0
1184673|NCT01056484|3889629|P1|Randomized Controlled Trial|Physician Decision|1
1184674|NCT01056484|3889628|P2|Randomized Controlled Trial|Withdrawal by Subject|1
1184675|NCT01056484|3889629|P1|Randomized Controlled Trial|Withdrawal by Subject|6
1184676|NCT01056380|3889645|P2|Overall Study|Lost to Follow-up|3
1184677|NCT01056380|3889646|P1|Overall Study|Lost to Follow-up|2
1184678|NCT01056341|3889673|P5|Overall Study|Other reasons|5
1184679|NCT01056341|3889674|P4|Overall Study|Other reasons|9
1184680|NCT01056341|3889675|P3|Overall Study|Other reasons|8
1184681|NCT01056341|3889676|P2|Overall Study|Other reasons|4
1184682|NCT01056341|3889677|P1|Overall Study|Other reasons|4
1184683|NCT01056341|3889673|P5|Overall Study|Lack of Efficacy|9
1184684|NCT01056341|3889674|P4|Overall Study|Lack of Efficacy|25
1184685|NCT01056341|3889675|P3|Overall Study|Lack of Efficacy|7
1184686|NCT01056341|3889676|P2|Overall Study|Lack of Efficacy|30
1184687|NCT01056341|3889677|P1|Overall Study|Lack of Efficacy|32
1184688|NCT01056341|3889673|P5|Overall Study|Treatment Intolerance|0
1184689|NCT01056341|3889674|P4|Overall Study|Treatment Intolerance|2
1184690|NCT01056341|3889675|P3|Overall Study|Treatment Intolerance|0
1184691|NCT01056341|3889676|P2|Overall Study|Treatment Intolerance|2
1184692|NCT01056341|3889677|P1|Overall Study|Treatment Intolerance|0
1184693|NCT01056289|3889750|P4|Double-blind Phase|Physician Decision|0
1184694|NCT01056289|3889751|P3|Double-blind Phase|Physician Decision|1
1184695|NCT01056289|3889752|P2|Double-blind Phase|Physician Decision|0
1184696|NCT01056289|3889753|P1|Double-blind Phase|Physician Decision|0
1184697|NCT01056289|3889750|P4|Double-blind Phase|Discontinuation symptom|2
1184698|NCT01056289|3889751|P3|Double-blind Phase|Discontinuation symptom|2
1184699|NCT01056289|3889752|P2|Double-blind Phase|Discontinuation symptom|1
1184700|NCT01056289|3889753|P1|Double-blind Phase|Discontinuation symptom|0
1184701|NCT01056289|3889750|P4|Double-blind Phase|Withdrawal by Subject|2
1184702|NCT01056289|3889751|P3|Double-blind Phase|Withdrawal by Subject|4
1184703|NCT01056289|3889752|P2|Double-blind Phase|Withdrawal by Subject|0
1184704|NCT01056289|3889753|P1|Double-blind Phase|Withdrawal by Subject|0
1184705|NCT01056289|3889750|P4|Double-blind Phase|Protocol Violation|1
1184706|NCT01056289|3889751|P3|Double-blind Phase|Protocol Violation|1
1184707|NCT01056289|3889752|P2|Double-blind Phase|Protocol Violation|0
1184708|NCT01056289|3889753|P1|Double-blind Phase|Protocol Violation|0
1184709|NCT01056289|3889750|P4|Double-blind Phase|Other|2
1184710|NCT01056289|3889751|P3|Double-blind Phase|Other|1
1184711|NCT01056289|3889752|P2|Double-blind Phase|Other|0
1184712|NCT01056289|3889753|P1|Double-blind Phase|Other|0
1184713|NCT01056289|3889750|P4|Double-blind Phase|Lost to Follow-up|2
1184714|NCT01056289|3889751|P3|Double-blind Phase|Lost to Follow-up|2
1184715|NCT01056289|3889752|P2|Double-blind Phase|Lost to Follow-up|2
1184716|NCT01056289|3889753|P1|Double-blind Phase|Lost to Follow-up|0
1184717|NCT01056289|3889750|P4|Double-blind Phase|Adverse Event|1
1184718|NCT01056289|3889751|P3|Double-blind Phase|Adverse Event|2
1184719|NCT01056289|3889752|P2|Double-blind Phase|Adverse Event|1
1184720|NCT01056289|3889753|P1|Double-blind Phase|Adverse Event|0
1184721|NCT01056289|3889750|P4|Open-label Phase|Not randomized to Double-blind phase|0
1184722|NCT01056289|3889751|P3|Open-label Phase|Not randomized to Double-blind phase|0
1184723|NCT01056289|3889752|P2|Open-label Phase|Not randomized to Double-blind phase|0
1184724|NCT01056289|3889753|P1|Open-label Phase|Not randomized to Double-blind phase|1
1184725|NCT01056289|3889750|P4|Open-label Phase|Lack of Efficacy|0
1184726|NCT01056289|3889751|P3|Open-label Phase|Lack of Efficacy|0
1184727|NCT01056289|3889752|P2|Open-label Phase|Lack of Efficacy|0
1184728|NCT01056289|3889753|P1|Open-label Phase|Lack of Efficacy|18
1184729|NCT01056289|3889750|P4|Open-label Phase|Withdrawal by Subject|0
1184730|NCT01056289|3889751|P3|Open-label Phase|Withdrawal by Subject|0
1184731|NCT01056289|3889752|P2|Open-label Phase|Withdrawal by Subject|0
1184732|NCT01056289|3889753|P1|Open-label Phase|Withdrawal by Subject|26
1184733|NCT01056289|3889750|P4|Open-label Phase|Protocol Violation|0
1184734|NCT01056289|3889751|P3|Open-label Phase|Protocol Violation|0
1184735|NCT01056289|3889752|P2|Open-label Phase|Protocol Violation|0
1184736|NCT01056289|3889753|P1|Open-label Phase|Protocol Violation|6
1184737|NCT01056289|3889750|P4|Open-label Phase|Other|0
1184738|NCT01056289|3889751|P3|Open-label Phase|Other|0
1184739|NCT01056289|3889752|P2|Open-label Phase|Other|0
1184740|NCT01056289|3889753|P1|Open-label Phase|Other|9
1184741|NCT01056289|3889750|P4|Open-label Phase|Lost to Follow-up|0
1184742|NCT01056289|3889751|P3|Open-label Phase|Lost to Follow-up|0
1184743|NCT01056289|3889752|P2|Open-label Phase|Lost to Follow-up|0
1184744|NCT01056289|3889753|P1|Open-label Phase|Lost to Follow-up|30
1184745|NCT01056289|3889750|P4|Open-label Phase|Adverse Event|0
1184746|NCT01056289|3889751|P3|Open-label Phase|Adverse Event|0
1184747|NCT01056289|3889752|P2|Open-label Phase|Adverse Event|0
1184748|NCT01056289|3889753|P1|Open-label Phase|Adverse Event|29
1184749|NCT01056276|3889770|P2|Maintenance Therapy|Continuing maintenance therapy|14
1184750|NCT01056276|3889771|P1|Maintenance Therapy|Continuing maintenance therapy|0
1184751|NCT01056276|3889770|P2|Maintenance Therapy|Intercurrent Illness|1
1184752|NCT01056276|3889771|P1|Maintenance Therapy|Intercurrent Illness|0
1184753|NCT01056276|3889770|P2|Maintenance Therapy|Withdrawal by Subject|1
1184754|NCT01056276|3889771|P1|Maintenance Therapy|Withdrawal by Subject|0
1184755|NCT01056276|3889770|P2|Maintenance Therapy|Physician Decision|1
1184756|NCT01056276|3889771|P1|Maintenance Therapy|Physician Decision|0
1184757|NCT01056276|3889770|P2|Maintenance Therapy|Progressive Disease|9
1184758|NCT01056276|3889771|P1|Maintenance Therapy|Progressive Disease|0
1184759|NCT01056276|3889770|P2|Maintenance Therapy|Toxicity|2
1184760|NCT01056276|3889771|P1|Maintenance Therapy|Toxicity|0
1184761|NCT01056276|3889770|P2|Treatment Period-Cycles 1-8|Lost to Follow-up|0
1184762|NCT01056276|3889771|P1|Treatment Period-Cycles 1-8|Lost to Follow-up|1
1184763|NCT01056276|3889770|P2|Treatment Period-Cycles 1-8|Death|1
1184764|NCT01056276|3889771|P1|Treatment Period-Cycles 1-8|Death|3
1184765|NCT01056276|3889770|P2|Treatment Period-Cycles 1-8|Physician Decision|0
1184766|NCT01056276|3889771|P1|Treatment Period-Cycles 1-8|Physician Decision|3
1184767|NCT01056276|3889770|P2|Treatment Period-Cycles 1-8|Intercurrent Illness|2
1184768|NCT01056276|3889771|P1|Treatment Period-Cycles 1-8|Intercurrent Illness|1
1184769|NCT01056276|3889770|P2|Treatment Period-Cycles 1-8|Disease Progression|2
1184770|NCT01056276|3889771|P1|Treatment Period-Cycles 1-8|Disease Progression|2
1184771|NCT01056276|3889770|P2|Treatment Period-Cycles 1-8|Withdrawal by Subject|2
1184772|NCT01056276|3889771|P1|Treatment Period-Cycles 1-8|Withdrawal by Subject|1
1184773|NCT01056276|3889770|P2|Treatment Period-Cycles 1-8|Toxicity|1
1184774|NCT01056276|3889771|P1|Treatment Period-Cycles 1-8|Toxicity|2
1184775|NCT01056263|3889785|P1|Overall Study|Ongoing in study A4061008 (NCT00828919)|5
1184776|NCT01056263|3889785|P1|Overall Study|Objective progression or relapse|1
1184777|NCT01056263|3889785|P1|Overall Study|Neoplasm progression|1
1184778|NCT01056263|3889785|P1|Overall Study|Progressive disease|2
1184779|NCT01056263|3889785|P1|Overall Study|Lack of Efficacy|29
1184780|NCT01056263|3889785|P1|Overall Study|Withdrawal by Subject|1
1184781|NCT01056263|3889785|P1|Overall Study|Death|1
1184782|NCT01056263|3889785|P1|Overall Study|Adverse Event|12
1184783|NCT01056107|3889808|P4|Overall Study|Withdrawal by Subject|0
1184784|NCT01056107|3889809|P3|Overall Study|Withdrawal by Subject|3
1184785|NCT01056107|3889810|P2|Overall Study|Withdrawal by Subject|1
1184786|NCT01056107|3889811|P1|Overall Study|Withdrawal by Subject|0
1184787|NCT01055886|3889868|P2|Overall Study|Withdrawal by PI|1
1184788|NCT01055886|3889869|P1|Overall Study|Withdrawal by PI|0
1184789|NCT01055886|3889868|P2|Overall Study|Lost to Follow-up|1
1184790|NCT01055886|3889869|P1|Overall Study|Lost to Follow-up|1
1184791|NCT01055886|3889868|P2|Overall Study|Withdrawal by Subject|9
1184792|NCT01055886|3889869|P1|Overall Study|Withdrawal by Subject|4
1184793|NCT01055834|3889881|P2|Treatment Period I|Adverse Event|0
1184794|NCT01055834|3889882|P1|Treatment Period I|Adverse Event|1
1184795|NCT01055639|3889967|P2|Overall Study|Withdrawal by Subject|11
1184796|NCT01055639|3889968|P1|Overall Study|Withdrawal by Subject|8
1184797|NCT01055639|3889967|P2|Overall Study|Protocol Violation|5
1184798|NCT01055639|3889968|P1|Overall Study|Protocol Violation|5
1184799|NCT01055639|3889967|P2|Overall Study|Lost to Follow-up|11
1184800|NCT01055639|3889968|P1|Overall Study|Lost to Follow-up|8
1184801|NCT01055639|3889967|P2|Overall Study|Lack of Efficacy|1
1184802|NCT01055639|3889968|P1|Overall Study|Lack of Efficacy|0
1184803|NCT01055639|3889967|P2|Overall Study|Adverse Event|1
1184804|NCT01055639|3889968|P1|Overall Study|Adverse Event|0
1184805|NCT01055613|3889992|P2|Overall Study|Subject Disinterest|1
1184806|NCT01055613|3889993|P1|Overall Study|Subject Disinterest|1
1184807|NCT01055613|3889992|P2|Overall Study|Protocol Violation|1
1184808|NCT01055613|3889993|P1|Overall Study|Protocol Violation|1
1184809|NCT01055613|3889992|P2|Overall Study|Lost to Follow-up|1
1184810|NCT01055613|3889993|P1|Overall Study|Lost to Follow-up|1
1184811|NCT01055613|3889992|P2|Overall Study|Discomfort|1
1184812|NCT01055613|3889993|P1|Overall Study|Discomfort|2
1184813|NCT01055613|3889992|P2|Overall Study|Unacceptable lens fit|0
1184814|NCT01055613|3889993|P1|Overall Study|Unacceptable lens fit|1
1184815|NCT01055613|3889992|P2|Overall Study|No Longer Meets Eligibility Criteria|0
1184816|NCT01055613|3889993|P1|Overall Study|No Longer Meets Eligibility Criteria|3
1184817|NCT01055457|3890011|P10|Overall Study|Adverse Event|0
1184818|NCT01055457|3890012|P9|Overall Study|Adverse Event|0
1184819|NCT01055457|3890013|P8|Overall Study|Adverse Event|0
1184820|NCT01055457|3890014|P7|Overall Study|Adverse Event|0
1184821|NCT01055457|3890015|P6|Overall Study|Adverse Event|0
1184822|NCT01055457|3890016|P5|Overall Study|Adverse Event|0
1184823|NCT01055457|3890017|P4|Overall Study|Adverse Event|1
1184824|NCT01055457|3890018|P3|Overall Study|Adverse Event|0
1184825|NCT01055457|3890019|P2|Overall Study|Adverse Event|0
1184826|NCT01055457|3890020|P1|Overall Study|Adverse Event|0
1184827|NCT01055457|3890011|P10|Overall Study|Pregnancy|0
1184828|NCT01055457|3890012|P9|Overall Study|Pregnancy|0
1184829|NCT01055457|3890013|P8|Overall Study|Pregnancy|0
1184830|NCT01055457|3890014|P7|Overall Study|Pregnancy|0
1184831|NCT01055457|3890015|P6|Overall Study|Pregnancy|0
1184832|NCT01055457|3890016|P5|Overall Study|Pregnancy|0
1184833|NCT01055457|3890017|P4|Overall Study|Pregnancy|1
1184834|NCT01055457|3890018|P3|Overall Study|Pregnancy|0
1184835|NCT01055457|3890019|P2|Overall Study|Pregnancy|0
1184836|NCT01055457|3890020|P1|Overall Study|Pregnancy|0
1184837|NCT01055457|3890011|P10|Overall Study|Discomfort|0
1184838|NCT01055457|3890012|P9|Overall Study|Discomfort|0
1184839|NCT01055457|3890013|P8|Overall Study|Discomfort|0
1184840|NCT01055457|3890014|P7|Overall Study|Discomfort|0
1184841|NCT01055457|3890015|P6|Overall Study|Discomfort|0
1184842|NCT01055457|3890016|P5|Overall Study|Discomfort|1
1184843|NCT01055457|3890017|P4|Overall Study|Discomfort|0
1184844|NCT01055457|3890018|P3|Overall Study|Discomfort|0
1184845|NCT01055457|3890019|P2|Overall Study|Discomfort|0
1184846|NCT01055457|3890020|P1|Overall Study|Discomfort|0
1184847|NCT01055457|3890011|P10|Overall Study|Subject Ineligible|0
1184848|NCT01055457|3890012|P9|Overall Study|Subject Ineligible|0
1184849|NCT01055457|3890013|P8|Overall Study|Subject Ineligible|0
1184850|NCT01055457|3890014|P7|Overall Study|Subject Ineligible|0
1184851|NCT01055457|3890015|P6|Overall Study|Subject Ineligible|0
1184852|NCT01055457|3890016|P5|Overall Study|Subject Ineligible|1
1184853|NCT01055457|3890017|P4|Overall Study|Subject Ineligible|0
1184854|NCT01055457|3890018|P3|Overall Study|Subject Ineligible|1
1184855|NCT01055457|3890019|P2|Overall Study|Subject Ineligible|0
1184856|NCT01055457|3890020|P1|Overall Study|Subject Ineligible|1
1184857|NCT01055457|3890011|P10|Overall Study|Subject Disinterest|0
1184858|NCT01055457|3890012|P9|Overall Study|Subject Disinterest|0
1184859|NCT01055457|3890013|P8|Overall Study|Subject Disinterest|1
1184860|NCT01055457|3890014|P7|Overall Study|Subject Disinterest|0
1184861|NCT01055457|3890015|P6|Overall Study|Subject Disinterest|0
1184862|NCT01055457|3890016|P5|Overall Study|Subject Disinterest|0
1184863|NCT01055457|3890017|P4|Overall Study|Subject Disinterest|0
1184864|NCT01055457|3890018|P3|Overall Study|Subject Disinterest|0
1184865|NCT01055457|3890019|P2|Overall Study|Subject Disinterest|0
1184866|NCT01055457|3890020|P1|Overall Study|Subject Disinterest|0
1184867|NCT01055457|3890011|P10|Overall Study|Protocol Violation|1
1184868|NCT01055457|3890012|P9|Overall Study|Protocol Violation|0
1184869|NCT01055457|3890013|P8|Overall Study|Protocol Violation|0
1184870|NCT01055457|3890014|P7|Overall Study|Protocol Violation|1
1184871|NCT01055457|3890015|P6|Overall Study|Protocol Violation|2
1184872|NCT01055457|3890016|P5|Overall Study|Protocol Violation|1
1184873|NCT01055457|3890017|P4|Overall Study|Protocol Violation|1
1184874|NCT01055457|3890018|P3|Overall Study|Protocol Violation|1
1184875|NCT01055457|3890019|P2|Overall Study|Protocol Violation|0
1184876|NCT01055457|3890020|P1|Overall Study|Protocol Violation|0
1184877|NCT01055457|3890011|P10|Overall Study|Lost to Follow-up|0
1184878|NCT01055457|3890012|P9|Overall Study|Lost to Follow-up|0
1184879|NCT01055457|3890013|P8|Overall Study|Lost to Follow-up|0
1184880|NCT01055457|3890014|P7|Overall Study|Lost to Follow-up|0
1184881|NCT01055457|3890015|P6|Overall Study|Lost to Follow-up|1
1184882|NCT01055457|3890016|P5|Overall Study|Lost to Follow-up|0
1184883|NCT01055457|3890017|P4|Overall Study|Lost to Follow-up|0
1184884|NCT01055457|3890018|P3|Overall Study|Lost to Follow-up|0
1184885|NCT01055457|3890019|P2|Overall Study|Lost to Follow-up|1
1184886|NCT01055457|3890020|P1|Overall Study|Lost to Follow-up|0
1184887|NCT01055314|3890054|P2|Overall Study|No treatment|0
1184888|NCT01055314|3890055|P1|Overall Study|No treatment|1
1184889|NCT01055314|3890054|P2|Overall Study|Refusal of further protocol therapy|4
1184890|NCT01055314|3890055|P1|Overall Study|Refusal of further protocol therapy|10
1184891|NCT01055314|3890054|P2|Overall Study|Ineligible|5
1184892|NCT01055314|3890055|P1|Overall Study|Ineligible|3
1184893|NCT01055314|3890054|P2|Overall Study|Withdrawal by Subject|0
1184894|NCT01055314|3890055|P1|Overall Study|Withdrawal by Subject|1
1184895|NCT01055314|3890054|P2|Overall Study|Physician Decision|5
1184896|NCT01055314|3890055|P1|Overall Study|Physician Decision|10
1184897|NCT01055314|3890054|P2|Overall Study|Lack of Efficacy|19
1184898|NCT01055314|3890055|P1|Overall Study|Lack of Efficacy|11
1184899|NCT01055314|3890054|P2|Overall Study|Death|1
1184900|NCT01055314|3890055|P1|Overall Study|Death|2
1184901|NCT01055314|3890054|P2|Overall Study|Adverse Event|4
1184902|NCT01055314|3890055|P1|Overall Study|Adverse Event|7
1184903|NCT01055262|3890067|P1|Overall Study|Uncooperativeness|1
1184904|NCT01055262|3890067|P1|Overall Study|Protocol Violation|3
1184905|NCT01055262|3890067|P1|Overall Study|Adverse Event|5
1184906|NCT01055197|3890108|P2|Overall Study|Withdrawal by Subject|0
1184907|NCT01055197|3890109|P1|Overall Study|Withdrawal by Subject|2
1184908|NCT01055197|3890108|P2|Overall Study|Protocol Violation|2
1184909|NCT01055197|3890109|P1|Overall Study|Protocol Violation|7
1184910|NCT01055132|3890144|P2|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1
1184911|NCT01055132|3890145|P1|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0
1184912|NCT01055132|3890144|P2|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0
1184913|NCT01055132|3890145|P1|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1
1184914|NCT01055028|3890158|P2|Inter-treatment Period|Did not start Cycle 4|3
1184915|NCT01055028|3890159|P1|Inter-treatment Period|Did not start Cycle 4|0
1184916|NCT01055028|3890158|P2|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
1184917|NCT01055028|3890159|P1|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
1184918|NCT01055028|3890158|P2|Treatment Cycles 1 to 3|Adverse Event|1
1184919|NCT01055028|3890159|P1|Treatment Cycles 1 to 3|Adverse Event|0
1184920|NCT01055028|3890158|P2|Screening|Screen Failure|1
1184921|NCT01055028|3890159|P1|Screening|Screen Failure|1
1184922|NCT01054976|3890173|P1|Overall Study|Not specified|8
1184923|NCT01054976|3890173|P1|Overall Study|Withdrawal by Subject|4
1184924|NCT01054976|3890173|P1|Overall Study|Uncooperative participations to study|7
1184925|NCT01054976|3890173|P1|Overall Study|Adverse Event|16
1184926|NCT01054885|3890194|P7|24-week, Double-blind Treatment Period|Withdrawal by Subject|2
1184927|NCT01054885|3890195|P6|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
1184928|NCT01054885|3890196|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
1184929|NCT01054885|3890197|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
1184930|NCT01054885|3890198|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
1184931|NCT01054885|3890199|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|8
1184932|NCT01054885|3890200|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
1184933|NCT01054885|3890194|P7|24-week, Double-blind Treatment Period|Physician Decision|1
1184934|NCT01054885|3890195|P6|24-week, Double-blind Treatment Period|Physician Decision|1
1184935|NCT01054885|3890196|P5|24-week, Double-blind Treatment Period|Physician Decision|3
1184936|NCT01054885|3890197|P4|24-week, Double-blind Treatment Period|Physician Decision|6
1184937|NCT01054885|3890198|P3|24-week, Double-blind Treatment Period|Physician Decision|1
1184938|NCT01054885|3890199|P2|24-week, Double-blind Treatment Period|Physician Decision|4
1184939|NCT01054885|3890200|P1|24-week, Double-blind Treatment Period|Physician Decision|0
1184940|NCT01054885|3890194|P7|24-week, Double-blind Treatment Period|Lost to Follow-up|1
1184941|NCT01054885|3890195|P6|24-week, Double-blind Treatment Period|Lost to Follow-up|2
1184942|NCT01054885|3890196|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|0
1184943|NCT01054885|3890197|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|0
1184944|NCT01054885|3890198|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|2
1184945|NCT01054885|3890199|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|3
1184946|NCT01054885|3890200|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
1184947|NCT01054885|3890194|P7|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
1184948|NCT01054885|3890195|P6|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
1184949|NCT01054885|3890196|P5|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
1184950|NCT01054885|3890197|P4|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
1184951|NCT01054885|3890198|P3|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
1184952|NCT01054885|3890199|P2|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
1184953|NCT01054885|3890200|P1|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
1184954|NCT01054885|3890194|P7|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
1184955|NCT01054885|3890195|P6|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15
1184956|NCT01054885|3890196|P5|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
1184957|NCT01054885|3890197|P4|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
1184958|NCT01054885|3890198|P3|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
1184959|NCT01054885|3890199|P2|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
1184960|NCT01054885|3890200|P1|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0
1184961|NCT01054885|3890194|P7|24-week, Double-blind Treatment Period|Protocol Violation|4
1184962|NCT01054885|3890195|P6|24-week, Double-blind Treatment Period|Protocol Violation|8
1184963|NCT01054885|3890196|P5|24-week, Double-blind Treatment Period|Protocol Violation|3
1184964|NCT01054885|3890197|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
1184965|NCT01054885|3890198|P3|24-week, Double-blind Treatment Period|Protocol Violation|7
1184966|NCT01054885|3890199|P2|24-week, Double-blind Treatment Period|Protocol Violation|7
1184967|NCT01054885|3890200|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
1184968|NCT01054885|3890194|P7|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
1184969|NCT01054885|3890195|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
1184970|NCT01054885|3890196|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11
1184971|NCT01054885|3890197|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5
1184972|NCT01054885|3890198|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2
1184973|NCT01054885|3890199|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
1184974|NCT01054885|3890200|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
1184975|NCT01054885|3890194|P7|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
1184976|NCT01054885|3890195|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
1184977|NCT01054885|3890196|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
1184978|NCT01054885|3890197|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
1184979|NCT01054885|3890198|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
1184980|NCT01054885|3890199|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
1184981|NCT01054885|3890200|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
1184982|NCT01054885|3890194|P7|24-week, Double-blind Treatment Period|Adverse Event|19
1184983|NCT01054885|3890195|P6|24-week, Double-blind Treatment Period|Adverse Event|17
1184984|NCT01054885|3890196|P5|24-week, Double-blind Treatment Period|Adverse Event|15
1184985|NCT01054885|3890197|P4|24-week, Double-blind Treatment Period|Adverse Event|15
1184986|NCT01054885|3890198|P3|24-week, Double-blind Treatment Period|Adverse Event|12
1184987|NCT01054885|3890199|P2|24-week, Double-blind Treatment Period|Adverse Event|18
1184988|NCT01054885|3890200|P1|24-week, Double-blind Treatment Period|Adverse Event|0
1184989|NCT01054885|3890194|P7|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
1184990|NCT01054885|3890195|P6|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
1184991|NCT01054885|3890196|P5|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
1184992|NCT01054885|3890197|P4|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
1184993|NCT01054885|3890198|P3|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
1184994|NCT01054885|3890199|P2|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
1184995|NCT01054885|3890200|P1|2-week, Single-blind Run-In Period|Study Closed/Terminated|68
1184996|NCT01054885|3890194|P7|2-week, Single-blind Run-In Period|Adverse Event|0
1184997|NCT01054885|3890195|P6|2-week, Single-blind Run-In Period|Adverse Event|0
1184998|NCT01054885|3890196|P5|2-week, Single-blind Run-In Period|Adverse Event|0
1184999|NCT01054885|3890197|P4|2-week, Single-blind Run-In Period|Adverse Event|0
1185000|NCT01054885|3890198|P3|2-week, Single-blind Run-In Period|Adverse Event|0
1185001|NCT01054885|3890199|P2|2-week, Single-blind Run-In Period|Adverse Event|0
1185002|NCT01054885|3890200|P1|2-week, Single-blind Run-In Period|Adverse Event|7
1185003|NCT01054885|3890194|P7|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1185004|NCT01054885|3890195|P6|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1185005|NCT01054885|3890196|P5|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1185006|NCT01054885|3890197|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1185007|NCT01054885|3890198|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1185008|NCT01054885|3890199|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1185009|NCT01054885|3890200|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|1
1185010|NCT01054885|3890194|P7|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1185011|NCT01054885|3890195|P6|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1185012|NCT01054885|3890196|P5|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1185013|NCT01054885|3890197|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1185014|NCT01054885|3890198|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1185015|NCT01054885|3890199|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1185016|NCT01054885|3890200|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|23
1185017|NCT01054885|3890194|P7|2-week, Single-blind Run-In Period|Physician Decision|0
1185018|NCT01054885|3890195|P6|2-week, Single-blind Run-In Period|Physician Decision|0
1185019|NCT01054885|3890196|P5|2-week, Single-blind Run-In Period|Physician Decision|0
1185020|NCT01054885|3890197|P4|2-week, Single-blind Run-In Period|Physician Decision|0
1185021|NCT01054885|3890198|P3|2-week, Single-blind Run-In Period|Physician Decision|0
1185022|NCT01054885|3890199|P2|2-week, Single-blind Run-In Period|Physician Decision|0
1185023|NCT01054885|3890200|P1|2-week, Single-blind Run-In Period|Physician Decision|6
1185024|NCT01054885|3890194|P7|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1185025|NCT01054885|3890195|P6|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1185026|NCT01054885|3890196|P5|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1185027|NCT01054885|3890197|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1185028|NCT01054885|3890198|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1185029|NCT01054885|3890199|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1185030|NCT01054885|3890200|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246
1185031|NCT01054846|3890240|P2|Overall Study|Lost to Follow-up|17
1185032|NCT01054846|3890241|P1|Overall Study|Lost to Follow-up|76
1185033|NCT01054820|3890248|P1|Overall Study|Withdrawal by Subject|2
1185034|NCT01054729|3890270|P4|Overall Study|Lack of Efficacy|1
1185035|NCT01054729|3890271|P3|Overall Study|Lack of Efficacy|0
1185036|NCT01054729|3890272|P2|Overall Study|Lack of Efficacy|0
1185037|NCT01054729|3890273|P1|Overall Study|Lack of Efficacy|0
1185038|NCT01054729|3890270|P4|Overall Study|Subject moved|0
1185039|NCT01054729|3890271|P3|Overall Study|Subject moved|1
1185040|NCT01054729|3890272|P2|Overall Study|Subject moved|0
1185041|NCT01054729|3890273|P1|Overall Study|Subject moved|0
1185042|NCT01054729|3890270|P4|Overall Study|Personal/Obligations|0
1185043|NCT01054729|3890271|P3|Overall Study|Personal/Obligations|0
1185044|NCT01054729|3890272|P2|Overall Study|Personal/Obligations|1
1185045|NCT01054729|3890273|P1|Overall Study|Personal/Obligations|0
1185046|NCT01054729|3890270|P4|Overall Study|PEG/RBV Non-responder|0
1185047|NCT01054729|3890271|P3|Overall Study|PEG/RBV Non-responder|1
1185048|NCT01054729|3890272|P2|Overall Study|PEG/RBV Non-responder|0
1185049|NCT01054729|3890273|P1|Overall Study|PEG/RBV Non-responder|1
1185050|NCT01054729|3890270|P4|Overall Study|Non-responder|1
1185051|NCT01054729|3890271|P3|Overall Study|Non-responder|1
1185052|NCT01054729|3890272|P2|Overall Study|Non-responder|0
1185053|NCT01054729|3890273|P1|Overall Study|Non-responder|1
1185054|NCT01054729|3890270|P4|Overall Study|Lost to Follow-up, Later Contacted Site|0
1185055|NCT01054729|3890271|P3|Overall Study|Lost to Follow-up, Later Contacted Site|0
1185056|NCT01054729|3890272|P2|Overall Study|Lost to Follow-up, Later Contacted Site|1
1185057|NCT01054729|3890273|P1|Overall Study|Lost to Follow-up, Later Contacted Site|0
1185058|NCT01054729|3890270|P4|Overall Study|Lost to Follow-up|0
1185059|NCT01054729|3890271|P3|Overall Study|Lost to Follow-up|0
1185060|NCT01054729|3890272|P2|Overall Study|Lost to Follow-up|1
1185061|NCT01054729|3890273|P1|Overall Study|Lost to Follow-up|0
1185062|NCT01054729|3890270|P4|Overall Study|Withdrawal by Subject|0
1185063|NCT01054729|3890271|P3|Overall Study|Withdrawal by Subject|1
1185064|NCT01054729|3890272|P2|Overall Study|Withdrawal by Subject|0
1185065|NCT01054729|3890273|P1|Overall Study|Withdrawal by Subject|1
1185066|NCT01054729|3890270|P4|Overall Study|Adverse Event|1
1185067|NCT01054729|3890271|P3|Overall Study|Adverse Event|2
1185068|NCT01054729|3890272|P2|Overall Study|Adverse Event|1
1185069|NCT01054729|3890273|P1|Overall Study|Adverse Event|1
1185070|NCT01054729|3890270|P4|Overall Study|Randomized but Not Treated|0
1185071|NCT01054729|3890271|P3|Overall Study|Randomized but Not Treated|0
1185072|NCT01054729|3890272|P2|Overall Study|Randomized but Not Treated|1
1185073|NCT01054729|3890273|P1|Overall Study|Randomized but Not Treated|0
1185074|NCT01054599|3890371|P2|Overall Study|Withdrawal by Subject|1
1185075|NCT01054599|3890372|P1|Overall Study|Withdrawal by Subject|0
1185076|NCT01054599|3890371|P2|Overall Study|Adverse Event|1
1185077|NCT01054599|3890372|P1|Overall Study|Adverse Event|0
1185078|NCT01054599|3890371|P2|Overall Study|Lost to Follow-up|2
1185079|NCT01054599|3890372|P1|Overall Study|Lost to Follow-up|0
1185080|NCT01054599|3890371|P2|Overall Study|Visual impairment, WTAR <80|1
1185081|NCT01054599|3890372|P1|Overall Study|Visual impairment, WTAR <80|0
1185082|NCT01054599|3890371|P2|Overall Study|Timing/scheduling difficulties|1
1185083|NCT01054599|3890372|P1|Overall Study|Timing/scheduling difficulties|1
1185084|NCT01054599|3890371|P2|Overall Study|Spells/seizure-like episodes|1
1185085|NCT01054599|3890372|P1|Overall Study|Spells/seizure-like episodes|1
1185086|NCT01054599|3890371|P2|Overall Study|Protocol Violation|0
1185087|NCT01054599|3890372|P1|Overall Study|Protocol Violation|1
1185088|NCT01054599|3890371|P2|Overall Study|Dizziness due to phenytoin toxicity|0
1185089|NCT01054599|3890372|P1|Overall Study|Dizziness due to phenytoin toxicity|1
1185090|NCT01054573|3890479|P4|Overall Study|Withdrawal by Subject|1
1185091|NCT01054573|3890480|P3|Overall Study|Withdrawal by Subject|2
1185092|NCT01054573|3890481|P2|Overall Study|Withdrawal by Subject|2
1185093|NCT01054573|3890482|P1|Overall Study|Withdrawal by Subject|0
1185094|NCT01054573|3890479|P4|Overall Study|Lost to Follow-up|0
1185095|NCT01054573|3890480|P3|Overall Study|Lost to Follow-up|0
1185096|NCT01054573|3890481|P2|Overall Study|Lost to Follow-up|2
1185097|NCT01054573|3890482|P1|Overall Study|Lost to Follow-up|0
1185098|NCT01054573|3890479|P4|Overall Study|Adverse Event|1
1185099|NCT01054573|3890480|P3|Overall Study|Adverse Event|1
1185100|NCT01054573|3890481|P2|Overall Study|Adverse Event|0
1185101|NCT01054573|3890482|P1|Overall Study|Adverse Event|1
1185102|NCT01054560|3890528|P2|Overall Study|Physician Decision|0
1185103|NCT01054560|3890529|P1|Overall Study|Physician Decision|1
1185104|NCT01054560|3890528|P2|Overall Study|Withdrawal by Subject|2
1185105|NCT01054560|3890529|P1|Overall Study|Withdrawal by Subject|0
1185106|NCT01054560|3890528|P2|Overall Study|Lost to Follow-up|5
1185107|NCT01054560|3890529|P1|Overall Study|Lost to Follow-up|2
1185108|NCT01054560|3890528|P2|Overall Study|Death|21
1185109|NCT01054560|3890529|P1|Overall Study|Death|10
1185110|NCT01054300|3890581|P4|Period 2|Withdrawal by Subject|0
1185111|NCT01054300|3890582|P3|Period 2|Withdrawal by Subject|1
1185112|NCT01054300|3890583|P2|Period 2|Withdrawal by Subject|0
1185113|NCT01054300|3890584|P1|Period 2|Withdrawal by Subject|0
1185114|NCT01054300|3890581|P4|Period 1|Adverse Event|0
1185115|NCT01054300|3890582|P3|Period 1|Adverse Event|0
1185116|NCT01054300|3890583|P2|Period 1|Adverse Event|0
1185117|NCT01054300|3890584|P1|Period 1|Adverse Event|1
1185118|NCT01054222|3890634|P1|Overall Study|Withdrawal by Subject|6
1185119|NCT01054222|3890634|P1|Overall Study|Lost to Follow-up|4
1185120|NCT01054222|3890634|P1|Overall Study|Lack of Efficacy|1
1185121|NCT01054170|3890675|P2|Overall Study|Adverse Event|4
1185122|NCT01054170|3890676|P1|Overall Study|Adverse Event|0
1185123|NCT01054170|3890675|P2|Overall Study|Withdrawal by Subject|2
1185124|NCT01054170|3890676|P1|Overall Study|Withdrawal by Subject|3
1185125|NCT01054170|3890675|P2|Overall Study|Protocol Violation|0
1185126|NCT01054170|3890676|P1|Overall Study|Protocol Violation|1
1185127|NCT01053988|3890741|P6|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
1185128|NCT01053988|3890742|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|10
1185129|NCT01053988|3890743|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
1185130|NCT01053988|3890744|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
1185131|NCT01053988|3890745|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|11
1185132|NCT01053988|3890746|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
1185133|NCT01053988|3890741|P6|24-week, Double-blind Treatment Period|Physician Decision|4
1185134|NCT01053988|3890742|P5|24-week, Double-blind Treatment Period|Physician Decision|5
1185135|NCT01053988|3890743|P4|24-week, Double-blind Treatment Period|Physician Decision|5
1185136|NCT01053988|3890744|P3|24-week, Double-blind Treatment Period|Physician Decision|2
1185137|NCT01053988|3890745|P2|24-week, Double-blind Treatment Period|Physician Decision|5
1185138|NCT01053988|3890746|P1|24-week, Double-blind Treatment Period|Physician Decision|0
1185139|NCT01053988|3890741|P6|24-week, Double-blind Treatment Period|Lost to Follow-up|3
1185140|NCT01053988|3890742|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|1
1185141|NCT01053988|3890743|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|2
1185142|NCT01053988|3890744|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
1185143|NCT01053988|3890745|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|4
1185144|NCT01053988|3890746|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
1185145|NCT01053988|3890741|P6|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
1185146|NCT01053988|3890742|P5|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
1185147|NCT01053988|3890743|P4|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8
1185148|NCT01053988|3890744|P3|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5
1185149|NCT01053988|3890745|P2|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
1185150|NCT01053988|3890746|P1|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
1185151|NCT01053988|3890741|P6|24-week, Double-blind Treatment Period|Protocol Violation|4
1185152|NCT01053988|3890742|P5|24-week, Double-blind Treatment Period|Protocol Violation|1
1185153|NCT01053988|3890743|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
1185154|NCT01053988|3890744|P3|24-week, Double-blind Treatment Period|Protocol Violation|4
1185155|NCT01053988|3890745|P2|24-week, Double-blind Treatment Period|Protocol Violation|3
1185156|NCT01053988|3890746|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
1185157|NCT01053988|3890741|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
1185158|NCT01053988|3890742|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9
1185159|NCT01053988|3890743|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
1185160|NCT01053988|3890744|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16
1185161|NCT01053988|3890745|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17
1185162|NCT01053988|3890746|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
1185163|NCT01053988|3890741|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
1185164|NCT01053988|3890742|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
1185165|NCT01053988|3890743|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
1185166|NCT01053988|3890744|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
1185167|NCT01053988|3890745|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
1185168|NCT01053988|3890746|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
1185169|NCT01053988|3890741|P6|24-week, Double-blind Treatment Period|Adverse Event|14
1185170|NCT01053988|3890742|P5|24-week, Double-blind Treatment Period|Adverse Event|17
1185171|NCT01053988|3890743|P4|24-week, Double-blind Treatment Period|Adverse Event|24
1185172|NCT01053988|3890744|P3|24-week, Double-blind Treatment Period|Adverse Event|23
1185173|NCT01053988|3890745|P2|24-week, Double-blind Treatment Period|Adverse Event|15
1185174|NCT01053988|3890746|P1|24-week, Double-blind Treatment Period|Adverse Event|0
1185175|NCT01053988|3890741|P6|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1185176|NCT01053988|3890742|P5|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1185257|NCT01052714|3891025|P2|Overall Study|Death|2
1185177|NCT01053988|3890743|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1185178|NCT01053988|3890744|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1185179|NCT01053988|3890745|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1185180|NCT01053988|3890746|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|1
1185181|NCT01053988|3890741|P6|2-week, Single-blind Run-In Period|Physician Decision|0
1185182|NCT01053988|3890742|P5|2-week, Single-blind Run-In Period|Physician Decision|0
1185183|NCT01053988|3890743|P4|2-week, Single-blind Run-In Period|Physician Decision|0
1185184|NCT01053988|3890744|P3|2-week, Single-blind Run-In Period|Physician Decision|0
1185185|NCT01053988|3890745|P2|2-week, Single-blind Run-In Period|Physician Decision|0
1185186|NCT01053988|3890746|P1|2-week, Single-blind Run-In Period|Physician Decision|5
1185187|NCT01053988|3890741|P6|2-week, Single-blind Run-In Period|Adverse Event|0
1185188|NCT01053988|3890742|P5|2-week, Single-blind Run-In Period|Adverse Event|0
1185189|NCT01053988|3890743|P4|2-week, Single-blind Run-In Period|Adverse Event|0
1185190|NCT01053988|3890744|P3|2-week, Single-blind Run-In Period|Adverse Event|0
1185191|NCT01053988|3890745|P2|2-week, Single-blind Run-In Period|Adverse Event|0
1185192|NCT01053988|3890746|P1|2-week, Single-blind Run-In Period|Adverse Event|6
1185193|NCT01053988|3890741|P6|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1185194|NCT01053988|3890742|P5|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1185195|NCT01053988|3890743|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1185196|NCT01053988|3890744|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1185197|NCT01053988|3890745|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1185198|NCT01053988|3890746|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|30
1185199|NCT01053988|3890741|P6|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
1185200|NCT01053988|3890742|P5|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
1185201|NCT01053988|3890743|P4|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
1185202|NCT01053988|3890744|P3|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
1185203|NCT01053988|3890745|P2|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
1185204|NCT01053988|3890746|P1|2-week, Single-blind Run-In Period|Study Closed/Terminated|98
1185205|NCT01053988|3890741|P6|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1185206|NCT01053988|3890742|P5|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1185207|NCT01053988|3890743|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1185208|NCT01053988|3890744|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1185209|NCT01053988|3890745|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1185210|NCT01053988|3890746|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220
1185211|NCT01053741|3890797|P2|2nd Study Intervention|Physician Decision|1
1185212|NCT01053741|3890798|P1|2nd Study Intervention|Physician Decision|0
1185213|NCT01053663|3890807|P1|Overall Study|Negative Influenza Diagnosis|1
1185214|NCT01053663|3890807|P1|Overall Study|Transferred to Another Hospital|1
1185215|NCT01053663|3890807|P1|Overall Study|Poor IV Access|1
1185216|NCT01053663|3890807|P1|Overall Study|Lost to Follow-up|1
1185217|NCT01053663|3890807|P1|Overall Study|Death|2
1185218|NCT01053429|3890865|P1|Overall Study|Other|309
1185219|NCT01053429|3890865|P1|Overall Study|Adverse Event|64
1185220|NCT01053247|3890895|P3|Overall Study|Adverse Event|3
1185221|NCT01053247|3890896|P2|Overall Study|Adverse Event|9
1185222|NCT01053247|3890897|P1|Overall Study|Adverse Event|0
1185223|NCT01053247|3890895|P3|Overall Study|Lost to Follow-up|7
1185224|NCT01053247|3890896|P2|Overall Study|Lost to Follow-up|5
1185225|NCT01053247|3890897|P1|Overall Study|Lost to Follow-up|8
1185226|NCT01053247|3890895|P3|Overall Study|Protocol Violation|2
1185227|NCT01053247|3890896|P2|Overall Study|Protocol Violation|1
1185228|NCT01053247|3890897|P1|Overall Study|Protocol Violation|2
1185229|NCT01053247|3890895|P3|Overall Study|Lack of Efficacy|1
1185230|NCT01053247|3890896|P2|Overall Study|Lack of Efficacy|0
1185231|NCT01053247|3890897|P1|Overall Study|Lack of Efficacy|1
1185232|NCT01053247|3890895|P3|Overall Study|Withdrawal by Subject|15
1185233|NCT01053247|3890896|P2|Overall Study|Withdrawal by Subject|4
1185234|NCT01053247|3890897|P1|Overall Study|Withdrawal by Subject|9
1185235|NCT01052844|3890991|P2|Overall Study|Adverse Event|1
1185236|NCT01052844|3890992|P1|Overall Study|Adverse Event|0
1185237|NCT01052779|3891013|P2|Overall Study|Other-Missed Week 5 Visit|0
1185238|NCT01052779|3891014|P1|Overall Study|Other-Missed Week 5 Visit|2
1185239|NCT01052779|3891013|P2|Overall Study|Other-Surgery|2
1185240|NCT01052779|3891014|P1|Overall Study|Other-Surgery|0
1185241|NCT01052779|3891013|P2|Overall Study|Other-Protocol Violation|1
1185242|NCT01052779|3891014|P1|Overall Study|Other-Protocol Violation|1
1185243|NCT01052779|3891013|P2|Overall Study|Withdrawal by Subject|2
1185244|NCT01052779|3891014|P1|Overall Study|Withdrawal by Subject|1
1185245|NCT01052779|3891013|P2|Overall Study|Adverse Event|4
1185246|NCT01052779|3891014|P1|Overall Study|Adverse Event|1
1185247|NCT01052714|3891024|P3|Overall Study|Withdrawal by Subject|1
1185248|NCT01052714|3891025|P2|Overall Study|Withdrawal by Subject|12
1185249|NCT01052714|3891026|P1|Overall Study|Withdrawal by Subject|7
1185250|NCT01052714|3891024|P3|Overall Study|Physician Decision|1
1185251|NCT01052714|3891025|P2|Overall Study|Physician Decision|9
1185252|NCT01052714|3891026|P1|Overall Study|Physician Decision|9
1185253|NCT01052714|3891024|P3|Overall Study|Lost to Follow-up|0
1185254|NCT01052714|3891025|P2|Overall Study|Lost to Follow-up|3
1185255|NCT01052714|3891026|P1|Overall Study|Lost to Follow-up|2
1185256|NCT01052714|3891024|P3|Overall Study|Death|0
1185258|NCT01052714|3891026|P1|Overall Study|Death|1
1185259|NCT01052714|3891024|P3|Overall Study|Adverse Event|0
1185260|NCT01052714|3891025|P2|Overall Study|Adverse Event|3
1185261|NCT01052714|3891026|P1|Overall Study|Adverse Event|6
1185262|NCT01052662|3891080|P3|Overall Study|Administrative|0
1185263|NCT01052662|3891081|P2|Overall Study|Administrative|3
1185264|NCT01052662|3891082|P1|Overall Study|Administrative|0
1185265|NCT01052662|3891080|P3|Overall Study|Legal Problem|0
1185266|NCT01052662|3891081|P2|Overall Study|Legal Problem|0
1185267|NCT01052662|3891082|P1|Overall Study|Legal Problem|2
1185268|NCT01052662|3891080|P3|Overall Study|Adverse Event|0
1185269|NCT01052662|3891081|P2|Overall Study|Adverse Event|1
1185270|NCT01052662|3891082|P1|Overall Study|Adverse Event|1
1185271|NCT01052662|3891080|P3|Overall Study|Pharmacy issue|3
1185272|NCT01052662|3891081|P2|Overall Study|Pharmacy issue|3
1185273|NCT01052662|3891082|P1|Overall Study|Pharmacy issue|1
1185274|NCT01052662|3891080|P3|Overall Study|Withdrawal by Subject|1
1185275|NCT01052662|3891081|P2|Overall Study|Withdrawal by Subject|2
1185276|NCT01052662|3891082|P1|Overall Study|Withdrawal by Subject|3
1185277|NCT01052662|3891080|P3|Overall Study|Lost to Follow-up|18
1185278|NCT01052662|3891081|P2|Overall Study|Lost to Follow-up|13
1185279|NCT01052662|3891082|P1|Overall Study|Lost to Follow-up|15
1185280|NCT01052480|3891113|P2|Overall Study|Death|5
1185281|NCT01052480|3891114|P1|Overall Study|Death|1
1185282|NCT01052480|3891113|P2|Overall Study|Physician Decision|2
1185283|NCT01052480|3891114|P1|Overall Study|Physician Decision|0
1185284|NCT01052480|3891113|P2|Overall Study|Withdrawal by Subject|7
1185285|NCT01052480|3891114|P1|Overall Study|Withdrawal by Subject|3
1185286|NCT01052480|3891113|P2|Overall Study|Protocol Violation|0
1185287|NCT01052480|3891114|P1|Overall Study|Protocol Violation|1
1185288|NCT01052480|3891113|P2|Overall Study|Lost to Follow-up|3
1185289|NCT01052480|3891114|P1|Overall Study|Lost to Follow-up|3
1185290|NCT01052428|3891164|P2|Overall Study|Withdrawal by Subject|1
1185291|NCT01052428|3891165|P1|Overall Study|Withdrawal by Subject|0
1185292|NCT01052428|3891164|P2|Overall Study|Death|0
1185293|NCT01052428|3891165|P1|Overall Study|Death|1
1185294|NCT01052272|3891187|P4|Overall Study|decline in health|0
1185295|NCT01052272|3891188|P3|Overall Study|decline in health|1
1185296|NCT01052272|3891189|P2|Overall Study|decline in health|0
1185297|NCT01052272|3891190|P1|Overall Study|decline in health|0
1185298|NCT01052272|3891187|P4|Overall Study|placed in long-term care|0
1185299|NCT01052272|3891188|P3|Overall Study|placed in long-term care|1
1185300|NCT01052272|3891189|P2|Overall Study|placed in long-term care|0
1185301|NCT01052272|3891190|P1|Overall Study|placed in long-term care|0
1185302|NCT01052272|3891187|P4|Overall Study|Withdrawal by Subject|2
1185303|NCT01052272|3891188|P3|Overall Study|Withdrawal by Subject|3
1185304|NCT01052272|3891189|P2|Overall Study|Withdrawal by Subject|2
1185305|NCT01052272|3891190|P1|Overall Study|Withdrawal by Subject|0
1185306|NCT01052272|3891187|P4|Overall Study|patient refuses follow-up|4
1185307|NCT01052272|3891188|P3|Overall Study|patient refuses follow-up|2
1185308|NCT01052272|3891189|P2|Overall Study|patient refuses follow-up|4
1185309|NCT01052272|3891190|P1|Overall Study|patient refuses follow-up|5
1185310|NCT01052272|3891187|P4|Overall Study|Physician Decision|0
1185311|NCT01052272|3891188|P3|Overall Study|Physician Decision|0
1185312|NCT01052272|3891189|P2|Overall Study|Physician Decision|1
1185313|NCT01052272|3891190|P1|Overall Study|Physician Decision|0
1185314|NCT01052272|3891187|P4|Overall Study|Death|1
1185315|NCT01052272|3891188|P3|Overall Study|Death|1
1185316|NCT01052272|3891189|P2|Overall Study|Death|0
1185317|NCT01052272|3891190|P1|Overall Study|Death|0
1185318|NCT01052116|3891235|P2|Overall Study|Spirometry not performed|4
1185319|NCT01052116|3891236|P1|Overall Study|Spirometry not performed|0
1185320|NCT01052116|3891235|P2|Overall Study|Withdrawal by Subject|6
1185321|NCT01052116|3891236|P1|Overall Study|Withdrawal by Subject|3
1185322|NCT01052116|3891235|P2|Overall Study|Lost to Follow-up|17
1185323|NCT01052116|3891236|P1|Overall Study|Lost to Follow-up|11
1185324|NCT01052077|3891244|P4|Phase A+|Withdrawal by Subject|7
1185325|NCT01052077|3891245|P3|Phase A+|Withdrawal by Subject|0
1185326|NCT01052077|3891246|P2|Phase A+|Withdrawal by Subject|0
1185327|NCT01052077|3891247|P1|Phase A+|Withdrawal by Subject|0
1185328|NCT01052077|3891244|P4|Phase A+|Met Withdrawal Criteria|2
1185329|NCT01052077|3891245|P3|Phase A+|Met Withdrawal Criteria|0
1185330|NCT01052077|3891246|P2|Phase A+|Met Withdrawal Criteria|0
1185331|NCT01052077|3891247|P1|Phase A+|Met Withdrawal Criteria|0
1185332|NCT01052077|3891244|P4|Phase A+|Adverse Event|4
1185333|NCT01052077|3891245|P3|Phase A+|Adverse Event|0
1185334|NCT01052077|3891246|P2|Phase A+|Adverse Event|0
1185335|NCT01052077|3891247|P1|Phase A+|Adverse Event|0
1185336|NCT01052077|3891244|P4|Phase A+|Lost to Follow-up|8
1185337|NCT01052077|3891245|P3|Phase A+|Lost to Follow-up|0
1185338|NCT01052077|3891246|P2|Phase A+|Lost to Follow-up|0
1185339|NCT01052077|3891247|P1|Phase A+|Lost to Follow-up|0
1185340|NCT01052077|3891244|P4|Phase B|Lack of Efficacy|0
1185341|NCT01052077|3891245|P3|Phase B|Lack of Efficacy|0
1185342|NCT01052077|3891246|P2|Phase B|Lack of Efficacy|1
1185343|NCT01052077|3891247|P1|Phase B|Lack of Efficacy|0
1185344|NCT01052077|3891244|P4|Phase B|Protocol Deviation|0
1185345|NCT01052077|3891245|P3|Phase B|Protocol Deviation|4
1185346|NCT01052077|3891246|P2|Phase B|Protocol Deviation|3
1185347|NCT01052077|3891247|P1|Phase B|Protocol Deviation|0
1185348|NCT01052077|3891244|P4|Phase B|Withdrawal by Subject|0
1185349|NCT01052077|3891245|P3|Phase B|Withdrawal by Subject|5
1185350|NCT01052077|3891246|P2|Phase B|Withdrawal by Subject|0
1185351|NCT01052077|3891247|P1|Phase B|Withdrawal by Subject|0
1185352|NCT01052077|3891244|P4|Phase B|Physician Decision|0
1185353|NCT01052077|3891245|P3|Phase B|Physician Decision|1
1185354|NCT01052077|3891246|P2|Phase B|Physician Decision|1
1185355|NCT01052077|3891247|P1|Phase B|Physician Decision|0
1185356|NCT01052077|3891244|P4|Phase B|Met Withdrawal Criteria|0
1185357|NCT01052077|3891245|P3|Phase B|Met Withdrawal Criteria|1
1185358|NCT01052077|3891246|P2|Phase B|Met Withdrawal Criteria|2
1185359|NCT01052077|3891247|P1|Phase B|Met Withdrawal Criteria|0
1185360|NCT01052077|3891244|P4|Phase B|Adverse Event|0
1185361|NCT01052077|3891245|P3|Phase B|Adverse Event|2
1185362|NCT01052077|3891246|P2|Phase B|Adverse Event|9
1185363|NCT01052077|3891247|P1|Phase B|Adverse Event|0
1185364|NCT01052077|3891244|P4|Phase B|Lost to Follow-up|0
1185365|NCT01052077|3891245|P3|Phase B|Lost to Follow-up|3
1185366|NCT01052077|3891246|P2|Phase B|Lost to Follow-up|2
1185367|NCT01052077|3891247|P1|Phase B|Lost to Follow-up|0
1185368|NCT01052077|3891244|P4|Phase A|Protocol Deviation|0
1185369|NCT01052077|3891245|P3|Phase A|Protocol Deviation|0
1185370|NCT01052077|3891246|P2|Phase A|Protocol Deviation|0
1185371|NCT01052077|3891247|P1|Phase A|Protocol Deviation|27
1185372|NCT01052077|3891244|P4|Phase A|Withdrawal by Subject|0
1185373|NCT01052077|3891245|P3|Phase A|Withdrawal by Subject|0
1185374|NCT01052077|3891246|P2|Phase A|Withdrawal by Subject|0
1185375|NCT01052077|3891247|P1|Phase A|Withdrawal by Subject|29
1185376|NCT01052077|3891244|P4|Phase A|Physician Decision|0
1185377|NCT01052077|3891245|P3|Phase A|Physician Decision|0
1185378|NCT01052077|3891246|P2|Phase A|Physician Decision|0
1185379|NCT01052077|3891247|P1|Phase A|Physician Decision|10
1185380|NCT01052077|3891244|P4|Phase A|Met Withdrawal Criteria|0
1185381|NCT01052077|3891245|P3|Phase A|Met Withdrawal Criteria|0
1185382|NCT01052077|3891246|P2|Phase A|Met Withdrawal Criteria|0
1185383|NCT01052077|3891247|P1|Phase A|Met Withdrawal Criteria|26
1185384|NCT01052077|3891244|P4|Phase A|Adverse Event|0
1185385|NCT01052077|3891245|P3|Phase A|Adverse Event|0
1185386|NCT01052077|3891246|P2|Phase A|Adverse Event|0
1185387|NCT01052077|3891247|P1|Phase A|Adverse Event|32
1185388|NCT01052077|3891244|P4|Phase A|Lost to Follow-up|0
1185389|NCT01052077|3891245|P3|Phase A|Lost to Follow-up|0
1185390|NCT01052077|3891246|P2|Phase A|Lost to Follow-up|0
1185391|NCT01052077|3891247|P1|Phase A|Lost to Follow-up|22
1185392|NCT01052038|3891274|P3|Overall Study|Protocol Violation|3
1185393|NCT01052038|3891275|P2|Overall Study|Protocol Violation|3
1185394|NCT01052038|3891276|P1|Overall Study|Protocol Violation|2
1185395|NCT01052038|3891274|P3|Overall Study|Lost to Follow-up|1
1185396|NCT01052038|3891275|P2|Overall Study|Lost to Follow-up|3
1185397|NCT01052038|3891276|P1|Overall Study|Lost to Follow-up|2
1185398|NCT01051986|3891298|P2|Overall Study|Protocol Violation|3
1185399|NCT01051986|3891299|P1|Overall Study|Protocol Violation|2
1185400|NCT01051986|3891298|P2|Overall Study|Withdrawal by Subject|1
1185401|NCT01051986|3891299|P1|Overall Study|Withdrawal by Subject|2
1185402|NCT01051986|3891298|P2|Overall Study|Death|0
1185403|NCT01051986|3891299|P1|Overall Study|Death|1
1185404|NCT01051921|3891313|P1|Overall Study|patient moved|1
1185405|NCT01051921|3891313|P1|Overall Study|virological failure|1
1185406|NCT01051921|3891313|P1|Overall Study|Lost to Follow-up|4
1185407|NCT01051921|3891313|P1|Overall Study|Withdrawal by Subject|7
1185408|NCT01051921|3891313|P1|Overall Study|Adverse Event|8
1185409|NCT01051921|3891313|P1|Overall Study|Physician Decision|9
1185410|NCT01051856|3891320|P2|Overall Study|Withdrawal by Subject|0
1185411|NCT01051856|3891321|P1|Overall Study|Withdrawal by Subject|1
1185412|NCT01051817|3891331|P2|Overall Study|Protocol Violation|1
1185413|NCT01051817|3891332|P1|Overall Study|Protocol Violation|0
1185414|NCT01051817|3891331|P2|Overall Study|Withdrawal by Subject|5
1185415|NCT01051817|3891332|P1|Overall Study|Withdrawal by Subject|3
1185416|NCT01051817|3891331|P2|Overall Study|Abnormal Test Proceedure reults|1
1185417|NCT01051817|3891332|P1|Overall Study|Abnormal Test Proceedure reults|0
1185418|NCT01051817|3891331|P2|Overall Study|Adverse Event|2
1185419|NCT01051817|3891332|P1|Overall Study|Adverse Event|0
1185420|NCT01051791|3891342|P1|Overall Study|Withdrawal by Subject|1
1185421|NCT01051791|3891342|P1|Overall Study|Failed screening|3
1185422|NCT01051739|3891360|P2|Overall Study|Withdrawal by Subject|10
1185423|NCT01051739|3891361|P1|Overall Study|Withdrawal by Subject|25
1185424|NCT01051739|3891360|P2|Overall Study|Death|3
1185425|NCT01051739|3891361|P1|Overall Study|Death|3
1185426|NCT01051557|3891378|P7|Overall Study|Adverse Event|4
1185427|NCT01051557|3891379|P6|Overall Study|Adverse Event|3
1185428|NCT01051557|3891380|P5|Overall Study|Adverse Event|1
1185429|NCT01051557|3891381|P4|Overall Study|Adverse Event|1
1185430|NCT01051557|3891382|P3|Overall Study|Adverse Event|0
1185431|NCT01051557|3891383|P2|Overall Study|Adverse Event|0
1185432|NCT01051557|3891384|P1|Overall Study|Adverse Event|0
1185433|NCT01051557|3891378|P7|Overall Study|Withdrawal by Subject|1
1185434|NCT01051557|3891379|P6|Overall Study|Withdrawal by Subject|0
1185435|NCT01051557|3891380|P5|Overall Study|Withdrawal by Subject|2
1185436|NCT01051557|3891381|P4|Overall Study|Withdrawal by Subject|0
1185437|NCT01051557|3891382|P3|Overall Study|Withdrawal by Subject|1
1185438|NCT01051557|3891383|P2|Overall Study|Withdrawal by Subject|0
1185439|NCT01051557|3891384|P1|Overall Study|Withdrawal by Subject|0
1185440|NCT01051557|3891378|P7|Overall Study|disease progression|1
1185441|NCT01051557|3891379|P6|Overall Study|disease progression|3
1185442|NCT01051557|3891380|P5|Overall Study|disease progression|4
1185443|NCT01051557|3891381|P4|Overall Study|disease progression|2
1185444|NCT01051557|3891382|P3|Overall Study|disease progression|5
1185445|NCT01051557|3891383|P2|Overall Study|disease progression|3
1185446|NCT01051557|3891384|P1|Overall Study|disease progression|3
1185447|NCT01051557|3891378|P7|Overall Study|Physician Decision|0
1185448|NCT01051557|3891379|P6|Overall Study|Physician Decision|0
1185449|NCT01051557|3891380|P5|Overall Study|Physician Decision|0
1185450|NCT01051557|3891381|P4|Overall Study|Physician Decision|0
1185451|NCT01051557|3891382|P3|Overall Study|Physician Decision|0
1185452|NCT01051557|3891383|P2|Overall Study|Physician Decision|0
1185453|NCT01051557|3891384|P1|Overall Study|Physician Decision|1
1185454|NCT01051466|3891403|P2|Overall Study|Physician Decision|0
1185455|NCT01051466|3891404|P1|Overall Study|Physician Decision|1
1185456|NCT01051466|3891403|P2|Overall Study|Entry Criteria Not Met|3
1185457|NCT01051466|3891404|P1|Overall Study|Entry Criteria Not Met|0
1185458|NCT01051466|3891403|P2|Overall Study|Withdrawal by Subject|1
1185459|NCT01051466|3891404|P1|Overall Study|Withdrawal by Subject|5
1185460|NCT01051466|3891403|P2|Overall Study|Lost to Follow-up|1
1185461|NCT01051466|3891404|P1|Overall Study|Lost to Follow-up|1
1185462|NCT01051466|3891403|P2|Overall Study|Adverse Event|0
1185463|NCT01051466|3891404|P1|Overall Study|Adverse Event|1
1185464|NCT01051349|3891449|P1|Overall Study|Reason not Specified|12
1185465|NCT01051349|3891449|P1|Overall Study|Subject non-compliance|7
1185466|NCT01051349|3891449|P1|Overall Study|Lost to Follow-up|6
1185467|NCT01051349|3891449|P1|Overall Study|Investigator Decision|6
1185468|NCT01051349|3891449|P1|Overall Study|Consent Withdrawn|54
1185469|NCT01051349|3891449|P1|Overall Study|Adverse Event|88
1185470|NCT01051323|3891478|P1|Overall Study|Missing|37
1185471|NCT01051323|3891478|P1|Overall Study|Other|148
1185472|NCT01051323|3891478|P1|Overall Study|Hospitalization|28
1185473|NCT01051323|3891478|P1|Overall Study|Death|129
1185474|NCT01051323|3891478|P1|Overall Study|Lost to Follow-up|31
1185475|NCT01051323|3891478|P1|Overall Study|Withdrawal by Subject|13
1185476|NCT01051323|3891478|P1|Overall Study|Dialysis dependency|22
1185477|NCT01051323|3891478|P1|Overall Study|Transplantation|28
1185478|NCT01051323|3891478|P1|Overall Study|Discontinuation of treatment|103
1185479|NCT01051063|3891502|P2|Overall Study|Lost to Follow-up|1
1185480|NCT01051063|3891503|P1|Overall Study|Lost to Follow-up|0
1185481|NCT01051063|3891502|P2|Overall Study|Not specified|0
1185482|NCT01051063|3891503|P1|Overall Study|Not specified|1
1185483|NCT01051063|3891502|P2|Overall Study|Moved from the study site area|0
1185484|NCT01051063|3891503|P1|Overall Study|Moved from the study site area|1
1185485|NCT01051063|3891502|P2|Overall Study|Termination of the study|0
1185486|NCT01051063|3891503|P1|Overall Study|Termination of the study|5
1185487|NCT01051063|3891502|P2|Overall Study|Withdrawal by Subject|1
1185488|NCT01051063|3891503|P1|Overall Study|Withdrawal by Subject|1
1185489|NCT01051063|3891502|P2|Overall Study|Death|2
1185490|NCT01051063|3891503|P1|Overall Study|Death|2
1185491|NCT01050998|3891523|P5|Overall Study|Data integrity issues|4
1185492|NCT01050998|3891524|P4|Overall Study|Data integrity issues|1
1185493|NCT01050998|3891525|P3|Overall Study|Data integrity issues|1
1185494|NCT01050998|3891526|P2|Overall Study|Data integrity issues|0
1185495|NCT01050998|3891527|P1|Overall Study|Data integrity issues|0
1185496|NCT01050998|3891523|P5|Overall Study|Other|5
1185497|NCT01050998|3891524|P4|Overall Study|Other|1
1185498|NCT01050998|3891525|P3|Overall Study|Other|1
1185499|NCT01050998|3891526|P2|Overall Study|Other|2
1185500|NCT01050998|3891527|P1|Overall Study|Other|3
1185501|NCT01050998|3891523|P5|Overall Study|Withdrawal by Subject|3
1185502|NCT01050998|3891524|P4|Overall Study|Withdrawal by Subject|1
1185503|NCT01050998|3891525|P3|Overall Study|Withdrawal by Subject|0
1185504|NCT01050998|3891526|P2|Overall Study|Withdrawal by Subject|0
1185505|NCT01050998|3891527|P1|Overall Study|Withdrawal by Subject|0
1185506|NCT01050998|3891523|P5|Overall Study|Adverse Event|2
1185507|NCT01050998|3891524|P4|Overall Study|Adverse Event|0
1185508|NCT01050998|3891525|P3|Overall Study|Adverse Event|1
1185509|NCT01050998|3891526|P2|Overall Study|Adverse Event|0
1185510|NCT01050998|3891527|P1|Overall Study|Adverse Event|1
1185511|NCT01050816|3891861|P1|Overall Study|patient's refusal|2
1185512|NCT01050816|3891861|P1|Overall Study|Lost to Follow-up|2
1185513|NCT01050790|3891867|P1|Overall Study|Adverse Event|1
1185514|NCT01050764|3891877|P1|Overall Study|Death after HSCT, before T-cell infusion|1
1185515|NCT01050764|3891877|P1|Overall Study|Donor mobilization failure, death|1
1185516|NCT01050764|3891877|P1|Overall Study|Death, before HSCT|1
1185517|NCT01050673|3891888|P2|Overall Study|Physician Decision|5
1185518|NCT01050673|3891889|P1|Overall Study|Physician Decision|4
1185519|NCT01050634|3891957|P1|Overall Study|Ongoing at Date of Cut-Off|5
1185520|NCT01050634|3891957|P1|Overall Study|Other|21
1185521|NCT01050634|3891957|P1|Overall Study|Lost to Follow-up|2
1185522|NCT01050634|3891957|P1|Overall Study|Adverse Event|42
1185523|NCT01050634|3891957|P1|Overall Study|Death|2
1185524|NCT01050634|3891957|P1|Overall Study|Enrolled, but Not Treated|56
1185525|NCT01050569|3891981|P3|Overall Study|Physician Decision|3
1185526|NCT01050569|3891982|P2|Overall Study|Physician Decision|3
1185527|NCT01050569|3891983|P1|Overall Study|Physician Decision|3
1185528|NCT01050569|3891981|P3|Overall Study|Adverse Event|0
1185529|NCT01050569|3891982|P2|Overall Study|Adverse Event|0
1185530|NCT01050569|3891983|P1|Overall Study|Adverse Event|1
1185531|NCT01050569|3891981|P3|Overall Study|Lack of Efficacy|3
1185532|NCT01050569|3891982|P2|Overall Study|Lack of Efficacy|4
1185533|NCT01050569|3891983|P1|Overall Study|Lack of Efficacy|5
1185534|NCT01050569|3891981|P3|Overall Study|Withdrawal by Subject|11
1185535|NCT01050569|3891982|P2|Overall Study|Withdrawal by Subject|3
1185536|NCT01050569|3891983|P1|Overall Study|Withdrawal by Subject|9
1185537|NCT01050569|3891981|P3|Overall Study|Lost to Follow-up|16
1185538|NCT01050569|3891982|P2|Overall Study|Lost to Follow-up|14
1185539|NCT01050569|3891983|P1|Overall Study|Lost to Follow-up|20
1185540|NCT01050543|3892002|P2|Overall Study|Administrative|1
1185541|NCT01050543|3892003|P1|Overall Study|Administrative|4
1185542|NCT01050543|3892002|P2|Overall Study|Protocol Violation|1
1185543|NCT01050543|3892003|P1|Overall Study|Protocol Violation|0
1185544|NCT01050543|3892002|P2|Overall Study|Withdrawal by Subject|2
1185545|NCT01050543|3892003|P1|Overall Study|Withdrawal by Subject|0
1185546|NCT01050530|3892011|P2|Overall Study|Protocol Violation|0
1185547|NCT01050530|3892012|P1|Overall Study|Protocol Violation|1
1185548|NCT01050530|3892011|P2|Overall Study|Withdrawal by Subject|3
1185549|NCT01050530|3892012|P1|Overall Study|Withdrawal by Subject|0
1185550|NCT01050530|3892011|P2|Overall Study|Lack of Efficacy|4
1185551|NCT01050530|3892012|P1|Overall Study|Lack of Efficacy|1
1185552|NCT01050530|3892011|P2|Overall Study|Adverse Event|3
1185553|NCT01050530|3892012|P1|Overall Study|Adverse Event|6
1185554|NCT01050257|3892023|P3|Overall Study|Death|1
1185555|NCT01050257|3892024|P2|Overall Study|Death|0
1185556|NCT01050257|3892025|P1|Overall Study|Death|0
1185557|NCT01050257|3892023|P3|Overall Study|Failure to return|0
1185558|NCT01050257|3892024|P2|Overall Study|Failure to return|2
1185559|NCT01050257|3892025|P1|Overall Study|Failure to return|0
1185560|NCT01050257|3892023|P3|Overall Study|Violation criteria|0
1185561|NCT01050257|3892024|P2|Overall Study|Violation criteria|1
1185562|NCT01050257|3892025|P1|Overall Study|Violation criteria|0
1185563|NCT01050257|3892023|P3|Overall Study|Refused treatment/ Did not Cooperate|0
1185564|NCT01050257|3892024|P2|Overall Study|Refused treatment/ Did not Cooperate|1
1185565|NCT01050257|3892025|P1|Overall Study|Refused treatment/ Did not Cooperate|1
1185566|NCT01050257|3892023|P3|Overall Study|No reason specified|2
1185567|NCT01050257|3892024|P2|Overall Study|No reason specified|0
1185568|NCT01050257|3892025|P1|Overall Study|No reason specified|0
1185569|NCT01050257|3892023|P3|Overall Study|Withdrawal by Subject|0
1185570|NCT01050257|3892024|P2|Overall Study|Withdrawal by Subject|3
1185571|NCT01050257|3892025|P1|Overall Study|Withdrawal by Subject|0
1185572|NCT01050257|3892023|P3|Overall Study|Admin/Other (did not switch to oral)|2
1185573|NCT01050257|3892024|P2|Overall Study|Admin/Other (did not switch to oral)|2
1185574|NCT01050257|3892025|P1|Overall Study|Admin/Other (did not switch to oral)|6
1185575|NCT01050257|3892023|P3|Overall Study|Adverse Event|2
1185576|NCT01050257|3892024|P2|Overall Study|Adverse Event|4
1185577|NCT01050257|3892025|P1|Overall Study|Adverse Event|4
1185578|NCT01050218|3892060|P1|Overall Study|Family emergency|1
1185579|NCT01050218|3892060|P1|Overall Study|Serious Adverse Event|1
1185580|NCT01050218|3892060|P1|Overall Study|Failed to return|7
1185581|NCT01050218|3892060|P1|Overall Study|Compliance|2
1185582|NCT01050218|3892060|P1|Overall Study|Discontinued by sponsor|18
1185583|NCT01050218|3892060|P1|Overall Study|Withdrawal by Subject|18
1185584|NCT01050218|3892060|P1|Overall Study|Protocol Violation|3
1185585|NCT01050218|3892060|P1|Overall Study|Lack of Efficacy|8
1185586|NCT01050218|3892060|P1|Overall Study|Adverse Event|37
1185587|NCT01050205|3892066|P2|Overall Study|Discontinued Intervention|0
1185588|NCT01050205|3892067|P1|Overall Study|Discontinued Intervention|2
1185589|NCT01050205|3892066|P2|Overall Study|Relocated from area|2
1185590|NCT01050205|3892067|P1|Overall Study|Relocated from area|1
1185591|NCT01050205|3892066|P2|Overall Study|Withdrawal by Subject|1
1185592|NCT01050205|3892067|P1|Overall Study|Withdrawal by Subject|1
1185593|NCT01050205|3892066|P2|Overall Study|Lost to Follow-up|1
1185594|NCT01050205|3892067|P1|Overall Study|Lost to Follow-up|7
1185595|NCT01050062|3892124|P2|Overall Study|Others|11
1185596|NCT01050062|3892125|P1|Overall Study|Others|17
1185597|NCT01050062|3892124|P2|Overall Study|Physician Decision|9
1185598|NCT01050062|3892125|P1|Overall Study|Physician Decision|74
1185599|NCT01050062|3892124|P2|Overall Study|Lack of Efficacy|35
1185600|NCT01050062|3892125|P1|Overall Study|Lack of Efficacy|22
1185601|NCT01050062|3892124|P2|Overall Study|Lost to Follow-up|35
1185602|NCT01050062|3892125|P1|Overall Study|Lost to Follow-up|83
1185603|NCT01050062|3892124|P2|Overall Study|Adverse Event|22
1185604|NCT01050062|3892125|P1|Overall Study|Adverse Event|75
1185605|NCT01049984|3892147|P2|Overall Study|Treatment failure|2
1185606|NCT01049984|3892148|P1|Overall Study|Treatment failure|0
1185607|NCT01049984|3892147|P2|Overall Study|Adverse Event|7
1185608|NCT01049984|3892148|P1|Overall Study|Adverse Event|13
1185609|NCT01049984|3892147|P2|Overall Study|Lost to Follow-up|1
1185610|NCT01049984|3892148|P1|Overall Study|Lost to Follow-up|2
1185611|NCT01049984|3892147|P2|Overall Study|Protocol Violation|4
1185612|NCT01049984|3892148|P1|Overall Study|Protocol Violation|3
1185613|NCT01049984|3892147|P2|Overall Study|Withdrawal by Subject|5
1185614|NCT01049984|3892148|P1|Overall Study|Withdrawal by Subject|1
1185615|NCT01049581|3892208|P2|Overall Study|Lost to Follow-up|1
1185616|NCT01049581|3892209|P1|Overall Study|Lost to Follow-up|2
1185617|NCT01049503|3892224|P6|Overall Study|Lost to Follow-up|8
1185618|NCT01049503|3892225|P5|Overall Study|Lost to Follow-up|27
1185619|NCT01049503|3892226|P4|Overall Study|Lost to Follow-up|26
1185620|NCT01049503|3892227|P3|Overall Study|Lost to Follow-up|24
1185621|NCT01049503|3892228|P2|Overall Study|Lost to Follow-up|12
1185622|NCT01049503|3892229|P1|Overall Study|Lost to Follow-up|11
1185623|NCT01049412|3892260|P2|Period II|Lost to Follow-up|0
1185624|NCT01049412|3892261|P1|Period II|Lost to Follow-up|1
1185625|NCT01049412|3892260|P2|Period II|Adverse Event|0
1185626|NCT01049412|3892261|P1|Period II|Adverse Event|1
1185627|NCT01049412|3892260|P2|Period II|Withdrawal by Subject|3
1185628|NCT01049412|3892261|P1|Period II|Withdrawal by Subject|2
1185629|NCT01049412|3892260|P2|Period I|Adverse Event|0
1185630|NCT01049412|3892261|P1|Period I|Adverse Event|1
1185631|NCT01049412|3892260|P2|Period I|Protocol Violation|2
1185632|NCT01049412|3892261|P1|Period I|Protocol Violation|1
1185633|NCT01049412|3892260|P2|Period I|Physician Decision|3
1185634|NCT01049412|3892261|P1|Period I|Physician Decision|0
1185635|NCT01049412|3892260|P2|Period I|Lost to Follow-up|2
1185636|NCT01049412|3892261|P1|Period I|Lost to Follow-up|2
1185637|NCT01049412|3892260|P2|Period I|Withdrawal by Subject|6
1185638|NCT01049412|3892261|P1|Period I|Withdrawal by Subject|4
1185639|NCT01049373|3892290|P2|Overall Study|Non-cooperation|1
1185640|NCT01049373|3892291|P1|Overall Study|Non-cooperation|0
1185641|NCT01049373|3892290|P2|Overall Study|Not specified|1
1185642|NCT01049373|3892291|P1|Overall Study|Not specified|1
1185643|NCT01049373|3892290|P2|Overall Study|no evaluable study values|21
1185644|NCT01049373|3892291|P1|Overall Study|no evaluable study values|9
1185645|NCT01049373|3892290|P2|Overall Study|Lost to Follow-up|4
1185646|NCT01049373|3892291|P1|Overall Study|Lost to Follow-up|9
1185647|NCT01049373|3892290|P2|Overall Study|Adverse Event|3
1185648|NCT01049373|3892291|P1|Overall Study|Adverse Event|3
1185649|NCT01049373|3892290|P2|Overall Study|Withdrawal by Subject|5
1185650|NCT01049373|3892291|P1|Overall Study|Withdrawal by Subject|8
1185651|NCT01049373|3892290|P2|Overall Study|Protocol Violation|9
1185652|NCT01049373|3892291|P1|Overall Study|Protocol Violation|9
1185653|NCT01049360|3892305|P20|Period 4|Withdrawal by Subject|0
1185654|NCT01049360|3892306|P19|Period 4|Withdrawal by Subject|0
1185655|NCT01049360|3892307|P18|Period 4|Withdrawal by Subject|0
1185656|NCT01049360|3892308|P17|Period 4|Withdrawal by Subject|0
1185657|NCT01049360|3892309|P16|Period 4|Withdrawal by Subject|0
1185658|NCT01049360|3892310|P15|Period 4|Withdrawal by Subject|0
1185659|NCT01049360|3892311|P14|Period 4|Withdrawal by Subject|0
1185660|NCT01049360|3892312|P13|Period 4|Withdrawal by Subject|0
1185661|NCT01049360|3892313|P12|Period 4|Withdrawal by Subject|0
1185662|NCT01049360|3892314|P11|Period 4|Withdrawal by Subject|0
1185663|NCT01049360|3892315|P10|Period 4|Withdrawal by Subject|0
1185664|NCT01049360|3892316|P9|Period 4|Withdrawal by Subject|0
1185665|NCT01049360|3892317|P8|Period 4|Withdrawal by Subject|0
1185666|NCT01049360|3892318|P7|Period 4|Withdrawal by Subject|0
1185667|NCT01049360|3892319|P6|Period 4|Withdrawal by Subject|0
1185668|NCT01049360|3892320|P5|Period 4|Withdrawal by Subject|0
1185669|NCT01049360|3892321|P4|Period 4|Withdrawal by Subject|1
1185670|NCT01049360|3892322|P3|Period 4|Withdrawal by Subject|0
1185671|NCT01049360|3892323|P2|Period 4|Withdrawal by Subject|0
1185672|NCT01049360|3892324|P1|Period 4|Withdrawal by Subject|0
1185673|NCT01049360|3892305|P20|Period 4|Protocol Violation|0
1185674|NCT01049360|3892306|P19|Period 4|Protocol Violation|0
1185675|NCT01049360|3892307|P18|Period 4|Protocol Violation|1
1185676|NCT01049360|3892308|P17|Period 4|Protocol Violation|0
1185677|NCT01049360|3892309|P16|Period 4|Protocol Violation|0
1185678|NCT01049360|3892310|P15|Period 4|Protocol Violation|0
1185679|NCT01049360|3892311|P14|Period 4|Protocol Violation|0
1185680|NCT01049360|3892312|P13|Period 4|Protocol Violation|0
1185681|NCT01049360|3892313|P12|Period 4|Protocol Violation|0
1185682|NCT01049360|3892314|P11|Period 4|Protocol Violation|0
1185683|NCT01049360|3892315|P10|Period 4|Protocol Violation|0
1185684|NCT01049360|3892316|P9|Period 4|Protocol Violation|0
1185685|NCT01049360|3892317|P8|Period 4|Protocol Violation|0
1185686|NCT01049360|3892318|P7|Period 4|Protocol Violation|0
1185687|NCT01049360|3892319|P6|Period 4|Protocol Violation|0
1185688|NCT01049360|3892320|P5|Period 4|Protocol Violation|0
1185689|NCT01049360|3892321|P4|Period 4|Protocol Violation|0
1185690|NCT01049360|3892322|P3|Period 4|Protocol Violation|0
1185691|NCT01049360|3892323|P2|Period 4|Protocol Violation|0
1185692|NCT01049360|3892324|P1|Period 4|Protocol Violation|0
1185693|NCT01049360|3892305|P20|Period 2|Lack of Efficacy|0
1185694|NCT01049360|3892306|P19|Period 2|Lack of Efficacy|0
1185695|NCT01049360|3892307|P18|Period 2|Lack of Efficacy|0
1185696|NCT01049360|3892308|P17|Period 2|Lack of Efficacy|0
1185697|NCT01049360|3892309|P16|Period 2|Lack of Efficacy|0
1185698|NCT01049360|3892310|P15|Period 2|Lack of Efficacy|0
1185699|NCT01049360|3892311|P14|Period 2|Lack of Efficacy|0
1185700|NCT01049360|3892312|P13|Period 2|Lack of Efficacy|0
1185701|NCT01049360|3892313|P12|Period 2|Lack of Efficacy|0
1185702|NCT01049360|3892314|P11|Period 2|Lack of Efficacy|0
1185703|NCT01049360|3892315|P10|Period 2|Lack of Efficacy|0
1185704|NCT01049360|3892316|P9|Period 2|Lack of Efficacy|0
1185705|NCT01049360|3892317|P8|Period 2|Lack of Efficacy|0
1185706|NCT01049360|3892318|P7|Period 2|Lack of Efficacy|0
1185707|NCT01049360|3892319|P6|Period 2|Lack of Efficacy|1
1185708|NCT01049360|3892320|P5|Period 2|Lack of Efficacy|0
1185709|NCT01049360|3892321|P4|Period 2|Lack of Efficacy|0
1185710|NCT01049360|3892322|P3|Period 2|Lack of Efficacy|0
1185711|NCT01049360|3892323|P2|Period 2|Lack of Efficacy|0
1185712|NCT01049360|3892324|P1|Period 2|Lack of Efficacy|0
1185713|NCT01049360|3892305|P20|Period 2|Withdrawal by Subject|1
1185714|NCT01049360|3892306|P19|Period 2|Withdrawal by Subject|0
1185715|NCT01049360|3892307|P18|Period 2|Withdrawal by Subject|0
1185716|NCT01049360|3892308|P17|Period 2|Withdrawal by Subject|0
1185717|NCT01049360|3892309|P16|Period 2|Withdrawal by Subject|0
1185718|NCT01049360|3892310|P15|Period 2|Withdrawal by Subject|1
1185719|NCT01049360|3892311|P14|Period 2|Withdrawal by Subject|0
1185720|NCT01049360|3892312|P13|Period 2|Withdrawal by Subject|0
1185721|NCT01049360|3892313|P12|Period 2|Withdrawal by Subject|0
1185722|NCT01049360|3892314|P11|Period 2|Withdrawal by Subject|0
1185723|NCT01049360|3892315|P10|Period 2|Withdrawal by Subject|0
1185724|NCT01049360|3892316|P9|Period 2|Withdrawal by Subject|0
1185725|NCT01049360|3892317|P8|Period 2|Withdrawal by Subject|0
1185726|NCT01049360|3892318|P7|Period 2|Withdrawal by Subject|0
1185727|NCT01049360|3892319|P6|Period 2|Withdrawal by Subject|0
1185728|NCT01049360|3892320|P5|Period 2|Withdrawal by Subject|0
1185729|NCT01049360|3892321|P4|Period 2|Withdrawal by Subject|1
1185730|NCT01049360|3892322|P3|Period 2|Withdrawal by Subject|0
1185731|NCT01049360|3892323|P2|Period 2|Withdrawal by Subject|0
1185732|NCT01049360|3892324|P1|Period 2|Withdrawal by Subject|0
1185733|NCT01049360|3892305|P20|Period 2|Adverse Event|1
1185734|NCT01049360|3892306|P19|Period 2|Adverse Event|0
1185735|NCT01049360|3892307|P18|Period 2|Adverse Event|0
1185736|NCT01049360|3892308|P17|Period 2|Adverse Event|0
1185737|NCT01049360|3892309|P16|Period 2|Adverse Event|0
1185738|NCT01049360|3892310|P15|Period 2|Adverse Event|0
1185739|NCT01049360|3892311|P14|Period 2|Adverse Event|0
1185740|NCT01049360|3892312|P13|Period 2|Adverse Event|0
1185741|NCT01049360|3892313|P12|Period 2|Adverse Event|0
1185742|NCT01049360|3892314|P11|Period 2|Adverse Event|0
1185743|NCT01049360|3892315|P10|Period 2|Adverse Event|0
1185744|NCT01049360|3892316|P9|Period 2|Adverse Event|1
1185745|NCT01049360|3892317|P8|Period 2|Adverse Event|0
1185746|NCT01049360|3892318|P7|Period 2|Adverse Event|0
1185747|NCT01049360|3892319|P6|Period 2|Adverse Event|0
1185748|NCT01049360|3892320|P5|Period 2|Adverse Event|0
1185749|NCT01049360|3892321|P4|Period 2|Adverse Event|0
1185750|NCT01049360|3892322|P3|Period 2|Adverse Event|0
1185751|NCT01049360|3892323|P2|Period 2|Adverse Event|1
1185752|NCT01049360|3892324|P1|Period 2|Adverse Event|0
1185753|NCT01049360|3892305|P20|Period 2|Protocol Violation|0
1185754|NCT01049360|3892306|P19|Period 2|Protocol Violation|0
1185755|NCT01049360|3892307|P18|Period 2|Protocol Violation|0
1185756|NCT01049360|3892308|P17|Period 2|Protocol Violation|0
1185757|NCT01049360|3892309|P16|Period 2|Protocol Violation|1
1185758|NCT01049360|3892310|P15|Period 2|Protocol Violation|1
1185759|NCT01049360|3892311|P14|Period 2|Protocol Violation|0
1185760|NCT01049360|3892312|P13|Period 2|Protocol Violation|0
1185761|NCT01049360|3892313|P12|Period 2|Protocol Violation|0
1185762|NCT01049360|3892314|P11|Period 2|Protocol Violation|0
1185763|NCT01049360|3892315|P10|Period 2|Protocol Violation|0
1185764|NCT01049360|3892316|P9|Period 2|Protocol Violation|0
1185765|NCT01049360|3892317|P8|Period 2|Protocol Violation|0
1185766|NCT01049360|3892318|P7|Period 2|Protocol Violation|0
1185767|NCT01049360|3892319|P6|Period 2|Protocol Violation|0
1185768|NCT01049360|3892320|P5|Period 2|Protocol Violation|0
1185769|NCT01049360|3892321|P4|Period 2|Protocol Violation|1
1185770|NCT01049360|3892322|P3|Period 2|Protocol Violation|0
1185771|NCT01049360|3892323|P2|Period 2|Protocol Violation|0
1185772|NCT01049360|3892324|P1|Period 2|Protocol Violation|0
1185773|NCT01049360|3892305|P20|Period 1|Withdrawal by Subject|0
1185774|NCT01049360|3892306|P19|Period 1|Withdrawal by Subject|0
1185775|NCT01049360|3892307|P18|Period 1|Withdrawal by Subject|0
1185776|NCT01049360|3892308|P17|Period 1|Withdrawal by Subject|0
1185777|NCT01049360|3892309|P16|Period 1|Withdrawal by Subject|0
1185778|NCT01049360|3892310|P15|Period 1|Withdrawal by Subject|0
1185779|NCT01049360|3892311|P14|Period 1|Withdrawal by Subject|0
1185780|NCT01049360|3892312|P13|Period 1|Withdrawal by Subject|1
1185781|NCT01049360|3892313|P12|Period 1|Withdrawal by Subject|0
1185782|NCT01049360|3892314|P11|Period 1|Withdrawal by Subject|1
1185783|NCT01049360|3892315|P10|Period 1|Withdrawal by Subject|0
1185784|NCT01049360|3892316|P9|Period 1|Withdrawal by Subject|1
1185785|NCT01049360|3892317|P8|Period 1|Withdrawal by Subject|0
1185786|NCT01049360|3892318|P7|Period 1|Withdrawal by Subject|0
1185787|NCT01049360|3892319|P6|Period 1|Withdrawal by Subject|0
1185788|NCT01049360|3892320|P5|Period 1|Withdrawal by Subject|0
1185789|NCT01049360|3892321|P4|Period 1|Withdrawal by Subject|0
1185790|NCT01049360|3892322|P3|Period 1|Withdrawal by Subject|0
1185791|NCT01049360|3892323|P2|Period 1|Withdrawal by Subject|0
1185792|NCT01049360|3892324|P1|Period 1|Withdrawal by Subject|0
1185793|NCT01049360|3892305|P20|Period 1|Did not meet inc/exc criteria|0
1185794|NCT01049360|3892306|P19|Period 1|Did not meet inc/exc criteria|0
1185795|NCT01049360|3892307|P18|Period 1|Did not meet inc/exc criteria|0
1185796|NCT01049360|3892308|P17|Period 1|Did not meet inc/exc criteria|0
1185797|NCT01049360|3892309|P16|Period 1|Did not meet inc/exc criteria|0
1185798|NCT01049360|3892310|P15|Period 1|Did not meet inc/exc criteria|0
1185799|NCT01049360|3892311|P14|Period 1|Did not meet inc/exc criteria|0
1185800|NCT01049360|3892312|P13|Period 1|Did not meet inc/exc criteria|0
1185801|NCT01049360|3892313|P12|Period 1|Did not meet inc/exc criteria|0
1185802|NCT01049360|3892314|P11|Period 1|Did not meet inc/exc criteria|0
1185803|NCT01049360|3892315|P10|Period 1|Did not meet inc/exc criteria|0
1185804|NCT01049360|3892316|P9|Period 1|Did not meet inc/exc criteria|1
1185805|NCT01049360|3892317|P8|Period 1|Did not meet inc/exc criteria|1
1185806|NCT01049360|3892318|P7|Period 1|Did not meet inc/exc criteria|0
1185807|NCT01049360|3892319|P6|Period 1|Did not meet inc/exc criteria|0
1185808|NCT01049360|3892320|P5|Period 1|Did not meet inc/exc criteria|0
1185809|NCT01049360|3892321|P4|Period 1|Did not meet inc/exc criteria|0
1185810|NCT01049360|3892322|P3|Period 1|Did not meet inc/exc criteria|0
1185811|NCT01049360|3892323|P2|Period 1|Did not meet inc/exc criteria|0
1185812|NCT01049360|3892324|P1|Period 1|Did not meet inc/exc criteria|0
1185813|NCT01049360|3892305|P20|Period 1|Adverse Event|0
1185814|NCT01049360|3892306|P19|Period 1|Adverse Event|1
1185815|NCT01049360|3892307|P18|Period 1|Adverse Event|0
1185816|NCT01049360|3892308|P17|Period 1|Adverse Event|1
1185817|NCT01049360|3892309|P16|Period 1|Adverse Event|0
1185818|NCT01049360|3892310|P15|Period 1|Adverse Event|0
1185819|NCT01049360|3892311|P14|Period 1|Adverse Event|1
1185820|NCT01049360|3892312|P13|Period 1|Adverse Event|1
1185821|NCT01049360|3892313|P12|Period 1|Adverse Event|0
1185822|NCT01049360|3892314|P11|Period 1|Adverse Event|0
1185823|NCT01049360|3892315|P10|Period 1|Adverse Event|0
1185824|NCT01049360|3892316|P9|Period 1|Adverse Event|0
1185825|NCT01049360|3892317|P8|Period 1|Adverse Event|1
1185826|NCT01049360|3892318|P7|Period 1|Adverse Event|0
1185827|NCT01049360|3892319|P6|Period 1|Adverse Event|0
1185828|NCT01049360|3892320|P5|Period 1|Adverse Event|0
1185829|NCT01049360|3892321|P4|Period 1|Adverse Event|1
1185830|NCT01049360|3892322|P3|Period 1|Adverse Event|0
1185831|NCT01049360|3892323|P2|Period 1|Adverse Event|1
1185832|NCT01049360|3892324|P1|Period 1|Adverse Event|0
1185833|NCT01049334|3892348|P2|Overall Study|Protocol Violation|1
1185834|NCT01049334|3892349|P1|Overall Study|Protocol Violation|0
1185835|NCT01049334|3892348|P2|Overall Study|Physician Decision|0
1185836|NCT01049334|3892349|P1|Overall Study|Physician Decision|2
1185837|NCT01049334|3892348|P2|Overall Study|Adverse Event|3
1185838|NCT01049334|3892349|P1|Overall Study|Adverse Event|2
1185839|NCT01049334|3892348|P2|Overall Study|Withdrawal by Subject|3
1185840|NCT01049334|3892349|P1|Overall Study|Withdrawal by Subject|5
1185841|NCT01049308|3892385|P1|Pill Counts|Withdrawal by Subject|83
1185842|NCT01049217|3892399|P2|Overall Study|Randomized but not Treated|2
1185843|NCT01049217|3892400|P1|Overall Study|Randomized but not Treated|0
1185844|NCT01049217|3892399|P2|Overall Study|Other|2
1185845|NCT01049217|3892400|P1|Overall Study|Other|1
1185846|NCT01049217|3892399|P2|Overall Study|Study Terminated by Sponsor|43
1185847|NCT01049217|3892400|P1|Overall Study|Study Terminated by Sponsor|43
1185848|NCT01049217|3892399|P2|Overall Study|Pregnancy|0
1185849|NCT01049217|3892400|P1|Overall Study|Pregnancy|1
1185850|NCT01049217|3892399|P2|Overall Study|Protocol Violation|3
1185851|NCT01049217|3892400|P1|Overall Study|Protocol Violation|1
1185852|NCT01049217|3892399|P2|Overall Study|Withdrawal by Subject|3
1185853|NCT01049217|3892400|P1|Overall Study|Withdrawal by Subject|4
1185854|NCT01049217|3892399|P2|Overall Study|Lost to Follow-up|8
1185855|NCT01049217|3892400|P1|Overall Study|Lost to Follow-up|3
1185856|NCT01049217|3892399|P2|Overall Study|Lack of Efficacy|1
1185857|NCT01049217|3892400|P1|Overall Study|Lack of Efficacy|1
1185858|NCT01049217|3892399|P2|Overall Study|Adverse Event|1
1185859|NCT01049217|3892400|P1|Overall Study|Adverse Event|2
1185860|NCT01049009|3892472|P2|Treatment Period 2 (12 Weeks)|Protocol Violation|7
1185861|NCT01049009|3892473|P1|Treatment Period 2 (12 Weeks)|Protocol Violation|8
1185862|NCT01049009|3892472|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3
1185863|NCT01049009|3892473|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
1185864|NCT01049009|3892472|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
1185865|NCT01049009|3892473|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1185866|NCT01049009|3892472|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|2
1185867|NCT01049009|3892473|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|2
1185868|NCT01048944|3892485|P4|Overall Study|Protocol Violation|2
1185869|NCT01048944|3892486|P3|Overall Study|Protocol Violation|10
1185870|NCT01048944|3892487|P2|Overall Study|Protocol Violation|10
1185871|NCT01048944|3892488|P1|Overall Study|Protocol Violation|8
1185872|NCT01048866|3892520|P2|Overall Study|not specified|1
1185873|NCT01048866|3892521|P1|Overall Study|not specified|1
1185874|NCT01048866|3892520|P2|Overall Study|Lost to Follow-up|2
1185875|NCT01048866|3892521|P1|Overall Study|Lost to Follow-up|0
1185876|NCT01048866|3892520|P2|Overall Study|Withdrawal by Subject|2
1185877|NCT01048866|3892521|P1|Overall Study|Withdrawal by Subject|0
1185878|NCT01048866|3892520|P2|Overall Study|Physician Decision|0
1185879|NCT01048866|3892521|P1|Overall Study|Physician Decision|1
1185880|NCT01048866|3892520|P2|Overall Study|Protocol Violation|0
1185881|NCT01048866|3892521|P1|Overall Study|Protocol Violation|1
1185882|NCT01048866|3892520|P2|Overall Study|Adverse Event|0
1185883|NCT01048866|3892521|P1|Overall Study|Adverse Event|1
1185884|NCT01048788|3892566|P3|Overall Study|Withdrawal by Subject|0
1185885|NCT01048788|3892567|P2|Overall Study|Withdrawal by Subject|1
1185886|NCT01048788|3892568|P1|Overall Study|Withdrawal by Subject|0
1185887|NCT01048788|3892566|P3|Overall Study|Lack of Efficacy|1
1185888|NCT01048788|3892567|P2|Overall Study|Lack of Efficacy|0
1185889|NCT01048788|3892568|P1|Overall Study|Lack of Efficacy|0
1185890|NCT01048788|3892566|P3|Overall Study|Adverse Event|1
1185891|NCT01048788|3892567|P2|Overall Study|Adverse Event|1
1185892|NCT01048788|3892568|P1|Overall Study|Adverse Event|5
1185893|NCT01048671|3892590|P3|Overall Study|Protocol Violation|1
1185894|NCT01048671|3892591|P2|Overall Study|Protocol Violation|1
1185895|NCT01048671|3892592|P1|Overall Study|Protocol Violation|0
1185896|NCT01048541|3892672|P2|Overall Study|Withdrawal by Subject|0
1185897|NCT01048541|3892673|P1|Overall Study|Withdrawal by Subject|1
1185898|NCT01048502|3892683|P4|Overall Study|Physician Decision|1
1185899|NCT01048502|3892684|P3|Overall Study|Physician Decision|0
1185900|NCT01048502|3892685|P2|Overall Study|Physician Decision|3
1185901|NCT01048502|3892686|P1|Overall Study|Physician Decision|0
1185902|NCT01048502|3892683|P4|Overall Study|Withdrawal by Subject|3
1185903|NCT01048502|3892684|P3|Overall Study|Withdrawal by Subject|5
1185904|NCT01048502|3892685|P2|Overall Study|Withdrawal by Subject|4
1185905|NCT01048502|3892686|P1|Overall Study|Withdrawal by Subject|1
1185906|NCT01048502|3892683|P4|Overall Study|Adverse Event|0
1185907|NCT01048502|3892684|P3|Overall Study|Adverse Event|0
1185908|NCT01048502|3892685|P2|Overall Study|Adverse Event|0
1185909|NCT01048502|3892686|P1|Overall Study|Adverse Event|1
1185910|NCT01048502|3892683|P4|Overall Study|Lost to Follow-up|0
1185911|NCT01048502|3892684|P3|Overall Study|Lost to Follow-up|0
1185912|NCT01048502|3892685|P2|Overall Study|Lost to Follow-up|0
1185913|NCT01048502|3892686|P1|Overall Study|Lost to Follow-up|2
1185914|NCT01048333|3892722|P6|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
1185915|NCT01048333|3892723|P5|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
1185916|NCT01048333|3892724|P4|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
1185917|NCT01048333|3892725|P3|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
1185918|NCT01048333|3892726|P2|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1
1185919|NCT01048333|3892727|P1|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
1185920|NCT01048242|3892749|P2|Overall Study|See study flow chart|2
1185921|NCT01048242|3892750|P1|Overall Study|See study flow chart|4
1185922|NCT01048099|3892765|P1|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202
1185923|NCT01048099|3892765|P1|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57
1185924|NCT01047553|3892795|P2|Overall Study|PI's decision|1
1185925|NCT01047553|3892796|P1|Overall Study|PI's decision|0
1185926|NCT01047553|3892795|P2|Overall Study|Sever Non-Compliance to Protocol|0
1185927|NCT01047553|3892796|P1|Overall Study|Sever Non-Compliance to Protocol|1
1185928|NCT01047553|3892795|P2|Overall Study|Lost to Follow-up|0
1185929|NCT01047553|3892796|P1|Overall Study|Lost to Follow-up|1
1185930|NCT01047553|3892795|P2|Overall Study|Development of Study-Specific Withdrawal|1
1185931|NCT01047553|3892796|P1|Overall Study|Development of Study-Specific Withdrawal|1
1185932|NCT01047553|3892795|P2|Overall Study|Withdrawal by Subject|2
1185933|NCT01047553|3892796|P1|Overall Study|Withdrawal by Subject|4
1185934|NCT01047553|3892795|P2|Overall Study|Adverse Event|5
1185935|NCT01047553|3892796|P1|Overall Study|Adverse Event|10
1185936|NCT01047436|3892903|P2|Overall Study|Protocol Violation|0
1185937|NCT01047436|3892904|P1|Overall Study|Protocol Violation|1
1185938|NCT01047345|3892929|P3|Extension|Lost to Follow-up|5
1185939|NCT01047345|3892930|P2|Extension|Lost to Follow-up|0
1185940|NCT01047345|3892931|P1|Extension|Lost to Follow-up|0
1185941|NCT01047345|3892929|P3|Extension|Withdrawal by Subject|1
1185942|NCT01047345|3892930|P2|Extension|Withdrawal by Subject|0
1185943|NCT01047345|3892931|P1|Extension|Withdrawal by Subject|0
1185944|NCT01047345|3892929|P3|Base Study|Withdrawal by Subject|0
1185945|NCT01047345|3892930|P2|Base Study|Withdrawal by Subject|4
1185946|NCT01047345|3892931|P1|Base Study|Withdrawal by Subject|12
1185947|NCT01047345|3892929|P3|Base Study|Protocol Violation|0
1185948|NCT01047345|3892930|P2|Base Study|Protocol Violation|1
1185949|NCT01047345|3892931|P1|Base Study|Protocol Violation|3
1185950|NCT01047345|3892929|P3|Base Study|Lost to Follow-up|0
1185951|NCT01047345|3892930|P2|Base Study|Lost to Follow-up|1
1185952|NCT01047345|3892931|P1|Base Study|Lost to Follow-up|4
1185953|NCT01047345|3892929|P3|Base Study|Adverse Event|0
1185954|NCT01047345|3892930|P2|Base Study|Adverse Event|0
1185955|NCT01047345|3892931|P1|Base Study|Adverse Event|3
1185956|NCT01047332|3892953|P2|Overall Study|Lost to Follow-up|3
1185957|NCT01047332|3892954|P1|Overall Study|Lost to Follow-up|8
1185958|NCT01047332|3892953|P2|Overall Study|Died Unobstructed|41
1185959|NCT01047332|3892954|P1|Overall Study|Died Unobstructed|38
1185960|NCT01047332|3892953|P2|Overall Study|SEMS Obstruction|20
1185961|NCT01047332|3892954|P1|Overall Study|SEMS Obstruction|11
1185962|NCT01047306|3892968|P2|Overall Study|Lost to Follow-up|0
1185963|NCT01047306|3892969|P1|Overall Study|Lost to Follow-up|1
1185964|NCT01047306|3892968|P2|Overall Study|Withdrawal by Subject|0
1185965|NCT01047306|3892969|P1|Overall Study|Withdrawal by Subject|2
1185966|NCT01047293|3893043|P4|Overall Study|DLT criteria not fulfilled|0
1185967|NCT01047293|3893044|P3|Overall Study|DLT criteria not fulfilled|0
1185968|NCT01047293|3893045|P2|Overall Study|DLT criteria not fulfilled|1
1185969|NCT01047293|3893046|P1|Overall Study|DLT criteria not fulfilled|1
1185970|NCT01047007|3893077|P4|Overall Study|Progressive Disease|0
1185971|NCT01047007|3893078|P3|Overall Study|Progressive Disease|1
1185972|NCT01047007|3893079|P2|Overall Study|Progressive Disease|4
1185973|NCT01047007|3893080|P1|Overall Study|Progressive Disease|2
1185974|NCT01047007|3893077|P4|Overall Study|Adverse Event|0
1185975|NCT01047007|3893078|P3|Overall Study|Adverse Event|1
1185976|NCT01047007|3893079|P2|Overall Study|Adverse Event|2
1185977|NCT01047007|3893080|P1|Overall Study|Adverse Event|0
1185978|NCT01046903|3893091|P1|Overall Study|Other|5
1185979|NCT01046903|3893091|P1|Overall Study|Withdrawal by Subject|3
1185980|NCT01046903|3893091|P1|Overall Study|Adverse Event|4
1185981|NCT01046903|3893091|P1|Overall Study|Lost to Follow-up|16
1185982|NCT01046877|3893104|P1|Overall Study|Exited voluntarily after tube extrusion|11
1185983|NCT01046877|3893104|P1|Overall Study|Exited voluntarily before tube extrusion|7
1185984|NCT01046695|3893120|P2|Overall Study|TENS interfered with the cardiac monitor|1
1185985|NCT01046695|3893121|P1|Overall Study|TENS interfered with the cardiac monitor|0
1185986|NCT01046695|3893120|P2|Overall Study|Subject had a pacemaker|1
1185987|NCT01046695|3893121|P1|Overall Study|Subject had a pacemaker|0
1185988|NCT01046682|3893133|P2|Overall Study|Adverse Event|0
1185989|NCT01046682|3893134|P1|Overall Study|Adverse Event|2
1185990|NCT01046643|3893142|P4|First Period Treatment or Placebo|Withdrawal by Subject|0
1185991|NCT01046643|3893143|P3|First Period Treatment or Placebo|Withdrawal by Subject|0
1185992|NCT01046643|3893144|P2|First Period Treatment or Placebo|Withdrawal by Subject|1
1185993|NCT01046643|3893145|P1|First Period Treatment or Placebo|Withdrawal by Subject|0
1185994|NCT01046565|3893167|P1|Overall Study|Withdrawal by Subject|7
1185995|NCT01046565|3893167|P1|Overall Study|Adverse Event|2
1185996|NCT01046396|3893176|P1|Overall Study|Withdrawal by Subject|5
1185997|NCT01046253|3893187|P2|Second Intervention|Protocol Violation|1
1185998|NCT01046253|3893188|P1|Second Intervention|Protocol Violation|0
1185999|NCT01046253|3893187|P2|Second Intervention|Adverse Event|1
1186000|NCT01046253|3893188|P1|Second Intervention|Adverse Event|0
1186001|NCT01046136|3893200|P2|Overall Study|Lost to Follow-up|3
1186002|NCT01046136|3893201|P1|Overall Study|Lost to Follow-up|3
1186003|NCT01046136|3893200|P2|Overall Study|Physician Decision|1
1186004|NCT01046136|3893201|P1|Overall Study|Physician Decision|1
1186005|NCT01046136|3893200|P2|Overall Study|Withdrawal by Subject|4
1186006|NCT01046136|3893201|P1|Overall Study|Withdrawal by Subject|0
1186007|NCT01046110|3893213|P2|Overall Study|Unclassified|35
1186008|NCT01046110|3893214|P1|Overall Study|Unclassified|36
1186009|NCT01046110|3893213|P2|Overall Study|Withdrawal Criteria|5
1186010|NCT01046110|3893214|P1|Overall Study|Withdrawal Criteria|3
1186011|NCT01046110|3893213|P2|Overall Study|Protocol Violation|12
1186012|NCT01046110|3893214|P1|Overall Study|Protocol Violation|7
1186013|NCT01046110|3893213|P2|Overall Study|Lack of Efficacy|1
1186014|NCT01046110|3893214|P1|Overall Study|Lack of Efficacy|0
1186015|NCT01046110|3893213|P2|Overall Study|Adverse Event|2
1186016|NCT01046110|3893214|P1|Overall Study|Adverse Event|9
1186017|NCT01046084|3893224|P2|Third Washout of 7 Days|Withdrawal by Subject|0
1186018|NCT01046084|3893225|P1|Third Washout of 7 Days|Withdrawal by Subject|2
1186019|NCT01045993|3893239|P4|Overall Study|Treated-later found eligibility not met|0
1186020|NCT01045993|3893240|P3|Overall Study|Treated-later found eligibility not met|0
1186021|NCT01045993|3893241|P2|Overall Study|Treated-later found eligibility not met|1
1186022|NCT01045993|3893242|P1|Overall Study|Treated-later found eligibility not met|0
1186023|NCT01045967|3893318|P2|Second Intervention|Protocol Violation|1
1186024|NCT01045967|3893319|P1|Second Intervention|Protocol Violation|0
1186025|NCT01045798|3893331|P2|Overall Study|Received Systemic Antifungal Prestudy|1
1186026|NCT01045798|3893332|P1|Overall Study|Received Systemic Antifungal Prestudy|0
1186027|NCT01045798|3893331|P2|Overall Study|Changed to Other Antifungal Therapy|2
1186028|NCT01045798|3893332|P1|Overall Study|Changed to Other Antifungal Therapy|1
1186029|NCT01045798|3893331|P2|Overall Study|Invasive Fungal Infection at Baseline|1
1186030|NCT01045798|3893332|P1|Overall Study|Invasive Fungal Infection at Baseline|0
1186031|NCT01045798|3893331|P2|Overall Study|Changed to Open-Label Caspofungin|0
1186032|NCT01045798|3893332|P1|Overall Study|Changed to Open-Label Caspofungin|1
1186033|NCT01045707|3893340|P2|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5
1186034|NCT01045707|3893341|P1|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6
1186035|NCT01045707|3893340|P2|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1
1186036|NCT01045707|3893341|P1|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2
1186037|NCT01045707|3893340|P2|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3
1186038|NCT01045707|3893341|P1|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2
1186039|NCT01045707|3893340|P2|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
1186040|NCT01045707|3893341|P1|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
1186041|NCT01045707|3893340|P2|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11
1186042|NCT01045707|3893341|P1|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10
1186043|NCT01045707|3893340|P2|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11
1186044|NCT01045707|3893341|P1|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22
1186045|NCT01045707|3893340|P2|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5
1186046|NCT01045707|3893341|P1|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6
1186047|NCT01045707|3893340|P2|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2
1186048|NCT01045707|3893341|P1|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4
1186049|NCT01045707|3893340|P2|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3
1186050|NCT01045707|3893341|P1|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5
1186051|NCT01045694|3893357|P1|Overall Study|Withdrawal by Subject|2
1186052|NCT01045447|3893373|P2|Overall Study|Unclassified|13
1186053|NCT01045447|3893374|P1|Overall Study|Unclassified|17
1186054|NCT01045447|3893373|P2|Overall Study|Withdrawal Criteria|10
1186055|NCT01045447|3893374|P1|Overall Study|Withdrawal Criteria|10
1186056|NCT01045447|3893373|P2|Overall Study|Protocol Violation|3
1186057|NCT01045447|3893374|P1|Overall Study|Protocol Violation|6
1186058|NCT01045447|3893373|P2|Overall Study|Lack of Efficacy|1
1186059|NCT01045447|3893374|P1|Overall Study|Lack of Efficacy|3
1186060|NCT01045447|3893373|P2|Overall Study|Adverse Event|1
1186061|NCT01045447|3893374|P1|Overall Study|Adverse Event|0
1186062|NCT01045421|3893388|P11|Phase 2|Other|1
1186063|NCT01045421|3893389|P10|Phase 2|Other|0
1186064|NCT01045421|3893390|P9|Phase 2|Other|0
1186065|NCT01045421|3893391|P8|Phase 2|Other|3
1186066|NCT01045421|3893392|P7|Phase 2|Other|0
1186067|NCT01045421|3893393|P6|Phase 2|Other|0
1186068|NCT01045421|3893394|P5|Phase 2|Other|0
1186069|NCT01045421|3893395|P4|Phase 2|Other|0
1186070|NCT01045421|3893396|P3|Phase 2|Other|0
1186071|NCT01045421|3893397|P2|Phase 2|Other|0
1186072|NCT01045421|3893398|P1|Phase 2|Other|0
1186073|NCT01045421|3893388|P11|Phase 2|Death|0
1186074|NCT01045421|3893389|P10|Phase 2|Death|2
1186075|NCT01045421|3893390|P9|Phase 2|Death|1
1186076|NCT01045421|3893391|P8|Phase 2|Death|1
1186077|NCT01045421|3893392|P7|Phase 2|Death|0
1186078|NCT01045421|3893393|P6|Phase 2|Death|0
1186079|NCT01045421|3893394|P5|Phase 2|Death|0
1186080|NCT01045421|3893395|P4|Phase 2|Death|0
1186081|NCT01045421|3893396|P3|Phase 2|Death|0
1186082|NCT01045421|3893397|P2|Phase 2|Death|0
1186083|NCT01045421|3893398|P1|Phase 2|Death|0
1186084|NCT01045421|3893388|P11|Phase 2|Progressive Disease|1
1186085|NCT01045421|3893389|P10|Phase 2|Progressive Disease|1
1186086|NCT01045421|3893390|P9|Phase 2|Progressive Disease|1
1186087|NCT01045421|3893391|P8|Phase 2|Progressive Disease|1
1186088|NCT01045421|3893392|P7|Phase 2|Progressive Disease|0
1186089|NCT01045421|3893393|P6|Phase 2|Progressive Disease|0
1186090|NCT01045421|3893394|P5|Phase 2|Progressive Disease|0
1186091|NCT01045421|3893395|P4|Phase 2|Progressive Disease|0
1186092|NCT01045421|3893396|P3|Phase 2|Progressive Disease|0
1186093|NCT01045421|3893397|P2|Phase 2|Progressive Disease|0
1186094|NCT01045421|3893398|P1|Phase 2|Progressive Disease|0
1186095|NCT01045421|3893388|P11|Phase 1|Withdrawal by Subject|0
1186096|NCT01045421|3893389|P10|Phase 1|Withdrawal by Subject|0
1186097|NCT01045421|3893390|P9|Phase 1|Withdrawal by Subject|0
1186098|NCT01045421|3893391|P8|Phase 1|Withdrawal by Subject|0
1186099|NCT01045421|3893392|P7|Phase 1|Withdrawal by Subject|0
1186100|NCT01045421|3893393|P6|Phase 1|Withdrawal by Subject|0
1186101|NCT01045421|3893394|P5|Phase 1|Withdrawal by Subject|0
1186102|NCT01045421|3893395|P4|Phase 1|Withdrawal by Subject|1
1186103|NCT01045421|3893396|P3|Phase 1|Withdrawal by Subject|0
1186104|NCT01045421|3893397|P2|Phase 1|Withdrawal by Subject|0
1186105|NCT01045421|3893398|P1|Phase 1|Withdrawal by Subject|0
1186106|NCT01045421|3893388|P11|Phase 1|Progressive Disease|0
1186107|NCT01045421|3893389|P10|Phase 1|Progressive Disease|0
1186108|NCT01045421|3893390|P9|Phase 1|Progressive Disease|0
1186109|NCT01045421|3893391|P8|Phase 1|Progressive Disease|0
1186110|NCT01045421|3893392|P7|Phase 1|Progressive Disease|0
1186111|NCT01045421|3893393|P6|Phase 1|Progressive Disease|0
1186112|NCT01045421|3893394|P5|Phase 1|Progressive Disease|1
1186113|NCT01045421|3893395|P4|Phase 1|Progressive Disease|0
1186114|NCT01045421|3893396|P3|Phase 1|Progressive Disease|0
1186115|NCT01045421|3893397|P2|Phase 1|Progressive Disease|0
1186116|NCT01045421|3893398|P1|Phase 1|Progressive Disease|0
1186117|NCT01045161|3893492|P3|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6
1186118|NCT01045161|3893493|P2|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1
1186119|NCT01045161|3893494|P1|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5
1186120|NCT01045161|3893492|P3|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
1186121|NCT01045161|3893493|P2|Part B - 40 Additional Weeks Open Label|Protocol Violation|6
1186122|NCT01045161|3893494|P1|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
1186123|NCT01045161|3893492|P3|Part B - 40 Additional Weeks Open Label|Other Reason|1
1186124|NCT01045161|3893493|P2|Part B - 40 Additional Weeks Open Label|Other Reason|2
1186125|NCT01045161|3893494|P1|Part B - 40 Additional Weeks Open Label|Other Reason|4
1186126|NCT01045161|3893492|P3|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
1186127|NCT01045161|3893493|P2|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5
1186128|NCT01045161|3893494|P1|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
1186129|NCT01045161|3893492|P3|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
1186130|NCT01045161|3893493|P2|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
1186131|NCT01045161|3893494|P1|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3
1186132|NCT01045161|3893492|P3|Part B - 40 Additional Weeks Open Label|Adverse Event|7
1186133|NCT01045161|3893493|P2|Part B - 40 Additional Weeks Open Label|Adverse Event|10
1186134|NCT01045161|3893494|P1|Part B - 40 Additional Weeks Open Label|Adverse Event|10
1186135|NCT01045161|3893492|P3|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9
1186136|NCT01045161|3893493|P2|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7
1186137|NCT01045161|3893494|P1|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10
1186138|NCT01045161|3893492|P3|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2
1186139|NCT01045161|3893493|P2|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
1186140|NCT01045161|3893494|P1|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
1186141|NCT01045161|3893492|P3|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
1186142|NCT01045161|3893493|P2|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4
1186143|NCT01045161|3893494|P1|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
1186144|NCT01045161|3893492|P3|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
1186145|NCT01045161|3893493|P2|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
1186146|NCT01045161|3893494|P1|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
1186147|NCT01045161|3893492|P3|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6
1186148|NCT01045161|3893493|P2|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1
1186149|NCT01045161|3893494|P1|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4
1186150|NCT01045161|3893492|P3|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2
1186151|NCT01045161|3893493|P2|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3
1186152|NCT01045161|3893494|P1|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6
1186153|NCT01045161|3893492|P3|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8
1186154|NCT01045161|3893493|P2|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3
1186155|NCT01045161|3893494|P1|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4
1186156|NCT01045161|3893492|P3|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6
1186157|NCT01045161|3893493|P2|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12
1186158|NCT01045161|3893494|P1|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8
1186159|NCT01045096|3893524|P3|Overall Study|Other|0
1186160|NCT01045096|3893525|P2|Overall Study|Other|0
1186161|NCT01045096|3893526|P1|Overall Study|Other|1
1186162|NCT01045096|3893524|P3|Overall Study|Withdrawal by Subject|0
1186163|NCT01045096|3893525|P2|Overall Study|Withdrawal by Subject|0
1186164|NCT01045096|3893526|P1|Overall Study|Withdrawal by Subject|2
1186165|NCT01044732|3893637|P2|Overall Study|Technical error or malfunction|14
1186166|NCT01044732|3893638|P1|Overall Study|Technical error or malfunction|15
1186167|NCT01044732|3893637|P2|Overall Study|Inability to reach cecum|2
1186168|NCT01044732|3893638|P1|Overall Study|Inability to reach cecum|5
1186169|NCT01044732|3893637|P2|Overall Study|Inadequate bowel preparation|17
1186170|NCT01044732|3893638|P1|Overall Study|Inadequate bowel preparation|11
1186171|NCT01044732|3893637|P2|Overall Study|Withdrawal by Subject|1
1186172|NCT01044732|3893638|P1|Overall Study|Withdrawal by Subject|0
1186173|NCT01044732|3893637|P2|Overall Study|Protocol Violation|12
1186174|NCT01044732|3893638|P1|Overall Study|Protocol Violation|11
1186175|NCT01044732|3893637|P2|Overall Study|Physician Decision|3
1186176|NCT01044732|3893638|P1|Overall Study|Physician Decision|5
1186177|NCT01044732|3893637|P2|Overall Study|Lost to Follow-up|1
1186178|NCT01044732|3893638|P1|Overall Study|Lost to Follow-up|2
1186179|NCT01044498|3893827|P2|Overall Study|Not specified|0
1186180|NCT01044498|3893828|P1|Overall Study|Not specified|1
1186181|NCT01044498|3893827|P2|Overall Study|Adverse Event|1
1186182|NCT01044498|3893828|P1|Overall Study|Adverse Event|1
1186183|NCT01044498|3893827|P2|Overall Study|Withdrew consent|1
1186184|NCT01044498|3893828|P1|Overall Study|Withdrew consent|1
1186185|NCT01044459|3893854|P2|Overall Study|Lost to Follow-up|12
1186186|NCT01044459|3893855|P1|Overall Study|Lost to Follow-up|18
1186187|NCT01044459|3893854|P2|Overall Study|COPD exacerbation|8
1186188|NCT01044459|3893855|P1|Overall Study|COPD exacerbation|9
1186189|NCT01044459|3893854|P2|Overall Study|Other Reason|14
1186190|NCT01044459|3893855|P1|Overall Study|Other Reason|7
1186191|NCT01044459|3893854|P2|Overall Study|Protocol Violation|16
1186192|NCT01044459|3893855|P1|Overall Study|Protocol Violation|11
1186193|NCT01044459|3893854|P2|Overall Study|Lack of Efficacy|12
1186194|NCT01044459|3893855|P1|Overall Study|Lack of Efficacy|23
1186195|NCT01044459|3893854|P2|Overall Study|Adverse Event|20
1186196|NCT01044459|3893855|P1|Overall Study|Adverse Event|22
1186197|NCT01044459|3893854|P2|Overall Study|Terminated by Sponsor|21
1186198|NCT01044459|3893855|P1|Overall Study|Terminated by Sponsor|22
1186199|NCT01044459|3893854|P2|Overall Study|Withdrawal by Subject|28
1186200|NCT01044459|3893855|P1|Overall Study|Withdrawal by Subject|21
1186201|NCT01044303|3893863|P1|Overall Study|Lost to Follow-up|2
1186202|NCT01044290|3893873|P3|Follow-Up 2|Withdrawal by Subject|1
1186203|NCT01044290|3893874|P2|Follow-Up 2|Withdrawal by Subject|1
1186204|NCT01044290|3893875|P1|Follow-Up 2|Withdrawal by Subject|0
1186205|NCT01044290|3893873|P3|Follow-Up 2|Death|1
1186206|NCT01044290|3893874|P2|Follow-Up 2|Death|1
1186207|NCT01044290|3893875|P1|Follow-Up 2|Death|0
1186208|NCT01044290|3893873|P3|Follow-up 1|Withdrawal by Subject|0
1186209|NCT01044290|3893874|P2|Follow-up 1|Withdrawal by Subject|2
1186210|NCT01044290|3893875|P1|Follow-up 1|Withdrawal by Subject|2
1186211|NCT01044290|3893873|P3|Follow-up 1|Death|1
1186212|NCT01044290|3893874|P2|Follow-up 1|Death|3
1186213|NCT01044290|3893875|P1|Follow-up 1|Death|3
1186214|NCT01043874|3893995|P1|Overall Study|Administrative Problems|1
1186215|NCT01043874|3893995|P1|Overall Study|Lack of Efficacy|1
1186216|NCT01043874|3893995|P1|Overall Study|Withdrawal by Subject|1
1186217|NCT01043874|3893995|P1|Overall Study|Adverse Event|3
1186218|NCT01043705|3894005|P3|Overall Study|Other|25
1186219|NCT01043705|3894006|P2|Overall Study|Other|19
1186220|NCT01043705|3894007|P1|Overall Study|Other|0
1186221|NCT01043705|3894005|P3|Overall Study|Screen Fail|0
1186222|NCT01043705|3894006|P2|Overall Study|Screen Fail|0
1186223|NCT01043705|3894007|P1|Overall Study|Screen Fail|21
1186224|NCT01043705|3894005|P3|Overall Study|Adverse Event|0
1186225|NCT01043705|3894006|P2|Overall Study|Adverse Event|2
1186226|NCT01043705|3894007|P1|Overall Study|Adverse Event|0
1186227|NCT01043705|3894005|P3|Overall Study|Subsequent Procedure|29
1186228|NCT01043705|3894006|P2|Overall Study|Subsequent Procedure|24
1186229|NCT01043705|3894007|P1|Overall Study|Subsequent Procedure|9
1186230|NCT01043705|3894005|P3|Overall Study|Site Closure|0
1186231|NCT01043705|3894006|P2|Overall Study|Site Closure|0
1186232|NCT01043705|3894007|P1|Overall Study|Site Closure|8
1186233|NCT01043705|3894005|P3|Overall Study|Withdrawal by Subject|0
1186234|NCT01043705|3894006|P2|Overall Study|Withdrawal by Subject|6
1186235|NCT01043705|3894007|P1|Overall Study|Withdrawal by Subject|8
1186236|NCT01043705|3894005|P3|Overall Study|Protocol Violation|0
1186237|NCT01043705|3894006|P2|Overall Study|Protocol Violation|1
1186238|NCT01043705|3894007|P1|Overall Study|Protocol Violation|2
1186239|NCT01043705|3894005|P3|Overall Study|Multiple Reasons|0
1186240|NCT01043705|3894006|P2|Overall Study|Multiple Reasons|7
1186241|NCT01043705|3894007|P1|Overall Study|Multiple Reasons|4
1186242|NCT01043705|3894005|P3|Overall Study|Lost to Follow-up|0
1186243|NCT01043705|3894006|P2|Overall Study|Lost to Follow-up|12
1186244|NCT01043705|3894007|P1|Overall Study|Lost to Follow-up|27
1186245|NCT01043705|3894005|P3|Overall Study|Death|26
1186246|NCT01043705|3894006|P2|Overall Study|Death|60
1186247|NCT01043705|3894007|P1|Overall Study|Death|28
1186248|NCT01043185|3894096|P10|Period 6 - Third Washout Period|Protocol Violation|0
1186249|NCT01043185|3894097|P9|Period 6 - Third Washout Period|Protocol Violation|1
1186250|NCT01043185|3894098|P8|Period 6 - Third Washout Period|Protocol Violation|0
1186251|NCT01043185|3894099|P7|Period 6 - Third Washout Period|Protocol Violation|0
1186252|NCT01043185|3894100|P6|Period 6 - Third Washout Period|Protocol Violation|0
1186253|NCT01043185|3894101|P5|Period 6 - Third Washout Period|Protocol Violation|0
1186254|NCT01043185|3894102|P4|Period 6 - Third Washout Period|Protocol Violation|0
1186255|NCT01043185|3894103|P3|Period 6 - Third Washout Period|Protocol Violation|0
1186256|NCT01043185|3894104|P2|Period 6 - Third Washout Period|Protocol Violation|0
1186257|NCT01043185|3894105|P1|Period 6 - Third Washout Period|Protocol Violation|0
1186258|NCT01042977|3894181|P2|Overall Study|Various|0
1186259|NCT01042977|3894182|P1|Overall Study|Various|3
1186260|NCT01042977|3894181|P2|Overall Study|Administrative reason by sponsor|1
1186261|NCT01042977|3894182|P1|Overall Study|Administrative reason by sponsor|0
1186262|NCT01042977|3894181|P2|Overall Study|Safety|2
1186263|NCT01042977|3894182|P1|Overall Study|Safety|0
1186264|NCT01042977|3894181|P2|Overall Study|Incorrect enrollment|4
1186265|NCT01042977|3894182|P1|Overall Study|Incorrect enrollment|6
1186266|NCT01042977|3894181|P2|Overall Study|Subject no longer meets study criteria|13
1186267|NCT01042977|3894182|P1|Overall Study|Subject no longer meets study criteria|15
1186268|NCT01042977|3894181|P2|Overall Study|Poor/non-compliance|4
1186269|NCT01042977|3894182|P1|Overall Study|Poor/non-compliance|3
1186270|NCT01042977|3894181|P2|Overall Study|Lost to Follow-up|2
1186271|NCT01042977|3894182|P1|Overall Study|Lost to Follow-up|0
1186272|NCT01042977|3894181|P2|Overall Study|Withdrawal by Subject|16
1186273|NCT01042977|3894182|P1|Overall Study|Withdrawal by Subject|8
1186274|NCT01042977|3894181|P2|Overall Study|Death|1
1186275|NCT01042977|3894182|P1|Overall Study|Death|2
1186276|NCT01042977|3894181|P2|Overall Study|Adverse Event|12
1186277|NCT01042977|3894182|P1|Overall Study|Adverse Event|4
1186278|NCT01042938|3894202|P2|Overall Study|Ineligible: RTOG study conflict|0
1186279|NCT01042938|3894203|P1|Overall Study|Ineligible: RTOG study conflict|1
1186280|NCT01042938|3894202|P2|Overall Study|Protocol Violation|1
1186281|NCT01042938|3894203|P1|Overall Study|Protocol Violation|1
1186282|NCT01042938|3894202|P2|Overall Study|Withdrawal by Subject|1
1186283|NCT01042938|3894203|P1|Overall Study|Withdrawal by Subject|1
1186284|NCT01042678|3894222|P6|Overall Study|Physician Decision|0
1186285|NCT01042678|3894223|P5|Overall Study|Physician Decision|0
1186286|NCT01042678|3894224|P4|Overall Study|Physician Decision|0
1186287|NCT01042678|3894225|P3|Overall Study|Physician Decision|0
1186288|NCT01042678|3894226|P2|Overall Study|Physician Decision|0
1186289|NCT01042678|3894227|P1|Overall Study|Physician Decision|1
1186290|NCT01042600|3894265|P2|Overall Study|Ineligible|0
1186291|NCT01042600|3894266|P1|Overall Study|Ineligible|1
1186292|NCT01042535|3894274|P1|Overall Study|complications from other disease|2
1186293|NCT01042535|3894274|P1|Overall Study|disease progression during treatment|3
1186294|NCT01042535|3894274|P1|Overall Study|disease progression prior to treatment|3
1186295|NCT01042392|3894308|P4|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
1186296|NCT01042392|3894309|P3|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
1186297|NCT01042392|3894310|P2|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
1186298|NCT01042392|3894311|P1|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0
1186299|NCT01042392|3894308|P4|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
1186300|NCT01042392|3894309|P3|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2
1186301|NCT01042392|3894310|P2|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
1186302|NCT01042392|3894311|P1|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
1186303|NCT01042392|3894308|P4|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
1186304|NCT01042392|3894309|P3|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
1186305|NCT01042392|3894310|P2|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
1186306|NCT01042392|3894311|P1|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2
1186307|NCT01042392|3894308|P4|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
1186308|NCT01042392|3894309|P3|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1
1186309|NCT01042392|3894310|P2|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
1186310|NCT01042392|3894311|P1|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
1186311|NCT01042392|3894308|P4|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
1186312|NCT01042392|3894309|P3|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
1186313|NCT01042392|3894310|P2|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
1186314|NCT01042392|3894311|P1|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2
1186315|NCT01042392|3894308|P4|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
1186316|NCT01042392|3894309|P3|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1
1186317|NCT01042392|3894310|P2|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
1186318|NCT01042392|3894311|P1|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
1186319|NCT01042392|3894308|P4|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
1186320|NCT01042392|3894309|P3|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2
1186321|NCT01042392|3894310|P2|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
1186322|NCT01042392|3894311|P1|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1
1186323|NCT01042392|3894308|P4|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
1186324|NCT01042392|3894309|P3|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
1186325|NCT01042392|3894310|P2|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
1186326|NCT01042392|3894311|P1|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1
1186327|NCT01042392|3894308|P4|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
1186328|NCT01042392|3894309|P3|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5
1186329|NCT01042392|3894310|P2|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
1186330|NCT01042392|3894311|P1|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6
1186331|NCT01042236|3894359|P6|Treatment Period 3|Protocol Violation|0
1186332|NCT01042236|3894360|P5|Treatment Period 3|Protocol Violation|0
1186333|NCT01042236|3894361|P4|Treatment Period 3|Protocol Violation|1
1186334|NCT01042236|3894362|P3|Treatment Period 3|Protocol Violation|0
1186335|NCT01042236|3894363|P2|Treatment Period 3|Protocol Violation|0
1186336|NCT01042236|3894364|P1|Treatment Period 3|Protocol Violation|0
1186337|NCT01042236|3894359|P6|Treatment Period 3|Adverse Event|0
1186338|NCT01042236|3894360|P5|Treatment Period 3|Adverse Event|0
1186339|NCT01042236|3894361|P4|Treatment Period 3|Adverse Event|1
1186340|NCT01042236|3894362|P3|Treatment Period 3|Adverse Event|0
1186341|NCT01042236|3894363|P2|Treatment Period 3|Adverse Event|0
1186342|NCT01042236|3894364|P1|Treatment Period 3|Adverse Event|0
1186343|NCT01042236|3894359|P6|Treatment Period 1|Adverse Event|0
1186344|NCT01042236|3894360|P5|Treatment Period 1|Adverse Event|1
1186345|NCT01042236|3894361|P4|Treatment Period 1|Adverse Event|0
1186346|NCT01042236|3894362|P3|Treatment Period 1|Adverse Event|0
1186347|NCT01042236|3894363|P2|Treatment Period 1|Adverse Event|1
1186348|NCT01042236|3894364|P1|Treatment Period 1|Adverse Event|0
1186349|NCT01042158|3894401|P1|Overall Study|Physician Decision|1
1186350|NCT01042093|3894431|P4|Overall Study|Withdrawal by Subject|1
1186351|NCT01042093|3894432|P3|Overall Study|Withdrawal by Subject|0
1186352|NCT01042093|3894433|P2|Overall Study|Withdrawal by Subject|0
1186353|NCT01042093|3894434|P1|Overall Study|Withdrawal by Subject|0
1186354|NCT01042093|3894431|P4|Overall Study|Protocol Violation|3
1186355|NCT01042093|3894432|P3|Overall Study|Protocol Violation|2
1186356|NCT01042093|3894433|P2|Overall Study|Protocol Violation|2
1186357|NCT01042093|3894434|P1|Overall Study|Protocol Violation|2
1186358|NCT01041976|3894454|P2|Overall Study|Death|4
1186359|NCT01041976|3894455|P1|Overall Study|Death|0
1186360|NCT01041976|3894454|P2|Overall Study|Incarceration|0
1186361|NCT01041976|3894455|P1|Overall Study|Incarceration|2
1186362|NCT01041976|3894454|P2|Overall Study|Withdrawal by Subject|0
1186363|NCT01041976|3894455|P1|Overall Study|Withdrawal by Subject|3
1186364|NCT01041859|3894465|P3|Double-Blind Maintenance|Withdrawal by Subject|9
1186365|NCT01041859|3894466|P2|Double-Blind Maintenance|Withdrawal by Subject|8
1186366|NCT01041859|3894467|P1|Double-Blind Maintenance|Withdrawal by Subject|0
1186367|NCT01041859|3894465|P3|Double-Blind Maintenance|Noncompliance With Study Drug|6
1186368|NCT01041859|3894466|P2|Double-Blind Maintenance|Noncompliance With Study Drug|2
1186369|NCT01041859|3894467|P1|Double-Blind Maintenance|Noncompliance With Study Drug|0
1186370|NCT01041859|3894465|P3|Double-Blind Maintenance|Other|2
1186371|NCT01041859|3894466|P2|Double-Blind Maintenance|Other|6
1186372|NCT01041859|3894467|P1|Double-Blind Maintenance|Other|0
1186373|NCT01041859|3894465|P3|Double-Blind Maintenance|Protocol Violation|3
1186374|NCT01041859|3894466|P2|Double-Blind Maintenance|Protocol Violation|1
1186375|NCT01041859|3894467|P1|Double-Blind Maintenance|Protocol Violation|0
1186376|NCT01041859|3894465|P3|Double-Blind Maintenance|Physician Decision|1
1186377|NCT01041859|3894466|P2|Double-Blind Maintenance|Physician Decision|2
1186378|NCT01041859|3894467|P1|Double-Blind Maintenance|Physician Decision|0
1186379|NCT01041859|3894465|P3|Double-Blind Maintenance|Lost to Follow-up|0
1186380|NCT01041859|3894466|P2|Double-Blind Maintenance|Lost to Follow-up|1
1186381|NCT01041859|3894467|P1|Double-Blind Maintenance|Lost to Follow-up|0
1186382|NCT01041859|3894465|P3|Double-Blind Maintenance|Lack of Efficacy|11
1186383|NCT01041859|3894466|P2|Double-Blind Maintenance|Lack of Efficacy|3
1186384|NCT01041859|3894467|P1|Double-Blind Maintenance|Lack of Efficacy|0
1186385|NCT01041859|3894465|P3|Double-Blind Maintenance|Adverse Event|13
1186386|NCT01041859|3894466|P2|Double-Blind Maintenance|Adverse Event|23
1186387|NCT01041859|3894467|P1|Double-Blind Maintenance|Adverse Event|0
1186388|NCT01041859|3894465|P3|Open-Label Titration|Withdrawal by Subject|0
1186389|NCT01041859|3894466|P2|Open-Label Titration|Withdrawal by Subject|0
1186390|NCT01041859|3894467|P1|Open-Label Titration|Withdrawal by Subject|11
1186391|NCT01041859|3894465|P3|Open-Label Titration|Noncompliance With Study Drug|0
1186392|NCT01041859|3894466|P2|Open-Label Titration|Noncompliance With Study Drug|0
1186393|NCT01041859|3894467|P1|Open-Label Titration|Noncompliance With Study Drug|8
1186394|NCT01041859|3894465|P3|Open-Label Titration|Other|0
1186395|NCT01041859|3894466|P2|Open-Label Titration|Other|0
1186396|NCT01041859|3894467|P1|Open-Label Titration|Other|7
1186397|NCT01041859|3894465|P3|Open-Label Titration|Protocol Violation|0
1186398|NCT01041859|3894466|P2|Open-Label Titration|Protocol Violation|0
1186399|NCT01041859|3894467|P1|Open-Label Titration|Protocol Violation|1
1186400|NCT01041859|3894465|P3|Open-Label Titration|Physician Decision|0
1186401|NCT01041859|3894466|P2|Open-Label Titration|Physician Decision|0
1186402|NCT01041859|3894467|P1|Open-Label Titration|Physician Decision|1
1186403|NCT01041859|3894465|P3|Open-Label Titration|Lost to Follow-up|0
1186404|NCT01041859|3894466|P2|Open-Label Titration|Lost to Follow-up|0
1186405|NCT01041859|3894467|P1|Open-Label Titration|Lost to Follow-up|1
1186406|NCT01041859|3894465|P3|Open-Label Titration|Lack of Efficacy|0
1186407|NCT01041859|3894466|P2|Open-Label Titration|Lack of Efficacy|0
1186408|NCT01041859|3894467|P1|Open-Label Titration|Lack of Efficacy|3
1186409|NCT01041859|3894465|P3|Open-Label Titration|Adverse Event|0
1186410|NCT01041859|3894466|P2|Open-Label Titration|Adverse Event|0
1186411|NCT01041859|3894467|P1|Open-Label Titration|Adverse Event|69
1186412|NCT01041638|3894503|P1|Overall Study|Withdrawal by Subject|11
1186413|NCT01041638|3894503|P1|Overall Study|Physician Decision|4
1186414|NCT01041638|3894503|P1|Overall Study|Lack of Efficacy|7
1186415|NCT01041638|3894503|P1|Overall Study|Death|1
1186416|NCT01041638|3894503|P1|Overall Study|Adverse Event|4
1186417|NCT01041573|3894511|P4|Overall Study|positive to anti-HCV|0
1186418|NCT01041573|3894512|P3|Overall Study|positive to anti-HCV|0
1186419|NCT01041573|3894513|P2|Overall Study|positive to anti-HCV|0
1186420|NCT01041573|3894514|P1|Overall Study|positive to anti-HCV|1
1186421|NCT01041573|3894511|P4|Overall Study|further blood extraction|0
1186422|NCT01041573|3894512|P3|Overall Study|further blood extraction|0
1186423|NCT01041573|3894513|P2|Overall Study|further blood extraction|1
1186424|NCT01041573|3894514|P1|Overall Study|further blood extraction|0
1186425|NCT01041573|3894511|P4|Overall Study|relocation|1
1186426|NCT01041573|3894512|P3|Overall Study|relocation|3
1186427|NCT01041573|3894513|P2|Overall Study|relocation|4
1186428|NCT01041573|3894514|P1|Overall Study|relocation|1
1186429|NCT01041573|3894511|P4|Overall Study|Adverse Event|0
1186430|NCT01041573|3894512|P3|Overall Study|Adverse Event|0
1186431|NCT01041573|3894513|P2|Overall Study|Adverse Event|2
1186432|NCT01041573|3894514|P1|Overall Study|Adverse Event|0
1186433|NCT01041573|3894511|P4|Overall Study|Lost to Follow-up|1
1186434|NCT01041573|3894512|P3|Overall Study|Lost to Follow-up|2
1186435|NCT01041573|3894513|P2|Overall Study|Lost to Follow-up|1
1186436|NCT01041573|3894514|P1|Overall Study|Lost to Follow-up|0
1186437|NCT01041573|3894511|P4|Overall Study|Death|0
1186438|NCT01041573|3894512|P3|Overall Study|Death|0
1186439|NCT01041573|3894513|P2|Overall Study|Death|0
1186440|NCT01041573|3894514|P1|Overall Study|Death|1
1186441|NCT01041573|3894511|P4|Overall Study|Withdrawal by Subject|0
1186442|NCT01041573|3894512|P3|Overall Study|Withdrawal by Subject|2
1186443|NCT01041573|3894513|P2|Overall Study|Withdrawal by Subject|5
1186444|NCT01041573|3894514|P1|Overall Study|Withdrawal by Subject|2
1186445|NCT01041417|3894526|P2|Overall Study|Death|0
1186446|NCT01041417|3894527|P1|Overall Study|Death|1
1186447|NCT01041417|3894526|P2|Overall Study|Lost to Follow-up|1
1186448|NCT01041417|3894527|P1|Overall Study|Lost to Follow-up|1
1186449|NCT01041417|3894526|P2|Overall Study|Adverse Event|2
1186450|NCT01041417|3894527|P1|Overall Study|Adverse Event|5
1186451|NCT01041404|3894565|P2|Overall Study|Not Specified|23
1186452|NCT01041404|3894566|P1|Overall Study|Not Specified|11
1186453|NCT01041404|3894565|P2|Overall Study|Failure to Return|2
1186454|NCT01041404|3894566|P1|Overall Study|Failure to Return|1
1186455|NCT01041404|3894565|P2|Overall Study|Withdrawal by Subject|23
1186456|NCT01041404|3894566|P1|Overall Study|Withdrawal by Subject|29
1186457|NCT01041404|3894565|P2|Overall Study|Protocol Violation|0
1186458|NCT01041404|3894566|P1|Overall Study|Protocol Violation|4
1186459|NCT01041404|3894565|P2|Overall Study|Violation of Selection Criteria|1
1186460|NCT01041404|3894566|P1|Overall Study|Violation of Selection Criteria|0
1186461|NCT01041404|3894565|P2|Overall Study|Lack of Efficacy|210
1186462|NCT01041404|3894566|P1|Overall Study|Lack of Efficacy|200
1186463|NCT01041404|3894565|P2|Overall Study|Adverse Event|35
1186464|NCT01041404|3894566|P1|Overall Study|Adverse Event|45
1186465|NCT01041287|3894607|P2|Treatment Period 2 (3 Months)|Adverse Event|2
1186466|NCT01041287|3894608|P1|Treatment Period 2 (3 Months)|Adverse Event|0
1186467|NCT01041287|3894607|P2|Treatment Period 2 (3 Months)|Lost to Follow-up|3
1186468|NCT01041287|3894608|P1|Treatment Period 2 (3 Months)|Lost to Follow-up|3
1186469|NCT01040871|3894646|P2|Overall Study|Randomized and Not Treated|1
1186470|NCT01040871|3894647|P1|Overall Study|Randomized and Not Treated|2
1186471|NCT01040871|3894646|P2|Overall Study|drug supply issue|0
1186472|NCT01040871|3894647|P1|Overall Study|drug supply issue|1
1186473|NCT01040871|3894646|P2|Overall Study|Lack of Efficacy|1
1186474|NCT01040871|3894647|P1|Overall Study|Lack of Efficacy|1
1186475|NCT01040871|3894646|P2|Overall Study|Death|3
1186476|NCT01040871|3894647|P1|Overall Study|Death|1
1186477|NCT01040871|3894646|P2|Overall Study|Withdrawal by Subject|0
1186478|NCT01040871|3894647|P1|Overall Study|Withdrawal by Subject|2
1186479|NCT01040871|3894646|P2|Overall Study|Adverse Event|2
1186480|NCT01040871|3894647|P1|Overall Study|Adverse Event|6
1186481|NCT01040845|3894698|P2|Overall Study|Physician Decision|0
1186482|NCT01040845|3894699|P1|Overall Study|Physician Decision|1
1186483|NCT01040845|3894698|P2|Overall Study|Withdrawal by Subject|1
1186484|NCT01040845|3894699|P1|Overall Study|Withdrawal by Subject|1
1186485|NCT01040832|3894714|P2|Overall Study|Other|1
1186486|NCT01040832|3894715|P1|Overall Study|Other|2
1186487|NCT01040832|3894714|P2|Overall Study|Symptomatic deterioration|5
1186488|NCT01040832|3894715|P1|Overall Study|Symptomatic deterioration|2
1186489|NCT01040832|3894714|P2|Overall Study|Progressive disease|17
1186490|NCT01040832|3894715|P1|Overall Study|Progressive disease|32
1186491|NCT01040832|3894714|P2|Overall Study|Withdrawal by Subject|3
1186492|NCT01040832|3894715|P1|Overall Study|Withdrawal by Subject|2
1186493|NCT01040832|3894714|P2|Overall Study|Death|6
1186494|NCT01040832|3894715|P1|Overall Study|Death|4
1186495|NCT01040832|3894714|P2|Overall Study|Adverse Event|5
1186496|NCT01040832|3894715|P1|Overall Study|Adverse Event|4
1186497|NCT01040793|3894738|P6|Overall Study|Other reasons not listed above|0
1186498|NCT01040793|3894739|P5|Overall Study|Other reasons not listed above|1
1186499|NCT01040793|3894740|P4|Overall Study|Other reasons not listed above|0
1186500|NCT01040793|3894741|P3|Overall Study|Other reasons not listed above|1
1186501|NCT01040793|3894742|P2|Overall Study|Other reasons not listed above|0
1186502|NCT01040793|3894743|P1|Overall Study|Other reasons not listed above|0
1186503|NCT01040793|3894738|P6|Overall Study|Withdrawal by Subject|0
1186504|NCT01040793|3894739|P5|Overall Study|Withdrawal by Subject|0
1186505|NCT01040793|3894740|P4|Overall Study|Withdrawal by Subject|2
1186506|NCT01040793|3894741|P3|Overall Study|Withdrawal by Subject|0
1186507|NCT01040793|3894742|P2|Overall Study|Withdrawal by Subject|0
1186508|NCT01040793|3894743|P1|Overall Study|Withdrawal by Subject|0
1186509|NCT01040793|3894738|P6|Overall Study|Lost to Follow-up|0
1186510|NCT01040793|3894739|P5|Overall Study|Lost to Follow-up|0
1186511|NCT01040793|3894740|P4|Overall Study|Lost to Follow-up|0
1186512|NCT01040793|3894741|P3|Overall Study|Lost to Follow-up|1
1186513|NCT01040793|3894742|P2|Overall Study|Lost to Follow-up|1
1186514|NCT01040793|3894743|P1|Overall Study|Lost to Follow-up|0
1186515|NCT01040793|3894738|P6|Overall Study|Protocol Violation|0
1186516|NCT01040793|3894739|P5|Overall Study|Protocol Violation|1
1186517|NCT01040793|3894740|P4|Overall Study|Protocol Violation|0
1186518|NCT01040793|3894741|P3|Overall Study|Protocol Violation|1
1186519|NCT01040793|3894742|P2|Overall Study|Protocol Violation|1
1186520|NCT01040793|3894743|P1|Overall Study|Protocol Violation|1
1186521|NCT01040793|3894738|P6|Overall Study|Adverse Event|1
1186522|NCT01040793|3894739|P5|Overall Study|Adverse Event|2
1186523|NCT01040793|3894740|P4|Overall Study|Adverse Event|2
1186524|NCT01040793|3894741|P3|Overall Study|Adverse Event|0
1186525|NCT01040793|3894742|P2|Overall Study|Adverse Event|3
1186526|NCT01040793|3894743|P1|Overall Study|Adverse Event|5
1186527|NCT01040780|3894822|P2|Overall Study|Protocol Violation|3
1186528|NCT01040780|3894823|P1|Overall Study|Protocol Violation|1
1186529|NCT01040728|3894837|P4|Overall Study|Other reasons not listed above|0
1186530|NCT01040728|3894838|P3|Overall Study|Other reasons not listed above|0
1186531|NCT01040728|3894839|P2|Overall Study|Other reasons not listed above|1
1186532|NCT01040728|3894840|P1|Overall Study|Other reasons not listed above|0
1186533|NCT01040728|3894837|P4|Overall Study|Lack of Efficacy|1
1186534|NCT01040728|3894838|P3|Overall Study|Lack of Efficacy|0
1186535|NCT01040728|3894839|P2|Overall Study|Lack of Efficacy|1
1186536|NCT01040728|3894840|P1|Overall Study|Lack of Efficacy|0
1186537|NCT01040728|3894837|P4|Overall Study|Protocol Violation|1
1186538|NCT01040728|3894838|P3|Overall Study|Protocol Violation|0
1186539|NCT01040728|3894839|P2|Overall Study|Protocol Violation|0
1186540|NCT01040728|3894840|P1|Overall Study|Protocol Violation|0
1186541|NCT01040728|3894837|P4|Overall Study|Withdrawal by Subject|0
1186542|NCT01040728|3894838|P3|Overall Study|Withdrawal by Subject|1
1186543|NCT01040728|3894839|P2|Overall Study|Withdrawal by Subject|1
1186544|NCT01040728|3894840|P1|Overall Study|Withdrawal by Subject|0
1186545|NCT01040728|3894837|P4|Overall Study|Adverse Event|4
1186546|NCT01040728|3894838|P3|Overall Study|Adverse Event|0
1186547|NCT01040728|3894839|P2|Overall Study|Adverse Event|8
1186548|NCT01040728|3894840|P1|Overall Study|Adverse Event|4
1186549|NCT01040689|3894910|P4|Overall Study|Other reasons not listed above|0
1186550|NCT01040689|3894911|P3|Overall Study|Other reasons not listed above|0
1186551|NCT01040689|3894912|P2|Overall Study|Other reasons not listed above|1
1186552|NCT01040689|3894913|P1|Overall Study|Other reasons not listed above|0
1186553|NCT01040689|3894910|P4|Overall Study|Withdrawal by Subject|0
1186554|NCT01040689|3894911|P3|Overall Study|Withdrawal by Subject|1
1186555|NCT01040689|3894912|P2|Overall Study|Withdrawal by Subject|1
1186556|NCT01040689|3894913|P1|Overall Study|Withdrawal by Subject|2
1186557|NCT01040689|3894910|P4|Overall Study|Lost to Follow-up|0
1186558|NCT01040689|3894911|P3|Overall Study|Lost to Follow-up|0
1186559|NCT01040689|3894912|P2|Overall Study|Lost to Follow-up|0
1186560|NCT01040689|3894913|P1|Overall Study|Lost to Follow-up|1
1186561|NCT01040689|3894910|P4|Overall Study|Lack of Efficacy|0
1186562|NCT01040689|3894911|P3|Overall Study|Lack of Efficacy|1
1186563|NCT01040689|3894912|P2|Overall Study|Lack of Efficacy|0
1186564|NCT01040689|3894913|P1|Overall Study|Lack of Efficacy|0
1186565|NCT01040689|3894910|P4|Overall Study|Adverse Event|4
1186566|NCT01040689|3894911|P3|Overall Study|Adverse Event|2
1186567|NCT01040689|3894912|P2|Overall Study|Adverse Event|0
1186568|NCT01040689|3894913|P1|Overall Study|Adverse Event|0
1186569|NCT01040403|3894992|P1|Overall Study|Other reason not defined above|6
1186570|NCT01040403|3894992|P1|Overall Study|Not treated|1
1186571|NCT01040403|3894992|P1|Overall Study|Lost to Follow-up|1
1186572|NCT01040403|3894992|P1|Overall Study|Protocol Violation|2
1186573|NCT01040403|3894992|P1|Overall Study|Adverse Event|10
1186574|NCT01040351|3895180|P2|Overall Study|poor ovarian response|2
1186575|NCT01040351|3895181|P1|Overall Study|poor ovarian response|1
1186576|NCT01040260|3895191|P2|Overall Study|Lost to Follow-up|5
1186577|NCT01040260|3895192|P1|Overall Study|Lost to Follow-up|3
1186578|NCT01040260|3895191|P2|Overall Study|Withdrawal by Subject|6
1186579|NCT01040260|3895192|P1|Overall Study|Withdrawal by Subject|12
1186580|NCT01040169|3895219|P2|Overall Study|Lost to Follow-up|8
1186581|NCT01040169|3895220|P1|Overall Study|Lost to Follow-up|3
1186582|NCT01040130|3895228|P6|Overall Study|Other reasons not listed above|0
1186583|NCT01040130|3895229|P5|Overall Study|Other reasons not listed above|0
1186584|NCT01040130|3895230|P4|Overall Study|Other reasons not listed above|0
1186585|NCT01040130|3895231|P3|Overall Study|Other reasons not listed above|0
1186586|NCT01040130|3895232|P2|Overall Study|Other reasons not listed above|0
1186587|NCT01040130|3895233|P1|Overall Study|Other reasons not listed above|2
1186588|NCT01040130|3895228|P6|Overall Study|Withdrawal by Subject|1
1186589|NCT01040130|3895229|P5|Overall Study|Withdrawal by Subject|0
1186590|NCT01040130|3895230|P4|Overall Study|Withdrawal by Subject|0
1186591|NCT01040130|3895231|P3|Overall Study|Withdrawal by Subject|0
1186592|NCT01040130|3895232|P2|Overall Study|Withdrawal by Subject|2
1186593|NCT01040130|3895233|P1|Overall Study|Withdrawal by Subject|0
1186594|NCT01040130|3895228|P6|Overall Study|Protocol Violation|0
1186595|NCT01040130|3895229|P5|Overall Study|Protocol Violation|0
1186596|NCT01040130|3895230|P4|Overall Study|Protocol Violation|0
1186597|NCT01040130|3895231|P3|Overall Study|Protocol Violation|2
1186598|NCT01040130|3895232|P2|Overall Study|Protocol Violation|0
1186599|NCT01040130|3895233|P1|Overall Study|Protocol Violation|0
1186600|NCT01040130|3895228|P6|Overall Study|Adverse Event|3
1186601|NCT01040130|3895229|P5|Overall Study|Adverse Event|0
1186602|NCT01040130|3895230|P4|Overall Study|Adverse Event|5
1186603|NCT01040130|3895231|P3|Overall Study|Adverse Event|0
1186604|NCT01040130|3895232|P2|Overall Study|Adverse Event|1
1186605|NCT01040130|3895233|P1|Overall Study|Adverse Event|1
1186606|NCT01039688|3895326|P3|Overall Study|Death|0
1186607|NCT01039688|3895327|P2|Overall Study|Death|0
1186608|NCT01039688|3895328|P1|Overall Study|Death|2
1186609|NCT01039688|3895326|P3|Overall Study|Withdrawal by Subject|13
1186610|NCT01039688|3895327|P2|Overall Study|Withdrawal by Subject|27
1186611|NCT01039688|3895328|P1|Overall Study|Withdrawal by Subject|23
1186612|NCT01039688|3895326|P3|Overall Study|Not specified|12
1186613|NCT01039688|3895327|P2|Overall Study|Not specified|25
1186614|NCT01039688|3895328|P1|Overall Study|Not specified|13
1186615|NCT01039688|3895326|P3|Overall Study|Lost to Follow-up|5
1186616|NCT01039688|3895327|P2|Overall Study|Lost to Follow-up|9
1186617|NCT01039688|3895328|P1|Overall Study|Lost to Follow-up|11
1186618|NCT01039688|3895326|P3|Overall Study|Lack of Efficacy|26
1186619|NCT01039688|3895327|P2|Overall Study|Lack of Efficacy|11
1186620|NCT01039688|3895328|P1|Overall Study|Lack of Efficacy|20
1186621|NCT01039688|3895326|P3|Overall Study|Adverse Event|24
1186622|NCT01039688|3895327|P2|Overall Study|Adverse Event|39
1186623|NCT01039688|3895328|P1|Overall Study|Adverse Event|38
1186624|NCT01039675|3895599|P2|Overall Study|Physician Decision|1
1186625|NCT01039675|3895600|P1|Overall Study|Physician Decision|0
1186626|NCT01039675|3895599|P2|Overall Study|Lost to Follow-up|1
1186627|NCT01039675|3895600|P1|Overall Study|Lost to Follow-up|0
1186628|NCT01039675|3895599|P2|Overall Study|Withdrawal by Subject|1
1186629|NCT01039675|3895600|P1|Overall Study|Withdrawal by Subject|0
1186630|NCT01039675|3895599|P2|Overall Study|Lack of Efficacy|2
1186631|NCT01039675|3895600|P1|Overall Study|Lack of Efficacy|0
1186632|NCT01039675|3895599|P2|Overall Study|Adverse Event|2
1186633|NCT01039675|3895600|P1|Overall Study|Adverse Event|0
1186634|NCT01039584|3895613|P3|Overall Study|Positive for Chlamydia or gonorrhea|8
1186635|NCT01039584|3895614|P2|Overall Study|Positive for Chlamydia or gonorrhea|10
1186636|NCT01039584|3895615|P1|Overall Study|Positive for Chlamydia or gonorrhea|7
1186637|NCT01039584|3895613|P3|Overall Study|Pap smear with significant pathology|3
1186638|NCT01039584|3895614|P2|Overall Study|Pap smear with significant pathology|10
1186639|NCT01039584|3895615|P1|Overall Study|Pap smear with significant pathology|10
1186640|NCT01039584|3895613|P3|Overall Study|other|1
1186641|NCT01039584|3895614|P2|Overall Study|other|3
1186642|NCT01039584|3895615|P1|Overall Study|other|1
1186643|NCT01039584|3895613|P3|Overall Study|Lack of Efficacy|10
1186644|NCT01039584|3895614|P2|Overall Study|Lack of Efficacy|6
1186645|NCT01039584|3895615|P1|Overall Study|Lack of Efficacy|7
1186646|NCT01039584|3895613|P3|Overall Study|Negative Baseline culture for Candida|24
1186647|NCT01039584|3895614|P2|Overall Study|Negative Baseline culture for Candida|59
1186648|NCT01039584|3895615|P1|Overall Study|Negative Baseline culture for Candida|59
1186649|NCT01039584|3895613|P3|Overall Study|Lost to Follow-up|4
1186650|NCT01039584|3895614|P2|Overall Study|Lost to Follow-up|3
1186651|NCT01039584|3895615|P1|Overall Study|Lost to Follow-up|5
1186652|NCT01039584|3895613|P3|Overall Study|Protocol Violation|6
1186653|NCT01039584|3895614|P2|Overall Study|Protocol Violation|4
1186654|NCT01039584|3895615|P1|Overall Study|Protocol Violation|10
1186655|NCT01039584|3895613|P3|Overall Study|Withdrawal by Subject|1
1186656|NCT01039584|3895614|P2|Overall Study|Withdrawal by Subject|2
1186657|NCT01039584|3895615|P1|Overall Study|Withdrawal by Subject|4
1186658|NCT01039519|3895629|P1|Survival Follow-up|Sponsor decision|4
1186659|NCT01039519|3895629|P1|Survival Follow-up|Death|23
1186660|NCT01039519|3895629|P1|Treatment|Physician Decision|2
1186661|NCT01039519|3895629|P1|Treatment|Adverse Event|3
1186662|NCT01039519|3895629|P1|Treatment|Treatment failure|2
1186663|NCT01039519|3895629|P1|Treatment|Progressive disease|20
1186664|NCT01039428|3895640|P2|Overall Study|Withdrawal by Subject|0
1186665|NCT01039428|3895641|P1|Overall Study|Withdrawal by Subject|1
1186666|NCT01039428|3895640|P2|Overall Study|Protocol Violation|0
1186667|NCT01039428|3895641|P1|Overall Study|Protocol Violation|1
1186668|NCT01039376|3895665|P2|Overall Study|Ongoing|182
1186669|NCT01039376|3895666|P1|Overall Study|Ongoing|189
1186670|NCT01039376|3895665|P2|Overall Study|Withdrawal by Subject|17
1186671|NCT01039376|3895666|P1|Overall Study|Withdrawal by Subject|11
1186672|NCT01039376|3895665|P2|Overall Study|Physician Decision|2
1186673|NCT01039376|3895666|P1|Overall Study|Physician Decision|4
1186674|NCT01039376|3895665|P2|Overall Study|Lost to Follow-up|1
1186675|NCT01039376|3895666|P1|Overall Study|Lost to Follow-up|2
1186676|NCT01038921|3895734|P2|Overall Study|Physician Decision|0
1186677|NCT01038921|3895735|P1|Overall Study|Physician Decision|1
1186678|NCT01038921|3895734|P2|Overall Study|Withdrawal by Subject|0
1186679|NCT01038921|3895735|P1|Overall Study|Withdrawal by Subject|1
1186680|NCT01038869|3895741|P1|Overall Study|Lost to Follow-up|6
1186681|NCT01038869|3895741|P1|Overall Study|Withdrawal by Subject|1
1186682|NCT01038856|3895749|P1|Overall Study|Adverse Event|2
1186683|NCT01038752|3895758|P2|Overall Study|Lost to Follow-up|3
1186684|NCT01038752|3895759|P1|Overall Study|Lost to Follow-up|3
1186685|NCT01038752|3895758|P2|Overall Study|Tumor Progression|2
1186686|NCT01038752|3895759|P1|Overall Study|Tumor Progression|2
1186687|NCT01038713|3895782|P3|Overall Study|Autoimmune Pancreatitis|0
1186688|NCT01038713|3895783|P2|Overall Study|Autoimmune Pancreatitis|0
1186689|NCT01038713|3895784|P1|Overall Study|Autoimmune Pancreatitis|1
1186690|NCT01038713|3895782|P3|Overall Study|died from PEP|0
1186691|NCT01038713|3895783|P2|Overall Study|died from PEP|1
1186692|NCT01038713|3895784|P1|Overall Study|died from PEP|0
1186693|NCT01038713|3895782|P3|Overall Study|Neuroendocrine Tumor|0
1186694|NCT01038713|3895783|P2|Overall Study|Neuroendocrine Tumor|1
1186695|NCT01038713|3895784|P1|Overall Study|Neuroendocrine Tumor|0
1186696|NCT01038713|3895782|P3|Overall Study|Lost to Follow-up|0
1186697|NCT01038713|3895783|P2|Overall Study|Lost to Follow-up|0
1186698|NCT01038713|3895784|P1|Overall Study|Lost to Follow-up|3
1186699|NCT01038713|3895782|P3|Overall Study|Patient to hospice|1
1186700|NCT01038713|3895783|P2|Overall Study|Patient to hospice|1
1186701|NCT01038713|3895784|P1|Overall Study|Patient to hospice|1
1186702|NCT01038635|3895813|P9|Overall Study|Death|2
1186703|NCT01038635|3895814|P8|Overall Study|Death|1
1186704|NCT01038635|3895815|P7|Overall Study|Death|1
1186705|NCT01038635|3895816|P6|Overall Study|Death|0
1186706|NCT01038635|3895817|P5|Overall Study|Death|1
1186707|NCT01038635|3895818|P4|Overall Study|Death|0
1186708|NCT01038635|3895819|P3|Overall Study|Death|0
1186709|NCT01038635|3895820|P2|Overall Study|Death|0
1186710|NCT01038635|3895821|P1|Overall Study|Death|0
1186711|NCT01038635|3895813|P9|Overall Study|Disease Progression|0
1186712|NCT01038635|3895814|P8|Overall Study|Disease Progression|4
1186713|NCT01038635|3895815|P7|Overall Study|Disease Progression|1
1186714|NCT01038635|3895816|P6|Overall Study|Disease Progression|0
1186715|NCT01038635|3895817|P5|Overall Study|Disease Progression|0
1186716|NCT01038635|3895818|P4|Overall Study|Disease Progression|0
1186717|NCT01038635|3895819|P3|Overall Study|Disease Progression|0
1186718|NCT01038635|3895820|P2|Overall Study|Disease Progression|0
1186719|NCT01038635|3895821|P1|Overall Study|Disease Progression|2
1186720|NCT01038609|3895847|P5|Overall Study|Refusal of Blood Draws|0
1186721|NCT01038609|3895848|P4|Overall Study|Refusal of Blood Draws|0
1186722|NCT01038609|3895849|P3|Overall Study|Refusal of Blood Draws|0
1186723|NCT01038609|3895850|P2|Overall Study|Refusal of Blood Draws|1
1186724|NCT01038609|3895851|P1|Overall Study|Refusal of Blood Draws|0
1186725|NCT01038609|3895847|P5|Overall Study|Death in the Family|0
1186726|NCT01038609|3895848|P4|Overall Study|Death in the Family|0
1186727|NCT01038609|3895849|P3|Overall Study|Death in the Family|0
1186728|NCT01038609|3895850|P2|Overall Study|Death in the Family|0
1186729|NCT01038609|3895851|P1|Overall Study|Death in the Family|1
1186730|NCT01038609|3895847|P5|Overall Study|Dosing Error|1
1186731|NCT01038609|3895848|P4|Overall Study|Dosing Error|1
1186732|NCT01038609|3895849|P3|Overall Study|Dosing Error|0
1186733|NCT01038609|3895850|P2|Overall Study|Dosing Error|0
1186734|NCT01038609|3895851|P1|Overall Study|Dosing Error|0
1186735|NCT01038609|3895847|P5|Overall Study|Adverse Event|0
1186736|NCT01038609|3895848|P4|Overall Study|Adverse Event|0
1186737|NCT01038609|3895849|P3|Overall Study|Adverse Event|1
1186738|NCT01038609|3895850|P2|Overall Study|Adverse Event|0
1186739|NCT01038609|3895851|P1|Overall Study|Adverse Event|0
1186740|NCT01038323|3895930|P3|Overall Study|Withdrawal by Subject|4
1186741|NCT01038323|3895931|P2|Overall Study|Withdrawal by Subject|2
1186742|NCT01038323|3895932|P1|Overall Study|Withdrawal by Subject|3
1186743|NCT01038128|3895946|P1|Overall Study|Withdrawal by Subject|2
1186744|NCT01038128|3895946|P1|Overall Study|Lost to Follow-up|1
1186745|NCT01038128|3895946|P1|Overall Study|Lack of Efficacy|1
1186746|NCT01037244|3896039|P4|Overall Study|Various|1
1186747|NCT01037244|3896040|P3|Overall Study|Various|1
1186748|NCT01037244|3896041|P2|Overall Study|Various|2
1186749|NCT01037244|3896042|P1|Overall Study|Various|3
1186750|NCT01037244|3896039|P4|Overall Study|Partner Withdrew Consent|0
1186751|NCT01037244|3896040|P3|Overall Study|Partner Withdrew Consent|0
1186752|NCT01037244|3896041|P2|Overall Study|Partner Withdrew Consent|1
1186753|NCT01037244|3896042|P1|Overall Study|Partner Withdrew Consent|2
1186754|NCT01037244|3896039|P4|Overall Study|Withdrawal by Subject|5
1186755|NCT01037244|3896040|P3|Overall Study|Withdrawal by Subject|3
1186756|NCT01037244|3896041|P2|Overall Study|Withdrawal by Subject|5
1186757|NCT01037244|3896042|P1|Overall Study|Withdrawal by Subject|1
1186758|NCT01037244|3896039|P4|Overall Study|Lost to Follow-up|4
1186759|NCT01037244|3896040|P3|Overall Study|Lost to Follow-up|4
1186760|NCT01037244|3896041|P2|Overall Study|Lost to Follow-up|3
1186761|NCT01037244|3896042|P1|Overall Study|Lost to Follow-up|3
1186762|NCT01037244|3896039|P4|Overall Study|Lack of Efficacy|1
1186763|NCT01037244|3896040|P3|Overall Study|Lack of Efficacy|0
1186764|NCT01037244|3896041|P2|Overall Study|Lack of Efficacy|1
1186765|NCT01037244|3896042|P1|Overall Study|Lack of Efficacy|1
1186766|NCT01037244|3896039|P4|Overall Study|Adverse Event|3
1186767|NCT01037244|3896040|P3|Overall Study|Adverse Event|6
1186768|NCT01037244|3896041|P2|Overall Study|Adverse Event|2
1186769|NCT01037244|3896042|P1|Overall Study|Adverse Event|3
1186770|NCT01037218|3896104|P4|Overall Study|Various|1
1186771|NCT01037218|3896105|P3|Overall Study|Various|3
1186772|NCT01037218|3896106|P2|Overall Study|Various|2
1186773|NCT01037218|3896107|P1|Overall Study|Various|3
1186774|NCT01037218|3896104|P4|Overall Study|Protocol Violation|2
1186775|NCT01037218|3896105|P3|Overall Study|Protocol Violation|2
1186776|NCT01037218|3896106|P2|Overall Study|Protocol Violation|0
1186777|NCT01037218|3896107|P1|Overall Study|Protocol Violation|0
1186778|NCT01037218|3896104|P4|Overall Study|Partner Withdrew Consent|1
1186779|NCT01037218|3896105|P3|Overall Study|Partner Withdrew Consent|2
1186780|NCT01037218|3896106|P2|Overall Study|Partner Withdrew Consent|3
1186781|NCT01037218|3896107|P1|Overall Study|Partner Withdrew Consent|0
1186782|NCT01037218|3896104|P4|Overall Study|Withdrawal by Subject|4
1186783|NCT01037218|3896105|P3|Overall Study|Withdrawal by Subject|7
1186784|NCT01037218|3896106|P2|Overall Study|Withdrawal by Subject|7
1186785|NCT01037218|3896107|P1|Overall Study|Withdrawal by Subject|6
1186786|NCT01037218|3896104|P4|Overall Study|Lost to Follow-up|2
1186787|NCT01037218|3896105|P3|Overall Study|Lost to Follow-up|4
1186788|NCT01037218|3896106|P2|Overall Study|Lost to Follow-up|5
1186789|NCT01037218|3896107|P1|Overall Study|Lost to Follow-up|3
1186790|NCT01037218|3896104|P4|Overall Study|Lack of Efficacy|5
1186791|NCT01037218|3896105|P3|Overall Study|Lack of Efficacy|1
1186792|NCT01037218|3896106|P2|Overall Study|Lack of Efficacy|2
1186793|NCT01037218|3896107|P1|Overall Study|Lack of Efficacy|0
1186794|NCT01037218|3896104|P4|Overall Study|Adverse Event|1
1186795|NCT01037218|3896105|P3|Overall Study|Adverse Event|2
1186796|NCT01037218|3896106|P2|Overall Study|Adverse Event|2
1186797|NCT01037218|3896107|P1|Overall Study|Adverse Event|4
1186798|NCT01037127|3896178|P2|Overall Study|Study Closed Terminated|17
1186799|NCT01037127|3896179|P1|Overall Study|Study Closed Terminated|2
1186800|NCT01037127|3896178|P2|Overall Study|Physician Decision|0
1186801|NCT01037127|3896179|P1|Overall Study|Physician Decision|1
1186802|NCT01037127|3896178|P2|Overall Study|Lost to Follow-up|4
1186803|NCT01037127|3896179|P1|Overall Study|Lost to Follow-up|2
1186804|NCT01037114|3896211|P1|Year 20|Others|1
1186805|NCT01037088|3896224|P1|Overall Study|Withdrawal by Subject|3
1186806|NCT01036763|3896256|P1|Overall Study|Other reason (not specified)|40
1186807|NCT01036763|3896256|P1|Overall Study|Lost to Follow-up|28
1186808|NCT01036763|3896256|P1|Overall Study|Adverse Event|25
1186809|NCT01036724|3896268|P2|Overall Study|Protocol Violation|5
1186810|NCT01036724|3896269|P1|Overall Study|Protocol Violation|4
1186811|NCT01036724|3896268|P2|Overall Study|Lack of Efficacy|1
1186812|NCT01036724|3896269|P1|Overall Study|Lack of Efficacy|1
1186813|NCT01036724|3896268|P2|Overall Study|Adverse Event|2
1186814|NCT01036724|3896269|P1|Overall Study|Adverse Event|1
1186815|NCT01036529|3896279|P2|Overall Study|Sponsor study termination|12
1186816|NCT01036529|3896280|P1|Overall Study|Sponsor study termination|11
1186817|NCT01036529|3896279|P2|Overall Study|Withdrawal by Subject|1
1186818|NCT01036529|3896280|P1|Overall Study|Withdrawal by Subject|1
1186819|NCT01036529|3896279|P2|Overall Study|Physician Decision|0
1186820|NCT01036529|3896280|P1|Overall Study|Physician Decision|1
1186821|NCT01036529|3896279|P2|Overall Study|Lost to Follow-up|1
1186822|NCT01036529|3896280|P1|Overall Study|Lost to Follow-up|0
1186823|NCT01036529|3896279|P2|Overall Study|Adverse Event|1
1186824|NCT01036529|3896280|P1|Overall Study|Adverse Event|0
1186825|NCT01036438|3896307|P2|Overall Study|No effect of study treatment|1
1186826|NCT01036438|3896308|P1|Overall Study|No effect of study treatment|3
1186827|NCT01036438|3896307|P2|Overall Study|Death|1
1186828|NCT01036438|3896308|P1|Overall Study|Death|0
1186829|NCT01036438|3896307|P2|Overall Study|Adverse Event|8
1186830|NCT01036438|3896308|P1|Overall Study|Adverse Event|7
1186831|NCT01036321|3896316|P2|Overall Study|Adverse Event|1
1186832|NCT01036321|3896317|P1|Overall Study|Adverse Event|2
1186833|NCT01036321|3896316|P2|Overall Study|Withdrawal by Subject|2
1186834|NCT01036321|3896317|P1|Overall Study|Withdrawal by Subject|3
1186835|NCT01036321|3896316|P2|Overall Study|Ineligible after randomization|1
1186836|NCT01036321|3896317|P1|Overall Study|Ineligible after randomization|0
1186837|NCT01036165|3896341|P1|Overall Study|Problems finding proper area to inject|1
1186838|NCT01036165|3896341|P1|Overall Study|Device Related Issues|3
1186839|NCT01036165|3896341|P1|Overall Study|Withdrawal by Subject|3
1186840|NCT01036165|3896341|P1|Overall Study|Lost to Follow-up|2
1186841|NCT01036165|3896341|P1|Overall Study|Adverse Event|6
1186842|NCT01036022|3896352|P6|Overall Study|Withdrawal by Subject|0
1186843|NCT01036022|3896353|P5|Overall Study|Withdrawal by Subject|2
1186844|NCT01036022|3896354|P4|Overall Study|Withdrawal by Subject|1
1186845|NCT01036022|3896355|P3|Overall Study|Withdrawal by Subject|0
1186846|NCT01036022|3896356|P2|Overall Study|Withdrawal by Subject|0
1186847|NCT01036022|3896357|P1|Overall Study|Withdrawal by Subject|0
1186848|NCT01036022|3896352|P6|Overall Study|Physician Decision|0
1186849|NCT01036022|3896353|P5|Overall Study|Physician Decision|0
1186850|NCT01036022|3896354|P4|Overall Study|Physician Decision|0
1186851|NCT01036022|3896355|P3|Overall Study|Physician Decision|1
1186852|NCT01036022|3896356|P2|Overall Study|Physician Decision|0
1186853|NCT01036022|3896357|P1|Overall Study|Physician Decision|0
1186854|NCT01036022|3896352|P6|Overall Study|Lack of Efficacy|1
1186855|NCT01036022|3896353|P5|Overall Study|Lack of Efficacy|1
1186856|NCT01036022|3896354|P4|Overall Study|Lack of Efficacy|0
1186857|NCT01036022|3896355|P3|Overall Study|Lack of Efficacy|1
1186858|NCT01036022|3896356|P2|Overall Study|Lack of Efficacy|1
1186859|NCT01036022|3896357|P1|Overall Study|Lack of Efficacy|1
1186860|NCT01036022|3896352|P6|Overall Study|Adverse Event|2
1186861|NCT01036022|3896353|P5|Overall Study|Adverse Event|0
1186862|NCT01036022|3896354|P4|Overall Study|Adverse Event|1
1186863|NCT01036022|3896355|P3|Overall Study|Adverse Event|2
1186864|NCT01036022|3896356|P2|Overall Study|Adverse Event|3
1186865|NCT01036022|3896357|P1|Overall Study|Adverse Event|1
1186866|NCT01035905|3896493|P2|Overall Study|Lack of Efficacy|1
1186867|NCT01035905|3896494|P1|Overall Study|Lack of Efficacy|1
1186868|NCT01035606|3896667|P3|Overall Study|change in health, job demands,family|4
1186869|NCT01035606|3896668|P2|Overall Study|change in health, job demands,family|3
1186870|NCT01035606|3896669|P1|Overall Study|change in health, job demands,family|3
1186871|NCT01035255|3896711|P2|Overall Study|patient's request|13
1186872|NCT01035255|3896712|P1|Overall Study|patient's request|15
1186873|NCT01035255|3896711|P2|Overall Study|Lost to Follow-up|5
1186874|NCT01035255|3896712|P1|Overall Study|Lost to Follow-up|2
1186875|NCT01035255|3896711|P2|Overall Study|Death|844
1186876|NCT01035255|3896712|P1|Overall Study|Death|724
1186877|NCT01035229|3896730|P2|Overall Study|Disease Progression|152
1186878|NCT01035229|3896731|P1|Overall Study|Disease Progression|261
1186879|NCT01035229|3896730|P2|Overall Study|Sponsor's decision to end study|3
1186880|NCT01035229|3896731|P1|Overall Study|Sponsor's decision to end study|3
1186881|NCT01035229|3896730|P2|Overall Study|Protocol Violation|2
1186882|NCT01035229|3896731|P1|Overall Study|Protocol Violation|0
1186883|NCT01035229|3896730|P2|Overall Study|New cancer therapy|0
1186884|NCT01035229|3896731|P1|Overall Study|New cancer therapy|2
1186885|NCT01035229|3896730|P2|Overall Study|Death|5
1186886|NCT01035229|3896731|P1|Overall Study|Death|13
1186887|NCT01035229|3896730|P2|Overall Study|Administrative problems|1
1186888|NCT01035229|3896731|P1|Overall Study|Administrative problems|1
1186889|NCT01035229|3896730|P2|Overall Study|Lost to Follow-up|0
1186890|NCT01035229|3896731|P1|Overall Study|Lost to Follow-up|1
1186891|NCT01035229|3896730|P2|Overall Study|Withdrawal by Subject|7
1186892|NCT01035229|3896731|P1|Overall Study|Withdrawal by Subject|20
1186893|NCT01035229|3896730|P2|Overall Study|Adverse Event|14
1186894|NCT01035229|3896731|P1|Overall Study|Adverse Event|61
1186895|NCT01035138|3896761|P3|Overall Study|Lost to Follow-up|1
1186896|NCT01035138|3896762|P2|Overall Study|Lost to Follow-up|0
1186897|NCT01035138|3896763|P1|Overall Study|Lost to Follow-up|0
1186898|NCT01035138|3896761|P3|Overall Study|Sponsor Decision|42
1186899|NCT01035138|3896762|P2|Overall Study|Sponsor Decision|60
1186900|NCT01035138|3896763|P1|Overall Study|Sponsor Decision|66
1186901|NCT01035138|3896761|P3|Overall Study|Physician Decision|1
1186902|NCT01035138|3896762|P2|Overall Study|Physician Decision|0
1186903|NCT01035138|3896763|P1|Overall Study|Physician Decision|0
1186904|NCT01035138|3896761|P3|Overall Study|Withdrawal by Subject|0
1186905|NCT01035138|3896762|P2|Overall Study|Withdrawal by Subject|0
1186906|NCT01035138|3896763|P1|Overall Study|Withdrawal by Subject|1
1186907|NCT01035138|3896761|P3|Overall Study|Caregiver Decision|1
1186908|NCT01035138|3896762|P2|Overall Study|Caregiver Decision|0
1186909|NCT01035138|3896763|P1|Overall Study|Caregiver Decision|2
1186910|NCT01035138|3896761|P3|Overall Study|Adverse Event|2
1186911|NCT01035138|3896762|P2|Overall Study|Adverse Event|0
1186912|NCT01035138|3896763|P1|Overall Study|Adverse Event|4
1186913|NCT01035060|3896819|P2|Overall Study|Physician Decision|0
1186914|NCT01035060|3896820|P1|Overall Study|Physician Decision|2
1186915|NCT01035060|3896819|P2|Overall Study|Withdrawal by Subject|6
1186916|NCT01035060|3896820|P1|Overall Study|Withdrawal by Subject|8
1186917|NCT01035060|3896819|P2|Overall Study|Did not quality after 2nd screening|1
1186918|NCT01035060|3896820|P1|Overall Study|Did not quality after 2nd screening|14
1186919|NCT01035060|3896819|P2|Overall Study|Lost to Follow-up|7
1186920|NCT01035060|3896820|P1|Overall Study|Lost to Follow-up|0
1186921|NCT01034709|3896845|P2|Overall Study|Protocol Violation|16
1186922|NCT01034709|3896846|P1|Overall Study|Protocol Violation|9
1186923|NCT01034657|3896852|P3|Randomized Phase|Adverse Event|1
1186924|NCT01034657|3896853|P2|Randomized Phase|Adverse Event|2
1186925|NCT01034657|3896854|P1|Randomized Phase|Adverse Event|0
1186926|NCT01034657|3896852|P3|Randomized Phase|Abnormal laboratory value|0
1186927|NCT01034657|3896853|P2|Randomized Phase|Abnormal laboratory value|1
1186928|NCT01034657|3896854|P1|Randomized Phase|Abnormal laboratory value|0
1186929|NCT01034657|3896852|P3|Randomized Phase|Lack of Efficacy|0
1186930|NCT01034657|3896853|P2|Randomized Phase|Lack of Efficacy|1
1186931|NCT01034657|3896854|P1|Randomized Phase|Lack of Efficacy|5
1186932|NCT01034657|3896852|P3|Randomized Phase|Withdrawal by Subject|0
1186933|NCT01034657|3896853|P2|Randomized Phase|Withdrawal by Subject|2
1186934|NCT01034657|3896854|P1|Randomized Phase|Withdrawal by Subject|0
1186935|NCT01034657|3896852|P3|Core Phase|Protocol Violation|0
1186936|NCT01034657|3896853|P2|Core Phase|Protocol Violation|0
1186937|NCT01034657|3896854|P1|Core Phase|Protocol Violation|2
1186938|NCT01034657|3896852|P3|Core Phase|Adverse Event|0
1186939|NCT01034657|3896853|P2|Core Phase|Adverse Event|0
1186940|NCT01034657|3896854|P1|Core Phase|Adverse Event|8
1186941|NCT01034657|3896852|P3|Core Phase|Abnormal laboratory value|0
1186942|NCT01034657|3896853|P2|Core Phase|Abnormal laboratory value|0
1186943|NCT01034657|3896854|P1|Core Phase|Abnormal laboratory value|1
1186944|NCT01034657|3896852|P3|Core Phase|Lack of Efficacy|0
1186945|NCT01034657|3896853|P2|Core Phase|Lack of Efficacy|0
1186946|NCT01034657|3896854|P1|Core Phase|Lack of Efficacy|2
1186947|NCT01034657|3896852|P3|Core Phase|Withdrawal by Subject|0
1186948|NCT01034657|3896853|P2|Core Phase|Withdrawal by Subject|0
1186949|NCT01034657|3896854|P1|Core Phase|Withdrawal by Subject|1
1186950|NCT01034631|3896895|P3|Phase II|Determined Ineligible per protocol|0
1186951|NCT01034631|3896896|P2|Phase II|Determined Ineligible per protocol|1
1186952|NCT01034631|3896897|P1|Phase II|Determined Ineligible per protocol|0
1186953|NCT01034631|3896895|P3|Phase II|Not Evaluable per protocol|2
1186954|NCT01034631|3896896|P2|Phase II|Not Evaluable per protocol|0
1186955|NCT01034631|3896897|P1|Phase II|Not Evaluable per protocol|0
1186956|NCT01034631|3896895|P3|Phase I|Symptomatic Deterioration before Treatme|0
1186957|NCT01034631|3896896|P2|Phase I|Symptomatic Deterioration before Treatme|0
1186958|NCT01034631|3896897|P1|Phase I|Symptomatic Deterioration before Treatme|3
1186959|NCT01034540|3896964|P2|Overall Study|Adverse Event|1
1186960|NCT01034540|3896965|P1|Overall Study|Adverse Event|0
1186961|NCT01034462|3896975|P2|Overall Study|Other reasons|2
1186962|NCT01034462|3896976|P1|Overall Study|Other reasons|1
1186963|NCT01034462|3896975|P2|Overall Study|Lost to Follow-up|16
1186964|NCT01034462|3896976|P1|Overall Study|Lost to Follow-up|14
1186965|NCT01034462|3896975|P2|Overall Study|Withdrawal by Subject|8
1186966|NCT01034462|3896976|P1|Overall Study|Withdrawal by Subject|9
1186967|NCT01034462|3896975|P2|Overall Study|Protocol Violation|7
1186968|NCT01034462|3896976|P1|Overall Study|Protocol Violation|10
1186969|NCT01034462|3896975|P2|Overall Study|Lack of Efficacy|4
1186970|NCT01034462|3896976|P1|Overall Study|Lack of Efficacy|4
1186971|NCT01034462|3896975|P2|Overall Study|Adverse Event|17
1186972|NCT01034462|3896976|P1|Overall Study|Adverse Event|7
1186973|NCT01034397|3896986|P2|Overall Study|Not specified|1
1186974|NCT01034397|3896987|P1|Overall Study|Not specified|0
1186975|NCT01034397|3896986|P2|Overall Study|Adverse Event|0
1186976|NCT01034397|3896987|P1|Overall Study|Adverse Event|4
1186977|NCT01034397|3896986|P2|Overall Study|Lack of Efficacy|0
1186978|NCT01034397|3896987|P1|Overall Study|Lack of Efficacy|3
1186979|NCT01034397|3896986|P2|Overall Study|Lack of compliance|1
1186980|NCT01034397|3896987|P1|Overall Study|Lack of compliance|0
1186981|NCT01034358|3897136|P1|Overall Study|Protocol Violation|1
1186982|NCT01034358|3897136|P1|Overall Study|Withdrawal by Subject|1
1186983|NCT01034306|3897142|P2|Overall Study|Noncomplience|0
1186984|NCT01034306|3897143|P1|Overall Study|Noncomplience|1
1186985|NCT01034306|3897142|P2|Overall Study|hospitalized and decided to stop|0
1186986|NCT01034306|3897143|P1|Overall Study|hospitalized and decided to stop|1
1186987|NCT01034306|3897142|P2|Overall Study|Withdrawal by Subject|2
1186988|NCT01034306|3897143|P1|Overall Study|Withdrawal by Subject|2
1186989|NCT01034306|3897142|P2|Overall Study|Lost to Follow-up|1
1186990|NCT01034306|3897143|P1|Overall Study|Lost to Follow-up|0
1186991|NCT01034306|3897142|P2|Overall Study|Adverse Event|0
1186992|NCT01034306|3897143|P1|Overall Study|Adverse Event|1
1186993|NCT01034176|3897151|P2|Overall Study|Lost to Follow-up|1
1186994|NCT01034176|3897152|P1|Overall Study|Lost to Follow-up|0
1186995|NCT01034176|3897151|P2|Overall Study|Withdrawal by Subject|1
1186996|NCT01034176|3897152|P1|Overall Study|Withdrawal by Subject|0
1186997|NCT01034176|3897151|P2|Overall Study|Physician Decision|0
1186998|NCT01034176|3897152|P1|Overall Study|Physician Decision|2
1186999|NCT01034163|3897162|P2|Overall Study|Abnormal laboratory value|0
1187000|NCT01034163|3897163|P1|Overall Study|Abnormal laboratory value|1
1187001|NCT01034163|3897162|P2|Overall Study|Administrative problems|1
1187002|NCT01034163|3897163|P1|Overall Study|Administrative problems|0
1187003|NCT01034163|3897162|P2|Overall Study|Adverse Event|0
1187004|NCT01034163|3897163|P1|Overall Study|Adverse Event|6
1187005|NCT01034163|3897162|P2|Overall Study|Disease progression|4
1187006|NCT01034163|3897163|P1|Overall Study|Disease progression|3
1187007|NCT01034163|3897162|P2|Overall Study|Protocol deviation|0
1187008|NCT01034163|3897163|P1|Overall Study|Protocol deviation|1
1187009|NCT01034163|3897162|P2|Overall Study|Withdrawal by Subject|2
1187010|NCT01034163|3897163|P1|Overall Study|Withdrawal by Subject|8
1187011|NCT01034163|3897162|P2|Overall Study|Treatment completed as per protocol|7
1187012|NCT01034163|3897163|P1|Overall Study|Treatment completed as per protocol|8
1187013|NCT01034137|3897172|P3|Overall Study|Administrative or other|4
1187014|NCT01034137|3897173|P2|Overall Study|Administrative or other|3
1187015|NCT01034137|3897174|P1|Overall Study|Administrative or other|2
1187016|NCT01034137|3897172|P3|Overall Study|Refused treatment or did not cooperate|1
1187017|NCT01034137|3897173|P2|Overall Study|Refused treatment or did not cooperate|0
1187018|NCT01034137|3897174|P1|Overall Study|Refused treatment or did not cooperate|2
1187019|NCT01034137|3897172|P3|Overall Study|Protocol Violation|1
1187020|NCT01034137|3897173|P2|Overall Study|Protocol Violation|2
1187021|NCT01034137|3897174|P1|Overall Study|Protocol Violation|2
1187022|NCT01034137|3897172|P3|Overall Study|Lack of Efficacy|13
1187023|NCT01034137|3897173|P2|Overall Study|Lack of Efficacy|4
1187024|NCT01034137|3897174|P1|Overall Study|Lack of Efficacy|9
1187025|NCT01034137|3897172|P3|Overall Study|Withdrawal by Subject|3
1187026|NCT01034137|3897173|P2|Overall Study|Withdrawal by Subject|3
1187027|NCT01034137|3897174|P1|Overall Study|Withdrawal by Subject|4
1187028|NCT01034137|3897172|P3|Overall Study|Adverse Event|8
1187029|NCT01034137|3897173|P2|Overall Study|Adverse Event|10
1187030|NCT01034137|3897174|P1|Overall Study|Adverse Event|9
1187031|NCT01033942|3897313|P3|Overall Study|Enrolled in Extension Study|0
1187032|NCT01033942|3897314|P2|Overall Study|Enrolled in Extension Study|3
1187033|NCT01033942|3897315|P1|Overall Study|Enrolled in Extension Study|0
1187034|NCT01033942|3897313|P3|Overall Study|Lost to Follow-up|0
1187035|NCT01033942|3897314|P2|Overall Study|Lost to Follow-up|0
1187036|NCT01033942|3897315|P1|Overall Study|Lost to Follow-up|1
1187037|NCT01033942|3897313|P3|Overall Study|Withdrawal by Subject|1
1187038|NCT01033942|3897314|P2|Overall Study|Withdrawal by Subject|1
1187039|NCT01033942|3897315|P1|Overall Study|Withdrawal by Subject|1
1187040|NCT01033851|3897613|P2|Overall Study|Withdrawal by Subject|7
1187041|NCT01033851|3897614|P1|Overall Study|Withdrawal by Subject|3
1187042|NCT01033825|3897629|P7|Overall Study|Other|0
1187043|NCT01033825|3897630|P6|Overall Study|Other|0
1187044|NCT01033825|3897631|P5|Overall Study|Other|1
1187045|NCT01033825|3897632|P4|Overall Study|Other|0
1187046|NCT01033825|3897633|P3|Overall Study|Other|0
1187047|NCT01033825|3897634|P2|Overall Study|Other|0
1187048|NCT01033825|3897635|P1|Overall Study|Other|0
1187049|NCT01033825|3897629|P7|Overall Study|Protocol Violation|0
1187050|NCT01033825|3897630|P6|Overall Study|Protocol Violation|0
1187051|NCT01033825|3897631|P5|Overall Study|Protocol Violation|0
1187052|NCT01033825|3897632|P4|Overall Study|Protocol Violation|0
1187053|NCT01033825|3897633|P3|Overall Study|Protocol Violation|0
1187054|NCT01033825|3897634|P2|Overall Study|Protocol Violation|0
1187055|NCT01033825|3897635|P1|Overall Study|Protocol Violation|1
1187056|NCT01033825|3897629|P7|Overall Study|Adverse Event|0
1187057|NCT01033825|3897630|P6|Overall Study|Adverse Event|0
1187058|NCT01033825|3897631|P5|Overall Study|Adverse Event|0
1187059|NCT01033825|3897632|P4|Overall Study|Adverse Event|1
1187060|NCT01033825|3897633|P3|Overall Study|Adverse Event|0
1187061|NCT01033825|3897634|P2|Overall Study|Adverse Event|0
1187062|NCT01033825|3897635|P1|Overall Study|Adverse Event|0
1187063|NCT01033825|3897629|P7|Overall Study|Withdrawal by Subject|0
1187064|NCT01033825|3897630|P6|Overall Study|Withdrawal by Subject|0
1187065|NCT01033825|3897631|P5|Overall Study|Withdrawal by Subject|1
1187066|NCT01033825|3897632|P4|Overall Study|Withdrawal by Subject|1
1187067|NCT01033825|3897633|P3|Overall Study|Withdrawal by Subject|2
1187068|NCT01033825|3897634|P2|Overall Study|Withdrawal by Subject|3
1187069|NCT01033825|3897635|P1|Overall Study|Withdrawal by Subject|2
1187070|NCT01033747|3897856|P2|Overall Study|Stopped at end of Extension 1|0
1187071|NCT01033747|3897857|P1|Overall Study|Stopped at end of Extension 1|2
1187072|NCT01033747|3897856|P2|Overall Study|Stopped at end of prolongation visit 1|0
1187073|NCT01033747|3897857|P1|Overall Study|Stopped at end of prolongation visit 1|1
1187074|NCT01033747|3897856|P2|Overall Study|Withdrawal by Subject|6
1187075|NCT01033747|3897857|P1|Overall Study|Withdrawal by Subject|9
1187076|NCT01033747|3897856|P2|Overall Study|Protocol Violation|0
1187077|NCT01033747|3897857|P1|Overall Study|Protocol Violation|1
1187078|NCT01033747|3897856|P2|Overall Study|Unsatisfactory therapeutic effect|4
1187079|NCT01033747|3897857|P1|Overall Study|Unsatisfactory therapeutic effect|14
1187080|NCT01033747|3897856|P2|Overall Study|Abnormal test procedure|1
1187081|NCT01033747|3897857|P1|Overall Study|Abnormal test procedure|0
1187082|NCT01033747|3897856|P2|Overall Study|Abnormal Laboratory Value|0
1187083|NCT01033747|3897857|P1|Overall Study|Abnormal Laboratory Value|1
1187084|NCT01033747|3897856|P2|Overall Study|Adverse Event|4
1187085|NCT01033747|3897857|P1|Overall Study|Adverse Event|9
1187086|NCT01033734|3897865|P1|Overall Study|Withdrawal by Subject|1
1187087|NCT01033487|3897921|P10|Fourth Intervention Period|Adverse Event|0
1187088|NCT01033487|3897922|P9|Fourth Intervention Period|Adverse Event|1
1187089|NCT01033487|3897923|P8|Fourth Intervention Period|Adverse Event|0
1187090|NCT01033487|3897924|P7|Fourth Intervention Period|Adverse Event|0
1187091|NCT01033487|3897925|P6|Fourth Intervention Period|Adverse Event|0
1187092|NCT01033487|3897926|P5|Fourth Intervention Period|Adverse Event|0
1187093|NCT01033487|3897927|P4|Fourth Intervention Period|Adverse Event|0
1187094|NCT01033487|3897928|P3|Fourth Intervention Period|Adverse Event|0
1187095|NCT01033487|3897929|P2|Fourth Intervention Period|Adverse Event|0
1187096|NCT01033487|3897930|P1|Fourth Intervention Period|Adverse Event|0
1187097|NCT01033448|3897984|P1|Overall Study|Unknown disposition|1
1187098|NCT01033448|3897984|P1|Overall Study|Withdrew due to other reasons|3
1187099|NCT01033448|3897984|P1|Overall Study|Lost to Follow-up|3
1187100|NCT01033448|3897984|P1|Overall Study|Positive HCV-RNA at week 48|1
1187101|NCT01033448|3897984|P1|Overall Study|Withdrawal by Subject|4
1187102|NCT01033136|3898030|P2|Follow-Up (3 Month)|Lost to Follow-up|2
1187103|NCT01033136|3898031|P1|Follow-Up (3 Month)|Lost to Follow-up|2
1187104|NCT01033071|3898042|P3|Overall Study|Other|3
1187105|NCT01033071|3898043|P2|Overall Study|Other|4
1187106|NCT01033071|3898044|P1|Overall Study|Other|6
1187107|NCT01033071|3898042|P3|Overall Study|Lack of Efficacy|1
1187108|NCT01033071|3898043|P2|Overall Study|Lack of Efficacy|1
1187109|NCT01033071|3898044|P1|Overall Study|Lack of Efficacy|0
1187110|NCT01033071|3898042|P3|Overall Study|Withdrawal by Subject|11
1187111|NCT01033071|3898043|P2|Overall Study|Withdrawal by Subject|14
1187112|NCT01033071|3898044|P1|Overall Study|Withdrawal by Subject|17
1187113|NCT01033071|3898042|P3|Overall Study|Lost to Follow-up|5
1187114|NCT01033071|3898043|P2|Overall Study|Lost to Follow-up|5
1187115|NCT01033071|3898044|P1|Overall Study|Lost to Follow-up|4
1187116|NCT01033071|3898042|P3|Overall Study|Protocol Violation|1
1187117|NCT01033071|3898043|P2|Overall Study|Protocol Violation|2
1187118|NCT01033071|3898044|P1|Overall Study|Protocol Violation|0
1187119|NCT01033071|3898042|P3|Overall Study|Adverse Event|26
1187120|NCT01033071|3898043|P2|Overall Study|Adverse Event|51
1187121|NCT01033071|3898044|P1|Overall Study|Adverse Event|28
1187122|NCT01033019|3898115|P2|Overall Study|Withdrawal by Subject|0
1187123|NCT01033019|3898116|P1|Overall Study|Withdrawal by Subject|1
1187124|NCT01032915|3898154|P4|Overall Study|Protocol Violation|1
1187125|NCT01032915|3898155|P3|Overall Study|Protocol Violation|0
1187126|NCT01032915|3898156|P2|Overall Study|Protocol Violation|0
1187127|NCT01032915|3898157|P1|Overall Study|Protocol Violation|1
1187128|NCT01032915|3898154|P4|Overall Study|Administrative reasons|4
1187129|NCT01032915|3898155|P3|Overall Study|Administrative reasons|4
1187130|NCT01032915|3898156|P2|Overall Study|Administrative reasons|6
1187131|NCT01032915|3898157|P1|Overall Study|Administrative reasons|5
1187132|NCT01032915|3898154|P4|Overall Study|Withdrawal by Subject|1
1187133|NCT01032915|3898155|P3|Overall Study|Withdrawal by Subject|1
1187134|NCT01032915|3898156|P2|Overall Study|Withdrawal by Subject|3
1187135|NCT01032915|3898157|P1|Overall Study|Withdrawal by Subject|0
1187136|NCT01032915|3898154|P4|Overall Study|Abnormal test procedure result|0
1187137|NCT01032915|3898155|P3|Overall Study|Abnormal test procedure result|1
1187138|NCT01032915|3898156|P2|Overall Study|Abnormal test procedure result|0
1187139|NCT01032915|3898157|P1|Overall Study|Abnormal test procedure result|0
1187140|NCT01032915|3898154|P4|Overall Study|Adverse Event|1
1187141|NCT01032915|3898155|P3|Overall Study|Adverse Event|1
1187142|NCT01032915|3898156|P2|Overall Study|Adverse Event|2
1187143|NCT01032915|3898157|P1|Overall Study|Adverse Event|2
1187144|NCT01032889|3898182|P3|Overall Study|Miscellaneous Reasons|1
1187145|NCT01032889|3898183|P2|Overall Study|Miscellaneous Reasons|1
1187146|NCT01032889|3898184|P1|Overall Study|Miscellaneous Reasons|2
1187147|NCT01032889|3898182|P3|Overall Study|Lack of Submental Fat|1
1187148|NCT01032889|3898183|P2|Overall Study|Lack of Submental Fat|8
1187149|NCT01032889|3898184|P1|Overall Study|Lack of Submental Fat|2
1187150|NCT01032889|3898182|P3|Overall Study|Lost to Follow-up|0
1187151|NCT01032889|3898183|P2|Overall Study|Lost to Follow-up|1
1187152|NCT01032889|3898184|P1|Overall Study|Lost to Follow-up|1
1187153|NCT01032889|3898182|P3|Overall Study|Patient Request|0
1187154|NCT01032889|3898183|P2|Overall Study|Patient Request|1
1187155|NCT01032889|3898184|P1|Overall Study|Patient Request|0
1187156|NCT01032889|3898182|P3|Overall Study|Withdrawal of Consent|1
1187157|NCT01032889|3898183|P2|Overall Study|Withdrawal of Consent|2
1187158|NCT01032889|3898184|P1|Overall Study|Withdrawal of Consent|1
1187159|NCT01032889|3898182|P3|Overall Study|Adverse Event|0
1187160|NCT01032889|3898183|P2|Overall Study|Adverse Event|2
1187161|NCT01032889|3898184|P1|Overall Study|Adverse Event|2
1187162|NCT01032837|3898215|P4|Overall Study|Refused treatment|1
1187163|NCT01032837|3898216|P3|Overall Study|Refused treatment|0
1187164|NCT01032837|3898217|P2|Overall Study|Refused treatment|0
1187165|NCT01032837|3898218|P1|Overall Study|Refused treatment|0
1187166|NCT01032837|3898215|P4|Overall Study|Failed to return|0
1187167|NCT01032837|3898216|P3|Overall Study|Failed to return|1
1187168|NCT01032837|3898217|P2|Overall Study|Failed to return|0
1187169|NCT01032837|3898218|P1|Overall Study|Failed to return|0
1187170|NCT01032837|3898215|P4|Overall Study|Withdrew consent|1
1187171|NCT01032837|3898216|P3|Overall Study|Withdrew consent|0
1187172|NCT01032837|3898217|P2|Overall Study|Withdrew consent|2
1187173|NCT01032837|3898218|P1|Overall Study|Withdrew consent|0
1187174|NCT01032837|3898215|P4|Overall Study|Adverse event/internal illness|1
1187175|NCT01032837|3898216|P3|Overall Study|Adverse event/internal illness|0
1187176|NCT01032837|3898217|P2|Overall Study|Adverse event/internal illness|1
1187177|NCT01032837|3898218|P1|Overall Study|Adverse event/internal illness|0
1187178|NCT01032629|3898318|P3|Overall Study|Lost to Follow-up|37
1187179|NCT01032629|3898319|P2|Overall Study|Lost to Follow-up|47
1187180|NCT01032629|3898320|P1|Overall Study|Lost to Follow-up|74
1187181|NCT01032629|3898318|P3|Overall Study|Withdrawal by Subject|35
1187182|NCT01032629|3898319|P2|Overall Study|Withdrawal by Subject|36
1187183|NCT01032629|3898320|P1|Overall Study|Withdrawal by Subject|50
1187184|NCT01032629|3898318|P3|Overall Study|Closed Site|16
1187185|NCT01032629|3898319|P2|Overall Study|Closed Site|18
1187186|NCT01032629|3898320|P1|Overall Study|Closed Site|21
1187187|NCT01032382|3898373|P2|Overall Study|Index lesion relapse|3
1187188|NCT01032382|3898374|P1|Overall Study|Index lesion relapse|1
1187189|NCT01032382|3898373|P2|Overall Study|Treatment failure|1
1187190|NCT01032382|3898374|P1|Overall Study|Treatment failure|3
1187191|NCT01032382|3898373|P2|Overall Study|Disease dissemination|1
1187192|NCT01032382|3898374|P1|Overall Study|Disease dissemination|1
1187193|NCT01032291|3898403|P3|Proof of Concept|Never Received Study Drug|0
1187194|NCT01032291|3898404|P2|Proof of Concept|Never Received Study Drug|1
1187195|NCT01032291|3898405|P1|Proof of Concept|Never Received Study Drug|0
1187196|NCT01032291|3898403|P3|Proof of Concept|Lack of Efficacy|0
1187197|NCT01032291|3898404|P2|Proof of Concept|Lack of Efficacy|1
1187198|NCT01032291|3898405|P1|Proof of Concept|Lack of Efficacy|0
1187199|NCT01032291|3898403|P3|Proof of Concept|Death|2
1187200|NCT01032291|3898404|P2|Proof of Concept|Death|1
1187201|NCT01032291|3898405|P1|Proof of Concept|Death|0
1187202|NCT01032291|3898403|P3|Proof of Concept|Adverse Event|1
1187203|NCT01032291|3898404|P2|Proof of Concept|Adverse Event|5
1187204|NCT01032291|3898405|P1|Proof of Concept|Adverse Event|0
1187205|NCT01032291|3898403|P3|Safety Lead-in|Death|0
1187206|NCT01032291|3898404|P2|Safety Lead-in|Death|0
1187207|NCT01032291|3898405|P1|Safety Lead-in|Death|1
1187208|NCT01032291|3898403|P3|Safety Lead-in|Adverse Event|0
1187209|NCT01032291|3898404|P2|Safety Lead-in|Adverse Event|0
1187210|NCT01032291|3898405|P1|Safety Lead-in|Adverse Event|1
1187211|NCT01032239|3898452|P2|Overall Study|Protocol Violation|0
1187212|NCT01032239|3898453|P1|Overall Study|Protocol Violation|1
1187213|NCT01032239|3898452|P2|Overall Study|Death|0
1187214|NCT01032239|3898453|P1|Overall Study|Death|1
1187215|NCT01032239|3898452|P2|Overall Study|Withdrawal by Subject|3
1187216|NCT01032239|3898453|P1|Overall Study|Withdrawal by Subject|2
1187217|NCT01032239|3898452|P2|Overall Study|Lost to Follow-up|2
1187218|NCT01032239|3898453|P1|Overall Study|Lost to Follow-up|3
1187219|NCT01032200|3898483|P2|Overall Study|Multiple|1
1187220|NCT01032200|3898484|P1|Overall Study|Multiple|1
1187221|NCT01032200|3898483|P2|Overall Study|Progression|0
1187222|NCT01032200|3898484|P1|Overall Study|Progression|1
1187223|NCT01032200|3898483|P2|Overall Study|Toxicity|2
1187224|NCT01032200|3898484|P1|Overall Study|Toxicity|0
1187225|NCT01032200|3898483|P2|Overall Study|Withdrawal by Subject|3
1187226|NCT01032200|3898484|P1|Overall Study|Withdrawal by Subject|1
1187227|NCT01032200|3898483|P2|Overall Study|Death|1
1187228|NCT01032200|3898484|P1|Overall Study|Death|1
1187229|NCT01032174|3898500|P2|Overall Study|Adverse Event|1
1187230|NCT01032174|3898501|P1|Overall Study|Adverse Event|0
1187231|NCT01032070|3898741|P2|Overall Study|Withdrawal by Subject|2
1187232|NCT01032070|3898742|P1|Overall Study|Withdrawal by Subject|0
1187233|NCT01032070|3898741|P2|Overall Study|Medical or ethical reasons|2
1187234|NCT01032070|3898742|P1|Overall Study|Medical or ethical reasons|0
1187235|NCT01032070|3898741|P2|Overall Study|Disease progression|8
1187236|NCT01032070|3898742|P1|Overall Study|Disease progression|13
1187237|NCT01032044|3898771|P2|Overall Study|Lost to Follow-up|11
1187238|NCT01032044|3898772|P1|Overall Study|Lost to Follow-up|11
1187239|NCT01032044|3898771|P2|Overall Study|Adverse Event|1
1187240|NCT01032044|3898772|P1|Overall Study|Adverse Event|0
1187241|NCT01032044|3898771|P2|Overall Study|Protocol Violation|8
1187242|NCT01032044|3898772|P1|Overall Study|Protocol Violation|14
1187243|NCT01032018|3898780|P2|Overall Study|Death|1
1187244|NCT01032018|3898781|P1|Overall Study|Death|0
1187245|NCT01032018|3898780|P2|Overall Study|Lost to Follow-up|5
1187246|NCT01032018|3898781|P1|Overall Study|Lost to Follow-up|6
1187247|NCT01031979|3898791|P2|Overall Study|Lost to Follow-up|4
1187248|NCT01031979|3898792|P1|Overall Study|Lost to Follow-up|5
1187249|NCT01031836|3898825|P6|Stage II|Other|0
1187250|NCT01031836|3898826|P5|Stage II|Other|1
1187251|NCT01031836|3898827|P4|Stage II|Other|1
1187252|NCT01031836|3898828|P3|Stage II|Other|0
1187253|NCT01031836|3898829|P2|Stage II|Other|0
1187254|NCT01031836|3898830|P1|Stage II|Other|2
1187255|NCT01031836|3898825|P6|Stage II|Adverse Event|1
1187256|NCT01031836|3898826|P5|Stage II|Adverse Event|1
1187257|NCT01031836|3898827|P4|Stage II|Adverse Event|2
1187258|NCT01031836|3898828|P3|Stage II|Adverse Event|2
1187259|NCT01031836|3898829|P2|Stage II|Adverse Event|0
1187260|NCT01031836|3898830|P1|Stage II|Adverse Event|0
1187261|NCT01031836|3898825|P6|Stage I|Other|1
1187262|NCT01031836|3898826|P5|Stage I|Other|0
1187263|NCT01031836|3898827|P4|Stage I|Other|0
1187264|NCT01031836|3898828|P3|Stage I|Other|0
1187265|NCT01031836|3898829|P2|Stage I|Other|1
1187266|NCT01031836|3898830|P1|Stage I|Other|0
1187267|NCT01031836|3898825|P6|Stage I|Adverse Event|0
1187268|NCT01031836|3898826|P5|Stage I|Adverse Event|0
1187269|NCT01031836|3898827|P4|Stage I|Adverse Event|0
1187270|NCT01031836|3898828|P3|Stage I|Adverse Event|0
1187271|NCT01031836|3898829|P2|Stage I|Adverse Event|1
1187272|NCT01031836|3898830|P1|Stage I|Adverse Event|1
1187273|NCT01031706|3898891|P2|Overall Study|Withdrawal by Subject|1
1187274|NCT01031706|3898892|P1|Overall Study|Withdrawal by Subject|1
1187275|NCT01031706|3898891|P2|Overall Study|Adverse Event|0
1187276|NCT01031706|3898892|P1|Overall Study|Adverse Event|1
1187277|NCT01031680|3898902|P2|Overall Study|Various|2
1187278|NCT01031680|3898903|P1|Overall Study|Various|0
1187279|NCT01031680|3898902|P2|Overall Study|Administrative Reason by Sponsor|1
1187280|NCT01031680|3898903|P1|Overall Study|Administrative Reason by Sponsor|0
1187281|NCT01031680|3898902|P2|Overall Study|Incorrect Enrolment|2
1187282|NCT01031680|3898903|P1|Overall Study|Incorrect Enrolment|1
1187283|NCT01031680|3898902|P2|Overall Study|Safety|0
1187284|NCT01031680|3898903|P1|Overall Study|Safety|1
1187285|NCT01031680|3898902|P2|Overall Study|Poor/Non-compliance|6
1187286|NCT01031680|3898903|P1|Overall Study|Poor/Non-compliance|5
1187287|NCT01031680|3898902|P2|Overall Study|Subject No Longer Meets Study Criteria|17
1187288|NCT01031680|3898903|P1|Overall Study|Subject No Longer Meets Study Criteria|26
1187289|NCT01031680|3898902|P2|Overall Study|Death|1
1187290|NCT01031680|3898903|P1|Overall Study|Death|2
1187291|NCT01031680|3898902|P2|Overall Study|Withdrawal by Subject|16
1187292|NCT01031680|3898903|P1|Overall Study|Withdrawal by Subject|12
1187293|NCT01031680|3898902|P2|Overall Study|Lost to Follow-up|10
1187294|NCT01031680|3898903|P1|Overall Study|Lost to Follow-up|2
1187295|NCT01031680|3898902|P2|Overall Study|Adverse Event|3
1187296|NCT01031680|3898903|P1|Overall Study|Adverse Event|8
1187297|NCT01031628|3898923|P4|Overall Study|Study terminated early|0
1187298|NCT01031628|3898924|P3|Overall Study|Study terminated early|3
1187299|NCT01031628|3898925|P2|Overall Study|Study terminated early|1
1187300|NCT01031628|3898926|P1|Overall Study|Study terminated early|0
1187301|NCT01031537|3898951|P1|Overall Study|PI removal, no longer met eligibility|12
1187302|NCT01031537|3898951|P1|Overall Study|Withdrawal by Subject|5
1187303|NCT01031537|3898951|P1|Overall Study|moved, met exclusion criteria|10
1187304|NCT01031537|3898951|P1|Overall Study|retired from NIH, met exclusion criteria|1
1187305|NCT01031537|3898951|P1|Overall Study|Lack of Efficacy|1
1187306|NCT01031537|3898951|P1|Overall Study|medical reasons not related to study|3
1187307|NCT01031446|3898969|P1|Overall Study|Still on treatment|1
1187308|NCT01031446|3898969|P1|Overall Study|Withdrawal by Subject|3
1187309|NCT01031446|3898969|P1|Overall Study|Physician Decision|4
1187310|NCT01031446|3898969|P1|Overall Study|Adverse Event|9
1187311|NCT01031446|3898969|P1|Overall Study|Disease Progression|38
1187312|NCT01031381|3898978|P1|Overall Study|Withdrawal by Subject|6
1187313|NCT01031381|3898978|P1|Overall Study|Physician Decision|3
1187314|NCT01031004|3899009|P2|Overall Study|Lost to Follow-up|0
1187315|NCT01031004|3899010|P1|Overall Study|Lost to Follow-up|1
1187316|NCT01031004|3899009|P2|Overall Study|Protocol Violation|1
1187317|NCT01031004|3899010|P1|Overall Study|Protocol Violation|0
1187318|NCT01030965|3899054|P4|Overall Study|Withdrawal by Subject|2
1187319|NCT01030965|3899055|P3|Overall Study|Withdrawal by Subject|0
1187320|NCT01030965|3899056|P2|Overall Study|Withdrawal by Subject|1
1187321|NCT01030965|3899057|P1|Overall Study|Withdrawal by Subject|0
1187322|NCT01030965|3899054|P4|Overall Study|Protocol-defined Stopping Criteria|0
1187323|NCT01030965|3899055|P3|Overall Study|Protocol-defined Stopping Criteria|1
1187324|NCT01030965|3899056|P2|Overall Study|Protocol-defined Stopping Criteria|1
1187325|NCT01030965|3899057|P1|Overall Study|Protocol-defined Stopping Criteria|0
1187326|NCT01030965|3899054|P4|Overall Study|Adverse Event|1
1187327|NCT01030965|3899055|P3|Overall Study|Adverse Event|2
1187328|NCT01030965|3899056|P2|Overall Study|Adverse Event|1
1187329|NCT01030965|3899057|P1|Overall Study|Adverse Event|0
1187330|NCT01030965|3899054|P4|Overall Study|Protocol Violation|1
1187331|NCT01030965|3899055|P3|Overall Study|Protocol Violation|1
1187332|NCT01030965|3899056|P2|Overall Study|Protocol Violation|1
1187333|NCT01030965|3899057|P1|Overall Study|Protocol Violation|1
1187334|NCT01030965|3899054|P4|Overall Study|Lack of Efficacy|3
1187335|NCT01030965|3899055|P3|Overall Study|Lack of Efficacy|0
1187336|NCT01030965|3899056|P2|Overall Study|Lack of Efficacy|2
1187337|NCT01030965|3899057|P1|Overall Study|Lack of Efficacy|3
1187338|NCT01030952|3899077|P2|Overall Study|Unexplained|1
1187339|NCT01030952|3899078|P1|Overall Study|Unexplained|1
1187340|NCT01030952|3899077|P2|Overall Study|Lost to Follow-up|1
1187341|NCT01030952|3899078|P1|Overall Study|Lost to Follow-up|0
1187342|NCT01030952|3899077|P2|Overall Study|Informed consent withdrawal|0
1187343|NCT01030952|3899078|P1|Overall Study|Informed consent withdrawal|1
1187344|NCT01030952|3899077|P2|Overall Study|Protocol Violation|1
1187345|NCT01030952|3899078|P1|Overall Study|Protocol Violation|0
1187346|NCT01030822|3899115|P3|Overall Study|Lost to Follow-up|7
1187347|NCT01030822|3899116|P2|Overall Study|Lost to Follow-up|4
1187348|NCT01030822|3899117|P1|Overall Study|Lost to Follow-up|9
1187349|NCT01030822|3899115|P3|Overall Study|Withdrawal by Subject|16
1187350|NCT01030822|3899116|P2|Overall Study|Withdrawal by Subject|13
1187351|NCT01030822|3899117|P1|Overall Study|Withdrawal by Subject|16
1187352|NCT01030822|3899115|P3|Overall Study|Moved/migrated from study area|3
1187353|NCT01030822|3899116|P2|Overall Study|Moved/migrated from study area|7
1187354|NCT01030822|3899117|P1|Overall Study|Moved/migrated from study area|6
1187355|NCT01030718|3899172|P3|Study CA180-036 Only|Other Reasons|0
1187356|NCT01030718|3899173|P2|Study CA180-036 Only|Other Reasons|2
1187357|NCT01030718|3899174|P1|Study CA180-036 Only|Other Reasons|0
1187358|NCT01030718|3899172|P3|Study CA180-036 Only|Death|0
1187359|NCT01030718|3899173|P2|Study CA180-036 Only|Death|1
1187360|NCT01030718|3899174|P1|Study CA180-036 Only|Death|0
1187361|NCT01030718|3899172|P3|Study CA180-036 Only|Adverse Event|0
1187362|NCT01030718|3899173|P2|Study CA180-036 Only|Adverse Event|3
1187363|NCT01030718|3899174|P1|Study CA180-036 Only|Adverse Event|2
1187364|NCT01030718|3899172|P3|Study CA180-036 Only|insufficient effect|5
1187365|NCT01030718|3899173|P2|Study CA180-036 Only|insufficient effect|1
1187366|NCT01030718|3899174|P1|Study CA180-036 Only|insufficient effect|1
1187367|NCT01030718|3899172|P3|Studies CA180-031 and -036 Combined|other reasons|0
1187368|NCT01030718|3899173|P2|Studies CA180-031 and -036 Combined|other reasons|2
1187369|NCT01030718|3899174|P1|Studies CA180-031 and -036 Combined|other reasons|0
1187370|NCT01030718|3899172|P3|Studies CA180-031 and -036 Combined|Death|0
1187371|NCT01030718|3899173|P2|Studies CA180-031 and -036 Combined|Death|1
1187372|NCT01030718|3899174|P1|Studies CA180-031 and -036 Combined|Death|0
1187373|NCT01030718|3899172|P3|Studies CA180-031 and -036 Combined|Adverse Event|1
1187374|NCT01030718|3899173|P2|Studies CA180-031 and -036 Combined|Adverse Event|5
1187375|NCT01030718|3899174|P1|Studies CA180-031 and -036 Combined|Adverse Event|3
1187376|NCT01030718|3899172|P3|Studies CA180-031 and -036 Combined|Insufficient effect|11
1187377|NCT01030718|3899173|P2|Studies CA180-031 and -036 Combined|Insufficient effect|1
1187378|NCT01030718|3899174|P1|Studies CA180-031 and -036 Combined|Insufficient effect|1
1187379|NCT01030666|3899235|P2|Overall Study|Lost to Follow-up|2
1187380|NCT01030666|3899236|P1|Overall Study|Lost to Follow-up|3
1187381|NCT01030536|3899261|P5|Overall Study|Death|0
1187382|NCT01030536|3899262|P4|Overall Study|Death|0
1187383|NCT01030536|3899263|P3|Overall Study|Death|0
1187384|NCT01030536|3899264|P2|Overall Study|Death|1
1187385|NCT01030536|3899265|P1|Overall Study|Death|0
1187386|NCT01030536|3899261|P5|Overall Study|Progressive disease|0
1187387|NCT01030536|3899262|P4|Overall Study|Progressive disease|2
1187388|NCT01030536|3899263|P3|Overall Study|Progressive disease|3
1187389|NCT01030536|3899264|P2|Overall Study|Progressive disease|2
1187390|NCT01030536|3899265|P1|Overall Study|Progressive disease|6
1187391|NCT01030536|3899261|P5|Overall Study|Adverse Event|1
1187392|NCT01030536|3899262|P4|Overall Study|Adverse Event|0
1187393|NCT01030536|3899263|P3|Overall Study|Adverse Event|1
1187394|NCT01030536|3899264|P2|Overall Study|Adverse Event|3
1187395|NCT01030536|3899265|P1|Overall Study|Adverse Event|0
1187396|NCT01030536|3899261|P5|Overall Study|undefined|0
1187397|NCT01030536|3899262|P4|Overall Study|undefined|1
1187398|NCT01030536|3899263|P3|Overall Study|undefined|1
1187399|NCT01030536|3899264|P2|Overall Study|undefined|0
1187400|NCT01030536|3899265|P1|Overall Study|undefined|1
1187401|NCT01030536|3899261|P5|Overall Study|Withdrawal by Subject|0
1187402|NCT01030536|3899262|P4|Overall Study|Withdrawal by Subject|0
1187403|NCT01030536|3899263|P3|Overall Study|Withdrawal by Subject|1
1187404|NCT01030536|3899264|P2|Overall Study|Withdrawal by Subject|0
1187405|NCT01030536|3899265|P1|Overall Study|Withdrawal by Subject|0
1187406|NCT01030458|3899370|P2|Overall Study|Side effect of medication|1
1187407|NCT01030458|3899371|P1|Overall Study|Side effect of medication|1
1187408|NCT01030458|3899370|P2|Overall Study|Moved or changed job|13
1187409|NCT01030458|3899371|P1|Overall Study|Moved or changed job|6
1187410|NCT01030458|3899370|P2|Overall Study|Logistical reasons|5
1187411|NCT01030458|3899371|P1|Overall Study|Logistical reasons|9
1187412|NCT01030458|3899370|P2|Overall Study|Withdrawal by Subject|3
1187413|NCT01030458|3899371|P1|Overall Study|Withdrawal by Subject|2
1187414|NCT01030458|3899370|P2|Overall Study|Lost to Follow-up|10
1187415|NCT01030458|3899371|P1|Overall Study|Lost to Follow-up|9
1187416|NCT01030341|3899404|P1|Overall Study|Lost to Follow-up|2
1187417|NCT01030341|3899404|P1|Overall Study|Withdrawal by Subject|1
1187418|NCT01030133|3899427|P2|Overall Study|failed to experience pain at level 7/10|2
1187419|NCT01030133|3899428|P1|Overall Study|failed to experience pain at level 7/10|2
1187420|NCT01029925|3899440|P1|Completion of Cycle 2 (56 Days)|off study due to disease progression|1
1187421|NCT01029925|3899440|P1|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2
1187422|NCT01029925|3899440|P1|Completion of Cycle 1 (28 Days)|Death|2
1187423|NCT01029886|3899459|P2|Overall Study|Loss Glucose Control|1
1187424|NCT01029886|3899460|P1|Overall Study|Loss Glucose Control|7
1187425|NCT01029886|3899459|P2|Overall Study|Sponsor Decision|0
1187426|NCT01029886|3899460|P1|Overall Study|Sponsor Decision|1
1187427|NCT01029886|3899459|P2|Overall Study|Entry Criteria Not Met|5
1187428|NCT01029886|3899460|P1|Overall Study|Entry Criteria Not Met|13
1187429|NCT01029886|3899459|P2|Overall Study|Withdrawal by Subject|18
1187430|NCT01029886|3899460|P1|Overall Study|Withdrawal by Subject|8
1187431|NCT01029886|3899459|P2|Overall Study|Protocol Violation|5
1187432|NCT01029886|3899460|P1|Overall Study|Protocol Violation|17
1187433|NCT01029886|3899459|P2|Overall Study|Physician Decision|6
1187434|NCT01029886|3899460|P1|Overall Study|Physician Decision|2
1187435|NCT01029886|3899459|P2|Overall Study|Lost to Follow-up|0
1187436|NCT01029886|3899460|P1|Overall Study|Lost to Follow-up|1
1187437|NCT01029886|3899459|P2|Overall Study|Adverse Event|25
1187438|NCT01029886|3899460|P1|Overall Study|Adverse Event|12
1187439|NCT01029795|3899488|P2|Overall Study|Withdrawal by Subject|3
1187440|NCT01029795|3899489|P1|Overall Study|Withdrawal by Subject|1
1187441|NCT01029795|3899488|P2|Overall Study|Sponsor Decision|17
1187442|NCT01029795|3899489|P1|Overall Study|Sponsor Decision|11
1187443|NCT01029795|3899488|P2|Overall Study|Physician Decision|1
1187444|NCT01029795|3899489|P1|Overall Study|Physician Decision|2
1187445|NCT01029795|3899488|P2|Overall Study|Entry Criteria Not Met|1
1187446|NCT01029795|3899489|P1|Overall Study|Entry Criteria Not Met|2
1187447|NCT01029782|3899543|P2|Overall Study|Withdrawal by Subject|1
1187448|NCT01029782|3899544|P1|Overall Study|Withdrawal by Subject|0
1187449|NCT01029782|3899543|P2|Overall Study|Protocol Violation|2
1187450|NCT01029782|3899544|P1|Overall Study|Protocol Violation|0
1187451|NCT01029782|3899543|P2|Overall Study|Physician Decision|1
1187452|NCT01029782|3899544|P1|Overall Study|Physician Decision|0
1187453|NCT01029782|3899543|P2|Overall Study|Adverse Event|1
1187454|NCT01029782|3899544|P1|Overall Study|Adverse Event|0
1187455|NCT01029782|3899543|P2|Overall Study|Diagnosis changed|1
1187456|NCT01029782|3899544|P1|Overall Study|Diagnosis changed|1
1187457|NCT01029782|3899543|P2|Overall Study|Lost to Follow-up|2
1187458|NCT01029782|3899544|P1|Overall Study|Lost to Follow-up|2
1187459|NCT01029691|3899596|P3|Continued APAP to Delivery|Death|1
1187460|NCT01029691|3899597|P2|Continued APAP to Delivery|Death|0
1187461|NCT01029691|3899598|P1|Continued APAP to Delivery|Death|0
1187462|NCT01029652|3899623|P2|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1
1187463|NCT01029652|3899624|P1|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0
1187464|NCT01029652|3899623|P2|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1
1187465|NCT01029652|3899624|P1|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0
1187466|NCT01029652|3899623|P2|Extension Study 2 (25-72 Weeks)|Death|1
1187467|NCT01029652|3899624|P1|Extension Study 2 (25-72 Weeks)|Death|1
1187468|NCT01029652|3899623|P2|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1
1187469|NCT01029652|3899624|P1|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0
1187470|NCT01029652|3899623|P2|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0
1187471|NCT01029652|3899624|P1|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1
1187472|NCT01029652|3899623|P2|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3
1187473|NCT01029652|3899624|P1|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2
1187474|NCT01029652|3899623|P2|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1
1187475|NCT01029652|3899624|P1|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0
1187476|NCT01029652|3899623|P2|Core Study (0-12 Weeks)|Death|1
1187477|NCT01029652|3899624|P1|Core Study (0-12 Weeks)|Death|0
1187478|NCT01029652|3899623|P2|Core Study (0-12 Weeks)|Administrative problems|1
1187479|NCT01029652|3899624|P1|Core Study (0-12 Weeks)|Administrative problems|2
1187480|NCT01029652|3899623|P2|Core Study (0-12 Weeks)|Lost to Follow-up|1
1187481|NCT01029652|3899624|P1|Core Study (0-12 Weeks)|Lost to Follow-up|3
1187482|NCT01029652|3899623|P2|Core Study (0-12 Weeks)|Patient Withdrew Consent|3
1187483|NCT01029652|3899624|P1|Core Study (0-12 Weeks)|Patient Withdrew Consent|1
1187484|NCT01029652|3899623|P2|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4
1187485|NCT01029652|3899624|P1|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0
1187486|NCT01029535|3899702|P1|Overall Study|Death|1
1187487|NCT01029535|3899702|P1|Overall Study|Use of Another Treatment|1
1187488|NCT01029535|3899702|P1|Overall Study|Adverse Event|1
1187489|NCT01029535|3899702|P1|Overall Study|Participant Withdrew Consent|2
1187490|NCT01029535|3899702|P1|Overall Study|Protocol Violation|2
1187491|NCT01029535|3899702|P1|Overall Study|Lost to Follow-up|24
1187492|NCT01029405|3899731|P4|Overall Study|Other|1
1187493|NCT01029405|3899732|P3|Overall Study|Other|0
1187494|NCT01029405|3899733|P2|Overall Study|Other|1
1187495|NCT01029405|3899734|P1|Overall Study|Other|0
1187496|NCT01029405|3899731|P4|Overall Study|Lost to Follow-up|2
1187497|NCT01029405|3899732|P3|Overall Study|Lost to Follow-up|1
1187498|NCT01029405|3899733|P2|Overall Study|Lost to Follow-up|1
1187499|NCT01029405|3899734|P1|Overall Study|Lost to Follow-up|2
1187500|NCT01029405|3899731|P4|Overall Study|Adverse Event|1
1187501|NCT01029405|3899732|P3|Overall Study|Adverse Event|1
1187502|NCT01029405|3899733|P2|Overall Study|Adverse Event|0
1187503|NCT01029405|3899734|P1|Overall Study|Adverse Event|0
1187504|NCT01029405|3899731|P4|Overall Study|Protocol Violation|1
1187505|NCT01029405|3899732|P3|Overall Study|Protocol Violation|0
1187506|NCT01029405|3899733|P2|Overall Study|Protocol Violation|0
1187507|NCT01029405|3899734|P1|Overall Study|Protocol Violation|0
1187508|NCT01029405|3899731|P4|Overall Study|Withdrawal by Subject|0
1187509|NCT01029405|3899732|P3|Overall Study|Withdrawal by Subject|2
1187510|NCT01029405|3899733|P2|Overall Study|Withdrawal by Subject|1
1187511|NCT01029405|3899734|P1|Overall Study|Withdrawal by Subject|0
1187512|NCT01029392|3899746|P2|Overall Study|Physician Decision|0
1187513|NCT01029392|3899747|P1|Overall Study|Physician Decision|2
1187514|NCT01029392|3899746|P2|Overall Study|Withdrawal by Subject|11
1187515|NCT01029392|3899747|P1|Overall Study|Withdrawal by Subject|18
1187516|NCT01029366|3899757|P2|Overall Study|manufacturing failure|1
1187517|NCT01029366|3899758|P1|Overall Study|manufacturing failure|0
1187518|NCT01029366|3899757|P2|Overall Study|disease progression|0
1187519|NCT01029366|3899758|P1|Overall Study|disease progression|2
1187520|NCT01029366|3899757|P2|Overall Study|Death|1
1187521|NCT01029366|3899758|P1|Overall Study|Death|1
1187522|NCT01029366|3899757|P2|Overall Study|Withdrawal by Subject|0
1187523|NCT01029366|3899758|P1|Overall Study|Withdrawal by Subject|1
1187524|NCT01029340|3899770|P6|Extension Period|Physician Decision|1
1187525|NCT01029340|3899771|P5|Extension Period|Physician Decision|0
1187526|NCT01029340|3899772|P4|Extension Period|Physician Decision|0
1187527|NCT01029340|3899773|P3|Extension Period|Physician Decision|0
1187528|NCT01029340|3899774|P2|Extension Period|Physician Decision|0
1187529|NCT01029340|3899775|P1|Extension Period|Physician Decision|0
1187530|NCT01029340|3899770|P6|Extension Period|Withdrawal by Subject|1
1187531|NCT01029340|3899771|P5|Extension Period|Withdrawal by Subject|0
1187532|NCT01029340|3899772|P4|Extension Period|Withdrawal by Subject|0
1187533|NCT01029340|3899773|P3|Extension Period|Withdrawal by Subject|0
1187534|NCT01029340|3899774|P2|Extension Period|Withdrawal by Subject|0
1187535|NCT01029340|3899775|P1|Extension Period|Withdrawal by Subject|0
1187536|NCT01029340|3899770|P6|Extension Period|non-compliance|1
1187537|NCT01029340|3899771|P5|Extension Period|non-compliance|0
1187538|NCT01029340|3899772|P4|Extension Period|non-compliance|0
1187539|NCT01029340|3899773|P3|Extension Period|non-compliance|0
1187540|NCT01029340|3899774|P2|Extension Period|non-compliance|0
1187541|NCT01029340|3899775|P1|Extension Period|non-compliance|0
1187542|NCT01029340|3899770|P6|Extension Period|starting another study|8
1187543|NCT01029340|3899771|P5|Extension Period|starting another study|0
1187544|NCT01029340|3899772|P4|Extension Period|starting another study|0
1187545|NCT01029340|3899773|P3|Extension Period|starting another study|0
1187546|NCT01029340|3899774|P2|Extension Period|starting another study|0
1187547|NCT01029340|3899775|P1|Extension Period|starting another study|0
1187548|NCT01029340|3899770|P6|Extension Period|Adverse Event|1
1187549|NCT01029340|3899771|P5|Extension Period|Adverse Event|0
1187550|NCT01029340|3899772|P4|Extension Period|Adverse Event|0
1187551|NCT01029340|3899773|P3|Extension Period|Adverse Event|0
1187552|NCT01029340|3899774|P2|Extension Period|Adverse Event|0
1187553|NCT01029340|3899775|P1|Extension Period|Adverse Event|0
1187554|NCT01029340|3899770|P6|Part B Treatment Period|Protocol Violation|0
1187555|NCT01029340|3899771|P5|Part B Treatment Period|Protocol Violation|0
1187556|NCT01029340|3899772|P4|Part B Treatment Period|Protocol Violation|0
1187557|NCT01029340|3899773|P3|Part B Treatment Period|Protocol Violation|1
1187558|NCT01029340|3899774|P2|Part B Treatment Period|Protocol Violation|0
1187559|NCT01029340|3899775|P1|Part B Treatment Period|Protocol Violation|0
1187560|NCT01029340|3899770|P6|Part B Treatment Period|Withdrawal by Subject|0
1187561|NCT01029340|3899771|P5|Part B Treatment Period|Withdrawal by Subject|0
1187562|NCT01029340|3899772|P4|Part B Treatment Period|Withdrawal by Subject|0
1187563|NCT01029340|3899773|P3|Part B Treatment Period|Withdrawal by Subject|1
1187564|NCT01029340|3899774|P2|Part B Treatment Period|Withdrawal by Subject|0
1187565|NCT01029340|3899775|P1|Part B Treatment Period|Withdrawal by Subject|0
1187566|NCT01029262|3899806|P2|Overall Study|Other|5
1187567|NCT01029262|3899807|P1|Overall Study|Other|1
1187568|NCT01029262|3899806|P2|Overall Study|Protocol Violation|3
1187569|NCT01029262|3899807|P1|Overall Study|Protocol Violation|2
1187570|NCT01029262|3899806|P2|Overall Study|Withdrawal by Subject|16
1187571|NCT01029262|3899807|P1|Overall Study|Withdrawal by Subject|10
1187572|NCT01029262|3899806|P2|Overall Study|Lack of therapeutic effect|69
1187573|NCT01029262|3899807|P1|Overall Study|Lack of therapeutic effect|56
1187574|NCT01029262|3899806|P2|Overall Study|Adverse Event|52
1187575|NCT01029262|3899807|P1|Overall Study|Adverse Event|9
1187576|NCT01028651|3899965|P1|Overall Study|Adverse Event|1
1187577|NCT01028651|3899965|P1|Overall Study|Death|2
1187578|NCT01028391|3899988|P2|Overall Study|Needed excluded medication|1
1187579|NCT01028391|3899989|P1|Overall Study|Needed excluded medication|1
1187580|NCT01028391|3899988|P2|Overall Study|Withdrawal by Subject|3
1187581|NCT01028391|3899989|P1|Overall Study|Withdrawal by Subject|6
1187582|NCT01028391|3899988|P2|Overall Study|Physician Decision|1
1187583|NCT01028391|3899989|P1|Overall Study|Physician Decision|0
1187584|NCT01028391|3899988|P2|Overall Study|Lost to Follow-up|4
1187585|NCT01028391|3899989|P1|Overall Study|Lost to Follow-up|3
1187586|NCT01028391|3899988|P2|Overall Study|Lack of Efficacy|2
1187587|NCT01028391|3899989|P1|Overall Study|Lack of Efficacy|0
1187588|NCT01028391|3899988|P2|Overall Study|Adverse Event|0
1187589|NCT01028391|3899989|P1|Overall Study|Adverse Event|4
1187590|NCT01028378|3899997|P1|Overall Study|Adminstrative Reasons|4
1187591|NCT01028378|3899997|P1|Overall Study|Withdrawal by Subject|1
1187592|NCT01028378|3899997|P1|Overall Study|Lost to Follow-up|12
1187593|NCT01028352|3900009|P1|Overall Study|Withdrawal by Subject|1
1187594|NCT01028352|3900009|P1|Overall Study|Ineligible due to baseline average pain|5
1187595|NCT01028300|3900014|P1|Overall Study|Study Terminated|4
1187596|NCT01028222|3900023|P2|Overall Study|Adverse Event|0
1187597|NCT01028222|3900024|P1|Overall Study|Adverse Event|2
1187598|NCT01028222|3900023|P2|Overall Study|Crossover to nilotinib w/out progression|2
1187599|NCT01028222|3900024|P1|Overall Study|Crossover to nilotinib w/out progression|0
1187600|NCT01028222|3900023|P2|Overall Study|Withdrawal by Subject|0
1187601|NCT01028222|3900024|P1|Overall Study|Withdrawal by Subject|1
1187602|NCT01028222|3900023|P2|Overall Study|Lost to Follow-up|1
1187603|NCT01028222|3900024|P1|Overall Study|Lost to Follow-up|0
1187604|NCT01028222|3900023|P2|Overall Study|Administrative problems|1
1187605|NCT01028222|3900024|P1|Overall Study|Administrative problems|1
1187606|NCT01028222|3900023|P2|Overall Study|Disease progression|9
1187607|NCT01028222|3900024|P1|Overall Study|Disease progression|33
1187608|NCT01028222|3900023|P2|Overall Study|Protocol deviation|0
1187609|NCT01028222|3900024|P1|Overall Study|Protocol deviation|1
1187610|NCT01028053|3900066|P1|Overall Study|Various reasons|4
1187611|NCT01028053|3900066|P1|Overall Study|Terminated by Sponsor|1
1187612|NCT01028053|3900066|P1|Overall Study|Technical Problem|1
1187613|NCT01028053|3900066|P1|Overall Study|Physician Decision|2
1187614|NCT01028053|3900066|P1|Overall Study|Protocol Violation|1
1187615|NCT01028053|3900066|P1|Overall Study|Patient Request|11
1187616|NCT01028053|3900066|P1|Overall Study|Screen Failure|113
1187617|NCT01028027|3900074|P2|Overall Study|Lack of Efficacy|1
1187618|NCT01028027|3900075|P1|Overall Study|Lack of Efficacy|0
1187619|NCT01028027|3900074|P2|Overall Study|Protocol Violation|1
1187620|NCT01028027|3900075|P1|Overall Study|Protocol Violation|3
1187621|NCT01028027|3900074|P2|Overall Study|Adverse Event|7
1187622|NCT01028027|3900075|P1|Overall Study|Adverse Event|4
1187623|NCT01028027|3900074|P2|Overall Study|Withdrawal by Subject|3
1187624|NCT01028027|3900075|P1|Overall Study|Withdrawal by Subject|5
1187625|NCT01028027|3900074|P2|Overall Study|Lost to Follow-up|1
1187626|NCT01028027|3900075|P1|Overall Study|Lost to Follow-up|4
1187627|NCT01028014|3900097|P6|Overall Study|Lost to Follow-up|2
1187628|NCT01028014|3900098|P5|Overall Study|Lost to Follow-up|1
1187629|NCT01028014|3900099|P4|Overall Study|Lost to Follow-up|1
1187630|NCT01028014|3900100|P3|Overall Study|Lost to Follow-up|0
1187631|NCT01028014|3900101|P2|Overall Study|Lost to Follow-up|2
1187632|NCT01028014|3900102|P1|Overall Study|Lost to Follow-up|1
1187633|NCT01027897|3900143|P1|Overall Study|Withdrawal by Subject|1
1187634|NCT01027897|3900143|P1|Overall Study|Protocol Violation|1
1187635|NCT01027884|3900151|P2|Overall Study|Spinal fixation surgery|3
1187636|NCT01027884|3900152|P1|Overall Study|Spinal fixation surgery|0
1187637|NCT01027884|3900151|P2|Overall Study|Lost to Follow-up|1
1187638|NCT01027884|3900152|P1|Overall Study|Lost to Follow-up|0
1187639|NCT01027884|3900151|P2|Overall Study|Withdrawal by Subject|1
1187640|NCT01027884|3900152|P1|Overall Study|Withdrawal by Subject|0
1187641|NCT01027884|3900151|P2|Overall Study|Non-compliance|1
1187642|NCT01027884|3900152|P1|Overall Study|Non-compliance|1
1187643|NCT01027884|3900151|P2|Overall Study|Protocol Violation|0
1187644|NCT01027884|3900152|P1|Overall Study|Protocol Violation|1
1187645|NCT01027884|3900151|P2|Overall Study|Adverse Event|1
1187646|NCT01027884|3900152|P1|Overall Study|Adverse Event|2
1187647|NCT01027871|3900169|P3|Overall Study|Discontinued Prior to Treatment|1
1187648|NCT01027871|3900170|P2|Overall Study|Discontinued Prior to Treatment|0
1187649|NCT01027871|3900171|P1|Overall Study|Discontinued Prior to Treatment|0
1187650|NCT01027871|3900169|P3|Overall Study|Sponsor Decision|0
1187651|NCT01027871|3900170|P2|Overall Study|Sponsor Decision|2
1187652|NCT01027871|3900171|P1|Overall Study|Sponsor Decision|0
1187653|NCT01027871|3900169|P3|Overall Study|Adverse Event|2
1187654|NCT01027871|3900170|P2|Overall Study|Adverse Event|2
1187655|NCT01027871|3900171|P1|Overall Study|Adverse Event|0
1187656|NCT01027871|3900169|P3|Overall Study|Withdrawal by Subject|2
1187657|NCT01027871|3900170|P2|Overall Study|Withdrawal by Subject|2
1187658|NCT01027871|3900171|P1|Overall Study|Withdrawal by Subject|1
1187659|NCT01027871|3900169|P3|Overall Study|Protocol Violation|2
1187660|NCT01027871|3900170|P2|Overall Study|Protocol Violation|2
1187661|NCT01027871|3900171|P1|Overall Study|Protocol Violation|0
1187662|NCT01027871|3900169|P3|Overall Study|Physician Decision|0
1187663|NCT01027871|3900170|P2|Overall Study|Physician Decision|5
1187664|NCT01027871|3900171|P1|Overall Study|Physician Decision|1
1187665|NCT01027702|3900250|P7|Overall Study|Death|0
1187666|NCT01027702|3900251|P6|Overall Study|Death|0
1187667|NCT01027702|3900252|P5|Overall Study|Death|0
1187668|NCT01027702|3900253|P4|Overall Study|Death|0
1187669|NCT01027702|3900254|P3|Overall Study|Death|1
1187670|NCT01027702|3900255|P2|Overall Study|Death|0
1187671|NCT01027702|3900256|P1|Overall Study|Death|0
1187672|NCT01027702|3900250|P7|Overall Study|Received subsequent therapy|1
1187673|NCT01027702|3900251|P6|Overall Study|Received subsequent therapy|0
1187674|NCT01027702|3900252|P5|Overall Study|Received subsequent therapy|1
1187675|NCT01027702|3900253|P4|Overall Study|Received subsequent therapy|4
1187676|NCT01027702|3900254|P3|Overall Study|Received subsequent therapy|0
1187677|NCT01027702|3900255|P2|Overall Study|Received subsequent therapy|2
1187678|NCT01027702|3900256|P1|Overall Study|Received subsequent therapy|1
1187679|NCT01027650|3900282|P8|Overall Study|Lack of Efficacy|0
1187680|NCT01027650|3900283|P7|Overall Study|Lack of Efficacy|0
1187681|NCT01027650|3900284|P6|Overall Study|Lack of Efficacy|1
1187682|NCT01027650|3900285|P5|Overall Study|Lack of Efficacy|0
1187683|NCT01027650|3900286|P4|Overall Study|Lack of Efficacy|0
1187684|NCT01027650|3900287|P3|Overall Study|Lack of Efficacy|0
1187685|NCT01027650|3900288|P2|Overall Study|Lack of Efficacy|0
1187686|NCT01027650|3900289|P1|Overall Study|Lack of Efficacy|0
1187687|NCT01027650|3900282|P8|Overall Study|Lost to Follow-up|0
1187688|NCT01027650|3900283|P7|Overall Study|Lost to Follow-up|1
1187689|NCT01027650|3900284|P6|Overall Study|Lost to Follow-up|0
1187690|NCT01027650|3900285|P5|Overall Study|Lost to Follow-up|0
1187691|NCT01027650|3900286|P4|Overall Study|Lost to Follow-up|0
1187692|NCT01027650|3900287|P3|Overall Study|Lost to Follow-up|0
1187693|NCT01027650|3900288|P2|Overall Study|Lost to Follow-up|0
1187694|NCT01027650|3900289|P1|Overall Study|Lost to Follow-up|0
1187695|NCT01027650|3900282|P8|Overall Study|Personal Reasons|0
1187696|NCT01027650|3900283|P7|Overall Study|Personal Reasons|0
1187697|NCT01027650|3900284|P6|Overall Study|Personal Reasons|1
1187698|NCT01027650|3900285|P5|Overall Study|Personal Reasons|2
1187699|NCT01027650|3900286|P4|Overall Study|Personal Reasons|0
1187700|NCT01027650|3900287|P3|Overall Study|Personal Reasons|0
1187701|NCT01027650|3900288|P2|Overall Study|Personal Reasons|0
1187702|NCT01027650|3900289|P1|Overall Study|Personal Reasons|0
1187703|NCT01027416|3900365|P2|Overall Study|Physician Decision|4
1187704|NCT01027416|3900366|P1|Overall Study|Physician Decision|1
1187705|NCT01027416|3900365|P2|Overall Study|Withdrawal by Subject|1
1187706|NCT01027416|3900366|P1|Overall Study|Withdrawal by Subject|0
1187707|NCT01027364|3900378|P4|Overall Study|Withdrawal by Subject|0
1187708|NCT01027364|3900379|P3|Overall Study|Withdrawal by Subject|0
1187709|NCT01027364|3900380|P2|Overall Study|Withdrawal by Subject|2
1187710|NCT01027364|3900381|P1|Overall Study|Withdrawal by Subject|1
1187711|NCT01027364|3900378|P4|Overall Study|Protocol Violation|1
1187712|NCT01027364|3900379|P3|Overall Study|Protocol Violation|0
1187713|NCT01027364|3900380|P2|Overall Study|Protocol Violation|0
1187714|NCT01027364|3900381|P1|Overall Study|Protocol Violation|1
1187715|NCT01027364|3900378|P4|Overall Study|Lost to Follow-up|0
1187716|NCT01027364|3900379|P3|Overall Study|Lost to Follow-up|0
1187717|NCT01027364|3900380|P2|Overall Study|Lost to Follow-up|0
1187718|NCT01027364|3900381|P1|Overall Study|Lost to Follow-up|1
1187719|NCT01027364|3900378|P4|Overall Study|Adverse Event|0
1187720|NCT01027364|3900379|P3|Overall Study|Adverse Event|1
1187721|NCT01027364|3900380|P2|Overall Study|Adverse Event|0
1187722|NCT01027364|3900381|P1|Overall Study|Adverse Event|1
1187723|NCT01027351|3900476|P6|Overall Study|Protocol Violation|0
1187724|NCT01027351|3900477|P5|Overall Study|Protocol Violation|1
1187725|NCT01027351|3900478|P4|Overall Study|Protocol Violation|1
1187726|NCT01027351|3900479|P3|Overall Study|Protocol Violation|0
1187727|NCT01027351|3900480|P2|Overall Study|Protocol Violation|0
1187728|NCT01027351|3900481|P1|Overall Study|Protocol Violation|1
1187729|NCT01027351|3900476|P6|Overall Study|Inappropriate enrollment|0
1187730|NCT01027351|3900477|P5|Overall Study|Inappropriate enrollment|1
1187731|NCT01027351|3900478|P4|Overall Study|Inappropriate enrollment|0
1187732|NCT01027351|3900479|P3|Overall Study|Inappropriate enrollment|0
1187733|NCT01027351|3900480|P2|Overall Study|Inappropriate enrollment|0
1187734|NCT01027351|3900481|P1|Overall Study|Inappropriate enrollment|0
1187735|NCT01027351|3900476|P6|Overall Study|Lost to Follow-up|0
1187736|NCT01027351|3900477|P5|Overall Study|Lost to Follow-up|6
1187737|NCT01027351|3900478|P4|Overall Study|Lost to Follow-up|1
1187738|NCT01027351|3900479|P3|Overall Study|Lost to Follow-up|0
1187739|NCT01027351|3900480|P2|Overall Study|Lost to Follow-up|1
1187740|NCT01027351|3900481|P1|Overall Study|Lost to Follow-up|1
1187741|NCT01027351|3900476|P6|Overall Study|Withdrawal by Subject|5
1187742|NCT01027351|3900477|P5|Overall Study|Withdrawal by Subject|3
1187743|NCT01027351|3900478|P4|Overall Study|Withdrawal by Subject|0
1187744|NCT01027351|3900479|P3|Overall Study|Withdrawal by Subject|1
1187745|NCT01027351|3900480|P2|Overall Study|Withdrawal by Subject|0
1187746|NCT01027351|3900481|P1|Overall Study|Withdrawal by Subject|1
1187747|NCT01027286|3900565|P2|Overall Study|Lost to Follow-up|1
1187748|NCT01027286|3900566|P1|Overall Study|Lost to Follow-up|0
1187749|NCT01027286|3900565|P2|Overall Study|Unable to Obtain Required Blood Volume|0
1187750|NCT01027286|3900566|P1|Overall Study|Unable to Obtain Required Blood Volume|1
1187751|NCT01027273|3900586|P2|Overall Study|Death|2
1187752|NCT01027273|3900587|P1|Overall Study|Death|2
1187753|NCT01027273|3900586|P2|Overall Study|Lost to Follow-up|31
1187754|NCT01027273|3900587|P1|Overall Study|Lost to Follow-up|57
1187755|NCT01026974|3900634|P4|Overall Study|Inappropriate enrollment|0
1187756|NCT01026974|3900635|P3|Overall Study|Inappropriate enrollment|1
1187757|NCT01026974|3900636|P2|Overall Study|Inappropriate enrollment|0
1187758|NCT01026974|3900637|P1|Overall Study|Inappropriate enrollment|0
1187759|NCT01026974|3900634|P4|Overall Study|Adverse Event|1
1187760|NCT01026974|3900635|P3|Overall Study|Adverse Event|0
1187761|NCT01026974|3900636|P2|Overall Study|Adverse Event|0
1187762|NCT01026974|3900637|P1|Overall Study|Adverse Event|0
1187763|NCT01026974|3900634|P4|Overall Study|Lost to Follow-up|0
1187764|NCT01026974|3900635|P3|Overall Study|Lost to Follow-up|4
1187765|NCT01026974|3900636|P2|Overall Study|Lost to Follow-up|1
1187766|NCT01026974|3900637|P1|Overall Study|Lost to Follow-up|1
1187767|NCT01026974|3900634|P4|Overall Study|Withdrawal by Subject|2
1187768|NCT01026974|3900635|P3|Overall Study|Withdrawal by Subject|7
1187769|NCT01026974|3900636|P2|Overall Study|Withdrawal by Subject|1
1187770|NCT01026974|3900637|P1|Overall Study|Withdrawal by Subject|0
1187771|NCT01026948|3900694|P1|Overall Study|Physician Decision|8
1187772|NCT01026831|3900727|P2|Overall Study|Withdrawal by Subject|5
1187773|NCT01026831|3900728|P1|Overall Study|Withdrawal by Subject|7
1187774|NCT01026831|3900727|P2|Overall Study|Protocol Violation|2
1187775|NCT01026831|3900728|P1|Overall Study|Protocol Violation|0
1187776|NCT01026831|3900727|P2|Overall Study|Physician Decision|1
1187777|NCT01026831|3900728|P1|Overall Study|Physician Decision|1
1187778|NCT01026831|3900727|P2|Overall Study|Lost to Follow-up|0
1187779|NCT01026831|3900728|P1|Overall Study|Lost to Follow-up|2
1187780|NCT01026831|3900727|P2|Overall Study|Adverse Event|3
1187781|NCT01026831|3900728|P1|Overall Study|Adverse Event|4
1187782|NCT01026818|3900739|P4|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1
1187783|NCT01026818|3900740|P3|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
1187784|NCT01026818|3900741|P2|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2
1187785|NCT01026818|3900742|P1|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
1187786|NCT01026818|3900739|P4|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
1187787|NCT01026818|3900740|P3|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3
1187788|NCT01026818|3900741|P2|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
1187789|NCT01026818|3900742|P1|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0
1187790|NCT01026818|3900739|P4|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
1187791|NCT01026818|3900740|P3|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2
1187792|NCT01026818|3900741|P2|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
1187793|NCT01026818|3900742|P1|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0
1187794|NCT01026818|3900739|P4|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
1187795|NCT01026818|3900740|P3|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
1187796|NCT01026818|3900741|P2|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1
1187797|NCT01026818|3900742|P1|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
1187798|NCT01026818|3900739|P4|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
1187799|NCT01026818|3900740|P3|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
1187800|NCT01026818|3900741|P2|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2
1187801|NCT01026818|3900742|P1|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
1187802|NCT01026818|3900739|P4|Drug-Free Washout Period (Month 9-10.5)|Death|1
1187803|NCT01026818|3900740|P3|Drug-Free Washout Period (Month 9-10.5)|Death|0
1187804|NCT01026818|3900741|P2|Drug-Free Washout Period (Month 9-10.5)|Death|0
1187805|NCT01026818|3900742|P1|Drug-Free Washout Period (Month 9-10.5)|Death|0
1187881|NCT01026493|3900844|P6|Overall Study|Protocol Violation|3
1187806|NCT01026818|3900739|P4|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
1187807|NCT01026818|3900740|P3|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2
1187808|NCT01026818|3900741|P2|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1
1187809|NCT01026818|3900742|P1|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
1187810|NCT01026818|3900739|P4|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
1187811|NCT01026818|3900740|P3|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
1187812|NCT01026818|3900741|P2|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1
1187813|NCT01026818|3900742|P1|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
1187814|NCT01026818|3900739|P4|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
1187815|NCT01026818|3900740|P3|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
1187816|NCT01026818|3900741|P2|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
1187817|NCT01026818|3900742|P1|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
1187818|NCT01026818|3900739|P4|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2
1187819|NCT01026818|3900740|P3|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
1187820|NCT01026818|3900741|P2|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1
1187821|NCT01026818|3900742|P1|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
1187822|NCT01026818|3900739|P4|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
1187823|NCT01026818|3900740|P3|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
1187824|NCT01026818|3900741|P2|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1
1187825|NCT01026818|3900742|P1|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
1187826|NCT01026818|3900739|P4|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
1187827|NCT01026818|3900740|P3|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1
1187828|NCT01026818|3900741|P2|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
1187829|NCT01026818|3900742|P1|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0
1187830|NCT01026818|3900739|P4|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
1187831|NCT01026818|3900740|P3|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1
1187832|NCT01026818|3900741|P2|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
1187833|NCT01026818|3900742|P1|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0
1187834|NCT01026818|3900739|P4|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2
1187835|NCT01026818|3900740|P3|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1
1187836|NCT01026818|3900741|P2|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
1187837|NCT01026818|3900742|P1|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
1187838|NCT01026818|3900739|P4|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7
1187839|NCT01026818|3900740|P3|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9
1187840|NCT01026818|3900741|P2|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2
1187841|NCT01026818|3900742|P1|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0
1187842|NCT01026818|3900739|P4|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4
1187843|NCT01026818|3900740|P3|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
1187844|NCT01026818|3900741|P2|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3
1187845|NCT01026818|3900742|P1|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
1187846|NCT01026818|3900739|P4|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6
1187847|NCT01026818|3900740|P3|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2
1187848|NCT01026818|3900741|P2|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3
1187849|NCT01026818|3900742|P1|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0
1187850|NCT01026818|3900739|P4|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
1187851|NCT01026818|3900740|P3|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
1187852|NCT01026818|3900741|P2|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7
1187853|NCT01026818|3900742|P1|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0
1187854|NCT01026818|3900739|P4|DB Treatment Period (Month 0 - 9)|Adverse Event|4
1187855|NCT01026818|3900740|P3|DB Treatment Period (Month 0 - 9)|Adverse Event|6
1187856|NCT01026818|3900741|P2|DB Treatment Period (Month 0 - 9)|Adverse Event|10
1187857|NCT01026818|3900742|P1|DB Treatment Period (Month 0 - 9)|Adverse Event|0
1187858|NCT01026818|3900739|P4|Screening Period|Physician Decision|0
1187859|NCT01026818|3900740|P3|Screening Period|Physician Decision|0
1187860|NCT01026818|3900741|P2|Screening Period|Physician Decision|0
1187861|NCT01026818|3900742|P1|Screening Period|Physician Decision|1
1187862|NCT01026818|3900739|P4|Screening Period|Adverse Event|0
1187863|NCT01026818|3900740|P3|Screening Period|Adverse Event|0
1187864|NCT01026818|3900741|P2|Screening Period|Adverse Event|0
1187865|NCT01026818|3900742|P1|Screening Period|Adverse Event|2
1187866|NCT01026818|3900739|P4|Screening Period|Protocol Deviation|0
1187867|NCT01026818|3900740|P3|Screening Period|Protocol Deviation|0
1187868|NCT01026818|3900741|P2|Screening Period|Protocol Deviation|0
1187869|NCT01026818|3900742|P1|Screening Period|Protocol Deviation|3
1187870|NCT01026818|3900739|P4|Screening Period|Withdrawal by Subject|0
1187871|NCT01026818|3900740|P3|Screening Period|Withdrawal by Subject|0
1187872|NCT01026818|3900741|P2|Screening Period|Withdrawal by Subject|0
1187873|NCT01026818|3900742|P1|Screening Period|Withdrawal by Subject|49
1187874|NCT01026818|3900739|P4|Screening Period|Entry Criteria Not Met|0
1187875|NCT01026818|3900740|P3|Screening Period|Entry Criteria Not Met|0
1187876|NCT01026818|3900741|P2|Screening Period|Entry Criteria Not Met|0
1187877|NCT01026818|3900742|P1|Screening Period|Entry Criteria Not Met|105
1187878|NCT01026792|3900830|P1|Overall Study|Protocol Violation|1
1187879|NCT01026493|3900842|P8|Overall Study|Protocol Violation|1
1187880|NCT01026493|3900843|P7|Overall Study|Protocol Violation|4
1187882|NCT01026493|3900845|P5|Overall Study|Protocol Violation|2
1187883|NCT01026493|3900846|P4|Overall Study|Protocol Violation|0
1187884|NCT01026493|3900847|P3|Overall Study|Protocol Violation|0
1187885|NCT01026493|3900848|P2|Overall Study|Protocol Violation|1
1187886|NCT01026493|3900849|P1|Overall Study|Protocol Violation|0
1187887|NCT01026454|3900877|P2|Second Intervention|Pregnancy|1
1187888|NCT01026454|3900878|P1|Second Intervention|Pregnancy|1
1187889|NCT01026389|3901227|P2|Overall Study|change of treatment, patient moved|2
1187890|NCT01026389|3901228|P1|Overall Study|change of treatment, patient moved|4
1187891|NCT01026389|3901227|P2|Overall Study|Withdrawal by Subject|3
1187892|NCT01026389|3901228|P1|Overall Study|Withdrawal by Subject|1
1187893|NCT01026324|3901243|P3|Follow up/Survival|Withdrawal by Subject|0
1187894|NCT01026324|3901244|P2|Follow up/Survival|Withdrawal by Subject|0
1187895|NCT01026324|3901245|P1|Follow up/Survival|Withdrawal by Subject|1
1187896|NCT01026220|3901255|P3|Consolidation Maintenance|Withdrawal by Subject|6
1187897|NCT01026220|3901256|P2|Consolidation Maintenance|Withdrawal by Subject|2
1187898|NCT01026220|3901257|P1|Consolidation Maintenance|Withdrawal by Subject|0
1187899|NCT01026220|3901255|P3|Consolidation Maintenance|Physician Decision|7
1187900|NCT01026220|3901256|P2|Consolidation Maintenance|Physician Decision|2
1187901|NCT01026220|3901257|P1|Consolidation Maintenance|Physician Decision|0
1187902|NCT01026220|3901255|P3|Consolidation Maintenance|Lack of Efficacy|1
1187903|NCT01026220|3901256|P2|Consolidation Maintenance|Lack of Efficacy|1
1187904|NCT01026220|3901257|P1|Consolidation Maintenance|Lack of Efficacy|0
1187905|NCT01026220|3901255|P3|Consolidation Maintenance|Death|0
1187906|NCT01026220|3901256|P2|Consolidation Maintenance|Death|1
1187907|NCT01026220|3901257|P1|Consolidation Maintenance|Death|0
1187908|NCT01026220|3901255|P3|Induction|Ineligible|0
1187909|NCT01026220|3901256|P2|Induction|Ineligible|0
1187910|NCT01026220|3901257|P1|Induction|Ineligible|1
1187911|NCT01026220|3901255|P3|Induction|Withdrawal by Subject|0
1187912|NCT01026220|3901256|P2|Induction|Withdrawal by Subject|0
1187913|NCT01026220|3901257|P1|Induction|Withdrawal by Subject|9
1187914|NCT01026220|3901255|P3|Induction|Physician Decision|0
1187915|NCT01026220|3901256|P2|Induction|Physician Decision|0
1187916|NCT01026220|3901257|P1|Induction|Physician Decision|12
1187917|NCT01026220|3901255|P3|Induction|Lack of Efficacy|0
1187918|NCT01026220|3901256|P2|Induction|Lack of Efficacy|0
1187919|NCT01026220|3901257|P1|Induction|Lack of Efficacy|2
1187920|NCT01026220|3901255|P3|Induction|Death|0
1187921|NCT01026220|3901256|P2|Induction|Death|0
1187922|NCT01026220|3901257|P1|Induction|Death|1
1187923|NCT01026194|3901281|P2|Period 2：Open-label Period|Withdrawal by Subject|4
1187924|NCT01026194|3901282|P1|Period 2：Open-label Period|Withdrawal by Subject|0
1187925|NCT01026194|3901281|P2|Period 2：Open-label Period|Physician Decision|1
1187926|NCT01026194|3901282|P1|Period 2：Open-label Period|Physician Decision|3
1187927|NCT01026194|3901281|P2|Period 2：Open-label Period|Adverse Event|5
1187928|NCT01026194|3901282|P1|Period 2：Open-label Period|Adverse Event|4
1187929|NCT01026194|3901281|P2|Period 1：Double Blind Period|Physician Decision|4
1187930|NCT01026194|3901282|P1|Period 1：Double Blind Period|Physician Decision|0
1187931|NCT01026194|3901281|P2|Period 1：Double Blind Period|Lack of Efficacy|0
1187932|NCT01026194|3901282|P1|Period 1：Double Blind Period|Lack of Efficacy|1
1187933|NCT01026194|3901281|P2|Period 1：Double Blind Period|Adverse Event|1
1187934|NCT01026194|3901282|P1|Period 1：Double Blind Period|Adverse Event|2
1187935|NCT01026142|3901314|P2|Overall Study|Withdrew consent or lost to follow-up|29
1187936|NCT01026142|3901315|P1|Overall Study|Withdrew consent or lost to follow-up|36
1187937|NCT01026142|3901314|P2|Overall Study|Death|134
1187938|NCT01026142|3901315|P1|Overall Study|Death|136
1187939|NCT01026103|3901337|P1|Overall Study|did not receive study device bc of error|1
1187940|NCT01026103|3901337|P1|Overall Study|Physician Decision|1
1187941|NCT01026038|3901347|P3|Overall Study|Lost to Follow-up|0
1187942|NCT01026038|3901348|P2|Overall Study|Lost to Follow-up|1
1187943|NCT01026038|3901349|P1|Overall Study|Lost to Follow-up|1
1187944|NCT01025843|3901398|P10|Washout 4|Withdrawal by Subject|0
1187945|NCT01025843|3901399|P9|Washout 4|Withdrawal by Subject|0
1187946|NCT01025843|3901400|P8|Washout 4|Withdrawal by Subject|0
1187947|NCT01025843|3901401|P7|Washout 4|Withdrawal by Subject|0
1187948|NCT01025843|3901402|P6|Washout 4|Withdrawal by Subject|0
1187949|NCT01025843|3901403|P5|Washout 4|Withdrawal by Subject|0
1187950|NCT01025843|3901404|P4|Washout 4|Withdrawal by Subject|1
1187951|NCT01025843|3901405|P3|Washout 4|Withdrawal by Subject|1
1187952|NCT01025843|3901406|P2|Washout 4|Withdrawal by Subject|0
1187953|NCT01025843|3901407|P1|Washout 4|Withdrawal by Subject|0
1187954|NCT01025817|3901501|P2|Completed Study|Lost to Follow-up|1
1187955|NCT01025817|3901502|P1|Completed Study|Lost to Follow-up|0
1187956|NCT01025817|3901501|P2|Completed Study|Missing|0
1187957|NCT01025817|3901502|P1|Completed Study|Missing|2
1187958|NCT01025817|3901501|P2|Completed Study|Death|5
1187959|NCT01025817|3901502|P1|Completed Study|Death|6
1187960|NCT01025817|3901501|P2|Completed Study|Withdrawal by Subject|16
1187961|NCT01025817|3901502|P1|Completed Study|Withdrawal by Subject|8
1187962|NCT01025817|3901501|P2|Completed Study Medication|Lost to Follow-up|1
1187963|NCT01025817|3901502|P1|Completed Study Medication|Lost to Follow-up|0
1187964|NCT01025817|3901501|P2|Completed Study Medication|Subject no longer required study drug|1
1187965|NCT01025817|3901502|P1|Completed Study Medication|Subject no longer required study drug|0
1187966|NCT01025817|3901501|P2|Completed Study Medication|Abnormal lab values|2
1187967|NCT01025817|3901502|P1|Completed Study Medication|Abnormal lab values|0
1187968|NCT01025817|3901501|P2|Completed Study Medication|Death|2
1187969|NCT01025817|3901502|P1|Completed Study Medication|Death|2
1187970|NCT01025817|3901501|P2|Completed Study Medication|Graft loss|5
1187971|NCT01025817|3901502|P1|Completed Study Medication|Graft loss|2
1187972|NCT01025817|3901501|P2|Completed Study Medication|Abnormal test procedure|0
1187973|NCT01025817|3901502|P1|Completed Study Medication|Abnormal test procedure|4
1187974|NCT01025817|3901501|P2|Completed Study Medication|Unsatisfactory therapeutic effect|0
1187975|NCT01025817|3901502|P1|Completed Study Medication|Unsatisfactory therapeutic effect|7
1187976|NCT01025817|3901501|P2|Completed Study Medication|Administrative problems|5
1187977|NCT01025817|3901502|P1|Completed Study Medication|Administrative problems|7
1187978|NCT01025817|3901501|P2|Completed Study Medication|Withdrawal by Subject|9
1187979|NCT01025817|3901502|P1|Completed Study Medication|Withdrawal by Subject|8
1187980|NCT01025817|3901501|P2|Completed Study Medication|Protocol Deviation|8
1187981|NCT01025817|3901502|P1|Completed Study Medication|Protocol Deviation|9
1187982|NCT01025817|3901501|P2|Completed Study Medication|Adverse Event|39
1187983|NCT01025817|3901502|P1|Completed Study Medication|Adverse Event|66
1187984|NCT01025752|3901522|P2|Overall Study|Physician Decision|3
1187985|NCT01025752|3901523|P1|Overall Study|Physician Decision|1
1187986|NCT01025752|3901522|P2|Overall Study|Lost to Follow-up|10
1187987|NCT01025752|3901523|P1|Overall Study|Lost to Follow-up|7
1187988|NCT01025635|3901543|P2|Overall Study|Reason not known|2
1187989|NCT01025635|3901544|P1|Overall Study|Reason not known|4
1187990|NCT01025635|3901543|P2|Overall Study|Lost to Follow-up|13
1187991|NCT01025635|3901544|P1|Overall Study|Lost to Follow-up|9
1187992|NCT01025635|3901543|P2|Overall Study|Lack of Efficacy|1
1187993|NCT01025635|3901544|P1|Overall Study|Lack of Efficacy|0
1187994|NCT01025635|3901543|P2|Overall Study|Protocol Violation|2
1187995|NCT01025635|3901544|P1|Overall Study|Protocol Violation|4
1187996|NCT01025635|3901543|P2|Overall Study|Withdrawal by Subject|7
1187997|NCT01025635|3901544|P1|Overall Study|Withdrawal by Subject|6
1187998|NCT01025336|3901572|P5|Overall Study|Protocol Violation|0
1187999|NCT01025336|3901573|P4|Overall Study|Protocol Violation|2
1188000|NCT01025336|3901574|P3|Overall Study|Protocol Violation|0
1188001|NCT01025336|3901575|P2|Overall Study|Protocol Violation|0
1188002|NCT01025336|3901576|P1|Overall Study|Protocol Violation|0
1188003|NCT01025284|3901631|P3|Overall Study|Withdrawal by Subject|0
1188004|NCT01025284|3901632|P2|Overall Study|Withdrawal by Subject|1
1188005|NCT01025284|3901633|P1|Overall Study|Withdrawal by Subject|0
1188006|NCT01025284|3901631|P3|Overall Study|Investigator Decision|0
1188007|NCT01025284|3901632|P2|Overall Study|Investigator Decision|1
1188008|NCT01025284|3901633|P1|Overall Study|Investigator Decision|0
1188009|NCT01025232|3901658|P2|Overall Study|Study drug no longer available|6
1188010|NCT01025232|3901659|P1|Overall Study|Study drug no longer available|3
1188011|NCT01025193|3901677|P1|Overall Study|Adverse Event|3
1188012|NCT01025193|3901677|P1|Overall Study|Protocol Violation|1
1188013|NCT01025154|3901687|P1|Overall Study|Withdrawal by Subject|1
1188014|NCT01025154|3901687|P1|Overall Study|Lost to Follow-up|1
1188015|NCT01025037|3901696|P1|Overall Study|Withdrawal by Subject|1
1188016|NCT01025037|3901696|P1|Overall Study|Lost to Follow-up|7
1188017|NCT01025037|3901696|P1|Overall Study|Adverse Event|3
1188018|NCT01024959|3901718|P1|Overall Study|missing results required for analysis|17
1188019|NCT01024959|3901718|P1|Overall Study|results not evaluable|12
1188020|NCT01024959|3901718|P1|Overall Study|ineligible|12
1188021|NCT01024946|3901727|P1|Overall Study|Adverse Event|1
1188022|NCT01024946|3901727|P1|Overall Study|Withdrawal by Subject|1
1188023|NCT01024946|3901727|P1|Overall Study|Screen Failure|3
1188024|NCT01024855|3901731|P1|Overall Study|Inclusion/exclusion criteria|1
1188025|NCT01024751|3901738|P2|Eligible Participants|Ineligible|1
1188026|NCT01024751|3901739|P1|Eligible Participants|Ineligible|0
1188027|NCT01024751|3901738|P2|Eligible Participants|Lost to Follow-up|1
1188028|NCT01024751|3901739|P1|Eligible Participants|Lost to Follow-up|0
1188029|NCT01024751|3901738|P2|Eligible Participants|Withdrawal by Subject|1
1188030|NCT01024751|3901739|P1|Eligible Participants|Withdrawal by Subject|0
1188031|NCT01024751|3901738|P2|Enrolled Participants|Ineligible at baseline|4
1188032|NCT01024751|3901739|P1|Enrolled Participants|Ineligible at baseline|3
1188033|NCT01024608|3901762|P2|Overall Study|Never received study treatment|0
1188034|NCT01024608|3901763|P1|Overall Study|Never received study treatment|2
1188035|NCT01024608|3901762|P2|Overall Study|Protocol Violation|3
1188036|NCT01024608|3901763|P1|Overall Study|Protocol Violation|0
1188037|NCT01024608|3901762|P2|Overall Study|Lost to Follow-up|1
1188038|NCT01024608|3901763|P1|Overall Study|Lost to Follow-up|0
1188039|NCT01024608|3901762|P2|Overall Study|Withdrawal by Subject|0
1188040|NCT01024608|3901763|P1|Overall Study|Withdrawal by Subject|1
1188041|NCT01024608|3901762|P2|Overall Study|Adverse Event|0
1188042|NCT01024608|3901763|P1|Overall Study|Adverse Event|1
1188043|NCT01024465|3901775|P1|Overall Study|Physician Decision|1
1188044|NCT01024465|3901775|P1|Overall Study|Adverse Event|2
1188045|NCT01024387|3901779|P1|Overall Study|Other|5
1188046|NCT01024387|3901779|P1|Overall Study|Adverse Event|3
1188047|NCT01024387|3901779|P1|Overall Study|Prolonged Treatment Delay|1
1188048|NCT01024387|3901779|P1|Overall Study|Death|2
1188049|NCT01024387|3901779|P1|Overall Study|Withdrawal by Subject|5
1188050|NCT01024387|3901779|P1|Overall Study|Physician Decision|5
1188051|NCT01024387|3901779|P1|Overall Study|Symptomatic Progression|10
1188052|NCT01024387|3901779|P1|Overall Study|Radiographic Progression|29
1188053|NCT01024309|3901800|P2|Overall Study|Withdrawal by Subject|4
1188054|NCT01024309|3901801|P1|Overall Study|Withdrawal by Subject|4
1188055|NCT01024309|3901800|P2|Overall Study|Physician Decision|0
1188056|NCT01024309|3901801|P1|Overall Study|Physician Decision|4
1188057|NCT01024244|3901833|P5|Overall Study|Withdrawal by Subject|0
1188058|NCT01024244|3901834|P4|Overall Study|Withdrawal by Subject|0
1188059|NCT01024244|3901835|P3|Overall Study|Withdrawal by Subject|0
1188060|NCT01024244|3901836|P2|Overall Study|Withdrawal by Subject|1
1188061|NCT01024244|3901837|P1|Overall Study|Withdrawal by Subject|0
1188062|NCT01024244|3901833|P5|Overall Study|Sponsor Decision|10
1188063|NCT01024244|3901834|P4|Overall Study|Sponsor Decision|12
1188064|NCT01024244|3901835|P3|Overall Study|Sponsor Decision|14
1188065|NCT01024244|3901836|P2|Overall Study|Sponsor Decision|7
1188066|NCT01024244|3901837|P1|Overall Study|Sponsor Decision|14
1188067|NCT01024244|3901833|P5|Overall Study|Protocol Violation|2
1188068|NCT01024244|3901834|P4|Overall Study|Protocol Violation|0
1188069|NCT01024244|3901835|P3|Overall Study|Protocol Violation|0
1188070|NCT01024244|3901836|P2|Overall Study|Protocol Violation|0
1188071|NCT01024244|3901837|P1|Overall Study|Protocol Violation|1
1188072|NCT01024244|3901833|P5|Overall Study|Lack of Efficacy|0
1188073|NCT01024244|3901834|P4|Overall Study|Lack of Efficacy|0
1188074|NCT01024244|3901835|P3|Overall Study|Lack of Efficacy|0
1188075|NCT01024244|3901836|P2|Overall Study|Lack of Efficacy|0
1188076|NCT01024244|3901837|P1|Overall Study|Lack of Efficacy|1
1188077|NCT01024244|3901833|P5|Overall Study|Entry Criteria Not Met|0
1188078|NCT01024244|3901834|P4|Overall Study|Entry Criteria Not Met|0
1188079|NCT01024244|3901835|P3|Overall Study|Entry Criteria Not Met|0
1188080|NCT01024244|3901836|P2|Overall Study|Entry Criteria Not Met|1
1188081|NCT01024244|3901837|P1|Overall Study|Entry Criteria Not Met|0
1188082|NCT01024244|3901833|P5|Overall Study|Adverse Event|2
1188083|NCT01024244|3901834|P4|Overall Study|Adverse Event|1
1188084|NCT01024244|3901835|P3|Overall Study|Adverse Event|0
1188085|NCT01024244|3901836|P2|Overall Study|Adverse Event|2
1188086|NCT01024244|3901837|P1|Overall Study|Adverse Event|1
1188087|NCT01024036|3901951|P2|Follow-Up Period|Adverse Event|1
1188088|NCT01024036|3901952|P1|Follow-Up Period|Adverse Event|4
1188089|NCT01024036|3901951|P2|Follow-Up Period|Withdrawal by Subject|1
1188090|NCT01024036|3901952|P1|Follow-Up Period|Withdrawal by Subject|0
1188091|NCT01024036|3901951|P2|Follow-Up Period|Lost to Follow-up|1
1188092|NCT01024036|3901952|P1|Follow-Up Period|Lost to Follow-up|1
1188093|NCT01024036|3901951|P2|Unblinded Treatment|Lack of Efficacy|2
1188094|NCT01024036|3901952|P1|Unblinded Treatment|Lack of Efficacy|0
1188095|NCT01024036|3901951|P2|Unblinded Treatment|Adverse Event|1
1188096|NCT01024036|3901952|P1|Unblinded Treatment|Adverse Event|0
1188097|NCT01024036|3901951|P2|Blinded Treatment|Withdrawal by Subject|3
1188098|NCT01024036|3901952|P1|Blinded Treatment|Withdrawal by Subject|4
1188099|NCT01024036|3901951|P2|Blinded Treatment|Death|2
1188100|NCT01024036|3901952|P1|Blinded Treatment|Death|0
1188101|NCT01024036|3901951|P2|Blinded Treatment|Physician Decision|0
1188102|NCT01024036|3901952|P1|Blinded Treatment|Physician Decision|1
1188103|NCT01024036|3901951|P2|Blinded Treatment|Lack of Efficacy|14
1188104|NCT01024036|3901952|P1|Blinded Treatment|Lack of Efficacy|16
1188105|NCT01024036|3901951|P2|Blinded Treatment|Adverse Event|1
1188106|NCT01024036|3901952|P1|Blinded Treatment|Adverse Event|1
1188107|NCT01023958|3901999|P1|Overall Study|Refused to continue medication|1
1188108|NCT01023958|3901999|P1|Overall Study|Other adverse event|1
1188109|NCT01023958|3901999|P1|Overall Study|Progressive disease|48
1188110|NCT01023815|3902047|P4|Randomized Period (Day 90 to Month 12)|Graft Loss|0
1188111|NCT01023815|3902048|P3|Randomized Period (Day 90 to Month 12)|Graft Loss|0
1188112|NCT01023815|3902049|P2|Randomized Period (Day 90 to Month 12)|Graft Loss|1
1188113|NCT01023815|3902050|P1|Randomized Period (Day 90 to Month 12)|Graft Loss|0
1188114|NCT01023815|3902047|P4|Randomized Period (Day 90 to Month 12)|Administrative Problems|2
1188115|NCT01023815|3902048|P3|Randomized Period (Day 90 to Month 12)|Administrative Problems|6
1188116|NCT01023815|3902049|P2|Randomized Period (Day 90 to Month 12)|Administrative Problems|1
1188117|NCT01023815|3902050|P1|Randomized Period (Day 90 to Month 12)|Administrative Problems|0
1188118|NCT01023815|3902047|P4|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
1188119|NCT01023815|3902048|P3|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
1188120|NCT01023815|3902049|P2|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
1188121|NCT01023815|3902050|P1|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
1188122|NCT01023815|3902047|P4|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
1188123|NCT01023815|3902048|P3|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
1188124|NCT01023815|3902049|P2|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
1188125|NCT01023815|3902050|P1|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
1188126|NCT01023815|3902047|P4|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
1188127|NCT01023815|3902048|P3|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
1188128|NCT01023815|3902049|P2|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
1188129|NCT01023815|3902050|P1|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144
1188130|NCT01023789|3902069|P1|3 - Year Visit|Lost to Follow-up|13
1188131|NCT01023789|3902069|P1|3 - Year Visit|Withdrawal of consent|1
1188132|NCT01023789|3902069|P1|3 - Year Visit|Death|29
1188133|NCT01023672|3902155|P1|Overall Study|Death|1
1188134|NCT01023672|3902155|P1|Overall Study|Worsening disease|2
1188135|NCT01023659|3902162|P3|Overall Study|Lost to Follow-up|99
1188136|NCT01023659|3902163|P2|Overall Study|Lost to Follow-up|228
1188137|NCT01023659|3902164|P1|Overall Study|Lost to Follow-up|73
1188138|NCT01023581|3902180|P7|Overall Study|Other|0
1188139|NCT01023581|3902181|P6|Overall Study|Other|0
1188140|NCT01023581|3902182|P5|Overall Study|Other|1
1188141|NCT01023581|3902183|P4|Overall Study|Other|0
1188142|NCT01023581|3902184|P3|Overall Study|Other|1
1188143|NCT01023581|3902185|P2|Overall Study|Other|0
1188144|NCT01023581|3902186|P1|Overall Study|Other|1
1188145|NCT01023581|3902180|P7|Overall Study|Physician Decision|1
1188146|NCT01023581|3902181|P6|Overall Study|Physician Decision|1
1188147|NCT01023581|3902182|P5|Overall Study|Physician Decision|1
1188148|NCT01023581|3902183|P4|Overall Study|Physician Decision|1
1188149|NCT01023581|3902184|P3|Overall Study|Physician Decision|2
1188150|NCT01023581|3902185|P2|Overall Study|Physician Decision|0
1188151|NCT01023581|3902186|P1|Overall Study|Physician Decision|2
1188152|NCT01023581|3902180|P7|Overall Study|Lack of Efficacy|1
1188153|NCT01023581|3902181|P6|Overall Study|Lack of Efficacy|2
1188154|NCT01023581|3902182|P5|Overall Study|Lack of Efficacy|1
1188155|NCT01023581|3902183|P4|Overall Study|Lack of Efficacy|2
1188156|NCT01023581|3902184|P3|Overall Study|Lack of Efficacy|6
1188157|NCT01023581|3902185|P2|Overall Study|Lack of Efficacy|3
1188158|NCT01023581|3902186|P1|Overall Study|Lack of Efficacy|9
1188159|NCT01023581|3902180|P7|Overall Study|Pregnancy|0
1188160|NCT01023581|3902181|P6|Overall Study|Pregnancy|1
1188161|NCT01023581|3902182|P5|Overall Study|Pregnancy|0
1188162|NCT01023581|3902183|P4|Overall Study|Pregnancy|2
1188163|NCT01023581|3902184|P3|Overall Study|Pregnancy|0
1188164|NCT01023581|3902185|P2|Overall Study|Pregnancy|0
1188165|NCT01023581|3902186|P1|Overall Study|Pregnancy|0
1188166|NCT01023581|3902180|P7|Overall Study|Withdrawal by Subject|5
1188167|NCT01023581|3902181|P6|Overall Study|Withdrawal by Subject|8
1188168|NCT01023581|3902182|P5|Overall Study|Withdrawal by Subject|6
1188169|NCT01023581|3902183|P4|Overall Study|Withdrawal by Subject|10
1188170|NCT01023581|3902184|P3|Overall Study|Withdrawal by Subject|16
1188171|NCT01023581|3902185|P2|Overall Study|Withdrawal by Subject|8
1188172|NCT01023581|3902186|P1|Overall Study|Withdrawal by Subject|13
1188173|NCT01023581|3902180|P7|Overall Study|Lost to Follow-up|2
1188174|NCT01023581|3902181|P6|Overall Study|Lost to Follow-up|2
1188175|NCT01023581|3902182|P5|Overall Study|Lost to Follow-up|5
1188176|NCT01023581|3902183|P4|Overall Study|Lost to Follow-up|2
1188177|NCT01023581|3902184|P3|Overall Study|Lost to Follow-up|7
1188178|NCT01023581|3902185|P2|Overall Study|Lost to Follow-up|8
1188179|NCT01023581|3902186|P1|Overall Study|Lost to Follow-up|4
1188180|NCT01023581|3902180|P7|Overall Study|Major protocol deviation|0
1188181|NCT01023581|3902181|P6|Overall Study|Major protocol deviation|0
1188182|NCT01023581|3902182|P5|Overall Study|Major protocol deviation|0
1188183|NCT01023581|3902183|P4|Overall Study|Major protocol deviation|0
1188184|NCT01023581|3902184|P3|Overall Study|Major protocol deviation|3
1188185|NCT01023581|3902185|P2|Overall Study|Major protocol deviation|0
1188186|NCT01023581|3902186|P1|Overall Study|Major protocol deviation|2
1188187|NCT01023581|3902180|P7|Overall Study|Adverse Event|11
1188188|NCT01023581|3902181|P6|Overall Study|Adverse Event|5
1188189|NCT01023581|3902182|P5|Overall Study|Adverse Event|2
1188190|NCT01023581|3902183|P4|Overall Study|Adverse Event|3
1188191|NCT01023581|3902184|P3|Overall Study|Adverse Event|7
1188192|NCT01023581|3902185|P2|Overall Study|Adverse Event|4
1188193|NCT01023581|3902186|P1|Overall Study|Adverse Event|4
1188194|NCT01023516|3902243|P2|Overall Study|Incorrect enrolment|2
1188195|NCT01023516|3902244|P1|Overall Study|Incorrect enrolment|4
1188196|NCT01023516|3902243|P2|Overall Study|Study-specific criteria|2
1188197|NCT01023516|3902244|P1|Overall Study|Study-specific criteria|4
1188198|NCT01023516|3902243|P2|Overall Study|Safety reason|3
1188199|NCT01023516|3902244|P1|Overall Study|Safety reason|0
1188200|NCT01023516|3902243|P2|Overall Study|Adverse Event|6
1188201|NCT01023516|3902244|P1|Overall Study|Adverse Event|9
1188202|NCT01023516|3902243|P2|Overall Study|Voluntary discontinuation|5
1188203|NCT01023516|3902244|P1|Overall Study|Voluntary discontinuation|7
1188204|NCT01023308|3902326|P2|Overall Study|Withdrawal by Subject|18
1188205|NCT01023308|3902327|P1|Overall Study|Withdrawal by Subject|34
1188206|NCT01023308|3902326|P2|Overall Study|Lost to Follow-up|0
1188207|NCT01023308|3902327|P1|Overall Study|Lost to Follow-up|1
1188208|NCT01023308|3902326|P2|Overall Study|Untreated|5
1188209|NCT01023308|3902327|P1|Overall Study|Untreated|5
1188210|NCT01023308|3902326|P2|Overall Study|Protocol Violation|4
1188211|NCT01023308|3902327|P1|Overall Study|Protocol Violation|3
1188212|NCT01023308|3902326|P2|Overall Study|New Cancer therapy|7
1188213|NCT01023308|3902327|P1|Overall Study|New Cancer therapy|4
1188214|NCT01023308|3902326|P2|Overall Study|Disease progression|153
1188215|NCT01023308|3902327|P1|Overall Study|Disease progression|82
1188216|NCT01023308|3902326|P2|Overall Study|Death|17
1188217|NCT01023308|3902327|P1|Overall Study|Death|21
1188218|NCT01023308|3902326|P2|Overall Study|Adverse Event|66
1188219|NCT01023308|3902327|P1|Overall Study|Adverse Event|130
1188220|NCT01023308|3902326|P2|Overall Study|Administrative problems|1
1188221|NCT01023308|3902327|P1|Overall Study|Administrative problems|2
1188222|NCT01023308|3902326|P2|Overall Study|Abnormal test proceedure results|8
1188223|NCT01023308|3902327|P1|Overall Study|Abnormal test proceedure results|3
1188224|NCT01023256|3902357|P4|Overall Study|Withdrawal by Subject|2
1188225|NCT01023256|3902358|P3|Overall Study|Withdrawal by Subject|0
1188226|NCT01023256|3902359|P2|Overall Study|Withdrawal by Subject|0
1188227|NCT01023256|3902360|P1|Overall Study|Withdrawal by Subject|0
1188228|NCT01023256|3902357|P4|Overall Study|Adverse Event|1
1188229|NCT01023256|3902358|P3|Overall Study|Adverse Event|0
1188230|NCT01023256|3902359|P2|Overall Study|Adverse Event|0
1188231|NCT01023256|3902360|P1|Overall Study|Adverse Event|0
1188232|NCT01023256|3902357|P4|Overall Study|Not specified|2
1188233|NCT01023256|3902358|P3|Overall Study|Not specified|0
1188234|NCT01023256|3902359|P2|Overall Study|Not specified|0
1188235|NCT01023256|3902360|P1|Overall Study|Not specified|1
1188236|NCT01023256|3902357|P4|Overall Study|Randomized but not treated|0
1188237|NCT01023256|3902358|P3|Overall Study|Randomized but not treated|1
1188238|NCT01023256|3902359|P2|Overall Study|Randomized but not treated|0
1188239|NCT01023256|3902360|P1|Overall Study|Randomized but not treated|1
1188240|NCT01023256|3902357|P4|Overall Study|Protocol Violation|0
1188241|NCT01023256|3902358|P3|Overall Study|Protocol Violation|0
1188242|NCT01023256|3902359|P2|Overall Study|Protocol Violation|3
1188243|NCT01023256|3902360|P1|Overall Study|Protocol Violation|2
1188244|NCT01023217|3902402|P2|Overall Study|Withdrawal by Subject|0
1188245|NCT01023217|3902403|P1|Overall Study|Withdrawal by Subject|1
1188246|NCT01023061|3902441|P1|Overall Study|Withdrawal prior to treatment|2
1188247|NCT01023035|3902450|P3|Follow-up Period (up to Week 72)|Non-medical Reason|38
1188248|NCT01023035|3902451|P2|Follow-up Period (up to Week 72)|Non-medical Reason|28
1188249|NCT01023035|3902452|P1|Follow-up Period (up to Week 72)|Non-medical Reason|26
1188250|NCT01023035|3902450|P3|Follow-up Period (up to Week 72)|Adverse Event|1
1188251|NCT01023035|3902451|P2|Follow-up Period (up to Week 72)|Adverse Event|0
1188252|NCT01023035|3902452|P1|Follow-up Period (up to Week 72)|Adverse Event|2
1188253|NCT01023035|3902450|P3|Treatment Period|Treatment Failure|24
1188254|NCT01023035|3902451|P2|Treatment Period|Treatment Failure|31
1188255|NCT01023035|3902452|P1|Treatment Period|Treatment Failure|26
1188256|NCT01023035|3902450|P3|Treatment Period|Non-Medical Reasons|44
1188257|NCT01023035|3902451|P2|Treatment Period|Non-Medical Reasons|22
1188258|NCT01023035|3902452|P1|Treatment Period|Non-Medical Reasons|19
1188259|NCT01023035|3902450|P3|Treatment Period|Adverse Event|50
1188260|NCT01023035|3902451|P2|Treatment Period|Adverse Event|32
1188261|NCT01023035|3902452|P1|Treatment Period|Adverse Event|27
1188262|NCT01023022|3902462|P1|Overall Study|due to technical issues|2
1188263|NCT01023022|3902462|P1|Overall Study|Lost to Follow-up|7
1188264|NCT01023022|3902462|P1|Overall Study|Death|5
1188265|NCT01022996|3902468|P1|Overall Study|Protocol Violation|1
1188266|NCT01022996|3902468|P1|Overall Study|Disease Progression|32
1188267|NCT01022996|3902468|P1|Overall Study|Administrative problems|6
1188268|NCT01022996|3902468|P1|Overall Study|Lost to Follow-up|1
1188269|NCT01022996|3902468|P1|Overall Study|Withdrawal by Subject|3
1188270|NCT01022996|3902468|P1|Overall Study|Adverse Event|14
1188271|NCT01022853|3902482|P5|Overall Study|Other not stated above|0
1188272|NCT01022853|3902483|P4|Overall Study|Other not stated above|0
1188273|NCT01022853|3902484|P3|Overall Study|Other not stated above|1
1188274|NCT01022853|3902485|P2|Overall Study|Other not stated above|0
1188275|NCT01022853|3902486|P1|Overall Study|Other not stated above|1
1188276|NCT01022853|3902482|P5|Overall Study|Withdrawal by Subject|0
1188277|NCT01022853|3902483|P4|Overall Study|Withdrawal by Subject|1
1188278|NCT01022853|3902484|P3|Overall Study|Withdrawal by Subject|1
1188279|NCT01022853|3902485|P2|Overall Study|Withdrawal by Subject|1
1188280|NCT01022853|3902486|P1|Overall Study|Withdrawal by Subject|0
1188281|NCT01022853|3902482|P5|Overall Study|Dose-limiting toxicity|1
1188282|NCT01022853|3902483|P4|Overall Study|Dose-limiting toxicity|0
1188283|NCT01022853|3902484|P3|Overall Study|Dose-limiting toxicity|0
1188284|NCT01022853|3902485|P2|Overall Study|Dose-limiting toxicity|0
1188285|NCT01022853|3902486|P1|Overall Study|Dose-limiting toxicity|0
1188286|NCT01022853|3902482|P5|Overall Study|Progressive disease|1
1188287|NCT01022853|3902483|P4|Overall Study|Progressive disease|7
1188288|NCT01022853|3902484|P3|Overall Study|Progressive disease|11
1188289|NCT01022853|3902485|P2|Overall Study|Progressive disease|3
1188290|NCT01022853|3902486|P1|Overall Study|Progressive disease|2
1188291|NCT01022762|3902565|P2|Overall Study|Unclassified|20
1188292|NCT01022762|3902566|P1|Overall Study|Unclassified|12
1188293|NCT01022762|3902565|P2|Overall Study|Protocol Violation|6
1188294|NCT01022762|3902566|P1|Overall Study|Protocol Violation|7
1188295|NCT01022762|3902565|P2|Overall Study|Lack of Efficacy|1
1188296|NCT01022762|3902566|P1|Overall Study|Lack of Efficacy|0
1188297|NCT01022762|3902565|P2|Overall Study|Adverse Event|1
1188298|NCT01022762|3902566|P1|Overall Study|Adverse Event|3
1188299|NCT01022502|3902601|P1|Overall Study|Withdrawal by Subject|1
1188300|NCT01022502|3902601|P1|Overall Study|employment related reasons|1
1188301|NCT01022502|3902601|P1|Overall Study|Adverse Event|1
1188302|NCT01022424|3902615|P1|Overall Study|eGFR under the withdrawal criteria|2
1188303|NCT01022424|3902615|P1|Overall Study|Physician Decision|1
1188304|NCT01022424|3902615|P1|Overall Study|Adverse Event|1
1188305|NCT01022398|3902630|P2|Overall Study|Study terminated|2
1188306|NCT01022398|3902631|P1|Overall Study|Study terminated|2
1188307|NCT01022203|3902656|P2|Follow-Up Assessment|Lost to Follow-up|2
1188308|NCT01022203|3902657|P1|Follow-Up Assessment|Lost to Follow-up|2
1188309|NCT01022203|3902656|P2|Post Treatment Assessment|Adverse Event|2
1188310|NCT01022203|3902657|P1|Post Treatment Assessment|Adverse Event|0
1188311|NCT01022203|3902656|P2|Post Treatment Assessment|Physician Decision|0
1188312|NCT01022203|3902657|P1|Post Treatment Assessment|Physician Decision|2
1188313|NCT01022203|3902656|P2|Post Treatment Assessment|Withdrawal by Subject|12
1188314|NCT01022203|3902657|P1|Post Treatment Assessment|Withdrawal by Subject|12
1188315|NCT01022112|3902676|P5|Overall Study|Fasting plasma glucose level increased|7
1188316|NCT01022112|3902677|P4|Overall Study|Fasting plasma glucose level increased|0
1188317|NCT01022112|3902678|P3|Overall Study|Fasting plasma glucose level increased|0
1188318|NCT01022112|3902679|P2|Overall Study|Fasting plasma glucose level increased|0
1188319|NCT01022112|3902680|P1|Overall Study|Fasting plasma glucose level increased|1
1188320|NCT01022112|3902676|P5|Overall Study|Withdrawal by Subject|1
1188321|NCT01022112|3902677|P4|Overall Study|Withdrawal by Subject|2
1188322|NCT01022112|3902678|P3|Overall Study|Withdrawal by Subject|2
1188323|NCT01022112|3902679|P2|Overall Study|Withdrawal by Subject|1
1188324|NCT01022112|3902680|P1|Overall Study|Withdrawal by Subject|0
1188325|NCT01022112|3902676|P5|Overall Study|Physician Decision|1
1188326|NCT01022112|3902677|P4|Overall Study|Physician Decision|0
1188327|NCT01022112|3902678|P3|Overall Study|Physician Decision|1
1188328|NCT01022112|3902679|P2|Overall Study|Physician Decision|0
1188329|NCT01022112|3902680|P1|Overall Study|Physician Decision|0
1188330|NCT01022112|3902676|P5|Overall Study|Lack of Efficacy|1
1188331|NCT01022112|3902677|P4|Overall Study|Lack of Efficacy|0
1188332|NCT01022112|3902678|P3|Overall Study|Lack of Efficacy|0
1188333|NCT01022112|3902679|P2|Overall Study|Lack of Efficacy|0
1188334|NCT01022112|3902680|P1|Overall Study|Lack of Efficacy|1
1188335|NCT01022112|3902676|P5|Overall Study|Adverse Event|0
1188336|NCT01022112|3902677|P4|Overall Study|Adverse Event|1
1188337|NCT01022112|3902678|P3|Overall Study|Adverse Event|0
1188338|NCT01022112|3902679|P2|Overall Study|Adverse Event|2
1188339|NCT01022112|3902680|P1|Overall Study|Adverse Event|1
1188340|NCT01021878|3902729|P2|Overall Study|Transplantation|1
1188341|NCT01021878|3902730|P1|Overall Study|Transplantation|6
1188342|NCT01021878|3902729|P2|Overall Study|Adverse Event|5
1188343|NCT01021878|3902730|P1|Overall Study|Adverse Event|6
1188344|NCT01021878|3902729|P2|Overall Study|Death|1
1188345|NCT01021878|3902730|P1|Overall Study|Death|0
1188346|NCT01021878|3902729|P2|Overall Study|Lost to Follow-up|3
1188347|NCT01021878|3902730|P1|Overall Study|Lost to Follow-up|4
1188348|NCT01021852|3902752|P8|Treatment Period 2|Withdrawal by Subject|2
1188349|NCT01021852|3902753|P7|Treatment Period 2|Withdrawal by Subject|1
1188350|NCT01021852|3902754|P6|Treatment Period 2|Withdrawal by Subject|0
1188351|NCT01021852|3902755|P5|Treatment Period 2|Withdrawal by Subject|0
1188352|NCT01021852|3902756|P4|Treatment Period 2|Withdrawal by Subject|0
1188353|NCT01021852|3902757|P3|Treatment Period 2|Withdrawal by Subject|0
1188354|NCT01021852|3902758|P2|Treatment Period 2|Withdrawal by Subject|0
1188355|NCT01021852|3902759|P1|Treatment Period 2|Withdrawal by Subject|0
1188356|NCT01021852|3902752|P8|Treatment Period 2|Protocol Violation|0
1188357|NCT01021852|3902753|P7|Treatment Period 2|Protocol Violation|1
1188358|NCT01021852|3902754|P6|Treatment Period 2|Protocol Violation|0
1188359|NCT01021852|3902755|P5|Treatment Period 2|Protocol Violation|1
1188360|NCT01021852|3902756|P4|Treatment Period 2|Protocol Violation|0
1188361|NCT01021852|3902757|P3|Treatment Period 2|Protocol Violation|0
1188362|NCT01021852|3902758|P2|Treatment Period 2|Protocol Violation|0
1188363|NCT01021852|3902759|P1|Treatment Period 2|Protocol Violation|0
1188364|NCT01021852|3902752|P8|Treatment Period 2|Physician Decision|0
1188365|NCT01021852|3902753|P7|Treatment Period 2|Physician Decision|0
1188366|NCT01021852|3902754|P6|Treatment Period 2|Physician Decision|0
1188367|NCT01021852|3902755|P5|Treatment Period 2|Physician Decision|0
1188368|NCT01021852|3902756|P4|Treatment Period 2|Physician Decision|0
1188369|NCT01021852|3902757|P3|Treatment Period 2|Physician Decision|1
1188370|NCT01021852|3902758|P2|Treatment Period 2|Physician Decision|0
1188371|NCT01021852|3902759|P1|Treatment Period 2|Physician Decision|0
1188372|NCT01021852|3902752|P8|Treatment Period 2|Lack of Efficacy|0
1188373|NCT01021852|3902753|P7|Treatment Period 2|Lack of Efficacy|0
1188374|NCT01021852|3902754|P6|Treatment Period 2|Lack of Efficacy|1
1188375|NCT01021852|3902755|P5|Treatment Period 2|Lack of Efficacy|0
1188376|NCT01021852|3902756|P4|Treatment Period 2|Lack of Efficacy|0
1188377|NCT01021852|3902757|P3|Treatment Period 2|Lack of Efficacy|0
1188378|NCT01021852|3902758|P2|Treatment Period 2|Lack of Efficacy|0
1188379|NCT01021852|3902759|P1|Treatment Period 2|Lack of Efficacy|0
1188380|NCT01021852|3902752|P8|Treatment Period 2|Adverse Event|0
1188381|NCT01021852|3902753|P7|Treatment Period 2|Adverse Event|1
1188382|NCT01021852|3902754|P6|Treatment Period 2|Adverse Event|0
1188383|NCT01021852|3902755|P5|Treatment Period 2|Adverse Event|1
1188384|NCT01021852|3902756|P4|Treatment Period 2|Adverse Event|0
1188385|NCT01021852|3902757|P3|Treatment Period 2|Adverse Event|0
1188386|NCT01021852|3902758|P2|Treatment Period 2|Adverse Event|1
1188387|NCT01021852|3902759|P1|Treatment Period 2|Adverse Event|0
1188388|NCT01021852|3902752|P8|Washout Period-No Drug|Adverse Event|0
1188389|NCT01021852|3902753|P7|Washout Period-No Drug|Adverse Event|0
1188390|NCT01021852|3902754|P6|Washout Period-No Drug|Adverse Event|1
1188391|NCT01021852|3902755|P5|Washout Period-No Drug|Adverse Event|0
1188392|NCT01021852|3902756|P4|Washout Period-No Drug|Adverse Event|0
1188393|NCT01021852|3902757|P3|Washout Period-No Drug|Adverse Event|0
1188394|NCT01021852|3902758|P2|Washout Period-No Drug|Adverse Event|0
1188395|NCT01021852|3902759|P1|Washout Period-No Drug|Adverse Event|1
1188396|NCT01021852|3902752|P8|Washout Period-Placebo|Protocol Violation|0
1188397|NCT01021852|3902753|P7|Washout Period-Placebo|Protocol Violation|1
1188398|NCT01021852|3902754|P6|Washout Period-Placebo|Protocol Violation|0
1188399|NCT01021852|3902755|P5|Washout Period-Placebo|Protocol Violation|0
1188400|NCT01021852|3902756|P4|Washout Period-Placebo|Protocol Violation|0
1188401|NCT01021852|3902757|P3|Washout Period-Placebo|Protocol Violation|0
1188402|NCT01021852|3902758|P2|Washout Period-Placebo|Protocol Violation|0
1188403|NCT01021852|3902759|P1|Washout Period-Placebo|Protocol Violation|0
1188404|NCT01021852|3902752|P8|Washout Period-Placebo|Lost to Follow-up|0
1188405|NCT01021852|3902753|P7|Washout Period-Placebo|Lost to Follow-up|0
1188406|NCT01021852|3902754|P6|Washout Period-Placebo|Lost to Follow-up|0
1188407|NCT01021852|3902755|P5|Washout Period-Placebo|Lost to Follow-up|1
1188408|NCT01021852|3902756|P4|Washout Period-Placebo|Lost to Follow-up|0
1188409|NCT01021852|3902757|P3|Washout Period-Placebo|Lost to Follow-up|0
1188410|NCT01021852|3902758|P2|Washout Period-Placebo|Lost to Follow-up|0
1188411|NCT01021852|3902759|P1|Washout Period-Placebo|Lost to Follow-up|0
1188412|NCT01021852|3902752|P8|Washout Period-Placebo|Adverse Event|0
1188413|NCT01021852|3902753|P7|Washout Period-Placebo|Adverse Event|0
1188414|NCT01021852|3902754|P6|Washout Period-Placebo|Adverse Event|1
1188415|NCT01021852|3902755|P5|Washout Period-Placebo|Adverse Event|0
1188416|NCT01021852|3902756|P4|Washout Period-Placebo|Adverse Event|1
1188417|NCT01021852|3902757|P3|Washout Period-Placebo|Adverse Event|0
1188418|NCT01021852|3902758|P2|Washout Period-Placebo|Adverse Event|0
1188419|NCT01021852|3902759|P1|Washout Period-Placebo|Adverse Event|0
1188420|NCT01021852|3902752|P8|Treatment Period 1|Not Treated|0
1188421|NCT01021852|3902753|P7|Treatment Period 1|Not Treated|0
1188422|NCT01021852|3902754|P6|Treatment Period 1|Not Treated|0
1188423|NCT01021852|3902755|P5|Treatment Period 1|Not Treated|0
1188424|NCT01021852|3902756|P4|Treatment Period 1|Not Treated|2
1188425|NCT01021852|3902757|P3|Treatment Period 1|Not Treated|0
1188426|NCT01021852|3902758|P2|Treatment Period 1|Not Treated|0
1188427|NCT01021852|3902759|P1|Treatment Period 1|Not Treated|0
1188428|NCT01021852|3902752|P8|Treatment Period 1|Withdrawal by Subject|1
1188429|NCT01021852|3902753|P7|Treatment Period 1|Withdrawal by Subject|0
1188430|NCT01021852|3902754|P6|Treatment Period 1|Withdrawal by Subject|0
1188431|NCT01021852|3902755|P5|Treatment Period 1|Withdrawal by Subject|1
1188432|NCT01021852|3902756|P4|Treatment Period 1|Withdrawal by Subject|0
1188433|NCT01021852|3902757|P3|Treatment Period 1|Withdrawal by Subject|0
1188434|NCT01021852|3902758|P2|Treatment Period 1|Withdrawal by Subject|0
1188435|NCT01021852|3902759|P1|Treatment Period 1|Withdrawal by Subject|0
1188436|NCT01021852|3902752|P8|Treatment Period 1|Pregnancy|0
1188437|NCT01021852|3902753|P7|Treatment Period 1|Pregnancy|0
1188438|NCT01021852|3902754|P6|Treatment Period 1|Pregnancy|0
1188439|NCT01021852|3902755|P5|Treatment Period 1|Pregnancy|0
1188440|NCT01021852|3902756|P4|Treatment Period 1|Pregnancy|0
1188441|NCT01021852|3902757|P3|Treatment Period 1|Pregnancy|1
1188442|NCT01021852|3902758|P2|Treatment Period 1|Pregnancy|0
1188443|NCT01021852|3902759|P1|Treatment Period 1|Pregnancy|0
1188444|NCT01021852|3902752|P8|Treatment Period 1|Adverse Event|0
1188445|NCT01021852|3902753|P7|Treatment Period 1|Adverse Event|0
1188446|NCT01021852|3902754|P6|Treatment Period 1|Adverse Event|2
1188447|NCT01021852|3902755|P5|Treatment Period 1|Adverse Event|2
1188448|NCT01021852|3902756|P4|Treatment Period 1|Adverse Event|0
1188449|NCT01021852|3902757|P3|Treatment Period 1|Adverse Event|1
1188450|NCT01021852|3902758|P2|Treatment Period 1|Adverse Event|1
1188451|NCT01021852|3902759|P1|Treatment Period 1|Adverse Event|3
1188452|NCT01021813|3902795|P5|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
1188453|NCT01021813|3902796|P4|DB Randomized Discontinuation Phase|Withdrawal by Subject|1
1188454|NCT01021813|3902797|P3|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
1188455|NCT01021813|3902798|P2|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
1188456|NCT01021813|3902799|P1|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
1188457|NCT01021813|3902795|P5|DB Randomized Discontinuation Phase|Protocol Violation|0
1188458|NCT01021813|3902796|P4|DB Randomized Discontinuation Phase|Protocol Violation|0
1188459|NCT01021813|3902797|P3|DB Randomized Discontinuation Phase|Protocol Violation|1
1188460|NCT01021813|3902798|P2|DB Randomized Discontinuation Phase|Protocol Violation|0
1188461|NCT01021813|3902799|P1|DB Randomized Discontinuation Phase|Protocol Violation|0
1188462|NCT01021813|3902795|P5|DB Randomized Discontinuation Phase|Lost to Follow-up|1
1188463|NCT01021813|3902796|P4|DB Randomized Discontinuation Phase|Lost to Follow-up|0
1188464|NCT01021813|3902797|P3|DB Randomized Discontinuation Phase|Lost to Follow-up|0
1188465|NCT01021813|3902798|P2|DB Randomized Discontinuation Phase|Lost to Follow-up|0
1188466|NCT01021813|3902799|P1|DB Randomized Discontinuation Phase|Lost to Follow-up|0
1188467|NCT01021813|3902795|P5|DB Randomized Discontinuation Phase|Lack of Efficacy|0
1188468|NCT01021813|3902796|P4|DB Randomized Discontinuation Phase|Lack of Efficacy|1
1188469|NCT01021813|3902797|P3|DB Randomized Discontinuation Phase|Lack of Efficacy|0
1188470|NCT01021813|3902798|P2|DB Randomized Discontinuation Phase|Lack of Efficacy|0
1188471|NCT01021813|3902799|P1|DB Randomized Discontinuation Phase|Lack of Efficacy|0
1188472|NCT01021813|3902795|P5|DB Randomized Discontinuation Phase|Adverse Event|1
1188473|NCT01021813|3902796|P4|DB Randomized Discontinuation Phase|Adverse Event|3
1188474|NCT01021813|3902797|P3|DB Randomized Discontinuation Phase|Adverse Event|0
1188475|NCT01021813|3902798|P2|DB Randomized Discontinuation Phase|Adverse Event|0
1188476|NCT01021813|3902799|P1|DB Randomized Discontinuation Phase|Adverse Event|0
1188477|NCT01021813|3902795|P5|DB Treatment Phase|Withdrawal by Subject|0
1188478|NCT01021813|3902796|P4|DB Treatment Phase|Withdrawal by Subject|0
1188479|NCT01021813|3902797|P3|DB Treatment Phase|Withdrawal by Subject|0
1188480|NCT01021813|3902798|P2|DB Treatment Phase|Withdrawal by Subject|24
1188481|NCT01021813|3902799|P1|DB Treatment Phase|Withdrawal by Subject|60
1188482|NCT01021813|3902795|P5|DB Treatment Phase|Protocol Violation|0
1188483|NCT01021813|3902796|P4|DB Treatment Phase|Protocol Violation|0
1188484|NCT01021813|3902797|P3|DB Treatment Phase|Protocol Violation|0
1188485|NCT01021813|3902798|P2|DB Treatment Phase|Protocol Violation|3
1188486|NCT01021813|3902799|P1|DB Treatment Phase|Protocol Violation|4
1188487|NCT01021813|3902795|P5|DB Treatment Phase|Pregnancy|0
1188488|NCT01021813|3902796|P4|DB Treatment Phase|Pregnancy|0
1188489|NCT01021813|3902797|P3|DB Treatment Phase|Pregnancy|0
1188490|NCT01021813|3902798|P2|DB Treatment Phase|Pregnancy|0
1188491|NCT01021813|3902799|P1|DB Treatment Phase|Pregnancy|1
1188492|NCT01021813|3902795|P5|DB Treatment Phase|Physician Decision|0
1188493|NCT01021813|3902796|P4|DB Treatment Phase|Physician Decision|0
1188494|NCT01021813|3902797|P3|DB Treatment Phase|Physician Decision|0
1188495|NCT01021813|3902798|P2|DB Treatment Phase|Physician Decision|8
1188496|NCT01021813|3902799|P1|DB Treatment Phase|Physician Decision|17
1188497|NCT01021813|3902795|P5|DB Treatment Phase|Lost to Follow-up|0
1188498|NCT01021813|3902796|P4|DB Treatment Phase|Lost to Follow-up|0
1188499|NCT01021813|3902797|P3|DB Treatment Phase|Lost to Follow-up|0
1188500|NCT01021813|3902798|P2|DB Treatment Phase|Lost to Follow-up|12
1188501|NCT01021813|3902799|P1|DB Treatment Phase|Lost to Follow-up|14
1188502|NCT01021813|3902795|P5|DB Treatment Phase|Lack of Efficacy|0
1188503|NCT01021813|3902796|P4|DB Treatment Phase|Lack of Efficacy|0
1188504|NCT01021813|3902797|P3|DB Treatment Phase|Lack of Efficacy|0
1188505|NCT01021813|3902798|P2|DB Treatment Phase|Lack of Efficacy|28
1188506|NCT01021813|3902799|P1|DB Treatment Phase|Lack of Efficacy|44
1188507|NCT01021813|3902795|P5|DB Treatment Phase|Adverse Event|0
1188508|NCT01021813|3902796|P4|DB Treatment Phase|Adverse Event|0
1188509|NCT01021813|3902797|P3|DB Treatment Phase|Adverse Event|0
1188510|NCT01021813|3902798|P2|DB Treatment Phase|Adverse Event|22
1188511|NCT01021813|3902799|P1|DB Treatment Phase|Adverse Event|60
1188512|NCT01021748|3902860|P9|Overall Study|Not Treated|0
1188513|NCT01021748|3902861|P8|Overall Study|Not Treated|0
1188514|NCT01021748|3902862|P7|Overall Study|Not Treated|0
1188515|NCT01021748|3902863|P6|Overall Study|Not Treated|0
1188516|NCT01021748|3902864|P5|Overall Study|Not Treated|0
1188517|NCT01021748|3902865|P4|Overall Study|Not Treated|0
1188518|NCT01021748|3902866|P3|Overall Study|Not Treated|0
1188519|NCT01021748|3902867|P2|Overall Study|Not Treated|1
1188520|NCT01021748|3902868|P1|Overall Study|Not Treated|0
1188521|NCT01021748|3902860|P9|Overall Study|Withdrawal by Subject|1
1188522|NCT01021748|3902861|P8|Overall Study|Withdrawal by Subject|0
1188523|NCT01021748|3902862|P7|Overall Study|Withdrawal by Subject|1
1188524|NCT01021748|3902863|P6|Overall Study|Withdrawal by Subject|0
1188525|NCT01021748|3902864|P5|Overall Study|Withdrawal by Subject|0
1188526|NCT01021748|3902865|P4|Overall Study|Withdrawal by Subject|0
1188527|NCT01021748|3902866|P3|Overall Study|Withdrawal by Subject|0
1188528|NCT01021748|3902867|P2|Overall Study|Withdrawal by Subject|0
1188529|NCT01021748|3902868|P1|Overall Study|Withdrawal by Subject|0
1188530|NCT01021748|3902860|P9|Overall Study|Progressive Disease|6
1188531|NCT01021748|3902861|P8|Overall Study|Progressive Disease|5
1188532|NCT01021748|3902862|P7|Overall Study|Progressive Disease|0
1188533|NCT01021748|3902863|P6|Overall Study|Progressive Disease|3
1188534|NCT01021748|3902864|P5|Overall Study|Progressive Disease|7
1188535|NCT01021748|3902865|P4|Overall Study|Progressive Disease|6
1188536|NCT01021748|3902866|P3|Overall Study|Progressive Disease|4
1188537|NCT01021748|3902867|P2|Overall Study|Progressive Disease|3
1188538|NCT01021748|3902868|P1|Overall Study|Progressive Disease|3
1188539|NCT01021748|3902860|P9|Overall Study|Physician Decision|2
1188540|NCT01021748|3902861|P8|Overall Study|Physician Decision|1
1188541|NCT01021748|3902862|P7|Overall Study|Physician Decision|1
1188542|NCT01021748|3902863|P6|Overall Study|Physician Decision|0
1188543|NCT01021748|3902864|P5|Overall Study|Physician Decision|0
1188544|NCT01021748|3902865|P4|Overall Study|Physician Decision|1
1188545|NCT01021748|3902866|P3|Overall Study|Physician Decision|1
1188546|NCT01021748|3902867|P2|Overall Study|Physician Decision|0
1188547|NCT01021748|3902868|P1|Overall Study|Physician Decision|1
1188548|NCT01021748|3902860|P9|Overall Study|Adverse Event|7
1188549|NCT01021748|3902861|P8|Overall Study|Adverse Event|0
1188550|NCT01021748|3902862|P7|Overall Study|Adverse Event|1
1188551|NCT01021748|3902863|P6|Overall Study|Adverse Event|0
1188552|NCT01021748|3902864|P5|Overall Study|Adverse Event|2
1188553|NCT01021748|3902865|P4|Overall Study|Adverse Event|0
1188554|NCT01021748|3902866|P3|Overall Study|Adverse Event|2
1188555|NCT01021748|3902867|P2|Overall Study|Adverse Event|1
1188556|NCT01021748|3902868|P1|Overall Study|Adverse Event|2
1188557|NCT01021683|3902915|P1|Overall Study|Other|8
1188558|NCT01021683|3902915|P1|Overall Study|Recovery of neutrophil count|51
1188559|NCT01021683|3902915|P1|Overall Study|Lack of Efficacy|12
1188560|NCT01021553|3902941|P3|Overall Study|Withdrawal by Subject|0
1188561|NCT01021553|3902942|P2|Overall Study|Withdrawal by Subject|1
1188562|NCT01021553|3902943|P1|Overall Study|Withdrawal by Subject|1
1188563|NCT01021553|3902941|P3|Overall Study|Lost to Follow-up|1
1188564|NCT01021553|3902942|P2|Overall Study|Lost to Follow-up|0
1188565|NCT01021553|3902943|P1|Overall Study|Lost to Follow-up|0
1188566|NCT01021553|3902941|P3|Overall Study|Protocol Violation|2
1188567|NCT01021553|3902942|P2|Overall Study|Protocol Violation|2
1188568|NCT01021553|3902943|P1|Overall Study|Protocol Violation|0
1188569|NCT01021553|3902941|P3|Overall Study|Lack of Efficacy|0
1188570|NCT01021553|3902942|P2|Overall Study|Lack of Efficacy|2
1188571|NCT01021553|3902943|P1|Overall Study|Lack of Efficacy|2
1188572|NCT01021553|3902941|P3|Overall Study|Adverse Event|0
1188573|NCT01021553|3902942|P2|Overall Study|Adverse Event|0
1188574|NCT01021553|3902943|P1|Overall Study|Adverse Event|1
1188575|NCT01021423|3902997|P2|Overall Study|Study terminated|5
1188576|NCT01021423|3902998|P1|Overall Study|Study terminated|4
1188577|NCT01021332|3903014|P1|Overall Study|Miscellaneous|3
1188578|NCT01021332|3903014|P1|Overall Study|Protocol Violation|9
1188579|NCT01021332|3903014|P1|Overall Study|Lost to Follow-up|4
1188580|NCT01021332|3903014|P1|Overall Study|Withdrawal of Consent|23
1188581|NCT01021332|3903014|P1|Overall Study|Lack of Efficacy|19
1188582|NCT01021332|3903014|P1|Overall Study|Adverse Event|43
1188583|NCT01021332|3903014|P1|Overall Study|Not fulfilling incl./excl.criteria|5
1188584|NCT01021293|3903075|P2|Overall Study|Lost to Follow-up|1
1188585|NCT01021293|3903076|P1|Overall Study|Lost to Follow-up|1
1188586|NCT01021293|3903075|P2|Overall Study|Migrated/moved from study area|18
1188587|NCT01021293|3903076|P1|Overall Study|Migrated/moved from study area|6
1188588|NCT01021293|3903075|P2|Overall Study|Withdrawal by Subject|3
1188589|NCT01021293|3903076|P1|Overall Study|Withdrawal by Subject|1
1188590|NCT01021293|3903075|P2|Overall Study|Adverse Event|1
1188591|NCT01021293|3903076|P1|Overall Study|Adverse Event|2
1188592|NCT01021293|3903075|P2|Overall Study|Serious Adverse Event|1
1188593|NCT01021293|3903076|P1|Overall Study|Serious Adverse Event|2
1188594|NCT01021215|3903095|P2|Overall Study|Lost to Follow-up|0
1188595|NCT01021215|3903096|P1|Overall Study|Lost to Follow-up|3
1188596|NCT01021020|3903111|P1|14 Day Washout Period A|Physician Decision|1
1188597|NCT01021020|3903111|P1|Period I|Withdrawal by Subject|1
1188598|NCT01021020|3903111|P1|Period I|Protocol Violation|1
1188599|NCT01021007|3903127|P2|Overall Study|Adverse Event|3
1188600|NCT01021007|3903128|P1|Overall Study|Adverse Event|1
1188601|NCT01021007|3903127|P2|Overall Study|Lost to Follow-up|1
1188602|NCT01021007|3903128|P1|Overall Study|Lost to Follow-up|1
1188603|NCT01020981|3903140|P2|Overall Study|Participant declined to complete survey|0
1188604|NCT01020981|3903141|P1|Overall Study|Participant declined to complete survey|2
1188605|NCT01020981|3903140|P2|Overall Study|Survey returned undeliverable|32
1188606|NCT01020981|3903141|P1|Overall Study|Survey returned undeliverable|8
1188607|NCT01020981|3903140|P2|Overall Study|Did not return mailed survey|58
1188608|NCT01020981|3903141|P1|Overall Study|Did not return mailed survey|74
1188609|NCT01020877|3903162|P2|Second Intervention|Withdrawal by Subject|0
1188610|NCT01020877|3903163|P1|Second Intervention|Withdrawal by Subject|1
1188611|NCT01020838|3903173|P1|Overall Study|Most common: Study ended by sponsor|77
1188612|NCT01020838|3903173|P1|Overall Study|Lost to Follow-up|6
1188613|NCT01020838|3903173|P1|Overall Study|Withdrawal by Subject|9
1188614|NCT01020838|3903173|P1|Overall Study|Adverse Event|1
1188615|NCT01020838|3903173|P1|Overall Study|Death|90
1188616|NCT01020812|3903188|P1|Overall Study|Protocol Violation|1
1188617|NCT01020812|3903188|P1|Overall Study|Withdrawal by Subject|1
1188618|NCT01020812|3903188|P1|Overall Study|Physician Decision|1
1188619|NCT01020799|3903198|P3|Overall Study|Lost to Follow-up|2
1188620|NCT01020799|3903199|P2|Overall Study|Lost to Follow-up|4
1188621|NCT01020799|3903200|P1|Overall Study|Lost to Follow-up|6
1188622|NCT01020799|3903198|P3|Overall Study|Withdrawal by Subject|3
1188623|NCT01020799|3903199|P2|Overall Study|Withdrawal by Subject|2
1188624|NCT01020799|3903200|P1|Overall Study|Withdrawal by Subject|2
1188625|NCT01020799|3903198|P3|Overall Study|Protocol Violation|0
1188626|NCT01020799|3903199|P2|Overall Study|Protocol Violation|2
1188627|NCT01020799|3903200|P1|Overall Study|Protocol Violation|3
1188628|NCT01020799|3903198|P3|Overall Study|non-compliance; lack of efficacy; etc.|0
1188629|NCT01020799|3903199|P2|Overall Study|non-compliance; lack of efficacy; etc.|3
1188630|NCT01020799|3903200|P1|Overall Study|non-compliance; lack of efficacy; etc.|4
1188631|NCT01020799|3903198|P3|Overall Study|Adverse Event|2
1188632|NCT01020799|3903199|P2|Overall Study|Adverse Event|3
1188633|NCT01020799|3903200|P1|Overall Study|Adverse Event|4
1188634|NCT01020786|3903223|P1|Maintenance Period|Sponsor Decision|1
1188635|NCT01020786|3903223|P1|Maintenance Period|Withdrawal by Subject|8
1188636|NCT01020786|3903223|P1|Maintenance Period|Progressive Disease|43
1188637|NCT01020786|3903223|P1|Maintenance Period|Adverse Event|8
1188638|NCT01020786|3903223|P1|Induction Period|Withdrawal by Subject|3
1188639|NCT01020786|3903223|P1|Induction Period|Investigator Decision|3
1188640|NCT01020786|3903223|P1|Induction Period|Progressive Disease|31
1188641|NCT01020786|3903223|P1|Induction Period|Adverse Event|10
1188642|NCT01020786|3903223|P1|Induction Period|Entry Criteria Not Met|2
1188643|NCT01020773|3903237|P2|Overall Study|Withdrawal by Subject|3
1188644|NCT01020773|3903238|P1|Overall Study|Withdrawal by Subject|4
1188645|NCT01020747|3903244|P1|Overall Study|Withdrawal by Subject|1
1188646|NCT01020526|3903260|P1|Overall Study|Adverse Event|2
1188647|NCT01020526|3903260|P1|Overall Study|Lost to Follow-up|1
1188648|NCT01020526|3903260|P1|Overall Study|Insufficient clinical response|3
1188649|NCT01020526|3903260|P1|Overall Study|Other reasons|3
1188650|NCT01020526|3903260|P1|Overall Study|Withdrawal by Subject|5
1188651|NCT01020474|3903266|P2|Overall Study|Insufficient Clinical Response|3
1188652|NCT01020474|3903267|P1|Overall Study|Insufficient Clinical Response|0
1188653|NCT01020474|3903266|P2|Overall Study|Other Reasons|1
1188654|NCT01020474|3903267|P1|Overall Study|Other Reasons|1
1188655|NCT01020474|3903266|P2|Overall Study|Withdrawal by Subject|7
1188656|NCT01020474|3903267|P1|Overall Study|Withdrawal by Subject|5
1188657|NCT01020474|3903266|P2|Overall Study|Protocol Violation|2
1188658|NCT01020474|3903267|P1|Overall Study|Protocol Violation|0
1188659|NCT01020474|3903266|P2|Overall Study|Adverse Event|4
1188660|NCT01020474|3903267|P1|Overall Study|Adverse Event|4
1188661|NCT01020448|3903287|P1|Treatment|Lost to Follow-up|2
1188662|NCT01020448|3903287|P1|Treatment|Lack of Efficacy|8
1188663|NCT01020448|3903287|P1|Treatment|Disease Progression|2
1188664|NCT01020448|3903287|P1|Treatment|Consent Withdrawn|3
1188665|NCT01020448|3903287|P1|Treatment|Adverse Event|11
1188666|NCT01020448|3903287|P1|Pre-assignment|Does Not Meet Entry Criteria|2
1188667|NCT01020448|3903287|P1|Pre-assignment|Withdrawal by Subject|5
1188668|NCT01020448|3903287|P1|Pre-assignment|Adverse Event|6
1188669|NCT01020435|3903298|P2|Overall Study|Lost to Follow-up|1
1188670|NCT01020435|3903299|P1|Overall Study|Lost to Follow-up|0
1188671|NCT01020305|3903307|P1|Overall Study|Adverse Event|2
1188672|NCT01020123|3903318|P7|Extention Period|Lost to Follow-up|0
1188673|NCT01020123|3903319|P6|Extention Period|Lost to Follow-up|2
1188674|NCT01020123|3903320|P5|Extention Period|Lost to Follow-up|0
1188675|NCT01020123|3903321|P4|Extention Period|Lost to Follow-up|0
1188676|NCT01020123|3903322|P3|Extention Period|Lost to Follow-up|0
1188677|NCT01020123|3903323|P2|Extention Period|Lost to Follow-up|0
1188678|NCT01020123|3903324|P1|Extention Period|Lost to Follow-up|0
1188679|NCT01020123|3903318|P7|Extention Period|Protocol Violation|1
1188680|NCT01020123|3903319|P6|Extention Period|Protocol Violation|0
1188681|NCT01020123|3903320|P5|Extention Period|Protocol Violation|0
1188682|NCT01020123|3903321|P4|Extention Period|Protocol Violation|0
1188683|NCT01020123|3903322|P3|Extention Period|Protocol Violation|1
1188684|NCT01020123|3903323|P2|Extention Period|Protocol Violation|1
1188685|NCT01020123|3903324|P1|Extention Period|Protocol Violation|1
1188686|NCT01020123|3903318|P7|Extention Period|Adverse Event|0
1188687|NCT01020123|3903319|P6|Extention Period|Adverse Event|0
1188688|NCT01020123|3903320|P5|Extention Period|Adverse Event|0
1188689|NCT01020123|3903321|P4|Extention Period|Adverse Event|1
1188690|NCT01020123|3903322|P3|Extention Period|Adverse Event|0
1188691|NCT01020123|3903323|P2|Extention Period|Adverse Event|0
1188692|NCT01020123|3903324|P1|Extention Period|Adverse Event|0
1188693|NCT01020123|3903318|P7|Extention Period|Withdrawal by Subject|0
1188694|NCT01020123|3903319|P6|Extention Period|Withdrawal by Subject|0
1188695|NCT01020123|3903320|P5|Extention Period|Withdrawal by Subject|0
1188696|NCT01020123|3903321|P4|Extention Period|Withdrawal by Subject|0
1188697|NCT01020123|3903322|P3|Extention Period|Withdrawal by Subject|1
1188698|NCT01020123|3903323|P2|Extention Period|Withdrawal by Subject|1
1188699|NCT01020123|3903324|P1|Extention Period|Withdrawal by Subject|2
1188700|NCT01020123|3903318|P7|Main Period|Unclasified|6
1188701|NCT01020123|3903319|P6|Main Period|Unclasified|3
1188702|NCT01020123|3903320|P5|Main Period|Unclasified|1
1188703|NCT01020123|3903321|P4|Main Period|Unclasified|0
1188704|NCT01020123|3903322|P3|Main Period|Unclasified|1
1188705|NCT01020123|3903323|P2|Main Period|Unclasified|0
1188706|NCT01020123|3903324|P1|Main Period|Unclasified|2
1188707|NCT01020123|3903318|P7|Main Period|Lost to Follow-up|0
1188708|NCT01020123|3903319|P6|Main Period|Lost to Follow-up|0
1188709|NCT01020123|3903320|P5|Main Period|Lost to Follow-up|0
1188710|NCT01020123|3903321|P4|Main Period|Lost to Follow-up|0
1188711|NCT01020123|3903322|P3|Main Period|Lost to Follow-up|0
1188712|NCT01020123|3903323|P2|Main Period|Lost to Follow-up|2
1188713|NCT01020123|3903324|P1|Main Period|Lost to Follow-up|0
1188714|NCT01020123|3903318|P7|Main Period|Protocol Violation|2
1188715|NCT01020123|3903319|P6|Main Period|Protocol Violation|3
1188716|NCT01020123|3903320|P5|Main Period|Protocol Violation|2
1188717|NCT01020123|3903321|P4|Main Period|Protocol Violation|5
1188718|NCT01020123|3903322|P3|Main Period|Protocol Violation|2
1188719|NCT01020123|3903323|P2|Main Period|Protocol Violation|4
1188720|NCT01020123|3903324|P1|Main Period|Protocol Violation|4
1188721|NCT01020123|3903318|P7|Main Period|Adverse Event|1
1188722|NCT01020123|3903319|P6|Main Period|Adverse Event|2
1188723|NCT01020123|3903320|P5|Main Period|Adverse Event|1
1188724|NCT01020123|3903321|P4|Main Period|Adverse Event|1
1188725|NCT01020123|3903322|P3|Main Period|Adverse Event|2
1188726|NCT01020123|3903323|P2|Main Period|Adverse Event|2
1188727|NCT01020123|3903324|P1|Main Period|Adverse Event|5
1188728|NCT01020123|3903318|P7|Main Period|Eligibility Criteria not fullfilled|0
1188729|NCT01020123|3903319|P6|Main Period|Eligibility Criteria not fullfilled|0
1188730|NCT01020123|3903320|P5|Main Period|Eligibility Criteria not fullfilled|1
1188731|NCT01020123|3903321|P4|Main Period|Eligibility Criteria not fullfilled|0
1188732|NCT01020123|3903322|P3|Main Period|Eligibility Criteria not fullfilled|0
1188733|NCT01020123|3903323|P2|Main Period|Eligibility Criteria not fullfilled|1
1188734|NCT01020123|3903324|P1|Main Period|Eligibility Criteria not fullfilled|0
1188735|NCT01020123|3903318|P7|Main Period|Withdrawal by Subject|2
1188736|NCT01020123|3903319|P6|Main Period|Withdrawal by Subject|3
1188737|NCT01020123|3903320|P5|Main Period|Withdrawal by Subject|6
1188738|NCT01020123|3903321|P4|Main Period|Withdrawal by Subject|1
1188739|NCT01020123|3903322|P3|Main Period|Withdrawal by Subject|3
1188740|NCT01020123|3903323|P2|Main Period|Withdrawal by Subject|5
1188741|NCT01020123|3903324|P1|Main Period|Withdrawal by Subject|6
1188742|NCT01020019|3903519|P2|Overall Study|moving|2
1188743|NCT01020019|3903520|P1|Overall Study|moving|0
1188744|NCT01020019|3903519|P2|Overall Study|not interested in treatment|4
1188745|NCT01020019|3903520|P1|Overall Study|not interested in treatment|4
1188746|NCT01020019|3903519|P2|Overall Study|Adverse Event|5
1188747|NCT01020019|3903520|P1|Overall Study|Adverse Event|1
1188748|NCT01020019|3903519|P2|Overall Study|Lost to Follow-up|18
1188749|NCT01020019|3903520|P1|Overall Study|Lost to Follow-up|21
1188750|NCT01019980|3903541|P2|Overall Study|Drug not available.|0
1188751|NCT01019980|3903542|P1|Overall Study|Drug not available.|2
1188752|NCT01019694|3903605|P3|Overall Study|Other reason (not specified)|6
1188753|NCT01019694|3903606|P2|Overall Study|Other reason (not specified)|5
1188754|NCT01019694|3903607|P1|Overall Study|Other reason (not specified)|1
1188755|NCT01019694|3903605|P3|Overall Study|Not treated|3
1188756|NCT01019694|3903606|P2|Overall Study|Not treated|2
1188757|NCT01019694|3903607|P1|Overall Study|Not treated|0
1188758|NCT01019694|3903605|P3|Overall Study|Withdrawal by Subject|12
1188759|NCT01019694|3903606|P2|Overall Study|Withdrawal by Subject|6
1188760|NCT01019694|3903607|P1|Overall Study|Withdrawal by Subject|4
1188761|NCT01019694|3903605|P3|Overall Study|Lost to Follow-up|3
1188762|NCT01019694|3903606|P2|Overall Study|Lost to Follow-up|3
1188763|NCT01019694|3903607|P1|Overall Study|Lost to Follow-up|5
1188764|NCT01019694|3903605|P3|Overall Study|Protocol Violation|4
1188765|NCT01019694|3903606|P2|Overall Study|Protocol Violation|6
1188766|NCT01019694|3903607|P1|Overall Study|Protocol Violation|2
1188767|NCT01019694|3903605|P3|Overall Study|Adverse Event|19
1188768|NCT01019694|3903606|P2|Overall Study|Adverse Event|16
1188769|NCT01019694|3903607|P1|Overall Study|Adverse Event|12
1188770|NCT01019486|3903732|P3|Overall Study|Withdrawal by Subject|1
1188771|NCT01019486|3903733|P2|Overall Study|Withdrawal by Subject|1
1188772|NCT01019486|3903734|P1|Overall Study|Withdrawal by Subject|1
1188773|NCT01019369|3903748|P2|Overall Study|Withdrawal by Subject|1
1188774|NCT01019369|3903749|P1|Overall Study|Withdrawal by Subject|0
1188775|NCT01019369|3903748|P2|Overall Study|Lost to Follow-up|6
1188776|NCT01019369|3903749|P1|Overall Study|Lost to Follow-up|10
1188777|NCT01019317|3903757|P1|Overall Study|Not Eligible|4
1188778|NCT01019252|3903763|P2|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5
1188779|NCT01019252|3903764|P1|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0
1188780|NCT01019252|3903763|P2|Wait List Cross-over to CBT for ADHD|Time constraints|2
1188781|NCT01019252|3903764|P1|Wait List Cross-over to CBT for ADHD|Time constraints|0
1188782|NCT01019252|3903763|P2|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0
1188783|NCT01019252|3903764|P1|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1
1188784|NCT01019252|3903763|P2|Initial CBT for ADHD vs. Wait List|Time constraints|0
1188785|NCT01019252|3903764|P1|Initial CBT for ADHD vs. Wait List|Time constraints|2
1188786|NCT01019135|3903777|P3|Overall Study|Did not attend CR|6
1188787|NCT01019135|3903778|P2|Overall Study|Did not attend CR|13
1188788|NCT01019135|3903779|P1|Overall Study|Did not attend CR|8
1188789|NCT01019135|3903777|P3|Overall Study|Did not receive allocated intervention|25
1188790|NCT01019135|3903778|P2|Overall Study|Did not receive allocated intervention|6
1188791|NCT01019135|3903779|P1|Overall Study|Did not receive allocated intervention|12
1188792|NCT01018992|3903807|P2|Overall Study|Lost to Follow-up|1
1188793|NCT01018992|3903808|P1|Overall Study|Lost to Follow-up|5
1188794|NCT01018992|3903807|P2|Overall Study|Protocol Violation|4
1188795|NCT01018992|3903808|P1|Overall Study|Protocol Violation|0
1188796|NCT01018992|3903807|P2|Overall Study|Withdrawal by Subject|8
1188797|NCT01018992|3903808|P1|Overall Study|Withdrawal by Subject|3
1188798|NCT01018992|3903807|P2|Overall Study|Adverse Event|3
1188799|NCT01018992|3903808|P1|Overall Study|Adverse Event|8
1188800|NCT01018979|3903822|P2|Overall Study|Not received at least one dose|1
1188801|NCT01018979|3903823|P1|Overall Study|Not received at least one dose|0
1188802|NCT01018979|3903822|P2|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9
1188803|NCT01018979|3903823|P1|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3
1188804|NCT01018953|3903853|P1|Overall Study|Study termination by sponsor|5
1188805|NCT01018953|3903853|P1|Overall Study|Withdrawal by Subject|1
1188806|NCT01018953|3903853|P1|Overall Study|Adverse Event|2
1188807|NCT01018862|3903866|P3|Overall Study|administrative problems|4
1188808|NCT01018862|3903867|P2|Overall Study|administrative problems|4
1188809|NCT01018862|3903868|P1|Overall Study|administrative problems|5
1188810|NCT01018862|3903866|P3|Overall Study|Withdrawal by Subject|1
1188811|NCT01018862|3903867|P2|Overall Study|Withdrawal by Subject|2
1188812|NCT01018862|3903868|P1|Overall Study|Withdrawal by Subject|1
1188813|NCT01018862|3903866|P3|Overall Study|Protocol Violation|3
1188814|NCT01018862|3903867|P2|Overall Study|Protocol Violation|3
1188815|NCT01018862|3903868|P1|Overall Study|Protocol Violation|1
1188816|NCT01018862|3903866|P3|Overall Study|Lost to Follow-up|0
1188817|NCT01018862|3903867|P2|Overall Study|Lost to Follow-up|1
1188818|NCT01018862|3903868|P1|Overall Study|Lost to Follow-up|3
1188819|NCT01018862|3903866|P3|Overall Study|Lack of Efficacy|2
1188820|NCT01018862|3903867|P2|Overall Study|Lack of Efficacy|0
1188821|NCT01018862|3903868|P1|Overall Study|Lack of Efficacy|1
1188822|NCT01018862|3903866|P3|Overall Study|Adverse Event|6
1188823|NCT01018862|3903867|P2|Overall Study|Adverse Event|0
1188824|NCT01018862|3903868|P1|Overall Study|Adverse Event|2
1188825|NCT01018810|3903890|P5|Overall Study|Sponsor Decision|1
1188826|NCT01018810|3903891|P4|Overall Study|Sponsor Decision|1
1188827|NCT01018810|3903892|P3|Overall Study|Sponsor Decision|1
1188828|NCT01018810|3903893|P2|Overall Study|Sponsor Decision|0
1188829|NCT01018810|3903894|P1|Overall Study|Sponsor Decision|2
1188830|NCT01018810|3903890|P5|Overall Study|Withdrawal by Subject|0
1188831|NCT01018810|3903891|P4|Overall Study|Withdrawal by Subject|0
1188832|NCT01018810|3903892|P3|Overall Study|Withdrawal by Subject|0
1188833|NCT01018810|3903893|P2|Overall Study|Withdrawal by Subject|1
1188834|NCT01018810|3903894|P1|Overall Study|Withdrawal by Subject|0
1188835|NCT01018732|3903954|P3|Overall Study|Unable to Classify|1
1188836|NCT01018732|3903955|P2|Overall Study|Unable to Classify|0
1188837|NCT01018732|3903956|P1|Overall Study|Unable to Classify|0
1188838|NCT01018732|3903954|P3|Overall Study|Inappropriate Enrollment|0
1188839|NCT01018732|3903955|P2|Overall Study|Inappropriate Enrollment|1
1188840|NCT01018732|3903956|P1|Overall Study|Inappropriate Enrollment|0
1188841|NCT01018732|3903954|P3|Overall Study|Protocol Violation|0
1188842|NCT01018732|3903955|P2|Overall Study|Protocol Violation|1
1188843|NCT01018732|3903956|P1|Overall Study|Protocol Violation|1
1188844|NCT01018732|3903954|P3|Overall Study|Lost to Follow-up|3
1188845|NCT01018732|3903955|P2|Overall Study|Lost to Follow-up|0
1188846|NCT01018732|3903956|P1|Overall Study|Lost to Follow-up|0
1188847|NCT01018680|3903990|P2|Overall Study|Physician Decision|1
1188848|NCT01018680|3903991|P1|Overall Study|Physician Decision|3
1188849|NCT01018680|3903990|P2|Overall Study|Entry Criteria Not Met|4
1188850|NCT01018680|3903991|P1|Overall Study|Entry Criteria Not Met|1
1188851|NCT01018680|3903990|P2|Overall Study|Lost to Follow-up|3
1188852|NCT01018680|3903991|P1|Overall Study|Lost to Follow-up|5
1188853|NCT01018680|3903990|P2|Overall Study|Lack of Efficacy|2
1188854|NCT01018680|3903991|P1|Overall Study|Lack of Efficacy|8
1188855|NCT01018680|3903990|P2|Overall Study|Sponsor Decision|7
1188856|NCT01018680|3903991|P1|Overall Study|Sponsor Decision|6
1188857|NCT01018680|3903990|P2|Overall Study|Protocol Violation|8
1188858|NCT01018680|3903991|P1|Overall Study|Protocol Violation|5
1188859|NCT01018680|3903990|P2|Overall Study|Withdrawal by Subject|10
1188860|NCT01018680|3903991|P1|Overall Study|Withdrawal by Subject|10
1188861|NCT01018680|3903990|P2|Overall Study|Adverse Event|40
1188862|NCT01018680|3903991|P1|Overall Study|Adverse Event|23
1188863|NCT01020487|3904034|P3|Part 2 Open-label Period|Adverse Event|1
1188864|NCT01020487|3904035|P2|Part 2 Open-label Period|Adverse Event|4
1188865|NCT01020487|3904036|P1|Part 2 Open-label Period|Adverse Event|0
1188866|NCT01020487|3904034|P3|Part 2 Double-blind Treatment Period|Randomized in Error|1
1188867|NCT01020487|3904035|P2|Part 2 Double-blind Treatment Period|Randomized in Error|0
1188868|NCT01020487|3904036|P1|Part 2 Double-blind Treatment Period|Randomized in Error|0
1188869|NCT01020487|3904034|P3|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3
1188870|NCT01020487|3904035|P2|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
1188871|NCT01020487|3904036|P1|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
1188872|NCT01020487|3904034|P3|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1
1188873|NCT01020487|3904035|P2|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
1188874|NCT01020487|3904036|P1|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
1188875|NCT01020487|3904034|P3|Part 2 Double-blind Treatment Period|Adverse Event|1
1188876|NCT01020487|3904035|P2|Part 2 Double-blind Treatment Period|Adverse Event|2
1188877|NCT01020487|3904036|P1|Part 2 Double-blind Treatment Period|Adverse Event|0
1188878|NCT01018511|3904061|P4|Overall Study|Miscellaneous|0
1188879|NCT01018511|3904062|P3|Overall Study|Miscellaneous|0
1188880|NCT01018511|3904063|P2|Overall Study|Miscellaneous|2
1188881|NCT01018511|3904064|P1|Overall Study|Miscellaneous|0
1188882|NCT01018511|3904061|P4|Overall Study|Protocol Violation|9
1188883|NCT01018511|3904062|P3|Overall Study|Protocol Violation|7
1188884|NCT01018511|3904063|P2|Overall Study|Protocol Violation|8
1188885|NCT01018511|3904064|P1|Overall Study|Protocol Violation|5
1188886|NCT01018511|3904061|P4|Overall Study|Lost to Follow-up|0
1188887|NCT01018511|3904062|P3|Overall Study|Lost to Follow-up|1
1188888|NCT01018511|3904063|P2|Overall Study|Lost to Follow-up|0
1188889|NCT01018511|3904064|P1|Overall Study|Lost to Follow-up|0
1188890|NCT01018511|3904061|P4|Overall Study|Withdrawal by Subject|9
1188891|NCT01018511|3904062|P3|Overall Study|Withdrawal by Subject|11
1188892|NCT01018511|3904063|P2|Overall Study|Withdrawal by Subject|5
1188893|NCT01018511|3904064|P1|Overall Study|Withdrawal by Subject|6
1188894|NCT01018511|3904061|P4|Overall Study|Lack of Efficacy|2
1188895|NCT01018511|3904062|P3|Overall Study|Lack of Efficacy|1
1188896|NCT01018511|3904063|P2|Overall Study|Lack of Efficacy|1
1188897|NCT01018511|3904064|P1|Overall Study|Lack of Efficacy|4
1188898|NCT01018511|3904061|P4|Overall Study|Adverse Event|10
1188899|NCT01018511|3904062|P3|Overall Study|Adverse Event|13
1188900|NCT01018511|3904063|P2|Overall Study|Adverse Event|9
1188901|NCT01018511|3904064|P1|Overall Study|Adverse Event|5
1188902|NCT01018511|3904061|P4|Overall Study|Not fulfilling eligibility criteria|3
1188903|NCT01018511|3904062|P3|Overall Study|Not fulfilling eligibility criteria|7
1188904|NCT01018511|3904063|P2|Overall Study|Not fulfilling eligibility criteria|7
1188905|NCT01018511|3904064|P1|Overall Study|Not fulfilling eligibility criteria|6
1188906|NCT01018394|3904261|P2|Overall Study|Lost to Follow-up|3
1188907|NCT01018394|3904262|P1|Overall Study|Lost to Follow-up|4
1188908|NCT01018394|3904261|P2|Overall Study|Withdrawal by Subject|5
1188909|NCT01018394|3904262|P1|Overall Study|Withdrawal by Subject|5
1188910|NCT01018264|3904272|P2|Overall Study|Lost to Follow-up|1
1188911|NCT01018264|3904273|P1|Overall Study|Lost to Follow-up|0
1188912|NCT01018264|3904272|P2|Overall Study|Withdrawal by Subject|0
1188913|NCT01018264|3904273|P1|Overall Study|Withdrawal by Subject|1
1188914|NCT01018186|3904290|P4|52-week Double-blind Treatment Period|Withdrawal by Subject|9
1188915|NCT01018186|3904291|P3|52-week Double-blind Treatment Period|Withdrawal by Subject|7
1188916|NCT01018186|3904292|P2|52-week Double-blind Treatment Period|Withdrawal by Subject|10
1188917|NCT01018186|3904293|P1|52-week Double-blind Treatment Period|Withdrawal by Subject|0
1188918|NCT01018186|3904290|P4|52-week Double-blind Treatment Period|Physician Decision|3
1188919|NCT01018186|3904291|P3|52-week Double-blind Treatment Period|Physician Decision|0
1188920|NCT01018186|3904292|P2|52-week Double-blind Treatment Period|Physician Decision|1
1188921|NCT01018186|3904293|P1|52-week Double-blind Treatment Period|Physician Decision|0
1188922|NCT01018186|3904290|P4|52-week Double-blind Treatment Period|Lost to Follow-up|4
1188923|NCT01018186|3904291|P3|52-week Double-blind Treatment Period|Lost to Follow-up|3
1188924|NCT01018186|3904292|P2|52-week Double-blind Treatment Period|Lost to Follow-up|1
1188925|NCT01018186|3904293|P1|52-week Double-blind Treatment Period|Lost to Follow-up|0
1188926|NCT01018186|3904290|P4|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
1188927|NCT01018186|3904291|P3|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16
1188928|NCT01018186|3904292|P2|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14
1188929|NCT01018186|3904293|P1|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
1188930|NCT01018186|3904290|P4|52-week Double-blind Treatment Period|Protocol Violation|2
1188931|NCT01018186|3904291|P3|52-week Double-blind Treatment Period|Protocol Violation|8
1188932|NCT01018186|3904292|P2|52-week Double-blind Treatment Period|Protocol Violation|8
1188933|NCT01018186|3904293|P1|52-week Double-blind Treatment Period|Protocol Violation|0
1188934|NCT01018186|3904290|P4|52-week Double-blind Treatment Period|Lack of Efficacy|1
1188935|NCT01018186|3904291|P3|52-week Double-blind Treatment Period|Lack of Efficacy|4
1188936|NCT01018186|3904292|P2|52-week Double-blind Treatment Period|Lack of Efficacy|1
1188937|NCT01018186|3904293|P1|52-week Double-blind Treatment Period|Lack of Efficacy|0
1188938|NCT01018186|3904290|P4|52-week Double-blind Treatment Period|Adverse Event|6
1188939|NCT01018186|3904291|P3|52-week Double-blind Treatment Period|Adverse Event|3
1188940|NCT01018186|3904292|P2|52-week Double-blind Treatment Period|Adverse Event|5
1188941|NCT01018186|3904293|P1|52-week Double-blind Treatment Period|Adverse Event|0
1188942|NCT01018186|3904290|P4|2-week Run-in Period|Did Not Meet Continuation Criteria|0
1188943|NCT01018186|3904291|P3|2-week Run-in Period|Did Not Meet Continuation Criteria|0
1188944|NCT01018186|3904292|P2|2-week Run-in Period|Did Not Meet Continuation Criteria|0
1188945|NCT01018186|3904293|P1|2-week Run-in Period|Did Not Meet Continuation Criteria|97
1188946|NCT01018186|3904290|P4|2-week Run-in Period|Withdrawal by Subject|0
1188947|NCT01018186|3904291|P3|2-week Run-in Period|Withdrawal by Subject|0
1188948|NCT01018186|3904292|P2|2-week Run-in Period|Withdrawal by Subject|0
1188949|NCT01018186|3904293|P1|2-week Run-in Period|Withdrawal by Subject|11
1188950|NCT01018186|3904290|P4|2-week Run-in Period|Physician Decision|0
1188951|NCT01018186|3904291|P3|2-week Run-in Period|Physician Decision|0
1188952|NCT01018186|3904292|P2|2-week Run-in Period|Physician Decision|0
1188953|NCT01018186|3904293|P1|2-week Run-in Period|Physician Decision|3
1188954|NCT01018186|3904290|P4|2-week Run-in Period|Lost to Follow-up|0
1188955|NCT01018186|3904291|P3|2-week Run-in Period|Lost to Follow-up|0
1188956|NCT01018186|3904292|P2|2-week Run-in Period|Lost to Follow-up|0
1188957|NCT01018186|3904293|P1|2-week Run-in Period|Lost to Follow-up|2
1188958|NCT01018186|3904290|P4|2-week Run-in Period|Protocol Violation|0
1188959|NCT01018186|3904291|P3|2-week Run-in Period|Protocol Violation|0
1188960|NCT01018186|3904292|P2|2-week Run-in Period|Protocol Violation|0
1188961|NCT01018186|3904293|P1|2-week Run-in Period|Protocol Violation|1
1188962|NCT01018030|3904494|P3|Overall Study|Did Not Receive Study Drug|0
1188963|NCT01018030|3904495|P2|Overall Study|Did Not Receive Study Drug|3
1188964|NCT01018030|3904496|P1|Overall Study|Did Not Receive Study Drug|1
1188965|NCT01018030|3904494|P3|Overall Study|Lack of Efficacy|0
1188966|NCT01018030|3904495|P2|Overall Study|Lack of Efficacy|0
1188967|NCT01018030|3904496|P1|Overall Study|Lack of Efficacy|1
1188968|NCT01018030|3904494|P3|Overall Study|Physician Decision|1
1188969|NCT01018030|3904495|P2|Overall Study|Physician Decision|0
1188970|NCT01018030|3904496|P1|Overall Study|Physician Decision|1
1188971|NCT01018030|3904494|P3|Overall Study|Protocol Violation|0
1188972|NCT01018030|3904495|P2|Overall Study|Protocol Violation|1
1188973|NCT01018030|3904496|P1|Overall Study|Protocol Violation|2
1188974|NCT01018030|3904494|P3|Overall Study|Lost to Follow-up|3
1188975|NCT01018030|3904495|P2|Overall Study|Lost to Follow-up|0
1188976|NCT01018030|3904496|P1|Overall Study|Lost to Follow-up|2
1188977|NCT01018030|3904494|P3|Overall Study|Withdrawal by Subject|4
1188978|NCT01018030|3904495|P2|Overall Study|Withdrawal by Subject|2
1188979|NCT01018030|3904496|P1|Overall Study|Withdrawal by Subject|2
1188980|NCT01018030|3904494|P3|Overall Study|Adverse Event|5
1188981|NCT01018030|3904495|P2|Overall Study|Adverse Event|5
1188982|NCT01018030|3904496|P1|Overall Study|Adverse Event|10
1188983|NCT01017952|3904547|P5|52-week, Double-blind Treatment Period|Physician Decision|7
1188984|NCT01017952|3904548|P4|52-week, Double-blind Treatment Period|Physician Decision|9
1188985|NCT01017952|3904549|P3|52-week, Double-blind Treatment Period|Physician Decision|8
1188986|NCT01017952|3904550|P2|52-week, Double-blind Treatment Period|Physician Decision|10
1188987|NCT01017952|3904551|P1|52-week, Double-blind Treatment Period|Physician Decision|0
1188988|NCT01017952|3904547|P5|52-week, Double-blind Treatment Period|Lost to Follow-up|10
1188989|NCT01017952|3904548|P4|52-week, Double-blind Treatment Period|Lost to Follow-up|6
1188990|NCT01017952|3904549|P3|52-week, Double-blind Treatment Period|Lost to Follow-up|8
1188991|NCT01017952|3904550|P2|52-week, Double-blind Treatment Period|Lost to Follow-up|6
1188992|NCT01017952|3904551|P1|52-week, Double-blind Treatment Period|Lost to Follow-up|0
1188993|NCT01017952|3904547|P5|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
1188994|NCT01017952|3904548|P4|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
1188995|NCT01017952|3904549|P3|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
1188996|NCT01017952|3904550|P2|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
1188997|NCT01017952|3904551|P1|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
1188998|NCT01017952|3904547|P5|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
1188999|NCT01017952|3904548|P4|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12
1189000|NCT01017952|3904549|P3|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
1189001|NCT01017952|3904550|P2|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
1189002|NCT01017952|3904551|P1|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
1189003|NCT01017952|3904547|P5|52-week, Double-blind Treatment Period|Protocol Violation|8
1189004|NCT01017952|3904548|P4|52-week, Double-blind Treatment Period|Protocol Violation|9
1189005|NCT01017952|3904549|P3|52-week, Double-blind Treatment Period|Protocol Violation|11
1189006|NCT01017952|3904550|P2|52-week, Double-blind Treatment Period|Protocol Violation|7
1189007|NCT01017952|3904551|P1|52-week, Double-blind Treatment Period|Protocol Violation|0
1189008|NCT01017952|3904547|P5|52-week, Double-blind Treatment Period|Lack of Efficacy|14
1189009|NCT01017952|3904548|P4|52-week, Double-blind Treatment Period|Lack of Efficacy|16
1189010|NCT01017952|3904549|P3|52-week, Double-blind Treatment Period|Lack of Efficacy|14
1189011|NCT01017952|3904550|P2|52-week, Double-blind Treatment Period|Lack of Efficacy|35
1189012|NCT01017952|3904551|P1|52-week, Double-blind Treatment Period|Lack of Efficacy|0
1189013|NCT01017952|3904547|P5|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
1189014|NCT01017952|3904548|P4|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
1189015|NCT01017952|3904549|P3|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
1189016|NCT01017952|3904550|P2|52-week, Double-blind Treatment Period|Withdrawal by Subject|30
1189017|NCT01017952|3904551|P1|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
1189018|NCT01017952|3904547|P5|52-week, Double-blind Treatment Period|Adverse Event|30
1189019|NCT01017952|3904548|P4|52-week, Double-blind Treatment Period|Adverse Event|35
1189020|NCT01017952|3904549|P3|52-week, Double-blind Treatment Period|Adverse Event|32
1189021|NCT01017952|3904550|P2|52-week, Double-blind Treatment Period|Adverse Event|25
1189022|NCT01017952|3904551|P1|52-week, Double-blind Treatment Period|Adverse Event|0
1189023|NCT01017952|3904547|P5|4-week, Open-label Run-In Period|Withdrawal by Subject|0
1189024|NCT01017952|3904548|P4|4-week, Open-label Run-In Period|Withdrawal by Subject|0
1189025|NCT01017952|3904549|P3|4-week, Open-label Run-In Period|Withdrawal by Subject|0
1189026|NCT01017952|3904550|P2|4-week, Open-label Run-In Period|Withdrawal by Subject|0
1189027|NCT01017952|3904551|P1|4-week, Open-label Run-In Period|Withdrawal by Subject|63
1189028|NCT01017952|3904547|P5|4-week, Open-label Run-In Period|Physician Decision|0
1189029|NCT01017952|3904548|P4|4-week, Open-label Run-In Period|Physician Decision|0
1189030|NCT01017952|3904549|P3|4-week, Open-label Run-In Period|Physician Decision|0
1189031|NCT01017952|3904550|P2|4-week, Open-label Run-In Period|Physician Decision|0
1189032|NCT01017952|3904551|P1|4-week, Open-label Run-In Period|Physician Decision|10
1189033|NCT01017952|3904547|P5|4-week, Open-label Run-In Period|Lost to Follow-up|0
1189034|NCT01017952|3904548|P4|4-week, Open-label Run-In Period|Lost to Follow-up|0
1189035|NCT01017952|3904549|P3|4-week, Open-label Run-In Period|Lost to Follow-up|0
1189036|NCT01017952|3904550|P2|4-week, Open-label Run-In Period|Lost to Follow-up|0
1189037|NCT01017952|3904551|P1|4-week, Open-label Run-In Period|Lost to Follow-up|6
1189038|NCT01017952|3904547|P5|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
1189039|NCT01017952|3904548|P4|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
1189040|NCT01017952|3904549|P3|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
1189041|NCT01017952|3904550|P2|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
1189042|NCT01017952|3904551|P1|4-week, Open-label Run-In Period|Study Closed/Tterminated|1
1189043|NCT01017952|3904547|P5|4-week, Open-label Run-In Period|Adverse Event|0
1189044|NCT01017952|3904548|P4|4-week, Open-label Run-In Period|Adverse Event|0
1189045|NCT01017952|3904549|P3|4-week, Open-label Run-In Period|Adverse Event|0
1189046|NCT01017952|3904550|P2|4-week, Open-label Run-In Period|Adverse Event|0
1189047|NCT01017952|3904551|P1|4-week, Open-label Run-In Period|Adverse Event|23
1189048|NCT01017952|3904547|P5|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
1189049|NCT01017952|3904548|P4|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
1189050|NCT01017952|3904549|P3|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
1189051|NCT01017952|3904550|P2|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
1189052|NCT01017952|3904551|P1|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356
1189053|NCT01017874|3904575|P2|Overall Study|Physician Decision|3
1189054|NCT01017874|3904576|P1|Overall Study|Physician Decision|1
1189055|NCT01017874|3904575|P2|Overall Study|Lost to Follow-up|2
1189056|NCT01017874|3904576|P1|Overall Study|Lost to Follow-up|3
1189057|NCT01017874|3904575|P2|Overall Study|Sponsor decision|1
1189058|NCT01017874|3904576|P1|Overall Study|Sponsor decision|3
1189059|NCT01017874|3904575|P2|Overall Study|Withdrawal by Subject|20
1189060|NCT01017874|3904576|P1|Overall Study|Withdrawal by Subject|23
1189061|NCT01017731|3904594|P1|Overall Study|Adverse Event|1
1189062|NCT01017731|3904594|P1|Overall Study|Physician Decision|2
1189063|NCT01017731|3904594|P1|Overall Study|Withdrawal by Subject|3
1189064|NCT01017731|3904594|P1|Overall Study|Lost to Follow-up|2
1189065|NCT01017601|3904623|P2|Overall Study|Withdrawal by Subject|1
1189066|NCT01017601|3904624|P1|Overall Study|Withdrawal by Subject|0
1189067|NCT01017601|3904623|P2|Overall Study|Disease Progression|12
1189068|NCT01017601|3904624|P1|Overall Study|Disease Progression|12
1189069|NCT01017575|3904651|P5|Overall Study|Withdrawal by Subject|0
1189070|NCT01017575|3904652|P4|Overall Study|Withdrawal by Subject|0
1189071|NCT01017575|3904653|P3|Overall Study|Withdrawal by Subject|0
1189072|NCT01017575|3904654|P2|Overall Study|Withdrawal by Subject|0
1189073|NCT01017575|3904655|P1|Overall Study|Withdrawal by Subject|1
1189074|NCT01017575|3904651|P5|Overall Study|Adverse Event|2
1189075|NCT01017575|3904652|P4|Overall Study|Adverse Event|0
1189076|NCT01017575|3904653|P3|Overall Study|Adverse Event|0
1189077|NCT01017575|3904654|P2|Overall Study|Adverse Event|1
1189078|NCT01017575|3904655|P1|Overall Study|Adverse Event|0
1189079|NCT01017575|3904651|P5|Overall Study|Lack of Efficacy|1
1189080|NCT01017575|3904652|P4|Overall Study|Lack of Efficacy|1
1189081|NCT01017575|3904653|P3|Overall Study|Lack of Efficacy|0
1189082|NCT01017575|3904654|P2|Overall Study|Lack of Efficacy|1
1189083|NCT01017575|3904655|P1|Overall Study|Lack of Efficacy|0
1189084|NCT01017549|3904692|P1|One-year Follow-up|Withdrawal by Subject|5
1189085|NCT01017549|3904692|P1|One-year Follow-up|Lost to Follow-up|2
1189086|NCT01017549|3904692|P1|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1
1189087|NCT01017263|3904723|P1|Overall Study|not eligible|12
1189088|NCT01017146|3904804|P2|Overall Study|Change in Work Situation|0
1189089|NCT01017146|3904805|P1|Overall Study|Change in Work Situation|1
1189090|NCT01017146|3904804|P2|Overall Study|Did Not Meet Eligibility Criteria|2
1189091|NCT01017146|3904805|P1|Overall Study|Did Not Meet Eligibility Criteria|1
1189092|NCT01017146|3904804|P2|Overall Study|Took Excluded Medication|0
1189093|NCT01017146|3904805|P1|Overall Study|Took Excluded Medication|2
1189094|NCT01017146|3904804|P2|Overall Study|Protocol Violation|0
1189095|NCT01017146|3904805|P1|Overall Study|Protocol Violation|2
1189096|NCT01017146|3904804|P2|Overall Study|Pregnancy|1
1189097|NCT01017146|3904805|P1|Overall Study|Pregnancy|2
1189098|NCT01017146|3904804|P2|Overall Study|Relocation|4
1189099|NCT01017146|3904805|P1|Overall Study|Relocation|0
1189100|NCT01017146|3904804|P2|Overall Study|Withdrawal by Subject|16
1189101|NCT01017146|3904805|P1|Overall Study|Withdrawal by Subject|32
1189102|NCT01017146|3904804|P2|Overall Study|Noncompliance with Study Product|1
1189103|NCT01017146|3904805|P1|Overall Study|Noncompliance with Study Product|1
1189104|NCT01017146|3904804|P2|Overall Study|Lost to Follow-up|14
1189105|NCT01017146|3904805|P1|Overall Study|Lost to Follow-up|14
1189106|NCT01017146|3904804|P2|Overall Study|Adverse Event|1
1189107|NCT01017146|3904805|P1|Overall Study|Adverse Event|11
1189108|NCT01017120|3904843|P2|Overall Study|Parent Unable to Provide Transportation|0
1189109|NCT01017120|3904844|P1|Overall Study|Parent Unable to Provide Transportation|1
1189110|NCT01017120|3904843|P2|Overall Study|Protocol Violation|0
1189111|NCT01017120|3904844|P1|Overall Study|Protocol Violation|1
1189112|NCT01017120|3904843|P2|Overall Study|Relocated Out of Town|2
1189113|NCT01017120|3904844|P1|Overall Study|Relocated Out of Town|0
1189114|NCT01017120|3904843|P2|Overall Study|Did Not Meet Eligibility Criteria|0
1189115|NCT01017120|3904844|P1|Overall Study|Did Not Meet Eligibility Criteria|1
1189116|NCT01017120|3904843|P2|Overall Study|Pregnancy|1
1189117|NCT01017120|3904844|P1|Overall Study|Pregnancy|1
1189118|NCT01017120|3904843|P2|Overall Study|Withdrawal by Subject|21
1189119|NCT01017120|3904844|P1|Overall Study|Withdrawal by Subject|39
1189120|NCT01017120|3904843|P2|Overall Study|Lack of Efficacy|0
1189121|NCT01017120|3904844|P1|Overall Study|Lack of Efficacy|1
1189122|NCT01017120|3904843|P2|Overall Study|Lost to Follow-up|11
1189123|NCT01017120|3904844|P1|Overall Study|Lost to Follow-up|13
1189124|NCT01017120|3904843|P2|Overall Study|Adverse Event|0
1189125|NCT01017120|3904844|P1|Overall Study|Adverse Event|9
1189126|NCT01017029|3904905|P2|Overall Study|Death|1
1189127|NCT01017029|3904906|P1|Overall Study|Death|3
1189128|NCT01017029|3904905|P2|Overall Study|Administrative problem|1
1189129|NCT01017029|3904906|P1|Overall Study|Administrative problem|0
1189130|NCT01017029|3904905|P2|Overall Study|Lost to Follow-up|0
1189131|NCT01017029|3904906|P1|Overall Study|Lost to Follow-up|1
1189132|NCT01016977|3904934|P2|Overall Study|Withdrawal by Subject|2
1189133|NCT01016977|3904935|P1|Overall Study|Withdrawal by Subject|2
1189134|NCT01016977|3904934|P2|Overall Study|Lost to Follow-up|0
1189135|NCT01016977|3904935|P1|Overall Study|Lost to Follow-up|1
1189136|NCT01016964|3904971|P2|Overall Study|Lost to Follow-up|3
1189137|NCT01016964|3904972|P1|Overall Study|Lost to Follow-up|3
1189138|NCT01016912|3904988|P5|Follow-up Period|Other reason|0
1189139|NCT01016912|3904989|P4|Follow-up Period|Other reason|1
1189140|NCT01016912|3904990|P3|Follow-up Period|Other reason|1
1189141|NCT01016912|3904991|P2|Follow-up Period|Other reason|0
1189142|NCT01016912|3904992|P1|Follow-up Period|Other reason|0
1189143|NCT01016912|3904988|P5|End of Treatment Period|Completed double-blind period only|0
1189144|NCT01016912|3904989|P4|End of Treatment Period|Completed double-blind period only|0
1189145|NCT01016912|3904990|P3|End of Treatment Period|Completed double-blind period only|0
1189146|NCT01016912|3904991|P2|End of Treatment Period|Completed double-blind period only|1
1189147|NCT01016912|3904992|P1|End of Treatment Period|Completed double-blind period only|0
1189148|NCT01016912|3904988|P5|End of Treatment Period|Adverse Event|0
1189149|NCT01016912|3904989|P4|End of Treatment Period|Adverse Event|0
1189150|NCT01016912|3904990|P3|End of Treatment Period|Adverse Event|1
1189151|NCT01016912|3904991|P2|End of Treatment Period|Adverse Event|1
1189152|NCT01016912|3904992|P1|End of Treatment Period|Adverse Event|0
1189153|NCT01016912|3904988|P5|End of Treatment Period|Lack of Efficacy|4
1189154|NCT01016912|3904989|P4|End of Treatment Period|Lack of Efficacy|4
1189155|NCT01016912|3904990|P3|End of Treatment Period|Lack of Efficacy|0
1189156|NCT01016912|3904991|P2|End of Treatment Period|Lack of Efficacy|1
1189157|NCT01016912|3904992|P1|End of Treatment Period|Lack of Efficacy|0
1189158|NCT01016600|3905153|P4|Overall Study|Did not start treatment|0
1189159|NCT01016600|3905154|P3|Overall Study|Did not start treatment|0
1189160|NCT01016600|3905155|P2|Overall Study|Did not start treatment|0
1189161|NCT01016600|3905156|P1|Overall Study|Did not start treatment|1
1189162|NCT01016132|3905341|P1|Overall Study|Discomfort|1
1189163|NCT01016067|3905356|P2|Overall Study|Withdrew due to Relocation|1
1189164|NCT01016067|3905357|P1|Overall Study|Withdrew due to Relocation|0
1189165|NCT01016067|3905356|P2|Overall Study|Physician Decision|1
1189166|NCT01016067|3905357|P1|Overall Study|Physician Decision|1
1189167|NCT01016067|3905356|P2|Overall Study|Lost to Follow-up|2
1189168|NCT01016067|3905357|P1|Overall Study|Lost to Follow-up|1
1189169|NCT01016015|3905375|P1|Overall Study|Adverse Event|15
1189170|NCT01016015|3905375|P1|Overall Study|Withdrawal by Subject|1
1189171|NCT01016015|3905375|P1|Overall Study|Not Treated|3
1189172|NCT01015833|3905386|P2|Overall Study|Did not start treatment|0
1189173|NCT01015833|3905387|P1|Overall Study|Did not start treatment|1
1189174|NCT01015833|3905386|P2|Overall Study|Motor Vehicle Accidents|0
1189175|NCT01015833|3905387|P1|Overall Study|Motor Vehicle Accidents|1
1189176|NCT01015833|3905386|P2|Overall Study|Other|1
1189177|NCT01015833|3905387|P1|Overall Study|Other|5
1189178|NCT01015833|3905386|P2|Overall Study|Symptomatic deterioration|1
1189179|NCT01015833|3905387|P1|Overall Study|Symptomatic deterioration|0
1189180|NCT01015833|3905386|P2|Overall Study|Physician Decision|0
1189181|NCT01015833|3905387|P1|Overall Study|Physician Decision|2
1189182|NCT01015833|3905386|P2|Overall Study|Adverse Event|1
1189183|NCT01015833|3905387|P1|Overall Study|Adverse Event|0
1189184|NCT01015833|3905386|P2|Overall Study|Withdrawal by Subject|2
1189185|NCT01015833|3905387|P1|Overall Study|Withdrawal by Subject|3
1189186|NCT01015833|3905386|P2|Overall Study|Death|0
1189187|NCT01015833|3905387|P1|Overall Study|Death|1
1189188|NCT01015820|3905403|P2|Overall Study|Suboptimal measurements|0
1189189|NCT01015820|3905404|P1|Overall Study|Suboptimal measurements|1
1189190|NCT01015703|3905439|P5|Overall Study|Protocol Violation|0
1189191|NCT01015703|3905440|P4|Overall Study|Protocol Violation|0
1189192|NCT01015703|3905441|P3|Overall Study|Protocol Violation|0
1189193|NCT01015703|3905442|P2|Overall Study|Protocol Violation|0
1189194|NCT01015703|3905443|P1|Overall Study|Protocol Violation|1
1189195|NCT01015703|3905439|P5|Overall Study|Adverse Event|0
1189196|NCT01015703|3905440|P4|Overall Study|Adverse Event|0
1189197|NCT01015703|3905441|P3|Overall Study|Adverse Event|0
1189198|NCT01015703|3905442|P2|Overall Study|Adverse Event|0
1189199|NCT01015703|3905443|P1|Overall Study|Adverse Event|1
1189200|NCT01015703|3905439|P5|Overall Study|Withdrawal by Subject|0
1189201|NCT01015703|3905440|P4|Overall Study|Withdrawal by Subject|0
1189202|NCT01015703|3905441|P3|Overall Study|Withdrawal by Subject|0
1189203|NCT01015703|3905442|P2|Overall Study|Withdrawal by Subject|1
1189204|NCT01015703|3905443|P1|Overall Study|Withdrawal by Subject|0
1189205|NCT01015677|3905458|P3|Overall Study|Withdrawal by Subject|0
1189206|NCT01015677|3905459|P2|Overall Study|Withdrawal by Subject|1
1189207|NCT01015677|3905460|P1|Overall Study|Withdrawal by Subject|1
1189208|NCT01015677|3905458|P3|Overall Study|Protocol Violation|0
1189209|NCT01015677|3905459|P2|Overall Study|Protocol Violation|1
1189210|NCT01015677|3905460|P1|Overall Study|Protocol Violation|0
1189211|NCT01015677|3905458|P3|Overall Study|Lack of Efficacy|0
1189212|NCT01015677|3905459|P2|Overall Study|Lack of Efficacy|1
1189213|NCT01015677|3905460|P1|Overall Study|Lack of Efficacy|0
1189214|NCT01015677|3905458|P3|Overall Study|Adverse Event|0
1189215|NCT01015677|3905459|P2|Overall Study|Adverse Event|1
1189216|NCT01015677|3905460|P1|Overall Study|Adverse Event|0
1189217|NCT01015638|3905482|P2|Overall Study|Withdrawal by Subject|0
1189218|NCT01015638|3905483|P1|Overall Study|Withdrawal by Subject|1
1189219|NCT01015612|3905511|P1|Overall Study|Withdrawal by Subject|40
1189220|NCT01015612|3905511|P1|Overall Study|Death|113
1189221|NCT01015560|3905521|P1|Overall Study|Withdrawal by Subject|1
1189222|NCT01015560|3905521|P1|Overall Study|Not protocol specified|1
1189223|NCT01015560|3905521|P1|Overall Study|Adverse Event|1
1189224|NCT01015287|3905570|P2|Overall Study|Protocol Violation|1
1189225|NCT01015287|3905571|P1|Overall Study|Protocol Violation|1
1189226|NCT01015287|3905570|P2|Overall Study|Lost to Follow-up|1
1189227|NCT01015287|3905571|P1|Overall Study|Lost to Follow-up|2
1189228|NCT01015287|3905570|P2|Overall Study|Entry Criteria not Met|14
1189229|NCT01015287|3905571|P1|Overall Study|Entry Criteria not Met|11
1189230|NCT01015287|3905570|P2|Overall Study|Withdrawal by Subject|19
1189231|NCT01015287|3905571|P1|Overall Study|Withdrawal by Subject|14
1189232|NCT01015287|3905570|P2|Overall Study|Physician Decision|21
1189233|NCT01015287|3905571|P1|Overall Study|Physician Decision|19
1189234|NCT01015287|3905570|P2|Overall Study|Sponsor Decision|7
1189235|NCT01015287|3905571|P1|Overall Study|Sponsor Decision|3
1189236|NCT01015287|3905570|P2|Overall Study|Adverse Event|0
1189237|NCT01015287|3905571|P1|Overall Study|Adverse Event|1
1189238|NCT01015287|3905570|P2|Overall Study|Death|16
1189239|NCT01015287|3905571|P1|Overall Study|Death|21
1189240|NCT01015131|3905603|P1|Overall Study|Other Protocol Specified Criteria|4
1189241|NCT01015131|3905603|P1|Overall Study|Withdrawal by Subject|2
1189242|NCT01015131|3905603|P1|Overall Study|Protocol Violation|1
1189243|NCT01015131|3905603|P1|Overall Study|Physician Decision|1
1189244|NCT01015118|3905619|P2|Overall Study|Other than stated above|23
1189245|NCT01015118|3905620|P1|Overall Study|Other than stated above|42
1189246|NCT01015118|3905619|P2|Overall Study|Not treated|5
1189247|NCT01015118|3905620|P1|Overall Study|Not treated|9
1189248|NCT01015118|3905619|P2|Overall Study|Progressive disease|229
1189249|NCT01015118|3905620|P1|Overall Study|Progressive disease|364
1189250|NCT01015118|3905619|P2|Overall Study|Worsening or AE of underlying disease|4
1189251|NCT01015118|3905620|P1|Overall Study|Worsening or AE of underlying disease|5
1189252|NCT01015118|3905619|P2|Overall Study|Other Adverse Event (AE)|33
1189253|NCT01015118|3905620|P1|Overall Study|Other Adverse Event (AE)|141
1189254|NCT01015118|3905619|P2|Overall Study|Withdrawal by Subject|27
1189255|NCT01015118|3905620|P1|Overall Study|Withdrawal by Subject|103
1189256|NCT01015118|3905619|P2|Overall Study|Protocol Violation|6
1189257|NCT01015118|3905620|P1|Overall Study|Protocol Violation|5
1189258|NCT01014988|3905648|P6|Overall Study|Withdrawal by Subject|0
1189259|NCT01014988|3905649|P5|Overall Study|Withdrawal by Subject|0
1189260|NCT01014988|3905650|P4|Overall Study|Withdrawal by Subject|0
1189261|NCT01014988|3905651|P3|Overall Study|Withdrawal by Subject|0
1189262|NCT01014988|3905652|P2|Overall Study|Withdrawal by Subject|0
1189263|NCT01014988|3905653|P1|Overall Study|Withdrawal by Subject|1
1189264|NCT01014988|3905648|P6|Overall Study|Physician Decision|0
1189265|NCT01014988|3905649|P5|Overall Study|Physician Decision|0
1189266|NCT01014988|3905650|P4|Overall Study|Physician Decision|0
1189267|NCT01014988|3905651|P3|Overall Study|Physician Decision|0
1189268|NCT01014988|3905652|P2|Overall Study|Physician Decision|0
1189269|NCT01014988|3905653|P1|Overall Study|Physician Decision|1
1189270|NCT01014988|3905648|P6|Overall Study|Lost to Follow-up|0
1189271|NCT01014988|3905649|P5|Overall Study|Lost to Follow-up|0
1189272|NCT01014988|3905650|P4|Overall Study|Lost to Follow-up|0
1189273|NCT01014988|3905651|P3|Overall Study|Lost to Follow-up|1
1189274|NCT01014988|3905652|P2|Overall Study|Lost to Follow-up|0
1189275|NCT01014988|3905653|P1|Overall Study|Lost to Follow-up|1
1189276|NCT01014988|3905648|P6|Overall Study|Adverse Event|3
1189277|NCT01014988|3905649|P5|Overall Study|Adverse Event|1
1189278|NCT01014988|3905650|P4|Overall Study|Adverse Event|0
1189279|NCT01014988|3905651|P3|Overall Study|Adverse Event|1
1189280|NCT01014988|3905652|P2|Overall Study|Adverse Event|0
1189281|NCT01014988|3905653|P1|Overall Study|Adverse Event|20
1189282|NCT01014975|3905825|P3|Overall Study|Lost to Follow-up|1
1189283|NCT01014975|3905826|P2|Overall Study|Lost to Follow-up|0
1189284|NCT01014975|3905827|P1|Overall Study|Lost to Follow-up|0
1189285|NCT01014975|3905825|P3|Overall Study|Death|4
1189286|NCT01014975|3905826|P2|Overall Study|Death|3
1189287|NCT01014975|3905827|P1|Overall Study|Death|3
1189288|NCT01014975|3905825|P3|Overall Study|Withdrawal by Subject|1
1189289|NCT01014975|3905826|P2|Overall Study|Withdrawal by Subject|0
1189290|NCT01014975|3905827|P1|Overall Study|Withdrawal by Subject|1
1189291|NCT01014910|3906332|P2|Overall Study|Withdrawal by Subject|2
1189292|NCT01014910|3906333|P1|Overall Study|Withdrawal by Subject|0
1189293|NCT01014689|3906377|P2|Overall Study|Pregnancy|0
1189294|NCT01014689|3906378|P1|Overall Study|Pregnancy|1
1189295|NCT01014689|3906377|P2|Overall Study|Lost to Follow-up|7
1189296|NCT01014689|3906378|P1|Overall Study|Lost to Follow-up|3
1189297|NCT01014689|3906377|P2|Overall Study|Protocol Violation|1
1189298|NCT01014689|3906378|P1|Overall Study|Protocol Violation|1
1189299|NCT01014689|3906377|P2|Overall Study|Withdrawal by Subject|4
1189300|NCT01014689|3906378|P1|Overall Study|Withdrawal by Subject|5
1189301|NCT01014689|3906377|P2|Overall Study|Adverse Event|0
1189302|NCT01014689|3906378|P1|Overall Study|Adverse Event|3
1189303|NCT01014689|3906377|P2|Overall Study|Lack of Efficacy|1
1189304|NCT01014689|3906378|P1|Overall Study|Lack of Efficacy|0
1189305|NCT01014585|3906413|P4|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
1189306|NCT01014585|3906414|P3|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
1189307|NCT01014585|3906415|P2|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23
1189308|NCT01014585|3906416|P1|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18
1189309|NCT01014585|3906413|P4|Overall Study|Lost to Follow-up|2
1189310|NCT01014585|3906414|P3|Overall Study|Lost to Follow-up|0
1189311|NCT01014585|3906415|P2|Overall Study|Lost to Follow-up|0
1189312|NCT01014585|3906416|P1|Overall Study|Lost to Follow-up|0
1189313|NCT01014585|3906413|P4|Overall Study|Withdrawal by Subject|3
1189314|NCT01014585|3906414|P3|Overall Study|Withdrawal by Subject|1
1189315|NCT01014585|3906415|P2|Overall Study|Withdrawal by Subject|0
1189316|NCT01014585|3906416|P1|Overall Study|Withdrawal by Subject|2
1189317|NCT01014585|3906413|P4|Overall Study|Adverse Event|3
1189318|NCT01014585|3906414|P3|Overall Study|Adverse Event|0
1189319|NCT01014585|3906415|P2|Overall Study|Adverse Event|2
1189320|NCT01014585|3906416|P1|Overall Study|Adverse Event|0
1189321|NCT01014533|3906436|P2|Overall Study|unable to come to appointment|3
1189322|NCT01014533|3906437|P1|Overall Study|unable to come to appointment|0
1189323|NCT01014533|3906436|P2|Overall Study|Withdrawal by Subject|0
1189324|NCT01014533|3906437|P1|Overall Study|Withdrawal by Subject|2
1189325|NCT01014533|3906436|P2|Overall Study|Protocol Violation|2
1189326|NCT01014533|3906437|P1|Overall Study|Protocol Violation|3
1189327|NCT01014442|3906458|P2|Overall Study|Unspecified Reason|1
1189328|NCT01014442|3906459|P1|Overall Study|Unspecified Reason|1
1189329|NCT01014442|3906458|P2|Overall Study|Lack of Compliance|1
1189330|NCT01014442|3906459|P1|Overall Study|Lack of Compliance|0
1189331|NCT01014442|3906458|P2|Overall Study|Protocol Violation|5
1189332|NCT01014442|3906459|P1|Overall Study|Protocol Violation|2
1189333|NCT01014442|3906458|P2|Overall Study|Withdrawal by Subject|4
1189334|NCT01014442|3906459|P1|Overall Study|Withdrawal by Subject|4
1189335|NCT01014442|3906458|P2|Overall Study|Adverse Event|8
1189336|NCT01014442|3906459|P1|Overall Study|Adverse Event|0
1189337|NCT01014208|3906579|P2|Overall Study|Study Closed/terminated|83
1189338|NCT01014208|3906580|P1|Overall Study|Study Closed/terminated|78
1189339|NCT01014208|3906579|P2|Overall Study|Did Not Receive Study Drug|0
1189340|NCT01014208|3906580|P1|Overall Study|Did Not Receive Study Drug|2
1189341|NCT01014208|3906579|P2|Overall Study|Participant Withdrew Consent|12
1189342|NCT01014208|3906580|P1|Overall Study|Participant Withdrew Consent|12
1189343|NCT01014208|3906579|P2|Overall Study|Lost to Follow-up|5
1189344|NCT01014208|3906580|P1|Overall Study|Lost to Follow-up|2
1189345|NCT01014143|3906622|P3|Second Intervention|Lost to Follow-up|0
1189346|NCT01014143|3906623|P2|Second Intervention|Lost to Follow-up|0
1189347|NCT01014143|3906624|P1|Second Intervention|Lost to Follow-up|2
1189348|NCT01014013|3906719|P2|Overall Study|Inappropriate therapy duration, < 7 Days|1
1189349|NCT01014013|3906720|P1|Overall Study|Inappropriate therapy duration, < 7 Days|0
1189350|NCT01014013|3906719|P2|Overall Study|Appendectomy|0
1189351|NCT01014013|3906720|P1|Overall Study|Appendectomy|1
1189352|NCT01014013|3906719|P2|Overall Study|Another antibiotic therapy required|1
1189353|NCT01014013|3906720|P1|Overall Study|Another antibiotic therapy required|0
1189354|NCT01014013|3906719|P2|Overall Study|Physician Decision|1
1189355|NCT01014013|3906720|P1|Overall Study|Physician Decision|0
1189356|NCT01014013|3906719|P2|Overall Study|Pathogen resistant|4
1189357|NCT01014013|3906720|P1|Overall Study|Pathogen resistant|7
1189358|NCT01014013|3906719|P2|Overall Study|Negative urine culture|0
1189359|NCT01014013|3906720|P1|Overall Study|Negative urine culture|2
1189360|NCT01014013|3906719|P2|Overall Study|Pathogen culture = no growth|34
1189361|NCT01014013|3906720|P1|Overall Study|Pathogen culture = no growth|26
1189362|NCT01014013|3906719|P2|Overall Study|Clinical/microbiologic failure|2
1189363|NCT01014013|3906720|P1|Overall Study|Clinical/microbiologic failure|1
1189364|NCT01014013|3906719|P2|Overall Study|Withdrawal by Subject|4
1189365|NCT01014013|3906720|P1|Overall Study|Withdrawal by Subject|7
1189366|NCT01014013|3906719|P2|Overall Study|Protocol Violation|3
1189367|NCT01014013|3906720|P1|Overall Study|Protocol Violation|1
1189368|NCT01014013|3906719|P2|Overall Study|Laboratory adverse experience|1
1189369|NCT01014013|3906720|P1|Overall Study|Laboratory adverse experience|1
1189370|NCT01014013|3906719|P2|Overall Study|Clinical adverse experience|2
1189371|NCT01014013|3906720|P1|Overall Study|Clinical adverse experience|4
1189372|NCT01014013|3906719|P2|Overall Study|Inclusion/Exclusion criteria not met|3
1189373|NCT01014013|3906720|P1|Overall Study|Inclusion/Exclusion criteria not met|1
1189374|NCT01013961|3906732|P2|Overall Study|Physician Decision|1
1189375|NCT01013961|3906733|P1|Overall Study|Physician Decision|0
1189376|NCT01013961|3906732|P2|Overall Study|Withdrawal by Subject|0
1189377|NCT01013961|3906733|P1|Overall Study|Withdrawal by Subject|1
1189378|NCT01013961|3906732|P2|Overall Study|Adverse Event|2
1189379|NCT01013961|3906733|P1|Overall Study|Adverse Event|2
1189380|NCT01013883|3906751|P2|Overall Study|Lost to Follow-up|2
1189381|NCT01013883|3906752|P1|Overall Study|Lost to Follow-up|2
1189382|NCT01013870|3906764|P2|Overall Study|Lost to Follow-up|3
1189383|NCT01013870|3906765|P1|Overall Study|Lost to Follow-up|1
1189384|NCT01013792|3906814|P2|Overall Study|Lost to Follow-up|1
1189385|NCT01013792|3906815|P1|Overall Study|Lost to Follow-up|0
1189386|NCT01013792|3906814|P2|Overall Study|Adverse Event|3
1189387|NCT01013792|3906815|P1|Overall Study|Adverse Event|0
1189388|NCT01013792|3906814|P2|Overall Study|Study suspended|1
1189389|NCT01013792|3906815|P1|Overall Study|Study suspended|2
1189390|NCT01013753|3906821|P1|Overall Study|Other|2
1189391|NCT01013753|3906821|P1|Overall Study|Withdrawal by Subject|2
1189392|NCT01013753|3906821|P1|Overall Study|Lost to Follow-up|1
1189393|NCT01013753|3906821|P1|Overall Study|Protocol Violation|3
1189394|NCT01013753|3906821|P1|Overall Study|Adverse Event|8
1189395|NCT01013740|3907017|P2|Overall Study|Ongoing: Study records not completed|2
1189396|NCT01013740|3907018|P1|Overall Study|Ongoing: Study records not completed|0
1189397|NCT01013740|3907017|P2|Overall Study|Missing|1
1189398|NCT01013740|3907018|P1|Overall Study|Missing|2
1189399|NCT01013740|3907017|P2|Overall Study|study close / terminated : done in error|1
1189400|NCT01013740|3907018|P1|Overall Study|study close / terminated : done in error|2
1189401|NCT01013740|3907017|P2|Overall Study|Withdrawal by Subject|10
1189402|NCT01013740|3907018|P1|Overall Study|Withdrawal by Subject|2
1189403|NCT01013740|3907017|P2|Overall Study|Physician Decision|0
1189404|NCT01013740|3907018|P1|Overall Study|Physician Decision|2
1189405|NCT01013740|3907017|P2|Overall Study|Lost to Follow-up|5
1189406|NCT01013740|3907018|P1|Overall Study|Lost to Follow-up|3
1189407|NCT01013701|3907042|P1|Overall Study|study prematurely terminated|7
1189408|NCT01013597|3907049|P1|Overall Study|Withdrawal by Subject|1
1189409|NCT01013207|3907059|P1|CPAP Post Nexus (S9)|Lost to Follow-up|6
1189410|NCT01012999|3907077|P1|Overall Study|Protocol Violation|1
1189411|NCT01012973|3907083|P2|Overall Study|Withdrawal by Subject|6
1189412|NCT01012973|3907084|P1|Overall Study|Withdrawal by Subject|4
1189413|NCT01012973|3907083|P2|Overall Study|Protocol Violation|2
1189414|NCT01012973|3907084|P1|Overall Study|Protocol Violation|5
1189415|NCT01012973|3907083|P2|Overall Study|Increase in vis. acuity, never injected|1
1189416|NCT01012973|3907084|P1|Overall Study|Increase in vis. acuity, never injected|0
1189417|NCT01012973|3907083|P2|Overall Study|(Overseas travel - indefinite period)|0
1189418|NCT01012973|3907084|P1|Overall Study|(Overseas travel - indefinite period)|1
1189419|NCT01012973|3907083|P2|Overall Study|Lost to Follow-up|0
1189420|NCT01012973|3907084|P1|Overall Study|Lost to Follow-up|1
1189421|NCT01012973|3907083|P2|Overall Study|Lack of Efficacy|5
1189422|NCT01012973|3907084|P1|Overall Study|Lack of Efficacy|0
1189423|NCT01012973|3907083|P2|Overall Study|Adverse Event|5
1189424|NCT01012973|3907084|P1|Overall Study|Adverse Event|5
1189425|NCT01012947|3907109|P5|Overall Study|Lost to Follow-up|142
1189426|NCT01012947|3907110|P4|Overall Study|Lost to Follow-up|118
1189427|NCT01012947|3907111|P3|Overall Study|Lost to Follow-up|130
1189428|NCT01012947|3907112|P2|Overall Study|Lost to Follow-up|135
1189429|NCT01012947|3907113|P1|Overall Study|Lost to Follow-up|131
1189430|NCT01012765|3907134|P6|Treatment Period 2|Unsatisfactory therapeutic effect|0
1189431|NCT01012765|3907135|P5|Treatment Period 2|Unsatisfactory therapeutic effect|0
1189432|NCT01012765|3907136|P4|Treatment Period 2|Unsatisfactory therapeutic effect|0
1189433|NCT01012765|3907137|P3|Treatment Period 2|Unsatisfactory therapeutic effect|1
1189434|NCT01012765|3907138|P2|Treatment Period 2|Unsatisfactory therapeutic effect|1
1189435|NCT01012765|3907139|P1|Treatment Period 2|Unsatisfactory therapeutic effect|0
1189436|NCT01012765|3907134|P6|Treatment Period 2|Adverse Event|0
1189437|NCT01012765|3907135|P5|Treatment Period 2|Adverse Event|0
1189438|NCT01012765|3907136|P4|Treatment Period 2|Adverse Event|0
1189439|NCT01012765|3907137|P3|Treatment Period 2|Adverse Event|1
1189440|NCT01012765|3907138|P2|Treatment Period 2|Adverse Event|1
1189441|NCT01012765|3907139|P1|Treatment Period 2|Adverse Event|0
1189442|NCT01012765|3907134|P6|Treatment Period 2|Abnormal laboratory value(s)|1
1189443|NCT01012765|3907135|P5|Treatment Period 2|Abnormal laboratory value(s)|0
1189444|NCT01012765|3907136|P4|Treatment Period 2|Abnormal laboratory value(s)|0
1189445|NCT01012765|3907137|P3|Treatment Period 2|Abnormal laboratory value(s)|0
1189446|NCT01012765|3907138|P2|Treatment Period 2|Abnormal laboratory value(s)|0
1189447|NCT01012765|3907139|P1|Treatment Period 2|Abnormal laboratory value(s)|0
1189448|NCT01012765|3907134|P6|Treatment Period 2|Withdrawal by Subject|0
1189449|NCT01012765|3907135|P5|Treatment Period 2|Withdrawal by Subject|1
1189450|NCT01012765|3907136|P4|Treatment Period 2|Withdrawal by Subject|0
1189451|NCT01012765|3907137|P3|Treatment Period 2|Withdrawal by Subject|1
1189452|NCT01012765|3907138|P2|Treatment Period 2|Withdrawal by Subject|0
1189453|NCT01012765|3907139|P1|Treatment Period 2|Withdrawal by Subject|1
1189454|NCT01012765|3907134|P6|Treatment Period 1|Unsatisfactory therapeutic effect|0
1189455|NCT01012765|3907135|P5|Treatment Period 1|Unsatisfactory therapeutic effect|1
1189456|NCT01012765|3907136|P4|Treatment Period 1|Unsatisfactory therapeutic effect|0
1189457|NCT01012765|3907137|P3|Treatment Period 1|Unsatisfactory therapeutic effect|0
1189458|NCT01012765|3907138|P2|Treatment Period 1|Unsatisfactory therapeutic effect|0
1189459|NCT01012765|3907139|P1|Treatment Period 1|Unsatisfactory therapeutic effect|0
1189460|NCT01012765|3907134|P6|Treatment Period 1|Protocol Violation|0
1189461|NCT01012765|3907135|P5|Treatment Period 1|Protocol Violation|1
1189462|NCT01012765|3907136|P4|Treatment Period 1|Protocol Violation|2
1189463|NCT01012765|3907137|P3|Treatment Period 1|Protocol Violation|0
1189464|NCT01012765|3907138|P2|Treatment Period 1|Protocol Violation|0
1189465|NCT01012765|3907139|P1|Treatment Period 1|Protocol Violation|0
1189466|NCT01012765|3907134|P6|Treatment Period 1|Administrative problems|0
1189467|NCT01012765|3907135|P5|Treatment Period 1|Administrative problems|1
1189468|NCT01012765|3907136|P4|Treatment Period 1|Administrative problems|1
1189469|NCT01012765|3907137|P3|Treatment Period 1|Administrative problems|1
1189470|NCT01012765|3907138|P2|Treatment Period 1|Administrative problems|0
1189471|NCT01012765|3907139|P1|Treatment Period 1|Administrative problems|0
1189472|NCT01012765|3907134|P6|Treatment Period 1|Withdrawal by Subject|0
1189473|NCT01012765|3907135|P5|Treatment Period 1|Withdrawal by Subject|0
1189474|NCT01012765|3907136|P4|Treatment Period 1|Withdrawal by Subject|0
1189475|NCT01012765|3907137|P3|Treatment Period 1|Withdrawal by Subject|0
1189476|NCT01012765|3907138|P2|Treatment Period 1|Withdrawal by Subject|0
1189477|NCT01012765|3907139|P1|Treatment Period 1|Withdrawal by Subject|2
1189478|NCT01012765|3907134|P6|Treatment Period 1|Adverse Event|0
1189479|NCT01012765|3907135|P5|Treatment Period 1|Adverse Event|0
1189480|NCT01012765|3907136|P4|Treatment Period 1|Adverse Event|0
1189481|NCT01012765|3907137|P3|Treatment Period 1|Adverse Event|1
1189482|NCT01012765|3907138|P2|Treatment Period 1|Adverse Event|0
1189483|NCT01012765|3907139|P1|Treatment Period 1|Adverse Event|1
1189484|NCT01012739|3907168|P4|Treatment Period 2|Abnormal test procedure results|1
1189485|NCT01012739|3907169|P3|Treatment Period 2|Abnormal test procedure results|0
1189486|NCT01012739|3907170|P2|Treatment Period 2|Abnormal test procedure results|0
1189487|NCT01012739|3907171|P1|Treatment Period 2|Abnormal test procedure results|0
1189488|NCT01012739|3907168|P4|Treatment Period 1|Adverse Event|1
1189489|NCT01012739|3907169|P3|Treatment Period 1|Adverse Event|0
1189490|NCT01012739|3907170|P2|Treatment Period 1|Adverse Event|0
1189491|NCT01012739|3907171|P1|Treatment Period 1|Adverse Event|0
1189492|NCT01012713|3907199|P1|Overall Study|Lack of Efficacy|3
1189493|NCT01012622|3907225|P1|Overall Study|withdrawal of consent by a parent|2
1189494|NCT01012622|3907225|P1|Overall Study|screening failure|1
1189495|NCT01012622|3907225|P1|Overall Study|Other|1
1189496|NCT01012622|3907225|P1|Overall Study|non-compliance with the drug|9
1189497|NCT01012622|3907225|P1|Overall Study|Adverse Event|7
1189498|NCT01012622|3907225|P1|Overall Study|Lost to Follow-up|5
1189499|NCT01012622|3907225|P1|Overall Study|Withdrawal by Subject|6
1189500|NCT01012440|3907249|P1|Overall Study|Withdrawal by Subject|2
1189501|NCT01012414|3907253|P1|Overall Study|Trial was stopped before completed|7
1189502|NCT01012414|3907253|P1|Overall Study|Lost to Follow-up|1
1189503|NCT01012414|3907253|P1|Overall Study|Withdrawal by Subject|2
1189504|NCT01012323|3907294|P1|Overall Study|Investigator Judgment|1
1189505|NCT01012258|3907331|P1|Overall Study|Ongoing|29
1189506|NCT01012258|3907331|P1|Overall Study|Another Tumor Discovered|1
1189507|NCT01012258|3907331|P1|Overall Study|Another Anti-cancer Drug Received|1
1189508|NCT01012258|3907331|P1|Overall Study|Symptomatic Deterioration|1
1189509|NCT01012258|3907331|P1|Overall Study|Progressive Disease (PD)|18
1189510|NCT01012258|3907331|P1|Overall Study|Adverse Event|1
1189511|NCT01012258|3907331|P1|Overall Study|Lost to Follow-up|1
1189512|NCT01012258|3907331|P1|Overall Study|Death|14
1189513|NCT01012219|3907378|P1|Period 2|Withdrawal by Subject|1
1189514|NCT01012219|3907378|P1|Period 1|Withdrawal by Subject|1
1189515|NCT01012037|3907669|P3|Overall Study|Other reason (not specified)|1
1189516|NCT01012037|3907670|P2|Overall Study|Other reason (not specified)|1
1189517|NCT01012037|3907671|P1|Overall Study|Other reason (not specified)|1
1189518|NCT01012037|3907669|P3|Overall Study|Withdrawal by Subject|1
1189519|NCT01012037|3907670|P2|Overall Study|Withdrawal by Subject|4
1189520|NCT01012037|3907671|P1|Overall Study|Withdrawal by Subject|0
1189521|NCT01012037|3907669|P3|Overall Study|Protocol Violation|5
1189522|NCT01012037|3907670|P2|Overall Study|Protocol Violation|3
1189523|NCT01012037|3907671|P1|Overall Study|Protocol Violation|0
1189524|NCT01012037|3907669|P3|Overall Study|Adverse Event|3
1189525|NCT01012037|3907670|P2|Overall Study|Adverse Event|8
1189526|NCT01012037|3907671|P1|Overall Study|Adverse Event|0
1189527|NCT01011946|3907706|P1|Overall Study|No pathological lab value|1
1189528|NCT01011946|3907706|P1|Overall Study|Transferred to another hospital|2
1189529|NCT01011933|3907710|P1|Overall Study|Never treated|1
1189530|NCT01011933|3907710|P1|Overall Study|Inadequate pathology|1
1189531|NCT01011933|3907710|P1|Overall Study|Improper pre-protocol Rx|1
1189532|NCT01011933|3907710|P1|Overall Study|Wrong cell type|1
1189533|NCT01011907|3907727|P2|Overall Study|Adverse Event|4
1189534|NCT01011907|3907728|P1|Overall Study|Adverse Event|1
1189535|NCT01011907|3907727|P2|Overall Study|Withdrawal by Subject|11
1189536|NCT01011907|3907728|P1|Overall Study|Withdrawal by Subject|13
1189537|NCT01011868|3907745|P3|After Week 78 Follow-up|Other reason not defined above|16
1189538|NCT01011868|3907746|P2|After Week 78 Follow-up|Other reason not defined above|5
1189539|NCT01011868|3907747|P1|After Week 78 Follow-up|Other reason not defined above|5
1189540|NCT01011868|3907745|P3|After Week 78 Follow-up|Withdrawal by Subject|1
1189541|NCT01011868|3907746|P2|After Week 78 Follow-up|Withdrawal by Subject|8
1189542|NCT01011868|3907747|P1|After Week 78 Follow-up|Withdrawal by Subject|9
1189543|NCT01011868|3907745|P3|After Week 78 Follow-up|Lost to Follow-up|4
1189544|NCT01011868|3907746|P2|After Week 78 Follow-up|Lost to Follow-up|6
1189545|NCT01011868|3907747|P1|After Week 78 Follow-up|Lost to Follow-up|11
1189546|NCT01011868|3907745|P3|After Week 78 Follow-up|Protocol Violation|2
1189547|NCT01011868|3907746|P2|After Week 78 Follow-up|Protocol Violation|1
1189548|NCT01011868|3907747|P1|After Week 78 Follow-up|Protocol Violation|9
1189549|NCT01011868|3907745|P3|After Week 78 Follow-up|Lack of Efficacy|0
1189550|NCT01011868|3907746|P2|After Week 78 Follow-up|Lack of Efficacy|0
1189551|NCT01011868|3907747|P1|After Week 78 Follow-up|Lack of Efficacy|4
1189552|NCT01011868|3907745|P3|After Week 78 Follow-up|Adverse Event|21
1189553|NCT01011868|3907746|P2|After Week 78 Follow-up|Adverse Event|18
1189554|NCT01011868|3907747|P1|After Week 78 Follow-up|Adverse Event|14
1189555|NCT01011868|3907745|P3|After Week 18 Follow-up|Other reason not defined above|12
1189556|NCT01011868|3907746|P2|After Week 18 Follow-up|Other reason not defined above|3
1189557|NCT01011868|3907747|P1|After Week 18 Follow-up|Other reason not defined above|2
1189558|NCT01011868|3907745|P3|After Week 18 Follow-up|Withdrawal by Subject|0
1189559|NCT01011868|3907746|P2|After Week 18 Follow-up|Withdrawal by Subject|3
1189560|NCT01011868|3907747|P1|After Week 18 Follow-up|Withdrawal by Subject|6
1189561|NCT01011868|3907745|P3|After Week 18 Follow-up|Lost to Follow-up|0
1189562|NCT01011868|3907746|P2|After Week 18 Follow-up|Lost to Follow-up|3
1189563|NCT01011868|3907747|P1|After Week 18 Follow-up|Lost to Follow-up|5
1189564|NCT01011868|3907745|P3|After Week 18 Follow-up|Protocol Violation|1
1189565|NCT01011868|3907746|P2|After Week 18 Follow-up|Protocol Violation|1
1189566|NCT01011868|3907747|P1|After Week 18 Follow-up|Protocol Violation|1
1189567|NCT01011868|3907745|P3|After Week 18 Follow-up|Lack of Efficacy|0
1189568|NCT01011868|3907746|P2|After Week 18 Follow-up|Lack of Efficacy|0
1189569|NCT01011868|3907747|P1|After Week 18 Follow-up|Lack of Efficacy|1
1189570|NCT01011868|3907745|P3|After Week 18 Follow-up|Adverse Event|13
1189571|NCT01011868|3907746|P2|After Week 18 Follow-up|Adverse Event|6
1189572|NCT01011868|3907747|P1|After Week 18 Follow-up|Adverse Event|8
1189573|NCT01011738|3907809|P3|Overall Study|Unknown reasons|17
1189574|NCT01011738|3907810|P2|Overall Study|Unknown reasons|291
1189575|NCT01011738|3907811|P1|Overall Study|Unknown reasons|312
1189576|NCT01011738|3907809|P3|Overall Study|Death|0
1189577|NCT01011738|3907810|P2|Overall Study|Death|3
1189578|NCT01011738|3907811|P1|Overall Study|Death|12
1189579|NCT01011673|3907851|P2|24 Hour Follow-up|Lost to Follow-up|3
1189580|NCT01011673|3907852|P1|24 Hour Follow-up|Lost to Follow-up|3
1189581|NCT01011673|3907851|P2|Randomized|Secondary headache|1
1189582|NCT01011673|3907852|P1|Randomized|Secondary headache|2
1189583|NCT01011556|3907875|P4|Overall Study|Inclusion/exclusion criteria not met|5
1189584|NCT01011556|3907876|P3|Overall Study|Inclusion/exclusion criteria not met|3
1189585|NCT01011556|3907877|P2|Overall Study|Inclusion/exclusion criteria not met|1
1189586|NCT01011556|3907878|P1|Overall Study|Inclusion/exclusion criteria not met|2
1189587|NCT01011556|3907875|P4|Overall Study|Sponsor decision|2
1189588|NCT01011556|3907876|P3|Overall Study|Sponsor decision|1
1189589|NCT01011556|3907877|P2|Overall Study|Sponsor decision|1
1189590|NCT01011556|3907878|P1|Overall Study|Sponsor decision|0
1189591|NCT01011556|3907875|P4|Overall Study|Withdrawal by Subject|4
1189592|NCT01011556|3907876|P3|Overall Study|Withdrawal by Subject|4
1189593|NCT01011556|3907877|P2|Overall Study|Withdrawal by Subject|2
1189594|NCT01011556|3907878|P1|Overall Study|Withdrawal by Subject|1
1189595|NCT01011556|3907875|P4|Overall Study|Protocol Violation|0
1189596|NCT01011556|3907876|P3|Overall Study|Protocol Violation|0
1189597|NCT01011556|3907877|P2|Overall Study|Protocol Violation|1
1189598|NCT01011556|3907878|P1|Overall Study|Protocol Violation|0
1189599|NCT01011556|3907875|P4|Overall Study|Physician Decision|1
1189600|NCT01011556|3907876|P3|Overall Study|Physician Decision|0
1189601|NCT01011556|3907877|P2|Overall Study|Physician Decision|0
1189602|NCT01011556|3907878|P1|Overall Study|Physician Decision|1
1189603|NCT01011556|3907875|P4|Overall Study|Lost to Follow-up|0
1189604|NCT01011556|3907876|P3|Overall Study|Lost to Follow-up|0
1189605|NCT01011556|3907877|P2|Overall Study|Lost to Follow-up|0
1189606|NCT01011556|3907878|P1|Overall Study|Lost to Follow-up|1
1189607|NCT01011556|3907875|P4|Overall Study|Adverse Event|1
1189608|NCT01011556|3907876|P3|Overall Study|Adverse Event|2
1189609|NCT01011556|3907877|P2|Overall Study|Adverse Event|3
1189610|NCT01011556|3907878|P1|Overall Study|Adverse Event|1
1189611|NCT01011465|3907956|P8|Overall Study|Withdrawal by Subject|0
1189612|NCT01011465|3907957|P7|Overall Study|Withdrawal by Subject|1
1189613|NCT01011465|3907958|P6|Overall Study|Withdrawal by Subject|0
1189614|NCT01011465|3907959|P5|Overall Study|Withdrawal by Subject|1
1189615|NCT01011465|3907960|P4|Overall Study|Withdrawal by Subject|0
1189616|NCT01011465|3907961|P3|Overall Study|Withdrawal by Subject|0
1189617|NCT01011465|3907962|P2|Overall Study|Withdrawal by Subject|1
1189618|NCT01011465|3907963|P1|Overall Study|Withdrawal by Subject|2
1189619|NCT01011439|3907991|P1|Overall Study|Sponsor's decision|15
1189620|NCT01011439|3907991|P1|Overall Study|Withdrawal by Subject|1
1189621|NCT01011439|3907991|P1|Overall Study|Lost to Follow-up|4
1189622|NCT01011439|3907991|P1|Overall Study|Death|37
1189623|NCT01011387|3908001|P1|Overall Study|Protocol Violation|1
1189624|NCT01011387|3908001|P1|Overall Study|Adverse Event|2
1189625|NCT01011387|3908001|P1|Overall Study|Withdrawal by Subject|3
1189626|NCT01011335|3908009|P13|Overall Study|Adverse Event|1
1189627|NCT01011335|3908010|P12|Overall Study|Adverse Event|0
1189628|NCT01011335|3908011|P11|Overall Study|Adverse Event|4
1189629|NCT01011335|3908012|P10|Overall Study|Adverse Event|0
1189630|NCT01011335|3908013|P9|Overall Study|Adverse Event|0
1189631|NCT01011335|3908014|P8|Overall Study|Adverse Event|0
1189632|NCT01011335|3908015|P7|Overall Study|Adverse Event|0
1189633|NCT01011335|3908016|P6|Overall Study|Adverse Event|0
1189634|NCT01011335|3908017|P5|Overall Study|Adverse Event|0
1189635|NCT01011335|3908018|P4|Overall Study|Adverse Event|0
1189636|NCT01011335|3908019|P3|Overall Study|Adverse Event|0
1189637|NCT01011335|3908020|P2|Overall Study|Adverse Event|0
1189638|NCT01011335|3908021|P1|Overall Study|Adverse Event|0
1189639|NCT01011335|3908009|P13|Overall Study|Moved/deployed or no booster|0
1189640|NCT01011335|3908010|P12|Overall Study|Moved/deployed or no booster|0
1189641|NCT01011335|3908011|P11|Overall Study|Moved/deployed or no booster|2
1189642|NCT01011335|3908012|P10|Overall Study|Moved/deployed or no booster|0
1189643|NCT01011335|3908013|P9|Overall Study|Moved/deployed or no booster|1
1189644|NCT01011335|3908014|P8|Overall Study|Moved/deployed or no booster|0
1189645|NCT01011335|3908015|P7|Overall Study|Moved/deployed or no booster|1
1189646|NCT01011335|3908016|P6|Overall Study|Moved/deployed or no booster|0
1189647|NCT01011335|3908017|P5|Overall Study|Moved/deployed or no booster|0
1189648|NCT01011335|3908018|P4|Overall Study|Moved/deployed or no booster|1
1189649|NCT01011335|3908019|P3|Overall Study|Moved/deployed or no booster|0
1189650|NCT01011335|3908020|P2|Overall Study|Moved/deployed or no booster|0
1189651|NCT01011335|3908021|P1|Overall Study|Moved/deployed or no booster|1
1189652|NCT01011335|3908009|P13|Overall Study|Protocol Violation|0
1189653|NCT01011335|3908010|P12|Overall Study|Protocol Violation|0
1189654|NCT01011335|3908011|P11|Overall Study|Protocol Violation|0
1189655|NCT01011335|3908012|P10|Overall Study|Protocol Violation|0
1189656|NCT01011335|3908013|P9|Overall Study|Protocol Violation|0
1189657|NCT01011335|3908014|P8|Overall Study|Protocol Violation|0
1189658|NCT01011335|3908015|P7|Overall Study|Protocol Violation|0
1189659|NCT01011335|3908016|P6|Overall Study|Protocol Violation|0
1189660|NCT01011335|3908017|P5|Overall Study|Protocol Violation|0
1189661|NCT01011335|3908018|P4|Overall Study|Protocol Violation|0
1189662|NCT01011335|3908019|P3|Overall Study|Protocol Violation|0
1189663|NCT01011335|3908020|P2|Overall Study|Protocol Violation|1
1189664|NCT01011335|3908021|P1|Overall Study|Protocol Violation|0
1189665|NCT01011335|3908009|P13|Overall Study|Lost to Follow-up|2
1189666|NCT01011335|3908010|P12|Overall Study|Lost to Follow-up|1
1189667|NCT01011335|3908011|P11|Overall Study|Lost to Follow-up|0
1189668|NCT01011335|3908012|P10|Overall Study|Lost to Follow-up|0
1189669|NCT01011335|3908013|P9|Overall Study|Lost to Follow-up|1
1189670|NCT01011335|3908014|P8|Overall Study|Lost to Follow-up|2
1189671|NCT01011335|3908015|P7|Overall Study|Lost to Follow-up|2
1189672|NCT01011335|3908016|P6|Overall Study|Lost to Follow-up|1
1189673|NCT01011335|3908017|P5|Overall Study|Lost to Follow-up|1
1189674|NCT01011335|3908018|P4|Overall Study|Lost to Follow-up|1
1189675|NCT01011335|3908019|P3|Overall Study|Lost to Follow-up|1
1189676|NCT01011335|3908020|P2|Overall Study|Lost to Follow-up|0
1189677|NCT01011335|3908021|P1|Overall Study|Lost to Follow-up|0
1189678|NCT01011309|3908061|P3|Overall Study|Protocol Violation|3
1189679|NCT01011309|3908062|P2|Overall Study|Protocol Violation|1
1189680|NCT01011309|3908063|P1|Overall Study|Protocol Violation|0
1189681|NCT01011309|3908061|P3|Overall Study|Lack of Efficacy|0
1189682|NCT01011309|3908062|P2|Overall Study|Lack of Efficacy|1
1189683|NCT01011309|3908063|P1|Overall Study|Lack of Efficacy|0
1189684|NCT01011309|3908061|P3|Overall Study|Adverse Event|2
1189685|NCT01011309|3908062|P2|Overall Study|Adverse Event|1
1189686|NCT01011309|3908063|P1|Overall Study|Adverse Event|2
1189687|NCT01011283|3908079|P2|Overall Study|Not Specified|2
1189688|NCT01011283|3908080|P1|Overall Study|Not Specified|2
1189689|NCT01011283|3908079|P2|Overall Study|Terminated by Sponsor|5
1189690|NCT01011283|3908080|P1|Overall Study|Terminated by Sponsor|5
1189691|NCT01011283|3908079|P2|Overall Study|Progressive Disease|2
1189692|NCT01011283|3908080|P1|Overall Study|Progressive Disease|0
1189693|NCT01011283|3908079|P2|Overall Study|Adverse Event|2
1189694|NCT01011283|3908080|P1|Overall Study|Adverse Event|4
1189695|NCT01011153|3908129|P3|Overall Study|Less than 78 cases completed|9
1189696|NCT01011153|3908130|P2|Overall Study|Less than 78 cases completed|11
1189697|NCT01011153|3908131|P1|Overall Study|Less than 78 cases completed|8
1189698|NCT01011049|3908160|P4|Overall Study|Withdrawal by Subject|0
1189699|NCT01011049|3908161|P3|Overall Study|Withdrawal by Subject|1
1189700|NCT01011049|3908162|P2|Overall Study|Withdrawal by Subject|0
1189701|NCT01011049|3908163|P1|Overall Study|Withdrawal by Subject|0
1189702|NCT01011049|3908160|P4|Overall Study|Lost to Follow-up|0
1189703|NCT01011049|3908161|P3|Overall Study|Lost to Follow-up|1
1189704|NCT01011049|3908162|P2|Overall Study|Lost to Follow-up|2
1189705|NCT01011049|3908163|P1|Overall Study|Lost to Follow-up|1
1189706|NCT01011049|3908160|P4|Overall Study|Protocol Violation|0
1189707|NCT01011049|3908161|P3|Overall Study|Protocol Violation|2
1189708|NCT01011049|3908162|P2|Overall Study|Protocol Violation|0
1189709|NCT01011049|3908163|P1|Overall Study|Protocol Violation|0
1189710|NCT01010971|3908193|P3|Overall Study|Other|2
1189711|NCT01010971|3908194|P2|Overall Study|Other|0
1189712|NCT01010971|3908195|P1|Overall Study|Other|1
1189713|NCT01010971|3908193|P3|Overall Study|Lost to Follow-up|3
1189714|NCT01010971|3908194|P2|Overall Study|Lost to Follow-up|2
1189715|NCT01010971|3908195|P1|Overall Study|Lost to Follow-up|0
1189716|NCT01010971|3908193|P3|Overall Study|Withdrawal by Subject|5
1189717|NCT01010971|3908194|P2|Overall Study|Withdrawal by Subject|2
1189718|NCT01010971|3908195|P1|Overall Study|Withdrawal by Subject|0
1189719|NCT01010971|3908193|P3|Overall Study|Adverse Event|3
1189720|NCT01010971|3908194|P2|Overall Study|Adverse Event|4
1189721|NCT01010971|3908195|P1|Overall Study|Adverse Event|2
1189722|NCT01010867|3908323|P1|Overall Study|< 50% adherence to probiotic|1
1189723|NCT01010776|3908335|P1|Extension Phase|Not specified|3
1189724|NCT01010776|3908335|P1|In-Between Main Phase & Extension Phase|Extension phase was optional|15
1189725|NCT01010776|3908335|P1|Main Phase|Did not received study medication|5
1189726|NCT01010776|3908335|P1|Main Phase|Not specified|1
1189727|NCT01010776|3908335|P1|Main Phase|Inform consent withdrawal|1
1189728|NCT01010776|3908335|P1|Main Phase|Selection failure|2
1189729|NCT01010776|3908335|P1|Main Phase|Non-compliance to study medication|5
1189730|NCT01010776|3908335|P1|Main Phase|Lost to Follow-up|6
1189731|NCT01010776|3908335|P1|Main Phase|Adverse Event|7
1189732|NCT01010776|3908335|P1|Main Phase|Lack of Efficacy|8
1189733|NCT01010776|3908335|P1|Main Phase|Withdrawal by Subject|14
1189734|NCT01010750|3908363|P6|Second Intervention|Adverse Event|0
1189735|NCT01010750|3908364|P5|Second Intervention|Adverse Event|0
1189736|NCT01010750|3908365|P4|Second Intervention|Adverse Event|0
1189737|NCT01010750|3908366|P3|Second Intervention|Adverse Event|0
1189738|NCT01010750|3908367|P2|Second Intervention|Adverse Event|1
1189739|NCT01010750|3908368|P1|Second Intervention|Adverse Event|0
1189740|NCT01010633|3908393|P2|Overall Study|Investigator decision|1
1189741|NCT01010633|3908394|P1|Overall Study|Investigator decision|0
1189742|NCT01010633|3908393|P2|Overall Study|Withdrawal by Subject|1
1189743|NCT01010633|3908394|P1|Overall Study|Withdrawal by Subject|2
1189744|NCT01010633|3908393|P2|Overall Study|Protocol Violation|2
1189745|NCT01010633|3908394|P1|Overall Study|Protocol Violation|1
1189746|NCT01010633|3908393|P2|Overall Study|Adverse Event|1
1189747|NCT01010633|3908394|P1|Overall Study|Adverse Event|1
1189748|NCT01010503|3908421|P1|Overall Study|Death|1
1189749|NCT01010503|3908421|P1|Overall Study|Adverse Event|1
1189750|NCT01010230|3908480|P2|Overall Study|Lost to Follow-up|2
1189751|NCT01010230|3908481|P1|Overall Study|Lost to Follow-up|4
1189752|NCT01010230|3908480|P2|Overall Study|Withdrawal by Subject|5
1189753|NCT01010230|3908481|P1|Overall Study|Withdrawal by Subject|6
1189754|NCT01010204|3908513|P2|Overall Study|psychiatric hospitalization|1
1189755|NCT01010204|3908514|P1|Overall Study|psychiatric hospitalization|2
1189756|NCT01010204|3908513|P2|Overall Study|Withdrawal by Subject|3
1189757|NCT01010204|3908514|P1|Overall Study|Withdrawal by Subject|2
1189758|NCT01010204|3908513|P2|Overall Study|Adverse Event|3
1189759|NCT01010204|3908514|P1|Overall Study|Adverse Event|1
1189760|NCT01010204|3908513|P2|Overall Study|Lost to Follow-up|2
1189761|NCT01010204|3908514|P1|Overall Study|Lost to Follow-up|2
1189762|NCT01010061|3908526|P2|Overall Study|Did Not Receive Treatment|2
1189763|NCT01010061|3908527|P1|Overall Study|Did Not Receive Treatment|2
1189764|NCT01010061|3908526|P2|Overall Study|Violation of Selection Criteria|1
1189765|NCT01010061|3908527|P1|Overall Study|Violation of Selection Criteria|0
1189766|NCT01010061|3908526|P2|Overall Study|Insufficient Therapeutic Response|5
1189767|NCT01010061|3908527|P1|Overall Study|Insufficient Therapeutic Response|1
1189768|NCT01010061|3908526|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
1189769|NCT01010061|3908527|P1|Overall Study|Refused Treatment/Did Not Cooperate|2
1189770|NCT01010061|3908526|P2|Overall Study|Administrative/Other|1
1189771|NCT01010061|3908527|P1|Overall Study|Administrative/Other|0
1189772|NCT01010061|3908526|P2|Overall Study|Death|6
1189773|NCT01010061|3908527|P1|Overall Study|Death|3
1189774|NCT01010061|3908526|P2|Overall Study|Withdrew Consent|1
1189775|NCT01010061|3908527|P1|Overall Study|Withdrew Consent|5
1189776|NCT01010061|3908526|P2|Overall Study|Disease Progression|8
1189777|NCT01010061|3908527|P1|Overall Study|Disease Progression|2
1189778|NCT01010061|3908526|P2|Overall Study|Adverse Events or Intercurrent Illness|16
1189779|NCT01010061|3908527|P1|Overall Study|Adverse Events or Intercurrent Illness|33
1189780|NCT01009983|3908578|P1|Overall Study|necessary scans not completed|1
1189781|NCT01009840|3908591|P1|Overall Study|Subject Withdrew Consent to Participate|1
1189782|NCT01009840|3908591|P1|Overall Study|Subject was Withdrawn by Investigator|1
1189783|NCT01009840|3908591|P1|Overall Study|Subject Met Withdrawal Criteria|7
1189784|NCT01009840|3908591|P1|Overall Study|Adverse Event|4
1189785|NCT01009840|3908591|P1|Overall Study|Lost to Follow-up|1
1189786|NCT01009645|3908621|P4|Overall Study|Lost to Follow-up|5
1189787|NCT01009645|3908622|P3|Overall Study|Lost to Follow-up|4
1189788|NCT01009645|3908623|P2|Overall Study|Lost to Follow-up|8
1189789|NCT01009645|3908624|P1|Overall Study|Lost to Follow-up|2
1189790|NCT01009580|3908661|P2|Overall Study|Unclassified|21
1189791|NCT01009580|3908662|P1|Overall Study|Unclassified|17
1189792|NCT01009580|3908661|P2|Overall Study|Withdrawal Criteria|6
1189793|NCT01009580|3908662|P1|Overall Study|Withdrawal Criteria|4
1189794|NCT01009580|3908661|P2|Overall Study|Protocol Violation|3
1189795|NCT01009580|3908662|P1|Overall Study|Protocol Violation|2
1189796|NCT01009580|3908661|P2|Overall Study|Lack of Efficacy|1
1189797|NCT01009580|3908662|P1|Overall Study|Lack of Efficacy|0
1189798|NCT01009580|3908661|P2|Overall Study|Adverse Event|4
1189799|NCT01009580|3908662|P1|Overall Study|Adverse Event|4
1189800|NCT01009554|3908676|P2|Overall Study|Noncompliant with Study Product|3
1189801|NCT01009554|3908677|P1|Overall Study|Noncompliant with Study Product|0
1189802|NCT01009554|3908676|P2|Overall Study|Withdrawal by Subject|3
1189803|NCT01009554|3908677|P1|Overall Study|Withdrawal by Subject|1
1189804|NCT01009554|3908676|P2|Overall Study|Adverse Event|1
1189805|NCT01009554|3908677|P1|Overall Study|Adverse Event|1
1189806|NCT01009515|3908809|P1|Overall Study|Withdrawal by Subject|3
1189807|NCT01009463|3908820|P5|52-week, Double-blind Treatment Period|Physician Decision|8
1189808|NCT01009463|3908821|P4|52-week, Double-blind Treatment Period|Physician Decision|6
1189809|NCT01009463|3908822|P3|52-week, Double-blind Treatment Period|Physician Decision|6
1189810|NCT01009463|3908823|P2|52-week, Double-blind Treatment Period|Physician Decision|4
1189811|NCT01009463|3908824|P1|52-week, Double-blind Treatment Period|Physician Decision|0
1189812|NCT01009463|3908820|P5|52-week, Double-blind Treatment Period|Lost to Follow-up|5
1189813|NCT01009463|3908821|P4|52-week, Double-blind Treatment Period|Lost to Follow-up|6
1189814|NCT01009463|3908822|P3|52-week, Double-blind Treatment Period|Lost to Follow-up|7
1189815|NCT01009463|3908823|P2|52-week, Double-blind Treatment Period|Lost to Follow-up|11
1189816|NCT01009463|3908824|P1|52-week, Double-blind Treatment Period|Lost to Follow-up|0
1189817|NCT01009463|3908820|P5|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
1189818|NCT01009463|3908821|P4|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
1189819|NCT01009463|3908822|P3|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
1189820|NCT01009463|3908823|P2|52-week, Double-blind Treatment Period|Study Closed/Terminated|2
1189821|NCT01009463|3908824|P1|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
1189822|NCT01009463|3908820|P5|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
1189823|NCT01009463|3908821|P4|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
1189824|NCT01009463|3908822|P3|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14
1189825|NCT01009463|3908823|P2|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
1189826|NCT01009463|3908824|P1|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
1189827|NCT01009463|3908820|P5|52-week, Double-blind Treatment Period|Protocol Violation|7
1189828|NCT01009463|3908821|P4|52-week, Double-blind Treatment Period|Protocol Violation|8
1189829|NCT01009463|3908822|P3|52-week, Double-blind Treatment Period|Protocol Violation|7
1189830|NCT01009463|3908823|P2|52-week, Double-blind Treatment Period|Protocol Violation|8
1189831|NCT01009463|3908824|P1|52-week, Double-blind Treatment Period|Protocol Violation|0
1189832|NCT01009463|3908820|P5|52-week, Double-blind Treatment Period|Lack of Efficacy|18
1189833|NCT01009463|3908821|P4|52-week, Double-blind Treatment Period|Lack of Efficacy|11
1189834|NCT01009463|3908822|P3|52-week, Double-blind Treatment Period|Lack of Efficacy|16
1189835|NCT01009463|3908823|P2|52-week, Double-blind Treatment Period|Lack of Efficacy|24
1189836|NCT01009463|3908824|P1|52-week, Double-blind Treatment Period|Lack of Efficacy|0
1189837|NCT01009463|3908820|P5|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
1189838|NCT01009463|3908821|P4|52-week, Double-blind Treatment Period|Withdrawal by Subject|17
1189839|NCT01009463|3908822|P3|52-week, Double-blind Treatment Period|Withdrawal by Subject|18
1189840|NCT01009463|3908823|P2|52-week, Double-blind Treatment Period|Withdrawal by Subject|34
1189841|NCT01009463|3908824|P1|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
1189842|NCT01009463|3908820|P5|52-week, Double-blind Treatment Period|Adverse Event|31
1189843|NCT01009463|3908821|P4|52-week, Double-blind Treatment Period|Adverse Event|29
1189844|NCT01009463|3908822|P3|52-week, Double-blind Treatment Period|Adverse Event|25
1189845|NCT01009463|3908823|P2|52-week, Double-blind Treatment Period|Adverse Event|22
1189846|NCT01009463|3908824|P1|52-week, Double-blind Treatment Period|Adverse Event|0
1189847|NCT01009463|3908820|P5|4-week, Open-label Run-In Period|Withdrawal by Subject|0
1189848|NCT01009463|3908821|P4|4-week, Open-label Run-In Period|Withdrawal by Subject|0
1189849|NCT01009463|3908822|P3|4-week, Open-label Run-In Period|Withdrawal by Subject|0
1189850|NCT01009463|3908823|P2|4-week, Open-label Run-In Period|Withdrawal by Subject|0
1189851|NCT01009463|3908824|P1|4-week, Open-label Run-In Period|Withdrawal by Subject|50
1189852|NCT01009463|3908820|P5|4-week, Open-label Run-In Period|Physician Decision|0
1189853|NCT01009463|3908821|P4|4-week, Open-label Run-In Period|Physician Decision|0
1189854|NCT01009463|3908822|P3|4-week, Open-label Run-In Period|Physician Decision|0
1189855|NCT01009463|3908823|P2|4-week, Open-label Run-In Period|Physician Decision|0
1189856|NCT01009463|3908824|P1|4-week, Open-label Run-In Period|Physician Decision|10
1189857|NCT01009463|3908820|P5|4-week, Open-label Run-In Period|Lost to Follow-up|0
1189858|NCT01009463|3908821|P4|4-week, Open-label Run-In Period|Lost to Follow-up|0
1189859|NCT01009463|3908822|P3|4-week, Open-label Run-In Period|Lost to Follow-up|0
1189860|NCT01009463|3908823|P2|4-week, Open-label Run-In Period|Lost to Follow-up|0
1189861|NCT01009463|3908824|P1|4-week, Open-label Run-In Period|Lost to Follow-up|6
1189862|NCT01009463|3908820|P5|4-week, Open-label Run-In Period|Adverse Event|0
1189863|NCT01009463|3908821|P4|4-week, Open-label Run-In Period|Adverse Event|0
1189864|NCT01009463|3908822|P3|4-week, Open-label Run-In Period|Adverse Event|0
1189865|NCT01009463|3908823|P2|4-week, Open-label Run-In Period|Adverse Event|0
1189866|NCT01009463|3908824|P1|4-week, Open-label Run-In Period|Adverse Event|10
1189867|NCT01009463|3908820|P5|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
1189868|NCT01009463|3908821|P4|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
1189869|NCT01009463|3908822|P3|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
1189870|NCT01009463|3908823|P2|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
1189871|NCT01009463|3908824|P1|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373
1189872|NCT01009346|3908846|P1|Overall Study|Adverse Event|4
1189873|NCT01009203|3908870|P1|Overall Study|Treatment-unrelated death|1
1189874|NCT01009203|3908870|P1|Overall Study|Adverse Event|5
1189875|NCT01009203|3908870|P1|Overall Study|Withdrawal by Subject|1
1189876|NCT01009099|3908910|P2|Overall Study|Death|1
1189877|NCT01009099|3908911|P1|Overall Study|Death|0
1189878|NCT01009099|3908910|P2|Overall Study|Withdrawal by Subject|1
1189879|NCT01009099|3908911|P1|Overall Study|Withdrawal by Subject|1
1189880|NCT01009099|3908910|P2|Overall Study|Physician Decision|2
1189881|NCT01009099|3908911|P1|Overall Study|Physician Decision|3
1189882|NCT01009099|3908910|P2|Overall Study|Lost to Follow-up|0
1189883|NCT01009099|3908911|P1|Overall Study|Lost to Follow-up|1
1189884|NCT01009086|3908920|P3|Overall Study|Other|1
1189885|NCT01009086|3908921|P2|Overall Study|Other|5
1189886|NCT01009086|3908922|P1|Overall Study|Other|3
1189887|NCT01009086|3908920|P3|Overall Study|Withdrawal by Subject|13
1189888|NCT01009086|3908921|P2|Overall Study|Withdrawal by Subject|11
1189889|NCT01009086|3908922|P1|Overall Study|Withdrawal by Subject|9
1189890|NCT01009086|3908920|P3|Overall Study|Adverse Event|8
1189891|NCT01009086|3908921|P2|Overall Study|Adverse Event|11
1189892|NCT01009086|3908922|P1|Overall Study|Adverse Event|12
1189893|NCT01009086|3908920|P3|Overall Study|Lost to Follow-up|3
1189894|NCT01009086|3908921|P2|Overall Study|Lost to Follow-up|5
1189895|NCT01009086|3908922|P1|Overall Study|Lost to Follow-up|4
1189896|NCT01009086|3908920|P3|Overall Study|Lack of Efficacy|9
1189897|NCT01009086|3908921|P2|Overall Study|Lack of Efficacy|15
1189898|NCT01009086|3908922|P1|Overall Study|Lack of Efficacy|16
1189899|NCT01009060|3908957|P2|Overall Study|Withdrawal by Subject|1
1189900|NCT01009060|3908958|P1|Overall Study|Withdrawal by Subject|1
1189901|NCT01009060|3908957|P2|Overall Study|Physician Decision|1
1189902|NCT01009060|3908958|P1|Overall Study|Physician Decision|1
1189903|NCT01009060|3908957|P2|Overall Study|Lost to Follow-up|0
1189904|NCT01009060|3908958|P1|Overall Study|Lost to Follow-up|1
1189905|NCT01009060|3908957|P2|Overall Study|Protocol Violation|1
1189906|NCT01009060|3908958|P1|Overall Study|Protocol Violation|0
1189907|NCT01009060|3908957|P2|Overall Study|Adverse Event|2
1189908|NCT01009060|3908958|P1|Overall Study|Adverse Event|1
1189909|NCT01009047|3908996|P2|Overall Study|Other|2
1189910|NCT01009047|3908997|P1|Overall Study|Other|3
1189911|NCT01009047|3908996|P2|Overall Study|Withdrawal by consent|11
1189912|NCT01009047|3908997|P1|Overall Study|Withdrawal by consent|16
1189913|NCT01009047|3908996|P2|Overall Study|Lack of Efficacy|11
1189914|NCT01009047|3908997|P1|Overall Study|Lack of Efficacy|4
1189915|NCT01009047|3908996|P2|Overall Study|Lost to Follow-up|2
1189916|NCT01009047|3908997|P1|Overall Study|Lost to Follow-up|0
1189917|NCT01009047|3908996|P2|Overall Study|Adverse Event|0
1189918|NCT01009047|3908997|P1|Overall Study|Adverse Event|5
1189919|NCT01009034|3909019|P1|Overall Study|Withdrawal by Subject|2
1189920|NCT01009034|3909019|P1|Overall Study|Lost to Follow-up|2
1189921|NCT01008995|3909027|P4|After Controlled Period|Not specified|0
1189922|NCT01008995|3909028|P3|After Controlled Period|Not specified|1
1189923|NCT01008995|3909029|P2|After Controlled Period|Not specified|0
1189924|NCT01008995|3909030|P1|After Controlled Period|Not specified|0
1189925|NCT01008995|3909027|P4|After Controlled Period|Adverse Event|1
1189926|NCT01008995|3909028|P3|After Controlled Period|Adverse Event|1
1189927|NCT01008995|3909029|P2|After Controlled Period|Adverse Event|0
1189928|NCT01008995|3909030|P1|After Controlled Period|Adverse Event|0
1189929|NCT01008995|3909027|P4|Controlled Period|Not specified|0
1189930|NCT01008995|3909028|P3|Controlled Period|Not specified|0
1189931|NCT01008995|3909029|P2|Controlled Period|Not specified|1
1189932|NCT01008995|3909030|P1|Controlled Period|Not specified|2
1189933|NCT01008995|3909027|P4|Controlled Period|Adverse Event|0
1189934|NCT01008995|3909028|P3|Controlled Period|Adverse Event|0
1189935|NCT01008995|3909029|P2|Controlled Period|Adverse Event|2
1189936|NCT01008995|3909030|P1|Controlled Period|Adverse Event|1
1189937|NCT01008943|3909047|P1|Overall Study|Withdrawal by Subject|1
1189938|NCT01008904|3909054|P1|Overall Study|unexpected unrelated surgery|1
1189939|NCT01008904|3909054|P1|Overall Study|Adverse Event|2
1189940|NCT01008904|3909054|P1|Overall Study|Lost to Follow-up|1
1189941|NCT01008696|3909072|P2|Overall Study|Other|2
1189942|NCT01008696|3909073|P1|Overall Study|Other|0
1189943|NCT01008696|3909072|P2|Overall Study|Other|3
1189944|NCT01008696|3909073|P1|Overall Study|Other|2
1189945|NCT01008696|3909072|P2|Overall Study|Participants' non-cooperation|3
1189946|NCT01008696|3909073|P1|Overall Study|Participants' non-cooperation|2
1189947|NCT01008696|3909072|P2|Overall Study|Adverse Event|0
1189948|NCT01008696|3909073|P1|Overall Study|Adverse Event|1
1189949|NCT01008696|3909072|P2|Overall Study|Physician Decision|1
1189950|NCT01008696|3909073|P1|Overall Study|Physician Decision|5
1189951|NCT01008696|3909072|P2|Overall Study|Withdrawal by Subject|4
1189952|NCT01008696|3909073|P1|Overall Study|Withdrawal by Subject|2
1189953|NCT01008696|3909072|P2|Overall Study|Participant's evasion of hospital visit|4
1189954|NCT01008696|3909073|P1|Overall Study|Participant's evasion of hospital visit|5
1189955|NCT01008618|3909083|P3|Period 2 (Double-Blind Period)|Not appropriate for this study|1
1189956|NCT01008618|3909084|P2|Period 2 (Double-Blind Period)|Not appropriate for this study|0
1189957|NCT01008618|3909085|P1|Period 2 (Double-Blind Period)|Not appropriate for this study|0
1189958|NCT01008618|3909083|P3|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29
1189959|NCT01008618|3909084|P2|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21
1189960|NCT01008618|3909085|P1|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
1189961|NCT01008618|3909083|P3|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
1189962|NCT01008618|3909084|P2|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
1189963|NCT01008618|3909085|P1|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
1189964|NCT01008618|3909083|P3|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3
1189965|NCT01008618|3909084|P2|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
1189966|NCT01008618|3909085|P1|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
1189967|NCT01008618|3909083|P3|Period 2 (Double-Blind Period)|Physician Decision|0
1189968|NCT01008618|3909084|P2|Period 2 (Double-Blind Period)|Physician Decision|1
1189969|NCT01008618|3909085|P1|Period 2 (Double-Blind Period)|Physician Decision|0
1189970|NCT01008618|3909083|P3|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
1189971|NCT01008618|3909084|P2|Period 2 (Double-Blind Period)|Withdrawal by Subject|3
1189972|NCT01008618|3909085|P1|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
1189973|NCT01008618|3909083|P3|Period 2 (Double-Blind Period)|Adverse Event|2
1189974|NCT01008618|3909084|P2|Period 2 (Double-Blind Period)|Adverse Event|11
1189975|NCT01008618|3909085|P1|Period 2 (Double-Blind Period)|Adverse Event|0
1189976|NCT01008618|3909083|P3|Period 1 (Titration Period)|Aggravated symptom|0
1189977|NCT01008618|3909084|P2|Period 1 (Titration Period)|Aggravated symptom|0
1189978|NCT01008618|3909085|P1|Period 1 (Titration Period)|Aggravated symptom|2
1189979|NCT01008618|3909083|P3|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
1189980|NCT01008618|3909084|P2|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
1189981|NCT01008618|3909085|P1|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20
1189982|NCT01008618|3909083|P3|Period 1 (Titration Period)|Withdrawal by Subject|0
1189983|NCT01008618|3909084|P2|Period 1 (Titration Period)|Withdrawal by Subject|0
1189984|NCT01008618|3909085|P1|Period 1 (Titration Period)|Withdrawal by Subject|11
1189985|NCT01008618|3909083|P3|Period 1 (Titration Period)|Adverse Event|0
1189986|NCT01008618|3909084|P2|Period 1 (Titration Period)|Adverse Event|0
1189987|NCT01008618|3909085|P1|Period 1 (Titration Period)|Adverse Event|33
1189988|NCT01008618|3909083|P3|Period 1 (Titration Period)|Physician Decision|0
1189989|NCT01008618|3909084|P2|Period 1 (Titration Period)|Physician Decision|0
1189990|NCT01008618|3909085|P1|Period 1 (Titration Period)|Physician Decision|2
1189991|NCT01008553|3909134|P3|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35
1189992|NCT01008553|3909135|P2|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18
1189993|NCT01008553|3909136|P1|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
1189994|NCT01008553|3909134|P3|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
1189995|NCT01008553|3909135|P2|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
1189996|NCT01008553|3909136|P1|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
1189997|NCT01008553|3909134|P3|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3
1189998|NCT01008553|3909135|P2|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
1189999|NCT01008553|3909136|P1|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
1190000|NCT01008553|3909134|P3|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4
1190001|NCT01008553|3909135|P2|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1
1190002|NCT01008553|3909136|P1|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
1190003|NCT01008553|3909134|P3|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
1190004|NCT01008553|3909135|P2|Period 2 (Double-Blind Period)|Impossible to perform required tests|1
1190005|NCT01008553|3909136|P1|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
1190006|NCT01008553|3909134|P3|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
1190007|NCT01008553|3909135|P2|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
1190008|NCT01008553|3909136|P1|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
1190009|NCT01008553|3909134|P3|Period 2 (Double-Blind Period)|Adverse Event|4
1190010|NCT01008553|3909135|P2|Period 2 (Double-Blind Period)|Adverse Event|14
1190011|NCT01008553|3909136|P1|Period 2 (Double-Blind Period)|Adverse Event|0
1190012|NCT01008553|3909134|P3|Period 2 (Double-Blind Period)|Physician Decision|2
1190013|NCT01008553|3909135|P2|Period 2 (Double-Blind Period)|Physician Decision|1
1190014|NCT01008553|3909136|P1|Period 2 (Double-Blind Period)|Physician Decision|0
1190015|NCT01008553|3909134|P3|Period 1 (Titration Period)|Not appropriate for this study|0
1190016|NCT01008553|3909135|P2|Period 1 (Titration Period)|Not appropriate for this study|0
1190017|NCT01008553|3909136|P1|Period 1 (Titration Period)|Not appropriate for this study|1
1190018|NCT01008553|3909134|P3|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
1190019|NCT01008553|3909135|P2|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
1190020|NCT01008553|3909136|P1|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50
1190021|NCT01008553|3909134|P3|Period 1 (Titration Period)|Determined to increase dosage|0
1190022|NCT01008553|3909135|P2|Period 1 (Titration Period)|Determined to increase dosage|0
1190023|NCT01008553|3909136|P1|Period 1 (Titration Period)|Determined to increase dosage|3
1190024|NCT01008553|3909134|P3|Period 1 (Titration Period)|Withdrawal by Subject|0
1190025|NCT01008553|3909135|P2|Period 1 (Titration Period)|Withdrawal by Subject|0
1190026|NCT01008553|3909136|P1|Period 1 (Titration Period)|Withdrawal by Subject|6
1190027|NCT01008553|3909134|P3|Period 1 (Titration Period)|Adverse Event|0
1190028|NCT01008553|3909135|P2|Period 1 (Titration Period)|Adverse Event|0
1190029|NCT01008553|3909136|P1|Period 1 (Titration Period)|Adverse Event|33
1190030|NCT01008553|3909134|P3|Period 1 (Titration Period)|Physician Decision|0
1190031|NCT01008553|3909135|P2|Period 1 (Titration Period)|Physician Decision|0
1190032|NCT01008553|3909136|P1|Period 1 (Titration Period)|Physician Decision|2
1190033|NCT01008475|3909168|P7|Overall Study|Ongoing treatment at data cut-off date|4
1190034|NCT01008475|3909169|P6|Overall Study|Ongoing treatment at data cut-off date|6
1190035|NCT01008475|3909170|P5|Overall Study|Ongoing treatment at data cut-off date|5
1190036|NCT01008475|3909171|P4|Overall Study|Ongoing treatment at data cut-off date|0
1190037|NCT01008475|3909172|P3|Overall Study|Ongoing treatment at data cut-off date|0
1190038|NCT01008475|3909173|P2|Overall Study|Ongoing treatment at data cut-off date|0
1190039|NCT01008475|3909174|P1|Overall Study|Ongoing treatment at data cut-off date|0
1190040|NCT01008449|3909204|P2|Overall Study|Lost to Follow-up|19
1190041|NCT01008449|3909205|P1|Overall Study|Lost to Follow-up|29
1190042|NCT01008150|3909255|P4|Overall Study|did not receive study drug|0
1190043|NCT01008150|3909256|P3|Overall Study|did not receive study drug|1
1190044|NCT01008150|3909257|P2|Overall Study|did not receive study drug|1
1190045|NCT01008150|3909258|P1|Overall Study|did not receive study drug|1
1190046|NCT01007916|3909288|P2|Period 2, 4 Weeks of Wear|Relocation|0
1190047|NCT01007916|3909289|P1|Period 2, 4 Weeks of Wear|Relocation|1
1190048|NCT01007916|3909288|P2|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0
1190049|NCT01007916|3909289|P1|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1
1190050|NCT01007942|3909297|P2|Overall Study|Patients untreated|3
1190051|NCT01007942|3909298|P1|Overall Study|Patients untreated|4
1190052|NCT01007942|3909297|P2|Overall Study|Death|2
1190053|NCT01007942|3909298|P1|Overall Study|Death|3
1190054|NCT01007942|3909297|P2|Overall Study|Administrative problems|0
1190055|NCT01007942|3909298|P1|Overall Study|Administrative problems|2
1190056|NCT01007942|3909297|P2|Overall Study|Lost to Follow-up|0
1190057|NCT01007942|3909298|P1|Overall Study|Lost to Follow-up|1
1190058|NCT01007942|3909297|P2|Overall Study|Withdrawal by Subject|14
1190059|NCT01007942|3909298|P1|Overall Study|Withdrawal by Subject|19
1190060|NCT01007942|3909297|P2|Overall Study|Protocol Violation|1
1190061|NCT01007942|3909298|P1|Overall Study|Protocol Violation|1
1190062|NCT01007942|3909297|P2|Overall Study|New cancer therapy|1
1190063|NCT01007942|3909298|P1|Overall Study|New cancer therapy|5
1190064|NCT01007942|3909297|P2|Overall Study|Disease progression|242
1190065|NCT01007942|3909298|P1|Overall Study|Disease progression|217
1190066|NCT01007942|3909297|P2|Overall Study|Abnormal test procedure|1
1190067|NCT01007942|3909298|P1|Overall Study|Abnormal test procedure|0
1190068|NCT01007942|3909297|P2|Overall Study|Adverse Event|14
1190069|NCT01007942|3909298|P1|Overall Study|Adverse Event|29
1190070|NCT01007838|3909324|P4|Overall Study|Started home haemodialysis|0
1190071|NCT01007838|3909325|P3|Overall Study|Started home haemodialysis|0
1190072|NCT01007838|3909326|P2|Overall Study|Started home haemodialysis|0
1190073|NCT01007838|3909327|P1|Overall Study|Started home haemodialysis|1
1190074|NCT01007838|3909324|P4|Overall Study|Physician Decision|0
1190075|NCT01007838|3909325|P3|Overall Study|Physician Decision|0
1190076|NCT01007838|3909326|P2|Overall Study|Physician Decision|0
1190077|NCT01007838|3909327|P1|Overall Study|Physician Decision|1
1190078|NCT01007838|3909324|P4|Overall Study|Withdrawal by Subject|0
1190079|NCT01007838|3909325|P3|Overall Study|Withdrawal by Subject|0
1190080|NCT01007838|3909326|P2|Overall Study|Withdrawal by Subject|0
1190081|NCT01007838|3909327|P1|Overall Study|Withdrawal by Subject|1
1190082|NCT01007812|3909337|P2|Period 1, One Week|Discomfort|0
1190083|NCT01007812|3909338|P1|Period 1, One Week|Discomfort|1
1190084|NCT01007812|3909337|P2|Period 1, One Week|Lost to Follow-up|1
1190085|NCT01007812|3909338|P1|Period 1, One Week|Lost to Follow-up|0
1190086|NCT01007552|3909371|P1|Overall Study|Withdrawal by Subject|1
1190087|NCT01007435|3909385|P4|Overall Study|Reason not Specified|1
1190088|NCT01007435|3909386|P3|Overall Study|Reason not Specified|2
1190089|NCT01007435|3909387|P2|Overall Study|Reason not Specified|1
1190090|NCT01007435|3909388|P1|Overall Study|Reason not Specified|1
1190091|NCT01007435|3909385|P4|Overall Study|Failure to Return|6
1190092|NCT01007435|3909386|P3|Overall Study|Failure to Return|3
1190093|NCT01007435|3909387|P2|Overall Study|Failure to Return|4
1190094|NCT01007435|3909388|P1|Overall Study|Failure to Return|5
1190095|NCT01007435|3909385|P4|Overall Study|Refused Treatment|8
1190096|NCT01007435|3909386|P3|Overall Study|Refused Treatment|5
1190097|NCT01007435|3909387|P2|Overall Study|Refused Treatment|13
1190098|NCT01007435|3909388|P1|Overall Study|Refused Treatment|13
1190099|NCT01007435|3909385|P4|Overall Study|Other Protocol Violation|0
1190100|NCT01007435|3909386|P3|Overall Study|Other Protocol Violation|1
1190101|NCT01007435|3909387|P2|Overall Study|Other Protocol Violation|0
1190102|NCT01007435|3909388|P1|Overall Study|Other Protocol Violation|2
1190103|NCT01007435|3909385|P4|Overall Study|Violation of Selection Criteria at Entry|0
1190104|NCT01007435|3909386|P3|Overall Study|Violation of Selection Criteria at Entry|2
1190105|NCT01007435|3909387|P2|Overall Study|Violation of Selection Criteria at Entry|5
1190106|NCT01007435|3909388|P1|Overall Study|Violation of Selection Criteria at Entry|3
1190107|NCT01007435|3909385|P4|Overall Study|Insufficient Therapeutic Response|9
1190108|NCT01007435|3909386|P3|Overall Study|Insufficient Therapeutic Response|2
1190109|NCT01007435|3909387|P2|Overall Study|Insufficient Therapeutic Response|7
1190110|NCT01007435|3909388|P1|Overall Study|Insufficient Therapeutic Response|21
1190111|NCT01007435|3909385|P4|Overall Study|Death|1
1190112|NCT01007435|3909386|P3|Overall Study|Death|2
1190113|NCT01007435|3909387|P2|Overall Study|Death|4
1190114|NCT01007435|3909388|P1|Overall Study|Death|2
1190115|NCT01007435|3909385|P4|Overall Study|Adverse Event|31
1190116|NCT01007435|3909386|P3|Overall Study|Adverse Event|47
1190117|NCT01007435|3909387|P2|Overall Study|Adverse Event|25
1190118|NCT01007435|3909388|P1|Overall Study|Adverse Event|16
1190119|NCT01007396|3909430|P1|Overall Study|Lost to Follow-up|47
1190120|NCT01007253|3909435|P4|Washout Period (2 Weeks) # 3|Physician Decision|0
1190121|NCT01007253|3909436|P3|Washout Period (2 Weeks) # 3|Physician Decision|0
1190122|NCT01007253|3909437|P2|Washout Period (2 Weeks) # 3|Physician Decision|0
1190123|NCT01007253|3909438|P1|Washout Period (2 Weeks) # 3|Physician Decision|1
1190124|NCT01007149|3909470|P2|Overall Study|Administrative problems|1
1190125|NCT01007149|3909471|P1|Overall Study|Administrative problems|0
1190126|NCT01007123|3909497|P4|Overall Study|Lost to Follow-up|0
1190127|NCT01007123|3909498|P3|Overall Study|Lost to Follow-up|0
1190128|NCT01007123|3909499|P2|Overall Study|Lost to Follow-up|1
1190129|NCT01007123|3909500|P1|Overall Study|Lost to Follow-up|0
1190130|NCT01007123|3909497|P4|Overall Study|Withdrawal by Subject|0
1190131|NCT01007123|3909498|P3|Overall Study|Withdrawal by Subject|1
1190132|NCT01007123|3909499|P2|Overall Study|Withdrawal by Subject|0
1190133|NCT01007123|3909500|P1|Overall Study|Withdrawal by Subject|1
1190134|NCT01007123|3909497|P4|Overall Study|Protocol Violation|1
1190135|NCT01007123|3909498|P3|Overall Study|Protocol Violation|2
1190136|NCT01007123|3909499|P2|Overall Study|Protocol Violation|1
1190137|NCT01007123|3909500|P1|Overall Study|Protocol Violation|1
1190138|NCT01007123|3909497|P4|Overall Study|Lack of Efficacy|4
1190139|NCT01007123|3909498|P3|Overall Study|Lack of Efficacy|1
1190140|NCT01007123|3909499|P2|Overall Study|Lack of Efficacy|0
1190141|NCT01007123|3909500|P1|Overall Study|Lack of Efficacy|1
1190142|NCT01007123|3909497|P4|Overall Study|Adverse Event|1
1190143|NCT01007123|3909498|P3|Overall Study|Adverse Event|7
1190144|NCT01007123|3909499|P2|Overall Study|Adverse Event|4
1190145|NCT01007123|3909500|P1|Overall Study|Adverse Event|3
1190146|NCT01006980|3909559|P2|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10
1190147|NCT01006980|3909560|P1|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0
1190148|NCT01006980|3909559|P2|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1
1190149|NCT01006980|3909560|P1|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0
1190150|NCT01006980|3909559|P2|Crossover: Dacarbazine to Vemurafenib|Progression|65
1190151|NCT01006980|3909560|P1|Crossover: Dacarbazine to Vemurafenib|Progression|0
1190152|NCT01006980|3909559|P2|Crossover: Dacarbazine to Vemurafenib|Death|4
1190153|NCT01006980|3909560|P1|Crossover: Dacarbazine to Vemurafenib|Death|0
1190154|NCT01006980|3909559|P2|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4
1190155|NCT01006980|3909560|P1|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0
1190156|NCT01006980|3909559|P2|Vemurafenib and Dacarbazine|Reason Not Specified|43
1190157|NCT01006980|3909560|P1|Vemurafenib and Dacarbazine|Reason Not Specified|26
1190158|NCT01006980|3909559|P2|Vemurafenib and Dacarbazine|Protocol Violation|3
1190159|NCT01006980|3909560|P1|Vemurafenib and Dacarbazine|Protocol Violation|2
1190160|NCT01006980|3909559|P2|Vemurafenib and Dacarbazine|Refuse Treatment|6
1190161|NCT01006980|3909560|P1|Vemurafenib and Dacarbazine|Refuse Treatment|9
1190162|NCT01006980|3909559|P2|Vemurafenib and Dacarbazine|Withdrawal of Consent|6
1190163|NCT01006980|3909560|P1|Vemurafenib and Dacarbazine|Withdrawal of Consent|4
1190164|NCT01006980|3909559|P2|Vemurafenib and Dacarbazine|Progression|218
1190165|NCT01006980|3909560|P1|Vemurafenib and Dacarbazine|Progression|257
1190166|NCT01006980|3909559|P2|Vemurafenib and Dacarbazine|Death|12
1190167|NCT01006980|3909560|P1|Vemurafenib and Dacarbazine|Death|13
1190168|NCT01006980|3909559|P2|Vemurafenib and Dacarbazine|Adverse Event|5
1190169|NCT01006980|3909560|P1|Vemurafenib and Dacarbazine|Adverse Event|25
1190170|NCT01006980|3909559|P2|Vemurafenib and Dacarbazine|Randomized but Not Treated|45
1190171|NCT01006980|3909560|P1|Vemurafenib and Dacarbazine|Randomized but Not Treated|1
1190172|NCT01006889|3909599|P1|Overall Study|Withdrawal by Subject|3
1190173|NCT01006707|3909610|P3|Study Session 1|Could not tolerate withdrawal in scanner|0
1190174|NCT01006707|3909611|P2|Study Session 1|Could not tolerate withdrawal in scanner|0
1190175|NCT01006707|3909612|P1|Study Session 1|Could not tolerate withdrawal in scanner|3
1190176|NCT01006707|3909610|P3|Study Session 1|Lost to Follow-up|0
1190177|NCT01006707|3909611|P2|Study Session 1|Lost to Follow-up|0
1190178|NCT01006707|3909612|P1|Study Session 1|Lost to Follow-up|2
1190179|NCT01006629|3909632|P1|Overall Study|Parent unable to perform site visit|4
1190180|NCT01006629|3909632|P1|Overall Study|Parent refused to continue participation|1
1190181|NCT01006629|3909632|P1|Overall Study|Adverse Event|1
1190182|NCT01006616|3909647|P4|Period 2 (18 Months)|Study Terminated|70
1190183|NCT01006616|3909648|P3|Period 2 (18 Months)|Study Terminated|44
1190184|NCT01006616|3909649|P2|Period 2 (18 Months)|Study Terminated|46
1190185|NCT01006616|3909650|P1|Period 2 (18 Months)|Study Terminated|63
1190186|NCT01006616|3909647|P4|Period 2 (18 Months)|Noncompliance With Protocol|1
1190187|NCT01006616|3909648|P3|Period 2 (18 Months)|Noncompliance With Protocol|0
1190188|NCT01006616|3909649|P2|Period 2 (18 Months)|Noncompliance With Protocol|1
1190189|NCT01006616|3909650|P1|Period 2 (18 Months)|Noncompliance With Protocol|0
1190190|NCT01006616|3909647|P4|Period 2 (18 Months)|Withdrawal by Subject|1
1190191|NCT01006616|3909648|P3|Period 2 (18 Months)|Withdrawal by Subject|0
1190192|NCT01006616|3909649|P2|Period 2 (18 Months)|Withdrawal by Subject|4
1190193|NCT01006616|3909650|P1|Period 2 (18 Months)|Withdrawal by Subject|1
1190194|NCT01006616|3909647|P4|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2
1190195|NCT01006616|3909648|P3|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1
1190196|NCT01006616|3909649|P2|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6
1190197|NCT01006616|3909650|P1|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0
1190198|NCT01006616|3909647|P4|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2
1190199|NCT01006616|3909648|P3|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
1190200|NCT01006616|3909649|P2|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0
1190201|NCT01006616|3909650|P1|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
1190202|NCT01006616|3909647|P4|Period 2 (18 Months)|Lost to Follow-up|0
1190203|NCT01006616|3909648|P3|Period 2 (18 Months)|Lost to Follow-up|0
1190204|NCT01006616|3909649|P2|Period 2 (18 Months)|Lost to Follow-up|0
1190205|NCT01006616|3909650|P1|Period 2 (18 Months)|Lost to Follow-up|2
1190206|NCT01006616|3909647|P4|Period 2 (18 Months)|Lack of Efficacy|2
1190207|NCT01006616|3909648|P3|Period 2 (18 Months)|Lack of Efficacy|1
1190208|NCT01006616|3909649|P2|Period 2 (18 Months)|Lack of Efficacy|0
1190209|NCT01006616|3909650|P1|Period 2 (18 Months)|Lack of Efficacy|0
1190210|NCT01006616|3909647|P4|Period 2 (18 Months)|Adverse Event|4
1190211|NCT01006616|3909648|P3|Period 2 (18 Months)|Adverse Event|6
1190212|NCT01006616|3909649|P2|Period 2 (18 Months)|Adverse Event|6
1190213|NCT01006616|3909650|P1|Period 2 (18 Months)|Adverse Event|6
1190214|NCT01006616|3909647|P4|Period 1 (6 Months)|Not Treated|1
1190215|NCT01006616|3909648|P3|Period 1 (6 Months)|Not Treated|1
1190216|NCT01006616|3909649|P2|Period 1 (6 Months)|Not Treated|0
1190217|NCT01006616|3909650|P1|Period 1 (6 Months)|Not Treated|0
1190218|NCT01006616|3909647|P4|Period 1 (6 Months)|Noncompliance With Protocol|3
1190219|NCT01006616|3909648|P3|Period 1 (6 Months)|Noncompliance With Protocol|2
1190220|NCT01006616|3909649|P2|Period 1 (6 Months)|Noncompliance With Protocol|2
1190221|NCT01006616|3909650|P1|Period 1 (6 Months)|Noncompliance With Protocol|0
1190222|NCT01006616|3909647|P4|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
1190223|NCT01006616|3909648|P3|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
1190224|NCT01006616|3909649|P2|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7
1190225|NCT01006616|3909650|P1|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
1190226|NCT01006616|3909647|P4|Period 1 (6 Months)|Withdrawal by Subject|0
1190227|NCT01006616|3909648|P3|Period 1 (6 Months)|Withdrawal by Subject|2
1190228|NCT01006616|3909649|P2|Period 1 (6 Months)|Withdrawal by Subject|2
1190229|NCT01006616|3909650|P1|Period 1 (6 Months)|Withdrawal by Subject|2
1190230|NCT01006616|3909647|P4|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2
1190231|NCT01006616|3909648|P3|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1
1190232|NCT01006616|3909649|P2|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3
1190233|NCT01006616|3909650|P1|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0
1190234|NCT01006616|3909647|P4|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3
1190235|NCT01006616|3909648|P3|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2
1190236|NCT01006616|3909649|P2|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5
1190237|NCT01006616|3909650|P1|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6
1190238|NCT01006616|3909647|P4|Period 1 (6 Months)|Lost to Follow-up|0
1190239|NCT01006616|3909648|P3|Period 1 (6 Months)|Lost to Follow-up|1
1190240|NCT01006616|3909649|P2|Period 1 (6 Months)|Lost to Follow-up|0
1190241|NCT01006616|3909650|P1|Period 1 (6 Months)|Lost to Follow-up|0
1190242|NCT01006616|3909647|P4|Period 1 (6 Months)|Lack of Efficacy|4
1190243|NCT01006616|3909648|P3|Period 1 (6 Months)|Lack of Efficacy|0
1190244|NCT01006616|3909649|P2|Period 1 (6 Months)|Lack of Efficacy|4
1190245|NCT01006616|3909650|P1|Period 1 (6 Months)|Lack of Efficacy|3
1190246|NCT01006616|3909647|P4|Period 1 (6 Months)|Adverse Event|9
1190247|NCT01006616|3909648|P3|Period 1 (6 Months)|Adverse Event|37
1190248|NCT01006616|3909649|P2|Period 1 (6 Months)|Adverse Event|31
1190249|NCT01006616|3909650|P1|Period 1 (6 Months)|Adverse Event|10
1190250|NCT01006603|3909786|P2|Overall Study|Other|7
1190251|NCT01006603|3909787|P1|Overall Study|Other|3
1190252|NCT01006603|3909786|P2|Overall Study|Study specific discontinuation criteria|34
1190253|NCT01006603|3909787|P1|Overall Study|Study specific discontinuation criteria|33
1190254|NCT01006603|3909786|P2|Overall Study|Death|1
1190255|NCT01006603|3909787|P1|Overall Study|Death|1
1190256|NCT01006603|3909786|P2|Overall Study|Adverse Event|7
1190257|NCT01006603|3909787|P1|Overall Study|Adverse Event|15
1190258|NCT01006603|3909786|P2|Overall Study|Incorrect enrolment|2
1190259|NCT01006603|3909787|P1|Overall Study|Incorrect enrolment|0
1190260|NCT01006603|3909786|P2|Overall Study|Protocol Violation|3
1190261|NCT01006603|3909787|P1|Overall Study|Protocol Violation|1
1190262|NCT01006603|3909786|P2|Overall Study|Safety reason|1
1190263|NCT01006603|3909787|P1|Overall Study|Safety reason|1
1190264|NCT01006603|3909786|P2|Overall Study|Lost to Follow-up|1
1190265|NCT01006603|3909787|P1|Overall Study|Lost to Follow-up|0
1190266|NCT01006603|3909786|P2|Overall Study|Withdrawal by Subject|19
1190267|NCT01006603|3909787|P1|Overall Study|Withdrawal by Subject|17
1190268|NCT01006590|3909807|P2|Overall Study|Not specified|2
1190269|NCT01006590|3909808|P1|Overall Study|Not specified|3
1190270|NCT01006590|3909807|P2|Overall Study|Study specific discontinuation criteria|23
1190271|NCT01006590|3909808|P1|Overall Study|Study specific discontinuation criteria|16
1190272|NCT01006590|3909807|P2|Overall Study|Withdrawal by Subject|2
1190273|NCT01006590|3909808|P1|Overall Study|Withdrawal by Subject|4
1190274|NCT01006590|3909807|P2|Overall Study|Protocol Violation|0
1190275|NCT01006590|3909808|P1|Overall Study|Protocol Violation|1
1190276|NCT01006590|3909807|P2|Overall Study|Lost to Follow-up|1
1190277|NCT01006590|3909808|P1|Overall Study|Lost to Follow-up|1
1190278|NCT01006590|3909807|P2|Overall Study|Death|1
1190279|NCT01006590|3909808|P1|Overall Study|Death|1
1190280|NCT01006590|3909807|P2|Overall Study|Adverse Event|3
1190281|NCT01006590|3909808|P1|Overall Study|Adverse Event|2
1190282|NCT01006356|3909824|P1|Overall Study|Other|23
1190283|NCT01006356|3909824|P1|Overall Study|Protocol Violation|3
1190284|NCT01006356|3909824|P1|Overall Study|Choice by participants|2
1190285|NCT01006356|3909824|P1|Overall Study|Withdrawal by Subject|1
1190286|NCT01006356|3909824|P1|Overall Study|Paticipants did not cooperate|6
1190287|NCT01006356|3909824|P1|Overall Study|Physician Decision|1
1190288|NCT01006356|3909824|P1|Overall Study|Adverse Event|6
1190289|NCT01006291|3909839|P3|Overall Study|Other|17
1190290|NCT01006291|3909840|P2|Overall Study|Other|14
1190291|NCT01006291|3909841|P1|Overall Study|Other|14
1190292|NCT01006291|3909839|P3|Overall Study|Withdrawal criteria|4
1190293|NCT01006291|3909840|P2|Overall Study|Withdrawal criteria|4
1190294|NCT01006291|3909841|P1|Overall Study|Withdrawal criteria|5
1190295|NCT01006291|3909839|P3|Overall Study|Protocol Violation|3
1190296|NCT01006291|3909840|P2|Overall Study|Protocol Violation|3
1190297|NCT01006291|3909841|P1|Overall Study|Protocol Violation|3
1190298|NCT01006291|3909839|P3|Overall Study|Lack of Efficacy|1
1190299|NCT01006291|3909840|P2|Overall Study|Lack of Efficacy|2
1190300|NCT01006291|3909841|P1|Overall Study|Lack of Efficacy|2
1190301|NCT01006291|3909839|P3|Overall Study|Adverse Event|2
1190302|NCT01006291|3909840|P2|Overall Study|Adverse Event|1
1190303|NCT01006291|3909841|P1|Overall Study|Adverse Event|2
1190304|NCT01006135|3909891|P1|Overall Study|Other|72
1190305|NCT01006135|3909891|P1|Overall Study|Lost to Follow-up|32
1190306|NCT01006135|3909891|P1|Overall Study|Protocol Violation|14
1190307|NCT01006135|3909891|P1|Overall Study|Adverse Event|22
1190308|NCT01006122|3909898|P2|Second Double-blind Intervention Period|Death|1
1190309|NCT01006122|3909899|P1|Second Double-blind Intervention Period|Death|0
1190310|NCT01006122|3909898|P2|Second Double-blind Intervention Period|Withdrawal by Subject|2
1190311|NCT01006122|3909899|P1|Second Double-blind Intervention Period|Withdrawal by Subject|0
1190312|NCT01006122|3909898|P2|Second Double-blind Intervention Period|Lost to Follow-up|3
1190313|NCT01006122|3909899|P1|Second Double-blind Intervention Period|Lost to Follow-up|0
1190314|NCT01006122|3909898|P2|Second Double-blind Intervention Period|Protocol Violation|0
1190315|NCT01006122|3909899|P1|Second Double-blind Intervention Period|Protocol Violation|1
1190316|NCT01006122|3909898|P2|Second Double-blind Intervention Period|Adverse Event|1
1190317|NCT01006122|3909899|P1|Second Double-blind Intervention Period|Adverse Event|1
1190318|NCT01006122|3909898|P2|First Double-blind Intervention Period|Adverse Event|4
1190319|NCT01006122|3909899|P1|First Double-blind Intervention Period|Adverse Event|0
1190320|NCT01006122|3909898|P2|First Double-blind Intervention Period|Other|0
1190321|NCT01006122|3909899|P1|First Double-blind Intervention Period|Other|3
1190322|NCT01006122|3909898|P2|First Double-blind Intervention Period|Lack of Efficacy|1
1190323|NCT01006122|3909899|P1|First Double-blind Intervention Period|Lack of Efficacy|2
1190324|NCT01006122|3909898|P2|First Double-blind Intervention Period|Does not meet entrance criteria|0
1190325|NCT01006122|3909899|P1|First Double-blind Intervention Period|Does not meet entrance criteria|1
1190326|NCT01006122|3909898|P2|First Double-blind Intervention Period|Withdrawal by Subject|8
1190327|NCT01006122|3909899|P1|First Double-blind Intervention Period|Withdrawal by Subject|9
1190328|NCT01006122|3909898|P2|First Double-blind Intervention Period|Pregnancy|1
1190329|NCT01006122|3909899|P1|First Double-blind Intervention Period|Pregnancy|0
1190330|NCT01006122|3909898|P2|First Double-blind Intervention Period|Protocol Violation|1
1190331|NCT01006122|3909899|P1|First Double-blind Intervention Period|Protocol Violation|1
1190332|NCT01006122|3909898|P2|First Double-blind Intervention Period|Lost to Follow-up|2
1190333|NCT01006122|3909899|P1|First Double-blind Intervention Period|Lost to Follow-up|0
1190334|NCT01005966|3909950|P5|Treatment Period 4 (14 Days)|Other Reason|1
1190335|NCT01005966|3909951|P4|Treatment Period 4 (14 Days)|Other Reason|0
1190336|NCT01005966|3909952|P3|Treatment Period 4 (14 Days)|Other Reason|0
1190337|NCT01005966|3909953|P2|Treatment Period 4 (14 Days)|Other Reason|0
1190338|NCT01005966|3909954|P1|Treatment Period 4 (14 Days)|Other Reason|0
1190339|NCT01005966|3909950|P5|Treatment Period 4 (14 Days)|Protocol Violation|0
1190340|NCT01005966|3909951|P4|Treatment Period 4 (14 Days)|Protocol Violation|0
1190341|NCT01005966|3909952|P3|Treatment Period 4 (14 Days)|Protocol Violation|0
1190342|NCT01005966|3909953|P2|Treatment Period 4 (14 Days)|Protocol Violation|1
1190343|NCT01005966|3909954|P1|Treatment Period 4 (14 Days)|Protocol Violation|0
1190344|NCT01005966|3909950|P5|Treatment Period 3 (14 Days)|Protocol Violation|1
1190345|NCT01005966|3909951|P4|Treatment Period 3 (14 Days)|Protocol Violation|0
1190346|NCT01005966|3909952|P3|Treatment Period 3 (14 Days)|Protocol Violation|0
1190347|NCT01005966|3909953|P2|Treatment Period 3 (14 Days)|Protocol Violation|1
1190348|NCT01005966|3909954|P1|Treatment Period 3 (14 Days)|Protocol Violation|0
1190349|NCT01005966|3909950|P5|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
1190350|NCT01005966|3909951|P4|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
1190351|NCT01005966|3909952|P3|Treatment Period 2 (14 Days)|Withdrawal by Subject|1
1190352|NCT01005966|3909953|P2|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
1190353|NCT01005966|3909954|P1|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
1190354|NCT01005966|3909950|P5|Treatment Period 2 (14 Days)|Protocol Violation|0
1190355|NCT01005966|3909951|P4|Treatment Period 2 (14 Days)|Protocol Violation|1
1190356|NCT01005966|3909952|P3|Treatment Period 2 (14 Days)|Protocol Violation|0
1190357|NCT01005966|3909953|P2|Treatment Period 2 (14 Days)|Protocol Violation|0
1190358|NCT01005966|3909954|P1|Treatment Period 2 (14 Days)|Protocol Violation|0
1190359|NCT01005966|3909950|P5|Treatment Period 2 (14 Days)|Adverse Event|0
1190360|NCT01005966|3909951|P4|Treatment Period 2 (14 Days)|Adverse Event|0
1190361|NCT01005966|3909952|P3|Treatment Period 2 (14 Days)|Adverse Event|1
1190362|NCT01005966|3909953|P2|Treatment Period 2 (14 Days)|Adverse Event|1
1190363|NCT01005966|3909954|P1|Treatment Period 2 (14 Days)|Adverse Event|0
1190364|NCT01005966|3909950|P5|Washout Period 1 (4 Days)|Withdrawal by Subject|0
1190365|NCT01005966|3909951|P4|Washout Period 1 (4 Days)|Withdrawal by Subject|1
1190366|NCT01005966|3909952|P3|Washout Period 1 (4 Days)|Withdrawal by Subject|0
1190367|NCT01005966|3909953|P2|Washout Period 1 (4 Days)|Withdrawal by Subject|0
1190368|NCT01005966|3909954|P1|Washout Period 1 (4 Days)|Withdrawal by Subject|0
1190369|NCT01005966|3909950|P5|Treatment Period 1 (14 Days)|Protocol Violation|0
1190370|NCT01005966|3909951|P4|Treatment Period 1 (14 Days)|Protocol Violation|0
1190371|NCT01005966|3909952|P3|Treatment Period 1 (14 Days)|Protocol Violation|1
1190372|NCT01005966|3909953|P2|Treatment Period 1 (14 Days)|Protocol Violation|0
1190373|NCT01005966|3909954|P1|Treatment Period 1 (14 Days)|Protocol Violation|1
1190374|NCT01005966|3909950|P5|Treatment Period 1 (14 Days)|Adverse Event|0
1190375|NCT01005966|3909951|P4|Treatment Period 1 (14 Days)|Adverse Event|0
1190376|NCT01005966|3909952|P3|Treatment Period 1 (14 Days)|Adverse Event|0
1190377|NCT01005966|3909953|P2|Treatment Period 1 (14 Days)|Adverse Event|0
1190378|NCT01005966|3909954|P1|Treatment Period 1 (14 Days)|Adverse Event|1
1190379|NCT01005914|3909974|P1|Overall Study|Withdrawal by Subject|1
1190380|NCT01005914|3909974|P1|Overall Study|Lack of Efficacy|1
1190381|NCT01005914|3909974|P1|Overall Study|Death|4
1190382|NCT01005914|3909974|P1|Overall Study|Adverse Event|4
1190383|NCT01005901|3909980|P2|Overall Study|No longer requires study drug|1
1190384|NCT01005901|3909981|P1|Overall Study|No longer requires study drug|0
1190385|NCT01005901|3909980|P2|Overall Study|Patient's inability to use the device|1
1190386|NCT01005901|3909981|P1|Overall Study|Patient's inability to use the device|1
1190387|NCT01005901|3909980|P2|Overall Study|Lost to Follow-up|2
1190388|NCT01005901|3909981|P1|Overall Study|Lost to Follow-up|1
1190389|NCT01005901|3909980|P2|Overall Study|Death|3
1190390|NCT01005901|3909981|P1|Overall Study|Death|2
1190391|NCT01005901|3909980|P2|Overall Study|Protocol Violation|3
1190392|NCT01005901|3909981|P1|Overall Study|Protocol Violation|4
1190393|NCT01005901|3909980|P2|Overall Study|Unsatisfactory therapeutic effect|5
1190394|NCT01005901|3909981|P1|Overall Study|Unsatisfactory therapeutic effect|5
1190395|NCT01005901|3909980|P2|Overall Study|Administrative problems|13
1190396|NCT01005901|3909981|P1|Overall Study|Administrative problems|21
1190397|NCT01005901|3909980|P2|Overall Study|Adverse Event|16
1190398|NCT01005901|3909981|P1|Overall Study|Adverse Event|30
1190399|NCT01005901|3909980|P2|Overall Study|Withdrawal by Subject|14
1190400|NCT01005901|3909981|P1|Overall Study|Withdrawal by Subject|38
1190401|NCT01005875|3910044|P1|Overall Study|Death|3
1190402|NCT01005745|3910061|P1|Overall Study|Inappropriate antidiuretic hormone|1
1190403|NCT01005745|3910061|P1|Overall Study|Death prior to treatment|1
1190404|NCT01005745|3910061|P1|Overall Study|Disease progressed during TIL growth|3
1190405|NCT01005745|3910061|P1|Overall Study|No TIL growth|1
1190406|NCT01005732|3910066|P1|Overall Study|Death|1
1190407|NCT01005732|3910066|P1|Overall Study|Lost to Follow-up|10
1190408|NCT01005719|3910082|P6|Period 2|Adverse Event|1
1190409|NCT01005719|3910083|P5|Period 2|Adverse Event|1
1190410|NCT01005719|3910084|P4|Period 2|Adverse Event|0
1190411|NCT01005719|3910085|P3|Period 2|Adverse Event|0
1190412|NCT01005719|3910086|P2|Period 2|Adverse Event|0
1190413|NCT01005719|3910087|P1|Period 2|Adverse Event|0
1190414|NCT01005719|3910082|P6|Period 1|Delay in completing study procedures|1
1190415|NCT01005719|3910083|P5|Period 1|Delay in completing study procedures|0
1190416|NCT01005719|3910084|P4|Period 1|Delay in completing study procedures|0
1190417|NCT01005719|3910085|P3|Period 1|Delay in completing study procedures|0
1190418|NCT01005719|3910086|P2|Period 1|Delay in completing study procedures|0
1190419|NCT01005719|3910087|P1|Period 1|Delay in completing study procedures|0
1190420|NCT01005719|3910082|P6|Period 1|Adverse Event|0
1190421|NCT01005719|3910083|P5|Period 1|Adverse Event|0
1190422|NCT01005719|3910084|P4|Period 1|Adverse Event|1
1190423|NCT01005719|3910085|P3|Period 1|Adverse Event|0
1190424|NCT01005719|3910086|P2|Period 1|Adverse Event|0
1190425|NCT01005719|3910087|P1|Period 1|Adverse Event|0
1190426|NCT01005680|3910154|P2|Overall Study|Physician Decision|1
1190427|NCT01005680|3910155|P1|Overall Study|Physician Decision|1
1190428|NCT01005680|3910154|P2|Overall Study|Withdrawal by Subject|4
1190429|NCT01005680|3910155|P1|Overall Study|Withdrawal by Subject|1
1190430|NCT01005680|3910154|P2|Overall Study|Lost to Follow-up|6
1190431|NCT01005680|3910155|P1|Overall Study|Lost to Follow-up|4
1190432|NCT01005602|3910179|P2|Overall Study|Excluded due to unreliable clinical data|0
1190433|NCT01005602|3910180|P1|Overall Study|Excluded due to unreliable clinical data|1
1190434|NCT01005329|3910268|P1|Overall Study|Ineligible or received no protocol trt.|4
1190435|NCT01005316|3910281|P4|Overall Study|Retransplanted|0
1190436|NCT01005316|3910282|P3|Overall Study|Retransplanted|0
1190437|NCT01005316|3910283|P2|Overall Study|Retransplanted|1
1190438|NCT01005316|3910284|P1|Overall Study|Retransplanted|0
1190439|NCT01005316|3910281|P4|Overall Study|Transferred Care|3
1190440|NCT01005316|3910282|P3|Overall Study|Transferred Care|1
1190441|NCT01005316|3910283|P2|Overall Study|Transferred Care|0
1190442|NCT01005316|3910284|P1|Overall Study|Transferred Care|1
1190443|NCT01005316|3910281|P4|Overall Study|Delisted|0
1190444|NCT01005316|3910282|P3|Overall Study|Delisted|0
1190445|NCT01005316|3910283|P2|Overall Study|Delisted|0
1190446|NCT01005316|3910284|P1|Overall Study|Delisted|8
1190447|NCT01005316|3910281|P4|Overall Study|Consented to Another Study|0
1190448|NCT01005316|3910282|P3|Overall Study|Consented to Another Study|0
1190449|NCT01005316|3910283|P2|Overall Study|Consented to Another Study|0
1190450|NCT01005316|3910284|P1|Overall Study|Consented to Another Study|2
1190451|NCT01005316|3910281|P4|Overall Study|Withdrawal by Subject|2
1190452|NCT01005316|3910282|P3|Overall Study|Withdrawal by Subject|0
1190453|NCT01005316|3910283|P2|Overall Study|Withdrawal by Subject|1
1190454|NCT01005316|3910284|P1|Overall Study|Withdrawal by Subject|1
1190455|NCT01005316|3910281|P4|Overall Study|Sponsor Decision|0
1190456|NCT01005316|3910282|P3|Overall Study|Sponsor Decision|0
1190457|NCT01005316|3910283|P2|Overall Study|Sponsor Decision|3
1190458|NCT01005316|3910284|P1|Overall Study|Sponsor Decision|6
1190459|NCT01005316|3910281|P4|Overall Study|Physician Decision|0
1190460|NCT01005316|3910282|P3|Overall Study|Physician Decision|0
1190461|NCT01005316|3910283|P2|Overall Study|Physician Decision|0
1190462|NCT01005316|3910284|P1|Overall Study|Physician Decision|6
1190463|NCT01005316|3910281|P4|Overall Study|Lost to Follow-up|2
1190464|NCT01005316|3910282|P3|Overall Study|Lost to Follow-up|0
1190465|NCT01005316|3910283|P2|Overall Study|Lost to Follow-up|3
1190466|NCT01005316|3910284|P1|Overall Study|Lost to Follow-up|1
1190467|NCT01005316|3910281|P4|Overall Study|Study Termination|85
1190468|NCT01005316|3910282|P3|Overall Study|Study Termination|9
1190469|NCT01005316|3910283|P2|Overall Study|Study Termination|63
1190470|NCT01005316|3910284|P1|Overall Study|Study Termination|5
1190471|NCT01005316|3910281|P4|Overall Study|Death|15
1190472|NCT01005316|3910282|P3|Overall Study|Death|1
1190473|NCT01005316|3910283|P2|Overall Study|Death|5
1190474|NCT01005316|3910284|P1|Overall Study|Death|20
1190475|NCT01005316|3910281|P4|Overall Study|Adverse Event|1
1190476|NCT01005316|3910282|P3|Overall Study|Adverse Event|0
1190477|NCT01005316|3910283|P2|Overall Study|Adverse Event|0
1190478|NCT01005316|3910284|P1|Overall Study|Adverse Event|0
1190479|NCT01005251|3910351|P5|Overall Study|Lack of Efficacy|0
1190480|NCT01005251|3910352|P4|Overall Study|Lack of Efficacy|1
1190481|NCT01005251|3910353|P3|Overall Study|Lack of Efficacy|1
1190482|NCT01005251|3910354|P2|Overall Study|Lack of Efficacy|0
1190483|NCT01005251|3910355|P1|Overall Study|Lack of Efficacy|0
1190484|NCT01005251|3910351|P5|Overall Study|Randomized in error|0
1190485|NCT01005251|3910352|P4|Overall Study|Randomized in error|1
1190486|NCT01005251|3910353|P3|Overall Study|Randomized in error|1
1190487|NCT01005251|3910354|P2|Overall Study|Randomized in error|0
1190488|NCT01005251|3910355|P1|Overall Study|Randomized in error|0
1190489|NCT01005251|3910351|P5|Overall Study|Wrong drug dispensed|0
1190490|NCT01005251|3910352|P4|Overall Study|Wrong drug dispensed|0
1190491|NCT01005251|3910353|P3|Overall Study|Wrong drug dispensed|0
1190492|NCT01005251|3910354|P2|Overall Study|Wrong drug dispensed|1
1190493|NCT01005251|3910355|P1|Overall Study|Wrong drug dispensed|0
1190494|NCT01005251|3910351|P5|Overall Study|Patient moved|0
1190495|NCT01005251|3910352|P4|Overall Study|Patient moved|0
1190496|NCT01005251|3910353|P3|Overall Study|Patient moved|0
1190497|NCT01005251|3910354|P2|Overall Study|Patient moved|0
1190498|NCT01005251|3910355|P1|Overall Study|Patient moved|1
1190499|NCT01005251|3910351|P5|Overall Study|Physician Decision|2
1190500|NCT01005251|3910352|P4|Overall Study|Physician Decision|0
1190501|NCT01005251|3910353|P3|Overall Study|Physician Decision|0
1190502|NCT01005251|3910354|P2|Overall Study|Physician Decision|0
1190503|NCT01005251|3910355|P1|Overall Study|Physician Decision|0
1190504|NCT01005251|3910351|P5|Overall Study|Lost to Follow-up|0
1190505|NCT01005251|3910352|P4|Overall Study|Lost to Follow-up|0
1190506|NCT01005251|3910353|P3|Overall Study|Lost to Follow-up|2
1190507|NCT01005251|3910354|P2|Overall Study|Lost to Follow-up|4
1190508|NCT01005251|3910355|P1|Overall Study|Lost to Follow-up|1
1190509|NCT01005251|3910351|P5|Overall Study|Developed study-specific withdrawal crit|1
1190510|NCT01005251|3910352|P4|Overall Study|Developed study-specific withdrawal crit|0
1190511|NCT01005251|3910353|P3|Overall Study|Developed study-specific withdrawal crit|3
1190512|NCT01005251|3910354|P2|Overall Study|Developed study-specific withdrawal crit|0
1190513|NCT01005251|3910355|P1|Overall Study|Developed study-specific withdrawal crit|2
1190514|NCT01005251|3910351|P5|Overall Study|Protocol Violation|2
1190515|NCT01005251|3910352|P4|Overall Study|Protocol Violation|0
1190516|NCT01005251|3910353|P3|Overall Study|Protocol Violation|0
1190517|NCT01005251|3910354|P2|Overall Study|Protocol Violation|0
1190518|NCT01005251|3910355|P1|Overall Study|Protocol Violation|1
1190519|NCT01005251|3910351|P5|Overall Study|Adverse Event|4
1190520|NCT01005251|3910352|P4|Overall Study|Adverse Event|5
1190521|NCT01005251|3910353|P3|Overall Study|Adverse Event|8
1190522|NCT01005251|3910354|P2|Overall Study|Adverse Event|6
1190523|NCT01005251|3910355|P1|Overall Study|Adverse Event|2
1190524|NCT01005251|3910351|P5|Overall Study|Eligibility criteria not fulfilled|0
1190525|NCT01005251|3910352|P4|Overall Study|Eligibility criteria not fulfilled|1
1190526|NCT01005251|3910353|P3|Overall Study|Eligibility criteria not fulfilled|4
1190527|NCT01005251|3910354|P2|Overall Study|Eligibility criteria not fulfilled|0
1190528|NCT01005251|3910355|P1|Overall Study|Eligibility criteria not fulfilled|4
1190529|NCT01005251|3910351|P5|Overall Study|Withdrawal by Subject|9
1190530|NCT01005251|3910352|P4|Overall Study|Withdrawal by Subject|4
1190531|NCT01005251|3910353|P3|Overall Study|Withdrawal by Subject|3
1190532|NCT01005251|3910354|P2|Overall Study|Withdrawal by Subject|5
1190533|NCT01005251|3910355|P1|Overall Study|Withdrawal by Subject|2
1190534|NCT01004848|3910428|P2|Overall Study|Lost to Follow-up|45
1190535|NCT01004848|3910429|P1|Overall Study|Lost to Follow-up|55
1190536|NCT01004822|3910467|P8|Overall Study|Other|0
1190537|NCT01004822|3910468|P7|Overall Study|Other|0
1190538|NCT01004822|3910469|P6|Overall Study|Other|1
1190539|NCT01004822|3910470|P5|Overall Study|Other|0
1190540|NCT01004822|3910471|P4|Overall Study|Other|1
1190541|NCT01004822|3910472|P3|Overall Study|Other|4
1190542|NCT01004822|3910473|P2|Overall Study|Other|0
1190543|NCT01004822|3910474|P1|Overall Study|Other|0
1190544|NCT01004822|3910467|P8|Overall Study|Adverse Event|1
1190545|NCT01004822|3910468|P7|Overall Study|Adverse Event|1
1190546|NCT01004822|3910469|P6|Overall Study|Adverse Event|0
1190547|NCT01004822|3910470|P5|Overall Study|Adverse Event|0
1190548|NCT01004822|3910471|P4|Overall Study|Adverse Event|0
1190549|NCT01004822|3910472|P3|Overall Study|Adverse Event|0
1190550|NCT01004822|3910473|P2|Overall Study|Adverse Event|0
1190551|NCT01004822|3910474|P1|Overall Study|Adverse Event|0
1190552|NCT01004822|3910467|P8|Overall Study|No longer willing to continue|0
1190553|NCT01004822|3910468|P7|Overall Study|No longer willing to continue|1
1190554|NCT01004822|3910469|P6|Overall Study|No longer willing to continue|1
1190555|NCT01004822|3910470|P5|Overall Study|No longer willing to continue|2
1190556|NCT01004822|3910471|P4|Overall Study|No longer willing to continue|1
1190557|NCT01004822|3910472|P3|Overall Study|No longer willing to continue|0
1190558|NCT01004822|3910473|P2|Overall Study|No longer willing to continue|0
1190559|NCT01004822|3910474|P1|Overall Study|No longer willing to continue|0
1190560|NCT01004822|3910467|P8|Overall Study|Global deterioration of health status|0
1190561|NCT01004822|3910468|P7|Overall Study|Global deterioration of health status|1
1190562|NCT01004822|3910469|P6|Overall Study|Global deterioration of health status|0
1190563|NCT01004822|3910470|P5|Overall Study|Global deterioration of health status|0
1190564|NCT01004822|3910471|P4|Overall Study|Global deterioration of health status|1
1190565|NCT01004822|3910472|P3|Overall Study|Global deterioration of health status|0
1190566|NCT01004822|3910473|P2|Overall Study|Global deterioration of health status|0
1190567|NCT01004822|3910474|P1|Overall Study|Global deterioration of health status|0
1190568|NCT01004822|3910467|P8|Overall Study|Objective progression or relapse|4
1190569|NCT01004822|3910468|P7|Overall Study|Objective progression or relapse|1
1190570|NCT01004822|3910469|P6|Overall Study|Objective progression or relapse|2
1190571|NCT01004822|3910470|P5|Overall Study|Objective progression or relapse|2
1190572|NCT01004822|3910471|P4|Overall Study|Objective progression or relapse|1
1190573|NCT01004822|3910472|P3|Overall Study|Objective progression or relapse|0
1190574|NCT01004822|3910473|P2|Overall Study|Objective progression or relapse|3
1190575|NCT01004822|3910474|P1|Overall Study|Objective progression or relapse|3
1190576|NCT01004614|3910639|P4|Washout|Withdrawal by Subject|0
1190577|NCT01004614|3910640|P3|Washout|Withdrawal by Subject|0
1190578|NCT01004614|3910641|P2|Washout|Withdrawal by Subject|1
1190579|NCT01004614|3910642|P1|Washout|Withdrawal by Subject|0
1190580|NCT01004510|3910676|P1|Overall Study|Adverse Event|1
1190581|NCT01004432|3910680|P5|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10
1190582|NCT01004432|3910681|P4|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
1190583|NCT01004432|3910682|P3|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
1190584|NCT01004432|3910683|P2|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
1190585|NCT01004432|3910684|P1|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
1190586|NCT01004432|3910680|P5|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2
1190587|NCT01004432|3910681|P4|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
1190588|NCT01004432|3910682|P3|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
1190589|NCT01004432|3910683|P2|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
1190590|NCT01004432|3910684|P1|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
1190591|NCT01004432|3910680|P5|OL Study Extension (Week 52 - 76)|Protocol Violation|4
1190592|NCT01004432|3910681|P4|OL Study Extension (Week 52 - 76)|Protocol Violation|0
1190593|NCT01004432|3910682|P3|OL Study Extension (Week 52 - 76)|Protocol Violation|0
1190594|NCT01004432|3910683|P2|OL Study Extension (Week 52 - 76)|Protocol Violation|0
1190595|NCT01004432|3910684|P1|OL Study Extension (Week 52 - 76)|Protocol Violation|0
1190596|NCT01004432|3910680|P5|OL Study Extension (Week 52 - 76)|Adverse Event|2
1190597|NCT01004432|3910681|P4|OL Study Extension (Week 52 - 76)|Adverse Event|0
1190598|NCT01004432|3910682|P3|OL Study Extension (Week 52 - 76)|Adverse Event|0
1190599|NCT01004432|3910683|P2|OL Study Extension (Week 52 - 76)|Adverse Event|0
1190600|NCT01004432|3910684|P1|OL Study Extension (Week 52 - 76)|Adverse Event|0
1190601|NCT01004432|3910680|P5|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
1190602|NCT01004432|3910681|P4|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
1190603|NCT01004432|3910682|P3|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1
1190604|NCT01004432|3910683|P2|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
1190605|NCT01004432|3910684|P1|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
1190606|NCT01004432|3910680|P5|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
1190607|NCT01004432|3910681|P4|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37
1190608|NCT01004432|3910682|P3|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24
1190609|NCT01004432|3910683|P2|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2
1190610|NCT01004432|3910684|P1|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
1190611|NCT01004432|3910680|P5|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
1190612|NCT01004432|3910681|P4|OL/Double-Blind (DB) Period (Week 16-52)|Death|1
1190613|NCT01004432|3910682|P3|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
1190614|NCT01004432|3910683|P2|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
1190615|NCT01004432|3910684|P1|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
1190616|NCT01004432|3910680|P5|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
1190617|NCT01004432|3910681|P4|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7
1190618|NCT01004432|3910682|P3|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4
1190619|NCT01004432|3910683|P2|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1
1190620|NCT01004432|3910684|P1|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
1190621|NCT01004432|3910680|P5|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
1190622|NCT01004432|3910681|P4|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4
1190623|NCT01004432|3910682|P3|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
1190624|NCT01004432|3910683|P2|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
1190625|NCT01004432|3910684|P1|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
1190626|NCT01004432|3910680|P5|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
1190627|NCT01004432|3910681|P4|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6
1190628|NCT01004432|3910682|P3|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5
1190629|NCT01004432|3910683|P2|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1
1190630|NCT01004432|3910684|P1|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
1190631|NCT01004432|3910680|P5|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
1190632|NCT01004432|3910681|P4|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
1190633|NCT01004432|3910682|P3|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
1190634|NCT01004432|3910683|P2|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
1190635|NCT01004432|3910684|P1|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|2
1190636|NCT01004432|3910680|P5|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
1190637|NCT01004432|3910681|P4|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
1190638|NCT01004432|3910682|P3|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
1190639|NCT01004432|3910683|P2|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
1190640|NCT01004432|3910684|P1|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|15
1190641|NCT01004432|3910680|P5|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
1190642|NCT01004432|3910681|P4|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
1190727|NCT01004003|3910872|P3|Overall Study|Progressive disease|1
1190643|NCT01004432|3910682|P3|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
1190644|NCT01004432|3910683|P2|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
1190645|NCT01004432|3910684|P1|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|17
1190646|NCT01004432|3910680|P5|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
1190647|NCT01004432|3910681|P4|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
1190648|NCT01004432|3910682|P3|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
1190649|NCT01004432|3910683|P2|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
1190650|NCT01004432|3910684|P1|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|29
1190651|NCT01004432|3910680|P5|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
1190652|NCT01004432|3910681|P4|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
1190653|NCT01004432|3910682|P3|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
1190654|NCT01004432|3910683|P2|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
1190655|NCT01004432|3910684|P1|Open-label (OL) Period (Week 0 – 16)|Adverse Event|20
1190656|NCT01004263|3910727|P1|Overall Study|Lack of Qualifying Event|2
1190657|NCT01004263|3910727|P1|Overall Study|Physician Decision|15
1190658|NCT01004263|3910727|P1|Overall Study|Pregnancy|2
1190659|NCT01004263|3910727|P1|Overall Study|Lack of Efficacy|13
1190660|NCT01004263|3910727|P1|Overall Study|Lost to Follow-up|64
1190661|NCT01004263|3910727|P1|Overall Study|Protocol Violation|10
1190662|NCT01004263|3910727|P1|Overall Study|Withdrawal by Subject|58
1190663|NCT01004263|3910727|P1|Overall Study|Adverse Event|15
1190664|NCT01004250|3910735|P1|Follow-Up (FU) Period|Lost to Follow-up|1
1190665|NCT01004250|3910735|P1|Maintenance Therapy Period|Physician Decision|4
1190666|NCT01004250|3910735|P1|Maintenance Therapy Period|Withdrawal by Subject|5
1190667|NCT01004250|3910735|P1|Maintenance Therapy Period|Protocol Violation|1
1190668|NCT01004250|3910735|P1|Maintenance Therapy Period|Lost to Follow-up|1
1190669|NCT01004250|3910735|P1|Maintenance Therapy Period|Adverse Event|15
1190670|NCT01004250|3910735|P1|Induction Therapy Period|Physician Decision|2
1190671|NCT01004250|3910735|P1|Induction Therapy Period|Withdrawal by Subject|2
1190672|NCT01004250|3910735|P1|Induction Therapy Period|Entry Criteria Not Met|1
1190673|NCT01004250|3910735|P1|Induction Therapy Period|Adverse Event|10
1190674|NCT01004185|3910747|P2|Overall Study|Withdrawal by Subject|1
1190675|NCT01004185|3910748|P1|Overall Study|Withdrawal by Subject|2
1190676|NCT01004185|3910747|P2|Overall Study|Sponsor Terminated Study|5
1190677|NCT01004185|3910748|P1|Overall Study|Sponsor Terminated Study|4
1190678|NCT01004185|3910747|P2|Overall Study|Lack of Efficacy|1
1190679|NCT01004185|3910748|P1|Overall Study|Lack of Efficacy|2
1190680|NCT01004185|3910747|P2|Overall Study|Lost to Follow-up|1
1190681|NCT01004185|3910748|P1|Overall Study|Lost to Follow-up|0
1190682|NCT01004185|3910747|P2|Overall Study|Adverse Event|1
1190683|NCT01004185|3910748|P1|Overall Study|Adverse Event|1
1190684|NCT01004172|3910756|P1|Overall Study|Symptomatic Deterioration|2
1190685|NCT01004172|3910756|P1|Overall Study|Physician Decision|1
1190686|NCT01004172|3910756|P1|Overall Study|Adverse Event|1
1190687|NCT01004172|3910756|P1|Overall Study|Progressive Disease in CNS and Non-CNS|2
1190688|NCT01004172|3910756|P1|Overall Study|Progressive Disease in Non-CNS Only|16
1190689|NCT01004172|3910756|P1|Overall Study|Progressive Disease in CNS Only|16
1190690|NCT01004159|3910764|P1|Overall Study|Disease Progression|18
1190691|NCT01004159|3910764|P1|Overall Study|Adverse Event|2
1190692|NCT01004146|3910771|P2|Overall Study|Withdrawal by Subject|5
1190693|NCT01004146|3910772|P1|Overall Study|Withdrawal by Subject|4
1190694|NCT01004003|3910866|P9|Overall Study|Other|0
1190695|NCT01004003|3910867|P8|Overall Study|Other|0
1190696|NCT01004003|3910868|P7|Overall Study|Other|0
1190697|NCT01004003|3910869|P6|Overall Study|Other|1
1190698|NCT01004003|3910870|P5|Overall Study|Other|0
1190699|NCT01004003|3910871|P4|Overall Study|Other|0
1190700|NCT01004003|3910872|P3|Overall Study|Other|0
1190701|NCT01004003|3910873|P2|Overall Study|Other|0
1190702|NCT01004003|3910874|P1|Overall Study|Other|0
1190703|NCT01004003|3910866|P9|Overall Study|Refused to continue taking trial med.|2
1190704|NCT01004003|3910867|P8|Overall Study|Refused to continue taking trial med.|0
1190705|NCT01004003|3910868|P7|Overall Study|Refused to continue taking trial med.|0
1190706|NCT01004003|3910869|P6|Overall Study|Refused to continue taking trial med.|0
1190707|NCT01004003|3910870|P5|Overall Study|Refused to continue taking trial med.|0
1190708|NCT01004003|3910871|P4|Overall Study|Refused to continue taking trial med.|0
1190709|NCT01004003|3910872|P3|Overall Study|Refused to continue taking trial med.|0
1190710|NCT01004003|3910873|P2|Overall Study|Refused to continue taking trial med.|0
1190711|NCT01004003|3910874|P1|Overall Study|Refused to continue taking trial med.|0
1190712|NCT01004003|3910866|P9|Overall Study|Adverse Event|6
1190713|NCT01004003|3910867|P8|Overall Study|Adverse Event|21
1190714|NCT01004003|3910868|P7|Overall Study|Adverse Event|7
1190715|NCT01004003|3910869|P6|Overall Study|Adverse Event|2
1190716|NCT01004003|3910870|P5|Overall Study|Adverse Event|2
1190717|NCT01004003|3910871|P4|Overall Study|Adverse Event|3
1190718|NCT01004003|3910872|P3|Overall Study|Adverse Event|3
1190719|NCT01004003|3910873|P2|Overall Study|Adverse Event|2
1190720|NCT01004003|3910874|P1|Overall Study|Adverse Event|4
1190721|NCT01004003|3910866|P9|Overall Study|Progressive disease|22
1190722|NCT01004003|3910867|P8|Overall Study|Progressive disease|39
1190723|NCT01004003|3910868|P7|Overall Study|Progressive disease|1
1190724|NCT01004003|3910869|P6|Overall Study|Progressive disease|1
1190725|NCT01004003|3910870|P5|Overall Study|Progressive disease|2
1190726|NCT01004003|3910871|P4|Overall Study|Progressive disease|0
1190728|NCT01004003|3910873|P2|Overall Study|Progressive disease|1
1190729|NCT01004003|3910874|P1|Overall Study|Progressive disease|2
1190730|NCT01003990|3910905|P3|Overall Study|Subject Withdrew Consent|7
1190731|NCT01003990|3910906|P2|Overall Study|Subject Withdrew Consent|5
1190732|NCT01003990|3910907|P1|Overall Study|Subject Withdrew Consent|12
1190733|NCT01003990|3910905|P3|Overall Study|No Longer Met Study Criteria|0
1190734|NCT01003990|3910906|P2|Overall Study|No Longer Met Study Criteria|1
1190735|NCT01003990|3910907|P1|Overall Study|No Longer Met Study Criteria|4
1190736|NCT01003990|3910905|P3|Overall Study|Pregnancy|4
1190737|NCT01003990|3910906|P2|Overall Study|Pregnancy|2
1190738|NCT01003990|3910907|P1|Overall Study|Pregnancy|10
1190739|NCT01003990|3910905|P3|Overall Study|Poor/Non-compliance|2
1190740|NCT01003990|3910906|P2|Overall Study|Poor/Non-compliance|3
1190741|NCT01003990|3910907|P1|Overall Study|Poor/Non-compliance|4
1190742|NCT01003990|3910905|P3|Overall Study|Reasons Not Identified|8
1190743|NCT01003990|3910906|P2|Overall Study|Reasons Not Identified|13
1190744|NCT01003990|3910907|P1|Overall Study|Reasons Not Identified|14
1190745|NCT01003990|3910905|P3|Overall Study|Lost to Follow-up|7
1190746|NCT01003990|3910906|P2|Overall Study|Lost to Follow-up|12
1190747|NCT01003990|3910907|P1|Overall Study|Lost to Follow-up|30
1190748|NCT01003990|3910905|P3|Overall Study|Lack of Efficacy|3
1190749|NCT01003990|3910906|P2|Overall Study|Lack of Efficacy|2
1190750|NCT01003990|3910907|P1|Overall Study|Lack of Efficacy|10
1190751|NCT01003990|3910905|P3|Overall Study|Death|1
1190752|NCT01003990|3910906|P2|Overall Study|Death|8
1190753|NCT01003990|3910907|P1|Overall Study|Death|0
1190754|NCT01003990|3910905|P3|Overall Study|Adverse Event|11
1190755|NCT01003990|3910906|P2|Overall Study|Adverse Event|5
1190756|NCT01003990|3910907|P1|Overall Study|Adverse Event|8
1190757|NCT01003899|3910924|P1|Overall Study|Progressive disease|34
1190758|NCT01003899|3910924|P1|Overall Study|Not treated|1
1190759|NCT01003899|3910924|P1|Overall Study|Not entered|4
1190760|NCT01003899|3910924|P1|Overall Study|Other Adverse Event|8
1190761|NCT01003886|3910933|P1|Overall Study|Adverse Event|3
1190762|NCT01003886|3910933|P1|Overall Study|Other|14
1190763|NCT01003886|3910933|P1|Overall Study|Withdrawal by Subject|39
1190764|NCT01003886|3910933|P1|Overall Study|Lost to Follow-up|169
1190765|NCT01003886|3910933|P1|Overall Study|Lack of Efficacy|5
1190766|NCT01003639|3910944|P2|Overall Study|Physician Decision|0
1190767|NCT01003639|3910945|P1|Overall Study|Physician Decision|1
1190768|NCT01003639|3910944|P2|Overall Study|Protocol Violation|1
1190769|NCT01003639|3910945|P1|Overall Study|Protocol Violation|0
1190770|NCT01003639|3910944|P2|Overall Study|Adverse Event|1
1190771|NCT01003639|3910945|P1|Overall Study|Adverse Event|0
1190772|NCT01003639|3910944|P2|Overall Study|Lack of Efficacy|6
1190773|NCT01003639|3910945|P1|Overall Study|Lack of Efficacy|1
1190774|NCT01003639|3910944|P2|Overall Study|Withdrawal by Subject|5
1190775|NCT01003639|3910945|P1|Overall Study|Withdrawal by Subject|9
1190776|NCT01003639|3910944|P2|Overall Study|Lost to Follow-up|9
1190777|NCT01003639|3910945|P1|Overall Study|Lost to Follow-up|6
1190778|NCT01003249|3910982|P2|Second Intervention (4 Weeks)|Adverse Event|0
1190779|NCT01003249|3910983|P1|Second Intervention (4 Weeks)|Adverse Event|1
1190780|NCT01003249|3910982|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|1
1190781|NCT01003249|3910983|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|0
1190782|NCT01003249|3910982|P2|First Intervention (4 Weeks)|Non-Serious Event|1
1190783|NCT01003249|3910983|P1|First Intervention (4 Weeks)|Non-Serious Event|1
1190784|NCT01003249|3910982|P2|First Intervention (4 Weeks)|Withdrawal by Subject|1
1190785|NCT01003249|3910983|P1|First Intervention (4 Weeks)|Withdrawal by Subject|1
1190786|NCT01003210|3911001|P2|Overall Study|Lost to Follow-up|3
1190787|NCT01003210|3911002|P1|Overall Study|Lost to Follow-up|1
1190788|NCT01003184|3911014|P2|Overall Study|Physician Decision|0
1190789|NCT01003184|3911015|P1|Overall Study|Physician Decision|1
1190790|NCT01003184|3911014|P2|Overall Study|Withdrawal by Subject|6
1190791|NCT01003184|3911015|P1|Overall Study|Withdrawal by Subject|1
1190792|NCT01003184|3911014|P2|Overall Study|Protocol Violation|0
1190793|NCT01003184|3911015|P1|Overall Study|Protocol Violation|3
1190794|NCT01003184|3911014|P2|Overall Study|Loss of glucose control|1
1190795|NCT01003184|3911015|P1|Overall Study|Loss of glucose control|1
1190796|NCT01003184|3911014|P2|Overall Study|Lost to Follow-up|0
1190797|NCT01003184|3911015|P1|Overall Study|Lost to Follow-up|1
1190798|NCT01003184|3911014|P2|Overall Study|Adverse Event|5
1190799|NCT01003184|3911015|P1|Overall Study|Adverse Event|12
1190800|NCT01002989|3911098|P1|Overall Study|exclusion criteria, no consent|5
1190801|NCT01002742|3911107|P2|Overall Study|Determined to be ineligible|1
1190802|NCT01002742|3911108|P1|Overall Study|Determined to be ineligible|0
1190803|NCT01002573|3911144|P2|Overall Study|Subject did not receive at least 1 dose|7
1190804|NCT01002573|3911145|P1|Overall Study|Subject did not receive at least 1 dose|11
1190805|NCT01002547|3911166|P3|Overall Study|Adverse Event|0
1190806|NCT01002547|3911167|P2|Overall Study|Adverse Event|0
1190807|NCT01002547|3911168|P1|Overall Study|Adverse Event|1
1190808|NCT01002547|3911166|P3|Overall Study|Death|2
1190809|NCT01002547|3911167|P2|Overall Study|Death|2
1190810|NCT01002547|3911168|P1|Overall Study|Death|0
1190811|NCT01002547|3911166|P3|Overall Study|Physician Decision|0
1190812|NCT01002547|3911167|P2|Overall Study|Physician Decision|0
1190813|NCT01002547|3911168|P1|Overall Study|Physician Decision|1
1190814|NCT01002547|3911166|P3|Overall Study|Lost to Follow-up|1
1190815|NCT01002547|3911167|P2|Overall Study|Lost to Follow-up|1
1190816|NCT01002547|3911168|P1|Overall Study|Lost to Follow-up|2
1190817|NCT01002547|3911166|P3|Overall Study|Withdrawal by Subject|5
1190818|NCT01002547|3911167|P2|Overall Study|Withdrawal by Subject|0
1190819|NCT01002547|3911168|P1|Overall Study|Withdrawal by Subject|4
1190820|NCT01002482|3911226|P2|Overall Study|Included twice|0
1190821|NCT01002482|3911227|P1|Overall Study|Included twice|1
1190822|NCT01002482|3911226|P2|Overall Study|Withdrawal by Subject|21
1190823|NCT01002482|3911227|P1|Overall Study|Withdrawal by Subject|14
1190824|NCT01002339|3911261|P3|Overall Study|Randomized. Not transplanted|1
1190825|NCT01002339|3911262|P2|Overall Study|Randomized. Not transplanted|0
1190826|NCT01002339|3911263|P1|Overall Study|Randomized. Not transplanted|0
1190827|NCT01002339|3911261|P3|Overall Study|Lung cancer detected before transplant|1
1190828|NCT01002339|3911262|P2|Overall Study|Lung cancer detected before transplant|0
1190829|NCT01002339|3911263|P1|Overall Study|Lung cancer detected before transplant|0
1190830|NCT01002339|3911261|P3|Overall Study|Protocol Violation|2
1190831|NCT01002339|3911262|P2|Overall Study|Protocol Violation|0
1190832|NCT01002339|3911263|P1|Overall Study|Protocol Violation|0
1190833|NCT01002339|3911261|P3|Overall Study|Incorrect treatment assignment|1
1190834|NCT01002339|3911262|P2|Overall Study|Incorrect treatment assignment|0
1190835|NCT01002339|3911263|P1|Overall Study|Incorrect treatment assignment|0
1190836|NCT01002339|3911261|P3|Overall Study|Withdrawal by Subject|0
1190837|NCT01002339|3911262|P2|Overall Study|Withdrawal by Subject|1
1190838|NCT01002339|3911263|P1|Overall Study|Withdrawal by Subject|0
1190839|NCT01002105|3911339|P2|Overall Study|condition worsened|2
1190840|NCT01002105|3911340|P1|Overall Study|condition worsened|4
1190841|NCT01002105|3911339|P2|Overall Study|non compliance|3
1190842|NCT01002105|3911340|P1|Overall Study|non compliance|5
1190843|NCT01002105|3911339|P2|Overall Study|Lost to Follow-up|16
1190844|NCT01002105|3911340|P1|Overall Study|Lost to Follow-up|10
1190845|NCT01001988|3911356|P1|Overall Study|Lost to Follow-up|15
1190846|NCT01001988|3911356|P1|Overall Study|Withdrawal by Subject|18
1190847|NCT01001988|3911356|P1|Overall Study|Protocol Violation|84
1190848|NCT01001832|3911374|P2|Follow-up Period|Not specified|1
1190849|NCT01001832|3911375|P1|Follow-up Period|Not specified|2
1190850|NCT01001832|3911374|P2|Follow-up Period|Follow-up no longer required /protocol|20
1190851|NCT01001832|3911375|P1|Follow-up Period|Follow-up no longer required /protocol|15
1190852|NCT01001832|3911374|P2|Follow-up Period|Withdrawal by Subject|0
1190853|NCT01001832|3911375|P1|Follow-up Period|Withdrawal by Subject|1
1190854|NCT01001832|3911374|P2|Long-term Period|Not specified|2
1190855|NCT01001832|3911375|P1|Long-term Period|Not specified|1
1190856|NCT01001832|3911374|P2|Long-term Period|Lack of Efficacy|2
1190857|NCT01001832|3911375|P1|Long-term Period|Lack of Efficacy|0
1190858|NCT01001832|3911374|P2|Long-term Period|Withdrawal by Subject|0
1190859|NCT01001832|3911375|P1|Long-term Period|Withdrawal by Subject|1
1190860|NCT01001832|3911374|P2|Long-term Period|Adverse Event|1
1190861|NCT01001832|3911375|P1|Long-term Period|Adverse Event|2
1190862|NCT01001832|3911374|P2|Short-term Period|Adverse Event|3
1190863|NCT01001832|3911375|P1|Short-term Period|Adverse Event|2
1190864|NCT01001767|3911433|P2|Overall Study|Physician Decision|0
1190865|NCT01001767|3911434|P1|Overall Study|Physician Decision|1
1190866|NCT01001767|3911433|P2|Overall Study|Lost to Follow-up|0
1190867|NCT01001767|3911434|P1|Overall Study|Lost to Follow-up|1
1190868|NCT01001767|3911433|P2|Overall Study|Protocol Violation|0
1190869|NCT01001767|3911434|P1|Overall Study|Protocol Violation|1
1190870|NCT01001767|3911433|P2|Overall Study|no baseline study performed|0
1190871|NCT01001767|3911434|P1|Overall Study|no baseline study performed|1
1190872|NCT01001702|3911440|P1|Overall Study|Lack of Efficacy per Investigator|3
1190873|NCT01001702|3911440|P1|Overall Study|Withdrawal by Subject|19
1190874|NCT01001702|3911440|P1|Overall Study|Investigator withdrew Subject|10
1190875|NCT01001702|3911440|P1|Overall Study|Subject met Withdrawal Criteria|22
1190876|NCT01001702|3911440|P1|Overall Study|Sponsor Discontinued Study|4
1190877|NCT01001702|3911440|P1|Overall Study|Adverse Event|7
1190878|NCT01001702|3911440|P1|Overall Study|Lost to Follow-up|7
1190879|NCT01001572|3911453|P3|Double-Blind Treatment Phase|Lost to Follow-up|1
1190880|NCT01001572|3911454|P2|Double-Blind Treatment Phase|Lost to Follow-up|0
1190881|NCT01001572|3911455|P1|Double-Blind Treatment Phase|Lost to Follow-up|0
1190882|NCT01001572|3911453|P3|Double-Blind Treatment Phase|Protocol deviation|1
1190883|NCT01001572|3911454|P2|Double-Blind Treatment Phase|Protocol deviation|0
1190884|NCT01001572|3911455|P1|Double-Blind Treatment Phase|Protocol deviation|0
1190885|NCT01001572|3911453|P3|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1
1190886|NCT01001572|3911454|P2|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
1190887|NCT01001572|3911455|P1|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
1190888|NCT01001572|3911453|P3|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1
1190889|NCT01001572|3911454|P2|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
1190890|NCT01001572|3911455|P1|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
1190891|NCT01001572|3911453|P3|Double-Blind Treatment Phase|Withdrawal by Subject|13
1190892|NCT01001572|3911454|P2|Double-Blind Treatment Phase|Withdrawal by Subject|8
1190893|NCT01001572|3911455|P1|Double-Blind Treatment Phase|Withdrawal by Subject|0
1190894|NCT01001572|3911453|P3|Double-Blind Treatment Phase|Adverse Event|2
1190895|NCT01001572|3911454|P2|Double-Blind Treatment Phase|Adverse Event|2
1190896|NCT01001572|3911455|P1|Double-Blind Treatment Phase|Adverse Event|0
1190897|NCT01001572|3911453|P3|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
1190898|NCT01001572|3911454|P2|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
1190899|NCT01001572|3911455|P1|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45
1190900|NCT01001572|3911453|P3|Single-Blind Valsartan 160 mg|Administrative problems|0
1190901|NCT01001572|3911454|P2|Single-Blind Valsartan 160 mg|Administrative problems|0
1190902|NCT01001572|3911455|P1|Single-Blind Valsartan 160 mg|Administrative problems|82
1190903|NCT01001572|3911453|P3|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
1190904|NCT01001572|3911454|P2|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
1190905|NCT01001572|3911455|P1|Single-Blind Valsartan 160 mg|Lost to Follow-up|4
1190906|NCT01001572|3911453|P3|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
1190907|NCT01001572|3911454|P2|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
1190908|NCT01001572|3911455|P1|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1
1190909|NCT01001572|3911453|P3|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
1190910|NCT01001572|3911454|P2|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
1190911|NCT01001572|3911455|P1|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7
1190912|NCT01001572|3911453|P3|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
1190913|NCT01001572|3911454|P2|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
1190914|NCT01001572|3911455|P1|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96
1190915|NCT01001572|3911453|P3|Single-Blind Valsartan 160 mg|Adverse Event|0
1190916|NCT01001572|3911454|P2|Single-Blind Valsartan 160 mg|Adverse Event|0
1190917|NCT01001572|3911455|P1|Single-Blind Valsartan 160 mg|Adverse Event|11
1190918|NCT01001572|3911453|P3|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
1190919|NCT01001572|3911454|P2|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
1190920|NCT01001572|3911455|P1|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32
1190921|NCT01001520|3911493|P2|Medication Period 2|Withdrawal by Subject|3
1190922|NCT01001520|3911494|P1|Medication Period 2|Withdrawal by Subject|0
1190923|NCT01001520|3911493|P2|Washout Period|Withdrawal by Subject|1
1190924|NCT01001520|3911494|P1|Washout Period|Withdrawal by Subject|2
1190925|NCT01001520|3911493|P2|Medication Period 1|Ineligible: Claustrophobia in fMRI|0
1190926|NCT01001520|3911494|P1|Medication Period 1|Ineligible: Claustrophobia in fMRI|2
1190927|NCT01001520|3911493|P2|Medication Period 1|Ineligible: fMRI contraindicated metal|2
1190928|NCT01001520|3911494|P1|Medication Period 1|Ineligible: fMRI contraindicated metal|0
1190929|NCT01001520|3911493|P2|Medication Period 1|Ineligible: Positive Urine Drug Screen|3
1190930|NCT01001520|3911494|P1|Medication Period 1|Ineligible: Positive Urine Drug Screen|0
1190931|NCT01001520|3911493|P2|Medication Period 1|Withdrawal by Subject|2
1190932|NCT01001520|3911494|P1|Medication Period 1|Withdrawal by Subject|2
1190933|NCT01001494|3911521|P3|Overall Study|Other|3
1190934|NCT01001494|3911522|P2|Overall Study|Other|1
1190935|NCT01001494|3911523|P1|Overall Study|Other|0
1190936|NCT01001494|3911521|P3|Overall Study|Lack of Efficacy|8
1190937|NCT01001494|3911522|P2|Overall Study|Lack of Efficacy|0
1190938|NCT01001494|3911523|P1|Overall Study|Lack of Efficacy|2
1190939|NCT01001494|3911521|P3|Overall Study|COPD exacerbation|5
1190940|NCT01001494|3911522|P2|Overall Study|COPD exacerbation|4
1190941|NCT01001494|3911523|P1|Overall Study|COPD exacerbation|3
1190942|NCT01001494|3911521|P3|Overall Study|Withdrawal by Subject|17
1190943|NCT01001494|3911522|P2|Overall Study|Withdrawal by Subject|7
1190944|NCT01001494|3911523|P1|Overall Study|Withdrawal by Subject|9
1190945|NCT01001494|3911521|P3|Overall Study|Lost to Follow-up|1
1190946|NCT01001494|3911522|P2|Overall Study|Lost to Follow-up|0
1190947|NCT01001494|3911523|P1|Overall Study|Lost to Follow-up|2
1190948|NCT01001494|3911521|P3|Overall Study|Protocol Violation|1
1190949|NCT01001494|3911522|P2|Overall Study|Protocol Violation|1
1190950|NCT01001494|3911523|P1|Overall Study|Protocol Violation|0
1190951|NCT01001494|3911521|P3|Overall Study|Adverse Event|6
1190952|NCT01001494|3911522|P2|Overall Study|Adverse Event|4
1190953|NCT01001494|3911523|P1|Overall Study|Adverse Event|8
1190954|NCT01001429|3911608|P2|Overall Study|surgery cancelled|1
1190955|NCT01001429|3911609|P1|Overall Study|surgery cancelled|0
1190956|NCT01001390|3911648|P2|Overall Study|Failure to wear AFO device|0
1190957|NCT01001390|3911649|P1|Overall Study|Failure to wear AFO device|2
1190958|NCT01001377|3911657|P2|Overall Study|Death|384
1190959|NCT01001377|3911658|P1|Overall Study|Death|391
1190960|NCT01001377|3911657|P2|Overall Study|Lost to Follow-up|17
1190961|NCT01001377|3911658|P1|Overall Study|Lost to Follow-up|14
1190962|NCT01001377|3911657|P2|Overall Study|Withdrawal by Subject|20
1190963|NCT01001377|3911658|P1|Overall Study|Withdrawal by Subject|19
1190964|NCT01001377|3911657|P2|Overall Study|Ineligibility determined|0
1190965|NCT01001377|3911658|P1|Overall Study|Ineligibility determined|2
1190966|NCT01001325|3911688|P2|Overall Study|Protocol Violation|0
1190967|NCT01001325|3911689|P1|Overall Study|Protocol Violation|2
1190968|NCT01001325|3911688|P2|Overall Study|Lost to Follow-up|10
1190969|NCT01001325|3911689|P1|Overall Study|Lost to Follow-up|16
1190970|NCT01001299|3911695|P1|Overall Study|Withdrew Consent|1
1190971|NCT01001299|3911695|P1|Overall Study|Began Taking Commercially Available Drug|2
1190972|NCT01001299|3911695|P1|Overall Study|Death|1
1190973|NCT01001299|3911695|P1|Overall Study|Adverse event or Intercurrent Illness|1
1190974|NCT01001299|3911695|P1|Overall Study|Insufficient Therapeutic Response|20
1190975|NCT01001234|3911724|P5|Overall Study|Not Treated: Lack of Qualifying Event|0
1190976|NCT01001234|3911725|P4|Overall Study|Not Treated: Lack of Qualifying Event|0
1190977|NCT01001234|3911726|P3|Overall Study|Not Treated: Lack of Qualifying Event|0
1190978|NCT01001234|3911727|P2|Overall Study|Not Treated: Lack of Qualifying Event|13
1190979|NCT01001234|3911728|P1|Overall Study|Not Treated: Lack of Qualifying Event|248
1190980|NCT01001234|3911724|P5|Overall Study|Not Treated: Physician Decision|0
1190981|NCT01001234|3911725|P4|Overall Study|Not Treated: Physician Decision|0
1190982|NCT01001234|3911726|P3|Overall Study|Not Treated: Physician Decision|0
1190983|NCT01001234|3911727|P2|Overall Study|Not Treated: Physician Decision|4
1190984|NCT01001234|3911728|P1|Overall Study|Not Treated: Physician Decision|37
1190985|NCT01001234|3911724|P5|Overall Study|Not Treated: Pregnancy|0
1190986|NCT01001234|3911725|P4|Overall Study|Not Treated: Pregnancy|0
1190987|NCT01001234|3911726|P3|Overall Study|Not Treated: Pregnancy|0
1190988|NCT01001234|3911727|P2|Overall Study|Not Treated: Pregnancy|0
1190989|NCT01001234|3911728|P1|Overall Study|Not Treated: Pregnancy|3
1190990|NCT01001234|3911724|P5|Overall Study|Not Treated: Lost to Follow-up|0
1190991|NCT01001234|3911725|P4|Overall Study|Not Treated: Lost to Follow-up|5
1190992|NCT01001234|3911726|P3|Overall Study|Not Treated: Lost to Follow-up|7
1190993|NCT01001234|3911727|P2|Overall Study|Not Treated: Lost to Follow-up|4
1190994|NCT01001234|3911728|P1|Overall Study|Not Treated: Lost to Follow-up|53
1190995|NCT01001234|3911724|P5|Overall Study|Not Treated: Protocol Violation|0
1190996|NCT01001234|3911725|P4|Overall Study|Not Treated: Protocol Violation|0
1190997|NCT01001234|3911726|P3|Overall Study|Not Treated: Protocol Violation|0
1190998|NCT01001234|3911727|P2|Overall Study|Not Treated: Protocol Violation|0
1190999|NCT01001234|3911728|P1|Overall Study|Not Treated: Protocol Violation|3
1191000|NCT01001234|3911724|P5|Overall Study|Not Treated: Withdrawal by Subject|0
1191001|NCT01001234|3911725|P4|Overall Study|Not Treated: Withdrawal by Subject|0
1191002|NCT01001234|3911726|P3|Overall Study|Not Treated: Withdrawal by Subject|2
1191003|NCT01001234|3911727|P2|Overall Study|Not Treated: Withdrawal by Subject|2
1191004|NCT01001234|3911728|P1|Overall Study|Not Treated: Withdrawal by Subject|23
1191005|NCT01001234|3911724|P5|Overall Study|Not Treated: Adverse Event|0
1191006|NCT01001234|3911725|P4|Overall Study|Not Treated: Adverse Event|0
1191007|NCT01001234|3911726|P3|Overall Study|Not Treated: Adverse Event|0
1191008|NCT01001234|3911727|P2|Overall Study|Not Treated: Adverse Event|0
1191009|NCT01001234|3911728|P1|Overall Study|Not Treated: Adverse Event|1
1191010|NCT01001234|3911724|P5|Overall Study|Physician Decision|0
1191011|NCT01001234|3911725|P4|Overall Study|Physician Decision|0
1191012|NCT01001234|3911726|P3|Overall Study|Physician Decision|0
1191013|NCT01001234|3911727|P2|Overall Study|Physician Decision|0
1191014|NCT01001234|3911728|P1|Overall Study|Physician Decision|1
1191015|NCT01001234|3911724|P5|Overall Study|Lost to Follow-up|0
1191016|NCT01001234|3911725|P4|Overall Study|Lost to Follow-up|2
1191017|NCT01001234|3911726|P3|Overall Study|Lost to Follow-up|1
1191018|NCT01001234|3911727|P2|Overall Study|Lost to Follow-up|0
1191019|NCT01001234|3911728|P1|Overall Study|Lost to Follow-up|0
1191020|NCT01001234|3911724|P5|Overall Study|Protocol Violation|0
1191021|NCT01001234|3911725|P4|Overall Study|Protocol Violation|18
1191022|NCT01001234|3911726|P3|Overall Study|Protocol Violation|19
1191023|NCT01001234|3911727|P2|Overall Study|Protocol Violation|3
1191024|NCT01001234|3911728|P1|Overall Study|Protocol Violation|34
1191025|NCT01001234|3911724|P5|Overall Study|Withdrawal by Subject|0
1191026|NCT01001234|3911725|P4|Overall Study|Withdrawal by Subject|0
1191027|NCT01001234|3911726|P3|Overall Study|Withdrawal by Subject|3
1191028|NCT01001234|3911727|P2|Overall Study|Withdrawal by Subject|0
1191029|NCT01001234|3911728|P1|Overall Study|Withdrawal by Subject|2
1191030|NCT01001221|3911744|P5|Overall Study|Not treated; protocol exclusion|0
1191031|NCT01001221|3911745|P4|Overall Study|Not treated; protocol exclusion|0
1191032|NCT01001221|3911746|P3|Overall Study|Not treated; protocol exclusion|1
1191033|NCT01001221|3911747|P2|Overall Study|Not treated; protocol exclusion|0
1191034|NCT01001221|3911748|P1|Overall Study|Not treated; protocol exclusion|0
1191035|NCT01001221|3911744|P5|Overall Study|Not specified|0
1191036|NCT01001221|3911745|P4|Overall Study|Not specified|0
1191037|NCT01001221|3911746|P3|Overall Study|Not specified|0
1191038|NCT01001221|3911747|P2|Overall Study|Not specified|1
1191039|NCT01001221|3911748|P1|Overall Study|Not specified|1
1191040|NCT01001221|3911744|P5|Overall Study|Disease progression|0
1191041|NCT01001221|3911745|P4|Overall Study|Disease progression|4
1191042|NCT01001221|3911746|P3|Overall Study|Disease progression|2
1191043|NCT01001221|3911747|P2|Overall Study|Disease progression|2
1191044|NCT01001221|3911748|P1|Overall Study|Disease progression|3
1191045|NCT01001221|3911744|P5|Overall Study|Adverse Event|0
1191046|NCT01001221|3911745|P4|Overall Study|Adverse Event|2
1191047|NCT01001221|3911746|P3|Overall Study|Adverse Event|0
1191048|NCT01001221|3911747|P2|Overall Study|Adverse Event|2
1191049|NCT01001221|3911748|P1|Overall Study|Adverse Event|1
1191050|NCT01001208|3911923|P2|Overall Study|Other|2
1191051|NCT01001208|3911924|P1|Overall Study|Other|0
1191052|NCT01001208|3911923|P2|Overall Study|Disease Progression|3
1191053|NCT01001208|3911924|P1|Overall Study|Disease Progression|0
1191054|NCT01001208|3911923|P2|Overall Study|Noncompliance|7
1191055|NCT01001208|3911924|P1|Overall Study|Noncompliance|4
1191056|NCT01001208|3911923|P2|Overall Study|Ineligibility Determined|2
1191057|NCT01001208|3911924|P1|Overall Study|Ineligibility Determined|4
1191058|NCT01001208|3911923|P2|Overall Study|Withdrawal by Subject|5
1191059|NCT01001208|3911924|P1|Overall Study|Withdrawal by Subject|4
1191060|NCT01001208|3911923|P2|Overall Study|Physician Decision|0
1191061|NCT01001208|3911924|P1|Overall Study|Physician Decision|1
1191062|NCT01001208|3911923|P2|Overall Study|Lost to Follow-up|9
1191063|NCT01001208|3911924|P1|Overall Study|Lost to Follow-up|5
1191064|NCT01001208|3911923|P2|Overall Study|Adverse Event|5
1191065|NCT01001208|3911924|P1|Overall Study|Adverse Event|10
1191066|NCT01001169|3911967|P2|Overall Study|Withdrawal by Subject|1
1191067|NCT01001169|3911968|P1|Overall Study|Withdrawal by Subject|2
1191068|NCT01001104|3912076|P4|Overall Study|Withdrawal by Subject|2
1191069|NCT01001104|3912077|P3|Overall Study|Withdrawal by Subject|0
1191070|NCT01001104|3912078|P2|Overall Study|Withdrawal by Subject|0
1191071|NCT01001104|3912079|P1|Overall Study|Withdrawal by Subject|0
1191072|NCT01001104|3912076|P4|Overall Study|Entry Criteria Not Met|1
1191073|NCT01001104|3912077|P3|Overall Study|Entry Criteria Not Met|0
1191074|NCT01001104|3912078|P2|Overall Study|Entry Criteria Not Met|0
1191075|NCT01001104|3912079|P1|Overall Study|Entry Criteria Not Met|0
1191076|NCT01001104|3912076|P4|Overall Study|Lost to Follow-up|0
1191077|NCT01001104|3912077|P3|Overall Study|Lost to Follow-up|1
1191078|NCT01001104|3912078|P2|Overall Study|Lost to Follow-up|0
1191079|NCT01001104|3912079|P1|Overall Study|Lost to Follow-up|0
1191080|NCT01001104|3912076|P4|Overall Study|Adverse Event|0
1191081|NCT01001104|3912077|P3|Overall Study|Adverse Event|0
1191082|NCT01001104|3912078|P2|Overall Study|Adverse Event|1
1191083|NCT01001104|3912079|P1|Overall Study|Adverse Event|2
1191084|NCT01000974|3912170|P3|Booster Vaccination Phase|Other|4
1191085|NCT01000974|3912171|P2|Booster Vaccination Phase|Other|6
1191086|NCT01000974|3912172|P1|Booster Vaccination Phase|Other|24
1191087|NCT01000974|3912170|P3|Booster Vaccination Phase|Lost to Follow-up|7
1191088|NCT01000974|3912171|P2|Booster Vaccination Phase|Lost to Follow-up|5
1191089|NCT01000974|3912172|P1|Booster Vaccination Phase|Lost to Follow-up|40
1191090|NCT01000974|3912170|P3|Booster Vaccination Phase|Withdrawal by Subject|1
1191091|NCT01000974|3912171|P2|Booster Vaccination Phase|Withdrawal by Subject|1
1191092|NCT01000974|3912172|P1|Booster Vaccination Phase|Withdrawal by Subject|3
1191093|NCT01000974|3912170|P3|Booster Vaccination Phase|Protocol Violation|2
1191094|NCT01000974|3912171|P2|Booster Vaccination Phase|Protocol Violation|0
1191095|NCT01000974|3912172|P1|Booster Vaccination Phase|Protocol Violation|0
1191096|NCT01000974|3912170|P3|Primary Vaccination Phase|Other|12
1191097|NCT01000974|3912171|P2|Primary Vaccination Phase|Other|9
1191098|NCT01000974|3912172|P1|Primary Vaccination Phase|Other|4
1191099|NCT01000974|3912170|P3|Primary Vaccination Phase|Adverse Event|2
1191100|NCT01000974|3912171|P2|Primary Vaccination Phase|Adverse Event|2
1191101|NCT01000974|3912172|P1|Primary Vaccination Phase|Adverse Event|14
1191102|NCT01000974|3912170|P3|Primary Vaccination Phase|Protocol Violation|2
1191103|NCT01000974|3912171|P2|Primary Vaccination Phase|Protocol Violation|3
1191104|NCT01000974|3912172|P1|Primary Vaccination Phase|Protocol Violation|40
1191105|NCT01000974|3912170|P3|Primary Vaccination Phase|Lost to Follow-up|26
1191106|NCT01000974|3912171|P2|Primary Vaccination Phase|Lost to Follow-up|19
1191107|NCT01000974|3912172|P1|Primary Vaccination Phase|Lost to Follow-up|171
1191108|NCT01000974|3912170|P3|Primary Vaccination Phase|Withdrawal by Subject|21
1191109|NCT01000974|3912171|P2|Primary Vaccination Phase|Withdrawal by Subject|17
1191110|NCT01000974|3912172|P1|Primary Vaccination Phase|Withdrawal by Subject|109
1191111|NCT01000961|3912279|P2|First Intervention (3 Weeks)|Infection after pre-planned surgery|1
1191112|NCT01000961|3912280|P1|First Intervention (3 Weeks)|Infection after pre-planned surgery|0
1191113|NCT01000961|3912279|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
1191114|NCT01000961|3912280|P1|First Intervention (3 Weeks)|Withdrawal by Subject|0
1191115|NCT01000805|3912303|P2|Overall Study|Sponsor Decision|1
1191116|NCT01000805|3912304|P1|Overall Study|Sponsor Decision|0
1191117|NCT01000805|3912303|P2|Overall Study|Withdrawal by Subject|6
1191118|NCT01000805|3912304|P1|Overall Study|Withdrawal by Subject|16
1191119|NCT01000805|3912303|P2|Overall Study|Protocol Violation|8
1191120|NCT01000805|3912304|P1|Overall Study|Protocol Violation|12
1191121|NCT01000805|3912303|P2|Overall Study|Physician Decision|1
1191122|NCT01000805|3912304|P1|Overall Study|Physician Decision|0
1191123|NCT01000805|3912303|P2|Overall Study|Lost to Follow-up|21
1191124|NCT01000805|3912304|P1|Overall Study|Lost to Follow-up|16
1191125|NCT01000805|3912303|P2|Overall Study|Lack of Efficacy|16
1191126|NCT01000805|3912304|P1|Overall Study|Lack of Efficacy|5
1191127|NCT01000805|3912303|P2|Overall Study|Adverse Event|9
1191128|NCT01000805|3912304|P1|Overall Study|Adverse Event|21
1191129|NCT01000727|3912338|P2|Overall Study|Study closed/terminated|24
1191130|NCT01000727|3912339|P1|Overall Study|Study closed/terminated|23
1191131|NCT01000727|3912338|P2|Overall Study|Withdrawal by Subject|109
1191132|NCT01000727|3912339|P1|Overall Study|Withdrawal by Subject|111
1191133|NCT01000727|3912338|P2|Overall Study|Lost to Follow-up|43
1191134|NCT01000727|3912339|P1|Overall Study|Lost to Follow-up|41
1191135|NCT01000649|3912380|P4|Overall Study|Lost to Follow-up|2
1191136|NCT01000649|3912381|P3|Overall Study|Lost to Follow-up|0
1191137|NCT01000649|3912382|P2|Overall Study|Lost to Follow-up|2
1191138|NCT01000649|3912383|P1|Overall Study|Lost to Follow-up|0
1191139|NCT01000649|3912380|P4|Overall Study|Adverse Event|4
1191140|NCT01000649|3912381|P3|Overall Study|Adverse Event|2
1191141|NCT01000649|3912382|P2|Overall Study|Adverse Event|1
1191142|NCT01000649|3912383|P1|Overall Study|Adverse Event|5
1191143|NCT01000610|3912464|P1|Overall Study|Treatment failure|1
1191144|NCT01000610|3912464|P1|Overall Study|Lost to Follow-up|4
1191145|NCT01000610|3912464|P1|Overall Study|Adverse Event|1
1191146|NCT01000506|3912475|P4|Overall Study|Withdrawal by Subject|7
1191147|NCT01000506|3912476|P3|Overall Study|Withdrawal by Subject|2
1191148|NCT01000506|3912477|P2|Overall Study|Withdrawal by Subject|8
1191149|NCT01000506|3912478|P1|Overall Study|Withdrawal by Subject|11
1191150|NCT01000506|3912475|P4|Overall Study|Physician Decision|3
1191151|NCT01000506|3912476|P3|Overall Study|Physician Decision|3
1191152|NCT01000506|3912477|P2|Overall Study|Physician Decision|3
1191153|NCT01000506|3912478|P1|Overall Study|Physician Decision|1
1191154|NCT01000506|3912475|P4|Overall Study|Lost to Follow-up|0
1191155|NCT01000506|3912476|P3|Overall Study|Lost to Follow-up|4
1191156|NCT01000506|3912477|P2|Overall Study|Lost to Follow-up|1
1191157|NCT01000506|3912478|P1|Overall Study|Lost to Follow-up|1
1191158|NCT01000506|3912475|P4|Overall Study|Protocol Violation|0
1191159|NCT01000506|3912476|P3|Overall Study|Protocol Violation|0
1191160|NCT01000506|3912477|P2|Overall Study|Protocol Violation|1
1191161|NCT01000506|3912478|P1|Overall Study|Protocol Violation|1
1191162|NCT01000506|3912475|P4|Overall Study|Lack of Efficacy|4
1191163|NCT01000506|3912476|P3|Overall Study|Lack of Efficacy|4
1191164|NCT01000506|3912477|P2|Overall Study|Lack of Efficacy|6
1191165|NCT01000506|3912478|P1|Overall Study|Lack of Efficacy|8
1191166|NCT01000506|3912475|P4|Overall Study|Adverse Event|9
1191167|NCT01000506|3912476|P3|Overall Study|Adverse Event|8
1191168|NCT01000506|3912477|P2|Overall Study|Adverse Event|5
1191169|NCT01000506|3912478|P1|Overall Study|Adverse Event|6
1191170|NCT01000493|3912522|P2|Overall Study|Withdrawal by Subject|7
1191171|NCT01000493|3912523|P1|Overall Study|Withdrawal by Subject|3
1191172|NCT01000493|3912522|P2|Overall Study|Physician Decision|1
1191173|NCT01000493|3912523|P1|Overall Study|Physician Decision|1
1191174|NCT01000493|3912522|P2|Overall Study|Lost to Follow-up|9
1191175|NCT01000493|3912523|P1|Overall Study|Lost to Follow-up|5
1191176|NCT01000493|3912522|P2|Overall Study|Study closed/terminated|23
1191177|NCT01000493|3912523|P1|Overall Study|Study closed/terminated|25
1191178|NCT01000493|3912522|P2|Overall Study|Protocol Violation|8
1191179|NCT01000493|3912523|P1|Overall Study|Protocol Violation|1
1191180|NCT01000493|3912522|P2|Overall Study|Lack of Efficacy|1
1191181|NCT01000493|3912523|P1|Overall Study|Lack of Efficacy|1
1191182|NCT01000493|3912522|P2|Overall Study|Adverse Event|6
1191183|NCT01000493|3912523|P1|Overall Study|Adverse Event|3
1191184|NCT01000480|3912573|P1|Concurrent Therapy Phase|Physician Decision|1
1191185|NCT01000480|3912573|P1|Concurrent Therapy Phase|Withdrawal by Subject|3
1191186|NCT01000480|3912573|P1|Concurrent Therapy Phase|Protocol Violation|2
1191187|NCT01000480|3912573|P1|Concurrent Therapy Phase|Adverse Event|4
1191188|NCT01000480|3912573|P1|Induction Phase|Entry Criteria Not Met|3
1191189|NCT01000480|3912573|P1|Induction Phase|Physician Decision|1
1191190|NCT01000480|3912573|P1|Induction Phase|Lost to Follow-up|1
1191191|NCT01000480|3912573|P1|Induction Phase|Adverse Event|2
1191192|NCT01000376|3912581|P2|Cycle 1 Day 1|Progressive Disease|0
1191193|NCT01000376|3912582|P1|Cycle 1 Day 1|Progressive Disease|1
1191194|NCT01000376|3912581|P2|Cycle 1 Day 1|Adverse Event|0
1191195|NCT01000376|3912582|P1|Cycle 1 Day 1|Adverse Event|1
1191196|NCT01000337|3912592|P2|Overall Study|Lost to Follow-up|3
1191197|NCT01000337|3912593|P1|Overall Study|Lost to Follow-up|4
1191198|NCT01000311|3912611|P2|Overall Study|Administrative reason|15
1191199|NCT01000311|3912612|P1|Overall Study|Administrative reason|9
1191200|NCT01000311|3912611|P2|Overall Study|Inappropriate enrollment|0
1191201|NCT01000311|3912612|P1|Overall Study|Inappropriate enrollment|2
1191202|NCT01000311|3912611|P2|Overall Study|Protocol Violation|2
1191203|NCT01000311|3912612|P1|Overall Study|Protocol Violation|1
1191204|NCT01000311|3912611|P2|Overall Study|Lost to Follow-up|24
1191205|NCT01000311|3912612|P1|Overall Study|Lost to Follow-up|15
1191206|NCT01000311|3912611|P2|Overall Study|Withdrawal by Subject|24
1191207|NCT01000311|3912612|P1|Overall Study|Withdrawal by Subject|16
1191208|NCT01000311|3912611|P2|Overall Study|Adverse Event|5
1191209|NCT01000311|3912612|P1|Overall Study|Adverse Event|2
1191210|NCT01000155|3912662|P1|Overall Study|Adverse Event|1
1191211|NCT01000155|3912662|P1|Overall Study|Withdrawal by Subject|1
1191212|NCT01000064|3912668|P2|Overall Study|Withdrawal by Subject|1
1191213|NCT01000064|3912669|P1|Overall Study|Withdrawal by Subject|1
1191214|NCT01000025|3912692|P2|Overall Study|Intercurrent Illness|7
1191215|NCT01000025|3912693|P1|Overall Study|Intercurrent Illness|26
1191216|NCT01000025|3912692|P2|Overall Study|Lack of Efficacy|208
1191217|NCT01000025|3912693|P1|Overall Study|Lack of Efficacy|363
1191218|NCT01000025|3912692|P2|Overall Study|Death|13
1191219|NCT01000025|3912693|P1|Overall Study|Death|23
1191220|NCT01000025|3912692|P2|Overall Study|Withdrawal by Subject|8
1191221|NCT01000025|3912693|P1|Overall Study|Withdrawal by Subject|13
1191222|NCT01000025|3912692|P2|Overall Study|Adverse Event|2
1191223|NCT01000025|3912693|P1|Overall Study|Adverse Event|43
1191224|NCT00999921|3912711|P2|Overall Study|Lost to Follow-up|19
1191225|NCT00999921|3912712|P1|Overall Study|Lost to Follow-up|10
1191226|NCT00999908|3912722|P3|Treatment Period 2|Protocol Violation|0
1191227|NCT00999908|3912723|P2|Treatment Period 2|Protocol Violation|0
1191228|NCT00999908|3912724|P1|Treatment Period 2|Protocol Violation|1
1191229|NCT00999908|3912722|P3|Treatment Period 1|Subject withdrew consent|0
1191230|NCT00999908|3912723|P2|Treatment Period 1|Subject withdrew consent|0
1191231|NCT00999908|3912724|P1|Treatment Period 1|Subject withdrew consent|2
1191232|NCT00999804|3912753|P2|Overall Study|Ineligible|0
1191233|NCT00999804|3912754|P1|Overall Study|Ineligible|3
1191234|NCT00999804|3912753|P2|Overall Study|Death|0
1191235|NCT00999804|3912754|P1|Overall Study|Death|1
1191236|NCT00999804|3912753|P2|Overall Study|Withdrawal by Subject|0
1191237|NCT00999804|3912754|P1|Overall Study|Withdrawal by Subject|4
1191238|NCT00999804|3912753|P2|Overall Study|Adverse Event|3
1191239|NCT00999804|3912754|P1|Overall Study|Adverse Event|4
1191240|NCT00999804|3912753|P2|Overall Study|Lack of Efficacy|2
1191241|NCT00999804|3912754|P1|Overall Study|Lack of Efficacy|9
1191242|NCT00999713|3912768|P2|Overall Study|Physician Decision|0
1191243|NCT00999713|3912769|P1|Overall Study|Physician Decision|2
1191244|NCT00999687|3912783|P1|Second Intervention|Lack of Efficacy|1
1191245|NCT00999687|3912783|P1|Second Intervention|Withdrawal by Subject|2
1191246|NCT00999687|3912783|P1|First Intervention|Withdrawal by Subject|1
1191247|NCT00999661|3912790|P1|Overall Study|Not meeting eligibility criteria|9
1191248|NCT00999661|3912790|P1|Overall Study|Withdrawal by Subject|1
1191249|NCT00999661|3912790|P1|Overall Study|Adverse Event|1
1191250|NCT00999661|3912790|P1|Overall Study|Lost to Follow-up|59
1191251|NCT00999596|3912811|P1|Overall Study|Statistical population not required|101
1191252|NCT00999544|3912816|P1|Overall Study|Withdrawal by Subject|1
1191253|NCT00999466|3912852|P3|Main Part|Adverse Event|2
1191254|NCT00999466|3912853|P2|Main Part|Adverse Event|4
1191255|NCT00999466|3912854|P1|Main Part|Adverse Event|0
1191256|NCT00999466|3912852|P3|Main Part|Withdrawal by Subject|2
1191257|NCT00999466|3912853|P2|Main Part|Withdrawal by Subject|0
1191258|NCT00999466|3912854|P1|Main Part|Withdrawal by Subject|0
1191259|NCT00999167|3913131|P3|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
1191260|NCT00999167|3913132|P2|Part B: Randomized, Placebo Controlled|Physician stopped drug|1
1191261|NCT00999167|3913133|P1|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
1191262|NCT00999167|3913131|P3|Part B: Randomized, Placebo Controlled|Physician Decision|0
1191263|NCT00999167|3913132|P2|Part B: Randomized, Placebo Controlled|Physician Decision|1
1191264|NCT00999167|3913133|P1|Part B: Randomized, Placebo Controlled|Physician Decision|0
1191265|NCT00999167|3913131|P3|Part B: Randomized, Placebo Controlled|Noncompliance|0
1191266|NCT00999167|3913132|P2|Part B: Randomized, Placebo Controlled|Noncompliance|1
1191267|NCT00999167|3913133|P1|Part B: Randomized, Placebo Controlled|Noncompliance|0
1191268|NCT00999167|3913131|P3|Part B: Randomized, Placebo Controlled|Adverse Event|1
1191269|NCT00999167|3913132|P2|Part B: Randomized, Placebo Controlled|Adverse Event|6
1191270|NCT00999167|3913133|P1|Part B: Randomized, Placebo Controlled|Adverse Event|0
1191271|NCT00999167|3913131|P3|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4
1191272|NCT00999167|3913132|P2|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7
1191273|NCT00999167|3913133|P1|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0
1191274|NCT00999167|3913131|P3|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16
1191275|NCT00999167|3913132|P2|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19
1191276|NCT00999167|3913133|P1|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0
1191277|NCT00999167|3913131|P3|Part A: Open Label Safety run-in|Adverse Event|0
1191278|NCT00999167|3913132|P2|Part A: Open Label Safety run-in|Adverse Event|0
1191279|NCT00999167|3913133|P1|Part A: Open Label Safety run-in|Adverse Event|3
1191280|NCT00999167|3913131|P3|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
1191281|NCT00999167|3913132|P2|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
1191282|NCT00999167|3913133|P1|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4
1191283|NCT00998985|3913271|P14|Overall Study|Protocol Violation|0
1191284|NCT00998985|3913272|P13|Overall Study|Protocol Violation|0
1191285|NCT00998985|3913273|P12|Overall Study|Protocol Violation|0
1191286|NCT00998985|3913274|P11|Overall Study|Protocol Violation|0
1191287|NCT00998985|3913275|P10|Overall Study|Protocol Violation|0
1191288|NCT00998985|3913276|P9|Overall Study|Protocol Violation|0
1191289|NCT00998985|3913277|P8|Overall Study|Protocol Violation|0
1191290|NCT00998985|3913278|P7|Overall Study|Protocol Violation|0
1191291|NCT00998985|3913279|P6|Overall Study|Protocol Violation|1
1191292|NCT00998985|3913280|P5|Overall Study|Protocol Violation|0
1191293|NCT00998985|3913281|P4|Overall Study|Protocol Violation|0
1191294|NCT00998985|3913282|P3|Overall Study|Protocol Violation|0
1191295|NCT00998985|3913283|P2|Overall Study|Protocol Violation|0
1191296|NCT00998985|3913284|P1|Overall Study|Protocol Violation|0
1191297|NCT00998985|3913271|P14|Overall Study|Withdrawal by Subject|0
1191298|NCT00998985|3913272|P13|Overall Study|Withdrawal by Subject|0
1191299|NCT00998985|3913273|P12|Overall Study|Withdrawal by Subject|0
1191300|NCT00998985|3913274|P11|Overall Study|Withdrawal by Subject|0
1191301|NCT00998985|3913275|P10|Overall Study|Withdrawal by Subject|0
1191302|NCT00998985|3913276|P9|Overall Study|Withdrawal by Subject|1
1191303|NCT00998985|3913277|P8|Overall Study|Withdrawal by Subject|0
1191304|NCT00998985|3913278|P7|Overall Study|Withdrawal by Subject|0
1191305|NCT00998985|3913279|P6|Overall Study|Withdrawal by Subject|0
1191306|NCT00998985|3913280|P5|Overall Study|Withdrawal by Subject|0
1191307|NCT00998985|3913281|P4|Overall Study|Withdrawal by Subject|0
1191308|NCT00998985|3913282|P3|Overall Study|Withdrawal by Subject|0
1191309|NCT00998985|3913283|P2|Overall Study|Withdrawal by Subject|0
1191310|NCT00998985|3913284|P1|Overall Study|Withdrawal by Subject|0
1191311|NCT00998881|3913352|P2|Overall Study|Personal matter|0
1191312|NCT00998881|3913353|P1|Overall Study|Personal matter|1
1191313|NCT00998881|3913352|P2|Overall Study|Withdrawal by Subject|0
1191314|NCT00998881|3913353|P1|Overall Study|Withdrawal by Subject|1
1191315|NCT00998881|3913352|P2|Overall Study|Physician Decision|0
1191316|NCT00998881|3913353|P1|Overall Study|Physician Decision|3
1191317|NCT00998881|3913352|P2|Overall Study|Lack of Efficacy|0
1191318|NCT00998881|3913353|P1|Overall Study|Lack of Efficacy|1
1191319|NCT00998881|3913352|P2|Overall Study|Adverse Event|2
1191320|NCT00998881|3913353|P1|Overall Study|Adverse Event|2
1191321|NCT00998790|3913372|P1|Overall Study|Withdrawal by Subject|21
1191322|NCT00998764|3913382|P2|Overall Study|Recurrent Episode of vasogenic edema|0
1191323|NCT00998764|3913383|P1|Overall Study|Recurrent Episode of vasogenic edema|1
1191324|NCT00998764|3913382|P2|Overall Study|Not specified|4
1191325|NCT00998764|3913383|P1|Overall Study|Not specified|4
1191326|NCT00998764|3913382|P2|Overall Study|Loss of Caregiver|3
1191327|NCT00998764|3913383|P1|Overall Study|Loss of Caregiver|0
1191328|NCT00998764|3913382|P2|Overall Study|Lost to Follow-up|1
1191329|NCT00998764|3913383|P1|Overall Study|Lost to Follow-up|1
1191330|NCT00998764|3913382|P2|Overall Study|Failed to Return|1
1191331|NCT00998764|3913383|P1|Overall Study|Failed to Return|1
1191332|NCT00998764|3913382|P2|Overall Study|Protocol Violation|1
1191333|NCT00998764|3913383|P1|Overall Study|Protocol Violation|0
1191334|NCT00998764|3913382|P2|Overall Study|Discontinuation of Study by Sponsor|217
1191335|NCT00998764|3913383|P1|Overall Study|Discontinuation of Study by Sponsor|164
1191336|NCT00998764|3913382|P2|Overall Study|Death|1
1191337|NCT00998764|3913383|P1|Overall Study|Death|3
1191338|NCT00998764|3913382|P2|Overall Study|Physician Decision|3
1191339|NCT00998764|3913383|P1|Overall Study|Physician Decision|3
1191340|NCT00998764|3913382|P2|Overall Study|Withdrawal by Subject|25
1191341|NCT00998764|3913383|P1|Overall Study|Withdrawal by Subject|19
1191342|NCT00998764|3913382|P2|Overall Study|Adverse Event|12
1191343|NCT00998764|3913383|P1|Overall Study|Adverse Event|17
1191344|NCT00998764|3913382|P2|Overall Study|Lack of Efficacy|6
1191345|NCT00998764|3913383|P1|Overall Study|Lack of Efficacy|3
1191346|NCT00998738|3913405|P1|Overall Study|Uknown|1
1191347|NCT00998335|3913488|P2|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2
1191348|NCT00998335|3913489|P1|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0
1191349|NCT00998309|3913517|P1|Overall Study|Protocol Violation|4
1191350|NCT00998296|3913584|P11|Overall Study|Reason other than those specified above|0
1191351|NCT00998296|3913585|P10|Overall Study|Reason other than those specified above|1
1191352|NCT00998296|3913586|P9|Overall Study|Reason other than those specified above|0
1191353|NCT00998296|3913587|P8|Overall Study|Reason other than those specified above|0
1191354|NCT00998296|3913588|P7|Overall Study|Reason other than those specified above|0
1191355|NCT00998296|3913589|P6|Overall Study|Reason other than those specified above|0
1191356|NCT00998296|3913590|P5|Overall Study|Reason other than those specified above|0
1191357|NCT00998296|3913591|P4|Overall Study|Reason other than those specified above|0
1191358|NCT00998296|3913592|P3|Overall Study|Reason other than those specified above|0
1191359|NCT00998296|3913593|P2|Overall Study|Reason other than those specified above|0
1191360|NCT00998296|3913594|P1|Overall Study|Reason other than those specified above|0
1191361|NCT00998296|3913584|P11|Overall Study|Refused to continue taking trial med.|0
1191362|NCT00998296|3913585|P10|Overall Study|Refused to continue taking trial med.|2
1191363|NCT00998296|3913586|P9|Overall Study|Refused to continue taking trial med.|0
1191364|NCT00998296|3913587|P8|Overall Study|Refused to continue taking trial med.|0
1191365|NCT00998296|3913588|P7|Overall Study|Refused to continue taking trial med.|0
1191366|NCT00998296|3913589|P6|Overall Study|Refused to continue taking trial med.|0
1191367|NCT00998296|3913590|P5|Overall Study|Refused to continue taking trial med.|0
1191368|NCT00998296|3913591|P4|Overall Study|Refused to continue taking trial med.|0
1191369|NCT00998296|3913592|P3|Overall Study|Refused to continue taking trial med.|0
1191370|NCT00998296|3913593|P2|Overall Study|Refused to continue taking trial med.|0
1191371|NCT00998296|3913594|P1|Overall Study|Refused to continue taking trial med.|0
1191372|NCT00998296|3913584|P11|Overall Study|Other adverse event|2
1191373|NCT00998296|3913585|P10|Overall Study|Other adverse event|1
1191374|NCT00998296|3913586|P9|Overall Study|Other adverse event|0
1191375|NCT00998296|3913587|P8|Overall Study|Other adverse event|0
1191376|NCT00998296|3913588|P7|Overall Study|Other adverse event|0
1191377|NCT00998296|3913589|P6|Overall Study|Other adverse event|0
1191378|NCT00998296|3913590|P5|Overall Study|Other adverse event|1
1191379|NCT00998296|3913591|P4|Overall Study|Other adverse event|0
1191380|NCT00998296|3913592|P3|Overall Study|Other adverse event|0
1191381|NCT00998296|3913593|P2|Overall Study|Other adverse event|0
1191382|NCT00998296|3913594|P1|Overall Study|Other adverse event|0
1191383|NCT00998296|3913584|P11|Overall Study|Dose limiting or dose reducing toxicity|0
1191384|NCT00998296|3913585|P10|Overall Study|Dose limiting or dose reducing toxicity|0
1191385|NCT00998296|3913586|P9|Overall Study|Dose limiting or dose reducing toxicity|2
1191386|NCT00998296|3913587|P8|Overall Study|Dose limiting or dose reducing toxicity|2
1191387|NCT00998296|3913588|P7|Overall Study|Dose limiting or dose reducing toxicity|0
1191388|NCT00998296|3913589|P6|Overall Study|Dose limiting or dose reducing toxicity|0
1191389|NCT00998296|3913590|P5|Overall Study|Dose limiting or dose reducing toxicity|1
1191390|NCT00998296|3913591|P4|Overall Study|Dose limiting or dose reducing toxicity|0
1191391|NCT00998296|3913592|P3|Overall Study|Dose limiting or dose reducing toxicity|0
1191392|NCT00998296|3913593|P2|Overall Study|Dose limiting or dose reducing toxicity|0
1191393|NCT00998296|3913594|P1|Overall Study|Dose limiting or dose reducing toxicity|0
1191394|NCT00998296|3913584|P11|Overall Study|Progressive disease|5
1191395|NCT00998296|3913585|P10|Overall Study|Progressive disease|14
1191396|NCT00998296|3913586|P9|Overall Study|Progressive disease|0
1191397|NCT00998296|3913587|P8|Overall Study|Progressive disease|0
1191398|NCT00998296|3913588|P7|Overall Study|Progressive disease|1
1191399|NCT00998296|3913589|P6|Overall Study|Progressive disease|0
1191400|NCT00998296|3913590|P5|Overall Study|Progressive disease|0
1191401|NCT00998296|3913591|P4|Overall Study|Progressive disease|0
1191402|NCT00998296|3913592|P3|Overall Study|Progressive disease|0
1191403|NCT00998296|3913593|P2|Overall Study|Progressive disease|1
1191404|NCT00998296|3913594|P1|Overall Study|Progressive disease|0
1191405|NCT00997984|3913689|P3|Overall Study|Work schedule|2
1191406|NCT00997984|3913690|P2|Overall Study|Work schedule|0
1191407|NCT00997984|3913691|P1|Overall Study|Work schedule|0
1191408|NCT00997984|3913689|P3|Overall Study|Suicidal ideation|1
1191409|NCT00997984|3913690|P2|Overall Study|Suicidal ideation|0
1191410|NCT00997984|3913691|P1|Overall Study|Suicidal ideation|0
1191411|NCT00997984|3913689|P3|Overall Study|Wrong medication dispensed|0
1191412|NCT00997984|3913690|P2|Overall Study|Wrong medication dispensed|1
1191413|NCT00997984|3913691|P1|Overall Study|Wrong medication dispensed|0
1191414|NCT00997984|3913689|P3|Overall Study|non-compliance|3
1191415|NCT00997984|3913690|P2|Overall Study|non-compliance|2
1191416|NCT00997984|3913691|P1|Overall Study|non-compliance|0
1191417|NCT00997984|3913689|P3|Overall Study|Met exclusion criteria|0
1191418|NCT00997984|3913690|P2|Overall Study|Met exclusion criteria|0
1191419|NCT00997984|3913691|P1|Overall Study|Met exclusion criteria|1
1191420|NCT00997984|3913689|P3|Overall Study|Lack of Efficacy|3
1191421|NCT00997984|3913690|P2|Overall Study|Lack of Efficacy|6
1191422|NCT00997984|3913691|P1|Overall Study|Lack of Efficacy|20
1191423|NCT00997984|3913689|P3|Overall Study|Lost to Follow-up|4
1191424|NCT00997984|3913690|P2|Overall Study|Lost to Follow-up|5
1191425|NCT00997984|3913691|P1|Overall Study|Lost to Follow-up|8
1191426|NCT00997984|3913689|P3|Overall Study|Withdrawal by Subject|5
1191427|NCT00997984|3913690|P2|Overall Study|Withdrawal by Subject|9
1191428|NCT00997984|3913691|P1|Overall Study|Withdrawal by Subject|6
1191429|NCT00997984|3913689|P3|Overall Study|Protocol Violation|0
1191430|NCT00997984|3913690|P2|Overall Study|Protocol Violation|3
1191431|NCT00997984|3913691|P1|Overall Study|Protocol Violation|1
1191432|NCT00997984|3913689|P3|Overall Study|Adverse Event|8
1191433|NCT00997984|3913690|P2|Overall Study|Adverse Event|8
1191434|NCT00997984|3913691|P1|Overall Study|Adverse Event|1
1191435|NCT00997503|3913849|P1|Overall Study|Other reason|13
1191436|NCT00997503|3913849|P1|Overall Study|Missed 12-month follow-up|85
1191437|NCT00997503|3913849|P1|Overall Study|Physician Decision|10
1191438|NCT00997503|3913849|P1|Overall Study|Adverse Event|3
1191439|NCT00997503|3913849|P1|Overall Study|Lost to Follow-up|33
1191440|NCT00997503|3913849|P1|Overall Study|Withdrawal by Subject|76
1191441|NCT00997503|3913849|P1|Overall Study|Death|53
1191442|NCT00997438|3913892|P3|Overall Study|Exclusion criteria at visit 1|3
1191443|NCT00997438|3913893|P2|Overall Study|Exclusion criteria at visit 1|2
1191444|NCT00997438|3913894|P1|Overall Study|Exclusion criteria at visit 1|2
1191445|NCT00997438|3913892|P3|Overall Study|Withdrawal by Subject|0
1191446|NCT00997438|3913893|P2|Overall Study|Withdrawal by Subject|1
1191447|NCT00997438|3913894|P1|Overall Study|Withdrawal by Subject|1
1191448|NCT00997438|3913892|P3|Overall Study|Blood draw difficulty|1
1191449|NCT00997438|3913893|P2|Overall Study|Blood draw difficulty|0
1191450|NCT00997438|3913894|P1|Overall Study|Blood draw difficulty|2
1191451|NCT00997386|3913934|P1|Overall Study|Death|7
1191452|NCT00997373|3913943|P2|Overall Study|could not have hysterectomy|0
1191453|NCT00997373|3913944|P1|Overall Study|could not have hysterectomy|6
1191454|NCT00997373|3913943|P2|Overall Study|wrong tumor type|0
1191455|NCT00997373|3913944|P1|Overall Study|wrong tumor type|4
1191456|NCT00997373|3913943|P2|Overall Study|Withdrawal by Subject|0
1191457|NCT00997373|3913944|P1|Overall Study|Withdrawal by Subject|5
1191458|NCT00997334|3913950|P1|Overall Study|Ineligible|1
1191459|NCT00997334|3913950|P1|Overall Study|No lesion amenable|1
1191460|NCT00997334|3913950|P1|Overall Study|Urgent Palliative Care|2
1191461|NCT00997334|3913950|P1|Overall Study|Death|2
1191462|NCT00997334|3913950|P1|Overall Study|Withdrawal by Subject|3
1191463|NCT00997334|3913950|P1|Overall Study|Patient non-compliance|1
1191464|NCT00997334|3913950|P1|Overall Study|Adverse Event|3
1191465|NCT00997334|3913950|P1|Overall Study|still on therapy|12
1191466|NCT00997321|3913959|P2|Overall Study|did not undergo sedation after enrollmen|3
1191467|NCT00997321|3913960|P1|Overall Study|did not undergo sedation after enrollmen|0
1191468|NCT00997243|3913972|P1|Overall Study|Early termination of study by sponsor|7
1191469|NCT00997126|3914004|P2|Overall Study|Physician Decision|11
1191470|NCT00997126|3914005|P1|Overall Study|Physician Decision|7
1191471|NCT00997035|3914034|P2|3-month Follow-up Visit|Lost to Follow-up|6
1191472|NCT00997035|3914035|P1|3-month Follow-up Visit|Lost to Follow-up|12
1191473|NCT00997035|3914034|P2|3-week Followup Visit|Lost to Follow-up|6
1191474|NCT00997035|3914035|P1|3-week Followup Visit|Lost to Follow-up|9
1191475|NCT00996996|3914055|P1|Overall Study|Did Not Receive Study Medications|1
1191476|NCT00996996|3914055|P1|Overall Study|Death|5
1191477|NCT00996996|3914055|P1|Overall Study|Lost to Follow-up|9
1191478|NCT00996996|3914055|P1|Overall Study|Non-compliance|8
1191479|NCT00996996|3914055|P1|Overall Study|Progressive Disease|10
1191480|NCT00996944|3914089|P2|Long-term Treatment Period|Study Closed/Terminated|5
1191481|NCT00996944|3914090|P1|Long-term Treatment Period|Study Closed/Terminated|12
1191482|NCT00996944|3914089|P2|Double-blind Treatment Period|Withdrawal by Subject|1
1191483|NCT00996944|3914090|P1|Double-blind Treatment Period|Withdrawal by Subject|1
1191484|NCT00996944|3914089|P2|Double-blind Treatment Period|Study Closed/Terminated|5
1191485|NCT00996944|3914090|P1|Double-blind Treatment Period|Study Closed/Terminated|6
1191486|NCT00996944|3914089|P2|Double-blind Treatment Period|Protocol Violation|0
1191487|NCT00996944|3914090|P1|Double-blind Treatment Period|Protocol Violation|1
1191488|NCT00996944|3914089|P2|Double-blind Treatment Period|Adverse Event|1
1191489|NCT00996944|3914090|P1|Double-blind Treatment Period|Adverse Event|2
1191490|NCT00996918|3914142|P5|Overall Study|Not Specified|0
1191491|NCT00996918|3914143|P4|Overall Study|Not Specified|0
1191492|NCT00996918|3914144|P3|Overall Study|Not Specified|0
1191493|NCT00996918|3914145|P2|Overall Study|Not Specified|1
1191494|NCT00996918|3914146|P1|Overall Study|Not Specified|3
1191495|NCT00996918|3914142|P5|Overall Study|Loss of Caregiver|0
1191496|NCT00996918|3914143|P4|Overall Study|Loss of Caregiver|0
1191497|NCT00996918|3914144|P3|Overall Study|Loss of Caregiver|0
1191498|NCT00996918|3914145|P2|Overall Study|Loss of Caregiver|1
1191499|NCT00996918|3914146|P1|Overall Study|Loss of Caregiver|0
1191500|NCT00996918|3914142|P5|Overall Study|Discontinuation of Study by Sponsor|2
1191501|NCT00996918|3914143|P4|Overall Study|Discontinuation of Study by Sponsor|45
1191502|NCT00996918|3914144|P3|Overall Study|Discontinuation of Study by Sponsor|30
1191503|NCT00996918|3914145|P2|Overall Study|Discontinuation of Study by Sponsor|54
1191504|NCT00996918|3914146|P1|Overall Study|Discontinuation of Study by Sponsor|31
1191505|NCT00996918|3914142|P5|Overall Study|Physician Decision|0
1191506|NCT00996918|3914143|P4|Overall Study|Physician Decision|0
1191507|NCT00996918|3914144|P3|Overall Study|Physician Decision|0
1191508|NCT00996918|3914145|P2|Overall Study|Physician Decision|0
1191509|NCT00996918|3914146|P1|Overall Study|Physician Decision|1
1191510|NCT00996918|3914142|P5|Overall Study|Withdrawal by Subject|2
1191511|NCT00996918|3914143|P4|Overall Study|Withdrawal by Subject|3
1191512|NCT00996918|3914144|P3|Overall Study|Withdrawal by Subject|3
1191513|NCT00996918|3914145|P2|Overall Study|Withdrawal by Subject|4
1191514|NCT00996918|3914146|P1|Overall Study|Withdrawal by Subject|1
1191515|NCT00996918|3914142|P5|Overall Study|Adverse Event|0
1191516|NCT00996918|3914143|P4|Overall Study|Adverse Event|6
1191517|NCT00996918|3914144|P3|Overall Study|Adverse Event|2
1191518|NCT00996918|3914145|P2|Overall Study|Adverse Event|5
1191519|NCT00996918|3914146|P1|Overall Study|Adverse Event|2
1191520|NCT00996918|3914142|P5|Overall Study|Lack of Efficacy|0
1191521|NCT00996918|3914143|P4|Overall Study|Lack of Efficacy|2
1191522|NCT00996918|3914144|P3|Overall Study|Lack of Efficacy|2
1191523|NCT00996918|3914145|P2|Overall Study|Lack of Efficacy|1
1191524|NCT00996918|3914146|P1|Overall Study|Lack of Efficacy|1
1191525|NCT00996892|3914190|P20|Expansion Stage 2A|Disease Progression|31
1191526|NCT00996892|3914191|P19|Expansion Stage 2A|Disease Progression|0
1191527|NCT00996892|3914192|P18|Expansion Stage 2A|Disease Progression|0
1191528|NCT00996892|3914193|P17|Expansion Stage 2A|Disease Progression|0
1191529|NCT00996892|3914194|P16|Expansion Stage 2A|Disease Progression|0
1191530|NCT00996892|3914195|P15|Expansion Stage 2A|Disease Progression|0
1191531|NCT00996892|3914196|P14|Expansion Stage 2A|Disease Progression|0
1191532|NCT00996892|3914197|P13|Expansion Stage 2A|Disease Progression|0
1191533|NCT00996892|3914198|P12|Expansion Stage 2A|Disease Progression|0
1191534|NCT00996892|3914199|P11|Expansion Stage 2A|Disease Progression|0
1191535|NCT00996892|3914200|P10|Expansion Stage 2A|Disease Progression|0
1191536|NCT00996892|3914201|P9|Expansion Stage 2A|Disease Progression|0
1191537|NCT00996892|3914202|P8|Expansion Stage 2A|Disease Progression|0
1191538|NCT00996892|3914203|P7|Expansion Stage 2A|Disease Progression|0
1191539|NCT00996892|3914204|P6|Expansion Stage 2A|Disease Progression|0
1191540|NCT00996892|3914205|P5|Expansion Stage 2A|Disease Progression|0
1191541|NCT00996892|3914206|P4|Expansion Stage 2A|Disease Progression|0
1191542|NCT00996892|3914207|P3|Expansion Stage 2A|Disease Progression|0
1191543|NCT00996892|3914208|P2|Expansion Stage 2A|Disease Progression|0
1191544|NCT00996892|3914209|P1|Expansion Stage 2A|Disease Progression|0
1191545|NCT00996892|3914190|P20|Expansion Stage 2A|Withdrawal by Subject|4
1191546|NCT00996892|3914191|P19|Expansion Stage 2A|Withdrawal by Subject|0
1191547|NCT00996892|3914192|P18|Expansion Stage 2A|Withdrawal by Subject|0
1191548|NCT00996892|3914193|P17|Expansion Stage 2A|Withdrawal by Subject|0
1191549|NCT00996892|3914194|P16|Expansion Stage 2A|Withdrawal by Subject|0
1191550|NCT00996892|3914195|P15|Expansion Stage 2A|Withdrawal by Subject|0
1191551|NCT00996892|3914196|P14|Expansion Stage 2A|Withdrawal by Subject|0
1191552|NCT00996892|3914197|P13|Expansion Stage 2A|Withdrawal by Subject|0
1191553|NCT00996892|3914198|P12|Expansion Stage 2A|Withdrawal by Subject|0
1191554|NCT00996892|3914199|P11|Expansion Stage 2A|Withdrawal by Subject|0
1191555|NCT00996892|3914200|P10|Expansion Stage 2A|Withdrawal by Subject|0
1191556|NCT00996892|3914201|P9|Expansion Stage 2A|Withdrawal by Subject|0
1191557|NCT00996892|3914202|P8|Expansion Stage 2A|Withdrawal by Subject|0
1191558|NCT00996892|3914203|P7|Expansion Stage 2A|Withdrawal by Subject|0
1191559|NCT00996892|3914204|P6|Expansion Stage 2A|Withdrawal by Subject|0
1191560|NCT00996892|3914205|P5|Expansion Stage 2A|Withdrawal by Subject|0
1191561|NCT00996892|3914206|P4|Expansion Stage 2A|Withdrawal by Subject|0
1191562|NCT00996892|3914207|P3|Expansion Stage 2A|Withdrawal by Subject|0
1191563|NCT00996892|3914208|P2|Expansion Stage 2A|Withdrawal by Subject|0
1191564|NCT00996892|3914209|P1|Expansion Stage 2A|Withdrawal by Subject|0
1191565|NCT00996892|3914190|P20|Expansion Stage 2A|Physician Decision|2
1191566|NCT00996892|3914191|P19|Expansion Stage 2A|Physician Decision|0
1191567|NCT00996892|3914192|P18|Expansion Stage 2A|Physician Decision|0
1191568|NCT00996892|3914193|P17|Expansion Stage 2A|Physician Decision|0
1191569|NCT00996892|3914194|P16|Expansion Stage 2A|Physician Decision|0
1191570|NCT00996892|3914195|P15|Expansion Stage 2A|Physician Decision|0
1191571|NCT00996892|3914196|P14|Expansion Stage 2A|Physician Decision|0
1191572|NCT00996892|3914197|P13|Expansion Stage 2A|Physician Decision|0
1191573|NCT00996892|3914198|P12|Expansion Stage 2A|Physician Decision|0
1191574|NCT00996892|3914199|P11|Expansion Stage 2A|Physician Decision|0
1191575|NCT00996892|3914200|P10|Expansion Stage 2A|Physician Decision|0
1191576|NCT00996892|3914201|P9|Expansion Stage 2A|Physician Decision|0
1191577|NCT00996892|3914202|P8|Expansion Stage 2A|Physician Decision|0
1191578|NCT00996892|3914203|P7|Expansion Stage 2A|Physician Decision|0
1191579|NCT00996892|3914204|P6|Expansion Stage 2A|Physician Decision|0
1191580|NCT00996892|3914205|P5|Expansion Stage 2A|Physician Decision|0
1191581|NCT00996892|3914206|P4|Expansion Stage 2A|Physician Decision|0
1191582|NCT00996892|3914207|P3|Expansion Stage 2A|Physician Decision|0
1191583|NCT00996892|3914208|P2|Expansion Stage 2A|Physician Decision|0
1191584|NCT00996892|3914209|P1|Expansion Stage 2A|Physician Decision|0
1191585|NCT00996892|3914190|P20|Expansion Stage 2A|Adverse Event|8
1191586|NCT00996892|3914191|P19|Expansion Stage 2A|Adverse Event|0
1191587|NCT00996892|3914192|P18|Expansion Stage 2A|Adverse Event|0
1191588|NCT00996892|3914193|P17|Expansion Stage 2A|Adverse Event|0
1191589|NCT00996892|3914194|P16|Expansion Stage 2A|Adverse Event|0
1191590|NCT00996892|3914195|P15|Expansion Stage 2A|Adverse Event|0
1191591|NCT00996892|3914196|P14|Expansion Stage 2A|Adverse Event|0
1191592|NCT00996892|3914197|P13|Expansion Stage 2A|Adverse Event|0
1191593|NCT00996892|3914198|P12|Expansion Stage 2A|Adverse Event|0
1191594|NCT00996892|3914199|P11|Expansion Stage 2A|Adverse Event|0
1191595|NCT00996892|3914200|P10|Expansion Stage 2A|Adverse Event|0
1191596|NCT00996892|3914201|P9|Expansion Stage 2A|Adverse Event|0
1191597|NCT00996892|3914202|P8|Expansion Stage 2A|Adverse Event|0
1191598|NCT00996892|3914203|P7|Expansion Stage 2A|Adverse Event|0
1191599|NCT00996892|3914204|P6|Expansion Stage 2A|Adverse Event|0
1191600|NCT00996892|3914205|P5|Expansion Stage 2A|Adverse Event|0
1191601|NCT00996892|3914206|P4|Expansion Stage 2A|Adverse Event|0
1191602|NCT00996892|3914207|P3|Expansion Stage 2A|Adverse Event|0
1191603|NCT00996892|3914208|P2|Expansion Stage 2A|Adverse Event|0
1191604|NCT00996892|3914209|P1|Expansion Stage 2A|Adverse Event|0
1191605|NCT00996892|3914190|P20|Expansion Stage 2|Disease Progression|0
1191606|NCT00996892|3914191|P19|Expansion Stage 2|Disease Progression|28
1191607|NCT00996892|3914192|P18|Expansion Stage 2|Disease Progression|0
1191608|NCT00996892|3914193|P17|Expansion Stage 2|Disease Progression|0
1191609|NCT00996892|3914194|P16|Expansion Stage 2|Disease Progression|0
1191610|NCT00996892|3914195|P15|Expansion Stage 2|Disease Progression|0
1191611|NCT00996892|3914196|P14|Expansion Stage 2|Disease Progression|0
1191612|NCT00996892|3914197|P13|Expansion Stage 2|Disease Progression|0
1191613|NCT00996892|3914198|P12|Expansion Stage 2|Disease Progression|0
1191614|NCT00996892|3914199|P11|Expansion Stage 2|Disease Progression|0
1191615|NCT00996892|3914200|P10|Expansion Stage 2|Disease Progression|0
1191616|NCT00996892|3914201|P9|Expansion Stage 2|Disease Progression|0
1191617|NCT00996892|3914202|P8|Expansion Stage 2|Disease Progression|0
1191618|NCT00996892|3914203|P7|Expansion Stage 2|Disease Progression|0
1191619|NCT00996892|3914204|P6|Expansion Stage 2|Disease Progression|0
1191620|NCT00996892|3914205|P5|Expansion Stage 2|Disease Progression|0
1191621|NCT00996892|3914206|P4|Expansion Stage 2|Disease Progression|0
1191622|NCT00996892|3914207|P3|Expansion Stage 2|Disease Progression|0
1191623|NCT00996892|3914208|P2|Expansion Stage 2|Disease Progression|0
1191624|NCT00996892|3914209|P1|Expansion Stage 2|Disease Progression|0
1191625|NCT00996892|3914190|P20|Expansion Stage 2|Withdrawal by Subject|0
1191626|NCT00996892|3914191|P19|Expansion Stage 2|Withdrawal by Subject|1
1191627|NCT00996892|3914192|P18|Expansion Stage 2|Withdrawal by Subject|0
1191628|NCT00996892|3914193|P17|Expansion Stage 2|Withdrawal by Subject|0
1191629|NCT00996892|3914194|P16|Expansion Stage 2|Withdrawal by Subject|0
1191630|NCT00996892|3914195|P15|Expansion Stage 2|Withdrawal by Subject|0
1191631|NCT00996892|3914196|P14|Expansion Stage 2|Withdrawal by Subject|0
1191632|NCT00996892|3914197|P13|Expansion Stage 2|Withdrawal by Subject|0
1191633|NCT00996892|3914198|P12|Expansion Stage 2|Withdrawal by Subject|0
1191634|NCT00996892|3914199|P11|Expansion Stage 2|Withdrawal by Subject|0
1191635|NCT00996892|3914200|P10|Expansion Stage 2|Withdrawal by Subject|0
1191636|NCT00996892|3914201|P9|Expansion Stage 2|Withdrawal by Subject|0
1191637|NCT00996892|3914202|P8|Expansion Stage 2|Withdrawal by Subject|0
1191638|NCT00996892|3914203|P7|Expansion Stage 2|Withdrawal by Subject|0
1191639|NCT00996892|3914204|P6|Expansion Stage 2|Withdrawal by Subject|0
1191640|NCT00996892|3914205|P5|Expansion Stage 2|Withdrawal by Subject|0
1191641|NCT00996892|3914206|P4|Expansion Stage 2|Withdrawal by Subject|0
1191642|NCT00996892|3914207|P3|Expansion Stage 2|Withdrawal by Subject|0
1191643|NCT00996892|3914208|P2|Expansion Stage 2|Withdrawal by Subject|0
1191644|NCT00996892|3914209|P1|Expansion Stage 2|Withdrawal by Subject|0
1191645|NCT00996892|3914190|P20|Expansion Stage 2|Physician Decision|0
1191646|NCT00996892|3914191|P19|Expansion Stage 2|Physician Decision|1
1191647|NCT00996892|3914192|P18|Expansion Stage 2|Physician Decision|0
1191648|NCT00996892|3914193|P17|Expansion Stage 2|Physician Decision|0
1191649|NCT00996892|3914194|P16|Expansion Stage 2|Physician Decision|0
1191650|NCT00996892|3914195|P15|Expansion Stage 2|Physician Decision|0
1191651|NCT00996892|3914196|P14|Expansion Stage 2|Physician Decision|0
1191652|NCT00996892|3914197|P13|Expansion Stage 2|Physician Decision|0
1191653|NCT00996892|3914198|P12|Expansion Stage 2|Physician Decision|0
1191654|NCT00996892|3914199|P11|Expansion Stage 2|Physician Decision|0
1191655|NCT00996892|3914200|P10|Expansion Stage 2|Physician Decision|0
1191656|NCT00996892|3914201|P9|Expansion Stage 2|Physician Decision|0
1191657|NCT00996892|3914202|P8|Expansion Stage 2|Physician Decision|0
1191658|NCT00996892|3914203|P7|Expansion Stage 2|Physician Decision|0
1191659|NCT00996892|3914204|P6|Expansion Stage 2|Physician Decision|0
1191660|NCT00996892|3914205|P5|Expansion Stage 2|Physician Decision|0
1191661|NCT00996892|3914206|P4|Expansion Stage 2|Physician Decision|0
1191662|NCT00996892|3914207|P3|Expansion Stage 2|Physician Decision|0
1191663|NCT00996892|3914208|P2|Expansion Stage 2|Physician Decision|0
1191664|NCT00996892|3914209|P1|Expansion Stage 2|Physician Decision|0
1191665|NCT00996892|3914190|P20|Expansion Stage 2|Death|0
1191666|NCT00996892|3914191|P19|Expansion Stage 2|Death|2
1191667|NCT00996892|3914192|P18|Expansion Stage 2|Death|0
1191668|NCT00996892|3914193|P17|Expansion Stage 2|Death|0
1191669|NCT00996892|3914194|P16|Expansion Stage 2|Death|0
1191670|NCT00996892|3914195|P15|Expansion Stage 2|Death|0
1191671|NCT00996892|3914196|P14|Expansion Stage 2|Death|0
1191672|NCT00996892|3914197|P13|Expansion Stage 2|Death|0
1191673|NCT00996892|3914198|P12|Expansion Stage 2|Death|0
1191674|NCT00996892|3914199|P11|Expansion Stage 2|Death|0
1191675|NCT00996892|3914200|P10|Expansion Stage 2|Death|0
1191676|NCT00996892|3914201|P9|Expansion Stage 2|Death|0
1191677|NCT00996892|3914202|P8|Expansion Stage 2|Death|0
1191678|NCT00996892|3914203|P7|Expansion Stage 2|Death|0
1191679|NCT00996892|3914204|P6|Expansion Stage 2|Death|0
1191680|NCT00996892|3914205|P5|Expansion Stage 2|Death|0
1191681|NCT00996892|3914206|P4|Expansion Stage 2|Death|0
1191682|NCT00996892|3914207|P3|Expansion Stage 2|Death|0
1191683|NCT00996892|3914208|P2|Expansion Stage 2|Death|0
1191684|NCT00996892|3914209|P1|Expansion Stage 2|Death|0
1191685|NCT00996892|3914190|P20|Expansion Stage 2|Adverse Event|0
1191686|NCT00996892|3914191|P19|Expansion Stage 2|Adverse Event|3
1191687|NCT00996892|3914192|P18|Expansion Stage 2|Adverse Event|0
1191688|NCT00996892|3914193|P17|Expansion Stage 2|Adverse Event|0
1191689|NCT00996892|3914194|P16|Expansion Stage 2|Adverse Event|0
1191690|NCT00996892|3914195|P15|Expansion Stage 2|Adverse Event|0
1191691|NCT00996892|3914196|P14|Expansion Stage 2|Adverse Event|0
1191692|NCT00996892|3914197|P13|Expansion Stage 2|Adverse Event|0
1191693|NCT00996892|3914198|P12|Expansion Stage 2|Adverse Event|0
1191694|NCT00996892|3914199|P11|Expansion Stage 2|Adverse Event|0
1191695|NCT00996892|3914200|P10|Expansion Stage 2|Adverse Event|0
1191696|NCT00996892|3914201|P9|Expansion Stage 2|Adverse Event|0
1191697|NCT00996892|3914202|P8|Expansion Stage 2|Adverse Event|0
1191698|NCT00996892|3914203|P7|Expansion Stage 2|Adverse Event|0
1191699|NCT00996892|3914204|P6|Expansion Stage 2|Adverse Event|0
1191700|NCT00996892|3914205|P5|Expansion Stage 2|Adverse Event|0
1191701|NCT00996892|3914206|P4|Expansion Stage 2|Adverse Event|0
1191702|NCT00996892|3914207|P3|Expansion Stage 2|Adverse Event|0
1191703|NCT00996892|3914208|P2|Expansion Stage 2|Adverse Event|0
1191704|NCT00996892|3914209|P1|Expansion Stage 2|Adverse Event|0
1191705|NCT00996892|3914190|P20|Dose-Escalation Stage 1B|Disease Progression|0
1191706|NCT00996892|3914191|P19|Dose-Escalation Stage 1B|Disease Progression|0
1191707|NCT00996892|3914192|P18|Dose-Escalation Stage 1B|Disease Progression|3
1191708|NCT00996892|3914193|P17|Dose-Escalation Stage 1B|Disease Progression|3
1191709|NCT00996892|3914194|P16|Dose-Escalation Stage 1B|Disease Progression|3
1191710|NCT00996892|3914195|P15|Dose-Escalation Stage 1B|Disease Progression|4
1191711|NCT00996892|3914196|P14|Dose-Escalation Stage 1B|Disease Progression|0
1191712|NCT00996892|3914197|P13|Dose-Escalation Stage 1B|Disease Progression|0
1191713|NCT00996892|3914198|P12|Dose-Escalation Stage 1B|Disease Progression|0
1191714|NCT00996892|3914199|P11|Dose-Escalation Stage 1B|Disease Progression|0
1191715|NCT00996892|3914200|P10|Dose-Escalation Stage 1B|Disease Progression|0
1191716|NCT00996892|3914201|P9|Dose-Escalation Stage 1B|Disease Progression|0
1191717|NCT00996892|3914202|P8|Dose-Escalation Stage 1B|Disease Progression|0
1191718|NCT00996892|3914203|P7|Dose-Escalation Stage 1B|Disease Progression|0
1191719|NCT00996892|3914204|P6|Dose-Escalation Stage 1B|Disease Progression|0
1191720|NCT00996892|3914205|P5|Dose-Escalation Stage 1B|Disease Progression|0
1191721|NCT00996892|3914206|P4|Dose-Escalation Stage 1B|Disease Progression|0
1191722|NCT00996892|3914207|P3|Dose-Escalation Stage 1B|Disease Progression|0
1191723|NCT00996892|3914208|P2|Dose-Escalation Stage 1B|Disease Progression|0
1191724|NCT00996892|3914209|P1|Dose-Escalation Stage 1B|Disease Progression|0
1191725|NCT00996892|3914190|P20|Dose-Escalation Stage 1B|Physician Decision|0
1191726|NCT00996892|3914191|P19|Dose-Escalation Stage 1B|Physician Decision|0
1191727|NCT00996892|3914192|P18|Dose-Escalation Stage 1B|Physician Decision|2
1191728|NCT00996892|3914193|P17|Dose-Escalation Stage 1B|Physician Decision|0
1191729|NCT00996892|3914194|P16|Dose-Escalation Stage 1B|Physician Decision|0
1191730|NCT00996892|3914195|P15|Dose-Escalation Stage 1B|Physician Decision|0
1191731|NCT00996892|3914196|P14|Dose-Escalation Stage 1B|Physician Decision|0
1191732|NCT00996892|3914197|P13|Dose-Escalation Stage 1B|Physician Decision|0
1191733|NCT00996892|3914198|P12|Dose-Escalation Stage 1B|Physician Decision|0
1191734|NCT00996892|3914199|P11|Dose-Escalation Stage 1B|Physician Decision|0
1191735|NCT00996892|3914200|P10|Dose-Escalation Stage 1B|Physician Decision|0
1191736|NCT00996892|3914201|P9|Dose-Escalation Stage 1B|Physician Decision|0
1191737|NCT00996892|3914202|P8|Dose-Escalation Stage 1B|Physician Decision|0
1191738|NCT00996892|3914203|P7|Dose-Escalation Stage 1B|Physician Decision|0
1191739|NCT00996892|3914204|P6|Dose-Escalation Stage 1B|Physician Decision|0
1191740|NCT00996892|3914205|P5|Dose-Escalation Stage 1B|Physician Decision|0
1191741|NCT00996892|3914206|P4|Dose-Escalation Stage 1B|Physician Decision|0
1191742|NCT00996892|3914207|P3|Dose-Escalation Stage 1B|Physician Decision|0
1191743|NCT00996892|3914208|P2|Dose-Escalation Stage 1B|Physician Decision|0
1191744|NCT00996892|3914209|P1|Dose-Escalation Stage 1B|Physician Decision|0
1191745|NCT00996892|3914190|P20|Dose-Escalation Stage 1A|Disease Progression|0
1191746|NCT00996892|3914191|P19|Dose-Escalation Stage 1A|Disease Progression|0
1191747|NCT00996892|3914192|P18|Dose-Escalation Stage 1A|Disease Progression|0
1191748|NCT00996892|3914193|P17|Dose-Escalation Stage 1A|Disease Progression|0
1191749|NCT00996892|3914194|P16|Dose-Escalation Stage 1A|Disease Progression|0
1191750|NCT00996892|3914195|P15|Dose-Escalation Stage 1A|Disease Progression|0
1191751|NCT00996892|3914196|P14|Dose-Escalation Stage 1A|Disease Progression|4
1191752|NCT00996892|3914197|P13|Dose-Escalation Stage 1A|Disease Progression|6
1191753|NCT00996892|3914198|P12|Dose-Escalation Stage 1A|Disease Progression|7
1191754|NCT00996892|3914199|P11|Dose-Escalation Stage 1A|Disease Progression|5
1191755|NCT00996892|3914200|P10|Dose-Escalation Stage 1A|Disease Progression|1
1191756|NCT00996892|3914201|P9|Dose-Escalation Stage 1A|Disease Progression|3
1191757|NCT00996892|3914202|P8|Dose-Escalation Stage 1A|Disease Progression|2
1191758|NCT00996892|3914203|P7|Dose-Escalation Stage 1A|Disease Progression|0
1191759|NCT00996892|3914204|P6|Dose-Escalation Stage 1A|Disease Progression|0
1191760|NCT00996892|3914205|P5|Dose-Escalation Stage 1A|Disease Progression|0
1191761|NCT00996892|3914206|P4|Dose-Escalation Stage 1A|Disease Progression|0
1191762|NCT00996892|3914207|P3|Dose-Escalation Stage 1A|Disease Progression|0
1191763|NCT00996892|3914208|P2|Dose-Escalation Stage 1A|Disease Progression|0
1191764|NCT00996892|3914209|P1|Dose-Escalation Stage 1A|Disease Progression|0
1191765|NCT00996892|3914190|P20|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1191766|NCT00996892|3914191|P19|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1191767|NCT00996892|3914192|P18|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1191768|NCT00996892|3914193|P17|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1191769|NCT00996892|3914194|P16|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1191770|NCT00996892|3914195|P15|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1191771|NCT00996892|3914196|P14|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1191772|NCT00996892|3914197|P13|Dose-Escalation Stage 1A|Withdrawal by Subject|1
1191773|NCT00996892|3914198|P12|Dose-Escalation Stage 1A|Withdrawal by Subject|1
1191774|NCT00996892|3914199|P11|Dose-Escalation Stage 1A|Withdrawal by Subject|1
1191775|NCT00996892|3914200|P10|Dose-Escalation Stage 1A|Withdrawal by Subject|1
1191776|NCT00996892|3914201|P9|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1191777|NCT00996892|3914202|P8|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1191778|NCT00996892|3914203|P7|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1191779|NCT00996892|3914204|P6|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1191780|NCT00996892|3914205|P5|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1191781|NCT00996892|3914206|P4|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1191782|NCT00996892|3914207|P3|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1191783|NCT00996892|3914208|P2|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1191784|NCT00996892|3914209|P1|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1191785|NCT00996892|3914190|P20|Dose-Escalation Stage 1A|Physician Decision|0
1191786|NCT00996892|3914191|P19|Dose-Escalation Stage 1A|Physician Decision|0
1191787|NCT00996892|3914192|P18|Dose-Escalation Stage 1A|Physician Decision|0
1191788|NCT00996892|3914193|P17|Dose-Escalation Stage 1A|Physician Decision|0
1191789|NCT00996892|3914194|P16|Dose-Escalation Stage 1A|Physician Decision|0
1191790|NCT00996892|3914195|P15|Dose-Escalation Stage 1A|Physician Decision|0
1191791|NCT00996892|3914196|P14|Dose-Escalation Stage 1A|Physician Decision|0
1191792|NCT00996892|3914197|P13|Dose-Escalation Stage 1A|Physician Decision|0
1191793|NCT00996892|3914198|P12|Dose-Escalation Stage 1A|Physician Decision|0
1191794|NCT00996892|3914199|P11|Dose-Escalation Stage 1A|Physician Decision|0
1191795|NCT00996892|3914200|P10|Dose-Escalation Stage 1A|Physician Decision|0
1191796|NCT00996892|3914201|P9|Dose-Escalation Stage 1A|Physician Decision|0
1191797|NCT00996892|3914202|P8|Dose-Escalation Stage 1A|Physician Decision|1
1191798|NCT00996892|3914203|P7|Dose-Escalation Stage 1A|Physician Decision|0
1191799|NCT00996892|3914204|P6|Dose-Escalation Stage 1A|Physician Decision|0
1191800|NCT00996892|3914205|P5|Dose-Escalation Stage 1A|Physician Decision|0
1191801|NCT00996892|3914206|P4|Dose-Escalation Stage 1A|Physician Decision|0
1191802|NCT00996892|3914207|P3|Dose-Escalation Stage 1A|Physician Decision|0
1191803|NCT00996892|3914208|P2|Dose-Escalation Stage 1A|Physician Decision|0
1191804|NCT00996892|3914209|P1|Dose-Escalation Stage 1A|Physician Decision|0
1191805|NCT00996892|3914190|P20|Dose-Escalation Stage 1A|Death|0
1191806|NCT00996892|3914191|P19|Dose-Escalation Stage 1A|Death|0
1191807|NCT00996892|3914192|P18|Dose-Escalation Stage 1A|Death|0
1191808|NCT00996892|3914193|P17|Dose-Escalation Stage 1A|Death|0
1191809|NCT00996892|3914194|P16|Dose-Escalation Stage 1A|Death|0
1191810|NCT00996892|3914195|P15|Dose-Escalation Stage 1A|Death|0
1191811|NCT00996892|3914196|P14|Dose-Escalation Stage 1A|Death|0
1191812|NCT00996892|3914197|P13|Dose-Escalation Stage 1A|Death|1
1191813|NCT00996892|3914198|P12|Dose-Escalation Stage 1A|Death|1
1191814|NCT00996892|3914199|P11|Dose-Escalation Stage 1A|Death|0
1191815|NCT00996892|3914200|P10|Dose-Escalation Stage 1A|Death|2
1191816|NCT00996892|3914201|P9|Dose-Escalation Stage 1A|Death|0
1191817|NCT00996892|3914202|P8|Dose-Escalation Stage 1A|Death|0
1191818|NCT00996892|3914203|P7|Dose-Escalation Stage 1A|Death|0
1191819|NCT00996892|3914204|P6|Dose-Escalation Stage 1A|Death|0
1191820|NCT00996892|3914205|P5|Dose-Escalation Stage 1A|Death|0
1191821|NCT00996892|3914206|P4|Dose-Escalation Stage 1A|Death|0
1191822|NCT00996892|3914207|P3|Dose-Escalation Stage 1A|Death|0
1191823|NCT00996892|3914208|P2|Dose-Escalation Stage 1A|Death|0
1191824|NCT00996892|3914209|P1|Dose-Escalation Stage 1A|Death|0
1191825|NCT00996892|3914190|P20|Dose-Escalation Stage 1A|Adverse Event|0
1191826|NCT00996892|3914191|P19|Dose-Escalation Stage 1A|Adverse Event|0
1191827|NCT00996892|3914192|P18|Dose-Escalation Stage 1A|Adverse Event|0
1191828|NCT00996892|3914193|P17|Dose-Escalation Stage 1A|Adverse Event|0
1191829|NCT00996892|3914194|P16|Dose-Escalation Stage 1A|Adverse Event|0
1191830|NCT00996892|3914195|P15|Dose-Escalation Stage 1A|Adverse Event|0
1191831|NCT00996892|3914196|P14|Dose-Escalation Stage 1A|Adverse Event|1
1191832|NCT00996892|3914197|P13|Dose-Escalation Stage 1A|Adverse Event|0
1191833|NCT00996892|3914198|P12|Dose-Escalation Stage 1A|Adverse Event|0
1191834|NCT00996892|3914199|P11|Dose-Escalation Stage 1A|Adverse Event|1
1191835|NCT00996892|3914200|P10|Dose-Escalation Stage 1A|Adverse Event|0
1191836|NCT00996892|3914201|P9|Dose-Escalation Stage 1A|Adverse Event|0
1191837|NCT00996892|3914202|P8|Dose-Escalation Stage 1A|Adverse Event|0
1191838|NCT00996892|3914203|P7|Dose-Escalation Stage 1A|Adverse Event|0
1191839|NCT00996892|3914204|P6|Dose-Escalation Stage 1A|Adverse Event|0
1191840|NCT00996892|3914205|P5|Dose-Escalation Stage 1A|Adverse Event|0
1191841|NCT00996892|3914206|P4|Dose-Escalation Stage 1A|Adverse Event|0
1191842|NCT00996892|3914207|P3|Dose-Escalation Stage 1A|Adverse Event|0
1191843|NCT00996892|3914208|P2|Dose-Escalation Stage 1A|Adverse Event|0
1191844|NCT00996892|3914209|P1|Dose-Escalation Stage 1A|Adverse Event|0
1191845|NCT00996892|3914190|P20|Dose-Escalation Stage 1|Disease Progression|0
1191846|NCT00996892|3914191|P19|Dose-Escalation Stage 1|Disease Progression|0
1191847|NCT00996892|3914192|P18|Dose-Escalation Stage 1|Disease Progression|0
1191848|NCT00996892|3914193|P17|Dose-Escalation Stage 1|Disease Progression|0
1191849|NCT00996892|3914194|P16|Dose-Escalation Stage 1|Disease Progression|0
1191850|NCT00996892|3914195|P15|Dose-Escalation Stage 1|Disease Progression|0
1191851|NCT00996892|3914196|P14|Dose-Escalation Stage 1|Disease Progression|0
1191852|NCT00996892|3914197|P13|Dose-Escalation Stage 1|Disease Progression|0
1191853|NCT00996892|3914198|P12|Dose-Escalation Stage 1|Disease Progression|0
1191854|NCT00996892|3914199|P11|Dose-Escalation Stage 1|Disease Progression|0
1191855|NCT00996892|3914200|P10|Dose-Escalation Stage 1|Disease Progression|0
1191856|NCT00996892|3914201|P9|Dose-Escalation Stage 1|Disease Progression|0
1191857|NCT00996892|3914202|P8|Dose-Escalation Stage 1|Disease Progression|0
1191858|NCT00996892|3914203|P7|Dose-Escalation Stage 1|Disease Progression|0
1191859|NCT00996892|3914204|P6|Dose-Escalation Stage 1|Disease Progression|7
1191860|NCT00996892|3914205|P5|Dose-Escalation Stage 1|Disease Progression|10
1191861|NCT00996892|3914206|P4|Dose-Escalation Stage 1|Disease Progression|4
1191862|NCT00996892|3914207|P3|Dose-Escalation Stage 1|Disease Progression|3
1191863|NCT00996892|3914208|P2|Dose-Escalation Stage 1|Disease Progression|2
1191864|NCT00996892|3914209|P1|Dose-Escalation Stage 1|Disease Progression|2
1191865|NCT00996892|3914190|P20|Dose-Escalation Stage 1|Withdrawal by Subject|0
1191866|NCT00996892|3914191|P19|Dose-Escalation Stage 1|Withdrawal by Subject|0
1191867|NCT00996892|3914192|P18|Dose-Escalation Stage 1|Withdrawal by Subject|0
1191868|NCT00996892|3914193|P17|Dose-Escalation Stage 1|Withdrawal by Subject|0
1191869|NCT00996892|3914194|P16|Dose-Escalation Stage 1|Withdrawal by Subject|0
1191870|NCT00996892|3914195|P15|Dose-Escalation Stage 1|Withdrawal by Subject|0
1191871|NCT00996892|3914196|P14|Dose-Escalation Stage 1|Withdrawal by Subject|0
1191872|NCT00996892|3914197|P13|Dose-Escalation Stage 1|Withdrawal by Subject|0
1191873|NCT00996892|3914198|P12|Dose-Escalation Stage 1|Withdrawal by Subject|0
1191874|NCT00996892|3914199|P11|Dose-Escalation Stage 1|Withdrawal by Subject|0
1191875|NCT00996892|3914200|P10|Dose-Escalation Stage 1|Withdrawal by Subject|0
1191876|NCT00996892|3914201|P9|Dose-Escalation Stage 1|Withdrawal by Subject|0
1191877|NCT00996892|3914202|P8|Dose-Escalation Stage 1|Withdrawal by Subject|0
1191878|NCT00996892|3914203|P7|Dose-Escalation Stage 1|Withdrawal by Subject|1
1191879|NCT00996892|3914204|P6|Dose-Escalation Stage 1|Withdrawal by Subject|1
1191880|NCT00996892|3914205|P5|Dose-Escalation Stage 1|Withdrawal by Subject|1
1191881|NCT00996892|3914206|P4|Dose-Escalation Stage 1|Withdrawal by Subject|2
1191882|NCT00996892|3914207|P3|Dose-Escalation Stage 1|Withdrawal by Subject|0
1191883|NCT00996892|3914208|P2|Dose-Escalation Stage 1|Withdrawal by Subject|1
1191884|NCT00996892|3914209|P1|Dose-Escalation Stage 1|Withdrawal by Subject|0
1191885|NCT00996892|3914190|P20|Dose-Escalation Stage 1|Physician Decision|0
1191886|NCT00996892|3914191|P19|Dose-Escalation Stage 1|Physician Decision|0
1191887|NCT00996892|3914192|P18|Dose-Escalation Stage 1|Physician Decision|0
1191888|NCT00996892|3914193|P17|Dose-Escalation Stage 1|Physician Decision|0
1191889|NCT00996892|3914194|P16|Dose-Escalation Stage 1|Physician Decision|0
1191890|NCT00996892|3914195|P15|Dose-Escalation Stage 1|Physician Decision|0
1191891|NCT00996892|3914196|P14|Dose-Escalation Stage 1|Physician Decision|0
1191892|NCT00996892|3914197|P13|Dose-Escalation Stage 1|Physician Decision|0
1191893|NCT00996892|3914198|P12|Dose-Escalation Stage 1|Physician Decision|0
1191894|NCT00996892|3914199|P11|Dose-Escalation Stage 1|Physician Decision|0
1191895|NCT00996892|3914200|P10|Dose-Escalation Stage 1|Physician Decision|0
1191896|NCT00996892|3914201|P9|Dose-Escalation Stage 1|Physician Decision|0
1191897|NCT00996892|3914202|P8|Dose-Escalation Stage 1|Physician Decision|0
1191898|NCT00996892|3914203|P7|Dose-Escalation Stage 1|Physician Decision|2
1191899|NCT00996892|3914204|P6|Dose-Escalation Stage 1|Physician Decision|1
1191900|NCT00996892|3914205|P5|Dose-Escalation Stage 1|Physician Decision|0
1191901|NCT00996892|3914206|P4|Dose-Escalation Stage 1|Physician Decision|1
1191902|NCT00996892|3914207|P3|Dose-Escalation Stage 1|Physician Decision|0
1191903|NCT00996892|3914208|P2|Dose-Escalation Stage 1|Physician Decision|0
1191904|NCT00996892|3914209|P1|Dose-Escalation Stage 1|Physician Decision|1
1191905|NCT00996892|3914190|P20|Dose-Escalation Stage 1|Death|0
1191906|NCT00996892|3914191|P19|Dose-Escalation Stage 1|Death|0
1191907|NCT00996892|3914192|P18|Dose-Escalation Stage 1|Death|0
1191908|NCT00996892|3914193|P17|Dose-Escalation Stage 1|Death|0
1191909|NCT00996892|3914194|P16|Dose-Escalation Stage 1|Death|0
1191910|NCT00996892|3914195|P15|Dose-Escalation Stage 1|Death|0
1191911|NCT00996892|3914196|P14|Dose-Escalation Stage 1|Death|0
1191912|NCT00996892|3914197|P13|Dose-Escalation Stage 1|Death|0
1191913|NCT00996892|3914198|P12|Dose-Escalation Stage 1|Death|0
1191914|NCT00996892|3914199|P11|Dose-Escalation Stage 1|Death|0
1191915|NCT00996892|3914200|P10|Dose-Escalation Stage 1|Death|0
1191916|NCT00996892|3914201|P9|Dose-Escalation Stage 1|Death|0
1191917|NCT00996892|3914202|P8|Dose-Escalation Stage 1|Death|0
1191918|NCT00996892|3914203|P7|Dose-Escalation Stage 1|Death|0
1191919|NCT00996892|3914204|P6|Dose-Escalation Stage 1|Death|1
1191920|NCT00996892|3914205|P5|Dose-Escalation Stage 1|Death|0
1191921|NCT00996892|3914206|P4|Dose-Escalation Stage 1|Death|0
1191922|NCT00996892|3914207|P3|Dose-Escalation Stage 1|Death|0
1191923|NCT00996892|3914208|P2|Dose-Escalation Stage 1|Death|0
1191924|NCT00996892|3914209|P1|Dose-Escalation Stage 1|Death|1
1191925|NCT00996892|3914190|P20|Dose-Escalation Stage 1|Adverse Event|0
1191926|NCT00996892|3914191|P19|Dose-Escalation Stage 1|Adverse Event|0
1191927|NCT00996892|3914192|P18|Dose-Escalation Stage 1|Adverse Event|0
1191928|NCT00996892|3914193|P17|Dose-Escalation Stage 1|Adverse Event|0
1191929|NCT00996892|3914194|P16|Dose-Escalation Stage 1|Adverse Event|0
1191930|NCT00996892|3914195|P15|Dose-Escalation Stage 1|Adverse Event|0
1191931|NCT00996892|3914196|P14|Dose-Escalation Stage 1|Adverse Event|0
1191932|NCT00996892|3914197|P13|Dose-Escalation Stage 1|Adverse Event|0
1191933|NCT00996892|3914198|P12|Dose-Escalation Stage 1|Adverse Event|0
1191934|NCT00996892|3914199|P11|Dose-Escalation Stage 1|Adverse Event|0
1191935|NCT00996892|3914200|P10|Dose-Escalation Stage 1|Adverse Event|0
1191936|NCT00996892|3914201|P9|Dose-Escalation Stage 1|Adverse Event|0
1191937|NCT00996892|3914202|P8|Dose-Escalation Stage 1|Adverse Event|0
1191938|NCT00996892|3914203|P7|Dose-Escalation Stage 1|Adverse Event|1
1191939|NCT00996892|3914204|P6|Dose-Escalation Stage 1|Adverse Event|0
1191940|NCT00996892|3914205|P5|Dose-Escalation Stage 1|Adverse Event|0
1191941|NCT00996892|3914206|P4|Dose-Escalation Stage 1|Adverse Event|2
1191942|NCT00996892|3914207|P3|Dose-Escalation Stage 1|Adverse Event|0
1191943|NCT00996892|3914208|P2|Dose-Escalation Stage 1|Adverse Event|0
1191944|NCT00996892|3914209|P1|Dose-Escalation Stage 1|Adverse Event|0
1191945|NCT00996840|3914803|P5|Overall Study|Withdrawal by Subject|0
1191946|NCT00996840|3914804|P4|Overall Study|Withdrawal by Subject|0
1191947|NCT00996840|3914805|P3|Overall Study|Withdrawal by Subject|0
1191948|NCT00996840|3914806|P2|Overall Study|Withdrawal by Subject|1
1191949|NCT00996840|3914807|P1|Overall Study|Withdrawal by Subject|1
1191950|NCT00996840|3914803|P5|Overall Study|Physician Decision|2
1191951|NCT00996840|3914804|P4|Overall Study|Physician Decision|1
1191952|NCT00996840|3914805|P3|Overall Study|Physician Decision|1
1191953|NCT00996840|3914806|P2|Overall Study|Physician Decision|0
1191954|NCT00996840|3914807|P1|Overall Study|Physician Decision|0
1191955|NCT00996840|3914803|P5|Overall Study|Adverse Event|0
1191956|NCT00996840|3914804|P4|Overall Study|Adverse Event|0
1191957|NCT00996840|3914805|P3|Overall Study|Adverse Event|0
1191958|NCT00996840|3914806|P2|Overall Study|Adverse Event|1
1191959|NCT00996840|3914807|P1|Overall Study|Adverse Event|0
1191960|NCT00996801|3914957|P6|Overall Study|Withdrawal by Subject|9
1191961|NCT00996801|3914958|P5|Overall Study|Withdrawal by Subject|5
1191962|NCT00996801|3914959|P4|Overall Study|Withdrawal by Subject|5
1191963|NCT00996801|3914960|P3|Overall Study|Withdrawal by Subject|9
1191964|NCT00996801|3914961|P2|Overall Study|Withdrawal by Subject|6
1191965|NCT00996801|3914962|P1|Overall Study|Withdrawal by Subject|8
1191966|NCT00996801|3914957|P6|Overall Study|Study Terminated by Sponsor|0
1191967|NCT00996801|3914958|P5|Overall Study|Study Terminated by Sponsor|46
1191968|NCT00996801|3914959|P4|Overall Study|Study Terminated by Sponsor|0
1191969|NCT00996801|3914960|P3|Overall Study|Study Terminated by Sponsor|0
1191970|NCT00996801|3914961|P2|Overall Study|Study Terminated by Sponsor|1
1191971|NCT00996801|3914962|P1|Overall Study|Study Terminated by Sponsor|0
1191972|NCT00996801|3914957|P6|Overall Study|Protocol Violation|4
1191973|NCT00996801|3914958|P5|Overall Study|Protocol Violation|3
1191974|NCT00996801|3914959|P4|Overall Study|Protocol Violation|2
1191975|NCT00996801|3914960|P3|Overall Study|Protocol Violation|1
1191976|NCT00996801|3914961|P2|Overall Study|Protocol Violation|4
1191977|NCT00996801|3914962|P1|Overall Study|Protocol Violation|3
1191978|NCT00996801|3914957|P6|Overall Study|Progressive Disease|0
1191979|NCT00996801|3914958|P5|Overall Study|Progressive Disease|0
1191980|NCT00996801|3914959|P4|Overall Study|Progressive Disease|0
1191981|NCT00996801|3914960|P3|Overall Study|Progressive Disease|0
1191982|NCT00996801|3914961|P2|Overall Study|Progressive Disease|1
1191983|NCT00996801|3914962|P1|Overall Study|Progressive Disease|0
1191984|NCT00996801|3914957|P6|Overall Study|Physician Decision|0
1191985|NCT00996801|3914958|P5|Overall Study|Physician Decision|0
1191986|NCT00996801|3914959|P4|Overall Study|Physician Decision|1
1191987|NCT00996801|3914960|P3|Overall Study|Physician Decision|0
1191988|NCT00996801|3914961|P2|Overall Study|Physician Decision|0
1191989|NCT00996801|3914962|P1|Overall Study|Physician Decision|0
1191990|NCT00996801|3914957|P6|Overall Study|Lost to Follow-up|2
1191991|NCT00996801|3914958|P5|Overall Study|Lost to Follow-up|3
1191992|NCT00996801|3914959|P4|Overall Study|Lost to Follow-up|3
1191993|NCT00996801|3914960|P3|Overall Study|Lost to Follow-up|0
1191994|NCT00996801|3914961|P2|Overall Study|Lost to Follow-up|0
1191995|NCT00996801|3914962|P1|Overall Study|Lost to Follow-up|0
1191996|NCT00996801|3914957|P6|Overall Study|Lack of Efficacy|1
1191997|NCT00996801|3914958|P5|Overall Study|Lack of Efficacy|0
1191998|NCT00996801|3914959|P4|Overall Study|Lack of Efficacy|3
1191999|NCT00996801|3914960|P3|Overall Study|Lack of Efficacy|1
1192000|NCT00996801|3914961|P2|Overall Study|Lack of Efficacy|0
1192001|NCT00996801|3914962|P1|Overall Study|Lack of Efficacy|3
1192002|NCT00996801|3914957|P6|Overall Study|Adverse Event|3
1192003|NCT00996801|3914958|P5|Overall Study|Adverse Event|31
1192004|NCT00996801|3914959|P4|Overall Study|Adverse Event|17
1192005|NCT00996801|3914960|P3|Overall Study|Adverse Event|12
1192006|NCT00996801|3914961|P2|Overall Study|Adverse Event|4
1192007|NCT00996801|3914962|P1|Overall Study|Adverse Event|6
1192008|NCT00996736|3915074|P2|Overall Study|Visit not within 3-month window|3
1192009|NCT00996736|3915075|P1|Overall Study|Visit not within 3-month window|5
1192010|NCT00996736|3915074|P2|Overall Study|Lost to Follow-up|14
1192011|NCT00996736|3915075|P1|Overall Study|Lost to Follow-up|15
1192012|NCT00996736|3915074|P2|Overall Study|Death|1
1192013|NCT00996736|3915075|P1|Overall Study|Death|1
1192014|NCT00996658|3915095|P2|Overall Study|Other|7
1192015|NCT00996658|3915096|P1|Overall Study|Other|9
1192016|NCT00996658|3915095|P2|Overall Study|Non-compliance issues|3
1192017|NCT00996658|3915096|P1|Overall Study|Non-compliance issues|3
1192018|NCT00996658|3915095|P2|Overall Study|Lost to Follow-up|5
1192019|NCT00996658|3915096|P1|Overall Study|Lost to Follow-up|2
1192020|NCT00996658|3915095|P2|Overall Study|Protocol Violation|1
1192021|NCT00996658|3915096|P1|Overall Study|Protocol Violation|0
1192022|NCT00996658|3915095|P2|Overall Study|Adverse Event|5
1192023|NCT00996658|3915096|P1|Overall Study|Adverse Event|2
1192024|NCT00996632|3915124|P2|Overall Study|Physician Decision|0
1192025|NCT00996632|3915125|P1|Overall Study|Physician Decision|0
1192026|NCT00996606|3915133|P1|Overall Study|Withdrawal by Subject|3
1192027|NCT00996606|3915133|P1|Overall Study|Protocol Violation|1
1192028|NCT00996606|3915133|P1|Overall Study|Insufficient Therapeutic Response|2
1192029|NCT00996606|3915133|P1|Overall Study|Adverse Event or Intercurrent Illness|2
1192030|NCT00996593|3915227|P1|Long-Term Follow-Up|Site Closed|1
1192031|NCT00996593|3915227|P1|Long-Term Follow-Up|Withdrawal by Subject|2
1192032|NCT00996593|3915227|P1|Dosimetric and Therapeutic Treatment|Non-compliance|1
1192033|NCT00996593|3915227|P1|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3
1192034|NCT00996593|3915227|P1|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6
1192035|NCT00996593|3915227|P1|Dosimetric and Therapeutic Treatment|Death|1
1192036|NCT00996593|3915227|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|22
1192037|NCT00996593|3915227|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3
1192038|NCT00996593|3915227|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7
1192039|NCT00996580|3915255|P1|Overall Study|Not specified|29
1192040|NCT00996580|3915255|P1|Overall Study|Withdrawal by Subject|217
1192041|NCT00996580|3915255|P1|Overall Study|Sponsor requested participant withdrawal|35
1192042|NCT00996580|3915255|P1|Overall Study|Protocol Violation|16
1192043|NCT00996580|3915255|P1|Overall Study|Pregnancy|68
1192044|NCT00996580|3915255|P1|Overall Study|Physician Decision|5
1192045|NCT00996580|3915255|P1|Overall Study|Noncompliance with the protocol|137
1192046|NCT00996580|3915255|P1|Overall Study|Lost to Follow-up|480
1192047|NCT00996580|3915255|P1|Overall Study|Adverse Event|466
1192048|NCT00996476|3915292|P5|Overall Study|Adverse Event|1
1192049|NCT00996476|3915293|P4|Overall Study|Adverse Event|0
1192050|NCT00996476|3915294|P3|Overall Study|Adverse Event|0
1192051|NCT00996476|3915295|P2|Overall Study|Adverse Event|1
1192052|NCT00996476|3915296|P1|Overall Study|Adverse Event|0
1192053|NCT00996476|3915292|P5|Overall Study|Withdrawal by Subject|1
1192054|NCT00996476|3915293|P4|Overall Study|Withdrawal by Subject|0
1192055|NCT00996476|3915294|P3|Overall Study|Withdrawal by Subject|1
1192056|NCT00996476|3915295|P2|Overall Study|Withdrawal by Subject|2
1192057|NCT00996476|3915296|P1|Overall Study|Withdrawal by Subject|1
1192058|NCT00996437|3915364|P2|Overall Study|Missed|5
1192059|NCT00996437|3915365|P1|Overall Study|Missed|2
1192060|NCT00996437|3915364|P2|Overall Study|Dropped|2
1192061|NCT00996437|3915365|P1|Overall Study|Dropped|2
1192062|NCT00996437|3915364|P2|Overall Study|Death|0
1192063|NCT00996437|3915365|P1|Overall Study|Death|1
1192064|NCT00996333|3915410|P1|Overall Study|Other|5
1192065|NCT00996333|3915410|P1|Overall Study|Physician Decision|1
1192066|NCT00996333|3915410|P1|Overall Study|Adverse Event|1
1192067|NCT00996333|3915410|P1|Overall Study|Death|4
1192068|NCT00996333|3915410|P1|Overall Study|Withdrawal by Subject|1
1192069|NCT00996333|3915410|P1|Overall Study|Screen failure|1
1192070|NCT00996307|3915420|P4|Overall Study|Unable to classify|1
1192071|NCT00996307|3915421|P3|Overall Study|Unable to classify|2
1192072|NCT00996307|3915422|P2|Overall Study|Unable to classify|0
1192073|NCT00996307|3915423|P1|Overall Study|Unable to classify|4
1192074|NCT00996307|3915420|P4|Overall Study|Administrative reason|0
1192075|NCT00996307|3915421|P3|Overall Study|Administrative reason|0
1192076|NCT00996307|3915422|P2|Overall Study|Administrative reason|1
1192077|NCT00996307|3915423|P1|Overall Study|Administrative reason|0
1192078|NCT00996307|3915420|P4|Overall Study|Lost to Follow-up|15
1192079|NCT00996307|3915421|P3|Overall Study|Lost to Follow-up|7
1192080|NCT00996307|3915422|P2|Overall Study|Lost to Follow-up|13
1192081|NCT00996307|3915423|P1|Overall Study|Lost to Follow-up|13
1192082|NCT00996307|3915420|P4|Overall Study|Withdrawal by Subject|5
1192083|NCT00996307|3915421|P3|Overall Study|Withdrawal by Subject|5
1192084|NCT00996307|3915422|P2|Overall Study|Withdrawal by Subject|2
1192085|NCT00996307|3915423|P1|Overall Study|Withdrawal by Subject|3
1192086|NCT00996307|3915420|P4|Overall Study|Adverse Event|0
1192087|NCT00996307|3915421|P3|Overall Study|Adverse Event|0
1192088|NCT00996307|3915422|P2|Overall Study|Adverse Event|1
1192089|NCT00996307|3915423|P1|Overall Study|Adverse Event|0
1192090|NCT00996281|3915483|P2|Overall Study|Other|7
1192091|NCT00996281|3915484|P1|Overall Study|Other|5
1192092|NCT00996281|3915483|P2|Overall Study|Lack of Efficacy|2
1192093|NCT00996281|3915484|P1|Overall Study|Lack of Efficacy|0
1192094|NCT00996281|3915483|P2|Overall Study|Withdrawal by Subject|20
1192095|NCT00996281|3915484|P1|Overall Study|Withdrawal by Subject|31
1192096|NCT00996281|3915483|P2|Overall Study|Lost to Follow-up|16
1192097|NCT00996281|3915484|P1|Overall Study|Lost to Follow-up|14
1192098|NCT00996281|3915483|P2|Overall Study|Major Protocol Deviation|7
1192099|NCT00996281|3915484|P1|Overall Study|Major Protocol Deviation|6
1192100|NCT00996281|3915483|P2|Overall Study|Adverse Event|37
1192101|NCT00996281|3915484|P1|Overall Study|Adverse Event|75
1192102|NCT00996216|3915492|P1|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1
1192103|NCT00996216|3915492|P1|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3
1192104|NCT00996216|3915492|P1|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1
1192105|NCT00996203|3915508|P1|Overall Study|Protocol Violation|2
1192106|NCT00996203|3915508|P1|Overall Study|Lack of Efficacy|1
1192107|NCT00996203|3915508|P1|Overall Study|Lost to Follow-up|1
1192108|NCT00996203|3915508|P1|Overall Study|Adverse Event|3
1192109|NCT00996125|3915540|P2|Overall Study|Withdrawal by Subject|3
1192110|NCT00996125|3915541|P1|Overall Study|Withdrawal by Subject|4
1192111|NCT00996125|3915540|P2|Overall Study|Lost to Follow-up|6
1192112|NCT00996125|3915541|P1|Overall Study|Lost to Follow-up|1
1192113|NCT00996125|3915540|P2|Overall Study|Adverse Event|2
1192114|NCT00996125|3915541|P1|Overall Study|Adverse Event|0
1192115|NCT00996034|3915561|P1|Overall Study|withdrawn by PI|1
1192116|NCT00996034|3915561|P1|Overall Study|Lost to Follow-up|2
1192117|NCT00995930|3915567|P2|Overall Study|Adverse Event|14
1192118|NCT00995930|3915568|P1|Overall Study|Adverse Event|11
1192119|NCT00995930|3915567|P2|Overall Study|Withdrawal by Subject|4
1192120|NCT00995930|3915568|P1|Overall Study|Withdrawal by Subject|3
1192121|NCT00995930|3915567|P2|Overall Study|Lost to Follow-up|2
1192122|NCT00995930|3915568|P1|Overall Study|Lost to Follow-up|1
1192123|NCT00995930|3915567|P2|Overall Study|Administrative problems|2
1192124|NCT00995930|3915568|P1|Overall Study|Administrative problems|4
1192125|NCT00995930|3915567|P2|Overall Study|Death|1
1192126|NCT00995930|3915568|P1|Overall Study|Death|0
1192127|NCT00995930|3915567|P2|Overall Study|Protocol deviation|5
1192128|NCT00995930|3915568|P1|Overall Study|Protocol deviation|2
1192129|NCT00995865|3915619|P3|Overall Study|Lost to Follow-up|1
1192130|NCT00995865|3915620|P2|Overall Study|Lost to Follow-up|0
1192131|NCT00995865|3915621|P1|Overall Study|Lost to Follow-up|0
1192132|NCT00995865|3915619|P3|Overall Study|Protocol Violation|0
1192133|NCT00995865|3915620|P2|Overall Study|Protocol Violation|0
1192134|NCT00995865|3915621|P1|Overall Study|Protocol Violation|2
1192135|NCT00995774|3915643|P2|Training Period 2|Withdrawal by Subject|0
1192136|NCT00995774|3915644|P1|Training Period 2|Withdrawal by Subject|2
1192137|NCT00995709|3915678|P3|Overall Study|Protocol Violation|0
1192138|NCT00995709|3915679|P2|Overall Study|Protocol Violation|1
1192139|NCT00995709|3915680|P1|Overall Study|Protocol Violation|2
1192140|NCT00995709|3915678|P3|Overall Study|Death|0
1192141|NCT00995709|3915679|P2|Overall Study|Death|1
1192142|NCT00995709|3915680|P1|Overall Study|Death|0
1192143|NCT00995709|3915678|P3|Overall Study|Lost to Follow-up|0
1192144|NCT00995709|3915679|P2|Overall Study|Lost to Follow-up|0
1192145|NCT00995709|3915680|P1|Overall Study|Lost to Follow-up|1
1192146|NCT00995709|3915678|P3|Overall Study|Withdrawal by Subject|1
1192147|NCT00995709|3915679|P2|Overall Study|Withdrawal by Subject|4
1192148|NCT00995709|3915680|P1|Overall Study|Withdrawal by Subject|0
1192149|NCT00995709|3915678|P3|Overall Study|Lack of Efficacy|4
1192150|NCT00995709|3915679|P2|Overall Study|Lack of Efficacy|1
1192151|NCT00995709|3915680|P1|Overall Study|Lack of Efficacy|0
1192152|NCT00995709|3915678|P3|Overall Study|Adverse Event|0
1192153|NCT00995709|3915679|P2|Overall Study|Adverse Event|2
1192154|NCT00995709|3915680|P1|Overall Study|Adverse Event|4
1192155|NCT00995670|3915706|P3|Overall Study|Failed arterial cannulation|3
1192156|NCT00995670|3915707|P2|Overall Study|Failed arterial cannulation|0
1192157|NCT00995670|3915708|P1|Overall Study|Failed arterial cannulation|1
1192158|NCT00995566|3915716|P1|Overall Study|Early study termination|52
1192159|NCT00995566|3915716|P1|Overall Study|Adverse Event|2
1192160|NCT00995553|3915730|P2|Overall Study|Withdrawal by Subject|6
1192161|NCT00995553|3915731|P1|Overall Study|Withdrawal by Subject|2
1192162|NCT00995488|3915780|P1|Overall Study|Withdrawal by Subject|1
1192163|NCT00995436|3915803|P3|Overall Study|Withdrawal by Subject|0
1192164|NCT00995436|3915804|P2|Overall Study|Withdrawal by Subject|5
1192165|NCT00995436|3915805|P1|Overall Study|Withdrawal by Subject|2
1192166|NCT00995410|3915813|P1|Overall Study|Misc|28
1192167|NCT00995410|3915813|P1|Overall Study|Lost to Follow-up|2
1192168|NCT00995410|3915813|P1|Overall Study|Withdrawal by Subject|7
1192169|NCT00995410|3915813|P1|Overall Study|Adverse Event|51
1192170|NCT00995371|3915820|P2|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
1192171|NCT00995371|3915821|P1|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
1192172|NCT00995345|3915839|P5|Overall Study|all other reasons combined|3
1192173|NCT00995345|3915840|P4|Overall Study|all other reasons combined|1
1192174|NCT00995345|3915841|P3|Overall Study|all other reasons combined|2
1192175|NCT00995345|3915842|P2|Overall Study|all other reasons combined|2
1192176|NCT00995345|3915843|P1|Overall Study|all other reasons combined|2
1192177|NCT00995345|3915839|P5|Overall Study|Lost to Follow-up|0
1192178|NCT00995345|3915840|P4|Overall Study|Lost to Follow-up|1
1192179|NCT00995345|3915841|P3|Overall Study|Lost to Follow-up|2
1192180|NCT00995345|3915842|P2|Overall Study|Lost to Follow-up|2
1192181|NCT00995345|3915843|P1|Overall Study|Lost to Follow-up|2
1192182|NCT00995345|3915839|P5|Overall Study|Adverse Event|1
1192183|NCT00995345|3915840|P4|Overall Study|Adverse Event|0
1192184|NCT00995345|3915841|P3|Overall Study|Adverse Event|2
1192185|NCT00995345|3915842|P2|Overall Study|Adverse Event|1
1192186|NCT00995345|3915843|P1|Overall Study|Adverse Event|3
1192187|NCT00995345|3915839|P5|Overall Study|Withdrawal by Subject|1
1192188|NCT00995345|3915840|P4|Overall Study|Withdrawal by Subject|3
1192189|NCT00995345|3915841|P3|Overall Study|Withdrawal by Subject|1
1192190|NCT00995345|3915842|P2|Overall Study|Withdrawal by Subject|2
1192191|NCT00995345|3915843|P1|Overall Study|Withdrawal by Subject|4
1192192|NCT00995085|3915870|P1|Overall Study|Withdrawal by Subject|5
1192193|NCT00995020|3915876|P2|Overall Study|specimen fragmentation, thermal damage|2
1192194|NCT00995020|3915877|P1|Overall Study|specimen fragmentation, thermal damage|1
1192195|NCT00995020|3915876|P2|Overall Study|margin analysis not performed|5
1192196|NCT00995020|3915877|P1|Overall Study|margin analysis not performed|2
1192197|NCT00995007|3915887|P2|Overall Study|Toxicity|0
1192198|NCT00995007|3915888|P1|Overall Study|Toxicity|8
1192199|NCT00995007|3915887|P2|Overall Study|Refused further treatment|2
1192200|NCT00995007|3915888|P1|Overall Study|Refused further treatment|8
1192201|NCT00995007|3915887|P2|Overall Study|Withdrew consent|0
1192202|NCT00995007|3915888|P1|Overall Study|Withdrew consent|1
1192203|NCT00994682|3915951|P2|Pioglitazone Open Label|Physician Decision|1
1192204|NCT00994682|3915952|P1|Pioglitazone Open Label|Physician Decision|6
1192205|NCT00994682|3915951|P2|Pioglitazone Open Label|Lost to Follow-up|2
1192206|NCT00994682|3915952|P1|Pioglitazone Open Label|Lost to Follow-up|3
1192207|NCT00994682|3915951|P2|Pioglitazone Open Label|Withdrawal by Subject|4
1192208|NCT00994682|3915952|P1|Pioglitazone Open Label|Withdrawal by Subject|4
1192209|NCT00994682|3915951|P2|Double Bilnd|Adverse Event|0
1192210|NCT00994682|3915952|P1|Double Bilnd|Adverse Event|1
1192211|NCT00994682|3915951|P2|Double Bilnd|Lost to Follow-up|3
1192212|NCT00994682|3915952|P1|Double Bilnd|Lost to Follow-up|3
1192213|NCT00994682|3915951|P2|Double Bilnd|Withdrawal by Subject|6
1192214|NCT00994682|3915952|P1|Double Bilnd|Withdrawal by Subject|5
1192215|NCT00994643|3915996|P1|Overall Study|Withdrawal by Subject|1
1192216|NCT00994461|3916010|P3|Overall Study|Adverse Event|0
1192217|NCT00994461|3916011|P2|Overall Study|Adverse Event|1
1192218|NCT00994461|3916012|P1|Overall Study|Adverse Event|2
1192219|NCT00994448|3916040|P2|Overall Study|Physician Decision|0
1192220|NCT00994448|3916041|P1|Overall Study|Physician Decision|1
1192221|NCT00994448|3916040|P2|Overall Study|Withdrawal by Subject|1
1192222|NCT00994448|3916041|P1|Overall Study|Withdrawal by Subject|1
1192223|NCT00994448|3916040|P2|Overall Study|Lost to Follow-up|1
1192224|NCT00994448|3916041|P1|Overall Study|Lost to Follow-up|5
1192225|NCT00994448|3916040|P2|Overall Study|Adverse Event|0
1192226|NCT00994448|3916041|P1|Overall Study|Adverse Event|1
1192227|NCT00994422|3916049|P2|Overall Study|Lost to Follow-up|1
1192228|NCT00994422|3916050|P1|Overall Study|Lost to Follow-up|7
1192229|NCT00994279|3916075|P2|Overall Study|Multiple reasons|3
1192230|NCT00994279|3916076|P1|Overall Study|Multiple reasons|1
1192231|NCT00994279|3916075|P2|Overall Study|Toxicity|0
1192232|NCT00994279|3916076|P1|Overall Study|Toxicity|1
1192233|NCT00994279|3916075|P2|Overall Study|Withdrawal by Subject|2
1192234|NCT00994279|3916076|P1|Overall Study|Withdrawal by Subject|2
1192235|NCT00994240|3916086|P2|Overall Study|study termination|3
1192236|NCT00994240|3916087|P1|Overall Study|study termination|2
1192237|NCT00994240|3916086|P2|Overall Study|Withdrawal by Subject|0
1192238|NCT00994240|3916087|P1|Overall Study|Withdrawal by Subject|1
1192239|NCT00994240|3916086|P2|Overall Study|Lost to Follow-up|2
1192240|NCT00994240|3916087|P1|Overall Study|Lost to Follow-up|3
1192241|NCT00994214|3916097|P4|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
1192242|NCT00994214|3916098|P3|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
1192243|NCT00994214|3916099|P2|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3
1192244|NCT00994214|3916100|P1|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4
1192245|NCT00994214|3916097|P4|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1
1192246|NCT00994214|3916098|P3|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
1192247|NCT00994214|3916099|P2|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
1192248|NCT00994214|3916100|P1|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
1192249|NCT00994214|3916097|P4|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14
1192250|NCT00994214|3916098|P3|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
1192251|NCT00994214|3916099|P2|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12
1192252|NCT00994214|3916100|P1|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
1192253|NCT00994214|3916097|P4|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
1192254|NCT00994214|3916098|P3|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
1192255|NCT00994214|3916099|P2|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
1192256|NCT00994214|3916100|P1|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1
1192257|NCT00994214|3916097|P4|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1
1192258|NCT00994214|3916098|P3|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
1192259|NCT00994214|3916099|P2|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
1192260|NCT00994214|3916100|P1|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
1192261|NCT00994214|3916097|P4|ITT (Intention-to-Treat) - Part A|Adverse Event|0
1192262|NCT00994214|3916098|P3|ITT (Intention-to-Treat) - Part A|Adverse Event|0
1192263|NCT00994214|3916099|P2|ITT (Intention-to-Treat) - Part A|Adverse Event|1
1192264|NCT00994214|3916100|P1|ITT (Intention-to-Treat) - Part A|Adverse Event|0
1192265|NCT00994110|3916179|P2|Overall Study|Pt not eligible|5
1192266|NCT00994110|3916180|P1|Overall Study|Pt not eligible|10
1192267|NCT00994110|3916179|P2|Overall Study|Patient not resected|52
1192268|NCT00994110|3916180|P1|Overall Study|Patient not resected|41
1192269|NCT00994110|3916179|P2|Overall Study|Adverse Event|0
1192270|NCT00994110|3916180|P1|Overall Study|Adverse Event|1
1192271|NCT00994110|3916179|P2|Overall Study|Not Treated|8
1192272|NCT00994110|3916180|P1|Overall Study|Not Treated|4
1192273|NCT00994110|3916179|P2|Overall Study|Withdrawal by Subject|9
1192274|NCT00994110|3916180|P1|Overall Study|Withdrawal by Subject|9
1192275|NCT00993967|3916186|P1|Overall Study|Protocol Violation|2
1192276|NCT00993967|3916186|P1|Overall Study|Withdrawal by Subject|36
1192277|NCT00993967|3916186|P1|Overall Study|Lost to Follow-up|14
1192278|NCT00993967|3916186|P1|Overall Study|Death|1
1192279|NCT00993967|3916186|P1|Overall Study|Adverse Event|8
1192280|NCT00993954|3916193|P2|Overall Study|Protocol Violation|2
1192281|NCT00993954|3916194|P1|Overall Study|Protocol Violation|21
1192282|NCT00993928|3916207|P2|Overall Study|ineligible|0
1192283|NCT00993928|3916208|P1|Overall Study|ineligible|1
1192284|NCT00993928|3916207|P2|Overall Study|Withdrawal by Subject|7
1192285|NCT00993928|3916208|P1|Overall Study|Withdrawal by Subject|4
1192286|NCT00993915|3916222|P1|Overall Study|Ongoing|3
1192287|NCT00993915|3916222|P1|Overall Study|Not specified|1
1192288|NCT00993915|3916222|P1|Overall Study|Withdrawal by Subject|2
1192289|NCT00993915|3916222|P1|Overall Study|Insufficient clinical response|3
1192290|NCT00993668|3916248|P2|Open-Label Period|Lost to Follow-up|1
1192291|NCT00993668|3916249|P1|Open-Label Period|Lost to Follow-up|6
1192292|NCT00993668|3916248|P2|Open-Label Period|Withdrawal by Subject|3
1192293|NCT00993668|3916249|P1|Open-Label Period|Withdrawal by Subject|4
1192294|NCT00993668|3916248|P2|Open-Label Period|Lack of Efficacy|3
1192295|NCT00993668|3916249|P1|Open-Label Period|Lack of Efficacy|4
1192296|NCT00993668|3916248|P2|Open-Label Period|Adverse Event|8
1192297|NCT00993668|3916249|P1|Open-Label Period|Adverse Event|9
1192298|NCT00993668|3916248|P2|Single-Blind Period|Lost to Follow-up|1
1192299|NCT00993668|3916249|P1|Single-Blind Period|Lost to Follow-up|3
1192300|NCT00993668|3916248|P2|Single-Blind Period|Lack of Efficacy|1
1192301|NCT00993668|3916249|P1|Single-Blind Period|Lack of Efficacy|0
1192302|NCT00993668|3916248|P2|Single-Blind Period|Adverse Event|1
1192303|NCT00993668|3916249|P1|Single-Blind Period|Adverse Event|1
1192304|NCT00993616|3916293|P1|Overall Study|Never treated|1
1192305|NCT00993616|3916293|P1|Overall Study|No tumor at entry|1
1192306|NCT00993499|3916311|P6|Discontinued After Starting Course 3|Other adverse event|0
1192307|NCT00993499|3916312|P5|Discontinued After Starting Course 3|Other adverse event|0
1192308|NCT00993499|3916313|P4|Discontinued After Starting Course 3|Other adverse event|0
1192309|NCT00993499|3916314|P3|Discontinued After Starting Course 3|Other adverse event|1
1192310|NCT00993499|3916315|P2|Discontinued After Starting Course 3|Other adverse event|0
1192311|NCT00993499|3916316|P1|Discontinued After Starting Course 3|Other adverse event|1
1192312|NCT00993499|3916311|P6|Discontinued After Starting Course 3|DLT|0
1192313|NCT00993499|3916312|P5|Discontinued After Starting Course 3|DLT|0
1192314|NCT00993499|3916313|P4|Discontinued After Starting Course 3|DLT|1
1192315|NCT00993499|3916314|P3|Discontinued After Starting Course 3|DLT|2
1192316|NCT00993499|3916315|P2|Discontinued After Starting Course 3|DLT|0
1192317|NCT00993499|3916316|P1|Discontinued After Starting Course 3|DLT|1
1192318|NCT00993499|3916311|P6|Discontinued After Starting Course 3|Progressive Disease|3
1192319|NCT00993499|3916312|P5|Discontinued After Starting Course 3|Progressive Disease|3
1192320|NCT00993499|3916313|P4|Discontinued After Starting Course 3|Progressive Disease|1
1192321|NCT00993499|3916314|P3|Discontinued After Starting Course 3|Progressive Disease|3
1192322|NCT00993499|3916315|P2|Discontinued After Starting Course 3|Progressive Disease|4
1192323|NCT00993499|3916316|P1|Discontinued After Starting Course 3|Progressive Disease|6
1192324|NCT00993499|3916311|P6|Discontinued After Starting Course 3|Withdrawal by Subject|0
1192325|NCT00993499|3916312|P5|Discontinued After Starting Course 3|Withdrawal by Subject|0
1192326|NCT00993499|3916313|P4|Discontinued After Starting Course 3|Withdrawal by Subject|0
1192327|NCT00993499|3916314|P3|Discontinued After Starting Course 3|Withdrawal by Subject|0
1192328|NCT00993499|3916315|P2|Discontinued After Starting Course 3|Withdrawal by Subject|1
1192329|NCT00993499|3916316|P1|Discontinued After Starting Course 3|Withdrawal by Subject|0
1192330|NCT00993499|3916311|P6|Discontinued Before Starting Course 3|Non compliance with the protocol|0
1192331|NCT00993499|3916312|P5|Discontinued Before Starting Course 3|Non compliance with the protocol|0
1192332|NCT00993499|3916313|P4|Discontinued Before Starting Course 3|Non compliance with the protocol|0
1192333|NCT00993499|3916314|P3|Discontinued Before Starting Course 3|Non compliance with the protocol|2
1192334|NCT00993499|3916315|P2|Discontinued Before Starting Course 3|Non compliance with the protocol|0
1192335|NCT00993499|3916316|P1|Discontinued Before Starting Course 3|Non compliance with the protocol|0
1192336|NCT00993499|3916311|P6|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
1192337|NCT00993499|3916312|P5|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
1192338|NCT00993499|3916313|P4|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
1192339|NCT00993499|3916314|P3|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
1192340|NCT00993499|3916315|P2|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
1192341|NCT00993499|3916316|P1|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
1192342|NCT00993499|3916311|P6|Discontinued Before Starting Course 3|Withdrawal by Subject|0
1192343|NCT00993499|3916312|P5|Discontinued Before Starting Course 3|Withdrawal by Subject|0
1192344|NCT00993499|3916313|P4|Discontinued Before Starting Course 3|Withdrawal by Subject|0
1192345|NCT00993499|3916314|P3|Discontinued Before Starting Course 3|Withdrawal by Subject|0
1192346|NCT00993499|3916315|P2|Discontinued Before Starting Course 3|Withdrawal by Subject|2
1192347|NCT00993499|3916316|P1|Discontinued Before Starting Course 3|Withdrawal by Subject|2
1192348|NCT00993499|3916311|P6|Discontinued Before Starting Course 3|Progressive Disease|0
1192349|NCT00993499|3916312|P5|Discontinued Before Starting Course 3|Progressive Disease|0
1192350|NCT00993499|3916313|P4|Discontinued Before Starting Course 3|Progressive Disease|0
1192351|NCT00993499|3916314|P3|Discontinued Before Starting Course 3|Progressive Disease|0
1192352|NCT00993499|3916315|P2|Discontinued Before Starting Course 3|Progressive Disease|2
1192353|NCT00993499|3916316|P1|Discontinued Before Starting Course 3|Progressive Disease|2
1192354|NCT00993499|3916311|P6|Run-in Period (8 Days)|Progressive disease|0
1192355|NCT00993499|3916312|P5|Run-in Period (8 Days)|Progressive disease|0
1192356|NCT00993499|3916313|P4|Run-in Period (8 Days)|Progressive disease|0
1192357|NCT00993499|3916314|P3|Run-in Period (8 Days)|Progressive disease|1
1192358|NCT00993499|3916315|P2|Run-in Period (8 Days)|Progressive disease|1
1192359|NCT00993499|3916316|P1|Run-in Period (8 Days)|Progressive disease|0
1192360|NCT00993499|3916311|P6|Run-in Period (8 Days)|Consent withdrawn|0
1192361|NCT00993499|3916312|P5|Run-in Period (8 Days)|Consent withdrawn|0
1192362|NCT00993499|3916313|P4|Run-in Period (8 Days)|Consent withdrawn|0
1192363|NCT00993499|3916314|P3|Run-in Period (8 Days)|Consent withdrawn|0
1192364|NCT00993499|3916315|P2|Run-in Period (8 Days)|Consent withdrawn|1
1192365|NCT00993499|3916316|P1|Run-in Period (8 Days)|Consent withdrawn|0
1192366|NCT00993499|3916311|P6|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
1192367|NCT00993499|3916312|P5|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
1192368|NCT00993499|3916313|P4|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
1192369|NCT00993499|3916314|P3|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
1192370|NCT00993499|3916315|P2|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
1192371|NCT00993499|3916316|P1|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1
1192372|NCT00993499|3916311|P6|Run-in Period (8 Days)|Adverse Event|0
1192373|NCT00993499|3916312|P5|Run-in Period (8 Days)|Adverse Event|0
1192374|NCT00993499|3916313|P4|Run-in Period (8 Days)|Adverse Event|0
1192375|NCT00993499|3916314|P3|Run-in Period (8 Days)|Adverse Event|0
1192376|NCT00993499|3916315|P2|Run-in Period (8 Days)|Adverse Event|1
1192377|NCT00993499|3916316|P1|Run-in Period (8 Days)|Adverse Event|0
1192378|NCT00993473|3916398|P2|Overall Study|Family event|0
1192379|NCT00993473|3916399|P1|Overall Study|Family event|1
1192380|NCT00993473|3916398|P2|Overall Study|Technical problem with CGM device|1
1192381|NCT00993473|3916399|P1|Overall Study|Technical problem with CGM device|0
1192382|NCT00993473|3916398|P2|Overall Study|Withdrawal by Subject|5
1192383|NCT00993473|3916399|P1|Overall Study|Withdrawal by Subject|1
1192384|NCT00993473|3916398|P2|Overall Study|Lost to Follow-up|0
1192385|NCT00993473|3916399|P1|Overall Study|Lost to Follow-up|1
1192386|NCT00993473|3916398|P2|Overall Study|Protocol Violation|2
1192387|NCT00993473|3916399|P1|Overall Study|Protocol Violation|1
1192388|NCT00993473|3916398|P2|Overall Study|Adverse Event|2
1192389|NCT00993473|3916399|P1|Overall Study|Adverse Event|0
1192390|NCT00993447|3916437|P2|Overall Study|Adverse Event|0
1192391|NCT00993447|3916438|P1|Overall Study|Adverse Event|1
1192392|NCT00993447|3916437|P2|Overall Study|Lost to Follow-up|3
1192393|NCT00993447|3916438|P1|Overall Study|Lost to Follow-up|1
1192394|NCT00993447|3916437|P2|Overall Study|Protocol Violation|8
1192395|NCT00993447|3916438|P1|Overall Study|Protocol Violation|12
1192396|NCT00993447|3916437|P2|Overall Study|Withdrawal by Subject|8
1192397|NCT00993447|3916438|P1|Overall Study|Withdrawal by Subject|23
1192398|NCT00993421|3916475|P7|Overall Study|Protocol Violation|1
1192399|NCT00993421|3916476|P6|Overall Study|Protocol Violation|2
1192400|NCT00993421|3916477|P5|Overall Study|Protocol Violation|0
1192401|NCT00993421|3916478|P4|Overall Study|Protocol Violation|0
1192402|NCT00993421|3916479|P3|Overall Study|Protocol Violation|0
1192403|NCT00993421|3916480|P2|Overall Study|Protocol Violation|0
1192404|NCT00993421|3916481|P1|Overall Study|Protocol Violation|0
1192405|NCT00993421|3916475|P7|Overall Study|Physician Decision|1
1192406|NCT00993421|3916476|P6|Overall Study|Physician Decision|1
1192407|NCT00993421|3916477|P5|Overall Study|Physician Decision|0
1192408|NCT00993421|3916478|P4|Overall Study|Physician Decision|0
1192409|NCT00993421|3916479|P3|Overall Study|Physician Decision|0
1192410|NCT00993421|3916480|P2|Overall Study|Physician Decision|0
1192411|NCT00993421|3916481|P1|Overall Study|Physician Decision|0
1192412|NCT00993421|3916475|P7|Overall Study|Entry Criteria Exclusion|0
1192413|NCT00993421|3916476|P6|Overall Study|Entry Criteria Exclusion|1
1192414|NCT00993421|3916477|P5|Overall Study|Entry Criteria Exclusion|0
1192415|NCT00993421|3916478|P4|Overall Study|Entry Criteria Exclusion|3
1192416|NCT00993421|3916479|P3|Overall Study|Entry Criteria Exclusion|1
1192417|NCT00993421|3916480|P2|Overall Study|Entry Criteria Exclusion|0
1192418|NCT00993421|3916481|P1|Overall Study|Entry Criteria Exclusion|0
1192419|NCT00993421|3916475|P7|Overall Study|Death|1
1192420|NCT00993421|3916476|P6|Overall Study|Death|0
1192421|NCT00993421|3916477|P5|Overall Study|Death|0
1192422|NCT00993421|3916478|P4|Overall Study|Death|0
1192423|NCT00993421|3916479|P3|Overall Study|Death|0
1192424|NCT00993421|3916480|P2|Overall Study|Death|0
1192425|NCT00993421|3916481|P1|Overall Study|Death|0
1192426|NCT00993421|3916475|P7|Overall Study|Withdrawal by Subject|3
1192427|NCT00993421|3916476|P6|Overall Study|Withdrawal by Subject|5
1192428|NCT00993421|3916477|P5|Overall Study|Withdrawal by Subject|3
1192429|NCT00993421|3916478|P4|Overall Study|Withdrawal by Subject|3
1192430|NCT00993421|3916479|P3|Overall Study|Withdrawal by Subject|3
1192431|NCT00993421|3916480|P2|Overall Study|Withdrawal by Subject|2
1192432|NCT00993421|3916481|P1|Overall Study|Withdrawal by Subject|3
1192433|NCT00993421|3916475|P7|Overall Study|Lost to Follow-up|6
1192434|NCT00993421|3916476|P6|Overall Study|Lost to Follow-up|0
1192435|NCT00993421|3916477|P5|Overall Study|Lost to Follow-up|0
1192436|NCT00993421|3916478|P4|Overall Study|Lost to Follow-up|0
1192437|NCT00993421|3916479|P3|Overall Study|Lost to Follow-up|5
1192438|NCT00993421|3916480|P2|Overall Study|Lost to Follow-up|5
1192439|NCT00993421|3916481|P1|Overall Study|Lost to Follow-up|3
1192440|NCT00993421|3916475|P7|Overall Study|Sponsor Decision|29
1192441|NCT00993421|3916476|P6|Overall Study|Sponsor Decision|30
1192442|NCT00993421|3916477|P5|Overall Study|Sponsor Decision|38
1192443|NCT00993421|3916478|P4|Overall Study|Sponsor Decision|30
1192444|NCT00993421|3916479|P3|Overall Study|Sponsor Decision|28
1192445|NCT00993421|3916480|P2|Overall Study|Sponsor Decision|31
1192446|NCT00993421|3916481|P1|Overall Study|Sponsor Decision|36
1192447|NCT00993421|3916475|P7|Overall Study|Adverse Event|1
1192448|NCT00993421|3916476|P6|Overall Study|Adverse Event|7
1192449|NCT00993421|3916477|P5|Overall Study|Adverse Event|5
1192450|NCT00993421|3916478|P4|Overall Study|Adverse Event|9
1192451|NCT00993421|3916479|P3|Overall Study|Adverse Event|6
1192452|NCT00993421|3916480|P2|Overall Study|Adverse Event|7
1192453|NCT00993421|3916481|P1|Overall Study|Adverse Event|2
1192454|NCT00993317|3916632|P2|Overall Study|Early study termination at the site|0
1192455|NCT00993317|3916633|P1|Overall Study|Early study termination at the site|1
1192456|NCT00993317|3916632|P2|Overall Study|Investigator's opinion|1
1192457|NCT00993317|3916633|P1|Overall Study|Investigator's opinion|0
1192458|NCT00993317|3916632|P2|Overall Study|Withdrawal by Subject|2
1192459|NCT00993317|3916633|P1|Overall Study|Withdrawal by Subject|0
1192460|NCT00993317|3916632|P2|Overall Study|Lack of Efficacy|18
1192461|NCT00993317|3916633|P1|Overall Study|Lack of Efficacy|18
1192462|NCT00993317|3916632|P2|Overall Study|Adverse Event|4
1192463|NCT00993317|3916633|P1|Overall Study|Adverse Event|2
1192464|NCT00993291|3916651|P1|Overall Study|Withdrawal by Subject|1
1192465|NCT00993265|3916657|P2|Overall Study|Non-compliant with study medication|0
1192466|NCT00993265|3916658|P1|Overall Study|Non-compliant with study medication|1
1192467|NCT00993265|3916657|P2|Overall Study|Changed dose of concomitant drug|0
1192468|NCT00993265|3916658|P1|Overall Study|Changed dose of concomitant drug|2
1192469|NCT00993265|3916657|P2|Overall Study|Adverse Event|0
1192470|NCT00993265|3916658|P1|Overall Study|Adverse Event|1
1192471|NCT00993148|3916710|P1|Overall Study|never initiated treatment|1
1192472|NCT00993148|3916710|P1|Overall Study|Lost to Follow-up|2
1192473|NCT00993044|3916722|P1|Irinotecan 50 mg|Physician Decision|1
1192474|NCT00993031|3916729|P2|Overall Study|Lost to Follow-up|13
1192475|NCT00993031|3916730|P1|Overall Study|Lost to Follow-up|19
1192476|NCT00993031|3916729|P2|Overall Study|Withdrawal by Subject|3
1192477|NCT00993031|3916730|P1|Overall Study|Withdrawal by Subject|3
1192478|NCT00993031|3916729|P2|Overall Study|Physician Decision|2
1192479|NCT00993031|3916730|P1|Overall Study|Physician Decision|0
1192480|NCT00993031|3916729|P2|Overall Study|Death|1
1192481|NCT00993031|3916730|P1|Overall Study|Death|0
1192482|NCT00992992|3916748|P1|Overall Study|Sponsor Closed the Study|4
1192483|NCT00992992|3916748|P1|Overall Study|GlaxoSmithKline Closed the Study|2
1192484|NCT00992992|3916748|P1|Overall Study|Death|16
1192485|NCT00992992|3916748|P1|Overall Study|Lost to Follow-up|3
1192486|NCT00992836|3916779|P1|Overall Study|Protocol Violation|2
1192487|NCT00992836|3916779|P1|Overall Study|Withdrawal by Subject|2
1192488|NCT00992836|3916779|P1|Overall Study|Lost to Follow-up|1
1192489|NCT00992784|3916794|P3|Overall Study|Withdrawal by Subject|1
1192490|NCT00992784|3916795|P2|Overall Study|Withdrawal by Subject|1
1192491|NCT00992784|3916796|P1|Overall Study|Withdrawal by Subject|1
1192492|NCT00992784|3916794|P3|Overall Study|Adverse Event|0
1192493|NCT00992784|3916795|P2|Overall Study|Adverse Event|1
1192494|NCT00992784|3916796|P1|Overall Study|Adverse Event|2
1192495|NCT00992589|3916908|P4|Double-Blind Phase|Not specified|3
1192496|NCT00992589|3916909|P3|Double-Blind Phase|Not specified|6
1192497|NCT00992589|3916910|P2|Double-Blind Phase|Not specified|1
1192498|NCT00992589|3916911|P1|Double-Blind Phase|Not specified|0
1192499|NCT00992589|3916908|P4|Double-Blind Phase|Lost to Follow-up|2
1192500|NCT00992589|3916909|P3|Double-Blind Phase|Lost to Follow-up|0
1192501|NCT00992589|3916910|P2|Double-Blind Phase|Lost to Follow-up|0
1192502|NCT00992589|3916911|P1|Double-Blind Phase|Lost to Follow-up|0
1192503|NCT00992589|3916908|P4|Double-Blind Phase|Withdrawal by Subject|2
1192504|NCT00992589|3916909|P3|Double-Blind Phase|Withdrawal by Subject|5
1192505|NCT00992589|3916910|P2|Double-Blind Phase|Withdrawal by Subject|6
1192506|NCT00992589|3916911|P1|Double-Blind Phase|Withdrawal by Subject|0
1192507|NCT00992589|3916908|P4|Double-Blind Phase|Adverse Event|3
1192508|NCT00992589|3916909|P3|Double-Blind Phase|Adverse Event|2
1192509|NCT00992589|3916910|P2|Double-Blind Phase|Adverse Event|6
1192510|NCT00992589|3916911|P1|Double-Blind Phase|Adverse Event|0
1192511|NCT00992589|3916908|P4|Open-Label Phase|Not specified|0
1192512|NCT00992589|3916909|P3|Open-Label Phase|Not specified|0
1192513|NCT00992589|3916910|P2|Open-Label Phase|Not specified|0
1192514|NCT00992589|3916911|P1|Open-Label Phase|Not specified|45
1192515|NCT00992589|3916908|P4|Open-Label Phase|Physician Decision|0
1192516|NCT00992589|3916909|P3|Open-Label Phase|Physician Decision|0
1192517|NCT00992589|3916910|P2|Open-Label Phase|Physician Decision|0
1192518|NCT00992589|3916911|P1|Open-Label Phase|Physician Decision|4
1192519|NCT00992589|3916908|P4|Open-Label Phase|Protocol Violation|0
1192520|NCT00992589|3916909|P3|Open-Label Phase|Protocol Violation|0
1192521|NCT00992589|3916910|P2|Open-Label Phase|Protocol Violation|0
1192522|NCT00992589|3916911|P1|Open-Label Phase|Protocol Violation|3
1192523|NCT00992589|3916908|P4|Open-Label Phase|Lost to Follow-up|0
1192524|NCT00992589|3916909|P3|Open-Label Phase|Lost to Follow-up|0
1192525|NCT00992589|3916910|P2|Open-Label Phase|Lost to Follow-up|0
1192526|NCT00992589|3916911|P1|Open-Label Phase|Lost to Follow-up|1
1192527|NCT00992589|3916908|P4|Open-Label Phase|Withdrawal by Subject|0
1192528|NCT00992589|3916909|P3|Open-Label Phase|Withdrawal by Subject|0
1192529|NCT00992589|3916910|P2|Open-Label Phase|Withdrawal by Subject|0
1192530|NCT00992589|3916911|P1|Open-Label Phase|Withdrawal by Subject|20
1192531|NCT00992589|3916908|P4|Open-Label Phase|Adverse Event|0
1192532|NCT00992589|3916909|P3|Open-Label Phase|Adverse Event|0
1192533|NCT00992589|3916910|P2|Open-Label Phase|Adverse Event|0
1192534|NCT00992589|3916911|P1|Open-Label Phase|Adverse Event|4
1192535|NCT00992459|3916955|P2|Overall Study|Adverse Event|0
1192536|NCT00992459|3916956|P1|Overall Study|Adverse Event|1
1192537|NCT00992459|3916955|P2|Overall Study|Withdrawal by Subject|1
1192538|NCT00992459|3916956|P1|Overall Study|Withdrawal by Subject|0
1192539|NCT00992446|3916980|P1|Overall Study|Maintenance Therapy Screen Fail|5
1192540|NCT00992446|3916980|P1|Overall Study|Withdrawal by Subject|2
1192541|NCT00992446|3916980|P1|Overall Study|Disease Progression|1
1192542|NCT00992407|3917052|P2|Overall Study|Study medication not administered|13
1192543|NCT00992407|3917053|P1|Overall Study|Study medication not administered|17
1192544|NCT00992407|3917052|P2|Overall Study|Loss of follow-up & Adverse events|1
1192545|NCT00992407|3917053|P1|Overall Study|Loss of follow-up & Adverse events|2
1192546|NCT00992407|3917052|P2|Overall Study|Other|0
1192547|NCT00992407|3917053|P1|Overall Study|Other|2
1192548|NCT00992407|3917052|P2|Overall Study|protocol Violation & Adverse events|4
1192549|NCT00992407|3917053|P1|Overall Study|protocol Violation & Adverse events|2
1192550|NCT00992407|3917052|P2|Overall Study|Adverse Event|2
1192551|NCT00992407|3917053|P1|Overall Study|Adverse Event|3
1192552|NCT00992407|3917052|P2|Overall Study|Lost to Follow-up|3
1192553|NCT00992407|3917053|P1|Overall Study|Lost to Follow-up|3
1192554|NCT00992407|3917052|P2|Overall Study|Protocol Violation|1
1192555|NCT00992407|3917053|P1|Overall Study|Protocol Violation|2
1192556|NCT00992394|3917103|P2|Overall Study|Other event|0
1192557|NCT00992394|3917104|P1|Overall Study|Other event|1
1192558|NCT00992394|3917103|P2|Overall Study|Lost to Follow-up|0
1192559|NCT00992394|3917104|P1|Overall Study|Lost to Follow-up|2
1192560|NCT00992394|3917103|P2|Overall Study|Protocol Violation|4
1192561|NCT00992394|3917104|P1|Overall Study|Protocol Violation|2
1192562|NCT00992394|3917103|P2|Overall Study|Physician Decision|0
1192563|NCT00992394|3917104|P1|Overall Study|Physician Decision|1
1192564|NCT00992394|3917103|P2|Overall Study|Withdrawal by Subject|2
1192565|NCT00992394|3917104|P1|Overall Study|Withdrawal by Subject|8
1192566|NCT00992394|3917103|P2|Overall Study|Adverse Event|5
1192567|NCT00992394|3917104|P1|Overall Study|Adverse Event|4
1192568|NCT00992394|3917103|P2|Overall Study|Lack of Efficacy|3
1192569|NCT00992394|3917104|P1|Overall Study|Lack of Efficacy|6
1192570|NCT00992225|3917191|P1|Overall Study|Adverse Event|2
1192571|NCT00992225|3917191|P1|Overall Study|Entry Criteria Not Met|8
1192572|NCT00992186|3917201|P1|Overall Study|Refusal To Receive Study Agent|3
1192573|NCT00992186|3917201|P1|Overall Study|Progressive Disease|30
1192574|NCT00992186|3917201|P1|Overall Study|Adverse Event|9
1192575|NCT00992186|3917201|P1|Overall Study|Physician Decision|1
1192576|NCT00992186|3917201|P1|Overall Study|Protocol Violation|1
1192577|NCT00992186|3917201|P1|Overall Study|Withdrawal by Subject|2
1192578|NCT00992108|3917220|P2|Overall Study|Lost to Follow-up|1
1192579|NCT00992108|3917221|P1|Overall Study|Lost to Follow-up|0
1192580|NCT00992056|3917235|P2|Washout Period (2 Weeks)|Physician Decision|0
1192581|NCT00992056|3917236|P1|Washout Period (2 Weeks)|Physician Decision|1
1192582|NCT00992056|3917235|P2|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2
1192583|NCT00992056|3917236|P1|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1
1192584|NCT00992017|3917242|P1|Overall Study|Not adhere to study requirements|1
1192585|NCT00992017|3917242|P1|Overall Study|Unable to get to clinic|5
1192586|NCT00992017|3917242|P1|Overall Study|Withdrawal by Subject|2
1192587|NCT00992017|3917242|P1|Overall Study|Lost to Follow-up|2
1192588|NCT00991952|3917257|P2|Overall Study|Adverse Event|1
1192589|NCT00991952|3917258|P1|Overall Study|Adverse Event|0
1192590|NCT00991939|3917266|P2|Overall Study|Entire study terminated|1
1192591|NCT00991939|3917267|P1|Overall Study|Entire study terminated|4
1192592|NCT00991939|3917266|P2|Overall Study|Withdrawal by Subject|0
1192593|NCT00991939|3917267|P1|Overall Study|Withdrawal by Subject|1
1192594|NCT00991939|3917266|P2|Overall Study|Lost to Follow-up|1
1192595|NCT00991939|3917267|P1|Overall Study|Lost to Follow-up|0
1192596|NCT00991887|3917301|P2|Overall Study|Lost to Follow-up|1
1192597|NCT00991887|3917302|P1|Overall Study|Lost to Follow-up|2
1192598|NCT00991510|3917321|P2|Period III (Days 29-112)|Adverse Event|1
1192599|NCT00991510|3917322|P1|Period III (Days 29-112)|Adverse Event|1
1192600|NCT00991510|3917321|P2|Period I (Days 1-14)|Adverse Event|0
1192601|NCT00991510|3917322|P1|Period I (Days 1-14)|Adverse Event|1
1192602|NCT00991341|3917368|P2|Overall Study|Withdrawal by Subject|4
1192603|NCT00991341|3917369|P1|Overall Study|Withdrawal by Subject|3
1192604|NCT00991341|3917368|P2|Overall Study|Physician Decision|2
1192605|NCT00991341|3917369|P1|Overall Study|Physician Decision|1
1192606|NCT00991341|3917368|P2|Overall Study|no RBCs received 96hrs after randomized|155
1192607|NCT00991341|3917369|P1|Overall Study|no RBCs received 96hrs after randomized|186
1192608|NCT00991341|3917368|P2|Overall Study|Death|0
1192609|NCT00991341|3917369|P1|Overall Study|Death|3
1192610|NCT00991341|3917368|P2|Overall Study|no surgery w/in 30 days of randomization|18
1192611|NCT00991341|3917369|P1|Overall Study|no surgery w/in 30 days of randomization|11
1192612|NCT00991302|3917407|P2|Overall Study|Lost to Follow-up|12
1192613|NCT00991302|3917408|P1|Overall Study|Lost to Follow-up|14
1192614|NCT00991302|3917407|P2|Overall Study|Death|1
1192615|NCT00991302|3917408|P1|Overall Study|Death|0
1192616|NCT00991289|3917424|P1|Overall Study|Protocol Violation|2
1192617|NCT00991289|3917424|P1|Overall Study|Lost to Follow-up|4
1192618|NCT00991289|3917424|P1|Overall Study|Withdrawal by Subject|3
1192619|NCT00991289|3917424|P1|Overall Study|Physician Decision|2
1192620|NCT00991289|3917424|P1|Overall Study|Adverse Event|1
1192621|NCT00991276|3917444|P6|Third Intervention Period|Withdrawal by Subject|0
1192622|NCT00991276|3917445|P5|Third Intervention Period|Withdrawal by Subject|0
1192623|NCT00991276|3917446|P4|Third Intervention Period|Withdrawal by Subject|1
1192624|NCT00991276|3917447|P3|Third Intervention Period|Withdrawal by Subject|0
1192625|NCT00991276|3917448|P2|Third Intervention Period|Withdrawal by Subject|0
1192626|NCT00991276|3917449|P1|Third Intervention Period|Withdrawal by Subject|0
1192627|NCT00991276|3917444|P6|Third Intervention Period|Adverse Event|0
1192628|NCT00991276|3917445|P5|Third Intervention Period|Adverse Event|0
1192629|NCT00991276|3917446|P4|Third Intervention Period|Adverse Event|0
1192630|NCT00991276|3917447|P3|Third Intervention Period|Adverse Event|1
1192631|NCT00991276|3917448|P2|Third Intervention Period|Adverse Event|0
1192632|NCT00991276|3917449|P1|Third Intervention Period|Adverse Event|0
1192633|NCT00991276|3917444|P6|Third Intervention Period|Other|1
1192634|NCT00991276|3917445|P5|Third Intervention Period|Other|0
1192635|NCT00991276|3917446|P4|Third Intervention Period|Other|0
1192636|NCT00991276|3917447|P3|Third Intervention Period|Other|0
1192637|NCT00991276|3917448|P2|Third Intervention Period|Other|0
1192638|NCT00991276|3917449|P1|Third Intervention Period|Other|0
1192639|NCT00991276|3917444|P6|Third Intervention Period|Protocol Violation|0
1192640|NCT00991276|3917445|P5|Third Intervention Period|Protocol Violation|0
1192641|NCT00991276|3917446|P4|Third Intervention Period|Protocol Violation|0
1192642|NCT00991276|3917447|P3|Third Intervention Period|Protocol Violation|0
1192643|NCT00991276|3917448|P2|Third Intervention Period|Protocol Violation|0
1192644|NCT00991276|3917449|P1|Third Intervention Period|Protocol Violation|1
1192645|NCT00991276|3917444|P6|Second Intervention Period|Other|1
1192646|NCT00991276|3917445|P5|Second Intervention Period|Other|0
1192647|NCT00991276|3917446|P4|Second Intervention Period|Other|1
1192648|NCT00991276|3917447|P3|Second Intervention Period|Other|0
1192649|NCT00991276|3917448|P2|Second Intervention Period|Other|0
1192650|NCT00991276|3917449|P1|Second Intervention Period|Other|0
1192651|NCT00991276|3917444|P6|Second Intervention Period|Protocol Violation|0
1192652|NCT00991276|3917445|P5|Second Intervention Period|Protocol Violation|0
1192653|NCT00991276|3917446|P4|Second Intervention Period|Protocol Violation|0
1192654|NCT00991276|3917447|P3|Second Intervention Period|Protocol Violation|0
1192655|NCT00991276|3917448|P2|Second Intervention Period|Protocol Violation|0
1192656|NCT00991276|3917449|P1|Second Intervention Period|Protocol Violation|1
1192657|NCT00991276|3917444|P6|Second Intervention Period|Adverse Event|0
1192658|NCT00991276|3917445|P5|Second Intervention Period|Adverse Event|1
1192659|NCT00991276|3917446|P4|Second Intervention Period|Adverse Event|1
1192660|NCT00991276|3917447|P3|Second Intervention Period|Adverse Event|0
1192661|NCT00991276|3917448|P2|Second Intervention Period|Adverse Event|2
1192662|NCT00991276|3917449|P1|Second Intervention Period|Adverse Event|0
1192663|NCT00991276|3917444|P6|First Intervention Period|Lost to Follow-up|0
1192664|NCT00991276|3917445|P5|First Intervention Period|Lost to Follow-up|0
1192665|NCT00991276|3917446|P4|First Intervention Period|Lost to Follow-up|1
1192666|NCT00991276|3917447|P3|First Intervention Period|Lost to Follow-up|0
1192667|NCT00991276|3917448|P2|First Intervention Period|Lost to Follow-up|1
1192668|NCT00991276|3917449|P1|First Intervention Period|Lost to Follow-up|0
1192669|NCT00991276|3917444|P6|First Intervention Period|Withdrawal by Subject|1
1192670|NCT00991276|3917445|P5|First Intervention Period|Withdrawal by Subject|0
1192671|NCT00991276|3917446|P4|First Intervention Period|Withdrawal by Subject|1
1192672|NCT00991276|3917447|P3|First Intervention Period|Withdrawal by Subject|0
1192673|NCT00991276|3917448|P2|First Intervention Period|Withdrawal by Subject|1
1192674|NCT00991276|3917449|P1|First Intervention Period|Withdrawal by Subject|0
1192675|NCT00991276|3917444|P6|First Intervention Period|Other|0
1192676|NCT00991276|3917445|P5|First Intervention Period|Other|1
1192677|NCT00991276|3917446|P4|First Intervention Period|Other|1
1192678|NCT00991276|3917447|P3|First Intervention Period|Other|0
1192679|NCT00991276|3917448|P2|First Intervention Period|Other|0
1192680|NCT00991276|3917449|P1|First Intervention Period|Other|0
1192681|NCT00991276|3917444|P6|First Intervention Period|Insufficient clinical response|0
1192682|NCT00991276|3917445|P5|First Intervention Period|Insufficient clinical response|1
1192683|NCT00991276|3917446|P4|First Intervention Period|Insufficient clinical response|0
1192684|NCT00991276|3917447|P3|First Intervention Period|Insufficient clinical response|0
1192685|NCT00991276|3917448|P2|First Intervention Period|Insufficient clinical response|0
1192686|NCT00991276|3917449|P1|First Intervention Period|Insufficient clinical response|0
1192687|NCT00991276|3917444|P6|First Intervention Period|Protocol Violation|0
1192688|NCT00991276|3917445|P5|First Intervention Period|Protocol Violation|2
1192689|NCT00991276|3917446|P4|First Intervention Period|Protocol Violation|0
1192690|NCT00991276|3917447|P3|First Intervention Period|Protocol Violation|0
1192691|NCT00991276|3917448|P2|First Intervention Period|Protocol Violation|0
1192692|NCT00991276|3917449|P1|First Intervention Period|Protocol Violation|0
1192693|NCT00991276|3917444|P6|First Intervention Period|Adverse Event|0
1192694|NCT00991276|3917445|P5|First Intervention Period|Adverse Event|0
1192695|NCT00991276|3917446|P4|First Intervention Period|Adverse Event|1
1192696|NCT00991276|3917447|P3|First Intervention Period|Adverse Event|0
1192697|NCT00991276|3917448|P2|First Intervention Period|Adverse Event|1
1192698|NCT00991276|3917449|P1|First Intervention Period|Adverse Event|0
1192699|NCT00990821|3917639|P14|Overall Study|Withdrawal by Subject|1
1192700|NCT00990821|3917640|P13|Overall Study|Withdrawal by Subject|2
1192701|NCT00990821|3917641|P12|Overall Study|Withdrawal by Subject|5
1192702|NCT00990821|3917642|P11|Overall Study|Withdrawal by Subject|3
1192703|NCT00990821|3917643|P10|Overall Study|Withdrawal by Subject|1
1192704|NCT00990821|3917644|P9|Overall Study|Withdrawal by Subject|0
1192705|NCT00990821|3917645|P8|Overall Study|Withdrawal by Subject|0
1192706|NCT00990821|3917646|P7|Overall Study|Withdrawal by Subject|1
1192707|NCT00990821|3917647|P6|Overall Study|Withdrawal by Subject|3
1192708|NCT00990821|3917648|P5|Overall Study|Withdrawal by Subject|3
1192709|NCT00990821|3917649|P4|Overall Study|Withdrawal by Subject|0
1192710|NCT00990821|3917650|P3|Overall Study|Withdrawal by Subject|0
1192711|NCT00990821|3917651|P2|Overall Study|Withdrawal by Subject|2
1192712|NCT00990821|3917652|P1|Overall Study|Withdrawal by Subject|0
1192713|NCT00990704|3917689|P2|Overall Study|Physician Decision|1
1192714|NCT00990704|3917690|P1|Overall Study|Physician Decision|0
1192715|NCT00990704|3917689|P2|Overall Study|Adverse Event|1
1192716|NCT00990704|3917690|P1|Overall Study|Adverse Event|1
1192717|NCT00990652|3917710|P1|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1
1192718|NCT00990652|3917710|P1|Pre-surgical Bortezomib|Adverse Event|1
1192719|NCT00990340|3917744|P2|First 14-day Treatment|Protocol Violation|2
1192720|NCT00990340|3917745|P1|First 14-day Treatment|Protocol Violation|2
1192721|NCT00990340|3917744|P2|First 14-day Treatment|Lost to Follow-up|1
1192722|NCT00990340|3917745|P1|First 14-day Treatment|Lost to Follow-up|2
1192723|NCT00990340|3917744|P2|First 14-day Treatment|Not Compliant|1
1192724|NCT00990340|3917745|P1|First 14-day Treatment|Not Compliant|2
1192725|NCT00990249|3917792|P1|Overall Study|Not treated|2
1192726|NCT00990249|3917792|P1|Overall Study|Death|2
1192727|NCT00990249|3917792|P1|Overall Study|Non-Compliance|1
1192728|NCT00990249|3917792|P1|Overall Study|Disease Progression|8
1192729|NCT00990184|3917796|P1|Overall Study|Physician Decision|1
1192730|NCT00990106|3917804|P2|Overall Study|scheduling conflicts|2
1192731|NCT00990106|3917805|P1|Overall Study|scheduling conflicts|0
1192732|NCT00990106|3917804|P2|Overall Study|planned major surgery|1
1192733|NCT00990106|3917805|P1|Overall Study|planned major surgery|0
1192734|NCT00990106|3917804|P2|Overall Study|started exclusionary medication|1
1192735|NCT00990106|3917805|P1|Overall Study|started exclusionary medication|0
1192736|NCT00990106|3917804|P2|Overall Study|relocation/deployment|1
1192737|NCT00990106|3917805|P1|Overall Study|relocation/deployment|4
1192738|NCT00990106|3917804|P2|Overall Study|opted for open label prazosin|1
1192739|NCT00990106|3917805|P1|Overall Study|opted for open label prazosin|1
1192740|NCT00990106|3917804|P2|Overall Study|Withdrawal by Subject|1
1192741|NCT00990106|3917805|P1|Overall Study|Withdrawal by Subject|2
1192742|NCT00990106|3917804|P2|Overall Study|Lost to Follow-up|3
1192743|NCT00990106|3917805|P1|Overall Study|Lost to Follow-up|1
1192744|NCT00990106|3917804|P2|Overall Study|"too busy to continue"|2
1192745|NCT00990106|3917805|P1|Overall Study|"too busy to continue"|1
1192746|NCT00990093|3917815|P2|Test Period 2 (15-28 Days)|Not specified|1
1192747|NCT00990093|3917816|P1|Test Period 2 (15-28 Days)|Not specified|0
1192748|NCT00990093|3917815|P2|Test Period 2 (15-28 Days)|Lack of Efficacy|0
1192749|NCT00990093|3917816|P1|Test Period 2 (15-28 Days)|Lack of Efficacy|1
1192750|NCT00990093|3917815|P2|Test Period 2 (15-28 Days)|Adverse Event|0
1192751|NCT00990093|3917816|P1|Test Period 2 (15-28 Days)|Adverse Event|1
1192752|NCT00990093|3917815|P2|Test Period 1 (1-14 Days)|Lack of Efficacy|2
1192753|NCT00990093|3917816|P1|Test Period 1 (1-14 Days)|Lack of Efficacy|0
1192754|NCT00990093|3917815|P2|Test Period 1 (1-14 Days)|Not Specified|0
1192755|NCT00990093|3917816|P1|Test Period 1 (1-14 Days)|Not Specified|1
1192756|NCT00990093|3917815|P2|Test Period 1 (1-14 Days)|Withdrawal by Subject|0
1192757|NCT00990093|3917816|P1|Test Period 1 (1-14 Days)|Withdrawal by Subject|2
1192758|NCT00990093|3917815|P2|Test Period 1 (1-14 Days)|Adverse Event|0
1192759|NCT00990093|3917816|P1|Test Period 1 (1-14 Days)|Adverse Event|1
1192760|NCT00989950|3917869|P4|Randomized Phase|Adverse Event|0
1192761|NCT00989950|3917870|P3|Randomized Phase|Adverse Event|0
1192762|NCT00989950|3917871|P2|Randomized Phase|Adverse Event|1
1192763|NCT00989950|3917872|P1|Randomized Phase|Adverse Event|0
1192764|NCT00989950|3917869|P4|Randomized Phase|Protocol Violation|0
1192765|NCT00989950|3917870|P3|Randomized Phase|Protocol Violation|0
1192766|NCT00989950|3917871|P2|Randomized Phase|Protocol Violation|0
1192767|NCT00989950|3917872|P1|Randomized Phase|Protocol Violation|1
1192768|NCT00989833|3917889|P3|Overall Study|Incorrectly randomized|0
1192769|NCT00989833|3917890|P2|Overall Study|Incorrectly randomized|0
1192770|NCT00989833|3917891|P1|Overall Study|Incorrectly randomized|1
1192771|NCT00989833|3917889|P3|Overall Study|Withdrawal by Subject|1
1192772|NCT00989833|3917890|P2|Overall Study|Withdrawal by Subject|0
1192773|NCT00989833|3917891|P1|Overall Study|Withdrawal by Subject|0
1192774|NCT00989833|3917889|P3|Overall Study|Protocol Violation|1
1192775|NCT00989833|3917890|P2|Overall Study|Protocol Violation|2
1192776|NCT00989833|3917891|P1|Overall Study|Protocol Violation|1
1192777|NCT00989833|3917889|P3|Overall Study|Lost to Follow-up|0
1192778|NCT00989833|3917890|P2|Overall Study|Lost to Follow-up|1
1192779|NCT00989833|3917891|P1|Overall Study|Lost to Follow-up|0
1192780|NCT00989781|3917922|P2|Ovarian Response to hCG|Lost to Follow-up|2
1192781|NCT00989781|3917923|P1|Ovarian Response to hCG|Lost to Follow-up|3
1192782|NCT00989664|3917953|P1|Long-Term Follow-Up|Death|3
1192783|NCT00989664|3917953|P1|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1
1192784|NCT00989664|3917953|P1|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7
1192785|NCT00989664|3917953|P1|Dosimetric and Therapeutic Treatment|Death|1
1192786|NCT00989664|3917953|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|49
1192787|NCT00989664|3917953|P1|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2
1192788|NCT00989664|3917953|P1|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1
1192789|NCT00989287|3917999|P2|Overall Study|Lost to Follow-up|1
1192790|NCT00989287|3918000|P1|Overall Study|Lost to Follow-up|0
1192791|NCT00989287|3917999|P2|Overall Study|Adverse Event|0
1192792|NCT00989287|3918000|P1|Overall Study|Adverse Event|1
1192793|NCT00989235|3918102|P2|Overall Study|Lost to Follow-up|1
1192794|NCT00989235|3918103|P1|Overall Study|Lost to Follow-up|0
1192795|NCT00989235|3918102|P2|Overall Study|Randomized by Mistake|2
1192796|NCT00989235|3918103|P1|Overall Study|Randomized by Mistake|0
1192797|NCT00989235|3918102|P2|Overall Study|Desire to Become Pregnant|0
1192798|NCT00989235|3918103|P1|Overall Study|Desire to Become Pregnant|1
1192799|NCT00989235|3918102|P2|Overall Study|Withdrawal of Consent|1
1192800|NCT00989235|3918103|P1|Overall Study|Withdrawal of Consent|1
1192801|NCT00989235|3918102|P2|Overall Study|Lack of Efficacy|0
1192802|NCT00989235|3918103|P1|Overall Study|Lack of Efficacy|1
1192803|NCT00989235|3918102|P2|Overall Study|Adverse Event|1
1192804|NCT00989235|3918103|P1|Overall Study|Adverse Event|0
1192805|NCT00989235|3918102|P2|Overall Study|Death|1
1192806|NCT00989235|3918103|P1|Overall Study|Death|0
1192807|NCT00989196|3918148|P2|Treatment Period|Lost to Follow-up|0
1192808|NCT00989196|3918149|P1|Treatment Period|Lost to Follow-up|1
1192809|NCT00989092|3918187|P2|Overall Study|Did not receive study drug|0
1192810|NCT00989092|3918188|P1|Overall Study|Did not receive study drug|2
1192811|NCT00989092|3918187|P2|Overall Study|Erythropoietin therapy initiated|0
1192812|NCT00989092|3918188|P1|Overall Study|Erythropoietin therapy initiated|2
1192813|NCT00989092|3918187|P2|Overall Study|Protocol deviation|0
1192814|NCT00989092|3918188|P1|Overall Study|Protocol deviation|2
1192815|NCT00989092|3918187|P2|Overall Study|Other|1
1192816|NCT00989092|3918188|P1|Overall Study|Other|3
1192817|NCT00989092|3918187|P2|Overall Study|Lost to Follow-up|2
1192818|NCT00989092|3918188|P1|Overall Study|Lost to Follow-up|6
1192819|NCT00989092|3918187|P2|Overall Study|Ineligibility determined|3
1192820|NCT00989092|3918188|P1|Overall Study|Ineligibility determined|3
1192821|NCT00989092|3918187|P2|Overall Study|Death|2
1192822|NCT00989092|3918188|P1|Overall Study|Death|14
1192823|NCT00989092|3918187|P2|Overall Study|Withdrawal by Subject|9
1192824|NCT00989092|3918188|P1|Overall Study|Withdrawal by Subject|17
1192825|NCT00989092|3918187|P2|Overall Study|Chemotherapy initiated|4
1192826|NCT00989092|3918188|P1|Overall Study|Chemotherapy initiated|12
1192827|NCT00989092|3918187|P2|Overall Study|Adverse Event|1
1192828|NCT00989092|3918188|P1|Overall Study|Adverse Event|20
1192829|NCT00989092|3918187|P2|Overall Study|Physician Decision|6
1192830|NCT00989092|3918188|P1|Overall Study|Physician Decision|9
1192831|NCT00988884|3918240|P2|Overall Study|Withdrawal by Subject|18
1192832|NCT00988884|3918241|P1|Overall Study|Withdrawal by Subject|15
1192833|NCT00988884|3918240|P2|Overall Study|Protocol Violation|1
1192834|NCT00988884|3918241|P1|Overall Study|Protocol Violation|0
1192835|NCT00988884|3918240|P2|Overall Study|Lost to Follow-up|16
1192836|NCT00988884|3918241|P1|Overall Study|Lost to Follow-up|20
1192837|NCT00988884|3918240|P2|Overall Study|Adverse Event|1
1192838|NCT00988884|3918241|P1|Overall Study|Adverse Event|0
1192839|NCT00988858|3918263|P1|Overall Study|Sponsor Decision|1
1192840|NCT00988858|3918263|P1|Overall Study|Physician Decision|1
1192841|NCT00988858|3918263|P1|Overall Study|Death|1
1192842|NCT00988858|3918263|P1|Overall Study|Adverse Event|7
1192843|NCT00988637|3918312|P2|Overall Study|non-compliance with study drug|1
1192844|NCT00988637|3918313|P1|Overall Study|non-compliance with study drug|0
1192845|NCT00988637|3918312|P2|Overall Study|Withdrawal by Subject|1
1192846|NCT00988637|3918313|P1|Overall Study|Withdrawal by Subject|1
1192847|NCT00988637|3918312|P2|Overall Study|Lost to Follow-up|1
1192848|NCT00988637|3918313|P1|Overall Study|Lost to Follow-up|2
1192849|NCT00988559|3918347|P4|Overall Study|Lost to Follow-up|0
1192850|NCT00988559|3918348|P3|Overall Study|Lost to Follow-up|1
1192851|NCT00988559|3918349|P2|Overall Study|Lost to Follow-up|0
1192852|NCT00988559|3918350|P1|Overall Study|Lost to Follow-up|0
1192853|NCT00988559|3918347|P4|Overall Study|Pregnancy|0
1192854|NCT00988559|3918348|P3|Overall Study|Pregnancy|1
1192855|NCT00988559|3918349|P2|Overall Study|Pregnancy|1
1192856|NCT00988559|3918350|P1|Overall Study|Pregnancy|0
1192857|NCT00988559|3918347|P4|Overall Study|Withdrawal by Subject|1
1192858|NCT00988559|3918348|P3|Overall Study|Withdrawal by Subject|0
1192859|NCT00988559|3918349|P2|Overall Study|Withdrawal by Subject|1
1192860|NCT00988559|3918350|P1|Overall Study|Withdrawal by Subject|1
1192861|NCT00988533|3918364|P1|Overall Study|Lost to Follow-up|3
1192862|NCT00988442|3918378|P2|Overall Study|Early Study Closure|25
1192863|NCT00988442|3918379|P1|Overall Study|Early Study Closure|29
1192864|NCT00988442|3918378|P2|Overall Study|Lost to Follow-up|1
1192865|NCT00988442|3918379|P1|Overall Study|Lost to Follow-up|0
1192866|NCT00988442|3918378|P2|Overall Study|Death|2
1192867|NCT00988442|3918379|P1|Overall Study|Death|1
1192868|NCT00988429|3918442|P3|Overall Study|other reasons|1
1192869|NCT00988429|3918443|P2|Overall Study|other reasons|8
1192870|NCT00988429|3918444|P1|Overall Study|other reasons|8
1192871|NCT00988429|3918442|P3|Overall Study|Administrative Reasons|1
1192872|NCT00988429|3918443|P2|Overall Study|Administrative Reasons|2
1192873|NCT00988429|3918444|P1|Overall Study|Administrative Reasons|1
1192874|NCT00988429|3918442|P3|Overall Study|Withdrawal by Subject|12
1192875|NCT00988429|3918443|P2|Overall Study|Withdrawal by Subject|7
1192876|NCT00988429|3918444|P1|Overall Study|Withdrawal by Subject|7
1192877|NCT00988429|3918442|P3|Overall Study|Protocol Violation|3
1192878|NCT00988429|3918443|P2|Overall Study|Protocol Violation|3
1192879|NCT00988429|3918444|P1|Overall Study|Protocol Violation|4
1192880|NCT00988429|3918442|P3|Overall Study|Pregnancy|0
1192881|NCT00988429|3918443|P2|Overall Study|Pregnancy|1
1192882|NCT00988429|3918444|P1|Overall Study|Pregnancy|2
1192883|NCT00988429|3918442|P3|Overall Study|Physician Decision|3
1192884|NCT00988429|3918443|P2|Overall Study|Physician Decision|0
1192885|NCT00988429|3918444|P1|Overall Study|Physician Decision|1
1192886|NCT00988429|3918442|P3|Overall Study|Non-Compliance with Study Drug|3
1192887|NCT00988429|3918443|P2|Overall Study|Non-Compliance with Study Drug|1
1192888|NCT00988429|3918444|P1|Overall Study|Non-Compliance with Study Drug|5
1192889|NCT00988429|3918442|P3|Overall Study|Lack of Efficacy|1
1192890|NCT00988429|3918443|P2|Overall Study|Lack of Efficacy|0
1192891|NCT00988429|3918444|P1|Overall Study|Lack of Efficacy|0
1192892|NCT00988429|3918442|P3|Overall Study|Adverse Event|45
1192893|NCT00988429|3918443|P2|Overall Study|Adverse Event|21
1192894|NCT00988429|3918444|P1|Overall Study|Adverse Event|9
1192895|NCT00988351|3918457|P2|Overall Study|not using CPAP|3
1192896|NCT00988351|3918458|P1|Overall Study|not using CPAP|5
1192897|NCT00988351|3918457|P2|Overall Study|Lost to Follow-up|9
1192898|NCT00988351|3918458|P1|Overall Study|Lost to Follow-up|6
1192899|NCT00988351|3918457|P2|Overall Study|Withdrawal by Subject|0
1192900|NCT00988351|3918458|P1|Overall Study|Withdrawal by Subject|8
1192901|NCT00988247|3918535|P2|Overall Study|Not specified|0
1192902|NCT00988247|3918536|P1|Overall Study|Not specified|3
1192903|NCT00988247|3918535|P2|Overall Study|Sponsor requested withdrawal|1
1192904|NCT00988247|3918536|P1|Overall Study|Sponsor requested withdrawal|3
1192905|NCT00988247|3918535|P2|Overall Study|Protocol Violation|5
1192906|NCT00988247|3918536|P1|Overall Study|Protocol Violation|4
1192907|NCT00988247|3918535|P2|Overall Study|Lost to Follow-up|2
1192908|NCT00988247|3918536|P1|Overall Study|Lost to Follow-up|11
1192909|NCT00988247|3918535|P2|Overall Study|Pregnancy|2
1192910|NCT00988247|3918536|P1|Overall Study|Pregnancy|1
1192911|NCT00988247|3918535|P2|Overall Study|Withdrawal by Subject|13
1192912|NCT00988247|3918536|P1|Overall Study|Withdrawal by Subject|44
1192913|NCT00988247|3918535|P2|Overall Study|Adverse Event|3
1192914|NCT00988247|3918536|P1|Overall Study|Adverse Event|17
1192915|NCT00988221|3918555|P4|Part III|Refused Treatment|0
1192916|NCT00988221|3918556|P3|Part III|Refused Treatment|1
1192917|NCT00988221|3918557|P2|Part III|Refused Treatment|0
1192918|NCT00988221|3918558|P1|Part III|Refused Treatment|0
1192919|NCT00988221|3918555|P4|Part III|Insufficient Therapeutic Response|0
1192920|NCT00988221|3918556|P3|Part III|Insufficient Therapeutic Response|1
1192921|NCT00988221|3918557|P2|Part III|Insufficient Therapeutic Response|1
1192922|NCT00988221|3918558|P1|Part III|Insufficient Therapeutic Response|0
1192923|NCT00988221|3918555|P4|Part III|Adverse Event|0
1192924|NCT00988221|3918556|P3|Part III|Adverse Event|1
1192925|NCT00988221|3918557|P2|Part III|Adverse Event|0
1192926|NCT00988221|3918558|P1|Part III|Adverse Event|1
1192927|NCT00988221|3918555|P4|Part II|Reason not Specified|0
1192928|NCT00988221|3918556|P3|Part II|Reason not Specified|1
1192929|NCT00988221|3918557|P2|Part II|Reason not Specified|0
1192930|NCT00988221|3918558|P1|Part II|Reason not Specified|0
1192931|NCT00988221|3918555|P4|Part II|Withdrawal by Subject|2
1192932|NCT00988221|3918556|P3|Part II|Withdrawal by Subject|2
1192933|NCT00988221|3918557|P2|Part II|Withdrawal by Subject|0
1192934|NCT00988221|3918558|P1|Part II|Withdrawal by Subject|0
1192935|NCT00988221|3918555|P4|Part II|Adverse Event|1
1192936|NCT00988221|3918556|P3|Part II|Adverse Event|0
1192937|NCT00988221|3918557|P2|Part II|Adverse Event|0
1192938|NCT00988221|3918558|P1|Part II|Adverse Event|1
1192939|NCT00988221|3918555|P4|Part I|Lost to Follow-up|0
1192940|NCT00988221|3918556|P3|Part I|Lost to Follow-up|0
1192941|NCT00988221|3918557|P2|Part I|Lost to Follow-up|1
1192942|NCT00988221|3918558|P1|Part I|Lost to Follow-up|0
1192943|NCT00988221|3918555|P4|Part I|Refused Treatment|0
1192944|NCT00988221|3918556|P3|Part I|Refused Treatment|1
1192945|NCT00988221|3918557|P2|Part I|Refused Treatment|2
1192946|NCT00988221|3918558|P1|Part I|Refused Treatment|0
1192947|NCT00988221|3918555|P4|Part I|Insufficient Therapeutic Response|0
1192948|NCT00988221|3918556|P3|Part I|Insufficient Therapeutic Response|5
1192949|NCT00988221|3918557|P2|Part I|Insufficient Therapeutic Response|6
1192950|NCT00988221|3918558|P1|Part I|Insufficient Therapeutic Response|4
1192951|NCT00988221|3918555|P4|Part I|Adverse Event|0
1192952|NCT00988221|3918556|P3|Part I|Adverse Event|2
1192953|NCT00988221|3918557|P2|Part I|Adverse Event|1
1192954|NCT00988221|3918558|P1|Part I|Adverse Event|0
1192955|NCT00988208|3918731|P2|Overall Study|Other|3
1192956|NCT00988208|3918732|P1|Overall Study|Other|8
1192957|NCT00988208|3918731|P2|Overall Study|Subject Decision/Investigator Discretion|32
1192958|NCT00988208|3918732|P1|Overall Study|Subject Decision/Investigator Discretion|32
1192959|NCT00988208|3918731|P2|Overall Study|Clinical Deterioration|14
1192960|NCT00988208|3918732|P1|Overall Study|Clinical Deterioration|7
1192961|NCT00988208|3918731|P2|Overall Study|Biochemical Progression|7
1192962|NCT00988208|3918732|P1|Overall Study|Biochemical Progression|21
1192963|NCT00988208|3918731|P2|Overall Study|Clinical Progression|16
1192964|NCT00988208|3918732|P1|Overall Study|Clinical Progression|17
1192965|NCT00988208|3918731|P2|Overall Study|Sponsor Decision|78
1192966|NCT00988208|3918732|P1|Overall Study|Sponsor Decision|102
1192967|NCT00988208|3918731|P2|Overall Study|Protocol Violation|2
1192968|NCT00988208|3918732|P1|Overall Study|Protocol Violation|9
1192969|NCT00988208|3918731|P2|Overall Study|Lost to Follow-up|3
1192970|NCT00988208|3918732|P1|Overall Study|Lost to Follow-up|2
1192971|NCT00988208|3918731|P2|Overall Study|Death|15
1192972|NCT00988208|3918732|P1|Overall Study|Death|9
1192973|NCT00988208|3918731|P2|Overall Study|Withdrawal by Subject|57
1192974|NCT00988208|3918732|P1|Overall Study|Withdrawal by Subject|50
1192975|NCT00988208|3918731|P2|Overall Study|Disease Progression|89
1192976|NCT00988208|3918732|P1|Overall Study|Disease Progression|103
1192977|NCT00988208|3918731|P2|Overall Study|Adverse Event|122
1192978|NCT00988208|3918732|P1|Overall Study|Adverse Event|71
1192979|NCT00988169|3918750|P1|Overall Study|Withdrawal by Subject|1
1192980|NCT00988117|3918802|P1|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2
1192981|NCT00988117|3918802|P1|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1
1192982|NCT00988091|3918811|P2|Open-label Period|Not specified|3
1192983|NCT00988091|3918812|P1|Open-label Period|Not specified|2
1192984|NCT00988091|3918811|P2|Open-label Period|Lost to Follow-up|5
1192985|NCT00988091|3918812|P1|Open-label Period|Lost to Follow-up|3
1192986|NCT00988091|3918811|P2|Open-label Period|Withdrawal by Subject|16
1192987|NCT00988091|3918812|P1|Open-label Period|Withdrawal by Subject|10
1192988|NCT00988091|3918811|P2|Open-label Period|Protocol Violation|1
1192989|NCT00988091|3918812|P1|Open-label Period|Protocol Violation|1
1192990|NCT00988091|3918811|P2|Open-label Period|Use of exclusionary medication|1
1192991|NCT00988091|3918812|P1|Open-label Period|Use of exclusionary medication|1
1192992|NCT00988091|3918811|P2|Open-label Period|Adverse Event|7
1192993|NCT00988091|3918812|P1|Open-label Period|Adverse Event|4
1192994|NCT00988091|3918811|P2|Double-blind Period|Use of exclusionary medication|3
1192995|NCT00988091|3918812|P1|Double-blind Period|Use of exclusionary medication|2
1192996|NCT00988091|3918811|P2|Double-blind Period|Adverse Event|9
1192997|NCT00988091|3918812|P1|Double-blind Period|Adverse Event|6
1192998|NCT00988091|3918811|P2|Double-blind Period|Not specified|8
1192999|NCT00988091|3918812|P1|Double-blind Period|Not specified|8
1193000|NCT00988091|3918811|P2|Double-blind Period|Lost to Follow-up|14
1193001|NCT00988091|3918812|P1|Double-blind Period|Lost to Follow-up|12
1193002|NCT00988091|3918811|P2|Double-blind Period|Withdrawal by Subject|13
1193003|NCT00988091|3918812|P1|Double-blind Period|Withdrawal by Subject|15
1193004|NCT00988065|3918834|P3|Overall Study|Noncompliance with protocol|9
1193005|NCT00988065|3918835|P2|Overall Study|Noncompliance with protocol|6
1193006|NCT00988065|3918836|P1|Overall Study|Noncompliance with protocol|5
1193007|NCT00988065|3918834|P3|Overall Study|Subject withdrew consent|2
1193008|NCT00988065|3918835|P2|Overall Study|Subject withdrew consent|5
1193009|NCT00988065|3918836|P1|Overall Study|Subject withdrew consent|3
1193010|NCT00988065|3918834|P3|Overall Study|Lost to Follow-up|2
1193011|NCT00988065|3918835|P2|Overall Study|Lost to Follow-up|2
1193012|NCT00988065|3918836|P1|Overall Study|Lost to Follow-up|1
1193013|NCT00988065|3918834|P3|Overall Study|Adverse Event|2
1193014|NCT00988065|3918835|P2|Overall Study|Adverse Event|10
1193015|NCT00988065|3918836|P1|Overall Study|Adverse Event|4
1193016|NCT00987935|3918870|P9|Overall Study|Reason other than those specified above|1
1193017|NCT00987935|3918871|P8|Overall Study|Reason other than those specified above|0
1193018|NCT00987935|3918872|P7|Overall Study|Reason other than those specified above|0
1193019|NCT00987935|3918873|P6|Overall Study|Reason other than those specified above|0
1193020|NCT00987935|3918874|P5|Overall Study|Reason other than those specified above|0
1193021|NCT00987935|3918875|P4|Overall Study|Reason other than those specified above|0
1193022|NCT00987935|3918876|P3|Overall Study|Reason other than those specified above|0
1193023|NCT00987935|3918877|P2|Overall Study|Reason other than those specified above|0
1193024|NCT00987935|3918878|P1|Overall Study|Reason other than those specified above|0
1193025|NCT00987935|3918870|P9|Overall Study|Refused to continue taking trial med.|2
1193026|NCT00987935|3918871|P8|Overall Study|Refused to continue taking trial med.|4
1193027|NCT00987935|3918872|P7|Overall Study|Refused to continue taking trial med.|4
1193028|NCT00987935|3918873|P6|Overall Study|Refused to continue taking trial med.|0
1193029|NCT00987935|3918874|P5|Overall Study|Refused to continue taking trial med.|1
1193030|NCT00987935|3918875|P4|Overall Study|Refused to continue taking trial med.|0
1193031|NCT00987935|3918876|P3|Overall Study|Refused to continue taking trial med.|0
1193032|NCT00987935|3918877|P2|Overall Study|Refused to continue taking trial med.|0
1193033|NCT00987935|3918878|P1|Overall Study|Refused to continue taking trial med.|1
1193034|NCT00987935|3918870|P9|Overall Study|Adverse Event|6
1193035|NCT00987935|3918871|P8|Overall Study|Adverse Event|10
1193036|NCT00987935|3918872|P7|Overall Study|Adverse Event|2
1193037|NCT00987935|3918873|P6|Overall Study|Adverse Event|0
1193038|NCT00987935|3918874|P5|Overall Study|Adverse Event|1
1193039|NCT00987935|3918875|P4|Overall Study|Adverse Event|1
1193040|NCT00987935|3918876|P3|Overall Study|Adverse Event|0
1193041|NCT00987935|3918877|P2|Overall Study|Adverse Event|1
1193042|NCT00987935|3918878|P1|Overall Study|Adverse Event|0
1193043|NCT00987935|3918870|P9|Overall Study|Progressive disease|23
1193044|NCT00987935|3918871|P8|Overall Study|Progressive disease|48
1193045|NCT00987935|3918872|P7|Overall Study|Progressive disease|9
1193046|NCT00987935|3918873|P6|Overall Study|Progressive disease|3
1193047|NCT00987935|3918874|P5|Overall Study|Progressive disease|5
1193048|NCT00987935|3918875|P4|Overall Study|Progressive disease|2
1193049|NCT00987935|3918876|P3|Overall Study|Progressive disease|3
1193050|NCT00987935|3918877|P2|Overall Study|Progressive disease|2
1193051|NCT00987935|3918878|P1|Overall Study|Progressive disease|3
1193052|NCT00987831|3918934|P3|Overall Study|Lost to Follow-up|0
1193053|NCT00987831|3918935|P2|Overall Study|Lost to Follow-up|3
1193054|NCT00987831|3918936|P1|Overall Study|Lost to Follow-up|0
1193055|NCT00987831|3918934|P3|Overall Study|Never flared in 12 months|0
1193056|NCT00987831|3918935|P2|Overall Study|Never flared in 12 months|0
1193057|NCT00987831|3918936|P1|Overall Study|Never flared in 12 months|1
1193058|NCT00987623|3918958|P2|Overall Study|Influenza|1
1193059|NCT00987623|3918959|P1|Overall Study|Influenza|0
1193060|NCT00987623|3918958|P2|Overall Study|Biomicroscopy|1
1193061|NCT00987623|3918959|P1|Overall Study|Biomicroscopy|0
1193062|NCT00987623|3918958|P2|Overall Study|Discomfort|0
1193063|NCT00987623|3918959|P1|Overall Study|Discomfort|1
1193064|NCT00987623|3918958|P2|Overall Study|Time/job conflict|0
1193065|NCT00987623|3918959|P1|Overall Study|Time/job conflict|2
1193066|NCT00987623|3918958|P2|Overall Study|Lost to Follow-up|1
1193067|NCT00987623|3918959|P1|Overall Study|Lost to Follow-up|2
1193068|NCT00987467|3918988|P1|Overall Study|Lost to Follow-up|2
1193069|NCT00987402|3919012|P2|Overall Study|Insufficient data entry|98
1193070|NCT00987402|3919013|P1|Overall Study|Insufficient data entry|86
1193071|NCT00987337|3919022|P3|Overall Study|Participant Relapsed|5
1193072|NCT00987337|3919023|P2|Overall Study|Participant Relapsed|20
1193073|NCT00987337|3919024|P1|Overall Study|Participant Relapsed|18
1193074|NCT00987337|3919022|P3|Overall Study|Protocol Violation|2
1193075|NCT00987337|3919023|P2|Overall Study|Protocol Violation|0
1193076|NCT00987337|3919024|P1|Overall Study|Protocol Violation|1
1193077|NCT00987337|3919022|P3|Overall Study|Other|5
1193078|NCT00987337|3919023|P2|Overall Study|Other|2
1193079|NCT00987337|3919024|P1|Overall Study|Other|0
1193080|NCT00987337|3919022|P3|Overall Study|Withdrawal by Subject|9
1193081|NCT00987337|3919023|P2|Overall Study|Withdrawal by Subject|9
1193082|NCT00987337|3919024|P1|Overall Study|Withdrawal by Subject|6
1193083|NCT00987337|3919022|P3|Overall Study|Lost to Follow-up|2
1193084|NCT00987337|3919023|P2|Overall Study|Lost to Follow-up|6
1193085|NCT00987337|3919024|P1|Overall Study|Lost to Follow-up|10
1193086|NCT00987337|3919022|P3|Overall Study|Virologic Breakthrough|8
1193087|NCT00987337|3919023|P2|Overall Study|Virologic Breakthrough|2
1193088|NCT00987337|3919024|P1|Overall Study|Virologic Breakthrough|2
1193089|NCT00987337|3919022|P3|Overall Study|Insufficient Virologic Response|12
1193090|NCT00987337|3919023|P2|Overall Study|Insufficient Virologic Response|7
1193091|NCT00987337|3919024|P1|Overall Study|Insufficient Virologic Response|10
1193092|NCT00987337|3919022|P3|Overall Study|Adverse Event|8
1193093|NCT00987337|3919023|P2|Overall Study|Adverse Event|9
1193094|NCT00987337|3919024|P1|Overall Study|Adverse Event|10
1193095|NCT00986986|3919079|P2|Overall Study|Lost to Follow-up|1
1193096|NCT00986986|3919080|P1|Overall Study|Lost to Follow-up|0
1193097|NCT00986973|3919090|P1|Overall Study|Withdrawn by study team|1
1193098|NCT00986921|3919116|P2|Overall Study|Physician Decision|0
1193099|NCT00986921|3919117|P1|Overall Study|Physician Decision|1
1193100|NCT00986674|3919153|P3|Overall Study|unknown/not specify|9
1193101|NCT00986674|3919154|P2|Overall Study|unknown/not specify|7
1193102|NCT00986674|3919155|P1|Overall Study|unknown/not specify|0
1193103|NCT00986674|3919153|P3|Overall Study|not start protocol therapy|1
1193104|NCT00986674|3919154|P2|Overall Study|not start protocol therapy|3
1193105|NCT00986674|3919155|P1|Overall Study|not start protocol therapy|4
1193106|NCT00986674|3919153|P3|Overall Study|alternative therapy|1
1193107|NCT00986674|3919154|P2|Overall Study|alternative therapy|0
1193108|NCT00986674|3919155|P1|Overall Study|alternative therapy|0
1193109|NCT00986674|3919153|P3|Overall Study|Withdrawal by Subject|1
1193110|NCT00986674|3919154|P2|Overall Study|Withdrawal by Subject|2
1193111|NCT00986674|3919155|P1|Overall Study|Withdrawal by Subject|6
1193112|NCT00986674|3919153|P3|Overall Study|Death|4
1193113|NCT00986674|3919154|P2|Overall Study|Death|0
1193114|NCT00986674|3919155|P1|Overall Study|Death|5
1193115|NCT00986674|3919153|P3|Overall Study|Adverse Event|9
1193116|NCT00986674|3919154|P2|Overall Study|Adverse Event|8
1193117|NCT00986674|3919155|P1|Overall Study|Adverse Event|4
1193118|NCT00986674|3919153|P3|Overall Study|Lack of Efficacy|23
1193119|NCT00986674|3919154|P2|Overall Study|Lack of Efficacy|25
1193120|NCT00986674|3919155|P1|Overall Study|Lack of Efficacy|28
1193121|NCT00986570|3919188|P1|Overall Study|Potential bias for objective assessment|1
1193122|NCT00986570|3919188|P1|Overall Study|Lost to Follow-up|6
1193123|NCT00986479|3919205|P2|Period 1|Administrative reasons|0
1193124|NCT00986479|3919206|P1|Period 1|Administrative reasons|1
1193125|NCT00986479|3919205|P2|Period 1|Improved mood|0
1193126|NCT00986479|3919206|P1|Period 1|Improved mood|1
1193127|NCT00986427|3919252|P2|Overall Study|Withdrawal by Subject|0
1193128|NCT00986427|3919253|P1|Overall Study|Withdrawal by Subject|1
1193129|NCT00986427|3919252|P2|Overall Study|Lack of Efficacy|0
1193130|NCT00986427|3919253|P1|Overall Study|Lack of Efficacy|1
1193131|NCT00986427|3919252|P2|Overall Study|Lost to Follow-up|0
1193132|NCT00986427|3919253|P1|Overall Study|Lost to Follow-up|2
1193133|NCT00986362|3919281|P2|Overall Study|Lost to Follow-up|1
1193134|NCT00986362|3919282|P1|Overall Study|Lost to Follow-up|0
1193135|NCT00986362|3919281|P2|Overall Study|Death|0
1193136|NCT00986362|3919282|P1|Overall Study|Death|2
1193137|NCT00986349|3919288|P1|Overall Study|device migration|1
1193138|NCT00986349|3919288|P1|Overall Study|Physician Decision|1
1193139|NCT00986349|3919288|P1|Overall Study|Adverse Event|2
1193140|NCT00986349|3919288|P1|Overall Study|Unsuccessful implant procedure|3
1193141|NCT00986258|3919301|P1|Maintenance Period|Withdrawal by Subject|2
1193142|NCT00986258|3919301|P1|Maintenance Period|Lack of Efficacy|2
1193143|NCT00986258|3919301|P1|Maintenance Period|Adverse Event|5
1193144|NCT00986258|3919301|P1|Titration and Optimal Dose Period|Other|1
1193145|NCT00986258|3919301|P1|Titration and Optimal Dose Period|Non-Compliance|1
1193146|NCT00986258|3919301|P1|Titration and Optimal Dose Period|Withdrawal by Subject|3
1193147|NCT00986258|3919301|P1|Titration and Optimal Dose Period|Lack of Efficacy|3
1193148|NCT00986258|3919301|P1|Titration and Optimal Dose Period|Adverse Event|15
1193149|NCT00986258|3919301|P1|Observation Period|Not eligible to be dosed|11
1193150|NCT00986245|3919329|P2|Second Intervention|Protocol Violation|1
1193151|NCT00986245|3919330|P1|Second Intervention|Protocol Violation|0
1193152|NCT00986245|3919329|P2|Second Intervention|Lost to Follow-up|0
1193153|NCT00986245|3919330|P1|Second Intervention|Lost to Follow-up|1
1193154|NCT00986245|3919329|P2|Second Intervention|Poor compliance|0
1193155|NCT00986245|3919330|P1|Second Intervention|Poor compliance|1
1193156|NCT00986245|3919329|P2|First Intervention|Out of indication|0
1193157|NCT00986245|3919330|P1|First Intervention|Out of indication|1
1193158|NCT00986245|3919329|P2|First Intervention|Protocol Violation|1
1193159|NCT00986245|3919330|P1|First Intervention|Protocol Violation|0
1193160|NCT00986245|3919329|P2|First Intervention|Withdrawal by Subject|1
1193161|NCT00986245|3919330|P1|First Intervention|Withdrawal by Subject|0
1193162|NCT00986245|3919329|P2|First Intervention|Lack of Efficacy|2
1193163|NCT00986245|3919330|P1|First Intervention|Lack of Efficacy|1
1193164|NCT00986245|3919329|P2|First Intervention|Poor compliance|4
1193165|NCT00986245|3919330|P1|First Intervention|Poor compliance|8
1193166|NCT00986232|3919367|P4|Overall Study|Incomplete safety follow-up|2
1193167|NCT00986232|3919368|P3|Overall Study|Incomplete safety follow-up|2
1193168|NCT00986232|3919369|P2|Overall Study|Incomplete safety follow-up|7
1193169|NCT00986232|3919370|P1|Overall Study|Incomplete safety follow-up|3
1193170|NCT00986232|3919367|P4|Overall Study|Missed one or more bleeds|7
1193171|NCT00986232|3919368|P3|Overall Study|Missed one or more bleeds|6
1193172|NCT00986232|3919369|P2|Overall Study|Missed one or more bleeds|10
1193173|NCT00986232|3919370|P1|Overall Study|Missed one or more bleeds|13
1193174|NCT00986232|3919367|P4|Overall Study|Withdrawal by Subject|3
1193175|NCT00986232|3919368|P3|Overall Study|Withdrawal by Subject|12
1193176|NCT00986232|3919369|P2|Overall Study|Withdrawal by Subject|16
1193177|NCT00986232|3919370|P1|Overall Study|Withdrawal by Subject|13
1193178|NCT00986232|3919367|P4|Overall Study|Protocol Violation|1
1193179|NCT00986232|3919368|P3|Overall Study|Protocol Violation|0
1193180|NCT00986232|3919369|P2|Overall Study|Protocol Violation|3
1193181|NCT00986232|3919370|P1|Overall Study|Protocol Violation|2
1193182|NCT00986232|3919367|P4|Overall Study|Lost to Follow-up|7
1193183|NCT00986232|3919368|P3|Overall Study|Lost to Follow-up|12
1193184|NCT00986232|3919369|P2|Overall Study|Lost to Follow-up|12
1193185|NCT00986232|3919370|P1|Overall Study|Lost to Follow-up|19
1193186|NCT00986232|3919367|P4|Overall Study|Adverse Event|0
1193187|NCT00986232|3919368|P3|Overall Study|Adverse Event|3
1193188|NCT00986232|3919369|P2|Overall Study|Adverse Event|2
1193189|NCT00986232|3919370|P1|Overall Study|Adverse Event|1
1193190|NCT00986180|3919444|P2|Overall Study|Miscellanies|11
1193191|NCT00986180|3919445|P1|Overall Study|Miscellanies|10
1193192|NCT00986180|3919444|P2|Overall Study|Withdrawal by Subject|9
1193193|NCT00986180|3919445|P1|Overall Study|Withdrawal by Subject|1
1193194|NCT00986180|3919444|P2|Overall Study|Protocol Violation|0
1193195|NCT00986180|3919445|P1|Overall Study|Protocol Violation|2
1193196|NCT00986180|3919444|P2|Overall Study|Physician Decision|3
1193197|NCT00986180|3919445|P1|Overall Study|Physician Decision|1
1193198|NCT00986180|3919444|P2|Overall Study|Lost to Follow-up|7
1193199|NCT00986180|3919445|P1|Overall Study|Lost to Follow-up|5
1193200|NCT00986180|3919444|P2|Overall Study|Lack of Efficacy|3
1193201|NCT00986180|3919445|P1|Overall Study|Lack of Efficacy|4
1193202|NCT00986180|3919444|P2|Overall Study|Adverse Event|23
1193203|NCT00986180|3919445|P1|Overall Study|Adverse Event|21
1193204|NCT00986154|3919523|P2|Overall Study|never received study drug|27
1193205|NCT00986154|3919524|P1|Overall Study|never received study drug|25
1193206|NCT00986154|3919523|P2|Overall Study|investigator/subject decide not continue|3
1193207|NCT00986154|3919524|P1|Overall Study|investigator/subject decide not continue|6
1193208|NCT00986154|3919523|P2|Overall Study|Withdrawal by Subject|33
1193209|NCT00986154|3919524|P1|Overall Study|Withdrawal by Subject|32
1193210|NCT00986154|3919523|P2|Overall Study|Lost to Follow-up|4
1193211|NCT00986154|3919524|P1|Overall Study|Lost to Follow-up|7
1193212|NCT00986154|3919523|P2|Overall Study|Death|127
1193213|NCT00986154|3919524|P1|Overall Study|Death|136
1193214|NCT00986102|3919538|P4|Overall Study|Withdrawal by Subject|0
1193215|NCT00986102|3919539|P3|Overall Study|Withdrawal by Subject|0
1193216|NCT00986102|3919540|P2|Overall Study|Withdrawal by Subject|1
1193217|NCT00986102|3919541|P1|Overall Study|Withdrawal by Subject|1
1193218|NCT00986102|3919538|P4|Overall Study|Lost to Follow-up|1
1193219|NCT00986102|3919539|P3|Overall Study|Lost to Follow-up|0
1193220|NCT00986102|3919540|P2|Overall Study|Lost to Follow-up|1
1193221|NCT00986102|3919541|P1|Overall Study|Lost to Follow-up|0
1193222|NCT00985985|3919591|P4|Overall Study|Other Reason|2
1193223|NCT00985985|3919592|P3|Overall Study|Other Reason|4
1193224|NCT00985985|3919593|P2|Overall Study|Other Reason|1
1193225|NCT00985985|3919594|P1|Overall Study|Other Reason|6
1193226|NCT00985985|3919591|P4|Overall Study|Withdrawal by Subject|2
1193227|NCT00985985|3919592|P3|Overall Study|Withdrawal by Subject|2
1193228|NCT00985985|3919593|P2|Overall Study|Withdrawal by Subject|2
1193229|NCT00985985|3919594|P1|Overall Study|Withdrawal by Subject|4
1193230|NCT00985985|3919591|P4|Overall Study|Lack of Efficacy|3
1193231|NCT00985985|3919592|P3|Overall Study|Lack of Efficacy|1
1193232|NCT00985985|3919593|P2|Overall Study|Lack of Efficacy|6
1193233|NCT00985985|3919594|P1|Overall Study|Lack of Efficacy|5
1193234|NCT00985985|3919591|P4|Overall Study|Protocol Violation|1
1193235|NCT00985985|3919592|P3|Overall Study|Protocol Violation|0
1193236|NCT00985985|3919593|P2|Overall Study|Protocol Violation|2
1193237|NCT00985985|3919594|P1|Overall Study|Protocol Violation|1
1193238|NCT00985985|3919591|P4|Overall Study|Lost to Follow-up|3
1193239|NCT00985985|3919592|P3|Overall Study|Lost to Follow-up|2
1193240|NCT00985985|3919593|P2|Overall Study|Lost to Follow-up|11
1193241|NCT00985985|3919594|P1|Overall Study|Lost to Follow-up|4
1193242|NCT00985985|3919591|P4|Overall Study|Adverse Event|2
1193243|NCT00985985|3919592|P3|Overall Study|Adverse Event|2
1193244|NCT00985985|3919593|P2|Overall Study|Adverse Event|2
1193245|NCT00985985|3919594|P1|Overall Study|Adverse Event|4
1193246|NCT00985959|3919635|P3|Overall Study|Other|11
1193247|NCT00985959|3919636|P2|Overall Study|Other|0
1193248|NCT00985959|3919637|P1|Overall Study|Other|0
1193249|NCT00985959|3919635|P3|Overall Study|Complete response observed over 2 cycles|4
1193250|NCT00985959|3919636|P2|Overall Study|Complete response observed over 2 cycles|1
1193251|NCT00985959|3919637|P1|Overall Study|Complete response observed over 2 cycles|0
1193252|NCT00985959|3919635|P3|Overall Study|Pneumonitis or pulmonary fibrosis|2
1193253|NCT00985959|3919636|P2|Overall Study|Pneumonitis or pulmonary fibrosis|0
1193254|NCT00985959|3919637|P1|Overall Study|Pneumonitis or pulmonary fibrosis|2
1193255|NCT00985959|3919635|P3|Overall Study|Unrecovered toxicity|7
1193256|NCT00985959|3919636|P2|Overall Study|Unrecovered toxicity|0
1193257|NCT00985959|3919637|P1|Overall Study|Unrecovered toxicity|0
1193258|NCT00985959|3919635|P3|Overall Study|Progressive disease|8
1193259|NCT00985959|3919636|P2|Overall Study|Progressive disease|2
1193260|NCT00985959|3919637|P1|Overall Study|Progressive disease|1
1193261|NCT00985959|3919635|P3|Overall Study|Withdrawal by Subject|8
1193262|NCT00985959|3919636|P2|Overall Study|Withdrawal by Subject|0
1193263|NCT00985959|3919637|P1|Overall Study|Withdrawal by Subject|0
1193264|NCT00985959|3919635|P3|Overall Study|Adverse Event|19
1193265|NCT00985959|3919636|P2|Overall Study|Adverse Event|0
1193266|NCT00985959|3919637|P1|Overall Study|Adverse Event|0
1193267|NCT00985946|3919660|P1|Overall Study|Withdrawal by Subject|1
1193268|NCT00985946|3919660|P1|Overall Study|Lost to Follow-up|6
1193269|NCT00985790|3919679|P2|Overall Study|Lost to Follow-up|7
1193270|NCT00985790|3919680|P1|Overall Study|Lost to Follow-up|6
1193271|NCT00985790|3919679|P2|Overall Study|Withdrawal by Subject|1
1193272|NCT00985790|3919680|P1|Overall Study|Withdrawal by Subject|1
1193273|NCT00985751|3919721|P5|Overall Study|Adverse Event|1
1193274|NCT00985751|3919722|P4|Overall Study|Adverse Event|0
1193275|NCT00985751|3919723|P3|Overall Study|Adverse Event|0
1193276|NCT00985751|3919724|P2|Overall Study|Adverse Event|0
1193277|NCT00985751|3919725|P1|Overall Study|Adverse Event|0
1193278|NCT00985738|3919788|P2|Overall Study|Study closed prematurely|8
1193279|NCT00985738|3919789|P1|Overall Study|Study closed prematurely|8
1193280|NCT00985725|3919797|P2|Overall Study|Out-of-window visits|1
1193281|NCT00985725|3919798|P1|Overall Study|Out-of-window visits|0
1193282|NCT00985725|3919797|P2|Overall Study|Non-compliance|2
1193283|NCT00985725|3919798|P1|Overall Study|Non-compliance|1
1193284|NCT00985725|3919797|P2|Overall Study|Lack of Efficacy|1
1193285|NCT00985725|3919798|P1|Overall Study|Lack of Efficacy|0
1193286|NCT00985725|3919797|P2|Overall Study|Lost to Follow-up|1
1193287|NCT00985725|3919798|P1|Overall Study|Lost to Follow-up|1
1193288|NCT00985725|3919797|P2|Overall Study|Withdrawal by Subject|4
1193289|NCT00985725|3919798|P1|Overall Study|Withdrawal by Subject|4
1193290|NCT00985725|3919797|P2|Overall Study|Protocol Violation|3
1193291|NCT00985725|3919798|P1|Overall Study|Protocol Violation|1
1193292|NCT00985725|3919797|P2|Overall Study|Adverse Event|1
1193293|NCT00985725|3919798|P1|Overall Study|Adverse Event|4
1193294|NCT00985712|3919834|P2|Overall Study|Sponsor decision|2
1193295|NCT00985712|3919835|P1|Overall Study|Sponsor decision|0
1193296|NCT00985712|3919834|P2|Overall Study|Withdrawal by Subject|1
1193297|NCT00985712|3919835|P1|Overall Study|Withdrawal by Subject|4
1193298|NCT00985712|3919834|P2|Overall Study|Protocol Violation|1
1193299|NCT00985712|3919835|P1|Overall Study|Protocol Violation|0
1193300|NCT00985712|3919834|P2|Overall Study|Lost to Follow-up|2
1193301|NCT00985712|3919835|P1|Overall Study|Lost to Follow-up|2
1193302|NCT00985712|3919834|P2|Overall Study|Adverse Event|1
1193303|NCT00985712|3919835|P1|Overall Study|Adverse Event|0
1193304|NCT00985686|3919853|P4|Overall Study|Lost to Follow-up|2
1193305|NCT00985686|3919854|P3|Overall Study|Lost to Follow-up|0
1193306|NCT00985686|3919855|P2|Overall Study|Lost to Follow-up|1
1193307|NCT00985686|3919856|P1|Overall Study|Lost to Follow-up|1
1193308|NCT00985673|3919870|P6|Overall Study|Other|0
1193309|NCT00985673|3919871|P5|Overall Study|Other|1
1193310|NCT00985673|3919872|P4|Overall Study|Other|0
1193311|NCT00985673|3919873|P3|Overall Study|Other|1
1193312|NCT00985673|3919874|P2|Overall Study|Other|0
1193313|NCT00985673|3919875|P1|Overall Study|Other|1
1193314|NCT00985673|3919870|P6|Overall Study|Withdrawal by Subject|3
1193315|NCT00985673|3919871|P5|Overall Study|Withdrawal by Subject|2
1193316|NCT00985673|3919872|P4|Overall Study|Withdrawal by Subject|2
1193317|NCT00985673|3919873|P3|Overall Study|Withdrawal by Subject|5
1193318|NCT00985673|3919874|P2|Overall Study|Withdrawal by Subject|4
1193319|NCT00985673|3919875|P1|Overall Study|Withdrawal by Subject|0
1193320|NCT00985673|3919870|P6|Overall Study|Lost to Follow-up|3
1193321|NCT00985673|3919871|P5|Overall Study|Lost to Follow-up|5
1193322|NCT00985673|3919872|P4|Overall Study|Lost to Follow-up|10
1193323|NCT00985673|3919873|P3|Overall Study|Lost to Follow-up|6
1193324|NCT00985673|3919874|P2|Overall Study|Lost to Follow-up|7
1193325|NCT00985673|3919875|P1|Overall Study|Lost to Follow-up|6
1193326|NCT00985504|3920137|P2|Optimization Period|Withdrawal by Subject|8
1193327|NCT00985504|3920138|P1|Optimization Period|Withdrawal by Subject|10
1193328|NCT00985504|3920137|P2|Optimization Period|Protocol Violation|1
1193329|NCT00985504|3920138|P1|Optimization Period|Protocol Violation|3
1193330|NCT00985504|3920137|P2|Optimization Period|Physician Decision|0
1193331|NCT00985504|3920138|P1|Optimization Period|Physician Decision|1
1193332|NCT00985504|3920137|P2|Optimization Period|Lost to Follow-up|1
1193333|NCT00985504|3920138|P1|Optimization Period|Lost to Follow-up|0
1193334|NCT00985504|3920137|P2|Optimization Period|Lack of Efficacy|3
1193335|NCT00985504|3920138|P1|Optimization Period|Lack of Efficacy|5
1193336|NCT00985504|3920137|P2|Optimization Period|Death|1
1193337|NCT00985504|3920138|P1|Optimization Period|Death|0
1193338|NCT00985504|3920137|P2|Optimization Period|Adverse Event|9
1193339|NCT00985504|3920138|P1|Optimization Period|Adverse Event|7
1193340|NCT00985504|3920137|P2|Acute Treatment Period|Withdrawal by Subject|5
1193341|NCT00985504|3920138|P1|Acute Treatment Period|Withdrawal by Subject|9
1193342|NCT00985504|3920137|P2|Acute Treatment Period|Sponsor Decision|1
1193343|NCT00985504|3920138|P1|Acute Treatment Period|Sponsor Decision|0
1193344|NCT00985504|3920137|P2|Acute Treatment Period|Protocol Violation|0
1193345|NCT00985504|3920138|P1|Acute Treatment Period|Protocol Violation|2
1193346|NCT00985504|3920137|P2|Acute Treatment Period|Entry Criteria Not Met|2
1193347|NCT00985504|3920138|P1|Acute Treatment Period|Entry Criteria Not Met|1
1193348|NCT00985504|3920137|P2|Acute Treatment Period|Adverse Event|4
1193349|NCT00985504|3920138|P1|Acute Treatment Period|Adverse Event|3
1193350|NCT00985491|3920164|P1|Overall Study|implant failure|3
1193351|NCT00985491|3920164|P1|Overall Study|Withdrawal by Subject|1
1193352|NCT00985491|3920164|P1|Overall Study|device migration|7
1193353|NCT00985491|3920164|P1|Overall Study|Adverse Event|8
1193354|NCT00985465|3920171|P2|Overall Study|Considered to be part of the other group|1
1193355|NCT00985465|3920172|P1|Overall Study|Considered to be part of the other group|0
1193356|NCT00985465|3920171|P2|Overall Study|Withdrawal by Subject|2
1193357|NCT00985465|3920172|P1|Overall Study|Withdrawal by Subject|1
1193358|NCT00985439|3920199|P4|Overall Study|Adverse Event|0
1193359|NCT00985439|3920200|P3|Overall Study|Adverse Event|1
1193360|NCT00985439|3920201|P2|Overall Study|Adverse Event|0
1193361|NCT00985439|3920202|P1|Overall Study|Adverse Event|0
1193362|NCT00985231|3920218|P2|Overall Study|Study related symptoms & complaints|2
1193363|NCT00985231|3920219|P1|Overall Study|Study related symptoms & complaints|0
1193364|NCT00985231|3920218|P2|Overall Study|Lost to Follow-up|1
1193365|NCT00985231|3920219|P1|Overall Study|Lost to Follow-up|0
1193366|NCT00985231|3920218|P2|Overall Study|Withdrawal by Subject|0
1193367|NCT00985231|3920219|P1|Overall Study|Withdrawal by Subject|1
1193368|NCT00985231|3920218|P2|Overall Study|Protocol Violation|0
1193369|NCT00985231|3920219|P1|Overall Study|Protocol Violation|1
1193370|NCT00985231|3920218|P2|Overall Study|ineligible|0
1193371|NCT00985231|3920219|P1|Overall Study|ineligible|1
1193372|NCT00985192|3920227|P1|Overall Study|Determined to be Ineligible During Trial|2
1193373|NCT00985192|3920227|P1|Overall Study|Disease Progression|1
1193374|NCT00985192|3920227|P1|Overall Study|Withdrawal by Subject|1
1193375|NCT00985166|3920239|P3|Overall Study|Other|1
1193376|NCT00985166|3920240|P2|Overall Study|Other|0
1193377|NCT00985166|3920241|P1|Overall Study|Other|1
1193378|NCT00985166|3920239|P3|Overall Study|Test not done|4
1193379|NCT00985166|3920240|P2|Overall Study|Test not done|0
1193380|NCT00985166|3920241|P1|Overall Study|Test not done|2
1193381|NCT00985166|3920239|P3|Overall Study|Withdrawal by Subject|0
1193382|NCT00985166|3920240|P2|Overall Study|Withdrawal by Subject|2
1193383|NCT00985166|3920241|P1|Overall Study|Withdrawal by Subject|3
1193384|NCT00985166|3920239|P3|Overall Study|Lost to Follow-up|2
1193385|NCT00985166|3920240|P2|Overall Study|Lost to Follow-up|2
1193386|NCT00985166|3920241|P1|Overall Study|Lost to Follow-up|3
1193387|NCT00985153|3920261|P4|Overall Study|Incomplete Safety Follow-up|4
1193388|NCT00985153|3920262|P3|Overall Study|Incomplete Safety Follow-up|4
1193389|NCT00985153|3920263|P2|Overall Study|Incomplete Safety Follow-up|5
1193390|NCT00985153|3920264|P1|Overall Study|Incomplete Safety Follow-up|3
1193391|NCT00985153|3920261|P4|Overall Study|Missed One or More Bleeds|10
1193392|NCT00985153|3920262|P3|Overall Study|Missed One or More Bleeds|8
1193393|NCT00985153|3920263|P2|Overall Study|Missed One or More Bleeds|7
1193394|NCT00985153|3920264|P1|Overall Study|Missed One or More Bleeds|7
1193395|NCT00985153|3920261|P4|Overall Study|Withdrawal by Subject|10
1193396|NCT00985153|3920262|P3|Overall Study|Withdrawal by Subject|11
1193397|NCT00985153|3920263|P2|Overall Study|Withdrawal by Subject|11
1193398|NCT00985153|3920264|P1|Overall Study|Withdrawal by Subject|6
1193399|NCT00985153|3920261|P4|Overall Study|Protocol Violation|3
1193400|NCT00985153|3920262|P3|Overall Study|Protocol Violation|4
1193401|NCT00985153|3920263|P2|Overall Study|Protocol Violation|2
1193402|NCT00985153|3920264|P1|Overall Study|Protocol Violation|3
1193403|NCT00985153|3920261|P4|Overall Study|Lost to Follow-up|20
1193404|NCT00985153|3920262|P3|Overall Study|Lost to Follow-up|17
1193405|NCT00985153|3920263|P2|Overall Study|Lost to Follow-up|19
1193406|NCT00985153|3920264|P1|Overall Study|Lost to Follow-up|16
1193407|NCT00985114|3920312|P2|Overall Study|Withdrawal by Subject|2
1193408|NCT00985114|3920313|P1|Overall Study|Withdrawal by Subject|0
1193409|NCT00985114|3920312|P2|Overall Study|Adverse Event|0
1193410|NCT00985114|3920313|P1|Overall Study|Adverse Event|1
1193411|NCT00985088|3920327|P8|Overall Study|Lost to Follow-up|2
1193412|NCT00985088|3920328|P7|Overall Study|Lost to Follow-up|3
1193413|NCT00985088|3920329|P6|Overall Study|Lost to Follow-up|5
1193414|NCT00985088|3920330|P5|Overall Study|Lost to Follow-up|6
1193415|NCT00985088|3920331|P4|Overall Study|Lost to Follow-up|6
1193416|NCT00985088|3920332|P3|Overall Study|Lost to Follow-up|2
1193417|NCT00985088|3920333|P2|Overall Study|Lost to Follow-up|1
1193418|NCT00985088|3920334|P1|Overall Study|Lost to Follow-up|6
1193419|NCT00985088|3920327|P8|Overall Study|Migrated/moved from study area|1
1193420|NCT00985088|3920328|P7|Overall Study|Migrated/moved from study area|0
1193421|NCT00985088|3920329|P6|Overall Study|Migrated/moved from study area|0
1193422|NCT00985088|3920330|P5|Overall Study|Migrated/moved from study area|0
1193423|NCT00985088|3920331|P4|Overall Study|Migrated/moved from study area|0
1193424|NCT00985088|3920332|P3|Overall Study|Migrated/moved from study area|1
1193425|NCT00985088|3920333|P2|Overall Study|Migrated/moved from study area|0
1193426|NCT00985088|3920334|P1|Overall Study|Migrated/moved from study area|0
1193427|NCT00985088|3920327|P8|Overall Study|Withdrawal by Subject|2
1193428|NCT00985088|3920328|P7|Overall Study|Withdrawal by Subject|1
1193429|NCT00985088|3920329|P6|Overall Study|Withdrawal by Subject|2
1193430|NCT00985088|3920330|P5|Overall Study|Withdrawal by Subject|3
1193431|NCT00985088|3920331|P4|Overall Study|Withdrawal by Subject|1
1193432|NCT00985088|3920332|P3|Overall Study|Withdrawal by Subject|0
1193433|NCT00985088|3920333|P2|Overall Study|Withdrawal by Subject|0
1193434|NCT00985088|3920334|P1|Overall Study|Withdrawal by Subject|4
1193435|NCT00985088|3920327|P8|Overall Study|Adverse Event|0
1193436|NCT00985088|3920328|P7|Overall Study|Adverse Event|0
1193437|NCT00985088|3920329|P6|Overall Study|Adverse Event|0
1193438|NCT00985088|3920330|P5|Overall Study|Adverse Event|0
1193439|NCT00985088|3920331|P4|Overall Study|Adverse Event|0
1193440|NCT00985088|3920332|P3|Overall Study|Adverse Event|1
1193441|NCT00985088|3920333|P2|Overall Study|Adverse Event|0
1193442|NCT00985088|3920334|P1|Overall Study|Adverse Event|0
1193443|NCT00985088|3920327|P8|Overall Study|Serious Adverse Event|1
1193444|NCT00985088|3920328|P7|Overall Study|Serious Adverse Event|0
1193445|NCT00985088|3920329|P6|Overall Study|Serious Adverse Event|0
1193446|NCT00985088|3920330|P5|Overall Study|Serious Adverse Event|0
1193447|NCT00985088|3920331|P4|Overall Study|Serious Adverse Event|0
1193448|NCT00985088|3920332|P3|Overall Study|Serious Adverse Event|0
1193449|NCT00985088|3920333|P2|Overall Study|Serious Adverse Event|1
1193450|NCT00985088|3920334|P1|Overall Study|Serious Adverse Event|1
1193451|NCT00984867|3920603|P2|Overall Study|lack of efficacy and subject compliance|0
1193452|NCT00984867|3920604|P1|Overall Study|lack of efficacy and subject compliance|1
1193453|NCT00984867|3920603|P2|Overall Study|site closing|0
1193454|NCT00984867|3920604|P1|Overall Study|site closing|1
1193455|NCT00984867|3920603|P2|Overall Study|Subject no longer meets study criteria|1
1193456|NCT00984867|3920604|P1|Overall Study|Subject no longer meets study criteria|1
1193457|NCT00984867|3920603|P2|Overall Study|Poor/non-compliance|1
1193458|NCT00984867|3920604|P1|Overall Study|Poor/non-compliance|0
1193459|NCT00984867|3920603|P2|Overall Study|Lost to Follow-up|4
1193460|NCT00984867|3920604|P1|Overall Study|Lost to Follow-up|3
1193461|NCT00984867|3920603|P2|Overall Study|Withdrawal by Subject|4
1193462|NCT00984867|3920604|P1|Overall Study|Withdrawal by Subject|13
1193463|NCT00984867|3920603|P2|Overall Study|Death|0
1193464|NCT00984867|3920604|P1|Overall Study|Death|1
1193465|NCT00984867|3920603|P2|Overall Study|Adverse Event|7
1193466|NCT00984867|3920604|P1|Overall Study|Adverse Event|3
1193467|NCT00984659|3920644|P4|6-week Double-blind Treatment Period|Withdrawal by Subject|1
1193468|NCT00984659|3920645|P3|6-week Double-blind Treatment Period|Withdrawal by Subject|7
1193469|NCT00984659|3920646|P2|6-week Double-blind Treatment Period|Withdrawal by Subject|1
1193470|NCT00984659|3920647|P1|6-week Double-blind Treatment Period|Withdrawal by Subject|0
1193471|NCT00984659|3920644|P4|6-week Double-blind Treatment Period|Study Closed/Terminated|0
1193472|NCT00984659|3920645|P3|6-week Double-blind Treatment Period|Study Closed/Terminated|1
1193473|NCT00984659|3920646|P2|6-week Double-blind Treatment Period|Study Closed/Terminated|0
1193474|NCT00984659|3920647|P1|6-week Double-blind Treatment Period|Study Closed/Terminated|0
1193475|NCT00984659|3920644|P4|6-week Double-blind Treatment Period|Protocol Violation|4
1193476|NCT00984659|3920645|P3|6-week Double-blind Treatment Period|Protocol Violation|0
1193477|NCT00984659|3920646|P2|6-week Double-blind Treatment Period|Protocol Violation|0
1193478|NCT00984659|3920647|P1|6-week Double-blind Treatment Period|Protocol Violation|0
1193479|NCT00984659|3920644|P4|6-week Double-blind Treatment Period|Lack of Efficacy|1
1193480|NCT00984659|3920645|P3|6-week Double-blind Treatment Period|Lack of Efficacy|0
1193481|NCT00984659|3920646|P2|6-week Double-blind Treatment Period|Lack of Efficacy|2
1193482|NCT00984659|3920647|P1|6-week Double-blind Treatment Period|Lack of Efficacy|0
1193483|NCT00984659|3920644|P4|6-week Double-blind Treatment Period|Adverse Event|7
1193484|NCT00984659|3920645|P3|6-week Double-blind Treatment Period|Adverse Event|3
1193485|NCT00984659|3920646|P2|6-week Double-blind Treatment Period|Adverse Event|3
1193486|NCT00984659|3920647|P1|6-week Double-blind Treatment Period|Adverse Event|0
1193487|NCT00984659|3920644|P4|2-week Run-in Period|Did Not Meet Continuation Criteria|0
1193488|NCT00984659|3920645|P3|2-week Run-in Period|Did Not Meet Continuation Criteria|0
1193489|NCT00984659|3920646|P2|2-week Run-in Period|Did Not Meet Continuation Criteria|0
1193490|NCT00984659|3920647|P1|2-week Run-in Period|Did Not Meet Continuation Criteria|14
1193491|NCT00984659|3920644|P4|2-week Run-in Period|Withdrawal by Subject|0
1193492|NCT00984659|3920645|P3|2-week Run-in Period|Withdrawal by Subject|0
1193493|NCT00984659|3920646|P2|2-week Run-in Period|Withdrawal by Subject|0
1193494|NCT00984659|3920647|P1|2-week Run-in Period|Withdrawal by Subject|10
1193495|NCT00984659|3920644|P4|2-week Run-in Period|Physician Decision|0
1193496|NCT00984659|3920645|P3|2-week Run-in Period|Physician Decision|0
1193497|NCT00984659|3920646|P2|2-week Run-in Period|Physician Decision|0
1193498|NCT00984659|3920647|P1|2-week Run-in Period|Physician Decision|10
1193499|NCT00984659|3920644|P4|2-week Run-in Period|Lost to Follow-up|0
1193500|NCT00984659|3920645|P3|2-week Run-in Period|Lost to Follow-up|0
1193501|NCT00984659|3920646|P2|2-week Run-in Period|Lost to Follow-up|0
1193502|NCT00984659|3920647|P1|2-week Run-in Period|Lost to Follow-up|3
1193503|NCT00984659|3920644|P4|2-week Run-in Period|Study Closed/Terminated|0
1193504|NCT00984659|3920645|P3|2-week Run-in Period|Study Closed/Terminated|0
1193505|NCT00984659|3920646|P2|2-week Run-in Period|Study Closed/Terminated|0
1193506|NCT00984659|3920647|P1|2-week Run-in Period|Study Closed/Terminated|2
1193507|NCT00984659|3920644|P4|2-week Run-in Period|Protocol Violation|0
1193508|NCT00984659|3920645|P3|2-week Run-in Period|Protocol Violation|0
1193509|NCT00984659|3920646|P2|2-week Run-in Period|Protocol Violation|0
1193510|NCT00984659|3920647|P1|2-week Run-in Period|Protocol Violation|5
1193511|NCT00984659|3920644|P4|2-week Run-in Period|Adverse Event|0
1193512|NCT00984659|3920645|P3|2-week Run-in Period|Adverse Event|0
1193513|NCT00984659|3920646|P2|2-week Run-in Period|Adverse Event|0
1193514|NCT00984659|3920647|P1|2-week Run-in Period|Adverse Event|8
1193515|NCT00984620|3920674|P2|Overall Study|reason other than listed above|4
1193516|NCT00984620|3920675|P1|Overall Study|reason other than listed above|0
1193517|NCT00984620|3920674|P2|Overall Study|Withdrawal by Subject|2
1193518|NCT00984620|3920675|P1|Overall Study|Withdrawal by Subject|0
1193519|NCT00984620|3920674|P2|Overall Study|Lost to Follow-up|1
1193520|NCT00984620|3920675|P1|Overall Study|Lost to Follow-up|1
1193521|NCT00984620|3920674|P2|Overall Study|Adverse Event|5
1193522|NCT00984620|3920675|P1|Overall Study|Adverse Event|5
1193523|NCT00984594|3920713|P2|Overall Study|Withdrawal by Subject|1
1193524|NCT00984594|3920714|P1|Overall Study|Withdrawal by Subject|0
1193525|NCT00984594|3920713|P2|Overall Study|Lost to Follow-up|0
1193526|NCT00984594|3920714|P1|Overall Study|Lost to Follow-up|1
1193527|NCT00984568|3920730|P2|Overall Study|Unknown Reason|3
1193528|NCT00984568|3920731|P1|Overall Study|Unknown Reason|1
1193529|NCT00984568|3920730|P2|Overall Study|Opportunistic Infection|0
1193530|NCT00984568|3920731|P1|Overall Study|Opportunistic Infection|1
1193531|NCT00984568|3920730|P2|Overall Study|Lost to Follow-up|1
1193532|NCT00984568|3920731|P1|Overall Study|Lost to Follow-up|0
1193533|NCT00984568|3920730|P2|Overall Study|Did Not Meet Randomization Criteria|0
1193534|NCT00984568|3920731|P1|Overall Study|Did Not Meet Randomization Criteria|1
1193535|NCT00984568|3920730|P2|Overall Study|Adverse Event|0
1193536|NCT00984568|3920731|P1|Overall Study|Adverse Event|2
1193537|NCT00984568|3920730|P2|Overall Study|Lack of Efficacy|0
1193538|NCT00984568|3920731|P1|Overall Study|Lack of Efficacy|2
1193539|NCT00984568|3920730|P2|Overall Study|Withdrawal by Subject|2
1193540|NCT00984568|3920731|P1|Overall Study|Withdrawal by Subject|1
1193541|NCT00984542|3920739|P1|Overall Study|clinical deterioration|2
1193542|NCT00984542|3920739|P1|Overall Study|Withdrawal by Subject|3
1193543|NCT00984542|3920739|P1|Overall Study|complicating disease|3
1193544|NCT00984542|3920739|P1|Overall Study|Death|7
1193545|NCT00984542|3920739|P1|Overall Study|toxicity|7
1193546|NCT00984542|3920739|P1|Overall Study|disease progression|19
1193547|NCT00984295|3920789|P3|Overall Study|Incomplete safety follow-up|3
1193548|NCT00984295|3920790|P2|Overall Study|Incomplete safety follow-up|2
1193549|NCT00984295|3920791|P1|Overall Study|Incomplete safety follow-up|11
1193550|NCT00984295|3920789|P3|Overall Study|Missed one or more blood samplings|2
1193551|NCT00984295|3920790|P2|Overall Study|Missed one or more blood samplings|7
1193552|NCT00984295|3920791|P1|Overall Study|Missed one or more blood samplings|3
1193553|NCT00984295|3920789|P3|Overall Study|CAE – discontinued test vaccine|3
1193554|NCT00984295|3920790|P2|Overall Study|CAE – discontinued test vaccine|1
1193555|NCT00984295|3920791|P1|Overall Study|CAE – discontinued test vaccine|0
1193556|NCT00984295|3920789|P3|Overall Study|Withdrawal by Subject|12
1193557|NCT00984295|3920790|P2|Overall Study|Withdrawal by Subject|9
1193558|NCT00984295|3920791|P1|Overall Study|Withdrawal by Subject|18
1193559|NCT00984295|3920789|P3|Overall Study|Protocol Violation|4
1193560|NCT00984295|3920790|P2|Overall Study|Protocol Violation|1
1193561|NCT00984295|3920791|P1|Overall Study|Protocol Violation|2
1193562|NCT00984295|3920789|P3|Overall Study|Lost to Follow-up|13
1193563|NCT00984295|3920790|P2|Overall Study|Lost to Follow-up|12
1193564|NCT00984295|3920791|P1|Overall Study|Lost to Follow-up|31
1193565|NCT00984282|3920858|P2|Long Term Follow-up|Disease prog., recurrence or relapse|1
1193566|NCT00984282|3920859|P1|Long Term Follow-up|Disease prog., recurrence or relapse|0
1193567|NCT00984282|3920858|P2|Long Term Follow-up|Switched to commercial drug|2
1193568|NCT00984282|3920859|P1|Long Term Follow-up|Switched to commercial drug|4
1193569|NCT00984282|3920858|P2|Long Term Follow-up|Transferred to treat. continuation study|3
1193570|NCT00984282|3920859|P1|Long Term Follow-up|Transferred to treat. continuation study|2
1193571|NCT00984282|3920858|P2|Long Term Follow-up|Protocol driven decision point|26
1193572|NCT00984282|3920859|P1|Long Term Follow-up|Protocol driven decision point|25
1193573|NCT00984282|3920858|P2|Long Term Follow-up|Lost to Follow-up|6
1193574|NCT00984282|3920859|P1|Long Term Follow-up|Lost to Follow-up|3
1193575|NCT00984282|3920858|P2|Long Term Follow-up|Death|68
1193576|NCT00984282|3920859|P1|Long Term Follow-up|Death|27
1193577|NCT00984282|3920858|P2|Long Term Follow-up|Withdrawal by Subject|14
1193578|NCT00984282|3920859|P1|Long Term Follow-up|Withdrawal by Subject|8
1193579|NCT00984282|3920858|P2|Open-label Treatment|Physician Decision|0
1193580|NCT00984282|3920859|P1|Open-label Treatment|Physician Decision|1
1193581|NCT00984282|3920858|P2|Open-label Treatment|Switched to commercial drug|7
1193582|NCT00984282|3920859|P1|Open-label Treatment|Switched to commercial drug|6
1193583|NCT00984282|3920858|P2|Open-label Treatment|Transferred to treat. continuation study|3
1193584|NCT00984282|3920859|P1|Open-label Treatment|Transferred to treat. continuation study|2
1193585|NCT00984282|3920858|P2|Open-label Treatment|Protocol driven decision point|1
1193586|NCT00984282|3920859|P1|Open-label Treatment|Protocol driven decision point|1
1193587|NCT00984282|3920858|P2|Open-label Treatment|Target lesion removed|1
1193588|NCT00984282|3920859|P1|Open-label Treatment|Target lesion removed|0
1193589|NCT00984282|3920858|P2|Open-label Treatment|Non-compliant with study medication|0
1193590|NCT00984282|3920859|P1|Open-label Treatment|Non-compliant with study medication|1
1193591|NCT00984282|3920858|P2|Open-label Treatment|Patient convenience|0
1193592|NCT00984282|3920859|P1|Open-label Treatment|Patient convenience|1
1193593|NCT00984282|3920858|P2|Open-label Treatment|Lost to Follow-up|1
1193594|NCT00984282|3920859|P1|Open-label Treatment|Lost to Follow-up|1
1193595|NCT00984282|3920858|P2|Open-label Treatment|Progression, recurrence or relapse|82
1193596|NCT00984282|3920859|P1|Open-label Treatment|Progression, recurrence or relapse|40
1193597|NCT00984282|3920858|P2|Open-label Treatment|Death|15
1193598|NCT00984282|3920859|P1|Open-label Treatment|Death|7
1193599|NCT00984282|3920858|P2|Open-label Treatment|Withdrawal by Subject|21
1193600|NCT00984282|3920859|P1|Open-label Treatment|Withdrawal by Subject|6
1193601|NCT00984282|3920858|P2|Open-label Treatment|Adverse Event|30
1193602|NCT00984282|3920859|P1|Open-label Treatment|Adverse Event|20
1193603|NCT00984282|3920858|P2|Double Blind Treatment|Transferred to treat. continuation study|1
1193604|NCT00984282|3920859|P1|Double Blind Treatment|Transferred to treat. continuation study|2
1193605|NCT00984282|3920858|P2|Double Blind Treatment|Radiological and clinical progression|1
1193606|NCT00984282|3920859|P1|Double Blind Treatment|Radiological and clinical progression|0
1193607|NCT00984282|3920858|P2|Double Blind Treatment|protocol driven decision point|1
1193608|NCT00984282|3920859|P1|Double Blind Treatment|protocol driven decision point|1
1193609|NCT00984282|3920858|P2|Double Blind Treatment|Switched to commercial drug|1
1193610|NCT00984282|3920859|P1|Double Blind Treatment|Switched to commercial drug|6
1193611|NCT00984282|3920858|P2|Double Blind Treatment|Not treated|1
1193612|NCT00984282|3920859|P1|Double Blind Treatment|Not treated|0
1193613|NCT00984282|3920858|P2|Double Blind Treatment|Death|4
1193614|NCT00984282|3920859|P1|Double Blind Treatment|Death|8
1193615|NCT00984282|3920858|P2|Double Blind Treatment|Lost to Follow-up|0
1193616|NCT00984282|3920859|P1|Double Blind Treatment|Lost to Follow-up|3
1193617|NCT00984282|3920858|P2|Double Blind Treatment|Withdrawal by Subject|18
1193618|NCT00984282|3920859|P1|Double Blind Treatment|Withdrawal by Subject|13
1193619|NCT00984282|3920858|P2|Double Blind Treatment|Progression by clinical judgment|0
1193620|NCT00984282|3920859|P1|Double Blind Treatment|Progression by clinical judgment|2
1193621|NCT00984282|3920858|P2|Double Blind Treatment|Noncompliance with study medication|0
1193622|NCT00984282|3920859|P1|Double Blind Treatment|Noncompliance with study medication|3
1193623|NCT00984282|3920858|P2|Double Blind Treatment|Physician Decision|2
1193624|NCT00984282|3920859|P1|Double Blind Treatment|Physician Decision|1
1193625|NCT00984282|3920858|P2|Double Blind Treatment|Progression, recurrence or relapse|3
1193626|NCT00984282|3920859|P1|Double Blind Treatment|Progression, recurrence or relapse|25
1193627|NCT00984282|3920858|P2|Double Blind Treatment|Adverse Event|6
1193628|NCT00984282|3920859|P1|Double Blind Treatment|Adverse Event|40
1193629|NCT00984256|3920882|P2|Overall Study|Withdrawal by Subject|1
1193630|NCT00984256|3920883|P1|Overall Study|Withdrawal by Subject|0
1193631|NCT00984204|3920903|P1|Overall Study|Lack of Efficacy|10
1193632|NCT00984204|3920903|P1|Overall Study|Lost to Follow-up|4
1193633|NCT00984204|3920903|P1|Overall Study|Death|1
1193634|NCT00984165|3920913|P4|Overall Study|removed with a pair recipient|1
1193635|NCT00984165|3920914|P3|Overall Study|removed with a pair recipient|0
1193636|NCT00984165|3920915|P2|Overall Study|removed with a pair recipient|0
1193637|NCT00984165|3920916|P1|Overall Study|removed with a pair recipient|0
1193638|NCT00984165|3920913|P4|Overall Study|P+/donor pair removed from protocol|1
1193639|NCT00984165|3920914|P3|Overall Study|P+/donor pair removed from protocol|0
1193640|NCT00984165|3920915|P2|Overall Study|P+/donor pair removed from protocol|0
1193641|NCT00984165|3920916|P1|Overall Study|P+/donor pair removed from protocol|0
1193642|NCT00984165|3920913|P4|Overall Study|New protocol|1
1193643|NCT00984165|3920914|P3|Overall Study|New protocol|0
1193644|NCT00984165|3920915|P2|Overall Study|New protocol|0
1193645|NCT00984165|3920916|P1|Overall Study|New protocol|0
1193646|NCT00984165|3920913|P4|Overall Study|Death of recipient|1
1193647|NCT00984165|3920914|P3|Overall Study|Death of recipient|0
1193648|NCT00984165|3920915|P2|Overall Study|Death of recipient|0
1193649|NCT00984165|3920916|P1|Overall Study|Death of recipient|0
1193650|NCT00984165|3920913|P4|Overall Study|Disease progression on study|0
1193651|NCT00984165|3920914|P3|Overall Study|Disease progression on study|0
1193652|NCT00984165|3920915|P2|Overall Study|Disease progression on study|1
1193653|NCT00984165|3920916|P1|Overall Study|Disease progression on study|5
1193654|NCT00984165|3920913|P4|Overall Study|Death on study|0
1193655|NCT00984165|3920914|P3|Overall Study|Death on study|0
1193656|NCT00984165|3920915|P2|Overall Study|Death on study|0
1193657|NCT00984165|3920916|P1|Overall Study|Death on study|2
1193658|NCT00984126|3920945|P4|Overall Study|Withdrawal criteria|9
1193659|NCT00984126|3920946|P3|Overall Study|Withdrawal criteria|3
1193660|NCT00984126|3920947|P2|Overall Study|Withdrawal criteria|1
1193661|NCT00984126|3920948|P1|Overall Study|Withdrawal criteria|0
1193662|NCT00984126|3920945|P4|Overall Study|Choose to join Pathfinder trial™ + other|46
1193663|NCT00984126|3920946|P3|Overall Study|Choose to join Pathfinder trial™ + other|3
1193664|NCT00984126|3920947|P2|Overall Study|Choose to join Pathfinder trial™ + other|7
1193665|NCT00984126|3920948|P1|Overall Study|Choose to join Pathfinder trial™ + other|7
1193666|NCT00984126|3920945|P4|Overall Study|Adverse Event|2
1193667|NCT00984126|3920946|P3|Overall Study|Adverse Event|0
1193668|NCT00984126|3920947|P2|Overall Study|Adverse Event|0
1193669|NCT00984126|3920948|P1|Overall Study|Adverse Event|0
1193670|NCT00984126|3920945|P4|Overall Study|Protocol Violation|2
1193671|NCT00984126|3920946|P3|Overall Study|Protocol Violation|1
1193672|NCT00984126|3920947|P2|Overall Study|Protocol Violation|0
1193673|NCT00984126|3920948|P1|Overall Study|Protocol Violation|0
1193674|NCT00984061|3920973|P1|Clarithromycin Alone|Protocol Violation|1
1193675|NCT00984022|3920986|P2|Overall Study|Lost to Follow-up|14
1193676|NCT00984022|3920987|P1|Overall Study|Lost to Follow-up|10
1193677|NCT00984009|3920997|P1|Grapefruit Juice Alone|missed serving of grapefruit juice|1
1193678|NCT00983957|3921030|P1|Overall Study|Personal Reasons|1
1193679|NCT00983957|3921030|P1|Overall Study|Adverse Event|1
1193680|NCT00983931|3921064|P1|14 Day Washout Period|Physician Decision|1
1193681|NCT00983918|3921078|P4|Overall Study|conversion to open cholecystectomy|2
1193682|NCT00983918|3921079|P3|Overall Study|conversion to open cholecystectomy|2
1193683|NCT00983918|3921080|P2|Overall Study|conversion to open cholecystectomy|2
1193684|NCT00983918|3921081|P1|Overall Study|conversion to open cholecystectomy|0
1193685|NCT00983905|3921091|P1|Colchicine Alone|Adverse Event|2
1193686|NCT00983905|3921091|P1|Theophylline Alone|Adverse Event|1
1193687|NCT00983892|3921104|P2|Overall Study|Withdrawal by Subject|12
1193688|NCT00983892|3921105|P1|Overall Study|Withdrawal by Subject|10
1193689|NCT00983853|3921117|P6|Overall Study|Unable to come to study follow-up visits|0
1193690|NCT00983853|3921118|P5|Overall Study|Unable to come to study follow-up visits|0
1193691|NCT00983853|3921119|P4|Overall Study|Unable to come to study follow-up visits|0
1193692|NCT00983853|3921120|P3|Overall Study|Unable to come to study follow-up visits|0
1193693|NCT00983853|3921121|P2|Overall Study|Unable to come to study follow-up visits|1
1193694|NCT00983853|3921122|P1|Overall Study|Unable to come to study follow-up visits|0
1193695|NCT00983853|3921117|P6|Overall Study|Withdrawal by Subject|0
1193696|NCT00983853|3921118|P5|Overall Study|Withdrawal by Subject|1
1193697|NCT00983853|3921119|P4|Overall Study|Withdrawal by Subject|0
1193698|NCT00983853|3921120|P3|Overall Study|Withdrawal by Subject|1
1193699|NCT00983853|3921121|P2|Overall Study|Withdrawal by Subject|0
1193700|NCT00983853|3921122|P1|Overall Study|Withdrawal by Subject|0
1193701|NCT00983853|3921117|P6|Overall Study|Lost to Follow-up|1
1193702|NCT00983853|3921118|P5|Overall Study|Lost to Follow-up|2
1193703|NCT00983853|3921119|P4|Overall Study|Lost to Follow-up|2
1193704|NCT00983853|3921120|P3|Overall Study|Lost to Follow-up|2
1193705|NCT00983853|3921121|P2|Overall Study|Lost to Follow-up|1
1193706|NCT00983853|3921122|P1|Overall Study|Lost to Follow-up|1
1193707|NCT00983827|3921150|P1|Overall Study|Withdrawal by Subject|1
1193708|NCT00983749|3921168|P2|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3
1193709|NCT00983749|3921169|P1|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1
1193710|NCT00983580|3921194|P2|Overall Study|Ineligible|0
1193711|NCT00983580|3921195|P1|Overall Study|Ineligible|3
1193712|NCT00983580|3921194|P2|Overall Study|Protocol Violation|1
1193713|NCT00983580|3921195|P1|Overall Study|Protocol Violation|1
1193714|NCT00983580|3921194|P2|Overall Study|Cancel Prior to treatment|3
1193715|NCT00983580|3921195|P1|Overall Study|Cancel Prior to treatment|1
1193716|NCT00983515|3921221|P1|Colchicine With Ritonavir|Lost to Follow-up|1
1193717|NCT00983515|3921221|P1|Ritonavir Alone|liver panel out of range|6
1193718|NCT00983476|3921248|P3|Overall Study|Did not receive intervention|0
1193719|NCT00983476|3921249|P2|Overall Study|Did not receive intervention|22
1193720|NCT00983476|3921250|P1|Overall Study|Did not receive intervention|17
1193721|NCT00983437|3921282|P1|Overall Study|Other Reason|26
1193722|NCT00983437|3921282|P1|Overall Study|Lost to Follow-up|2
1193723|NCT00983437|3921282|P1|Overall Study|Noncompliance to Study Procedures|1
1193724|NCT00983437|3921282|P1|Overall Study|Withdrawal by Subject|8
1193725|NCT00983437|3921282|P1|Overall Study|Lack of Efficacy|1
1193726|NCT00983437|3921282|P1|Overall Study|Adverse Event|9
1193727|NCT00983385|3921301|P1|Observation Period|Not Evaluable due to Non Compliance|12
1193728|NCT00983385|3921301|P1|Observation Period|Not eligible to be dosed|20
1193729|NCT00983372|3921346|P1|Diltiazem ER Alone|Adverse Event|1
1193730|NCT00983372|3921346|P1|Diltiazem ER Alone|missed diltiazem dose|2
1193731|NCT00983372|3921346|P1|14 Day Washout Period|Withdrawal by Subject|1
1193732|NCT00983294|3921373|P1|Colchicine With Azithromycin|Adverse Event|1
1193733|NCT00983294|3921373|P1|14 Day Washout Period|Withdrawal by Subject|2
1193734|NCT00983073|3921415|P1|Maintenance Period|Other Reason|7
1193735|NCT00983073|3921415|P1|Maintenance Period|Lack of Efficacy|2
1193736|NCT00983073|3921415|P1|Maintenance Period|Withdrawal by Subject|2
1193737|NCT00983073|3921415|P1|Maintenance Period|Adverse Event|5
1193738|NCT00983073|3921415|P1|Titration and Optimal Dose Period|Other reason|4
1193739|NCT00983073|3921415|P1|Titration and Optimal Dose Period|Non-Compliance|1
1193740|NCT00983073|3921415|P1|Titration and Optimal Dose Period|Lack of Efficacy|5
1193741|NCT00983073|3921415|P1|Titration and Optimal Dose Period|Withdrawal by Subject|11
1193742|NCT00983073|3921415|P1|Titration and Optimal Dose Period|Adverse Event|19
1193743|NCT00982735|3921734|P1|Overall Study|Patient ineligible for trial|224
1193744|NCT00982735|3921734|P1|Overall Study|Lost to Follow-up|6
1193745|NCT00982657|3921744|P4|Overall Study|On going at date of cut-off|1
1193746|NCT00982657|3921745|P3|Overall Study|On going at date of cut-off|0
1193747|NCT00982657|3921746|P2|Overall Study|On going at date of cut-off|0
1193748|NCT00982657|3921747|P1|Overall Study|On going at date of cut-off|0
1193749|NCT00982657|3921744|P4|Overall Study|Other|4
1193750|NCT00982657|3921745|P3|Overall Study|Other|0
1193751|NCT00982657|3921746|P2|Overall Study|Other|0
1193752|NCT00982657|3921747|P1|Overall Study|Other|0
1193753|NCT00982657|3921744|P4|Overall Study|Withdrawal by Subject|3
1193754|NCT00982657|3921745|P3|Overall Study|Withdrawal by Subject|1
1193755|NCT00982657|3921746|P2|Overall Study|Withdrawal by Subject|0
1193756|NCT00982657|3921747|P1|Overall Study|Withdrawal by Subject|0
1193757|NCT00982657|3921744|P4|Overall Study|Death|1
1193758|NCT00982657|3921745|P3|Overall Study|Death|1
1193759|NCT00982657|3921746|P2|Overall Study|Death|0
1193760|NCT00982657|3921747|P1|Overall Study|Death|1
1193761|NCT00982644|3921788|P2|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7
1193762|NCT00982644|3921789|P1|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23
1193763|NCT00982644|3921788|P2|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3
1193764|NCT00982644|3921789|P1|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6
1193765|NCT00982644|3921788|P2|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4
1193766|NCT00982644|3921789|P1|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2
1193767|NCT00982644|3921788|P2|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1
1193768|NCT00982644|3921789|P1|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3
1193769|NCT00982644|3921788|P2|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5
1193770|NCT00982644|3921789|P1|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12
1193771|NCT00982644|3921788|P2|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30
1193772|NCT00982644|3921789|P1|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84
1193773|NCT00982644|3921788|P2|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5
1193774|NCT00982644|3921789|P1|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9
1193775|NCT00982644|3921788|P2|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18
1193776|NCT00982644|3921789|P1|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46
1193777|NCT00982644|3921788|P2|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2
1193778|NCT00982644|3921789|P1|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7
1193779|NCT00982644|3921788|P2|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5
1193780|NCT00982644|3921789|P1|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20
1193781|NCT00982488|3921840|P5|Overall Study|Withdrawal by Subject|0
1193782|NCT00982488|3921841|P4|Overall Study|Withdrawal by Subject|0
1193783|NCT00982488|3921842|P3|Overall Study|Withdrawal by Subject|1
1193784|NCT00982488|3921843|P2|Overall Study|Withdrawal by Subject|1
1193785|NCT00982488|3921844|P1|Overall Study|Withdrawal by Subject|5
1193786|NCT00982488|3921840|P5|Overall Study|Study drug toxicity|0
1193787|NCT00982488|3921841|P4|Overall Study|Study drug toxicity|0
1193788|NCT00982488|3921842|P3|Overall Study|Study drug toxicity|6
1193789|NCT00982488|3921843|P2|Overall Study|Study drug toxicity|1
1193790|NCT00982488|3921844|P1|Overall Study|Study drug toxicity|34
1193791|NCT00982488|3921840|P5|Overall Study|Stem cell transplant|0
1193792|NCT00982488|3921841|P4|Overall Study|Stem cell transplant|1
1193793|NCT00982488|3921842|P3|Overall Study|Stem cell transplant|0
1193794|NCT00982488|3921843|P2|Overall Study|Stem cell transplant|0
1193795|NCT00982488|3921844|P1|Overall Study|Stem cell transplant|2
1193796|NCT00982488|3921840|P5|Overall Study|Poor compliance/noncompliance|0
1193797|NCT00982488|3921841|P4|Overall Study|Poor compliance/noncompliance|0
1193798|NCT00982488|3921842|P3|Overall Study|Poor compliance/noncompliance|0
1193799|NCT00982488|3921843|P2|Overall Study|Poor compliance/noncompliance|1
1193800|NCT00982488|3921844|P1|Overall Study|Poor compliance/noncompliance|0
1193801|NCT00982488|3921840|P5|Overall Study|Not specified|0
1193802|NCT00982488|3921841|P4|Overall Study|Not specified|1
1193803|NCT00982488|3921842|P3|Overall Study|Not specified|3
1193804|NCT00982488|3921843|P2|Overall Study|Not specified|1
1193805|NCT00982488|3921844|P1|Overall Study|Not specified|15
1193806|NCT00982488|3921840|P5|Overall Study|Maximum clinical benefit|0
1193807|NCT00982488|3921841|P4|Overall Study|Maximum clinical benefit|0
1193808|NCT00982488|3921842|P3|Overall Study|Maximum clinical benefit|1
1193809|NCT00982488|3921843|P2|Overall Study|Maximum clinical benefit|1
1193810|NCT00982488|3921844|P1|Overall Study|Maximum clinical benefit|1
1193811|NCT00982488|3921840|P5|Overall Study|Lost to Follow-up|0
1193812|NCT00982488|3921841|P4|Overall Study|Lost to Follow-up|0
1193813|NCT00982488|3921842|P3|Overall Study|Lost to Follow-up|0
1193814|NCT00982488|3921843|P2|Overall Study|Lost to Follow-up|0
1193815|NCT00982488|3921844|P1|Overall Study|Lost to Follow-up|1
1193816|NCT00982488|3921840|P5|Overall Study|Disease progression|1
1193817|NCT00982488|3921841|P4|Overall Study|Disease progression|1
1193818|NCT00982488|3921842|P3|Overall Study|Disease progression|10
1193819|NCT00982488|3921843|P2|Overall Study|Disease progression|5
1193820|NCT00982488|3921844|P1|Overall Study|Disease progression|30
1193821|NCT00982488|3921840|P5|Overall Study|Death|0
1193822|NCT00982488|3921841|P4|Overall Study|Death|0
1193823|NCT00982488|3921842|P3|Overall Study|Death|2
1193824|NCT00982488|3921843|P2|Overall Study|Death|0
1193825|NCT00982488|3921844|P1|Overall Study|Death|11
1193826|NCT00982488|3921840|P5|Overall Study|Adverse event unrelated to study drug|0
1193827|NCT00982488|3921841|P4|Overall Study|Adverse event unrelated to study drug|0
1193828|NCT00982488|3921842|P3|Overall Study|Adverse event unrelated to study drug|0
1193829|NCT00982488|3921843|P2|Overall Study|Adverse event unrelated to study drug|1
1193830|NCT00982488|3921844|P1|Overall Study|Adverse event unrelated to study drug|5
1193831|NCT00982488|3921840|P5|Overall Study|Administrative reason by sponsor|0
1193832|NCT00982488|3921841|P4|Overall Study|Administrative reason by sponsor|0
1193833|NCT00982488|3921842|P3|Overall Study|Administrative reason by sponsor|11
1193834|NCT00982488|3921843|P2|Overall Study|Administrative reason by sponsor|3
1193835|NCT00982488|3921844|P1|Overall Study|Administrative reason by sponsor|81
1193836|NCT00982410|3921877|P2|12-month Follow-up Assessment|scheduled, no-show|0
1193837|NCT00982410|3921878|P1|12-month Follow-up Assessment|scheduled, no-show|1
1193838|NCT00982410|3921877|P2|12-month Follow-up Assessment|incarceration|1
1193839|NCT00982410|3921878|P1|12-month Follow-up Assessment|incarceration|2
1193840|NCT00982410|3921877|P2|12-month Follow-up Assessment|Withdrawal by Subject|1
1193841|NCT00982410|3921878|P1|12-month Follow-up Assessment|Withdrawal by Subject|0
1193842|NCT00982410|3921877|P2|12-month Follow-up Assessment|could not reach to schedule|5
1193843|NCT00982410|3921878|P1|12-month Follow-up Assessment|could not reach to schedule|6
1193844|NCT00982410|3921877|P2|12-month Follow-up Assessment|Death|2
1193845|NCT00982410|3921878|P1|12-month Follow-up Assessment|Death|0
1193846|NCT00982410|3921877|P2|6-month Follow-up Assessment|scheduled, no-show|1
1193847|NCT00982410|3921878|P1|6-month Follow-up Assessment|scheduled, no-show|0
1193848|NCT00982410|3921877|P2|6-month Follow-up Assessment|patent surgery|1
1193849|NCT00982410|3921878|P1|6-month Follow-up Assessment|patent surgery|0
1193850|NCT00982410|3921877|P2|6-month Follow-up Assessment|incarceration|2
1193851|NCT00982410|3921878|P1|6-month Follow-up Assessment|incarceration|0
1193852|NCT00982410|3921877|P2|6-month Follow-up Assessment|participant no transportation|0
1193853|NCT00982410|3921878|P1|6-month Follow-up Assessment|participant no transportation|1
1193854|NCT00982410|3921877|P2|6-month Follow-up Assessment|Could not reach to schedule|7
1193855|NCT00982410|3921878|P1|6-month Follow-up Assessment|Could not reach to schedule|5
1193856|NCT00982410|3921877|P2|3-month Follow-up Assessment|Withdrawal by Subject|2
1193857|NCT00982410|3921878|P1|3-month Follow-up Assessment|Withdrawal by Subject|0
1193858|NCT00982410|3921877|P2|3-month Follow-up Assessment|Scheduled, no-show|2
1193859|NCT00982410|3921878|P1|3-month Follow-up Assessment|Scheduled, no-show|1
1193860|NCT00982410|3921877|P2|3-month Follow-up Assessment|Could not reach to schedule|9
1193861|NCT00982410|3921878|P1|3-month Follow-up Assessment|Could not reach to schedule|8
1193862|NCT00982319|3921919|P2|Overall Study|Pregnancy|1
1193863|NCT00982319|3921920|P1|Overall Study|Pregnancy|0
1193864|NCT00982319|3921919|P2|Overall Study|Preop values out of acceptable range|1
1193865|NCT00982319|3921920|P1|Overall Study|Preop values out of acceptable range|1
1193866|NCT00982319|3921919|P2|Overall Study|Surgery date change|0
1193867|NCT00982319|3921920|P1|Overall Study|Surgery date change|1
1193868|NCT00982280|3921928|P1|Maintenance Period|Adverse Event|1
1193869|NCT00982280|3921928|P1|Titration and Optimal Dose Period|Withdrawal by Subject|1
1193870|NCT00982280|3921928|P1|Titration and Optimal Dose Period|Lack of Efficacy|2
1193871|NCT00982280|3921928|P1|Titration and Optimal Dose Period|Adverse Event|5
1193872|NCT00982280|3921928|P1|Observation Period|Not eligible to be dosed|19
1193873|NCT00982228|3921953|P2|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1
1193874|NCT00982228|3921954|P1|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11
1193875|NCT00982228|3921953|P2|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0
1193876|NCT00982228|3921954|P1|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5
1193877|NCT00982228|3921953|P2|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2
1193878|NCT00982228|3921954|P1|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1
1193879|NCT00982228|3921953|P2|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0
1193880|NCT00982228|3921954|P1|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1
1193881|NCT00982228|3921953|P2|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2
1193882|NCT00982228|3921954|P1|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3
1193883|NCT00982228|3921953|P2|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13
1193884|NCT00982228|3921954|P1|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28
1193885|NCT00982228|3921953|P2|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3
1193886|NCT00982228|3921954|P1|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15
1193887|NCT00982228|3921953|P2|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2
1193888|NCT00982228|3921954|P1|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11
1193889|NCT00982228|3921953|P2|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0
1193890|NCT00982228|3921954|P1|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2
1193891|NCT00982228|3921953|P2|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2
1193892|NCT00982228|3921954|P1|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12
1193893|NCT00982137|3922013|P4|Overall Study|Withdrawal by Subject|0
1193894|NCT00982137|3922014|P3|Overall Study|Withdrawal by Subject|0
1193895|NCT00982137|3922015|P2|Overall Study|Withdrawal by Subject|1
1193896|NCT00982137|3922016|P1|Overall Study|Withdrawal by Subject|0
1193897|NCT00982137|3922013|P4|Overall Study|Lost to Follow-up|1
1193898|NCT00982137|3922014|P3|Overall Study|Lost to Follow-up|0
1193899|NCT00982137|3922015|P2|Overall Study|Lost to Follow-up|0
1193900|NCT00982137|3922016|P1|Overall Study|Lost to Follow-up|0
1193901|NCT00982111|3922048|P2|Overall Study|Withdrawal by Subject|17
1193902|NCT00982111|3922049|P1|Overall Study|Withdrawal by Subject|16
1193903|NCT00982111|3922048|P2|Overall Study|On Study Treatment at Conclusion|0
1193904|NCT00982111|3922049|P1|Overall Study|On Study Treatment at Conclusion|7
1193905|NCT00982111|3922048|P2|Overall Study|New Anti-Cancer Therapy|5
1193906|NCT00982111|3922049|P1|Overall Study|New Anti-Cancer Therapy|5
1193907|NCT00982111|3922048|P2|Overall Study|Lost to Follow-up|6
1193908|NCT00982111|3922049|P1|Overall Study|Lost to Follow-up|9
1193909|NCT00982111|3922048|P2|Overall Study|Progressive Disease|37
1193910|NCT00982111|3922049|P1|Overall Study|Progressive Disease|37
1193911|NCT00982111|3922048|P2|Overall Study|Adverse Event|1
1193912|NCT00982111|3922049|P1|Overall Study|Adverse Event|1
1193913|NCT00982020|3922082|P2|Overall Study|Clinical Relapse|1
1193914|NCT00982020|3922083|P1|Overall Study|Clinical Relapse|0
1193915|NCT00982020|3922082|P2|Overall Study|Protocol Violation|2
1193916|NCT00982020|3922083|P1|Overall Study|Protocol Violation|0
1193917|NCT00982020|3922082|P2|Overall Study|Entry Criteria Not Met|1
1193918|NCT00982020|3922083|P1|Overall Study|Entry Criteria Not Met|2
1193919|NCT00982020|3922082|P2|Overall Study|Physician Decision|5
1193920|NCT00982020|3922083|P1|Overall Study|Physician Decision|2
1193921|NCT00982020|3922082|P2|Overall Study|Treatment Non-compliance|6
1193922|NCT00982020|3922083|P1|Overall Study|Treatment Non-compliance|3
1193923|NCT00982020|3922082|P2|Overall Study|Parent/Caregiver Decision|5
1193924|NCT00982020|3922083|P1|Overall Study|Parent/Caregiver Decision|5
1193925|NCT00982020|3922082|P2|Overall Study|Lack of Efficacy|4
1193926|NCT00982020|3922083|P1|Overall Study|Lack of Efficacy|10
1193927|NCT00982020|3922082|P2|Overall Study|Lost to Follow-up|11
1193928|NCT00982020|3922083|P1|Overall Study|Lost to Follow-up|5
1193929|NCT00982020|3922082|P2|Overall Study|Withdrawal by Subject|14
1193930|NCT00982020|3922083|P1|Overall Study|Withdrawal by Subject|11
1193931|NCT00982020|3922082|P2|Overall Study|Adverse Event|15
1193932|NCT00982020|3922083|P1|Overall Study|Adverse Event|19
1193933|NCT00981747|3922133|P1|Placebo Oral Tablet|Withdrawal by Subject|1
1193934|NCT00981747|3922133|P1|Losartan|Death|1
1193935|NCT00981747|3922133|P1|Losartan|Withdrawal by Subject|1
1193936|NCT00981526|3922201|P2|Overall Study|Physician Decision|4
1193937|NCT00981526|3922202|P1|Overall Study|Physician Decision|4
1193938|NCT00981526|3922201|P2|Overall Study|Withdrawal by Subject|2
1193939|NCT00981526|3922202|P1|Overall Study|Withdrawal by Subject|0
1193940|NCT00981461|3922220|P2|Overall Study|Lost to Follow-up|2
1193941|NCT00981461|3922221|P1|Overall Study|Lost to Follow-up|5
1193942|NCT00981409|3922245|P2|Overall Study|Prostate Cancer Treatment before Trial|0
1193943|NCT00981409|3922246|P1|Overall Study|Prostate Cancer Treatment before Trial|2
1193944|NCT00981409|3922245|P2|Overall Study|Protocol Violation|1
1193945|NCT00981409|3922246|P1|Overall Study|Protocol Violation|0
1193946|NCT00981409|3922245|P2|Overall Study|Adverse Event|0
1193947|NCT00981409|3922246|P1|Overall Study|Adverse Event|4
1193948|NCT00981292|3922285|P6|Day 3|Protocol Violation|1
1193949|NCT00981292|3922286|P5|Day 3|Protocol Violation|0
1193950|NCT00981292|3922287|P4|Day 3|Protocol Violation|0
1193951|NCT00981292|3922288|P3|Day 3|Protocol Violation|0
1193952|NCT00981292|3922289|P2|Day 3|Protocol Violation|0
1193953|NCT00981292|3922290|P1|Day 3|Protocol Violation|0
1193954|NCT00981292|3922285|P6|Day 2|Protocol Violation|0
1193955|NCT00981292|3922286|P5|Day 2|Protocol Violation|0
1193956|NCT00981292|3922287|P4|Day 2|Protocol Violation|0
1193957|NCT00981292|3922288|P3|Day 2|Protocol Violation|0
1193958|NCT00981292|3922289|P2|Day 2|Protocol Violation|0
1193959|NCT00981292|3922290|P1|Day 2|Protocol Violation|2
1193960|NCT00981292|3922285|P6|Day 1|Protocol Violation|2
1193961|NCT00981292|3922286|P5|Day 1|Protocol Violation|0
1193962|NCT00981292|3922287|P4|Day 1|Protocol Violation|0
1193963|NCT00981292|3922288|P3|Day 1|Protocol Violation|0
1193964|NCT00981292|3922289|P2|Day 1|Protocol Violation|0
1193965|NCT00981292|3922290|P1|Day 1|Protocol Violation|1
1193966|NCT00981175|3922374|P2|Booster Dose Vaccination|Lost to Follow-up|3
1193967|NCT00981175|3922375|P1|Booster Dose Vaccination|Lost to Follow-up|2
1193968|NCT00981175|3922374|P2|Primary Dose Vaccination|Lost to Follow-up|1
1193969|NCT00981175|3922375|P1|Primary Dose Vaccination|Lost to Follow-up|2
1193970|NCT00981175|3922374|P2|Primary Dose Vaccination|Protocol Violation|1
1193971|NCT00981175|3922375|P1|Primary Dose Vaccination|Protocol Violation|0
1193972|NCT00981175|3922374|P2|Primary Dose Vaccination|Adverse Event|0
1193973|NCT00981175|3922375|P1|Primary Dose Vaccination|Adverse Event|1
1193974|NCT00981149|3922400|P2|Overall Study|Withdrawal by Subject|1
1193975|NCT00981149|3922401|P1|Overall Study|Withdrawal by Subject|1
1193976|NCT00981149|3922400|P2|Overall Study|Lost to Follow-up|2
1193977|NCT00981149|3922401|P1|Overall Study|Lost to Follow-up|1
1193978|NCT00981084|3922411|P2|Post Intervention (Data Analysis)|imbalance in disease subtype|0
1193979|NCT00981084|3922412|P1|Post Intervention (Data Analysis)|imbalance in disease subtype|1
1193980|NCT00981084|3922411|P2|Post Intervention (Data Analysis)|poor effort|1
1193981|NCT00981084|3922412|P1|Post Intervention (Data Analysis)|poor effort|1
1193982|NCT00981058|3922428|P2|Overall Study|On study treatment at conclusion|0
1193983|NCT00981058|3922429|P1|Overall Study|On study treatment at conclusion|9
1193984|NCT00981058|3922428|P2|Overall Study|Withdrawal by Subject|23
1193985|NCT00981058|3922429|P1|Overall Study|Withdrawal by Subject|25
1193986|NCT00981058|3922428|P2|Overall Study|Randomization Error|2
1193987|NCT00981058|3922429|P1|Overall Study|Randomization Error|1
1193988|NCT00981058|3922428|P2|Overall Study|Radiologist Error|1
1193989|NCT00981058|3922429|P1|Overall Study|Radiologist Error|0
1193990|NCT00981058|3922428|P2|Overall Study|Noncompliance|0
1193991|NCT00981058|3922429|P1|Overall Study|Noncompliance|1
1193992|NCT00981058|3922428|P2|Overall Study|New Anticancer Therapy|6
1193993|NCT00981058|3922429|P1|Overall Study|New Anticancer Therapy|6
1193994|NCT00981058|3922428|P2|Overall Study|Lost to Follow-up|15
1193995|NCT00981058|3922429|P1|Overall Study|Lost to Follow-up|16
1193996|NCT00981058|3922428|P2|Overall Study|Progressive Disease|49
1193997|NCT00981058|3922429|P1|Overall Study|Progressive Disease|61
1193998|NCT00981058|3922428|P2|Overall Study|Adverse Event|1
1193999|NCT00981058|3922429|P1|Overall Study|Adverse Event|1
1194000|NCT00981019|3922460|P1|Overall Study|Hit the survey after closure|79
1194001|NCT00981019|3922460|P1|Overall Study|Inadvertent exclusion|239
1194002|NCT00981019|3922460|P1|Overall Study|Did not match target population|94
1194003|NCT00981019|3922460|P1|Overall Study|Did not respond|65
1194004|NCT00980980|3922467|P3|Overall Study|Withdrawal by Hospital|0
1194005|NCT00980980|3922468|P2|Overall Study|Withdrawal by Hospital|1
1194006|NCT00980980|3922469|P1|Overall Study|Withdrawal by Hospital|0
1194007|NCT00980798|3922500|P2|Overall Study|Other|1
1194008|NCT00980798|3922501|P1|Overall Study|Other|0
1194009|NCT00980798|3922500|P2|Overall Study|Withdrawal by Subject|11
1194010|NCT00980798|3922501|P1|Overall Study|Withdrawal by Subject|8
1194011|NCT00980798|3922500|P2|Overall Study|Physician Decision|1
1194012|NCT00980798|3922501|P1|Overall Study|Physician Decision|2
1194013|NCT00980798|3922500|P2|Overall Study|Lost to Follow-up|1
1194014|NCT00980798|3922501|P1|Overall Study|Lost to Follow-up|0
1194015|NCT00980798|3922500|P2|Overall Study|Lack of Efficacy|5
1194016|NCT00980798|3922501|P1|Overall Study|Lack of Efficacy|16
1194017|NCT00980798|3922500|P2|Overall Study|Adverse Event|36
1194018|NCT00980798|3922501|P1|Overall Study|Adverse Event|7
1194019|NCT00980655|3922542|P2|Overall Study|Other|1
1194020|NCT00980655|3922543|P1|Overall Study|Other|0
1194021|NCT00980655|3922542|P2|Overall Study|Parent/legal guardian request|0
1194022|NCT00980655|3922543|P1|Overall Study|Parent/legal guardian request|1
1194023|NCT00980655|3922542|P2|Overall Study|Lost to Follow-up|1
1194024|NCT00980655|3922543|P1|Overall Study|Lost to Follow-up|0
1194025|NCT00980655|3922542|P2|Overall Study|Withdrawal by Subject|4
1194026|NCT00980655|3922543|P1|Overall Study|Withdrawal by Subject|0
1194027|NCT00980655|3922542|P2|Overall Study|Protocol Violation|7
1194028|NCT00980655|3922543|P1|Overall Study|Protocol Violation|2
1194029|NCT00980655|3922542|P2|Overall Study|Death|7
1194030|NCT00980655|3922543|P1|Overall Study|Death|0
1194031|NCT00980655|3922542|P2|Overall Study|Adverse Event|31
1194032|NCT00980655|3922543|P1|Overall Study|Adverse Event|13
1194033|NCT00980343|3922619|P2|Overall Study|no tumor at surgery - treatment effect|3
1194034|NCT00980343|3922620|P1|Overall Study|no tumor at surgery - treatment effect|1
1194035|NCT00980330|3922644|P7|Overall Study|(not specified)|0
1194036|NCT00980330|3922645|P6|Overall Study|(not specified)|1
1194037|NCT00980330|3922646|P5|Overall Study|(not specified)|1
1194038|NCT00980330|3922647|P4|Overall Study|(not specified)|1
1194039|NCT00980330|3922648|P3|Overall Study|(not specified)|0
1194040|NCT00980330|3922649|P2|Overall Study|(not specified)|0
1194041|NCT00980330|3922650|P1|Overall Study|(not specified)|2
1194042|NCT00980330|3922644|P7|Overall Study|Withdrawal by Subject|5
1194043|NCT00980330|3922645|P6|Overall Study|Withdrawal by Subject|2
1194044|NCT00980330|3922646|P5|Overall Study|Withdrawal by Subject|3
1194045|NCT00980330|3922647|P4|Overall Study|Withdrawal by Subject|1
1194046|NCT00980330|3922648|P3|Overall Study|Withdrawal by Subject|4
1194047|NCT00980330|3922649|P2|Overall Study|Withdrawal by Subject|4
1194048|NCT00980330|3922650|P1|Overall Study|Withdrawal by Subject|2
1194049|NCT00980330|3922644|P7|Overall Study|Lost to Follow-up|2
1194050|NCT00980330|3922645|P6|Overall Study|Lost to Follow-up|1
1194051|NCT00980330|3922646|P5|Overall Study|Lost to Follow-up|1
1194052|NCT00980330|3922647|P4|Overall Study|Lost to Follow-up|2
1194053|NCT00980330|3922648|P3|Overall Study|Lost to Follow-up|4
1194054|NCT00980330|3922649|P2|Overall Study|Lost to Follow-up|1
1194055|NCT00980330|3922650|P1|Overall Study|Lost to Follow-up|1
1194056|NCT00980330|3922644|P7|Overall Study|Adverse Event|0
1194057|NCT00980330|3922645|P6|Overall Study|Adverse Event|0
1194058|NCT00980330|3922646|P5|Overall Study|Adverse Event|0
1194059|NCT00980330|3922647|P4|Overall Study|Adverse Event|1
1194060|NCT00980330|3922648|P3|Overall Study|Adverse Event|0
1194061|NCT00980330|3922649|P2|Overall Study|Adverse Event|0
1194062|NCT00980330|3922650|P1|Overall Study|Adverse Event|0
1194063|NCT00980200|3922765|P5|7-day Treatment Period 3|Lack of Efficacy|1
1194064|NCT00980200|3922766|P4|7-day Treatment Period 3|Lack of Efficacy|0
1194065|NCT00980200|3922767|P3|7-day Treatment Period 3|Lack of Efficacy|0
1194066|NCT00980200|3922768|P2|7-day Treatment Period 3|Lack of Efficacy|1
1194067|NCT00980200|3922769|P1|7-day Treatment Period 3|Lack of Efficacy|0
1194068|NCT00980200|3922765|P5|7-day Treatment Period 1|Withdrawal by Subject|0
1194069|NCT00980200|3922766|P4|7-day Treatment Period 1|Withdrawal by Subject|0
1194070|NCT00980200|3922767|P3|7-day Treatment Period 1|Withdrawal by Subject|0
1194071|NCT00980200|3922768|P2|7-day Treatment Period 1|Withdrawal by Subject|1
1194072|NCT00980200|3922769|P1|7-day Treatment Period 1|Withdrawal by Subject|0
1194073|NCT00980174|3922788|P2|Overall Study|Other|1
1194074|NCT00980174|3922789|P1|Overall Study|Other|0
1194075|NCT00980174|3922788|P2|Overall Study|Death|1
1194076|NCT00980174|3922789|P1|Overall Study|Death|1
1194077|NCT00980174|3922788|P2|Overall Study|Ineligibility determined|1
1194078|NCT00980174|3922789|P1|Overall Study|Ineligibility determined|2
1194079|NCT00980174|3922788|P2|Overall Study|Adverse Event|3
1194080|NCT00980174|3922789|P1|Overall Study|Adverse Event|0
1194081|NCT00980174|3922788|P2|Overall Study|Withdrawal by Subject|4
1194082|NCT00980174|3922789|P1|Overall Study|Withdrawal by Subject|1
1194083|NCT00980148|3922807|P2|Overall Study|Various other reasons|9
1194084|NCT00980148|3922808|P1|Overall Study|Various other reasons|8
1194085|NCT00980148|3922807|P2|Overall Study|Negative for chlamydia at enrollment|9
1194086|NCT00980148|3922808|P1|Overall Study|Negative for chlamydia at enrollment|12
1194087|NCT00980148|3922807|P2|Overall Study|Received other antichlamydia treatment|14
1194088|NCT00980148|3922808|P1|Overall Study|Received other antichlamydia treatment|20
1194089|NCT00980148|3922807|P2|Overall Study|Discharged from facility|96
1194090|NCT00980148|3922808|P1|Overall Study|Discharged from facility|89
1194091|NCT00980057|3922816|P2|Overall Study|Withdrawal by Subject|1
1194092|NCT00980057|3922817|P1|Overall Study|Withdrawal by Subject|1
1194093|NCT00980057|3922816|P2|Overall Study|Lost to Follow-up|0
1194094|NCT00980057|3922817|P1|Overall Study|Lost to Follow-up|1
1194095|NCT00980057|3922816|P2|Overall Study|Physician Decision|0
1194096|NCT00980057|3922817|P1|Overall Study|Physician Decision|4
1194097|NCT00980057|3922816|P2|Overall Study|Adverse Event|1
1194098|NCT00980057|3922817|P1|Overall Study|Adverse Event|0
1194099|NCT00980057|3922816|P2|Overall Study|Death|3
1194100|NCT00980057|3922817|P1|Overall Study|Death|13
1194101|NCT00980044|3922840|P3|Overall Study|Protocol Violation|2
1194102|NCT00980044|3922841|P2|Overall Study|Protocol Violation|0
1194103|NCT00980044|3922842|P1|Overall Study|Protocol Violation|0
1194104|NCT00980044|3922840|P3|Overall Study|Withdrawal by Subject|3
1194105|NCT00980044|3922841|P2|Overall Study|Withdrawal by Subject|7
1194106|NCT00980044|3922842|P1|Overall Study|Withdrawal by Subject|5
1194107|NCT00980005|3922861|P2|Overall Study|Other|3
1194108|NCT00980005|3922862|P1|Overall Study|Other|4
1194109|NCT00980005|3922861|P2|Overall Study|Lost to Follow-up|43
1194110|NCT00980005|3922862|P1|Overall Study|Lost to Follow-up|37
1194111|NCT00980005|3922861|P2|Overall Study|Withdrawal by Subject|17
1194112|NCT00980005|3922862|P1|Overall Study|Withdrawal by Subject|6
1194113|NCT00979992|3922902|P1|Overall Study|Refused – Never Treated|2
1194114|NCT00979992|3922902|P1|Overall Study|Ineligible - wrong cell type|2
1194115|NCT00979992|3922902|P1|Overall Study|Ineligible - inadequate pathology|1
1194116|NCT00979953|3922914|P4|Overall Study|Protocol Violation|2
1194117|NCT00979953|3922915|P3|Overall Study|Protocol Violation|2
1194118|NCT00979953|3922916|P2|Overall Study|Protocol Violation|0
1194119|NCT00979953|3922917|P1|Overall Study|Protocol Violation|1
1194120|NCT00979953|3922914|P4|Overall Study|Withdrawal by Subject|1
1194121|NCT00979953|3922915|P3|Overall Study|Withdrawal by Subject|2
1194122|NCT00979953|3922916|P2|Overall Study|Withdrawal by Subject|0
1194123|NCT00979953|3922917|P1|Overall Study|Withdrawal by Subject|0
1194124|NCT00979953|3922914|P4|Overall Study|Lost to Follow-up|0
1194125|NCT00979953|3922915|P3|Overall Study|Lost to Follow-up|1
1194126|NCT00979953|3922916|P2|Overall Study|Lost to Follow-up|1
1194127|NCT00979953|3922917|P1|Overall Study|Lost to Follow-up|1
1194128|NCT00979953|3922914|P4|Overall Study|Lack of Efficacy|0
1194129|NCT00979953|3922915|P3|Overall Study|Lack of Efficacy|0
1194130|NCT00979953|3922916|P2|Overall Study|Lack of Efficacy|2
1194131|NCT00979953|3922917|P1|Overall Study|Lack of Efficacy|1
1194132|NCT00979953|3922914|P4|Overall Study|Adverse Event|4
1194133|NCT00979953|3922915|P3|Overall Study|Adverse Event|17
1194134|NCT00979953|3922916|P2|Overall Study|Adverse Event|2
1194135|NCT00979953|3922917|P1|Overall Study|Adverse Event|5
1194136|NCT00979901|3922940|P4|Overall Study|Treatment Group Terminated by Sponsor|112
1194137|NCT00979901|3922941|P3|Overall Study|Treatment Group Terminated by Sponsor|0
1194138|NCT00979901|3922942|P2|Overall Study|Treatment Group Terminated by Sponsor|0
1194139|NCT00979901|3922943|P1|Overall Study|Treatment Group Terminated by Sponsor|0
1194140|NCT00979901|3922940|P4|Overall Study|Left Country|0
1194141|NCT00979901|3922941|P3|Overall Study|Left Country|1
1194142|NCT00979901|3922942|P2|Overall Study|Left Country|0
1194143|NCT00979901|3922943|P1|Overall Study|Left Country|0
1194144|NCT00979901|3922940|P4|Overall Study|Discontinued in Error|0
1194145|NCT00979901|3922941|P3|Overall Study|Discontinued in Error|0
1194146|NCT00979901|3922942|P2|Overall Study|Discontinued in Error|1
1194147|NCT00979901|3922943|P1|Overall Study|Discontinued in Error|0
1194148|NCT00979901|3922940|P4|Overall Study|elevated lab values pre-randomization|0
1194149|NCT00979901|3922941|P3|Overall Study|elevated lab values pre-randomization|0
1194150|NCT00979901|3922942|P2|Overall Study|elevated lab values pre-randomization|0
1194151|NCT00979901|3922943|P1|Overall Study|elevated lab values pre-randomization|1
1194152|NCT00979901|3922940|P4|Overall Study|vacation|0
1194153|NCT00979901|3922941|P3|Overall Study|vacation|0
1194154|NCT00979901|3922942|P2|Overall Study|vacation|0
1194155|NCT00979901|3922943|P1|Overall Study|vacation|1
1194156|NCT00979901|3922940|P4|Overall Study|out-of-state|0
1194157|NCT00979901|3922941|P3|Overall Study|out-of-state|0
1194158|NCT00979901|3922942|P2|Overall Study|out-of-state|0
1194159|NCT00979901|3922943|P1|Overall Study|out-of-state|1
1194160|NCT00979901|3922940|P4|Overall Study|Noncompliance|0
1194161|NCT00979901|3922941|P3|Overall Study|Noncompliance|0
1194162|NCT00979901|3922942|P2|Overall Study|Noncompliance|0
1194163|NCT00979901|3922943|P1|Overall Study|Noncompliance|1
1194164|NCT00979901|3922940|P4|Overall Study|Withdrawal by Subject|1
1194165|NCT00979901|3922941|P3|Overall Study|Withdrawal by Subject|1
1194166|NCT00979901|3922942|P2|Overall Study|Withdrawal by Subject|1
1194167|NCT00979901|3922943|P1|Overall Study|Withdrawal by Subject|2
1194168|NCT00979901|3922940|P4|Overall Study|Protocol Violation|1
1194169|NCT00979901|3922941|P3|Overall Study|Protocol Violation|7
1194170|NCT00979901|3922942|P2|Overall Study|Protocol Violation|2
1194171|NCT00979901|3922943|P1|Overall Study|Protocol Violation|2
1194172|NCT00979901|3922940|P4|Overall Study|Lost to Follow-up|0
1194173|NCT00979901|3922941|P3|Overall Study|Lost to Follow-up|2
1194174|NCT00979901|3922942|P2|Overall Study|Lost to Follow-up|1
1194175|NCT00979901|3922943|P1|Overall Study|Lost to Follow-up|1
1194176|NCT00979901|3922940|P4|Overall Study|Lack of Efficacy|0
1194177|NCT00979901|3922941|P3|Overall Study|Lack of Efficacy|9
1194178|NCT00979901|3922942|P2|Overall Study|Lack of Efficacy|4
1194179|NCT00979901|3922943|P1|Overall Study|Lack of Efficacy|8
1194180|NCT00979901|3922940|P4|Overall Study|Adverse Event|2
1194181|NCT00979901|3922941|P3|Overall Study|Adverse Event|9
1194182|NCT00979901|3922942|P2|Overall Study|Adverse Event|3
1194183|NCT00979901|3922943|P1|Overall Study|Adverse Event|1
1194184|NCT00979654|3923016|P1|Overall Study|Unfavorable Risk-Benefit Analysis|1
1194185|NCT00979654|3923016|P1|Overall Study|Serious Adverse Event|1
1194186|NCT00979654|3923016|P1|Overall Study|Patient Wanted to Pursue Other Treatment|1
1194187|NCT00979654|3923016|P1|Overall Study|Per Principal Investigator’s Discretion|1
1194188|NCT00979654|3923016|P1|Overall Study|Adverse Event of Diverticulitis|1
1194189|NCT00979654|3923016|P1|Overall Study|Adverse Event|1
1194190|NCT00979654|3923016|P1|Overall Study|Lack of Efficacy|6
1194191|NCT00979654|3923016|P1|Overall Study|Death|1
1194192|NCT00979654|3923016|P1|Overall Study|Withdrawal by Subject|22
1194193|NCT00979654|3923016|P1|Overall Study|Lost to Follow-up|1
1194194|NCT00979628|3923031|P3|Overall Study|transferred to ICU|1
1194195|NCT00979628|3923032|P2|Overall Study|transferred to ICU|2
1194196|NCT00979628|3923033|P1|Overall Study|transferred to ICU|1
1194197|NCT00979628|3923031|P3|Overall Study|received steroids|0
1194198|NCT00979628|3923032|P2|Overall Study|received steroids|1
1194199|NCT00979628|3923033|P1|Overall Study|received steroids|1
1194200|NCT00979628|3923031|P3|Overall Study|received regimen < 24 hours|5
1194201|NCT00979628|3923032|P2|Overall Study|received regimen < 24 hours|6
1194202|NCT00979628|3923033|P1|Overall Study|received regimen < 24 hours|7
1194203|NCT00979602|3923063|P2|Overall Study|Others|3
1194204|NCT00979602|3923064|P1|Overall Study|Others|3
1194205|NCT00979602|3923063|P2|Overall Study|Migrated/moved from study area|6
1194206|NCT00979602|3923064|P1|Overall Study|Migrated/moved from study area|3
1194207|NCT00979602|3923063|P2|Overall Study|Lost to Follow-up|96
1194208|NCT00979602|3923064|P1|Overall Study|Lost to Follow-up|100
1194209|NCT00979602|3923063|P2|Overall Study|Withdrawal by Subject|25
1194210|NCT00979602|3923064|P1|Overall Study|Withdrawal by Subject|31
1194211|NCT00979602|3923063|P2|Overall Study|Protocol Violation|0
1194212|NCT00979602|3923064|P1|Overall Study|Protocol Violation|3
1194213|NCT00979602|3923063|P2|Overall Study|Serious Adverse Event|3
1194214|NCT00979602|3923064|P1|Overall Study|Serious Adverse Event|5
1194215|NCT00979576|3923235|P3|Combination Followed by Monotherapy|Progressive Disease|1
1194216|NCT00979576|3923236|P2|Combination Followed by Monotherapy|Progressive Disease|2
1194217|NCT00979576|3923237|P1|Combination Followed by Monotherapy|Progressive Disease|0
1194218|NCT00979576|3923235|P3|Combination Treatment Phase|Adverse Event|2
1194219|NCT00979576|3923236|P2|Combination Treatment Phase|Adverse Event|2
1194220|NCT00979576|3923237|P1|Combination Treatment Phase|Adverse Event|0
1194221|NCT00979576|3923235|P3|Combination Treatment Phase|Dose limiting toxicity|2
1194222|NCT00979576|3923236|P2|Combination Treatment Phase|Dose limiting toxicity|3
1194223|NCT00979576|3923237|P1|Combination Treatment Phase|Dose limiting toxicity|0
1194224|NCT00979576|3923235|P3|Combination Treatment Phase|Progressive disease|5
1194225|NCT00979576|3923236|P2|Combination Treatment Phase|Progressive disease|1
1194226|NCT00979576|3923237|P1|Combination Treatment Phase|Progressive disease|3
1194227|NCT00979420|3923294|P4|Overall Study|Other reasons not related to Viramune|1
1194228|NCT00979420|3923295|P3|Overall Study|Other reasons not related to Viramune|0
1194229|NCT00979420|3923296|P2|Overall Study|Other reasons not related to Viramune|0
1194230|NCT00979420|3923297|P1|Overall Study|Other reasons not related to Viramune|3
1194231|NCT00979420|3923294|P4|Overall Study|Lack of Efficacy|1
1194232|NCT00979420|3923295|P3|Overall Study|Lack of Efficacy|1
1194233|NCT00979420|3923296|P2|Overall Study|Lack of Efficacy|0
1194234|NCT00979420|3923297|P1|Overall Study|Lack of Efficacy|3
1194235|NCT00979420|3923294|P4|Overall Study|Adverse Event|0
1194236|NCT00979420|3923295|P3|Overall Study|Adverse Event|0
1194237|NCT00979420|3923296|P2|Overall Study|Adverse Event|0
1194238|NCT00979420|3923297|P1|Overall Study|Adverse Event|1
1194239|NCT00979407|3923367|P2|Overall Study|Lost to Follow-up|3
1194240|NCT00979407|3923368|P1|Overall Study|Lost to Follow-up|3
1194241|NCT00979407|3923367|P2|Overall Study|Withdrawal by Subject|4
1194242|NCT00979407|3923368|P1|Overall Study|Withdrawal by Subject|3
1194243|NCT00979212|3923421|P2|Overall Study|No protocol therapy received|0
1194244|NCT00979212|3923422|P1|Overall Study|No protocol therapy received|1
1194245|NCT00979212|3923421|P2|Overall Study|Protocol Violation|8
1194246|NCT00979212|3923422|P1|Overall Study|Protocol Violation|1
1194247|NCT00978757|3923482|P2|Overall Study|Physician Decision|3
1194248|NCT00978757|3923483|P1|Overall Study|Physician Decision|1
1194249|NCT00978731|3923493|P4|Overall Study|No response|0
1194250|NCT00978731|3923494|P3|Overall Study|No response|0
1194251|NCT00978731|3923495|P2|Overall Study|No response|0
1194252|NCT00978731|3923496|P1|Overall Study|No response|1
1194253|NCT00978731|3923493|P4|Overall Study|Study closure|1
1194254|NCT00978731|3923494|P3|Overall Study|Study closure|1
1194255|NCT00978731|3923495|P2|Overall Study|Study closure|4
1194256|NCT00978731|3923496|P1|Overall Study|Study closure|3
1194257|NCT00978731|3923493|P4|Overall Study|Disease progression/relapse|2
1194258|NCT00978731|3923494|P3|Overall Study|Disease progression/relapse|2
1194259|NCT00978731|3923495|P2|Overall Study|Disease progression/relapse|4
1194260|NCT00978731|3923496|P1|Overall Study|Disease progression/relapse|5
1194261|NCT00978731|3923493|P4|Overall Study|Deterioration without progression|0
1194262|NCT00978731|3923494|P3|Overall Study|Deterioration without progression|0
1194263|NCT00978731|3923495|P2|Overall Study|Deterioration without progression|1
1194264|NCT00978731|3923496|P1|Overall Study|Deterioration without progression|0
1194265|NCT00978731|3923493|P4|Overall Study|Administrative reason|0
1194266|NCT00978731|3923494|P3|Overall Study|Administrative reason|1
1194267|NCT00978731|3923495|P2|Overall Study|Administrative reason|3
1194268|NCT00978731|3923496|P1|Overall Study|Administrative reason|3
1194269|NCT00978731|3923493|P4|Overall Study|Participant's request|0
1194270|NCT00978731|3923494|P3|Overall Study|Participant's request|0
1194271|NCT00978731|3923495|P2|Overall Study|Participant's request|0
1194272|NCT00978731|3923496|P1|Overall Study|Participant's request|1
1194273|NCT00978731|3923493|P4|Overall Study|Adverse Event|0
1194274|NCT00978731|3923494|P3|Overall Study|Adverse Event|0
1194275|NCT00978731|3923495|P2|Overall Study|Adverse Event|2
1194276|NCT00978731|3923496|P1|Overall Study|Adverse Event|5
1194277|NCT00978731|3923493|P4|Overall Study|Lost to Follow-up|1
1194278|NCT00978731|3923494|P3|Overall Study|Lost to Follow-up|0
1194279|NCT00978731|3923495|P2|Overall Study|Lost to Follow-up|0
1194280|NCT00978731|3923496|P1|Overall Study|Lost to Follow-up|0
1194281|NCT00978731|3923493|P4|Overall Study|Death|0
1194282|NCT00978731|3923494|P3|Overall Study|Death|1
1194283|NCT00978731|3923495|P2|Overall Study|Death|1
1194284|NCT00978731|3923496|P1|Overall Study|Death|4
1194285|NCT00978627|3923536|P2|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7
1194286|NCT00978627|3923537|P1|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12
1194287|NCT00978627|3923536|P2|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1
1194288|NCT00978627|3923537|P1|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2
1194289|NCT00978627|3923536|P2|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1
1194290|NCT00978627|3923537|P1|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4
1194291|NCT00978627|3923536|P2|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0
1194292|NCT00978627|3923537|P1|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3
1194293|NCT00978627|3923536|P2|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12
1194294|NCT00978627|3923537|P1|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25
1194295|NCT00978627|3923536|P2|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5
1194296|NCT00978627|3923537|P1|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7
1194297|NCT00978627|3923536|P2|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6
1194298|NCT00978627|3923537|P1|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8
1194299|NCT00978627|3923536|P2|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0
1194300|NCT00978627|3923537|P1|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2
1194301|NCT00978627|3923536|P2|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3
1194302|NCT00978627|3923537|P1|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4
1194303|NCT00978432|3923575|P3|Overall Study|Adverse Event|1
1194304|NCT00978432|3923576|P2|Overall Study|Adverse Event|0
1194305|NCT00978432|3923577|P1|Overall Study|Adverse Event|2
1194306|NCT00978432|3923575|P3|Overall Study|Lack of Efficacy|3
1194307|NCT00978432|3923576|P2|Overall Study|Lack of Efficacy|1
1194308|NCT00978432|3923577|P1|Overall Study|Lack of Efficacy|1
1194309|NCT00978432|3923575|P3|Overall Study|Withdrawal by Subject|1
1194310|NCT00978432|3923576|P2|Overall Study|Withdrawal by Subject|0
1194311|NCT00978432|3923577|P1|Overall Study|Withdrawal by Subject|0
1194312|NCT00978380|3923628|P1|Overall Study|Unclassified|8
1194313|NCT00978380|3923628|P1|Overall Study|Withdrawal criteria|9
1194314|NCT00978380|3923628|P1|Overall Study|Protocol Violation|2
1194315|NCT00978341|3923634|P2|Washout Period of 2 Weeks|Adverse Event|0
1194316|NCT00978341|3923635|P1|Washout Period of 2 Weeks|Adverse Event|1
1194317|NCT00978120|3923657|P4|Overall Study|Moved out of state|1
1194318|NCT00978120|3923658|P3|Overall Study|Moved out of state|0
1194319|NCT00978120|3923659|P2|Overall Study|Moved out of state|0
1194320|NCT00978120|3923660|P1|Overall Study|Moved out of state|0
1194321|NCT00978120|3923657|P4|Overall Study|Withdrawal by Subject|0
1194322|NCT00978120|3923658|P3|Overall Study|Withdrawal by Subject|0
1194323|NCT00978120|3923659|P2|Overall Study|Withdrawal by Subject|0
1194324|NCT00978120|3923660|P1|Overall Study|Withdrawal by Subject|2
1194325|NCT00978120|3923657|P4|Overall Study|Lost to Follow-up|0
1194326|NCT00978120|3923658|P3|Overall Study|Lost to Follow-up|3
1194327|NCT00978120|3923659|P2|Overall Study|Lost to Follow-up|0
1194328|NCT00978120|3923660|P1|Overall Study|Lost to Follow-up|0
1194329|NCT00978120|3923657|P4|Overall Study|Death|1
1194330|NCT00978120|3923658|P3|Overall Study|Death|0
1194331|NCT00978120|3923659|P2|Overall Study|Death|0
1194332|NCT00978120|3923660|P1|Overall Study|Death|0
1194333|NCT00978068|3923712|P2|Overall Study|Unable to Comply with Study|2
1194334|NCT00978068|3923713|P1|Overall Study|Unable to Comply with Study|0
1194335|NCT00978068|3923712|P2|Overall Study|Physician Decision|1
1194336|NCT00978068|3923713|P1|Overall Study|Physician Decision|0
1194337|NCT00978068|3923712|P2|Overall Study|Lost to Follow-up|2
1194338|NCT00978068|3923713|P1|Overall Study|Lost to Follow-up|1
1194339|NCT00978068|3923712|P2|Overall Study|Death|2
1194340|NCT00978068|3923713|P1|Overall Study|Death|1
1194341|NCT00978068|3923712|P2|Overall Study|Were Awaiting Initiation of ART|2
1194342|NCT00978068|3923713|P1|Overall Study|Were Awaiting Initiation of ART|2
1194343|NCT00978042|3923731|P2|Initial Treatment Period|Other Miscellaneous Reasons|0
1194344|NCT00978042|3923732|P1|Initial Treatment Period|Other Miscellaneous Reasons|13
1194345|NCT00978042|3923731|P2|Initial Treatment Period|Consent withdrawn|9
1194346|NCT00978042|3923732|P1|Initial Treatment Period|Consent withdrawn|22
1194347|NCT00978042|3923731|P2|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0
1194348|NCT00978042|3923732|P1|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2
1194349|NCT00978042|3923731|P2|Initial Treatment Period|Adverse Event|0
1194350|NCT00978042|3923732|P1|Initial Treatment Period|Adverse Event|2
1194351|NCT00978042|3923731|P2|Initial Treatment Period|Lost to Follow-up|3
1194352|NCT00978042|3923732|P1|Initial Treatment Period|Lost to Follow-up|21
1194353|NCT00978042|3923731|P2|Initial Treatment Period|Ineligibility|0
1194354|NCT00978042|3923732|P1|Initial Treatment Period|Ineligibility|1
1194355|NCT00978042|3923731|P2|Initial Treatment Period|Treated in Error|3
1194356|NCT00978042|3923732|P1|Initial Treatment Period|Treated in Error|0
1194357|NCT00978029|3923745|P3|Overall Study|Protocol Violation|0
1194358|NCT00978029|3923746|P2|Overall Study|Protocol Violation|1
1194359|NCT00978029|3923747|P1|Overall Study|Protocol Violation|0
1194360|NCT00978029|3923745|P3|Overall Study|Withdrawal by Subject|1
1194361|NCT00978029|3923746|P2|Overall Study|Withdrawal by Subject|0
1194362|NCT00978029|3923747|P1|Overall Study|Withdrawal by Subject|0
1194363|NCT00978029|3923745|P3|Overall Study|Adverse Event|5
1194364|NCT00978029|3923746|P2|Overall Study|Adverse Event|2
1194365|NCT00978029|3923747|P1|Overall Study|Adverse Event|1
1194366|NCT00977938|3923774|P4|Observation (30-33 mo. Post Procedure)|Other|0
1194367|NCT00977938|3923775|P3|Observation (30-33 mo. Post Procedure)|Other|0
1194368|NCT00977938|3923776|P2|Observation (30-33 mo. Post Procedure)|Other|4
1194369|NCT00977938|3923777|P1|Observation (30-33 mo. Post Procedure)|Other|8
1194370|NCT00977938|3923774|P4|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3
1194371|NCT00977938|3923775|P3|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10
1194372|NCT00977938|3923776|P2|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42
1194373|NCT00977938|3923777|P1|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34
1194374|NCT00977938|3923774|P4|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0
1194375|NCT00977938|3923775|P3|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2
1194464|NCT00977106|3924071|P1|Overall Study|Lack of Efficacy|2
1194376|NCT00977938|3923776|P2|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12
1194377|NCT00977938|3923777|P1|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9
1194378|NCT00977938|3923774|P4|Treatment (12-30 mo. Post Procedure)|Other|4
1194379|NCT00977938|3923775|P3|Treatment (12-30 mo. Post Procedure)|Other|3
1194380|NCT00977938|3923776|P2|Treatment (12-30 mo. Post Procedure)|Other|18
1194381|NCT00977938|3923777|P1|Treatment (12-30 mo. Post Procedure)|Other|17
1194382|NCT00977938|3923774|P4|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37
1194383|NCT00977938|3923775|P3|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30
1194384|NCT00977938|3923776|P2|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91
1194385|NCT00977938|3923777|P1|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88
1194386|NCT00977938|3923774|P4|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20
1194387|NCT00977938|3923775|P3|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13
1194388|NCT00977938|3923776|P2|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116
1194389|NCT00977938|3923777|P1|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132
1194390|NCT00977665|3923841|P2|Overall Study|Treatment failure|1
1194391|NCT00977665|3923842|P1|Overall Study|Treatment failure|0
1194392|NCT00977665|3923841|P2|Overall Study|Adverse Event|7
1194393|NCT00977665|3923842|P1|Overall Study|Adverse Event|14
1194394|NCT00977665|3923841|P2|Overall Study|Death|2
1194395|NCT00977665|3923842|P1|Overall Study|Death|3
1194396|NCT00977665|3923841|P2|Overall Study|Lost to Follow-up|0
1194397|NCT00977665|3923842|P1|Overall Study|Lost to Follow-up|1
1194398|NCT00977665|3923841|P2|Overall Study|Sponsor requested withdrawal|1
1194399|NCT00977665|3923842|P1|Overall Study|Sponsor requested withdrawal|0
1194400|NCT00977665|3923841|P2|Overall Study|Physician Decision|1
1194401|NCT00977665|3923842|P1|Overall Study|Physician Decision|2
1194402|NCT00977665|3923841|P2|Overall Study|Withdrawal by Subject|3
1194403|NCT00977665|3923842|P1|Overall Study|Withdrawal by Subject|1
1194404|NCT00977613|3923874|P1|Overall Study|Lost to Follow-up|16
1194405|NCT00977574|3923881|P3|Overall Study|Never Treated|4
1194406|NCT00977574|3923882|P2|Overall Study|Never Treated|2
1194407|NCT00977574|3923883|P1|Overall Study|Never Treated|4
1194408|NCT00977561|3923902|P2|Overall Study|Other|0
1194409|NCT00977561|3923903|P1|Overall Study|Other|2
1194410|NCT00977561|3923902|P2|Overall Study|Study terminated|2
1194411|NCT00977561|3923903|P1|Overall Study|Study terminated|0
1194412|NCT00977561|3923902|P2|Overall Study|Death|2
1194413|NCT00977561|3923903|P1|Overall Study|Death|3
1194414|NCT00977548|3923930|P1|Overall Study|Withdrawal by Subject|1
1194415|NCT00977548|3923930|P1|Overall Study|Adverse Event|8
1194416|NCT00977548|3923930|P1|Overall Study|Ineligible|4
1194417|NCT00977470|3923939|P2|Overall Study|Still on-study|0
1194418|NCT00977470|3923940|P1|Overall Study|Still on-study|2
1194419|NCT00977470|3923939|P2|Overall Study|prolonged recovery post-surgery|1
1194420|NCT00977470|3923940|P1|Overall Study|prolonged recovery post-surgery|0
1194421|NCT00977470|3923939|P2|Overall Study|clinical decline|1
1194422|NCT00977470|3923940|P1|Overall Study|clinical decline|0
1194423|NCT00977470|3923939|P2|Overall Study|Death|2
1194424|NCT00977470|3923940|P1|Overall Study|Death|0
1194425|NCT00977470|3923939|P2|Overall Study|Withdrawal by Subject|2
1194426|NCT00977470|3923940|P1|Overall Study|Withdrawal by Subject|0
1194427|NCT00977470|3923939|P2|Overall Study|Protocol Violation|0
1194428|NCT00977470|3923940|P1|Overall Study|Protocol Violation|1
1194429|NCT00977470|3923939|P2|Overall Study|Adverse Event|2
1194430|NCT00977470|3923940|P1|Overall Study|Adverse Event|1
1194431|NCT00977470|3923939|P2|Overall Study|Physician Decision|0
1194432|NCT00977470|3923940|P1|Overall Study|Physician Decision|2
1194433|NCT00977470|3923939|P2|Overall Study|Lack of Efficacy|30
1194434|NCT00977470|3923940|P1|Overall Study|Lack of Efficacy|32
1194435|NCT00977379|3923960|P2|Overall Study|Randomization Error|1
1194436|NCT00977379|3923961|P1|Overall Study|Randomization Error|0
1194437|NCT00977379|3923960|P2|Overall Study|Participant Moving House|1
1194438|NCT00977379|3923961|P1|Overall Study|Participant Moving House|0
1194439|NCT00977379|3923960|P2|Overall Study|Premature Study Termination|0
1194440|NCT00977379|3923961|P1|Overall Study|Premature Study Termination|4
1194441|NCT00977379|3923960|P2|Overall Study|Death|9
1194442|NCT00977379|3923961|P1|Overall Study|Death|7
1194443|NCT00977379|3923960|P2|Overall Study|Withdrawal by Subject|1
1194444|NCT00977379|3923961|P1|Overall Study|Withdrawal by Subject|1
1194445|NCT00977314|3923997|P2|Overall Study|Physician Decision|0
1194446|NCT00977314|3923998|P1|Overall Study|Physician Decision|1
1194447|NCT00977314|3923997|P2|Overall Study|Withdrawal by Subject|0
1194448|NCT00977314|3923998|P1|Overall Study|Withdrawal by Subject|1
1194449|NCT00977197|3924006|P2|Overall Study|Nonadherence|1
1194450|NCT00977197|3924007|P1|Overall Study|Nonadherence|1
1194451|NCT00977197|3924006|P2|Overall Study|Lost to Follow-up|3
1194452|NCT00977197|3924007|P1|Overall Study|Lost to Follow-up|1
1194453|NCT00977197|3924006|P2|Overall Study|Lack of Efficacy|0
1194454|NCT00977197|3924007|P1|Overall Study|Lack of Efficacy|1
1194455|NCT00977197|3924006|P2|Overall Study|Adverse Event|1
1194456|NCT00977197|3924007|P1|Overall Study|Adverse Event|3
1194457|NCT00977197|3924006|P2|Overall Study|Withdrawal by Subject|4
1194458|NCT00977197|3924007|P1|Overall Study|Withdrawal by Subject|3
1194459|NCT00977106|3924070|P2|Overall Study|Not specified|0
1194460|NCT00977106|3924071|P1|Overall Study|Not specified|1
1194461|NCT00977106|3924070|P2|Overall Study|Protocol Violation|1
1194462|NCT00977106|3924071|P1|Overall Study|Protocol Violation|0
1194463|NCT00977106|3924070|P2|Overall Study|Lack of Efficacy|2
1194465|NCT00977106|3924070|P2|Overall Study|Withdrawal by Subject|2
1194466|NCT00977106|3924071|P1|Overall Study|Withdrawal by Subject|2
1194467|NCT00977106|3924070|P2|Overall Study|Adverse Event|6
1194468|NCT00977106|3924071|P1|Overall Study|Adverse Event|5
1194469|NCT00977080|3924163|P4|Overall Study|Travel for family reasons|0
1194470|NCT00977080|3924164|P3|Overall Study|Travel for family reasons|0
1194471|NCT00977080|3924165|P2|Overall Study|Travel for family reasons|0
1194472|NCT00977080|3924166|P1|Overall Study|Travel for family reasons|1
1194473|NCT00977080|3924163|P4|Overall Study|Required kidney transplantation|1
1194474|NCT00977080|3924164|P3|Overall Study|Required kidney transplantation|3
1194475|NCT00977080|3924165|P2|Overall Study|Required kidney transplantation|3
1194476|NCT00977080|3924166|P1|Overall Study|Required kidney transplantation|1
1194477|NCT00977080|3924163|P4|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1
1194478|NCT00977080|3924164|P3|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
1194479|NCT00977080|3924165|P2|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
1194480|NCT00977080|3924166|P1|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
1194481|NCT00977080|3924163|P4|Overall Study|Noncompliance|0
1194482|NCT00977080|3924164|P3|Overall Study|Noncompliance|1
1194483|NCT00977080|3924165|P2|Overall Study|Noncompliance|2
1194484|NCT00977080|3924166|P1|Overall Study|Noncompliance|0
1194485|NCT00977080|3924163|P4|Overall Study|Protocol Violation|3
1194486|NCT00977080|3924164|P3|Overall Study|Protocol Violation|4
1194487|NCT00977080|3924165|P2|Overall Study|Protocol Violation|3
1194488|NCT00977080|3924166|P1|Overall Study|Protocol Violation|7
1194489|NCT00977080|3924163|P4|Overall Study|Withdrawal by Subject|5
1194490|NCT00977080|3924164|P3|Overall Study|Withdrawal by Subject|1
1194491|NCT00977080|3924165|P2|Overall Study|Withdrawal by Subject|5
1194492|NCT00977080|3924166|P1|Overall Study|Withdrawal by Subject|1
1194493|NCT00977080|3924163|P4|Overall Study|Adverse Event|7
1194494|NCT00977080|3924164|P3|Overall Study|Adverse Event|7
1194495|NCT00977080|3924165|P2|Overall Study|Adverse Event|7
1194496|NCT00977080|3924166|P1|Overall Study|Adverse Event|2
1194497|NCT00976989|3924199|P3|Overall Study|Other|1
1194498|NCT00976989|3924200|P2|Overall Study|Other|0
1194499|NCT00976989|3924201|P1|Overall Study|Other|1
1194500|NCT00976989|3924199|P3|Overall Study|Recurrence of Disease|0
1194501|NCT00976989|3924200|P2|Overall Study|Recurrence of Disease|1
1194502|NCT00976989|3924201|P1|Overall Study|Recurrence of Disease|0
1194503|NCT00976989|3924199|P3|Overall Study|Failure to Return|0
1194504|NCT00976989|3924200|P2|Overall Study|Failure to Return|1
1194505|NCT00976989|3924201|P1|Overall Study|Failure to Return|2
1194506|NCT00976989|3924199|P3|Overall Study|Refused Treatment|5
1194507|NCT00976989|3924200|P2|Overall Study|Refused Treatment|3
1194508|NCT00976989|3924201|P1|Overall Study|Refused Treatment|4
1194509|NCT00976989|3924199|P3|Overall Study|Death|10
1194510|NCT00976989|3924200|P2|Overall Study|Death|7
1194511|NCT00976989|3924201|P1|Overall Study|Death|5
1194512|NCT00976989|3924199|P3|Overall Study|Violation of Selection Criteria at Entry|1
1194513|NCT00976989|3924200|P2|Overall Study|Violation of Selection Criteria at Entry|0
1194514|NCT00976989|3924201|P1|Overall Study|Violation of Selection Criteria at Entry|1
1194515|NCT00976950|3924242|P1|Overall Study|Events with no relationship to Aptivus|3
1194516|NCT00976950|3924242|P1|Overall Study|Adverse Event|3
1194517|NCT00976937|3924250|P2|Overall Study|Personal and Familial Reason|2
1194518|NCT00976937|3924251|P1|Overall Study|Personal and Familial Reason|2
1194519|NCT00976937|3924250|P2|Overall Study|Poor compliance to protocol|0
1194520|NCT00976937|3924251|P1|Overall Study|Poor compliance to protocol|3
1194521|NCT00976937|3924250|P2|Overall Study|Withdrawal by Subject|3
1194522|NCT00976937|3924251|P1|Overall Study|Withdrawal by Subject|5
1194523|NCT00976937|3924250|P2|Overall Study|Lost to Follow-up|1
1194524|NCT00976937|3924251|P1|Overall Study|Lost to Follow-up|2
1194525|NCT00976937|3924250|P2|Overall Study|Adverse Event|5
1194526|NCT00976937|3924251|P1|Overall Study|Adverse Event|4
1194527|NCT00976911|3924293|P2|Overall Study|In Follow-Up as of 25 Jan 2013|37
1194528|NCT00976911|3924294|P1|Overall Study|In Follow-Up as of 25 Jan 2013|30
1194529|NCT00976911|3924293|P2|Overall Study|Not Specified|9
1194530|NCT00976911|3924294|P1|Overall Study|Not Specified|8
1194531|NCT00976911|3924293|P2|Overall Study|Protocol Violation|0
1194532|NCT00976911|3924294|P1|Overall Study|Protocol Violation|2
1194533|NCT00976911|3924293|P2|Overall Study|Adverse Event|1
1194534|NCT00976911|3924294|P1|Overall Study|Adverse Event|0
1194535|NCT00976911|3924293|P2|Overall Study|Death|126
1194536|NCT00976911|3924294|P1|Overall Study|Death|138
1194537|NCT00976911|3924293|P2|Overall Study|Withdrawal by Subject|6
1194538|NCT00976911|3924294|P1|Overall Study|Withdrawal by Subject|4
1194539|NCT00976898|3924312|P1|Overall Study|Progressive Disease|1
1194540|NCT00976898|3924312|P1|Overall Study|Liver Transplant|1
1194541|NCT00976898|3924312|P1|Overall Study|Physician Decision|1
1194542|NCT00976898|3924312|P1|Overall Study|Adverse Event|1
1194543|NCT00976898|3924312|P1|Overall Study|Protocol Violation|1
1194544|NCT00976820|3924323|P4|Overall Study|Withdrawal by Subject|4
1194545|NCT00976820|3924324|P3|Overall Study|Withdrawal by Subject|1
1194546|NCT00976820|3924325|P2|Overall Study|Withdrawal by Subject|4
1194547|NCT00976820|3924326|P1|Overall Study|Withdrawal by Subject|2
1194548|NCT00976820|3924323|P4|Overall Study|Poor Compliance. Numerous Visits Booked|0
1194549|NCT00976820|3924324|P3|Overall Study|Poor Compliance. Numerous Visits Booked|1
1194550|NCT00976820|3924325|P2|Overall Study|Poor Compliance. Numerous Visits Booked|0
1194551|NCT00976820|3924326|P1|Overall Study|Poor Compliance. Numerous Visits Booked|1
1194552|NCT00976820|3924323|P4|Overall Study|Lost to Follow-up|3
1194553|NCT00976820|3924324|P3|Overall Study|Lost to Follow-up|2
1194554|NCT00976820|3924325|P2|Overall Study|Lost to Follow-up|16
1194555|NCT00976820|3924326|P1|Overall Study|Lost to Follow-up|5
1194556|NCT00976716|3924662|P1|Overall Study|Adverse Event|1
1194557|NCT00976703|3924680|P2|Overall Study|ineligible for study|2
1194558|NCT00976703|3924681|P1|Overall Study|ineligible for study|2
1194559|NCT00976703|3924680|P2|Overall Study|Physician Decision|1
1194560|NCT00976703|3924681|P1|Overall Study|Physician Decision|1
1194561|NCT00976677|3924695|P2|Overall Study|Unknown/Missing|0
1194562|NCT00976677|3924696|P1|Overall Study|Unknown/Missing|1
1194563|NCT00976677|3924695|P2|Overall Study|Trial unblinded|2
1194564|NCT00976677|3924696|P1|Overall Study|Trial unblinded|2
1194565|NCT00976677|3924695|P2|Overall Study|Disease progression|1
1194566|NCT00976677|3924696|P1|Overall Study|Disease progression|1
1194567|NCT00976677|3924695|P2|Overall Study|Withdrawal by Subject|2
1194568|NCT00976677|3924696|P1|Overall Study|Withdrawal by Subject|0
1194569|NCT00976677|3924695|P2|Overall Study|Adverse Event|0
1194570|NCT00976677|3924696|P1|Overall Study|Adverse Event|1
1194571|NCT00976573|3924904|P2|Overall Study|Cancel prior to receiving treatment|2
1194572|NCT00976573|3924905|P1|Overall Study|Cancel prior to receiving treatment|4
1194573|NCT00976573|3924904|P2|Overall Study|Ineligible|1
1194574|NCT00976573|3924905|P1|Overall Study|Ineligible|0
1194575|NCT00976560|3924919|P2|Overall Study|Withdrawal by Subject|3
1194576|NCT00976560|3924920|P1|Overall Study|Withdrawal by Subject|2
1194577|NCT00976560|3924919|P2|Overall Study|Physician Decision|0
1194578|NCT00976560|3924920|P1|Overall Study|Physician Decision|2
1194579|NCT00976560|3924919|P2|Overall Study|Lost to Follow-up|0
1194580|NCT00976560|3924920|P1|Overall Study|Lost to Follow-up|1
1194581|NCT00976560|3924919|P2|Overall Study|Protocol Violation|0
1194582|NCT00976560|3924920|P1|Overall Study|Protocol Violation|1
1194583|NCT00976560|3924919|P2|Overall Study|Lack of Efficacy|5
1194584|NCT00976560|3924920|P1|Overall Study|Lack of Efficacy|3
1194585|NCT00976560|3924919|P2|Overall Study|Adverse Event|5
1194586|NCT00976560|3924920|P1|Overall Study|Adverse Event|5
1194587|NCT00976508|3924989|P2|Overall Study|Terminated by the Sponsor|1
1194588|NCT00976508|3924990|P1|Overall Study|Terminated by the Sponsor|0
1194589|NCT00976508|3924989|P2|Overall Study|Subject Enrolled in Hospice|0
1194590|NCT00976508|3924990|P1|Overall Study|Subject Enrolled in Hospice|1
1194591|NCT00976508|3924989|P2|Overall Study|Disease Progression|4
1194592|NCT00976508|3924990|P1|Overall Study|Disease Progression|4
1194593|NCT00976508|3924989|P2|Overall Study|Withdrawal by Subject|0
1194594|NCT00976508|3924990|P1|Overall Study|Withdrawal by Subject|1
1194595|NCT00976508|3924989|P2|Overall Study|Lost to Follow-up|0
1194596|NCT00976508|3924990|P1|Overall Study|Lost to Follow-up|1
1194597|NCT00976508|3924989|P2|Overall Study|Death|1
1194598|NCT00976508|3924990|P1|Overall Study|Death|7
1194599|NCT00976495|3925023|P3|Overall Study|Withdrawal by Subject|0
1194600|NCT00976495|3925024|P2|Overall Study|Withdrawal by Subject|1
1194601|NCT00976495|3925025|P1|Overall Study|Withdrawal by Subject|0
1194602|NCT00976482|3925042|P1|Overall Study|Protocol Violation|5
1194603|NCT00976482|3925042|P1|Overall Study|Center terminated|1
1194604|NCT00976482|3925042|P1|Overall Study|Withdrawal by Subject|45
1194605|NCT00976482|3925042|P1|Overall Study|Death|208
1194606|NCT00976456|3925048|P2|Overall Study|screening failure, unknown|4
1194607|NCT00976456|3925049|P1|Overall Study|screening failure, unknown|11
1194608|NCT00976456|3925048|P2|Overall Study|Withdrawal by Subject|1
1194609|NCT00976456|3925049|P1|Overall Study|Withdrawal by Subject|3
1194610|NCT00976456|3925048|P2|Overall Study|Lack of Efficacy|2
1194611|NCT00976456|3925049|P1|Overall Study|Lack of Efficacy|5
1194612|NCT00976456|3925048|P2|Overall Study|Death|9
1194613|NCT00976456|3925049|P1|Overall Study|Death|7
1194614|NCT00976456|3925048|P2|Overall Study|Adverse Event|22
1194615|NCT00976456|3925049|P1|Overall Study|Adverse Event|17
1194616|NCT00976391|3925076|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
1194617|NCT00976391|3925077|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
1194618|NCT00976391|3925076|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|7
1194619|NCT00976391|3925077|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
1194620|NCT00976391|3925076|P2|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8
1194621|NCT00976391|3925077|P1|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6
1194622|NCT00976391|3925076|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|12
1194623|NCT00976391|3925077|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|14
1194624|NCT00976391|3925076|P2|Follow-up Period (8 Weeks)|Noncompliance|2
1194625|NCT00976391|3925077|P1|Follow-up Period (8 Weeks)|Noncompliance|2
1194626|NCT00976391|3925076|P2|Follow-up Period (8 Weeks)|Adverse Event|1
1194627|NCT00976391|3925077|P1|Follow-up Period (8 Weeks)|Adverse Event|3
1194628|NCT00976391|3925076|P2|Treatment Period (52 Weeks)|Pregnancy|0
1194629|NCT00976391|3925077|P1|Treatment Period (52 Weeks)|Pregnancy|1
1194630|NCT00976391|3925076|P2|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4
1194631|NCT00976391|3925077|P1|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0
1194632|NCT00976391|3925076|P2|Treatment Period (52 Weeks)|Physician Decision|1
1194633|NCT00976391|3925077|P1|Treatment Period (52 Weeks)|Physician Decision|1
1194634|NCT00976391|3925076|P2|Treatment Period (52 Weeks)|Withdrawal by Subject|19
1194635|NCT00976391|3925077|P1|Treatment Period (52 Weeks)|Withdrawal by Subject|9
1194636|NCT00976391|3925076|P2|Treatment Period (52 Weeks)|Lost to Follow-up|8
1194637|NCT00976391|3925077|P1|Treatment Period (52 Weeks)|Lost to Follow-up|10
1194638|NCT00976391|3925076|P2|Treatment Period (52 Weeks)|Noncompliance|4
1194639|NCT00976391|3925077|P1|Treatment Period (52 Weeks)|Noncompliance|4
1194640|NCT00976391|3925076|P2|Treatment Period (52 Weeks)|Protocol Violation|1
1194641|NCT00976391|3925077|P1|Treatment Period (52 Weeks)|Protocol Violation|1
1194642|NCT00976391|3925076|P2|Treatment Period (52 Weeks)|Adverse Event|2
1194643|NCT00976391|3925077|P1|Treatment Period (52 Weeks)|Adverse Event|16
1194644|NCT00976274|3925125|P2|Overall Study|Physician Decision|2
1194645|NCT00976274|3925126|P1|Overall Study|Physician Decision|1
1194646|NCT00976274|3925125|P2|Overall Study|Withdrawal by Subject|1
1194647|NCT00976274|3925126|P1|Overall Study|Withdrawal by Subject|1
1194648|NCT00976274|3925125|P2|Overall Study|Lost to Follow-up|5
1194649|NCT00976274|3925126|P1|Overall Study|Lost to Follow-up|5
1194650|NCT00976209|3925142|P2|Treatment Period 2|Lost to Follow-up|1
1194651|NCT00976209|3925143|P1|Treatment Period 2|Lost to Follow-up|0
1194652|NCT00976209|3925142|P2|Treatment Period 2|Withdrawal by Subject|1
1194653|NCT00976209|3925143|P1|Treatment Period 2|Withdrawal by Subject|0
1194654|NCT00976209|3925142|P2|Wash-out Period|Other|0
1194655|NCT00976209|3925143|P1|Wash-out Period|Other|1
1194656|NCT00976209|3925142|P2|Wash-out Period|Protocol Violation|0
1194657|NCT00976209|3925143|P1|Wash-out Period|Protocol Violation|1
1194658|NCT00976209|3925142|P2|Wash-out Period|Lost to Follow-up|0
1194659|NCT00976209|3925143|P1|Wash-out Period|Lost to Follow-up|1
1194660|NCT00976209|3925142|P2|Wash-out Period|Adverse Event|2
1194661|NCT00976209|3925143|P1|Wash-out Period|Adverse Event|1
1194662|NCT00976209|3925142|P2|Treatment Period 1|Other|1
1194663|NCT00976209|3925143|P1|Treatment Period 1|Other|0
1194664|NCT00976209|3925142|P2|Treatment Period 1|Lost to Follow-up|0
1194665|NCT00976209|3925143|P1|Treatment Period 1|Lost to Follow-up|2
1194666|NCT00976209|3925142|P2|Treatment Period 1|Protocol Violation|0
1194667|NCT00976209|3925143|P1|Treatment Period 1|Protocol Violation|1
1194668|NCT00976027|3925156|P2|Overall Study|Withdrawal by Subject|66
1194669|NCT00976027|3925157|P1|Overall Study|Withdrawal by Subject|107
1194670|NCT00976027|3925156|P2|Overall Study|Lost to Follow-up|103
1194671|NCT00976027|3925157|P1|Overall Study|Lost to Follow-up|208
1194672|NCT00976027|3925156|P2|Overall Study|Protocol Violation|27
1194673|NCT00976027|3925157|P1|Overall Study|Protocol Violation|60
1194674|NCT00976027|3925156|P2|Overall Study|Adverse Event|2
1194675|NCT00976027|3925157|P1|Overall Study|Adverse Event|0
1194676|NCT00976027|3925156|P2|Overall Study|Serious Adverse Event|17
1194677|NCT00976027|3925157|P1|Overall Study|Serious Adverse Event|36
1194678|NCT00975975|3925169|P1|Overall Study|Death|6
1194679|NCT00975923|3925177|P2|Overall Study|Withdrawal by Subject|1
1194680|NCT00975923|3925178|P1|Overall Study|Withdrawal by Subject|0
1194681|NCT00975806|3925189|P3|Overall Study|Physician decision and disease related|1
1194682|NCT00975806|3925190|P2|Overall Study|Physician decision and disease related|0
1194683|NCT00975806|3925191|P1|Overall Study|Physician decision and disease related|1
1194684|NCT00975806|3925189|P3|Overall Study|Death|0
1194685|NCT00975806|3925190|P2|Overall Study|Death|1
1194686|NCT00975806|3925191|P1|Overall Study|Death|0
1194687|NCT00975806|3925189|P3|Overall Study|Withdrawal by Subject|0
1194688|NCT00975806|3925190|P2|Overall Study|Withdrawal by Subject|0
1194689|NCT00975806|3925191|P1|Overall Study|Withdrawal by Subject|1
1194690|NCT00975806|3925189|P3|Overall Study|Disease Progression|1
1194691|NCT00975806|3925190|P2|Overall Study|Disease Progression|5
1194692|NCT00975806|3925191|P1|Overall Study|Disease Progression|1
1194693|NCT00975806|3925189|P3|Overall Study|Adverse Event|2
1194694|NCT00975806|3925190|P2|Overall Study|Adverse Event|1
1194695|NCT00975806|3925191|P1|Overall Study|Adverse Event|2
1194696|NCT00975780|3925215|P2|Follow Up|Discharged from Facility|12
1194697|NCT00975780|3925216|P1|Follow Up|Discharged from Facility|7
1194698|NCT00975780|3925215|P2|Follow Up|Facility Withdrawal|23
1194699|NCT00975780|3925216|P1|Follow Up|Facility Withdrawal|7
1194700|NCT00975780|3925215|P2|Follow Up|Death|122
1194701|NCT00975780|3925216|P1|Follow Up|Death|88
1194702|NCT00975715|3925226|P2|Maintenance Period|Adverse Event|1
1194703|NCT00975715|3925227|P1|Maintenance Period|Adverse Event|2
1194704|NCT00975715|3925226|P2|Titration Period|Protocol Violation|0
1194705|NCT00975715|3925227|P1|Titration Period|Protocol Violation|1
1194706|NCT00975715|3925226|P2|Titration Period|Adverse Event|0
1194707|NCT00975715|3925227|P1|Titration Period|Adverse Event|6
1194708|NCT00975689|3925243|P2|Overall Study|Physician Decision|0
1194709|NCT00975689|3925244|P1|Overall Study|Physician Decision|1
1194710|NCT00975689|3925243|P2|Overall Study|Withdrawal by Subject|0
1194711|NCT00975689|3925244|P1|Overall Study|Withdrawal by Subject|1
1194712|NCT00975689|3925243|P2|Overall Study|Adverse Event|3
1194713|NCT00975689|3925244|P1|Overall Study|Adverse Event|0
1194714|NCT00975611|3925313|P1|Overall Study|Physician Decision|1
1194715|NCT00975611|3925313|P1|Overall Study|Screen Fail|16
1194716|NCT00975585|3925319|P2|Overall Study|Lens issue|2
1194717|NCT00975585|3925320|P1|Overall Study|Lens issue|2
1194718|NCT00975585|3925319|P2|Overall Study|Withdrawal by Subject|1
1194719|NCT00975585|3925320|P1|Overall Study|Withdrawal by Subject|2
1194720|NCT00975585|3925319|P2|Overall Study|Lost to Follow-up|5
1194721|NCT00975585|3925320|P1|Overall Study|Lost to Follow-up|3
1194722|NCT00975585|3925319|P2|Overall Study|Adverse Event|4
1194723|NCT00975585|3925320|P1|Overall Study|Adverse Event|0
1194724|NCT00975507|3925340|P2|Overall Study|Withdrawal by Subject|3
1194725|NCT00975507|3925341|P1|Overall Study|Withdrawal by Subject|10
1194726|NCT00975507|3925340|P2|Overall Study|Protocol Violation|0
1194727|NCT00975507|3925341|P1|Overall Study|Protocol Violation|2
1194728|NCT00975507|3925340|P2|Overall Study|Lost to Follow-up|1
1194729|NCT00975507|3925341|P1|Overall Study|Lost to Follow-up|7
1194730|NCT00975507|3925340|P2|Overall Study|Adverse Event|0
1194731|NCT00975507|3925341|P1|Overall Study|Adverse Event|1
1194732|NCT00975481|3925361|P6|Fifth Intervention Period|Withdrawal by Subject|0
1194733|NCT00975481|3925362|P5|Fifth Intervention Period|Withdrawal by Subject|1
1194734|NCT00975481|3925363|P4|Fifth Intervention Period|Withdrawal by Subject|0
1194735|NCT00975481|3925364|P3|Fifth Intervention Period|Withdrawal by Subject|0
1194736|NCT00975481|3925365|P2|Fifth Intervention Period|Withdrawal by Subject|0
1194737|NCT00975481|3925366|P1|Fifth Intervention Period|Withdrawal by Subject|0
1194738|NCT00975481|3925361|P6|Fourth Intervention Period|Withdrawal by Subject|0
1194739|NCT00975481|3925362|P5|Fourth Intervention Period|Withdrawal by Subject|0
1194740|NCT00975481|3925363|P4|Fourth Intervention Period|Withdrawal by Subject|1
1194741|NCT00975481|3925364|P3|Fourth Intervention Period|Withdrawal by Subject|1
1194742|NCT00975481|3925365|P2|Fourth Intervention Period|Withdrawal by Subject|0
1194743|NCT00975481|3925366|P1|Fourth Intervention Period|Withdrawal by Subject|0
1194744|NCT00975481|3925361|P6|Second Intervention Period|Withdrawal by Subject|0
1194745|NCT00975481|3925362|P5|Second Intervention Period|Withdrawal by Subject|0
1194746|NCT00975481|3925363|P4|Second Intervention Period|Withdrawal by Subject|0
1194747|NCT00975481|3925364|P3|Second Intervention Period|Withdrawal by Subject|1
1194748|NCT00975481|3925365|P2|Second Intervention Period|Withdrawal by Subject|0
1194749|NCT00975481|3925366|P1|Second Intervention Period|Withdrawal by Subject|0
1194750|NCT00975481|3925361|P6|Second Intervention Period|Adverse Event|0
1194751|NCT00975481|3925362|P5|Second Intervention Period|Adverse Event|0
1194752|NCT00975481|3925363|P4|Second Intervention Period|Adverse Event|0
1194753|NCT00975481|3925364|P3|Second Intervention Period|Adverse Event|0
1194754|NCT00975481|3925365|P2|Second Intervention Period|Adverse Event|1
1194755|NCT00975481|3925366|P1|Second Intervention Period|Adverse Event|2
1194756|NCT00975416|3925466|P2|Overall Study|early discharge from tx|5
1194757|NCT00975416|3925467|P1|Overall Study|early discharge from tx|3
1194758|NCT00975286|3925476|P2|Overall Study|Sponsor Decision|2
1194759|NCT00975286|3925477|P1|Overall Study|Sponsor Decision|0
1194760|NCT00975286|3925476|P2|Overall Study|Poor Compliance to Protocol|2
1194761|NCT00975286|3925477|P1|Overall Study|Poor Compliance to Protocol|0
1194762|NCT00975286|3925476|P2|Overall Study|Familial and Personal Reasons|2
1194763|NCT00975286|3925477|P1|Overall Study|Familial and Personal Reasons|2
1194764|NCT00975286|3925476|P2|Overall Study|Withdrawal by Subject|2
1194765|NCT00975286|3925477|P1|Overall Study|Withdrawal by Subject|0
1194766|NCT00975286|3925476|P2|Overall Study|Protocol Violation|2
1194767|NCT00975286|3925477|P1|Overall Study|Protocol Violation|1
1194768|NCT00975286|3925476|P2|Overall Study|Adverse Event|19
1194769|NCT00975286|3925477|P1|Overall Study|Adverse Event|9
1194770|NCT00975221|3925509|P2|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0
1194771|NCT00975221|3925510|P1|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1
1194772|NCT00975221|3925509|P2|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
1194773|NCT00975221|3925510|P1|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
1194774|NCT00975221|3925509|P2|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1
1194775|NCT00975221|3925510|P1|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0
1194776|NCT00975221|3925509|P2|Titration Phase (Weeks 1-12)|Other|1
1194777|NCT00975221|3925510|P1|Titration Phase (Weeks 1-12)|Other|0
1194778|NCT00975221|3925509|P2|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0
1194779|NCT00975221|3925510|P1|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1
1194780|NCT00975221|3925509|P2|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3
1194781|NCT00975221|3925510|P1|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2
1194782|NCT00975195|3925526|P2|Overall Study|Not treated|2
1194783|NCT00975195|3925527|P1|Overall Study|Not treated|1
1194784|NCT00975195|3925526|P2|Overall Study|Other reason not defined above|33
1194785|NCT00975195|3925527|P1|Overall Study|Other reason not defined above|29
1194786|NCT00975195|3925526|P2|Overall Study|Withdrawal by Subject|61
1194787|NCT00975195|3925527|P1|Overall Study|Withdrawal by Subject|48
1194788|NCT00975195|3925526|P2|Overall Study|Lost to Follow-up|7
1194789|NCT00975195|3925527|P1|Overall Study|Lost to Follow-up|9
1194790|NCT00975195|3925526|P2|Overall Study|Protocol Violation|23
1194791|NCT00975195|3925527|P1|Overall Study|Protocol Violation|27
1194792|NCT00975195|3925526|P2|Overall Study|Lack of Efficacy|6
1194793|NCT00975195|3925527|P1|Overall Study|Lack of Efficacy|6
1194794|NCT00975195|3925526|P2|Overall Study|Adverse Event|101
1194795|NCT00975195|3925527|P1|Overall Study|Adverse Event|108
1194796|NCT00975156|3925587|P2|Overall Study|Protocol Violation|1
1194797|NCT00975156|3925588|P1|Overall Study|Protocol Violation|0
1194798|NCT00975143|3925600|P2|Overall Study|Details not available|4
1194799|NCT00975143|3925601|P1|Overall Study|Details not available|10
1194800|NCT00975143|3925600|P2|Overall Study|Physician Decision|2
1194801|NCT00975143|3925601|P1|Overall Study|Physician Decision|1
1194802|NCT00975143|3925600|P2|Overall Study|Non-compliance|8
1194803|NCT00975143|3925601|P1|Overall Study|Non-compliance|5
1194804|NCT00975143|3925600|P2|Overall Study|Lost to Follow-up|16
1194805|NCT00975143|3925601|P1|Overall Study|Lost to Follow-up|20
1194806|NCT00975143|3925600|P2|Overall Study|Withdrawal by Subject|15
1194807|NCT00975143|3925601|P1|Overall Study|Withdrawal by Subject|15
1194808|NCT00975143|3925600|P2|Overall Study|Adverse Event|15
1194809|NCT00975143|3925601|P1|Overall Study|Adverse Event|19
1194810|NCT00975130|3925611|P3|Study Part 2|Protocol Violation|1
1194811|NCT00975130|3925612|P2|Study Part 2|Protocol Violation|0
1194812|NCT00975130|3925613|P1|Study Part 2|Protocol Violation|0
1194813|NCT00975130|3925611|P3|Study Part 2|Administrative|0
1194814|NCT00975130|3925612|P2|Study Part 2|Administrative|1
1194815|NCT00975130|3925613|P1|Study Part 2|Administrative|0
1194816|NCT00975130|3925611|P3|Study Part 2|Did Not Meet Protocol Eligibility|1
1194817|NCT00975130|3925612|P2|Study Part 2|Did Not Meet Protocol Eligibility|4
1194818|NCT00975130|3925613|P1|Study Part 2|Did Not Meet Protocol Eligibility|0
1194819|NCT00975130|3925611|P3|Study Part 2|Withdrew Consent|2
1194820|NCT00975130|3925612|P2|Study Part 2|Withdrew Consent|6
1194821|NCT00975130|3925613|P1|Study Part 2|Withdrew Consent|0
1194822|NCT00975130|3925611|P3|Study Part 2|Withdrawal by Subject|5
1194823|NCT00975130|3925612|P2|Study Part 2|Withdrawal by Subject|13
1194824|NCT00975130|3925613|P1|Study Part 2|Withdrawal by Subject|0
1194825|NCT00975130|3925611|P3|Study Part 2|Lost to Follow-up|1
1194826|NCT00975130|3925612|P2|Study Part 2|Lost to Follow-up|0
1194827|NCT00975130|3925613|P1|Study Part 2|Lost to Follow-up|0
1194828|NCT00975130|3925611|P3|Study Part 2|Adverse Event|7
1194829|NCT00975130|3925612|P2|Study Part 2|Adverse Event|14
1194830|NCT00975130|3925613|P1|Study Part 2|Adverse Event|0
1194831|NCT00975130|3925611|P3|Study Part 1|Withdrew Consent|0
1194832|NCT00975130|3925612|P2|Study Part 1|Withdrew Consent|0
1194833|NCT00975130|3925613|P1|Study Part 1|Withdrew Consent|24
1194834|NCT00975130|3925611|P3|Study Part 1|Administrative|0
1194835|NCT00975130|3925612|P2|Study Part 1|Administrative|0
1194836|NCT00975130|3925613|P1|Study Part 1|Administrative|4
1194837|NCT00975130|3925611|P3|Study Part 1|Did Not Meet Protocol Eligibility|0
1194838|NCT00975130|3925612|P2|Study Part 1|Did Not Meet Protocol Eligibility|0
1194839|NCT00975130|3925613|P1|Study Part 1|Did Not Meet Protocol Eligibility|9
1194840|NCT00975130|3925611|P3|Study Part 1|Protocol Violation|0
1194841|NCT00975130|3925612|P2|Study Part 1|Protocol Violation|0
1194842|NCT00975130|3925613|P1|Study Part 1|Protocol Violation|13
1194843|NCT00975130|3925611|P3|Study Part 1|Withdrawal by Subject|0
1194844|NCT00975130|3925612|P2|Study Part 1|Withdrawal by Subject|0
1194845|NCT00975130|3925613|P1|Study Part 1|Withdrawal by Subject|61
1194846|NCT00975130|3925611|P3|Study Part 1|Lost to Follow-up|0
1194847|NCT00975130|3925612|P2|Study Part 1|Lost to Follow-up|0
1194848|NCT00975130|3925613|P1|Study Part 1|Lost to Follow-up|19
1194849|NCT00975130|3925611|P3|Study Part 1|Adverse Event|0
1194850|NCT00975130|3925612|P2|Study Part 1|Adverse Event|0
1194851|NCT00975130|3925613|P1|Study Part 1|Adverse Event|150
1194852|NCT00975000|3925797|P2|Overall Study|Non-compliance|1
1194853|NCT00975000|3925798|P1|Overall Study|Non-compliance|0
1194854|NCT00975000|3925797|P2|Overall Study|Protocol-specified Criteria|0
1194855|NCT00975000|3925798|P1|Overall Study|Protocol-specified Criteria|1
1194856|NCT00975000|3925797|P2|Overall Study|Lost to Follow-up|1
1194857|NCT00975000|3925798|P1|Overall Study|Lost to Follow-up|0
1194858|NCT00975000|3925797|P2|Overall Study|Withdrawal by Subject|2
1194859|NCT00975000|3925798|P1|Overall Study|Withdrawal by Subject|2
1194860|NCT00975000|3925797|P2|Overall Study|Adverse Event|1
1194861|NCT00975000|3925798|P1|Overall Study|Adverse Event|1
1194862|NCT00975000|3925797|P2|Overall Study|Other|0
1194863|NCT00975000|3925798|P1|Overall Study|Other|1
1194864|NCT00974974|3925822|P2|Maintenance - Double Blind Treatment|Various|0
1194865|NCT00974974|3925823|P1|Maintenance - Double Blind Treatment|Various|4
1194866|NCT00974974|3925822|P2|Maintenance - Double Blind Treatment|Withdrawal by Subject|2
1194867|NCT00974974|3925823|P1|Maintenance - Double Blind Treatment|Withdrawal by Subject|5
1194868|NCT00974974|3925822|P2|Maintenance - Double Blind Treatment|Lost to Follow-up|1
1194869|NCT00974974|3925823|P1|Maintenance - Double Blind Treatment|Lost to Follow-up|0
1194870|NCT00974974|3925822|P2|Maintenance - Double Blind Treatment|Lack of Efficacy|2
1194871|NCT00974974|3925823|P1|Maintenance - Double Blind Treatment|Lack of Efficacy|2
1194872|NCT00974974|3925822|P2|Maintenance - Double Blind Treatment|Noncompliance with study drug|1
1194873|NCT00974974|3925823|P1|Maintenance - Double Blind Treatment|Noncompliance with study drug|0
1194874|NCT00974974|3925822|P2|Maintenance - Double Blind Treatment|Protocol Violation|1
1194875|NCT00974974|3925823|P1|Maintenance - Double Blind Treatment|Protocol Violation|1
1194876|NCT00974974|3925822|P2|Maintenance - Double Blind Treatment|Adverse Event|3
1194877|NCT00974974|3925823|P1|Maintenance - Double Blind Treatment|Adverse Event|3
1194878|NCT00974974|3925822|P2|IPX066 Dose Conversion|Protocol Violation|0
1194879|NCT00974974|3925823|P1|IPX066 Dose Conversion|Protocol Violation|4
1194880|NCT00974974|3925822|P2|IPX066 Dose Conversion|Various|0
1194881|NCT00974974|3925823|P1|IPX066 Dose Conversion|Various|3
1194882|NCT00974974|3925822|P2|IPX066 Dose Conversion|Withdrawal by Subject|0
1194883|NCT00974974|3925823|P1|IPX066 Dose Conversion|Withdrawal by Subject|12
1194884|NCT00974974|3925822|P2|IPX066 Dose Conversion|Lack of Efficacy|0
1194885|NCT00974974|3925823|P1|IPX066 Dose Conversion|Lack of Efficacy|13
1194886|NCT00974974|3925822|P2|IPX066 Dose Conversion|Death|0
1194887|NCT00974974|3925823|P1|IPX066 Dose Conversion|Death|2
1194888|NCT00974974|3925822|P2|IPX066 Dose Conversion|Adverse Event|0
1194889|NCT00974974|3925823|P1|IPX066 Dose Conversion|Adverse Event|23
1194890|NCT00974974|3925822|P2|IR CD-LD Dose Adjustment|Various|9
1194891|NCT00974974|3925823|P1|IR CD-LD Dose Adjustment|Various|0
1194892|NCT00974974|3925822|P2|IR CD-LD Dose Adjustment|Withdrawal by Subject|7
1194893|NCT00974974|3925823|P1|IR CD-LD Dose Adjustment|Withdrawal by Subject|0
1194894|NCT00974974|3925822|P2|IR CD-LD Dose Adjustment|Noncompliance with study drug|1
1194895|NCT00974974|3925823|P1|IR CD-LD Dose Adjustment|Noncompliance with study drug|0
1194896|NCT00974974|3925822|P2|IR CD-LD Dose Adjustment|Protocol Violation|1
1194897|NCT00974974|3925823|P1|IR CD-LD Dose Adjustment|Protocol Violation|0
1194898|NCT00974974|3925822|P2|IR CD-LD Dose Adjustment|Adverse Event|3
1194899|NCT00974974|3925823|P1|IR CD-LD Dose Adjustment|Adverse Event|0
1194900|NCT00974922|3925833|P1|Overall Study|study terminated|24
1194901|NCT00974675|3925851|P4|Overall Study|Participant on holiday; unable to attend|1
1194902|NCT00974675|3925852|P3|Overall Study|Participant on holiday; unable to attend|0
1194903|NCT00974675|3925853|P2|Overall Study|Participant on holiday; unable to attend|0
1194904|NCT00974675|3925854|P1|Overall Study|Participant on holiday; unable to attend|0
1194905|NCT00974675|3925851|P4|Overall Study|Physician Decision|0
1194906|NCT00974675|3925852|P3|Overall Study|Physician Decision|1
1194907|NCT00974675|3925853|P2|Overall Study|Physician Decision|0
1194908|NCT00974675|3925854|P1|Overall Study|Physician Decision|0
1194909|NCT00974675|3925851|P4|Overall Study|Adverse Event|1
1194910|NCT00974675|3925852|P3|Overall Study|Adverse Event|1
1194911|NCT00974675|3925853|P2|Overall Study|Adverse Event|1
1194912|NCT00974675|3925854|P1|Overall Study|Adverse Event|2
1194913|NCT00974571|3925903|P3|Overall Study|Other|10
1194914|NCT00974571|3925904|P2|Overall Study|Other|0
1194915|NCT00974571|3925905|P1|Overall Study|Other|4
1194916|NCT00974571|3925903|P3|Overall Study|Patient Moved|1
1194917|NCT00974571|3925904|P2|Overall Study|Patient Moved|0
1194918|NCT00974571|3925905|P1|Overall Study|Patient Moved|1
1194919|NCT00974571|3925903|P3|Overall Study|Withdrawal by Subject|16
1194920|NCT00974571|3925904|P2|Overall Study|Withdrawal by Subject|5
1194921|NCT00974571|3925905|P1|Overall Study|Withdrawal by Subject|14
1194922|NCT00974571|3925903|P3|Overall Study|Protocol Violation|18
1194923|NCT00974571|3925904|P2|Overall Study|Protocol Violation|4
1194924|NCT00974571|3925905|P1|Overall Study|Protocol Violation|13
1194925|NCT00974571|3925903|P3|Overall Study|Lost to Follow-up|2
1194926|NCT00974571|3925904|P2|Overall Study|Lost to Follow-up|1
1194927|NCT00974571|3925905|P1|Overall Study|Lost to Follow-up|2
1194928|NCT00974571|3925903|P3|Overall Study|Lack of Efficacy|9
1194929|NCT00974571|3925904|P2|Overall Study|Lack of Efficacy|2
1194930|NCT00974571|3925905|P1|Overall Study|Lack of Efficacy|3
1194931|NCT00974571|3925903|P3|Overall Study|Adverse Event|27
1194932|NCT00974571|3925904|P2|Overall Study|Adverse Event|4
1194933|NCT00974571|3925905|P1|Overall Study|Adverse Event|31
1194934|NCT00974311|3926002|P2|OLE Phase (up to 77 Months)|Withdrawal by Subject|1
1194935|NCT00974311|3926003|P1|OLE Phase (up to 77 Months)|Withdrawal by Subject|2
1194936|NCT00974311|3926002|P2|OLE Phase (up to 77 Months)|Other|2
1194937|NCT00974311|3926003|P1|OLE Phase (up to 77 Months)|Other|15
1194938|NCT00974311|3926002|P2|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26
1194939|NCT00974311|3926003|P1|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78
1194940|NCT00974311|3926002|P2|OLE Phase (up to 77 Months)|Death|21
1194941|NCT00974311|3926003|P1|OLE Phase (up to 77 Months)|Death|14
1194942|NCT00974311|3926002|P2|DB Phase (up to 24 Months)|Other|0
1194943|NCT00974311|3926003|P1|DB Phase (up to 24 Months)|Other|1
1194944|NCT00974311|3926002|P2|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42
1194945|NCT00974311|3926003|P1|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108
1194946|NCT00974311|3926002|P2|DB Phase (up to 24 Months)|Withdrawal by Subject|7
1194947|NCT00974311|3926003|P1|DB Phase (up to 24 Months)|Withdrawal by Subject|16
1194948|NCT00974311|3926002|P2|DB Phase (up to 24 Months)|Death|298
1194949|NCT00974311|3926003|P1|DB Phase (up to 24 Months)|Death|561
1194950|NCT00974311|3926002|P2|DB Phase (up to 24 Months)|Lost to Follow-up|2
1194951|NCT00974311|3926003|P1|DB Phase (up to 24 Months)|Lost to Follow-up|5
1194952|NCT00974233|3926045|P1|Maintenance Lenalidomide|Adverse Event|8
1194953|NCT00974233|3926045|P1|Maintenance Lenalidomide|Lack of Efficacy|5
1194954|NCT00974233|3926045|P1|Induction Chemoimmunotherapy|Withdrawal by Subject|1
1194955|NCT00974233|3926045|P1|Induction Chemoimmunotherapy|Adverse Event|7
1194956|NCT00974233|3926045|P1|Induction Chemoimmunotherapy|Lack of Efficacy|5
1194957|NCT00974233|3926045|P1|Induction Chemoimmunotherapy|Death|2
1194958|NCT00974220|3926060|P2|Treatment Period 1|noncompliant subjects|1
1194959|NCT00974220|3926061|P1|Treatment Period 1|noncompliant subjects|0
1194960|NCT00974220|3926060|P2|Treatment Period 1|Adverse Event|1
1194961|NCT00974220|3926061|P1|Treatment Period 1|Adverse Event|2
1194962|NCT00974090|3926106|P2|Period 2: Open-label Period|Withdrawal by Subject|0
1194963|NCT00974090|3926107|P1|Period 2: Open-label Period|Withdrawal by Subject|1
1194964|NCT00974090|3926106|P2|Period 2: Open-label Period|Physician Decision|3
1194965|NCT00974090|3926107|P1|Period 2: Open-label Period|Physician Decision|0
1194966|NCT00974090|3926106|P2|Period 2: Open-label Period|Lack of Efficacy|1
1194967|NCT00974090|3926107|P1|Period 2: Open-label Period|Lack of Efficacy|3
1194968|NCT00974090|3926106|P2|Period 2: Open-label Period|Adverse Event|6
1194969|NCT00974090|3926107|P1|Period 2: Open-label Period|Adverse Event|4
1194970|NCT00974090|3926106|P2|Period 1: Double Blind Period|Physician Decision|0
1194971|NCT00974090|3926107|P1|Period 1: Double Blind Period|Physician Decision|1
1194972|NCT00974090|3926106|P2|Period 1: Double Blind Period|Adverse Event|1
1194973|NCT00974090|3926107|P1|Period 1: Double Blind Period|Adverse Event|2
1194974|NCT00973973|3926143|P2|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0
1194975|NCT00973973|3926144|P1|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1
1195057|NCT00973349|3926351|P8|Overall Study|Unable to classify|0
1194976|NCT00973973|3926143|P2|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0
1194977|NCT00973973|3926144|P1|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1
1194978|NCT00973973|3926143|P2|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3
1194979|NCT00973973|3926144|P1|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1
1194980|NCT00973973|3926143|P2|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0
1194981|NCT00973973|3926144|P1|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1
1194982|NCT00973973|3926143|P2|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0
1194983|NCT00973973|3926144|P1|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1
1194984|NCT00973973|3926143|P2|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2
1194985|NCT00973973|3926144|P1|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1
1194986|NCT00973973|3926143|P2|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1
1194987|NCT00973973|3926144|P1|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1
1194988|NCT00973973|3926143|P2|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1
1194989|NCT00973973|3926144|P1|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1
1194990|NCT00973973|3926143|P2|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0
1194991|NCT00973973|3926144|P1|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1
1194992|NCT00973973|3926143|P2|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3
1194993|NCT00973973|3926144|P1|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1
1194994|NCT00973973|3926143|P2|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0
1194995|NCT00973973|3926144|P1|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1
1194996|NCT00973973|3926143|P2|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3
1194997|NCT00973973|3926144|P1|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1
1194998|NCT00973921|3926204|P1|Overall Study|IVUS results were not available|9
1194999|NCT00973765|3926213|P2|Overall Study|Lost to Follow-up|14
1195000|NCT00973765|3926214|P1|Overall Study|Lost to Follow-up|8
1195001|NCT00973700|3926236|P5|Overall Study|Unable to Classify|1
1195002|NCT00973700|3926237|P4|Overall Study|Unable to Classify|2
1195003|NCT00973700|3926238|P3|Overall Study|Unable to Classify|1
1195004|NCT00973700|3926239|P2|Overall Study|Unable to Classify|0
1195005|NCT00973700|3926240|P1|Overall Study|Unable to Classify|0
1195006|NCT00973700|3926236|P5|Overall Study|Inappropriate enrolment|0
1195007|NCT00973700|3926237|P4|Overall Study|Inappropriate enrolment|4
1195008|NCT00973700|3926238|P3|Overall Study|Inappropriate enrolment|0
1195009|NCT00973700|3926239|P2|Overall Study|Inappropriate enrolment|0
1195010|NCT00973700|3926240|P1|Overall Study|Inappropriate enrolment|0
1195011|NCT00973700|3926236|P5|Overall Study|Lost to Follow-up|5
1195012|NCT00973700|3926237|P4|Overall Study|Lost to Follow-up|8
1195013|NCT00973700|3926238|P3|Overall Study|Lost to Follow-up|1
1195014|NCT00973700|3926239|P2|Overall Study|Lost to Follow-up|0
1195015|NCT00973700|3926240|P1|Overall Study|Lost to Follow-up|5
1195016|NCT00973700|3926236|P5|Overall Study|Withdrawal by Subject|4
1195017|NCT00973700|3926237|P4|Overall Study|Withdrawal by Subject|4
1195018|NCT00973700|3926238|P3|Overall Study|Withdrawal by Subject|8
1195019|NCT00973700|3926239|P2|Overall Study|Withdrawal by Subject|2
1195020|NCT00973700|3926240|P1|Overall Study|Withdrawal by Subject|2
1195021|NCT00973622|3926289|P2|Overall Study|did not complete rTMS sessions|2
1195022|NCT00973622|3926290|P1|Overall Study|did not complete rTMS sessions|11
1195023|NCT00973622|3926289|P2|Overall Study|did not pass MRI screen|0
1195024|NCT00973622|3926290|P1|Overall Study|did not pass MRI screen|6
1195025|NCT00973622|3926289|P2|Overall Study|did not attend MRI|3
1195026|NCT00973622|3926290|P1|Overall Study|did not attend MRI|14
1195027|NCT00973479|3926298|P2|Overall Study|Not Specified|7
1195028|NCT00973479|3926299|P1|Overall Study|Not Specified|1
1195029|NCT00973479|3926298|P2|Overall Study|Protocol Violation|2
1195030|NCT00973479|3926299|P1|Overall Study|Protocol Violation|2
1195031|NCT00973479|3926298|P2|Overall Study|Adverse Event|32
1195032|NCT00973479|3926299|P1|Overall Study|Adverse Event|12
1195033|NCT00973479|3926298|P2|Overall Study|Lack of Efficacy|7
1195034|NCT00973479|3926299|P1|Overall Study|Lack of Efficacy|5
1195035|NCT00973479|3926298|P2|Overall Study|Withdrawal by Subject|16
1195036|NCT00973479|3926299|P1|Overall Study|Withdrawal by Subject|15
1195037|NCT00973479|3926298|P2|Overall Study|Death|2
1195038|NCT00973479|3926299|P1|Overall Study|Death|2
1195039|NCT00973479|3926298|P2|Overall Study|Lost to Follow-up|3
1195040|NCT00973479|3926299|P1|Overall Study|Lost to Follow-up|0
1195041|NCT00973362|3926317|P2|3-Year Follow-up|Lost to Follow-up|0
1195042|NCT00973362|3926318|P1|3-Year Follow-up|Lost to Follow-up|17
1195043|NCT00973362|3926317|P2|Baseline Evaluation|Inevaluable|223
1195044|NCT00973362|3926318|P1|Baseline Evaluation|Inevaluable|686
1195045|NCT00973362|3926317|P2|Baseline Evaluation|No colposcopy visit|0
1195046|NCT00973362|3926318|P1|Baseline Evaluation|No colposcopy visit|62
1195047|NCT00973362|3926317|P2|Baseline Evaluation|W/D, later determined to be ineligible|0
1195048|NCT00973362|3926318|P1|Baseline Evaluation|W/D, later determined to be ineligible|25
1195049|NCT00973349|3926343|P16|Overall Study|Unable to classify|0
1195050|NCT00973349|3926344|P15|Overall Study|Unable to classify|0
1195051|NCT00973349|3926345|P14|Overall Study|Unable to classify|0
1195052|NCT00973349|3926346|P13|Overall Study|Unable to classify|0
1195053|NCT00973349|3926347|P12|Overall Study|Unable to classify|0
1195054|NCT00973349|3926348|P11|Overall Study|Unable to classify|0
1195055|NCT00973349|3926349|P10|Overall Study|Unable to classify|1
1195056|NCT00973349|3926350|P9|Overall Study|Unable to classify|0
1195058|NCT00973349|3926352|P7|Overall Study|Unable to classify|0
1195059|NCT00973349|3926353|P6|Overall Study|Unable to classify|1
1195060|NCT00973349|3926354|P5|Overall Study|Unable to classify|1
1195061|NCT00973349|3926355|P4|Overall Study|Unable to classify|0
1195062|NCT00973349|3926356|P3|Overall Study|Unable to classify|0
1195063|NCT00973349|3926357|P2|Overall Study|Unable to classify|0
1195064|NCT00973349|3926358|P1|Overall Study|Unable to classify|0
1195065|NCT00973349|3926343|P16|Overall Study|Protocol Violation|0
1195066|NCT00973349|3926344|P15|Overall Study|Protocol Violation|0
1195067|NCT00973349|3926345|P14|Overall Study|Protocol Violation|0
1195068|NCT00973349|3926346|P13|Overall Study|Protocol Violation|0
1195069|NCT00973349|3926347|P12|Overall Study|Protocol Violation|0
1195070|NCT00973349|3926348|P11|Overall Study|Protocol Violation|0
1195071|NCT00973349|3926349|P10|Overall Study|Protocol Violation|0
1195072|NCT00973349|3926350|P9|Overall Study|Protocol Violation|1
1195073|NCT00973349|3926351|P8|Overall Study|Protocol Violation|0
1195074|NCT00973349|3926352|P7|Overall Study|Protocol Violation|0
1195075|NCT00973349|3926353|P6|Overall Study|Protocol Violation|0
1195076|NCT00973349|3926354|P5|Overall Study|Protocol Violation|0
1195077|NCT00973349|3926355|P4|Overall Study|Protocol Violation|0
1195078|NCT00973349|3926356|P3|Overall Study|Protocol Violation|0
1195079|NCT00973349|3926357|P2|Overall Study|Protocol Violation|0
1195080|NCT00973349|3926358|P1|Overall Study|Protocol Violation|0
1195081|NCT00973349|3926343|P16|Overall Study|Inappropriate enrolment|1
1195082|NCT00973349|3926344|P15|Overall Study|Inappropriate enrolment|1
1195083|NCT00973349|3926345|P14|Overall Study|Inappropriate enrolment|0
1195084|NCT00973349|3926346|P13|Overall Study|Inappropriate enrolment|1
1195085|NCT00973349|3926347|P12|Overall Study|Inappropriate enrolment|0
1195086|NCT00973349|3926348|P11|Overall Study|Inappropriate enrolment|0
1195087|NCT00973349|3926349|P10|Overall Study|Inappropriate enrolment|2
1195088|NCT00973349|3926350|P9|Overall Study|Inappropriate enrolment|0
1195089|NCT00973349|3926351|P8|Overall Study|Inappropriate enrolment|0
1195090|NCT00973349|3926352|P7|Overall Study|Inappropriate enrolment|0
1195091|NCT00973349|3926353|P6|Overall Study|Inappropriate enrolment|0
1195092|NCT00973349|3926354|P5|Overall Study|Inappropriate enrolment|0
1195093|NCT00973349|3926355|P4|Overall Study|Inappropriate enrolment|0
1195094|NCT00973349|3926356|P3|Overall Study|Inappropriate enrolment|1
1195095|NCT00973349|3926357|P2|Overall Study|Inappropriate enrolment|0
1195096|NCT00973349|3926358|P1|Overall Study|Inappropriate enrolment|0
1195097|NCT00973349|3926343|P16|Overall Study|Lost to Follow-up|1
1195098|NCT00973349|3926344|P15|Overall Study|Lost to Follow-up|0
1195099|NCT00973349|3926345|P14|Overall Study|Lost to Follow-up|0
1195100|NCT00973349|3926346|P13|Overall Study|Lost to Follow-up|0
1195101|NCT00973349|3926347|P12|Overall Study|Lost to Follow-up|1
1195102|NCT00973349|3926348|P11|Overall Study|Lost to Follow-up|0
1195103|NCT00973349|3926349|P10|Overall Study|Lost to Follow-up|1
1195104|NCT00973349|3926350|P9|Overall Study|Lost to Follow-up|2
1195105|NCT00973349|3926351|P8|Overall Study|Lost to Follow-up|1
1195106|NCT00973349|3926352|P7|Overall Study|Lost to Follow-up|0
1195107|NCT00973349|3926353|P6|Overall Study|Lost to Follow-up|3
1195108|NCT00973349|3926354|P5|Overall Study|Lost to Follow-up|1
1195109|NCT00973349|3926355|P4|Overall Study|Lost to Follow-up|2
1195110|NCT00973349|3926356|P3|Overall Study|Lost to Follow-up|2
1195111|NCT00973349|3926357|P2|Overall Study|Lost to Follow-up|1
1195112|NCT00973349|3926358|P1|Overall Study|Lost to Follow-up|3
1195113|NCT00973349|3926343|P16|Overall Study|Withdrawal by Subject|0
1195114|NCT00973349|3926344|P15|Overall Study|Withdrawal by Subject|0
1195115|NCT00973349|3926345|P14|Overall Study|Withdrawal by Subject|0
1195116|NCT00973349|3926346|P13|Overall Study|Withdrawal by Subject|0
1195117|NCT00973349|3926347|P12|Overall Study|Withdrawal by Subject|1
1195118|NCT00973349|3926348|P11|Overall Study|Withdrawal by Subject|0
1195119|NCT00973349|3926349|P10|Overall Study|Withdrawal by Subject|2
1195120|NCT00973349|3926350|P9|Overall Study|Withdrawal by Subject|0
1195121|NCT00973349|3926351|P8|Overall Study|Withdrawal by Subject|2
1195122|NCT00973349|3926352|P7|Overall Study|Withdrawal by Subject|2
1195123|NCT00973349|3926353|P6|Overall Study|Withdrawal by Subject|0
1195124|NCT00973349|3926354|P5|Overall Study|Withdrawal by Subject|2
1195125|NCT00973349|3926355|P4|Overall Study|Withdrawal by Subject|3
1195126|NCT00973349|3926356|P3|Overall Study|Withdrawal by Subject|2
1195127|NCT00973349|3926357|P2|Overall Study|Withdrawal by Subject|2
1195128|NCT00973349|3926358|P1|Overall Study|Withdrawal by Subject|1
1195129|NCT00973349|3926343|P16|Overall Study|Adverse Event|0
1195130|NCT00973349|3926344|P15|Overall Study|Adverse Event|1
1195131|NCT00973349|3926345|P14|Overall Study|Adverse Event|0
1195132|NCT00973349|3926346|P13|Overall Study|Adverse Event|0
1195133|NCT00973349|3926347|P12|Overall Study|Adverse Event|0
1195134|NCT00973349|3926348|P11|Overall Study|Adverse Event|0
1195135|NCT00973349|3926349|P10|Overall Study|Adverse Event|0
1195136|NCT00973349|3926350|P9|Overall Study|Adverse Event|1
1195137|NCT00973349|3926351|P8|Overall Study|Adverse Event|0
1195138|NCT00973349|3926352|P7|Overall Study|Adverse Event|0
1195139|NCT00973349|3926353|P6|Overall Study|Adverse Event|0
1195140|NCT00973349|3926354|P5|Overall Study|Adverse Event|1
1195141|NCT00973349|3926355|P4|Overall Study|Adverse Event|0
1195142|NCT00973349|3926356|P3|Overall Study|Adverse Event|0
1195143|NCT00973349|3926357|P2|Overall Study|Adverse Event|0
1195144|NCT00973349|3926358|P1|Overall Study|Adverse Event|0
1195145|NCT00972816|3926479|P8|Overall Study|Unable to classify|0
1195146|NCT00972816|3926480|P7|Overall Study|Unable to classify|0
1195147|NCT00972816|3926481|P6|Overall Study|Unable to classify|0
1195148|NCT00972816|3926482|P5|Overall Study|Unable to classify|1
1195149|NCT00972816|3926483|P4|Overall Study|Unable to classify|0
1195150|NCT00972816|3926484|P3|Overall Study|Unable to classify|0
1195151|NCT00972816|3926485|P2|Overall Study|Unable to classify|0
1195152|NCT00972816|3926486|P1|Overall Study|Unable to classify|2
1195153|NCT00972816|3926479|P8|Overall Study|Inappropriate enrolment|0
1195154|NCT00972816|3926480|P7|Overall Study|Inappropriate enrolment|2
1195155|NCT00972816|3926481|P6|Overall Study|Inappropriate enrolment|0
1195156|NCT00972816|3926482|P5|Overall Study|Inappropriate enrolment|0
1195157|NCT00972816|3926483|P4|Overall Study|Inappropriate enrolment|0
1195158|NCT00972816|3926484|P3|Overall Study|Inappropriate enrolment|0
1195159|NCT00972816|3926485|P2|Overall Study|Inappropriate enrolment|0
1195160|NCT00972816|3926486|P1|Overall Study|Inappropriate enrolment|0
1195161|NCT00972816|3926479|P8|Overall Study|Lost to Follow-up|7
1195162|NCT00972816|3926480|P7|Overall Study|Lost to Follow-up|7
1195163|NCT00972816|3926481|P6|Overall Study|Lost to Follow-up|10
1195164|NCT00972816|3926482|P5|Overall Study|Lost to Follow-up|11
1195165|NCT00972816|3926483|P4|Overall Study|Lost to Follow-up|5
1195166|NCT00972816|3926484|P3|Overall Study|Lost to Follow-up|7
1195167|NCT00972816|3926485|P2|Overall Study|Lost to Follow-up|9
1195168|NCT00972816|3926486|P1|Overall Study|Lost to Follow-up|11
1195169|NCT00972816|3926479|P8|Overall Study|Withdrawal by Subject|2
1195170|NCT00972816|3926480|P7|Overall Study|Withdrawal by Subject|1
1195171|NCT00972816|3926481|P6|Overall Study|Withdrawal by Subject|1
1195172|NCT00972816|3926482|P5|Overall Study|Withdrawal by Subject|0
1195173|NCT00972816|3926483|P4|Overall Study|Withdrawal by Subject|3
1195174|NCT00972816|3926484|P3|Overall Study|Withdrawal by Subject|1
1195175|NCT00972816|3926485|P2|Overall Study|Withdrawal by Subject|2
1195176|NCT00972816|3926486|P1|Overall Study|Withdrawal by Subject|4
1195177|NCT00972816|3926479|P8|Overall Study|Adverse Event|0
1195178|NCT00972816|3926480|P7|Overall Study|Adverse Event|0
1195179|NCT00972816|3926481|P6|Overall Study|Adverse Event|0
1195180|NCT00972816|3926482|P5|Overall Study|Adverse Event|0
1195181|NCT00972816|3926483|P4|Overall Study|Adverse Event|0
1195182|NCT00972816|3926484|P3|Overall Study|Adverse Event|1
1195183|NCT00972816|3926485|P2|Overall Study|Adverse Event|0
1195184|NCT00972816|3926486|P1|Overall Study|Adverse Event|0
1195185|NCT00972777|3926570|P2|Overall Study|Missed visit|0
1195186|NCT00972777|3926571|P1|Overall Study|Missed visit|1
1195187|NCT00972777|3926570|P2|Overall Study|Screening Failure|1
1195188|NCT00972777|3926571|P1|Overall Study|Screening Failure|2
1195189|NCT00972777|3926570|P2|Overall Study|Protocol Violation|2
1195190|NCT00972777|3926571|P1|Overall Study|Protocol Violation|0
1195191|NCT00972777|3926570|P2|Overall Study|Physician Decision|0
1195192|NCT00972777|3926571|P1|Overall Study|Physician Decision|4
1195193|NCT00972777|3926570|P2|Overall Study|Withdrawal by Subject|5
1195194|NCT00972777|3926571|P1|Overall Study|Withdrawal by Subject|4
1195195|NCT00972777|3926570|P2|Overall Study|Lost to Follow-up|4
1195196|NCT00972777|3926571|P1|Overall Study|Lost to Follow-up|0
1195197|NCT00972777|3926570|P2|Overall Study|Adverse Event|2
1195198|NCT00972777|3926571|P1|Overall Study|Adverse Event|3
1195199|NCT00972738|3926586|P3|Overall Study|Other|1
1195200|NCT00972738|3926587|P2|Overall Study|Other|2
1195201|NCT00972738|3926588|P1|Overall Study|Other|1
1195202|NCT00972738|3926586|P3|Overall Study|Moved|1
1195203|NCT00972738|3926587|P2|Overall Study|Moved|0
1195204|NCT00972738|3926588|P1|Overall Study|Moved|0
1195205|NCT00972738|3926586|P3|Overall Study|Withdrawal by Subject|4
1195206|NCT00972738|3926587|P2|Overall Study|Withdrawal by Subject|1
1195207|NCT00972738|3926588|P1|Overall Study|Withdrawal by Subject|5
1195208|NCT00972738|3926586|P3|Overall Study|Lack of Efficacy|11
1195209|NCT00972738|3926587|P2|Overall Study|Lack of Efficacy|1
1195210|NCT00972738|3926588|P1|Overall Study|Lack of Efficacy|5
1195211|NCT00972738|3926586|P3|Overall Study|Lost to Follow-up|1
1195212|NCT00972738|3926587|P2|Overall Study|Lost to Follow-up|0
1195213|NCT00972738|3926588|P1|Overall Study|Lost to Follow-up|1
1195214|NCT00972738|3926586|P3|Overall Study|Protocol Violation|3
1195215|NCT00972738|3926587|P2|Overall Study|Protocol Violation|1
1195216|NCT00972738|3926588|P1|Overall Study|Protocol Violation|2
1195217|NCT00972738|3926586|P3|Overall Study|Adverse Event|8
1195218|NCT00972738|3926587|P2|Overall Study|Adverse Event|1
1195219|NCT00972738|3926588|P1|Overall Study|Adverse Event|7
1195220|NCT00972595|3926705|P2|Period 1|Adverse Event|0
1195221|NCT00972595|3926706|P1|Period 1|Adverse Event|1
1195222|NCT00972543|3926716|P2|Overall Study|Early study termination by sponsor|1
1195223|NCT00972543|3926717|P1|Overall Study|Early study termination by sponsor|4
1195224|NCT00972543|3926716|P2|Overall Study|Adverse Event|0
1195225|NCT00972543|3926717|P1|Overall Study|Adverse Event|1
1195226|NCT00972517|3926800|P6|Overall Study|Withdrawal by Subject|0
1195227|NCT00972517|3926801|P5|Overall Study|Withdrawal by Subject|1
1195228|NCT00972517|3926802|P4|Overall Study|Withdrawal by Subject|2
1195229|NCT00972517|3926803|P3|Overall Study|Withdrawal by Subject|0
1195230|NCT00972517|3926804|P2|Overall Study|Withdrawal by Subject|1
1195231|NCT00972517|3926805|P1|Overall Study|Withdrawal by Subject|0
1195232|NCT00972517|3926800|P6|Overall Study|Adverse Event|0
1195233|NCT00972517|3926801|P5|Overall Study|Adverse Event|0
1195234|NCT00972517|3926802|P4|Overall Study|Adverse Event|1
1195235|NCT00972517|3926803|P3|Overall Study|Adverse Event|0
1195236|NCT00972517|3926804|P2|Overall Study|Adverse Event|0
1195237|NCT00972517|3926805|P1|Overall Study|Adverse Event|0
1195238|NCT00972504|3926900|P1|Overall Study|Investigator discretion|1
1195239|NCT00972504|3926900|P1|Overall Study|Adverse Event|2
1195240|NCT00972478|3926932|P2|Overall Study|Not start protocol treatment|2
1195241|NCT00972478|3926933|P1|Overall Study|Not start protocol treatment|1
1195242|NCT00972478|3926932|P2|Overall Study|Ineligible|7
1195243|NCT00972478|3926933|P1|Overall Study|Ineligible|1
1195244|NCT00972478|3926932|P2|Overall Study|Not protocol specified|1
1195245|NCT00972478|3926933|P1|Overall Study|Not protocol specified|1
1195246|NCT00972478|3926932|P2|Overall Study|Death|2
1195247|NCT00972478|3926933|P1|Overall Study|Death|0
1195248|NCT00972478|3926932|P2|Overall Study|Progression/Relapse|2
1195249|NCT00972478|3926933|P1|Overall Study|Progression/Relapse|0
1195250|NCT00972478|3926932|P2|Overall Study|Withdrawal by Subject|8
1195251|NCT00972478|3926933|P1|Overall Study|Withdrawal by Subject|1
1195252|NCT00972478|3926932|P2|Overall Study|Adverse Event|16
1195253|NCT00972478|3926933|P1|Overall Study|Adverse Event|3
1195254|NCT00972322|3926978|P2|Overall Study|Consistently high glucose values|0
1195255|NCT00972322|3926979|P1|Overall Study|Consistently high glucose values|1
1195256|NCT00972322|3926978|P2|Overall Study|Lost to Follow-up|1
1195257|NCT00972322|3926979|P1|Overall Study|Lost to Follow-up|0
1195258|NCT00972322|3926978|P2|Overall Study|Positive drug screen|1
1195259|NCT00972322|3926979|P1|Overall Study|Positive drug screen|0
1195260|NCT00972322|3926978|P2|Overall Study|Adverse Event|1
1195261|NCT00972322|3926979|P1|Overall Study|Adverse Event|2
1195262|NCT00972283|3926991|P2|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5
1195263|NCT00972283|3926992|P1|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11
1195264|NCT00972283|3926991|P2|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2
1195265|NCT00972283|3926992|P1|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6
1195266|NCT00972283|3926991|P2|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0
1195267|NCT00972283|3926992|P1|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5
1195268|NCT00972283|3926991|P2|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
1195269|NCT00972283|3926992|P1|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
1195270|NCT00972283|3926991|P2|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0
1195271|NCT00972283|3926992|P1|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4
1195272|NCT00972283|3926991|P2|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17
1195273|NCT00972283|3926992|P1|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72
1195274|NCT00972283|3926991|P2|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2
1195275|NCT00972283|3926992|P1|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8
1195276|NCT00972283|3926991|P2|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12
1195277|NCT00972283|3926992|P1|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23
1195278|NCT00972283|3926991|P2|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0
1195279|NCT00972283|3926992|P1|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3
1195280|NCT00972283|3926991|P2|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9
1195281|NCT00972283|3926992|P1|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31
1195282|NCT00972244|3927019|P5|Overall Study|Various|2
1195283|NCT00972244|3927020|P4|Overall Study|Various|0
1195284|NCT00972244|3927021|P3|Overall Study|Various|0
1195285|NCT00972244|3927022|P2|Overall Study|Various|0
1195286|NCT00972244|3927023|P1|Overall Study|Various|0
1195287|NCT00972244|3927019|P5|Overall Study|Death|0
1195288|NCT00972244|3927020|P4|Overall Study|Death|0
1195289|NCT00972244|3927021|P3|Overall Study|Death|0
1195290|NCT00972244|3927022|P2|Overall Study|Death|0
1195291|NCT00972244|3927023|P1|Overall Study|Death|1
1195292|NCT00972244|3927019|P5|Overall Study|Safety|1
1195293|NCT00972244|3927020|P4|Overall Study|Safety|0
1195294|NCT00972244|3927021|P3|Overall Study|Safety|0
1195295|NCT00972244|3927022|P2|Overall Study|Safety|0
1195296|NCT00972244|3927023|P1|Overall Study|Safety|0
1195297|NCT00972244|3927019|P5|Overall Study|Withdrawal by Subject|1
1195298|NCT00972244|3927020|P4|Overall Study|Withdrawal by Subject|0
1195299|NCT00972244|3927021|P3|Overall Study|Withdrawal by Subject|1
1195300|NCT00972244|3927022|P2|Overall Study|Withdrawal by Subject|2
1195301|NCT00972244|3927023|P1|Overall Study|Withdrawal by Subject|1
1195302|NCT00972244|3927019|P5|Overall Study|Subject No Longer Meets Study Criteria|5
1195303|NCT00972244|3927020|P4|Overall Study|Subject No Longer Meets Study Criteria|0
1195304|NCT00972244|3927021|P3|Overall Study|Subject No Longer Meets Study Criteria|0
1195305|NCT00972244|3927022|P2|Overall Study|Subject No Longer Meets Study Criteria|2
1195306|NCT00972244|3927023|P1|Overall Study|Subject No Longer Meets Study Criteria|2
1195307|NCT00972244|3927019|P5|Overall Study|Adverse Event|0
1195308|NCT00972244|3927020|P4|Overall Study|Adverse Event|0
1195309|NCT00972244|3927021|P3|Overall Study|Adverse Event|1
1195310|NCT00972244|3927022|P2|Overall Study|Adverse Event|1
1195311|NCT00972244|3927023|P1|Overall Study|Adverse Event|0
1195312|NCT00972244|3927019|P5|Overall Study|Incorrect Enrolment|0
1195313|NCT00972244|3927020|P4|Overall Study|Incorrect Enrolment|0
1195314|NCT00972244|3927021|P3|Overall Study|Incorrect Enrolment|0
1195315|NCT00972244|3927022|P2|Overall Study|Incorrect Enrolment|0
1195316|NCT00972244|3927023|P1|Overall Study|Incorrect Enrolment|1
1195317|NCT00972153|3927055|P3|Overall Study|Equipment malfunction during case|0
1195318|NCT00972153|3927056|P2|Overall Study|Equipment malfunction during case|1
1195319|NCT00972153|3927057|P1|Overall Study|Equipment malfunction during case|0
1195320|NCT00972023|3927072|P1|Overall Study|Withdrawal by Subject|1
1195321|NCT00971997|3927079|P1|Overall Study|Physician Decision|7
1195322|NCT00971997|3927079|P1|Overall Study|Withdrawal by Subject|5
1195323|NCT00971997|3927079|P1|Overall Study|Protocol Violation|4
1195324|NCT00971997|3927079|P1|Overall Study|Death|1
1195325|NCT00971997|3927079|P1|Overall Study|Adverse Event|2
1195326|NCT00971932|3927097|P1|Overall Study|Ongoing|4
1195327|NCT00971932|3927097|P1|Overall Study|Investigator's decision|2
1195328|NCT00971932|3927097|P1|Overall Study|Withdrawal by Subject|1
1195329|NCT00971425|3927177|P2|Overall Study|Withdrawal by Subject|1
1195330|NCT00971425|3927178|P1|Overall Study|Withdrawal by Subject|0
1195331|NCT00971425|3927177|P2|Overall Study|Adverse Event|1
1195332|NCT00971425|3927178|P1|Overall Study|Adverse Event|1
1195333|NCT00971243|3927242|P5|Open-label Period|Other reason|2
1195334|NCT00971243|3927243|P4|Open-label Period|Other reason|0
1195335|NCT00971243|3927244|P3|Open-label Period|Other reason|0
1195336|NCT00971243|3927245|P2|Open-label Period|Other reason|0
1195337|NCT00971243|3927246|P1|Open-label Period|Other reason|0
1195338|NCT00971243|3927242|P5|Open-label Period|Withdrawal by Subject|1
1195339|NCT00971243|3927243|P4|Open-label Period|Withdrawal by Subject|2
1195340|NCT00971243|3927244|P3|Open-label Period|Withdrawal by Subject|0
1195341|NCT00971243|3927245|P2|Open-label Period|Withdrawal by Subject|0
1195342|NCT00971243|3927246|P1|Open-label Period|Withdrawal by Subject|1
1195343|NCT00971243|3927242|P5|Open-label Period|Protocol Violation|1
1195344|NCT00971243|3927243|P4|Open-label Period|Protocol Violation|0
1195345|NCT00971243|3927244|P3|Open-label Period|Protocol Violation|1
1195346|NCT00971243|3927245|P2|Open-label Period|Protocol Violation|1
1195347|NCT00971243|3927246|P1|Open-label Period|Protocol Violation|1
1195348|NCT00971243|3927242|P5|Open-label Period|Physician Decision|2
1195349|NCT00971243|3927243|P4|Open-label Period|Physician Decision|7
1195350|NCT00971243|3927244|P3|Open-label Period|Physician Decision|3
1195351|NCT00971243|3927245|P2|Open-label Period|Physician Decision|9
1195352|NCT00971243|3927246|P1|Open-label Period|Physician Decision|5
1195353|NCT00971243|3927242|P5|Open-label Period|Adverse Event|0
1195354|NCT00971243|3927243|P4|Open-label Period|Adverse Event|1
1195355|NCT00971243|3927244|P3|Open-label Period|Adverse Event|1
1195356|NCT00971243|3927245|P2|Open-label Period|Adverse Event|0
1195357|NCT00971243|3927246|P1|Open-label Period|Adverse Event|1
1195358|NCT00971243|3927242|P5|Double Blind Period|Other reasons|1
1195359|NCT00971243|3927243|P4|Double Blind Period|Other reasons|0
1195360|NCT00971243|3927244|P3|Double Blind Period|Other reasons|2
1195361|NCT00971243|3927245|P2|Double Blind Period|Other reasons|0
1195362|NCT00971243|3927246|P1|Double Blind Period|Other reasons|1
1195363|NCT00971243|3927242|P5|Double Blind Period|Withdrawal by Subject|4
1195364|NCT00971243|3927243|P4|Double Blind Period|Withdrawal by Subject|4
1195365|NCT00971243|3927244|P3|Double Blind Period|Withdrawal by Subject|4
1195366|NCT00971243|3927245|P2|Double Blind Period|Withdrawal by Subject|1
1195367|NCT00971243|3927246|P1|Double Blind Period|Withdrawal by Subject|4
1195368|NCT00971243|3927242|P5|Double Blind Period|Protocol Violation|2
1195369|NCT00971243|3927243|P4|Double Blind Period|Protocol Violation|2
1195370|NCT00971243|3927244|P3|Double Blind Period|Protocol Violation|3
1195371|NCT00971243|3927245|P2|Double Blind Period|Protocol Violation|0
1195372|NCT00971243|3927246|P1|Double Blind Period|Protocol Violation|2
1195373|NCT00971243|3927242|P5|Double Blind Period|Physician Decision|7
1195374|NCT00971243|3927243|P4|Double Blind Period|Physician Decision|6
1195375|NCT00971243|3927244|P3|Double Blind Period|Physician Decision|7
1195376|NCT00971243|3927245|P2|Double Blind Period|Physician Decision|6
1195377|NCT00971243|3927246|P1|Double Blind Period|Physician Decision|10
1195378|NCT00971243|3927242|P5|Double Blind Period|Lost to Follow-up|1
1195379|NCT00971243|3927243|P4|Double Blind Period|Lost to Follow-up|0
1195380|NCT00971243|3927244|P3|Double Blind Period|Lost to Follow-up|1
1195381|NCT00971243|3927245|P2|Double Blind Period|Lost to Follow-up|1
1195382|NCT00971243|3927246|P1|Double Blind Period|Lost to Follow-up|0
1195383|NCT00971243|3927242|P5|Double Blind Period|Adverse Event|3
1195384|NCT00971243|3927243|P4|Double Blind Period|Adverse Event|2
1195385|NCT00971243|3927244|P3|Double Blind Period|Adverse Event|2
1195386|NCT00971243|3927245|P2|Double Blind Period|Adverse Event|3
1195387|NCT00971243|3927246|P1|Double Blind Period|Adverse Event|2
1195388|NCT00971204|3927263|P1|Overall Study|Lost to Follow-up|10
1195389|NCT00971204|3927263|P1|Overall Study|Did not meet all criteria-not treated|14
1195390|NCT00971048|3927271|P4|Overall Study|Physician Decision|1
1195391|NCT00971048|3927272|P3|Overall Study|Physician Decision|0
1195392|NCT00971048|3927273|P2|Overall Study|Physician Decision|0
1195393|NCT00971048|3927274|P1|Overall Study|Physician Decision|0
1195394|NCT00971048|3927271|P4|Overall Study|Adverse Event|0
1195395|NCT00971048|3927272|P3|Overall Study|Adverse Event|1
1195396|NCT00971048|3927273|P2|Overall Study|Adverse Event|0
1195397|NCT00971048|3927274|P1|Overall Study|Adverse Event|0
1195398|NCT00971048|3927271|P4|Overall Study|Protocol Violation|1
1195399|NCT00971048|3927272|P3|Overall Study|Protocol Violation|0
1195400|NCT00971048|3927273|P2|Overall Study|Protocol Violation|2
1195401|NCT00971048|3927274|P1|Overall Study|Protocol Violation|1
1195402|NCT00970944|3927298|P2|Overall Study|Physician Decision|2
1195403|NCT00970944|3927299|P1|Overall Study|Physician Decision|0
1195404|NCT00970944|3927298|P2|Overall Study|Death|0
1195405|NCT00970944|3927299|P1|Overall Study|Death|1
1195406|NCT00970684|3927351|P1|Overall Study|Withdrawal by Subject|1
1195407|NCT00970684|3927351|P1|Overall Study|Adverse Event|4
1195408|NCT00970684|3927351|P1|Overall Study|Lack of Efficacy|5
1195409|NCT00970632|3927360|P3|Overall Study|Sponsor decision|1
1195410|NCT00970632|3927361|P2|Overall Study|Sponsor decision|0
1195411|NCT00970632|3927362|P1|Overall Study|Sponsor decision|1
1195412|NCT00970632|3927360|P3|Overall Study|Entry criteria not met|2
1195413|NCT00970632|3927361|P2|Overall Study|Entry criteria not met|2
1195414|NCT00970632|3927362|P1|Overall Study|Entry criteria not met|0
1195415|NCT00970632|3927360|P3|Overall Study|Withdrawal by Subject|4
1195416|NCT00970632|3927361|P2|Overall Study|Withdrawal by Subject|6
1195417|NCT00970632|3927362|P1|Overall Study|Withdrawal by Subject|7
1195418|NCT00970632|3927360|P3|Overall Study|Protocol Violation|8
1195419|NCT00970632|3927361|P2|Overall Study|Protocol Violation|5
1195420|NCT00970632|3927362|P1|Overall Study|Protocol Violation|8
1195421|NCT00970632|3927360|P3|Overall Study|Lost to Follow-up|2
1195422|NCT00970632|3927361|P2|Overall Study|Lost to Follow-up|0
1195423|NCT00970632|3927362|P1|Overall Study|Lost to Follow-up|3
1195424|NCT00970632|3927360|P3|Overall Study|Lack of Efficacy|0
1195425|NCT00970632|3927361|P2|Overall Study|Lack of Efficacy|0
1195426|NCT00970632|3927362|P1|Overall Study|Lack of Efficacy|3
1195427|NCT00970632|3927360|P3|Overall Study|Adverse Event|1
1195428|NCT00970632|3927361|P2|Overall Study|Adverse Event|2
1195429|NCT00970632|3927362|P1|Overall Study|Adverse Event|2
1195430|NCT00970502|3927427|P1|Overall Study|Withdrawal by Subject|1
1195431|NCT00970489|3927438|P2|Overall Study|Death/Withdrew/Criteria Violation|41
1195432|NCT00970489|3927439|P1|Overall Study|Death/Withdrew/Criteria Violation|54
1195433|NCT00970359|3927451|P1|Overall Study|Not Treated|4
1195434|NCT00970307|3927481|P3|Overall Study|Withdrawal by Subject|2
1195435|NCT00970307|3927482|P2|Overall Study|Withdrawal by Subject|3
1195436|NCT00970307|3927483|P1|Overall Study|Withdrawal by Subject|2
1195437|NCT00970307|3927481|P3|Overall Study|Serious Adverse Event|0
1195438|NCT00970307|3927482|P2|Overall Study|Serious Adverse Event|0
1195439|NCT00970307|3927483|P1|Overall Study|Serious Adverse Event|1
1195440|NCT00970294|3927557|P1|Overall Study|Withdrawal by Subject|1
1195441|NCT00970294|3927557|P1|Overall Study|Physician Decision|4
1195442|NCT00970281|3927565|P2|Overall Study|Physician Decision|1
1195443|NCT00970281|3927566|P1|Overall Study|Physician Decision|1
1195444|NCT00970281|3927565|P2|Overall Study|Withdrawal by Subject|1
1195445|NCT00970281|3927566|P1|Overall Study|Withdrawal by Subject|0
1195446|NCT00970281|3927565|P2|Overall Study|Lack of Efficacy|14
1195447|NCT00970281|3927566|P1|Overall Study|Lack of Efficacy|1
1195448|NCT00970268|3927584|P2|Overall Study|Inclusion/Exclusion Criteria|0
1195449|NCT00970268|3927585|P1|Overall Study|Inclusion/Exclusion Criteria|1
1195450|NCT00970268|3927584|P2|Overall Study|Lost to Follow-up|2
1195451|NCT00970268|3927585|P1|Overall Study|Lost to Follow-up|1
1195452|NCT00970268|3927584|P2|Overall Study|COPD Exacerbation|2
1195453|NCT00970268|3927585|P1|Overall Study|COPD Exacerbation|4
1195454|NCT00970268|3927584|P2|Overall Study|Other Reason|1
1195455|NCT00970268|3927585|P1|Overall Study|Other Reason|3
1195456|NCT00970268|3927584|P2|Overall Study|Protocol Violation|7
1195457|NCT00970268|3927585|P1|Overall Study|Protocol Violation|4
1195458|NCT00970268|3927584|P2|Overall Study|Lack of Efficacy|6
1195459|NCT00970268|3927585|P1|Overall Study|Lack of Efficacy|3
1195460|NCT00970268|3927584|P2|Overall Study|Adverse Event|12
1195461|NCT00970268|3927585|P1|Overall Study|Adverse Event|15
1195462|NCT00970268|3927584|P2|Overall Study|Withdrawal by Subject|19
1195463|NCT00970268|3927585|P1|Overall Study|Withdrawal by Subject|12
1195464|NCT00969709|3927640|P4|Overall Study|Other reasons|0
1195465|NCT00969709|3927641|P3|Overall Study|Other reasons|3
1195466|NCT00969709|3927642|P2|Overall Study|Other reasons|0
1195467|NCT00969709|3927643|P1|Overall Study|Other reasons|0
1195468|NCT00969709|3927640|P4|Overall Study|Lost to Follow-up|15
1195469|NCT00969709|3927641|P3|Overall Study|Lost to Follow-up|8
1195470|NCT00969709|3927642|P2|Overall Study|Lost to Follow-up|14
1195471|NCT00969709|3927643|P1|Overall Study|Lost to Follow-up|10
1195472|NCT00969709|3927640|P4|Overall Study|Withdrawal by Subject|23
1195473|NCT00969709|3927641|P3|Overall Study|Withdrawal by Subject|11
1195474|NCT00969709|3927642|P2|Overall Study|Withdrawal by Subject|12
1195475|NCT00969709|3927643|P1|Overall Study|Withdrawal by Subject|9
1195476|NCT00969709|3927640|P4|Overall Study|Protocol Violation|10
1195477|NCT00969709|3927641|P3|Overall Study|Protocol Violation|9
1195478|NCT00969709|3927642|P2|Overall Study|Protocol Violation|5
1195479|NCT00969709|3927643|P1|Overall Study|Protocol Violation|9
1195480|NCT00969709|3927640|P4|Overall Study|Lack of Efficacy|3
1195481|NCT00969709|3927641|P3|Overall Study|Lack of Efficacy|1
1195482|NCT00969709|3927642|P2|Overall Study|Lack of Efficacy|4
1195483|NCT00969709|3927643|P1|Overall Study|Lack of Efficacy|7
1195484|NCT00969709|3927640|P4|Overall Study|Adverse Event|12
1195485|NCT00969709|3927641|P3|Overall Study|Adverse Event|26
1195486|NCT00969709|3927642|P2|Overall Study|Adverse Event|13
1195487|NCT00969709|3927643|P1|Overall Study|Adverse Event|3
1195488|NCT00969618|3927657|P1|Overall Study|Withdrawal by Subject|27
1195489|NCT00969618|3927657|P1|Overall Study|Protocol Violation|9
1195490|NCT00969618|3927657|P1|Overall Study|Physician Decision|1
1195491|NCT00969618|3927657|P1|Overall Study|Lost to Follow-up|7
1195492|NCT00969618|3927657|P1|Overall Study|Lack of Efficacy|2
1195493|NCT00969618|3927657|P1|Overall Study|Entry Criteria Not Met|3
1195494|NCT00969618|3927657|P1|Overall Study|Adverse Event|29
1195495|NCT00969540|3927670|P2|Overall Study|Lost to Follow-up|1
1195496|NCT00969540|3927671|P1|Overall Study|Lost to Follow-up|1
1195497|NCT00969436|3927696|P3|Overall Study|Lost to Follow-up|5
1195498|NCT00969436|3927697|P2|Overall Study|Lost to Follow-up|8
1195499|NCT00969436|3927698|P1|Overall Study|Lost to Follow-up|8
1195500|NCT00969436|3927696|P3|Overall Study|Withdrawal by Subject|2
1195501|NCT00969436|3927697|P2|Overall Study|Withdrawal by Subject|0
1195502|NCT00969436|3927698|P1|Overall Study|Withdrawal by Subject|3
1195503|NCT00969436|3927696|P3|Overall Study|Subject eliminated (other vaccine)|0
1195504|NCT00969436|3927697|P2|Overall Study|Subject eliminated (other vaccine)|0
1195505|NCT00969436|3927698|P1|Overall Study|Subject eliminated (other vaccine)|1
1195506|NCT00969436|3927696|P3|Overall Study|Parents personal problem|1
1195507|NCT00969436|3927697|P2|Overall Study|Parents personal problem|0
1195508|NCT00969436|3927698|P1|Overall Study|Parents personal problem|0
1195509|NCT00969436|3927696|P3|Overall Study|Father - serious health problem|1
1195510|NCT00969436|3927697|P2|Overall Study|Father - serious health problem|0
1195511|NCT00969436|3927698|P1|Overall Study|Father - serious health problem|0
1195512|NCT00969436|3927696|P3|Overall Study|Migrated/moved from study area|2
1195513|NCT00969436|3927697|P2|Overall Study|Migrated/moved from study area|10
1195514|NCT00969436|3927698|P1|Overall Study|Migrated/moved from study area|12
1195515|NCT00969436|3927696|P3|Overall Study|Protocol Violation|0
1195516|NCT00969436|3927697|P2|Overall Study|Protocol Violation|3
1195517|NCT00969436|3927698|P1|Overall Study|Protocol Violation|1
1195518|NCT00969280|3927732|P2|Overall Study|infection of influenza A(H1N1)|1
1195519|NCT00969280|3927733|P1|Overall Study|infection of influenza A(H1N1)|0
1195520|NCT00969280|3927732|P2|Overall Study|Withdrawal by Subject|1
1195521|NCT00969280|3927733|P1|Overall Study|Withdrawal by Subject|0
1195522|NCT00969280|3927732|P2|Overall Study|Protocol Violation|1
1195523|NCT00969280|3927733|P1|Overall Study|Protocol Violation|2
1195524|NCT00969228|3927741|P2|Overall Study|Porcine circovirus detection in vaccine|14
1195525|NCT00969228|3927742|P1|Overall Study|Porcine circovirus detection in vaccine|38
1195526|NCT00969228|3927741|P2|Overall Study|Withdrawal by Subject|0
1195527|NCT00969228|3927742|P1|Overall Study|Withdrawal by Subject|4
1195528|NCT00969228|3927741|P2|Overall Study|Adverse Event|0
1195529|NCT00969228|3927742|P1|Overall Study|Adverse Event|1
1195530|NCT00969150|3927760|P2|Overall Study|Other reasons|0
1195531|NCT00969150|3927761|P1|Overall Study|Other reasons|1
1195532|NCT00969150|3927760|P2|Overall Study|Lost to Follow-up|4
1195533|NCT00969150|3927761|P1|Overall Study|Lost to Follow-up|5
1195534|NCT00969150|3927760|P2|Overall Study|Withdrawal by Subject|9
1195535|NCT00969150|3927761|P1|Overall Study|Withdrawal by Subject|13
1195536|NCT00969150|3927760|P2|Overall Study|Protocol Violation|12
1195537|NCT00969150|3927761|P1|Overall Study|Protocol Violation|9
1195538|NCT00969150|3927760|P2|Overall Study|Lack of Efficacy|1
1195539|NCT00969150|3927761|P1|Overall Study|Lack of Efficacy|1
1195540|NCT00969150|3927760|P2|Overall Study|Adverse Event|14
1195541|NCT00969150|3927761|P1|Overall Study|Adverse Event|4
1195542|NCT00969124|3927769|P1|Overall Study|Technical error|1
1195543|NCT00969124|3927769|P1|Overall Study|Previously unrecognized disease|3
1195544|NCT00969124|3927769|P1|Overall Study|Inability to reach cecum|9
1195545|NCT00969124|3927769|P1|Overall Study|Inadequate bowel preparation|15
1195546|NCT00969124|3927769|P1|Overall Study|Protocol Violation|2
1195547|NCT00968981|3927778|P3|Overall Study|Withdrawal by Subject|3
1195548|NCT00968981|3927779|P2|Overall Study|Withdrawal by Subject|3
1195549|NCT00968981|3927780|P1|Overall Study|Withdrawal by Subject|1
1195550|NCT00968981|3927778|P3|Overall Study|Physician Decision|5
1195551|NCT00968981|3927779|P2|Overall Study|Physician Decision|3
1195552|NCT00968981|3927780|P1|Overall Study|Physician Decision|5
1195553|NCT00968981|3927778|P3|Overall Study|Lost to Follow-up|1
1195554|NCT00968981|3927779|P2|Overall Study|Lost to Follow-up|0
1195555|NCT00968981|3927780|P1|Overall Study|Lost to Follow-up|0
1195556|NCT00968981|3927778|P3|Overall Study|Disease Progression|13
1195557|NCT00968981|3927779|P2|Overall Study|Disease Progression|16
1195558|NCT00968981|3927780|P1|Overall Study|Disease Progression|14
1195559|NCT00968981|3927778|P3|Overall Study|Adverse Event|0
1195560|NCT00968981|3927779|P2|Overall Study|Adverse Event|0
1195561|NCT00968981|3927780|P1|Overall Study|Adverse Event|2
1195562|NCT00968864|3927847|P1|Overall Study|Protocol exception/ not evaluable|1
1195563|NCT00968812|3927875|P3|Overall Study|Not specified|40
1195564|NCT00968812|3927876|P2|Overall Study|Not specified|37
1195565|NCT00968812|3927877|P1|Overall Study|Not specified|25
1195566|NCT00968812|3927875|P3|Overall Study|Unable to take rescue therapy|17
1195567|NCT00968812|3927876|P2|Overall Study|Unable to take rescue therapy|12
1195568|NCT00968812|3927877|P1|Overall Study|Unable to take rescue therapy|12
1195569|NCT00968812|3927875|P3|Overall Study|Noncompliance with study drug|6
1195570|NCT00968812|3927876|P2|Overall Study|Noncompliance with study drug|1
1195571|NCT00968812|3927877|P1|Overall Study|Noncompliance with study drug|4
1195572|NCT00968812|3927875|P3|Overall Study|Creatinine or eGFR withdrawal criteria|7
1195573|NCT00968812|3927876|P2|Overall Study|Creatinine or eGFR withdrawal criteria|13
1195574|NCT00968812|3927877|P1|Overall Study|Creatinine or eGFR withdrawal criteria|9
1195575|NCT00968812|3927875|P3|Overall Study|Withdrawal by Subject|25
1195576|NCT00968812|3927876|P2|Overall Study|Withdrawal by Subject|23
1195577|NCT00968812|3927877|P1|Overall Study|Withdrawal by Subject|17
1195578|NCT00968812|3927875|P3|Overall Study|Protocol Violation|3
1195579|NCT00968812|3927876|P2|Overall Study|Protocol Violation|4
1195580|NCT00968812|3927877|P1|Overall Study|Protocol Violation|7
1195581|NCT00968812|3927875|P3|Overall Study|Physician Decision|9
1195582|NCT00968812|3927876|P2|Overall Study|Physician Decision|5
1195583|NCT00968812|3927877|P1|Overall Study|Physician Decision|8
1195584|NCT00968812|3927875|P3|Overall Study|Lost to Follow-up|11
1195585|NCT00968812|3927876|P2|Overall Study|Lost to Follow-up|12
1195586|NCT00968812|3927877|P1|Overall Study|Lost to Follow-up|17
1195587|NCT00968812|3927875|P3|Overall Study|Lack of Efficacy|16
1195588|NCT00968812|3927876|P2|Overall Study|Lack of Efficacy|7
1195589|NCT00968812|3927877|P1|Overall Study|Lack of Efficacy|9
1195590|NCT00968812|3927875|P3|Overall Study|Death|1
1195591|NCT00968812|3927876|P2|Overall Study|Death|2
1195592|NCT00968812|3927877|P1|Overall Study|Death|2
1195593|NCT00968812|3927875|P3|Overall Study|Adverse Event|33
1195594|NCT00968812|3927876|P2|Overall Study|Adverse Event|46
1195595|NCT00968812|3927877|P1|Overall Study|Adverse Event|30
1195596|NCT00968799|3927897|P1|Overall Study|Advanced disease, HIPEC not applicable|2
1195597|NCT00968708|3927907|P2|Overall Study|Other|34
1195598|NCT00968708|3927908|P1|Overall Study|Other|26
1195599|NCT00968708|3927907|P2|Overall Study|Investigator Discretion|1
1195600|NCT00968708|3927908|P1|Overall Study|Investigator Discretion|0
1195601|NCT00968708|3927907|P2|Overall Study|Voluntary Withdrawal|101
1195602|NCT00968708|3927908|P1|Overall Study|Voluntary Withdrawal|104
1195603|NCT00968708|3927907|P2|Overall Study|Lost to Follow-up|11
1195604|NCT00968708|3927908|P1|Overall Study|Lost to Follow-up|19
1195605|NCT00968708|3927907|P2|Overall Study|Major Protocol Deviation|1
1195606|NCT00968708|3927908|P1|Overall Study|Major Protocol Deviation|0
1195607|NCT00968708|3927907|P2|Overall Study|Adverse Event|150
1195608|NCT00968708|3927908|P1|Overall Study|Adverse Event|169
1195609|NCT00968669|3927920|P4|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1
1195610|NCT00968669|3927921|P3|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
1195611|NCT00968669|3927922|P2|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
1195612|NCT00968669|3927923|P1|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
1195613|NCT00968669|3927920|P4|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
1195614|NCT00968669|3927921|P3|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
1195615|NCT00968669|3927922|P2|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1
1195616|NCT00968669|3927923|P1|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
1195617|NCT00968669|3927920|P4|Overall Study|SUBJECT INCARCERATED|0
1195618|NCT00968669|3927921|P3|Overall Study|SUBJECT INCARCERATED|0
1195619|NCT00968669|3927922|P2|Overall Study|SUBJECT INCARCERATED|1
1195620|NCT00968669|3927923|P1|Overall Study|SUBJECT INCARCERATED|0
1195621|NCT00968669|3927920|P4|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
1195622|NCT00968669|3927921|P3|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
1195623|NCT00968669|3927922|P2|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1
1195624|NCT00968669|3927923|P1|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
1195625|NCT00968669|3927920|P4|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
1195626|NCT00968669|3927921|P3|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1
1195627|NCT00968669|3927922|P2|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
1195628|NCT00968669|3927923|P1|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
1195629|NCT00968669|3927920|P4|Overall Study|SPONSOR DECISION|0
1195630|NCT00968669|3927921|P3|Overall Study|SPONSOR DECISION|0
1195631|NCT00968669|3927922|P2|Overall Study|SPONSOR DECISION|1
1195632|NCT00968669|3927923|P1|Overall Study|SPONSOR DECISION|0
1195633|NCT00968669|3927920|P4|Overall Study|PATIENT WILL BE WORKING ABROAD|0
1195634|NCT00968669|3927921|P3|Overall Study|PATIENT WILL BE WORKING ABROAD|0
1195635|NCT00968669|3927922|P2|Overall Study|PATIENT WILL BE WORKING ABROAD|1
1195636|NCT00968669|3927923|P1|Overall Study|PATIENT WILL BE WORKING ABROAD|0
1195637|NCT00968669|3927920|P4|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
1195638|NCT00968669|3927921|P3|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
1195639|NCT00968669|3927922|P2|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1
1195640|NCT00968669|3927923|P1|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
1195641|NCT00968669|3927920|P4|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
1195642|NCT00968669|3927921|P3|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
1195643|NCT00968669|3927922|P2|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1
1195644|NCT00968669|3927923|P1|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
1195645|NCT00968669|3927920|P4|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
1195646|NCT00968669|3927921|P3|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
1195647|NCT00968669|3927922|P2|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1
1195648|NCT00968669|3927923|P1|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
1195649|NCT00968669|3927920|P4|Overall Study|INEGIBILITY TO PERFORM VISIT|0
1195650|NCT00968669|3927921|P3|Overall Study|INEGIBILITY TO PERFORM VISIT|0
1195651|NCT00968669|3927922|P2|Overall Study|INEGIBILITY TO PERFORM VISIT|0
1195652|NCT00968669|3927923|P1|Overall Study|INEGIBILITY TO PERFORM VISIT|1
1195653|NCT00968669|3927920|P4|Overall Study|ERROR IN HADS ADMINISTRATION|0
1195654|NCT00968669|3927921|P3|Overall Study|ERROR IN HADS ADMINISTRATION|1
1195655|NCT00968669|3927922|P2|Overall Study|ERROR IN HADS ADMINISTRATION|0
1195656|NCT00968669|3927923|P1|Overall Study|ERROR IN HADS ADMINISTRATION|0
1195657|NCT00968669|3927920|P4|Overall Study|EARLY WITHDRAWAL|0
1195658|NCT00968669|3927921|P3|Overall Study|EARLY WITHDRAWAL|0
1195659|NCT00968669|3927922|P2|Overall Study|EARLY WITHDRAWAL|1
1195660|NCT00968669|3927923|P1|Overall Study|EARLY WITHDRAWAL|0
1195661|NCT00968669|3927920|P4|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
1195662|NCT00968669|3927921|P3|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1
1195663|NCT00968669|3927922|P2|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
1195664|NCT00968669|3927923|P1|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
1195665|NCT00968669|3927920|P4|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
1195666|NCT00968669|3927921|P3|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
1195667|NCT00968669|3927922|P2|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
1195668|NCT00968669|3927923|P1|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1
1195669|NCT00968669|3927920|P4|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
1195670|NCT00968669|3927921|P3|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
1195671|NCT00968669|3927922|P2|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
1195672|NCT00968669|3927923|P1|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1
1195673|NCT00968669|3927920|P4|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1
1195674|NCT00968669|3927921|P3|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
1195675|NCT00968669|3927922|P2|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
1195676|NCT00968669|3927923|P1|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
1195677|NCT00968669|3927920|P4|Overall Study|AE|0
1195678|NCT00968669|3927921|P3|Overall Study|AE|0
1195679|NCT00968669|3927922|P2|Overall Study|AE|0
1195680|NCT00968669|3927923|P1|Overall Study|AE|1
1195681|NCT00968669|3927920|P4|Overall Study|Pregnancy|0
1195682|NCT00968669|3927921|P3|Overall Study|Pregnancy|2
1195683|NCT00968669|3927922|P2|Overall Study|Pregnancy|0
1195684|NCT00968669|3927923|P1|Overall Study|Pregnancy|0
1195685|NCT00968669|3927920|P4|Overall Study|Withdrawal by Subject|3
1195686|NCT00968669|3927921|P3|Overall Study|Withdrawal by Subject|5
1195687|NCT00968669|3927922|P2|Overall Study|Withdrawal by Subject|7
1195688|NCT00968669|3927923|P1|Overall Study|Withdrawal by Subject|9
1195689|NCT00968669|3927920|P4|Overall Study|Lost to Follow-up|4
1195690|NCT00968669|3927921|P3|Overall Study|Lost to Follow-up|1
1195691|NCT00968669|3927922|P2|Overall Study|Lost to Follow-up|2
1195692|NCT00968669|3927923|P1|Overall Study|Lost to Follow-up|5
1195693|NCT00968617|3928013|P1|Overall Study|Study terminated by sponsor|6
1195694|NCT00968539|3928027|P2|Overall Study|Lost to follow-up (incompl. vaccination)|0
1195695|NCT00968539|3928028|P1|Overall Study|Lost to follow-up (incompl. vaccination)|1
1195696|NCT00968526|3928088|P2|Overall Study|Migrated/moved from study area|0
1195697|NCT00968526|3928089|P1|Overall Study|Migrated/moved from study area|1
1195698|NCT00968526|3928088|P2|Overall Study|Adverse Event|0
1195699|NCT00968526|3928089|P1|Overall Study|Adverse Event|2
1195700|NCT00968253|3928182|P3|Overall Study|Adverse Event|1
1195701|NCT00968253|3928183|P2|Overall Study|Adverse Event|0
1195702|NCT00968253|3928184|P1|Overall Study|Adverse Event|0
1195703|NCT00968253|3928182|P3|Overall Study|Disease Progression|3
1195704|NCT00968253|3928183|P2|Overall Study|Disease Progression|3
1195705|NCT00968253|3928184|P1|Overall Study|Disease Progression|0
1195706|NCT00968253|3928182|P3|Overall Study|Withdrawal by Subject|1
1195707|NCT00968253|3928183|P2|Overall Study|Withdrawal by Subject|0
1195708|NCT00968253|3928184|P1|Overall Study|Withdrawal by Subject|0
1195709|NCT00968253|3928182|P3|Overall Study|Death|2
1195710|NCT00968253|3928183|P2|Overall Study|Death|0
1195711|NCT00968253|3928184|P1|Overall Study|Death|0
1195712|NCT00968201|3928205|P3|Extension Study - (Period III)|Study Terminated for Admin Reasons|185
1195713|NCT00968201|3928206|P2|Extension Study - (Period III)|Study Terminated for Admin Reasons|74
1195714|NCT00968201|3928207|P1|Extension Study - (Period III)|Study Terminated for Admin Reasons|0
1195715|NCT00968201|3928205|P3|Extension Study - (Period III)|Not Specified|2
1195716|NCT00968201|3928206|P2|Extension Study - (Period III)|Not Specified|0
1195717|NCT00968201|3928207|P1|Extension Study - (Period III)|Not Specified|0
1195718|NCT00968201|3928205|P3|Extension Study - (Period III)|Noncompliance|3
1195719|NCT00968201|3928206|P2|Extension Study - (Period III)|Noncompliance|0
1195720|NCT00968201|3928207|P1|Extension Study - (Period III)|Noncompliance|0
1195721|NCT00968201|3928205|P3|Extension Study - (Period III)|Patient Relocated|1
1195722|NCT00968201|3928206|P2|Extension Study - (Period III)|Patient Relocated|1
1195723|NCT00968201|3928207|P1|Extension Study - (Period III)|Patient Relocated|0
1195724|NCT00968201|3928205|P3|Extension Study - (Period III)|Withdrawal by Subject|40
1195725|NCT00968201|3928206|P2|Extension Study - (Period III)|Withdrawal by Subject|20
1195726|NCT00968201|3928207|P1|Extension Study - (Period III)|Withdrawal by Subject|0
1195727|NCT00968201|3928205|P3|Extension Study - (Period III)|Protocol Violation|14
1195728|NCT00968201|3928206|P2|Extension Study - (Period III)|Protocol Violation|17
1195729|NCT00968201|3928207|P1|Extension Study - (Period III)|Protocol Violation|0
1195730|NCT00968201|3928205|P3|Extension Study - (Period III)|Lost to Follow-up|13
1195731|NCT00968201|3928206|P2|Extension Study - (Period III)|Lost to Follow-up|7
1195732|NCT00968201|3928207|P1|Extension Study - (Period III)|Lost to Follow-up|0
1195733|NCT00968201|3928205|P3|Extension Study - (Period III)|Adverse Event|22
1195734|NCT00968201|3928206|P2|Extension Study - (Period III)|Adverse Event|5
1195735|NCT00968201|3928207|P1|Extension Study - (Period III)|Adverse Event|0
1195736|NCT00968201|3928205|P3|Base Study - (Period II)|Site Error|1
1195737|NCT00968201|3928206|P2|Base Study - (Period II)|Site Error|0
1195738|NCT00968201|3928207|P1|Base Study - (Period II)|Site Error|0
1195739|NCT00968201|3928205|P3|Base Study - (Period II)|Withdrawal by Subject|8
1195740|NCT00968201|3928206|P2|Base Study - (Period II)|Withdrawal by Subject|0
1195741|NCT00968201|3928207|P1|Base Study - (Period II)|Withdrawal by Subject|4
1195742|NCT00968201|3928205|P3|Base Study - (Period II)|Protocol Violation|12
1195743|NCT00968201|3928206|P2|Base Study - (Period II)|Protocol Violation|0
1195744|NCT00968201|3928207|P1|Base Study - (Period II)|Protocol Violation|12
1195745|NCT00968201|3928205|P3|Base Study - (Period II)|Lost to Follow-up|7
1195746|NCT00968201|3928206|P2|Base Study - (Period II)|Lost to Follow-up|0
1195747|NCT00968201|3928207|P1|Base Study - (Period II)|Lost to Follow-up|2
1195748|NCT00968201|3928205|P3|Base Study - (Period II)|Lack of Efficacy|1
1195749|NCT00968201|3928206|P2|Base Study - (Period II)|Lack of Efficacy|0
1195750|NCT00968201|3928207|P1|Base Study - (Period II)|Lack of Efficacy|0
1195751|NCT00968201|3928205|P3|Base Study - (Period II)|Adverse Event|16
1195752|NCT00968201|3928206|P2|Base Study - (Period II)|Adverse Event|0
1195753|NCT00968201|3928207|P1|Base Study - (Period II)|Adverse Event|8
1195754|NCT00968149|3928268|P2|Overall Study|Withdrawal by Subject|0
1195755|NCT00968149|3928269|P1|Overall Study|Withdrawal by Subject|2
1195756|NCT00968149|3928268|P2|Overall Study|Protocol Violation|0
1195757|NCT00968149|3928269|P1|Overall Study|Protocol Violation|4
1195758|NCT00968149|3928268|P2|Overall Study|Lost to Follow-up|1
1195759|NCT00968149|3928269|P1|Overall Study|Lost to Follow-up|0
1195760|NCT00968149|3928268|P2|Overall Study|Lack of Efficacy|4
1195761|NCT00968149|3928269|P1|Overall Study|Lack of Efficacy|0
1195762|NCT00968149|3928268|P2|Overall Study|Adverse Event|1
1195763|NCT00968149|3928269|P1|Overall Study|Adverse Event|5
1195764|NCT00967798|3928324|P2|Overall Study|Lost to Follow-up|1
1195765|NCT00967798|3928325|P1|Overall Study|Lost to Follow-up|4
1195766|NCT00967798|3928324|P2|Overall Study|Withdrawal by Subject|2
1195767|NCT00967798|3928325|P1|Overall Study|Withdrawal by Subject|5
1195768|NCT00967694|3928339|P1|Overall Study|Withdrawal by Subject|6
1195769|NCT00967668|3928346|P3|Overall Study|Pregnancy|0
1195770|NCT00967668|3928347|P2|Overall Study|Pregnancy|0
1195771|NCT00967668|3928348|P1|Overall Study|Pregnancy|1
1195772|NCT00967668|3928346|P3|Overall Study|Refused 12-mo assessment|9
1195773|NCT00967668|3928347|P2|Overall Study|Refused 12-mo assessment|1
1195774|NCT00967668|3928348|P1|Overall Study|Refused 12-mo assessment|3
1195775|NCT00967668|3928346|P3|Overall Study|Lost to Follow-up|16
1195776|NCT00967668|3928347|P2|Overall Study|Lost to Follow-up|9
1195777|NCT00967668|3928348|P1|Overall Study|Lost to Follow-up|15
1195778|NCT00967668|3928346|P3|Overall Study|Lost to follow-up at 12-mo|26
1195779|NCT00967668|3928347|P2|Overall Study|Lost to follow-up at 12-mo|29
1195780|NCT00967668|3928348|P1|Overall Study|Lost to follow-up at 12-mo|27
1195781|NCT00967668|3928346|P3|Overall Study|Refused Year 2|4
1195782|NCT00967668|3928347|P2|Overall Study|Refused Year 2|6
1195783|NCT00967668|3928348|P1|Overall Study|Refused Year 2|11
1195784|NCT00967668|3928346|P3|Overall Study|Removed due to behavior|2
1195785|NCT00967668|3928347|P2|Overall Study|Removed due to behavior|1
1195786|NCT00967668|3928348|P1|Overall Study|Removed due to behavior|1
1195787|NCT00967668|3928346|P3|Overall Study|Death|4
1195788|NCT00967668|3928347|P2|Overall Study|Death|2
1195789|NCT00967668|3928348|P1|Overall Study|Death|0
1195790|NCT00967668|3928346|P3|Overall Study|Withdrawal by Subject|8
1195791|NCT00967668|3928347|P2|Overall Study|Withdrawal by Subject|8
1195792|NCT00967668|3928348|P1|Overall Study|Withdrawal by Subject|13
1195793|NCT00967330|3928394|P2|Overall Study|Severe protocol deviation|1
1195794|NCT00967330|3928395|P1|Overall Study|Severe protocol deviation|0
1195795|NCT00967330|3928394|P2|Overall Study|Death|51
1195796|NCT00967330|3928395|P1|Overall Study|Death|102
1195797|NCT00967330|3928394|P2|Overall Study|Lost to Follow-up|1
1195798|NCT00967330|3928395|P1|Overall Study|Lost to Follow-up|1
1195799|NCT00967330|3928394|P2|Overall Study|Withdrawal by Subject|0
1195800|NCT00967330|3928395|P1|Overall Study|Withdrawal by Subject|6
1195801|NCT00967330|3928394|P2|Overall Study|Regular|3
1195802|NCT00967330|3928395|P1|Overall Study|Regular|10
1195803|NCT00967330|3928394|P2|Overall Study|Protocol Violation|4
1195804|NCT00967330|3928395|P1|Overall Study|Protocol Violation|3
1195805|NCT00967226|3928425|P2|Overall Study|Physician Decision|1
1195806|NCT00967226|3928426|P1|Overall Study|Physician Decision|0
1195807|NCT00967226|3928425|P2|Overall Study|Protocol Violation|0
1195808|NCT00967226|3928426|P1|Overall Study|Protocol Violation|2
1195809|NCT00967226|3928425|P2|Overall Study|Adverse Event|5
1195810|NCT00967226|3928426|P1|Overall Study|Adverse Event|0
1195811|NCT00967018|3928460|P1|Overall Study|Miscellaneous Reasons|9
1195812|NCT00967018|3928460|P1|Overall Study|Withdrawal by Subject|1
1195813|NCT00967018|3928460|P1|Overall Study|Lost to Follow-up|2
1195814|NCT00967018|3928460|P1|Overall Study|Physician Decision|7
1195815|NCT00967018|3928460|P1|Overall Study|Adverse Event|2
1195816|NCT00967005|3928469|P2|Overall Study|Lost to Follow-up|10
1195817|NCT00967005|3928470|P1|Overall Study|Lost to Follow-up|7
1195818|NCT00966940|3928556|P2|Period 1, First 6 Weeks|Protocol Violation|0
1195819|NCT00966940|3928557|P1|Period 1, First 6 Weeks|Protocol Violation|1
1195820|NCT00966940|3928556|P2|Period 1, First 6 Weeks|Withdrawal by Subject|0
1195821|NCT00966940|3928557|P1|Period 1, First 6 Weeks|Withdrawal by Subject|2
1195822|NCT00966875|3928584|P9|Part B|Entry Criteria|1
1195823|NCT00966875|3928585|P8|Part B|Entry Criteria|0
1195824|NCT00966875|3928586|P7|Part B|Entry Criteria|1
1195825|NCT00966875|3928587|P6|Part B|Entry Criteria|0
1195826|NCT00966875|3928588|P5|Part B|Entry Criteria|0
1195827|NCT00966875|3928589|P4|Part B|Entry Criteria|0
1195828|NCT00966875|3928590|P3|Part B|Entry Criteria|0
1195829|NCT00966875|3928591|P2|Part B|Entry Criteria|0
1195830|NCT00966875|3928592|P1|Part B|Entry Criteria|0
1195831|NCT00966875|3928584|P9|Part B|Withdrawal by Subject|5
1195832|NCT00966875|3928585|P8|Part B|Withdrawal by Subject|5
1195833|NCT00966875|3928586|P7|Part B|Withdrawal by Subject|4
1195834|NCT00966875|3928587|P6|Part B|Withdrawal by Subject|1
1195835|NCT00966875|3928588|P5|Part B|Withdrawal by Subject|2
1195836|NCT00966875|3928589|P4|Part B|Withdrawal by Subject|1
1195837|NCT00966875|3928590|P3|Part B|Withdrawal by Subject|2
1195838|NCT00966875|3928591|P2|Part B|Withdrawal by Subject|1
1195839|NCT00966875|3928592|P1|Part B|Withdrawal by Subject|2
1195840|NCT00966875|3928584|P9|Part B|Sponsor Decision|1
1195841|NCT00966875|3928585|P8|Part B|Sponsor Decision|2
1195842|NCT00966875|3928586|P7|Part B|Sponsor Decision|0
1195843|NCT00966875|3928587|P6|Part B|Sponsor Decision|1
1195844|NCT00966875|3928588|P5|Part B|Sponsor Decision|0
1195845|NCT00966875|3928589|P4|Part B|Sponsor Decision|0
1195846|NCT00966875|3928590|P3|Part B|Sponsor Decision|0
1195847|NCT00966875|3928591|P2|Part B|Sponsor Decision|0
1195848|NCT00966875|3928592|P1|Part B|Sponsor Decision|1
1195849|NCT00966875|3928584|P9|Part B|Physician Decision|2
1195850|NCT00966875|3928585|P8|Part B|Physician Decision|0
1195851|NCT00966875|3928586|P7|Part B|Physician Decision|0
1195852|NCT00966875|3928587|P6|Part B|Physician Decision|1
1195853|NCT00966875|3928588|P5|Part B|Physician Decision|2
1195854|NCT00966875|3928589|P4|Part B|Physician Decision|0
1195855|NCT00966875|3928590|P3|Part B|Physician Decision|1
1195856|NCT00966875|3928591|P2|Part B|Physician Decision|0
1195857|NCT00966875|3928592|P1|Part B|Physician Decision|0
1195858|NCT00966875|3928584|P9|Part B|Lost to Follow-up|1
1195859|NCT00966875|3928585|P8|Part B|Lost to Follow-up|0
1195860|NCT00966875|3928586|P7|Part B|Lost to Follow-up|0
1195861|NCT00966875|3928587|P6|Part B|Lost to Follow-up|0
1195862|NCT00966875|3928588|P5|Part B|Lost to Follow-up|0
1195863|NCT00966875|3928589|P4|Part B|Lost to Follow-up|1
1195864|NCT00966875|3928590|P3|Part B|Lost to Follow-up|0
1195865|NCT00966875|3928591|P2|Part B|Lost to Follow-up|0
1195866|NCT00966875|3928592|P1|Part B|Lost to Follow-up|0
1195867|NCT00966875|3928584|P9|Part B|Lack of Efficacy|6
1195868|NCT00966875|3928585|P8|Part B|Lack of Efficacy|9
1195869|NCT00966875|3928586|P7|Part B|Lack of Efficacy|12
1195870|NCT00966875|3928587|P6|Part B|Lack of Efficacy|3
1195871|NCT00966875|3928588|P5|Part B|Lack of Efficacy|2
1195872|NCT00966875|3928589|P4|Part B|Lack of Efficacy|1
1195873|NCT00966875|3928590|P3|Part B|Lack of Efficacy|1
1195874|NCT00966875|3928591|P2|Part B|Lack of Efficacy|1
1195875|NCT00966875|3928592|P1|Part B|Lack of Efficacy|2
1195876|NCT00966875|3928584|P9|Part B|Death|0
1195877|NCT00966875|3928585|P8|Part B|Death|1
1195878|NCT00966875|3928586|P7|Part B|Death|0
1195879|NCT00966875|3928587|P6|Part B|Death|0
1195880|NCT00966875|3928588|P5|Part B|Death|0
1195881|NCT00966875|3928589|P4|Part B|Death|0
1195882|NCT00966875|3928590|P3|Part B|Death|1
1195883|NCT00966875|3928591|P2|Part B|Death|0
1195884|NCT00966875|3928592|P1|Part B|Death|0
1195885|NCT00966875|3928584|P9|Part B|Adverse Event|2
1195886|NCT00966875|3928585|P8|Part B|Adverse Event|2
1195887|NCT00966875|3928586|P7|Part B|Adverse Event|5
1195888|NCT00966875|3928587|P6|Part B|Adverse Event|0
1195889|NCT00966875|3928588|P5|Part B|Adverse Event|1
1195890|NCT00966875|3928589|P4|Part B|Adverse Event|0
1195891|NCT00966875|3928590|P3|Part B|Adverse Event|1
1195892|NCT00966875|3928591|P2|Part B|Adverse Event|1
1195893|NCT00966875|3928592|P1|Part B|Adverse Event|0
1195894|NCT00966875|3928584|P9|Part A|Protocol Violation|1
1195895|NCT00966875|3928585|P8|Part A|Protocol Violation|1
1195896|NCT00966875|3928586|P7|Part A|Protocol Violation|2
1195897|NCT00966875|3928587|P6|Part A|Protocol Violation|0
1195898|NCT00966875|3928588|P5|Part A|Protocol Violation|0
1195899|NCT00966875|3928589|P4|Part A|Protocol Violation|0
1195900|NCT00966875|3928590|P3|Part A|Protocol Violation|0
1195901|NCT00966875|3928591|P2|Part A|Protocol Violation|0
1195902|NCT00966875|3928592|P1|Part A|Protocol Violation|0
1195903|NCT00966875|3928584|P9|Part A|Withdrawal by Subject|1
1195904|NCT00966875|3928585|P8|Part A|Withdrawal by Subject|1
1195905|NCT00966875|3928586|P7|Part A|Withdrawal by Subject|5
1195906|NCT00966875|3928587|P6|Part A|Withdrawal by Subject|0
1195907|NCT00966875|3928588|P5|Part A|Withdrawal by Subject|3
1195908|NCT00966875|3928589|P4|Part A|Withdrawal by Subject|1
1195909|NCT00966875|3928590|P3|Part A|Withdrawal by Subject|1
1195910|NCT00966875|3928591|P2|Part A|Withdrawal by Subject|2
1195911|NCT00966875|3928592|P1|Part A|Withdrawal by Subject|2
1195912|NCT00966875|3928584|P9|Part A|Sponsor Decision|1
1195913|NCT00966875|3928585|P8|Part A|Sponsor Decision|2
1195914|NCT00966875|3928586|P7|Part A|Sponsor Decision|0
1195915|NCT00966875|3928587|P6|Part A|Sponsor Decision|0
1195916|NCT00966875|3928588|P5|Part A|Sponsor Decision|1
1195917|NCT00966875|3928589|P4|Part A|Sponsor Decision|0
1195918|NCT00966875|3928590|P3|Part A|Sponsor Decision|1
1195919|NCT00966875|3928591|P2|Part A|Sponsor Decision|0
1195920|NCT00966875|3928592|P1|Part A|Sponsor Decision|0
1195921|NCT00966875|3928584|P9|Part A|Physician Decision|2
1195922|NCT00966875|3928585|P8|Part A|Physician Decision|0
1195923|NCT00966875|3928586|P7|Part A|Physician Decision|1
1195924|NCT00966875|3928587|P6|Part A|Physician Decision|0
1195925|NCT00966875|3928588|P5|Part A|Physician Decision|1
1195926|NCT00966875|3928589|P4|Part A|Physician Decision|0
1195927|NCT00966875|3928590|P3|Part A|Physician Decision|0
1195928|NCT00966875|3928591|P2|Part A|Physician Decision|0
1195929|NCT00966875|3928592|P1|Part A|Physician Decision|0
1195930|NCT00966875|3928584|P9|Part A|Parent/Caregiver Decision|0
1195931|NCT00966875|3928585|P8|Part A|Parent/Caregiver Decision|0
1195932|NCT00966875|3928586|P7|Part A|Parent/Caregiver Decision|0
1195933|NCT00966875|3928587|P6|Part A|Parent/Caregiver Decision|0
1195934|NCT00966875|3928588|P5|Part A|Parent/Caregiver Decision|0
1195935|NCT00966875|3928589|P4|Part A|Parent/Caregiver Decision|1
1195936|NCT00966875|3928590|P3|Part A|Parent/Caregiver Decision|0
1195937|NCT00966875|3928591|P2|Part A|Parent/Caregiver Decision|0
1195938|NCT00966875|3928592|P1|Part A|Parent/Caregiver Decision|0
1195939|NCT00966875|3928584|P9|Part A|Lost to Follow-up|0
1195940|NCT00966875|3928585|P8|Part A|Lost to Follow-up|0
1195941|NCT00966875|3928586|P7|Part A|Lost to Follow-up|0
1195942|NCT00966875|3928587|P6|Part A|Lost to Follow-up|1
1195943|NCT00966875|3928588|P5|Part A|Lost to Follow-up|0
1195944|NCT00966875|3928589|P4|Part A|Lost to Follow-up|0
1195945|NCT00966875|3928590|P3|Part A|Lost to Follow-up|0
1195946|NCT00966875|3928591|P2|Part A|Lost to Follow-up|0
1195947|NCT00966875|3928592|P1|Part A|Lost to Follow-up|2
1195948|NCT00966875|3928584|P9|Part A|Lack of Efficacy|0
1195949|NCT00966875|3928585|P8|Part A|Lack of Efficacy|0
1195950|NCT00966875|3928586|P7|Part A|Lack of Efficacy|4
1195951|NCT00966875|3928587|P6|Part A|Lack of Efficacy|0
1195952|NCT00966875|3928588|P5|Part A|Lack of Efficacy|0
1195953|NCT00966875|3928589|P4|Part A|Lack of Efficacy|0
1195954|NCT00966875|3928590|P3|Part A|Lack of Efficacy|0
1195955|NCT00966875|3928591|P2|Part A|Lack of Efficacy|1
1195956|NCT00966875|3928592|P1|Part A|Lack of Efficacy|0
1195957|NCT00966875|3928584|P9|Part A|Entry Criteria|0
1195958|NCT00966875|3928585|P8|Part A|Entry Criteria|0
1195959|NCT00966875|3928586|P7|Part A|Entry Criteria|0
1195960|NCT00966875|3928587|P6|Part A|Entry Criteria|2
1195961|NCT00966875|3928588|P5|Part A|Entry Criteria|0
1195962|NCT00966875|3928589|P4|Part A|Entry Criteria|0
1195963|NCT00966875|3928590|P3|Part A|Entry Criteria|0
1195964|NCT00966875|3928591|P2|Part A|Entry Criteria|0
1195965|NCT00966875|3928592|P1|Part A|Entry Criteria|0
1195966|NCT00966875|3928584|P9|Part A|Adverse Event|3
1195967|NCT00966875|3928585|P8|Part A|Adverse Event|3
1195968|NCT00966875|3928586|P7|Part A|Adverse Event|0
1195969|NCT00966875|3928587|P6|Part A|Adverse Event|1
1195970|NCT00966875|3928588|P5|Part A|Adverse Event|0
1195971|NCT00966875|3928589|P4|Part A|Adverse Event|1
1195972|NCT00966875|3928590|P3|Part A|Adverse Event|0
1195973|NCT00966875|3928591|P2|Part A|Adverse Event|1
1195974|NCT00966875|3928592|P1|Part A|Adverse Event|2
1195975|NCT00966654|3928919|P1|Overall Study|Study was terminated,PI left institution|12
1195976|NCT00966355|3928993|P3|Overall Study|Lost to Follow-up|3
1195977|NCT00966355|3928994|P2|Overall Study|Lost to Follow-up|4
1195978|NCT00966355|3928995|P1|Overall Study|Lost to Follow-up|5
1195979|NCT00966355|3928993|P3|Overall Study|newly diagnosed advanced HCC|10
1195980|NCT00966355|3928994|P2|Overall Study|newly diagnosed advanced HCC|12
1195981|NCT00966355|3928995|P1|Overall Study|newly diagnosed advanced HCC|11
1195982|NCT00966355|3928993|P3|Overall Study|non-variceal bleeding on endoscopy|71
1195983|NCT00966355|3928994|P2|Overall Study|non-variceal bleeding on endoscopy|70
1195984|NCT00966355|3928995|P1|Overall Study|non-variceal bleeding on endoscopy|68
1195985|NCT00966277|3929008|P2|Overall Study|Treatment Plan Changed|1
1195986|NCT00966277|3929009|P1|Overall Study|Treatment Plan Changed|0
1195987|NCT00966277|3929008|P2|Overall Study|Ineligible|3
1195988|NCT00966277|3929009|P1|Overall Study|Ineligible|1
1195989|NCT00966277|3929008|P2|Overall Study|Withdrawal by Subject|0
1195990|NCT00966277|3929009|P1|Overall Study|Withdrawal by Subject|3
1195991|NCT00966264|3929017|P2|Overall Study|Lost to Follow-up|3
1195992|NCT00966264|3929018|P1|Overall Study|Lost to Follow-up|4
1195993|NCT00965848|3929064|P3|Overall Study|Other|1
1195994|NCT00965848|3929065|P2|Overall Study|Other|0
1195995|NCT00965848|3929066|P1|Overall Study|Other|5
1195996|NCT00965848|3929064|P3|Overall Study|Not Clinically Evaluable|1
1195997|NCT00965848|3929065|P2|Overall Study|Not Clinically Evaluable|1
1195998|NCT00965848|3929066|P1|Overall Study|Not Clinically Evaluable|7
1195999|NCT00965848|3929064|P3|Overall Study|Indeterminate Clinical Outcome|1
1196000|NCT00965848|3929065|P2|Overall Study|Indeterminate Clinical Outcome|0
1196001|NCT00965848|3929066|P1|Overall Study|Indeterminate Clinical Outcome|2
1196002|NCT00965848|3929064|P3|Overall Study|Withdrawal by Subject|0
1196003|NCT00965848|3929065|P2|Overall Study|Withdrawal by Subject|0
1196004|NCT00965848|3929066|P1|Overall Study|Withdrawal by Subject|1
1196005|NCT00965848|3929064|P3|Overall Study|Lost to Follow-up|1
1196006|NCT00965848|3929065|P2|Overall Study|Lost to Follow-up|0
1196007|NCT00965848|3929066|P1|Overall Study|Lost to Follow-up|0
1196008|NCT00965848|3929064|P3|Overall Study|Death|5
1196009|NCT00965848|3929065|P2|Overall Study|Death|1
1196010|NCT00965848|3929066|P1|Overall Study|Death|11
1196011|NCT00965848|3929064|P3|Overall Study|Protocol Violation|1
1196012|NCT00965848|3929065|P2|Overall Study|Protocol Violation|0
1196013|NCT00965848|3929066|P1|Overall Study|Protocol Violation|3
1196014|NCT00965757|3929085|P4|Extension Phase|Not Specified|1
1196015|NCT00965757|3929086|P3|Extension Phase|Not Specified|2
1196016|NCT00965757|3929087|P2|Extension Phase|Not Specified|0
1196017|NCT00965757|3929088|P1|Extension Phase|Not Specified|0
1196018|NCT00965757|3929085|P4|Extension Phase|Protocol Violation|1
1196019|NCT00965757|3929086|P3|Extension Phase|Protocol Violation|0
1196020|NCT00965757|3929087|P2|Extension Phase|Protocol Violation|0
1196021|NCT00965757|3929088|P1|Extension Phase|Protocol Violation|0
1196022|NCT00965757|3929085|P4|Extension Phase|Ineligible after Taking Study Drug|3
1196023|NCT00965757|3929086|P3|Extension Phase|Ineligible after Taking Study Drug|3
1196024|NCT00965757|3929087|P2|Extension Phase|Ineligible after Taking Study Drug|0
1196025|NCT00965757|3929088|P1|Extension Phase|Ineligible after Taking Study Drug|0
1196026|NCT00965757|3929085|P4|Extension Phase|Lost to Follow-up|1
1196027|NCT00965757|3929086|P3|Extension Phase|Lost to Follow-up|0
1196028|NCT00965757|3929087|P2|Extension Phase|Lost to Follow-up|0
1196029|NCT00965757|3929088|P1|Extension Phase|Lost to Follow-up|0
1196030|NCT00965757|3929085|P4|Extension Phase|Drug Refusal Due to Adverse Event|0
1196031|NCT00965757|3929086|P3|Extension Phase|Drug Refusal Due to Adverse Event|4
1196032|NCT00965757|3929087|P2|Extension Phase|Drug Refusal Due to Adverse Event|0
1196033|NCT00965757|3929088|P1|Extension Phase|Drug Refusal Due to Adverse Event|0
1196034|NCT00965757|3929085|P4|Extension Phase|Lack of Efficacy|12
1196035|NCT00965757|3929086|P3|Extension Phase|Lack of Efficacy|8
1196036|NCT00965757|3929087|P2|Extension Phase|Lack of Efficacy|0
1196037|NCT00965757|3929088|P1|Extension Phase|Lack of Efficacy|0
1196038|NCT00965757|3929085|P4|Extension Phase|Abnormal Laboratory Value|1
1196039|NCT00965757|3929086|P3|Extension Phase|Abnormal Laboratory Value|6
1196040|NCT00965757|3929087|P2|Extension Phase|Abnormal Laboratory Value|0
1196041|NCT00965757|3929088|P1|Extension Phase|Abnormal Laboratory Value|0
1196042|NCT00965757|3929085|P4|Extension Phase|Adverse drug reaction|3
1196043|NCT00965757|3929086|P3|Extension Phase|Adverse drug reaction|6
1196044|NCT00965757|3929087|P2|Extension Phase|Adverse drug reaction|0
1196045|NCT00965757|3929088|P1|Extension Phase|Adverse drug reaction|0
1196046|NCT00965757|3929085|P4|Extension Phase|Progression of concomitant disease|2
1196047|NCT00965757|3929086|P3|Extension Phase|Progression of concomitant disease|4
1196048|NCT00965757|3929087|P2|Extension Phase|Progression of concomitant disease|0
1196049|NCT00965757|3929088|P1|Extension Phase|Progression of concomitant disease|0
1196050|NCT00965757|3929085|P4|Double-blind Phase|Not specified|0
1196051|NCT00965757|3929086|P3|Double-blind Phase|Not specified|0
1196052|NCT00965757|3929087|P2|Double-blind Phase|Not specified|0
1196053|NCT00965757|3929088|P1|Double-blind Phase|Not specified|1
1196054|NCT00965757|3929085|P4|Double-blind Phase|Ineligible after Taking Study Drug|0
1196055|NCT00965757|3929086|P3|Double-blind Phase|Ineligible after Taking Study Drug|0
1196056|NCT00965757|3929087|P2|Double-blind Phase|Ineligible after Taking Study Drug|3
1196057|NCT00965757|3929088|P1|Double-blind Phase|Ineligible after Taking Study Drug|2
1196058|NCT00965757|3929085|P4|Double-blind Phase|Lost to Follow-up|0
1196059|NCT00965757|3929086|P3|Double-blind Phase|Lost to Follow-up|0
1196060|NCT00965757|3929087|P2|Double-blind Phase|Lost to Follow-up|1
1196061|NCT00965757|3929088|P1|Double-blind Phase|Lost to Follow-up|0
1196062|NCT00965757|3929085|P4|Double-blind Phase|Drug Refusal Due to Adverse Event|0
1196063|NCT00965757|3929086|P3|Double-blind Phase|Drug Refusal Due to Adverse Event|0
1196064|NCT00965757|3929087|P2|Double-blind Phase|Drug Refusal Due to Adverse Event|0
1196065|NCT00965757|3929088|P1|Double-blind Phase|Drug Refusal Due to Adverse Event|2
1196066|NCT00965757|3929085|P4|Double-blind Phase|Lack of Efficacy|0
1196067|NCT00965757|3929086|P3|Double-blind Phase|Lack of Efficacy|0
1196068|NCT00965757|3929087|P2|Double-blind Phase|Lack of Efficacy|11
1196069|NCT00965757|3929088|P1|Double-blind Phase|Lack of Efficacy|7
1196070|NCT00965757|3929085|P4|Double-blind Phase|Abnormal Laboratory Value|0
1196071|NCT00965757|3929086|P3|Double-blind Phase|Abnormal Laboratory Value|0
1196072|NCT00965757|3929087|P2|Double-blind Phase|Abnormal Laboratory Value|0
1196073|NCT00965757|3929088|P1|Double-blind Phase|Abnormal Laboratory Value|2
1196074|NCT00965757|3929085|P4|Double-blind Phase|Adverse drug reaction|0
1196075|NCT00965757|3929086|P3|Double-blind Phase|Adverse drug reaction|0
1196076|NCT00965757|3929087|P2|Double-blind Phase|Adverse drug reaction|1
1196077|NCT00965757|3929088|P1|Double-blind Phase|Adverse drug reaction|2
1196078|NCT00965757|3929085|P4|Double-blind Phase|Progression of concomitant disease|0
1196079|NCT00965757|3929086|P3|Double-blind Phase|Progression of concomitant disease|0
1196080|NCT00965757|3929087|P2|Double-blind Phase|Progression of concomitant disease|2
1196081|NCT00965757|3929088|P1|Double-blind Phase|Progression of concomitant disease|1
1196082|NCT00965731|3929122|P2|Overall Study|Not specified|15
1196083|NCT00965731|3929123|P1|Overall Study|Not specified|7
1196084|NCT00965731|3929122|P2|Overall Study|Withdrawal by Subject|1
1196085|NCT00965731|3929123|P1|Overall Study|Withdrawal by Subject|0
1196086|NCT00965731|3929122|P2|Overall Study|Death|4
1196087|NCT00965731|3929123|P1|Overall Study|Death|0
1196088|NCT00965718|3929187|P1|Overall Study|Withdrawal by Subject|4
1196089|NCT00965562|3929200|P3|Overall Study|Withdrawal by Subject|0
1196090|NCT00965562|3929201|P2|Overall Study|Withdrawal by Subject|2
1196091|NCT00965562|3929202|P1|Overall Study|Withdrawal by Subject|2
1196092|NCT00965562|3929200|P3|Overall Study|Lost to Follow-up|3
1196093|NCT00965562|3929201|P2|Overall Study|Lost to Follow-up|2
1196094|NCT00965562|3929202|P1|Overall Study|Lost to Follow-up|1
1196095|NCT00965523|3929240|P1|Study 224|Physician Decision|1
1196096|NCT00965523|3929240|P1|Study 224|Progressive Disease|5
1196097|NCT00965523|3929240|P1|Study 221|Physician Decision|3
1196098|NCT00965523|3929240|P1|Study 221|Progressive Disease|4
1196099|NCT00965497|3929245|P1|Overall Study|Physician Decision|1
1196100|NCT00965484|3929250|P1|Overall Study|Withdrawal by Subject|1
1196101|NCT00965484|3929250|P1|Overall Study|Protocol Violation|1
1196102|NCT00965458|3929259|P2|Overall Study|Withdrawal by Subject|1
1196103|NCT00965458|3929260|P1|Overall Study|Withdrawal by Subject|0
1196104|NCT00965458|3929259|P2|Overall Study|Lost to Follow-up|3
1196105|NCT00965458|3929260|P1|Overall Study|Lost to Follow-up|1
1196106|NCT00965458|3929259|P2|Overall Study|Adverse Event|0
1196107|NCT00965458|3929260|P1|Overall Study|Adverse Event|1
1196108|NCT00965419|3929276|P1|Follow-up Phase|Lack of Efficacy|28
1196109|NCT00965419|3929276|P1|Follow-up Phase|Parent/Caregiver Decision|9
1196110|NCT00965419|3929276|P1|Follow-up Phase|Physician Decision|4
1196111|NCT00965419|3929276|P1|Follow-up Phase|Withdrawal by Subject|8
1196112|NCT00965419|3929276|P1|Follow-up Phase|Protocol Violation|4
1196113|NCT00965419|3929276|P1|Follow-up Phase|Adverse Event|9
1196114|NCT00965419|3929276|P1|Open Label Treatment for Responders|Lost to Follow-up|46
1196115|NCT00965419|3929276|P1|Open Label Treatment for Responders|Lack of Efficacy|67
1196116|NCT00965419|3929276|P1|Open Label Treatment for Responders|Parent/Caregiver Decision|41
1196117|NCT00965419|3929276|P1|Open Label Treatment for Responders|Sponsor Decision|5
1196118|NCT00965419|3929276|P1|Open Label Treatment for Responders|Physician Decision|6
1196119|NCT00965419|3929276|P1|Open Label Treatment for Responders|Withdrawal by Subject|27
1196120|NCT00965419|3929276|P1|Open Label Treatment for Responders|Protocol Violation|21
1196121|NCT00965419|3929276|P1|Open Label Treatment for Responders|Entry Criteria Not Met|1
1196122|NCT00965419|3929276|P1|Open Label Treatment for Responders|Adverse Event|33
1196123|NCT00965341|3929322|P2|Overall Study|Transportation issues|3
1196124|NCT00965341|3929323|P1|Overall Study|Transportation issues|4
1196125|NCT00965341|3929322|P2|Overall Study|Lost to Follow-up|0
1196126|NCT00965341|3929323|P1|Overall Study|Lost to Follow-up|1
1196127|NCT00965341|3929322|P2|Overall Study|Withdrew consent|5
1196128|NCT00965341|3929323|P1|Overall Study|Withdrew consent|1
1196129|NCT00965263|3929333|P2|Overall Study|Protocol Violation|2
1196130|NCT00965263|3929334|P1|Overall Study|Protocol Violation|0
1196131|NCT00965263|3929333|P2|Overall Study|Family emergency|1
1196132|NCT00965263|3929334|P1|Overall Study|Family emergency|0
1196133|NCT00965263|3929333|P2|Overall Study|Physician Decision|0
1196134|NCT00965263|3929334|P1|Overall Study|Physician Decision|2
1196135|NCT00965185|3929394|P2|Overall Study|Withdrawal by Subject|1
1196136|NCT00965185|3929395|P1|Overall Study|Withdrawal by Subject|0
1196137|NCT00965185|3929394|P2|Overall Study|Lost to Follow-up|0
1196138|NCT00965185|3929395|P1|Overall Study|Lost to Follow-up|2
1196139|NCT00965146|3929415|P1|Overall Study|Overall Study Termination|145
1196140|NCT00965146|3929415|P1|Overall Study|Revision / Removal of Study Implant|6
1196141|NCT00965146|3929415|P1|Overall Study|Intercurrent illness|1
1196142|NCT00965146|3929415|P1|Overall Study|Unwilling to return|11
1196143|NCT00965146|3929415|P1|Overall Study|Unable to return|1
1196144|NCT00965146|3929415|P1|Overall Study|Withdrawal by Subject|17
1196145|NCT00965146|3929415|P1|Overall Study|Lost to Follow-up|22
1196146|NCT00965146|3929415|P1|Overall Study|Death|7
1196147|NCT00965094|3929422|P2|Overall Study|Lost to Follow-up|1
1196148|NCT00965094|3929423|P1|Overall Study|Lost to Follow-up|0
1196149|NCT00965094|3929422|P2|Overall Study|Adverse Event|0
1196150|NCT00965094|3929423|P1|Overall Study|Adverse Event|5
1196151|NCT00965081|3929439|P2|Overall Study|Switched to Rescue Arm|12
1196152|NCT00965081|3929440|P1|Overall Study|Switched to Rescue Arm|5
1196153|NCT00965081|3929439|P2|Overall Study|Withdrawal by Subject|7
1196154|NCT00965081|3929440|P1|Overall Study|Withdrawal by Subject|4
1196155|NCT00965081|3929439|P2|Overall Study|Sponsor Decision|0
1196156|NCT00965081|3929440|P1|Overall Study|Sponsor Decision|1
1196157|NCT00965081|3929439|P2|Overall Study|Protocol Violation|5
1196158|NCT00965081|3929440|P1|Overall Study|Protocol Violation|2
1196159|NCT00965081|3929439|P2|Overall Study|Physician Decision|0
1196160|NCT00965081|3929440|P1|Overall Study|Physician Decision|2
1196161|NCT00965081|3929439|P2|Overall Study|Lost to Follow-up|5
1196162|NCT00965081|3929440|P1|Overall Study|Lost to Follow-up|4
1196163|NCT00965081|3929439|P2|Overall Study|Lack of Efficacy|5
1196164|NCT00965081|3929440|P1|Overall Study|Lack of Efficacy|2
1196165|NCT00965081|3929439|P2|Overall Study|Adverse Event|9
1196166|NCT00965081|3929440|P1|Overall Study|Adverse Event|14
1196167|NCT00964886|3929467|P4|Overall Study|Protocol Violation|0
1196168|NCT00964886|3929468|P3|Overall Study|Protocol Violation|0
1196169|NCT00964886|3929469|P2|Overall Study|Protocol Violation|2
1196170|NCT00964886|3929470|P1|Overall Study|Protocol Violation|0
1196171|NCT00964886|3929467|P4|Overall Study|Adverse Event|2
1196172|NCT00964886|3929468|P3|Overall Study|Adverse Event|5
1196173|NCT00964886|3929469|P2|Overall Study|Adverse Event|1
1196174|NCT00964886|3929470|P1|Overall Study|Adverse Event|3
1196175|NCT00964886|3929467|P4|Overall Study|Withdrawal by Subject|3
1196176|NCT00964886|3929468|P3|Overall Study|Withdrawal by Subject|5
1196177|NCT00964886|3929469|P2|Overall Study|Withdrawal by Subject|2
1196178|NCT00964886|3929470|P1|Overall Study|Withdrawal by Subject|6
1196179|NCT00964886|3929467|P4|Overall Study|Lost to Follow-up|4
1196180|NCT00964886|3929468|P3|Overall Study|Lost to Follow-up|6
1196181|NCT00964886|3929469|P2|Overall Study|Lost to Follow-up|2
1196182|NCT00964886|3929470|P1|Overall Study|Lost to Follow-up|2
1196183|NCT00964860|3929486|P2|Overall Study|Withdrawal by Subject|1
1196184|NCT00964860|3929487|P1|Overall Study|Withdrawal by Subject|0
1196185|NCT00964795|3929495|P1|Overall Study|Other|23
1196186|NCT00964795|3929495|P1|Overall Study|Unwilling to sign ICF for amendment 4|3
1196187|NCT00964795|3929495|P1|Overall Study|Termination of Study by Sponsor|169
1196188|NCT00964795|3929495|P1|Overall Study|Lost to Follow-up|7
1196189|NCT00964795|3929495|P1|Overall Study|Death|14
1196190|NCT00964795|3929495|P1|Overall Study|Adverse Event|12
1196191|NCT00964795|3929495|P1|Overall Study|Withdrawal by Subject|79
1196192|NCT00964743|3929502|P1|Overall Study|Neither patient completed 8 weeks of tre|2
1196193|NCT00964678|3929510|P1|Overall Study|Physician Decision|4
1196194|NCT00964392|3929574|P2|Overall Study|Not completed|168
1196195|NCT00964392|3929575|P1|Overall Study|Not completed|44
1196196|NCT00964392|3929574|P2|Overall Study|Early Termination, non-study arrhythmia|6
1196197|NCT00964392|3929575|P1|Overall Study|Early Termination, non-study arrhythmia|1
1196198|NCT00964392|3929574|P2|Overall Study|Lost to Follow-up|10
1196199|NCT00964392|3929575|P1|Overall Study|Lost to Follow-up|4
1196200|NCT00964392|3929574|P2|Overall Study|Withdrawal by Subject|6
1196201|NCT00964392|3929575|P1|Overall Study|Withdrawal by Subject|4
1196202|NCT00964366|3929585|P2|Overall Study|Withdrawal by Subject|1
1196203|NCT00964366|3929586|P1|Overall Study|Withdrawal by Subject|0
1196204|NCT00964366|3929585|P2|Overall Study|Did not qualify at Day 1|0
1196205|NCT00964366|3929586|P1|Overall Study|Did not qualify at Day 1|1
1196206|NCT00964223|3929600|P1|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
1196207|NCT00964158|3929668|P3|Overall Study|Withdrawal by Subject|6
1196208|NCT00964158|3929669|P2|Overall Study|Withdrawal by Subject|0
1196209|NCT00964158|3929670|P1|Overall Study|Withdrawal by Subject|0
1196210|NCT00964158|3929668|P3|Overall Study|Lost to Follow-up|2
1196211|NCT00964158|3929669|P2|Overall Study|Lost to Follow-up|1
1196212|NCT00964158|3929670|P1|Overall Study|Lost to Follow-up|0
1196213|NCT00964028|3929745|P2|Overall Study|Withdrawal by Subject|1
1196214|NCT00964028|3929746|P1|Overall Study|Withdrawal by Subject|0
1196215|NCT00963937|3929761|P3|Overall Study|Physician Decision|4
1196216|NCT00963937|3929762|P2|Overall Study|Physician Decision|10
1196217|NCT00963937|3929763|P1|Overall Study|Physician Decision|18
1196218|NCT00963937|3929761|P3|Overall Study|Protocol Violation|0
1196219|NCT00963937|3929762|P2|Overall Study|Protocol Violation|1
1196220|NCT00963937|3929763|P1|Overall Study|Protocol Violation|1
1196221|NCT00963924|3929801|P2|Overall Study|Lost to Follow-up|1
1196222|NCT00963924|3929802|P1|Overall Study|Lost to Follow-up|0
1196223|NCT00963924|3929801|P2|Overall Study|Changed antipsychotic|1
1196224|NCT00963924|3929802|P1|Overall Study|Changed antipsychotic|0
1196225|NCT00963924|3929801|P2|Overall Study|Withdrawal by Subject|1
1196226|NCT00963924|3929802|P1|Overall Study|Withdrawal by Subject|0
1196227|NCT00963924|3929801|P2|Overall Study|Adverse Event|0
1196228|NCT00963924|3929802|P1|Overall Study|Adverse Event|1
1196229|NCT00963820|3929876|P12|Expansion Phase|Unsatisfactory Therapeutic Response|1
1196230|NCT00963820|3929877|P11|Expansion Phase|Unsatisfactory Therapeutic Response|0
1196231|NCT00963820|3929878|P10|Expansion Phase|Unsatisfactory Therapeutic Response|0
1196232|NCT00963820|3929879|P9|Expansion Phase|Unsatisfactory Therapeutic Response|0
1196233|NCT00963820|3929880|P8|Expansion Phase|Unsatisfactory Therapeutic Response|0
1196234|NCT00963820|3929881|P7|Expansion Phase|Unsatisfactory Therapeutic Response|0
1196235|NCT00963820|3929882|P6|Expansion Phase|Unsatisfactory Therapeutic Response|0
1196236|NCT00963820|3929883|P5|Expansion Phase|Unsatisfactory Therapeutic Response|0
1196237|NCT00963820|3929884|P4|Expansion Phase|Unsatisfactory Therapeutic Response|0
1196238|NCT00963820|3929885|P3|Expansion Phase|Unsatisfactory Therapeutic Response|0
1196239|NCT00963820|3929886|P2|Expansion Phase|Unsatisfactory Therapeutic Response|0
1196240|NCT00963820|3929887|P1|Expansion Phase|Unsatisfactory Therapeutic Response|0
1196241|NCT00963820|3929876|P12|Expansion Phase|Withdrawal by Subject|1
1196242|NCT00963820|3929877|P11|Expansion Phase|Withdrawal by Subject|1
1196243|NCT00963820|3929878|P10|Expansion Phase|Withdrawal by Subject|0
1196244|NCT00963820|3929879|P9|Expansion Phase|Withdrawal by Subject|1
1196245|NCT00963820|3929880|P8|Expansion Phase|Withdrawal by Subject|0
1196246|NCT00963820|3929881|P7|Expansion Phase|Withdrawal by Subject|0
1196247|NCT00963820|3929882|P6|Expansion Phase|Withdrawal by Subject|0
1196248|NCT00963820|3929883|P5|Expansion Phase|Withdrawal by Subject|0
1196249|NCT00963820|3929884|P4|Expansion Phase|Withdrawal by Subject|0
1196250|NCT00963820|3929885|P3|Expansion Phase|Withdrawal by Subject|0
1196251|NCT00963820|3929886|P2|Expansion Phase|Withdrawal by Subject|0
1196252|NCT00963820|3929887|P1|Expansion Phase|Withdrawal by Subject|0
1196253|NCT00963820|3929876|P12|Expansion Phase|Adverse Event|0
1196254|NCT00963820|3929877|P11|Expansion Phase|Adverse Event|0
1196255|NCT00963820|3929878|P10|Expansion Phase|Adverse Event|3
1196256|NCT00963820|3929879|P9|Expansion Phase|Adverse Event|1
1196257|NCT00963820|3929880|P8|Expansion Phase|Adverse Event|0
1196258|NCT00963820|3929881|P7|Expansion Phase|Adverse Event|0
1196259|NCT00963820|3929882|P6|Expansion Phase|Adverse Event|0
1196260|NCT00963820|3929883|P5|Expansion Phase|Adverse Event|0
1196261|NCT00963820|3929884|P4|Expansion Phase|Adverse Event|0
1196262|NCT00963820|3929885|P3|Expansion Phase|Adverse Event|0
1196263|NCT00963820|3929886|P2|Expansion Phase|Adverse Event|0
1196264|NCT00963820|3929887|P1|Expansion Phase|Adverse Event|0
1196265|NCT00963820|3929876|P12|Expansion Phase|Progressive Disease|2
1196266|NCT00963820|3929877|P11|Expansion Phase|Progressive Disease|4
1196267|NCT00963820|3929878|P10|Expansion Phase|Progressive Disease|6
1196268|NCT00963820|3929879|P9|Expansion Phase|Progressive Disease|8
1196269|NCT00963820|3929880|P8|Expansion Phase|Progressive Disease|0
1196270|NCT00963820|3929881|P7|Expansion Phase|Progressive Disease|0
1196271|NCT00963820|3929882|P6|Expansion Phase|Progressive Disease|0
1196272|NCT00963820|3929883|P5|Expansion Phase|Progressive Disease|0
1196273|NCT00963820|3929884|P4|Expansion Phase|Progressive Disease|0
1196274|NCT00963820|3929885|P3|Expansion Phase|Progressive Disease|0
1196275|NCT00963820|3929886|P2|Expansion Phase|Progressive Disease|0
1196276|NCT00963820|3929887|P1|Expansion Phase|Progressive Disease|0
1196277|NCT00963820|3929876|P12|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
1196278|NCT00963820|3929877|P11|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
1196279|NCT00963820|3929878|P10|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
1196280|NCT00963820|3929879|P9|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
1196281|NCT00963820|3929880|P8|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
1196282|NCT00963820|3929881|P7|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
1196283|NCT00963820|3929882|P6|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
1196284|NCT00963820|3929883|P5|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
1196285|NCT00963820|3929884|P4|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
1196286|NCT00963820|3929885|P3|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
1196287|NCT00963820|3929886|P2|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
1196288|NCT00963820|3929887|P1|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
1196289|NCT00963820|3929876|P12|Dose Escalation Phase|Withdrawal by Subject|0
1196290|NCT00963820|3929877|P11|Dose Escalation Phase|Withdrawal by Subject|0
1196291|NCT00963820|3929878|P10|Dose Escalation Phase|Withdrawal by Subject|0
1196292|NCT00963820|3929879|P9|Dose Escalation Phase|Withdrawal by Subject|0
1196293|NCT00963820|3929880|P8|Dose Escalation Phase|Withdrawal by Subject|2
1196294|NCT00963820|3929881|P7|Dose Escalation Phase|Withdrawal by Subject|1
1196295|NCT00963820|3929882|P6|Dose Escalation Phase|Withdrawal by Subject|0
1196296|NCT00963820|3929883|P5|Dose Escalation Phase|Withdrawal by Subject|0
1196297|NCT00963820|3929884|P4|Dose Escalation Phase|Withdrawal by Subject|0
1196298|NCT00963820|3929885|P3|Dose Escalation Phase|Withdrawal by Subject|0
1196299|NCT00963820|3929886|P2|Dose Escalation Phase|Withdrawal by Subject|0
1196300|NCT00963820|3929887|P1|Dose Escalation Phase|Withdrawal by Subject|0
1196301|NCT00963820|3929876|P12|Dose Escalation Phase|Adverse Event|0
1196302|NCT00963820|3929877|P11|Dose Escalation Phase|Adverse Event|0
1196303|NCT00963820|3929878|P10|Dose Escalation Phase|Adverse Event|0
1196304|NCT00963820|3929879|P9|Dose Escalation Phase|Adverse Event|0
1196305|NCT00963820|3929880|P8|Dose Escalation Phase|Adverse Event|1
1196306|NCT00963820|3929881|P7|Dose Escalation Phase|Adverse Event|3
1196307|NCT00963820|3929882|P6|Dose Escalation Phase|Adverse Event|0
1196308|NCT00963820|3929883|P5|Dose Escalation Phase|Adverse Event|0
1196309|NCT00963820|3929884|P4|Dose Escalation Phase|Adverse Event|0
1196310|NCT00963820|3929885|P3|Dose Escalation Phase|Adverse Event|0
1196311|NCT00963820|3929886|P2|Dose Escalation Phase|Adverse Event|0
1196312|NCT00963820|3929887|P1|Dose Escalation Phase|Adverse Event|0
1196313|NCT00963820|3929876|P12|Dose Escalation Phase|Progressive Disease|0
1196314|NCT00963820|3929877|P11|Dose Escalation Phase|Progressive Disease|0
1196315|NCT00963820|3929878|P10|Dose Escalation Phase|Progressive Disease|0
1196316|NCT00963820|3929879|P9|Dose Escalation Phase|Progressive Disease|0
1196317|NCT00963820|3929880|P8|Dose Escalation Phase|Progressive Disease|2
1196318|NCT00963820|3929881|P7|Dose Escalation Phase|Progressive Disease|3
1196319|NCT00963820|3929882|P6|Dose Escalation Phase|Progressive Disease|3
1196320|NCT00963820|3929883|P5|Dose Escalation Phase|Progressive Disease|4
1196321|NCT00963820|3929884|P4|Dose Escalation Phase|Progressive Disease|3
1196322|NCT00963820|3929885|P3|Dose Escalation Phase|Progressive Disease|3
1196323|NCT00963820|3929886|P2|Dose Escalation Phase|Progressive Disease|3
1196324|NCT00963820|3929887|P1|Dose Escalation Phase|Progressive Disease|3
1196325|NCT00963807|3930023|P1|Overall Study|Disease progression|15
1196326|NCT00963807|3930023|P1|Overall Study|Reaction to study chemotherapy regimen|1
1196327|NCT00963807|3930023|P1|Overall Study|Physician Decision|2
1196328|NCT00963599|3930056|P4|Overall Study|Withdrawal by Subject|3
1196329|NCT00963599|3930057|P3|Overall Study|Withdrawal by Subject|3
1196330|NCT00963599|3930058|P2|Overall Study|Withdrawal by Subject|1
1196331|NCT00963599|3930059|P1|Overall Study|Withdrawal by Subject|2
1196332|NCT00963599|3930056|P4|Overall Study|Protocol Violation|4
1196333|NCT00963599|3930057|P3|Overall Study|Protocol Violation|3
1196334|NCT00963599|3930058|P2|Overall Study|Protocol Violation|2
1196335|NCT00963599|3930059|P1|Overall Study|Protocol Violation|2
1196336|NCT00963599|3930056|P4|Overall Study|Lost to Follow-up|1
1196337|NCT00963599|3930057|P3|Overall Study|Lost to Follow-up|1
1196338|NCT00963599|3930058|P2|Overall Study|Lost to Follow-up|1
1196339|NCT00963599|3930059|P1|Overall Study|Lost to Follow-up|0
1196340|NCT00963599|3930056|P4|Overall Study|Lack of Efficacy|4
1196341|NCT00963599|3930057|P3|Overall Study|Lack of Efficacy|1
1196342|NCT00963599|3930058|P2|Overall Study|Lack of Efficacy|2
1196343|NCT00963599|3930059|P1|Overall Study|Lack of Efficacy|0
1196344|NCT00963599|3930056|P4|Overall Study|Adverse Event|2
1196345|NCT00963599|3930057|P3|Overall Study|Adverse Event|1
1196346|NCT00963599|3930058|P2|Overall Study|Adverse Event|0
1196347|NCT00963599|3930059|P1|Overall Study|Adverse Event|2
1196348|NCT00963547|3930130|P7|Overall Study|Reason Unknown|0
1196349|NCT00963547|3930131|P6|Overall Study|Reason Unknown|0
1196350|NCT00963547|3930132|P5|Overall Study|Reason Unknown|0
1196351|NCT00963547|3930133|P4|Overall Study|Reason Unknown|0
1196352|NCT00963547|3930134|P3|Overall Study|Reason Unknown|0
1196353|NCT00963547|3930135|P2|Overall Study|Reason Unknown|1
1196354|NCT00963547|3930136|P1|Overall Study|Reason Unknown|0
1196355|NCT00963547|3930130|P7|Overall Study|Withdrawal by Subject|0
1196356|NCT00963547|3930131|P6|Overall Study|Withdrawal by Subject|0
1196357|NCT00963547|3930132|P5|Overall Study|Withdrawal by Subject|0
1196358|NCT00963547|3930133|P4|Overall Study|Withdrawal by Subject|0
1196359|NCT00963547|3930134|P3|Overall Study|Withdrawal by Subject|3
1196360|NCT00963547|3930135|P2|Overall Study|Withdrawal by Subject|0
1196361|NCT00963547|3930136|P1|Overall Study|Withdrawal by Subject|0
1196362|NCT00963547|3930130|P7|Overall Study|Progressive Disease|0
1196363|NCT00963547|3930131|P6|Overall Study|Progressive Disease|0
1196364|NCT00963547|3930132|P5|Overall Study|Progressive Disease|0
1196365|NCT00963547|3930133|P4|Overall Study|Progressive Disease|5
1196366|NCT00963547|3930134|P3|Overall Study|Progressive Disease|9
1196367|NCT00963547|3930135|P2|Overall Study|Progressive Disease|8
1196368|NCT00963547|3930136|P1|Overall Study|Progressive Disease|3
1196369|NCT00963547|3930130|P7|Overall Study|Physician Decision|0
1196370|NCT00963547|3930131|P6|Overall Study|Physician Decision|0
1196371|NCT00963547|3930132|P5|Overall Study|Physician Decision|0
1196372|NCT00963547|3930133|P4|Overall Study|Physician Decision|0
1196373|NCT00963547|3930134|P3|Overall Study|Physician Decision|0
1196374|NCT00963547|3930135|P2|Overall Study|Physician Decision|1
1196375|NCT00963547|3930136|P1|Overall Study|Physician Decision|1
1196376|NCT00963547|3930130|P7|Overall Study|Adverse Event|0
1196377|NCT00963547|3930131|P6|Overall Study|Adverse Event|0
1196378|NCT00963547|3930132|P5|Overall Study|Adverse Event|0
1196379|NCT00963547|3930133|P4|Overall Study|Adverse Event|1
1196380|NCT00963547|3930134|P3|Overall Study|Adverse Event|0
1196381|NCT00963547|3930135|P2|Overall Study|Adverse Event|1
1196382|NCT00963547|3930136|P1|Overall Study|Adverse Event|0
1196383|NCT00963469|3930183|P3|Overall Study|Site closed (local pollen Season ended)|3
1196384|NCT00963469|3930184|P2|Overall Study|Site closed (local pollen Season ended)|1
1196385|NCT00963469|3930185|P1|Overall Study|Site closed (local pollen Season ended)|4
1196386|NCT00963469|3930183|P3|Overall Study|Moved|0
1196387|NCT00963469|3930184|P2|Overall Study|Moved|0
1196388|NCT00963469|3930185|P1|Overall Study|Moved|1
1196389|NCT00963469|3930183|P3|Overall Study|Pre-randomization Adverse Event|0
1196390|NCT00963469|3930184|P2|Overall Study|Pre-randomization Adverse Event|2
1196391|NCT00963469|3930185|P1|Overall Study|Pre-randomization Adverse Event|1
1196392|NCT00963469|3930183|P3|Overall Study|Withdrawal by Subject|1
1196393|NCT00963469|3930184|P2|Overall Study|Withdrawal by Subject|1
1196394|NCT00963469|3930185|P1|Overall Study|Withdrawal by Subject|4
1196395|NCT00963469|3930183|P3|Overall Study|Protocol Violation|3
1196396|NCT00963469|3930184|P2|Overall Study|Protocol Violation|5
1196397|NCT00963469|3930185|P1|Overall Study|Protocol Violation|5
1196398|NCT00963469|3930183|P3|Overall Study|Lost to Follow-up|0
1196399|NCT00963469|3930184|P2|Overall Study|Lost to Follow-up|1
1196400|NCT00963469|3930185|P1|Overall Study|Lost to Follow-up|1
1196401|NCT00963469|3930183|P3|Overall Study|Lack of Efficacy|2
1196402|NCT00963469|3930184|P2|Overall Study|Lack of Efficacy|7
1196403|NCT00963469|3930185|P1|Overall Study|Lack of Efficacy|10
1196404|NCT00963469|3930183|P3|Overall Study|Adverse Event|1
1196405|NCT00963469|3930184|P2|Overall Study|Adverse Event|11
1196406|NCT00963469|3930185|P1|Overall Study|Adverse Event|15
1196407|NCT00963235|3930252|P1|Overall Study|Other|1
1196408|NCT00963235|3930252|P1|Overall Study|Physician Decision|2
1196409|NCT00963235|3930252|P1|Overall Study|Adverse Event|5
1196410|NCT00963235|3930252|P1|Overall Study|Protocol Violation|7
1196411|NCT00963235|3930252|P1|Overall Study|Failed to return|9
1196412|NCT00963235|3930252|P1|Overall Study|Lost to Follow-up|14
1196413|NCT00963235|3930252|P1|Overall Study|Withdrawal by Subject|22
1196414|NCT00962780|3930544|P2|Overall Study|Other|1
1196415|NCT00962780|3930545|P1|Overall Study|Other|0
1196416|NCT00962780|3930544|P2|Overall Study|Withdrawal by Subject|8
1196417|NCT00962780|3930545|P1|Overall Study|Withdrawal by Subject|1
1196418|NCT00962780|3930544|P2|Overall Study|Protocol Violation|4
1196419|NCT00962780|3930545|P1|Overall Study|Protocol Violation|9
1196420|NCT00962780|3930544|P2|Overall Study|Death|1
1196421|NCT00962780|3930545|P1|Overall Study|Death|0
1196422|NCT00962741|3930620|P1|Overall Study|drug ineffective+prohibited drug taken|1
1196423|NCT00962741|3930620|P1|Overall Study|Lack of Efficacy|1
1196424|NCT00962741|3930620|P1|Overall Study|Withdrawal by Subject|1
1196425|NCT00962741|3930620|P1|Overall Study|Lost to Follow-up|2
1196426|NCT00962741|3930620|P1|Overall Study|Failed to return|3
1196427|NCT00962650|3930711|P1|Overall Study|Transgastric DP was not completed|2
1196428|NCT00962585|3930730|P4|Overall Study|Withdrew Consent|0
1196429|NCT00962585|3930731|P3|Overall Study|Withdrew Consent|0
1196430|NCT00962585|3930732|P2|Overall Study|Withdrew Consent|0
1196431|NCT00962585|3930733|P1|Overall Study|Withdrew Consent|2
1196432|NCT00962585|3930730|P4|Overall Study|Withdrawal by Subject|0
1196433|NCT00962585|3930731|P3|Overall Study|Withdrawal by Subject|0
1196434|NCT00962585|3930732|P2|Overall Study|Withdrawal by Subject|0
1196435|NCT00962585|3930733|P1|Overall Study|Withdrawal by Subject|1
1196436|NCT00962585|3930730|P4|Overall Study|Protocol Violation|0
1196437|NCT00962585|3930731|P3|Overall Study|Protocol Violation|1
1196438|NCT00962585|3930732|P2|Overall Study|Protocol Violation|0
1196439|NCT00962585|3930733|P1|Overall Study|Protocol Violation|0
1196440|NCT00962585|3930730|P4|Overall Study|Lost to Follow-up|0
1196441|NCT00962585|3930731|P3|Overall Study|Lost to Follow-up|1
1196442|NCT00962585|3930732|P2|Overall Study|Lost to Follow-up|0
1196443|NCT00962585|3930733|P1|Overall Study|Lost to Follow-up|3
1196444|NCT00962585|3930730|P4|Overall Study|Adverse Event|0
1196445|NCT00962585|3930731|P3|Overall Study|Adverse Event|1
1196446|NCT00962585|3930732|P2|Overall Study|Adverse Event|2
1196447|NCT00962585|3930733|P1|Overall Study|Adverse Event|0
1196448|NCT00962390|3930795|P4|Overall Study|Withdrawal by Subject|0
1196449|NCT00962390|3930796|P3|Overall Study|Withdrawal by Subject|1
1196450|NCT00962390|3930797|P2|Overall Study|Withdrawal by Subject|1
1196451|NCT00962390|3930798|P1|Overall Study|Withdrawal by Subject|1
1196452|NCT00962390|3930795|P4|Overall Study|Protocol Violation|0
1196453|NCT00962390|3930796|P3|Overall Study|Protocol Violation|0
1196454|NCT00962390|3930797|P2|Overall Study|Protocol Violation|0
1196455|NCT00962390|3930798|P1|Overall Study|Protocol Violation|1
1196456|NCT00962390|3930795|P4|Overall Study|Lost to Follow-up|0
1196457|NCT00962390|3930796|P3|Overall Study|Lost to Follow-up|0
1196458|NCT00962390|3930797|P2|Overall Study|Lost to Follow-up|2
1196459|NCT00962390|3930798|P1|Overall Study|Lost to Follow-up|2
1196460|NCT00962390|3930795|P4|Overall Study|Adverse Event|1
1196461|NCT00962390|3930796|P3|Overall Study|Adverse Event|3
1196462|NCT00962390|3930797|P2|Overall Study|Adverse Event|0
1196463|NCT00962390|3930798|P1|Overall Study|Adverse Event|0
1196464|NCT00962247|3930860|P1|25% Reduction of Sedentary Activity|Withdrawal by Subject|1
1196465|NCT00962247|3930860|P1|25% Reduction of Sedentary Activity|Protocol Violation|4
1196466|NCT00962247|3930860|P1|Usual Sedentary|Withdrawal by Subject|5
1196467|NCT00962247|3930860|P1|Usual Sedentary|Protocol Violation|13
1196468|NCT00962208|3930871|P2|Overall Study|Lost to Follow-up|9
1196469|NCT00962208|3930872|P1|Overall Study|Lost to Follow-up|0
1196470|NCT00962208|3930871|P2|Overall Study|Contraindicated to continue study|1
1196471|NCT00962208|3930872|P1|Overall Study|Contraindicated to continue study|5
1196472|NCT00962208|3930871|P2|Overall Study|Could not achieve good vision|0
1196473|NCT00962208|3930872|P1|Overall Study|Could not achieve good vision|9
1196474|NCT00962104|3930880|P2|Overall Study|Other|0
1196475|NCT00962104|3930881|P1|Overall Study|Other|2
1196476|NCT00962104|3930880|P2|Overall Study|Withdrawal by Subject|6
1196477|NCT00962104|3930881|P1|Overall Study|Withdrawal by Subject|10
1196478|NCT00962104|3930880|P2|Overall Study|Sponsor Decision|1
1196479|NCT00962104|3930881|P1|Overall Study|Sponsor Decision|0
1196480|NCT00962104|3930880|P2|Overall Study|Protocol Violation|8
1196481|NCT00962104|3930881|P1|Overall Study|Protocol Violation|6
1196482|NCT00962104|3930880|P2|Overall Study|Physician Decision|0
1196483|NCT00962104|3930881|P1|Overall Study|Physician Decision|1
1196484|NCT00962104|3930880|P2|Overall Study|Lost to Follow-up|4
1196485|NCT00962104|3930881|P1|Overall Study|Lost to Follow-up|10
1196486|NCT00962104|3930880|P2|Overall Study|Lack of Efficacy|1
1196487|NCT00962104|3930881|P1|Overall Study|Lack of Efficacy|0
1196488|NCT00962104|3930880|P2|Overall Study|Entry Criteria Not Met|2
1196489|NCT00962104|3930881|P1|Overall Study|Entry Criteria Not Met|1
1196490|NCT00962104|3930880|P2|Overall Study|Adverse Event|3
1196491|NCT00962104|3930881|P1|Overall Study|Adverse Event|10
1196492|NCT00962013|3930935|P1|Overall Study|No 5 year evaluation|6
1196493|NCT00962013|3930935|P1|Overall Study|Site Termination|24
1196494|NCT00962013|3930935|P1|Overall Study|Removal of study device|3
1196495|NCT00962013|3930935|P1|Overall Study|Withdrawal by Subject|8
1196496|NCT00962013|3930935|P1|Overall Study|Unable/Unwilling to return|6
1196497|NCT00962013|3930935|P1|Overall Study|Lost to Follow-up|12
1196498|NCT00962013|3930935|P1|Overall Study|Death|8
1196499|NCT00962013|3930935|P1|Overall Study|Did not have surgery|1
1196500|NCT00961896|3930958|P3|Overall Study|Abnormal laboratory value|1
1196501|NCT00961896|3930959|P2|Overall Study|Abnormal laboratory value|0
1196502|NCT00961896|3930960|P1|Overall Study|Abnormal laboratory value|0
1196503|NCT00961649|3931027|P4|Overall Study|Study terminated by sponsor|1
1196504|NCT00961649|3931028|P3|Overall Study|Study terminated by sponsor|4
1196505|NCT00961649|3931029|P2|Overall Study|Study terminated by sponsor|4
1196506|NCT00961649|3931030|P1|Overall Study|Study terminated by sponsor|4
1196507|NCT00961649|3931027|P4|Overall Study|Patient left to Mexico-family emergency|0
1196508|NCT00961649|3931028|P3|Overall Study|Patient left to Mexico-family emergency|0
1196509|NCT00961649|3931029|P2|Overall Study|Patient left to Mexico-family emergency|0
1196510|NCT00961649|3931030|P1|Overall Study|Patient left to Mexico-family emergency|1
1196511|NCT00961649|3931027|P4|Overall Study|Patient has travel plans during holidays|0
1196512|NCT00961649|3931028|P3|Overall Study|Patient has travel plans during holidays|1
1196513|NCT00961649|3931029|P2|Overall Study|Patient has travel plans during holidays|0
1196514|NCT00961649|3931030|P1|Overall Study|Patient has travel plans during holidays|0
1196515|NCT00961649|3931027|P4|Overall Study|Inadequate control of IOP|1
1196516|NCT00961649|3931028|P3|Overall Study|Inadequate control of IOP|0
1196517|NCT00961649|3931029|P2|Overall Study|Inadequate control of IOP|0
1196518|NCT00961649|3931030|P1|Overall Study|Inadequate control of IOP|0
1196519|NCT00961649|3931027|P4|Overall Study|Adverse Event|2
1196520|NCT00961649|3931028|P3|Overall Study|Adverse Event|0
1196521|NCT00961649|3931029|P2|Overall Study|Adverse Event|0
1196522|NCT00961649|3931030|P1|Overall Study|Adverse Event|4
1196523|NCT00961636|3931044|P3|Overall Study|Withdrawal by Subject|13
1196524|NCT00961636|3931045|P2|Overall Study|Withdrawal by Subject|22
1196525|NCT00961636|3931046|P1|Overall Study|Withdrawal by Subject|29
1196526|NCT00961636|3931044|P3|Overall Study|Protocol Violation|1
1196527|NCT00961636|3931045|P2|Overall Study|Protocol Violation|5
1196528|NCT00961636|3931046|P1|Overall Study|Protocol Violation|9
1196529|NCT00961636|3931044|P3|Overall Study|Physician Decision|1
1196530|NCT00961636|3931045|P2|Overall Study|Physician Decision|1
1196531|NCT00961636|3931046|P1|Overall Study|Physician Decision|3
1196532|NCT00961636|3931044|P3|Overall Study|Lost to Follow-up|1
1196533|NCT00961636|3931045|P2|Overall Study|Lost to Follow-up|3
1196534|NCT00961636|3931046|P1|Overall Study|Lost to Follow-up|2
1196535|NCT00961636|3931044|P3|Overall Study|Flushing Symptoms|3
1196536|NCT00961636|3931045|P2|Overall Study|Flushing Symptoms|46
1196537|NCT00961636|3931046|P1|Overall Study|Flushing Symptoms|29
1196538|NCT00961636|3931044|P3|Overall Study|Adverse Event|13
1196539|NCT00961636|3931045|P2|Overall Study|Adverse Event|54
1196540|NCT00961636|3931046|P1|Overall Study|Adverse Event|35
1196541|NCT00961571|3931057|P1|Overall Study|Physician Decision|39
1196542|NCT00961415|3931085|P3|Maintenance Treatment Phase|Other reason|3
1196543|NCT00961415|3931086|P2|Maintenance Treatment Phase|Other reason|1
1196544|NCT00961415|3931087|P1|Maintenance Treatment Phase|Other reason|0
1196545|NCT00961415|3931085|P3|Maintenance Treatment Phase|Withdrawal by Subject|8
1196546|NCT00961415|3931086|P2|Maintenance Treatment Phase|Withdrawal by Subject|3
1196547|NCT00961415|3931087|P1|Maintenance Treatment Phase|Withdrawal by Subject|0
1196548|NCT00961415|3931085|P3|Maintenance Treatment Phase|Investigators decision|0
1196549|NCT00961415|3931086|P2|Maintenance Treatment Phase|Investigators decision|2
1196550|NCT00961415|3931087|P1|Maintenance Treatment Phase|Investigators decision|0
1196551|NCT00961415|3931085|P3|Maintenance Treatment Phase|Death|34
1196552|NCT00961415|3931086|P2|Maintenance Treatment Phase|Death|42
1196553|NCT00961415|3931087|P1|Maintenance Treatment Phase|Death|0
1196554|NCT00961415|3931085|P3|Induction Treatment Phase|Other Reason|0
1196555|NCT00961415|3931086|P2|Induction Treatment Phase|Other Reason|0
1196556|NCT00961415|3931087|P1|Induction Treatment Phase|Other Reason|5
1196557|NCT00961415|3931085|P3|Induction Treatment Phase|Didn’t meet maintenance phase criteria|0
1196558|NCT00961415|3931086|P2|Induction Treatment Phase|Didn’t meet maintenance phase criteria|0
1196559|NCT00961415|3931087|P1|Induction Treatment Phase|Didn’t meet maintenance phase criteria|27
1196560|NCT00961415|3931085|P3|Induction Treatment Phase|Physician Decision|0
1196561|NCT00961415|3931086|P2|Induction Treatment Phase|Physician Decision|0
1196562|NCT00961415|3931087|P1|Induction Treatment Phase|Physician Decision|2
1196563|NCT00961415|3931085|P3|Induction Treatment Phase|Protocol Violation|0
1196564|NCT00961415|3931086|P2|Induction Treatment Phase|Protocol Violation|0
1196565|NCT00961415|3931087|P1|Induction Treatment Phase|Protocol Violation|1
1196566|NCT00961415|3931085|P3|Induction Treatment Phase|Death|0
1196567|NCT00961415|3931086|P2|Induction Treatment Phase|Death|0
1196568|NCT00961415|3931087|P1|Induction Treatment Phase|Death|77
1196569|NCT00961415|3931085|P3|Induction Treatment Phase|Withdrawal by Subject|0
1196570|NCT00961415|3931086|P2|Induction Treatment Phase|Withdrawal by Subject|0
1196571|NCT00961415|3931087|P1|Induction Treatment Phase|Withdrawal by Subject|11
1196572|NCT00961350|3931127|P2|Overall Study|Misc|21
1196573|NCT00961350|3931128|P1|Overall Study|Misc|16
1196574|NCT00961350|3931127|P2|Overall Study|Lost to Follow-up|3
1196575|NCT00961350|3931128|P1|Overall Study|Lost to Follow-up|3
1196576|NCT00961350|3931127|P2|Overall Study|Withdrawal by Subject|10
1196577|NCT00961350|3931128|P1|Overall Study|Withdrawal by Subject|10
1196578|NCT00961350|3931127|P2|Overall Study|Adverse Event|33
1196579|NCT00961350|3931128|P1|Overall Study|Adverse Event|18
1196580|NCT00961298|3931149|P1|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1
1196581|NCT00961298|3931149|P1|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2
1196582|NCT00961298|3931149|P1|Two Week Placebo Run in|Withdrawal by Subject|1
1196583|NCT00961259|3931156|P3|Washout Period of 7 Days|due to concomitant medication used|0
1196584|NCT00961259|3931157|P2|Washout Period of 7 Days|due to concomitant medication used|1
1196585|NCT00961259|3931158|P1|Washout Period of 7 Days|due to concomitant medication used|0
1196586|NCT00961220|3931186|P1|Overall Study|Complete Response prior to 12 courses|1
1196587|NCT00961220|3931186|P1|Overall Study|O6BG no longer supplied|1
1196588|NCT00961220|3931186|P1|Overall Study|No IV access for O6BG|1
1196589|NCT00961220|3931186|P1|Overall Study|Lack of Efficacy|1
1196590|NCT00961220|3931186|P1|Overall Study|Adverse Event|3
1196591|NCT00961181|3931202|P1|Overall Study|Lost to Follow-up|1
1196592|NCT00961181|3931202|P1|Overall Study|Withdrawal by Subject|2
1196593|NCT00961181|3931202|P1|Overall Study|Death|2
1196594|NCT00961116|3931215|P2|Washout Period of 7 Days|Protocol Violation|1
1196595|NCT00961116|3931216|P1|Washout Period of 7 Days|Protocol Violation|0
1196596|NCT00961116|3931215|P2|Washout Period of 7 Days|Withdrawal by Subject|1
1196597|NCT00961116|3931216|P1|Washout Period of 7 Days|Withdrawal by Subject|1
1196598|NCT00961116|3931215|P2|Washout Period of 7 Days|Adverse Event|1
1196599|NCT00961116|3931216|P1|Washout Period of 7 Days|Adverse Event|1
1196600|NCT00960999|3931239|P2|Overall Study|RT dose constraints not met|0
1196601|NCT00960999|3931240|P1|Overall Study|RT dose constraints not met|2
1196602|NCT00960999|3931239|P2|Overall Study|Protocol Violation|2
1196603|NCT00960999|3931240|P1|Overall Study|Protocol Violation|5
1196604|NCT00960999|3931239|P2|Overall Study|Withdrawal by Subject|0
1196605|NCT00960999|3931240|P1|Overall Study|Withdrawal by Subject|1
1196606|NCT00960986|3931250|P4|Period 3 (7-week Therapy Period)|Lack of Efficacy|0
1196607|NCT00960986|3931251|P3|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
1196608|NCT00960986|3931252|P2|Period 3 (7-week Therapy Period)|Lack of Efficacy|2
1196609|NCT00960986|3931253|P1|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
1196610|NCT00960986|3931250|P4|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
1196611|NCT00960986|3931251|P3|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4
1196612|NCT00960986|3931252|P2|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
1196613|NCT00960986|3931253|P1|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
1196614|NCT00960986|3931250|P4|Period 3 (7-week Therapy Period)|Protocol Violation|11
1196615|NCT00960986|3931251|P3|Period 3 (7-week Therapy Period)|Protocol Violation|3
1196616|NCT00960986|3931252|P2|Period 3 (7-week Therapy Period)|Protocol Violation|4
1196617|NCT00960986|3931253|P1|Period 3 (7-week Therapy Period)|Protocol Violation|10
1196618|NCT00960986|3931250|P4|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
1196619|NCT00960986|3931251|P3|Period 3 (7-week Therapy Period)|Lost to Follow-up|1
1196620|NCT00960986|3931252|P2|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
1196621|NCT00960986|3931253|P1|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
1196622|NCT00960986|3931250|P4|Period 3 (7-week Therapy Period)|Death|0
1196623|NCT00960986|3931251|P3|Period 3 (7-week Therapy Period)|Death|1
1196624|NCT00960986|3931252|P2|Period 3 (7-week Therapy Period)|Death|0
1196625|NCT00960986|3931253|P1|Period 3 (7-week Therapy Period)|Death|0
1196626|NCT00960986|3931250|P4|Period 3 (7-week Therapy Period)|Adverse Event|12
1196627|NCT00960986|3931251|P3|Period 3 (7-week Therapy Period)|Adverse Event|10
1196628|NCT00960986|3931252|P2|Period 3 (7-week Therapy Period)|Adverse Event|15
1196629|NCT00960986|3931253|P1|Period 3 (7-week Therapy Period)|Adverse Event|17
1196630|NCT00960986|3931250|P4|Period 1 (Screening and Washout)|Withdrawal by Subject|1
1196631|NCT00960986|3931251|P3|Period 1 (Screening and Washout)|Withdrawal by Subject|1
1196632|NCT00960986|3931252|P2|Period 1 (Screening and Washout)|Withdrawal by Subject|2
1196633|NCT00960986|3931253|P1|Period 1 (Screening and Washout)|Withdrawal by Subject|1
1196634|NCT00960986|3931250|P4|Period 1 (Screening and Washout)|Protocol Violation|0
1196635|NCT00960986|3931251|P3|Period 1 (Screening and Washout)|Protocol Violation|0
1196636|NCT00960986|3931252|P2|Period 1 (Screening and Washout)|Protocol Violation|0
1196637|NCT00960986|3931253|P1|Period 1 (Screening and Washout)|Protocol Violation|1
1196638|NCT00960986|3931250|P4|Period 1 (Screening and Washout)|Lost to Follow-up|1
1196639|NCT00960986|3931251|P3|Period 1 (Screening and Washout)|Lost to Follow-up|2
1196640|NCT00960986|3931252|P2|Period 1 (Screening and Washout)|Lost to Follow-up|0
1196641|NCT00960986|3931253|P1|Period 1 (Screening and Washout)|Lost to Follow-up|0
1196642|NCT00960986|3931250|P4|Period 1 (Screening and Washout)|Adverse Event|1
1196643|NCT00960986|3931251|P3|Period 1 (Screening and Washout)|Adverse Event|1
1196644|NCT00960986|3931252|P2|Period 1 (Screening and Washout)|Adverse Event|2
1196645|NCT00960986|3931253|P1|Period 1 (Screening and Washout)|Adverse Event|1
1196646|NCT00960934|3931329|P6|Overall Study|Study Terminated by Sponsor|49
1196647|NCT00960934|3931330|P5|Overall Study|Study Terminated by Sponsor|49
1196648|NCT00960934|3931331|P4|Overall Study|Study Terminated by Sponsor|50
1196649|NCT00960934|3931332|P3|Overall Study|Study Terminated by Sponsor|52
1196650|NCT00960934|3931333|P2|Overall Study|Study Terminated by Sponsor|46
1196651|NCT00960934|3931334|P1|Overall Study|Study Terminated by Sponsor|50
1196652|NCT00960934|3931329|P6|Overall Study|Withdrawal by Subject|7
1196653|NCT00960934|3931330|P5|Overall Study|Withdrawal by Subject|5
1196654|NCT00960934|3931331|P4|Overall Study|Withdrawal by Subject|5
1196655|NCT00960934|3931332|P3|Overall Study|Withdrawal by Subject|4
1196656|NCT00960934|3931333|P2|Overall Study|Withdrawal by Subject|6
1196657|NCT00960934|3931334|P1|Overall Study|Withdrawal by Subject|5
1196658|NCT00960934|3931329|P6|Overall Study|Protocol Violation|2
1196659|NCT00960934|3931330|P5|Overall Study|Protocol Violation|3
1196660|NCT00960934|3931331|P4|Overall Study|Protocol Violation|3
1196661|NCT00960934|3931332|P3|Overall Study|Protocol Violation|0
1196662|NCT00960934|3931333|P2|Overall Study|Protocol Violation|4
1196663|NCT00960934|3931334|P1|Overall Study|Protocol Violation|3
1196664|NCT00960934|3931329|P6|Overall Study|Progressive Disease|1
1196665|NCT00960934|3931330|P5|Overall Study|Progressive Disease|1
1196666|NCT00960934|3931331|P4|Overall Study|Progressive Disease|0
1196667|NCT00960934|3931332|P3|Overall Study|Progressive Disease|0
1196668|NCT00960934|3931333|P2|Overall Study|Progressive Disease|1
1196669|NCT00960934|3931334|P1|Overall Study|Progressive Disease|1
1196670|NCT00960934|3931329|P6|Overall Study|Physician Decision|0
1196671|NCT00960934|3931330|P5|Overall Study|Physician Decision|0
1196672|NCT00960934|3931331|P4|Overall Study|Physician Decision|0
1196673|NCT00960934|3931332|P3|Overall Study|Physician Decision|0
1196674|NCT00960934|3931333|P2|Overall Study|Physician Decision|1
1196675|NCT00960934|3931334|P1|Overall Study|Physician Decision|0
1196676|NCT00960934|3931329|P6|Overall Study|Not Specified|2
1196677|NCT00960934|3931330|P5|Overall Study|Not Specified|2
1196678|NCT00960934|3931331|P4|Overall Study|Not Specified|4
1196679|NCT00960934|3931332|P3|Overall Study|Not Specified|5
1196680|NCT00960934|3931333|P2|Overall Study|Not Specified|1
1196681|NCT00960934|3931334|P1|Overall Study|Not Specified|2
1196682|NCT00960934|3931329|P6|Overall Study|Lost to Follow-up|0
1196683|NCT00960934|3931330|P5|Overall Study|Lost to Follow-up|0
1196684|NCT00960934|3931331|P4|Overall Study|Lost to Follow-up|0
1196685|NCT00960934|3931332|P3|Overall Study|Lost to Follow-up|0
1196686|NCT00960934|3931333|P2|Overall Study|Lost to Follow-up|1
1196687|NCT00960934|3931334|P1|Overall Study|Lost to Follow-up|0
1196688|NCT00960934|3931329|P6|Overall Study|Lack of Efficacy|0
1196689|NCT00960934|3931330|P5|Overall Study|Lack of Efficacy|0
1196690|NCT00960934|3931331|P4|Overall Study|Lack of Efficacy|0
1196691|NCT00960934|3931332|P3|Overall Study|Lack of Efficacy|0
1196692|NCT00960934|3931333|P2|Overall Study|Lack of Efficacy|0
1196693|NCT00960934|3931334|P1|Overall Study|Lack of Efficacy|1
1196694|NCT00960934|3931329|P6|Overall Study|Adverse Event|3
1196695|NCT00960934|3931330|P5|Overall Study|Adverse Event|4
1196696|NCT00960934|3931331|P4|Overall Study|Adverse Event|2
1196697|NCT00960934|3931332|P3|Overall Study|Adverse Event|3
1196698|NCT00960934|3931333|P2|Overall Study|Adverse Event|3
1196699|NCT00960934|3931334|P1|Overall Study|Adverse Event|2
1196700|NCT00960869|3931446|P2|Overall Study|Misc|18
1196701|NCT00960869|3931447|P1|Overall Study|Misc|19
1196702|NCT00960869|3931446|P2|Overall Study|Lost to Follow-up|4
1196703|NCT00960869|3931447|P1|Overall Study|Lost to Follow-up|1
1196704|NCT00960869|3931446|P2|Overall Study|Withdrawal by Subject|14
1196705|NCT00960869|3931447|P1|Overall Study|Withdrawal by Subject|16
1196706|NCT00960869|3931446|P2|Overall Study|Adverse Event|26
1196707|NCT00960869|3931447|P1|Overall Study|Adverse Event|17
1196708|NCT00960856|3931461|P4|Washout Period of 7 Days|Adverse Event|0
1196709|NCT00960856|3931462|P3|Washout Period of 7 Days|Adverse Event|1
1196710|NCT00960856|3931463|P2|Washout Period of 7 Days|Adverse Event|0
1196711|NCT00960856|3931464|P1|Washout Period of 7 Days|Adverse Event|0
1196712|NCT00960856|3931461|P4|Washout Period of 7 Days|Withdrawal by Subject|0
1196713|NCT00960856|3931462|P3|Washout Period of 7 Days|Withdrawal by Subject|0
1196714|NCT00960856|3931463|P2|Washout Period of 7 Days|Withdrawal by Subject|2
1196715|NCT00960856|3931464|P1|Washout Period of 7 Days|Withdrawal by Subject|0
1196716|NCT00960843|3931484|P2|Overall Study|Repeated needle dislodgment|1
1196717|NCT00960843|3931485|P1|Overall Study|Repeated needle dislodgment|0
1196718|NCT00960843|3931484|P2|Overall Study|Protocol Violation|4
1196719|NCT00960843|3931485|P1|Overall Study|Protocol Violation|0
1196720|NCT00960843|3931484|P2|Overall Study|Lost to Follow-up|0
1196721|NCT00960843|3931485|P1|Overall Study|Lost to Follow-up|2
1196722|NCT00960687|3931506|P2|Washout Period of 7 Days|Withdrawal by Subject|1
1196723|NCT00960687|3931507|P1|Washout Period of 7 Days|Withdrawal by Subject|1
1196724|NCT00960687|3931506|P2|Washout Period of 7 Days|Adverse Event|2
1196725|NCT00960687|3931507|P1|Washout Period of 7 Days|Adverse Event|3
1196726|NCT00960661|3931519|P3|Interventional Phase|Lack of Efficacy|0
1196727|NCT00960661|3931520|P2|Interventional Phase|Lack of Efficacy|2
1196728|NCT00960661|3931521|P1|Interventional Phase|Lack of Efficacy|0
1196729|NCT00960661|3931519|P3|Interventional Phase|sponsor decision|0
1196730|NCT00960661|3931520|P2|Interventional Phase|sponsor decision|1
1196731|NCT00960661|3931521|P1|Interventional Phase|sponsor decision|0
1196732|NCT00960661|3931519|P3|Interventional Phase|Physician Decision|5
1196733|NCT00960661|3931520|P2|Interventional Phase|Physician Decision|3
1196734|NCT00960661|3931521|P1|Interventional Phase|Physician Decision|0
1196735|NCT00960661|3931519|P3|Interventional Phase|Withdrawal by Subject|29
1196736|NCT00960661|3931520|P2|Interventional Phase|Withdrawal by Subject|18
1196737|NCT00960661|3931521|P1|Interventional Phase|Withdrawal by Subject|0
1196738|NCT00960661|3931519|P3|Interventional Phase|Protocol Violation|2
1196739|NCT00960661|3931520|P2|Interventional Phase|Protocol Violation|7
1196740|NCT00960661|3931521|P1|Interventional Phase|Protocol Violation|0
1196741|NCT00960661|3931519|P3|Interventional Phase|entry criteria not met|0
1196742|NCT00960661|3931520|P2|Interventional Phase|entry criteria not met|3
1196743|NCT00960661|3931521|P1|Interventional Phase|entry criteria not met|0
1196744|NCT00960661|3931519|P3|Interventional Phase|Lost to Follow-up|2
1196745|NCT00960661|3931520|P2|Interventional Phase|Lost to Follow-up|0
1196746|NCT00960661|3931521|P1|Interventional Phase|Lost to Follow-up|0
1196747|NCT00960661|3931519|P3|Interventional Phase|Death|0
1196748|NCT00960661|3931520|P2|Interventional Phase|Death|1
1196749|NCT00960661|3931521|P1|Interventional Phase|Death|0
1196750|NCT00960661|3931519|P3|Interventional Phase|Adverse Event|8
1196751|NCT00960661|3931520|P2|Interventional Phase|Adverse Event|17
1196752|NCT00960661|3931521|P1|Interventional Phase|Adverse Event|0
1196753|NCT00960661|3931519|P3|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
1196754|NCT00960661|3931520|P2|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
1196755|NCT00960661|3931521|P1|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3
1196756|NCT00960661|3931519|P3|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
1196757|NCT00960661|3931520|P2|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
1196758|NCT00960661|3931521|P1|Basal Insulin Optimization Phase (BIO)|Physician Decision|8
1196759|NCT00960661|3931519|P3|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
1196760|NCT00960661|3931520|P2|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
1196761|NCT00960661|3931521|P1|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47
1196762|NCT00960661|3931519|P3|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
1196763|NCT00960661|3931520|P2|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
1196764|NCT00960661|3931521|P1|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331
1196765|NCT00960661|3931519|P3|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
1196766|NCT00960661|3931520|P2|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
1196767|NCT00960661|3931521|P1|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4
1196768|NCT00960661|3931519|P3|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
1196769|NCT00960661|3931520|P2|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
1196770|NCT00960661|3931521|P1|Basal Insulin Optimization Phase (BIO)|Adverse Event|6
1196771|NCT00960570|3931560|P1|1 Day Period Between Dosing|Withdrawal by Subject|1
1196772|NCT00960570|3931560|P1|1 Day Period Between Dosing|Adverse Event|2
1196773|NCT00960570|3931560|P1|21 Day Washout Period|Withdrawal by Subject|1
1196774|NCT00960570|3931560|P1|21 Day Washout Period|Adverse Event|1
1196775|NCT00960531|3931581|P10|Overall Study|Reason not Specified|1
1196776|NCT00960531|3931582|P9|Overall Study|Reason not Specified|8
1196777|NCT00960531|3931583|P8|Overall Study|Reason not Specified|0
1196778|NCT00960531|3931584|P7|Overall Study|Reason not Specified|16
1196779|NCT00960531|3931585|P6|Overall Study|Reason not Specified|0
1196780|NCT00960531|3931586|P5|Overall Study|Reason not Specified|2
1196781|NCT00960531|3931587|P4|Overall Study|Reason not Specified|1
1196782|NCT00960531|3931588|P3|Overall Study|Reason not Specified|13
1196783|NCT00960531|3931589|P2|Overall Study|Reason not Specified|1
1196784|NCT00960531|3931590|P1|Overall Study|Reason not Specified|2
1196785|NCT00960531|3931581|P10|Overall Study|Adverse Event (AE)|0
1196786|NCT00960531|3931582|P9|Overall Study|Adverse Event (AE)|2
1196787|NCT00960531|3931583|P8|Overall Study|Adverse Event (AE)|0
1196788|NCT00960531|3931584|P7|Overall Study|Adverse Event (AE)|2
1196789|NCT00960531|3931585|P6|Overall Study|Adverse Event (AE)|1
1196790|NCT00960531|3931586|P5|Overall Study|Adverse Event (AE)|0
1196791|NCT00960531|3931587|P4|Overall Study|Adverse Event (AE)|0
1196792|NCT00960531|3931588|P3|Overall Study|Adverse Event (AE)|0
1196793|NCT00960531|3931589|P2|Overall Study|Adverse Event (AE)|0
1196794|NCT00960531|3931590|P1|Overall Study|Adverse Event (AE)|2
1196795|NCT00960531|3931581|P10|Overall Study|Failed to Return|0
1196796|NCT00960531|3931582|P9|Overall Study|Failed to Return|0
1196797|NCT00960531|3931583|P8|Overall Study|Failed to Return|2
1196798|NCT00960531|3931584|P7|Overall Study|Failed to Return|0
1196799|NCT00960531|3931585|P6|Overall Study|Failed to Return|0
1196800|NCT00960531|3931586|P5|Overall Study|Failed to Return|0
1196801|NCT00960531|3931587|P4|Overall Study|Failed to Return|0
1196802|NCT00960531|3931588|P3|Overall Study|Failed to Return|0
1196803|NCT00960531|3931589|P2|Overall Study|Failed to Return|0
1196804|NCT00960531|3931590|P1|Overall Study|Failed to Return|2
1196805|NCT00960531|3931581|P10|Overall Study|Lost to Follow-up|0
1196806|NCT00960531|3931582|P9|Overall Study|Lost to Follow-up|0
1196807|NCT00960531|3931583|P8|Overall Study|Lost to Follow-up|0
1196808|NCT00960531|3931584|P7|Overall Study|Lost to Follow-up|1
1196809|NCT00960531|3931585|P6|Overall Study|Lost to Follow-up|0
1196810|NCT00960531|3931586|P5|Overall Study|Lost to Follow-up|0
1196811|NCT00960531|3931587|P4|Overall Study|Lost to Follow-up|0
1196812|NCT00960531|3931588|P3|Overall Study|Lost to Follow-up|1
1196813|NCT00960531|3931589|P2|Overall Study|Lost to Follow-up|0
1196814|NCT00960531|3931590|P1|Overall Study|Lost to Follow-up|0
1196815|NCT00960531|3931581|P10|Overall Study|Discontinuation of Study by Sponsor|0
1196816|NCT00960531|3931582|P9|Overall Study|Discontinuation of Study by Sponsor|0
1196817|NCT00960531|3931583|P8|Overall Study|Discontinuation of Study by Sponsor|1
1196818|NCT00960531|3931584|P7|Overall Study|Discontinuation of Study by Sponsor|0
1196819|NCT00960531|3931585|P6|Overall Study|Discontinuation of Study by Sponsor|0
1196820|NCT00960531|3931586|P5|Overall Study|Discontinuation of Study by Sponsor|0
1196821|NCT00960531|3931587|P4|Overall Study|Discontinuation of Study by Sponsor|0
1196822|NCT00960531|3931588|P3|Overall Study|Discontinuation of Study by Sponsor|0
1196823|NCT00960531|3931589|P2|Overall Study|Discontinuation of Study by Sponsor|0
1196824|NCT00960531|3931590|P1|Overall Study|Discontinuation of Study by Sponsor|0
1196825|NCT00960531|3931581|P10|Overall Study|Investigator Request|0
1196826|NCT00960531|3931582|P9|Overall Study|Investigator Request|0
1196827|NCT00960531|3931583|P8|Overall Study|Investigator Request|0
1196828|NCT00960531|3931584|P7|Overall Study|Investigator Request|0
1196829|NCT00960531|3931585|P6|Overall Study|Investigator Request|0
1196830|NCT00960531|3931586|P5|Overall Study|Investigator Request|0
1196831|NCT00960531|3931587|P4|Overall Study|Investigator Request|0
1196832|NCT00960531|3931588|P3|Overall Study|Investigator Request|1
1196833|NCT00960531|3931589|P2|Overall Study|Investigator Request|0
1196834|NCT00960531|3931590|P1|Overall Study|Investigator Request|0
1196835|NCT00960531|3931581|P10|Overall Study|Caregiver Request|0
1196836|NCT00960531|3931582|P9|Overall Study|Caregiver Request|3
1196837|NCT00960531|3931583|P8|Overall Study|Caregiver Request|1
1196838|NCT00960531|3931584|P7|Overall Study|Caregiver Request|3
1196839|NCT00960531|3931585|P6|Overall Study|Caregiver Request|2
1196840|NCT00960531|3931586|P5|Overall Study|Caregiver Request|0
1196841|NCT00960531|3931587|P4|Overall Study|Caregiver Request|5
1196842|NCT00960531|3931588|P3|Overall Study|Caregiver Request|6
1196843|NCT00960531|3931589|P2|Overall Study|Caregiver Request|0
1196844|NCT00960531|3931590|P1|Overall Study|Caregiver Request|2
1196845|NCT00960531|3931581|P10|Overall Study|Withdrawal by Subject|0
1196846|NCT00960531|3931582|P9|Overall Study|Withdrawal by Subject|1
1196847|NCT00960531|3931583|P8|Overall Study|Withdrawal by Subject|0
1196848|NCT00960531|3931584|P7|Overall Study|Withdrawal by Subject|2
1196849|NCT00960531|3931585|P6|Overall Study|Withdrawal by Subject|0
1196850|NCT00960531|3931586|P5|Overall Study|Withdrawal by Subject|0
1196851|NCT00960531|3931587|P4|Overall Study|Withdrawal by Subject|2
1196852|NCT00960531|3931588|P3|Overall Study|Withdrawal by Subject|5
1196853|NCT00960531|3931589|P2|Overall Study|Withdrawal by Subject|0
1196854|NCT00960531|3931590|P1|Overall Study|Withdrawal by Subject|1
1196855|NCT00960531|3931581|P10|Overall Study|Lack of Efficacy|0
1196856|NCT00960531|3931582|P9|Overall Study|Lack of Efficacy|0
1196857|NCT00960531|3931583|P8|Overall Study|Lack of Efficacy|0
1196858|NCT00960531|3931584|P7|Overall Study|Lack of Efficacy|0
1196859|NCT00960531|3931585|P6|Overall Study|Lack of Efficacy|0
1196860|NCT00960531|3931586|P5|Overall Study|Lack of Efficacy|0
1196861|NCT00960531|3931587|P4|Overall Study|Lack of Efficacy|0
1196862|NCT00960531|3931588|P3|Overall Study|Lack of Efficacy|0
1196863|NCT00960531|3931589|P2|Overall Study|Lack of Efficacy|0
1196864|NCT00960531|3931590|P1|Overall Study|Lack of Efficacy|1
1196865|NCT00960440|3931638|P4|Overall Study|Other|0
1196866|NCT00960440|3931639|P3|Overall Study|Other|1
1196867|NCT00960440|3931640|P2|Overall Study|Other|1
1196868|NCT00960440|3931641|P1|Overall Study|Other|1
1196869|NCT00960440|3931638|P4|Overall Study|Withdrawal by Subject|1
1196870|NCT00960440|3931639|P3|Overall Study|Withdrawal by Subject|2
1196871|NCT00960440|3931640|P2|Overall Study|Withdrawal by Subject|5
1196872|NCT00960440|3931641|P1|Overall Study|Withdrawal by Subject|9
1196873|NCT00960440|3931638|P4|Overall Study|Protocol Violation|4
1196874|NCT00960440|3931639|P3|Overall Study|Protocol Violation|3
1196875|NCT00960440|3931640|P2|Overall Study|Protocol Violation|8
1196876|NCT00960440|3931641|P1|Overall Study|Protocol Violation|2
1196877|NCT00960440|3931638|P4|Overall Study|Lack of Efficacy|8
1196878|NCT00960440|3931639|P3|Overall Study|Lack of Efficacy|3
1196879|NCT00960440|3931640|P2|Overall Study|Lack of Efficacy|5
1196880|NCT00960440|3931641|P1|Overall Study|Lack of Efficacy|2
1196881|NCT00960440|3931638|P4|Overall Study|Adverse Event|4
1196882|NCT00960440|3931639|P3|Overall Study|Adverse Event|4
1196883|NCT00960440|3931640|P2|Overall Study|Adverse Event|12
1196884|NCT00960440|3931641|P1|Overall Study|Adverse Event|12
1196885|NCT00960440|3931638|P4|Overall Study|Death|1
1196886|NCT00960440|3931639|P3|Overall Study|Death|0
1196887|NCT00960440|3931640|P2|Overall Study|Death|0
1196888|NCT00960440|3931641|P1|Overall Study|Death|0
1196889|NCT00960375|3931813|P2|Overall Study|Lost to Follow-up|22
1196890|NCT00960375|3931814|P1|Overall Study|Lost to Follow-up|20
1196891|NCT00960323|3931822|P1|Atorvastatin Alone|Withdrawal by Subject|1
1196892|NCT00960297|3931833|P1|Overall Study|Disease progression|1
1196893|NCT00960297|3931833|P1|Overall Study|Venous port infection|1
1196894|NCT00960297|3931833|P1|Overall Study|Physician Decision|1
1196895|NCT00960206|3931840|P3|Overall Study|Missing 10 year data|1
1196896|NCT00960206|3931841|P2|Overall Study|Missing 10 year data|1
1196897|NCT00960206|3931842|P1|Overall Study|Missing 10 year data|20
1196898|NCT00960206|3931840|P3|Overall Study|Revision of study component|2
1196899|NCT00960206|3931841|P2|Overall Study|Revision of study component|2
1196900|NCT00960206|3931842|P1|Overall Study|Revision of study component|2
1196901|NCT00960206|3931840|P3|Overall Study|Withdrawal by Subject|0
1196902|NCT00960206|3931841|P2|Overall Study|Withdrawal by Subject|4
1196903|NCT00960206|3931842|P1|Overall Study|Withdrawal by Subject|2
1196904|NCT00960206|3931840|P3|Overall Study|Lost to Follow-up|8
1196905|NCT00960206|3931841|P2|Overall Study|Lost to Follow-up|14
1196906|NCT00960206|3931842|P1|Overall Study|Lost to Follow-up|8
1196907|NCT00960206|3931840|P3|Overall Study|Unwilling/Unable to return|0
1196908|NCT00960206|3931841|P2|Overall Study|Unwilling/Unable to return|2
1196909|NCT00960206|3931842|P1|Overall Study|Unwilling/Unable to return|1
1196910|NCT00960206|3931840|P3|Overall Study|Death|1
1196911|NCT00960206|3931841|P2|Overall Study|Death|4
1196912|NCT00960206|3931842|P1|Overall Study|Death|7
1196913|NCT00960193|3931860|P1|14 Day Washout Period|Withdrawal by Subject|1
1196914|NCT00960154|3931873|P2|Overall Study|Study termination|25
1196915|NCT00960154|3931874|P1|Overall Study|Study termination|25
1196916|NCT00960141|3931885|P3|Overall Study|Withdrawal by Subject|1
1196917|NCT00960141|3931886|P2|Overall Study|Withdrawal by Subject|2
1196918|NCT00960141|3931887|P1|Overall Study|Withdrawal by Subject|1
1196919|NCT00960141|3931885|P3|Overall Study|Protocol Violation|2
1196920|NCT00960141|3931886|P2|Overall Study|Protocol Violation|3
1196921|NCT00960141|3931887|P1|Overall Study|Protocol Violation|1
1196922|NCT00960141|3931885|P3|Overall Study|Lost to Follow-up|0
1196923|NCT00960141|3931886|P2|Overall Study|Lost to Follow-up|0
1196924|NCT00960141|3931887|P1|Overall Study|Lost to Follow-up|1
1196925|NCT00960141|3931885|P3|Overall Study|Lack of Efficacy|2
1196926|NCT00960141|3931886|P2|Overall Study|Lack of Efficacy|4
1196927|NCT00960141|3931887|P1|Overall Study|Lack of Efficacy|3
1196928|NCT00960141|3931885|P3|Overall Study|Adverse Event|2
1196929|NCT00960141|3931886|P2|Overall Study|Adverse Event|8
1196930|NCT00960141|3931887|P1|Overall Study|Adverse Event|4
1196931|NCT00960115|3931912|P2|Overall Study|Ongoing treatment at data cut-off date|15
1196932|NCT00960115|3931913|P1|Overall Study|Ongoing treatment at data cut-off date|19
1196933|NCT00960076|3931927|P2|Overall Study|Did not attend the termination visit|1
1196934|NCT00960076|3931928|P1|Overall Study|Did not attend the termination visit|0
1196935|NCT00960076|3931927|P2|Overall Study|Hyperglycemia|5
1196936|NCT00960076|3931928|P1|Overall Study|Hyperglycemia|1
1196937|NCT00960076|3931927|P2|Overall Study|Severe non-compliance to protocol|2
1196938|NCT00960076|3931928|P1|Overall Study|Severe non-compliance to protocol|1
1196939|NCT00960076|3931927|P2|Overall Study|Lost to Follow-up|3
1196940|NCT00960076|3931928|P1|Overall Study|Lost to Follow-up|3
1196941|NCT00960076|3931927|P2|Overall Study|Withdrawal by Subject|2
1196942|NCT00960076|3931928|P1|Overall Study|Withdrawal by Subject|1
1196943|NCT00960076|3931927|P2|Overall Study|No longer met study criteria|5
1196944|NCT00960076|3931928|P1|Overall Study|No longer met study criteria|1
1196945|NCT00960076|3931927|P2|Overall Study|Adverse Event|7
1196946|NCT00960076|3931928|P1|Overall Study|Adverse Event|1
1196947|NCT00960063|3931943|P3|Overall Study|Progression of Disease|3
1196948|NCT00960063|3931944|P2|Overall Study|Progression of Disease|0
1196949|NCT00960063|3931945|P1|Overall Study|Progression of Disease|0
1196950|NCT00960063|3931943|P3|Overall Study|Adverse Event|0
1196951|NCT00960063|3931944|P2|Overall Study|Adverse Event|0
1196952|NCT00960063|3931945|P1|Overall Study|Adverse Event|1
1196953|NCT00959946|3932036|P8|Overall Study|Withdrawal by Subject|0
1196954|NCT00959946|3932037|P7|Overall Study|Withdrawal by Subject|0
1196955|NCT00959946|3932038|P6|Overall Study|Withdrawal by Subject|1
1196956|NCT00959946|3932039|P5|Overall Study|Withdrawal by Subject|0
1196957|NCT00959946|3932040|P4|Overall Study|Withdrawal by Subject|0
1196958|NCT00959946|3932041|P3|Overall Study|Withdrawal by Subject|0
1196959|NCT00959946|3932042|P2|Overall Study|Withdrawal by Subject|0
1196960|NCT00959946|3932043|P1|Overall Study|Withdrawal by Subject|0
1196961|NCT00959946|3932036|P8|Overall Study|Disease Progression|2
1196962|NCT00959946|3932037|P7|Overall Study|Disease Progression|2
1196963|NCT00959946|3932038|P6|Overall Study|Disease Progression|6
1196964|NCT00959946|3932039|P5|Overall Study|Disease Progression|4
1196965|NCT00959946|3932040|P4|Overall Study|Disease Progression|4
1196966|NCT00959946|3932041|P3|Overall Study|Disease Progression|2
1196967|NCT00959946|3932042|P2|Overall Study|Disease Progression|4
1196968|NCT00959946|3932043|P1|Overall Study|Disease Progression|2
1196969|NCT00959946|3932036|P8|Overall Study|Death|0
1196970|NCT00959946|3932037|P7|Overall Study|Death|0
1196971|NCT00959946|3932038|P6|Overall Study|Death|1
1196972|NCT00959946|3932039|P5|Overall Study|Death|0
1196973|NCT00959946|3932040|P4|Overall Study|Death|0
1196974|NCT00959946|3932041|P3|Overall Study|Death|0
1196975|NCT00959946|3932042|P2|Overall Study|Death|0
1196976|NCT00959946|3932043|P1|Overall Study|Death|0
1196977|NCT00959946|3932036|P8|Overall Study|Adverse Event|0
1196978|NCT00959946|3932037|P7|Overall Study|Adverse Event|0
1196979|NCT00959946|3932038|P6|Overall Study|Adverse Event|1
1196980|NCT00959946|3932039|P5|Overall Study|Adverse Event|0
1196981|NCT00959946|3932040|P4|Overall Study|Adverse Event|1
1196982|NCT00959946|3932041|P3|Overall Study|Adverse Event|2
1196983|NCT00959946|3932042|P2|Overall Study|Adverse Event|0
1196984|NCT00959946|3932043|P1|Overall Study|Adverse Event|0
1196985|NCT00959907|3932107|P2|Overall Study|Withdrawal by Subject|0
1196986|NCT00959907|3932108|P1|Overall Study|Withdrawal by Subject|2
1196987|NCT00959907|3932107|P2|Overall Study|Adverse Event|0
1196988|NCT00959907|3932108|P1|Overall Study|Adverse Event|1
1196989|NCT00959907|3932107|P2|Overall Study|Protocol Violation|1
1196990|NCT00959907|3932108|P1|Overall Study|Protocol Violation|0
1196991|NCT00959894|3932118|P1|Overall Study|Subject moved out of town|1
1196992|NCT00959894|3932118|P1|Overall Study|Need for contraindicated medication|1
1196993|NCT00959894|3932118|P1|Overall Study|Withdrawal by Subject|1
1196994|NCT00959894|3932118|P1|Overall Study|Adverse Event|3
1196995|NCT00959894|3932118|P1|Overall Study|Lost to Follow-up|10
1196996|NCT00959751|3932167|P2|Overall Study|No migraine headache without aura|7
1196997|NCT00959751|3932168|P1|Overall Study|No migraine headache without aura|7
1196998|NCT00959751|3932167|P2|Overall Study|Non-compliance to Study Procedures|1
1196999|NCT00959751|3932168|P1|Overall Study|Non-compliance to Study Procedures|0
1197000|NCT00959751|3932167|P2|Overall Study|Consent Withdrawn|1
1197001|NCT00959751|3932168|P1|Overall Study|Consent Withdrawn|0
1197002|NCT00959751|3932167|P2|Overall Study|Lost to Follow-up|3
1197003|NCT00959751|3932168|P1|Overall Study|Lost to Follow-up|2
1197004|NCT00959699|3932190|P2|Follow-up Period|Withdrawal by Subject|4
1197005|NCT00959699|3932191|P1|Follow-up Period|Withdrawal by Subject|3
1197006|NCT00959699|3932190|P2|Follow-up Period|Lost to Follow-up|2
1197007|NCT00959699|3932191|P1|Follow-up Period|Lost to Follow-up|3
1197008|NCT00959699|3932190|P2|Treatment Period|Futility/crossover to boceprevir|0
1197009|NCT00959699|3932191|P1|Treatment Period|Futility/crossover to boceprevir|4
1197010|NCT00959699|3932190|P2|Treatment Period|Did not receive treatment|1
1197011|NCT00959699|3932191|P1|Treatment Period|Did not receive treatment|0
1197012|NCT00959699|3932190|P2|Treatment Period|Non-Compliance with Protocol|1
1197013|NCT00959699|3932191|P1|Treatment Period|Non-Compliance with Protocol|0
1197014|NCT00959699|3932190|P2|Treatment Period|Withdrawal by Subject|3
1197015|NCT00959699|3932191|P1|Treatment Period|Withdrawal by Subject|1
1197016|NCT00959699|3932190|P2|Treatment Period|Lost to Follow-up|1
1197017|NCT00959699|3932191|P1|Treatment Period|Lost to Follow-up|0
1197018|NCT00959699|3932190|P2|Treatment Period|Lack of Efficacy|6
1197019|NCT00959699|3932191|P1|Treatment Period|Lack of Efficacy|15
1197020|NCT00959699|3932190|P2|Treatment Period|Adverse Event|13
1197021|NCT00959699|3932191|P1|Treatment Period|Adverse Event|3
1197022|NCT00959647|3932237|P1|Overall Study|Withdrawal by Subject|7
1197023|NCT00959647|3932237|P1|Overall Study|Study terminated by sponsor|4
1197024|NCT00959647|3932237|P1|Overall Study|Progressive disease|6
1197025|NCT00959647|3932237|P1|Overall Study|Adverse Event|2
1197026|NCT00959374|3932242|P1|Overall Study|Physician Decision|1
1197027|NCT00959374|3932242|P1|Overall Study|Implant Removed/Not Replaced|4
1197028|NCT00959374|3932242|P1|Overall Study|Protocol Violation|1
1197029|NCT00959374|3932242|P1|Overall Study|Death|1
1197030|NCT00959374|3932242|P1|Overall Study|Lost to Follow-up|14
1197031|NCT00959374|3932242|P1|Overall Study|Withdrawal by Subject|2
1197032|NCT00959192|3932256|P4|Overall Study|Caregiver Request|1
1197033|NCT00959192|3932257|P3|Overall Study|Caregiver Request|2
1197034|NCT00959192|3932258|P2|Overall Study|Caregiver Request|0
1197035|NCT00959192|3932259|P1|Overall Study|Caregiver Request|0
1197036|NCT00959192|3932256|P4|Overall Study|Investigator Request|0
1197037|NCT00959192|3932257|P3|Overall Study|Investigator Request|0
1197038|NCT00959192|3932258|P2|Overall Study|Investigator Request|0
1197039|NCT00959192|3932259|P1|Overall Study|Investigator Request|1
1197040|NCT00959192|3932256|P4|Overall Study|Adverse Event|0
1197041|NCT00959192|3932257|P3|Overall Study|Adverse Event|1
1197042|NCT00959192|3932258|P2|Overall Study|Adverse Event|1
1197043|NCT00959192|3932259|P1|Overall Study|Adverse Event|1
1197044|NCT00959049|3932307|P6|Overall Study|Withdrawal by Subject|0
1197045|NCT00959049|3932308|P5|Overall Study|Withdrawal by Subject|0
1197046|NCT00959049|3932309|P4|Overall Study|Withdrawal by Subject|0
1197047|NCT00959049|3932310|P3|Overall Study|Withdrawal by Subject|0
1197048|NCT00959049|3932311|P2|Overall Study|Withdrawal by Subject|2
1197049|NCT00959049|3932312|P1|Overall Study|Withdrawal by Subject|0
1197050|NCT00959049|3932307|P6|Overall Study|Contraindicated medication|0
1197051|NCT00959049|3932308|P5|Overall Study|Contraindicated medication|0
1197052|NCT00959049|3932309|P4|Overall Study|Contraindicated medication|1
1197053|NCT00959049|3932310|P3|Overall Study|Contraindicated medication|0
1197054|NCT00959049|3932311|P2|Overall Study|Contraindicated medication|0
1197055|NCT00959049|3932312|P1|Overall Study|Contraindicated medication|0
1197056|NCT00959049|3932307|P6|Overall Study|Lost to Follow-up|1
1197057|NCT00959049|3932308|P5|Overall Study|Lost to Follow-up|9
1197058|NCT00959049|3932309|P4|Overall Study|Lost to Follow-up|10
1197059|NCT00959049|3932310|P3|Overall Study|Lost to Follow-up|1
1197060|NCT00959049|3932311|P2|Overall Study|Lost to Follow-up|5
1197061|NCT00959049|3932312|P1|Overall Study|Lost to Follow-up|17
1197062|NCT00959049|3932307|P6|Overall Study|Adverse Event|0
1197063|NCT00959049|3932308|P5|Overall Study|Adverse Event|0
1197064|NCT00959049|3932309|P4|Overall Study|Adverse Event|0
1197065|NCT00959049|3932310|P3|Overall Study|Adverse Event|0
1197066|NCT00959049|3932311|P2|Overall Study|Adverse Event|0
1197067|NCT00959049|3932312|P1|Overall Study|Adverse Event|1
1197068|NCT00958893|3932377|P1|Overall Study|Study prematurely terminated|4
1197069|NCT00958880|3932383|P2|Overall Study|Lost to Follow-up|2
1197070|NCT00958880|3932384|P1|Overall Study|Lost to Follow-up|2
1197071|NCT00958841|3932392|P1|Overall Study|Discontinued prior to M*|28
1197072|NCT00958841|3932392|P1|Overall Study|Completed M6/did not enter extension|27
1197073|NCT00958841|3932392|P1|Overall Study|Unsatisfactory therapeutic effect|22
1197074|NCT00958841|3932392|P1|Overall Study|Withdrawal by Subject|1
1197075|NCT00958841|3932392|P1|Overall Study|New cancer therapy|5
1197076|NCT00958841|3932392|P1|Overall Study|Adverse Event|8
1197077|NCT00958841|3932392|P1|Overall Study|Administrative problems|1
1197078|NCT00958841|3932392|P1|Overall Study|Abnormal test procedure result(s)|3
1197079|NCT00958841|3932392|P1|Overall Study|Abnormal laboratory value(s)|1
1197080|NCT00958828|3932410|P2|Period 2, 1 Week of Wear|Unacceptable lens fit|1
1197081|NCT00958828|3932411|P1|Period 2, 1 Week of Wear|Unacceptable lens fit|0
1197082|NCT00958828|3932410|P2|Period 1, 1 Week of Wear|Randomization break|1
1197083|NCT00958828|3932411|P1|Period 1, 1 Week of Wear|Randomization break|0
1197084|NCT00958789|3932417|P1|Overall Study|Revision|7
1197085|NCT00958789|3932417|P1|Overall Study|Subject terminated|3
1197086|NCT00958789|3932417|P1|Overall Study|2 yr. Knee Society Score not calculable|2
1197087|NCT00958789|3932417|P1|Overall Study|No 2 yr. Knee Society Score data|12
1197088|NCT00958789|3932417|P1|Overall Study|Withdrawal by Subject|16
1197089|NCT00958789|3932417|P1|Overall Study|Lost to Follow-up|7
1197090|NCT00958789|3932417|P1|Overall Study|Death|3
1197091|NCT00958776|3932424|P2|Overall Study|Missing|1
1197092|NCT00958776|3932425|P1|Overall Study|Missing|1
1197093|NCT00958776|3932424|P2|Overall Study|Noncompliance; Protocol Deviations|3
1197094|NCT00958776|3932425|P1|Overall Study|Noncompliance; Protocol Deviations|2
1197095|NCT00958776|3932424|P2|Overall Study|Death|1
1197096|NCT00958776|3932425|P1|Overall Study|Death|2
1197097|NCT00958776|3932424|P2|Overall Study|Protocol Violation|1
1197098|NCT00958776|3932425|P1|Overall Study|Protocol Violation|1
1197099|NCT00958776|3932424|P2|Overall Study|Withdrawal by Subject|16
1197100|NCT00958776|3932425|P1|Overall Study|Withdrawal by Subject|7
1197101|NCT00958776|3932424|P2|Overall Study|Lost to Follow-up|6
1197102|NCT00958776|3932425|P1|Overall Study|Lost to Follow-up|2
1197103|NCT00958776|3932424|P2|Overall Study|Physician Decision|0
1197104|NCT00958776|3932425|P1|Overall Study|Physician Decision|1
1197105|NCT00958776|3932424|P2|Overall Study|Adverse Event|1
1197106|NCT00958776|3932425|P1|Overall Study|Adverse Event|0
1197107|NCT00958724|3932455|P1|Overall Study|Disease Progression|6
1197108|NCT00958568|3932484|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
1197109|NCT00958568|3932485|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1
1197110|NCT00958568|3932486|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
1197111|NCT00958568|3932487|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
1197112|NCT00958568|3932484|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
1197113|NCT00958568|3932485|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1
1197114|NCT00958568|3932486|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
1197115|NCT00958568|3932487|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
1197116|NCT00958568|3932484|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1
1197117|NCT00958568|3932485|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2
1197118|NCT00958568|3932486|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
1197119|NCT00958568|3932487|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
1197120|NCT00958568|3932484|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4
1197121|NCT00958568|3932485|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5
1197122|NCT00958568|3932486|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
1197123|NCT00958568|3932487|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
1197124|NCT00958568|3932484|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8
1197125|NCT00958568|3932485|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3
1197126|NCT00958568|3932486|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
1197127|NCT00958568|3932487|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
1197128|NCT00958568|3932484|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5
1197129|NCT00958568|3932485|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11
1197130|NCT00958568|3932486|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
1197131|NCT00958568|3932487|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
1197132|NCT00958568|3932484|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15
1197133|NCT00958568|3932485|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16
1197134|NCT00958568|3932486|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
1197135|NCT00958568|3932487|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
1197136|NCT00958568|3932484|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10
1197137|NCT00958568|3932485|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19
1197138|NCT00958568|3932486|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
1197139|NCT00958568|3932487|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
1197140|NCT00958568|3932484|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63
1197141|NCT00958568|3932485|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24
1197142|NCT00958568|3932486|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
1197143|NCT00958568|3932487|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
1197144|NCT00958568|3932484|P4|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
1197145|NCT00958568|3932485|P3|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
1197146|NCT00958568|3932486|P2|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1
1197147|NCT00958568|3932487|P1|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
1197148|NCT00958568|3932484|P4|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
1197149|NCT00958568|3932485|P3|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
1197150|NCT00958568|3932486|P2|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1
1197151|NCT00958568|3932487|P1|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
1197152|NCT00958568|3932484|P4|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
1197153|NCT00958568|3932485|P3|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
1197154|NCT00958568|3932486|P2|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4
1197155|NCT00958568|3932487|P1|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
1197156|NCT00958568|3932484|P4|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
1197157|NCT00958568|3932485|P3|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
1197158|NCT00958568|3932486|P2|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5
1197159|NCT00958568|3932487|P1|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
1197160|NCT00958568|3932484|P4|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
1197161|NCT00958568|3932485|P3|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
1197162|NCT00958568|3932486|P2|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6
1197163|NCT00958568|3932487|P1|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
1197164|NCT00958568|3932484|P4|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
1197165|NCT00958568|3932485|P3|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
1197166|NCT00958568|3932486|P2|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9
1197167|NCT00958568|3932487|P1|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
1197168|NCT00958568|3932484|P4|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
1197169|NCT00958568|3932485|P3|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
1197170|NCT00958568|3932486|P2|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24
1197171|NCT00958568|3932487|P1|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
1197172|NCT00958568|3932484|P4|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
1197173|NCT00958568|3932485|P3|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
1197174|NCT00958568|3932486|P2|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41
1197175|NCT00958568|3932487|P1|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
1197176|NCT00958568|3932484|P4|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
1197177|NCT00958568|3932485|P3|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
1197178|NCT00958568|3932486|P2|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28
1197179|NCT00958568|3932487|P1|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
1197180|NCT00958568|3932484|P4|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
1197181|NCT00958568|3932485|P3|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
1197182|NCT00958568|3932486|P2|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30
1197183|NCT00958568|3932487|P1|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
1197184|NCT00958568|3932484|P4|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
1197185|NCT00958568|3932485|P3|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
1197186|NCT00958568|3932486|P2|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62
1197187|NCT00958568|3932487|P1|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
1197188|NCT00958568|3932484|P4|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
1197189|NCT00958568|3932485|P3|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
1197190|NCT00958568|3932486|P2|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
1197191|NCT00958568|3932487|P1|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1
1197192|NCT00958568|3932484|P4|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
1197193|NCT00958568|3932485|P3|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
1197194|NCT00958568|3932486|P2|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
1197195|NCT00958568|3932487|P1|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8
1197196|NCT00958568|3932484|P4|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
1197197|NCT00958568|3932485|P3|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
1197198|NCT00958568|3932486|P2|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
1197199|NCT00958568|3932487|P1|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4
1197200|NCT00958568|3932484|P4|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
1197201|NCT00958568|3932485|P3|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
1197202|NCT00958568|3932486|P2|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
1197203|NCT00958568|3932487|P1|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13
1197204|NCT00958568|3932484|P4|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
1197205|NCT00958568|3932485|P3|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
1197206|NCT00958568|3932486|P2|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
1197207|NCT00958568|3932487|P1|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14
1197208|NCT00958568|3932484|P4|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
1197209|NCT00958568|3932485|P3|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
1197210|NCT00958568|3932486|P2|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
1197211|NCT00958568|3932487|P1|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39
1197212|NCT00958568|3932484|P4|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
1197213|NCT00958568|3932485|P3|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
1197214|NCT00958568|3932486|P2|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
1197215|NCT00958568|3932487|P1|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34
1197216|NCT00958568|3932484|P4|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
1197217|NCT00958568|3932485|P3|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
1197218|NCT00958568|3932486|P2|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
1197219|NCT00958568|3932487|P1|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44
1197220|NCT00958568|3932484|P4|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
1197221|NCT00958568|3932485|P3|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
1197222|NCT00958568|3932486|P2|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
1197223|NCT00958568|3932487|P1|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80
1197224|NCT00958438|3932724|P3|Overall Study|Other than specified above|2
1197225|NCT00958438|3932725|P2|Overall Study|Other than specified above|3
1197226|NCT00958438|3932726|P1|Overall Study|Other than specified above|2
1197227|NCT00958438|3932724|P3|Overall Study|Physician Decision|1
1197228|NCT00958438|3932725|P2|Overall Study|Physician Decision|0
1197229|NCT00958438|3932726|P1|Overall Study|Physician Decision|1
1197230|NCT00958438|3932724|P3|Overall Study|Adverse Event|0
1197231|NCT00958438|3932725|P2|Overall Study|Adverse Event|3
1197232|NCT00958438|3932726|P1|Overall Study|Adverse Event|0
1197233|NCT00958438|3932724|P3|Overall Study|Withdrawal by Subject|1
1197234|NCT00958438|3932725|P2|Overall Study|Withdrawal by Subject|2
1197235|NCT00958438|3932726|P1|Overall Study|Withdrawal by Subject|4
1197236|NCT00958438|3932724|P3|Overall Study|Protocol Violation|2
1197237|NCT00958438|3932725|P2|Overall Study|Protocol Violation|2
1197238|NCT00958438|3932726|P1|Overall Study|Protocol Violation|3
1197239|NCT00958360|3932751|P2|Overall Study|Lost to Follow-up|1
1197240|NCT00958360|3932752|P1|Overall Study|Lost to Follow-up|0
1197241|NCT00958360|3932751|P2|Overall Study|Physician Decision|1
1197242|NCT00958360|3932752|P1|Overall Study|Physician Decision|2
1197243|NCT00958360|3932751|P2|Overall Study|Death|7
1197244|NCT00958360|3932752|P1|Overall Study|Death|6
1197245|NCT00958360|3932751|P2|Overall Study|Withdrawal by Subject|1
1197246|NCT00958360|3932752|P1|Overall Study|Withdrawal by Subject|3
1197247|NCT00958347|3932766|P1|Overall Study|study termination|135
1197248|NCT00958347|3932766|P1|Overall Study|revision/removal|10
1197249|NCT00958347|3932766|P1|Overall Study|Lost to Follow-up|15
1197250|NCT00958347|3932766|P1|Overall Study|Withdrawal by Subject|23
1197251|NCT00958347|3932766|P1|Overall Study|Death|43
1197252|NCT00958256|3932807|P1|Overall Study|Adverse Event|3
1197253|NCT00958243|3932817|P6|Overall Study|Lost to Follow-up|5
1197254|NCT00958243|3932818|P5|Overall Study|Lost to Follow-up|8
1197255|NCT00958243|3932819|P4|Overall Study|Lost to Follow-up|2
1197256|NCT00958243|3932820|P3|Overall Study|Lost to Follow-up|11
1197257|NCT00958243|3932821|P2|Overall Study|Lost to Follow-up|5
1197258|NCT00958243|3932822|P1|Overall Study|Lost to Follow-up|2
1197259|NCT00958243|3932817|P6|Overall Study|Withdrawal by Subject|5
1197260|NCT00958243|3932818|P5|Overall Study|Withdrawal by Subject|1
1197261|NCT00958243|3932819|P4|Overall Study|Withdrawal by Subject|1
1197262|NCT00958243|3932820|P3|Overall Study|Withdrawal by Subject|3
1197263|NCT00958243|3932821|P2|Overall Study|Withdrawal by Subject|1
1197264|NCT00958243|3932822|P1|Overall Study|Withdrawal by Subject|0
1197265|NCT00958217|3932880|P2|Overall Study|Inpatient hospitalization|1
1197266|NCT00958217|3932881|P1|Overall Study|Inpatient hospitalization|0
1197267|NCT00958217|3932880|P2|Overall Study|Moved out of area|1
1197268|NCT00958217|3932881|P1|Overall Study|Moved out of area|1
1197269|NCT00958217|3932880|P2|Overall Study|Lost to Follow-up|19
1197270|NCT00958217|3932881|P1|Overall Study|Lost to Follow-up|17
1197271|NCT00958217|3932880|P2|Overall Study|Withdrawal by Subject|3
1197272|NCT00958217|3932881|P1|Overall Study|Withdrawal by Subject|4
1197273|NCT00958217|3932880|P2|Overall Study|Death|1
1197274|NCT00958217|3932881|P1|Overall Study|Death|2
1197275|NCT00958191|3932892|P1|Overall Study|No 5 yr x-rays|56
1197276|NCT00958191|3932892|P1|Overall Study|Site termination|11
1197277|NCT00958191|3932892|P1|Overall Study|Revision of study device|4
1197278|NCT00958191|3932892|P1|Overall Study|Unable/Unwilling to Return/Withdrawal|21
1197279|NCT00958191|3932892|P1|Overall Study|Inadequate 5 yr x-ray quality|10
1197280|NCT00958191|3932892|P1|Overall Study|Lost to Follow-up|5
1197281|NCT00958191|3932892|P1|Overall Study|Death|4
1197282|NCT00958165|3932907|P1|Overall Study|Not eligible|9
1197283|NCT00958165|3932907|P1|Overall Study|Lost to Follow-up|5
1197284|NCT00958126|3932919|P8|Overall Study|Other Reason|0
1197285|NCT00958126|3932920|P7|Overall Study|Other Reason|0
1197286|NCT00958126|3932921|P6|Overall Study|Other Reason|1
1197287|NCT00958126|3932922|P5|Overall Study|Other Reason|0
1197288|NCT00958126|3932923|P4|Overall Study|Other Reason|1
1197289|NCT00958126|3932924|P3|Overall Study|Other Reason|0
1197290|NCT00958126|3932925|P2|Overall Study|Other Reason|0
1197291|NCT00958126|3932926|P1|Overall Study|Other Reason|0
1197292|NCT00958126|3932919|P8|Overall Study|Sponsor/Investigator decision|0
1197293|NCT00958126|3932920|P7|Overall Study|Sponsor/Investigator decision|0
1197294|NCT00958126|3932921|P6|Overall Study|Sponsor/Investigator decision|0
1197295|NCT00958126|3932922|P5|Overall Study|Sponsor/Investigator decision|0
1197296|NCT00958126|3932923|P4|Overall Study|Sponsor/Investigator decision|1
1197297|NCT00958126|3932924|P3|Overall Study|Sponsor/Investigator decision|0
1197298|NCT00958126|3932925|P2|Overall Study|Sponsor/Investigator decision|0
1197299|NCT00958126|3932926|P1|Overall Study|Sponsor/Investigator decision|0
1197300|NCT00958126|3932919|P8|Overall Study|Lost to Follow-up|0
1197301|NCT00958126|3932920|P7|Overall Study|Lost to Follow-up|0
1197302|NCT00958126|3932921|P6|Overall Study|Lost to Follow-up|0
1197303|NCT00958126|3932922|P5|Overall Study|Lost to Follow-up|0
1197304|NCT00958126|3932923|P4|Overall Study|Lost to Follow-up|8
1197305|NCT00958126|3932924|P3|Overall Study|Lost to Follow-up|9
1197306|NCT00958126|3932925|P2|Overall Study|Lost to Follow-up|5
1197307|NCT00958126|3932926|P1|Overall Study|Lost to Follow-up|1
1197308|NCT00958126|3932919|P8|Overall Study|Moved away from study area|0
1197309|NCT00958126|3932920|P7|Overall Study|Moved away from study area|0
1197310|NCT00958126|3932921|P6|Overall Study|Moved away from study area|0
1197311|NCT00958126|3932922|P5|Overall Study|Moved away from study area|0
1197312|NCT00958126|3932923|P4|Overall Study|Moved away from study area|1
1197313|NCT00958126|3932924|P3|Overall Study|Moved away from study area|1
1197314|NCT00958126|3932925|P2|Overall Study|Moved away from study area|0
1197315|NCT00958126|3932926|P1|Overall Study|Moved away from study area|0
1197316|NCT00958126|3932919|P8|Overall Study|Withdrawal by Subject|0
1197317|NCT00958126|3932920|P7|Overall Study|Withdrawal by Subject|0
1197318|NCT00958126|3932921|P6|Overall Study|Withdrawal by Subject|0
1197319|NCT00958126|3932922|P5|Overall Study|Withdrawal by Subject|0
1197320|NCT00958126|3932923|P4|Overall Study|Withdrawal by Subject|0
1197321|NCT00958126|3932924|P3|Overall Study|Withdrawal by Subject|0
1197322|NCT00958126|3932925|P2|Overall Study|Withdrawal by Subject|2
1197323|NCT00958126|3932926|P1|Overall Study|Withdrawal by Subject|0
1197324|NCT00958126|3932919|P8|Overall Study|Serious Adverse Event|0
1197325|NCT00958126|3932920|P7|Overall Study|Serious Adverse Event|1
1197326|NCT00958126|3932921|P6|Overall Study|Serious Adverse Event|0
1197327|NCT00958126|3932922|P5|Overall Study|Serious Adverse Event|0
1197328|NCT00958126|3932923|P4|Overall Study|Serious Adverse Event|0
1197329|NCT00958126|3932924|P3|Overall Study|Serious Adverse Event|0
1197330|NCT00958126|3932925|P2|Overall Study|Serious Adverse Event|2
1197331|NCT00958126|3932926|P1|Overall Study|Serious Adverse Event|0
1197332|NCT00958074|3932998|P2|Overall Study|Withdrawal by Subject|1
1197333|NCT00958074|3932999|P1|Overall Study|Withdrawal by Subject|0
1197334|NCT00958009|3933022|P1|Overall Study|Subject found device difficult to use|1
1197335|NCT00958009|3933022|P1|Overall Study|Adverse Event|1
1197336|NCT00957996|3933029|P2|Overall Study|Noncompliance; Protocol Deviations|6
1197337|NCT00957996|3933030|P1|Overall Study|Noncompliance; Protocol Deviations|5
1197338|NCT00957996|3933029|P2|Overall Study|Missing|0
1197339|NCT00957996|3933030|P1|Overall Study|Missing|1
1197340|NCT00957996|3933029|P2|Overall Study|Influenza-related complication|1
1197341|NCT00957996|3933030|P1|Overall Study|Influenza-related complication|0
1197342|NCT00957996|3933029|P2|Overall Study|Physician Decision|1
1197343|NCT00957996|3933030|P1|Overall Study|Physician Decision|1
1197344|NCT00957996|3933029|P2|Overall Study|Adverse Event|1
1197345|NCT00957996|3933030|P1|Overall Study|Adverse Event|2
1197346|NCT00957996|3933029|P2|Overall Study|Withdrawal by Subject|2
1197347|NCT00957996|3933030|P1|Overall Study|Withdrawal by Subject|9
1197348|NCT00957996|3933029|P2|Overall Study|Lost to Follow-up|7
1197349|NCT00957996|3933030|P1|Overall Study|Lost to Follow-up|4
1197350|NCT00957996|3933029|P2|Overall Study|Death|10
1197351|NCT00957996|3933030|P1|Overall Study|Death|4
1197352|NCT00957944|3933062|P2|First Intervention- 24 Hours|Withdrawal by Subject|1
1197353|NCT00957944|3933063|P1|First Intervention- 24 Hours|Withdrawal by Subject|0
1197354|NCT00957931|3933097|P1|Overall Study|Death|4
1197355|NCT00957905|3933107|P2|Part B|Protocol Violation|1
1197356|NCT00957905|3933108|P1|Part B|Protocol Violation|0
1197357|NCT00957905|3933107|P2|Part B|Death|1
1197358|NCT00957905|3933108|P1|Part B|Death|0
1197359|NCT00957905|3933107|P2|Part B|Physician Decision|1
1197360|NCT00957905|3933108|P1|Part B|Physician Decision|0
1197361|NCT00957905|3933107|P2|Part B|Not Treated|1
1197362|NCT00957905|3933108|P1|Part B|Not Treated|0
1197363|NCT00957801|3933118|P4|Overall Study|Withdrawal by Subject|1
1197364|NCT00957801|3933119|P3|Overall Study|Withdrawal by Subject|0
1197365|NCT00957801|3933120|P2|Overall Study|Withdrawal by Subject|0
1197366|NCT00957801|3933121|P1|Overall Study|Withdrawal by Subject|0
1197367|NCT00957723|3933287|P1|Overall Study|2yr ROM Data Not Evaluable|12
1197368|NCT00957723|3933287|P1|Overall Study|Intercurrent Illness|2
1197369|NCT00957723|3933287|P1|Overall Study|Investigative Site Terminated|61
1197370|NCT00957723|3933287|P1|Overall Study|Withdrawal by Subject|24
1197371|NCT00957723|3933287|P1|Overall Study|Lost to Follow-up|8
1197372|NCT00957723|3933287|P1|Overall Study|Revision/ Removal of Study Implant|3
1197373|NCT00957723|3933287|P1|Overall Study|Death|3
1197374|NCT00957658|3933376|P1|Overall Study|Protocol Violation|5
1197375|NCT00957658|3933376|P1|Overall Study|surgery cancelled|2
1197376|NCT00957658|3933376|P1|Overall Study|unwilling/unable to return|2
1197377|NCT00957658|3933376|P1|Overall Study|Site termination|10
1197378|NCT00957658|3933376|P1|Overall Study|Incomplete 2 yr data|28
1197379|NCT00957658|3933376|P1|Overall Study|Revision|1
1197380|NCT00957658|3933376|P1|Overall Study|Withdrawal by Subject|12
1197381|NCT00957658|3933376|P1|Overall Study|Lost to Follow-up|4
1197382|NCT00957658|3933376|P1|Overall Study|Death|1
1197383|NCT00957580|3933401|P3|Overall Study|Enrolled but not treated|0
1197384|NCT00957580|3933402|P2|Overall Study|Enrolled but not treated|1
1197385|NCT00957580|3933403|P1|Overall Study|Enrolled but not treated|0
1197386|NCT00957580|3933401|P3|Overall Study|Ongoing at data cut-off|0
1197387|NCT00957580|3933402|P2|Overall Study|Ongoing at data cut-off|1
1197388|NCT00957580|3933403|P1|Overall Study|Ongoing at data cut-off|0
1197389|NCT00957528|3933550|P3|Overall Study|Withdrawal by Subject|1
1197390|NCT00957528|3933551|P2|Overall Study|Withdrawal by Subject|0
1197391|NCT00957528|3933552|P1|Overall Study|Withdrawal by Subject|0
1197392|NCT00957528|3933550|P3|Overall Study|Protocol Violation|0
1197393|NCT00957528|3933551|P2|Overall Study|Protocol Violation|1
1197394|NCT00957528|3933552|P1|Overall Study|Protocol Violation|0
1197395|NCT00957424|3933575|P1|Overall Study|Withdrawal by Subject|1
1197396|NCT00957424|3933575|P1|Overall Study|Protocol Violation|3
1197397|NCT00957424|3933575|P1|Overall Study|Lost to Follow-up|19
1197398|NCT00957372|3933585|P4|PART II|Patient non-compliance|4
1197399|NCT00957372|3933586|P3|PART II|Patient non-compliance|0
1197400|NCT00957372|3933587|P2|PART II|Patient non-compliance|0
1197401|NCT00957372|3933588|P1|PART II|Patient non-compliance|0
1197402|NCT00957372|3933585|P4|PART II|Adverse Event|10
1197403|NCT00957372|3933586|P3|PART II|Adverse Event|0
1197404|NCT00957372|3933587|P2|PART II|Adverse Event|0
1197405|NCT00957372|3933588|P1|PART II|Adverse Event|0
1197406|NCT00957372|3933585|P4|PART II|Not Know|20
1197407|NCT00957372|3933586|P3|PART II|Not Know|0
1197408|NCT00957372|3933587|P2|PART II|Not Know|0
1197409|NCT00957372|3933588|P1|PART II|Not Know|0
1197410|NCT00957372|3933585|P4|PART II|Pregnancy|1
1197411|NCT00957372|3933586|P3|PART II|Pregnancy|0
1197412|NCT00957372|3933587|P2|PART II|Pregnancy|0
1197413|NCT00957372|3933588|P1|PART II|Pregnancy|0
1197414|NCT00957372|3933585|P4|PART II|Physician Decision|1
1197415|NCT00957372|3933586|P3|PART II|Physician Decision|0
1197416|NCT00957372|3933587|P2|PART II|Physician Decision|0
1197417|NCT00957372|3933588|P1|PART II|Physician Decision|0
1197418|NCT00957372|3933585|P4|PART II|Withdrawal by Subject|8
1197419|NCT00957372|3933586|P3|PART II|Withdrawal by Subject|0
1197420|NCT00957372|3933587|P2|PART II|Withdrawal by Subject|0
1197421|NCT00957372|3933588|P1|PART II|Withdrawal by Subject|0
1197422|NCT00957372|3933585|P4|PART I|Lost to Follow-up|0
1197423|NCT00957372|3933586|P3|PART I|Lost to Follow-up|1
1197424|NCT00957372|3933587|P2|PART I|Lost to Follow-up|0
1197425|NCT00957372|3933588|P1|PART I|Lost to Follow-up|0
1197426|NCT00957268|3933613|P5|Overall Study|Voluntary Withdrawal|0
1197427|NCT00957268|3933614|P4|Overall Study|Voluntary Withdrawal|0
1197428|NCT00957268|3933615|P3|Overall Study|Voluntary Withdrawal|1
1197429|NCT00957268|3933616|P2|Overall Study|Voluntary Withdrawal|0
1197430|NCT00957268|3933617|P1|Overall Study|Voluntary Withdrawal|0
1197431|NCT00957034|3933739|P3|Overall Study|Withdrawal by Subject|0
1197432|NCT00957034|3933740|P2|Overall Study|Withdrawal by Subject|2
1197433|NCT00957034|3933741|P1|Overall Study|Withdrawal by Subject|0
1197434|NCT00957034|3933739|P3|Overall Study|Sponsor Terminated Study|5
1197435|NCT00957034|3933740|P2|Overall Study|Sponsor Terminated Study|1
1197436|NCT00957034|3933741|P1|Overall Study|Sponsor Terminated Study|6
1197437|NCT00957034|3933739|P3|Overall Study|Adverse Event|1
1197438|NCT00957034|3933740|P2|Overall Study|Adverse Event|1
1197439|NCT00957034|3933741|P1|Overall Study|Adverse Event|0
1197440|NCT00957021|3933764|P1|Overall Study|Termination due to language issue|2
1197441|NCT00957021|3933764|P1|Overall Study|Surgery Cancelled|9
1197442|NCT00957021|3933764|P1|Overall Study|Site Termination by the 2 yr visit|16
1197443|NCT00957021|3933764|P1|Overall Study|Revised study component by 2 yr visit|8
1197444|NCT00957021|3933764|P1|Overall Study|No 2 yr ROM data|35
1197445|NCT00957021|3933764|P1|Overall Study|Withdrawal by Subject|34
1197446|NCT00957021|3933764|P1|Overall Study|Lost to Follow-up|8
1197447|NCT00957021|3933764|P1|Overall Study|Death|5
1197448|NCT00957008|3933777|P4|Overall Study|Relocated; Family conflict|3
1197449|NCT00957008|3933778|P3|Overall Study|Relocated; Family conflict|1
1197450|NCT00957008|3933779|P2|Overall Study|Relocated; Family conflict|1
1197451|NCT00957008|3933780|P1|Overall Study|Relocated; Family conflict|4
1197452|NCT00957008|3933777|P4|Overall Study|Physician Decision|1
1197453|NCT00957008|3933778|P3|Overall Study|Physician Decision|1
1197454|NCT00957008|3933779|P2|Overall Study|Physician Decision|0
1197455|NCT00957008|3933780|P1|Overall Study|Physician Decision|1
1197456|NCT00957008|3933777|P4|Overall Study|Lost to Follow-up|4
1197457|NCT00957008|3933778|P3|Overall Study|Lost to Follow-up|3
1197458|NCT00957008|3933779|P2|Overall Study|Lost to Follow-up|1
1197459|NCT00957008|3933780|P1|Overall Study|Lost to Follow-up|3
1197460|NCT00957008|3933777|P4|Overall Study|Withdrawal by Subject|16
1197461|NCT00957008|3933778|P3|Overall Study|Withdrawal by Subject|12
1197462|NCT00957008|3933779|P2|Overall Study|Withdrawal by Subject|10
1197463|NCT00957008|3933780|P1|Overall Study|Withdrawal by Subject|13
1197464|NCT00956943|3933808|P2|Overall Study|Lost to Follow-up|10
1197465|NCT00956943|3933809|P1|Overall Study|Lost to Follow-up|9
1197466|NCT00956839|3933820|P3|Overall Study|Lost to Follow-up|3
1197467|NCT00956839|3933821|P2|Overall Study|Lost to Follow-up|0
1197468|NCT00956839|3933822|P1|Overall Study|Lost to Follow-up|3
1197469|NCT00956813|3933835|P2|Flaxseed and Placebo|Ineligible|1
1197470|NCT00956813|3933836|P1|Flaxseed and Placebo|Ineligible|3
1197471|NCT00956813|3933835|P2|Flaxseed and Placebo|Withdrawal by Subject|4
1197472|NCT00956813|3933836|P1|Flaxseed and Placebo|Withdrawal by Subject|5
1197473|NCT00956592|3933888|P2|Overall Study|Protocol Violation|3
1197474|NCT00956592|3933889|P1|Overall Study|Protocol Violation|1
1197475|NCT00956293|3933924|P3|Follow-up Period|Follow-up period was terminated.|0
1197476|NCT00956293|3933925|P2|Follow-up Period|Follow-up period was terminated.|32
1197477|NCT00956293|3933926|P1|Follow-up Period|Follow-up period was terminated.|20
1197478|NCT00956293|3933924|P3|Main Period (Randomization)|Adverse Event|0
1197479|NCT00956293|3933925|P2|Main Period (Randomization)|Adverse Event|15
1197480|NCT00956293|3933926|P1|Main Period (Randomization)|Adverse Event|0
1197481|NCT00956293|3933924|P3|Main Period (Randomization)|Lack of Efficacy|0
1197482|NCT00956293|3933925|P2|Main Period (Randomization)|Lack of Efficacy|10
1197483|NCT00956293|3933926|P1|Main Period (Randomization)|Lack of Efficacy|1
1197484|NCT00956293|3933924|P3|Main Period (Randomization)|Abnormal laboratory value|0
1197485|NCT00956293|3933925|P2|Main Period (Randomization)|Abnormal laboratory value|2
1197486|NCT00956293|3933926|P1|Main Period (Randomization)|Abnormal laboratory value|0
1197487|NCT00956293|3933924|P3|Main Period (Pre-randomization)|Abnormal laboratory value|44
1197488|NCT00956293|3933925|P2|Main Period (Pre-randomization)|Abnormal laboratory value|0
1197489|NCT00956293|3933926|P1|Main Period (Pre-randomization)|Abnormal laboratory value|0
1197490|NCT00956293|3933924|P3|Main Period (Pre-randomization)|Adverse Event|36
1197491|NCT00956293|3933925|P2|Main Period (Pre-randomization)|Adverse Event|0
1197492|NCT00956293|3933926|P1|Main Period (Pre-randomization)|Adverse Event|0
1197493|NCT00956293|3933924|P3|Main Period (Pre-randomization)|Lack of Efficacy|20
1197494|NCT00956293|3933925|P2|Main Period (Pre-randomization)|Lack of Efficacy|0
1197495|NCT00956293|3933926|P1|Main Period (Pre-randomization)|Lack of Efficacy|0
1197496|NCT00956293|3933924|P3|Main Period (Pre-randomization)|Withdrawal by Subject|12
1197497|NCT00956293|3933925|P2|Main Period (Pre-randomization)|Withdrawal by Subject|0
1197498|NCT00956293|3933926|P1|Main Period (Pre-randomization)|Withdrawal by Subject|0
1197499|NCT00956293|3933924|P3|Main Period (Pre-randomization)|Graft loss|7
1197500|NCT00956293|3933925|P2|Main Period (Pre-randomization)|Graft loss|0
1197501|NCT00956293|3933926|P1|Main Period (Pre-randomization)|Graft loss|0
1197502|NCT00956293|3933924|P3|Main Period (Pre-randomization)|Administrative problems|6
1197503|NCT00956293|3933925|P2|Main Period (Pre-randomization)|Administrative problems|0
1197504|NCT00956293|3933926|P1|Main Period (Pre-randomization)|Administrative problems|0
1197505|NCT00956293|3933924|P3|Main Period (Pre-randomization)|Abnormal test procedure result|2
1197506|NCT00956293|3933925|P2|Main Period (Pre-randomization)|Abnormal test procedure result|0
1197507|NCT00956293|3933926|P1|Main Period (Pre-randomization)|Abnormal test procedure result|0
1197508|NCT00956293|3933924|P3|Main Period (Pre-randomization)|Protocol Violation|1
1197509|NCT00956293|3933925|P2|Main Period (Pre-randomization)|Protocol Violation|0
1197510|NCT00956293|3933926|P1|Main Period (Pre-randomization)|Protocol Violation|0
1197511|NCT00956293|3933924|P3|Main Period (Pre-randomization)|Death|1
1197512|NCT00956293|3933925|P2|Main Period (Pre-randomization)|Death|0
1197513|NCT00956293|3933926|P1|Main Period (Pre-randomization)|Death|0
1197514|NCT00956293|3933924|P3|Main Period (Pre-randomization)|Not specified (data missing)|1
1197515|NCT00956293|3933925|P2|Main Period (Pre-randomization)|Not specified (data missing)|0
1197516|NCT00956293|3933926|P1|Main Period (Pre-randomization)|Not specified (data missing)|0
1197517|NCT00955968|3933981|P2|Overall Study|Site closed|52
1197518|NCT00955968|3933982|P1|Overall Study|Site closed|55
1197519|NCT00955968|3933981|P2|Overall Study|Lost to Follow-up|39
1197520|NCT00955968|3933982|P1|Overall Study|Lost to Follow-up|45
1197521|NCT00955968|3933981|P2|Overall Study|Withdrawal by Subject|31
1197522|NCT00955968|3933982|P1|Overall Study|Withdrawal by Subject|35
1197523|NCT00955968|3933981|P2|Overall Study|Death|4
1197524|NCT00955968|3933982|P1|Overall Study|Death|2
1197525|NCT00955955|3934020|P3|Overall Study|Lost to Follow-up|0
1197526|NCT00955955|3934021|P2|Overall Study|Lost to Follow-up|0
1197527|NCT00955955|3934022|P1|Overall Study|Lost to Follow-up|2
1197528|NCT00955825|3934106|P2|Overall Study|Any other reason not above-mentioned|9
1197529|NCT00955825|3934107|P1|Overall Study|Any other reason not above-mentioned|7
1197530|NCT00955825|3934106|P2|Overall Study|Withdrawal by Subject|6
1197531|NCT00955825|3934107|P1|Overall Study|Withdrawal by Subject|4
1197532|NCT00955825|3934106|P2|Overall Study|Adverse Event|2
1197533|NCT00955825|3934107|P1|Overall Study|Adverse Event|15
1197534|NCT00955721|3934124|P2|Overall Study|Withdrawal by Subject|0
1197535|NCT00955721|3934125|P1|Overall Study|Withdrawal by Subject|1
1197536|NCT00955721|3934124|P2|Overall Study|Death|0
1197537|NCT00955721|3934125|P1|Overall Study|Death|1
1197538|NCT00955721|3934124|P2|Overall Study|Physician Decision|0
1197539|NCT00955721|3934125|P1|Overall Study|Physician Decision|1
1197540|NCT00955617|3934135|P2|Second MRA (Between Day 1 and Day 51)|conventional angiography|0
1197541|NCT00955617|3934136|P1|Second MRA (Between Day 1 and Day 51)|conventional angiography|1
1197542|NCT00955617|3934135|P2|Second MRA (Between Day 1 and Day 51)|technical incident|1
1197543|NCT00955617|3934136|P1|Second MRA (Between Day 1 and Day 51)|technical incident|0
1197544|NCT00955617|3934135|P2|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1
1197545|NCT00955617|3934136|P1|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0
1197546|NCT00955617|3934135|P2|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1
1197547|NCT00955617|3934136|P1|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2
1197548|NCT00955474|3934200|P2|Overall Study|Physician Decision|5
1197549|NCT00955474|3934201|P1|Overall Study|Physician Decision|7
1197550|NCT00955357|3934237|P2|Maintenance Phase|Non compliance to study procedures|0
1197551|NCT00955357|3934238|P1|Maintenance Phase|Non compliance to study procedures|1
1197552|NCT00955357|3934237|P2|Maintenance Phase|Patient moving out of area|1
1197553|NCT00955357|3934238|P1|Maintenance Phase|Patient moving out of area|0
1197554|NCT00955357|3934237|P2|Maintenance Phase|Withdrawal by Subject|4
1197555|NCT00955357|3934238|P1|Maintenance Phase|Withdrawal by Subject|4
1197556|NCT00955357|3934237|P2|Maintenance Phase|Lost to Follow-up|7
1197557|NCT00955357|3934238|P1|Maintenance Phase|Lost to Follow-up|2
1197558|NCT00955357|3934237|P2|Maintenance Phase|Protocol Violation|6
1197559|NCT00955357|3934238|P1|Maintenance Phase|Protocol Violation|2
1197560|NCT00955357|3934237|P2|Maintenance Phase|Lack of Efficacy|4
1197561|NCT00955357|3934238|P1|Maintenance Phase|Lack of Efficacy|0
1197562|NCT00955357|3934237|P2|Maintenance Phase|Adverse Event|23
1197563|NCT00955357|3934238|P1|Maintenance Phase|Adverse Event|3
1197564|NCT00955357|3934237|P2|Titration Phase|Non compliance to study procedures|1
1197565|NCT00955357|3934238|P1|Titration Phase|Non compliance to study procedures|0
1197566|NCT00955357|3934237|P2|Titration Phase|Study medication not tolerated|1
1197567|NCT00955357|3934238|P1|Titration Phase|Study medication not tolerated|0
1197568|NCT00955357|3934237|P2|Titration Phase|Prohibited Antiepileptic Drug change|1
1197569|NCT00955357|3934238|P1|Titration Phase|Prohibited Antiepileptic Drug change|0
1197570|NCT00955357|3934237|P2|Titration Phase|Withdrawal by Subject|5
1197571|NCT00955357|3934238|P1|Titration Phase|Withdrawal by Subject|3
1197572|NCT00955357|3934237|P2|Titration Phase|Lost to Follow-up|3
1197573|NCT00955357|3934238|P1|Titration Phase|Lost to Follow-up|1
1197574|NCT00955357|3934237|P2|Titration Phase|Protocol Violation|7
1197575|NCT00955357|3934238|P1|Titration Phase|Protocol Violation|3
1197576|NCT00955357|3934237|P2|Titration Phase|Lack of Efficacy|2
1197577|NCT00955357|3934238|P1|Titration Phase|Lack of Efficacy|0
1197578|NCT00955357|3934237|P2|Titration Phase|Adverse Event|46
1197579|NCT00955357|3934238|P1|Titration Phase|Adverse Event|9
1197580|NCT00955305|3934246|P2|Overall Study|Ineligible|7
1197581|NCT00955305|3934247|P1|Overall Study|Ineligible|5
1197582|NCT00955305|3934246|P2|Overall Study|Never started protocol treatment|5
1197583|NCT00955305|3934247|P1|Overall Study|Never started protocol treatment|5
1197584|NCT00955305|3934246|P2|Overall Study|No off-treatment reason submitted|0
1197585|NCT00955305|3934247|P1|Overall Study|No off-treatment reason submitted|1
1197586|NCT00955305|3934246|P2|Overall Study|Lost to Follow-up|1
1197587|NCT00955305|3934247|P1|Overall Study|Lost to Follow-up|0
1197588|NCT00955305|3934246|P2|Overall Study|Maximum response achieved|1
1197589|NCT00955305|3934247|P1|Overall Study|Maximum response achieved|0
1197590|NCT00955305|3934246|P2|Overall Study|Functional decline|0
1197591|NCT00955305|3934247|P1|Overall Study|Functional decline|2
1197592|NCT00955305|3934246|P2|Overall Study|Continued presence of residual disease|1
1197593|NCT00955305|3934247|P1|Overall Study|Continued presence of residual disease|0
1197594|NCT00955305|3934246|P2|Overall Study|Physician Decision|0
1197595|NCT00955305|3934247|P1|Overall Study|Physician Decision|1
1197596|NCT00955305|3934246|P2|Overall Study|Other complicating disease|4
1197597|NCT00955305|3934247|P1|Overall Study|Other complicating disease|2
1197598|NCT00955305|3934246|P2|Overall Study|Alternative therapy|0
1197599|NCT00955305|3934247|P1|Overall Study|Alternative therapy|4
1197600|NCT00955305|3934246|P2|Overall Study|Withdrawal by Subject|4
1197601|NCT00955305|3934247|P1|Overall Study|Withdrawal by Subject|5
1197602|NCT00955305|3934246|P2|Overall Study|Death|1
1197603|NCT00955305|3934247|P1|Overall Study|Death|2
1197604|NCT00955305|3934246|P2|Overall Study|Adverse Event|22
1197605|NCT00955305|3934247|P1|Overall Study|Adverse Event|22
1197606|NCT00955305|3934246|P2|Overall Study|Disease progression|41
1197607|NCT00955305|3934247|P1|Overall Study|Disease progression|39
1197608|NCT00955279|3934260|P3|Overall Study|Withdrawal by Subject|3
1197609|NCT00955279|3934261|P2|Overall Study|Withdrawal by Subject|0
1197610|NCT00955279|3934262|P1|Overall Study|Withdrawal by Subject|2
1197611|NCT00955279|3934260|P3|Overall Study|Lost to Follow-up|1
1197612|NCT00955279|3934261|P2|Overall Study|Lost to Follow-up|3
1197613|NCT00955279|3934262|P1|Overall Study|Lost to Follow-up|0
1197614|NCT00955279|3934260|P3|Overall Study|Death|1
1197615|NCT00955279|3934261|P2|Overall Study|Death|1
1197616|NCT00955279|3934262|P1|Overall Study|Death|1
1197617|NCT00955279|3934260|P3|Overall Study|Other|3
1197618|NCT00955279|3934261|P2|Overall Study|Other|0
1197619|NCT00955279|3934262|P1|Overall Study|Other|0
1197620|NCT00955110|3934299|P1|Treatment Phase|Withdrawn by physician pre-treatment|1
1197621|NCT00955110|3934299|P1|Treatment Phase|Non-compliance with study restrictions|1
1197622|NCT00955110|3934299|P1|Treatment Phase|Administrative reasons|2
1197623|NCT00955110|3934299|P1|Treatment Phase|Adverse Event|2
1197624|NCT00955110|3934299|P1|Qualification Phase|Did not meet eligibility criteria|24
1197625|NCT00954941|3934346|P2|Overall Study|Adverse Event|1
1197626|NCT00954941|3934347|P1|Overall Study|Adverse Event|0
1197627|NCT00954941|3934346|P2|Overall Study|Ineligible|2
1197628|NCT00954941|3934347|P1|Overall Study|Ineligible|2
1197629|NCT00954941|3934346|P2|Overall Study|Physician Decision|2
1197630|NCT00954941|3934347|P1|Overall Study|Physician Decision|2
1197631|NCT00954941|3934346|P2|Overall Study|Insurance Denial|2
1197632|NCT00954941|3934347|P1|Overall Study|Insurance Denial|2
1197633|NCT00954941|3934346|P2|Overall Study|Withdrawal by Subject|0
1197634|NCT00954941|3934347|P1|Overall Study|Withdrawal by Subject|1
1197635|NCT00954941|3934346|P2|Overall Study|Received treatment at home|0
1197636|NCT00954941|3934347|P1|Overall Study|Received treatment at home|1
1197637|NCT00954733|3934363|P1|Overall Study|blood gas machine did not work|1
1197638|NCT00954707|3934367|P1|Overall Study|Lost to Follow-up|33
1197639|NCT00954707|3934367|P1|Overall Study|Withdrawal by Subject|100
1197640|NCT00954707|3934367|P1|Overall Study|Death|34
1197641|NCT00954538|3934389|P6|Part III|Withdrawal by Subject|0
1197642|NCT00954538|3934390|P5|Part III|Withdrawal by Subject|1
1197643|NCT00954538|3934391|P4|Part III|Withdrawal by Subject|0
1197644|NCT00954538|3934392|P3|Part III|Withdrawal by Subject|0
1197645|NCT00954538|3934393|P2|Part III|Withdrawal by Subject|0
1197646|NCT00954538|3934394|P1|Part III|Withdrawal by Subject|0
1197647|NCT00954512|3934411|P6|Overall Study|Progression of Disease|1
1197648|NCT00954512|3934412|P5|Overall Study|Progression of Disease|1
1197649|NCT00954512|3934413|P4|Overall Study|Progression of Disease|1
1197650|NCT00954512|3934414|P3|Overall Study|Progression of Disease|0
1197651|NCT00954512|3934415|P2|Overall Study|Progression of Disease|1
1197652|NCT00954512|3934416|P1|Overall Study|Progression of Disease|2
1197653|NCT00954512|3934411|P6|Overall Study|Symptomatic Deterioration|0
1197654|NCT00954512|3934412|P5|Overall Study|Symptomatic Deterioration|2
1197655|NCT00954512|3934413|P4|Overall Study|Symptomatic Deterioration|0
1197656|NCT00954512|3934414|P3|Overall Study|Symptomatic Deterioration|0
1197657|NCT00954512|3934415|P2|Overall Study|Symptomatic Deterioration|1
1197658|NCT00954512|3934416|P1|Overall Study|Symptomatic Deterioration|0
1197659|NCT00954512|3934411|P6|Overall Study|Physician Decision|0
1197660|NCT00954512|3934412|P5|Overall Study|Physician Decision|0
1197661|NCT00954512|3934413|P4|Overall Study|Physician Decision|1
1197662|NCT00954512|3934414|P3|Overall Study|Physician Decision|0
1197663|NCT00954512|3934415|P2|Overall Study|Physician Decision|1
1197664|NCT00954512|3934416|P1|Overall Study|Physician Decision|0
1197665|NCT00954512|3934411|P6|Overall Study|Adverse Event|2
1197666|NCT00954512|3934412|P5|Overall Study|Adverse Event|1
1197667|NCT00954512|3934413|P4|Overall Study|Adverse Event|0
1197668|NCT00954512|3934414|P3|Overall Study|Adverse Event|0
1197669|NCT00954512|3934415|P2|Overall Study|Adverse Event|0
1197670|NCT00954512|3934416|P1|Overall Study|Adverse Event|0
1197671|NCT00954512|3934411|P6|Overall Study|Withdrawal by Subject|1
1197672|NCT00954512|3934412|P5|Overall Study|Withdrawal by Subject|0
1197673|NCT00954512|3934413|P4|Overall Study|Withdrawal by Subject|0
1197674|NCT00954512|3934414|P3|Overall Study|Withdrawal by Subject|0
1197675|NCT00954512|3934415|P2|Overall Study|Withdrawal by Subject|0
1197676|NCT00954512|3934416|P1|Overall Study|Withdrawal by Subject|0
1197677|NCT00954447|3934437|P2|Overall Study|Other|18
1197678|NCT00954447|3934438|P1|Overall Study|Other|21
1197679|NCT00954447|3934437|P2|Overall Study|Withdrawal by Subject|21
1197680|NCT00954447|3934438|P1|Overall Study|Withdrawal by Subject|26
1197681|NCT00954447|3934437|P2|Overall Study|Lost to Follow-up|14
1197682|NCT00954447|3934438|P1|Overall Study|Lost to Follow-up|8
1197683|NCT00954447|3934437|P2|Overall Study|Protocol Violation|7
1197684|NCT00954447|3934438|P1|Overall Study|Protocol Violation|5
1197685|NCT00954447|3934437|P2|Overall Study|Lack of Efficacy|3
1197686|NCT00954447|3934438|P1|Overall Study|Lack of Efficacy|17
1197687|NCT00954447|3934437|P2|Overall Study|Adverse Event|25
1197688|NCT00954447|3934438|P1|Overall Study|Adverse Event|33
1197689|NCT00954421|3934474|P1|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1
1197690|NCT00954421|3934474|P1|6 Months of DBS|Withdrawal by Subject|1
1197691|NCT00954421|3934474|P1|Screening|screen failures|3
1197692|NCT00954122|3934520|P1|Overall Study|Safety Reason|1
1197693|NCT00954122|3934520|P1|Overall Study|Adverse Event|1
1197694|NCT00954122|3934520|P1|Overall Study|Withdrawal by Subject|5
1197695|NCT00953927|3934537|P2|Overall Study|Other study discontinuation|1
1197696|NCT00953927|3934538|P1|Overall Study|Other study discontinuation|1
1197697|NCT00953927|3934537|P2|Overall Study|Death|4
1197698|NCT00953927|3934538|P1|Overall Study|Death|7
1197699|NCT00953927|3934537|P2|Overall Study|Withdrawal by Subject|25
1197700|NCT00953927|3934538|P1|Overall Study|Withdrawal by Subject|36
1197701|NCT00953927|3934537|P2|Overall Study|Lost to Follow-up|65
1197702|NCT00953927|3934538|P1|Overall Study|Lost to Follow-up|61
1197703|NCT00953745|3934593|P2|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0
1197704|NCT00953745|3934594|P1|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1
1197705|NCT00953745|3934593|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0
1197706|NCT00953745|3934594|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6
1197707|NCT00953745|3934593|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0
1197708|NCT00953745|3934594|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1
1197709|NCT00953745|3934593|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0
1197710|NCT00953745|3934594|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3
1197711|NCT00953745|3934593|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0
1197712|NCT00953745|3934594|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2
1197713|NCT00953745|3934593|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0
1197714|NCT00953745|3934594|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1
1197715|NCT00953706|3934627|P4|Part B (96-Week Open-Label Extension)|Other|2
1197716|NCT00953706|3934628|P3|Part B (96-Week Open-Label Extension)|Other|0
1197717|NCT00953706|3934629|P2|Part B (96-Week Open-Label Extension)|Other|0
1197718|NCT00953706|3934630|P1|Part B (96-Week Open-Label Extension)|Other|0
1197719|NCT00953706|3934627|P4|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2
1197720|NCT00953706|3934628|P3|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1
1197721|NCT00953706|3934629|P2|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
1197722|NCT00953706|3934630|P1|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
1197723|NCT00953706|3934627|P4|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25
1197724|NCT00953706|3934628|P3|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4
1197725|NCT00953706|3934629|P2|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
1197726|NCT00953706|3934630|P1|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
1197727|NCT00953706|3934627|P4|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1
1197728|NCT00953706|3934628|P3|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
1197729|NCT00953706|3934629|P2|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
1197730|NCT00953706|3934630|P1|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
1197731|NCT00953706|3934627|P4|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1
1197732|NCT00953706|3934628|P3|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
1197733|NCT00953706|3934629|P2|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
1197734|NCT00953706|3934630|P1|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
1197735|NCT00953706|3934627|P4|Part B (96-Week Open-Label Extension)|Adverse Event|2
1197736|NCT00953706|3934628|P3|Part B (96-Week Open-Label Extension)|Adverse Event|0
1197737|NCT00953706|3934629|P2|Part B (96-Week Open-Label Extension)|Adverse Event|0
1197738|NCT00953706|3934630|P1|Part B (96-Week Open-Label Extension)|Adverse Event|0
1197739|NCT00953706|3934627|P4|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
1197740|NCT00953706|3934628|P3|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
1197741|NCT00953706|3934629|P2|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1
1197742|NCT00953706|3934630|P1|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
1197743|NCT00953706|3934627|P4|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
1197744|NCT00953706|3934628|P3|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
1197745|NCT00953706|3934629|P2|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1
1197746|NCT00953706|3934630|P1|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
1197747|NCT00953706|3934627|P4|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
1197748|NCT00953706|3934628|P3|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
1197749|NCT00953706|3934629|P2|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2
1197750|NCT00953706|3934630|P1|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
1197751|NCT00953706|3934627|P4|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
1197752|NCT00953706|3934628|P3|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
1197753|NCT00953706|3934629|P2|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1
1197754|NCT00953706|3934630|P1|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
1197755|NCT00953706|3934627|P4|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
1197756|NCT00953706|3934628|P3|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
1197757|NCT00953706|3934629|P2|Part A (16-Week Double-Blind Treatment)|Adverse Event|3
1197758|NCT00953706|3934630|P1|Part A (16-Week Double-Blind Treatment)|Adverse Event|2
1197759|NCT00953680|3934662|P2|Period 1|Withdrawal by Subject|1
1197760|NCT00953680|3934663|P1|Period 1|Withdrawal by Subject|0
1197761|NCT00953667|3934675|P1|Overall Study|poor venous access,unable to draw blood|4
1197762|NCT00953667|3934675|P1|Overall Study|Adverse Event|10
1197763|NCT00953667|3934675|P1|Overall Study|Withdrawal by Subject|63
1197764|NCT00953667|3934675|P1|Overall Study|Physician Decision|35
1197765|NCT00953667|3934675|P1|Overall Study|Lost to Follow-up|11
1197766|NCT00953615|3934696|P1|Overall Study|Adverse Event|1
1197767|NCT00953576|3934705|P2|Overall Study|Ineligible after Consent|0
1197768|NCT00953576|3934706|P1|Overall Study|Ineligible after Consent|2
1197769|NCT00953576|3934705|P2|Overall Study|Adverse Event|1
1197770|NCT00953576|3934706|P1|Overall Study|Adverse Event|0
1197771|NCT00953524|3934721|P4|Overall Study|Withdrawal by Subject|0
1197772|NCT00953524|3934722|P3|Overall Study|Withdrawal by Subject|1
1197773|NCT00953524|3934723|P2|Overall Study|Withdrawal by Subject|4
1197774|NCT00953524|3934724|P1|Overall Study|Withdrawal by Subject|2
1197775|NCT00953524|3934721|P4|Overall Study|Lost to Follow-up|0
1197776|NCT00953524|3934722|P3|Overall Study|Lost to Follow-up|1
1197777|NCT00953524|3934723|P2|Overall Study|Lost to Follow-up|1
1197778|NCT00953524|3934724|P1|Overall Study|Lost to Follow-up|0
1197779|NCT00953524|3934721|P4|Overall Study|Protocol Violation|6
1197780|NCT00953524|3934722|P3|Overall Study|Protocol Violation|11
1197781|NCT00953524|3934723|P2|Overall Study|Protocol Violation|10
1197782|NCT00953524|3934724|P1|Overall Study|Protocol Violation|18
1197783|NCT00953524|3934721|P4|Overall Study|Adverse Event|2
1197784|NCT00953524|3934722|P3|Overall Study|Adverse Event|1
1197785|NCT00953524|3934723|P2|Overall Study|Adverse Event|0
1197786|NCT00953524|3934724|P1|Overall Study|Adverse Event|2
1197787|NCT00953407|3934767|P5|Overall Study|Lost to Follow-up|0
1197788|NCT00953407|3934768|P4|Overall Study|Lost to Follow-up|1
1197789|NCT00953407|3934769|P3|Overall Study|Lost to Follow-up|0
1197790|NCT00953407|3934770|P2|Overall Study|Lost to Follow-up|0
1197791|NCT00953407|3934771|P1|Overall Study|Lost to Follow-up|0
1197792|NCT00953407|3934767|P5|Overall Study|Failed inclusion criteria|1
1197793|NCT00953407|3934768|P4|Overall Study|Failed inclusion criteria|1
1197794|NCT00953407|3934769|P3|Overall Study|Failed inclusion criteria|1
1197795|NCT00953407|3934770|P2|Overall Study|Failed inclusion criteria|1
1197796|NCT00953407|3934771|P1|Overall Study|Failed inclusion criteria|1
1197797|NCT00953329|3934783|P1|Overall Study|Lack of Efficacy|1
1197798|NCT00953225|3934796|P2|Overall Study|Withdrawal by Subject|0
1197799|NCT00953225|3934797|P1|Overall Study|Withdrawal by Subject|2
1197800|NCT00953160|3934881|P1|Overall Study|Withdrawal by Subject|4
1197801|NCT00953160|3934881|P1|Overall Study|Lost to Follow-up|23
1197802|NCT00953147|3934890|P3|Overall Study|Other|13
1197803|NCT00953147|3934891|P2|Overall Study|Other|11
1197804|NCT00953147|3934892|P1|Overall Study|Other|4
1197805|NCT00953147|3934890|P3|Overall Study|Physician Decision|3
1197806|NCT00953147|3934891|P2|Overall Study|Physician Decision|7
1197807|NCT00953147|3934892|P1|Overall Study|Physician Decision|2
1197808|NCT00953147|3934890|P3|Overall Study|Lost to Follow-up|4
1197809|NCT00953147|3934891|P2|Overall Study|Lost to Follow-up|9
1197810|NCT00953147|3934892|P1|Overall Study|Lost to Follow-up|8
1197811|NCT00953147|3934890|P3|Overall Study|Withdrawal by Subject|12
1197812|NCT00953147|3934891|P2|Overall Study|Withdrawal by Subject|15
1197813|NCT00953147|3934892|P1|Overall Study|Withdrawal by Subject|13
1197814|NCT00953147|3934890|P3|Overall Study|Protocol Violation|4
1197815|NCT00953147|3934891|P2|Overall Study|Protocol Violation|8
1197816|NCT00953147|3934892|P1|Overall Study|Protocol Violation|2
1197817|NCT00953147|3934890|P3|Overall Study|Adverse Event|6
1197818|NCT00953147|3934891|P2|Overall Study|Adverse Event|16
1197819|NCT00953147|3934892|P1|Overall Study|Adverse Event|8
1197820|NCT00953056|3934970|P6|Overall Study|Serious Adverse Event|1
1197821|NCT00953056|3934971|P5|Overall Study|Serious Adverse Event|0
1197822|NCT00953056|3934972|P4|Overall Study|Serious Adverse Event|0
1197823|NCT00953056|3934973|P3|Overall Study|Serious Adverse Event|0
1197824|NCT00953056|3934974|P2|Overall Study|Serious Adverse Event|0
1197825|NCT00953056|3934975|P1|Overall Study|Serious Adverse Event|0
1197826|NCT00953056|3934970|P6|Overall Study|Withdrew Consent|3
1197827|NCT00953056|3934971|P5|Overall Study|Withdrew Consent|2
1197828|NCT00953056|3934972|P4|Overall Study|Withdrew Consent|0
1197829|NCT00953056|3934973|P3|Overall Study|Withdrew Consent|0
1197830|NCT00953056|3934974|P2|Overall Study|Withdrew Consent|0
1197831|NCT00953056|3934975|P1|Overall Study|Withdrew Consent|0
1197832|NCT00953043|3934999|P2|Overall Study|Physician Decision|2
1197833|NCT00953043|3935000|P1|Overall Study|Physician Decision|0
1197834|NCT00953043|3934999|P2|Overall Study|Withdrawal by Subject|0
1197835|NCT00953043|3935000|P1|Overall Study|Withdrawal by Subject|4
1197836|NCT00953017|3935024|P4|Overall Study|Brown stool prior to procedure|0
1197837|NCT00953017|3935025|P3|Overall Study|Brown stool prior to procedure|1
1197838|NCT00953017|3935026|P2|Overall Study|Brown stool prior to procedure|0
1197839|NCT00953017|3935027|P1|Overall Study|Brown stool prior to procedure|0
1197840|NCT00953017|3935024|P4|Overall Study|Procedure incomplete due to pain/looping|1
1197841|NCT00953017|3935025|P3|Overall Study|Procedure incomplete due to pain/looping|0
1197842|NCT00953017|3935026|P2|Overall Study|Procedure incomplete due to pain/looping|1
1197843|NCT00953017|3935027|P1|Overall Study|Procedure incomplete due to pain/looping|0
1197844|NCT00953017|3935024|P4|Overall Study|Incomplete data|0
1197845|NCT00953017|3935025|P3|Overall Study|Incomplete data|0
1197846|NCT00953017|3935026|P2|Overall Study|Incomplete data|1
1197847|NCT00953017|3935027|P1|Overall Study|Incomplete data|1
1197848|NCT00953017|3935024|P4|Overall Study|DId not show up for colonoscopy|4
1197849|NCT00953017|3935025|P3|Overall Study|DId not show up for colonoscopy|5
1197850|NCT00953017|3935026|P2|Overall Study|DId not show up for colonoscopy|4
1197851|NCT00953017|3935027|P1|Overall Study|DId not show up for colonoscopy|4
1197852|NCT00952848|3935049|P1|Overall Study|Withdrawal by Subject|4
1197853|NCT00952822|3935056|P4|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
1197854|NCT00952822|3935057|P3|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1
1197855|NCT00952822|3935058|P2|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
1197856|NCT00952822|3935059|P1|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
1197857|NCT00952822|3935056|P4|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
1197858|NCT00952822|3935057|P3|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
1197859|NCT00952822|3935058|P2|1st Pharmacokinetic Evaluation|Lost to Follow-up|1
1197860|NCT00952822|3935059|P1|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
1197861|NCT00952731|3935091|P2|Overall Study|Drug supply expired|0
1197862|NCT00952731|3935092|P1|Overall Study|Drug supply expired|1
1197863|NCT00952705|3935111|P3|Overall Study|Exclusion criteria not met pre dose|0
1197864|NCT00952705|3935112|P2|Overall Study|Exclusion criteria not met pre dose|1
1197865|NCT00952705|3935113|P1|Overall Study|Exclusion criteria not met pre dose|0
1197866|NCT00952705|3935111|P3|Overall Study|Incarcerated post dose|0
1197867|NCT00952705|3935112|P2|Overall Study|Incarcerated post dose|0
1197868|NCT00952705|3935113|P1|Overall Study|Incarcerated post dose|5
1197869|NCT00952705|3935111|P3|Overall Study|Death|0
1197870|NCT00952705|3935112|P2|Overall Study|Death|0
1197871|NCT00952705|3935113|P1|Overall Study|Death|2
1197872|NCT00952705|3935111|P3|Overall Study|Withdrawal by Subject|1
1197873|NCT00952705|3935112|P2|Overall Study|Withdrawal by Subject|1
1197874|NCT00952705|3935113|P1|Overall Study|Withdrawal by Subject|2
1197875|NCT00952705|3935111|P3|Overall Study|Lost to Follow-up|9
1197876|NCT00952705|3935112|P2|Overall Study|Lost to Follow-up|8
1197877|NCT00952705|3935113|P1|Overall Study|Lost to Follow-up|24
1197878|NCT00952614|3935200|P1|Overall Study|other reason|1
1197879|NCT00952614|3935200|P1|Overall Study|Lost to Follow-up|3
1197880|NCT00952614|3935200|P1|Overall Study|Death|3
1197881|NCT00952588|3935207|P2|Overall Study|Lack of Efficacy|2
1197882|NCT00952588|3935208|P1|Overall Study|Lack of Efficacy|2
1197883|NCT00952588|3935207|P2|Overall Study|Physician Decision|1
1197884|NCT00952588|3935208|P1|Overall Study|Physician Decision|0
1197885|NCT00952588|3935207|P2|Overall Study|Lost to Follow-up|0
1197886|NCT00952588|3935208|P1|Overall Study|Lost to Follow-up|2
1197887|NCT00952588|3935207|P2|Overall Study|Adverse Event|3
1197888|NCT00952588|3935208|P1|Overall Study|Adverse Event|2
1197889|NCT00952588|3935207|P2|Overall Study|Withdrawal by Subject|5
1197890|NCT00952588|3935208|P1|Overall Study|Withdrawal by Subject|2
1197891|NCT00952588|3935207|P2|Overall Study|Death|13
1197892|NCT00952588|3935208|P1|Overall Study|Death|28
1197893|NCT00952523|3935226|P1|Overall Study|Withdrawal by Subject|7
1197894|NCT00952484|3935235|P3|Overall Study|Withdrawal by Subject|0
1197895|NCT00952484|3935236|P2|Overall Study|Withdrawal by Subject|1
1197896|NCT00952484|3935237|P1|Overall Study|Withdrawal by Subject|0
1197897|NCT00952419|3935264|P3|Overall Study|Withdrawal by Subject|0
1197898|NCT00952419|3935265|P2|Overall Study|Withdrawal by Subject|3
1197899|NCT00952419|3935266|P1|Overall Study|Withdrawal by Subject|1
1197900|NCT00952419|3935264|P3|Overall Study|Protocol Violation|0
1197901|NCT00952419|3935265|P2|Overall Study|Protocol Violation|7
1197902|NCT00952419|3935266|P1|Overall Study|Protocol Violation|3
1197903|NCT00952419|3935264|P3|Overall Study|Adverse Event|0
1197904|NCT00952419|3935265|P2|Overall Study|Adverse Event|0
1197905|NCT00952419|3935266|P1|Overall Study|Adverse Event|2
1197906|NCT00952367|3935302|P1|Overall Study|Protocol Violation|3
1197907|NCT00952367|3935302|P1|Overall Study|Noncoordination|1
1197908|NCT00952367|3935302|P1|Overall Study|Withdrawal by Subject|2
1197909|NCT00952341|3935317|P2|Cycle 2|Progressive Disease|1
1197910|NCT00952341|3935318|P1|Cycle 2|Progressive Disease|0
1197911|NCT00952341|3935317|P2|Cycle 2|Physician Decision|1
1197912|NCT00952341|3935318|P1|Cycle 2|Physician Decision|1
1197913|NCT00952341|3935317|P2|Cycle 2|Lost to Follow-up|9
1197914|NCT00952341|3935318|P1|Cycle 2|Lost to Follow-up|6
1197915|NCT00952341|3935317|P2|Cycle 2|Protocol Violation|0
1197916|NCT00952341|3935318|P1|Cycle 2|Protocol Violation|1
1197917|NCT00952341|3935317|P2|Cycle 2|Withdrawal by Subject|1
1197918|NCT00952341|3935318|P1|Cycle 2|Withdrawal by Subject|1
1197919|NCT00952341|3935317|P2|Cycle 1|Physician Decision|1
1197920|NCT00952341|3935318|P1|Cycle 1|Physician Decision|0
1197921|NCT00952341|3935317|P2|Cycle 1|Lost to Follow-up|2
1197922|NCT00952341|3935318|P1|Cycle 1|Lost to Follow-up|11
1197923|NCT00952341|3935317|P2|Cycle 1|Protocol Violation|1
1197924|NCT00952341|3935318|P1|Cycle 1|Protocol Violation|2
1197925|NCT00952341|3935317|P2|Cycle 1|Withdrawal by Subject|8
1197926|NCT00952341|3935318|P1|Cycle 1|Withdrawal by Subject|3
1197927|NCT00952341|3935317|P2|Cycle 1|Adverse Event|1
1197928|NCT00952341|3935318|P1|Cycle 1|Adverse Event|4
1197929|NCT00952289|3935340|P2|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7
1197930|NCT00952289|3935341|P1|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0
1197931|NCT00952289|3935340|P2|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2
1197932|NCT00952289|3935341|P1|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0
1197933|NCT00952289|3935340|P2|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11
1197934|NCT00952289|3935341|P1|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0
1197935|NCT00952289|3935340|P2|Patients Who Crossed Over to Ruxolitinib|Disease progression|15
1197936|NCT00952289|3935341|P1|Patients Who Crossed Over to Ruxolitinib|Disease progression|0
1197937|NCT00952289|3935340|P2|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19
1197938|NCT00952289|3935341|P1|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0
1197939|NCT00952289|3935340|P2|All Participants|Data lost during site relocation|1
1197940|NCT00952289|3935341|P1|All Participants|Data lost during site relocation|0
1197941|NCT00952289|3935340|P2|All Participants|Withdrawal by Subject|10
1197942|NCT00952289|3935341|P1|All Participants|Withdrawal by Subject|1
1197943|NCT00952289|3935340|P2|All Participants|Disease progression|12
1197944|NCT00952289|3935341|P1|All Participants|Disease progression|3
1197945|NCT00952289|3935340|P2|All Participants|Adverse Event|8
1197946|NCT00952289|3935341|P1|All Participants|Adverse Event|8
1197947|NCT00952289|3935340|P2|All Participants|Death|9
1197948|NCT00952289|3935341|P1|All Participants|Death|9
1197949|NCT00952276|3935370|P5|Overall Study|Withdrawal by Subject|0
1197950|NCT00952276|3935371|P4|Overall Study|Withdrawal by Subject|1
1197951|NCT00952276|3935372|P3|Overall Study|Withdrawal by Subject|0
1197952|NCT00952276|3935373|P2|Overall Study|Withdrawal by Subject|0
1197953|NCT00952276|3935374|P1|Overall Study|Withdrawal by Subject|1
1197954|NCT00952068|3935460|P1|Overall Study|Withdrawal by Subject|4
1197955|NCT00952068|3935460|P1|Overall Study|Adverse Event|3
1197956|NCT00951912|3935471|P3|Overall Study|Other: Stroke|0
1197957|NCT00951912|3935472|P2|Overall Study|Other: Stroke|1
1197958|NCT00951912|3935473|P1|Overall Study|Other: Stroke|0
1197959|NCT00951912|3935471|P3|Overall Study|Other: Colon cancer|0
1197960|NCT00951912|3935472|P2|Overall Study|Other: Colon cancer|0
1197961|NCT00951912|3935473|P1|Overall Study|Other: Colon cancer|1
1197962|NCT00951912|3935471|P3|Overall Study|Other:Depression|0
1197963|NCT00951912|3935472|P2|Overall Study|Other:Depression|0
1197964|NCT00951912|3935473|P1|Overall Study|Other:Depression|1
1197965|NCT00951912|3935471|P3|Overall Study|Withdrawal by Subject|0
1197966|NCT00951912|3935472|P2|Overall Study|Withdrawal by Subject|1
1197967|NCT00951912|3935473|P1|Overall Study|Withdrawal by Subject|1
1197968|NCT00951912|3935471|P3|Overall Study|Physician Decision|1
1197969|NCT00951912|3935472|P2|Overall Study|Physician Decision|0
1197970|NCT00951912|3935473|P1|Overall Study|Physician Decision|1
1197971|NCT00951912|3935471|P3|Overall Study|Lost to Follow-up|0
1197972|NCT00951912|3935472|P2|Overall Study|Lost to Follow-up|2
1197973|NCT00951912|3935473|P1|Overall Study|Lost to Follow-up|2
1197974|NCT00951912|3935471|P3|Overall Study|Adverse Event|1
1197975|NCT00951912|3935472|P2|Overall Study|Adverse Event|1
1197976|NCT00951912|3935473|P1|Overall Study|Adverse Event|0
1197977|NCT00951912|3935471|P3|Overall Study|Lack of Efficacy|0
1197978|NCT00951912|3935472|P2|Overall Study|Lack of Efficacy|0
1197979|NCT00951912|3935473|P1|Overall Study|Lack of Efficacy|1
1197980|NCT00951665|3935573|P6|Phase 2a|Disease Progression|5
1197981|NCT00951665|3935574|P5|Phase 2a|Disease Progression|6
1197982|NCT00951665|3935575|P4|Phase 2a|Disease Progression|0
1197983|NCT00951665|3935576|P3|Phase 2a|Disease Progression|0
1197984|NCT00951665|3935577|P2|Phase 2a|Disease Progression|0
1197985|NCT00951665|3935578|P1|Phase 2a|Disease Progression|0
1197986|NCT00951665|3935573|P6|Phase 2a|Withdrawal by Subject|0
1197987|NCT00951665|3935574|P5|Phase 2a|Withdrawal by Subject|2
1197988|NCT00951665|3935575|P4|Phase 2a|Withdrawal by Subject|0
1197989|NCT00951665|3935576|P3|Phase 2a|Withdrawal by Subject|0
1197990|NCT00951665|3935577|P2|Phase 2a|Withdrawal by Subject|0
1197991|NCT00951665|3935578|P1|Phase 2a|Withdrawal by Subject|0
1197992|NCT00951665|3935573|P6|Phase 2a|Physician Decision|1
1197993|NCT00951665|3935574|P5|Phase 2a|Physician Decision|0
1197994|NCT00951665|3935575|P4|Phase 2a|Physician Decision|0
1197995|NCT00951665|3935576|P3|Phase 2a|Physician Decision|0
1197996|NCT00951665|3935577|P2|Phase 2a|Physician Decision|0
1197997|NCT00951665|3935578|P1|Phase 2a|Physician Decision|0
1197998|NCT00951665|3935573|P6|Phase 2a|Lost to Follow-up|0
1197999|NCT00951665|3935574|P5|Phase 2a|Lost to Follow-up|1
1198000|NCT00951665|3935575|P4|Phase 2a|Lost to Follow-up|0
1198001|NCT00951665|3935576|P3|Phase 2a|Lost to Follow-up|0
1198002|NCT00951665|3935577|P2|Phase 2a|Lost to Follow-up|0
1198003|NCT00951665|3935578|P1|Phase 2a|Lost to Follow-up|0
1198004|NCT00951665|3935573|P6|Phase 2a|Death|1
1198005|NCT00951665|3935574|P5|Phase 2a|Death|1
1198006|NCT00951665|3935575|P4|Phase 2a|Death|0
1198007|NCT00951665|3935576|P3|Phase 2a|Death|0
1198008|NCT00951665|3935577|P2|Phase 2a|Death|0
1198009|NCT00951665|3935578|P1|Phase 2a|Death|0
1198010|NCT00951665|3935573|P6|Phase 2a|Adverse Event|0
1198011|NCT00951665|3935574|P5|Phase 2a|Adverse Event|2
1198012|NCT00951665|3935575|P4|Phase 2a|Adverse Event|0
1198013|NCT00951665|3935576|P3|Phase 2a|Adverse Event|0
1198014|NCT00951665|3935577|P2|Phase 2a|Adverse Event|0
1198015|NCT00951665|3935578|P1|Phase 2a|Adverse Event|0
1198016|NCT00951665|3935573|P6|Phase 1b|Protocol Violation|0
1198017|NCT00951665|3935574|P5|Phase 1b|Protocol Violation|0
1198018|NCT00951665|3935575|P4|Phase 1b|Protocol Violation|0
1198019|NCT00951665|3935576|P3|Phase 1b|Protocol Violation|0
1198020|NCT00951665|3935577|P2|Phase 1b|Protocol Violation|0
1198021|NCT00951665|3935578|P1|Phase 1b|Protocol Violation|2
1198022|NCT00951665|3935573|P6|Phase 1b|Disease Progression|0
1198023|NCT00951665|3935574|P5|Phase 1b|Disease Progression|0
1198024|NCT00951665|3935575|P4|Phase 1b|Disease Progression|0
1198025|NCT00951665|3935576|P3|Phase 1b|Disease Progression|14
1198026|NCT00951665|3935577|P2|Phase 1b|Disease Progression|2
1198027|NCT00951665|3935578|P1|Phase 1b|Disease Progression|13
1198028|NCT00951665|3935573|P6|Phase 1b|Withdrawal by Subject|0
1198029|NCT00951665|3935574|P5|Phase 1b|Withdrawal by Subject|0
1198030|NCT00951665|3935575|P4|Phase 1b|Withdrawal by Subject|0
1198031|NCT00951665|3935576|P3|Phase 1b|Withdrawal by Subject|0
1198032|NCT00951665|3935577|P2|Phase 1b|Withdrawal by Subject|1
1198033|NCT00951665|3935578|P1|Phase 1b|Withdrawal by Subject|0
1198034|NCT00951665|3935573|P6|Phase 1b|Physician Decision|0
1198035|NCT00951665|3935574|P5|Phase 1b|Physician Decision|0
1198036|NCT00951665|3935575|P4|Phase 1b|Physician Decision|0
1198037|NCT00951665|3935576|P3|Phase 1b|Physician Decision|1
1198038|NCT00951665|3935577|P2|Phase 1b|Physician Decision|0
1198039|NCT00951665|3935578|P1|Phase 1b|Physician Decision|4
1198040|NCT00951665|3935573|P6|Phase 1b|Death|0
1198041|NCT00951665|3935574|P5|Phase 1b|Death|0
1198042|NCT00951665|3935575|P4|Phase 1b|Death|0
1198043|NCT00951665|3935576|P3|Phase 1b|Death|2
1198044|NCT00951665|3935577|P2|Phase 1b|Death|0
1198045|NCT00951665|3935578|P1|Phase 1b|Death|1
1198046|NCT00951665|3935573|P6|Phase 1b|Adverse Event|0
1198047|NCT00951665|3935574|P5|Phase 1b|Adverse Event|0
1198048|NCT00951665|3935575|P4|Phase 1b|Adverse Event|1
1198049|NCT00951665|3935576|P3|Phase 1b|Adverse Event|0
1198050|NCT00951665|3935577|P2|Phase 1b|Adverse Event|1
1198051|NCT00951665|3935578|P1|Phase 1b|Adverse Event|2
1198052|NCT00951509|3935687|P1|Overall Study|Withdrawal by Subject|2
1198053|NCT00951496|3935698|P3|Overall Study|Did not initiate study treatment|13
1198054|NCT00951496|3935699|P2|Overall Study|Did not initiate study treatment|8
1198055|NCT00951496|3935700|P1|Overall Study|Did not initiate study treatment|10
1198056|NCT00951483|3935728|P2|Overall Study|Withdrawal by Subject|0
1198057|NCT00951483|3935729|P1|Overall Study|Withdrawal by Subject|15
1198058|NCT00951483|3935728|P2|Overall Study|Physician Decision|0
1198059|NCT00951483|3935729|P1|Overall Study|Physician Decision|4
1198060|NCT00951379|3935749|P2|Overall Study|Disease Progression|1
1198061|NCT00951379|3935750|P1|Overall Study|Disease Progression|0
1198062|NCT00951379|3935749|P2|Overall Study|Noncompliance|0
1198063|NCT00951379|3935750|P1|Overall Study|Noncompliance|1
1198064|NCT00951379|3935749|P2|Overall Study|Withdrawal by Subject|0
1198065|NCT00951379|3935750|P1|Overall Study|Withdrawal by Subject|1
1198066|NCT00951379|3935749|P2|Overall Study|Adverse Event|1
1198067|NCT00951379|3935750|P1|Overall Study|Adverse Event|4
1198068|NCT00951275|3935792|P1|Overall Study|Protocol Violation|1
1198069|NCT00951275|3935792|P1|Overall Study|Withdrawal by Subject|4
1198070|NCT00951275|3935792|P1|Overall Study|Adverse Event|7
1198071|NCT00951275|3935792|P1|Overall Study|Administrative Reason|1
1198072|NCT00951171|3935824|P2|Overall Study|Adverse Event|0
1198073|NCT00951171|3935825|P1|Overall Study|Adverse Event|2
1198074|NCT00951041|3935857|P2|Overall Study|Other|0
1198075|NCT00951041|3935858|P1|Overall Study|Other|3
1198076|NCT00951041|3935857|P2|Overall Study|Lost to Follow-up|0
1198077|NCT00951041|3935858|P1|Overall Study|Lost to Follow-up|1
1198078|NCT00951041|3935857|P2|Overall Study|Withdrawal by Subject|1
1198079|NCT00951041|3935858|P1|Overall Study|Withdrawal by Subject|1
1198080|NCT00951015|3935913|P5|Open-label Phase|Physician Decision|8
1198081|NCT00951015|3935914|P4|Open-label Phase|Physician Decision|0
1198082|NCT00951015|3935915|P3|Open-label Phase|Physician Decision|0
1198083|NCT00951015|3935916|P2|Open-label Phase|Physician Decision|0
1198084|NCT00951015|3935917|P1|Open-label Phase|Physician Decision|0
1198085|NCT00951015|3935913|P5|Open-label Phase|Withdrawal by Subject|14
1198086|NCT00951015|3935914|P4|Open-label Phase|Withdrawal by Subject|0
1198087|NCT00951015|3935915|P3|Open-label Phase|Withdrawal by Subject|0
1198088|NCT00951015|3935916|P2|Open-label Phase|Withdrawal by Subject|0
1198089|NCT00951015|3935917|P1|Open-label Phase|Withdrawal by Subject|0
1198090|NCT00951015|3935913|P5|Open-label Phase|Lost to Follow-up|12
1198091|NCT00951015|3935914|P4|Open-label Phase|Lost to Follow-up|0
1198092|NCT00951015|3935915|P3|Open-label Phase|Lost to Follow-up|0
1198093|NCT00951015|3935916|P2|Open-label Phase|Lost to Follow-up|0
1198094|NCT00951015|3935917|P1|Open-label Phase|Lost to Follow-up|0
1198095|NCT00951015|3935913|P5|Open-label Phase|Protocol Violation|12
1198096|NCT00951015|3935914|P4|Open-label Phase|Protocol Violation|0
1198097|NCT00951015|3935915|P3|Open-label Phase|Protocol Violation|0
1198098|NCT00951015|3935916|P2|Open-label Phase|Protocol Violation|0
1198099|NCT00951015|3935917|P1|Open-label Phase|Protocol Violation|0
1198100|NCT00951015|3935913|P5|Open-label Phase|Lack of Efficacy|1
1198101|NCT00951015|3935914|P4|Open-label Phase|Lack of Efficacy|0
1198102|NCT00951015|3935915|P3|Open-label Phase|Lack of Efficacy|0
1198103|NCT00951015|3935916|P2|Open-label Phase|Lack of Efficacy|0
1198104|NCT00951015|3935917|P1|Open-label Phase|Lack of Efficacy|0
1198105|NCT00951015|3935913|P5|Open-label Phase|Adverse Event|3
1198106|NCT00951015|3935914|P4|Open-label Phase|Adverse Event|0
1198107|NCT00951015|3935915|P3|Open-label Phase|Adverse Event|0
1198108|NCT00951015|3935916|P2|Open-label Phase|Adverse Event|0
1198109|NCT00951015|3935917|P1|Open-label Phase|Adverse Event|0
1198110|NCT00951015|3935913|P5|Randomization Phase 96 Week|Withdrawal by Subject|0
1198111|NCT00951015|3935914|P4|Randomization Phase 96 Week|Withdrawal by Subject|2
1198112|NCT00951015|3935915|P3|Randomization Phase 96 Week|Withdrawal by Subject|1
1198113|NCT00951015|3935916|P2|Randomization Phase 96 Week|Withdrawal by Subject|1
1198114|NCT00951015|3935917|P1|Randomization Phase 96 Week|Withdrawal by Subject|2
1198115|NCT00951015|3935913|P5|Randomization Phase 96 Week|Lost to Follow-up|0
1198116|NCT00951015|3935914|P4|Randomization Phase 96 Week|Lost to Follow-up|2
1198117|NCT00951015|3935915|P3|Randomization Phase 96 Week|Lost to Follow-up|1
1198118|NCT00951015|3935916|P2|Randomization Phase 96 Week|Lost to Follow-up|3
1198119|NCT00951015|3935917|P1|Randomization Phase 96 Week|Lost to Follow-up|0
1198120|NCT00951015|3935913|P5|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
1198121|NCT00951015|3935914|P4|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1
1198122|NCT00951015|3935915|P3|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
1198123|NCT00951015|3935916|P2|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
1198124|NCT00951015|3935917|P1|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
1198125|NCT00951015|3935913|P5|Randomization Phase 96 Week|Protocol Violation|0
1198126|NCT00951015|3935914|P4|Randomization Phase 96 Week|Protocol Violation|0
1198127|NCT00951015|3935915|P3|Randomization Phase 96 Week|Protocol Violation|1
1198128|NCT00951015|3935916|P2|Randomization Phase 96 Week|Protocol Violation|1
1198129|NCT00951015|3935917|P1|Randomization Phase 96 Week|Protocol Violation|1
1198130|NCT00951015|3935913|P5|Randomization Phase 96 Week|Lack of Efficacy|0
1198131|NCT00951015|3935914|P4|Randomization Phase 96 Week|Lack of Efficacy|0
1198132|NCT00951015|3935915|P3|Randomization Phase 96 Week|Lack of Efficacy|0
1198133|NCT00951015|3935916|P2|Randomization Phase 96 Week|Lack of Efficacy|1
1198134|NCT00951015|3935917|P1|Randomization Phase 96 Week|Lack of Efficacy|1
1198135|NCT00951015|3935913|P5|Randomization Phase 96 Week|Adverse Event|0
1198136|NCT00951015|3935914|P4|Randomization Phase 96 Week|Adverse Event|5
1198137|NCT00951015|3935915|P3|Randomization Phase 96 Week|Adverse Event|2
1198138|NCT00951015|3935916|P2|Randomization Phase 96 Week|Adverse Event|1
1198139|NCT00951015|3935917|P1|Randomization Phase 96 Week|Adverse Event|1
1198140|NCT00950963|3936014|P2|Overall Study|Lost to Follow-up|24
1198141|NCT00950963|3936015|P1|Overall Study|Lost to Follow-up|29
1198142|NCT00950911|3936050|P2|Overall Study|Poor performance status|1
1198143|NCT00950911|3936051|P1|Overall Study|Poor performance status|0
1198144|NCT00950911|3936050|P2|Overall Study|Noncompliance|0
1198145|NCT00950911|3936051|P1|Overall Study|Noncompliance|1
1198146|NCT00950911|3936050|P2|Overall Study|Ineligibility determined|0
1198147|NCT00950911|3936051|P1|Overall Study|Ineligibility determined|1
1198148|NCT00950911|3936050|P2|Overall Study|Administrative decision|1
1198149|NCT00950911|3936051|P1|Overall Study|Administrative decision|3
1198150|NCT00950911|3936050|P2|Overall Study|Consent withdrawn|3
1198151|NCT00950911|3936051|P1|Overall Study|Consent withdrawn|1
1198152|NCT00950911|3936050|P2|Overall Study|Disease progression|2
1198153|NCT00950911|3936051|P1|Overall Study|Disease progression|2
1198154|NCT00950911|3936050|P2|Overall Study|Death|6
1198155|NCT00950911|3936051|P1|Overall Study|Death|4
1198156|NCT00950911|3936050|P2|Overall Study|Adverse Event|2
1198157|NCT00950911|3936051|P1|Overall Study|Adverse Event|0
1198158|NCT00950872|3936057|P1|Overall Study|Did not have surgery|2
1198159|NCT00950872|3936057|P1|Overall Study|Withdrawal by Subject|1
1198160|NCT00950859|3936066|P2|Overall Study|Lost to Follow-up|3
1198161|NCT00950859|3936067|P1|Overall Study|Lost to Follow-up|0
1198162|NCT00950859|3936066|P2|Overall Study|Protocol Violation|1
1198163|NCT00950859|3936067|P1|Overall Study|Protocol Violation|1
1198164|NCT00950859|3936066|P2|Overall Study|Insufficient Viral Load Response|3
1198165|NCT00950859|3936067|P1|Overall Study|Insufficient Viral Load Response|12
1198166|NCT00950859|3936066|P2|Overall Study|Adverse Event|3
1198167|NCT00950859|3936067|P1|Overall Study|Adverse Event|3
1198168|NCT00950807|3936166|P10|Treatment Period 3|Adverse Event|0
1198169|NCT00950807|3936167|P9|Treatment Period 3|Adverse Event|0
1198170|NCT00950807|3936168|P8|Treatment Period 3|Adverse Event|0
1198171|NCT00950807|3936169|P7|Treatment Period 3|Adverse Event|1
1198172|NCT00950807|3936170|P6|Treatment Period 3|Adverse Event|0
1198173|NCT00950807|3936171|P5|Treatment Period 3|Adverse Event|0
1198174|NCT00950807|3936172|P4|Treatment Period 3|Adverse Event|0
1198175|NCT00950807|3936173|P3|Treatment Period 3|Adverse Event|0
1198176|NCT00950807|3936174|P2|Treatment Period 3|Adverse Event|0
1198177|NCT00950807|3936175|P1|Treatment Period 3|Adverse Event|0
1198178|NCT00950807|3936166|P10|Treatment Period 3|Protocol-defined Stopping Criteria|0
1198179|NCT00950807|3936167|P9|Treatment Period 3|Protocol-defined Stopping Criteria|0
1198180|NCT00950807|3936168|P8|Treatment Period 3|Protocol-defined Stopping Criteria|1
1198181|NCT00950807|3936169|P7|Treatment Period 3|Protocol-defined Stopping Criteria|0
1198182|NCT00950807|3936170|P6|Treatment Period 3|Protocol-defined Stopping Criteria|0
1198183|NCT00950807|3936171|P5|Treatment Period 3|Protocol-defined Stopping Criteria|0
1198184|NCT00950807|3936172|P4|Treatment Period 3|Protocol-defined Stopping Criteria|0
1198185|NCT00950807|3936173|P3|Treatment Period 3|Protocol-defined Stopping Criteria|0
1198186|NCT00950807|3936174|P2|Treatment Period 3|Protocol-defined Stopping Criteria|0
1198187|NCT00950807|3936175|P1|Treatment Period 3|Protocol-defined Stopping Criteria|1
1198188|NCT00950807|3936166|P10|Treatment Period 3|Withdrawal by Subject|1
1198189|NCT00950807|3936167|P9|Treatment Period 3|Withdrawal by Subject|0
1198190|NCT00950807|3936168|P8|Treatment Period 3|Withdrawal by Subject|0
1198191|NCT00950807|3936169|P7|Treatment Period 3|Withdrawal by Subject|0
1198192|NCT00950807|3936170|P6|Treatment Period 3|Withdrawal by Subject|0
1198193|NCT00950807|3936171|P5|Treatment Period 3|Withdrawal by Subject|0
1198194|NCT00950807|3936172|P4|Treatment Period 3|Withdrawal by Subject|0
1198195|NCT00950807|3936173|P3|Treatment Period 3|Withdrawal by Subject|0
1198196|NCT00950807|3936174|P2|Treatment Period 3|Withdrawal by Subject|0
1198197|NCT00950807|3936175|P1|Treatment Period 3|Withdrawal by Subject|0
1198198|NCT00950807|3936166|P10|Washout Period 2|Adverse Event|0
1198199|NCT00950807|3936167|P9|Washout Period 2|Adverse Event|0
1198200|NCT00950807|3936168|P8|Washout Period 2|Adverse Event|0
1198201|NCT00950807|3936169|P7|Washout Period 2|Adverse Event|0
1198202|NCT00950807|3936170|P6|Washout Period 2|Adverse Event|0
1198203|NCT00950807|3936171|P5|Washout Period 2|Adverse Event|0
1198204|NCT00950807|3936172|P4|Washout Period 2|Adverse Event|1
1198205|NCT00950807|3936173|P3|Washout Period 2|Adverse Event|0
1198206|NCT00950807|3936174|P2|Washout Period 2|Adverse Event|0
1198207|NCT00950807|3936175|P1|Washout Period 2|Adverse Event|3
1198208|NCT00950807|3936166|P10|Washout Period 2|Protocol-defined Stopping Criteria|0
1198209|NCT00950807|3936167|P9|Washout Period 2|Protocol-defined Stopping Criteria|0
1198210|NCT00950807|3936168|P8|Washout Period 2|Protocol-defined Stopping Criteria|1
1198211|NCT00950807|3936169|P7|Washout Period 2|Protocol-defined Stopping Criteria|1
1198212|NCT00950807|3936170|P6|Washout Period 2|Protocol-defined Stopping Criteria|0
1198213|NCT00950807|3936171|P5|Washout Period 2|Protocol-defined Stopping Criteria|1
1198214|NCT00950807|3936172|P4|Washout Period 2|Protocol-defined Stopping Criteria|0
1198215|NCT00950807|3936173|P3|Washout Period 2|Protocol-defined Stopping Criteria|0
1198216|NCT00950807|3936174|P2|Washout Period 2|Protocol-defined Stopping Criteria|1
1198217|NCT00950807|3936175|P1|Washout Period 2|Protocol-defined Stopping Criteria|0
1198218|NCT00950807|3936166|P10|Washout Period 2|Lack of Efficacy|0
1198219|NCT00950807|3936167|P9|Washout Period 2|Lack of Efficacy|0
1198220|NCT00950807|3936168|P8|Washout Period 2|Lack of Efficacy|0
1198221|NCT00950807|3936169|P7|Washout Period 2|Lack of Efficacy|0
1198222|NCT00950807|3936170|P6|Washout Period 2|Lack of Efficacy|0
1198223|NCT00950807|3936171|P5|Washout Period 2|Lack of Efficacy|0
1198224|NCT00950807|3936172|P4|Washout Period 2|Lack of Efficacy|0
1198225|NCT00950807|3936173|P3|Washout Period 2|Lack of Efficacy|0
1198226|NCT00950807|3936174|P2|Washout Period 2|Lack of Efficacy|0
1198227|NCT00950807|3936175|P1|Washout Period 2|Lack of Efficacy|1
1198228|NCT00950807|3936166|P10|Treatment Period 2|Adverse Event|0
1198229|NCT00950807|3936167|P9|Treatment Period 2|Adverse Event|0
1198230|NCT00950807|3936168|P8|Treatment Period 2|Adverse Event|1
1198231|NCT00950807|3936169|P7|Treatment Period 2|Adverse Event|0
1198232|NCT00950807|3936170|P6|Treatment Period 2|Adverse Event|1
1198233|NCT00950807|3936171|P5|Treatment Period 2|Adverse Event|0
1198234|NCT00950807|3936172|P4|Treatment Period 2|Adverse Event|1
1198235|NCT00950807|3936173|P3|Treatment Period 2|Adverse Event|0
1198236|NCT00950807|3936174|P2|Treatment Period 2|Adverse Event|1
1198237|NCT00950807|3936175|P1|Treatment Period 2|Adverse Event|0
1198238|NCT00950807|3936166|P10|Treatment Period 2|Protocol-defined Stopping Criteria|0
1198239|NCT00950807|3936167|P9|Treatment Period 2|Protocol-defined Stopping Criteria|0
1198240|NCT00950807|3936168|P8|Treatment Period 2|Protocol-defined Stopping Criteria|0
1198241|NCT00950807|3936169|P7|Treatment Period 2|Protocol-defined Stopping Criteria|0
1198242|NCT00950807|3936170|P6|Treatment Period 2|Protocol-defined Stopping Criteria|0
1198243|NCT00950807|3936171|P5|Treatment Period 2|Protocol-defined Stopping Criteria|0
1198244|NCT00950807|3936172|P4|Treatment Period 2|Protocol-defined Stopping Criteria|0
1198245|NCT00950807|3936173|P3|Treatment Period 2|Protocol-defined Stopping Criteria|0
1198246|NCT00950807|3936174|P2|Treatment Period 2|Protocol-defined Stopping Criteria|0
1198247|NCT00950807|3936175|P1|Treatment Period 2|Protocol-defined Stopping Criteria|1
1198248|NCT00950807|3936166|P10|Treatment Period 2|Withdrawal by Subject|0
1198249|NCT00950807|3936167|P9|Treatment Period 2|Withdrawal by Subject|0
1198250|NCT00950807|3936168|P8|Treatment Period 2|Withdrawal by Subject|2
1198251|NCT00950807|3936169|P7|Treatment Period 2|Withdrawal by Subject|1
1198252|NCT00950807|3936170|P6|Treatment Period 2|Withdrawal by Subject|0
1198253|NCT00950807|3936171|P5|Treatment Period 2|Withdrawal by Subject|0
1198254|NCT00950807|3936172|P4|Treatment Period 2|Withdrawal by Subject|0
1198255|NCT00950807|3936173|P3|Treatment Period 2|Withdrawal by Subject|0
1198256|NCT00950807|3936174|P2|Treatment Period 2|Withdrawal by Subject|0
1198257|NCT00950807|3936175|P1|Treatment Period 2|Withdrawal by Subject|0
1198258|NCT00950807|3936166|P10|Treatment Period 2|Lack of Efficacy|0
1198259|NCT00950807|3936167|P9|Treatment Period 2|Lack of Efficacy|0
1198260|NCT00950807|3936168|P8|Treatment Period 2|Lack of Efficacy|0
1198261|NCT00950807|3936169|P7|Treatment Period 2|Lack of Efficacy|0
1198262|NCT00950807|3936170|P6|Treatment Period 2|Lack of Efficacy|0
1198263|NCT00950807|3936171|P5|Treatment Period 2|Lack of Efficacy|0
1198264|NCT00950807|3936172|P4|Treatment Period 2|Lack of Efficacy|0
1198265|NCT00950807|3936173|P3|Treatment Period 2|Lack of Efficacy|0
1198266|NCT00950807|3936174|P2|Treatment Period 2|Lack of Efficacy|0
1198267|NCT00950807|3936175|P1|Treatment Period 2|Lack of Efficacy|1
1198268|NCT00950807|3936166|P10|Washout Period 1|Adverse Event|0
1198269|NCT00950807|3936167|P9|Washout Period 1|Adverse Event|0
1198270|NCT00950807|3936168|P8|Washout Period 1|Adverse Event|0
1198271|NCT00950807|3936169|P7|Washout Period 1|Adverse Event|0
1198272|NCT00950807|3936170|P6|Washout Period 1|Adverse Event|0
1198273|NCT00950807|3936171|P5|Washout Period 1|Adverse Event|1
1198274|NCT00950807|3936172|P4|Washout Period 1|Adverse Event|1
1198275|NCT00950807|3936173|P3|Washout Period 1|Adverse Event|0
1198276|NCT00950807|3936174|P2|Washout Period 1|Adverse Event|0
1198277|NCT00950807|3936175|P1|Washout Period 1|Adverse Event|2
1198278|NCT00950807|3936166|P10|Washout Period 1|Protocol-defined Stopping Criteria|0
1198279|NCT00950807|3936167|P9|Washout Period 1|Protocol-defined Stopping Criteria|0
1198280|NCT00950807|3936168|P8|Washout Period 1|Protocol-defined Stopping Criteria|1
1198281|NCT00950807|3936169|P7|Washout Period 1|Protocol-defined Stopping Criteria|1
1198282|NCT00950807|3936170|P6|Washout Period 1|Protocol-defined Stopping Criteria|0
1198283|NCT00950807|3936171|P5|Washout Period 1|Protocol-defined Stopping Criteria|0
1198284|NCT00950807|3936172|P4|Washout Period 1|Protocol-defined Stopping Criteria|0
1198285|NCT00950807|3936173|P3|Washout Period 1|Protocol-defined Stopping Criteria|0
1198286|NCT00950807|3936174|P2|Washout Period 1|Protocol-defined Stopping Criteria|0
1198287|NCT00950807|3936175|P1|Washout Period 1|Protocol-defined Stopping Criteria|3
1198288|NCT00950807|3936166|P10|Washout Period 1|Withdrawal by Subject|0
1198289|NCT00950807|3936167|P9|Washout Period 1|Withdrawal by Subject|1
1198290|NCT00950807|3936168|P8|Washout Period 1|Withdrawal by Subject|0
1198291|NCT00950807|3936169|P7|Washout Period 1|Withdrawal by Subject|0
1198292|NCT00950807|3936170|P6|Washout Period 1|Withdrawal by Subject|0
1198293|NCT00950807|3936171|P5|Washout Period 1|Withdrawal by Subject|0
1198294|NCT00950807|3936172|P4|Washout Period 1|Withdrawal by Subject|0
1198295|NCT00950807|3936173|P3|Washout Period 1|Withdrawal by Subject|0
1198296|NCT00950807|3936174|P2|Washout Period 1|Withdrawal by Subject|0
1198297|NCT00950807|3936175|P1|Washout Period 1|Withdrawal by Subject|0
1198298|NCT00950807|3936166|P10|Washout Period 1|Lack of Efficacy|0
1198299|NCT00950807|3936167|P9|Washout Period 1|Lack of Efficacy|0
1198300|NCT00950807|3936168|P8|Washout Period 1|Lack of Efficacy|0
1198301|NCT00950807|3936169|P7|Washout Period 1|Lack of Efficacy|1
1198302|NCT00950807|3936170|P6|Washout Period 1|Lack of Efficacy|0
1198303|NCT00950807|3936171|P5|Washout Period 1|Lack of Efficacy|0
1198304|NCT00950807|3936172|P4|Washout Period 1|Lack of Efficacy|0
1198305|NCT00950807|3936173|P3|Washout Period 1|Lack of Efficacy|0
1198306|NCT00950807|3936174|P2|Washout Period 1|Lack of Efficacy|0
1198307|NCT00950807|3936175|P1|Washout Period 1|Lack of Efficacy|0
1198308|NCT00950807|3936166|P10|Treatment Period 1|Adverse Event|0
1198309|NCT00950807|3936167|P9|Treatment Period 1|Adverse Event|0
1198310|NCT00950807|3936168|P8|Treatment Period 1|Adverse Event|0
1198311|NCT00950807|3936169|P7|Treatment Period 1|Adverse Event|0
1198312|NCT00950807|3936170|P6|Treatment Period 1|Adverse Event|1
1198313|NCT00950807|3936171|P5|Treatment Period 1|Adverse Event|0
1198314|NCT00950807|3936172|P4|Treatment Period 1|Adverse Event|0
1198315|NCT00950807|3936173|P3|Treatment Period 1|Adverse Event|0
1198316|NCT00950807|3936174|P2|Treatment Period 1|Adverse Event|0
1198317|NCT00950807|3936175|P1|Treatment Period 1|Adverse Event|0
1198318|NCT00950807|3936166|P10|Treatment Period 1|Withdrawal by Subject|0
1198319|NCT00950807|3936167|P9|Treatment Period 1|Withdrawal by Subject|1
1198320|NCT00950807|3936168|P8|Treatment Period 1|Withdrawal by Subject|0
1198321|NCT00950807|3936169|P7|Treatment Period 1|Withdrawal by Subject|0
1198322|NCT00950807|3936170|P6|Treatment Period 1|Withdrawal by Subject|0
1198323|NCT00950807|3936171|P5|Treatment Period 1|Withdrawal by Subject|1
1198324|NCT00950807|3936172|P4|Treatment Period 1|Withdrawal by Subject|0
1198325|NCT00950807|3936173|P3|Treatment Period 1|Withdrawal by Subject|0
1198326|NCT00950807|3936174|P2|Treatment Period 1|Withdrawal by Subject|0
1198327|NCT00950807|3936175|P1|Treatment Period 1|Withdrawal by Subject|1
1198328|NCT00950807|3936166|P10|Treatment Period 1|Lost to Follow-up|0
1198329|NCT00950807|3936167|P9|Treatment Period 1|Lost to Follow-up|0
1198330|NCT00950807|3936168|P8|Treatment Period 1|Lost to Follow-up|0
1198331|NCT00950807|3936169|P7|Treatment Period 1|Lost to Follow-up|0
1198332|NCT00950807|3936170|P6|Treatment Period 1|Lost to Follow-up|0
1198333|NCT00950807|3936171|P5|Treatment Period 1|Lost to Follow-up|0
1198334|NCT00950807|3936172|P4|Treatment Period 1|Lost to Follow-up|0
1198335|NCT00950807|3936173|P3|Treatment Period 1|Lost to Follow-up|1
1198336|NCT00950807|3936174|P2|Treatment Period 1|Lost to Follow-up|0
1198337|NCT00950807|3936175|P1|Treatment Period 1|Lost to Follow-up|0
1198338|NCT00950807|3936166|P10|Treatment Period 1|Protocol Violation|0
1198339|NCT00950807|3936167|P9|Treatment Period 1|Protocol Violation|0
1198340|NCT00950807|3936168|P8|Treatment Period 1|Protocol Violation|0
1198341|NCT00950807|3936169|P7|Treatment Period 1|Protocol Violation|0
1198342|NCT00950807|3936170|P6|Treatment Period 1|Protocol Violation|0
1198343|NCT00950807|3936171|P5|Treatment Period 1|Protocol Violation|0
1198344|NCT00950807|3936172|P4|Treatment Period 1|Protocol Violation|0
1198345|NCT00950807|3936173|P3|Treatment Period 1|Protocol Violation|0
1198346|NCT00950807|3936174|P2|Treatment Period 1|Protocol Violation|0
1198347|NCT00950807|3936175|P1|Treatment Period 1|Protocol Violation|1
1198348|NCT00950807|3936166|P10|Treatment Period 1|Lack of Efficacy|0
1198349|NCT00950807|3936167|P9|Treatment Period 1|Lack of Efficacy|0
1198350|NCT00950807|3936168|P8|Treatment Period 1|Lack of Efficacy|0
1198351|NCT00950807|3936169|P7|Treatment Period 1|Lack of Efficacy|0
1198352|NCT00950807|3936170|P6|Treatment Period 1|Lack of Efficacy|1
1198353|NCT00950807|3936171|P5|Treatment Period 1|Lack of Efficacy|0
1198354|NCT00950807|3936172|P4|Treatment Period 1|Lack of Efficacy|0
1198355|NCT00950807|3936173|P3|Treatment Period 1|Lack of Efficacy|0
1198356|NCT00950807|3936174|P2|Treatment Period 1|Lack of Efficacy|0
1198357|NCT00950807|3936175|P1|Treatment Period 1|Lack of Efficacy|1
1198358|NCT00950755|3936217|P1|Long-Term Follow-Up|Death|8
1198359|NCT00950755|3936217|P1|Long-Term Follow-Up|Lost to Follow-up|1
1198360|NCT00950755|3936217|P1|Dosimetric and Therapeutic Treatment|Investigator Discretion|1
1198361|NCT00950755|3936217|P1|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6
1198362|NCT00950755|3936217|P1|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1
1198363|NCT00950755|3936217|P1|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1
1198364|NCT00950755|3936217|P1|Dosimetric and Therapeutic Treatment|Death|1
1198365|NCT00950755|3936217|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|27
1198366|NCT00950755|3936217|P1|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1
1198367|NCT00950755|3936217|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
1198368|NCT00950742|3936243|P2|Overall Study|Dose limiting toxicity|0
1198369|NCT00950742|3936244|P1|Overall Study|Dose limiting toxicity|6
1198370|NCT00950742|3936243|P2|Overall Study|Progressive Disease|2
1198371|NCT00950742|3936244|P1|Overall Study|Progressive Disease|6
1198372|NCT00950742|3936243|P2|Overall Study|Withdrawal by Subject|0
1198373|NCT00950742|3936244|P1|Overall Study|Withdrawal by Subject|3
1198374|NCT00950742|3936243|P2|Overall Study|Other Adverse Event|0
1198375|NCT00950742|3936244|P1|Overall Study|Other Adverse Event|1
1198376|NCT00950690|3936265|P1|Overall Study|Other|163
1198377|NCT00950690|3936265|P1|Overall Study|Lost to Follow-up|40
1198378|NCT00950690|3936265|P1|Overall Study|Lack of Efficacy|22
1198379|NCT00950690|3936265|P1|Overall Study|Adverse Event|15
1198380|NCT00950690|3936265|P1|Overall Study|Death|4
1198381|NCT00950664|3936272|P2|First Intervention|Withdrawal by Subject|2
1198382|NCT00950664|3936273|P1|First Intervention|Withdrawal by Subject|2
1198383|NCT00950664|3936272|P2|First Intervention|Lost to Follow-up|3
1198384|NCT00950664|3936273|P1|First Intervention|Lost to Follow-up|1
1198385|NCT00950651|3936293|P2|Overall Study|Withdrawal by Subject|9
1198386|NCT00950651|3936294|P1|Overall Study|Withdrawal by Subject|8
1198387|NCT00950651|3936293|P2|Overall Study|Protocol Violation|4
1198388|NCT00950651|3936294|P1|Overall Study|Protocol Violation|3
1198389|NCT00950651|3936293|P2|Overall Study|Lack of Efficacy|2
1198390|NCT00950651|3936294|P1|Overall Study|Lack of Efficacy|2
1198391|NCT00950651|3936293|P2|Overall Study|Death|0
1198392|NCT00950651|3936294|P1|Overall Study|Death|1
1198393|NCT00950651|3936293|P2|Overall Study|Adverse Event|20
1198394|NCT00950651|3936294|P1|Overall Study|Adverse Event|17
1198395|NCT00950599|3936387|P10|Follow-Up Period|Subject withdrew Consent|1
1198396|NCT00950599|3936388|P9|Follow-Up Period|Subject withdrew Consent|2
1198397|NCT00950599|3936389|P8|Follow-Up Period|Subject withdrew Consent|0
1198398|NCT00950599|3936390|P7|Follow-Up Period|Subject withdrew Consent|0
1198399|NCT00950599|3936391|P6|Follow-Up Period|Subject withdrew Consent|0
1198400|NCT00950599|3936392|P5|Follow-Up Period|Subject withdrew Consent|0
1198401|NCT00950599|3936393|P4|Follow-Up Period|Subject withdrew Consent|0
1198402|NCT00950599|3936394|P3|Follow-Up Period|Subject withdrew Consent|0
1198403|NCT00950599|3936395|P2|Follow-Up Period|Subject withdrew Consent|0
1198404|NCT00950599|3936396|P1|Follow-Up Period|Subject withdrew Consent|0
1198405|NCT00950599|3936387|P10|Follow-Up Period|Poor/Noncompliance|0
1198406|NCT00950599|3936388|P9|Follow-Up Period|Poor/Noncompliance|1
1198407|NCT00950599|3936389|P8|Follow-Up Period|Poor/Noncompliance|0
1198408|NCT00950599|3936390|P7|Follow-Up Period|Poor/Noncompliance|0
1198409|NCT00950599|3936391|P6|Follow-Up Period|Poor/Noncompliance|0
1198410|NCT00950599|3936392|P5|Follow-Up Period|Poor/Noncompliance|0
1198411|NCT00950599|3936393|P4|Follow-Up Period|Poor/Noncompliance|0
1198412|NCT00950599|3936394|P3|Follow-Up Period|Poor/Noncompliance|0
1198413|NCT00950599|3936395|P2|Follow-Up Period|Poor/Noncompliance|0
1198414|NCT00950599|3936396|P1|Follow-Up Period|Poor/Noncompliance|0
1198415|NCT00950599|3936387|P10|Follow-Up Period|Physician Decision|0
1198416|NCT00950599|3936388|P9|Follow-Up Period|Physician Decision|1
1198417|NCT00950599|3936389|P8|Follow-Up Period|Physician Decision|0
1198418|NCT00950599|3936390|P7|Follow-Up Period|Physician Decision|0
1198419|NCT00950599|3936391|P6|Follow-Up Period|Physician Decision|0
1198420|NCT00950599|3936392|P5|Follow-Up Period|Physician Decision|0
1198421|NCT00950599|3936393|P4|Follow-Up Period|Physician Decision|0
1198422|NCT00950599|3936394|P3|Follow-Up Period|Physician Decision|0
1198423|NCT00950599|3936395|P2|Follow-Up Period|Physician Decision|0
1198424|NCT00950599|3936396|P1|Follow-Up Period|Physician Decision|0
1198425|NCT00950599|3936387|P10|Follow-Up Period|Lost to Follow-up|1
1198426|NCT00950599|3936388|P9|Follow-Up Period|Lost to Follow-up|5
1198427|NCT00950599|3936389|P8|Follow-Up Period|Lost to Follow-up|0
1198428|NCT00950599|3936390|P7|Follow-Up Period|Lost to Follow-up|0
1198429|NCT00950599|3936391|P6|Follow-Up Period|Lost to Follow-up|0
1198430|NCT00950599|3936392|P5|Follow-Up Period|Lost to Follow-up|0
1198431|NCT00950599|3936393|P4|Follow-Up Period|Lost to Follow-up|0
1198432|NCT00950599|3936394|P3|Follow-Up Period|Lost to Follow-up|0
1198433|NCT00950599|3936395|P2|Follow-Up Period|Lost to Follow-up|0
1198434|NCT00950599|3936396|P1|Follow-Up Period|Lost to Follow-up|0
1198435|NCT00950599|3936387|P10|Follow-Up Period|Lack of Efficacy|0
1198436|NCT00950599|3936388|P9|Follow-Up Period|Lack of Efficacy|3
1198437|NCT00950599|3936389|P8|Follow-Up Period|Lack of Efficacy|0
1198438|NCT00950599|3936390|P7|Follow-Up Period|Lack of Efficacy|0
1198439|NCT00950599|3936391|P6|Follow-Up Period|Lack of Efficacy|0
1198440|NCT00950599|3936392|P5|Follow-Up Period|Lack of Efficacy|0
1198441|NCT00950599|3936393|P4|Follow-Up Period|Lack of Efficacy|0
1198442|NCT00950599|3936394|P3|Follow-Up Period|Lack of Efficacy|0
1198443|NCT00950599|3936395|P2|Follow-Up Period|Lack of Efficacy|0
1198444|NCT00950599|3936396|P1|Follow-Up Period|Lack of Efficacy|0
1198445|NCT00950599|3936387|P10|Follow-Up Period|Adverse Event|0
1198446|NCT00950599|3936388|P9|Follow-Up Period|Adverse Event|1
1198447|NCT00950599|3936389|P8|Follow-Up Period|Adverse Event|0
1198448|NCT00950599|3936390|P7|Follow-Up Period|Adverse Event|0
1198449|NCT00950599|3936391|P6|Follow-Up Period|Adverse Event|0
1198450|NCT00950599|3936392|P5|Follow-Up Period|Adverse Event|0
1198451|NCT00950599|3936393|P4|Follow-Up Period|Adverse Event|0
1198452|NCT00950599|3936394|P3|Follow-Up Period|Adverse Event|0
1198453|NCT00950599|3936395|P2|Follow-Up Period|Adverse Event|0
1198454|NCT00950599|3936396|P1|Follow-Up Period|Adverse Event|0
1198455|NCT00950599|3936387|P10|Double-Blind Treatment Period|Subject Withdrew consent|0
1198456|NCT00950599|3936388|P9|Double-Blind Treatment Period|Subject Withdrew consent|0
1198457|NCT00950599|3936389|P8|Double-Blind Treatment Period|Subject Withdrew consent|3
1198458|NCT00950599|3936390|P7|Double-Blind Treatment Period|Subject Withdrew consent|0
1198459|NCT00950599|3936391|P6|Double-Blind Treatment Period|Subject Withdrew consent|2
1198460|NCT00950599|3936392|P5|Double-Blind Treatment Period|Subject Withdrew consent|1
1198461|NCT00950599|3936393|P4|Double-Blind Treatment Period|Subject Withdrew consent|1
1198462|NCT00950599|3936394|P3|Double-Blind Treatment Period|Subject Withdrew consent|3
1198463|NCT00950599|3936395|P2|Double-Blind Treatment Period|Subject Withdrew consent|3
1198464|NCT00950599|3936396|P1|Double-Blind Treatment Period|Subject Withdrew consent|4
1198465|NCT00950599|3936387|P10|Double-Blind Treatment Period|Subject no longer meets study criteria|0
1198466|NCT00950599|3936388|P9|Double-Blind Treatment Period|Subject no longer meets study criteria|0
1198467|NCT00950599|3936389|P8|Double-Blind Treatment Period|Subject no longer meets study criteria|0
1198468|NCT00950599|3936390|P7|Double-Blind Treatment Period|Subject no longer meets study criteria|0
1198469|NCT00950599|3936391|P6|Double-Blind Treatment Period|Subject no longer meets study criteria|1
1198470|NCT00950599|3936392|P5|Double-Blind Treatment Period|Subject no longer meets study criteria|1
1198471|NCT00950599|3936393|P4|Double-Blind Treatment Period|Subject no longer meets study criteria|0
1198472|NCT00950599|3936394|P3|Double-Blind Treatment Period|Subject no longer meets study criteria|0
1198473|NCT00950599|3936395|P2|Double-Blind Treatment Period|Subject no longer meets study criteria|0
1198474|NCT00950599|3936396|P1|Double-Blind Treatment Period|Subject no longer meets study criteria|0
1198475|NCT00950599|3936387|P10|Double-Blind Treatment Period|Poor/Noncompliance|0
1198476|NCT00950599|3936388|P9|Double-Blind Treatment Period|Poor/Noncompliance|0
1198477|NCT00950599|3936389|P8|Double-Blind Treatment Period|Poor/Noncompliance|1
1198478|NCT00950599|3936390|P7|Double-Blind Treatment Period|Poor/Noncompliance|0
1198479|NCT00950599|3936391|P6|Double-Blind Treatment Period|Poor/Noncompliance|0
1198480|NCT00950599|3936392|P5|Double-Blind Treatment Period|Poor/Noncompliance|0
1198481|NCT00950599|3936393|P4|Double-Blind Treatment Period|Poor/Noncompliance|0
1198482|NCT00950599|3936394|P3|Double-Blind Treatment Period|Poor/Noncompliance|0
1198483|NCT00950599|3936395|P2|Double-Blind Treatment Period|Poor/Noncompliance|1
1198484|NCT00950599|3936396|P1|Double-Blind Treatment Period|Poor/Noncompliance|1
1198485|NCT00950599|3936387|P10|Double-Blind Treatment Period|Lost to Follow-up|0
1198486|NCT00950599|3936388|P9|Double-Blind Treatment Period|Lost to Follow-up|0
1198487|NCT00950599|3936389|P8|Double-Blind Treatment Period|Lost to Follow-up|1
1198488|NCT00950599|3936390|P7|Double-Blind Treatment Period|Lost to Follow-up|0
1198489|NCT00950599|3936391|P6|Double-Blind Treatment Period|Lost to Follow-up|2
1198490|NCT00950599|3936392|P5|Double-Blind Treatment Period|Lost to Follow-up|1
1198491|NCT00950599|3936393|P4|Double-Blind Treatment Period|Lost to Follow-up|1
1198492|NCT00950599|3936394|P3|Double-Blind Treatment Period|Lost to Follow-up|0
1198493|NCT00950599|3936395|P2|Double-Blind Treatment Period|Lost to Follow-up|0
1198494|NCT00950599|3936396|P1|Double-Blind Treatment Period|Lost to Follow-up|0
1198495|NCT00950599|3936387|P10|Double-Blind Treatment Period|Lack of Efficacy|0
1198496|NCT00950599|3936388|P9|Double-Blind Treatment Period|Lack of Efficacy|0
1198497|NCT00950599|3936389|P8|Double-Blind Treatment Period|Lack of Efficacy|1
1198498|NCT00950599|3936390|P7|Double-Blind Treatment Period|Lack of Efficacy|0
1198499|NCT00950599|3936391|P6|Double-Blind Treatment Period|Lack of Efficacy|6
1198500|NCT00950599|3936392|P5|Double-Blind Treatment Period|Lack of Efficacy|3
1198501|NCT00950599|3936393|P4|Double-Blind Treatment Period|Lack of Efficacy|7
1198502|NCT00950599|3936394|P3|Double-Blind Treatment Period|Lack of Efficacy|5
1198503|NCT00950599|3936395|P2|Double-Blind Treatment Period|Lack of Efficacy|5
1198504|NCT00950599|3936396|P1|Double-Blind Treatment Period|Lack of Efficacy|2
1198505|NCT00950599|3936387|P10|Double-Blind Treatment Period|Adverse Event|0
1198506|NCT00950599|3936388|P9|Double-Blind Treatment Period|Adverse Event|0
1198507|NCT00950599|3936389|P8|Double-Blind Treatment Period|Adverse Event|0
1198508|NCT00950599|3936390|P7|Double-Blind Treatment Period|Adverse Event|0
1198509|NCT00950599|3936391|P6|Double-Blind Treatment Period|Adverse Event|1
1198510|NCT00950599|3936392|P5|Double-Blind Treatment Period|Adverse Event|1
1198511|NCT00950599|3936393|P4|Double-Blind Treatment Period|Adverse Event|1
1198512|NCT00950599|3936394|P3|Double-Blind Treatment Period|Adverse Event|1
1198513|NCT00950599|3936395|P2|Double-Blind Treatment Period|Adverse Event|1
1198514|NCT00950599|3936396|P1|Double-Blind Treatment Period|Adverse Event|0
1198515|NCT00950599|3936387|P10|Double-Blind Treatment Period|Administrative reason by sponsor|0
1198516|NCT00950599|3936388|P9|Double-Blind Treatment Period|Administrative reason by sponsor|0
1198517|NCT00950599|3936389|P8|Double-Blind Treatment Period|Administrative reason by sponsor|0
1198518|NCT00950599|3936390|P7|Double-Blind Treatment Period|Administrative reason by sponsor|0
1198519|NCT00950599|3936391|P6|Double-Blind Treatment Period|Administrative reason by sponsor|0
1198520|NCT00950599|3936392|P5|Double-Blind Treatment Period|Administrative reason by sponsor|0
1198521|NCT00950599|3936393|P4|Double-Blind Treatment Period|Administrative reason by sponsor|1
1198522|NCT00950599|3936394|P3|Double-Blind Treatment Period|Administrative reason by sponsor|0
1198523|NCT00950599|3936395|P2|Double-Blind Treatment Period|Administrative reason by sponsor|0
1198524|NCT00950599|3936396|P1|Double-Blind Treatment Period|Administrative reason by sponsor|0
1198525|NCT00950300|3936969|P2|SFU Period|Withdrawal by Subject|8
1198526|NCT00950300|3936970|P1|SFU Period|Withdrawal by Subject|4
1198527|NCT00950300|3936969|P2|SFU Period|Lost to Follow-up|28
1198528|NCT00950300|3936970|P1|SFU Period|Lost to Follow-up|30
1198529|NCT00950300|3936969|P2|SFU Period|Death|42
1198530|NCT00950300|3936970|P1|SFU Period|Death|44
1198531|NCT00950300|3936969|P2|TFFU Period|Not Specified|3
1198532|NCT00950300|3936970|P1|TFFU Period|Not Specified|4
1198533|NCT00950300|3936969|P2|TFFU Period|Recurrence of Disease|72
1198534|NCT00950300|3936970|P1|TFFU Period|Recurrence of Disease|63
1198535|NCT00950300|3936969|P2|TFFU Period|Failure to Return|16
1198536|NCT00950300|3936970|P1|TFFU Period|Failure to Return|16
1198537|NCT00950300|3936969|P2|TFFU Period|Refused Treatment|11
1198538|NCT00950300|3936970|P1|TFFU Period|Refused Treatment|10
1198539|NCT00950300|3936969|P2|TFFU Period|Death|1
1198540|NCT00950300|3936970|P1|TFFU Period|Death|4
1198541|NCT00950300|3936969|P2|TFFU Period|Adverse Event or Intercurrent Illness|4
1198542|NCT00950300|3936970|P1|TFFU Period|Adverse Event or Intercurrent Illness|3
1198543|NCT00950300|3936969|P2|Neoadjuvant/Adjuvant Treatment Periods|Not Specified|1
1198544|NCT00950300|3936970|P1|Neoadjuvant/Adjuvant Treatment Periods|Not Specified|1
1198545|NCT00950300|3936969|P2|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5
1198546|NCT00950300|3936970|P1|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10
1198547|NCT00950300|3936969|P2|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11
1198548|NCT00950300|3936970|P1|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12
1198549|NCT00950300|3936969|P2|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1
1198550|NCT00950300|3936970|P1|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2
1198551|NCT00950300|3936969|P2|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5
1198552|NCT00950300|3936970|P1|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4
1198553|NCT00950300|3936969|P2|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0
1198554|NCT00950300|3936970|P1|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1
1198555|NCT00950300|3936969|P2|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1
1198556|NCT00950300|3936970|P1|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2
1198557|NCT00950300|3936969|P2|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0
1198558|NCT00950300|3936970|P1|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3
1198559|NCT00950300|3936969|P2|Neoadjuvant/Adjuvant Treatment Periods|Death|3
1198560|NCT00950300|3936970|P1|Neoadjuvant/Adjuvant Treatment Periods|Death|1
1198561|NCT00950300|3936969|P2|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15
1198562|NCT00950300|3936970|P1|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6
1198563|NCT00949975|3937042|P4|Overall Study|Other|0
1198564|NCT00949975|3937043|P3|Overall Study|Other|0
1198565|NCT00949975|3937044|P2|Overall Study|Other|0
1198566|NCT00949975|3937045|P1|Overall Study|Other|1
1198567|NCT00949975|3937042|P4|Overall Study|Lost to Follow-up|3
1198568|NCT00949975|3937043|P3|Overall Study|Lost to Follow-up|1
1198569|NCT00949975|3937044|P2|Overall Study|Lost to Follow-up|0
1198570|NCT00949975|3937045|P1|Overall Study|Lost to Follow-up|1
1198571|NCT00949975|3937042|P4|Overall Study|Severe non-compliance|2
1198572|NCT00949975|3937043|P3|Overall Study|Severe non-compliance|0
1198573|NCT00949975|3937044|P2|Overall Study|Severe non-compliance|1
1198574|NCT00949975|3937045|P1|Overall Study|Severe non-compliance|3
1198575|NCT00949975|3937042|P4|Overall Study|Incorrect enrolment|7
1198576|NCT00949975|3937043|P3|Overall Study|Incorrect enrolment|4
1198577|NCT00949975|3937044|P2|Overall Study|Incorrect enrolment|10
1198578|NCT00949975|3937045|P1|Overall Study|Incorrect enrolment|5
1198579|NCT00949975|3937042|P4|Overall Study|Study-specific criteria|0
1198580|NCT00949975|3937043|P3|Overall Study|Study-specific criteria|1
1198581|NCT00949975|3937044|P2|Overall Study|Study-specific criteria|1
1198582|NCT00949975|3937045|P1|Overall Study|Study-specific criteria|0
1198583|NCT00949975|3937042|P4|Overall Study|Safety reason|0
1198584|NCT00949975|3937043|P3|Overall Study|Safety reason|0
1198585|NCT00949975|3937044|P2|Overall Study|Safety reason|1
1198586|NCT00949975|3937045|P1|Overall Study|Safety reason|0
1198587|NCT00949975|3937042|P4|Overall Study|Adverse Event|10
1198588|NCT00949975|3937043|P3|Overall Study|Adverse Event|10
1198589|NCT00949975|3937044|P2|Overall Study|Adverse Event|11
1198590|NCT00949975|3937045|P1|Overall Study|Adverse Event|11
1198591|NCT00949975|3937042|P4|Overall Study|Voluntary discontinuation|6
1198592|NCT00949975|3937043|P3|Overall Study|Voluntary discontinuation|3
1198593|NCT00949975|3937044|P2|Overall Study|Voluntary discontinuation|5
1198594|NCT00949975|3937045|P1|Overall Study|Voluntary discontinuation|6
1198595|NCT00949910|3937163|P1|Overall Study|No Data|9
1198596|NCT00949910|3937163|P1|Overall Study|Other|4
1198597|NCT00949910|3937163|P1|Overall Study|Physician/Participant Decision|7
1198598|NCT00949910|3937163|P1|Overall Study|Serious Adverse Event|6
1198599|NCT00949910|3937163|P1|Overall Study|Adverse Event|83
1198600|NCT00949910|3937163|P1|Overall Study|Prolonged Dosing Interruption|4
1198601|NCT00949910|3937163|P1|Overall Study|Non-Compliance|10
1198602|NCT00949910|3937163|P1|Overall Study|Logistical Reasons|13
1198603|NCT00949910|3937163|P1|Overall Study|Violation of Eligibility|23
1198604|NCT00949910|3937163|P1|Overall Study|Switched to Commercial Treatment|4
1198605|NCT00949910|3937163|P1|Overall Study|Switched to Compassionate/Other Use|174
1198606|NCT00949910|3937163|P1|Overall Study|Unspecified Progression/Deterioration|13
1198607|NCT00949910|3937163|P1|Overall Study|Death from Unknown Cause|5
1198608|NCT00949910|3937163|P1|Overall Study|Death Due to Toxicity|3
1198609|NCT00949910|3937163|P1|Overall Study|Death Due to Adverse Event|115
1198610|NCT00949910|3937163|P1|Overall Study|Death Due to Progression/Deterioration|4
1198611|NCT00949910|3937163|P1|Overall Study|Death Due to Malignant Disease|456
1198612|NCT00949910|3937163|P1|Overall Study|Participant Refusal|390
1198613|NCT00949910|3937163|P1|Overall Study|Study Drug-Related Adverse Event|315
1198614|NCT00949910|3937163|P1|Overall Study|Lost to Follow-up|100
1198615|NCT00949910|3937163|P1|Overall Study|Symptomatic Deterioration|1088
1198616|NCT00949910|3937163|P1|Overall Study|Progressive Disease|3750
1198617|NCT00949884|3937176|P3|Overall Study|Study terminated by sponsor|1
1198618|NCT00949884|3937177|P2|Overall Study|Study terminated by sponsor|0
1198619|NCT00949884|3937178|P1|Overall Study|Study terminated by sponsor|0
1198620|NCT00949884|3937176|P3|Overall Study|Lack of Efficacy|7
1198621|NCT00949884|3937177|P2|Overall Study|Lack of Efficacy|2
1198622|NCT00949884|3937178|P1|Overall Study|Lack of Efficacy|4
1198623|NCT00949884|3937176|P3|Overall Study|Withdrawal by Subject|16
1198624|NCT00949884|3937177|P2|Overall Study|Withdrawal by Subject|4
1198625|NCT00949884|3937178|P1|Overall Study|Withdrawal by Subject|13
1198626|NCT00949884|3937176|P3|Overall Study|Treatment non-compliance|8
1198627|NCT00949884|3937177|P2|Overall Study|Treatment non-compliance|0
1198628|NCT00949884|3937178|P1|Overall Study|Treatment non-compliance|5
1198629|NCT00949884|3937176|P3|Overall Study|Physician Decision|6
1198630|NCT00949884|3937177|P2|Overall Study|Physician Decision|0
1198631|NCT00949884|3937178|P1|Overall Study|Physician Decision|5
1198632|NCT00949884|3937176|P3|Overall Study|Lost to Follow-up|5
1198633|NCT00949884|3937177|P2|Overall Study|Lost to Follow-up|5
1198634|NCT00949884|3937178|P1|Overall Study|Lost to Follow-up|7
1198635|NCT00949884|3937176|P3|Overall Study|Did not meet inclusion/exclusion|3
1198636|NCT00949884|3937177|P2|Overall Study|Did not meet inclusion/exclusion|1
1198637|NCT00949884|3937178|P1|Overall Study|Did not meet inclusion/exclusion|2
1198638|NCT00949884|3937176|P3|Overall Study|Adverse Event|12
1198639|NCT00949884|3937177|P2|Overall Study|Adverse Event|3
1198640|NCT00949884|3937178|P1|Overall Study|Adverse Event|14
1198641|NCT00949715|3937233|P2|Overall Study|Missing 24 month LVEF measurement|0
1198642|NCT00949715|3937234|P1|Overall Study|Missing 24 month LVEF measurement|2
1198643|NCT00949715|3937233|P2|Overall Study|Lost to Follow-up|0
1198644|NCT00949715|3937234|P1|Overall Study|Lost to Follow-up|1
1198645|NCT00949715|3937233|P2|Overall Study|Physician Decision|0
1198646|NCT00949715|3937234|P1|Overall Study|Physician Decision|1
1198647|NCT00949702|3937245|P1|Overall Study|Withdrawal of consent|1
1198648|NCT00949702|3937245|P1|Overall Study|Disease progression|7
1198649|NCT00949702|3937245|P1|Overall Study|Death|40
1198650|NCT00949650|3937262|P2|Overall Study|Other not specified above|0
1198651|NCT00949650|3937263|P1|Overall Study|Other not specified above|5
1198652|NCT00949650|3937262|P2|Overall Study|Not treated|4
1198653|NCT00949650|3937263|P1|Overall Study|Not treated|1
1198654|NCT00949650|3937262|P2|Overall Study|Refusal to continue medication|11
1198655|NCT00949650|3937263|P1|Overall Study|Refusal to continue medication|7
1198656|NCT00949650|3937262|P2|Overall Study|Protocol Violation|4
1198657|NCT00949650|3937263|P1|Overall Study|Protocol Violation|1
1198658|NCT00949650|3937262|P2|Overall Study|Other Adverse Event (AE)|17
1198659|NCT00949650|3937263|P1|Overall Study|Other Adverse Event (AE)|28
1198660|NCT00949650|3937262|P2|Overall Study|Completed 6 courses of chemotherapy|60
1198661|NCT00949650|3937263|P1|Overall Study|Completed 6 courses of chemotherapy|0
1198662|NCT00949650|3937262|P2|Overall Study|Progressive disease|19
1198663|NCT00949650|3937263|P1|Overall Study|Progressive disease|188
1198664|NCT00949533|3937301|P2|Overall Study|Lost to Follow-up|1
1198665|NCT00949533|3937302|P1|Overall Study|Lost to Follow-up|0
1198666|NCT00949117|3937320|P2|Overall Study|Adverse Event|1
1198667|NCT00949117|3937321|P1|Overall Study|Adverse Event|0
1198668|NCT00949117|3937320|P2|Overall Study|Protocol Violation|1
1198669|NCT00949117|3937321|P1|Overall Study|Protocol Violation|1
1198670|NCT00949117|3937320|P2|Overall Study|Lack of Efficacy|3
1198671|NCT00949117|3937321|P1|Overall Study|Lack of Efficacy|2
1198672|NCT00948974|3937362|P2|Overall Study|Lost to Follow-up|20
1198673|NCT00948974|3937363|P1|Overall Study|Lost to Follow-up|23
1198674|NCT00948922|3937376|P3|Overall Study|Not evaluable at time of analysis|0
1198675|NCT00948922|3937377|P2|Overall Study|Not evaluable at time of analysis|3
1198676|NCT00948922|3937378|P1|Overall Study|Not evaluable at time of analysis|0
1198677|NCT00948922|3937376|P3|Overall Study|Transplant eligibility issues|0
1198678|NCT00948922|3937377|P2|Overall Study|Transplant eligibility issues|3
1198679|NCT00948922|3937378|P1|Overall Study|Transplant eligibility issues|2
1198680|NCT00948922|3937376|P3|Overall Study|Insurance issues|0
1198681|NCT00948922|3937377|P2|Overall Study|Insurance issues|0
1198682|NCT00948922|3937378|P1|Overall Study|Insurance issues|1
1198683|NCT00948922|3937376|P3|Overall Study|Disease progression|0
1198684|NCT00948922|3937377|P2|Overall Study|Disease progression|1
1198685|NCT00948922|3937378|P1|Overall Study|Disease progression|0
1198686|NCT00948922|3937376|P3|Overall Study|Death|0
1198687|NCT00948922|3937377|P2|Overall Study|Death|0
1198688|NCT00948922|3937378|P1|Overall Study|Death|3
1198689|NCT00948922|3937376|P3|Overall Study|Adverse Event|2
1198690|NCT00948922|3937377|P2|Overall Study|Adverse Event|0
1198691|NCT00948922|3937378|P1|Overall Study|Adverse Event|0
1198692|NCT00948922|3937376|P3|Overall Study|Withdrawal by Subject|2
1198693|NCT00948922|3937377|P2|Overall Study|Withdrawal by Subject|0
1198694|NCT00948922|3937378|P1|Overall Study|Withdrawal by Subject|0
1198695|NCT00948922|3937376|P3|Overall Study|Did not start study treatment|0
1198696|NCT00948922|3937377|P2|Overall Study|Did not start study treatment|5
1198697|NCT00948922|3937378|P1|Overall Study|Did not start study treatment|2
1198698|NCT00948896|3937394|P8|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
1198699|NCT00948896|3937395|P7|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
1198700|NCT00948896|3937396|P6|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
1198701|NCT00948896|3937397|P5|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
1198702|NCT00948896|3937398|P4|24 Months of Age to 36 Months of Age|Moved out of Study Area|1
1198703|NCT00948896|3937399|P3|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
1198704|NCT00948896|3937400|P2|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
1198705|NCT00948896|3937401|P1|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
1198706|NCT00948896|3937394|P8|24 Months of Age to 36 Months of Age|Protocol Violation|0
1198707|NCT00948896|3937395|P7|24 Months of Age to 36 Months of Age|Protocol Violation|0
1198708|NCT00948896|3937396|P6|24 Months of Age to 36 Months of Age|Protocol Violation|1
1198709|NCT00948896|3937397|P5|24 Months of Age to 36 Months of Age|Protocol Violation|0
1198710|NCT00948896|3937398|P4|24 Months of Age to 36 Months of Age|Protocol Violation|0
1198711|NCT00948896|3937399|P3|24 Months of Age to 36 Months of Age|Protocol Violation|1
1198712|NCT00948896|3937400|P2|24 Months of Age to 36 Months of Age|Protocol Violation|0
1198713|NCT00948896|3937401|P1|24 Months of Age to 36 Months of Age|Protocol Violation|0
1198714|NCT00948896|3937394|P8|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
1198715|NCT00948896|3937395|P7|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
1198716|NCT00948896|3937396|P6|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
1198717|NCT00948896|3937397|P5|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
1198718|NCT00948896|3937398|P4|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
1198719|NCT00948896|3937399|P3|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
1198720|NCT00948896|3937400|P2|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
1198721|NCT00948896|3937401|P1|24 Months of Age to 36 Months of Age|Lost to Follow-up|2
1198722|NCT00948896|3937394|P8|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
1198723|NCT00948896|3937395|P7|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
1198724|NCT00948896|3937396|P6|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
1198725|NCT00948896|3937397|P5|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
1198726|NCT00948896|3937398|P4|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
1198727|NCT00948896|3937399|P3|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
1198728|NCT00948896|3937400|P2|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
1198729|NCT00948896|3937401|P1|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
1198730|NCT00948896|3937394|P8|24 Months of Age to 36 Months of Age|Death|0
1198731|NCT00948896|3937395|P7|24 Months of Age to 36 Months of Age|Death|0
1198732|NCT00948896|3937396|P6|24 Months of Age to 36 Months of Age|Death|1
1198733|NCT00948896|3937397|P5|24 Months of Age to 36 Months of Age|Death|0
1198734|NCT00948896|3937398|P4|24 Months of Age to 36 Months of Age|Death|0
1198735|NCT00948896|3937399|P3|24 Months of Age to 36 Months of Age|Death|2
1198736|NCT00948896|3937400|P2|24 Months of Age to 36 Months of Age|Death|2
1198737|NCT00948896|3937401|P1|24 Months of Age to 36 Months of Age|Death|0
1198738|NCT00948896|3937394|P8|Randomization to 24 Months of Age|Moved out of Study Area|0
1198739|NCT00948896|3937395|P7|Randomization to 24 Months of Age|Moved out of Study Area|0
1198740|NCT00948896|3937396|P6|Randomization to 24 Months of Age|Moved out of Study Area|2
1198741|NCT00948896|3937397|P5|Randomization to 24 Months of Age|Moved out of Study Area|0
1198742|NCT00948896|3937398|P4|Randomization to 24 Months of Age|Moved out of Study Area|1
1198743|NCT00948896|3937399|P3|Randomization to 24 Months of Age|Moved out of Study Area|3
1198744|NCT00948896|3937400|P2|Randomization to 24 Months of Age|Moved out of Study Area|3
1198745|NCT00948896|3937401|P1|Randomization to 24 Months of Age|Moved out of Study Area|0
1198746|NCT00948896|3937394|P8|Randomization to 24 Months of Age|Protocol Violation|1
1198747|NCT00948896|3937395|P7|Randomization to 24 Months of Age|Protocol Violation|1
1198748|NCT00948896|3937396|P6|Randomization to 24 Months of Age|Protocol Violation|0
1198749|NCT00948896|3937397|P5|Randomization to 24 Months of Age|Protocol Violation|0
1198750|NCT00948896|3937398|P4|Randomization to 24 Months of Age|Protocol Violation|1
1198751|NCT00948896|3937399|P3|Randomization to 24 Months of Age|Protocol Violation|0
1198752|NCT00948896|3937400|P2|Randomization to 24 Months of Age|Protocol Violation|1
1198753|NCT00948896|3937401|P1|Randomization to 24 Months of Age|Protocol Violation|0
1198754|NCT00948896|3937394|P8|Randomization to 24 Months of Age|Lost to Follow-up|0
1198755|NCT00948896|3937395|P7|Randomization to 24 Months of Age|Lost to Follow-up|1
1198756|NCT00948896|3937396|P6|Randomization to 24 Months of Age|Lost to Follow-up|0
1198757|NCT00948896|3937397|P5|Randomization to 24 Months of Age|Lost to Follow-up|0
1198758|NCT00948896|3937398|P4|Randomization to 24 Months of Age|Lost to Follow-up|5
1198759|NCT00948896|3937399|P3|Randomization to 24 Months of Age|Lost to Follow-up|2
1198760|NCT00948896|3937400|P2|Randomization to 24 Months of Age|Lost to Follow-up|4
1198761|NCT00948896|3937401|P1|Randomization to 24 Months of Age|Lost to Follow-up|4
1198762|NCT00948896|3937394|P8|Randomization to 24 Months of Age|Withdrawal by Subject|0
1198763|NCT00948896|3937395|P7|Randomization to 24 Months of Age|Withdrawal by Subject|0
1198764|NCT00948896|3937396|P6|Randomization to 24 Months of Age|Withdrawal by Subject|1
1198765|NCT00948896|3937397|P5|Randomization to 24 Months of Age|Withdrawal by Subject|0
1198766|NCT00948896|3937398|P4|Randomization to 24 Months of Age|Withdrawal by Subject|4
1198767|NCT00948896|3937399|P3|Randomization to 24 Months of Age|Withdrawal by Subject|4
1198768|NCT00948896|3937400|P2|Randomization to 24 Months of Age|Withdrawal by Subject|5
1198769|NCT00948896|3937401|P1|Randomization to 24 Months of Age|Withdrawal by Subject|3
1198770|NCT00948896|3937394|P8|Randomization to 24 Months of Age|Death|1
1198771|NCT00948896|3937395|P7|Randomization to 24 Months of Age|Death|2
1198772|NCT00948896|3937396|P6|Randomization to 24 Months of Age|Death|1
1198773|NCT00948896|3937397|P5|Randomization to 24 Months of Age|Death|2
1198774|NCT00948896|3937398|P4|Randomization to 24 Months of Age|Death|0
1198775|NCT00948896|3937399|P3|Randomization to 24 Months of Age|Death|0
1198776|NCT00948896|3937400|P2|Randomization to 24 Months of Age|Death|0
1198777|NCT00948896|3937401|P1|Randomization to 24 Months of Age|Death|1
1198778|NCT00948857|3937437|P2|Overall Study|Lost to Follow-up|0
1198779|NCT00948857|3937438|P1|Overall Study|Lost to Follow-up|1
1198780|NCT00948818|3937446|P2|Overall Study|Other Reason|5
1198781|NCT00948818|3937447|P1|Overall Study|Other Reason|4
1198782|NCT00948818|3937446|P2|Overall Study|Lack of Efficacy|5
1198783|NCT00948818|3937447|P1|Overall Study|Lack of Efficacy|4
1198784|NCT00948818|3937446|P2|Overall Study|Lost to Follow-up|17
1198785|NCT00948818|3937447|P1|Overall Study|Lost to Follow-up|10
1198786|NCT00948818|3937446|P2|Overall Study|Withdrawal by Subject|25
1198787|NCT00948818|3937447|P1|Overall Study|Withdrawal by Subject|25
1198788|NCT00948818|3937446|P2|Overall Study|Protocol Violation|10
1198789|NCT00948818|3937447|P1|Overall Study|Protocol Violation|9
1198790|NCT00948818|3937446|P2|Overall Study|Adverse Event|32
1198791|NCT00948818|3937447|P1|Overall Study|Adverse Event|10
1198792|NCT00948766|3937494|P2|Extension Study|Death|0
1198793|NCT00948766|3937495|P1|Extension Study|Death|4
1198794|NCT00948766|3937494|P2|Extension Study|Administrative Problems|0
1198795|NCT00948766|3937495|P1|Extension Study|Administrative Problems|1
1198796|NCT00948766|3937494|P2|Extension Study|Lost to Follow-up|0
1198797|NCT00948766|3937495|P1|Extension Study|Lost to Follow-up|8
1198798|NCT00948766|3937494|P2|Extension Study|Patient Withdrew Consent|0
1198799|NCT00948766|3937495|P1|Extension Study|Patient Withdrew Consent|32
1198800|NCT00948766|3937494|P2|Extension Study|Study Drug No Longer Required|0
1198801|NCT00948766|3937495|P1|Extension Study|Study Drug No Longer Required|1
1198802|NCT00948766|3937494|P2|Extension Study|Unsatisfactory Therapeutic Effect|0
1198803|NCT00948766|3937495|P1|Extension Study|Unsatisfactory Therapeutic Effect|2
1198804|NCT00948766|3937494|P2|Extension Study|Adverse Event|0
1198805|NCT00948766|3937495|P1|Extension Study|Adverse Event|43
1198806|NCT00948766|3937494|P2|Core Study|Protocol Deviation|10
1198807|NCT00948766|3937495|P1|Core Study|Protocol Deviation|8
1198808|NCT00948766|3937494|P2|Core Study|Death|1
1198809|NCT00948766|3937495|P1|Core Study|Death|1
1198810|NCT00948766|3937494|P2|Core Study|Administrative Problems|2
1198811|NCT00948766|3937495|P1|Core Study|Administrative Problems|2
1198812|NCT00948766|3937494|P2|Core Study|Lost to Follow-up|2
1198813|NCT00948766|3937495|P1|Core Study|Lost to Follow-up|3
1198814|NCT00948766|3937494|P2|Core Study|Patient Withdrew Consent|46
1198815|NCT00948766|3937495|P1|Core Study|Patient Withdrew Consent|27
1198816|NCT00948766|3937494|P2|Core Study|Unsatisfactory Therapeutic Effect|14
1198817|NCT00948766|3937495|P1|Core Study|Unsatisfactory Therapeutic Effect|13
1198818|NCT00948766|3937494|P2|Core Study|Adverse Event|51
1198819|NCT00948766|3937495|P1|Core Study|Adverse Event|73
1198820|NCT00948688|3937511|P2|Period 2: 100 mg Vorinostat|Adverse Event|1
1198821|NCT00948688|3937512|P1|Period 2: 100 mg Vorinostat|Adverse Event|0
1198822|NCT00948688|3937511|P2|Period 1: 200 mg Vorinostat|Protocol Violation|0
1198823|NCT00948688|3937512|P1|Period 1: 200 mg Vorinostat|Protocol Violation|1
1198824|NCT00948688|3937511|P2|Period 1: 200 mg Vorinostat|Adverse Event|0
1198825|NCT00948688|3937512|P1|Period 1: 200 mg Vorinostat|Adverse Event|1
1198826|NCT00948675|3937526|P2|Overall Study|Treatment ongoing|4
1198827|NCT00948675|3937527|P1|Overall Study|Treatment ongoing|5
1198828|NCT00948675|3937526|P2|Overall Study|Lost to Follow-up|0
1198829|NCT00948675|3937527|P1|Overall Study|Lost to Follow-up|2
1198830|NCT00948506|3937554|P2|Overall Study|Withdrawal by Subject|1
1198831|NCT00948506|3937555|P1|Overall Study|Withdrawal by Subject|3
1198832|NCT00948441|3937566|P2|Overall Study|no longer meet inclusion criteria|4
1198833|NCT00948441|3937567|P1|Overall Study|no longer meet inclusion criteria|1
1198834|NCT00948389|3937580|P5|Overall Study|Both Progression and Toxicity|0
1198835|NCT00948389|3937581|P4|Overall Study|Both Progression and Toxicity|0
1198836|NCT00948389|3937582|P3|Overall Study|Both Progression and Toxicity|0
1198837|NCT00948389|3937583|P2|Overall Study|Both Progression and Toxicity|0
1198838|NCT00948389|3937584|P1|Overall Study|Both Progression and Toxicity|1
1198839|NCT00948389|3937580|P5|Overall Study|Thrombocytopenia, Grade 4|0
1198840|NCT00948389|3937581|P4|Overall Study|Thrombocytopenia, Grade 4|1
1198841|NCT00948389|3937582|P3|Overall Study|Thrombocytopenia, Grade 4|0
1198842|NCT00948389|3937583|P2|Overall Study|Thrombocytopenia, Grade 4|0
1198843|NCT00948389|3937584|P1|Overall Study|Thrombocytopenia, Grade 4|2
1198844|NCT00948389|3937580|P5|Overall Study|Disease Progression/Relapse/Death|1
1198845|NCT00948389|3937581|P4|Overall Study|Disease Progression/Relapse/Death|8
1198846|NCT00948389|3937582|P3|Overall Study|Disease Progression/Relapse/Death|7
1198847|NCT00948389|3937583|P2|Overall Study|Disease Progression/Relapse/Death|3
1198848|NCT00948389|3937584|P1|Overall Study|Disease Progression/Relapse/Death|3
1198849|NCT00948246|3937632|P1|Overall Study|Withdrawal by Subject|1
1198850|NCT00948246|3937632|P1|Overall Study|Death|1
1198851|NCT00948246|3937632|P1|Overall Study|Adverse Event|11
1198852|NCT00948246|3937632|P1|Overall Study|Lost to Follow-up|11
1198853|NCT00948155|3937641|P2|Washout 14 Days|Lost to Follow-up|2
1198854|NCT00948155|3937642|P1|Washout 14 Days|Lost to Follow-up|1
1198855|NCT00948155|3937641|P2|First Intervention 21 Days|Lost to Follow-up|2
1198856|NCT00948155|3937642|P1|First Intervention 21 Days|Lost to Follow-up|2
1198857|NCT00948064|3937689|P3|Phase II|Withdrawal by Subject|0
1198858|NCT00948064|3937690|P2|Phase II|Withdrawal by Subject|1
1198859|NCT00948064|3937691|P1|Phase II|Withdrawal by Subject|0
1198860|NCT00948064|3937689|P3|Phase II|Physician Decision|1
1198861|NCT00948064|3937690|P2|Phase II|Physician Decision|0
1198862|NCT00948064|3937691|P1|Phase II|Physician Decision|0
1198863|NCT00948064|3937689|P3|Phase I|No treatment received|0
1198864|NCT00948064|3937690|P2|Phase I|No treatment received|0
1198865|NCT00948064|3937691|P1|Phase I|No treatment received|1
1198866|NCT00947882|3937706|P4|Overall Study|Trial Terminated by Sponsor|70
1198867|NCT00947882|3937707|P3|Overall Study|Trial Terminated by Sponsor|62
1198868|NCT00947882|3937708|P2|Overall Study|Trial Terminated by Sponsor|61
1198869|NCT00947882|3937709|P1|Overall Study|Trial Terminated by Sponsor|62
1198870|NCT00947882|3937706|P4|Overall Study|Other/Unknown|6
1198871|NCT00947882|3937707|P3|Overall Study|Other/Unknown|3
1198872|NCT00947882|3937708|P2|Overall Study|Other/Unknown|13
1198873|NCT00947882|3937709|P1|Overall Study|Other/Unknown|10
1198874|NCT00947882|3937706|P4|Overall Study|Lost to Follow-up|0
1198875|NCT00947882|3937707|P3|Overall Study|Lost to Follow-up|1
1198876|NCT00947882|3937708|P2|Overall Study|Lost to Follow-up|2
1198877|NCT00947882|3937709|P1|Overall Study|Lost to Follow-up|0
1198878|NCT00947882|3937706|P4|Overall Study|Protocol Violation|0
1198879|NCT00947882|3937707|P3|Overall Study|Protocol Violation|1
1198880|NCT00947882|3937708|P2|Overall Study|Protocol Violation|0
1198881|NCT00947882|3937709|P1|Overall Study|Protocol Violation|0
1198882|NCT00947882|3937706|P4|Overall Study|Withdrawal by Subject|2
1198883|NCT00947882|3937707|P3|Overall Study|Withdrawal by Subject|8
1198884|NCT00947882|3937708|P2|Overall Study|Withdrawal by Subject|0
1198885|NCT00947882|3937709|P1|Overall Study|Withdrawal by Subject|2
1198886|NCT00947882|3937706|P4|Overall Study|Adverse Event|4
1198887|NCT00947882|3937707|P3|Overall Study|Adverse Event|4
1198888|NCT00947882|3937708|P2|Overall Study|Adverse Event|1
1198889|NCT00947882|3937709|P1|Overall Study|Adverse Event|0
1198890|NCT00947856|3937737|P2|Follow-up Period|Withdrawal by Subject|0
1198891|NCT00947856|3937738|P1|Follow-up Period|Withdrawal by Subject|1
1198892|NCT00947856|3937737|P2|Follow-up Period|Patient unavailable for site visits|0
1198893|NCT00947856|3937738|P1|Follow-up Period|Patient unavailable for site visits|1
1198894|NCT00947856|3937737|P2|Follow-up Period|Lost to Follow-up|0
1198895|NCT00947856|3937738|P1|Follow-up Period|Lost to Follow-up|7
1198896|NCT00947856|3937737|P2|Follow-up Period|Re-enrolled for Retreatment|3
1198897|NCT00947856|3937738|P1|Follow-up Period|Re-enrolled for Retreatment|2
1198898|NCT00947856|3937737|P2|Follow-up Period|Study Stopped by Sponsor|20
1198899|NCT00947856|3937738|P1|Follow-up Period|Study Stopped by Sponsor|40
1198900|NCT00947856|3937737|P2|Treatment Period|Withdrawal by Subject|1
1198901|NCT00947856|3937738|P1|Treatment Period|Withdrawal by Subject|12
1198902|NCT00947856|3937737|P2|Treatment Period|Study Stopped by Sponsor|4
1198903|NCT00947856|3937738|P1|Treatment Period|Study Stopped by Sponsor|4
1198904|NCT00947856|3937737|P2|Treatment Period|Physician Decision|6
1198905|NCT00947856|3937738|P1|Treatment Period|Physician Decision|14
1198906|NCT00947856|3937737|P2|Treatment Period|Adverse Event|9
1198907|NCT00947856|3937738|P1|Treatment Period|Adverse Event|15
1198908|NCT00947856|3937737|P2|Treatment Period|Progressive Disease|12
1198909|NCT00947856|3937738|P1|Treatment Period|Progressive Disease|33
1198910|NCT00947544|3937827|P2|Safety-Extension Period (12 Months)|Withdrawal by Subject|0
1198911|NCT00947544|3937828|P1|Safety-Extension Period (12 Months)|Withdrawal by Subject|1
1198912|NCT00947531|3937854|P2|Overall Study|Other|1
1198913|NCT00947531|3937855|P1|Overall Study|Other|1
1198914|NCT00947531|3937854|P2|Overall Study|Lack of Efficacy|0
1198915|NCT00947531|3937855|P1|Overall Study|Lack of Efficacy|1
1198916|NCT00947531|3937854|P2|Overall Study|Adverse Event|2
1198917|NCT00947531|3937855|P1|Overall Study|Adverse Event|2
1198918|NCT00947531|3937854|P2|Overall Study|Administrative Reason|1
1198919|NCT00947531|3937855|P1|Overall Study|Administrative Reason|0
1198920|NCT00947531|3937854|P2|Overall Study|Withdrawal by Subject|7
1198921|NCT00947531|3937855|P1|Overall Study|Withdrawal by Subject|10
1198922|NCT00947427|3937891|P2|Overall Study|Protocol Violation|1
1198923|NCT00947427|3937892|P1|Overall Study|Protocol Violation|0
1198924|NCT00947427|3937891|P2|Overall Study|Withdrawal by Subject|3
1198925|NCT00947427|3937892|P1|Overall Study|Withdrawal by Subject|1
1198926|NCT00947349|3937902|P4|Overall Study Standard of Care|not specified|1
1198927|NCT00947349|3937903|P3|Overall Study Standard of Care|not specified|0
1198928|NCT00947349|3937904|P2|Overall Study Standard of Care|not specified|0
1198929|NCT00947349|3937905|P1|Overall Study Standard of Care|not specified|0
1198930|NCT00947349|3937902|P4|Overall Study Standard of Care|Withdrawal by Subject|0
1198931|NCT00947349|3937903|P3|Overall Study Standard of Care|Withdrawal by Subject|1
1198932|NCT00947349|3937904|P2|Overall Study Standard of Care|Withdrawal by Subject|0
1198933|NCT00947349|3937905|P1|Overall Study Standard of Care|Withdrawal by Subject|0
1198934|NCT00947349|3937902|P4|Overall Study Standard of Care|Lack of Efficacy|1
1198935|NCT00947349|3937903|P3|Overall Study Standard of Care|Lack of Efficacy|1
1198936|NCT00947349|3937904|P2|Overall Study Standard of Care|Lack of Efficacy|0
1198937|NCT00947349|3937905|P1|Overall Study Standard of Care|Lack of Efficacy|0
1198938|NCT00947349|3937902|P4|Triple Treatment Combination Period|Adverse Event|0
1198939|NCT00947349|3937903|P3|Triple Treatment Combination Period|Adverse Event|0
1198940|NCT00947349|3937904|P2|Triple Treatment Combination Period|Adverse Event|1
1198941|NCT00947349|3937905|P1|Triple Treatment Combination Period|Adverse Event|0
1198942|NCT00947154|3938119|P1|Overall Study|Lost to Follow-up|1
1198943|NCT00947115|3938129|P3|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|8
1198944|NCT00947115|3938130|P2|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|12
1198945|NCT00947115|3938131|P1|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|11
1198946|NCT00947115|3938129|P3|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|4
1198947|NCT00947115|3938130|P2|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|3
1198948|NCT00947115|3938131|P1|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|1
1198949|NCT00947115|3938129|P3|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|0
1198950|NCT00947115|3938130|P2|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|0
1198951|NCT00947115|3938131|P1|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|2
1198952|NCT00947115|3938129|P3|Year 0 (Month 0) - Year 10 (Month 120)|Death|1
1198953|NCT00947115|3938130|P2|Year 0 (Month 0) - Year 10 (Month 120)|Death|1
1198954|NCT00947115|3938131|P1|Year 0 (Month 0) - Year 10 (Month 120)|Death|0
1198955|NCT00947115|3938129|P3|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|0
1198956|NCT00947115|3938130|P2|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|2
1198957|NCT00947115|3938131|P1|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|0
1198958|NCT00947115|3938129|P3|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|2
1198959|NCT00947115|3938130|P2|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|4
1198960|NCT00947115|3938131|P1|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|3
1198961|NCT00947011|3938193|P1|Overall Study|Study was terminated,PI left institution|12
1198962|NCT00946998|3938203|P2|Overall Study|Exited prior to first outcome assessment|3
1198963|NCT00946998|3938204|P1|Overall Study|Exited prior to first outcome assessment|5
1198964|NCT00946985|3938218|P1|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2
1198965|NCT00946985|3938218|P1|Stabilization Phase (25 Weeks)|Patient Moved Away|2
1198966|NCT00946985|3938218|P1|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1
1198967|NCT00946985|3938218|P1|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2
1198968|NCT00946985|3938218|P1|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139
1198969|NCT00946985|3938218|P1|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4
1198970|NCT00946985|3938218|P1|Stabilization Phase (25 Weeks)|Lost to Follow-up|5
1198971|NCT00946985|3938218|P1|Stabilization Phase (25 Weeks)|Lack of Efficacy|3
1198972|NCT00946985|3938218|P1|Stabilization Phase (25 Weeks)|Adverse Event|4
1198973|NCT00946920|3938224|P2|Overall Study|Miscellaneous reasons|3
1198974|NCT00946920|3938225|P1|Overall Study|Miscellaneous reasons|18
1198975|NCT00946920|3938224|P2|Overall Study|Protocol Violation|8
1198976|NCT00946920|3938225|P1|Overall Study|Protocol Violation|16
1198977|NCT00946920|3938224|P2|Overall Study|Adverse Event|14
1198978|NCT00946920|3938225|P1|Overall Study|Adverse Event|41
1198979|NCT00946920|3938224|P2|Overall Study|Physician Decision|2
1198980|NCT00946920|3938225|P1|Overall Study|Physician Decision|5
1198981|NCT00946920|3938224|P2|Overall Study|Lost to Follow-up|2
1198982|NCT00946920|3938225|P1|Overall Study|Lost to Follow-up|2
1198983|NCT00946920|3938224|P2|Overall Study|Withdrawal by Subject|15
1198984|NCT00946920|3938225|P1|Overall Study|Withdrawal by Subject|28
1198985|NCT00946881|3938240|P1|Retreatment|Withdrawal by Subject|1
1198986|NCT00946881|3938240|P1|First Treatment|Patient relocated to another state|1
1198987|NCT00946881|3938240|P1|First Treatment|Withdrawal by Subject|1
1198988|NCT00946530|3938273|P4|Overall Study|Physician Decision|1
1198989|NCT00946530|3938274|P3|Overall Study|Physician Decision|1
1198990|NCT00946530|3938275|P2|Overall Study|Physician Decision|1
1198991|NCT00946530|3938276|P1|Overall Study|Physician Decision|1
1198992|NCT00946530|3938273|P4|Overall Study|Withdrawal by Subject|3
1198993|NCT00946530|3938274|P3|Overall Study|Withdrawal by Subject|0
1198994|NCT00946530|3938275|P2|Overall Study|Withdrawal by Subject|3
1198995|NCT00946530|3938276|P1|Overall Study|Withdrawal by Subject|0
1198996|NCT00946322|3938308|P1|Post-treatment|participant failure to follow up|2
1198997|NCT00946322|3938308|P1|Pre-treatment|participant failure to follow up|1
1198998|NCT00946309|3938321|P2|Overall Study|Procedure cancelled/discontinued|3
1198999|NCT00946309|3938322|P1|Overall Study|Procedure cancelled/discontinued|0
1199000|NCT00946309|3938321|P2|Overall Study|Lost to Follow-up|1
1199001|NCT00946309|3938322|P1|Overall Study|Lost to Follow-up|0
1199002|NCT00946309|3938321|P2|Overall Study|Protocol Violation|0
1199003|NCT00946309|3938322|P1|Overall Study|Protocol Violation|1
1199004|NCT00946296|3938340|P2|Overall Study|Physician Decision|0
1199005|NCT00946296|3938341|P1|Overall Study|Physician Decision|3
1199006|NCT00946114|3938349|P2|Overall Study|Withdrawal by Subject|0
1199007|NCT00946114|3938350|P1|Overall Study|Withdrawal by Subject|2
1199008|NCT00946114|3938349|P2|Overall Study|Other|0
1199009|NCT00946114|3938350|P1|Overall Study|Other|1
1199010|NCT00946114|3938349|P2|Overall Study|Death|2
1199011|NCT00946114|3938350|P1|Overall Study|Death|5
1199012|NCT00946101|3938358|P2|Overall Study|Physician Decision|1
1199013|NCT00946101|3938359|P1|Overall Study|Physician Decision|0
1199014|NCT00946101|3938358|P2|Overall Study|Withdrawal of consent|0
1199015|NCT00946101|3938359|P1|Overall Study|Withdrawal of consent|2
1199016|NCT00946101|3938358|P2|Overall Study|Lost to Follow-up|1
1199017|NCT00946101|3938359|P1|Overall Study|Lost to Follow-up|2
1199018|NCT00946088|3938425|P2|Overall Study|Withdrawal by Subject|1
1199019|NCT00946088|3938426|P1|Overall Study|Withdrawal by Subject|0
1199020|NCT00945945|3938470|P2|Overall Study|Entry Criteria Not Met|1
1199021|NCT00945945|3938471|P1|Overall Study|Entry Criteria Not Met|0
1199022|NCT00945945|3938470|P2|Overall Study|Protocol Violation|2
1199023|NCT00945945|3938471|P1|Overall Study|Protocol Violation|4
1199024|NCT00945945|3938470|P2|Overall Study|Lack of Efficacy|2
1199025|NCT00945945|3938471|P1|Overall Study|Lack of Efficacy|6
1199026|NCT00945945|3938470|P2|Overall Study|Lost to Follow-up|5
1199027|NCT00945945|3938471|P1|Overall Study|Lost to Follow-up|4
1199028|NCT00945945|3938470|P2|Overall Study|Withdrawal by Subject|10
1199029|NCT00945945|3938471|P1|Overall Study|Withdrawal by Subject|7
1199030|NCT00945945|3938470|P2|Overall Study|Adverse Event|35
1199031|NCT00945945|3938471|P1|Overall Study|Adverse Event|15
1199032|NCT00945906|3938497|P1|Overall Study|Moved to another country|2
1199033|NCT00945906|3938497|P1|Overall Study|Unable to return for last visit|2
1199034|NCT00945906|3938497|P1|Overall Study|Did not want to return for last visit|2
1199035|NCT00945906|3938497|P1|Overall Study|Withdrawal by Subject|1
1199036|NCT00945893|3938508|P2|Overall Study|Withdrawal of consent|2
1199037|NCT00945893|3938509|P1|Overall Study|Withdrawal of consent|1
1199038|NCT00945893|3938508|P2|Overall Study|Lost to Follow-up|8
1199039|NCT00945893|3938509|P1|Overall Study|Lost to Follow-up|2
1199040|NCT00945815|3938586|P1|Overall Study|Did not begin protocol therapy|1
1199041|NCT00945815|3938586|P1|Overall Study|Ineligible|3
1199042|NCT00945815|3938586|P1|Overall Study|Not protocol specified|1
1199043|NCT00945815|3938586|P1|Overall Study|Death|3
1199044|NCT00945659|3938618|P3|Overall Study|Lost to Follow-up|17
1199045|NCT00945659|3938619|P2|Overall Study|Lost to Follow-up|20
1199046|NCT00945659|3938620|P1|Overall Study|Lost to Follow-up|7
1199047|NCT00945555|3938664|P1|Overall Study|Other|1
1199048|NCT00945555|3938664|P1|Overall Study|Death|18
1199049|NCT00945555|3938664|P1|Overall Study|Participant continued treatment at home|1
1199050|NCT00945555|3938664|P1|Overall Study|Withdrawal by Subject|2
1199051|NCT00945555|3938664|P1|Overall Study|Worsening condition, intensive care unit|1
1199052|NCT00945555|3938664|P1|Overall Study|Referred to another hospital|5
1199053|NCT00945477|3938675|P1|Overall Study|Withdrawal by Subject|1
1199054|NCT00945477|3938675|P1|Overall Study|Lack of Efficacy|2
1199055|NCT00945477|3938675|P1|Overall Study|Adverse Event|3
1199056|NCT00945321|3938691|P6|Period 4|Lost to Follow-up|1
1199057|NCT00945321|3938692|P5|Period 4|Lost to Follow-up|0
1199058|NCT00945321|3938693|P4|Period 4|Lost to Follow-up|0
1199059|NCT00945321|3938694|P3|Period 4|Lost to Follow-up|0
1199060|NCT00945321|3938695|P2|Period 4|Lost to Follow-up|0
1199061|NCT00945321|3938696|P1|Period 4|Lost to Follow-up|0
1199062|NCT00945321|3938691|P6|Period 1|Adverse Event|0
1199063|NCT00945321|3938692|P5|Period 1|Adverse Event|1
1199064|NCT00945321|3938693|P4|Period 1|Adverse Event|0
1199065|NCT00945321|3938694|P3|Period 1|Adverse Event|0
1199066|NCT00945321|3938695|P2|Period 1|Adverse Event|0
1199067|NCT00945321|3938696|P1|Period 1|Adverse Event|0
1199068|NCT00945243|3938829|P1|Overall Study|Study Terminated: Subjects Dispositioned|3
1199069|NCT00944697|3938986|P2|Overall Study|Administrative|1
1199070|NCT00944697|3938987|P1|Overall Study|Administrative|1
1199071|NCT00944697|3938986|P2|Overall Study|Adverse Event|3
1199072|NCT00944697|3938987|P1|Overall Study|Adverse Event|0
1199073|NCT00944697|3938986|P2|Overall Study|Withdrawal by Subject|1
1199074|NCT00944697|3938987|P1|Overall Study|Withdrawal by Subject|1
1199075|NCT00944645|3939017|P2|Period 2|Withdrawal by Subject|6
1199076|NCT00944645|3939018|P1|Period 2|Withdrawal by Subject|7
1199077|NCT00944645|3939017|P2|Period 2|Lost to Follow-up|3
1199078|NCT00944645|3939018|P1|Period 2|Lost to Follow-up|0
1199079|NCT00944645|3939017|P2|Period 2|Adverse Event|0
1199080|NCT00944645|3939018|P1|Period 2|Adverse Event|1
1199081|NCT00944229|3939048|P1|Overall Study|Physician Decision|14
1199082|NCT00944229|3939048|P1|Overall Study|Withdrawal by Subject|11
1199083|NCT00944125|3939054|P2|6 Months to Study Completion|Withdrawal by Subject|2
1199084|NCT00944125|3939055|P1|6 Months to Study Completion|Withdrawal by Subject|0
1199085|NCT00944125|3939054|P2|3 to 6 Months|Withdrawal by Subject|2
1199086|NCT00944125|3939055|P1|3 to 6 Months|Withdrawal by Subject|0
1199087|NCT00944034|3939158|P12|Overall Study|Administrative reason|0
1199088|NCT00944034|3939159|P11|Overall Study|Administrative reason|0
1199089|NCT00944034|3939160|P10|Overall Study|Administrative reason|0
1199090|NCT00944034|3939161|P9|Overall Study|Administrative reason|0
1199091|NCT00944034|3939162|P8|Overall Study|Administrative reason|0
1199092|NCT00944034|3939163|P7|Overall Study|Administrative reason|1
1199093|NCT00944034|3939164|P6|Overall Study|Administrative reason|0
1199094|NCT00944034|3939165|P5|Overall Study|Administrative reason|0
1199095|NCT00944034|3939166|P4|Overall Study|Administrative reason|0
1199096|NCT00944034|3939167|P3|Overall Study|Administrative reason|0
1199097|NCT00944034|3939168|P2|Overall Study|Administrative reason|0
1199098|NCT00944034|3939169|P1|Overall Study|Administrative reason|0
1199099|NCT00944034|3939158|P12|Overall Study|Unable to classify|0
1199100|NCT00944034|3939159|P11|Overall Study|Unable to classify|0
1199101|NCT00944034|3939160|P10|Overall Study|Unable to classify|0
1199102|NCT00944034|3939161|P9|Overall Study|Unable to classify|0
1199103|NCT00944034|3939162|P8|Overall Study|Unable to classify|1
1199104|NCT00944034|3939163|P7|Overall Study|Unable to classify|1
1199105|NCT00944034|3939164|P6|Overall Study|Unable to classify|1
1199106|NCT00944034|3939165|P5|Overall Study|Unable to classify|0
1199107|NCT00944034|3939166|P4|Overall Study|Unable to classify|0
1199108|NCT00944034|3939167|P3|Overall Study|Unable to classify|0
1199109|NCT00944034|3939168|P2|Overall Study|Unable to classify|0
1199110|NCT00944034|3939169|P1|Overall Study|Unable to classify|0
1199111|NCT00944034|3939158|P12|Overall Study|Protocol Violation|0
1199112|NCT00944034|3939159|P11|Overall Study|Protocol Violation|0
1199113|NCT00944034|3939160|P10|Overall Study|Protocol Violation|4
1199114|NCT00944034|3939161|P9|Overall Study|Protocol Violation|1
1199115|NCT00944034|3939162|P8|Overall Study|Protocol Violation|1
1199116|NCT00944034|3939163|P7|Overall Study|Protocol Violation|0
1199117|NCT00944034|3939164|P6|Overall Study|Protocol Violation|3
1199118|NCT00944034|3939165|P5|Overall Study|Protocol Violation|2
1199119|NCT00944034|3939166|P4|Overall Study|Protocol Violation|1
1199120|NCT00944034|3939167|P3|Overall Study|Protocol Violation|0
1199121|NCT00944034|3939168|P2|Overall Study|Protocol Violation|0
1199122|NCT00944034|3939169|P1|Overall Study|Protocol Violation|2
1199123|NCT00944034|3939158|P12|Overall Study|Death|0
1199124|NCT00944034|3939159|P11|Overall Study|Death|0
1199125|NCT00944034|3939160|P10|Overall Study|Death|0
1199126|NCT00944034|3939161|P9|Overall Study|Death|0
1199127|NCT00944034|3939162|P8|Overall Study|Death|0
1199128|NCT00944034|3939163|P7|Overall Study|Death|0
1199129|NCT00944034|3939164|P6|Overall Study|Death|0
1199130|NCT00944034|3939165|P5|Overall Study|Death|0
1199131|NCT00944034|3939166|P4|Overall Study|Death|0
1199132|NCT00944034|3939167|P3|Overall Study|Death|1
1199133|NCT00944034|3939168|P2|Overall Study|Death|0
1199134|NCT00944034|3939169|P1|Overall Study|Death|0
1199135|NCT00944034|3939158|P12|Overall Study|Lost to Follow-up|0
1199136|NCT00944034|3939159|P11|Overall Study|Lost to Follow-up|1
1199137|NCT00944034|3939160|P10|Overall Study|Lost to Follow-up|1
1199138|NCT00944034|3939161|P9|Overall Study|Lost to Follow-up|5
1199139|NCT00944034|3939162|P8|Overall Study|Lost to Follow-up|1
1199140|NCT00944034|3939163|P7|Overall Study|Lost to Follow-up|0
1199141|NCT00944034|3939164|P6|Overall Study|Lost to Follow-up|7
1199142|NCT00944034|3939165|P5|Overall Study|Lost to Follow-up|5
1199143|NCT00944034|3939166|P4|Overall Study|Lost to Follow-up|0
1199144|NCT00944034|3939167|P3|Overall Study|Lost to Follow-up|2
1199145|NCT00944034|3939168|P2|Overall Study|Lost to Follow-up|4
1199146|NCT00944034|3939169|P1|Overall Study|Lost to Follow-up|0
1199147|NCT00944034|3939158|P12|Overall Study|Withdrawal by Subject|4
1199148|NCT00944034|3939159|P11|Overall Study|Withdrawal by Subject|0
1199149|NCT00944034|3939160|P10|Overall Study|Withdrawal by Subject|4
1199150|NCT00944034|3939161|P9|Overall Study|Withdrawal by Subject|3
1199151|NCT00944034|3939162|P8|Overall Study|Withdrawal by Subject|2
1199152|NCT00944034|3939163|P7|Overall Study|Withdrawal by Subject|2
1199153|NCT00944034|3939164|P6|Overall Study|Withdrawal by Subject|8
1199154|NCT00944034|3939165|P5|Overall Study|Withdrawal by Subject|5
1199155|NCT00944034|3939166|P4|Overall Study|Withdrawal by Subject|2
1199156|NCT00944034|3939167|P3|Overall Study|Withdrawal by Subject|6
1199157|NCT00944034|3939168|P2|Overall Study|Withdrawal by Subject|2
1199158|NCT00944034|3939169|P1|Overall Study|Withdrawal by Subject|3
1199159|NCT00944034|3939158|P12|Overall Study|Inappropriate enrollment|0
1199160|NCT00944034|3939159|P11|Overall Study|Inappropriate enrollment|0
1199161|NCT00944034|3939160|P10|Overall Study|Inappropriate enrollment|1
1199162|NCT00944034|3939161|P9|Overall Study|Inappropriate enrollment|1
1199163|NCT00944034|3939162|P8|Overall Study|Inappropriate enrollment|0
1199164|NCT00944034|3939163|P7|Overall Study|Inappropriate enrollment|0
1199165|NCT00944034|3939164|P6|Overall Study|Inappropriate enrollment|1
1199166|NCT00944034|3939165|P5|Overall Study|Inappropriate enrollment|2
1199167|NCT00944034|3939166|P4|Overall Study|Inappropriate enrollment|1
1199168|NCT00944034|3939167|P3|Overall Study|Inappropriate enrollment|0
1199169|NCT00944034|3939168|P2|Overall Study|Inappropriate enrollment|1
1199170|NCT00944034|3939169|P1|Overall Study|Inappropriate enrollment|0
1199171|NCT00943917|3939315|P15|Stage II Continuation|A1C elevation|0
1199172|NCT00943917|3939316|P14|Stage II Continuation|A1C elevation|1
1199173|NCT00943917|3939317|P13|Stage II Continuation|A1C elevation|0
1199174|NCT00943917|3939318|P12|Stage II Continuation|A1C elevation|0
1199175|NCT00943917|3939319|P11|Stage II Continuation|A1C elevation|0
1199176|NCT00943917|3939320|P10|Stage II Continuation|A1C elevation|0
1199177|NCT00943917|3939321|P9|Stage II Continuation|A1C elevation|0
1199178|NCT00943917|3939322|P8|Stage II Continuation|A1C elevation|0
1199179|NCT00943917|3939323|P7|Stage II Continuation|A1C elevation|0
1199180|NCT00943917|3939324|P6|Stage II Continuation|A1C elevation|0
1199181|NCT00943917|3939325|P5|Stage II Continuation|A1C elevation|0
1199182|NCT00943917|3939326|P4|Stage II Continuation|A1C elevation|0
1199183|NCT00943917|3939327|P3|Stage II Continuation|A1C elevation|0
1199184|NCT00943917|3939328|P2|Stage II Continuation|A1C elevation|0
1199185|NCT00943917|3939329|P1|Stage II Continuation|A1C elevation|0
1199186|NCT00943917|3939315|P15|Stage II Continuation|hypoglycemia|0
1199187|NCT00943917|3939316|P14|Stage II Continuation|hypoglycemia|0
1199188|NCT00943917|3939317|P13|Stage II Continuation|hypoglycemia|1
1199189|NCT00943917|3939318|P12|Stage II Continuation|hypoglycemia|0
1199190|NCT00943917|3939319|P11|Stage II Continuation|hypoglycemia|0
1199191|NCT00943917|3939320|P10|Stage II Continuation|hypoglycemia|0
1199192|NCT00943917|3939321|P9|Stage II Continuation|hypoglycemia|0
1199193|NCT00943917|3939322|P8|Stage II Continuation|hypoglycemia|0
1199194|NCT00943917|3939323|P7|Stage II Continuation|hypoglycemia|0
1199195|NCT00943917|3939324|P6|Stage II Continuation|hypoglycemia|0
1199196|NCT00943917|3939325|P5|Stage II Continuation|hypoglycemia|0
1199197|NCT00943917|3939326|P4|Stage II Continuation|hypoglycemia|0
1199198|NCT00943917|3939327|P3|Stage II Continuation|hypoglycemia|0
1199199|NCT00943917|3939328|P2|Stage II Continuation|hypoglycemia|0
1199200|NCT00943917|3939329|P1|Stage II Continuation|hypoglycemia|0
1199201|NCT00943917|3939315|P15|Stage II Continuation|Protocol Violation|0
1199202|NCT00943917|3939316|P14|Stage II Continuation|Protocol Violation|0
1199203|NCT00943917|3939317|P13|Stage II Continuation|Protocol Violation|0
1199204|NCT00943917|3939318|P12|Stage II Continuation|Protocol Violation|1
1199205|NCT00943917|3939319|P11|Stage II Continuation|Protocol Violation|0
1199206|NCT00943917|3939320|P10|Stage II Continuation|Protocol Violation|1
1199207|NCT00943917|3939321|P9|Stage II Continuation|Protocol Violation|0
1199208|NCT00943917|3939322|P8|Stage II Continuation|Protocol Violation|0
1199209|NCT00943917|3939323|P7|Stage II Continuation|Protocol Violation|0
1199210|NCT00943917|3939324|P6|Stage II Continuation|Protocol Violation|0
1199211|NCT00943917|3939325|P5|Stage II Continuation|Protocol Violation|0
1199212|NCT00943917|3939326|P4|Stage II Continuation|Protocol Violation|0
1199213|NCT00943917|3939327|P3|Stage II Continuation|Protocol Violation|0
1199214|NCT00943917|3939328|P2|Stage II Continuation|Protocol Violation|0
1199215|NCT00943917|3939329|P1|Stage II Continuation|Protocol Violation|0
1199216|NCT00943917|3939315|P15|Stage II Continuation|Withdrawal by Subject|3
1199217|NCT00943917|3939316|P14|Stage II Continuation|Withdrawal by Subject|1
1199218|NCT00943917|3939317|P13|Stage II Continuation|Withdrawal by Subject|0
1199219|NCT00943917|3939318|P12|Stage II Continuation|Withdrawal by Subject|0
1199220|NCT00943917|3939319|P11|Stage II Continuation|Withdrawal by Subject|0
1199221|NCT00943917|3939320|P10|Stage II Continuation|Withdrawal by Subject|0
1199222|NCT00943917|3939321|P9|Stage II Continuation|Withdrawal by Subject|0
1199223|NCT00943917|3939322|P8|Stage II Continuation|Withdrawal by Subject|0
1199224|NCT00943917|3939323|P7|Stage II Continuation|Withdrawal by Subject|0
1199225|NCT00943917|3939324|P6|Stage II Continuation|Withdrawal by Subject|0
1199226|NCT00943917|3939325|P5|Stage II Continuation|Withdrawal by Subject|0
1199227|NCT00943917|3939326|P4|Stage II Continuation|Withdrawal by Subject|0
1199228|NCT00943917|3939327|P3|Stage II Continuation|Withdrawal by Subject|0
1199229|NCT00943917|3939328|P2|Stage II Continuation|Withdrawal by Subject|0
1199230|NCT00943917|3939329|P1|Stage II Continuation|Withdrawal by Subject|0
1199231|NCT00943917|3939315|P15|Stage II Continuation|Adverse Event|1
1199232|NCT00943917|3939316|P14|Stage II Continuation|Adverse Event|1
1199233|NCT00943917|3939317|P13|Stage II Continuation|Adverse Event|2
1199234|NCT00943917|3939318|P12|Stage II Continuation|Adverse Event|1
1199235|NCT00943917|3939319|P11|Stage II Continuation|Adverse Event|0
1199236|NCT00943917|3939320|P10|Stage II Continuation|Adverse Event|0
1199237|NCT00943917|3939321|P9|Stage II Continuation|Adverse Event|0
1199238|NCT00943917|3939322|P8|Stage II Continuation|Adverse Event|0
1199239|NCT00943917|3939323|P7|Stage II Continuation|Adverse Event|0
1199240|NCT00943917|3939324|P6|Stage II Continuation|Adverse Event|0
1199241|NCT00943917|3939325|P5|Stage II Continuation|Adverse Event|0
1199242|NCT00943917|3939326|P4|Stage II Continuation|Adverse Event|0
1199243|NCT00943917|3939327|P3|Stage II Continuation|Adverse Event|0
1199244|NCT00943917|3939328|P2|Stage II Continuation|Adverse Event|0
1199245|NCT00943917|3939329|P1|Stage II Continuation|Adverse Event|0
1199246|NCT00943917|3939315|P15|Stage II|Pregnancy|0
1199247|NCT00943917|3939316|P14|Stage II|Pregnancy|0
1199248|NCT00943917|3939317|P13|Stage II|Pregnancy|0
1199249|NCT00943917|3939318|P12|Stage II|Pregnancy|0
1199250|NCT00943917|3939319|P11|Stage II|Pregnancy|0
1199251|NCT00943917|3939320|P10|Stage II|Pregnancy|0
1199252|NCT00943917|3939321|P9|Stage II|Pregnancy|0
1199253|NCT00943917|3939322|P8|Stage II|Pregnancy|0
1199254|NCT00943917|3939323|P7|Stage II|Pregnancy|0
1199255|NCT00943917|3939324|P6|Stage II|Pregnancy|1
1199256|NCT00943917|3939325|P5|Stage II|Pregnancy|0
1199257|NCT00943917|3939326|P4|Stage II|Pregnancy|0
1199258|NCT00943917|3939327|P3|Stage II|Pregnancy|0
1199259|NCT00943917|3939328|P2|Stage II|Pregnancy|0
1199260|NCT00943917|3939329|P1|Stage II|Pregnancy|0
1199261|NCT00943917|3939315|P15|Stage II|Withdrawal by Subject|0
1199262|NCT00943917|3939316|P14|Stage II|Withdrawal by Subject|0
1199263|NCT00943917|3939317|P13|Stage II|Withdrawal by Subject|0
1199264|NCT00943917|3939318|P12|Stage II|Withdrawal by Subject|0
1199265|NCT00943917|3939319|P11|Stage II|Withdrawal by Subject|0
1199266|NCT00943917|3939320|P10|Stage II|Withdrawal by Subject|0
1199267|NCT00943917|3939321|P9|Stage II|Withdrawal by Subject|0
1199268|NCT00943917|3939322|P8|Stage II|Withdrawal by Subject|0
1199269|NCT00943917|3939323|P7|Stage II|Withdrawal by Subject|0
1199270|NCT00943917|3939324|P6|Stage II|Withdrawal by Subject|1
1199271|NCT00943917|3939325|P5|Stage II|Withdrawal by Subject|0
1199272|NCT00943917|3939326|P4|Stage II|Withdrawal by Subject|0
1199273|NCT00943917|3939327|P3|Stage II|Withdrawal by Subject|0
1199274|NCT00943917|3939328|P2|Stage II|Withdrawal by Subject|0
1199275|NCT00943917|3939329|P1|Stage II|Withdrawal by Subject|0
1199276|NCT00943917|3939315|P15|Stage II|Adverse Event|0
1199277|NCT00943917|3939316|P14|Stage II|Adverse Event|0
1199278|NCT00943917|3939317|P13|Stage II|Adverse Event|0
1199279|NCT00943917|3939318|P12|Stage II|Adverse Event|0
1199280|NCT00943917|3939319|P11|Stage II|Adverse Event|0
1199281|NCT00943917|3939320|P10|Stage II|Adverse Event|0
1199282|NCT00943917|3939321|P9|Stage II|Adverse Event|1
1199283|NCT00943917|3939322|P8|Stage II|Adverse Event|0
1199284|NCT00943917|3939323|P7|Stage II|Adverse Event|3
1199285|NCT00943917|3939324|P6|Stage II|Adverse Event|1
1199286|NCT00943917|3939325|P5|Stage II|Adverse Event|0
1199287|NCT00943917|3939326|P4|Stage II|Adverse Event|0
1199288|NCT00943917|3939327|P3|Stage II|Adverse Event|0
1199289|NCT00943917|3939328|P2|Stage II|Adverse Event|0
1199290|NCT00943917|3939329|P1|Stage II|Adverse Event|0
1199291|NCT00943917|3939315|P15|Stage I|Withdrawal by Subject|0
1199292|NCT00943917|3939316|P14|Stage I|Withdrawal by Subject|0
1199293|NCT00943917|3939317|P13|Stage I|Withdrawal by Subject|0
1199294|NCT00943917|3939318|P12|Stage I|Withdrawal by Subject|0
1199295|NCT00943917|3939319|P11|Stage I|Withdrawal by Subject|0
1199296|NCT00943917|3939320|P10|Stage I|Withdrawal by Subject|0
1199297|NCT00943917|3939321|P9|Stage I|Withdrawal by Subject|0
1199298|NCT00943917|3939322|P8|Stage I|Withdrawal by Subject|0
1199299|NCT00943917|3939323|P7|Stage I|Withdrawal by Subject|0
1199300|NCT00943917|3939324|P6|Stage I|Withdrawal by Subject|0
1199301|NCT00943917|3939325|P5|Stage I|Withdrawal by Subject|0
1199302|NCT00943917|3939326|P4|Stage I|Withdrawal by Subject|0
1199303|NCT00943917|3939327|P3|Stage I|Withdrawal by Subject|2
1199304|NCT00943917|3939328|P2|Stage I|Withdrawal by Subject|1
1199305|NCT00943917|3939329|P1|Stage I|Withdrawal by Subject|2
1199306|NCT00943917|3939315|P15|Stage I|A1C elevation|0
1199307|NCT00943917|3939316|P14|Stage I|A1C elevation|0
1199308|NCT00943917|3939317|P13|Stage I|A1C elevation|0
1199309|NCT00943917|3939318|P12|Stage I|A1C elevation|0
1199310|NCT00943917|3939319|P11|Stage I|A1C elevation|0
1199311|NCT00943917|3939320|P10|Stage I|A1C elevation|0
1199312|NCT00943917|3939321|P9|Stage I|A1C elevation|0
1199313|NCT00943917|3939322|P8|Stage I|A1C elevation|0
1199314|NCT00943917|3939323|P7|Stage I|A1C elevation|0
1199315|NCT00943917|3939324|P6|Stage I|A1C elevation|0
1199316|NCT00943917|3939325|P5|Stage I|A1C elevation|0
1199317|NCT00943917|3939326|P4|Stage I|A1C elevation|0
1199318|NCT00943917|3939327|P3|Stage I|A1C elevation|0
1199319|NCT00943917|3939328|P2|Stage I|A1C elevation|0
1199320|NCT00943917|3939329|P1|Stage I|A1C elevation|1
1199321|NCT00943917|3939315|P15|Stage I|hyperglycemia|0
1199322|NCT00943917|3939316|P14|Stage I|hyperglycemia|0
1199323|NCT00943917|3939317|P13|Stage I|hyperglycemia|0
1199324|NCT00943917|3939318|P12|Stage I|hyperglycemia|0
1199325|NCT00943917|3939319|P11|Stage I|hyperglycemia|0
1199326|NCT00943917|3939320|P10|Stage I|hyperglycemia|0
1199327|NCT00943917|3939321|P9|Stage I|hyperglycemia|0
1199328|NCT00943917|3939322|P8|Stage I|hyperglycemia|0
1199329|NCT00943917|3939323|P7|Stage I|hyperglycemia|0
1199330|NCT00943917|3939324|P6|Stage I|hyperglycemia|0
1199331|NCT00943917|3939325|P5|Stage I|hyperglycemia|0
1199332|NCT00943917|3939326|P4|Stage I|hyperglycemia|0
1199333|NCT00943917|3939327|P3|Stage I|hyperglycemia|1
1199334|NCT00943917|3939328|P2|Stage I|hyperglycemia|0
1199335|NCT00943917|3939329|P1|Stage I|hyperglycemia|0
1199336|NCT00943917|3939315|P15|Stage I|Lost to Follow-up|0
1199337|NCT00943917|3939316|P14|Stage I|Lost to Follow-up|0
1199338|NCT00943917|3939317|P13|Stage I|Lost to Follow-up|0
1199339|NCT00943917|3939318|P12|Stage I|Lost to Follow-up|0
1199340|NCT00943917|3939319|P11|Stage I|Lost to Follow-up|0
1199341|NCT00943917|3939320|P10|Stage I|Lost to Follow-up|0
1199342|NCT00943917|3939321|P9|Stage I|Lost to Follow-up|0
1199343|NCT00943917|3939322|P8|Stage I|Lost to Follow-up|0
1199344|NCT00943917|3939323|P7|Stage I|Lost to Follow-up|0
1199345|NCT00943917|3939324|P6|Stage I|Lost to Follow-up|0
1199346|NCT00943917|3939325|P5|Stage I|Lost to Follow-up|0
1199347|NCT00943917|3939326|P4|Stage I|Lost to Follow-up|0
1199348|NCT00943917|3939327|P3|Stage I|Lost to Follow-up|1
1199349|NCT00943917|3939328|P2|Stage I|Lost to Follow-up|0
1199350|NCT00943917|3939329|P1|Stage I|Lost to Follow-up|0
1199351|NCT00943917|3939315|P15|Stage I|Adverse Event|0
1199352|NCT00943917|3939316|P14|Stage I|Adverse Event|0
1199353|NCT00943917|3939317|P13|Stage I|Adverse Event|0
1199354|NCT00943917|3939318|P12|Stage I|Adverse Event|0
1199355|NCT00943917|3939319|P11|Stage I|Adverse Event|0
1199356|NCT00943917|3939320|P10|Stage I|Adverse Event|0
1199357|NCT00943917|3939321|P9|Stage I|Adverse Event|0
1199358|NCT00943917|3939322|P8|Stage I|Adverse Event|0
1199359|NCT00943917|3939323|P7|Stage I|Adverse Event|0
1199360|NCT00943917|3939324|P6|Stage I|Adverse Event|0
1199361|NCT00943917|3939325|P5|Stage I|Adverse Event|0
1199362|NCT00943917|3939326|P4|Stage I|Adverse Event|0
1199363|NCT00943917|3939327|P3|Stage I|Adverse Event|2
1199364|NCT00943917|3939328|P2|Stage I|Adverse Event|2
1199365|NCT00943917|3939329|P1|Stage I|Adverse Event|1
1199366|NCT00943852|3939505|P10|Washout Period After Period 4 Treatment|Trial stopped early|0
1199367|NCT00943852|3939506|P9|Washout Period After Period 4 Treatment|Trial stopped early|0
1199368|NCT00943852|3939507|P8|Washout Period After Period 4 Treatment|Trial stopped early|0
1199369|NCT00943852|3939508|P7|Washout Period After Period 4 Treatment|Trial stopped early|1
1199370|NCT00943852|3939509|P6|Washout Period After Period 4 Treatment|Trial stopped early|0
1199371|NCT00943852|3939510|P5|Washout Period After Period 4 Treatment|Trial stopped early|0
1199372|NCT00943852|3939511|P4|Washout Period After Period 4 Treatment|Trial stopped early|1
1199373|NCT00943852|3939512|P3|Washout Period After Period 4 Treatment|Trial stopped early|1
1199374|NCT00943852|3939513|P2|Washout Period After Period 4 Treatment|Trial stopped early|0
1199375|NCT00943852|3939514|P1|Washout Period After Period 4 Treatment|Trial stopped early|1
1199376|NCT00943852|3939505|P10|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
1199377|NCT00943852|3939506|P9|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
1199378|NCT00943852|3939507|P8|Washout Period After Period 4 Treatment|Not taking medication per protocol|1
1199379|NCT00943852|3939508|P7|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
1199380|NCT00943852|3939509|P6|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
1199381|NCT00943852|3939510|P5|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
1199382|NCT00943852|3939511|P4|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
1199383|NCT00943852|3939512|P3|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
1199384|NCT00943852|3939513|P2|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
1199385|NCT00943852|3939514|P1|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
1199386|NCT00943852|3939505|P10|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
1199387|NCT00943852|3939506|P9|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
1199388|NCT00943852|3939507|P8|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
1199389|NCT00943852|3939508|P7|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1
1199390|NCT00943852|3939509|P6|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
1199391|NCT00943852|3939510|P5|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
1199392|NCT00943852|3939511|P4|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
1199393|NCT00943852|3939512|P3|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
1199394|NCT00943852|3939513|P2|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
1199395|NCT00943852|3939514|P1|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
1199396|NCT00943852|3939505|P10|Washout Period After Period 2 Treatment|Trial stopped early|0
1199397|NCT00943852|3939506|P9|Washout Period After Period 2 Treatment|Trial stopped early|0
1199398|NCT00943852|3939507|P8|Washout Period After Period 2 Treatment|Trial stopped early|0
1199399|NCT00943852|3939508|P7|Washout Period After Period 2 Treatment|Trial stopped early|0
1199400|NCT00943852|3939509|P6|Washout Period After Period 2 Treatment|Trial stopped early|1
1199401|NCT00943852|3939510|P5|Washout Period After Period 2 Treatment|Trial stopped early|0
1199402|NCT00943852|3939511|P4|Washout Period After Period 2 Treatment|Trial stopped early|0
1199403|NCT00943852|3939512|P3|Washout Period After Period 2 Treatment|Trial stopped early|0
1199404|NCT00943852|3939513|P2|Washout Period After Period 2 Treatment|Trial stopped early|0
1199405|NCT00943852|3939514|P1|Washout Period After Period 2 Treatment|Trial stopped early|0
1199406|NCT00943852|3939505|P10|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
1199407|NCT00943852|3939506|P9|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
1199408|NCT00943852|3939507|P8|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
1199409|NCT00943852|3939508|P7|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
1199410|NCT00943852|3939509|P6|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
1199411|NCT00943852|3939510|P5|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
1199412|NCT00943852|3939511|P4|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1
1199413|NCT00943852|3939512|P3|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
1199414|NCT00943852|3939513|P2|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
1199415|NCT00943852|3939514|P1|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
1199416|NCT00943826|3939527|P2|After Primary Overall Survival Analysis|Withdrew Consent|0
1199417|NCT00943826|3939528|P1|After Primary Overall Survival Analysis|Withdrew Consent|4
1199418|NCT00943826|3939527|P2|After Primary Overall Survival Analysis|Progression of Disease|4
1199419|NCT00943826|3939528|P1|After Primary Overall Survival Analysis|Progression of Disease|2
1199420|NCT00943826|3939527|P2|After Primary Overall Survival Analysis|Administrative reasons|16
1199421|NCT00943826|3939528|P1|After Primary Overall Survival Analysis|Administrative reasons|10
1199422|NCT00943826|3939527|P2|After Primary Overall Survival Analysis|Adverse Event|0
1199423|NCT00943826|3939528|P1|After Primary Overall Survival Analysis|Adverse Event|11
1199424|NCT00943826|3939527|P2|Monotherapy Phase|Failure to return|1
1199425|NCT00943826|3939528|P1|Monotherapy Phase|Failure to return|2
1199426|NCT00943826|3939527|P2|Monotherapy Phase|Withdrew Consent|3
1199427|NCT00943826|3939528|P1|Monotherapy Phase|Withdrew Consent|2
1199428|NCT00943826|3939527|P2|Monotherapy Phase|Refused treatment/ Did not cooperate|2
1199429|NCT00943826|3939528|P1|Monotherapy Phase|Refused treatment/ Did not cooperate|8
1199430|NCT00943826|3939527|P2|Monotherapy Phase|Administrative reasons|5
1199431|NCT00943826|3939528|P1|Monotherapy Phase|Administrative reasons|11
1199432|NCT00943826|3939527|P2|Monotherapy Phase|Adverse Event|5
1199433|NCT00943826|3939528|P1|Monotherapy Phase|Adverse Event|42
1199434|NCT00943826|3939527|P2|Maintenance Phase|Failure to return|1
1199435|NCT00943826|3939528|P1|Maintenance Phase|Failure to return|0
1199436|NCT00943826|3939527|P2|Maintenance Phase|Administrative reasons|1
1199437|NCT00943826|3939528|P1|Maintenance Phase|Administrative reasons|4
1199438|NCT00943826|3939527|P2|Maintenance Phase|Refused treatment/Did not cooperate|3
1199439|NCT00943826|3939528|P1|Maintenance Phase|Refused treatment/Did not cooperate|6
1199440|NCT00943826|3939527|P2|Maintenance Phase|Withdrew consent|4
1199441|NCT00943826|3939528|P1|Maintenance Phase|Withdrew consent|2
1199442|NCT00943826|3939527|P2|Maintenance Phase|Adverse Event|30
1199443|NCT00943826|3939528|P1|Maintenance Phase|Adverse Event|31
1199444|NCT00943826|3939527|P2|Concurrent Phase|Protocol Violation|0
1199445|NCT00943826|3939528|P1|Concurrent Phase|Protocol Violation|1
1199446|NCT00943826|3939527|P2|Concurrent Phase|Administrative reasons|1
1199447|NCT00943826|3939528|P1|Concurrent Phase|Administrative reasons|2
1199448|NCT00943826|3939527|P2|Concurrent Phase|Refused treatment/Did not cooperate|7
1199449|NCT00943826|3939528|P1|Concurrent Phase|Refused treatment/Did not cooperate|5
1199450|NCT00943826|3939527|P2|Concurrent Phase|Withdrew consent|7
1199451|NCT00943826|3939528|P1|Concurrent Phase|Withdrew consent|3
1199452|NCT00943826|3939527|P2|Concurrent Phase|Adverse Event|27
1199453|NCT00943826|3939528|P1|Concurrent Phase|Adverse Event|50
1199454|NCT00943787|3939546|P1|Overall Study|Withdrawal by Subject|3
1199455|NCT00943787|3939546|P1|Overall Study|Physician Decision|4
1199456|NCT00943761|3939553|P2|Overall Study|Withdrawal by Subject|1
1199457|NCT00943761|3939554|P1|Overall Study|Withdrawal by Subject|2
1199458|NCT00943761|3939553|P2|Overall Study|Lost to Follow-up|0
1199459|NCT00943761|3939554|P1|Overall Study|Lost to Follow-up|2
1199460|NCT00943735|3939566|P1|Overall Study|Other|3
1199461|NCT00943735|3939566|P1|Overall Study|Other|8
1199462|NCT00943735|3939566|P1|Overall Study|Death|1
1199463|NCT00943735|3939566|P1|Overall Study|Withdrawal by Subject|8
1199464|NCT00943735|3939566|P1|Overall Study|Adverse Event|12
1199465|NCT00943722|3939604|P5|Overall Study|Withdrawal by Subject|8
1199466|NCT00943722|3939605|P4|Overall Study|Withdrawal by Subject|13
1199467|NCT00943722|3939606|P3|Overall Study|Withdrawal by Subject|2
1199468|NCT00943722|3939607|P2|Overall Study|Withdrawal by Subject|13
1199469|NCT00943722|3939608|P1|Overall Study|Withdrawal by Subject|12
1199470|NCT00943722|3939604|P5|Overall Study|Protocol Violation|2
1199471|NCT00943722|3939605|P4|Overall Study|Protocol Violation|0
1199472|NCT00943722|3939606|P3|Overall Study|Protocol Violation|0
1199473|NCT00943722|3939607|P2|Overall Study|Protocol Violation|1
1199474|NCT00943722|3939608|P1|Overall Study|Protocol Violation|0
1199475|NCT00943722|3939604|P5|Overall Study|Pregnancy|0
1199476|NCT00943722|3939605|P4|Overall Study|Pregnancy|0
1199477|NCT00943722|3939606|P3|Overall Study|Pregnancy|1
1199478|NCT00943722|3939607|P2|Overall Study|Pregnancy|0
1199479|NCT00943722|3939608|P1|Overall Study|Pregnancy|0
1199480|NCT00943722|3939604|P5|Overall Study|Physician Decision|1
1199481|NCT00943722|3939605|P4|Overall Study|Physician Decision|0
1199482|NCT00943722|3939606|P3|Overall Study|Physician Decision|0
1199483|NCT00943722|3939607|P2|Overall Study|Physician Decision|0
1199484|NCT00943722|3939608|P1|Overall Study|Physician Decision|1
1199485|NCT00943722|3939604|P5|Overall Study|Lost to Follow-up|11
1199486|NCT00943722|3939605|P4|Overall Study|Lost to Follow-up|8
1199487|NCT00943722|3939606|P3|Overall Study|Lost to Follow-up|10
1199488|NCT00943722|3939607|P2|Overall Study|Lost to Follow-up|8
1199489|NCT00943722|3939608|P1|Overall Study|Lost to Follow-up|12
1199490|NCT00943722|3939604|P5|Overall Study|Adverse Event|0
1199491|NCT00943722|3939605|P4|Overall Study|Adverse Event|1
1199492|NCT00943722|3939606|P3|Overall Study|Adverse Event|0
1199493|NCT00943722|3939607|P2|Overall Study|Adverse Event|0
1199494|NCT00943722|3939608|P1|Overall Study|Adverse Event|0
1199495|NCT00943683|3939638|P2|Overall Study|Patient Moved|0
1199496|NCT00943683|3939639|P1|Overall Study|Patient Moved|1
1199497|NCT00943683|3939638|P2|Overall Study|Withdrawal by Subject|0
1199498|NCT00943683|3939639|P1|Overall Study|Withdrawal by Subject|1
1199499|NCT00943683|3939638|P2|Overall Study|Protocol Violation|2
1199500|NCT00943683|3939639|P1|Overall Study|Protocol Violation|1
1199501|NCT00943683|3939638|P2|Overall Study|Lost to Follow-up|1
1199502|NCT00943683|3939639|P1|Overall Study|Lost to Follow-up|1
1199503|NCT00943683|3939638|P2|Overall Study|Adverse Event|3
1199504|NCT00943683|3939639|P1|Overall Study|Adverse Event|3
1199505|NCT00943670|3939645|P1|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5
1199506|NCT00943670|3939645|P1|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2
1199507|NCT00943670|3939645|P1|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6
1199508|NCT00943670|3939645|P1|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4
1199509|NCT00943670|3939645|P1|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1
1199510|NCT00943670|3939645|P1|Single-agent Trastuzumab Emtansine|Early progressive disease|20
1199511|NCT00943670|3939645|P1|Single-agent Trastuzumab Emtansine|Adverse Event|2
1199512|NCT00943670|3939645|P1|Single-agent Trastuzumab Emtansine|Systemic progression|15
1199513|NCT00943670|3939645|P1|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3
1199514|NCT00943670|3939645|P1|Single-agent Trastuzumab Emtansine|Physician Decision|2
1199515|NCT00943605|3939734|P2|Overall Study|Study termination|30
1199516|NCT00943605|3939735|P1|Overall Study|Study termination|30
1199517|NCT00943592|3939745|P1|Overall Study|Death|3
1199518|NCT00943579|3939758|P2|Overall Study|Lack of Efficacy|2
1199519|NCT00943579|3939759|P1|Overall Study|Lack of Efficacy|2
1199520|NCT00943579|3939758|P2|Overall Study|Adverse Event|3
1199521|NCT00943579|3939759|P1|Overall Study|Adverse Event|4
1199522|NCT00943397|3939860|P2|Overall Study|Site terminated and other|56
1199523|NCT00943397|3939861|P1|Overall Study|Site terminated and other|12
1199524|NCT00943397|3939860|P2|Overall Study|Withdrawal by Subject|1
1199525|NCT00943397|3939861|P1|Overall Study|Withdrawal by Subject|1
1199526|NCT00943397|3939860|P2|Overall Study|Protocol Violation|5
1199527|NCT00943397|3939861|P1|Overall Study|Protocol Violation|2
1199528|NCT00943397|3939860|P2|Overall Study|Lost to Follow-up|4
1199529|NCT00943397|3939861|P1|Overall Study|Lost to Follow-up|0
1199530|NCT00943397|3939860|P2|Overall Study|Adverse Event|6
1199531|NCT00943397|3939861|P1|Overall Study|Adverse Event|0
1199532|NCT00943384|3939867|P1|Overall Study|Withdrawal by Subject|5
1199533|NCT00943384|3939867|P1|Overall Study|Lost to Follow-up|16
1199534|NCT00943384|3939867|P1|Overall Study|Treated off protocol-protocol violation|5
1199535|NCT00943384|3939867|P1|Overall Study|Dispositioned prior to treatment|23
1199536|NCT00943306|3939881|P1|Overall Study|Sponsor decision due to non-compliance|1
1199537|NCT00943306|3939881|P1|Overall Study|Death|1
1199538|NCT00943306|3939881|P1|Overall Study|Physician Decision|1
1199539|NCT00943124|3940183|P2|Period 1|Personal Reasons|1
1199540|NCT00943124|3940184|P1|Period 1|Personal Reasons|0
1199541|NCT00943124|3940183|P2|Period 1|Did Not Follow Study Procedures|0
1199542|NCT00943124|3940184|P1|Period 1|Did Not Follow Study Procedures|1
1199543|NCT00943124|3940183|P2|Period 1|Withdrawal by Subject|1
1199544|NCT00943124|3940184|P1|Period 1|Withdrawal by Subject|1
1199545|NCT00943111|3940206|P3|5 Years Long-term Treatment Period|Other than specified above|2
1199546|NCT00943111|3940207|P2|5 Years Long-term Treatment Period|Other than specified above|0
1199547|NCT00943111|3940208|P1|5 Years Long-term Treatment Period|Other than specified above|0
1199548|NCT00943111|3940206|P3|5 Years Long-term Treatment Period|Lost to Follow-up|1
1199549|NCT00943111|3940207|P2|5 Years Long-term Treatment Period|Lost to Follow-up|0
1199550|NCT00943111|3940208|P1|5 Years Long-term Treatment Period|Lost to Follow-up|0
1199551|NCT00943111|3940206|P3|5 Years Long-term Treatment Period|Pregnancy|4
1199552|NCT00943111|3940207|P2|5 Years Long-term Treatment Period|Pregnancy|0
1199553|NCT00943111|3940208|P1|5 Years Long-term Treatment Period|Pregnancy|0
1199554|NCT00943111|3940206|P3|5 Years Long-term Treatment Period|Withdrawal by Subject|8
1199555|NCT00943111|3940207|P2|5 Years Long-term Treatment Period|Withdrawal by Subject|0
1199556|NCT00943111|3940208|P1|5 Years Long-term Treatment Period|Withdrawal by Subject|0
1199557|NCT00943111|3940206|P3|5 Years Long-term Treatment Period|Adverse Event|9
1199558|NCT00943111|3940207|P2|5 Years Long-term Treatment Period|Adverse Event|0
1199559|NCT00943111|3940208|P1|5 Years Long-term Treatment Period|Adverse Event|0
1199560|NCT00943111|3940206|P3|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51
1199561|NCT00943111|3940207|P2|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
1199562|NCT00943111|3940208|P1|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
1199563|NCT00943111|3940206|P3|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
1199564|NCT00943111|3940207|P2|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1
1199565|NCT00943111|3940208|P1|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
1199566|NCT00943111|3940206|P3|52-Weeks Primary Analysis Period|Adverse Event|0
1199567|NCT00943111|3940207|P2|52-Weeks Primary Analysis Period|Adverse Event|1
1199568|NCT00943111|3940208|P1|52-Weeks Primary Analysis Period|Adverse Event|2
1199569|NCT00943072|3940276|P2|Overall Study|Other|1
1199570|NCT00943072|3940277|P1|Overall Study|Other|1
1199571|NCT00943072|3940276|P2|Overall Study|Lack of Efficacy|4
1199572|NCT00943072|3940277|P1|Overall Study|Lack of Efficacy|0
1199573|NCT00943072|3940276|P2|Overall Study|Lost to Follow-up|2
1199574|NCT00943072|3940277|P1|Overall Study|Lost to Follow-up|1
1199575|NCT00943072|3940276|P2|Overall Study|Protocol Violation|1
1199576|NCT00943072|3940277|P1|Overall Study|Protocol Violation|0
1199577|NCT00943072|3940276|P2|Overall Study|Withdrawal by Subject|1
1199578|NCT00943072|3940277|P1|Overall Study|Withdrawal by Subject|3
1199579|NCT00943072|3940276|P2|Overall Study|Death|2
1199580|NCT00943072|3940277|P1|Overall Study|Death|0
1199581|NCT00943072|3940276|P2|Overall Study|Adverse Event|3
1199582|NCT00943072|3940277|P1|Overall Study|Adverse Event|0
1199583|NCT00942994|3940295|P2|Overall Study|Protocol deviation|2
1199584|NCT00942994|3940296|P1|Overall Study|Protocol deviation|1
1199585|NCT00942994|3940295|P2|Overall Study|Lost to Follow-up|4
1199586|NCT00942994|3940296|P1|Overall Study|Lost to Follow-up|1
1199587|NCT00942994|3940295|P2|Overall Study|Patient withdrew consent|8
1199588|NCT00942994|3940296|P1|Overall Study|Patient withdrew consent|5
1199589|NCT00942994|3940295|P2|Overall Study|Unsatisfactory therapeutic effect|1
1199590|NCT00942994|3940296|P1|Overall Study|Unsatisfactory therapeutic effect|1
1199591|NCT00942994|3940295|P2|Overall Study|Abnormal laboratory value(s)|0
1199592|NCT00942994|3940296|P1|Overall Study|Abnormal laboratory value(s)|1
1199593|NCT00942994|3940295|P2|Overall Study|Adverse Event|4
1199594|NCT00942994|3940296|P1|Overall Study|Adverse Event|7
1199595|NCT00942968|3940312|P1|Overall Study|Deep vein thrombosis (DVT)|2
1199596|NCT00942968|3940312|P1|Overall Study|Participant required pancreatic biopsy|1
1199597|NCT00942968|3940312|P1|Overall Study|Pulmonary embolism (PE)|1
1199598|NCT00942968|3940312|P1|Overall Study|Inferior vena cava filter placement|4
1199599|NCT00942968|3940312|P1|Overall Study|Progression of disease|12
1199600|NCT00942968|3940312|P1|Overall Study|Physician Decision|11
1199601|NCT00942968|3940312|P1|Overall Study|Sponsor request|5
1199602|NCT00942968|3940312|P1|Overall Study|Withdrawal by Subject|44
1199603|NCT00942968|3940312|P1|Overall Study|Lost to Follow-up|4
1199604|NCT00942968|3940312|P1|Overall Study|Protocol Violation|9
1199605|NCT00942968|3940312|P1|Overall Study|Death|76
1199606|NCT00942968|3940312|P1|Overall Study|Adverse Event|60
1199607|NCT00942734|3940390|P1|Overall Study|Physician Decision|1
1199608|NCT00942734|3940390|P1|Overall Study|Disease Progression|2
1199609|NCT00942734|3940390|P1|Overall Study|Protocol Violation|3
1199610|NCT00942734|3940390|P1|Overall Study|Adverse Event|2
1199611|NCT00942604|3940396|P2|Overall Study|Patient relocation|1
1199612|NCT00942604|3940397|P1|Overall Study|Patient relocation|1
1199613|NCT00942604|3940396|P2|Overall Study|Withdrawal by Subject|1
1199614|NCT00942604|3940397|P1|Overall Study|Withdrawal by Subject|0
1199615|NCT00942604|3940396|P2|Overall Study|Adverse Event|1
1199616|NCT00942604|3940397|P1|Overall Study|Adverse Event|0
1199617|NCT00942604|3940396|P2|Overall Study|Protocol Violation|1
1199618|NCT00942604|3940397|P1|Overall Study|Protocol Violation|1
1199619|NCT00942422|3940505|P1|Overall Study|Progressive diease|1
1199620|NCT00942422|3940505|P1|Overall Study|Death|1
1199621|NCT00942422|3940505|P1|Overall Study|Withdrawal by Subject|1
1199622|NCT00942409|3940509|P1|Overall Study|study drug unavailable|2
1199623|NCT00942409|3940509|P1|Overall Study|Lack of Efficacy|1
1199624|NCT00942357|3940515|P2|Overall Study|Ineligible|40
1199625|NCT00942357|3940516|P1|Overall Study|Ineligible|37
1199626|NCT00942266|3940532|P2|Overall Study|medical deterioration (pneumonia)|1
1199627|NCT00942266|3940533|P1|Overall Study|medical deterioration (pneumonia)|0
1199628|NCT00942266|3940532|P2|Overall Study|Physician Decision|0
1199629|NCT00942266|3940533|P1|Overall Study|Physician Decision|2
1199630|NCT00942266|3940532|P2|Overall Study|Intercurrent illness|1
1199631|NCT00942266|3940533|P1|Overall Study|Intercurrent illness|0
1199632|NCT00942266|3940532|P2|Overall Study|Failure to thrive and pt withdrawal|1
1199633|NCT00942266|3940533|P1|Overall Study|Failure to thrive and pt withdrawal|0
1199634|NCT00942266|3940532|P2|Overall Study|Disease Progression|11
1199635|NCT00942266|3940533|P1|Overall Study|Disease Progression|38
1199636|NCT00942266|3940532|P2|Overall Study|Adverse Event|1
1199637|NCT00942266|3940533|P1|Overall Study|Adverse Event|2
1199638|NCT00942266|3940532|P2|Overall Study|Withdrawal by Subject|0
1199639|NCT00942266|3940533|P1|Overall Study|Withdrawal by Subject|1
1199640|NCT00942188|3940555|P4|Overall Study|Sponsor Decision|1
1199641|NCT00942188|3940556|P3|Overall Study|Sponsor Decision|0
1199642|NCT00942188|3940557|P2|Overall Study|Sponsor Decision|2
1199643|NCT00942188|3940558|P1|Overall Study|Sponsor Decision|0
1199644|NCT00942188|3940555|P4|Overall Study|Physician Decision|0
1199645|NCT00942188|3940556|P3|Overall Study|Physician Decision|1
1199646|NCT00942188|3940557|P2|Overall Study|Physician Decision|0
1199647|NCT00942188|3940558|P1|Overall Study|Physician Decision|0
1199648|NCT00942188|3940555|P4|Overall Study|Withdrawal by Subject|2
1199649|NCT00942188|3940556|P3|Overall Study|Withdrawal by Subject|4
1199650|NCT00942188|3940557|P2|Overall Study|Withdrawal by Subject|3
1199651|NCT00942188|3940558|P1|Overall Study|Withdrawal by Subject|1
1199652|NCT00942188|3940555|P4|Overall Study|Lost to Follow-up|0
1199653|NCT00942188|3940556|P3|Overall Study|Lost to Follow-up|2
1199654|NCT00942188|3940557|P2|Overall Study|Lost to Follow-up|1
1199655|NCT00942188|3940558|P1|Overall Study|Lost to Follow-up|2
1199656|NCT00942188|3940555|P4|Overall Study|Protocol Violation|0
1199657|NCT00942188|3940556|P3|Overall Study|Protocol Violation|0
1199658|NCT00942188|3940557|P2|Overall Study|Protocol Violation|1
1199659|NCT00942188|3940558|P1|Overall Study|Protocol Violation|1
1199660|NCT00942188|3940555|P4|Overall Study|Lack of Efficacy|1
1199661|NCT00942188|3940556|P3|Overall Study|Lack of Efficacy|0
1199662|NCT00942188|3940557|P2|Overall Study|Lack of Efficacy|0
1199663|NCT00942188|3940558|P1|Overall Study|Lack of Efficacy|0
1199664|NCT00942188|3940555|P4|Overall Study|Adverse Event|0
1199665|NCT00942188|3940556|P3|Overall Study|Adverse Event|2
1199666|NCT00942188|3940557|P2|Overall Study|Adverse Event|3
1199667|NCT00942188|3940558|P1|Overall Study|Adverse Event|0
1199668|NCT00942175|3940597|P4|Overall Study|Low Platelet Count|0
1199669|NCT00942175|3940598|P3|Overall Study|Low Platelet Count|0
1199670|NCT00942175|3940599|P2|Overall Study|Low Platelet Count|2
1199671|NCT00942175|3940600|P1|Overall Study|Low Platelet Count|0
1199672|NCT00942175|3940597|P4|Overall Study|Elevated Alanine Amino Transferase|1
1199673|NCT00942175|3940598|P3|Overall Study|Elevated Alanine Amino Transferase|0
1199674|NCT00942175|3940599|P2|Overall Study|Elevated Alanine Amino Transferase|0
1199675|NCT00942175|3940600|P1|Overall Study|Elevated Alanine Amino Transferase|0
1199676|NCT00942175|3940597|P4|Overall Study|Pregnancy|1
1199677|NCT00942175|3940598|P3|Overall Study|Pregnancy|0
1199678|NCT00942175|3940599|P2|Overall Study|Pregnancy|0
1199679|NCT00942175|3940600|P1|Overall Study|Pregnancy|0
1199680|NCT00942175|3940597|P4|Overall Study|Protocol Violation|0
1199681|NCT00942175|3940598|P3|Overall Study|Protocol Violation|2
1199682|NCT00942175|3940599|P2|Overall Study|Protocol Violation|1
1199683|NCT00942175|3940600|P1|Overall Study|Protocol Violation|0
1199684|NCT00942175|3940597|P4|Overall Study|Adverse Event|0
1199685|NCT00942175|3940598|P3|Overall Study|Adverse Event|0
1199686|NCT00942175|3940599|P2|Overall Study|Adverse Event|1
1199687|NCT00942175|3940600|P1|Overall Study|Adverse Event|2
1199688|NCT00942162|3940653|P3|Overall Study|Other|0
1199689|NCT00942162|3940654|P2|Overall Study|Other|2
1199690|NCT00942162|3940655|P1|Overall Study|Other|8
1199691|NCT00942162|3940653|P3|Overall Study|Withdrawal by Subject|0
1199692|NCT00942162|3940654|P2|Overall Study|Withdrawal by Subject|2
1199693|NCT00942162|3940655|P1|Overall Study|Withdrawal by Subject|4
1199694|NCT00942162|3940653|P3|Overall Study|Protocol Violation|0
1199695|NCT00942162|3940654|P2|Overall Study|Protocol Violation|0
1199696|NCT00942162|3940655|P1|Overall Study|Protocol Violation|1
1199697|NCT00942162|3940653|P3|Overall Study|Adverse Event|0
1199698|NCT00942162|3940654|P2|Overall Study|Adverse Event|0
1199699|NCT00942162|3940655|P1|Overall Study|Adverse Event|2
1199700|NCT00942162|3940653|P3|Overall Study|Disease progression|1
1199701|NCT00942162|3940654|P2|Overall Study|Disease progression|43
1199702|NCT00942162|3940655|P1|Overall Study|Disease progression|53
1199703|NCT00942084|3940724|P1|Overall Study|Death|2
1199704|NCT00941928|3940741|P1|Overall Study|Disease Progression|1
1199705|NCT00941928|3940741|P1|Overall Study|Withdrawal by Subject|1
1199706|NCT00941863|3940759|P5|Continued After PCD|Disease progression, recurrence, relapse|18
1199707|NCT00941863|3940760|P4|Continued After PCD|Disease progression, recurrence, relapse|0
1199708|NCT00941863|3940761|P3|Continued After PCD|Disease progression, recurrence, relapse|0
1199709|NCT00941863|3940762|P2|Continued After PCD|Disease progression, recurrence, relapse|0
1199710|NCT00941863|3940763|P1|Continued After PCD|Disease progression, recurrence, relapse|0
1199711|NCT00941863|3940759|P5|Continued After PCD|Withdrawal by Subject|1
1199712|NCT00941863|3940760|P4|Continued After PCD|Withdrawal by Subject|0
1199713|NCT00941863|3940761|P3|Continued After PCD|Withdrawal by Subject|0
1199714|NCT00941863|3940762|P2|Continued After PCD|Withdrawal by Subject|0
1199715|NCT00941863|3940763|P1|Continued After PCD|Withdrawal by Subject|0
1199716|NCT00941863|3940759|P5|Until Primary Completion Date (PCD)|Disease progression|73
1199717|NCT00941863|3940760|P4|Until Primary Completion Date (PCD)|Disease progression|14
1199718|NCT00941863|3940761|P3|Until Primary Completion Date (PCD)|Disease progression|8
1199719|NCT00941863|3940762|P2|Until Primary Completion Date (PCD)|Disease progression|1
1199720|NCT00941863|3940763|P1|Until Primary Completion Date (PCD)|Disease progression|6
1199721|NCT00941863|3940759|P5|Until Primary Completion Date (PCD)|Death|7
1199722|NCT00941863|3940760|P4|Until Primary Completion Date (PCD)|Death|2
1199723|NCT00941863|3940761|P3|Until Primary Completion Date (PCD)|Death|1
1199724|NCT00941863|3940762|P2|Until Primary Completion Date (PCD)|Death|0
1199725|NCT00941863|3940763|P1|Until Primary Completion Date (PCD)|Death|0
1199726|NCT00941863|3940759|P5|Until Primary Completion Date (PCD)|Withdrawal by Subject|8
1199727|NCT00941863|3940760|P4|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
1199728|NCT00941863|3940761|P3|Until Primary Completion Date (PCD)|Withdrawal by Subject|1
1199729|NCT00941863|3940762|P2|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
1199730|NCT00941863|3940763|P1|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
1199731|NCT00941863|3940759|P5|Until Primary Completion Date (PCD)|Physician Decision|1
1199732|NCT00941863|3940760|P4|Until Primary Completion Date (PCD)|Physician Decision|0
1199733|NCT00941863|3940761|P3|Until Primary Completion Date (PCD)|Physician Decision|0
1199734|NCT00941863|3940762|P2|Until Primary Completion Date (PCD)|Physician Decision|0
1199735|NCT00941863|3940763|P1|Until Primary Completion Date (PCD)|Physician Decision|0
1199736|NCT00941863|3940759|P5|Until Primary Completion Date (PCD)|Adverse Event|5
1199737|NCT00941863|3940760|P4|Until Primary Completion Date (PCD)|Adverse Event|1
1199738|NCT00941863|3940761|P3|Until Primary Completion Date (PCD)|Adverse Event|2
1199739|NCT00941863|3940762|P2|Until Primary Completion Date (PCD)|Adverse Event|2
1199740|NCT00941863|3940763|P1|Until Primary Completion Date (PCD)|Adverse Event|1
1199741|NCT00941798|3940790|P2|Overall Study|Death|1
1199742|NCT00941798|3940791|P1|Overall Study|Death|0
1199743|NCT00941798|3940790|P2|Overall Study|Abnormal laboratory values|2
1199744|NCT00941798|3940791|P1|Overall Study|Abnormal laboratory values|1
1199745|NCT00941798|3940790|P2|Overall Study|Abnormal test procedure results|1
1199746|NCT00941798|3940791|P1|Overall Study|Abnormal test procedure results|3
1199747|NCT00941798|3940790|P2|Overall Study|Patient's inability to use device|1
1199748|NCT00941798|3940791|P1|Overall Study|Patient's inability to use device|6
1199749|NCT00941798|3940790|P2|Overall Study|Lack of Efficacy|17
1199750|NCT00941798|3940791|P1|Overall Study|Lack of Efficacy|10
1199751|NCT00941798|3940790|P2|Overall Study|Administrative problems|23
1199752|NCT00941798|3940791|P1|Overall Study|Administrative problems|13
1199753|NCT00941798|3940790|P2|Overall Study|Protocol Violation|20
1199754|NCT00941798|3940791|P1|Overall Study|Protocol Violation|17
1199755|NCT00941798|3940790|P2|Overall Study|Lost to Follow-up|23
1199756|NCT00941798|3940791|P1|Overall Study|Lost to Follow-up|29
1199757|NCT00941798|3940790|P2|Overall Study|Adverse Event|23
1199758|NCT00941798|3940791|P1|Overall Study|Adverse Event|43
1199759|NCT00941798|3940790|P2|Overall Study|Withdrawal by Subject|74
1199760|NCT00941798|3940791|P1|Overall Study|Withdrawal by Subject|72
1199761|NCT00941733|3940821|P2|Overall Study|Protocol Violation|6
1199762|NCT00941733|3940822|P1|Overall Study|Protocol Violation|15
1199763|NCT00941733|3940821|P2|Overall Study|Lost to Follow-up|2
1199764|NCT00941733|3940822|P1|Overall Study|Lost to Follow-up|1
1199765|NCT00941733|3940821|P2|Overall Study|Adverse Event|4
1199766|NCT00941733|3940822|P1|Overall Study|Adverse Event|20
1199767|NCT00941733|3940821|P2|Overall Study|Withdrawal by Subject|6
1199768|NCT00941733|3940822|P1|Overall Study|Withdrawal by Subject|14
1199769|NCT00941733|3940821|P2|Overall Study|Death|10
1199770|NCT00941733|3940822|P1|Overall Study|Death|24
1199771|NCT00941720|3940862|P1|Overall Study|ineligible|2
1199772|NCT00941720|3940862|P1|Overall Study|Insurance denied participation|11
1199773|NCT00941720|3940862|P1|Overall Study|Withdrawal by Subject|1
1199774|NCT00941655|3940909|P2|Overall Study|non-compliant|1
1199775|NCT00941655|3940910|P1|Overall Study|non-compliant|0
1199776|NCT00941655|3940909|P2|Overall Study|withdrew consent|1
1199777|NCT00941655|3940910|P1|Overall Study|withdrew consent|0
1199778|NCT00941655|3940909|P2|Overall Study|refused further treatment|1
1199779|NCT00941655|3940910|P1|Overall Study|refused further treatment|0
1199780|NCT00941655|3940909|P2|Overall Study|progressed while on chemo|2
1199781|NCT00941655|3940910|P1|Overall Study|progressed while on chemo|0
1199782|NCT00941655|3940909|P2|Overall Study|not meet criteria for chemo foll surgery|0
1199783|NCT00941655|3940910|P1|Overall Study|not meet criteria for chemo foll surgery|4
1199784|NCT00941655|3940909|P2|Overall Study|received some chemo, 4 and 9 cycles|0
1199785|NCT00941655|3940910|P1|Overall Study|received some chemo, 4 and 9 cycles|1
1199786|NCT00941603|3940935|P6|Overall Study|Did not meet protocol eligibility|0
1199787|NCT00941603|3940936|P5|Overall Study|Did not meet protocol eligibility|0
1199788|NCT00941603|3940937|P4|Overall Study|Did not meet protocol eligibility|0
1199789|NCT00941603|3940938|P3|Overall Study|Did not meet protocol eligibility|0
1199790|NCT00941603|3940939|P2|Overall Study|Did not meet protocol eligibility|0
1199791|NCT00941603|3940940|P1|Overall Study|Did not meet protocol eligibility|1
1199792|NCT00941603|3940935|P6|Overall Study|Protocol Violation|0
1199793|NCT00941603|3940936|P5|Overall Study|Protocol Violation|0
1199794|NCT00941603|3940937|P4|Overall Study|Protocol Violation|0
1199795|NCT00941603|3940938|P3|Overall Study|Protocol Violation|0
1199796|NCT00941603|3940939|P2|Overall Study|Protocol Violation|1
1199797|NCT00941603|3940940|P1|Overall Study|Protocol Violation|0
1199798|NCT00941603|3940935|P6|Overall Study|Withdrawal by Subject|1
1199799|NCT00941603|3940936|P5|Overall Study|Withdrawal by Subject|0
1199800|NCT00941603|3940937|P4|Overall Study|Withdrawal by Subject|2
1199801|NCT00941603|3940938|P3|Overall Study|Withdrawal by Subject|0
1199802|NCT00941603|3940939|P2|Overall Study|Withdrawal by Subject|0
1199803|NCT00941603|3940940|P1|Overall Study|Withdrawal by Subject|0
1199804|NCT00941603|3940935|P6|Overall Study|Lost to Follow-up|2
1199805|NCT00941603|3940936|P5|Overall Study|Lost to Follow-up|0
1199806|NCT00941603|3940937|P4|Overall Study|Lost to Follow-up|1
1199807|NCT00941603|3940938|P3|Overall Study|Lost to Follow-up|0
1199808|NCT00941603|3940939|P2|Overall Study|Lost to Follow-up|0
1199809|NCT00941603|3940940|P1|Overall Study|Lost to Follow-up|0
1199810|NCT00941603|3940935|P6|Overall Study|Adverse Event|0
1199811|NCT00941603|3940936|P5|Overall Study|Adverse Event|4
1199812|NCT00941603|3940937|P4|Overall Study|Adverse Event|1
1199813|NCT00941603|3940938|P3|Overall Study|Adverse Event|5
1199814|NCT00941603|3940939|P2|Overall Study|Adverse Event|15
1199815|NCT00941603|3940940|P1|Overall Study|Adverse Event|10
1199816|NCT00941330|3940962|P2|Overall Study|Physician Decision|2
1199817|NCT00941330|3940963|P1|Overall Study|Physician Decision|0
1199818|NCT00941330|3940962|P2|Overall Study|Other|0
1199819|NCT00941330|3940963|P1|Overall Study|Other|1
1199820|NCT00941304|3940976|P5|Overall Study|Lost to Follow-up|0
1199821|NCT00941304|3940977|P4|Overall Study|Lost to Follow-up|0
1199822|NCT00941304|3940978|P3|Overall Study|Lost to Follow-up|0
1199823|NCT00941304|3940979|P2|Overall Study|Lost to Follow-up|0
1199824|NCT00941304|3940980|P1|Overall Study|Lost to Follow-up|1
1199825|NCT00941070|3941042|P1|Overall Study|Patient non-compliant|1
1199826|NCT00941031|3941062|P7|Maintenance Period|Lack of Efficacy|13
1199827|NCT00941031|3941063|P6|Maintenance Period|Lack of Efficacy|0
1199828|NCT00941031|3941064|P5|Maintenance Period|Lack of Efficacy|0
1199829|NCT00941031|3941065|P4|Maintenance Period|Lack of Efficacy|0
1199830|NCT00941031|3941066|P3|Maintenance Period|Lack of Efficacy|0
1199831|NCT00941031|3941067|P2|Maintenance Period|Lack of Efficacy|0
1199832|NCT00941031|3941068|P1|Maintenance Period|Lack of Efficacy|0
1199833|NCT00941031|3941062|P7|Maintenance Period|Lost to Follow-up|7
1199834|NCT00941031|3941063|P6|Maintenance Period|Lost to Follow-up|2
1199835|NCT00941031|3941064|P5|Maintenance Period|Lost to Follow-up|2
1199836|NCT00941031|3941065|P4|Maintenance Period|Lost to Follow-up|0
1199837|NCT00941031|3941066|P3|Maintenance Period|Lost to Follow-up|0
1199838|NCT00941031|3941067|P2|Maintenance Period|Lost to Follow-up|0
1199839|NCT00941031|3941068|P1|Maintenance Period|Lost to Follow-up|0
1199840|NCT00941031|3941062|P7|Maintenance Period|Adverse Event|8
1199841|NCT00941031|3941063|P6|Maintenance Period|Adverse Event|2
1199842|NCT00941031|3941064|P5|Maintenance Period|Adverse Event|0
1199843|NCT00941031|3941065|P4|Maintenance Period|Adverse Event|0
1199844|NCT00941031|3941066|P3|Maintenance Period|Adverse Event|0
1199845|NCT00941031|3941067|P2|Maintenance Period|Adverse Event|0
1199846|NCT00941031|3941068|P1|Maintenance Period|Adverse Event|0
1199847|NCT00941031|3941062|P7|Maintenance Period|Protocol Violation|1
1199848|NCT00941031|3941063|P6|Maintenance Period|Protocol Violation|0
1199849|NCT00941031|3941064|P5|Maintenance Period|Protocol Violation|0
1199850|NCT00941031|3941065|P4|Maintenance Period|Protocol Violation|0
1199851|NCT00941031|3941066|P3|Maintenance Period|Protocol Violation|0
1199852|NCT00941031|3941067|P2|Maintenance Period|Protocol Violation|0
1199853|NCT00941031|3941068|P1|Maintenance Period|Protocol Violation|0
1199854|NCT00941031|3941062|P7|Maintenance Period|Administrative Problems|1
1199855|NCT00941031|3941063|P6|Maintenance Period|Administrative Problems|0
1199856|NCT00941031|3941064|P5|Maintenance Period|Administrative Problems|1
1199857|NCT00941031|3941065|P4|Maintenance Period|Administrative Problems|0
1199858|NCT00941031|3941066|P3|Maintenance Period|Administrative Problems|0
1199859|NCT00941031|3941067|P2|Maintenance Period|Administrative Problems|0
1199860|NCT00941031|3941068|P1|Maintenance Period|Administrative Problems|0
1199861|NCT00941031|3941062|P7|Maintenance Period|Withdrawal by Subject|13
1199862|NCT00941031|3941063|P6|Maintenance Period|Withdrawal by Subject|2
1199863|NCT00941031|3941064|P5|Maintenance Period|Withdrawal by Subject|6
1199864|NCT00941031|3941065|P4|Maintenance Period|Withdrawal by Subject|0
1199865|NCT00941031|3941066|P3|Maintenance Period|Withdrawal by Subject|0
1199866|NCT00941031|3941067|P2|Maintenance Period|Withdrawal by Subject|0
1199867|NCT00941031|3941068|P1|Maintenance Period|Withdrawal by Subject|0
1199868|NCT00941031|3941062|P7|Induction Period|Adverse Event|0
1199869|NCT00941031|3941063|P6|Induction Period|Adverse Event|0
1199870|NCT00941031|3941064|P5|Induction Period|Adverse Event|0
1199871|NCT00941031|3941065|P4|Induction Period|Adverse Event|2
1199872|NCT00941031|3941066|P3|Induction Period|Adverse Event|3
1199873|NCT00941031|3941067|P2|Induction Period|Adverse Event|0
1199874|NCT00941031|3941068|P1|Induction Period|Adverse Event|1
1199875|NCT00941031|3941062|P7|Induction Period|Adminstative Problems|0
1199876|NCT00941031|3941063|P6|Induction Period|Adminstative Problems|0
1199877|NCT00941031|3941064|P5|Induction Period|Adminstative Problems|0
1199878|NCT00941031|3941065|P4|Induction Period|Adminstative Problems|0
1199879|NCT00941031|3941066|P3|Induction Period|Adminstative Problems|1
1199880|NCT00941031|3941067|P2|Induction Period|Adminstative Problems|1
1199881|NCT00941031|3941068|P1|Induction Period|Adminstative Problems|1
1199882|NCT00941031|3941062|P7|Induction Period|Withdrawal by Subject|0
1199883|NCT00941031|3941063|P6|Induction Period|Withdrawal by Subject|0
1199884|NCT00941031|3941064|P5|Induction Period|Withdrawal by Subject|0
1199885|NCT00941031|3941065|P4|Induction Period|Withdrawal by Subject|2
1199886|NCT00941031|3941066|P3|Induction Period|Withdrawal by Subject|2
1199887|NCT00941031|3941067|P2|Induction Period|Withdrawal by Subject|2
1199888|NCT00941031|3941068|P1|Induction Period|Withdrawal by Subject|1
1199889|NCT00941031|3941062|P7|Induction Period|Lack of Efficacy|0
1199890|NCT00941031|3941063|P6|Induction Period|Lack of Efficacy|0
1199891|NCT00941031|3941064|P5|Induction Period|Lack of Efficacy|0
1199892|NCT00941031|3941065|P4|Induction Period|Lack of Efficacy|5
1199893|NCT00941031|3941066|P3|Induction Period|Lack of Efficacy|0
1199894|NCT00941031|3941067|P2|Induction Period|Lack of Efficacy|1
1199895|NCT00941031|3941068|P1|Induction Period|Lack of Efficacy|2
1199896|NCT00940992|3941094|P3|Overall Study|Lost to Follow-up|1
1199897|NCT00940992|3941095|P2|Overall Study|Lost to Follow-up|1
1199898|NCT00940992|3941096|P1|Overall Study|Lost to Follow-up|0
1199899|NCT00940992|3941094|P3|Overall Study|subject request|0
1199900|NCT00940992|3941095|P2|Overall Study|subject request|1
1199901|NCT00940992|3941096|P1|Overall Study|subject request|2
1199902|NCT00940992|3941094|P3|Overall Study|Adverse Event|1
1199903|NCT00940992|3941095|P2|Overall Study|Adverse Event|0
1199904|NCT00940992|3941096|P1|Overall Study|Adverse Event|2
1199905|NCT00940888|3941125|P1|Overall Study|Lost to Follow-up|6
1199906|NCT00940888|3941125|P1|Overall Study|Withdrawn - Non-Death|364
1199907|NCT00940888|3941125|P1|Overall Study|Death|461
1199908|NCT00940888|3941125|P1|Overall Study|Unsuccessful Implant|4
1199909|NCT00940875|3941132|P2|Post-Study Treatment|Disease Progression|2
1199910|NCT00940875|3941133|P1|Post-Study Treatment|Disease Progression|0
1199911|NCT00940875|3941132|P2|Post-Study Treatment|Death|1
1199912|NCT00940875|3941133|P1|Post-Study Treatment|Death|0
1199913|NCT00940875|3941132|P2|Treatment Phase|Physician Decision|0
1199914|NCT00940875|3941133|P1|Treatment Phase|Physician Decision|1
1199915|NCT00940875|3941132|P2|Treatment Phase|Disease progression|11
1199916|NCT00940875|3941133|P1|Treatment Phase|Disease progression|9
1199917|NCT00940875|3941132|P2|Treatment Phase|Withdrawal by Subject|0
1199918|NCT00940875|3941133|P1|Treatment Phase|Withdrawal by Subject|3
1199919|NCT00940875|3941132|P2|Treatment Phase|Lack of Efficacy|0
1199920|NCT00940875|3941133|P1|Treatment Phase|Lack of Efficacy|1
1199921|NCT00940875|3941132|P2|Treatment Phase|Death|5
1199922|NCT00940875|3941133|P1|Treatment Phase|Death|3
1199923|NCT00940875|3941132|P2|Treatment Phase|Adverse Event|3
1199924|NCT00940875|3941133|P1|Treatment Phase|Adverse Event|9
1199925|NCT00940823|3941153|P2|Overall Study|Lost to Follow-up|20
1199926|NCT00940823|3941154|P1|Overall Study|Lost to Follow-up|27
1199927|NCT00940823|3941153|P2|Overall Study|Death|12
1199928|NCT00940823|3941154|P1|Overall Study|Death|8
1199929|NCT00940498|3941211|P8|Overall Study|Not treated due to disease related pain|0
1199930|NCT00940498|3941212|P7|Overall Study|Not treated due to disease related pain|0
1199931|NCT00940498|3941213|P6|Overall Study|Not treated due to disease related pain|0
1199932|NCT00940498|3941214|P5|Overall Study|Not treated due to disease related pain|1
1199933|NCT00940498|3941215|P4|Overall Study|Not treated due to disease related pain|0
1199934|NCT00940498|3941216|P3|Overall Study|Not treated due to disease related pain|0
1199935|NCT00940498|3941217|P2|Overall Study|Not treated due to disease related pain|0
1199936|NCT00940498|3941218|P1|Overall Study|Not treated due to disease related pain|0
1199937|NCT00940498|3941211|P8|Overall Study|Physician Decision|0
1199938|NCT00940498|3941212|P7|Overall Study|Physician Decision|0
1199939|NCT00940498|3941213|P6|Overall Study|Physician Decision|0
1199940|NCT00940498|3941214|P5|Overall Study|Physician Decision|2
1199941|NCT00940498|3941215|P4|Overall Study|Physician Decision|0
1199942|NCT00940498|3941216|P3|Overall Study|Physician Decision|0
1199943|NCT00940498|3941217|P2|Overall Study|Physician Decision|0
1199944|NCT00940498|3941218|P1|Overall Study|Physician Decision|0
1199945|NCT00940498|3941211|P8|Overall Study|Disease Progression|0
1199946|NCT00940498|3941212|P7|Overall Study|Disease Progression|0
1199947|NCT00940498|3941213|P6|Overall Study|Disease Progression|1
1199948|NCT00940498|3941214|P5|Overall Study|Disease Progression|0
1199949|NCT00940498|3941215|P4|Overall Study|Disease Progression|1
1199950|NCT00940498|3941216|P3|Overall Study|Disease Progression|1
1199951|NCT00940498|3941217|P2|Overall Study|Disease Progression|0
1199952|NCT00940498|3941218|P1|Overall Study|Disease Progression|0
1199953|NCT00940498|3941211|P8|Overall Study|Lost to Follow-up|1
1199954|NCT00940498|3941212|P7|Overall Study|Lost to Follow-up|0
1199955|NCT00940498|3941213|P6|Overall Study|Lost to Follow-up|0
1199956|NCT00940498|3941214|P5|Overall Study|Lost to Follow-up|1
1199957|NCT00940498|3941215|P4|Overall Study|Lost to Follow-up|0
1199958|NCT00940498|3941216|P3|Overall Study|Lost to Follow-up|2
1199959|NCT00940498|3941217|P2|Overall Study|Lost to Follow-up|1
1199960|NCT00940498|3941218|P1|Overall Study|Lost to Follow-up|1
1199961|NCT00940498|3941211|P8|Overall Study|Death|0
1199962|NCT00940498|3941212|P7|Overall Study|Death|1
1199963|NCT00940498|3941213|P6|Overall Study|Death|0
1199964|NCT00940498|3941214|P5|Overall Study|Death|5
1199965|NCT00940498|3941215|P4|Overall Study|Death|1
1199966|NCT00940498|3941216|P3|Overall Study|Death|0
1199967|NCT00940498|3941217|P2|Overall Study|Death|0
1199968|NCT00940498|3941218|P1|Overall Study|Death|2
1199969|NCT00940485|3941336|P2|Overall Study|Others|1
1199970|NCT00940485|3941337|P1|Overall Study|Others|1
1199971|NCT00940485|3941336|P2|Overall Study|Withdrawal by Subject|1
1199972|NCT00940485|3941337|P1|Overall Study|Withdrawal by Subject|1
1199973|NCT00940485|3941336|P2|Overall Study|Adverse Event|0
1199974|NCT00940485|3941337|P1|Overall Study|Adverse Event|8
1199975|NCT00940485|3941336|P2|Overall Study|Lost to Follow-up|3
1199976|NCT00940485|3941337|P1|Overall Study|Lost to Follow-up|2
1199977|NCT00940485|3941336|P2|Overall Study|HBeAb positive at Baseline|2
1199978|NCT00940485|3941337|P1|Overall Study|HBeAb positive at Baseline|3
1199979|NCT00940342|3941375|P3|Overall Study|Adverse Event|1
1199980|NCT00940342|3941376|P2|Overall Study|Adverse Event|2
1199981|NCT00940342|3941377|P1|Overall Study|Adverse Event|0
1199982|NCT00940108|3941406|P4|Overall Study|Diagnosed with H1N1|1
1199983|NCT00940108|3941407|P3|Overall Study|Diagnosed with H1N1|0
1199984|NCT00940108|3941408|P2|Overall Study|Diagnosed with H1N1|0
1199985|NCT00940108|3941409|P1|Overall Study|Diagnosed with H1N1|0
1199986|NCT00940108|3941406|P4|Overall Study|Viral illness after Dose 1|0
1199987|NCT00940108|3941407|P3|Overall Study|Viral illness after Dose 1|0
1199988|NCT00940108|3941408|P2|Overall Study|Viral illness after Dose 1|1
1199989|NCT00940108|3941409|P1|Overall Study|Viral illness after Dose 1|0
1199990|NCT00940108|3941406|P4|Overall Study|Refused - pyrexia after Dose 1|0
1199991|NCT00940108|3941407|P3|Overall Study|Refused - pyrexia after Dose 1|0
1199992|NCT00940108|3941408|P2|Overall Study|Refused - pyrexia after Dose 1|1
1199993|NCT00940108|3941409|P1|Overall Study|Refused - pyrexia after Dose 1|0
1199994|NCT00940108|3941406|P4|Overall Study|Declined further vaccination|0
1199995|NCT00940108|3941407|P3|Overall Study|Declined further vaccination|3
1199996|NCT00940108|3941408|P2|Overall Study|Declined further vaccination|1
1199997|NCT00940108|3941409|P1|Overall Study|Declined further vaccination|0
1199998|NCT00940108|3941406|P4|Overall Study|Dose 2 contraindicated|1
1199999|NCT00940108|3941407|P3|Overall Study|Dose 2 contraindicated|0
1200000|NCT00940108|3941408|P2|Overall Study|Dose 2 contraindicated|1
1200001|NCT00940108|3941409|P1|Overall Study|Dose 2 contraindicated|1
1200002|NCT00940108|3941406|P4|Overall Study|Withdrew Consent|1
1200003|NCT00940108|3941407|P3|Overall Study|Withdrew Consent|0
1200004|NCT00940108|3941408|P2|Overall Study|Withdrew Consent|1
1200005|NCT00940108|3941409|P1|Overall Study|Withdrew Consent|2
1200006|NCT00940108|3941406|P4|Overall Study|Adverse Event|2
1200007|NCT00940108|3941407|P3|Overall Study|Adverse Event|0
1200008|NCT00940108|3941408|P2|Overall Study|Adverse Event|4
1200009|NCT00940108|3941409|P1|Overall Study|Adverse Event|2
1200010|NCT00940017|3941459|P1|Overall Study|Adverse Event|1
1200011|NCT00940017|3941459|P1|Overall Study|did not meet entrance criteria|3
1200012|NCT00939809|3941515|P1|Overall Study|Death|1
1200013|NCT00939809|3941515|P1|Overall Study|Adverse Event|2
1200014|NCT00939783|3941530|P1|Overall Study|Enrolled but not treated|1
1200015|NCT00939783|3941530|P1|Overall Study|Protocol Violation|3
1200016|NCT00939783|3941530|P1|Overall Study|Lost to Follow-up|8
1200017|NCT00939783|3941530|P1|Overall Study|Other|16
1200018|NCT00939783|3941530|P1|Overall Study|Withdrawal by Subject|78
1200019|NCT00939783|3941530|P1|Overall Study|Study Terminated by Sponsor|498
1200020|NCT00939783|3941530|P1|Overall Study|Adverse Event|39
1200021|NCT00939783|3941530|P1|Overall Study|Death|6
1200022|NCT00939692|3941571|P2|Period 2 - Second Intervent - 5 Days|Protocol Violation|1
1200023|NCT00939692|3941572|P1|Period 2 - Second Intervent - 5 Days|Protocol Violation|0
1200024|NCT00939692|3941571|P2|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0
1200025|NCT00939692|3941572|P1|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1
1200026|NCT00939640|3941582|P1|Overall Study|Physician Decision|1
1200027|NCT00939627|3941605|P3|Overall Study|No off-tx reason given|0
1200028|NCT00939627|3941606|P2|Overall Study|No off-tx reason given|2
1200029|NCT00939627|3941607|P1|Overall Study|No off-tx reason given|0
1200030|NCT00939627|3941605|P3|Overall Study|Not compliant|0
1200031|NCT00939627|3941606|P2|Overall Study|Not compliant|0
1200032|NCT00939627|3941607|P1|Overall Study|Not compliant|2
1200033|NCT00939627|3941605|P3|Overall Study|Other complicating disease|0
1200034|NCT00939627|3941606|P2|Overall Study|Other complicating disease|1
1200035|NCT00939627|3941607|P1|Overall Study|Other complicating disease|1
1200036|NCT00939627|3941605|P3|Overall Study|Withdrawal by Subject|0
1200037|NCT00939627|3941606|P2|Overall Study|Withdrawal by Subject|4
1200038|NCT00939627|3941607|P1|Overall Study|Withdrawal by Subject|2
1200039|NCT00939627|3941605|P3|Overall Study|Death|0
1200040|NCT00939627|3941606|P2|Overall Study|Death|2
1200041|NCT00939627|3941607|P1|Overall Study|Death|0
1200042|NCT00939627|3941605|P3|Overall Study|Adverse Event|0
1200043|NCT00939627|3941606|P2|Overall Study|Adverse Event|7
1200044|NCT00939627|3941607|P1|Overall Study|Adverse Event|6
1200045|NCT00939627|3941605|P3|Overall Study|Disease Progression|0
1200046|NCT00939627|3941606|P2|Overall Study|Disease Progression|12
1200047|NCT00939627|3941607|P1|Overall Study|Disease Progression|16
1200048|NCT00939510|3941647|P1|Overall Study|Withdrawal by Subject|1
1200049|NCT00939484|3941656|P3|Overall Study|Progression/Relapse|3
1200050|NCT00939484|3941657|P2|Overall Study|Progression/Relapse|20
1200051|NCT00939484|3941658|P1|Overall Study|Progression/Relapse|8
1200052|NCT00939393|3941684|P2|Overall Study|Lost to Follow-up|0
1200053|NCT00939393|3941685|P1|Overall Study|Lost to Follow-up|3
1200054|NCT00939393|3941684|P2|Overall Study|Withdrawal by Subject|0
1200055|NCT00939393|3941685|P1|Overall Study|Withdrawal by Subject|1
1200056|NCT00939341|3941716|P1|Overall Study|Incorrect enrolment|8
1200057|NCT00939341|3941716|P1|Overall Study|Protocol Violation|6
1200058|NCT00939341|3941716|P1|Overall Study|Withdrawal by Subject|13
1200059|NCT00939341|3941716|P1|Overall Study|Lost to Follow-up|23
1200060|NCT00939341|3941716|P1|Overall Study|Pregnancy|1
1200061|NCT00939341|3941716|P1|Overall Study|Adverse Event|15
1200062|NCT00939185|3941803|P1|Overall Study|Randomized But Did Not Receive Treatment|10
1200063|NCT00939185|3941803|P1|Overall Study|Withdrawal by Subject|2
1200064|NCT00939185|3941803|P1|Overall Study|Other|3
1200065|NCT00939185|3941803|P1|Overall Study|Lost to Follow-up|6
1200066|NCT00939185|3941803|P1|Overall Study|Lack of Efficacy|1
1200067|NCT00939185|3941803|P1|Overall Study|Adverse Event|3
1200068|NCT00939107|3941841|P2|Overall Study|Lost to Follow-up|12
1200069|NCT00939107|3941842|P1|Overall Study|Lost to Follow-up|14
1200070|NCT00939094|3941856|P2|Overall Study|Abnormal ECG findings|0
1200071|NCT00939094|3941857|P1|Overall Study|Abnormal ECG findings|1
1200072|NCT00939094|3941856|P2|Overall Study|Study stopped by sponsor|2
1200073|NCT00939094|3941857|P1|Overall Study|Study stopped by sponsor|0
1200074|NCT00939094|3941856|P2|Overall Study|Severe non-compliance to protocol|1
1200075|NCT00939094|3941857|P1|Overall Study|Severe non-compliance to protocol|0
1200076|NCT00939094|3941856|P2|Overall Study|Eligibility criteria not fulfilled|0
1200077|NCT00939094|3941857|P1|Overall Study|Eligibility criteria not fulfilled|2
1200078|NCT00939094|3941856|P2|Overall Study|Lost to Follow-up|1
1200079|NCT00939094|3941857|P1|Overall Study|Lost to Follow-up|1
1200080|NCT00939094|3941856|P2|Overall Study|Withdrawal by Subject|6
1200081|NCT00939094|3941857|P1|Overall Study|Withdrawal by Subject|1
1200082|NCT00939094|3941856|P2|Overall Study|Adverse Event|0
1200083|NCT00939094|3941857|P1|Overall Study|Adverse Event|9
1200084|NCT00939055|3941879|P2|Overall Study|Discontinuation prior to procedure|0
1200085|NCT00939055|3941880|P1|Overall Study|Discontinuation prior to procedure|4
1200086|NCT00939029|3941890|P2|Overall Study|Adverse Event|1
1200087|NCT00939029|3941891|P1|Overall Study|Adverse Event|0
1200088|NCT00939029|3941890|P2|Overall Study|Lost to Follow-up|4
1200089|NCT00939029|3941891|P1|Overall Study|Lost to Follow-up|3
1200090|NCT00939029|3941890|P2|Overall Study|Withdrawal by Subject|7
1200091|NCT00939029|3941891|P1|Overall Study|Withdrawal by Subject|3
1200092|NCT00939003|3941903|P2|Open-label Treatment Period|Site Closure|4
1200093|NCT00939003|3941904|P1|Open-label Treatment Period|Site Closure|3
1200094|NCT00939003|3941903|P2|Open-label Treatment Period|Exclusion Criteria|0
1200095|NCT00939003|3941904|P1|Open-label Treatment Period|Exclusion Criteria|1
1200096|NCT00939003|3941903|P2|Open-label Treatment Period|Pregnancy|1
1200097|NCT00939003|3941904|P1|Open-label Treatment Period|Pregnancy|1
1200098|NCT00939003|3941903|P2|Open-label Treatment Period|Lack of Efficacy|9
1200099|NCT00939003|3941904|P1|Open-label Treatment Period|Lack of Efficacy|6
1200100|NCT00939003|3941903|P2|Open-label Treatment Period|Withdrawal by Subject|7
1200101|NCT00939003|3941904|P1|Open-label Treatment Period|Withdrawal by Subject|14
1200102|NCT00939003|3941903|P2|Open-label Treatment Period|Adverse Event|8
1200103|NCT00939003|3941904|P1|Open-label Treatment Period|Adverse Event|4
1200104|NCT00939003|3941903|P2|Double-blind Treatment Period|MRI Not Diagnostic|1
1200105|NCT00939003|3941904|P1|Double-blind Treatment Period|MRI Not Diagnostic|1
1200106|NCT00939003|3941903|P2|Double-blind Treatment Period|Pregnancy|1
1200107|NCT00939003|3941904|P1|Double-blind Treatment Period|Pregnancy|0
1200108|NCT00939003|3941903|P2|Double-blind Treatment Period|Lack of Efficacy|1
1200109|NCT00939003|3941904|P1|Double-blind Treatment Period|Lack of Efficacy|0
1200110|NCT00939003|3941903|P2|Double-blind Treatment Period|Adverse Event|1
1200111|NCT00939003|3941904|P1|Double-blind Treatment Period|Adverse Event|1
1200112|NCT00938964|3941941|P2|Overall Study|Found to Meet Exclusion Criteria|4
1200113|NCT00938964|3941942|P1|Overall Study|Found to Meet Exclusion Criteria|3
1200114|NCT00938964|3941941|P2|Overall Study|Withdrawal by Subject|18
1200115|NCT00938964|3941942|P1|Overall Study|Withdrawal by Subject|22
1200116|NCT00938964|3941941|P2|Overall Study|Lost to Follow-up|3
1200117|NCT00938964|3941942|P1|Overall Study|Lost to Follow-up|2
1200118|NCT00938964|3941941|P2|Overall Study|Death|3
1200119|NCT00938964|3941942|P1|Overall Study|Death|3
1200120|NCT00938886|3942006|P2|Overall Study|Lost to Follow-up|2
1200121|NCT00938886|3942007|P1|Overall Study|Lost to Follow-up|3
1200122|NCT00938886|3942006|P2|Overall Study|Withdrawal by Subject|7
1200123|NCT00938886|3942007|P1|Overall Study|Withdrawal by Subject|4
1200124|NCT00938886|3942006|P2|Overall Study|Death|1
1200125|NCT00938886|3942007|P1|Overall Study|Death|0
1200126|NCT00938860|3942017|P2|Overall Study|Protocol Violation|1
1200127|NCT00938860|3942018|P1|Overall Study|Protocol Violation|3
1200128|NCT00938860|3942017|P2|Overall Study|Death|1
1200129|NCT00938860|3942018|P1|Overall Study|Death|1
1200130|NCT00938860|3942017|P2|Overall Study|Administration problems|0
1200131|NCT00938860|3942018|P1|Overall Study|Administration problems|2
1200132|NCT00938860|3942017|P2|Overall Study|Lost to Follow-up|4
1200133|NCT00938860|3942018|P1|Overall Study|Lost to Follow-up|4
1200134|NCT00938860|3942017|P2|Overall Study|Withdrawal by Subject|8
1200135|NCT00938860|3942018|P1|Overall Study|Withdrawal by Subject|11
1200136|NCT00938860|3942017|P2|Overall Study|Abnormal laboratory values|2
1200137|NCT00938860|3942018|P1|Overall Study|Abnormal laboratory values|2
1200138|NCT00938860|3942017|P2|Overall Study|Adverse Event|1
1200139|NCT00938860|3942018|P1|Overall Study|Adverse Event|2
1200140|NCT00938717|3942051|P2|Overall Study|Other reason|2
1200141|NCT00938717|3942052|P1|Overall Study|Other reason|5
1200142|NCT00938717|3942051|P2|Overall Study|Lack of Efficacy|15
1200143|NCT00938717|3942052|P1|Overall Study|Lack of Efficacy|33
1200144|NCT00938717|3942051|P2|Overall Study|Lost to Follow-up|18
1200145|NCT00938717|3942052|P1|Overall Study|Lost to Follow-up|13
1200146|NCT00938717|3942051|P2|Overall Study|Withdrawal by Subject|24
1200147|NCT00938717|3942052|P1|Overall Study|Withdrawal by Subject|26
1200148|NCT00938717|3942051|P2|Overall Study|Protocol Violation|8
1200149|NCT00938717|3942052|P1|Overall Study|Protocol Violation|11
1200150|NCT00938717|3942051|P2|Overall Study|Adverse Event|41
1200151|NCT00938717|3942052|P1|Overall Study|Adverse Event|10
1200152|NCT00938639|3942103|P2|Overall Study|Participant noncompliance|0
1200153|NCT00938639|3942104|P1|Overall Study|Participant noncompliance|1
1200154|NCT00938639|3942103|P2|Overall Study|Family issues|1
1200155|NCT00938639|3942104|P1|Overall Study|Family issues|1
1200156|NCT00938639|3942103|P2|Overall Study|Lost to Follow-up|2
1200157|NCT00938639|3942104|P1|Overall Study|Lost to Follow-up|1
1200158|NCT00938639|3942103|P2|Overall Study|Moved away from study area|1
1200159|NCT00938639|3942104|P1|Overall Study|Moved away from study area|0
1200160|NCT00938470|3942187|P2|Overall Study|Other Reason|1
1200161|NCT00938470|3942188|P1|Overall Study|Other Reason|0
1200162|NCT00938470|3942187|P2|Overall Study|Death|2
1200163|NCT00938470|3942188|P1|Overall Study|Death|3
1200164|NCT00938470|3942187|P2|Overall Study|Alternate Treatment|0
1200165|NCT00938470|3942188|P1|Overall Study|Alternate Treatment|1
1200166|NCT00938470|3942187|P2|Overall Study|Disease Progression|0
1200167|NCT00938470|3942188|P1|Overall Study|Disease Progression|3
1200168|NCT00938431|3942218|P3|Overall Study|Reached maximum dose early|1
1200169|NCT00938431|3942219|P2|Overall Study|Reached maximum dose early|0
1200170|NCT00938431|3942220|P1|Overall Study|Reached maximum dose early|0
1200171|NCT00938431|3942218|P3|Overall Study|Dosing compliance issue|1
1200172|NCT00938431|3942219|P2|Overall Study|Dosing compliance issue|0
1200173|NCT00938431|3942220|P1|Overall Study|Dosing compliance issue|0
1200174|NCT00938431|3942218|P3|Overall Study|Did not up titrate to 12 mg kg/day|0
1200175|NCT00938431|3942219|P2|Overall Study|Did not up titrate to 12 mg kg/day|0
1200176|NCT00938431|3942220|P1|Overall Study|Did not up titrate to 12 mg kg/day|1
1200177|NCT00938431|3942218|P3|Overall Study|Lack of Efficacy|0
1200178|NCT00938431|3942219|P2|Overall Study|Lack of Efficacy|1
1200179|NCT00938431|3942220|P1|Overall Study|Lack of Efficacy|0
1200180|NCT00938431|3942218|P3|Overall Study|Adverse Event|6
1200181|NCT00938431|3942219|P2|Overall Study|Adverse Event|8
1200182|NCT00938431|3942220|P1|Overall Study|Adverse Event|5
1200183|NCT00938392|3942247|P2|Overall Study|Lost to Follow-up|2
1200184|NCT00938392|3942248|P1|Overall Study|Lost to Follow-up|2
1200185|NCT00938392|3942247|P2|Overall Study|Withdrawal by Subject|1
1200186|NCT00938392|3942248|P1|Overall Study|Withdrawal by Subject|0
1200187|NCT00938392|3942247|P2|Overall Study|Adverse Event|1
1200188|NCT00938392|3942248|P1|Overall Study|Adverse Event|0
1200189|NCT00938366|3942274|P2|Overall Study|Withdrawal by Subject|0
1200190|NCT00938366|3942275|P1|Overall Study|Withdrawal by Subject|1
1200191|NCT00938340|3942295|P1|Overall Study|Adverse Event|1
1200192|NCT00938340|3942295|P1|Overall Study|Protocol Violation|1
1200193|NCT00938340|3942295|P1|Overall Study|Withdrawal by Subject|3
1200194|NCT00938327|3942425|P1|Overall Study|Vaccine not received as out of stock|9
1200195|NCT00938327|3942425|P1|Overall Study|2nd dose received outside of the study|7
1200196|NCT00938327|3942425|P1|Overall Study|Lost to Follow-up|37
1200197|NCT00938327|3942425|P1|Overall Study|Withdrawal by Subject|4
1200198|NCT00938327|3942425|P1|Overall Study|Protocol Violation|1
1200199|NCT00938327|3942425|P1|Overall Study|Adverse Event|2
1200200|NCT00938041|3942493|P1|Overall Study|Adrenal Insufficiency|3
1200201|NCT00938041|3942493|P1|Overall Study|Death|12
1200202|NCT00938041|3942493|P1|Overall Study|Progressive Disease|5
1200203|NCT00938041|3942493|P1|Overall Study|Received Alternative Therapy|1
1200204|NCT00938041|3942493|P1|Overall Study|Lost to Follow-up|6
1200205|NCT00938015|3942502|P1|Overall Study|Reason not related to Etanercept|29
1200206|NCT00938015|3942502|P1|Overall Study|Non-responder|52
1200207|NCT00938015|3942502|P1|Overall Study|Adverse Event|32
1200208|NCT00938015|3942502|P1|Overall Study|Lost to Follow-up|32
1200209|NCT00938015|3942502|P1|Overall Study|Death|2
1200210|NCT00937950|3942518|P1|Overall Study|Others|18
1200211|NCT00937950|3942518|P1|Overall Study|Missing confirmed|4
1200212|NCT00937950|3942518|P1|Overall Study|Lost to Follow-up|144
1200213|NCT00937950|3942518|P1|Overall Study|Migrated/moved from study area|27
1200214|NCT00937950|3942518|P1|Overall Study|Withdrawal by Subject|23
1200215|NCT00937937|3942534|P1|Overall Study|Not specified|2
1200216|NCT00937937|3942534|P1|Overall Study|Death|1
1200217|NCT00937937|3942534|P1|Overall Study|Progression/relapse|61
1200218|NCT00937937|3942534|P1|Overall Study|Withdrawal by Subject|2
1200219|NCT00937937|3942534|P1|Overall Study|Adverse Event|6
1200220|NCT00937833|3942543|P2|Overall Study|Withdrawal by Subject|6
1200221|NCT00937833|3942544|P1|Overall Study|Withdrawal by Subject|4
1200222|NCT00937833|3942543|P2|Overall Study|Lost to Follow-up|8
1200223|NCT00937833|3942544|P1|Overall Study|Lost to Follow-up|10
1200224|NCT00937833|3942543|P2|Overall Study|Procedure delayed; enrollment closed|1
1200225|NCT00937833|3942544|P1|Overall Study|Procedure delayed; enrollment closed|0
1200226|NCT00937833|3942543|P2|Overall Study|Protocol Violation|2
1200227|NCT00937833|3942544|P1|Overall Study|Protocol Violation|1
1200228|NCT00937768|3942557|P2|Overall Study|No Further Funding|4
1200229|NCT00937768|3942558|P1|Overall Study|No Further Funding|4
1200230|NCT00937768|3942557|P2|Overall Study|Alternate Treatment|1
1200231|NCT00937768|3942558|P1|Overall Study|Alternate Treatment|0
1200232|NCT00937768|3942557|P2|Overall Study|Disease Progression|1
1200233|NCT00937768|3942558|P1|Overall Study|Disease Progression|1
1200234|NCT00937768|3942557|P2|Overall Study|Refused Further Treatment|2
1200235|NCT00937768|3942558|P1|Overall Study|Refused Further Treatment|3
1200236|NCT00937560|3942564|P1|Maintenance Treatment|According to protocol|1
1200237|NCT00937560|3942564|P1|Maintenance Treatment|Withdraw consent|5
1200238|NCT00937560|3942564|P1|Maintenance Treatment|Death|12
1200239|NCT00937560|3942564|P1|Initial Treatment|No end of study page|10
1200240|NCT00937560|3942564|P1|Initial Treatment|Lost to Follow-up|1
1200241|NCT00937560|3942564|P1|Initial Treatment|Adverse Event|1
1200242|NCT00937560|3942564|P1|Initial Treatment|Withdraw consent|3
1200243|NCT00937560|3942564|P1|Initial Treatment|Death|6
1200244|NCT00937547|3942575|P3|Overall Study|misdiagnosis|7
1200245|NCT00937547|3942576|P2|Overall Study|misdiagnosis|6
1200246|NCT00937547|3942577|P1|Overall Study|misdiagnosis|1
1200247|NCT00937521|3942614|P8|Booster Phase|Protocol Deviation|0
1200248|NCT00937521|3942615|P7|Booster Phase|Protocol Deviation|1
1200249|NCT00937521|3942616|P6|Booster Phase|Protocol Deviation|0
1200250|NCT00937521|3942617|P5|Booster Phase|Protocol Deviation|0
1200251|NCT00937521|3942618|P4|Booster Phase|Protocol Deviation|0
1200252|NCT00937521|3942619|P3|Booster Phase|Protocol Deviation|0
1200253|NCT00937521|3942620|P2|Booster Phase|Protocol Deviation|0
1200254|NCT00937521|3942621|P1|Booster Phase|Protocol Deviation|0
1200255|NCT00937521|3942614|P8|Booster Phase|Administrative Reason|0
1200256|NCT00937521|3942615|P7|Booster Phase|Administrative Reason|0
1200257|NCT00937521|3942616|P6|Booster Phase|Administrative Reason|1
1200258|NCT00937521|3942617|P5|Booster Phase|Administrative Reason|1
1200259|NCT00937521|3942618|P4|Booster Phase|Administrative Reason|0
1200260|NCT00937521|3942619|P3|Booster Phase|Administrative Reason|1
1200261|NCT00937521|3942620|P2|Booster Phase|Administrative Reason|0
1200262|NCT00937521|3942621|P1|Booster Phase|Administrative Reason|0
1200263|NCT00937521|3942614|P8|Booster Phase|Lost to Follow-up|0
1200264|NCT00937521|3942615|P7|Booster Phase|Lost to Follow-up|3
1200265|NCT00937521|3942616|P6|Booster Phase|Lost to Follow-up|4
1200266|NCT00937521|3942617|P5|Booster Phase|Lost to Follow-up|4
1200267|NCT00937521|3942618|P4|Booster Phase|Lost to Follow-up|2
1200268|NCT00937521|3942619|P3|Booster Phase|Lost to Follow-up|4
1200269|NCT00937521|3942620|P2|Booster Phase|Lost to Follow-up|2
1200270|NCT00937521|3942621|P1|Booster Phase|Lost to Follow-up|2
1200271|NCT00937521|3942614|P8|Booster Phase|Withdrawal by Subject|2
1200272|NCT00937521|3942615|P7|Booster Phase|Withdrawal by Subject|0
1200273|NCT00937521|3942616|P6|Booster Phase|Withdrawal by Subject|0
1200274|NCT00937521|3942617|P5|Booster Phase|Withdrawal by Subject|0
1200275|NCT00937521|3942618|P4|Booster Phase|Withdrawal by Subject|1
1200276|NCT00937521|3942619|P3|Booster Phase|Withdrawal by Subject|0
1200277|NCT00937521|3942620|P2|Booster Phase|Withdrawal by Subject|0
1200278|NCT00937521|3942621|P1|Booster Phase|Withdrawal by Subject|1
1200279|NCT00937521|3942614|P8|Booster Phase|Adverse Event|0
1200280|NCT00937521|3942615|P7|Booster Phase|Adverse Event|1
1200281|NCT00937521|3942616|P6|Booster Phase|Adverse Event|0
1200282|NCT00937521|3942617|P5|Booster Phase|Adverse Event|0
1200283|NCT00937521|3942618|P4|Booster Phase|Adverse Event|0
1200284|NCT00937521|3942619|P3|Booster Phase|Adverse Event|0
1200285|NCT00937521|3942620|P2|Booster Phase|Adverse Event|0
1200286|NCT00937521|3942621|P1|Booster Phase|Adverse Event|0
1200287|NCT00937521|3942614|P8|Overall Study - Prior to Booster Dose|Protocol Deviation|0
1200288|NCT00937521|3942615|P7|Overall Study - Prior to Booster Dose|Protocol Deviation|1
1200289|NCT00937521|3942616|P6|Overall Study - Prior to Booster Dose|Protocol Deviation|0
1200290|NCT00937521|3942617|P5|Overall Study - Prior to Booster Dose|Protocol Deviation|0
1200291|NCT00937521|3942618|P4|Overall Study - Prior to Booster Dose|Protocol Deviation|0
1200292|NCT00937521|3942619|P3|Overall Study - Prior to Booster Dose|Protocol Deviation|0
1200293|NCT00937521|3942620|P2|Overall Study - Prior to Booster Dose|Protocol Deviation|0
1200294|NCT00937521|3942621|P1|Overall Study - Prior to Booster Dose|Protocol Deviation|1
1200295|NCT00937521|3942614|P8|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
1200296|NCT00937521|3942615|P7|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
1200297|NCT00937521|3942616|P6|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
1200298|NCT00937521|3942617|P5|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2
1200299|NCT00937521|3942618|P4|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
1200300|NCT00937521|3942619|P3|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
1200301|NCT00937521|3942620|P2|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4
1200302|NCT00937521|3942621|P1|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
1200303|NCT00937521|3942614|P8|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
1200304|NCT00937521|3942615|P7|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
1200305|NCT00937521|3942616|P6|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
1200306|NCT00937521|3942617|P5|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
1200307|NCT00937521|3942618|P4|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
1200308|NCT00937521|3942619|P3|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
1200309|NCT00937521|3942620|P2|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
1200310|NCT00937521|3942621|P1|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
1200311|NCT00937521|3942614|P8|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
1200312|NCT00937521|3942615|P7|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
1200313|NCT00937521|3942616|P6|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
1200314|NCT00937521|3942617|P5|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
1200315|NCT00937521|3942618|P4|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
1200316|NCT00937521|3942619|P3|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3
1200317|NCT00937521|3942620|P2|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
1200318|NCT00937521|3942621|P1|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
1200319|NCT00937521|3942614|P8|Overall Study - Prior to Booster Dose|Adverse Event|0
1200320|NCT00937521|3942615|P7|Overall Study - Prior to Booster Dose|Adverse Event|1
1200321|NCT00937521|3942616|P6|Overall Study - Prior to Booster Dose|Adverse Event|0
1200322|NCT00937521|3942617|P5|Overall Study - Prior to Booster Dose|Adverse Event|0
1200323|NCT00937521|3942618|P4|Overall Study - Prior to Booster Dose|Adverse Event|0
1200324|NCT00937521|3942619|P3|Overall Study - Prior to Booster Dose|Adverse Event|2
1200325|NCT00937521|3942620|P2|Overall Study - Prior to Booster Dose|Adverse Event|0
1200326|NCT00937521|3942621|P1|Overall Study - Prior to Booster Dose|Adverse Event|0
1200327|NCT00937495|3942727|P1|Overall Study|Protocol Violation|2
1200328|NCT00937404|3942733|P1|Overall Study|Withdrawal by Subject|1
1200329|NCT00937404|3942733|P1|Overall Study|Protocol Violation|1
1200330|NCT00937391|3942742|P1|Stage 2|Withdrawal by Subject|1
1200331|NCT00937326|3942798|P5|Overall Study|Chest X-ray showed a suspicious shadow|0
1200332|NCT00937326|3942799|P4|Overall Study|Chest X-ray showed a suspicious shadow|0
1200333|NCT00937326|3942800|P3|Overall Study|Chest X-ray showed a suspicious shadow|1
1200334|NCT00937326|3942801|P2|Overall Study|Chest X-ray showed a suspicious shadow|0
1200335|NCT00937326|3942802|P1|Overall Study|Chest X-ray showed a suspicious shadow|0
1200336|NCT00937326|3942798|P5|Overall Study|Withdrawal by Subject|3
1200337|NCT00937326|3942799|P4|Overall Study|Withdrawal by Subject|4
1200338|NCT00937326|3942800|P3|Overall Study|Withdrawal by Subject|1
1200339|NCT00937326|3942801|P2|Overall Study|Withdrawal by Subject|4
1200340|NCT00937326|3942802|P1|Overall Study|Withdrawal by Subject|3
1200341|NCT00937326|3942798|P5|Overall Study|Death|0
1200342|NCT00937326|3942799|P4|Overall Study|Death|0
1200343|NCT00937326|3942800|P3|Overall Study|Death|1
1200344|NCT00937326|3942801|P2|Overall Study|Death|0
1200345|NCT00937326|3942802|P1|Overall Study|Death|0
1200346|NCT00937326|3942798|P5|Overall Study|Adverse Event|2
1200347|NCT00937326|3942799|P4|Overall Study|Adverse Event|1
1200348|NCT00937326|3942800|P3|Overall Study|Adverse Event|1
1200349|NCT00937326|3942801|P2|Overall Study|Adverse Event|3
1200350|NCT00937326|3942802|P1|Overall Study|Adverse Event|0
1200351|NCT00937157|3943051|P1|Overall Study|Lost to Follow-up|3
1200352|NCT00937157|3943051|P1|Overall Study|Pregnancy|1
1200353|NCT00937040|3943082|P2|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8
1200354|NCT00937040|3943083|P1|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5
1200355|NCT00937040|3943082|P2|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2
1200356|NCT00937040|3943083|P1|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3
1200357|NCT00937040|3943082|P2|Overall Study|Withdrawal by Subject|7
1200358|NCT00937040|3943083|P1|Overall Study|Withdrawal by Subject|13
1200359|NCT00937040|3943082|P2|Overall Study|Protocol Violation|0
1200360|NCT00937040|3943083|P1|Overall Study|Protocol Violation|3
1200361|NCT00937040|3943082|P2|Overall Study|Lost to Follow-up|12
1200362|NCT00937040|3943083|P1|Overall Study|Lost to Follow-up|12
1200363|NCT00937040|3943082|P2|Overall Study|Adverse Event|8
1200364|NCT00937040|3943083|P1|Overall Study|Adverse Event|5
1200365|NCT00936975|3943125|P1|Overall Study|Post-Tx scan uninterpretable|2
1200366|NCT00936975|3943125|P1|Overall Study|Disease progression|3
1200367|NCT00936975|3943125|P1|Overall Study|Withdrawal by Subject|1
1200368|NCT00936910|3943134|P1|Overall Study|Lack of Efficacy|3
1200369|NCT00936897|3943143|P2|Overall Study|Death|1
1200370|NCT00936897|3943144|P1|Overall Study|Death|0
1200371|NCT00936897|3943143|P2|Overall Study|Noncompliance|2
1200372|NCT00936897|3943144|P1|Overall Study|Noncompliance|0
1200373|NCT00936897|3943143|P2|Overall Study|Ineligibility Determined|3
1200374|NCT00936897|3943144|P1|Overall Study|Ineligibility Determined|0
1200375|NCT00936897|3943143|P2|Overall Study|Protocol Violation|1
1200376|NCT00936897|3943144|P1|Overall Study|Protocol Violation|1
1200377|NCT00936897|3943143|P2|Overall Study|Administrative Decision|2
1200378|NCT00936897|3943144|P1|Overall Study|Administrative Decision|1
1200379|NCT00936897|3943143|P2|Overall Study|Lost to Follow-up|10
1200380|NCT00936897|3943144|P1|Overall Study|Lost to Follow-up|1
1200381|NCT00936897|3943143|P2|Overall Study|Other|9
1200382|NCT00936897|3943144|P1|Overall Study|Other|3
1200383|NCT00936897|3943143|P2|Overall Study|Adverse Event|13
1200384|NCT00936897|3943144|P1|Overall Study|Adverse Event|4
1200385|NCT00936897|3943143|P2|Overall Study|Withdrawal by Subject|19
1200386|NCT00936897|3943144|P1|Overall Study|Withdrawal by Subject|9
1200387|NCT00936715|3943161|P1|Overall Study|Safety or Tolerability Reasons|4
1200388|NCT00936715|3943161|P1|Overall Study|Protocol Violation|1
1200389|NCT00936715|3943161|P1|Overall Study|Investigators Discretion|1
1200390|NCT00936702|3943165|P1|Overall Study|Other|1
1200391|NCT00936702|3943165|P1|Overall Study|Alternative Treatment|1
1200392|NCT00936702|3943165|P1|Overall Study|Withdrawal by Subject|2
1200393|NCT00936702|3943165|P1|Overall Study|Adverse Event|8
1200394|NCT00936702|3943165|P1|Overall Study|Disease progression|34
1200395|NCT00936598|3943198|P2|Overall Study|Ineligible after consent|0
1200396|NCT00936598|3943199|P1|Overall Study|Ineligible after consent|1
1200397|NCT00936598|3943198|P2|Overall Study|Withdrawal by Subject|0
1200398|NCT00936598|3943199|P1|Overall Study|Withdrawal by Subject|1
1200399|NCT00936221|3943288|P2|Overall Study|Withdrawal by Subject|1
1200400|NCT00936221|3943289|P1|Overall Study|Withdrawal by Subject|1
1200401|NCT00936208|3943303|P2|Overall Study|Protocol Violation|22
1200402|NCT00936208|3943304|P1|Overall Study|Protocol Violation|37
1200403|NCT00936117|3943322|P1|Overall Study|Unable to continue oral medication|3
1200404|NCT00936117|3943322|P1|Overall Study|Adverse Event|7
1200405|NCT00936065|3943330|P3|Overall Study|Withdrawal by Subject|4
1200406|NCT00936065|3943331|P2|Overall Study|Withdrawal by Subject|2
1200407|NCT00936065|3943332|P1|Overall Study|Withdrawal by Subject|0
1200408|NCT00936065|3943330|P3|Overall Study|Protocol Violation|1
1200409|NCT00936065|3943331|P2|Overall Study|Protocol Violation|2
1200410|NCT00936065|3943332|P1|Overall Study|Protocol Violation|1
1200411|NCT00936065|3943330|P3|Overall Study|Lost to Follow-up|0
1200412|NCT00936065|3943331|P2|Overall Study|Lost to Follow-up|0
1200413|NCT00936065|3943332|P1|Overall Study|Lost to Follow-up|1
1200414|NCT00936065|3943330|P3|Overall Study|Lack of Efficacy|1
1200415|NCT00936065|3943331|P2|Overall Study|Lack of Efficacy|0
1200416|NCT00936065|3943332|P1|Overall Study|Lack of Efficacy|1
1200417|NCT00936065|3943330|P3|Overall Study|Adverse Event|1
1200418|NCT00936065|3943331|P2|Overall Study|Adverse Event|0
1200419|NCT00936065|3943332|P1|Overall Study|Adverse Event|1
1200420|NCT00935883|3943438|P2|Treatment Period|Withdrawal by Subject|2
1200421|NCT00935883|3943439|P1|Treatment Period|Withdrawal by Subject|0
1200422|NCT00935883|3943438|P2|Treatment Period|Physician Decision|0
1200423|NCT00935883|3943439|P1|Treatment Period|Physician Decision|1
1200424|NCT00935818|3943466|P2|Overall Study|Physician Decision|1
1200425|NCT00935818|3943467|P1|Overall Study|Physician Decision|0
1200426|NCT00935818|3943466|P2|Overall Study|Adverse Event|7
1200427|NCT00935818|3943467|P1|Overall Study|Adverse Event|6
1200428|NCT00935818|3943466|P2|Overall Study|Lost to Follow-up|42
1200429|NCT00935818|3943467|P1|Overall Study|Lost to Follow-up|40
1200430|NCT00935818|3943466|P2|Overall Study|Withdrawal by Subject|50
1200431|NCT00935818|3943467|P1|Overall Study|Withdrawal by Subject|45
1200432|NCT00935701|3943518|P1|Overall Study|Failure to Transition to Acupuncture|1
1200433|NCT00935584|3943535|P2|Overall Study|Provider dropped out of study|4
1200434|NCT00935584|3943536|P1|Overall Study|Provider dropped out of study|14
1200435|NCT00935584|3943535|P2|Overall Study|Patient changed provider|0
1200436|NCT00935584|3943536|P1|Overall Study|Patient changed provider|3
1200437|NCT00935584|3943535|P2|Overall Study|Relocated|0
1200438|NCT00935584|3943536|P1|Overall Study|Relocated|3
1200439|NCT00935584|3943535|P2|Overall Study|No show|0
1200440|NCT00935584|3943536|P1|Overall Study|No show|9
1200441|NCT00935584|3943535|P2|Overall Study|Lost to Follow-up|0
1200442|NCT00935584|3943536|P1|Overall Study|Lost to Follow-up|8
1200443|NCT00935584|3943535|P2|Overall Study|Death|0
1200444|NCT00935584|3943536|P1|Overall Study|Death|3
1200445|NCT00935584|3943535|P2|Overall Study|Withdrawal by Subject|0
1200446|NCT00935584|3943536|P1|Overall Study|Withdrawal by Subject|9
1200447|NCT00935532|3943548|P2|Overall Study|Loss Glucose Control|0
1200448|NCT00935532|3943549|P1|Overall Study|Loss Glucose Control|4
1200449|NCT00935532|3943548|P2|Overall Study|Sponsor Decision|1
1200450|NCT00935532|3943549|P1|Overall Study|Sponsor Decision|0
1200451|NCT00935532|3943548|P2|Overall Study|Subject Decision|1
1200452|NCT00935532|3943549|P1|Overall Study|Subject Decision|2
1200453|NCT00935532|3943548|P2|Overall Study|Protocol Violation|1
1200454|NCT00935532|3943549|P1|Overall Study|Protocol Violation|2
1200455|NCT00935532|3943548|P2|Overall Study|Physician Decision|2
1200456|NCT00935532|3943549|P1|Overall Study|Physician Decision|1
1200457|NCT00935532|3943548|P2|Overall Study|Lost to Follow-up|0
1200458|NCT00935532|3943549|P1|Overall Study|Lost to Follow-up|1
1200459|NCT00935532|3943548|P2|Overall Study|Death|0
1200460|NCT00935532|3943549|P1|Overall Study|Death|1
1200461|NCT00935532|3943548|P2|Overall Study|Adverse Event|6
1200462|NCT00935532|3943549|P1|Overall Study|Adverse Event|11
1200463|NCT00935493|3943578|P3|Overall Study|Treatment Discontinued|0
1200464|NCT00935493|3943579|P2|Overall Study|Treatment Discontinued|1
1200465|NCT00935493|3943580|P1|Overall Study|Treatment Discontinued|0
1200466|NCT00935493|3943578|P3|Overall Study|Lost to Follow-up|1
1200467|NCT00935493|3943579|P2|Overall Study|Lost to Follow-up|1
1200468|NCT00935493|3943580|P1|Overall Study|Lost to Follow-up|1
1200469|NCT00935272|3943618|P2|Overall Study|Protocol Violation|1
1200470|NCT00935272|3943619|P1|Overall Study|Protocol Violation|0
1200471|NCT00935272|3943618|P2|Overall Study|Physician Decision|0
1200472|NCT00935272|3943619|P1|Overall Study|Physician Decision|1
1200473|NCT00935272|3943618|P2|Overall Study|Withdrawal by Subject|2
1200474|NCT00935272|3943619|P1|Overall Study|Withdrawal by Subject|8
1200475|NCT00935272|3943618|P2|Overall Study|Lost to Follow-up|3
1200476|NCT00935272|3943619|P1|Overall Study|Lost to Follow-up|10
1200477|NCT00935259|3943628|P2|Period 1|Administrative (scheduling conflict)|1
1200478|NCT00935259|3943629|P1|Period 1|Administrative (scheduling conflict)|1
1200479|NCT00935220|3943643|P1|Overall Study|Other reason (not specified)|1
1200480|NCT00935220|3943643|P1|Overall Study|Adverse Event|1
1200481|NCT00934947|3943674|P2|Overall Study|Adverse Event|2
1200482|NCT00934947|3943675|P1|Overall Study|Adverse Event|0
1200483|NCT00934856|3943704|P6|Extension Part|Non-compliance with drug|1
1200484|NCT00934856|3943705|P5|Extension Part|Non-compliance with drug|0
1200485|NCT00934856|3943706|P4|Extension Part|Non-compliance with drug|0
1200486|NCT00934856|3943707|P3|Extension Part|Non-compliance with drug|0
1200487|NCT00934856|3943708|P2|Extension Part|Non-compliance with drug|0
1200488|NCT00934856|3943709|P1|Extension Part|Non-compliance with drug|0
1200489|NCT00934856|3943704|P6|Extension Part|Progressive disease|0
1200490|NCT00934856|3943705|P5|Extension Part|Progressive disease|0
1200491|NCT00934856|3943706|P4|Extension Part|Progressive disease|1
1200492|NCT00934856|3943707|P3|Extension Part|Progressive disease|0
1200493|NCT00934856|3943708|P2|Extension Part|Progressive disease|0
1200494|NCT00934856|3943709|P1|Extension Part|Progressive disease|0
1200495|NCT00934856|3943704|P6|Extension Part|Adverse Event|4
1200496|NCT00934856|3943705|P5|Extension Part|Adverse Event|4
1200497|NCT00934856|3943706|P4|Extension Part|Adverse Event|1
1200498|NCT00934856|3943707|P3|Extension Part|Adverse Event|0
1200499|NCT00934856|3943708|P2|Extension Part|Adverse Event|0
1200500|NCT00934856|3943709|P1|Extension Part|Adverse Event|0
1200501|NCT00934856|3943704|P6|Feasibility Part|Withdrawal by Subject|1
1200502|NCT00934856|3943705|P5|Feasibility Part|Withdrawal by Subject|0
1200503|NCT00934856|3943706|P4|Feasibility Part|Withdrawal by Subject|1
1200504|NCT00934856|3943707|P3|Feasibility Part|Withdrawal by Subject|0
1200505|NCT00934856|3943708|P2|Feasibility Part|Withdrawal by Subject|0
1200506|NCT00934856|3943709|P1|Feasibility Part|Withdrawal by Subject|0
1200507|NCT00934856|3943704|P6|Feasibility Part|Adverse Event|2
1200508|NCT00934856|3943705|P5|Feasibility Part|Adverse Event|0
1200509|NCT00934856|3943706|P4|Feasibility Part|Adverse Event|1
1200510|NCT00934856|3943707|P3|Feasibility Part|Adverse Event|0
1200511|NCT00934856|3943708|P2|Feasibility Part|Adverse Event|1
1200512|NCT00934856|3943709|P1|Feasibility Part|Adverse Event|1
1200513|NCT00934856|3943704|P6|Feasibility Part|Physician Decision|0
1200514|NCT00934856|3943705|P5|Feasibility Part|Physician Decision|0
1200515|NCT00934856|3943706|P4|Feasibility Part|Physician Decision|0
1200516|NCT00934856|3943707|P3|Feasibility Part|Physician Decision|1
1200517|NCT00934856|3943708|P2|Feasibility Part|Physician Decision|0
1200518|NCT00934856|3943709|P1|Feasibility Part|Physician Decision|0
1200519|NCT00934856|3943704|P6|Feasibility Part|Progressive disease|0
1200520|NCT00934856|3943705|P5|Feasibility Part|Progressive disease|0
1200521|NCT00934856|3943706|P4|Feasibility Part|Progressive disease|3
1200522|NCT00934856|3943707|P3|Feasibility Part|Progressive disease|2
1200523|NCT00934856|3943708|P2|Feasibility Part|Progressive disease|4
1200524|NCT00934856|3943709|P1|Feasibility Part|Progressive disease|4
1200525|NCT00934843|3943807|P2|Overall Study|Protocol Violation|1
1200526|NCT00934843|3943808|P1|Overall Study|Protocol Violation|0
1200527|NCT00934791|3943824|P2|Overall Study|Withdrawal by Subject|0
1200528|NCT00934791|3943825|P1|Overall Study|Withdrawal by Subject|1
1200529|NCT00934661|3943833|P2|Overall Study|Failure of Combined/Spinal Epidural|0
1200530|NCT00934661|3943834|P1|Overall Study|Failure of Combined/Spinal Epidural|1
1200531|NCT00934648|3943854|P1|Overall Study|Withdrawal by Subject|1
1200532|NCT00934648|3943854|P1|Overall Study|Failure to return|8
1200533|NCT00934622|3943898|P1|Overall Study|2nd Intraoperative exclusion criteria|1
1200534|NCT00934622|3943898|P1|Overall Study|Lost to Follow-up|7
1200535|NCT00934544|3943936|P2|Overall Study|Entered Extension phase INC424|18
1200536|NCT00934544|3943937|P1|Overall Study|Entered Extension phase INC424|29
1200537|NCT00934544|3943936|P2|Overall Study|Other Reasons|7
1200538|NCT00934544|3943937|P1|Overall Study|Other Reasons|7
1200539|NCT00934544|3943936|P2|Overall Study|Non-compliance with study procedures|1
1200540|NCT00934544|3943937|P1|Overall Study|Non-compliance with study procedures|0
1200541|NCT00934544|3943936|P2|Overall Study|Non-compliance with study Medication|0
1200542|NCT00934544|3943937|P1|Overall Study|Non-compliance with study Medication|2
1200543|NCT00934544|3943936|P2|Overall Study|Disease Progression|3
1200544|NCT00934544|3943937|P1|Overall Study|Disease Progression|1
1200545|NCT00934544|3943936|P2|Overall Study|Protocol Violation|0
1200546|NCT00934544|3943937|P1|Overall Study|Protocol Violation|2
1200547|NCT00934544|3943936|P2|Overall Study|Withdrawal by Subject|9
1200548|NCT00934544|3943937|P1|Overall Study|Withdrawal by Subject|2
1200549|NCT00934544|3943936|P2|Overall Study|Adverse Event|4
1200550|NCT00934544|3943937|P1|Overall Study|Adverse Event|12
1200551|NCT00934440|3943951|P1|Overall Study|Lost to Follow-up|1
1200552|NCT00934362|3943967|P2|Overall Study|Adverse Event|0
1200553|NCT00934362|3943968|P1|Overall Study|Adverse Event|1
1200554|NCT00934128|3944018|P2|Second Intervention (2 Hours)|Claustrophobia/anxiety|3
1200555|NCT00934128|3944019|P1|Second Intervention (2 Hours)|Claustrophobia/anxiety|0
1200556|NCT00934128|3944018|P2|Washout Period (1 Hour)|Dyspnea too low to continue|2
1200557|NCT00934128|3944019|P1|Washout Period (1 Hour)|Dyspnea too low to continue|4
1200558|NCT00934128|3944018|P2|Washout Period (1 Hour)|Too tired|0
1200559|NCT00934128|3944019|P1|Washout Period (1 Hour)|Too tired|1
1200560|NCT00934128|3944018|P2|Washout Period (1 Hour)|Pain|0
1200561|NCT00934128|3944019|P1|Washout Period (1 Hour)|Pain|1
1200562|NCT00934128|3944018|P2|Washout Period (1 Hour)|Patient preference|3
1200563|NCT00934128|3944019|P1|Washout Period (1 Hour)|Patient preference|1
1200564|NCT00934128|3944018|P2|First Intervention (2 Hours)|Treatment Delivery Order Switched|0
1200565|NCT00934128|3944019|P1|First Intervention (2 Hours)|Treatment Delivery Order Switched|1
1200566|NCT00934128|3944018|P2|First Intervention (2 Hours)|Adverse Event|1
1200567|NCT00934128|3944019|P1|First Intervention (2 Hours)|Adverse Event|4
1200568|NCT00934128|3944018|P2|First Intervention (2 Hours)|Withdrawal by Subject|1
1200569|NCT00934128|3944019|P1|First Intervention (2 Hours)|Withdrawal by Subject|0
1200570|NCT00934102|3944027|P3|Period 1, One Night of Wear|Personal Reasons|0
1200571|NCT00934102|3944028|P2|Period 1, One Night of Wear|Personal Reasons|0
1200572|NCT00934102|3944029|P1|Period 1, One Night of Wear|Personal Reasons|1
1200573|NCT00934050|3944043|P6|Enrolled After 15 Dec 2009|Withdrawal by Subject|2
1200574|NCT00934050|3944044|P5|Enrolled After 15 Dec 2009|Withdrawal by Subject|4
1200575|NCT00934050|3944045|P4|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
1200576|NCT00934050|3944046|P3|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
1200577|NCT00934050|3944047|P2|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
1200578|NCT00934050|3944048|P1|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
1200579|NCT00934050|3944043|P6|Enrolled After 15 Dec 2009|Lost to Follow-up|1
1200580|NCT00934050|3944044|P5|Enrolled After 15 Dec 2009|Lost to Follow-up|0
1200581|NCT00934050|3944045|P4|Enrolled After 15 Dec 2009|Lost to Follow-up|0
1200582|NCT00934050|3944046|P3|Enrolled After 15 Dec 2009|Lost to Follow-up|0
1200583|NCT00934050|3944047|P2|Enrolled After 15 Dec 2009|Lost to Follow-up|0
1200584|NCT00934050|3944048|P1|Enrolled After 15 Dec 2009|Lost to Follow-up|0
1200585|NCT00934050|3944043|P6|Enrolled After 15 Dec 2009|Death|1
1200586|NCT00934050|3944044|P5|Enrolled After 15 Dec 2009|Death|0
1200587|NCT00934050|3944045|P4|Enrolled After 15 Dec 2009|Death|0
1200588|NCT00934050|3944046|P3|Enrolled After 15 Dec 2009|Death|0
1200589|NCT00934050|3944047|P2|Enrolled After 15 Dec 2009|Death|0
1200590|NCT00934050|3944048|P1|Enrolled After 15 Dec 2009|Death|0
1200591|NCT00934050|3944043|P6|Enrolled After 15 Dec 2009|Adverse Event|0
1200592|NCT00934050|3944044|P5|Enrolled After 15 Dec 2009|Adverse Event|3
1200593|NCT00934050|3944045|P4|Enrolled After 15 Dec 2009|Adverse Event|0
1200594|NCT00934050|3944046|P3|Enrolled After 15 Dec 2009|Adverse Event|0
1200595|NCT00934050|3944047|P2|Enrolled After 15 Dec 2009|Adverse Event|0
1200596|NCT00934050|3944048|P1|Enrolled After 15 Dec 2009|Adverse Event|0
1200597|NCT00934050|3944043|P6|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
1200598|NCT00934050|3944044|P5|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
1200599|NCT00934050|3944045|P4|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
1200600|NCT00934050|3944046|P3|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1
1200601|NCT00934050|3944047|P2|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
1200602|NCT00934050|3944048|P1|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
1200603|NCT00934050|3944043|P6|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
1200604|NCT00934050|3944044|P5|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
1200605|NCT00934050|3944045|P4|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13
1200606|NCT00934050|3944046|P3|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
1200607|NCT00934050|3944047|P2|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12
1200608|NCT00934050|3944048|P1|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
1200609|NCT00934050|3944043|P6|Enrolled Prior to 15 Dec 2009|Adverse Event|0
1200610|NCT00934050|3944044|P5|Enrolled Prior to 15 Dec 2009|Adverse Event|0
1200611|NCT00934050|3944045|P4|Enrolled Prior to 15 Dec 2009|Adverse Event|1
1200612|NCT00934050|3944046|P3|Enrolled Prior to 15 Dec 2009|Adverse Event|0
1200613|NCT00934050|3944047|P2|Enrolled Prior to 15 Dec 2009|Adverse Event|0
1200614|NCT00934050|3944048|P1|Enrolled Prior to 15 Dec 2009|Adverse Event|1
1200615|NCT00933933|3944071|P3|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
1200616|NCT00933933|3944072|P2|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2
1200617|NCT00933933|3944073|P1|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
1200618|NCT00933933|3944071|P3|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
1200619|NCT00933933|3944072|P2|General Population From 16 to 89 Years|Did not meet criteria for analysis|20
1200620|NCT00933933|3944073|P1|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
1200621|NCT00933686|3944091|P2|Overall Study|Failure to show up at endpoint visits|2
1200622|NCT00933686|3944092|P1|Overall Study|Failure to show up at endpoint visits|0
1200623|NCT00933686|3944091|P2|Overall Study|Physician Decision|0
1200624|NCT00933686|3944092|P1|Overall Study|Physician Decision|1
1200625|NCT00933686|3944091|P2|Overall Study|Adverse Event|1
1200626|NCT00933686|3944092|P1|Overall Study|Adverse Event|1
1200627|NCT00933686|3944091|P2|Overall Study|Withdrawal by Subject|5
1200628|NCT00933686|3944092|P1|Overall Study|Withdrawal by Subject|6
1200629|NCT00933686|3944091|P2|Overall Study|Lost to Follow-up|2
1200630|NCT00933686|3944092|P1|Overall Study|Lost to Follow-up|2
1200631|NCT00933686|3944091|P2|Overall Study|Protocol Violation|1
1200632|NCT00933686|3944092|P1|Overall Study|Protocol Violation|0
1200633|NCT00933608|3944112|P2|Overall Study|Physician Decision|0
1200634|NCT00933608|3944113|P1|Overall Study|Physician Decision|1
1200635|NCT00933608|3944112|P2|Overall Study|Adverse Event|2
1200636|NCT00933608|3944113|P1|Overall Study|Adverse Event|4
1200637|NCT00933543|3944121|P2|Overall Study|Other|1
1200638|NCT00933543|3944122|P1|Overall Study|Other|1
1200639|NCT00933543|3944121|P2|Overall Study|Lack of Efficacy|3
1200640|NCT00933543|3944122|P1|Overall Study|Lack of Efficacy|0
1200641|NCT00933543|3944121|P2|Overall Study|Withdrawal by Subject|1
1200642|NCT00933543|3944122|P1|Overall Study|Withdrawal by Subject|0
1200643|NCT00933543|3944121|P2|Overall Study|Lost to Follow-up|1
1200644|NCT00933543|3944122|P1|Overall Study|Lost to Follow-up|0
1200645|NCT00933543|3944121|P2|Overall Study|Adverse Event|1
1200646|NCT00933543|3944122|P1|Overall Study|Adverse Event|2
1200647|NCT00933335|3944191|P2|Overall Study|Co-morbid Illness|0
1200648|NCT00933335|3944192|P1|Overall Study|Co-morbid Illness|1
1200649|NCT00933335|3944191|P2|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1
1200650|NCT00933335|3944192|P1|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0
1200651|NCT00933335|3944191|P2|Overall Study|Progressive Disease|11
1200652|NCT00933335|3944192|P1|Overall Study|Progressive Disease|0
1200653|NCT00933335|3944191|P2|Overall Study|Withdrawal by Subject|1
1200654|NCT00933335|3944192|P1|Overall Study|Withdrawal by Subject|0
1200655|NCT00933335|3944191|P2|Overall Study|Lost to Follow-up|3
1200656|NCT00933335|3944192|P1|Overall Study|Lost to Follow-up|1
1200657|NCT00933270|3944262|P1|Overall Study|Moved or would not return|10
1200658|NCT00933270|3944262|P1|Overall Study|Death|24
1200659|NCT00933270|3944262|P1|Overall Study|Missed Visit|2
1200660|NCT00933270|3944262|P1|Overall Study|Adverse Event|1
1200661|NCT00933270|3944262|P1|Overall Study|Lost to Follow-up|14
1200662|NCT00933270|3944262|P1|Overall Study|Insufficient Follow-up|10
1200663|NCT00933270|3944262|P1|Overall Study|Withdrawal by Subject|26
1200664|NCT00933244|3944356|P3|Overall Study|Withdrawal by Subject|3
1200665|NCT00933244|3944357|P2|Overall Study|Withdrawal by Subject|1
1200666|NCT00933244|3944358|P1|Overall Study|Withdrawal by Subject|5
1200667|NCT00933166|3944375|P1|Overall Study|Withdrawal by Subject|1
1200668|NCT00933166|3944375|P1|Overall Study|Unavailable|4
1200669|NCT00933166|3944375|P1|Overall Study|Lack of Efficacy|9
1200670|NCT00933166|3944375|P1|Overall Study|Lost to Follow-up|4
1200671|NCT00932893|3944381|P2|Overall Study|Other|144
1200672|NCT00932893|3944382|P1|Overall Study|Other|5
1200673|NCT00932893|3944381|P2|Overall Study|Withdrawal by Subject|2
1200674|NCT00932893|3944382|P1|Overall Study|Withdrawal by Subject|5
1200675|NCT00932893|3944381|P2|Overall Study|Lost to Follow-up|0
1200676|NCT00932893|3944382|P1|Overall Study|Lost to Follow-up|8
1200677|NCT00932893|3944381|P2|Overall Study|Death|24
1200678|NCT00932893|3944382|P1|Overall Study|Death|115
1200679|NCT00932646|3944424|P4|Overall Study|Withdrawal by Subject|0
1200680|NCT00932646|3944425|P3|Overall Study|Withdrawal by Subject|3
1200681|NCT00932646|3944426|P2|Overall Study|Withdrawal by Subject|1
1200682|NCT00932646|3944427|P1|Overall Study|Withdrawal by Subject|1
1200683|NCT00932646|3944424|P4|Overall Study|Lost to Follow-up|0
1200684|NCT00932646|3944425|P3|Overall Study|Lost to Follow-up|0
1200685|NCT00932646|3944426|P2|Overall Study|Lost to Follow-up|1
1200686|NCT00932646|3944427|P1|Overall Study|Lost to Follow-up|2
1200687|NCT00932646|3944424|P4|Overall Study|Adverse Event|1
1200688|NCT00932646|3944425|P3|Overall Study|Adverse Event|1
1200689|NCT00932646|3944426|P2|Overall Study|Adverse Event|1
1200690|NCT00932646|3944427|P1|Overall Study|Adverse Event|2
1200691|NCT00932451|3944514|P1|Overall Study|Other reasons|5
1200692|NCT00932451|3944514|P1|Overall Study|Death|726
1200693|NCT00932451|3944514|P1|Overall Study|Lost to Follow-up|22
1200694|NCT00932451|3944514|P1|Overall Study|Withdrawal by Subject|69
1200695|NCT00932425|3944538|P2|Overall Study|Withdrawal by Subject|1
1200696|NCT00932425|3944539|P1|Overall Study|Withdrawal by Subject|0
1200697|NCT00932425|3944538|P2|Overall Study|Lost to Follow-up|1
1200698|NCT00932425|3944539|P1|Overall Study|Lost to Follow-up|0
1200699|NCT00932373|3944572|P11|Overall Study|Lack of Efficacy|0
1200700|NCT00932373|3944573|P10|Overall Study|Lack of Efficacy|1
1200701|NCT00932373|3944574|P9|Overall Study|Lack of Efficacy|0
1200702|NCT00932373|3944575|P8|Overall Study|Lack of Efficacy|0
1200703|NCT00932373|3944576|P7|Overall Study|Lack of Efficacy|0
1200704|NCT00932373|3944577|P6|Overall Study|Lack of Efficacy|0
1200705|NCT00932373|3944578|P5|Overall Study|Lack of Efficacy|0
1200706|NCT00932373|3944579|P4|Overall Study|Lack of Efficacy|0
1200707|NCT00932373|3944580|P3|Overall Study|Lack of Efficacy|0
1200708|NCT00932373|3944581|P2|Overall Study|Lack of Efficacy|0
1200709|NCT00932373|3944582|P1|Overall Study|Lack of Efficacy|0
1200710|NCT00932373|3944572|P11|Overall Study|Clinical progression|0
1200711|NCT00932373|3944573|P10|Overall Study|Clinical progression|0
1200712|NCT00932373|3944574|P9|Overall Study|Clinical progression|0
1200713|NCT00932373|3944575|P8|Overall Study|Clinical progression|0
1200714|NCT00932373|3944576|P7|Overall Study|Clinical progression|1
1200715|NCT00932373|3944577|P6|Overall Study|Clinical progression|0
1200716|NCT00932373|3944578|P5|Overall Study|Clinical progression|0
1200717|NCT00932373|3944579|P4|Overall Study|Clinical progression|0
1200718|NCT00932373|3944580|P3|Overall Study|Clinical progression|0
1200719|NCT00932373|3944581|P2|Overall Study|Clinical progression|0
1200720|NCT00932373|3944582|P1|Overall Study|Clinical progression|0
1200721|NCT00932373|3944572|P11|Overall Study|Withdrawal by Subject|0
1200722|NCT00932373|3944573|P10|Overall Study|Withdrawal by Subject|0
1200723|NCT00932373|3944574|P9|Overall Study|Withdrawal by Subject|1
1200724|NCT00932373|3944575|P8|Overall Study|Withdrawal by Subject|0
1200725|NCT00932373|3944576|P7|Overall Study|Withdrawal by Subject|0
1200726|NCT00932373|3944577|P6|Overall Study|Withdrawal by Subject|0
1200727|NCT00932373|3944578|P5|Overall Study|Withdrawal by Subject|0
1200728|NCT00932373|3944579|P4|Overall Study|Withdrawal by Subject|0
1200729|NCT00932373|3944580|P3|Overall Study|Withdrawal by Subject|0
1200730|NCT00932373|3944581|P2|Overall Study|Withdrawal by Subject|0
1200731|NCT00932373|3944582|P1|Overall Study|Withdrawal by Subject|0
1200732|NCT00932373|3944572|P11|Overall Study|Dose limiting toxicity|0
1200733|NCT00932373|3944573|P10|Overall Study|Dose limiting toxicity|0
1200734|NCT00932373|3944574|P9|Overall Study|Dose limiting toxicity|0
1200735|NCT00932373|3944575|P8|Overall Study|Dose limiting toxicity|0
1200736|NCT00932373|3944576|P7|Overall Study|Dose limiting toxicity|0
1200737|NCT00932373|3944577|P6|Overall Study|Dose limiting toxicity|1
1200738|NCT00932373|3944578|P5|Overall Study|Dose limiting toxicity|0
1200739|NCT00932373|3944579|P4|Overall Study|Dose limiting toxicity|0
1200740|NCT00932373|3944580|P3|Overall Study|Dose limiting toxicity|0
1200741|NCT00932373|3944581|P2|Overall Study|Dose limiting toxicity|0
1200742|NCT00932373|3944582|P1|Overall Study|Dose limiting toxicity|0
1200743|NCT00932373|3944572|P11|Overall Study|Physician Decision|0
1200744|NCT00932373|3944573|P10|Overall Study|Physician Decision|1
1200745|NCT00932373|3944574|P9|Overall Study|Physician Decision|0
1200746|NCT00932373|3944575|P8|Overall Study|Physician Decision|0
1200747|NCT00932373|3944576|P7|Overall Study|Physician Decision|0
1200748|NCT00932373|3944577|P6|Overall Study|Physician Decision|0
1200749|NCT00932373|3944578|P5|Overall Study|Physician Decision|2
1200750|NCT00932373|3944579|P4|Overall Study|Physician Decision|0
1200751|NCT00932373|3944580|P3|Overall Study|Physician Decision|1
1200752|NCT00932373|3944581|P2|Overall Study|Physician Decision|0
1200753|NCT00932373|3944582|P1|Overall Study|Physician Decision|0
1200754|NCT00932373|3944572|P11|Overall Study|Adverse Event|1
1200755|NCT00932373|3944573|P10|Overall Study|Adverse Event|2
1200756|NCT00932373|3944574|P9|Overall Study|Adverse Event|0
1200757|NCT00932373|3944575|P8|Overall Study|Adverse Event|1
1200758|NCT00932373|3944576|P7|Overall Study|Adverse Event|0
1200759|NCT00932373|3944577|P6|Overall Study|Adverse Event|1
1200760|NCT00932373|3944578|P5|Overall Study|Adverse Event|2
1200761|NCT00932373|3944579|P4|Overall Study|Adverse Event|0
1200762|NCT00932373|3944580|P3|Overall Study|Adverse Event|0
1200763|NCT00932373|3944581|P2|Overall Study|Adverse Event|0
1200764|NCT00932373|3944582|P1|Overall Study|Adverse Event|0
1200765|NCT00932373|3944572|P11|Overall Study|Progressive disease|2
1200766|NCT00932373|3944573|P10|Overall Study|Progressive disease|9
1200767|NCT00932373|3944574|P9|Overall Study|Progressive disease|1
1200768|NCT00932373|3944575|P8|Overall Study|Progressive disease|2
1200769|NCT00932373|3944576|P7|Overall Study|Progressive disease|0
1200770|NCT00932373|3944577|P6|Overall Study|Progressive disease|1
1200771|NCT00932373|3944578|P5|Overall Study|Progressive disease|10
1200772|NCT00932373|3944579|P4|Overall Study|Progressive disease|0
1200773|NCT00932373|3944580|P3|Overall Study|Progressive disease|0
1200774|NCT00932373|3944581|P2|Overall Study|Progressive disease|1
1200775|NCT00932373|3944582|P1|Overall Study|Progressive disease|3
1200776|NCT00932165|3944710|P1|Overall Study|Lost to Follow-up|1
1200777|NCT00932126|3944734|P8|Overall Study|Other|2
1200778|NCT00932126|3944735|P7|Overall Study|Other|1
1200779|NCT00932126|3944736|P6|Overall Study|Other|0
1200780|NCT00932126|3944737|P5|Overall Study|Other|1
1200781|NCT00932126|3944738|P4|Overall Study|Other|0
1200782|NCT00932126|3944739|P3|Overall Study|Other|0
1200783|NCT00932126|3944740|P2|Overall Study|Other|0
1200784|NCT00932126|3944741|P1|Overall Study|Other|0
1200785|NCT00932126|3944734|P8|Overall Study|Objective progression or relapse|5
1200786|NCT00932126|3944735|P7|Overall Study|Objective progression or relapse|3
1200787|NCT00932126|3944736|P6|Overall Study|Objective progression or relapse|3
1200788|NCT00932126|3944737|P5|Overall Study|Objective progression or relapse|3
1200789|NCT00932126|3944738|P4|Overall Study|Objective progression or relapse|3
1200790|NCT00932126|3944739|P3|Overall Study|Objective progression or relapse|2
1200791|NCT00932126|3944740|P2|Overall Study|Objective progression or relapse|3
1200792|NCT00932126|3944741|P1|Overall Study|Objective progression or relapse|3
1200793|NCT00932126|3944734|P8|Overall Study|Withdrawal by Subject|1
1200794|NCT00932126|3944735|P7|Overall Study|Withdrawal by Subject|0
1200795|NCT00932126|3944736|P6|Overall Study|Withdrawal by Subject|0
1200796|NCT00932126|3944737|P5|Overall Study|Withdrawal by Subject|0
1200797|NCT00932126|3944738|P4|Overall Study|Withdrawal by Subject|0
1200798|NCT00932126|3944739|P3|Overall Study|Withdrawal by Subject|1
1200799|NCT00932126|3944740|P2|Overall Study|Withdrawal by Subject|0
1200800|NCT00932126|3944741|P1|Overall Study|Withdrawal by Subject|0
1200801|NCT00932126|3944734|P8|Overall Study|Protocol Violation|0
1200802|NCT00932126|3944735|P7|Overall Study|Protocol Violation|0
1200803|NCT00932126|3944736|P6|Overall Study|Protocol Violation|0
1200804|NCT00932126|3944737|P5|Overall Study|Protocol Violation|1
1200805|NCT00932126|3944738|P4|Overall Study|Protocol Violation|0
1200806|NCT00932126|3944739|P3|Overall Study|Protocol Violation|0
1200807|NCT00932126|3944740|P2|Overall Study|Protocol Violation|0
1200808|NCT00932126|3944741|P1|Overall Study|Protocol Violation|0
1200809|NCT00932126|3944734|P8|Overall Study|Adverse Event|2
1200810|NCT00932126|3944735|P7|Overall Study|Adverse Event|1
1200811|NCT00932126|3944736|P6|Overall Study|Adverse Event|0
1200812|NCT00932126|3944737|P5|Overall Study|Adverse Event|0
1200813|NCT00932126|3944738|P4|Overall Study|Adverse Event|0
1200814|NCT00932126|3944739|P3|Overall Study|Adverse Event|0
1200815|NCT00932126|3944740|P2|Overall Study|Adverse Event|0
1200816|NCT00932126|3944741|P1|Overall Study|Adverse Event|0
1200817|NCT00932113|3944779|P2|Overall Study|Lost to Follow-up|0
1200818|NCT00932113|3944780|P1|Overall Study|Lost to Follow-up|1
1200819|NCT00931918|3944832|P2|Overall Study|Did not receive study drug|2
1200820|NCT00931918|3944833|P1|Overall Study|Did not receive study drug|3
1200821|NCT00931918|3944832|P2|Overall Study|Other Reason not Specified|4
1200822|NCT00931918|3944833|P1|Overall Study|Other Reason not Specified|4
1200823|NCT00931918|3944832|P2|Overall Study|Withdrawal by Patient|4
1200824|NCT00931918|3944833|P1|Overall Study|Withdrawal by Patient|3
1200825|NCT00931918|3944832|P2|Overall Study|Symptomatic Deterioration|0
1200826|NCT00931918|3944833|P1|Overall Study|Symptomatic Deterioration|1
1200827|NCT00931918|3944832|P2|Overall Study|Progressive Disease|1
1200828|NCT00931918|3944833|P1|Overall Study|Progressive Disease|2
1200829|NCT00931918|3944832|P2|Overall Study|Adverse Event|6
1200830|NCT00931918|3944833|P1|Overall Study|Adverse Event|4
1200831|NCT00931801|3944885|P3|Overall Study|Confirmed Virologic Failure|3
1200832|NCT00931801|3944886|P2|Overall Study|Confirmed Virologic Failure|0
1200833|NCT00931801|3944887|P1|Overall Study|Confirmed Virologic Failure|0
1200834|NCT00931801|3944885|P3|Overall Study|Withdrawal by Subject|0
1200835|NCT00931801|3944886|P2|Overall Study|Withdrawal by Subject|0
1200836|NCT00931801|3944887|P1|Overall Study|Withdrawal by Subject|1
1200837|NCT00931801|3944885|P3|Overall Study|Lost to Follow-up|0
1200838|NCT00931801|3944886|P2|Overall Study|Lost to Follow-up|1
1200839|NCT00931801|3944887|P1|Overall Study|Lost to Follow-up|0
1200840|NCT00931801|3944885|P3|Overall Study|Adverse Event|1
1200841|NCT00931801|3944886|P2|Overall Study|Adverse Event|0
1200842|NCT00931801|3944887|P1|Overall Study|Adverse Event|0
1200843|NCT00931723|3944910|P2|Overall Study|Late hospital discharge|0
1200844|NCT00931723|3944911|P1|Overall Study|Late hospital discharge|1
1200845|NCT00931723|3944910|P2|Overall Study|Sponsor decision|0
1200846|NCT00931723|3944911|P1|Overall Study|Sponsor decision|1
1200847|NCT00931723|3944910|P2|Overall Study|Lack or insufficient theraputic response|5
1200848|NCT00931723|3944911|P1|Overall Study|Lack or insufficient theraputic response|2
1200849|NCT00931723|3944910|P2|Overall Study|Took prohibited concomitant medication|1
1200850|NCT00931723|3944911|P1|Overall Study|Took prohibited concomitant medication|0
1200851|NCT00931723|3944910|P2|Overall Study|Safety reasons|1
1200852|NCT00931723|3944911|P1|Overall Study|Safety reasons|0
1200853|NCT00931723|3944910|P2|Overall Study|Severe non-compliance to protocol|0
1200854|NCT00931723|3944911|P1|Overall Study|Severe non-compliance to protocol|2
1200855|NCT00931723|3944910|P2|Overall Study|Study-specific discontinuation criteria|1
1200856|NCT00931723|3944911|P1|Overall Study|Study-specific discontinuation criteria|1
1200857|NCT00931723|3944910|P2|Overall Study|Lost to Follow-up|2
1200858|NCT00931723|3944911|P1|Overall Study|Lost to Follow-up|1
1200859|NCT00931723|3944910|P2|Overall Study|Condition under investigation worsened|2
1200860|NCT00931723|3944911|P1|Overall Study|Condition under investigation worsened|1
1200861|NCT00931723|3944910|P2|Overall Study|Lithium found in blood|1
1200862|NCT00931723|3944911|P1|Overall Study|Lithium found in blood|0
1200863|NCT00931723|3944910|P2|Overall Study|Adverse Event|13
1200864|NCT00931723|3944911|P1|Overall Study|Adverse Event|6
1200865|NCT00931723|3944910|P2|Overall Study|Withdrawal by Subject|13
1200866|NCT00931723|3944911|P1|Overall Study|Withdrawal by Subject|11
1200867|NCT00931710|3944959|P2|Overall Study|Protocol deviation|2
1200868|NCT00931710|3944960|P1|Overall Study|Protocol deviation|1
1200869|NCT00931710|3944959|P2|Overall Study|Lost to Follow-up|5
1200870|NCT00931710|3944960|P1|Overall Study|Lost to Follow-up|6
1200871|NCT00931710|3944959|P2|Overall Study|Patient withdrew consent|9
1200872|NCT00931710|3944960|P1|Overall Study|Patient withdrew consent|4
1200873|NCT00931710|3944959|P2|Overall Study|Unsatisfactory therapeutic effects|12
1200874|NCT00931710|3944960|P1|Overall Study|Unsatisfactory therapeutic effects|5
1200875|NCT00931710|3944959|P2|Overall Study|Abnormal test procedure results|0
1200876|NCT00931710|3944960|P1|Overall Study|Abnormal test procedure results|2
1200877|NCT00931710|3944959|P2|Overall Study|Adverse Event|10
1200878|NCT00931710|3944960|P1|Overall Study|Adverse Event|16
1200879|NCT00931632|3944978|P2|Overall Study|Adverse Event|15
1200880|NCT00931632|3944979|P1|Overall Study|Adverse Event|19
1200881|NCT00931632|3944978|P2|Overall Study|Withdrawal by Subject|3
1200882|NCT00931632|3944979|P1|Overall Study|Withdrawal by Subject|2
1200883|NCT00931528|3945001|P2|Overall Study|Assessment outside of Time Frame|23
1200884|NCT00931528|3945002|P1|Overall Study|Assessment outside of Time Frame|22
1200885|NCT00931528|3945001|P2|Overall Study|Lost to Follow-up|13
1200886|NCT00931528|3945002|P1|Overall Study|Lost to Follow-up|6
1200887|NCT00931528|3945001|P2|Overall Study|Withdrawal by Subject|12
1200888|NCT00931528|3945002|P1|Overall Study|Withdrawal by Subject|4
1200889|NCT00931528|3945001|P2|Overall Study|Protocol Violation|12
1200890|NCT00931528|3945002|P1|Overall Study|Protocol Violation|9
1200891|NCT00931515|3945022|P2|Overall Study|Lost to Follow-up|5
1200892|NCT00931515|3945023|P1|Overall Study|Lost to Follow-up|2
1200893|NCT00931463|3945053|P2|Overall Study|Lost to Follow-up|1
1200894|NCT00931463|3945054|P1|Overall Study|Lost to Follow-up|4
1200895|NCT00931463|3945053|P2|Overall Study|Withdrawal by Subject|0
1200896|NCT00931463|3945054|P1|Overall Study|Withdrawal by Subject|5
1200897|NCT00931463|3945053|P2|Overall Study|Death|4
1200898|NCT00931463|3945054|P1|Overall Study|Death|8
1200899|NCT00931411|3945070|P2|After Crossover - 14 Days (up to Day 56)|Adverse Event|1
1200900|NCT00931411|3945071|P1|After Crossover - 14 Days (up to Day 56)|Adverse Event|0
1200901|NCT00931411|3945070|P2|First Intervention - 42 Days|Lost to Follow-up|0
1200902|NCT00931411|3945071|P1|First Intervention - 42 Days|Lost to Follow-up|2
1200903|NCT00931411|3945070|P2|First Intervention - 42 Days|Adverse Event|3
1200904|NCT00931411|3945071|P1|First Intervention - 42 Days|Adverse Event|2
1200905|NCT00931385|3945092|P4|Overall Study|Lost to Follow-up|1
1200906|NCT00931385|3945093|P3|Overall Study|Lost to Follow-up|0
1200907|NCT00931385|3945094|P2|Overall Study|Lost to Follow-up|0
1200908|NCT00931385|3945095|P1|Overall Study|Lost to Follow-up|0
1200909|NCT00931385|3945092|P4|Overall Study|Withdrawal by Subject|1
1200910|NCT00931385|3945093|P3|Overall Study|Withdrawal by Subject|0
1200911|NCT00931385|3945094|P2|Overall Study|Withdrawal by Subject|1
1200912|NCT00931385|3945095|P1|Overall Study|Withdrawal by Subject|0
1200913|NCT00931385|3945092|P4|Overall Study|Protocol Violation|0
1200914|NCT00931385|3945093|P3|Overall Study|Protocol Violation|1
1200915|NCT00931385|3945094|P2|Overall Study|Protocol Violation|0
1200916|NCT00931385|3945095|P1|Overall Study|Protocol Violation|0
1200917|NCT00931385|3945092|P4|Overall Study|Adverse Event|3
1200918|NCT00931385|3945093|P3|Overall Study|Adverse Event|0
1200919|NCT00931385|3945094|P2|Overall Study|Adverse Event|1
1200920|NCT00931385|3945095|P1|Overall Study|Adverse Event|2
1200921|NCT00931307|3945164|P1|Overall Study|Biomicroscopy|1
1200922|NCT00931307|3945164|P1|Overall Study|Lack of Efficacy|12
1200923|NCT00931268|3945168|P1|Overall Study|Lost to Follow-up|6
1200924|NCT00931255|3945180|P2|Overall Study|Follow up biopsy not done|3
1200925|NCT00931255|3945181|P1|Overall Study|Follow up biopsy not done|2
1200926|NCT00930982|3945218|P2|Overall Study|Withdrawal by Subject|1
1200927|NCT00930982|3945219|P1|Overall Study|Withdrawal by Subject|1
1200928|NCT00930982|3945218|P2|Overall Study|Protocol Violation|5
1200929|NCT00930982|3945219|P1|Overall Study|Protocol Violation|1
1200930|NCT00930982|3945218|P2|Overall Study|Adverse Event|23
1200931|NCT00930982|3945219|P1|Overall Study|Adverse Event|19
1200932|NCT00930969|3945253|P1|Overall Study|Withdrawal by Subject|19
1200933|NCT00930969|3945253|P1|Overall Study|Physician Decision|13
1200934|NCT00930969|3945253|P1|Overall Study|Lost to Follow-up|1
1200935|NCT00930969|3945253|P1|Overall Study|Death|5
1200936|NCT00930930|3945263|P2|Overall Study|patients not compliant|1
1200937|NCT00930930|3945264|P1|Overall Study|patients not compliant|1
1200938|NCT00930930|3945263|P2|Overall Study|excessive lapse btw txs, not eligible|1
1200939|NCT00930930|3945264|P1|Overall Study|excessive lapse btw txs, not eligible|0
1200940|NCT00930930|3945263|P2|Overall Study|Disease progression|3
1200941|NCT00930930|3945264|P1|Overall Study|Disease progression|2
1200942|NCT00930930|3945263|P2|Overall Study|Withdrawal by Subject|1
1200943|NCT00930930|3945264|P1|Overall Study|Withdrawal by Subject|3
1200944|NCT00930930|3945263|P2|Overall Study|Adverse Event|3
1200945|NCT00930930|3945264|P1|Overall Study|Adverse Event|13
1200946|NCT00930930|3945263|P2|Overall Study|Physician Decision|0
1200947|NCT00930930|3945264|P1|Overall Study|Physician Decision|1
1200948|NCT00930930|3945263|P2|Overall Study|Death|0
1200949|NCT00930930|3945264|P1|Overall Study|Death|1
1200950|NCT00930813|3945278|P2|Overall Study|Lost to Follow-up|4
1200951|NCT00930813|3945279|P1|Overall Study|Lost to Follow-up|2
1200952|NCT00930813|3945278|P2|Overall Study|Withdrawal by Subject|5
1200953|NCT00930813|3945279|P1|Overall Study|Withdrawal by Subject|2
1200954|NCT00930813|3945278|P2|Overall Study|Death|5
1200955|NCT00930813|3945279|P1|Overall Study|Death|4
1200956|NCT00930774|3945300|P4|Overall Study|Withdrawal by Subject|0
1200957|NCT00930774|3945301|P3|Overall Study|Withdrawal by Subject|2
1200958|NCT00930774|3945302|P2|Overall Study|Withdrawal by Subject|9
1200959|NCT00930774|3945303|P1|Overall Study|Withdrawal by Subject|1
1200960|NCT00930761|3945343|P2|Overall Study|less than 3 music therapy sessions|3
1200961|NCT00930761|3945344|P1|Overall Study|less than 3 music therapy sessions|0
1200962|NCT00930761|3945343|P2|Overall Study|3 newborns died; 1 mother quit the study|0
1200963|NCT00930761|3945344|P1|Overall Study|3 newborns died; 1 mother quit the study|4
1200964|NCT00930722|3945356|P1|Overall Study|Study terminated by sponsor|2
1200965|NCT00930722|3945356|P1|Overall Study|No longer willing to participate|9
1200966|NCT00930722|3945356|P1|Overall Study|Lost to Follow-up|16
1200967|NCT00930644|3945371|P1|Overall Study|Adverse Event|16
1200968|NCT00930644|3945371|P1|Overall Study|Death|1
1200969|NCT00930644|3945371|P1|Overall Study|Physician Decision|2
1200970|NCT00930644|3945371|P1|Overall Study|Withdrawal by Subject|4
1200971|NCT00930553|3945384|P1|Overall Study|Other than specified above|28
1200972|NCT00930553|3945384|P1|Overall Study|Study terminated by sponsor|24
1200973|NCT00930553|3945384|P1|Overall Study|Death|9
1200974|NCT00930553|3945384|P1|Overall Study|Lost to Follow-up|25
1200975|NCT00930553|3945384|P1|Overall Study|Withdrawal by Subject|88
1200976|NCT00930553|3945384|P1|Overall Study|Pregnancy|1
1200977|NCT00930553|3945384|P1|Overall Study|Protocol Violation|1
1200978|NCT00930553|3945384|P1|Overall Study|Physician Decision|39
1200979|NCT00930553|3945384|P1|Overall Study|Lack of Efficacy|7
1200980|NCT00930553|3945384|P1|Overall Study|Adverse Event|1
1200981|NCT00930176|3945461|P1|Overall Study|Death|1
1200982|NCT00929864|3945478|P2|Overall Study|Non-specified|7
1200983|NCT00929864|3945479|P1|Overall Study|Non-specified|2
1200984|NCT00929864|3945478|P2|Overall Study|Administrative reason by Sponsor|1
1200985|NCT00929864|3945479|P1|Overall Study|Administrative reason by Sponsor|1
1200986|NCT00929864|3945478|P2|Overall Study|Pregnancy|3
1200987|NCT00929864|3945479|P1|Overall Study|Pregnancy|0
1200988|NCT00929864|3945478|P2|Overall Study|Poor or non-compliance|3
1200989|NCT00929864|3945479|P1|Overall Study|Poor or non-compliance|3
1200990|NCT00929864|3945478|P2|Overall Study|No longer met criteria|1
1200991|NCT00929864|3945479|P1|Overall Study|No longer met criteria|2
1200992|NCT00929864|3945478|P2|Overall Study|Withdrawal by Subject|9
1200993|NCT00929864|3945479|P1|Overall Study|Withdrawal by Subject|20
1200994|NCT00929864|3945478|P2|Overall Study|Lost to Follow-up|12
1200995|NCT00929864|3945479|P1|Overall Study|Lost to Follow-up|7
1200996|NCT00929864|3945478|P2|Overall Study|Lack of Efficacy|16
1200997|NCT00929864|3945479|P1|Overall Study|Lack of Efficacy|19
1200998|NCT00929864|3945478|P2|Overall Study|Adverse Event|30
1200999|NCT00929864|3945479|P1|Overall Study|Adverse Event|11
1201000|NCT00929864|3945478|P2|Overall Study|Death|1
1201001|NCT00929864|3945479|P1|Overall Study|Death|1
1201002|NCT00929734|3945518|P2|Overall Study|Withdrawal by Subject|2
1201003|NCT00929734|3945519|P1|Overall Study|Withdrawal by Subject|0
1201004|NCT00929734|3945518|P2|Overall Study|Lost to Follow-up|1
1201005|NCT00929734|3945519|P1|Overall Study|Lost to Follow-up|2
1201006|NCT00929708|3945536|P5|Overall Study|Lost to Follow-up|0
1201007|NCT00929708|3945537|P4|Overall Study|Lost to Follow-up|1
1201008|NCT00929708|3945538|P3|Overall Study|Lost to Follow-up|0
1201009|NCT00929708|3945539|P2|Overall Study|Lost to Follow-up|0
1201010|NCT00929708|3945540|P1|Overall Study|Lost to Follow-up|0
1201011|NCT00929708|3945536|P5|Overall Study|Physician Decision|1
1201012|NCT00929708|3945537|P4|Overall Study|Physician Decision|2
1201013|NCT00929708|3945538|P3|Overall Study|Physician Decision|2
1201014|NCT00929708|3945539|P2|Overall Study|Physician Decision|2
1201015|NCT00929708|3945540|P1|Overall Study|Physician Decision|0
1201016|NCT00929708|3945536|P5|Overall Study|Adverse Event|3
1201017|NCT00929708|3945537|P4|Overall Study|Adverse Event|0
1201018|NCT00929708|3945538|P3|Overall Study|Adverse Event|0
1201019|NCT00929708|3945539|P2|Overall Study|Adverse Event|0
1201020|NCT00929708|3945540|P1|Overall Study|Adverse Event|0
1201021|NCT00929708|3945536|P5|Overall Study|Withdrawal by Subject|1
1201022|NCT00929708|3945537|P4|Overall Study|Withdrawal by Subject|2
1201023|NCT00929708|3945538|P3|Overall Study|Withdrawal by Subject|0
1201024|NCT00929708|3945539|P2|Overall Study|Withdrawal by Subject|0
1201025|NCT00929708|3945540|P1|Overall Study|Withdrawal by Subject|2
1201026|NCT00929708|3945536|P5|Overall Study|Protocol Violation|1
1201027|NCT00929708|3945537|P4|Overall Study|Protocol Violation|1
1201028|NCT00929708|3945538|P3|Overall Study|Protocol Violation|1
1201029|NCT00929708|3945539|P2|Overall Study|Protocol Violation|1
1201030|NCT00929708|3945540|P1|Overall Study|Protocol Violation|2
1201031|NCT00929695|3945594|P2|Overall Study|incorrect stratification|0
1201032|NCT00929695|3945595|P1|Overall Study|incorrect stratification|2
1201033|NCT00929695|3945594|P2|Overall Study|discharge home|3
1201034|NCT00929695|3945595|P1|Overall Study|discharge home|4
1201035|NCT00929695|3945594|P2|Overall Study|Withdrawal by Subject|2
1201036|NCT00929695|3945595|P1|Overall Study|Withdrawal by Subject|0
1201037|NCT00929695|3945594|P2|Overall Study|Death|1
1201038|NCT00929695|3945595|P1|Overall Study|Death|2
1201039|NCT00929669|3945625|P1|Overall Study|elevated glucose levels|1
1201040|NCT00929656|3945632|P2|Overall Study|Lost to Follow-up|1
1201041|NCT00929656|3945633|P1|Overall Study|Lost to Follow-up|0
1201042|NCT00929643|3945647|P1|Overall Study|Protocol Violation|2
1201043|NCT00929526|3945669|P2|Overall Study|Other|6
1201044|NCT00929526|3945670|P1|Overall Study|Other|8
1201045|NCT00929526|3945669|P2|Overall Study|Lost to Follow-up|12
1201046|NCT00929526|3945670|P1|Overall Study|Lost to Follow-up|8
1201047|NCT00929526|3945669|P2|Overall Study|Withdrawal by Subject|11
1201048|NCT00929526|3945670|P1|Overall Study|Withdrawal by Subject|1
1201049|NCT00929240|3945824|P3|Maintenance Phase|Participant not treated|0
1201050|NCT00929240|3945825|P2|Maintenance Phase|Participant not treated|2
1201051|NCT00929240|3945826|P1|Maintenance Phase|Participant not treated|0
1201052|NCT00929240|3945824|P3|Maintenance Phase|Treatment ongoing at study closure|10
1201053|NCT00929240|3945825|P2|Maintenance Phase|Treatment ongoing at study closure|0
1201054|NCT00929240|3945826|P1|Maintenance Phase|Treatment ongoing at study closure|0
1201055|NCT00929240|3945824|P3|Maintenance Phase|Change of treatment|0
1201056|NCT00929240|3945825|P2|Maintenance Phase|Change of treatment|4
1201057|NCT00929240|3945826|P1|Maintenance Phase|Change of treatment|0
1201058|NCT00929240|3945824|P3|Maintenance Phase|Physician Decision|1
1201059|NCT00929240|3945825|P2|Maintenance Phase|Physician Decision|2
1201060|NCT00929240|3945826|P1|Maintenance Phase|Physician Decision|0
1201061|NCT00929240|3945824|P3|Maintenance Phase|Health authority/Study termination|2
1201062|NCT00929240|3945825|P2|Maintenance Phase|Health authority/Study termination|1
1201063|NCT00929240|3945826|P1|Maintenance Phase|Health authority/Study termination|0
1201064|NCT00929240|3945824|P3|Maintenance Phase|Protocol Violation|0
1201065|NCT00929240|3945825|P2|Maintenance Phase|Protocol Violation|1
1201066|NCT00929240|3945826|P1|Maintenance Phase|Protocol Violation|0
1201067|NCT00929240|3945824|P3|Maintenance Phase|Withdrawal by Subject|6
1201068|NCT00929240|3945825|P2|Maintenance Phase|Withdrawal by Subject|2
1201069|NCT00929240|3945826|P1|Maintenance Phase|Withdrawal by Subject|0
1201070|NCT00929240|3945824|P3|Maintenance Phase|Adverse Event|12
1201071|NCT00929240|3945825|P2|Maintenance Phase|Adverse Event|9
1201072|NCT00929240|3945826|P1|Maintenance Phase|Adverse Event|0
1201073|NCT00929240|3945824|P3|Maintenance Phase|Disease progression|60
1201074|NCT00929240|3945825|P2|Maintenance Phase|Disease progression|73
1201075|NCT00929240|3945826|P1|Maintenance Phase|Disease progression|0
1201076|NCT00929240|3945824|P3|Initial Treatment Phase|Physician Decision|0
1201077|NCT00929240|3945825|P2|Initial Treatment Phase|Physician Decision|0
1201078|NCT00929240|3945826|P1|Initial Treatment Phase|Physician Decision|4
1201079|NCT00929240|3945824|P3|Initial Treatment Phase|Health authority/Study termination|0
1201080|NCT00929240|3945825|P2|Initial Treatment Phase|Health authority/Study termination|0
1201081|NCT00929240|3945826|P1|Initial Treatment Phase|Health authority/Study termination|3
1201082|NCT00929240|3945824|P3|Initial Treatment Phase|Death|0
1201083|NCT00929240|3945825|P2|Initial Treatment Phase|Death|0
1201084|NCT00929240|3945826|P1|Initial Treatment Phase|Death|2
1201085|NCT00929240|3945824|P3|Initial Treatment Phase|Protocol Violation|0
1201086|NCT00929240|3945825|P2|Initial Treatment Phase|Protocol Violation|0
1201087|NCT00929240|3945826|P1|Initial Treatment Phase|Protocol Violation|5
1201088|NCT00929240|3945824|P3|Initial Treatment Phase|Withdrawal by Subject|0
1201089|NCT00929240|3945825|P2|Initial Treatment Phase|Withdrawal by Subject|0
1201090|NCT00929240|3945826|P1|Initial Treatment Phase|Withdrawal by Subject|13
1201091|NCT00929240|3945824|P3|Initial Treatment Phase|Disease progression|0
1201092|NCT00929240|3945825|P2|Initial Treatment Phase|Disease progression|0
1201093|NCT00929240|3945826|P1|Initial Treatment Phase|Disease progression|41
1201094|NCT00929240|3945824|P3|Initial Treatment Phase|Adverse Event|0
1201095|NCT00929240|3945825|P2|Initial Treatment Phase|Adverse Event|0
1201096|NCT00929240|3945826|P1|Initial Treatment Phase|Adverse Event|31
1201097|NCT00929201|3945853|P2|Period 1|Withdrawal by Subject|1
1201098|NCT00929201|3945854|P1|Period 1|Withdrawal by Subject|0
1201099|NCT00929162|3945864|P2|Overall Study|Other termination reason|6
1201100|NCT00929162|3945865|P1|Overall Study|Other termination reason|5
1201101|NCT00929162|3945864|P2|Overall Study|Protocol Violation|30
1201102|NCT00929162|3945865|P1|Overall Study|Protocol Violation|32
1201103|NCT00929162|3945864|P2|Overall Study|Withdrawal by Subject|1
1201104|NCT00929162|3945865|P1|Overall Study|Withdrawal by Subject|3
1201105|NCT00929162|3945864|P2|Overall Study|Adverse Event|5
1201106|NCT00929162|3945865|P1|Overall Study|Adverse Event|8
1201107|NCT00929110|3945878|P3|Overall Study|Patient inability to use the device|0
1201108|NCT00929110|3945879|P2|Overall Study|Patient inability to use the device|1
1201109|NCT00929110|3945880|P1|Overall Study|Patient inability to use the device|0
1201110|NCT00929110|3945878|P3|Overall Study|Abnormal test procedure result(s)|1
1201111|NCT00929110|3945879|P2|Overall Study|Abnormal test procedure result(s)|1
1201112|NCT00929110|3945880|P1|Overall Study|Abnormal test procedure result(s)|0
1201113|NCT00929110|3945878|P3|Overall Study|Abnormal laboratory value(s)|0
1201114|NCT00929110|3945879|P2|Overall Study|Abnormal laboratory value(s)|1
1201115|NCT00929110|3945880|P1|Overall Study|Abnormal laboratory value(s)|0
1201116|NCT00929110|3945878|P3|Overall Study|Death|2
1201117|NCT00929110|3945879|P2|Overall Study|Death|2
1201118|NCT00929110|3945880|P1|Overall Study|Death|2
1201119|NCT00929110|3945878|P3|Overall Study|Administrative problems|2
1201120|NCT00929110|3945879|P2|Overall Study|Administrative problems|1
1201121|NCT00929110|3945880|P1|Overall Study|Administrative problems|4
1201122|NCT00929110|3945878|P3|Overall Study|Protocol deviation|4
1201123|NCT00929110|3945879|P2|Overall Study|Protocol deviation|2
1201124|NCT00929110|3945880|P1|Overall Study|Protocol deviation|5
1201125|NCT00929110|3945878|P3|Overall Study|Lost to Follow-up|3
1201126|NCT00929110|3945879|P2|Overall Study|Lost to Follow-up|7
1201127|NCT00929110|3945880|P1|Overall Study|Lost to Follow-up|7
1201128|NCT00929110|3945878|P3|Overall Study|Unsatisfactory therapeutic effect|6
1201129|NCT00929110|3945879|P2|Overall Study|Unsatisfactory therapeutic effect|9
1201130|NCT00929110|3945880|P1|Overall Study|Unsatisfactory therapeutic effect|20
1201131|NCT00929110|3945878|P3|Overall Study|Subject withdrew consent|26
1201132|NCT00929110|3945879|P2|Overall Study|Subject withdrew consent|23
1201133|NCT00929110|3945880|P1|Overall Study|Subject withdrew consent|40
1201134|NCT00929110|3945878|P3|Overall Study|Adverse Event|18
1201135|NCT00929110|3945879|P2|Overall Study|Adverse Event|29
1201136|NCT00929110|3945880|P1|Overall Study|Adverse Event|40
1201137|NCT00928889|3945963|P2|Overall Study|Other|0
1201138|NCT00928889|3945964|P1|Overall Study|Other|1
1201139|NCT00928889|3945963|P2|Overall Study|Adverse Event|0
1201140|NCT00928889|3945964|P1|Overall Study|Adverse Event|1
1201141|NCT00928889|3945963|P2|Overall Study|Protocol Violation|1
1201142|NCT00928889|3945964|P1|Overall Study|Protocol Violation|0
1201143|NCT00928889|3945963|P2|Overall Study|Lost to Follow-up|1
1201144|NCT00928889|3945964|P1|Overall Study|Lost to Follow-up|3
1201145|NCT00928746|3946010|P1|Overall Study|Other|2
1201146|NCT00928746|3946010|P1|Overall Study|Withdrawal by Subject|1
1201147|NCT00928746|3946010|P1|Overall Study|Protocol Violation|1
1201148|NCT00928746|3946010|P1|Overall Study|Adverse Event|2
1201149|NCT00928668|3946067|P5|Overall Study|Other reasons not listed above|0
1201150|NCT00928668|3946068|P4|Overall Study|Other reasons not listed above|1
1201151|NCT00928668|3946069|P3|Overall Study|Other reasons not listed above|0
1201152|NCT00928668|3946070|P2|Overall Study|Other reasons not listed above|0
1201153|NCT00928668|3946071|P1|Overall Study|Other reasons not listed above|0
1201154|NCT00928668|3946067|P5|Overall Study|Withdrawal by Subject|0
1201155|NCT00928668|3946068|P4|Overall Study|Withdrawal by Subject|0
1201156|NCT00928668|3946069|P3|Overall Study|Withdrawal by Subject|1
1201157|NCT00928668|3946070|P2|Overall Study|Withdrawal by Subject|1
1201158|NCT00928668|3946071|P1|Overall Study|Withdrawal by Subject|0
1201159|NCT00928668|3946067|P5|Overall Study|Protocol Violation|1
1201160|NCT00928668|3946068|P4|Overall Study|Protocol Violation|0
1201161|NCT00928668|3946069|P3|Overall Study|Protocol Violation|0
1201162|NCT00928668|3946070|P2|Overall Study|Protocol Violation|0
1201163|NCT00928668|3946071|P1|Overall Study|Protocol Violation|0
1201164|NCT00928668|3946067|P5|Overall Study|Adverse Event|0
1201165|NCT00928668|3946068|P4|Overall Study|Adverse Event|0
1201166|NCT00928668|3946069|P3|Overall Study|Adverse Event|0
1201167|NCT00928668|3946070|P2|Overall Study|Adverse Event|0
1201168|NCT00928668|3946071|P1|Overall Study|Adverse Event|1
1201169|NCT00928512|3946127|P5|Overall Study|Administrative Problems|0
1201170|NCT00928512|3946128|P4|Overall Study|Administrative Problems|0
1201171|NCT00928512|3946129|P3|Overall Study|Administrative Problems|0
1201172|NCT00928512|3946130|P2|Overall Study|Administrative Problems|1
1201173|NCT00928512|3946131|P1|Overall Study|Administrative Problems|0
1201174|NCT00928512|3946127|P5|Overall Study|Lost to Follow-up|3
1201175|NCT00928512|3946128|P4|Overall Study|Lost to Follow-up|1
1201176|NCT00928512|3946129|P3|Overall Study|Lost to Follow-up|2
1201177|NCT00928512|3946130|P2|Overall Study|Lost to Follow-up|1
1201178|NCT00928512|3946131|P1|Overall Study|Lost to Follow-up|1
1201179|NCT00928512|3946127|P5|Overall Study|Withdrawal by Subject|0
1201180|NCT00928512|3946128|P4|Overall Study|Withdrawal by Subject|4
1201181|NCT00928512|3946129|P3|Overall Study|Withdrawal by Subject|3
1201182|NCT00928512|3946130|P2|Overall Study|Withdrawal by Subject|0
1201183|NCT00928512|3946131|P1|Overall Study|Withdrawal by Subject|3
1201184|NCT00928512|3946127|P5|Overall Study|Protocol Violation|3
1201185|NCT00928512|3946128|P4|Overall Study|Protocol Violation|1
1201186|NCT00928512|3946129|P3|Overall Study|Protocol Violation|0
1201187|NCT00928512|3946130|P2|Overall Study|Protocol Violation|1
1201188|NCT00928512|3946131|P1|Overall Study|Protocol Violation|0
1201189|NCT00928512|3946127|P5|Overall Study|Lack of Efficacy|3
1201190|NCT00928512|3946128|P4|Overall Study|Lack of Efficacy|7
1201191|NCT00928512|3946129|P3|Overall Study|Lack of Efficacy|4
1201192|NCT00928512|3946130|P2|Overall Study|Lack of Efficacy|0
1201193|NCT00928512|3946131|P1|Overall Study|Lack of Efficacy|2
1201194|NCT00928512|3946127|P5|Overall Study|Adverse Event|6
1201195|NCT00928512|3946128|P4|Overall Study|Adverse Event|8
1201196|NCT00928512|3946129|P3|Overall Study|Adverse Event|2
1201197|NCT00928512|3946130|P2|Overall Study|Adverse Event|3
1201198|NCT00928512|3946131|P1|Overall Study|Adverse Event|4
1201199|NCT00928486|3946232|P1|Overall Study|Withdrawal by Subject|1
1201200|NCT00928486|3946232|P1|Overall Study|Disease Progression|7
1201201|NCT00928486|3946232|P1|Overall Study|Adverse Event|2
1201202|NCT00928434|3946241|P3|Overall Study|Other (not meeting above criteria)|2
1201203|NCT00928434|3946242|P2|Overall Study|Other (not meeting above criteria)|1
1201204|NCT00928434|3946243|P1|Overall Study|Other (not meeting above criteria)|5
1201205|NCT00928434|3946241|P3|Overall Study|PSA failure (>2 ng/mL) on other visit|1
1201206|NCT00928434|3946242|P2|Overall Study|PSA failure (>2 ng/mL) on other visit|1
1201207|NCT00928434|3946243|P1|Overall Study|PSA failure (>2 ng/mL) on other visit|2
1201208|NCT00928434|3946241|P3|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7
1201209|NCT00928434|3946242|P2|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4
1201210|NCT00928434|3946243|P1|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10
1201211|NCT00928434|3946241|P3|Overall Study|Withdrawal by Subject|2
1201212|NCT00928434|3946242|P2|Overall Study|Withdrawal by Subject|3
1201213|NCT00928434|3946243|P1|Overall Study|Withdrawal by Subject|5
1201214|NCT00928434|3946241|P3|Overall Study|Lost to Follow-up|3
1201215|NCT00928434|3946242|P2|Overall Study|Lost to Follow-up|0
1201216|NCT00928434|3946243|P1|Overall Study|Lost to Follow-up|1
1201217|NCT00928434|3946241|P3|Overall Study|Physician Decision|3
1201218|NCT00928434|3946242|P2|Overall Study|Physician Decision|0
1201219|NCT00928434|3946243|P1|Overall Study|Physician Decision|2
1201220|NCT00928434|3946241|P3|Overall Study|Protocol Violation|8
1201221|NCT00928434|3946242|P2|Overall Study|Protocol Violation|0
1201222|NCT00928434|3946243|P1|Overall Study|Protocol Violation|5
1201223|NCT00928434|3946241|P3|Overall Study|Adverse Event|18
1201224|NCT00928434|3946242|P2|Overall Study|Adverse Event|5
1201225|NCT00928434|3946243|P1|Overall Study|Adverse Event|14
1201226|NCT00928408|3946319|P1|Overall Study|Lost to Follow-up|12
1201227|NCT00928408|3946319|P1|Overall Study|Death|5
1201228|NCT00928408|3946319|P1|Overall Study|Withdrawal by Subject|4
1201229|NCT00928408|3946319|P1|Overall Study|Other|2
1201230|NCT00928252|3946365|P1|Overall Study|Physician Decision|3
1201231|NCT00928187|3946374|P3|Overall Study|Protocol Violation|0
1201232|NCT00928187|3946375|P2|Overall Study|Protocol Violation|1
1201233|NCT00928187|3946376|P1|Overall Study|Protocol Violation|0
1201234|NCT00928187|3946374|P3|Overall Study|Withdrawal by Subject|1
1201235|NCT00928187|3946375|P2|Overall Study|Withdrawal by Subject|1
1201236|NCT00928187|3946376|P1|Overall Study|Withdrawal by Subject|0
1201237|NCT00928187|3946374|P3|Overall Study|Lost to Follow-up|1
1201238|NCT00928187|3946375|P2|Overall Study|Lost to Follow-up|2
1201239|NCT00928187|3946376|P1|Overall Study|Lost to Follow-up|1
1201240|NCT00928187|3946374|P3|Overall Study|Death|3
1201241|NCT00928187|3946375|P2|Overall Study|Death|2
1201242|NCT00928187|3946376|P1|Overall Study|Death|1
1201243|NCT00928070|3946546|P2|Overall Study|Other|5
1201244|NCT00928070|3946547|P1|Overall Study|Other|5
1201245|NCT00928070|3946546|P2|Overall Study|Randomized but not treated|2
1201246|NCT00928070|3946547|P1|Overall Study|Randomized but not treated|2
1201247|NCT00928070|3946546|P2|Overall Study|Protocol Violation|5
1201248|NCT00928070|3946547|P1|Overall Study|Protocol Violation|6
1201249|NCT00928070|3946546|P2|Overall Study|Did not meet entrance criteria|9
1201250|NCT00928070|3946547|P1|Overall Study|Did not meet entrance criteria|16
1201251|NCT00928070|3946546|P2|Overall Study|Lack of Efficacy|5
1201252|NCT00928070|3946547|P1|Overall Study|Lack of Efficacy|9
1201253|NCT00928070|3946546|P2|Overall Study|Adverse Event|26
1201254|NCT00928070|3946547|P1|Overall Study|Adverse Event|14
1201255|NCT00928070|3946546|P2|Overall Study|Withdrawal by Subject|3
1201256|NCT00928070|3946547|P1|Overall Study|Withdrawal by Subject|10
1201257|NCT00928070|3946546|P2|Overall Study|Lost to Follow-up|2
1201258|NCT00928070|3946547|P1|Overall Study|Lost to Follow-up|1
1201259|NCT00928057|3946605|P2|Overall Study|Protocol Violation|1
1201260|NCT00928057|3946606|P1|Overall Study|Protocol Violation|0
1201261|NCT00928057|3946605|P2|Overall Study|Lost to Follow-up|1
1201262|NCT00928057|3946606|P1|Overall Study|Lost to Follow-up|0
1201263|NCT00928057|3946605|P2|Overall Study|Withdrawal by Subject|0
1201264|NCT00928057|3946606|P1|Overall Study|Withdrawal by Subject|1
1201265|NCT00928057|3946605|P2|Overall Study|Adverse Event|2
1201266|NCT00928057|3946606|P1|Overall Study|Adverse Event|1
1201267|NCT00928018|3946631|P2|Overall Study|Withdrawal by Subject|0
1201268|NCT00928018|3946632|P1|Overall Study|Withdrawal by Subject|1
1201269|NCT00927953|3946662|P2|Overall Study|Death|1
1201270|NCT00927953|3946663|P1|Overall Study|Death|2
1201271|NCT00927940|3946677|P1|Overall Study|Death|1
1201272|NCT00927927|3946697|P15|Overall Study|Withdrawal by Subject|0
1201273|NCT00927927|3946698|P14|Overall Study|Withdrawal by Subject|0
1201274|NCT00927927|3946699|P13|Overall Study|Withdrawal by Subject|0
1201275|NCT00927927|3946700|P12|Overall Study|Withdrawal by Subject|2
1201276|NCT00927927|3946701|P11|Overall Study|Withdrawal by Subject|0
1201277|NCT00927927|3946702|P10|Overall Study|Withdrawal by Subject|0
1201278|NCT00927927|3946703|P9|Overall Study|Withdrawal by Subject|0
1201279|NCT00927927|3946704|P8|Overall Study|Withdrawal by Subject|2
1201280|NCT00927927|3946705|P7|Overall Study|Withdrawal by Subject|0
1201281|NCT00927927|3946706|P6|Overall Study|Withdrawal by Subject|0
1201282|NCT00927927|3946707|P5|Overall Study|Withdrawal by Subject|0
1201283|NCT00927927|3946708|P4|Overall Study|Withdrawal by Subject|0
1201284|NCT00927927|3946709|P3|Overall Study|Withdrawal by Subject|0
1201285|NCT00927927|3946710|P2|Overall Study|Withdrawal by Subject|0
1201286|NCT00927927|3946711|P1|Overall Study|Withdrawal by Subject|0
1201287|NCT00927901|3946758|P4|Treatment Period 4|Subject withdrew consent|0
1201288|NCT00927901|3946759|P3|Treatment Period 4|Subject withdrew consent|1
1201289|NCT00927901|3946760|P2|Treatment Period 4|Subject withdrew consent|0
1201290|NCT00927901|3946761|P1|Treatment Period 4|Subject withdrew consent|0
1201291|NCT00927901|3946758|P4|Treatment Period 4|Adverse Event|1
1201292|NCT00927901|3946759|P3|Treatment Period 4|Adverse Event|0
1201293|NCT00927901|3946760|P2|Treatment Period 4|Adverse Event|0
1201294|NCT00927901|3946761|P1|Treatment Period 4|Adverse Event|0
1201295|NCT00927901|3946758|P4|Treatment Period 1|Subject withdrew consent|0
1201296|NCT00927901|3946759|P3|Treatment Period 1|Subject withdrew consent|1
1201297|NCT00927901|3946760|P2|Treatment Period 1|Subject withdrew consent|0
1201298|NCT00927901|3946761|P1|Treatment Period 1|Subject withdrew consent|0
1201299|NCT00927862|3946802|P2|Overall Study|Missing data needed for endpt analyses|45
1201300|NCT00927862|3946803|P1|Overall Study|Missing data needed for endpt analyses|27
1201301|NCT00927823|3946838|P4|Continuous Dosing Period|Other|3
1201302|NCT00927823|3946839|P3|Continuous Dosing Period|Other|9
1201303|NCT00927823|3946840|P2|Continuous Dosing Period|Other|2
1201304|NCT00927823|3946841|P1|Continuous Dosing Period|Other|1
1201305|NCT00927823|3946838|P4|Continuous Dosing Period|Withdrawal by Subject|2
1201306|NCT00927823|3946839|P3|Continuous Dosing Period|Withdrawal by Subject|2
1201307|NCT00927823|3946840|P2|Continuous Dosing Period|Withdrawal by Subject|0
1201308|NCT00927823|3946841|P1|Continuous Dosing Period|Withdrawal by Subject|1
1201309|NCT00927823|3946838|P4|Continuous Dosing Period|Lost to Follow-up|0
1201310|NCT00927823|3946839|P3|Continuous Dosing Period|Lost to Follow-up|9
1201311|NCT00927823|3946840|P2|Continuous Dosing Period|Lost to Follow-up|1
1201312|NCT00927823|3946841|P1|Continuous Dosing Period|Lost to Follow-up|1
1201313|NCT00927823|3946838|P4|Continuous Dosing Period|Death|0
1201314|NCT00927823|3946839|P3|Continuous Dosing Period|Death|6
1201315|NCT00927823|3946840|P2|Continuous Dosing Period|Death|0
1201316|NCT00927823|3946841|P1|Continuous Dosing Period|Death|0
1201317|NCT00927758|3946905|P6|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
1201318|NCT00927758|3946906|P5|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
1201319|NCT00927758|3946907|P4|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
1201320|NCT00927758|3946908|P3|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
1201321|NCT00927758|3946909|P2|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
1201322|NCT00927758|3946910|P1|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
1201323|NCT00927758|3946905|P6|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
1201324|NCT00927758|3946906|P5|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
1201325|NCT00927758|3946907|P4|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
1201326|NCT00927758|3946908|P3|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
1201327|NCT00927758|3946909|P2|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
1201328|NCT00927758|3946910|P1|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
1201329|NCT00927589|3946918|P1|Overall Study|Non-compliance|1
1201330|NCT00927589|3946918|P1|Overall Study|Disease Progression|8
1201331|NCT00927589|3946918|P1|Overall Study|Adverse Event|2
1201332|NCT00927589|3946918|P1|Overall Study|Withdrawal by Subject|3
1201333|NCT00927589|3946918|P1|Overall Study|Physician Decision|1
1201334|NCT00927589|3946918|P1|Overall Study|Death|1
1201335|NCT00927563|3946948|P1|Overall Study|Withdrawal by Subject|1
1201336|NCT00927563|3946948|P1|Overall Study|Lost to Follow-up|1
1201337|NCT00927472|3946956|P2|Overall Study|Post treatment Assessment out of window|4
1201338|NCT00927472|3946957|P1|Overall Study|Post treatment Assessment out of window|0
1201339|NCT00927472|3946956|P2|Overall Study|Protocol Violation|1
1201340|NCT00927472|3946957|P1|Overall Study|Protocol Violation|0
1201341|NCT00927472|3946956|P2|Overall Study|Lost to Follow-up|6
1201342|NCT00927472|3946957|P1|Overall Study|Lost to Follow-up|1
1201343|NCT00927472|3946956|P2|Overall Study|Withdrawal by Subject|11
1201344|NCT00927472|3946957|P1|Overall Study|Withdrawal by Subject|10
1201345|NCT00927394|3946983|P2|Overall Study|Randomized in error|1
1201346|NCT00927394|3946984|P1|Overall Study|Randomized in error|0
1201347|NCT00927394|3946983|P2|Overall Study|Protocol deviation|13
1201348|NCT00927394|3946984|P1|Overall Study|Protocol deviation|16
1201349|NCT00927394|3946983|P2|Overall Study|Death|1
1201350|NCT00927394|3946984|P1|Overall Study|Death|1
1201351|NCT00927394|3946983|P2|Overall Study|Administrative Problem|0
1201352|NCT00927394|3946984|P1|Overall Study|Administrative Problem|1
1201353|NCT00927394|3946983|P2|Overall Study|Lost to Follow-up|14
1201354|NCT00927394|3946984|P1|Overall Study|Lost to Follow-up|8
1201355|NCT00927394|3946983|P2|Overall Study|Withdrawal by Subject|24
1201356|NCT00927394|3946984|P1|Overall Study|Withdrawal by Subject|20
1201357|NCT00927394|3946983|P2|Overall Study|Unsatisfactory therapeutic effect|23
1201358|NCT00927394|3946984|P1|Overall Study|Unsatisfactory therapeutic effect|17
1201359|NCT00927394|3946983|P2|Overall Study|Adverse Event|9
1201360|NCT00927394|3946984|P1|Overall Study|Adverse Event|14
1201361|NCT00927368|3947015|P3|Overall Study|cancellation of surgery|2
1201362|NCT00927368|3947016|P2|Overall Study|cancellation of surgery|1
1201363|NCT00927368|3947017|P1|Overall Study|cancellation of surgery|0
1201364|NCT00927368|3947015|P3|Overall Study|ineligible post randomization|1
1201365|NCT00927368|3947016|P2|Overall Study|ineligible post randomization|3
1201366|NCT00927368|3947017|P1|Overall Study|ineligible post randomization|0
1201367|NCT00927368|3947015|P3|Overall Study|equipment failure|0
1201368|NCT00927368|3947016|P2|Overall Study|equipment failure|0
1201369|NCT00927368|3947017|P1|Overall Study|equipment failure|1
1201370|NCT00927368|3947015|P3|Overall Study|Lost to Follow-up|0
1201371|NCT00927368|3947016|P2|Overall Study|Lost to Follow-up|0
1201372|NCT00927368|3947017|P1|Overall Study|Lost to Follow-up|4
1201373|NCT00927368|3947015|P3|Overall Study|enrollment in another study|2
1201374|NCT00927368|3947016|P2|Overall Study|enrollment in another study|1
1201375|NCT00927368|3947017|P1|Overall Study|enrollment in another study|1
1201376|NCT00927355|3947036|P2|Overall Study|Adverse Event|1
1201377|NCT00927355|3947037|P1|Overall Study|Adverse Event|1
1201378|NCT00927251|3947072|P1|Overall Study|Patients not implanted with 4296 lead|8
1201379|NCT00927186|3947078|P2|12 Months Primary Study|Withdrawal by Subject|1
1201380|NCT00927186|3947079|P1|12 Months Primary Study|Withdrawal by Subject|1
1201381|NCT00927186|3947078|P2|12 Months Primary Study|Protocol Violation|1
1201382|NCT00927186|3947079|P1|12 Months Primary Study|Protocol Violation|0
1201383|NCT00927186|3947078|P2|12 Months Primary Study|Lost to Follow-up|0
1201384|NCT00927186|3947079|P1|12 Months Primary Study|Lost to Follow-up|1
1201385|NCT00927186|3947078|P2|12 Months Primary Study|Adverse Event|2
1201386|NCT00927186|3947079|P1|12 Months Primary Study|Adverse Event|5
1201387|NCT00927095|3947209|P3|Overall Study|Physician Decision|1
1201388|NCT00927095|3947210|P2|Overall Study|Physician Decision|2
1201389|NCT00927095|3947211|P1|Overall Study|Physician Decision|1
1201390|NCT00927095|3947209|P3|Overall Study|Withdrawal by Subject|1
1201391|NCT00927095|3947210|P2|Overall Study|Withdrawal by Subject|1
1201392|NCT00927095|3947211|P1|Overall Study|Withdrawal by Subject|2
1201393|NCT00927095|3947209|P3|Overall Study|Adverse Event|0
1201394|NCT00927095|3947210|P2|Overall Study|Adverse Event|1
1201395|NCT00927095|3947211|P1|Overall Study|Adverse Event|3
1201396|NCT00927082|3947223|P4|Overall Study|Screen fail,Participant migrated,Unknown|1
1201397|NCT00927082|3947224|P3|Overall Study|Screen fail,Participant migrated,Unknown|2
1201398|NCT00927082|3947225|P2|Overall Study|Screen fail,Participant migrated,Unknown|0
1201399|NCT00927082|3947226|P1|Overall Study|Screen fail,Participant migrated,Unknown|0
1201400|NCT00927082|3947223|P4|Overall Study|Death|0
1201401|NCT00927082|3947224|P3|Overall Study|Death|1
1201402|NCT00927082|3947225|P2|Overall Study|Death|0
1201403|NCT00927082|3947226|P1|Overall Study|Death|0
1201404|NCT00927082|3947223|P4|Overall Study|Withdrawal by Subject|2
1201405|NCT00927082|3947224|P3|Overall Study|Withdrawal by Subject|7
1201406|NCT00927082|3947225|P2|Overall Study|Withdrawal by Subject|2
1201407|NCT00927082|3947226|P1|Overall Study|Withdrawal by Subject|3
1201408|NCT00927082|3947223|P4|Overall Study|Lost to Follow-up|16
1201409|NCT00927082|3947224|P3|Overall Study|Lost to Follow-up|12
1201410|NCT00927082|3947225|P2|Overall Study|Lost to Follow-up|8
1201411|NCT00927082|3947226|P1|Overall Study|Lost to Follow-up|9
1201412|NCT00927069|3947290|P4|Week 12 to Week 24|Had a vaccination, removed from study|0
1201413|NCT00927069|3947291|P3|Week 12 to Week 24|Had a vaccination, removed from study|0
1201414|NCT00927069|3947292|P2|Week 12 to Week 24|Had a vaccination, removed from study|0
1201415|NCT00927069|3947293|P1|Week 12 to Week 24|Had a vaccination, removed from study|1
1201416|NCT00927069|3947290|P4|Week 12 to Week 24|Withdrawal by Subject|0
1201417|NCT00927069|3947291|P3|Week 12 to Week 24|Withdrawal by Subject|0
1201418|NCT00927069|3947292|P2|Week 12 to Week 24|Withdrawal by Subject|0
1201419|NCT00927069|3947293|P1|Week 12 to Week 24|Withdrawal by Subject|1
1201420|NCT00927069|3947290|P4|Week 12 to Week 24|Lost to Follow-up|0
1201421|NCT00927069|3947291|P3|Week 12 to Week 24|Lost to Follow-up|1
1201422|NCT00927069|3947292|P2|Week 12 to Week 24|Lost to Follow-up|0
1201423|NCT00927069|3947293|P1|Week 12 to Week 24|Lost to Follow-up|0
1201424|NCT00927069|3947290|P4|Week 12 to Week 24|Lack of Efficacy|3
1201425|NCT00927069|3947291|P3|Week 12 to Week 24|Lack of Efficacy|2
1201426|NCT00927069|3947292|P2|Week 12 to Week 24|Lack of Efficacy|0
1201427|NCT00927069|3947293|P1|Week 12 to Week 24|Lack of Efficacy|0
1201428|NCT00927069|3947290|P4|Week 0 to Week 12|Worsening of psoriasis|0
1201429|NCT00927069|3947291|P3|Week 0 to Week 12|Worsening of psoriasis|0
1201430|NCT00927069|3947292|P2|Week 0 to Week 12|Worsening of psoriasis|1
1201431|NCT00927069|3947293|P1|Week 0 to Week 12|Worsening of psoriasis|1
1201432|NCT00926796|3947349|P2|Overall Study|Withdrawal by Subject|0
1201433|NCT00926796|3947350|P1|Overall Study|Withdrawal by Subject|1
1201434|NCT00926796|3947349|P2|Overall Study|Protocol Violation|11
1201435|NCT00926796|3947350|P1|Overall Study|Protocol Violation|15
1201436|NCT00926796|3947349|P2|Overall Study|Lost to Follow-up|13
1201437|NCT00926796|3947350|P1|Overall Study|Lost to Follow-up|22
1201438|NCT00926796|3947349|P2|Overall Study|Adverse Event|14
1201439|NCT00926796|3947350|P1|Overall Study|Adverse Event|7
1201440|NCT00926796|3947349|P2|Overall Study|Ineligible, but positive for gonorrhea|1
1201441|NCT00926796|3947350|P1|Overall Study|Ineligible, but positive for gonorrhea|1
1201442|NCT00926796|3947349|P2|Overall Study|Ineligible, negative for gonorrhea|60
1201443|NCT00926796|3947350|P1|Overall Study|Ineligible, negative for gonorrhea|57
1201444|NCT00926796|3947349|P2|Overall Study|Did not receive randomized treatment|7
1201445|NCT00926796|3947350|P1|Overall Study|Did not receive randomized treatment|4
1201446|NCT00926783|3947371|P2|Overall Study|Incomplete CFAE Procedures|3
1201447|NCT00926783|3947372|P1|Overall Study|Incomplete CFAE Procedures|3
1201448|NCT00926575|3947399|P2|Overall Study|Withdrawal by Subject|9
1201449|NCT00926575|3947400|P1|Overall Study|Withdrawal by Subject|8
1201450|NCT00926575|3947399|P2|Overall Study|Protocol Violation|0
1201451|NCT00926575|3947400|P1|Overall Study|Protocol Violation|1
1201452|NCT00926575|3947399|P2|Overall Study|Physician Decision|2
1201453|NCT00926575|3947400|P1|Overall Study|Physician Decision|1
1201454|NCT00926575|3947399|P2|Overall Study|Lost to Follow-up|1
1201455|NCT00926575|3947400|P1|Overall Study|Lost to Follow-up|1
1201456|NCT00926575|3947399|P2|Overall Study|Death|4
1201457|NCT00926575|3947400|P1|Overall Study|Death|4
1201458|NCT00926575|3947399|P2|Overall Study|Adverse Event|1
1201459|NCT00926575|3947400|P1|Overall Study|Adverse Event|1
1201460|NCT00926536|3947412|P2|Overall Study|Physician Decision|2
1201461|NCT00926536|3947413|P1|Overall Study|Physician Decision|1
1201462|NCT00926393|3947434|P2|Overall Study|Adverse Event|1
1201463|NCT00926393|3947435|P1|Overall Study|Adverse Event|1
1201464|NCT00926393|3947434|P2|Overall Study|Withdrawal by Subject|2
1201465|NCT00926393|3947435|P1|Overall Study|Withdrawal by Subject|1
1201466|NCT00926367|3947480|P2|Overall Study|Skin Irritation|2
1201467|NCT00926367|3947481|P1|Overall Study|Skin Irritation|1
1201468|NCT00926367|3947480|P2|Overall Study|Lost to Follow-up|0
1201469|NCT00926367|3947481|P1|Overall Study|Lost to Follow-up|1
1201470|NCT00926367|3947480|P2|Overall Study|Withdrawal by Subject|1
1201471|NCT00926367|3947481|P1|Overall Study|Withdrawal by Subject|0
1201472|NCT00926328|3947523|P2|Overall Study|Lost to Follow-up|14
1201473|NCT00926328|3947524|P1|Overall Study|Lost to Follow-up|12
1201474|NCT00926289|3947534|P2|Overall Study|not specified|3
1201475|NCT00926289|3947535|P1|Overall Study|not specified|1
1201476|NCT00926289|3947534|P2|Overall Study|Withdrawal by Subject|4
1201477|NCT00926289|3947535|P1|Overall Study|Withdrawal by Subject|4
1201478|NCT00926289|3947534|P2|Overall Study|Lost to Follow-up|6
1201479|NCT00926289|3947535|P1|Overall Study|Lost to Follow-up|3
1201480|NCT00926289|3947534|P2|Overall Study|Protocol Violation|12
1201481|NCT00926289|3947535|P1|Overall Study|Protocol Violation|8
1201482|NCT00926289|3947534|P2|Overall Study|Adverse Event|11
1201483|NCT00926289|3947535|P1|Overall Study|Adverse Event|9
1201484|NCT00926211|3947603|P1|Overall Study|Lost to Follow-up|1
1201485|NCT00926029|3947634|P3|Overall Study|Lost to Follow-up|1
1201486|NCT00926029|3947635|P2|Overall Study|Lost to Follow-up|1
1201487|NCT00926029|3947636|P1|Overall Study|Lost to Follow-up|2
1201488|NCT00925990|3947649|P2|Overall Study|moved out of state, missed medication|2
1201489|NCT00925990|3947650|P1|Overall Study|moved out of state, missed medication|0
1201490|NCT00925990|3947649|P2|Overall Study|Physician Decision|1
1201491|NCT00925990|3947650|P1|Overall Study|Physician Decision|1
1201492|NCT00925990|3947649|P2|Overall Study|Lost to Follow-up|3
1201493|NCT00925990|3947650|P1|Overall Study|Lost to Follow-up|1
1201494|NCT00925990|3947649|P2|Overall Study|Withdrawal by Subject|2
1201495|NCT00925990|3947650|P1|Overall Study|Withdrawal by Subject|2
1201496|NCT00925990|3947649|P2|Overall Study|Adverse Event|3
1201497|NCT00925990|3947650|P1|Overall Study|Adverse Event|1
1201498|NCT00925899|3947685|P2|Part 1|Withdrawal by Subject|9
1201499|NCT00925899|3947686|P1|Part 1|Withdrawal by Subject|10
1201500|NCT00925899|3947685|P2|Part 1|Death|2
1201501|NCT00925899|3947686|P1|Part 1|Death|1
1201502|NCT00925769|3947714|P6|Overall Study|Adverse Event|0
1201503|NCT00925769|3947715|P5|Overall Study|Adverse Event|1
1201504|NCT00925769|3947716|P4|Overall Study|Adverse Event|0
1201505|NCT00925769|3947717|P3|Overall Study|Adverse Event|0
1201506|NCT00925769|3947718|P2|Overall Study|Adverse Event|0
1201507|NCT00925769|3947719|P1|Overall Study|Adverse Event|0
1201508|NCT00925769|3947714|P6|Overall Study|Participant is unable to swallow drug|0
1201509|NCT00925769|3947715|P5|Overall Study|Participant is unable to swallow drug|0
1201510|NCT00925769|3947716|P4|Overall Study|Participant is unable to swallow drug|1
1201511|NCT00925769|3947717|P3|Overall Study|Participant is unable to swallow drug|0
1201512|NCT00925769|3947718|P2|Overall Study|Participant is unable to swallow drug|0
1201513|NCT00925769|3947719|P1|Overall Study|Participant is unable to swallow drug|0
1201514|NCT00925769|3947714|P6|Overall Study|End of study visit not done|0
1201515|NCT00925769|3947715|P5|Overall Study|End of study visit not done|0
1201516|NCT00925769|3947716|P4|Overall Study|End of study visit not done|0
1201517|NCT00925769|3947717|P3|Overall Study|End of study visit not done|1
1201518|NCT00925769|3947718|P2|Overall Study|End of study visit not done|0
1201519|NCT00925769|3947719|P1|Overall Study|End of study visit not done|0
1201520|NCT00925769|3947714|P6|Overall Study|Missing documentation|0
1201521|NCT00925769|3947715|P5|Overall Study|Missing documentation|0
1201522|NCT00925769|3947716|P4|Overall Study|Missing documentation|0
1201523|NCT00925769|3947717|P3|Overall Study|Missing documentation|0
1201524|NCT00925769|3947718|P2|Overall Study|Missing documentation|1
1201525|NCT00925769|3947719|P1|Overall Study|Missing documentation|0
1201526|NCT00925769|3947714|P6|Overall Study|Physician Decision|0
1201527|NCT00925769|3947715|P5|Overall Study|Physician Decision|0
1201528|NCT00925769|3947716|P4|Overall Study|Physician Decision|0
1201529|NCT00925769|3947717|P3|Overall Study|Physician Decision|0
1201530|NCT00925769|3947718|P2|Overall Study|Physician Decision|0
1201531|NCT00925769|3947719|P1|Overall Study|Physician Decision|1
1201532|NCT00925769|3947714|P6|Overall Study|Death|0
1201533|NCT00925769|3947715|P5|Overall Study|Death|0
1201534|NCT00925769|3947716|P4|Overall Study|Death|0
1201535|NCT00925769|3947717|P3|Overall Study|Death|1
1201536|NCT00925769|3947718|P2|Overall Study|Death|0
1201537|NCT00925769|3947719|P1|Overall Study|Death|0
1201538|NCT00925769|3947714|P6|Overall Study|Disease progression|3
1201539|NCT00925769|3947715|P5|Overall Study|Disease progression|2
1201540|NCT00925769|3947716|P4|Overall Study|Disease progression|4
1201541|NCT00925769|3947717|P3|Overall Study|Disease progression|3
1201542|NCT00925769|3947718|P2|Overall Study|Disease progression|5
1201543|NCT00925769|3947719|P1|Overall Study|Disease progression|4
1201544|NCT00925769|3947714|P6|Overall Study|Major toxicity|0
1201545|NCT00925769|3947715|P5|Overall Study|Major toxicity|0
1201546|NCT00925769|3947716|P4|Overall Study|Major toxicity|1
1201547|NCT00925769|3947717|P3|Overall Study|Major toxicity|1
1201548|NCT00925769|3947718|P2|Overall Study|Major toxicity|0
1201549|NCT00925769|3947719|P1|Overall Study|Major toxicity|1
1201550|NCT00925704|3947787|P6|Third Intervention|Withdrew consent|1
1201551|NCT00925704|3947788|P5|Third Intervention|Withdrew consent|0
1201552|NCT00925704|3947789|P4|Third Intervention|Withdrew consent|0
1201553|NCT00925704|3947790|P3|Third Intervention|Withdrew consent|0
1201554|NCT00925704|3947791|P2|Third Intervention|Withdrew consent|0
1201555|NCT00925704|3947792|P1|Third Intervention|Withdrew consent|0
1201556|NCT00925704|3947787|P6|Second Intervention|Withdrawal by Subject|0
1201557|NCT00925704|3947788|P5|Second Intervention|Withdrawal by Subject|1
1201558|NCT00925704|3947789|P4|Second Intervention|Withdrawal by Subject|0
1201559|NCT00925704|3947790|P3|Second Intervention|Withdrawal by Subject|0
1201560|NCT00925704|3947791|P2|Second Intervention|Withdrawal by Subject|0
1201561|NCT00925704|3947792|P1|Second Intervention|Withdrawal by Subject|1
1201562|NCT00925704|3947787|P6|First Intervention|Withdrew consent|0
1201563|NCT00925704|3947788|P5|First Intervention|Withdrew consent|1
1201564|NCT00925704|3947789|P4|First Intervention|Withdrew consent|1
1201565|NCT00925704|3947790|P3|First Intervention|Withdrew consent|0
1201566|NCT00925704|3947791|P2|First Intervention|Withdrew consent|0
1201567|NCT00925704|3947792|P1|First Intervention|Withdrew consent|0
1201568|NCT00925600|3947805|P2|Overall Study|Adverse Event|2
1201569|NCT00925600|3947806|P1|Overall Study|Adverse Event|1
1201570|NCT00925600|3947805|P2|Overall Study|Other|1
1201571|NCT00925600|3947806|P1|Overall Study|Other|3
1201572|NCT00925600|3947805|P2|Overall Study|Requirement for Alternative Therapy|1
1201573|NCT00925600|3947806|P1|Overall Study|Requirement for Alternative Therapy|0
1201574|NCT00925600|3947805|P2|Overall Study|Protocol Deviation|1
1201575|NCT00925600|3947806|P1|Overall Study|Protocol Deviation|0
1201576|NCT00925600|3947805|P2|Overall Study|Ineligibility Determined|0
1201577|NCT00925600|3947806|P1|Overall Study|Ineligibility Determined|2
1201578|NCT00925600|3947805|P2|Overall Study|Noncompliance|0
1201579|NCT00925600|3947806|P1|Overall Study|Noncompliance|2
1201580|NCT00925600|3947805|P2|Overall Study|Administrative Decision|1
1201581|NCT00925600|3947806|P1|Overall Study|Administrative Decision|1
1201582|NCT00925600|3947805|P2|Overall Study|Disease Progression|3
1201583|NCT00925600|3947806|P1|Overall Study|Disease Progression|1
1201584|NCT00925600|3947805|P2|Overall Study|Lost to Follow-up|2
1201585|NCT00925600|3947806|P1|Overall Study|Lost to Follow-up|2
1201586|NCT00925600|3947805|P2|Overall Study|Death|3
1201587|NCT00925600|3947806|P1|Overall Study|Death|4
1201588|NCT00925600|3947805|P2|Overall Study|Withdrawal by Subject|14
1201589|NCT00925600|3947806|P1|Overall Study|Withdrawal by Subject|16
1201590|NCT00925587|3947828|P2|Overall Study|Lost to Follow-up|1
1201591|NCT00925587|3947829|P1|Overall Study|Lost to Follow-up|0
1201592|NCT00925587|3947828|P2|Overall Study|Adverse Event|2
1201593|NCT00925587|3947829|P1|Overall Study|Adverse Event|6
1201594|NCT00925587|3947828|P2|Overall Study|Death|5
1201595|NCT00925587|3947829|P1|Overall Study|Death|5
1201596|NCT00925587|3947828|P2|Overall Study|Withdrawal by Subject|6
1201597|NCT00925587|3947829|P1|Overall Study|Withdrawal by Subject|9
1201598|NCT00925587|3947828|P2|Overall Study|Protocol Violation|4
1201599|NCT00925587|3947829|P1|Overall Study|Protocol Violation|6
1201600|NCT00925587|3947828|P2|Overall Study|Physician Decision|1
1201601|NCT00925587|3947829|P1|Overall Study|Physician Decision|4
1201602|NCT00925587|3947828|P2|Overall Study|Protocol Specified Criteria|6
1201603|NCT00925587|3947829|P1|Overall Study|Protocol Specified Criteria|6
1201604|NCT00925548|3947943|P2|Overall Study|Discontinuation of trial by sponsor|5
1201605|NCT00925548|3947944|P1|Overall Study|Discontinuation of trial by sponsor|10
1201606|NCT00925353|3947974|P1|Overall Study|Failed preliminary EKG or lab criteria.|3
1201607|NCT00925301|3947980|P4|12-Month Open-label Extension (Optional)|Lost to Follow-up|1
1201608|NCT00925301|3947981|P3|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
1201609|NCT00925301|3947982|P2|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
1201610|NCT00925301|3947983|P1|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
1201611|NCT00925301|3947980|P4|12-Month Open-label Extension (Optional)|Pregnancy|1
1201612|NCT00925301|3947981|P3|12-Month Open-label Extension (Optional)|Pregnancy|0
1201613|NCT00925301|3947982|P2|12-Month Open-label Extension (Optional)|Pregnancy|0
1201614|NCT00925301|3947983|P1|12-Month Open-label Extension (Optional)|Pregnancy|0
1201615|NCT00925301|3947980|P4|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1
1201616|NCT00925301|3947981|P3|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
1201617|NCT00925301|3947982|P2|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
1201618|NCT00925301|3947983|P1|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
1201619|NCT00925301|3947980|P4|6-Month Open-label (Stage 2)|Adverse Event|0
1201620|NCT00925301|3947981|P3|6-Month Open-label (Stage 2)|Adverse Event|2
1201621|NCT00925301|3947982|P2|6-Month Open-label (Stage 2)|Adverse Event|0
1201622|NCT00925301|3947983|P1|6-Month Open-label (Stage 2)|Adverse Event|0
1201623|NCT00925301|3947980|P4|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
1201624|NCT00925301|3947981|P3|6-Month Open-label (Stage 2)|Withdrawal by Subject|1
1201625|NCT00925301|3947982|P2|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
1201626|NCT00925301|3947983|P1|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
1201627|NCT00925301|3947980|P4|6-Month Double-blind (Stage 1)|Pregnancy|0
1201628|NCT00925301|3947981|P3|6-Month Double-blind (Stage 1)|Pregnancy|0
1201629|NCT00925301|3947982|P2|6-Month Double-blind (Stage 1)|Pregnancy|1
1201630|NCT00925301|3947983|P1|6-Month Double-blind (Stage 1)|Pregnancy|0
1201631|NCT00925301|3947980|P4|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
1201632|NCT00925301|3947981|P3|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
1201633|NCT00925301|3947982|P2|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2
1201634|NCT00925301|3947983|P1|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
1201635|NCT00925288|3947999|P2|Overall Study|Lost to Follow-up|7
1201636|NCT00925288|3948000|P1|Overall Study|Lost to Follow-up|9
1201637|NCT00925132|3948012|P5|Overall Study|Removed due to disease progression|4
1201638|NCT00925132|3948013|P4|Overall Study|Removed due to disease progression|0
1201639|NCT00925132|3948014|P3|Overall Study|Removed due to disease progression|0
1201640|NCT00925132|3948015|P2|Overall Study|Removed due to disease progression|0
1201641|NCT00925132|3948016|P1|Overall Study|Removed due to disease progression|0
1201642|NCT00925132|3948012|P5|Overall Study|Withdrawal by Subject|1
1201643|NCT00925132|3948013|P4|Overall Study|Withdrawal by Subject|0
1201644|NCT00925132|3948014|P3|Overall Study|Withdrawal by Subject|0
1201645|NCT00925132|3948015|P2|Overall Study|Withdrawal by Subject|0
1201646|NCT00925132|3948016|P1|Overall Study|Withdrawal by Subject|2
1201647|NCT00925015|3948035|P3|Overall Study|Withdrawal by Subject|1
1201648|NCT00925015|3948036|P2|Overall Study|Withdrawal by Subject|0
1201649|NCT00925015|3948037|P1|Overall Study|Withdrawal by Subject|0
1201650|NCT00925015|3948035|P3|Overall Study|Progressive Disease|4
1201651|NCT00925015|3948036|P2|Overall Study|Progressive Disease|3
1201652|NCT00925015|3948037|P1|Overall Study|Progressive Disease|7
1201653|NCT00925015|3948035|P3|Overall Study|Physician Decision|0
1201654|NCT00925015|3948036|P2|Overall Study|Physician Decision|1
1201655|NCT00925015|3948037|P1|Overall Study|Physician Decision|0
1201656|NCT00925015|3948035|P3|Overall Study|Adverse Event|1
1201657|NCT00925015|3948036|P2|Overall Study|Adverse Event|2
1201658|NCT00925015|3948037|P1|Overall Study|Adverse Event|1
1201659|NCT00924950|3948093|P1|Overall Study|Lost to Follow-up|2
1201660|NCT00924898|3948098|P1|Overall Study|Withdrawal by Subject|2
1201661|NCT00924781|3948135|P2|Overall Study|Study terminated by sponsor|10
1201662|NCT00924781|3948136|P1|Overall Study|Study terminated by sponsor|12
1201663|NCT00924729|3948170|P2|Overall Study|Protocol Violation|0
1201664|NCT00924729|3948171|P1|Overall Study|Protocol Violation|1
1201665|NCT00924729|3948170|P2|Overall Study|insufficient volume for analysis|0
1201666|NCT00924729|3948171|P1|Overall Study|insufficient volume for analysis|1
1201667|NCT00924651|3948181|P2|Overall Study|Incomplete Form|1
1201668|NCT00924651|3948182|P1|Overall Study|Incomplete Form|2
1201669|NCT00924651|3948181|P2|Overall Study|Changed Mind|1
1201670|NCT00924651|3948182|P1|Overall Study|Changed Mind|10
1201671|NCT00924651|3948181|P2|Overall Study|Medical|3
1201672|NCT00924651|3948182|P1|Overall Study|Medical|1
1201673|NCT00924651|3948181|P2|Overall Study|Noncompliant|4
1201674|NCT00924651|3948182|P1|Overall Study|Noncompliant|1
1201675|NCT00924651|3948181|P2|Overall Study|Overwhelmed|6
1201676|NCT00924651|3948182|P1|Overall Study|Overwhelmed|6
1201677|NCT00924651|3948181|P2|Overall Study|No Reason|7
1201678|NCT00924651|3948182|P1|Overall Study|No Reason|3
1201679|NCT00924651|3948181|P2|Overall Study|Chemo started too soon|3
1201680|NCT00924651|3948182|P1|Overall Study|Chemo started too soon|2
1201681|NCT00924638|3948190|P2|Overall Study|Physician Decision|3
1201682|NCT00924638|3948191|P1|Overall Study|Physician Decision|3
1201683|NCT00924638|3948190|P2|Overall Study|Withdrawal by Subject|7
1201684|NCT00924638|3948191|P1|Overall Study|Withdrawal by Subject|5
1201685|NCT00924638|3948190|P2|Overall Study|Lost to Follow-up|1
1201686|NCT00924638|3948191|P1|Overall Study|Lost to Follow-up|1
1201687|NCT00924638|3948190|P2|Overall Study|Death|2
1201688|NCT00924638|3948191|P1|Overall Study|Death|3
1201689|NCT00924560|3948213|P3|Overall Study|Miscellaneous Reasons|10
1201690|NCT00924560|3948214|P2|Overall Study|Miscellaneous Reasons|10
1201691|NCT00924560|3948215|P1|Overall Study|Miscellaneous Reasons|13
1201692|NCT00924560|3948213|P3|Overall Study|Lost to Follow-up|45
1201693|NCT00924560|3948214|P2|Overall Study|Lost to Follow-up|94
1201694|NCT00924560|3948215|P1|Overall Study|Lost to Follow-up|78
1201695|NCT00924560|3948213|P3|Overall Study|Pregnancy|1
1201696|NCT00924560|3948214|P2|Overall Study|Pregnancy|7
1201697|NCT00924560|3948215|P1|Overall Study|Pregnancy|5
1201698|NCT00924560|3948213|P3|Overall Study|Adverse Event|0
1201699|NCT00924560|3948214|P2|Overall Study|Adverse Event|33
1201700|NCT00924560|3948215|P1|Overall Study|Adverse Event|39
1201701|NCT00924560|3948213|P3|Overall Study|Withdrawal by Subject|18
1201702|NCT00924560|3948214|P2|Overall Study|Withdrawal by Subject|44
1201703|NCT00924560|3948215|P1|Overall Study|Withdrawal by Subject|50
1201704|NCT00924560|3948213|P3|Overall Study|Physician Decision|4
1201705|NCT00924560|3948214|P2|Overall Study|Physician Decision|3
1201706|NCT00924560|3948215|P1|Overall Study|Physician Decision|2
1201707|NCT00924560|3948213|P3|Overall Study|Non Compliance with the Protocol|4
1201708|NCT00924560|3948214|P2|Overall Study|Non Compliance with the Protocol|15
1201709|NCT00924560|3948215|P1|Overall Study|Non Compliance with the Protocol|20
1201710|NCT00924560|3948213|P3|Overall Study|Did Not Meet Protocol Requirements|1
1201711|NCT00924560|3948214|P2|Overall Study|Did Not Meet Protocol Requirements|2
1201712|NCT00924560|3948215|P1|Overall Study|Did Not Meet Protocol Requirements|4
1201713|NCT00924508|3948259|P1|Overall Study|Withdrawal by Subject|3
1201714|NCT00924469|3948273|P2|Overall Study|Lost to Follow-up|1
1201715|NCT00924469|3948274|P1|Overall Study|Lost to Follow-up|0
1201716|NCT00924469|3948273|P2|Overall Study|Withdrawal by Subject|1
1201717|NCT00924469|3948274|P1|Overall Study|Withdrawal by Subject|0
1201718|NCT00924469|3948273|P2|Overall Study|Adverse Event|0
1201719|NCT00924469|3948274|P1|Overall Study|Adverse Event|2
1201720|NCT00924443|3948296|P1|Overall Study|Protocol Violation|1
1201721|NCT00924443|3948296|P1|Overall Study|Physician Decision|2
1201722|NCT00924404|3948306|P2|Overall Study|Lost to Follow-up|4
1201723|NCT00924404|3948307|P1|Overall Study|Lost to Follow-up|6
1201724|NCT00924313|3948329|P1|Overall Study|not imaged due to failed tracer imaging|1
1201725|NCT00924287|3948341|P1|Overall Study|Death|1
1201726|NCT00924170|3948357|P2|Overall Study|Death|0
1201727|NCT00924170|3948358|P1|Overall Study|Death|1
1201728|NCT00924170|3948357|P2|Overall Study|Stopped due to neutralizing antibodies|0
1201729|NCT00924170|3948358|P1|Overall Study|Stopped due to neutralizing antibodies|3
1201730|NCT00924170|3948357|P2|Overall Study|Progressive disease|6
1201731|NCT00924170|3948358|P1|Overall Study|Progressive disease|3
1201732|NCT00924170|3948357|P2|Overall Study|Physician Decision|1
1201733|NCT00924170|3948358|P1|Overall Study|Physician Decision|0
1201734|NCT00924170|3948357|P2|Overall Study|Refused further treatment|1
1201735|NCT00924170|3948358|P1|Overall Study|Refused further treatment|0
1201736|NCT00923975|3948483|P1|Overall Study|Did not meet inclusion criteria|1
1201737|NCT00923936|3948502|P2|Overall Study|Continuing in follow up period|1
1201738|NCT00923936|3948503|P1|Overall Study|Continuing in follow up period|2
1201739|NCT00923936|3948502|P2|Overall Study|Lost to follow up|0
1201740|NCT00923936|3948503|P1|Overall Study|Lost to follow up|2
1201741|NCT00923936|3948502|P2|Overall Study|Adverse Event|1
1201742|NCT00923936|3948503|P1|Overall Study|Adverse Event|2
1201743|NCT00923936|3948502|P2|Overall Study|progressive disease on study|1
1201744|NCT00923936|3948503|P1|Overall Study|progressive disease on study|2
1201745|NCT00923845|3948532|P2|Induction Therapy|Poor performance status|2
1201746|NCT00923845|3948533|P1|Induction Therapy|Poor performance status|0
1201747|NCT00923364|3948559|P2|Overall Study|Did not go to transplant|0
1201748|NCT00923364|3948560|P1|Overall Study|Did not go to transplant|1
1201749|NCT00923364|3948559|P2|Overall Study|Death|0
1201750|NCT00923364|3948560|P1|Overall Study|Death|3
1201751|NCT00923351|3948572|P3|Overall Study|no apheresis/adequate tumor sample|12
1201752|NCT00923351|3948573|P2|Overall Study|no apheresis/adequate tumor sample|0
1201753|NCT00923351|3948574|P1|Overall Study|no apheresis/adequate tumor sample|0
1201754|NCT00923273|3948589|P5|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
1201755|NCT00923273|3948590|P4|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6
1201756|NCT00923273|3948591|P3|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
1201757|NCT00923273|3948592|P2|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
1201758|NCT00923273|3948593|P1|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
1201759|NCT00923273|3948589|P5|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
1201760|NCT00923273|3948590|P4|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1
1201761|NCT00923273|3948591|P3|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
1201762|NCT00923273|3948592|P2|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
1201763|NCT00923273|3948593|P1|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
1201764|NCT00923260|3948618|P2|Overall Study|Lost to Follow-up|1
1201765|NCT00923260|3948619|P1|Overall Study|Lost to Follow-up|1
1201766|NCT00923195|3948782|P2|Overall Study|Death|1
1201767|NCT00923195|3948783|P1|Overall Study|Death|0
1201768|NCT00923156|3948794|P3|Overall Study|Lack of Efficacy|1
1201769|NCT00923156|3948795|P2|Overall Study|Lack of Efficacy|0
1201770|NCT00923156|3948796|P1|Overall Study|Lack of Efficacy|0
1201771|NCT00923156|3948794|P3|Overall Study|Death|0
1201772|NCT00923156|3948795|P2|Overall Study|Death|1
1201773|NCT00923156|3948796|P1|Overall Study|Death|0
1201774|NCT00923156|3948794|P3|Overall Study|Withdrawal by Subject|0
1201775|NCT00923156|3948795|P2|Overall Study|Withdrawal by Subject|1
1201776|NCT00923156|3948796|P1|Overall Study|Withdrawal by Subject|0
1201777|NCT00923156|3948794|P3|Overall Study|Abnormal laboratory values|1
1201778|NCT00923156|3948795|P2|Overall Study|Abnormal laboratory values|0
1201779|NCT00923156|3948796|P1|Overall Study|Abnormal laboratory values|0
1201780|NCT00923156|3948794|P3|Overall Study|Adverse Event|1
1201781|NCT00923156|3948795|P2|Overall Study|Adverse Event|2
1201782|NCT00923156|3948796|P1|Overall Study|Adverse Event|0
1201783|NCT00923130|3948822|P1|Overall Study|Refused further treatment|2
1201784|NCT00923130|3948822|P1|Overall Study|Switched to alternative treatment|2
1201785|NCT00923130|3948822|P1|Overall Study|Discontinued treatment due to toxicities|3
1201786|NCT00923130|3948822|P1|Overall Study|Death|1
1201787|NCT00923130|3948822|P1|Overall Study|Stopped treatment due to progression|17
1201788|NCT00923091|3948857|P13|Period VI (Open-Label)|Other Reason|0
1201789|NCT00923091|3948858|P12|Period VI (Open-Label)|Other Reason|0
1201790|NCT00923091|3948859|P11|Period VI (Open-Label)|Other Reason|0
1201791|NCT00923091|3948860|P10|Period VI (Open-Label)|Other Reason|0
1201792|NCT00923091|3948861|P9|Period VI (Open-Label)|Other Reason|0
1201793|NCT00923091|3948862|P8|Period VI (Open-Label)|Other Reason|0
1201794|NCT00923091|3948863|P7|Period VI (Open-Label)|Other Reason|0
1201795|NCT00923091|3948864|P6|Period VI (Open-Label)|Other Reason|0
1201796|NCT00923091|3948865|P5|Period VI (Open-Label)|Other Reason|1
1201797|NCT00923091|3948866|P4|Period VI (Open-Label)|Other Reason|1
1201798|NCT00923091|3948867|P3|Period VI (Open-Label)|Other Reason|0
1201799|NCT00923091|3948868|P2|Period VI (Open-Label)|Other Reason|0
1201800|NCT00923091|3948869|P1|Period VI (Open-Label)|Other Reason|0
1201801|NCT00923091|3948857|P13|Period VI (Open-Label)|Lost to Follow-up|0
1201802|NCT00923091|3948858|P12|Period VI (Open-Label)|Lost to Follow-up|0
1201803|NCT00923091|3948859|P11|Period VI (Open-Label)|Lost to Follow-up|0
1201804|NCT00923091|3948860|P10|Period VI (Open-Label)|Lost to Follow-up|0
1201805|NCT00923091|3948861|P9|Period VI (Open-Label)|Lost to Follow-up|0
1201806|NCT00923091|3948862|P8|Period VI (Open-Label)|Lost to Follow-up|0
1201807|NCT00923091|3948863|P7|Period VI (Open-Label)|Lost to Follow-up|0
1201808|NCT00923091|3948864|P6|Period VI (Open-Label)|Lost to Follow-up|0
1201809|NCT00923091|3948865|P5|Period VI (Open-Label)|Lost to Follow-up|0
1201810|NCT00923091|3948866|P4|Period VI (Open-Label)|Lost to Follow-up|0
1201811|NCT00923091|3948867|P3|Period VI (Open-Label)|Lost to Follow-up|1
1201812|NCT00923091|3948868|P2|Period VI (Open-Label)|Lost to Follow-up|0
1201813|NCT00923091|3948869|P1|Period VI (Open-Label)|Lost to Follow-up|1
1201814|NCT00923091|3948857|P13|Period VI (Open-Label)|Protocol Violation|0
1201815|NCT00923091|3948858|P12|Period VI (Open-Label)|Protocol Violation|0
1201816|NCT00923091|3948859|P11|Period VI (Open-Label)|Protocol Violation|0
1201817|NCT00923091|3948860|P10|Period VI (Open-Label)|Protocol Violation|0
1201818|NCT00923091|3948861|P9|Period VI (Open-Label)|Protocol Violation|0
1201819|NCT00923091|3948862|P8|Period VI (Open-Label)|Protocol Violation|0
1201820|NCT00923091|3948863|P7|Period VI (Open-Label)|Protocol Violation|0
1201821|NCT00923091|3948864|P6|Period VI (Open-Label)|Protocol Violation|0
1201822|NCT00923091|3948865|P5|Period VI (Open-Label)|Protocol Violation|4
1201823|NCT00923091|3948866|P4|Period VI (Open-Label)|Protocol Violation|1
1201824|NCT00923091|3948867|P3|Period VI (Open-Label)|Protocol Violation|3
1201825|NCT00923091|3948868|P2|Period VI (Open-Label)|Protocol Violation|1
1201826|NCT00923091|3948869|P1|Period VI (Open-Label)|Protocol Violation|6
1201827|NCT00923091|3948857|P13|Period VI (Open-Label)|Withdrawal by Subject|0
1201828|NCT00923091|3948858|P12|Period VI (Open-Label)|Withdrawal by Subject|0
1201829|NCT00923091|3948859|P11|Period VI (Open-Label)|Withdrawal by Subject|0
1201830|NCT00923091|3948860|P10|Period VI (Open-Label)|Withdrawal by Subject|0
1201831|NCT00923091|3948861|P9|Period VI (Open-Label)|Withdrawal by Subject|0
1201832|NCT00923091|3948862|P8|Period VI (Open-Label)|Withdrawal by Subject|0
1201833|NCT00923091|3948863|P7|Period VI (Open-Label)|Withdrawal by Subject|0
1201834|NCT00923091|3948864|P6|Period VI (Open-Label)|Withdrawal by Subject|0
1201835|NCT00923091|3948865|P5|Period VI (Open-Label)|Withdrawal by Subject|1
1201836|NCT00923091|3948866|P4|Period VI (Open-Label)|Withdrawal by Subject|0
1201837|NCT00923091|3948867|P3|Period VI (Open-Label)|Withdrawal by Subject|5
1201838|NCT00923091|3948868|P2|Period VI (Open-Label)|Withdrawal by Subject|7
1201839|NCT00923091|3948869|P1|Period VI (Open-Label)|Withdrawal by Subject|15
1201840|NCT00923091|3948857|P13|Period VI (Open-Label)|Adverse Event|0
1201841|NCT00923091|3948858|P12|Period VI (Open-Label)|Adverse Event|0
1201842|NCT00923091|3948859|P11|Period VI (Open-Label)|Adverse Event|0
1201843|NCT00923091|3948860|P10|Period VI (Open-Label)|Adverse Event|0
1201844|NCT00923091|3948861|P9|Period VI (Open-Label)|Adverse Event|0
1201845|NCT00923091|3948862|P8|Period VI (Open-Label)|Adverse Event|0
1201846|NCT00923091|3948863|P7|Period VI (Open-Label)|Adverse Event|0
1201847|NCT00923091|3948864|P6|Period VI (Open-Label)|Adverse Event|0
1201848|NCT00923091|3948865|P5|Period VI (Open-Label)|Adverse Event|1
1201849|NCT00923091|3948866|P4|Period VI (Open-Label)|Adverse Event|1
1201850|NCT00923091|3948867|P3|Period VI (Open-Label)|Adverse Event|4
1201851|NCT00923091|3948868|P2|Period VI (Open-Label)|Adverse Event|0
1201852|NCT00923091|3948869|P1|Period VI (Open-Label)|Adverse Event|17
1201853|NCT00923091|3948857|P13|Period V (Double -Blind)|Lost to Follow-up|0
1201854|NCT00923091|3948858|P12|Period V (Double -Blind)|Lost to Follow-up|0
1201855|NCT00923091|3948859|P11|Period V (Double -Blind)|Lost to Follow-up|1
1201856|NCT00923091|3948860|P10|Period V (Double -Blind)|Lost to Follow-up|0
1201857|NCT00923091|3948861|P9|Period V (Double -Blind)|Lost to Follow-up|0
1201858|NCT00923091|3948862|P8|Period V (Double -Blind)|Lost to Follow-up|0
1201859|NCT00923091|3948863|P7|Period V (Double -Blind)|Lost to Follow-up|0
1201860|NCT00923091|3948864|P6|Period V (Double -Blind)|Lost to Follow-up|0
1201861|NCT00923091|3948865|P5|Period V (Double -Blind)|Lost to Follow-up|0
1201862|NCT00923091|3948866|P4|Period V (Double -Blind)|Lost to Follow-up|0
1201863|NCT00923091|3948867|P3|Period V (Double -Blind)|Lost to Follow-up|0
1201864|NCT00923091|3948868|P2|Period V (Double -Blind)|Lost to Follow-up|0
1201865|NCT00923091|3948869|P1|Period V (Double -Blind)|Lost to Follow-up|0
1201866|NCT00923091|3948857|P13|Period V (Double -Blind)|Protocol Violation|1
1201867|NCT00923091|3948858|P12|Period V (Double -Blind)|Protocol Violation|0
1201868|NCT00923091|3948859|P11|Period V (Double -Blind)|Protocol Violation|0
1201869|NCT00923091|3948860|P10|Period V (Double -Blind)|Protocol Violation|0
1201870|NCT00923091|3948861|P9|Period V (Double -Blind)|Protocol Violation|0
1201871|NCT00923091|3948862|P8|Period V (Double -Blind)|Protocol Violation|0
1201872|NCT00923091|3948863|P7|Period V (Double -Blind)|Protocol Violation|0
1201873|NCT00923091|3948864|P6|Period V (Double -Blind)|Protocol Violation|0
1201874|NCT00923091|3948865|P5|Period V (Double -Blind)|Protocol Violation|0
1201875|NCT00923091|3948866|P4|Period V (Double -Blind)|Protocol Violation|0
1201876|NCT00923091|3948867|P3|Period V (Double -Blind)|Protocol Violation|0
1201877|NCT00923091|3948868|P2|Period V (Double -Blind)|Protocol Violation|0
1201878|NCT00923091|3948869|P1|Period V (Double -Blind)|Protocol Violation|0
1201879|NCT00923091|3948857|P13|Period V (Double -Blind)|Withdrawal by Subject|1
1201880|NCT00923091|3948858|P12|Period V (Double -Blind)|Withdrawal by Subject|0
1201881|NCT00923091|3948859|P11|Period V (Double -Blind)|Withdrawal by Subject|0
1201882|NCT00923091|3948860|P10|Period V (Double -Blind)|Withdrawal by Subject|0
1201883|NCT00923091|3948861|P9|Period V (Double -Blind)|Withdrawal by Subject|1
1201884|NCT00923091|3948862|P8|Period V (Double -Blind)|Withdrawal by Subject|0
1201885|NCT00923091|3948863|P7|Period V (Double -Blind)|Withdrawal by Subject|0
1201886|NCT00923091|3948864|P6|Period V (Double -Blind)|Withdrawal by Subject|0
1201887|NCT00923091|3948865|P5|Period V (Double -Blind)|Withdrawal by Subject|0
1201888|NCT00923091|3948866|P4|Period V (Double -Blind)|Withdrawal by Subject|0
1201889|NCT00923091|3948867|P3|Period V (Double -Blind)|Withdrawal by Subject|0
1201890|NCT00923091|3948868|P2|Period V (Double -Blind)|Withdrawal by Subject|0
1201891|NCT00923091|3948869|P1|Period V (Double -Blind)|Withdrawal by Subject|0
1201892|NCT00923091|3948857|P13|Period IV (Double-Blind)|Protocol Violation|0
1201893|NCT00923091|3948858|P12|Period IV (Double-Blind)|Protocol Violation|0
1201894|NCT00923091|3948859|P11|Period IV (Double-Blind)|Protocol Violation|0
1201895|NCT00923091|3948860|P10|Period IV (Double-Blind)|Protocol Violation|0
1201896|NCT00923091|3948861|P9|Period IV (Double-Blind)|Protocol Violation|0
1201897|NCT00923091|3948862|P8|Period IV (Double-Blind)|Protocol Violation|0
1201898|NCT00923091|3948863|P7|Period IV (Double-Blind)|Protocol Violation|0
1201899|NCT00923091|3948864|P6|Period IV (Double-Blind)|Protocol Violation|0
1201900|NCT00923091|3948865|P5|Period IV (Double-Blind)|Protocol Violation|0
1201901|NCT00923091|3948866|P4|Period IV (Double-Blind)|Protocol Violation|0
1201902|NCT00923091|3948867|P3|Period IV (Double-Blind)|Protocol Violation|0
1201903|NCT00923091|3948868|P2|Period IV (Double-Blind)|Protocol Violation|1
1201904|NCT00923091|3948869|P1|Period IV (Double-Blind)|Protocol Violation|0
1201905|NCT00923091|3948857|P13|Period IV (Double-Blind)|Withdrawal by Subject|0
1201906|NCT00923091|3948858|P12|Period IV (Double-Blind)|Withdrawal by Subject|0
1201907|NCT00923091|3948859|P11|Period IV (Double-Blind)|Withdrawal by Subject|0
1201908|NCT00923091|3948860|P10|Period IV (Double-Blind)|Withdrawal by Subject|0
1201909|NCT00923091|3948861|P9|Period IV (Double-Blind)|Withdrawal by Subject|0
1201910|NCT00923091|3948862|P8|Period IV (Double-Blind)|Withdrawal by Subject|0
1201911|NCT00923091|3948863|P7|Period IV (Double-Blind)|Withdrawal by Subject|0
1201912|NCT00923091|3948864|P6|Period IV (Double-Blind)|Withdrawal by Subject|0
1201913|NCT00923091|3948865|P5|Period IV (Double-Blind)|Withdrawal by Subject|0
1201914|NCT00923091|3948866|P4|Period IV (Double-Blind)|Withdrawal by Subject|0
1201915|NCT00923091|3948867|P3|Period IV (Double-Blind)|Withdrawal by Subject|0
1201916|NCT00923091|3948868|P2|Period IV (Double-Blind)|Withdrawal by Subject|1
1201917|NCT00923091|3948869|P1|Period IV (Double-Blind)|Withdrawal by Subject|0
1201918|NCT00923091|3948857|P13|Period IV (Double-Blind)|Adverse Event|0
1201919|NCT00923091|3948858|P12|Period IV (Double-Blind)|Adverse Event|0
1201920|NCT00923091|3948859|P11|Period IV (Double-Blind)|Adverse Event|0
1201921|NCT00923091|3948860|P10|Period IV (Double-Blind)|Adverse Event|0
1201922|NCT00923091|3948861|P9|Period IV (Double-Blind)|Adverse Event|0
1201923|NCT00923091|3948862|P8|Period IV (Double-Blind)|Adverse Event|0
1201924|NCT00923091|3948863|P7|Period IV (Double-Blind)|Adverse Event|0
1201925|NCT00923091|3948864|P6|Period IV (Double-Blind)|Adverse Event|0
1201926|NCT00923091|3948865|P5|Period IV (Double-Blind)|Adverse Event|0
1201927|NCT00923091|3948866|P4|Period IV (Double-Blind)|Adverse Event|0
1201928|NCT00923091|3948867|P3|Period IV (Double-Blind)|Adverse Event|0
1201929|NCT00923091|3948868|P2|Period IV (Double-Blind)|Adverse Event|0
1201930|NCT00923091|3948869|P1|Period IV (Double-Blind)|Adverse Event|2
1201931|NCT00923091|3948857|P13|Period III (Single-Blind)|Lost to Follow-up|0
1201932|NCT00923091|3948858|P12|Period III (Single-Blind)|Lost to Follow-up|0
1201933|NCT00923091|3948859|P11|Period III (Single-Blind)|Lost to Follow-up|0
1201934|NCT00923091|3948860|P10|Period III (Single-Blind)|Lost to Follow-up|0
1201935|NCT00923091|3948861|P9|Period III (Single-Blind)|Lost to Follow-up|0
1201936|NCT00923091|3948862|P8|Period III (Single-Blind)|Lost to Follow-up|0
1201937|NCT00923091|3948863|P7|Period III (Single-Blind)|Lost to Follow-up|0
1201938|NCT00923091|3948864|P6|Period III (Single-Blind)|Lost to Follow-up|0
1201939|NCT00923091|3948865|P5|Period III (Single-Blind)|Lost to Follow-up|0
1201940|NCT00923091|3948866|P4|Period III (Single-Blind)|Lost to Follow-up|0
1201941|NCT00923091|3948867|P3|Period III (Single-Blind)|Lost to Follow-up|0
1201942|NCT00923091|3948868|P2|Period III (Single-Blind)|Lost to Follow-up|0
1201943|NCT00923091|3948869|P1|Period III (Single-Blind)|Lost to Follow-up|2
1201944|NCT00923091|3948857|P13|Period III (Single-Blind)|Protocol Violation|0
1201945|NCT00923091|3948858|P12|Period III (Single-Blind)|Protocol Violation|0
1201946|NCT00923091|3948859|P11|Period III (Single-Blind)|Protocol Violation|0
1201947|NCT00923091|3948860|P10|Period III (Single-Blind)|Protocol Violation|0
1201948|NCT00923091|3948861|P9|Period III (Single-Blind)|Protocol Violation|0
1201949|NCT00923091|3948862|P8|Period III (Single-Blind)|Protocol Violation|0
1201950|NCT00923091|3948863|P7|Period III (Single-Blind)|Protocol Violation|0
1201951|NCT00923091|3948864|P6|Period III (Single-Blind)|Protocol Violation|0
1201952|NCT00923091|3948865|P5|Period III (Single-Blind)|Protocol Violation|0
1201953|NCT00923091|3948866|P4|Period III (Single-Blind)|Protocol Violation|0
1201954|NCT00923091|3948867|P3|Period III (Single-Blind)|Protocol Violation|0
1201955|NCT00923091|3948868|P2|Period III (Single-Blind)|Protocol Violation|0
1201956|NCT00923091|3948869|P1|Period III (Single-Blind)|Protocol Violation|3
1201957|NCT00923091|3948857|P13|Period III (Single-Blind)|Withdrawal by Subject|0
1201958|NCT00923091|3948858|P12|Period III (Single-Blind)|Withdrawal by Subject|0
1201959|NCT00923091|3948859|P11|Period III (Single-Blind)|Withdrawal by Subject|0
1201960|NCT00923091|3948860|P10|Period III (Single-Blind)|Withdrawal by Subject|0
1201961|NCT00923091|3948861|P9|Period III (Single-Blind)|Withdrawal by Subject|0
1201962|NCT00923091|3948862|P8|Period III (Single-Blind)|Withdrawal by Subject|0
1201963|NCT00923091|3948863|P7|Period III (Single-Blind)|Withdrawal by Subject|0
1201964|NCT00923091|3948864|P6|Period III (Single-Blind)|Withdrawal by Subject|0
1201965|NCT00923091|3948865|P5|Period III (Single-Blind)|Withdrawal by Subject|0
1201966|NCT00923091|3948866|P4|Period III (Single-Blind)|Withdrawal by Subject|0
1201967|NCT00923091|3948867|P3|Period III (Single-Blind)|Withdrawal by Subject|0
1201968|NCT00923091|3948868|P2|Period III (Single-Blind)|Withdrawal by Subject|0
1201969|NCT00923091|3948869|P1|Period III (Single-Blind)|Withdrawal by Subject|10
1201970|NCT00923091|3948857|P13|Period III (Single-Blind)|Adverse Event|0
1201971|NCT00923091|3948858|P12|Period III (Single-Blind)|Adverse Event|0
1201972|NCT00923091|3948859|P11|Period III (Single-Blind)|Adverse Event|0
1201973|NCT00923091|3948860|P10|Period III (Single-Blind)|Adverse Event|0
1201974|NCT00923091|3948861|P9|Period III (Single-Blind)|Adverse Event|0
1201975|NCT00923091|3948862|P8|Period III (Single-Blind)|Adverse Event|0
1201976|NCT00923091|3948863|P7|Period III (Single-Blind)|Adverse Event|0
1201977|NCT00923091|3948864|P6|Period III (Single-Blind)|Adverse Event|0
1201978|NCT00923091|3948865|P5|Period III (Single-Blind)|Adverse Event|0
1201979|NCT00923091|3948866|P4|Period III (Single-Blind)|Adverse Event|0
1201980|NCT00923091|3948867|P3|Period III (Single-Blind)|Adverse Event|0
1201981|NCT00923091|3948868|P2|Period III (Single-Blind)|Adverse Event|0
1201982|NCT00923091|3948869|P1|Period III (Single-Blind)|Adverse Event|5
1201983|NCT00923091|3948857|P13|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
1201984|NCT00923091|3948858|P12|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
1201985|NCT00923091|3948859|P11|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
1201986|NCT00923091|3948860|P10|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
1201987|NCT00923091|3948861|P9|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
1201988|NCT00923091|3948862|P8|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
1201989|NCT00923091|3948863|P7|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
1201990|NCT00923091|3948864|P6|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
1201991|NCT00923091|3948865|P5|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
1201992|NCT00923091|3948866|P4|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
1201993|NCT00923091|3948867|P3|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
1201994|NCT00923091|3948868|P2|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
1201995|NCT00923091|3948869|P1|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
1201996|NCT00923091|3948857|P13|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
1201997|NCT00923091|3948858|P12|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
1201998|NCT00923091|3948859|P11|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
1201999|NCT00923091|3948860|P10|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
1202000|NCT00923091|3948861|P9|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
1202001|NCT00923091|3948862|P8|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
1202002|NCT00923091|3948863|P7|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
1202003|NCT00923091|3948864|P6|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1
1202004|NCT00923091|3948865|P5|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
1202005|NCT00923091|3948866|P4|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
1202006|NCT00923091|3948867|P3|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
1202007|NCT00923091|3948868|P2|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
1202008|NCT00923091|3948869|P1|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
1202009|NCT00923091|3948857|P13|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
1202010|NCT00923091|3948858|P12|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
1202011|NCT00923091|3948859|P11|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
1202012|NCT00923091|3948860|P10|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
1202013|NCT00923091|3948861|P9|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
1202014|NCT00923091|3948862|P8|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3
1202015|NCT00923091|3948863|P7|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
1202016|NCT00923091|3948864|P6|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2
1202017|NCT00923091|3948865|P5|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
1202018|NCT00923091|3948866|P4|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5
1202019|NCT00923091|3948867|P3|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
1202020|NCT00923091|3948868|P2|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
1202021|NCT00923091|3948869|P1|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
1202022|NCT00923091|3948857|P13|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
1202023|NCT00923091|3948858|P12|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
1202024|NCT00923091|3948859|P11|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
1202025|NCT00923091|3948860|P10|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
1202026|NCT00923091|3948861|P9|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
1202027|NCT00923091|3948862|P8|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
1202028|NCT00923091|3948863|P7|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
1202029|NCT00923091|3948864|P6|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
1202030|NCT00923091|3948865|P5|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7
1202031|NCT00923091|3948866|P4|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8
1202032|NCT00923091|3948867|P3|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
1202033|NCT00923091|3948868|P2|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
1202034|NCT00923091|3948869|P1|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4
1202035|NCT00923091|3948857|P13|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
1202036|NCT00923091|3948858|P12|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
1202037|NCT00923091|3948859|P11|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
1202038|NCT00923091|3948860|P10|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
1202039|NCT00923091|3948861|P9|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
1202040|NCT00923091|3948862|P8|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17
1202041|NCT00923091|3948863|P7|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9
1202042|NCT00923091|3948864|P6|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5
1202043|NCT00923091|3948865|P5|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10
1202044|NCT00923091|3948866|P4|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13
1202045|NCT00923091|3948867|P3|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7
1202046|NCT00923091|3948868|P2|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3
1202047|NCT00923091|3948869|P1|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11
1202048|NCT00923078|3948919|P3|First Intervention (Weeks 1-4)|No intervention per protocol|20
1202049|NCT00923078|3948920|P2|First Intervention (Weeks 1-4)|No intervention per protocol|0
1202050|NCT00923078|3948921|P1|First Intervention (Weeks 1-4)|No intervention per protocol|0
1202051|NCT00923078|3948919|P3|First Intervention (Weeks 1-4)|Withdrawal by Subject|0
1202052|NCT00923078|3948920|P2|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
1202053|NCT00923078|3948921|P1|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
1202054|NCT00922987|3948940|P1|Overall Study|Adverse Event|1
1202055|NCT00922987|3948940|P1|Overall Study|Protocol Violation|2
1202056|NCT00922987|3948940|P1|Overall Study|Insufficient clinical response|1
1202057|NCT00922935|3948955|P3|Overall Study|Lost to Follow-up|0
1202058|NCT00922935|3948956|P2|Overall Study|Lost to Follow-up|1
1202059|NCT00922935|3948957|P1|Overall Study|Lost to Follow-up|0
1202060|NCT00922935|3948955|P3|Overall Study|Physician Decision|0
1202061|NCT00922935|3948956|P2|Overall Study|Physician Decision|1
1202062|NCT00922935|3948957|P1|Overall Study|Physician Decision|1
1202063|NCT00922935|3948955|P3|Overall Study|Protocol Violation|0
1202064|NCT00922935|3948956|P2|Overall Study|Protocol Violation|3
1202065|NCT00922935|3948957|P1|Overall Study|Protocol Violation|0
1202066|NCT00922779|3948969|P1|Overall Study|Missing|1874
1202067|NCT00922779|3948969|P1|Overall Study|Other|27
1202068|NCT00922779|3948969|P1|Overall Study|Lost to Follow-up|44
1202069|NCT00922779|3948969|P1|Overall Study|Withdrawal by Subject|308
1202070|NCT00922779|3948969|P1|Overall Study|Pregnancy|7
1202071|NCT00922779|3948969|P1|Overall Study|Adverse Event|67
1202072|NCT00922766|3948976|P1|Overall Study|Adverse Event|1
1202073|NCT00922766|3948976|P1|Overall Study|Other|1
1202074|NCT00922766|3948976|P1|Overall Study|Withdrawal by Subject|2
1202075|NCT00922766|3948976|P1|Overall Study|Death|3
1202076|NCT00922636|3948994|P5|Overall Study|Lost to Follow-up|4
1202077|NCT00922636|3948995|P4|Overall Study|Lost to Follow-up|2
1202078|NCT00922636|3948996|P3|Overall Study|Lost to Follow-up|2
1202079|NCT00922636|3948997|P2|Overall Study|Lost to Follow-up|2
1202080|NCT00922636|3948998|P1|Overall Study|Lost to Follow-up|1
1202081|NCT00922636|3948994|P5|Overall Study|Parent/Caregiver Decision|2
1202082|NCT00922636|3948995|P4|Overall Study|Parent/Caregiver Decision|5
1202083|NCT00922636|3948996|P3|Overall Study|Parent/Caregiver Decision|3
1202084|NCT00922636|3948997|P2|Overall Study|Parent/Caregiver Decision|4
1202085|NCT00922636|3948998|P1|Overall Study|Parent/Caregiver Decision|2
1202086|NCT00922636|3948994|P5|Overall Study|Entry Criteria Not Met|0
1202087|NCT00922636|3948995|P4|Overall Study|Entry Criteria Not Met|1
1202088|NCT00922636|3948996|P3|Overall Study|Entry Criteria Not Met|1
1202089|NCT00922636|3948997|P2|Overall Study|Entry Criteria Not Met|0
1202090|NCT00922636|3948998|P1|Overall Study|Entry Criteria Not Met|0
1202091|NCT00922636|3948994|P5|Overall Study|Protocol Violation|0
1202092|NCT00922636|3948995|P4|Overall Study|Protocol Violation|2
1202093|NCT00922636|3948996|P3|Overall Study|Protocol Violation|2
1202094|NCT00922636|3948997|P2|Overall Study|Protocol Violation|0
1202095|NCT00922636|3948998|P1|Overall Study|Protocol Violation|0
1202096|NCT00922636|3948994|P5|Overall Study|Withdrawal by Subject|4
1202097|NCT00922636|3948995|P4|Overall Study|Withdrawal by Subject|2
1202098|NCT00922636|3948996|P3|Overall Study|Withdrawal by Subject|5
1202099|NCT00922636|3948997|P2|Overall Study|Withdrawal by Subject|0
1202100|NCT00922636|3948998|P1|Overall Study|Withdrawal by Subject|0
1202101|NCT00922636|3948994|P5|Overall Study|Sponsor Decision|0
1202102|NCT00922636|3948995|P4|Overall Study|Sponsor Decision|0
1202103|NCT00922636|3948996|P3|Overall Study|Sponsor Decision|2
1202104|NCT00922636|3948997|P2|Overall Study|Sponsor Decision|0
1202105|NCT00922636|3948998|P1|Overall Study|Sponsor Decision|0
1202106|NCT00922636|3948994|P5|Overall Study|Lack of Efficacy|4
1202107|NCT00922636|3948995|P4|Overall Study|Lack of Efficacy|2
1202108|NCT00922636|3948996|P3|Overall Study|Lack of Efficacy|3
1202109|NCT00922636|3948997|P2|Overall Study|Lack of Efficacy|7
1202110|NCT00922636|3948998|P1|Overall Study|Lack of Efficacy|1
1202111|NCT00922636|3948994|P5|Overall Study|Adverse Event|2
1202112|NCT00922636|3948995|P4|Overall Study|Adverse Event|3
1202113|NCT00922636|3948996|P3|Overall Study|Adverse Event|2
1202114|NCT00922636|3948997|P2|Overall Study|Adverse Event|3
1202115|NCT00922636|3948998|P1|Overall Study|Adverse Event|3
1202116|NCT00922623|3949145|P1|Overall Study|Lost to Follow-up|1
1202117|NCT00922623|3949145|P1|Overall Study|Other|4
1202118|NCT00922480|3949153|P2|Extension Study|Others|1
1202119|NCT00922480|3949154|P1|Extension Study|Others|0
1202120|NCT00922480|3949153|P2|Extension Study|Withdrawal by Subject|1
1202121|NCT00922480|3949154|P1|Extension Study|Withdrawal by Subject|1
1202122|NCT00922480|3949153|P2|Extension Study|Adverse Event|1
1202123|NCT00922480|3949154|P1|Extension Study|Adverse Event|1
1202124|NCT00922480|3949153|P2|Extension Study|Protocol Violation|0
1202125|NCT00922480|3949154|P1|Extension Study|Protocol Violation|3
1202126|NCT00922480|3949153|P2|Main Study|Physician Decision|1
1202127|NCT00922480|3949154|P1|Main Study|Physician Decision|0
1202128|NCT00922480|3949153|P2|Main Study|Lost to Follow-up|0
1202129|NCT00922480|3949154|P1|Main Study|Lost to Follow-up|5
1202130|NCT00922480|3949153|P2|Main Study|Withdrawal by Subject|15
1202131|NCT00922480|3949154|P1|Main Study|Withdrawal by Subject|20
1202132|NCT00922480|3949153|P2|Main Study|Lack of Efficacy|0
1202133|NCT00922480|3949154|P1|Main Study|Lack of Efficacy|3
1202134|NCT00922480|3949153|P2|Main Study|Adverse Event|7
1202135|NCT00922480|3949154|P1|Main Study|Adverse Event|6
1202136|NCT00922480|3949153|P2|Main Study|Protocol Violation|6
1202137|NCT00922480|3949154|P1|Main Study|Protocol Violation|3
1202138|NCT00922441|3949165|P3|Overall Study|Withdrawal by Subject|1
1202139|NCT00922441|3949166|P2|Overall Study|Withdrawal by Subject|0
1202140|NCT00922441|3949167|P1|Overall Study|Withdrawal by Subject|0
1202141|NCT00922441|3949165|P3|Overall Study|Protocol Violation|2
1202142|NCT00922441|3949166|P2|Overall Study|Protocol Violation|0
1202143|NCT00922441|3949167|P1|Overall Study|Protocol Violation|0
1202144|NCT00922428|3949175|P1|Overall Study|no medication use or questionable use|13
1202145|NCT00922428|3949175|P1|Overall Study|retrospective/extremely implausible data|2
1202146|NCT00922272|3949204|P2|Double-blind Phase|Positive urine drug screen|1
1202147|NCT00922272|3949205|P1|Double-blind Phase|Positive urine drug screen|1
1202148|NCT00922272|3949204|P2|Double-blind Phase|Noncompliance|1
1202149|NCT00922272|3949205|P1|Double-blind Phase|Noncompliance|1
1202150|NCT00922272|3949204|P2|Double-blind Phase|Withdrawal criteria met|1
1202151|NCT00922272|3949205|P1|Double-blind Phase|Withdrawal criteria met|1
1202152|NCT00922272|3949204|P2|Double-blind Phase|Lost to Follow-up|1
1202153|NCT00922272|3949205|P1|Double-blind Phase|Lost to Follow-up|2
1202154|NCT00922272|3949204|P2|Double-blind Phase|Withdrawal by Subject|1
1202155|NCT00922272|3949205|P1|Double-blind Phase|Withdrawal by Subject|1
1202156|NCT00922272|3949204|P2|Double-blind Phase|Adverse Event|1
1202157|NCT00922272|3949205|P1|Double-blind Phase|Adverse Event|1
1202158|NCT00922272|3949204|P2|Open-label Phase|Withdrawal criteria met|0
1202159|NCT00922272|3949205|P1|Open-label Phase|Withdrawal criteria met|5
1202160|NCT00922272|3949204|P2|Open-label Phase|Failure to meet randomization criteria|0
1202161|NCT00922272|3949205|P1|Open-label Phase|Failure to meet randomization criteria|1
1202162|NCT00922272|3949204|P2|Open-label Phase|Withdrawal by Subject|0
1202163|NCT00922272|3949205|P1|Open-label Phase|Withdrawal by Subject|11
1202164|NCT00922272|3949204|P2|Open-label Phase|Protocol Violation|0
1202165|NCT00922272|3949205|P1|Open-label Phase|Protocol Violation|1
1202166|NCT00922272|3949204|P2|Open-label Phase|Adverse Event|0
1202167|NCT00922272|3949205|P1|Open-label Phase|Adverse Event|5
1202168|NCT00922207|3949270|P3|Overall Study|Abnormality of Laboratory Test|1
1202169|NCT00922207|3949271|P2|Overall Study|Abnormality of Laboratory Test|1
1202170|NCT00922207|3949272|P1|Overall Study|Abnormality of Laboratory Test|0
1202171|NCT00922207|3949270|P3|Overall Study|Withdrew Consent|2
1202172|NCT00922207|3949271|P2|Overall Study|Withdrew Consent|5
1202173|NCT00922207|3949272|P1|Overall Study|Withdrew Consent|2
1202174|NCT00922207|3949270|P3|Overall Study|Refused Treatment/Did Not Cooperate|0
1202175|NCT00922207|3949271|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
1202176|NCT00922207|3949272|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
1202177|NCT00922207|3949270|P3|Overall Study|Violation of Selection Criteria at Entry|0
1202178|NCT00922207|3949271|P2|Overall Study|Violation of Selection Criteria at Entry|1
1202179|NCT00922207|3949272|P1|Overall Study|Violation of Selection Criteria at Entry|0
1202180|NCT00922207|3949270|P3|Overall Study|Insufficient Therapeutic Response|1
1202181|NCT00922207|3949271|P2|Overall Study|Insufficient Therapeutic Response|0
1202182|NCT00922207|3949272|P1|Overall Study|Insufficient Therapeutic Response|0
1202183|NCT00922207|3949270|P3|Overall Study|Adverse Event/Intercurrent Illness|0
1202184|NCT00922207|3949271|P2|Overall Study|Adverse Event/Intercurrent Illness|0
1202185|NCT00922207|3949272|P1|Overall Study|Adverse Event/Intercurrent Illness|3
1202186|NCT00922116|3949308|P1|Overall Study|Other|5
1202187|NCT00922116|3949308|P1|Overall Study|Withdrawal by Subject|4
1202188|NCT00922116|3949308|P1|Overall Study|Lost to Follow-up|1
1202189|NCT00922116|3949308|P1|Overall Study|Death|1
1202190|NCT00922116|3949308|P1|Overall Study|Adverse Event|4
1202191|NCT00921557|3949353|P3|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
1202192|NCT00921557|3949354|P2|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
1202193|NCT00921557|3949355|P1|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2
1202194|NCT00921557|3949353|P3|Weeks 96-144 (Off Study Treatment)|Site closure|0
1202195|NCT00921557|3949354|P2|Weeks 96-144 (Off Study Treatment)|Site closure|0
1202196|NCT00921557|3949355|P1|Weeks 96-144 (Off Study Treatment)|Site closure|1
1202197|NCT00921557|3949353|P3|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1
1202198|NCT00921557|3949354|P2|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
1202199|NCT00921557|3949355|P1|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
1202200|NCT00921557|3949353|P3|Weeks 48-96 (on Study Treatment)|Site Closure|0
1202201|NCT00921557|3949354|P2|Weeks 48-96 (on Study Treatment)|Site Closure|1
1202202|NCT00921557|3949355|P1|Weeks 48-96 (on Study Treatment)|Site Closure|0
1202203|NCT00921557|3949353|P3|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
1202204|NCT00921557|3949354|P2|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
1202205|NCT00921557|3949355|P1|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2
1202206|NCT00921024|3949457|P2|Overall Study|Withdrawal by Subject|3
1202207|NCT00921024|3949458|P1|Overall Study|Withdrawal by Subject|0
1202208|NCT00921024|3949457|P2|Overall Study|Received concomittant therapy|0
1202209|NCT00921024|3949458|P1|Overall Study|Received concomittant therapy|2
1202210|NCT00921024|3949457|P2|Overall Study|Lost to Follow-up|0
1202211|NCT00921024|3949458|P1|Overall Study|Lost to Follow-up|2
1202212|NCT00920907|3949468|P2|Maintenance Period|Adverse Event|1
1202213|NCT00920907|3949469|P1|Maintenance Period|Adverse Event|0
1202214|NCT00920907|3949468|P2|Maintenance Period|Withdrawal by Subject|0
1202215|NCT00920907|3949469|P1|Maintenance Period|Withdrawal by Subject|1
1202216|NCT00920907|3949468|P2|Maintenance Period|Death|1
1202217|NCT00920907|3949469|P1|Maintenance Period|Death|1
1202218|NCT00920907|3949468|P2|Maintenance Period|Study Drug Toxicity|2
1202219|NCT00920907|3949469|P1|Maintenance Period|Study Drug Toxicity|0
1202220|NCT00920907|3949468|P2|Maintenance Period|Administrative (study closure)|2
1202221|NCT00920907|3949469|P1|Maintenance Period|Administrative (study closure)|7
1202222|NCT00920907|3949468|P2|Maintenance Period|Disease Progression|7
1202223|NCT00920907|3949469|P1|Maintenance Period|Disease Progression|3
1202224|NCT00920907|3949468|P2|Induction Period|Withdrawal by Subject|1
1202225|NCT00920907|3949469|P1|Induction Period|Withdrawal by Subject|1
1202226|NCT00920907|3949468|P2|Induction Period|No longer meets study criteria|1
1202227|NCT00920907|3949469|P1|Induction Period|No longer meets study criteria|0
1202228|NCT00920907|3949468|P2|Induction Period|Study Drug Toxicity|6
1202229|NCT00920907|3949469|P1|Induction Period|Study Drug Toxicity|8
1202230|NCT00920907|3949468|P2|Induction Period|Disease Progression|11
1202231|NCT00920907|3949469|P1|Induction Period|Disease Progression|12
1202232|NCT00920907|3949468|P2|Induction Period|Death|1
1202233|NCT00920907|3949469|P1|Induction Period|Death|1
1202234|NCT00920907|3949468|P2|Induction Period|Adverse Event|2
1202235|NCT00920907|3949469|P1|Induction Period|Adverse Event|0
1202236|NCT00920855|3949510|P3|Overall Study|Response plateau; started maintenance|1
1202237|NCT00920855|3949511|P2|Overall Study|Response plateau; started maintenance|0
1202238|NCT00920855|3949512|P1|Overall Study|Response plateau; started maintenance|0
1202239|NCT00920855|3949510|P3|Overall Study|Noncompliance to study medication|1
1202240|NCT00920855|3949511|P2|Overall Study|Noncompliance to study medication|0
1202241|NCT00920855|3949512|P1|Overall Study|Noncompliance to study medication|0
1202242|NCT00920855|3949510|P3|Overall Study|Disease progression|10
1202243|NCT00920855|3949511|P2|Overall Study|Disease progression|1
1202244|NCT00920855|3949512|P1|Overall Study|Disease progression|2
1202245|NCT00920855|3949510|P3|Overall Study|Withdrawal by Subject|6
1202246|NCT00920855|3949511|P2|Overall Study|Withdrawal by Subject|1
1202247|NCT00920855|3949512|P1|Overall Study|Withdrawal by Subject|2
1202248|NCT00920855|3949510|P3|Overall Study|Adverse Event|4
1202249|NCT00920855|3949511|P2|Overall Study|Adverse Event|1
1202250|NCT00920855|3949512|P1|Overall Study|Adverse Event|1
1202251|NCT00920829|3949538|P4|Available for Analysis|Required more treatment|1
1202252|NCT00920829|3949539|P3|Available for Analysis|Required more treatment|0
1202253|NCT00920829|3949540|P2|Available for Analysis|Required more treatment|2
1202254|NCT00920829|3949541|P1|Available for Analysis|Required more treatment|0
1202255|NCT00920829|3949538|P4|Available for Analysis|Protocol Violation|0
1202256|NCT00920829|3949539|P3|Available for Analysis|Protocol Violation|1
1202257|NCT00920829|3949540|P2|Available for Analysis|Protocol Violation|0
1202258|NCT00920829|3949541|P1|Available for Analysis|Protocol Violation|0
1202259|NCT00920829|3949538|P4|Available for Analysis|Death|0
1202260|NCT00920829|3949539|P3|Available for Analysis|Death|0
1202261|NCT00920829|3949540|P2|Available for Analysis|Death|0
1202262|NCT00920829|3949541|P1|Available for Analysis|Death|1
1202263|NCT00920829|3949538|P4|Available for Analysis|Adverse Event|0
1202264|NCT00920829|3949539|P3|Available for Analysis|Adverse Event|1
1202265|NCT00920829|3949540|P2|Available for Analysis|Adverse Event|2
1202266|NCT00920829|3949541|P1|Available for Analysis|Adverse Event|1
1202267|NCT00920829|3949538|P4|Available for Analysis|Required Medical Treatment|0
1202268|NCT00920829|3949539|P3|Available for Analysis|Required Medical Treatment|2
1202269|NCT00920829|3949540|P2|Available for Analysis|Required Medical Treatment|1
1202270|NCT00920829|3949541|P1|Available for Analysis|Required Medical Treatment|0
1202271|NCT00920829|3949538|P4|Available for Analysis|Withdrawal by Subject|10
1202272|NCT00920829|3949539|P3|Available for Analysis|Withdrawal by Subject|6
1202273|NCT00920829|3949540|P2|Available for Analysis|Withdrawal by Subject|6
1202274|NCT00920829|3949541|P1|Available for Analysis|Withdrawal by Subject|6
1202275|NCT00920829|3949538|P4|Allocation|No post randomization data|2
1202276|NCT00920829|3949539|P3|Allocation|No post randomization data|0
1202277|NCT00920829|3949540|P2|Allocation|No post randomization data|1
1202278|NCT00920829|3949541|P1|Allocation|No post randomization data|3
1202279|NCT00920816|3949555|P4|Overall Study|Ongoing|36
1202280|NCT00920816|3949556|P3|Overall Study|Ongoing|70
1202281|NCT00920816|3949557|P2|Overall Study|Ongoing|56
1202282|NCT00920816|3949558|P1|Overall Study|Ongoing|106
1202283|NCT00920816|3949555|P4|Overall Study|Withdrawal by Subject|1
1202284|NCT00920816|3949556|P3|Overall Study|Withdrawal by Subject|1
1202285|NCT00920816|3949557|P2|Overall Study|Withdrawal by Subject|2
1202286|NCT00920816|3949558|P1|Overall Study|Withdrawal by Subject|7
1202287|NCT00920816|3949555|P4|Overall Study|Objective progression or relapse|0
1202288|NCT00920816|3949556|P3|Overall Study|Objective progression or relapse|2
1202289|NCT00920816|3949557|P2|Overall Study|Objective progression or relapse|0
1202290|NCT00920816|3949558|P1|Overall Study|Objective progression or relapse|0
1202291|NCT00920816|3949555|P4|Overall Study|Lost to Follow-up|4
1202292|NCT00920816|3949556|P3|Overall Study|Lost to Follow-up|3
1202293|NCT00920816|3949557|P2|Overall Study|Lost to Follow-up|2
1202294|NCT00920816|3949558|P1|Overall Study|Lost to Follow-up|1
1202295|NCT00920816|3949555|P4|Overall Study|Adverse Event|0
1202296|NCT00920816|3949556|P3|Overall Study|Adverse Event|1
1202297|NCT00920816|3949557|P2|Overall Study|Adverse Event|0
1202298|NCT00920816|3949558|P1|Overall Study|Adverse Event|1
1202299|NCT00920816|3949555|P4|Overall Study|Death|28
1202300|NCT00920816|3949556|P3|Overall Study|Death|58
1202301|NCT00920816|3949557|P2|Overall Study|Death|36
1202302|NCT00920816|3949558|P1|Overall Study|Death|77
1202303|NCT00920790|3949596|P1|Overall Study|aggravation of general condition|14
1202304|NCT00920699|3949608|P3|Overall Study|Lost to Follow-up|2
1202305|NCT00920699|3949609|P2|Overall Study|Lost to Follow-up|0
1202306|NCT00920699|3949610|P1|Overall Study|Lost to Follow-up|0
1202307|NCT00920699|3949608|P3|Overall Study|no longer met eligibility|0
1202308|NCT00920699|3949609|P2|Overall Study|no longer met eligibility|1
1202309|NCT00920699|3949610|P1|Overall Study|no longer met eligibility|0
1202310|NCT00920699|3949608|P3|Overall Study|Withdrawal by Subject|2
1202311|NCT00920699|3949609|P2|Overall Study|Withdrawal by Subject|0
1202312|NCT00920699|3949610|P1|Overall Study|Withdrawal by Subject|2
1202313|NCT00920686|3949627|P3|Overall Study|Study drug dosing criteria not met|12
1202314|NCT00920686|3949628|P2|Overall Study|Study drug dosing criteria not met|19
1202315|NCT00920686|3949629|P1|Overall Study|Study drug dosing criteria not met|17
1202316|NCT00920686|3949627|P3|Overall Study|Lost to Follow-up|1
1202317|NCT00920686|3949628|P2|Overall Study|Lost to Follow-up|3
1202318|NCT00920686|3949629|P1|Overall Study|Lost to Follow-up|2
1202319|NCT00920621|3949708|P4|Overall Study|Blood sample not collected|0
1202320|NCT00920621|3949709|P3|Overall Study|Blood sample not collected|0
1202321|NCT00920621|3949710|P2|Overall Study|Blood sample not collected|14
1202322|NCT00920621|3949711|P1|Overall Study|Blood sample not collected|22
1202323|NCT00920621|3949708|P4|Overall Study|Fetal/neonatal deaths|14
1202324|NCT00920621|3949709|P3|Overall Study|Fetal/neonatal deaths|16
1202325|NCT00920621|3949710|P2|Overall Study|Fetal/neonatal deaths|14
1202326|NCT00920621|3949711|P1|Overall Study|Fetal/neonatal deaths|16
1202327|NCT00920621|3949708|P4|Overall Study|Lost to Follow-up|21
1202328|NCT00920621|3949709|P3|Overall Study|Lost to Follow-up|19
1202329|NCT00920621|3949710|P2|Overall Study|Lost to Follow-up|17
1202330|NCT00920621|3949711|P1|Overall Study|Lost to Follow-up|16
1202331|NCT00920426|3949745|P4|ITZ111451|Adverse Event|0
1202332|NCT00920426|3949746|P3|ITZ111451|Adverse Event|0
1202333|NCT00920426|3949747|P2|ITZ111451|Adverse Event|0
1202334|NCT00920426|3949748|P1|ITZ111451|Adverse Event|1
1202335|NCT00920218|3949868|P4|Overall Study|Not specified|0
1202336|NCT00920218|3949869|P3|Overall Study|Not specified|1
1202337|NCT00920218|3949870|P2|Overall Study|Not specified|0
1202338|NCT00920218|3949871|P1|Overall Study|Not specified|0
1202339|NCT00920218|3949868|P4|Overall Study|Transplant failed/malignancy recurrence|3
1202340|NCT00920218|3949869|P3|Overall Study|Transplant failed/malignancy recurrence|2
1202341|NCT00920218|3949870|P2|Overall Study|Transplant failed/malignancy recurrence|1
1202342|NCT00920218|3949871|P1|Overall Study|Transplant failed/malignancy recurrence|0
1202343|NCT00920218|3949868|P4|Overall Study|Lost to Follow-up|3
1202344|NCT00920218|3949869|P3|Overall Study|Lost to Follow-up|0
1202345|NCT00920218|3949870|P2|Overall Study|Lost to Follow-up|1
1202346|NCT00920218|3949871|P1|Overall Study|Lost to Follow-up|0
1202347|NCT00920218|3949868|P4|Overall Study|Migrated/moved from study area|0
1202348|NCT00920218|3949869|P3|Overall Study|Migrated/moved from study area|1
1202349|NCT00920218|3949870|P2|Overall Study|Migrated/moved from study area|0
1202350|NCT00920218|3949871|P1|Overall Study|Migrated/moved from study area|0
1202351|NCT00920218|3949868|P4|Overall Study|Withdrawal by Subject|0
1202352|NCT00920218|3949869|P3|Overall Study|Withdrawal by Subject|2
1202353|NCT00920218|3949870|P2|Overall Study|Withdrawal by Subject|3
1202354|NCT00920218|3949871|P1|Overall Study|Withdrawal by Subject|0
1202355|NCT00920218|3949868|P4|Overall Study|Serious Adverse Event|1
1202356|NCT00920218|3949869|P3|Overall Study|Serious Adverse Event|2
1202357|NCT00920218|3949870|P2|Overall Study|Serious Adverse Event|0
1202358|NCT00920218|3949871|P1|Overall Study|Serious Adverse Event|2
1202359|NCT00920140|3949974|P5|Phase 2|Withdrawal by Subject|1
1202360|NCT00920140|3949975|P4|Phase 2|Withdrawal by Subject|2
1202361|NCT00920140|3949976|P3|Phase 2|Withdrawal by Subject|4
1202362|NCT00920140|3949977|P2|Phase 2|Withdrawal by Subject|0
1202363|NCT00920140|3949978|P1|Phase 2|Withdrawal by Subject|0
1202364|NCT00920140|3949974|P5|Phase 2|Physician Decision|2
1202365|NCT00920140|3949975|P4|Phase 2|Physician Decision|3
1202366|NCT00920140|3949976|P3|Phase 2|Physician Decision|3
1202367|NCT00920140|3949977|P2|Phase 2|Physician Decision|0
1202368|NCT00920140|3949978|P1|Phase 2|Physician Decision|0
1202369|NCT00920140|3949974|P5|Phase 2|Lost to Follow-up|0
1202370|NCT00920140|3949975|P4|Phase 2|Lost to Follow-up|1
1202371|NCT00920140|3949976|P3|Phase 2|Lost to Follow-up|0
1202372|NCT00920140|3949977|P2|Phase 2|Lost to Follow-up|0
1202373|NCT00920140|3949978|P1|Phase 2|Lost to Follow-up|0
1202374|NCT00920140|3949974|P5|Phase 2|Lack of Efficacy|5
1202375|NCT00920140|3949975|P4|Phase 2|Lack of Efficacy|14
1202376|NCT00920140|3949976|P3|Phase 2|Lack of Efficacy|29
1202377|NCT00920140|3949977|P2|Phase 2|Lack of Efficacy|0
1202378|NCT00920140|3949978|P1|Phase 2|Lack of Efficacy|0
1202379|NCT00920140|3949974|P5|Phase 2|Adverse Event|3
1202380|NCT00920140|3949975|P4|Phase 2|Adverse Event|2
1202381|NCT00920140|3949976|P3|Phase 2|Adverse Event|14
1202382|NCT00920140|3949977|P2|Phase 2|Adverse Event|0
1202383|NCT00920140|3949978|P1|Phase 2|Adverse Event|0
1202384|NCT00920140|3949974|P5|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
1202385|NCT00920140|3949975|P4|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
1202386|NCT00920140|3949976|P3|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
1202387|NCT00920140|3949977|P2|Phase 1 (Dose Escalation)|Withdrawal by Subject|2
1202388|NCT00920140|3949978|P1|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
1202389|NCT00920140|3949974|P5|Phase 1 (Dose Escalation)|Lack of Efficacy|0
1202390|NCT00920140|3949975|P4|Phase 1 (Dose Escalation)|Lack of Efficacy|0
1202391|NCT00920140|3949976|P3|Phase 1 (Dose Escalation)|Lack of Efficacy|0
1202392|NCT00920140|3949977|P2|Phase 1 (Dose Escalation)|Lack of Efficacy|4
1202393|NCT00920140|3949978|P1|Phase 1 (Dose Escalation)|Lack of Efficacy|2
1202394|NCT00920140|3949974|P5|Phase 1 (Dose Escalation)|Adverse Event|0
1202395|NCT00920140|3949975|P4|Phase 1 (Dose Escalation)|Adverse Event|0
1202396|NCT00920140|3949976|P3|Phase 1 (Dose Escalation)|Adverse Event|0
1202397|NCT00920140|3949977|P2|Phase 1 (Dose Escalation)|Adverse Event|3
1202398|NCT00920140|3949978|P1|Phase 1 (Dose Escalation)|Adverse Event|3
1202399|NCT00919893|3950040|P2|Overall Study|Protocol Violation|9
1202400|NCT00919893|3950041|P1|Overall Study|Protocol Violation|19
1202401|NCT00919867|3950053|P6|First Intervention|Physician Decision|1
1202402|NCT00919867|3950054|P5|First Intervention|Physician Decision|0
1202403|NCT00919867|3950055|P4|First Intervention|Physician Decision|0
1202404|NCT00919867|3950056|P3|First Intervention|Physician Decision|0
1202405|NCT00919867|3950057|P2|First Intervention|Physician Decision|0
1202406|NCT00919867|3950058|P1|First Intervention|Physician Decision|0
1202407|NCT00919867|3950053|P6|First Intervention|Withdrawal by Subject|0
1202408|NCT00919867|3950054|P5|First Intervention|Withdrawal by Subject|0
1202409|NCT00919867|3950055|P4|First Intervention|Withdrawal by Subject|0
1202410|NCT00919867|3950056|P3|First Intervention|Withdrawal by Subject|1
1202411|NCT00919867|3950057|P2|First Intervention|Withdrawal by Subject|0
1202412|NCT00919867|3950058|P1|First Intervention|Withdrawal by Subject|0
1202413|NCT00919854|3950079|P1|Overall Study|Adverse Event|1
1202414|NCT00919711|3950117|P2|Overall Study|Noncompliance|0
1202415|NCT00919711|3950118|P1|Overall Study|Noncompliance|1
1202416|NCT00919711|3950117|P2|Overall Study|Death|0
1202417|NCT00919711|3950118|P1|Overall Study|Death|1
1202418|NCT00919711|3950117|P2|Overall Study|Lost to Follow-up|0
1202419|NCT00919711|3950118|P1|Overall Study|Lost to Follow-up|2
1202420|NCT00919711|3950117|P2|Overall Study|Administrative Decision|1
1202421|NCT00919711|3950118|P1|Overall Study|Administrative Decision|0
1202422|NCT00919711|3950117|P2|Overall Study|Other|2
1202423|NCT00919711|3950118|P1|Overall Study|Other|1
1202424|NCT00919711|3950117|P2|Overall Study|Adverse Event|3
1202425|NCT00919711|3950118|P1|Overall Study|Adverse Event|13
1202426|NCT00919711|3950117|P2|Overall Study|Withdrawal by Subject|7
1202427|NCT00919711|3950118|P1|Overall Study|Withdrawal by Subject|15
1202428|NCT00919633|3950134|P4|Overall Study|Viral rebound outside protocol timepoint|0
1202429|NCT00919633|3950135|P3|Overall Study|Viral rebound outside protocol timepoint|1
1202430|NCT00919633|3950136|P2|Overall Study|Viral rebound outside protocol timepoint|0
1202431|NCT00919633|3950137|P1|Overall Study|Viral rebound outside protocol timepoint|0
1202432|NCT00919633|3950134|P4|Overall Study|Request of withdrawal w/o future contact|0
1202433|NCT00919633|3950135|P3|Overall Study|Request of withdrawal w/o future contact|1
1202434|NCT00919633|3950136|P2|Overall Study|Request of withdrawal w/o future contact|0
1202435|NCT00919633|3950137|P1|Overall Study|Request of withdrawal w/o future contact|0
1202436|NCT00919633|3950134|P4|Overall Study|Physician Decision|1
1202437|NCT00919633|3950135|P3|Overall Study|Physician Decision|0
1202438|NCT00919633|3950136|P2|Overall Study|Physician Decision|0
1202439|NCT00919633|3950137|P1|Overall Study|Physician Decision|0
1202440|NCT00919633|3950134|P4|Overall Study|Protocol Violation|1
1202441|NCT00919633|3950135|P3|Overall Study|Protocol Violation|0
1202442|NCT00919633|3950136|P2|Overall Study|Protocol Violation|0
1202443|NCT00919633|3950137|P1|Overall Study|Protocol Violation|0
1202444|NCT00919633|3950134|P4|Overall Study|Withdraw consent post transition to SOC|1
1202445|NCT00919633|3950135|P3|Overall Study|Withdraw consent post transition to SOC|1
1202446|NCT00919633|3950136|P2|Overall Study|Withdraw consent post transition to SOC|0
1202447|NCT00919633|3950137|P1|Overall Study|Withdraw consent post transition to SOC|0
1202448|NCT00919633|3950134|P4|Overall Study|Lost to Follow-up|2
1202449|NCT00919633|3950135|P3|Overall Study|Lost to Follow-up|0
1202450|NCT00919633|3950136|P2|Overall Study|Lost to Follow-up|1
1202451|NCT00919633|3950137|P1|Overall Study|Lost to Follow-up|3
1202452|NCT00919633|3950134|P4|Overall Study|Withdrawal by Subject|3
1202453|NCT00919633|3950135|P3|Overall Study|Withdrawal by Subject|4
1202454|NCT00919633|3950136|P2|Overall Study|Withdrawal by Subject|2
1202455|NCT00919633|3950137|P1|Overall Study|Withdrawal by Subject|1
1202456|NCT00919633|3950134|P4|Overall Study|Lack of Efficacy|3
1202457|NCT00919633|3950135|P3|Overall Study|Lack of Efficacy|2
1202458|NCT00919633|3950136|P2|Overall Study|Lack of Efficacy|3
1202459|NCT00919633|3950137|P1|Overall Study|Lack of Efficacy|17
1202460|NCT00919633|3950134|P4|Overall Study|Death|0
1202461|NCT00919633|3950135|P3|Overall Study|Death|2
1202462|NCT00919633|3950136|P2|Overall Study|Death|0
1202463|NCT00919633|3950137|P1|Overall Study|Death|0
1202464|NCT00919633|3950134|P4|Overall Study|Adverse Event|10
1202465|NCT00919633|3950135|P3|Overall Study|Adverse Event|12
1202466|NCT00919633|3950136|P2|Overall Study|Adverse Event|9
1202467|NCT00919633|3950137|P1|Overall Study|Adverse Event|1
1202468|NCT00919061|3950235|P1|Overall Study|Withdrawal by Subject|1
1202469|NCT00919061|3950235|P1|Overall Study|Adverse Event|1
1202470|NCT00918957|3950248|P2|Overall Study|Withdrawal by Subject|0
1202471|NCT00918957|3950249|P1|Overall Study|Withdrawal by Subject|1
1202472|NCT00918957|3950248|P2|Overall Study|Adverse Event|0
1202473|NCT00918957|3950249|P1|Overall Study|Adverse Event|2
1202474|NCT00918879|3950282|P2|Overall Study|Severe non-compliance to protocol|1
1202475|NCT00918879|3950283|P1|Overall Study|Severe non-compliance to protocol|1
1202476|NCT00918879|3950282|P2|Overall Study|Lost to Follow-up|1
1202477|NCT00918879|3950283|P1|Overall Study|Lost to Follow-up|1
1202478|NCT00918879|3950282|P2|Overall Study|Withdrawal by Subject|4
1202479|NCT00918879|3950283|P1|Overall Study|Withdrawal by Subject|4
1202480|NCT00918749|3950315|P3|Overall Study|No Study Medication Taken|0
1202481|NCT00918749|3950316|P2|Overall Study|No Study Medication Taken|0
1202482|NCT00918749|3950317|P1|Overall Study|No Study Medication Taken|1
1202483|NCT00918749|3950315|P3|Overall Study|Withdrawal by Subject|5
1202484|NCT00918749|3950316|P2|Overall Study|Withdrawal by Subject|3
1202485|NCT00918749|3950317|P1|Overall Study|Withdrawal by Subject|5
1202486|NCT00918749|3950315|P3|Overall Study|Lost to Follow-up|1
1202487|NCT00918749|3950316|P2|Overall Study|Lost to Follow-up|0
1202488|NCT00918749|3950317|P1|Overall Study|Lost to Follow-up|0
1202489|NCT00918749|3950315|P3|Overall Study|Adverse Event|1
1202490|NCT00918749|3950316|P2|Overall Study|Adverse Event|0
1202491|NCT00918749|3950317|P1|Overall Study|Adverse Event|1
1202492|NCT00918736|3950349|P1|Overall Study|Withdrawal by Subject|4
1202493|NCT00918684|3950362|P1|Treatment Phase|Withdrawal by Subject|8
1202494|NCT00918684|3950362|P1|Treatment Phase|Protocol Violation|1
1202495|NCT00918684|3950362|P1|Treatment Phase|Physician Decision|8
1202496|NCT00918684|3950362|P1|Treatment Phase|Lost to Follow-up|2
1202497|NCT00918684|3950362|P1|Treatment Phase|Lack of Efficacy|6
1202498|NCT00918684|3950362|P1|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16
1202499|NCT00918645|3950373|P1|Overall Study|Withdrawal by Subject|1
1202500|NCT00918580|3950379|P1|After 6-month FU to 1-year FU|Failed to Return|2
1202501|NCT00918580|3950379|P1|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58
1202502|NCT00918580|3950379|P1|Up to 6-month Follow-up(FU)|Failed to Return|1
1202503|NCT00918580|3950379|P1|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2
1202504|NCT00918580|3950379|P1|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2
1202505|NCT00918580|3950379|P1|Up to 6-month Follow-up(FU)|Lost to Follow-up|5
1202506|NCT00918580|3950379|P1|Up to 6-month Follow-up(FU)|Adverse Event|1
1202507|NCT00918463|3950397|P1|Overall Study|Lack of Efficacy|1
1202508|NCT00918463|3950397|P1|Overall Study|Death|1
1202509|NCT00918385|3950405|P2|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7
1202510|NCT00918385|3950406|P1|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
1202511|NCT00918385|3950405|P2|Combination Nilutamide and Dasatinib|Complicating illness|0
1202512|NCT00918385|3950406|P1|Combination Nilutamide and Dasatinib|Complicating illness|1
1202513|NCT00918385|3950405|P2|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0
1202514|NCT00918385|3950406|P1|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
1202515|NCT00918385|3950405|P2|Combination Nilutamide and Dasatinib|Adverse Event|1
1202516|NCT00918385|3950406|P1|Combination Nilutamide and Dasatinib|Adverse Event|1
1202517|NCT00918385|3950405|P2|Monotherapy|Complicating illness|0
1202518|NCT00918385|3950406|P1|Monotherapy|Complicating illness|1
1202519|NCT00918385|3950405|P2|Monotherapy|Adverse Event|6
1202520|NCT00918385|3950406|P1|Monotherapy|Adverse Event|1
1202521|NCT00918346|3950415|P2|First Treatment Period (4 Weeks)|Lack of Efficacy|1
1202522|NCT00918346|3950416|P1|First Treatment Period (4 Weeks)|Lack of Efficacy|0
1202523|NCT00918333|3950432|P2|Overall Study|Withdrawal by Subject|1
1202524|NCT00918333|3950433|P1|Overall Study|Withdrawal by Subject|0
1202525|NCT00918333|3950432|P2|Overall Study|Ineligible|0
1202526|NCT00918333|3950433|P1|Overall Study|Ineligible|1
1202527|NCT00918333|3950432|P2|Overall Study|Inadequate amount of drugs provided|4
1202528|NCT00918333|3950433|P1|Overall Study|Inadequate amount of drugs provided|1
1202529|NCT00918333|3950432|P2|Overall Study|Drug not taken per protocol|0
1202530|NCT00918333|3950433|P1|Overall Study|Drug not taken per protocol|1
1202531|NCT00918281|3950453|P1|Overall Study|Physician Decision|29
1202532|NCT00918255|3950463|P3|Overall Study|Investigator discretion|0
1202533|NCT00918255|3950464|P2|Overall Study|Investigator discretion|0
1202534|NCT00918255|3950465|P1|Overall Study|Investigator discretion|1
1202535|NCT00918255|3950463|P3|Overall Study|Non-compliance|0
1202536|NCT00918255|3950464|P2|Overall Study|Non-compliance|0
1202537|NCT00918255|3950465|P1|Overall Study|Non-compliance|1
1202538|NCT00918255|3950463|P3|Overall Study|Exceeded allowed number of interventions|1
1202539|NCT00918255|3950464|P2|Overall Study|Exceeded allowed number of interventions|0
1202540|NCT00918255|3950465|P1|Overall Study|Exceeded allowed number of interventions|0
1202541|NCT00918255|3950463|P3|Overall Study|Lost to Follow-up|2
1202542|NCT00918255|3950464|P2|Overall Study|Lost to Follow-up|0
1202543|NCT00918255|3950465|P1|Overall Study|Lost to Follow-up|1
1202544|NCT00918255|3950463|P3|Overall Study|Lack of Efficacy|0
1202545|NCT00918255|3950464|P2|Overall Study|Lack of Efficacy|0
1202546|NCT00918255|3950465|P1|Overall Study|Lack of Efficacy|1
1202547|NCT00918255|3950463|P3|Overall Study|Withdrawal by Subject|2
1202548|NCT00918255|3950464|P2|Overall Study|Withdrawal by Subject|0
1202549|NCT00918255|3950465|P1|Overall Study|Withdrawal by Subject|1
1202550|NCT00918255|3950463|P3|Overall Study|Adverse Event|0
1202551|NCT00918255|3950464|P2|Overall Study|Adverse Event|0
1202552|NCT00918255|3950465|P1|Overall Study|Adverse Event|1
1202553|NCT00918203|3950498|P3|Treatment With or Without Olaratumab|Never Treated/Death|0
1202554|NCT00918203|3950499|P2|Treatment With or Without Olaratumab|Never Treated/Death|0
1202555|NCT00918203|3950500|P1|Treatment With or Without Olaratumab|Never Treated/Death|1
1202556|NCT00918203|3950498|P3|Treatment With or Without Olaratumab|Other Therapy Started|0
1202557|NCT00918203|3950499|P2|Treatment With or Without Olaratumab|Other Therapy Started|1
1202558|NCT00918203|3950500|P1|Treatment With or Without Olaratumab|Other Therapy Started|2
1202559|NCT00918203|3950498|P3|Treatment With or Without Olaratumab|Withdrawal by Subject|0
1202560|NCT00918203|3950499|P2|Treatment With or Without Olaratumab|Withdrawal by Subject|8
1202561|NCT00918203|3950500|P1|Treatment With or Without Olaratumab|Withdrawal by Subject|2
1202562|NCT00918203|3950498|P3|Treatment With or Without Olaratumab|Lost to Follow-up|0
1202563|NCT00918203|3950499|P2|Treatment With or Without Olaratumab|Lost to Follow-up|1
1202564|NCT00918203|3950500|P1|Treatment With or Without Olaratumab|Lost to Follow-up|1
1202565|NCT00918138|3950531|P2|Overall Study|Death|0
1202566|NCT00918138|3950532|P1|Overall Study|Death|1
1202567|NCT00918138|3950531|P2|Overall Study|Subject withdrew consent|1
1202568|NCT00918138|3950532|P1|Overall Study|Subject withdrew consent|1
1202569|NCT00917852|3950571|P1|Overall Study|Death|6
1202570|NCT00917644|3950589|P2|Period 2: Second Intervention|family emergency|0
1202571|NCT00917644|3950590|P1|Period 2: Second Intervention|family emergency|1
1202572|NCT00917644|3950589|P2|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0
1202573|NCT00917644|3950590|P1|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1
1202574|NCT00917644|3950589|P2|Period: Washout Period of > = 2 Weeks|Protocol Violation|0
1202575|NCT00917644|3950590|P1|Period: Washout Period of > = 2 Weeks|Protocol Violation|1
1202576|NCT00917579|3950604|P2|Washout >= 2 Weeks|Withdrawal by Subject|0
1202577|NCT00917579|3950605|P1|Washout >= 2 Weeks|Withdrawal by Subject|1
1202578|NCT00917579|3950604|P2|Washout >= 2 Weeks|Adverse Event|0
1202579|NCT00917579|3950605|P1|Washout >= 2 Weeks|Adverse Event|1
1202580|NCT00917553|3950621|P2|Overall Study|Lost to Follow-up|1
1202581|NCT00917553|3950622|P1|Overall Study|Lost to Follow-up|2
1202582|NCT00917501|3950638|P2|Overall Study|trouble swollowing capsules|1
1202583|NCT00917501|3950639|P1|Overall Study|trouble swollowing capsules|0
1202584|NCT00917501|3950638|P2|Overall Study|Lack of Efficacy|2
1202585|NCT00917501|3950639|P1|Overall Study|Lack of Efficacy|1
1202586|NCT00917501|3950638|P2|Overall Study|Withdrawal by Subject|1
1202587|NCT00917501|3950639|P1|Overall Study|Withdrawal by Subject|3
1202588|NCT00917501|3950638|P2|Overall Study|Lost to Follow-up|1
1202589|NCT00917501|3950639|P1|Overall Study|Lost to Follow-up|4
1202590|NCT00917384|3950647|P2|Overall Study|Withdrawal by Subject|2
1202591|NCT00917384|3950648|P1|Overall Study|Withdrawal by Subject|10
1202592|NCT00917384|3950647|P2|Overall Study|Lost to Follow-up|2
1202593|NCT00917384|3950648|P1|Overall Study|Lost to Follow-up|4
1202594|NCT00917267|3950672|P2|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
1202595|NCT00917267|3950673|P1|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
1202596|NCT00917267|3950672|P2|Overall Study|Sponsor Decision|5
1202597|NCT00917267|3950673|P1|Overall Study|Sponsor Decision|5
1202598|NCT00917267|3950672|P2|Overall Study|Entry Criteria Not Met|0
1202599|NCT00917267|3950673|P1|Overall Study|Entry Criteria Not Met|1
1202600|NCT00917267|3950672|P2|Overall Study|Lost to follow up|2
1202601|NCT00917267|3950673|P1|Overall Study|Lost to follow up|0
1202602|NCT00917267|3950672|P2|Overall Study|Withdrawal by Subject|12
1202603|NCT00917267|3950673|P1|Overall Study|Withdrawal by Subject|5
1202604|NCT00917267|3950672|P2|Overall Study|Protocol Violation|18
1202605|NCT00917267|3950673|P1|Overall Study|Protocol Violation|9
1202606|NCT00917267|3950672|P2|Overall Study|Physician Decision|4
1202607|NCT00917267|3950673|P1|Overall Study|Physician Decision|2
1202608|NCT00917267|3950672|P2|Overall Study|Adverse Event|36
1202609|NCT00917267|3950673|P1|Overall Study|Adverse Event|15
1202610|NCT00917124|3950701|P2|Overall Study|Protocol Violation|6
1202611|NCT00917124|3950702|P1|Overall Study|Protocol Violation|4
1202612|NCT00916929|3950712|P2|Overall Study|Device unable to process impedance data|7
1202613|NCT00916929|3950713|P1|Overall Study|Device unable to process impedance data|0
1202614|NCT00916929|3950712|P2|Overall Study|Moved to another state|1
1202615|NCT00916929|3950713|P1|Overall Study|Moved to another state|0
1202616|NCT00916929|3950712|P2|Overall Study|System explant|0
1202617|NCT00916929|3950713|P1|Overall Study|System explant|1
1202618|NCT00916929|3950712|P2|Overall Study|Transferred to hospice care|1
1202619|NCT00916929|3950713|P1|Overall Study|Transferred to hospice care|1
1202620|NCT00916929|3950712|P2|Overall Study|Left ventricular epicardial lead|2
1202621|NCT00916929|3950713|P1|Overall Study|Left ventricular epicardial lead|1
1202622|NCT00916929|3950712|P2|Overall Study|Withdrawal by Subject|5
1202623|NCT00916929|3950713|P1|Overall Study|Withdrawal by Subject|1
1202624|NCT00916929|3950712|P2|Overall Study|Death|10
1202625|NCT00916929|3950713|P1|Overall Study|Death|5
1202626|NCT00916929|3950712|P2|Overall Study|Lost to Follow-up|3
1202627|NCT00916929|3950713|P1|Overall Study|Lost to Follow-up|1
1202628|NCT00916721|3950723|P2|Overall Study|Protocol Violation|4
1202629|NCT00916721|3950724|P1|Overall Study|Protocol Violation|2
1202630|NCT00916721|3950723|P2|Overall Study|Withdrawal by Subject|2
1202631|NCT00916721|3950724|P1|Overall Study|Withdrawal by Subject|2
1202632|NCT00916721|3950723|P2|Overall Study|Adverse Event|3
1202633|NCT00916721|3950724|P1|Overall Study|Adverse Event|6
1202634|NCT00916721|3950723|P2|Overall Study|Lost to Follow-up|1
1202635|NCT00916721|3950724|P1|Overall Study|Lost to Follow-up|0
1202636|NCT00916617|3950747|P4|Overall Study|Not specified|2
1202637|NCT00916617|3950748|P3|Overall Study|Not specified|0
1202638|NCT00916617|3950749|P2|Overall Study|Not specified|0
1202639|NCT00916617|3950750|P1|Overall Study|Not specified|2
1202640|NCT00916617|3950747|P4|Overall Study|Lack of Efficacy|0
1202641|NCT00916617|3950748|P3|Overall Study|Lack of Efficacy|0
1202642|NCT00916617|3950749|P2|Overall Study|Lack of Efficacy|0
1202643|NCT00916617|3950750|P1|Overall Study|Lack of Efficacy|1
1202644|NCT00916617|3950747|P4|Overall Study|Lost to Follow-up|0
1202645|NCT00916617|3950748|P3|Overall Study|Lost to Follow-up|0
1202646|NCT00916617|3950749|P2|Overall Study|Lost to Follow-up|1
1202647|NCT00916617|3950750|P1|Overall Study|Lost to Follow-up|2
1202648|NCT00916617|3950747|P4|Overall Study|Discontinuation of Study by Sponsor|1
1202649|NCT00916617|3950748|P3|Overall Study|Discontinuation of Study by Sponsor|3
1202650|NCT00916617|3950749|P2|Overall Study|Discontinuation of Study by Sponsor|13
1202651|NCT00916617|3950750|P1|Overall Study|Discontinuation of Study by Sponsor|8
1202652|NCT00916617|3950747|P4|Overall Study|Physician Decision|0
1202653|NCT00916617|3950748|P3|Overall Study|Physician Decision|0
1202654|NCT00916617|3950749|P2|Overall Study|Physician Decision|1
1202655|NCT00916617|3950750|P1|Overall Study|Physician Decision|1
1202656|NCT00916617|3950747|P4|Overall Study|Caregiver Request|0
1202657|NCT00916617|3950748|P3|Overall Study|Caregiver Request|1
1202658|NCT00916617|3950749|P2|Overall Study|Caregiver Request|2
1202659|NCT00916617|3950750|P1|Overall Study|Caregiver Request|3
1202660|NCT00916617|3950747|P4|Overall Study|Withdrawal by Subject|1
1202661|NCT00916617|3950748|P3|Overall Study|Withdrawal by Subject|0
1202662|NCT00916617|3950749|P2|Overall Study|Withdrawal by Subject|2
1202663|NCT00916617|3950750|P1|Overall Study|Withdrawal by Subject|3
1202664|NCT00916617|3950747|P4|Overall Study|Adverse Event|3
1202665|NCT00916617|3950748|P3|Overall Study|Adverse Event|6
1202666|NCT00916617|3950749|P2|Overall Study|Adverse Event|2
1202667|NCT00916617|3950750|P1|Overall Study|Adverse Event|3
1202668|NCT00916578|3950764|P1|Overall Study|Insurance Denial|2
1202669|NCT00916578|3950764|P1|Overall Study|Withdrawal by Subject|3
1202670|NCT00916578|3950764|P1|Overall Study|Physician Decision|2
1202671|NCT00916383|3950793|P1|Overall Study|Protocol Violation|1
1202672|NCT00916383|3950793|P1|Overall Study|Death|1
1202673|NCT00916383|3950793|P1|Overall Study|Adverse Event|1
1202674|NCT00916370|3950821|P2|Overall Study|Physician Decision|1
1202675|NCT00916370|3950822|P1|Overall Study|Physician Decision|0
1202676|NCT00916370|3950821|P2|Overall Study|Withdrawal by Subject|0
1202677|NCT00916370|3950822|P1|Overall Study|Withdrawal by Subject|2
1202678|NCT00916370|3950821|P2|Overall Study|Death|1
1202679|NCT00916370|3950822|P1|Overall Study|Death|3
1202680|NCT00916357|3950996|P6|Period 2|Weight loss > 3 kilograms (kg)|0
1202681|NCT00916357|3950997|P5|Period 2|Weight loss > 3 kilograms (kg)|0
1202682|NCT00916357|3950998|P4|Period 2|Weight loss > 3 kilograms (kg)|1
1202683|NCT00916357|3950999|P3|Period 2|Weight loss > 3 kilograms (kg)|0
1202684|NCT00916357|3951000|P2|Period 2|Weight loss > 3 kilograms (kg)|0
1202685|NCT00916357|3951001|P1|Period 2|Weight loss > 3 kilograms (kg)|0
1202686|NCT00916357|3950996|P6|Period 1|Withdrawal by Subject|0
1202687|NCT00916357|3950997|P5|Period 1|Withdrawal by Subject|0
1202688|NCT00916357|3950998|P4|Period 1|Withdrawal by Subject|0
1202689|NCT00916357|3950999|P3|Period 1|Withdrawal by Subject|0
1202690|NCT00916357|3951000|P2|Period 1|Withdrawal by Subject|0
1202691|NCT00916357|3951001|P1|Period 1|Withdrawal by Subject|1
1202692|NCT00916344|3951039|P1|Overall Study|Drop-out|5
1202693|NCT00916344|3951039|P1|Overall Study|ICD upgrade|1
1202694|NCT00916344|3951039|P1|Overall Study|Death|2
1202695|NCT00916305|3951046|P2|Overall Study|Withdrawal by Subject|1
1202696|NCT00916305|3951047|P1|Overall Study|Withdrawal by Subject|0
1202697|NCT00916305|3951046|P2|Overall Study|Lost to Follow-up|27
1202698|NCT00916305|3951047|P1|Overall Study|Lost to Follow-up|21
1202699|NCT00916279|3951055|P1|Overall Study|Lost to Follow-up|2
1202700|NCT00916279|3951055|P1|Overall Study|Death|2
1202701|NCT00916149|3951066|P3|Overall Study|Unable to place scalp EEG leads|0
1202702|NCT00916149|3951067|P2|Overall Study|Unable to place scalp EEG leads|0
1202703|NCT00916149|3951068|P1|Overall Study|Unable to place scalp EEG leads|1
1202704|NCT00916149|3951066|P3|Overall Study|Lost to Follow-up|0
1202705|NCT00916149|3951067|P2|Overall Study|Lost to Follow-up|2
1202706|NCT00916149|3951068|P1|Overall Study|Lost to Follow-up|3
1202707|NCT00916006|3951191|P2|Overall Study|Protocol Violation|1
1202708|NCT00916006|3951192|P1|Overall Study|Protocol Violation|0
1202709|NCT00916006|3951191|P2|Overall Study|Withdrawal by Subject|5
1202710|NCT00916006|3951192|P1|Overall Study|Withdrawal by Subject|2
1202711|NCT00916006|3951191|P2|Overall Study|Adverse Event|1
1202712|NCT00916006|3951192|P1|Overall Study|Adverse Event|1
1202713|NCT00915876|3951213|P2|Overall Study|Adverse Event|1
1202714|NCT00915876|3951214|P1|Overall Study|Adverse Event|0
1202715|NCT00915772|3951250|P3|Overall Study|Any other reason|7
1202716|NCT00915772|3951251|P2|Overall Study|Any other reason|7
1202717|NCT00915772|3951252|P1|Overall Study|Any other reason|4
1202718|NCT00915772|3951250|P3|Overall Study|Refused to continue trial medication|4
1202719|NCT00915772|3951251|P2|Overall Study|Refused to continue trial medication|8
1202720|NCT00915772|3951252|P1|Overall Study|Refused to continue trial medication|6
1202721|NCT00915772|3951250|P3|Overall Study|Lack of Efficacy|3
1202722|NCT00915772|3951251|P2|Overall Study|Lack of Efficacy|15
1202723|NCT00915772|3951252|P1|Overall Study|Lack of Efficacy|9
1202724|NCT00915772|3951250|P3|Overall Study|Lost to Follow-up|2
1202725|NCT00915772|3951251|P2|Overall Study|Lost to Follow-up|2
1202726|NCT00915772|3951252|P1|Overall Study|Lost to Follow-up|1
1202727|NCT00915772|3951250|P3|Overall Study|Protocol Violation|2
1202728|NCT00915772|3951251|P2|Overall Study|Protocol Violation|1
1202729|NCT00915772|3951252|P1|Overall Study|Protocol Violation|4
1202730|NCT00915772|3951250|P3|Overall Study|Adverse Event|11
1202731|NCT00915772|3951251|P2|Overall Study|Adverse Event|13
1202732|NCT00915772|3951252|P1|Overall Study|Adverse Event|12
1202733|NCT00915551|3951351|P2|Overall Study|Withdrawal by Subject|1
1202734|NCT00915551|3951352|P1|Overall Study|Withdrawal by Subject|0
1202735|NCT00915525|3951362|P2|Overall Study|Patient Moved|9
1202736|NCT00915525|3951363|P1|Overall Study|Patient Moved|15
1202737|NCT00915525|3951362|P2|Overall Study|Non-Compliance|1
1202738|NCT00915525|3951363|P1|Overall Study|Non-Compliance|3
1202739|NCT00915525|3951362|P2|Overall Study|Study Burden|12
1202740|NCT00915525|3951363|P1|Overall Study|Study Burden|28
1202741|NCT00915525|3951362|P2|Overall Study|Retreat Request >Wk 144 (exclusionary)|5
1202742|NCT00915525|3951363|P1|Overall Study|Retreat Request >Wk 144 (exclusionary)|4
1202743|NCT00915525|3951362|P2|Overall Study|Site Closed|9
1202744|NCT00915525|3951363|P1|Overall Study|Site Closed|27
1202745|NCT00915525|3951362|P2|Overall Study|Other Reason|12
1202746|NCT00915525|3951363|P1|Overall Study|Other Reason|35
1202747|NCT00915525|3951362|P2|Overall Study|Missing|1
1202748|NCT00915525|3951363|P1|Overall Study|Missing|12
1202749|NCT00915525|3951362|P2|Overall Study|Adverse Event|13
1202750|NCT00915525|3951363|P1|Overall Study|Adverse Event|29
1202751|NCT00915525|3951362|P2|Overall Study|Lack of Efficacy|32
1202752|NCT00915525|3951363|P1|Overall Study|Lack of Efficacy|15
1202753|NCT00915525|3951362|P2|Overall Study|Pregnancy|0
1202754|NCT00915525|3951363|P1|Overall Study|Pregnancy|2
1202755|NCT00915525|3951362|P2|Overall Study|Lost to Follow-up|16
1202756|NCT00915525|3951363|P1|Overall Study|Lost to Follow-up|27
1202757|NCT00915525|3951362|P2|Overall Study|Withdrawal by Subject|21
1202758|NCT00915525|3951363|P1|Overall Study|Withdrawal by Subject|59
1202759|NCT00915525|3951362|P2|Overall Study|Protocol Violation|4
1202760|NCT00915525|3951363|P1|Overall Study|Protocol Violation|9
1202761|NCT00915473|3951477|P2|4-week Follow Up|Lost to Follow-up|5
1202762|NCT00915473|3951478|P1|4-week Follow Up|Lost to Follow-up|1
1202763|NCT00915473|3951477|P2|Screening|Withdrawal by Subject|0
1202764|NCT00915473|3951478|P1|Screening|Withdrawal by Subject|1
1202765|NCT00915356|3951495|P5|Overall Study|Withdrawal by Subject|0
1202766|NCT00915356|3951496|P4|Overall Study|Withdrawal by Subject|0
1202767|NCT00915356|3951497|P3|Overall Study|Withdrawal by Subject|0
1202768|NCT00915356|3951498|P2|Overall Study|Withdrawal by Subject|0
1202769|NCT00915356|3951499|P1|Overall Study|Withdrawal by Subject|1
1202770|NCT00915343|3951561|P3|Part B - Open Label Period|Did not attend the last visit|1
1202771|NCT00915343|3951562|P2|Part B - Open Label Period|Did not attend the last visit|0
1202772|NCT00915343|3951563|P1|Part B - Open Label Period|Did not attend the last visit|0
1202773|NCT00915343|3951561|P3|Part B - Open Label Period|Treatment switch|1
1202774|NCT00915343|3951562|P2|Part B - Open Label Period|Treatment switch|0
1202775|NCT00915343|3951563|P1|Part B - Open Label Period|Treatment switch|0
1202776|NCT00915278|3951648|P6|Overall Study|Admission to hospice|0
1202777|NCT00915278|3951649|P5|Overall Study|Admission to hospice|0
1202778|NCT00915278|3951650|P4|Overall Study|Admission to hospice|0
1202779|NCT00915278|3951651|P3|Overall Study|Admission to hospice|1
1202780|NCT00915278|3951652|P2|Overall Study|Admission to hospice|0
1202781|NCT00915278|3951653|P1|Overall Study|Admission to hospice|0
1202782|NCT00915278|3951648|P6|Overall Study|Infusion related AEs|2
1202783|NCT00915278|3951649|P5|Overall Study|Infusion related AEs|0
1202784|NCT00915278|3951650|P4|Overall Study|Infusion related AEs|0
1202785|NCT00915278|3951651|P3|Overall Study|Infusion related AEs|0
1202786|NCT00915278|3951652|P2|Overall Study|Infusion related AEs|0
1202787|NCT00915278|3951653|P1|Overall Study|Infusion related AEs|0
1202788|NCT00915278|3951648|P6|Overall Study|Progressive disease/clinical progression|2
1202789|NCT00915278|3951649|P5|Overall Study|Progressive disease/clinical progression|1
1202790|NCT00915278|3951650|P4|Overall Study|Progressive disease/clinical progression|3
1202791|NCT00915278|3951651|P3|Overall Study|Progressive disease/clinical progression|0
1202792|NCT00915278|3951652|P2|Overall Study|Progressive disease/clinical progression|0
1202793|NCT00915278|3951653|P1|Overall Study|Progressive disease/clinical progression|0
1202794|NCT00915278|3951648|P6|Overall Study|Adverse Event|0
1202795|NCT00915278|3951649|P5|Overall Study|Adverse Event|0
1202796|NCT00915278|3951650|P4|Overall Study|Adverse Event|0
1202797|NCT00915278|3951651|P3|Overall Study|Adverse Event|0
1202798|NCT00915278|3951652|P2|Overall Study|Adverse Event|1
1202799|NCT00915278|3951653|P1|Overall Study|Adverse Event|4
1202800|NCT00915278|3951648|P6|Overall Study|Withdrawal by Subject|4
1202801|NCT00915278|3951649|P5|Overall Study|Withdrawal by Subject|1
1202802|NCT00915278|3951650|P4|Overall Study|Withdrawal by Subject|0
1202803|NCT00915278|3951651|P3|Overall Study|Withdrawal by Subject|0
1202804|NCT00915278|3951652|P2|Overall Study|Withdrawal by Subject|1
1202805|NCT00915278|3951653|P1|Overall Study|Withdrawal by Subject|0
1202806|NCT00915278|3951648|P6|Overall Study|Lost to Follow-up|0
1202807|NCT00915278|3951649|P5|Overall Study|Lost to Follow-up|0
1202808|NCT00915278|3951650|P4|Overall Study|Lost to Follow-up|0
1202809|NCT00915278|3951651|P3|Overall Study|Lost to Follow-up|0
1202810|NCT00915278|3951652|P2|Overall Study|Lost to Follow-up|1
1202811|NCT00915278|3951653|P1|Overall Study|Lost to Follow-up|0
1202812|NCT00915278|3951648|P6|Overall Study|Death|0
1202813|NCT00915278|3951649|P5|Overall Study|Death|0
1202814|NCT00915278|3951650|P4|Overall Study|Death|0
1202815|NCT00915278|3951651|P3|Overall Study|Death|0
1202816|NCT00915278|3951652|P2|Overall Study|Death|0
1202817|NCT00915278|3951653|P1|Overall Study|Death|1
1202818|NCT00915018|3951806|P2|Overall Study|By Sponsor due to Protocol Amendment|105
1202819|NCT00915018|3951807|P1|Overall Study|By Sponsor due to Protocol Amendment|92
1202820|NCT00915018|3951806|P2|Overall Study|Withdrawal by Subject|27
1202821|NCT00915018|3951807|P1|Overall Study|Withdrawal by Subject|38
1202822|NCT00915018|3951806|P2|Overall Study|Lost to Follow-up|5
1202823|NCT00915018|3951807|P1|Overall Study|Lost to Follow-up|10
1202824|NCT00915018|3951806|P2|Overall Study|Death|70
1202825|NCT00915018|3951807|P1|Overall Study|Death|75
1202826|NCT00914966|3951821|P1|Step 2: 2000 Units|Withdrawal by Subject|1
1202827|NCT00914966|3951821|P1|Step 1: 1500 Units|Physician Decision|1
1202828|NCT00914966|3951821|P1|Step 1: 1500 Units|Withdrawal by Subject|1
1202829|NCT00914927|3951840|P7|Overall Study|Administrative/Other|0
1202830|NCT00914927|3951841|P6|Overall Study|Administrative/Other|0
1202831|NCT00914927|3951842|P5|Overall Study|Administrative/Other|1
1202832|NCT00914927|3951843|P4|Overall Study|Administrative/Other|0
1202833|NCT00914927|3951844|P3|Overall Study|Administrative/Other|0
1202834|NCT00914927|3951845|P2|Overall Study|Administrative/Other|1
1202835|NCT00914927|3951846|P1|Overall Study|Administrative/Other|2
1202836|NCT00914927|3951840|P7|Overall Study|Lost to Follow-up|0
1202837|NCT00914927|3951841|P6|Overall Study|Lost to Follow-up|0
1202838|NCT00914927|3951842|P5|Overall Study|Lost to Follow-up|0
1202839|NCT00914927|3951843|P4|Overall Study|Lost to Follow-up|1
1202840|NCT00914927|3951844|P3|Overall Study|Lost to Follow-up|0
1202841|NCT00914927|3951845|P2|Overall Study|Lost to Follow-up|0
1202842|NCT00914927|3951846|P1|Overall Study|Lost to Follow-up|0
1202843|NCT00914927|3951840|P7|Overall Study|Withdrawal by Subject|0
1202844|NCT00914927|3951841|P6|Overall Study|Withdrawal by Subject|0
1202845|NCT00914927|3951842|P5|Overall Study|Withdrawal by Subject|0
1202846|NCT00914927|3951843|P4|Overall Study|Withdrawal by Subject|1
1202847|NCT00914927|3951844|P3|Overall Study|Withdrawal by Subject|0
1202848|NCT00914927|3951845|P2|Overall Study|Withdrawal by Subject|1
1202849|NCT00914927|3951846|P1|Overall Study|Withdrawal by Subject|0
1202850|NCT00914927|3951840|P7|Overall Study|Adverse Event|0
1202851|NCT00914927|3951841|P6|Overall Study|Adverse Event|0
1202852|NCT00914927|3951842|P5|Overall Study|Adverse Event|1
1202853|NCT00914927|3951843|P4|Overall Study|Adverse Event|0
1202854|NCT00914927|3951844|P3|Overall Study|Adverse Event|0
1202855|NCT00914927|3951845|P2|Overall Study|Adverse Event|0
1202856|NCT00914927|3951846|P1|Overall Study|Adverse Event|0
1202857|NCT00914849|3951973|P2|Overall Study|Not eligible|1
1202858|NCT00914849|3951974|P1|Overall Study|Not eligible|0
1202859|NCT00914849|3951973|P2|Overall Study|Withdrawal by Subject|0
1202860|NCT00914849|3951974|P1|Overall Study|Withdrawal by Subject|1
1202861|NCT00914810|3952008|P2|Overall Study|Hospitalized and unable to follow up.|1
1202862|NCT00914810|3952009|P1|Overall Study|Hospitalized and unable to follow up.|0
1202863|NCT00914810|3952008|P2|Overall Study|Relocated out of state|0
1202864|NCT00914810|3952009|P1|Overall Study|Relocated out of state|1
1202865|NCT00914810|3952008|P2|Overall Study|Withdrawal by Subject|0
1202866|NCT00914810|3952009|P1|Overall Study|Withdrawal by Subject|1
1202867|NCT00914589|3952020|P3|Overall Study|Death|1
1202868|NCT00914589|3952021|P2|Overall Study|Death|1
1202869|NCT00914589|3952022|P1|Overall Study|Death|0
1202870|NCT00914589|3952020|P3|Overall Study|unclassified|7
1202871|NCT00914589|3952021|P2|Overall Study|unclassified|9
1202872|NCT00914589|3952022|P1|Overall Study|unclassified|16
1202873|NCT00914589|3952020|P3|Overall Study|Protocol Violation|3
1202874|NCT00914589|3952021|P2|Overall Study|Protocol Violation|6
1202875|NCT00914589|3952022|P1|Overall Study|Protocol Violation|8
1202876|NCT00914589|3952020|P3|Overall Study|Adverse Event|1
1202877|NCT00914589|3952021|P2|Overall Study|Adverse Event|0
1202878|NCT00914589|3952022|P1|Overall Study|Adverse Event|1
1202879|NCT00914459|3952048|P2|Overall Study|Parent/Legal guardian request|0
1202880|NCT00914459|3952049|P1|Overall Study|Parent/Legal guardian request|1
1202881|NCT00914459|3952048|P2|Overall Study|Protocol Violation|1
1202882|NCT00914459|3952049|P1|Overall Study|Protocol Violation|0
1202883|NCT00914316|3952079|P4|Phase 2|Withdrawal by Subject|0
1202884|NCT00914316|3952080|P3|Phase 2|Withdrawal by Subject|1
1202885|NCT00914316|3952081|P2|Phase 2|Withdrawal by Subject|0
1202886|NCT00914316|3952082|P1|Phase 2|Withdrawal by Subject|1
1202887|NCT00914316|3952079|P4|Phase 1|Adverse Event|0
1202888|NCT00914316|3952080|P3|Phase 1|Adverse Event|0
1202889|NCT00914316|3952081|P2|Phase 1|Adverse Event|0
1202890|NCT00914316|3952082|P1|Phase 1|Adverse Event|1
1202891|NCT00914316|3952079|P4|Phase 1|Withdrawal by Subject|0
1202892|NCT00914316|3952080|P3|Phase 1|Withdrawal by Subject|4
1202893|NCT00914316|3952081|P2|Phase 1|Withdrawal by Subject|2
1202894|NCT00914316|3952082|P1|Phase 1|Withdrawal by Subject|0
1202895|NCT00914316|3952079|P4|Phase 1|Physician Decision|2
1202896|NCT00914316|3952080|P3|Phase 1|Physician Decision|1
1202897|NCT00914316|3952081|P2|Phase 1|Physician Decision|0
1202898|NCT00914316|3952082|P1|Phase 1|Physician Decision|4
1202899|NCT00913835|3952161|P2|Lip Dox: Olaratumab Monotherapy|Not Specified|3
1202900|NCT00913835|3952162|P1|Lip Dox: Olaratumab Monotherapy|Not Specified|0
1202901|NCT00913835|3952161|P2|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
1202902|NCT00913835|3952162|P1|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
1202903|NCT00913835|3952161|P2|Olara+Lip Dox and Lip Dox Monotherapy|Not Specified|3
1202904|NCT00913835|3952162|P1|Olara+Lip Dox and Lip Dox Monotherapy|Not Specified|4
1202905|NCT00913835|3952161|P2|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0
1202906|NCT00913835|3952162|P1|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1
1202907|NCT00913835|3952161|P2|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3
1202908|NCT00913835|3952162|P1|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2
1202909|NCT00913770|3952201|P3|Overall Study|Refused|8
1202910|NCT00913770|3952202|P2|Overall Study|Refused|10
1202911|NCT00913770|3952203|P1|Overall Study|Refused|11
1202912|NCT00913770|3952201|P3|Overall Study|Unable to contact|13
1202913|NCT00913770|3952202|P2|Overall Study|Unable to contact|19
1202914|NCT00913770|3952203|P1|Overall Study|Unable to contact|24
1202915|NCT00913744|3952216|P2|Overall Study|Death|0
1202916|NCT00913744|3952217|P1|Overall Study|Death|1
1202917|NCT00913744|3952216|P2|Overall Study|Withdrawal by Subject|1
1202918|NCT00913744|3952217|P1|Overall Study|Withdrawal by Subject|2
1202919|NCT00913744|3952216|P2|Overall Study|Adverse Event|0
1202920|NCT00913744|3952217|P1|Overall Study|Adverse Event|2
1202921|NCT00913692|3952223|P1|Treatment Phase 1 (5 Months)|Physician Decision|1
1202922|NCT00913692|3952223|P1|Screening (4 Months)|Not eligible after screening phase.|6
1202923|NCT00913692|3952223|P1|Screening (4 Months)|Physician Decision|3
1202924|NCT00913523|3952317|P3|Overall Study|Inadequate Number of Tampons Used|3
1202925|NCT00913523|3952318|P2|Overall Study|Inadequate Number of Tampons Used|2
1202926|NCT00913523|3952319|P1|Overall Study|Inadequate Number of Tampons Used|7
1202927|NCT00913523|3952317|P3|Overall Study|Pregnancy|0
1202928|NCT00913523|3952318|P2|Overall Study|Pregnancy|3
1202929|NCT00913523|3952319|P1|Overall Study|Pregnancy|1
1202930|NCT00913523|3952317|P3|Overall Study|Protocol Violation|8
1202931|NCT00913523|3952318|P2|Overall Study|Protocol Violation|8
1202932|NCT00913523|3952319|P1|Overall Study|Protocol Violation|5
1202933|NCT00913523|3952317|P3|Overall Study|Adverse Event|0
1202934|NCT00913523|3952318|P2|Overall Study|Adverse Event|0
1202935|NCT00913523|3952319|P1|Overall Study|Adverse Event|1
1202936|NCT00913523|3952317|P3|Overall Study|Lost to Follow-up|1
1202937|NCT00913523|3952318|P2|Overall Study|Lost to Follow-up|1
1202938|NCT00913523|3952319|P1|Overall Study|Lost to Follow-up|1
1202939|NCT00913523|3952317|P3|Overall Study|Withdrawal by Subject|2
1202940|NCT00913523|3952318|P2|Overall Study|Withdrawal by Subject|2
1202941|NCT00913523|3952319|P1|Overall Study|Withdrawal by Subject|3
1202942|NCT00913458|3952351|P7|Phase 3|Unsatisfactory Response per Investigator|4
1202943|NCT00913458|3952352|P6|Phase 3|Unsatisfactory Response per Investigator|11
1202944|NCT00913458|3952353|P5|Phase 3|Unsatisfactory Response per Investigator|14
1202945|NCT00913458|3952354|P4|Phase 3|Unsatisfactory Response per Investigator|0
1202946|NCT00913458|3952355|P3|Phase 3|Unsatisfactory Response per Investigator|0
1202947|NCT00913458|3952356|P2|Phase 3|Unsatisfactory Response per Investigator|0
1202948|NCT00913458|3952357|P1|Phase 3|Unsatisfactory Response per Investigator|0
1202949|NCT00913458|3952351|P7|Phase 3|Withdrawal by Subject|0
1202950|NCT00913458|3952352|P6|Phase 3|Withdrawal by Subject|2
1202951|NCT00913458|3952353|P5|Phase 3|Withdrawal by Subject|1
1202952|NCT00913458|3952354|P4|Phase 3|Withdrawal by Subject|0
1202953|NCT00913458|3952355|P3|Phase 3|Withdrawal by Subject|0
1202954|NCT00913458|3952356|P2|Phase 3|Withdrawal by Subject|0
1202955|NCT00913458|3952357|P1|Phase 3|Withdrawal by Subject|0
1202956|NCT00913458|3952351|P7|Phase 3|Non-Responder|3
1202957|NCT00913458|3952352|P6|Phase 3|Non-Responder|1
1202958|NCT00913458|3952353|P5|Phase 3|Non-Responder|0
1202959|NCT00913458|3952354|P4|Phase 3|Non-Responder|0
1202960|NCT00913458|3952355|P3|Phase 3|Non-Responder|0
1202961|NCT00913458|3952356|P2|Phase 3|Non-Responder|0
1202962|NCT00913458|3952357|P1|Phase 3|Non-Responder|0
1202963|NCT00913458|3952351|P7|Phase 3|Lost to Follow-up|0
1202964|NCT00913458|3952352|P6|Phase 3|Lost to Follow-up|0
1202965|NCT00913458|3952353|P5|Phase 3|Lost to Follow-up|2
1202966|NCT00913458|3952354|P4|Phase 3|Lost to Follow-up|0
1202967|NCT00913458|3952355|P3|Phase 3|Lost to Follow-up|0
1202968|NCT00913458|3952356|P2|Phase 3|Lost to Follow-up|0
1202969|NCT00913458|3952357|P1|Phase 3|Lost to Follow-up|0
1202970|NCT00913458|3952351|P7|Phase 3|Adverse Event|1
1202971|NCT00913458|3952352|P6|Phase 3|Adverse Event|4
1202972|NCT00913458|3952353|P5|Phase 3|Adverse Event|5
1202973|NCT00913458|3952354|P4|Phase 3|Adverse Event|0
1202974|NCT00913458|3952355|P3|Phase 3|Adverse Event|0
1202975|NCT00913458|3952356|P2|Phase 3|Adverse Event|0
1202976|NCT00913458|3952357|P1|Phase 3|Adverse Event|0
1202977|NCT00913458|3952351|P7|Phase 2|Unsatisfactory Response per Investigator|0
1202978|NCT00913458|3952352|P6|Phase 2|Unsatisfactory Response per Investigator|0
1202979|NCT00913458|3952353|P5|Phase 2|Unsatisfactory Response per Investigator|0
1202980|NCT00913458|3952354|P4|Phase 2|Unsatisfactory Response per Investigator|17
1202981|NCT00913458|3952355|P3|Phase 2|Unsatisfactory Response per Investigator|11
1202982|NCT00913458|3952356|P2|Phase 2|Unsatisfactory Response per Investigator|0
1202983|NCT00913458|3952357|P1|Phase 2|Unsatisfactory Response per Investigator|0
1202984|NCT00913458|3952351|P7|Phase 2|Protocol Violation|0
1202985|NCT00913458|3952352|P6|Phase 2|Protocol Violation|0
1202986|NCT00913458|3952353|P5|Phase 2|Protocol Violation|0
1202987|NCT00913458|3952354|P4|Phase 2|Protocol Violation|0
1202988|NCT00913458|3952355|P3|Phase 2|Protocol Violation|0
1202989|NCT00913458|3952356|P2|Phase 2|Protocol Violation|2
1202990|NCT00913458|3952357|P1|Phase 2|Protocol Violation|0
1202991|NCT00913458|3952351|P7|Phase 2|Lost to Follow-up|0
1202992|NCT00913458|3952352|P6|Phase 2|Lost to Follow-up|0
1202993|NCT00913458|3952353|P5|Phase 2|Lost to Follow-up|0
1202994|NCT00913458|3952354|P4|Phase 2|Lost to Follow-up|1
1202995|NCT00913458|3952355|P3|Phase 2|Lost to Follow-up|0
1202996|NCT00913458|3952356|P2|Phase 2|Lost to Follow-up|0
1202997|NCT00913458|3952357|P1|Phase 2|Lost to Follow-up|0
1202998|NCT00913458|3952351|P7|Phase 2|Adverse Event|0
1202999|NCT00913458|3952352|P6|Phase 2|Adverse Event|0
1203000|NCT00913458|3952353|P5|Phase 2|Adverse Event|0
1203001|NCT00913458|3952354|P4|Phase 2|Adverse Event|1
1203002|NCT00913458|3952355|P3|Phase 2|Adverse Event|0
1203003|NCT00913458|3952356|P2|Phase 2|Adverse Event|3
1203004|NCT00913458|3952357|P1|Phase 2|Adverse Event|0
1203005|NCT00913458|3952351|P7|Phase 2|Subject Request|0
1203006|NCT00913458|3952352|P6|Phase 2|Subject Request|0
1203007|NCT00913458|3952353|P5|Phase 2|Subject Request|0
1203008|NCT00913458|3952354|P4|Phase 2|Subject Request|2
1203009|NCT00913458|3952355|P3|Phase 2|Subject Request|1
1203010|NCT00913458|3952356|P2|Phase 2|Subject Request|0
1203011|NCT00913458|3952357|P1|Phase 2|Subject Request|0
1203012|NCT00913458|3952351|P7|Phase 2|Non-Responder|0
1203013|NCT00913458|3952352|P6|Phase 2|Non-Responder|0
1203014|NCT00913458|3952353|P5|Phase 2|Non-Responder|0
1203015|NCT00913458|3952354|P4|Phase 2|Non-Responder|12
1203016|NCT00913458|3952355|P3|Phase 2|Non-Responder|7
1203017|NCT00913458|3952356|P2|Phase 2|Non-Responder|5
1203018|NCT00913458|3952357|P1|Phase 2|Non-Responder|0
1203019|NCT00913458|3952351|P7|Phase 1|Unsatisfactory Response per Investigator|0
1203020|NCT00913458|3952352|P6|Phase 1|Unsatisfactory Response per Investigator|0
1203021|NCT00913458|3952353|P5|Phase 1|Unsatisfactory Response per Investigator|0
1203022|NCT00913458|3952354|P4|Phase 1|Unsatisfactory Response per Investigator|0
1203023|NCT00913458|3952355|P3|Phase 1|Unsatisfactory Response per Investigator|0
1203024|NCT00913458|3952356|P2|Phase 1|Unsatisfactory Response per Investigator|0
1203025|NCT00913458|3952357|P1|Phase 1|Unsatisfactory Response per Investigator|7
1203026|NCT00913458|3952351|P7|Phase 1|Sponsor|0
1203027|NCT00913458|3952352|P6|Phase 1|Sponsor|0
1203028|NCT00913458|3952353|P5|Phase 1|Sponsor|0
1203029|NCT00913458|3952354|P4|Phase 1|Sponsor|0
1203030|NCT00913458|3952355|P3|Phase 1|Sponsor|0
1203031|NCT00913458|3952356|P2|Phase 1|Sponsor|0
1203032|NCT00913458|3952357|P1|Phase 1|Sponsor|2
1203033|NCT00913458|3952351|P7|Phase 1|Protocol Violation|0
1203034|NCT00913458|3952352|P6|Phase 1|Protocol Violation|0
1203035|NCT00913458|3952353|P5|Phase 1|Protocol Violation|0
1203036|NCT00913458|3952354|P4|Phase 1|Protocol Violation|0
1203037|NCT00913458|3952355|P3|Phase 1|Protocol Violation|0
1203038|NCT00913458|3952356|P2|Phase 1|Protocol Violation|0
1203039|NCT00913458|3952357|P1|Phase 1|Protocol Violation|10
1203040|NCT00913458|3952351|P7|Phase 1|Lost to Follow-up|0
1203041|NCT00913458|3952352|P6|Phase 1|Lost to Follow-up|0
1203042|NCT00913458|3952353|P5|Phase 1|Lost to Follow-up|0
1203043|NCT00913458|3952354|P4|Phase 1|Lost to Follow-up|0
1203044|NCT00913458|3952355|P3|Phase 1|Lost to Follow-up|0
1203045|NCT00913458|3952356|P2|Phase 1|Lost to Follow-up|0
1203046|NCT00913458|3952357|P1|Phase 1|Lost to Follow-up|2
1203047|NCT00913458|3952351|P7|Phase 1|Adverse Event|0
1203048|NCT00913458|3952352|P6|Phase 1|Adverse Event|0
1203049|NCT00913458|3952353|P5|Phase 1|Adverse Event|0
1203050|NCT00913458|3952354|P4|Phase 1|Adverse Event|0
1203051|NCT00913458|3952355|P3|Phase 1|Adverse Event|0
1203052|NCT00913458|3952356|P2|Phase 1|Adverse Event|0
1203053|NCT00913458|3952357|P1|Phase 1|Adverse Event|20
1203054|NCT00913458|3952351|P7|Phase 1|Subject Request|0
1203055|NCT00913458|3952352|P6|Phase 1|Subject Request|0
1203056|NCT00913458|3952353|P5|Phase 1|Subject Request|0
1203057|NCT00913458|3952354|P4|Phase 1|Subject Request|0
1203058|NCT00913458|3952355|P3|Phase 1|Subject Request|0
1203059|NCT00913458|3952356|P2|Phase 1|Subject Request|0
1203060|NCT00913458|3952357|P1|Phase 1|Subject Request|17
1203061|NCT00913458|3952351|P7|Phase 1|Non-Responder|0
1203062|NCT00913458|3952352|P6|Phase 1|Non-Responder|0
1203063|NCT00913458|3952353|P5|Phase 1|Non-Responder|0
1203064|NCT00913458|3952354|P4|Phase 1|Non-Responder|0
1203065|NCT00913458|3952355|P3|Phase 1|Non-Responder|0
1203066|NCT00913458|3952356|P2|Phase 1|Non-Responder|0
1203067|NCT00913458|3952357|P1|Phase 1|Non-Responder|54
1203068|NCT00913380|3952450|P2|Clinical Outcomes|Lost to Follow-up|6
1203069|NCT00913380|3952451|P1|Clinical Outcomes|Lost to Follow-up|6
1203070|NCT00912964|3952517|P3|Overall Study|Randomized but never received study drug|0
1203071|NCT00912964|3952518|P2|Overall Study|Randomized but never received study drug|1
1203072|NCT00912964|3952519|P1|Overall Study|Randomized but never received study drug|0
1203073|NCT00912964|3952517|P3|Overall Study|Violation of exclusion criterion|2
1203074|NCT00912964|3952518|P2|Overall Study|Violation of exclusion criterion|0
1203075|NCT00912964|3952519|P1|Overall Study|Violation of exclusion criterion|0
1203076|NCT00912964|3952517|P3|Overall Study|Non-compliance with study procedures|0
1203077|NCT00912964|3952518|P2|Overall Study|Non-compliance with study procedures|0
1203078|NCT00912964|3952519|P1|Overall Study|Non-compliance with study procedures|2
1203079|NCT00912964|3952517|P3|Overall Study|Medical History|0
1203080|NCT00912964|3952518|P2|Overall Study|Medical History|0
1203081|NCT00912964|3952519|P1|Overall Study|Medical History|1
1203082|NCT00912964|3952517|P3|Overall Study|Taking exclusionary medications|8
1203083|NCT00912964|3952518|P2|Overall Study|Taking exclusionary medications|4
1203084|NCT00912964|3952519|P1|Overall Study|Taking exclusionary medications|7
1203085|NCT00912964|3952517|P3|Overall Study|Protocol Violation|8
1203086|NCT00912964|3952518|P2|Overall Study|Protocol Violation|3
1203087|NCT00912964|3952519|P1|Overall Study|Protocol Violation|5
1203088|NCT00912964|3952517|P3|Overall Study|Lost to Follow-up|3
1203089|NCT00912964|3952518|P2|Overall Study|Lost to Follow-up|3
1203090|NCT00912964|3952519|P1|Overall Study|Lost to Follow-up|4
1203091|NCT00912964|3952517|P3|Overall Study|Withdrawal by Subject|18
1203092|NCT00912964|3952518|P2|Overall Study|Withdrawal by Subject|12
1203093|NCT00912964|3952519|P1|Overall Study|Withdrawal by Subject|20
1203094|NCT00912964|3952517|P3|Overall Study|Lack of Efficacy|3
1203095|NCT00912964|3952518|P2|Overall Study|Lack of Efficacy|4
1203096|NCT00912964|3952519|P1|Overall Study|Lack of Efficacy|11
1203097|NCT00912964|3952517|P3|Overall Study|Adverse Event|12
1203098|NCT00912964|3952518|P2|Overall Study|Adverse Event|18
1203099|NCT00912964|3952519|P1|Overall Study|Adverse Event|15
1203100|NCT00912964|3952517|P3|Overall Study|Eligibility criterion not met|0
1203101|NCT00912964|3952518|P2|Overall Study|Eligibility criterion not met|1
1203102|NCT00912964|3952519|P1|Overall Study|Eligibility criterion not met|1
1203103|NCT00912912|3952662|P1|Overall Study|Disease Progression|3
1203104|NCT00912912|3952662|P1|Overall Study|Withdrawal by Subject|1
1203105|NCT00912808|3952668|P2|Second Intervention (6 Weeks)|Withdrawal by Subject|0
1203106|NCT00912808|3952669|P1|Second Intervention (6 Weeks)|Withdrawal by Subject|1
1203107|NCT00912808|3952668|P2|Second Intervention (6 Weeks)|Adverse Event|1
1203108|NCT00912808|3952669|P1|Second Intervention (6 Weeks)|Adverse Event|0
1203109|NCT00912808|3952668|P2|Washout|Withdrawal by Subject|1
1203110|NCT00912808|3952669|P1|Washout|Withdrawal by Subject|0
1203111|NCT00912808|3952668|P2|First Intervention (6 Weeks)|Adverse Event|1
1203112|NCT00912808|3952669|P1|First Intervention (6 Weeks)|Adverse Event|2
1203113|NCT00912782|3952694|P2|Overall Study|Relocated before study completion|1
1203114|NCT00912782|3952695|P1|Overall Study|Relocated before study completion|0
1203115|NCT00912782|3952694|P2|Overall Study|Did not receive vascular access type|2
1203116|NCT00912782|3952695|P1|Overall Study|Did not receive vascular access type|1
1203117|NCT00912782|3952694|P2|Overall Study|Lost to Follow-up|1
1203118|NCT00912782|3952695|P1|Overall Study|Lost to Follow-up|0
1203119|NCT00912782|3952694|P2|Overall Study|Death|1
1203120|NCT00912782|3952695|P1|Overall Study|Death|2
1203121|NCT00912743|3952705|P2|Overall Study|End of treatment form was not collected|0
1203122|NCT00912743|3952706|P1|Overall Study|End of treatment form was not collected|1
1203123|NCT00912743|3952705|P2|Overall Study|Toxicity|1
1203124|NCT00912743|3952706|P1|Overall Study|Toxicity|0
1203125|NCT00912743|3952705|P2|Overall Study|Lack of Efficacy|18
1203126|NCT00912743|3952706|P1|Overall Study|Lack of Efficacy|9
1203127|NCT00912743|3952705|P2|Overall Study|Adverse Event|1
1203128|NCT00912743|3952706|P1|Overall Study|Adverse Event|3
1203129|NCT00912509|3952718|P2|Overall Study|Lack of Efficacy|3
1203130|NCT00912509|3952719|P1|Overall Study|Lack of Efficacy|4
1203131|NCT00912509|3952718|P2|Overall Study|Lost to Follow-up|0
1203132|NCT00912509|3952719|P1|Overall Study|Lost to Follow-up|1
1203133|NCT00912405|3952727|P1|Overall Study|Lost to Follow-up|5
1203134|NCT00912340|3952737|P3|Overall Study|Protocol revised to remove arm|4
1203135|NCT00912340|3952738|P2|Overall Study|Protocol revised to remove arm|0
1203136|NCT00912340|3952739|P1|Overall Study|Protocol revised to remove arm|0
1203137|NCT00912340|3952737|P3|Overall Study|Adverse Event|0
1203138|NCT00912340|3952738|P2|Overall Study|Adverse Event|4
1203139|NCT00912340|3952739|P1|Overall Study|Adverse Event|2
1203140|NCT00912288|3952777|P2|Overall Study|Other|0
1203141|NCT00912288|3952778|P1|Overall Study|Other|1
1203142|NCT00912288|3952777|P2|Overall Study|Study terminated by sponsor|35
1203143|NCT00912288|3952778|P1|Overall Study|Study terminated by sponsor|34
1203144|NCT00912288|3952777|P2|Overall Study|Withdrawal by Subject|3
1203145|NCT00912288|3952778|P1|Overall Study|Withdrawal by Subject|3
1203146|NCT00912288|3952777|P2|Overall Study|Protocol Violation|0
1203147|NCT00912288|3952778|P1|Overall Study|Protocol Violation|1
1203148|NCT00912288|3952777|P2|Overall Study|Lost to Follow-up|0
1203149|NCT00912288|3952778|P1|Overall Study|Lost to Follow-up|1
1203150|NCT00912288|3952777|P2|Overall Study|Adverse Event|1
1203151|NCT00912288|3952778|P1|Overall Study|Adverse Event|1
1203152|NCT00912288|3952777|P2|Overall Study|Death|1
1203153|NCT00912288|3952778|P1|Overall Study|Death|0
1203154|NCT00912223|3952800|P1|Overall Study|Transformed disease|1
1203155|NCT00912223|3952800|P1|Overall Study|Not transplanted|1
1203156|NCT00912223|3952800|P1|Overall Study|Withdrawal by Subject|1
1203157|NCT00912093|3952831|P5|The Controlled Phase|Lost to Follow-up|1
1203158|NCT00912093|3952832|P4|The Controlled Phase|Lost to Follow-up|0
1203159|NCT00912093|3952833|P3|The Controlled Phase|Lost to Follow-up|0
1203160|NCT00912093|3952834|P2|The Controlled Phase|Lost to Follow-up|0
1203161|NCT00912093|3952835|P1|The Controlled Phase|Lost to Follow-up|0
1203162|NCT00912093|3952831|P5|The Controlled Phase|Medical Condition|0
1203163|NCT00912093|3952832|P4|The Controlled Phase|Medical Condition|0
1203164|NCT00912093|3952833|P3|The Controlled Phase|Medical Condition|0
1203165|NCT00912093|3952834|P2|The Controlled Phase|Medical Condition|1
1203166|NCT00912093|3952835|P1|The Controlled Phase|Medical Condition|0
1203167|NCT00912093|3952831|P5|The Controlled Phase|Death|0
1203168|NCT00912093|3952832|P4|The Controlled Phase|Death|0
1203169|NCT00912093|3952833|P3|The Controlled Phase|Death|0
1203170|NCT00912093|3952834|P2|The Controlled Phase|Death|1
1203171|NCT00912093|3952835|P1|The Controlled Phase|Death|0
1203172|NCT00912028|3952854|P5|Overall Study|Withdrawal by Subject|0
1203173|NCT00912028|3952855|P4|Overall Study|Withdrawal by Subject|0
1203174|NCT00912028|3952856|P3|Overall Study|Withdrawal by Subject|0
1203175|NCT00912028|3952857|P2|Overall Study|Withdrawal by Subject|0
1203176|NCT00912028|3952858|P1|Overall Study|Withdrawal by Subject|3
1203177|NCT00912028|3952854|P5|Overall Study|Lost to Follow-up|3
1203178|NCT00912028|3952855|P4|Overall Study|Lost to Follow-up|1
1203179|NCT00912028|3952856|P3|Overall Study|Lost to Follow-up|0
1203180|NCT00912028|3952857|P2|Overall Study|Lost to Follow-up|3
1203181|NCT00912028|3952858|P1|Overall Study|Lost to Follow-up|2
1203182|NCT00912015|3952887|P4|Overall Study|Adverse Event|1
1203183|NCT00912015|3952888|P3|Overall Study|Adverse Event|0
1203184|NCT00912015|3952889|P2|Overall Study|Adverse Event|0
1203185|NCT00912015|3952890|P1|Overall Study|Adverse Event|6
1203186|NCT00912015|3952887|P4|Overall Study|Protocol Violation|1
1203187|NCT00912015|3952888|P3|Overall Study|Protocol Violation|0
1203188|NCT00912015|3952889|P2|Overall Study|Protocol Violation|0
1203189|NCT00912015|3952890|P1|Overall Study|Protocol Violation|1
1203190|NCT00912015|3952887|P4|Overall Study|Withdrawal by Subject|0
1203191|NCT00912015|3952888|P3|Overall Study|Withdrawal by Subject|3
1203192|NCT00912015|3952889|P2|Overall Study|Withdrawal by Subject|8
1203193|NCT00912015|3952890|P1|Overall Study|Withdrawal by Subject|8
1203194|NCT00912015|3952887|P4|Overall Study|Lack of Efficacy|0
1203195|NCT00912015|3952888|P3|Overall Study|Lack of Efficacy|0
1203196|NCT00912015|3952889|P2|Overall Study|Lack of Efficacy|0
1203197|NCT00912015|3952890|P1|Overall Study|Lack of Efficacy|1
1203198|NCT00911989|3952906|P1|Overall Study|Adverse Event|1
1203199|NCT00911937|3952912|P2|Overall Study|Other|5
1203200|NCT00911937|3952913|P1|Overall Study|Other|9
1203201|NCT00911937|3952912|P2|Overall Study|Randomized but not treated|13
1203202|NCT00911937|3952913|P1|Overall Study|Randomized but not treated|13
1203203|NCT00911937|3952912|P2|Overall Study|Protocol Violation|23
1203204|NCT00911937|3952913|P1|Overall Study|Protocol Violation|14
1203205|NCT00911937|3952912|P2|Overall Study|Did not meet inclusion criteria|11
1203206|NCT00911937|3952913|P1|Overall Study|Did not meet inclusion criteria|9
1203207|NCT00911937|3952912|P2|Overall Study|Lack of Efficacy|6
1203208|NCT00911937|3952913|P1|Overall Study|Lack of Efficacy|11
1203209|NCT00911937|3952912|P2|Overall Study|Adverse Event|25
1203210|NCT00911937|3952913|P1|Overall Study|Adverse Event|11
1203211|NCT00911937|3952912|P2|Overall Study|Withdrawn due to pregnancy|0
1203212|NCT00911937|3952913|P1|Overall Study|Withdrawn due to pregnancy|1
1203213|NCT00911937|3952912|P2|Overall Study|Withdrawal by Subject|7
1203214|NCT00911937|3952913|P1|Overall Study|Withdrawal by Subject|10
1203215|NCT00911937|3952912|P2|Overall Study|Lost to Follow-up|5
1203216|NCT00911937|3952913|P1|Overall Study|Lost to Follow-up|8
1203217|NCT00911937|3952912|P2|Overall Study|Death|0
1203218|NCT00911937|3952913|P1|Overall Study|Death|1
1203219|NCT00911859|3952980|P3|Follow-up Period|Study terminated by sponsor|27
1203220|NCT00911859|3952981|P2|Follow-up Period|Study terminated by sponsor|33
1203221|NCT00911859|3952982|P1|Follow-up Period|Study terminated by sponsor|5
1203222|NCT00911859|3952980|P3|Follow-up Period|Withdrawal by Subject|4
1203223|NCT00911859|3952981|P2|Follow-up Period|Withdrawal by Subject|4
1203224|NCT00911859|3952982|P1|Follow-up Period|Withdrawal by Subject|0
1203225|NCT00911859|3952980|P3|Follow-up Period|Lost to Follow-up|0
1203226|NCT00911859|3952981|P2|Follow-up Period|Lost to Follow-up|1
1203227|NCT00911859|3952982|P1|Follow-up Period|Lost to Follow-up|1
1203228|NCT00911859|3952980|P3|Follow-up Period|Death|10
1203229|NCT00911859|3952981|P2|Follow-up Period|Death|8
1203230|NCT00911859|3952982|P1|Follow-up Period|Death|5
1203231|NCT00911859|3952980|P3|Maintainance Period|Withdrawal by Subject|3
1203232|NCT00911859|3952981|P2|Maintainance Period|Withdrawal by Subject|0
1203233|NCT00911859|3952982|P1|Maintainance Period|Withdrawal by Subject|0
1203234|NCT00911859|3952980|P3|Maintainance Period|Physician Decision|9
1203235|NCT00911859|3952981|P2|Maintainance Period|Physician Decision|0
1203236|NCT00911859|3952982|P1|Maintainance Period|Physician Decision|0
1203237|NCT00911859|3952980|P3|Maintainance Period|Lack of Efficacy|9
1203238|NCT00911859|3952981|P2|Maintainance Period|Lack of Efficacy|0
1203239|NCT00911859|3952982|P1|Maintainance Period|Lack of Efficacy|0
1203240|NCT00911859|3952980|P3|Treatment Period|Did not receive study treatment|0
1203241|NCT00911859|3952981|P2|Treatment Period|Did not receive study treatment|1
1203242|NCT00911859|3952982|P1|Treatment Period|Did not receive study treatment|0
1203243|NCT00911859|3952980|P3|Treatment Period|Withdrawal by Subject|5
1203244|NCT00911859|3952981|P2|Treatment Period|Withdrawal by Subject|4
1203245|NCT00911859|3952982|P1|Treatment Period|Withdrawal by Subject|0
1203246|NCT00911859|3952980|P3|Treatment Period|Physician Decision|3
1203247|NCT00911859|3952981|P2|Treatment Period|Physician Decision|3
1203248|NCT00911859|3952982|P1|Treatment Period|Physician Decision|3
1203249|NCT00911859|3952980|P3|Treatment Period|Lack of Efficacy|5
1203250|NCT00911859|3952981|P2|Treatment Period|Lack of Efficacy|7
1203251|NCT00911859|3952982|P1|Treatment Period|Lack of Efficacy|1
1203252|NCT00911859|3952980|P3|Treatment Period|Death|5
1203253|NCT00911859|3952981|P2|Treatment Period|Death|3
1203254|NCT00911859|3952982|P1|Treatment Period|Death|1
1203255|NCT00911859|3952980|P3|Treatment Period|Adverse Event|7
1203256|NCT00911859|3952981|P2|Treatment Period|Adverse Event|3
1203257|NCT00911859|3952982|P1|Treatment Period|Adverse Event|3
1203258|NCT00911820|3953008|P2|Overall Study|Withdraw before Receive Treatment|2
1203259|NCT00911820|3953009|P1|Overall Study|Withdraw before Receive Treatment|0
1203260|NCT00911820|3953008|P2|Overall Study|Pathology Not Confirmed|0
1203261|NCT00911820|3953009|P1|Overall Study|Pathology Not Confirmed|1
1203262|NCT00911820|3953008|P2|Overall Study|Still on Therapy|2
1203263|NCT00911820|3953009|P1|Overall Study|Still on Therapy|2
1203264|NCT00911820|3953008|P2|Overall Study|Pursue Radiation|0
1203265|NCT00911820|3953009|P1|Overall Study|Pursue Radiation|1
1203266|NCT00911820|3953008|P2|Overall Study|Pursue surgery|1
1203267|NCT00911820|3953009|P1|Overall Study|Pursue surgery|1
1203268|NCT00911820|3953008|P2|Overall Study|Death|2
1203269|NCT00911820|3953009|P1|Overall Study|Death|1
1203270|NCT00911820|3953008|P2|Overall Study|Withdrawal by Subject|4
1203271|NCT00911820|3953009|P1|Overall Study|Withdrawal by Subject|3
1203272|NCT00911820|3953008|P2|Overall Study|Decline in Performance Status|2
1203273|NCT00911820|3953009|P1|Overall Study|Decline in Performance Status|4
1203274|NCT00911820|3953008|P2|Overall Study|Physician Decision|9
1203275|NCT00911820|3953009|P1|Overall Study|Physician Decision|5
1203276|NCT00911820|3953008|P2|Overall Study|Clinical Progression|5
1203277|NCT00911820|3953009|P1|Overall Study|Clinical Progression|7
1203278|NCT00911820|3953008|P2|Overall Study|Adverse Event|8
1203279|NCT00911820|3953009|P1|Overall Study|Adverse Event|8
1203280|NCT00911820|3953008|P2|Overall Study|RECIST progression|8
1203281|NCT00911820|3953009|P1|Overall Study|RECIST progression|12
1203282|NCT00911807|3953026|P3|Overall Study|Organizational reasons|1
1203283|NCT00911807|3953027|P2|Overall Study|Organizational reasons|3
1203284|NCT00911807|3953028|P1|Overall Study|Organizational reasons|1
1203285|NCT00911807|3953026|P3|Overall Study|Withdrawal by Subject|7
1203286|NCT00911807|3953027|P2|Overall Study|Withdrawal by Subject|10
1203287|NCT00911807|3953028|P1|Overall Study|Withdrawal by Subject|8
1203288|NCT00911807|3953026|P3|Overall Study|Protocol Violation|9
1203289|NCT00911807|3953027|P2|Overall Study|Protocol Violation|4
1203290|NCT00911807|3953028|P1|Overall Study|Protocol Violation|6
1203291|NCT00911807|3953026|P3|Overall Study|Death|1
1203292|NCT00911807|3953027|P2|Overall Study|Death|0
1203293|NCT00911807|3953028|P1|Overall Study|Death|0
1203294|NCT00911807|3953026|P3|Overall Study|Adverse Event|5
1203295|NCT00911807|3953027|P2|Overall Study|Adverse Event|1
1203296|NCT00911807|3953028|P1|Overall Study|Adverse Event|2
1203297|NCT00911768|3953038|P2|Overall Study|Withdrawal by Subject|0
1203298|NCT00911768|3953039|P1|Overall Study|Withdrawal by Subject|1
1203299|NCT00911768|3953038|P2|Overall Study|Protocol Violation|4
1203300|NCT00911768|3953039|P1|Overall Study|Protocol Violation|5
1203301|NCT00911625|3953068|P2|Overall Study|Lost to Follow-up|0
1203302|NCT00911625|3953069|P1|Overall Study|Lost to Follow-up|7
1203303|NCT00911547|3953098|P4|Overall Study|Withdrawal by Subject|8
1203304|NCT00911547|3953099|P3|Overall Study|Withdrawal by Subject|4
1203305|NCT00911547|3953100|P2|Overall Study|Withdrawal by Subject|10
1203306|NCT00911547|3953101|P1|Overall Study|Withdrawal by Subject|3
1203307|NCT00911547|3953098|P4|Overall Study|Protocol Violation|1
1203308|NCT00911547|3953099|P3|Overall Study|Protocol Violation|5
1203309|NCT00911547|3953100|P2|Overall Study|Protocol Violation|5
1203310|NCT00911547|3953101|P1|Overall Study|Protocol Violation|0
1203311|NCT00911547|3953098|P4|Overall Study|Lost to Follow-up|1
1203312|NCT00911547|3953099|P3|Overall Study|Lost to Follow-up|2
1203313|NCT00911547|3953100|P2|Overall Study|Lost to Follow-up|0
1203314|NCT00911547|3953101|P1|Overall Study|Lost to Follow-up|0
1203315|NCT00911547|3953098|P4|Overall Study|Adverse Event|6
1203316|NCT00911547|3953099|P3|Overall Study|Adverse Event|11
1203317|NCT00911547|3953100|P2|Overall Study|Adverse Event|27
1203318|NCT00911547|3953101|P1|Overall Study|Adverse Event|8
1203319|NCT00911534|3953129|P2|Overall Study|Not specified|2
1203320|NCT00911534|3953130|P1|Overall Study|Not specified|2
1203321|NCT00911534|3953129|P2|Overall Study|Withdrawal of consent|4
1203322|NCT00911534|3953130|P1|Overall Study|Withdrawal of consent|1
1203323|NCT00911534|3953129|P2|Overall Study|Lack of Efficacy|1
1203324|NCT00911534|3953130|P1|Overall Study|Lack of Efficacy|4
1203325|NCT00911534|3953129|P2|Overall Study|Withdrawal by Subject|1
1203326|NCT00911534|3953130|P1|Overall Study|Withdrawal by Subject|2
1203327|NCT00911534|3953129|P2|Overall Study|Lost to Follow-up|4
1203328|NCT00911534|3953130|P1|Overall Study|Lost to Follow-up|2
1203329|NCT00911534|3953129|P2|Overall Study|Adverse Event|4
1203330|NCT00911534|3953130|P1|Overall Study|Adverse Event|4
1203331|NCT00911300|3953185|P2|Overall Study|Randomized; No Study Medication Received|2
1203332|NCT00911300|3953186|P1|Overall Study|Randomized; No Study Medication Received|0
1203333|NCT00911300|3953185|P2|Overall Study|Treatment Stopped by Mistake|1
1203334|NCT00911300|3953186|P1|Overall Study|Treatment Stopped by Mistake|0
1203335|NCT00911300|3953185|P2|Overall Study|Physician Decision|1
1203336|NCT00911300|3953186|P1|Overall Study|Physician Decision|0
1203337|NCT00911300|3953185|P2|Overall Study|Underlying Disease (Myocarditis)|1
1203338|NCT00911300|3953186|P1|Overall Study|Underlying Disease (Myocarditis)|0
1203339|NCT00911300|3953185|P2|Overall Study|Participant Refused Hospital Consulation|1
1203340|NCT00911300|3953186|P1|Overall Study|Participant Refused Hospital Consulation|0
1203341|NCT00911300|3953185|P2|Overall Study|International Normalized Ratio Too High|1
1203342|NCT00911300|3953186|P1|Overall Study|International Normalized Ratio Too High|0
1203343|NCT00911300|3953185|P2|Overall Study|Investigator's Decision; New AF Episode|1
1203344|NCT00911300|3953186|P1|Overall Study|Investigator's Decision; New AF Episode|0
1203345|NCT00911300|3953185|P2|Overall Study|Participant Could Not Stay in Hospital|1
1203346|NCT00911300|3953186|P1|Overall Study|Participant Could Not Stay in Hospital|0
1203347|NCT00911300|3953185|P2|Overall Study|CV Unsuccessful; Phenprocoumon Received|0
1203348|NCT00911300|3953186|P1|Overall Study|CV Unsuccessful; Phenprocoumon Received|1
1203349|NCT00911300|3953185|P2|Overall Study|Nurse Unavailable in Participant's City|0
1203350|NCT00911300|3953186|P1|Overall Study|Nurse Unavailable in Participant's City|1
1203351|NCT00911300|3953185|P2|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
1203352|NCT00911300|3953186|P1|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
1203353|NCT00911300|3953185|P2|Overall Study|Recurrent Tachyarrhythmia|1
1203354|NCT00911300|3953186|P1|Overall Study|Recurrent Tachyarrhythmia|1
1203355|NCT00911300|3953185|P2|Overall Study|Received Commercial Treatment|0
1203356|NCT00911300|3953186|P1|Overall Study|Received Commercial Treatment|1
1203357|NCT00911300|3953185|P2|Overall Study|Atrial Fibrillation (AF) Recurrence|3
1203358|NCT00911300|3953186|P1|Overall Study|Atrial Fibrillation (AF) Recurrence|3
1203359|NCT00911300|3953185|P2|Overall Study|Coronary Angiography Performed|0
1203360|NCT00911300|3953186|P1|Overall Study|Coronary Angiography Performed|1
1203361|NCT00911300|3953185|P2|Overall Study|Consent Withdrawn|12
1203362|NCT00911300|3953186|P1|Overall Study|Consent Withdrawn|4
1203363|NCT00911300|3953185|P2|Overall Study|Protocol Violation|2
1203364|NCT00911300|3953186|P1|Overall Study|Protocol Violation|3
1203365|NCT00911300|3953185|P2|Overall Study|Adverse Event|6
1203366|NCT00911300|3953186|P1|Overall Study|Adverse Event|14
1203367|NCT00911300|3953185|P2|Overall Study|Thrombus Persistant in Second TEE|7
1203368|NCT00911300|3953186|P1|Overall Study|Thrombus Persistant in Second TEE|3
1203369|NCT00911300|3953185|P2|Overall Study|Death|0
1203370|NCT00911300|3953186|P1|Overall Study|Death|1
1203371|NCT00911300|3953185|P2|Overall Study|Primary Endpoint Component Occurred|2
1203372|NCT00911300|3953186|P1|Overall Study|Primary Endpoint Component Occurred|1
1203373|NCT00911170|3953223|P2|Long Term Follow-Up|Death|121
1203374|NCT00911170|3953224|P1|Long Term Follow-Up|Death|116
1203375|NCT00911170|3953223|P2|Long Term Follow-Up|Lost to Follow-up|7
1203376|NCT00911170|3953224|P1|Long Term Follow-Up|Lost to Follow-up|8
1203377|NCT00911170|3953223|P2|Long Term Follow-Up|Physician Decision|4
1203378|NCT00911170|3953224|P1|Long Term Follow-Up|Physician Decision|5
1203379|NCT00911170|3953223|P2|Long Term Follow-Up|Withdrawal by Subject|21
1203380|NCT00911170|3953224|P1|Long Term Follow-Up|Withdrawal by Subject|20
1203381|NCT00911170|3953223|P2|Long Term Follow-Up|Continuing in study|269
1203382|NCT00911170|3953224|P1|Long Term Follow-Up|Continuing in study|274
1203383|NCT00911170|3953223|P2|Treatment Period|Death|9
1203384|NCT00911170|3953224|P1|Treatment Period|Death|6
1203385|NCT00911170|3953223|P2|Treatment Period|Lost to Follow-up|1
1203386|NCT00911170|3953224|P1|Treatment Period|Lost to Follow-up|0
1203387|NCT00911170|3953223|P2|Treatment Period|Physician Decision|5
1203388|NCT00911170|3953224|P1|Treatment Period|Physician Decision|5
1203389|NCT00911170|3953223|P2|Treatment Period|Disease progression|2
1203390|NCT00911170|3953224|P1|Treatment Period|Disease progression|0
1203391|NCT00911170|3953223|P2|Treatment Period|Withdrawal by Subject|4
1203392|NCT00911170|3953224|P1|Treatment Period|Withdrawal by Subject|4
1203393|NCT00911170|3953223|P2|Treatment Period|Adverse Event|10
1203394|NCT00911170|3953224|P1|Treatment Period|Adverse Event|9
1203395|NCT00911170|3953223|P2|Treatment Period|Protocol deviation|2
1203396|NCT00911170|3953224|P1|Treatment Period|Protocol deviation|1
1203397|NCT00911170|3953223|P2|Treatment Period|Ineligibility determined|3
1203398|NCT00911170|3953224|P1|Treatment Period|Ineligibility determined|1
1203399|NCT00911170|3953223|P2|Treatment Period|Randomized in error|1
1203400|NCT00911170|3953224|P1|Treatment Period|Randomized in error|1
1203401|NCT00911157|3953248|P2|Overall Study|Need to treat for lung cancer|0
1203402|NCT00911157|3953249|P1|Overall Study|Need to treat for lung cancer|1
1203403|NCT00911157|3953248|P2|Overall Study|Need for prohibited drug (heparin)|0
1203404|NCT00911157|3953249|P1|Overall Study|Need for prohibited drug (heparin)|1
1203405|NCT00911157|3953248|P2|Overall Study|Withdrawal by Subject|1
1203406|NCT00911157|3953249|P1|Overall Study|Withdrawal by Subject|1
1203407|NCT00911157|3953248|P2|Overall Study|Adverse Event|1
1203408|NCT00911157|3953249|P1|Overall Study|Adverse Event|4
1203409|NCT00911144|3953265|P2|Overall Study|Withdrawal by Subject|5
1203410|NCT00911144|3953266|P1|Overall Study|Withdrawal by Subject|16
1203411|NCT00910988|3953294|P4|Overall Study|Lost to Follow-up|0
1203412|NCT00910988|3953295|P3|Overall Study|Lost to Follow-up|3
1203413|NCT00910988|3953296|P2|Overall Study|Lost to Follow-up|4
1203414|NCT00910988|3953297|P1|Overall Study|Lost to Follow-up|2
1203415|NCT00910962|3953342|P3|Overall Study|Reached defined stopping criteria|17
1203416|NCT00910962|3953343|P2|Overall Study|Reached defined stopping criteria|14
1203417|NCT00910962|3953344|P1|Overall Study|Reached defined stopping criteria|12
1203418|NCT00910962|3953342|P3|Overall Study|Withdrawal by Subject|32
1203419|NCT00910962|3953343|P2|Overall Study|Withdrawal by Subject|32
1203420|NCT00910962|3953344|P1|Overall Study|Withdrawal by Subject|25
1203421|NCT00910962|3953342|P3|Overall Study|Physician Decision|6
1203422|NCT00910962|3953343|P2|Overall Study|Physician Decision|6
1203423|NCT00910962|3953344|P1|Overall Study|Physician Decision|0
1203424|NCT00910962|3953342|P3|Overall Study|Lost to Follow-up|1
1203425|NCT00910962|3953343|P2|Overall Study|Lost to Follow-up|3
1203426|NCT00910962|3953344|P1|Overall Study|Lost to Follow-up|0
1203427|NCT00910962|3953342|P3|Overall Study|Protocol Violation|3
1203428|NCT00910962|3953343|P2|Overall Study|Protocol Violation|3
1203429|NCT00910962|3953344|P1|Overall Study|Protocol Violation|1
1203430|NCT00910962|3953342|P3|Overall Study|Adverse Event|17
1203431|NCT00910962|3953343|P2|Overall Study|Adverse Event|20
1203432|NCT00910962|3953344|P1|Overall Study|Adverse Event|5
1203433|NCT00910910|3953436|P2|Overall Study|Untreated before cycle 1|2
1203434|NCT00910910|3953437|P1|Overall Study|Untreated before cycle 1|1
1203435|NCT00910910|3953436|P2|Overall Study|Other|32
1203436|NCT00910910|3953437|P1|Overall Study|Other|114
1203437|NCT00910910|3953436|P2|Overall Study|Completed 13 cycles of treatment|118
1203438|NCT00910910|3953437|P1|Overall Study|Completed 13 cycles of treatment|0
1203439|NCT00910910|3953436|P2|Overall Study|Protocol Violation|2
1203440|NCT00910910|3953437|P1|Overall Study|Protocol Violation|2
1203441|NCT00910910|3953436|P2|Overall Study|Death|3
1203442|NCT00910910|3953437|P1|Overall Study|Death|9
1203443|NCT00910910|3953436|P2|Overall Study|Lost to Follow-up|2
1203444|NCT00910910|3953437|P1|Overall Study|Lost to Follow-up|2
1203445|NCT00910910|3953436|P2|Overall Study|Withdrawal by Subject|5
1203446|NCT00910910|3953437|P1|Overall Study|Withdrawal by Subject|7
1203447|NCT00910910|3953436|P2|Overall Study|PD with histologic change|2
1203448|NCT00910910|3953437|P1|Overall Study|PD with histologic change|0
1203449|NCT00910910|3953436|P2|Overall Study|PD without histologic change|23
1203450|NCT00910910|3953437|P1|Overall Study|PD without histologic change|27
1203451|NCT00910910|3953436|P2|Overall Study|Adverse Event|35
1203452|NCT00910910|3953437|P1|Overall Study|Adverse Event|63
1203453|NCT00910871|3953471|P1|Overall Study|Undefined|1
1203454|NCT00910871|3953471|P1|Overall Study|Subject didn’t meet eligibility criteria|5
1203455|NCT00910871|3953471|P1|Overall Study|Withdrawal by Subject|12
1203456|NCT00910871|3953471|P1|Overall Study|Protocol Violation|11
1203457|NCT00910871|3953471|P1|Overall Study|Lost to Follow-up|8
1203458|NCT00910871|3953471|P1|Overall Study|Death|12
1203459|NCT00910871|3953471|P1|Overall Study|Adverse Event|5
1203460|NCT00910858|3953479|P3|Combined Treatment Phase|Other|1
1203461|NCT00910858|3953480|P2|Combined Treatment Phase|Other|2
1203462|NCT00910858|3953481|P1|Combined Treatment Phase|Other|0
1203463|NCT00910858|3953479|P3|Combined Treatment Phase|Protocol Violation|0
1203464|NCT00910858|3953480|P2|Combined Treatment Phase|Protocol Violation|0
1203465|NCT00910858|3953481|P1|Combined Treatment Phase|Protocol Violation|1
1203466|NCT00910858|3953479|P3|Combined Treatment Phase|Withdrawal by Subject|0
1203467|NCT00910858|3953480|P2|Combined Treatment Phase|Withdrawal by Subject|2
1203468|NCT00910858|3953481|P1|Combined Treatment Phase|Withdrawal by Subject|0
1203469|NCT00910858|3953479|P3|Combined Treatment Phase|Lack of therapeutic effect|3
1203470|NCT00910858|3953480|P2|Combined Treatment Phase|Lack of therapeutic effect|6
1203471|NCT00910858|3953481|P1|Combined Treatment Phase|Lack of therapeutic effect|8
1203472|NCT00910858|3953479|P3|Monotherapy Phase|Other|2
1203473|NCT00910858|3953480|P2|Monotherapy Phase|Other|4
1203474|NCT00910858|3953481|P1|Monotherapy Phase|Other|3
1203475|NCT00910858|3953479|P3|Monotherapy Phase|Protocol Violation|0
1203476|NCT00910858|3953480|P2|Monotherapy Phase|Protocol Violation|0
1203477|NCT00910858|3953481|P1|Monotherapy Phase|Protocol Violation|1
1203478|NCT00910858|3953479|P3|Monotherapy Phase|Withdrawal by Subject|1
1203479|NCT00910858|3953480|P2|Monotherapy Phase|Withdrawal by Subject|3
1203480|NCT00910858|3953481|P1|Monotherapy Phase|Withdrawal by Subject|1
1203481|NCT00910858|3953479|P3|Monotherapy Phase|Lack of therapeutic effect|4
1203482|NCT00910858|3953480|P2|Monotherapy Phase|Lack of therapeutic effect|6
1203483|NCT00910858|3953481|P1|Monotherapy Phase|Lack of therapeutic effect|9
1203484|NCT00910858|3953479|P3|Monotherapy Phase|Adverse Event|0
1203485|NCT00910858|3953480|P2|Monotherapy Phase|Adverse Event|2
1203486|NCT00910858|3953481|P1|Monotherapy Phase|Adverse Event|3
1203487|NCT00910858|3953479|P3|Pharmacokinetic Phase|Adverse Event|0
1203488|NCT00910858|3953480|P2|Pharmacokinetic Phase|Adverse Event|0
1203489|NCT00910858|3953481|P1|Pharmacokinetic Phase|Adverse Event|1
1203490|NCT00910728|3953526|P9|Overall Study|Adverse Event|1
1203491|NCT00910728|3953527|P8|Overall Study|Adverse Event|1
1203492|NCT00910728|3953528|P7|Overall Study|Adverse Event|2
1203493|NCT00910728|3953529|P6|Overall Study|Adverse Event|0
1203494|NCT00910728|3953530|P5|Overall Study|Adverse Event|0
1203495|NCT00910728|3953531|P4|Overall Study|Adverse Event|1
1203496|NCT00910728|3953532|P3|Overall Study|Adverse Event|1
1203497|NCT00910728|3953533|P2|Overall Study|Adverse Event|0
1203498|NCT00910728|3953534|P1|Overall Study|Adverse Event|2
1203499|NCT00910728|3953526|P9|Overall Study|(not specified)|0
1203500|NCT00910728|3953527|P8|Overall Study|(not specified)|0
1203501|NCT00910728|3953528|P7|Overall Study|(not specified)|0
1203502|NCT00910728|3953529|P6|Overall Study|(not specified)|0
1203503|NCT00910728|3953530|P5|Overall Study|(not specified)|1
1203504|NCT00910728|3953531|P4|Overall Study|(not specified)|0
1203505|NCT00910728|3953532|P3|Overall Study|(not specified)|1
1203506|NCT00910728|3953533|P2|Overall Study|(not specified)|0
1203507|NCT00910728|3953534|P1|Overall Study|(not specified)|2
1203508|NCT00910728|3953526|P9|Overall Study|Withdrawal by Subject|0
1203509|NCT00910728|3953527|P8|Overall Study|Withdrawal by Subject|0
1203510|NCT00910728|3953528|P7|Overall Study|Withdrawal by Subject|2
1203511|NCT00910728|3953529|P6|Overall Study|Withdrawal by Subject|1
1203512|NCT00910728|3953530|P5|Overall Study|Withdrawal by Subject|3
1203513|NCT00910728|3953531|P4|Overall Study|Withdrawal by Subject|0
1203514|NCT00910728|3953532|P3|Overall Study|Withdrawal by Subject|0
1203515|NCT00910728|3953533|P2|Overall Study|Withdrawal by Subject|0
1203516|NCT00910728|3953534|P1|Overall Study|Withdrawal by Subject|0
1203517|NCT00910728|3953526|P9|Overall Study|Lack of Efficacy|2
1203518|NCT00910728|3953527|P8|Overall Study|Lack of Efficacy|2
1203519|NCT00910728|3953528|P7|Overall Study|Lack of Efficacy|2
1203520|NCT00910728|3953529|P6|Overall Study|Lack of Efficacy|0
1203521|NCT00910728|3953530|P5|Overall Study|Lack of Efficacy|1
1203522|NCT00910728|3953531|P4|Overall Study|Lack of Efficacy|2
1203523|NCT00910728|3953532|P3|Overall Study|Lack of Efficacy|1
1203524|NCT00910728|3953533|P2|Overall Study|Lack of Efficacy|3
1203525|NCT00910728|3953534|P1|Overall Study|Lack of Efficacy|2
1203526|NCT00910715|3953656|P3|Overall Study|Lost to Follow-up|0
1203527|NCT00910715|3953657|P2|Overall Study|Lost to Follow-up|26
1203528|NCT00910715|3953658|P1|Overall Study|Lost to Follow-up|22
1203529|NCT00910689|3953672|P4|Months 11- 16: Evaluation Period II|Physician Decision|0
1203530|NCT00910689|3953673|P3|Months 11- 16: Evaluation Period II|Physician Decision|1
1203531|NCT00910689|3953674|P2|Months 11- 16: Evaluation Period II|Physician Decision|2
1203532|NCT00910689|3953675|P1|Months 11- 16: Evaluation Period II|Physician Decision|0
1203533|NCT00910689|3953672|P4|Months 11- 16: Evaluation Period II|Perceived Improvement|1
1203534|NCT00910689|3953673|P3|Months 11- 16: Evaluation Period II|Perceived Improvement|0
1203535|NCT00910689|3953674|P2|Months 11- 16: Evaluation Period II|Perceived Improvement|0
1203536|NCT00910689|3953675|P1|Months 11- 16: Evaluation Period II|Perceived Improvement|0
1203537|NCT00910689|3953672|P4|Months 11- 16: Evaluation Period II|Time Demands|0
1203538|NCT00910689|3953673|P3|Months 11- 16: Evaluation Period II|Time Demands|0
1203539|NCT00910689|3953674|P2|Months 11- 16: Evaluation Period II|Time Demands|1
1203540|NCT00910689|3953675|P1|Months 11- 16: Evaluation Period II|Time Demands|2
1203541|NCT00910689|3953672|P4|Months 11- 16: Evaluation Period II|Lack of Efficacy|1
1203542|NCT00910689|3953673|P3|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
1203543|NCT00910689|3953674|P2|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
1203544|NCT00910689|3953675|P1|Months 11- 16: Evaluation Period II|Lack of Efficacy|2
1203545|NCT00910689|3953672|P4|Months 11- 16: Evaluation Period II|Pregnancy|0
1203546|NCT00910689|3953673|P3|Months 11- 16: Evaluation Period II|Pregnancy|0
1203547|NCT00910689|3953674|P2|Months 11- 16: Evaluation Period II|Pregnancy|0
1203548|NCT00910689|3953675|P1|Months 11- 16: Evaluation Period II|Pregnancy|1
1203549|NCT00910689|3953672|P4|Months 11- 16: Evaluation Period II|Adverse Event|2
1203550|NCT00910689|3953673|P3|Months 11- 16: Evaluation Period II|Adverse Event|2
1203551|NCT00910689|3953674|P2|Months 11- 16: Evaluation Period II|Adverse Event|4
1203552|NCT00910689|3953675|P1|Months 11- 16: Evaluation Period II|Adverse Event|2
1203553|NCT00910689|3953672|P4|Months 11- 16: Evaluation Period II|Lost to Follow-up|2
1203554|NCT00910689|3953673|P3|Months 11- 16: Evaluation Period II|Lost to Follow-up|1
1203555|NCT00910689|3953674|P2|Months 11- 16: Evaluation Period II|Lost to Follow-up|0
1203556|NCT00910689|3953675|P1|Months 11- 16: Evaluation Period II|Lost to Follow-up|3
1203557|NCT00910689|3953672|P4|Months 5 - 10: Evaluation Period I|Time Demands|1
1203558|NCT00910689|3953673|P3|Months 5 - 10: Evaluation Period I|Time Demands|1
1203559|NCT00910689|3953674|P2|Months 5 - 10: Evaluation Period I|Time Demands|0
1203560|NCT00910689|3953675|P1|Months 5 - 10: Evaluation Period I|Time Demands|0
1203561|NCT00910689|3953672|P4|Months 5 - 10: Evaluation Period I|Pregnancy|0
1203562|NCT00910689|3953673|P3|Months 5 - 10: Evaluation Period I|Pregnancy|2
1203563|NCT00910689|3953674|P2|Months 5 - 10: Evaluation Period I|Pregnancy|0
1203564|NCT00910689|3953675|P1|Months 5 - 10: Evaluation Period I|Pregnancy|0
1203565|NCT00910689|3953672|P4|Months 5 - 10: Evaluation Period I|Protocol Violation|0
1203566|NCT00910689|3953673|P3|Months 5 - 10: Evaluation Period I|Protocol Violation|0
1203567|NCT00910689|3953674|P2|Months 5 - 10: Evaluation Period I|Protocol Violation|1
1203568|NCT00910689|3953675|P1|Months 5 - 10: Evaluation Period I|Protocol Violation|1
1203569|NCT00910689|3953672|P4|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
1203570|NCT00910689|3953673|P3|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
1203571|NCT00910689|3953674|P2|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
1203572|NCT00910689|3953675|P1|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0
1203573|NCT00910689|3953672|P4|Months 5 - 10: Evaluation Period I|Adverse Event|4
1203574|NCT00910689|3953673|P3|Months 5 - 10: Evaluation Period I|Adverse Event|2
1203575|NCT00910689|3953674|P2|Months 5 - 10: Evaluation Period I|Adverse Event|0
1203576|NCT00910689|3953675|P1|Months 5 - 10: Evaluation Period I|Adverse Event|1
1203577|NCT00910689|3953672|P4|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
1203578|NCT00910689|3953673|P3|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
1203579|NCT00910689|3953674|P2|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5
1203580|NCT00910689|3953675|P1|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2
1203581|NCT00910689|3953672|P4|Month 2- 4: Treatment Period|Protocol Violation|0
1203582|NCT00910689|3953673|P3|Month 2- 4: Treatment Period|Protocol Violation|0
1203583|NCT00910689|3953674|P2|Month 2- 4: Treatment Period|Protocol Violation|0
1203584|NCT00910689|3953675|P1|Month 2- 4: Treatment Period|Protocol Violation|1
1203585|NCT00910689|3953672|P4|Month 2- 4: Treatment Period|Pregnancy|0
1203586|NCT00910689|3953673|P3|Month 2- 4: Treatment Period|Pregnancy|0
1203587|NCT00910689|3953674|P2|Month 2- 4: Treatment Period|Pregnancy|2
1203588|NCT00910689|3953675|P1|Month 2- 4: Treatment Period|Pregnancy|0
1203589|NCT00910689|3953672|P4|Month 2- 4: Treatment Period|Perceived Improvement|0
1203590|NCT00910689|3953673|P3|Month 2- 4: Treatment Period|Perceived Improvement|1
1203591|NCT00910689|3953674|P2|Month 2- 4: Treatment Period|Perceived Improvement|0
1203592|NCT00910689|3953675|P1|Month 2- 4: Treatment Period|Perceived Improvement|0
1203593|NCT00910689|3953672|P4|Month 2- 4: Treatment Period|Lack of Efficacy|0
1203594|NCT00910689|3953673|P3|Month 2- 4: Treatment Period|Lack of Efficacy|0
1203595|NCT00910689|3953674|P2|Month 2- 4: Treatment Period|Lack of Efficacy|1
1203596|NCT00910689|3953675|P1|Month 2- 4: Treatment Period|Lack of Efficacy|2
1203597|NCT00910689|3953672|P4|Month 2- 4: Treatment Period|Time Demands|8
1203598|NCT00910689|3953673|P3|Month 2- 4: Treatment Period|Time Demands|4
1203599|NCT00910689|3953674|P2|Month 2- 4: Treatment Period|Time Demands|0
1203600|NCT00910689|3953675|P1|Month 2- 4: Treatment Period|Time Demands|1
1203601|NCT00910689|3953672|P4|Month 2- 4: Treatment Period|Adverse Event|0
1203602|NCT00910689|3953673|P3|Month 2- 4: Treatment Period|Adverse Event|2
1203603|NCT00910689|3953674|P2|Month 2- 4: Treatment Period|Adverse Event|3
1203604|NCT00910689|3953675|P1|Month 2- 4: Treatment Period|Adverse Event|2
1203605|NCT00910689|3953672|P4|Month 2- 4: Treatment Period|Lost to Follow-up|3
1203606|NCT00910689|3953673|P3|Month 2- 4: Treatment Period|Lost to Follow-up|1
1203607|NCT00910689|3953674|P2|Month 2- 4: Treatment Period|Lost to Follow-up|4
1203608|NCT00910689|3953675|P1|Month 2- 4: Treatment Period|Lost to Follow-up|3
1203609|NCT00910689|3953672|P4|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10
1203610|NCT00910689|3953673|P3|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5
1203611|NCT00910689|3953674|P2|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1
1203612|NCT00910689|3953675|P1|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2
1203613|NCT00910663|3953707|P2|Period 1|Withdrawal by Subject|1
1203614|NCT00910663|3953708|P1|Period 1|Withdrawal by Subject|0
1203615|NCT00910624|3953722|P4|Follow-Up Phase|Administrative|0
1203616|NCT00910624|3953723|P3|Follow-Up Phase|Administrative|1
1203617|NCT00910624|3953724|P2|Follow-Up Phase|Administrative|1
1203618|NCT00910624|3953725|P1|Follow-Up Phase|Administrative|0
1203619|NCT00910624|3953722|P4|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
1203620|NCT00910624|3953723|P3|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
1203621|NCT00910624|3953724|P2|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
1203622|NCT00910624|3953725|P1|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1
1203623|NCT00910624|3953722|P4|Follow-Up Phase|Withdrawal by Subject|0
1203624|NCT00910624|3953723|P3|Follow-Up Phase|Withdrawal by Subject|0
1203625|NCT00910624|3953724|P2|Follow-Up Phase|Withdrawal by Subject|0
1203626|NCT00910624|3953725|P1|Follow-Up Phase|Withdrawal by Subject|1
1203627|NCT00910624|3953722|P4|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
1203628|NCT00910624|3953723|P3|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
1203629|NCT00910624|3953724|P2|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2
1203630|NCT00910624|3953725|P1|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1
1203631|NCT00910624|3953722|P4|Follow-Up Phase|Lost to Follow-up|0
1203632|NCT00910624|3953723|P3|Follow-Up Phase|Lost to Follow-up|2
1203633|NCT00910624|3953724|P2|Follow-Up Phase|Lost to Follow-up|1
1203634|NCT00910624|3953725|P1|Follow-Up Phase|Lost to Follow-up|3
1203635|NCT00910624|3953722|P4|Follow-Up Phase|Adverse Event|0
1203636|NCT00910624|3953723|P3|Follow-Up Phase|Adverse Event|1
1203637|NCT00910624|3953724|P2|Follow-Up Phase|Adverse Event|0
1203638|NCT00910624|3953725|P1|Follow-Up Phase|Adverse Event|0
1203639|NCT00910624|3953722|P4|Treatment Phase|Non-Compliance With Protocol|0
1203640|NCT00910624|3953723|P3|Treatment Phase|Non-Compliance With Protocol|1
1203641|NCT00910624|3953724|P2|Treatment Phase|Non-Compliance With Protocol|1
1203642|NCT00910624|3953725|P1|Treatment Phase|Non-Compliance With Protocol|0
1203643|NCT00910624|3953722|P4|Treatment Phase|Withdrawal by Subject|0
1203644|NCT00910624|3953723|P3|Treatment Phase|Withdrawal by Subject|0
1203645|NCT00910624|3953724|P2|Treatment Phase|Withdrawal by Subject|1
1203646|NCT00910624|3953725|P1|Treatment Phase|Withdrawal by Subject|2
1203647|NCT00910624|3953722|P4|Treatment Phase|Reasons Unrelated To Assigned Treatment|0
1203648|NCT00910624|3953723|P3|Treatment Phase|Reasons Unrelated To Assigned Treatment|1
1203649|NCT00910624|3953724|P2|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
1203650|NCT00910624|3953725|P1|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
1203651|NCT00910624|3953722|P4|Treatment Phase|Lost to Follow-up|0
1203652|NCT00910624|3953723|P3|Treatment Phase|Lost to Follow-up|1
1203653|NCT00910624|3953724|P2|Treatment Phase|Lost to Follow-up|0
1203654|NCT00910624|3953725|P1|Treatment Phase|Lost to Follow-up|0
1203655|NCT00910624|3953722|P4|Treatment Phase|Treatment Failure|0
1203656|NCT00910624|3953723|P3|Treatment Phase|Treatment Failure|0
1203657|NCT00910624|3953724|P2|Treatment Phase|Treatment Failure|10
1203658|NCT00910624|3953725|P1|Treatment Phase|Treatment Failure|23
1203659|NCT00910624|3953722|P4|Treatment Phase|Adverse Event|0
1203660|NCT00910624|3953723|P3|Treatment Phase|Adverse Event|6
1203661|NCT00910624|3953724|P2|Treatment Phase|Adverse Event|6
1203662|NCT00910624|3953725|P1|Treatment Phase|Adverse Event|2
1203663|NCT00910299|3953752|P2|Overall Study|Didn't receive any study drug|1
1203664|NCT00910299|3953753|P1|Overall Study|Didn't receive any study drug|2
1203665|NCT00910299|3953752|P2|Overall Study|Sponsor Decision|60
1203666|NCT00910299|3953753|P1|Overall Study|Sponsor Decision|58
1203667|NCT00910299|3953752|P2|Overall Study|Withdrawal by Subject|13
1203668|NCT00910299|3953753|P1|Overall Study|Withdrawal by Subject|16
1203669|NCT00910273|3953765|P2|Overall Study|Lost to Follow-up|1
1203670|NCT00910273|3953766|P1|Overall Study|Lost to Follow-up|1
1203671|NCT00910273|3953765|P2|Overall Study|Protocol Violation|0
1203672|NCT00910273|3953766|P1|Overall Study|Protocol Violation|1
1203673|NCT00910273|3953765|P2|Overall Study|Discontinuation of study by sponsor|2
1203674|NCT00910273|3953766|P1|Overall Study|Discontinuation of study by sponsor|8
1203675|NCT00910273|3953765|P2|Overall Study|Withdrawal by Subject|0
1203676|NCT00910273|3953766|P1|Overall Study|Withdrawal by Subject|1
1203677|NCT00910273|3953765|P2|Overall Study|Adverse Event|1
1203678|NCT00910273|3953766|P1|Overall Study|Adverse Event|1
1203679|NCT00910273|3953765|P2|Overall Study|Lack of Efficacy|9
1203680|NCT00910273|3953766|P1|Overall Study|Lack of Efficacy|6
1203681|NCT00910247|3953816|P1|Overall Study|Not collected|4
1203682|NCT00910247|3953816|P1|Overall Study|Withdrawal by Subject|25
1203683|NCT00910247|3953816|P1|Overall Study|Protocol Violation|10
1203684|NCT00910247|3953816|P1|Overall Study|Physician Decision|3
1203685|NCT00910247|3953816|P1|Overall Study|Lost to Follow-up|10
1203686|NCT00910247|3953816|P1|Overall Study|Death|2
1203687|NCT00910247|3953816|P1|Overall Study|Adverse Event|15
1203688|NCT00910091|3953838|P2|Treatment and Survival|Adverse Event|0
1203689|NCT00910091|3953839|P1|Treatment and Survival|Adverse Event|1
1203690|NCT00910091|3953838|P2|Treatment and Survival|Withdrawal by Subject|4
1203691|NCT00910091|3953839|P1|Treatment and Survival|Withdrawal by Subject|3
1203692|NCT00910091|3953838|P2|Pre-assignment|Withdrawal by Subject|2
1203693|NCT00910091|3953839|P1|Pre-assignment|Withdrawal by Subject|0
1203694|NCT00910039|3953867|P1|Overall Study|Physician Decision|1
1203695|NCT00910000|3953884|P6|Overall Study|Withdrawal by Subject|0
1203696|NCT00910000|3953885|P5|Overall Study|Withdrawal by Subject|1
1203697|NCT00910000|3953886|P4|Overall Study|Withdrawal by Subject|0
1203698|NCT00910000|3953887|P3|Overall Study|Withdrawal by Subject|1
1203699|NCT00910000|3953888|P2|Overall Study|Withdrawal by Subject|0
1203700|NCT00910000|3953889|P1|Overall Study|Withdrawal by Subject|0
1203701|NCT00910000|3953884|P6|Overall Study|Adverse Event|1
1203702|NCT00910000|3953885|P5|Overall Study|Adverse Event|0
1203703|NCT00910000|3953886|P4|Overall Study|Adverse Event|2
1203704|NCT00910000|3953887|P3|Overall Study|Adverse Event|2
1203705|NCT00910000|3953888|P2|Overall Study|Adverse Event|3
1203706|NCT00910000|3953889|P1|Overall Study|Adverse Event|0
1203707|NCT00909870|3953907|P2|Overall Study|Other|5
1203708|NCT00909870|3953908|P1|Overall Study|Other|1
1203709|NCT00909870|3953907|P2|Overall Study|Physician Decision|2
1203710|NCT00909870|3953908|P1|Overall Study|Physician Decision|0
1203711|NCT00909870|3953907|P2|Overall Study|Lost to Follow-up|3
1203712|NCT00909870|3953908|P1|Overall Study|Lost to Follow-up|3
1203713|NCT00909870|3953907|P2|Overall Study|Withdrawal by Subject|8
1203714|NCT00909870|3953908|P1|Overall Study|Withdrawal by Subject|5
1203715|NCT00909870|3953907|P2|Overall Study|Protocol Violation|2
1203716|NCT00909870|3953908|P1|Overall Study|Protocol Violation|1
1203717|NCT00909870|3953907|P2|Overall Study|Adverse Event|7
1203718|NCT00909870|3953908|P1|Overall Study|Adverse Event|13
1203719|NCT00909857|3953920|P2|Overall Study|Did not receive study medication|24
1203720|NCT00909857|3953921|P1|Overall Study|Did not receive study medication|19
1203721|NCT00909857|3953920|P2|Overall Study|Other|0
1203722|NCT00909857|3953921|P1|Overall Study|Other|1
1203723|NCT00909857|3953920|P2|Overall Study|Pregnancy|0
1203724|NCT00909857|3953921|P1|Overall Study|Pregnancy|1
1203725|NCT00909857|3953920|P2|Overall Study|Protocol Violation|1
1203726|NCT00909857|3953921|P1|Overall Study|Protocol Violation|2
1203727|NCT00909857|3953920|P2|Overall Study|Lost to Follow-up|5
1203728|NCT00909857|3953921|P1|Overall Study|Lost to Follow-up|2
1203729|NCT00909857|3953920|P2|Overall Study|Adverse Event|5
1203730|NCT00909857|3953921|P1|Overall Study|Adverse Event|5
1203731|NCT00909857|3953920|P2|Overall Study|Withdrawal by Subject|10
1203732|NCT00909857|3953921|P1|Overall Study|Withdrawal by Subject|6
1203733|NCT00909844|3954061|P1|Overall Study|Lost to Follow-up|2
1203734|NCT00909844|3954061|P1|Overall Study|Withdrawal by Subject|1
1203735|NCT00909844|3954061|P1|Overall Study|Adverse Event|1
1203736|NCT00909792|3954079|P2|Period 2|Lost to Follow-up|1
1203737|NCT00909792|3954080|P1|Period 2|Lost to Follow-up|0
1203738|NCT00909792|3954079|P2|Period 2|Biomicroscopy|0
1203739|NCT00909792|3954080|P1|Period 2|Biomicroscopy|1
1203740|NCT00909792|3954079|P2|Period 1|Did not meet inclusion criteria|1
1203741|NCT00909792|3954080|P1|Period 1|Did not meet inclusion criteria|0
1203742|NCT00909779|3954088|P2|Overall Study|Randomized in error|1
1203743|NCT00909779|3954089|P1|Overall Study|Randomized in error|1
1203744|NCT00909779|3954088|P2|Overall Study|Noncompliance|1
1203745|NCT00909779|3954089|P1|Overall Study|Noncompliance|1
1203746|NCT00909779|3954088|P2|Overall Study|Medical Monitor Decision|0
1203747|NCT00909779|3954089|P1|Overall Study|Medical Monitor Decision|1
1203748|NCT00909779|3954088|P2|Overall Study|Site Ceasing Operation|2
1203749|NCT00909779|3954089|P1|Overall Study|Site Ceasing Operation|2
1203750|NCT00909779|3954088|P2|Overall Study|Withdrawal by Subject|80
1203751|NCT00909779|3954089|P1|Overall Study|Withdrawal by Subject|116
1203752|NCT00909779|3954088|P2|Overall Study|Protocol Violation|5
1203753|NCT00909779|3954089|P1|Overall Study|Protocol Violation|2
1203754|NCT00909779|3954088|P2|Overall Study|Physician Decision|2
1203755|NCT00909779|3954089|P1|Overall Study|Physician Decision|8
1203756|NCT00909779|3954088|P2|Overall Study|Lost to Follow-up|15
1203757|NCT00909779|3954089|P1|Overall Study|Lost to Follow-up|19
1203758|NCT00909779|3954088|P2|Overall Study|Lack of Efficacy|4
1203759|NCT00909779|3954089|P1|Overall Study|Lack of Efficacy|7
1203760|NCT00909779|3954088|P2|Overall Study|Adverse Event|55
1203761|NCT00909779|3954089|P1|Overall Study|Adverse Event|53
1203762|NCT00909753|3954113|P2|Period: Second Intervention|Protocol Violation|0
1203763|NCT00909753|3954114|P1|Period: Second Intervention|Protocol Violation|1
1203764|NCT00909753|3954113|P2|Period: Washout of 28 Days|Protocol Violation|3
1203765|NCT00909753|3954114|P1|Period: Washout of 28 Days|Protocol Violation|2
1203766|NCT00909727|3954134|P2|Overall Study|Prohibited Medication|0
1203767|NCT00909727|3954135|P1|Overall Study|Prohibited Medication|1
1203768|NCT00909727|3954134|P2|Overall Study|Withdrawal of Consent|0
1203769|NCT00909727|3954135|P1|Overall Study|Withdrawal of Consent|1
1203770|NCT00909727|3954134|P2|Overall Study|Wrong Genotype|0
1203771|NCT00909727|3954135|P1|Overall Study|Wrong Genotype|1
1203772|NCT00909727|3954134|P2|Overall Study|Adverse Event|0
1203773|NCT00909727|3954135|P1|Overall Study|Adverse Event|1
1203774|NCT00909610|3954158|P2|Period: Second Intervention|Adverse Event|0
1203775|NCT00909610|3954159|P1|Period: Second Intervention|Adverse Event|1
1203776|NCT00909610|3954158|P2|Period: Washout of 28 Days|Withdrawal by Subject|6
1203777|NCT00909610|3954159|P1|Period: Washout of 28 Days|Withdrawal by Subject|3
1203778|NCT00909610|3954158|P2|Period: First Intervention|Adverse Event|1
1203779|NCT00909610|3954159|P1|Period: First Intervention|Adverse Event|0
1203780|NCT00909532|3954320|P2|Overall Study|Increased Lab Draws, Difficult Lab Stick|0
1203781|NCT00909532|3954321|P1|Overall Study|Increased Lab Draws, Difficult Lab Stick|1
1203782|NCT00909532|3954320|P2|Overall Study|Wrong Genotype|0
1203783|NCT00909532|3954321|P1|Overall Study|Wrong Genotype|1
1203784|NCT00909532|3954320|P2|Overall Study|Physician Decision|0
1203785|NCT00909532|3954321|P1|Overall Study|Physician Decision|1
1203786|NCT00909532|3954320|P2|Overall Study|Noncompliance with Study Requirements|2
1203787|NCT00909532|3954321|P1|Overall Study|Noncompliance with Study Requirements|0
1203788|NCT00909532|3954320|P2|Overall Study|Withdrawal of Consent|1
1203789|NCT00909532|3954321|P1|Overall Study|Withdrawal of Consent|1
1203790|NCT00909532|3954320|P2|Overall Study|Prohibited Medication|1
1203791|NCT00909532|3954321|P1|Overall Study|Prohibited Medication|2
1203792|NCT00909532|3954320|P2|Overall Study|Pregnancy|1
1203793|NCT00909532|3954321|P1|Overall Study|Pregnancy|0
1203794|NCT00909532|3954320|P2|Overall Study|Adverse Event|1
1203795|NCT00909532|3954321|P1|Overall Study|Adverse Event|4
1203796|NCT00909480|3954339|P2|Overall Study|Unclassified|19
1203797|NCT00909480|3954340|P1|Overall Study|Unclassified|18
1203798|NCT00909480|3954339|P2|Overall Study|Withdrawal criteria|11
1203799|NCT00909480|3954340|P1|Overall Study|Withdrawal criteria|9
1203800|NCT00909480|3954339|P2|Overall Study|Protocol Violation|8
1203801|NCT00909480|3954340|P1|Overall Study|Protocol Violation|6
1203802|NCT00909480|3954339|P2|Overall Study|Adverse Event|3
1203803|NCT00909480|3954340|P1|Overall Study|Adverse Event|5
1203804|NCT00909428|3954375|P3|Overall Study|Lost to Follow-up|9
1203805|NCT00909428|3954376|P2|Overall Study|Lost to Follow-up|10
1203806|NCT00909428|3954377|P1|Overall Study|Lost to Follow-up|13
1203807|NCT00909389|3954384|P1|Overall Study|No Information|103
1203808|NCT00909389|3954384|P1|Overall Study|Lost to Follow-up|4
1203809|NCT00909389|3954384|P1|Overall Study|Poor Compliance|16
1203810|NCT00909389|3954384|P1|Overall Study|Death|4
1203811|NCT00909389|3954384|P1|Overall Study|Adverse Event|6
1203812|NCT00909181|3954418|P3|Overall Study|Lost to Follow-up|33
1203813|NCT00909181|3954419|P2|Overall Study|Lost to Follow-up|18
1203814|NCT00909181|3954420|P1|Overall Study|Lost to Follow-up|39
1203815|NCT00909038|3954450|P1|Overall Study|Non-evaluable Subjects|230
1203816|NCT00909038|3954450|P1|Overall Study|Protocol Violation|187
1203817|NCT00908960|3954462|P3|Overall Study|Presence VTE dx or Absent VTE eval|2
1203818|NCT00908960|3954463|P2|Overall Study|Presence VTE dx or Absent VTE eval|1
1203819|NCT00908960|3954464|P1|Overall Study|Presence VTE dx or Absent VTE eval|1
1203820|NCT00908895|3954486|P2|Overall Study|Adverse Event|1
1203821|NCT00908895|3954487|P1|Overall Study|Adverse Event|1
1203822|NCT00908895|3954486|P2|Overall Study|algodystrophy|2
1203823|NCT00908895|3954487|P1|Overall Study|algodystrophy|2
1203824|NCT00908895|3954486|P2|Overall Study|Lost to Follow-up|3
1203825|NCT00908895|3954487|P1|Overall Study|Lost to Follow-up|1
1203826|NCT00908596|3954571|P4|Overall Study|Withdrawal by Subject|1
1203827|NCT00908596|3954572|P3|Overall Study|Withdrawal by Subject|3
1203828|NCT00908596|3954573|P2|Overall Study|Withdrawal by Subject|1
1203829|NCT00908596|3954574|P1|Overall Study|Withdrawal by Subject|0
1203830|NCT00908596|3954571|P4|Overall Study|Protocol Violation|0
1203831|NCT00908596|3954572|P3|Overall Study|Protocol Violation|0
1203832|NCT00908596|3954573|P2|Overall Study|Protocol Violation|0
1203833|NCT00908596|3954574|P1|Overall Study|Protocol Violation|1
1203834|NCT00908596|3954571|P4|Overall Study|Death|32
1203835|NCT00908596|3954572|P3|Overall Study|Death|57
1203836|NCT00908596|3954573|P2|Overall Study|Death|5
1203837|NCT00908596|3954574|P1|Overall Study|Death|0
1203838|NCT00908596|3954571|P4|Overall Study|Lost to Follow-up|4
1203839|NCT00908596|3954572|P3|Overall Study|Lost to Follow-up|12
1203840|NCT00908596|3954573|P2|Overall Study|Lost to Follow-up|1
1203841|NCT00908596|3954574|P1|Overall Study|Lost to Follow-up|0
1203842|NCT00908596|3954571|P4|Overall Study|Other reasons|0
1203843|NCT00908596|3954572|P3|Overall Study|Other reasons|2
1203844|NCT00908596|3954573|P2|Overall Study|Other reasons|6
1203845|NCT00908596|3954574|P1|Overall Study|Other reasons|46
1203846|NCT00908583|3954604|P1|Phase 5|Adverse Event|3
1203847|NCT00908583|3954604|P1|Phase 4|Physician Decision|1
1203848|NCT00908583|3954604|P1|Phase 4|Adverse Event|1
1203849|NCT00908583|3954604|P1|Phase 3|Adverse Event|2
1203850|NCT00908583|3954604|P1|Phase 2|Adverse Event|1
1203851|NCT00908583|3954604|P1|Phase 2|Physician Decision|1
1203852|NCT00908583|3954604|P1|Phase 1|Adverse Event|4
1203853|NCT00908583|3954604|P1|Phase 1|Withdrawal by Subject|1
1203854|NCT00908375|3954641|P2|Overall Study|Lost to Follow-up|6
1203855|NCT00908375|3954642|P1|Overall Study|Lost to Follow-up|8
1203856|NCT00908375|3954641|P2|Overall Study|Withdrawal by Subject|4
1203857|NCT00908375|3954642|P1|Overall Study|Withdrawal by Subject|2
1203858|NCT00908349|3954652|P1|Overall Study|Various|6
1203859|NCT00908349|3954652|P1|Overall Study|Lost to Follow-up|5
1203860|NCT00908349|3954652|P1|Overall Study|Physician Decision|5
1203861|NCT00908349|3954652|P1|Overall Study|Withdrawal by Subject|9
1203862|NCT00908349|3954652|P1|Overall Study|Adverse Event|10
1203863|NCT00908310|3954656|P1|Overall Study|Other reasons|4
1203864|NCT00908310|3954656|P1|Overall Study|Screening failure|5
1203865|NCT00908310|3954656|P1|Overall Study|Lost to Follow-up|7
1203866|NCT00908310|3954656|P1|Overall Study|Withdrawal by Subject|7
1203867|NCT00908310|3954656|P1|Overall Study|Death|37
1203868|NCT00908232|3954660|P4|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
1203869|NCT00908232|3954661|P3|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
1203870|NCT00908232|3954662|P2|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
1203871|NCT00908232|3954663|P1|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1
1203872|NCT00908232|3954660|P4|Randomization (Cycle 5) to Cycle 8|Other|0
1203873|NCT00908232|3954661|P3|Randomization (Cycle 5) to Cycle 8|Other|0
1203874|NCT00908232|3954662|P2|Randomization (Cycle 5) to Cycle 8|Other|1
1203875|NCT00908232|3954663|P1|Randomization (Cycle 5) to Cycle 8|Other|3
1203876|NCT00908232|3954660|P4|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
1203877|NCT00908232|3954661|P3|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
1203878|NCT00908232|3954662|P2|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
1203879|NCT00908232|3954663|P1|Randomization (Cycle 5) to Cycle 8|Physician Decision|2
1203880|NCT00908232|3954660|P4|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
1203881|NCT00908232|3954661|P3|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
1203882|NCT00908232|3954662|P2|Randomization (Cycle 5) to Cycle 8|Adverse Event|2
1203883|NCT00908232|3954663|P1|Randomization (Cycle 5) to Cycle 8|Adverse Event|17
1203884|NCT00908232|3954660|P4|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
1203885|NCT00908232|3954661|P3|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1
1203886|NCT00908232|3954662|P2|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
1203887|NCT00908232|3954663|P1|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4
1203888|NCT00908232|3954660|P4|Randomization (Cycle 5) to Cycle 8|Death|0
1203889|NCT00908232|3954661|P3|Randomization (Cycle 5) to Cycle 8|Death|0
1203890|NCT00908232|3954662|P2|Randomization (Cycle 5) to Cycle 8|Death|0
1203891|NCT00908232|3954663|P1|Randomization (Cycle 5) to Cycle 8|Death|2
1203892|NCT00908232|3954660|P4|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
1203893|NCT00908232|3954661|P3|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
1203894|NCT00908232|3954662|P2|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
1203895|NCT00908232|3954663|P1|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5
1203896|NCT00908232|3954660|P4|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
1203897|NCT00908232|3954661|P3|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
1203898|NCT00908232|3954662|P2|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
1203899|NCT00908232|3954663|P1|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1
1203900|NCT00908232|3954660|P4|Cycle 1 to 4|not specified|0
1203901|NCT00908232|3954661|P3|Cycle 1 to 4|not specified|0
1203902|NCT00908232|3954662|P2|Cycle 1 to 4|not specified|0
1203903|NCT00908232|3954663|P1|Cycle 1 to 4|not specified|1
1203904|NCT00908232|3954660|P4|Cycle 1 to 4|Adverse Event|0
1203905|NCT00908232|3954661|P3|Cycle 1 to 4|Adverse Event|0
1203906|NCT00908232|3954662|P2|Cycle 1 to 4|Adverse Event|0
1203907|NCT00908232|3954663|P1|Cycle 1 to 4|Adverse Event|12
1203908|NCT00908232|3954660|P4|Cycle 1 to 4|Progressive Disease|0
1203909|NCT00908232|3954661|P3|Cycle 1 to 4|Progressive Disease|0
1203910|NCT00908232|3954662|P2|Cycle 1 to 4|Progressive Disease|0
1203911|NCT00908232|3954663|P1|Cycle 1 to 4|Progressive Disease|6
1203912|NCT00908232|3954660|P4|Cycle 1 to 4|Withdrawal by Subject|0
1203913|NCT00908232|3954661|P3|Cycle 1 to 4|Withdrawal by Subject|0
1203914|NCT00908232|3954662|P2|Cycle 1 to 4|Withdrawal by Subject|0
1203915|NCT00908232|3954663|P1|Cycle 1 to 4|Withdrawal by Subject|4
1203916|NCT00908232|3954660|P4|Cycle 1 to 4|Death|0
1203917|NCT00908232|3954661|P3|Cycle 1 to 4|Death|0
1203918|NCT00908232|3954662|P2|Cycle 1 to 4|Death|0
1203919|NCT00908232|3954663|P1|Cycle 1 to 4|Death|5
1203920|NCT00908141|3954681|P2|Overall Study|Withdrawal by Subject|1
1203921|NCT00908141|3954682|P1|Overall Study|Withdrawal by Subject|0
1203922|NCT00908115|3954699|P1|Overall Study|Other|14
1203923|NCT00908076|3954707|P2|Overall Study|Lack of Efficacy|1
1203924|NCT00908076|3954708|P1|Overall Study|Lack of Efficacy|1
1203925|NCT00908037|3954721|P12|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
1203926|NCT00908037|3954722|P11|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2
1203927|NCT00908037|3954723|P10|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
1203928|NCT00908037|3954724|P9|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
1203929|NCT00908037|3954725|P8|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
1203930|NCT00908037|3954726|P7|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
1203931|NCT00908037|3954727|P6|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
1203932|NCT00908037|3954728|P5|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
1203933|NCT00908037|3954729|P4|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
1203934|NCT00908037|3954730|P3|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
1203935|NCT00908037|3954731|P2|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
1203936|NCT00908037|3954732|P1|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
1203937|NCT00908037|3954721|P12|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
1203938|NCT00908037|3954722|P11|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
1203939|NCT00908037|3954723|P10|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1
1203940|NCT00908037|3954724|P9|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
1203941|NCT00908037|3954725|P8|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
1203942|NCT00908037|3954726|P7|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
1203943|NCT00908037|3954727|P6|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
1203944|NCT00908037|3954728|P5|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
1203945|NCT00908037|3954729|P4|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
1203946|NCT00908037|3954730|P3|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
1203947|NCT00908037|3954731|P2|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
1203948|NCT00908037|3954732|P1|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
1203949|NCT00908037|3954721|P12|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
1203950|NCT00908037|3954722|P11|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2
1203951|NCT00908037|3954723|P10|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
1203952|NCT00908037|3954724|P9|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
1203953|NCT00908037|3954725|P8|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
1203954|NCT00908037|3954726|P7|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
1203955|NCT00908037|3954727|P6|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
1203956|NCT00908037|3954728|P5|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
1203957|NCT00908037|3954729|P4|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
1203958|NCT00908037|3954730|P3|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
1203959|NCT00908037|3954731|P2|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
1203960|NCT00908037|3954732|P1|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
1203961|NCT00908037|3954721|P12|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
1203962|NCT00908037|3954722|P11|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
1203963|NCT00908037|3954723|P10|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1
1203964|NCT00908037|3954724|P9|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
1203965|NCT00908037|3954725|P8|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
1203966|NCT00908037|3954726|P7|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
1203967|NCT00908037|3954727|P6|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
1203968|NCT00908037|3954728|P5|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
1203969|NCT00908037|3954729|P4|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
1203970|NCT00908037|3954730|P3|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
1203971|NCT00908037|3954731|P2|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
1203972|NCT00908037|3954732|P1|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
1203973|NCT00908037|3954721|P12|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2
1203974|NCT00908037|3954722|P11|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
1203975|NCT00908037|3954723|P10|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1
1203976|NCT00908037|3954724|P9|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
1203977|NCT00908037|3954725|P8|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
1203978|NCT00908037|3954726|P7|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
1203979|NCT00908037|3954727|P6|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
1203980|NCT00908037|3954728|P5|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
1203981|NCT00908037|3954729|P4|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
1203982|NCT00908037|3954730|P3|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
1203983|NCT00908037|3954731|P2|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
1203984|NCT00908037|3954732|P1|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
1203985|NCT00908037|3954721|P12|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1
1203986|NCT00908037|3954722|P11|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
1203987|NCT00908037|3954723|P10|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
1203988|NCT00908037|3954724|P9|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
1203989|NCT00908037|3954725|P8|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
1203990|NCT00908037|3954726|P7|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
1203991|NCT00908037|3954727|P6|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
1203992|NCT00908037|3954728|P5|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
1203993|NCT00908037|3954729|P4|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
1203994|NCT00908037|3954730|P3|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
1203995|NCT00908037|3954731|P2|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
1203996|NCT00908037|3954732|P1|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
1203997|NCT00908037|3954721|P12|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
1203998|NCT00908037|3954722|P11|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
1203999|NCT00908037|3954723|P10|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
1204000|NCT00908037|3954724|P9|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
1204001|NCT00908037|3954725|P8|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
1204002|NCT00908037|3954726|P7|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
1204003|NCT00908037|3954727|P6|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
1204004|NCT00908037|3954728|P5|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
1204005|NCT00908037|3954729|P4|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
1204006|NCT00908037|3954730|P3|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
1204007|NCT00908037|3954731|P2|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
1204008|NCT00908037|3954732|P1|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
1204009|NCT00908037|3954721|P12|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
1204010|NCT00908037|3954722|P11|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
1204011|NCT00908037|3954723|P10|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
1204012|NCT00908037|3954724|P9|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4
1204013|NCT00908037|3954725|P8|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
1204014|NCT00908037|3954726|P7|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
1204015|NCT00908037|3954727|P6|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
1204016|NCT00908037|3954728|P5|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2
1204017|NCT00908037|3954729|P4|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
1204018|NCT00908037|3954730|P3|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
1204019|NCT00908037|3954731|P2|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
1204020|NCT00908037|3954732|P1|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
1204021|NCT00908037|3954721|P12|Part 2 (7 Week Randomized Period)|Protocol Violation|0
1204022|NCT00908037|3954722|P11|Part 2 (7 Week Randomized Period)|Protocol Violation|0
1204023|NCT00908037|3954723|P10|Part 2 (7 Week Randomized Period)|Protocol Violation|0
1204024|NCT00908037|3954724|P9|Part 2 (7 Week Randomized Period)|Protocol Violation|1
1204025|NCT00908037|3954725|P8|Part 2 (7 Week Randomized Period)|Protocol Violation|0
1204026|NCT00908037|3954726|P7|Part 2 (7 Week Randomized Period)|Protocol Violation|3
1204027|NCT00908037|3954727|P6|Part 2 (7 Week Randomized Period)|Protocol Violation|0
1204028|NCT00908037|3954728|P5|Part 2 (7 Week Randomized Period)|Protocol Violation|1
1204029|NCT00908037|3954729|P4|Part 2 (7 Week Randomized Period)|Protocol Violation|0
1204030|NCT00908037|3954730|P3|Part 2 (7 Week Randomized Period)|Protocol Violation|0
1204031|NCT00908037|3954731|P2|Part 2 (7 Week Randomized Period)|Protocol Violation|0
1204032|NCT00908037|3954732|P1|Part 2 (7 Week Randomized Period)|Protocol Violation|0
1204033|NCT00908011|3954881|P2|Overall Study|Withdrawal by Subject|2
1204034|NCT00908011|3954882|P1|Overall Study|Withdrawal by Subject|2
1204035|NCT00907881|3954899|P1|Overall Study|Missing discontinuation information|15
1204036|NCT00907881|3954899|P1|Overall Study|Protocol Violation|1
1204037|NCT00907881|3954899|P1|Overall Study|Withdrawal by Subject|5
1204038|NCT00907881|3954899|P1|Overall Study|Noncompliance|5
1204039|NCT00907881|3954899|P1|Overall Study|Lost to Follow-up|59
1204040|NCT00907803|3954909|P3|Overall Study|Protocol Violation|0
1204041|NCT00907803|3954910|P2|Overall Study|Protocol Violation|1
1204042|NCT00907803|3954911|P1|Overall Study|Protocol Violation|0
1204043|NCT00907803|3954909|P3|Overall Study|Lost to Follow-up|0
1204044|NCT00907803|3954910|P2|Overall Study|Lost to Follow-up|1
1204045|NCT00907803|3954911|P1|Overall Study|Lost to Follow-up|0
1204046|NCT00907803|3954909|P3|Overall Study|Withdrawal by Subject|0
1204047|NCT00907803|3954910|P2|Overall Study|Withdrawal by Subject|1
1204048|NCT00907803|3954911|P1|Overall Study|Withdrawal by Subject|0
1204049|NCT00907803|3954909|P3|Overall Study|Adverse Event|0
1204050|NCT00907803|3954910|P2|Overall Study|Adverse Event|0
1204051|NCT00907803|3954911|P1|Overall Study|Adverse Event|2
1204052|NCT00907803|3954909|P3|Overall Study|Withdrawal of consent - long commute|0
1204053|NCT00907803|3954910|P2|Overall Study|Withdrawal of consent - long commute|0
1204054|NCT00907803|3954911|P1|Overall Study|Withdrawal of consent - long commute|1
1204055|NCT00907777|3954942|P2|Overall Study|Withdrawal by Subject|1
1204056|NCT00907777|3954943|P1|Overall Study|Withdrawal by Subject|0
1204057|NCT00907738|3954970|P5|Overall Study|Disease progression|2
1204058|NCT00907738|3954971|P4|Overall Study|Disease progression|4
1204059|NCT00907738|3954972|P3|Overall Study|Disease progression|6
1204060|NCT00907738|3954973|P2|Overall Study|Disease progression|1
1204061|NCT00907738|3954974|P1|Overall Study|Disease progression|8
1204062|NCT00907738|3954970|P5|Overall Study|not specified or withdrew consent|0
1204063|NCT00907738|3954971|P4|Overall Study|not specified or withdrew consent|0
1204064|NCT00907738|3954972|P3|Overall Study|not specified or withdrew consent|0
1204065|NCT00907738|3954973|P2|Overall Study|not specified or withdrew consent|0
1204066|NCT00907738|3954974|P1|Overall Study|not specified or withdrew consent|3
1204067|NCT00907738|3954970|P5|Overall Study|Adverse Event|0
1204068|NCT00907738|3954971|P4|Overall Study|Adverse Event|0
1204069|NCT00907738|3954972|P3|Overall Study|Adverse Event|1
1204070|NCT00907738|3954973|P2|Overall Study|Adverse Event|0
1204071|NCT00907738|3954974|P1|Overall Study|Adverse Event|2
1204072|NCT00907621|3954992|P2|Overall Study|intercurrent febrile illness|1
1204073|NCT00907621|3954993|P1|Overall Study|intercurrent febrile illness|1
1204074|NCT00907621|3954992|P2|Overall Study|Lost to Follow-up|3
1204075|NCT00907621|3954993|P1|Overall Study|Lost to Follow-up|6
1204076|NCT00907517|3955006|P5|Overall Study|Symptomatic Deterioration|1
1204077|NCT00907517|3955007|P4|Overall Study|Symptomatic Deterioration|0
1204078|NCT00907517|3955008|P3|Overall Study|Symptomatic Deterioration|0
1204079|NCT00907517|3955009|P2|Overall Study|Symptomatic Deterioration|0
1204080|NCT00907517|3955010|P1|Overall Study|Symptomatic Deterioration|0
1204081|NCT00907517|3955006|P5|Overall Study|Progressive Disease|4
1204082|NCT00907517|3955007|P4|Overall Study|Progressive Disease|4
1204083|NCT00907517|3955008|P3|Overall Study|Progressive Disease|4
1204084|NCT00907517|3955009|P2|Overall Study|Progressive Disease|3
1204085|NCT00907517|3955010|P1|Overall Study|Progressive Disease|3
1204086|NCT00907478|3955035|P3|Overall Study|Other|1
1204087|NCT00907478|3955036|P2|Overall Study|Other|0
1204088|NCT00907478|3955037|P1|Overall Study|Other|3
1204089|NCT00907478|3955035|P3|Overall Study|Lost to Follow-up|0
1204090|NCT00907478|3955036|P2|Overall Study|Lost to Follow-up|0
1204091|NCT00907478|3955037|P1|Overall Study|Lost to Follow-up|1
1204092|NCT00907478|3955035|P3|Overall Study|Pregnancy|1
1204093|NCT00907478|3955036|P2|Overall Study|Pregnancy|1
1204094|NCT00907478|3955037|P1|Overall Study|Pregnancy|0
1204095|NCT00907478|3955035|P3|Overall Study|Protocol-specified criteria|3
1204096|NCT00907478|3955036|P2|Overall Study|Protocol-specified criteria|2
1204097|NCT00907478|3955037|P1|Overall Study|Protocol-specified criteria|5
1204098|NCT00907478|3955035|P3|Overall Study|Death|1
1204099|NCT00907478|3955036|P2|Overall Study|Death|2
1204100|NCT00907478|3955037|P1|Overall Study|Death|4
1204101|NCT00907478|3955035|P3|Overall Study|Physician Decision|3
1204102|NCT00907478|3955036|P2|Overall Study|Physician Decision|0
1204103|NCT00907478|3955037|P1|Overall Study|Physician Decision|2
1204104|NCT00907478|3955035|P3|Overall Study|Requirement for alternative therapy|3
1204105|NCT00907478|3955036|P2|Overall Study|Requirement for alternative therapy|2
1204106|NCT00907478|3955037|P1|Overall Study|Requirement for alternative therapy|1
1204107|NCT00907478|3955035|P3|Overall Study|Withdrawal by Subject|6
1204108|NCT00907478|3955036|P2|Overall Study|Withdrawal by Subject|9
1204109|NCT00907478|3955037|P1|Overall Study|Withdrawal by Subject|8
1204110|NCT00907478|3955035|P3|Overall Study|Adverse Event|2
1204111|NCT00907478|3955036|P2|Overall Study|Adverse Event|1
1204112|NCT00907478|3955037|P1|Overall Study|Adverse Event|3
1204113|NCT00907478|3955035|P3|Overall Study|Noncompliance|1
1204114|NCT00907478|3955036|P2|Overall Study|Noncompliance|0
1204115|NCT00907478|3955037|P1|Overall Study|Noncompliance|0
1204116|NCT00907478|3955035|P3|Overall Study|Ineligibility determined|1
1204117|NCT00907478|3955036|P2|Overall Study|Ineligibility determined|0
1204118|NCT00907478|3955037|P1|Overall Study|Ineligibility determined|0
1204119|NCT00907374|3955087|P2|Overall Study|Noncompliant w/study protocol at <3 mos|2
1204120|NCT00907374|3955088|P1|Overall Study|Noncompliant w/study protocol at <3 mos|2
1204121|NCT00907335|3955102|P2|Overall Study|Lost to Follow-up|0
1204122|NCT00907335|3955103|P1|Overall Study|Lost to Follow-up|2
1204123|NCT00907335|3955102|P2|Overall Study|Adverse Event|1
1204124|NCT00907335|3955103|P1|Overall Study|Adverse Event|4
1204125|NCT00907335|3955102|P2|Overall Study|Withdrawal by Subject|0
1204126|NCT00907335|3955103|P1|Overall Study|Withdrawal by Subject|2
1204127|NCT00907257|3955121|P2|Overall Study|Personal Reasons|1
1204128|NCT00907257|3955122|P1|Overall Study|Personal Reasons|6
1204129|NCT00907257|3955121|P2|Overall Study|Moved|0
1204130|NCT00907257|3955122|P1|Overall Study|Moved|1
1204131|NCT00907257|3955121|P2|Overall Study|Per IRB-Subject became vulnerable|0
1204132|NCT00907257|3955122|P1|Overall Study|Per IRB-Subject became vulnerable|1
1204133|NCT00907257|3955121|P2|Overall Study|Withdrawal by Subject|2
1204134|NCT00907257|3955122|P1|Overall Study|Withdrawal by Subject|1
1204135|NCT00907257|3955121|P2|Overall Study|Lost to Follow-up|3
1204136|NCT00907257|3955122|P1|Overall Study|Lost to Follow-up|3
1204137|NCT00907257|3955121|P2|Overall Study|Protocol Violation|2
1204138|NCT00907257|3955122|P1|Overall Study|Protocol Violation|1
1204139|NCT00907257|3955121|P2|Overall Study|Adverse Event|4
1204140|NCT00907257|3955122|P1|Overall Study|Adverse Event|0
1204141|NCT00907153|3955144|P2|Overall Study|Withdrawal by Subject|3
1204142|NCT00907153|3955145|P1|Overall Study|Withdrawal by Subject|1
1204143|NCT00907153|3955144|P2|Overall Study|Lost to Follow-up|1
1204144|NCT00907153|3955145|P1|Overall Study|Lost to Follow-up|1
1204145|NCT00906971|3955206|P2|Overall Study|Lost to Follow-up|1
1204146|NCT00906971|3955207|P1|Overall Study|Lost to Follow-up|0
1204147|NCT00906971|3955206|P2|Overall Study|Withdrawal by Subject|2
1204148|NCT00906971|3955207|P1|Overall Study|Withdrawal by Subject|8
1204149|NCT00906945|3955220|P6|Overall Study|Physician Decision|1
1204150|NCT00906945|3955221|P5|Overall Study|Physician Decision|0
1204151|NCT00906945|3955222|P4|Overall Study|Physician Decision|0
1204152|NCT00906945|3955223|P3|Overall Study|Physician Decision|0
1204153|NCT00906945|3955224|P2|Overall Study|Physician Decision|0
1204154|NCT00906945|3955225|P1|Overall Study|Physician Decision|0
1204155|NCT00906945|3955220|P6|Overall Study|Found to be not eligible|1
1204156|NCT00906945|3955221|P5|Overall Study|Found to be not eligible|1
1204157|NCT00906945|3955222|P4|Overall Study|Found to be not eligible|1
1204158|NCT00906945|3955223|P3|Overall Study|Found to be not eligible|0
1204159|NCT00906945|3955224|P2|Overall Study|Found to be not eligible|0
1204160|NCT00906945|3955225|P1|Overall Study|Found to be not eligible|0
1204161|NCT00906698|3955285|P6|Overall Study|incl. non compliance, lost to follow-up|0
1204162|NCT00906698|3955286|P5|Overall Study|incl. non compliance, lost to follow-up|0
1204163|NCT00906698|3955287|P4|Overall Study|incl. non compliance, lost to follow-up|0
1204164|NCT00906698|3955288|P3|Overall Study|incl. non compliance, lost to follow-up|0
1204165|NCT00906698|3955289|P2|Overall Study|incl. non compliance, lost to follow-up|1
1204166|NCT00906698|3955290|P1|Overall Study|incl. non compliance, lost to follow-up|0
1204167|NCT00906698|3955285|P6|Overall Study|Withdrawal by Subject|0
1204168|NCT00906698|3955286|P5|Overall Study|Withdrawal by Subject|1
1204169|NCT00906698|3955287|P4|Overall Study|Withdrawal by Subject|0
1204170|NCT00906698|3955288|P3|Overall Study|Withdrawal by Subject|0
1204171|NCT00906698|3955289|P2|Overall Study|Withdrawal by Subject|0
1204172|NCT00906698|3955290|P1|Overall Study|Withdrawal by Subject|0
1204173|NCT00906698|3955285|P6|Overall Study|Disease progression|4
1204174|NCT00906698|3955286|P5|Overall Study|Disease progression|12
1204175|NCT00906698|3955287|P4|Overall Study|Disease progression|4
1204176|NCT00906698|3955288|P3|Overall Study|Disease progression|4
1204177|NCT00906698|3955289|P2|Overall Study|Disease progression|12
1204178|NCT00906698|3955290|P1|Overall Study|Disease progression|3
1204179|NCT00906698|3955285|P6|Overall Study|Adverse Event|1
1204180|NCT00906698|3955286|P5|Overall Study|Adverse Event|4
1204181|NCT00906698|3955287|P4|Overall Study|Adverse Event|0
1204182|NCT00906698|3955288|P3|Overall Study|Adverse Event|2
1204183|NCT00906698|3955289|P2|Overall Study|Adverse Event|0
1204184|NCT00906698|3955290|P1|Overall Study|Adverse Event|0
1204185|NCT00906698|3955285|P6|Overall Study|Dose-limiting toxicity (DLT)|0
1204186|NCT00906698|3955286|P5|Overall Study|Dose-limiting toxicity (DLT)|1
1204187|NCT00906698|3955287|P4|Overall Study|Dose-limiting toxicity (DLT)|0
1204188|NCT00906698|3955288|P3|Overall Study|Dose-limiting toxicity (DLT)|0
1204189|NCT00906698|3955289|P2|Overall Study|Dose-limiting toxicity (DLT)|6
1204190|NCT00906698|3955290|P1|Overall Study|Dose-limiting toxicity (DLT)|0
1204191|NCT00906399|3955392|P7|Year 2|Not specified|0
1204192|NCT00906399|3955393|P6|Year 2|Not specified|1
1204193|NCT00906399|3955394|P5|Year 2|Not specified|3
1204194|NCT00906399|3955395|P4|Year 2|Not specified|2
1204195|NCT00906399|3955396|P3|Year 2|Not specified|0
1204196|NCT00906399|3955397|P2|Year 2|Not specified|0
1204197|NCT00906399|3955398|P1|Year 2|Not specified|0
1204198|NCT00906399|3955392|P7|Year 2|Death|3
1204199|NCT00906399|3955393|P6|Year 2|Death|0
1204200|NCT00906399|3955394|P5|Year 2|Death|0
1204201|NCT00906399|3955395|P4|Year 2|Death|1
1204202|NCT00906399|3955396|P3|Year 2|Death|0
1204203|NCT00906399|3955397|P2|Year 2|Death|0
1204204|NCT00906399|3955398|P1|Year 2|Death|0
1204205|NCT00906399|3955392|P7|Year 2|Physician Decision|3
1204206|NCT00906399|3955393|P6|Year 2|Physician Decision|6
1204207|NCT00906399|3955394|P5|Year 2|Physician Decision|2
1204208|NCT00906399|3955395|P4|Year 2|Physician Decision|0
1204209|NCT00906399|3955396|P3|Year 2|Physician Decision|0
1204210|NCT00906399|3955397|P2|Year 2|Physician Decision|0
1204211|NCT00906399|3955398|P1|Year 2|Physician Decision|0
1204212|NCT00906399|3955392|P7|Year 2|Withdrawal by Subject|13
1204213|NCT00906399|3955393|P6|Year 2|Withdrawal by Subject|27
1204214|NCT00906399|3955394|P5|Year 2|Withdrawal by Subject|18
1204215|NCT00906399|3955395|P4|Year 2|Withdrawal by Subject|17
1204216|NCT00906399|3955396|P3|Year 2|Withdrawal by Subject|0
1204217|NCT00906399|3955397|P2|Year 2|Withdrawal by Subject|0
1204218|NCT00906399|3955398|P1|Year 2|Withdrawal by Subject|0
1204219|NCT00906399|3955392|P7|Year 2|Lost to Follow-up|4
1204220|NCT00906399|3955393|P6|Year 2|Lost to Follow-up|2
1204221|NCT00906399|3955394|P5|Year 2|Lost to Follow-up|4
1204222|NCT00906399|3955395|P4|Year 2|Lost to Follow-up|1
1204223|NCT00906399|3955396|P3|Year 2|Lost to Follow-up|0
1204224|NCT00906399|3955397|P2|Year 2|Lost to Follow-up|0
1204225|NCT00906399|3955398|P1|Year 2|Lost to Follow-up|0
1204226|NCT00906399|3955392|P7|Year 2|Adverse Event|6
1204227|NCT00906399|3955393|P6|Year 2|Adverse Event|11
1204228|NCT00906399|3955394|P5|Year 2|Adverse Event|8
1204229|NCT00906399|3955395|P4|Year 2|Adverse Event|9
1204230|NCT00906399|3955396|P3|Year 2|Adverse Event|0
1204231|NCT00906399|3955397|P2|Year 2|Adverse Event|0
1204232|NCT00906399|3955398|P1|Year 2|Adverse Event|0
1204233|NCT00906399|3955392|P7|Year 1|Not specified|0
1204234|NCT00906399|3955393|P6|Year 1|Not specified|0
1204235|NCT00906399|3955394|P5|Year 1|Not specified|0
1204236|NCT00906399|3955395|P4|Year 1|Not specified|0
1204237|NCT00906399|3955396|P3|Year 1|Not specified|7
1204238|NCT00906399|3955397|P2|Year 1|Not specified|2
1204239|NCT00906399|3955398|P1|Year 1|Not specified|4
1204240|NCT00906399|3955392|P7|Year 1|Death|0
1204241|NCT00906399|3955393|P6|Year 1|Death|0
1204242|NCT00906399|3955394|P5|Year 1|Death|0
1204243|NCT00906399|3955395|P4|Year 1|Death|0
1204244|NCT00906399|3955396|P3|Year 1|Death|1
1204245|NCT00906399|3955397|P2|Year 1|Death|1
1204246|NCT00906399|3955398|P1|Year 1|Death|2
1204247|NCT00906399|3955392|P7|Year 1|Physician Decision|0
1204248|NCT00906399|3955393|P6|Year 1|Physician Decision|0
1204249|NCT00906399|3955394|P5|Year 1|Physician Decision|0
1204250|NCT00906399|3955395|P4|Year 1|Physician Decision|0
1204251|NCT00906399|3955396|P3|Year 1|Physician Decision|3
1204252|NCT00906399|3955397|P2|Year 1|Physician Decision|1
1204253|NCT00906399|3955398|P1|Year 1|Physician Decision|0
1204254|NCT00906399|3955392|P7|Year 1|Withdrawal by Subject|0
1204255|NCT00906399|3955393|P6|Year 1|Withdrawal by Subject|0
1204256|NCT00906399|3955394|P5|Year 1|Withdrawal by Subject|0
1204257|NCT00906399|3955395|P4|Year 1|Withdrawal by Subject|0
1204258|NCT00906399|3955396|P3|Year 1|Withdrawal by Subject|36
1204259|NCT00906399|3955397|P2|Year 1|Withdrawal by Subject|32
1204260|NCT00906399|3955398|P1|Year 1|Withdrawal by Subject|30
1204261|NCT00906399|3955392|P7|Year 1|Lost to Follow-up|0
1204262|NCT00906399|3955393|P6|Year 1|Lost to Follow-up|0
1204263|NCT00906399|3955394|P5|Year 1|Lost to Follow-up|0
1204264|NCT00906399|3955395|P4|Year 1|Lost to Follow-up|0
1204265|NCT00906399|3955396|P3|Year 1|Lost to Follow-up|2
1204266|NCT00906399|3955397|P2|Year 1|Lost to Follow-up|4
1204267|NCT00906399|3955398|P1|Year 1|Lost to Follow-up|4
1204268|NCT00906399|3955392|P7|Year 1|Adverse Event|0
1204269|NCT00906399|3955393|P6|Year 1|Adverse Event|0
1204270|NCT00906399|3955394|P5|Year 1|Adverse Event|0
1204271|NCT00906399|3955395|P4|Year 1|Adverse Event|0
1204272|NCT00906399|3955396|P3|Year 1|Adverse Event|24
1204273|NCT00906399|3955397|P2|Year 1|Adverse Event|22
1204274|NCT00906399|3955398|P1|Year 1|Adverse Event|4
1204275|NCT00906399|3955392|P7|Year 1|Randomized But Not Treated|0
1204276|NCT00906399|3955393|P6|Year 1|Randomized But Not Treated|0
1204277|NCT00906399|3955394|P5|Year 1|Randomized But Not Treated|0
1204278|NCT00906399|3955395|P4|Year 1|Randomized But Not Treated|0
1204279|NCT00906399|3955396|P3|Year 1|Randomized But Not Treated|3
1204280|NCT00906399|3955397|P2|Year 1|Randomized But Not Treated|1
1204281|NCT00906399|3955398|P1|Year 1|Randomized But Not Treated|0
1204282|NCT00906373|3955421|P2|Overall Study|Still on treatment at cutoff date|2
1204283|NCT00906373|3955422|P1|Overall Study|Still on treatment at cutoff date|0
1204284|NCT00906373|3955421|P2|Overall Study|Other|1
1204285|NCT00906373|3955422|P1|Overall Study|Other|0
1204286|NCT00906373|3955421|P2|Overall Study|Withdrawal by Subject|5
1204287|NCT00906373|3955422|P1|Overall Study|Withdrawal by Subject|0
1204288|NCT00906347|3955461|P2|Received Study Drug|Uterine tachysystole or hypertonus|0
1204289|NCT00906347|3955462|P1|Received Study Drug|Uterine tachysystole or hypertonus|8
1204290|NCT00906347|3955461|P2|Received Study Drug|Refused study drug|0
1204291|NCT00906347|3955462|P1|Received Study Drug|Refused study drug|1
1204292|NCT00906347|3955461|P2|Received Study Drug|Nonreassuring fetal heart rate|1
1204293|NCT00906347|3955462|P1|Received Study Drug|Nonreassuring fetal heart rate|13
1204294|NCT00906347|3955461|P2|Received Study Drug|8 cm prior to initiation of study drug|30
1204295|NCT00906347|3955462|P1|Received Study Drug|8 cm prior to initiation of study drug|18
1204296|NCT00906282|3955482|P1|Preoperative Chemotherapy|Toxicity|1
1204297|NCT00906282|3955482|P1|Preoperative Chemotherapy|Progressive disease|6
1204298|NCT00906282|3955482|P1|Preoperative Chemotherapy|Not surgical candidates, off study|10
1204299|NCT00906282|3955482|P1|Preoperative Chemotherapy|Withdrawal by Subject|2
1204300|NCT00906204|3955496|P2|Secondary Endpoints (Long-term Safety)|Death|1
1204301|NCT00906204|3955497|P1|Secondary Endpoints (Long-term Safety)|Death|0
1204302|NCT00906204|3955496|P2|Secondary Endpoints (Long-term Safety)|Adverse Event|2
1204303|NCT00906204|3955497|P1|Secondary Endpoints (Long-term Safety)|Adverse Event|2
1204304|NCT00906204|3955496|P2|Primary Endpoint (Early Safety)|Withdrawal by Subject|0
1204305|NCT00906204|3955497|P1|Primary Endpoint (Early Safety)|Withdrawal by Subject|1
1204306|NCT00906204|3955496|P2|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1
1204307|NCT00906204|3955497|P1|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0
1204308|NCT00906204|3955496|P2|Primary Endpoint (Early Safety)|Physician Decision|0
1204309|NCT00906204|3955497|P1|Primary Endpoint (Early Safety)|Physician Decision|1
1204310|NCT00906087|3955528|P1|Initial Washout|Physician Decision|1
1204311|NCT00906087|3955528|P1|Initial Washout|Withdrawal by Subject|1
1204312|NCT00906035|3955565|P3|Overall Study|Withdrawal by Subject|0
1204313|NCT00906035|3955566|P2|Overall Study|Withdrawal by Subject|3
1204314|NCT00906035|3955567|P1|Overall Study|Withdrawal by Subject|2
1204315|NCT00905840|3955581|P1|Overall Study|Adverse Event|1
1204316|NCT00905840|3955581|P1|Overall Study|Withdrawal by Subject|1
1204317|NCT00905840|3955581|P1|Overall Study|Death|3
1204318|NCT00905840|3955581|P1|Overall Study|Lost to Follow-up|11
1204319|NCT00905632|3955612|P7|Overall Study|Adverse Event|4
1204320|NCT00905632|3955613|P6|Overall Study|Adverse Event|1
1204321|NCT00905632|3955614|P5|Overall Study|Adverse Event|0
1204322|NCT00905632|3955615|P4|Overall Study|Adverse Event|0
1204323|NCT00905632|3955616|P3|Overall Study|Adverse Event|0
1204324|NCT00905632|3955617|P2|Overall Study|Adverse Event|0
1204325|NCT00905632|3955618|P1|Overall Study|Adverse Event|0
1204326|NCT00905606|3955756|P2|Washout|Withdrawal by Subject|0
1204327|NCT00905606|3955757|P1|Washout|Withdrawal by Subject|1
1204328|NCT00905606|3955756|P2|Period 1|Adverse Event|1
1204329|NCT00905606|3955757|P1|Period 1|Adverse Event|0
1204330|NCT00905567|3955782|P2|Washout|Withdrawal by Subject|1
1204331|NCT00905567|3955783|P1|Washout|Withdrawal by Subject|0
1204332|NCT00905489|3955815|P1|Optional Extension Phase (OEP)|Adverse Event|1
1204333|NCT00905489|3955815|P1|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3
1204334|NCT00905489|3955815|P1|Pharmaco-kinetic (PK) Phase|Protocol Violation|2
1204335|NCT00905437|3955864|P2|Overall Study|Other|6
1204336|NCT00905437|3955865|P1|Overall Study|Other|5
1204337|NCT00905437|3955864|P2|Overall Study|Withdrawal by Subject|1
1204338|NCT00905437|3955865|P1|Overall Study|Withdrawal by Subject|0
1204339|NCT00905437|3955864|P2|Overall Study|Lost to Follow-up|1
1204340|NCT00905437|3955865|P1|Overall Study|Lost to Follow-up|0
1204341|NCT00905437|3955864|P2|Overall Study|Adverse Event|2
1204342|NCT00905437|3955865|P1|Overall Study|Adverse Event|3
1204343|NCT00905424|3955885|P2|Overall Study|Non-adherence to visit schedule|1
1204344|NCT00905424|3955886|P1|Overall Study|Non-adherence to visit schedule|0
1204345|NCT00905424|3955885|P2|Overall Study|Positive urine drug screen|1
1204346|NCT00905424|3955886|P1|Overall Study|Positive urine drug screen|0
1204347|NCT00905424|3955885|P2|Overall Study|Sponsor decision|0
1204348|NCT00905424|3955886|P1|Overall Study|Sponsor decision|1
1204349|NCT00905424|3955885|P2|Overall Study|Non-compliance with study medication|0
1204350|NCT00905424|3955886|P1|Overall Study|Non-compliance with study medication|2
1204351|NCT00905424|3955885|P2|Overall Study|Adverse Event|2
1204352|NCT00905424|3955886|P1|Overall Study|Adverse Event|4
1204353|NCT00905424|3955885|P2|Overall Study|Withdrawal by Subject|2
1204354|NCT00905424|3955886|P1|Overall Study|Withdrawal by Subject|1
1204355|NCT00905424|3955885|P2|Overall Study|Lost to Follow-up|3
1204356|NCT00905424|3955886|P1|Overall Study|Lost to Follow-up|3
1204357|NCT00905359|3955928|P2|Overall Study|Withdrawal consent|6
1204358|NCT00905359|3955929|P1|Overall Study|Withdrawal consent|5
1204359|NCT00905359|3955928|P2|Overall Study|Death|0
1204360|NCT00905359|3955929|P1|Overall Study|Death|2
1204361|NCT00905359|3955928|P2|Overall Study|Lost to Follow-up|10
1204362|NCT00905359|3955929|P1|Overall Study|Lost to Follow-up|17
1204363|NCT00905346|3955965|P2|Period 1|Withdrawal by Subject|0
1204364|NCT00905346|3955966|P1|Period 1|Withdrawal by Subject|1
1204365|NCT00905307|3955980|P6|Overall Study|Lack of Efficacy|8
1204366|NCT00905307|3955981|P5|Overall Study|Lack of Efficacy|4
1204367|NCT00905307|3955982|P4|Overall Study|Lack of Efficacy|4
1204368|NCT00905307|3955983|P3|Overall Study|Lack of Efficacy|5
1204369|NCT00905307|3955984|P2|Overall Study|Lack of Efficacy|3
1204370|NCT00905307|3955985|P1|Overall Study|Lack of Efficacy|6
1204371|NCT00905307|3955980|P6|Overall Study|Protocol Violation|0
1204372|NCT00905307|3955981|P5|Overall Study|Protocol Violation|0
1204373|NCT00905307|3955982|P4|Overall Study|Protocol Violation|0
1204374|NCT00905307|3955983|P3|Overall Study|Protocol Violation|1
1204375|NCT00905307|3955984|P2|Overall Study|Protocol Violation|0
1204376|NCT00905307|3955985|P1|Overall Study|Protocol Violation|1
1204377|NCT00905307|3955980|P6|Overall Study|Withdrawal by Subject|13
1204378|NCT00905307|3955981|P5|Overall Study|Withdrawal by Subject|4
1204379|NCT00905307|3955982|P4|Overall Study|Withdrawal by Subject|11
1204380|NCT00905307|3955983|P3|Overall Study|Withdrawal by Subject|15
1204381|NCT00905307|3955984|P2|Overall Study|Withdrawal by Subject|13
1204382|NCT00905307|3955985|P1|Overall Study|Withdrawal by Subject|5
1204383|NCT00905307|3955980|P6|Overall Study|Adverse Event|5
1204384|NCT00905307|3955981|P5|Overall Study|Adverse Event|3
1204385|NCT00905307|3955982|P4|Overall Study|Adverse Event|11
1204386|NCT00905307|3955983|P3|Overall Study|Adverse Event|5
1204387|NCT00905307|3955984|P2|Overall Study|Adverse Event|4
1204388|NCT00905307|3955985|P1|Overall Study|Adverse Event|3
1204389|NCT00905307|3955980|P6|Overall Study|Lost to Follow-up|1
1204390|NCT00905307|3955981|P5|Overall Study|Lost to Follow-up|1
1204391|NCT00905307|3955982|P4|Overall Study|Lost to Follow-up|0
1204392|NCT00905307|3955983|P3|Overall Study|Lost to Follow-up|0
1204393|NCT00905307|3955984|P2|Overall Study|Lost to Follow-up|0
1204394|NCT00905307|3955985|P1|Overall Study|Lost to Follow-up|0
1204395|NCT00905307|3955980|P6|Overall Study|Switched to Open Label Rescue|15
1204396|NCT00905307|3955981|P5|Overall Study|Switched to Open Label Rescue|4
1204397|NCT00905307|3955982|P4|Overall Study|Switched to Open Label Rescue|11
1204398|NCT00905307|3955983|P3|Overall Study|Switched to Open Label Rescue|11
1204399|NCT00905307|3955984|P2|Overall Study|Switched to Open Label Rescue|17
1204400|NCT00905307|3955985|P1|Overall Study|Switched to Open Label Rescue|7
1204401|NCT00905255|3956080|P2|Overall Study|Familial and Personal Reasons|0
1204402|NCT00905255|3956081|P1|Overall Study|Familial and Personal Reasons|1
1204403|NCT00905255|3956080|P2|Overall Study|Withdrawal by Subject|4
1204404|NCT00905255|3956081|P1|Overall Study|Withdrawal by Subject|5
1204405|NCT00905255|3956080|P2|Overall Study|Adverse Event|5
1204406|NCT00905255|3956081|P1|Overall Study|Adverse Event|7
1204407|NCT00905164|3956099|P2|Period 1|Protocol Violation|1
1204408|NCT00905164|3956100|P1|Period 1|Protocol Violation|0
1204409|NCT00905034|3956147|P1|Overall Study|Withdrawal by Subject|1
1204410|NCT00905021|3956151|P1|Overall Study|Adverse Event|2
1204411|NCT00904982|3956169|P4|Overall Study|Withdrawal by Subject|0
1204412|NCT00904982|3956170|P3|Overall Study|Withdrawal by Subject|0
1204413|NCT00904982|3956171|P2|Overall Study|Withdrawal by Subject|0
1204414|NCT00904982|3956172|P1|Overall Study|Withdrawal by Subject|2
1204415|NCT00904969|3956182|P1|Overall Study|Case Aborted; Subject Exited|1
1204416|NCT00904969|3956182|P1|Overall Study|Additional Treatments|11
1204417|NCT00904969|3956182|P1|Overall Study|Withdrawal by Subject|3
1204418|NCT00904969|3956182|P1|Overall Study|Lost to Follow-up|4
1204419|NCT00904917|3956247|P4|Overall Study|Lost to Follow-up|2
1204420|NCT00904917|3956248|P3|Overall Study|Lost to Follow-up|2
1204421|NCT00904917|3956249|P2|Overall Study|Lost to Follow-up|2
1204422|NCT00904917|3956250|P1|Overall Study|Lost to Follow-up|2
1204423|NCT00904839|3956268|P3|Overall Study|Other than above|7
1204424|NCT00904839|3956269|P2|Overall Study|Other than above|9
1204425|NCT00904839|3956270|P1|Overall Study|Other than above|0
1204426|NCT00904839|3956268|P3|Overall Study|Not treated|1
1204427|NCT00904839|3956269|P2|Overall Study|Not treated|0
1204428|NCT00904839|3956270|P1|Overall Study|Not treated|1
1204429|NCT00904839|3956268|P3|Overall Study|Withdrawal by Subject|0
1204430|NCT00904839|3956269|P2|Overall Study|Withdrawal by Subject|2
1204431|NCT00904839|3956270|P1|Overall Study|Withdrawal by Subject|0
1204432|NCT00904839|3956268|P3|Overall Study|Lost to Follow-up|2
1204433|NCT00904839|3956269|P2|Overall Study|Lost to Follow-up|1
1204434|NCT00904839|3956270|P1|Overall Study|Lost to Follow-up|0
1204435|NCT00904839|3956268|P3|Overall Study|Protocol Violation|1
1204436|NCT00904839|3956269|P2|Overall Study|Protocol Violation|1
1204437|NCT00904839|3956270|P1|Overall Study|Protocol Violation|0
1204438|NCT00904839|3956268|P3|Overall Study|Adverse Event|4
1204439|NCT00904839|3956269|P2|Overall Study|Adverse Event|5
1204440|NCT00904839|3956270|P1|Overall Study|Adverse Event|0
1204441|NCT00904748|3956316|P6|Overall Study|Adverse Event|0
1204442|NCT00904748|3956317|P5|Overall Study|Adverse Event|1
1204443|NCT00904748|3956318|P4|Overall Study|Adverse Event|0
1204444|NCT00904748|3956319|P3|Overall Study|Adverse Event|0
1204445|NCT00904748|3956320|P2|Overall Study|Adverse Event|0
1204446|NCT00904748|3956321|P1|Overall Study|Adverse Event|0
1204447|NCT00904748|3956316|P6|Overall Study|Withdrawal by Subject|0
1204448|NCT00904748|3956317|P5|Overall Study|Withdrawal by Subject|0
1204449|NCT00904748|3956318|P4|Overall Study|Withdrawal by Subject|2
1204450|NCT00904748|3956319|P3|Overall Study|Withdrawal by Subject|1
1204451|NCT00904748|3956320|P2|Overall Study|Withdrawal by Subject|1
1204452|NCT00904748|3956321|P1|Overall Study|Withdrawal by Subject|1
1204453|NCT00904722|3956345|P1|Overall Study|Physician Decision|1
1204454|NCT00904670|3956350|P2|Open Label Phase|Lost to Follow-up|0
1204455|NCT00904670|3956351|P1|Open Label Phase|Lost to Follow-up|1
1204456|NCT00904670|3956350|P2|Open Label Phase|Lack of Efficacy|0
1204457|NCT00904670|3956351|P1|Open Label Phase|Lack of Efficacy|1
1204458|NCT00904670|3956350|P2|Open Label Phase|Adverse Event|0
1204459|NCT00904670|3956351|P1|Open Label Phase|Adverse Event|2
1204460|NCT00904670|3956350|P2|Open Label Phase|Withdrawal by Subject|0
1204461|NCT00904670|3956351|P1|Open Label Phase|Withdrawal by Subject|2
1204462|NCT00904371|3956421|P1|Overall Study|Continued with Tritace|1
1204463|NCT00904371|3956421|P1|Overall Study|Discontinued at target blood pressure|2
1204464|NCT00904371|3956421|P1|Overall Study|Lost to Follow-up|4
1204465|NCT00904371|3956421|P1|Overall Study|Adverse Event|2
1204466|NCT00904215|3956435|P1|Overall Study|Other|28
1204467|NCT00904215|3956435|P1|Overall Study|Withdrawal by Subject|9
1204468|NCT00904215|3956435|P1|Overall Study|Lost to Follow-up|63
1204469|NCT00904215|3956435|P1|Overall Study|Protocol Violation|10
1204470|NCT00904215|3956435|P1|Overall Study|Adverse Event|25
1204471|NCT00904150|3956449|P2|Saliva Samples (DNA)|Australian samples of different genotype|145
1204472|NCT00904150|3956450|P1|Saliva Samples (DNA)|Australian samples of different genotype|0
1204473|NCT00904150|3956449|P2|Saliva Samples (DNA)|saliva samples not suitable for assay|0
1204474|NCT00904150|3956450|P1|Saliva Samples (DNA)|saliva samples not suitable for assay|3
1204475|NCT00903968|3956479|P8|Overall Study|Lack of Efficacy|3
1204476|NCT00903968|3956480|P7|Overall Study|Lack of Efficacy|0
1204477|NCT00903968|3956481|P6|Overall Study|Lack of Efficacy|0
1204478|NCT00903968|3956482|P5|Overall Study|Lack of Efficacy|0
1204479|NCT00903968|3956483|P4|Overall Study|Lack of Efficacy|0
1204480|NCT00903968|3956484|P3|Overall Study|Lack of Efficacy|0
1204481|NCT00903968|3956485|P2|Overall Study|Lack of Efficacy|0
1204482|NCT00903968|3956486|P1|Overall Study|Lack of Efficacy|0
1204483|NCT00903968|3956479|P8|Overall Study|Progressive Disease|18
1204484|NCT00903968|3956480|P7|Overall Study|Progressive Disease|0
1204485|NCT00903968|3956481|P6|Overall Study|Progressive Disease|3
1204486|NCT00903968|3956482|P5|Overall Study|Progressive Disease|3
1204487|NCT00903968|3956483|P4|Overall Study|Progressive Disease|3
1204488|NCT00903968|3956484|P3|Overall Study|Progressive Disease|2
1204489|NCT00903968|3956485|P2|Overall Study|Progressive Disease|3
1204490|NCT00903968|3956486|P1|Overall Study|Progressive Disease|2
1204491|NCT00903968|3956479|P8|Overall Study|Physician Decision|0
1204492|NCT00903968|3956480|P7|Overall Study|Physician Decision|0
1204493|NCT00903968|3956481|P6|Overall Study|Physician Decision|1
1204494|NCT00903968|3956482|P5|Overall Study|Physician Decision|0
1204495|NCT00903968|3956483|P4|Overall Study|Physician Decision|0
1204496|NCT00903968|3956484|P3|Overall Study|Physician Decision|0
1204497|NCT00903968|3956485|P2|Overall Study|Physician Decision|0
1204498|NCT00903968|3956486|P1|Overall Study|Physician Decision|0
1204499|NCT00903968|3956479|P8|Overall Study|Non-Compliance|0
1204500|NCT00903968|3956480|P7|Overall Study|Non-Compliance|0
1204501|NCT00903968|3956481|P6|Overall Study|Non-Compliance|1
1204502|NCT00903968|3956482|P5|Overall Study|Non-Compliance|0
1204503|NCT00903968|3956483|P4|Overall Study|Non-Compliance|0
1204504|NCT00903968|3956484|P3|Overall Study|Non-Compliance|0
1204505|NCT00903968|3956485|P2|Overall Study|Non-Compliance|0
1204506|NCT00903968|3956486|P1|Overall Study|Non-Compliance|0
1204507|NCT00903968|3956479|P8|Overall Study|Withdrawal by Subject|4
1204508|NCT00903968|3956480|P7|Overall Study|Withdrawal by Subject|0
1204509|NCT00903968|3956481|P6|Overall Study|Withdrawal by Subject|1
1204510|NCT00903968|3956482|P5|Overall Study|Withdrawal by Subject|1
1204511|NCT00903968|3956483|P4|Overall Study|Withdrawal by Subject|0
1204512|NCT00903968|3956484|P3|Overall Study|Withdrawal by Subject|1
1204513|NCT00903968|3956485|P2|Overall Study|Withdrawal by Subject|0
1204514|NCT00903968|3956486|P1|Overall Study|Withdrawal by Subject|1
1204515|NCT00903968|3956479|P8|Overall Study|DLT|0
1204516|NCT00903968|3956480|P7|Overall Study|DLT|2
1204517|NCT00903968|3956481|P6|Overall Study|DLT|0
1204518|NCT00903968|3956482|P5|Overall Study|DLT|0
1204519|NCT00903968|3956483|P4|Overall Study|DLT|0
1204520|NCT00903968|3956484|P3|Overall Study|DLT|0
1204521|NCT00903968|3956485|P2|Overall Study|DLT|0
1204522|NCT00903968|3956486|P1|Overall Study|DLT|0
1204523|NCT00903968|3956479|P8|Overall Study|Adverse Event|8
1204524|NCT00903968|3956480|P7|Overall Study|Adverse Event|1
1204525|NCT00903968|3956481|P6|Overall Study|Adverse Event|0
1204526|NCT00903968|3956482|P5|Overall Study|Adverse Event|0
1204527|NCT00903968|3956483|P4|Overall Study|Adverse Event|0
1204528|NCT00903968|3956484|P3|Overall Study|Adverse Event|0
1204529|NCT00903968|3956485|P2|Overall Study|Adverse Event|0
1204530|NCT00903968|3956486|P1|Overall Study|Adverse Event|0
1204531|NCT00903929|3956516|P4|Overall Study|Adverse Event|1
1204532|NCT00903929|3956517|P3|Overall Study|Adverse Event|0
1204533|NCT00903929|3956518|P2|Overall Study|Adverse Event|0
1204534|NCT00903929|3956519|P1|Overall Study|Adverse Event|0
1204535|NCT00903929|3956516|P4|Overall Study|Withdrawal by Subject|2
1204536|NCT00903929|3956517|P3|Overall Study|Withdrawal by Subject|1
1204537|NCT00903929|3956518|P2|Overall Study|Withdrawal by Subject|0
1204538|NCT00903929|3956519|P1|Overall Study|Withdrawal by Subject|0
1204539|NCT00903877|3956525|P1|Overall Study|Participation put on hold|4
1204540|NCT00903877|3956525|P1|Overall Study|Lost to Follow-up|1
1204541|NCT00903877|3956525|P1|Overall Study|Adverse Event|2
1204542|NCT00903877|3956525|P1|Overall Study|Withdrawal by Subject|3
1204543|NCT00903877|3956525|P1|Overall Study|Did not meet study criteria|33
1204544|NCT00903786|3956529|P1|Overall Study|Reason other than lack of efficacy|4
1204545|NCT00903786|3956529|P1|Overall Study|Lack of Efficacy|5
1204546|NCT00903786|3956529|P1|Overall Study|Physician Decision|6
1204547|NCT00903760|3956539|P2|Overall Study|Off treatment for long period|1
1204548|NCT00903760|3956540|P1|Overall Study|Off treatment for long period|0
1204549|NCT00903760|3956539|P2|Overall Study|Withdrawal by Subject|2
1204550|NCT00903760|3956540|P1|Overall Study|Withdrawal by Subject|1
1204551|NCT00903760|3956539|P2|Overall Study|Lost to Follow-up|0
1204552|NCT00903760|3956540|P1|Overall Study|Lost to Follow-up|1
1204553|NCT00903760|3956539|P2|Overall Study|Death|1
1204554|NCT00903760|3956540|P1|Overall Study|Death|0
1204555|NCT00903760|3956539|P2|Overall Study|Physician Decision|2
1204556|NCT00903760|3956540|P1|Overall Study|Physician Decision|1
1204557|NCT00903760|3956539|P2|Overall Study|Stem Cell Transplant|4
1204558|NCT00903760|3956540|P1|Overall Study|Stem Cell Transplant|8
1204559|NCT00903760|3956539|P2|Overall Study|Disease Progression/Death|6
1204560|NCT00903760|3956540|P1|Overall Study|Disease Progression/Death|8
1204561|NCT00903695|3956550|P2|Overall Study|lung cancer|0
1204562|NCT00903695|3956551|P1|Overall Study|lung cancer|1
1204563|NCT00903695|3956550|P2|Overall Study|medical exclusion after 1st testing|0
1204564|NCT00903695|3956551|P1|Overall Study|medical exclusion after 1st testing|1
1204565|NCT00903682|3956573|P2|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0
1204566|NCT00903682|3956574|P1|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1
1204567|NCT00903682|3956573|P2|Overall Study|Patient Couldn't Come For The Visit Due|0
1204568|NCT00903682|3956574|P1|Overall Study|Patient Couldn't Come For The Visit Due|1
1204569|NCT00903682|3956573|P2|Overall Study|Subject Non-Compliant|0
1204570|NCT00903682|3956574|P1|Overall Study|Subject Non-Compliant|1
1204571|NCT00903682|3956573|P2|Overall Study|Subject Reached A Virologic Endpoint|1
1204572|NCT00903682|3956574|P1|Overall Study|Subject Reached A Virologic Endpoint|1
1204573|NCT00903682|3956573|P2|Overall Study|Pregnancy|1
1204574|NCT00903682|3956574|P1|Overall Study|Pregnancy|0
1204575|NCT00903682|3956573|P2|Overall Study|Withdrawal by Subject|0
1204576|NCT00903682|3956574|P1|Overall Study|Withdrawal by Subject|5
1204577|NCT00903682|3956573|P2|Overall Study|Lost to Follow-up|0
1204578|NCT00903682|3956574|P1|Overall Study|Lost to Follow-up|1
1204579|NCT00903682|3956573|P2|Overall Study|Adverse Event|13
1204580|NCT00903682|3956574|P1|Overall Study|Adverse Event|6
1204581|NCT00903630|3956595|P3|Phase 2|Adverse Event|1
1204582|NCT00903630|3956596|P2|Phase 2|Adverse Event|0
1204583|NCT00903630|3956597|P1|Phase 2|Adverse Event|0
1204584|NCT00903617|3956615|P4|Overall Study|Withdrawal by Subject|0
1204585|NCT00903617|3956616|P3|Overall Study|Withdrawal by Subject|3
1204586|NCT00903617|3956617|P2|Overall Study|Withdrawal by Subject|2
1204587|NCT00903617|3956618|P1|Overall Study|Withdrawal by Subject|1
1204588|NCT00903617|3956615|P4|Overall Study|Lost to Follow-up|1
1204589|NCT00903617|3956616|P3|Overall Study|Lost to Follow-up|1
1204590|NCT00903617|3956617|P2|Overall Study|Lost to Follow-up|0
1204591|NCT00903617|3956618|P1|Overall Study|Lost to Follow-up|2
1204592|NCT00903617|3956615|P4|Overall Study|Protocol-defined stopping criteria|0
1204593|NCT00903617|3956616|P3|Overall Study|Protocol-defined stopping criteria|0
1204594|NCT00903617|3956617|P2|Overall Study|Protocol-defined stopping criteria|2
1204595|NCT00903617|3956618|P1|Overall Study|Protocol-defined stopping criteria|0
1204596|NCT00903617|3956615|P4|Overall Study|Adverse Event|0
1204597|NCT00903617|3956616|P3|Overall Study|Adverse Event|1
1204598|NCT00903617|3956617|P2|Overall Study|Adverse Event|1
1204599|NCT00903617|3956618|P1|Overall Study|Adverse Event|0
1204600|NCT00903409|3956721|P2|Overall Study|Lost to Follow-up|6
1204601|NCT00903409|3956722|P1|Overall Study|Lost to Follow-up|2
1204602|NCT00903409|3956721|P2|Overall Study|Not specified|3
1204603|NCT00903409|3956722|P1|Overall Study|Not specified|2
1204604|NCT00903409|3956721|P2|Overall Study|Withdrawal by Subject|8
1204605|NCT00903409|3956722|P1|Overall Study|Withdrawal by Subject|8
1204606|NCT00903409|3956721|P2|Overall Study|Laboratory Abnormality|0
1204607|NCT00903409|3956722|P1|Overall Study|Laboratory Abnormality|2
1204608|NCT00903409|3956721|P2|Overall Study|Non-compliance with Protocol|1
1204609|NCT00903409|3956722|P1|Overall Study|Non-compliance with Protocol|1
1204610|NCT00903409|3956721|P2|Overall Study|Adverse Event|9
1204611|NCT00903409|3956722|P1|Overall Study|Adverse Event|11
1204612|NCT00903383|3956773|P4|Overall Study|Patient Decision|1
1204613|NCT00903383|3956774|P3|Overall Study|Patient Decision|0
1204614|NCT00903383|3956775|P2|Overall Study|Patient Decision|0
1204615|NCT00903383|3956776|P1|Overall Study|Patient Decision|0
1204616|NCT00903383|3956773|P4|Overall Study|Patient Decision - Lack of Efficacy|0
1204617|NCT00903383|3956774|P3|Overall Study|Patient Decision - Lack of Efficacy|0
1204618|NCT00903383|3956775|P2|Overall Study|Patient Decision - Lack of Efficacy|1
1204619|NCT00903383|3956776|P1|Overall Study|Patient Decision - Lack of Efficacy|0
1204620|NCT00903383|3956773|P4|Overall Study|Withdrawal by Subject|2
1204621|NCT00903383|3956774|P3|Overall Study|Withdrawal by Subject|0
1204622|NCT00903383|3956775|P2|Overall Study|Withdrawal by Subject|1
1204623|NCT00903383|3956776|P1|Overall Study|Withdrawal by Subject|4
1204624|NCT00903383|3956773|P4|Overall Study|Decision of Sponsor|0
1204625|NCT00903383|3956774|P3|Overall Study|Decision of Sponsor|0
1204626|NCT00903383|3956775|P2|Overall Study|Decision of Sponsor|0
1204627|NCT00903383|3956776|P1|Overall Study|Decision of Sponsor|1
1204628|NCT00903383|3956773|P4|Overall Study|Lost to Follow-up|1
1204629|NCT00903383|3956774|P3|Overall Study|Lost to Follow-up|0
1204630|NCT00903383|3956775|P2|Overall Study|Lost to Follow-up|0
1204631|NCT00903383|3956776|P1|Overall Study|Lost to Follow-up|0
1204632|NCT00903383|3956773|P4|Overall Study|Physician Decision|0
1204633|NCT00903383|3956774|P3|Overall Study|Physician Decision|0
1204634|NCT00903383|3956775|P2|Overall Study|Physician Decision|2
1204635|NCT00903383|3956776|P1|Overall Study|Physician Decision|1
1204636|NCT00903383|3956773|P4|Overall Study|Adverse Event|1
1204637|NCT00903383|3956774|P3|Overall Study|Adverse Event|3
1204638|NCT00903383|3956775|P2|Overall Study|Adverse Event|2
1204639|NCT00903383|3956776|P1|Overall Study|Adverse Event|1
1204640|NCT00903370|3956808|P2|Overall Study|Lost to Follow-up|8
1204641|NCT00903370|3956809|P1|Overall Study|Lost to Follow-up|6
1204642|NCT00903370|3956808|P2|Overall Study|Withdrawal by Subject|6
1204643|NCT00903370|3956809|P1|Overall Study|Withdrawal by Subject|9
1204644|NCT00903370|3956808|P2|Overall Study|Death|10
1204645|NCT00903370|3956809|P1|Overall Study|Death|13
1204646|NCT00903357|3956817|P2|Second Intervention|Lost to Follow-up|0
1204647|NCT00903357|3956818|P1|Second Intervention|Lost to Follow-up|1
1204648|NCT00903357|3956817|P2|Wash Out Period of 2 Weeks|Flu|1
1204649|NCT00903357|3956818|P1|Wash Out Period of 2 Weeks|Flu|0
1204650|NCT00903357|3956817|P2|First Intervention|Flu|1
1204651|NCT00903357|3956818|P1|First Intervention|Flu|0
1204652|NCT00903357|3956817|P2|First Intervention|Withdrawal by Subject|3
1204653|NCT00903357|3956818|P1|First Intervention|Withdrawal by Subject|5
1204654|NCT00903344|3956830|P2|Overall Study|Lost to Follow-up|0
1204655|NCT00903344|3956831|P1|Overall Study|Lost to Follow-up|3
1204656|NCT00903344|3956830|P2|Overall Study|Pregnancy|3
1204657|NCT00903344|3956831|P1|Overall Study|Pregnancy|2
1204658|NCT00903331|3956849|P2|Overall Study|Lung transplant|2
1204659|NCT00903331|3956850|P1|Overall Study|Lung transplant|0
1204660|NCT00903331|3956849|P2|Overall Study|Withdrawal of consent|8
1204661|NCT00903331|3956850|P1|Overall Study|Withdrawal of consent|1
1204662|NCT00903331|3956849|P2|Overall Study|Death|8
1204663|NCT00903331|3956850|P1|Overall Study|Death|4
1204664|NCT00903201|3956861|P3|Overall Study|Withdrawal by Subject|1
1204665|NCT00903201|3956862|P2|Overall Study|Withdrawal by Subject|0
1204666|NCT00903201|3956863|P1|Overall Study|Withdrawal by Subject|1
1204667|NCT00903201|3956861|P3|Overall Study|Physician Decision|1
1204668|NCT00903201|3956862|P2|Overall Study|Physician Decision|0
1204669|NCT00903201|3956863|P1|Overall Study|Physician Decision|1
1204670|NCT00903201|3956861|P3|Overall Study|Lost to Follow-up|0
1204671|NCT00903201|3956862|P2|Overall Study|Lost to Follow-up|1
1204672|NCT00903201|3956863|P1|Overall Study|Lost to Follow-up|0
1204673|NCT00903201|3956861|P3|Overall Study|Protocol Violation|0
1204674|NCT00903201|3956862|P2|Overall Study|Protocol Violation|1
1204675|NCT00903201|3956863|P1|Overall Study|Protocol Violation|2
1204676|NCT00903201|3956861|P3|Overall Study|Adverse Event|0
1204677|NCT00903201|3956862|P2|Overall Study|Adverse Event|4
1204678|NCT00903201|3956863|P1|Overall Study|Adverse Event|1
1204679|NCT00903175|3956921|P2|Period 2 - Second Line|Death|2
1204680|NCT00903175|3956922|P1|Period 2 - Second Line|Death|5
1204681|NCT00903175|3956921|P2|Period 2 - Second Line|Administrative problems|9
1204682|NCT00903175|3956922|P1|Period 2 - Second Line|Administrative problems|19
1204683|NCT00903175|3956921|P2|Period 2 - Second Line|Lost to Follow-up|0
1204684|NCT00903175|3956922|P1|Period 2 - Second Line|Lost to Follow-up|1
1204685|NCT00903175|3956921|P2|Period 2 - Second Line|Withdrawal by Subject|5
1204686|NCT00903175|3956922|P1|Period 2 - Second Line|Withdrawal by Subject|7
1204687|NCT00903175|3956921|P2|Period 2 - Second Line|Adverse Event|20
1204688|NCT00903175|3956922|P1|Period 2 - Second Line|Adverse Event|16
1204689|NCT00903175|3956921|P2|Period 2 - Second Line|Missing|0
1204690|NCT00903175|3956922|P1|Period 2 - Second Line|Missing|1
1204691|NCT00903175|3956921|P2|Period 1 - First Line|Death|10
1204692|NCT00903175|3956922|P1|Period 1 - First Line|Death|17
1204693|NCT00903175|3956921|P2|Period 1 - First Line|Administrative problems|13
1204694|NCT00903175|3956922|P1|Period 1 - First Line|Administrative problems|12
1204695|NCT00903175|3956921|P2|Period 1 - First Line|Withdrawal by Subject|12
1204696|NCT00903175|3956922|P1|Period 1 - First Line|Withdrawal by Subject|8
1204697|NCT00903175|3956921|P2|Period 1 - First Line|Protocol Violation|3
1204698|NCT00903175|3956922|P1|Period 1 - First Line|Protocol Violation|3
1204699|NCT00903175|3956921|P2|Period 1 - First Line|Abnormal test procedure result(s)|0
1204700|NCT00903175|3956922|P1|Period 1 - First Line|Abnormal test procedure result(s)|1
1204701|NCT00903175|3956921|P2|Period 1 - First Line|Abnormal lab value(s)|1
1204702|NCT00903175|3956922|P1|Period 1 - First Line|Abnormal lab value(s)|0
1204703|NCT00903175|3956921|P2|Period 1 - First Line|Adverse Event|50
1204704|NCT00903175|3956922|P1|Period 1 - First Line|Adverse Event|36
1204705|NCT00903032|3956960|P2|Overall Study|Lost to Follow-up|2
1204706|NCT00903032|3956961|P1|Overall Study|Lost to Follow-up|2
1204707|NCT00903032|3956960|P2|Overall Study|Withdrawal by Subject|3
1204708|NCT00903032|3956961|P1|Overall Study|Withdrawal by Subject|5
1204709|NCT00903006|3956971|P4|Overall Study|Progressive Disease|0
1204710|NCT00903006|3956972|P3|Overall Study|Progressive Disease|1
1204711|NCT00903006|3956973|P2|Overall Study|Progressive Disease|3
1204712|NCT00903006|3956974|P1|Overall Study|Progressive Disease|0
1204713|NCT00903006|3956971|P4|Overall Study|Withdrawal by Subject|0
1204714|NCT00903006|3956972|P3|Overall Study|Withdrawal by Subject|0
1204715|NCT00903006|3956973|P2|Overall Study|Withdrawal by Subject|0
1204716|NCT00903006|3956974|P1|Overall Study|Withdrawal by Subject|2
1204717|NCT00902850|3956986|P2|Overall Study|Physician Decision|2
1204718|NCT00902850|3956987|P1|Overall Study|Physician Decision|2
1204719|NCT00902746|3956993|P1|Overall Study|Physician Decision|2
1204720|NCT00902746|3956993|P1|Overall Study|Lost to Follow-up|3
1204721|NCT00902746|3956993|P1|Overall Study|Adverse Event|8
1204722|NCT00902746|3956993|P1|Overall Study|Withdrawal by Subject|16
1204723|NCT00902746|3956993|P1|Overall Study|Protocol Violation|7
1204724|NCT00902668|3956998|P1|Overall Study|Protocol stopped due to slow accrual.|3
1204725|NCT00902564|3957002|P1|Overall Study|Withdrawal by Subject|2
1204726|NCT00902538|3957017|P6|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
1204727|NCT00902538|3957018|P5|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
1204728|NCT00902538|3957019|P4|4-Randomized Double-blind 2 Treatments|Protocol Violation|3
1204729|NCT00902538|3957020|P3|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
1204730|NCT00902538|3957021|P2|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
1204731|NCT00902538|3957022|P1|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
1204732|NCT00902538|3957017|P6|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
1204733|NCT00902538|3957018|P5|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1
1204734|NCT00902538|3957019|P4|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3
1204735|NCT00902538|3957020|P3|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
1204736|NCT00902538|3957021|P2|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
1204737|NCT00902538|3957022|P1|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
1204738|NCT00902538|3957017|P6|4-Randomized Double-blind 2 Treatments|Adverse Event|1
1204739|NCT00902538|3957018|P5|4-Randomized Double-blind 2 Treatments|Adverse Event|1
1204740|NCT00902538|3957019|P4|4-Randomized Double-blind 2 Treatments|Adverse Event|3
1204741|NCT00902538|3957020|P3|4-Randomized Double-blind 2 Treatments|Adverse Event|0
1204742|NCT00902538|3957021|P2|4-Randomized Double-blind 2 Treatments|Adverse Event|0
1204743|NCT00902538|3957022|P1|4-Randomized Double-blind 2 Treatments|Adverse Event|0
1204744|NCT00902538|3957017|P6|3-Single-blind, Single Treatment|Lost to Follow-up|0
1204745|NCT00902538|3957018|P5|3-Single-blind, Single Treatment|Lost to Follow-up|0
1204746|NCT00902538|3957019|P4|3-Single-blind, Single Treatment|Lost to Follow-up|0
1204747|NCT00902538|3957020|P3|3-Single-blind, Single Treatment|Lost to Follow-up|0
1204748|NCT00902538|3957021|P2|3-Single-blind, Single Treatment|Lost to Follow-up|1
1204749|NCT00902538|3957022|P1|3-Single-blind, Single Treatment|Lost to Follow-up|0
1204750|NCT00902538|3957017|P6|3-Single-blind, Single Treatment|Withdrawal by Subject|0
1204751|NCT00902538|3957018|P5|3-Single-blind, Single Treatment|Withdrawal by Subject|0
1204752|NCT00902538|3957019|P4|3-Single-blind, Single Treatment|Withdrawal by Subject|0
1204753|NCT00902538|3957020|P3|3-Single-blind, Single Treatment|Withdrawal by Subject|0
1204754|NCT00902538|3957021|P2|3-Single-blind, Single Treatment|Withdrawal by Subject|4
1204755|NCT00902538|3957022|P1|3-Single-blind, Single Treatment|Withdrawal by Subject|0
1204756|NCT00902538|3957017|P6|3-Single-blind, Single Treatment|Protocol Violation|0
1204757|NCT00902538|3957018|P5|3-Single-blind, Single Treatment|Protocol Violation|0
1204758|NCT00902538|3957019|P4|3-Single-blind, Single Treatment|Protocol Violation|0
1204759|NCT00902538|3957020|P3|3-Single-blind, Single Treatment|Protocol Violation|0
1204760|NCT00902538|3957021|P2|3-Single-blind, Single Treatment|Protocol Violation|5
1204761|NCT00902538|3957022|P1|3-Single-blind, Single Treatment|Protocol Violation|0
1204762|NCT00902538|3957017|P6|3-Single-blind, Single Treatment|Adverse Event|0
1204763|NCT00902538|3957018|P5|3-Single-blind, Single Treatment|Adverse Event|0
1204764|NCT00902538|3957019|P4|3-Single-blind, Single Treatment|Adverse Event|0
1204765|NCT00902538|3957020|P3|3-Single-blind, Single Treatment|Adverse Event|0
1204766|NCT00902538|3957021|P2|3-Single-blind, Single Treatment|Adverse Event|5
1204767|NCT00902538|3957022|P1|3-Single-blind, Single Treatment|Adverse Event|0
1204768|NCT00902538|3957017|P6|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
1204769|NCT00902538|3957018|P5|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
1204770|NCT00902538|3957019|P4|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
1204771|NCT00902538|3957020|P3|2-Randomized Double-blind 3 Treatments|Protocol Violation|2
1204772|NCT00902538|3957021|P2|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
1204773|NCT00902538|3957022|P1|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
1204774|NCT00902538|3957017|P6|2-Randomized Double-blind 3 Treatments|Other|0
1204775|NCT00902538|3957018|P5|2-Randomized Double-blind 3 Treatments|Other|0
1204776|NCT00902538|3957019|P4|2-Randomized Double-blind 3 Treatments|Other|0
1204777|NCT00902538|3957020|P3|2-Randomized Double-blind 3 Treatments|Other|0
1204778|NCT00902538|3957021|P2|2-Randomized Double-blind 3 Treatments|Other|1
1204779|NCT00902538|3957022|P1|2-Randomized Double-blind 3 Treatments|Other|2
1204780|NCT00902538|3957017|P6|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
1204781|NCT00902538|3957018|P5|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
1204782|NCT00902538|3957019|P4|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
1204783|NCT00902538|3957020|P3|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2
1204784|NCT00902538|3957021|P2|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
1204785|NCT00902538|3957022|P1|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1
1204786|NCT00902538|3957017|P6|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
1204787|NCT00902538|3957018|P5|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
1204788|NCT00902538|3957019|P4|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
1204789|NCT00902538|3957020|P3|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
1204790|NCT00902538|3957021|P2|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2
1204791|NCT00902538|3957022|P1|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
1204792|NCT00902538|3957017|P6|2-Randomized Double-blind 3 Treatments|Adverse Event|0
1204793|NCT00902538|3957018|P5|2-Randomized Double-blind 3 Treatments|Adverse Event|0
1204794|NCT00902538|3957019|P4|2-Randomized Double-blind 3 Treatments|Adverse Event|0
1204795|NCT00902538|3957020|P3|2-Randomized Double-blind 3 Treatments|Adverse Event|3
1204796|NCT00902538|3957021|P2|2-Randomized Double-blind 3 Treatments|Adverse Event|2
1204797|NCT00902538|3957022|P1|2-Randomized Double-blind 3 Treatments|Adverse Event|4
1204798|NCT00902538|3957017|P6|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
1204799|NCT00902538|3957018|P5|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
1204800|NCT00902538|3957019|P4|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
1204801|NCT00902538|3957020|P3|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
1204802|NCT00902538|3957021|P2|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
1204803|NCT00902538|3957022|P1|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4
1204804|NCT00902538|3957017|P6|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
1204805|NCT00902538|3957018|P5|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
1204806|NCT00902538|3957019|P4|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
1204807|NCT00902538|3957020|P3|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
1204808|NCT00902538|3957021|P2|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
1204809|NCT00902538|3957022|P1|1-Single-blind, Run-in, Single-Treatment|Other Reason|13
1204810|NCT00902538|3957017|P6|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
1204811|NCT00902538|3957018|P5|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
1204812|NCT00902538|3957019|P4|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
1204813|NCT00902538|3957020|P3|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
1204814|NCT00902538|3957021|P2|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
1204815|NCT00902538|3957022|P1|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22
1204816|NCT00902538|3957017|P6|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
1204817|NCT00902538|3957018|P5|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
1204818|NCT00902538|3957019|P4|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
1204819|NCT00902538|3957020|P3|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
1204820|NCT00902538|3957021|P2|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
1204821|NCT00902538|3957022|P1|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30
1204822|NCT00902538|3957017|P6|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
1204823|NCT00902538|3957018|P5|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
1204824|NCT00902538|3957019|P4|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
1204825|NCT00902538|3957020|P3|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
1204826|NCT00902538|3957021|P2|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
1204827|NCT00902538|3957022|P1|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49
1204828|NCT00902486|3957056|P6|Follow-up (After Week 24)|Lost to Follow-up|0
1204829|NCT00902486|3957057|P5|Follow-up (After Week 24)|Lost to Follow-up|0
1204830|NCT00902486|3957058|P4|Follow-up (After Week 24)|Lost to Follow-up|1
1204831|NCT00902486|3957059|P3|Follow-up (After Week 24)|Lost to Follow-up|0
1204832|NCT00902486|3957060|P2|Follow-up (After Week 24)|Lost to Follow-up|0
1204833|NCT00902486|3957061|P1|Follow-up (After Week 24)|Lost to Follow-up|0
1204834|NCT00902486|3957056|P6|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
1204835|NCT00902486|3957057|P5|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
1204836|NCT00902486|3957058|P4|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
1204837|NCT00902486|3957059|P3|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1
1204838|NCT00902486|3957060|P2|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
1204839|NCT00902486|3957061|P1|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
1204840|NCT00902486|3957056|P6|Extension Period (Weeks 12 Through 24)|Disease Progression|0
1204841|NCT00902486|3957057|P5|Extension Period (Weeks 12 Through 24)|Disease Progression|0
1204842|NCT00902486|3957058|P4|Extension Period (Weeks 12 Through 24)|Disease Progression|1
1204843|NCT00902486|3957059|P3|Extension Period (Weeks 12 Through 24)|Disease Progression|0
1204844|NCT00902486|3957060|P2|Extension Period (Weeks 12 Through 24)|Disease Progression|0
1204845|NCT00902486|3957061|P1|Extension Period (Weeks 12 Through 24)|Disease Progression|0
1204846|NCT00902486|3957056|P6|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1
1204847|NCT00902486|3957057|P5|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
1204848|NCT00902486|3957058|P4|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
1204849|NCT00902486|3957059|P3|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
1204850|NCT00902486|3957060|P2|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
1204851|NCT00902486|3957061|P1|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
1204852|NCT00902486|3957056|P6|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
1204853|NCT00902486|3957057|P5|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
1204854|NCT00902486|3957058|P4|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1
1204855|NCT00902486|3957059|P3|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1
1204856|NCT00902486|3957060|P2|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
1204857|NCT00902486|3957061|P1|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
1204858|NCT00902486|3957056|P6|Extension Period (Weeks 12 Through 24)|Adverse Event|2
1204859|NCT00902486|3957057|P5|Extension Period (Weeks 12 Through 24)|Adverse Event|1
1204860|NCT00902486|3957058|P4|Extension Period (Weeks 12 Through 24)|Adverse Event|0
1204861|NCT00902486|3957059|P3|Extension Period (Weeks 12 Through 24)|Adverse Event|0
1204862|NCT00902486|3957060|P2|Extension Period (Weeks 12 Through 24)|Adverse Event|0
1204863|NCT00902486|3957061|P1|Extension Period (Weeks 12 Through 24)|Adverse Event|0
1204864|NCT00902486|3957056|P6|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
1204865|NCT00902486|3957057|P5|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
1204866|NCT00902486|3957058|P4|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1
1204867|NCT00902486|3957059|P3|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
1204868|NCT00902486|3957060|P2|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
1204869|NCT00902486|3957061|P1|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
1204870|NCT00902486|3957056|P6|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
1204871|NCT00902486|3957057|P5|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
1204872|NCT00902486|3957058|P4|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1
1204873|NCT00902486|3957059|P3|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
1204874|NCT00902486|3957060|P2|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
1204875|NCT00902486|3957061|P1|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
1204876|NCT00902486|3957056|P6|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1
1204877|NCT00902486|3957057|P5|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1
1204878|NCT00902486|3957058|P4|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
1204879|NCT00902486|3957059|P3|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
1204880|NCT00902486|3957060|P2|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
1204881|NCT00902486|3957061|P1|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
1204882|NCT00902486|3957056|P6|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2
1204883|NCT00902486|3957057|P5|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
1204884|NCT00902486|3957058|P4|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
1204885|NCT00902486|3957059|P3|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
1204886|NCT00902486|3957060|P2|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
1204887|NCT00902486|3957061|P1|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1
1204888|NCT00902486|3957056|P6|Treatment Period (Weeks 0 Through 12)|Adverse Event|2
1204889|NCT00902486|3957057|P5|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
1204890|NCT00902486|3957058|P4|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
1204891|NCT00902486|3957059|P3|Treatment Period (Weeks 0 Through 12)|Adverse Event|0
1204892|NCT00902486|3957060|P2|Treatment Period (Weeks 0 Through 12)|Adverse Event|0
1204893|NCT00902486|3957061|P1|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
1204894|NCT00902330|3957199|P2|Overall Study|No post baseline data|0
1204895|NCT00902330|3957200|P1|Overall Study|No post baseline data|1
1204896|NCT00902330|3957199|P2|Overall Study|Adverse Event|0
1204897|NCT00902330|3957200|P1|Overall Study|Adverse Event|1
1204898|NCT00902330|3957199|P2|Overall Study|Too overwhelmed by treatment|5
1204899|NCT00902330|3957200|P1|Overall Study|Too overwhelmed by treatment|2
1204900|NCT00902304|3957237|P3|Overall Study|includes pregnancy|2
1204901|NCT00902304|3957238|P2|Overall Study|includes pregnancy|9
1204902|NCT00902304|3957239|P1|Overall Study|includes pregnancy|3
1204903|NCT00902304|3957237|P3|Overall Study|Withdrawal by Subject|43
1204904|NCT00902304|3957238|P2|Overall Study|Withdrawal by Subject|22
1204905|NCT00902304|3957239|P1|Overall Study|Withdrawal by Subject|32
1204906|NCT00902304|3957237|P3|Overall Study|Protocol Violation|20
1204907|NCT00902304|3957238|P2|Overall Study|Protocol Violation|18
1204908|NCT00902304|3957239|P1|Overall Study|Protocol Violation|9
1204909|NCT00902304|3957237|P3|Overall Study|Lost to Follow-up|7
1204910|NCT00902304|3957238|P2|Overall Study|Lost to Follow-up|7
1204911|NCT00902304|3957239|P1|Overall Study|Lost to Follow-up|7
1204912|NCT00902304|3957237|P3|Overall Study|Investigator discretion|13
1204913|NCT00902304|3957238|P2|Overall Study|Investigator discretion|5
1204914|NCT00902304|3957239|P1|Overall Study|Investigator discretion|3
1204915|NCT00902304|3957237|P3|Overall Study|Adverse Event|25
1204916|NCT00902304|3957238|P2|Overall Study|Adverse Event|10
1204917|NCT00902304|3957239|P1|Overall Study|Adverse Event|4
1204918|NCT00902278|3957289|P5|Overall Study|Lost to Follow-up|1
1204919|NCT00902278|3957290|P4|Overall Study|Lost to Follow-up|0
1204920|NCT00902278|3957291|P3|Overall Study|Lost to Follow-up|3
1204921|NCT00902278|3957292|P2|Overall Study|Lost to Follow-up|2
1204922|NCT00902278|3957293|P1|Overall Study|Lost to Follow-up|3
1204923|NCT00902278|3957289|P5|Overall Study|Physician Decision|1
1204924|NCT00902278|3957290|P4|Overall Study|Physician Decision|0
1204925|NCT00902278|3957291|P3|Overall Study|Physician Decision|2
1204926|NCT00902278|3957292|P2|Overall Study|Physician Decision|0
1204927|NCT00902278|3957293|P1|Overall Study|Physician Decision|1
1204928|NCT00902265|3957310|P1|Overall Study|Protocol Violation|1
1204929|NCT00902265|3957310|P1|Overall Study|Lack of Efficacy|2
1204930|NCT00902265|3957310|P1|Overall Study|Adverse Event|2
1204931|NCT00902265|3957310|P1|Overall Study|Lost to Follow-up Prior to First Visit|1
1204932|NCT00902174|3957334|P2|Overall Study|Administration problem|1
1204933|NCT00902174|3957335|P1|Overall Study|Administration problem|0
1204934|NCT00902174|3957334|P2|Overall Study|Protocol Violation|1
1204935|NCT00902174|3957335|P1|Overall Study|Protocol Violation|1
1204936|NCT00902174|3957334|P2|Overall Study|Abnormal labs|1
1204937|NCT00902174|3957335|P1|Overall Study|Abnormal labs|1
1204938|NCT00902174|3957334|P2|Overall Study|Withdrawal by Subject|1
1204939|NCT00902174|3957335|P1|Overall Study|Withdrawal by Subject|2
1204940|NCT00902174|3957334|P2|Overall Study|Death|2
1204941|NCT00902174|3957335|P1|Overall Study|Death|2
1204942|NCT00902174|3957334|P2|Overall Study|Lack of Efficacy|5
1204943|NCT00902174|3957335|P1|Overall Study|Lack of Efficacy|1
1204944|NCT00902174|3957334|P2|Overall Study|Adverse Event|7
1204945|NCT00902174|3957335|P1|Overall Study|Adverse Event|27
1204946|NCT00901901|3957392|P2|Follow-up Period|Lost to Follow-up|8
1204947|NCT00901901|3957393|P1|Follow-up Period|Lost to Follow-up|12
1204948|NCT00901901|3957392|P2|Follow-up Period|Withdrawal by Subject|9
1204949|NCT00901901|3957393|P1|Follow-up Period|Withdrawal by Subject|6
1204950|NCT00901901|3957392|P2|Follow-up Period|Protocol driven decision point|35
1204951|NCT00901901|3957393|P1|Follow-up Period|Protocol driven decision point|47
1204952|NCT00901901|3957392|P2|Follow-up Period|Death|207
1204953|NCT00901901|3957393|P1|Follow-up Period|Death|181
1204954|NCT00901901|3957392|P2|Treatment Period|Never treated|3
1204955|NCT00901901|3957393|P1|Treatment Period|Never treated|0
1204956|NCT00901901|3957392|P2|Treatment Period|Missing|1
1204957|NCT00901901|3957393|P1|Treatment Period|Missing|1
1204958|NCT00901901|3957392|P2|Treatment Period|Protocol Violation|9
1204959|NCT00901901|3957393|P1|Treatment Period|Protocol Violation|4
1204960|NCT00901901|3957392|P2|Treatment Period|Noncompliance with study medication|1
1204961|NCT00901901|3957393|P1|Treatment Period|Noncompliance with study medication|4
1204962|NCT00901901|3957392|P2|Treatment Period|Lost to Follow-up|5
1204963|NCT00901901|3957393|P1|Treatment Period|Lost to Follow-up|3
1204964|NCT00901901|3957392|P2|Treatment Period|Physician Decision|2
1204965|NCT00901901|3957393|P1|Treatment Period|Physician Decision|2
1204966|NCT00901901|3957392|P2|Treatment Period|Withdrawal by Subject|24
1204967|NCT00901901|3957393|P1|Treatment Period|Withdrawal by Subject|26
1204968|NCT00901901|3957392|P2|Treatment Period|Adverse Event|123
1204969|NCT00901901|3957393|P1|Treatment Period|Adverse Event|117
1204970|NCT00901628|3957415|P2|Overall Study|peroneal nerve palsy|1
1204971|NCT00901628|3957416|P1|Overall Study|peroneal nerve palsy|0
1204972|NCT00901628|3957415|P2|Overall Study|disconnection of drain|1
1204973|NCT00901628|3957416|P1|Overall Study|disconnection of drain|0
1204974|NCT00901628|3957415|P2|Overall Study|disconnection of catheter|8
1204975|NCT00901628|3957416|P1|Overall Study|disconnection of catheter|4
1204976|NCT00901576|3957438|P6|Second Intervention|Physician Decision|0
1204977|NCT00901576|3957439|P5|Second Intervention|Physician Decision|0
1204978|NCT00901576|3957440|P4|Second Intervention|Physician Decision|0
1204979|NCT00901576|3957441|P3|Second Intervention|Physician Decision|0
1204980|NCT00901576|3957442|P2|Second Intervention|Physician Decision|0
1204981|NCT00901576|3957443|P1|Second Intervention|Physician Decision|1
1204982|NCT00901576|3957438|P6|Second Intervention|Withdrawal by Subject|1
1204983|NCT00901576|3957439|P5|Second Intervention|Withdrawal by Subject|0
1204984|NCT00901576|3957440|P4|Second Intervention|Withdrawal by Subject|1
1204985|NCT00901576|3957441|P3|Second Intervention|Withdrawal by Subject|0
1204986|NCT00901576|3957442|P2|Second Intervention|Withdrawal by Subject|0
1204987|NCT00901576|3957443|P1|Second Intervention|Withdrawal by Subject|0
1204988|NCT00901459|3957464|P1|Overall Study|Withdrawal by Subject|6
1204989|NCT00901342|3957475|P1|Overall Study|Withdrawal by Subject|9
1204990|NCT00901342|3957475|P1|Overall Study|Disease progression|1
1204991|NCT00901342|3957475|P1|Overall Study|Death|4
1204992|NCT00901342|3957475|P1|Overall Study|Adverse Event|1
1204993|NCT00901186|3957508|P2|Overall Study|Protocol deviations|4
1204994|NCT00901186|3957509|P1|Overall Study|Protocol deviations|5
1204995|NCT00901186|3957508|P2|Overall Study|Administration problems|1
1204996|NCT00901186|3957509|P1|Overall Study|Administration problems|0
1204997|NCT00901186|3957508|P2|Overall Study|Adverse Event|4
1204998|NCT00901186|3957509|P1|Overall Study|Adverse Event|2
1204999|NCT00901186|3957508|P2|Overall Study|Lost to Follow-up|0
1205000|NCT00901186|3957509|P1|Overall Study|Lost to Follow-up|2
1205001|NCT00901186|3957508|P2|Overall Study|Abnormal laboratory values|1
1205002|NCT00901186|3957509|P1|Overall Study|Abnormal laboratory values|0
1205003|NCT00901186|3957508|P2|Overall Study|Lack of Efficacy|1
1205004|NCT00901186|3957509|P1|Overall Study|Lack of Efficacy|0
1205005|NCT00900796|3957549|P1|Phase 2|Lost to Follow-up|5
1205006|NCT00900796|3957549|P1|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110
1205007|NCT00900796|3957549|P1|Phase 1|Missing information at Week 16|7
1205008|NCT00900796|3957549|P1|Phase 1|Lacked sufficient information|4
1205009|NCT00900757|3957559|P1|Overall Study|screen failure|19
1205010|NCT00900731|3957569|P2|Overall Study|Death|2
1205011|NCT00900731|3957570|P1|Overall Study|Death|0
1205012|NCT00900731|3957569|P2|Overall Study|Lack of Efficacy|3
1205013|NCT00900731|3957570|P1|Overall Study|Lack of Efficacy|1
1205014|NCT00900731|3957569|P2|Overall Study|Lost to Follow-up|3
1205015|NCT00900731|3957570|P1|Overall Study|Lost to Follow-up|2
1205016|NCT00900731|3957569|P2|Overall Study|Abnormal Laboratory Value(s)|4
1205017|NCT00900731|3957570|P1|Overall Study|Abnormal Laboratory Value(s)|2
1205018|NCT00900731|3957569|P2|Overall Study|Abnormal Test Procedure Result(s)|0
1205019|NCT00900731|3957570|P1|Overall Study|Abnormal Test Procedure Result(s)|3
1205020|NCT00900731|3957569|P2|Overall Study|Administrative Problems|4
1205021|NCT00900731|3957570|P1|Overall Study|Administrative Problems|5
1205022|NCT00900731|3957569|P2|Overall Study|Protocol Deviation|11
1205023|NCT00900731|3957570|P1|Overall Study|Protocol Deviation|8
1205024|NCT00900731|3957569|P2|Overall Study|Withdrawal by Subject|7
1205025|NCT00900731|3957570|P1|Overall Study|Withdrawal by Subject|8
1205026|NCT00900731|3957569|P2|Overall Study|Adverse Event|27
1205027|NCT00900731|3957570|P1|Overall Study|Adverse Event|31
1205028|NCT00900627|3957607|P6|Overall Study|Death|24
1205029|NCT00900627|3957608|P5|Overall Study|Death|28
1205030|NCT00900627|3957609|P4|Overall Study|Death|0
1205031|NCT00900627|3957610|P3|Overall Study|Death|0
1205032|NCT00900627|3957611|P2|Overall Study|Death|0
1205033|NCT00900627|3957612|P1|Overall Study|Death|0
1205034|NCT00900627|3957607|P6|Overall Study|Adverse Event|0
1205035|NCT00900627|3957608|P5|Overall Study|Adverse Event|0
1205036|NCT00900627|3957609|P4|Overall Study|Adverse Event|3
1205037|NCT00900627|3957610|P3|Overall Study|Adverse Event|0
1205038|NCT00900627|3957611|P2|Overall Study|Adverse Event|2
1205039|NCT00900627|3957612|P1|Overall Study|Adverse Event|1
1205040|NCT00900627|3957607|P6|Overall Study|Withdrawal by Subject|2
1205041|NCT00900627|3957608|P5|Overall Study|Withdrawal by Subject|1
1205042|NCT00900627|3957609|P4|Overall Study|Withdrawal by Subject|0
1205043|NCT00900627|3957610|P3|Overall Study|Withdrawal by Subject|1
1205044|NCT00900627|3957611|P2|Overall Study|Withdrawal by Subject|0
1205045|NCT00900627|3957612|P1|Overall Study|Withdrawal by Subject|1
1205046|NCT00900627|3957607|P6|Overall Study|Condition under investigation worsened|0
1205047|NCT00900627|3957608|P5|Overall Study|Condition under investigation worsened|0
1205048|NCT00900627|3957609|P4|Overall Study|Condition under investigation worsened|3
1205049|NCT00900627|3957610|P3|Overall Study|Condition under investigation worsened|5
1205050|NCT00900627|3957611|P2|Overall Study|Condition under investigation worsened|0
1205051|NCT00900627|3957612|P1|Overall Study|Condition under investigation worsened|4
1205052|NCT00900601|3957630|P1|Overall Study|Physician Decision|1
1205053|NCT00900159|3957649|P2|Second Intervention|disempanelled for inappropriate behavior|0
1205054|NCT00900159|3957650|P1|Second Intervention|disempanelled for inappropriate behavior|1
1205055|NCT00900146|3957669|P5|Intermediate: Period III|Administrative problems|163
1205056|NCT00900146|3957670|P4|Intermediate: Period III|Administrative problems|90
1205057|NCT00900146|3957671|P3|Intermediate: Period III|Administrative problems|84
1205058|NCT00900146|3957672|P2|Intermediate: Period III|Administrative problems|92
1205059|NCT00900146|3957673|P1|Intermediate: Period III|Administrative problems|85
1205060|NCT00900146|3957669|P5|Intermediate: Period III|Lost to Follow-up|1
1205061|NCT00900146|3957670|P4|Intermediate: Period III|Lost to Follow-up|0
1205062|NCT00900146|3957671|P3|Intermediate: Period III|Lost to Follow-up|0
1205063|NCT00900146|3957672|P2|Intermediate: Period III|Lost to Follow-up|0
1205064|NCT00900146|3957673|P1|Intermediate: Period III|Lost to Follow-up|2
1205065|NCT00900146|3957669|P5|Intermediate: Period III|Withdrawal by Subject|3
1205066|NCT00900146|3957670|P4|Intermediate: Period III|Withdrawal by Subject|0
1205067|NCT00900146|3957671|P3|Intermediate: Period III|Withdrawal by Subject|0
1205068|NCT00900146|3957672|P2|Intermediate: Period III|Withdrawal by Subject|1
1205069|NCT00900146|3957673|P1|Intermediate: Period III|Withdrawal by Subject|0
1205070|NCT00900146|3957669|P5|Dose Finding: Period II (4 Months)|Administrative problems|0
1205071|NCT00900146|3957670|P4|Dose Finding: Period II (4 Months)|Administrative problems|0
1205072|NCT00900146|3957671|P3|Dose Finding: Period II (4 Months)|Administrative problems|0
1205073|NCT00900146|3957672|P2|Dose Finding: Period II (4 Months)|Administrative problems|0
1205074|NCT00900146|3957673|P1|Dose Finding: Period II (4 Months)|Administrative problems|1
1205075|NCT00900146|3957669|P5|Dose Finding: Period II (4 Months)|Lost to Follow-up|3
1205076|NCT00900146|3957670|P4|Dose Finding: Period II (4 Months)|Lost to Follow-up|1
1205077|NCT00900146|3957671|P3|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
1205078|NCT00900146|3957672|P2|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
1205079|NCT00900146|3957673|P1|Dose Finding: Period II (4 Months)|Lost to Follow-up|2
1205080|NCT00900146|3957669|P5|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9
1205081|NCT00900146|3957670|P4|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1
1205082|NCT00900146|3957671|P3|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5
1205083|NCT00900146|3957672|P2|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
1205084|NCT00900146|3957673|P1|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
1205085|NCT00900029|3957790|P5|Overall Study|Death|0
1205086|NCT00900029|3957791|P4|Overall Study|Death|1
1205087|NCT00900029|3957792|P3|Overall Study|Death|0
1205088|NCT00900029|3957793|P2|Overall Study|Death|0
1205089|NCT00900029|3957794|P1|Overall Study|Death|1
1205090|NCT00900029|3957790|P5|Overall Study|Adverse Event|1
1205091|NCT00900029|3957791|P4|Overall Study|Adverse Event|1
1205092|NCT00900029|3957792|P3|Overall Study|Adverse Event|1
1205093|NCT00900029|3957793|P2|Overall Study|Adverse Event|0
1205094|NCT00900029|3957794|P1|Overall Study|Adverse Event|0
1205095|NCT00900029|3957790|P5|Overall Study|Withdrawal by Subject|1
1205096|NCT00900029|3957791|P4|Overall Study|Withdrawal by Subject|1
1205097|NCT00900029|3957792|P3|Overall Study|Withdrawal by Subject|1
1205098|NCT00900029|3957793|P2|Overall Study|Withdrawal by Subject|2
1205099|NCT00900029|3957794|P1|Overall Study|Withdrawal by Subject|2
1205100|NCT00900029|3957790|P5|Overall Study|Lost to Follow-up|4
1205101|NCT00900029|3957791|P4|Overall Study|Lost to Follow-up|4
1205102|NCT00900029|3957792|P3|Overall Study|Lost to Follow-up|1
1205103|NCT00900029|3957793|P2|Overall Study|Lost to Follow-up|2
1205104|NCT00900029|3957794|P1|Overall Study|Lost to Follow-up|0
1205105|NCT00899847|3957811|P1|Overall Study|Lack of suitable allogeneic donor|2
1205106|NCT00899678|3957842|P3|Maintenance Period (Weeks 8 to 62)|Other reason|2
1205107|NCT00899678|3957843|P2|Maintenance Period (Weeks 8 to 62)|Other reason|2
1205108|NCT00899678|3957844|P1|Maintenance Period (Weeks 8 to 62)|Other reason|0
1205109|NCT00899678|3957842|P3|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2
1205110|NCT00899678|3957843|P2|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1
1205111|NCT00899678|3957844|P1|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0
1205112|NCT00899678|3957842|P3|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
1205113|NCT00899678|3957843|P2|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
1205114|NCT00899678|3957844|P1|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0
1205115|NCT00899678|3957842|P3|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18
1205116|NCT00899678|3957843|P2|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11
1205117|NCT00899678|3957844|P1|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0
1205118|NCT00899678|3957842|P3|Maintenance Period (Weeks 8 to 62)|Adverse Event|5
1205119|NCT00899678|3957843|P2|Maintenance Period (Weeks 8 to 62)|Adverse Event|10
1205120|NCT00899678|3957844|P1|Maintenance Period (Weeks 8 to 62)|Adverse Event|0
1205121|NCT00899678|3957842|P3|Induction Period (Weeks 0 to 6)|Other reason|0
1205122|NCT00899678|3957843|P2|Induction Period (Weeks 0 to 6)|Other reason|0
1205123|NCT00899678|3957844|P1|Induction Period (Weeks 0 to 6)|Other reason|1
1205124|NCT00899678|3957842|P3|Induction Period (Weeks 0 to 6)|Protocol Violation|0
1205125|NCT00899678|3957843|P2|Induction Period (Weeks 0 to 6)|Protocol Violation|0
1205126|NCT00899678|3957844|P1|Induction Period (Weeks 0 to 6)|Protocol Violation|1
1205127|NCT00899678|3957842|P3|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
1205128|NCT00899678|3957843|P2|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
1205129|NCT00899678|3957844|P1|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17
1205130|NCT00899678|3957842|P3|Induction Period (Weeks 0 to 6)|Adverse Event|0
1205131|NCT00899678|3957843|P2|Induction Period (Weeks 0 to 6)|Adverse Event|0
1205132|NCT00899678|3957844|P1|Induction Period (Weeks 0 to 6)|Adverse Event|6
1205133|NCT00899392|3957975|P2|Overall Study|Subject didn't finish/partial pilot data|24
1205134|NCT00899392|3957976|P1|Overall Study|Subject didn't finish/partial pilot data|21
1205135|NCT00899379|3957993|P5|Overall Study|Inc/Exc Criteria Not Met|0
1205136|NCT00899379|3957994|P4|Overall Study|Inc/Exc Criteria Not Met|0
1205137|NCT00899379|3957995|P3|Overall Study|Inc/Exc Criteria Not Met|1
1205138|NCT00899379|3957996|P2|Overall Study|Inc/Exc Criteria Not Met|0
1205139|NCT00899379|3957997|P1|Overall Study|Inc/Exc Criteria Not Met|0
1205140|NCT00899379|3957993|P5|Overall Study|No Longer Met Inc/Exc Criteria|0
1205141|NCT00899379|3957994|P4|Overall Study|No Longer Met Inc/Exc Criteria|0
1205142|NCT00899379|3957995|P3|Overall Study|No Longer Met Inc/Exc Criteria|0
1205143|NCT00899379|3957996|P2|Overall Study|No Longer Met Inc/Exc Criteria|0
1205144|NCT00899379|3957997|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
1205145|NCT00899379|3957993|P5|Overall Study|No Attack Pretreatment|4
1205146|NCT00899379|3957994|P4|Overall Study|No Attack Pretreatment|6
1205147|NCT00899379|3957995|P3|Overall Study|No Attack Pretreatment|5
1205148|NCT00899379|3957996|P2|Overall Study|No Attack Pretreatment|5
1205149|NCT00899379|3957997|P1|Overall Study|No Attack Pretreatment|3
1205150|NCT00899379|3957993|P5|Overall Study|Abnormal Baseline ECG|0
1205151|NCT00899379|3957994|P4|Overall Study|Abnormal Baseline ECG|1
1205152|NCT00899379|3957995|P3|Overall Study|Abnormal Baseline ECG|1
1205153|NCT00899379|3957996|P2|Overall Study|Abnormal Baseline ECG|0
1205154|NCT00899379|3957997|P1|Overall Study|Abnormal Baseline ECG|0
1205155|NCT00899379|3957993|P5|Overall Study|Abnormal Prestudy Labs|2
1205156|NCT00899379|3957994|P4|Overall Study|Abnormal Prestudy Labs|0
1205157|NCT00899379|3957995|P3|Overall Study|Abnormal Prestudy Labs|0
1205158|NCT00899379|3957996|P2|Overall Study|Abnormal Prestudy Labs|0
1205159|NCT00899379|3957997|P1|Overall Study|Abnormal Prestudy Labs|0
1205160|NCT00899379|3957993|P5|Overall Study|Patient Uncooperative|0
1205161|NCT00899379|3957994|P4|Overall Study|Patient Uncooperative|1
1205162|NCT00899379|3957995|P3|Overall Study|Patient Uncooperative|0
1205163|NCT00899379|3957996|P2|Overall Study|Patient Uncooperative|0
1205164|NCT00899379|3957997|P1|Overall Study|Patient Uncooperative|0
1205165|NCT00899379|3957993|P5|Overall Study|Pregnancy|0
1205166|NCT00899379|3957994|P4|Overall Study|Pregnancy|0
1205167|NCT00899379|3957995|P3|Overall Study|Pregnancy|0
1205168|NCT00899379|3957996|P2|Overall Study|Pregnancy|0
1205169|NCT00899379|3957997|P1|Overall Study|Pregnancy|1
1205170|NCT00899379|3957993|P5|Overall Study|Withdrawal by Subject|2
1205171|NCT00899379|3957994|P4|Overall Study|Withdrawal by Subject|7
1205172|NCT00899379|3957995|P3|Overall Study|Withdrawal by Subject|4
1205173|NCT00899379|3957996|P2|Overall Study|Withdrawal by Subject|7
1205174|NCT00899379|3957997|P1|Overall Study|Withdrawal by Subject|4
1205175|NCT00899379|3957993|P5|Overall Study|Lost to Follow-up|5
1205176|NCT00899379|3957994|P4|Overall Study|Lost to Follow-up|2
1205177|NCT00899379|3957995|P3|Overall Study|Lost to Follow-up|0
1205178|NCT00899379|3957996|P2|Overall Study|Lost to Follow-up|1
1205179|NCT00899379|3957997|P1|Overall Study|Lost to Follow-up|3
1205180|NCT00899379|3957993|P5|Overall Study|Study Terminated|1
1205181|NCT00899379|3957994|P4|Overall Study|Study Terminated|3
1205182|NCT00899379|3957995|P3|Overall Study|Study Terminated|3
1205183|NCT00899379|3957996|P2|Overall Study|Study Terminated|0
1205184|NCT00899379|3957997|P1|Overall Study|Study Terminated|3
1205185|NCT00899379|3957993|P5|Overall Study|Not Completed/Entered Extn|3
1205186|NCT00899379|3957994|P4|Overall Study|Not Completed/Entered Extn|4
1205187|NCT00899379|3957995|P3|Overall Study|Not Completed/Entered Extn|6
1205188|NCT00899379|3957996|P2|Overall Study|Not Completed/Entered Extn|1
1205189|NCT00899379|3957997|P1|Overall Study|Not Completed/Entered Extn|5
1205190|NCT00899379|3957993|P5|Overall Study|No Longer Met Inc/Exc Criteria|0
1205191|NCT00899379|3957994|P4|Overall Study|No Longer Met Inc/Exc Criteria|0
1205192|NCT00899379|3957995|P3|Overall Study|No Longer Met Inc/Exc Criteria|1
1205193|NCT00899379|3957996|P2|Overall Study|No Longer Met Inc/Exc Criteria|1
1205194|NCT00899379|3957997|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
1205195|NCT00899379|3957993|P5|Overall Study|Abnormal Baseline ECG|0
1205196|NCT00899379|3957994|P4|Overall Study|Abnormal Baseline ECG|1
1205197|NCT00899379|3957995|P3|Overall Study|Abnormal Baseline ECG|0
1205198|NCT00899379|3957996|P2|Overall Study|Abnormal Baseline ECG|0
1205199|NCT00899379|3957997|P1|Overall Study|Abnormal Baseline ECG|0
1205200|NCT00899379|3957993|P5|Overall Study|Patient Uncooperative|2
1205201|NCT00899379|3957994|P4|Overall Study|Patient Uncooperative|1
1205202|NCT00899379|3957995|P3|Overall Study|Patient Uncooperative|0
1205203|NCT00899379|3957996|P2|Overall Study|Patient Uncooperative|1
1205204|NCT00899379|3957997|P1|Overall Study|Patient Uncooperative|0
1205205|NCT00899379|3957993|P5|Overall Study|Pregnancy|1
1205206|NCT00899379|3957994|P4|Overall Study|Pregnancy|0
1205207|NCT00899379|3957995|P3|Overall Study|Pregnancy|1
1205208|NCT00899379|3957996|P2|Overall Study|Pregnancy|0
1205209|NCT00899379|3957997|P1|Overall Study|Pregnancy|0
1205210|NCT00899379|3957993|P5|Overall Study|Withdrawal by Subject|6
1205211|NCT00899379|3957994|P4|Overall Study|Withdrawal by Subject|3
1205212|NCT00899379|3957995|P3|Overall Study|Withdrawal by Subject|2
1205213|NCT00899379|3957996|P2|Overall Study|Withdrawal by Subject|4
1205214|NCT00899379|3957997|P1|Overall Study|Withdrawal by Subject|2
1205215|NCT00899379|3957993|P5|Overall Study|Protocol Violation|0
1205216|NCT00899379|3957994|P4|Overall Study|Protocol Violation|1
1205217|NCT00899379|3957995|P3|Overall Study|Protocol Violation|1
1205218|NCT00899379|3957996|P2|Overall Study|Protocol Violation|0
1205219|NCT00899379|3957997|P1|Overall Study|Protocol Violation|0
1205220|NCT00899379|3957993|P5|Overall Study|Lost to Follow-up|2
1205221|NCT00899379|3957994|P4|Overall Study|Lost to Follow-up|6
1205222|NCT00899379|3957995|P3|Overall Study|Lost to Follow-up|0
1205223|NCT00899379|3957996|P2|Overall Study|Lost to Follow-up|3
1205224|NCT00899379|3957997|P1|Overall Study|Lost to Follow-up|9
1205225|NCT00899379|3957993|P5|Overall Study|Lack of Efficacy|1
1205226|NCT00899379|3957994|P4|Overall Study|Lack of Efficacy|0
1205227|NCT00899379|3957995|P3|Overall Study|Lack of Efficacy|3
1205228|NCT00899379|3957996|P2|Overall Study|Lack of Efficacy|4
1205229|NCT00899379|3957997|P1|Overall Study|Lack of Efficacy|0
1205230|NCT00899379|3957993|P5|Overall Study|Adverse Event|2
1205231|NCT00899379|3957994|P4|Overall Study|Adverse Event|1
1205232|NCT00899379|3957995|P3|Overall Study|Adverse Event|1
1205233|NCT00899379|3957996|P2|Overall Study|Adverse Event|2
1205234|NCT00899379|3957997|P1|Overall Study|Adverse Event|2
1205235|NCT00899353|3958009|P1|Overall Study|Withdrawal by Subject|2
1205236|NCT00899353|3958009|P1|Overall Study|Lost to Follow-up|1
1205237|NCT00899353|3958009|P1|Overall Study|Adverse Event|2
1205238|NCT00898807|3958045|P2|Overall Study|Death|1
1205239|NCT00898807|3958046|P1|Overall Study|Death|0
1205240|NCT00898807|3958045|P2|Overall Study|Lost to Follow-up|3
1205241|NCT00898807|3958046|P1|Overall Study|Lost to Follow-up|1
1205242|NCT00898807|3958045|P2|Overall Study|Family pressure to discontinue|2
1205243|NCT00898807|3958046|P1|Overall Study|Family pressure to discontinue|2
1205244|NCT00898807|3958045|P2|Overall Study|Withdrawal by Subject|3
1205245|NCT00898807|3958046|P1|Overall Study|Withdrawal by Subject|5
1205246|NCT00898677|3958062|P4|Overall Study|Not Treated: Other (Not Specified)|0
1205247|NCT00898677|3958063|P3|Overall Study|Not Treated: Other (Not Specified)|2
1205248|NCT00898677|3958064|P2|Overall Study|Not Treated: Other (Not Specified)|0
1205249|NCT00898677|3958065|P1|Overall Study|Not Treated: Other (Not Specified)|0
1205250|NCT00898677|3958062|P4|Overall Study|Not Treated: Lack of Migraine Attack|12
1205251|NCT00898677|3958063|P3|Overall Study|Not Treated: Lack of Migraine Attack|43
1205252|NCT00898677|3958064|P2|Overall Study|Not Treated: Lack of Migraine Attack|39
1205253|NCT00898677|3958065|P1|Overall Study|Not Treated: Lack of Migraine Attack|9
1205254|NCT00898677|3958062|P4|Overall Study|Not Treated: No Longer Met Inc Criteria|0
1205255|NCT00898677|3958063|P3|Overall Study|Not Treated: No Longer Met Inc Criteria|1
1205256|NCT00898677|3958064|P2|Overall Study|Not Treated: No Longer Met Inc Criteria|3
1205257|NCT00898677|3958065|P1|Overall Study|Not Treated: No Longer Met Inc Criteria|0
1205258|NCT00898677|3958062|P4|Overall Study|Not Treated: Abnormal Baseline ECG|0
1205259|NCT00898677|3958063|P3|Overall Study|Not Treated: Abnormal Baseline ECG|0
1205260|NCT00898677|3958064|P2|Overall Study|Not Treated: Abnormal Baseline ECG|0
1205261|NCT00898677|3958065|P1|Overall Study|Not Treated: Abnormal Baseline ECG|1
1205262|NCT00898677|3958062|P4|Overall Study|Not Treated: Abnormal Prestudy Labs|1
1205263|NCT00898677|3958063|P3|Overall Study|Not Treated: Abnormal Prestudy Labs|0
1205264|NCT00898677|3958064|P2|Overall Study|Not Treated: Abnormal Prestudy Labs|0
1205265|NCT00898677|3958065|P1|Overall Study|Not Treated: Abnormal Prestudy Labs|0
1205266|NCT00898677|3958062|P4|Overall Study|Not Treated: Patient uncooperative|0
1205267|NCT00898677|3958063|P3|Overall Study|Not Treated: Patient uncooperative|1
1205268|NCT00898677|3958064|P2|Overall Study|Not Treated: Patient uncooperative|3
1205269|NCT00898677|3958065|P1|Overall Study|Not Treated: Patient uncooperative|2
1205270|NCT00898677|3958062|P4|Overall Study|Not Treated: Withdraw by Subject|3
1205271|NCT00898677|3958063|P3|Overall Study|Not Treated: Withdraw by Subject|11
1205272|NCT00898677|3958064|P2|Overall Study|Not Treated: Withdraw by Subject|16
1205273|NCT00898677|3958065|P1|Overall Study|Not Treated: Withdraw by Subject|2
1205274|NCT00898677|3958062|P4|Overall Study|Not Treated: Protocol Violation|0
1205275|NCT00898677|3958063|P3|Overall Study|Not Treated: Protocol Violation|2
1205276|NCT00898677|3958064|P2|Overall Study|Not Treated: Protocol Violation|0
1205277|NCT00898677|3958065|P1|Overall Study|Not Treated: Protocol Violation|2
1205278|NCT00898677|3958062|P4|Overall Study|Not Treated: Pregnancy|0
1205279|NCT00898677|3958063|P3|Overall Study|Not Treated: Pregnancy|1
1205280|NCT00898677|3958064|P2|Overall Study|Not Treated: Pregnancy|0
1205281|NCT00898677|3958065|P1|Overall Study|Not Treated: Pregnancy|0
1205282|NCT00898677|3958062|P4|Overall Study|Not Treated: Lost to Follow-Up|2
1205283|NCT00898677|3958063|P3|Overall Study|Not Treated: Lost to Follow-Up|5
1205284|NCT00898677|3958064|P2|Overall Study|Not Treated: Lost to Follow-Up|5
1205285|NCT00898677|3958065|P1|Overall Study|Not Treated: Lost to Follow-Up|0
1205286|NCT00898677|3958062|P4|Overall Study|Not Treated: Adverse Event|0
1205287|NCT00898677|3958063|P3|Overall Study|Not Treated: Adverse Event|1
1205288|NCT00898677|3958064|P2|Overall Study|Not Treated: Adverse Event|2
1205289|NCT00898677|3958065|P1|Overall Study|Not Treated: Adverse Event|0
1205290|NCT00898677|3958062|P4|Overall Study|Withdrawal by Subject|1
1205291|NCT00898677|3958063|P3|Overall Study|Withdrawal by Subject|0
1205292|NCT00898677|3958064|P2|Overall Study|Withdrawal by Subject|0
1205293|NCT00898677|3958065|P1|Overall Study|Withdrawal by Subject|0
1205294|NCT00898677|3958062|P4|Overall Study|Protocol Violation|0
1205295|NCT00898677|3958063|P3|Overall Study|Protocol Violation|2
1205296|NCT00898677|3958064|P2|Overall Study|Protocol Violation|1
1205297|NCT00898677|3958065|P1|Overall Study|Protocol Violation|1
1205298|NCT00898677|3958062|P4|Overall Study|Lost to Follow-up|0
1205299|NCT00898677|3958063|P3|Overall Study|Lost to Follow-up|2
1205300|NCT00898677|3958064|P2|Overall Study|Lost to Follow-up|0
1205301|NCT00898677|3958065|P1|Overall Study|Lost to Follow-up|0
1205302|NCT00898677|3958062|P4|Overall Study|Adverse Event|0
1205303|NCT00898677|3958063|P3|Overall Study|Adverse Event|1
1205304|NCT00898677|3958064|P2|Overall Study|Adverse Event|0
1205305|NCT00898677|3958065|P1|Overall Study|Adverse Event|0
1205306|NCT00898443|3958103|P2|Overall Study|Withdrawal by Subject|0
1205307|NCT00898443|3958104|P1|Overall Study|Withdrawal by Subject|1
1205308|NCT00897949|3958119|P3|Overall Study|Did not take study drug|4
1205309|NCT00897949|3958120|P2|Overall Study|Did not take study drug|3
1205310|NCT00897949|3958121|P1|Overall Study|Did not take study drug|9
1205311|NCT00897949|3958119|P3|Overall Study|Lack of Migraine Attack|19
1205312|NCT00897949|3958120|P2|Overall Study|Lack of Migraine Attack|30
1205313|NCT00897949|3958121|P1|Overall Study|Lack of Migraine Attack|29
1205314|NCT00897949|3958119|P3|Overall Study|Need for Concom. Med.|1
1205315|NCT00897949|3958120|P2|Overall Study|Need for Concom. Med.|1
1205316|NCT00897949|3958121|P1|Overall Study|Need for Concom. Med.|0
1205317|NCT00897949|3958119|P3|Overall Study|Abnormal Baseline ECG|4
1205318|NCT00897949|3958120|P2|Overall Study|Abnormal Baseline ECG|2
1205319|NCT00897949|3958121|P1|Overall Study|Abnormal Baseline ECG|2
1205320|NCT00897949|3958119|P3|Overall Study|Abnormal Prestudy Labs|4
1205321|NCT00897949|3958120|P2|Overall Study|Abnormal Prestudy Labs|3
1205322|NCT00897949|3958121|P1|Overall Study|Abnormal Prestudy Labs|2
1205323|NCT00897949|3958119|P3|Overall Study|Withdrawal by Subject|17
1205324|NCT00897949|3958120|P2|Overall Study|Withdrawal by Subject|31
1205325|NCT00897949|3958121|P1|Overall Study|Withdrawal by Subject|24
1205326|NCT00897949|3958119|P3|Overall Study|Lost to Follow-up|17
1205327|NCT00897949|3958120|P2|Overall Study|Lost to Follow-up|23
1205328|NCT00897949|3958121|P1|Overall Study|Lost to Follow-up|30
1205329|NCT00897949|3958119|P3|Overall Study|Patient Uncoorperative|1
1205330|NCT00897949|3958120|P2|Overall Study|Patient Uncoorperative|2
1205331|NCT00897949|3958121|P1|Overall Study|Patient Uncoorperative|0
1205332|NCT00897949|3958119|P3|Overall Study|Withdrawal by Subject|0
1205333|NCT00897949|3958120|P2|Overall Study|Withdrawal by Subject|2
1205334|NCT00897949|3958121|P1|Overall Study|Withdrawal by Subject|1
1205335|NCT00897949|3958119|P3|Overall Study|Protocol Violation|1
1205336|NCT00897949|3958120|P2|Overall Study|Protocol Violation|3
1205337|NCT00897949|3958121|P1|Overall Study|Protocol Violation|6
1205338|NCT00897949|3958119|P3|Overall Study|Lost to Follow-up|1
1205339|NCT00897949|3958120|P2|Overall Study|Lost to Follow-up|2
1205340|NCT00897949|3958121|P1|Overall Study|Lost to Follow-up|0
1205341|NCT00897949|3958119|P3|Overall Study|Adverse Event|0
1205342|NCT00897949|3958120|P2|Overall Study|Adverse Event|1
1205343|NCT00897949|3958121|P1|Overall Study|Adverse Event|1
1205344|NCT00897715|3958155|P2|Overall Study|increased risk of infection|0
1205345|NCT00897715|3958156|P1|Overall Study|increased risk of infection|1
1205346|NCT00897715|3958155|P2|Overall Study|Physician Decision|0
1205347|NCT00897715|3958156|P1|Overall Study|Physician Decision|1
1205348|NCT00897715|3958155|P2|Overall Study|Lost to Follow-up|1
1205349|NCT00897715|3958156|P1|Overall Study|Lost to Follow-up|0
1205350|NCT00897390|3958181|P1|Overall Study|Did not Return for the Clinic Visit|2
1205351|NCT00897390|3958181|P1|Overall Study|Personal Reasons|1
1205352|NCT00897390|3958181|P1|Overall Study|No Longer Met Study Criteria|1
1205353|NCT00897390|3958181|P1|Overall Study|Adverse Event|2
1205354|NCT00897104|3958271|P3|Overall Study|Withdrawal by Subject|1
1205355|NCT00897104|3958272|P2|Overall Study|Withdrawal by Subject|0
1205356|NCT00897104|3958273|P1|Overall Study|Withdrawal by Subject|0
1205357|NCT00897104|3958271|P3|Overall Study|Protocol Violation|0
1205358|NCT00897104|3958272|P2|Overall Study|Protocol Violation|0
1205359|NCT00897104|3958273|P1|Overall Study|Protocol Violation|1
1205360|NCT00897104|3958271|P3|Overall Study|Not Specified|0
1205361|NCT00897104|3958272|P2|Overall Study|Not Specified|0
1205362|NCT00897104|3958273|P1|Overall Study|Not Specified|3
1205363|NCT00897104|3958271|P3|Overall Study|No Longer Met Inc/Exc Criteria|0
1205364|NCT00897104|3958272|P2|Overall Study|No Longer Met Inc/Exc Criteria|0
1205365|NCT00897104|3958273|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
1205366|NCT00897104|3958271|P3|Overall Study|Lack of Migraine Attack|1
1205367|NCT00897104|3958272|P2|Overall Study|Lack of Migraine Attack|22
1205368|NCT00897104|3958273|P1|Overall Study|Lack of Migraine Attack|20
1205369|NCT00897104|3958271|P3|Overall Study|Need for Concom. Med.|1
1205370|NCT00897104|3958272|P2|Overall Study|Need for Concom. Med.|1
1205371|NCT00897104|3958273|P1|Overall Study|Need for Concom. Med.|0
1205372|NCT00897104|3958271|P3|Overall Study|Abnormal Baseline ECG|0
1205373|NCT00897104|3958272|P2|Overall Study|Abnormal Baseline ECG|2
1205374|NCT00897104|3958273|P1|Overall Study|Abnormal Baseline ECG|2
1205375|NCT00897104|3958271|P3|Overall Study|Abnormal Prestudy Labs|0
1205376|NCT00897104|3958272|P2|Overall Study|Abnormal Prestudy Labs|0
1205377|NCT00897104|3958273|P1|Overall Study|Abnormal Prestudy Labs|2
1205378|NCT00897104|3958271|P3|Overall Study|Withdrawal by Subject|3
1205379|NCT00897104|3958272|P2|Overall Study|Withdrawal by Subject|27
1205380|NCT00897104|3958273|P1|Overall Study|Withdrawal by Subject|23
1205381|NCT00897104|3958271|P3|Overall Study|Protocol Violation|0
1205382|NCT00897104|3958272|P2|Overall Study|Protocol Violation|1
1205383|NCT00897104|3958273|P1|Overall Study|Protocol Violation|0
1205384|NCT00897104|3958271|P3|Overall Study|Pregnancy|0
1205385|NCT00897104|3958272|P2|Overall Study|Pregnancy|1
1205386|NCT00897104|3958273|P1|Overall Study|Pregnancy|0
1205387|NCT00897104|3958271|P3|Overall Study|Lost to Follow-up|2
1205388|NCT00897104|3958272|P2|Overall Study|Lost to Follow-up|17
1205389|NCT00897104|3958273|P1|Overall Study|Lost to Follow-up|12
1205390|NCT00896649|3958308|P1|Overall Study|technical difficulties|2
1205391|NCT00896649|3958308|P1|Overall Study|missing documentation|1
1205392|NCT00896649|3958308|P1|Overall Study|Pregnancy|1
1205393|NCT00896649|3958308|P1|Overall Study|Physician Decision|1
1205394|NCT00896532|3958321|P23|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1205395|NCT00896532|3958322|P22|Months 48-72: Follow-on Phase|Withdrawal by Subject|1
1205396|NCT00896532|3958323|P21|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1205397|NCT00896532|3958324|P20|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1205398|NCT00896532|3958325|P19|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1205399|NCT00896532|3958326|P18|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1205400|NCT00896532|3958327|P17|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1205401|NCT00896532|3958328|P16|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1205402|NCT00896532|3958329|P15|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1205403|NCT00896532|3958330|P14|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1205404|NCT00896532|3958331|P13|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1205405|NCT00896532|3958332|P12|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1205406|NCT00896532|3958333|P11|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1205407|NCT00896532|3958334|P10|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1205408|NCT00896532|3958335|P9|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1205409|NCT00896532|3958336|P8|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1205410|NCT00896532|3958337|P7|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1205411|NCT00896532|3958338|P6|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1205412|NCT00896532|3958339|P5|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1205413|NCT00896532|3958340|P4|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1205414|NCT00896532|3958341|P3|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1205415|NCT00896532|3958342|P2|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1205416|NCT00896532|3958343|P1|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1205417|NCT00896532|3958321|P23|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1205418|NCT00896532|3958322|P22|Months 48-72: Follow-on Phase|Ineligibility Determined|1
1205419|NCT00896532|3958323|P21|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1205420|NCT00896532|3958324|P20|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1205421|NCT00896532|3958325|P19|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1205422|NCT00896532|3958326|P18|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1205423|NCT00896532|3958327|P17|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1205424|NCT00896532|3958328|P16|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1205425|NCT00896532|3958329|P15|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1205426|NCT00896532|3958330|P14|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1205427|NCT00896532|3958331|P13|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1205428|NCT00896532|3958332|P12|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1205429|NCT00896532|3958333|P11|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1205430|NCT00896532|3958334|P10|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1205431|NCT00896532|3958335|P9|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1205432|NCT00896532|3958336|P8|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1205433|NCT00896532|3958337|P7|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1205434|NCT00896532|3958338|P6|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1205435|NCT00896532|3958339|P5|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1205436|NCT00896532|3958340|P4|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1205437|NCT00896532|3958341|P3|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1205438|NCT00896532|3958342|P2|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1205439|NCT00896532|3958343|P1|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1205440|NCT00896532|3958321|P23|Months 48-72: Follow-on Phase|Death|0
1205441|NCT00896532|3958322|P22|Months 48-72: Follow-on Phase|Death|0
1205442|NCT00896532|3958323|P21|Months 48-72: Follow-on Phase|Death|0
1205443|NCT00896532|3958324|P20|Months 48-72: Follow-on Phase|Death|0
1205444|NCT00896532|3958325|P19|Months 48-72: Follow-on Phase|Death|1
1205445|NCT00896532|3958326|P18|Months 48-72: Follow-on Phase|Death|0
1205446|NCT00896532|3958327|P17|Months 48-72: Follow-on Phase|Death|0
1205447|NCT00896532|3958328|P16|Months 48-72: Follow-on Phase|Death|0
1205448|NCT00896532|3958329|P15|Months 48-72: Follow-on Phase|Death|0
1205449|NCT00896532|3958330|P14|Months 48-72: Follow-on Phase|Death|0
1205450|NCT00896532|3958331|P13|Months 48-72: Follow-on Phase|Death|0
1205451|NCT00896532|3958332|P12|Months 48-72: Follow-on Phase|Death|0
1205452|NCT00896532|3958333|P11|Months 48-72: Follow-on Phase|Death|0
1205453|NCT00896532|3958334|P10|Months 48-72: Follow-on Phase|Death|0
1205454|NCT00896532|3958335|P9|Months 48-72: Follow-on Phase|Death|0
1205455|NCT00896532|3958336|P8|Months 48-72: Follow-on Phase|Death|0
1205456|NCT00896532|3958337|P7|Months 48-72: Follow-on Phase|Death|0
1205457|NCT00896532|3958338|P6|Months 48-72: Follow-on Phase|Death|0
1205458|NCT00896532|3958339|P5|Months 48-72: Follow-on Phase|Death|0
1205459|NCT00896532|3958340|P4|Months 48-72: Follow-on Phase|Death|0
1205460|NCT00896532|3958341|P3|Months 48-72: Follow-on Phase|Death|0
1205461|NCT00896532|3958342|P2|Months 48-72: Follow-on Phase|Death|0
1205462|NCT00896532|3958343|P1|Months 48-72: Follow-on Phase|Death|0
1205463|NCT00896532|3958321|P23|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1205464|NCT00896532|3958322|P22|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1205465|NCT00896532|3958323|P21|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1205466|NCT00896532|3958324|P20|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1205467|NCT00896532|3958325|P19|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1205468|NCT00896532|3958326|P18|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1205469|NCT00896532|3958327|P17|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1
1205470|NCT00896532|3958328|P16|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1205471|NCT00896532|3958329|P15|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1205472|NCT00896532|3958330|P14|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1205473|NCT00896532|3958331|P13|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1205474|NCT00896532|3958332|P12|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1205475|NCT00896532|3958333|P11|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1205476|NCT00896532|3958334|P10|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1205477|NCT00896532|3958335|P9|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1205478|NCT00896532|3958336|P8|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1205479|NCT00896532|3958337|P7|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1205480|NCT00896532|3958338|P6|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1205481|NCT00896532|3958339|P5|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1205482|NCT00896532|3958340|P4|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1205483|NCT00896532|3958341|P3|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1205484|NCT00896532|3958342|P2|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1205485|NCT00896532|3958343|P1|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1205486|NCT00896532|3958321|P23|Months 36-48: Romosozumab Retreatment|Other|0
1205487|NCT00896532|3958322|P22|Months 36-48: Romosozumab Retreatment|Other|0
1205488|NCT00896532|3958323|P21|Months 36-48: Romosozumab Retreatment|Other|0
1205489|NCT00896532|3958324|P20|Months 36-48: Romosozumab Retreatment|Other|0
1205490|NCT00896532|3958325|P19|Months 36-48: Romosozumab Retreatment|Other|0
1205491|NCT00896532|3958326|P18|Months 36-48: Romosozumab Retreatment|Other|1
1205492|NCT00896532|3958327|P17|Months 36-48: Romosozumab Retreatment|Other|0
1205493|NCT00896532|3958328|P16|Months 36-48: Romosozumab Retreatment|Other|0
1205494|NCT00896532|3958329|P15|Months 36-48: Romosozumab Retreatment|Other|0
1205495|NCT00896532|3958330|P14|Months 36-48: Romosozumab Retreatment|Other|0
1205496|NCT00896532|3958331|P13|Months 36-48: Romosozumab Retreatment|Other|0
1205497|NCT00896532|3958332|P12|Months 36-48: Romosozumab Retreatment|Other|0
1205498|NCT00896532|3958333|P11|Months 36-48: Romosozumab Retreatment|Other|0
1205499|NCT00896532|3958334|P10|Months 36-48: Romosozumab Retreatment|Other|0
1205500|NCT00896532|3958335|P9|Months 36-48: Romosozumab Retreatment|Other|0
1205501|NCT00896532|3958336|P8|Months 36-48: Romosozumab Retreatment|Other|0
1205502|NCT00896532|3958337|P7|Months 36-48: Romosozumab Retreatment|Other|0
1205503|NCT00896532|3958338|P6|Months 36-48: Romosozumab Retreatment|Other|0
1205504|NCT00896532|3958339|P5|Months 36-48: Romosozumab Retreatment|Other|0
1205505|NCT00896532|3958340|P4|Months 36-48: Romosozumab Retreatment|Other|0
1205506|NCT00896532|3958341|P3|Months 36-48: Romosozumab Retreatment|Other|0
1205507|NCT00896532|3958342|P2|Months 36-48: Romosozumab Retreatment|Other|0
1205508|NCT00896532|3958343|P1|Months 36-48: Romosozumab Retreatment|Other|0
1205509|NCT00896532|3958321|P23|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1205510|NCT00896532|3958322|P22|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1205511|NCT00896532|3958323|P21|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1205512|NCT00896532|3958324|P20|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1205513|NCT00896532|3958325|P19|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1205514|NCT00896532|3958326|P18|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1205515|NCT00896532|3958327|P17|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1
1205516|NCT00896532|3958328|P16|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1205517|NCT00896532|3958329|P15|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1205518|NCT00896532|3958330|P14|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1205519|NCT00896532|3958331|P13|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1205520|NCT00896532|3958332|P12|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1205521|NCT00896532|3958333|P11|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1205522|NCT00896532|3958334|P10|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1205523|NCT00896532|3958335|P9|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1205524|NCT00896532|3958336|P8|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1205525|NCT00896532|3958337|P7|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1205526|NCT00896532|3958338|P6|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1205527|NCT00896532|3958339|P5|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1205528|NCT00896532|3958340|P4|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1205529|NCT00896532|3958341|P3|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1205530|NCT00896532|3958342|P2|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1205531|NCT00896532|3958343|P1|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1205532|NCT00896532|3958321|P23|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1205533|NCT00896532|3958322|P22|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1205534|NCT00896532|3958323|P21|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1205535|NCT00896532|3958324|P20|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1205536|NCT00896532|3958325|P19|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1205537|NCT00896532|3958326|P18|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2
1205538|NCT00896532|3958327|P17|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2
1205539|NCT00896532|3958328|P16|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1
1205540|NCT00896532|3958329|P15|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1205541|NCT00896532|3958330|P14|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1205542|NCT00896532|3958331|P13|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1205543|NCT00896532|3958332|P12|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1205544|NCT00896532|3958333|P11|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1205545|NCT00896532|3958334|P10|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1205546|NCT00896532|3958335|P9|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1205547|NCT00896532|3958336|P8|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1205548|NCT00896532|3958337|P7|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1205549|NCT00896532|3958338|P6|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1205550|NCT00896532|3958339|P5|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1205551|NCT00896532|3958340|P4|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1205552|NCT00896532|3958341|P3|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1205553|NCT00896532|3958342|P2|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1205554|NCT00896532|3958343|P1|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1205555|NCT00896532|3958321|P23|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1205556|NCT00896532|3958322|P22|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1205557|NCT00896532|3958323|P21|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1205558|NCT00896532|3958324|P20|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1205559|NCT00896532|3958325|P19|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1205560|NCT00896532|3958326|P18|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1205561|NCT00896532|3958327|P17|Months 36-48: Romosozumab Retreatment|Adverse Event|3
1205562|NCT00896532|3958328|P16|Months 36-48: Romosozumab Retreatment|Adverse Event|1
1205563|NCT00896532|3958329|P15|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1205564|NCT00896532|3958330|P14|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1205565|NCT00896532|3958331|P13|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1205566|NCT00896532|3958332|P12|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1205567|NCT00896532|3958333|P11|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1205568|NCT00896532|3958334|P10|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1205569|NCT00896532|3958335|P9|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1205570|NCT00896532|3958336|P8|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1205571|NCT00896532|3958337|P7|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1205572|NCT00896532|3958338|P6|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1205573|NCT00896532|3958339|P5|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1205574|NCT00896532|3958340|P4|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1205575|NCT00896532|3958341|P3|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1205576|NCT00896532|3958342|P2|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1205577|NCT00896532|3958343|P1|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1205578|NCT00896532|3958321|P23|Months 24-36: Denosumab Extension Phase|Other|0
1205579|NCT00896532|3958322|P22|Months 24-36: Denosumab Extension Phase|Other|0
1205580|NCT00896532|3958323|P21|Months 24-36: Denosumab Extension Phase|Other|0
1205581|NCT00896532|3958324|P20|Months 24-36: Denosumab Extension Phase|Other|0
1205582|NCT00896532|3958325|P19|Months 24-36: Denosumab Extension Phase|Other|0
1205583|NCT00896532|3958326|P18|Months 24-36: Denosumab Extension Phase|Other|0
1205584|NCT00896532|3958327|P17|Months 24-36: Denosumab Extension Phase|Other|0
1205585|NCT00896532|3958328|P16|Months 24-36: Denosumab Extension Phase|Other|0
1205586|NCT00896532|3958329|P15|Months 24-36: Denosumab Extension Phase|Other|0
1205587|NCT00896532|3958330|P14|Months 24-36: Denosumab Extension Phase|Other|1
1205588|NCT00896532|3958331|P13|Months 24-36: Denosumab Extension Phase|Other|2
1205589|NCT00896532|3958332|P12|Months 24-36: Denosumab Extension Phase|Other|2
1205590|NCT00896532|3958333|P11|Months 24-36: Denosumab Extension Phase|Other|1
1205591|NCT00896532|3958334|P10|Months 24-36: Denosumab Extension Phase|Other|0
1205592|NCT00896532|3958335|P9|Months 24-36: Denosumab Extension Phase|Other|0
1205593|NCT00896532|3958336|P8|Months 24-36: Denosumab Extension Phase|Other|0
1205594|NCT00896532|3958337|P7|Months 24-36: Denosumab Extension Phase|Other|0
1205595|NCT00896532|3958338|P6|Months 24-36: Denosumab Extension Phase|Other|0
1205596|NCT00896532|3958339|P5|Months 24-36: Denosumab Extension Phase|Other|0
1205597|NCT00896532|3958340|P4|Months 24-36: Denosumab Extension Phase|Other|0
1205598|NCT00896532|3958341|P3|Months 24-36: Denosumab Extension Phase|Other|0
1205599|NCT00896532|3958342|P2|Months 24-36: Denosumab Extension Phase|Other|0
1205600|NCT00896532|3958343|P1|Months 24-36: Denosumab Extension Phase|Other|0
1205601|NCT00896532|3958321|P23|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1205602|NCT00896532|3958322|P22|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1205603|NCT00896532|3958323|P21|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1205604|NCT00896532|3958324|P20|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1205605|NCT00896532|3958325|P19|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1205606|NCT00896532|3958326|P18|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1205607|NCT00896532|3958327|P17|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1205608|NCT00896532|3958328|P16|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1205609|NCT00896532|3958329|P15|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1205610|NCT00896532|3958330|P14|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1
1205611|NCT00896532|3958331|P13|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1
1205612|NCT00896532|3958332|P12|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1205613|NCT00896532|3958333|P11|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1205614|NCT00896532|3958334|P10|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1205615|NCT00896532|3958335|P9|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1205616|NCT00896532|3958336|P8|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1205617|NCT00896532|3958337|P7|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1205618|NCT00896532|3958338|P6|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1205619|NCT00896532|3958339|P5|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1205620|NCT00896532|3958340|P4|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1205621|NCT00896532|3958341|P3|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1205622|NCT00896532|3958342|P2|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1205623|NCT00896532|3958343|P1|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1205624|NCT00896532|3958321|P23|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1205625|NCT00896532|3958322|P22|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1205626|NCT00896532|3958323|P21|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1205627|NCT00896532|3958324|P20|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1205628|NCT00896532|3958325|P19|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1205629|NCT00896532|3958326|P18|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1205630|NCT00896532|3958327|P17|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1205631|NCT00896532|3958328|P16|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1205632|NCT00896532|3958329|P15|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1205633|NCT00896532|3958330|P14|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1205634|NCT00896532|3958331|P13|Months 24-36: Denosumab Extension Phase|Adverse Event|1
1205635|NCT00896532|3958332|P12|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1205636|NCT00896532|3958333|P11|Months 24-36: Denosumab Extension Phase|Adverse Event|1
1205637|NCT00896532|3958334|P10|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1205638|NCT00896532|3958335|P9|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1205639|NCT00896532|3958336|P8|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1205640|NCT00896532|3958337|P7|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1205641|NCT00896532|3958338|P6|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1205642|NCT00896532|3958339|P5|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1205643|NCT00896532|3958340|P4|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1205644|NCT00896532|3958341|P3|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1205645|NCT00896532|3958342|P2|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1205646|NCT00896532|3958343|P1|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1205647|NCT00896532|3958321|P23|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1205648|NCT00896532|3958322|P22|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1205649|NCT00896532|3958323|P21|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1205650|NCT00896532|3958324|P20|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1205651|NCT00896532|3958325|P19|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1205652|NCT00896532|3958326|P18|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1205653|NCT00896532|3958327|P17|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1205654|NCT00896532|3958328|P16|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1205655|NCT00896532|3958329|P15|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1205656|NCT00896532|3958330|P14|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1205657|NCT00896532|3958331|P13|Months 24-36: Denosumab Extension Phase|Noncompliance|1
1205658|NCT00896532|3958332|P12|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1205659|NCT00896532|3958333|P11|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1205660|NCT00896532|3958334|P10|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1205661|NCT00896532|3958335|P9|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1205662|NCT00896532|3958336|P8|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1205663|NCT00896532|3958337|P7|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1205664|NCT00896532|3958338|P6|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1205665|NCT00896532|3958339|P5|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1205666|NCT00896532|3958340|P4|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1205667|NCT00896532|3958341|P3|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1205668|NCT00896532|3958342|P2|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1205669|NCT00896532|3958343|P1|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1205670|NCT00896532|3958321|P23|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1205671|NCT00896532|3958322|P22|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1205672|NCT00896532|3958323|P21|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1205673|NCT00896532|3958324|P20|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1205674|NCT00896532|3958325|P19|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1205675|NCT00896532|3958326|P18|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1205676|NCT00896532|3958327|P17|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1205677|NCT00896532|3958328|P16|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1205678|NCT00896532|3958329|P15|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1205679|NCT00896532|3958330|P14|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1205680|NCT00896532|3958331|P13|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1205681|NCT00896532|3958332|P12|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1205682|NCT00896532|3958333|P11|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1205683|NCT00896532|3958334|P10|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1205684|NCT00896532|3958335|P9|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1
1205685|NCT00896532|3958336|P8|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1205686|NCT00896532|3958337|P7|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1205687|NCT00896532|3958338|P6|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1205688|NCT00896532|3958339|P5|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1205689|NCT00896532|3958340|P4|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1205690|NCT00896532|3958341|P3|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1205691|NCT00896532|3958342|P2|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1205692|NCT00896532|3958343|P1|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1205693|NCT00896532|3958321|P23|Months 1-24: Romosozumab Treatment Phase|Other|0
1205694|NCT00896532|3958322|P22|Months 1-24: Romosozumab Treatment Phase|Other|0
1205695|NCT00896532|3958323|P21|Months 1-24: Romosozumab Treatment Phase|Other|0
1205696|NCT00896532|3958324|P20|Months 1-24: Romosozumab Treatment Phase|Other|0
1205697|NCT00896532|3958325|P19|Months 1-24: Romosozumab Treatment Phase|Other|0
1205698|NCT00896532|3958326|P18|Months 1-24: Romosozumab Treatment Phase|Other|0
1205699|NCT00896532|3958327|P17|Months 1-24: Romosozumab Treatment Phase|Other|0
1205700|NCT00896532|3958328|P16|Months 1-24: Romosozumab Treatment Phase|Other|0
1205701|NCT00896532|3958329|P15|Months 1-24: Romosozumab Treatment Phase|Other|0
1205702|NCT00896532|3958330|P14|Months 1-24: Romosozumab Treatment Phase|Other|0
1205703|NCT00896532|3958331|P13|Months 1-24: Romosozumab Treatment Phase|Other|0
1205704|NCT00896532|3958332|P12|Months 1-24: Romosozumab Treatment Phase|Other|0
1205705|NCT00896532|3958333|P11|Months 1-24: Romosozumab Treatment Phase|Other|0
1205706|NCT00896532|3958334|P10|Months 1-24: Romosozumab Treatment Phase|Other|0
1205707|NCT00896532|3958335|P9|Months 1-24: Romosozumab Treatment Phase|Other|0
1205708|NCT00896532|3958336|P8|Months 1-24: Romosozumab Treatment Phase|Other|0
1205709|NCT00896532|3958337|P7|Months 1-24: Romosozumab Treatment Phase|Other|0
1205710|NCT00896532|3958338|P6|Months 1-24: Romosozumab Treatment Phase|Other|0
1205711|NCT00896532|3958339|P5|Months 1-24: Romosozumab Treatment Phase|Other|1
1205712|NCT00896532|3958340|P4|Months 1-24: Romosozumab Treatment Phase|Other|1
1205713|NCT00896532|3958341|P3|Months 1-24: Romosozumab Treatment Phase|Other|0
1205714|NCT00896532|3958342|P2|Months 1-24: Romosozumab Treatment Phase|Other|1
1205715|NCT00896532|3958343|P1|Months 1-24: Romosozumab Treatment Phase|Other|0
1205716|NCT00896532|3958321|P23|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1205717|NCT00896532|3958322|P22|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1205718|NCT00896532|3958323|P21|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1205719|NCT00896532|3958324|P20|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1205720|NCT00896532|3958325|P19|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1205721|NCT00896532|3958326|P18|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1205722|NCT00896532|3958327|P17|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1205723|NCT00896532|3958328|P16|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1205724|NCT00896532|3958329|P15|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1205725|NCT00896532|3958330|P14|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1205726|NCT00896532|3958331|P13|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1205727|NCT00896532|3958332|P12|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1205728|NCT00896532|3958333|P11|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1205729|NCT00896532|3958334|P10|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1205730|NCT00896532|3958335|P9|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1205731|NCT00896532|3958336|P8|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1205732|NCT00896532|3958337|P7|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1205733|NCT00896532|3958338|P6|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1205734|NCT00896532|3958339|P5|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1205735|NCT00896532|3958340|P4|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1
1205736|NCT00896532|3958341|P3|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1205737|NCT00896532|3958342|P2|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1205738|NCT00896532|3958343|P1|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1205739|NCT00896532|3958321|P23|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1205740|NCT00896532|3958322|P22|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1205741|NCT00896532|3958323|P21|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1205742|NCT00896532|3958324|P20|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1205743|NCT00896532|3958325|P19|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1205744|NCT00896532|3958326|P18|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1205745|NCT00896532|3958327|P17|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1205746|NCT00896532|3958328|P16|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1205747|NCT00896532|3958329|P15|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1205748|NCT00896532|3958330|P14|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1205749|NCT00896532|3958331|P13|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1205750|NCT00896532|3958332|P12|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1205751|NCT00896532|3958333|P11|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1205752|NCT00896532|3958334|P10|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1205753|NCT00896532|3958335|P9|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1205754|NCT00896532|3958336|P8|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1205755|NCT00896532|3958337|P7|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1205756|NCT00896532|3958338|P6|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1205757|NCT00896532|3958339|P5|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1205758|NCT00896532|3958340|P4|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1205759|NCT00896532|3958341|P3|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1
1205760|NCT00896532|3958342|P2|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1205761|NCT00896532|3958343|P1|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1205762|NCT00896532|3958321|P23|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1205763|NCT00896532|3958322|P22|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1205764|NCT00896532|3958323|P21|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1205765|NCT00896532|3958324|P20|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1205766|NCT00896532|3958325|P19|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1205767|NCT00896532|3958326|P18|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1205768|NCT00896532|3958327|P17|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1205769|NCT00896532|3958328|P16|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1205770|NCT00896532|3958329|P15|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1205771|NCT00896532|3958330|P14|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1205772|NCT00896532|3958331|P13|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1205773|NCT00896532|3958332|P12|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1205774|NCT00896532|3958333|P11|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1205775|NCT00896532|3958334|P10|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1205776|NCT00896532|3958335|P9|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1205777|NCT00896532|3958336|P8|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1205778|NCT00896532|3958337|P7|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1205779|NCT00896532|3958338|P6|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1205780|NCT00896532|3958339|P5|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1205781|NCT00896532|3958340|P4|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1205782|NCT00896532|3958341|P3|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1
1205783|NCT00896532|3958342|P2|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1205784|NCT00896532|3958343|P1|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1205785|NCT00896532|3958321|P23|Months 1-24: Romosozumab Treatment Phase|Death|0
1205786|NCT00896532|3958322|P22|Months 1-24: Romosozumab Treatment Phase|Death|0
1205787|NCT00896532|3958323|P21|Months 1-24: Romosozumab Treatment Phase|Death|0
1205788|NCT00896532|3958324|P20|Months 1-24: Romosozumab Treatment Phase|Death|0
1205789|NCT00896532|3958325|P19|Months 1-24: Romosozumab Treatment Phase|Death|0
1205790|NCT00896532|3958326|P18|Months 1-24: Romosozumab Treatment Phase|Death|0
1205791|NCT00896532|3958327|P17|Months 1-24: Romosozumab Treatment Phase|Death|0
1205792|NCT00896532|3958328|P16|Months 1-24: Romosozumab Treatment Phase|Death|0
1205793|NCT00896532|3958329|P15|Months 1-24: Romosozumab Treatment Phase|Death|0
1205794|NCT00896532|3958330|P14|Months 1-24: Romosozumab Treatment Phase|Death|0
1205795|NCT00896532|3958331|P13|Months 1-24: Romosozumab Treatment Phase|Death|0
1205796|NCT00896532|3958332|P12|Months 1-24: Romosozumab Treatment Phase|Death|0
1205797|NCT00896532|3958333|P11|Months 1-24: Romosozumab Treatment Phase|Death|0
1205798|NCT00896532|3958334|P10|Months 1-24: Romosozumab Treatment Phase|Death|0
1205799|NCT00896532|3958335|P9|Months 1-24: Romosozumab Treatment Phase|Death|0
1205800|NCT00896532|3958336|P8|Months 1-24: Romosozumab Treatment Phase|Death|0
1205801|NCT00896532|3958337|P7|Months 1-24: Romosozumab Treatment Phase|Death|0
1205802|NCT00896532|3958338|P6|Months 1-24: Romosozumab Treatment Phase|Death|0
1205803|NCT00896532|3958339|P5|Months 1-24: Romosozumab Treatment Phase|Death|0
1205804|NCT00896532|3958340|P4|Months 1-24: Romosozumab Treatment Phase|Death|1
1205805|NCT00896532|3958341|P3|Months 1-24: Romosozumab Treatment Phase|Death|0
1205806|NCT00896532|3958342|P2|Months 1-24: Romosozumab Treatment Phase|Death|0
1205807|NCT00896532|3958343|P1|Months 1-24: Romosozumab Treatment Phase|Death|1
1205808|NCT00896532|3958321|P23|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1205809|NCT00896532|3958322|P22|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1205810|NCT00896532|3958323|P21|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1205811|NCT00896532|3958324|P20|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1205812|NCT00896532|3958325|P19|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1205813|NCT00896532|3958326|P18|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1205814|NCT00896532|3958327|P17|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1205815|NCT00896532|3958328|P16|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1205816|NCT00896532|3958329|P15|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1205817|NCT00896532|3958330|P14|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1205818|NCT00896532|3958331|P13|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1205819|NCT00896532|3958332|P12|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1205820|NCT00896532|3958333|P11|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1205821|NCT00896532|3958334|P10|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1205822|NCT00896532|3958335|P9|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1205823|NCT00896532|3958336|P8|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1205824|NCT00896532|3958337|P7|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1205825|NCT00896532|3958338|P6|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1205826|NCT00896532|3958339|P5|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1
1205827|NCT00896532|3958340|P4|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1205828|NCT00896532|3958341|P3|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2
1205829|NCT00896532|3958342|P2|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1205830|NCT00896532|3958343|P1|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1205831|NCT00896532|3958321|P23|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
1205832|NCT00896532|3958322|P22|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
1205833|NCT00896532|3958323|P21|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
1205834|NCT00896532|3958324|P20|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
1205835|NCT00896532|3958325|P19|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
1205836|NCT00896532|3958326|P18|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
1205837|NCT00896532|3958327|P17|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
1205838|NCT00896532|3958328|P16|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
1205839|NCT00896532|3958329|P15|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
1205840|NCT00896532|3958330|P14|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
1205841|NCT00896532|3958331|P13|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
1205842|NCT00896532|3958332|P12|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
1205843|NCT00896532|3958333|P11|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
1205844|NCT00896532|3958334|P10|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
1205845|NCT00896532|3958335|P9|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
1205846|NCT00896532|3958336|P8|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
1205847|NCT00896532|3958337|P7|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
1205848|NCT00896532|3958338|P6|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6
1205849|NCT00896532|3958339|P5|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5
1205850|NCT00896532|3958340|P4|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6
1205851|NCT00896532|3958341|P3|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
1205852|NCT00896532|3958342|P2|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3
1205853|NCT00896532|3958343|P1|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
1205854|NCT00896532|3958321|P23|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
1205855|NCT00896532|3958322|P22|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
1205856|NCT00896532|3958323|P21|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
1205857|NCT00896532|3958324|P20|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
1205858|NCT00896532|3958325|P19|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
1205859|NCT00896532|3958326|P18|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
1205860|NCT00896532|3958327|P17|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
1205861|NCT00896532|3958328|P16|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
1205862|NCT00896532|3958329|P15|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
1205863|NCT00896532|3958330|P14|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
1205864|NCT00896532|3958331|P13|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
1205865|NCT00896532|3958332|P12|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
1205866|NCT00896532|3958333|P11|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
1205867|NCT00896532|3958334|P10|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
1205868|NCT00896532|3958335|P9|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
1205869|NCT00896532|3958336|P8|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
1205870|NCT00896532|3958337|P7|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
1205871|NCT00896532|3958338|P6|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
1205872|NCT00896532|3958339|P5|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
1205873|NCT00896532|3958340|P4|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2
1205874|NCT00896532|3958341|P3|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
1205875|NCT00896532|3958342|P2|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2
1205876|NCT00896532|3958343|P1|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
1205877|NCT00896532|3958321|P23|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1205878|NCT00896532|3958322|P22|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1205879|NCT00896532|3958323|P21|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1205880|NCT00896532|3958324|P20|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1205881|NCT00896532|3958325|P19|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1205882|NCT00896532|3958326|P18|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1205883|NCT00896532|3958327|P17|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1205884|NCT00896532|3958328|P16|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1205885|NCT00896532|3958329|P15|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1205886|NCT00896532|3958330|P14|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1205887|NCT00896532|3958331|P13|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1205888|NCT00896532|3958332|P12|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1205889|NCT00896532|3958333|P11|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1205890|NCT00896532|3958334|P10|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1205891|NCT00896532|3958335|P9|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1205892|NCT00896532|3958336|P8|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1205893|NCT00896532|3958337|P7|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1205894|NCT00896532|3958338|P6|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1
1205895|NCT00896532|3958339|P5|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1205896|NCT00896532|3958340|P4|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1
1205897|NCT00896532|3958341|P3|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1205898|NCT00896532|3958342|P2|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1205899|NCT00896532|3958343|P1|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1205900|NCT00896454|3958470|P1|Overall Study|Withdrawal by Subject|1
1205901|NCT00896454|3958470|P1|Overall Study|Ongoing in study|2
1205902|NCT00896454|3958470|P1|Overall Study|Requirement for alternative therapy|3
1205903|NCT00896454|3958470|P1|Overall Study|Other|4
1205904|NCT00896454|3958470|P1|Overall Study|Disease Progression|5
1205905|NCT00896454|3958470|P1|Overall Study|Adverse Event|8
1205906|NCT00896454|3958470|P1|Overall Study|Death|10
1205907|NCT00896363|3958509|P3|Overall Study|Withdrawal by Subject|5
1205908|NCT00896363|3958510|P2|Overall Study|Withdrawal by Subject|5
1205909|NCT00896363|3958511|P1|Overall Study|Withdrawal by Subject|3
1205910|NCT00896363|3958509|P3|Overall Study|Lack of Efficacy|1
1205911|NCT00896363|3958510|P2|Overall Study|Lack of Efficacy|2
1205912|NCT00896363|3958511|P1|Overall Study|Lack of Efficacy|0
1205913|NCT00896363|3958509|P3|Overall Study|Adverse Event|2
1205914|NCT00896363|3958510|P2|Overall Study|Adverse Event|4
1205915|NCT00896363|3958511|P1|Overall Study|Adverse Event|3
1205916|NCT00896337|3958563|P1|Overall Study|Lost to Follow-up|11
1205917|NCT00896337|3958563|P1|Overall Study|Withdrawal by Subject|7
1205918|NCT00896337|3958563|P1|Overall Study|Death|7
1205919|NCT00896233|3958630|P1|Overall Study|Claustrophobia during MRI|1
1205920|NCT00896168|3958643|P2|Overall Study|Other|1
1205921|NCT00896168|3958644|P1|Overall Study|Other|1
1205922|NCT00896168|3958643|P2|Overall Study|Lost to Follow-up|1
1205923|NCT00896168|3958644|P1|Overall Study|Lost to Follow-up|1
1205924|NCT00896168|3958643|P2|Overall Study|Treatment failure|10
1205925|NCT00896168|3958644|P1|Overall Study|Treatment failure|8
1205926|NCT00896168|3958643|P2|Overall Study|Adverse Event|7
1205927|NCT00896168|3958644|P1|Overall Study|Adverse Event|4
1205928|NCT00896051|3958705|P2|Overall Study|Not specified|1
1205929|NCT00896051|3958706|P1|Overall Study|Not specified|1
1205930|NCT00896051|3958705|P2|Overall Study|Subject noncompliant|3
1205931|NCT00896051|3958706|P1|Overall Study|Subject noncompliant|1
1205932|NCT00896051|3958705|P2|Overall Study|Withdrawal by Subject|2
1205933|NCT00896051|3958706|P1|Overall Study|Withdrawal by Subject|3
1205934|NCT00896051|3958705|P2|Overall Study|Lost to Follow-up|2
1205935|NCT00896051|3958706|P1|Overall Study|Lost to Follow-up|3
1205936|NCT00896051|3958705|P2|Overall Study|Adverse Event|1
1205937|NCT00896051|3958706|P1|Overall Study|Adverse Event|2
1205938|NCT00895947|3958793|P2|Overall Study|Withdrawal by Subject|0
1205939|NCT00895947|3958794|P1|Overall Study|Withdrawal by Subject|2
1205940|NCT00895947|3958793|P2|Overall Study|Protocol Violation|2
1205941|NCT00895947|3958794|P1|Overall Study|Protocol Violation|4
1205942|NCT00895947|3958793|P2|Overall Study|Lost to Follow-up|4
1205943|NCT00895947|3958794|P1|Overall Study|Lost to Follow-up|3
1205944|NCT00895947|3958793|P2|Overall Study|Adverse Event|4
1205945|NCT00895947|3958794|P1|Overall Study|Adverse Event|3
1205946|NCT00895934|3958812|P2|Overall Study|ineligible|0
1205947|NCT00895934|3958813|P1|Overall Study|ineligible|1
1205948|NCT00895934|3958812|P2|Overall Study|Death|1
1205949|NCT00895934|3958813|P1|Overall Study|Death|0
1205950|NCT00895934|3958812|P2|Overall Study|Lack of Efficacy|24
1205951|NCT00895934|3958813|P1|Overall Study|Lack of Efficacy|5
1205952|NCT00895895|3958824|P5|Period 2|unsatisfactory response-efficacy|0
1205953|NCT00895895|3958825|P4|Period 2|unsatisfactory response-efficacy|0
1205954|NCT00895895|3958826|P3|Period 2|unsatisfactory response-efficacy|0
1205955|NCT00895895|3958827|P2|Period 2|unsatisfactory response-efficacy|1
1205956|NCT00895895|3958828|P1|Period 2|unsatisfactory response-efficacy|2
1205957|NCT00895895|3958824|P5|Period 2|Withdrawal by Subject|5
1205958|NCT00895895|3958825|P4|Period 2|Withdrawal by Subject|3
1205959|NCT00895895|3958826|P3|Period 2|Withdrawal by Subject|0
1205960|NCT00895895|3958827|P2|Period 2|Withdrawal by Subject|2
1205961|NCT00895895|3958828|P1|Period 2|Withdrawal by Subject|0
1205962|NCT00895895|3958824|P5|Period 2|Protocol Violation|1
1205963|NCT00895895|3958825|P4|Period 2|Protocol Violation|1
1205964|NCT00895895|3958826|P3|Period 2|Protocol Violation|1
1205965|NCT00895895|3958827|P2|Period 2|Protocol Violation|0
1205966|NCT00895895|3958828|P1|Period 2|Protocol Violation|1
1205967|NCT00895895|3958824|P5|Period 2|Other|1
1205968|NCT00895895|3958825|P4|Period 2|Other|1
1205969|NCT00895895|3958826|P3|Period 2|Other|3
1205970|NCT00895895|3958827|P2|Period 2|Other|1
1205971|NCT00895895|3958828|P1|Period 2|Other|1
1205972|NCT00895895|3958824|P5|Period 2|Lost to Follow-up|0
1205973|NCT00895895|3958825|P4|Period 2|Lost to Follow-up|1
1205974|NCT00895895|3958826|P3|Period 2|Lost to Follow-up|1
1205975|NCT00895895|3958827|P2|Period 2|Lost to Follow-up|2
1205976|NCT00895895|3958828|P1|Period 2|Lost to Follow-up|1
1205977|NCT00895895|3958824|P5|Period 2|investigator request|0
1205978|NCT00895895|3958825|P4|Period 2|investigator request|0
1205979|NCT00895895|3958826|P3|Period 2|investigator request|0
1205980|NCT00895895|3958827|P2|Period 2|investigator request|0
1205981|NCT00895895|3958828|P1|Period 2|investigator request|2
1205982|NCT00895895|3958824|P5|Period 2|failed to return|0
1205983|NCT00895895|3958825|P4|Period 2|failed to return|0
1205984|NCT00895895|3958826|P3|Period 2|failed to return|0
1205985|NCT00895895|3958827|P2|Period 2|failed to return|0
1205986|NCT00895895|3958828|P1|Period 2|failed to return|2
1205987|NCT00895895|3958824|P5|Period 2|discontinued by sponsor|37
1205988|NCT00895895|3958825|P4|Period 2|discontinued by sponsor|46
1205989|NCT00895895|3958826|P3|Period 2|discontinued by sponsor|38
1205990|NCT00895895|3958827|P2|Period 2|discontinued by sponsor|44
1205991|NCT00895895|3958828|P1|Period 2|discontinued by sponsor|44
1205992|NCT00895895|3958824|P5|Period 2|Death|0
1205993|NCT00895895|3958825|P4|Period 2|Death|0
1205994|NCT00895895|3958826|P3|Period 2|Death|1
1205995|NCT00895895|3958827|P2|Period 2|Death|0
1205996|NCT00895895|3958828|P1|Period 2|Death|0
1205997|NCT00895895|3958824|P5|Period 2|Adverse Event|5
1205998|NCT00895895|3958825|P4|Period 2|Adverse Event|2
1205999|NCT00895895|3958826|P3|Period 2|Adverse Event|5
1206000|NCT00895895|3958827|P2|Period 2|Adverse Event|3
1206001|NCT00895895|3958828|P1|Period 2|Adverse Event|3
1206002|NCT00895895|3958824|P5|After Period 1, Prior to Period 2|Withdrawal by Subject|1
1206003|NCT00895895|3958825|P4|After Period 1, Prior to Period 2|Withdrawal by Subject|0
1206004|NCT00895895|3958826|P3|After Period 1, Prior to Period 2|Withdrawal by Subject|0
1206005|NCT00895895|3958827|P2|After Period 1, Prior to Period 2|Withdrawal by Subject|0
1206006|NCT00895895|3958828|P1|After Period 1, Prior to Period 2|Withdrawal by Subject|0
1206007|NCT00895895|3958824|P5|After Period 1, Prior to Period 2|Protocol Violation|1
1206008|NCT00895895|3958825|P4|After Period 1, Prior to Period 2|Protocol Violation|0
1206009|NCT00895895|3958826|P3|After Period 1, Prior to Period 2|Protocol Violation|0
1206010|NCT00895895|3958827|P2|After Period 1, Prior to Period 2|Protocol Violation|0
1206011|NCT00895895|3958828|P1|After Period 1, Prior to Period 2|Protocol Violation|0
1206012|NCT00895895|3958824|P5|After Period 1, Prior to Period 2|Other|0
1206013|NCT00895895|3958825|P4|After Period 1, Prior to Period 2|Other|0
1206014|NCT00895895|3958826|P3|After Period 1, Prior to Period 2|Other|1
1206015|NCT00895895|3958827|P2|After Period 1, Prior to Period 2|Other|0
1206016|NCT00895895|3958828|P1|After Period 1, Prior to Period 2|Other|0
1206017|NCT00895895|3958824|P5|After Period 1, Prior to Period 2|Adverse Event|0
1206018|NCT00895895|3958825|P4|After Period 1, Prior to Period 2|Adverse Event|0
1206019|NCT00895895|3958826|P3|After Period 1, Prior to Period 2|Adverse Event|1
1206020|NCT00895895|3958827|P2|After Period 1, Prior to Period 2|Adverse Event|0
1206021|NCT00895895|3958828|P1|After Period 1, Prior to Period 2|Adverse Event|0
1206022|NCT00895895|3958824|P5|Period 1|randomized and not treated|2
1206023|NCT00895895|3958825|P4|Period 1|randomized and not treated|1
1206024|NCT00895895|3958826|P3|Period 1|randomized and not treated|1
1206025|NCT00895895|3958827|P2|Period 1|randomized and not treated|3
1206026|NCT00895895|3958828|P1|Period 1|randomized and not treated|1
1206027|NCT00895895|3958824|P5|Period 1|unsatisfactory response-efficacy|0
1206028|NCT00895895|3958825|P4|Period 1|unsatisfactory response-efficacy|0
1206029|NCT00895895|3958826|P3|Period 1|unsatisfactory response-efficacy|0
1206030|NCT00895895|3958827|P2|Period 1|unsatisfactory response-efficacy|0
1206031|NCT00895895|3958828|P1|Period 1|unsatisfactory response-efficacy|2
1206032|NCT00895895|3958824|P5|Period 1|Withdrawal by Subject|4
1206033|NCT00895895|3958825|P4|Period 1|Withdrawal by Subject|2
1206034|NCT00895895|3958826|P3|Period 1|Withdrawal by Subject|8
1206035|NCT00895895|3958827|P2|Period 1|Withdrawal by Subject|6
1206036|NCT00895895|3958828|P1|Period 1|Withdrawal by Subject|6
1206037|NCT00895895|3958824|P5|Period 1|Protocol Violation|0
1206038|NCT00895895|3958825|P4|Period 1|Protocol Violation|0
1206039|NCT00895895|3958826|P3|Period 1|Protocol Violation|0
1206040|NCT00895895|3958827|P2|Period 1|Protocol Violation|1
1206041|NCT00895895|3958828|P1|Period 1|Protocol Violation|0
1206042|NCT00895895|3958824|P5|Period 1|Other|1
1206043|NCT00895895|3958825|P4|Period 1|Other|1
1206044|NCT00895895|3958826|P3|Period 1|Other|1
1206045|NCT00895895|3958827|P2|Period 1|Other|2
1206046|NCT00895895|3958828|P1|Period 1|Other|1
1206047|NCT00895895|3958824|P5|Period 1|Lost to Follow-up|3
1206048|NCT00895895|3958825|P4|Period 1|Lost to Follow-up|2
1206049|NCT00895895|3958826|P3|Period 1|Lost to Follow-up|3
1206050|NCT00895895|3958827|P2|Period 1|Lost to Follow-up|1
1206051|NCT00895895|3958828|P1|Period 1|Lost to Follow-up|2
1206052|NCT00895895|3958824|P5|Period 1|investigator request|0
1206053|NCT00895895|3958825|P4|Period 1|investigator request|0
1206054|NCT00895895|3958826|P3|Period 1|investigator request|0
1206055|NCT00895895|3958827|P2|Period 1|investigator request|1
1206056|NCT00895895|3958828|P1|Period 1|investigator request|0
1206057|NCT00895895|3958824|P5|Period 1|failed to return|1
1206058|NCT00895895|3958825|P4|Period 1|failed to return|0
1206059|NCT00895895|3958826|P3|Period 1|failed to return|1
1206060|NCT00895895|3958827|P2|Period 1|failed to return|0
1206061|NCT00895895|3958828|P1|Period 1|failed to return|0
1206062|NCT00895895|3958824|P5|Period 1|discontinued by sponsor|1
1206063|NCT00895895|3958825|P4|Period 1|discontinued by sponsor|1
1206064|NCT00895895|3958826|P3|Period 1|discontinued by sponsor|2
1206065|NCT00895895|3958827|P2|Period 1|discontinued by sponsor|1
1206066|NCT00895895|3958828|P1|Period 1|discontinued by sponsor|2
1206067|NCT00895895|3958824|P5|Period 1|Death|1
1206068|NCT00895895|3958825|P4|Period 1|Death|0
1206069|NCT00895895|3958826|P3|Period 1|Death|0
1206070|NCT00895895|3958827|P2|Period 1|Death|0
1206071|NCT00895895|3958828|P1|Period 1|Death|0
1206072|NCT00895895|3958824|P5|Period 1|Adverse Event|7
1206073|NCT00895895|3958825|P4|Period 1|Adverse Event|6
1206074|NCT00895895|3958826|P3|Period 1|Adverse Event|4
1206075|NCT00895895|3958827|P2|Period 1|Adverse Event|6
1206076|NCT00895895|3958828|P1|Period 1|Adverse Event|7
1206077|NCT00895843|3958942|P2|Overall Study|Protocol Violation|12
1206078|NCT00895843|3958943|P1|Overall Study|Protocol Violation|12
1206079|NCT00895661|3958990|P1|Overall Study|reason unknown|2
1206080|NCT00895661|3958990|P1|Overall Study|Death|1
1206081|NCT00895622|3959000|P3|Overall Study|Protocol Violation|4
1206082|NCT00895622|3959001|P2|Overall Study|Protocol Violation|4
1206083|NCT00895622|3959002|P1|Overall Study|Protocol Violation|5
1206084|NCT00895583|3959025|P2|Overall Study|Not specified|1
1206085|NCT00895583|3959026|P1|Overall Study|Not specified|0
1206086|NCT00895583|3959025|P2|Overall Study|Lack of Efficacy|0
1206087|NCT00895583|3959026|P1|Overall Study|Lack of Efficacy|5
1206088|NCT00895583|3959025|P2|Overall Study|Withdrawal by Subject|2
1206089|NCT00895583|3959026|P1|Overall Study|Withdrawal by Subject|4
1206090|NCT00895583|3959025|P2|Overall Study|Protocol Violation|0
1206091|NCT00895583|3959026|P1|Overall Study|Protocol Violation|1
1206092|NCT00895583|3959025|P2|Overall Study|Lost to Follow-up|3
1206093|NCT00895583|3959026|P1|Overall Study|Lost to Follow-up|1
1206094|NCT00895583|3959025|P2|Overall Study|Physician Decision|1
1206095|NCT00895583|3959026|P1|Overall Study|Physician Decision|3
1206096|NCT00895583|3959025|P2|Overall Study|Death|1
1206097|NCT00895583|3959026|P1|Overall Study|Death|2
1206098|NCT00895583|3959025|P2|Overall Study|Adverse Event|4
1206099|NCT00895583|3959026|P1|Overall Study|Adverse Event|28
1206100|NCT00895453|3959116|P3|Overall Study|Lost to Follow-up|23
1206101|NCT00895453|3959117|P2|Overall Study|Lost to Follow-up|25
1206102|NCT00895453|3959118|P1|Overall Study|Lost to Follow-up|25
1206103|NCT00895310|3959126|P1|Overall Study|Withdrawal by Subject|1
1206104|NCT00895245|3959142|P1|Overall Study|Lack of Efficacy|6
1206105|NCT00895037|3959221|P3|Overall Study|Death|1
1206106|NCT00895037|3959222|P2|Overall Study|Death|2
1206107|NCT00895037|3959223|P1|Overall Study|Death|0
1206108|NCT00895011|3959254|P3|Overall Study|schedule conflict|0
1206109|NCT00895011|3959255|P2|Overall Study|schedule conflict|0
1206110|NCT00895011|3959256|P1|Overall Study|schedule conflict|1
1206111|NCT00895011|3959254|P3|Overall Study|Adverse Event|2
1206112|NCT00895011|3959255|P2|Overall Study|Adverse Event|2
1206113|NCT00895011|3959256|P1|Overall Study|Adverse Event|1
1206114|NCT00895011|3959254|P3|Overall Study|Protocol Violation|3
1206115|NCT00895011|3959255|P2|Overall Study|Protocol Violation|1
1206116|NCT00895011|3959256|P1|Overall Study|Protocol Violation|3
1206117|NCT00895011|3959254|P3|Overall Study|Lost to Follow-up|1
1206118|NCT00895011|3959255|P2|Overall Study|Lost to Follow-up|4
1206119|NCT00895011|3959256|P1|Overall Study|Lost to Follow-up|5
1206120|NCT00895011|3959254|P3|Overall Study|Withdrawal by Subject|2
1206121|NCT00895011|3959255|P2|Overall Study|Withdrawal by Subject|7
1206122|NCT00895011|3959256|P1|Overall Study|Withdrawal by Subject|14
1206123|NCT00894933|3959270|P1|Overall Study|Did not meeting incl/excl criteria|1
1206124|NCT00894933|3959270|P1|Overall Study|Cancelled Procedure|1
1206125|NCT00894933|3959270|P1|Overall Study|Lost to Follow-up|2
1206126|NCT00894803|3959288|P2|Overall Study|Lost to Follow-up|1
1206127|NCT00894803|3959289|P1|Overall Study|Lost to Follow-up|0
1206128|NCT00894803|3959288|P2|Overall Study|Death|4
1206129|NCT00894803|3959289|P1|Overall Study|Death|20
1206130|NCT00894790|3959325|P2|Overall Study|Did not meet entrance criteria|0
1206131|NCT00894790|3959326|P1|Overall Study|Did not meet entrance criteria|1
1206132|NCT00894790|3959325|P2|Overall Study|Lost to Follow-up|1
1206133|NCT00894790|3959326|P1|Overall Study|Lost to Follow-up|0
1206134|NCT00894790|3959325|P2|Overall Study|Protocol Violation|1
1206135|NCT00894790|3959326|P1|Overall Study|Protocol Violation|0
1206136|NCT00894686|3959357|P1|Overall Study|Other|5
1206137|NCT00894686|3959357|P1|Overall Study|Physician Decision|1
1206138|NCT00894686|3959357|P1|Overall Study|Withdrawal by Subject|50
1206139|NCT00894647|3959381|P2|Overall Study|Other, not due to AE|2
1206140|NCT00894647|3959382|P1|Overall Study|Other, not due to AE|1
1206141|NCT00894647|3959381|P2|Overall Study|Non-compliance with study procedures|2
1206142|NCT00894647|3959382|P1|Overall Study|Non-compliance with study procedures|0
1206143|NCT00894647|3959381|P2|Overall Study|Lost to Follow-up|2
1206144|NCT00894647|3959382|P1|Overall Study|Lost to Follow-up|0
1206145|NCT00894647|3959381|P2|Overall Study|Withdrawal by Subject|4
1206146|NCT00894647|3959382|P1|Overall Study|Withdrawal by Subject|4
1206147|NCT00894647|3959381|P2|Overall Study|Adverse Event|4
1206148|NCT00894647|3959382|P1|Overall Study|Adverse Event|5
1206149|NCT00894556|3959395|P4|Treatment Phase|Lack of Qualifying Event|0
1206150|NCT00894556|3959396|P3|Treatment Phase|Lack of Qualifying Event|0
1206151|NCT00894556|3959397|P2|Treatment Phase|Lack of Qualifying Event|1
1206152|NCT00894556|3959398|P1|Treatment Phase|Lack of Qualifying Event|2
1206153|NCT00894556|3959395|P4|Treatment Phase|Lost to Follow-up|0
1206154|NCT00894556|3959396|P3|Treatment Phase|Lost to Follow-up|1
1206155|NCT00894556|3959397|P2|Treatment Phase|Lost to Follow-up|3
1206156|NCT00894556|3959398|P1|Treatment Phase|Lost to Follow-up|2
1206157|NCT00894556|3959395|P4|Baseline Phase|Did not meet Randomization Criteria|85
1206158|NCT00894556|3959396|P3|Baseline Phase|Did not meet Randomization Criteria|0
1206159|NCT00894556|3959397|P2|Baseline Phase|Did not meet Randomization Criteria|0
1206160|NCT00894556|3959398|P1|Baseline Phase|Did not meet Randomization Criteria|0
1206161|NCT00894543|3959409|P2|Week 4 to Week 8|No diary or lost or withdrew|2
1206162|NCT00894543|3959410|P1|Week 4 to Week 8|No diary or lost or withdrew|4
1206163|NCT00894543|3959409|P2|Baseline to Week 4|No diary or lost or withdrew|2
1206164|NCT00894543|3959410|P1|Baseline to Week 4|No diary or lost or withdrew|3
1206165|NCT00894387|3959476|P2|Overall Study|GCP non-compliance|2
1206166|NCT00894387|3959477|P1|Overall Study|GCP non-compliance|0
1206167|NCT00894387|3959476|P2|Overall Study|Mis-randomized|9
1206168|NCT00894387|3959477|P1|Overall Study|Mis-randomized|13
1206169|NCT00894387|3959476|P2|Overall Study|Other (Missing)|3
1206170|NCT00894387|3959477|P1|Overall Study|Other (Missing)|5
1206171|NCT00894387|3959476|P2|Overall Study|Patient's request|30
1206172|NCT00894387|3959477|P1|Overall Study|Patient's request|25
1206173|NCT00894387|3959476|P2|Overall Study|Protocol Deviation|0
1206174|NCT00894387|3959477|P1|Overall Study|Protocol Deviation|4
1206175|NCT00894387|3959476|P2|Overall Study|Death|76
1206176|NCT00894387|3959477|P1|Overall Study|Death|77
1206177|NCT00894387|3959476|P2|Overall Study|Administrative problems|2
1206178|NCT00894387|3959477|P1|Overall Study|Administrative problems|2
1206179|NCT00894387|3959476|P2|Overall Study|Lost to Follow-up|5
1206180|NCT00894387|3959477|P1|Overall Study|Lost to Follow-up|3
1206181|NCT00894387|3959476|P2|Overall Study|Unsatisfactory therapeutic effect|1
1206182|NCT00894387|3959477|P1|Overall Study|Unsatisfactory therapeutic effect|0
1206183|NCT00894387|3959476|P2|Overall Study|Abnormal Laboratory values|2
1206184|NCT00894387|3959477|P1|Overall Study|Abnormal Laboratory values|2
1206185|NCT00894387|3959476|P2|Overall Study|Adverse Event|45
1206186|NCT00894387|3959477|P1|Overall Study|Adverse Event|44
1206187|NCT00894361|3959497|P2|Overall Study|deaths and less than 2 yr followup|64
1206188|NCT00894361|3959498|P1|Overall Study|deaths and less than 2 yr followup|24
1206189|NCT00894322|3959507|P3|Overall Study|Withdrawal by Subject|0
1206190|NCT00894322|3959508|P2|Overall Study|Withdrawal by Subject|0
1206191|NCT00894322|3959509|P1|Overall Study|Withdrawal by Subject|1
1206192|NCT00894166|3959560|P8|Overall Study|Death|0
1206193|NCT00894166|3959561|P7|Overall Study|Death|0
1206194|NCT00894166|3959562|P6|Overall Study|Death|0
1206195|NCT00894166|3959563|P5|Overall Study|Death|0
1206196|NCT00894166|3959564|P4|Overall Study|Death|1
1206197|NCT00894166|3959565|P3|Overall Study|Death|0
1206198|NCT00894166|3959566|P2|Overall Study|Death|0
1206199|NCT00894166|3959567|P1|Overall Study|Death|0
1206200|NCT00894166|3959560|P8|Overall Study|Withdrew or Lost to Follow-Up|34
1206201|NCT00894166|3959561|P7|Overall Study|Withdrew or Lost to Follow-Up|16
1206202|NCT00894166|3959562|P6|Overall Study|Withdrew or Lost to Follow-Up|16
1206203|NCT00894166|3959563|P5|Overall Study|Withdrew or Lost to Follow-Up|24
1206204|NCT00894166|3959564|P4|Overall Study|Withdrew or Lost to Follow-Up|68
1206205|NCT00894166|3959565|P3|Overall Study|Withdrew or Lost to Follow-Up|62
1206206|NCT00894166|3959566|P2|Overall Study|Withdrew or Lost to Follow-Up|63
1206207|NCT00894166|3959567|P1|Overall Study|Withdrew or Lost to Follow-Up|61
1206208|NCT00893971|3959606|P1|Overall Study|Physician Decision|3
1206209|NCT00893789|3959724|P4|Overall Study|Lost to Follow-up|1
1206210|NCT00893789|3959725|P3|Overall Study|Lost to Follow-up|0
1206211|NCT00893789|3959726|P2|Overall Study|Lost to Follow-up|0
1206212|NCT00893789|3959727|P1|Overall Study|Lost to Follow-up|0
1206213|NCT00893789|3959724|P4|Overall Study|Protocol Violation|4
1206214|NCT00893789|3959725|P3|Overall Study|Protocol Violation|1
1206215|NCT00893789|3959726|P2|Overall Study|Protocol Violation|1
1206216|NCT00893789|3959727|P1|Overall Study|Protocol Violation|0
1206217|NCT00893789|3959724|P4|Overall Study|Adverse Event|5
1206218|NCT00893789|3959725|P3|Overall Study|Adverse Event|1
1206219|NCT00893789|3959726|P2|Overall Study|Adverse Event|2
1206220|NCT00893789|3959727|P1|Overall Study|Adverse Event|0
1206221|NCT00893789|3959724|P4|Overall Study|Taking Excluded Concomitant Medication|0
1206222|NCT00893789|3959725|P3|Overall Study|Taking Excluded Concomitant Medication|1
1206223|NCT00893789|3959726|P2|Overall Study|Taking Excluded Concomitant Medication|0
1206224|NCT00893789|3959727|P1|Overall Study|Taking Excluded Concomitant Medication|1
1206225|NCT00893789|3959724|P4|Overall Study|Noncompliance With Study Procedures|0
1206226|NCT00893789|3959725|P3|Overall Study|Noncompliance With Study Procedures|0
1206227|NCT00893789|3959726|P2|Overall Study|Noncompliance With Study Procedures|0
1206228|NCT00893789|3959727|P1|Overall Study|Noncompliance With Study Procedures|1
1206229|NCT00893789|3959724|P4|Overall Study|Noncompliance With Study Drug|2
1206230|NCT00893789|3959725|P3|Overall Study|Noncompliance With Study Drug|1
1206231|NCT00893789|3959726|P2|Overall Study|Noncompliance With Study Drug|0
1206232|NCT00893789|3959727|P1|Overall Study|Noncompliance With Study Drug|1
1206233|NCT00893789|3959724|P4|Overall Study|Withdrawal by Subject|1
1206234|NCT00893789|3959725|P3|Overall Study|Withdrawal by Subject|3
1206235|NCT00893789|3959726|P2|Overall Study|Withdrawal by Subject|1
1206236|NCT00893789|3959727|P1|Overall Study|Withdrawal by Subject|3
1206237|NCT00893763|3959811|P2|Overall Study|extubated|110
1206238|NCT00893763|3959812|P1|Overall Study|extubated|110
1206239|NCT00893737|3959820|P1|Overall Study|Lost to Follow-up|6
1206240|NCT00893737|3959820|P1|Overall Study|Withdrawal by Subject|2
1206241|NCT00893737|3959820|P1|Overall Study|Adverse Event|4
1206242|NCT00893464|3959834|P8|Overall Study|Did not complete therapy/experience PD|2
1206243|NCT00893464|3959835|P7|Overall Study|Did not complete therapy/experience PD|2
1206244|NCT00893464|3959836|P6|Overall Study|Did not complete therapy/experience PD|0
1206245|NCT00893464|3959837|P5|Overall Study|Did not complete therapy/experience PD|0
1206246|NCT00893464|3959838|P4|Overall Study|Did not complete therapy/experience PD|0
1206247|NCT00893464|3959839|P3|Overall Study|Did not complete therapy/experience PD|0
1206248|NCT00893464|3959840|P2|Overall Study|Did not complete therapy/experience PD|0
1206249|NCT00893464|3959841|P1|Overall Study|Did not complete therapy/experience PD|0
1206250|NCT00893113|3959968|P2|Overall Study|Withdrew Consent|7
1206251|NCT00893113|3959969|P1|Overall Study|Withdrew Consent|8
1206252|NCT00893113|3959968|P2|Overall Study|Early Termination|1
1206253|NCT00893113|3959969|P1|Overall Study|Early Termination|1
1206254|NCT00893113|3959968|P2|Overall Study|Lost to Follow-up|8
1206255|NCT00893113|3959969|P1|Overall Study|Lost to Follow-up|4
1206256|NCT00892957|3959999|P2|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2
1206257|NCT00892957|3960000|P1|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0
1206258|NCT00892957|3959999|P2|Between Postoperative Day 1 and Day 14|Death|2
1206259|NCT00892957|3960000|P1|Between Postoperative Day 1 and Day 14|Death|0
1206260|NCT00892775|3960088|P2|Overall Study|Lost to Follow-up|0
1206261|NCT00892775|3960089|P1|Overall Study|Lost to Follow-up|1
1206262|NCT00892775|3960088|P2|Overall Study|Withdrawal by Subject|1
1206263|NCT00892775|3960089|P1|Overall Study|Withdrawal by Subject|0
1206264|NCT00892775|3960088|P2|Overall Study|Migrated/ moved from study area|0
1206265|NCT00892775|3960089|P1|Overall Study|Migrated/ moved from study area|1
1206266|NCT00892775|3960088|P2|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0
1206267|NCT00892775|3960089|P1|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1
1206268|NCT00892775|3960088|P2|Overall Study|Subject difficulties with blood drawing|0
1206269|NCT00892775|3960089|P1|Overall Study|Subject difficulties with blood drawing|1
1206270|NCT00892775|3960088|P2|Overall Study|Protocol Violation|0
1206271|NCT00892775|3960089|P1|Overall Study|Protocol Violation|1
1206272|NCT00892723|3960116|P3|Overall Study|Withdrawal by Subject|1
1206273|NCT00892723|3960117|P2|Overall Study|Withdrawal by Subject|1
1206274|NCT00892723|3960118|P1|Overall Study|Withdrawal by Subject|1
1206275|NCT00892723|3960116|P3|Overall Study|Lost to Follow-up|1
1206276|NCT00892723|3960117|P2|Overall Study|Lost to Follow-up|3
1206277|NCT00892723|3960118|P1|Overall Study|Lost to Follow-up|1
1206278|NCT00892437|3960207|P2|Open-Label Extension Phase|Withdrew Consent|1
1206279|NCT00892437|3960208|P1|Open-Label Extension Phase|Withdrew Consent|3
1206280|NCT00892437|3960207|P2|Open-Label Extension Phase|Investigator's Discretion|0
1206281|NCT00892437|3960208|P1|Open-Label Extension Phase|Investigator's Discretion|1
1206282|NCT00892437|3960207|P2|Open-Label Extension Phase|Lost to Follow-up|1
1206283|NCT00892437|3960208|P1|Open-Label Extension Phase|Lost to Follow-up|3
1206284|NCT00892437|3960207|P2|Open-Label Extension Phase|Lack of Efficacy|0
1206285|NCT00892437|3960208|P1|Open-Label Extension Phase|Lack of Efficacy|1
1206286|NCT00892437|3960207|P2|Open-Label Extension Phase|Adverse Event|2
1206287|NCT00892437|3960208|P1|Open-Label Extension Phase|Adverse Event|4
1206288|NCT00892437|3960207|P2|Randomized Phase|Withdrew Consent|0
1206289|NCT00892437|3960208|P1|Randomized Phase|Withdrew Consent|1
1206290|NCT00892437|3960207|P2|Randomized Phase|Investigator’s Discretion|0
1206291|NCT00892437|3960208|P1|Randomized Phase|Investigator’s Discretion|1
1206292|NCT00892437|3960207|P2|Randomized Phase|Lost to Follow-up|3
1206293|NCT00892437|3960208|P1|Randomized Phase|Lost to Follow-up|1
1206294|NCT00892437|3960207|P2|Randomized Phase|Adverse Event|2
1206295|NCT00892437|3960208|P1|Randomized Phase|Adverse Event|2
1206296|NCT00892437|3960207|P2|Randomized Phase|Randomized but not treated|0
1206297|NCT00892437|3960208|P1|Randomized Phase|Randomized but not treated|6
1206298|NCT00892281|3960227|P2|Overall Study|Visit 4 date out of window|0
1206299|NCT00892281|3960228|P1|Overall Study|Visit 4 date out of window|1
1206300|NCT00892281|3960227|P2|Overall Study|Rash on hand|0
1206301|NCT00892281|3960228|P1|Overall Study|Rash on hand|1
1206302|NCT00892281|3960227|P2|Overall Study|Subject had history of drug abuse|0
1206303|NCT00892281|3960228|P1|Overall Study|Subject had history of drug abuse|1
1206304|NCT00892281|3960227|P2|Overall Study|Non-compliant with visits as scheduled|0
1206305|NCT00892281|3960228|P1|Overall Study|Non-compliant with visits as scheduled|1
1206306|NCT00892281|3960227|P2|Overall Study|Missed visits rescheduled out of window|0
1206307|NCT00892281|3960228|P1|Overall Study|Missed visits rescheduled out of window|1
1206308|NCT00892281|3960227|P2|Overall Study|Missed multiple visits|0
1206309|NCT00892281|3960228|P1|Overall Study|Missed multiple visits|1
1206310|NCT00892281|3960227|P2|Overall Study|No show Visit 2; prescription not filled|0
1206311|NCT00892281|3960228|P1|Overall Study|No show Visit 2; prescription not filled|1
1206312|NCT00892281|3960227|P2|Overall Study|Subject not seen by PI at final visit|0
1206313|NCT00892281|3960228|P1|Overall Study|Subject not seen by PI at final visit|1
1206314|NCT00892281|3960227|P2|Overall Study|Lack of efficacy of study product|0
1206315|NCT00892281|3960228|P1|Overall Study|Lack of efficacy of study product|2
1206316|NCT00892281|3960227|P2|Overall Study|Death in family|0
1206317|NCT00892281|3960228|P1|Overall Study|Death in family|1
1206318|NCT00892281|3960227|P2|Overall Study|Bad taste in mouth after taking Oracea®|1
1206319|NCT00892281|3960228|P1|Overall Study|Bad taste in mouth after taking Oracea®|0
1206320|NCT00892281|3960227|P2|Overall Study|Subject lost interest in program|1
1206321|NCT00892281|3960228|P1|Overall Study|Subject lost interest in program|0
1206322|NCT00892281|3960227|P2|Overall Study|PI complained of inadequate compensation|0
1206323|NCT00892281|3960228|P1|Overall Study|PI complained of inadequate compensation|3
1206324|NCT00892281|3960227|P2|Overall Study|Scheduled for knee replacement|1
1206325|NCT00892281|3960228|P1|Overall Study|Scheduled for knee replacement|0
1206326|NCT00892281|3960227|P2|Overall Study|Missed Visit 4 and off meds for 65 days|1
1206327|NCT00892281|3960228|P1|Overall Study|Missed Visit 4 and off meds for 65 days|1
1206328|NCT00892281|3960227|P2|Overall Study|Subject missed several visits/lost meds|0
1206329|NCT00892281|3960228|P1|Overall Study|Subject missed several visits/lost meds|1
1206330|NCT00892281|3960227|P2|Overall Study|Subject did not return for any visits|0
1206331|NCT00892281|3960228|P1|Overall Study|Subject did not return for any visits|1
1206332|NCT00892281|3960227|P2|Overall Study|Subject not good candidate for study|0
1206333|NCT00892281|3960228|P1|Overall Study|Subject not good candidate for study|1
1206334|NCT00892281|3960227|P2|Overall Study|Unable to redeem the drug voucher|0
1206335|NCT00892281|3960228|P1|Overall Study|Unable to redeem the drug voucher|1
1206336|NCT00892281|3960227|P2|Overall Study|Rosacea cleared; subject D/C'd self|0
1206337|NCT00892281|3960228|P1|Overall Study|Rosacea cleared; subject D/C'd self|1
1206338|NCT00892281|3960227|P2|Overall Study|Did not meet incl/excl criteria|0
1206339|NCT00892281|3960228|P1|Overall Study|Did not meet incl/excl criteria|1
1206340|NCT00892281|3960227|P2|Overall Study|Last visit not done - death in family|0
1206341|NCT00892281|3960228|P1|Overall Study|Last visit not done - death in family|1
1206342|NCT00892281|3960227|P2|Overall Study|Family emergency|0
1206343|NCT00892281|3960228|P1|Overall Study|Family emergency|1
1206344|NCT00892281|3960227|P2|Overall Study|Subject completed day after study closed|0
1206345|NCT00892281|3960228|P1|Overall Study|Subject completed day after study closed|1
1206346|NCT00892281|3960227|P2|Overall Study|Final visit completed 4 weeks late|1
1206347|NCT00892281|3960228|P1|Overall Study|Final visit completed 4 weeks late|0
1206348|NCT00892281|3960227|P2|Overall Study|Subject unable to keep follow-up visits|0
1206349|NCT00892281|3960228|P1|Overall Study|Subject unable to keep follow-up visits|1
1206350|NCT00892281|3960227|P2|Overall Study|Subject failed to return for final visit|0
1206351|NCT00892281|3960228|P1|Overall Study|Subject failed to return for final visit|2
1206352|NCT00892281|3960227|P2|Overall Study|Withdrawal by Subject|14
1206353|NCT00892281|3960228|P1|Overall Study|Withdrawal by Subject|86
1206354|NCT00892281|3960227|P2|Overall Study|Protocol Violation|2
1206355|NCT00892281|3960228|P1|Overall Study|Protocol Violation|7
1206356|NCT00892281|3960227|P2|Overall Study|Pregnancy|0
1206357|NCT00892281|3960228|P1|Overall Study|Pregnancy|1
1206358|NCT00892281|3960227|P2|Overall Study|Lost to Follow-up|8
1206359|NCT00892281|3960228|P1|Overall Study|Lost to Follow-up|81
1206360|NCT00892281|3960227|P2|Overall Study|Adverse Event|8
1206361|NCT00892281|3960228|P1|Overall Study|Adverse Event|65
1206362|NCT00892177|3960241|P6|Phase II|Withdrawal by Subject|1
1206363|NCT00892177|3960242|P5|Phase II|Withdrawal by Subject|4
1206364|NCT00892177|3960243|P4|Phase II|Withdrawal by Subject|0
1206365|NCT00892177|3960244|P3|Phase II|Withdrawal by Subject|0
1206366|NCT00892177|3960245|P2|Phase II|Withdrawal by Subject|0
1206367|NCT00892177|3960246|P1|Phase II|Withdrawal by Subject|0
1206368|NCT00892177|3960241|P6|Phase II|Ineligible|1
1206369|NCT00892177|3960242|P5|Phase II|Ineligible|1
1206370|NCT00892177|3960243|P4|Phase II|Ineligible|0
1206371|NCT00892177|3960244|P3|Phase II|Ineligible|0
1206372|NCT00892177|3960245|P2|Phase II|Ineligible|0
1206373|NCT00892177|3960246|P1|Phase II|Ineligible|0
1206374|NCT00892151|3960271|P1|Overall Study|Protocol Violation|1
1206375|NCT00892099|3960280|P3|Overall Study|Lost to Follow-up|1
1206376|NCT00892099|3960281|P2|Overall Study|Lost to Follow-up|0
1206377|NCT00892099|3960282|P1|Overall Study|Lost to Follow-up|0
1206378|NCT00892099|3960280|P3|Overall Study|investigator decision|1
1206379|NCT00892099|3960281|P2|Overall Study|investigator decision|0
1206380|NCT00892099|3960282|P1|Overall Study|investigator decision|0
1206381|NCT00892099|3960280|P3|Overall Study|kidney function recovered|0
1206382|NCT00892099|3960281|P2|Overall Study|kidney function recovered|1
1206383|NCT00892099|3960282|P1|Overall Study|kidney function recovered|0
1206384|NCT00892099|3960280|P3|Overall Study|no further details|1
1206385|NCT00892099|3960281|P2|Overall Study|no further details|0
1206386|NCT00892099|3960282|P1|Overall Study|no further details|1
1206387|NCT00892099|3960280|P3|Overall Study|Prolonged hospitalization|1
1206388|NCT00892099|3960281|P2|Overall Study|Prolonged hospitalization|0
1206389|NCT00892099|3960282|P1|Overall Study|Prolonged hospitalization|1
1206390|NCT00892099|3960280|P3|Overall Study|replocated|2
1206391|NCT00892099|3960281|P2|Overall Study|replocated|0
1206392|NCT00892099|3960282|P1|Overall Study|replocated|1
1206393|NCT00892099|3960280|P3|Overall Study|Adverse Event|0
1206394|NCT00892099|3960281|P2|Overall Study|Adverse Event|0
1206395|NCT00892099|3960282|P1|Overall Study|Adverse Event|1
1206396|NCT00892099|3960280|P3|Overall Study|Death|1
1206397|NCT00892099|3960281|P2|Overall Study|Death|0
1206398|NCT00892099|3960282|P1|Overall Study|Death|1
1206399|NCT00892047|3960307|P2|Overall Study|Lack of Efficacy|2
1206400|NCT00892047|3960308|P1|Overall Study|Lack of Efficacy|0
1206401|NCT00892047|3960307|P2|Overall Study|subject burden|3
1206402|NCT00892047|3960308|P1|Overall Study|subject burden|2
1206403|NCT00892047|3960307|P2|Overall Study|Adverse Event|2
1206404|NCT00892047|3960308|P1|Overall Study|Adverse Event|2
1206405|NCT00892008|3960324|P1|Overall Study|Adverse Event|37
1206406|NCT00892008|3960324|P1|Overall Study|Other|378
1206407|NCT00892008|3960324|P1|Overall Study|Lost to Follow-up|142
1206408|NCT00892008|3960324|P1|Overall Study|Lack of Efficacy|3
1206409|NCT00892008|3960324|P1|Overall Study|Death|5
1206410|NCT00891930|3960410|P1|Part 2: Panitumumab + Ganitumab|Withdrawal by Subject|1
1206411|NCT00891930|3960410|P1|Part 2: Panitumumab + Ganitumab|Death|30
1206412|NCT00891930|3960410|P1|Part 1: Panitumumab +Irinotecan|Lost to Follow-up|1
1206413|NCT00891930|3960410|P1|Part 1: Panitumumab +Irinotecan|Withdrawal by Subject|1
1206414|NCT00891930|3960410|P1|Part 1: Panitumumab +Irinotecan|Death|38
1206415|NCT00891904|3960431|P1|Overall Study|Adverse Event|1
1206416|NCT00891904|3960431|P1|Overall Study|Death|1
1206417|NCT00891839|3960457|P1|Overall Study|Disease progression|3
1206418|NCT00891839|3960457|P1|Overall Study|Withdrawal by Subject|2
1206419|NCT00891839|3960457|P1|Overall Study|Adverse Event|2
1206420|NCT00891813|3960466|P1|Overall Study|Protocol Violation|2
1206421|NCT00891813|3960466|P1|Overall Study|Patient Noncompliance|6
1206422|NCT00891813|3960466|P1|Overall Study|Withdrawal by Subject|1
1206423|NCT00891813|3960466|P1|Overall Study|Adverse Event|3
1206424|NCT00891774|3960472|P1|Overall Study|Protocol Violation|4
1206425|NCT00891774|3960472|P1|Overall Study|Withdrawal by Subject|2
1206426|NCT00891774|3960472|P1|Overall Study|Illness (Self/Mother)|3
1206427|NCT00891774|3960472|P1|Overall Study|Lost to Follow-up|5
1206428|NCT00891735|3960480|P4|Overall Study|Patient's decision to withdraw|8
1206429|NCT00891735|3960481|P3|Overall Study|Patient's decision to withdraw|4
1206430|NCT00891735|3960482|P2|Overall Study|Patient's decision to withdraw|9
1206431|NCT00891735|3960483|P1|Overall Study|Patient's decision to withdraw|4
1206432|NCT00891735|3960480|P4|Overall Study|Physician's decision to withdraw patient|0
1206433|NCT00891735|3960481|P3|Overall Study|Physician's decision to withdraw patient|0
1206434|NCT00891735|3960482|P2|Overall Study|Physician's decision to withdraw patient|0
1206435|NCT00891735|3960483|P1|Overall Study|Physician's decision to withdraw patient|1
1206436|NCT00891735|3960480|P4|Overall Study|Lost to Follow-up|2
1206437|NCT00891735|3960481|P3|Overall Study|Lost to Follow-up|2
1206438|NCT00891735|3960482|P2|Overall Study|Lost to Follow-up|2
1206439|NCT00891735|3960483|P1|Overall Study|Lost to Follow-up|2
1206440|NCT00891735|3960480|P4|Overall Study|Death|5
1206441|NCT00891735|3960481|P3|Overall Study|Death|4
1206442|NCT00891735|3960482|P2|Overall Study|Death|5
1206443|NCT00891735|3960483|P1|Overall Study|Death|8
1206444|NCT00891735|3960480|P4|Overall Study|Adverse Event|0
1206445|NCT00891735|3960481|P3|Overall Study|Adverse Event|2
1206446|NCT00891735|3960482|P2|Overall Study|Adverse Event|0
1206447|NCT00891735|3960483|P1|Overall Study|Adverse Event|2
1206448|NCT00891657|3960523|P2|Overall Study|Withdrawal by Subject|1
1206449|NCT00891657|3960524|P1|Overall Study|Withdrawal by Subject|1
1206450|NCT00891618|3960536|P1|Overall Study|Withdrawal by Subject|1
1206451|NCT00891527|3960540|P1|Overall Study|Withdrawal by Subject|2
1206452|NCT00891462|3960549|P3|Overall Study|Lost to Follow-up|0
1206453|NCT00891462|3960550|P2|Overall Study|Lost to Follow-up|2
1206454|NCT00891462|3960551|P1|Overall Study|Lost to Follow-up|0
1206455|NCT00891462|3960549|P3|Overall Study|Inclusion/exclusion criteria|2
1206456|NCT00891462|3960550|P2|Overall Study|Inclusion/exclusion criteria|2
1206457|NCT00891462|3960551|P1|Overall Study|Inclusion/exclusion criteria|0
1206458|NCT00891462|3960549|P3|Overall Study|Protocol Violation|3
1206459|NCT00891462|3960550|P2|Overall Study|Protocol Violation|1
1206460|NCT00891462|3960551|P1|Overall Study|Protocol Violation|2
1206461|NCT00891462|3960549|P3|Overall Study|Other Reason|3
1206462|NCT00891462|3960550|P2|Overall Study|Other Reason|5
1206463|NCT00891462|3960551|P1|Overall Study|Other Reason|2
1206464|NCT00891462|3960549|P3|Overall Study|COPD exacerbation|1
1206465|NCT00891462|3960550|P2|Overall Study|COPD exacerbation|4
1206466|NCT00891462|3960551|P1|Overall Study|COPD exacerbation|7
1206467|NCT00891462|3960549|P3|Overall Study|Lack of Efficacy|1
1206468|NCT00891462|3960550|P2|Overall Study|Lack of Efficacy|5
1206469|NCT00891462|3960551|P1|Overall Study|Lack of Efficacy|10
1206470|NCT00891462|3960549|P3|Overall Study|Adverse Event|7
1206471|NCT00891462|3960550|P2|Overall Study|Adverse Event|8
1206472|NCT00891462|3960551|P1|Overall Study|Adverse Event|7
1206473|NCT00891462|3960549|P3|Overall Study|Withdrawal by Subject|7
1206474|NCT00891462|3960550|P2|Overall Study|Withdrawal by Subject|6
1206475|NCT00891462|3960551|P1|Overall Study|Withdrawal by Subject|9
1206476|NCT00891371|3960573|P1|Treatment|Lost to Follow-up|1
1206477|NCT00891371|3960573|P1|Treatment|Death|1
1206478|NCT00891371|3960573|P1|Treatment|Adverse Event|2
1206479|NCT00891371|3960573|P1|Treatment|Lack of Efficacy|5
1206480|NCT00891371|3960573|P1|Pre-assignment|Consent withdrawal|1
1206481|NCT00891371|3960573|P1|Pre-assignment|Inclusion/exclusion|5
1206482|NCT00891293|3960595|P1|Overall Study|Sponsor termination|62
1206483|NCT00891293|3960595|P1|Overall Study|Subject withdrew consent|7
1206484|NCT00891293|3960595|P1|Overall Study|Lost to Follow-up|7
1206485|NCT00891293|3960595|P1|Overall Study|Laboratory abnormality|4
1206486|NCT00891293|3960595|P1|Overall Study|Protocol Violation|2
1206487|NCT00891293|3960595|P1|Overall Study|Adverse Event|2
1206488|NCT00891228|3960610|P3|Overall Study|Pregnancy|0
1206489|NCT00891228|3960611|P2|Overall Study|Pregnancy|1
1206490|NCT00891228|3960612|P1|Overall Study|Pregnancy|0
1206491|NCT00891228|3960610|P3|Overall Study|Lost to Follow-up|5
1206492|NCT00891228|3960611|P2|Overall Study|Lost to Follow-up|4
1206493|NCT00891228|3960612|P1|Overall Study|Lost to Follow-up|4
1206494|NCT00891228|3960610|P3|Overall Study|Physician Decision|0
1206495|NCT00891228|3960611|P2|Overall Study|Physician Decision|1
1206496|NCT00891228|3960612|P1|Overall Study|Physician Decision|2
1206497|NCT00891228|3960610|P3|Overall Study|Protocol Violation|2
1206498|NCT00891228|3960611|P2|Overall Study|Protocol Violation|1
1206499|NCT00891228|3960612|P1|Overall Study|Protocol Violation|3
1206500|NCT00891228|3960610|P3|Overall Study|Withdrawal by Subject|5
1206501|NCT00891228|3960611|P2|Overall Study|Withdrawal by Subject|4
1206502|NCT00891228|3960612|P1|Overall Study|Withdrawal by Subject|2
1206503|NCT00891228|3960610|P3|Overall Study|Adverse Event|3
1206504|NCT00891228|3960611|P2|Overall Study|Adverse Event|2
1206505|NCT00891228|3960612|P1|Overall Study|Adverse Event|0
1206506|NCT00891202|3960634|P4|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5
1206507|NCT00891202|3960635|P3|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2
1206508|NCT00891202|3960636|P2|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
1206509|NCT00891202|3960637|P1|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
1206510|NCT00891202|3960634|P4|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
1206511|NCT00891202|3960635|P3|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1
1206512|NCT00891202|3960636|P2|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
1206513|NCT00891202|3960637|P1|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
1206514|NCT00891202|3960634|P4|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
1206515|NCT00891202|3960635|P3|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4
1206516|NCT00891202|3960636|P2|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
1206517|NCT00891202|3960637|P1|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
1206518|NCT00891202|3960634|P4|PAP (Up To Week 39)|Withdrawal by Subject|0
1206519|NCT00891202|3960635|P3|PAP (Up To Week 39)|Withdrawal by Subject|0
1206520|NCT00891202|3960636|P2|PAP (Up To Week 39)|Withdrawal by Subject|0
1206521|NCT00891202|3960637|P1|PAP (Up To Week 39)|Withdrawal by Subject|1
1206522|NCT00891046|3960813|P5|Overall Study|Lost to Follow-up|1
1206523|NCT00891046|3960814|P4|Overall Study|Lost to Follow-up|0
1206524|NCT00891046|3960815|P3|Overall Study|Lost to Follow-up|0
1206525|NCT00891046|3960816|P2|Overall Study|Lost to Follow-up|0
1206526|NCT00891046|3960817|P1|Overall Study|Lost to Follow-up|0
1206527|NCT00891046|3960813|P5|Overall Study|Withdrawal by Subject|1
1206528|NCT00891046|3960814|P4|Overall Study|Withdrawal by Subject|1
1206529|NCT00891046|3960815|P3|Overall Study|Withdrawal by Subject|2
1206530|NCT00891046|3960816|P2|Overall Study|Withdrawal by Subject|1
1206531|NCT00891046|3960817|P1|Overall Study|Withdrawal by Subject|2
1206532|NCT00891046|3960813|P5|Overall Study|Adverse Event|14
1206533|NCT00891046|3960814|P4|Overall Study|Adverse Event|0
1206534|NCT00891046|3960815|P3|Overall Study|Adverse Event|2
1206535|NCT00891046|3960816|P2|Overall Study|Adverse Event|3
1206536|NCT00891046|3960817|P1|Overall Study|Adverse Event|4
1206537|NCT00891046|3960813|P5|Overall Study|Participant no longer required drug|1
1206538|NCT00891046|3960814|P4|Overall Study|Participant no longer required drug|0
1206539|NCT00891046|3960815|P3|Overall Study|Participant no longer required drug|0
1206540|NCT00891046|3960816|P2|Overall Study|Participant no longer required drug|2
1206541|NCT00891046|3960817|P1|Overall Study|Participant no longer required drug|0
1206542|NCT00891046|3960813|P5|Overall Study|Administrative problems|1
1206543|NCT00891046|3960814|P4|Overall Study|Administrative problems|0
1206544|NCT00891046|3960815|P3|Overall Study|Administrative problems|0
1206545|NCT00891046|3960816|P2|Overall Study|Administrative problems|0
1206546|NCT00891046|3960817|P1|Overall Study|Administrative problems|0
1206547|NCT00891046|3960813|P5|Overall Study|Unsatisfactory therapeutic effect|20
1206548|NCT00891046|3960814|P4|Overall Study|Unsatisfactory therapeutic effect|2
1206549|NCT00891046|3960815|P3|Overall Study|Unsatisfactory therapeutic effect|19
1206550|NCT00891046|3960816|P2|Overall Study|Unsatisfactory therapeutic effect|2
1206551|NCT00891046|3960817|P1|Overall Study|Unsatisfactory therapeutic effect|5
1206552|NCT00891046|3960813|P5|Overall Study|Protocol Violation|1
1206553|NCT00891046|3960814|P4|Overall Study|Protocol Violation|0
1206554|NCT00891046|3960815|P3|Overall Study|Protocol Violation|0
1206555|NCT00891046|3960816|P2|Overall Study|Protocol Violation|1
1206556|NCT00891046|3960817|P1|Overall Study|Protocol Violation|1
1206557|NCT00891020|3960893|P3|Long-term Extension Period|Administrative|2
1206558|NCT00891020|3960894|P2|Long-term Extension Period|Administrative|2
1206559|NCT00891020|3960895|P1|Long-term Extension Period|Administrative|1
1206560|NCT00891020|3960893|P3|Long-term Extension Period|Failure to return|3
1206561|NCT00891020|3960894|P2|Long-term Extension Period|Failure to return|2
1206562|NCT00891020|3960895|P1|Long-term Extension Period|Failure to return|0
1206563|NCT00891020|3960893|P3|Long-term Extension Period|Refused treatment/did not cooperate|4
1206564|NCT00891020|3960894|P2|Long-term Extension Period|Refused treatment/did not cooperate|6
1206565|NCT00891020|3960895|P1|Long-term Extension Period|Refused treatment/did not cooperate|1
1206566|NCT00891020|3960893|P3|Long-term Extension Period|Protocol Violation|1
1206567|NCT00891020|3960894|P2|Long-term Extension Period|Protocol Violation|1
1206568|NCT00891020|3960895|P1|Long-term Extension Period|Protocol Violation|0
1206569|NCT00891020|3960893|P3|Long-term Extension Period|Insufficient therapeutic response|2
1206570|NCT00891020|3960894|P2|Long-term Extension Period|Insufficient therapeutic response|2
1206571|NCT00891020|3960895|P1|Long-term Extension Period|Insufficient therapeutic response|3
1206572|NCT00891020|3960893|P3|Long-term Extension Period|Death|1
1206573|NCT00891020|3960894|P2|Long-term Extension Period|Death|0
1206574|NCT00891020|3960895|P1|Long-term Extension Period|Death|0
1206575|NCT00891020|3960893|P3|Long-term Extension Period|Adverse Event|10
1206576|NCT00891020|3960894|P2|Long-term Extension Period|Adverse Event|11
1206577|NCT00891020|3960895|P1|Long-term Extension Period|Adverse Event|1
1206578|NCT00891020|3960893|P3|24 Week Treatment Period|Administrative/Other|1
1206579|NCT00891020|3960894|P2|24 Week Treatment Period|Administrative/Other|6
1206580|NCT00891020|3960895|P1|24 Week Treatment Period|Administrative/Other|5
1206581|NCT00891020|3960893|P3|24 Week Treatment Period|Withdrew consent|15
1206582|NCT00891020|3960894|P2|24 Week Treatment Period|Withdrew consent|3
1206583|NCT00891020|3960895|P1|24 Week Treatment Period|Withdrew consent|6
1206584|NCT00891020|3960893|P3|24 Week Treatment Period|Refused treatment/did not cooperate|1
1206585|NCT00891020|3960894|P2|24 Week Treatment Period|Refused treatment/did not cooperate|2
1206586|NCT00891020|3960895|P1|24 Week Treatment Period|Refused treatment/did not cooperate|3
1206587|NCT00891020|3960893|P3|24 Week Treatment Period|Other protocol violation|2
1206588|NCT00891020|3960894|P2|24 Week Treatment Period|Other protocol violation|1
1206589|NCT00891020|3960895|P1|24 Week Treatment Period|Other protocol violation|1
1206590|NCT00891020|3960893|P3|24 Week Treatment Period|Violation of selection criteria at entry|2
1206591|NCT00891020|3960894|P2|24 Week Treatment Period|Violation of selection criteria at entry|0
1206592|NCT00891020|3960895|P1|24 Week Treatment Period|Violation of selection criteria at entry|1
1206593|NCT00891020|3960893|P3|24 Week Treatment Period|Failure to return|5
1206594|NCT00891020|3960894|P2|24 Week Treatment Period|Failure to return|5
1206595|NCT00891020|3960895|P1|24 Week Treatment Period|Failure to return|4
1206596|NCT00891020|3960893|P3|24 Week Treatment Period|Insufficient therapeutic response|15
1206597|NCT00891020|3960894|P2|24 Week Treatment Period|Insufficient therapeutic response|9
1206598|NCT00891020|3960895|P1|24 Week Treatment Period|Insufficient therapeutic response|6
1206599|NCT00891020|3960893|P3|24 Week Treatment Period|Death|0
1206600|NCT00891020|3960894|P2|24 Week Treatment Period|Death|2
1206601|NCT00891020|3960895|P1|24 Week Treatment Period|Death|0
1206602|NCT00891020|3960893|P3|24 Week Treatment Period|Adverse event or intercurrent illness|17
1206603|NCT00891020|3960894|P2|24 Week Treatment Period|Adverse event or intercurrent illness|32
1206604|NCT00891020|3960895|P1|24 Week Treatment Period|Adverse event or intercurrent illness|11
1206605|NCT00890929|3960959|P1|Overall Study|Physician Decision|1
1206606|NCT00890929|3960959|P1|Overall Study|Withdrawal by Subject|3
1206607|NCT00890929|3960959|P1|Overall Study|Death before treatment|2
1206608|NCT00890825|3960977|P2|Overall Study|Alive at data cut off (DCO)|14
1206609|NCT00890825|3960978|P1|Overall Study|Alive at data cut off (DCO)|13
1206610|NCT00890825|3960977|P2|Overall Study|Withdrawal by Subject|0
1206611|NCT00890825|3960978|P1|Overall Study|Withdrawal by Subject|1
1206612|NCT00890695|3961007|P2|Overall Study|Protocol Violation|0
1206613|NCT00890695|3961008|P1|Overall Study|Protocol Violation|1
1206614|NCT00890591|3961037|P1|Overall Study|Lack of Efficacy|20
1206615|NCT00890552|3961043|P1|On-treatment|Early prog disease/ death|10
1206616|NCT00890552|3961043|P1|Enrollment and Pre-treatment|Death/ lost to follow up|1
1206617|NCT00890409|3961052|P2|Overall Study|Lost to Follow-up|21
1206618|NCT00890409|3961053|P1|Overall Study|Lost to Follow-up|20
1206619|NCT00890201|3961063|P2|Overall Study|Protocol Violation|56
1206620|NCT00890201|3961064|P1|Overall Study|Protocol Violation|5
1206621|NCT00890097|3961073|P3|Overall Study|Protocol Deviation|1
1206622|NCT00890097|3961074|P2|Overall Study|Protocol Deviation|1
1206623|NCT00890097|3961075|P1|Overall Study|Protocol Deviation|1
1206624|NCT00890097|3961073|P3|Overall Study|Subject Moved|0
1206625|NCT00890097|3961074|P2|Overall Study|Subject Moved|4
1206626|NCT00890097|3961075|P1|Overall Study|Subject Moved|0
1206627|NCT00890097|3961073|P3|Overall Study|Transportation|0
1206628|NCT00890097|3961074|P2|Overall Study|Transportation|2
1206629|NCT00890097|3961075|P1|Overall Study|Transportation|0
1206630|NCT00890097|3961073|P3|Overall Study|Failed inclusion criteria|0
1206631|NCT00890097|3961074|P2|Overall Study|Failed inclusion criteria|4
1206632|NCT00890097|3961075|P1|Overall Study|Failed inclusion criteria|3
1206633|NCT00890097|3961073|P3|Overall Study|Randomization Error|0
1206634|NCT00890097|3961074|P2|Overall Study|Randomization Error|0
1206635|NCT00890097|3961075|P1|Overall Study|Randomization Error|2
1206636|NCT00890097|3961073|P3|Overall Study|Subject Decision|6
1206637|NCT00890097|3961074|P2|Overall Study|Subject Decision|2
1206638|NCT00890097|3961075|P1|Overall Study|Subject Decision|3
1206639|NCT00890097|3961073|P3|Overall Study|Did not attend final visit|0
1206640|NCT00890097|3961074|P2|Overall Study|Did not attend final visit|3
1206641|NCT00890097|3961075|P1|Overall Study|Did not attend final visit|2
1206642|NCT00890097|3961073|P3|Overall Study|Sponsor Decision|7
1206643|NCT00890097|3961074|P2|Overall Study|Sponsor Decision|11
1206644|NCT00890097|3961075|P1|Overall Study|Sponsor Decision|7
1206645|NCT00890097|3961073|P3|Overall Study|Noncompliance|4
1206646|NCT00890097|3961074|P2|Overall Study|Noncompliance|4
1206647|NCT00890097|3961075|P1|Overall Study|Noncompliance|0
1206648|NCT00890097|3961073|P3|Overall Study|Lost to Follow-up|5
1206649|NCT00890097|3961074|P2|Overall Study|Lost to Follow-up|5
1206650|NCT00890097|3961075|P1|Overall Study|Lost to Follow-up|5
1206651|NCT00890097|3961073|P3|Overall Study|Withdrew Consent|9
1206652|NCT00890097|3961074|P2|Overall Study|Withdrew Consent|6
1206653|NCT00890097|3961075|P1|Overall Study|Withdrew Consent|9
1206654|NCT00890097|3961073|P3|Overall Study|Decision Unrelated to an Adverse Event|17
1206655|NCT00890097|3961074|P2|Overall Study|Decision Unrelated to an Adverse Event|12
1206656|NCT00890097|3961075|P1|Overall Study|Decision Unrelated to an Adverse Event|15
1206657|NCT00890097|3961073|P3|Overall Study|Adverse Event|28
1206658|NCT00890097|3961074|P2|Overall Study|Adverse Event|32
1206659|NCT00890097|3961075|P1|Overall Study|Adverse Event|21
1206660|NCT00890084|3961083|P1|Overall Study|Lost to Follow-up|126
1206661|NCT00890084|3961083|P1|Overall Study|Adverse Event|16
1206662|NCT00889863|3961123|P2|Part II: Randomized Double Blind|Protocol deviation|1
1206663|NCT00889863|3961124|P1|Part II: Randomized Double Blind|Protocol deviation|0
1206664|NCT00889863|3961123|P2|Part II: Randomized Double Blind|Withdrawal by Subject|1
1206665|NCT00889863|3961124|P1|Part II: Randomized Double Blind|Withdrawal by Subject|0
1206666|NCT00889863|3961123|P2|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20
1206667|NCT00889863|3961124|P1|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11
1206668|NCT00889863|3961123|P2|Part II: Randomized Double Blind|Adverse Event|4
1206669|NCT00889863|3961124|P1|Part II: Randomized Double Blind|Adverse Event|0
1206670|NCT00889863|3961123|P2|Part I: Open Label|Unsatisfactory therapeutic effect|0
1206671|NCT00889863|3961124|P1|Part I: Open Label|Unsatisfactory therapeutic effect|72
1206672|NCT00889863|3961123|P2|Part I: Open Label|Adverse Event|0
1206673|NCT00889863|3961124|P1|Part I: Open Label|Adverse Event|4
1206674|NCT00889863|3961123|P2|Part I: Open Label|Death|0
1206675|NCT00889863|3961124|P1|Part I: Open Label|Death|1
1206676|NCT00889720|3961150|P1|Overall Study|Other|4
1206677|NCT00889720|3961150|P1|Overall Study|Withdrawal by Subject|4
1206678|NCT00889707|3961177|P2|Overall Study|Lack of Efficacy|5
1206679|NCT00889707|3961178|P1|Overall Study|Lack of Efficacy|2
1206680|NCT00889707|3961177|P2|Overall Study|Lost to Follow-up|2
1206681|NCT00889707|3961178|P1|Overall Study|Lost to Follow-up|0
1206682|NCT00889707|3961177|P2|Overall Study|Withdrawal by Subject|3
1206683|NCT00889707|3961178|P1|Overall Study|Withdrawal by Subject|4
1206684|NCT00889707|3961177|P2|Overall Study|Adverse Event|0
1206685|NCT00889707|3961178|P1|Overall Study|Adverse Event|1
1206686|NCT00889681|3961186|P1|Overall Study|Insurance disapproval|1
1206687|NCT00889681|3961186|P1|Overall Study|Not meeting qualification Criteria|2
1206688|NCT00889603|3961193|P1|Overall Study|Not Specified|4
1206689|NCT00889603|3961193|P1|Overall Study|No longer willing to participant in stud|4
1206690|NCT00889603|3961193|P1|Overall Study|Lost to Follow-up|19
1206691|NCT00889603|3961193|P1|Overall Study|Death|3
1206692|NCT00889603|3961193|P1|Overall Study|Adverse Event|7
1206693|NCT00889421|3961215|P1|Overall Study|Lack of Efficacy|3
1206694|NCT00889265|3961256|P1|Overall Study|Protocol Violation|1
1206695|NCT00889265|3961256|P1|Overall Study|Lost to Follow-up|5
1206696|NCT00889265|3961256|P1|Overall Study|Adverse Event|1
1206697|NCT00889252|3961263|P2|Overall Study|Protocol Violation|0
1206698|NCT00889252|3961264|P1|Overall Study|Protocol Violation|2
1206699|NCT00889252|3961263|P2|Overall Study|Withdrawal by Subject|0
1206700|NCT00889252|3961264|P1|Overall Study|Withdrawal by Subject|3
1206701|NCT00889252|3961263|P2|Overall Study|Adverse Event|4
1206702|NCT00889252|3961264|P1|Overall Study|Adverse Event|2
1206703|NCT00889005|3961330|P2|Overall Study|Withdrawal by Subject|0
1206704|NCT00889005|3961331|P1|Overall Study|Withdrawal by Subject|4
1206705|NCT00889005|3961330|P2|Overall Study|Lost to Follow-up|2
1206706|NCT00889005|3961331|P1|Overall Study|Lost to Follow-up|4
1206707|NCT00888940|3961345|P2|Overall Study|Randomized Not Treated|13
1206708|NCT00888940|3961346|P1|Overall Study|Randomized Not Treated|11
1206709|NCT00888940|3961345|P2|Overall Study|Lost to Follow-up|5
1206710|NCT00888940|3961346|P1|Overall Study|Lost to Follow-up|5
1206711|NCT00888940|3961345|P2|Overall Study|Adverse Event|3
1206712|NCT00888940|3961346|P1|Overall Study|Adverse Event|12
1206713|NCT00888849|3961356|P2|Overall Study|Lost to Follow-up|2
1206714|NCT00888849|3961357|P1|Overall Study|Lost to Follow-up|1
1206715|NCT00888849|3961356|P2|Overall Study|Death|7
1206716|NCT00888849|3961357|P1|Overall Study|Death|4
1206717|NCT00888654|3961367|P1|Overall Study|Stopped meds due to headaches|1
1206718|NCT00888654|3961367|P1|Overall Study|Change in surg date|1
1206719|NCT00888654|3961367|P1|Overall Study|Inelig. due to contraindication of med|1
1206720|NCT00888654|3961367|P1|Overall Study|Withdrawal by Subject|1
1206721|NCT00888654|3961367|P1|Overall Study|Surgery aborted|2
1206722|NCT00888654|3961367|P1|Overall Study|Not enough oral meds before surgery|3
1206723|NCT00888654|3961367|P1|Overall Study|Problems swallowing oral meds.|1
1206724|NCT00888433|3961396|P2|Overall Study|Missed Visit|1
1206725|NCT00888433|3961397|P1|Overall Study|Missed Visit|2
1206726|NCT00888433|3961396|P2|Overall Study|Withdrawal by Subject|2
1206727|NCT00888433|3961397|P1|Overall Study|Withdrawal by Subject|1
1206728|NCT00888381|3961405|P2|Overall Study|Lost to Follow-up|1
1206729|NCT00888381|3961406|P1|Overall Study|Lost to Follow-up|0
1206730|NCT00888355|3961426|P4|Overall Study|Withdrawal by Subject|3
1206731|NCT00888355|3961427|P3|Overall Study|Withdrawal by Subject|1
1206732|NCT00888355|3961428|P2|Overall Study|Withdrawal by Subject|3
1206733|NCT00888355|3961429|P1|Overall Study|Withdrawal by Subject|0
1206734|NCT00888355|3961426|P4|Overall Study|Protocol Violation|2
1206735|NCT00888355|3961427|P3|Overall Study|Protocol Violation|1
1206736|NCT00888355|3961428|P2|Overall Study|Protocol Violation|2
1206737|NCT00888355|3961429|P1|Overall Study|Protocol Violation|3
1206738|NCT00888355|3961426|P4|Overall Study|Lost to Follow-up|0
1206739|NCT00888355|3961427|P3|Overall Study|Lost to Follow-up|2
1206740|NCT00888355|3961428|P2|Overall Study|Lost to Follow-up|2
1206741|NCT00888355|3961429|P1|Overall Study|Lost to Follow-up|0
1206742|NCT00888355|3961426|P4|Overall Study|Lack of Efficacy|2
1206743|NCT00888355|3961427|P3|Overall Study|Lack of Efficacy|5
1206744|NCT00888355|3961428|P2|Overall Study|Lack of Efficacy|2
1206745|NCT00888355|3961429|P1|Overall Study|Lack of Efficacy|9
1206746|NCT00888355|3961426|P4|Overall Study|Adverse Event|3
1206747|NCT00888355|3961427|P3|Overall Study|Adverse Event|3
1206748|NCT00888355|3961428|P2|Overall Study|Adverse Event|0
1206749|NCT00888355|3961429|P1|Overall Study|Adverse Event|10
1206750|NCT00888329|3961485|P2|Overall Study|Physician Decision|9
1206751|NCT00888329|3961486|P1|Overall Study|Physician Decision|6
1206752|NCT00888238|3961492|P3|Washout Period After Period 2|Adverse Event|1
1206753|NCT00888238|3961493|P2|Washout Period After Period 2|Adverse Event|0
1206754|NCT00888238|3961494|P1|Washout Period After Period 2|Adverse Event|0
1206755|NCT00888173|3961502|P1|Overall Study|Ineligible: required test not done|1
1206756|NCT00888173|3961502|P1|Overall Study|Wrong Primary|1
1206757|NCT00888134|3961510|P1|Follow-up|being followed for long-term survival|1
1206758|NCT00888134|3961510|P1|Treatment With Study Drug|Withdrawal by Subject|1
1206759|NCT00887978|3961520|P2|Overall Study|Lost to Follow-up|1
1206760|NCT00887978|3961521|P1|Overall Study|Lost to Follow-up|0
1206761|NCT00887978|3961520|P2|Overall Study|Withdrawal by Subject|2
1206762|NCT00887978|3961521|P1|Overall Study|Withdrawal by Subject|1
1206763|NCT00887978|3961520|P2|Overall Study|Death|3
1206764|NCT00887978|3961521|P1|Overall Study|Death|2
1206765|NCT00887978|3961520|P2|Overall Study|Clinical Worsening|4
1206766|NCT00887978|3961521|P1|Overall Study|Clinical Worsening|4
1206767|NCT00887978|3961520|P2|Overall Study|Adverse Event|5
1206768|NCT00887978|3961521|P1|Overall Study|Adverse Event|18
1206769|NCT00887913|3961587|P1|Overall Study|Withdrawal by Subject|6
1206770|NCT00887822|3961595|P2|Overall Study|Randomized but not treated|1
1206771|NCT00887822|3961596|P1|Overall Study|Randomized but not treated|0
1206772|NCT00887822|3961595|P2|Overall Study|Protocol Violation|1
1206773|NCT00887822|3961596|P1|Overall Study|Protocol Violation|0
1206774|NCT00887822|3961595|P2|Overall Study|Death|3
1206775|NCT00887822|3961596|P1|Overall Study|Death|2
1206776|NCT00887822|3961595|P2|Overall Study|Administrative/Other than specified|4
1206777|NCT00887822|3961596|P1|Overall Study|Administrative/Other than specified|5
1206778|NCT00887822|3961595|P2|Overall Study|Refused treatment/Did not cooperate|10
1206779|NCT00887822|3961596|P1|Overall Study|Refused treatment/Did not cooperate|12
1206780|NCT00887822|3961595|P2|Overall Study|Failure to return|11
1206781|NCT00887822|3961596|P1|Overall Study|Failure to return|11
1206782|NCT00887822|3961595|P2|Overall Study|Adverse Event|17
1206783|NCT00887822|3961596|P1|Overall Study|Adverse Event|14
1206784|NCT00887822|3961595|P2|Overall Study|Insufficient therapeutic response|55
1206785|NCT00887822|3961596|P1|Overall Study|Insufficient therapeutic response|53
1206786|NCT00887809|3961628|P2|Overall Study|Death|0
1206787|NCT00887809|3961629|P1|Overall Study|Death|1
1206788|NCT00887809|3961628|P2|Overall Study|Patient Not Treated|0
1206789|NCT00887809|3961629|P1|Overall Study|Patient Not Treated|3
1206790|NCT00887744|3961635|P1|Overall Study|Various reasons|9
1206791|NCT00887744|3961635|P1|Overall Study|Withdrawal by Subject|18
1206792|NCT00887744|3961635|P1|Overall Study|Lost to Follow-up|3
1206793|NCT00887744|3961635|P1|Overall Study|Death|1
1206794|NCT00887744|3961635|P1|Overall Study|Adverse Event|3
1206795|NCT00887679|3961644|P1|Overall Study|Physician Decision|5
1206796|NCT00887679|3961644|P1|Overall Study|Lost to Follow-up|4
1206797|NCT00887679|3961644|P1|Overall Study|Withdrawal by Subject|1
1206798|NCT00887588|3961674|P2|Extension Period|Lost to Follow-up|0
1206799|NCT00887588|3961675|P1|Extension Period|Lost to Follow-up|1
1206800|NCT00887588|3961674|P2|Extension Period|Protocol deviation|0
1206801|NCT00887588|3961675|P1|Extension Period|Protocol deviation|1
1206802|NCT00887588|3961674|P2|Extension Period|Death|1
1206803|NCT00887588|3961675|P1|Extension Period|Death|0
1206804|NCT00887588|3961674|P2|Extension Period|Adverse Event|4
1206805|NCT00887588|3961675|P1|Extension Period|Adverse Event|4
1206806|NCT00887588|3961674|P2|Core Period|Adverse Event|11
1206807|NCT00887588|3961675|P1|Core Period|Adverse Event|9
1206808|NCT00887588|3961674|P2|Core Period|Withdrawal by Subject|8
1206809|NCT00887588|3961675|P1|Core Period|Withdrawal by Subject|6
1206810|NCT00887588|3961674|P2|Core Period|Lost to Follow-up|1
1206811|NCT00887588|3961675|P1|Core Period|Lost to Follow-up|3
1206812|NCT00887588|3961674|P2|Core Period|Death|1
1206813|NCT00887588|3961675|P1|Core Period|Death|1
1206814|NCT00887549|3961756|P1|Maintenance Therapy|Death due to adverse event|1
1206815|NCT00887549|3961756|P1|Maintenance Therapy|Progressive Disease|25
1206816|NCT00887549|3961756|P1|Maintenance Therapy|Physician Decision|1
1206817|NCT00887549|3961756|P1|Maintenance Therapy|Adverse Event|16
1206818|NCT00887549|3961756|P1|Induction Therapy|Death due to Study Drug Toxicity|1
1206819|NCT00887549|3961756|P1|Induction Therapy|Death due to Study Disease|4
1206820|NCT00887549|3961756|P1|Induction Therapy|Progressive Disease|13
1206821|NCT00887549|3961756|P1|Induction Therapy|Physician Decision|1
1206822|NCT00887549|3961756|P1|Induction Therapy|Adverse Event|8
1206823|NCT00887484|3961774|P1|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1
1206824|NCT00887484|3961774|P1|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
1206825|NCT00887484|3961774|P1|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1
1206826|NCT00887354|3961862|P2|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
1206827|NCT00887354|3961863|P1|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
1206828|NCT00887354|3961862|P2|Open Label Phase (Week 26 to Week 78)|Adverse Event|0
1206829|NCT00887354|3961863|P1|Open Label Phase (Week 26 to Week 78)|Adverse Event|1
1206830|NCT00887354|3961862|P2|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2
1206831|NCT00887354|3961863|P1|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1
1206832|NCT00887354|3961862|P2|Open Label Phase (Week 26 to Week 78)|Physician Decision|1
1206833|NCT00887354|3961863|P1|Open Label Phase (Week 26 to Week 78)|Physician Decision|0
1206834|NCT00887354|3961862|P2|Open Label Phase (Week 26 to Week 78)|Death|2
1206835|NCT00887354|3961863|P1|Open Label Phase (Week 26 to Week 78)|Death|0
1206836|NCT00887354|3961862|P2|Treatment Phase (Week 0 to Week 26)|Not Treated|3
1206837|NCT00887354|3961863|P1|Treatment Phase (Week 0 to Week 26)|Not Treated|5
1206838|NCT00887354|3961862|P2|Treatment Phase (Week 0 to Week 26)|No efficacy data|25
1206839|NCT00887354|3961863|P1|Treatment Phase (Week 0 to Week 26)|No efficacy data|20
1206840|NCT00887354|3961862|P2|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2
1206841|NCT00887354|3961863|P1|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1
1206842|NCT00887354|3961862|P2|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
1206843|NCT00887354|3961863|P1|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
1206844|NCT00887354|3961862|P2|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1
1206845|NCT00887354|3961863|P1|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2
1206846|NCT00887354|3961862|P2|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
1206847|NCT00887354|3961863|P1|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
1206848|NCT00887354|3961862|P2|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8
1206849|NCT00887354|3961863|P1|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14
1206850|NCT00887354|3961862|P2|Treatment Phase (Week 0 to Week 26)|Physician Decision|1
1206851|NCT00887354|3961863|P1|Treatment Phase (Week 0 to Week 26)|Physician Decision|2
1206852|NCT00887354|3961862|P2|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
1206853|NCT00887354|3961863|P1|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
1206854|NCT00887354|3961862|P2|Treatment Phase (Week 0 to Week 26)|Death|1
1206855|NCT00887354|3961863|P1|Treatment Phase (Week 0 to Week 26)|Death|0
1206856|NCT00887341|3961883|P2|Overall Study|Lost to Follow-up|1
1206857|NCT00887341|3961884|P1|Overall Study|Lost to Follow-up|0
1206858|NCT00887341|3961883|P2|Overall Study|Adverse Event|1
1206859|NCT00887341|3961884|P1|Overall Study|Adverse Event|0
1206860|NCT00887341|3961883|P2|Overall Study|Withdrawal by Subject|1
1206861|NCT00887341|3961884|P1|Overall Study|Withdrawal by Subject|1
1206862|NCT00887341|3961883|P2|Overall Study|Refused treatment|0
1206863|NCT00887341|3961884|P1|Overall Study|Refused treatment|1
1206864|NCT00887315|3961920|P2|Overall Study|Study termination|4
1206865|NCT00887315|3961921|P1|Overall Study|Study termination|7
1206866|NCT00887289|3961929|P1|Overall Study|not specified|20
1206867|NCT00887289|3961929|P1|Overall Study|Lost to Follow-up|8
1206868|NCT00887289|3961929|P1|Overall Study|Withdrawal by Subject|26
1206869|NCT00887289|3961929|P1|Overall Study|Adverse Event|27
1206870|NCT00887289|3961929|P1|Overall Study|Lack of Efficacy|14
1206871|NCT00887250|3961941|P3|Overall Study|Patient uncooperative|1
1206872|NCT00887250|3961942|P2|Overall Study|Patient uncooperative|0
1206873|NCT00887250|3961943|P1|Overall Study|Patient uncooperative|0
1206874|NCT00887250|3961941|P3|Overall Study|Withdrawal by Subject|2
1206875|NCT00887250|3961942|P2|Overall Study|Withdrawal by Subject|1
1206876|NCT00887250|3961943|P1|Overall Study|Withdrawal by Subject|2
1206877|NCT00887250|3961941|P3|Overall Study|Protocol Violation|1
1206878|NCT00887250|3961942|P2|Overall Study|Protocol Violation|2
1206879|NCT00887250|3961943|P1|Overall Study|Protocol Violation|2
1206880|NCT00887250|3961941|P3|Overall Study|Lost to Follow-up|1
1206881|NCT00887250|3961942|P2|Overall Study|Lost to Follow-up|3
1206882|NCT00887250|3961943|P1|Overall Study|Lost to Follow-up|2
1206883|NCT00887250|3961941|P3|Overall Study|Lack of Efficacy|1
1206884|NCT00887250|3961942|P2|Overall Study|Lack of Efficacy|6
1206885|NCT00887250|3961943|P1|Overall Study|Lack of Efficacy|9
1206886|NCT00887250|3961941|P3|Overall Study|Adverse Event|7
1206887|NCT00887250|3961942|P2|Overall Study|Adverse Event|0
1206888|NCT00887250|3961943|P1|Overall Study|Adverse Event|3
1206889|NCT00887224|3961966|P3|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11
1206890|NCT00887224|3961967|P2|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8
1206891|NCT00887224|3961968|P1|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0
1206892|NCT00887224|3961966|P3|DB Taper Phase / Post Study Follow Up|Protocol Violation|1
1206893|NCT00887224|3961967|P2|DB Taper Phase / Post Study Follow Up|Protocol Violation|4
1206894|NCT00887224|3961968|P1|DB Taper Phase / Post Study Follow Up|Protocol Violation|0
1206895|NCT00887224|3961966|P3|DB Taper Phase / Post Study Follow Up|Other|12
1206896|NCT00887224|3961967|P2|DB Taper Phase / Post Study Follow Up|Other|11
1206897|NCT00887224|3961968|P1|DB Taper Phase / Post Study Follow Up|Other|0
1206898|NCT00887224|3961966|P3|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
1206899|NCT00887224|3961967|P2|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
1206900|NCT00887224|3961968|P1|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0
1206901|NCT00887224|3961966|P3|DB Taper Phase / Post Study Follow Up|Physician Decision|0
1206902|NCT00887224|3961967|P2|DB Taper Phase / Post Study Follow Up|Physician Decision|6
1206903|NCT00887224|3961968|P1|DB Taper Phase / Post Study Follow Up|Physician Decision|0
1206904|NCT00887224|3961966|P3|DB Taper Phase / Post Study Follow Up|Failed to return|4
1206905|NCT00887224|3961967|P2|DB Taper Phase / Post Study Follow Up|Failed to return|5
1206906|NCT00887224|3961968|P1|DB Taper Phase / Post Study Follow Up|Failed to return|0
1206907|NCT00887224|3961966|P3|DB Taper Phase / Post Study Follow Up|Adverse Event|0
1206908|NCT00887224|3961967|P2|DB Taper Phase / Post Study Follow Up|Adverse Event|5
1206909|NCT00887224|3961968|P1|DB Taper Phase / Post Study Follow Up|Adverse Event|0
1206910|NCT00887224|3961966|P3|Double-blind (DB) Phase|Withdrawal by Subject|12
1206911|NCT00887224|3961967|P2|Double-blind (DB) Phase|Withdrawal by Subject|6
1206912|NCT00887224|3961968|P1|Double-blind (DB) Phase|Withdrawal by Subject|0
1206913|NCT00887224|3961966|P3|Double-blind (DB) Phase|Protocol Violation|5
1206914|NCT00887224|3961967|P2|Double-blind (DB) Phase|Protocol Violation|8
1206915|NCT00887224|3961968|P1|Double-blind (DB) Phase|Protocol Violation|0
1206916|NCT00887224|3961966|P3|Double-blind (DB) Phase|Other|0
1206917|NCT00887224|3961967|P2|Double-blind (DB) Phase|Other|2
1206918|NCT00887224|3961968|P1|Double-blind (DB) Phase|Other|0
1206919|NCT00887224|3961966|P3|Double-blind (DB) Phase|Lost to Follow-up|8
1206920|NCT00887224|3961967|P2|Double-blind (DB) Phase|Lost to Follow-up|8
1206921|NCT00887224|3961968|P1|Double-blind (DB) Phase|Lost to Follow-up|0
1206922|NCT00887224|3961966|P3|Double-blind (DB) Phase|Lack of Efficacy|33
1206923|NCT00887224|3961967|P2|Double-blind (DB) Phase|Lack of Efficacy|67
1206924|NCT00887224|3961968|P1|Double-blind (DB) Phase|Lack of Efficacy|0
1206925|NCT00887224|3961966|P3|Double-blind (DB) Phase|Failed to return|2
1206926|NCT00887224|3961967|P2|Double-blind (DB) Phase|Failed to return|2
1206927|NCT00887224|3961968|P1|Double-blind (DB) Phase|Failed to return|0
1206928|NCT00887224|3961966|P3|Double-blind (DB) Phase|Adverse Event|2
1206929|NCT00887224|3961967|P2|Double-blind (DB) Phase|Adverse Event|7
1206930|NCT00887224|3961968|P1|Double-blind (DB) Phase|Adverse Event|0
1206931|NCT00887224|3961966|P3|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
1206932|NCT00887224|3961967|P2|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
1206933|NCT00887224|3961968|P1|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48
1206934|NCT00887224|3961966|P3|OL Taper Phase / OL Follow Up|Protocol Violation|0
1206935|NCT00887224|3961967|P2|OL Taper Phase / OL Follow Up|Protocol Violation|0
1206936|NCT00887224|3961968|P1|OL Taper Phase / OL Follow Up|Protocol Violation|3
1206937|NCT00887224|3961966|P3|OL Taper Phase / OL Follow Up|Other|0
1206938|NCT00887224|3961967|P2|OL Taper Phase / OL Follow Up|Other|0
1206939|NCT00887224|3961968|P1|OL Taper Phase / OL Follow Up|Other|30
1206940|NCT00887224|3961966|P3|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
1206941|NCT00887224|3961967|P2|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
1206942|NCT00887224|3961968|P1|OL Taper Phase / OL Follow Up|Lost to Follow-up|8
1206943|NCT00887224|3961966|P3|OL Taper Phase / OL Follow Up|Physician Decision|0
1206944|NCT00887224|3961967|P2|OL Taper Phase / OL Follow Up|Physician Decision|0
1206945|NCT00887224|3961968|P1|OL Taper Phase / OL Follow Up|Physician Decision|10
1206946|NCT00887224|3961966|P3|OL Taper Phase / OL Follow Up|Failed to return|0
1206947|NCT00887224|3961967|P2|OL Taper Phase / OL Follow Up|Failed to return|0
1206948|NCT00887224|3961968|P1|OL Taper Phase / OL Follow Up|Failed to return|17
1206949|NCT00887224|3961966|P3|OL Taper Phase / OL Follow Up|Adverse Event|0
1206950|NCT00887224|3961967|P2|OL Taper Phase / OL Follow Up|Adverse Event|0
1206951|NCT00887224|3961968|P1|OL Taper Phase / OL Follow Up|Adverse Event|28
1206952|NCT00887224|3961966|P3|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
1206953|NCT00887224|3961967|P2|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
1206954|NCT00887224|3961968|P1|Open-label Stability (OLS) Phase|Withdrawal by Subject|19
1206955|NCT00887224|3961966|P3|Open-label Stability (OLS) Phase|Protocol Violation|0
1206956|NCT00887224|3961967|P2|Open-label Stability (OLS) Phase|Protocol Violation|0
1206957|NCT00887224|3961968|P1|Open-label Stability (OLS) Phase|Protocol Violation|13
1206958|NCT00887224|3961966|P3|Open-label Stability (OLS) Phase|Other|0
1206959|NCT00887224|3961967|P2|Open-label Stability (OLS) Phase|Other|0
1206960|NCT00887224|3961968|P1|Open-label Stability (OLS) Phase|Other|1
1206961|NCT00887224|3961966|P3|Open-label Stability (OLS) Phase|Lost to Follow-up|0
1206962|NCT00887224|3961967|P2|Open-label Stability (OLS) Phase|Lost to Follow-up|0
1206963|NCT00887224|3961968|P1|Open-label Stability (OLS) Phase|Lost to Follow-up|9
1206964|NCT00887224|3961966|P3|Open-label Stability (OLS) Phase|Lack of Efficacy|0
1206965|NCT00887224|3961967|P2|Open-label Stability (OLS) Phase|Lack of Efficacy|0
1206966|NCT00887224|3961968|P1|Open-label Stability (OLS) Phase|Lack of Efficacy|16
1206967|NCT00887224|3961966|P3|Open-label Stability (OLS) Phase|Failed to return|0
1206968|NCT00887224|3961967|P2|Open-label Stability (OLS) Phase|Failed to return|0
1206969|NCT00887224|3961968|P1|Open-label Stability (OLS) Phase|Failed to return|3
1206970|NCT00887224|3961966|P3|Open-label Stability (OLS) Phase|Adverse Event|0
1206971|NCT00887224|3961967|P2|Open-label Stability (OLS) Phase|Adverse Event|0
1206972|NCT00887224|3961968|P1|Open-label Stability (OLS) Phase|Adverse Event|22
1206973|NCT00887224|3961966|P3|Open-label Response (OLR) Phase|Withdrawal by Subject|0
1206974|NCT00887224|3961967|P2|Open-label Response (OLR) Phase|Withdrawal by Subject|0
1206975|NCT00887224|3961968|P1|Open-label Response (OLR) Phase|Withdrawal by Subject|15
1206976|NCT00887224|3961966|P3|Open-label Response (OLR) Phase|Protocol Violation|0
1206977|NCT00887224|3961967|P2|Open-label Response (OLR) Phase|Protocol Violation|0
1206978|NCT00887224|3961968|P1|Open-label Response (OLR) Phase|Protocol Violation|12
1206979|NCT00887224|3961966|P3|Open-label Response (OLR) Phase|Other|0
1206980|NCT00887224|3961967|P2|Open-label Response (OLR) Phase|Other|0
1206981|NCT00887224|3961968|P1|Open-label Response (OLR) Phase|Other|1
1206982|NCT00887224|3961966|P3|Open-label Response (OLR) Phase|Lost to Follow-up|0
1206983|NCT00887224|3961967|P2|Open-label Response (OLR) Phase|Lost to Follow-up|0
1206984|NCT00887224|3961968|P1|Open-label Response (OLR) Phase|Lost to Follow-up|16
1206985|NCT00887224|3961966|P3|Open-label Response (OLR) Phase|Lack of Efficacy|0
1206986|NCT00887224|3961967|P2|Open-label Response (OLR) Phase|Lack of Efficacy|0
1206987|NCT00887224|3961968|P1|Open-label Response (OLR) Phase|Lack of Efficacy|26
1206988|NCT00887224|3961966|P3|Open-label Response (OLR) Phase|Failed to return|0
1206989|NCT00887224|3961967|P2|Open-label Response (OLR) Phase|Failed to return|0
1206990|NCT00887224|3961968|P1|Open-label Response (OLR) Phase|Failed to return|6
1206991|NCT00887224|3961966|P3|Open-label Response (OLR) Phase|Adverse Event|0
1206992|NCT00887224|3961967|P2|Open-label Response (OLR) Phase|Adverse Event|0
1206993|NCT00887224|3961968|P1|Open-label Response (OLR) Phase|Adverse Event|46
1206994|NCT00887198|3961995|P3|Cross Over (Placebo to AA)|Other|19
1206995|NCT00887198|3961996|P2|Cross Over (Placebo to AA)|Other|0
1206996|NCT00887198|3961997|P1|Cross Over (Placebo to AA)|Other|0
1206997|NCT00887198|3961995|P3|Cross Over (Placebo to AA)|Progressive disease|20
1206998|NCT00887198|3961996|P2|Cross Over (Placebo to AA)|Progressive disease|0
1206999|NCT00887198|3961997|P1|Cross Over (Placebo to AA)|Progressive disease|0
1207000|NCT00887198|3961995|P3|Cross Over (Placebo to AA)|Withdrawal by Subject|2
1207001|NCT00887198|3961996|P2|Cross Over (Placebo to AA)|Withdrawal by Subject|0
1207002|NCT00887198|3961997|P1|Cross Over (Placebo to AA)|Withdrawal by Subject|0
1207003|NCT00887198|3961995|P3|Cross Over (Placebo to AA)|Adverse Event|9
1207004|NCT00887198|3961996|P2|Cross Over (Placebo to AA)|Adverse Event|0
1207005|NCT00887198|3961997|P1|Cross Over (Placebo to AA)|Adverse Event|0
1207006|NCT00887198|3961995|P3|Cross Over (Placebo to AA)|Ongoing|35
1207007|NCT00887198|3961996|P2|Cross Over (Placebo to AA)|Ongoing|0
1207008|NCT00887198|3961997|P1|Cross Over (Placebo to AA)|Ongoing|0
1207009|NCT00887198|3961995|P3|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8
1207010|NCT00887198|3961996|P2|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
1207011|NCT00887198|3961997|P1|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
1207012|NCT00887198|3961995|P3|Randomized Period|Randomized, Not treated|0
1207013|NCT00887198|3961996|P2|Randomized Period|Randomized, Not treated|2
1207014|NCT00887198|3961997|P1|Randomized Period|Randomized, Not treated|4
1207015|NCT00887198|3961995|P3|Randomized Period|Other|0
1207016|NCT00887198|3961996|P2|Randomized Period|Other|30
1207017|NCT00887198|3961997|P1|Randomized Period|Other|42
1207018|NCT00887198|3961995|P3|Randomized Period|Progressive disease|0
1207019|NCT00887198|3961996|P2|Randomized Period|Progressive disease|370
1207020|NCT00887198|3961997|P1|Randomized Period|Progressive disease|366
1207021|NCT00887198|3961995|P3|Randomized Period|Withdrawal by Subject|0
1207022|NCT00887198|3961996|P2|Randomized Period|Withdrawal by Subject|56
1207023|NCT00887198|3961997|P1|Randomized Period|Withdrawal by Subject|41
1207024|NCT00887198|3961995|P3|Randomized Period|Cross-over to AA (under amendment 3)|0
1207025|NCT00887198|3961996|P2|Randomized Period|Cross-over to AA (under amendment 3)|51
1207026|NCT00887198|3961997|P1|Randomized Period|Cross-over to AA (under amendment 3)|0
1207027|NCT00887198|3961995|P3|Randomized Period|Lost to Follow-up|0
1207028|NCT00887198|3961996|P2|Randomized Period|Lost to Follow-up|0
1207029|NCT00887198|3961997|P1|Randomized Period|Lost to Follow-up|1
1207030|NCT00887198|3961995|P3|Randomized Period|Adverse Event|0
1207031|NCT00887198|3961996|P2|Randomized Period|Adverse Event|33
1207032|NCT00887198|3961997|P1|Randomized Period|Adverse Event|50
1207033|NCT00887198|3961995|P3|Randomized Period|Ongoing|0
1207034|NCT00887198|3961996|P2|Randomized Period|Ongoing|0
1207035|NCT00887198|3961997|P1|Randomized Period|Ongoing|42
1207036|NCT00887159|3962028|P3|Overall Study|Never started assigned therapy|4
1207037|NCT00887159|3962029|P2|Overall Study|Never started assigned therapy|3
1207038|NCT00887159|3962030|P1|Overall Study|Never started assigned therapy|3
1207039|NCT00887159|3962028|P3|Overall Study|Ineligible|0
1207040|NCT00887159|3962029|P2|Overall Study|Ineligible|1
1207041|NCT00887159|3962030|P1|Overall Study|Ineligible|5
1207042|NCT00887159|3962028|P3|Overall Study|Received more tx instead of observation|0
1207043|NCT00887159|3962029|P2|Overall Study|Received more tx instead of observation|0
1207044|NCT00887159|3962030|P1|Overall Study|Received more tx instead of observation|1
1207045|NCT00887159|3962028|P3|Overall Study|Pt had PD but was SD when re-measured|0
1207046|NCT00887159|3962029|P2|Overall Study|Pt had PD but was SD when re-measured|1
1207047|NCT00887159|3962030|P1|Overall Study|Pt had PD but was SD when re-measured|0
1207048|NCT00887159|3962028|P3|Overall Study|Treatment delayed|0
1207049|NCT00887159|3962029|P2|Overall Study|Treatment delayed|1
1207050|NCT00887159|3962030|P1|Overall Study|Treatment delayed|1
1207051|NCT00887159|3962028|P3|Overall Study|Sympomatic deterioration|0
1207052|NCT00887159|3962029|P2|Overall Study|Sympomatic deterioration|0
1207053|NCT00887159|3962030|P1|Overall Study|Sympomatic deterioration|1
1207054|NCT00887159|3962028|P3|Overall Study|Physician Decision|0
1207055|NCT00887159|3962029|P2|Overall Study|Physician Decision|1
1207056|NCT00887159|3962030|P1|Overall Study|Physician Decision|1
1207057|NCT00887159|3962028|P3|Overall Study|Alternative therapy|0
1207058|NCT00887159|3962029|P2|Overall Study|Alternative therapy|0
1207059|NCT00887159|3962030|P1|Overall Study|Alternative therapy|2
1207060|NCT00887159|3962028|P3|Overall Study|Withdrawal by Subject|2
1207061|NCT00887159|3962029|P2|Overall Study|Withdrawal by Subject|4
1207062|NCT00887159|3962030|P1|Overall Study|Withdrawal by Subject|4
1207063|NCT00887159|3962028|P3|Overall Study|Death|0
1207064|NCT00887159|3962029|P2|Overall Study|Death|2
1207065|NCT00887159|3962030|P1|Overall Study|Death|2
1207066|NCT00887159|3962028|P3|Overall Study|Adverse Event|17
1207067|NCT00887159|3962029|P2|Overall Study|Adverse Event|4
1207068|NCT00887159|3962030|P1|Overall Study|Adverse Event|3
1207069|NCT00887159|3962028|P3|Overall Study|Disease progression|33
1207070|NCT00887159|3962029|P2|Overall Study|Disease progression|39
1207071|NCT00887159|3962030|P1|Overall Study|Disease progression|6
1207072|NCT00886938|3962046|P1|Overall Study|Withdrawal by Subject|1
1207073|NCT00886938|3962046|P1|Overall Study|Adverse Event|1
1207074|NCT00886834|3962059|P2|Overall Study|Protocol Violation|3
1207075|NCT00886834|3962060|P1|Overall Study|Protocol Violation|0
1207076|NCT00886821|3962082|P14|Stage 2|Lost to Follow-up|1
1207077|NCT00886821|3962083|P13|Stage 2|Lost to Follow-up|2
1207078|NCT00886821|3962084|P12|Stage 2|Lost to Follow-up|0
1207079|NCT00886821|3962085|P11|Stage 2|Lost to Follow-up|0
1207080|NCT00886821|3962086|P10|Stage 2|Lost to Follow-up|0
1207081|NCT00886821|3962087|P9|Stage 2|Lost to Follow-up|0
1207082|NCT00886821|3962088|P8|Stage 2|Lost to Follow-up|0
1207083|NCT00886821|3962089|P7|Stage 2|Lost to Follow-up|0
1207084|NCT00886821|3962090|P6|Stage 2|Lost to Follow-up|0
1207085|NCT00886821|3962091|P5|Stage 2|Lost to Follow-up|0
1207086|NCT00886821|3962092|P4|Stage 2|Lost to Follow-up|0
1207087|NCT00886821|3962093|P3|Stage 2|Lost to Follow-up|0
1207088|NCT00886821|3962094|P2|Stage 2|Lost to Follow-up|0
1207089|NCT00886821|3962095|P1|Stage 2|Lost to Follow-up|0
1207090|NCT00886821|3962082|P14|Stage 2|Adverse Event|0
1207091|NCT00886821|3962083|P13|Stage 2|Adverse Event|3
1207092|NCT00886821|3962084|P12|Stage 2|Adverse Event|1
1207093|NCT00886821|3962085|P11|Stage 2|Adverse Event|0
1207094|NCT00886821|3962086|P10|Stage 2|Adverse Event|0
1207095|NCT00886821|3962087|P9|Stage 2|Adverse Event|0
1207096|NCT00886821|3962088|P8|Stage 2|Adverse Event|0
1207097|NCT00886821|3962089|P7|Stage 2|Adverse Event|0
1207098|NCT00886821|3962090|P6|Stage 2|Adverse Event|0
1207099|NCT00886821|3962091|P5|Stage 2|Adverse Event|0
1207100|NCT00886821|3962092|P4|Stage 2|Adverse Event|0
1207101|NCT00886821|3962093|P3|Stage 2|Adverse Event|0
1207102|NCT00886821|3962094|P2|Stage 2|Adverse Event|0
1207103|NCT00886821|3962095|P1|Stage 2|Adverse Event|0
1207104|NCT00886795|3962320|P1|Overall Study|Lack of Efficacy|1
1207105|NCT00886769|3962327|P2|Overall Study|Unsatisfactory therapeutic effect|37
1207106|NCT00886769|3962328|P1|Overall Study|Unsatisfactory therapeutic effect|6
1207107|NCT00886743|3962352|P1|Overall Study|Other|1
1207108|NCT00886743|3962352|P1|Overall Study|Adverse Event|3
1207109|NCT00886639|3962390|P1|Overall Study|non-compliance|2
1207110|NCT00886639|3962390|P1|Overall Study|acute exacerbation|14
1207111|NCT00886613|3962404|P3|Overall Study|Subject withdrew consent (Part A)|2
1207112|NCT00886613|3962405|P2|Overall Study|Subject withdrew consent (Part A)|0
1207113|NCT00886613|3962406|P1|Overall Study|Subject withdrew consent (Part A)|0
1207114|NCT00886613|3962404|P3|Overall Study|Lost to follow-up (Part B)|1
1207115|NCT00886613|3962405|P2|Overall Study|Lost to follow-up (Part B)|0
1207116|NCT00886613|3962406|P1|Overall Study|Lost to follow-up (Part B)|1
1207117|NCT00886613|3962404|P3|Overall Study|Protocol deviation (Part B)|0
1207118|NCT00886613|3962405|P2|Overall Study|Protocol deviation (Part B)|0
1207119|NCT00886613|3962406|P1|Overall Study|Protocol deviation (Part B)|1
1207120|NCT00886600|3962428|P4|Combination Therapy Period|Protocol Violation|0
1207121|NCT00886600|3962429|P3|Combination Therapy Period|Protocol Violation|1
1207122|NCT00886600|3962430|P2|Combination Therapy Period|Protocol Violation|0
1207123|NCT00886600|3962431|P1|Combination Therapy Period|Protocol Violation|0
1207124|NCT00886600|3962428|P4|Combination Therapy Period|Adverse Event|0
1207125|NCT00886600|3962429|P3|Combination Therapy Period|Adverse Event|1
1207126|NCT00886600|3962430|P2|Combination Therapy Period|Adverse Event|0
1207127|NCT00886600|3962431|P1|Combination Therapy Period|Adverse Event|0
1207128|NCT00886600|3962428|P4|Double-blind Monotherapy|Withdrawal by Subject|0
1207129|NCT00886600|3962429|P3|Double-blind Monotherapy|Withdrawal by Subject|0
1207130|NCT00886600|3962430|P2|Double-blind Monotherapy|Withdrawal by Subject|0
1207131|NCT00886600|3962431|P1|Double-blind Monotherapy|Withdrawal by Subject|1
1207132|NCT00886600|3962428|P4|Double-blind Monotherapy|Protocol Violation|1
1207133|NCT00886600|3962429|P3|Double-blind Monotherapy|Protocol Violation|0
1207134|NCT00886600|3962430|P2|Double-blind Monotherapy|Protocol Violation|0
1207135|NCT00886600|3962431|P1|Double-blind Monotherapy|Protocol Violation|0
1207136|NCT00886600|3962428|P4|Double-blind Monotherapy|Adverse Event|1
1207137|NCT00886600|3962429|P3|Double-blind Monotherapy|Adverse Event|1
1207138|NCT00886600|3962430|P2|Double-blind Monotherapy|Adverse Event|1
1207139|NCT00886600|3962431|P1|Double-blind Monotherapy|Adverse Event|1
1207140|NCT00886587|3962455|P2|Overall Study|Withdrawal by Subject|1
1207141|NCT00886587|3962456|P1|Overall Study|Withdrawal by Subject|0
1207142|NCT00886587|3962455|P2|Overall Study|Protocol Violation|0
1207143|NCT00886587|3962456|P1|Overall Study|Protocol Violation|2
1207144|NCT00886587|3962455|P2|Overall Study|Adverse Event|1
1207145|NCT00886587|3962456|P1|Overall Study|Adverse Event|2
1207146|NCT00886483|3962470|P2|Overall Study|Distance to center, poor grades|0
1207147|NCT00886483|3962471|P1|Overall Study|Distance to center, poor grades|1
1207148|NCT00886483|3962470|P2|Overall Study|Pursue medications|2
1207149|NCT00886483|3962471|P1|Overall Study|Pursue medications|1
1207150|NCT00886483|3962470|P2|Overall Study|Lost to Follow-up|1
1207151|NCT00886483|3962471|P1|Overall Study|Lost to Follow-up|0
1207152|NCT00886340|3962489|P2|Overall Study|Withdrawal by Subject|7
1207153|NCT00886340|3962490|P1|Overall Study|Withdrawal by Subject|0
1207154|NCT00886288|3962498|P2|Overall Study|Lost to Follow-up|0
1207155|NCT00886288|3962499|P1|Overall Study|Lost to Follow-up|86
1207156|NCT00886288|3962498|P2|Overall Study|no respect of the 12 weeks period|227
1207157|NCT00886288|3962499|P1|Overall Study|no respect of the 12 weeks period|657
1207158|NCT00886119|3962555|P2|Period 1|Did not meet inclusion criteria|0
1207159|NCT00886119|3962556|P1|Period 1|Did not meet inclusion criteria|1
1207160|NCT00886015|3962564|P2|Overall Study|Death|2
1207161|NCT00886015|3962565|P1|Overall Study|Death|0
1207162|NCT00885846|3962584|P3|Overall Study|Withdrawal by Subject|2
1207163|NCT00885846|3962585|P2|Overall Study|Withdrawal by Subject|5
1207164|NCT00885846|3962586|P1|Overall Study|Withdrawal by Subject|2
1207165|NCT00885755|3962601|P3|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
1207166|NCT00885755|3962602|P2|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
1207167|NCT00885755|3962603|P1|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5
1207168|NCT00885755|3962601|P3|Part I: Trastuzumab+Taxane|Death|1
1207169|NCT00885755|3962602|P2|Part I: Trastuzumab+Taxane|Death|0
1207170|NCT00885755|3962603|P1|Part I: Trastuzumab+Taxane|Death|0
1207171|NCT00885755|3962601|P3|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
1207172|NCT00885755|3962602|P2|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
1207173|NCT00885755|3962603|P1|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1
1207174|NCT00885755|3962601|P3|Part I: Trastuzumab+Taxane|Unknown Reason|0
1207175|NCT00885755|3962602|P2|Part I: Trastuzumab+Taxane|Unknown Reason|0
1207176|NCT00885755|3962603|P1|Part I: Trastuzumab+Taxane|Unknown Reason|16
1207177|NCT00885755|3962601|P3|Part I: Trastuzumab+Taxane|Adverse Event|0
1207178|NCT00885755|3962602|P2|Part I: Trastuzumab+Taxane|Adverse Event|0
1207179|NCT00885755|3962603|P1|Part I: Trastuzumab+Taxane|Adverse Event|1
1207180|NCT00885703|3962646|P7|Overall Study|Ineligible (no CM)|1
1207181|NCT00885703|3962647|P6|Overall Study|Ineligible (no CM)|3
1207182|NCT00885703|3962648|P5|Overall Study|Ineligible (no CM)|2
1207183|NCT00885703|3962649|P4|Overall Study|Ineligible (no CM)|1
1207184|NCT00885703|3962650|P3|Overall Study|Ineligible (no CM)|2
1207185|NCT00885703|3962651|P2|Overall Study|Ineligible (no CM)|3
1207186|NCT00885703|3962652|P1|Overall Study|Ineligible (no CM)|1
1207187|NCT00885703|3962646|P7|Overall Study|Withdrawal by Subject|1
1207188|NCT00885703|3962647|P6|Overall Study|Withdrawal by Subject|1
1207189|NCT00885703|3962648|P5|Overall Study|Withdrawal by Subject|3
1207190|NCT00885703|3962649|P4|Overall Study|Withdrawal by Subject|1
1207191|NCT00885703|3962650|P3|Overall Study|Withdrawal by Subject|0
1207192|NCT00885703|3962651|P2|Overall Study|Withdrawal by Subject|0
1207193|NCT00885703|3962652|P1|Overall Study|Withdrawal by Subject|0
1207194|NCT00885703|3962646|P7|Overall Study|Lost to Follow-up|0
1207195|NCT00885703|3962647|P6|Overall Study|Lost to Follow-up|1
1207196|NCT00885703|3962648|P5|Overall Study|Lost to Follow-up|0
1207197|NCT00885703|3962649|P4|Overall Study|Lost to Follow-up|0
1207198|NCT00885703|3962650|P3|Overall Study|Lost to Follow-up|1
1207199|NCT00885703|3962651|P2|Overall Study|Lost to Follow-up|0
1207200|NCT00885703|3962652|P1|Overall Study|Lost to Follow-up|0
1207201|NCT00885703|3962646|P7|Overall Study|Death|4
1207202|NCT00885703|3962647|P6|Overall Study|Death|8
1207203|NCT00885703|3962648|P5|Overall Study|Death|7
1207204|NCT00885703|3962649|P4|Overall Study|Death|7
1207205|NCT00885703|3962650|P3|Overall Study|Death|8
1207206|NCT00885703|3962651|P2|Overall Study|Death|7
1207207|NCT00885703|3962652|P1|Overall Study|Death|9
1207208|NCT00885677|3962710|P2|Overall Study|Inclusion/exclusion not met|27
1207209|NCT00885677|3962711|P1|Overall Study|Inclusion/exclusion not met|25
1207210|NCT00885677|3962710|P2|Overall Study|Heart transplantation|0
1207211|NCT00885677|3962711|P1|Overall Study|Heart transplantation|1
1207212|NCT00885677|3962710|P2|Overall Study|device/lead revision or replacement|6
1207213|NCT00885677|3962711|P1|Overall Study|device/lead revision or replacement|7
1207214|NCT00885677|3962710|P2|Overall Study|premature study closure|44
1207215|NCT00885677|3962711|P1|Overall Study|premature study closure|41
1207216|NCT00885677|3962710|P2|Overall Study|Protocol Violation|54
1207217|NCT00885677|3962711|P1|Overall Study|Protocol Violation|54
1207218|NCT00885677|3962710|P2|Overall Study|Lost to Follow-up|13
1207219|NCT00885677|3962711|P1|Overall Study|Lost to Follow-up|15
1207220|NCT00885677|3962710|P2|Overall Study|Death|34
1207221|NCT00885677|3962711|P1|Overall Study|Death|40
1207222|NCT00885534|3962727|P1|Overall Study|Patient deemed ineligible|1
1207223|NCT00885482|3962731|P1|Overall Study|low Therapeutic drug monitoring (TDM)|1
1207224|NCT00885482|3962731|P1|Overall Study|Death|1
1207225|NCT00885482|3962731|P1|Overall Study|Lack of Efficacy|1
1207226|NCT00885482|3962731|P1|Overall Study|Pregnancy|1
1207227|NCT00885378|3962737|P2|Overall Study|Protocol Violation|0
1207228|NCT00885378|3962738|P1|Overall Study|Protocol Violation|2
1207229|NCT00885378|3962737|P2|Overall Study|Poor/Noncompliance|2
1207230|NCT00885378|3962738|P1|Overall Study|Poor/Noncompliance|2
1207231|NCT00885378|3962737|P2|Overall Study|Lost to Follow-up|2
1207232|NCT00885378|3962738|P1|Overall Study|Lost to Follow-up|1
1207233|NCT00885378|3962737|P2|Overall Study|Withdrawal by Subject|2
1207234|NCT00885378|3962738|P1|Overall Study|Withdrawal by Subject|1
1207235|NCT00885378|3962737|P2|Overall Study|Lack of Efficacy|2
1207236|NCT00885378|3962738|P1|Overall Study|Lack of Efficacy|2
1207237|NCT00885365|3962768|P2|4 Weeks ON Treatment|Withdrawal by Subject|0
1207238|NCT00885365|3962769|P1|4 Weeks ON Treatment|Withdrawal by Subject|1
1207239|NCT00885365|3962768|P2|4 Weeks ON Treatment|Protocol Violation|2
1207240|NCT00885365|3962769|P1|4 Weeks ON Treatment|Protocol Violation|1
1207241|NCT00885365|3962768|P2|4 Weeks ON Treatment|Adverse Event|4
1207242|NCT00885365|3962769|P1|4 Weeks ON Treatment|Adverse Event|2
1207243|NCT00885352|3962805|P2|Overall Study|Lab abnormalities|1
1207244|NCT00885352|3962806|P1|Overall Study|Lab abnormalities|1
1207245|NCT00885352|3962805|P2|Overall Study|Excluded medication|2
1207246|NCT00885352|3962806|P1|Overall Study|Excluded medication|2
1207247|NCT00885352|3962805|P2|Overall Study|Contradiction to study medication|2
1207248|NCT00885352|3962806|P1|Overall Study|Contradiction to study medication|0
1207249|NCT00885352|3962805|P2|Overall Study|Withdrawal by Subject|5
1207250|NCT00885352|3962806|P1|Overall Study|Withdrawal by Subject|1
1207251|NCT00885352|3962805|P2|Overall Study|Protocol Violation|2
1207252|NCT00885352|3962806|P1|Overall Study|Protocol Violation|0
1207253|NCT00885352|3962805|P2|Overall Study|Physician Decision|3
1207254|NCT00885352|3962806|P1|Overall Study|Physician Decision|0
1207255|NCT00885352|3962805|P2|Overall Study|Lost to Follow-up|2
1207256|NCT00885352|3962806|P1|Overall Study|Lost to Follow-up|2
1207257|NCT00885352|3962805|P2|Overall Study|Adverse Event|3
1207258|NCT00885352|3962806|P1|Overall Study|Adverse Event|2
1207259|NCT00885170|3962818|P2|Overall Study|Withdrawal by Subject|13
1207260|NCT00885170|3962819|P1|Overall Study|Withdrawal by Subject|13
1207261|NCT00885170|3962818|P2|Overall Study|Protocol Violation|1
1207262|NCT00885170|3962819|P1|Overall Study|Protocol Violation|3
1207263|NCT00885170|3962818|P2|Overall Study|Physician Decision|1
1207264|NCT00885170|3962819|P1|Overall Study|Physician Decision|2
1207265|NCT00885170|3962818|P2|Overall Study|Lost to Follow-up|1
1207266|NCT00885170|3962819|P1|Overall Study|Lost to Follow-up|2
1207267|NCT00885170|3962818|P2|Overall Study|Excessive bone loss|3
1207268|NCT00885170|3962819|P1|Overall Study|Excessive bone loss|6
1207269|NCT00885170|3962818|P2|Overall Study|Adverse Event|4
1207270|NCT00885170|3962819|P1|Overall Study|Adverse Event|12
1207271|NCT00885118|3962878|P5|Overall Study|Other reason not defined above|0
1207272|NCT00885118|3962879|P4|Overall Study|Other reason not defined above|0
1207273|NCT00885118|3962880|P3|Overall Study|Other reason not defined above|1
1207274|NCT00885118|3962881|P2|Overall Study|Other reason not defined above|0
1207275|NCT00885118|3962882|P1|Overall Study|Other reason not defined above|0
1207276|NCT00885118|3962878|P5|Overall Study|Withdrawal by Subject|1
1207277|NCT00885118|3962879|P4|Overall Study|Withdrawal by Subject|0
1207278|NCT00885118|3962880|P3|Overall Study|Withdrawal by Subject|0
1207279|NCT00885118|3962881|P2|Overall Study|Withdrawal by Subject|0
1207280|NCT00885118|3962882|P1|Overall Study|Withdrawal by Subject|0
1207281|NCT00885118|3962878|P5|Overall Study|Adverse Event|0
1207282|NCT00885118|3962879|P4|Overall Study|Adverse Event|0
1207283|NCT00885118|3962880|P3|Overall Study|Adverse Event|0
1207284|NCT00885118|3962881|P2|Overall Study|Adverse Event|0
1207285|NCT00885118|3962882|P1|Overall Study|Adverse Event|1
1207286|NCT00885105|3963021|P2|Overall Study|Protocol Violation|2
1207287|NCT00885105|3963022|P1|Overall Study|Protocol Violation|0
1207288|NCT00885105|3963021|P2|Overall Study|Adverse Event|0
1207289|NCT00885105|3963022|P1|Overall Study|Adverse Event|1
1207290|NCT00885105|3963021|P2|Overall Study|Withdrawal by Subject|8
1207291|NCT00885105|3963022|P1|Overall Study|Withdrawal by Subject|0
1207292|NCT00884949|3963062|P1|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1
1207293|NCT00884949|3963062|P1|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1
1207294|NCT00884832|3963097|P2|Overall Study|Withdrawal by Subject|1
1207295|NCT00884832|3963098|P1|Overall Study|Withdrawal by Subject|0
1207296|NCT00884793|3963133|P1|Overall Study|Withdrawal by Subject|1
1207297|NCT00884741|3963152|P4|Randomization|Protocol Violation|8
1207298|NCT00884741|3963153|P3|Randomization|Protocol Violation|8
1207299|NCT00884741|3963154|P2|Randomization|Protocol Violation|0
1207300|NCT00884741|3963155|P1|Randomization|Protocol Violation|0
1207301|NCT00884741|3963152|P4|Step 2 Registration: Tissue Analysis|Disease Progression|0
1207302|NCT00884741|3963153|P3|Step 2 Registration: Tissue Analysis|Disease Progression|0
1207303|NCT00884741|3963154|P2|Step 2 Registration: Tissue Analysis|Disease Progression|4
1207304|NCT00884741|3963155|P1|Step 2 Registration: Tissue Analysis|Disease Progression|0
1207305|NCT00884741|3963152|P4|Step 2 Registration: Tissue Analysis|Patient refusal|0
1207306|NCT00884741|3963153|P3|Step 2 Registration: Tissue Analysis|Patient refusal|0
1207307|NCT00884741|3963154|P2|Step 2 Registration: Tissue Analysis|Patient refusal|7
1207308|NCT00884741|3963155|P1|Step 2 Registration: Tissue Analysis|Patient refusal|0
1207309|NCT00884741|3963152|P4|Step 2 Registration: Tissue Analysis|Adverse Event|0
1207310|NCT00884741|3963153|P3|Step 2 Registration: Tissue Analysis|Adverse Event|0
1207311|NCT00884741|3963154|P2|Step 2 Registration: Tissue Analysis|Adverse Event|2
1207312|NCT00884741|3963155|P1|Step 2 Registration: Tissue Analysis|Adverse Event|0
1207313|NCT00884741|3963152|P4|Step 2 Registration: Tissue Analysis|Death|0
1207314|NCT00884741|3963153|P3|Step 2 Registration: Tissue Analysis|Death|0
1207315|NCT00884741|3963154|P2|Step 2 Registration: Tissue Analysis|Death|1
1207316|NCT00884741|3963155|P1|Step 2 Registration: Tissue Analysis|Death|0
1207317|NCT00884741|3963152|P4|Step 2 Registration: Tissue Analysis|Protocol Violation|0
1207318|NCT00884741|3963153|P3|Step 2 Registration: Tissue Analysis|Protocol Violation|0
1207319|NCT00884741|3963154|P2|Step 2 Registration: Tissue Analysis|Protocol Violation|15
1207320|NCT00884741|3963155|P1|Step 2 Registration: Tissue Analysis|Protocol Violation|0
1207321|NCT00884741|3963152|P4|Step 1 Registration: Tissue Screening|Patient refusal|0
1207322|NCT00884741|3963153|P3|Step 1 Registration: Tissue Screening|Patient refusal|0
1207323|NCT00884741|3963154|P2|Step 1 Registration: Tissue Screening|Patient refusal|0
1207324|NCT00884741|3963155|P1|Step 1 Registration: Tissue Screening|Patient refusal|32
1207325|NCT00884741|3963152|P4|Step 1 Registration: Tissue Screening|Disease progression|0
1207326|NCT00884741|3963153|P3|Step 1 Registration: Tissue Screening|Disease progression|0
1207327|NCT00884741|3963154|P2|Step 1 Registration: Tissue Screening|Disease progression|0
1207328|NCT00884741|3963155|P1|Step 1 Registration: Tissue Screening|Disease progression|12
1207329|NCT00884741|3963152|P4|Step 1 Registration: Tissue Screening|Insufficient tissue|0
1207330|NCT00884741|3963153|P3|Step 1 Registration: Tissue Screening|Insufficient tissue|0
1207331|NCT00884741|3963154|P2|Step 1 Registration: Tissue Screening|Insufficient tissue|0
1207332|NCT00884741|3963155|P1|Step 1 Registration: Tissue Screening|Insufficient tissue|105
1207333|NCT00884741|3963152|P4|Step 1 Registration: Tissue Screening|Physician Decision|0
1207334|NCT00884741|3963153|P3|Step 1 Registration: Tissue Screening|Physician Decision|0
1207335|NCT00884741|3963154|P2|Step 1 Registration: Tissue Screening|Physician Decision|0
1207336|NCT00884741|3963155|P1|Step 1 Registration: Tissue Screening|Physician Decision|3
1207337|NCT00884741|3963152|P4|Step 1 Registration: Tissue Screening|Death|0
1207338|NCT00884741|3963153|P3|Step 1 Registration: Tissue Screening|Death|0
1207339|NCT00884741|3963154|P2|Step 1 Registration: Tissue Screening|Death|0
1207340|NCT00884741|3963155|P1|Step 1 Registration: Tissue Screening|Death|3
1207341|NCT00884741|3963152|P4|Step 1 Registration: Tissue Screening|Protocol Violation|0
1207342|NCT00884741|3963153|P3|Step 1 Registration: Tissue Screening|Protocol Violation|0
1207343|NCT00884741|3963154|P2|Step 1 Registration: Tissue Screening|Protocol Violation|0
1207344|NCT00884741|3963155|P1|Step 1 Registration: Tissue Screening|Protocol Violation|157
1207345|NCT00884390|3963205|P2|Overall Study|Not specified|1
1207346|NCT00884390|3963206|P1|Overall Study|Not specified|11
1207347|NCT00884390|3963205|P2|Overall Study|Discontinuation of Study by Sponsor|2
1207348|NCT00884390|3963206|P1|Overall Study|Discontinuation of Study by Sponsor|2
1207349|NCT00884390|3963205|P2|Overall Study|Withdrawal by Subject|1
1207350|NCT00884390|3963206|P1|Overall Study|Withdrawal by Subject|4
1207351|NCT00884390|3963205|P2|Overall Study|Protocol Violation|1
1207352|NCT00884390|3963206|P1|Overall Study|Protocol Violation|4
1207353|NCT00884390|3963205|P2|Overall Study|Physician Decision|1
1207354|NCT00884390|3963206|P1|Overall Study|Physician Decision|2
1207355|NCT00884390|3963205|P2|Overall Study|Lost to Follow-up|1
1207356|NCT00884390|3963206|P1|Overall Study|Lost to Follow-up|0
1207357|NCT00884390|3963205|P2|Overall Study|Adverse Event|1
1207358|NCT00884390|3963206|P1|Overall Study|Adverse Event|0
1207359|NCT00884377|3963224|P2|Overall Study|Physician Decision|1
1207360|NCT00884377|3963225|P1|Overall Study|Physician Decision|0
1207361|NCT00884377|3963224|P2|Overall Study|Could not confirm diagnosis|0
1207362|NCT00884377|3963225|P1|Overall Study|Could not confirm diagnosis|1
1207363|NCT00884377|3963224|P2|Overall Study|Withdrawal by Subject|0
1207364|NCT00884377|3963225|P1|Overall Study|Withdrawal by Subject|1
1207365|NCT00884325|3963247|P2|Overall Study|Not provided|0
1207366|NCT00884325|3963248|P1|Overall Study|Not provided|1
1207367|NCT00884325|3963247|P2|Overall Study|Withdrawal by Subject|1
1207368|NCT00884325|3963248|P1|Overall Study|Withdrawal by Subject|1
1207369|NCT00884325|3963247|P2|Overall Study|Lack of Efficacy|1
1207370|NCT00884325|3963248|P1|Overall Study|Lack of Efficacy|0
1207371|NCT00884325|3963247|P2|Overall Study|Lost to Follow-up|2
1207372|NCT00884325|3963248|P1|Overall Study|Lost to Follow-up|1
1207373|NCT00884312|3963258|P2|Overall Study|Did Not Receive Study Drug|1
1207374|NCT00884312|3963259|P1|Overall Study|Did Not Receive Study Drug|0
1207375|NCT00884312|3963258|P2|Overall Study|Other|4
1207376|NCT00884312|3963259|P1|Overall Study|Other|0
1207377|NCT00884312|3963258|P2|Overall Study|Physician Decision|1
1207378|NCT00884312|3963259|P1|Overall Study|Physician Decision|0
1207379|NCT00884312|3963258|P2|Overall Study|Withdrawal by Subject|6
1207380|NCT00884312|3963259|P1|Overall Study|Withdrawal by Subject|0
1207381|NCT00884312|3963258|P2|Overall Study|Fatal Adverse Event|4
1207382|NCT00884312|3963259|P1|Overall Study|Fatal Adverse Event|1
1207383|NCT00884312|3963258|P2|Overall Study|Non-fatal Adverse Event|0
1207384|NCT00884312|3963259|P1|Overall Study|Non-fatal Adverse Event|1
1207385|NCT00884312|3963258|P2|Overall Study|Fatal Progressive Disease|1
1207386|NCT00884312|3963259|P1|Overall Study|Fatal Progressive Disease|0
1207387|NCT00884312|3963258|P2|Overall Study|Non-fatal Progressive Disease|8
1207388|NCT00884312|3963259|P1|Overall Study|Non-fatal Progressive Disease|0
1207389|NCT00884286|3963275|P2|Overall Study|Comprised lung carcinoma|1
1207390|NCT00884286|3963276|P1|Overall Study|Comprised lung carcinoma|0
1207391|NCT00884286|3963275|P2|Overall Study|Not treated|1
1207392|NCT00884286|3963276|P1|Overall Study|Not treated|2
1207393|NCT00884286|3963275|P2|Overall Study|Thrombus in right auricle|0
1207394|NCT00884286|3963276|P1|Overall Study|Thrombus in right auricle|1
1207395|NCT00884286|3963275|P2|Overall Study|Septic shock|0
1207396|NCT00884286|3963276|P1|Overall Study|Septic shock|1
1207397|NCT00884286|3963275|P2|Overall Study|Physician Decision|0
1207398|NCT00884286|3963276|P1|Overall Study|Physician Decision|1
1207399|NCT00884286|3963275|P2|Overall Study|Death|2
1207400|NCT00884286|3963276|P1|Overall Study|Death|2
1207401|NCT00884286|3963275|P2|Overall Study|Toxicity|1
1207402|NCT00884286|3963276|P1|Overall Study|Toxicity|4
1207403|NCT00884286|3963275|P2|Overall Study|Progressive disease|28
1207404|NCT00884286|3963276|P1|Overall Study|Progressive disease|21
1207405|NCT00884273|3963290|P2|Overall Study|Practical reasons|0
1207406|NCT00884273|3963291|P1|Overall Study|Practical reasons|1
1207407|NCT00884273|3963290|P2|Overall Study|Protocol Violation|3
1207408|NCT00884273|3963291|P1|Overall Study|Protocol Violation|1
1207409|NCT00884273|3963290|P2|Overall Study|Adverse Event|2
1207410|NCT00884273|3963291|P1|Overall Study|Adverse Event|0
1207411|NCT00884221|3963317|P2|Overall Study|Cancellation of Cycle and Other Reason|13
1207412|NCT00884221|3963318|P1|Overall Study|Cancellation of Cycle and Other Reason|12
1207413|NCT00884221|3963317|P2|Overall Study|Protocol Violation|13
1207414|NCT00884221|3963318|P1|Overall Study|Protocol Violation|16
1207415|NCT00884221|3963317|P2|Overall Study|Adverse Event|3
1207416|NCT00884221|3963318|P1|Overall Study|Adverse Event|6
1207417|NCT00884221|3963317|P2|Overall Study|Withdrawal by Subject|3
1207418|NCT00884221|3963318|P1|Overall Study|Withdrawal by Subject|0
1207419|NCT00884117|3963354|P1|Overall Study|Not Specified|12
1207420|NCT00884117|3963354|P1|Overall Study|Lost to Follow-up|143
1207421|NCT00884117|3963354|P1|Overall Study|Death|3
1207422|NCT00884117|3963354|P1|Overall Study|Withdrawal by Subject|89
1207423|NCT00884117|3963354|P1|Overall Study|Adverse Event|2
1207424|NCT00884039|3963417|P2|Overall Study|Lack of Efficacy|0
1207425|NCT00884039|3963418|P1|Overall Study|Lack of Efficacy|2
1207426|NCT00884039|3963417|P2|Overall Study|Withdrawal by Subject|1
1207427|NCT00884039|3963418|P1|Overall Study|Withdrawal by Subject|0
1207428|NCT00883779|3963426|P2|Off-study Phase|Other|21
1207429|NCT00883779|3963427|P1|Off-study Phase|Other|18
1207430|NCT00883779|3963426|P2|Off-study Phase|Failure to return|6
1207431|NCT00883779|3963427|P1|Off-study Phase|Failure to return|5
1207432|NCT00883779|3963426|P2|Off-study Phase|Refused treatment|1
1207433|NCT00883779|3963427|P1|Off-study Phase|Refused treatment|1
1207434|NCT00883779|3963426|P2|Off-study Phase|Death|174
1207435|NCT00883779|3963427|P1|Off-study Phase|Death|185
1207436|NCT00883779|3963426|P2|Post-Study Treatment Phase|Ongoing in the study|6
1207437|NCT00883779|3963427|P1|Post-Study Treatment Phase|Ongoing in the study|0
1207438|NCT00883779|3963426|P2|Post-Study Treatment Phase|Other|0
1207439|NCT00883779|3963427|P1|Post-Study Treatment Phase|Other|3
1207440|NCT00883779|3963426|P2|Post-Study Treatment Phase|Disease progression|122
1207441|NCT00883779|3963427|P1|Post-Study Treatment Phase|Disease progression|103
1207442|NCT00883779|3963426|P2|Post-Study Treatment Phase|Refused Treatment|0
1207443|NCT00883779|3963427|P1|Post-Study Treatment Phase|Refused Treatment|3
1207444|NCT00883779|3963426|P2|Post-Study Treatment Phase|Protocol Violation|1
1207445|NCT00883779|3963427|P1|Post-Study Treatment Phase|Protocol Violation|0
1207446|NCT00883779|3963426|P2|Post-Study Treatment Phase|Death|3
1207447|NCT00883779|3963427|P1|Post-Study Treatment Phase|Death|1
1207448|NCT00883779|3963426|P2|Post-Study Treatment Phase|Adverse Event|3
1207449|NCT00883779|3963427|P1|Post-Study Treatment Phase|Adverse Event|2
1207450|NCT00883779|3963426|P2|Primary Study Treatment Phase|Other|0
1207451|NCT00883779|3963427|P1|Primary Study Treatment Phase|Other|3
1207452|NCT00883779|3963426|P2|Primary Study Treatment Phase|Refused Treatment|4
1207453|NCT00883779|3963427|P1|Primary Study Treatment Phase|Refused Treatment|5
1207454|NCT00883779|3963426|P2|Primary Study Treatment Phase|Death|3
1207455|NCT00883779|3963427|P1|Primary Study Treatment Phase|Death|2
1207456|NCT00883779|3963426|P2|Primary Study Treatment Phase|Adverse Event|16
1207457|NCT00883779|3963427|P1|Primary Study Treatment Phase|Adverse Event|16
1207458|NCT00883779|3963426|P2|Primary Study Treatment Phase|Disease progression|59
1207459|NCT00883779|3963427|P1|Primary Study Treatment Phase|Disease progression|75
1207460|NCT00883779|3963426|P2|Primary Study Treatment Phase|Did not receive allocated intervention|4
1207461|NCT00883779|3963427|P1|Primary Study Treatment Phase|Did not receive allocated intervention|4
1207462|NCT00883753|3963463|P1|Overall Study|Administrative/Other|8
1207463|NCT00883753|3963463|P1|Overall Study|Investigator's decision|17
1207464|NCT00883753|3963463|P1|Overall Study|Withdrew consent|10
1207465|NCT00883753|3963463|P1|Overall Study|Refused treatment|4
1207466|NCT00883753|3963463|P1|Overall Study|Protocol Violation|2
1207467|NCT00883753|3963463|P1|Overall Study|Violation of selection criteria at entry|7
1207468|NCT00883753|3963463|P1|Overall Study|Lost to Follow-up|4
1207469|NCT00883753|3963463|P1|Overall Study|Insufficient therapeutic response|16
1207470|NCT00883753|3963463|P1|Overall Study|Death|2
1207471|NCT00883753|3963463|P1|Overall Study|Adverse Event|37
1207472|NCT00883740|3963503|P2|Second Intervention|No longer willing to participate|1
1207473|NCT00883740|3963504|P1|Second Intervention|No longer willing to participate|0
1207474|NCT00883740|3963503|P2|Second Intervention|Protocol Violation|0
1207475|NCT00883740|3963504|P1|Second Intervention|Protocol Violation|1
1207476|NCT00883740|3963503|P2|First Intervention|Adverse Event|2
1207477|NCT00883740|3963504|P1|First Intervention|Adverse Event|1
1207478|NCT00883740|3963503|P2|First Intervention|Protocol Violation|6
1207479|NCT00883740|3963504|P1|First Intervention|Protocol Violation|3
1207480|NCT00883740|3963503|P2|First Intervention|No longer willing to participate|0
1207481|NCT00883740|3963504|P1|First Intervention|No longer willing to participate|2
1207482|NCT00883740|3963503|P2|First Intervention|Lost to Follow-up|0
1207483|NCT00883740|3963504|P1|First Intervention|Lost to Follow-up|1
1207484|NCT00883558|3963548|P3|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1
1207485|NCT00883558|3963549|P2|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
1207486|NCT00883558|3963550|P1|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
1207487|NCT00883558|3963548|P3|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
1207488|NCT00883558|3963549|P2|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1
1207489|NCT00883558|3963550|P1|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
1207490|NCT00883558|3963548|P3|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
1207491|NCT00883558|3963549|P2|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
1207492|NCT00883558|3963550|P1|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0
1207493|NCT00883558|3963548|P3|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
1207494|NCT00883558|3963549|P2|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1
1207495|NCT00883558|3963550|P1|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
1207496|NCT00883558|3963548|P3|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
1207497|NCT00883558|3963549|P2|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
1207498|NCT00883558|3963550|P1|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2
1207499|NCT00883493|3963562|P2|Overall Study|Not specified|3
1207500|NCT00883493|3963563|P1|Overall Study|Not specified|5
1207501|NCT00883493|3963562|P2|Overall Study|Study specific disc. criteria|0
1207502|NCT00883493|3963563|P1|Overall Study|Study specific disc. criteria|2
1207503|NCT00883493|3963562|P2|Overall Study|Eligibility Criteria not fullfilled|6
1207504|NCT00883493|3963563|P1|Overall Study|Eligibility Criteria not fullfilled|6
1207505|NCT00883493|3963562|P2|Overall Study|Withdrawal by Subject|20
1207506|NCT00883493|3963563|P1|Overall Study|Withdrawal by Subject|11
1207507|NCT00883493|3963562|P2|Overall Study|Lost to Follow-up|6
1207508|NCT00883493|3963563|P1|Overall Study|Lost to Follow-up|7
1207509|NCT00883493|3963562|P2|Overall Study|Lack of Efficacy|3
1207510|NCT00883493|3963563|P1|Overall Study|Lack of Efficacy|4
1207511|NCT00883493|3963562|P2|Overall Study|Adverse Event|12
1207512|NCT00883493|3963563|P1|Overall Study|Adverse Event|11
1207513|NCT00883337|3963594|P3|Extension Treatment Period|Other than above|5
1207514|NCT00883337|3963595|P2|Extension Treatment Period|Other than above|9
1207515|NCT00883337|3963596|P1|Extension Treatment Period|Other than above|10
1207516|NCT00883337|3963594|P3|Extension Treatment Period|Lost to Follow-up|0
1207517|NCT00883337|3963595|P2|Extension Treatment Period|Lost to Follow-up|0
1207518|NCT00883337|3963596|P1|Extension Treatment Period|Lost to Follow-up|1
1207519|NCT00883337|3963594|P3|Extension Treatment Period|Poor compliance to protocol|1
1207520|NCT00883337|3963595|P2|Extension Treatment Period|Poor compliance to protocol|1
1207521|NCT00883337|3963596|P1|Extension Treatment Period|Poor compliance to protocol|1
1207522|NCT00883337|3963594|P3|Extension Treatment Period|Lack of Efficacy|8
1207523|NCT00883337|3963595|P2|Extension Treatment Period|Lack of Efficacy|8
1207524|NCT00883337|3963596|P1|Extension Treatment Period|Lack of Efficacy|8
1207525|NCT00883337|3963594|P3|Extension Treatment Period|Adverse Event|5
1207526|NCT00883337|3963595|P2|Extension Treatment Period|Adverse Event|5
1207527|NCT00883337|3963596|P1|Extension Treatment Period|Adverse Event|8
1207528|NCT00883337|3963594|P3|Core Treatment Period|Other than above|1
1207529|NCT00883337|3963595|P2|Core Treatment Period|Other than above|1
1207530|NCT00883337|3963596|P1|Core Treatment Period|Other than above|0
1207531|NCT00883337|3963594|P3|Core Treatment Period|Poor compliance to protocol|1
1207532|NCT00883337|3963595|P2|Core Treatment Period|Poor compliance to protocol|0
1207533|NCT00883337|3963596|P1|Core Treatment Period|Poor compliance to protocol|0
1207534|NCT00883337|3963594|P3|Core Treatment Period|Wish to be pregnant|1
1207535|NCT00883337|3963595|P2|Core Treatment Period|Wish to be pregnant|2
1207536|NCT00883337|3963596|P1|Core Treatment Period|Wish to be pregnant|1
1207537|NCT00883337|3963594|P3|Core Treatment Period|Withdrawal by Subject|6
1207538|NCT00883337|3963595|P2|Core Treatment Period|Withdrawal by Subject|2
1207539|NCT00883337|3963596|P1|Core Treatment Period|Withdrawal by Subject|2
1207540|NCT00883337|3963594|P3|Core Treatment Period|Lost to Follow-up|0
1207541|NCT00883337|3963595|P2|Core Treatment Period|Lost to Follow-up|1
1207542|NCT00883337|3963596|P1|Core Treatment Period|Lost to Follow-up|1
1207543|NCT00883337|3963594|P3|Core Treatment Period|Lack of Efficacy|2
1207544|NCT00883337|3963595|P2|Core Treatment Period|Lack of Efficacy|4
1207545|NCT00883337|3963596|P1|Core Treatment Period|Lack of Efficacy|7
1207546|NCT00883337|3963594|P3|Core Treatment Period|Adverse Event|22
1207547|NCT00883337|3963595|P2|Core Treatment Period|Adverse Event|12
1207548|NCT00883337|3963596|P1|Core Treatment Period|Adverse Event|9
1207549|NCT00883181|3963663|P1|Overall Study|Noncompliance|3
1207550|NCT00883181|3963663|P1|Overall Study|Protocol Deviation|3
1207551|NCT00883181|3963663|P1|Overall Study|Other|38
1207552|NCT00883181|3963663|P1|Overall Study|Death|31
1207553|NCT00883181|3963663|P1|Overall Study|Withdrawal by Subject|4
1207554|NCT00883181|3963663|P1|Overall Study|Administrative Reason|24
1207555|NCT00883181|3963663|P1|Overall Study|Disease Progression|94
1207556|NCT00883181|3963663|P1|Overall Study|Non-hematological Adverse Event|55
1207557|NCT00883181|3963663|P1|Overall Study|Hematological Adverse Event|26
1207558|NCT00883129|3963899|P2|Overall Study|Defined Treatment Failure|2
1207559|NCT00883129|3963900|P1|Overall Study|Defined Treatment Failure|0
1207560|NCT00883129|3963899|P2|Overall Study|Death|2
1207561|NCT00883129|3963900|P1|Overall Study|Death|1
1207562|NCT00883129|3963899|P2|Overall Study|Lost to Follow-up|2
1207563|NCT00883129|3963900|P1|Overall Study|Lost to Follow-up|1
1207564|NCT00883129|3963899|P2|Overall Study|Non-compliance|6
1207565|NCT00883129|3963900|P1|Overall Study|Non-compliance|3
1207566|NCT00883129|3963899|P2|Overall Study|Withdrawal by Subject|9
1207567|NCT00883129|3963900|P1|Overall Study|Withdrawal by Subject|8
1207568|NCT00883129|3963899|P2|Overall Study|Adverse Event|15
1207569|NCT00883129|3963900|P1|Overall Study|Adverse Event|7
1207570|NCT00883116|3963924|P2|Overall Study|No longer meets study criteria|2
1207571|NCT00883116|3963925|P1|Overall Study|No longer meets study criteria|2
1207572|NCT00883116|3963924|P2|Overall Study|Withdrawal by Subject|8
1207573|NCT00883116|3963925|P1|Overall Study|Withdrawal by Subject|14
1207574|NCT00883116|3963924|P2|Overall Study|Study drug toxicity|16
1207575|NCT00883116|3963925|P1|Overall Study|Study drug toxicity|36
1207576|NCT00883116|3963924|P2|Overall Study|Not identified|6
1207577|NCT00883116|3963925|P1|Overall Study|Not identified|3
1207578|NCT00883116|3963924|P2|Overall Study|Maximum clinical benefit|46
1207579|NCT00883116|3963925|P1|Overall Study|Maximum clinical benefit|13
1207580|NCT00883116|3963924|P2|Overall Study|Lost to Follow-up|1
1207581|NCT00883116|3963925|P1|Overall Study|Lost to Follow-up|0
1207582|NCT00883116|3963924|P2|Overall Study|Disease progression|128
1207583|NCT00883116|3963925|P1|Overall Study|Disease progression|130
1207584|NCT00883116|3963924|P2|Overall Study|Death|2
1207585|NCT00883116|3963925|P1|Overall Study|Death|6
1207586|NCT00883116|3963924|P2|Overall Study|Adverse event unrelated to study drug|10
1207587|NCT00883116|3963925|P1|Overall Study|Adverse event unrelated to study drug|5
1207588|NCT00883090|3963947|P1|Overall Study|Withdrawal by Subject|1
1207589|NCT00883090|3963947|P1|Overall Study|Sponsor's decision|1
1207590|NCT00882999|3963969|P7|Overall Study|Physician Decision|1
1207591|NCT00882999|3963970|P6|Overall Study|Physician Decision|1
1207592|NCT00882999|3963971|P5|Overall Study|Physician Decision|0
1207593|NCT00882999|3963972|P4|Overall Study|Physician Decision|0
1207594|NCT00882999|3963973|P3|Overall Study|Physician Decision|0
1207595|NCT00882999|3963974|P2|Overall Study|Physician Decision|0
1207596|NCT00882999|3963975|P1|Overall Study|Physician Decision|1
1207597|NCT00882999|3963969|P7|Overall Study|Lost to Follow-up|2
1207598|NCT00882999|3963970|P6|Overall Study|Lost to Follow-up|1
1207599|NCT00882999|3963971|P5|Overall Study|Lost to Follow-up|1
1207600|NCT00882999|3963972|P4|Overall Study|Lost to Follow-up|2
1207601|NCT00882999|3963973|P3|Overall Study|Lost to Follow-up|1
1207602|NCT00882999|3963974|P2|Overall Study|Lost to Follow-up|1
1207603|NCT00882999|3963975|P1|Overall Study|Lost to Follow-up|0
1207604|NCT00882999|3963969|P7|Overall Study|Withdrawal by Subject|5
1207605|NCT00882999|3963970|P6|Overall Study|Withdrawal by Subject|5
1207606|NCT00882999|3963971|P5|Overall Study|Withdrawal by Subject|6
1207607|NCT00882999|3963972|P4|Overall Study|Withdrawal by Subject|3
1207608|NCT00882999|3963973|P3|Overall Study|Withdrawal by Subject|3
1207609|NCT00882999|3963974|P2|Overall Study|Withdrawal by Subject|6
1207610|NCT00882999|3963975|P1|Overall Study|Withdrawal by Subject|7
1207611|NCT00882999|3963969|P7|Overall Study|Death|0
1207612|NCT00882999|3963970|P6|Overall Study|Death|0
1207613|NCT00882999|3963971|P5|Overall Study|Death|0
1207614|NCT00882999|3963972|P4|Overall Study|Death|0
1207615|NCT00882999|3963973|P3|Overall Study|Death|0
1207616|NCT00882999|3963974|P2|Overall Study|Death|1
1207617|NCT00882999|3963975|P1|Overall Study|Death|0
1207618|NCT00882999|3963969|P7|Overall Study|Adverse Event|0
1207619|NCT00882999|3963970|P6|Overall Study|Adverse Event|0
1207620|NCT00882999|3963971|P5|Overall Study|Adverse Event|1
1207621|NCT00882999|3963972|P4|Overall Study|Adverse Event|0
1207622|NCT00882999|3963973|P3|Overall Study|Adverse Event|0
1207623|NCT00882999|3963974|P2|Overall Study|Adverse Event|0
1207624|NCT00882999|3963975|P1|Overall Study|Adverse Event|0
1207625|NCT00882921|3964102|P1|Overall Study|Withdrawal Of Consent|1
1207626|NCT00882921|3964102|P1|Overall Study|Termination By Investigator|3
1207627|NCT00882921|3964102|P1|Overall Study|Lost to Follow-up|2
1207628|NCT00882921|3964102|P1|Overall Study|Not specified|3
1207629|NCT00882921|3964102|P1|Overall Study|Death|2
1207630|NCT00882908|3964112|P5|Overall Study|Study terminated in error|0
1207631|NCT00882908|3964113|P4|Overall Study|Study terminated in error|1
1207632|NCT00882908|3964114|P3|Overall Study|Study terminated in error|0
1207633|NCT00882908|3964115|P2|Overall Study|Study terminated in error|0
1207634|NCT00882908|3964116|P1|Overall Study|Study terminated in error|0
1207635|NCT00882908|3964112|P5|Overall Study|Subject reached a virologic endpoint|1
1207636|NCT00882908|3964113|P4|Overall Study|Subject reached a virologic endpoint|0
1207637|NCT00882908|3964114|P3|Overall Study|Subject reached a virologic endpoint|0
1207638|NCT00882908|3964115|P2|Overall Study|Subject reached a virologic endpoint|0
1207639|NCT00882908|3964116|P1|Overall Study|Subject reached a virologic endpoint|0
1207640|NCT00882908|3964112|P5|Overall Study|Withdrawal by Subject|2
1207641|NCT00882908|3964113|P4|Overall Study|Withdrawal by Subject|5
1207642|NCT00882908|3964114|P3|Overall Study|Withdrawal by Subject|3
1207643|NCT00882908|3964115|P2|Overall Study|Withdrawal by Subject|0
1207644|NCT00882908|3964116|P1|Overall Study|Withdrawal by Subject|0
1207645|NCT00882908|3964112|P5|Overall Study|Protocol Violation|0
1207646|NCT00882908|3964113|P4|Overall Study|Protocol Violation|0
1207647|NCT00882908|3964114|P3|Overall Study|Protocol Violation|0
1207648|NCT00882908|3964115|P2|Overall Study|Protocol Violation|1
1207649|NCT00882908|3964116|P1|Overall Study|Protocol Violation|0
1207650|NCT00882908|3964112|P5|Overall Study|Lost to Follow-up|2
1207651|NCT00882908|3964113|P4|Overall Study|Lost to Follow-up|1
1207652|NCT00882908|3964114|P3|Overall Study|Lost to Follow-up|3
1207653|NCT00882908|3964115|P2|Overall Study|Lost to Follow-up|5
1207654|NCT00882908|3964116|P1|Overall Study|Lost to Follow-up|3
1207655|NCT00882908|3964112|P5|Overall Study|Adverse Event|1
1207656|NCT00882908|3964113|P4|Overall Study|Adverse Event|0
1207657|NCT00882908|3964114|P3|Overall Study|Adverse Event|1
1207658|NCT00882908|3964115|P2|Overall Study|Adverse Event|0
1207659|NCT00882908|3964116|P1|Overall Study|Adverse Event|0
1207660|NCT00882713|3964222|P1|Overall Study|Other - Reasons|2
1207661|NCT00882713|3964222|P1|Overall Study|Failure to return|2
1207662|NCT00882713|3964222|P1|Overall Study|Insufficient therapeutic response|3
1207663|NCT00882713|3964222|P1|Overall Study|Blood transfusion|2
1207664|NCT00882713|3964222|P1|Overall Study|refused treatment/withdrew consent|4
1207665|NCT00882713|3964222|P1|Overall Study|Administrative reasons|4
1207666|NCT00882713|3964222|P1|Overall Study|Death|3
1207667|NCT00882713|3964222|P1|Overall Study|Adverse Event|2
1207668|NCT00882583|3964315|P2|Overall Study|Adverse Event|1
1207669|NCT00882583|3964316|P1|Overall Study|Adverse Event|0
1207670|NCT00882583|3964315|P2|Overall Study|Physician Decision|0
1207671|NCT00882583|3964316|P1|Overall Study|Physician Decision|1
1207672|NCT00882557|3964324|P2|Overall Study|Randomized Not Treated|1
1207673|NCT00882557|3964325|P1|Overall Study|Randomized Not Treated|0
1207674|NCT00882557|3964324|P2|Overall Study|Trouble with Vein Access|0
1207675|NCT00882557|3964325|P1|Overall Study|Trouble with Vein Access|1
1207676|NCT00882557|3964324|P2|Overall Study|Withdrawal by Subject|0
1207677|NCT00882557|3964325|P1|Overall Study|Withdrawal by Subject|1
1207678|NCT00882518|3964345|P2|Overall Study|Allocating random number by mistake|1
1207679|NCT00882518|3964346|P1|Overall Study|Allocating random number by mistake|0
1207680|NCT00882518|3964345|P2|Overall Study|Central lab closure for National day|0
1207681|NCT00882518|3964346|P1|Overall Study|Central lab closure for National day|1
1207682|NCT00882518|3964345|P2|Overall Study|Incorrect enrolment|2
1207683|NCT00882518|3964346|P1|Overall Study|Incorrect enrolment|4
1207684|NCT00882518|3964345|P2|Overall Study|Severe non-compliance to protocol|1
1207685|NCT00882518|3964346|P1|Overall Study|Severe non-compliance to protocol|3
1207686|NCT00882518|3964345|P2|Overall Study|Lack of Efficacy|9
1207687|NCT00882518|3964346|P1|Overall Study|Lack of Efficacy|12
1207688|NCT00882518|3964345|P2|Overall Study|Withdrawal by Subject|13
1207689|NCT00882518|3964346|P1|Overall Study|Withdrawal by Subject|9
1207690|NCT00882518|3964345|P2|Overall Study|Adverse Event|18
1207691|NCT00882518|3964346|P1|Overall Study|Adverse Event|9
1207692|NCT00882440|3964375|P7|Overall Study|Patient Uncooperative|0
1207693|NCT00882440|3964376|P6|Overall Study|Patient Uncooperative|0
1207694|NCT00882440|3964377|P5|Overall Study|Patient Uncooperative|1
1207695|NCT00882440|3964378|P4|Overall Study|Patient Uncooperative|0
1207696|NCT00882440|3964379|P3|Overall Study|Patient Uncooperative|0
1207697|NCT00882440|3964380|P2|Overall Study|Patient Uncooperative|0
1207698|NCT00882440|3964381|P1|Overall Study|Patient Uncooperative|2
1207699|NCT00882440|3964375|P7|Overall Study|Withdrawal by Subject|1
1207700|NCT00882440|3964376|P6|Overall Study|Withdrawal by Subject|0
1207701|NCT00882440|3964377|P5|Overall Study|Withdrawal by Subject|6
1207702|NCT00882440|3964378|P4|Overall Study|Withdrawal by Subject|0
1207703|NCT00882440|3964379|P3|Overall Study|Withdrawal by Subject|1
1207704|NCT00882440|3964380|P2|Overall Study|Withdrawal by Subject|1
1207705|NCT00882440|3964381|P1|Overall Study|Withdrawal by Subject|2
1207706|NCT00882440|3964375|P7|Overall Study|Protocol Violation|0
1207707|NCT00882440|3964376|P6|Overall Study|Protocol Violation|0
1207708|NCT00882440|3964377|P5|Overall Study|Protocol Violation|1
1207709|NCT00882440|3964378|P4|Overall Study|Protocol Violation|1
1207710|NCT00882440|3964379|P3|Overall Study|Protocol Violation|1
1207711|NCT00882440|3964380|P2|Overall Study|Protocol Violation|0
1207712|NCT00882440|3964381|P1|Overall Study|Protocol Violation|0
1207713|NCT00882440|3964375|P7|Overall Study|Lost to Follow-up|1
1207714|NCT00882440|3964376|P6|Overall Study|Lost to Follow-up|0
1207715|NCT00882440|3964377|P5|Overall Study|Lost to Follow-up|1
1207716|NCT00882440|3964378|P4|Overall Study|Lost to Follow-up|1
1207717|NCT00882440|3964379|P3|Overall Study|Lost to Follow-up|1
1207718|NCT00882440|3964380|P2|Overall Study|Lost to Follow-up|0
1207719|NCT00882440|3964381|P1|Overall Study|Lost to Follow-up|2
1207720|NCT00882440|3964375|P7|Overall Study|Lack of Efficacy|0
1207721|NCT00882440|3964376|P6|Overall Study|Lack of Efficacy|3
1207722|NCT00882440|3964377|P5|Overall Study|Lack of Efficacy|0
1207723|NCT00882440|3964378|P4|Overall Study|Lack of Efficacy|0
1207724|NCT00882440|3964379|P3|Overall Study|Lack of Efficacy|2
1207725|NCT00882440|3964380|P2|Overall Study|Lack of Efficacy|5
1207726|NCT00882440|3964381|P1|Overall Study|Lack of Efficacy|3
1207727|NCT00882440|3964375|P7|Overall Study|Adverse Event|2
1207728|NCT00882440|3964376|P6|Overall Study|Adverse Event|4
1207729|NCT00882440|3964377|P5|Overall Study|Adverse Event|1
1207730|NCT00882440|3964378|P4|Overall Study|Adverse Event|1
1207731|NCT00882440|3964379|P3|Overall Study|Adverse Event|2
1207732|NCT00882440|3964380|P2|Overall Study|Adverse Event|2
1207733|NCT00882440|3964381|P1|Overall Study|Adverse Event|2
1207734|NCT00882362|3964406|P2|Overall Study|change of residence or other commitments|0
1207735|NCT00882362|3964407|P1|Overall Study|change of residence or other commitments|5
1207736|NCT00882362|3964406|P2|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
1207737|NCT00882362|3964407|P1|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2
1207738|NCT00882362|3964406|P2|Overall Study|Physician Decision|1
1207739|NCT00882362|3964407|P1|Overall Study|Physician Decision|5
1207740|NCT00882362|3964406|P2|Overall Study|Pregnancy|0
1207741|NCT00882362|3964407|P1|Overall Study|Pregnancy|1
1207742|NCT00882362|3964406|P2|Overall Study|Protocol Violation|2
1207743|NCT00882362|3964407|P1|Overall Study|Protocol Violation|7
1207744|NCT00882362|3964406|P2|Overall Study|Lack of Efficacy|0
1207745|NCT00882362|3964407|P1|Overall Study|Lack of Efficacy|3
1207746|NCT00882362|3964406|P2|Overall Study|Withdrawal by Subject|10
1207747|NCT00882362|3964407|P1|Overall Study|Withdrawal by Subject|13
1207748|NCT00882362|3964406|P2|Overall Study|Adverse Event|10
1207749|NCT00882362|3964407|P1|Overall Study|Adverse Event|13
1207750|NCT00882310|3964413|P1|Overall Study|Adverse Event|1
1207751|NCT00882310|3964413|P1|Overall Study|Progression of disease|4
1207752|NCT00882310|3964413|P1|Overall Study|Death|6
1207753|NCT00882310|3964413|P1|Overall Study|Never received treatment|1
1207754|NCT00882310|3964413|P1|Overall Study|Screen Failure|10
1207755|NCT00882115|3964426|P1|Overall Study|did not respond to DEP challe|6
1207756|NCT00882115|3964426|P1|Overall Study|Withdrawal by Subject|3
1207757|NCT00881959|3964436|P2|Overall Study|Lost to Follow-up|4
1207758|NCT00881959|3964437|P1|Overall Study|Lost to Follow-up|2
1207759|NCT00881894|3964445|P2|Overall Study|Other reasons for premature termination|2
1207760|NCT00881894|3964446|P1|Overall Study|Other reasons for premature termination|1
1207761|NCT00881894|3964445|P2|Overall Study|Consent withdrawn|1
1207762|NCT00881894|3964446|P1|Overall Study|Consent withdrawn|0
1207763|NCT00881868|3964478|P2|Overall Study|Protocol Violation|0
1207764|NCT00881868|3964479|P1|Overall Study|Protocol Violation|2
1207765|NCT00881868|3964478|P2|Overall Study|Physician Decision|0
1207766|NCT00881868|3964479|P1|Overall Study|Physician Decision|4
1207767|NCT00881868|3964478|P2|Overall Study|Lost to Follow-up|1
1207768|NCT00881868|3964479|P1|Overall Study|Lost to Follow-up|2
1207769|NCT00881868|3964478|P2|Overall Study|Adverse Event|1
1207770|NCT00881868|3964479|P1|Overall Study|Adverse Event|0
1207771|NCT00881751|3964493|P2|Overall Study|Withdrawal by Subject|2
1207772|NCT00881751|3964494|P1|Overall Study|Withdrawal by Subject|0
1207773|NCT00881751|3964493|P2|Overall Study|Adverse Event|2
1207774|NCT00881751|3964494|P1|Overall Study|Adverse Event|0
1207775|NCT00881751|3964493|P2|Overall Study|Physician Decision|1
1207776|NCT00881751|3964494|P1|Overall Study|Physician Decision|0
1207777|NCT00881712|3964509|P3|Overall Study|Withdrawal by Subject|0
1207778|NCT00881712|3964510|P2|Overall Study|Withdrawal by Subject|0
1207779|NCT00881712|3964511|P1|Overall Study|Withdrawal by Subject|1
1207780|NCT00881712|3964509|P3|Overall Study|Death|0
1207781|NCT00881712|3964510|P2|Overall Study|Death|0
1207782|NCT00881712|3964511|P1|Overall Study|Death|1
1207783|NCT00881621|3964544|P1|Overall Study|Physician Decision|34
1207784|NCT00881608|3964556|P1|Overall Study|Study prematurely terminated|11
1207785|NCT00881530|3964579|P6|Overall Study|Other reason not defined above|2
1207786|NCT00881530|3964580|P5|Overall Study|Other reason not defined above|0
1207787|NCT00881530|3964581|P4|Overall Study|Other reason not defined above|0
1207788|NCT00881530|3964582|P3|Overall Study|Other reason not defined above|2
1207789|NCT00881530|3964583|P2|Overall Study|Other reason not defined above|1
1207790|NCT00881530|3964584|P1|Overall Study|Other reason not defined above|1
1207791|NCT00881530|3964579|P6|Overall Study|Refused to continue medication|0
1207792|NCT00881530|3964580|P5|Overall Study|Refused to continue medication|0
1207793|NCT00881530|3964581|P4|Overall Study|Refused to continue medication|2
1207794|NCT00881530|3964582|P3|Overall Study|Refused to continue medication|1
1207795|NCT00881530|3964583|P2|Overall Study|Refused to continue medication|2
1207796|NCT00881530|3964584|P1|Overall Study|Refused to continue medication|7
1207797|NCT00881530|3964579|P6|Overall Study|Lost to Follow-up|0
1207798|NCT00881530|3964580|P5|Overall Study|Lost to Follow-up|1
1207799|NCT00881530|3964581|P4|Overall Study|Lost to Follow-up|3
1207800|NCT00881530|3964582|P3|Overall Study|Lost to Follow-up|1
1207801|NCT00881530|3964583|P2|Overall Study|Lost to Follow-up|1
1207802|NCT00881530|3964584|P1|Overall Study|Lost to Follow-up|0
1207803|NCT00881530|3964579|P6|Overall Study|Not compliant with the protocol|0
1207804|NCT00881530|3964580|P5|Overall Study|Not compliant with the protocol|2
1207805|NCT00881530|3964581|P4|Overall Study|Not compliant with the protocol|0
1207806|NCT00881530|3964582|P3|Overall Study|Not compliant with the protocol|0
1207807|NCT00881530|3964583|P2|Overall Study|Not compliant with the protocol|0
1207808|NCT00881530|3964584|P1|Overall Study|Not compliant with the protocol|0
1207809|NCT00881530|3964579|P6|Overall Study|Lack of Efficacy|1
1207810|NCT00881530|3964580|P5|Overall Study|Lack of Efficacy|1
1207811|NCT00881530|3964581|P4|Overall Study|Lack of Efficacy|0
1207812|NCT00881530|3964582|P3|Overall Study|Lack of Efficacy|0
1207813|NCT00881530|3964583|P2|Overall Study|Lack of Efficacy|0
1207814|NCT00881530|3964584|P1|Overall Study|Lack of Efficacy|1
1207815|NCT00881530|3964579|P6|Overall Study|Adverse Event|2
1207816|NCT00881530|3964580|P5|Overall Study|Adverse Event|10
1207817|NCT00881530|3964581|P4|Overall Study|Adverse Event|4
1207818|NCT00881530|3964582|P3|Overall Study|Adverse Event|1
1207819|NCT00881530|3964583|P2|Overall Study|Adverse Event|1
1207820|NCT00881530|3964584|P1|Overall Study|Adverse Event|5
1207821|NCT00881504|3964640|P1|Overall Study|Withdrawal by Subject|1
1207822|NCT00881361|3964660|P3|Overall Study|Ineligible|2
1207823|NCT00881361|3964661|P2|Overall Study|Ineligible|2
1207824|NCT00881361|3964662|P1|Overall Study|Ineligible|17
1207825|NCT00881361|3964660|P3|Overall Study|Terminated prior to surgery|0
1207826|NCT00881361|3964661|P2|Overall Study|Terminated prior to surgery|7
1207827|NCT00881361|3964662|P1|Overall Study|Terminated prior to surgery|27
1207828|NCT00881335|3964677|P2|Overall Study|Lost to Follow-up|2
1207829|NCT00881335|3964678|P1|Overall Study|Lost to Follow-up|3
1207830|NCT00881205|3964698|P2|Overall Study|Condition no longer requires drug|0
1207831|NCT00881205|3964699|P1|Overall Study|Condition no longer requires drug|1
1207832|NCT00881205|3964698|P2|Overall Study|Administrative problems|1
1207833|NCT00881205|3964699|P1|Overall Study|Administrative problems|1
1207834|NCT00881205|3964698|P2|Overall Study|Lost to Follow-up|1
1207835|NCT00881205|3964699|P1|Overall Study|Lost to Follow-up|0
1207836|NCT00881205|3964698|P2|Overall Study|Withdrawal by Subject|2
1207837|NCT00881205|3964699|P1|Overall Study|Withdrawal by Subject|1
1207838|NCT00881205|3964698|P2|Overall Study|Adverse Event|3
1207839|NCT00881205|3964699|P1|Overall Study|Adverse Event|8
1207840|NCT00880906|3964745|P2|Overall Study|Did not meet criteria following patholog|6
1207841|NCT00880906|3964746|P1|Overall Study|Did not meet criteria following patholog|12
1207842|NCT00880906|3964745|P2|Overall Study|Lost to Follow-up|1
1207843|NCT00880906|3964746|P1|Overall Study|Lost to Follow-up|0
1207844|NCT00880763|3964758|P4|Extension Period (Part 2)|Lack of Efficacy|1
1207845|NCT00880763|3964759|P3|Extension Period (Part 2)|Lack of Efficacy|0
1207846|NCT00880763|3964760|P2|Extension Period (Part 2)|Lack of Efficacy|0
1207847|NCT00880763|3964761|P1|Extension Period (Part 2)|Lack of Efficacy|0
1207848|NCT00880763|3964758|P4|Extension Period (Part 2)|Physician Decision|0
1207849|NCT00880763|3964759|P3|Extension Period (Part 2)|Physician Decision|1
1207850|NCT00880763|3964760|P2|Extension Period (Part 2)|Physician Decision|1
1207851|NCT00880763|3964761|P1|Extension Period (Part 2)|Physician Decision|0
1207852|NCT00880763|3964758|P4|Extension Period (Part 2)|Withdrawal by Subject|1
1207853|NCT00880763|3964759|P3|Extension Period (Part 2)|Withdrawal by Subject|1
1207854|NCT00880763|3964760|P2|Extension Period (Part 2)|Withdrawal by Subject|2
1207855|NCT00880763|3964761|P1|Extension Period (Part 2)|Withdrawal by Subject|0
1207856|NCT00880763|3964758|P4|Extension Period (Part 2)|Adverse Event|1
1207857|NCT00880763|3964759|P3|Extension Period (Part 2)|Adverse Event|1
1207858|NCT00880763|3964760|P2|Extension Period (Part 2)|Adverse Event|0
1207859|NCT00880763|3964761|P1|Extension Period (Part 2)|Adverse Event|0
1207860|NCT00880750|3964793|P2|Second Intervention|Unable to collect urine|0
1207861|NCT00880750|3964794|P1|Second Intervention|Unable to collect urine|1
1207862|NCT00880750|3964793|P2|Second Intervention|Protocol Violation|0
1207863|NCT00880750|3964794|P1|Second Intervention|Protocol Violation|1
1207864|NCT00880750|3964793|P2|Second Intervention|Withdrawal by Subject|2
1207865|NCT00880750|3964794|P1|Second Intervention|Withdrawal by Subject|2
1207866|NCT00880750|3964793|P2|First Intervention|Lost to Follow-up|0
1207867|NCT00880750|3964794|P1|First Intervention|Lost to Follow-up|2
1207868|NCT00880750|3964793|P2|First Intervention|Withdrawal by Subject|0
1207869|NCT00880750|3964794|P1|First Intervention|Withdrawal by Subject|2
1207870|NCT00880750|3964793|P2|First Intervention|Non-compliance with meals|1
1207871|NCT00880750|3964794|P1|First Intervention|Non-compliance with meals|0
1207872|NCT00880750|3964793|P2|First Intervention|Unable to collect urine|0
1207873|NCT00880750|3964794|P1|First Intervention|Unable to collect urine|4
1207874|NCT00880750|3964793|P2|First Intervention|Adverse Event|0
1207875|NCT00880750|3964794|P1|First Intervention|Adverse Event|1
1207876|NCT00880698|3964812|P4|Overall Study|Lost to Follow-up|1
1207877|NCT00880698|3964813|P3|Overall Study|Lost to Follow-up|0
1207878|NCT00880698|3964814|P2|Overall Study|Lost to Follow-up|3
1207879|NCT00880698|3964815|P1|Overall Study|Lost to Follow-up|1
1207880|NCT00880698|3964812|P4|Overall Study|Death|2
1207881|NCT00880698|3964813|P3|Overall Study|Death|1
1207882|NCT00880698|3964814|P2|Overall Study|Death|0
1207883|NCT00880698|3964815|P1|Overall Study|Death|0
1207884|NCT00880685|3964841|P1|Memantine 20mg|Withdrawal by Subject|1
1207885|NCT00880685|3964841|P1|Memantine 10mg|Lost to Follow-up|2
1207886|NCT00880620|3964853|P4|Overall Study|Not specified|2
1207887|NCT00880620|3964854|P3|Overall Study|Not specified|2
1207888|NCT00880620|3964855|P2|Overall Study|Not specified|1
1207889|NCT00880620|3964856|P1|Overall Study|Not specified|1
1207890|NCT00880620|3964853|P4|Overall Study|Noncompliance|1
1207891|NCT00880620|3964854|P3|Overall Study|Noncompliance|1
1207892|NCT00880620|3964855|P2|Overall Study|Noncompliance|0
1207893|NCT00880620|3964856|P1|Overall Study|Noncompliance|0
1207894|NCT00880620|3964853|P4|Overall Study|Withdrawal by Subject|3
1207895|NCT00880620|3964854|P3|Overall Study|Withdrawal by Subject|1
1207896|NCT00880620|3964855|P2|Overall Study|Withdrawal by Subject|3
1207897|NCT00880620|3964856|P1|Overall Study|Withdrawal by Subject|4
1207898|NCT00880620|3964853|P4|Overall Study|Protocol Violation|2
1207899|NCT00880620|3964854|P3|Overall Study|Protocol Violation|0
1207900|NCT00880620|3964855|P2|Overall Study|Protocol Violation|1
1207901|NCT00880620|3964856|P1|Overall Study|Protocol Violation|0
1207902|NCT00880620|3964853|P4|Overall Study|Lost to Follow-up|0
1207903|NCT00880620|3964854|P3|Overall Study|Lost to Follow-up|1
1207904|NCT00880620|3964855|P2|Overall Study|Lost to Follow-up|1
1207905|NCT00880620|3964856|P1|Overall Study|Lost to Follow-up|0
1207906|NCT00880620|3964853|P4|Overall Study|Lack of Efficacy|1
1207907|NCT00880620|3964854|P3|Overall Study|Lack of Efficacy|0
1207908|NCT00880620|3964855|P2|Overall Study|Lack of Efficacy|4
1207909|NCT00880620|3964856|P1|Overall Study|Lack of Efficacy|12
1207910|NCT00880620|3964853|P4|Overall Study|Death|0
1207911|NCT00880620|3964854|P3|Overall Study|Death|1
1207912|NCT00880620|3964855|P2|Overall Study|Death|0
1207913|NCT00880620|3964856|P1|Overall Study|Death|0
1207914|NCT00880620|3964853|P4|Overall Study|Adverse Event|15
1207915|NCT00880620|3964854|P3|Overall Study|Adverse Event|15
1207916|NCT00880620|3964855|P2|Overall Study|Adverse Event|5
1207917|NCT00880620|3964856|P1|Overall Study|Adverse Event|4
1207918|NCT00880568|3964884|P9|Overall Study|Withdrawal by Subject|0
1207919|NCT00880568|3964885|P8|Overall Study|Withdrawal by Subject|1
1207920|NCT00880568|3964886|P7|Overall Study|Withdrawal by Subject|0
1207921|NCT00880568|3964887|P6|Overall Study|Withdrawal by Subject|0
1207922|NCT00880568|3964888|P5|Overall Study|Withdrawal by Subject|0
1207923|NCT00880568|3964889|P4|Overall Study|Withdrawal by Subject|0
1207924|NCT00880568|3964890|P3|Overall Study|Withdrawal by Subject|0
1207925|NCT00880568|3964891|P2|Overall Study|Withdrawal by Subject|0
1207926|NCT00880568|3964892|P1|Overall Study|Withdrawal by Subject|0
1207927|NCT00880568|3964884|P9|Overall Study|Adverse Event|0
1207928|NCT00880568|3964885|P8|Overall Study|Adverse Event|1
1207929|NCT00880568|3964886|P7|Overall Study|Adverse Event|1
1207930|NCT00880568|3964887|P6|Overall Study|Adverse Event|0
1207931|NCT00880568|3964888|P5|Overall Study|Adverse Event|0
1207932|NCT00880568|3964889|P4|Overall Study|Adverse Event|0
1207933|NCT00880568|3964890|P3|Overall Study|Adverse Event|0
1207934|NCT00880568|3964891|P2|Overall Study|Adverse Event|0
1207935|NCT00880568|3964892|P1|Overall Study|Adverse Event|0
1207936|NCT00880568|3964884|P9|Overall Study|Disease progression|3
1207937|NCT00880568|3964885|P8|Overall Study|Disease progression|0
1207938|NCT00880568|3964886|P7|Overall Study|Disease progression|5
1207939|NCT00880568|3964887|P6|Overall Study|Disease progression|3
1207940|NCT00880568|3964888|P5|Overall Study|Disease progression|3
1207941|NCT00880568|3964889|P4|Overall Study|Disease progression|1
1207942|NCT00880568|3964890|P3|Overall Study|Disease progression|3
1207943|NCT00880568|3964891|P2|Overall Study|Disease progression|3
1207944|NCT00880568|3964892|P1|Overall Study|Disease progression|3
1207945|NCT00880555|3964938|P6|Overall Study|Lost to Follow-up|0
1207946|NCT00880555|3964939|P5|Overall Study|Lost to Follow-up|0
1207947|NCT00880555|3964940|P4|Overall Study|Lost to Follow-up|0
1207948|NCT00880555|3964941|P3|Overall Study|Lost to Follow-up|0
1207949|NCT00880555|3964942|P2|Overall Study|Lost to Follow-up|1
1207950|NCT00880555|3964943|P1|Overall Study|Lost to Follow-up|0
1207951|NCT00880555|3964938|P6|Overall Study|Death|1
1207952|NCT00880555|3964939|P5|Overall Study|Death|0
1207953|NCT00880555|3964940|P4|Overall Study|Death|0
1207954|NCT00880555|3964941|P3|Overall Study|Death|0
1207955|NCT00880555|3964942|P2|Overall Study|Death|0
1207956|NCT00880555|3964943|P1|Overall Study|Death|0
1207957|NCT00880555|3964938|P6|Overall Study|Lack of resources (hired rater)|0
1207958|NCT00880555|3964939|P5|Overall Study|Lack of resources (hired rater)|0
1207959|NCT00880555|3964940|P4|Overall Study|Lack of resources (hired rater)|0
1207960|NCT00880555|3964941|P3|Overall Study|Lack of resources (hired rater)|5
1207961|NCT00880555|3964942|P2|Overall Study|Lack of resources (hired rater)|7
1207962|NCT00880555|3964943|P1|Overall Study|Lack of resources (hired rater)|9
1207963|NCT00880555|3964938|P6|Overall Study|Withdrawal by Subject|0
1207964|NCT00880555|3964939|P5|Overall Study|Withdrawal by Subject|0
1207965|NCT00880555|3964940|P4|Overall Study|Withdrawal by Subject|0
1207966|NCT00880555|3964941|P3|Overall Study|Withdrawal by Subject|0
1207967|NCT00880555|3964942|P2|Overall Study|Withdrawal by Subject|1
1207968|NCT00880555|3964943|P1|Overall Study|Withdrawal by Subject|1
1207969|NCT00880555|3964938|P6|Overall Study|Physician Decision|0
1207970|NCT00880555|3964939|P5|Overall Study|Physician Decision|1
1207971|NCT00880555|3964940|P4|Overall Study|Physician Decision|2
1207972|NCT00880555|3964941|P3|Overall Study|Physician Decision|0
1207973|NCT00880555|3964942|P2|Overall Study|Physician Decision|8
1207974|NCT00880555|3964943|P1|Overall Study|Physician Decision|0
1207975|NCT00880542|3964954|P1|REP: Surgical Resection|progressive disease|1
1207976|NCT00880542|3964954|P1|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2
1207977|NCT00880542|3964954|P1|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1
1207978|NCT00880399|3964971|P3|Overall Study|Withdrawal by Subject|3
1207979|NCT00880399|3964972|P2|Overall Study|Withdrawal by Subject|3
1207980|NCT00880399|3964973|P1|Overall Study|Withdrawal by Subject|6
1207981|NCT00880399|3964971|P3|Overall Study|Physician Decision|3
1207982|NCT00880399|3964972|P2|Overall Study|Physician Decision|0
1207983|NCT00880399|3964973|P1|Overall Study|Physician Decision|5
1207984|NCT00880399|3964971|P3|Overall Study|Lost to Follow-up|3
1207985|NCT00880399|3964972|P2|Overall Study|Lost to Follow-up|5
1207986|NCT00880399|3964973|P1|Overall Study|Lost to Follow-up|8
1207987|NCT00880399|3964971|P3|Overall Study|Study closed/terminated|4
1207988|NCT00880399|3964972|P2|Overall Study|Study closed/terminated|7
1207989|NCT00880399|3964973|P1|Overall Study|Study closed/terminated|3
1207990|NCT00880399|3964971|P3|Overall Study|Protocol Violation|6
1207991|NCT00880399|3964972|P2|Overall Study|Protocol Violation|4
1207992|NCT00880399|3964973|P1|Overall Study|Protocol Violation|4
1207993|NCT00880399|3964971|P3|Overall Study|Lack of Efficacy|2
1207994|NCT00880399|3964972|P2|Overall Study|Lack of Efficacy|4
1207995|NCT00880399|3964973|P1|Overall Study|Lack of Efficacy|1
1207996|NCT00880399|3964971|P3|Overall Study|Adverse Event|5
1207997|NCT00880399|3964972|P2|Overall Study|Adverse Event|6
1207998|NCT00880399|3964973|P1|Overall Study|Adverse Event|4
1207999|NCT00880334|3965036|P2|Randomized Phase|Crossover Participants|37
1208000|NCT00880334|3965037|P1|Randomized Phase|Crossover Participants|0
1208001|NCT00880334|3965036|P2|Randomized Phase|Brain Metastasis|1
1208002|NCT00880334|3965037|P1|Randomized Phase|Brain Metastasis|0
1208003|NCT00880334|3965036|P2|Randomized Phase|Inadequate Labs|1
1208004|NCT00880334|3965037|P1|Randomized Phase|Inadequate Labs|1
1208005|NCT00880334|3965036|P2|Randomized Phase|Withdrawal by Subject|1
1208006|NCT00880334|3965037|P1|Randomized Phase|Withdrawal by Subject|2
1208007|NCT00880334|3965036|P2|Randomized Phase|Physician Decision|0
1208008|NCT00880334|3965037|P1|Randomized Phase|Physician Decision|1
1208009|NCT00880269|3965054|P2|Overall Study|Adverse Event|9
1208010|NCT00880269|3965055|P1|Overall Study|Adverse Event|10
1208011|NCT00880269|3965054|P2|Overall Study|Withdrawal by Subject|4
1208012|NCT00880269|3965055|P1|Overall Study|Withdrawal by Subject|3
1208013|NCT00880269|3965054|P2|Overall Study|Lost to Follow-up|1
1208014|NCT00880269|3965055|P1|Overall Study|Lost to Follow-up|0
1208015|NCT00880269|3965054|P2|Overall Study|Death|2
1208016|NCT00880269|3965055|P1|Overall Study|Death|4
1208017|NCT00880269|3965054|P2|Overall Study|New Cancer Therapy|0
1208018|NCT00880269|3965055|P1|Overall Study|New Cancer Therapy|1
1208019|NCT00880269|3965054|P2|Overall Study|Disease Progression|11
1208020|NCT00880269|3965055|P1|Overall Study|Disease Progression|13
1208021|NCT00880269|3965054|P2|Overall Study|Protocol Violation|0
1208022|NCT00880269|3965055|P1|Overall Study|Protocol Violation|1
1208023|NCT00880256|3965071|P1|Overall Study|Lost to Follow-up|28
1208024|NCT00880191|3965098|P2|Overall Study|Hospitalization/efficacy|1
1208025|NCT00880191|3965099|P1|Overall Study|Hospitalization/efficacy|1
1208026|NCT00880191|3965098|P2|Overall Study|Adverse Event|6
1208027|NCT00880191|3965099|P1|Overall Study|Adverse Event|8
1208028|NCT00880191|3965098|P2|Overall Study|Refused further treatment|1
1208029|NCT00880191|3965099|P1|Overall Study|Refused further treatment|4
1208030|NCT00880165|3965119|P2|Overall Study|Lost to follow|15
1208031|NCT00880165|3965120|P1|Overall Study|Lost to follow|9
1208032|NCT00880165|3965119|P2|Overall Study|Required BIPAP or oxygen treatment|4
1208033|NCT00880165|3965120|P1|Overall Study|Required BIPAP or oxygen treatment|12
1208034|NCT00880165|3965119|P2|Overall Study|Not diagnosed with OSA|8
1208035|NCT00880165|3965120|P1|Overall Study|Not diagnosed with OSA|14
1208036|NCT00880165|3965119|P2|Overall Study|Withdrawal by Subject|23
1208037|NCT00880165|3965120|P1|Overall Study|Withdrawal by Subject|27
1208038|NCT00880100|3965130|P1|Treatment Phase With Ultrase® MT12|Protocol Violation|2
1208039|NCT00880100|3965130|P1|Treatment Phase With Ultrase® MT12|Adverse Event|1
1208040|NCT00880100|3965130|P1|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1
1208041|NCT00880087|3965143|P2|Overall Study|Lost to Follow-up|2
1208042|NCT00880087|3965144|P1|Overall Study|Lost to Follow-up|0
1208043|NCT00880048|3965159|P3|Overall Study|Study closed/terminated|6
1208044|NCT00880048|3965160|P2|Overall Study|Study closed/terminated|7
1208045|NCT00880048|3965161|P1|Overall Study|Study closed/terminated|9
1208046|NCT00880048|3965159|P3|Overall Study|Withdrawal by Subject|5
1208047|NCT00880048|3965160|P2|Overall Study|Withdrawal by Subject|8
1208048|NCT00880048|3965161|P1|Overall Study|Withdrawal by Subject|5
1208049|NCT00880048|3965159|P3|Overall Study|Physician Decision|7
1208050|NCT00880048|3965160|P2|Overall Study|Physician Decision|1
1208051|NCT00880048|3965161|P1|Overall Study|Physician Decision|1
1208052|NCT00880048|3965159|P3|Overall Study|Lost to Follow-up|5
1208053|NCT00880048|3965160|P2|Overall Study|Lost to Follow-up|6
1208054|NCT00880048|3965161|P1|Overall Study|Lost to Follow-up|6
1208055|NCT00880048|3965159|P3|Overall Study|Protocol Violation|5
1208056|NCT00880048|3965160|P2|Overall Study|Protocol Violation|6
1208057|NCT00880048|3965161|P1|Overall Study|Protocol Violation|4
1208058|NCT00880048|3965159|P3|Overall Study|Lack of Efficacy|2
1208059|NCT00880048|3965160|P2|Overall Study|Lack of Efficacy|2
1208060|NCT00880048|3965161|P1|Overall Study|Lack of Efficacy|1
1208061|NCT00880048|3965159|P3|Overall Study|Adverse Event|5
1208062|NCT00880048|3965160|P2|Overall Study|Adverse Event|3
1208063|NCT00880048|3965161|P1|Overall Study|Adverse Event|2
1208064|NCT00880009|3965228|P1|Overall Study|Protocol Violation|1
1208065|NCT00880009|3965228|P1|Overall Study|Withdrawal by Subject|1
1208066|NCT00880009|3965228|P1|Overall Study|Study terminated by sponsor|14
1208067|NCT00879996|3965252|P2|Overall Study|put on parole|0
1208068|NCT00879996|3965253|P1|Overall Study|put on parole|1
1208069|NCT00879996|3965252|P2|Overall Study|psychiatric problem|1
1208070|NCT00879996|3965253|P1|Overall Study|psychiatric problem|0
1208071|NCT00879996|3965252|P2|Overall Study|Physician Decision|2
1208072|NCT00879996|3965253|P1|Overall Study|Physician Decision|1
1208073|NCT00879996|3965252|P2|Overall Study|non-compliance|4
1208074|NCT00879996|3965253|P1|Overall Study|non-compliance|6
1208075|NCT00879996|3965252|P2|Overall Study|Lost to Follow-up|6
1208076|NCT00879996|3965253|P1|Overall Study|Lost to Follow-up|7
1208077|NCT00879970|3965268|P5|Period 2 Vitamin D Randomization|Death|0
1208078|NCT00879970|3965269|P4|Period 2 Vitamin D Randomization|Death|2
1208079|NCT00879970|3965270|P3|Period 2 Vitamin D Randomization|Death|0
1208080|NCT00879970|3965271|P2|Period 2 Vitamin D Randomization|Death|0
1208081|NCT00879970|3965272|P1|Period 2 Vitamin D Randomization|Death|0
1208082|NCT00879970|3965268|P5|Period 2 Vitamin D Randomization|Lost to Follow-up|1
1208083|NCT00879970|3965269|P4|Period 2 Vitamin D Randomization|Lost to Follow-up|0
1208084|NCT00879970|3965270|P3|Period 2 Vitamin D Randomization|Lost to Follow-up|0
1208085|NCT00879970|3965271|P2|Period 2 Vitamin D Randomization|Lost to Follow-up|0
1208086|NCT00879970|3965272|P1|Period 2 Vitamin D Randomization|Lost to Follow-up|0
1208087|NCT00879970|3965268|P5|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6
1208088|NCT00879970|3965269|P4|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2
1208089|NCT00879970|3965270|P3|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
1208090|NCT00879970|3965271|P2|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
1208091|NCT00879970|3965272|P1|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
1208092|NCT00879970|3965268|P5|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
1208093|NCT00879970|3965269|P4|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
1208094|NCT00879970|3965270|P3|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1
1208095|NCT00879970|3965271|P2|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
1208096|NCT00879970|3965272|P1|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2
1208097|NCT00879970|3965268|P5|Period 1 TZD Randomization|Death|0
1208098|NCT00879970|3965269|P4|Period 1 TZD Randomization|Death|0
1208099|NCT00879970|3965270|P3|Period 1 TZD Randomization|Death|0
1208100|NCT00879970|3965271|P2|Period 1 TZD Randomization|Death|1
1208101|NCT00879970|3965272|P1|Period 1 TZD Randomization|Death|2
1208102|NCT00879970|3965268|P5|Period 1 TZD Randomization|Lost to Follow-up|0
1208103|NCT00879970|3965269|P4|Period 1 TZD Randomization|Lost to Follow-up|0
1208104|NCT00879970|3965270|P3|Period 1 TZD Randomization|Lost to Follow-up|1
1208105|NCT00879970|3965271|P2|Period 1 TZD Randomization|Lost to Follow-up|0
1208106|NCT00879970|3965272|P1|Period 1 TZD Randomization|Lost to Follow-up|1
1208107|NCT00879970|3965268|P5|Period 1 TZD Randomization|Refused to Attend Final Visit|0
1208108|NCT00879970|3965269|P4|Period 1 TZD Randomization|Refused to Attend Final Visit|0
1208109|NCT00879970|3965270|P3|Period 1 TZD Randomization|Refused to Attend Final Visit|4
1208110|NCT00879970|3965271|P2|Period 1 TZD Randomization|Refused to Attend Final Visit|3
1208111|NCT00879970|3965272|P1|Period 1 TZD Randomization|Refused to Attend Final Visit|3
1208112|NCT00879879|3965354|P1|Overall Study|Physician Decision|1
1208113|NCT00879879|3965354|P1|Overall Study|Withdrawal by Subject|1
1208114|NCT00879879|3965354|P1|Overall Study|Death|1
1208115|NCT00879814|3965362|P4|Overall Study|Other|0
1208116|NCT00879814|3965363|P3|Overall Study|Other|1
1208117|NCT00879814|3965364|P2|Overall Study|Other|0
1208118|NCT00879814|3965365|P1|Overall Study|Other|0
1208119|NCT00879814|3965362|P4|Overall Study|Physician Decision|0
1208120|NCT00879814|3965363|P3|Overall Study|Physician Decision|1
1208121|NCT00879814|3965364|P2|Overall Study|Physician Decision|0
1208122|NCT00879814|3965365|P1|Overall Study|Physician Decision|0
1208123|NCT00879814|3965362|P4|Overall Study|Withdrawal by Subject|2
1208124|NCT00879814|3965363|P3|Overall Study|Withdrawal by Subject|1
1208125|NCT00879814|3965364|P2|Overall Study|Withdrawal by Subject|1
1208126|NCT00879814|3965365|P1|Overall Study|Withdrawal by Subject|3
1208127|NCT00879814|3965362|P4|Overall Study|Participant Failed to Return|1
1208128|NCT00879814|3965363|P3|Overall Study|Participant Failed to Return|0
1208129|NCT00879814|3965364|P2|Overall Study|Participant Failed to Return|0
1208130|NCT00879814|3965365|P1|Overall Study|Participant Failed to Return|0
1208131|NCT00879814|3965362|P4|Overall Study|Lost to Follow-up|2
1208132|NCT00879814|3965363|P3|Overall Study|Lost to Follow-up|0
1208133|NCT00879814|3965364|P2|Overall Study|Lost to Follow-up|0
1208134|NCT00879814|3965365|P1|Overall Study|Lost to Follow-up|1
1208135|NCT00879814|3965362|P4|Overall Study|Adverse Event|0
1208136|NCT00879814|3965363|P3|Overall Study|Adverse Event|0
1208137|NCT00879814|3965364|P2|Overall Study|Adverse Event|1
1208138|NCT00879814|3965365|P1|Overall Study|Adverse Event|0
1208139|NCT00879775|3965473|P2|Overall Study|Lost to Follow-up|1
1208140|NCT00879775|3965474|P1|Overall Study|Lost to Follow-up|2
1208141|NCT00879710|3965490|P4|Phase 1 - 6 Weeks|Adverse Event|0
1208142|NCT00879710|3965491|P3|Phase 1 - 6 Weeks|Adverse Event|1
1208143|NCT00879710|3965492|P2|Phase 1 - 6 Weeks|Adverse Event|0
1208144|NCT00879710|3965493|P1|Phase 1 - 6 Weeks|Adverse Event|0
1208145|NCT00879710|3965490|P4|Phase 1 - 6 Weeks|Lost to Follow-up|4
1208146|NCT00879710|3965491|P3|Phase 1 - 6 Weeks|Lost to Follow-up|1
1208147|NCT00879710|3965492|P2|Phase 1 - 6 Weeks|Lost to Follow-up|3
1208148|NCT00879710|3965493|P1|Phase 1 - 6 Weeks|Lost to Follow-up|2
1208149|NCT00879697|3965503|P2|Overall Study|Physician Decision|2
1208150|NCT00879697|3965504|P1|Overall Study|Physician Decision|2
1208151|NCT00879684|3965510|P7|Stage 2: Expanded Cohort|Investigator declined participation|1
1208152|NCT00879684|3965511|P6|Stage 2: Expanded Cohort|Investigator declined participation|0
1208153|NCT00879684|3965512|P5|Stage 2: Expanded Cohort|Investigator declined participation|0
1208154|NCT00879684|3965513|P4|Stage 2: Expanded Cohort|Investigator declined participation|0
1208155|NCT00879684|3965514|P3|Stage 2: Expanded Cohort|Investigator declined participation|0
1208156|NCT00879684|3965515|P2|Stage 2: Expanded Cohort|Investigator declined participation|0
1208157|NCT00879684|3965516|P1|Stage 2: Expanded Cohort|Investigator declined participation|0
1208158|NCT00879684|3965510|P7|Stage 2: Expanded Cohort|Progressive Disease|11
1208159|NCT00879684|3965511|P6|Stage 2: Expanded Cohort|Progressive Disease|0
1208160|NCT00879684|3965512|P5|Stage 2: Expanded Cohort|Progressive Disease|0
1208161|NCT00879684|3965513|P4|Stage 2: Expanded Cohort|Progressive Disease|0
1208162|NCT00879684|3965514|P3|Stage 2: Expanded Cohort|Progressive Disease|0
1208163|NCT00879684|3965515|P2|Stage 2: Expanded Cohort|Progressive Disease|0
1208164|NCT00879684|3965516|P1|Stage 2: Expanded Cohort|Progressive Disease|0
1208165|NCT00879684|3965510|P7|Stage 2: Expanded Cohort|Lost to Follow-up|1
1208166|NCT00879684|3965511|P6|Stage 2: Expanded Cohort|Lost to Follow-up|0
1208167|NCT00879684|3965512|P5|Stage 2: Expanded Cohort|Lost to Follow-up|0
1208168|NCT00879684|3965513|P4|Stage 2: Expanded Cohort|Lost to Follow-up|0
1208169|NCT00879684|3965514|P3|Stage 2: Expanded Cohort|Lost to Follow-up|0
1208170|NCT00879684|3965515|P2|Stage 2: Expanded Cohort|Lost to Follow-up|0
1208171|NCT00879684|3965516|P1|Stage 2: Expanded Cohort|Lost to Follow-up|0
1208172|NCT00879684|3965510|P7|Stage 1: Dose Escalation|Death|0
1208173|NCT00879684|3965511|P6|Stage 1: Dose Escalation|Death|0
1208174|NCT00879684|3965512|P5|Stage 1: Dose Escalation|Death|0
1208175|NCT00879684|3965513|P4|Stage 1: Dose Escalation|Death|0
1208176|NCT00879684|3965514|P3|Stage 1: Dose Escalation|Death|1
1208177|NCT00879684|3965515|P2|Stage 1: Dose Escalation|Death|0
1208178|NCT00879684|3965516|P1|Stage 1: Dose Escalation|Death|0
1208179|NCT00879684|3965510|P7|Stage 1: Dose Escalation|Investigator declined participation|0
1208180|NCT00879684|3965511|P6|Stage 1: Dose Escalation|Investigator declined participation|0
1208181|NCT00879684|3965512|P5|Stage 1: Dose Escalation|Investigator declined participation|0
1208182|NCT00879684|3965513|P4|Stage 1: Dose Escalation|Investigator declined participation|2
1208183|NCT00879684|3965514|P3|Stage 1: Dose Escalation|Investigator declined participation|2
1208184|NCT00879684|3965515|P2|Stage 1: Dose Escalation|Investigator declined participation|0
1208185|NCT00879684|3965516|P1|Stage 1: Dose Escalation|Investigator declined participation|0
1208186|NCT00879684|3965510|P7|Stage 1: Dose Escalation|Progressive Disease|0
1208187|NCT00879684|3965511|P6|Stage 1: Dose Escalation|Progressive Disease|3
1208188|NCT00879684|3965512|P5|Stage 1: Dose Escalation|Progressive Disease|3
1208189|NCT00879684|3965513|P4|Stage 1: Dose Escalation|Progressive Disease|4
1208190|NCT00879684|3965514|P3|Stage 1: Dose Escalation|Progressive Disease|0
1208191|NCT00879684|3965515|P2|Stage 1: Dose Escalation|Progressive Disease|3
1208192|NCT00879684|3965516|P1|Stage 1: Dose Escalation|Progressive Disease|2
1208193|NCT00879684|3965510|P7|Stage 1: Dose Escalation|Adverse Event|0
1208194|NCT00879684|3965511|P6|Stage 1: Dose Escalation|Adverse Event|0
1208195|NCT00879684|3965512|P5|Stage 1: Dose Escalation|Adverse Event|0
1208196|NCT00879684|3965513|P4|Stage 1: Dose Escalation|Adverse Event|0
1208197|NCT00879684|3965514|P3|Stage 1: Dose Escalation|Adverse Event|0
1208198|NCT00879684|3965515|P2|Stage 1: Dose Escalation|Adverse Event|0
1208199|NCT00879684|3965516|P1|Stage 1: Dose Escalation|Adverse Event|1
1208200|NCT00879645|3965582|P4|Overall Study|Adverse Event|0
1208201|NCT00879645|3965583|P3|Overall Study|Adverse Event|0
1208202|NCT00879645|3965584|P2|Overall Study|Adverse Event|0
1208203|NCT00879645|3965585|P1|Overall Study|Adverse Event|1
1208204|NCT00879411|3965612|P1|Overall Study|lost to follow-up (non-AE)|162
1208205|NCT00879398|3965618|P1|Overall Study|Other Reasons|171
1208206|NCT00879398|3965618|P1|Overall Study|Adverse Event|41
1208207|NCT00879398|3965618|P1|Overall Study|Lack of Efficacy|64
1208208|NCT00879398|3965618|P1|Overall Study|Visit Stop|399
1208209|NCT00879333|3965636|P2|Overall Study|Protocol Violation|1
1208210|NCT00879333|3965637|P1|Overall Study|Protocol Violation|1
1208211|NCT00879333|3965636|P2|Overall Study|Disease Progression|169
1208212|NCT00879333|3965637|P1|Overall Study|Disease Progression|292
1208213|NCT00879333|3965636|P2|Overall Study|Death|5
1208214|NCT00879333|3965637|P1|Overall Study|Death|16
1208215|NCT00879333|3965636|P2|Overall Study|Administrative Problems|0
1208216|NCT00879333|3965637|P1|Overall Study|Administrative Problems|2
1208217|NCT00879333|3965636|P2|Overall Study|Lost to Follow-up|1
1208218|NCT00879333|3965637|P1|Overall Study|Lost to Follow-up|2
1208219|NCT00879333|3965636|P2|Overall Study|Withdrawal by Subject|7
1208220|NCT00879333|3965637|P1|Overall Study|Withdrawal by Subject|20
1208221|NCT00879333|3965636|P2|Overall Study|Abnormal Laboratory Value|0
1208222|NCT00879333|3965637|P1|Overall Study|Abnormal Laboratory Value|1
1208223|NCT00879333|3965636|P2|Overall Study|Adverse Event|34
1208224|NCT00879333|3965637|P1|Overall Study|Adverse Event|94
1208225|NCT00879229|3965670|P2|Overall Study|Other|0
1208226|NCT00879229|3965671|P1|Overall Study|Other|1
1208227|NCT00879229|3965670|P2|Overall Study|Clinical status did not improve|0
1208228|NCT00879229|3965671|P1|Overall Study|Clinical status did not improve|1
1208229|NCT00879229|3965670|P2|Overall Study|Withdrawal by Subject|0
1208230|NCT00879229|3965671|P1|Overall Study|Withdrawal by Subject|1
1208231|NCT00879229|3965670|P2|Overall Study|Adverse Event|0
1208232|NCT00879229|3965671|P1|Overall Study|Adverse Event|2
1208233|NCT00879229|3965670|P2|Overall Study|Death|2
1208234|NCT00879229|3965671|P1|Overall Study|Death|4
1208235|NCT00879229|3965670|P2|Overall Study|Study terminated by Sponsor|12
1208236|NCT00879229|3965671|P1|Overall Study|Study terminated by Sponsor|13
1208237|NCT00878995|3965719|P2|Baseline Study - Midpoint Study|Withdrawal by Subject|2
1208238|NCT00878995|3965720|P1|Baseline Study - Midpoint Study|Withdrawal by Subject|0
1208239|NCT00878969|3965821|P3|Overall Study|Pregnancy|0
1208240|NCT00878969|3965822|P2|Overall Study|Pregnancy|1
1208241|NCT00878969|3965823|P1|Overall Study|Pregnancy|0
1208242|NCT00878969|3965821|P3|Overall Study|Death|2
1208243|NCT00878969|3965822|P2|Overall Study|Death|0
1208244|NCT00878969|3965823|P1|Overall Study|Death|0
1208245|NCT00878969|3965821|P3|Overall Study|Protocol Violation|0
1208246|NCT00878969|3965822|P2|Overall Study|Protocol Violation|0
1208247|NCT00878969|3965823|P1|Overall Study|Protocol Violation|2
1208248|NCT00878969|3965821|P3|Overall Study|Lost to Follow-up|0
1208249|NCT00878969|3965822|P2|Overall Study|Lost to Follow-up|1
1208250|NCT00878969|3965823|P1|Overall Study|Lost to Follow-up|2
1208251|NCT00878969|3965821|P3|Overall Study|Adverse Event|2
1208252|NCT00878969|3965822|P2|Overall Study|Adverse Event|1
1208253|NCT00878969|3965823|P1|Overall Study|Adverse Event|3
1208254|NCT00878969|3965821|P3|Overall Study|kidney transplant|2
1208255|NCT00878969|3965822|P2|Overall Study|kidney transplant|3
1208256|NCT00878969|3965823|P1|Overall Study|kidney transplant|2
1208257|NCT00878969|3965821|P3|Overall Study|Withdrawal by Subject|3
1208258|NCT00878969|3965822|P2|Overall Study|Withdrawal by Subject|6
1208259|NCT00878969|3965823|P1|Overall Study|Withdrawal by Subject|1
1208260|NCT00878969|3965821|P3|Overall Study|Physician Decision|2
1208261|NCT00878969|3965822|P2|Overall Study|Physician Decision|3
1208262|NCT00878969|3965823|P1|Overall Study|Physician Decision|5
1208263|NCT00878800|3965871|P5|Overall Study|Other|1
1208264|NCT00878800|3965872|P4|Overall Study|Other|0
1208265|NCT00878800|3965873|P3|Overall Study|Other|0
1208266|NCT00878800|3965874|P2|Overall Study|Other|1
1208267|NCT00878800|3965875|P1|Overall Study|Other|1
1208268|NCT00878800|3965871|P5|Overall Study|Death|0
1208269|NCT00878800|3965872|P4|Overall Study|Death|0
1208270|NCT00878800|3965873|P3|Overall Study|Death|1
1208271|NCT00878800|3965874|P2|Overall Study|Death|0
1208272|NCT00878800|3965875|P1|Overall Study|Death|0
1208273|NCT00878800|3965871|P5|Overall Study|Withdrew consent|1
1208274|NCT00878800|3965872|P4|Overall Study|Withdrew consent|1
1208275|NCT00878800|3965873|P3|Overall Study|Withdrew consent|0
1208276|NCT00878800|3965874|P2|Overall Study|Withdrew consent|1
1208277|NCT00878800|3965875|P1|Overall Study|Withdrew consent|1
1208278|NCT00878800|3965871|P5|Overall Study|Progressive disease|13
1208279|NCT00878800|3965872|P4|Overall Study|Progressive disease|5
1208280|NCT00878800|3965873|P3|Overall Study|Progressive disease|6
1208281|NCT00878800|3965874|P2|Overall Study|Progressive disease|5
1208282|NCT00878800|3965875|P1|Overall Study|Progressive disease|1
1208283|NCT00878800|3965871|P5|Overall Study|Adverse Event|1
1208284|NCT00878800|3965872|P4|Overall Study|Adverse Event|0
1208285|NCT00878800|3965873|P3|Overall Study|Adverse Event|2
1208286|NCT00878800|3965874|P2|Overall Study|Adverse Event|0
1208287|NCT00878800|3965875|P1|Overall Study|Adverse Event|0
1208288|NCT00878722|3965910|P8|Overall Study|Relapse|0
1208289|NCT00878722|3965911|P7|Overall Study|Relapse|0
1208290|NCT00878722|3965912|P6|Overall Study|Relapse|0
1208291|NCT00878722|3965913|P5|Overall Study|Relapse|0
1208292|NCT00878722|3965914|P4|Overall Study|Relapse|1
1208293|NCT00878722|3965915|P3|Overall Study|Relapse|0
1208294|NCT00878722|3965916|P2|Overall Study|Relapse|0
1208295|NCT00878722|3965917|P1|Overall Study|Relapse|0
1208296|NCT00878722|3965910|P8|Overall Study|Withdrawal by Subject|2
1208297|NCT00878722|3965911|P7|Overall Study|Withdrawal by Subject|0
1208298|NCT00878722|3965912|P6|Overall Study|Withdrawal by Subject|0
1208299|NCT00878722|3965913|P5|Overall Study|Withdrawal by Subject|0
1208300|NCT00878722|3965914|P4|Overall Study|Withdrawal by Subject|0
1208301|NCT00878722|3965915|P3|Overall Study|Withdrawal by Subject|0
1208302|NCT00878722|3965916|P2|Overall Study|Withdrawal by Subject|0
1208303|NCT00878722|3965917|P1|Overall Study|Withdrawal by Subject|0
1208304|NCT00878722|3965910|P8|Overall Study|Adverse Event|0
1208305|NCT00878722|3965911|P7|Overall Study|Adverse Event|2
1208306|NCT00878722|3965912|P6|Overall Study|Adverse Event|0
1208307|NCT00878722|3965913|P5|Overall Study|Adverse Event|0
1208308|NCT00878722|3965914|P4|Overall Study|Adverse Event|0
1208309|NCT00878722|3965915|P3|Overall Study|Adverse Event|0
1208310|NCT00878722|3965916|P2|Overall Study|Adverse Event|0
1208311|NCT00878722|3965917|P1|Overall Study|Adverse Event|0
1208312|NCT00878722|3965910|P8|Overall Study|Death|2
1208313|NCT00878722|3965911|P7|Overall Study|Death|0
1208314|NCT00878722|3965912|P6|Overall Study|Death|1
1208315|NCT00878722|3965913|P5|Overall Study|Death|0
1208316|NCT00878722|3965914|P4|Overall Study|Death|1
1208317|NCT00878722|3965915|P3|Overall Study|Death|0
1208318|NCT00878722|3965916|P2|Overall Study|Death|0
1208319|NCT00878722|3965917|P1|Overall Study|Death|0
1208320|NCT00878722|3965910|P8|Overall Study|Progressive disease|3
1208321|NCT00878722|3965911|P7|Overall Study|Progressive disease|4
1208322|NCT00878722|3965912|P6|Overall Study|Progressive disease|1
1208323|NCT00878722|3965913|P5|Overall Study|Progressive disease|7
1208324|NCT00878722|3965914|P4|Overall Study|Progressive disease|7
1208325|NCT00878722|3965915|P3|Overall Study|Progressive disease|3
1208326|NCT00878722|3965916|P2|Overall Study|Progressive disease|3
1208327|NCT00878722|3965917|P1|Overall Study|Progressive disease|3
1208328|NCT00878709|3966002|P2|Overall Study|Other Reasons|84
1208329|NCT00878709|3966003|P1|Overall Study|Other Reasons|93
1208330|NCT00878709|3966002|P2|Overall Study|Lost to Follow-up|33
1208331|NCT00878709|3966003|P1|Overall Study|Lost to Follow-up|35
1208332|NCT00878709|3966002|P2|Overall Study|Withdrawal by Subject|120
1208333|NCT00878709|3966003|P1|Overall Study|Withdrawal by Subject|197
1208334|NCT00878553|3966063|P5|PK Study|Withdrawal by Subject|0
1208335|NCT00878553|3966064|P4|PK Study|Withdrawal by Subject|1
1208336|NCT00878553|3966065|P3|PK Study|Withdrawal by Subject|0
1208337|NCT00878553|3966066|P2|PK Study|Withdrawal by Subject|0
1208338|NCT00878553|3966067|P1|PK Study|Withdrawal by Subject|0
1208339|NCT00878553|3966063|P5|Sleep Study|family emergency|0
1208340|NCT00878553|3966064|P4|Sleep Study|family emergency|0
1208341|NCT00878553|3966065|P3|Sleep Study|family emergency|0
1208342|NCT00878553|3966066|P2|Sleep Study|family emergency|0
1208343|NCT00878553|3966067|P1|Sleep Study|family emergency|1
1208344|NCT00878553|3966063|P5|Sleep Study|car accident|0
1208345|NCT00878553|3966064|P4|Sleep Study|car accident|0
1208346|NCT00878553|3966065|P3|Sleep Study|car accident|0
1208347|NCT00878553|3966066|P2|Sleep Study|car accident|0
1208348|NCT00878553|3966067|P1|Sleep Study|car accident|1
1208349|NCT00878553|3966063|P5|Sleep Study|Lost to Follow-up|0
1208350|NCT00878553|3966064|P4|Sleep Study|Lost to Follow-up|0
1208351|NCT00878553|3966065|P3|Sleep Study|Lost to Follow-up|0
1208352|NCT00878553|3966066|P2|Sleep Study|Lost to Follow-up|0
1208353|NCT00878553|3966067|P1|Sleep Study|Lost to Follow-up|1
1208354|NCT00878553|3966063|P5|Sleep Study|Withdrawal by Subject|0
1208355|NCT00878553|3966064|P4|Sleep Study|Withdrawal by Subject|0
1208356|NCT00878553|3966065|P3|Sleep Study|Withdrawal by Subject|0
1208357|NCT00878553|3966066|P2|Sleep Study|Withdrawal by Subject|0
1208358|NCT00878553|3966067|P1|Sleep Study|Withdrawal by Subject|2
1208359|NCT00878501|3966126|P3|Overall Study|Administrative|1
1208360|NCT00878501|3966127|P2|Overall Study|Administrative|0
1208361|NCT00878501|3966128|P1|Overall Study|Administrative|0
1208362|NCT00878501|3966126|P3|Overall Study|Mis-randomisation of patient|0
1208363|NCT00878501|3966127|P2|Overall Study|Mis-randomisation of patient|0
1208364|NCT00878501|3966128|P1|Overall Study|Mis-randomisation of patient|1
1208365|NCT00878501|3966126|P3|Overall Study|Intake of prohibited concom. medication|1
1208366|NCT00878501|3966127|P2|Overall Study|Intake of prohibited concom. medication|0
1208367|NCT00878501|3966128|P1|Overall Study|Intake of prohibited concom. medication|0
1208368|NCT00878501|3966126|P3|Overall Study|Incorrect enrolment|0
1208369|NCT00878501|3966127|P2|Overall Study|Incorrect enrolment|2
1208370|NCT00878501|3966128|P1|Overall Study|Incorrect enrolment|1
1208371|NCT00878501|3966126|P3|Overall Study|Protocol Violation|1
1208372|NCT00878501|3966127|P2|Overall Study|Protocol Violation|0
1208373|NCT00878501|3966128|P1|Overall Study|Protocol Violation|0
1208374|NCT00878501|3966126|P3|Overall Study|Withdrawal by Subject|2
1208375|NCT00878501|3966127|P2|Overall Study|Withdrawal by Subject|1
1208376|NCT00878501|3966128|P1|Overall Study|Withdrawal by Subject|2
1208377|NCT00878501|3966126|P3|Overall Study|Lack of Efficacy|0
1208378|NCT00878501|3966127|P2|Overall Study|Lack of Efficacy|1
1208379|NCT00878501|3966128|P1|Overall Study|Lack of Efficacy|2
1208380|NCT00878501|3966126|P3|Overall Study|Adverse Event|3
1208381|NCT00878501|3966127|P2|Overall Study|Adverse Event|3
1208382|NCT00878501|3966128|P1|Overall Study|Adverse Event|11
1208383|NCT00878215|3966177|P4|Overall Study|Determined to be ineligible|0
1208384|NCT00878215|3966178|P3|Overall Study|Determined to be ineligible|0
1208385|NCT00878215|3966179|P2|Overall Study|Determined to be ineligible|10
1208386|NCT00878215|3966180|P1|Overall Study|Determined to be ineligible|0
1208387|NCT00877929|3966192|P2|Overall Study|Other reason (not specified)|6
1208388|NCT00877929|3966193|P1|Overall Study|Other reason (not specified)|2
1208389|NCT00877929|3966192|P2|Overall Study|Lack of Efficacy|1
1208390|NCT00877929|3966193|P1|Overall Study|Lack of Efficacy|0
1208391|NCT00877929|3966192|P2|Overall Study|Withdrawal by Subject|4
1208392|NCT00877929|3966193|P1|Overall Study|Withdrawal by Subject|4
1208393|NCT00877929|3966192|P2|Overall Study|Lost to Follow-up|1
1208394|NCT00877929|3966193|P1|Overall Study|Lost to Follow-up|0
1208395|NCT00877929|3966192|P2|Overall Study|Protocol Violation|3
1208396|NCT00877929|3966193|P1|Overall Study|Protocol Violation|3
1208397|NCT00877929|3966192|P2|Overall Study|Adverse Event|20
1208398|NCT00877929|3966193|P1|Overall Study|Adverse Event|11
1208399|NCT00877890|3966281|P2|Overall Study|Loss of Glucose Control|4
1208400|NCT00877890|3966282|P1|Overall Study|Loss of Glucose Control|3
1208401|NCT00877890|3966281|P2|Overall Study|Investigator Decision|2
1208402|NCT00877890|3966282|P1|Overall Study|Investigator Decision|0
1208403|NCT00877890|3966281|P2|Overall Study|Withdrawal of Consent|12
1208404|NCT00877890|3966282|P1|Overall Study|Withdrawal of Consent|6
1208405|NCT00877890|3966281|P2|Overall Study|Protocol Violation|1
1208406|NCT00877890|3966282|P1|Overall Study|Protocol Violation|0
1208407|NCT00877890|3966281|P2|Overall Study|Lost to Follow-up|5
1208408|NCT00877890|3966282|P1|Overall Study|Lost to Follow-up|5
1208409|NCT00877890|3966281|P2|Overall Study|Adverse Event|6
1208410|NCT00877890|3966282|P1|Overall Study|Adverse Event|6
1208411|NCT00877799|3966347|P5|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
1208412|NCT00877799|3966348|P4|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
1208413|NCT00877799|3966349|P3|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
1208414|NCT00877799|3966350|P2|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
1208415|NCT00877799|3966351|P1|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
1208416|NCT00877799|3966347|P5|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
1208417|NCT00877799|3966348|P4|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1
1208418|NCT00877799|3966349|P3|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
1208419|NCT00877799|3966350|P2|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
1208420|NCT00877799|3966351|P1|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
1208421|NCT00877799|3966347|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
1208422|NCT00877799|3966348|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
1208423|NCT00877799|3966349|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
1208424|NCT00877799|3966350|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3
1208425|NCT00877799|3966351|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
1208426|NCT00877799|3966347|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
1208427|NCT00877799|3966348|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
1208428|NCT00877799|3966349|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2
1208429|NCT00877799|3966350|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
1208430|NCT00877799|3966351|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
1208431|NCT00877799|3966347|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
1208432|NCT00877799|3966348|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
1208433|NCT00877799|3966349|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
1208434|NCT00877799|3966350|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
1208435|NCT00877799|3966351|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2
1208436|NCT00877773|3966366|P1|Overall Study|Disease Progression|44
1208437|NCT00877487|3966379|P2|Double-blind Randomized Withdrawal Phase|Moved out of state|0
1208438|NCT00877487|3966380|P1|Double-blind Randomized Withdrawal Phase|Moved out of state|1
1208439|NCT00877487|3966379|P2|Double-blind Randomized Withdrawal Phase|Protocol Violation|1
1208440|NCT00877487|3966380|P1|Double-blind Randomized Withdrawal Phase|Protocol Violation|0
1208441|NCT00877487|3966379|P2|Double-blind Randomized Withdrawal Phase|Adverse Event|1
1208442|NCT00877487|3966380|P1|Double-blind Randomized Withdrawal Phase|Adverse Event|0
1208443|NCT00877487|3966379|P2|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45
1208444|NCT00877487|3966380|P1|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5
1208445|NCT00877487|3966379|P2|Open-label Treatment Phase|Out of country for business|0
1208446|NCT00877487|3966380|P1|Open-label Treatment Phase|Out of country for business|1
1208447|NCT00877487|3966379|P2|Open-label Treatment Phase|Lost to Follow-up|0
1208448|NCT00877487|3966380|P1|Open-label Treatment Phase|Lost to Follow-up|1
1208449|NCT00877487|3966379|P2|Open-label Treatment Phase|Withdrawal by Subject|0
1208450|NCT00877487|3966380|P1|Open-label Treatment Phase|Withdrawal by Subject|1
1208451|NCT00877487|3966379|P2|Open-label Treatment Phase|Protocol Violation|0
1208452|NCT00877487|3966380|P1|Open-label Treatment Phase|Protocol Violation|3
1208453|NCT00877487|3966379|P2|Open-label Treatment Phase|Adverse Event|0
1208454|NCT00877487|3966380|P1|Open-label Treatment Phase|Adverse Event|1
1208455|NCT00877383|3966428|P2|Overall Study|Death|2
1208456|NCT00877383|3966429|P1|Overall Study|Death|1
1208457|NCT00877383|3966428|P2|Overall Study|Unsatisfactory therapeutic effect|0
1208458|NCT00877383|3966429|P1|Overall Study|Unsatisfactory therapeutic effect|1
1208459|NCT00877383|3966428|P2|Overall Study|Protocol deviation|6
1208460|NCT00877383|3966429|P1|Overall Study|Protocol deviation|2
1208461|NCT00877383|3966428|P2|Overall Study|Administrative problems|0
1208462|NCT00877383|3966429|P1|Overall Study|Administrative problems|2
1208463|NCT00877383|3966428|P2|Overall Study|Subject no longer requires study drug|0
1208464|NCT00877383|3966429|P1|Overall Study|Subject no longer requires study drug|2
1208465|NCT00877383|3966428|P2|Overall Study|Subject withdrew consent|12
1208466|NCT00877383|3966429|P1|Overall Study|Subject withdrew consent|3
1208467|NCT00877383|3966428|P2|Overall Study|Lost to Follow-up|3
1208468|NCT00877383|3966429|P1|Overall Study|Lost to Follow-up|5
1208469|NCT00877383|3966428|P2|Overall Study|Adverse Event|14
1208470|NCT00877383|3966429|P1|Overall Study|Adverse Event|13
1208471|NCT00877071|3966449|P1|Overall Study|disease progression|2
1208472|NCT00877032|3966482|P7|Overall Study|Did not meet entrance criteria|2
1208473|NCT00877032|3966483|P6|Overall Study|Did not meet entrance criteria|0
1208474|NCT00877032|3966484|P5|Overall Study|Did not meet entrance criteria|0
1208475|NCT00877032|3966485|P4|Overall Study|Did not meet entrance criteria|1
1208476|NCT00877032|3966486|P3|Overall Study|Did not meet entrance criteria|0
1208477|NCT00877032|3966487|P2|Overall Study|Did not meet entrance criteria|0
1208478|NCT00877032|3966488|P1|Overall Study|Did not meet entrance criteria|0
1208479|NCT00877006|3966589|P2|Long-Term Follow-up Period|Not specified|9
1208480|NCT00877006|3966590|P1|Long-Term Follow-up Period|Not specified|7
1208481|NCT00877006|3966589|P2|Long-Term Follow-up Period|Death|18
1208482|NCT00877006|3966590|P1|Long-Term Follow-up Period|Death|26
1208483|NCT00877006|3966589|P2|Long-Term Follow-up Period|Lost to Follow-up|9
1208484|NCT00877006|3966590|P1|Long-Term Follow-up Period|Lost to Follow-up|8
1208485|NCT00877006|3966589|P2|Long-Term Follow-up Period|Withdrawal by Subject|19
1208486|NCT00877006|3966590|P1|Long-Term Follow-up Period|Withdrawal by Subject|12
1208487|NCT00877006|3966589|P2|Treatment Period|Randomized but Not Treated|8
1208488|NCT00877006|3966590|P1|Treatment Period|Randomized but Not Treated|3
1208489|NCT00877006|3966589|P2|Treatment Period|Not Specified|4
1208490|NCT00877006|3966590|P1|Treatment Period|Not Specified|4
1208491|NCT00877006|3966589|P2|Treatment Period|Started New Treatment Regimen|5
1208492|NCT00877006|3966590|P1|Treatment Period|Started New Treatment Regimen|2
1208493|NCT00877006|3966589|P2|Treatment Period|Disease Progression|2
1208494|NCT00877006|3966590|P1|Treatment Period|Disease Progression|1
1208495|NCT00877006|3966589|P2|Treatment Period|Lost to Follow-up|1
1208496|NCT00877006|3966590|P1|Treatment Period|Lost to Follow-up|0
1208497|NCT00877006|3966589|P2|Treatment Period|Protocol Violation|0
1208498|NCT00877006|3966590|P1|Treatment Period|Protocol Violation|1
1208499|NCT00877006|3966589|P2|Treatment Period|Withdrawal by Subject|3
1208500|NCT00877006|3966590|P1|Treatment Period|Withdrawal by Subject|2
1208501|NCT00877006|3966589|P2|Treatment Period|Adverse Event|3
1208502|NCT00877006|3966590|P1|Treatment Period|Adverse Event|10
1208503|NCT00877006|3966589|P2|Treatment Period|Death|1
1208504|NCT00877006|3966590|P1|Treatment Period|Death|2
1208505|NCT00876928|3966630|P2|Overall Study|Hypokalemia-affects insulin secretion|0
1208506|NCT00876928|3966631|P1|Overall Study|Hypokalemia-affects insulin secretion|1
1208507|NCT00876928|3966630|P2|Overall Study|Lost to Follow-up|5
1208508|NCT00876928|3966631|P1|Overall Study|Lost to Follow-up|2
1208509|NCT00876733|3966668|P4|Overall Study|Data not available|1
1208510|NCT00876733|3966669|P3|Overall Study|Data not available|7
1208511|NCT00876733|3966670|P2|Overall Study|Data not available|3
1208512|NCT00876733|3966671|P1|Overall Study|Data not available|14
1208513|NCT00876733|3966668|P4|Overall Study|Lost to Follow-up|2
1208514|NCT00876733|3966669|P3|Overall Study|Lost to Follow-up|3
1208515|NCT00876733|3966670|P2|Overall Study|Lost to Follow-up|10
1208516|NCT00876733|3966671|P1|Overall Study|Lost to Follow-up|26
1208517|NCT00876733|3966668|P4|Overall Study|Lack of Efficacy|1
1208518|NCT00876733|3966669|P3|Overall Study|Lack of Efficacy|10
1208519|NCT00876733|3966670|P2|Overall Study|Lack of Efficacy|9
1208520|NCT00876733|3966671|P1|Overall Study|Lack of Efficacy|17
1208521|NCT00876733|3966668|P4|Overall Study|Adverse Event|3
1208522|NCT00876733|3966669|P3|Overall Study|Adverse Event|10
1208523|NCT00876733|3966670|P2|Overall Study|Adverse Event|20
1208524|NCT00876733|3966671|P1|Overall Study|Adverse Event|34
1208525|NCT00876694|3966779|P2|Overall Study|Death|0
1208526|NCT00876694|3966780|P1|Overall Study|Death|1
1208527|NCT00876694|3966779|P2|Overall Study|Administrative problems|1
1208528|NCT00876694|3966780|P1|Overall Study|Administrative problems|1
1208529|NCT00876694|3966779|P2|Overall Study|Abnormal test procedure result(s)|0
1208530|NCT00876694|3966780|P1|Overall Study|Abnormal test procedure result(s)|1
1208531|NCT00876694|3966779|P2|Overall Study|Unsatisfactory therapeutic effect|0
1208532|NCT00876694|3966780|P1|Overall Study|Unsatisfactory therapeutic effect|2
1208533|NCT00876694|3966779|P2|Overall Study|Subject withdrew consent|4
1208534|NCT00876694|3966780|P1|Overall Study|Subject withdrew consent|6
1208535|NCT00876694|3966779|P2|Overall Study|Adverse Event|7
1208536|NCT00876694|3966780|P1|Overall Study|Adverse Event|10
1208537|NCT00876460|3966806|P8|Mono Therapy Phase|Adverse Event|0
1208538|NCT00876460|3966807|P7|Mono Therapy Phase|Adverse Event|0
1208539|NCT00876460|3966808|P6|Mono Therapy Phase|Adverse Event|0
1208540|NCT00876460|3966809|P5|Mono Therapy Phase|Adverse Event|0
1208541|NCT00876460|3966810|P4|Mono Therapy Phase|Adverse Event|1
1208542|NCT00876460|3966811|P3|Mono Therapy Phase|Adverse Event|0
1208543|NCT00876460|3966812|P2|Mono Therapy Phase|Adverse Event|0
1208544|NCT00876460|3966813|P1|Mono Therapy Phase|Adverse Event|0
1208545|NCT00876460|3966806|P8|Mono Therapy Phase|Withdrawal by Subject|0
1208546|NCT00876460|3966807|P7|Mono Therapy Phase|Withdrawal by Subject|0
1208547|NCT00876460|3966808|P6|Mono Therapy Phase|Withdrawal by Subject|0
1208548|NCT00876460|3966809|P5|Mono Therapy Phase|Withdrawal by Subject|0
1208549|NCT00876460|3966810|P4|Mono Therapy Phase|Withdrawal by Subject|0
1208550|NCT00876460|3966811|P3|Mono Therapy Phase|Withdrawal by Subject|0
1208551|NCT00876460|3966812|P2|Mono Therapy Phase|Withdrawal by Subject|1
1208552|NCT00876460|3966813|P1|Mono Therapy Phase|Withdrawal by Subject|0
1208553|NCT00876460|3966806|P8|Mono Therapy Phase|Progressive disease|3
1208554|NCT00876460|3966807|P7|Mono Therapy Phase|Progressive disease|1
1208555|NCT00876460|3966808|P6|Mono Therapy Phase|Progressive disease|0
1208556|NCT00876460|3966809|P5|Mono Therapy Phase|Progressive disease|2
1208557|NCT00876460|3966810|P4|Mono Therapy Phase|Progressive disease|0
1208558|NCT00876460|3966811|P3|Mono Therapy Phase|Progressive disease|0
1208559|NCT00876460|3966812|P2|Mono Therapy Phase|Progressive disease|0
1208560|NCT00876460|3966813|P1|Mono Therapy Phase|Progressive disease|0
1208561|NCT00876460|3966806|P8|Combination Therapy Phase|Not treated|0
1208562|NCT00876460|3966807|P7|Combination Therapy Phase|Not treated|1
1208563|NCT00876460|3966808|P6|Combination Therapy Phase|Not treated|0
1208564|NCT00876460|3966809|P5|Combination Therapy Phase|Not treated|0
1208565|NCT00876460|3966810|P4|Combination Therapy Phase|Not treated|0
1208566|NCT00876460|3966811|P3|Combination Therapy Phase|Not treated|0
1208567|NCT00876460|3966812|P2|Combination Therapy Phase|Not treated|0
1208568|NCT00876460|3966813|P1|Combination Therapy Phase|Not treated|0
1208569|NCT00876460|3966806|P8|Combination Therapy Phase|Other reason not defined above|2
1208570|NCT00876460|3966807|P7|Combination Therapy Phase|Other reason not defined above|1
1208571|NCT00876460|3966808|P6|Combination Therapy Phase|Other reason not defined above|0
1208572|NCT00876460|3966809|P5|Combination Therapy Phase|Other reason not defined above|0
1208573|NCT00876460|3966810|P4|Combination Therapy Phase|Other reason not defined above|0
1208574|NCT00876460|3966811|P3|Combination Therapy Phase|Other reason not defined above|0
1208575|NCT00876460|3966812|P2|Combination Therapy Phase|Other reason not defined above|0
1208576|NCT00876460|3966813|P1|Combination Therapy Phase|Other reason not defined above|0
1208577|NCT00876460|3966806|P8|Combination Therapy Phase|Withdrawal by Subject|0
1208578|NCT00876460|3966807|P7|Combination Therapy Phase|Withdrawal by Subject|0
1208579|NCT00876460|3966808|P6|Combination Therapy Phase|Withdrawal by Subject|0
1208580|NCT00876460|3966809|P5|Combination Therapy Phase|Withdrawal by Subject|1
1208581|NCT00876460|3966810|P4|Combination Therapy Phase|Withdrawal by Subject|0
1208582|NCT00876460|3966811|P3|Combination Therapy Phase|Withdrawal by Subject|0
1208583|NCT00876460|3966812|P2|Combination Therapy Phase|Withdrawal by Subject|1
1208584|NCT00876460|3966813|P1|Combination Therapy Phase|Withdrawal by Subject|1
1208585|NCT00876460|3966806|P8|Combination Therapy Phase|Adverse Event|2
1208586|NCT00876460|3966807|P7|Combination Therapy Phase|Adverse Event|3
1208587|NCT00876460|3966808|P6|Combination Therapy Phase|Adverse Event|0
1208588|NCT00876460|3966809|P5|Combination Therapy Phase|Adverse Event|2
1208589|NCT00876460|3966810|P4|Combination Therapy Phase|Adverse Event|2
1208590|NCT00876460|3966811|P3|Combination Therapy Phase|Adverse Event|0
1208591|NCT00876460|3966812|P2|Combination Therapy Phase|Adverse Event|2
1208592|NCT00876460|3966813|P1|Combination Therapy Phase|Adverse Event|0
1208593|NCT00876460|3966806|P8|Combination Therapy Phase|Dose limiting toxicity|1
1208594|NCT00876460|3966807|P7|Combination Therapy Phase|Dose limiting toxicity|2
1208595|NCT00876460|3966808|P6|Combination Therapy Phase|Dose limiting toxicity|2
1208596|NCT00876460|3966809|P5|Combination Therapy Phase|Dose limiting toxicity|1
1208597|NCT00876460|3966810|P4|Combination Therapy Phase|Dose limiting toxicity|1
1208598|NCT00876460|3966811|P3|Combination Therapy Phase|Dose limiting toxicity|0
1208599|NCT00876460|3966812|P2|Combination Therapy Phase|Dose limiting toxicity|1
1208600|NCT00876460|3966813|P1|Combination Therapy Phase|Dose limiting toxicity|0
1208601|NCT00876460|3966806|P8|Combination Therapy Phase|Progressive disease|1
1208602|NCT00876460|3966807|P7|Combination Therapy Phase|Progressive disease|1
1208603|NCT00876460|3966808|P6|Combination Therapy Phase|Progressive disease|1
1208604|NCT00876460|3966809|P5|Combination Therapy Phase|Progressive disease|3
1208605|NCT00876460|3966810|P4|Combination Therapy Phase|Progressive disease|3
1208606|NCT00876460|3966811|P3|Combination Therapy Phase|Progressive disease|3
1208607|NCT00876460|3966812|P2|Combination Therapy Phase|Progressive disease|3
1208608|NCT00876460|3966813|P1|Combination Therapy Phase|Progressive disease|2
1208609|NCT00876447|3966885|P2|Overall Study|Adverse Event|8
1208610|NCT00876447|3966886|P1|Overall Study|Adverse Event|4
1208611|NCT00876447|3966885|P2|Overall Study|Lack of Efficacy|3
1208612|NCT00876447|3966886|P1|Overall Study|Lack of Efficacy|5
1208613|NCT00876447|3966885|P2|Overall Study|Pregnancy|2
1208614|NCT00876447|3966886|P1|Overall Study|Pregnancy|4
1208615|NCT00876447|3966885|P2|Overall Study|Lost to Follow-up|15
1208616|NCT00876447|3966886|P1|Overall Study|Lost to Follow-up|6
1208617|NCT00876447|3966885|P2|Overall Study|Personal reasons|28
1208618|NCT00876447|3966886|P1|Overall Study|Personal reasons|30
1208619|NCT00876447|3966885|P2|Overall Study|Protocol Violation|3
1208620|NCT00876447|3966886|P1|Overall Study|Protocol Violation|9
1208621|NCT00876447|3966885|P2|Overall Study|Site closure|14
1208622|NCT00876447|3966886|P1|Overall Study|Site closure|19
1208623|NCT00876447|3966885|P2|Overall Study|Other miscellaneous reasons|8
1208624|NCT00876447|3966886|P1|Overall Study|Other miscellaneous reasons|3
1208625|NCT00876395|3966946|P2|Overall Study|Death|0
1208626|NCT00876395|3966947|P1|Overall Study|Death|12
1208627|NCT00876395|3966946|P2|Overall Study|Administrative problems|23
1208628|NCT00876395|3966947|P1|Overall Study|Administrative problems|39
1208629|NCT00876395|3966946|P2|Overall Study|Lost to Follow-up|0
1208630|NCT00876395|3966947|P1|Overall Study|Lost to Follow-up|2
1208631|NCT00876395|3966946|P2|Overall Study|Withdrawal by Subject|33
1208632|NCT00876395|3966947|P1|Overall Study|Withdrawal by Subject|66
1208633|NCT00876395|3966946|P2|Overall Study|Protocol Violation|2
1208634|NCT00876395|3966947|P1|Overall Study|Protocol Violation|5
1208635|NCT00876395|3966946|P2|Overall Study|New cancer therapy|7
1208636|NCT00876395|3966947|P1|Overall Study|New cancer therapy|25
1208637|NCT00876395|3966946|P2|Overall Study|Disease progression|162
1208638|NCT00876395|3966947|P1|Overall Study|Disease progression|259
1208639|NCT00876395|3966946|P2|Overall Study|Abnormal test procedure result(s)|0
1208640|NCT00876395|3966947|P1|Overall Study|Abnormal test procedure result(s)|1
1208641|NCT00876395|3966946|P2|Overall Study|Adverse Event|11
1208642|NCT00876395|3966947|P1|Overall Study|Adverse Event|63
1208643|NCT00876395|3966946|P2|Overall Study|Untreated|1
1208644|NCT00876395|3966947|P1|Overall Study|Untreated|8
1208645|NCT00876343|3966988|P3|Overall Study|Change of residence or other commitments|3
1208646|NCT00876343|3966989|P2|Overall Study|Change of residence or other commitments|2
1208647|NCT00876343|3966990|P1|Overall Study|Change of residence or other commitments|2
1208648|NCT00876343|3966988|P3|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
1208649|NCT00876343|3966989|P2|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
1208650|NCT00876343|3966990|P1|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
1208651|NCT00876343|3966988|P3|Overall Study|Physician Decision|1
1208652|NCT00876343|3966989|P2|Overall Study|Physician Decision|1
1208653|NCT00876343|3966990|P1|Overall Study|Physician Decision|0
1208654|NCT00876343|3966988|P3|Overall Study|Protocol Violation|1
1208655|NCT00876343|3966989|P2|Overall Study|Protocol Violation|1
1208656|NCT00876343|3966990|P1|Overall Study|Protocol Violation|4
1208657|NCT00876343|3966988|P3|Overall Study|Lack of Efficacy|1
1208658|NCT00876343|3966989|P2|Overall Study|Lack of Efficacy|0
1208659|NCT00876343|3966990|P1|Overall Study|Lack of Efficacy|0
1208660|NCT00876343|3966988|P3|Overall Study|Withdrawal by Subject|3
1208661|NCT00876343|3966989|P2|Overall Study|Withdrawal by Subject|4
1208662|NCT00876343|3966990|P1|Overall Study|Withdrawal by Subject|4
1208663|NCT00876343|3966988|P3|Overall Study|Adverse Event|2
1208664|NCT00876343|3966989|P2|Overall Study|Adverse Event|8
1208665|NCT00876343|3966990|P1|Overall Study|Adverse Event|7
1208666|NCT00876265|3967004|P1|Overall Study|Withdrawal by Subject|2
1208667|NCT00876265|3967004|P1|Overall Study|Lost to Follow-up|6
1208668|NCT00876265|3967004|P1|Overall Study|Miscellaneous reasons|4
1208669|NCT00876018|3967013|P3|Overall Study|Withdrew Consent due to Adverse Event|2
1208670|NCT00876018|3967014|P2|Overall Study|Withdrew Consent due to Adverse Event|4
1208671|NCT00876018|3967015|P1|Overall Study|Withdrew Consent due to Adverse Event|5
1208672|NCT00876018|3967013|P3|Overall Study|Lost to Follow-up|1
1208673|NCT00876018|3967014|P2|Overall Study|Lost to Follow-up|1
1208674|NCT00876018|3967015|P1|Overall Study|Lost to Follow-up|0
1208675|NCT00875979|3967070|P2|Dose Expansion Phase - 3.6 mg/kg|Death|1
1208676|NCT00875979|3967071|P1|Dose Expansion Phase - 3.6 mg/kg|Death|0
1208677|NCT00875979|3967070|P2|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3
1208678|NCT00875979|3967071|P1|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0
1208679|NCT00875979|3967070|P2|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3
1208680|NCT00875979|3967071|P1|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0
1208681|NCT00875979|3967070|P2|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3
1208682|NCT00875979|3967071|P1|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0
1208683|NCT00875979|3967070|P2|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37
1208684|NCT00875979|3967071|P1|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0
1208685|NCT00875979|3967070|P2|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6
1208686|NCT00875979|3967071|P1|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0
1208687|NCT00875979|3967070|P2|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0
1208688|NCT00875979|3967071|P1|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1
1208689|NCT00875979|3967070|P2|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0
1208690|NCT00875979|3967071|P1|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1
1208691|NCT00875979|3967070|P2|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0
1208692|NCT00875979|3967071|P1|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1
1208693|NCT00875810|3967094|P1|Overall Study|Device explanted|1
1208694|NCT00875810|3967094|P1|Overall Study|Patient enroled but not implanted|2
1208695|NCT00875810|3967094|P1|Overall Study|Lost to Follow-up|39
1208696|NCT00875810|3967094|P1|Overall Study|Physician Decision|3
1208697|NCT00875810|3967094|P1|Overall Study|Withdrawal by Subject|1
1208698|NCT00875797|3967103|P2|Overall Study|Protocol Violation|3
1208699|NCT00875797|3967104|P1|Overall Study|Protocol Violation|6
1208700|NCT00875706|3967117|P3|Overall Study|Withdrawal by Subject|0
1208701|NCT00875706|3967118|P2|Overall Study|Withdrawal by Subject|0
1208702|NCT00875706|3967119|P1|Overall Study|Withdrawal by Subject|1
1208703|NCT00875615|3967136|P1|Overall Study|Withdrawal by Subject|1
1208704|NCT00875563|3967150|P1|Overall Study|Still be eligible for follow-up|7
1208705|NCT00875563|3967150|P1|Overall Study|No long-term (3-5 year) consent|6
1208706|NCT00875563|3967150|P1|Overall Study|Withdrawal by Subject|7
1208707|NCT00875563|3967150|P1|Overall Study|Death|4
1208708|NCT00875485|3967175|P2|Challenge Dose Epoch|Pregnancy|0
1208709|NCT00875485|3967176|P1|Challenge Dose Epoch|Pregnancy|1
1208710|NCT00875433|3967216|P1|Overall Study|Not specified|3
1208711|NCT00875433|3967216|P1|Overall Study|Withdrawal by Subject|2
1208712|NCT00875433|3967216|P1|Overall Study|Other Adverse Event|14
1208713|NCT00875433|3967216|P1|Overall Study|Progressive disease|41
1208714|NCT00875420|3967246|P5|Overall Study|Withdrawal by Subject|0
1208715|NCT00875420|3967247|P4|Overall Study|Withdrawal by Subject|0
1208716|NCT00875420|3967248|P3|Overall Study|Withdrawal by Subject|1
1208717|NCT00875420|3967249|P2|Overall Study|Withdrawal by Subject|0
1208718|NCT00875420|3967250|P1|Overall Study|Withdrawal by Subject|0
1208719|NCT00875420|3967246|P5|Overall Study|Sponsor decision|0
1208720|NCT00875420|3967247|P4|Overall Study|Sponsor decision|0
1208721|NCT00875420|3967248|P3|Overall Study|Sponsor decision|0
1208722|NCT00875420|3967249|P2|Overall Study|Sponsor decision|1
1208723|NCT00875420|3967250|P1|Overall Study|Sponsor decision|0
1208724|NCT00875420|3967246|P5|Overall Study|Prohibited medication|0
1208725|NCT00875420|3967247|P4|Overall Study|Prohibited medication|1
1208726|NCT00875420|3967248|P3|Overall Study|Prohibited medication|0
1208727|NCT00875420|3967249|P2|Overall Study|Prohibited medication|0
1208728|NCT00875420|3967250|P1|Overall Study|Prohibited medication|0
1208729|NCT00875420|3967246|P5|Overall Study|Personal reason|1
1208730|NCT00875420|3967247|P4|Overall Study|Personal reason|0
1208731|NCT00875420|3967248|P3|Overall Study|Personal reason|0
1208732|NCT00875420|3967249|P2|Overall Study|Personal reason|0
1208733|NCT00875420|3967250|P1|Overall Study|Personal reason|0
1208734|NCT00875420|3967246|P5|Overall Study|Lost to Follow-up|0
1208735|NCT00875420|3967247|P4|Overall Study|Lost to Follow-up|0
1208736|NCT00875420|3967248|P3|Overall Study|Lost to Follow-up|0
1208737|NCT00875420|3967249|P2|Overall Study|Lost to Follow-up|0
1208738|NCT00875420|3967250|P1|Overall Study|Lost to Follow-up|1
1208739|NCT00875420|3967246|P5|Overall Study|Inability to complete study procedures|1
1208740|NCT00875420|3967247|P4|Overall Study|Inability to complete study procedures|1
1208741|NCT00875420|3967248|P3|Overall Study|Inability to complete study procedures|1
1208742|NCT00875420|3967249|P2|Overall Study|Inability to complete study procedures|0
1208743|NCT00875420|3967250|P1|Overall Study|Inability to complete study procedures|1
1208744|NCT00875420|3967246|P5|Overall Study|Adverse Event|0
1208745|NCT00875420|3967247|P4|Overall Study|Adverse Event|0
1208746|NCT00875420|3967248|P3|Overall Study|Adverse Event|1
1208747|NCT00875420|3967249|P2|Overall Study|Adverse Event|1
1208748|NCT00875420|3967250|P1|Overall Study|Adverse Event|0
1208749|NCT00875017|3967311|P6|Fourth Intervention|Inability to comply with fasting|1
1208750|NCT00875017|3967312|P5|Fourth Intervention|Inability to comply with fasting|0
1208751|NCT00875017|3967313|P4|Fourth Intervention|Inability to comply with fasting|0
1208752|NCT00875017|3967314|P3|Fourth Intervention|Inability to comply with fasting|0
1208753|NCT00875017|3967315|P2|Fourth Intervention|Inability to comply with fasting|0
1208754|NCT00875017|3967316|P1|Fourth Intervention|Inability to comply with fasting|0
1208755|NCT00875017|3967311|P6|Washout|Withdrawal by Subject|0
1208756|NCT00875017|3967312|P5|Washout|Withdrawal by Subject|1
1208757|NCT00875017|3967313|P4|Washout|Withdrawal by Subject|0
1208758|NCT00875017|3967314|P3|Washout|Withdrawal by Subject|0
1208759|NCT00875017|3967315|P2|Washout|Withdrawal by Subject|0
1208760|NCT00875017|3967316|P1|Washout|Withdrawal by Subject|0
1208761|NCT00875017|3967311|P6|Third Intervention|Adverse Event|0
1208762|NCT00875017|3967312|P5|Third Intervention|Adverse Event|0
1208763|NCT00875017|3967313|P4|Third Intervention|Adverse Event|0
1208764|NCT00875017|3967314|P3|Third Intervention|Adverse Event|1
1208765|NCT00875017|3967315|P2|Third Intervention|Adverse Event|1
1208766|NCT00875017|3967316|P1|Third Intervention|Adverse Event|0
1208767|NCT00875017|3967311|P6|Washout|Problems collecting rectal effluent|0
1208768|NCT00875017|3967312|P5|Washout|Problems collecting rectal effluent|0
1208769|NCT00875017|3967313|P4|Washout|Problems collecting rectal effluent|0
1208770|NCT00875017|3967314|P3|Washout|Problems collecting rectal effluent|0
1208771|NCT00875017|3967315|P2|Washout|Problems collecting rectal effluent|1
1208772|NCT00875017|3967316|P1|Washout|Problems collecting rectal effluent|0
1208773|NCT00875017|3967311|P6|Second Intervention|Adverse Event|0
1208774|NCT00875017|3967312|P5|Second Intervention|Adverse Event|0
1208775|NCT00875017|3967313|P4|Second Intervention|Adverse Event|1
1208776|NCT00875017|3967314|P3|Second Intervention|Adverse Event|0
1208777|NCT00875017|3967315|P2|Second Intervention|Adverse Event|0
1208778|NCT00875017|3967316|P1|Second Intervention|Adverse Event|0
1208779|NCT00875017|3967311|P6|Washout|Problem collecting rectal effluent|0
1208780|NCT00875017|3967312|P5|Washout|Problem collecting rectal effluent|0
1208781|NCT00875017|3967313|P4|Washout|Problem collecting rectal effluent|0
1208782|NCT00875017|3967314|P3|Washout|Problem collecting rectal effluent|1
1208783|NCT00875017|3967315|P2|Washout|Problem collecting rectal effluent|0
1208784|NCT00875017|3967316|P1|Washout|Problem collecting rectal effluent|0
1208785|NCT00875017|3967311|P6|First Intervention|Intolerance to nasogastric tube|0
1208786|NCT00875017|3967312|P5|First Intervention|Intolerance to nasogastric tube|1
1208787|NCT00875017|3967313|P4|First Intervention|Intolerance to nasogastric tube|0
1208788|NCT00875017|3967314|P3|First Intervention|Intolerance to nasogastric tube|0
1208789|NCT00875017|3967315|P2|First Intervention|Intolerance to nasogastric tube|0
1208790|NCT00875017|3967316|P1|First Intervention|Intolerance to nasogastric tube|0
1208791|NCT00875017|3967311|P6|First Intervention|Problems collecting rectal effluent|0
1208792|NCT00875017|3967312|P5|First Intervention|Problems collecting rectal effluent|0
1208793|NCT00875017|3967313|P4|First Intervention|Problems collecting rectal effluent|0
1208794|NCT00875017|3967314|P3|First Intervention|Problems collecting rectal effluent|0
1208795|NCT00875017|3967315|P2|First Intervention|Problems collecting rectal effluent|0
1208796|NCT00875017|3967316|P1|First Intervention|Problems collecting rectal effluent|1
1208797|NCT00875017|3967311|P6|First Intervention|Adverse Event|0
1208798|NCT00875017|3967312|P5|First Intervention|Adverse Event|0
1208799|NCT00875017|3967313|P4|First Intervention|Adverse Event|1
1208800|NCT00875017|3967314|P3|First Intervention|Adverse Event|0
1208801|NCT00875017|3967315|P2|First Intervention|Adverse Event|0
1208802|NCT00875017|3967316|P1|First Intervention|Adverse Event|0
1208803|NCT00875017|3967311|P6|First Intervention|Withdrawal by Subject|0
1208804|NCT00875017|3967312|P5|First Intervention|Withdrawal by Subject|0
1208805|NCT00875017|3967313|P4|First Intervention|Withdrawal by Subject|0
1208806|NCT00875017|3967314|P3|First Intervention|Withdrawal by Subject|1
1208807|NCT00875017|3967315|P2|First Intervention|Withdrawal by Subject|0
1208808|NCT00875017|3967316|P1|First Intervention|Withdrawal by Subject|1
1208809|NCT00874939|3967330|P1|Overall Study|Study terminated|4
1208810|NCT00874848|3967363|P2|Overall Study|Physician Decision|2
1208811|NCT00874848|3967364|P1|Overall Study|Physician Decision|0
1208812|NCT00874848|3967363|P2|Overall Study|Failure to comply with protocol|1
1208813|NCT00874848|3967364|P1|Overall Study|Failure to comply with protocol|0
1208814|NCT00874848|3967363|P2|Overall Study|Noncompliance|1
1208815|NCT00874848|3967364|P1|Overall Study|Noncompliance|1
1208816|NCT00874848|3967363|P2|Overall Study|Withdrawal by Subject|4
1208817|NCT00874848|3967364|P1|Overall Study|Withdrawal by Subject|7
1208818|NCT00874848|3967363|P2|Overall Study|Progressive neoplastic disease|18
1208819|NCT00874848|3967364|P1|Overall Study|Progressive neoplastic disease|38
1208820|NCT00874848|3967363|P2|Overall Study|Adverse Event|2
1208821|NCT00874848|3967364|P1|Overall Study|Adverse Event|13
1208822|NCT00874822|3967380|P1|Overall Study|excluded by criteria|8
1208823|NCT00874770|3967388|P4|Overall Study|Subject no Longer Meets Study Criteria|0
1208824|NCT00874770|3967389|P3|Overall Study|Subject no Longer Meets Study Criteria|0
1208825|NCT00874770|3967390|P2|Overall Study|Subject no Longer Meets Study Criteria|0
1208826|NCT00874770|3967391|P1|Overall Study|Subject no Longer Meets Study Criteria|1
1208827|NCT00874770|3967388|P4|Overall Study|Lost to Follow-up|1
1208828|NCT00874770|3967389|P3|Overall Study|Lost to Follow-up|0
1208829|NCT00874770|3967390|P2|Overall Study|Lost to Follow-up|0
1208830|NCT00874770|3967391|P1|Overall Study|Lost to Follow-up|1
1208831|NCT00874770|3967388|P4|Overall Study|Adverse Event|2
1208832|NCT00874770|3967389|P3|Overall Study|Adverse Event|4
1208833|NCT00874770|3967390|P2|Overall Study|Adverse Event|1
1208834|NCT00874770|3967391|P1|Overall Study|Adverse Event|1
1208835|NCT00874770|3967388|P4|Overall Study|Lack of Efficacy|2
1208836|NCT00874770|3967389|P3|Overall Study|Lack of Efficacy|0
1208837|NCT00874770|3967390|P2|Overall Study|Lack of Efficacy|0
1208838|NCT00874770|3967391|P1|Overall Study|Lack of Efficacy|2
1208839|NCT00874549|3967437|P4|Overall Study|Withdrawal by Subject|1
1208840|NCT00874549|3967438|P3|Overall Study|Withdrawal by Subject|0
1208841|NCT00874549|3967439|P2|Overall Study|Withdrawal by Subject|1
1208842|NCT00874549|3967440|P1|Overall Study|Withdrawal by Subject|0
1208843|NCT00874549|3967437|P4|Overall Study|Lost to Follow-up|0
1208844|NCT00874549|3967438|P3|Overall Study|Lost to Follow-up|1
1208845|NCT00874549|3967439|P2|Overall Study|Lost to Follow-up|0
1208846|NCT00874549|3967440|P1|Overall Study|Lost to Follow-up|0
1208847|NCT00874549|3967437|P4|Overall Study|Protocol Violation|1
1208848|NCT00874549|3967438|P3|Overall Study|Protocol Violation|2
1208849|NCT00874549|3967439|P2|Overall Study|Protocol Violation|0
1208850|NCT00874549|3967440|P1|Overall Study|Protocol Violation|1
1208851|NCT00874549|3967437|P4|Overall Study|Adverse Event|0
1208852|NCT00874549|3967438|P3|Overall Study|Adverse Event|1
1208853|NCT00874549|3967439|P2|Overall Study|Adverse Event|0
1208854|NCT00874549|3967440|P1|Overall Study|Adverse Event|0
1208855|NCT00874497|3967517|P2|Overall Study|Withdrawal by Subject|4
1208856|NCT00874497|3967518|P1|Overall Study|Withdrawal by Subject|5
1208857|NCT00874497|3967517|P2|Overall Study|Physician Decision|1
1208858|NCT00874497|3967518|P1|Overall Study|Physician Decision|1
1208859|NCT00874497|3967517|P2|Overall Study|Met Withdrawal Criteria|2
1208860|NCT00874497|3967518|P1|Overall Study|Met Withdrawal Criteria|4
1208861|NCT00874497|3967517|P2|Overall Study|Sponsor Discontinued Trial|3
1208862|NCT00874497|3967518|P1|Overall Study|Sponsor Discontinued Trial|7
1208863|NCT00874497|3967517|P2|Overall Study|Adverse Event|4
1208864|NCT00874497|3967518|P1|Overall Study|Adverse Event|9
1208865|NCT00874497|3967517|P2|Overall Study|Lost to Follow-up|4
1208866|NCT00874497|3967518|P1|Overall Study|Lost to Follow-up|2
1208867|NCT00874276|3967558|P2|Overall Study|Withdrawal by Subject|1
1208868|NCT00874276|3967559|P1|Overall Study|Withdrawal by Subject|1
1208869|NCT00874120|3967581|P2|Second Intervention|Protocol Violation|0
1208870|NCT00874120|3967582|P1|Second Intervention|Protocol Violation|1
1208871|NCT00874120|3967581|P2|Second Intervention|Withdrawal by Subject|0
1208872|NCT00874120|3967582|P1|Second Intervention|Withdrawal by Subject|1
1208873|NCT00874120|3967581|P2|First Intervention|positive drug test|0
1208874|NCT00874120|3967582|P1|First Intervention|positive drug test|1
1208875|NCT00874120|3967581|P2|First Intervention|Protocol Violation|0
1208876|NCT00874120|3967582|P1|First Intervention|Protocol Violation|3
1208877|NCT00874120|3967581|P2|First Intervention|Lost to Follow-up|1
1208878|NCT00874120|3967582|P1|First Intervention|Lost to Follow-up|0
1208879|NCT00874120|3967581|P2|First Intervention|Withdrawal by Subject|0
1208880|NCT00874120|3967582|P1|First Intervention|Withdrawal by Subject|2
1208881|NCT00874120|3967581|P2|First Intervention|Adverse Event|1
1208882|NCT00874120|3967582|P1|First Intervention|Adverse Event|0
1208883|NCT00874029|3967595|P1|Overall Study|Lost to Follow-up|5
1208884|NCT00874029|3967595|P1|Overall Study|Adverse Event|1
1208885|NCT00874029|3967595|P1|Overall Study|Physician Decision|1
1208886|NCT00874029|3967595|P1|Overall Study|Pregnancy|4
1208887|NCT00874029|3967595|P1|Overall Study|Withdrawal by Subject|10
1208888|NCT00873912|3967611|P2|Overall Study|Lost to Follow-up|0
1208889|NCT00873912|3967612|P1|Overall Study|Lost to Follow-up|2
1208890|NCT00873912|3967611|P2|Overall Study|Withdrawal by Subject|0
1208891|NCT00873912|3967612|P1|Overall Study|Withdrawal by Subject|1
1208892|NCT00873860|3967651|P4|Overall Study|Other|0
1208893|NCT00873860|3967652|P3|Overall Study|Other|1
1208894|NCT00873860|3967653|P2|Overall Study|Other|0
1208895|NCT00873860|3967654|P1|Overall Study|Other|1
1208896|NCT00873860|3967651|P4|Overall Study|Death|0
1208897|NCT00873860|3967652|P3|Overall Study|Death|0
1208898|NCT00873860|3967653|P2|Overall Study|Death|0
1208899|NCT00873860|3967654|P1|Overall Study|Death|1
1208900|NCT00873860|3967651|P4|Overall Study|Withdrawal by Subject|0
1208901|NCT00873860|3967652|P3|Overall Study|Withdrawal by Subject|2
1208902|NCT00873860|3967653|P2|Overall Study|Withdrawal by Subject|0
1208903|NCT00873860|3967654|P1|Overall Study|Withdrawal by Subject|1
1208904|NCT00873860|3967651|P4|Overall Study|Lost to Follow-up|1
1208905|NCT00873860|3967652|P3|Overall Study|Lost to Follow-up|0
1208906|NCT00873860|3967653|P2|Overall Study|Lost to Follow-up|0
1208907|NCT00873860|3967654|P1|Overall Study|Lost to Follow-up|1
1208908|NCT00873730|3967742|P2|Overall Study|Sponsor decision|0
1208909|NCT00873730|3967743|P1|Overall Study|Sponsor decision|1
1208910|NCT00873730|3967742|P2|Overall Study|Withdrawal by Subject|1
1208911|NCT00873730|3967743|P1|Overall Study|Withdrawal by Subject|0
1208912|NCT00873730|3967742|P2|Overall Study|Adverse Event|2
1208913|NCT00873730|3967743|P1|Overall Study|Adverse Event|0
1208914|NCT00873730|3967742|P2|Overall Study|Protocol Deviation|2
1208915|NCT00873730|3967743|P1|Overall Study|Protocol Deviation|5
1208916|NCT00873366|3967786|P1|Overall Study|Refused to continue DM-BT testing|3
1208917|NCT00873366|3967786|P1|Overall Study|Off tamoxifen due to side effects|2
1208918|NCT00873366|3967786|P1|Overall Study|Off tamoxifen for reconstructive surgery|1
1208919|NCT00873119|3967811|P2|Overall Study|Not treated|0
1208920|NCT00873119|3967812|P1|Overall Study|Not treated|2
1208921|NCT00873119|3967811|P2|Overall Study|Other|5
1208922|NCT00873119|3967812|P1|Overall Study|Other|2
1208923|NCT00873119|3967811|P2|Overall Study|Death|1
1208924|NCT00873119|3967812|P1|Overall Study|Death|2
1208925|NCT00873119|3967811|P2|Overall Study|Progressive disease|18
1208926|NCT00873119|3967812|P1|Overall Study|Progressive disease|26
1208927|NCT00873119|3967811|P2|Overall Study|Adverse Event|0
1208928|NCT00873119|3967812|P1|Overall Study|Adverse Event|8
1208929|NCT00873119|3967811|P2|Overall Study|Patient request|2
1208930|NCT00873119|3967812|P1|Overall Study|Patient request|4
1208931|NCT00873093|3967833|P5|Overall Study|Ineligible|0
1208932|NCT00873093|3967834|P4|Overall Study|Ineligible|1
1208933|NCT00873093|3967835|P3|Overall Study|Ineligible|0
1208934|NCT00873093|3967836|P2|Overall Study|Ineligible|1
1208935|NCT00873093|3967837|P1|Overall Study|Ineligible|0
1208936|NCT00873093|3967833|P5|Overall Study|Withdrawal by Subject|0
1208937|NCT00873093|3967834|P4|Overall Study|Withdrawal by Subject|0
1208938|NCT00873093|3967835|P3|Overall Study|Withdrawal by Subject|4
1208939|NCT00873093|3967836|P2|Overall Study|Withdrawal by Subject|4
1208940|NCT00873093|3967837|P1|Overall Study|Withdrawal by Subject|1
1208941|NCT00873093|3967833|P5|Overall Study|Physician Decision|2
1208942|NCT00873093|3967834|P4|Overall Study|Physician Decision|10
1208943|NCT00873093|3967835|P3|Overall Study|Physician Decision|10
1208944|NCT00873093|3967836|P2|Overall Study|Physician Decision|17
1208945|NCT00873093|3967837|P1|Overall Study|Physician Decision|0
1208946|NCT00873093|3967833|P5|Overall Study|Death|0
1208947|NCT00873093|3967834|P4|Overall Study|Death|0
1208948|NCT00873093|3967835|P3|Overall Study|Death|2
1208949|NCT00873093|3967836|P2|Overall Study|Death|3
1208950|NCT00873093|3967837|P1|Overall Study|Death|0
1208951|NCT00873093|3967833|P5|Overall Study|Adverse Event|0
1208952|NCT00873093|3967834|P4|Overall Study|Adverse Event|0
1208953|NCT00873093|3967835|P3|Overall Study|Adverse Event|0
1208954|NCT00873093|3967836|P2|Overall Study|Adverse Event|2
1208955|NCT00873093|3967837|P1|Overall Study|Adverse Event|0
1208956|NCT00873041|3967894|P3|Extension Study|Administrative reasons|1
1208957|NCT00873041|3967895|P2|Extension Study|Administrative reasons|0
1208958|NCT00873041|3967896|P1|Extension Study|Administrative reasons|0
1208959|NCT00873041|3967894|P3|Extension Study|Adverse Event|1
1208960|NCT00873041|3967895|P2|Extension Study|Adverse Event|0
1208961|NCT00873041|3967896|P1|Extension Study|Adverse Event|1
1208962|NCT00873041|3967894|P3|Core Study|Protocol deviation|1
1208963|NCT00873041|3967895|P2|Core Study|Protocol deviation|0
1208964|NCT00873041|3967896|P1|Core Study|Protocol deviation|1
1208965|NCT00873041|3967894|P3|Core Study|Abnormal laboratory value|1
1208966|NCT00873041|3967895|P2|Core Study|Abnormal laboratory value|0
1208967|NCT00873041|3967896|P1|Core Study|Abnormal laboratory value|0
1208968|NCT00873041|3967894|P3|Core Study|Lost to Follow-up|0
1208969|NCT00873041|3967895|P2|Core Study|Lost to Follow-up|1
1208970|NCT00873041|3967896|P1|Core Study|Lost to Follow-up|3
1208971|NCT00873041|3967894|P3|Core Study|Withdrawal by Subject|2
1208972|NCT00873041|3967895|P2|Core Study|Withdrawal by Subject|2
1208973|NCT00873041|3967896|P1|Core Study|Withdrawal by Subject|1
1208974|NCT00873041|3967894|P3|Core Study|Adverse Event|1
1208975|NCT00873041|3967895|P2|Core Study|Adverse Event|3
1208976|NCT00873041|3967896|P1|Core Study|Adverse Event|2
1208977|NCT00873015|3967954|P4|Overall Study|Withdrawal by Subject|0
1208978|NCT00873015|3967955|P3|Overall Study|Withdrawal by Subject|0
1208979|NCT00873015|3967956|P2|Overall Study|Withdrawal by Subject|1
1208980|NCT00873015|3967957|P1|Overall Study|Withdrawal by Subject|0
1208981|NCT00872989|3967966|P2|Overall Study|Not protocol specified|8
1208982|NCT00872989|3967967|P1|Overall Study|Not protocol specified|3
1208983|NCT00872989|3967966|P2|Overall Study|Progression/relapse|35
1208984|NCT00872989|3967967|P1|Overall Study|Progression/relapse|47
1208985|NCT00872989|3967966|P2|Overall Study|Withdrawal by Subject|5
1208986|NCT00872989|3967967|P1|Overall Study|Withdrawal by Subject|8
1208987|NCT00872989|3967966|P2|Overall Study|Adverse Event|15
1208988|NCT00872989|3967967|P1|Overall Study|Adverse Event|7
1208989|NCT00872898|3967986|P2|Part Two - Double Blind|Other reasons|0
1208990|NCT00872898|3967987|P1|Part Two - Double Blind|Other reasons|2
1208991|NCT00872898|3967986|P2|Part Two - Double Blind|Lost to Follow-up|2
1208992|NCT00872898|3967987|P1|Part Two - Double Blind|Lost to Follow-up|0
1208993|NCT00872898|3967986|P2|Part Two - Double Blind|Withdrawal by Subject|1
1208994|NCT00872898|3967987|P1|Part Two - Double Blind|Withdrawal by Subject|3
1208995|NCT00872898|3967986|P2|Part Two - Double Blind|Protocol Violation|0
1208996|NCT00872898|3967987|P1|Part Two - Double Blind|Protocol Violation|1
1208997|NCT00872898|3967986|P2|Part Two - Double Blind|Lack of Efficacy|0
1208998|NCT00872898|3967987|P1|Part Two - Double Blind|Lack of Efficacy|1
1208999|NCT00872898|3967986|P2|Part Two - Double Blind|Adverse Event|3
1209000|NCT00872898|3967987|P1|Part Two - Double Blind|Adverse Event|4
1209001|NCT00872599|3968061|P2|Second Washout Period|Adverse Event|1
1209002|NCT00872599|3968062|P1|Second Washout Period|Adverse Event|1
1209003|NCT00872521|3968082|P3|Secondary Endpoint Analysis|Efficacy data unavailable|1
1209004|NCT00872521|3968083|P2|Secondary Endpoint Analysis|Efficacy data unavailable|2
1209005|NCT00872521|3968084|P1|Secondary Endpoint Analysis|Efficacy data unavailable|0
1209006|NCT00872521|3968082|P3|Completed 3-month Follow up|Physician Decision|0
1209007|NCT00872521|3968083|P2|Completed 3-month Follow up|Physician Decision|1
1209008|NCT00872521|3968084|P1|Completed 3-month Follow up|Physician Decision|0
1209009|NCT00872521|3968082|P3|Completed 3-month Follow up|Not specified|0
1209010|NCT00872521|3968083|P2|Completed 3-month Follow up|Not specified|2
1209011|NCT00872521|3968084|P1|Completed 3-month Follow up|Not specified|0
1209012|NCT00872521|3968082|P3|Primary Endpoint Analysis|Patient response missing|1
1209013|NCT00872521|3968083|P2|Primary Endpoint Analysis|Patient response missing|0
1209014|NCT00872521|3968084|P1|Primary Endpoint Analysis|Patient response missing|0
1209015|NCT00872521|3968082|P3|Primary Endpoint Analysis|Efficacy data unavailable|0
1209016|NCT00872521|3968083|P2|Primary Endpoint Analysis|Efficacy data unavailable|2
1209017|NCT00872521|3968084|P1|Primary Endpoint Analysis|Efficacy data unavailable|0
1209018|NCT00872521|3968082|P3|Primary Endpoint Analysis|Patient choice|0
1209019|NCT00872521|3968083|P2|Primary Endpoint Analysis|Patient choice|1
1209020|NCT00872521|3968084|P1|Primary Endpoint Analysis|Patient choice|0
1209021|NCT00872521|3968082|P3|Primary Endpoint Analysis|Not specified|0
1209022|NCT00872521|3968083|P2|Primary Endpoint Analysis|Not specified|2
1209023|NCT00872521|3968084|P1|Primary Endpoint Analysis|Not specified|1
1209024|NCT00872521|3968082|P3|Completed PAD Induction|Death|0
1209025|NCT00872521|3968083|P2|Completed PAD Induction|Death|1
1209026|NCT00872521|3968084|P1|Completed PAD Induction|Death|1
1209027|NCT00872521|3968082|P3|Completed PAD Induction|Adverse Event|0
1209028|NCT00872521|3968083|P2|Completed PAD Induction|Adverse Event|0
1209029|NCT00872521|3968084|P1|Completed PAD Induction|Adverse Event|4
1209030|NCT00872521|3968082|P3|Completed PAD Induction|Disease progression|0
1209031|NCT00872521|3968083|P2|Completed PAD Induction|Disease progression|2
1209032|NCT00872521|3968084|P1|Completed PAD Induction|Disease progression|0
1209033|NCT00872521|3968082|P3|Completed PAD Induction|Patient choice|0
1209034|NCT00872521|3968083|P2|Completed PAD Induction|Patient choice|1
1209035|NCT00872521|3968084|P1|Completed PAD Induction|Patient choice|0
1209036|NCT00872170|3968155|P2|Overall Study|Adverse Event|0
1209037|NCT00872170|3968156|P1|Overall Study|Adverse Event|1
1209038|NCT00872001|3968186|P2|Overall Study|Administrative|15
1209039|NCT00872001|3968187|P1|Overall Study|Administrative|23
1209040|NCT00872001|3968186|P2|Overall Study|Did Not Meet Protocol Eligibility|36
1209041|NCT00872001|3968187|P1|Overall Study|Did Not Meet Protocol Eligibility|38
1209042|NCT00872001|3968186|P2|Overall Study|Protocol Violation|8
1209043|NCT00872001|3968187|P1|Overall Study|Protocol Violation|5
1209044|NCT00872001|3968186|P2|Overall Study|Withdrawal by Subject|30
1209045|NCT00872001|3968187|P1|Overall Study|Withdrawal by Subject|18
1209046|NCT00872001|3968186|P2|Overall Study|Lost to Follow-up|12
1209047|NCT00872001|3968187|P1|Overall Study|Lost to Follow-up|13
1209048|NCT00872001|3968186|P2|Overall Study|Protocol Defined Clinical Event|7
1209049|NCT00872001|3968187|P1|Overall Study|Protocol Defined Clinical Event|5
1209050|NCT00872001|3968186|P2|Overall Study|Adverse Event|23
1209051|NCT00872001|3968187|P1|Overall Study|Adverse Event|34
1209052|NCT00871975|3968195|P1|Overall Study|Motion artifact, tracing uninterpretable|5
1209053|NCT00871975|3968195|P1|Overall Study|Patient unable to void/insufficient vol|13
1209054|NCT00871975|3968195|P1|Overall Study|Catheters could not be inserted|1
1209055|NCT00871975|3968195|P1|Overall Study|Technical difficulty w155-1ith equipment|3
1209056|NCT00871871|3968201|P4|Part II|Protocol Violation|1
1209057|NCT00871871|3968202|P3|Part II|Protocol Violation|0
1209058|NCT00871871|3968203|P2|Part II|Protocol Violation|0
1209059|NCT00871871|3968204|P1|Part II|Protocol Violation|0
1209060|NCT00871871|3968201|P4|Part II|Adverse Event|2
1209061|NCT00871871|3968202|P3|Part II|Adverse Event|1
1209062|NCT00871871|3968203|P2|Part II|Adverse Event|0
1209063|NCT00871871|3968204|P1|Part II|Adverse Event|0
1209064|NCT00871871|3968201|P4|Part II|Withdrawal by Subject|1
1209065|NCT00871871|3968202|P3|Part II|Withdrawal by Subject|2
1209066|NCT00871871|3968203|P2|Part II|Withdrawal by Subject|0
1209067|NCT00871871|3968204|P1|Part II|Withdrawal by Subject|0
1209068|NCT00871871|3968201|P4|Part II|Lack of Efficacy|0
1209069|NCT00871871|3968202|P3|Part II|Lack of Efficacy|1
1209070|NCT00871871|3968203|P2|Part II|Lack of Efficacy|0
1209071|NCT00871871|3968204|P1|Part II|Lack of Efficacy|0
1209072|NCT00871871|3968201|P4|Part I|Laboratory abnormality|0
1209073|NCT00871871|3968202|P3|Part I|Laboratory abnormality|0
1209074|NCT00871871|3968203|P2|Part I|Laboratory abnormality|1
1209075|NCT00871871|3968204|P1|Part I|Laboratory abnormality|0
1209076|NCT00871871|3968201|P4|Part I|Withdrawal by Subject|0
1209077|NCT00871871|3968202|P3|Part I|Withdrawal by Subject|0
1209078|NCT00871871|3968203|P2|Part I|Withdrawal by Subject|0
1209079|NCT00871871|3968204|P1|Part I|Withdrawal by Subject|3
1209080|NCT00871871|3968201|P4|Part I|Adverse Event|0
1209081|NCT00871871|3968202|P3|Part I|Adverse Event|0
1209082|NCT00871871|3968203|P2|Part I|Adverse Event|2
1209083|NCT00871871|3968204|P1|Part I|Adverse Event|0
1209084|NCT00871780|3968241|P1|Overall Study|Physician Decision|1
1209085|NCT00871780|3968241|P1|Overall Study|Death|1
1209086|NCT00871780|3968241|P1|Overall Study|Voluntary Discontinuation|4
1209087|NCT00871780|3968241|P1|Overall Study|Adverse Event|6
1209088|NCT00871780|3968241|P1|Overall Study|Withdrawal by Subject|9
1209089|NCT00871780|3968241|P1|Overall Study|Enrolled But Not Treated|6
1209090|NCT00871741|3968261|P2|Overall Study|Premature study termination|7
1209091|NCT00871741|3968262|P1|Overall Study|Premature study termination|9
1209092|NCT00871728|3968276|P1|Overall Study|Withdrawal of Informed Consent|5
1209093|NCT00871728|3968276|P1|Overall Study|Participant Non-compliance|1
1209094|NCT00871728|3968276|P1|Overall Study|Failed to Visit Hospital|4
1209095|NCT00871728|3968276|P1|Overall Study|Lost to Follow-up|2
1209096|NCT00871728|3968276|P1|Overall Study|Protocol Violation|7
1209097|NCT00871728|3968276|P1|Overall Study|Adverse Event|1
1209098|NCT00871715|3968289|P3|Overall Study|Lost to Follow-up|9
1209099|NCT00871715|3968290|P2|Overall Study|Lost to Follow-up|6
1209100|NCT00871715|3968291|P1|Overall Study|Lost to Follow-up|3
1209101|NCT00871715|3968289|P3|Overall Study|Physician Decision|2
1209102|NCT00871715|3968290|P2|Overall Study|Physician Decision|0
1209103|NCT00871715|3968291|P1|Overall Study|Physician Decision|6
1209104|NCT00871715|3968289|P3|Overall Study|Withdrawal by Subject|15
1209105|NCT00871715|3968290|P2|Overall Study|Withdrawal by Subject|10
1209106|NCT00871715|3968291|P1|Overall Study|Withdrawal by Subject|6
1209107|NCT00871572|3968335|P4|Overall Study|Withdrawal by Subject|1
1209108|NCT00871572|3968336|P3|Overall Study|Withdrawal by Subject|3
1209109|NCT00871572|3968337|P2|Overall Study|Withdrawal by Subject|2
1209110|NCT00871572|3968338|P1|Overall Study|Withdrawal by Subject|1
1209111|NCT00871572|3968335|P4|Overall Study|Sponsor Decision|0
1209112|NCT00871572|3968336|P3|Overall Study|Sponsor Decision|0
1209113|NCT00871572|3968337|P2|Overall Study|Sponsor Decision|0
1209114|NCT00871572|3968338|P1|Overall Study|Sponsor Decision|1
1209115|NCT00871572|3968335|P4|Overall Study|Protocol Violation|1
1209116|NCT00871572|3968336|P3|Overall Study|Protocol Violation|1
1209117|NCT00871572|3968337|P2|Overall Study|Protocol Violation|0
1209118|NCT00871572|3968338|P1|Overall Study|Protocol Violation|0
1209119|NCT00871572|3968335|P4|Overall Study|Lost to Follow-up|1
1209120|NCT00871572|3968336|P3|Overall Study|Lost to Follow-up|0
1209121|NCT00871572|3968337|P2|Overall Study|Lost to Follow-up|1
1209122|NCT00871572|3968338|P1|Overall Study|Lost to Follow-up|0
1209123|NCT00871572|3968335|P4|Overall Study|Investigator Decision|1
1209124|NCT00871572|3968336|P3|Overall Study|Investigator Decision|0
1209125|NCT00871572|3968337|P2|Overall Study|Investigator Decision|1
1209126|NCT00871572|3968338|P1|Overall Study|Investigator Decision|0
1209127|NCT00871572|3968335|P4|Overall Study|Adverse Event|3
1209128|NCT00871572|3968336|P3|Overall Study|Adverse Event|0
1209129|NCT00871572|3968337|P2|Overall Study|Adverse Event|2
1209130|NCT00871572|3968338|P1|Overall Study|Adverse Event|0
1209131|NCT00871494|3968408|P1|Overall Study|Lost to Follow-up|1
1209132|NCT00871494|3968408|P1|Overall Study|Adverse Event|4
1209133|NCT00871494|3968408|P1|Overall Study|Lack of Efficacy|4
1209134|NCT00871494|3968408|P1|Overall Study|Protocol Violation|5
1209135|NCT00871429|3968415|P1|Overall Study|Questionnaire not completed|1
1209136|NCT00871429|3968415|P1|Overall Study|Withdrawal by Subject|17
1209137|NCT00871429|3968415|P1|Overall Study|Lost to Follow-up|6
1209138|NCT00871403|3968426|P3|Monotherapy Treatment Phase|Adverse Event|0
1209139|NCT00871403|3968427|P2|Monotherapy Treatment Phase|Adverse Event|4
1209140|NCT00871403|3968428|P1|Monotherapy Treatment Phase|Adverse Event|0
1209141|NCT00871403|3968426|P3|Monotherapy Treatment Phase|Disease Progression|1
1209142|NCT00871403|3968427|P2|Monotherapy Treatment Phase|Disease Progression|9
1209143|NCT00871403|3968428|P1|Monotherapy Treatment Phase|Disease Progression|0
1209144|NCT00871403|3968426|P3|Combination Treatment Phase|Physician Decision|3
1209145|NCT00871403|3968427|P2|Combination Treatment Phase|Physician Decision|1
1209146|NCT00871403|3968428|P1|Combination Treatment Phase|Physician Decision|0
1209147|NCT00871403|3968426|P3|Combination Treatment Phase|Withdrawal by Subject|1
1209232|NCT00870740|3968738|P6|Overall Study|Subject Non-compliance|1
1209148|NCT00871403|3968427|P2|Combination Treatment Phase|Withdrawal by Subject|3
1209149|NCT00871403|3968428|P1|Combination Treatment Phase|Withdrawal by Subject|0
1209150|NCT00871403|3968426|P3|Combination Treatment Phase|Disease Progression|5
1209151|NCT00871403|3968427|P2|Combination Treatment Phase|Disease Progression|8
1209152|NCT00871403|3968428|P1|Combination Treatment Phase|Disease Progression|0
1209153|NCT00871403|3968426|P3|Combination Treatment Phase|Adverse Event|2
1209154|NCT00871403|3968427|P2|Combination Treatment Phase|Adverse Event|17
1209155|NCT00871403|3968428|P1|Combination Treatment Phase|Adverse Event|0
1209156|NCT00871403|3968426|P3|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0
1209157|NCT00871403|3968427|P2|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19
1209158|NCT00871403|3968428|P1|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8
1209159|NCT00871403|3968426|P3|Combination Treatment Phase|Randomized but Not Treated|1
1209160|NCT00871403|3968427|P2|Combination Treatment Phase|Randomized but Not Treated|1
1209161|NCT00871403|3968428|P1|Combination Treatment Phase|Randomized but Not Treated|1
1209162|NCT00871377|3968441|P6|Third Intervention (10 Weeks)|Death|0
1209163|NCT00871377|3968442|P5|Third Intervention (10 Weeks)|Death|0
1209164|NCT00871377|3968443|P4|Third Intervention (10 Weeks)|Death|1
1209165|NCT00871377|3968444|P3|Third Intervention (10 Weeks)|Death|0
1209166|NCT00871377|3968445|P2|Third Intervention (10 Weeks)|Death|0
1209167|NCT00871377|3968446|P1|Third Intervention (10 Weeks)|Death|0
1209168|NCT00871377|3968441|P6|Washout (6 Weeks)|Withdrawal by Subject|1
1209169|NCT00871377|3968442|P5|Washout (6 Weeks)|Withdrawal by Subject|0
1209170|NCT00871377|3968443|P4|Washout (6 Weeks)|Withdrawal by Subject|0
1209171|NCT00871377|3968444|P3|Washout (6 Weeks)|Withdrawal by Subject|0
1209172|NCT00871377|3968445|P2|Washout (6 Weeks)|Withdrawal by Subject|0
1209173|NCT00871377|3968446|P1|Washout (6 Weeks)|Withdrawal by Subject|0
1209174|NCT00871377|3968441|P6|Washout (6 Weeks)|Withdrawal by Subject|0
1209175|NCT00871377|3968442|P5|Washout (6 Weeks)|Withdrawal by Subject|0
1209176|NCT00871377|3968443|P4|Washout (6 Weeks)|Withdrawal by Subject|0
1209177|NCT00871377|3968444|P3|Washout (6 Weeks)|Withdrawal by Subject|0
1209178|NCT00871377|3968445|P2|Washout (6 Weeks)|Withdrawal by Subject|0
1209179|NCT00871377|3968446|P1|Washout (6 Weeks)|Withdrawal by Subject|1
1209180|NCT00871377|3968441|P6|First Intervention (10 Weeks)|Lost to Follow-up|1
1209181|NCT00871377|3968442|P5|First Intervention (10 Weeks)|Lost to Follow-up|0
1209182|NCT00871377|3968443|P4|First Intervention (10 Weeks)|Lost to Follow-up|0
1209183|NCT00871377|3968444|P3|First Intervention (10 Weeks)|Lost to Follow-up|0
1209184|NCT00871377|3968445|P2|First Intervention (10 Weeks)|Lost to Follow-up|0
1209185|NCT00871377|3968446|P1|First Intervention (10 Weeks)|Lost to Follow-up|0
1209186|NCT00871377|3968441|P6|First Intervention (10 Weeks)|Withdrawal by Subject|0
1209187|NCT00871377|3968442|P5|First Intervention (10 Weeks)|Withdrawal by Subject|0
1209188|NCT00871377|3968443|P4|First Intervention (10 Weeks)|Withdrawal by Subject|0
1209189|NCT00871377|3968444|P3|First Intervention (10 Weeks)|Withdrawal by Subject|1
1209190|NCT00871377|3968445|P2|First Intervention (10 Weeks)|Withdrawal by Subject|0
1209191|NCT00871377|3968446|P1|First Intervention (10 Weeks)|Withdrawal by Subject|0
1209192|NCT00871351|3968457|P3|Overall Study|Adverse Event|0
1209193|NCT00871351|3968458|P2|Overall Study|Adverse Event|1
1209194|NCT00871351|3968459|P1|Overall Study|Adverse Event|3
1209195|NCT00871351|3968457|P3|Overall Study|Withdrawal by Subject|0
1209196|NCT00871351|3968458|P2|Overall Study|Withdrawal by Subject|0
1209197|NCT00871351|3968459|P1|Overall Study|Withdrawal by Subject|1
1209198|NCT00871338|3968481|P2|Prior to Booster|Lost to Follow-up|0
1209199|NCT00871338|3968482|P1|Prior to Booster|Lost to Follow-up|1
1209200|NCT00871338|3968481|P2|Prior to Booster|Withdrawal by Subject|3
1209201|NCT00871338|3968482|P1|Prior to Booster|Withdrawal by Subject|1
1209202|NCT00871234|3968571|P1|Overall Study|Lost to Follow-up|3
1209203|NCT00871234|3968571|P1|Overall Study|Adverse Event|2
1209204|NCT00871169|3968575|P1|Overall Study|Patient did not receive study treatment|2
1209205|NCT00871169|3968575|P1|Overall Study|Protocol Violation|1
1209206|NCT00871117|3968603|P2|Overall Study|Other|4
1209207|NCT00871117|3968604|P1|Overall Study|Other|0
1209208|NCT00871117|3968603|P2|Overall Study|Lost to Follow-up|6
1209209|NCT00871117|3968604|P1|Overall Study|Lost to Follow-up|5
1209210|NCT00871000|3968638|P2|Overall Study|Withdrawal by Subject|0
1209211|NCT00871000|3968639|P1|Overall Study|Withdrawal by Subject|1
1209212|NCT00870870|3968691|P4|Overall Study|Adverse Event|2
1209213|NCT00870870|3968692|P3|Overall Study|Adverse Event|2
1209214|NCT00870870|3968693|P2|Overall Study|Adverse Event|0
1209215|NCT00870870|3968694|P1|Overall Study|Adverse Event|0
1209216|NCT00870870|3968691|P4|Overall Study|Withdrawal by Subject|3
1209217|NCT00870870|3968692|P3|Overall Study|Withdrawal by Subject|1
1209218|NCT00870870|3968693|P2|Overall Study|Withdrawal by Subject|1
1209219|NCT00870870|3968694|P1|Overall Study|Withdrawal by Subject|0
1209220|NCT00870740|3968738|P6|Overall Study|Not Specified|5
1209221|NCT00870740|3968739|P5|Overall Study|Not Specified|3
1209222|NCT00870740|3968740|P4|Overall Study|Not Specified|4
1209223|NCT00870740|3968741|P3|Overall Study|Not Specified|2
1209224|NCT00870740|3968742|P2|Overall Study|Not Specified|5
1209225|NCT00870740|3968743|P1|Overall Study|Not Specified|2
1209226|NCT00870740|3968738|P6|Overall Study|Death|0
1209227|NCT00870740|3968739|P5|Overall Study|Death|1
1209228|NCT00870740|3968740|P4|Overall Study|Death|0
1209229|NCT00870740|3968741|P3|Overall Study|Death|0
1209230|NCT00870740|3968742|P2|Overall Study|Death|0
1209231|NCT00870740|3968743|P1|Overall Study|Death|0
1209233|NCT00870740|3968739|P5|Overall Study|Subject Non-compliance|0
1209234|NCT00870740|3968740|P4|Overall Study|Subject Non-compliance|0
1209235|NCT00870740|3968741|P3|Overall Study|Subject Non-compliance|0
1209236|NCT00870740|3968742|P2|Overall Study|Subject Non-compliance|0
1209237|NCT00870740|3968743|P1|Overall Study|Subject Non-compliance|0
1209238|NCT00870740|3968738|P6|Overall Study|Investigator Decision|0
1209239|NCT00870740|3968739|P5|Overall Study|Investigator Decision|0
1209240|NCT00870740|3968740|P4|Overall Study|Investigator Decision|0
1209241|NCT00870740|3968741|P3|Overall Study|Investigator Decision|1
1209242|NCT00870740|3968742|P2|Overall Study|Investigator Decision|0
1209243|NCT00870740|3968743|P1|Overall Study|Investigator Decision|2
1209244|NCT00870740|3968738|P6|Overall Study|Consent Withdrawn|5
1209245|NCT00870740|3968739|P5|Overall Study|Consent Withdrawn|6
1209246|NCT00870740|3968740|P4|Overall Study|Consent Withdrawn|6
1209247|NCT00870740|3968741|P3|Overall Study|Consent Withdrawn|4
1209248|NCT00870740|3968742|P2|Overall Study|Consent Withdrawn|3
1209249|NCT00870740|3968743|P1|Overall Study|Consent Withdrawn|6
1209250|NCT00870740|3968738|P6|Overall Study|Adverse Event|6
1209251|NCT00870740|3968739|P5|Overall Study|Adverse Event|1
1209252|NCT00870740|3968740|P4|Overall Study|Adverse Event|2
1209253|NCT00870740|3968741|P3|Overall Study|Adverse Event|3
1209254|NCT00870740|3968742|P2|Overall Study|Adverse Event|1
1209255|NCT00870740|3968743|P1|Overall Study|Adverse Event|2
1209256|NCT00870727|3968819|P2|Overall Study|Adverse Event|1
1209257|NCT00870727|3968820|P1|Overall Study|Adverse Event|0
1209258|NCT00870727|3968819|P2|Overall Study|Lack of Efficacy|3
1209259|NCT00870727|3968820|P1|Overall Study|Lack of Efficacy|1
1209260|NCT00870727|3968819|P2|Overall Study|Lost to Follow-up|1
1209261|NCT00870727|3968820|P1|Overall Study|Lost to Follow-up|0
1209262|NCT00870688|3968836|P1|Overall Study|Granules in the Stools|1
1209263|NCT00870688|3968836|P1|Overall Study|Death, Unrelated|1
1209264|NCT00870688|3968836|P1|Overall Study|Lost to Follow-up|2
1209265|NCT00870584|3968841|P2|Overall Study|Protocol Deviation|2
1209266|NCT00870584|3968842|P1|Overall Study|Protocol Deviation|2
1209267|NCT00870584|3968841|P2|Overall Study|Lost to Follow-up|1
1209268|NCT00870584|3968842|P1|Overall Study|Lost to Follow-up|5
1209269|NCT00870584|3968841|P2|Overall Study|Withdrawal by Subject|7
1209270|NCT00870584|3968842|P1|Overall Study|Withdrawal by Subject|6
1209271|NCT00870584|3968841|P2|Overall Study|Adverse Event|3
1209272|NCT00870584|3968842|P1|Overall Study|Adverse Event|3
1209273|NCT00870233|3968951|P1|Overall Study|Death|1
1209274|NCT00870233|3968951|P1|Overall Study|Incompatible internet browser|2
1209275|NCT00870233|3968951|P1|Overall Study|Did not undergo laparotomy|3
1209276|NCT00870233|3968951|P1|Overall Study|Withdrawal by Subject|18
1209277|NCT00870194|3968960|P2|Overall Study|Subject Decision|2
1209278|NCT00870194|3968961|P1|Overall Study|Subject Decision|7
1209279|NCT00870194|3968960|P2|Overall Study|Entry Criteria Not Met|2
1209280|NCT00870194|3968961|P1|Overall Study|Entry Criteria Not Met|1
1209281|NCT00870194|3968960|P2|Overall Study|Protocol Violation|3
1209282|NCT00870194|3968961|P1|Overall Study|Protocol Violation|3
1209283|NCT00870194|3968960|P2|Overall Study|Physician Decision|1
1209284|NCT00870194|3968961|P1|Overall Study|Physician Decision|3
1209285|NCT00870194|3968960|P2|Overall Study|Lost to Follow-up|0
1209286|NCT00870194|3968961|P1|Overall Study|Lost to Follow-up|2
1209287|NCT00870194|3968960|P2|Overall Study|Lack of Efficacy|1
1209288|NCT00870194|3968961|P1|Overall Study|Lack of Efficacy|0
1209289|NCT00870194|3968960|P2|Overall Study|Adverse Event|5
1209290|NCT00870194|3968961|P1|Overall Study|Adverse Event|10
1209291|NCT00870103|3968999|P1|Overall Study|Lost to Follow-up|2
1209292|NCT00870103|3968999|P1|Overall Study|Physician Decision|2
1209293|NCT00869999|3969004|P1|Overall Study|removed prior to starting therapy|1
1209294|NCT00869999|3969004|P1|Overall Study|Withdrawal by Subject|1
1209295|NCT00869960|3969010|P1|Overall Study|Lost to Follow-up|2
1209296|NCT00869778|3969059|P3|Overall Study|Unblinding|0
1209297|NCT00869778|3969060|P2|Overall Study|Unblinding|0
1209298|NCT00869778|3969061|P1|Overall Study|Unblinding|1
1209299|NCT00869778|3969059|P3|Overall Study|Protocol Violation|5
1209300|NCT00869778|3969060|P2|Overall Study|Protocol Violation|3
1209301|NCT00869778|3969061|P1|Overall Study|Protocol Violation|5
1209302|NCT00869778|3969059|P3|Overall Study|Pregnancy|0
1209303|NCT00869778|3969060|P2|Overall Study|Pregnancy|0
1209304|NCT00869778|3969061|P1|Overall Study|Pregnancy|1
1209305|NCT00869778|3969059|P3|Overall Study|Withdrawal by Subject|5
1209306|NCT00869778|3969060|P2|Overall Study|Withdrawal by Subject|4
1209307|NCT00869778|3969061|P1|Overall Study|Withdrawal by Subject|3
1209308|NCT00869778|3969059|P3|Overall Study|Adverse Event|0
1209309|NCT00869778|3969060|P2|Overall Study|Adverse Event|0
1209310|NCT00869778|3969061|P1|Overall Study|Adverse Event|2
1209311|NCT00869557|3969136|P2|Extension Phase|Withdrew Consent|0
1209312|NCT00869557|3969137|P1|Extension Phase|Withdrew Consent|2
1209313|NCT00869557|3969136|P2|Extension Phase|Investigator's Discretion|0
1209314|NCT00869557|3969137|P1|Extension Phase|Investigator's Discretion|2
1209315|NCT00869557|3969136|P2|Extension Phase|Lost to Follow-up|1
1209316|NCT00869557|3969137|P1|Extension Phase|Lost to Follow-up|3
1209317|NCT00869557|3969136|P2|Extension Phase|Lack of Efficacy|0
1209318|NCT00869557|3969137|P1|Extension Phase|Lack of Efficacy|1
1209319|NCT00869557|3969136|P2|Extension Phase|Adverse Event|2
1209320|NCT00869557|3969137|P1|Extension Phase|Adverse Event|2
1209321|NCT00869557|3969136|P2|Randomized Phase|Withdrew Consent|1
1209322|NCT00869557|3969137|P1|Randomized Phase|Withdrew Consent|0
1209323|NCT00869557|3969136|P2|Randomized Phase|Investigator's Discretion|0
1209324|NCT00869557|3969137|P1|Randomized Phase|Investigator's Discretion|1
1209325|NCT00869557|3969136|P2|Randomized Phase|Lost to Follow-up|1
1209326|NCT00869557|3969137|P1|Randomized Phase|Lost to Follow-up|2
1209327|NCT00869518|3969156|P2|Overall Study|Lost to Follow-up|1
1209328|NCT00869518|3969157|P1|Overall Study|Lost to Follow-up|1
1209329|NCT00869401|3969185|P5|Overall Study|Withdrawal by Subject|3
1209330|NCT00869401|3969186|P4|Overall Study|Withdrawal by Subject|5
1209331|NCT00869401|3969187|P3|Overall Study|Withdrawal by Subject|0
1209332|NCT00869401|3969188|P2|Overall Study|Withdrawal by Subject|0
1209333|NCT00869401|3969189|P1|Overall Study|Withdrawal by Subject|0
1209334|NCT00869362|3969218|P2|Overall Study|Lost to Follow-up|3
1209335|NCT00869362|3969219|P1|Overall Study|Lost to Follow-up|1
1209336|NCT00869362|3969218|P2|Overall Study|Death|2
1209337|NCT00869362|3969219|P1|Overall Study|Death|0
1209338|NCT00869323|3969240|P1|Maintenance Therapy|concurrent illness|1
1209339|NCT00869258|3969248|P1|Overall Study|Physician Decision|1
1209340|NCT00869128|3969313|P2|Overall Study|lack of Compliance|6
1209341|NCT00869128|3969314|P1|Overall Study|lack of Compliance|6
1209342|NCT00869089|3969318|P1|Overall Study|Screen Fail|1
1209343|NCT00869089|3969318|P1|Overall Study|Withdrawal by Subject|1
1209344|NCT00869089|3969318|P1|Overall Study|Lost to Follow-up|1
1209345|NCT00869050|3969322|P1|Overall Study|Screen Failure|3
1209346|NCT00868998|3969327|P1|Overall Study|Death|1
1209347|NCT00868998|3969327|P1|Overall Study|Progression of disease|2
1209348|NCT00868998|3969327|P1|Overall Study|Withdrawal by Subject|1
1209349|NCT00868998|3969327|P1|Overall Study|Screen Failure|1
1209350|NCT00868790|3969338|P14|Post-study|Excluded Medication|0
1209351|NCT00868790|3969339|P13|Post-study|Excluded Medication|0
1209352|NCT00868790|3969340|P12|Post-study|Excluded Medication|0
1209353|NCT00868790|3969341|P11|Post-study|Excluded Medication|0
1209354|NCT00868790|3969342|P10|Post-study|Excluded Medication|1
1209355|NCT00868790|3969343|P9|Post-study|Excluded Medication|0
1209356|NCT00868790|3969344|P8|Post-study|Excluded Medication|2
1209357|NCT00868790|3969345|P7|Post-study|Excluded Medication|0
1209358|NCT00868790|3969346|P6|Post-study|Excluded Medication|0
1209359|NCT00868790|3969347|P5|Post-study|Excluded Medication|0
1209360|NCT00868790|3969348|P4|Post-study|Excluded Medication|0
1209361|NCT00868790|3969349|P3|Post-study|Excluded Medication|0
1209362|NCT00868790|3969350|P2|Post-study|Excluded Medication|0
1209363|NCT00868790|3969351|P1|Post-study|Excluded Medication|0
1209364|NCT00868790|3969338|P14|Post-study|Withdrawal by Subject|0
1209365|NCT00868790|3969339|P13|Post-study|Withdrawal by Subject|0
1209366|NCT00868790|3969340|P12|Post-study|Withdrawal by Subject|0
1209367|NCT00868790|3969341|P11|Post-study|Withdrawal by Subject|0
1209368|NCT00868790|3969342|P10|Post-study|Withdrawal by Subject|0
1209369|NCT00868790|3969343|P9|Post-study|Withdrawal by Subject|0
1209370|NCT00868790|3969344|P8|Post-study|Withdrawal by Subject|0
1209371|NCT00868790|3969345|P7|Post-study|Withdrawal by Subject|0
1209372|NCT00868790|3969346|P6|Post-study|Withdrawal by Subject|0
1209373|NCT00868790|3969347|P5|Post-study|Withdrawal by Subject|1
1209374|NCT00868790|3969348|P4|Post-study|Withdrawal by Subject|0
1209375|NCT00868790|3969349|P3|Post-study|Withdrawal by Subject|0
1209376|NCT00868790|3969350|P2|Post-study|Withdrawal by Subject|0
1209377|NCT00868790|3969351|P1|Post-study|Withdrawal by Subject|0
1209378|NCT00868790|3969338|P14|Period 4|Abnormal ALT/AST|0
1209379|NCT00868790|3969339|P13|Period 4|Abnormal ALT/AST|0
1209380|NCT00868790|3969340|P12|Period 4|Abnormal ALT/AST|0
1209381|NCT00868790|3969341|P11|Period 4|Abnormal ALT/AST|0
1209382|NCT00868790|3969342|P10|Period 4|Abnormal ALT/AST|0
1209383|NCT00868790|3969343|P9|Period 4|Abnormal ALT/AST|0
1209384|NCT00868790|3969344|P8|Period 4|Abnormal ALT/AST|0
1209385|NCT00868790|3969345|P7|Period 4|Abnormal ALT/AST|0
1209386|NCT00868790|3969346|P6|Period 4|Abnormal ALT/AST|0
1209387|NCT00868790|3969347|P5|Period 4|Abnormal ALT/AST|0
1209388|NCT00868790|3969348|P4|Period 4|Abnormal ALT/AST|0
1209389|NCT00868790|3969349|P3|Period 4|Abnormal ALT/AST|1
1209390|NCT00868790|3969350|P2|Period 4|Abnormal ALT/AST|0
1209391|NCT00868790|3969351|P1|Period 4|Abnormal ALT/AST|0
1209392|NCT00868790|3969338|P14|Period 4|Study Terminated by Sponsor|1
1209393|NCT00868790|3969339|P13|Period 4|Study Terminated by Sponsor|0
1209394|NCT00868790|3969340|P12|Period 4|Study Terminated by Sponsor|1
1209395|NCT00868790|3969341|P11|Period 4|Study Terminated by Sponsor|2
1209396|NCT00868790|3969342|P10|Period 4|Study Terminated by Sponsor|0
1209397|NCT00868790|3969343|P9|Period 4|Study Terminated by Sponsor|2
1209398|NCT00868790|3969344|P8|Period 4|Study Terminated by Sponsor|1
1209399|NCT00868790|3969345|P7|Period 4|Study Terminated by Sponsor|0
1209400|NCT00868790|3969346|P6|Period 4|Study Terminated by Sponsor|0
1209401|NCT00868790|3969347|P5|Period 4|Study Terminated by Sponsor|0
1209402|NCT00868790|3969348|P4|Period 4|Study Terminated by Sponsor|0
1209403|NCT00868790|3969349|P3|Period 4|Study Terminated by Sponsor|0
1209404|NCT00868790|3969350|P2|Period 4|Study Terminated by Sponsor|0
1209405|NCT00868790|3969351|P1|Period 4|Study Terminated by Sponsor|2
1209406|NCT00868790|3969338|P14|Period 4|Lost to Follow-up|0
1209407|NCT00868790|3969339|P13|Period 4|Lost to Follow-up|0
1209408|NCT00868790|3969340|P12|Period 4|Lost to Follow-up|0
1209409|NCT00868790|3969341|P11|Period 4|Lost to Follow-up|0
1209410|NCT00868790|3969342|P10|Period 4|Lost to Follow-up|0
1209411|NCT00868790|3969343|P9|Period 4|Lost to Follow-up|0
1209412|NCT00868790|3969344|P8|Period 4|Lost to Follow-up|1
1209413|NCT00868790|3969345|P7|Period 4|Lost to Follow-up|0
1209414|NCT00868790|3969346|P6|Period 4|Lost to Follow-up|0
1209415|NCT00868790|3969347|P5|Period 4|Lost to Follow-up|0
1209416|NCT00868790|3969348|P4|Period 4|Lost to Follow-up|0
1209417|NCT00868790|3969349|P3|Period 4|Lost to Follow-up|0
1209418|NCT00868790|3969350|P2|Period 4|Lost to Follow-up|0
1209419|NCT00868790|3969351|P1|Period 4|Lost to Follow-up|0
1209420|NCT00868790|3969338|P14|Period 4|Adverse Event|0
1209421|NCT00868790|3969339|P13|Period 4|Adverse Event|1
1209422|NCT00868790|3969340|P12|Period 4|Adverse Event|0
1209423|NCT00868790|3969341|P11|Period 4|Adverse Event|1
1209424|NCT00868790|3969342|P10|Period 4|Adverse Event|0
1209425|NCT00868790|3969343|P9|Period 4|Adverse Event|0
1209426|NCT00868790|3969344|P8|Period 4|Adverse Event|1
1209427|NCT00868790|3969345|P7|Period 4|Adverse Event|0
1209428|NCT00868790|3969346|P6|Period 4|Adverse Event|0
1209429|NCT00868790|3969347|P5|Period 4|Adverse Event|0
1209430|NCT00868790|3969348|P4|Period 4|Adverse Event|0
1209431|NCT00868790|3969349|P3|Period 4|Adverse Event|0
1209432|NCT00868790|3969350|P2|Period 4|Adverse Event|0
1209433|NCT00868790|3969351|P1|Period 4|Adverse Event|0
1209434|NCT00868790|3969338|P14|Period 3|Study Terminated by Sponsor|0
1209435|NCT00868790|3969339|P13|Period 3|Study Terminated by Sponsor|0
1209436|NCT00868790|3969340|P12|Period 3|Study Terminated by Sponsor|0
1209437|NCT00868790|3969341|P11|Period 3|Study Terminated by Sponsor|0
1209438|NCT00868790|3969342|P10|Period 3|Study Terminated by Sponsor|0
1209439|NCT00868790|3969343|P9|Period 3|Study Terminated by Sponsor|0
1209440|NCT00868790|3969344|P8|Period 3|Study Terminated by Sponsor|0
1209441|NCT00868790|3969345|P7|Period 3|Study Terminated by Sponsor|0
1209442|NCT00868790|3969346|P6|Period 3|Study Terminated by Sponsor|0
1209443|NCT00868790|3969347|P5|Period 3|Study Terminated by Sponsor|0
1209444|NCT00868790|3969348|P4|Period 3|Study Terminated by Sponsor|1
1209445|NCT00868790|3969349|P3|Period 3|Study Terminated by Sponsor|0
1209446|NCT00868790|3969350|P2|Period 3|Study Terminated by Sponsor|0
1209447|NCT00868790|3969351|P1|Period 3|Study Terminated by Sponsor|0
1209448|NCT00868790|3969338|P14|Period 3|Protocol Violation|0
1209449|NCT00868790|3969339|P13|Period 3|Protocol Violation|0
1209450|NCT00868790|3969340|P12|Period 3|Protocol Violation|0
1209451|NCT00868790|3969341|P11|Period 3|Protocol Violation|1
1209452|NCT00868790|3969342|P10|Period 3|Protocol Violation|0
1209453|NCT00868790|3969343|P9|Period 3|Protocol Violation|0
1209454|NCT00868790|3969344|P8|Period 3|Protocol Violation|0
1209455|NCT00868790|3969345|P7|Period 3|Protocol Violation|0
1209456|NCT00868790|3969346|P6|Period 3|Protocol Violation|0
1209457|NCT00868790|3969347|P5|Period 3|Protocol Violation|0
1209458|NCT00868790|3969348|P4|Period 3|Protocol Violation|0
1209459|NCT00868790|3969349|P3|Period 3|Protocol Violation|0
1209460|NCT00868790|3969350|P2|Period 3|Protocol Violation|0
1209461|NCT00868790|3969351|P1|Period 3|Protocol Violation|0
1209462|NCT00868790|3969338|P14|Period 3|Adverse Event|0
1209463|NCT00868790|3969339|P13|Period 3|Adverse Event|0
1209464|NCT00868790|3969340|P12|Period 3|Adverse Event|0
1209465|NCT00868790|3969341|P11|Period 3|Adverse Event|0
1209466|NCT00868790|3969342|P10|Period 3|Adverse Event|1
1209467|NCT00868790|3969343|P9|Period 3|Adverse Event|0
1209468|NCT00868790|3969344|P8|Period 3|Adverse Event|0
1209469|NCT00868790|3969345|P7|Period 3|Adverse Event|0
1209470|NCT00868790|3969346|P6|Period 3|Adverse Event|0
1209471|NCT00868790|3969347|P5|Period 3|Adverse Event|0
1209472|NCT00868790|3969348|P4|Period 3|Adverse Event|0
1209473|NCT00868790|3969349|P3|Period 3|Adverse Event|0
1209474|NCT00868790|3969350|P2|Period 3|Adverse Event|0
1209475|NCT00868790|3969351|P1|Period 3|Adverse Event|0
1209476|NCT00868790|3969338|P14|Period 2|Withdrawal by Subject|1
1209477|NCT00868790|3969339|P13|Period 2|Withdrawal by Subject|0
1209478|NCT00868790|3969340|P12|Period 2|Withdrawal by Subject|0
1209479|NCT00868790|3969341|P11|Period 2|Withdrawal by Subject|0
1209480|NCT00868790|3969342|P10|Period 2|Withdrawal by Subject|0
1209481|NCT00868790|3969343|P9|Period 2|Withdrawal by Subject|1
1209482|NCT00868790|3969344|P8|Period 2|Withdrawal by Subject|0
1209483|NCT00868790|3969345|P7|Period 2|Withdrawal by Subject|0
1209484|NCT00868790|3969346|P6|Period 2|Withdrawal by Subject|0
1209485|NCT00868790|3969347|P5|Period 2|Withdrawal by Subject|0
1209486|NCT00868790|3969348|P4|Period 2|Withdrawal by Subject|0
1209487|NCT00868790|3969349|P3|Period 2|Withdrawal by Subject|0
1209488|NCT00868790|3969350|P2|Period 2|Withdrawal by Subject|0
1209489|NCT00868790|3969351|P1|Period 2|Withdrawal by Subject|0
1209490|NCT00868790|3969338|P14|Period 2|Lost to Follow-up|0
1209491|NCT00868790|3969339|P13|Period 2|Lost to Follow-up|0
1209492|NCT00868790|3969340|P12|Period 2|Lost to Follow-up|0
1209493|NCT00868790|3969341|P11|Period 2|Lost to Follow-up|0
1209494|NCT00868790|3969342|P10|Period 2|Lost to Follow-up|0
1209495|NCT00868790|3969343|P9|Period 2|Lost to Follow-up|0
1209496|NCT00868790|3969344|P8|Period 2|Lost to Follow-up|0
1209497|NCT00868790|3969345|P7|Period 2|Lost to Follow-up|0
1209498|NCT00868790|3969346|P6|Period 2|Lost to Follow-up|1
1209499|NCT00868790|3969347|P5|Period 2|Lost to Follow-up|0
1209500|NCT00868790|3969348|P4|Period 2|Lost to Follow-up|0
1209501|NCT00868790|3969349|P3|Period 2|Lost to Follow-up|0
1209502|NCT00868790|3969350|P2|Period 2|Lost to Follow-up|1
1209503|NCT00868790|3969351|P1|Period 2|Lost to Follow-up|0
1209504|NCT00868790|3969338|P14|Period 2|Adverse Event|0
1209505|NCT00868790|3969339|P13|Period 2|Adverse Event|0
1209506|NCT00868790|3969340|P12|Period 2|Adverse Event|0
1209507|NCT00868790|3969341|P11|Period 2|Adverse Event|0
1209508|NCT00868790|3969342|P10|Period 2|Adverse Event|0
1209509|NCT00868790|3969343|P9|Period 2|Adverse Event|1
1209510|NCT00868790|3969344|P8|Period 2|Adverse Event|0
1209511|NCT00868790|3969345|P7|Period 2|Adverse Event|0
1209512|NCT00868790|3969346|P6|Period 2|Adverse Event|0
1209513|NCT00868790|3969347|P5|Period 2|Adverse Event|0
1209514|NCT00868790|3969348|P4|Period 2|Adverse Event|0
1209515|NCT00868790|3969349|P3|Period 2|Adverse Event|0
1209516|NCT00868790|3969350|P2|Period 2|Adverse Event|0
1209517|NCT00868790|3969351|P1|Period 2|Adverse Event|0
1209518|NCT00868790|3969338|P14|Period 1|Lost to Follow-up|0
1209519|NCT00868790|3969339|P13|Period 1|Lost to Follow-up|0
1209520|NCT00868790|3969340|P12|Period 1|Lost to Follow-up|0
1209521|NCT00868790|3969341|P11|Period 1|Lost to Follow-up|0
1209522|NCT00868790|3969342|P10|Period 1|Lost to Follow-up|0
1209523|NCT00868790|3969343|P9|Period 1|Lost to Follow-up|0
1209524|NCT00868790|3969344|P8|Period 1|Lost to Follow-up|0
1209525|NCT00868790|3969345|P7|Period 1|Lost to Follow-up|0
1209526|NCT00868790|3969346|P6|Period 1|Lost to Follow-up|1
1209527|NCT00868790|3969347|P5|Period 1|Lost to Follow-up|0
1209528|NCT00868790|3969348|P4|Period 1|Lost to Follow-up|0
1209529|NCT00868790|3969349|P3|Period 1|Lost to Follow-up|0
1209530|NCT00868790|3969350|P2|Period 1|Lost to Follow-up|0
1209531|NCT00868790|3969351|P1|Period 1|Lost to Follow-up|0
1209532|NCT00868790|3969338|P14|Period 1|Abnormal Triglycerides|0
1209533|NCT00868790|3969339|P13|Period 1|Abnormal Triglycerides|0
1209534|NCT00868790|3969340|P12|Period 1|Abnormal Triglycerides|0
1209535|NCT00868790|3969341|P11|Period 1|Abnormal Triglycerides|0
1209536|NCT00868790|3969342|P10|Period 1|Abnormal Triglycerides|0
1209537|NCT00868790|3969343|P9|Period 1|Abnormal Triglycerides|0
1209538|NCT00868790|3969344|P8|Period 1|Abnormal Triglycerides|0
1209539|NCT00868790|3969345|P7|Period 1|Abnormal Triglycerides|0
1209540|NCT00868790|3969346|P6|Period 1|Abnormal Triglycerides|0
1209541|NCT00868790|3969347|P5|Period 1|Abnormal Triglycerides|1
1209542|NCT00868790|3969348|P4|Period 1|Abnormal Triglycerides|0
1209543|NCT00868790|3969349|P3|Period 1|Abnormal Triglycerides|0
1209544|NCT00868790|3969350|P2|Period 1|Abnormal Triglycerides|0
1209545|NCT00868790|3969351|P1|Period 1|Abnormal Triglycerides|0
1209546|NCT00868790|3969338|P14|Period 1|Withdrawal by Subject|1
1209547|NCT00868790|3969339|P13|Period 1|Withdrawal by Subject|0
1209548|NCT00868790|3969340|P12|Period 1|Withdrawal by Subject|0
1209549|NCT00868790|3969341|P11|Period 1|Withdrawal by Subject|0
1209550|NCT00868790|3969342|P10|Period 1|Withdrawal by Subject|0
1209551|NCT00868790|3969343|P9|Period 1|Withdrawal by Subject|0
1209552|NCT00868790|3969344|P8|Period 1|Withdrawal by Subject|0
1209553|NCT00868790|3969345|P7|Period 1|Withdrawal by Subject|0
1209554|NCT00868790|3969346|P6|Period 1|Withdrawal by Subject|0
1209555|NCT00868790|3969347|P5|Period 1|Withdrawal by Subject|0
1209556|NCT00868790|3969348|P4|Period 1|Withdrawal by Subject|0
1209557|NCT00868790|3969349|P3|Period 1|Withdrawal by Subject|0
1209558|NCT00868790|3969350|P2|Period 1|Withdrawal by Subject|1
1209559|NCT00868790|3969351|P1|Period 1|Withdrawal by Subject|0
1209560|NCT00868790|3969338|P14|Period 1|Protocol Violation|0
1209561|NCT00868790|3969339|P13|Period 1|Protocol Violation|0
1209562|NCT00868790|3969340|P12|Period 1|Protocol Violation|0
1209563|NCT00868790|3969341|P11|Period 1|Protocol Violation|0
1209564|NCT00868790|3969342|P10|Period 1|Protocol Violation|0
1209565|NCT00868790|3969343|P9|Period 1|Protocol Violation|0
1209566|NCT00868790|3969344|P8|Period 1|Protocol Violation|0
1209567|NCT00868790|3969345|P7|Period 1|Protocol Violation|0
1209568|NCT00868790|3969346|P6|Period 1|Protocol Violation|0
1209569|NCT00868790|3969347|P5|Period 1|Protocol Violation|0
1209570|NCT00868790|3969348|P4|Period 1|Protocol Violation|0
1209571|NCT00868790|3969349|P3|Period 1|Protocol Violation|0
1209572|NCT00868790|3969350|P2|Period 1|Protocol Violation|0
1209573|NCT00868790|3969351|P1|Period 1|Protocol Violation|1
1209574|NCT00868790|3969338|P14|Period 1|Adverse Event|1
1209575|NCT00868790|3969339|P13|Period 1|Adverse Event|0
1209576|NCT00868790|3969340|P12|Period 1|Adverse Event|0
1209577|NCT00868790|3969341|P11|Period 1|Adverse Event|0
1209578|NCT00868790|3969342|P10|Period 1|Adverse Event|0
1209579|NCT00868790|3969343|P9|Period 1|Adverse Event|1
1209580|NCT00868790|3969344|P8|Period 1|Adverse Event|3
1209581|NCT00868790|3969345|P7|Period 1|Adverse Event|0
1209582|NCT00868790|3969346|P6|Period 1|Adverse Event|0
1209583|NCT00868790|3969347|P5|Period 1|Adverse Event|0
1209584|NCT00868790|3969348|P4|Period 1|Adverse Event|0
1209585|NCT00868790|3969349|P3|Period 1|Adverse Event|0
1209586|NCT00868790|3969350|P2|Period 1|Adverse Event|0
1209587|NCT00868790|3969351|P1|Period 1|Adverse Event|1
1209588|NCT00868608|3969434|P3|Overall Study|Other - Unspecified|0
1209589|NCT00868608|3969435|P2|Overall Study|Other - Unspecified|0
1209590|NCT00868608|3969436|P1|Overall Study|Other - Unspecified|1
1209591|NCT00868608|3969434|P3|Overall Study|Death|4
1209592|NCT00868608|3969435|P2|Overall Study|Death|2
1209593|NCT00868608|3969436|P1|Overall Study|Death|16
1209594|NCT00868608|3969434|P3|Overall Study|Lost to Follow-up|1
1209595|NCT00868608|3969435|P2|Overall Study|Lost to Follow-up|0
1209596|NCT00868608|3969436|P1|Overall Study|Lost to Follow-up|3
1209597|NCT00868608|3969434|P3|Overall Study|Withdrawal by Subject|0
1209598|NCT00868608|3969435|P2|Overall Study|Withdrawal by Subject|1
1209599|NCT00868608|3969436|P1|Overall Study|Withdrawal by Subject|3
1209600|NCT00868530|3969460|P1|Overall Study|Lost to Follow-up|1
1209601|NCT00868530|3969460|P1|Overall Study|Adverse Event|3
1209602|NCT00868517|3969475|P3|Overall Study|Protocol Violation|0
1209603|NCT00868517|3969476|P2|Overall Study|Protocol Violation|1
1209604|NCT00868517|3969477|P1|Overall Study|Protocol Violation|1
1209605|NCT00868517|3969475|P3|Overall Study|Withdrawal by Subject|2
1209606|NCT00868517|3969476|P2|Overall Study|Withdrawal by Subject|3
1209607|NCT00868517|3969477|P1|Overall Study|Withdrawal by Subject|3
1209608|NCT00868439|3969515|P2|Overall Study|Withdrawal by Subject|1
1209609|NCT00868439|3969516|P1|Overall Study|Withdrawal by Subject|0
1209610|NCT00868439|3969515|P2|Overall Study|Physician Decision|0
1209611|NCT00868439|3969516|P1|Overall Study|Physician Decision|1
1209612|NCT00868439|3969515|P2|Overall Study|Protocol Violation|1
1209613|NCT00868439|3969516|P1|Overall Study|Protocol Violation|1
1209614|NCT00868439|3969515|P2|Overall Study|Death|1
1209615|NCT00868439|3969516|P1|Overall Study|Death|0
1209616|NCT00868439|3969515|P2|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3
1209617|NCT00868439|3969516|P1|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2
1209618|NCT00868439|3969515|P2|Overall Study|Adverse Event|3
1209619|NCT00868439|3969516|P1|Overall Study|Adverse Event|4
1209620|NCT00868296|3969573|P2|Overall Study|Withdrawal by Subject|1
1209621|NCT00868296|3969574|P1|Overall Study|Withdrawal by Subject|0
1209622|NCT00868296|3969573|P2|Overall Study|Adverse Event|2
1209623|NCT00868296|3969574|P1|Overall Study|Adverse Event|0
1209624|NCT00868231|3969582|P6|Treatment Period 3|Adverse Event|0
1209625|NCT00868231|3969583|P5|Treatment Period 3|Adverse Event|0
1209626|NCT00868231|3969584|P4|Treatment Period 3|Adverse Event|0
1209627|NCT00868231|3969585|P3|Treatment Period 3|Adverse Event|1
1209628|NCT00868231|3969586|P2|Treatment Period 3|Adverse Event|0
1209629|NCT00868231|3969587|P1|Treatment Period 3|Adverse Event|0
1209630|NCT00868231|3969582|P6|Treatment Period 2|Adverse Event|0
1209631|NCT00868231|3969583|P5|Treatment Period 2|Adverse Event|0
1209632|NCT00868231|3969584|P4|Treatment Period 2|Adverse Event|0
1209633|NCT00868231|3969585|P3|Treatment Period 2|Adverse Event|0
1209634|NCT00868231|3969586|P2|Treatment Period 2|Adverse Event|0
1209635|NCT00868231|3969587|P1|Treatment Period 2|Adverse Event|1
1209636|NCT00868231|3969582|P6|Treatment Period 1|Adverse Event|0
1209637|NCT00868231|3969583|P5|Treatment Period 1|Adverse Event|1
1209638|NCT00868231|3969584|P4|Treatment Period 1|Adverse Event|0
1209639|NCT00868231|3969585|P3|Treatment Period 1|Adverse Event|0
1209640|NCT00868231|3969586|P2|Treatment Period 1|Adverse Event|0
1209641|NCT00868231|3969587|P1|Treatment Period 1|Adverse Event|0
1209642|NCT00868192|3969653|P1|Overall Study|Ineligible|4
1209643|NCT00867568|3969715|P1|Overall Study|Withdrawal by Subject|1
1209644|NCT00867568|3969715|P1|Overall Study|Adverse Event|4
1209645|NCT00867568|3969715|P1|Overall Study|Lack of Efficacy|10
1209646|NCT00867503|3969732|P1|Overall Study|Withdrawal by Subject|1
1209647|NCT00867490|3969738|P1|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1
1209648|NCT00867490|3969738|P1|Phase 2 - Aliskiren+HCTZ|Adverse Event|2
1209649|NCT00867490|3969738|P1|Phase 1 - Candesartan+HCTZ|Administrative Problems|1
1209650|NCT00867490|3969738|P1|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4
1209651|NCT00867490|3969738|P1|Phase 1 - Candesartan+HCTZ|Adverse Event|5
1209652|NCT00867360|3969780|P2|Overall Study|Physician Decision|1
1209653|NCT00867360|3969781|P1|Overall Study|Physician Decision|0
1209654|NCT00867360|3969780|P2|Overall Study|Withdrawal by Subject|0
1209655|NCT00867360|3969781|P1|Overall Study|Withdrawal by Subject|1
1209656|NCT00867308|3969819|P2|Overall Study|Withdrawal by Subject|2
1209657|NCT00867308|3969820|P1|Overall Study|Withdrawal by Subject|1
1209658|NCT00867308|3969819|P2|Overall Study|Lack of Efficacy|12
1209659|NCT00867308|3969820|P1|Overall Study|Lack of Efficacy|6
1209660|NCT00867308|3969819|P2|Overall Study|Adverse Event|4
1209661|NCT00867308|3969820|P1|Overall Study|Adverse Event|1
1209662|NCT00867308|3969819|P2|Overall Study|Death|0
1209663|NCT00867308|3969820|P1|Overall Study|Death|1
1209664|NCT00867165|3969839|P2|Overall Study|Withdrawal by Subject|0
1209665|NCT00867165|3969840|P1|Overall Study|Withdrawal by Subject|1
1209666|NCT00867165|3969839|P2|Overall Study|Adverse Event|0
1209667|NCT00867165|3969840|P1|Overall Study|Adverse Event|3
1209668|NCT00867113|3969988|P1|Post Treatment After Survival Follow-up|Administrative problems|4
1209669|NCT00867113|3969988|P1|Post Treatment After Survival Follow-up|Lost to Follow-up|5
1209670|NCT00867113|3969988|P1|Post Treatment After Survival Follow-up|Withdrawal by Subject|1
1209671|NCT00867113|3969988|P1|Post Treatment After Survival Follow-up|Death|1
1209672|NCT00867113|3969988|P1|Treatment Period|Protocol Violation|4
1209673|NCT00867113|3969988|P1|Treatment Period|Disease progression/relapse|1
1209674|NCT00867113|3969988|P1|Treatment Period|Administrative problems|1
1209675|NCT00867113|3969988|P1|Treatment Period|Lost to Follow-up|3
1209676|NCT00867113|3969988|P1|Treatment Period|Withdrawal by Subject|19
1209677|NCT00867113|3969988|P1|Treatment Period|Death|2
1209678|NCT00867113|3969988|P1|Treatment Period|Adverse Event|15
1209679|NCT00867087|3969995|P1|Overall Study|Death|37
1209680|NCT00867087|3969995|P1|Overall Study|Withdrawal by Subject|4
1209681|NCT00867087|3969995|P1|Overall Study|Other|1
1209682|NCT00867035|3970011|P2|Baseline to 1 Week|Withdrawal by Subject|0
1209683|NCT00867035|3970012|P1|Baseline to 1 Week|Withdrawal by Subject|1
1209684|NCT00867035|3970011|P2|Baseline to 1 Hour|Withdrawal by Subject|1
1209685|NCT00867035|3970012|P1|Baseline to 1 Hour|Withdrawal by Subject|1
1209686|NCT00867009|3970038|P1|Maintenance Period|On-going in the Study at Data Cut-off|4
1209687|NCT00867009|3970038|P1|Induction Period|Progressive Disease (PD)|25
1209688|NCT00867009|3970038|P1|Induction Period|Physician Decision|3
1209689|NCT00867009|3970038|P1|Induction Period|Withdrawal by Subject|8
1209690|NCT00867009|3970038|P1|Induction Period|Protocol Violation|1
1209691|NCT00867009|3970038|P1|Induction Period|Death due to Study Disease|4
1209692|NCT00867009|3970038|P1|Induction Period|Death due to serious adverse event|6
1209693|NCT00867009|3970038|P1|Induction Period|Serious Adverse Event|10
1209694|NCT00867009|3970038|P1|Induction Period|Nonserious Adverse Event|5
1209695|NCT00866918|3970047|P2|Overall Study|Secondary malignancy|0
1209696|NCT00866918|3970048|P1|Overall Study|Secondary malignancy|1
1209697|NCT00866918|3970047|P2|Overall Study|Inevaluable- RQPCR negative at diagnosi|0
1209698|NCT00866918|3970048|P1|Overall Study|Inevaluable- RQPCR negative at diagnosi|1
1209699|NCT00866918|3970047|P2|Overall Study|Ineligible|4
1209700|NCT00866918|3970048|P1|Overall Study|Ineligible|2
1209701|NCT00866918|3970047|P2|Overall Study|Physician Decision|2
1209702|NCT00866918|3970048|P1|Overall Study|Physician Decision|10
1209703|NCT00866918|3970047|P2|Overall Study|Lack of Efficacy|1
1209704|NCT00866918|3970048|P1|Overall Study|Lack of Efficacy|1
1209705|NCT00866918|3970047|P2|Overall Study|Death|5
1209706|NCT00866918|3970048|P1|Overall Study|Death|1
1209707|NCT00866814|3970065|P1|Overall Study|Moved to area without study site|1
1209708|NCT00866814|3970065|P1|Overall Study|Unable to meet follow-up requirements|2
1209709|NCT00866814|3970065|P1|Overall Study|No longer wished to participate|1
1209710|NCT00866814|3970065|P1|Overall Study|Death|1
1209711|NCT00866814|3970065|P1|Overall Study|Physician Decision|1
1209712|NCT00866814|3970065|P1|Overall Study|Adverse Event|2
1209713|NCT00866814|3970065|P1|Overall Study|Lost to Follow-up|12
1209714|NCT00866788|3970078|P4|Overall Study|Physician Decision|1
1209715|NCT00866788|3970079|P3|Overall Study|Physician Decision|1
1209716|NCT00866788|3970080|P2|Overall Study|Physician Decision|0
1209717|NCT00866788|3970081|P1|Overall Study|Physician Decision|0
1209718|NCT00866788|3970078|P4|Overall Study|Disease progression|0
1209719|NCT00866788|3970079|P3|Overall Study|Disease progression|1
1209720|NCT00866788|3970080|P2|Overall Study|Disease progression|1
1209721|NCT00866788|3970081|P1|Overall Study|Disease progression|3
1209722|NCT00866788|3970078|P4|Overall Study|Pregnancy|0
1209723|NCT00866788|3970079|P3|Overall Study|Pregnancy|0
1209724|NCT00866788|3970080|P2|Overall Study|Pregnancy|1
1209725|NCT00866788|3970081|P1|Overall Study|Pregnancy|0
1209726|NCT00866788|3970078|P4|Overall Study|Withdrawal by Subject|1
1209727|NCT00866788|3970079|P3|Overall Study|Withdrawal by Subject|0
1209728|NCT00866788|3970080|P2|Overall Study|Withdrawal by Subject|1
1209729|NCT00866788|3970081|P1|Overall Study|Withdrawal by Subject|2
1209730|NCT00866788|3970078|P4|Overall Study|Lost to Follow-up|2
1209731|NCT00866788|3970079|P3|Overall Study|Lost to Follow-up|0
1209732|NCT00866788|3970080|P2|Overall Study|Lost to Follow-up|1
1209733|NCT00866788|3970081|P1|Overall Study|Lost to Follow-up|1
1209734|NCT00866788|3970078|P4|Overall Study|Adverse Event|1
1209735|NCT00866788|3970079|P3|Overall Study|Adverse Event|0
1209736|NCT00866788|3970080|P2|Overall Study|Adverse Event|2
1209737|NCT00866788|3970081|P1|Overall Study|Adverse Event|0
1209738|NCT00866775|3970129|P2|Overall Study|discontinued due to communication error|1
1209739|NCT00866775|3970130|P1|Overall Study|discontinued due to communication error|0
1209740|NCT00866775|3970129|P2|Overall Study|met exit criteria|17
1209741|NCT00866775|3970130|P1|Overall Study|met exit criteria|23
1209742|NCT00866775|3970129|P2|Overall Study|Withdrawal by Subject|4
1209743|NCT00866775|3970130|P1|Overall Study|Withdrawal by Subject|4
1209744|NCT00866775|3970129|P2|Overall Study|Protocol Violation|4
1209745|NCT00866775|3970130|P1|Overall Study|Protocol Violation|3
1209746|NCT00866775|3970129|P2|Overall Study|Physician Decision|3
1209747|NCT00866775|3970130|P1|Overall Study|Physician Decision|0
1209748|NCT00866775|3970129|P2|Overall Study|Lost to Follow-up|4
1209749|NCT00866775|3970130|P1|Overall Study|Lost to Follow-up|0
1209750|NCT00866775|3970129|P2|Overall Study|Death|0
1209751|NCT00866775|3970130|P1|Overall Study|Death|1
1209752|NCT00866775|3970129|P2|Overall Study|Adverse Event|19
1209753|NCT00866775|3970130|P1|Overall Study|Adverse Event|5
1209754|NCT00866723|3970166|P1|Overall Study|Disease Progression|4
1209755|NCT00866723|3970166|P1|Overall Study|Withdrawal by Subject|1
1209756|NCT00866697|3970173|P2|Overall Study|Withdrawal by Subject|57
1209757|NCT00866697|3970174|P1|Overall Study|Withdrawal by Subject|33
1209758|NCT00866697|3970173|P2|Overall Study|Physician Decision|5
1209759|NCT00866697|3970174|P1|Overall Study|Physician Decision|3
1209760|NCT00866697|3970173|P2|Overall Study|Lost to Follow-up|28
1209761|NCT00866697|3970174|P1|Overall Study|Lost to Follow-up|22
1209762|NCT00866697|3970173|P2|Overall Study|Study closed/terminated|138
1209763|NCT00866697|3970174|P1|Overall Study|Study closed/terminated|156
1209764|NCT00866658|3970216|P2|Overall Study|Familial and Personal Reasons|5
1209765|NCT00866658|3970217|P1|Overall Study|Familial and Personal Reasons|4
1209766|NCT00866658|3970216|P2|Overall Study|Protocol Violation|1
1209767|NCT00866658|3970217|P1|Overall Study|Protocol Violation|1
1209768|NCT00866658|3970216|P2|Overall Study|Withdrawal by Subject|0
1209769|NCT00866658|3970217|P1|Overall Study|Withdrawal by Subject|1
1209770|NCT00866658|3970216|P2|Overall Study|Lack of Efficacy|1
1209771|NCT00866658|3970217|P1|Overall Study|Lack of Efficacy|2
1209772|NCT00866658|3970216|P2|Overall Study|Adverse Event|14
1209773|NCT00866658|3970217|P1|Overall Study|Adverse Event|5
1209774|NCT00866606|3970245|P1|Overall Study|Adverse Event|1
1209775|NCT00866606|3970245|P1|Overall Study|Lost to Follow-up|3
1209776|NCT00866359|3970259|P4|Extension Phase (Day 86 to 169)|Adverse Event|3
1209777|NCT00866359|3970260|P3|Extension Phase (Day 86 to 169)|Adverse Event|1
1209778|NCT00866359|3970261|P2|Extension Phase (Day 86 to 169)|Adverse Event|0
1209779|NCT00866359|3970262|P1|Extension Phase (Day 86 to 169)|Adverse Event|0
1209780|NCT00866359|3970259|P4|Treatment Phase (Days 1 to 85)|Other|0
1209781|NCT00866359|3970260|P3|Treatment Phase (Days 1 to 85)|Other|0
1209782|NCT00866359|3970261|P2|Treatment Phase (Days 1 to 85)|Other|0
1209783|NCT00866359|3970262|P1|Treatment Phase (Days 1 to 85)|Other|1
1209784|NCT00866359|3970259|P4|Treatment Phase (Days 1 to 85)|Protocol Violation|0
1209785|NCT00866359|3970260|P3|Treatment Phase (Days 1 to 85)|Protocol Violation|0
1209786|NCT00866359|3970261|P2|Treatment Phase (Days 1 to 85)|Protocol Violation|1
1209787|NCT00866359|3970262|P1|Treatment Phase (Days 1 to 85)|Protocol Violation|1
1209788|NCT00866359|3970259|P4|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
1209789|NCT00866359|3970260|P3|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
1209790|NCT00866359|3970261|P2|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
1209791|NCT00866359|3970262|P1|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1
1209792|NCT00866359|3970259|P4|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
1209793|NCT00866359|3970260|P3|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
1209794|NCT00866359|3970261|P2|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
1209795|NCT00866359|3970262|P1|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3
1209796|NCT00866359|3970259|P4|Treatment Phase (Days 1 to 85)|Adverse Event|0
1209797|NCT00866359|3970260|P3|Treatment Phase (Days 1 to 85)|Adverse Event|0
1209798|NCT00866359|3970261|P2|Treatment Phase (Days 1 to 85)|Adverse Event|4
1209799|NCT00866359|3970262|P1|Treatment Phase (Days 1 to 85)|Adverse Event|5
1209800|NCT00866320|3970315|P1|Overall Study|Death|2
1209801|NCT00866320|3970315|P1|Overall Study|Withdrawal by Subject|4
1209802|NCT00866307|3970322|P3|Consolidation/Maintenance|Patient moved to non-participating inst|0
1209803|NCT00866307|3970323|P2|Consolidation/Maintenance|Patient moved to non-participating inst|1
1209804|NCT00866307|3970324|P1|Consolidation/Maintenance|Patient moved to non-participating inst|0
1209805|NCT00866307|3970322|P3|Consolidation/Maintenance|Non-compliance|1
1209806|NCT00866307|3970323|P2|Consolidation/Maintenance|Non-compliance|0
1209807|NCT00866307|3970324|P1|Consolidation/Maintenance|Non-compliance|0
1209808|NCT00866307|3970322|P3|Consolidation/Maintenance|Therapy error|0
1209809|NCT00866307|3970323|P2|Consolidation/Maintenance|Therapy error|1
1209810|NCT00866307|3970324|P1|Consolidation/Maintenance|Therapy error|0
1209811|NCT00866307|3970322|P3|Consolidation/Maintenance|Recurrent leukemia following remission|1
1209812|NCT00866307|3970323|P2|Consolidation/Maintenance|Recurrent leukemia following remission|3
1209813|NCT00866307|3970324|P1|Consolidation/Maintenance|Recurrent leukemia following remission|0
1209814|NCT00866307|3970322|P3|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2
1209815|NCT00866307|3970323|P2|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
1209816|NCT00866307|3970324|P1|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
1209817|NCT00866307|3970322|P3|Consolidation/Maintenance|Withdrawal by Subject|1
1209818|NCT00866307|3970323|P2|Consolidation/Maintenance|Withdrawal by Subject|1
1209819|NCT00866307|3970324|P1|Consolidation/Maintenance|Withdrawal by Subject|0
1209820|NCT00866307|3970322|P3|Consolidation/Maintenance|Physician Decision|2
1209821|NCT00866307|3970323|P2|Consolidation/Maintenance|Physician Decision|3
1209822|NCT00866307|3970324|P1|Consolidation/Maintenance|Physician Decision|0
1209823|NCT00866307|3970322|P3|Consolidation/Maintenance|Death|1
1209824|NCT00866307|3970323|P2|Consolidation/Maintenance|Death|0
1209825|NCT00866307|3970324|P1|Consolidation/Maintenance|Death|0
1209826|NCT00866307|3970322|P3|Consolidation/Maintenance|Adverse Event|8
1209827|NCT00866307|3970323|P2|Consolidation/Maintenance|Adverse Event|0
1209828|NCT00866307|3970324|P1|Consolidation/Maintenance|Adverse Event|0
1209829|NCT00866307|3970322|P3|Induction|Study was closed at the time|0
1209830|NCT00866307|3970323|P2|Induction|Study was closed at the time|0
1209831|NCT00866307|3970324|P1|Induction|Study was closed at the time|1
1209832|NCT00866307|3970322|P3|Induction|Improper post-induction consent|0
1209833|NCT00866307|3970323|P2|Induction|Improper post-induction consent|0
1209834|NCT00866307|3970324|P1|Induction|Improper post-induction consent|2
1209835|NCT00866307|3970322|P3|Induction|Inadequate cytognetic samples th|0
1209836|NCT00866307|3970323|P2|Induction|Inadequate cytognetic samples th|0
1209837|NCT00866307|3970324|P1|Induction|Inadequate cytognetic samples th|1
1209838|NCT00866307|3970322|P3|Induction|Identification of Patients with Day 29 M|0
1209839|NCT00866307|3970323|P2|Induction|Identification of Patients with Day 29 M|0
1209840|NCT00866307|3970324|P1|Induction|Identification of Patients with Day 29 M|3
1209841|NCT00866307|3970322|P3|Induction|Progressive Disease|0
1209842|NCT00866307|3970323|P2|Induction|Progressive Disease|0
1209843|NCT00866307|3970324|P1|Induction|Progressive Disease|1
1209844|NCT00866307|3970322|P3|Induction|Physician Decision|0
1209845|NCT00866307|3970323|P2|Induction|Physician Decision|0
1209846|NCT00866307|3970324|P1|Induction|Physician Decision|5
1209847|NCT00866307|3970322|P3|Induction|Death|0
1209848|NCT00866307|3970323|P2|Induction|Death|0
1209849|NCT00866307|3970324|P1|Induction|Death|2
1209850|NCT00866307|3970322|P3|Induction|Adverse Event|0
1209851|NCT00866307|3970323|P2|Induction|Adverse Event|0
1209852|NCT00866307|3970324|P1|Induction|Adverse Event|5
1209853|NCT00866294|3970334|P3|Overall Study|Physician Decision|1
1209854|NCT00866294|3970335|P2|Overall Study|Physician Decision|2
1209855|NCT00866294|3970336|P1|Overall Study|Physician Decision|6
1209856|NCT00866294|3970334|P3|Overall Study|Lost to Follow-up|0
1209857|NCT00866294|3970335|P2|Overall Study|Lost to Follow-up|3
1209858|NCT00866294|3970336|P1|Overall Study|Lost to Follow-up|1
1209859|NCT00866294|3970334|P3|Overall Study|Met Protocol-defined Stopping Criteria|1
1209860|NCT00866294|3970335|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
1209861|NCT00866294|3970336|P1|Overall Study|Met Protocol-defined Stopping Criteria|5
1209862|NCT00866294|3970334|P3|Overall Study|Protocol Violation|0
1209863|NCT00866294|3970335|P2|Overall Study|Protocol Violation|0
1209864|NCT00866294|3970336|P1|Overall Study|Protocol Violation|2
1209865|NCT00866294|3970334|P3|Overall Study|Lack of Efficacy|0
1209866|NCT00866294|3970335|P2|Overall Study|Lack of Efficacy|1
1209867|NCT00866294|3970336|P1|Overall Study|Lack of Efficacy|7
1209868|NCT00866294|3970334|P3|Overall Study|Adverse Event|9
1209869|NCT00866294|3970335|P2|Overall Study|Adverse Event|13
1209870|NCT00866294|3970336|P1|Overall Study|Adverse Event|12
1209871|NCT00866281|3970365|P2|Overall Study|New cancer therapy|4
1209872|NCT00866281|3970366|P1|Overall Study|New cancer therapy|0
1209873|NCT00866281|3970365|P2|Overall Study|Disease progression|11
1209874|NCT00866281|3970366|P1|Overall Study|Disease progression|3
1209875|NCT00866281|3970365|P2|Overall Study|Withdrawal by participants|0
1209876|NCT00866281|3970366|P1|Overall Study|Withdrawal by participants|3
1209877|NCT00866281|3970365|P2|Overall Study|Adverse Event|0
1209878|NCT00866281|3970366|P1|Overall Study|Adverse Event|1
1209879|NCT00866177|3970382|P1|Overall Study|Not Treated|151
1209880|NCT00866177|3970382|P1|Overall Study|Withdrawal by Subject|1
1209881|NCT00866047|3970386|P1|Follow-up Period|Lost to Follow-up|5
1209882|NCT00866047|3970386|P1|Treatment Period|Withdrawal by Subject|5
1209883|NCT00866047|3970386|P1|Treatment Period|Physician Decision|14
1209884|NCT00866047|3970386|P1|Treatment Period|Adverse Event|16
1209885|NCT00866047|3970386|P1|Treatment Period|Progressive disease|13
1209886|NCT00865904|3970418|P5|Overall Study|Randomized but not Treated|1
1209887|NCT00865904|3970419|P4|Overall Study|Randomized but not Treated|1
1209888|NCT00865904|3970420|P3|Overall Study|Randomized but not Treated|0
1209889|NCT00865904|3970421|P2|Overall Study|Randomized but not Treated|0
1209890|NCT00865904|3970422|P1|Overall Study|Randomized but not Treated|2
1209891|NCT00865709|3970479|P2|Treatment|Surgery|3
1209892|NCT00865709|3970480|P1|Treatment|Surgery|8
1209893|NCT00865709|3970479|P2|Treatment|Physician Decision|2
1209894|NCT00865709|3970480|P1|Treatment|Physician Decision|3
1209895|NCT00865709|3970479|P2|Treatment|Withdrawal by Subject|7
1209896|NCT00865709|3970480|P1|Treatment|Withdrawal by Subject|10
1209897|NCT00865709|3970479|P2|Treatment|Adverse Event|6
1209898|NCT00865709|3970480|P1|Treatment|Adverse Event|9
1209899|NCT00865514|3970496|P1|Overall Study|Infusion cost exceeded funding|2
1209900|NCT00865345|3970501|P1|Overall Study|Withdrawal by Subject|2
1209901|NCT00865306|3970508|P2|Controlled Trial|Withdrawal by Subject|1
1209902|NCT00865306|3970509|P1|Controlled Trial|Withdrawal by Subject|0
1209903|NCT00865306|3970508|P2|Controlled Trial|Sought treatment for conduct disorder|0
1209904|NCT00865306|3970509|P1|Controlled Trial|Sought treatment for conduct disorder|1
1209905|NCT00865306|3970508|P2|Controlled Trial|Improved btw baseline and first session|0
1209906|NCT00865306|3970509|P1|Controlled Trial|Improved btw baseline and first session|1
1209907|NCT00865306|3970508|P2|Controlled Trial|Difficulty commuting|0
1209908|NCT00865306|3970509|P1|Controlled Trial|Difficulty commuting|2
1209909|NCT00865306|3970508|P2|Controlled Trial|Lost to Follow-up|1
1209910|NCT00865306|3970509|P1|Controlled Trial|Lost to Follow-up|1
1209911|NCT00865189|3970538|P2|Overall Study|Withdrawal by Subject|0
1209912|NCT00865189|3970539|P1|Overall Study|Withdrawal by Subject|1
1209913|NCT00865189|3970538|P2|Overall Study|Lost to Follow-up|6
1209914|NCT00865189|3970539|P1|Overall Study|Lost to Follow-up|6
1209915|NCT00865189|3970538|P2|Overall Study|Death|11
1209916|NCT00865189|3970539|P1|Overall Study|Death|4
1209917|NCT00865189|3970538|P2|Overall Study|Other|2
1209918|NCT00865189|3970539|P1|Overall Study|Other|1
1209919|NCT00865124|3970567|P3|Overall Study|Withdrawn consent|0
1209920|NCT00865124|3970568|P2|Overall Study|Withdrawn consent|0
1209921|NCT00865124|3970569|P1|Overall Study|Withdrawn consent|2
1209922|NCT00865124|3970567|P3|Overall Study|Physician Decision|0
1209923|NCT00865124|3970568|P2|Overall Study|Physician Decision|1
1209924|NCT00865124|3970569|P1|Overall Study|Physician Decision|2
1209925|NCT00865098|3970586|P1|Overall Study|Progressive disease|1
1209926|NCT00865046|3970598|P3|Overall Study|Withdrawal by Subject|0
1209927|NCT00865046|3970599|P2|Overall Study|Withdrawal by Subject|0
1209928|NCT00865046|3970600|P1|Overall Study|Withdrawal by Subject|5
1209929|NCT00865046|3970598|P3|Overall Study|Death|1
1209930|NCT00865046|3970599|P2|Overall Study|Death|1
1209931|NCT00865046|3970600|P1|Overall Study|Death|0
1209932|NCT00865046|3970598|P3|Overall Study|Lost to Follow-up|0
1209933|NCT00865046|3970599|P2|Overall Study|Lost to Follow-up|4
1209934|NCT00865046|3970600|P1|Overall Study|Lost to Follow-up|1
1209935|NCT00865020|3970610|P2|Overall Study|Randomized but discontinued|4
1209936|NCT00865020|3970611|P1|Overall Study|Randomized but discontinued|2
1209937|NCT00865020|3970610|P2|Overall Study|Death|1
1209938|NCT00865020|3970611|P1|Overall Study|Death|0
1209939|NCT00865020|3970610|P2|Overall Study|Abnormal laboratory value(s)|1
1209940|NCT00865020|3970611|P1|Overall Study|Abnormal laboratory value(s)|0
1209941|NCT00865020|3970610|P2|Overall Study|Administrative problems|2
1209942|NCT00865020|3970611|P1|Overall Study|Administrative problems|0
1209943|NCT00865020|3970610|P2|Overall Study|Protocol deviation|1
1209944|NCT00865020|3970611|P1|Overall Study|Protocol deviation|4
1209945|NCT00865020|3970610|P2|Overall Study|Lost to Follow-up|4
1209946|NCT00865020|3970611|P1|Overall Study|Lost to Follow-up|6
1209947|NCT00865020|3970610|P2|Overall Study|Abnormal test procedure result(s)|8
1209948|NCT00865020|3970611|P1|Overall Study|Abnormal test procedure result(s)|6
1209949|NCT00865020|3970610|P2|Overall Study|Adverse Event|14
1209950|NCT00865020|3970611|P1|Overall Study|Adverse Event|9
1209951|NCT00865020|3970610|P2|Overall Study|Withdrawal by Subject|16
1209952|NCT00865020|3970611|P1|Overall Study|Withdrawal by Subject|22
1209953|NCT00864916|3970627|P2|Overall Study|Withdrawal by Subject|0
1209954|NCT00864916|3970628|P1|Overall Study|Withdrawal by Subject|1
1209955|NCT00864916|3970627|P2|Overall Study|Protocol Violation|0
1209956|NCT00864916|3970628|P1|Overall Study|Protocol Violation|1
1209957|NCT00864916|3970627|P2|Overall Study|Lost to Follow-up|4
1209958|NCT00864916|3970628|P1|Overall Study|Lost to Follow-up|4
1209959|NCT00864851|3970637|P3|Overall Study|Patient uncooperative|0
1209960|NCT00864851|3970638|P2|Overall Study|Patient uncooperative|0
1209961|NCT00864851|3970639|P1|Overall Study|Patient uncooperative|1
1209962|NCT00864851|3970637|P3|Overall Study|Death|0
1209963|NCT00864851|3970638|P2|Overall Study|Death|0
1209964|NCT00864851|3970639|P1|Overall Study|Death|1
1209965|NCT00864851|3970637|P3|Overall Study|Physician Decision|0
1209966|NCT00864851|3970638|P2|Overall Study|Physician Decision|0
1209967|NCT00864851|3970639|P1|Overall Study|Physician Decision|1
1209968|NCT00864851|3970637|P3|Overall Study|Withdrawal by Subject|0
1209969|NCT00864851|3970638|P2|Overall Study|Withdrawal by Subject|1
1209970|NCT00864851|3970639|P1|Overall Study|Withdrawal by Subject|0
1209971|NCT00864721|3970673|P1|Overall Study|Adverse Event|21
1209972|NCT00864721|3970673|P1|Overall Study|Drug hold/delay more than 4 weeks|1
1209973|NCT00864721|3970673|P1|Overall Study|Hospitalized|1
1209974|NCT00864721|3970673|P1|Overall Study|Patient request|11
1209975|NCT00864682|3970693|P3|Overall Study|Protocol Violation|2
1209976|NCT00864682|3970694|P2|Overall Study|Protocol Violation|1
1209977|NCT00864682|3970695|P1|Overall Study|Protocol Violation|2
1209978|NCT00864513|3970734|P1|Overall Study|Withdrawal by Subject|3
1209979|NCT00864253|3970780|P2|Overall Study|Untreated|7
1209980|NCT00864253|3970781|P1|Overall Study|Untreated|7
1209981|NCT00864253|3970780|P2|Overall Study|Ongoing|3
1209982|NCT00864253|3970781|P1|Overall Study|Ongoing|2
1209983|NCT00864253|3970780|P2|Overall Study|Death|0
1209984|NCT00864253|3970781|P1|Overall Study|Death|1
1209985|NCT00864253|3970780|P2|Overall Study|Withdrawal by Subject|18
1209986|NCT00864253|3970781|P1|Overall Study|Withdrawal by Subject|18
1209987|NCT00864253|3970780|P2|Overall Study|Lost to Follow-up|1
1209988|NCT00864253|3970781|P1|Overall Study|Lost to Follow-up|1
1209989|NCT00864253|3970780|P2|Overall Study|Protocol Violation|2
1209990|NCT00864253|3970781|P1|Overall Study|Protocol Violation|0
1209991|NCT00864253|3970780|P2|Overall Study|Physician Decision|15
1209992|NCT00864253|3970781|P1|Overall Study|Physician Decision|11
1209993|NCT00864253|3970780|P2|Overall Study|Unrelated Adverse Event|1
1209994|NCT00864253|3970781|P1|Overall Study|Unrelated Adverse Event|3
1209995|NCT00864253|3970780|P2|Overall Study|Adverse Event|11
1209996|NCT00864253|3970781|P1|Overall Study|Adverse Event|56
1209997|NCT00864227|3970811|P1|Overall Study|Disease Relapse/Progression|3
1209998|NCT00864227|3970811|P1|Overall Study|Withdrawal by Subject|1
1209999|NCT00863798|3970873|P3|Overall Study|Randomized not treated|3
1210000|NCT00863798|3970874|P2|Overall Study|Randomized not treated|2
1210001|NCT00863798|3970875|P1|Overall Study|Randomized not treated|4
1210002|NCT00863798|3970873|P3|Overall Study|Withdrawal by Subject|4
1210003|NCT00863798|3970874|P2|Overall Study|Withdrawal by Subject|7
1210004|NCT00863798|3970875|P1|Overall Study|Withdrawal by Subject|8
1210005|NCT00863798|3970873|P3|Overall Study|Protocol Violation|1
1210006|NCT00863798|3970874|P2|Overall Study|Protocol Violation|1
1210007|NCT00863798|3970875|P1|Overall Study|Protocol Violation|0
1210008|NCT00863798|3970873|P3|Overall Study|Other|1
1210009|NCT00863798|3970874|P2|Overall Study|Other|3
1210010|NCT00863798|3970875|P1|Overall Study|Other|2
1210011|NCT00863798|3970873|P3|Overall Study|Lost to Follow-up|5
1210012|NCT00863798|3970874|P2|Overall Study|Lost to Follow-up|9
1210013|NCT00863798|3970875|P1|Overall Study|Lost to Follow-up|6
1210014|NCT00863798|3970873|P3|Overall Study|Lack of Efficacy|6
1210015|NCT00863798|3970874|P2|Overall Study|Lack of Efficacy|3
1210016|NCT00863798|3970875|P1|Overall Study|Lack of Efficacy|4
1210017|NCT00863798|3970873|P3|Overall Study|Investigator request|1
1210018|NCT00863798|3970874|P2|Overall Study|Investigator request|2
1210019|NCT00863798|3970875|P1|Overall Study|Investigator request|1
1210020|NCT00863798|3970873|P3|Overall Study|Participant failed to return|0
1210021|NCT00863798|3970874|P2|Overall Study|Participant failed to return|1
1210022|NCT00863798|3970875|P1|Overall Study|Participant failed to return|2
1210023|NCT00863798|3970873|P3|Overall Study|Adverse Event|4
1210024|NCT00863798|3970874|P2|Overall Study|Adverse Event|2
1210025|NCT00863798|3970875|P1|Overall Study|Adverse Event|5
1210026|NCT00863746|3970927|P2|Survival Follow up|Consent Withdrawn|8
1210027|NCT00863746|3970928|P1|Survival Follow up|Consent Withdrawn|7
1210028|NCT00863746|3970927|P2|Survival Follow up|Lost to Follow-up|1
1210029|NCT00863746|3970928|P1|Survival Follow up|Lost to Follow-up|2
1210030|NCT00863746|3970927|P2|Survival Follow up|Death|271
1210031|NCT00863746|3970928|P1|Survival Follow up|Death|244
1210032|NCT00863746|3970927|P2|Treatment|not available|0
1210033|NCT00863746|3970928|P1|Treatment|not available|1
1210034|NCT00863746|3970927|P2|Treatment|Protocol Violation|3
1210035|NCT00863746|3970928|P1|Treatment|Protocol Violation|5
1210036|NCT00863746|3970927|P2|Treatment|Lost to Follow-up|0
1210037|NCT00863746|3970928|P1|Treatment|Lost to Follow-up|1
1210038|NCT00863746|3970927|P2|Treatment|Consent withdrawn|14
1210039|NCT00863746|3970928|P1|Treatment|Consent withdrawn|15
1210040|NCT00863746|3970927|P2|Treatment|non-compliant with study medication|0
1210041|NCT00863746|3970928|P1|Treatment|non-compliant with study medication|4
1210042|NCT00863746|3970927|P2|Treatment|Adverse Event|16
1210043|NCT00863746|3970928|P1|Treatment|Adverse Event|41
1210044|NCT00863746|3970927|P2|Treatment|Not treated|2
1210045|NCT00863746|3970928|P1|Treatment|Not treated|4
1210046|NCT00863707|3970954|P2|Overall Study|Randomized, but drug not received|3
1210047|NCT00863707|3970955|P1|Overall Study|Randomized, but drug not received|4
1210048|NCT00863655|3970963|P2|Overall Study|Treatment completed as per protocol|1
1210049|NCT00863655|3970964|P1|Overall Study|Treatment completed as per protocol|5
1210050|NCT00863655|3970963|P2|Overall Study|Disease progression|221
1210051|NCT00863655|3970964|P1|Overall Study|Disease progression|364
1210052|NCT00863655|3970963|P2|Overall Study|New cancer therapy|1
1210053|NCT00863655|3970964|P1|Overall Study|New cancer therapy|5
1210054|NCT00863655|3970963|P2|Overall Study|Death|1
1210055|NCT00863655|3970964|P1|Overall Study|Death|7
1210056|NCT00863655|3970963|P2|Overall Study|Administrative problems|0
1210057|NCT00863655|3970964|P1|Overall Study|Administrative problems|1
1210058|NCT00863655|3970963|P2|Overall Study|Withdrawal by Subject|7
1210059|NCT00863655|3970964|P1|Overall Study|Withdrawal by Subject|47
1210060|NCT00863655|3970963|P2|Overall Study|Adverse Event|8
1210061|NCT00863655|3970964|P1|Overall Study|Adverse Event|52
1210062|NCT00863655|3970963|P2|Overall Study|Protocol Violation|0
1210063|NCT00863655|3970964|P1|Overall Study|Protocol Violation|4
1210064|NCT00863512|3971001|P2|Overall Study|Physician Decision|0
1210065|NCT00863512|3971002|P1|Overall Study|Physician Decision|1
1210066|NCT00863512|3971001|P2|Overall Study|Withdrawal by Subject|0
1210067|NCT00863512|3971002|P1|Overall Study|Withdrawal by Subject|11
1210068|NCT00863512|3971001|P2|Overall Study|Adverse Event|0
1210069|NCT00863512|3971002|P1|Overall Study|Adverse Event|2
1210070|NCT00863330|3971033|P1|Overall Study|study terminated early due to administra|6
1210071|NCT00863317|3971039|P2|Overall Study|Lost to Follow-up|9
1210072|NCT00863317|3971040|P1|Overall Study|Lost to Follow-up|8
1210073|NCT00863057|3971095|P4|Period 2 (Weeks 6-10)|Physician Decision|1
1210074|NCT00863057|3971096|P3|Period 2 (Weeks 6-10)|Physician Decision|0
1210075|NCT00863057|3971097|P2|Period 2 (Weeks 6-10)|Physician Decision|0
1210076|NCT00863057|3971098|P1|Period 2 (Weeks 6-10)|Physician Decision|0
1210077|NCT00863057|3971095|P4|Period 2 (Weeks 6-10)|Adverse Event|0
1210078|NCT00863057|3971096|P3|Period 2 (Weeks 6-10)|Adverse Event|1
1210079|NCT00863057|3971097|P2|Period 2 (Weeks 6-10)|Adverse Event|1
1210080|NCT00863057|3971098|P1|Period 2 (Weeks 6-10)|Adverse Event|0
1210081|NCT00863057|3971095|P4|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
1210082|NCT00863057|3971096|P3|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
1210083|NCT00863057|3971097|P2|Milestones Period 1 (Weeks 0-5)|Physician Decision|1
1210084|NCT00863057|3971098|P1|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
1210085|NCT00863057|3971095|P4|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
1210086|NCT00863057|3971096|P3|Milestones Period 1 (Weeks 0-5)|Adverse Event|0
1210087|NCT00863057|3971097|P2|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
1210088|NCT00863057|3971098|P1|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
1210089|NCT00862979|3971148|P2|Overall Study|Death|1
1210090|NCT00862979|3971149|P1|Overall Study|Death|0
1210091|NCT00862979|3971148|P2|Overall Study|Administrative problems|1
1210092|NCT00862979|3971149|P1|Overall Study|Administrative problems|0
1210093|NCT00862979|3971148|P2|Overall Study|Patient withdrew consent|1
1210094|NCT00862979|3971149|P1|Overall Study|Patient withdrew consent|2
1210095|NCT00862979|3971148|P2|Overall Study|Protocol Violation|1
1210096|NCT00862979|3971149|P1|Overall Study|Protocol Violation|0
1210097|NCT00862979|3971148|P2|Overall Study|Adverse Event|3
1210098|NCT00862979|3971149|P1|Overall Study|Adverse Event|6
1210099|NCT00862940|3971167|P2|Overall Study|Administrative or other reason(s)|3
1210100|NCT00862940|3971168|P1|Overall Study|Administrative or other reason(s)|4
1210101|NCT00862940|3971167|P2|Overall Study|Lost to Follow-up|1
1210102|NCT00862940|3971168|P1|Overall Study|Lost to Follow-up|0
1210103|NCT00862940|3971167|P2|Overall Study|Non-compliance|0
1210104|NCT00862940|3971168|P1|Overall Study|Non-compliance|4
1210105|NCT00862940|3971167|P2|Overall Study|Withdrawal by Subject|6
1210106|NCT00862940|3971168|P1|Overall Study|Withdrawal by Subject|4
1210107|NCT00862940|3971167|P2|Overall Study|Protocol Violation|5
1210108|NCT00862940|3971168|P1|Overall Study|Protocol Violation|2
1210109|NCT00862940|3971167|P2|Overall Study|Lack of Efficacy|3
1210110|NCT00862940|3971168|P1|Overall Study|Lack of Efficacy|1
1210111|NCT00862940|3971167|P2|Overall Study|Adverse Event|12
1210112|NCT00862940|3971168|P1|Overall Study|Adverse Event|15
1210113|NCT00862849|3971180|P6|Washout 2 (3 to 14 Days)|Protocol Violation|0
1210114|NCT00862849|3971181|P5|Washout 2 (3 to 14 Days)|Protocol Violation|0
1210115|NCT00862849|3971182|P4|Washout 2 (3 to 14 Days)|Protocol Violation|0
1210116|NCT00862849|3971183|P3|Washout 2 (3 to 14 Days)|Protocol Violation|0
1210117|NCT00862849|3971184|P2|Washout 2 (3 to 14 Days)|Protocol Violation|1
1210118|NCT00862849|3971185|P1|Washout 2 (3 to 14 Days)|Protocol Violation|0
1210119|NCT00862849|3971180|P6|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
1210120|NCT00862849|3971181|P5|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
1210121|NCT00862849|3971182|P4|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
1210122|NCT00862849|3971183|P3|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
1210123|NCT00862849|3971184|P2|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1
1210124|NCT00862849|3971185|P1|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
1210125|NCT00862836|3971208|P1|Overall Study|Withdrawal by Subject|1
1210126|NCT00862823|3971219|P2|First Intervention|Withdrawal by Subject|1
1210127|NCT00862823|3971220|P1|First Intervention|Withdrawal by Subject|1
1210128|NCT00862719|3971269|P4|Overall Study|Veno-Occlusive Disease|0
1210129|NCT00862719|3971270|P3|Overall Study|Veno-Occlusive Disease|1
1210130|NCT00862719|3971271|P2|Overall Study|Veno-Occlusive Disease|0
1210131|NCT00862719|3971272|P1|Overall Study|Veno-Occlusive Disease|0
1210132|NCT00862719|3971269|P4|Overall Study|Engraftment failure|0
1210133|NCT00862719|3971270|P3|Overall Study|Engraftment failure|1
1210134|NCT00862719|3971271|P2|Overall Study|Engraftment failure|0
1210135|NCT00862719|3971272|P1|Overall Study|Engraftment failure|0
1210136|NCT00862719|3971269|P4|Overall Study|Death|1
1210137|NCT00862719|3971270|P3|Overall Study|Death|1
1210138|NCT00862719|3971271|P2|Overall Study|Death|6
1210139|NCT00862719|3971272|P1|Overall Study|Death|5
1210140|NCT00862719|3971269|P4|Overall Study|Disease Progression|0
1210141|NCT00862719|3971270|P3|Overall Study|Disease Progression|1
1210142|NCT00862719|3971271|P2|Overall Study|Disease Progression|0
1210143|NCT00862719|3971272|P1|Overall Study|Disease Progression|5
1210144|NCT00862654|3971295|P4|Overall Study|Included after end of inclusions|0
1210145|NCT00862654|3971296|P3|Overall Study|Included after end of inclusions|1
1210146|NCT00862654|3971297|P2|Overall Study|Included after end of inclusions|0
1210147|NCT00862654|3971298|P1|Overall Study|Included after end of inclusions|0
1210148|NCT00862654|3971295|P4|Overall Study|Never used study drugs|0
1210149|NCT00862654|3971296|P3|Overall Study|Never used study drugs|0
1210150|NCT00862654|3971297|P2|Overall Study|Never used study drugs|0
1210151|NCT00862654|3971298|P1|Overall Study|Never used study drugs|1
1210152|NCT00862654|3971295|P4|Overall Study|Familly constraint|0
1210153|NCT00862654|3971296|P3|Overall Study|Familly constraint|0
1210154|NCT00862654|3971297|P2|Overall Study|Familly constraint|1
1210155|NCT00862654|3971298|P1|Overall Study|Familly constraint|0
1210156|NCT00862654|3971295|P4|Overall Study|Subject mistake|0
1210157|NCT00862654|3971296|P3|Overall Study|Subject mistake|0
1210158|NCT00862654|3971297|P2|Overall Study|Subject mistake|1
1210159|NCT00862654|3971298|P1|Overall Study|Subject mistake|0
1210160|NCT00862654|3971295|P4|Overall Study|Withdrawal by Subject|3
1210161|NCT00862654|3971296|P3|Overall Study|Withdrawal by Subject|2
1210162|NCT00862654|3971297|P2|Overall Study|Withdrawal by Subject|2
1210163|NCT00862654|3971298|P1|Overall Study|Withdrawal by Subject|2
1210164|NCT00862654|3971295|P4|Overall Study|Pregnancy|0
1210165|NCT00862654|3971296|P3|Overall Study|Pregnancy|0
1210166|NCT00862654|3971297|P2|Overall Study|Pregnancy|1
1210167|NCT00862654|3971298|P1|Overall Study|Pregnancy|1
1210168|NCT00862654|3971295|P4|Overall Study|Adverse Event|0
1210169|NCT00862654|3971296|P3|Overall Study|Adverse Event|1
1210170|NCT00862654|3971297|P2|Overall Study|Adverse Event|1
1210171|NCT00862654|3971298|P1|Overall Study|Adverse Event|0
1210172|NCT00862654|3971295|P4|Overall Study|Lost to Follow-up|3
1210173|NCT00862654|3971296|P3|Overall Study|Lost to Follow-up|1
1210174|NCT00862654|3971297|P2|Overall Study|Lost to Follow-up|2
1210175|NCT00862654|3971298|P1|Overall Study|Lost to Follow-up|1
1210176|NCT00862654|3971295|P4|Overall Study|Lack of Efficacy|0
1210177|NCT00862654|3971296|P3|Overall Study|Lack of Efficacy|1
1210178|NCT00862654|3971297|P2|Overall Study|Lack of Efficacy|0
1210179|NCT00862654|3971298|P1|Overall Study|Lack of Efficacy|1
1210180|NCT00862641|3971312|P4|Overall Study|Randomized, but drug not received|4
1210181|NCT00862641|3971313|P3|Overall Study|Randomized, but drug not received|1
1210182|NCT00862641|3971314|P2|Overall Study|Randomized, but drug not received|4
1210183|NCT00862641|3971315|P1|Overall Study|Randomized, but drug not received|1
1210184|NCT00862459|3971409|P3|Overall Study|Administrative problems|0
1210185|NCT00862459|3971410|P2|Overall Study|Administrative problems|1
1210186|NCT00862459|3971411|P1|Overall Study|Administrative problems|0
1210187|NCT00862459|3971409|P3|Overall Study|Inclusion/exclusion criteria not met|0
1210188|NCT00862459|3971410|P2|Overall Study|Inclusion/exclusion criteria not met|1
1210189|NCT00862459|3971411|P1|Overall Study|Inclusion/exclusion criteria not met|0
1210190|NCT00862459|3971409|P3|Overall Study|Unable to hold still for imaging|0
1210191|NCT00862459|3971410|P2|Overall Study|Unable to hold still for imaging|1
1210192|NCT00862459|3971411|P1|Overall Study|Unable to hold still for imaging|0
1210193|NCT00862459|3971409|P3|Overall Study|Intravenous (IV) site problems|1
1210194|NCT00862459|3971410|P2|Overall Study|Intravenous (IV) site problems|0
1210195|NCT00862459|3971411|P1|Overall Study|Intravenous (IV) site problems|1
1210196|NCT00862459|3971409|P3|Overall Study|Operation|0
1210197|NCT00862459|3971410|P2|Overall Study|Operation|1
1210198|NCT00862459|3971411|P1|Overall Study|Operation|1
1210199|NCT00862459|3971409|P3|Overall Study|Personal reasons|0
1210200|NCT00862459|3971410|P2|Overall Study|Personal reasons|0
1210201|NCT00862459|3971411|P1|Overall Study|Personal reasons|1
1210202|NCT00862459|3971409|P3|Overall Study|Adverse Event|0
1210203|NCT00862459|3971410|P2|Overall Study|Adverse Event|1
1210204|NCT00862459|3971411|P1|Overall Study|Adverse Event|0
1210205|NCT00862459|3971409|P3|Overall Study|Withdrawal by Subject|3
1210206|NCT00862459|3971410|P2|Overall Study|Withdrawal by Subject|1
1210207|NCT00862459|3971411|P1|Overall Study|Withdrawal by Subject|1
1210208|NCT00862459|3971409|P3|Overall Study|Protocol Violation|0
1210209|NCT00862459|3971410|P2|Overall Study|Protocol Violation|0
1210210|NCT00862459|3971411|P1|Overall Study|Protocol Violation|1
1210211|NCT00862459|3971409|P3|Overall Study|Lost to Follow-up|2
1210212|NCT00862459|3971410|P2|Overall Study|Lost to Follow-up|2
1210213|NCT00862459|3971411|P1|Overall Study|Lost to Follow-up|1
1210214|NCT00862277|3971558|P3|Overall Study|Protocol Violation|5
1210215|NCT00862277|3971559|P2|Overall Study|Protocol Violation|2
1210216|NCT00862277|3971560|P1|Overall Study|Protocol Violation|1
1210217|NCT00862251|3971574|P3|Overall Study|Withdrawal by Subject|6
1210218|NCT00862251|3971575|P2|Overall Study|Withdrawal by Subject|2
1210219|NCT00862251|3971576|P1|Overall Study|Withdrawal by Subject|9
1210220|NCT00862251|3971574|P3|Overall Study|Protocol Violation|1
1210221|NCT00862251|3971575|P2|Overall Study|Protocol Violation|0
1210222|NCT00862251|3971576|P1|Overall Study|Protocol Violation|2
1210223|NCT00862251|3971574|P3|Overall Study|Lost to Follow-up|1
1210224|NCT00862251|3971575|P2|Overall Study|Lost to Follow-up|0
1210225|NCT00862251|3971576|P1|Overall Study|Lost to Follow-up|0
1210226|NCT00862251|3971574|P3|Overall Study|Adverse Event|1
1210227|NCT00862251|3971575|P2|Overall Study|Adverse Event|3
1210228|NCT00862251|3971576|P1|Overall Study|Adverse Event|8
1210229|NCT00862134|3971636|P2|Overall Study|Withdrew prior to dosing|0
1210230|NCT00862134|3971637|P1|Overall Study|Withdrew prior to dosing|2
1210231|NCT00862134|3971636|P2|Overall Study|Adverse Event|2
1210232|NCT00862134|3971637|P1|Overall Study|Adverse Event|2
1210233|NCT00862134|3971636|P2|Overall Study|Sponsor terminated study|7
1210234|NCT00862134|3971637|P1|Overall Study|Sponsor terminated study|5
1210235|NCT00862134|3971636|P2|Overall Study|Withdrawal by Subject|2
1210236|NCT00862134|3971637|P1|Overall Study|Withdrawal by Subject|1
1210237|NCT00862134|3971636|P2|Overall Study|Physician Decision|1
1210238|NCT00862134|3971637|P1|Overall Study|Physician Decision|0
1210239|NCT00862134|3971636|P2|Overall Study|Death|0
1210240|NCT00862134|3971637|P1|Overall Study|Death|1
1210241|NCT00862121|3971649|P2|Overall Study|Incorrect randomisation|1
1210242|NCT00862121|3971650|P1|Overall Study|Incorrect randomisation|0
1210243|NCT00862121|3971649|P2|Overall Study|Exclusion criterion violation|1
1210244|NCT00862121|3971650|P1|Overall Study|Exclusion criterion violation|0
1210245|NCT00862121|3971649|P2|Overall Study|Protocol Violation|1
1210246|NCT00862121|3971650|P1|Overall Study|Protocol Violation|0
1210247|NCT00862121|3971649|P2|Overall Study|Lack of Efficacy|3
1210248|NCT00862121|3971650|P1|Overall Study|Lack of Efficacy|0
1210249|NCT00862121|3971649|P2|Overall Study|Adverse Event|2
1210250|NCT00862121|3971650|P1|Overall Study|Adverse Event|1
1210251|NCT00862082|3971668|P2|Overall Study|Withdrawal by Subject|1
1210252|NCT00862082|3971669|P1|Overall Study|Withdrawal by Subject|0
1210253|NCT00862082|3971668|P2|Overall Study|Sponsor decision to terminate the study|0
1210254|NCT00862082|3971669|P1|Overall Study|Sponsor decision to terminate the study|5
1210255|NCT00861757|3971724|P4|Overall Study|Withdrawal by Subject|2
1210256|NCT00861757|3971725|P3|Overall Study|Withdrawal by Subject|5
1210257|NCT00861757|3971726|P2|Overall Study|Withdrawal by Subject|5
1210258|NCT00861757|3971727|P1|Overall Study|Withdrawal by Subject|1
1210259|NCT00861757|3971724|P4|Overall Study|Protocol Violation|1
1210260|NCT00861757|3971725|P3|Overall Study|Protocol Violation|4
1210261|NCT00861757|3971726|P2|Overall Study|Protocol Violation|2
1210262|NCT00861757|3971727|P1|Overall Study|Protocol Violation|2
1210263|NCT00861757|3971724|P4|Overall Study|Physician Decision|1
1210264|NCT00861757|3971725|P3|Overall Study|Physician Decision|0
1210265|NCT00861757|3971726|P2|Overall Study|Physician Decision|0
1210266|NCT00861757|3971727|P1|Overall Study|Physician Decision|0
1210267|NCT00861757|3971724|P4|Overall Study|Lost to Follow-up|1
1210268|NCT00861757|3971725|P3|Overall Study|Lost to Follow-up|1
1210269|NCT00861757|3971726|P2|Overall Study|Lost to Follow-up|0
1210270|NCT00861757|3971727|P1|Overall Study|Lost to Follow-up|1
1210271|NCT00861757|3971724|P4|Overall Study|Lack of Efficacy|1
1210272|NCT00861757|3971725|P3|Overall Study|Lack of Efficacy|0
1210273|NCT00861757|3971726|P2|Overall Study|Lack of Efficacy|1
1210274|NCT00861757|3971727|P1|Overall Study|Lack of Efficacy|3
1210275|NCT00861757|3971724|P4|Overall Study|Entry Criteria Not Met|1
1210276|NCT00861757|3971725|P3|Overall Study|Entry Criteria Not Met|1
1210277|NCT00861757|3971726|P2|Overall Study|Entry Criteria Not Met|2
1210278|NCT00861757|3971727|P1|Overall Study|Entry Criteria Not Met|1
1210279|NCT00861757|3971724|P4|Overall Study|Adverse Event|2
1210280|NCT00861757|3971725|P3|Overall Study|Adverse Event|7
1210281|NCT00861757|3971726|P2|Overall Study|Adverse Event|5
1210282|NCT00861757|3971727|P1|Overall Study|Adverse Event|1
1210283|NCT00861744|3971785|P4|Overall Study|Blood draws|1
1210284|NCT00861744|3971786|P3|Overall Study|Blood draws|0
1210285|NCT00861744|3971787|P2|Overall Study|Blood draws|0
1210286|NCT00861744|3971788|P1|Overall Study|Blood draws|0
1210287|NCT00861744|3971785|P4|Overall Study|Migration from study area|0
1210288|NCT00861744|3971786|P3|Overall Study|Migration from study area|1
1210289|NCT00861744|3971787|P2|Overall Study|Migration from study area|3
1210290|NCT00861744|3971788|P1|Overall Study|Migration from study area|0
1210291|NCT00861744|3971785|P4|Overall Study|Protocol Violation|0
1210292|NCT00861744|3971786|P3|Overall Study|Protocol Violation|0
1210293|NCT00861744|3971787|P2|Overall Study|Protocol Violation|1
1210294|NCT00861744|3971788|P1|Overall Study|Protocol Violation|0
1210295|NCT00861744|3971785|P4|Overall Study|Withdrawal by Subject|19
1210296|NCT00861744|3971786|P3|Overall Study|Withdrawal by Subject|6
1210297|NCT00861744|3971787|P2|Overall Study|Withdrawal by Subject|6
1210298|NCT00861744|3971788|P1|Overall Study|Withdrawal by Subject|10
1210299|NCT00861744|3971785|P4|Overall Study|Lost to Follow-up|12
1210300|NCT00861744|3971786|P3|Overall Study|Lost to Follow-up|17
1210301|NCT00861744|3971787|P2|Overall Study|Lost to Follow-up|19
1210302|NCT00861744|3971788|P1|Overall Study|Lost to Follow-up|7
1210303|NCT00861744|3971785|P4|Overall Study|Adverse Event|1
1210304|NCT00861744|3971786|P3|Overall Study|Adverse Event|0
1210305|NCT00861744|3971787|P2|Overall Study|Adverse Event|0
1210306|NCT00861744|3971788|P1|Overall Study|Adverse Event|0
1210307|NCT00861705|3971970|P4|Overall Study|Never Began Treatment|1
1210308|NCT00861705|3971971|P3|Overall Study|Never Began Treatment|0
1210309|NCT00861705|3971972|P2|Overall Study|Never Began Treatment|3
1210310|NCT00861705|3971973|P1|Overall Study|Never Began Treatment|7
1210311|NCT00861692|3971989|P1|Overall Study|Death|6
1210312|NCT00861614|3972001|P2|Overall Study|Other|22
1210313|NCT00861614|3972002|P1|Overall Study|Other|17
1210314|NCT00861614|3972001|P2|Overall Study|Withdrawal by Subject|35
1210315|NCT00861614|3972002|P1|Overall Study|Withdrawal by Subject|34
1210316|NCT00861614|3972001|P2|Overall Study|Adverse Event|23
1210317|NCT00861614|3972002|P1|Overall Study|Adverse Event|27
1210318|NCT00861614|3972001|P2|Overall Study|Death|19
1210319|NCT00861614|3972002|P1|Overall Study|Death|32
1210320|NCT00861614|3972001|P2|Overall Study|Study Drug Toxicity|6
1210321|NCT00861614|3972002|P1|Overall Study|Study Drug Toxicity|79
1210322|NCT00861614|3972001|P2|Overall Study|Disease Progression|263
1210323|NCT00861614|3972002|P1|Overall Study|Disease Progression|182
1210324|NCT00861471|3972087|P1|Overall Study|Physician Decision|2
1210325|NCT00861471|3972087|P1|Overall Study|treatment for lumbar laminectomy|1
1210326|NCT00861471|3972087|P1|Overall Study|Lack of Efficacy|3
1210327|NCT00861471|3972087|P1|Overall Study|Adverse Event|2
1210328|NCT00861471|3972087|P1|Overall Study|Withdrawal by Subject|1
1210329|NCT00861341|3972095|P1|Overall Study|Withdrawal by Subject|2
1210330|NCT00861198|3972104|P1|Overall Study|SpyGlass Failed|5
1210331|NCT00860951|3972121|P1|Overall Study|Lost to Follow-up|5
1210332|NCT00860951|3972121|P1|Overall Study|Withdrawal by Subject|2
1210333|NCT00860743|3972163|P2|Overall Study|Withdrawal by Subject|0
1210334|NCT00860743|3972164|P1|Overall Study|Withdrawal by Subject|3
1210335|NCT00860470|3972177|P2|Overall Study|Lost to Follow-up|39
1210336|NCT00860470|3972178|P1|Overall Study|Lost to Follow-up|34
1210337|NCT00860470|3972177|P2|Overall Study|Moved away|10
1210338|NCT00860470|3972178|P1|Overall Study|Moved away|8
1210339|NCT00860470|3972177|P2|Overall Study|Death|10
1210340|NCT00860470|3972178|P1|Overall Study|Death|6
1210341|NCT00860405|3972208|P2|Overall Study|Main reason: Follow-up data not complete|4
1210342|NCT00860405|3972209|P1|Overall Study|Main reason: Follow-up data not complete|5
1210343|NCT00860262|3972249|P3|Overall Study|Not Specified|1
1210344|NCT00860262|3972250|P2|Overall Study|Not Specified|3
1210345|NCT00860262|3972251|P1|Overall Study|Not Specified|5
1210346|NCT00860262|3972249|P3|Overall Study|Lack of Efficacy|3
1210347|NCT00860262|3972250|P2|Overall Study|Lack of Efficacy|4
1210348|NCT00860262|3972251|P1|Overall Study|Lack of Efficacy|0
1210349|NCT00860262|3972249|P3|Overall Study|Withdrawal by Subject|6
1210350|NCT00860262|3972250|P2|Overall Study|Withdrawal by Subject|8
1210351|NCT00860262|3972251|P1|Overall Study|Withdrawal by Subject|4
1210352|NCT00860262|3972249|P3|Overall Study|Lost to Follow-up|1
1210353|NCT00860262|3972250|P2|Overall Study|Lost to Follow-up|0
1210354|NCT00860262|3972251|P1|Overall Study|Lost to Follow-up|2
1210355|NCT00860262|3972249|P3|Overall Study|Protocol Violation|0
1210356|NCT00860262|3972250|P2|Overall Study|Protocol Violation|1
1210357|NCT00860262|3972251|P1|Overall Study|Protocol Violation|0
1210358|NCT00860262|3972249|P3|Overall Study|Adverse Event|7
1210359|NCT00860262|3972250|P2|Overall Study|Adverse Event|6
1210360|NCT00860262|3972251|P1|Overall Study|Adverse Event|9
1210361|NCT00860249|3972364|P3|Overall Study|trial was terminated prior to completion|21
1210362|NCT00860249|3972365|P2|Overall Study|trial was terminated prior to completion|18
1210363|NCT00860249|3972366|P1|Overall Study|trial was terminated prior to completion|21
1210364|NCT00860158|3972384|P1|Overall Study|Study Terminated|1
1210365|NCT00860067|3972396|P3|Overall Study|Pregnancy|0
1210366|NCT00860067|3972397|P2|Overall Study|Pregnancy|0
1210367|NCT00860067|3972398|P1|Overall Study|Pregnancy|1
1210368|NCT00860067|3972396|P3|Overall Study|Withdrawal by Subject|0
1210369|NCT00860067|3972397|P2|Overall Study|Withdrawal by Subject|0
1210370|NCT00860067|3972398|P1|Overall Study|Withdrawal by Subject|4
1210371|NCT00860067|3972396|P3|Overall Study|Lost to Follow-up|9
1210372|NCT00860067|3972397|P2|Overall Study|Lost to Follow-up|9
1210373|NCT00860067|3972398|P1|Overall Study|Lost to Follow-up|46
1210374|NCT00860028|3972458|P2|Placebo Controlled Pretreatment Period|No longer interested in treatment|1
1210375|NCT00860028|3972459|P1|Placebo Controlled Pretreatment Period|No longer interested in treatment|2
1210376|NCT00859937|3972480|P2|Overall Study|Protocol Violation|0
1210377|NCT00859937|3972481|P1|Overall Study|Protocol Violation|1
1210378|NCT00859898|3972496|P3|Overall Study|non-specified|1
1210379|NCT00859898|3972497|P2|Overall Study|non-specified|1
1210380|NCT00859898|3972498|P1|Overall Study|non-specified|1
1210381|NCT00859898|3972496|P3|Overall Study|No longer meets criteria|0
1210382|NCT00859898|3972497|P2|Overall Study|No longer meets criteria|1
1210383|NCT00859898|3972498|P1|Overall Study|No longer meets criteria|0
1210384|NCT00859898|3972496|P3|Overall Study|poor/non-compliance|0
1210385|NCT00859898|3972497|P2|Overall Study|poor/non-compliance|0
1210386|NCT00859898|3972498|P1|Overall Study|poor/non-compliance|2
1210387|NCT00859898|3972496|P3|Overall Study|Lost to Follow-up|5
1210388|NCT00859898|3972497|P2|Overall Study|Lost to Follow-up|11
1210389|NCT00859898|3972498|P1|Overall Study|Lost to Follow-up|10
1210390|NCT00859898|3972496|P3|Overall Study|Death|1
1210391|NCT00859898|3972497|P2|Overall Study|Death|0
1210392|NCT00859898|3972498|P1|Overall Study|Death|0
1210393|NCT00859898|3972496|P3|Overall Study|Withdrawal by Subject|11
1210394|NCT00859898|3972497|P2|Overall Study|Withdrawal by Subject|8
1210395|NCT00859898|3972498|P1|Overall Study|Withdrawal by Subject|11
1210396|NCT00859898|3972496|P3|Overall Study|Adverse Event|8
1210397|NCT00859898|3972497|P2|Overall Study|Adverse Event|9
1210398|NCT00859898|3972498|P1|Overall Study|Adverse Event|4
1210399|NCT00859898|3972496|P3|Overall Study|Lack of Efficacy|1
1210400|NCT00859898|3972497|P2|Overall Study|Lack of Efficacy|1
1210401|NCT00859898|3972498|P1|Overall Study|Lack of Efficacy|0
1210402|NCT00859638|3972557|P2|Overall Study|Ill health|1
1210403|NCT00859638|3972558|P1|Overall Study|Ill health|1
1210404|NCT00859638|3972557|P2|Overall Study|Withdrawal by Subject|2
1210405|NCT00859638|3972558|P1|Overall Study|Withdrawal by Subject|3
1210406|NCT00859638|3972557|P2|Overall Study|Lost to Follow-up|1
1210407|NCT00859638|3972558|P1|Overall Study|Lost to Follow-up|6
1210408|NCT00859586|3972564|P1|Overall Study|Donors|4
1210409|NCT00859573|3972570|P2|Overall Study|Physician Decision|1
1210410|NCT00859573|3972571|P1|Overall Study|Physician Decision|1
1210411|NCT00859573|3972570|P2|Overall Study|Withdrawal by Subject|1
1210412|NCT00859573|3972571|P1|Overall Study|Withdrawal by Subject|4
1210413|NCT00859547|3972577|P1|Overall Study|Parent withdrew consent|1
1210414|NCT00859547|3972577|P1|Overall Study|Lost to Follow-up|1
1210415|NCT00859521|3972590|P2|Washout|Withdrawal by Subject|1
1210416|NCT00859521|3972591|P1|Washout|Withdrawal by Subject|0
1210417|NCT00859469|3972608|P1|Overall Study|Death|16
1210418|NCT00859469|3972608|P1|Overall Study|Withdrawal by Subject|1
1210419|NCT00859469|3972608|P1|Overall Study|Lack of Efficacy|9
1210420|NCT00859469|3972608|P1|Overall Study|Adverse Event|2
1210421|NCT00859430|3972616|P2|First Intervention|Withdrawal by Subject|1
1210422|NCT00859430|3972617|P1|First Intervention|Withdrawal by Subject|0
1210423|NCT00859313|3972633|P1|Overall Study|staff error|1
1210424|NCT00859313|3972633|P1|Overall Study|Adverse Event|1
1210425|NCT00859313|3972633|P1|Overall Study|Lack of Efficacy|2
1210426|NCT00859222|3972640|P5|Overall Study|DLT|0
1210427|NCT00859222|3972641|P4|Overall Study|DLT|0
1210428|NCT00859222|3972642|P3|Overall Study|DLT|0
1210429|NCT00859222|3972643|P2|Overall Study|DLT|0
1210430|NCT00859222|3972644|P1|Overall Study|DLT|1
1210431|NCT00859222|3972640|P5|Overall Study|Adverse Event|15
1210432|NCT00859222|3972641|P4|Overall Study|Adverse Event|24
1210433|NCT00859222|3972642|P3|Overall Study|Adverse Event|6
1210434|NCT00859222|3972643|P2|Overall Study|Adverse Event|3
1210435|NCT00859222|3972644|P1|Overall Study|Adverse Event|2
1210436|NCT00859014|3972766|P1|Overall Study|Lost to Follow-up|1
1210437|NCT00859014|3972766|P1|Overall Study|Death|4
1210438|NCT00858845|3972781|P2|Overall Study|Patient underwent heart transplant.|1
1210439|NCT00858845|3972782|P1|Overall Study|Patient underwent heart transplant.|0
1210440|NCT00858832|3972794|P2|Overall Study|Adverse Event|1
1210441|NCT00858832|3972795|P1|Overall Study|Adverse Event|0
1210442|NCT00858832|3972794|P2|Overall Study|became ineligible: delivered vaginally|0
1210443|NCT00858832|3972795|P1|Overall Study|became ineligible: delivered vaginally|1
1210444|NCT00858780|3972801|P5|OL Re-Treatment (Failure to Week 48)|Other|1
1210445|NCT00858780|3972802|P4|OL Re-Treatment (Failure to Week 48)|Other|0
1210446|NCT00858780|3972803|P3|OL Re-Treatment (Failure to Week 48)|Other|0
1210447|NCT00858780|3972804|P2|OL Re-Treatment (Failure to Week 48)|Other|0
1210448|NCT00858780|3972805|P1|OL Re-Treatment (Failure to Week 48)|Other|0
1210449|NCT00858780|3972801|P5|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1
1210450|NCT00858780|3972802|P4|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
1210451|NCT00858780|3972803|P3|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
1210452|NCT00858780|3972804|P2|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
1210453|NCT00858780|3972805|P1|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
1210454|NCT00858780|3972801|P5|Double-Blind (Week 0 to Failure/Week 48)|Other|0
1210455|NCT00858780|3972802|P4|Double-Blind (Week 0 to Failure/Week 48)|Other|0
1210456|NCT00858780|3972803|P3|Double-Blind (Week 0 to Failure/Week 48)|Other|0
1210457|NCT00858780|3972804|P2|Double-Blind (Week 0 to Failure/Week 48)|Other|1
1210458|NCT00858780|3972805|P1|Double-Blind (Week 0 to Failure/Week 48)|Other|0
1210459|NCT00858780|3972801|P5|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
1210460|NCT00858780|3972802|P4|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
1210461|NCT00858780|3972803|P3|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
1210462|NCT00858780|3972804|P2|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
1210463|NCT00858780|3972805|P1|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
1210464|NCT00858780|3972801|P5|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
1210465|NCT00858780|3972802|P4|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
1210466|NCT00858780|3972803|P3|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1
1210467|NCT00858780|3972804|P2|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
1210468|NCT00858780|3972805|P1|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
1210469|NCT00858780|3972801|P5|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
1210470|NCT00858780|3972802|P4|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
1210471|NCT00858780|3972803|P3|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
1210472|NCT00858780|3972804|P2|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
1210473|NCT00858780|3972805|P1|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18
1210474|NCT00858702|3972880|P2|Overall Study|Withdrawal by Subject|0
1210475|NCT00858702|3972881|P1|Overall Study|Withdrawal by Subject|1
1210476|NCT00858702|3972880|P2|Overall Study|Other|1
1210477|NCT00858702|3972881|P1|Overall Study|Other|2
1210478|NCT00858702|3972880|P2|Overall Study|Protocol Violation|1
1210479|NCT00858702|3972881|P1|Overall Study|Protocol Violation|1
1210480|NCT00858702|3972880|P2|Overall Study|Lack of Efficacy|0
1210481|NCT00858702|3972881|P1|Overall Study|Lack of Efficacy|1
1210482|NCT00858637|3972896|P6|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1
1210483|NCT00858637|3972897|P5|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
1210484|NCT00858637|3972898|P4|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
1210485|NCT00858637|3972899|P3|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
1210486|NCT00858637|3972900|P2|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
1210487|NCT00858637|3972901|P1|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
1210488|NCT00858637|3972896|P6|Placebo-controlled Withdrawal Phase|Death|0
1210489|NCT00858637|3972897|P5|Placebo-controlled Withdrawal Phase|Death|1
1210490|NCT00858637|3972898|P4|Placebo-controlled Withdrawal Phase|Death|0
1210491|NCT00858637|3972899|P3|Placebo-controlled Withdrawal Phase|Death|1
1210492|NCT00858637|3972900|P2|Placebo-controlled Withdrawal Phase|Death|0
1210493|NCT00858637|3972901|P1|Placebo-controlled Withdrawal Phase|Death|0
1210494|NCT00858637|3972896|P6|Active Comparison Phase|Other Reasons|0
1210495|NCT00858637|3972897|P5|Active Comparison Phase|Other Reasons|0
1210496|NCT00858637|3972898|P4|Active Comparison Phase|Other Reasons|1
1210497|NCT00858637|3972899|P3|Active Comparison Phase|Other Reasons|0
1210498|NCT00858637|3972900|P2|Active Comparison Phase|Other Reasons|0
1210499|NCT00858637|3972901|P1|Active Comparison Phase|Other Reasons|1
1210500|NCT00858637|3972896|P6|Active Comparison Phase|Withdrawal by Subject|0
1210501|NCT00858637|3972897|P5|Active Comparison Phase|Withdrawal by Subject|0
1210502|NCT00858637|3972898|P4|Active Comparison Phase|Withdrawal by Subject|6
1210503|NCT00858637|3972899|P3|Active Comparison Phase|Withdrawal by Subject|0
1210504|NCT00858637|3972900|P2|Active Comparison Phase|Withdrawal by Subject|0
1210505|NCT00858637|3972901|P1|Active Comparison Phase|Withdrawal by Subject|7
1210506|NCT00858637|3972896|P6|Active Comparison Phase|Physician Decision|0
1210507|NCT00858637|3972897|P5|Active Comparison Phase|Physician Decision|0
1210508|NCT00858637|3972898|P4|Active Comparison Phase|Physician Decision|1
1210509|NCT00858637|3972899|P3|Active Comparison Phase|Physician Decision|0
1210510|NCT00858637|3972900|P2|Active Comparison Phase|Physician Decision|0
1210511|NCT00858637|3972901|P1|Active Comparison Phase|Physician Decision|1
1210512|NCT00858637|3972896|P6|Active Comparison Phase|Death|0
1210513|NCT00858637|3972897|P5|Active Comparison Phase|Death|0
1210514|NCT00858637|3972898|P4|Active Comparison Phase|Death|1
1210515|NCT00858637|3972899|P3|Active Comparison Phase|Death|0
1210516|NCT00858637|3972900|P2|Active Comparison Phase|Death|0
1210517|NCT00858637|3972901|P1|Active Comparison Phase|Death|1
1210518|NCT00858637|3972896|P6|Active Comparison Phase|Adverse Event|0
1210519|NCT00858637|3972897|P5|Active Comparison Phase|Adverse Event|0
1210520|NCT00858637|3972898|P4|Active Comparison Phase|Adverse Event|9
1210521|NCT00858637|3972899|P3|Active Comparison Phase|Adverse Event|0
1210522|NCT00858637|3972900|P2|Active Comparison Phase|Adverse Event|0
1210523|NCT00858637|3972901|P1|Active Comparison Phase|Adverse Event|14
1210524|NCT00858442|3972942|P2|Compression:Start to Finish|Lost to Follow-up|3
1210525|NCT00858442|3972943|P1|Compression:Start to Finish|Lost to Follow-up|1
1210526|NCT00858403|3972953|P1|Overall Study|Disease Progression|1
1210527|NCT00858403|3972953|P1|Overall Study|Death|3
1210528|NCT00858403|3972953|P1|Overall Study|Withdrawal by Subject|1
1210529|NCT00858364|3972974|P2|Overall Study|Still on-study|247
1210530|NCT00858364|3972975|P1|Overall Study|Still on-study|114
1210531|NCT00858364|3972974|P2|Overall Study|Missing|1
1210532|NCT00858364|3972975|P1|Overall Study|Missing|1
1210533|NCT00858364|3972974|P2|Overall Study|Other|17
1210534|NCT00858364|3972975|P1|Overall Study|Other|9
1210535|NCT00858364|3972974|P2|Overall Study|Protocol Deviation|2
1210536|NCT00858364|3972975|P1|Overall Study|Protocol Deviation|0
1210537|NCT00858364|3972974|P2|Overall Study|Noncompliance|4
1210538|NCT00858364|3972975|P1|Overall Study|Noncompliance|3
1210539|NCT00858364|3972974|P2|Overall Study|Lost to Follow-up|54
1210540|NCT00858364|3972975|P1|Overall Study|Lost to Follow-up|24
1210541|NCT00858364|3972974|P2|Overall Study|Ineligibility Determined|10
1210542|NCT00858364|3972975|P1|Overall Study|Ineligibility Determined|1
1210543|NCT00858364|3972974|P2|Overall Study|Withdrawal by Subject|118
1210544|NCT00858364|3972975|P1|Overall Study|Withdrawal by Subject|44
1210545|NCT00858364|3972974|P2|Overall Study|Adverse Event|2
1210546|NCT00858364|3972975|P1|Overall Study|Adverse Event|5
1210547|NCT00858364|3972974|P2|Overall Study|Administrative Decision|2
1210548|NCT00858364|3972975|P1|Overall Study|Administrative Decision|3
1210549|NCT00858247|3972997|P2|Week 12 Follow-up|Withdrawal by Subject|1
1210550|NCT00858247|3972998|P1|Week 12 Follow-up|Withdrawal by Subject|0
1210551|NCT00858247|3972997|P2|Baseline Assessment|Protocol Violation|1
1210552|NCT00858247|3972998|P1|Baseline Assessment|Protocol Violation|0
1210553|NCT00858247|3972997|P2|Baseline Assessment|Poor IV access|0
1210554|NCT00858247|3972998|P1|Baseline Assessment|Poor IV access|1
1210555|NCT00858247|3972997|P2|Baseline Assessment|Withdrawal by Subject|1
1210556|NCT00858247|3972998|P1|Baseline Assessment|Withdrawal by Subject|1
1210557|NCT00858208|3973014|P1|Overall Study|Other|10
1210558|NCT00858208|3973014|P1|Overall Study|Participant refused|40
1210559|NCT00858208|3973014|P1|Overall Study|Lost to Follow-up|26
1210560|NCT00858208|3973014|P1|Overall Study|Adverse Event|3
1210561|NCT00858143|3973031|P1|Overall Study|Other|23
1210562|NCT00858143|3973031|P1|Overall Study|Death|7
1210563|NCT00858143|3973031|P1|Overall Study|Lack of Efficacy|4
1210564|NCT00858143|3973031|P1|Overall Study|Adverse Event|16
1210565|NCT00857948|3973143|P4|Overall Study|Protocol Violation|0
1210566|NCT00857948|3973144|P3|Overall Study|Protocol Violation|1
1210567|NCT00857948|3973145|P2|Overall Study|Protocol Violation|0
1210568|NCT00857948|3973146|P1|Overall Study|Protocol Violation|1
1210569|NCT00857948|3973143|P4|Overall Study|Withdrawal by Subject|0
1210570|NCT00857948|3973144|P3|Overall Study|Withdrawal by Subject|0
1210571|NCT00857948|3973145|P2|Overall Study|Withdrawal by Subject|0
1210572|NCT00857948|3973146|P1|Overall Study|Withdrawal by Subject|2
1210573|NCT00857896|3973168|P1|Baseline to Week 4|Withdrawal by Subject|1
1210574|NCT00857818|3973324|P2|Overall Study|Investigator decision|0
1210575|NCT00857818|3973325|P1|Overall Study|Investigator decision|1
1210576|NCT00857818|3973324|P2|Overall Study|Sponsor terminated study|4
1210577|NCT00857818|3973325|P1|Overall Study|Sponsor terminated study|6
1210578|NCT00857818|3973324|P2|Overall Study|Withdrawal by Subject|4
1210579|NCT00857818|3973325|P1|Overall Study|Withdrawal by Subject|0
1210580|NCT00857818|3973324|P2|Overall Study|Adverse Event|0
1210581|NCT00857818|3973325|P1|Overall Study|Adverse Event|3
1210582|NCT00857818|3973324|P2|Overall Study|Lack of Efficacy|0
1210583|NCT00857818|3973325|P1|Overall Study|Lack of Efficacy|1
1210584|NCT00857792|3973353|P1|Overall Study|inadequate image quality for analysis|12
1210585|NCT00857766|3973359|P2|Overall Study|Participant Withdrew Consent|4
1210586|NCT00857766|3973360|P1|Overall Study|Participant Withdrew Consent|4
1210587|NCT00857766|3973359|P2|Overall Study|Investigator Discretion|3
1210588|NCT00857766|3973360|P1|Overall Study|Investigator Discretion|2
1210589|NCT00857766|3973359|P2|Overall Study|Lost to Follow-up|0
1210590|NCT00857766|3973360|P1|Overall Study|Lost to Follow-up|1
1210591|NCT00857766|3973359|P2|Overall Study|Protocol Violation|11
1210592|NCT00857766|3973360|P1|Overall Study|Protocol Violation|11
1210593|NCT00857766|3973359|P2|Overall Study|Adverse Event|12
1210594|NCT00857766|3973360|P1|Overall Study|Adverse Event|13
1210595|NCT00857649|3973402|P2|Overall Study|Other Reasons|3
1210596|NCT00857649|3973403|P1|Overall Study|Other Reasons|1
1210597|NCT00857649|3973402|P2|Overall Study|Nursing Home Placement|9
1210598|NCT00857649|3973403|P1|Overall Study|Nursing Home Placement|2
1210599|NCT00857649|3973402|P2|Overall Study|Withdrawal of Consent|7
1210600|NCT00857649|3973403|P1|Overall Study|Withdrawal of Consent|10
1210601|NCT00857649|3973402|P2|Overall Study|Protocol Violation|2
1210602|NCT00857649|3973403|P1|Overall Study|Protocol Violation|2
1210603|NCT00857649|3973402|P2|Overall Study|Non-compliance|1
1210604|NCT00857649|3973403|P1|Overall Study|Non-compliance|1
1210605|NCT00857649|3973402|P2|Overall Study|Adverse Event|10
1210606|NCT00857649|3973403|P1|Overall Study|Adverse Event|15
1210607|NCT00857623|3973419|P2|Overall Study|Positive for HEP C|1
1210608|NCT00857623|3973420|P1|Overall Study|Positive for HEP C|0
1210609|NCT00857623|3973419|P2|Overall Study|Intake of prohibited medication|1
1210610|NCT00857623|3973420|P1|Overall Study|Intake of prohibited medication|0
1210611|NCT00857623|3973419|P2|Overall Study|Severe non-compliance to protocol|1
1210612|NCT00857623|3973420|P1|Overall Study|Severe non-compliance to protocol|1
1210613|NCT00857623|3973419|P2|Overall Study|Lack of Efficacy|1
1210614|NCT00857623|3973420|P1|Overall Study|Lack of Efficacy|1
1210615|NCT00857623|3973419|P2|Overall Study|Withdrawal by Subject|1
1210616|NCT00857623|3973420|P1|Overall Study|Withdrawal by Subject|2
1210617|NCT00857623|3973419|P2|Overall Study|Study-specific discontinuation criteria|3
1210618|NCT00857623|3973420|P1|Overall Study|Study-specific discontinuation criteria|5
1210619|NCT00857623|3973419|P2|Overall Study|Adverse Event|2
1210620|NCT00857623|3973420|P1|Overall Study|Adverse Event|5
1210621|NCT00857584|3973444|P2|Overall Study|Physician Decision|1
1210622|NCT00857584|3973445|P1|Overall Study|Physician Decision|1
1210623|NCT00857584|3973444|P2|Overall Study|Adverse Event|2
1210624|NCT00857584|3973445|P1|Overall Study|Adverse Event|2
1210625|NCT00857584|3973444|P2|Overall Study|Lack of Efficacy|2
1210626|NCT00857584|3973445|P1|Overall Study|Lack of Efficacy|1
1210627|NCT00857454|3973537|P1|Overall Study|MTE09 enrollment criteria not met|6
1210628|NCT00857454|3973537|P1|Overall Study|Total Testosterone <300 ng/dL|8
1210629|NCT00857454|3973537|P1|Overall Study|Total Testosterone >1050 ng/dL|1
1210630|NCT00857454|3973537|P1|Overall Study|Adverse Event|2
1210631|NCT00857454|3973537|P1|Overall Study|Lost to Follow-up|1
1210632|NCT00857454|3973537|P1|Overall Study|Withdrawal by Subject|2
1210633|NCT00857415|3973550|P2|Overall Study|Deceased with no autopsy|0
1210634|NCT00857415|3973551|P1|Overall Study|Deceased with no autopsy|2
1210635|NCT00857415|3973550|P2|Overall Study|Subject still living at end of study|0
1210636|NCT00857415|3973551|P1|Overall Study|Subject still living at end of study|110
1210637|NCT00857415|3973550|P2|Overall Study|Invalid image or not imaged|0
1210638|NCT00857415|3973551|P1|Overall Study|Invalid image or not imaged|3
1210639|NCT00857415|3973550|P2|Overall Study|Image acquisition failure|0
1210640|NCT00857415|3973551|P1|Overall Study|Image acquisition failure|2
1210641|NCT00857311|3973562|P4|Overall Study|Lost to Follow-up|0
1210642|NCT00857311|3973563|P3|Overall Study|Lost to Follow-up|0
1210643|NCT00857311|3973564|P2|Overall Study|Lost to Follow-up|0
1210644|NCT00857311|3973565|P1|Overall Study|Lost to Follow-up|1
1210645|NCT00857285|3973577|P2|Overall Study|Randomization criteria not met|1
1210646|NCT00857285|3973578|P1|Overall Study|Randomization criteria not met|1
1210647|NCT00857285|3973577|P2|Overall Study|Withdrawal by Subject|0
1210648|NCT00857285|3973578|P1|Overall Study|Withdrawal by Subject|4
1210649|NCT00857285|3973577|P2|Overall Study|Protocol Violation|1
1210650|NCT00857285|3973578|P1|Overall Study|Protocol Violation|3
1210651|NCT00857285|3973577|P2|Overall Study|Lack of Efficacy|2
1210652|NCT00857285|3973578|P1|Overall Study|Lack of Efficacy|0
1210653|NCT00857285|3973577|P2|Overall Study|Adverse Event|2
1210654|NCT00857285|3973578|P1|Overall Study|Adverse Event|4
1210655|NCT00857259|3973594|P3|Overall Study|Protocol Violation|1
1210656|NCT00857259|3973595|P2|Overall Study|Protocol Violation|0
1210657|NCT00857259|3973596|P1|Overall Study|Protocol Violation|1
1210658|NCT00857246|3973606|P1|ChemoRT|Adverse Event|2
1210659|NCT00857246|3973606|P1|ChemoRT|Withdrawal by Subject|1
1210660|NCT00857246|3973606|P1|Surgery (Curative)|disease progression|6
1210661|NCT00857246|3973606|P1|Induction Regimen|Withdrawal by Subject|1
1210662|NCT00857246|3973606|P1|Induction Regimen|disease-related complications|1
1210663|NCT00857246|3973606|P1|Induction Regimen|Adverse Event|1
1210664|NCT00857233|3973616|P1|Overall Study|Other Reasons|2
1210665|NCT00857233|3973616|P1|Overall Study|Nursing Home Placement|14
1210666|NCT00857233|3973616|P1|Overall Study|Lost to Follow-up|4
1210667|NCT00857233|3973616|P1|Overall Study|Withdrawal of Consent|9
1210668|NCT00857233|3973616|P1|Overall Study|Non-compliance|1
1210669|NCT00857233|3973616|P1|Overall Study|Lack of Efficacy|1
1210670|NCT00857233|3973616|P1|Overall Study|Adverse Event|24
1210671|NCT00857220|3973625|P1|Overall Study|Miscellaneous|8
1210672|NCT00857220|3973625|P1|Overall Study|Site Closed|5
1210673|NCT00857220|3973625|P1|Overall Study|Clinical Hold|6
1210674|NCT00857220|3973625|P1|Overall Study|Withdrawal by Subject|67
1210675|NCT00857220|3973625|P1|Overall Study|Protocol Violation|16
1210676|NCT00857220|3973625|P1|Overall Study|Physician Decision|4
1210677|NCT00857220|3973625|P1|Overall Study|Lost to Follow-up|30
1210678|NCT00857220|3973625|P1|Overall Study|Lack of Efficacy|11
1210679|NCT00857220|3973625|P1|Overall Study|Death|1
1210680|NCT00857220|3973625|P1|Overall Study|Adverse Event|35
1210681|NCT00856986|3973647|P5|Extension Period, Weeks 26-52|Unclassified|0
1210682|NCT00856986|3973648|P4|Extension Period, Weeks 26-52|Unclassified|0
1210683|NCT00856986|3973649|P3|Extension Period, Weeks 26-52|Unclassified|11
1210684|NCT00856986|3973650|P2|Extension Period, Weeks 26-52|Unclassified|2
1210685|NCT00856986|3973651|P1|Extension Period, Weeks 26-52|Unclassified|4
1210686|NCT00856986|3973647|P5|Extension Period, Weeks 26-52|Lack of Efficacy|0
1210687|NCT00856986|3973648|P4|Extension Period, Weeks 26-52|Lack of Efficacy|0
1210688|NCT00856986|3973649|P3|Extension Period, Weeks 26-52|Lack of Efficacy|2
1210689|NCT00856986|3973650|P2|Extension Period, Weeks 26-52|Lack of Efficacy|2
1210690|NCT00856986|3973651|P1|Extension Period, Weeks 26-52|Lack of Efficacy|4
1210691|NCT00856986|3973647|P5|Extension Period, Weeks 26-52|Lost to Follow-up|0
1210692|NCT00856986|3973648|P4|Extension Period, Weeks 26-52|Lost to Follow-up|0
1210693|NCT00856986|3973649|P3|Extension Period, Weeks 26-52|Lost to Follow-up|2
1210694|NCT00856986|3973650|P2|Extension Period, Weeks 26-52|Lost to Follow-up|5
1210695|NCT00856986|3973651|P1|Extension Period, Weeks 26-52|Lost to Follow-up|0
1210696|NCT00856986|3973647|P5|Extension Period, Weeks 26-52|Withdrawal Criteria|0
1210697|NCT00856986|3973648|P4|Extension Period, Weeks 26-52|Withdrawal Criteria|0
1210698|NCT00856986|3973649|P3|Extension Period, Weeks 26-52|Withdrawal Criteria|8
1210699|NCT00856986|3973650|P2|Extension Period, Weeks 26-52|Withdrawal Criteria|0
1210700|NCT00856986|3973651|P1|Extension Period, Weeks 26-52|Withdrawal Criteria|2
1210701|NCT00856986|3973647|P5|Extension Period, Weeks 26-52|Protocol Violation|0
1210702|NCT00856986|3973648|P4|Extension Period, Weeks 26-52|Protocol Violation|0
1210703|NCT00856986|3973649|P3|Extension Period, Weeks 26-52|Protocol Violation|5
1210704|NCT00856986|3973650|P2|Extension Period, Weeks 26-52|Protocol Violation|2
1210705|NCT00856986|3973651|P1|Extension Period, Weeks 26-52|Protocol Violation|6
1210706|NCT00856986|3973647|P5|Extension Period, Weeks 26-52|Adverse Event|0
1210707|NCT00856986|3973648|P4|Extension Period, Weeks 26-52|Adverse Event|0
1210708|NCT00856986|3973649|P3|Extension Period, Weeks 26-52|Adverse Event|10
1210709|NCT00856986|3973650|P2|Extension Period, Weeks 26-52|Adverse Event|3
1210710|NCT00856986|3973651|P1|Extension Period, Weeks 26-52|Adverse Event|3
1210711|NCT00856986|3973647|P5|Main Period, Weeks 0-26|Unclassified|0
1210712|NCT00856986|3973648|P4|Main Period, Weeks 0-26|Unclassified|0
1210713|NCT00856986|3973649|P3|Main Period, Weeks 0-26|Unclassified|7
1210714|NCT00856986|3973650|P2|Main Period, Weeks 0-26|Unclassified|6
1210715|NCT00856986|3973651|P1|Main Period, Weeks 0-26|Unclassified|7
1210716|NCT00856986|3973647|P5|Main Period, Weeks 0-26|Lack of Efficacy|0
1210717|NCT00856986|3973648|P4|Main Period, Weeks 0-26|Lack of Efficacy|0
1210718|NCT00856986|3973649|P3|Main Period, Weeks 0-26|Lack of Efficacy|0
1210719|NCT00856986|3973650|P2|Main Period, Weeks 0-26|Lack of Efficacy|2
1210720|NCT00856986|3973651|P1|Main Period, Weeks 0-26|Lack of Efficacy|5
1210721|NCT00856986|3973647|P5|Main Period, Weeks 0-26|Lost to Follow-up|0
1210722|NCT00856986|3973648|P4|Main Period, Weeks 0-26|Lost to Follow-up|0
1210723|NCT00856986|3973649|P3|Main Period, Weeks 0-26|Lost to Follow-up|2
1210724|NCT00856986|3973650|P2|Main Period, Weeks 0-26|Lost to Follow-up|1
1210725|NCT00856986|3973651|P1|Main Period, Weeks 0-26|Lost to Follow-up|1
1210726|NCT00856986|3973647|P5|Main Period, Weeks 0-26|Withdrawal Criteria|0
1210727|NCT00856986|3973648|P4|Main Period, Weeks 0-26|Withdrawal Criteria|0
1210728|NCT00856986|3973649|P3|Main Period, Weeks 0-26|Withdrawal Criteria|3
1210729|NCT00856986|3973650|P2|Main Period, Weeks 0-26|Withdrawal Criteria|0
1210730|NCT00856986|3973651|P1|Main Period, Weeks 0-26|Withdrawal Criteria|11
1210731|NCT00856986|3973647|P5|Main Period, Weeks 0-26|Protocol Violation|0
1210732|NCT00856986|3973648|P4|Main Period, Weeks 0-26|Protocol Violation|0
1210733|NCT00856986|3973649|P3|Main Period, Weeks 0-26|Protocol Violation|7
1210734|NCT00856986|3973650|P2|Main Period, Weeks 0-26|Protocol Violation|5
1210735|NCT00856986|3973651|P1|Main Period, Weeks 0-26|Protocol Violation|4
1210736|NCT00856986|3973647|P5|Main Period, Weeks 0-26|Adverse Event|0
1210737|NCT00856986|3973648|P4|Main Period, Weeks 0-26|Adverse Event|0
1210738|NCT00856986|3973649|P3|Main Period, Weeks 0-26|Adverse Event|9
1210739|NCT00856986|3973650|P2|Main Period, Weeks 0-26|Adverse Event|4
1210740|NCT00856986|3973651|P1|Main Period, Weeks 0-26|Adverse Event|6
1210741|NCT00856986|3973647|P5|Run-in Period, Weeks -12-0|Unclassified|0
1210742|NCT00856986|3973648|P4|Run-in Period, Weeks -12-0|Unclassified|24
1210743|NCT00856986|3973649|P3|Run-in Period, Weeks -12-0|Unclassified|0
1210744|NCT00856986|3973650|P2|Run-in Period, Weeks -12-0|Unclassified|0
1210745|NCT00856986|3973651|P1|Run-in Period, Weeks -12-0|Unclassified|0
1210746|NCT00856986|3973647|P5|Run-in Period, Weeks -12-0|Lack of Efficacy|0
1210747|NCT00856986|3973648|P4|Run-in Period, Weeks -12-0|Lack of Efficacy|6
1210748|NCT00856986|3973649|P3|Run-in Period, Weeks -12-0|Lack of Efficacy|0
1210749|NCT00856986|3973650|P2|Run-in Period, Weeks -12-0|Lack of Efficacy|0
1210750|NCT00856986|3973651|P1|Run-in Period, Weeks -12-0|Lack of Efficacy|0
1210751|NCT00856986|3973647|P5|Run-in Period, Weeks -12-0|Lost to Follow-up|0
1210752|NCT00856986|3973648|P4|Run-in Period, Weeks -12-0|Lost to Follow-up|11
1210753|NCT00856986|3973649|P3|Run-in Period, Weeks -12-0|Lost to Follow-up|0
1210754|NCT00856986|3973650|P2|Run-in Period, Weeks -12-0|Lost to Follow-up|0
1210755|NCT00856986|3973651|P1|Run-in Period, Weeks -12-0|Lost to Follow-up|0
1210756|NCT00856986|3973647|P5|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
1210757|NCT00856986|3973648|P4|Run-in Period, Weeks -12-0|Withdrawal Criteria|10
1210758|NCT00856986|3973649|P3|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
1210759|NCT00856986|3973650|P2|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
1210760|NCT00856986|3973651|P1|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
1210761|NCT00856986|3973647|P5|Run-in Period, Weeks -12-0|Protocol Violation|0
1210762|NCT00856986|3973648|P4|Run-in Period, Weeks -12-0|Protocol Violation|24
1210763|NCT00856986|3973649|P3|Run-in Period, Weeks -12-0|Protocol Violation|0
1210764|NCT00856986|3973650|P2|Run-in Period, Weeks -12-0|Protocol Violation|0
1210765|NCT00856986|3973651|P1|Run-in Period, Weeks -12-0|Protocol Violation|0
1210766|NCT00856986|3973647|P5|Run-in Period, Weeks -12-0|Adverse Event|0
1210767|NCT00856986|3973648|P4|Run-in Period, Weeks -12-0|Adverse Event|92
1210768|NCT00856986|3973649|P3|Run-in Period, Weeks -12-0|Adverse Event|0
1210769|NCT00856986|3973650|P2|Run-in Period, Weeks -12-0|Adverse Event|0
1210770|NCT00856986|3973651|P1|Run-in Period, Weeks -12-0|Adverse Event|0
1210771|NCT00856973|3973821|P3|Overall Study|Other|13
1210772|NCT00856973|3973822|P2|Overall Study|Other|12
1210773|NCT00856973|3973823|P1|Overall Study|Other|11
1210774|NCT00856973|3973821|P3|Overall Study|Withdrawal by Subject|15
1210775|NCT00856973|3973822|P2|Overall Study|Withdrawal by Subject|16
1210776|NCT00856973|3973823|P1|Overall Study|Withdrawal by Subject|13
1210777|NCT00856973|3973821|P3|Overall Study|Protocol Violation|1
1210778|NCT00856973|3973822|P2|Overall Study|Protocol Violation|2
1210779|NCT00856973|3973823|P1|Overall Study|Protocol Violation|1
1210780|NCT00856973|3973821|P3|Overall Study|Physician Decision|1
1210781|NCT00856973|3973822|P2|Overall Study|Physician Decision|3
1210782|NCT00856973|3973823|P1|Overall Study|Physician Decision|0
1210783|NCT00856973|3973821|P3|Overall Study|Lost to Follow-up|5
1210784|NCT00856973|3973822|P2|Overall Study|Lost to Follow-up|3
1210785|NCT00856973|3973823|P1|Overall Study|Lost to Follow-up|6
1210786|NCT00856973|3973821|P3|Overall Study|Adverse Event|3
1210787|NCT00856973|3973822|P2|Overall Study|Adverse Event|5
1210788|NCT00856973|3973823|P1|Overall Study|Adverse Event|5
1210789|NCT00856908|3973903|P2|Overall Study|Lost to Follow-up|0
1210790|NCT00856908|3973904|P1|Overall Study|Lost to Follow-up|1
1210791|NCT00856843|3973931|P2|Overall Study|Lack of Efficacy|0
1210792|NCT00856843|3973932|P1|Overall Study|Lack of Efficacy|1
1210793|NCT00856843|3973931|P2|Overall Study|Withdrawal by Subject|5
1210794|NCT00856843|3973932|P1|Overall Study|Withdrawal by Subject|1
1210795|NCT00856830|3973968|P4|Irinotecan & Bendamustine|Physician Decision|1
1210796|NCT00856830|3973969|P3|Irinotecan & Bendamustine|Physician Decision|0
1210797|NCT00856830|3973970|P2|Irinotecan & Bendamustine|Physician Decision|0
1210798|NCT00856830|3973971|P1|Irinotecan & Bendamustine|Physician Decision|0
1210799|NCT00856830|3973968|P4|Irinotecan & Bendamustine|Death|2
1210800|NCT00856830|3973969|P3|Irinotecan & Bendamustine|Death|0
1210801|NCT00856830|3973970|P2|Irinotecan & Bendamustine|Death|0
1210802|NCT00856830|3973971|P1|Irinotecan & Bendamustine|Death|0
1210803|NCT00856778|3973982|P1|Overall Study|Lost to Follow-up|5
1210804|NCT00856778|3973982|P1|Overall Study|Study deviation|2
1210805|NCT00856778|3973982|P1|Overall Study|Withdrawal by Subject|10
1210806|NCT00856778|3973982|P1|Overall Study|Adverse Event|7
1210807|NCT00856661|3974025|P2|Overall Study|Physician Judgement|5
1210808|NCT00856661|3974026|P1|Overall Study|Physician Judgement|8
1210809|NCT00856661|3974025|P2|Overall Study|Lost to Follow-up|3
1210810|NCT00856661|3974026|P1|Overall Study|Lost to Follow-up|1
1210811|NCT00856661|3974025|P2|Overall Study|Withdrawal by Subject|2
1210812|NCT00856661|3974026|P1|Overall Study|Withdrawal by Subject|1
1210813|NCT00856661|3974025|P2|Overall Study|Protocol Violation|1
1210814|NCT00856661|3974026|P1|Overall Study|Protocol Violation|2
1210815|NCT00856661|3974025|P2|Overall Study|Death|18
1210816|NCT00856661|3974026|P1|Overall Study|Death|15
1210817|NCT00856635|3974040|P2|Overall Study|Discontinued at Randomization|2
1210818|NCT00856635|3974041|P1|Overall Study|Discontinued at Randomization|2
1210819|NCT00856635|3974040|P2|Overall Study|Other|0
1210820|NCT00856635|3974041|P1|Overall Study|Other|1
1210821|NCT00856635|3974040|P2|Overall Study|Serious Adverse Event|0
1210822|NCT00856635|3974041|P1|Overall Study|Serious Adverse Event|1
1210823|NCT00856635|3974040|P2|Overall Study|Withdrawal by Subject|1
1210824|NCT00856635|3974041|P1|Overall Study|Withdrawal by Subject|3
1210825|NCT00856635|3974040|P2|Overall Study|Pregnancy|0
1210826|NCT00856635|3974041|P1|Overall Study|Pregnancy|1
1210827|NCT00856635|3974040|P2|Overall Study|Lost to Follow-up|5
1210828|NCT00856635|3974041|P1|Overall Study|Lost to Follow-up|2
1210829|NCT00856609|3974051|P2|Overall Study|Adverse Event|0
1210830|NCT00856609|3974052|P1|Overall Study|Adverse Event|1
1210831|NCT00856583|3974064|P2|Overall Study|Non-evaluable: Patient on Polytherapy|604
1210832|NCT00856583|3974065|P1|Overall Study|Non-evaluable: Patient on Polytherapy|694
1210833|NCT00856583|3974064|P2|Overall Study|Other|104
1210834|NCT00856583|3974065|P1|Overall Study|Other|92
1210835|NCT00856583|3974064|P2|Overall Study|Pregnancy|5
1210836|NCT00856583|3974065|P1|Overall Study|Pregnancy|14
1210837|NCT00856583|3974064|P2|Overall Study|Physician Decision|82
1210838|NCT00856583|3974065|P1|Overall Study|Physician Decision|59
1210839|NCT00856583|3974064|P2|Overall Study|Withdrawal by Subject|919
1210840|NCT00856583|3974065|P1|Overall Study|Withdrawal by Subject|1092
1210841|NCT00856583|3974064|P2|Overall Study|Non-compliance|262
1210842|NCT00856583|3974065|P1|Overall Study|Non-compliance|305
1210843|NCT00856583|3974064|P2|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179
1210844|NCT00856583|3974065|P1|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393
1210845|NCT00856583|3974064|P2|Overall Study|Serious Adverse Event (SAE)|65
1210846|NCT00856583|3974065|P1|Overall Study|Serious Adverse Event (SAE)|99
1210847|NCT00856583|3974064|P2|Overall Study|Lack of Efficacy|377
1210848|NCT00856583|3974065|P1|Overall Study|Lack of Efficacy|389
1210849|NCT00856557|3974095|P2|Overall Study|No patients with contextual flags|16
1210850|NCT00856557|3974096|P1|Overall Study|No patients with contextual flags|12
1210851|NCT00856544|3974110|P4|Overall Study|Withdrawal by Subject|1
1210852|NCT00856544|3974111|P3|Overall Study|Withdrawal by Subject|0
1210853|NCT00856544|3974112|P2|Overall Study|Withdrawal by Subject|5
1210854|NCT00856544|3974113|P1|Overall Study|Withdrawal by Subject|8
1210855|NCT00856544|3974110|P4|Overall Study|Lost to Follow-up|0
1210856|NCT00856544|3974111|P3|Overall Study|Lost to Follow-up|2
1210857|NCT00856544|3974112|P2|Overall Study|Lost to Follow-up|2
1210858|NCT00856544|3974113|P1|Overall Study|Lost to Follow-up|1
1210859|NCT00856544|3974110|P4|Overall Study|Other|6
1210860|NCT00856544|3974111|P3|Overall Study|Other|1
1210861|NCT00856544|3974112|P2|Overall Study|Other|16
1210862|NCT00856544|3974113|P1|Overall Study|Other|9
1210863|NCT00856544|3974110|P4|Overall Study|Lack of Efficacy|3
1210864|NCT00856544|3974111|P3|Overall Study|Lack of Efficacy|3
1210865|NCT00856544|3974112|P2|Overall Study|Lack of Efficacy|12
1210866|NCT00856544|3974113|P1|Overall Study|Lack of Efficacy|16
1210867|NCT00856544|3974110|P4|Overall Study|Adverse Event|3
1210868|NCT00856544|3974111|P3|Overall Study|Adverse Event|2
1210869|NCT00856544|3974112|P2|Overall Study|Adverse Event|29
1210870|NCT00856544|3974113|P1|Overall Study|Adverse Event|20
1210871|NCT00856544|3974110|P4|Overall Study|Death|0
1210872|NCT00856544|3974111|P3|Overall Study|Death|0
1210873|NCT00856544|3974112|P2|Overall Study|Death|2
1210874|NCT00856544|3974113|P1|Overall Study|Death|0
1210875|NCT00856544|3974110|P4|Overall Study|Randomized but not treated|0
1210876|NCT00856544|3974111|P3|Overall Study|Randomized but not treated|0
1210877|NCT00856544|3974112|P2|Overall Study|Randomized but not treated|0
1210878|NCT00856544|3974113|P1|Overall Study|Randomized but not treated|3
1210879|NCT00856518|3974292|P2|Overall Study|Lost to Follow-up|2
1210880|NCT00856518|3974293|P1|Overall Study|Lost to Follow-up|4
1210881|NCT00856492|3974306|P3|Overall Study|Ineligible or withdrew consent|2
1210882|NCT00856492|3974307|P2|Overall Study|Ineligible or withdrew consent|1
1210883|NCT00856492|3974308|P1|Overall Study|Ineligible or withdrew consent|1
1210884|NCT00856388|3974330|P1|Overall Study|Not Specified|1
1210885|NCT00856349|3974341|P1|Overall Study|Subject changed Dr, insurance issue, etc|130
1210886|NCT00856349|3974341|P1|Overall Study|Site closure|78
1210887|NCT00856349|3974341|P1|Overall Study|Device explant|33
1210888|NCT00856349|3974341|P1|Overall Study|Subject relocation|104
1210889|NCT00856349|3974341|P1|Overall Study|Physician Decision|13
1210890|NCT00856349|3974341|P1|Overall Study|Protocol Violation|38
1210891|NCT00856349|3974341|P1|Overall Study|Lost to Follow-up|91
1210892|NCT00856349|3974341|P1|Overall Study|Withdrawal by Subject|116
1210893|NCT00856349|3974341|P1|Overall Study|Death|418
1210894|NCT00856323|3974350|P1|Overall Study|Withdrawal by Subject|2
1210895|NCT00856297|3974362|P5|Overall Study|Unable to classify|0
1210896|NCT00856297|3974363|P4|Overall Study|Unable to classify|0
1210897|NCT00856297|3974364|P3|Overall Study|Unable to classify|0
1210898|NCT00856297|3974365|P2|Overall Study|Unable to classify|0
1210899|NCT00856297|3974366|P1|Overall Study|Unable to classify|2
1210900|NCT00856284|3974399|P3|Overall Study|Randomized in error|1
1210901|NCT00856284|3974400|P2|Overall Study|Randomized in error|0
1210902|NCT00856284|3974401|P1|Overall Study|Randomized in error|0
1210903|NCT00856284|3974399|P3|Overall Study|Other|14
1210904|NCT00856284|3974400|P2|Overall Study|Other|17
1210905|NCT00856284|3974401|P1|Overall Study|Other|15
1210906|NCT00856284|3974399|P3|Overall Study|Investigator discretion|10
1210907|NCT00856284|3974400|P2|Overall Study|Investigator discretion|8
1210908|NCT00856284|3974401|P1|Overall Study|Investigator discretion|9
1210909|NCT00856284|3974399|P3|Overall Study|Pregnancy|0
1210910|NCT00856284|3974400|P2|Overall Study|Pregnancy|2
1210911|NCT00856284|3974401|P1|Overall Study|Pregnancy|1
1210912|NCT00856284|3974399|P3|Overall Study|Voluntary withdrawal|62
1210913|NCT00856284|3974400|P2|Overall Study|Voluntary withdrawal|52
1210914|NCT00856284|3974401|P1|Overall Study|Voluntary withdrawal|48
1210915|NCT00856284|3974399|P3|Overall Study|Lost to Follow-up|28
1210916|NCT00856284|3974400|P2|Overall Study|Lost to Follow-up|22
1210917|NCT00856284|3974401|P1|Overall Study|Lost to Follow-up|20
1210918|NCT00856284|3974399|P3|Overall Study|Major protocol deviation|15
1210919|NCT00856284|3974400|P2|Overall Study|Major protocol deviation|16
1210920|NCT00856284|3974401|P1|Overall Study|Major protocol deviation|24
1210921|NCT00856284|3974399|P3|Overall Study|Adverse Event|82
1210922|NCT00856284|3974400|P2|Overall Study|Adverse Event|74
1210923|NCT00856284|3974401|P1|Overall Study|Adverse Event|60
1210924|NCT00856284|3974399|P3|Overall Study|Hyperglycemic rescue|235
1210925|NCT00856284|3974400|P2|Overall Study|Hyperglycemic rescue|201
1210926|NCT00856284|3974401|P1|Overall Study|Hyperglycemic rescue|231
1210927|NCT00856245|3974427|P1|Overall Study|Was not transplanted|5
1210928|NCT00856206|3974450|P2|Overall Study|Other than specified above|10
1210929|NCT00856206|3974451|P1|Overall Study|Other than specified above|3
1210930|NCT00856206|3974450|P2|Overall Study|Decision by the Sponsor|8
1210931|NCT00856206|3974451|P1|Overall Study|Decision by the Sponsor|4
1210932|NCT00856206|3974450|P2|Overall Study|Death|2
1210933|NCT00856206|3974451|P1|Overall Study|Death|2
1210934|NCT00856206|3974450|P2|Overall Study|Lost to Follow-up|39
1210935|NCT00856206|3974451|P1|Overall Study|Lost to Follow-up|13
1210936|NCT00856206|3974450|P2|Overall Study|Withdrawal by Subject|36
1210937|NCT00856206|3974451|P1|Overall Study|Withdrawal by Subject|15
1210938|NCT00856206|3974450|P2|Overall Study|Lack of Efficacy|2
1210939|NCT00856206|3974451|P1|Overall Study|Lack of Efficacy|1
1210940|NCT00856206|3974450|P2|Overall Study|Adverse Event|46
1210941|NCT00856206|3974451|P1|Overall Study|Adverse Event|10
1210942|NCT00856206|3974450|P2|Overall Study|Protocol Violation|18
1210943|NCT00856206|3974451|P1|Overall Study|Protocol Violation|6
1210944|NCT00856193|3974465|P2|Period 2|Lost to Follow-up|1
1210945|NCT00856193|3974466|P1|Period 2|Lost to Follow-up|0
1210946|NCT00856193|3974465|P2|Period 2|Abnormal test procedure results|1
1210947|NCT00856193|3974466|P1|Period 2|Abnormal test procedure results|0
1210948|NCT00856180|3974478|P1|Overall Study|Progressive Disease|16
1210949|NCT00856180|3974478|P1|Overall Study|Adverse Event|4
1210950|NCT00855959|3974503|P1|Overall Study|Incorrect enrolment|1
1210951|NCT00855959|3974503|P1|Overall Study|Pregnancy|1
1210952|NCT00855959|3974503|P1|Overall Study|Withdrawal by Subject|3
1210953|NCT00855959|3974503|P1|Overall Study|Lost to Follow-up|2
1210954|NCT00855959|3974503|P1|Overall Study|Adverse Event|2
1210955|NCT00855933|3974520|P2|Overall Study|Withdrawal by Subject|1
1210956|NCT00855933|3974521|P1|Overall Study|Withdrawal by Subject|0
1210957|NCT00855920|3974530|P3|Overall Study|Other than specified above|1
1210958|NCT00855920|3974531|P2|Overall Study|Other than specified above|1
1210959|NCT00855920|3974532|P1|Overall Study|Other than specified above|1
1210960|NCT00855920|3974530|P3|Overall Study|Decision by the sponsor|1
1210961|NCT00855920|3974531|P2|Overall Study|Decision by the sponsor|1
1210962|NCT00855920|3974532|P1|Overall Study|Decision by the sponsor|0
1210963|NCT00855920|3974530|P3|Overall Study|Death|0
1210964|NCT00855920|3974531|P2|Overall Study|Death|1
1210965|NCT00855920|3974532|P1|Overall Study|Death|0
1210966|NCT00855920|3974530|P3|Overall Study|Lost to Follow-up|2
1210967|NCT00855920|3974531|P2|Overall Study|Lost to Follow-up|0
1210968|NCT00855920|3974532|P1|Overall Study|Lost to Follow-up|1
1210969|NCT00855920|3974530|P3|Overall Study|Withdrawal by Subject|2
1210970|NCT00855920|3974531|P2|Overall Study|Withdrawal by Subject|3
1210971|NCT00855920|3974532|P1|Overall Study|Withdrawal by Subject|2
1210972|NCT00855920|3974530|P3|Overall Study|Lack of Efficacy|2
1210973|NCT00855920|3974531|P2|Overall Study|Lack of Efficacy|2
1210974|NCT00855920|3974532|P1|Overall Study|Lack of Efficacy|2
1210975|NCT00855920|3974530|P3|Overall Study|Adverse Event|1
1210976|NCT00855920|3974531|P2|Overall Study|Adverse Event|1
1210977|NCT00855920|3974532|P1|Overall Study|Adverse Event|2
1210978|NCT00855920|3974530|P3|Overall Study|Protocol Violation|2
1210979|NCT00855920|3974531|P2|Overall Study|Protocol Violation|0
1210980|NCT00855920|3974532|P1|Overall Study|Protocol Violation|0
1210981|NCT00855894|3974549|P1|Overall Study|Disease progression|1
1210982|NCT00855894|3974549|P1|Overall Study|Patient's decision|1
1210983|NCT00855894|3974549|P1|Overall Study|Death|31
1210984|NCT00855816|3974572|P2|Overall Study|Became ineligible|1
1210985|NCT00855816|3974573|P1|Overall Study|Became ineligible|0
1210986|NCT00855816|3974572|P2|Overall Study|Death|0
1210987|NCT00855816|3974573|P1|Overall Study|Death|1
1210988|NCT00855816|3974572|P2|Overall Study|Lost to Follow-up|5
1210989|NCT00855816|3974573|P1|Overall Study|Lost to Follow-up|3
1210990|NCT00855816|3974572|P2|Overall Study|Withdrawal by Subject|15
1210991|NCT00855816|3974573|P1|Overall Study|Withdrawal by Subject|22
1210992|NCT00855738|3974579|P1|Overall Study|Death|1
1210993|NCT00855738|3974579|P1|Overall Study|Subject Defaulted|1
1210994|NCT00855738|3974579|P1|Overall Study|Adverse Event|1
1210995|NCT00855738|3974579|P1|Overall Study|Lost to Follow-up|2
1210996|NCT00855595|3974607|P2|Overall Study|patient left country|1
1210997|NCT00855595|3974608|P1|Overall Study|patient left country|0
1210998|NCT00855595|3974607|P2|Overall Study|patient moved out of state|0
1210999|NCT00855595|3974608|P1|Overall Study|patient moved out of state|1
1211000|NCT00855595|3974607|P2|Overall Study|Adverse Event|1
1211001|NCT00855595|3974608|P1|Overall Study|Adverse Event|1
1211002|NCT00855595|3974607|P2|Overall Study|Lost to Follow-up|3
1211003|NCT00855595|3974608|P1|Overall Study|Lost to Follow-up|3
1211004|NCT00855595|3974607|P2|Overall Study|Withdrawal by Subject|2
1211005|NCT00855595|3974608|P1|Overall Study|Withdrawal by Subject|1
1211006|NCT00855582|3974647|P3|Overall Study|Withdrawal by Subject|8
1211007|NCT00855582|3974648|P2|Overall Study|Withdrawal by Subject|4
1211008|NCT00855582|3974649|P1|Overall Study|Withdrawal by Subject|7
1211009|NCT00855582|3974647|P3|Overall Study|Entry Criteria Not Met|3
1211010|NCT00855582|3974648|P2|Overall Study|Entry Criteria Not Met|6
1211011|NCT00855582|3974649|P1|Overall Study|Entry Criteria Not Met|8
1211012|NCT00855582|3974647|P3|Overall Study|Protocol Violation|6
1211013|NCT00855582|3974648|P2|Overall Study|Protocol Violation|2
1211014|NCT00855582|3974649|P1|Overall Study|Protocol Violation|6
1211015|NCT00855582|3974647|P3|Overall Study|Physician Decision|1
1211016|NCT00855582|3974648|P2|Overall Study|Physician Decision|0
1211017|NCT00855582|3974649|P1|Overall Study|Physician Decision|0
1211018|NCT00855582|3974647|P3|Overall Study|Lost to Follow-up|1
1211019|NCT00855582|3974648|P2|Overall Study|Lost to Follow-up|3
1211020|NCT00855582|3974649|P1|Overall Study|Lost to Follow-up|1
1211021|NCT00855582|3974647|P3|Overall Study|Lack of Efficacy|8
1211022|NCT00855582|3974648|P2|Overall Study|Lack of Efficacy|3
1211023|NCT00855582|3974649|P1|Overall Study|Lack of Efficacy|1
1211024|NCT00855582|3974647|P3|Overall Study|Death|0
1211025|NCT00855582|3974648|P2|Overall Study|Death|0
1211026|NCT00855582|3974649|P1|Overall Study|Death|1
1211027|NCT00855582|3974647|P3|Overall Study|Adverse Event|3
1211028|NCT00855582|3974648|P2|Overall Study|Adverse Event|6
1211029|NCT00855582|3974649|P1|Overall Study|Adverse Event|2
1211030|NCT00855465|3974738|P2|Follow-up Period (FUP)|Missing|0
1211031|NCT00855465|3974739|P1|Follow-up Period (FUP)|Missing|1
1211032|NCT00855465|3974738|P2|Follow-up Period (FUP)|Withdrawal by Subject|0
1211033|NCT00855465|3974739|P1|Follow-up Period (FUP)|Withdrawal by Subject|4
1211034|NCT00855465|3974738|P2|Follow-up Period (FUP)|Lost to Follow-up|0
1211035|NCT00855465|3974739|P1|Follow-up Period (FUP)|Lost to Follow-up|3
1211036|NCT00855465|3974738|P2|Follow-up Period (FUP)|Death|1
1211037|NCT00855465|3974739|P1|Follow-up Period (FUP)|Death|0
1211038|NCT00855465|3974738|P2|Follow-up Period (FUP)|Adverse Event|1
1211039|NCT00855465|3974739|P1|Follow-up Period (FUP)|Adverse Event|0
1211040|NCT00855465|3974738|P2|Treatment Period|Not treated|0
1211041|NCT00855465|3974739|P1|Treatment Period|Not treated|1
1211042|NCT00855465|3974738|P2|Treatment Period|Withdrawal by Subject|0
1211043|NCT00855465|3974739|P1|Treatment Period|Withdrawal by Subject|2
1211044|NCT00855465|3974738|P2|Treatment Period|Protocol Violation|0
1211045|NCT00855465|3974739|P1|Treatment Period|Protocol Violation|2
1211046|NCT00855465|3974738|P2|Treatment Period|Non-compliance|0
1211047|NCT00855465|3974739|P1|Treatment Period|Non-compliance|1
1211048|NCT00855465|3974738|P2|Treatment Period|Lack of Efficacy|1
1211049|NCT00855465|3974739|P1|Treatment Period|Lack of Efficacy|2
1211050|NCT00855465|3974738|P2|Treatment Period|Death|2
1211051|NCT00855465|3974739|P1|Treatment Period|Death|2
1211052|NCT00855465|3974738|P2|Treatment Period|Adverse Event|2
1211053|NCT00855465|3974739|P1|Treatment Period|Adverse Event|4
1211054|NCT00855439|3974829|P2|Overall Study|Pregnancy|0
1211055|NCT00855439|3974830|P1|Overall Study|Pregnancy|1
1211056|NCT00855439|3974829|P2|Overall Study|Withdrawal by Subject|0
1211057|NCT00855439|3974830|P1|Overall Study|Withdrawal by Subject|2
1211058|NCT00855335|3974888|P5|Overall Study|Other|1
1211059|NCT00855335|3974889|P4|Overall Study|Other|5
1211060|NCT00855335|3974890|P3|Overall Study|Other|2
1211061|NCT00855335|3974891|P2|Overall Study|Other|1
1211062|NCT00855335|3974892|P1|Overall Study|Other|2
1211063|NCT00855335|3974888|P5|Overall Study|Physician Decision|0
1211064|NCT00855335|3974889|P4|Overall Study|Physician Decision|0
1211065|NCT00855335|3974890|P3|Overall Study|Physician Decision|0
1211066|NCT00855335|3974891|P2|Overall Study|Physician Decision|1
1211067|NCT00855335|3974892|P1|Overall Study|Physician Decision|1
1211068|NCT00855335|3974888|P5|Overall Study|Adverse Event|0
1211069|NCT00855335|3974889|P4|Overall Study|Adverse Event|0
1211070|NCT00855335|3974890|P3|Overall Study|Adverse Event|0
1211071|NCT00855335|3974891|P2|Overall Study|Adverse Event|0
1211072|NCT00855335|3974892|P1|Overall Study|Adverse Event|2
1211073|NCT00855335|3974888|P5|Overall Study|Withdrawal by Subject|0
1211074|NCT00855335|3974889|P4|Overall Study|Withdrawal by Subject|1
1211075|NCT00855335|3974890|P3|Overall Study|Withdrawal by Subject|0
1211076|NCT00855335|3974891|P2|Overall Study|Withdrawal by Subject|0
1211077|NCT00855335|3974892|P1|Overall Study|Withdrawal by Subject|0
1211078|NCT00855335|3974888|P5|Overall Study|Lost to Follow-up|0
1211079|NCT00855335|3974889|P4|Overall Study|Lost to Follow-up|1
1211080|NCT00855335|3974890|P3|Overall Study|Lost to Follow-up|3
1211081|NCT00855335|3974891|P2|Overall Study|Lost to Follow-up|0
1211082|NCT00855335|3974892|P1|Overall Study|Lost to Follow-up|0
1211083|NCT00855309|3974979|P2|Overall Study|patient never recieved drug|0
1211084|NCT00855309|3974980|P1|Overall Study|patient never recieved drug|1
1211085|NCT00855218|3974988|P2|Overall Study|Clinical endpoint reached|13
1211086|NCT00855218|3974989|P1|Overall Study|Clinical endpoint reached|10
1211087|NCT00855218|3974988|P2|Overall Study|Progression measurement proven|15
1211088|NCT00855218|3974989|P1|Overall Study|Progression measurement proven|7
1211089|NCT00855218|3974988|P2|Overall Study|Second malignancy|1
1211090|NCT00855218|3974989|P1|Overall Study|Second malignancy|0
1211091|NCT00855218|3974988|P2|Overall Study|Untreatable disease progression|67
1211092|NCT00855218|3974989|P1|Overall Study|Untreatable disease progression|54
1211093|NCT00855218|3974988|P2|Overall Study|Still treated with study medication|1
1211094|NCT00855218|3974989|P1|Overall Study|Still treated with study medication|0
1211095|NCT00855218|3974988|P2|Overall Study|technical problems|1
1211096|NCT00855218|3974989|P1|Overall Study|technical problems|2
1211097|NCT00855218|3974988|P2|Overall Study|patient convenience|0
1211098|NCT00855218|3974989|P1|Overall Study|patient convenience|2
1211099|NCT00855218|3974988|P2|Overall Study|non-compliant with study drug|1
1211100|NCT00855218|3974989|P1|Overall Study|non-compliant with study drug|3
1211101|NCT00855218|3974988|P2|Overall Study|Protocol Violation|9
1211102|NCT00855218|3974989|P1|Overall Study|Protocol Violation|5
1211103|NCT00855218|3974988|P2|Overall Study|Lost to Follow-up|1
1211104|NCT00855218|3974989|P1|Overall Study|Lost to Follow-up|0
1211105|NCT00855218|3974988|P2|Overall Study|Physician Decision|11
1211106|NCT00855218|3974989|P1|Overall Study|Physician Decision|18
1211107|NCT00855218|3974988|P2|Overall Study|Withdrawal by Subject|6
1211108|NCT00855218|3974989|P1|Overall Study|Withdrawal by Subject|10
1211109|NCT00855218|3974988|P2|Overall Study|Adverse Event|27
1211110|NCT00855218|3974989|P1|Overall Study|Adverse Event|43
1211111|NCT00855166|3975007|P2|Overall Study|Subject no longer meets study criteria|1
1211112|NCT00855166|3975008|P1|Overall Study|Subject no longer meets study criteria|1
1211113|NCT00855166|3975007|P2|Overall Study|Administrative reasons by sponsor|0
1211114|NCT00855166|3975008|P1|Overall Study|Administrative reasons by sponsor|1
1211115|NCT00855166|3975007|P2|Overall Study|Poor/non-compliance|0
1211116|NCT00855166|3975008|P1|Overall Study|Poor/non-compliance|2
1211117|NCT00855166|3975007|P2|Overall Study|Withdrawal by Subject|4
1211118|NCT00855166|3975008|P1|Overall Study|Withdrawal by Subject|1
1211119|NCT00855166|3975007|P2|Overall Study|Death|1
1211120|NCT00855166|3975008|P1|Overall Study|Death|0
1211121|NCT00855166|3975007|P2|Overall Study|Adverse Event|2
1211122|NCT00855166|3975008|P1|Overall Study|Adverse Event|0
1211123|NCT00855062|3975028|P2|Step2|Initiation of antiretroviral therapy/ART|1
1211124|NCT00855062|3975029|P1|Step2|Initiation of antiretroviral therapy/ART|0
1211125|NCT00855062|3975028|P2|Step2|Adverse Event|3
1211126|NCT00855062|3975029|P1|Step2|Adverse Event|0
1211127|NCT00855062|3975028|P2|Step2|Early Study Closure|2
1211128|NCT00855062|3975029|P1|Step2|Early Study Closure|6
1211129|NCT00855062|3975028|P2|Step1|Withdrawal by Subject|3
1211130|NCT00855062|3975029|P1|Step1|Withdrawal by Subject|2
1211131|NCT00855062|3975028|P2|Step1|Pregnancy|0
1211132|NCT00855062|3975029|P1|Step1|Pregnancy|1
1211133|NCT00855062|3975028|P2|Step1|Protocol Violation|0
1211134|NCT00855062|3975029|P1|Step1|Protocol Violation|1
1211135|NCT00855062|3975028|P2|Step1|Adverse Event|1
1211136|NCT00855062|3975029|P1|Step1|Adverse Event|1
1211137|NCT00855062|3975028|P2|Step1|Early Study Closure|7
1211138|NCT00855062|3975029|P1|Step1|Early Study Closure|5
1211139|NCT00854906|3975078|P1|Overall Study|One person had no ocular history|1
1211140|NCT00854724|3975087|P2|Second Intervention|Physician Decision|1
1211141|NCT00854724|3975088|P1|Second Intervention|Physician Decision|0
1211142|NCT00854724|3975087|P2|Second Intervention|Protocol Violation|0
1211143|NCT00854724|3975088|P1|Second Intervention|Protocol Violation|1
1211144|NCT00854724|3975087|P2|Washout|Withdrawal by Subject|1
1211145|NCT00854724|3975088|P1|Washout|Withdrawal by Subject|0
1211146|NCT00854724|3975087|P2|Washout|Protocol Violation|0
1211147|NCT00854724|3975088|P1|Washout|Protocol Violation|1
1211148|NCT00854724|3975087|P2|First Intervention|Withdrawal by Subject|1
1211149|NCT00854724|3975088|P1|First Intervention|Withdrawal by Subject|1
1211150|NCT00854620|3975094|P1|Overall Study|Adverse Event|1
1211151|NCT00854607|3975098|P1|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65
1211152|NCT00854581|3975146|P1|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3
1211153|NCT00854581|3975146|P1|Induction (Up to Day 21)|Physician Decision|1
1211154|NCT00854581|3975146|P1|Induction (Up to Day 21)|Death|1
1211155|NCT00854581|3975146|P1|Induction (Up to Day 21)|Lack of Efficacy|4
1211156|NCT00854373|3975161|P2|Overall Study|Forgot to take study drug|1
1211157|NCT00854373|3975162|P1|Overall Study|Forgot to take study drug|1
1211158|NCT00854373|3975161|P2|Overall Study|Withdrawal by Subject|3
1211159|NCT00854373|3975162|P1|Overall Study|Withdrawal by Subject|1
1211160|NCT00854360|3975176|P4|Overall Study|Other|3
1211161|NCT00854360|3975177|P3|Overall Study|Other|0
1211162|NCT00854360|3975178|P2|Overall Study|Other|0
1211163|NCT00854360|3975179|P1|Overall Study|Other|0
1211164|NCT00854360|3975176|P4|Overall Study|Lack of Efficacy|0
1211165|NCT00854360|3975177|P3|Overall Study|Lack of Efficacy|0
1211166|NCT00854360|3975178|P2|Overall Study|Lack of Efficacy|1
1211167|NCT00854360|3975179|P1|Overall Study|Lack of Efficacy|2
1211168|NCT00854360|3975176|P4|Overall Study|Pregnancy|0
1211169|NCT00854360|3975177|P3|Overall Study|Pregnancy|0
1211170|NCT00854360|3975178|P2|Overall Study|Pregnancy|1
1211171|NCT00854360|3975179|P1|Overall Study|Pregnancy|0
1211172|NCT00854360|3975176|P4|Overall Study|Withdrawal by Subject|1
1211173|NCT00854360|3975177|P3|Overall Study|Withdrawal by Subject|0
1211174|NCT00854360|3975178|P2|Overall Study|Withdrawal by Subject|0
1211175|NCT00854360|3975179|P1|Overall Study|Withdrawal by Subject|0
1211176|NCT00854360|3975176|P4|Overall Study|Adverse Event|6
1211177|NCT00854360|3975177|P3|Overall Study|Adverse Event|2
1211178|NCT00854360|3975178|P2|Overall Study|Adverse Event|1
1211179|NCT00854360|3975179|P1|Overall Study|Adverse Event|0
1211180|NCT00854308|3975211|P2|Overall Study|Sponsor's decision to terminate study|1
1211181|NCT00854308|3975212|P1|Overall Study|Sponsor's decision to terminate study|0
1211182|NCT00854308|3975211|P2|Overall Study|Withdrawal by Subject|2
1211183|NCT00854308|3975212|P1|Overall Study|Withdrawal by Subject|4
1211184|NCT00854308|3975211|P2|Overall Study|Physician Decision|6
1211185|NCT00854308|3975212|P1|Overall Study|Physician Decision|6
1211186|NCT00854308|3975211|P2|Overall Study|Death|5
1211187|NCT00854308|3975212|P1|Overall Study|Death|2
1211188|NCT00854308|3975211|P2|Overall Study|Adverse Event|3
1211189|NCT00854308|3975212|P1|Overall Study|Adverse Event|8
1211190|NCT00854308|3975211|P2|Overall Study|Disease progression|50
1211191|NCT00854308|3975212|P1|Overall Study|Disease progression|42
1211192|NCT00854113|3975237|P11|Overall Study|Withdrawal by Subject|0
1211193|NCT00854113|3975238|P10|Overall Study|Withdrawal by Subject|0
1211194|NCT00854113|3975239|P9|Overall Study|Withdrawal by Subject|1
1211195|NCT00854113|3975240|P8|Overall Study|Withdrawal by Subject|1
1211196|NCT00854113|3975241|P7|Overall Study|Withdrawal by Subject|0
1211197|NCT00854113|3975242|P6|Overall Study|Withdrawal by Subject|0
1211198|NCT00854113|3975243|P5|Overall Study|Withdrawal by Subject|0
1211199|NCT00854113|3975244|P4|Overall Study|Withdrawal by Subject|0
1211200|NCT00854113|3975245|P3|Overall Study|Withdrawal by Subject|0
1211201|NCT00854113|3975246|P2|Overall Study|Withdrawal by Subject|0
1211202|NCT00854113|3975247|P1|Overall Study|Withdrawal by Subject|0
1211203|NCT00854113|3975237|P11|Overall Study|Adverse Event|0
1211204|NCT00854113|3975238|P10|Overall Study|Adverse Event|0
1211205|NCT00854113|3975239|P9|Overall Study|Adverse Event|0
1211206|NCT00854113|3975240|P8|Overall Study|Adverse Event|2
1211207|NCT00854113|3975241|P7|Overall Study|Adverse Event|0
1211208|NCT00854113|3975242|P6|Overall Study|Adverse Event|0
1211209|NCT00854113|3975243|P5|Overall Study|Adverse Event|0
1211210|NCT00854113|3975244|P4|Overall Study|Adverse Event|0
1211211|NCT00854113|3975245|P3|Overall Study|Adverse Event|0
1211212|NCT00854113|3975246|P2|Overall Study|Adverse Event|0
1211213|NCT00854113|3975247|P1|Overall Study|Adverse Event|0
1211214|NCT00853970|3975369|P2|Overall Study|Cancelled surgery|2
1211215|NCT00853970|3975370|P1|Overall Study|Cancelled surgery|4
1211216|NCT00853970|3975369|P2|Overall Study|Withdrawal by Subject|1
1211217|NCT00853970|3975370|P1|Overall Study|Withdrawal by Subject|2
1211218|NCT00853957|3975380|P2|Overall Study|Protocol deviation|3
1211219|NCT00853957|3975381|P1|Overall Study|Protocol deviation|0
1211220|NCT00853957|3975380|P2|Overall Study|Lost to Follow-up|6
1211221|NCT00853957|3975381|P1|Overall Study|Lost to Follow-up|1
1211222|NCT00853957|3975380|P2|Overall Study|Subject withdrew consent|5
1211223|NCT00853957|3975381|P1|Overall Study|Subject withdrew consent|4
1211224|NCT00853957|3975380|P2|Overall Study|Unsatisfactory therapeutic effect|2
1211225|NCT00853957|3975381|P1|Overall Study|Unsatisfactory therapeutic effect|0
1211226|NCT00853957|3975380|P2|Overall Study|Adverse Event|3
1211227|NCT00853957|3975381|P1|Overall Study|Adverse Event|9
1211228|NCT00853905|3975399|P2|Overall Study|never had surgery|0
1211229|NCT00853905|3975400|P1|Overall Study|never had surgery|1
1211230|NCT00853905|3975399|P2|Overall Study|Withdrawal by Subject|1
1211231|NCT00853905|3975400|P1|Overall Study|Withdrawal by Subject|0
1211232|NCT00853905|3975399|P2|Overall Study|Lost to Follow-up|3
1211233|NCT00853905|3975400|P1|Overall Study|Lost to Follow-up|1
1211234|NCT00853827|3975432|P2|Double Blind Period (103 Weeks)|Death|6
1211235|NCT00853827|3975433|P1|Double Blind Period (103 Weeks)|Death|1
1211236|NCT00853827|3975432|P2|Double Blind Period (103 Weeks)|Administrative problems|56
1211237|NCT00853827|3975433|P1|Double Blind Period (103 Weeks)|Administrative problems|45
1211238|NCT00853827|3975432|P2|Double Blind Period (103 Weeks)|Lost to Follow-up|10
1211239|NCT00853827|3975433|P1|Double Blind Period (103 Weeks)|Lost to Follow-up|8
1211240|NCT00853827|3975432|P2|Double Blind Period (103 Weeks)|Withdrawal by Subject|18
1211241|NCT00853827|3975433|P1|Double Blind Period (103 Weeks)|Withdrawal by Subject|19
1211242|NCT00853827|3975432|P2|Double Blind Period (103 Weeks)|Protocol Violation|1
1211243|NCT00853827|3975433|P1|Double Blind Period (103 Weeks)|Protocol Violation|2
1211244|NCT00853827|3975432|P2|Double Blind Period (103 Weeks)|Patient’s no longer requires study drug|1
1211245|NCT00853827|3975433|P1|Double Blind Period (103 Weeks)|Patient’s no longer requires study drug|3
1211246|NCT00853827|3975432|P2|Double Blind Period (103 Weeks)|Lack of Efficacy|0
1211247|NCT00853827|3975433|P1|Double Blind Period (103 Weeks)|Lack of Efficacy|1
1211248|NCT00853827|3975432|P2|Double Blind Period (103 Weeks)|Abnormal laboratory values|3
1211249|NCT00853827|3975433|P1|Double Blind Period (103 Weeks)|Abnormal laboratory values|0
1211250|NCT00853827|3975432|P2|Double Blind Period (103 Weeks)|Adverse Event|14
1211251|NCT00853827|3975433|P1|Double Blind Period (103 Weeks)|Adverse Event|25
1211252|NCT00853827|3975432|P2|Single Blind Period (1 Week)|Protocol Violation|0
1211253|NCT00853827|3975433|P1|Single Blind Period (1 Week)|Protocol Violation|12
1211254|NCT00853827|3975432|P2|Single Blind Period (1 Week)|Lost to Follow-up|0
1211255|NCT00853827|3975433|P1|Single Blind Period (1 Week)|Lost to Follow-up|1
1211256|NCT00853827|3975432|P2|Single Blind Period (1 Week)|Withdrawal by Subject|0
1211257|NCT00853827|3975433|P1|Single Blind Period (1 Week)|Withdrawal by Subject|9
1211258|NCT00853827|3975432|P2|Single Blind Period (1 Week)|Abnormal test procedure result|0
1211259|NCT00853827|3975433|P1|Single Blind Period (1 Week)|Abnormal test procedure result|1
1211260|NCT00853827|3975432|P2|Single Blind Period (1 Week)|Abnormal laboratory value|0
1211261|NCT00853827|3975433|P1|Single Blind Period (1 Week)|Abnormal laboratory value|3
1211262|NCT00853827|3975432|P2|Single Blind Period (1 Week)|Adverse Event|0
1211263|NCT00853827|3975433|P1|Single Blind Period (1 Week)|Adverse Event|9
1211264|NCT00853827|3975432|P2|Single Blind Period (1 Week)|Other|0
1211265|NCT00853827|3975433|P1|Single Blind Period (1 Week)|Other|4
1211266|NCT00853762|3975449|P4|Overall Study|Randomised but not Treated|0
1211267|NCT00853762|3975450|P3|Overall Study|Randomised but not Treated|2
1211268|NCT00853762|3975451|P2|Overall Study|Randomised but not Treated|2
1211269|NCT00853762|3975452|P1|Overall Study|Randomised but not Treated|0
1211270|NCT00853762|3975449|P4|Overall Study|Other|0
1211271|NCT00853762|3975450|P3|Overall Study|Other|0
1211272|NCT00853762|3975451|P2|Overall Study|Other|2
1211273|NCT00853762|3975452|P1|Overall Study|Other|0
1211274|NCT00853762|3975449|P4|Overall Study|Withdrawal by Subject|0
1211275|NCT00853762|3975450|P3|Overall Study|Withdrawal by Subject|1
1211276|NCT00853762|3975451|P2|Overall Study|Withdrawal by Subject|0
1211277|NCT00853762|3975452|P1|Overall Study|Withdrawal by Subject|0
1211278|NCT00853762|3975449|P4|Overall Study|Protocol Violation|1
1211279|NCT00853762|3975450|P3|Overall Study|Protocol Violation|0
1211280|NCT00853762|3975451|P2|Overall Study|Protocol Violation|0
1211281|NCT00853762|3975452|P1|Overall Study|Protocol Violation|0
1211282|NCT00853762|3975449|P4|Overall Study|Premature Termination|21
1211283|NCT00853762|3975450|P3|Overall Study|Premature Termination|14
1211284|NCT00853762|3975451|P2|Overall Study|Premature Termination|15
1211285|NCT00853762|3975452|P1|Overall Study|Premature Termination|16
1211286|NCT00853749|3975520|P2|Overall Study|Lost to Follow-up|1
1211287|NCT00853749|3975521|P1|Overall Study|Lost to Follow-up|0
1211288|NCT00853723|3975542|P3|Overall Study|Protocol Violation|1
1211289|NCT00853723|3975543|P2|Overall Study|Protocol Violation|2
1211290|NCT00853723|3975544|P1|Overall Study|Protocol Violation|1
1211291|NCT00853723|3975542|P3|Overall Study|Withdrawal by Subject|0
1211292|NCT00853723|3975543|P2|Overall Study|Withdrawal by Subject|1
1211293|NCT00853723|3975544|P1|Overall Study|Withdrawal by Subject|2
1211294|NCT00853723|3975542|P3|Overall Study|Adverse Event|1
1211295|NCT00853723|3975543|P2|Overall Study|Adverse Event|4
1211296|NCT00853723|3975544|P1|Overall Study|Adverse Event|3
1211297|NCT00853658|3975598|P3|Overall Study|Missing study completion information|6
1211298|NCT00853658|3975599|P2|Overall Study|Missing study completion information|4
1211299|NCT00853658|3975600|P1|Overall Study|Missing study completion information|5
1211300|NCT00853658|3975598|P3|Overall Study|Patient's request|11
1211301|NCT00853658|3975599|P2|Overall Study|Patient's request|17
1211302|NCT00853658|3975600|P1|Overall Study|Patient's request|21
1211303|NCT00853658|3975598|P3|Overall Study|Vital Status at study end N/A|10
1211304|NCT00853658|3975599|P2|Overall Study|Vital Status at study end N/A|10
1211305|NCT00853658|3975600|P1|Overall Study|Vital Status at study end N/A|8
1211306|NCT00853658|3975598|P3|Overall Study|Vital Status unknown at study end|0
1211307|NCT00853658|3975599|P2|Overall Study|Vital Status unknown at study end|1
1211308|NCT00853658|3975600|P1|Overall Study|Vital Status unknown at study end|1
1211309|NCT00853658|3975598|P3|Overall Study|Vital Status known (alive) at study end|3
1211310|NCT00853658|3975599|P2|Overall Study|Vital Status known (alive) at study end|3
1211311|NCT00853658|3975600|P1|Overall Study|Vital Status known (alive) at study end|2
1211312|NCT00853658|3975598|P3|Overall Study|IRB request|2
1211313|NCT00853658|3975599|P2|Overall Study|IRB request|0
1211314|NCT00853658|3975600|P1|Overall Study|IRB request|0
1211315|NCT00853658|3975598|P3|Overall Study|H.A. Request|19
1211316|NCT00853658|3975599|P2|Overall Study|H.A. Request|23
1211317|NCT00853658|3975600|P1|Overall Study|H.A. Request|26
1211318|NCT00853658|3975598|P3|Overall Study|Lost to Follow-up|11
1211319|NCT00853658|3975599|P2|Overall Study|Lost to Follow-up|6
1211320|NCT00853658|3975600|P1|Overall Study|Lost to Follow-up|11
1211321|NCT00853658|3975598|P3|Overall Study|Death|753
1211322|NCT00853658|3975599|P2|Overall Study|Death|768
1211323|NCT00853658|3975600|P1|Overall Study|Death|713
1211324|NCT00853593|3975620|P1|Overall Study|Implant not attempted|4
1211325|NCT00853593|3975620|P1|Overall Study|Model 4396 lead not attempted|29
1211326|NCT00853593|3975620|P1|Overall Study|Subjects did not receive a 4396 lead|12
1211327|NCT00853580|3975647|P2|Overall Study|Commenced contraindicated therapy|2
1211328|NCT00853580|3975648|P1|Overall Study|Commenced contraindicated therapy|0
1211329|NCT00853580|3975647|P2|Overall Study|Withdrawal by Subject|8
1211330|NCT00853580|3975648|P1|Overall Study|Withdrawal by Subject|2
1211331|NCT00853580|3975647|P2|Overall Study|Protocol Violation|1
1211332|NCT00853580|3975648|P1|Overall Study|Protocol Violation|2
1211333|NCT00853580|3975647|P2|Overall Study|Lost to Follow-up|5
1211334|NCT00853580|3975648|P1|Overall Study|Lost to Follow-up|3
1211335|NCT00853567|3975695|P1|Overall Study|Study prematurely terminated|71
1211336|NCT00853489|3975705|P2|Overall Study|Lost to Follow-up|2
1211337|NCT00853489|3975706|P1|Overall Study|Lost to Follow-up|5
1211338|NCT00853385|3975721|P5|Overall Study|Other|12
1211339|NCT00853385|3975722|P4|Overall Study|Other|4
1211340|NCT00853385|3975723|P3|Overall Study|Other|4
1211341|NCT00853385|3975724|P2|Overall Study|Other|9
1211342|NCT00853385|3975725|P1|Overall Study|Other|18
1211343|NCT00853385|3975721|P5|Overall Study|Withdrawal by Subject|1
1211344|NCT00853385|3975722|P4|Overall Study|Withdrawal by Subject|1
1211345|NCT00853385|3975723|P3|Overall Study|Withdrawal by Subject|0
1211346|NCT00853385|3975724|P2|Overall Study|Withdrawal by Subject|2
1211347|NCT00853385|3975725|P1|Overall Study|Withdrawal by Subject|4
1211348|NCT00853385|3975721|P5|Overall Study|Lost to Follow-up|0
1211349|NCT00853385|3975722|P4|Overall Study|Lost to Follow-up|0
1211350|NCT00853385|3975723|P3|Overall Study|Lost to Follow-up|0
1211351|NCT00853385|3975724|P2|Overall Study|Lost to Follow-up|1
1211352|NCT00853385|3975725|P1|Overall Study|Lost to Follow-up|2
1211353|NCT00853385|3975721|P5|Overall Study|Lack of Efficacy|6
1211354|NCT00853385|3975722|P4|Overall Study|Lack of Efficacy|3
1211355|NCT00853385|3975723|P3|Overall Study|Lack of Efficacy|3
1211356|NCT00853385|3975724|P2|Overall Study|Lack of Efficacy|7
1211357|NCT00853385|3975725|P1|Overall Study|Lack of Efficacy|6
1211358|NCT00853385|3975721|P5|Overall Study|Adverse Event|22
1211359|NCT00853385|3975722|P4|Overall Study|Adverse Event|5
1211360|NCT00853385|3975723|P3|Overall Study|Adverse Event|2
1211361|NCT00853385|3975724|P2|Overall Study|Adverse Event|24
1211362|NCT00853385|3975725|P1|Overall Study|Adverse Event|24
1211363|NCT00853385|3975721|P5|Overall Study|Death|1
1211364|NCT00853385|3975722|P4|Overall Study|Death|0
1211365|NCT00853385|3975723|P3|Overall Study|Death|0
1211366|NCT00853385|3975724|P2|Overall Study|Death|0
1211367|NCT00853385|3975725|P1|Overall Study|Death|0
1211368|NCT00853307|3975953|P2|Overall Study|Reason Not Specified|1
1211369|NCT00853307|3975954|P1|Overall Study|Reason Not Specified|0
1211370|NCT00853307|3975953|P2|Overall Study|Withdrawal by Subject|2
1211371|NCT00853307|3975954|P1|Overall Study|Withdrawal by Subject|1
1211372|NCT00853307|3975953|P2|Overall Study|Adverse Event|2
1211373|NCT00853307|3975954|P1|Overall Study|Adverse Event|1
1211374|NCT00853242|3975981|P7|Overall Study|Other|2
1211375|NCT00853242|3975982|P6|Overall Study|Other|1
1211376|NCT00853242|3975983|P5|Overall Study|Other|0
1211377|NCT00853242|3975984|P4|Overall Study|Other|0
1211378|NCT00853242|3975985|P3|Overall Study|Other|2
1211379|NCT00853242|3975986|P2|Overall Study|Other|0
1211380|NCT00853242|3975987|P1|Overall Study|Other|2
1211381|NCT00853242|3975981|P7|Overall Study|Withdrawal by Subject|2
1211382|NCT00853242|3975982|P6|Overall Study|Withdrawal by Subject|0
1211383|NCT00853242|3975983|P5|Overall Study|Withdrawal by Subject|0
1211384|NCT00853242|3975984|P4|Overall Study|Withdrawal by Subject|4
1211385|NCT00853242|3975985|P3|Overall Study|Withdrawal by Subject|0
1211386|NCT00853242|3975986|P2|Overall Study|Withdrawal by Subject|2
1211387|NCT00853242|3975987|P1|Overall Study|Withdrawal by Subject|1
1211388|NCT00853242|3975981|P7|Overall Study|Noncompliant|0
1211389|NCT00853242|3975982|P6|Overall Study|Noncompliant|0
1211390|NCT00853242|3975983|P5|Overall Study|Noncompliant|1
1211391|NCT00853242|3975984|P4|Overall Study|Noncompliant|0
1211392|NCT00853242|3975985|P3|Overall Study|Noncompliant|0
1211393|NCT00853242|3975986|P2|Overall Study|Noncompliant|0
1211394|NCT00853242|3975987|P1|Overall Study|Noncompliant|0
1211395|NCT00853242|3975981|P7|Overall Study|Adverse Event|1
1211396|NCT00853242|3975982|P6|Overall Study|Adverse Event|1
1211397|NCT00853242|3975983|P5|Overall Study|Adverse Event|3
1211398|NCT00853242|3975984|P4|Overall Study|Adverse Event|0
1211399|NCT00853242|3975985|P3|Overall Study|Adverse Event|1
1211400|NCT00853242|3975986|P2|Overall Study|Adverse Event|1
1211401|NCT00853242|3975987|P1|Overall Study|Adverse Event|0
1211402|NCT00853229|3976029|P2|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
1211403|NCT00853229|3976030|P1|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
1211404|NCT00853151|3976040|P4|Overall Study|Sponsor Decision|0
1211405|NCT00853151|3976041|P3|Overall Study|Sponsor Decision|0
1211406|NCT00853151|3976042|P2|Overall Study|Sponsor Decision|3
1211407|NCT00853151|3976043|P1|Overall Study|Sponsor Decision|0
1211408|NCT00853151|3976040|P4|Overall Study|Physician Decision|0
1211409|NCT00853151|3976041|P3|Overall Study|Physician Decision|1
1211410|NCT00853151|3976042|P2|Overall Study|Physician Decision|2
1211411|NCT00853151|3976043|P1|Overall Study|Physician Decision|0
1211412|NCT00853151|3976040|P4|Overall Study|Withdrawal by Subject|1
1211413|NCT00853151|3976041|P3|Overall Study|Withdrawal by Subject|2
1211414|NCT00853151|3976042|P2|Overall Study|Withdrawal by Subject|4
1211415|NCT00853151|3976043|P1|Overall Study|Withdrawal by Subject|5
1211416|NCT00853151|3976040|P4|Overall Study|Protocol Violation|1
1211417|NCT00853151|3976041|P3|Overall Study|Protocol Violation|0
1211418|NCT00853151|3976042|P2|Overall Study|Protocol Violation|0
1211419|NCT00853151|3976043|P1|Overall Study|Protocol Violation|0
1211420|NCT00853151|3976040|P4|Overall Study|Death|1
1211421|NCT00853151|3976041|P3|Overall Study|Death|0
1211422|NCT00853151|3976042|P2|Overall Study|Death|0
1211423|NCT00853151|3976043|P1|Overall Study|Death|1
1211424|NCT00853151|3976040|P4|Overall Study|Lost to Follow-up|0
1211425|NCT00853151|3976041|P3|Overall Study|Lost to Follow-up|3
1211426|NCT00853151|3976042|P2|Overall Study|Lost to Follow-up|0
1211427|NCT00853151|3976043|P1|Overall Study|Lost to Follow-up|2
1211428|NCT00853151|3976040|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1211429|NCT00853151|3976041|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1211430|NCT00853151|3976042|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1211431|NCT00853151|3976043|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
1211432|NCT00853151|3976040|P4|Overall Study|Adverse Event|0
1211433|NCT00853151|3976041|P3|Overall Study|Adverse Event|2
1211434|NCT00853151|3976042|P2|Overall Study|Adverse Event|4
1211435|NCT00853151|3976043|P1|Overall Study|Adverse Event|1
1211436|NCT00853112|3976192|P7|Overall Study|Randomized but not treated|1
1211437|NCT00853112|3976193|P6|Overall Study|Randomized but not treated|0
1211438|NCT00853112|3976194|P5|Overall Study|Randomized but not treated|0
1211439|NCT00853112|3976195|P4|Overall Study|Randomized but not treated|2
1211440|NCT00853112|3976196|P3|Overall Study|Randomized but not treated|0
1211441|NCT00853112|3976197|P2|Overall Study|Randomized but not treated|1
1211442|NCT00853112|3976198|P1|Overall Study|Randomized but not treated|0
1211443|NCT00853099|3976308|P4|Double-blind + Open-label Periods|Not Specified|6
1211444|NCT00853099|3976309|P3|Double-blind + Open-label Periods|Not Specified|0
1211445|NCT00853099|3976310|P2|Double-blind + Open-label Periods|Not Specified|0
1211446|NCT00853099|3976311|P1|Double-blind + Open-label Periods|Not Specified|0
1211447|NCT00853099|3976308|P4|Double-blind + Open-label Periods|Withdrawal by Subject|20
1211448|NCT00853099|3976309|P3|Double-blind + Open-label Periods|Withdrawal by Subject|0
1211449|NCT00853099|3976310|P2|Double-blind + Open-label Periods|Withdrawal by Subject|0
1211450|NCT00853099|3976311|P1|Double-blind + Open-label Periods|Withdrawal by Subject|0
1211451|NCT00853099|3976308|P4|Double-blind + Open-label Periods|Adverse Event|47
1211452|NCT00853099|3976309|P3|Double-blind + Open-label Periods|Adverse Event|0
1211453|NCT00853099|3976310|P2|Double-blind + Open-label Periods|Adverse Event|0
1211454|NCT00853099|3976311|P1|Double-blind + Open-label Periods|Adverse Event|0
1211455|NCT00853099|3976308|P4|Double-blind + Open-label Periods|Lack of Efficacy|74
1211456|NCT00853099|3976309|P3|Double-blind + Open-label Periods|Lack of Efficacy|0
1211457|NCT00853099|3976310|P2|Double-blind + Open-label Periods|Lack of Efficacy|0
1211458|NCT00853099|3976311|P1|Double-blind + Open-label Periods|Lack of Efficacy|0
1211459|NCT00853099|3976308|P4|Double-blind Period|Mistreated with rescue study drug|0
1211460|NCT00853099|3976309|P3|Double-blind Period|Mistreated with rescue study drug|1
1211461|NCT00853099|3976310|P2|Double-blind Period|Mistreated with rescue study drug|0
1211462|NCT00853099|3976311|P1|Double-blind Period|Mistreated with rescue study drug|0
1211463|NCT00853099|3976308|P4|Double-blind Period|Not Specified|0
1211464|NCT00853099|3976309|P3|Double-blind Period|Not Specified|1
1211465|NCT00853099|3976310|P2|Double-blind Period|Not Specified|0
1211466|NCT00853099|3976311|P1|Double-blind Period|Not Specified|0
1211467|NCT00853099|3976308|P4|Double-blind Period|Lack of Efficacy|0
1211468|NCT00853099|3976309|P3|Double-blind Period|Lack of Efficacy|16
1211469|NCT00853099|3976310|P2|Double-blind Period|Lack of Efficacy|17
1211470|NCT00853099|3976311|P1|Double-blind Period|Lack of Efficacy|14
1211471|NCT00853099|3976308|P4|Double-blind Period|Withdrawal by Subject|0
1211472|NCT00853099|3976309|P3|Double-blind Period|Withdrawal by Subject|0
1211473|NCT00853099|3976310|P2|Double-blind Period|Withdrawal by Subject|3
1211474|NCT00853099|3976311|P1|Double-blind Period|Withdrawal by Subject|2
1211475|NCT00853099|3976308|P4|Double-blind Period|Adverse Event|0
1211476|NCT00853099|3976309|P3|Double-blind Period|Adverse Event|13
1211477|NCT00853099|3976310|P2|Double-blind Period|Adverse Event|9
1211478|NCT00853099|3976311|P1|Double-blind Period|Adverse Event|7
1211479|NCT00853073|3976353|P2|Overall Study|Withdrawal by Subject|2
1211480|NCT00853073|3976354|P1|Overall Study|Withdrawal by Subject|3
1211481|NCT00853047|3976367|P6|Open-Label Extension Phase|Reason Not Specified|6
1211482|NCT00853047|3976368|P5|Open-Label Extension Phase|Reason Not Specified|0
1211483|NCT00853047|3976369|P4|Open-Label Extension Phase|Reason Not Specified|0
1211484|NCT00853047|3976370|P3|Open-Label Extension Phase|Reason Not Specified|0
1211485|NCT00853047|3976371|P2|Open-Label Extension Phase|Reason Not Specified|0
1211486|NCT00853047|3976372|P1|Open-Label Extension Phase|Reason Not Specified|0
1211487|NCT00853047|3976367|P6|Open-Label Extension Phase|Investigator Decision|1
1211488|NCT00853047|3976368|P5|Open-Label Extension Phase|Investigator Decision|0
1211489|NCT00853047|3976369|P4|Open-Label Extension Phase|Investigator Decision|0
1211490|NCT00853047|3976370|P3|Open-Label Extension Phase|Investigator Decision|0
1211491|NCT00853047|3976371|P2|Open-Label Extension Phase|Investigator Decision|0
1211492|NCT00853047|3976372|P1|Open-Label Extension Phase|Investigator Decision|0
1211493|NCT00853047|3976367|P6|Open-Label Extension Phase|Transfer to LX1606-302|2
1211494|NCT00853047|3976368|P5|Open-Label Extension Phase|Transfer to LX1606-302|0
1211495|NCT00853047|3976369|P4|Open-Label Extension Phase|Transfer to LX1606-302|0
1211496|NCT00853047|3976370|P3|Open-Label Extension Phase|Transfer to LX1606-302|0
1211497|NCT00853047|3976371|P2|Open-Label Extension Phase|Transfer to LX1606-302|0
1211498|NCT00853047|3976372|P1|Open-Label Extension Phase|Transfer to LX1606-302|0
1211499|NCT00853047|3976367|P6|Open-Label Extension Phase|Lost to Follow-up|1
1211500|NCT00853047|3976368|P5|Open-Label Extension Phase|Lost to Follow-up|0
1211501|NCT00853047|3976369|P4|Open-Label Extension Phase|Lost to Follow-up|0
1211502|NCT00853047|3976370|P3|Open-Label Extension Phase|Lost to Follow-up|0
1211503|NCT00853047|3976371|P2|Open-Label Extension Phase|Lost to Follow-up|0
1211504|NCT00853047|3976372|P1|Open-Label Extension Phase|Lost to Follow-up|0
1211505|NCT00853047|3976367|P6|Open-Label Extension Phase|Participant Request|7
1211506|NCT00853047|3976368|P5|Open-Label Extension Phase|Participant Request|0
1211507|NCT00853047|3976369|P4|Open-Label Extension Phase|Participant Request|0
1211508|NCT00853047|3976370|P3|Open-Label Extension Phase|Participant Request|0
1211509|NCT00853047|3976371|P2|Open-Label Extension Phase|Participant Request|0
1211510|NCT00853047|3976372|P1|Open-Label Extension Phase|Participant Request|0
1211511|NCT00853047|3976367|P6|Core Phase|Participant Request|0
1211512|NCT00853047|3976368|P5|Core Phase|Participant Request|0
1211513|NCT00853047|3976369|P4|Core Phase|Participant Request|1
1211514|NCT00853047|3976370|P3|Core Phase|Participant Request|0
1211515|NCT00853047|3976371|P2|Core Phase|Participant Request|0
1211516|NCT00853047|3976372|P1|Core Phase|Participant Request|0
1211517|NCT00853021|3976438|P1|Overall Study|Death|1
1211518|NCT00853021|3976438|P1|Overall Study|Withdrawal by Subject|2
1211519|NCT00853021|3976438|P1|Overall Study|Adverse Event|2
1211520|NCT00852995|3976450|P5|Overall Study|Moved Out of Area|0
1211521|NCT00852995|3976451|P4|Overall Study|Moved Out of Area|0
1211522|NCT00852995|3976452|P3|Overall Study|Moved Out of Area|0
1211523|NCT00852995|3976453|P2|Overall Study|Moved Out of Area|0
1211524|NCT00852995|3976454|P1|Overall Study|Moved Out of Area|1
1211525|NCT00852995|3976450|P5|Overall Study|Protocol Violation|1
1211526|NCT00852995|3976451|P4|Overall Study|Protocol Violation|0
1211527|NCT00852995|3976452|P3|Overall Study|Protocol Violation|0
1211528|NCT00852995|3976453|P2|Overall Study|Protocol Violation|0
1211529|NCT00852995|3976454|P1|Overall Study|Protocol Violation|0
1211530|NCT00852995|3976450|P5|Overall Study|Physician Decision|0
1211531|NCT00852995|3976451|P4|Overall Study|Physician Decision|0
1211532|NCT00852995|3976452|P3|Overall Study|Physician Decision|0
1211533|NCT00852995|3976453|P2|Overall Study|Physician Decision|0
1211534|NCT00852995|3976454|P1|Overall Study|Physician Decision|1
1211535|NCT00852995|3976450|P5|Overall Study|Progressive Disease|1
1211536|NCT00852995|3976451|P4|Overall Study|Progressive Disease|2
1211537|NCT00852995|3976452|P3|Overall Study|Progressive Disease|0
1211538|NCT00852995|3976453|P2|Overall Study|Progressive Disease|0
1211539|NCT00852995|3976454|P1|Overall Study|Progressive Disease|1
1211540|NCT00852995|3976450|P5|Overall Study|Non-Compliance|0
1211541|NCT00852995|3976451|P4|Overall Study|Non-Compliance|2
1211542|NCT00852995|3976452|P3|Overall Study|Non-Compliance|0
1211543|NCT00852995|3976453|P2|Overall Study|Non-Compliance|0
1211544|NCT00852995|3976454|P1|Overall Study|Non-Compliance|0
1211545|NCT00852995|3976450|P5|Overall Study|Withdrawal by Subject|2
1211546|NCT00852995|3976451|P4|Overall Study|Withdrawal by Subject|1
1211547|NCT00852995|3976452|P3|Overall Study|Withdrawal by Subject|0
1211548|NCT00852995|3976453|P2|Overall Study|Withdrawal by Subject|0
1211549|NCT00852995|3976454|P1|Overall Study|Withdrawal by Subject|4
1211550|NCT00852995|3976450|P5|Overall Study|Lost to Follow-up|0
1211551|NCT00852995|3976451|P4|Overall Study|Lost to Follow-up|0
1211552|NCT00852995|3976452|P3|Overall Study|Lost to Follow-up|1
1211553|NCT00852995|3976453|P2|Overall Study|Lost to Follow-up|1
1211554|NCT00852995|3976454|P1|Overall Study|Lost to Follow-up|0
1211555|NCT00852995|3976450|P5|Overall Study|Adverse Event|0
1211556|NCT00852995|3976451|P4|Overall Study|Adverse Event|0
1211557|NCT00852995|3976452|P3|Overall Study|Adverse Event|4
1211558|NCT00852995|3976453|P2|Overall Study|Adverse Event|0
1211559|NCT00852995|3976454|P1|Overall Study|Adverse Event|1
1211560|NCT00852969|3976498|P2|Overall Study|Lost to Follow-up|1
1211561|NCT00852969|3976499|P1|Overall Study|Lost to Follow-up|0
1211562|NCT00852969|3976498|P2|Overall Study|Adverse Event|1
1211563|NCT00852969|3976499|P1|Overall Study|Adverse Event|0
1211564|NCT00852930|3976510|P3|Overall Study|Physician Decision|1
1211565|NCT00852930|3976511|P2|Overall Study|Physician Decision|0
1211566|NCT00852930|3976512|P1|Overall Study|Physician Decision|0
1211567|NCT00852930|3976510|P3|Overall Study|Withdrawal by Subject|1
1211568|NCT00852930|3976511|P2|Overall Study|Withdrawal by Subject|1
1211569|NCT00852930|3976512|P1|Overall Study|Withdrawal by Subject|1
1211570|NCT00852917|3976533|P4|Overall Study|Death|1
1211571|NCT00852917|3976534|P3|Overall Study|Death|0
1211572|NCT00852917|3976535|P2|Overall Study|Death|0
1211573|NCT00852917|3976536|P1|Overall Study|Death|0
1211574|NCT00852917|3976533|P4|Overall Study|Physician Decision|19
1211575|NCT00852917|3976534|P3|Overall Study|Physician Decision|2
1211576|NCT00852917|3976535|P2|Overall Study|Physician Decision|7
1211577|NCT00852917|3976536|P1|Overall Study|Physician Decision|6
1211578|NCT00852917|3976533|P4|Overall Study|Withdrawal by Subject|9
1211579|NCT00852917|3976534|P3|Overall Study|Withdrawal by Subject|10
1211580|NCT00852917|3976535|P2|Overall Study|Withdrawal by Subject|8
1211581|NCT00852917|3976536|P1|Overall Study|Withdrawal by Subject|4
1211582|NCT00852917|3976533|P4|Overall Study|Lack of Efficacy|47
1211583|NCT00852917|3976534|P3|Overall Study|Lack of Efficacy|11
1211584|NCT00852917|3976535|P2|Overall Study|Lack of Efficacy|11
1211585|NCT00852917|3976536|P1|Overall Study|Lack of Efficacy|21
1211586|NCT00852917|3976533|P4|Overall Study|Adverse Event|17
1211587|NCT00852917|3976534|P3|Overall Study|Adverse Event|35
1211588|NCT00852917|3976535|P2|Overall Study|Adverse Event|20
1211589|NCT00852917|3976536|P1|Overall Study|Adverse Event|13
1211590|NCT00852540|3976664|P2|Overall Study|Did Not Receive Study Drug|3
1211591|NCT00852540|3976665|P1|Overall Study|Did Not Receive Study Drug|3
1211592|NCT00852540|3976664|P2|Overall Study|Withdrawal by Subject|1
1211593|NCT00852540|3976665|P1|Overall Study|Withdrawal by Subject|3
1211594|NCT00852540|3976664|P2|Overall Study|Investigator Discretion|3
1211595|NCT00852540|3976665|P1|Overall Study|Investigator Discretion|2
1211596|NCT00852540|3976664|P2|Overall Study|Lost to Follow-up|3
1211597|NCT00852540|3976665|P1|Overall Study|Lost to Follow-up|2
1211598|NCT00852540|3976664|P2|Overall Study|Protocol Violation|2
1211599|NCT00852540|3976665|P1|Overall Study|Protocol Violation|1
1211600|NCT00852540|3976664|P2|Overall Study|Lack of Efficacy|3
1211601|NCT00852540|3976665|P1|Overall Study|Lack of Efficacy|15
1211602|NCT00852540|3976664|P2|Overall Study|Adverse Event|3
1211603|NCT00852540|3976665|P1|Overall Study|Adverse Event|10
1211604|NCT00852475|3976699|P2|Overall Study|Lost to Follow-up|4
1211605|NCT00852475|3976700|P1|Overall Study|Lost to Follow-up|3
1211606|NCT00852397|3976711|P3|Overall Study|Protocol Violation|1
1211607|NCT00852397|3976712|P2|Overall Study|Protocol Violation|0
1211608|NCT00852397|3976713|P1|Overall Study|Protocol Violation|0
1211609|NCT00852397|3976711|P3|Overall Study|Difficulty in study site visit|0
1211610|NCT00852397|3976712|P2|Overall Study|Difficulty in study site visit|0
1211611|NCT00852397|3976713|P1|Overall Study|Difficulty in study site visit|1
1211612|NCT00852397|3976711|P3|Overall Study|Study terminated by sponsor|6
1211613|NCT00852397|3976712|P2|Overall Study|Study terminated by sponsor|1
1211614|NCT00852397|3976713|P1|Overall Study|Study terminated by sponsor|2
1211615|NCT00852397|3976711|P3|Overall Study|Withdrawal by Subject|2
1211616|NCT00852397|3976712|P2|Overall Study|Withdrawal by Subject|1
1211617|NCT00852397|3976713|P1|Overall Study|Withdrawal by Subject|4
1211618|NCT00852397|3976711|P3|Overall Study|Death|1
1211619|NCT00852397|3976712|P2|Overall Study|Death|0
1211620|NCT00852397|3976713|P1|Overall Study|Death|0
1211621|NCT00852397|3976711|P3|Overall Study|Adverse Event|4
1211622|NCT00852397|3976712|P2|Overall Study|Adverse Event|6
1211623|NCT00852397|3976713|P1|Overall Study|Adverse Event|4
1211624|NCT00852241|3976742|P1|Overall Study|Physician Decision|18
1211625|NCT00852202|3976749|P3|Overall Study|pregnancy,moving away and surgery|2
1211626|NCT00852202|3976750|P2|Overall Study|pregnancy,moving away and surgery|0
1211627|NCT00852202|3976751|P1|Overall Study|pregnancy,moving away and surgery|1
1211628|NCT00852202|3976749|P3|Overall Study|Lost to Follow-up|6
1211629|NCT00852202|3976750|P2|Overall Study|Lost to Follow-up|5
1211630|NCT00852202|3976751|P1|Overall Study|Lost to Follow-up|5
1211631|NCT00852202|3976749|P3|Overall Study|Withdrawal by Subject|2
1211632|NCT00852202|3976750|P2|Overall Study|Withdrawal by Subject|1
1211633|NCT00852202|3976751|P1|Overall Study|Withdrawal by Subject|3
1211634|NCT00852202|3976749|P3|Overall Study|Protocol Violation|7
1211635|NCT00852202|3976750|P2|Overall Study|Protocol Violation|2
1211636|NCT00852202|3976751|P1|Overall Study|Protocol Violation|2
1211637|NCT00852202|3976749|P3|Overall Study|Lack of Efficacy|2
1211638|NCT00852202|3976750|P2|Overall Study|Lack of Efficacy|1
1211639|NCT00852202|3976751|P1|Overall Study|Lack of Efficacy|4
1211640|NCT00852202|3976749|P3|Overall Study|Adverse Event|7
1211641|NCT00852202|3976750|P2|Overall Study|Adverse Event|3
1211642|NCT00852202|3976751|P1|Overall Study|Adverse Event|2
1211643|NCT00851903|3976793|P1|Overall Study|Withdrawal by Subject|2
1211644|NCT00851890|3976807|P4|Overall Study|Lost to Follow-up|1
1211645|NCT00851890|3976808|P3|Overall Study|Lost to Follow-up|0
1211646|NCT00851890|3976809|P2|Overall Study|Lost to Follow-up|1
1211647|NCT00851890|3976810|P1|Overall Study|Lost to Follow-up|0
1211648|NCT00851877|3976867|P3|Phase II|Withdrawal by Subject|3
1211649|NCT00851877|3976868|P2|Phase II|Withdrawal by Subject|0
1211650|NCT00851877|3976869|P1|Phase II|Withdrawal by Subject|0
1211651|NCT00851877|3976867|P3|Phase I-1|Death|0
1211652|NCT00851877|3976868|P2|Phase I-1|Death|0
1211653|NCT00851877|3976869|P1|Phase I-1|Death|1
1211654|NCT00851799|3976879|P3|Overall Study|Completed protocol due to pregnancy|1
1211655|NCT00851799|3976880|P2|Overall Study|Completed protocol due to pregnancy|0
1211656|NCT00851799|3976881|P1|Overall Study|Completed protocol due to pregnancy|0
1211657|NCT00851799|3976879|P3|Overall Study|Severe Debilitation|0
1211658|NCT00851799|3976880|P2|Overall Study|Severe Debilitation|1
1211659|NCT00851799|3976881|P1|Overall Study|Severe Debilitation|0
1211660|NCT00851799|3976879|P3|Overall Study|Withdrew consent prior study completion|1
1211661|NCT00851799|3976880|P2|Overall Study|Withdrew consent prior study completion|2
1211662|NCT00851799|3976881|P1|Overall Study|Withdrew consent prior study completion|1
1211663|NCT00851799|3976879|P3|Overall Study|Not willing to adhere to requirements|2
1211664|NCT00851799|3976880|P2|Overall Study|Not willing to adhere to requirements|2
1211665|NCT00851799|3976881|P1|Overall Study|Not willing to adhere to requirements|1
1211666|NCT00851799|3976879|P3|Overall Study|Not able to get to clinic|9
1211667|NCT00851799|3976880|P2|Overall Study|Not able to get to clinic|5
1211668|NCT00851799|3976881|P1|Overall Study|Not able to get to clinic|8
1211669|NCT00851799|3976879|P3|Overall Study|Lost to Follow-up|10
1211670|NCT00851799|3976880|P2|Overall Study|Lost to Follow-up|3
1211671|NCT00851799|3976881|P1|Overall Study|Lost to Follow-up|5
1211672|NCT00851799|3976879|P3|Overall Study|Death|1
1211673|NCT00851799|3976880|P2|Overall Study|Death|0
1211674|NCT00851799|3976881|P1|Overall Study|Death|1
1211675|NCT00851786|3976969|P2|Overall Study|Cannot Adhere to Protocol Requirement|0
1211676|NCT00851786|3976970|P1|Overall Study|Cannot Adhere to Protocol Requirement|2
1211677|NCT00851786|3976969|P2|Overall Study|Site Closure|0
1211678|NCT00851786|3976970|P1|Overall Study|Site Closure|1
1211679|NCT00851786|3976969|P2|Overall Study|Incarceration|0
1211680|NCT00851786|3976970|P1|Overall Study|Incarceration|1
1211681|NCT00851786|3976969|P2|Overall Study|Lost to Follow-up|0
1211682|NCT00851786|3976970|P1|Overall Study|Lost to Follow-up|1
1211683|NCT00851786|3976969|P2|Overall Study|Protocol Violation|1
1211684|NCT00851786|3976970|P1|Overall Study|Protocol Violation|0
1211685|NCT00851786|3976969|P2|Overall Study|Withdrawal by Subject|1
1211686|NCT00851786|3976970|P1|Overall Study|Withdrawal by Subject|0
1211687|NCT00851747|3976983|P3|Overall Study|Physician Decision|6
1211688|NCT00851747|3976984|P2|Overall Study|Physician Decision|6
1211689|NCT00851747|3976985|P1|Overall Study|Physician Decision|6
1211690|NCT00851721|3976994|P2|Overall Study|Adverse Event|1
1211691|NCT00851721|3976995|P1|Overall Study|Adverse Event|0
1211692|NCT00851721|3976994|P2|Overall Study|Death|0
1211693|NCT00851721|3976995|P1|Overall Study|Death|1
1211694|NCT00851721|3976994|P2|Overall Study|planned surgery|0
1211695|NCT00851721|3976995|P1|Overall Study|planned surgery|1
1211696|NCT00851682|3977085|P2|Overall Study|screen failure|0
1211697|NCT00851682|3977086|P1|Overall Study|screen failure|5
1211698|NCT00851643|3977100|P6|Extension Study (Up to 36 Months)|Moved|1
1211699|NCT00851643|3977101|P5|Extension Study (Up to 36 Months)|Moved|0
1211700|NCT00851643|3977102|P4|Extension Study (Up to 36 Months)|Moved|1
1211701|NCT00851643|3977103|P3|Extension Study (Up to 36 Months)|Moved|1
1211702|NCT00851643|3977104|P2|Extension Study (Up to 36 Months)|Moved|2
1211703|NCT00851643|3977105|P1|Extension Study (Up to 36 Months)|Moved|0
1211704|NCT00851643|3977100|P6|Extension Study (Up to 36 Months)|Lost to Follow-up|0
1211705|NCT00851643|3977101|P5|Extension Study (Up to 36 Months)|Lost to Follow-up|2
1211706|NCT00851643|3977102|P4|Extension Study (Up to 36 Months)|Lost to Follow-up|1
1211707|NCT00851643|3977103|P3|Extension Study (Up to 36 Months)|Lost to Follow-up|4
1211708|NCT00851643|3977104|P2|Extension Study (Up to 36 Months)|Lost to Follow-up|2
1211709|NCT00851643|3977105|P1|Extension Study (Up to 36 Months)|Lost to Follow-up|4
1211710|NCT00851643|3977100|P6|Base Study (Up to 12 Months)|Other|1
1211711|NCT00851643|3977101|P5|Base Study (Up to 12 Months)|Other|0
1211712|NCT00851643|3977102|P4|Base Study (Up to 12 Months)|Other|0
1211713|NCT00851643|3977103|P3|Base Study (Up to 12 Months)|Other|0
1211714|NCT00851643|3977104|P2|Base Study (Up to 12 Months)|Other|0
1211715|NCT00851643|3977105|P1|Base Study (Up to 12 Months)|Other|0
1211716|NCT00851643|3977100|P6|Base Study (Up to 12 Months)|Withdrawal by Subject|0
1211717|NCT00851643|3977101|P5|Base Study (Up to 12 Months)|Withdrawal by Subject|0
1211718|NCT00851643|3977102|P4|Base Study (Up to 12 Months)|Withdrawal by Subject|0
1211719|NCT00851643|3977103|P3|Base Study (Up to 12 Months)|Withdrawal by Subject|0
1211720|NCT00851643|3977104|P2|Base Study (Up to 12 Months)|Withdrawal by Subject|0
1211721|NCT00851643|3977105|P1|Base Study (Up to 12 Months)|Withdrawal by Subject|1
1211722|NCT00851630|3977126|P2|Overall Study|Clinical failure|1
1211723|NCT00851630|3977127|P1|Overall Study|Clinical failure|0
1211724|NCT00851630|3977126|P2|Overall Study|Death|1
1211725|NCT00851630|3977127|P1|Overall Study|Death|2
1211726|NCT00851591|3977141|P2|Overall Study|Withdrawal by Subject|0
1211727|NCT00851591|3977142|P1|Overall Study|Withdrawal by Subject|2
1211728|NCT00851552|3977148|P1|Overall Study|Disease Progression|4
1211729|NCT00851552|3977148|P1|Overall Study|Adverse Event|1
1211730|NCT00851552|3977148|P1|Overall Study|Death|2
1211731|NCT00851318|3977162|P4|Overall Study|Physician Decision|1
1211732|NCT00851318|3977163|P3|Overall Study|Physician Decision|1
1211733|NCT00851318|3977164|P2|Overall Study|Physician Decision|0
1211734|NCT00851318|3977165|P1|Overall Study|Physician Decision|0
1211735|NCT00851318|3977162|P4|Overall Study|Non-compliance with Study Procedures|0
1211736|NCT00851318|3977163|P3|Overall Study|Non-compliance with Study Procedures|1
1211737|NCT00851318|3977164|P2|Overall Study|Non-compliance with Study Procedures|0
1211738|NCT00851318|3977165|P1|Overall Study|Non-compliance with Study Procedures|2
1211739|NCT00851318|3977162|P4|Overall Study|Lack of Efficacy|2
1211740|NCT00851318|3977163|P3|Overall Study|Lack of Efficacy|4
1211741|NCT00851318|3977164|P2|Overall Study|Lack of Efficacy|2
1211742|NCT00851318|3977165|P1|Overall Study|Lack of Efficacy|8
1211743|NCT00851318|3977162|P4|Overall Study|Pregnancy|1
1211744|NCT00851318|3977163|P3|Overall Study|Pregnancy|1
1211745|NCT00851318|3977164|P2|Overall Study|Pregnancy|0
1211746|NCT00851318|3977165|P1|Overall Study|Pregnancy|0
1211747|NCT00851318|3977162|P4|Overall Study|Adverse Event|12
1211748|NCT00851318|3977163|P3|Overall Study|Adverse Event|9
1211749|NCT00851318|3977164|P2|Overall Study|Adverse Event|2
1211750|NCT00851318|3977165|P1|Overall Study|Adverse Event|13
1211751|NCT00851318|3977162|P4|Overall Study|Withdrawal by Subject|3
1211752|NCT00851318|3977163|P3|Overall Study|Withdrawal by Subject|5
1211753|NCT00851318|3977164|P2|Overall Study|Withdrawal by Subject|1
1211754|NCT00851318|3977165|P1|Overall Study|Withdrawal by Subject|7
1211755|NCT00851253|3977201|P2|Overall Study|Disease Progression|0
1211756|NCT00851253|3977202|P1|Overall Study|Disease Progression|1
1211757|NCT00851084|3977212|P2|Overall Study|Not specified|1
1211758|NCT00851084|3977213|P1|Overall Study|Not specified|7
1211759|NCT00851084|3977212|P2|Overall Study|Metastatic surgery|6
1211760|NCT00851084|3977213|P1|Overall Study|Metastatic surgery|6
1211761|NCT00851084|3977212|P2|Overall Study|Withdrawal by Subject|12
1211762|NCT00851084|3977213|P1|Overall Study|Withdrawal by Subject|11
1211763|NCT00851084|3977212|P2|Overall Study|Consent withdrawn|2
1211764|NCT00851084|3977213|P1|Overall Study|Consent withdrawn|0
1211765|NCT00851084|3977212|P2|Overall Study|Physician Decision|14
1211766|NCT00851084|3977213|P1|Overall Study|Physician Decision|13
1211767|NCT00851084|3977212|P2|Overall Study|Poor compliance to protocol|1
1211768|NCT00851084|3977213|P1|Overall Study|Poor compliance to protocol|1
1211769|NCT00851084|3977212|P2|Overall Study|Disease progression|47
1211770|NCT00851084|3977213|P1|Overall Study|Disease progression|52
1211771|NCT00851084|3977212|P2|Overall Study|Adverse Event|36
1211772|NCT00851084|3977213|P1|Overall Study|Adverse Event|26
1211773|NCT00851084|3977212|P2|Overall Study|Randomized but not treated|0
1211774|NCT00851084|3977213|P1|Overall Study|Randomized but not treated|1
1211775|NCT00850759|3977273|P4|Overall Study|Lost to Follow-up|3
1211776|NCT00850759|3977274|P3|Overall Study|Lost to Follow-up|5
1211777|NCT00850759|3977275|P2|Overall Study|Lost to Follow-up|5
1211778|NCT00850759|3977276|P1|Overall Study|Lost to Follow-up|7
1211779|NCT00850564|3977357|P1|Overall Study|Withdrawal by Subject|2
1211780|NCT00850538|3977362|P1|Overall Study|Protocol Violation|2
1211781|NCT00850538|3977362|P1|Overall Study|radiology error|2
1211782|NCT00850538|3977362|P1|Overall Study|Withdrawal by Subject|3
1211783|NCT00850538|3977362|P1|Overall Study|specimen unusable|7
1211784|NCT00850538|3977362|P1|Overall Study|specimen missed due to scheduling error|14
1211785|NCT00850538|3977362|P1|Overall Study|unable/unwilling to complete MRI|13
1211786|NCT00850499|3977368|P2|Overall Study|Lack of Efficacy|1
1211787|NCT00850499|3977369|P1|Overall Study|Lack of Efficacy|0
1211788|NCT00850499|3977368|P2|Overall Study|Adverse Event|1
1211789|NCT00850499|3977369|P1|Overall Study|Adverse Event|3
1211790|NCT00850460|3977383|P2|Overall Study|Lost to Follow-up|4
1211791|NCT00850460|3977384|P1|Overall Study|Lost to Follow-up|4
1211792|NCT00850395|3977398|P1|Overall Study|Other|5
1211793|NCT00850395|3977398|P1|Overall Study|Insufficient clinical response|3
1211794|NCT00850395|3977398|P1|Overall Study|Adverse Event|1
1211795|NCT00850395|3977398|P1|Overall Study|Death|1
1211796|NCT00850343|3977418|P4|Overall Study|Physician Decision|1
1211797|NCT00850343|3977419|P3|Overall Study|Physician Decision|1
1211798|NCT00850343|3977420|P2|Overall Study|Physician Decision|1
1211799|NCT00850343|3977421|P1|Overall Study|Physician Decision|2
1211800|NCT00850343|3977418|P4|Overall Study|Non-compliance with Study Procedures|1
1211801|NCT00850343|3977419|P3|Overall Study|Non-compliance with Study Procedures|1
1211802|NCT00850343|3977420|P2|Overall Study|Non-compliance with Study Procedures|0
1211803|NCT00850343|3977421|P1|Overall Study|Non-compliance with Study Procedures|1
1211804|NCT00850343|3977418|P4|Overall Study|Lack of Efficacy|2
1211805|NCT00850343|3977419|P3|Overall Study|Lack of Efficacy|3
1211806|NCT00850343|3977420|P2|Overall Study|Lack of Efficacy|0
1211807|NCT00850343|3977421|P1|Overall Study|Lack of Efficacy|17
1211808|NCT00850343|3977418|P4|Overall Study|Pregnancy|1
1211809|NCT00850343|3977419|P3|Overall Study|Pregnancy|0
1211810|NCT00850343|3977420|P2|Overall Study|Pregnancy|0
1211811|NCT00850343|3977421|P1|Overall Study|Pregnancy|0
1211812|NCT00850343|3977418|P4|Overall Study|Adverse Event|6
1211813|NCT00850343|3977419|P3|Overall Study|Adverse Event|6
1211814|NCT00850343|3977420|P2|Overall Study|Adverse Event|2
1211815|NCT00850343|3977421|P1|Overall Study|Adverse Event|15
1211816|NCT00850343|3977418|P4|Overall Study|Withdrawal by Subject|2
1211817|NCT00850343|3977419|P3|Overall Study|Withdrawal by Subject|3
1211818|NCT00850343|3977420|P2|Overall Study|Withdrawal by Subject|0
1211819|NCT00850343|3977421|P1|Overall Study|Withdrawal by Subject|11
1211820|NCT00850200|3977451|P1|Overall Study|Withdrawal by Subject|1
1211821|NCT00850174|3977459|P2|Second Intervention|Withdrawal by Subject|0
1211822|NCT00850174|3977460|P1|Second Intervention|Withdrawal by Subject|1
1211823|NCT00850174|3977459|P2|Washout: One Week|Withdrawal by Subject|2
1211824|NCT00850174|3977460|P1|Washout: One Week|Withdrawal by Subject|0
1211825|NCT00850135|3977474|P1|Overall Study|Physician Decision|1
1211826|NCT00850070|3977493|P2|Overall Study|Adverse Event|0
1211827|NCT00850070|3977494|P1|Overall Study|Adverse Event|2
1211828|NCT00850070|3977493|P2|Overall Study|Lack of Efficacy|1
1211829|NCT00850070|3977494|P1|Overall Study|Lack of Efficacy|1
1211830|NCT00849940|3977523|P1|Overall Study|Physician Decision|4
1211831|NCT00849901|3977534|P3|Extension Phase|Lack of Efficacy|1
1211832|NCT00849901|3977535|P2|Extension Phase|Lack of Efficacy|4
1211833|NCT00849901|3977536|P1|Extension Phase|Lack of Efficacy|2
1211834|NCT00849901|3977534|P3|Extension Phase|Physician Decision|0
1211835|NCT00849901|3977535|P2|Extension Phase|Physician Decision|2
1211836|NCT00849901|3977536|P1|Extension Phase|Physician Decision|1
1211837|NCT00849901|3977534|P3|Extension Phase|Parent or Caregiver Decision|4
1211838|NCT00849901|3977535|P2|Extension Phase|Parent or Caregiver Decision|4
1211839|NCT00849901|3977536|P1|Extension Phase|Parent or Caregiver Decision|10
1211840|NCT00849901|3977534|P3|Extension Phase|Withdrawal by Subject|3
1211841|NCT00849901|3977535|P2|Extension Phase|Withdrawal by Subject|6
1211842|NCT00849901|3977536|P1|Extension Phase|Withdrawal by Subject|7
1211843|NCT00849901|3977534|P3|Extension Phase|Protocol Violation|4
1211844|NCT00849901|3977535|P2|Extension Phase|Protocol Violation|2
1211845|NCT00849901|3977536|P1|Extension Phase|Protocol Violation|2
1211846|NCT00849901|3977534|P3|Extension Phase|Lost to Follow-up|1
1211847|NCT00849901|3977535|P2|Extension Phase|Lost to Follow-up|0
1211848|NCT00849901|3977536|P1|Extension Phase|Lost to Follow-up|3
1211849|NCT00849901|3977534|P3|Extension Phase|Adverse Event|4
1211850|NCT00849901|3977535|P2|Extension Phase|Adverse Event|8
1211851|NCT00849901|3977536|P1|Extension Phase|Adverse Event|2
1211852|NCT00849901|3977534|P3|Acute Treatment Phase|Lack of Efficacy|2
1211853|NCT00849901|3977535|P2|Acute Treatment Phase|Lack of Efficacy|3
1211854|NCT00849901|3977536|P1|Acute Treatment Phase|Lack of Efficacy|2
1211855|NCT00849901|3977534|P3|Acute Treatment Phase|Sponsor Decision|0
1211856|NCT00849901|3977535|P2|Acute Treatment Phase|Sponsor Decision|0
1211857|NCT00849901|3977536|P1|Acute Treatment Phase|Sponsor Decision|1
1211858|NCT00849901|3977534|P3|Acute Treatment Phase|Physician Decision|1
1211859|NCT00849901|3977535|P2|Acute Treatment Phase|Physician Decision|1
1211860|NCT00849901|3977536|P1|Acute Treatment Phase|Physician Decision|1
1211861|NCT00849901|3977534|P3|Acute Treatment Phase|Parent or Caregiver Decision|4
1211862|NCT00849901|3977535|P2|Acute Treatment Phase|Parent or Caregiver Decision|5
1211863|NCT00849901|3977536|P1|Acute Treatment Phase|Parent or Caregiver Decision|11
1211864|NCT00849901|3977534|P3|Acute Treatment Phase|Withdrawal by Subject|4
1211865|NCT00849901|3977535|P2|Acute Treatment Phase|Withdrawal by Subject|10
1211866|NCT00849901|3977536|P1|Acute Treatment Phase|Withdrawal by Subject|4
1211867|NCT00849901|3977534|P3|Acute Treatment Phase|Protocol Violation|1
1211868|NCT00849901|3977535|P2|Acute Treatment Phase|Protocol Violation|2
1211869|NCT00849901|3977536|P1|Acute Treatment Phase|Protocol Violation|0
1211870|NCT00849901|3977534|P3|Acute Treatment Phase|Lost to Follow-up|1
1211871|NCT00849901|3977535|P2|Acute Treatment Phase|Lost to Follow-up|4
1211872|NCT00849901|3977536|P1|Acute Treatment Phase|Lost to Follow-up|2
1211873|NCT00849901|3977534|P3|Acute Treatment Phase|Adverse Event|3
1211874|NCT00849901|3977535|P2|Acute Treatment Phase|Adverse Event|1
1211875|NCT00849901|3977536|P1|Acute Treatment Phase|Adverse Event|9
1211876|NCT00849875|3977583|P1|Overall Study|Lost to Follow-up|2
1211877|NCT00849875|3977583|P1|Overall Study|Others|6
1211878|NCT00849875|3977583|P1|Overall Study|Ongoing (unknown completion status)|11
1211879|NCT00849875|3977583|P1|Overall Study|Death|28
1211880|NCT00849797|3977680|P2|Washout: One Week|Withdrawal by Subject|2
1211881|NCT00849797|3977681|P1|Washout: One Week|Withdrawal by Subject|0
1211882|NCT00849797|3977680|P2|First Intervention|Adverse Event|1
1211883|NCT00849797|3977681|P1|First Intervention|Adverse Event|0
1211884|NCT00849797|3977680|P2|First Intervention|bad veins|0
1211885|NCT00849797|3977681|P1|First Intervention|bad veins|1
1211886|NCT00849693|3977699|P4|Extension Phase|Lack of Efficacy|1
1211887|NCT00849693|3977700|P3|Extension Phase|Lack of Efficacy|2
1211888|NCT00849693|3977701|P2|Extension Phase|Lack of Efficacy|2
1211889|NCT00849693|3977702|P1|Extension Phase|Lack of Efficacy|2
1211890|NCT00849693|3977699|P4|Extension Phase|Sponsor decision|1
1211891|NCT00849693|3977700|P3|Extension Phase|Sponsor decision|0
1211892|NCT00849693|3977701|P2|Extension Phase|Sponsor decision|0
1211893|NCT00849693|3977702|P1|Extension Phase|Sponsor decision|1
1211894|NCT00849693|3977699|P4|Extension Phase|Physician Decision|0
1211895|NCT00849693|3977700|P3|Extension Phase|Physician Decision|2
1211896|NCT00849693|3977701|P2|Extension Phase|Physician Decision|1
1211897|NCT00849693|3977702|P1|Extension Phase|Physician Decision|1
1211898|NCT00849693|3977699|P4|Extension Phase|Parent or caregiver decision|5
1211899|NCT00849693|3977700|P3|Extension Phase|Parent or caregiver decision|10
1211900|NCT00849693|3977701|P2|Extension Phase|Parent or caregiver decision|4
1211901|NCT00849693|3977702|P1|Extension Phase|Parent or caregiver decision|9
1211902|NCT00849693|3977699|P4|Extension Phase|Withdrawal by Subject|15
1211903|NCT00849693|3977700|P3|Extension Phase|Withdrawal by Subject|10
1211904|NCT00849693|3977701|P2|Extension Phase|Withdrawal by Subject|9
1211905|NCT00849693|3977702|P1|Extension Phase|Withdrawal by Subject|6
1211906|NCT00849693|3977699|P4|Extension Phase|Protocol Violation|3
1211907|NCT00849693|3977700|P3|Extension Phase|Protocol Violation|2
1211908|NCT00849693|3977701|P2|Extension Phase|Protocol Violation|3
1211909|NCT00849693|3977702|P1|Extension Phase|Protocol Violation|0
1211910|NCT00849693|3977699|P4|Extension Phase|Lost to Follow-up|6
1211911|NCT00849693|3977700|P3|Extension Phase|Lost to Follow-up|6
1211912|NCT00849693|3977701|P2|Extension Phase|Lost to Follow-up|5
1211913|NCT00849693|3977702|P1|Extension Phase|Lost to Follow-up|7
1211914|NCT00849693|3977699|P4|Extension Phase|Adverse Event|7
1211915|NCT00849693|3977700|P3|Extension Phase|Adverse Event|3
1211916|NCT00849693|3977701|P2|Extension Phase|Adverse Event|6
1211917|NCT00849693|3977702|P1|Extension Phase|Adverse Event|4
1211918|NCT00849693|3977699|P4|Acute Treatment Phase|Lack of Efficacy|2
1211919|NCT00849693|3977700|P3|Acute Treatment Phase|Lack of Efficacy|1
1211920|NCT00849693|3977701|P2|Acute Treatment Phase|Lack of Efficacy|3
1211921|NCT00849693|3977702|P1|Acute Treatment Phase|Lack of Efficacy|1
1211922|NCT00849693|3977699|P4|Acute Treatment Phase|Sponsor decision|0
1211923|NCT00849693|3977700|P3|Acute Treatment Phase|Sponsor decision|1
1211924|NCT00849693|3977701|P2|Acute Treatment Phase|Sponsor decision|0
1211925|NCT00849693|3977702|P1|Acute Treatment Phase|Sponsor decision|0
1211926|NCT00849693|3977699|P4|Acute Treatment Phase|Physician Decision|1
1211927|NCT00849693|3977700|P3|Acute Treatment Phase|Physician Decision|2
1211928|NCT00849693|3977701|P2|Acute Treatment Phase|Physician Decision|1
1211929|NCT00849693|3977702|P1|Acute Treatment Phase|Physician Decision|2
1211930|NCT00849693|3977699|P4|Acute Treatment Phase|Parent or caregiver decision|7
1211931|NCT00849693|3977700|P3|Acute Treatment Phase|Parent or caregiver decision|7
1211932|NCT00849693|3977701|P2|Acute Treatment Phase|Parent or caregiver decision|6
1211933|NCT00849693|3977702|P1|Acute Treatment Phase|Parent or caregiver decision|7
1211934|NCT00849693|3977699|P4|Acute Treatment Phase|Withdrawal by Subject|8
1211935|NCT00849693|3977700|P3|Acute Treatment Phase|Withdrawal by Subject|3
1211936|NCT00849693|3977701|P2|Acute Treatment Phase|Withdrawal by Subject|5
1211937|NCT00849693|3977702|P1|Acute Treatment Phase|Withdrawal by Subject|5
1211938|NCT00849693|3977699|P4|Acute Treatment Phase|Protocol Violation|6
1211939|NCT00849693|3977700|P3|Acute Treatment Phase|Protocol Violation|2
1211940|NCT00849693|3977701|P2|Acute Treatment Phase|Protocol Violation|5
1211941|NCT00849693|3977702|P1|Acute Treatment Phase|Protocol Violation|1
1211942|NCT00849693|3977699|P4|Acute Treatment Phase|Lost to Follow-up|9
1211943|NCT00849693|3977700|P3|Acute Treatment Phase|Lost to Follow-up|11
1211944|NCT00849693|3977701|P2|Acute Treatment Phase|Lost to Follow-up|8
1211945|NCT00849693|3977702|P1|Acute Treatment Phase|Lost to Follow-up|5
1211946|NCT00849693|3977699|P4|Acute Treatment Phase|Adverse Event|4
1211947|NCT00849693|3977700|P3|Acute Treatment Phase|Adverse Event|6
1211948|NCT00849693|3977701|P2|Acute Treatment Phase|Adverse Event|7
1211949|NCT00849693|3977702|P1|Acute Treatment Phase|Adverse Event|12
1211950|NCT00849680|3977769|P8|Overall Study|Subject unable to comply with protocol|0
1211951|NCT00849680|3977770|P7|Overall Study|Subject unable to comply with protocol|0
1211952|NCT00849680|3977771|P6|Overall Study|Subject unable to comply with protocol|0
1211953|NCT00849680|3977772|P5|Overall Study|Subject unable to comply with protocol|0
1211954|NCT00849680|3977773|P4|Overall Study|Subject unable to comply with protocol|0
1211955|NCT00849680|3977774|P3|Overall Study|Subject unable to comply with protocol|0
1211956|NCT00849680|3977775|P2|Overall Study|Subject unable to comply with protocol|0
1211957|NCT00849680|3977776|P1|Overall Study|Subject unable to comply with protocol|1
1211958|NCT00849680|3977769|P8|Overall Study|Withdrawal by Subject|1
1211959|NCT00849680|3977770|P7|Overall Study|Withdrawal by Subject|1
1211960|NCT00849680|3977771|P6|Overall Study|Withdrawal by Subject|2
1211961|NCT00849680|3977772|P5|Overall Study|Withdrawal by Subject|2
1211962|NCT00849680|3977773|P4|Overall Study|Withdrawal by Subject|2
1211963|NCT00849680|3977774|P3|Overall Study|Withdrawal by Subject|0
1211964|NCT00849680|3977775|P2|Overall Study|Withdrawal by Subject|0
1211965|NCT00849680|3977776|P1|Overall Study|Withdrawal by Subject|2
1211966|NCT00849680|3977769|P8|Overall Study|Subject moved|2
1211967|NCT00849680|3977770|P7|Overall Study|Subject moved|2
1211968|NCT00849680|3977771|P6|Overall Study|Subject moved|2
1211969|NCT00849680|3977772|P5|Overall Study|Subject moved|0
1211970|NCT00849680|3977773|P4|Overall Study|Subject moved|1
1211971|NCT00849680|3977774|P3|Overall Study|Subject moved|3
1211972|NCT00849680|3977775|P2|Overall Study|Subject moved|0
1211973|NCT00849680|3977776|P1|Overall Study|Subject moved|1
1211974|NCT00849680|3977769|P8|Overall Study|Lost to Follow-up|5
1211975|NCT00849680|3977770|P7|Overall Study|Lost to Follow-up|12
1211976|NCT00849680|3977771|P6|Overall Study|Lost to Follow-up|11
1211977|NCT00849680|3977772|P5|Overall Study|Lost to Follow-up|8
1211978|NCT00849680|3977773|P4|Overall Study|Lost to Follow-up|11
1211979|NCT00849680|3977774|P3|Overall Study|Lost to Follow-up|12
1211980|NCT00849680|3977775|P2|Overall Study|Lost to Follow-up|3
1211981|NCT00849680|3977776|P1|Overall Study|Lost to Follow-up|7
1211982|NCT00849680|3977769|P8|Overall Study|Adverse Event|0
1211983|NCT00849680|3977770|P7|Overall Study|Adverse Event|2
1211984|NCT00849680|3977771|P6|Overall Study|Adverse Event|0
1211985|NCT00849680|3977772|P5|Overall Study|Adverse Event|0
1211986|NCT00849680|3977773|P4|Overall Study|Adverse Event|0
1211987|NCT00849680|3977774|P3|Overall Study|Adverse Event|0
1211988|NCT00849680|3977775|P2|Overall Study|Adverse Event|0
1211989|NCT00849680|3977776|P1|Overall Study|Adverse Event|0
1211990|NCT00849524|3977818|P1|Overall Study|Lack of Efficacy|3
1211991|NCT00849472|3977835|P1|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1
1211992|NCT00849472|3977835|P1|Pazopanib Postsurgery Treatment|Moved|1
1211993|NCT00849472|3977835|P1|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5
1211994|NCT00849472|3977835|P1|Pazopanib Postsurgery Treatment|Adverse Event|19
1211995|NCT00849472|3977835|P1|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1
1211996|NCT00849472|3977835|P1|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1
1211997|NCT00849472|3977835|P1|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4
1211998|NCT00849472|3977835|P1|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52
1211999|NCT00849472|3977835|P1|Weekly Paclitaxel|Physician Decision|3
1212000|NCT00849472|3977835|P1|Weekly Paclitaxel|Withdrawal by Subject|1
1212001|NCT00849472|3977835|P1|Weekly Paclitaxel|Adverse Event|11
1212002|NCT00849472|3977835|P1|Weekly Paclitaxel|Disease Progression|1
1212003|NCT00849472|3977835|P1|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1
1212004|NCT00849472|3977835|P1|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1
1212005|NCT00849472|3977835|P1|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1
1212006|NCT00849472|3977835|P1|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1
1212007|NCT00849472|3977835|P1|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2
1212008|NCT00849381|3977849|P1|Overall Study|Other|4
1212009|NCT00849381|3977849|P1|Overall Study|Withdrawal by Subject|6
1212010|NCT00849381|3977849|P1|Overall Study|Protocol Violation|5
1212011|NCT00849381|3977849|P1|Overall Study|Lost to Follow-up|129
1212012|NCT00849381|3977849|P1|Overall Study|Adverse Event|1
1212013|NCT00849290|3977855|P1|Overall Study|Disease Progression|20
1212014|NCT00849290|3977855|P1|Overall Study|Protocol Violation|5
1212015|NCT00849290|3977855|P1|Overall Study|Lost to Follow-up|2
1212016|NCT00849290|3977855|P1|Overall Study|Withdrawal by Subject|11
1212017|NCT00849290|3977855|P1|Overall Study|Death|14
1212018|NCT00849290|3977855|P1|Overall Study|Adverse Event|3
1212019|NCT00849212|3977866|P1|Overall Study|Miscellaneous|1
1212020|NCT00849212|3977866|P1|Overall Study|Adverse Event|2
1212021|NCT00849212|3977866|P1|Overall Study|Withdrawal by Subject|3
1212022|NCT00849212|3977866|P1|Overall Study|Lack of Efficacy|1
1212023|NCT00849186|3977871|P1|Overall Study|Other|1
1212024|NCT00849186|3977871|P1|Overall Study|not treated|6
1212025|NCT00849186|3977871|P1|Overall Study|Withdrawal by Subject|1
1212026|NCT00849186|3977871|P1|Overall Study|Adverse Event|2
1212027|NCT00849147|3977877|P1|Overall Study|Disease Relapse/Progression|2
1212028|NCT00849147|3977877|P1|Overall Study|Protocol Violation|2
1212029|NCT00849147|3977877|P1|Overall Study|Withdrawal by Subject|1
1212030|NCT00849108|3977910|P2|Cohort 2 Efficacy|Not specified|9
1212031|NCT00849108|3977911|P1|Cohort 2 Efficacy|Not specified|0
1212032|NCT00849108|3977910|P2|Cohort 2 Efficacy|Adverse Event|1
1212033|NCT00849108|3977911|P1|Cohort 2 Efficacy|Adverse Event|0
1212034|NCT00849108|3977910|P2|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0
1212035|NCT00849108|3977911|P1|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1
1212036|NCT00849056|3977921|P2|Follow-up Period (FUP) (8 Weeks)|Early Termination|0
1212037|NCT00849056|3977922|P1|Follow-up Period (FUP) (8 Weeks)|Early Termination|1
1212038|NCT00849056|3977921|P2|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4
1212039|NCT00849056|3977922|P1|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1
1212040|NCT00849056|3977921|P2|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
1212041|NCT00849056|3977922|P1|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
1212042|NCT00849056|3977921|P2|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7
1212043|NCT00849056|3977922|P1|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9
1212044|NCT00849056|3977921|P2|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9
1212045|NCT00849056|3977922|P1|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14
1212046|NCT00849056|3977921|P2|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
1212047|NCT00849056|3977922|P1|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
1212048|NCT00849056|3977921|P2|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3
1212049|NCT00849056|3977922|P1|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
1212050|NCT00849056|3977921|P2|Treatment Period (TP) (156 Weeks)|Pregnancy|0
1212051|NCT00849056|3977922|P1|Treatment Period (TP) (156 Weeks)|Pregnancy|1
1212052|NCT00849056|3977921|P2|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0
1212053|NCT00849056|3977922|P1|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1
1212054|NCT00849056|3977921|P2|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4
1212055|NCT00849056|3977922|P1|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1
1212056|NCT00849056|3977921|P2|Treatment Period (TP) (156 Weeks)|Physician Decision|3
1212057|NCT00849056|3977922|P1|Treatment Period (TP) (156 Weeks)|Physician Decision|3
1212058|NCT00849056|3977921|P2|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18
1212059|NCT00849056|3977922|P1|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31
1212060|NCT00849056|3977921|P2|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5
1212061|NCT00849056|3977922|P1|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
1212062|NCT00849056|3977921|P2|Treatment Period (TP) (156 Weeks)|Noncompliance|3
1212063|NCT00849056|3977922|P1|Treatment Period (TP) (156 Weeks)|Noncompliance|3
1212064|NCT00849056|3977921|P2|Treatment Period (TP) (156 Weeks)|Protocol Violation|6
1212065|NCT00849056|3977922|P1|Treatment Period (TP) (156 Weeks)|Protocol Violation|3
1212066|NCT00849056|3977921|P2|Treatment Period (TP) (156 Weeks)|Adverse Event|11
1212067|NCT00849056|3977922|P1|Treatment Period (TP) (156 Weeks)|Adverse Event|13
1212068|NCT00849017|3977947|P3|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
1212069|NCT00849017|3977948|P2|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
1212070|NCT00849017|3977949|P1|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1
1212071|NCT00849017|3977947|P3|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
1212072|NCT00849017|3977948|P2|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
1212073|NCT00849017|3977949|P1|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3
1212074|NCT00849017|3977947|P3|Follow-up Period (8 Weeks)|Physician Decision|1
1212075|NCT00849017|3977948|P2|Follow-up Period (8 Weeks)|Physician Decision|1
1212076|NCT00849017|3977949|P1|Follow-up Period (8 Weeks)|Physician Decision|0
1212077|NCT00849017|3977947|P3|Follow-up Period (8 Weeks)|Withdrawal by Subject|3
1212078|NCT00849017|3977948|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
1212079|NCT00849017|3977949|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
1212080|NCT00849017|3977947|P3|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4
1212081|NCT00849017|3977948|P2|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
1212082|NCT00849017|3977949|P1|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
1212083|NCT00849017|3977947|P3|Follow-up Period (8 Weeks)|Lost to Follow-up|16
1212084|NCT00849017|3977948|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|12
1212085|NCT00849017|3977949|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|13
1212086|NCT00849017|3977947|P3|Follow-up Period (8 Weeks)|Noncompliance|0
1212087|NCT00849017|3977948|P2|Follow-up Period (8 Weeks)|Noncompliance|1
1212088|NCT00849017|3977949|P1|Follow-up Period (8 Weeks)|Noncompliance|2
1212089|NCT00849017|3977947|P3|Follow-up Period (8 Weeks)|Adverse Event|0
1212090|NCT00849017|3977948|P2|Follow-up Period (8 Weeks)|Adverse Event|0
1212091|NCT00849017|3977949|P1|Follow-up Period (8 Weeks)|Adverse Event|1
1212092|NCT00849017|3977947|P3|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1
1212093|NCT00849017|3977948|P2|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
1212094|NCT00849017|3977949|P1|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
1212095|NCT00849017|3977947|P3|Treatment Period (156 Weeks)|Pregnancy|1
1212096|NCT00849017|3977948|P2|Treatment Period (156 Weeks)|Pregnancy|0
1212097|NCT00849017|3977949|P1|Treatment Period (156 Weeks)|Pregnancy|1
1212098|NCT00849017|3977947|P3|Treatment Period (156 Weeks)|Participant Moved to Africa|0
1212099|NCT00849017|3977948|P2|Treatment Period (156 Weeks)|Participant Moved to Africa|0
1212100|NCT00849017|3977949|P1|Treatment Period (156 Weeks)|Participant Moved to Africa|1
1212101|NCT00849017|3977947|P3|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
1212102|NCT00849017|3977948|P2|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
1212103|NCT00849017|3977949|P1|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1
1212104|NCT00849017|3977947|P3|Treatment Period (156 Weeks)|Increased Calcitonin|0
1212105|NCT00849017|3977948|P2|Treatment Period (156 Weeks)|Increased Calcitonin|0
1212106|NCT00849017|3977949|P1|Treatment Period (156 Weeks)|Increased Calcitonin|1
1212107|NCT00849017|3977947|P3|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
1212108|NCT00849017|3977948|P2|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
1212109|NCT00849017|3977949|P1|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3
1212110|NCT00849017|3977947|P3|Treatment Period (156 Weeks)|Physician Decision|1
1212111|NCT00849017|3977948|P2|Treatment Period (156 Weeks)|Physician Decision|2
1212112|NCT00849017|3977949|P1|Treatment Period (156 Weeks)|Physician Decision|0
1212113|NCT00849017|3977947|P3|Treatment Period (156 Weeks)|Withdrawal by Subject|11
1212114|NCT00849017|3977948|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|14
1212115|NCT00849017|3977949|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|18
1212116|NCT00849017|3977947|P3|Treatment Period (156 Weeks)|Lost to Follow-up|8
1212117|NCT00849017|3977948|P2|Treatment Period (156 Weeks)|Lost to Follow-up|7
1212118|NCT00849017|3977949|P1|Treatment Period (156 Weeks)|Lost to Follow-up|10
1212119|NCT00849017|3977947|P3|Treatment Period (156 Weeks)|Noncompliance|4
1212120|NCT00849017|3977948|P2|Treatment Period (156 Weeks)|Noncompliance|3
1212121|NCT00849017|3977949|P1|Treatment Period (156 Weeks)|Noncompliance|3
1212122|NCT00849017|3977947|P3|Treatment Period (156 Weeks)|Adverse Event|15
1212123|NCT00849017|3977948|P2|Treatment Period (156 Weeks)|Adverse Event|6
1212124|NCT00849017|3977949|P1|Treatment Period (156 Weeks)|Adverse Event|5
1212125|NCT00848965|3977992|P1|Overall Study|Withdrawal by Subject|1
1212126|NCT00848965|3977992|P1|Overall Study|Adverse Event|1
1212127|NCT00848926|3978034|P1|Follow-up Period|Not specified|2
1212128|NCT00848926|3978034|P1|Follow-up Period|Withdrawal by Subject|3
1212129|NCT00848926|3978034|P1|Follow-up Period|Lost to Follow-up|7
1212130|NCT00848926|3978034|P1|Treatment Period|Withdrawal by Subject|7
1212131|NCT00848926|3978034|P1|Treatment Period|Physician Decision|12
1212132|NCT00848926|3978034|P1|Treatment Period|Adverse Event|20
1212133|NCT00848926|3978034|P1|Treatment Period|Progressive disease|45
1212134|NCT00848549|3978073|P2|E2090-E044-314 (Extension Study)|Not Specified|6
1212135|NCT00848549|3978074|P1|E2090-E044-314 (Extension Study)|Not Specified|5
1212136|NCT00848549|3978073|P2|E2090-E044-314 (Extension Study)|Physician Decision|2
1212137|NCT00848549|3978074|P1|E2090-E044-314 (Extension Study)|Physician Decision|0
1212138|NCT00848549|3978073|P2|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
1212139|NCT00848549|3978074|P1|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
1212140|NCT00848549|3978073|P2|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12
1212141|NCT00848549|3978074|P1|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8
1212142|NCT00848549|3978073|P2|E2090-E044-314 (Extension Study)|Protocol Violation|2
1212143|NCT00848549|3978074|P1|E2090-E044-314 (Extension Study)|Protocol Violation|1
1212144|NCT00848549|3978073|P2|E2090-E044-314 (Extension Study)|Adverse Event|1
1212145|NCT00848549|3978074|P1|E2090-E044-314 (Extension Study)|Adverse Event|2
1212146|NCT00848549|3978073|P2|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34
1212147|NCT00848549|3978074|P1|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24
1212148|NCT00848549|3978073|P2|E2090-E044-310 (Base Study) Disposition|Not Specified|3
1212149|NCT00848549|3978074|P1|E2090-E044-310 (Base Study) Disposition|Not Specified|4
1212150|NCT00848549|3978073|P2|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11
1212151|NCT00848549|3978074|P1|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21
1212152|NCT00848549|3978073|P2|E2090-E044-310 (Base Study) Disposition|Physician Decision|5
1212153|NCT00848549|3978074|P1|E2090-E044-310 (Base Study) Disposition|Physician Decision|4
1212154|NCT00848549|3978073|P2|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8
1212155|NCT00848549|3978074|P1|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3
1212156|NCT00848549|3978073|P2|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
1212157|NCT00848549|3978074|P1|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
1212158|NCT00848549|3978073|P2|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24
1212159|NCT00848549|3978074|P1|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35
1212160|NCT00848549|3978073|P2|E2090-E044-310 (Base Study) Disposition|Adverse Event|35
1212161|NCT00848549|3978074|P1|E2090-E044-310 (Base Study) Disposition|Adverse Event|31
1212162|NCT00848536|3978092|P2|Overall Study|Patient Moved|2
1212163|NCT00848536|3978093|P1|Overall Study|Patient Moved|0
1212164|NCT00848536|3978092|P2|Overall Study|Inadequate Control of IOP|1
1212165|NCT00848536|3978093|P1|Overall Study|Inadequate Control of IOP|1
1212166|NCT00848536|3978092|P2|Overall Study|Noncompliance|0
1212167|NCT00848536|3978093|P1|Overall Study|Noncompliance|1
1212168|NCT00848536|3978092|P2|Overall Study|Protocol Violation|1
1212169|NCT00848536|3978093|P1|Overall Study|Protocol Violation|0
1212170|NCT00848536|3978092|P2|Overall Study|Withdrawal by Subject|1
1212171|NCT00848536|3978093|P1|Overall Study|Withdrawal by Subject|0
1212172|NCT00848536|3978092|P2|Overall Study|Adverse Event|2
1212173|NCT00848536|3978093|P1|Overall Study|Adverse Event|2
1212174|NCT00848497|3978158|P2|Overall Study|Withdrawal by Subject|1
1212175|NCT00848497|3978159|P1|Overall Study|Withdrawal by Subject|0
1212176|NCT00848497|3978158|P2|Overall Study|Screen failure|0
1212177|NCT00848497|3978159|P1|Overall Study|Screen failure|2
1212178|NCT00848484|3978173|P2|Second Intervention (Treatment Period 2)|Lost to Follow-up|1
1212179|NCT00848484|3978174|P1|Second Intervention (Treatment Period 2)|Lost to Follow-up|0
1212180|NCT00848484|3978173|P2|Washout Period of Two Weeks|Withdrawal by Subject|3
1212181|NCT00848484|3978174|P1|Washout Period of Two Weeks|Withdrawal by Subject|0
1212182|NCT00848484|3978173|P2|First Intervention (Treatment Period 1)|Withdrawal by Subject|1
1212183|NCT00848484|3978174|P1|First Intervention (Treatment Period 1)|Withdrawal by Subject|0
1212184|NCT00848484|3978173|P2|First Intervention (Treatment Period 1)|Physician Decision|1
1212185|NCT00848484|3978174|P1|First Intervention (Treatment Period 1)|Physician Decision|0
1212186|NCT00848484|3978173|P2|First Intervention (Treatment Period 1)|Adverse Event|1
1212187|NCT00848484|3978174|P1|First Intervention (Treatment Period 1)|Adverse Event|2
1212188|NCT00848393|3978193|P3|Overall Study|surgical complications unrelated to stud|2
1212189|NCT00848393|3978194|P2|Overall Study|surgical complications unrelated to stud|0
1212190|NCT00848393|3978195|P1|Overall Study|surgical complications unrelated to stud|0
1212191|NCT00848393|3978193|P3|Overall Study|Protocol Violation|1
1212192|NCT00848393|3978194|P2|Overall Study|Protocol Violation|0
1212193|NCT00848393|3978195|P1|Overall Study|Protocol Violation|0
1212194|NCT00848354|3978234|P2|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0
1212195|NCT00848354|3978235|P1|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2
1212196|NCT00848354|3978234|P2|Phase 2 Year 2|Subject Request|1
1212197|NCT00848354|3978235|P1|Phase 2 Year 2|Subject Request|1
1212198|NCT00848354|3978234|P2|Phase 2 Year 2|Protocol Violation|1
1212199|NCT00848354|3978235|P1|Phase 2 Year 2|Protocol Violation|1
1212200|NCT00848354|3978234|P2|Phase 2 Year 2|Unspecified Reason|0
1212201|NCT00848354|3978235|P1|Phase 2 Year 2|Unspecified Reason|1
1212202|NCT00848354|3978234|P2|Phase 2 Year 2|Lost to Follow-up|3
1212203|NCT00848354|3978235|P1|Phase 2 Year 2|Lost to Follow-up|1
1212204|NCT00848354|3978234|P2|Phase 2 Year 2|Failed to return|0
1212205|NCT00848354|3978235|P1|Phase 2 Year 2|Failed to return|3
1212206|NCT00848354|3978234|P2|Phase 2 Year 2|Death|0
1212207|NCT00848354|3978235|P1|Phase 2 Year 2|Death|2
1212208|NCT00848354|3978234|P2|Phase 2 Year 2|Adverse Event|2
1212209|NCT00848354|3978235|P1|Phase 2 Year 2|Adverse Event|12
1212210|NCT00848354|3978234|P2|Phase 2 Year 1|Subject Request|2
1212211|NCT00848354|3978235|P1|Phase 2 Year 1|Subject Request|1
1212212|NCT00848354|3978234|P2|Phase 2 Year 1|Protocol Violation|1
1212213|NCT00848354|3978235|P1|Phase 2 Year 1|Protocol Violation|4
1212214|NCT00848354|3978234|P2|Phase 2 Year 1|Unspecified Reason|0
1212215|NCT00848354|3978235|P1|Phase 2 Year 1|Unspecified Reason|3
1212216|NCT00848354|3978234|P2|Phase 2 Year 1|Lost to Follow-up|0
1212217|NCT00848354|3978235|P1|Phase 2 Year 1|Lost to Follow-up|1
1212218|NCT00848354|3978234|P2|Phase 2 Year 1|Failed to Return|1
1212219|NCT00848354|3978235|P1|Phase 2 Year 1|Failed to Return|1
1212220|NCT00848354|3978234|P2|Phase 2 Year 1|Death|0
1212221|NCT00848354|3978235|P1|Phase 2 Year 1|Death|1
1212222|NCT00848354|3978234|P2|Phase 2 Year 1|Adverse Event|2
1212223|NCT00848354|3978235|P1|Phase 2 Year 1|Adverse Event|7
1212224|NCT00848354|3978234|P2|Phase 1|Lack of Efficacy|1
1212225|NCT00848354|3978235|P1|Phase 1|Lack of Efficacy|0
1212226|NCT00848354|3978234|P2|Phase 1|Withdrawal by Subject|4
1212227|NCT00848354|3978235|P1|Phase 1|Withdrawal by Subject|2
1212228|NCT00848354|3978234|P2|Phase 1|Protocol Violation|1
1212229|NCT00848354|3978235|P1|Phase 1|Protocol Violation|1
1212230|NCT00848354|3978234|P2|Phase 1|Unspecified Reason|1
1212231|NCT00848354|3978235|P1|Phase 1|Unspecified Reason|1
1212232|NCT00848354|3978234|P2|Phase 1|Lost to Follow-up|1
1212233|NCT00848354|3978235|P1|Phase 1|Lost to Follow-up|1
1212234|NCT00848354|3978234|P2|Phase 1|Failed to return|1
1212235|NCT00848354|3978235|P1|Phase 1|Failed to return|0
1212236|NCT00848354|3978234|P2|Phase 1|Discontinuation of study by sponsor|1
1212237|NCT00848354|3978235|P1|Phase 1|Discontinuation of study by sponsor|2
1212238|NCT00848354|3978234|P2|Phase 1|Adverse Event|4
1212239|NCT00848354|3978235|P1|Phase 1|Adverse Event|5
1212240|NCT00848250|3978387|P2|Overall Study|surgery was completed without cardiopulm|1
1212241|NCT00848250|3978388|P1|Overall Study|surgery was completed without cardiopulm|0
1212242|NCT00848211|3978419|P4|Overall Study|Adverse Event|0
1212243|NCT00848211|3978420|P3|Overall Study|Adverse Event|0
1212244|NCT00848211|3978421|P2|Overall Study|Adverse Event|0
1212245|NCT00848211|3978422|P1|Overall Study|Adverse Event|0
1212246|NCT00848211|3978419|P4|Overall Study|Protocol Violation|0
1212247|NCT00848211|3978420|P3|Overall Study|Protocol Violation|1
1212248|NCT00848211|3978421|P2|Overall Study|Protocol Violation|1
1212249|NCT00848211|3978422|P1|Overall Study|Protocol Violation|0
1212250|NCT00848198|3978440|P1|Overall Study|Incomplete Case Report Forms|15
1212251|NCT00848120|3978505|P1|Overall Study|Adverse Event|1
1212252|NCT00848107|3978517|P1|Overall Study|Pregnancy|1
1212253|NCT00848107|3978517|P1|Overall Study|Death|1
1212254|NCT00848107|3978517|P1|Overall Study|Adverse Event|9
1212255|NCT00848107|3978517|P1|Overall Study|Withdrawal by Subject|8
1212256|NCT00848107|3978517|P1|Overall Study|Lost to Follow-up|2
1212257|NCT00848081|3978527|P2|Overall Study|Withdrawal by Subject|3
1212258|NCT00848081|3978528|P1|Overall Study|Withdrawal by Subject|5
1212259|NCT00848081|3978527|P2|Overall Study|Physician Decision|3
1212260|NCT00848081|3978528|P1|Overall Study|Physician Decision|0
1212261|NCT00848081|3978527|P2|Overall Study|Lost to Follow-up|0
1212262|NCT00848081|3978528|P1|Overall Study|Lost to Follow-up|1
1212263|NCT00848081|3978527|P2|Overall Study|Protocol Violation|5
1212264|NCT00848081|3978528|P1|Overall Study|Protocol Violation|8
1212265|NCT00848081|3978527|P2|Overall Study|Adverse Event|7
1212266|NCT00848081|3978528|P1|Overall Study|Adverse Event|6
1212267|NCT00848042|3978545|P3|Overall Study|Other Therapy|0
1212268|NCT00848042|3978546|P2|Overall Study|Other Therapy|0
1212269|NCT00848042|3978547|P1|Overall Study|Other Therapy|3
1212270|NCT00848042|3978545|P3|Overall Study|Death|0
1212271|NCT00848042|3978546|P2|Overall Study|Death|2
1212272|NCT00848042|3978547|P1|Overall Study|Death|1
1212273|NCT00847912|3978566|P2|Overall Study|Withdrawal by Subject|6
1212274|NCT00847912|3978567|P1|Overall Study|Withdrawal by Subject|3
1212275|NCT00847912|3978566|P2|Overall Study|Protocol Violation|7
1212276|NCT00847912|3978567|P1|Overall Study|Protocol Violation|6
1212277|NCT00847886|3978577|P2|Overall Study|Adverse Event|1
1212278|NCT00847886|3978578|P1|Overall Study|Adverse Event|0
1212279|NCT00847808|3978604|P1|Overall Study|Participant Took Excluded Medication|1
1212280|NCT00847808|3978604|P1|Overall Study|Participant Reported Lack of Efficacy|1
1212281|NCT00847808|3978604|P1|Overall Study|Withdrawal by Subject|4
1212282|NCT00847808|3978604|P1|Overall Study|Lost to Follow-up|1
1212283|NCT00847808|3978604|P1|Overall Study|Protocol Violation|1
1212284|NCT00847808|3978604|P1|Overall Study|Adverse Event|7
1212285|NCT00847704|3978621|P1|Overall Study|Withdrawal by Subject|1
1212286|NCT00847665|3978632|P2|Overall Study|Withdrawal by Subject|0
1212287|NCT00847665|3978633|P1|Overall Study|Withdrawal by Subject|1
1212288|NCT00847626|3978656|P11|Overall Study|Other|3
1212289|NCT00847626|3978657|P10|Overall Study|Other|1
1212290|NCT00847626|3978658|P9|Overall Study|Other|1
1212291|NCT00847626|3978659|P8|Overall Study|Other|3
1212292|NCT00847626|3978660|P7|Overall Study|Other|2
1212293|NCT00847626|3978661|P6|Overall Study|Other|2
1212294|NCT00847626|3978662|P5|Overall Study|Other|2
1212295|NCT00847626|3978663|P4|Overall Study|Other|1
1212296|NCT00847626|3978664|P3|Overall Study|Other|4
1212297|NCT00847626|3978665|P2|Overall Study|Other|5
1212298|NCT00847626|3978666|P1|Overall Study|Other|1
1212299|NCT00847626|3978656|P11|Overall Study|Lack of Efficacy|7
1212300|NCT00847626|3978657|P10|Overall Study|Lack of Efficacy|1
1212301|NCT00847626|3978658|P9|Overall Study|Lack of Efficacy|5
1212302|NCT00847626|3978659|P8|Overall Study|Lack of Efficacy|2
1212303|NCT00847626|3978660|P7|Overall Study|Lack of Efficacy|6
1212304|NCT00847626|3978661|P6|Overall Study|Lack of Efficacy|0
1212305|NCT00847626|3978662|P5|Overall Study|Lack of Efficacy|2
1212306|NCT00847626|3978663|P4|Overall Study|Lack of Efficacy|1
1212307|NCT00847626|3978664|P3|Overall Study|Lack of Efficacy|0
1212308|NCT00847626|3978665|P2|Overall Study|Lack of Efficacy|1
1212309|NCT00847626|3978666|P1|Overall Study|Lack of Efficacy|3
1212310|NCT00847626|3978656|P11|Overall Study|Withdrawal by Subject|2
1212311|NCT00847626|3978657|P10|Overall Study|Withdrawal by Subject|5
1212312|NCT00847626|3978658|P9|Overall Study|Withdrawal by Subject|4
1212313|NCT00847626|3978659|P8|Overall Study|Withdrawal by Subject|4
1212314|NCT00847626|3978660|P7|Overall Study|Withdrawal by Subject|8
1212315|NCT00847626|3978661|P6|Overall Study|Withdrawal by Subject|9
1212316|NCT00847626|3978662|P5|Overall Study|Withdrawal by Subject|12
1212317|NCT00847626|3978663|P4|Overall Study|Withdrawal by Subject|8
1212318|NCT00847626|3978664|P3|Overall Study|Withdrawal by Subject|3
1212319|NCT00847626|3978665|P2|Overall Study|Withdrawal by Subject|5
1212320|NCT00847626|3978666|P1|Overall Study|Withdrawal by Subject|5
1212321|NCT00847626|3978656|P11|Overall Study|Lost to Follow-up|1
1212322|NCT00847626|3978657|P10|Overall Study|Lost to Follow-up|0
1212323|NCT00847626|3978658|P9|Overall Study|Lost to Follow-up|1
1212324|NCT00847626|3978659|P8|Overall Study|Lost to Follow-up|3
1212325|NCT00847626|3978660|P7|Overall Study|Lost to Follow-up|1
1212326|NCT00847626|3978661|P6|Overall Study|Lost to Follow-up|3
1212327|NCT00847626|3978662|P5|Overall Study|Lost to Follow-up|0
1212328|NCT00847626|3978663|P4|Overall Study|Lost to Follow-up|1
1212329|NCT00847626|3978664|P3|Overall Study|Lost to Follow-up|1
1212330|NCT00847626|3978665|P2|Overall Study|Lost to Follow-up|1
1212331|NCT00847626|3978666|P1|Overall Study|Lost to Follow-up|0
1212332|NCT00847626|3978656|P11|Overall Study|Protocol Violation|1
1212333|NCT00847626|3978657|P10|Overall Study|Protocol Violation|1
1212334|NCT00847626|3978658|P9|Overall Study|Protocol Violation|0
1212335|NCT00847626|3978659|P8|Overall Study|Protocol Violation|1
1212336|NCT00847626|3978660|P7|Overall Study|Protocol Violation|1
1212337|NCT00847626|3978661|P6|Overall Study|Protocol Violation|1
1212338|NCT00847626|3978662|P5|Overall Study|Protocol Violation|1
1212339|NCT00847626|3978663|P4|Overall Study|Protocol Violation|1
1212340|NCT00847626|3978664|P3|Overall Study|Protocol Violation|2
1212341|NCT00847626|3978665|P2|Overall Study|Protocol Violation|1
1212342|NCT00847626|3978666|P1|Overall Study|Protocol Violation|2
1212343|NCT00847626|3978656|P11|Overall Study|Adverse Event|6
1212344|NCT00847626|3978657|P10|Overall Study|Adverse Event|6
1212345|NCT00847626|3978658|P9|Overall Study|Adverse Event|3
1212346|NCT00847626|3978659|P8|Overall Study|Adverse Event|6
1212347|NCT00847626|3978660|P7|Overall Study|Adverse Event|4
1212348|NCT00847626|3978661|P6|Overall Study|Adverse Event|22
1212349|NCT00847626|3978662|P5|Overall Study|Adverse Event|11
1212350|NCT00847626|3978663|P4|Overall Study|Adverse Event|19
1212351|NCT00847626|3978664|P3|Overall Study|Adverse Event|6
1212352|NCT00847626|3978665|P2|Overall Study|Adverse Event|10
1212353|NCT00847626|3978666|P1|Overall Study|Adverse Event|10
1212354|NCT00847613|3978865|P4|Overall Study|Other|0
1212355|NCT00847613|3978866|P3|Overall Study|Other|2
1212356|NCT00847613|3978867|P2|Overall Study|Other|1
1212357|NCT00847613|3978868|P1|Overall Study|Other|1
1212358|NCT00847613|3978865|P4|Overall Study|Randomized, but not treated|0
1212359|NCT00847613|3978866|P3|Overall Study|Randomized, but not treated|0
1212360|NCT00847613|3978867|P2|Overall Study|Randomized, but not treated|3
1212361|NCT00847613|3978868|P1|Overall Study|Randomized, but not treated|0
1212362|NCT00847613|3978865|P4|Overall Study|Sponsor request|0
1212363|NCT00847613|3978866|P3|Overall Study|Sponsor request|0
1212364|NCT00847613|3978867|P2|Overall Study|Sponsor request|1
1212365|NCT00847613|3978868|P1|Overall Study|Sponsor request|0
1212366|NCT00847613|3978865|P4|Overall Study|Participant moved|0
1212367|NCT00847613|3978866|P3|Overall Study|Participant moved|0
1212368|NCT00847613|3978867|P2|Overall Study|Participant moved|1
1212369|NCT00847613|3978868|P1|Overall Study|Participant moved|4
1212370|NCT00847613|3978865|P4|Overall Study|Withdrawal by Subject|2
1212371|NCT00847613|3978866|P3|Overall Study|Withdrawal by Subject|2
1212372|NCT00847613|3978867|P2|Overall Study|Withdrawal by Subject|11
1212373|NCT00847613|3978868|P1|Overall Study|Withdrawal by Subject|8
1212374|NCT00847613|3978865|P4|Overall Study|Site closure|1
1212375|NCT00847613|3978866|P3|Overall Study|Site closure|0
1212376|NCT00847613|3978867|P2|Overall Study|Site closure|0
1212377|NCT00847613|3978868|P1|Overall Study|Site closure|1
1212378|NCT00847613|3978865|P4|Overall Study|Pregnancy|0
1212379|NCT00847613|3978866|P3|Overall Study|Pregnancy|0
1212380|NCT00847613|3978867|P2|Overall Study|Pregnancy|1
1212381|NCT00847613|3978868|P1|Overall Study|Pregnancy|1
1212382|NCT00847613|3978865|P4|Overall Study|Protocol Violation|1
1212383|NCT00847613|3978866|P3|Overall Study|Protocol Violation|3
1212384|NCT00847613|3978867|P2|Overall Study|Protocol Violation|6
1212385|NCT00847613|3978868|P1|Overall Study|Protocol Violation|6
1212386|NCT00847613|3978865|P4|Overall Study|Lost to Follow-up|3
1212387|NCT00847613|3978866|P3|Overall Study|Lost to Follow-up|0
1212388|NCT00847613|3978867|P2|Overall Study|Lost to Follow-up|0
1212389|NCT00847613|3978868|P1|Overall Study|Lost to Follow-up|5
1212390|NCT00847613|3978865|P4|Overall Study|Study terminated by Sponsor|1
1212391|NCT00847613|3978866|P3|Overall Study|Study terminated by Sponsor|2
1212392|NCT00847613|3978867|P2|Overall Study|Study terminated by Sponsor|0
1212393|NCT00847613|3978868|P1|Overall Study|Study terminated by Sponsor|1
1212394|NCT00847613|3978865|P4|Overall Study|Lack of Efficacy|1
1212395|NCT00847613|3978866|P3|Overall Study|Lack of Efficacy|3
1212396|NCT00847613|3978867|P2|Overall Study|Lack of Efficacy|3
1212397|NCT00847613|3978868|P1|Overall Study|Lack of Efficacy|7
1212398|NCT00847613|3978865|P4|Overall Study|Adverse Event|6
1212399|NCT00847613|3978866|P3|Overall Study|Adverse Event|5
1212400|NCT00847613|3978867|P2|Overall Study|Adverse Event|26
1212401|NCT00847613|3978868|P1|Overall Study|Adverse Event|36
1212402|NCT00847613|3978865|P4|Overall Study|Death|0
1212403|NCT00847613|3978866|P3|Overall Study|Death|0
1212404|NCT00847613|3978867|P2|Overall Study|Death|1
1212405|NCT00847613|3978868|P1|Overall Study|Death|1
1212406|NCT00847613|3978865|P4|Overall Study|Ongoing at cut-off date|64
1212407|NCT00847613|3978866|P3|Overall Study|Ongoing at cut-off date|64
1212408|NCT00847613|3978867|P2|Overall Study|Ongoing at cut-off date|265
1212409|NCT00847613|3978868|P1|Overall Study|Ongoing at cut-off date|250
1212410|NCT00847561|3979119|P2|Overall Study|Unable to schedule|1
1212411|NCT00847561|3979120|P1|Overall Study|Unable to schedule|9
1212412|NCT00847561|3979119|P2|Overall Study|Withdrawal by Subject|3
1212413|NCT00847561|3979120|P1|Overall Study|Withdrawal by Subject|4
1212414|NCT00847535|3979126|P3|Overall Study|Lost to Follow-up|0
1212415|NCT00847535|3979127|P2|Overall Study|Lost to Follow-up|1
1212416|NCT00847535|3979128|P1|Overall Study|Lost to Follow-up|0
1212417|NCT00847535|3979126|P3|Overall Study|Withdrawal by Subject|1
1212418|NCT00847535|3979127|P2|Overall Study|Withdrawal by Subject|1
1212419|NCT00847535|3979128|P1|Overall Study|Withdrawal by Subject|2
1212420|NCT00847405|3979147|P2|Washout of 7 Days|Withdrawal by Subject|0
1212421|NCT00847405|3979148|P1|Washout of 7 Days|Withdrawal by Subject|1
1212422|NCT00847405|3979147|P2|First Intervention|Adverse Event|1
1212423|NCT00847405|3979148|P1|First Intervention|Adverse Event|0
1212424|NCT00847301|3979156|P1|Overall Study|Other reason not defined above|1
1212425|NCT00847301|3979156|P1|Overall Study|No prescription after hospital discharge|1
1212426|NCT00847301|3979156|P1|Overall Study|Lost to Follow-up|1
1212427|NCT00847301|3979156|P1|Overall Study|Switch to other anticoagulants|16
1212428|NCT00847301|3979156|P1|Overall Study|Adverse Event|35
1212429|NCT00847197|3979204|P2|Overall Study|Withdrawal by Subject|1
1212430|NCT00847197|3979205|P1|Overall Study|Withdrawal by Subject|3
1212431|NCT00847197|3979204|P2|Overall Study|Protocol Violation|1
1212432|NCT00847197|3979205|P1|Overall Study|Protocol Violation|0
1212433|NCT00847197|3979204|P2|Overall Study|Adverse Event|3
1212434|NCT00847197|3979205|P1|Overall Study|Adverse Event|21
1212435|NCT00847145|3979229|P8|Overall Study|Protocol Violation|1
1212436|NCT00847145|3979230|P7|Overall Study|Protocol Violation|0
1212437|NCT00847145|3979231|P6|Overall Study|Protocol Violation|0
1212438|NCT00847145|3979232|P5|Overall Study|Protocol Violation|1
1212439|NCT00847145|3979233|P4|Overall Study|Protocol Violation|0
1212440|NCT00847145|3979234|P3|Overall Study|Protocol Violation|3
1212441|NCT00847145|3979235|P2|Overall Study|Protocol Violation|0
1212442|NCT00847145|3979236|P1|Overall Study|Protocol Violation|0
1212443|NCT00847145|3979229|P8|Overall Study|Inappropriate enrollment|0
1212444|NCT00847145|3979230|P7|Overall Study|Inappropriate enrollment|0
1212445|NCT00847145|3979231|P6|Overall Study|Inappropriate enrollment|0
1212446|NCT00847145|3979232|P5|Overall Study|Inappropriate enrollment|1
1212447|NCT00847145|3979233|P4|Overall Study|Inappropriate enrollment|0
1212448|NCT00847145|3979234|P3|Overall Study|Inappropriate enrollment|0
1212449|NCT00847145|3979235|P2|Overall Study|Inappropriate enrollment|0
1212450|NCT00847145|3979236|P1|Overall Study|Inappropriate enrollment|0
1212451|NCT00847145|3979229|P8|Overall Study|Lost to Follow-up|2
1212452|NCT00847145|3979230|P7|Overall Study|Lost to Follow-up|8
1212453|NCT00847145|3979231|P6|Overall Study|Lost to Follow-up|4
1212454|NCT00847145|3979232|P5|Overall Study|Lost to Follow-up|4
1212455|NCT00847145|3979233|P4|Overall Study|Lost to Follow-up|0
1212456|NCT00847145|3979234|P3|Overall Study|Lost to Follow-up|1
1212457|NCT00847145|3979235|P2|Overall Study|Lost to Follow-up|1
1212458|NCT00847145|3979236|P1|Overall Study|Lost to Follow-up|3
1212459|NCT00847145|3979229|P8|Overall Study|Withdrawal by Subject|1
1212460|NCT00847145|3979230|P7|Overall Study|Withdrawal by Subject|1
1212461|NCT00847145|3979231|P6|Overall Study|Withdrawal by Subject|0
1212462|NCT00847145|3979232|P5|Overall Study|Withdrawal by Subject|0
1212463|NCT00847145|3979233|P4|Overall Study|Withdrawal by Subject|1
1212464|NCT00847145|3979234|P3|Overall Study|Withdrawal by Subject|6
1212465|NCT00847145|3979235|P2|Overall Study|Withdrawal by Subject|4
1212466|NCT00847145|3979236|P1|Overall Study|Withdrawal by Subject|3
1212467|NCT00847145|3979229|P8|Overall Study|AE or Death|0
1212468|NCT00847145|3979230|P7|Overall Study|AE or Death|0
1212469|NCT00847145|3979231|P6|Overall Study|AE or Death|0
1212470|NCT00847145|3979232|P5|Overall Study|AE or Death|0
1212471|NCT00847145|3979233|P4|Overall Study|AE or Death|0
1212472|NCT00847145|3979234|P3|Overall Study|AE or Death|1
1212473|NCT00847145|3979235|P2|Overall Study|AE or Death|1
1212474|NCT00847145|3979236|P1|Overall Study|AE or Death|0
1212475|NCT00847132|3979286|P2|Overall Study|Death|1
1212476|NCT00847132|3979287|P1|Overall Study|Death|1
1212477|NCT00847015|3979295|P1|Overall Study|partial cystectomy vs radical cystectomy|1
1212478|NCT00847015|3979295|P1|Overall Study|declined any surgery|1
1212479|NCT00847015|3979295|P1|Overall Study|Withdrawal by Subject|1
1212480|NCT00846846|3979323|P1|Overall Study|Withdrawal by Subject|19
1212481|NCT00846846|3979323|P1|Overall Study|Death|56
1212482|NCT00846807|3979328|P1|Overall Study|Other|60
1212483|NCT00846807|3979328|P1|Overall Study|No prescription after hospital discharge|56
1212484|NCT00846807|3979328|P1|Overall Study|Switch to other anticoagulants|89
1212485|NCT00846807|3979328|P1|Overall Study|Non compliant with European label|7
1212486|NCT00846807|3979328|P1|Overall Study|Withdrawal by Subject|56
1212487|NCT00846807|3979328|P1|Overall Study|Lost to Follow-up|94
1212488|NCT00846807|3979328|P1|Overall Study|Adverse Event|270
1212489|NCT00846768|3979336|P4|Overall Study|Adverse Event|0
1212490|NCT00846768|3979337|P3|Overall Study|Adverse Event|0
1212491|NCT00846768|3979338|P2|Overall Study|Adverse Event|1
1212492|NCT00846768|3979339|P1|Overall Study|Adverse Event|0
1212493|NCT00846586|3979430|P2|Overall Study|Unsatisfactory therapeutic effect|1
1212494|NCT00846586|3979431|P1|Overall Study|Unsatisfactory therapeutic effect|0
1212495|NCT00846586|3979430|P2|Overall Study|Lost to Follow-up|4
1212496|NCT00846586|3979431|P1|Overall Study|Lost to Follow-up|1
1212497|NCT00846586|3979430|P2|Overall Study|Abnormal test procedure result(s)|0
1212498|NCT00846586|3979431|P1|Overall Study|Abnormal test procedure result(s)|1
1212499|NCT00846586|3979430|P2|Overall Study|Protocol deviation|6
1212500|NCT00846586|3979431|P1|Overall Study|Protocol deviation|2
1212501|NCT00846586|3979430|P2|Overall Study|Death|0
1212502|NCT00846586|3979431|P1|Overall Study|Death|2
1212503|NCT00846586|3979430|P2|Overall Study|Administrative problems|4
1212504|NCT00846586|3979431|P1|Overall Study|Administrative problems|5
1212505|NCT00846586|3979430|P2|Overall Study|Subject withdrew consent|10
1212506|NCT00846586|3979431|P1|Overall Study|Subject withdrew consent|8
1212507|NCT00846586|3979430|P2|Overall Study|Adverse Event|10
1212508|NCT00846586|3979431|P1|Overall Study|Adverse Event|20
1212509|NCT00846521|3979465|P1|Overall Study|Protocol Violation|1
1212510|NCT00846521|3979465|P1|Overall Study|Did not meet OGTT/ CGMS criteria|5
1212511|NCT00846521|3979465|P1|Overall Study|Withdrawal by Subject|5
1212512|NCT00846495|3979472|P2|Overall Study|Physician Decision|0
1212513|NCT00846495|3979473|P1|Overall Study|Physician Decision|1
1212514|NCT00846495|3979472|P2|Overall Study|Lack of Efficacy|2
1212515|NCT00846495|3979473|P1|Overall Study|Lack of Efficacy|1
1212516|NCT00846495|3979472|P2|Overall Study|Adverse Event|1
1212517|NCT00846495|3979473|P1|Overall Study|Adverse Event|5
1212518|NCT00846495|3979472|P2|Overall Study|Lost to Follow-up|0
1212519|NCT00846495|3979473|P1|Overall Study|Lost to Follow-up|1
1212520|NCT00846391|3979496|P3|Overall Study|Study Terminated by Sponsor|2
1212521|NCT00846391|3979497|P2|Overall Study|Study Terminated by Sponsor|2
1212522|NCT00846391|3979498|P1|Overall Study|Study Terminated by Sponsor|1
1212523|NCT00846391|3979496|P3|Overall Study|Physician Decision|1
1212524|NCT00846391|3979497|P2|Overall Study|Physician Decision|0
1212525|NCT00846391|3979498|P1|Overall Study|Physician Decision|0
1212526|NCT00846365|3979509|P3|Overall Study|Other|6
1212527|NCT00846365|3979510|P2|Overall Study|Other|1
1212528|NCT00846365|3979511|P1|Overall Study|Other|9
1212529|NCT00846365|3979509|P3|Overall Study|Lack of Efficacy|2
1212530|NCT00846365|3979510|P2|Overall Study|Lack of Efficacy|1
1212531|NCT00846365|3979511|P1|Overall Study|Lack of Efficacy|1
1212532|NCT00846365|3979509|P3|Overall Study|Pregnancy|0
1212533|NCT00846365|3979510|P2|Overall Study|Pregnancy|0
1212534|NCT00846365|3979511|P1|Overall Study|Pregnancy|1
1212535|NCT00846365|3979509|P3|Overall Study|Withdrawal by Subject|9
1212536|NCT00846365|3979510|P2|Overall Study|Withdrawal by Subject|11
1212537|NCT00846365|3979511|P1|Overall Study|Withdrawal by Subject|11
1212538|NCT00846365|3979509|P3|Overall Study|Lost to Follow-up|5
1212539|NCT00846365|3979510|P2|Overall Study|Lost to Follow-up|2
1212540|NCT00846365|3979511|P1|Overall Study|Lost to Follow-up|8
1212541|NCT00846365|3979509|P3|Overall Study|Protocol Violation|0
1212542|NCT00846365|3979510|P2|Overall Study|Protocol Violation|4
1212543|NCT00846365|3979511|P1|Overall Study|Protocol Violation|5
1212544|NCT00846365|3979509|P3|Overall Study|Adverse Event|11
1212545|NCT00846365|3979510|P2|Overall Study|Adverse Event|30
1212546|NCT00846365|3979511|P1|Overall Study|Adverse Event|20
1212547|NCT00846053|3979592|P2|Overall Study|Physician Decision|0
1212548|NCT00846053|3979593|P1|Overall Study|Physician Decision|3
1212549|NCT00846027|3979601|P1|Overall Study|Subject Not Treated|7
1212550|NCT00846027|3979601|P1|Overall Study|Protocol Violation|2
1212551|NCT00846027|3979601|P1|Overall Study|Investigator Discretion|29
1212552|NCT00846027|3979601|P1|Overall Study|Patient Decision|7
1212553|NCT00846027|3979601|P1|Overall Study|Toxicity|12
1212554|NCT00846027|3979601|P1|Overall Study|Disease Progression|30
1212555|NCT00846027|3979601|P1|Overall Study|Death|3
1212556|NCT00845897|3979624|P3|Overall Study|Too ill to participate|0
1212557|NCT00845897|3979625|P2|Overall Study|Too ill to participate|1
1212558|NCT00845897|3979626|P1|Overall Study|Too ill to participate|0
1212559|NCT00845897|3979624|P3|Overall Study|Ulcer did not heal|1
1212560|NCT00845897|3979625|P2|Overall Study|Ulcer did not heal|0
1212561|NCT00845897|3979626|P1|Overall Study|Ulcer did not heal|1
1212562|NCT00845897|3979624|P3|Overall Study|Withdrawal by Subject|2
1212563|NCT00845897|3979625|P2|Overall Study|Withdrawal by Subject|3
1212564|NCT00845897|3979626|P1|Overall Study|Withdrawal by Subject|0
1212565|NCT00845897|3979624|P3|Overall Study|Lost to Follow-up|0
1212566|NCT00845897|3979625|P2|Overall Study|Lost to Follow-up|1
1212567|NCT00845897|3979626|P1|Overall Study|Lost to Follow-up|1
1212568|NCT00845858|3979640|P3|Overall Study|not eligible|2
1212569|NCT00845858|3979641|P2|Overall Study|not eligible|3
1212570|NCT00845858|3979642|P1|Overall Study|not eligible|0
1212571|NCT00845858|3979640|P3|Overall Study|Protocol Violation|1
1212572|NCT00845858|3979641|P2|Overall Study|Protocol Violation|0
1212573|NCT00845858|3979642|P1|Overall Study|Protocol Violation|0
1212574|NCT00845858|3979640|P3|Overall Study|Adverse Event|4
1212575|NCT00845858|3979641|P2|Overall Study|Adverse Event|8
1212576|NCT00845858|3979642|P1|Overall Study|Adverse Event|3
1212577|NCT00845858|3979640|P3|Overall Study|Withdrawal by Subject|1
1212578|NCT00845858|3979641|P2|Overall Study|Withdrawal by Subject|1
1212579|NCT00845858|3979642|P1|Overall Study|Withdrawal by Subject|5
1212580|NCT00845845|3979655|P2|Overall Study|Lost to Follow-up|4
1212581|NCT00845845|3979656|P1|Overall Study|Lost to Follow-up|0
1212582|NCT00845832|3979667|P3|Extended Safety Follow-Up|Withdrawal by Subject|7
1212583|NCT00845832|3979668|P2|Extended Safety Follow-Up|Withdrawal by Subject|0
1212584|NCT00845832|3979669|P1|Extended Safety Follow-Up|Withdrawal by Subject|0
1212585|NCT00845832|3979667|P3|Safety Follow-Up|Withdrawal by Subject|0
1212586|NCT00845832|3979668|P2|Safety Follow-Up|Withdrawal by Subject|0
1212587|NCT00845832|3979669|P1|Safety Follow-Up|Withdrawal by Subject|1
1212588|NCT00845832|3979667|P3|Treatment Period|Protocol Violation|0
1212589|NCT00845832|3979668|P2|Treatment Period|Protocol Violation|1
1212590|NCT00845832|3979669|P1|Treatment Period|Protocol Violation|1
1212591|NCT00845832|3979667|P3|Treatment Period|Adverse Event|0
1212592|NCT00845832|3979668|P2|Treatment Period|Adverse Event|2
1212593|NCT00845832|3979669|P1|Treatment Period|Adverse Event|0
1212594|NCT00845728|3979715|P2|Overall Study|Withdrawal by Subject|108
1212595|NCT00845728|3979716|P1|Overall Study|Withdrawal by Subject|105
1212596|NCT00845728|3979715|P2|Overall Study|Adverse Event|96
1212597|NCT00845728|3979716|P1|Overall Study|Adverse Event|101
1212598|NCT00845728|3979715|P2|Overall Study|Lack of Efficacy|39
1212599|NCT00845728|3979716|P1|Overall Study|Lack of Efficacy|51
1212600|NCT00845728|3979715|P2|Overall Study|Protocol Violation|24
1212601|NCT00845728|3979716|P1|Overall Study|Protocol Violation|36
1212602|NCT00845728|3979715|P2|Overall Study|Administrative Problems|26
1212603|NCT00845728|3979716|P1|Overall Study|Administrative Problems|34
1212604|NCT00845728|3979715|P2|Overall Study|Death|26
1212605|NCT00845728|3979716|P1|Overall Study|Death|24
1212606|NCT00845728|3979715|P2|Overall Study|Lost to Follow-up|13
1212607|NCT00845728|3979716|P1|Overall Study|Lost to Follow-up|22
1212608|NCT00845728|3979715|P2|Overall Study|Abnormal test procedure result (s)|2
1212609|NCT00845728|3979716|P1|Overall Study|Abnormal test procedure result (s)|7
1212610|NCT00845728|3979715|P2|Overall Study|Patient's inability to use the device|6
1212611|NCT00845728|3979716|P1|Overall Study|Patient's inability to use the device|4
1212612|NCT00845728|3979715|P2|Overall Study|Abnormal laboratory value (s)|2
1212613|NCT00845728|3979716|P1|Overall Study|Abnormal laboratory value (s)|2
1212614|NCT00845676|3979730|P1|Overall Study|Adverse Event|1
1212615|NCT00845676|3979730|P1|Overall Study|Virologic breakthrough at week 20|1
1212616|NCT00845650|3979791|P6|Overall Study|Unable to access IV line|0
1212617|NCT00845650|3979792|P5|Overall Study|Unable to access IV line|0
1212618|NCT00845650|3979793|P4|Overall Study|Unable to access IV line|0
1212619|NCT00845650|3979794|P3|Overall Study|Unable to access IV line|0
1212620|NCT00845650|3979795|P2|Overall Study|Unable to access IV line|0
1212621|NCT00845650|3979796|P1|Overall Study|Unable to access IV line|1
1212622|NCT00845650|3979791|P6|Overall Study|Sponsor hold on dosing|1
1212623|NCT00845650|3979792|P5|Overall Study|Sponsor hold on dosing|1
1212624|NCT00845650|3979793|P4|Overall Study|Sponsor hold on dosing|0
1212625|NCT00845650|3979794|P3|Overall Study|Sponsor hold on dosing|0
1212626|NCT00845650|3979795|P2|Overall Study|Sponsor hold on dosing|0
1212627|NCT00845650|3979796|P1|Overall Study|Sponsor hold on dosing|0
1212628|NCT00845650|3979791|P6|Overall Study|Lost to Follow-up|1
1212629|NCT00845650|3979792|P5|Overall Study|Lost to Follow-up|0
1212630|NCT00845650|3979793|P4|Overall Study|Lost to Follow-up|1
1212631|NCT00845650|3979794|P3|Overall Study|Lost to Follow-up|3
1212632|NCT00845650|3979795|P2|Overall Study|Lost to Follow-up|0
1212633|NCT00845650|3979796|P1|Overall Study|Lost to Follow-up|0
1212634|NCT00845650|3979791|P6|Overall Study|Withdrawal by Subject|0
1212635|NCT00845650|3979792|P5|Overall Study|Withdrawal by Subject|2
1212636|NCT00845650|3979793|P4|Overall Study|Withdrawal by Subject|0
1212637|NCT00845650|3979794|P3|Overall Study|Withdrawal by Subject|0
1212638|NCT00845650|3979795|P2|Overall Study|Withdrawal by Subject|0
1212639|NCT00845650|3979796|P1|Overall Study|Withdrawal by Subject|0
1212640|NCT00845520|3979834|P3|Overall Study|Adverse Event|1
1212641|NCT00845520|3979835|P2|Overall Study|Adverse Event|0
1212642|NCT00845520|3979836|P1|Overall Study|Adverse Event|0
1212643|NCT00845520|3979834|P3|Overall Study|Lost to Follow-up|0
1212644|NCT00845520|3979835|P2|Overall Study|Lost to Follow-up|0
1212645|NCT00845520|3979836|P1|Overall Study|Lost to Follow-up|1
1212646|NCT00845520|3979834|P3|Overall Study|Death|0
1212647|NCT00845520|3979835|P2|Overall Study|Death|2
1212648|NCT00845520|3979836|P1|Overall Study|Death|1
1212649|NCT00845429|3979873|P3|Overall Study|Serious adverse event|1
1212650|NCT00845429|3979874|P2|Overall Study|Serious adverse event|0
1212651|NCT00845429|3979875|P1|Overall Study|Serious adverse event|0
1212652|NCT00845429|3979873|P3|Overall Study|Withdrawal by Subject|2
1212653|NCT00845429|3979874|P2|Overall Study|Withdrawal by Subject|2
1212654|NCT00845429|3979875|P1|Overall Study|Withdrawal by Subject|2
1212655|NCT00845429|3979873|P3|Overall Study|Lost to Follow-up|10
1212656|NCT00845429|3979874|P2|Overall Study|Lost to Follow-up|9
1212657|NCT00845429|3979875|P1|Overall Study|Lost to Follow-up|7
1212658|NCT00845429|3979873|P3|Overall Study|Protocol Violation|7
1212659|NCT00845429|3979874|P2|Overall Study|Protocol Violation|4
1212660|NCT00845429|3979875|P1|Overall Study|Protocol Violation|5
1212661|NCT00845182|3979910|P3|Overall Study|Physician Decision|1
1212662|NCT00845182|3979911|P2|Overall Study|Physician Decision|0
1212663|NCT00845182|3979912|P1|Overall Study|Physician Decision|0
1212664|NCT00845182|3979910|P3|Overall Study|Adverse Event|1
1212665|NCT00845182|3979911|P2|Overall Study|Adverse Event|1
1212666|NCT00845182|3979912|P1|Overall Study|Adverse Event|0
1212667|NCT00845182|3979910|P3|Overall Study|Lost to Follow-up|4
1212668|NCT00845182|3979911|P2|Overall Study|Lost to Follow-up|3
1212669|NCT00845182|3979912|P1|Overall Study|Lost to Follow-up|3
1212670|NCT00845065|3979937|P2|Overall Study|Non-Medical Reasons|11
1212671|NCT00845065|3979938|P1|Overall Study|Non-Medical Reasons|1
1212672|NCT00845065|3979937|P2|Overall Study|Lack of Efficacy|21
1212673|NCT00845065|3979938|P1|Overall Study|Lack of Efficacy|43
1212674|NCT00845065|3979937|P2|Overall Study|Adverse Event|23
1212675|NCT00845065|3979938|P1|Overall Study|Adverse Event|3
1212676|NCT00844896|3980006|P2|Overall Study|Parents did not have time to complete|1
1212677|NCT00844896|3980007|P1|Overall Study|Parents did not have time to complete|0
1212678|NCT00844896|3980006|P2|Overall Study|Lost to Follow-up|16
1212679|NCT00844896|3980007|P1|Overall Study|Lost to Follow-up|12
1212680|NCT00844883|3980029|P1|Overall Study|Bridged to resection|1
1212681|NCT00844883|3980029|P1|Overall Study|Bridged to liver transplant|3
1212682|NCT00844857|3980041|P2|Overall Study|Good Clinical Practice Violations|11
1212683|NCT00844857|3980042|P1|Overall Study|Good Clinical Practice Violations|21
1212684|NCT00844857|3980041|P2|Overall Study|Did Not Take Study Drug|1
1212685|NCT00844857|3980042|P1|Overall Study|Did Not Take Study Drug|3
1212686|NCT00844857|3980041|P2|Overall Study|Lost to Follow-up|3
1212687|NCT00844857|3980042|P1|Overall Study|Lost to Follow-up|2
1212688|NCT00844857|3980041|P2|Overall Study|Entry Criteria Not Met|1
1212689|NCT00844857|3980042|P1|Overall Study|Entry Criteria Not Met|0
1212690|NCT00844857|3980041|P2|Overall Study|Clinical Relapse|1
1212691|NCT00844857|3980042|P1|Overall Study|Clinical Relapse|0
1212692|NCT00844857|3980041|P2|Overall Study|Lack of Efficacy|5
1212693|NCT00844857|3980042|P1|Overall Study|Lack of Efficacy|5
1212694|NCT00844857|3980041|P2|Overall Study|Protocol Violation|0
1212695|NCT00844857|3980042|P1|Overall Study|Protocol Violation|6
1212696|NCT00844857|3980041|P2|Overall Study|Withdrawal by Subject|7
1212697|NCT00844857|3980042|P1|Overall Study|Withdrawal by Subject|8
1212698|NCT00844857|3980041|P2|Overall Study|Parent/Caregiver Decision|2
1212699|NCT00844857|3980042|P1|Overall Study|Parent/Caregiver Decision|6
1212700|NCT00844857|3980041|P2|Overall Study|Physician Decision|0
1212701|NCT00844857|3980042|P1|Overall Study|Physician Decision|2
1212702|NCT00844857|3980041|P2|Overall Study|Sponsor Decision|1
1212703|NCT00844857|3980042|P1|Overall Study|Sponsor Decision|1
1212704|NCT00844857|3980041|P2|Overall Study|Adverse Event|5
1212705|NCT00844857|3980042|P1|Overall Study|Adverse Event|24
1212706|NCT00844844|3980086|P1|Post Treatment Period|Withdrawal by Subject|1
1212707|NCT00844844|3980086|P1|Extension Treatment Period|Adverse Event|2
1212708|NCT00844844|3980086|P1|Treatment Period (26 Weeks)|Protocol Violation|1
1212709|NCT00844844|3980086|P1|Treatment Period (26 Weeks)|Adverse Event|1
1212710|NCT00844831|3980100|P1|Overall Study|Physician Decision|1
1212711|NCT00844831|3980100|P1|Overall Study|Adverse Event|1
1212712|NCT00844831|3980100|P1|Overall Study|Withdrawal by Subject|4
1212713|NCT00844805|3980110|P4|Follow-Up Phase|Did Not Meet Protocol Eligibility|1
1212714|NCT00844805|3980111|P3|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
1212715|NCT00844805|3980112|P2|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
1212716|NCT00844805|3980113|P1|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
1212717|NCT00844805|3980110|P4|Follow-Up Phase|Relapse/Recurrence|4
1212718|NCT00844805|3980111|P3|Follow-Up Phase|Relapse/Recurrence|2
1212719|NCT00844805|3980112|P2|Follow-Up Phase|Relapse/Recurrence|0
1212720|NCT00844805|3980113|P1|Follow-Up Phase|Relapse/Recurrence|0
1212721|NCT00844805|3980110|P4|Follow-Up Phase|Noncompliance With Protocol|1
1212722|NCT00844805|3980111|P3|Follow-Up Phase|Noncompliance With Protocol|0
1212723|NCT00844805|3980112|P2|Follow-Up Phase|Noncompliance With Protocol|0
1212724|NCT00844805|3980113|P1|Follow-Up Phase|Noncompliance With Protocol|0
1212725|NCT00844805|3980110|P4|Follow-Up Phase|Withdrawal by Subject|3
1212726|NCT00844805|3980111|P3|Follow-Up Phase|Withdrawal by Subject|6
1212727|NCT00844805|3980112|P2|Follow-Up Phase|Withdrawal by Subject|0
1212728|NCT00844805|3980113|P1|Follow-Up Phase|Withdrawal by Subject|0
1212729|NCT00844805|3980110|P4|Follow-Up Phase|Adverse Event|0
1212730|NCT00844805|3980111|P3|Follow-Up Phase|Adverse Event|1
1212731|NCT00844805|3980112|P2|Follow-Up Phase|Adverse Event|0
1212732|NCT00844805|3980113|P1|Follow-Up Phase|Adverse Event|0
1212733|NCT00844805|3980110|P4|Treatment Phase|Did Not Meet Protocol Eligibility|0
1212734|NCT00844805|3980111|P3|Treatment Phase|Did Not Meet Protocol Eligibility|0
1212735|NCT00844805|3980112|P2|Treatment Phase|Did Not Meet Protocol Eligibility|2
1212736|NCT00844805|3980113|P1|Treatment Phase|Did Not Meet Protocol Eligibility|1
1212737|NCT00844805|3980110|P4|Treatment Phase|Noncompliance With Protocol|0
1212738|NCT00844805|3980111|P3|Treatment Phase|Noncompliance With Protocol|0
1212739|NCT00844805|3980112|P2|Treatment Phase|Noncompliance With Protocol|0
1212740|NCT00844805|3980113|P1|Treatment Phase|Noncompliance With Protocol|1
1212741|NCT00844805|3980110|P4|Treatment Phase|Withdrawal by Subject|0
1212742|NCT00844805|3980111|P3|Treatment Phase|Withdrawal by Subject|0
1212743|NCT00844805|3980112|P2|Treatment Phase|Withdrawal by Subject|4
1212744|NCT00844805|3980113|P1|Treatment Phase|Withdrawal by Subject|3
1212745|NCT00844805|3980110|P4|Treatment Phase|Adverse Event|0
1212746|NCT00844805|3980111|P3|Treatment Phase|Adverse Event|0
1212747|NCT00844805|3980112|P2|Treatment Phase|Adverse Event|1
1212748|NCT00844805|3980113|P1|Treatment Phase|Adverse Event|5
1212749|NCT00844753|3980157|P4|Overall Study|Withdrawal by Subject|3
1212750|NCT00844753|3980158|P3|Overall Study|Withdrawal by Subject|0
1212751|NCT00844753|3980159|P2|Overall Study|Withdrawal by Subject|0
1212752|NCT00844753|3980160|P1|Overall Study|Withdrawal by Subject|1
1212753|NCT00844753|3980157|P4|Overall Study|could not swallow medication|0
1212754|NCT00844753|3980158|P3|Overall Study|could not swallow medication|0
1212755|NCT00844753|3980159|P2|Overall Study|could not swallow medication|0
1212756|NCT00844753|3980160|P1|Overall Study|could not swallow medication|2
1212757|NCT00844753|3980157|P4|Overall Study|Lost to Follow-up|1
1212758|NCT00844753|3980158|P3|Overall Study|Lost to Follow-up|0
1212759|NCT00844753|3980159|P2|Overall Study|Lost to Follow-up|1
1212760|NCT00844753|3980160|P1|Overall Study|Lost to Follow-up|1
1212761|NCT00844753|3980157|P4|Overall Study|Adverse Event|5
1212762|NCT00844753|3980158|P3|Overall Study|Adverse Event|5
1212763|NCT00844753|3980159|P2|Overall Study|Adverse Event|2
1212764|NCT00844753|3980160|P1|Overall Study|Adverse Event|3
1212765|NCT00844753|3980157|P4|Overall Study|Lack of Efficacy|2
1212766|NCT00844753|3980158|P3|Overall Study|Lack of Efficacy|2
1212767|NCT00844753|3980159|P2|Overall Study|Lack of Efficacy|0
1212768|NCT00844753|3980160|P1|Overall Study|Lack of Efficacy|1
1212769|NCT00844649|3980178|P2|Overall Study|Withdrew prior to starting treatment|27
1212770|NCT00844649|3980179|P1|Overall Study|Withdrew prior to starting treatment|11
1212771|NCT00844649|3980178|P2|Overall Study|Other|10
1212772|NCT00844649|3980179|P1|Overall Study|Other|7
1212773|NCT00844649|3980178|P2|Overall Study|Withdrawal by Subject|39
1212774|NCT00844649|3980179|P1|Overall Study|Withdrawal by Subject|28
1212775|NCT00844649|3980178|P2|Overall Study|Protocol Violation|6
1212776|NCT00844649|3980179|P1|Overall Study|Protocol Violation|10
1212777|NCT00844649|3980178|P2|Overall Study|Physician Decision|18
1212778|NCT00844649|3980179|P1|Overall Study|Physician Decision|25
1212779|NCT00844649|3980178|P2|Overall Study|Adverse Event|73
1212780|NCT00844649|3980179|P1|Overall Study|Adverse Event|128
1212781|NCT00844649|3980178|P2|Overall Study|Progressive Disease|245
1212782|NCT00844649|3980179|P1|Overall Study|Progressive Disease|196
1212783|NCT00844597|3980203|P6|Overall Study|Adverse Event|0
1212784|NCT00844597|3980204|P5|Overall Study|Adverse Event|0
1212785|NCT00844597|3980205|P4|Overall Study|Adverse Event|1
1212786|NCT00844597|3980206|P3|Overall Study|Adverse Event|0
1212787|NCT00844597|3980207|P2|Overall Study|Adverse Event|0
1212788|NCT00844597|3980208|P1|Overall Study|Adverse Event|0
1212789|NCT00844558|3980228|P2|Overall Study|Physician Decision|0
1212790|NCT00844558|3980229|P1|Overall Study|Physician Decision|1
1212791|NCT00844558|3980228|P2|Overall Study|Lost to Follow-up|1
1212792|NCT00844558|3980229|P1|Overall Study|Lost to Follow-up|0
1212793|NCT00844558|3980228|P2|Overall Study|Protocol Violation|1
1212794|NCT00844558|3980229|P1|Overall Study|Protocol Violation|1
1212795|NCT00844558|3980228|P2|Overall Study|Death|0
1212796|NCT00844558|3980229|P1|Overall Study|Death|1
1212797|NCT00844558|3980228|P2|Overall Study|Withdrawal by Subject|2
1212798|NCT00844558|3980229|P1|Overall Study|Withdrawal by Subject|9
1212799|NCT00844545|3980245|P1|Post Treatment Period|Withdrawal by Subject|1
1212800|NCT00844545|3980245|P1|Extension Treatment Period|Adverse Event|2
1212801|NCT00844545|3980245|P1|Treatment Period (26 Weeks)|Protocol Violation|1
1212802|NCT00844545|3980245|P1|Treatment Period (26 Weeks)|Adverse Event|1
1212803|NCT00844532|3980259|P1|Overall Study|Lost to Follow-up|7
1212804|NCT00844532|3980259|P1|Overall Study|Withdrawal by Subject|16
1212805|NCT00844532|3980259|P1|Overall Study|Death|16
1212806|NCT00844519|3980345|P2|Overall Study|Adverse Event|0
1212807|NCT00844519|3980346|P1|Overall Study|Adverse Event|1
1212808|NCT00844519|3980345|P2|Overall Study|Withdrawal by Subject|1
1212809|NCT00844519|3980346|P1|Overall Study|Withdrawal by Subject|1
1212810|NCT00844480|3980354|P2|Overall Study|Withdrawal by Subject|3
1212811|NCT00844480|3980355|P1|Overall Study|Withdrawal by Subject|2
1212812|NCT00844428|3980363|P1|Post Treatment Period (Patients Who Disc|Death|1
1212813|NCT00844428|3980363|P1|Extension Treatment Period|Death|1
1212814|NCT00844428|3980363|P1|Screening Period|Screen Failure|3
1212815|NCT00844415|3980379|P1|Overall Study|Withdrawal by Subject|1
1212816|NCT00844376|3980393|P2|Period 1: First Intervention|Withdrawal by Subject|0
1212817|NCT00844376|3980394|P1|Period 1: First Intervention|Withdrawal by Subject|1
1212818|NCT00844194|3980418|P2|Overall Study|Other reason (not specified)|0
1212819|NCT00844194|3980419|P1|Overall Study|Other reason (not specified)|1
1212820|NCT00844194|3980418|P2|Overall Study|Lack of Efficacy|0
1212821|NCT00844194|3980419|P1|Overall Study|Lack of Efficacy|3
1212822|NCT00844194|3980418|P2|Overall Study|Withdrawal by Subject|1
1212823|NCT00844194|3980419|P1|Overall Study|Withdrawal by Subject|2
1212824|NCT00844194|3980418|P2|Overall Study|Lost to Follow-up|1
1212825|NCT00844194|3980419|P1|Overall Study|Lost to Follow-up|1
1212826|NCT00844194|3980418|P2|Overall Study|Protocol Violation|1
1212827|NCT00844194|3980419|P1|Overall Study|Protocol Violation|1
1212828|NCT00844194|3980418|P2|Overall Study|Adverse Event|5
1212829|NCT00844194|3980419|P1|Overall Study|Adverse Event|17
1212830|NCT00843843|3980674|P2|Overall Study|Protocol Violation|1
1212831|NCT00843843|3980675|P1|Overall Study|Protocol Violation|1
1212832|NCT00843843|3980674|P2|Overall Study|Physician Decision|1
1212833|NCT00843843|3980675|P1|Overall Study|Physician Decision|1
1212834|NCT00843778|3980688|P1|Overall Study|Withdrawal by Subject|4
1212835|NCT00843778|3980688|P1|Overall Study|Loss of efficacy|2
1212836|NCT00843778|3980688|P1|Overall Study|Lack of Efficacy|14
1212837|NCT00843778|3980688|P1|Overall Study|Adverse Event|15
1212838|NCT00843635|3980733|P3|Overall Study|Adverse Event|0
1212839|NCT00843635|3980734|P2|Overall Study|Adverse Event|2
1212840|NCT00843635|3980735|P1|Overall Study|Adverse Event|2
1212841|NCT00843518|3980764|P2|Period 2 (Double-blind Treatment)|Caregiver decision|7
1212842|NCT00843518|3980765|P1|Period 2 (Double-blind Treatment)|Caregiver decision|7
1212843|NCT00843518|3980764|P2|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0
1212844|NCT00843518|3980765|P1|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2
1212845|NCT00843518|3980764|P2|Period 2 (Double-blind Treatment)|Protocol Violation|5
1212846|NCT00843518|3980765|P1|Period 2 (Double-blind Treatment)|Protocol Violation|2
1212847|NCT00843518|3980764|P2|Period 2 (Double-blind Treatment)|Physician Decision|1
1212848|NCT00843518|3980765|P1|Period 2 (Double-blind Treatment)|Physician Decision|2
1212849|NCT00843518|3980764|P2|Period 2 (Double-blind Treatment)|Lost to Follow-up|3
1212850|NCT00843518|3980765|P1|Period 2 (Double-blind Treatment)|Lost to Follow-up|2
1212851|NCT00843518|3980764|P2|Period 2 (Double-blind Treatment)|Death|1
1212852|NCT00843518|3980765|P1|Period 2 (Double-blind Treatment)|Death|0
1212853|NCT00843518|3980764|P2|Period 2 (Double-blind Treatment)|Adverse Event|3
1212854|NCT00843518|3980765|P1|Period 2 (Double-blind Treatment)|Adverse Event|5
1212855|NCT00843492|3980795|P2|Overall Study|Deep-vein Thrombosis|0
1212856|NCT00843492|3980796|P1|Overall Study|Deep-vein Thrombosis|1
1212857|NCT00843492|3980795|P2|Overall Study|Visit Not Performed|0
1212858|NCT00843492|3980796|P1|Overall Study|Visit Not Performed|1
1212859|NCT00843492|3980795|P2|Overall Study|Orthopedic Surgery|2
1212860|NCT00843492|3980796|P1|Overall Study|Orthopedic Surgery|0
1212861|NCT00843492|3980795|P2|Overall Study|Investigator/Orthopedic Surgeon Decision|1
1212862|NCT00843492|3980796|P1|Overall Study|Investigator/Orthopedic Surgeon Decision|1
1212863|NCT00843492|3980795|P2|Overall Study|Immobilization Stopped|0
1212864|NCT00843492|3980796|P1|Overall Study|Immobilization Stopped|1
1212865|NCT00843492|3980795|P2|Overall Study|Withdrawal by Subject|4
1212866|NCT00843492|3980796|P1|Overall Study|Withdrawal by Subject|0
1212867|NCT00843492|3980795|P2|Overall Study|Lost to Follow-up|4
1212868|NCT00843492|3980796|P1|Overall Study|Lost to Follow-up|4
1212869|NCT00843492|3980795|P2|Overall Study|Adverse Event|3
1212870|NCT00843492|3980796|P1|Overall Study|Adverse Event|0
1212871|NCT00843284|3980867|P1|Overall Study|Death|3
1212872|NCT00843284|3980867|P1|Overall Study|Withdrawal by Subject|4
1212873|NCT00843284|3980867|P1|Overall Study|Other|10
1212874|NCT00843284|3980867|P1|Overall Study|Lost to Follow-up|11
1212875|NCT00843284|3980867|P1|Overall Study|Lack of Efficacy|5
1212876|NCT00843284|3980867|P1|Overall Study|Adverse Event|39
1212877|NCT00843193|3980877|P2|Overall Study|Withdrawal by Subject|3
1212878|NCT00843193|3980878|P1|Overall Study|Withdrawal by Subject|3
1212879|NCT00843193|3980877|P2|Overall Study|Physician Decision|1
1212880|NCT00843193|3980878|P1|Overall Study|Physician Decision|0
1212881|NCT00843193|3980877|P2|Overall Study|Lost to Follow-up|0
1212882|NCT00843193|3980878|P1|Overall Study|Lost to Follow-up|1
1212883|NCT00843193|3980877|P2|Overall Study|Protocol Violation|2
1212884|NCT00843193|3980878|P1|Overall Study|Protocol Violation|1
1212885|NCT00843193|3980877|P2|Overall Study|Lack of Efficacy|1
1212886|NCT00843193|3980878|P1|Overall Study|Lack of Efficacy|1
1212887|NCT00843193|3980877|P2|Overall Study|Adverse Event|4
1212888|NCT00843193|3980878|P1|Overall Study|Adverse Event|2
1212889|NCT00843167|3980929|P2|Treatment Period|Withdrawal by Subject|3
1212890|NCT00843167|3980930|P1|Treatment Period|Withdrawal by Subject|2
1212891|NCT00843167|3980929|P2|Treatment Period|Adverse Event|5
1212892|NCT00843167|3980930|P1|Treatment Period|Adverse Event|1
1212893|NCT00843115|3980943|P1|Overall Study|Syndrome De Glissement|1
1212894|NCT00843115|3980943|P1|Overall Study|week 12 not done|1
1212895|NCT00843115|3980943|P1|Overall Study|hospitalized due to deterioration|1
1212896|NCT00843115|3980943|P1|Overall Study|patient never took the medication|1
1212897|NCT00843115|3980943|P1|Overall Study|patient took for 2 days then stopped|1
1212898|NCT00843115|3980943|P1|Overall Study|Family discontinued meds|1
1212899|NCT00843115|3980943|P1|Overall Study|Physician Decision|1
1212900|NCT00843115|3980943|P1|Overall Study|Does not meet entrance criteria|1
1212901|NCT00843115|3980943|P1|Overall Study|Patient forgot to take meds|1
1212902|NCT00843115|3980943|P1|Overall Study|Family does not want continuation|1
1212903|NCT00843115|3980943|P1|Overall Study|Family wanted meds stopped|1
1212904|NCT00843115|3980943|P1|Overall Study|Withdrawal by Subject|17
1212905|NCT00843115|3980943|P1|Overall Study|Lost to Follow-up|4
1212906|NCT00843115|3980943|P1|Overall Study|Adverse Event|30
1212907|NCT00843115|3980943|P1|Overall Study|Death|4
1212908|NCT00843024|3980999|P6|Double-blind Treatment Phase|Lack of Efficacy|0
1212909|NCT00843024|3981000|P5|Double-blind Treatment Phase|Lack of Efficacy|1
1212910|NCT00843024|3981001|P4|Double-blind Treatment Phase|Lack of Efficacy|0
1212911|NCT00843024|3981002|P3|Double-blind Treatment Phase|Lack of Efficacy|0
1212912|NCT00843024|3981003|P2|Double-blind Treatment Phase|Lack of Efficacy|0
1212913|NCT00843024|3981004|P1|Double-blind Treatment Phase|Lack of Efficacy|0
1212914|NCT00843024|3980999|P6|Double-blind Treatment Phase|Adverse Event|1
1212915|NCT00843024|3981000|P5|Double-blind Treatment Phase|Adverse Event|1
1212916|NCT00843024|3981001|P4|Double-blind Treatment Phase|Adverse Event|0
1212917|NCT00843024|3981002|P3|Double-blind Treatment Phase|Adverse Event|0
1212918|NCT00843024|3981003|P2|Double-blind Treatment Phase|Adverse Event|0
1212919|NCT00843024|3981004|P1|Double-blind Treatment Phase|Adverse Event|0
1212920|NCT00843024|3980999|P6|Double-blind Treatment Phase|Physician Decision|1
1212921|NCT00843024|3981000|P5|Double-blind Treatment Phase|Physician Decision|1
1212922|NCT00843024|3981001|P4|Double-blind Treatment Phase|Physician Decision|3
1212923|NCT00843024|3981002|P3|Double-blind Treatment Phase|Physician Decision|0
1212924|NCT00843024|3981003|P2|Double-blind Treatment Phase|Physician Decision|0
1212925|NCT00843024|3981004|P1|Double-blind Treatment Phase|Physician Decision|0
1212926|NCT00843024|3980999|P6|Double-blind Treatment Phase|Protocol Violation|3
1212927|NCT00843024|3981000|P5|Double-blind Treatment Phase|Protocol Violation|0
1212928|NCT00843024|3981001|P4|Double-blind Treatment Phase|Protocol Violation|0
1212929|NCT00843024|3981002|P3|Double-blind Treatment Phase|Protocol Violation|3
1212930|NCT00843024|3981003|P2|Double-blind Treatment Phase|Protocol Violation|0
1212931|NCT00843024|3981004|P1|Double-blind Treatment Phase|Protocol Violation|0
1212932|NCT00843024|3980999|P6|Double-blind Treatment Phase|Withdrawal by Subject|2
1212933|NCT00843024|3981000|P5|Double-blind Treatment Phase|Withdrawal by Subject|0
1212934|NCT00843024|3981001|P4|Double-blind Treatment Phase|Withdrawal by Subject|6
1212935|NCT00843024|3981002|P3|Double-blind Treatment Phase|Withdrawal by Subject|0
1212936|NCT00843024|3981003|P2|Double-blind Treatment Phase|Withdrawal by Subject|0
1212937|NCT00843024|3981004|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
1212938|NCT00843024|3980999|P6|Double-blind Treatment Phase|Lost to Follow-up|4
1212939|NCT00843024|3981000|P5|Double-blind Treatment Phase|Lost to Follow-up|4
1212940|NCT00843024|3981001|P4|Double-blind Treatment Phase|Lost to Follow-up|4
1212941|NCT00843024|3981002|P3|Double-blind Treatment Phase|Lost to Follow-up|8
1212942|NCT00843024|3981003|P2|Double-blind Treatment Phase|Lost to Follow-up|0
1212943|NCT00843024|3981004|P1|Double-blind Treatment Phase|Lost to Follow-up|0
1212944|NCT00843024|3980999|P6|Double-blind Treatment Phase|No opportunity to treat migraine|14
1212945|NCT00843024|3981000|P5|Double-blind Treatment Phase|No opportunity to treat migraine|13
1212946|NCT00843024|3981001|P4|Double-blind Treatment Phase|No opportunity to treat migraine|10
1212947|NCT00843024|3981002|P3|Double-blind Treatment Phase|No opportunity to treat migraine|20
1212948|NCT00843024|3981003|P2|Double-blind Treatment Phase|No opportunity to treat migraine|0
1212949|NCT00843024|3981004|P1|Double-blind Treatment Phase|No opportunity to treat migraine|0
1212950|NCT00843024|3980999|P6|Single-blind Placebo Run-In Phase|Other|0
1212951|NCT00843024|3981000|P5|Single-blind Placebo Run-In Phase|Other|0
1212952|NCT00843024|3981001|P4|Single-blind Placebo Run-In Phase|Other|0
1212953|NCT00843024|3981002|P3|Single-blind Placebo Run-In Phase|Other|0
1212954|NCT00843024|3981003|P2|Single-blind Placebo Run-In Phase|Other|1
1212955|NCT00843024|3981004|P1|Single-blind Placebo Run-In Phase|Other|0
1212956|NCT00843024|3980999|P6|Single-blind Placebo Run-In Phase|Adverse Event|0
1212957|NCT00843024|3981000|P5|Single-blind Placebo Run-In Phase|Adverse Event|0
1212958|NCT00843024|3981001|P4|Single-blind Placebo Run-In Phase|Adverse Event|0
1212959|NCT00843024|3981002|P3|Single-blind Placebo Run-In Phase|Adverse Event|0
1212960|NCT00843024|3981003|P2|Single-blind Placebo Run-In Phase|Adverse Event|1
1212961|NCT00843024|3981004|P1|Single-blind Placebo Run-In Phase|Adverse Event|0
1212962|NCT00843024|3980999|P6|Single-blind Placebo Run-In Phase|Physician Decision|0
1212963|NCT00843024|3981000|P5|Single-blind Placebo Run-In Phase|Physician Decision|0
1212964|NCT00843024|3981001|P4|Single-blind Placebo Run-In Phase|Physician Decision|0
1212965|NCT00843024|3981002|P3|Single-blind Placebo Run-In Phase|Physician Decision|0
1212966|NCT00843024|3981003|P2|Single-blind Placebo Run-In Phase|Physician Decision|6
1212967|NCT00843024|3981004|P1|Single-blind Placebo Run-In Phase|Physician Decision|2
1212968|NCT00843024|3980999|P6|Single-blind Placebo Run-In Phase|Protocol Violation|0
1212969|NCT00843024|3981000|P5|Single-blind Placebo Run-In Phase|Protocol Violation|0
1212970|NCT00843024|3981001|P4|Single-blind Placebo Run-In Phase|Protocol Violation|0
1212971|NCT00843024|3981002|P3|Single-blind Placebo Run-In Phase|Protocol Violation|0
1212972|NCT00843024|3981003|P2|Single-blind Placebo Run-In Phase|Protocol Violation|5
1212973|NCT00843024|3981004|P1|Single-blind Placebo Run-In Phase|Protocol Violation|4
1212974|NCT00843024|3980999|P6|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
1212975|NCT00843024|3981000|P5|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
1212976|NCT00843024|3981001|P4|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
1212977|NCT00843024|3981002|P3|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
1212978|NCT00843024|3981003|P2|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18
1212979|NCT00843024|3981004|P1|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19
1212980|NCT00843024|3980999|P6|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
1212981|NCT00843024|3981000|P5|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
1212982|NCT00843024|3981001|P4|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
1212983|NCT00843024|3981002|P3|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
1212984|NCT00843024|3981003|P2|Single-blind Placebo Run-In Phase|Lost to Follow-up|31
1212985|NCT00843024|3981004|P1|Single-blind Placebo Run-In Phase|Lost to Follow-up|36
1212986|NCT00843024|3980999|P6|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
1212987|NCT00843024|3981000|P5|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
1212988|NCT00843024|3981001|P4|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
1212989|NCT00843024|3981002|P3|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
1212990|NCT00843024|3981003|P2|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74
1212991|NCT00843024|3981004|P1|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79
1212992|NCT00842985|3981069|P1|Washout Period of GE 4 Days|Withdrawal by Subject|2
1212993|NCT00842985|3981069|P1|Washout Period of GE 4 Days|Withdrawal by Subject|2
1212994|NCT00842985|3981069|P1|First Intervention|Protocol Violation|3
1212995|NCT00842985|3981069|P1|First Intervention|Withdrawal by Subject|3
1212996|NCT00842985|3981069|P1|Screening|Did not meet entrance requirements|27
1212997|NCT00842829|3981087|P3|Continuation Period|Non-compliance to study drug|1
1212998|NCT00842829|3981088|P2|Continuation Period|Non-compliance to study drug|0
1212999|NCT00842829|3981089|P1|Continuation Period|Non-compliance to study drug|0
1213000|NCT00842829|3981087|P3|Continuation Period|Non-compliance to study procedures|2
1213001|NCT00842829|3981088|P2|Continuation Period|Non-compliance to study procedures|0
1213002|NCT00842829|3981089|P1|Continuation Period|Non-compliance to study procedures|0
1213003|NCT00842829|3981087|P3|Continuation Period|Not specified|7
1213004|NCT00842829|3981088|P2|Continuation Period|Not specified|0
1213005|NCT00842829|3981089|P1|Continuation Period|Not specified|0
1213006|NCT00842829|3981087|P3|Continuation Period|Withdrawal by Subject|10
1213007|NCT00842829|3981088|P2|Continuation Period|Withdrawal by Subject|0
1213008|NCT00842829|3981089|P1|Continuation Period|Withdrawal by Subject|0
1213009|NCT00842829|3981087|P3|Continuation Period|Unstable persistent cancer pain|3
1213010|NCT00842829|3981088|P2|Continuation Period|Unstable persistent cancer pain|0
1213011|NCT00842829|3981089|P1|Continuation Period|Unstable persistent cancer pain|0
1213012|NCT00842829|3981087|P3|Continuation Period|Lack of Efficacy|6
1213013|NCT00842829|3981088|P2|Continuation Period|Lack of Efficacy|0
1213014|NCT00842829|3981089|P1|Continuation Period|Lack of Efficacy|0
1213015|NCT00842829|3981087|P3|Continuation Period|Adverse Event|32
1213016|NCT00842829|3981088|P2|Continuation Period|Adverse Event|0
1213017|NCT00842829|3981089|P1|Continuation Period|Adverse Event|0
1213018|NCT00842829|3981087|P3|Treatment Period|Unclear completion status|1
1213019|NCT00842829|3981088|P2|Treatment Period|Unclear completion status|0
1213020|NCT00842829|3981089|P1|Treatment Period|Unclear completion status|0
1213021|NCT00842829|3981087|P3|Treatment Period|Non-compliance to study procedures|4
1213022|NCT00842829|3981088|P2|Treatment Period|Non-compliance to study procedures|0
1213023|NCT00842829|3981089|P1|Treatment Period|Non-compliance to study procedures|0
1213024|NCT00842829|3981087|P3|Treatment Period|Not specified|18
1213025|NCT00842829|3981088|P2|Treatment Period|Not specified|0
1213026|NCT00842829|3981089|P1|Treatment Period|Not specified|0
1213027|NCT00842829|3981087|P3|Treatment Period|Protocol Violation|2
1213028|NCT00842829|3981088|P2|Treatment Period|Protocol Violation|0
1213029|NCT00842829|3981089|P1|Treatment Period|Protocol Violation|0
1213030|NCT00842829|3981087|P3|Treatment Period|Consistently >4 BTP episodes daily|1
1213031|NCT00842829|3981088|P2|Treatment Period|Consistently >4 BTP episodes daily|0
1213032|NCT00842829|3981089|P1|Treatment Period|Consistently >4 BTP episodes daily|0
1213033|NCT00842829|3981087|P3|Treatment Period|Withdrawal by Subject|11
1213034|NCT00842829|3981088|P2|Treatment Period|Withdrawal by Subject|0
1213035|NCT00842829|3981089|P1|Treatment Period|Withdrawal by Subject|0
1213036|NCT00842829|3981087|P3|Treatment Period|Unstable persistent cancer pain|5
1213037|NCT00842829|3981088|P2|Treatment Period|Unstable persistent cancer pain|0
1213038|NCT00842829|3981089|P1|Treatment Period|Unstable persistent cancer pain|0
1213039|NCT00842829|3981087|P3|Treatment Period|Lack of Efficacy|6
1213040|NCT00842829|3981088|P2|Treatment Period|Lack of Efficacy|0
1213041|NCT00842829|3981089|P1|Treatment Period|Lack of Efficacy|0
1213042|NCT00842829|3981087|P3|Treatment Period|Adverse Event|15
1213043|NCT00842829|3981088|P2|Treatment Period|Adverse Event|0
1213044|NCT00842829|3981089|P1|Treatment Period|Adverse Event|0
1213045|NCT00842829|3981087|P3|Dose Titration Period|Non-compliance to study drug|0
1213046|NCT00842829|3981088|P2|Dose Titration Period|Non-compliance to study drug|1
1213047|NCT00842829|3981089|P1|Dose Titration Period|Non-compliance to study drug|2
1213048|NCT00842829|3981087|P3|Dose Titration Period|Non-compliance to study procedures|0
1213049|NCT00842829|3981088|P2|Dose Titration Period|Non-compliance to study procedures|1
1213050|NCT00842829|3981089|P1|Dose Titration Period|Non-compliance to study procedures|1
1213051|NCT00842829|3981087|P3|Dose Titration Period|Not specified|0
1213052|NCT00842829|3981088|P2|Dose Titration Period|Not specified|4
1213053|NCT00842829|3981089|P1|Dose Titration Period|Not specified|5
1213054|NCT00842829|3981087|P3|Dose Titration Period|Withdrawal by Subject|0
1213055|NCT00842829|3981088|P2|Dose Titration Period|Withdrawal by Subject|6
1213056|NCT00842829|3981089|P1|Dose Titration Period|Withdrawal by Subject|2
1213057|NCT00842829|3981087|P3|Dose Titration Period|Unstable persistent cancer pain|0
1213058|NCT00842829|3981088|P2|Dose Titration Period|Unstable persistent cancer pain|0
1213059|NCT00842829|3981089|P1|Dose Titration Period|Unstable persistent cancer pain|1
1213060|NCT00842829|3981087|P3|Dose Titration Period|Lack of Efficacy|0
1213061|NCT00842829|3981088|P2|Dose Titration Period|Lack of Efficacy|1
1213062|NCT00842829|3981089|P1|Dose Titration Period|Lack of Efficacy|4
1213063|NCT00842829|3981087|P3|Dose Titration Period|Adverse Event|0
1213064|NCT00842829|3981088|P2|Dose Titration Period|Adverse Event|10
1213065|NCT00842829|3981089|P1|Dose Titration Period|Adverse Event|11
1213066|NCT00842712|3981144|P7|Randomized Part|Ongoing at cut-off date|2
1213067|NCT00842712|3981145|P6|Randomized Part|Ongoing at cut-off date|0
1213068|NCT00842712|3981146|P5|Randomized Part|Ongoing at cut-off date|0
1213069|NCT00842712|3981147|P4|Randomized Part|Ongoing at cut-off date|0
1213070|NCT00842712|3981148|P3|Randomized Part|Ongoing at cut-off date|0
1213071|NCT00842712|3981149|P2|Randomized Part|Ongoing at cut-off date|0
1213072|NCT00842712|3981150|P1|Randomized Part|Ongoing at cut-off date|0
1213073|NCT00842712|3981144|P7|Randomized Part|Randomized but not treated|4
1213074|NCT00842712|3981145|P6|Randomized Part|Randomized but not treated|1
1213075|NCT00842712|3981146|P5|Randomized Part|Randomized but not treated|0
1213076|NCT00842712|3981147|P4|Randomized Part|Randomized but not treated|0
1213077|NCT00842712|3981148|P3|Randomized Part|Randomized but not treated|0
1213078|NCT00842712|3981149|P2|Randomized Part|Randomized but not treated|0
1213079|NCT00842712|3981150|P1|Randomized Part|Randomized but not treated|0
1213080|NCT00842712|3981144|P7|Safety Run-in Part|Progressive disease|0
1213081|NCT00842712|3981145|P6|Safety Run-in Part|Progressive disease|0
1213082|NCT00842712|3981146|P5|Safety Run-in Part|Progressive disease|0
1213083|NCT00842712|3981147|P4|Safety Run-in Part|Progressive disease|1
1213084|NCT00842712|3981148|P3|Safety Run-in Part|Progressive disease|0
1213085|NCT00842712|3981149|P2|Safety Run-in Part|Progressive disease|1
1213086|NCT00842712|3981150|P1|Safety Run-in Part|Progressive disease|3
1213087|NCT00842712|3981144|P7|Safety Run-in Part|Adverse Event|0
1213088|NCT00842712|3981145|P6|Safety Run-in Part|Adverse Event|0
1213089|NCT00842712|3981146|P5|Safety Run-in Part|Adverse Event|0
1213090|NCT00842712|3981147|P4|Safety Run-in Part|Adverse Event|0
1213091|NCT00842712|3981148|P3|Safety Run-in Part|Adverse Event|0
1213092|NCT00842712|3981149|P2|Safety Run-in Part|Adverse Event|1
1213093|NCT00842712|3981150|P1|Safety Run-in Part|Adverse Event|0
1213094|NCT00842543|3981207|P4|Overall Study|Withdrawal by Subject|4
1213095|NCT00842543|3981208|P3|Overall Study|Withdrawal by Subject|3
1213096|NCT00842543|3981209|P2|Overall Study|Withdrawal by Subject|0
1213097|NCT00842543|3981210|P1|Overall Study|Withdrawal by Subject|2
1213098|NCT00842361|3981224|P2|Overall Study|Unclassified|2
1213099|NCT00842361|3981225|P1|Overall Study|Unclassified|0
1213100|NCT00842361|3981224|P2|Overall Study|Protocol Violation|0
1213101|NCT00842361|3981225|P1|Overall Study|Protocol Violation|1
1213102|NCT00842348|3981245|P2|Study 729|Surgical resection|0
1213103|NCT00842348|3981246|P1|Study 729|Surgical resection|1
1213104|NCT00842348|3981245|P2|Study 729|Sponsor's decision|0
1213105|NCT00842348|3981246|P1|Study 729|Sponsor's decision|1
1213106|NCT00842348|3981245|P2|Study 729|Due to non-availability of IP|1
1213107|NCT00842348|3981246|P1|Study 729|Due to non-availability of IP|0
1213108|NCT00842348|3981245|P2|Study 729|Due to Sponsor stopping the study|1
1213109|NCT00842348|3981246|P1|Study 729|Due to Sponsor stopping the study|1
1213110|NCT00842348|3981245|P2|Study 729|Withdrawal by Subject|4
1213111|NCT00842348|3981246|P1|Study 729|Withdrawal by Subject|2
1213112|NCT00842348|3981245|P2|Study 729|Protocol Violation|1
1213113|NCT00842348|3981246|P1|Study 729|Protocol Violation|1
1213114|NCT00842348|3981245|P2|Study 729|Adverse Event|1
1213115|NCT00842348|3981246|P1|Study 729|Adverse Event|1
1213116|NCT00842348|3981245|P2|Study 729|Disease progression/death|30
1213117|NCT00842348|3981246|P1|Study 729|Disease progression/death|19
1213118|NCT00842348|3981245|P2|Patients Randomised in Study 726|Did not enter Study 729|56
1213119|NCT00842348|3981246|P1|Patients Randomised in Study 726|Did not enter Study 729|59
1213120|NCT00842257|3981289|P1|Overall Study|Adverse Event|1
1213121|NCT00842244|3981296|P1|Overall Study|Other|17
1213122|NCT00842244|3981296|P1|Overall Study|Withdrawal by Subject|1
1213123|NCT00842244|3981296|P1|Overall Study|Death|3
1213124|NCT00842153|3981323|P2|Overall Study|Lost to Follow-up|2
1213125|NCT00842153|3981324|P1|Overall Study|Lost to Follow-up|1
1213126|NCT00842153|3981323|P2|Overall Study|Adverse Event|1
1213127|NCT00842153|3981324|P1|Overall Study|Adverse Event|0
1213128|NCT00841906|3981399|P2|Overall Study|Withdrawal by Subject|0
1213129|NCT00841906|3981400|P1|Overall Study|Withdrawal by Subject|2
1213130|NCT00841815|3981425|P2|Washout|Withdrawal by Subject|1
1213131|NCT00841815|3981426|P1|Washout|Withdrawal by Subject|0
1213132|NCT00841776|3981436|P2|Overall Study|Withdrawal by Subject|1
1213133|NCT00841776|3981437|P1|Overall Study|Withdrawal by Subject|0
1213134|NCT00841776|3981436|P2|Overall Study|Lost to Follow-up|1
1213135|NCT00841776|3981437|P1|Overall Study|Lost to Follow-up|2
1213136|NCT00841776|3981436|P2|Overall Study|Lack of Efficacy|1
1213137|NCT00841776|3981437|P1|Overall Study|Lack of Efficacy|0
1213138|NCT00841763|3981455|P4|Overall Study|Unable to Classify|0
1213139|NCT00841763|3981456|P3|Overall Study|Unable to Classify|0
1213140|NCT00841763|3981457|P2|Overall Study|Unable to Classify|1
1213141|NCT00841763|3981458|P1|Overall Study|Unable to Classify|7
1213142|NCT00841763|3981455|P4|Overall Study|Administrative Reasons|0
1213143|NCT00841763|3981456|P3|Overall Study|Administrative Reasons|0
1213144|NCT00841763|3981457|P2|Overall Study|Administrative Reasons|1
1213145|NCT00841763|3981458|P1|Overall Study|Administrative Reasons|3
1213146|NCT00841763|3981455|P4|Overall Study|Protocol Violation|0
1213147|NCT00841763|3981456|P3|Overall Study|Protocol Violation|1
1213148|NCT00841763|3981457|P2|Overall Study|Protocol Violation|3
1213149|NCT00841763|3981458|P1|Overall Study|Protocol Violation|20
1213150|NCT00841763|3981455|P4|Overall Study|Lost to Follow-up|0
1213151|NCT00841763|3981456|P3|Overall Study|Lost to Follow-up|0
1213152|NCT00841763|3981457|P2|Overall Study|Lost to Follow-up|25
1213153|NCT00841763|3981458|P1|Overall Study|Lost to Follow-up|63
1213154|NCT00841763|3981455|P4|Overall Study|Adverse Event|2
1213155|NCT00841763|3981456|P3|Overall Study|Adverse Event|3
1213156|NCT00841763|3981457|P2|Overall Study|Adverse Event|10
1213157|NCT00841763|3981458|P1|Overall Study|Adverse Event|9
1213158|NCT00841763|3981455|P4|Overall Study|Withdrawal by Subject|1
1213159|NCT00841763|3981456|P3|Overall Study|Withdrawal by Subject|4
1213160|NCT00841763|3981457|P2|Overall Study|Withdrawal by Subject|17
1213161|NCT00841763|3981458|P1|Overall Study|Withdrawal by Subject|60
1213162|NCT00841698|3981520|P2|First Intervention|Withdrawal by Subject|0
1213163|NCT00841698|3981521|P1|First Intervention|Withdrawal by Subject|1
1213164|NCT00841672|3981531|P2|Overall Study|Protocol Deviation|1
1213165|NCT00841672|3981532|P1|Overall Study|Protocol Deviation|0
1213166|NCT00841672|3981531|P2|Overall Study|Misrandomized|0
1213167|NCT00841672|3981532|P1|Overall Study|Misrandomized|1
1213168|NCT00841672|3981531|P2|Overall Study|Administrative problems|9
1213169|NCT00841672|3981532|P1|Overall Study|Administrative problems|9
1213170|NCT00841672|3981531|P2|Overall Study|Lost to Follow-up|1
1213171|NCT00841672|3981532|P1|Overall Study|Lost to Follow-up|1
1213172|NCT00841672|3981531|P2|Overall Study|Subject withdrew consent|4
1213173|NCT00841672|3981532|P1|Overall Study|Subject withdrew consent|2
1213174|NCT00841672|3981531|P2|Overall Study|Abnormal test procedure result(s)|1
1213175|NCT00841672|3981532|P1|Overall Study|Abnormal test procedure result(s)|0
1213176|NCT00841672|3981531|P2|Overall Study|Adverse Event|16
1213177|NCT00841672|3981532|P1|Overall Study|Adverse Event|7
1213178|NCT00841659|3981548|P2|Washout: 2 Weeks|Protocol Violation|0
1213179|NCT00841659|3981549|P1|Washout: 2 Weeks|Protocol Violation|1
1213180|NCT00841568|3981557|P1|Overall Study|Creatinine over the withdrawal criteria|1
1213181|NCT00841568|3981557|P1|Overall Study|Withdrawal by Subject|2
1213182|NCT00841568|3981557|P1|Overall Study|Death|1
1213183|NCT00841568|3981557|P1|Overall Study|Adverse Event|1
1213184|NCT00841542|3981585|P2|Period 1|Adverse Event|0
1213185|NCT00841542|3981586|P1|Period 1|Adverse Event|1
1213186|NCT00841321|3981601|P2|Overall Study|Adverse Event|2
1213187|NCT00841321|3981602|P1|Overall Study|Adverse Event|0
1213188|NCT00841321|3981601|P2|Overall Study|Lost to Follow-up|1
1213189|NCT00841321|3981602|P1|Overall Study|Lost to Follow-up|1
1213190|NCT00841035|3981670|P1|Phase 1 Overall Study|Physician Decision|13
1213191|NCT00840996|3981677|P2|Overall Study|Withdrawal by Subject|0
1213192|NCT00840996|3981678|P1|Overall Study|Withdrawal by Subject|1
1213193|NCT00840879|3981698|P2|Second Intervention|Withdrawal by Subject|0
1213194|NCT00840879|3981699|P1|Second Intervention|Withdrawal by Subject|1
1213195|NCT00840658|3981739|P4|Overall Study|Lost to Follow-up|1
1213196|NCT00840658|3981740|P3|Overall Study|Lost to Follow-up|2
1213197|NCT00840658|3981741|P2|Overall Study|Lost to Follow-up|1
1213198|NCT00840658|3981742|P1|Overall Study|Lost to Follow-up|3
1213199|NCT00840658|3981739|P4|Overall Study|Death|3
1213200|NCT00840658|3981740|P3|Overall Study|Death|3
1213201|NCT00840658|3981741|P2|Overall Study|Death|2
1213202|NCT00840658|3981742|P1|Overall Study|Death|2
1213203|NCT00840632|3981754|P2|Washout|Withdrawal by Subject|1
1213204|NCT00840632|3981755|P1|Washout|Withdrawal by Subject|1
1213205|NCT00840632|3981754|P2|First Intervention|Withdrawal by Subject|1
1213206|NCT00840632|3981755|P1|First Intervention|Withdrawal by Subject|0
1213207|NCT00840450|3981780|P1|Overall Study|Lack of Efficacy|2
1213208|NCT00840450|3981780|P1|Overall Study|Adverse Event|1
1213209|NCT00840411|3981788|P2|Washout|Withdrawal by Subject|0
1213210|NCT00840411|3981789|P1|Washout|Withdrawal by Subject|1
1213211|NCT00840411|3981788|P2|First Intervention|Adverse Event|0
1213212|NCT00840411|3981789|P1|First Intervention|Adverse Event|1
1213213|NCT00840294|3981803|P2|Overall Study|Illness|1
1213214|NCT00840294|3981804|P1|Overall Study|Illness|0
1213215|NCT00840294|3981803|P2|Overall Study|Protocol Violation|3
1213216|NCT00840294|3981804|P1|Overall Study|Protocol Violation|1
1213217|NCT00840294|3981803|P2|Overall Study|Withdrawal by Subject|1
1213218|NCT00840294|3981804|P1|Overall Study|Withdrawal by Subject|2
1213219|NCT00840216|3981825|P2|Washout: 7 Days|Withdrawal by Subject|0
1213220|NCT00840216|3981826|P1|Washout: 7 Days|Withdrawal by Subject|1
1213221|NCT00840203|3981836|P2|Washout|Protocol Violation|0
1213222|NCT00840203|3981837|P1|Washout|Protocol Violation|1
1213223|NCT00840203|3981836|P2|First Intervention|Protocol Violation|1
1213224|NCT00840203|3981837|P1|First Intervention|Protocol Violation|1
1213225|NCT00840086|3981868|P1|Overall Study|Lost to Follow-up|1
1213226|NCT00840086|3981868|P1|Overall Study|Protocol Violation|2
1213227|NCT00840086|3981868|P1|Overall Study|Adverse Event|1
1213228|NCT00840073|3981877|P2|Second Intervention|Missed 72 hour blood draw|1
1213229|NCT00840073|3981878|P1|Second Intervention|Missed 72 hour blood draw|1
1213230|NCT00840060|3981892|P2|Overall Study|Change in emotional/behavioral status|1
1213231|NCT00840060|3981893|P1|Overall Study|Change in emotional/behavioral status|0
1213232|NCT00840060|3981892|P2|Overall Study|Withdrawal by Subject|0
1213233|NCT00840060|3981893|P1|Overall Study|Withdrawal by Subject|1
1213234|NCT00840034|3981903|P2|Taper Phase|Withdrawal by Subject|1
1213235|NCT00840034|3981904|P1|Taper Phase|Withdrawal by Subject|1
1213236|NCT00840034|3981903|P2|Taper Phase|Lost to Follow-up|1
1213237|NCT00840034|3981904|P1|Taper Phase|Lost to Follow-up|1
1213238|NCT00840034|3981903|P2|Taper Phase|Adverse Event|0
1213239|NCT00840034|3981904|P1|Taper Phase|Adverse Event|1
1213240|NCT00840034|3981903|P2|Acute Treatment Phase|Withdrawal by Subject|11
1213241|NCT00840034|3981904|P1|Acute Treatment Phase|Withdrawal by Subject|6
1213242|NCT00840034|3981903|P2|Acute Treatment Phase|Protocol Violation|4
1213243|NCT00840034|3981904|P1|Acute Treatment Phase|Protocol Violation|2
1213244|NCT00840034|3981903|P2|Acute Treatment Phase|Physician Decision|1
1213245|NCT00840034|3981904|P1|Acute Treatment Phase|Physician Decision|0
1213246|NCT00840034|3981903|P2|Acute Treatment Phase|Lost to Follow-up|12
1213247|NCT00840034|3981904|P1|Acute Treatment Phase|Lost to Follow-up|5
1213248|NCT00840034|3981903|P2|Acute Treatment Phase|Lack of Efficacy|0
1213249|NCT00840034|3981904|P1|Acute Treatment Phase|Lack of Efficacy|2
1213250|NCT00840034|3981903|P2|Acute Treatment Phase|Adverse Event|8
1213251|NCT00840034|3981904|P1|Acute Treatment Phase|Adverse Event|6
1213252|NCT00839956|3981957|P1|Overall Study|Withdrawal by Subject|3
1213253|NCT00839956|3981957|P1|Overall Study|Physician Decision|1
1213254|NCT00839956|3981957|P1|Overall Study|Lack of Efficacy|6
1213255|NCT00839956|3981957|P1|Overall Study|Adverse Event|2
1213256|NCT00839917|3981977|P2|Overall Study|Did not receive vaccine|1
1213257|NCT00839917|3981978|P1|Overall Study|Did not receive vaccine|0
1213258|NCT00839917|3981977|P2|Overall Study|Lost to Follow-up|0
1213259|NCT00839917|3981978|P1|Overall Study|Lost to Follow-up|1
1213260|NCT00839800|3982016|P2|Overall Study|Severe Non-Compliance to Protocol|7
1213261|NCT00839800|3982017|P1|Overall Study|Severe Non-Compliance to Protocol|7
1213262|NCT00839800|3982016|P2|Overall Study|Not Specified|14
1213263|NCT00839800|3982017|P1|Overall Study|Not Specified|8
1213264|NCT00839800|3982016|P2|Overall Study|Safety Reasons|1
1213265|NCT00839800|3982017|P1|Overall Study|Safety Reasons|2
1213266|NCT00839800|3982016|P2|Overall Study|Study-Specific Discontinuation Criteria|13
1213267|NCT00839800|3982017|P1|Overall Study|Study-Specific Discontinuation Criteria|6
1213268|NCT00839800|3982016|P2|Overall Study|Incorrect Enrolment|3
1213269|NCT00839800|3982017|P1|Overall Study|Incorrect Enrolment|3
1213270|NCT00839800|3982016|P2|Overall Study|Withdrawal by Subject|34
1213271|NCT00839800|3982017|P1|Overall Study|Withdrawal by Subject|28
1213272|NCT00839800|3982016|P2|Overall Study|Lost to Follow-up|26
1213273|NCT00839800|3982017|P1|Overall Study|Lost to Follow-up|31
1213274|NCT00839800|3982016|P2|Overall Study|Adverse Event|12
1213275|NCT00839800|3982017|P1|Overall Study|Adverse Event|8
1213276|NCT00839527|3982063|P3|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
1213277|NCT00839527|3982064|P2|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
1213278|NCT00839527|3982065|P1|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0
1213279|NCT00839527|3982063|P3|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
1213280|NCT00839527|3982064|P2|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1
1213281|NCT00839527|3982065|P1|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
1213282|NCT00839527|3982063|P3|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
1213283|NCT00839527|3982064|P2|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0
1213284|NCT00839527|3982065|P1|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
1213285|NCT00839527|3982063|P3|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
1213286|NCT00839527|3982064|P2|Follow-up Period (FUP) (8 Weeks)|Site Closed|1
1213287|NCT00839527|3982065|P1|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
1213288|NCT00839527|3982063|P3|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
1213289|NCT00839527|3982064|P2|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
1213290|NCT00839527|3982065|P1|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1
1213291|NCT00839527|3982063|P3|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
1213292|NCT00839527|3982064|P2|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
1213293|NCT00839527|3982065|P1|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1
1213294|NCT00839527|3982063|P3|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5
1213295|NCT00839527|3982064|P2|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10
1213296|NCT00839527|3982065|P1|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3
1213297|NCT00839527|3982063|P3|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
1213298|NCT00839527|3982064|P2|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
1213299|NCT00839527|3982065|P1|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
1213300|NCT00839527|3982063|P3|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19
1213301|NCT00839527|3982064|P2|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21
1213302|NCT00839527|3982065|P1|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12
1213303|NCT00839527|3982063|P3|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29
1213304|NCT00839527|3982064|P2|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20
1213305|NCT00839527|3982065|P1|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8
1213306|NCT00839527|3982063|P3|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5
1213307|NCT00839527|3982064|P2|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
1213308|NCT00839527|3982065|P1|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
1213309|NCT00839527|3982063|P3|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
1213310|NCT00839527|3982064|P2|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2
1213311|NCT00839527|3982065|P1|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
1213312|NCT00839527|3982063|P3|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1
1213313|NCT00839527|3982064|P2|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
1213314|NCT00839527|3982065|P1|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
1213315|NCT00839527|3982063|P3|Treatment Period (TP) (156 Weeks)|Site Closed|0
1213316|NCT00839527|3982064|P2|Treatment Period (TP) (156 Weeks)|Site Closed|2
1213317|NCT00839527|3982065|P1|Treatment Period (TP) (156 Weeks)|Site Closed|1
1213318|NCT00839527|3982063|P3|Treatment Period (TP) (156 Weeks)|Pregnancy|1
1213319|NCT00839527|3982064|P2|Treatment Period (TP) (156 Weeks)|Pregnancy|1
1213320|NCT00839527|3982065|P1|Treatment Period (TP) (156 Weeks)|Pregnancy|0
1213321|NCT00839527|3982063|P3|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1
1213322|NCT00839527|3982064|P2|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
1213323|NCT00839527|3982065|P1|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
1213324|NCT00839527|3982063|P3|Treatment Period (TP) (156 Weeks)|Missing|0
1213325|NCT00839527|3982064|P2|Treatment Period (TP) (156 Weeks)|Missing|1
1213326|NCT00839527|3982065|P1|Treatment Period (TP) (156 Weeks)|Missing|0
1213327|NCT00839527|3982063|P3|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5
1213328|NCT00839527|3982064|P2|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8
1213329|NCT00839527|3982065|P1|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3
1213330|NCT00839527|3982063|P3|Treatment Period (TP) (156 Weeks)|Physician Decision|1
1213331|NCT00839527|3982064|P2|Treatment Period (TP) (156 Weeks)|Physician Decision|6
1213332|NCT00839527|3982065|P1|Treatment Period (TP) (156 Weeks)|Physician Decision|1
1213333|NCT00839527|3982063|P3|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64
1213334|NCT00839527|3982064|P2|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46
1213335|NCT00839527|3982065|P1|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32
1213336|NCT00839527|3982063|P3|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
1213337|NCT00839527|3982064|P2|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12
1213338|NCT00839527|3982065|P1|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3
1213339|NCT00839527|3982063|P3|Treatment Period (TP) (156 Weeks)|Noncompliance|16
1213340|NCT00839527|3982064|P2|Treatment Period (TP) (156 Weeks)|Noncompliance|6
1213341|NCT00839527|3982065|P1|Treatment Period (TP) (156 Weeks)|Noncompliance|5
1213342|NCT00839527|3982063|P3|Treatment Period (TP) (156 Weeks)|Protocol Violation|1
1213343|NCT00839527|3982064|P2|Treatment Period (TP) (156 Weeks)|Protocol Violation|7
1213344|NCT00839527|3982065|P1|Treatment Period (TP) (156 Weeks)|Protocol Violation|4
1213345|NCT00839527|3982063|P3|Treatment Period (TP) (156 Weeks)|Adverse Event|22
1213346|NCT00839527|3982064|P2|Treatment Period (TP) (156 Weeks)|Adverse Event|29
1213347|NCT00839527|3982065|P1|Treatment Period (TP) (156 Weeks)|Adverse Event|11
1213348|NCT00839436|3982100|P3|Overall Study|Study drug no longer available|1
1213349|NCT00839436|3982101|P2|Overall Study|Study drug no longer available|0
1213350|NCT00839436|3982102|P1|Overall Study|Study drug no longer available|0
1213351|NCT00839436|3982100|P3|Overall Study|Withdrawal by Subject|0
1213352|NCT00839436|3982101|P2|Overall Study|Withdrawal by Subject|1
1213353|NCT00839436|3982102|P1|Overall Study|Withdrawal by Subject|0
1213354|NCT00839436|3982100|P3|Overall Study|Developed exclusionary condition|0
1213355|NCT00839436|3982101|P2|Overall Study|Developed exclusionary condition|0
1213356|NCT00839436|3982102|P1|Overall Study|Developed exclusionary condition|1
1213357|NCT00839423|3982114|P4|Overall Study|Administrative or other reasons|0
1213358|NCT00839423|3982115|P3|Overall Study|Administrative or other reasons|1
1213359|NCT00839423|3982116|P2|Overall Study|Administrative or other reasons|0
1213360|NCT00839423|3982117|P1|Overall Study|Administrative or other reasons|3
1213361|NCT00839423|3982114|P4|Overall Study|Lost to Follow-up|0
1213362|NCT00839423|3982115|P3|Overall Study|Lost to Follow-up|1
1213363|NCT00839423|3982116|P2|Overall Study|Lost to Follow-up|0
1213364|NCT00839423|3982117|P1|Overall Study|Lost to Follow-up|1
1213365|NCT00839423|3982114|P4|Overall Study|Withdrawal of consent|1
1213366|NCT00839423|3982115|P3|Overall Study|Withdrawal of consent|4
1213367|NCT00839423|3982116|P2|Overall Study|Withdrawal of consent|0
1213368|NCT00839423|3982117|P1|Overall Study|Withdrawal of consent|4
1213369|NCT00839423|3982114|P4|Overall Study|Protocol Violation|0
1213370|NCT00839423|3982115|P3|Overall Study|Protocol Violation|2
1213371|NCT00839423|3982116|P2|Overall Study|Protocol Violation|1
1213372|NCT00839423|3982117|P1|Overall Study|Protocol Violation|0
1213373|NCT00839423|3982114|P4|Overall Study|Non-compliance|1
1213374|NCT00839423|3982115|P3|Overall Study|Non-compliance|0
1213375|NCT00839423|3982116|P2|Overall Study|Non-compliance|0
1213376|NCT00839423|3982117|P1|Overall Study|Non-compliance|0
1213377|NCT00839423|3982114|P4|Overall Study|Lack of Efficacy|2
1213378|NCT00839423|3982115|P3|Overall Study|Lack of Efficacy|3
1213379|NCT00839423|3982116|P2|Overall Study|Lack of Efficacy|6
1213380|NCT00839423|3982117|P1|Overall Study|Lack of Efficacy|6
1213381|NCT00839423|3982114|P4|Overall Study|Adverse Event|16
1213382|NCT00839423|3982115|P3|Overall Study|Adverse Event|7
1213383|NCT00839423|3982116|P2|Overall Study|Adverse Event|3
1213384|NCT00839423|3982117|P1|Overall Study|Adverse Event|4
1213385|NCT00839332|3982158|P3|Phase 2|Lost to Follow-up|1
1213386|NCT00839332|3982159|P2|Phase 2|Lost to Follow-up|0
1213387|NCT00839332|3982160|P1|Phase 2|Lost to Follow-up|0
1213388|NCT00839332|3982158|P3|Phase 2|Physician Decision|1
1213389|NCT00839332|3982159|P2|Phase 2|Physician Decision|4
1213390|NCT00839332|3982160|P1|Phase 2|Physician Decision|0
1213391|NCT00839332|3982158|P3|Phase 2|Withdrawal by Subject|8
1213392|NCT00839332|3982159|P2|Phase 2|Withdrawal by Subject|5
1213393|NCT00839332|3982160|P1|Phase 2|Withdrawal by Subject|0
1213394|NCT00839332|3982158|P3|Phase 2|Death|2
1213395|NCT00839332|3982159|P2|Phase 2|Death|4
1213396|NCT00839332|3982160|P1|Phase 2|Death|0
1213397|NCT00839332|3982158|P3|Phase 2|Adverse Event|6
1213398|NCT00839332|3982159|P2|Phase 2|Adverse Event|8
1213399|NCT00839332|3982160|P1|Phase 2|Adverse Event|0
1213400|NCT00839332|3982158|P3|Phase 2|Disease Progression|21
1213401|NCT00839332|3982159|P2|Phase 2|Disease Progression|46
1213402|NCT00839332|3982160|P1|Phase 2|Disease Progression|0
1213403|NCT00839332|3982158|P3|Phase 2|Protocol Violation|0
1213404|NCT00839332|3982159|P2|Phase 2|Protocol Violation|1
1213405|NCT00839332|3982160|P1|Phase 2|Protocol Violation|0
1213406|NCT00839332|3982158|P3|Phase 1|Physician Decision|0
1213407|NCT00839332|3982159|P2|Phase 1|Physician Decision|0
1213408|NCT00839332|3982160|P1|Phase 1|Physician Decision|2
1213409|NCT00839332|3982158|P3|Phase 1|Withdrawal by Subject|0
1213410|NCT00839332|3982159|P2|Phase 1|Withdrawal by Subject|0
1213411|NCT00839332|3982160|P1|Phase 1|Withdrawal by Subject|4
1213412|NCT00839332|3982158|P3|Phase 1|Adverse Event|0
1213413|NCT00839332|3982159|P2|Phase 1|Adverse Event|0
1213414|NCT00839332|3982160|P1|Phase 1|Adverse Event|6
1213415|NCT00839332|3982158|P3|Phase 1|Disease Progression|0
1213416|NCT00839332|3982159|P2|Phase 1|Disease Progression|0
1213417|NCT00839332|3982160|P1|Phase 1|Disease Progression|38
1213418|NCT00839306|3982221|P2|Overall Study|Not specified|18
1213419|NCT00839306|3982222|P1|Overall Study|Not specified|6
1213420|NCT00839306|3982221|P2|Overall Study|Lack of Efficacy|4
1213421|NCT00839306|3982222|P1|Overall Study|Lack of Efficacy|5
1213422|NCT00839306|3982221|P2|Overall Study|Withdrawal by Subject|7
1213423|NCT00839306|3982222|P1|Overall Study|Withdrawal by Subject|5
1213424|NCT00839306|3982221|P2|Overall Study|Lost to Follow-up|9
1213425|NCT00839306|3982222|P1|Overall Study|Lost to Follow-up|6
1213426|NCT00839306|3982221|P2|Overall Study|Adverse Event|5
1213427|NCT00839306|3982222|P1|Overall Study|Adverse Event|3
1213428|NCT00839098|3982320|P3|Overall Study|Withdrawal by Subject|7
1213429|NCT00839098|3982321|P2|Overall Study|Withdrawal by Subject|1
1213430|NCT00839098|3982322|P1|Overall Study|Withdrawal by Subject|2
1213431|NCT00839072|3982348|P2|Second Intervention Period|Withdrawal by Subject|0
1213432|NCT00839072|3982349|P1|Second Intervention Period|Withdrawal by Subject|1
1213433|NCT00839072|3982348|P2|First Intervention Period|Adverse Event|1
1213434|NCT00839072|3982349|P1|First Intervention Period|Adverse Event|1
1213435|NCT00839072|3982348|P2|First Intervention Period|Withdrawal by Subject|0
1213436|NCT00839072|3982349|P1|First Intervention Period|Withdrawal by Subject|1
1213437|NCT00838929|3982393|P3|Overall Study|Disease progression|1
1213438|NCT00838929|3982394|P2|Overall Study|Disease progression|2
1213439|NCT00838929|3982395|P1|Overall Study|Disease progression|0
1213440|NCT00838929|3982393|P3|Overall Study|Protocol Violation|0
1213441|NCT00838929|3982394|P2|Overall Study|Protocol Violation|1
1213442|NCT00838929|3982395|P1|Overall Study|Protocol Violation|0
1213443|NCT00838916|3982403|P2|Follow-up Period (8 Weeks)|Missing|0
1213444|NCT00838916|3982404|P1|Follow-up Period (8 Weeks)|Missing|3
1213445|NCT00838916|3982403|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|0
1213446|NCT00838916|3982404|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
1213447|NCT00838916|3982403|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
1213448|NCT00838916|3982404|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2
1213449|NCT00838916|3982403|P2|Follow-up Period (8 Weeks)|Physician Decision|0
1213450|NCT00838916|3982404|P1|Follow-up Period (8 Weeks)|Physician Decision|2
1213451|NCT00838916|3982403|P2|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12
1213452|NCT00838916|3982404|P1|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26
1213453|NCT00838916|3982403|P2|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
1213454|NCT00838916|3982404|P1|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
1213455|NCT00838916|3982403|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|22
1213456|NCT00838916|3982404|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|38
1213457|NCT00838916|3982403|P2|Follow-up Period (8 Weeks)|Noncompliance|5
1213458|NCT00838916|3982404|P1|Follow-up Period (8 Weeks)|Noncompliance|6
1213459|NCT00838916|3982403|P2|Follow-up Period (8 Weeks)|Adverse Event|5
1213460|NCT00838916|3982404|P1|Follow-up Period (8 Weeks)|Adverse Event|10
1213461|NCT00838916|3982403|P2|Treatment Period (156 Weeks)|Pregnancy|0
1213462|NCT00838916|3982404|P1|Treatment Period (156 Weeks)|Pregnancy|2
1213463|NCT00838916|3982403|P2|Treatment Period (156 Weeks)|Missing|1
1213464|NCT00838916|3982404|P1|Treatment Period (156 Weeks)|Missing|3
1213465|NCT00838916|3982403|P2|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0
1213466|NCT00838916|3982404|P1|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1
1213467|NCT00838916|3982403|P2|Treatment Period (156 Weeks)|Physician Decision|1
1213468|NCT00838916|3982404|P1|Treatment Period (156 Weeks)|Physician Decision|6
1213469|NCT00838916|3982403|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|29
1213470|NCT00838916|3982404|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|81
1213471|NCT00838916|3982403|P2|Treatment Period (156 Weeks)|Lost to Follow-up|18
1213472|NCT00838916|3982404|P1|Treatment Period (156 Weeks)|Lost to Follow-up|19
1213473|NCT00838916|3982403|P2|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
1213474|NCT00838916|3982404|P1|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
1213475|NCT00838916|3982403|P2|Treatment Period (156 Weeks)|Noncompliance|14
1213476|NCT00838916|3982404|P1|Treatment Period (156 Weeks)|Noncompliance|21
1213477|NCT00838916|3982403|P2|Treatment Period (156 Weeks)|Protocol Violation|3
1213478|NCT00838916|3982404|P1|Treatment Period (156 Weeks)|Protocol Violation|12
1213479|NCT00838916|3982403|P2|Treatment Period (156 Weeks)|Adverse Event|11
1213480|NCT00838916|3982404|P1|Treatment Period (156 Weeks)|Adverse Event|50
1213481|NCT00838903|3982433|P4|Follow-up Period (8 Weeks)|Missing|1
1213482|NCT00838903|3982434|P3|Follow-up Period (8 Weeks)|Missing|1
1213483|NCT00838903|3982435|P2|Follow-up Period (8 Weeks)|Missing|2
1213484|NCT00838903|3982436|P1|Follow-up Period (8 Weeks)|Missing|1
1213485|NCT00838903|3982433|P4|Follow-up Period (8 Weeks)|Subject Moved out of Town|1
1213486|NCT00838903|3982434|P3|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
1213487|NCT00838903|3982435|P2|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
1213488|NCT00838903|3982436|P1|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
1213489|NCT00838903|3982433|P4|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
1213490|NCT00838903|3982434|P3|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
1213491|NCT00838903|3982435|P2|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1
1213492|NCT00838903|3982436|P1|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
1213493|NCT00838903|3982433|P4|Follow-up Period (8 Weeks)|ICF Withdrawn|0
1213494|NCT00838903|3982434|P3|Follow-up Period (8 Weeks)|ICF Withdrawn|0
1213495|NCT00838903|3982435|P2|Follow-up Period (8 Weeks)|ICF Withdrawn|1
1213496|NCT00838903|3982436|P1|Follow-up Period (8 Weeks)|ICF Withdrawn|0
1213497|NCT00838903|3982433|P4|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
1213498|NCT00838903|3982434|P3|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6
1213499|NCT00838903|3982435|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
1213500|NCT00838903|3982436|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3
1213501|NCT00838903|3982433|P4|Follow-up Period (8 Weeks)|Physician Decision|1
1213502|NCT00838903|3982434|P3|Follow-up Period (8 Weeks)|Physician Decision|1
1213503|NCT00838903|3982435|P2|Follow-up Period (8 Weeks)|Physician Decision|1
1213504|NCT00838903|3982436|P1|Follow-up Period (8 Weeks)|Physician Decision|1
1213505|NCT00838903|3982433|P4|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
1213506|NCT00838903|3982434|P3|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
1213507|NCT00838903|3982435|P2|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13
1213508|NCT00838903|3982436|P1|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8
1213509|NCT00838903|3982433|P4|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
1213510|NCT00838903|3982434|P3|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12
1213511|NCT00838903|3982435|P2|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
1213512|NCT00838903|3982436|P1|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5
1213513|NCT00838903|3982433|P4|Follow-up Period (8 Weeks)|Lost to Follow-up|24
1213514|NCT00838903|3982434|P3|Follow-up Period (8 Weeks)|Lost to Follow-up|22
1213515|NCT00838903|3982435|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|28
1213516|NCT00838903|3982436|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|6
1213517|NCT00838903|3982433|P4|Follow-up Period (8 Weeks)|Noncompliance|5
1213518|NCT00838903|3982434|P3|Follow-up Period (8 Weeks)|Noncompliance|5
1213519|NCT00838903|3982435|P2|Follow-up Period (8 Weeks)|Noncompliance|8
1213520|NCT00838903|3982436|P1|Follow-up Period (8 Weeks)|Noncompliance|2
1213521|NCT00838903|3982433|P4|Follow-up Period (8 Weeks)|Adverse Event|1
1213522|NCT00838903|3982434|P3|Follow-up Period (8 Weeks)|Adverse Event|3
1213523|NCT00838903|3982435|P2|Follow-up Period (8 Weeks)|Adverse Event|0
1213524|NCT00838903|3982436|P1|Follow-up Period (8 Weeks)|Adverse Event|0
1213525|NCT00838903|3982433|P4|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
1213526|NCT00838903|3982434|P3|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
1213527|NCT00838903|3982435|P2|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
1213528|NCT00838903|3982436|P1|Treatment Period (156 Weeks)|Missing Active Treatment Status|1
1213529|NCT00838903|3982433|P4|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
1213530|NCT00838903|3982434|P3|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
1213531|NCT00838903|3982435|P2|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
1213532|NCT00838903|3982436|P1|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
1213533|NCT00838903|3982433|P4|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
1213534|NCT00838903|3982434|P3|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
1213535|NCT00838903|3982435|P2|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
1213536|NCT00838903|3982436|P1|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1
1213537|NCT00838903|3982433|P4|Treatment Period (156 Weeks)|Site closed|0
1213538|NCT00838903|3982434|P3|Treatment Period (156 Weeks)|Site closed|1
1213539|NCT00838903|3982435|P2|Treatment Period (156 Weeks)|Site closed|0
1213540|NCT00838903|3982436|P1|Treatment Period (156 Weeks)|Site closed|0
1213541|NCT00838903|3982433|P4|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
1213542|NCT00838903|3982434|P3|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1
1213543|NCT00838903|3982435|P2|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
1213544|NCT00838903|3982436|P1|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
1213545|NCT00838903|3982433|P4|Treatment Period (156 Weeks)|Pregnancy|0
1213546|NCT00838903|3982434|P3|Treatment Period (156 Weeks)|Pregnancy|1
1213547|NCT00838903|3982435|P2|Treatment Period (156 Weeks)|Pregnancy|0
1213548|NCT00838903|3982436|P1|Treatment Period (156 Weeks)|Pregnancy|0
1213549|NCT00838903|3982433|P4|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
1213550|NCT00838903|3982434|P3|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
1213551|NCT00838903|3982435|P2|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
1213552|NCT00838903|3982436|P1|Treatment Period (156 Weeks)|Poor Therapeutic Response|1
1213553|NCT00838903|3982433|P4|Treatment Period (156 Weeks)|Poor Glycemic Control|1
1213554|NCT00838903|3982434|P3|Treatment Period (156 Weeks)|Poor Glycemic Control|0
1213555|NCT00838903|3982435|P2|Treatment Period (156 Weeks)|Poor Glycemic Control|0
1213556|NCT00838903|3982436|P1|Treatment Period (156 Weeks)|Poor Glycemic Control|0
1213557|NCT00838903|3982433|P4|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
1213558|NCT00838903|3982434|P3|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
1213559|NCT00838903|3982435|P2|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1
1213560|NCT00838903|3982436|P1|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
1213561|NCT00838903|3982433|P4|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4
1213562|NCT00838903|3982434|P3|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
1213563|NCT00838903|3982435|P2|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
1213564|NCT00838903|3982436|P1|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3
1213565|NCT00838903|3982433|P4|Treatment Period (156 Weeks)|Physician Decision|2
1213566|NCT00838903|3982434|P3|Treatment Period (156 Weeks)|Physician Decision|1
1213567|NCT00838903|3982435|P2|Treatment Period (156 Weeks)|Physician Decision|2
1213568|NCT00838903|3982436|P1|Treatment Period (156 Weeks)|Physician Decision|1
1213569|NCT00838903|3982433|P4|Treatment Period (156 Weeks)|Withdrawal by Subject|53
1213570|NCT00838903|3982434|P3|Treatment Period (156 Weeks)|Withdrawal by Subject|56
1213571|NCT00838903|3982435|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|55
1213572|NCT00838903|3982436|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|20
1213573|NCT00838903|3982433|P4|Treatment Period (156 Weeks)|Lost to Follow-up|13
1213574|NCT00838903|3982434|P3|Treatment Period (156 Weeks)|Lost to Follow-up|15
1213575|NCT00838903|3982435|P2|Treatment Period (156 Weeks)|Lost to Follow-up|16
1213576|NCT00838903|3982436|P1|Treatment Period (156 Weeks)|Lost to Follow-up|4
1213577|NCT00838903|3982433|P4|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
1213578|NCT00838903|3982434|P3|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
1213579|NCT00838903|3982435|P2|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
1213580|NCT00838903|3982436|P1|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
1213581|NCT00838903|3982433|P4|Treatment Period (156 Weeks)|Noncompliance|6
1213582|NCT00838903|3982434|P3|Treatment Period (156 Weeks)|Noncompliance|12
1213583|NCT00838903|3982435|P2|Treatment Period (156 Weeks)|Noncompliance|13
1213584|NCT00838903|3982436|P1|Treatment Period (156 Weeks)|Noncompliance|9
1213585|NCT00838903|3982433|P4|Treatment Period (156 Weeks)|Protocol Violation|5
1213586|NCT00838903|3982434|P3|Treatment Period (156 Weeks)|Protocol Violation|6
1213587|NCT00838903|3982435|P2|Treatment Period (156 Weeks)|Protocol Violation|6
1213588|NCT00838903|3982436|P1|Treatment Period (156 Weeks)|Protocol Violation|1
1213589|NCT00838903|3982433|P4|Treatment Period (156 Weeks)|Adverse Event|25
1213590|NCT00838903|3982434|P3|Treatment Period (156 Weeks)|Adverse Event|17
1213591|NCT00838903|3982435|P2|Treatment Period (156 Weeks)|Adverse Event|13
1213592|NCT00838903|3982436|P1|Treatment Period (156 Weeks)|Adverse Event|5
1213593|NCT00838682|3982491|P2|Overall Study|Withdrawal by Subject|1
1213594|NCT00838682|3982492|P1|Overall Study|Withdrawal by Subject|0
1213595|NCT00838682|3982491|P2|Overall Study|Protocol Violation|1
1213596|NCT00838682|3982492|P1|Overall Study|Protocol Violation|0
1213597|NCT00838682|3982491|P2|Overall Study|detection of exclusion criteria|3
1213598|NCT00838682|3982492|P1|Overall Study|detection of exclusion criteria|4
1213599|NCT00838682|3982491|P2|Overall Study|Lost to Follow-up|14
1213600|NCT00838682|3982492|P1|Overall Study|Lost to Follow-up|21
1213601|NCT00838630|3982510|P2|Washout: 7 Days|Protocol Violation|0
1213602|NCT00838630|3982511|P1|Washout: 7 Days|Protocol Violation|1
1213603|NCT00838630|3982510|P2|First Intervention|Adverse Event|0
1213604|NCT00838630|3982511|P1|First Intervention|Adverse Event|1
1213605|NCT00838578|3982519|P1|Overall Study|Protocol Violation|2
1213606|NCT00838565|3982533|P6|Overall Study|Randomized but not Treated|0
1213607|NCT00838565|3982534|P5|Overall Study|Randomized but not Treated|0
1213608|NCT00838565|3982535|P4|Overall Study|Randomized but not Treated|0
1213609|NCT00838565|3982536|P3|Overall Study|Randomized but not Treated|0
1213610|NCT00838565|3982537|P2|Overall Study|Randomized but not Treated|1
1213611|NCT00838565|3982538|P1|Overall Study|Randomized but not Treated|0
1213612|NCT00838565|3982533|P6|Overall Study|Other|0
1213613|NCT00838565|3982534|P5|Overall Study|Other|0
1213614|NCT00838565|3982535|P4|Overall Study|Other|0
1213615|NCT00838565|3982536|P3|Overall Study|Other|0
1213616|NCT00838565|3982537|P2|Overall Study|Other|2
1213617|NCT00838565|3982538|P1|Overall Study|Other|0
1213618|NCT00838565|3982533|P6|Overall Study|Withdrawal by Subject|2
1213619|NCT00838565|3982534|P5|Overall Study|Withdrawal by Subject|0
1213620|NCT00838565|3982535|P4|Overall Study|Withdrawal by Subject|0
1213621|NCT00838565|3982536|P3|Overall Study|Withdrawal by Subject|1
1213622|NCT00838565|3982537|P2|Overall Study|Withdrawal by Subject|0
1213623|NCT00838565|3982538|P1|Overall Study|Withdrawal by Subject|0
1213624|NCT00838539|3982643|P12|Overall Study|Symptomatic Deterioration|0
1213625|NCT00838539|3982644|P11|Overall Study|Symptomatic Deterioration|0
1213626|NCT00838539|3982645|P10|Overall Study|Symptomatic Deterioration|1
1213627|NCT00838539|3982646|P9|Overall Study|Symptomatic Deterioration|0
1213628|NCT00838539|3982647|P8|Overall Study|Symptomatic Deterioration|0
1213629|NCT00838539|3982648|P7|Overall Study|Symptomatic Deterioration|0
1213630|NCT00838539|3982649|P6|Overall Study|Symptomatic Deterioration|1
1213631|NCT00838539|3982650|P5|Overall Study|Symptomatic Deterioration|0
1213632|NCT00838539|3982651|P4|Overall Study|Symptomatic Deterioration|1
1213633|NCT00838539|3982652|P3|Overall Study|Symptomatic Deterioration|1
1213634|NCT00838539|3982653|P2|Overall Study|Symptomatic Deterioration|0
1213635|NCT00838539|3982654|P1|Overall Study|Symptomatic Deterioration|0
1213636|NCT00838539|3982643|P12|Overall Study|Clinical Progression|0
1213637|NCT00838539|3982644|P11|Overall Study|Clinical Progression|0
1213638|NCT00838539|3982645|P10|Overall Study|Clinical Progression|0
1213639|NCT00838539|3982646|P9|Overall Study|Clinical Progression|0
1213640|NCT00838539|3982647|P8|Overall Study|Clinical Progression|0
1213641|NCT00838539|3982648|P7|Overall Study|Clinical Progression|1
1213642|NCT00838539|3982649|P6|Overall Study|Clinical Progression|0
1213643|NCT00838539|3982650|P5|Overall Study|Clinical Progression|0
1213644|NCT00838539|3982651|P4|Overall Study|Clinical Progression|0
1213645|NCT00838539|3982652|P3|Overall Study|Clinical Progression|0
1213646|NCT00838539|3982653|P2|Overall Study|Clinical Progression|0
1213647|NCT00838539|3982654|P1|Overall Study|Clinical Progression|0
1213648|NCT00838539|3982643|P12|Overall Study|Physician Decision|0
1213649|NCT00838539|3982644|P11|Overall Study|Physician Decision|0
1213650|NCT00838539|3982645|P10|Overall Study|Physician Decision|0
1213651|NCT00838539|3982646|P9|Overall Study|Physician Decision|1
1213652|NCT00838539|3982647|P8|Overall Study|Physician Decision|0
1213653|NCT00838539|3982648|P7|Overall Study|Physician Decision|0
1213654|NCT00838539|3982649|P6|Overall Study|Physician Decision|0
1213655|NCT00838539|3982650|P5|Overall Study|Physician Decision|0
1213656|NCT00838539|3982651|P4|Overall Study|Physician Decision|0
1213657|NCT00838539|3982652|P3|Overall Study|Physician Decision|0
1213658|NCT00838539|3982653|P2|Overall Study|Physician Decision|0
1213659|NCT00838539|3982654|P1|Overall Study|Physician Decision|0
1213660|NCT00838539|3982643|P12|Overall Study|Death|0
1213661|NCT00838539|3982644|P11|Overall Study|Death|0
1213662|NCT00838539|3982645|P10|Overall Study|Death|0
1213663|NCT00838539|3982646|P9|Overall Study|Death|0
1213664|NCT00838539|3982647|P8|Overall Study|Death|0
1213665|NCT00838539|3982648|P7|Overall Study|Death|1
1213666|NCT00838539|3982649|P6|Overall Study|Death|0
1213667|NCT00838539|3982650|P5|Overall Study|Death|0
1213668|NCT00838539|3982651|P4|Overall Study|Death|0
1213669|NCT00838539|3982652|P3|Overall Study|Death|0
1213670|NCT00838539|3982653|P2|Overall Study|Death|0
1213671|NCT00838539|3982654|P1|Overall Study|Death|0
1213672|NCT00838539|3982643|P12|Overall Study|Withdrawal by Subject|0
1213673|NCT00838539|3982644|P11|Overall Study|Withdrawal by Subject|2
1213674|NCT00838539|3982645|P10|Overall Study|Withdrawal by Subject|1
1213675|NCT00838539|3982646|P9|Overall Study|Withdrawal by Subject|0
1213676|NCT00838539|3982647|P8|Overall Study|Withdrawal by Subject|0
1213677|NCT00838539|3982648|P7|Overall Study|Withdrawal by Subject|0
1213678|NCT00838539|3982649|P6|Overall Study|Withdrawal by Subject|0
1213679|NCT00838539|3982650|P5|Overall Study|Withdrawal by Subject|0
1213680|NCT00838539|3982651|P4|Overall Study|Withdrawal by Subject|0
1213681|NCT00838539|3982652|P3|Overall Study|Withdrawal by Subject|0
1213682|NCT00838539|3982653|P2|Overall Study|Withdrawal by Subject|1
1213683|NCT00838539|3982654|P1|Overall Study|Withdrawal by Subject|0
1213684|NCT00838539|3982643|P12|Overall Study|Adverse Event|0
1213685|NCT00838539|3982644|P11|Overall Study|Adverse Event|2
1213686|NCT00838539|3982645|P10|Overall Study|Adverse Event|1
1213687|NCT00838539|3982646|P9|Overall Study|Adverse Event|0
1213688|NCT00838539|3982647|P8|Overall Study|Adverse Event|2
1213689|NCT00838539|3982648|P7|Overall Study|Adverse Event|0
1213690|NCT00838539|3982649|P6|Overall Study|Adverse Event|1
1213691|NCT00838539|3982650|P5|Overall Study|Adverse Event|2
1213692|NCT00838539|3982651|P4|Overall Study|Adverse Event|1
1213693|NCT00838539|3982652|P3|Overall Study|Adverse Event|1
1213694|NCT00838539|3982653|P2|Overall Study|Adverse Event|1
1213695|NCT00838539|3982654|P1|Overall Study|Adverse Event|1
1213696|NCT00838539|3982643|P12|Overall Study|Disease Progression|4
1213697|NCT00838539|3982644|P11|Overall Study|Disease Progression|1
1213698|NCT00838539|3982645|P10|Overall Study|Disease Progression|5
1213699|NCT00838539|3982646|P9|Overall Study|Disease Progression|4
1213700|NCT00838539|3982647|P8|Overall Study|Disease Progression|4
1213701|NCT00838539|3982648|P7|Overall Study|Disease Progression|3
1213702|NCT00838539|3982649|P6|Overall Study|Disease Progression|2
1213703|NCT00838539|3982650|P5|Overall Study|Disease Progression|4
1213704|NCT00838539|3982651|P4|Overall Study|Disease Progression|2
1213705|NCT00838539|3982652|P3|Overall Study|Disease Progression|3
1213706|NCT00838539|3982653|P2|Overall Study|Disease Progression|4
1213707|NCT00838539|3982654|P1|Overall Study|Disease Progression|2
1213708|NCT00838526|3982704|P2|Overall Study|Not specified|7
1213709|NCT00838526|3982705|P1|Overall Study|Not specified|11
1213710|NCT00838526|3982704|P2|Overall Study|Lack of Efficacy|3
1213711|NCT00838526|3982705|P1|Overall Study|Lack of Efficacy|2
1213712|NCT00838526|3982704|P2|Overall Study|Withdrawal by Subject|5
1213713|NCT00838526|3982705|P1|Overall Study|Withdrawal by Subject|4
1213714|NCT00838526|3982704|P2|Overall Study|Lost to Follow-up|12
1213715|NCT00838526|3982705|P1|Overall Study|Lost to Follow-up|4
1213716|NCT00838526|3982704|P2|Overall Study|Adverse Event|12
1213717|NCT00838526|3982705|P1|Overall Study|Adverse Event|3
1213718|NCT00838513|3982713|P1|Post Treatment Period (Patients Who Disc|Death|1
1213719|NCT00838513|3982713|P1|Extension Treatment Period|Death|1
1213720|NCT00838513|3982713|P1|Screening Period|Screen Failure|3
1213721|NCT00838331|3982729|P1|Aged Blood Transfusion|Withdrawal by Subject|9
1213722|NCT00838279|3982735|P2|Washout|Withdrawal by Subject|1
1213723|NCT00838279|3982736|P1|Washout|Withdrawal by Subject|0
1213724|NCT00838279|3982735|P2|Washout|Protocol Violation|0
1213725|NCT00838279|3982736|P1|Washout|Protocol Violation|1
1213726|NCT00838201|3982746|P2|Overall Study|Death|13
1213727|NCT00838201|3982747|P1|Overall Study|Death|11
1213728|NCT00838201|3982746|P2|Overall Study|Adverse Event|9
1213729|NCT00838201|3982747|P1|Overall Study|Adverse Event|5
1213730|NCT00838201|3982746|P2|Overall Study|Lost to Follow-up|3
1213731|NCT00838201|3982747|P1|Overall Study|Lost to Follow-up|4
1213732|NCT00838201|3982746|P2|Overall Study|Consent withdrawn|19
1213733|NCT00838201|3982747|P1|Overall Study|Consent withdrawn|16
1213734|NCT00838201|3982746|P2|Overall Study|Disease progression|3
1213735|NCT00838201|3982747|P1|Overall Study|Disease progression|3
1213736|NCT00838201|3982746|P2|Overall Study|Administrative decision|2
1213737|NCT00838201|3982747|P1|Overall Study|Administrative decision|1
1213738|NCT00838201|3982746|P2|Overall Study|Noncompliance|1
1213739|NCT00838201|3982747|P1|Overall Study|Noncompliance|0
1213740|NCT00838201|3982746|P2|Overall Study|Investigator decision, or other reasons|3
1213741|NCT00838201|3982747|P1|Overall Study|Investigator decision, or other reasons|2
1213742|NCT00838110|3982815|P4|Overall Study|Randomized but not treated|0
1213743|NCT00838110|3982816|P3|Overall Study|Randomized but not treated|0
1213744|NCT00838110|3982817|P2|Overall Study|Randomized but not treated|1
1213745|NCT00838110|3982818|P1|Overall Study|Randomized but not treated|0
1213746|NCT00838110|3982815|P4|Overall Study|Did not meet eligibility criteria|2
1213747|NCT00838110|3982816|P3|Overall Study|Did not meet eligibility criteria|1
1213748|NCT00838110|3982817|P2|Overall Study|Did not meet eligibility criteria|0
1213749|NCT00838110|3982818|P1|Overall Study|Did not meet eligibility criteria|0
1213750|NCT00838110|3982815|P4|Overall Study|Lost to Follow-up|0
1213751|NCT00838110|3982816|P3|Overall Study|Lost to Follow-up|0
1213752|NCT00838110|3982817|P2|Overall Study|Lost to Follow-up|0
1213753|NCT00838110|3982818|P1|Overall Study|Lost to Follow-up|3
1213754|NCT00838110|3982815|P4|Overall Study|Protocol Violation|1
1213755|NCT00838110|3982816|P3|Overall Study|Protocol Violation|1
1213756|NCT00838110|3982817|P2|Overall Study|Protocol Violation|2
1213757|NCT00838110|3982818|P1|Overall Study|Protocol Violation|0
1213758|NCT00838110|3982815|P4|Overall Study|Other|2
1213759|NCT00838110|3982816|P3|Overall Study|Other|3
1213760|NCT00838110|3982817|P2|Overall Study|Other|3
1213761|NCT00838110|3982818|P1|Overall Study|Other|3
1213762|NCT00838110|3982815|P4|Overall Study|Withdrawal by Subject|4
1213763|NCT00838110|3982816|P3|Overall Study|Withdrawal by Subject|3
1213764|NCT00838110|3982817|P2|Overall Study|Withdrawal by Subject|6
1213765|NCT00838110|3982818|P1|Overall Study|Withdrawal by Subject|5
1213766|NCT00838110|3982815|P4|Overall Study|Adverse Event|7
1213767|NCT00838110|3982816|P3|Overall Study|Adverse Event|8
1213768|NCT00838110|3982817|P2|Overall Study|Adverse Event|10
1213769|NCT00838110|3982818|P1|Overall Study|Adverse Event|11
1213770|NCT00838110|3982815|P4|Overall Study|Death|2
1213771|NCT00838110|3982816|P3|Overall Study|Death|1
1213772|NCT00838110|3982817|P2|Overall Study|Death|0
1213773|NCT00838110|3982818|P1|Overall Study|Death|0
1213774|NCT00838097|3982838|P1|Overall Study|Protocol-specified criteria|142
1213775|NCT00838097|3982838|P1|Overall Study|Death|6
1213776|NCT00838097|3982838|P1|Overall Study|Lost to Follow-up|11
1213777|NCT00838097|3982838|P1|Overall Study|Physician Decision|4
1213778|NCT00838097|3982838|P1|Overall Study|Requirement for alternative therapy|2
1213779|NCT00838097|3982838|P1|Overall Study|Withdrawal by Subject|3
1213780|NCT00838097|3982838|P1|Overall Study|Adverse Event|2
1213781|NCT00838097|3982838|P1|Overall Study|Ineligibility determined|6
1213782|NCT00837967|3982846|P2|Washout Period of 7 - 14 Days|Adverse Event|0
1213783|NCT00837967|3982847|P1|Washout Period of 7 - 14 Days|Adverse Event|2
1213784|NCT00837876|3982873|P1|Overall Study|disease progression|24
1213785|NCT00837876|3982873|P1|Overall Study|Withdrawal by Subject|3
1213786|NCT00837876|3982873|P1|Overall Study|Physician Decision|1
1213787|NCT00837876|3982873|P1|Overall Study|Adverse Event|7
1213788|NCT00837876|3982873|P1|Overall Study|Death|2
1213789|NCT00837811|3982895|P3|Overall Study|Sponsor Decision|0
1213790|NCT00837811|3982896|P2|Overall Study|Sponsor Decision|2
1213791|NCT00837811|3982897|P1|Overall Study|Sponsor Decision|0
1213792|NCT00837811|3982895|P3|Overall Study|Withdrawal by Subject|0
1213793|NCT00837811|3982896|P2|Overall Study|Withdrawal by Subject|9
1213794|NCT00837811|3982897|P1|Overall Study|Withdrawal by Subject|1
1213795|NCT00837811|3982895|P3|Overall Study|Physician Decision|1
1213796|NCT00837811|3982896|P2|Overall Study|Physician Decision|2
1213797|NCT00837811|3982897|P1|Overall Study|Physician Decision|0
1213798|NCT00837811|3982895|P3|Overall Study|Lost to Follow-up|0
1213799|NCT00837811|3982896|P2|Overall Study|Lost to Follow-up|3
1213800|NCT00837811|3982897|P1|Overall Study|Lost to Follow-up|1
1213801|NCT00837811|3982895|P3|Overall Study|Lack of Efficacy|0
1213802|NCT00837811|3982896|P2|Overall Study|Lack of Efficacy|11
1213803|NCT00837811|3982897|P1|Overall Study|Lack of Efficacy|0
1213804|NCT00837811|3982895|P3|Overall Study|Death|0
1213805|NCT00837811|3982896|P2|Overall Study|Death|1
1213806|NCT00837811|3982897|P1|Overall Study|Death|1
1213807|NCT00837811|3982895|P3|Overall Study|Adverse Event|0
1213808|NCT00837811|3982896|P2|Overall Study|Adverse Event|6
1213809|NCT00837811|3982897|P1|Overall Study|Adverse Event|4
1213810|NCT00837759|3982982|P1|Overall Study|Lost to Follow-up|1
1213811|NCT00837759|3982982|P1|Overall Study|Protocol Violation|3
1213812|NCT00837616|3982993|P2|Overall Study|Withdrawal by Subject|1
1213813|NCT00837616|3982994|P1|Overall Study|Withdrawal by Subject|0
1213814|NCT00837577|3983020|P2|Open-label Period|Other Reason|1
1213815|NCT00837577|3983021|P1|Open-label Period|Other Reason|1
1213816|NCT00837577|3983020|P2|Open-label Period|Withdrawal by Subject|2
1213817|NCT00837577|3983021|P1|Open-label Period|Withdrawal by Subject|1
1213818|NCT00837577|3983020|P2|Open-label Period|Lack of Efficacy|3
1213819|NCT00837577|3983021|P1|Open-label Period|Lack of Efficacy|4
1213820|NCT00837577|3983020|P2|Open-label Period|Laboratory Adverse Event|1
1213821|NCT00837577|3983021|P1|Open-label Period|Laboratory Adverse Event|0
1213822|NCT00837577|3983020|P2|Open-label Period|Clinical Adverse Event|2
1213823|NCT00837577|3983021|P1|Open-label Period|Clinical Adverse Event|2
1213824|NCT00837577|3983020|P2|Double-blind Period|Withdrawal by Subject|0
1213825|NCT00837577|3983021|P1|Double-blind Period|Withdrawal by Subject|1
1213826|NCT00837577|3983020|P2|Double-blind Period|Clinical Adverse Event|0
1213827|NCT00837577|3983021|P1|Double-blind Period|Clinical Adverse Event|1
1213828|NCT00837486|3983041|P2|Long-term Follow-up Phase - Open Label|Death|0
1213829|NCT00837486|3983042|P1|Long-term Follow-up Phase - Open Label|Death|1
1213830|NCT00837486|3983041|P2|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0
1213831|NCT00837486|3983042|P1|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2
1213832|NCT00837486|3983041|P2|Long-term Follow-up Phase - Open Label|Physician Decision|0
1213833|NCT00837486|3983042|P1|Long-term Follow-up Phase - Open Label|Physician Decision|2
1213834|NCT00837486|3983041|P2|Blinded-treatment Phase|Physician Decision|0
1213835|NCT00837486|3983042|P1|Blinded-treatment Phase|Physician Decision|1
1213836|NCT00837473|3983054|P1|Overall Study|Withdrawal by Subject|2
1213837|NCT00837473|3983054|P1|Overall Study|Lost to Follow-up|1
1213838|NCT00837434|3983074|P2|Overall Study|Unable to obtain study drug|0
1213839|NCT00837434|3983075|P1|Overall Study|Unable to obtain study drug|1
1213840|NCT00837434|3983074|P2|Overall Study|Baseline assessments not done in time|0
1213841|NCT00837434|3983075|P1|Overall Study|Baseline assessments not done in time|1
1213842|NCT00837434|3983074|P2|Overall Study|Noncompliant|0
1213843|NCT00837434|3983075|P1|Overall Study|Noncompliant|2
1213844|NCT00837434|3983074|P2|Overall Study|Withdrawn by sponsor/regulatory agency|0
1213845|NCT00837434|3983075|P1|Overall Study|Withdrawn by sponsor/regulatory agency|1
1213846|NCT00837434|3983074|P2|Overall Study|Lost to Follow-up|1
1213847|NCT00837434|3983075|P1|Overall Study|Lost to Follow-up|1
1213848|NCT00837434|3983074|P2|Overall Study|Physician Decision|0
1213849|NCT00837434|3983075|P1|Overall Study|Physician Decision|3
1213850|NCT00837330|3983095|P2|Overall Study|Lost to Follow-up|3
1213851|NCT00837330|3983096|P1|Overall Study|Lost to Follow-up|1
1213852|NCT00837213|3983119|P2|Overall Study|not stated|1
1213853|NCT00837213|3983120|P1|Overall Study|not stated|1
1213854|NCT00837213|3983119|P2|Overall Study|Withdrawal by Subject|2
1213855|NCT00837213|3983120|P1|Overall Study|Withdrawal by Subject|2
1213856|NCT00837213|3983119|P2|Overall Study|Lost to Follow-up|2
1213857|NCT00837213|3983120|P1|Overall Study|Lost to Follow-up|3
1213858|NCT00837161|3983146|P1|Overall Study|refused hysterectomy|2
1213859|NCT00837148|3983154|P1|Overall Study|Death|1
1213860|NCT00837148|3983154|P1|Overall Study|Adverse Event|1
1213861|NCT00837096|3983160|P2|Overall Study|Not reported|8
1213862|NCT00837096|3983161|P1|Overall Study|Not reported|9
1213863|NCT00837096|3983160|P2|Overall Study|Physician Decision|1
1213864|NCT00837096|3983161|P1|Overall Study|Physician Decision|1
1213865|NCT00836953|3983173|P1|Overall Study|Lost to Follow-up|1
1213866|NCT00836953|3983173|P1|Overall Study|Withdrawal by Subject|1
1213867|NCT00836927|3983184|P5|Overall Study|Withdrawal by Subject|0
1213868|NCT00836927|3983185|P4|Overall Study|Withdrawal by Subject|0
1213869|NCT00836927|3983186|P3|Overall Study|Withdrawal by Subject|0
1213870|NCT00836927|3983187|P2|Overall Study|Withdrawal by Subject|0
1213871|NCT00836927|3983188|P1|Overall Study|Withdrawal by Subject|1
1213872|NCT00836927|3983184|P5|Overall Study|Study drug terminated by sponsor|0
1213873|NCT00836927|3983185|P4|Overall Study|Study drug terminated by sponsor|0
1213874|NCT00836927|3983186|P3|Overall Study|Study drug terminated by sponsor|1
1213875|NCT00836927|3983187|P2|Overall Study|Study drug terminated by sponsor|1
1213876|NCT00836927|3983188|P1|Overall Study|Study drug terminated by sponsor|0
1213877|NCT00836927|3983184|P5|Overall Study|Progressive disease|1
1213878|NCT00836927|3983185|P4|Overall Study|Progressive disease|1
1213879|NCT00836927|3983186|P3|Overall Study|Progressive disease|0
1213880|NCT00836927|3983187|P2|Overall Study|Progressive disease|0
1213881|NCT00836927|3983188|P1|Overall Study|Progressive disease|2
1213882|NCT00836901|3983222|P2|First Intervention|Withdrawal by Subject|0
1213883|NCT00836901|3983223|P1|First Intervention|Withdrawal by Subject|1
1213884|NCT00836875|3983239|P2|Overall Study|Withdrawal by Subject|1
1213885|NCT00836875|3983240|P1|Overall Study|Withdrawal by Subject|0
1213886|NCT00836875|3983239|P2|Overall Study|Death|2
1213887|NCT00836875|3983240|P1|Overall Study|Death|3
1213888|NCT00836810|3983256|P2|Overall Study|New diagnosis|0
1213889|NCT00836810|3983257|P1|Overall Study|New diagnosis|1
1213890|NCT00836745|3983273|P1|Overall Study|Other|2
1213891|NCT00836745|3983273|P1|Overall Study|Objective progression or relapse|4
1213892|NCT00836745|3983273|P1|Overall Study|Adverse Event|3
1213893|NCT00836745|3983273|P1|Overall Study|Lost to Follow-up|10
1213894|NCT00836745|3983273|P1|Overall Study|Death|2
1213895|NCT00836706|3983287|P2|Washout: 7 Days|Withdrawal by Subject|1
1213896|NCT00836706|3983288|P1|Washout: 7 Days|Withdrawal by Subject|0
1213897|NCT00836693|3983298|P2|Overall Study|Lost to Follow-up|0
1213898|NCT00836693|3983299|P1|Overall Study|Lost to Follow-up|1
1213899|NCT00836693|3983298|P2|Overall Study|Protocol Violation|0
1213900|NCT00836693|3983299|P1|Overall Study|Protocol Violation|1
1213901|NCT00836693|3983298|P2|Overall Study|Withdrawal by Subject|4
1213902|NCT00836693|3983299|P1|Overall Study|Withdrawal by Subject|9
1213903|NCT00836693|3983298|P2|Overall Study|Physician Decision|0
1213904|NCT00836693|3983299|P1|Overall Study|Physician Decision|2
1213905|NCT00836693|3983298|P2|Overall Study|Sponsor Decision|1
1213906|NCT00836693|3983299|P1|Overall Study|Sponsor Decision|0
1213907|NCT00836693|3983298|P2|Overall Study|Adverse Event|1
1213908|NCT00836693|3983299|P1|Overall Study|Adverse Event|4
1213909|NCT00836498|3983351|P2|Overall Study|Withdrawal by Subject|1
1213910|NCT00836498|3983352|P1|Overall Study|Withdrawal by Subject|2
1213911|NCT00836498|3983351|P2|Overall Study|Lost to Follow-up|0
1213912|NCT00836498|3983352|P1|Overall Study|Lost to Follow-up|1
1213913|NCT00836498|3983351|P2|Overall Study|Adverse Event|0
1213914|NCT00836498|3983352|P1|Overall Study|Adverse Event|1
1213915|NCT00836472|3983384|P2|Washout|Withdrawal by Subject|1
1213916|NCT00836472|3983385|P1|Washout|Withdrawal by Subject|1
1213917|NCT00836472|3983384|P2|Washout|Adverse Event|2
1213918|NCT00836472|3983385|P1|Washout|Adverse Event|1
1213919|NCT00836277|3983462|P1|Overall Study|Not evaluable for response|6
1213920|NCT00836095|3983472|P2|Overall Study|Physician Decision|3
1213921|NCT00836095|3983473|P1|Overall Study|Physician Decision|0
1213922|NCT00836056|3983483|P2|First Intervention|Adverse Event|0
1213923|NCT00836056|3983484|P1|First Intervention|Adverse Event|1
1213924|NCT00835991|3983513|P2|Washout|Withdrawal by Subject|1
1213925|NCT00835991|3983514|P1|Washout|Withdrawal by Subject|3
1213926|NCT00835991|3983513|P2|Washout|Protocol Violation|2
1213927|NCT00835991|3983514|P1|Washout|Protocol Violation|0
1213928|NCT00835991|3983513|P2|First Intervention|Adverse Event|1
1213929|NCT00835991|3983514|P1|First Intervention|Adverse Event|0
1213930|NCT00835978|3983532|P4|Overall Study|Study terminated by sponsor|0
1213931|NCT00835978|3983533|P3|Overall Study|Study terminated by sponsor|30
1213932|NCT00835978|3983534|P2|Overall Study|Study terminated by sponsor|8
1213933|NCT00835978|3983535|P1|Overall Study|Study terminated by sponsor|12
1213934|NCT00835978|3983532|P4|Overall Study|Withdrawal by Subject|5
1213935|NCT00835978|3983533|P3|Overall Study|Withdrawal by Subject|0
1213936|NCT00835978|3983534|P2|Overall Study|Withdrawal by Subject|3
1213937|NCT00835978|3983535|P1|Overall Study|Withdrawal by Subject|0
1213938|NCT00835978|3983532|P4|Overall Study|Adverse Event|0
1213939|NCT00835978|3983533|P3|Overall Study|Adverse Event|1
1213940|NCT00835978|3983534|P2|Overall Study|Adverse Event|0
1213941|NCT00835978|3983535|P1|Overall Study|Adverse Event|1
1213942|NCT00835978|3983532|P4|Overall Study|Objective progression or relapse|0
1213943|NCT00835978|3983533|P3|Overall Study|Objective progression or relapse|1
1213944|NCT00835978|3983534|P2|Overall Study|Objective progression or relapse|0
1213945|NCT00835978|3983535|P1|Overall Study|Objective progression or relapse|2
1213946|NCT00835978|3983532|P4|Overall Study|Not Specified|0
1213947|NCT00835978|3983533|P3|Overall Study|Not Specified|8
1213948|NCT00835978|3983534|P2|Overall Study|Not Specified|1
1213949|NCT00835978|3983535|P1|Overall Study|Not Specified|5
1213950|NCT00835978|3983532|P4|Overall Study|Lost to Follow-up|1
1213951|NCT00835978|3983533|P3|Overall Study|Lost to Follow-up|2
1213952|NCT00835978|3983534|P2|Overall Study|Lost to Follow-up|4
1213953|NCT00835978|3983535|P1|Overall Study|Lost to Follow-up|3
1213954|NCT00835978|3983532|P4|Overall Study|Death|4
1213955|NCT00835978|3983533|P3|Overall Study|Death|49
1213956|NCT00835978|3983534|P2|Overall Study|Death|40
1213957|NCT00835978|3983535|P1|Overall Study|Death|33
1213958|NCT00835796|3983646|P2|First Intervention|Withdrawal by Subject|1
1213959|NCT00835796|3983647|P1|First Intervention|Withdrawal by Subject|0
1213960|NCT00835731|3983657|P2|Overall Study|Physician Decision|1
1213961|NCT00835731|3983658|P1|Overall Study|Physician Decision|1
1213962|NCT00835731|3983657|P2|Overall Study|Withdrawal by Subject|0
1213963|NCT00835731|3983658|P1|Overall Study|Withdrawal by Subject|1
1213964|NCT00835705|3983678|P2|Second Intervention|Difficulty with vein|0
1213965|NCT00835705|3983679|P1|Second Intervention|Difficulty with vein|1
1213966|NCT00835705|3983678|P2|First Intervention|Difficulty with vein|0
1213967|NCT00835705|3983679|P1|First Intervention|Difficulty with vein|1
1213968|NCT00835692|3983695|P2|First Intervention|Withdrawal by Subject|0
1213969|NCT00835692|3983696|P1|First Intervention|Withdrawal by Subject|1
1213970|NCT00835679|3983708|P4|Overall Study|Withdrawal by Subject|0
1213971|NCT00835679|3983709|P3|Overall Study|Withdrawal by Subject|0
1213972|NCT00835679|3983710|P2|Overall Study|Withdrawal by Subject|0
1213973|NCT00835679|3983711|P1|Overall Study|Withdrawal by Subject|1
1213974|NCT00835666|3983735|P2|Washout|Withdrawal by Subject|0
1213975|NCT00835666|3983736|P1|Washout|Withdrawal by Subject|1
1213976|NCT00835666|3983735|P2|Washout|Protocol Violation|0
1213977|NCT00835666|3983736|P1|Washout|Protocol Violation|1
1213978|NCT00835640|3983746|P2|Second Intervention|Protocol Violation|0
1213979|NCT00835640|3983747|P1|Second Intervention|Protocol Violation|1
1213980|NCT00835575|3983779|P2|Washout of 14 Days|Withdrawal by Subject|0
1213981|NCT00835575|3983780|P1|Washout of 14 Days|Withdrawal by Subject|1
1213982|NCT00835549|3983790|P2|Washout of 7 Days|Withdrawal by Subject|0
1213983|NCT00835549|3983791|P1|Washout of 7 Days|Withdrawal by Subject|2
1213984|NCT00835536|3983801|P2|Washout of 5 Weeks|Withdrawal by Subject|0
1213985|NCT00835536|3983802|P1|Washout of 5 Weeks|Withdrawal by Subject|1
1213986|NCT00835406|3983863|P2|Period: Washout of 7 Days|Withdrawal by Subject|2
1213987|NCT00835406|3983864|P1|Period: Washout of 7 Days|Withdrawal by Subject|0
1213988|NCT00835406|3983863|P2|Period: First Intervention|Withdrawal by Subject|0
1213989|NCT00835406|3983864|P1|Period: First Intervention|Withdrawal by Subject|2
1213990|NCT00835406|3983863|P2|Period: First Intervention|Adverse Event|1
1213991|NCT00835406|3983864|P1|Period: First Intervention|Adverse Event|0
1213992|NCT00835380|3983870|P1|Overall Study|Withdrawal by Subject|2
1213993|NCT00835367|3983877|P2|Second Intervention|Adverse Event|1
1213994|NCT00835367|3983878|P1|Second Intervention|Adverse Event|1
1213995|NCT00835367|3983877|P2|Washout|Withdrawal by Subject|0
1213996|NCT00835367|3983878|P1|Washout|Withdrawal by Subject|1
1213997|NCT00835367|3983877|P2|Washout|Adverse Event|0
1213998|NCT00835367|3983878|P1|Washout|Adverse Event|2
1213999|NCT00835354|3983900|P2|First Intervention|Adverse Event|1
1214000|NCT00835354|3983901|P1|First Intervention|Adverse Event|0
1214001|NCT00835341|3983911|P2|Overall Study|Lost to Follow-up|12
1214002|NCT00835341|3983912|P1|Overall Study|Lost to Follow-up|3
1214003|NCT00835263|3983931|P2|Second Intervention|Adverse Event|0
1214004|NCT00835263|3983932|P1|Second Intervention|Adverse Event|1
1214005|NCT00835237|3983942|P2|Overall Study|Withdrawal by Subject|0
1214006|NCT00835237|3983943|P1|Overall Study|Withdrawal by Subject|2
1214007|NCT00835237|3983942|P2|Overall Study|Lost to Follow-up|0
1214008|NCT00835237|3983943|P1|Overall Study|Lost to Follow-up|4
1214009|NCT00835211|3983983|P2|Washout: 7 Days|Withdrawal by Subject|0
1214010|NCT00835211|3983984|P1|Washout: 7 Days|Withdrawal by Subject|1
1214011|NCT00835211|3983983|P2|Washout: 7 Days|Adverse Event|1
1214012|NCT00835211|3983984|P1|Washout: 7 Days|Adverse Event|2
1214013|NCT00835211|3983983|P2|First Intervention|Withdrawal by Subject|1
1214014|NCT00835211|3983984|P1|First Intervention|Withdrawal by Subject|0
1214015|NCT00835172|3984030|P2|Washout|Protocol Violation|1
1214016|NCT00835172|3984031|P1|Washout|Protocol Violation|0
1214017|NCT00835120|3984057|P1|Overall Study|Withdrawal by Subject|2
1214018|NCT00835120|3984057|P1|Overall Study|Adverse Event|2
1214019|NCT00835120|3984057|P1|Overall Study|Lost to Follow-up|3
1214020|NCT00835120|3984057|P1|Overall Study|Lack of Efficacy|1
1214021|NCT00835081|3984067|P2|Washout of 7 Days|Withdrawal by Subject|0
1214022|NCT00835081|3984068|P1|Washout of 7 Days|Withdrawal by Subject|1
1214023|NCT00835068|3984078|P2|Overall Study|Withdrawal by Subject|0
1214024|NCT00835068|3984079|P1|Overall Study|Withdrawal by Subject|1
1214025|NCT00835068|3984078|P2|Overall Study|Other|0
1214026|NCT00835068|3984079|P1|Overall Study|Other|8
1214027|NCT00835068|3984078|P2|Overall Study|Adverse Event|1
1214028|NCT00835068|3984079|P1|Overall Study|Adverse Event|0
1214029|NCT00835068|3984078|P2|Overall Study|Death|0
1214030|NCT00835068|3984079|P1|Overall Study|Death|1
1214031|NCT00835042|3984099|P2|Washout of 21 Days|Withdrawal by Subject|2
1214032|NCT00835042|3984100|P1|Washout of 21 Days|Withdrawal by Subject|0
1214033|NCT00835042|3984099|P2|First Intervention|Adverse Event|2
1214034|NCT00835042|3984100|P1|First Intervention|Adverse Event|1
1214035|NCT00835042|3984099|P2|First Intervention|Withdrawal by Subject|0
1214036|NCT00835042|3984100|P1|First Intervention|Withdrawal by Subject|3
1214037|NCT00834912|3984186|P6|Treatment Period 2|Withdrawal by Subject|0
1214038|NCT00834912|3984187|P5|Treatment Period 2|Withdrawal by Subject|1
1214039|NCT00834912|3984188|P4|Treatment Period 2|Withdrawal by Subject|0
1214040|NCT00834912|3984189|P3|Treatment Period 2|Withdrawal by Subject|1
1214041|NCT00834912|3984190|P2|Treatment Period 2|Withdrawal by Subject|0
1214042|NCT00834912|3984191|P1|Treatment Period 2|Withdrawal by Subject|0
1214043|NCT00834912|3984186|P6|Treatment Period 1|Adverse Event|0
1214044|NCT00834912|3984187|P5|Treatment Period 1|Adverse Event|0
1214045|NCT00834912|3984188|P4|Treatment Period 1|Adverse Event|1
1214046|NCT00834912|3984189|P3|Treatment Period 1|Adverse Event|0
1214047|NCT00834912|3984190|P2|Treatment Period 1|Adverse Event|1
1214048|NCT00834912|3984191|P1|Treatment Period 1|Adverse Event|0
1214049|NCT00834899|3984213|P2|Overall Study|Withdrawal by Subject|1
1214050|NCT00834899|3984214|P1|Overall Study|Withdrawal by Subject|1
1214051|NCT00834873|3984253|P2|First Intervention|Adverse Event|1
1214052|NCT00834873|3984254|P1|First Intervention|Adverse Event|0
1214053|NCT00834834|3984264|P2|Overall Study|Withdrawal by Subject|3
1214054|NCT00834834|3984265|P1|Overall Study|Withdrawal by Subject|4
1214055|NCT00834795|3984300|P2|Second Intervention|Adverse Event|0
1214056|NCT00834795|3984301|P1|Second Intervention|Adverse Event|1
1214057|NCT00834795|3984300|P2|Washout: 7 Days|Withdrawal by Subject|1
1214058|NCT00834795|3984301|P1|Washout: 7 Days|Withdrawal by Subject|0
1214059|NCT00834756|3984311|P2|Washout: 21 Days|Withdrawal by Subject|0
1214060|NCT00834756|3984312|P1|Washout: 21 Days|Withdrawal by Subject|1
1214061|NCT00834756|3984311|P2|First Intervention|Adverse Event|0
1214062|NCT00834756|3984312|P1|First Intervention|Adverse Event|1
1214063|NCT00834743|3984322|P2|Second Intervention|Withdrawal by Subject|0
1214064|NCT00834743|3984323|P1|Second Intervention|Withdrawal by Subject|1
1214065|NCT00834717|3984333|P2|First Intervention|Withdrawal by Subject|1
1214066|NCT00834717|3984334|P1|First Intervention|Withdrawal by Subject|0
1214067|NCT00834717|3984333|P2|First Intervention|Adverse Event|0
1214068|NCT00834717|3984334|P1|First Intervention|Adverse Event|1
1214069|NCT00834639|3984365|P2|Second Intervention|Physician Decision|2
1214070|NCT00834639|3984366|P1|Second Intervention|Physician Decision|0
1214071|NCT00834613|3984383|P2|First Intervention|Protocol Violation|0
1214072|NCT00834613|3984384|P1|First Intervention|Protocol Violation|1
1214073|NCT00834587|3984394|P2|Washout: 7 Days|Withdrawal by Subject|0
1214074|NCT00834587|3984395|P1|Washout: 7 Days|Withdrawal by Subject|1
1214075|NCT00834522|3984444|P2|Washout|Withdrawal by Subject|1
1214076|NCT00834522|3984445|P1|Washout|Withdrawal by Subject|2
1214077|NCT00834522|3984444|P2|Washout|Adverse Event|0
1214078|NCT00834522|3984445|P1|Washout|Adverse Event|1
1214079|NCT00834444|3984468|P2|Second Intervention|Adverse Event|0
1214080|NCT00834444|3984469|P1|Second Intervention|Adverse Event|1
1214081|NCT00834444|3984468|P2|Washout of 7 Days|Withdrawal by Subject|1
1214082|NCT00834444|3984469|P1|Washout of 7 Days|Withdrawal by Subject|0
1214083|NCT00834444|3984468|P2|First Intervention|Intolerance to Venopuncture|1
1214084|NCT00834444|3984469|P1|First Intervention|Intolerance to Venopuncture|0
1214085|NCT00834444|3984468|P2|First Intervention|Adverse Event|0
1214086|NCT00834444|3984469|P1|First Intervention|Adverse Event|1
1214087|NCT00834431|3984479|P2|Washout of 7 Days|Withdrawal by Subject|1
1214088|NCT00834431|3984480|P1|Washout of 7 Days|Withdrawal by Subject|0
1214089|NCT00834431|3984479|P2|First Intervention|Adverse Event|1
1214090|NCT00834431|3984480|P1|First Intervention|Adverse Event|0
1214091|NCT00834418|3984490|P2|Overall Study|Adverse Event|2
1214092|NCT00834418|3984491|P1|Overall Study|Adverse Event|0
1214093|NCT00834366|3984508|P2|Treatment Period 1|Adverse Event|1
1214094|NCT00834366|3984509|P1|Treatment Period 1|Adverse Event|1
1214095|NCT00834340|3984525|P2|Washout|Withdrawal by Subject|0
1214096|NCT00834340|3984526|P1|Washout|Withdrawal by Subject|1
1214097|NCT00834340|3984525|P2|Washout|Adverse Event|0
1214098|NCT00834340|3984526|P1|Washout|Adverse Event|1
1214099|NCT00834249|3984570|P2|Second Intervention|Adverse Event|0
1214100|NCT00834249|3984571|P1|Second Intervention|Adverse Event|1
1214101|NCT00834249|3984570|P2|Washout: 7 Days|Withdrawal by Subject|1
1214102|NCT00834249|3984571|P1|Washout: 7 Days|Withdrawal by Subject|1
1214103|NCT00834080|3984667|P1|Overall Study|Subject Relocated|1
1214104|NCT00834080|3984667|P1|Overall Study|Physician Decision|1
1214105|NCT00834080|3984667|P1|Overall Study|Other - False positive tests of the UDS|1
1214106|NCT00834080|3984667|P1|Overall Study|Other - Pregnancy|1
1214107|NCT00834080|3984667|P1|Overall Study|Withdrawal by Subject|5
1214108|NCT00834080|3984667|P1|Overall Study|Lost to Follow-up|7
1214109|NCT00834080|3984667|P1|Overall Study|Adverse Event|7
1214110|NCT00834067|3984673|P2|Washout of 21 Days|Protocol Violation|1
1214111|NCT00834067|3984674|P1|Washout of 21 Days|Protocol Violation|0
1214112|NCT00834041|3984696|P2|Overall Study|Lost to Follow-up|1
1214113|NCT00834041|3984697|P1|Overall Study|Lost to Follow-up|0
1214114|NCT00834041|3984696|P2|Overall Study|Withdrawal by Subject|0
1214115|NCT00834041|3984697|P1|Overall Study|Withdrawal by Subject|1
1214116|NCT00833989|3984715|P4|Overall Study|Withdrawal by Subject|1
1214117|NCT00833989|3984716|P3|Overall Study|Withdrawal by Subject|1
1214118|NCT00833989|3984717|P2|Overall Study|Withdrawal by Subject|0
1214119|NCT00833989|3984718|P1|Overall Study|Withdrawal by Subject|3
1214120|NCT00833989|3984715|P4|Overall Study|Physician Decision|1
1214121|NCT00833989|3984716|P3|Overall Study|Physician Decision|0
1214122|NCT00833989|3984717|P2|Overall Study|Physician Decision|0
1214123|NCT00833989|3984718|P1|Overall Study|Physician Decision|0
1214124|NCT00833976|3984822|P1|Overall Study|Physician Decision|1
1214125|NCT00833976|3984822|P1|Overall Study|Did not meet eligibility criteria|41
1214126|NCT00833976|3984822|P1|Overall Study|Lost to Follow-up|4
1214127|NCT00833976|3984822|P1|Overall Study|Withdrawal by Subject|5
1214128|NCT00833937|3984830|P2|Washout|Withdrawal by Subject|0
1214129|NCT00833937|3984831|P1|Washout|Withdrawal by Subject|1
1214130|NCT00833924|3984839|P1|Overall Study|In study follow-up|71
1214131|NCT00833924|3984839|P1|Overall Study|Withdrawal by Subject|13
1214132|NCT00833924|3984839|P1|Overall Study|Lost to Follow-up|2
1214133|NCT00833924|3984839|P1|Overall Study|Conversion|2
1214134|NCT00833924|3984839|P1|Overall Study|Death|21
1214135|NCT00833911|3984844|P1|Maintenance Phase II|Lack of Efficacy|1
1214136|NCT00833911|3984844|P1|Maintenance Phase II|Withdrawal by Subject|1
1214137|NCT00833911|3984844|P1|Maintenance Phase II|Physician Decision|2
1214138|NCT00833911|3984844|P1|Maintenance Phase II|Adverse Event|6
1214139|NCT00833911|3984844|P1|Maintenance Phase I|Lack of Efficacy|4
1214140|NCT00833911|3984844|P1|Maintenance Phase I|Physician Decision|10
1214141|NCT00833911|3984844|P1|Maintenance Phase I|Withdrawal by Subject|11
1214142|NCT00833911|3984844|P1|Maintenance Phase I|Adverse Event|73
1214143|NCT00833911|3984844|P1|Titration|Withdrawal by Subject|3
1214144|NCT00833911|3984844|P1|Titration|Adverse Event|18
1214145|NCT00833898|3984854|P2|Overall Study|Patient did not receive transplant|2
1214146|NCT00833898|3984855|P1|Overall Study|Patient did not receive transplant|0
1214147|NCT00833898|3984854|P2|Overall Study|Lost to Follow-up|7
1214148|NCT00833898|3984855|P1|Overall Study|Lost to Follow-up|7
1214149|NCT00833898|3984854|P2|Overall Study|Withdrawal by Subject|27
1214150|NCT00833898|3984855|P1|Overall Study|Withdrawal by Subject|33
1214151|NCT00833833|3984914|P6|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1
1214152|NCT00833833|3984915|P5|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
1214153|NCT00833833|3984916|P4|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
1214154|NCT00833833|3984917|P3|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
1214155|NCT00833833|3984918|P2|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
1214156|NCT00833833|3984919|P1|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
1214157|NCT00833833|3984914|P6|Phase 2 (as of 01 April 2011)|Other|3
1214158|NCT00833833|3984915|P5|Phase 2 (as of 01 April 2011)|Other|4
1214159|NCT00833833|3984916|P4|Phase 2 (as of 01 April 2011)|Other|0
1214160|NCT00833833|3984917|P3|Phase 2 (as of 01 April 2011)|Other|0
1214161|NCT00833833|3984918|P2|Phase 2 (as of 01 April 2011)|Other|0
1214162|NCT00833833|3984919|P1|Phase 2 (as of 01 April 2011)|Other|0
1214163|NCT00833833|3984914|P6|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7
1214164|NCT00833833|3984915|P5|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5
1214165|NCT00833833|3984916|P4|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
1214166|NCT00833833|3984917|P3|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
1214167|NCT00833833|3984918|P2|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
1214168|NCT00833833|3984919|P1|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
1214169|NCT00833833|3984914|P6|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6
1214170|NCT00833833|3984915|P5|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7
1214171|NCT00833833|3984916|P4|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
1214172|NCT00833833|3984917|P3|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
1214173|NCT00833833|3984918|P2|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
1214174|NCT00833833|3984919|P1|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
1214175|NCT00833833|3984914|P6|Phase 2 (as of 01 April 2011)|Death|9
1214176|NCT00833833|3984915|P5|Phase 2 (as of 01 April 2011)|Death|8
1214177|NCT00833833|3984916|P4|Phase 2 (as of 01 April 2011)|Death|0
1214178|NCT00833833|3984917|P3|Phase 2 (as of 01 April 2011)|Death|0
1214179|NCT00833833|3984918|P2|Phase 2 (as of 01 April 2011)|Death|0
1214180|NCT00833833|3984919|P1|Phase 2 (as of 01 April 2011)|Death|0
1214181|NCT00833833|3984914|P6|Phase 2 (as of 01 April 2011)|Adverse Event|13
1214182|NCT00833833|3984915|P5|Phase 2 (as of 01 April 2011)|Adverse Event|8
1214183|NCT00833833|3984916|P4|Phase 2 (as of 01 April 2011)|Adverse Event|0
1214184|NCT00833833|3984917|P3|Phase 2 (as of 01 April 2011)|Adverse Event|0
1214185|NCT00833833|3984918|P2|Phase 2 (as of 01 April 2011)|Adverse Event|0
1214186|NCT00833833|3984919|P1|Phase 2 (as of 01 April 2011)|Adverse Event|0
1214187|NCT00833833|3984914|P6|Phase 2 (as of 01 April 2011)|Still active in study|22
1214188|NCT00833833|3984915|P5|Phase 2 (as of 01 April 2011)|Still active in study|23
1214189|NCT00833833|3984916|P4|Phase 2 (as of 01 April 2011)|Still active in study|0
1214190|NCT00833833|3984917|P3|Phase 2 (as of 01 April 2011)|Still active in study|0
1214191|NCT00833833|3984918|P2|Phase 2 (as of 01 April 2011)|Still active in study|0
1214192|NCT00833833|3984919|P1|Phase 2 (as of 01 April 2011)|Still active in study|0
1214193|NCT00833833|3984914|P6|Phase 1 (as of 01 April 2011)|Other|0
1214194|NCT00833833|3984915|P5|Phase 1 (as of 01 April 2011)|Other|0
1214195|NCT00833833|3984916|P4|Phase 1 (as of 01 April 2011)|Other|1
1214196|NCT00833833|3984917|P3|Phase 1 (as of 01 April 2011)|Other|0
1214197|NCT00833833|3984918|P2|Phase 1 (as of 01 April 2011)|Other|3
1214198|NCT00833833|3984919|P1|Phase 1 (as of 01 April 2011)|Other|1
1214199|NCT00833833|3984914|P6|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
1214200|NCT00833833|3984915|P5|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
1214201|NCT00833833|3984916|P4|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
1214202|NCT00833833|3984917|P3|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
1214203|NCT00833833|3984918|P2|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
1214204|NCT00833833|3984919|P1|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
1214205|NCT00833833|3984914|P6|Phase 1 (as of 01 April 2011)|Death|0
1214206|NCT00833833|3984915|P5|Phase 1 (as of 01 April 2011)|Death|0
1214207|NCT00833833|3984916|P4|Phase 1 (as of 01 April 2011)|Death|0
1214208|NCT00833833|3984917|P3|Phase 1 (as of 01 April 2011)|Death|2
1214209|NCT00833833|3984918|P2|Phase 1 (as of 01 April 2011)|Death|1
1214210|NCT00833833|3984919|P1|Phase 1 (as of 01 April 2011)|Death|0
1214211|NCT00833833|3984914|P6|Phase 1 (as of 01 April 2011)|Adverse Event|0
1214212|NCT00833833|3984915|P5|Phase 1 (as of 01 April 2011)|Adverse Event|0
1214213|NCT00833833|3984916|P4|Phase 1 (as of 01 April 2011)|Adverse Event|1
1214214|NCT00833833|3984917|P3|Phase 1 (as of 01 April 2011)|Adverse Event|2
1214215|NCT00833833|3984918|P2|Phase 1 (as of 01 April 2011)|Adverse Event|0
1214216|NCT00833833|3984919|P1|Phase 1 (as of 01 April 2011)|Adverse Event|1
1214217|NCT00833833|3984914|P6|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
1214218|NCT00833833|3984915|P5|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
1214219|NCT00833833|3984916|P4|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
1214220|NCT00833833|3984917|P3|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
1214221|NCT00833833|3984918|P2|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
1214222|NCT00833833|3984919|P1|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
1214223|NCT00833833|3984914|P6|Phase 1 (as of 01 April 2011)|Still active in study|0
1214224|NCT00833833|3984915|P5|Phase 1 (as of 01 April 2011)|Still active in study|0
1214225|NCT00833833|3984916|P4|Phase 1 (as of 01 April 2011)|Still active in study|2
1214226|NCT00833833|3984917|P3|Phase 1 (as of 01 April 2011)|Still active in study|2
1214227|NCT00833833|3984918|P2|Phase 1 (as of 01 April 2011)|Still active in study|0
1214228|NCT00833833|3984919|P1|Phase 1 (as of 01 April 2011)|Still active in study|0
1214229|NCT00833794|3984959|P2|Double-blind Phase|Administrative reason|3
1214230|NCT00833794|3984960|P1|Double-blind Phase|Administrative reason|1
1214231|NCT00833794|3984959|P2|Double-blind Phase|Physician Decision|7
1214232|NCT00833794|3984960|P1|Double-blind Phase|Physician Decision|4
1214233|NCT00833794|3984959|P2|Double-blind Phase|Withdrawal by Subject|6
1214234|NCT00833794|3984960|P1|Double-blind Phase|Withdrawal by Subject|23
1214235|NCT00833794|3984959|P2|Double-blind Phase|Lack of Efficacy|22
1214236|NCT00833794|3984960|P1|Double-blind Phase|Lack of Efficacy|34
1214237|NCT00833794|3984959|P2|Double-blind Phase|Adverse Event|11
1214238|NCT00833794|3984960|P1|Double-blind Phase|Adverse Event|44
1214239|NCT00833794|3984959|P2|Open-label Phase|enrolled in error (immediately D/C)|0
1214240|NCT00833794|3984960|P1|Open-label Phase|enrolled in error (immediately D/C)|1
1214241|NCT00833794|3984959|P2|Open-label Phase|Did not complete wash-out period|0
1214242|NCT00833794|3984960|P1|Open-label Phase|Did not complete wash-out period|12
1214243|NCT00833794|3984959|P2|Open-label Phase|Protocol Violation|0
1214244|NCT00833794|3984960|P1|Open-label Phase|Protocol Violation|47
1214245|NCT00833794|3984959|P2|Open-label Phase|Administrative reason|0
1214246|NCT00833794|3984960|P1|Open-label Phase|Administrative reason|1
1214247|NCT00833794|3984959|P2|Open-label Phase|Physician Decision|0
1214248|NCT00833794|3984960|P1|Open-label Phase|Physician Decision|20
1214249|NCT00833794|3984959|P2|Open-label Phase|Withdrawal by Subject|0
1214250|NCT00833794|3984960|P1|Open-label Phase|Withdrawal by Subject|48
1214251|NCT00833794|3984959|P2|Open-label Phase|Lack of Efficacy|0
1214252|NCT00833794|3984960|P1|Open-label Phase|Lack of Efficacy|28
1214253|NCT00833794|3984959|P2|Open-label Phase|Adverse Event|0
1214254|NCT00833794|3984960|P1|Open-label Phase|Adverse Event|225
1214255|NCT00833755|3985004|P4|Overall Study|Subject had scheduling issues|0
1214256|NCT00833755|3985005|P3|Overall Study|Subject had scheduling issues|0
1214257|NCT00833755|3985006|P2|Overall Study|Subject had scheduling issues|1
1214258|NCT00833755|3985007|P1|Overall Study|Subject had scheduling issues|0
1214259|NCT00833755|3985004|P4|Overall Study|Physician Decision|6
1214260|NCT00833755|3985005|P3|Overall Study|Physician Decision|2
1214261|NCT00833755|3985006|P2|Overall Study|Physician Decision|4
1214262|NCT00833755|3985007|P1|Overall Study|Physician Decision|4
1214263|NCT00833703|3985027|P2|Overall Study|Parent(s)/guardian(s)'s request|1
1214264|NCT00833703|3985028|P1|Overall Study|Parent(s)/guardian(s)'s request|0
1214265|NCT00833690|3985041|P3|Overall Study|Discontinued study drug|0
1214266|NCT00833690|3985042|P2|Overall Study|Discontinued study drug|2
1214267|NCT00833690|3985043|P1|Overall Study|Discontinued study drug|3
1214268|NCT00833690|3985041|P3|Overall Study|Withdrawal by Subject|0
1214269|NCT00833690|3985042|P2|Overall Study|Withdrawal by Subject|0
1214270|NCT00833690|3985043|P1|Overall Study|Withdrawal by Subject|1
1214271|NCT00833638|3985179|P3|Phase 3: Open-label Extension Phase|Protocol Violation|2
1214272|NCT00833638|3985180|P2|Phase 3: Open-label Extension Phase|Protocol Violation|1
1214273|NCT00833638|3985181|P1|Phase 3: Open-label Extension Phase|Protocol Violation|0
1214274|NCT00833638|3985179|P3|Phase 3: Open-label Extension Phase|Lost to Follow-up|0
1214275|NCT00833638|3985180|P2|Phase 3: Open-label Extension Phase|Lost to Follow-up|2
1214276|NCT00833638|3985181|P1|Phase 3: Open-label Extension Phase|Lost to Follow-up|1
1214277|NCT00833638|3985179|P3|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2
1214278|NCT00833638|3985180|P2|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
1214279|NCT00833638|3985181|P1|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
1214280|NCT00833638|3985179|P3|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2
1214281|NCT00833638|3985180|P2|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
1214282|NCT00833638|3985181|P1|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
1214283|NCT00833638|3985179|P3|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
1214284|NCT00833638|3985180|P2|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
1214285|NCT00833638|3985181|P1|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
1214286|NCT00833638|3985179|P3|Phase 2: Double-blind Treatment Phase|Physician Decision|0
1214287|NCT00833638|3985180|P2|Phase 2: Double-blind Treatment Phase|Physician Decision|0
1214288|NCT00833638|3985181|P1|Phase 2: Double-blind Treatment Phase|Physician Decision|1
1214289|NCT00833638|3985179|P3|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
1214290|NCT00833638|3985180|P2|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2
1214291|NCT00833638|3985181|P1|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
1214292|NCT00833638|3985179|P3|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1
1214293|NCT00833638|3985180|P2|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2
1214294|NCT00833638|3985181|P1|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3
1214295|NCT00833638|3985179|P3|Phase 2: Double-blind Treatment Phase|Adverse Event|0
1214296|NCT00833638|3985180|P2|Phase 2: Double-blind Treatment Phase|Adverse Event|2
1214297|NCT00833638|3985181|P1|Phase 2: Double-blind Treatment Phase|Adverse Event|1
1214298|NCT00833560|3985232|P1|Overall Study|Not specified|5
1214299|NCT00833560|3985232|P1|Overall Study|Pregression of other disease|1
1214300|NCT00833560|3985232|P1|Overall Study|Death|2
1214301|NCT00833560|3985232|P1|Overall Study|Lack of Efficacy|4
1214302|NCT00833560|3985232|P1|Overall Study|Protocol Violation|6
1214303|NCT00833560|3985232|P1|Overall Study|Adverse Event|11
1214304|NCT00833560|3985232|P1|Overall Study|Toxicity|13
1214305|NCT00833547|3985241|P2|Overall Study|Withdrawal by Subject|2
1214306|NCT00833547|3985242|P1|Overall Study|Withdrawal by Subject|2
1214307|NCT00833482|3985263|P6|Days 21-30|Withdrawal by Subject|0
1214308|NCT00833482|3985264|P5|Days 21-30|Withdrawal by Subject|1
1214309|NCT00833482|3985265|P4|Days 21-30|Withdrawal by Subject|0
1214310|NCT00833482|3985266|P3|Days 21-30|Withdrawal by Subject|0
1214311|NCT00833482|3985267|P2|Days 21-30|Withdrawal by Subject|0
1214312|NCT00833482|3985268|P1|Days 21-30|Withdrawal by Subject|0
1214313|NCT00833482|3985263|P6|Days 21-30|Adverse Event|0
1214314|NCT00833482|3985264|P5|Days 21-30|Adverse Event|0
1214315|NCT00833482|3985265|P4|Days 21-30|Adverse Event|0
1214316|NCT00833482|3985266|P3|Days 21-30|Adverse Event|1
1214317|NCT00833482|3985267|P2|Days 21-30|Adverse Event|0
1214318|NCT00833482|3985268|P1|Days 21-30|Adverse Event|0
1214319|NCT00833482|3985263|P6|Days 11-20|Withdrawal by Subject|0
1214320|NCT00833482|3985264|P5|Days 11-20|Withdrawal by Subject|0
1214321|NCT00833482|3985265|P4|Days 11-20|Withdrawal by Subject|0
1214322|NCT00833482|3985266|P3|Days 11-20|Withdrawal by Subject|0
1214323|NCT00833482|3985267|P2|Days 11-20|Withdrawal by Subject|1
1214324|NCT00833482|3985268|P1|Days 11-20|Withdrawal by Subject|0
1214325|NCT00833482|3985263|P6|Days 11-20|Adverse Event|0
1214326|NCT00833482|3985264|P5|Days 11-20|Adverse Event|0
1214327|NCT00833482|3985265|P4|Days 11-20|Adverse Event|0
1214328|NCT00833482|3985266|P3|Days 11-20|Adverse Event|0
1214329|NCT00833482|3985267|P2|Days 11-20|Adverse Event|2
1214330|NCT00833482|3985268|P1|Days 11-20|Adverse Event|0
1214331|NCT00833469|3985324|P1|Overall Study|Lost to Follow-up|1
1214332|NCT00833469|3985324|P1|Overall Study|Withdrawal by Subject|1
1214333|NCT00833417|3985347|P2|Overall Study|Reason Not Specified|1
1214334|NCT00833417|3985348|P1|Overall Study|Reason Not Specified|0
1214335|NCT00833417|3985347|P2|Overall Study|Disease Progression|17
1214336|NCT00833417|3985348|P1|Overall Study|Disease Progression|18
1214337|NCT00833417|3985347|P2|Overall Study|Sponsor Decision to Terminate Study|2
1214338|NCT00833417|3985348|P1|Overall Study|Sponsor Decision to Terminate Study|1
1214339|NCT00833417|3985347|P2|Overall Study|Patient Decision to Withdraw|23
1214340|NCT00833417|3985348|P1|Overall Study|Patient Decision to Withdraw|4
1214341|NCT00833417|3985347|P2|Overall Study|Physician Decision to Withdraw Patient|7
1214342|NCT00833417|3985348|P1|Overall Study|Physician Decision to Withdraw Patient|3
1214343|NCT00833417|3985347|P2|Overall Study|Lost to Follow-up|2
1214344|NCT00833417|3985348|P1|Overall Study|Lost to Follow-up|1
1214345|NCT00833417|3985347|P2|Overall Study|Death|3
1214346|NCT00833417|3985348|P1|Overall Study|Death|1
1214347|NCT00833417|3985347|P2|Overall Study|Adverse Event|16
1214348|NCT00833417|3985348|P1|Overall Study|Adverse Event|5
1214349|NCT00833248|3985374|P2|Overall Study|Withdrawal by Subject|1
1214350|NCT00833248|3985375|P1|Overall Study|Withdrawal by Subject|0
1214351|NCT00833248|3985374|P2|Overall Study|Protocol Violation|2
1214352|NCT00833248|3985375|P1|Overall Study|Protocol Violation|1
1214353|NCT00833248|3985374|P2|Overall Study|Adverse Event|0
1214354|NCT00833248|3985375|P1|Overall Study|Adverse Event|3
1214355|NCT00833092|3985399|P2|Overall Study|constipation|1
1214356|NCT00833092|3985400|P1|Overall Study|constipation|0
1214357|NCT00833092|3985399|P2|Overall Study|Diarrhea|2
1214358|NCT00833092|3985400|P1|Overall Study|Diarrhea|0
1214359|NCT00833092|3985399|P2|Overall Study|Protocol Violation|1
1214360|NCT00833092|3985400|P1|Overall Study|Protocol Violation|2
1214361|NCT00833092|3985399|P2|Overall Study|Withdrawal by Subject|3
1214362|NCT00833092|3985400|P1|Overall Study|Withdrawal by Subject|2
1214363|NCT00833053|3985408|P2|Overall Study|Protocol Violation|1
1214364|NCT00833053|3985409|P1|Overall Study|Protocol Violation|2
1214365|NCT00833053|3985408|P2|Overall Study|Withdrawal by Subject|1
1214366|NCT00833053|3985409|P1|Overall Study|Withdrawal by Subject|0
1214367|NCT00833053|3985408|P2|Overall Study|Treatment Failure|1
1214368|NCT00833053|3985409|P1|Overall Study|Treatment Failure|3
1214369|NCT00833053|3985408|P2|Overall Study|Adverse Event|0
1214370|NCT00833053|3985409|P1|Overall Study|Adverse Event|4
1214371|NCT00833040|3985427|P6|Overall Study|Adverse Event|1
1214372|NCT00833040|3985428|P5|Overall Study|Adverse Event|0
1214373|NCT00833040|3985429|P4|Overall Study|Adverse Event|0
1214374|NCT00833040|3985430|P3|Overall Study|Adverse Event|0
1214375|NCT00833040|3985431|P2|Overall Study|Adverse Event|0
1214376|NCT00833040|3985432|P1|Overall Study|Adverse Event|0
1214377|NCT00833027|3985437|P1|Overall Study|Missing|10
1214378|NCT00833027|3985437|P1|Overall Study|Withdrawal by Subject|16
1214379|NCT00833027|3985437|P1|Overall Study|Protocol Violation|115
1214380|NCT00833027|3985437|P1|Overall Study|Lost to Follow-up|24
1214381|NCT00833027|3985437|P1|Overall Study|Lack of Efficacy|12
1214382|NCT00833027|3985437|P1|Overall Study|Death|1
1214383|NCT00833027|3985437|P1|Overall Study|Adverse Event|33
1214384|NCT00832975|3985442|P1|Overall Study|Other reasons|14
1214385|NCT00832975|3985442|P1|Overall Study|Withdrawal by Subject|3
1214386|NCT00832975|3985442|P1|Overall Study|Physician Decision|4
1214387|NCT00832975|3985442|P1|Overall Study|Death|5
1214388|NCT00832975|3985442|P1|Overall Study|Protocol Violation|6
1214389|NCT00832975|3985442|P1|Overall Study|Lost to Follow-up|7
1214390|NCT00832819|3985456|P3|Overall Study|Protocol Violation|1
1214391|NCT00832819|3985457|P2|Overall Study|Protocol Violation|0
1214392|NCT00832819|3985458|P1|Overall Study|Protocol Violation|0
1214393|NCT00832819|3985456|P3|Overall Study|Adverse Event|0
1214394|NCT00832819|3985457|P2|Overall Study|Adverse Event|1
1214395|NCT00832819|3985458|P1|Overall Study|Adverse Event|0
1214396|NCT00832780|3985464|P1|Overall Study|Physician Decision|1
1214397|NCT00832780|3985464|P1|Overall Study|other complicating condition|2
1214398|NCT00832780|3985464|P1|Overall Study|no reason given|2
1214399|NCT00832780|3985464|P1|Overall Study|Lost to Follow-up|4
1214400|NCT00832780|3985464|P1|Overall Study|Death|16
1214401|NCT00832650|3985506|P3|Overall Study|Randomized but not treated|1
1214402|NCT00832650|3985507|P2|Overall Study|Randomized but not treated|0
1214403|NCT00832650|3985508|P1|Overall Study|Randomized but not treated|0
1214404|NCT00832624|3985548|P1|Overall Study|Study Terminated|10
1214405|NCT00832585|3985558|P1|Overall Study|Lost to Follow-up|1
1214406|NCT00832585|3985558|P1|Overall Study|Withdrawal by Subject|1
1214407|NCT00832455|3985583|P1|Overall Study|Patient moved|1
1214408|NCT00832455|3985583|P1|Overall Study|No improvement|3
1214409|NCT00832455|3985583|P1|Overall Study|Parent dissatisfied|1
1214410|NCT00832455|3985583|P1|Overall Study|Parent misunderstood study|1
1214411|NCT00832455|3985583|P1|Overall Study|Stopped Medication|4
1214412|NCT00832455|3985583|P1|Overall Study|Screening Failure|2
1214413|NCT00832455|3985583|P1|Overall Study|Withdrawal by Subject|17
1214414|NCT00832455|3985583|P1|Overall Study|Protocol Violation|4
1214415|NCT00832455|3985583|P1|Overall Study|Lost to Follow-up|26
1214416|NCT00832455|3985583|P1|Overall Study|Adverse Event|13
1214417|NCT00832416|3985607|P4|Overall Study|Death|0
1214418|NCT00832416|3985608|P3|Overall Study|Death|0
1214419|NCT00832416|3985609|P2|Overall Study|Death|0
1214420|NCT00832416|3985610|P1|Overall Study|Death|1
1214421|NCT00832416|3985607|P4|Overall Study|Adverse Event|10
1214422|NCT00832416|3985608|P3|Overall Study|Adverse Event|41
1214423|NCT00832416|3985609|P2|Overall Study|Adverse Event|19
1214424|NCT00832416|3985610|P1|Overall Study|Adverse Event|21
1214425|NCT00832416|3985607|P4|Overall Study|Administrative|1
1214426|NCT00832416|3985608|P3|Overall Study|Administrative|0
1214427|NCT00832416|3985609|P2|Overall Study|Administrative|0
1214428|NCT00832416|3985610|P1|Overall Study|Administrative|0
1214429|NCT00832416|3985607|P4|Overall Study|Physician Decision|10
1214430|NCT00832416|3985608|P3|Overall Study|Physician Decision|5
1214431|NCT00832416|3985609|P2|Overall Study|Physician Decision|12
1214432|NCT00832416|3985610|P1|Overall Study|Physician Decision|2
1214433|NCT00832416|3985607|P4|Overall Study|Withdrawal by Subject|10
1214434|NCT00832416|3985608|P3|Overall Study|Withdrawal by Subject|2
1214435|NCT00832416|3985609|P2|Overall Study|Withdrawal by Subject|7
1214436|NCT00832416|3985610|P1|Overall Study|Withdrawal by Subject|5
1214437|NCT00832416|3985607|P4|Overall Study|Lack of Efficacy|52
1214438|NCT00832416|3985608|P3|Overall Study|Lack of Efficacy|13
1214439|NCT00832416|3985609|P2|Overall Study|Lack of Efficacy|15
1214440|NCT00832416|3985610|P1|Overall Study|Lack of Efficacy|17
1214441|NCT00832377|3985661|P1|Overall Study|Protocol Violation|1
1214442|NCT00832117|3985707|P1|Overall Study|Disease Progression|11
1214443|NCT00832117|3985707|P1|Overall Study|Death|1
1214444|NCT00832091|3985726|P2|Overall Study|Prohibited Medication|0
1214445|NCT00832091|3985727|P1|Overall Study|Prohibited Medication|1
1214446|NCT00832091|3985726|P2|Overall Study|Withdrawal by Subject|1
1214447|NCT00832091|3985727|P1|Overall Study|Withdrawal by Subject|2
1214448|NCT00832091|3985726|P2|Overall Study|Protocol Violation|0
1214449|NCT00832091|3985727|P1|Overall Study|Protocol Violation|1
1214450|NCT00832091|3985726|P2|Overall Study|Adverse Event|1
1214451|NCT00832091|3985727|P1|Overall Study|Adverse Event|1
1214452|NCT00832078|3985735|P2|Test Day 2 - 2 Period|Lack of Efficacy|0
1214453|NCT00832078|3985736|P1|Test Day 2 - 2 Period|Lack of Efficacy|1
1214454|NCT00832078|3985735|P2|Test Day 1-2 Period|Lack of Efficacy|2
1214455|NCT00832078|3985736|P1|Test Day 1-2 Period|Lack of Efficacy|0
1214456|NCT00832000|3985742|P2|Overall Study|No calls to IVR in period 2|0
1214457|NCT00832000|3985743|P1|Overall Study|No calls to IVR in period 2|2
1214458|NCT00832000|3985742|P2|Overall Study|No calls to IVR in either period|1
1214459|NCT00832000|3985743|P1|Overall Study|No calls to IVR in either period|1
1214460|NCT00832000|3985742|P2|Overall Study|Withdrawal by Subject|0
1214461|NCT00832000|3985743|P1|Overall Study|Withdrawal by Subject|1
1214462|NCT00832000|3985742|P2|Overall Study|Adverse Event|0
1214463|NCT00832000|3985743|P1|Overall Study|Adverse Event|2
1214464|NCT00831844|3985804|P10|Overall Study|Ineligible|0
1214465|NCT00831844|3985805|P9|Overall Study|Ineligible|0
1214466|NCT00831844|3985806|P8|Overall Study|Ineligible|0
1214467|NCT00831844|3985807|P7|Overall Study|Ineligible|0
1214468|NCT00831844|3985808|P6|Overall Study|Ineligible|0
1214469|NCT00831844|3985809|P5|Overall Study|Ineligible|1
1214470|NCT00831844|3985810|P4|Overall Study|Ineligible|0
1214471|NCT00831844|3985811|P3|Overall Study|Ineligible|1
1214472|NCT00831844|3985812|P2|Overall Study|Ineligible|1
1214473|NCT00831844|3985813|P1|Overall Study|Ineligible|0
1214474|NCT00831844|3985804|P10|Overall Study|Withdrawal by Subject|0
1214475|NCT00831844|3985805|P9|Overall Study|Withdrawal by Subject|1
1214476|NCT00831844|3985806|P8|Overall Study|Withdrawal by Subject|1
1214477|NCT00831844|3985807|P7|Overall Study|Withdrawal by Subject|0
1214478|NCT00831844|3985808|P6|Overall Study|Withdrawal by Subject|0
1214479|NCT00831844|3985809|P5|Overall Study|Withdrawal by Subject|0
1214480|NCT00831844|3985810|P4|Overall Study|Withdrawal by Subject|0
1214481|NCT00831844|3985811|P3|Overall Study|Withdrawal by Subject|1
1214482|NCT00831844|3985812|P2|Overall Study|Withdrawal by Subject|0
1214483|NCT00831844|3985813|P1|Overall Study|Withdrawal by Subject|0
1214484|NCT00831844|3985804|P10|Overall Study|Physician Decision|0
1214485|NCT00831844|3985805|P9|Overall Study|Physician Decision|1
1214486|NCT00831844|3985806|P8|Overall Study|Physician Decision|0
1214487|NCT00831844|3985807|P7|Overall Study|Physician Decision|0
1214488|NCT00831844|3985808|P6|Overall Study|Physician Decision|1
1214489|NCT00831844|3985809|P5|Overall Study|Physician Decision|1
1214490|NCT00831844|3985810|P4|Overall Study|Physician Decision|1
1214491|NCT00831844|3985811|P3|Overall Study|Physician Decision|3
1214492|NCT00831844|3985812|P2|Overall Study|Physician Decision|1
1214493|NCT00831844|3985813|P1|Overall Study|Physician Decision|0
1214494|NCT00831844|3985804|P10|Overall Study|Lack of Efficacy|0
1214495|NCT00831844|3985805|P9|Overall Study|Lack of Efficacy|7
1214496|NCT00831844|3985806|P8|Overall Study|Lack of Efficacy|9
1214497|NCT00831844|3985807|P7|Overall Study|Lack of Efficacy|8
1214498|NCT00831844|3985808|P6|Overall Study|Lack of Efficacy|17
1214499|NCT00831844|3985809|P5|Overall Study|Lack of Efficacy|11
1214500|NCT00831844|3985810|P4|Overall Study|Lack of Efficacy|8
1214501|NCT00831844|3985811|P3|Overall Study|Lack of Efficacy|15
1214502|NCT00831844|3985812|P2|Overall Study|Lack of Efficacy|10
1214503|NCT00831844|3985813|P1|Overall Study|Lack of Efficacy|8
1214504|NCT00831844|3985804|P10|Overall Study|Death|0
1214505|NCT00831844|3985805|P9|Overall Study|Death|0
1214506|NCT00831844|3985806|P8|Overall Study|Death|0
1214507|NCT00831844|3985807|P7|Overall Study|Death|0
1214508|NCT00831844|3985808|P6|Overall Study|Death|0
1214509|NCT00831844|3985809|P5|Overall Study|Death|0
1214510|NCT00831844|3985810|P4|Overall Study|Death|1
1214511|NCT00831844|3985811|P3|Overall Study|Death|0
1214512|NCT00831844|3985812|P2|Overall Study|Death|0
1214513|NCT00831844|3985813|P1|Overall Study|Death|0
1214514|NCT00831844|3985804|P10|Overall Study|Adverse Event|0
1214515|NCT00831844|3985805|P9|Overall Study|Adverse Event|0
1214516|NCT00831844|3985806|P8|Overall Study|Adverse Event|0
1214517|NCT00831844|3985807|P7|Overall Study|Adverse Event|2
1214518|NCT00831844|3985808|P6|Overall Study|Adverse Event|1
1214519|NCT00831844|3985809|P5|Overall Study|Adverse Event|1
1214520|NCT00831844|3985810|P4|Overall Study|Adverse Event|0
1214521|NCT00831844|3985811|P3|Overall Study|Adverse Event|0
1214522|NCT00831844|3985812|P2|Overall Study|Adverse Event|0
1214523|NCT00831844|3985813|P1|Overall Study|Adverse Event|2
1214524|NCT00831779|3985837|P2|Overall Study|No longer met criteria|1
1214525|NCT00831779|3985838|P1|Overall Study|No longer met criteria|0
1214526|NCT00831779|3985837|P2|Overall Study|Lost to Follow-up|0
1214527|NCT00831779|3985838|P1|Overall Study|Lost to Follow-up|1
1214528|NCT00831701|3985875|P2|Overall Study|Lost to Follow-up|3
1214529|NCT00831701|3985876|P1|Overall Study|Lost to Follow-up|1
1214530|NCT00831701|3985875|P2|Overall Study|Stone expulsion before first medication|2
1214531|NCT00831701|3985876|P1|Overall Study|Stone expulsion before first medication|2
1214532|NCT00831701|3985875|P2|Overall Study|Withdrawal by Subject|0
1214533|NCT00831701|3985876|P1|Overall Study|Withdrawal by Subject|2
1214534|NCT00831493|3985905|P1|Overall Study|Intractable nausea and vomiting|1
1214535|NCT00831441|3985915|P2|Follow Up (30 Days)|missing end of study status|1
1214536|NCT00831441|3985916|P1|Follow Up (30 Days)|missing end of study status|0
1214537|NCT00831441|3985915|P2|Follow Up (30 Days)|non-specified|26
1214538|NCT00831441|3985916|P1|Follow Up (30 Days)|non-specified|16
1214539|NCT00831441|3985915|P2|Follow Up (30 Days)|Death|86
1214540|NCT00831441|3985916|P1|Follow Up (30 Days)|Death|63
1214541|NCT00831441|3985915|P2|Follow Up (30 Days)|Lost to Follow-up|27
1214542|NCT00831441|3985916|P1|Follow Up (30 Days)|Lost to Follow-up|13
1214543|NCT00831441|3985915|P2|Follow Up (30 Days)|Withdrawal by Subject|34
1214544|NCT00831441|3985916|P1|Follow Up (30 Days)|Withdrawal by Subject|41
1214545|NCT00831441|3985915|P2|Randomized|non-specified|266
1214546|NCT00831441|3985916|P1|Randomized|non-specified|276
1214547|NCT00831441|3985915|P2|Randomized|poor/non-compliance|38
1214548|NCT00831441|3985916|P1|Randomized|poor/non-compliance|30
1214549|NCT00831441|3985915|P2|Randomized|Administrative reason by sponsor|2671
1214550|NCT00831441|3985916|P1|Randomized|Administrative reason by sponsor|2780
1214551|NCT00831441|3985915|P2|Randomized|Lost to Follow-up|35
1214552|NCT00831441|3985916|P1|Randomized|Lost to Follow-up|26
1214553|NCT00831441|3985915|P2|Randomized|Withdrawal by Subject|212
1214554|NCT00831441|3985916|P1|Randomized|Withdrawal by Subject|178
1214555|NCT00831441|3985915|P2|Randomized|No longer met criteria|19
1214556|NCT00831441|3985916|P1|Randomized|No longer met criteria|13
1214557|NCT00831441|3985915|P2|Randomized|Physician Decision|35
1214558|NCT00831441|3985916|P1|Randomized|Physician Decision|26
1214559|NCT00831441|3985915|P2|Randomized|Elective procedure|25
1214560|NCT00831441|3985916|P1|Randomized|Elective procedure|26
1214561|NCT00831441|3985915|P2|Randomized|Emergency procedure|2
1214562|NCT00831441|3985916|P1|Randomized|Emergency procedure|2
1214563|NCT00831441|3985915|P2|Randomized|Adverse Event|321
1214564|NCT00831441|3985916|P1|Randomized|Adverse Event|248
1214565|NCT00831441|3985915|P2|Randomized|Death|81
1214566|NCT00831441|3985916|P1|Randomized|Death|82
1214567|NCT00831415|3985948|P1|Overall Study|Death|1
1214568|NCT00831415|3985948|P1|Overall Study|Unsatisfactory response - Efficacy|4
1214569|NCT00831415|3985948|P1|Overall Study|Withdrawal by Subject|35
1214570|NCT00831415|3985948|P1|Overall Study|Protocol Violation|3
1214571|NCT00831415|3985948|P1|Overall Study|Lost to Follow-up|9
1214572|NCT00831415|3985948|P1|Overall Study|Physician Decision|6
1214573|NCT00831415|3985948|P1|Overall Study|Failed to return|3
1214574|NCT00831415|3985948|P1|Overall Study|Adverse Event|14
1214575|NCT00831389|3985957|P2|Overall Study|Withdrawal by Subject|1
1214576|NCT00831389|3985958|P1|Overall Study|Withdrawal by Subject|0
1214577|NCT00831311|3985984|P2|Overall Study|Withdrawal by Subject|4
1214578|NCT00831311|3985985|P1|Overall Study|Withdrawal by Subject|6
1214579|NCT00831311|3985984|P2|Overall Study|Physician Decision|1
1214580|NCT00831311|3985985|P1|Overall Study|Physician Decision|0
1214581|NCT00831311|3985984|P2|Overall Study|Lost to Follow-up|0
1214582|NCT00831311|3985985|P1|Overall Study|Lost to Follow-up|3
1214583|NCT00831311|3985984|P2|Overall Study|Definitive Contraindication|3
1214584|NCT00831311|3985985|P1|Overall Study|Definitive Contraindication|3
1214585|NCT00831233|3986022|P2|Overall Study|Selection Criteria Not Met|0
1214586|NCT00831233|3986023|P1|Overall Study|Selection Criteria Not Met|2
1214587|NCT00831233|3986022|P2|Overall Study|Protocol Violation|0
1214588|NCT00831233|3986023|P1|Overall Study|Protocol Violation|1
1214589|NCT00831233|3986022|P2|Overall Study|Adverse Event|1
1214590|NCT00831233|3986023|P1|Overall Study|Adverse Event|0
1214591|NCT00831181|3986047|P1|Overall Study|Adverse Event|12
1214592|NCT00831129|3986060|P2|Overall Study|9 lost to follow-up reasons uknown|9
1214593|NCT00831129|3986061|P1|Overall Study|9 lost to follow-up reasons uknown|0
1214594|NCT00831129|3986060|P2|Overall Study|Adverse Event|1
1214595|NCT00831129|3986061|P1|Overall Study|Adverse Event|0
1214596|NCT00830960|3986103|P6|Overall Study|No study drug received|7
1214597|NCT00830960|3986104|P5|Overall Study|No study drug received|5
1214598|NCT00830960|3986105|P4|Overall Study|No study drug received|3
1214599|NCT00830960|3986106|P3|Overall Study|No study drug received|4
1214600|NCT00830960|3986107|P2|Overall Study|No study drug received|2
1214601|NCT00830960|3986108|P1|Overall Study|No study drug received|7
1214602|NCT00830960|3986103|P6|Overall Study|Sponsor Decision|7
1214603|NCT00830960|3986104|P5|Overall Study|Sponsor Decision|5
1214604|NCT00830960|3986105|P4|Overall Study|Sponsor Decision|4
1214605|NCT00830960|3986106|P3|Overall Study|Sponsor Decision|3
1214606|NCT00830960|3986107|P2|Overall Study|Sponsor Decision|2
1214607|NCT00830960|3986108|P1|Overall Study|Sponsor Decision|1
1214608|NCT00830960|3986103|P6|Overall Study|Withdrawal by Subject|21
1214609|NCT00830960|3986104|P5|Overall Study|Withdrawal by Subject|16
1214610|NCT00830960|3986105|P4|Overall Study|Withdrawal by Subject|23
1214611|NCT00830960|3986106|P3|Overall Study|Withdrawal by Subject|18
1214612|NCT00830960|3986107|P2|Overall Study|Withdrawal by Subject|19
1214613|NCT00830960|3986108|P1|Overall Study|Withdrawal by Subject|19
1214614|NCT00830960|3986103|P6|Overall Study|Lost to Follow-up|1
1214615|NCT00830960|3986104|P5|Overall Study|Lost to Follow-up|0
1214616|NCT00830960|3986105|P4|Overall Study|Lost to Follow-up|0
1214617|NCT00830960|3986106|P3|Overall Study|Lost to Follow-up|1
1214618|NCT00830960|3986107|P2|Overall Study|Lost to Follow-up|1
1214619|NCT00830960|3986108|P1|Overall Study|Lost to Follow-up|1
1214620|NCT00830960|3986103|P6|Overall Study|Death|1
1214621|NCT00830960|3986104|P5|Overall Study|Death|6
1214622|NCT00830960|3986105|P4|Overall Study|Death|2
1214623|NCT00830960|3986106|P3|Overall Study|Death|3
1214624|NCT00830960|3986107|P2|Overall Study|Death|4
1214625|NCT00830960|3986108|P1|Overall Study|Death|5
1214626|NCT00830947|3986224|P2|Overall Study|Lost to Follow-up|4
1214627|NCT00830947|3986225|P1|Overall Study|Lost to Follow-up|4
1214628|NCT00830804|3986231|P1|Overall Study|Unwilling to adhere to study requirement|1
1214629|NCT00830804|3986231|P1|Overall Study|Consent withdrawn|2
1214630|NCT00830804|3986231|P1|Overall Study|Unable to get to clinic|7
1214631|NCT00830804|3986231|P1|Overall Study|Death|1
1214632|NCT00830804|3986231|P1|Overall Study|Lost to Follow-up|4
1214633|NCT00830765|3986311|P2|Overall Study|Protocol Violation|2
1214634|NCT00830765|3986312|P1|Overall Study|Protocol Violation|3
1214635|NCT00830518|3986345|P2|Overall Study|Reason not Specified|1
1214636|NCT00830518|3986346|P1|Overall Study|Reason not Specified|8
1214637|NCT00830518|3986345|P2|Overall Study|Withdrawal by Patient|0
1214638|NCT00830518|3986346|P1|Overall Study|Withdrawal by Patient|2
1214639|NCT00830518|3986345|P2|Overall Study|Adverse Event|1
1214640|NCT00830518|3986346|P1|Overall Study|Adverse Event|14
1214641|NCT00830518|3986345|P2|Overall Study|Symptomatic Deterioration|1
1214642|NCT00830518|3986346|P1|Overall Study|Symptomatic Deterioration|4
1214643|NCT00830518|3986345|P2|Overall Study|Progressive Disease|8
1214644|NCT00830518|3986346|P1|Overall Study|Progressive Disease|18
1214645|NCT00830440|3986365|P2|Overall Study|Adverse Event|0
1214646|NCT00830440|3986366|P1|Overall Study|Adverse Event|2
1214647|NCT00830440|3986365|P2|Overall Study|unsuccessful procedure|0
1214648|NCT00830440|3986366|P1|Overall Study|unsuccessful procedure|4
1214649|NCT00830440|3986365|P2|Overall Study|Withdrawal by Subject|0
1214650|NCT00830440|3986366|P1|Overall Study|Withdrawal by Subject|1
1214651|NCT00830440|3986365|P2|Overall Study|Protocol Violation|0
1214652|NCT00830440|3986366|P1|Overall Study|Protocol Violation|1
1214653|NCT00830375|3986381|P1|Overall Study|Lost to Follow-up|1
1214654|NCT00830336|3986396|P2|Washout: 21 Days|Withdrawal by Subject|0
1214655|NCT00830336|3986397|P1|Washout: 21 Days|Withdrawal by Subject|1
1214656|NCT00830258|3986424|P2|Washout: 7 Days|Protocol Violation|0
1214657|NCT00830258|3986425|P1|Washout: 7 Days|Protocol Violation|1
1214658|NCT00830258|3986424|P2|First Intervention|Adverse Event|0
1214659|NCT00830258|3986425|P1|First Intervention|Adverse Event|1
1214660|NCT00830219|3986444|P2|Washout of 7 Days|Withdrawal by Subject|1
1214661|NCT00830219|3986445|P1|Washout of 7 Days|Withdrawal by Subject|1
1214662|NCT00830206|3986455|P2|Washout: 21 Days|Withdrawal by Subject|1
1214663|NCT00830206|3986456|P1|Washout: 21 Days|Withdrawal by Subject|1
1214664|NCT00830167|3986466|P2|Overall Study|Other|2
1214665|NCT00830167|3986467|P1|Overall Study|Other|2
1214666|NCT00830167|3986466|P2|Overall Study|Protocol Violation|1
1214667|NCT00830167|3986467|P1|Overall Study|Protocol Violation|0
1214668|NCT00830167|3986466|P2|Overall Study|Lost to Follow-up|1
1214669|NCT00830167|3986467|P1|Overall Study|Lost to Follow-up|0
1214670|NCT00830167|3986466|P2|Overall Study|Withdrawal by Subject|0
1214671|NCT00830167|3986467|P1|Overall Study|Withdrawal by Subject|2
1214672|NCT00830167|3986466|P2|Overall Study|Not meeting entrance criteria|5
1214673|NCT00830167|3986467|P1|Overall Study|Not meeting entrance criteria|2
1214674|NCT00830167|3986466|P2|Overall Study|Adverse Event|24
1214675|NCT00830167|3986467|P1|Overall Study|Adverse Event|8
1214676|NCT00830167|3986466|P2|Overall Study|Lack of Efficacy|10
1214677|NCT00830167|3986467|P1|Overall Study|Lack of Efficacy|26
1214678|NCT00830128|3986537|P1|Overall Study|Operating a vehicle|1
1214679|NCT00830128|3986537|P1|Overall Study|Work obligation|1
1214680|NCT00830128|3986537|P1|Overall Study|Relocation|1
1214681|NCT00830128|3986537|P1|Overall Study|Family obligation|1
1214682|NCT00830128|3986537|P1|Overall Study|Withdrawal by Subject|2
1214683|NCT00830128|3986537|P1|Overall Study|Protocol Violation|1
1214684|NCT00830128|3986537|P1|Overall Study|Lack of Efficacy|7
1214685|NCT00830128|3986537|P1|Overall Study|Adverse Event|5
1214686|NCT00830115|3986552|P1|Overall Study|Improvement/recovery|1
1214687|NCT00830115|3986552|P1|Overall Study|Adverse Event|2
1214688|NCT00830037|3986579|P2|Overall Study|Active when terminated by DSMB|14
1214689|NCT00830037|3986580|P1|Overall Study|Active when terminated by DSMB|15
1214690|NCT00830037|3986579|P2|Overall Study|Lost to Follow-up|2
1214691|NCT00830037|3986580|P1|Overall Study|Lost to Follow-up|1
1214692|NCT00830037|3986579|P2|Overall Study|Withdrawal by Subject|3
1214693|NCT00830037|3986580|P1|Overall Study|Withdrawal by Subject|2
1214694|NCT00830024|3986590|P2|Washout: 7 Days|Withdrawal by Subject|0
1214695|NCT00830024|3986591|P1|Washout: 7 Days|Withdrawal by Subject|1
1214696|NCT00829998|3986601|P2|Washout|Adverse Event|1
1214697|NCT00829998|3986602|P1|Washout|Adverse Event|0
1214698|NCT00829933|3986631|P4|Overall Study|withdrew before treatment started|9
1214699|NCT00829933|3986632|P3|Overall Study|withdrew before treatment started|2
1214700|NCT00829933|3986633|P2|Overall Study|withdrew before treatment started|1
1214701|NCT00829933|3986634|P1|Overall Study|withdrew before treatment started|5
1214702|NCT00829933|3986631|P4|Overall Study|Protocol Violation|0
1214703|NCT00829933|3986632|P3|Overall Study|Protocol Violation|0
1214704|NCT00829933|3986633|P2|Overall Study|Protocol Violation|1
1214705|NCT00829933|3986634|P1|Overall Study|Protocol Violation|2
1214706|NCT00829933|3986631|P4|Overall Study|Pregnancy|2
1214707|NCT00829933|3986632|P3|Overall Study|Pregnancy|0
1214708|NCT00829933|3986633|P2|Overall Study|Pregnancy|0
1214709|NCT00829933|3986634|P1|Overall Study|Pregnancy|0
1214710|NCT00829933|3986631|P4|Overall Study|Physician Decision|1
1214711|NCT00829933|3986632|P3|Overall Study|Physician Decision|8
1214712|NCT00829933|3986633|P2|Overall Study|Physician Decision|7
1214713|NCT00829933|3986634|P1|Overall Study|Physician Decision|5
1214714|NCT00829933|3986631|P4|Overall Study|Lack of Efficacy|0
1214715|NCT00829933|3986632|P3|Overall Study|Lack of Efficacy|0
1214716|NCT00829933|3986633|P2|Overall Study|Lack of Efficacy|1
1214717|NCT00829933|3986634|P1|Overall Study|Lack of Efficacy|0
1214718|NCT00829933|3986631|P4|Overall Study|Death|1
1214719|NCT00829933|3986632|P3|Overall Study|Death|1
1214720|NCT00829933|3986633|P2|Overall Study|Death|0
1214721|NCT00829933|3986634|P1|Overall Study|Death|0
1214722|NCT00829933|3986631|P4|Overall Study|Adverse Event|1
1214723|NCT00829933|3986632|P3|Overall Study|Adverse Event|2
1214724|NCT00829933|3986633|P2|Overall Study|Adverse Event|3
1214725|NCT00829933|3986634|P1|Overall Study|Adverse Event|2
1214726|NCT00829868|3986646|P2|Washout|Physician Decision|0
1214727|NCT00829868|3986647|P1|Washout|Physician Decision|1
1214728|NCT00829829|3986658|P3|Overall Study|Other than specified above|1
1214729|NCT00829829|3986659|P2|Overall Study|Other than specified above|2
1214730|NCT00829829|3986660|P1|Overall Study|Other than specified above|2
1214731|NCT00829829|3986658|P3|Overall Study|Lost to Follow-up|3
1214732|NCT00829829|3986659|P2|Overall Study|Lost to Follow-up|3
1214733|NCT00829829|3986660|P1|Overall Study|Lost to Follow-up|7
1214734|NCT00829829|3986658|P3|Overall Study|Decision by the Sponsor|2
1214735|NCT00829829|3986659|P2|Overall Study|Decision by the Sponsor|0
1214736|NCT00829829|3986660|P1|Overall Study|Decision by the Sponsor|1
1214737|NCT00829829|3986658|P3|Overall Study|Withdrawal by Subject|2
1214738|NCT00829829|3986659|P2|Overall Study|Withdrawal by Subject|4
1214739|NCT00829829|3986660|P1|Overall Study|Withdrawal by Subject|8
1214740|NCT00829829|3986658|P3|Overall Study|Adverse Event|3
1214741|NCT00829829|3986659|P2|Overall Study|Adverse Event|4
1214742|NCT00829829|3986660|P1|Overall Study|Adverse Event|4
1214743|NCT00829829|3986658|P3|Overall Study|Protocol Violation|0
1214744|NCT00829829|3986659|P2|Overall Study|Protocol Violation|3
1214745|NCT00829829|3986660|P1|Overall Study|Protocol Violation|0
1214746|NCT00829790|3986685|P2|Washout of 14 Days|Withdrawal by Subject|1
1214747|NCT00829790|3986686|P1|Washout of 14 Days|Withdrawal by Subject|0
1214748|NCT00829764|3986696|P2|First Intervention|Withdrawal by Subject|1
1214749|NCT00829764|3986697|P1|First Intervention|Withdrawal by Subject|1
1214750|NCT00829764|3986696|P2|First Intervention|Adverse Event|0
1214751|NCT00829764|3986697|P1|First Intervention|Adverse Event|1
1214752|NCT00829712|3986723|P2|Washout of 7 Days|Withdrawal by Subject|1
1214753|NCT00829712|3986724|P1|Washout of 7 Days|Withdrawal by Subject|0
1214754|NCT00829673|3986743|P2|Washout of 7 Days|Withdrawal by Subject|0
1214755|NCT00829673|3986744|P1|Washout of 7 Days|Withdrawal by Subject|1
1214756|NCT00829621|3986754|P2|Overall Study|Lost to Follow-up|4
1214757|NCT00829621|3986755|P1|Overall Study|Lost to Follow-up|3
1214758|NCT00829621|3986754|P2|Overall Study|Death|0
1214759|NCT00829621|3986755|P1|Overall Study|Death|1
1214760|NCT00829530|3986763|P2|Second Intervention|Intolerance to Venopuncture|0
1214761|NCT00829530|3986764|P1|Second Intervention|Intolerance to Venopuncture|1
1214762|NCT00829530|3986763|P2|First Intervention|Intolerance to Venopuncture|1
1214763|NCT00829530|3986764|P1|First Intervention|Intolerance to Venopuncture|0
1214764|NCT00829530|3986763|P2|First Intervention|Adverse Event|1
1214765|NCT00829530|3986764|P1|First Intervention|Adverse Event|0
1214766|NCT00829504|3986778|P2|Second Intervention|Physician Decision|0
1214767|NCT00829504|3986779|P1|Second Intervention|Physician Decision|1
1214768|NCT00829504|3986778|P2|Washout of 7 Days|Withdrawal by Subject|0
1214769|NCT00829504|3986779|P1|Washout of 7 Days|Withdrawal by Subject|1
1214770|NCT00829504|3986778|P2|First Intervention|Adverse Event|0
1214771|NCT00829504|3986779|P1|First Intervention|Adverse Event|1
1214772|NCT00829452|3986789|P2|Second Intervention|Physician Decision|1
1214773|NCT00829452|3986790|P1|Second Intervention|Physician Decision|0
1214774|NCT00829452|3986789|P2|Washout of 42 Days|Withdrawal by Subject|1
1214775|NCT00829452|3986790|P1|Washout of 42 Days|Withdrawal by Subject|0
1214776|NCT00829452|3986789|P2|First Intervention|Withdrawal by Subject|1
1214777|NCT00829452|3986790|P1|First Intervention|Withdrawal by Subject|0
1214778|NCT00829439|3986802|P4|Overall Study|Adverse Event|0
1214779|NCT00829439|3986803|P3|Overall Study|Adverse Event|1
1214780|NCT00829439|3986804|P2|Overall Study|Adverse Event|0
1214781|NCT00829439|3986805|P1|Overall Study|Adverse Event|0
1214782|NCT00829426|3986811|P2|Washout: 7 Days|Withdrawal by Subject|0
1214783|NCT00829426|3986812|P1|Washout: 7 Days|Withdrawal by Subject|1
1214784|NCT00829413|3986820|P1|Overall Study|Indeterminate diagnosis from truth stand|3
1214785|NCT00829413|3986820|P1|Overall Study|Technically inadequate truth standard|2
1214786|NCT00829413|3986820|P1|Overall Study|No truth standard procedure available|9
1214787|NCT00829413|3986820|P1|Overall Study|Training Patients|67
1214788|NCT00829413|3986820|P1|Overall Study|No study drug admimnistered|13
1214789|NCT00829387|3986869|P2|Overall Study|Disqualified by PI|0
1214790|NCT00829387|3986870|P1|Overall Study|Disqualified by PI|1
1214791|NCT00829387|3986869|P2|Overall Study|Withdrawal by Subject|3
1214792|NCT00829387|3986870|P1|Overall Study|Withdrawal by Subject|2
1214793|NCT00829309|3986888|P2|Washout: 7 Days|Protocol Violation|0
1214794|NCT00829309|3986889|P1|Washout: 7 Days|Protocol Violation|1
1214795|NCT00829296|3986899|P2|Overall Study|Adverse Event|4
1214796|NCT00829296|3986900|P1|Overall Study|Adverse Event|5
1214797|NCT00829283|3986914|P2|Overall Study|Lost to Follow-up|25
1214798|NCT00829283|3986915|P1|Overall Study|Lost to Follow-up|7
1214799|NCT00829244|3986925|P2|Overall Study|No embryo cleavage|2
1214800|NCT00829244|3986926|P1|Overall Study|No embryo cleavage|0
1214801|NCT00829244|3986925|P2|Overall Study|All embryos discarded|3
1214802|NCT00829244|3986926|P1|Overall Study|All embryos discarded|0
1214803|NCT00829244|3986925|P2|Overall Study|No fertilization|2
1214804|NCT00829244|3986926|P1|Overall Study|No fertilization|2
1214805|NCT00829244|3986925|P2|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6
1214806|NCT00829244|3986926|P1|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1
1214807|NCT00829244|3986925|P2|Overall Study|Lack of ovarian response to stimulation|5
1214808|NCT00829244|3986926|P1|Overall Study|Lack of ovarian response to stimulation|9
1214809|NCT00829244|3986925|P2|Overall Study|Protocol Violation|0
1214810|NCT00829244|3986926|P1|Overall Study|Protocol Violation|1
1214811|NCT00829244|3986925|P2|Overall Study|Adverse Event|3
1214812|NCT00829244|3986926|P1|Overall Study|Adverse Event|1
1214813|NCT00829179|3986956|P1|Overall Study|Withdrawal by Subject|1
1214814|NCT00829166|3986962|P2|Overall Study|Reason Not Specified|3
1214815|NCT00829166|3986963|P1|Overall Study|Reason Not Specified|3
1214816|NCT00829166|3986962|P2|Overall Study|Sponsor’s Decision|98
1214817|NCT00829166|3986963|P1|Overall Study|Sponsor’s Decision|137
1214818|NCT00829166|3986962|P2|Overall Study|Subject's Decision|55
1214819|NCT00829166|3986963|P1|Overall Study|Subject's Decision|41
1214820|NCT00829166|3986962|P2|Overall Study|Physician's Decision|3
1214821|NCT00829166|3986963|P1|Overall Study|Physician's Decision|4
1214822|NCT00829166|3986962|P2|Overall Study|Lost to Follow-up|4
1214823|NCT00829166|3986963|P1|Overall Study|Lost to Follow-up|5
1214824|NCT00829166|3986962|P2|Overall Study|Death|333
1214825|NCT00829166|3986963|P1|Overall Study|Death|305
1214826|NCT00829010|3987026|P5|Overall Study|Migrated/Moved from study area|0
1214827|NCT00829010|3987027|P4|Overall Study|Migrated/Moved from study area|5
1214828|NCT00829010|3987028|P3|Overall Study|Migrated/Moved from study area|0
1214829|NCT00829010|3987029|P2|Overall Study|Migrated/Moved from study area|4
1214830|NCT00829010|3987030|P1|Overall Study|Migrated/Moved from study area|3
1214831|NCT00829010|3987026|P5|Overall Study|Fatality|0
1214832|NCT00829010|3987027|P4|Overall Study|Fatality|3
1214833|NCT00829010|3987028|P3|Overall Study|Fatality|0
1214834|NCT00829010|3987029|P2|Overall Study|Fatality|4
1214835|NCT00829010|3987030|P1|Overall Study|Fatality|5
1214836|NCT00829010|3987026|P5|Overall Study|Lost to Follow-up|0
1214837|NCT00829010|3987027|P4|Overall Study|Lost to Follow-up|0
1214838|NCT00829010|3987028|P3|Overall Study|Lost to Follow-up|2
1214839|NCT00829010|3987029|P2|Overall Study|Lost to Follow-up|0
1214840|NCT00829010|3987030|P1|Overall Study|Lost to Follow-up|1
1214841|NCT00829010|3987026|P5|Overall Study|Withdrawal by Subject|2
1214842|NCT00829010|3987027|P4|Overall Study|Withdrawal by Subject|0
1214843|NCT00829010|3987028|P3|Overall Study|Withdrawal by Subject|1
1214844|NCT00829010|3987029|P2|Overall Study|Withdrawal by Subject|1
1214845|NCT00829010|3987030|P1|Overall Study|Withdrawal by Subject|0
1214846|NCT00829010|3987026|P5|Overall Study|Adverse Event|0
1214847|NCT00829010|3987027|P4|Overall Study|Adverse Event|0
1214848|NCT00829010|3987028|P3|Overall Study|Adverse Event|0
1214849|NCT00829010|3987029|P2|Overall Study|Adverse Event|0
1214850|NCT00829010|3987030|P1|Overall Study|Adverse Event|1
1214851|NCT00828984|3987195|P3|Overall Study|ConMed|1
1214852|NCT00828984|3987196|P2|Overall Study|ConMed|1
1214853|NCT00828984|3987197|P1|Overall Study|ConMed|1
1214854|NCT00828984|3987195|P3|Overall Study|Noncompliant|3
1214855|NCT00828984|3987196|P2|Overall Study|Noncompliant|2
1214856|NCT00828984|3987197|P1|Overall Study|Noncompliant|1
1214857|NCT00828984|3987195|P3|Overall Study|Medical Contraindication|0
1214858|NCT00828984|3987196|P2|Overall Study|Medical Contraindication|1
1214859|NCT00828984|3987197|P1|Overall Study|Medical Contraindication|0
1214860|NCT00828984|3987195|P3|Overall Study|Ineligable|0
1214861|NCT00828984|3987196|P2|Overall Study|Ineligable|2
1214862|NCT00828984|3987197|P1|Overall Study|Ineligable|1
1214863|NCT00828984|3987195|P3|Overall Study|Withdrawal by Subject|4
1214864|NCT00828984|3987196|P2|Overall Study|Withdrawal by Subject|4
1214865|NCT00828984|3987197|P1|Overall Study|Withdrawal by Subject|4
1214866|NCT00828984|3987195|P3|Overall Study|Lost to Follow-up|1
1214867|NCT00828984|3987196|P2|Overall Study|Lost to Follow-up|3
1214868|NCT00828984|3987197|P1|Overall Study|Lost to Follow-up|5
1214869|NCT00828984|3987195|P3|Overall Study|Adverse Event|0
1214870|NCT00828984|3987196|P2|Overall Study|Adverse Event|3
1214871|NCT00828984|3987197|P1|Overall Study|Adverse Event|2
1214872|NCT00828945|3987220|P1|Overall Study|Other|36
1214873|NCT00828945|3987220|P1|Overall Study|Participant was missing|1
1214874|NCT00828945|3987220|P1|Overall Study|Death|4
1214875|NCT00828750|3987252|P1|Overall Study|Normal PC Remained While No Treatment|1
1214876|NCT00828750|3987252|P1|Overall Study|Lack of Efficacy|3
1214877|NCT00828711|3987266|P3|Overall Study|Lost to Follow-up|0
1214878|NCT00828711|3987267|P2|Overall Study|Lost to Follow-up|0
1214879|NCT00828711|3987268|P1|Overall Study|Lost to Follow-up|1
1214880|NCT00828568|3987300|P3|Treated - Received at Least One Dose|Protocol Violation|3
1214881|NCT00828568|3987301|P2|Treated - Received at Least One Dose|Protocol Violation|5
1214882|NCT00828568|3987302|P1|Treated - Received at Least One Dose|Protocol Violation|9
1214883|NCT00828568|3987300|P3|Treated - Received at Least One Dose|Lost to Follow-up|1
1214884|NCT00828568|3987301|P2|Treated - Received at Least One Dose|Lost to Follow-up|5
1214885|NCT00828568|3987302|P1|Treated - Received at Least One Dose|Lost to Follow-up|1
1214886|NCT00828568|3987300|P3|Treated - Received at Least One Dose|Withdrawal by Subject|0
1214887|NCT00828568|3987301|P2|Treated - Received at Least One Dose|Withdrawal by Subject|11
1214888|NCT00828568|3987302|P1|Treated - Received at Least One Dose|Withdrawal by Subject|9
1214889|NCT00828568|3987300|P3|Treated - Received at Least One Dose|Adverse Event|1
1214890|NCT00828568|3987301|P2|Treated - Received at Least One Dose|Adverse Event|8
1214891|NCT00828568|3987302|P1|Treated - Received at Least One Dose|Adverse Event|11
1214892|NCT00828568|3987300|P3|Randomized|Withdrawal by Subject|2
1214893|NCT00828568|3987301|P2|Randomized|Withdrawal by Subject|0
1214894|NCT00828568|3987302|P1|Randomized|Withdrawal by Subject|1
1214895|NCT00828516|3987324|P1|Clinical Phase: Series 1|Withdrawal by Subject|2
1214896|NCT00828464|3987329|P1|Overall Study|Withdrawal by Subject|1
1214897|NCT00828451|3987346|P1|Overall Study|Deterioration in clinical status|1
1214898|NCT00828451|3987346|P1|Overall Study|Withdrawal by Subject|1
1214899|NCT00828451|3987346|P1|Overall Study|Lack of intravenous line|7
1214900|NCT00828451|3987346|P1|Overall Study|Death|2
1214901|NCT00828321|3987372|P2|Second Intervention|Protocol Violation|1
1214902|NCT00828321|3987373|P1|Second Intervention|Protocol Violation|0
1214903|NCT00828321|3987372|P2|Washout of 42 Days|Withdrawal by Subject|0
1214904|NCT00828321|3987373|P1|Washout of 42 Days|Withdrawal by Subject|2
1214905|NCT00828204|3987402|P2|Extension Study|Physician Decision|2
1214906|NCT00828204|3987403|P1|Extension Study|Physician Decision|0
1214907|NCT00828204|3987402|P2|Extension Study|Lost to Follow-up|1
1214908|NCT00828204|3987403|P1|Extension Study|Lost to Follow-up|0
1214909|NCT00828204|3987402|P2|Main Study: After Study Restart|Noncompliance|1
1214910|NCT00828204|3987403|P1|Main Study: After Study Restart|Noncompliance|0
1214911|NCT00828204|3987402|P2|Main Study: After Study Restart|Adverse Event|2
1214912|NCT00828204|3987403|P1|Main Study: After Study Restart|Adverse Event|0
1214913|NCT00828204|3987402|P2|Main Study: Prior to Study Suspension|Study Suspension|0
1214914|NCT00828204|3987403|P1|Main Study: Prior to Study Suspension|Study Suspension|11
1214915|NCT00828204|3987402|P2|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0
1214916|NCT00828204|3987403|P1|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2
1214917|NCT00828204|3987402|P2|Main Study: Prior to Study Suspension|Adverse Event|0
1214918|NCT00828204|3987403|P1|Main Study: Prior to Study Suspension|Adverse Event|1
1214919|NCT00828139|3987450|P4|Overall Study|Not specified|2
1214920|NCT00828139|3987451|P3|Overall Study|Not specified|5
1214921|NCT00828139|3987452|P2|Overall Study|Not specified|2
1214922|NCT00828139|3987453|P1|Overall Study|Not specified|4
1214923|NCT00828139|3987450|P4|Overall Study|Disease Progression|39
1214924|NCT00828139|3987451|P3|Overall Study|Disease Progression|35
1214925|NCT00828139|3987452|P2|Overall Study|Disease Progression|33
1214926|NCT00828139|3987453|P1|Overall Study|Disease Progression|24
1214927|NCT00828139|3987450|P4|Overall Study|Refusal unrelated to toxicity|3
1214928|NCT00828139|3987451|P3|Overall Study|Refusal unrelated to toxicity|5
1214929|NCT00828139|3987452|P2|Overall Study|Refusal unrelated to toxicity|4
1214930|NCT00828139|3987453|P1|Overall Study|Refusal unrelated to toxicity|3
1214931|NCT00828139|3987450|P4|Overall Study|Death|2
1214932|NCT00828139|3987451|P3|Overall Study|Death|0
1214933|NCT00828139|3987452|P2|Overall Study|Death|1
1214934|NCT00828139|3987453|P1|Overall Study|Death|2
1214935|NCT00828139|3987450|P4|Overall Study|Adverse Event|5
1214936|NCT00828139|3987451|P3|Overall Study|Adverse Event|10
1214937|NCT00828139|3987452|P2|Overall Study|Adverse Event|1
1214938|NCT00828139|3987453|P1|Overall Study|Adverse Event|8
1214939|NCT00828113|3987473|P2|Overall Study|Lost to Follow-up|5
1214940|NCT00828113|3987474|P1|Overall Study|Lost to Follow-up|3
1214941|NCT00828113|3987473|P2|Overall Study|Withdrawal by Subject|26
1214942|NCT00828113|3987474|P1|Overall Study|Withdrawal by Subject|27
1214943|NCT00827931|3987548|P2|Overall Study|Other|0
1214944|NCT00827931|3987549|P1|Overall Study|Other|1
1214945|NCT00827931|3987548|P2|Overall Study|Withdrawal by Subject|1
1214946|NCT00827931|3987549|P1|Overall Study|Withdrawal by Subject|0
1214947|NCT00827931|3987548|P2|Overall Study|Lost to Follow-up|0
1214948|NCT00827931|3987549|P1|Overall Study|Lost to Follow-up|1
1214949|NCT00827931|3987548|P2|Overall Study|Adverse Event|0
1214950|NCT00827931|3987549|P1|Overall Study|Adverse Event|1
1214951|NCT00827931|3987548|P2|Overall Study|Death|5
1214952|NCT00827931|3987549|P1|Overall Study|Death|3
1214953|NCT00827918|3987570|P3|Overall Study|Withdrawal by Subject|6
1214954|NCT00827918|3987571|P2|Overall Study|Withdrawal by Subject|2
1214955|NCT00827918|3987572|P1|Overall Study|Withdrawal by Subject|6
1214956|NCT00827918|3987570|P3|Overall Study|Protocol Violation|0
1214957|NCT00827918|3987571|P2|Overall Study|Protocol Violation|1
1214958|NCT00827918|3987572|P1|Overall Study|Protocol Violation|0
1214959|NCT00827918|3987570|P3|Overall Study|Progressive Disease|0
1214960|NCT00827918|3987571|P2|Overall Study|Progressive Disease|1
1214961|NCT00827918|3987572|P1|Overall Study|Progressive Disease|1
1214962|NCT00827918|3987570|P3|Overall Study|Pregnancy|0
1214963|NCT00827918|3987571|P2|Overall Study|Pregnancy|1
1214964|NCT00827918|3987572|P1|Overall Study|Pregnancy|0
1214965|NCT00827918|3987570|P3|Overall Study|Physician Decision|0
1214966|NCT00827918|3987571|P2|Overall Study|Physician Decision|0
1214967|NCT00827918|3987572|P1|Overall Study|Physician Decision|1
1214968|NCT00827918|3987570|P3|Overall Study|Lack of Efficacy|15
1214969|NCT00827918|3987571|P2|Overall Study|Lack of Efficacy|4
1214970|NCT00827918|3987572|P1|Overall Study|Lack of Efficacy|16
1214971|NCT00827918|3987570|P3|Overall Study|Adverse Event|0
1214972|NCT00827918|3987571|P2|Overall Study|Adverse Event|0
1214973|NCT00827918|3987572|P1|Overall Study|Adverse Event|4
1214974|NCT00827827|3987600|P2|Overall Study|Burned with water at home|0
1214975|NCT00827827|3987601|P1|Overall Study|Burned with water at home|1
1214976|NCT00827827|3987600|P2|Overall Study|Transportation issues|0
1214977|NCT00827827|3987601|P1|Overall Study|Transportation issues|1
1214978|NCT00827827|3987600|P2|Overall Study|Gout|0
1214979|NCT00827827|3987601|P1|Overall Study|Gout|1
1214980|NCT00827827|3987600|P2|Overall Study|Another cerebrovascular accident (CVA)|0
1214981|NCT00827827|3987601|P1|Overall Study|Another cerebrovascular accident (CVA)|1
1214982|NCT00827827|3987600|P2|Overall Study|Fall at home- hospitalization|0
1214983|NCT00827827|3987601|P1|Overall Study|Fall at home- hospitalization|1
1214984|NCT00827827|3987600|P2|Overall Study|Lost to Follow-up|0
1214985|NCT00827827|3987601|P1|Overall Study|Lost to Follow-up|3
1214986|NCT00827632|3987645|P2|Overall Study|Early withdrawal|11
1214987|NCT00827632|3987646|P1|Overall Study|Early withdrawal|14
1214988|NCT00827632|3987645|P2|Overall Study|Lost to Follow-up|12
1214989|NCT00827632|3987646|P1|Overall Study|Lost to Follow-up|8
1214990|NCT00827606|3987654|P2|Overall Study|Adverse Event|2
1214991|NCT00827606|3987655|P1|Overall Study|Adverse Event|4
1214992|NCT00827606|3987654|P2|Overall Study|LDL below 2.59 mmol/L|12
1214993|NCT00827606|3987655|P1|Overall Study|LDL below 2.59 mmol/L|4
1214994|NCT00827606|3987654|P2|Overall Study|Not specified|13
1214995|NCT00827606|3987655|P1|Overall Study|Not specified|5
1214996|NCT00827606|3987654|P2|Overall Study|Pregnancy|1
1214997|NCT00827606|3987655|P1|Overall Study|Pregnancy|0
1214998|NCT00827606|3987654|P2|Overall Study|Withdrawal by Subject|6
1214999|NCT00827606|3987655|P1|Overall Study|Withdrawal by Subject|7
1215000|NCT00827606|3987654|P2|Overall Study|Lost to Follow-up|1
1215001|NCT00827606|3987655|P1|Overall Study|Lost to Follow-up|3
1215002|NCT00827606|3987654|P2|Overall Study|Protocol Violation|3
1215003|NCT00827606|3987655|P1|Overall Study|Protocol Violation|4
1215004|NCT00827567|3987716|P1|Overall Study|Progression of Disease/Screen Failure|4
1215005|NCT00827541|3987722|P2|Overall Study|Lack of effectiveness|0
1215006|NCT00827541|3987723|P1|Overall Study|Lack of effectiveness|1
1215007|NCT00827541|3987722|P2|Overall Study|Pathogen not susceptible|0
1215008|NCT00827541|3987723|P1|Overall Study|Pathogen not susceptible|1
1215009|NCT00827541|3987722|P2|Overall Study|Other|3
1215010|NCT00827541|3987723|P1|Overall Study|Other|1
1215011|NCT00827541|3987722|P2|Overall Study|Exitus|8
1215012|NCT00827541|3987723|P1|Overall Study|Exitus|1
1215013|NCT00827502|3987735|P1|Overall Study|Withdrawal by Subject|5
1215014|NCT00827502|3987735|P1|Overall Study|Lost to Follow-up|4
1215015|NCT00827502|3987735|P1|Overall Study|Adverse Event|1
1215016|NCT00827502|3987735|P1|Overall Study|randomized but not treated|11
1215017|NCT00827372|3987741|P1|Overall Study|Lack of Efficacy|3
1215018|NCT00827372|3987741|P1|Overall Study|Adverse Event|5
1215019|NCT00827242|3987756|P2|Overall Study|Lack of Efficacy|0
1215020|NCT00827242|3987757|P1|Overall Study|Lack of Efficacy|1
1215021|NCT00827242|3987756|P2|Overall Study|Death|0
1215022|NCT00827242|3987757|P1|Overall Study|Death|1
1215023|NCT00827242|3987756|P2|Overall Study|Physician Decision|0
1215024|NCT00827242|3987757|P1|Overall Study|Physician Decision|2
1215025|NCT00827242|3987756|P2|Overall Study|Entry Criteria Not Met|1
1215026|NCT00827242|3987757|P1|Overall Study|Entry Criteria Not Met|4
1215027|NCT00827242|3987756|P2|Overall Study|Adverse Event Excluding Death|1
1215028|NCT00827242|3987757|P1|Overall Study|Adverse Event Excluding Death|2
1215029|NCT00827242|3987756|P2|Overall Study|Lost to Follow-up|3
1215030|NCT00827242|3987757|P1|Overall Study|Lost to Follow-up|0
1215031|NCT00827242|3987756|P2|Overall Study|Protocol Violation|3
1215032|NCT00827242|3987757|P1|Overall Study|Protocol Violation|1
1215033|NCT00827242|3987756|P2|Overall Study|Withdrawal by Subject|4
1215034|NCT00827242|3987757|P1|Overall Study|Withdrawal by Subject|2
1215035|NCT00827112|3987795|P2|Overall Study|Other|3
1215036|NCT00827112|3987796|P1|Overall Study|Other|1
1215037|NCT00827112|3987795|P2|Overall Study|Randomized but not treated|3
1215038|NCT00827112|3987796|P1|Overall Study|Randomized but not treated|5
1215039|NCT00827112|3987795|P2|Overall Study|Withdrawal by Subject|1
1215040|NCT00827112|3987796|P1|Overall Study|Withdrawal by Subject|2
1215041|NCT00827112|3987795|P2|Overall Study|Protocol Violation|2
1215042|NCT00827112|3987796|P1|Overall Study|Protocol Violation|0
1215043|NCT00827112|3987795|P2|Overall Study|Pregnancy|1
1215044|NCT00827112|3987796|P1|Overall Study|Pregnancy|0
1215045|NCT00827112|3987795|P2|Overall Study|Lost to Follow-up|2
1215046|NCT00827112|3987796|P1|Overall Study|Lost to Follow-up|3
1215047|NCT00827112|3987795|P2|Overall Study|Lack of Efficacy|0
1215048|NCT00827112|3987796|P1|Overall Study|Lack of Efficacy|2
1215049|NCT00827112|3987795|P2|Overall Study|Adverse Event|0
1215050|NCT00827112|3987796|P1|Overall Study|Adverse Event|2
1215051|NCT00826943|3987849|P6|Overall Study|Withdrawal by Subject|0
1215052|NCT00826943|3987850|P5|Overall Study|Withdrawal by Subject|1
1215053|NCT00826943|3987851|P4|Overall Study|Withdrawal by Subject|0
1215054|NCT00826943|3987852|P3|Overall Study|Withdrawal by Subject|0
1215055|NCT00826943|3987853|P2|Overall Study|Withdrawal by Subject|0
1215056|NCT00826943|3987854|P1|Overall Study|Withdrawal by Subject|0
1215057|NCT00826748|3987875|P3|Overall Study|Samples Did Not pass QC|1
1215058|NCT00826748|3987876|P2|Overall Study|Samples Did Not pass QC|0
1215059|NCT00826748|3987877|P1|Overall Study|Samples Did Not pass QC|0
1215060|NCT00826748|3987875|P3|Overall Study|Physician Decision|1
1215061|NCT00826748|3987876|P2|Overall Study|Physician Decision|0
1215062|NCT00826748|3987877|P1|Overall Study|Physician Decision|0
1215063|NCT00826748|3987875|P3|Overall Study|Withdrawal by Subject|2
1215064|NCT00826748|3987876|P2|Overall Study|Withdrawal by Subject|0
1215065|NCT00826748|3987877|P1|Overall Study|Withdrawal by Subject|0
1215066|NCT00826618|3987885|P1|Overall Study|Withdrawal by Subject|1
1215067|NCT00826540|3987889|P1|Overall Study|Withdrawal by Subject|1
1215068|NCT00826540|3987889|P1|Overall Study|ineligible|3
1215069|NCT00826449|3987895|P1|Overall Study|Withdrawal by Subject|1
1215070|NCT00826449|3987895|P1|Overall Study|Disease Progression|4
1215071|NCT00826280|3987904|P3|Overall Study|One or more non-interpretable scan|1
1215072|NCT00826280|3987905|P2|Overall Study|One or more non-interpretable scan|1
1215073|NCT00826280|3987906|P1|Overall Study|One or more non-interpretable scan|0
1215074|NCT00826280|3987904|P3|Overall Study|Machine Failure|0
1215075|NCT00826280|3987905|P2|Overall Study|Machine Failure|1
1215076|NCT00826280|3987906|P1|Overall Study|Machine Failure|1
1215077|NCT00826280|3987904|P3|Overall Study|Interpretation Failure|0
1215078|NCT00826280|3987905|P2|Overall Study|Interpretation Failure|0
1215079|NCT00826280|3987906|P1|Overall Study|Interpretation Failure|1
1215080|NCT00826280|3987904|P3|Overall Study|Reversible ischemic defect not present|44
1215081|NCT00826280|3987905|P2|Overall Study|Reversible ischemic defect not present|40
1215082|NCT00826280|3987906|P1|Overall Study|Reversible ischemic defect not present|43
1215083|NCT00826280|3987904|P3|Overall Study|Sponsor discontinued subject or study|0
1215084|NCT00826280|3987905|P2|Overall Study|Sponsor discontinued subject or study|0
1215085|NCT00826280|3987906|P1|Overall Study|Sponsor discontinued subject or study|1
1215086|NCT00826280|3987904|P3|Overall Study|Lost to Follow-up|0
1215087|NCT00826280|3987905|P2|Overall Study|Lost to Follow-up|1
1215088|NCT00826280|3987906|P1|Overall Study|Lost to Follow-up|0
1215089|NCT00826280|3987904|P3|Overall Study|Adverse Event|0
1215090|NCT00826280|3987905|P2|Overall Study|Adverse Event|3
1215091|NCT00826280|3987906|P1|Overall Study|Adverse Event|1
1215092|NCT00826280|3987904|P3|Overall Study|Randomized but drug not received|1
1215093|NCT00826280|3987905|P2|Overall Study|Randomized but drug not received|0
1215094|NCT00826280|3987906|P1|Overall Study|Randomized but drug not received|1
1215095|NCT00826267|3987935|P3|Overall Study|Other Adverse Event|0
1215096|NCT00826267|3987936|P2|Overall Study|Other Adverse Event|0
1215097|NCT00826267|3987937|P1|Overall Study|Other Adverse Event|1
1215098|NCT00826228|3987955|P1|Overall Study|Withdrawal by Subject|1
1215099|NCT00826176|3987977|P2|Overall Study|Administrative|0
1215100|NCT00826176|3987978|P1|Overall Study|Administrative|9
1215101|NCT00826176|3987977|P2|Overall Study|Subject Withdrew Consent|0
1215102|NCT00826176|3987978|P1|Overall Study|Subject Withdrew Consent|3
1215103|NCT00826176|3987977|P2|Overall Study|Lost to Follow-up|0
1215104|NCT00826176|3987978|P1|Overall Study|Lost to Follow-up|1
1215105|NCT00826111|3987990|P2|Overall Study|Physician Decision|1
1215106|NCT00826111|3987991|P1|Overall Study|Physician Decision|1
1215107|NCT00826111|3987990|P2|Overall Study|Withdrawal by Subject|0
1215108|NCT00826111|3987991|P1|Overall Study|Withdrawal by Subject|5
1215109|NCT00826111|3987990|P2|Overall Study|Protocol Violation|0
1215110|NCT00826111|3987991|P1|Overall Study|Protocol Violation|1
1215111|NCT00826111|3987990|P2|Overall Study|Lost to Follow-up|1
1215112|NCT00826111|3987991|P1|Overall Study|Lost to Follow-up|0
1215113|NCT00825994|3988021|P1|Overall Study|Placebo Responder at V2|1
1215114|NCT00825994|3988021|P1|Overall Study|Protocol Violation|1
1215115|NCT00825994|3988021|P1|Overall Study|Lost to Follow-up|1
1215116|NCT00825994|3988021|P1|Overall Study|Withdrawal by Subject|2
1215117|NCT00825916|3988029|P3|Overall Study|Lost to Follow-up|1
1215118|NCT00825916|3988030|P2|Overall Study|Lost to Follow-up|2
1215119|NCT00825916|3988031|P1|Overall Study|Lost to Follow-up|4
1215120|NCT00825825|3988072|P6|Third Medication Period (14 Days)|poor data quality|0
1215121|NCT00825825|3988073|P5|Third Medication Period (14 Days)|poor data quality|0
1215122|NCT00825825|3988074|P4|Third Medication Period (14 Days)|poor data quality|0
1215123|NCT00825825|3988075|P3|Third Medication Period (14 Days)|poor data quality|0
1215124|NCT00825825|3988076|P2|Third Medication Period (14 Days)|poor data quality|1
1215125|NCT00825825|3988077|P1|Third Medication Period (14 Days)|poor data quality|0
1215126|NCT00825825|3988072|P6|Third Medication Period (14 Days)|Protocol Violation|2
1215127|NCT00825825|3988073|P5|Third Medication Period (14 Days)|Protocol Violation|0
1215128|NCT00825825|3988074|P4|Third Medication Period (14 Days)|Protocol Violation|0
1215129|NCT00825825|3988075|P3|Third Medication Period (14 Days)|Protocol Violation|0
1215130|NCT00825825|3988076|P2|Third Medication Period (14 Days)|Protocol Violation|0
1215131|NCT00825825|3988077|P1|Third Medication Period (14 Days)|Protocol Violation|0
1215132|NCT00825825|3988072|P6|Third Medication Period (14 Days)|Adverse Event|0
1215133|NCT00825825|3988073|P5|Third Medication Period (14 Days)|Adverse Event|0
1215134|NCT00825825|3988074|P4|Third Medication Period (14 Days)|Adverse Event|0
1215135|NCT00825825|3988075|P3|Third Medication Period (14 Days)|Adverse Event|0
1215136|NCT00825825|3988076|P2|Third Medication Period (14 Days)|Adverse Event|1
1215137|NCT00825825|3988077|P1|Third Medication Period (14 Days)|Adverse Event|0
1215138|NCT00825825|3988072|P6|Second Medication Period (14 Days)|Protocol Violation|0
1215139|NCT00825825|3988073|P5|Second Medication Period (14 Days)|Protocol Violation|1
1215140|NCT00825825|3988074|P4|Second Medication Period (14 Days)|Protocol Violation|0
1215141|NCT00825825|3988075|P3|Second Medication Period (14 Days)|Protocol Violation|0
1215142|NCT00825825|3988076|P2|Second Medication Period (14 Days)|Protocol Violation|0
1215143|NCT00825825|3988077|P1|Second Medication Period (14 Days)|Protocol Violation|1
1215144|NCT00825825|3988072|P6|Second Medication Period (14 Days)|Physician Decision|0
1215145|NCT00825825|3988073|P5|Second Medication Period (14 Days)|Physician Decision|0
1215146|NCT00825825|3988074|P4|Second Medication Period (14 Days)|Physician Decision|2
1215147|NCT00825825|3988075|P3|Second Medication Period (14 Days)|Physician Decision|0
1215148|NCT00825825|3988076|P2|Second Medication Period (14 Days)|Physician Decision|0
1215149|NCT00825825|3988077|P1|Second Medication Period (14 Days)|Physician Decision|1
1215150|NCT00825825|3988072|P6|First Medication Period (14 Days)|Physician Decision|1
1215151|NCT00825825|3988073|P5|First Medication Period (14 Days)|Physician Decision|0
1215152|NCT00825825|3988074|P4|First Medication Period (14 Days)|Physician Decision|0
1215153|NCT00825825|3988075|P3|First Medication Period (14 Days)|Physician Decision|1
1215154|NCT00825825|3988076|P2|First Medication Period (14 Days)|Physician Decision|0
1215155|NCT00825825|3988077|P1|First Medication Period (14 Days)|Physician Decision|2
1215156|NCT00825825|3988072|P6|First Medication Period (14 Days)|Adverse Event|1
1215157|NCT00825825|3988073|P5|First Medication Period (14 Days)|Adverse Event|0
1215158|NCT00825825|3988074|P4|First Medication Period (14 Days)|Adverse Event|0
1215159|NCT00825825|3988075|P3|First Medication Period (14 Days)|Adverse Event|0
1215160|NCT00825825|3988076|P2|First Medication Period (14 Days)|Adverse Event|0
1215161|NCT00825825|3988077|P1|First Medication Period (14 Days)|Adverse Event|1
1215162|NCT00825812|3988093|P4|Overall Study|Administrative|5
1215163|NCT00825812|3988094|P3|Overall Study|Administrative|3
1215164|NCT00825812|3988095|P2|Overall Study|Administrative|1
1215165|NCT00825812|3988096|P1|Overall Study|Administrative|0
1215166|NCT00825812|3988093|P4|Overall Study|Non-compliance with protocol|1
1215167|NCT00825812|3988094|P3|Overall Study|Non-compliance with protocol|0
1215168|NCT00825812|3988095|P2|Overall Study|Non-compliance with protocol|0
1215169|NCT00825812|3988096|P1|Overall Study|Non-compliance with protocol|0
1215170|NCT00825812|3988093|P4|Overall Study|Subject withdrew consent|2
1215171|NCT00825812|3988094|P3|Overall Study|Subject withdrew consent|3
1215172|NCT00825812|3988095|P2|Overall Study|Subject withdrew consent|0
1215173|NCT00825812|3988096|P1|Overall Study|Subject withdrew consent|0
1215174|NCT00825812|3988093|P4|Overall Study|Adverse Event|1
1215175|NCT00825812|3988094|P3|Overall Study|Adverse Event|0
1215176|NCT00825812|3988095|P2|Overall Study|Adverse Event|0
1215177|NCT00825812|3988096|P1|Overall Study|Adverse Event|0
1215178|NCT00825812|3988093|P4|Overall Study|Never entered follow up|1
1215179|NCT00825812|3988094|P3|Overall Study|Never entered follow up|0
1215180|NCT00825812|3988095|P2|Overall Study|Never entered follow up|0
1215181|NCT00825812|3988096|P1|Overall Study|Never entered follow up|0
1215182|NCT00825682|3988143|P2|Overall Study|personal reasons/ inconvenience|5
1215183|NCT00825682|3988144|P1|Overall Study|personal reasons/ inconvenience|13
1215184|NCT00825305|3988235|P2|Overall Study|Can not be classified|1
1215185|NCT00825305|3988236|P1|Overall Study|Can not be classified|0
1215186|NCT00825305|3988235|P2|Overall Study|Protocol Violation|9
1215187|NCT00825305|3988236|P1|Overall Study|Protocol Violation|9
1215188|NCT00825305|3988235|P2|Overall Study|Inappropriate inclusion|0
1215189|NCT00825305|3988236|P1|Overall Study|Inappropriate inclusion|1
1215190|NCT00825305|3988235|P2|Overall Study|Withdrawal by Subject|12
1215191|NCT00825305|3988236|P1|Overall Study|Withdrawal by Subject|6
1215192|NCT00825305|3988235|P2|Overall Study|Adverse Event|1
1215193|NCT00825305|3988236|P1|Overall Study|Adverse Event|1
1215194|NCT00825175|3988276|P2|Overall Study|Withdrawal by Subject|5
1215195|NCT00825175|3988277|P1|Overall Study|Withdrawal by Subject|0
1215196|NCT00825162|3988286|P3|Overall Study|Unable to attend the study visit|0
1215197|NCT00825162|3988287|P2|Overall Study|Unable to attend the study visit|2
1215198|NCT00825162|3988288|P1|Overall Study|Unable to attend the study visit|5
1215199|NCT00825162|3988286|P3|Overall Study|Move away from the study area|0
1215200|NCT00825162|3988287|P2|Overall Study|Move away from the study area|0
1215201|NCT00825162|3988288|P1|Overall Study|Move away from the study area|1
1215202|NCT00825162|3988286|P3|Overall Study|Physician Decision|0
1215203|NCT00825162|3988287|P2|Overall Study|Physician Decision|0
1215204|NCT00825162|3988288|P1|Overall Study|Physician Decision|2
1215205|NCT00825162|3988286|P3|Overall Study|Lost to Follow-up|3
1215206|NCT00825162|3988287|P2|Overall Study|Lost to Follow-up|6
1215207|NCT00825162|3988288|P1|Overall Study|Lost to Follow-up|9
1215208|NCT00825162|3988286|P3|Overall Study|Withdrawal by Subject|3
1215209|NCT00825162|3988287|P2|Overall Study|Withdrawal by Subject|13
1215210|NCT00825162|3988288|P1|Overall Study|Withdrawal by Subject|11
1215211|NCT00824993|3988314|P2|Overall Study|Death|3
1215212|NCT00824993|3988315|P1|Overall Study|Death|0
1215213|NCT00824993|3988314|P2|Overall Study|Insurance Issue|1
1215214|NCT00824993|3988315|P1|Overall Study|Insurance Issue|2
1215215|NCT00824993|3988314|P2|Overall Study|Non-Compliant|1
1215216|NCT00824993|3988315|P1|Overall Study|Non-Compliant|2
1215217|NCT00824993|3988314|P2|Overall Study|Rapid Bone Loss|1
1215218|NCT00824993|3988315|P1|Overall Study|Rapid Bone Loss|0
1215219|NCT00824993|3988314|P2|Overall Study|Malignancy Relapse|10
1215220|NCT00824993|3988315|P1|Overall Study|Malignancy Relapse|9
1215221|NCT00824993|3988314|P2|Overall Study|Withdrawal by Subject|1
1215222|NCT00824993|3988315|P1|Overall Study|Withdrawal by Subject|1
1215223|NCT00824850|3988323|P2|Overall Study|Withdrawal by Subject|1
1215224|NCT00824850|3988324|P1|Overall Study|Withdrawal by Subject|0
1215225|NCT00824772|3988377|P1|Overall Study|Withdrawal by Subject|8
1215226|NCT00824720|3988397|P3|Overall Study|Protocol Violation|1
1215227|NCT00824720|3988398|P2|Overall Study|Protocol Violation|0
1215228|NCT00824720|3988399|P1|Overall Study|Protocol Violation|0
1215229|NCT00824720|3988397|P3|Overall Study|failed plug insertion|0
1215230|NCT00824720|3988398|P2|Overall Study|failed plug insertion|1
1215231|NCT00824720|3988399|P1|Overall Study|failed plug insertion|3
1215232|NCT00824655|3988415|P2|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0
1215233|NCT00824655|3988416|P1|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1
1215234|NCT00824655|3988415|P2|Toddler Dose (12 Months of Age)|Adverse Event|0
1215235|NCT00824655|3988416|P1|Toddler Dose (12 Months of Age)|Adverse Event|1
1215236|NCT00824616|3988436|P2|Overall Study|Withdrawal by Subject|1
1215237|NCT00824616|3988437|P1|Overall Study|Withdrawal by Subject|1
1215238|NCT00824616|3988436|P2|Overall Study|Lost to Follow-up|1
1215239|NCT00824616|3988437|P1|Overall Study|Lost to Follow-up|0
1215240|NCT00824616|3988436|P2|Overall Study|Lack of Efficacy|1
1215241|NCT00824616|3988437|P1|Overall Study|Lack of Efficacy|2
1215242|NCT00824616|3988436|P2|Overall Study|Hyperglycemia|1
1215243|NCT00824616|3988437|P1|Overall Study|Hyperglycemia|1
1215244|NCT00824616|3988436|P2|Overall Study|Creatinine/Creatinine Clearance|2
1215245|NCT00824616|3988437|P1|Overall Study|Creatinine/Creatinine Clearance|0
1215246|NCT00824616|3988436|P2|Overall Study|Adverse Event|1
1215247|NCT00824616|3988437|P1|Overall Study|Adverse Event|2
1215248|NCT00824564|3988447|P2|Overall Study|Randomized, but not treated|0
1215249|NCT00824564|3988448|P1|Overall Study|Randomized, but not treated|1
1215250|NCT00824564|3988447|P2|Overall Study|Other|2
1215251|NCT00824564|3988448|P1|Overall Study|Other|1
1215252|NCT00824564|3988447|P2|Overall Study|Withdrawal by Subject|1
1215253|NCT00824564|3988448|P1|Overall Study|Withdrawal by Subject|1
1215254|NCT00824564|3988447|P2|Overall Study|Lost to Follow-up|7
1215255|NCT00824564|3988448|P1|Overall Study|Lost to Follow-up|5
1215256|NCT00824473|3988527|P2|Overall Study|Other|1
1215257|NCT00824473|3988528|P1|Overall Study|Other|1
1215258|NCT00824473|3988527|P2|Overall Study|Withdrawal by Subject|3
1215259|NCT00824473|3988528|P1|Overall Study|Withdrawal by Subject|2
1215260|NCT00824473|3988527|P2|Overall Study|Non-Compliance|2
1215261|NCT00824473|3988528|P1|Overall Study|Non-Compliance|4
1215262|NCT00824473|3988527|P2|Overall Study|Protocol Violation|0
1215263|NCT00824473|3988528|P1|Overall Study|Protocol Violation|2
1215264|NCT00824473|3988527|P2|Overall Study|Lack of Efficacy|2
1215265|NCT00824473|3988528|P1|Overall Study|Lack of Efficacy|2
1215266|NCT00824473|3988527|P2|Overall Study|Adverse Event|5
1215267|NCT00824473|3988528|P1|Overall Study|Adverse Event|4
1215268|NCT00824421|3988609|P3|Overall Study|Other|0
1215269|NCT00824421|3988610|P2|Overall Study|Other|1
1215270|NCT00824421|3988611|P1|Overall Study|Other|0
1215271|NCT00824421|3988609|P3|Overall Study|Randomized but not Treated|0
1215272|NCT00824421|3988610|P2|Overall Study|Randomized but not Treated|1
1215273|NCT00824421|3988611|P1|Overall Study|Randomized but not Treated|1
1215274|NCT00824421|3988609|P3|Overall Study|Withdrawal by Subject|3
1215275|NCT00824421|3988610|P2|Overall Study|Withdrawal by Subject|3
1215276|NCT00824421|3988611|P1|Overall Study|Withdrawal by Subject|2
1215277|NCT00824421|3988609|P3|Overall Study|Pregnancy|1
1215278|NCT00824421|3988610|P2|Overall Study|Pregnancy|0
1215279|NCT00824421|3988611|P1|Overall Study|Pregnancy|1
1215280|NCT00824421|3988609|P3|Overall Study|Lost to Follow-up|0
1215281|NCT00824421|3988610|P2|Overall Study|Lost to Follow-up|3
1215282|NCT00824421|3988611|P1|Overall Study|Lost to Follow-up|2
1215283|NCT00824421|3988609|P3|Overall Study|Lack of Efficacy|4
1215284|NCT00824421|3988610|P2|Overall Study|Lack of Efficacy|7
1215285|NCT00824421|3988611|P1|Overall Study|Lack of Efficacy|5
1215286|NCT00824421|3988609|P3|Overall Study|Death|0
1215287|NCT00824421|3988610|P2|Overall Study|Death|1
1215288|NCT00824421|3988611|P1|Overall Study|Death|0
1215289|NCT00824421|3988609|P3|Overall Study|Adverse Event|6
1215290|NCT00824421|3988610|P2|Overall Study|Adverse Event|6
1215291|NCT00824421|3988611|P1|Overall Study|Adverse Event|6
1215292|NCT00824408|3988662|P5|Randomized Phase|Other reason not defined above|4
1215293|NCT00824408|3988663|P4|Randomized Phase|Other reason not defined above|2
1215294|NCT00824408|3988664|P3|Randomized Phase|Other reason not defined above|4
1215295|NCT00824408|3988665|P2|Randomized Phase|Other reason not defined above|0
1215296|NCT00824408|3988666|P1|Randomized Phase|Other reason not defined above|0
1215297|NCT00824408|3988662|P5|Randomized Phase|Refused to continue medication|2
1215298|NCT00824408|3988663|P4|Randomized Phase|Refused to continue medication|2
1215299|NCT00824408|3988664|P3|Randomized Phase|Refused to continue medication|2
1215300|NCT00824408|3988665|P2|Randomized Phase|Refused to continue medication|0
1215301|NCT00824408|3988666|P1|Randomized Phase|Refused to continue medication|0
1215302|NCT00824408|3988662|P5|Randomized Phase|Adverse Event|5
1215303|NCT00824408|3988663|P4|Randomized Phase|Adverse Event|5
1215304|NCT00824408|3988664|P3|Randomized Phase|Adverse Event|4
1215305|NCT00824408|3988665|P2|Randomized Phase|Adverse Event|0
1215306|NCT00824408|3988666|P1|Randomized Phase|Adverse Event|0
1215307|NCT00824408|3988662|P5|Randomized Phase|Progressive disease|34
1215308|NCT00824408|3988663|P4|Randomized Phase|Progressive disease|36
1215309|NCT00824408|3988664|P3|Randomized Phase|Progressive disease|25
1215310|NCT00824408|3988665|P2|Randomized Phase|Progressive disease|0
1215311|NCT00824408|3988666|P1|Randomized Phase|Progressive disease|0
1215312|NCT00824408|3988662|P5|Randomized Phase|Not treated|1
1215313|NCT00824408|3988663|P4|Randomized Phase|Not treated|1
1215314|NCT00824408|3988664|P3|Randomized Phase|Not treated|1
1215315|NCT00824408|3988665|P2|Randomized Phase|Not treated|0
1215316|NCT00824408|3988666|P1|Randomized Phase|Not treated|0
1215317|NCT00824408|3988662|P5|Run-in Phase|Other reason not defined above|0
1215318|NCT00824408|3988663|P4|Run-in Phase|Other reason not defined above|0
1215319|NCT00824408|3988664|P3|Run-in Phase|Other reason not defined above|0
1215320|NCT00824408|3988665|P2|Run-in Phase|Other reason not defined above|1
1215321|NCT00824408|3988666|P1|Run-in Phase|Other reason not defined above|0
1215322|NCT00824408|3988662|P5|Run-in Phase|Refused to continue medication|0
1215323|NCT00824408|3988663|P4|Run-in Phase|Refused to continue medication|0
1215324|NCT00824408|3988664|P3|Run-in Phase|Refused to continue medication|0
1215325|NCT00824408|3988665|P2|Run-in Phase|Refused to continue medication|0
1215326|NCT00824408|3988666|P1|Run-in Phase|Refused to continue medication|1
1215327|NCT00824408|3988662|P5|Run-in Phase|Adverse Event|0
1215328|NCT00824408|3988663|P4|Run-in Phase|Adverse Event|0
1215329|NCT00824408|3988664|P3|Run-in Phase|Adverse Event|0
1215330|NCT00824408|3988665|P2|Run-in Phase|Adverse Event|1
1215331|NCT00824408|3988666|P1|Run-in Phase|Adverse Event|1
1215332|NCT00824408|3988662|P5|Run-in Phase|Progressive disease|0
1215333|NCT00824408|3988663|P4|Run-in Phase|Progressive disease|0
1215334|NCT00824408|3988664|P3|Run-in Phase|Progressive disease|0
1215335|NCT00824408|3988665|P2|Run-in Phase|Progressive disease|4
1215336|NCT00824408|3988666|P1|Run-in Phase|Progressive disease|4
1215337|NCT00824382|3988718|P4|Overall Study|Investigator's decision|0
1215338|NCT00824382|3988719|P3|Overall Study|Investigator's decision|2
1215339|NCT00824382|3988720|P2|Overall Study|Investigator's decision|1
1215340|NCT00824382|3988721|P1|Overall Study|Investigator's decision|0
1215341|NCT00824382|3988718|P4|Overall Study|Protocol Violation|1
1215342|NCT00824382|3988719|P3|Overall Study|Protocol Violation|0
1215343|NCT00824382|3988720|P2|Overall Study|Protocol Violation|0
1215344|NCT00824382|3988721|P1|Overall Study|Protocol Violation|1
1215345|NCT00824382|3988718|P4|Overall Study|Adverse Event|4
1215346|NCT00824382|3988719|P3|Overall Study|Adverse Event|1
1215347|NCT00824382|3988720|P2|Overall Study|Adverse Event|1
1215348|NCT00824382|3988721|P1|Overall Study|Adverse Event|4
1215349|NCT00824369|3988797|P6|Overall Study|Lost to Follow-up|0
1215350|NCT00824369|3988798|P5|Overall Study|Lost to Follow-up|1
1215351|NCT00824369|3988799|P4|Overall Study|Lost to Follow-up|0
1215352|NCT00824369|3988800|P3|Overall Study|Lost to Follow-up|0
1215353|NCT00824369|3988801|P2|Overall Study|Lost to Follow-up|0
1215354|NCT00824369|3988802|P1|Overall Study|Lost to Follow-up|0
1215355|NCT00824369|3988797|P6|Overall Study|Nolonger willing to participate in study|1
1215356|NCT00824369|3988798|P5|Overall Study|Nolonger willing to participate in study|0
1215357|NCT00824369|3988799|P4|Overall Study|Nolonger willing to participate in study|2
1215358|NCT00824369|3988800|P3|Overall Study|Nolonger willing to participate in study|1
1215359|NCT00824369|3988801|P2|Overall Study|Nolonger willing to participate in study|0
1215360|NCT00824369|3988802|P1|Overall Study|Nolonger willing to participate in study|1
1215361|NCT00824291|3988842|P2|Overall Study|Participant on prohibited medication|0
1215362|NCT00824291|3988843|P1|Overall Study|Participant on prohibited medication|1
1215363|NCT00824291|3988842|P2|Overall Study|Lack of Efficacy|8
1215364|NCT00824291|3988843|P1|Overall Study|Lack of Efficacy|7
1215365|NCT00824291|3988842|P2|Overall Study|Withdrawal by Subject|8
1215366|NCT00824291|3988843|P1|Overall Study|Withdrawal by Subject|14
1215367|NCT00824291|3988842|P2|Overall Study|Protocol Violation|1
1215368|NCT00824291|3988843|P1|Overall Study|Protocol Violation|4
1215369|NCT00824291|3988842|P2|Overall Study|Non-compliance|1
1215370|NCT00824291|3988843|P1|Overall Study|Non-compliance|1
1215371|NCT00824291|3988842|P2|Overall Study|Lost to Follow-up|9
1215372|NCT00824291|3988843|P1|Overall Study|Lost to Follow-up|11
1215373|NCT00824291|3988842|P2|Overall Study|Discontinuation of Study by Sponsor|2
1215374|NCT00824291|3988843|P1|Overall Study|Discontinuation of Study by Sponsor|1
1215375|NCT00824291|3988842|P2|Overall Study|Adverse Event|6
1215376|NCT00824291|3988843|P1|Overall Study|Adverse Event|15
1215377|NCT00824265|3988865|P2|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16
1215378|NCT00824265|3988866|P1|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9
1215379|NCT00824265|3988865|P2|Follow-up Phase|w/drew consent, no f/u, or MD choice|31
1215380|NCT00824265|3988866|P1|Follow-up Phase|w/drew consent, no f/u, or MD choice|18
1215381|NCT00824265|3988865|P2|Treatment Phase|Withdrawal by Subject|15
1215382|NCT00824265|3988866|P1|Treatment Phase|Withdrawal by Subject|6
1215383|NCT00824265|3988865|P2|Treatment Phase|Physician Decision|12
1215384|NCT00824265|3988866|P1|Treatment Phase|Physician Decision|6
1215385|NCT00824265|3988865|P2|Treatment Phase|Lost to Follow-up|1
1215386|NCT00824265|3988866|P1|Treatment Phase|Lost to Follow-up|1
1215387|NCT00824265|3988865|P2|Treatment Phase|Protocol Violation|0
1215388|NCT00824265|3988866|P1|Treatment Phase|Protocol Violation|1
1215389|NCT00824265|3988865|P2|Treatment Phase|Adverse Event,non-fatal|52
1215390|NCT00824265|3988866|P1|Treatment Phase|Adverse Event,non-fatal|50
1215391|NCT00824161|3988927|P1|Overall Study|Screen Failure|1
1215392|NCT00824161|3988927|P1|Overall Study|Withdrawal by Subject|1
1215393|NCT00824005|3988993|P2|Overall Study|Lost to Follow-up|1
1215394|NCT00824005|3988994|P1|Overall Study|Lost to Follow-up|0
1215395|NCT00824005|3988993|P2|Overall Study|Death|1
1215396|NCT00824005|3988994|P1|Overall Study|Death|0
1215397|NCT00823979|3989029|P3|Overall Study|Study Terminated by Sponsor|7
1215398|NCT00823979|3989030|P2|Overall Study|Study Terminated by Sponsor|5
1215399|NCT00823979|3989031|P1|Overall Study|Study Terminated by Sponsor|5
1215400|NCT00823979|3989029|P3|Overall Study|Randomized but not Treated|1
1215401|NCT00823979|3989030|P2|Overall Study|Randomized but not Treated|3
1215402|NCT00823979|3989031|P1|Overall Study|Randomized but not Treated|4
1215403|NCT00823979|3989029|P3|Overall Study|Other|1
1215404|NCT00823979|3989030|P2|Overall Study|Other|0
1215405|NCT00823979|3989031|P1|Overall Study|Other|2
1215406|NCT00823979|3989029|P3|Overall Study|Adverse Event|4
1215407|NCT00823979|3989030|P2|Overall Study|Adverse Event|2
1215408|NCT00823979|3989031|P1|Overall Study|Adverse Event|0
1215409|NCT00823979|3989029|P3|Overall Study|Pregnancy|0
1215410|NCT00823979|3989030|P2|Overall Study|Pregnancy|1
1215411|NCT00823979|3989031|P1|Overall Study|Pregnancy|0
1215412|NCT00823979|3989029|P3|Overall Study|Protocol Violation|0
1215413|NCT00823979|3989030|P2|Overall Study|Protocol Violation|1
1215414|NCT00823979|3989031|P1|Overall Study|Protocol Violation|1
1215415|NCT00823979|3989029|P3|Overall Study|Withdrawal by Subject|2
1215416|NCT00823979|3989030|P2|Overall Study|Withdrawal by Subject|3
1215417|NCT00823979|3989031|P1|Overall Study|Withdrawal by Subject|2
1215418|NCT00823979|3989029|P3|Overall Study|Lost to Follow-up|0
1215419|NCT00823979|3989030|P2|Overall Study|Lost to Follow-up|1
1215420|NCT00823979|3989031|P1|Overall Study|Lost to Follow-up|2
1215421|NCT00823979|3989029|P3|Overall Study|Lack of Efficacy|9
1215422|NCT00823979|3989030|P2|Overall Study|Lack of Efficacy|16
1215423|NCT00823979|3989031|P1|Overall Study|Lack of Efficacy|13
1215424|NCT00823901|3989076|P2|Overall Study|Lost to Follow-up|1
1215425|NCT00823901|3989077|P1|Overall Study|Lost to Follow-up|2
1215426|NCT00823901|3989076|P2|Overall Study|Lack of Efficacy|0
1215427|NCT00823901|3989077|P1|Overall Study|Lack of Efficacy|1
1215428|NCT00823901|3989076|P2|Overall Study|Adverse Event|1
1215429|NCT00823901|3989077|P1|Overall Study|Adverse Event|1
1215430|NCT00823836|3989085|P2|Long-term Phase|Withdrawal by Subject|1
1215431|NCT00823836|3989086|P1|Long-term Phase|Withdrawal by Subject|1
1215432|NCT00823836|3989085|P2|Long-term Phase|Physician Decision|2
1215433|NCT00823836|3989086|P1|Long-term Phase|Physician Decision|1
1215434|NCT00823836|3989085|P2|Long-term Phase|Adverse Event|2
1215435|NCT00823836|3989086|P1|Long-term Phase|Adverse Event|3
1215436|NCT00823836|3989085|P2|NV and PR/XR Switching Phases|Withdrawal by Subject|5
1215437|NCT00823836|3989086|P1|NV and PR/XR Switching Phases|Withdrawal by Subject|4
1215438|NCT00823836|3989085|P2|NV and PR/XR Switching Phases|Physician Decision|2
1215439|NCT00823836|3989086|P1|NV and PR/XR Switching Phases|Physician Decision|5
1215440|NCT00823836|3989085|P2|NV and PR/XR Switching Phases|Protocol Violation|1
1215441|NCT00823836|3989086|P1|NV and PR/XR Switching Phases|Protocol Violation|1
1215442|NCT00823836|3989085|P2|NV and PR/XR Switching Phases|Adverse Event|21
1215443|NCT00823836|3989086|P1|NV and PR/XR Switching Phases|Adverse Event|22
1215444|NCT00823823|3989192|P2|Overall Study|Protocol Violation|5
1215445|NCT00823823|3989193|P1|Overall Study|Protocol Violation|5
1215446|NCT00823823|3989192|P2|Overall Study|Lost to Follow-up|1
1215447|NCT00823823|3989193|P1|Overall Study|Lost to Follow-up|3
1215448|NCT00823719|3989217|P2|Overall Study|Disease Progression|4
1215449|NCT00823719|3989218|P1|Overall Study|Disease Progression|4
1215450|NCT00823719|3989217|P2|Overall Study|Withdrawal by Subject|1
1215451|NCT00823719|3989218|P1|Overall Study|Withdrawal by Subject|0
1215452|NCT00823719|3989217|P2|Overall Study|Physician Decision|4
1215453|NCT00823719|3989218|P1|Overall Study|Physician Decision|1
1215454|NCT00823719|3989217|P2|Overall Study|Adverse Event|2
1215455|NCT00823719|3989218|P1|Overall Study|Adverse Event|1
1215456|NCT00823615|3989271|P2|Period 2|Time/Job Conflict|2
1215457|NCT00823615|3989272|P1|Period 2|Time/Job Conflict|1
1215458|NCT00823615|3989271|P2|Period 2|Lost to Follow-up|0
1215459|NCT00823615|3989272|P1|Period 2|Lost to Follow-up|2
1215460|NCT00823472|3989282|P2|Overall Study|Physician Decision|28
1215461|NCT00823472|3989283|P1|Overall Study|Physician Decision|24
1215462|NCT00823264|3989302|P2|Overall Study|Protocol Violation|0
1215463|NCT00823264|3989303|P1|Overall Study|Protocol Violation|2
1215464|NCT00823212|3989311|P2|Overall Study|Missed 12-month visit|21
1215465|NCT00823212|3989312|P1|Overall Study|Missed 12-month visit|21
1215466|NCT00823212|3989311|P2|Overall Study|Incarcerated|1
1215467|NCT00823212|3989312|P1|Overall Study|Incarcerated|0
1215468|NCT00823212|3989311|P2|Overall Study|Withdrawal by Subject|1
1215469|NCT00823212|3989312|P1|Overall Study|Withdrawal by Subject|6
1215470|NCT00823212|3989311|P2|Overall Study|Death|10
1215471|NCT00823212|3989312|P1|Overall Study|Death|8
1215472|NCT00823199|3989394|P1|Overall Study|Withdrawal by Subject|2
1215473|NCT00822926|3989463|P2|Second Injection Visit|Withdrawal by Subject|1
1215474|NCT00822926|3989464|P1|Second Injection Visit|Withdrawal by Subject|0
1215475|NCT00822926|3989463|P2|Second Injection Visit|Lost to Follow-up|0
1215476|NCT00822926|3989464|P1|Second Injection Visit|Lost to Follow-up|1
1215477|NCT00822900|3989478|P2|Overall Study|Became a ward of the state|1
1215478|NCT00822900|3989479|P1|Overall Study|Became a ward of the state|2
1215479|NCT00822900|3989478|P2|Overall Study|Death|69
1215480|NCT00822900|3989479|P1|Overall Study|Death|83
1215481|NCT00822900|3989478|P2|Overall Study|Lost to Follow-up|9
1215482|NCT00822900|3989479|P1|Overall Study|Lost to Follow-up|9
1215483|NCT00822900|3989478|P2|Overall Study|Withdrawal by Subject|14
1215484|NCT00822900|3989479|P1|Overall Study|Withdrawal by Subject|14
1215485|NCT00822692|3989526|P2|Overall Study|Lost to Follow-up|25
1215486|NCT00822692|3989527|P1|Overall Study|Lost to Follow-up|17
1215487|NCT00822237|3989665|P2|Dose 2 Vaccination|Lost to Follow-up|9
1215488|NCT00822237|3989666|P1|Dose 2 Vaccination|Lost to Follow-up|2
1215489|NCT00822237|3989665|P2|Dose 2 Vaccination|Withdrawal by Subject|2
1215490|NCT00822237|3989666|P1|Dose 2 Vaccination|Withdrawal by Subject|2
1215491|NCT00822237|3989665|P2|Dose 1 Vaccination|Lost to Follow-up|12
1215492|NCT00822237|3989666|P1|Dose 1 Vaccination|Lost to Follow-up|9
1215493|NCT00822237|3989665|P2|Dose 1 Vaccination|Withdrawal by Subject|14
1215494|NCT00822237|3989666|P1|Dose 1 Vaccination|Withdrawal by Subject|13
1215495|NCT00822237|3989665|P2|Dose 1 Vaccination|Not vaccinated|0
1215496|NCT00822237|3989666|P1|Dose 1 Vaccination|Not vaccinated|3
1215497|NCT00822172|3989747|P2|Overall Study|Other|1
1215498|NCT00822172|3989748|P1|Overall Study|Other|0
1215499|NCT00822172|3989747|P2|Overall Study|site closed|1
1215500|NCT00822172|3989748|P1|Overall Study|site closed|0
1215501|NCT00822172|3989747|P2|Overall Study|Withdrawal by Subject|4
1215502|NCT00822172|3989748|P1|Overall Study|Withdrawal by Subject|1
1215503|NCT00822172|3989747|P2|Overall Study|Lost to Follow-up|1
1215504|NCT00822172|3989748|P1|Overall Study|Lost to Follow-up|3
1215505|NCT00822172|3989747|P2|Overall Study|Death|0
1215506|NCT00822172|3989748|P1|Overall Study|Death|1
1215507|NCT00822172|3989747|P2|Overall Study|Adverse Event|12
1215508|NCT00822172|3989748|P1|Overall Study|Adverse Event|10
1215509|NCT00822120|3989756|P6|PET-directed Therapy|Protocol Violation|0
1215510|NCT00822120|3989757|P5|PET-directed Therapy|Protocol Violation|0
1215511|NCT00822120|3989758|P4|PET-directed Therapy|Protocol Violation|6
1215512|NCT00822120|3989759|P3|PET-directed Therapy|Protocol Violation|0
1215513|NCT00822120|3989760|P2|PET-directed Therapy|Protocol Violation|0
1215514|NCT00822120|3989761|P1|PET-directed Therapy|Protocol Violation|0
1215515|NCT00822120|3989756|P6|PET-directed Therapy|Death|0
1215516|NCT00822120|3989757|P5|PET-directed Therapy|Death|0
1215517|NCT00822120|3989758|P4|PET-directed Therapy|Death|2
1215518|NCT00822120|3989759|P3|PET-directed Therapy|Death|0
1215519|NCT00822120|3989760|P2|PET-directed Therapy|Death|0
1215520|NCT00822120|3989761|P1|PET-directed Therapy|Death|0
1215521|NCT00822120|3989756|P6|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
1215522|NCT00822120|3989757|P5|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
1215523|NCT00822120|3989758|P4|PET-directed Therapy|Refusal Unrelated to Adverse Event|1
1215524|NCT00822120|3989759|P3|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
1215525|NCT00822120|3989760|P2|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
1215526|NCT00822120|3989761|P1|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
1215527|NCT00822120|3989756|P6|PET-directed Therapy|Adverse Event|0
1215528|NCT00822120|3989757|P5|PET-directed Therapy|Adverse Event|0
1215529|NCT00822120|3989758|P4|PET-directed Therapy|Adverse Event|1
1215530|NCT00822120|3989759|P3|PET-directed Therapy|Adverse Event|0
1215531|NCT00822120|3989760|P2|PET-directed Therapy|Adverse Event|0
1215532|NCT00822120|3989761|P1|PET-directed Therapy|Adverse Event|0
1215533|NCT00822120|3989756|P6|Initial Registration|Ineligible|0
1215534|NCT00822120|3989757|P5|Initial Registration|Ineligible|0
1215535|NCT00822120|3989758|P4|Initial Registration|Ineligible|0
1215536|NCT00822120|3989759|P3|Initial Registration|Ineligible|0
1215537|NCT00822120|3989760|P2|Initial Registration|Ineligible|1
1215538|NCT00822120|3989761|P1|Initial Registration|Ineligible|22
1215539|NCT00822120|3989756|P6|Initial Registration|Reasons not Protocol Specified|0
1215540|NCT00822120|3989757|P5|Initial Registration|Reasons not Protocol Specified|0
1215541|NCT00822120|3989758|P4|Initial Registration|Reasons not Protocol Specified|0
1215542|NCT00822120|3989759|P3|Initial Registration|Reasons not Protocol Specified|0
1215543|NCT00822120|3989760|P2|Initial Registration|Reasons not Protocol Specified|0
1215544|NCT00822120|3989761|P1|Initial Registration|Reasons not Protocol Specified|2
1215545|NCT00822120|3989756|P6|Initial Registration|Refusal Unrelated to Adverse Event|0
1215546|NCT00822120|3989757|P5|Initial Registration|Refusal Unrelated to Adverse Event|0
1215547|NCT00822120|3989758|P4|Initial Registration|Refusal Unrelated to Adverse Event|0
1215548|NCT00822120|3989759|P3|Initial Registration|Refusal Unrelated to Adverse Event|0
1215549|NCT00822120|3989760|P2|Initial Registration|Refusal Unrelated to Adverse Event|0
1215550|NCT00822120|3989761|P1|Initial Registration|Refusal Unrelated to Adverse Event|1
1215551|NCT00822120|3989756|P6|Initial Registration|Adverse Event|0
1215552|NCT00822120|3989757|P5|Initial Registration|Adverse Event|0
1215553|NCT00822120|3989758|P4|Initial Registration|Adverse Event|0
1215554|NCT00822120|3989759|P3|Initial Registration|Adverse Event|0
1215555|NCT00822120|3989760|P2|Initial Registration|Adverse Event|0
1215556|NCT00822120|3989761|P1|Initial Registration|Adverse Event|1
1215557|NCT00821873|3989823|P1|Overall Study|Lost to Follow-up|4
1215558|NCT00821678|3989844|P2|Overall Study|Death|2
1215559|NCT00821678|3989845|P1|Overall Study|Death|0
1215560|NCT00821678|3989844|P2|Overall Study|Lost to Follow-up|12
1215561|NCT00821678|3989845|P1|Overall Study|Lost to Follow-up|13
1215562|NCT00821678|3989844|P2|Overall Study|Withdrawal by Subject|0
1215563|NCT00821678|3989845|P1|Overall Study|Withdrawal by Subject|8
1215564|NCT00821587|3989867|P2|Overall Study|Physician Decision|1
1215565|NCT00821587|3989868|P1|Overall Study|Physician Decision|0
1215566|NCT00821509|3989877|P3|Overall Study|Withdrawal by Subject|34
1215567|NCT00821509|3989878|P2|Overall Study|Withdrawal by Subject|11
1215568|NCT00821509|3989879|P1|Overall Study|Withdrawal by Subject|12
1215569|NCT00821431|3989892|P2|Overall Study|Physician Decision|1
1215570|NCT00821431|3989893|P1|Overall Study|Physician Decision|0
1215571|NCT00821431|3989892|P2|Overall Study|Protocol Violation|1
1215572|NCT00821431|3989893|P1|Overall Study|Protocol Violation|3
1215573|NCT00821431|3989892|P2|Overall Study|Lost to Follow-up|0
1215574|NCT00821431|3989893|P1|Overall Study|Lost to Follow-up|1
1215575|NCT00821431|3989892|P2|Overall Study|Withdrawal by Subject|0
1215576|NCT00821431|3989893|P1|Overall Study|Withdrawal by Subject|5
1215577|NCT00821431|3989892|P2|Overall Study|Adverse Event|3
1215578|NCT00821431|3989893|P1|Overall Study|Adverse Event|6
1215579|NCT00821327|3989901|P1|Overall Study|Other/Unknown|5
1215580|NCT00821327|3989901|P1|Overall Study|Disease Progression|13
1215581|NCT00821327|3989901|P1|Overall Study|Sponsor Request|1
1215582|NCT00821327|3989901|P1|Overall Study|Investigator Request|2
1215583|NCT00821327|3989901|P1|Overall Study|Patient Request|1
1215584|NCT00821327|3989901|P1|Overall Study|Adverse Event|13
1215585|NCT00821236|3989910|P1|Overall Study|Lost to Follow-up|3
1215586|NCT00821093|3989950|P2|Overall Study|Administrative problems|2
1215587|NCT00821093|3989951|P1|Overall Study|Administrative problems|1
1215588|NCT00821093|3989950|P2|Overall Study|Abnormal test procedure result(s)|1
1215589|NCT00821093|3989951|P1|Overall Study|Abnormal test procedure result(s)|1
1215590|NCT00821093|3989950|P2|Overall Study|Death|1
1215591|NCT00821093|3989951|P1|Overall Study|Death|2
1215592|NCT00821093|3989950|P2|Overall Study|Lack of Efficacy|2
1215593|NCT00821093|3989951|P1|Overall Study|Lack of Efficacy|2
1215594|NCT00821093|3989950|P2|Overall Study|Abnormal laboratory value(s)|0
1215595|NCT00821093|3989951|P1|Overall Study|Abnormal laboratory value(s)|2
1215596|NCT00821093|3989950|P2|Overall Study|Protocol deviation|6
1215597|NCT00821093|3989951|P1|Overall Study|Protocol deviation|3
1215598|NCT00821093|3989950|P2|Overall Study|Lost to Follow-up|3
1215599|NCT00821093|3989951|P1|Overall Study|Lost to Follow-up|9
1215600|NCT00821093|3989950|P2|Overall Study|Withdrawal by Subject|13
1215601|NCT00821093|3989951|P1|Overall Study|Withdrawal by Subject|9
1215602|NCT00821093|3989950|P2|Overall Study|Adverse Event|12
1215603|NCT00821093|3989951|P1|Overall Study|Adverse Event|20
1215604|NCT00820898|3989970|P1|Overall Study|Inelgible - wrong primary site|1
1215605|NCT00820755|3989984|P3|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
1215606|NCT00820755|3989985|P2|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
1215607|NCT00820755|3989986|P1|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0
1215608|NCT00820755|3989984|P3|Period 1: Combination Therapy Phase|Other|0
1215609|NCT00820755|3989985|P2|Period 1: Combination Therapy Phase|Other|0
1215610|NCT00820755|3989986|P1|Period 1: Combination Therapy Phase|Other|11
1215611|NCT00820755|3989984|P3|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
1215612|NCT00820755|3989985|P2|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
1215613|NCT00820755|3989986|P1|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14
1215614|NCT00820755|3989984|P3|Period 1: Combination Therapy Phase|Progressive disease|0
1215615|NCT00820755|3989985|P2|Period 1: Combination Therapy Phase|Progressive disease|0
1215616|NCT00820755|3989986|P1|Period 1: Combination Therapy Phase|Progressive disease|114
1215617|NCT00820755|3989984|P3|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
1215618|NCT00820755|3989985|P2|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
1215619|NCT00820755|3989986|P1|Period 1: Combination Therapy Phase|Withdrawal by Subject|21
1215620|NCT00820755|3989984|P3|Period 1: Combination Therapy Phase|Lost to Follow-up|0
1215621|NCT00820755|3989985|P2|Period 1: Combination Therapy Phase|Lost to Follow-up|0
1215622|NCT00820755|3989986|P1|Period 1: Combination Therapy Phase|Lost to Follow-up|1
1215623|NCT00820755|3989984|P3|Period 1: Combination Therapy Phase|Protocol Violation|0
1215624|NCT00820755|3989985|P2|Period 1: Combination Therapy Phase|Protocol Violation|0
1215625|NCT00820755|3989986|P1|Period 1: Combination Therapy Phase|Protocol Violation|4
1215626|NCT00820755|3989984|P3|Period 1: Combination Therapy Phase|Death|0
1215627|NCT00820755|3989985|P2|Period 1: Combination Therapy Phase|Death|0
1215628|NCT00820755|3989986|P1|Period 1: Combination Therapy Phase|Death|28
1215629|NCT00820755|3989984|P3|Period 1: Combination Therapy Phase|Adverse Event|0
1215630|NCT00820755|3989985|P2|Period 1: Combination Therapy Phase|Adverse Event|0
1215631|NCT00820755|3989986|P1|Period 1: Combination Therapy Phase|Adverse Event|77
1215632|NCT00820248|3990079|P2|Overall Study|No treated|1
1215633|NCT00820248|3990080|P1|Overall Study|No treated|4
1215634|NCT00820222|3990090|P2|Overall Study|Ongoing|191
1215635|NCT00820222|3990091|P1|Overall Study|Ongoing|185
1215636|NCT00820222|3990090|P2|Overall Study|Sponsor Terminated Study|1
1215637|NCT00820222|3990091|P1|Overall Study|Sponsor Terminated Study|0
1215638|NCT00820222|3990090|P2|Overall Study|Physician Decision|6
1215639|NCT00820222|3990091|P1|Overall Study|Physician Decision|4
1215640|NCT00820222|3990090|P2|Overall Study|Withdrawal by Subject|9
1215641|NCT00820222|3990091|P1|Overall Study|Withdrawal by Subject|8
1215642|NCT00820222|3990090|P2|Overall Study|Lost to Follow-up|4
1215643|NCT00820222|3990091|P1|Overall Study|Lost to Follow-up|4
1215644|NCT00819910|3990121|P4|Overall Study|Lost to Follow-up|0
1215645|NCT00819910|3990122|P3|Overall Study|Lost to Follow-up|0
1215646|NCT00819910|3990123|P2|Overall Study|Lost to Follow-up|0
1215647|NCT00819910|3990124|P1|Overall Study|Lost to Follow-up|1
1215648|NCT00819910|3990121|P4|Overall Study|Withdrawal by Subject|0
1215649|NCT00819910|3990122|P3|Overall Study|Withdrawal by Subject|1
1215650|NCT00819910|3990123|P2|Overall Study|Withdrawal by Subject|1
1215651|NCT00819910|3990124|P1|Overall Study|Withdrawal by Subject|1
1215652|NCT00819910|3990121|P4|Overall Study|Adverse Event|1
1215653|NCT00819910|3990122|P3|Overall Study|Adverse Event|2
1215654|NCT00819910|3990123|P2|Overall Study|Adverse Event|0
1215655|NCT00819910|3990124|P1|Overall Study|Adverse Event|0
1215656|NCT00819832|3990156|P6|Overall Study|Sponsor Termination of Study|0
1215657|NCT00819832|3990157|P5|Overall Study|Sponsor Termination of Study|0
1215658|NCT00819832|3990158|P4|Overall Study|Sponsor Termination of Study|0
1215659|NCT00819832|3990159|P3|Overall Study|Sponsor Termination of Study|0
1215660|NCT00819832|3990160|P2|Overall Study|Sponsor Termination of Study|0
1215661|NCT00819832|3990161|P1|Overall Study|Sponsor Termination of Study|3
1215662|NCT00819780|3990177|P2|Overall Study|Still in treatment|17
1215663|NCT00819780|3990178|P1|Overall Study|Still in treatment|25
1215664|NCT00819780|3990177|P2|Overall Study|Did not receive study drug|4
1215665|NCT00819780|3990178|P1|Overall Study|Did not receive study drug|3
1215666|NCT00819767|3990212|P2|Overall Study|Unsatisfactory therapeutic effect|2
1215667|NCT00819767|3990213|P1|Overall Study|Unsatisfactory therapeutic effect|1
1215668|NCT00819741|3990225|P2|Overall Study|Reasons unknown|3
1215669|NCT00819741|3990226|P1|Overall Study|Reasons unknown|3
1215670|NCT00819741|3990225|P2|Overall Study|Unclassified|0
1215671|NCT00819741|3990226|P1|Overall Study|Unclassified|6
1215672|NCT00819741|3990225|P2|Overall Study|Withdrawal by Subject|2
1215673|NCT00819741|3990226|P1|Overall Study|Withdrawal by Subject|2
1215674|NCT00819741|3990225|P2|Overall Study|Protocol Violation|4
1215675|NCT00819741|3990226|P1|Overall Study|Protocol Violation|3
1215676|NCT00819741|3990225|P2|Overall Study|Lost to Follow-up|1
1215677|NCT00819741|3990226|P1|Overall Study|Lost to Follow-up|3
1215678|NCT00819741|3990225|P2|Overall Study|Lack of Efficacy|2
1215679|NCT00819741|3990226|P1|Overall Study|Lack of Efficacy|0
1215680|NCT00819741|3990225|P2|Overall Study|Adverse Event|2
1215681|NCT00819741|3990226|P1|Overall Study|Adverse Event|5
1215682|NCT00819585|3990280|P11|Extension Study|Death|0
1215683|NCT00819585|3990281|P10|Extension Study|Death|0
1215684|NCT00819585|3990282|P9|Extension Study|Death|2
1215685|NCT00819585|3990283|P8|Extension Study|Death|0
1215686|NCT00819585|3990284|P7|Extension Study|Death|0
1215687|NCT00819585|3990285|P6|Extension Study|Death|0
1215688|NCT00819585|3990286|P5|Extension Study|Death|0
1215689|NCT00819585|3990287|P4|Extension Study|Death|0
1215690|NCT00819585|3990288|P3|Extension Study|Death|0
1215691|NCT00819585|3990289|P2|Extension Study|Death|0
1215692|NCT00819585|3990290|P1|Extension Study|Death|0
1215693|NCT00819585|3990280|P11|Extension Study|Lost to Follow-up|1
1215694|NCT00819585|3990281|P10|Extension Study|Lost to Follow-up|1
1215695|NCT00819585|3990282|P9|Extension Study|Lost to Follow-up|2
1215696|NCT00819585|3990283|P8|Extension Study|Lost to Follow-up|0
1215697|NCT00819585|3990284|P7|Extension Study|Lost to Follow-up|0
1215698|NCT00819585|3990285|P6|Extension Study|Lost to Follow-up|0
1215699|NCT00819585|3990286|P5|Extension Study|Lost to Follow-up|0
1215700|NCT00819585|3990287|P4|Extension Study|Lost to Follow-up|0
1215701|NCT00819585|3990288|P3|Extension Study|Lost to Follow-up|0
1215702|NCT00819585|3990289|P2|Extension Study|Lost to Follow-up|0
1215703|NCT00819585|3990290|P1|Extension Study|Lost to Follow-up|0
1215704|NCT00819585|3990280|P11|Extension Study|Subject Withdrew Consent|1
1215705|NCT00819585|3990281|P10|Extension Study|Subject Withdrew Consent|0
1215706|NCT00819585|3990282|P9|Extension Study|Subject Withdrew Consent|3
1215707|NCT00819585|3990283|P8|Extension Study|Subject Withdrew Consent|0
1215708|NCT00819585|3990284|P7|Extension Study|Subject Withdrew Consent|0
1215709|NCT00819585|3990285|P6|Extension Study|Subject Withdrew Consent|0
1215710|NCT00819585|3990286|P5|Extension Study|Subject Withdrew Consent|0
1215711|NCT00819585|3990287|P4|Extension Study|Subject Withdrew Consent|0
1215712|NCT00819585|3990288|P3|Extension Study|Subject Withdrew Consent|0
1215713|NCT00819585|3990289|P2|Extension Study|Subject Withdrew Consent|0
1215714|NCT00819585|3990290|P1|Extension Study|Subject Withdrew Consent|0
1215715|NCT00819585|3990280|P11|Extension Study|Abnormal Laboratory Value(s)|0
1215716|NCT00819585|3990281|P10|Extension Study|Abnormal Laboratory Value(s)|0
1215717|NCT00819585|3990282|P9|Extension Study|Abnormal Laboratory Value(s)|1
1215718|NCT00819585|3990283|P8|Extension Study|Abnormal Laboratory Value(s)|0
1215719|NCT00819585|3990284|P7|Extension Study|Abnormal Laboratory Value(s)|0
1215720|NCT00819585|3990285|P6|Extension Study|Abnormal Laboratory Value(s)|0
1215721|NCT00819585|3990286|P5|Extension Study|Abnormal Laboratory Value(s)|0
1215722|NCT00819585|3990287|P4|Extension Study|Abnormal Laboratory Value(s)|0
1215723|NCT00819585|3990288|P3|Extension Study|Abnormal Laboratory Value(s)|0
1215724|NCT00819585|3990289|P2|Extension Study|Abnormal Laboratory Value(s)|0
1215725|NCT00819585|3990290|P1|Extension Study|Abnormal Laboratory Value(s)|0
1215726|NCT00819585|3990280|P11|Core Study|Protocol Violation|0
1215727|NCT00819585|3990281|P10|Core Study|Protocol Violation|0
1215728|NCT00819585|3990282|P9|Core Study|Protocol Violation|0
1215729|NCT00819585|3990283|P8|Core Study|Protocol Violation|0
1215730|NCT00819585|3990284|P7|Core Study|Protocol Violation|3
1215731|NCT00819585|3990285|P6|Core Study|Protocol Violation|1
1215732|NCT00819585|3990286|P5|Core Study|Protocol Violation|0
1215733|NCT00819585|3990287|P4|Core Study|Protocol Violation|0
1215734|NCT00819585|3990288|P3|Core Study|Protocol Violation|1
1215735|NCT00819585|3990289|P2|Core Study|Protocol Violation|0
1215736|NCT00819585|3990290|P1|Core Study|Protocol Violation|0
1215737|NCT00819585|3990280|P11|Core Study|Death|0
1215738|NCT00819585|3990281|P10|Core Study|Death|0
1215739|NCT00819585|3990282|P9|Core Study|Death|0
1215740|NCT00819585|3990283|P8|Core Study|Death|0
1215741|NCT00819585|3990284|P7|Core Study|Death|1
1215742|NCT00819585|3990285|P6|Core Study|Death|0
1215743|NCT00819585|3990286|P5|Core Study|Death|0
1215744|NCT00819585|3990287|P4|Core Study|Death|0
1215745|NCT00819585|3990288|P3|Core Study|Death|0
1215746|NCT00819585|3990289|P2|Core Study|Death|0
1215747|NCT00819585|3990290|P1|Core Study|Death|0
1215748|NCT00819585|3990280|P11|Core Study|Administrative Problems|0
1215749|NCT00819585|3990281|P10|Core Study|Administrative Problems|0
1215750|NCT00819585|3990282|P9|Core Study|Administrative Problems|0
1215751|NCT00819585|3990283|P8|Core Study|Administrative Problems|0
1215752|NCT00819585|3990284|P7|Core Study|Administrative Problems|2
1215753|NCT00819585|3990285|P6|Core Study|Administrative Problems|0
1215754|NCT00819585|3990286|P5|Core Study|Administrative Problems|0
1215755|NCT00819585|3990287|P4|Core Study|Administrative Problems|0
1215756|NCT00819585|3990288|P3|Core Study|Administrative Problems|0
1215757|NCT00819585|3990289|P2|Core Study|Administrative Problems|0
1215758|NCT00819585|3990290|P1|Core Study|Administrative Problems|0
1215759|NCT00819585|3990280|P11|Core Study|Lost to Follow-up|0
1215760|NCT00819585|3990281|P10|Core Study|Lost to Follow-up|0
1215761|NCT00819585|3990282|P9|Core Study|Lost to Follow-up|0
1215762|NCT00819585|3990283|P8|Core Study|Lost to Follow-up|0
1215763|NCT00819585|3990284|P7|Core Study|Lost to Follow-up|1
1215764|NCT00819585|3990285|P6|Core Study|Lost to Follow-up|1
1215765|NCT00819585|3990286|P5|Core Study|Lost to Follow-up|1
1215766|NCT00819585|3990287|P4|Core Study|Lost to Follow-up|0
1215767|NCT00819585|3990288|P3|Core Study|Lost to Follow-up|2
1215768|NCT00819585|3990289|P2|Core Study|Lost to Follow-up|1
1215769|NCT00819585|3990290|P1|Core Study|Lost to Follow-up|2
1215770|NCT00819585|3990280|P11|Core Study|Subject Withdrew Consent|0
1215771|NCT00819585|3990281|P10|Core Study|Subject Withdrew Consent|0
1215772|NCT00819585|3990282|P9|Core Study|Subject Withdrew Consent|0
1215773|NCT00819585|3990283|P8|Core Study|Subject Withdrew Consent|0
1215774|NCT00819585|3990284|P7|Core Study|Subject Withdrew Consent|3
1215775|NCT00819585|3990285|P6|Core Study|Subject Withdrew Consent|0
1215776|NCT00819585|3990286|P5|Core Study|Subject Withdrew Consent|0
1215777|NCT00819585|3990287|P4|Core Study|Subject Withdrew Consent|1
1215778|NCT00819585|3990288|P3|Core Study|Subject Withdrew Consent|2
1215779|NCT00819585|3990289|P2|Core Study|Subject Withdrew Consent|3
1215780|NCT00819585|3990290|P1|Core Study|Subject Withdrew Consent|0
1215781|NCT00819585|3990280|P11|Core Study|Subject No Longer Requires Study Drug|0
1215782|NCT00819585|3990281|P10|Core Study|Subject No Longer Requires Study Drug|0
1215783|NCT00819585|3990282|P9|Core Study|Subject No Longer Requires Study Drug|0
1215784|NCT00819585|3990283|P8|Core Study|Subject No Longer Requires Study Drug|0
1215785|NCT00819585|3990284|P7|Core Study|Subject No Longer Requires Study Drug|0
1215786|NCT00819585|3990285|P6|Core Study|Subject No Longer Requires Study Drug|0
1215787|NCT00819585|3990286|P5|Core Study|Subject No Longer Requires Study Drug|1
1215788|NCT00819585|3990287|P4|Core Study|Subject No Longer Requires Study Drug|0
1215789|NCT00819585|3990288|P3|Core Study|Subject No Longer Requires Study Drug|0
1215790|NCT00819585|3990289|P2|Core Study|Subject No Longer Requires Study Drug|0
1215791|NCT00819585|3990290|P1|Core Study|Subject No Longer Requires Study Drug|0
1215792|NCT00819585|3990280|P11|Core Study|Unsatisfactory Therapeutic Effect|0
1215793|NCT00819585|3990281|P10|Core Study|Unsatisfactory Therapeutic Effect|0
1215794|NCT00819585|3990282|P9|Core Study|Unsatisfactory Therapeutic Effect|0
1215795|NCT00819585|3990283|P8|Core Study|Unsatisfactory Therapeutic Effect|0
1215796|NCT00819585|3990284|P7|Core Study|Unsatisfactory Therapeutic Effect|1
1215797|NCT00819585|3990285|P6|Core Study|Unsatisfactory Therapeutic Effect|0
1215798|NCT00819585|3990286|P5|Core Study|Unsatisfactory Therapeutic Effect|0
1215799|NCT00819585|3990287|P4|Core Study|Unsatisfactory Therapeutic Effect|0
1215800|NCT00819585|3990288|P3|Core Study|Unsatisfactory Therapeutic Effect|0
1215801|NCT00819585|3990289|P2|Core Study|Unsatisfactory Therapeutic Effect|1
1215802|NCT00819585|3990290|P1|Core Study|Unsatisfactory Therapeutic Effect|0
1215803|NCT00819585|3990280|P11|Core Study|Abnormal Laboratory Value(s)|0
1215804|NCT00819585|3990281|P10|Core Study|Abnormal Laboratory Value(s)|0
1215805|NCT00819585|3990282|P9|Core Study|Abnormal Laboratory Value(s)|0
1215806|NCT00819585|3990283|P8|Core Study|Abnormal Laboratory Value(s)|0
1215807|NCT00819585|3990284|P7|Core Study|Abnormal Laboratory Value(s)|0
1215808|NCT00819585|3990285|P6|Core Study|Abnormal Laboratory Value(s)|0
1215809|NCT00819585|3990286|P5|Core Study|Abnormal Laboratory Value(s)|0
1215810|NCT00819585|3990287|P4|Core Study|Abnormal Laboratory Value(s)|0
1215811|NCT00819585|3990288|P3|Core Study|Abnormal Laboratory Value(s)|0
1215812|NCT00819585|3990289|P2|Core Study|Abnormal Laboratory Value(s)|0
1215813|NCT00819585|3990290|P1|Core Study|Abnormal Laboratory Value(s)|2
1215814|NCT00819585|3990280|P11|Core Study|Adverse Event|0
1215815|NCT00819585|3990281|P10|Core Study|Adverse Event|0
1215816|NCT00819585|3990282|P9|Core Study|Adverse Event|0
1215817|NCT00819585|3990283|P8|Core Study|Adverse Event|0
1215818|NCT00819585|3990284|P7|Core Study|Adverse Event|2
1215819|NCT00819585|3990285|P6|Core Study|Adverse Event|0
1215820|NCT00819585|3990286|P5|Core Study|Adverse Event|1
1215821|NCT00819585|3990287|P4|Core Study|Adverse Event|4
1215822|NCT00819585|3990288|P3|Core Study|Adverse Event|1
1215823|NCT00819585|3990289|P2|Core Study|Adverse Event|1
1215824|NCT00819585|3990290|P1|Core Study|Adverse Event|2
1215825|NCT00819390|3990381|P4|Overall Study|Adverse Event|0
1215826|NCT00819390|3990382|P3|Overall Study|Adverse Event|1
1215827|NCT00819390|3990383|P2|Overall Study|Adverse Event|0
1215828|NCT00819390|3990384|P1|Overall Study|Adverse Event|0
1215829|NCT00819390|3990381|P4|Overall Study|Withdrawal by Subject|0
1215830|NCT00819390|3990382|P3|Overall Study|Withdrawal by Subject|0
1215831|NCT00819390|3990383|P2|Overall Study|Withdrawal by Subject|0
1215832|NCT00819390|3990384|P1|Overall Study|Withdrawal by Subject|2
1215833|NCT00819390|3990381|P4|Overall Study|Lost to Follow-up|0
1215834|NCT00819390|3990382|P3|Overall Study|Lost to Follow-up|0
1215835|NCT00819390|3990383|P2|Overall Study|Lost to Follow-up|1
1215836|NCT00819390|3990384|P1|Overall Study|Lost to Follow-up|1
1215837|NCT00819247|3990520|P3|Overall Study|not specified|0
1215838|NCT00819247|3990521|P2|Overall Study|not specified|0
1215839|NCT00819247|3990522|P1|Overall Study|not specified|1
1215840|NCT00819247|3990520|P3|Overall Study|Bad prostate-specific antigen response|0
1215841|NCT00819247|3990521|P2|Overall Study|Bad prostate-specific antigen response|2
1215842|NCT00819247|3990522|P1|Overall Study|Bad prostate-specific antigen response|3
1215843|NCT00819247|3990520|P3|Overall Study|Mistakenly withdrawn|0
1215844|NCT00819247|3990521|P2|Overall Study|Mistakenly withdrawn|1
1215845|NCT00819247|3990522|P1|Overall Study|Mistakenly withdrawn|0
1215846|NCT00819247|3990520|P3|Overall Study|Protocol Violation|1
1215847|NCT00819247|3990521|P2|Overall Study|Protocol Violation|0
1215848|NCT00819247|3990522|P1|Overall Study|Protocol Violation|1
1215849|NCT00819247|3990520|P3|Overall Study|Withdrawal by Subject|0
1215850|NCT00819247|3990521|P2|Overall Study|Withdrawal by Subject|0
1215851|NCT00819247|3990522|P1|Overall Study|Withdrawal by Subject|1
1215852|NCT00819247|3990520|P3|Overall Study|Insufficient testosterone response|10
1215853|NCT00819247|3990521|P2|Overall Study|Insufficient testosterone response|8
1215854|NCT00819247|3990522|P1|Overall Study|Insufficient testosterone response|5
1215855|NCT00819247|3990520|P3|Overall Study|Adverse Event|3
1215856|NCT00819247|3990521|P2|Overall Study|Adverse Event|5
1215857|NCT00819247|3990522|P1|Overall Study|Adverse Event|0
1215858|NCT00819234|3990548|P10|Overall Study|Lost to Follow-up|2
1215859|NCT00819234|3990549|P9|Overall Study|Lost to Follow-up|1
1215860|NCT00819234|3990550|P8|Overall Study|Lost to Follow-up|1
1215861|NCT00819234|3990551|P7|Overall Study|Lost to Follow-up|1
1215862|NCT00819234|3990552|P6|Overall Study|Lost to Follow-up|1
1215863|NCT00819234|3990553|P5|Overall Study|Lost to Follow-up|1
1215864|NCT00819234|3990554|P4|Overall Study|Lost to Follow-up|2
1215865|NCT00819234|3990555|P3|Overall Study|Lost to Follow-up|0
1215866|NCT00819234|3990556|P2|Overall Study|Lost to Follow-up|2
1215867|NCT00819234|3990557|P1|Overall Study|Lost to Follow-up|2
1215868|NCT00819234|3990548|P10|Overall Study|Protocol Violation|0
1215869|NCT00819234|3990549|P9|Overall Study|Protocol Violation|0
1215870|NCT00819234|3990550|P8|Overall Study|Protocol Violation|0
1215871|NCT00819234|3990551|P7|Overall Study|Protocol Violation|0
1215872|NCT00819234|3990552|P6|Overall Study|Protocol Violation|0
1215873|NCT00819234|3990553|P5|Overall Study|Protocol Violation|0
1215874|NCT00819234|3990554|P4|Overall Study|Protocol Violation|0
1215875|NCT00819234|3990555|P3|Overall Study|Protocol Violation|1
1215876|NCT00819234|3990556|P2|Overall Study|Protocol Violation|0
1215877|NCT00819234|3990557|P1|Overall Study|Protocol Violation|0
1215878|NCT00819234|3990548|P10|Overall Study|Physician Decision|2
1215879|NCT00819234|3990549|P9|Overall Study|Physician Decision|0
1215880|NCT00819234|3990550|P8|Overall Study|Physician Decision|0
1215881|NCT00819234|3990551|P7|Overall Study|Physician Decision|0
1215882|NCT00819234|3990552|P6|Overall Study|Physician Decision|0
1215883|NCT00819234|3990553|P5|Overall Study|Physician Decision|0
1215884|NCT00819234|3990554|P4|Overall Study|Physician Decision|1
1215885|NCT00819234|3990555|P3|Overall Study|Physician Decision|0
1215886|NCT00819234|3990556|P2|Overall Study|Physician Decision|0
1215887|NCT00819234|3990557|P1|Overall Study|Physician Decision|0
1215888|NCT00819234|3990548|P10|Overall Study|Adverse Event|0
1215889|NCT00819234|3990549|P9|Overall Study|Adverse Event|0
1215890|NCT00819234|3990550|P8|Overall Study|Adverse Event|0
1215891|NCT00819234|3990551|P7|Overall Study|Adverse Event|0
1215892|NCT00819234|3990552|P6|Overall Study|Adverse Event|2
1215893|NCT00819234|3990553|P5|Overall Study|Adverse Event|0
1215894|NCT00819234|3990554|P4|Overall Study|Adverse Event|0
1215895|NCT00819234|3990555|P3|Overall Study|Adverse Event|1
1215896|NCT00819234|3990556|P2|Overall Study|Adverse Event|0
1215897|NCT00819234|3990557|P1|Overall Study|Adverse Event|0
1215898|NCT00819234|3990548|P10|Overall Study|Withdrawal by Subject|3
1215899|NCT00819234|3990549|P9|Overall Study|Withdrawal by Subject|5
1215900|NCT00819234|3990550|P8|Overall Study|Withdrawal by Subject|8
1215901|NCT00819234|3990551|P7|Overall Study|Withdrawal by Subject|4
1215902|NCT00819234|3990552|P6|Overall Study|Withdrawal by Subject|4
1215903|NCT00819234|3990553|P5|Overall Study|Withdrawal by Subject|0
1215904|NCT00819234|3990554|P4|Overall Study|Withdrawal by Subject|3
1215905|NCT00819234|3990555|P3|Overall Study|Withdrawal by Subject|6
1215906|NCT00819234|3990556|P2|Overall Study|Withdrawal by Subject|13
1215907|NCT00819234|3990557|P1|Overall Study|Withdrawal by Subject|8
1215908|NCT00819156|3990756|P6|Overall Study|Prostate-specific antigen progression|0
1215909|NCT00819156|3990757|P5|Overall Study|Prostate-specific antigen progression|1
1215910|NCT00819156|3990758|P4|Overall Study|Prostate-specific antigen progression|0
1215911|NCT00819156|3990759|P3|Overall Study|Prostate-specific antigen progression|0
1215912|NCT00819156|3990760|P2|Overall Study|Prostate-specific antigen progression|0
1215913|NCT00819156|3990761|P1|Overall Study|Prostate-specific antigen progression|0
1215914|NCT00819156|3990756|P6|Overall Study|Testosterone >=.5ng/ml 2 visits|0
1215915|NCT00819156|3990757|P5|Overall Study|Testosterone >=.5ng/ml 2 visits|1
1215916|NCT00819156|3990758|P4|Overall Study|Testosterone >=.5ng/ml 2 visits|0
1215917|NCT00819156|3990759|P3|Overall Study|Testosterone >=.5ng/ml 2 visits|0
1215918|NCT00819156|3990760|P2|Overall Study|Testosterone >=.5ng/ml 2 visits|0
1215919|NCT00819156|3990761|P1|Overall Study|Testosterone >=.5ng/ml 2 visits|3
1215920|NCT00819156|3990756|P6|Overall Study|Testosterone >1ng/ml from Day 28+|2
1215921|NCT00819156|3990757|P5|Overall Study|Testosterone >1ng/ml from Day 28+|1
1215922|NCT00819156|3990758|P4|Overall Study|Testosterone >1ng/ml from Day 28+|1
1215923|NCT00819156|3990759|P3|Overall Study|Testosterone >1ng/ml from Day 28+|1
1215924|NCT00819156|3990760|P2|Overall Study|Testosterone >1ng/ml from Day 28+|2
1215925|NCT00819156|3990761|P1|Overall Study|Testosterone >1ng/ml from Day 28+|5
1215926|NCT00819156|3990756|P6|Overall Study|Lost to Follow-up|2
1215927|NCT00819156|3990757|P5|Overall Study|Lost to Follow-up|0
1215928|NCT00819156|3990758|P4|Overall Study|Lost to Follow-up|0
1215929|NCT00819156|3990759|P3|Overall Study|Lost to Follow-up|0
1215930|NCT00819156|3990760|P2|Overall Study|Lost to Follow-up|1
1215931|NCT00819156|3990761|P1|Overall Study|Lost to Follow-up|0
1215932|NCT00819156|3990756|P6|Overall Study|Protocol Violation|1
1215933|NCT00819156|3990757|P5|Overall Study|Protocol Violation|0
1215934|NCT00819156|3990758|P4|Overall Study|Protocol Violation|0
1215935|NCT00819156|3990759|P3|Overall Study|Protocol Violation|1
1215936|NCT00819156|3990760|P2|Overall Study|Protocol Violation|0
1215937|NCT00819156|3990761|P1|Overall Study|Protocol Violation|1
1215938|NCT00819156|3990756|P6|Overall Study|Withdrawal by Subject|0
1215939|NCT00819156|3990757|P5|Overall Study|Withdrawal by Subject|1
1215940|NCT00819156|3990758|P4|Overall Study|Withdrawal by Subject|0
1215941|NCT00819156|3990759|P3|Overall Study|Withdrawal by Subject|2
1215942|NCT00819156|3990760|P2|Overall Study|Withdrawal by Subject|3
1215943|NCT00819156|3990761|P1|Overall Study|Withdrawal by Subject|0
1215944|NCT00819156|3990756|P6|Overall Study|Adverse Event|3
1215945|NCT00819156|3990757|P5|Overall Study|Adverse Event|2
1215946|NCT00819156|3990758|P4|Overall Study|Adverse Event|1
1215947|NCT00819156|3990759|P3|Overall Study|Adverse Event|2
1215948|NCT00819156|3990760|P2|Overall Study|Adverse Event|4
1215949|NCT00819156|3990761|P1|Overall Study|Adverse Event|1
1215950|NCT00819091|3990851|P2|Overall Study|Not Specified|2
1215951|NCT00819091|3990852|P1|Overall Study|Not Specified|1
1215952|NCT00819091|3990851|P2|Overall Study|Withdrawal by Subject|2
1215953|NCT00819091|3990852|P1|Overall Study|Withdrawal by Subject|1
1215954|NCT00819091|3990851|P2|Overall Study|Lost to Follow-up|0
1215955|NCT00819091|3990852|P1|Overall Study|Lost to Follow-up|2
1215956|NCT00819091|3990851|P2|Overall Study|Protocol Violation|1
1215957|NCT00819091|3990852|P1|Overall Study|Protocol Violation|0
1215958|NCT00819091|3990851|P2|Overall Study|Adverse Event|5
1215959|NCT00819091|3990852|P1|Overall Study|Adverse Event|3
1215960|NCT00819052|3990878|P2|Overall Study|Death or events leading to death|0
1215961|NCT00819052|3990879|P1|Overall Study|Death or events leading to death|1
1215962|NCT00819052|3990878|P2|Overall Study|Pregnancy|2
1215963|NCT00819052|3990879|P1|Overall Study|Pregnancy|1
1215964|NCT00819052|3990878|P2|Overall Study|Lack of Efficacy|1
1215965|NCT00819052|3990879|P1|Overall Study|Lack of Efficacy|1
1215966|NCT00819052|3990878|P2|Overall Study|Withdrawal by Subject|2
1215967|NCT00819052|3990879|P1|Overall Study|Withdrawal by Subject|1
1215968|NCT00819052|3990878|P2|Overall Study|Lost to Follow-up|2
1215969|NCT00819052|3990879|P1|Overall Study|Lost to Follow-up|1
1215970|NCT00819052|3990878|P2|Overall Study|Protocol Violation|2
1215971|NCT00819052|3990879|P1|Overall Study|Protocol Violation|1
1215972|NCT00819052|3990878|P2|Overall Study|Adverse Event|5
1215973|NCT00819052|3990879|P1|Overall Study|Adverse Event|0
1215974|NCT00819039|3990994|P3|Overall Study|Protocol Violation|0
1215975|NCT00819039|3990995|P2|Overall Study|Protocol Violation|0
1215976|NCT00819039|3990996|P1|Overall Study|Protocol Violation|1
1215977|NCT00819039|3990994|P3|Overall Study|Physician Decision|1
1215978|NCT00819039|3990995|P2|Overall Study|Physician Decision|0
1215979|NCT00819039|3990996|P1|Overall Study|Physician Decision|1
1215980|NCT00819013|3991026|P4|Overall Study|Death|1
1215981|NCT00819013|3991027|P3|Overall Study|Death|0
1215982|NCT00819013|3991028|P2|Overall Study|Death|0
1215983|NCT00819013|3991029|P1|Overall Study|Death|0
1215984|NCT00819013|3991026|P4|Overall Study|Lost to Follow-up|2
1215985|NCT00819013|3991027|P3|Overall Study|Lost to Follow-up|1
1215986|NCT00819013|3991028|P2|Overall Study|Lost to Follow-up|0
1215987|NCT00819013|3991029|P1|Overall Study|Lost to Follow-up|0
1215988|NCT00819013|3991026|P4|Overall Study|Withdrawal by Subject|0
1215989|NCT00819013|3991027|P3|Overall Study|Withdrawal by Subject|1
1215990|NCT00819013|3991028|P2|Overall Study|Withdrawal by Subject|0
1215991|NCT00819013|3991029|P1|Overall Study|Withdrawal by Subject|1
1215992|NCT00819013|3991026|P4|Overall Study|Adverse Event|0
1215993|NCT00819013|3991027|P3|Overall Study|Adverse Event|1
1215994|NCT00819013|3991028|P2|Overall Study|Adverse Event|0
1215995|NCT00819013|3991029|P1|Overall Study|Adverse Event|0
1215996|NCT00819013|3991026|P4|Overall Study|Not meeting continuing study eligibility|1
1215997|NCT00819013|3991027|P3|Overall Study|Not meeting continuing study eligibility|2
1215998|NCT00819013|3991028|P2|Overall Study|Not meeting continuing study eligibility|1
1215999|NCT00819013|3991029|P1|Overall Study|Not meeting continuing study eligibility|2
1216000|NCT00818883|3991095|P2|Overall Study|Other|7
1216001|NCT00818883|3991096|P1|Overall Study|Other|2
1216002|NCT00818883|3991095|P2|Overall Study|Lack of Efficacy|2
1216003|NCT00818883|3991096|P1|Overall Study|Lack of Efficacy|0
1216004|NCT00818883|3991095|P2|Overall Study|Withdrawal by Subject|14
1216005|NCT00818883|3991096|P1|Overall Study|Withdrawal by Subject|16
1216006|NCT00818883|3991095|P2|Overall Study|Lost to Follow-up|2
1216007|NCT00818883|3991096|P1|Overall Study|Lost to Follow-up|3
1216008|NCT00818883|3991095|P2|Overall Study|Protocol Violation|2
1216009|NCT00818883|3991096|P1|Overall Study|Protocol Violation|2
1216010|NCT00818883|3991095|P2|Overall Study|Adverse Event|19
1216011|NCT00818883|3991096|P1|Overall Study|Adverse Event|28
1216012|NCT00818779|3991143|P2|Overall Study|Adverse Event|1
1216013|NCT00818779|3991144|P1|Overall Study|Adverse Event|4
1216014|NCT00818779|3991143|P2|Overall Study|Lost to Follow-up|0
1216015|NCT00818779|3991144|P1|Overall Study|Lost to Follow-up|1
1216016|NCT00818779|3991143|P2|Overall Study|Protocol Violation|0
1216017|NCT00818779|3991144|P1|Overall Study|Protocol Violation|1
1216018|NCT00818766|3991160|P2|Overall Study|Did not Receive Allocated Intervention|0
1216019|NCT00818766|3991161|P1|Overall Study|Did not Receive Allocated Intervention|3
1216020|NCT00818766|3991160|P2|Overall Study|Death|0
1216021|NCT00818766|3991161|P1|Overall Study|Death|1
1216022|NCT00818766|3991160|P2|Overall Study|Could not be Contacted on Day 28|10
1216023|NCT00818766|3991161|P1|Overall Study|Could not be Contacted on Day 28|11
1216024|NCT00818753|3991190|P3|Overall Study|Randomised and not treated|0
1216025|NCT00818753|3991191|P2|Overall Study|Randomised and not treated|0
1216026|NCT00818753|3991192|P1|Overall Study|Randomised and not treated|2
1216027|NCT00818753|3991190|P3|Overall Study|Other reason (not specified)|1
1216028|NCT00818753|3991191|P2|Overall Study|Other reason (not specified)|0
1216029|NCT00818753|3991192|P1|Overall Study|Other reason (not specified)|0
1216030|NCT00818753|3991190|P3|Overall Study|Protocol Violation|0
1216031|NCT00818753|3991191|P2|Overall Study|Protocol Violation|0
1216032|NCT00818753|3991192|P1|Overall Study|Protocol Violation|1
1216033|NCT00818662|3991216|P4|Overall Study|Admitted to long term nursing care|0
1216034|NCT00818662|3991217|P3|Overall Study|Admitted to long term nursing care|0
1216035|NCT00818662|3991218|P2|Overall Study|Admitted to long term nursing care|1
1216036|NCT00818662|3991219|P1|Overall Study|Admitted to long term nursing care|0
1216037|NCT00818662|3991216|P4|Overall Study|Study partner decision|1
1216038|NCT00818662|3991217|P3|Overall Study|Study partner decision|0
1216039|NCT00818662|3991218|P2|Overall Study|Study partner decision|0
1216040|NCT00818662|3991219|P1|Overall Study|Study partner decision|0
1216041|NCT00818662|3991216|P4|Overall Study|Change in living situation|1
1216042|NCT00818662|3991217|P3|Overall Study|Change in living situation|0
1216043|NCT00818662|3991218|P2|Overall Study|Change in living situation|0
1216044|NCT00818662|3991219|P1|Overall Study|Change in living situation|0
1216045|NCT00818662|3991216|P4|Overall Study|Declined move to another study site|0
1216046|NCT00818662|3991217|P3|Overall Study|Declined move to another study site|0
1216047|NCT00818662|3991218|P2|Overall Study|Declined move to another study site|0
1216048|NCT00818662|3991219|P1|Overall Study|Declined move to another study site|1
1216049|NCT00818662|3991216|P4|Overall Study|Moving out of state|1
1216050|NCT00818662|3991217|P3|Overall Study|Moving out of state|0
1216051|NCT00818662|3991218|P2|Overall Study|Moving out of state|0
1216052|NCT00818662|3991219|P1|Overall Study|Moving out of state|0
1216053|NCT00818662|3991216|P4|Overall Study|Caregiver to pursue other treatment|0
1216054|NCT00818662|3991217|P3|Overall Study|Caregiver to pursue other treatment|0
1216055|NCT00818662|3991218|P2|Overall Study|Caregiver to pursue other treatment|1
1216056|NCT00818662|3991219|P1|Overall Study|Caregiver to pursue other treatment|0
1216057|NCT00818662|3991216|P4|Overall Study|Participant's health declined|1
1216058|NCT00818662|3991217|P3|Overall Study|Participant's health declined|0
1216059|NCT00818662|3991218|P2|Overall Study|Participant's health declined|0
1216060|NCT00818662|3991219|P1|Overall Study|Participant's health declined|0
1216061|NCT00818662|3991216|P4|Overall Study|Study Partner Unwilling or Unable|1
1216062|NCT00818662|3991217|P3|Overall Study|Study Partner Unwilling or Unable|1
1216063|NCT00818662|3991218|P2|Overall Study|Study Partner Unwilling or Unable|2
1216064|NCT00818662|3991219|P1|Overall Study|Study Partner Unwilling or Unable|3
1216065|NCT00818662|3991216|P4|Overall Study|Safety Risk|1
1216066|NCT00818662|3991217|P3|Overall Study|Safety Risk|0
1216067|NCT00818662|3991218|P2|Overall Study|Safety Risk|1
1216068|NCT00818662|3991219|P1|Overall Study|Safety Risk|1
1216069|NCT00818662|3991216|P4|Overall Study|Requires a Prohibited Medication|0
1216070|NCT00818662|3991217|P3|Overall Study|Requires a Prohibited Medication|0
1216071|NCT00818662|3991218|P2|Overall Study|Requires a Prohibited Medication|0
1216072|NCT00818662|3991219|P1|Overall Study|Requires a Prohibited Medication|1
1216073|NCT00818662|3991216|P4|Overall Study|Protocol Violation|0
1216074|NCT00818662|3991217|P3|Overall Study|Protocol Violation|0
1216075|NCT00818662|3991218|P2|Overall Study|Protocol Violation|1
1216076|NCT00818662|3991219|P1|Overall Study|Protocol Violation|1
1216077|NCT00818662|3991216|P4|Overall Study|Unwilling or Unable to Participate|4
1216078|NCT00818662|3991217|P3|Overall Study|Unwilling or Unable to Participate|2
1216079|NCT00818662|3991218|P2|Overall Study|Unwilling or Unable to Participate|6
1216080|NCT00818662|3991219|P1|Overall Study|Unwilling or Unable to Participate|4
1216081|NCT00818662|3991216|P4|Overall Study|Lost to Follow-up|1
1216082|NCT00818662|3991217|P3|Overall Study|Lost to Follow-up|0
1216083|NCT00818662|3991218|P2|Overall Study|Lost to Follow-up|0
1216084|NCT00818662|3991219|P1|Overall Study|Lost to Follow-up|0
1216085|NCT00818662|3991216|P4|Overall Study|Physician Decision|0
1216086|NCT00818662|3991217|P3|Overall Study|Physician Decision|0
1216087|NCT00818662|3991218|P2|Overall Study|Physician Decision|0
1216088|NCT00818662|3991219|P1|Overall Study|Physician Decision|1
1216089|NCT00818662|3991216|P4|Overall Study|Death|0
1216090|NCT00818662|3991217|P3|Overall Study|Death|0
1216091|NCT00818662|3991218|P2|Overall Study|Death|3
1216092|NCT00818662|3991219|P1|Overall Study|Death|1
1216093|NCT00818662|3991216|P4|Overall Study|Withdrawal by Subject|2
1216094|NCT00818662|3991217|P3|Overall Study|Withdrawal by Subject|2
1216095|NCT00818662|3991218|P2|Overall Study|Withdrawal by Subject|4
1216096|NCT00818662|3991219|P1|Overall Study|Withdrawal by Subject|5
1216097|NCT00818662|3991216|P4|Overall Study|Adverse Event|3
1216098|NCT00818662|3991217|P3|Overall Study|Adverse Event|4
1216099|NCT00818662|3991218|P2|Overall Study|Adverse Event|14
1216100|NCT00818662|3991219|P1|Overall Study|Adverse Event|5
1216101|NCT00818649|3991305|P1|Overall Study|Adverse Event|1
1216102|NCT00818649|3991305|P1|Overall Study|Unrelated hip fracture-unable to proceed|1
1216103|NCT00818649|3991305|P1|Overall Study|Declining performance status|2
1216104|NCT00818623|3991319|P8|Overall Study|Disease progression|0
1216105|NCT00818623|3991320|P7|Overall Study|Disease progression|1
1216106|NCT00818623|3991321|P6|Overall Study|Disease progression|0
1216107|NCT00818623|3991322|P5|Overall Study|Disease progression|0
1216108|NCT00818623|3991323|P4|Overall Study|Disease progression|0
1216109|NCT00818623|3991324|P3|Overall Study|Disease progression|0
1216110|NCT00818623|3991325|P2|Overall Study|Disease progression|0
1216111|NCT00818623|3991326|P1|Overall Study|Disease progression|0
1216112|NCT00818623|3991319|P8|Overall Study|Lack of trial drug at site|0
1216113|NCT00818623|3991320|P7|Overall Study|Lack of trial drug at site|1
1216114|NCT00818623|3991321|P6|Overall Study|Lack of trial drug at site|0
1216115|NCT00818623|3991322|P5|Overall Study|Lack of trial drug at site|2
1216116|NCT00818623|3991323|P4|Overall Study|Lack of trial drug at site|0
1216117|NCT00818623|3991324|P3|Overall Study|Lack of trial drug at site|0
1216118|NCT00818623|3991325|P2|Overall Study|Lack of trial drug at site|0
1216119|NCT00818623|3991326|P1|Overall Study|Lack of trial drug at site|0
1216120|NCT00818623|3991319|P8|Overall Study|Need of additional treatment|0
1216121|NCT00818623|3991320|P7|Overall Study|Need of additional treatment|0
1216122|NCT00818623|3991321|P6|Overall Study|Need of additional treatment|0
1216123|NCT00818623|3991322|P5|Overall Study|Need of additional treatment|1
1216124|NCT00818623|3991323|P4|Overall Study|Need of additional treatment|0
1216125|NCT00818623|3991324|P3|Overall Study|Need of additional treatment|0
1216126|NCT00818623|3991325|P2|Overall Study|Need of additional treatment|0
1216127|NCT00818623|3991326|P1|Overall Study|Need of additional treatment|0
1216128|NCT00818623|3991319|P8|Overall Study|Protocol Violation|0
1216129|NCT00818623|3991320|P7|Overall Study|Protocol Violation|1
1216130|NCT00818623|3991321|P6|Overall Study|Protocol Violation|0
1216131|NCT00818623|3991322|P5|Overall Study|Protocol Violation|1
1216132|NCT00818623|3991323|P4|Overall Study|Protocol Violation|0
1216133|NCT00818623|3991324|P3|Overall Study|Protocol Violation|0
1216134|NCT00818623|3991325|P2|Overall Study|Protocol Violation|0
1216135|NCT00818623|3991326|P1|Overall Study|Protocol Violation|1
1216136|NCT00818623|3991319|P8|Overall Study|Withdrawal by Subject|1
1216137|NCT00818623|3991320|P7|Overall Study|Withdrawal by Subject|1
1216138|NCT00818623|3991321|P6|Overall Study|Withdrawal by Subject|1
1216139|NCT00818623|3991322|P5|Overall Study|Withdrawal by Subject|0
1216140|NCT00818623|3991323|P4|Overall Study|Withdrawal by Subject|0
1216141|NCT00818623|3991324|P3|Overall Study|Withdrawal by Subject|1
1216142|NCT00818623|3991325|P2|Overall Study|Withdrawal by Subject|1
1216143|NCT00818623|3991326|P1|Overall Study|Withdrawal by Subject|0
1216144|NCT00818623|3991319|P8|Overall Study|Bad prostate specific antigen response|0
1216145|NCT00818623|3991320|P7|Overall Study|Bad prostate specific antigen response|0
1216146|NCT00818623|3991321|P6|Overall Study|Bad prostate specific antigen response|1
1216147|NCT00818623|3991322|P5|Overall Study|Bad prostate specific antigen response|0
1216148|NCT00818623|3991323|P4|Overall Study|Bad prostate specific antigen response|5
1216149|NCT00818623|3991324|P3|Overall Study|Bad prostate specific antigen response|2
1216150|NCT00818623|3991325|P2|Overall Study|Bad prostate specific antigen response|3
1216151|NCT00818623|3991326|P1|Overall Study|Bad prostate specific antigen response|0
1216152|NCT00818623|3991319|P8|Overall Study|Adverse Event|0
1216153|NCT00818623|3991320|P7|Overall Study|Adverse Event|0
1216154|NCT00818623|3991321|P6|Overall Study|Adverse Event|1
1216155|NCT00818623|3991322|P5|Overall Study|Adverse Event|0
1216156|NCT00818623|3991323|P4|Overall Study|Adverse Event|0
1216157|NCT00818623|3991324|P3|Overall Study|Adverse Event|1
1216158|NCT00818623|3991325|P2|Overall Study|Adverse Event|0
1216159|NCT00818623|3991326|P1|Overall Study|Adverse Event|1
1216160|NCT00818519|3991402|P2|Overall Study|participant will leave for long tme|0
1216161|NCT00818519|3991403|P1|Overall Study|participant will leave for long tme|1
1216162|NCT00818519|3991402|P2|Overall Study|participant recovered completely|0
1216163|NCT00818519|3991403|P1|Overall Study|participant recovered completely|1
1216164|NCT00818519|3991402|P2|Overall Study|Withdrawal by Subject|9
1216165|NCT00818519|3991403|P1|Overall Study|Withdrawal by Subject|4
1216166|NCT00818519|3991402|P2|Overall Study|Pregnancy|1
1216167|NCT00818519|3991403|P1|Overall Study|Pregnancy|0
1216168|NCT00818519|3991402|P2|Overall Study|Protocol Violation|1
1216169|NCT00818519|3991403|P1|Overall Study|Protocol Violation|2
1216170|NCT00818519|3991402|P2|Overall Study|Lost to Follow-up|6
1216171|NCT00818519|3991403|P1|Overall Study|Lost to Follow-up|4
1216172|NCT00818519|3991402|P2|Overall Study|Adverse Event|2
1216173|NCT00818519|3991403|P1|Overall Study|Adverse Event|2
1216174|NCT00818454|3991433|P4|Treatment Period 3|Adverse Event|1
1216175|NCT00818454|3991434|P3|Treatment Period 3|Adverse Event|0
1216176|NCT00818454|3991435|P2|Treatment Period 3|Adverse Event|0
1216177|NCT00818454|3991436|P1|Treatment Period 3|Adverse Event|0
1216178|NCT00818454|3991433|P4|Treatment Period 2|not specified|0
1216179|NCT00818454|3991434|P3|Treatment Period 2|not specified|0
1216180|NCT00818454|3991435|P2|Treatment Period 2|not specified|1
1216181|NCT00818454|3991436|P1|Treatment Period 2|not specified|2
1216182|NCT00818454|3991433|P4|Washout Period of 1 Week|not specified|0
1216183|NCT00818454|3991434|P3|Washout Period of 1 Week|not specified|0
1216184|NCT00818454|3991435|P2|Washout Period of 1 Week|not specified|2
1216185|NCT00818454|3991436|P1|Washout Period of 1 Week|not specified|1
1216186|NCT00818454|3991433|P4|Washout Period of 1 Week|Protocol Violation|0
1216187|NCT00818454|3991434|P3|Washout Period of 1 Week|Protocol Violation|0
1216188|NCT00818454|3991435|P2|Washout Period of 1 Week|Protocol Violation|0
1216189|NCT00818454|3991436|P1|Washout Period of 1 Week|Protocol Violation|2
1216190|NCT00818454|3991433|P4|Washout Period of 1 Week|Adverse Event|0
1216191|NCT00818454|3991434|P3|Washout Period of 1 Week|Adverse Event|0
1216192|NCT00818454|3991435|P2|Washout Period of 1 Week|Adverse Event|1
1216193|NCT00818454|3991436|P1|Washout Period of 1 Week|Adverse Event|1
1216194|NCT00818454|3991433|P4|Treatment Period 1|not specified|0
1216195|NCT00818454|3991434|P3|Treatment Period 1|not specified|0
1216196|NCT00818454|3991435|P2|Treatment Period 1|not specified|0
1216197|NCT00818454|3991436|P1|Treatment Period 1|not specified|3
1216198|NCT00818454|3991433|P4|Treatment Period 1|Adverse Event|0
1216199|NCT00818454|3991434|P3|Treatment Period 1|Adverse Event|0
1216200|NCT00818454|3991435|P2|Treatment Period 1|Adverse Event|1
1216201|NCT00818454|3991436|P1|Treatment Period 1|Adverse Event|0
1216202|NCT00818441|3991464|P2|Overall Study|Study terminated by sponsor|2
1216203|NCT00818441|3991465|P1|Overall Study|Study terminated by sponsor|11
1216204|NCT00818441|3991464|P2|Overall Study|Adverse Event|1
1216205|NCT00818441|3991465|P1|Overall Study|Adverse Event|0
1216206|NCT00818441|3991464|P2|Overall Study|Withdrawal by Subject|0
1216207|NCT00818441|3991465|P1|Overall Study|Withdrawal by Subject|2
1216208|NCT00818441|3991464|P2|Overall Study|Lost to Follow-up|1
1216209|NCT00818441|3991465|P1|Overall Study|Lost to Follow-up|2
1216210|NCT00818441|3991464|P2|Overall Study|Other|0
1216211|NCT00818441|3991465|P1|Overall Study|Other|5
1216212|NCT00818441|3991464|P2|Overall Study|Death|26
1216213|NCT00818441|3991465|P1|Overall Study|Death|69
1216214|NCT00818389|3991487|P2|Overall Study|Adverse Event|1
1216215|NCT00818389|3991488|P1|Overall Study|Adverse Event|0
1216216|NCT00818389|3991487|P2|Overall Study|Withdrawal by Subject|2
1216217|NCT00818389|3991488|P1|Overall Study|Withdrawal by Subject|2
1216218|NCT00818389|3991487|P2|Overall Study|ALS Disease Progression|0
1216219|NCT00818389|3991488|P1|Overall Study|ALS Disease Progression|1
1216220|NCT00818389|3991487|P2|Overall Study|Death|3
1216221|NCT00818389|3991488|P1|Overall Study|Death|1
1216222|NCT00818259|3991523|P9|Part V|Adverse Event|0
1216223|NCT00818259|3991524|P8|Part V|Adverse Event|1
1216224|NCT00818259|3991525|P7|Part V|Adverse Event|0
1216225|NCT00818259|3991526|P6|Part V|Adverse Event|0
1216226|NCT00818259|3991527|P5|Part V|Adverse Event|0
1216227|NCT00818259|3991528|P4|Part V|Adverse Event|0
1216228|NCT00818259|3991529|P3|Part V|Adverse Event|0
1216229|NCT00818259|3991530|P2|Part V|Adverse Event|0
1216230|NCT00818259|3991531|P1|Part V|Adverse Event|0
1216231|NCT00818259|3991523|P9|Part IV|Physician Decision|0
1216232|NCT00818259|3991524|P8|Part IV|Physician Decision|0
1216233|NCT00818259|3991525|P7|Part IV|Physician Decision|0
1216234|NCT00818259|3991526|P6|Part IV|Physician Decision|1
1216235|NCT00818259|3991527|P5|Part IV|Physician Decision|0
1216236|NCT00818259|3991528|P4|Part IV|Physician Decision|0
1216237|NCT00818259|3991529|P3|Part IV|Physician Decision|0
1216238|NCT00818259|3991530|P2|Part IV|Physician Decision|0
1216239|NCT00818259|3991531|P1|Part IV|Physician Decision|0
1216240|NCT00818259|3991523|P9|Part II|Not Treated|0
1216241|NCT00818259|3991524|P8|Part II|Not Treated|0
1216242|NCT00818259|3991525|P7|Part II|Not Treated|0
1216243|NCT00818259|3991526|P6|Part II|Not Treated|0
1216244|NCT00818259|3991527|P5|Part II|Not Treated|0
1216245|NCT00818259|3991528|P4|Part II|Not Treated|1
1216246|NCT00818259|3991529|P3|Part II|Not Treated|0
1216247|NCT00818259|3991530|P2|Part II|Not Treated|0
1216248|NCT00818259|3991531|P1|Part II|Not Treated|0
1216249|NCT00818259|3991523|P9|Part II|Lack of Efficacy|0
1216250|NCT00818259|3991524|P8|Part II|Lack of Efficacy|0
1216251|NCT00818259|3991525|P7|Part II|Lack of Efficacy|0
1216252|NCT00818259|3991526|P6|Part II|Lack of Efficacy|0
1216253|NCT00818259|3991527|P5|Part II|Lack of Efficacy|0
1216254|NCT00818259|3991528|P4|Part II|Lack of Efficacy|1
1216255|NCT00818259|3991529|P3|Part II|Lack of Efficacy|0
1216256|NCT00818259|3991530|P2|Part II|Lack of Efficacy|0
1216257|NCT00818259|3991531|P1|Part II|Lack of Efficacy|0
1216258|NCT00818259|3991523|P9|Part II|Physician Decision|0
1216259|NCT00818259|3991524|P8|Part II|Physician Decision|0
1216260|NCT00818259|3991525|P7|Part II|Physician Decision|0
1216261|NCT00818259|3991526|P6|Part II|Physician Decision|0
1216262|NCT00818259|3991527|P5|Part II|Physician Decision|0
1216263|NCT00818259|3991528|P4|Part II|Physician Decision|0
1216264|NCT00818259|3991529|P3|Part II|Physician Decision|1
1216265|NCT00818259|3991530|P2|Part II|Physician Decision|0
1216266|NCT00818259|3991531|P1|Part II|Physician Decision|0
1216267|NCT00818259|3991523|P9|Part I|Withdrawal by Subject|0
1216268|NCT00818259|3991524|P8|Part I|Withdrawal by Subject|0
1216269|NCT00818259|3991525|P7|Part I|Withdrawal by Subject|0
1216270|NCT00818259|3991526|P6|Part I|Withdrawal by Subject|0
1216271|NCT00818259|3991527|P5|Part I|Withdrawal by Subject|0
1216272|NCT00818259|3991528|P4|Part I|Withdrawal by Subject|0
1216273|NCT00818259|3991529|P3|Part I|Withdrawal by Subject|0
1216274|NCT00818259|3991530|P2|Part I|Withdrawal by Subject|0
1216275|NCT00818259|3991531|P1|Part I|Withdrawal by Subject|1
1216276|NCT00818246|3991603|P1|Overall Study|Impossible to match pictures|5
1216277|NCT00818207|3991612|P2|Overall Study|Death|5
1216278|NCT00818207|3991613|P1|Overall Study|Death|3
1216279|NCT00818207|3991612|P2|Overall Study|Withdrawal by Subject|104
1216280|NCT00818207|3991613|P1|Overall Study|Withdrawal by Subject|42
1216281|NCT00818207|3991612|P2|Overall Study|Multiple reasons|12
1216282|NCT00818207|3991613|P1|Overall Study|Multiple reasons|11
1216283|NCT00818207|3991612|P2|Overall Study|Lost to Follow-up|146
1216284|NCT00818207|3991613|P1|Overall Study|Lost to Follow-up|160
1216285|NCT00818207|3991612|P2|Overall Study|Adverse Event|0
1216286|NCT00818207|3991613|P1|Overall Study|Adverse Event|6
1216287|NCT00818168|3991627|P1|Overall Study|Participant Moved|2
1216288|NCT00818168|3991627|P1|Overall Study|Reason for Non-completion Not reported|6
1216289|NCT00818168|3991627|P1|Overall Study|Adverse Event|19
1216290|NCT00818168|3991627|P1|Overall Study|Lost to Follow-up|7
1216291|NCT00818168|3991627|P1|Overall Study|Withdrawal by Subject|16
1216292|NCT00818168|3991627|P1|Overall Study|Pregnancy|2
1216293|NCT00818168|3991627|P1|Overall Study|Lack of Efficacy|18
1216294|NCT00817778|3991667|P2|Overall Study|Poor venous access|0
1216295|NCT00817778|3991668|P1|Overall Study|Poor venous access|1
1216296|NCT00817778|3991667|P2|Overall Study|Study-specific discontinuation criteria|1
1216297|NCT00817778|3991668|P1|Overall Study|Study-specific discontinuation criteria|0
1216298|NCT00817778|3991667|P2|Overall Study|Protocol Violation|1
1216299|NCT00817778|3991668|P1|Overall Study|Protocol Violation|0
1216300|NCT00817778|3991667|P2|Overall Study|Withdrawal by Subject|1
1216301|NCT00817778|3991668|P1|Overall Study|Withdrawal by Subject|1
1216302|NCT00817778|3991667|P2|Overall Study|Adverse Event|0
1216303|NCT00817778|3991668|P1|Overall Study|Adverse Event|1
1216304|NCT00817531|3991697|P1|Overall Study|Lack of Efficacy|1
1216305|NCT00817531|3991697|P1|Overall Study|Adverse Event|1
1216306|NCT00817479|3991703|P2|Overall Study|Physician Decision|1
1216307|NCT00817479|3991704|P1|Overall Study|Physician Decision|1
1216308|NCT00817336|3991714|P2|Overall Study|Withdrawal by Subject|1
1216309|NCT00817336|3991715|P1|Overall Study|Withdrawal by Subject|1
1216310|NCT00817206|3991741|P2|Overall Study|Physician Decision|0
1216311|NCT00817206|3991742|P1|Overall Study|Physician Decision|2
1216312|NCT00817206|3991741|P2|Overall Study|Withdrawal by Subject|3
1216313|NCT00817206|3991742|P1|Overall Study|Withdrawal by Subject|7
1216314|NCT00817206|3991741|P2|Overall Study|Death|0
1216315|NCT00817206|3991742|P1|Overall Study|Death|2
1216316|NCT00817206|3991741|P2|Overall Study|Lost to Follow-up|1
1216317|NCT00817206|3991742|P1|Overall Study|Lost to Follow-up|0
1216318|NCT00817206|3991741|P2|Overall Study|Protocol Violation|2
1216319|NCT00817206|3991742|P1|Overall Study|Protocol Violation|0
1216320|NCT00817206|3991741|P2|Overall Study|Adverse Event|3
1216321|NCT00817206|3991742|P1|Overall Study|Adverse Event|10
1216322|NCT00817063|3991750|P2|Overall Study|Abnormality of Laboratory Test|1
1216323|NCT00817063|3991751|P1|Overall Study|Abnormality of Laboratory Test|2
1216324|NCT00817063|3991750|P2|Overall Study|Administrative|4
1216325|NCT00817063|3991751|P1|Overall Study|Administrative|10
1216326|NCT00817063|3991750|P2|Overall Study|Early Improvement|4
1216327|NCT00817063|3991751|P1|Overall Study|Early Improvement|19
1216328|NCT00817063|3991750|P2|Overall Study|Withdrawal by Subject|37
1216329|NCT00817063|3991751|P1|Overall Study|Withdrawal by Subject|17
1216330|NCT00817063|3991750|P2|Overall Study|Protocol Violation|8
1216331|NCT00817063|3991751|P1|Overall Study|Protocol Violation|3
1216332|NCT00817063|3991750|P2|Overall Study|Violation of Selection at Entry|4
1216333|NCT00817063|3991751|P1|Overall Study|Violation of Selection at Entry|7
1216334|NCT00817063|3991750|P2|Overall Study|Failure to Return|12
1216335|NCT00817063|3991751|P1|Overall Study|Failure to Return|13
1216336|NCT00817063|3991750|P2|Overall Study|Lack of Efficacy|86
1216337|NCT00817063|3991751|P1|Overall Study|Lack of Efficacy|33
1216338|NCT00817063|3991750|P2|Overall Study|Death|1
1216339|NCT00817063|3991751|P1|Overall Study|Death|1
1216340|NCT00817063|3991750|P2|Overall Study|Adverse Event|13
1216341|NCT00817063|3991751|P1|Overall Study|Adverse Event|32
1216342|NCT00816595|3991868|P2|Overall Study|Withdrawal by Subject|0
1216343|NCT00816595|3991869|P1|Overall Study|Withdrawal by Subject|2
1216344|NCT00816556|3991882|P3|Overall Study|Lost to Follow-up|1
1216345|NCT00816556|3991883|P2|Overall Study|Lost to Follow-up|0
1216346|NCT00816556|3991884|P1|Overall Study|Lost to Follow-up|0
1216347|NCT00816556|3991882|P3|Overall Study|Withdrawal by Subject|1
1216348|NCT00816556|3991883|P2|Overall Study|Withdrawal by Subject|1
1216349|NCT00816556|3991884|P1|Overall Study|Withdrawal by Subject|1
1216350|NCT00816556|3991882|P3|Overall Study|Adverse Event|1
1216351|NCT00816556|3991883|P2|Overall Study|Adverse Event|1
1216352|NCT00816556|3991884|P1|Overall Study|Adverse Event|1
1216353|NCT00816400|3991907|P9|Overall Study|In hospice care at the end of the study|0
1216354|NCT00816400|3991908|P8|Overall Study|In hospice care at the end of the study|0
1216355|NCT00816400|3991909|P7|Overall Study|In hospice care at the end of the study|0
1216356|NCT00816400|3991910|P6|Overall Study|In hospice care at the end of the study|0
1216357|NCT00816400|3991911|P5|Overall Study|In hospice care at the end of the study|0
1216358|NCT00816400|3991912|P4|Overall Study|In hospice care at the end of the study|0
1216359|NCT00816400|3991913|P3|Overall Study|In hospice care at the end of the study|2
1216360|NCT00816400|3991914|P2|Overall Study|In hospice care at the end of the study|0
1216361|NCT00816400|3991915|P1|Overall Study|In hospice care at the end of the study|0
1216362|NCT00816400|3991907|P9|Overall Study|Death|6
1216363|NCT00816400|3991908|P8|Overall Study|Death|5
1216364|NCT00816400|3991909|P7|Overall Study|Death|2
1216365|NCT00816400|3991910|P6|Overall Study|Death|3
1216366|NCT00816400|3991911|P5|Overall Study|Death|2
1216367|NCT00816400|3991912|P4|Overall Study|Death|3
1216368|NCT00816400|3991913|P3|Overall Study|Death|3
1216369|NCT00816400|3991914|P2|Overall Study|Death|3
1216370|NCT00816400|3991915|P1|Overall Study|Death|2
1216371|NCT00816166|3992105|P2|Overall Study|Death|2
1216372|NCT00816166|3992106|P1|Overall Study|Death|4
1216373|NCT00816166|3992105|P2|Overall Study|Lost to Follow-up|10
1216374|NCT00816166|3992106|P1|Overall Study|Lost to Follow-up|6
1216375|NCT00816036|3992138|P2|Overall Study|Withdrawal by Subject|23
1216376|NCT00816036|3992139|P1|Overall Study|Withdrawal by Subject|54
1216377|NCT00816036|3992138|P2|Overall Study|Lost to Follow-up|57
1216378|NCT00816036|3992139|P1|Overall Study|Lost to Follow-up|75
1216379|NCT00816036|3992138|P2|Overall Study|Death|28
1216380|NCT00816036|3992139|P1|Overall Study|Death|47
1216381|NCT00816023|3992153|P4|Overall Study|Randomized Not Treated|11
1216382|NCT00816023|3992154|P3|Overall Study|Randomized Not Treated|6
1216383|NCT00816023|3992155|P2|Overall Study|Randomized Not Treated|4
1216384|NCT00816023|3992156|P1|Overall Study|Randomized Not Treated|6
1216385|NCT00816023|3992153|P4|Overall Study|assessments complete prior to window|1
1216386|NCT00816023|3992154|P3|Overall Study|assessments complete prior to window|2
1216387|NCT00816023|3992155|P2|Overall Study|assessments complete prior to window|1
1216388|NCT00816023|3992156|P1|Overall Study|assessments complete prior to window|1
1216389|NCT00816023|3992153|P4|Overall Study|Physician Decision|0
1216390|NCT00816023|3992154|P3|Overall Study|Physician Decision|1
1216391|NCT00816023|3992155|P2|Overall Study|Physician Decision|0
1216392|NCT00816023|3992156|P1|Overall Study|Physician Decision|0
1216393|NCT00816023|3992153|P4|Overall Study|Withdrawal by Subject|0
1216394|NCT00816023|3992154|P3|Overall Study|Withdrawal by Subject|0
1216395|NCT00816023|3992155|P2|Overall Study|Withdrawal by Subject|0
1216396|NCT00816023|3992156|P1|Overall Study|Withdrawal by Subject|1
1216397|NCT00816023|3992153|P4|Overall Study|Lost to Follow-up|0
1216398|NCT00816023|3992154|P3|Overall Study|Lost to Follow-up|0
1216399|NCT00816023|3992155|P2|Overall Study|Lost to Follow-up|1
1216400|NCT00816023|3992156|P1|Overall Study|Lost to Follow-up|1
1216401|NCT00815919|3992170|P1|Overall Study|Lack of Efficacy|2
1216402|NCT00815919|3992170|P1|Overall Study|AML Relapse|1
1216403|NCT00815919|3992170|P1|Overall Study|Unrelated Fungal Infection|1
1216404|NCT00815659|3992213|P1|Overall Study|Protocol Violation|1
1216405|NCT00815659|3992213|P1|Overall Study|Lost to Follow-up|4
1216406|NCT00815659|3992213|P1|Overall Study|Withdrawal by Subject|9
1216407|NCT00815659|3992213|P1|Overall Study|Adverse Event|9
1216408|NCT00815633|3992256|P1|Overall Study|study terminated|1
1216409|NCT00815516|3992263|P2|Overall Study|Physician Decision|0
1216410|NCT00815516|3992264|P1|Overall Study|Physician Decision|1
1216411|NCT00815516|3992263|P2|Overall Study|Death|1
1216412|NCT00815516|3992264|P1|Overall Study|Death|3
1216413|NCT00815308|3992329|P1|Overall Study|Protocol Violation|6
1216414|NCT00815308|3992329|P1|Overall Study|Withdrawal by Subject|0
1216415|NCT00815308|3992329|P1|Overall Study|Adverse Event|4
1216416|NCT00815295|3992338|P3|Overall Study|Cetuximab hypersensitivity reaction|3
1216417|NCT00815295|3992339|P2|Overall Study|Cetuximab hypersensitivity reaction|1
1216418|NCT00815295|3992340|P1|Overall Study|Cetuximab hypersensitivity reaction|0
1216419|NCT00815191|3992352|P2|Overall Study|Protocol Violation|1
1216420|NCT00815191|3992353|P1|Overall Study|Protocol Violation|1
1216421|NCT00814983|3992390|P2|Overall Study|Graft failure|0
1216422|NCT00814983|3992391|P1|Overall Study|Graft failure|1
1216423|NCT00814983|3992390|P2|Overall Study|Withdrawal by Subject|0
1216424|NCT00814983|3992391|P1|Overall Study|Withdrawal by Subject|1
1216425|NCT00814983|3992390|P2|Overall Study|Screen failure|0
1216426|NCT00814983|3992391|P1|Overall Study|Screen failure|1
1216427|NCT00814892|3992422|P1|Overall Study|Study Termination|1
1216428|NCT00814892|3992422|P1|Overall Study|Disease Progression|1
1216429|NCT00814879|3992434|P2|By Week 48|Death|1
1216430|NCT00814879|3992435|P1|By Week 48|Death|0
1216431|NCT00814879|3992434|P2|By Week 48|Lost to Follow-up|2
1216432|NCT00814879|3992435|P1|By Week 48|Lost to Follow-up|2
1216433|NCT00814879|3992434|P2|By Week 24|Incarceration|1
1216434|NCT00814879|3992435|P1|By Week 24|Incarceration|0
1216435|NCT00814879|3992434|P2|By Week 24|Cancer Diagnosis|0
1216436|NCT00814879|3992435|P1|By Week 24|Cancer Diagnosis|1
1216437|NCT00814801|3992454|P3|Overall Study|Not specified|4
1216438|NCT00814801|3992455|P2|Overall Study|Not specified|6
1216439|NCT00814801|3992456|P1|Overall Study|Not specified|2
1216440|NCT00814801|3992454|P3|Overall Study|Non-compliance|1
1216441|NCT00814801|3992455|P2|Overall Study|Non-compliance|1
1216442|NCT00814801|3992456|P1|Overall Study|Non-compliance|0
1216443|NCT00814801|3992454|P3|Overall Study|Missing or change of caregiver|4
1216444|NCT00814801|3992455|P2|Overall Study|Missing or change of caregiver|2
1216445|NCT00814801|3992456|P1|Overall Study|Missing or change of caregiver|6
1216446|NCT00814801|3992454|P3|Overall Study|Change of patients for CIBIC plus-J|0
1216447|NCT00814801|3992455|P2|Overall Study|Change of patients for CIBIC plus-J|1
1216448|NCT00814801|3992456|P1|Overall Study|Change of patients for CIBIC plus-J|1
1216449|NCT00814801|3992454|P3|Overall Study|Inappropriate as a subject|1
1216450|NCT00814801|3992455|P2|Overall Study|Inappropriate as a subject|1
1216451|NCT00814801|3992456|P1|Overall Study|Inappropriate as a subject|1
1216452|NCT00814801|3992454|P3|Overall Study|Withdrawal by Subject|14
1216453|NCT00814801|3992455|P2|Overall Study|Withdrawal by Subject|11
1216454|NCT00814801|3992456|P1|Overall Study|Withdrawal by Subject|9
1216455|NCT00814801|3992454|P3|Overall Study|Adverse Event|19
1216456|NCT00814801|3992455|P2|Overall Study|Adverse Event|16
1216457|NCT00814801|3992456|P1|Overall Study|Adverse Event|15
1216458|NCT00814710|3992495|P2|Overall Study|Lost to Follow-up|3
1216459|NCT00814710|3992496|P1|Overall Study|Lost to Follow-up|7
1216460|NCT00814710|3992495|P2|Overall Study|Adverse Event|0
1216461|NCT00814710|3992496|P1|Overall Study|Adverse Event|1
1216462|NCT00814658|3992564|P2|Overall Study|Adverse Event|3
1216463|NCT00814658|3992565|P1|Overall Study|Adverse Event|3
1216464|NCT00814658|3992564|P2|Overall Study|Physician Decision|0
1216465|NCT00814658|3992565|P1|Overall Study|Physician Decision|1
1216466|NCT00814658|3992564|P2|Overall Study|Lost to Follow-up|1
1216467|NCT00814658|3992565|P1|Overall Study|Lost to Follow-up|0
1216468|NCT00814632|3992631|P1|Overall Study|Lack of Efficacy|2
1216469|NCT00814580|3992637|P2|Overall Study|Did Not Take Drug|2
1216470|NCT00814580|3992638|P1|Overall Study|Did Not Take Drug|2
1216471|NCT00814580|3992637|P2|Overall Study|Other|3
1216472|NCT00814580|3992638|P1|Overall Study|Other|1
1216473|NCT00814580|3992637|P2|Overall Study|Withdrawal by Subject|2
1216474|NCT00814580|3992638|P1|Overall Study|Withdrawal by Subject|2
1216475|NCT00814580|3992637|P2|Overall Study|Protocol Violation|0
1216476|NCT00814580|3992638|P1|Overall Study|Protocol Violation|2
1216477|NCT00814580|3992637|P2|Overall Study|Lack of Efficacy|25
1216478|NCT00814580|3992638|P1|Overall Study|Lack of Efficacy|18
1216479|NCT00814580|3992637|P2|Overall Study|Adverse Event|15
1216480|NCT00814580|3992638|P1|Overall Study|Adverse Event|6
1216481|NCT00814502|3992768|P2|Overall Study|Withdrawal by Subject|2
1216482|NCT00814502|3992769|P1|Overall Study|Withdrawal by Subject|0
1216483|NCT00814502|3992768|P2|Overall Study|Adverse Event|0
1216484|NCT00814502|3992769|P1|Overall Study|Adverse Event|1
1216485|NCT00814489|3992782|P3|Overall Study|Other|1
1216486|NCT00814489|3992783|P2|Overall Study|Other|0
1216487|NCT00814489|3992784|P1|Overall Study|Other|2
1216488|NCT00814463|3992816|P1|Overall Study|Lost to Follow-up|1
1216489|NCT00814346|3992822|P2|Open Phase (17 Months)|Not otherwise specified|0
1216490|NCT00814346|3992823|P1|Open Phase (17 Months)|Not otherwise specified|1
1216491|NCT00814346|3992822|P2|Open Phase (17 Months)|Lost to Follow-up|0
1216492|NCT00814346|3992823|P1|Open Phase (17 Months)|Lost to Follow-up|2
1216493|NCT00814346|3992822|P2|Open Phase (17 Months)|Consent|0
1216494|NCT00814346|3992823|P1|Open Phase (17 Months)|Consent|2
1216495|NCT00814346|3992822|P2|Open Phase (17 Months)|Adverse Event|0
1216496|NCT00814346|3992823|P1|Open Phase (17 Months)|Adverse Event|5
1216497|NCT00814346|3992822|P2|Double-blind Phase (4 Weeks)|Not otherwise specified|2
1216498|NCT00814346|3992823|P1|Double-blind Phase (4 Weeks)|Not otherwise specified|0
1216499|NCT00814346|3992822|P2|Double-blind Phase (4 Weeks)|Adverse Event|1
1216500|NCT00814346|3992823|P1|Double-blind Phase (4 Weeks)|Adverse Event|0
1216501|NCT00814333|3992889|P2|Enrollment|Lost to Follow-up|0
1216502|NCT00814333|3992890|P1|Enrollment|Lost to Follow-up|1
1216503|NCT00814320|3992898|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3
1216504|NCT00814320|3992899|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0
1216505|NCT00814320|3992898|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1
1216506|NCT00814320|3992899|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0
1216507|NCT00814320|3992898|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1
1216508|NCT00814320|3992899|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0
1216509|NCT00814320|3992898|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1
1216510|NCT00814320|3992899|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2
1216511|NCT00814320|3992898|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4
1216512|NCT00814320|3992899|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1
1216513|NCT00814320|3992898|P2|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0
1216514|NCT00814320|3992899|P1|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1
1216515|NCT00814320|3992898|P2|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0
1216516|NCT00814320|3992899|P1|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1
1216517|NCT00814320|3992898|P2|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1
1216518|NCT00814320|3992899|P1|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0
1216519|NCT00814320|3992898|P2|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2
1216520|NCT00814320|3992899|P1|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0
1216521|NCT00814320|3992898|P2|Epoch 1 (IV Treatment)|Withdrawal by Subject|0
1216522|NCT00814320|3992899|P1|Epoch 1 (IV Treatment)|Withdrawal by Subject|1
1216523|NCT00814307|3993031|P4|Overall Study|Death|0
1216524|NCT00814307|3993032|P3|Overall Study|Death|0
1216525|NCT00814307|3993033|P2|Overall Study|Death|1
1216526|NCT00814307|3993034|P1|Overall Study|Death|0
1216527|NCT00814307|3993031|P4|Overall Study|Withdrawal by Subject|2
1216528|NCT00814307|3993032|P3|Overall Study|Withdrawal by Subject|0
1216529|NCT00814307|3993033|P2|Overall Study|Withdrawal by Subject|6
1216530|NCT00814307|3993034|P1|Overall Study|Withdrawal by Subject|4
1216531|NCT00814307|3993031|P4|Overall Study|Protocol Violation|1
1216532|NCT00814307|3993032|P3|Overall Study|Protocol Violation|1
1216533|NCT00814307|3993033|P2|Overall Study|Protocol Violation|8
1216534|NCT00814307|3993034|P1|Overall Study|Protocol Violation|2
1216535|NCT00814307|3993031|P4|Overall Study|Other|1
1216536|NCT00814307|3993032|P3|Overall Study|Other|0
1216537|NCT00814307|3993033|P2|Overall Study|Other|2
1216538|NCT00814307|3993034|P1|Overall Study|Other|1
1216539|NCT00814307|3993031|P4|Overall Study|Lack of Efficacy|4
1216540|NCT00814307|3993032|P3|Overall Study|Lack of Efficacy|3
1216541|NCT00814307|3993033|P2|Overall Study|Lack of Efficacy|1
1216542|NCT00814307|3993034|P1|Overall Study|Lack of Efficacy|1
1216543|NCT00814307|3993031|P4|Overall Study|Adverse Event|2
1216544|NCT00814307|3993032|P3|Overall Study|Adverse Event|3
1216545|NCT00814307|3993033|P2|Overall Study|Adverse Event|9
1216546|NCT00814307|3993034|P1|Overall Study|Adverse Event|3
1216547|NCT00814307|3993031|P4|Overall Study|Randomized but not treated|0
1216548|NCT00814307|3993032|P3|Overall Study|Randomized but not treated|0
1216549|NCT00814307|3993033|P2|Overall Study|Randomized but not treated|0
1216550|NCT00814307|3993034|P1|Overall Study|Randomized but not treated|1
1216551|NCT00814164|3993230|P1|Overall Study|Death|5
1216552|NCT00814164|3993230|P1|Overall Study|not stated|7
1216553|NCT00814164|3993230|P1|Overall Study|Progression|7
1216554|NCT00813995|3993264|P2|Overall Study|Withdrawal by Subject|5
1216555|NCT00813995|3993265|P1|Overall Study|Withdrawal by Subject|0
1216556|NCT00813995|3993264|P2|Overall Study|Subject moved|0
1216557|NCT00813995|3993265|P1|Overall Study|Subject moved|4
1216558|NCT00813995|3993264|P2|Overall Study|Protocol Violation|2
1216559|NCT00813995|3993265|P1|Overall Study|Protocol Violation|3
1216560|NCT00813995|3993264|P2|Overall Study|Other reason|2
1216561|NCT00813995|3993265|P1|Overall Study|Other reason|2
1216562|NCT00813995|3993264|P2|Overall Study|Lost to Follow-up|2
1216563|NCT00813995|3993265|P1|Overall Study|Lost to Follow-up|4
1216564|NCT00813995|3993264|P2|Overall Study|Lack of Efficacy|0
1216565|NCT00813995|3993265|P1|Overall Study|Lack of Efficacy|1
1216566|NCT00813995|3993264|P2|Overall Study|Laboratory adverse event|2
1216567|NCT00813995|3993265|P1|Overall Study|Laboratory adverse event|0
1216568|NCT00813995|3993264|P2|Overall Study|Clinical adverse event|3
1216569|NCT00813995|3993265|P1|Overall Study|Clinical adverse event|9
1216570|NCT00813943|3993288|P3|Overall Study|Ongoing at cut-off date|3
1216571|NCT00813943|3993289|P2|Overall Study|Ongoing at cut-off date|5
1216572|NCT00813943|3993290|P1|Overall Study|Ongoing at cut-off date|5
1216573|NCT00813917|3993320|P2|Overall Study|Lost to Follow-up|1
1216574|NCT00813917|3993321|P1|Overall Study|Lost to Follow-up|3
1216575|NCT00813917|3993320|P2|Overall Study|Withdrawal by Subject|4
1216576|NCT00813917|3993321|P1|Overall Study|Withdrawal by Subject|3
1216577|NCT00813917|3993320|P2|Overall Study|Adverse Event|1
1216578|NCT00813917|3993321|P1|Overall Study|Adverse Event|0
1216579|NCT00813904|3993327|P1|Overall Study|Death|1
1216580|NCT00813865|3993333|P1|Overall Study|Withdrawal by Subject|1
1216581|NCT00813865|3993333|P1|Overall Study|Lost to Follow-up|3
1216582|NCT00813865|3993333|P1|Overall Study|Failure to Respond|3
1216583|NCT00813813|3993341|P2|Overall Study|Other|1
1216584|NCT00813813|3993342|P1|Overall Study|Other|0
1216585|NCT00813813|3993341|P2|Overall Study|Lost to Follow-up|7
1216586|NCT00813813|3993342|P1|Overall Study|Lost to Follow-up|2
1216587|NCT00813813|3993341|P2|Overall Study|Withdrawal by Subject|1
1216588|NCT00813813|3993342|P1|Overall Study|Withdrawal by Subject|1
1216589|NCT00813800|3993358|P1|Overall Study|Physician Decision|1
1216590|NCT00813800|3993358|P1|Overall Study|Worsening of depression|2
1216591|NCT00813800|3993358|P1|Overall Study|Adverse Event|1
1216592|NCT00813800|3993358|P1|Overall Study|Screen Failure after Consent|2
1216593|NCT00813761|3993366|P4|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
1216594|NCT00813761|3993367|P3|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6
1216595|NCT00813761|3993368|P2|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
1216596|NCT00813761|3993369|P1|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9
1216597|NCT00813761|3993366|P4|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3
1216598|NCT00813761|3993367|P3|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0
1216599|NCT00813761|3993368|P2|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4
1216600|NCT00813761|3993369|P1|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1
1216601|NCT00813761|3993366|P4|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0
1216602|NCT00813761|3993367|P3|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
1216603|NCT00813761|3993368|P2|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
1216604|NCT00813761|3993369|P1|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
1216605|NCT00813761|3993366|P4|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
1216606|NCT00813761|3993367|P3|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
1216607|NCT00813761|3993368|P2|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
1216608|NCT00813761|3993369|P1|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
1216609|NCT00813761|3993366|P4|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1
1216610|NCT00813761|3993367|P3|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2
1216611|NCT00813761|3993368|P2|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0
1216612|NCT00813761|3993369|P1|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3
1216613|NCT00813761|3993366|P4|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
1216614|NCT00813761|3993367|P3|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
1216615|NCT00813761|3993368|P2|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3
1216616|NCT00813761|3993369|P1|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2
1216617|NCT00813761|3993366|P4|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
1216618|NCT00813761|3993367|P3|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
1216619|NCT00813761|3993368|P2|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1
1216620|NCT00813761|3993369|P1|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
1216621|NCT00813761|3993366|P4|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
1216622|NCT00813761|3993367|P3|Phase 1 (Baseline to 4 Weeks)|poor comfort|5
1216623|NCT00813761|3993368|P2|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
1216624|NCT00813761|3993369|P1|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
1216625|NCT00813761|3993366|P4|Phase 1 (Baseline to 4 Weeks)|poor vision|0
1216626|NCT00813761|3993367|P3|Phase 1 (Baseline to 4 Weeks)|poor vision|3
1216627|NCT00813761|3993368|P2|Phase 1 (Baseline to 4 Weeks)|poor vision|0
1216628|NCT00813761|3993369|P1|Phase 1 (Baseline to 4 Weeks)|poor vision|0
1216629|NCT00813761|3993366|P4|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0
1216630|NCT00813761|3993367|P3|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
1216631|NCT00813761|3993368|P2|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
1216632|NCT00813761|3993369|P1|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
1216633|NCT00813761|3993366|P4|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1
1216634|NCT00813761|3993367|P3|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3
1216635|NCT00813761|3993368|P2|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
1216636|NCT00813761|3993369|P1|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
1216637|NCT00813761|3993366|P4|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
1216638|NCT00813761|3993367|P3|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
1216639|NCT00813761|3993368|P2|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
1216640|NCT00813761|3993369|P1|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2
1216641|NCT00813748|3993419|P2|Skin Test Substudy|Physician Decision|1
1216642|NCT00813748|3993420|P1|Skin Test Substudy|Physician Decision|0
1216643|NCT00813709|3993449|P6|Open Label Period|Other|6
1216644|NCT00813709|3993450|P5|Open Label Period|Other|5
1216645|NCT00813709|3993451|P4|Open Label Period|Other|11
1216646|NCT00813709|3993452|P3|Open Label Period|Other|0
1216647|NCT00813709|3993453|P2|Open Label Period|Other|0
1216648|NCT00813709|3993454|P1|Open Label Period|Other|0
1216649|NCT00813709|3993449|P6|Open Label Period|Randomized but not treated|1
1216650|NCT00813709|3993450|P5|Open Label Period|Randomized but not treated|0
1216651|NCT00813709|3993451|P4|Open Label Period|Randomized but not treated|1
1216652|NCT00813709|3993452|P3|Open Label Period|Randomized but not treated|0
1216653|NCT00813709|3993453|P2|Open Label Period|Randomized but not treated|0
1216654|NCT00813709|3993454|P1|Open Label Period|Randomized but not treated|0
1216655|NCT00813709|3993449|P6|Open Label Period|Lack of Efficacy|1
1216656|NCT00813709|3993450|P5|Open Label Period|Lack of Efficacy|1
1216657|NCT00813709|3993451|P4|Open Label Period|Lack of Efficacy|3
1216658|NCT00813709|3993452|P3|Open Label Period|Lack of Efficacy|0
1216659|NCT00813709|3993453|P2|Open Label Period|Lack of Efficacy|0
1216660|NCT00813709|3993454|P1|Open Label Period|Lack of Efficacy|0
1216661|NCT00813709|3993449|P6|Open Label Period|Adverse Event|3
1216662|NCT00813709|3993450|P5|Open Label Period|Adverse Event|4
1216663|NCT00813709|3993451|P4|Open Label Period|Adverse Event|5
1216664|NCT00813709|3993452|P3|Open Label Period|Adverse Event|0
1216665|NCT00813709|3993453|P2|Open Label Period|Adverse Event|0
1216666|NCT00813709|3993454|P1|Open Label Period|Adverse Event|0
1216667|NCT00813709|3993449|P6|Double Blind Period|Other|0
1216668|NCT00813709|3993450|P5|Double Blind Period|Other|0
1216669|NCT00813709|3993451|P4|Double Blind Period|Other|0
1216670|NCT00813709|3993452|P3|Double Blind Period|Other|6
1216671|NCT00813709|3993453|P2|Double Blind Period|Other|9
1216672|NCT00813709|3993454|P1|Double Blind Period|Other|14
1216673|NCT00813709|3993449|P6|Double Blind Period|Randomized but not treated|0
1216674|NCT00813709|3993450|P5|Double Blind Period|Randomized but not treated|0
1216675|NCT00813709|3993451|P4|Double Blind Period|Randomized but not treated|0
1216676|NCT00813709|3993452|P3|Double Blind Period|Randomized but not treated|1
1216677|NCT00813709|3993453|P2|Double Blind Period|Randomized but not treated|3
1216678|NCT00813709|3993454|P1|Double Blind Period|Randomized but not treated|1
1216679|NCT00813709|3993449|P6|Double Blind Period|Switched to open label phase|0
1216680|NCT00813709|3993450|P5|Double Blind Period|Switched to open label phase|0
1216681|NCT00813709|3993451|P4|Double Blind Period|Switched to open label phase|0
1216682|NCT00813709|3993452|P3|Double Blind Period|Switched to open label phase|18
1216683|NCT00813709|3993453|P2|Double Blind Period|Switched to open label phase|26
1216684|NCT00813709|3993454|P1|Double Blind Period|Switched to open label phase|9
1216685|NCT00813709|3993449|P6|Double Blind Period|Lost to Follow-up|0
1216686|NCT00813709|3993450|P5|Double Blind Period|Lost to Follow-up|0
1216687|NCT00813709|3993451|P4|Double Blind Period|Lost to Follow-up|0
1216688|NCT00813709|3993452|P3|Double Blind Period|Lost to Follow-up|2
1216689|NCT00813709|3993453|P2|Double Blind Period|Lost to Follow-up|2
1216690|NCT00813709|3993454|P1|Double Blind Period|Lost to Follow-up|3
1216691|NCT00813709|3993449|P6|Double Blind Period|Adverse Event|0
1216692|NCT00813709|3993450|P5|Double Blind Period|Adverse Event|0
1216693|NCT00813709|3993451|P4|Double Blind Period|Adverse Event|0
1216694|NCT00813709|3993452|P3|Double Blind Period|Adverse Event|4
1216695|NCT00813709|3993453|P2|Double Blind Period|Adverse Event|1
1216696|NCT00813709|3993454|P1|Double Blind Period|Adverse Event|4
1216697|NCT00813592|3993534|P1|Overall Study|Disease assessment was not completed per|2
1216698|NCT00813488|3993543|P2|Open-label Extension|Not specified|0
1216699|NCT00813488|3993544|P1|Open-label Extension|Not specified|1
1216700|NCT00813488|3993543|P2|Open-label Extension|Non-compliance study procedures|1
1216701|NCT00813488|3993544|P1|Open-label Extension|Non-compliance study procedures|2
1216702|NCT00813488|3993543|P2|Open-label Extension|Non-compliance study medication|0
1216703|NCT00813488|3993544|P1|Open-label Extension|Non-compliance study medication|4
1216704|NCT00813488|3993543|P2|Open-label Extension|Protocol Violation|2
1216705|NCT00813488|3993544|P1|Open-label Extension|Protocol Violation|1
1216706|NCT00813488|3993543|P2|Open-label Extension|Withdrawal by Subject|2
1216707|NCT00813488|3993544|P1|Open-label Extension|Withdrawal by Subject|0
1216708|NCT00813488|3993543|P2|Open-label Extension|Lack of Efficacy|0
1216709|NCT00813488|3993544|P1|Open-label Extension|Lack of Efficacy|3
1216710|NCT00813488|3993543|P2|Open-label Extension|Adverse Event|2
1216711|NCT00813488|3993544|P1|Open-label Extension|Adverse Event|1
1216712|NCT00813488|3993543|P2|Double-blind Treatment Period 2|Not Specified|0
1216713|NCT00813488|3993544|P1|Double-blind Treatment Period 2|Not Specified|1
1216714|NCT00813488|3993543|P2|Double-blind Treatment Period 2|Protocol Violation|0
1216715|NCT00813488|3993544|P1|Double-blind Treatment Period 2|Protocol Violation|2
1216716|NCT00813488|3993543|P2|Double-blind Treatment Period 2|Withdrawal by Subject|1
1216717|NCT00813488|3993544|P1|Double-blind Treatment Period 2|Withdrawal by Subject|1
1216718|NCT00813488|3993543|P2|Double-blind Treatment Period 2|Adverse Event|0
1216719|NCT00813488|3993544|P1|Double-blind Treatment Period 2|Adverse Event|1
1216720|NCT00813488|3993543|P2|Double-blind Treatment Period 1|Lost to Follow-up|1
1216721|NCT00813488|3993544|P1|Double-blind Treatment Period 1|Lost to Follow-up|0
1216722|NCT00813488|3993543|P2|Double-blind Treatment Period 1|Protocol Violation|2
1216723|NCT00813488|3993544|P1|Double-blind Treatment Period 1|Protocol Violation|0
1216724|NCT00813488|3993543|P2|Double-blind Treatment Period 1|Withdrawal by Subject|1
1216725|NCT00813488|3993544|P1|Double-blind Treatment Period 1|Withdrawal by Subject|0
1216726|NCT00813488|3993543|P2|Double-blind Treatment Period 1|Adverse Event|1
1216727|NCT00813488|3993544|P1|Double-blind Treatment Period 1|Adverse Event|1
1216728|NCT00813488|3993543|P2|Titration Period 2|Non-compliance with study procedures|1
1216729|NCT00813488|3993544|P1|Titration Period 2|Non-compliance with study procedures|2
1216730|NCT00813488|3993543|P2|Titration Period 2|Lost to Follow-up|0
1216731|NCT00813488|3993544|P1|Titration Period 2|Lost to Follow-up|1
1216732|NCT00813488|3993543|P2|Titration Period 2|Protocol Violation|2
1216733|NCT00813488|3993544|P1|Titration Period 2|Protocol Violation|3
1216734|NCT00813488|3993543|P2|Titration Period 2|Lack of Efficacy|4
1216735|NCT00813488|3993544|P1|Titration Period 2|Lack of Efficacy|8
1216736|NCT00813488|3993543|P2|Titration Period 2|Adverse Event|3
1216737|NCT00813488|3993544|P1|Titration Period 2|Adverse Event|2
1216738|NCT00813488|3993543|P2|Titration Period 1|Technical Difficulties|1
1216739|NCT00813488|3993544|P1|Titration Period 1|Technical Difficulties|0
1216740|NCT00813488|3993543|P2|Titration Period 1|Non-compliance to study procedures|2
1216741|NCT00813488|3993544|P1|Titration Period 1|Non-compliance to study procedures|2
1216742|NCT00813488|3993543|P2|Titration Period 1|Non-compliance to study medication|1
1216743|NCT00813488|3993544|P1|Titration Period 1|Non-compliance to study medication|4
1216744|NCT00813488|3993543|P2|Titration Period 1|Protocol Violation|3
1216745|NCT00813488|3993544|P1|Titration Period 1|Protocol Violation|4
1216746|NCT00813488|3993543|P2|Titration Period 1|Withdrawal by Subject|2
1216747|NCT00813488|3993544|P1|Titration Period 1|Withdrawal by Subject|2
1216748|NCT00813488|3993543|P2|Titration Period 1|Lack of Efficacy|7
1216749|NCT00813488|3993544|P1|Titration Period 1|Lack of Efficacy|9
1216750|NCT00813488|3993543|P2|Titration Period 1|Adverse Event|1
1216751|NCT00813488|3993544|P1|Titration Period 1|Adverse Event|6
1216752|NCT00813150|3993674|P2|Long Term Follow-up|Progression/Relapse|24
1216753|NCT00813150|3993675|P1|Long Term Follow-up|Progression/Relapse|22
1216754|NCT00813150|3993674|P2|Long Term Follow-up|Lost to Follow-up|0
1216755|NCT00813150|3993675|P1|Long Term Follow-up|Lost to Follow-up|2
1216756|NCT00813150|3993674|P2|Long Term Follow-up|Not specified|3
1216757|NCT00813150|3993675|P1|Long Term Follow-up|Not specified|0
1216758|NCT00813150|3993674|P2|Long Term Follow-up|Death|4
1216759|NCT00813150|3993675|P1|Long Term Follow-up|Death|0
1216760|NCT00813150|3993674|P2|Treatment Period|Data not available|2
1216761|NCT00813150|3993675|P1|Treatment Period|Data not available|1
1216762|NCT00813150|3993674|P2|Treatment Period|Reason not specified|4
1216763|NCT00813150|3993675|P1|Treatment Period|Reason not specified|3
1216764|NCT00813150|3993674|P2|Treatment Period|Non compliance|1
1216765|NCT00813150|3993675|P1|Treatment Period|Non compliance|0
1216766|NCT00813150|3993674|P2|Treatment Period|Withdrawal by Subject|3
1216767|NCT00813150|3993675|P1|Treatment Period|Withdrawal by Subject|5
1216768|NCT00813150|3993674|P2|Treatment Period|Protocol Violation|4
1216769|NCT00813150|3993675|P1|Treatment Period|Protocol Violation|3
1216770|NCT00813150|3993674|P2|Treatment Period|Stable disease|2
1216771|NCT00813150|3993675|P1|Treatment Period|Stable disease|1
1216772|NCT00813150|3993674|P2|Treatment Period|Complete response|1
1216773|NCT00813150|3993675|P1|Treatment Period|Complete response|0
1216774|NCT00813150|3993674|P2|Treatment Period|Progressive disease|0
1216775|NCT00813150|3993675|P1|Treatment Period|Progressive disease|1
1216776|NCT00813150|3993674|P2|Treatment Period|Death|0
1216777|NCT00813150|3993675|P1|Treatment Period|Death|2
1216778|NCT00813150|3993674|P2|Treatment Period|Adverse Event|15
1216779|NCT00813150|3993675|P1|Treatment Period|Adverse Event|16
1216780|NCT00813098|3993699|P3|Overall Study|Withdrew Consent|0
1216781|NCT00813098|3993700|P2|Overall Study|Withdrew Consent|1
1216782|NCT00813098|3993701|P1|Overall Study|Withdrew Consent|0
1216783|NCT00813098|3993699|P3|Overall Study|Principal Investigator decision|0
1216784|NCT00813098|3993700|P2|Overall Study|Principal Investigator decision|1
1216785|NCT00813098|3993701|P1|Overall Study|Principal Investigator decision|0
1216786|NCT00813098|3993699|P3|Overall Study|Protocol Violation|1
1216787|NCT00813098|3993700|P2|Overall Study|Protocol Violation|0
1216788|NCT00813098|3993701|P1|Overall Study|Protocol Violation|0
1216789|NCT00813098|3993699|P3|Overall Study|Lost to Follow-up|0
1216790|NCT00813098|3993700|P2|Overall Study|Lost to Follow-up|1
1216791|NCT00813098|3993701|P1|Overall Study|Lost to Follow-up|0
1216792|NCT00813098|3993699|P3|Overall Study|Inability to complete study procedures|0
1216793|NCT00813098|3993700|P2|Overall Study|Inability to complete study procedures|0
1216794|NCT00813098|3993701|P1|Overall Study|Inability to complete study procedures|1
1216795|NCT00813098|3993699|P3|Overall Study|Withdrawal by Subject|0
1216796|NCT00813098|3993700|P2|Overall Study|Withdrawal by Subject|1
1216797|NCT00813098|3993701|P1|Overall Study|Withdrawal by Subject|0
1216798|NCT00813098|3993699|P3|Overall Study|Adverse Event|1
1216799|NCT00813098|3993700|P2|Overall Study|Adverse Event|4
1216800|NCT00813098|3993701|P1|Overall Study|Adverse Event|2
1216801|NCT00812981|3993726|P2|Overall Study|Other|1
1216802|NCT00812981|3993727|P1|Overall Study|Other|0
1216803|NCT00812968|3993765|P1|Overall Study|Study closed due to marketing approval|3
1216804|NCT00812968|3993765|P1|Overall Study|No further treatment required|1
1216805|NCT00812968|3993765|P1|Overall Study|Disease progression|1
1216806|NCT00812968|3993765|P1|Overall Study|Relapse after erythroid response|6
1216807|NCT00812955|3993800|P4|Overall Study|randomized in error|0
1216808|NCT00812955|3993801|P3|Overall Study|randomized in error|1
1216809|NCT00812955|3993802|P2|Overall Study|randomized in error|0
1216810|NCT00812955|3993803|P1|Overall Study|randomized in error|0
1216811|NCT00812955|3993800|P4|Overall Study|Withdrawal by Subject|2
1216812|NCT00812955|3993801|P3|Overall Study|Withdrawal by Subject|1
1216813|NCT00812955|3993802|P2|Overall Study|Withdrawal by Subject|0
1216814|NCT00812955|3993803|P1|Overall Study|Withdrawal by Subject|1
1216815|NCT00812955|3993800|P4|Overall Study|Lost to Follow-up|2
1216816|NCT00812955|3993801|P3|Overall Study|Lost to Follow-up|1
1216817|NCT00812955|3993802|P2|Overall Study|Lost to Follow-up|1
1216818|NCT00812955|3993803|P1|Overall Study|Lost to Follow-up|2
1216819|NCT00812955|3993800|P4|Overall Study|Adverse Event|4
1216820|NCT00812955|3993801|P3|Overall Study|Adverse Event|3
1216821|NCT00812955|3993802|P2|Overall Study|Adverse Event|6
1216822|NCT00812955|3993803|P1|Overall Study|Adverse Event|7
1216823|NCT00812929|3993823|P10|Washout Period 3 (7 Days)|Adverse Event|0
1216824|NCT00812929|3993824|P9|Washout Period 3 (7 Days)|Adverse Event|0
1216825|NCT00812929|3993825|P8|Washout Period 3 (7 Days)|Adverse Event|0
1216826|NCT00812929|3993826|P7|Washout Period 3 (7 Days)|Adverse Event|0
1216827|NCT00812929|3993827|P6|Washout Period 3 (7 Days)|Adverse Event|1
1216828|NCT00812929|3993828|P5|Washout Period 3 (7 Days)|Adverse Event|0
1216829|NCT00812929|3993829|P4|Washout Period 3 (7 Days)|Adverse Event|0
1216830|NCT00812929|3993830|P3|Washout Period 3 (7 Days)|Adverse Event|0
1216831|NCT00812929|3993831|P2|Washout Period 3 (7 Days)|Adverse Event|0
1216832|NCT00812929|3993832|P1|Washout Period 3 (7 Days)|Adverse Event|0
1216833|NCT00812929|3993823|P10|Washout Period 2 (7 Days)|Physician Decision|1
1216834|NCT00812929|3993824|P9|Washout Period 2 (7 Days)|Physician Decision|0
1216835|NCT00812929|3993825|P8|Washout Period 2 (7 Days)|Physician Decision|0
1216836|NCT00812929|3993826|P7|Washout Period 2 (7 Days)|Physician Decision|0
1216837|NCT00812929|3993827|P6|Washout Period 2 (7 Days)|Physician Decision|0
1216838|NCT00812929|3993828|P5|Washout Period 2 (7 Days)|Physician Decision|0
1216839|NCT00812929|3993829|P4|Washout Period 2 (7 Days)|Physician Decision|0
1216840|NCT00812929|3993830|P3|Washout Period 2 (7 Days)|Physician Decision|0
1216841|NCT00812929|3993831|P2|Washout Period 2 (7 Days)|Physician Decision|0
1216842|NCT00812929|3993832|P1|Washout Period 2 (7 Days)|Physician Decision|0
1216843|NCT00812929|3993823|P10|Washout Period 1 (7 Days)|Physician Decision|0
1216844|NCT00812929|3993824|P9|Washout Period 1 (7 Days)|Physician Decision|0
1216845|NCT00812929|3993825|P8|Washout Period 1 (7 Days)|Physician Decision|0
1216846|NCT00812929|3993826|P7|Washout Period 1 (7 Days)|Physician Decision|0
1216847|NCT00812929|3993827|P6|Washout Period 1 (7 Days)|Physician Decision|0
1216848|NCT00812929|3993828|P5|Washout Period 1 (7 Days)|Physician Decision|0
1216849|NCT00812929|3993829|P4|Washout Period 1 (7 Days)|Physician Decision|0
1216850|NCT00812929|3993830|P3|Washout Period 1 (7 Days)|Physician Decision|1
1216851|NCT00812929|3993831|P2|Washout Period 1 (7 Days)|Physician Decision|0
1216852|NCT00812929|3993832|P1|Washout Period 1 (7 Days)|Physician Decision|0
1216853|NCT00812812|3993970|P2|Overall Study|Withdrawal by Subject|2
1216854|NCT00812812|3993971|P1|Overall Study|Withdrawal by Subject|0
1216855|NCT00812812|3993970|P2|Overall Study|Lost to Follow-up|1
1216856|NCT00812812|3993971|P1|Overall Study|Lost to Follow-up|0
1216857|NCT00812812|3993970|P2|Overall Study|Lack of Efficacy|0
1216858|NCT00812812|3993971|P1|Overall Study|Lack of Efficacy|1
1216859|NCT00812812|3993970|P2|Overall Study|Adverse Event|1
1216860|NCT00812812|3993971|P1|Overall Study|Adverse Event|2
1216861|NCT00812708|3993984|P1|Overall Study|Signed consent but later withdrew|3
1216862|NCT00812708|3993984|P1|Overall Study|Surgery cancelled due to uveitis|1
1216863|NCT00812708|3993984|P1|Overall Study|Switched to another study|1
1216864|NCT00812708|3993984|P1|Overall Study|Lack of medical insurance|1
1216865|NCT00812708|3993984|P1|Overall Study|Device could not be implanted|2
1216866|NCT00812565|3994012|P8|Overall Study|Reason Not Specified|0
1216867|NCT00812565|3994013|P7|Overall Study|Reason Not Specified|0
1216868|NCT00812565|3994014|P6|Overall Study|Reason Not Specified|1
1216869|NCT00812565|3994015|P5|Overall Study|Reason Not Specified|0
1216870|NCT00812565|3994016|P4|Overall Study|Reason Not Specified|0
1216871|NCT00812565|3994017|P3|Overall Study|Reason Not Specified|0
1216872|NCT00812565|3994018|P2|Overall Study|Reason Not Specified|0
1216873|NCT00812565|3994019|P1|Overall Study|Reason Not Specified|0
1216874|NCT00812565|3994012|P8|Overall Study|Withdrawal of Consent|0
1216875|NCT00812565|3994013|P7|Overall Study|Withdrawal of Consent|0
1216876|NCT00812565|3994014|P6|Overall Study|Withdrawal of Consent|0
1216877|NCT00812565|3994015|P5|Overall Study|Withdrawal of Consent|1
1216878|NCT00812565|3994016|P4|Overall Study|Withdrawal of Consent|0
1216879|NCT00812565|3994017|P3|Overall Study|Withdrawal of Consent|0
1216880|NCT00812565|3994018|P2|Overall Study|Withdrawal of Consent|0
1216881|NCT00812565|3994019|P1|Overall Study|Withdrawal of Consent|1
1216882|NCT00812565|3994012|P8|Overall Study|Did Not Come to Study Visit|0
1216883|NCT00812565|3994013|P7|Overall Study|Did Not Come to Study Visit|0
1216884|NCT00812565|3994014|P6|Overall Study|Did Not Come to Study Visit|0
1216885|NCT00812565|3994015|P5|Overall Study|Did Not Come to Study Visit|0
1216886|NCT00812565|3994016|P4|Overall Study|Did Not Come to Study Visit|0
1216887|NCT00812565|3994017|P3|Overall Study|Did Not Come to Study Visit|0
1216888|NCT00812565|3994018|P2|Overall Study|Did Not Come to Study Visit|0
1216889|NCT00812565|3994019|P1|Overall Study|Did Not Come to Study Visit|1
1216890|NCT00812565|3994012|P8|Overall Study|Adverse Event|1
1216891|NCT00812565|3994013|P7|Overall Study|Adverse Event|0
1216892|NCT00812565|3994014|P6|Overall Study|Adverse Event|0
1216893|NCT00812565|3994015|P5|Overall Study|Adverse Event|0
1216894|NCT00812565|3994016|P4|Overall Study|Adverse Event|2
1216895|NCT00812565|3994017|P3|Overall Study|Adverse Event|0
1216896|NCT00812565|3994018|P2|Overall Study|Adverse Event|0
1216897|NCT00812565|3994019|P1|Overall Study|Adverse Event|0
1216898|NCT00812565|3994012|P8|Overall Study|Did Not Receive Study Medication|0
1216899|NCT00812565|3994013|P7|Overall Study|Did Not Receive Study Medication|0
1216900|NCT00812565|3994014|P6|Overall Study|Did Not Receive Study Medication|0
1216901|NCT00812565|3994015|P5|Overall Study|Did Not Receive Study Medication|0
1216902|NCT00812565|3994016|P4|Overall Study|Did Not Receive Study Medication|0
1216903|NCT00812565|3994017|P3|Overall Study|Did Not Receive Study Medication|0
1216904|NCT00812565|3994018|P2|Overall Study|Did Not Receive Study Medication|1
1216905|NCT00812565|3994019|P1|Overall Study|Did Not Receive Study Medication|1
1216906|NCT00812487|3994143|P2|Overall Study|Protocol Violation|1
1216907|NCT00812487|3994144|P1|Overall Study|Protocol Violation|0
1216908|NCT00812487|3994143|P2|Overall Study|Transfer to ICU prior to intervention|0
1216909|NCT00812487|3994144|P1|Overall Study|Transfer to ICU prior to intervention|1
1216910|NCT00812487|3994143|P2|Overall Study|Withdrawal by Subject|2
1216911|NCT00812487|3994144|P1|Overall Study|Withdrawal by Subject|3
1216912|NCT00812487|3994143|P2|Overall Study|Lost to Follow-up|0
1216913|NCT00812487|3994144|P1|Overall Study|Lost to Follow-up|2
1216914|NCT00812461|3994170|P2|All Treated Patients|Other Reason|21
1216915|NCT00812461|3994171|P1|All Treated Patients|Other Reason|13
1216916|NCT00812461|3994170|P2|All Treated Patients|Lost to Follow-up|14
1216917|NCT00812461|3994171|P1|All Treated Patients|Lost to Follow-up|11
1216918|NCT00812461|3994170|P2|All Treated Patients|Withdrawal by Subject|54
1216919|NCT00812461|3994171|P1|All Treated Patients|Withdrawal by Subject|45
1216920|NCT00812461|3994170|P2|All Treated Patients|Protocol Violation|27
1216921|NCT00812461|3994171|P1|All Treated Patients|Protocol Violation|36
1216922|NCT00812461|3994170|P2|All Treated Patients|Non-compliance|9
1216923|NCT00812461|3994171|P1|All Treated Patients|Non-compliance|6
1216924|NCT00812461|3994170|P2|All Treated Patients|Lack of Efficacy|7
1216925|NCT00812461|3994171|P1|All Treated Patients|Lack of Efficacy|13
1216926|NCT00812461|3994170|P2|All Treated Patients|Adverse Event|15
1216927|NCT00812461|3994171|P1|All Treated Patients|Adverse Event|8
1216928|NCT00812461|3994170|P2|All Randomised Patients|Did not receive placebo/nalmefene|17
1216929|NCT00812461|3994171|P1|All Randomised Patients|Did not receive placebo/nalmefene|23
1216930|NCT00812331|3994194|P5|Overall Study|Adverse Event|0
1216931|NCT00812331|3994195|P4|Overall Study|Adverse Event|0
1216932|NCT00812331|3994196|P3|Overall Study|Adverse Event|0
1216933|NCT00812331|3994197|P2|Overall Study|Adverse Event|0
1216934|NCT00812331|3994198|P1|Overall Study|Adverse Event|1
1216935|NCT00812253|3994273|P2|Overall Study|Lost to Follow-up|0
1216936|NCT00812253|3994274|P1|Overall Study|Lost to Follow-up|2
1216937|NCT00812253|3994273|P2|Overall Study|Protocol Violation|1
1216938|NCT00812253|3994274|P1|Overall Study|Protocol Violation|1
1216939|NCT00812253|3994273|P2|Overall Study|Withdrawal by Subject|2
1216940|NCT00812253|3994274|P1|Overall Study|Withdrawal by Subject|3
1216941|NCT00812097|3994299|P4|Overall Study|Unknown reasons and patient/doctor moves|5
1216942|NCT00812097|3994300|P3|Overall Study|Unknown reasons and patient/doctor moves|15
1216943|NCT00812097|3994301|P2|Overall Study|Unknown reasons and patient/doctor moves|24
1216944|NCT00812097|3994302|P1|Overall Study|Unknown reasons and patient/doctor moves|111
1216945|NCT00812097|3994299|P4|Overall Study|Explantation of study device(s)|20
1216946|NCT00812097|3994300|P3|Overall Study|Explantation of study device(s)|14
1216947|NCT00812097|3994301|P2|Overall Study|Explantation of study device(s)|29
1216948|NCT00812097|3994302|P1|Overall Study|Explantation of study device(s)|27
1216949|NCT00812097|3994299|P4|Overall Study|Lost to Follow-up|5
1216950|NCT00812097|3994300|P3|Overall Study|Lost to Follow-up|17
1216951|NCT00812097|3994301|P2|Overall Study|Lost to Follow-up|14
1216952|NCT00812097|3994302|P1|Overall Study|Lost to Follow-up|90
1216953|NCT00812097|3994299|P4|Overall Study|Withdrawal by Subject|2
1216954|NCT00812097|3994300|P3|Overall Study|Withdrawal by Subject|8
1216955|NCT00812097|3994301|P2|Overall Study|Withdrawal by Subject|12
1216956|NCT00812097|3994302|P1|Overall Study|Withdrawal by Subject|14
1216957|NCT00812097|3994299|P4|Overall Study|Death|3
1216958|NCT00812097|3994300|P3|Overall Study|Death|3
1216959|NCT00812097|3994301|P2|Overall Study|Death|10
1216960|NCT00812097|3994302|P1|Overall Study|Death|3
1216961|NCT00812006|3994331|P3|Overall Study|Lack of Qualifying Event|2
1216962|NCT00812006|3994332|P2|Overall Study|Lack of Qualifying Event|2
1216963|NCT00812006|3994333|P1|Overall Study|Lack of Qualifying Event|4
1216964|NCT00812006|3994331|P3|Overall Study|Withdrawal by Subject|1
1216965|NCT00812006|3994332|P2|Overall Study|Withdrawal by Subject|1
1216966|NCT00812006|3994333|P1|Overall Study|Withdrawal by Subject|2
1216967|NCT00812006|3994331|P3|Overall Study|Physician Decision|1
1216968|NCT00812006|3994332|P2|Overall Study|Physician Decision|0
1216969|NCT00812006|3994333|P1|Overall Study|Physician Decision|0
1216970|NCT00812006|3994331|P3|Overall Study|Lost to Follow-up|2
1216971|NCT00812006|3994332|P2|Overall Study|Lost to Follow-up|0
1216972|NCT00812006|3994333|P1|Overall Study|Lost to Follow-up|0
1216973|NCT00811954|3994350|P3|Overall Study|Complete Protocol: No follow-up|1
1216974|NCT00811954|3994351|P2|Overall Study|Complete Protocol: No follow-up|0
1216975|NCT00811954|3994352|P1|Overall Study|Complete Protocol: No follow-up|0
1216976|NCT00811954|3994350|P3|Overall Study|Severe Debilitation|1
1216977|NCT00811954|3994351|P2|Overall Study|Severe Debilitation|0
1216978|NCT00811954|3994352|P1|Overall Study|Severe Debilitation|2
1216979|NCT00811954|3994350|P3|Overall Study|Site Closure|1
1216980|NCT00811954|3994351|P2|Overall Study|Site Closure|0
1216981|NCT00811954|3994352|P1|Overall Study|Site Closure|4
1216982|NCT00811954|3994350|P3|Overall Study|Withdraw consent prior study completion|5
1216983|NCT00811954|3994351|P2|Overall Study|Withdraw consent prior study completion|6
1216984|NCT00811954|3994352|P1|Overall Study|Withdraw consent prior study completion|4
1216985|NCT00811954|3994350|P3|Overall Study|Not willing to adhere to requirements|16
1216986|NCT00811954|3994351|P2|Overall Study|Not willing to adhere to requirements|2
1216987|NCT00811954|3994352|P1|Overall Study|Not willing to adhere to requirements|12
1216988|NCT00811954|3994350|P3|Overall Study|Not able to get to clinic|30
1216989|NCT00811954|3994351|P2|Overall Study|Not able to get to clinic|35
1216990|NCT00811954|3994352|P1|Overall Study|Not able to get to clinic|28
1216991|NCT00811954|3994350|P3|Overall Study|Lost to Follow-up|34
1216992|NCT00811954|3994351|P2|Overall Study|Lost to Follow-up|23
1216993|NCT00811954|3994352|P1|Overall Study|Lost to Follow-up|29
1216994|NCT00811954|3994350|P3|Overall Study|Death|13
1216995|NCT00811954|3994351|P2|Overall Study|Death|6
1216996|NCT00811954|3994352|P1|Overall Study|Death|10
1216997|NCT00811941|3994416|P2|All Treated Patients|Other Reason|14
1216998|NCT00811941|3994417|P1|All Treated Patients|Other Reason|4
1216999|NCT00811941|3994416|P2|All Treated Patients|Lost to Follow-up|12
1217000|NCT00811941|3994417|P1|All Treated Patients|Lost to Follow-up|3
1217001|NCT00811941|3994416|P2|All Treated Patients|Withdrawal by Subject|94
1217002|NCT00811941|3994417|P1|All Treated Patients|Withdrawal by Subject|35
1217003|NCT00811941|3994416|P2|All Treated Patients|Protocol Violation|17
1217004|NCT00811941|3994417|P1|All Treated Patients|Protocol Violation|5
1217005|NCT00811941|3994416|P2|All Treated Patients|Non-compliance|8
1217006|NCT00811941|3994417|P1|All Treated Patients|Non-compliance|1
1217007|NCT00811941|3994416|P2|All Treated Patients|Lack of Efficacy|3
1217008|NCT00811941|3994417|P1|All Treated Patients|Lack of Efficacy|2
1217009|NCT00811941|3994416|P2|All Treated Patients|Adverse Event|43
1217010|NCT00811941|3994417|P1|All Treated Patients|Adverse Event|2
1217011|NCT00811941|3994416|P2|All Randomised Patients|Did not receive placebo/nalmefene|8
1217012|NCT00811941|3994417|P1|All Randomised Patients|Did not receive placebo/nalmefene|2
1217013|NCT00811928|3994455|P2|Overall Study|Poor Compliance|5
1217014|NCT00811928|3994456|P1|Overall Study|Poor Compliance|2
1217015|NCT00811928|3994455|P2|Overall Study|Investigator Decision|1
1217016|NCT00811928|3994456|P1|Overall Study|Investigator Decision|2
1217017|NCT00811928|3994455|P2|Overall Study|Without Primary Efficacy Endpoint Data|4
1217018|NCT00811928|3994456|P1|Overall Study|Without Primary Efficacy Endpoint Data|7
1217019|NCT00811928|3994455|P2|Overall Study|Did Not Take Study Drug|0
1217020|NCT00811928|3994456|P1|Overall Study|Did Not Take Study Drug|3
1217021|NCT00811928|3994455|P2|Overall Study|Withdrawal by Subject|12
1217022|NCT00811928|3994456|P1|Overall Study|Withdrawal by Subject|18
1217023|NCT00811928|3994455|P2|Overall Study|AEs and SAEs Including Death|11
1217024|NCT00811928|3994456|P1|Overall Study|AEs and SAEs Including Death|7
1217025|NCT00811733|3994500|P2|Overall Study|Withdrawal by Subject|2
1217026|NCT00811733|3994501|P1|Overall Study|Withdrawal by Subject|1
1217027|NCT00811733|3994500|P2|Overall Study|Investigator Discretion|8
1217028|NCT00811733|3994501|P1|Overall Study|Investigator Discretion|10
1217029|NCT00811720|3994549|P2|All Treated Patients|Other Reason|4
1217030|NCT00811720|3994550|P1|All Treated Patients|Other Reason|7
1217031|NCT00811720|3994549|P2|All Treated Patients|Lost to Follow-up|16
1217032|NCT00811720|3994550|P1|All Treated Patients|Lost to Follow-up|10
1217033|NCT00811720|3994549|P2|All Treated Patients|Withdrawal by Subject|34
1217034|NCT00811720|3994550|P1|All Treated Patients|Withdrawal by Subject|28
1217035|NCT00811720|3994549|P2|All Treated Patients|Protocol Violation|16
1217036|NCT00811720|3994550|P1|All Treated Patients|Protocol Violation|9
1217037|NCT00811720|3994549|P2|All Treated Patients|Non-compliance|14
1217038|NCT00811720|3994550|P1|All Treated Patients|Non-compliance|0
1217039|NCT00811720|3994549|P2|All Treated Patients|Lack of Efficacy|18
1217040|NCT00811720|3994550|P1|All Treated Patients|Lack of Efficacy|22
1217041|NCT00811720|3994549|P2|All Treated Patients|Adverse Event|62
1217042|NCT00811720|3994550|P1|All Treated Patients|Adverse Event|20
1217043|NCT00811720|3994549|P2|All Randomised Patients|Did not receive placebo/nalmefene|4
1217044|NCT00811720|3994550|P1|All Randomised Patients|Did not receive placebo/nalmefene|2
1217045|NCT00811655|3994568|P1|Overall Study|Physician Decision|1
1217046|NCT00811642|3994580|P1|Overall Study|Cumulative use of antifungal agent|2
1217047|NCT00811642|3994580|P1|Overall Study|Withdrawal by Subject|7
1217048|NCT00811642|3994580|P1|Overall Study|Death|2
1217049|NCT00811642|3994580|P1|Overall Study|Protocol Violation|1
1217050|NCT00811642|3994580|P1|Overall Study|Adverse Event|3
1217051|NCT00811577|3994596|P2|Overall Study|Withdrawal by Subject|0
1217052|NCT00811577|3994597|P1|Overall Study|Withdrawal by Subject|3
1217053|NCT00811577|3994596|P2|Overall Study|Lost to Follow-up|1
1217054|NCT00811577|3994597|P1|Overall Study|Lost to Follow-up|7
1217055|NCT00811473|3994657|P2|Overall Study|Safety Reasons|0
1217056|NCT00811473|3994658|P1|Overall Study|Safety Reasons|1
1217057|NCT00811473|3994657|P2|Overall Study|Incorrect Enrollment|0
1217058|NCT00811473|3994658|P1|Overall Study|Incorrect Enrollment|1
1217059|NCT00811473|3994657|P2|Overall Study|Other 2|1
1217060|NCT00811473|3994658|P1|Overall Study|Other 2|4
1217061|NCT00811473|3994657|P2|Overall Study|Condition under investigation worsened|3
1217062|NCT00811473|3994658|P1|Overall Study|Condition under investigation worsened|1
1217063|NCT00811473|3994657|P2|Overall Study|Lack of therapeutic response|1
1217064|NCT00811473|3994658|P1|Overall Study|Lack of therapeutic response|4
1217065|NCT00811473|3994657|P2|Overall Study|Severe non-compliance to protocol|4
1217066|NCT00811473|3994658|P1|Overall Study|Severe non-compliance to protocol|2
1217067|NCT00811473|3994657|P2|Overall Study|Withdrawal by Subject|4
1217068|NCT00811473|3994658|P1|Overall Study|Withdrawal by Subject|2
1217069|NCT00811473|3994657|P2|Overall Study|Lost to Follow-up|1
1217070|NCT00811473|3994658|P1|Overall Study|Lost to Follow-up|5
1217071|NCT00811473|3994657|P2|Overall Study|Adverse Event|12
1217072|NCT00811473|3994658|P1|Overall Study|Adverse Event|3
1217073|NCT00811395|3994689|P6|Extension Treatment|Other than above|0
1217074|NCT00811395|3994690|P5|Extension Treatment|Other than above|0
1217075|NCT00811395|3994691|P4|Extension Treatment|Other than above|0
1217076|NCT00811395|3994692|P3|Extension Treatment|Other than above|1
1217077|NCT00811395|3994693|P2|Extension Treatment|Other than above|0
1217078|NCT00811395|3994694|P1|Extension Treatment|Other than above|0
1217079|NCT00811395|3994689|P6|Extension Treatment|Participant did not wish to continue|1
1217080|NCT00811395|3994690|P5|Extension Treatment|Participant did not wish to continue|0
1217081|NCT00811395|3994691|P4|Extension Treatment|Participant did not wish to continue|1
1217082|NCT00811395|3994692|P3|Extension Treatment|Participant did not wish to continue|0
1217083|NCT00811395|3994693|P2|Extension Treatment|Participant did not wish to continue|3
1217084|NCT00811395|3994694|P1|Extension Treatment|Participant did not wish to continue|0
1217085|NCT00811395|3994689|P6|Extension Treatment|Progressive disease|0
1217086|NCT00811395|3994690|P5|Extension Treatment|Progressive disease|0
1217087|NCT00811395|3994691|P4|Extension Treatment|Progressive disease|0
1217088|NCT00811395|3994692|P3|Extension Treatment|Progressive disease|0
1217089|NCT00811395|3994693|P2|Extension Treatment|Progressive disease|1
1217090|NCT00811395|3994694|P1|Extension Treatment|Progressive disease|1
1217091|NCT00811395|3994689|P6|Extension Treatment|Adverse Event|1
1217092|NCT00811395|3994690|P5|Extension Treatment|Adverse Event|0
1217093|NCT00811395|3994691|P4|Extension Treatment|Adverse Event|2
1217094|NCT00811395|3994692|P3|Extension Treatment|Adverse Event|2
1217095|NCT00811395|3994693|P2|Extension Treatment|Adverse Event|2
1217096|NCT00811395|3994694|P1|Extension Treatment|Adverse Event|1
1217097|NCT00811252|3994800|P3|Overall Study|Administrative or Other Reasons|2
1217098|NCT00811252|3994801|P2|Overall Study|Administrative or Other Reasons|3
1217099|NCT00811252|3994802|P1|Overall Study|Administrative or Other Reasons|0
1217100|NCT00811252|3994800|P3|Overall Study|Lost to Follow-up|2
1217101|NCT00811252|3994801|P2|Overall Study|Lost to Follow-up|0
1217102|NCT00811252|3994802|P1|Overall Study|Lost to Follow-up|0
1217103|NCT00811252|3994800|P3|Overall Study|Withdrawal of Consent|2
1217104|NCT00811252|3994801|P2|Overall Study|Withdrawal of Consent|2
1217105|NCT00811252|3994802|P1|Overall Study|Withdrawal of Consent|1
1217106|NCT00811252|3994800|P3|Overall Study|Protocol Violation|2
1217107|NCT00811252|3994801|P2|Overall Study|Protocol Violation|3
1217108|NCT00811252|3994802|P1|Overall Study|Protocol Violation|3
1217109|NCT00811252|3994800|P3|Overall Study|Lack of Efficacy|0
1217110|NCT00811252|3994801|P2|Overall Study|Lack of Efficacy|2
1217111|NCT00811252|3994802|P1|Overall Study|Lack of Efficacy|7
1217112|NCT00811252|3994800|P3|Overall Study|Adverse Event|15
1217113|NCT00811252|3994801|P2|Overall Study|Adverse Event|10
1217114|NCT00811252|3994802|P1|Overall Study|Adverse Event|6
1217115|NCT00811174|3994846|P1|Overall Study|Sponsors Decision|1
1217116|NCT00811174|3994846|P1|Overall Study|Protocol Violation|2
1217117|NCT00811135|3994857|P1|Overall Study|Ongoing|59
1217118|NCT00811135|3994857|P1|Overall Study|Administrative/Other Unspecified|11
1217119|NCT00811135|3994857|P1|Overall Study|Withdrawal by Subject|3
1217120|NCT00811135|3994857|P1|Overall Study|Refused Treatment|1
1217121|NCT00811135|3994857|P1|Overall Study|Violation of Selection Criteria|1
1217122|NCT00811135|3994857|P1|Overall Study|Protocol Violation|2
1217123|NCT00811135|3994857|P1|Overall Study|Death|3
1217124|NCT00811135|3994857|P1|Overall Study|Adverse Event/Intercurrent Illness|8
1217125|NCT00811070|3994875|P6|Overall Study|Physician Decision|1
1217126|NCT00811070|3994876|P5|Overall Study|Physician Decision|0
1217127|NCT00811070|3994877|P4|Overall Study|Physician Decision|0
1217128|NCT00811070|3994878|P3|Overall Study|Physician Decision|0
1217129|NCT00811070|3994879|P2|Overall Study|Physician Decision|0
1217130|NCT00811070|3994880|P1|Overall Study|Physician Decision|0
1217131|NCT00811070|3994875|P6|Overall Study|Withdrawal by Subject|0
1217132|NCT00811070|3994876|P5|Overall Study|Withdrawal by Subject|0
1217133|NCT00811070|3994877|P4|Overall Study|Withdrawal by Subject|0
1217134|NCT00811070|3994878|P3|Overall Study|Withdrawal by Subject|0
1217135|NCT00811070|3994879|P2|Overall Study|Withdrawal by Subject|1
1217136|NCT00811070|3994880|P1|Overall Study|Withdrawal by Subject|0
1217137|NCT00811070|3994875|P6|Overall Study|Other|0
1217138|NCT00811070|3994876|P5|Overall Study|Other|0
1217139|NCT00811070|3994877|P4|Overall Study|Other|0
1217140|NCT00811070|3994878|P3|Overall Study|Other|0
1217141|NCT00811070|3994879|P2|Overall Study|Other|0
1217142|NCT00811070|3994880|P1|Overall Study|Other|1
1217143|NCT00811070|3994875|P6|Overall Study|Death|0
1217144|NCT00811070|3994876|P5|Overall Study|Death|5
1217145|NCT00811070|3994877|P4|Overall Study|Death|2
1217146|NCT00811070|3994878|P3|Overall Study|Death|0
1217147|NCT00811070|3994879|P2|Overall Study|Death|0
1217148|NCT00811070|3994880|P1|Overall Study|Death|0
1217149|NCT00811057|3994940|P3|Overall Study|Protocol Violation|10
1217150|NCT00811057|3994941|P2|Overall Study|Protocol Violation|10
1217151|NCT00811057|3994942|P1|Overall Study|Protocol Violation|5
1217152|NCT00811018|3994953|P1|Overall Study|Other|26
1217153|NCT00811018|3994953|P1|Overall Study|WHO FC deterioration and 6MWD decrease|9
1217154|NCT00811018|3994953|P1|Overall Study|Withdrawal by Subject|70
1217155|NCT00811018|3994953|P1|Overall Study|Sponsor Decision|450
1217156|NCT00811018|3994953|P1|Overall Study|Pregnancy|6
1217157|NCT00811018|3994953|P1|Overall Study|Lost to Follow-up|19
1217158|NCT00811018|3994953|P1|Overall Study|Investigator Decision|57
1217159|NCT00811018|3994953|P1|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70
1217160|NCT00811018|3994953|P1|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4
1217161|NCT00811018|3994953|P1|Overall Study|Death|147
1217162|NCT00811018|3994953|P1|Overall Study|Adverse Event|79
1217163|NCT00811018|3994953|P1|Overall Study|Additional Chronic Treatment|31
1217164|NCT00810901|3994971|P2|Overall Study|Lost to Follow-up|58
1217165|NCT00810901|3994972|P1|Overall Study|Lost to Follow-up|88
1217166|NCT00810810|3995018|P4|Overall Study|Physician Decision|5
1217167|NCT00810810|3995019|P3|Overall Study|Physician Decision|1
1217168|NCT00810810|3995020|P2|Overall Study|Physician Decision|3
1217169|NCT00810810|3995021|P1|Overall Study|Physician Decision|0
1217170|NCT00810810|3995018|P4|Overall Study|Withdrawal by Subject|8
1217171|NCT00810810|3995019|P3|Overall Study|Withdrawal by Subject|10
1217172|NCT00810810|3995020|P2|Overall Study|Withdrawal by Subject|8
1217173|NCT00810810|3995021|P1|Overall Study|Withdrawal by Subject|0
1217174|NCT00810693|3995069|P3|Follow-up Period (FUP)|Withdrawal by Subject|0
1217175|NCT00810693|3995070|P2|Follow-up Period (FUP)|Withdrawal by Subject|1
1217176|NCT00810693|3995071|P1|Follow-up Period (FUP)|Withdrawal by Subject|2
1217177|NCT00810693|3995069|P3|Follow-up Period (FUP)|Protocol Violation|0
1217178|NCT00810693|3995070|P2|Follow-up Period (FUP)|Protocol Violation|1
1217179|NCT00810693|3995071|P1|Follow-up Period (FUP)|Protocol Violation|0
1217180|NCT00810693|3995069|P3|Follow-up Period (FUP)|Lost to Follow-up|2
1217181|NCT00810693|3995070|P2|Follow-up Period (FUP)|Lost to Follow-up|0
1217182|NCT00810693|3995071|P1|Follow-up Period (FUP)|Lost to Follow-up|1
1217183|NCT00810693|3995069|P3|Follow-up Period (FUP)|Death|1
1217184|NCT00810693|3995070|P2|Follow-up Period (FUP)|Death|0
1217185|NCT00810693|3995071|P1|Follow-up Period (FUP)|Death|2
1217186|NCT00810693|3995069|P3|Follow-up Period (FUP)|Adverse Event|1
1217187|NCT00810693|3995070|P2|Follow-up Period (FUP)|Adverse Event|1
1217188|NCT00810693|3995071|P1|Follow-up Period (FUP)|Adverse Event|3
1217189|NCT00810693|3995069|P3|Treatment Period|Not treated|1
1217190|NCT00810693|3995070|P2|Treatment Period|Not treated|1
1217191|NCT00810693|3995071|P1|Treatment Period|Not treated|0
1217192|NCT00810693|3995069|P3|Treatment Period|Withdrawal by Subject|3
1217193|NCT00810693|3995070|P2|Treatment Period|Withdrawal by Subject|2
1217194|NCT00810693|3995071|P1|Treatment Period|Withdrawal by Subject|6
1217195|NCT00810693|3995069|P3|Treatment Period|Protocol Violation|2
1217196|NCT00810693|3995070|P2|Treatment Period|Protocol Violation|2
1217197|NCT00810693|3995071|P1|Treatment Period|Protocol Violation|1
1217198|NCT00810693|3995069|P3|Treatment Period|Non-compliance|0
1217199|NCT00810693|3995070|P2|Treatment Period|Non-compliance|0
1217200|NCT00810693|3995071|P1|Treatment Period|Non-compliance|1
1217201|NCT00810693|3995069|P3|Treatment Period|Lost to Follow-up|0
1217202|NCT00810693|3995070|P2|Treatment Period|Lost to Follow-up|0
1217203|NCT00810693|3995071|P1|Treatment Period|Lost to Follow-up|1
1217204|NCT00810693|3995069|P3|Treatment Period|Lack of Efficacy|1
1217205|NCT00810693|3995070|P2|Treatment Period|Lack of Efficacy|0
1217206|NCT00810693|3995071|P1|Treatment Period|Lack of Efficacy|0
1217207|NCT00810693|3995069|P3|Treatment Period|Death|2
1217208|NCT00810693|3995070|P2|Treatment Period|Death|1
1217209|NCT00810693|3995071|P1|Treatment Period|Death|0
1217210|NCT00810693|3995069|P3|Treatment Period|Adverse Event|7
1217211|NCT00810693|3995070|P2|Treatment Period|Adverse Event|1
1217212|NCT00810693|3995071|P1|Treatment Period|Adverse Event|8
1217213|NCT00810641|3995103|P3|Overall Study|Withdrawal by Subject|2
1217214|NCT00810641|3995104|P2|Overall Study|Withdrawal by Subject|1
1217215|NCT00810641|3995105|P1|Overall Study|Withdrawal by Subject|0
1217216|NCT00810615|3995115|P2|Overall Study|Withdrawal by Subject|1
1217217|NCT00810615|3995116|P1|Overall Study|Withdrawal by Subject|1
1217218|NCT00810602|3995166|P2|Overall Study|Withdrawal by Subject|3
1217219|NCT00810602|3995167|P1|Overall Study|Withdrawal by Subject|8
1217220|NCT00810511|3995180|P2|Overall Study|deposits on contact lens|1
1217221|NCT00810511|3995181|P1|Overall Study|deposits on contact lens|0
1217222|NCT00810511|3995180|P2|Overall Study|Lost to Follow-up|0
1217223|NCT00810511|3995181|P1|Overall Study|Lost to Follow-up|1
1217224|NCT00810511|3995180|P2|Overall Study|death in the family|1
1217225|NCT00810511|3995181|P1|Overall Study|death in the family|0
1217226|NCT00810511|3995180|P2|Overall Study|Lack of Efficacy|1
1217227|NCT00810511|3995181|P1|Overall Study|Lack of Efficacy|9
1217228|NCT00810511|3995180|P2|Overall Study|Protocol Violation|1
1217229|NCT00810511|3995181|P1|Overall Study|Protocol Violation|0
1217230|NCT00810394|3995187|P1|Overall Study|Withdrawal by Subject|3
1217231|NCT00810368|3995195|P2|Overall Study|Lack of Efficacy|0
1217232|NCT00810368|3995196|P1|Overall Study|Lack of Efficacy|2
1217233|NCT00810368|3995195|P2|Overall Study|Lost to Follow-up|2
1217234|NCT00810368|3995196|P1|Overall Study|Lost to Follow-up|4
1217235|NCT00810355|3995217|P3|Overall Study|Withdrawal by Subject|0
1217236|NCT00810355|3995218|P2|Overall Study|Withdrawal by Subject|0
1217237|NCT00810355|3995219|P1|Overall Study|Withdrawal by Subject|1
1217238|NCT00810355|3995217|P3|Overall Study|Lost to Follow-up|11
1217239|NCT00810355|3995218|P2|Overall Study|Lost to Follow-up|17
1217240|NCT00810355|3995219|P1|Overall Study|Lost to Follow-up|13
1217241|NCT00810342|3995235|P2|12-month Followup|Lost to Follow-up|1
1217242|NCT00810342|3995236|P1|12-month Followup|Lost to Follow-up|3
1217243|NCT00810342|3995235|P2|12-month Followup|Pregnancy|10
1217244|NCT00810342|3995236|P1|12-month Followup|Pregnancy|9
1217245|NCT00810342|3995235|P2|6-month Follow-up|Pregnancy|2
1217246|NCT00810342|3995236|P1|6-month Follow-up|Pregnancy|6
1217247|NCT00810342|3995235|P2|6-month Follow-up|Lost to Follow-up|6
1217248|NCT00810342|3995236|P1|6-month Follow-up|Lost to Follow-up|18
1217249|NCT00810342|3995235|P2|Month 1 Follow-up|Pregnancy|0
1217250|NCT00810342|3995236|P1|Month 1 Follow-up|Pregnancy|1
1217251|NCT00810342|3995235|P2|Month 1 Follow-up|Lost to Follow-up|2
1217252|NCT00810342|3995236|P1|Month 1 Follow-up|Lost to Follow-up|4
1217253|NCT00810277|3995269|P1|Overall Study|Adverse Event|1
1217254|NCT00810199|3995284|P2|Overall Study|Did not receive study drug|1
1217255|NCT00810199|3995285|P1|Overall Study|Did not receive study drug|2
1217256|NCT00810199|3995284|P2|Overall Study|Failure to return|4
1217257|NCT00810199|3995285|P1|Overall Study|Failure to return|1
1217258|NCT00810199|3995284|P2|Overall Study|Protocol Violation|6
1217259|NCT00810199|3995285|P1|Overall Study|Protocol Violation|2
1217260|NCT00810199|3995284|P2|Overall Study|Administrative/Other|6
1217261|NCT00810199|3995285|P1|Overall Study|Administrative/Other|5
1217262|NCT00810199|3995284|P2|Overall Study|Refused treatment/Did not cooperate|7
1217263|NCT00810199|3995285|P1|Overall Study|Refused treatment/Did not cooperate|7
1217264|NCT00810199|3995284|P2|Overall Study|Insufficient therapeutic response|14
1217265|NCT00810199|3995285|P1|Overall Study|Insufficient therapeutic response|5
1217266|NCT00810199|3995284|P2|Overall Study|Withdrew consent|12
1217267|NCT00810199|3995285|P1|Overall Study|Withdrew consent|9
1217268|NCT00810199|3995284|P2|Overall Study|Death|6
1217269|NCT00810199|3995285|P1|Overall Study|Death|4
1217270|NCT00810199|3995284|P2|Overall Study|Adverse Event|26
1217271|NCT00810199|3995285|P1|Overall Study|Adverse Event|24
1217272|NCT00810108|3995363|P2|Overall Study|Withdrawal by Subject|0
1217273|NCT00810108|3995364|P1|Overall Study|Withdrawal by Subject|1
1217274|NCT00810082|3995378|P2|Overall Study|Lost to Follow-up|4
1217275|NCT00810082|3995379|P1|Overall Study|Lost to Follow-up|0
1217276|NCT00810069|3995387|P3|Double-Blind Period II|Protocol Violation|6
1217277|NCT00810069|3995388|P2|Double-Blind Period II|Protocol Violation|7
1217278|NCT00810069|3995389|P1|Double-Blind Period II|Protocol Violation|0
1217279|NCT00810069|3995387|P3|Double-Blind Period II|Clinical relapse|0
1217280|NCT00810069|3995388|P2|Double-Blind Period II|Clinical relapse|3
1217281|NCT00810069|3995389|P1|Double-Blind Period II|Clinical relapse|0
1217282|NCT00810069|3995387|P3|Double-Blind Period II|Protocol entry criterion not met|1
1217283|NCT00810069|3995388|P2|Double-Blind Period II|Protocol entry criterion not met|0
1217284|NCT00810069|3995389|P1|Double-Blind Period II|Protocol entry criterion not met|0
1217285|NCT00810069|3995387|P3|Double-Blind Period II|Withdrawal by Subject|35
1217286|NCT00810069|3995388|P2|Double-Blind Period II|Withdrawal by Subject|21
1217287|NCT00810069|3995389|P1|Double-Blind Period II|Withdrawal by Subject|0
1217288|NCT00810069|3995387|P3|Double-Blind Period II|Physician Decision|1
1217289|NCT00810069|3995388|P2|Double-Blind Period II|Physician Decision|0
1217290|NCT00810069|3995389|P1|Double-Blind Period II|Physician Decision|0
1217291|NCT00810069|3995387|P3|Double-Blind Period II|Lost to Follow-up|9
1217292|NCT00810069|3995388|P2|Double-Blind Period II|Lost to Follow-up|9
1217293|NCT00810069|3995389|P1|Double-Blind Period II|Lost to Follow-up|0
1217294|NCT00810069|3995387|P3|Double-Blind Period II|Lack of Efficacy|12
1217295|NCT00810069|3995388|P2|Double-Blind Period II|Lack of Efficacy|7
1217296|NCT00810069|3995389|P1|Double-Blind Period II|Lack of Efficacy|0
1217297|NCT00810069|3995387|P3|Double-Blind Period II|Adverse Event|8
1217298|NCT00810069|3995388|P2|Double-Blind Period II|Adverse Event|9
1217299|NCT00810069|3995389|P1|Double-Blind Period II|Adverse Event|0
1217300|NCT00810069|3995387|P3|Lead-in Period I|Randomization criteria not met|0
1217301|NCT00810069|3995388|P2|Lead-in Period I|Randomization criteria not met|0
1217302|NCT00810069|3995389|P1|Lead-in Period I|Randomization criteria not met|158
1217303|NCT00810069|3995387|P3|Lead-in Period I|Protocol entry criterion not met|0
1217304|NCT00810069|3995388|P2|Lead-in Period I|Protocol entry criterion not met|0
1217305|NCT00810069|3995389|P1|Lead-in Period I|Protocol entry criterion not met|5
1217306|NCT00810069|3995387|P3|Lead-in Period I|Withdrawal by Subject|0
1217307|NCT00810069|3995388|P2|Lead-in Period I|Withdrawal by Subject|0
1217308|NCT00810069|3995389|P1|Lead-in Period I|Withdrawal by Subject|46
1217309|NCT00810069|3995387|P3|Lead-in Period I|Protocol Violation|0
1217310|NCT00810069|3995388|P2|Lead-in Period I|Protocol Violation|0
1217311|NCT00810069|3995389|P1|Lead-in Period I|Protocol Violation|1
1217312|NCT00810069|3995387|P3|Lead-in Period I|Physician Decision|0
1217313|NCT00810069|3995388|P2|Lead-in Period I|Physician Decision|0
1217314|NCT00810069|3995389|P1|Lead-in Period I|Physician Decision|1
1217315|NCT00810069|3995387|P3|Lead-in Period I|Lost to Follow-up|0
1217316|NCT00810069|3995388|P2|Lead-in Period I|Lost to Follow-up|0
1217317|NCT00810069|3995389|P1|Lead-in Period I|Lost to Follow-up|19
1217318|NCT00810069|3995387|P3|Lead-in Period I|Lack of Efficacy|0
1217319|NCT00810069|3995388|P2|Lead-in Period I|Lack of Efficacy|0
1217320|NCT00810069|3995389|P1|Lead-in Period I|Lack of Efficacy|1
1217321|NCT00810069|3995387|P3|Lead-in Period I|Adverse Event|0
1217322|NCT00810069|3995388|P2|Lead-in Period I|Adverse Event|0
1217323|NCT00810069|3995389|P1|Lead-in Period I|Adverse Event|43
1217324|NCT00810043|3995434|P3|Overall Study|No longer met enrollment criteria|3
1217325|NCT00810043|3995435|P2|Overall Study|No longer met enrollment criteria|0
1217326|NCT00810043|3995436|P1|Overall Study|No longer met enrollment criteria|0
1217327|NCT00810043|3995434|P3|Overall Study|Non-medical problem|1
1217328|NCT00810043|3995435|P2|Overall Study|Non-medical problem|0
1217329|NCT00810043|3995436|P1|Overall Study|Non-medical problem|0
1217330|NCT00810043|3995434|P3|Overall Study|Unrelated medical problem|0
1217331|NCT00810043|3995435|P2|Overall Study|Unrelated medical problem|1
1217332|NCT00810043|3995436|P1|Overall Study|Unrelated medical problem|0
1217333|NCT00810043|3995434|P3|Overall Study|Death|0
1217334|NCT00810043|3995435|P2|Overall Study|Death|0
1217335|NCT00810043|3995436|P1|Overall Study|Death|2
1217336|NCT00810043|3995434|P3|Overall Study|Physician Decision|2
1217337|NCT00810043|3995435|P2|Overall Study|Physician Decision|0
1217338|NCT00810043|3995436|P1|Overall Study|Physician Decision|0
1217339|NCT00810043|3995434|P3|Overall Study|Lost to Follow-up|0
1217340|NCT00810043|3995435|P2|Overall Study|Lost to Follow-up|0
1217341|NCT00810043|3995436|P1|Overall Study|Lost to Follow-up|1
1217342|NCT00810043|3995434|P3|Overall Study|Withdrawal by Subject|2
1217343|NCT00810043|3995435|P2|Overall Study|Withdrawal by Subject|0
1217344|NCT00810043|3995436|P1|Overall Study|Withdrawal by Subject|1
1217345|NCT00809965|3995458|P3|Overall Study|Other Reason|189
1217346|NCT00809965|3995459|P2|Overall Study|Other Reason|170
1217347|NCT00809965|3995460|P1|Overall Study|Other Reason|167
1217348|NCT00809965|3995458|P3|Overall Study|Withdrawal by Subject|441
1217349|NCT00809965|3995459|P2|Overall Study|Withdrawal by Subject|448
1217350|NCT00809965|3995460|P1|Overall Study|Withdrawal by Subject|405
1217351|NCT00809965|3995458|P3|Overall Study|Lost to Follow-up|18
1217352|NCT00809965|3995459|P2|Overall Study|Lost to Follow-up|10
1217353|NCT00809965|3995460|P1|Overall Study|Lost to Follow-up|17
1217354|NCT00809965|3995458|P3|Overall Study|Death|196
1217355|NCT00809965|3995459|P2|Overall Study|Death|147
1217356|NCT00809965|3995460|P1|Overall Study|Death|194
1217357|NCT00809926|3995482|P2|Overall Study|Protocol deviation|2
1217358|NCT00809926|3995483|P1|Overall Study|Protocol deviation|0
1217359|NCT00809926|3995482|P2|Overall Study|Administrative Problems|1
1217360|NCT00809926|3995483|P1|Overall Study|Administrative Problems|0
1217361|NCT00809926|3995482|P2|Overall Study|Lost to Follow-up|1
1217362|NCT00809926|3995483|P1|Overall Study|Lost to Follow-up|2
1217363|NCT00809926|3995482|P2|Overall Study|Patient withdrew consent|6
1217364|NCT00809926|3995483|P1|Overall Study|Patient withdrew consent|8
1217365|NCT00809926|3995482|P2|Overall Study|Unsatisfactory therapeutic effect|3
1217366|NCT00809926|3995483|P1|Overall Study|Unsatisfactory therapeutic effect|3
1217367|NCT00809926|3995482|P2|Overall Study|Adverse Event|10
1217368|NCT00809926|3995483|P1|Overall Study|Adverse Event|18
1217369|NCT00809835|3995537|P4|Overall Study|Withdrawal by Subject|0
1217370|NCT00809835|3995538|P3|Overall Study|Withdrawal by Subject|1
1217371|NCT00809835|3995539|P2|Overall Study|Withdrawal by Subject|1
1217372|NCT00809835|3995540|P1|Overall Study|Withdrawal by Subject|1
1217373|NCT00809835|3995537|P4|Overall Study|Lost to Follow-up|2
1217374|NCT00809835|3995538|P3|Overall Study|Lost to Follow-up|10
1217375|NCT00809835|3995539|P2|Overall Study|Lost to Follow-up|6
1217376|NCT00809835|3995540|P1|Overall Study|Lost to Follow-up|7
1217377|NCT00809757|3995570|P3|Overall Study|Noncompliance with Medication|1
1217378|NCT00809757|3995571|P2|Overall Study|Noncompliance with Medication|0
1217379|NCT00809757|3995572|P1|Overall Study|Noncompliance with Medication|0
1217380|NCT00809757|3995570|P3|Overall Study|Subject Uncooperative|2
1217381|NCT00809757|3995571|P2|Overall Study|Subject Uncooperative|0
1217382|NCT00809757|3995572|P1|Overall Study|Subject Uncooperative|1
1217383|NCT00809757|3995570|P3|Overall Study|Withdrawal by Subject|3
1217384|NCT00809757|3995571|P2|Overall Study|Withdrawal by Subject|1
1217385|NCT00809757|3995572|P1|Overall Study|Withdrawal by Subject|2
1217386|NCT00809757|3995570|P3|Overall Study|Protocol Violation|1
1217387|NCT00809757|3995571|P2|Overall Study|Protocol Violation|1
1217388|NCT00809757|3995572|P1|Overall Study|Protocol Violation|1
1217389|NCT00809757|3995570|P3|Overall Study|Lost to Follow-up|1
1217390|NCT00809757|3995571|P2|Overall Study|Lost to Follow-up|0
1217391|NCT00809757|3995572|P1|Overall Study|Lost to Follow-up|0
1217392|NCT00809757|3995570|P3|Overall Study|Adverse Event|3
1217393|NCT00809757|3995571|P2|Overall Study|Adverse Event|3
1217394|NCT00809757|3995572|P1|Overall Study|Adverse Event|2
1217395|NCT00809614|3995657|P2|Overall Study|Withdrawal by Subject|1
1217396|NCT00809614|3995658|P1|Overall Study|Withdrawal by Subject|1
1217397|NCT00809614|3995657|P2|Overall Study|Lack of Efficacy|3
1217398|NCT00809614|3995658|P1|Overall Study|Lack of Efficacy|2
1217399|NCT00809471|3995702|P3|Overall Study|Requirement for restricted medication|0
1217400|NCT00809471|3995703|P2|Overall Study|Requirement for restricted medication|1
1217401|NCT00809471|3995704|P1|Overall Study|Requirement for restricted medication|1
1217402|NCT00809471|3995702|P3|Overall Study|Adverse Event|2
1217403|NCT00809471|3995703|P2|Overall Study|Adverse Event|2
1217404|NCT00809471|3995704|P1|Overall Study|Adverse Event|0
1217405|NCT00809471|3995702|P3|Overall Study|Lost to Follow-up|9
1217406|NCT00809471|3995703|P2|Overall Study|Lost to Follow-up|2
1217407|NCT00809471|3995704|P1|Overall Study|Lost to Follow-up|4
1217408|NCT00809471|3995702|P3|Overall Study|Protocol non-compliance|6
1217409|NCT00809471|3995703|P2|Overall Study|Protocol non-compliance|15
1217410|NCT00809471|3995704|P1|Overall Study|Protocol non-compliance|15
1217411|NCT00809445|3995734|P3|6 Month Follow-up|Withdrew consent|1
1217412|NCT00809445|3995735|P2|6 Month Follow-up|Withdrew consent|0
1217413|NCT00809445|3995736|P1|6 Month Follow-up|Withdrew consent|0
1217414|NCT00809445|3995734|P3|6 Month Follow-up|Incarcerated|8
1217415|NCT00809445|3995735|P2|6 Month Follow-up|Incarcerated|8
1217416|NCT00809445|3995736|P1|6 Month Follow-up|Incarcerated|6
1217417|NCT00809445|3995734|P3|6 Month Follow-up|Death|1
1217418|NCT00809445|3995735|P2|6 Month Follow-up|Death|1
1217419|NCT00809445|3995736|P1|6 Month Follow-up|Death|2
1217420|NCT00809445|3995734|P3|6 Month Follow-up|Lost contact|14
1217421|NCT00809445|3995735|P2|6 Month Follow-up|Lost contact|14
1217422|NCT00809445|3995736|P1|6 Month Follow-up|Lost contact|16
1217423|NCT00809445|3995734|P3|1 Month Follow-up|Incarcerated|1
1217424|NCT00809445|3995735|P2|1 Month Follow-up|Incarcerated|0
1217425|NCT00809445|3995736|P1|1 Month Follow-up|Incarcerated|0
1217426|NCT00809445|3995734|P3|1 Month Follow-up|Death|1
1217427|NCT00809445|3995735|P2|1 Month Follow-up|Death|1
1217428|NCT00809445|3995736|P1|1 Month Follow-up|Death|0
1217429|NCT00809445|3995734|P3|1 Month Follow-up|Withdrew consent|1
1217430|NCT00809445|3995735|P2|1 Month Follow-up|Withdrew consent|1
1217431|NCT00809445|3995736|P1|1 Month Follow-up|Withdrew consent|1
1217432|NCT00809445|3995734|P3|1 Month Follow-up|Lost contact|1
1217433|NCT00809445|3995735|P2|1 Month Follow-up|Lost contact|2
1217434|NCT00809445|3995736|P1|1 Month Follow-up|Lost contact|1
1217435|NCT00809341|3995755|P2|Overall Study|Physician Decision|1
1217436|NCT00809341|3995756|P1|Overall Study|Physician Decision|0
1217437|NCT00809328|3995764|P1|Overall Study|Withdrawal by Subject|2
1217438|NCT00809328|3995764|P1|Overall Study|Protocol Violation|3
1217439|NCT00809328|3995764|P1|Overall Study|Adverse Event|6
1217440|NCT00809328|3995764|P1|Overall Study|Lack of Efficacy|18
1217441|NCT00809159|3995784|P6|Part 1 and 2|Withdrawal by Subject|1
1217442|NCT00809159|3995785|P5|Part 1 and 2|Withdrawal by Subject|0
1217443|NCT00809159|3995786|P4|Part 1 and 2|Withdrawal by Subject|0
1217444|NCT00809159|3995787|P3|Part 1 and 2|Withdrawal by Subject|4
1217445|NCT00809159|3995788|P2|Part 1 and 2|Withdrawal by Subject|0
1217446|NCT00809159|3995789|P1|Part 1 and 2|Withdrawal by Subject|0
1217447|NCT00809159|3995784|P6|Part 1 and 2|Lost to Follow-up|0
1217448|NCT00809159|3995785|P5|Part 1 and 2|Lost to Follow-up|0
1217449|NCT00809159|3995786|P4|Part 1 and 2|Lost to Follow-up|1
1217450|NCT00809159|3995787|P3|Part 1 and 2|Lost to Follow-up|1
1217451|NCT00809159|3995788|P2|Part 1 and 2|Lost to Follow-up|0
1217452|NCT00809159|3995789|P1|Part 1 and 2|Lost to Follow-up|0
1217453|NCT00809159|3995784|P6|Part 1 and 2|Adverse Event|1
1217454|NCT00809159|3995785|P5|Part 1 and 2|Adverse Event|1
1217455|NCT00809159|3995786|P4|Part 1 and 2|Adverse Event|0
1217456|NCT00809159|3995787|P3|Part 1 and 2|Adverse Event|1
1217457|NCT00809159|3995788|P2|Part 1 and 2|Adverse Event|0
1217458|NCT00809159|3995789|P1|Part 1 and 2|Adverse Event|0
1217459|NCT00809159|3995784|P6|Part 1 and 2|Administrative problems|0
1217460|NCT00809159|3995785|P5|Part 1 and 2|Administrative problems|0
1217461|NCT00809159|3995786|P4|Part 1 and 2|Administrative problems|1
1217462|NCT00809159|3995787|P3|Part 1 and 2|Administrative problems|0
1217463|NCT00809159|3995788|P2|Part 1 and 2|Administrative problems|0
1217464|NCT00809159|3995789|P1|Part 1 and 2|Administrative problems|0
1217465|NCT00809159|3995784|P6|Part 1 and 2|Unsatisfactory therapeutic effect|1
1217466|NCT00809159|3995785|P5|Part 1 and 2|Unsatisfactory therapeutic effect|5
1217467|NCT00809159|3995786|P4|Part 1 and 2|Unsatisfactory therapeutic effect|3
1217468|NCT00809159|3995787|P3|Part 1 and 2|Unsatisfactory therapeutic effect|4
1217469|NCT00809159|3995788|P2|Part 1 and 2|Unsatisfactory therapeutic effect|0
1217470|NCT00809159|3995789|P1|Part 1 and 2|Unsatisfactory therapeutic effect|0
1217471|NCT00809159|3995784|P6|Part 1|Unsatisfactory therapeutic effect|0
1217472|NCT00809159|3995785|P5|Part 1|Unsatisfactory therapeutic effect|0
1217473|NCT00809159|3995786|P4|Part 1|Unsatisfactory therapeutic effect|0
1217474|NCT00809159|3995787|P3|Part 1|Unsatisfactory therapeutic effect|0
1217475|NCT00809159|3995788|P2|Part 1|Unsatisfactory therapeutic effect|1
1217476|NCT00809159|3995789|P1|Part 1|Unsatisfactory therapeutic effect|3
1217477|NCT00809159|3995784|P6|Part 1|Withdrawal by Subject|0
1217478|NCT00809159|3995785|P5|Part 1|Withdrawal by Subject|0
1217479|NCT00809159|3995786|P4|Part 1|Withdrawal by Subject|0
1217480|NCT00809159|3995787|P3|Part 1|Withdrawal by Subject|0
1217481|NCT00809159|3995788|P2|Part 1|Withdrawal by Subject|1
1217482|NCT00809159|3995789|P1|Part 1|Withdrawal by Subject|3
1217483|NCT00809159|3995784|P6|Part 1|Lost to Follow-up|0
1217484|NCT00809159|3995785|P5|Part 1|Lost to Follow-up|0
1217485|NCT00809159|3995786|P4|Part 1|Lost to Follow-up|0
1217486|NCT00809159|3995787|P3|Part 1|Lost to Follow-up|0
1217487|NCT00809159|3995788|P2|Part 1|Lost to Follow-up|0
1217488|NCT00809159|3995789|P1|Part 1|Lost to Follow-up|1
1217489|NCT00809159|3995784|P6|Part 1|Adverse Event|0
1217490|NCT00809159|3995785|P5|Part 1|Adverse Event|0
1217491|NCT00809159|3995786|P4|Part 1|Adverse Event|0
1217492|NCT00809159|3995787|P3|Part 1|Adverse Event|0
1217493|NCT00809159|3995788|P2|Part 1|Adverse Event|1
1217494|NCT00809159|3995789|P1|Part 1|Adverse Event|1
1217495|NCT00809133|3995894|P14|Overall Study|Other not mentioned above|0
1217496|NCT00809133|3995895|P13|Overall Study|Other not mentioned above|0
1217497|NCT00809133|3995896|P12|Overall Study|Other not mentioned above|0
1217498|NCT00809133|3995897|P11|Overall Study|Other not mentioned above|0
1217499|NCT00809133|3995898|P10|Overall Study|Other not mentioned above|0
1217500|NCT00809133|3995899|P9|Overall Study|Other not mentioned above|0
1217501|NCT00809133|3995900|P8|Overall Study|Other not mentioned above|0
1217502|NCT00809133|3995901|P7|Overall Study|Other not mentioned above|0
1217503|NCT00809133|3995902|P6|Overall Study|Other not mentioned above|1
1217504|NCT00809133|3995903|P5|Overall Study|Other not mentioned above|0
1217505|NCT00809133|3995904|P4|Overall Study|Other not mentioned above|0
1217506|NCT00809133|3995905|P3|Overall Study|Other not mentioned above|0
1217507|NCT00809133|3995906|P2|Overall Study|Other not mentioned above|1
1217508|NCT00809133|3995907|P1|Overall Study|Other not mentioned above|0
1217509|NCT00809133|3995894|P14|Overall Study|Consent withdrawn|0
1217510|NCT00809133|3995895|P13|Overall Study|Consent withdrawn|0
1217511|NCT00809133|3995896|P12|Overall Study|Consent withdrawn|0
1217512|NCT00809133|3995897|P11|Overall Study|Consent withdrawn|0
1217513|NCT00809133|3995898|P10|Overall Study|Consent withdrawn|0
1217514|NCT00809133|3995899|P9|Overall Study|Consent withdrawn|0
1217515|NCT00809133|3995900|P8|Overall Study|Consent withdrawn|0
1217516|NCT00809133|3995901|P7|Overall Study|Consent withdrawn|0
1217517|NCT00809133|3995902|P6|Overall Study|Consent withdrawn|0
1217518|NCT00809133|3995903|P5|Overall Study|Consent withdrawn|1
1217519|NCT00809133|3995904|P4|Overall Study|Consent withdrawn|0
1217520|NCT00809133|3995905|P3|Overall Study|Consent withdrawn|0
1217521|NCT00809133|3995906|P2|Overall Study|Consent withdrawn|0
1217522|NCT00809133|3995907|P1|Overall Study|Consent withdrawn|0
1217523|NCT00809133|3995894|P14|Overall Study|Lost to Follow-up|0
1217524|NCT00809133|3995895|P13|Overall Study|Lost to Follow-up|0
1217525|NCT00809133|3995896|P12|Overall Study|Lost to Follow-up|0
1217526|NCT00809133|3995897|P11|Overall Study|Lost to Follow-up|0
1217527|NCT00809133|3995898|P10|Overall Study|Lost to Follow-up|0
1217528|NCT00809133|3995899|P9|Overall Study|Lost to Follow-up|0
1217529|NCT00809133|3995900|P8|Overall Study|Lost to Follow-up|0
1217530|NCT00809133|3995901|P7|Overall Study|Lost to Follow-up|0
1217531|NCT00809133|3995902|P6|Overall Study|Lost to Follow-up|1
1217532|NCT00809133|3995903|P5|Overall Study|Lost to Follow-up|0
1217533|NCT00809133|3995904|P4|Overall Study|Lost to Follow-up|0
1217534|NCT00809133|3995905|P3|Overall Study|Lost to Follow-up|0
1217535|NCT00809133|3995906|P2|Overall Study|Lost to Follow-up|0
1217536|NCT00809133|3995907|P1|Overall Study|Lost to Follow-up|0
1217537|NCT00809133|3995894|P14|Overall Study|Other adverse event|1
1217538|NCT00809133|3995895|P13|Overall Study|Other adverse event|0
1217539|NCT00809133|3995896|P12|Overall Study|Other adverse event|1
1217540|NCT00809133|3995897|P11|Overall Study|Other adverse event|1
1217541|NCT00809133|3995898|P10|Overall Study|Other adverse event|0
1217542|NCT00809133|3995899|P9|Overall Study|Other adverse event|0
1217543|NCT00809133|3995900|P8|Overall Study|Other adverse event|4
1217544|NCT00809133|3995901|P7|Overall Study|Other adverse event|2
1217545|NCT00809133|3995902|P6|Overall Study|Other adverse event|3
1217546|NCT00809133|3995903|P5|Overall Study|Other adverse event|0
1217547|NCT00809133|3995904|P4|Overall Study|Other adverse event|0
1217548|NCT00809133|3995905|P3|Overall Study|Other adverse event|1
1217549|NCT00809133|3995906|P2|Overall Study|Other adverse event|1
1217550|NCT00809133|3995907|P1|Overall Study|Other adverse event|1
1217551|NCT00809133|3995894|P14|Overall Study|Dose Limiting Toxicity (DLT)|2
1217552|NCT00809133|3995895|P13|Overall Study|Dose Limiting Toxicity (DLT)|0
1217553|NCT00809133|3995896|P12|Overall Study|Dose Limiting Toxicity (DLT)|0
1217554|NCT00809133|3995897|P11|Overall Study|Dose Limiting Toxicity (DLT)|0
1217555|NCT00809133|3995898|P10|Overall Study|Dose Limiting Toxicity (DLT)|0
1217556|NCT00809133|3995899|P9|Overall Study|Dose Limiting Toxicity (DLT)|0
1217557|NCT00809133|3995900|P8|Overall Study|Dose Limiting Toxicity (DLT)|1
1217558|NCT00809133|3995901|P7|Overall Study|Dose Limiting Toxicity (DLT)|1
1217559|NCT00809133|3995902|P6|Overall Study|Dose Limiting Toxicity (DLT)|1
1217560|NCT00809133|3995903|P5|Overall Study|Dose Limiting Toxicity (DLT)|0
1217561|NCT00809133|3995904|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
1217562|NCT00809133|3995905|P3|Overall Study|Dose Limiting Toxicity (DLT)|0
1217563|NCT00809133|3995906|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
1217564|NCT00809133|3995907|P1|Overall Study|Dose Limiting Toxicity (DLT)|0
1217565|NCT00809133|3995894|P14|Overall Study|Progressive disease|4
1217566|NCT00809133|3995895|P13|Overall Study|Progressive disease|5
1217567|NCT00809133|3995896|P12|Overall Study|Progressive disease|7
1217568|NCT00809133|3995897|P11|Overall Study|Progressive disease|5
1217569|NCT00809133|3995898|P10|Overall Study|Progressive disease|9
1217570|NCT00809133|3995899|P9|Overall Study|Progressive disease|3
1217571|NCT00809133|3995900|P8|Overall Study|Progressive disease|3
1217572|NCT00809133|3995901|P7|Overall Study|Progressive disease|3
1217573|NCT00809133|3995902|P6|Overall Study|Progressive disease|1
1217574|NCT00809133|3995903|P5|Overall Study|Progressive disease|4
1217575|NCT00809133|3995904|P4|Overall Study|Progressive disease|3
1217576|NCT00809133|3995905|P3|Overall Study|Progressive disease|5
1217577|NCT00809133|3995906|P2|Overall Study|Progressive disease|5
1217578|NCT00809133|3995907|P1|Overall Study|Progressive disease|2
1217579|NCT00809094|3996061|P2|Overall Study|Lost to Follow-up|1
1217580|NCT00809094|3996062|P1|Overall Study|Lost to Follow-up|0
1217581|NCT00808899|3996107|P1|Overall Study|Physician Decision|3
1217582|NCT00808899|3996107|P1|Overall Study|Death|1
1217583|NCT00808808|3996121|P3|Overall Study|Employee was not vaccinated.|2255
1217584|NCT00808808|3996122|P2|Overall Study|Employee was not vaccinated.|2268
1217585|NCT00808808|3996123|P1|Overall Study|Employee was not vaccinated.|2686
1217586|NCT00808808|3996121|P3|Overall Study|Vaccinated; survey not completed|302
1217587|NCT00808808|3996122|P2|Overall Study|Vaccinated; survey not completed|169
1217588|NCT00808808|3996123|P1|Overall Study|Vaccinated; survey not completed|131
1217589|NCT00808665|3996158|P2|Overall Study|Medication stopped by resident|1
1217590|NCT00808665|3996159|P1|Overall Study|Medication stopped by resident|0
1217591|NCT00808665|3996158|P2|Overall Study|Physician Decision|1
1217592|NCT00808665|3996159|P1|Overall Study|Physician Decision|3
1217593|NCT00808665|3996158|P2|Overall Study|required an additional procedure|1
1217594|NCT00808665|3996159|P1|Overall Study|required an additional procedure|0
1217595|NCT00808665|3996158|P2|Overall Study|surgery cancelled|0
1217596|NCT00808665|3996159|P1|Overall Study|surgery cancelled|1
1217597|NCT00808665|3996158|P2|Overall Study|only required minimally invasive surgery|0
1217598|NCT00808665|3996159|P1|Overall Study|only required minimally invasive surgery|1
1217599|NCT00808665|3996158|P2|Overall Study|Withdrawal by Subject|0
1217600|NCT00808665|3996159|P1|Overall Study|Withdrawal by Subject|1
1217601|NCT00808639|3996165|P1|Overall Study|Disease progression before surgery.|1
1217602|NCT00808509|3996173|P2|Randomized Phase|Patient refused rescue therapy|3
1217603|NCT00808509|3996174|P1|Randomized Phase|Patient refused rescue therapy|0
1217604|NCT00808509|3996173|P2|Randomized Phase|Reduced methotrexate dose|2
1217605|NCT00808509|3996174|P1|Randomized Phase|Reduced methotrexate dose|1
1217606|NCT00808509|3996173|P2|Randomized Phase|Did not meet eligibility criteria|0
1217607|NCT00808509|3996174|P1|Randomized Phase|Did not meet eligibility criteria|1
1217608|NCT00808483|3996272|P2|From 5 Months to 12 Months|Lack of Efficacy|0
1217609|NCT00808483|3996273|P1|From 5 Months to 12 Months|Lack of Efficacy|1
1217610|NCT00808483|3996272|P2|From 3 to 5 Months After Surgery|Lack of Efficacy|0
1217611|NCT00808483|3996273|P1|From 3 to 5 Months After Surgery|Lack of Efficacy|1
1217612|NCT00808483|3996272|P2|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
1217613|NCT00808483|3996273|P1|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
1217614|NCT00808444|3996310|P2|Overall Study|Lost to Follow-up|1
1217615|NCT00808444|3996311|P1|Overall Study|Lost to Follow-up|0
1217616|NCT00808444|3996310|P2|Overall Study|Withdrawal by Subject|0
1217617|NCT00808444|3996311|P1|Overall Study|Withdrawal by Subject|1
1217618|NCT00808249|3996386|P4|Overall Study|All other reasons|1
1217619|NCT00808249|3996387|P3|Overall Study|All other reasons|3
1217620|NCT00808249|3996388|P2|Overall Study|All other reasons|1
1217621|NCT00808249|3996389|P1|Overall Study|All other reasons|2
1217622|NCT00808249|3996386|P4|Overall Study|study specific discontinuation criteria|0
1217623|NCT00808249|3996387|P3|Overall Study|study specific discontinuation criteria|1
1217624|NCT00808249|3996388|P2|Overall Study|study specific discontinuation criteria|0
1217625|NCT00808249|3996389|P1|Overall Study|study specific discontinuation criteria|1
1217626|NCT00808249|3996386|P4|Overall Study|Lack of Efficacy|0
1217627|NCT00808249|3996387|P3|Overall Study|Lack of Efficacy|0
1217628|NCT00808249|3996388|P2|Overall Study|Lack of Efficacy|1
1217629|NCT00808249|3996389|P1|Overall Study|Lack of Efficacy|1
1217630|NCT00808249|3996386|P4|Overall Study|Protocol Violation|0
1217631|NCT00808249|3996387|P3|Overall Study|Protocol Violation|3
1217632|NCT00808249|3996388|P2|Overall Study|Protocol Violation|3
1217633|NCT00808249|3996389|P1|Overall Study|Protocol Violation|3
1217634|NCT00808249|3996386|P4|Overall Study|Withdrawal by Subject|4
1217635|NCT00808249|3996387|P3|Overall Study|Withdrawal by Subject|2
1217636|NCT00808249|3996388|P2|Overall Study|Withdrawal by Subject|0
1217637|NCT00808249|3996389|P1|Overall Study|Withdrawal by Subject|4
1217638|NCT00808249|3996386|P4|Overall Study|Lost to Follow-up|5
1217639|NCT00808249|3996387|P3|Overall Study|Lost to Follow-up|3
1217640|NCT00808249|3996388|P2|Overall Study|Lost to Follow-up|3
1217641|NCT00808249|3996389|P1|Overall Study|Lost to Follow-up|2
1217642|NCT00808249|3996386|P4|Overall Study|Adverse Event|6
1217643|NCT00808249|3996387|P3|Overall Study|Adverse Event|10
1217644|NCT00808249|3996388|P2|Overall Study|Adverse Event|7
1217645|NCT00808249|3996389|P1|Overall Study|Adverse Event|4
1217646|NCT00808236|3996417|P2|Overall Study|Death|30
1217647|NCT00808236|3996418|P1|Overall Study|Death|18
1217648|NCT00808236|3996417|P2|Overall Study|Physician Decision|1
1217649|NCT00808236|3996418|P1|Overall Study|Physician Decision|0
1217650|NCT00808236|3996417|P2|Overall Study|Lost to Follow-up|1
1217651|NCT00808236|3996418|P1|Overall Study|Lost to Follow-up|1
1217652|NCT00808236|3996417|P2|Overall Study|Pre-defined exclusion|3
1217653|NCT00808236|3996418|P1|Overall Study|Pre-defined exclusion|13
1217654|NCT00808236|3996417|P2|Overall Study|Was not resuscitated|56
1217655|NCT00808236|3996418|P1|Overall Study|Was not resuscitated|50
1217656|NCT00808132|3996451|P5|Overall Study|Unsatisfactory response|12
1217657|NCT00808132|3996452|P4|Overall Study|Unsatisfactory response|4
1217658|NCT00808132|3996453|P3|Overall Study|Unsatisfactory response|6
1217659|NCT00808132|3996454|P2|Overall Study|Unsatisfactory response|6
1217660|NCT00808132|3996455|P1|Overall Study|Unsatisfactory response|5
1217661|NCT00808132|3996451|P5|Overall Study|Randomized, but not treated|9
1217662|NCT00808132|3996452|P4|Overall Study|Randomized, but not treated|8
1217663|NCT00808132|3996453|P3|Overall Study|Randomized, but not treated|9
1217664|NCT00808132|3996454|P2|Overall Study|Randomized, but not treated|7
1217665|NCT00808132|3996455|P1|Overall Study|Randomized, but not treated|10
1217666|NCT00808132|3996451|P5|Overall Study|Other|15
1217667|NCT00808132|3996452|P4|Overall Study|Other|2
1217668|NCT00808132|3996453|P3|Overall Study|Other|6
1217669|NCT00808132|3996454|P2|Overall Study|Other|4
1217670|NCT00808132|3996455|P1|Overall Study|Other|6
1217671|NCT00808132|3996451|P5|Overall Study|Withdrawal by Subject|16
1217672|NCT00808132|3996452|P4|Overall Study|Withdrawal by Subject|7
1217673|NCT00808132|3996453|P3|Overall Study|Withdrawal by Subject|2
1217674|NCT00808132|3996454|P2|Overall Study|Withdrawal by Subject|18
1217675|NCT00808132|3996455|P1|Overall Study|Withdrawal by Subject|27
1217676|NCT00808132|3996451|P5|Overall Study|Protocol Violation|5
1217677|NCT00808132|3996452|P4|Overall Study|Protocol Violation|9
1217678|NCT00808132|3996453|P3|Overall Study|Protocol Violation|4
1217679|NCT00808132|3996454|P2|Overall Study|Protocol Violation|9
1217680|NCT00808132|3996455|P1|Overall Study|Protocol Violation|8
1217681|NCT00808132|3996451|P5|Overall Study|Lost to Follow-up|9
1217682|NCT00808132|3996452|P4|Overall Study|Lost to Follow-up|8
1217683|NCT00808132|3996453|P3|Overall Study|Lost to Follow-up|11
1217684|NCT00808132|3996454|P2|Overall Study|Lost to Follow-up|10
1217685|NCT00808132|3996455|P1|Overall Study|Lost to Follow-up|8
1217686|NCT00808132|3996451|P5|Overall Study|Physician Decision|0
1217687|NCT00808132|3996452|P4|Overall Study|Physician Decision|0
1217688|NCT00808132|3996453|P3|Overall Study|Physician Decision|0
1217689|NCT00808132|3996454|P2|Overall Study|Physician Decision|1
1217690|NCT00808132|3996455|P1|Overall Study|Physician Decision|0
1217691|NCT00808132|3996451|P5|Overall Study|Death|1
1217692|NCT00808132|3996452|P4|Overall Study|Death|0
1217693|NCT00808132|3996453|P3|Overall Study|Death|0
1217694|NCT00808132|3996454|P2|Overall Study|Death|0
1217695|NCT00808132|3996455|P1|Overall Study|Death|0
1217696|NCT00808132|3996451|P5|Overall Study|Adverse Event|33
1217697|NCT00808132|3996452|P4|Overall Study|Adverse Event|31
1217698|NCT00808132|3996453|P3|Overall Study|Adverse Event|16
1217699|NCT00808132|3996454|P2|Overall Study|Adverse Event|33
1217700|NCT00808132|3996455|P1|Overall Study|Adverse Event|34
1217701|NCT00808080|3996527|P1|Overall Study|Patients Became Ineligible for infusion|6
1217702|NCT00808067|3996533|P2|Overall Study|Excluded from analysis|19
1217703|NCT00808067|3996534|P1|Overall Study|Excluded from analysis|13
1217704|NCT00808067|3996533|P2|Overall Study|Other reason not defined above|5
1217705|NCT00808067|3996534|P1|Overall Study|Other reason not defined above|5
1217706|NCT00808067|3996533|P2|Overall Study|Site closed for cause|19
1217707|NCT00808067|3996534|P1|Overall Study|Site closed for cause|19
1217708|NCT00808067|3996533|P2|Overall Study|Patient elected|9
1217709|NCT00808067|3996534|P1|Overall Study|Patient elected|7
1217710|NCT00808067|3996533|P2|Overall Study|Protocol Violation|11
1217711|NCT00808067|3996534|P1|Overall Study|Protocol Violation|3
1217712|NCT00808067|3996533|P2|Overall Study|Physician Decision|38
1217713|NCT00808067|3996534|P1|Overall Study|Physician Decision|47
1217714|NCT00808067|3996533|P2|Overall Study|Site closed|3
1217715|NCT00808067|3996534|P1|Overall Study|Site closed|4
1217716|NCT00808067|3996533|P2|Overall Study|Withdrawal by Subject|25
1217717|NCT00808067|3996534|P1|Overall Study|Withdrawal by Subject|21
1217718|NCT00808067|3996533|P2|Overall Study|Procedure|7
1217719|NCT00808067|3996534|P1|Overall Study|Procedure|6
1217720|NCT00808067|3996533|P2|Overall Study|Death|1
1217721|NCT00808067|3996534|P1|Overall Study|Death|1
1217722|NCT00808067|3996533|P2|Overall Study|Missing|0
1217723|NCT00808067|3996534|P1|Overall Study|Missing|1
1217724|NCT00808067|3996533|P2|Overall Study|Patient refused to take study medication|76
1217725|NCT00808067|3996534|P1|Overall Study|Patient refused to take study medication|65
1217726|NCT00808067|3996533|P2|Overall Study|Elevated LFT results|3
1217727|NCT00808067|3996534|P1|Overall Study|Elevated LFT results|7
1217728|NCT00808067|3996533|P2|Overall Study|Reduced creatinine clearance|55
1217729|NCT00808067|3996534|P1|Overall Study|Reduced creatinine clearance|53
1217730|NCT00808067|3996533|P2|Overall Study|Hospitalization due to surgery|40
1217731|NCT00808067|3996534|P1|Overall Study|Hospitalization due to surgery|37
1217732|NCT00808067|3996533|P2|Overall Study|Hospitalization (not including surgery)|17
1217733|NCT00808067|3996534|P1|Overall Study|Hospitalization (not including surgery)|18
1217734|NCT00808067|3996533|P2|Overall Study|Adverse Event|121
1217735|NCT00808067|3996534|P1|Overall Study|Adverse Event|111
1217736|NCT00808067|3996533|P2|Overall Study|Outcome event - other|25
1217737|NCT00808067|3996534|P1|Overall Study|Outcome event - other|33
1217738|NCT00808067|3996533|P2|Overall Study|Major/minor bleed|44
1217739|NCT00808067|3996534|P1|Overall Study|Major/minor bleed|30
1217740|NCT00808028|3996570|P4|Stage 2 (Followed up to 48 Months )|Non-compliance|0
1217741|NCT00808028|3996571|P3|Stage 2 (Followed up to 48 Months )|Non-compliance|1
1217742|NCT00808028|3996572|P2|Stage 2 (Followed up to 48 Months )|Non-compliance|0
1217743|NCT00808028|3996573|P1|Stage 2 (Followed up to 48 Months )|Non-compliance|0
1217744|NCT00808028|3996570|P4|Stage 2 (Followed up to 48 Months )|Death|0
1217745|NCT00808028|3996571|P3|Stage 2 (Followed up to 48 Months )|Death|1
1217746|NCT00808028|3996572|P2|Stage 2 (Followed up to 48 Months )|Death|0
1217747|NCT00808028|3996573|P1|Stage 2 (Followed up to 48 Months )|Death|0
1217748|NCT00808028|3996570|P4|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
1217749|NCT00808028|3996571|P3|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2
1217750|NCT00808028|3996572|P2|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
1217751|NCT00808028|3996573|P1|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
1217752|NCT00808028|3996570|P4|Stage 2 (Followed up to 48 Months )|Other|1
1217753|NCT00808028|3996571|P3|Stage 2 (Followed up to 48 Months )|Other|1
1217754|NCT00808028|3996572|P2|Stage 2 (Followed up to 48 Months )|Other|0
1217755|NCT00808028|3996573|P1|Stage 2 (Followed up to 48 Months )|Other|0
1217756|NCT00808028|3996570|P4|Stage 2 (Followed up to 48 Months )|Adverse Event|0
1217757|NCT00808028|3996571|P3|Stage 2 (Followed up to 48 Months )|Adverse Event|1
1217758|NCT00808028|3996572|P2|Stage 2 (Followed up to 48 Months )|Adverse Event|0
1217759|NCT00808028|3996573|P1|Stage 2 (Followed up to 48 Months )|Adverse Event|1
1217760|NCT00808028|3996570|P4|Stage 2 (Followed up to 48 Months )|Failed to return|4
1217761|NCT00808028|3996571|P3|Stage 2 (Followed up to 48 Months )|Failed to return|5
1217762|NCT00808028|3996572|P2|Stage 2 (Followed up to 48 Months )|Failed to return|0
1217763|NCT00808028|3996573|P1|Stage 2 (Followed up to 48 Months )|Failed to return|2
1217764|NCT00808028|3996570|P4|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7
1217765|NCT00808028|3996571|P3|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8
1217766|NCT00808028|3996572|P2|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0
1217767|NCT00808028|3996573|P1|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2
1217768|NCT00808028|3996570|P4|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
1217769|NCT00808028|3996571|P3|Stage 2 (Followed up to 48 Months )|Protocol Violation|1
1217770|NCT00808028|3996572|P2|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
1217771|NCT00808028|3996573|P1|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
1217772|NCT00808028|3996570|P4|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11
1217773|NCT00808028|3996571|P3|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9
1217774|NCT00808028|3996572|P2|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0
1217775|NCT00808028|3996573|P1|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6
1217776|NCT00808028|3996570|P4|Stage 1 (6 Months)|Protocol Violation|1
1217777|NCT00808028|3996571|P3|Stage 1 (6 Months)|Protocol Violation|0
1217778|NCT00808028|3996572|P2|Stage 1 (6 Months)|Protocol Violation|0
1217779|NCT00808028|3996573|P1|Stage 1 (6 Months)|Protocol Violation|0
1217780|NCT00808028|3996570|P4|Stage 1 (6 Months)|Lost to Follow-up|0
1217781|NCT00808028|3996571|P3|Stage 1 (6 Months)|Lost to Follow-up|1
1217782|NCT00808028|3996572|P2|Stage 1 (6 Months)|Lost to Follow-up|0
1217783|NCT00808028|3996573|P1|Stage 1 (6 Months)|Lost to Follow-up|1
1217784|NCT00808028|3996570|P4|Stage 1 (6 Months)|Adverse Event|2
1217785|NCT00808028|3996571|P3|Stage 1 (6 Months)|Adverse Event|1
1217786|NCT00808028|3996572|P2|Stage 1 (6 Months)|Adverse Event|0
1217787|NCT00808028|3996573|P1|Stage 1 (6 Months)|Adverse Event|0
1217788|NCT00808028|3996570|P4|Stage 1 (6 Months)|Parent/legal guardian request|3
1217789|NCT00808028|3996571|P3|Stage 1 (6 Months)|Parent/legal guardian request|1
1217790|NCT00808028|3996572|P2|Stage 1 (6 Months)|Parent/legal guardian request|1
1217791|NCT00808028|3996573|P1|Stage 1 (6 Months)|Parent/legal guardian request|0
1217792|NCT00808028|3996570|P4|Stage 1 (6 Months)|Other|4
1217793|NCT00808028|3996571|P3|Stage 1 (6 Months)|Other|2
1217794|NCT00808028|3996572|P2|Stage 1 (6 Months)|Other|0
1217795|NCT00808028|3996573|P1|Stage 1 (6 Months)|Other|1
1217796|NCT00808028|3996570|P4|Stage 1 (6 Months)|Withdrawal by Subject|5
1217797|NCT00808028|3996571|P3|Stage 1 (6 Months)|Withdrawal by Subject|2
1217798|NCT00808028|3996572|P2|Stage 1 (6 Months)|Withdrawal by Subject|0
1217799|NCT00808028|3996573|P1|Stage 1 (6 Months)|Withdrawal by Subject|3
1217800|NCT00808015|3996609|P1|Overall Study|Enrolled but not treated|4
1217801|NCT00808015|3996609|P1|Overall Study|Other|25
1217802|NCT00808015|3996609|P1|Overall Study|Adverse Event|22
1217803|NCT00808015|3996609|P1|Overall Study|Participants not willing to participate|158
1217804|NCT00808015|3996609|P1|Overall Study|Lost to Follow-up|76
1217805|NCT00808015|3996609|P1|Overall Study|Lack of Efficacy|58
1217806|NCT00808015|3996609|P1|Overall Study|Death|1
1217807|NCT00807937|3996638|P4|Overall Study|All other reasons (not provided)|1
1217808|NCT00807937|3996639|P3|Overall Study|All other reasons (not provided)|0
1217809|NCT00807937|3996640|P2|Overall Study|All other reasons (not provided)|4
1217810|NCT00807937|3996641|P1|Overall Study|All other reasons (not provided)|2
1217811|NCT00807937|3996638|P4|Overall Study|Intake of prohibited medicine|0
1217812|NCT00807937|3996639|P3|Overall Study|Intake of prohibited medicine|2
1217813|NCT00807937|3996640|P2|Overall Study|Intake of prohibited medicine|0
1217814|NCT00807937|3996641|P1|Overall Study|Intake of prohibited medicine|0
1217815|NCT00807937|3996638|P4|Overall Study|Lack of Efficacy|2
1217816|NCT00807937|3996639|P3|Overall Study|Lack of Efficacy|1
1217817|NCT00807937|3996640|P2|Overall Study|Lack of Efficacy|0
1217818|NCT00807937|3996641|P1|Overall Study|Lack of Efficacy|0
1217819|NCT00807937|3996638|P4|Overall Study|Lost to Follow-up|1
1217820|NCT00807937|3996639|P3|Overall Study|Lost to Follow-up|2
1217821|NCT00807937|3996640|P2|Overall Study|Lost to Follow-up|0
1217822|NCT00807937|3996641|P1|Overall Study|Lost to Follow-up|4
1217823|NCT00807937|3996638|P4|Overall Study|Withdrawal by Subject|4
1217824|NCT00807937|3996639|P3|Overall Study|Withdrawal by Subject|1
1217825|NCT00807937|3996640|P2|Overall Study|Withdrawal by Subject|4
1217826|NCT00807937|3996641|P1|Overall Study|Withdrawal by Subject|5
1217827|NCT00807937|3996638|P4|Overall Study|Protocol Violation|3
1217828|NCT00807937|3996639|P3|Overall Study|Protocol Violation|3
1217829|NCT00807937|3996640|P2|Overall Study|Protocol Violation|5
1217830|NCT00807937|3996641|P1|Overall Study|Protocol Violation|4
1217831|NCT00807937|3996638|P4|Overall Study|Adverse Event|4
1217832|NCT00807937|3996639|P3|Overall Study|Adverse Event|5
1217833|NCT00807937|3996640|P2|Overall Study|Adverse Event|12
1217834|NCT00807937|3996641|P1|Overall Study|Adverse Event|12
1217835|NCT00807885|3996676|P9|Overall Study|Lost to Follow-up|0
1217836|NCT00807885|3996677|P8|Overall Study|Lost to Follow-up|0
1217837|NCT00807885|3996678|P7|Overall Study|Lost to Follow-up|0
1217838|NCT00807885|3996679|P6|Overall Study|Lost to Follow-up|1
1217839|NCT00807885|3996680|P5|Overall Study|Lost to Follow-up|0
1217840|NCT00807885|3996681|P4|Overall Study|Lost to Follow-up|0
1217841|NCT00807885|3996682|P3|Overall Study|Lost to Follow-up|0
1217842|NCT00807885|3996683|P2|Overall Study|Lost to Follow-up|0
1217843|NCT00807885|3996684|P1|Overall Study|Lost to Follow-up|0
1217844|NCT00807846|3996733|P2|Overall Study|Not Specified|2
1217845|NCT00807846|3996734|P1|Overall Study|Not Specified|1
1217846|NCT00807846|3996733|P2|Overall Study|Withdrawal by Subject|1
1217847|NCT00807846|3996734|P1|Overall Study|Withdrawal by Subject|2
1217848|NCT00807846|3996733|P2|Overall Study|Protocol Violation|1
1217849|NCT00807846|3996734|P1|Overall Study|Protocol Violation|2
1217850|NCT00807846|3996733|P2|Overall Study|Lack of Efficacy|0
1217851|NCT00807846|3996734|P1|Overall Study|Lack of Efficacy|2
1217852|NCT00807846|3996733|P2|Overall Study|Adverse Event|0
1217853|NCT00807846|3996734|P1|Overall Study|Adverse Event|5
1217854|NCT00807573|3996798|P1|Overall Study|Adverse Event|1
1217855|NCT00807573|3996798|P1|Overall Study|Withdrawal by Subject|1
1217856|NCT00807495|3996844|P5|Overall Study|Reason Not Specified|3
1217857|NCT00807495|3996845|P4|Overall Study|Reason Not Specified|0
1217858|NCT00807495|3996846|P3|Overall Study|Reason Not Specified|2
1217859|NCT00807495|3996847|P2|Overall Study|Reason Not Specified|3
1217860|NCT00807495|3996848|P1|Overall Study|Reason Not Specified|0
1217861|NCT00807495|3996844|P5|Overall Study|Withdrawal by Patient|0
1217862|NCT00807495|3996845|P4|Overall Study|Withdrawal by Patient|0
1217863|NCT00807495|3996846|P3|Overall Study|Withdrawal by Patient|1
1217864|NCT00807495|3996847|P2|Overall Study|Withdrawal by Patient|0
1217865|NCT00807495|3996848|P1|Overall Study|Withdrawal by Patient|2
1217866|NCT00807495|3996844|P5|Overall Study|Adverse Event|2
1217867|NCT00807495|3996845|P4|Overall Study|Adverse Event|1
1217868|NCT00807495|3996846|P3|Overall Study|Adverse Event|1
1217869|NCT00807495|3996847|P2|Overall Study|Adverse Event|3
1217870|NCT00807495|3996848|P1|Overall Study|Adverse Event|6
1217871|NCT00807365|3996894|P1|Overall Study|Study Terminated|5
1217872|NCT00807248|3996902|P4|Overall Study|Other Reason|0
1217873|NCT00807248|3996903|P3|Overall Study|Other Reason|2
1217874|NCT00807248|3996904|P2|Overall Study|Other Reason|0
1217875|NCT00807248|3996905|P1|Overall Study|Other Reason|0
1217876|NCT00807248|3996902|P4|Overall Study|Lost to Follow-up|0
1217877|NCT00807248|3996903|P3|Overall Study|Lost to Follow-up|0
1217878|NCT00807248|3996904|P2|Overall Study|Lost to Follow-up|0
1217879|NCT00807248|3996905|P1|Overall Study|Lost to Follow-up|1
1217880|NCT00807248|3996902|P4|Overall Study|Withdrawal of Consent|5
1217881|NCT00807248|3996903|P3|Overall Study|Withdrawal of Consent|5
1217882|NCT00807248|3996904|P2|Overall Study|Withdrawal of Consent|5
1217883|NCT00807248|3996905|P1|Overall Study|Withdrawal of Consent|5
1217884|NCT00807248|3996902|P4|Overall Study|Protocol Violation|0
1217885|NCT00807248|3996903|P3|Overall Study|Protocol Violation|1
1217886|NCT00807248|3996904|P2|Overall Study|Protocol Violation|1
1217887|NCT00807248|3996905|P1|Overall Study|Protocol Violation|0
1217888|NCT00807248|3996902|P4|Overall Study|Lack of Efficacy|3
1217889|NCT00807248|3996903|P3|Overall Study|Lack of Efficacy|8
1217890|NCT00807248|3996904|P2|Overall Study|Lack of Efficacy|4
1217891|NCT00807248|3996905|P1|Overall Study|Lack of Efficacy|14
1217892|NCT00807248|3996902|P4|Overall Study|Adverse Event|6
1217893|NCT00807248|3996903|P3|Overall Study|Adverse Event|2
1217894|NCT00807248|3996904|P2|Overall Study|Adverse Event|2
1217895|NCT00807248|3996905|P1|Overall Study|Adverse Event|1
1217896|NCT00807235|3996949|P2|Overall Study|Adverse Event|0
1217897|NCT00807235|3996950|P1|Overall Study|Adverse Event|1
1217898|NCT00807092|3996995|P2|Overall Study|CGMS data collection failed|1
1217899|NCT00807092|3996996|P1|Overall Study|CGMS data collection failed|0
1217900|NCT00807092|3996995|P2|Overall Study|Withdrawal by Subject|0
1217901|NCT00807092|3996996|P1|Overall Study|Withdrawal by Subject|1
1217902|NCT00807092|3996995|P2|Overall Study|Protocol Violation|2
1217903|NCT00807092|3996996|P1|Overall Study|Protocol Violation|0
1217904|NCT00807092|3996995|P2|Overall Study|Adverse Event|1
1217905|NCT00807092|3996996|P1|Overall Study|Adverse Event|0
1217906|NCT00807040|3997026|P2|Overall Study|Lost to Follow-up|6
1217907|NCT00807040|3997027|P1|Overall Study|Lost to Follow-up|4
1217908|NCT00807040|3997026|P2|Overall Study|Withdrawal by Subject|6
1217909|NCT00807040|3997027|P1|Overall Study|Withdrawal by Subject|8
1217910|NCT00807040|3997026|P2|Overall Study|Death|29
1217911|NCT00807040|3997027|P1|Overall Study|Death|24
1217912|NCT00807014|3997037|P2|Overall Study|Missed Visit 2 Due to Personal Reasons|1
1217913|NCT00807014|3997038|P1|Overall Study|Missed Visit 2 Due to Personal Reasons|0
1217914|NCT00807014|3997037|P2|Overall Study|Recovery|0
1217915|NCT00807014|3997038|P1|Overall Study|Recovery|1
1217916|NCT00807014|3997037|P2|Overall Study|Lost to Follow-up|7
1217917|NCT00807014|3997038|P1|Overall Study|Lost to Follow-up|9
1217918|NCT00807014|3997037|P2|Overall Study|Adverse Event|2
1217919|NCT00807014|3997038|P1|Overall Study|Adverse Event|0
1217920|NCT00807014|3997037|P2|Overall Study|Protocol Violation|8
1217921|NCT00807014|3997038|P1|Overall Study|Protocol Violation|2
1217922|NCT00807014|3997037|P2|Overall Study|Participant Considered Disease Not Cured|7
1217923|NCT00807014|3997038|P1|Overall Study|Participant Considered Disease Not Cured|2
1217924|NCT00807014|3997037|P2|Overall Study|Participant Considered Disease Cured|2
1217925|NCT00807014|3997038|P1|Overall Study|Participant Considered Disease Cured|13
1217926|NCT00807001|3997069|P5|Overall Study|Non-compliance|0
1217927|NCT00807001|3997070|P4|Overall Study|Non-compliance|0
1217928|NCT00807001|3997071|P3|Overall Study|Non-compliance|0
1217929|NCT00807001|3997072|P2|Overall Study|Non-compliance|1
1217930|NCT00807001|3997073|P1|Overall Study|Non-compliance|0
1217931|NCT00806988|3997092|P2|Overall Study|Lost to Follow-up|19
1217932|NCT00806988|3997093|P1|Overall Study|Lost to Follow-up|4
1217933|NCT00806988|3997092|P2|Overall Study|Withdrawal by Subject|8
1217934|NCT00806988|3997093|P1|Overall Study|Withdrawal by Subject|8
1217935|NCT00806988|3997092|P2|Overall Study|Death|16
1217936|NCT00806988|3997093|P1|Overall Study|Death|15
1217937|NCT00806819|3997103|P2|Overall Study|Reasons other than stated above|41
1217938|NCT00806819|3997104|P1|Overall Study|Reasons other than stated above|25
1217939|NCT00806819|3997103|P2|Overall Study|Not treated|3
1217940|NCT00806819|3997104|P1|Overall Study|Not treated|6
1217941|NCT00806819|3997103|P2|Overall Study|Withdrawal by Subject|29
1217942|NCT00806819|3997104|P1|Overall Study|Withdrawal by Subject|32
1217943|NCT00806819|3997103|P2|Overall Study|Lost to Follow-up|0
1217944|NCT00806819|3997104|P1|Overall Study|Lost to Follow-up|1
1217945|NCT00806819|3997103|P2|Overall Study|Protocol Violation|4
1217946|NCT00806819|3997104|P1|Overall Study|Protocol Violation|9
1217947|NCT00806819|3997103|P2|Overall Study|Other AE|40
1217948|NCT00806819|3997104|P1|Overall Study|Other AE|38
1217949|NCT00806819|3997103|P2|Overall Study|Worsening or AE of underlying disease|25
1217950|NCT00806819|3997104|P1|Overall Study|Worsening or AE of underlying disease|18
1217951|NCT00806819|3997103|P2|Overall Study|progressive disease (modified RECIST )|216
1217952|NCT00806819|3997104|P1|Overall Study|progressive disease (modified RECIST )|217
1217953|NCT00806624|3997173|P3|Overall Study|discontinued before start of treatment|1
1217954|NCT00806624|3997174|P2|Overall Study|discontinued before start of treatment|0
1217955|NCT00806624|3997175|P1|Overall Study|discontinued before start of treatment|0
1217956|NCT00806624|3997173|P3|Overall Study|Withdrawal by Subject|3
1217957|NCT00806624|3997174|P2|Overall Study|Withdrawal by Subject|3
1217958|NCT00806624|3997175|P1|Overall Study|Withdrawal by Subject|6
1217959|NCT00806624|3997173|P3|Overall Study|Lost to Follow-up|1
1217960|NCT00806624|3997174|P2|Overall Study|Lost to Follow-up|0
1217961|NCT00806624|3997175|P1|Overall Study|Lost to Follow-up|1
1217962|NCT00806624|3997173|P3|Overall Study|Death|1
1217963|NCT00806624|3997174|P2|Overall Study|Death|1
1217964|NCT00806624|3997175|P1|Overall Study|Death|0
1217965|NCT00806624|3997173|P3|Overall Study|Adverse Event|0
1217966|NCT00806624|3997174|P2|Overall Study|Adverse Event|8
1217967|NCT00806624|3997175|P1|Overall Study|Adverse Event|2
1217968|NCT00806585|3997192|P5|Overall Study|Completion status unknown|12
1217969|NCT00806585|3997193|P4|Overall Study|Completion status unknown|4
1217970|NCT00806585|3997194|P3|Overall Study|Completion status unknown|12
1217971|NCT00806585|3997195|P2|Overall Study|Completion status unknown|14
1217972|NCT00806585|3997196|P1|Overall Study|Completion status unknown|15
1217973|NCT00806585|3997192|P5|Overall Study|Withdrawal by Subject|11
1217974|NCT00806585|3997193|P4|Overall Study|Withdrawal by Subject|3
1217975|NCT00806585|3997194|P3|Overall Study|Withdrawal by Subject|9
1217976|NCT00806585|3997195|P2|Overall Study|Withdrawal by Subject|8
1217977|NCT00806585|3997196|P1|Overall Study|Withdrawal by Subject|10
1217978|NCT00806585|3997192|P5|Overall Study|Adverse Event|2
1217979|NCT00806585|3997193|P4|Overall Study|Adverse Event|4
1217980|NCT00806585|3997194|P3|Overall Study|Adverse Event|3
1217981|NCT00806585|3997195|P2|Overall Study|Adverse Event|5
1217982|NCT00806585|3997196|P1|Overall Study|Adverse Event|1
1217983|NCT00806585|3997192|P5|Overall Study|Lack of Efficacy|0
1217984|NCT00806585|3997193|P4|Overall Study|Lack of Efficacy|0
1217985|NCT00806585|3997194|P3|Overall Study|Lack of Efficacy|0
1217986|NCT00806585|3997195|P2|Overall Study|Lack of Efficacy|0
1217987|NCT00806585|3997196|P1|Overall Study|Lack of Efficacy|1
1217988|NCT00806585|3997192|P5|Overall Study|Lost to Follow-up|5
1217989|NCT00806585|3997193|P4|Overall Study|Lost to Follow-up|2
1217990|NCT00806585|3997194|P3|Overall Study|Lost to Follow-up|2
1217991|NCT00806585|3997195|P2|Overall Study|Lost to Follow-up|1
1217992|NCT00806585|3997196|P1|Overall Study|Lost to Follow-up|2
1217993|NCT00806585|3997192|P5|Overall Study|Physician Decision|1
1217994|NCT00806585|3997193|P4|Overall Study|Physician Decision|0
1217995|NCT00806585|3997194|P3|Overall Study|Physician Decision|3
1217996|NCT00806585|3997195|P2|Overall Study|Physician Decision|2
1217997|NCT00806585|3997196|P1|Overall Study|Physician Decision|0
1217998|NCT00806585|3997192|P5|Overall Study|Protocol Violation|0
1217999|NCT00806585|3997193|P4|Overall Study|Protocol Violation|0
1218000|NCT00806585|3997194|P3|Overall Study|Protocol Violation|2
1218001|NCT00806585|3997195|P2|Overall Study|Protocol Violation|1
1218002|NCT00806585|3997196|P1|Overall Study|Protocol Violation|3
1218003|NCT00806585|3997192|P5|Overall Study|Study terminated by Sponsor|0
1218004|NCT00806585|3997193|P4|Overall Study|Study terminated by Sponsor|2
1218005|NCT00806585|3997194|P3|Overall Study|Study terminated by Sponsor|1
1218006|NCT00806585|3997195|P2|Overall Study|Study terminated by Sponsor|0
1218007|NCT00806585|3997196|P1|Overall Study|Study terminated by Sponsor|0
1218008|NCT00806546|3997228|P1|Overall Study|Various|42
1218009|NCT00806546|3997228|P1|Overall Study|Protocol Violation|49
1218010|NCT00806546|3997228|P1|Overall Study|Withdrawal by Subject|75
1218011|NCT00806546|3997228|P1|Overall Study|Adverse Event|74
1218012|NCT00806546|3997228|P1|Overall Study|Lost to Follow-up|32
1218013|NCT00806546|3997228|P1|Overall Study|Enrolled, not treated|35
1218014|NCT00806494|3997232|P1|Overall Study|Withdrawal by Subject|5
1218015|NCT00806494|3997232|P1|Overall Study|Other|30
1218016|NCT00806494|3997232|P1|Overall Study|Lost to Follow-up|10
1218017|NCT00806494|3997232|P1|Overall Study|Lack of Efficacy|6
1218018|NCT00806494|3997232|P1|Overall Study|Adverse Event|29
1218019|NCT00806442|3997256|P2|Overall Study|Withdrawal by Subject|5
1218020|NCT00806442|3997257|P1|Overall Study|Withdrawal by Subject|1
1218021|NCT00806442|3997256|P2|Overall Study|Lost to Follow-up|2
1218022|NCT00806442|3997257|P1|Overall Study|Lost to Follow-up|3
1218023|NCT00806416|3997279|P4|Period 1 - Part II|Withdrawal by Subject|2
1218024|NCT00806416|3997280|P3|Period 1 - Part II|Withdrawal by Subject|0
1218025|NCT00806416|3997281|P2|Period 1 - Part II|Withdrawal by Subject|0
1218026|NCT00806416|3997282|P1|Period 1 - Part II|Withdrawal by Subject|0
1218027|NCT00806416|3997279|P4|Period 1 - Part I|Withdrawal by Subject|0
1218028|NCT00806416|3997280|P3|Period 1 - Part I|Withdrawal by Subject|0
1218029|NCT00806416|3997281|P2|Period 1 - Part I|Withdrawal by Subject|1
1218030|NCT00806416|3997282|P1|Period 1 - Part I|Withdrawal by Subject|3
1218031|NCT00806416|3997279|P4|Period 1 - Part I|Lost to Follow-up|0
1218032|NCT00806416|3997280|P3|Period 1 - Part I|Lost to Follow-up|0
1218033|NCT00806416|3997281|P2|Period 1 - Part I|Lost to Follow-up|2
1218034|NCT00806416|3997282|P1|Period 1 - Part I|Lost to Follow-up|0
1218035|NCT00806416|3997279|P4|Period 1 - Part I|Adverse Event|0
1218036|NCT00806416|3997280|P3|Period 1 - Part I|Adverse Event|0
1218037|NCT00806416|3997281|P2|Period 1 - Part I|Adverse Event|1
1218038|NCT00806416|3997282|P1|Period 1 - Part I|Adverse Event|0
1218039|NCT00806403|3997295|P2|Overall Study|Death|3
1218040|NCT00806403|3997296|P1|Overall Study|Death|4
1218041|NCT00806351|3997319|P2|Overall Study|Death|4
1218042|NCT00806351|3997320|P1|Overall Study|Death|5
1218043|NCT00806260|3997357|P6|Period 3|Pregnancy|0
1218044|NCT00806260|3997358|P5|Period 3|Pregnancy|0
1218045|NCT00806260|3997359|P4|Period 3|Pregnancy|0
1218046|NCT00806260|3997360|P3|Period 3|Pregnancy|0
1218047|NCT00806260|3997361|P2|Period 3|Pregnancy|0
1218048|NCT00806260|3997362|P1|Period 3|Pregnancy|1
1218049|NCT00806260|3997357|P6|Period 3|Protocol Violation|0
1218050|NCT00806260|3997358|P5|Period 3|Protocol Violation|0
1218051|NCT00806260|3997359|P4|Period 3|Protocol Violation|0
1218052|NCT00806260|3997360|P3|Period 3|Protocol Violation|1
1218053|NCT00806260|3997361|P2|Period 3|Protocol Violation|1
1218054|NCT00806260|3997362|P1|Period 3|Protocol Violation|0
1218055|NCT00806260|3997357|P6|Period 2|sponsor request|0
1218056|NCT00806260|3997358|P5|Period 2|sponsor request|0
1218057|NCT00806260|3997359|P4|Period 2|sponsor request|1
1218058|NCT00806260|3997360|P3|Period 2|sponsor request|1
1218059|NCT00806260|3997361|P2|Period 2|sponsor request|0
1218060|NCT00806260|3997362|P1|Period 2|sponsor request|0
1218061|NCT00806260|3997357|P6|Period 2|Need to take concomitant medication|0
1218062|NCT00806260|3997358|P5|Period 2|Need to take concomitant medication|0
1218063|NCT00806260|3997359|P4|Period 2|Need to take concomitant medication|0
1218064|NCT00806260|3997360|P3|Period 2|Need to take concomitant medication|0
1218065|NCT00806260|3997361|P2|Period 2|Need to take concomitant medication|0
1218066|NCT00806260|3997362|P1|Period 2|Need to take concomitant medication|1
1218067|NCT00806260|3997357|P6|Period 2|Protocol Violation|0
1218068|NCT00806260|3997358|P5|Period 2|Protocol Violation|0
1218069|NCT00806260|3997359|P4|Period 2|Protocol Violation|0
1218070|NCT00806260|3997360|P3|Period 2|Protocol Violation|1
1218071|NCT00806260|3997361|P2|Period 2|Protocol Violation|0
1218072|NCT00806260|3997362|P1|Period 2|Protocol Violation|1
1218073|NCT00806260|3997357|P6|Period 2|Adverse Event|0
1218074|NCT00806260|3997358|P5|Period 2|Adverse Event|0
1218075|NCT00806260|3997359|P4|Period 2|Adverse Event|1
1218076|NCT00806260|3997360|P3|Period 2|Adverse Event|0
1218077|NCT00806260|3997361|P2|Period 2|Adverse Event|0
1218078|NCT00806260|3997362|P1|Period 2|Adverse Event|0
1218079|NCT00806260|3997357|P6|Period 1 (1 Day)|Adverse Event|0
1218080|NCT00806260|3997358|P5|Period 1 (1 Day)|Adverse Event|3
1218081|NCT00806260|3997359|P4|Period 1 (1 Day)|Adverse Event|0
1218082|NCT00806260|3997360|P3|Period 1 (1 Day)|Adverse Event|0
1218083|NCT00806260|3997361|P2|Period 1 (1 Day)|Adverse Event|0
1218084|NCT00806260|3997362|P1|Period 1 (1 Day)|Adverse Event|0
1218085|NCT00806195|3997407|P4|Overall Study|Protocol Violation|9
1218086|NCT00806195|3997408|P3|Overall Study|Protocol Violation|26
1218087|NCT00806195|3997409|P2|Overall Study|Protocol Violation|24
1218088|NCT00806195|3997410|P1|Overall Study|Protocol Violation|34
1218089|NCT00806195|3997407|P4|Overall Study|Administrative Reason|26
1218090|NCT00806195|3997408|P3|Overall Study|Administrative Reason|66
1218091|NCT00806195|3997409|P2|Overall Study|Administrative Reason|35
1218092|NCT00806195|3997410|P1|Overall Study|Administrative Reason|113
1218093|NCT00806195|3997407|P4|Overall Study|Inappropriate Enrollment|0
1218094|NCT00806195|3997408|P3|Overall Study|Inappropriate Enrollment|0
1218095|NCT00806195|3997409|P2|Overall Study|Inappropriate Enrollment|1
1218096|NCT00806195|3997410|P1|Overall Study|Inappropriate Enrollment|0
1218097|NCT00806195|3997407|P4|Overall Study|Lost to Follow-up|34
1218098|NCT00806195|3997408|P3|Overall Study|Lost to Follow-up|90
1218099|NCT00806195|3997409|P2|Overall Study|Lost to Follow-up|66
1218100|NCT00806195|3997410|P1|Overall Study|Lost to Follow-up|217
1218101|NCT00806195|3997407|P4|Overall Study|Withdrawal by Subject|35
1218102|NCT00806195|3997408|P3|Overall Study|Withdrawal by Subject|76
1218103|NCT00806195|3997409|P2|Overall Study|Withdrawal by Subject|31
1218104|NCT00806195|3997410|P1|Overall Study|Withdrawal by Subject|119
1218105|NCT00806195|3997407|P4|Overall Study|Adverse Event|2
1218106|NCT00806195|3997408|P3|Overall Study|Adverse Event|11
1218107|NCT00806195|3997409|P2|Overall Study|Adverse Event|5
1218108|NCT00806195|3997410|P1|Overall Study|Adverse Event|25
1218109|NCT00806195|3997407|P4|Overall Study|Death|0
1218110|NCT00806195|3997408|P3|Overall Study|Death|1
1218111|NCT00806195|3997409|P2|Overall Study|Death|0
1218112|NCT00806195|3997410|P1|Overall Study|Death|6
1218113|NCT00806026|3997441|P6|Overall Study|Adverse Event|9
1218114|NCT00806026|3997442|P5|Overall Study|Adverse Event|9
1218115|NCT00806026|3997443|P4|Overall Study|Adverse Event|17
1218116|NCT00806026|3997444|P3|Overall Study|Adverse Event|44
1218117|NCT00806026|3997445|P2|Overall Study|Adverse Event|35
1218118|NCT00806026|3997446|P1|Overall Study|Adverse Event|52
1218119|NCT00806026|3997441|P6|Overall Study|Protocol Violation|3
1218120|NCT00806026|3997442|P5|Overall Study|Protocol Violation|2
1218121|NCT00806026|3997443|P4|Overall Study|Protocol Violation|0
1218122|NCT00806026|3997444|P3|Overall Study|Protocol Violation|9
1218123|NCT00806026|3997445|P2|Overall Study|Protocol Violation|9
1218124|NCT00806026|3997446|P1|Overall Study|Protocol Violation|6
1218125|NCT00806026|3997441|P6|Overall Study|Other|4
1218126|NCT00806026|3997442|P5|Overall Study|Other|0
1218127|NCT00806026|3997443|P4|Overall Study|Other|2
1218128|NCT00806026|3997444|P3|Overall Study|Other|8
1218129|NCT00806026|3997445|P2|Overall Study|Other|6
1218130|NCT00806026|3997446|P1|Overall Study|Other|3
1218131|NCT00806026|3997441|P6|Overall Study|Withdrawal by Subject|3
1218132|NCT00806026|3997442|P5|Overall Study|Withdrawal by Subject|5
1218133|NCT00806026|3997443|P4|Overall Study|Withdrawal by Subject|2
1218134|NCT00806026|3997444|P3|Overall Study|Withdrawal by Subject|9
1218135|NCT00806026|3997445|P2|Overall Study|Withdrawal by Subject|17
1218136|NCT00806026|3997446|P1|Overall Study|Withdrawal by Subject|14
1218137|NCT00806026|3997441|P6|Overall Study|Lost to Follow-up|6
1218138|NCT00806026|3997442|P5|Overall Study|Lost to Follow-up|6
1218139|NCT00806026|3997443|P4|Overall Study|Lost to Follow-up|2
1218140|NCT00806026|3997444|P3|Overall Study|Lost to Follow-up|8
1218141|NCT00806026|3997445|P2|Overall Study|Lost to Follow-up|15
1218142|NCT00806026|3997446|P1|Overall Study|Lost to Follow-up|8
1218143|NCT00806026|3997441|P6|Overall Study|Lack of Efficacy|7
1218144|NCT00806026|3997442|P5|Overall Study|Lack of Efficacy|8
1218145|NCT00806026|3997443|P4|Overall Study|Lack of Efficacy|4
1218146|NCT00806026|3997444|P3|Overall Study|Lack of Efficacy|13
1218147|NCT00806026|3997445|P2|Overall Study|Lack of Efficacy|18
1218148|NCT00806026|3997446|P1|Overall Study|Lack of Efficacy|5
1218149|NCT00806026|3997441|P6|Overall Study|Did not meet entrance criteria|0
1218150|NCT00806026|3997442|P5|Overall Study|Did not meet entrance criteria|0
1218151|NCT00806026|3997443|P4|Overall Study|Did not meet entrance criteria|1
1218152|NCT00806026|3997444|P3|Overall Study|Did not meet entrance criteria|2
1218153|NCT00806026|3997445|P2|Overall Study|Did not meet entrance criteria|1
1218154|NCT00806026|3997446|P1|Overall Study|Did not meet entrance criteria|4
1218155|NCT00806026|3997441|P6|Overall Study|Death|0
1218156|NCT00806026|3997442|P5|Overall Study|Death|0
1218157|NCT00806026|3997443|P4|Overall Study|Death|1
1218158|NCT00806026|3997444|P3|Overall Study|Death|0
1218159|NCT00806026|3997445|P2|Overall Study|Death|0
1218160|NCT00806026|3997446|P1|Overall Study|Death|0
1218161|NCT00805961|3997541|P1|Maintenance Treatment|Withdrawn Consent|1
1218162|NCT00805961|3997541|P1|Maintenance Treatment|Symptomatic Deterioration|2
1218163|NCT00805961|3997541|P1|Maintenance Treatment|Withdrawal by Subject|5
1218164|NCT00805961|3997541|P1|Maintenance Treatment|Adverse Event|6
1218165|NCT00805961|3997541|P1|Maintenance Treatment|Intercurrent Illness|7
1218166|NCT00805961|3997541|P1|Maintenance Treatment|Lack of Efficacy|13
1218167|NCT00805961|3997541|P1|Treatment-Free Interval|Lack of Efficacy|1
1218168|NCT00805961|3997541|P1|Treatment-Free Interval|Physician Decision|1
1218169|NCT00805961|3997541|P1|Treatment-Free Interval|Intercurrent Illness|2
1218170|NCT00805961|3997541|P1|Treatment-Free Interval|Adverse Event|3
1218171|NCT00805961|3997541|P1|Modality Therapy|Disease Progression|2
1218172|NCT00805961|3997541|P1|Modality Therapy|Adverse Event|1
1218173|NCT00805961|3997541|P1|Modality Therapy|Withdrawal by Subject|1
1218174|NCT00805935|3997551|P4|Overall Study|Serious Adverse Event-congenital anomaly|0
1218175|NCT00805935|3997552|P3|Overall Study|Serious Adverse Event-congenital anomaly|0
1218176|NCT00805935|3997553|P2|Overall Study|Serious Adverse Event-congenital anomaly|1
1218177|NCT00805935|3997554|P1|Overall Study|Serious Adverse Event-congenital anomaly|0
1218178|NCT00805935|3997551|P4|Overall Study|Ectopic pregnancy|0
1218179|NCT00805935|3997552|P3|Overall Study|Ectopic pregnancy|1
1218180|NCT00805935|3997553|P2|Overall Study|Ectopic pregnancy|0
1218181|NCT00805935|3997554|P1|Overall Study|Ectopic pregnancy|0
1218182|NCT00805935|3997551|P4|Overall Study|Chemical pregnancy|2
1218183|NCT00805935|3997552|P3|Overall Study|Chemical pregnancy|3
1218184|NCT00805935|3997553|P2|Overall Study|Chemical pregnancy|5
1218185|NCT00805935|3997554|P1|Overall Study|Chemical pregnancy|0
1218186|NCT00805935|3997551|P4|Overall Study|Biochemical pregnancy|0
1218187|NCT00805935|3997552|P3|Overall Study|Biochemical pregnancy|0
1218188|NCT00805935|3997553|P2|Overall Study|Biochemical pregnancy|1
1218189|NCT00805935|3997554|P1|Overall Study|Biochemical pregnancy|0
1218190|NCT00805935|3997551|P4|Overall Study|Pregnancy loss/miscarriage|0
1218191|NCT00805935|3997552|P3|Overall Study|Pregnancy loss/miscarriage|0
1218192|NCT00805935|3997553|P2|Overall Study|Pregnancy loss/miscarriage|0
1218193|NCT00805935|3997554|P1|Overall Study|Pregnancy loss/miscarriage|2
1218194|NCT00805935|3997551|P4|Overall Study|Pregnancy not confirmed by ultrasound|1
1218195|NCT00805935|3997552|P3|Overall Study|Pregnancy not confirmed by ultrasound|0
1218196|NCT00805935|3997553|P2|Overall Study|Pregnancy not confirmed by ultrasound|0
1218197|NCT00805935|3997554|P1|Overall Study|Pregnancy not confirmed by ultrasound|0
1218198|NCT00805935|3997551|P4|Overall Study|No positive serum pregnancy|5
1218199|NCT00805935|3997552|P3|Overall Study|No positive serum pregnancy|6
1218200|NCT00805935|3997553|P2|Overall Study|No positive serum pregnancy|7
1218201|NCT00805935|3997554|P1|Overall Study|No positive serum pregnancy|8
1218202|NCT00805935|3997551|P4|Overall Study|Lost to Follow-up|0
1218203|NCT00805935|3997552|P3|Overall Study|Lost to Follow-up|0
1218204|NCT00805935|3997553|P2|Overall Study|Lost to Follow-up|0
1218205|NCT00805935|3997554|P1|Overall Study|Lost to Follow-up|1
1218206|NCT00805935|3997551|P4|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1
1218207|NCT00805935|3997552|P3|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
1218208|NCT00805935|3997553|P2|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
1218209|NCT00805935|3997554|P1|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
1218210|NCT00805935|3997551|P4|Overall Study|Cycle cancellation for risk of OHSS|0
1218211|NCT00805935|3997552|P3|Overall Study|Cycle cancellation for risk of OHSS|1
1218212|NCT00805935|3997553|P2|Overall Study|Cycle cancellation for risk of OHSS|0
1218213|NCT00805935|3997554|P1|Overall Study|Cycle cancellation for risk of OHSS|1
1218214|NCT00805935|3997551|P4|Overall Study|Cycle cancelled|0
1218215|NCT00805935|3997552|P3|Overall Study|Cycle cancelled|2
1218216|NCT00805935|3997553|P2|Overall Study|Cycle cancelled|0
1218217|NCT00805935|3997554|P1|Overall Study|Cycle cancelled|0
1218218|NCT00805935|3997551|P4|Overall Study|Stimulation Failure|2
1218219|NCT00805935|3997552|P3|Overall Study|Stimulation Failure|2
1218220|NCT00805935|3997553|P2|Overall Study|Stimulation Failure|5
1218221|NCT00805935|3997554|P1|Overall Study|Stimulation Failure|1
1218222|NCT00805792|3997621|P1|Overall Study|Lost to Follow-up|2
1218223|NCT00805792|3997621|P1|Overall Study|Death|3
1218224|NCT00805766|3997629|P1|Increased Dose Period|Withdrawal by Subject|1
1218225|NCT00805766|3997629|P1|Increased Dose Period|Pregnancy|1
1218226|NCT00805766|3997629|P1|Increased Dose Period|Lack of Efficacy|7
1218227|NCT00805766|3997629|P1|Increased Dose Period|Adverse Event|4
1218228|NCT00805766|3997629|P1|Screening Period|Responder|2
1218229|NCT00805766|3997629|P1|Screening Period|Pregnancy|1
1218230|NCT00805766|3997629|P1|Screening Period|Lack of Efficacy|2
1218231|NCT00805766|3997629|P1|Screening Period|Adverse Event|1
1218232|NCT00805740|3997643|P2|Overall Study|Randomized, but not treated|0
1218233|NCT00805740|3997644|P1|Overall Study|Randomized, but not treated|2
1218234|NCT00805740|3997643|P2|Overall Study|Lost to Follow-up|0
1218235|NCT00805740|3997644|P1|Overall Study|Lost to Follow-up|1
1218236|NCT00805740|3997643|P2|Overall Study|Withdrawal by Subject|0
1218237|NCT00805740|3997644|P1|Overall Study|Withdrawal by Subject|1
1218238|NCT00805740|3997643|P2|Overall Study|Death|4
1218239|NCT00805740|3997644|P1|Overall Study|Death|7
1218240|NCT00805675|3997669|P3|Overall Study|Adverse Event|1
1218241|NCT00805675|3997670|P2|Overall Study|Adverse Event|0
1218242|NCT00805675|3997671|P1|Overall Study|Adverse Event|0
1218243|NCT00805545|3997705|P2|Overall Study|Protocol Violation|1
1218244|NCT00805545|3997706|P1|Overall Study|Protocol Violation|3
1218245|NCT00805545|3997705|P2|Overall Study|Protocol Violation|2
1218246|NCT00805545|3997706|P1|Overall Study|Protocol Violation|3
1218247|NCT00805532|3997714|P2|Overall Study|invalid data|1
1218248|NCT00805532|3997715|P1|Overall Study|invalid data|0
1218249|NCT00805480|3997749|P4|Overall Study|Adverse Event|0
1218250|NCT00805480|3997750|P3|Overall Study|Adverse Event|1
1218251|NCT00805480|3997751|P2|Overall Study|Adverse Event|0
1218252|NCT00805480|3997752|P1|Overall Study|Adverse Event|0
1218253|NCT00805480|3997749|P4|Overall Study|Lost to Follow-up|0
1218254|NCT00805480|3997750|P3|Overall Study|Lost to Follow-up|0
1218255|NCT00805480|3997751|P2|Overall Study|Lost to Follow-up|2
1218256|NCT00805480|3997752|P1|Overall Study|Lost to Follow-up|1
1218257|NCT00805480|3997749|P4|Overall Study|Withdrawal by Subject|5
1218258|NCT00805480|3997750|P3|Overall Study|Withdrawal by Subject|11
1218259|NCT00805480|3997751|P2|Overall Study|Withdrawal by Subject|5
1218260|NCT00805480|3997752|P1|Overall Study|Withdrawal by Subject|13
1218261|NCT00805467|3997781|P4|Overall Study|Not reported|7
1218262|NCT00805467|3997782|P3|Overall Study|Not reported|3
1218263|NCT00805467|3997783|P2|Overall Study|Not reported|0
1218264|NCT00805467|3997784|P1|Overall Study|Not reported|0
1218265|NCT00805467|3997781|P4|Overall Study|Physician Decision|6
1218266|NCT00805467|3997782|P3|Overall Study|Physician Decision|2
1218267|NCT00805467|3997783|P2|Overall Study|Physician Decision|1
1218268|NCT00805467|3997784|P1|Overall Study|Physician Decision|0
1218269|NCT00805467|3997781|P4|Overall Study|Death|5
1218270|NCT00805467|3997782|P3|Overall Study|Death|7
1218271|NCT00805467|3997783|P2|Overall Study|Death|2
1218272|NCT00805467|3997784|P1|Overall Study|Death|0
1218273|NCT00805467|3997781|P4|Overall Study|Adverse Event|57
1218274|NCT00805467|3997782|P3|Overall Study|Adverse Event|26
1218275|NCT00805467|3997783|P2|Overall Study|Adverse Event|13
1218276|NCT00805467|3997784|P1|Overall Study|Adverse Event|0
1218277|NCT00805467|3997781|P4|Overall Study|Protocol Violation|5
1218278|NCT00805467|3997782|P3|Overall Study|Protocol Violation|0
1218279|NCT00805467|3997783|P2|Overall Study|Protocol Violation|3
1218280|NCT00805467|3997784|P1|Overall Study|Protocol Violation|0
1218281|NCT00805467|3997781|P4|Overall Study|Withdrawal by Subject|50
1218282|NCT00805467|3997782|P3|Overall Study|Withdrawal by Subject|45
1218283|NCT00805467|3997783|P2|Overall Study|Withdrawal by Subject|6
1218284|NCT00805467|3997784|P1|Overall Study|Withdrawal by Subject|0
1218285|NCT00805467|3997781|P4|Overall Study|Lost to Follow-up|21
1218286|NCT00805467|3997782|P3|Overall Study|Lost to Follow-up|7
1218287|NCT00805467|3997783|P2|Overall Study|Lost to Follow-up|1
1218288|NCT00805467|3997784|P1|Overall Study|Lost to Follow-up|0
1218289|NCT00805467|3997781|P4|Overall Study|Lack of Efficacy|86
1218290|NCT00805467|3997782|P3|Overall Study|Lack of Efficacy|13
1218291|NCT00805467|3997783|P2|Overall Study|Lack of Efficacy|8
1218292|NCT00805467|3997784|P1|Overall Study|Lack of Efficacy|0
1218293|NCT00805441|3997804|P2|Overall Study|Acute Alcohol Withdrawal|1
1218294|NCT00805441|3997805|P1|Overall Study|Acute Alcohol Withdrawal|0
1218295|NCT00805441|3997804|P2|Overall Study|Physician Decision|1
1218296|NCT00805441|3997805|P1|Overall Study|Physician Decision|0
1218297|NCT00805441|3997804|P2|Overall Study|Withdrawal by Subject|9
1218298|NCT00805441|3997805|P1|Overall Study|Withdrawal by Subject|15
1218299|NCT00805441|3997804|P2|Overall Study|Lost to Follow-up|13
1218300|NCT00805441|3997805|P1|Overall Study|Lost to Follow-up|10
1218301|NCT00805441|3997804|P2|Overall Study|Protocol Violation|8
1218302|NCT00805441|3997805|P1|Overall Study|Protocol Violation|4
1218303|NCT00805441|3997804|P2|Overall Study|Lack of Efficacy|2
1218304|NCT00805441|3997805|P1|Overall Study|Lack of Efficacy|0
1218305|NCT00805441|3997804|P2|Overall Study|Adverse Event|2
1218306|NCT00805441|3997805|P1|Overall Study|Adverse Event|5
1218307|NCT00805389|3997840|P5|Overall Study|Withdrawal by Subject|4
1218308|NCT00805389|3997841|P4|Overall Study|Withdrawal by Subject|5
1218309|NCT00805389|3997842|P3|Overall Study|Withdrawal by Subject|4
1218310|NCT00805389|3997843|P2|Overall Study|Withdrawal by Subject|2
1218311|NCT00805389|3997844|P1|Overall Study|Withdrawal by Subject|3
1218312|NCT00805389|3997840|P5|Overall Study|Protocol Violation|0
1218313|NCT00805389|3997841|P4|Overall Study|Protocol Violation|0
1218314|NCT00805389|3997842|P3|Overall Study|Protocol Violation|1
1218315|NCT00805389|3997843|P2|Overall Study|Protocol Violation|0
1218316|NCT00805389|3997844|P1|Overall Study|Protocol Violation|0
1218317|NCT00805389|3997840|P5|Overall Study|Lost to Follow-up|9
1218318|NCT00805389|3997841|P4|Overall Study|Lost to Follow-up|10
1218319|NCT00805389|3997842|P3|Overall Study|Lost to Follow-up|6
1218320|NCT00805389|3997843|P2|Overall Study|Lost to Follow-up|3
1218321|NCT00805389|3997844|P1|Overall Study|Lost to Follow-up|4
1218322|NCT00805389|3997840|P5|Overall Study|Adverse Event|0
1218323|NCT00805389|3997841|P4|Overall Study|Adverse Event|2
1218324|NCT00805389|3997842|P3|Overall Study|Adverse Event|1
1218325|NCT00805389|3997843|P2|Overall Study|Adverse Event|0
1218326|NCT00805389|3997844|P1|Overall Study|Adverse Event|0
1218327|NCT00805285|3998091|P1|Overall Study|Lack of Efficacy|1
1218328|NCT00805207|3998108|P9|Overall Study|Withdrawal by Subject|0
1218329|NCT00805207|3998109|P8|Overall Study|Withdrawal by Subject|0
1218330|NCT00805207|3998110|P7|Overall Study|Withdrawal by Subject|0
1218331|NCT00805207|3998111|P6|Overall Study|Withdrawal by Subject|2
1218332|NCT00805207|3998112|P5|Overall Study|Withdrawal by Subject|1
1218333|NCT00805207|3998113|P4|Overall Study|Withdrawal by Subject|0
1218334|NCT00805207|3998114|P3|Overall Study|Withdrawal by Subject|0
1218335|NCT00805207|3998115|P2|Overall Study|Withdrawal by Subject|1
1218336|NCT00805207|3998116|P1|Overall Study|Withdrawal by Subject|0
1218337|NCT00805207|3998108|P9|Overall Study|Physician Decision|0
1218338|NCT00805207|3998109|P8|Overall Study|Physician Decision|0
1218339|NCT00805207|3998110|P7|Overall Study|Physician Decision|0
1218340|NCT00805207|3998111|P6|Overall Study|Physician Decision|1
1218341|NCT00805207|3998112|P5|Overall Study|Physician Decision|0
1218342|NCT00805207|3998113|P4|Overall Study|Physician Decision|0
1218343|NCT00805207|3998114|P3|Overall Study|Physician Decision|0
1218344|NCT00805207|3998115|P2|Overall Study|Physician Decision|1
1218345|NCT00805207|3998116|P1|Overall Study|Physician Decision|0
1218346|NCT00805207|3998108|P9|Overall Study|Protocol Violation|0
1218347|NCT00805207|3998109|P8|Overall Study|Protocol Violation|0
1218348|NCT00805207|3998110|P7|Overall Study|Protocol Violation|0
1218349|NCT00805207|3998111|P6|Overall Study|Protocol Violation|0
1218350|NCT00805207|3998112|P5|Overall Study|Protocol Violation|0
1218351|NCT00805207|3998113|P4|Overall Study|Protocol Violation|0
1218352|NCT00805207|3998114|P3|Overall Study|Protocol Violation|1
1218353|NCT00805207|3998115|P2|Overall Study|Protocol Violation|0
1218354|NCT00805207|3998116|P1|Overall Study|Protocol Violation|0
1218355|NCT00805194|3998174|P2|Overall Study|Reasons other than stated above|16
1218356|NCT00805194|3998175|P1|Overall Study|Reasons other than stated above|20
1218357|NCT00805194|3998174|P2|Overall Study|Not treated|4
1218358|NCT00805194|3998175|P1|Overall Study|Not treated|3
1218359|NCT00805194|3998174|P2|Overall Study|Withdrawal by Subject|42
1218360|NCT00805194|3998175|P1|Overall Study|Withdrawal by Subject|60
1218361|NCT00805194|3998174|P2|Overall Study|Lost to Follow-up|5
1218362|NCT00805194|3998175|P1|Overall Study|Lost to Follow-up|5
1218363|NCT00805194|3998174|P2|Overall Study|Protocol Violation|9
1218364|NCT00805194|3998175|P1|Overall Study|Protocol Violation|9
1218365|NCT00805194|3998174|P2|Overall Study|Other AE|73
1218366|NCT00805194|3998175|P1|Overall Study|Other AE|84
1218367|NCT00805194|3998174|P2|Overall Study|Worsening or AE of underlying disease|70
1218368|NCT00805194|3998175|P1|Overall Study|Worsening or AE of underlying disease|64
1218369|NCT00805194|3998174|P2|Overall Study|Progressive disease (modified RECIST)|435
1218370|NCT00805194|3998175|P1|Overall Study|Progressive disease (modified RECIST)|404
1218371|NCT00805142|3998209|P2|Maintenance Period|Other|1
1218372|NCT00805142|3998210|P1|Maintenance Period|Other|0
1218373|NCT00805142|3998209|P2|Maintenance Period|Adverse Event|1
1218374|NCT00805142|3998210|P1|Maintenance Period|Adverse Event|0
1218375|NCT00805142|3998209|P2|Titration Period|Other|3
1218376|NCT00805142|3998210|P1|Titration Period|Other|0
1218377|NCT00805142|3998209|P2|Titration Period|Withdrawal of consent|1
1218378|NCT00805142|3998210|P1|Titration Period|Withdrawal of consent|0
1218379|NCT00805142|3998209|P2|Titration Period|Disease Progression|1
1218380|NCT00805142|3998210|P1|Titration Period|Disease Progression|2
1218381|NCT00805142|3998209|P2|Titration Period|Lost to Follow-up|1
1218382|NCT00805142|3998210|P1|Titration Period|Lost to Follow-up|0
1218383|NCT00805142|3998209|P2|Titration Period|Lack of Efficacy|1
1218384|NCT00805142|3998210|P1|Titration Period|Lack of Efficacy|1
1218385|NCT00805142|3998209|P2|Titration Period|Adverse Event|3
1218386|NCT00805142|3998210|P1|Titration Period|Adverse Event|3
1218387|NCT00805025|3998243|P1|Overall Study|Physician Decision|1
1218388|NCT00805025|3998243|P1|Overall Study|Withdrawal by Subject|2
1218389|NCT00805025|3998243|P1|Overall Study|Adverse Event|4
1218390|NCT00805025|3998243|P1|Overall Study|Screened but not enrolled/treated|42
1218391|NCT00804986|3998272|P6|Overall Study|Physician Decision|0
1218392|NCT00804986|3998273|P5|Overall Study|Physician Decision|0
1218393|NCT00804986|3998274|P4|Overall Study|Physician Decision|0
1218394|NCT00804986|3998275|P3|Overall Study|Physician Decision|0
1218395|NCT00804986|3998276|P2|Overall Study|Physician Decision|0
1218396|NCT00804986|3998277|P1|Overall Study|Physician Decision|1
1218397|NCT00804986|3998272|P6|Overall Study|Sponsor Decision|0
1218398|NCT00804986|3998273|P5|Overall Study|Sponsor Decision|0
1218399|NCT00804986|3998274|P4|Overall Study|Sponsor Decision|0
1218400|NCT00804986|3998275|P3|Overall Study|Sponsor Decision|0
1218401|NCT00804986|3998276|P2|Overall Study|Sponsor Decision|1
1218402|NCT00804986|3998277|P1|Overall Study|Sponsor Decision|0
1218403|NCT00804986|3998272|P6|Overall Study|Inclusion/Exclusion criteria not met|1
1218404|NCT00804986|3998273|P5|Overall Study|Inclusion/Exclusion criteria not met|0
1218405|NCT00804986|3998274|P4|Overall Study|Inclusion/Exclusion criteria not met|1
1218406|NCT00804986|3998275|P3|Overall Study|Inclusion/Exclusion criteria not met|0
1218407|NCT00804986|3998276|P2|Overall Study|Inclusion/Exclusion criteria not met|2
1218408|NCT00804986|3998277|P1|Overall Study|Inclusion/Exclusion criteria not met|0
1218409|NCT00804986|3998272|P6|Overall Study|Withdrawal by Subject|3
1218410|NCT00804986|3998273|P5|Overall Study|Withdrawal by Subject|5
1218411|NCT00804986|3998274|P4|Overall Study|Withdrawal by Subject|3
1218412|NCT00804986|3998275|P3|Overall Study|Withdrawal by Subject|0
1218413|NCT00804986|3998276|P2|Overall Study|Withdrawal by Subject|3
1218414|NCT00804986|3998277|P1|Overall Study|Withdrawal by Subject|0
1218415|NCT00804986|3998272|P6|Overall Study|Protocol Violation|0
1218416|NCT00804986|3998273|P5|Overall Study|Protocol Violation|0
1218417|NCT00804986|3998274|P4|Overall Study|Protocol Violation|1
1218418|NCT00804986|3998275|P3|Overall Study|Protocol Violation|0
1218419|NCT00804986|3998276|P2|Overall Study|Protocol Violation|1
1218420|NCT00804986|3998277|P1|Overall Study|Protocol Violation|0
1218421|NCT00804986|3998272|P6|Overall Study|Lost to Follow-up|3
1218422|NCT00804986|3998273|P5|Overall Study|Lost to Follow-up|1
1218423|NCT00804986|3998274|P4|Overall Study|Lost to Follow-up|1
1218424|NCT00804986|3998275|P3|Overall Study|Lost to Follow-up|0
1218425|NCT00804986|3998276|P2|Overall Study|Lost to Follow-up|0
1218426|NCT00804986|3998277|P1|Overall Study|Lost to Follow-up|0
1218427|NCT00804986|3998272|P6|Overall Study|Lack of Efficacy|3
1218428|NCT00804986|3998273|P5|Overall Study|Lack of Efficacy|0
1218429|NCT00804986|3998274|P4|Overall Study|Lack of Efficacy|1
1218430|NCT00804986|3998275|P3|Overall Study|Lack of Efficacy|0
1218431|NCT00804986|3998276|P2|Overall Study|Lack of Efficacy|0
1218432|NCT00804986|3998277|P1|Overall Study|Lack of Efficacy|0
1218433|NCT00804986|3998272|P6|Overall Study|Adverse Event|0
1218434|NCT00804986|3998273|P5|Overall Study|Adverse Event|3
1218435|NCT00804986|3998274|P4|Overall Study|Adverse Event|1
1218436|NCT00804986|3998275|P3|Overall Study|Adverse Event|2
1218437|NCT00804986|3998276|P2|Overall Study|Adverse Event|1
1218438|NCT00804986|3998277|P1|Overall Study|Adverse Event|0
1218439|NCT00804908|3998372|P3|Overall Study|Not specified|114
1218440|NCT00804908|3998373|P2|Overall Study|Not specified|116
1218441|NCT00804908|3998374|P1|Overall Study|Not specified|115
1218442|NCT00804843|3998405|P2|Overall Study|Withdrawal by Subject|2
1218443|NCT00804843|3998406|P1|Overall Study|Withdrawal by Subject|1
1218444|NCT00804843|3998405|P2|Overall Study|Adverse Event|5
1218445|NCT00804843|3998406|P1|Overall Study|Adverse Event|8
1218446|NCT00804843|3998405|P2|Overall Study|Protocol Violation|0
1218447|NCT00804843|3998406|P1|Overall Study|Protocol Violation|1
1218448|NCT00804687|3998424|P6|Period 5: Treatment Period|Positive drug test|0
1218449|NCT00804687|3998425|P5|Period 5: Treatment Period|Positive drug test|0
1218450|NCT00804687|3998426|P4|Period 5: Treatment Period|Positive drug test|0
1218451|NCT00804687|3998427|P3|Period 5: Treatment Period|Positive drug test|0
1218452|NCT00804687|3998428|P2|Period 5: Treatment Period|Positive drug test|0
1218453|NCT00804687|3998429|P1|Period 5: Treatment Period|Positive drug test|1
1218454|NCT00804687|3998424|P6|Period 5: Treatment Period|Positive drugs of abuse|0
1218455|NCT00804687|3998425|P5|Period 5: Treatment Period|Positive drugs of abuse|0
1218456|NCT00804687|3998426|P4|Period 5: Treatment Period|Positive drugs of abuse|0
1218457|NCT00804687|3998427|P3|Period 5: Treatment Period|Positive drugs of abuse|1
1218458|NCT00804687|3998428|P2|Period 5: Treatment Period|Positive drugs of abuse|0
1218459|NCT00804687|3998429|P1|Period 5: Treatment Period|Positive drugs of abuse|0
1218460|NCT00804687|3998424|P6|Period 5: Treatment Period|Withdrawal by Subject|0
1218461|NCT00804687|3998425|P5|Period 5: Treatment Period|Withdrawal by Subject|1
1218462|NCT00804687|3998426|P4|Period 5: Treatment Period|Withdrawal by Subject|0
1218463|NCT00804687|3998427|P3|Period 5: Treatment Period|Withdrawal by Subject|0
1218464|NCT00804687|3998428|P2|Period 5: Treatment Period|Withdrawal by Subject|0
1218465|NCT00804687|3998429|P1|Period 5: Treatment Period|Withdrawal by Subject|0
1218466|NCT00804687|3998424|P6|Period 3: Treatment Period|Positive Drug screen|0
1218467|NCT00804687|3998425|P5|Period 3: Treatment Period|Positive Drug screen|0
1218468|NCT00804687|3998426|P4|Period 3: Treatment Period|Positive Drug screen|1
1218469|NCT00804687|3998427|P3|Period 3: Treatment Period|Positive Drug screen|0
1218470|NCT00804687|3998428|P2|Period 3: Treatment Period|Positive Drug screen|0
1218471|NCT00804687|3998429|P1|Period 3: Treatment Period|Positive Drug screen|0
1218472|NCT00804570|3998508|P2|Overall Study|Withdrawal by Subject|38
1218473|NCT00804570|3998509|P1|Overall Study|Withdrawal by Subject|21
1218474|NCT00804570|3998508|P2|Overall Study|Sponsor decision|4
1218475|NCT00804570|3998509|P1|Overall Study|Sponsor decision|1
1218476|NCT00804570|3998508|P2|Overall Study|Physician Decision|2
1218477|NCT00804570|3998509|P1|Overall Study|Physician Decision|1
1218478|NCT00804570|3998508|P2|Overall Study|Protocol Violation|16
1218479|NCT00804570|3998509|P1|Overall Study|Protocol Violation|12
1218480|NCT00804570|3998508|P2|Overall Study|Entry criteria not met|5
1218481|NCT00804570|3998509|P1|Overall Study|Entry criteria not met|5
1218482|NCT00804570|3998508|P2|Overall Study|Lost to Follow-up|21
1218483|NCT00804570|3998509|P1|Overall Study|Lost to Follow-up|18
1218484|NCT00804570|3998508|P2|Overall Study|Lack of Efficacy|1
1218485|NCT00804570|3998509|P1|Overall Study|Lack of Efficacy|0
1218486|NCT00804570|3998508|P2|Overall Study|Adverse Event|7
1218487|NCT00804570|3998509|P1|Overall Study|Adverse Event|14
1218488|NCT00804193|3998568|P3|Overall Study|Withdrawal by Subject|2
1218489|NCT00804193|3998569|P2|Overall Study|Withdrawal by Subject|1
1218490|NCT00804193|3998570|P1|Overall Study|Withdrawal by Subject|3
1218491|NCT00804193|3998568|P3|Overall Study|Lost to Follow-up|4
1218492|NCT00804193|3998569|P2|Overall Study|Lost to Follow-up|3
1218493|NCT00804193|3998570|P1|Overall Study|Lost to Follow-up|3
1218494|NCT00804193|3998568|P3|Overall Study|Protocol Violation|2
1218495|NCT00804193|3998569|P2|Overall Study|Protocol Violation|8
1218496|NCT00804193|3998570|P1|Overall Study|Protocol Violation|0
1218497|NCT00804193|3998568|P3|Overall Study|Lack of Efficacy|3
1218498|NCT00804193|3998569|P2|Overall Study|Lack of Efficacy|1
1218499|NCT00804193|3998570|P1|Overall Study|Lack of Efficacy|1
1218500|NCT00804193|3998568|P3|Overall Study|Adverse Event|2
1218501|NCT00804193|3998569|P2|Overall Study|Adverse Event|0
1218502|NCT00804193|3998570|P1|Overall Study|Adverse Event|0
1218503|NCT00804193|3998568|P3|Overall Study|Lack of baseline fungus|19
1218504|NCT00804193|3998569|P2|Overall Study|Lack of baseline fungus|31
1218505|NCT00804193|3998570|P1|Overall Study|Lack of baseline fungus|32
1218506|NCT00803790|3998619|P4|Period 2|Positive Drug Screen or Personal Reasons|0
1218507|NCT00803790|3998620|P3|Period 2|Positive Drug Screen or Personal Reasons|0
1218508|NCT00803790|3998621|P2|Period 2|Positive Drug Screen or Personal Reasons|0
1218509|NCT00803790|3998622|P1|Period 2|Positive Drug Screen or Personal Reasons|1
1218510|NCT00803790|3998619|P4|Period 2|Withdrawal by Subject|0
1218511|NCT00803790|3998620|P3|Period 2|Withdrawal by Subject|0
1218512|NCT00803790|3998621|P2|Period 2|Withdrawal by Subject|0
1218513|NCT00803790|3998622|P1|Period 2|Withdrawal by Subject|1
1218514|NCT00803790|3998619|P4|Period 2|Adverse Event|1
1218515|NCT00803790|3998620|P3|Period 2|Adverse Event|1
1218516|NCT00803790|3998621|P2|Period 2|Adverse Event|0
1218517|NCT00803790|3998622|P1|Period 2|Adverse Event|0
1218518|NCT00803790|3998619|P4|Period 1|Protocol Violation|0
1218519|NCT00803790|3998620|P3|Period 1|Protocol Violation|1
1218520|NCT00803790|3998621|P2|Period 1|Protocol Violation|0
1218521|NCT00803790|3998622|P1|Period 1|Protocol Violation|0
1218522|NCT00803790|3998619|P4|Period 1|positive drug screen or personal reasons|4
1218523|NCT00803790|3998620|P3|Period 1|positive drug screen or personal reasons|0
1218524|NCT00803790|3998621|P2|Period 1|positive drug screen or personal reasons|3
1218525|NCT00803790|3998622|P1|Period 1|positive drug screen or personal reasons|0
1218526|NCT00803790|3998619|P4|Period 1|Withdrawal by Subject|0
1218527|NCT00803790|3998620|P3|Period 1|Withdrawal by Subject|0
1218528|NCT00803790|3998621|P2|Period 1|Withdrawal by Subject|6
1218529|NCT00803790|3998622|P1|Period 1|Withdrawal by Subject|8
1218530|NCT00803790|3998619|P4|Period 1|Lost to Follow-up|0
1218531|NCT00803790|3998620|P3|Period 1|Lost to Follow-up|0
1218532|NCT00803790|3998621|P2|Period 1|Lost to Follow-up|2
1218533|NCT00803790|3998622|P1|Period 1|Lost to Follow-up|1
1218534|NCT00803790|3998619|P4|Period 1|Adverse Event|0
1218535|NCT00803790|3998620|P3|Period 1|Adverse Event|0
1218536|NCT00803790|3998621|P2|Period 1|Adverse Event|1
1218537|NCT00803790|3998622|P1|Period 1|Adverse Event|0
1218538|NCT00803738|3998662|P2|Overall Study|Positive Results for STD or abnormal PAP|8
1218539|NCT00803738|3998663|P1|Overall Study|Positive Results for STD or abnormal PAP|2
1218540|NCT00803738|3998662|P2|Overall Study|Negative Baseline Culture of Candida|63
1218541|NCT00803738|3998663|P1|Overall Study|Negative Baseline Culture of Candida|56
1218542|NCT00803738|3998662|P2|Overall Study|Lack of Efficacy|16
1218543|NCT00803738|3998663|P1|Overall Study|Lack of Efficacy|10
1218544|NCT00803738|3998662|P2|Overall Study|Withdrawal by Subject|4
1218545|NCT00803738|3998663|P1|Overall Study|Withdrawal by Subject|1
1218546|NCT00803738|3998662|P2|Overall Study|Protocol Violation|10
1218547|NCT00803738|3998663|P1|Overall Study|Protocol Violation|18
1218548|NCT00803738|3998662|P2|Overall Study|Lost to Follow-up|4
1218549|NCT00803738|3998663|P1|Overall Study|Lost to Follow-up|4
1218550|NCT00803738|3998662|P2|Overall Study|Adverse Event|5
1218551|NCT00803738|3998663|P1|Overall Study|Adverse Event|3
1218552|NCT00803712|3998675|P2|Overall Study|Protocol criteria (parathyroidectomy)|1
1218553|NCT00803712|3998676|P1|Overall Study|Protocol criteria (parathyroidectomy)|1
1218554|NCT00803712|3998675|P2|Overall Study|Administrative decision|3
1218555|NCT00803712|3998676|P1|Overall Study|Administrative decision|2
1218556|NCT00803712|3998675|P2|Overall Study|Protocol criteria (renal transplant)|8
1218557|NCT00803712|3998676|P1|Overall Study|Protocol criteria (renal transplant)|12
1218558|NCT00803712|3998675|P2|Overall Study|Protocol criteria (other)|2
1218559|NCT00803712|3998676|P1|Overall Study|Protocol criteria (other)|0
1218560|NCT00803712|3998675|P2|Overall Study|"Other in electronic Case Report Form"|1
1218561|NCT00803712|3998676|P1|Overall Study|"Other in electronic Case Report Form"|0
1218562|NCT00803712|3998675|P2|Overall Study|Withdrawal by Subject|4
1218563|NCT00803712|3998676|P1|Overall Study|Withdrawal by Subject|2
1218564|NCT00803712|3998675|P2|Overall Study|Lost to Follow-up|1
1218565|NCT00803712|3998676|P1|Overall Study|Lost to Follow-up|3
1218566|NCT00803712|3998675|P2|Overall Study|Death|7
1218567|NCT00803712|3998676|P1|Overall Study|Death|8
1218568|NCT00803712|3998675|P2|Overall Study|Adverse Event|0
1218569|NCT00803712|3998676|P1|Overall Study|Adverse Event|5
1218570|NCT00803712|3998675|P2|Overall Study|Noncompliance|0
1218571|NCT00803712|3998676|P1|Overall Study|Noncompliance|3
1218572|NCT00803634|3998775|P2|Overall Study|Death|2
1218573|NCT00803634|3998776|P1|Overall Study|Death|3
1218574|NCT00803634|3998775|P2|Overall Study|Lost to Follow-up|3
1218575|NCT00803634|3998776|P1|Overall Study|Lost to Follow-up|2
1218576|NCT00803634|3998775|P2|Overall Study|Withdrew Consent|0
1218577|NCT00803634|3998776|P1|Overall Study|Withdrew Consent|1
1218578|NCT00803595|3998805|P3|Overall Study|Withdrawal by Subject|3
1218579|NCT00803595|3998806|P2|Overall Study|Withdrawal by Subject|2
1218580|NCT00803595|3998807|P1|Overall Study|Withdrawal by Subject|5
1218581|NCT00803595|3998805|P3|Overall Study|Protocol Violation|12
1218582|NCT00803595|3998806|P2|Overall Study|Protocol Violation|2
1218583|NCT00803595|3998807|P1|Overall Study|Protocol Violation|7
1218584|NCT00803595|3998805|P3|Overall Study|Adverse Event|1
1218585|NCT00803595|3998806|P2|Overall Study|Adverse Event|4
1218586|NCT00803595|3998807|P1|Overall Study|Adverse Event|3
1218587|NCT00803452|3998844|P2|Overall Study|Lost to Follow-up|3
1218588|NCT00803452|3998845|P1|Overall Study|Lost to Follow-up|0
1218589|NCT00803452|3998844|P2|Overall Study|Adverse Event|2
1218590|NCT00803452|3998845|P1|Overall Study|Adverse Event|0
1218591|NCT00803361|3998883|P2|Overall Study|Withdrawal by Subject|6
1218592|NCT00803361|3998884|P1|Overall Study|Withdrawal by Subject|5
1218593|NCT00803361|3998883|P2|Overall Study|Protocol Violation|4
1218594|NCT00803361|3998884|P1|Overall Study|Protocol Violation|2
1218595|NCT00803361|3998883|P2|Overall Study|Physician Decision|0
1218596|NCT00803361|3998884|P1|Overall Study|Physician Decision|1
1218597|NCT00803361|3998883|P2|Overall Study|Lost to Follow-up|2
1218598|NCT00803361|3998884|P1|Overall Study|Lost to Follow-up|1
1218599|NCT00803361|3998883|P2|Overall Study|Lack of Efficacy|13
1218600|NCT00803361|3998884|P1|Overall Study|Lack of Efficacy|4
1218601|NCT00803361|3998883|P2|Overall Study|Adverse Event|3
1218602|NCT00803361|3998884|P1|Overall Study|Adverse Event|13
1218603|NCT00803270|3998931|P2|Overall Study|Lost to Follow-up|2
1218604|NCT00803270|3998932|P1|Overall Study|Lost to Follow-up|1
1218605|NCT00803244|3998942|P2|Overall Study|Any other reason not above-mentioned|10
1218606|NCT00803244|3998943|P1|Overall Study|Any other reason not above-mentioned|4
1218607|NCT00803244|3998942|P2|Overall Study|Withdrawal by Subject|3
1218608|NCT00803244|3998943|P1|Overall Study|Withdrawal by Subject|2
1218609|NCT00803244|3998942|P2|Overall Study|Adverse Event|2
1218610|NCT00803244|3998943|P1|Overall Study|Adverse Event|1
1218611|NCT00803179|3998951|P1|Overall Study|Lost to Follow-up|3
1218612|NCT00803101|3998970|P2|Overall Study|Patient did not have surgery|1
1218613|NCT00803101|3998971|P1|Overall Study|Patient did not have surgery|1
1218614|NCT00803101|3998970|P2|Overall Study|Patient did not attend scheduled visit|1
1218615|NCT00803101|3998971|P1|Overall Study|Patient did not attend scheduled visit|2
1218616|NCT00803101|3998970|P2|Overall Study|Patient died outside SAE report period|0
1218617|NCT00803101|3998971|P1|Overall Study|Patient died outside SAE report period|1
1218618|NCT00803101|3998970|P2|Overall Study|Surgery finished outside protocol window|1
1218619|NCT00803101|3998971|P1|Overall Study|Surgery finished outside protocol window|1
1218620|NCT00803101|3998970|P2|Overall Study|Protocol Violation|7
1218621|NCT00803101|3998971|P1|Overall Study|Protocol Violation|1
1218622|NCT00803101|3998970|P2|Overall Study|Lost to Follow-up|2
1218623|NCT00803101|3998971|P1|Overall Study|Lost to Follow-up|2
1218624|NCT00803101|3998970|P2|Overall Study|Withdrawal by Subject|4
1218625|NCT00803101|3998971|P1|Overall Study|Withdrawal by Subject|6
1218626|NCT00803101|3998970|P2|Overall Study|Death / Serious Adverse Event|6
1218627|NCT00803101|3998971|P1|Overall Study|Death / Serious Adverse Event|4
1218628|NCT00803049|3999022|P4|Overall Study|Other than Specified Above|5
1218629|NCT00803049|3999023|P3|Overall Study|Other than Specified Above|2
1218630|NCT00803049|3999024|P2|Overall Study|Other than Specified Above|9
1218631|NCT00803049|3999025|P1|Overall Study|Other than Specified Above|3
1218632|NCT00803049|3999022|P4|Overall Study|Randomized and Not Treated|2
1218633|NCT00803049|3999023|P3|Overall Study|Randomized and Not Treated|0
1218634|NCT00803049|3999024|P2|Overall Study|Randomized and Not Treated|0
1218635|NCT00803049|3999025|P1|Overall Study|Randomized and Not Treated|0
1218636|NCT00803049|3999022|P4|Overall Study|Protocol Violation|0
1218637|NCT00803049|3999023|P3|Overall Study|Protocol Violation|1
1218638|NCT00803049|3999024|P2|Overall Study|Protocol Violation|1
1218639|NCT00803049|3999025|P1|Overall Study|Protocol Violation|0
1218640|NCT00803049|3999022|P4|Overall Study|Withdrawal by Subject|44
1218641|NCT00803049|3999023|P3|Overall Study|Withdrawal by Subject|16
1218642|NCT00803049|3999024|P2|Overall Study|Withdrawal by Subject|43
1218643|NCT00803049|3999025|P1|Overall Study|Withdrawal by Subject|19
1218644|NCT00803049|3999022|P4|Overall Study|Progressive Disease|6
1218645|NCT00803049|3999023|P3|Overall Study|Progressive Disease|6
1218646|NCT00803049|3999024|P2|Overall Study|Progressive Disease|10
1218647|NCT00803049|3999025|P1|Overall Study|Progressive Disease|6
1218648|NCT00803049|3999022|P4|Overall Study|Death|2
1218649|NCT00803049|3999023|P3|Overall Study|Death|0
1218650|NCT00803049|3999024|P2|Overall Study|Death|1
1218651|NCT00803049|3999025|P1|Overall Study|Death|2
1218652|NCT00803049|3999022|P4|Overall Study|Lost to Follow-up|3
1218653|NCT00803049|3999023|P3|Overall Study|Lost to Follow-up|0
1218654|NCT00803049|3999024|P2|Overall Study|Lost to Follow-up|2
1218655|NCT00803049|3999025|P1|Overall Study|Lost to Follow-up|0
1218656|NCT00803049|3999022|P4|Overall Study|Lack of Efficacy|13
1218657|NCT00803049|3999023|P3|Overall Study|Lack of Efficacy|6
1218658|NCT00803049|3999024|P2|Overall Study|Lack of Efficacy|19
1218659|NCT00803049|3999025|P1|Overall Study|Lack of Efficacy|10
1218660|NCT00803049|3999022|P4|Overall Study|Adverse Event|27
1218661|NCT00803049|3999023|P3|Overall Study|Adverse Event|13
1218662|NCT00803049|3999024|P2|Overall Study|Adverse Event|33
1218663|NCT00803049|3999025|P1|Overall Study|Adverse Event|21
1218664|NCT00803023|3999059|P4|Overall Study|Lack of Efficacy|1
1218665|NCT00803023|3999060|P3|Overall Study|Lack of Efficacy|1
1218666|NCT00803023|3999061|P2|Overall Study|Lack of Efficacy|1
1218667|NCT00803023|3999062|P1|Overall Study|Lack of Efficacy|0
1218668|NCT00803023|3999059|P4|Overall Study|Lost to Follow-up|1
1218669|NCT00803023|3999060|P3|Overall Study|Lost to Follow-up|2
1218670|NCT00803023|3999061|P2|Overall Study|Lost to Follow-up|1
1218671|NCT00803023|3999062|P1|Overall Study|Lost to Follow-up|0
1218672|NCT00803023|3999059|P4|Overall Study|Withdrawal by Subject|0
1218673|NCT00803023|3999060|P3|Overall Study|Withdrawal by Subject|0
1218674|NCT00803023|3999061|P2|Overall Study|Withdrawal by Subject|2
1218675|NCT00803023|3999062|P1|Overall Study|Withdrawal by Subject|0
1218676|NCT00803023|3999059|P4|Overall Study|Adverse Event|6
1218677|NCT00803023|3999060|P3|Overall Study|Adverse Event|8
1218678|NCT00803023|3999061|P2|Overall Study|Adverse Event|4
1218679|NCT00803023|3999062|P1|Overall Study|Adverse Event|5
1218680|NCT00802945|3999100|P2|Overall Study|Terminated by sponsor|12
1218681|NCT00802945|3999101|P1|Overall Study|Terminated by sponsor|8
1218682|NCT00802945|3999100|P2|Overall Study|Death|23
1218683|NCT00802945|3999101|P1|Overall Study|Death|27
1218684|NCT00802893|3999132|P1|Overall Study|study terminated|3
1218685|NCT00802867|3999156|P1|Overall Study|Withdrawal by Subject|1
1218686|NCT00802867|3999156|P1|Overall Study|Protocol Violation|6
1218687|NCT00802867|3999156|P1|Overall Study|Lost to Follow-up|6
1218688|NCT00802841|3999179|P2|Overall Study|Treatment duration completed|76
1218689|NCT00802841|3999180|P1|Overall Study|Treatment duration completed|66
1218690|NCT00802841|3999179|P2|Overall Study|Protocol deviation|6
1218691|NCT00802841|3999180|P1|Overall Study|Protocol deviation|2
1218692|NCT00802841|3999179|P2|Overall Study|Withdrawal by Subject|5
1218693|NCT00802841|3999180|P1|Overall Study|Withdrawal by Subject|9
1218694|NCT00802841|3999179|P2|Overall Study|Disease progression|3
1218695|NCT00802841|3999180|P1|Overall Study|Disease progression|7
1218696|NCT00802841|3999179|P2|Overall Study|Adverse Event|2
1218697|NCT00802841|3999180|P1|Overall Study|Adverse Event|8
1218698|NCT00802841|3999179|P2|Overall Study|Death|2
1218699|NCT00802841|3999180|P1|Overall Study|Death|1
1218700|NCT00802841|3999179|P2|Overall Study|Lost to Follow-up|1
1218701|NCT00802841|3999180|P1|Overall Study|Lost to Follow-up|2
1218702|NCT00802841|3999179|P2|Overall Study|Administrative problems|0
1218703|NCT00802841|3999180|P1|Overall Study|Administrative problems|1
1218704|NCT00802737|3999205|P3|Overall Study|Participant too Unwell|0
1218705|NCT00802737|3999206|P2|Overall Study|Participant too Unwell|2
1218706|NCT00802737|3999207|P1|Overall Study|Participant too Unwell|0
1218707|NCT00802737|3999205|P3|Overall Study|Ongoing CLL-Treatment|0
1218708|NCT00802737|3999206|P2|Overall Study|Ongoing CLL-Treatment|1
1218709|NCT00802737|3999207|P1|Overall Study|Ongoing CLL-Treatment|0
1218710|NCT00802737|3999205|P3|Overall Study|Received Prohibited Therapy|0
1218711|NCT00802737|3999206|P2|Overall Study|Received Prohibited Therapy|0
1218712|NCT00802737|3999207|P1|Overall Study|Received Prohibited Therapy|1
1218713|NCT00802737|3999205|P3|Overall Study|Adverse Event|0
1218714|NCT00802737|3999206|P2|Overall Study|Adverse Event|0
1218715|NCT00802737|3999207|P1|Overall Study|Adverse Event|1
1218716|NCT00802737|3999205|P3|Overall Study|Death|1
1218717|NCT00802737|3999206|P2|Overall Study|Death|5
1218718|NCT00802737|3999207|P1|Overall Study|Death|6
1218719|NCT00802737|3999205|P3|Overall Study|Withdrawn due to Disease Progression|0
1218720|NCT00802737|3999206|P2|Overall Study|Withdrawn due to Disease Progression|3
1218721|NCT00802737|3999207|P1|Overall Study|Withdrawn due to Disease Progression|9
1218722|NCT00802672|3999267|P3|Overall Study|other|2
1218723|NCT00802672|3999268|P2|Overall Study|other|1
1218724|NCT00802672|3999269|P1|Overall Study|other|3
1218725|NCT00802672|3999267|P3|Overall Study|Withdrawal by Subject|2
1218726|NCT00802672|3999268|P2|Overall Study|Withdrawal by Subject|1
1218727|NCT00802672|3999269|P1|Overall Study|Withdrawal by Subject|1
1218728|NCT00802672|3999267|P3|Overall Study|Lost to Follow-up|3
1218729|NCT00802672|3999268|P2|Overall Study|Lost to Follow-up|5
1218730|NCT00802672|3999269|P1|Overall Study|Lost to Follow-up|5
1218731|NCT00802672|3999267|P3|Overall Study|Protocol Violation|1
1218732|NCT00802672|3999268|P2|Overall Study|Protocol Violation|1
1218733|NCT00802672|3999269|P1|Overall Study|Protocol Violation|2
1218734|NCT00802672|3999267|P3|Overall Study|Adverse Event|1
1218735|NCT00802672|3999268|P2|Overall Study|Adverse Event|1
1218736|NCT00802672|3999269|P1|Overall Study|Adverse Event|1
1218737|NCT00802672|3999267|P3|Overall Study|Lack of fungal pathogen at baseline|25
1218738|NCT00802672|3999268|P2|Overall Study|Lack of fungal pathogen at baseline|43
1218739|NCT00802672|3999269|P1|Overall Study|Lack of fungal pathogen at baseline|56
1218740|NCT00802659|3999287|P4|Overall Study|Physician Decision|0
1218741|NCT00802659|3999288|P3|Overall Study|Physician Decision|0
1218742|NCT00802659|3999289|P2|Overall Study|Physician Decision|1
1218743|NCT00802659|3999290|P1|Overall Study|Physician Decision|0
1218744|NCT00802529|3999329|P2|Overall Study|Lost to Follow-up|1
1218745|NCT00802529|3999330|P1|Overall Study|Lost to Follow-up|0
1218746|NCT00802464|3999369|P4|Month 8 - Month 14|Lost to Follow-up|0
1218747|NCT00802464|3999370|P3|Month 8 - Month 14|Lost to Follow-up|1
1218748|NCT00802464|3999371|P2|Month 8 - Month 14|Lost to Follow-up|0
1218749|NCT00802464|3999372|P1|Month 8 - Month 14|Lost to Follow-up|0
1218750|NCT00802464|3999369|P4|Month 8 - Month 14|Withdrawal by Subject|0
1218751|NCT00802464|3999370|P3|Month 8 - Month 14|Withdrawal by Subject|0
1218752|NCT00802464|3999371|P2|Month 8 - Month 14|Withdrawal by Subject|1
1218753|NCT00802464|3999372|P1|Month 8 - Month 14|Withdrawal by Subject|1
1218754|NCT00802464|3999369|P4|Month 8 - Month 14|Adverse Event|0
1218755|NCT00802464|3999370|P3|Month 8 - Month 14|Adverse Event|0
1218756|NCT00802464|3999371|P2|Month 8 - Month 14|Adverse Event|1
1218757|NCT00802464|3999372|P1|Month 8 - Month 14|Adverse Event|0
1218758|NCT00802464|3999369|P4|Month 0 - Month 8|Not specified|0
1218759|NCT00802464|3999370|P3|Month 0 - Month 8|Not specified|1
1218760|NCT00802464|3999371|P2|Month 0 - Month 8|Not specified|0
1218761|NCT00802464|3999372|P1|Month 0 - Month 8|Not specified|0
1218762|NCT00802464|3999369|P4|Month 0 - Month 8|Lost to Follow-up|2
1218763|NCT00802464|3999370|P3|Month 0 - Month 8|Lost to Follow-up|2
1218764|NCT00802464|3999371|P2|Month 0 - Month 8|Lost to Follow-up|1
1218765|NCT00802464|3999372|P1|Month 0 - Month 8|Lost to Follow-up|0
1218766|NCT00802464|3999369|P4|Month 0 - Month 8|Withdrawal by Subject|5
1218767|NCT00802464|3999370|P3|Month 0 - Month 8|Withdrawal by Subject|2
1218768|NCT00802464|3999371|P2|Month 0 - Month 8|Withdrawal by Subject|1
1218769|NCT00802464|3999372|P1|Month 0 - Month 8|Withdrawal by Subject|0
1218770|NCT00802464|3999369|P4|Month 0 - Month 8|Protocol Violation|0
1218771|NCT00802464|3999370|P3|Month 0 - Month 8|Protocol Violation|1
1218772|NCT00802464|3999371|P2|Month 0 - Month 8|Protocol Violation|0
1218773|NCT00802464|3999372|P1|Month 0 - Month 8|Protocol Violation|0
1218774|NCT00802464|3999369|P4|Month 0 - Month 8|Adverse Event|2
1218775|NCT00802464|3999370|P3|Month 0 - Month 8|Adverse Event|1
1218776|NCT00802464|3999371|P2|Month 0 - Month 8|Adverse Event|1
1218777|NCT00802464|3999372|P1|Month 0 - Month 8|Adverse Event|0
1218778|NCT00802438|3999458|P1|Overall Study|Physician Decision|1
1218779|NCT00802438|3999458|P1|Overall Study|Withdrawal by Subject|7
1218780|NCT00802438|3999458|P1|Overall Study|Screen Failure|20
1218781|NCT00802360|3999478|P4|Overall Study|Other|3
1218782|NCT00802360|3999479|P3|Overall Study|Other|6
1218783|NCT00802360|3999480|P2|Overall Study|Other|3
1218784|NCT00802360|3999481|P1|Overall Study|Other|2
1218785|NCT00802360|3999478|P4|Overall Study|Pregnancy loss/miscarriage|3
1218786|NCT00802360|3999479|P3|Overall Study|Pregnancy loss/miscarriage|0
1218787|NCT00802360|3999480|P2|Overall Study|Pregnancy loss/miscarriage|2
1218788|NCT00802360|3999481|P1|Overall Study|Pregnancy loss/miscarriage|0
1218789|NCT00802360|3999478|P4|Overall Study|Pregnancy not confirmed by ultrasound|0
1218790|NCT00802360|3999479|P3|Overall Study|Pregnancy not confirmed by ultrasound|1
1218791|NCT00802360|3999480|P2|Overall Study|Pregnancy not confirmed by ultrasound|0
1218792|NCT00802360|3999481|P1|Overall Study|Pregnancy not confirmed by ultrasound|1
1218793|NCT00802360|3999478|P4|Overall Study|No positive serum pregnancy|10
1218794|NCT00802360|3999479|P3|Overall Study|No positive serum pregnancy|14
1218795|NCT00802360|3999480|P2|Overall Study|No positive serum pregnancy|20
1218796|NCT00802360|3999481|P1|Overall Study|No positive serum pregnancy|17
1218797|NCT00802360|3999478|P4|Overall Study|Risk of ovarian hyperstimulation syndrom|1
1218798|NCT00802360|3999479|P3|Overall Study|Risk of ovarian hyperstimulation syndrom|0
1218799|NCT00802360|3999480|P2|Overall Study|Risk of ovarian hyperstimulation syndrom|0
1218800|NCT00802360|3999481|P1|Overall Study|Risk of ovarian hyperstimulation syndrom|0
1218801|NCT00802360|3999478|P4|Overall Study|Cycle cancelled|1
1218802|NCT00802360|3999479|P3|Overall Study|Cycle cancelled|1
1218803|NCT00802360|3999480|P2|Overall Study|Cycle cancelled|1
1218804|NCT00802360|3999481|P1|Overall Study|Cycle cancelled|0
1218805|NCT00802360|3999478|P4|Overall Study|Inadequate number of oocytes retrieved|1
1218806|NCT00802360|3999479|P3|Overall Study|Inadequate number of oocytes retrieved|0
1218807|NCT00802360|3999480|P2|Overall Study|Inadequate number of oocytes retrieved|0
1218808|NCT00802360|3999481|P1|Overall Study|Inadequate number of oocytes retrieved|0
1218809|NCT00802360|3999478|P4|Overall Study|Stimulation failure|3
1218810|NCT00802360|3999479|P3|Overall Study|Stimulation failure|3
1218811|NCT00802360|3999480|P2|Overall Study|Stimulation failure|0
1218812|NCT00802360|3999481|P1|Overall Study|Stimulation failure|4
1218813|NCT00802178|3999548|P1|Overall Study|Patients wish and other reason|1
1218814|NCT00802178|3999548|P1|Overall Study|IT and patient wish|8
1218815|NCT00802178|3999548|P1|Overall Study|Lack of efficacy and patient wish|1
1218816|NCT00802178|3999548|P1|Overall Study|Other|32
1218817|NCT00802178|3999548|P1|Overall Study|Withdrawal by Subject|18
1218818|NCT00802178|3999548|P1|Overall Study|Insufficient tolerability (IT)|17
1218819|NCT00802178|3999548|P1|Overall Study|Lack of Efficacy|36
1218820|NCT00802074|3999575|P6|Overall Study|Withdrawal by Subject|0
1218821|NCT00802074|3999576|P5|Overall Study|Withdrawal by Subject|0
1218822|NCT00802074|3999577|P4|Overall Study|Withdrawal by Subject|0
1218823|NCT00802074|3999578|P3|Overall Study|Withdrawal by Subject|0
1218824|NCT00802074|3999579|P2|Overall Study|Withdrawal by Subject|0
1218825|NCT00802074|3999580|P1|Overall Study|Withdrawal by Subject|1
1218826|NCT00802074|3999575|P6|Overall Study|Adverse Event|0
1218827|NCT00802074|3999576|P5|Overall Study|Adverse Event|0
1218828|NCT00802074|3999577|P4|Overall Study|Adverse Event|0
1218829|NCT00802074|3999578|P3|Overall Study|Adverse Event|1
1218830|NCT00802074|3999579|P2|Overall Study|Adverse Event|1
1218831|NCT00802074|3999580|P1|Overall Study|Adverse Event|1
1218832|NCT00801983|3999614|P2|Period 2|Withdrawal by Subject|1
1218833|NCT00801983|3999615|P1|Period 2|Withdrawal by Subject|2
1218834|NCT00801983|3999614|P2|Period 1|Withdrawal by Subject|8
1218835|NCT00801983|3999615|P1|Period 1|Withdrawal by Subject|2
1218836|NCT00801983|3999614|P2|Period 1|Lost to Follow-up|0
1218837|NCT00801983|3999615|P1|Period 1|Lost to Follow-up|2
1218838|NCT00801892|3999623|P2|Sham Crossover Period|Lost to Follow-up|2
1218839|NCT00801892|3999624|P1|Sham Crossover Period|Lost to Follow-up|0
1218840|NCT00801892|3999623|P2|Main Study Period|Withdrawal by Subject|1
1218841|NCT00801892|3999624|P1|Main Study Period|Withdrawal by Subject|0
1218842|NCT00801632|3999671|P1|Overall Study|Re-transplant|1
1218843|NCT00801242|3999682|P1|Overall Study|Miscellaneous reasons|20
1218844|NCT00801242|3999682|P1|Overall Study|Lost to Follow-up|1
1218845|NCT00801242|3999682|P1|Overall Study|Physician Decision|3
1218846|NCT00801242|3999682|P1|Overall Study|Protocol Violation|5
1218847|NCT00801242|3999682|P1|Overall Study|Withdrawal by Subject|13
1218848|NCT00801242|3999682|P1|Overall Study|Adverse Event|10
1218849|NCT00801229|3999695|P2|Received Study Drug/Placebo|Adverse Event|1
1218850|NCT00801229|3999696|P1|Received Study Drug/Placebo|Adverse Event|1
1218851|NCT00801229|3999695|P2|Received Study Drug/Placebo|Lost to Follow-up|1
1218852|NCT00801229|3999696|P1|Received Study Drug/Placebo|Lost to Follow-up|0
1218853|NCT00801229|3999695|P2|Received Study Drug/Placebo|Withdrawal by Subject|0
1218854|NCT00801229|3999696|P1|Received Study Drug/Placebo|Withdrawal by Subject|1
1218855|NCT00801229|3999695|P2|Received Study Drug/Placebo|Simulator sickness|1
1218856|NCT00801229|3999696|P1|Received Study Drug/Placebo|Simulator sickness|1
1218857|NCT00801229|3999695|P2|Received Study Drug/Placebo|Sub-threshold ADHD|1
1218858|NCT00801229|3999696|P1|Received Study Drug/Placebo|Sub-threshold ADHD|0
1218859|NCT00801229|3999695|P2|Received Study Drug/Placebo|Elevated SGOT level|0
1218860|NCT00801229|3999696|P1|Received Study Drug/Placebo|Elevated SGOT level|1
1218861|NCT00801229|3999695|P2|Signed Consent|Found Ineligible|1
1218862|NCT00801229|3999696|P1|Signed Consent|Found Ineligible|1
1218863|NCT00801229|3999695|P2|Signed Consent|Withdrawal by Subject|2
1218864|NCT00801229|3999696|P1|Signed Consent|Withdrawal by Subject|2
1218865|NCT00801099|3999731|P1|Overall Study|Lost to Follow-up|101
1218866|NCT00800982|3999737|P2|Overall Study|Patient moved out of state|0
1218867|NCT00800982|3999738|P1|Overall Study|Patient moved out of state|1
1218868|NCT00800982|3999737|P2|Overall Study|Withdrawal by Subject|1
1218869|NCT00800982|3999738|P1|Overall Study|Withdrawal by Subject|0
1218870|NCT00800982|3999737|P2|Overall Study|Lost to Follow-up|2
1218871|NCT00800982|3999738|P1|Overall Study|Lost to Follow-up|1
1218872|NCT00800735|3999764|P1|Overall Study|Withdrew Consent|3
1218873|NCT00800735|3999764|P1|Overall Study|Violation of Selection Criteria at Entry|7
1218874|NCT00800735|3999764|P1|Overall Study|Insufficient Therapeutic Response|2
1218875|NCT00800735|3999764|P1|Overall Study|Administrative/Other|2
1218876|NCT00800683|3999770|P2|Overall Study|Not specified|2
1218877|NCT00800683|3999771|P1|Overall Study|Not specified|1
1218878|NCT00800683|3999770|P2|Overall Study|Lack of Efficacy|1
1218879|NCT00800683|3999771|P1|Overall Study|Lack of Efficacy|1
1218880|NCT00800683|3999770|P2|Overall Study|Withdrawal by Subject|7
1218881|NCT00800683|3999771|P1|Overall Study|Withdrawal by Subject|1
1218882|NCT00800683|3999770|P2|Overall Study|Lost to Follow-up|1
1218883|NCT00800683|3999771|P1|Overall Study|Lost to Follow-up|3
1218884|NCT00800683|3999770|P2|Overall Study|Adverse Event|8
1218885|NCT00800683|3999771|P1|Overall Study|Adverse Event|11
1218886|NCT00800540|3999817|P2|Period 2: 6 Weeks|Adverse Event|1
1218887|NCT00800540|3999818|P1|Period 2: 6 Weeks|Adverse Event|0
1218888|NCT00800540|3999817|P2|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1
1218889|NCT00800540|3999818|P1|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0
1218890|NCT00800540|3999817|P2|Period One: 6 Weeks|Noncompliance|0
1218891|NCT00800540|3999818|P1|Period One: 6 Weeks|Noncompliance|1
1218892|NCT00800436|3999853|P7|Overall Study|Withdrawal by Subject|0
1218893|NCT00800436|3999854|P6|Overall Study|Withdrawal by Subject|0
1218894|NCT00800436|3999855|P5|Overall Study|Withdrawal by Subject|0
1218895|NCT00800436|3999856|P4|Overall Study|Withdrawal by Subject|1
1218896|NCT00800436|3999857|P3|Overall Study|Withdrawal by Subject|1
1218897|NCT00800436|3999858|P2|Overall Study|Withdrawal by Subject|0
1218898|NCT00800436|3999859|P1|Overall Study|Withdrawal by Subject|0
1218899|NCT00800384|3999905|P2|Overall Study|Lost to Follow-up|26
1218900|NCT00800384|3999906|P1|Overall Study|Lost to Follow-up|17
1218901|NCT00800384|3999905|P2|Overall Study|Withdrawal by Subject|17
1218902|NCT00800384|3999906|P1|Overall Study|Withdrawal by Subject|24
1218903|NCT00800202|3999944|P2|Overall Study|Disease Progression|18
1218904|NCT00800202|3999945|P1|Overall Study|Disease Progression|54
1218905|NCT00800202|3999944|P2|Overall Study|Other|0
1218906|NCT00800202|3999945|P1|Overall Study|Other|5
1218907|NCT00800202|3999944|P2|Overall Study|Death|0
1218908|NCT00800202|3999945|P1|Overall Study|Death|1
1218909|NCT00800202|3999944|P2|Overall Study|Adverse Event|6
1218910|NCT00800202|3999945|P1|Overall Study|Adverse Event|7
1218911|NCT00799903|3999965|P2|Overall Study|Lost to Follow-up|80
1218912|NCT00799903|3999966|P1|Overall Study|Lost to Follow-up|69
1218913|NCT00799903|3999965|P2|Overall Study|Withdrawal by Subject|175
1218914|NCT00799903|3999966|P1|Overall Study|Withdrawal by Subject|179
1218915|NCT00799903|3999965|P2|Overall Study|Investigator Site Closed|23
1218916|NCT00799903|3999966|P1|Overall Study|Investigator Site Closed|25
1218917|NCT00799825|3999986|P1|Overall Study|Pregnancy|3
1218918|NCT00799825|3999986|P1|Overall Study|Lost to Follow-up|38
1218919|NCT00799825|3999986|P1|Overall Study|Withdrawal by Subject|6
1218920|NCT00799825|3999986|P1|Overall Study|Adverse Event|1
1218921|NCT00799708|4000026|P3|Overall Study|non-compliance|0
1218922|NCT00799708|4000027|P2|Overall Study|non-compliance|0
1218923|NCT00799708|4000028|P1|Overall Study|non-compliance|1
1218924|NCT00799617|4000051|P2|Anemia Trial|Withdrawal by Subject|3
1218925|NCT00799617|4000052|P1|Anemia Trial|Withdrawal by Subject|3
1218926|NCT00799617|4000051|P2|Cognitive Function Trial|Lost to Follow-up|1
1218927|NCT00799617|4000052|P1|Cognitive Function Trial|Lost to Follow-up|0
1218928|NCT00799617|4000051|P2|Bone Trial|Month 12 scan not available|16
1218929|NCT00799617|4000052|P1|Bone Trial|Month 12 scan not available|6
1218930|NCT00799617|4000051|P2|Cardiovascular Trial|Baseline scan not analyzable|2
1218931|NCT00799617|4000052|P1|Cardiovascular Trial|Baseline scan not analyzable|0
1218932|NCT00799617|4000051|P2|Cardiovascular Trial|Month 12 scan not available|15
1218933|NCT00799617|4000052|P1|Cardiovascular Trial|Month 12 scan not available|15
1218934|NCT00799617|4000051|P2|Vitality Trial|Lost to Follow-up|22
1218935|NCT00799617|4000052|P1|Vitality Trial|Lost to Follow-up|7
1218936|NCT00799617|4000051|P2|Physical Function Trial|Lost to Follow-up|11
1218937|NCT00799617|4000052|P1|Physical Function Trial|Lost to Follow-up|6
1218938|NCT00799617|4000051|P2|Sexual Funtion Trial|No Baseline Data|7
1218939|NCT00799617|4000052|P1|Sexual Funtion Trial|No Baseline Data|4
1218940|NCT00799617|4000051|P2|Sexual Funtion Trial|Lost to Follow-up|14
1218941|NCT00799617|4000052|P1|Sexual Funtion Trial|Lost to Follow-up|12
1218942|NCT00799617|4000051|P2|Main Testosterone Trial|Lost to Follow-up|20
1218943|NCT00799617|4000052|P1|Main Testosterone Trial|Lost to Follow-up|18
1218944|NCT00799617|4000051|P2|Main Testosterone Trial|Randomized in error|1
1218945|NCT00799617|4000052|P1|Main Testosterone Trial|Randomized in error|1
1218946|NCT00799591|4000159|P1|Overall Study|Infectious origin not probable|1
1218947|NCT00799591|4000159|P1|Overall Study|Antibiotic changed, no apparent reason|1
1218948|NCT00799591|4000159|P1|Overall Study|Persistance of fever undetermined origin|1
1218949|NCT00799591|4000159|P1|Overall Study|Resistance germ and technical failure|2
1218950|NCT00799591|4000159|P1|Overall Study|New infection|4
1218951|NCT00799591|4000159|P1|Overall Study|Resistant germ|11
1218952|NCT00799591|4000159|P1|Overall Study|Technical failure|12
1218953|NCT00799591|4000159|P1|Overall Study|Death|14
1218954|NCT00799591|4000159|P1|Overall Study|De-escalation of doses|20
1218955|NCT00799487|4000177|P3|Double-Blind Assessment Period|Overslept and missed lab day 2|0
1218956|NCT00799487|4000178|P2|Double-Blind Assessment Period|Overslept and missed lab day 2|1
1218957|NCT00799487|4000179|P1|Double-Blind Assessment Period|Overslept and missed lab day 2|0
1218958|NCT00799487|4000177|P3|Double-Blind Assessment Period|Subject was out of the state|1
1218959|NCT00799487|4000178|P2|Double-Blind Assessment Period|Subject was out of the state|0
1218960|NCT00799487|4000179|P1|Double-Blind Assessment Period|Subject was out of the state|0
1218961|NCT00799487|4000177|P3|Double-Blind Assessment Period|Lost to Follow-up|1
1218962|NCT00799487|4000178|P2|Double-Blind Assessment Period|Lost to Follow-up|0
1218963|NCT00799487|4000179|P1|Double-Blind Assessment Period|Lost to Follow-up|0
1218964|NCT00799487|4000177|P3|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
1218965|NCT00799487|4000178|P2|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
1218966|NCT00799487|4000179|P1|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2
1218967|NCT00799487|4000177|P3|Dose Adjustment Period|Missed laboratory day 1|0
1218968|NCT00799487|4000178|P2|Dose Adjustment Period|Missed laboratory day 1|0
1218969|NCT00799487|4000179|P1|Dose Adjustment Period|Missed laboratory day 1|1
1218970|NCT00799487|4000177|P3|Dose Adjustment Period|Child too young (exclusion)|0
1218971|NCT00799487|4000178|P2|Dose Adjustment Period|Child too young (exclusion)|0
1218972|NCT00799487|4000179|P1|Dose Adjustment Period|Child too young (exclusion)|1
1219057|NCT00798759|4000437|P2|Overall Study|Adverse Event|3
1218973|NCT00799487|4000177|P3|Dose Adjustment Period|Parent to home school child (exclusion)|0
1218974|NCT00799487|4000178|P2|Dose Adjustment Period|Parent to home school child (exclusion)|0
1218975|NCT00799487|4000179|P1|Dose Adjustment Period|Parent to home school child (exclusion)|1
1218976|NCT00799487|4000177|P3|Dose Adjustment Period|Withdrawal by Subject|0
1218977|NCT00799487|4000178|P2|Dose Adjustment Period|Withdrawal by Subject|0
1218978|NCT00799487|4000179|P1|Dose Adjustment Period|Withdrawal by Subject|3
1218979|NCT00799487|4000177|P3|Dose Adjustment Period|Investigator Discretion|0
1218980|NCT00799487|4000178|P2|Dose Adjustment Period|Investigator Discretion|0
1218981|NCT00799487|4000179|P1|Dose Adjustment Period|Investigator Discretion|2
1218982|NCT00799487|4000177|P3|Dose Adjustment Period|Optimal Dose Not Achieved|0
1218983|NCT00799487|4000178|P2|Dose Adjustment Period|Optimal Dose Not Achieved|0
1218984|NCT00799487|4000179|P1|Dose Adjustment Period|Optimal Dose Not Achieved|8
1218985|NCT00799487|4000177|P3|Dose Adjustment Period|Adverse Event|0
1218986|NCT00799487|4000178|P2|Dose Adjustment Period|Adverse Event|0
1218987|NCT00799487|4000179|P1|Dose Adjustment Period|Adverse Event|2
1218988|NCT00799487|4000177|P3|Dose Adjustment Period|Lost to Follow-up|0
1218989|NCT00799487|4000178|P2|Dose Adjustment Period|Lost to Follow-up|0
1218990|NCT00799487|4000179|P1|Dose Adjustment Period|Lost to Follow-up|1
1218991|NCT00799422|4000274|P6|First Week of Wear|Adverse Event|0
1218992|NCT00799422|4000275|P5|First Week of Wear|Adverse Event|0
1218993|NCT00799422|4000276|P4|First Week of Wear|Adverse Event|1
1218994|NCT00799422|4000277|P3|First Week of Wear|Adverse Event|0
1218995|NCT00799422|4000278|P2|First Week of Wear|Adverse Event|0
1218996|NCT00799422|4000279|P1|First Week of Wear|Adverse Event|0
1218997|NCT00799422|4000274|P6|First Week of Wear|Lost to Follow-up|0
1218998|NCT00799422|4000275|P5|First Week of Wear|Lost to Follow-up|0
1218999|NCT00799422|4000276|P4|First Week of Wear|Lost to Follow-up|0
1219000|NCT00799422|4000277|P3|First Week of Wear|Lost to Follow-up|1
1219001|NCT00799422|4000278|P2|First Week of Wear|Lost to Follow-up|0
1219002|NCT00799422|4000279|P1|First Week of Wear|Lost to Follow-up|0
1219003|NCT00799409|4000296|P3|Overall Study|medication compliance|0
1219004|NCT00799409|4000297|P2|Overall Study|medication compliance|0
1219005|NCT00799409|4000298|P1|Overall Study|medication compliance|1
1219006|NCT00799409|4000296|P3|Overall Study|Did not attend lab school day 1|0
1219007|NCT00799409|4000297|P2|Overall Study|Did not attend lab school day 1|0
1219008|NCT00799409|4000298|P1|Overall Study|Did not attend lab school day 1|1
1219009|NCT00799409|4000296|P3|Overall Study|Failure to follow study protocol)|0
1219010|NCT00799409|4000297|P2|Overall Study|Failure to follow study protocol)|0
1219011|NCT00799409|4000298|P1|Overall Study|Failure to follow study protocol)|1
1219012|NCT00799409|4000296|P3|Overall Study|Optimal Dose Not Achieved|0
1219013|NCT00799409|4000297|P2|Overall Study|Optimal Dose Not Achieved|0
1219014|NCT00799409|4000298|P1|Overall Study|Optimal Dose Not Achieved|2
1219015|NCT00799409|4000296|P3|Overall Study|Lost to Follow-up|0
1219016|NCT00799409|4000297|P2|Overall Study|Lost to Follow-up|0
1219017|NCT00799409|4000298|P1|Overall Study|Lost to Follow-up|1
1219018|NCT00799409|4000296|P3|Overall Study|Withdrawal by Subject|0
1219019|NCT00799409|4000297|P2|Overall Study|Withdrawal by Subject|0
1219020|NCT00799409|4000298|P1|Overall Study|Withdrawal by Subject|1
1219021|NCT00799396|4000378|P1|Clopidogrel Plus Aspirin|Physician Decision|4
1219022|NCT00799396|4000378|P1|Clopidogrel Plus Aspirin|Adverse Event|2
1219023|NCT00799396|4000378|P1|Clopidogrel Treatment|Withdrawal by Subject|2
1219024|NCT00799396|4000378|P1|Clopidogrel Treatment|Physician Decision|5
1219025|NCT00799396|4000378|P1|Clopidogrel Treatment|Adverse Event|6
1219026|NCT00799383|4000385|P2|Overall Study|Withdrawal by Subject|1
1219027|NCT00799383|4000386|P1|Overall Study|Withdrawal by Subject|0
1219028|NCT00799383|4000385|P2|Overall Study|Urinary Calcium/Creatinine > 0.2|1
1219029|NCT00799383|4000386|P1|Overall Study|Urinary Calcium/Creatinine > 0.2|1
1219030|NCT00799383|4000385|P2|Overall Study|Lost to Follow-up|2
1219031|NCT00799383|4000386|P1|Overall Study|Lost to Follow-up|1
1219032|NCT00799383|4000385|P2|Overall Study|Adverse Event|1
1219033|NCT00799383|4000386|P1|Overall Study|Adverse Event|0
1219034|NCT00799383|4000385|P2|Overall Study|Protocol Violation|1
1219035|NCT00799383|4000386|P1|Overall Study|Protocol Violation|1
1219036|NCT00798967|4000422|P2|Overall Study|Randomized in error by site|0
1219037|NCT00798967|4000423|P1|Overall Study|Randomized in error by site|1
1219038|NCT00798967|4000422|P2|Overall Study|Physician Decision|0
1219039|NCT00798967|4000423|P1|Overall Study|Physician Decision|1
1219040|NCT00798967|4000422|P2|Overall Study|Withdrawal by Subject|1
1219041|NCT00798967|4000423|P1|Overall Study|Withdrawal by Subject|0
1219042|NCT00798967|4000422|P2|Overall Study|Adverse Event|3
1219043|NCT00798967|4000423|P1|Overall Study|Adverse Event|2
1219044|NCT00798889|4000431|P1|Overall Study|Enrolled, Not treated|3
1219045|NCT00798889|4000431|P1|Overall Study|Decision of Sponsor|11
1219046|NCT00798889|4000431|P1|Overall Study|Lack of Efficacy|213
1219047|NCT00798889|4000431|P1|Overall Study|Lost to Follow-up|1
1219048|NCT00798889|4000431|P1|Overall Study|Withdrawal by Subject|31
1219049|NCT00798889|4000431|P1|Overall Study|Protocol Violation|2
1219050|NCT00798889|4000431|P1|Overall Study|Adverse Event|53
1219051|NCT00798759|4000437|P2|Overall Study|Not specified|1
1219052|NCT00798759|4000438|P1|Overall Study|Not specified|0
1219053|NCT00798759|4000437|P2|Overall Study|Protocol Violation|8
1219054|NCT00798759|4000438|P1|Overall Study|Protocol Violation|4
1219055|NCT00798759|4000437|P2|Overall Study|Lost to Follow-up|1
1219056|NCT00798759|4000438|P1|Overall Study|Lost to Follow-up|1
1219058|NCT00798759|4000438|P1|Overall Study|Adverse Event|3
1219059|NCT00798707|4000456|P3|Overall Study|Randomized not treated|1
1219060|NCT00798707|4000457|P2|Overall Study|Randomized not treated|5
1219061|NCT00798707|4000458|P1|Overall Study|Randomized not treated|4
1219062|NCT00798707|4000456|P3|Overall Study|Withdrawal by Subject|2
1219063|NCT00798707|4000457|P2|Overall Study|Withdrawal by Subject|8
1219064|NCT00798707|4000458|P1|Overall Study|Withdrawal by Subject|3
1219065|NCT00798707|4000456|P3|Overall Study|Protocol Violation|2
1219066|NCT00798707|4000457|P2|Overall Study|Protocol Violation|0
1219067|NCT00798707|4000458|P1|Overall Study|Protocol Violation|4
1219068|NCT00798707|4000456|P3|Overall Study|Other|0
1219069|NCT00798707|4000457|P2|Overall Study|Other|1
1219070|NCT00798707|4000458|P1|Overall Study|Other|0
1219071|NCT00798707|4000456|P3|Overall Study|Lost to Follow-up|6
1219072|NCT00798707|4000457|P2|Overall Study|Lost to Follow-up|6
1219073|NCT00798707|4000458|P1|Overall Study|Lost to Follow-up|5
1219074|NCT00798707|4000456|P3|Overall Study|Lack of Efficacy|1
1219075|NCT00798707|4000457|P2|Overall Study|Lack of Efficacy|2
1219076|NCT00798707|4000458|P1|Overall Study|Lack of Efficacy|2
1219077|NCT00798707|4000456|P3|Overall Study|Investigator|2
1219078|NCT00798707|4000457|P2|Overall Study|Investigator|1
1219079|NCT00798707|4000458|P1|Overall Study|Investigator|0
1219080|NCT00798707|4000456|P3|Overall Study|Failed to return|0
1219081|NCT00798707|4000457|P2|Overall Study|Failed to return|2
1219082|NCT00798707|4000458|P1|Overall Study|Failed to return|2
1219083|NCT00798707|4000456|P3|Overall Study|Adverse Event|8
1219084|NCT00798707|4000457|P2|Overall Study|Adverse Event|8
1219085|NCT00798707|4000458|P1|Overall Study|Adverse Event|6
1219086|NCT00798694|4000510|P2|Overall Study|Physician Decision|0
1219087|NCT00798694|4000511|P1|Overall Study|Physician Decision|1
1219088|NCT00798694|4000510|P2|Overall Study|Lost to Follow-up|1
1219089|NCT00798694|4000511|P1|Overall Study|Lost to Follow-up|1
1219090|NCT00798655|4000535|P1|Overall Study|Did not receive at least one dose of pan|2
1219091|NCT00798603|4000540|P1|Overall Study|Lack of insurance coverage|1
1219092|NCT00798603|4000540|P1|Overall Study|Physician Decision|1
1219093|NCT00798603|4000540|P1|Overall Study|Adverse Event|22
1219094|NCT00798603|4000540|P1|Overall Study|Withdrawal by Subject|10
1219095|NCT00798603|4000540|P1|Overall Study|Still on treatment as of 11/6/2012|1
1219096|NCT00798590|4000562|P2|Overall Study|P.I, Left institution. Study terminated|8
1219097|NCT00798590|4000563|P1|Overall Study|P.I, Left institution. Study terminated|11
1219098|NCT00798434|4000597|P2|Open-Label|Not Treated|1
1219099|NCT00798434|4000598|P1|Open-Label|Not Treated|0
1219100|NCT00798434|4000597|P2|Open-Label|Not Specified|2
1219101|NCT00798434|4000598|P1|Open-Label|Not Specified|1
1219102|NCT00798434|4000597|P2|Open-Label|Protocol Violation|0
1219103|NCT00798434|4000598|P1|Open-Label|Protocol Violation|1
1219104|NCT00798434|4000597|P2|Open-Label|Withdrawal by Subject|7
1219105|NCT00798434|4000598|P1|Open-Label|Withdrawal by Subject|2
1219106|NCT00798434|4000597|P2|Open-Label|Lack of Efficacy|11
1219107|NCT00798434|4000598|P1|Open-Label|Lack of Efficacy|5
1219108|NCT00798434|4000597|P2|Open-Label|Adverse Event|11
1219109|NCT00798434|4000598|P1|Open-Label|Adverse Event|33
1219110|NCT00798434|4000597|P2|Double-Blind|Not Treated|6
1219111|NCT00798434|4000598|P1|Double-Blind|Not Treated|3
1219112|NCT00798434|4000597|P2|Double-Blind|Not Specified|0
1219113|NCT00798434|4000598|P1|Double-Blind|Not Specified|1
1219114|NCT00798434|4000597|P2|Double-Blind|Did Not Meet Entrance Criteria|1
1219115|NCT00798434|4000598|P1|Double-Blind|Did Not Meet Entrance Criteria|2
1219116|NCT00798434|4000597|P2|Double-Blind|Protocol Violation|4
1219117|NCT00798434|4000598|P1|Double-Blind|Protocol Violation|1
1219118|NCT00798434|4000597|P2|Double-Blind|Withdrawal by Subject|14
1219119|NCT00798434|4000598|P1|Double-Blind|Withdrawal by Subject|17
1219120|NCT00798434|4000597|P2|Double-Blind|Lack of Efficacy|12
1219121|NCT00798434|4000598|P1|Double-Blind|Lack of Efficacy|8
1219122|NCT00798434|4000597|P2|Double-Blind|Lost to Follow-up|0
1219123|NCT00798434|4000598|P1|Double-Blind|Lost to Follow-up|1
1219124|NCT00798434|4000597|P2|Double-Blind|Death|1
1219125|NCT00798434|4000598|P1|Double-Blind|Death|0
1219126|NCT00798434|4000597|P2|Double-Blind|Adverse Event|46
1219127|NCT00798434|4000598|P1|Double-Blind|Adverse Event|22
1219128|NCT00798369|4000684|P6|Overall Study|Adminstrative problems|1
1219129|NCT00798369|4000685|P5|Overall Study|Adminstrative problems|0
1219130|NCT00798369|4000686|P4|Overall Study|Adminstrative problems|0
1219131|NCT00798369|4000687|P3|Overall Study|Adminstrative problems|0
1219132|NCT00798369|4000688|P2|Overall Study|Adminstrative problems|0
1219133|NCT00798369|4000689|P1|Overall Study|Adminstrative problems|0
1219134|NCT00798369|4000684|P6|Overall Study|Lost to Follow-up|0
1219135|NCT00798369|4000685|P5|Overall Study|Lost to Follow-up|1
1219136|NCT00798369|4000686|P4|Overall Study|Lost to Follow-up|0
1219137|NCT00798369|4000687|P3|Overall Study|Lost to Follow-up|1
1219138|NCT00798369|4000688|P2|Overall Study|Lost to Follow-up|1
1219139|NCT00798369|4000689|P1|Overall Study|Lost to Follow-up|1
1219140|NCT00798369|4000684|P6|Overall Study|Subject withdrew consent|2
1219141|NCT00798369|4000685|P5|Overall Study|Subject withdrew consent|0
1219142|NCT00798369|4000686|P4|Overall Study|Subject withdrew consent|1
1219143|NCT00798369|4000687|P3|Overall Study|Subject withdrew consent|1
1219144|NCT00798369|4000688|P2|Overall Study|Subject withdrew consent|0
1219145|NCT00798369|4000689|P1|Overall Study|Subject withdrew consent|0
1219146|NCT00798317|4000736|P2|Overall Study|Death|0
1219147|NCT00798317|4000737|P1|Overall Study|Death|1
1219148|NCT00798317|4000736|P2|Overall Study|Adverse Event|0
1219149|NCT00798317|4000737|P1|Overall Study|Adverse Event|2
1219150|NCT00798317|4000736|P2|Overall Study|Lost to Follow-up|2
1219151|NCT00798317|4000737|P1|Overall Study|Lost to Follow-up|2
1219152|NCT00798317|4000736|P2|Overall Study|Withdrawal by Subject|4
1219153|NCT00798317|4000737|P1|Overall Study|Withdrawal by Subject|5
1219154|NCT00798317|4000736|P2|Overall Study|Physician Decision|1
1219155|NCT00798317|4000737|P1|Overall Study|Physician Decision|0
1219156|NCT00798304|4000748|P3|Overall Study|Discontinuation by Sponsor|9
1219157|NCT00798304|4000749|P2|Overall Study|Discontinuation by Sponsor|21
1219158|NCT00798304|4000750|P1|Overall Study|Discontinuation by Sponsor|14
1219159|NCT00798304|4000748|P3|Overall Study|Adverse Event|1
1219160|NCT00798304|4000749|P2|Overall Study|Adverse Event|1
1219161|NCT00798304|4000750|P1|Overall Study|Adverse Event|0
1219162|NCT00798174|4000776|P2|Overall Study|Inability to sedate for DFT testing|0
1219163|NCT00798174|4000777|P1|Overall Study|Inability to sedate for DFT testing|1
1219164|NCT00798174|4000776|P2|Overall Study|inability to implant azygos coil|3
1219165|NCT00798174|4000777|P1|Overall Study|inability to implant azygos coil|3
1219166|NCT00798161|4000788|P7|Overall Study|Other reason (incl. lack of efficacy)|5
1219167|NCT00798161|4000789|P6|Overall Study|Other reason (incl. lack of efficacy)|4
1219168|NCT00798161|4000790|P5|Overall Study|Other reason (incl. lack of efficacy)|2
1219169|NCT00798161|4000791|P4|Overall Study|Other reason (incl. lack of efficacy)|5
1219170|NCT00798161|4000792|P3|Overall Study|Other reason (incl. lack of efficacy)|3
1219171|NCT00798161|4000793|P2|Overall Study|Other reason (incl. lack of efficacy)|5
1219172|NCT00798161|4000794|P1|Overall Study|Other reason (incl. lack of efficacy)|7
1219173|NCT00798161|4000788|P7|Overall Study|Withdrawal by Subject|1
1219174|NCT00798161|4000789|P6|Overall Study|Withdrawal by Subject|3
1219175|NCT00798161|4000790|P5|Overall Study|Withdrawal by Subject|2
1219176|NCT00798161|4000791|P4|Overall Study|Withdrawal by Subject|4
1219177|NCT00798161|4000792|P3|Overall Study|Withdrawal by Subject|5
1219178|NCT00798161|4000793|P2|Overall Study|Withdrawal by Subject|4
1219179|NCT00798161|4000794|P1|Overall Study|Withdrawal by Subject|5
1219180|NCT00798161|4000788|P7|Overall Study|Lost to Follow-up|0
1219181|NCT00798161|4000789|P6|Overall Study|Lost to Follow-up|0
1219182|NCT00798161|4000790|P5|Overall Study|Lost to Follow-up|4
1219183|NCT00798161|4000791|P4|Overall Study|Lost to Follow-up|3
1219184|NCT00798161|4000792|P3|Overall Study|Lost to Follow-up|4
1219185|NCT00798161|4000793|P2|Overall Study|Lost to Follow-up|3
1219186|NCT00798161|4000794|P1|Overall Study|Lost to Follow-up|1
1219187|NCT00798161|4000788|P7|Overall Study|Protocol Violation|0
1219188|NCT00798161|4000789|P6|Overall Study|Protocol Violation|2
1219189|NCT00798161|4000790|P5|Overall Study|Protocol Violation|3
1219190|NCT00798161|4000791|P4|Overall Study|Protocol Violation|3
1219191|NCT00798161|4000792|P3|Overall Study|Protocol Violation|3
1219192|NCT00798161|4000793|P2|Overall Study|Protocol Violation|1
1219193|NCT00798161|4000794|P1|Overall Study|Protocol Violation|2
1219194|NCT00798161|4000788|P7|Overall Study|Adverse Event|4
1219195|NCT00798161|4000789|P6|Overall Study|Adverse Event|2
1219196|NCT00798161|4000790|P5|Overall Study|Adverse Event|5
1219197|NCT00798161|4000791|P4|Overall Study|Adverse Event|6
1219198|NCT00798161|4000792|P3|Overall Study|Adverse Event|6
1219199|NCT00798161|4000793|P2|Overall Study|Adverse Event|4
1219200|NCT00798161|4000794|P1|Overall Study|Adverse Event|3
1219201|NCT00798135|4000901|P1|Overall Study|Physician Decision|1
1219202|NCT00798135|4000901|P1|Overall Study|Disease progression, refractory|1
1219203|NCT00798135|4000901|P1|Overall Study|Disease progression, relapse|11
1219204|NCT00798096|4000907|P1|Overall Study|Ongoing|2
1219205|NCT00797966|4000935|P6|Phase A+|Protocol deviation|4
1219206|NCT00797966|4000936|P5|Phase A+|Protocol deviation|0
1219207|NCT00797966|4000937|P4|Phase A+|Protocol deviation|0
1219208|NCT00797966|4000938|P3|Phase A+|Protocol deviation|0
1219209|NCT00797966|4000939|P2|Phase A+|Protocol deviation|0
1219210|NCT00797966|4000940|P1|Phase A+|Protocol deviation|0
1219211|NCT00797966|4000935|P6|Phase A+|Adverse Event|4
1219212|NCT00797966|4000936|P5|Phase A+|Adverse Event|0
1219213|NCT00797966|4000937|P4|Phase A+|Adverse Event|0
1219214|NCT00797966|4000938|P3|Phase A+|Adverse Event|0
1219215|NCT00797966|4000939|P2|Phase A+|Adverse Event|0
1219216|NCT00797966|4000940|P1|Phase A+|Adverse Event|0
1219217|NCT00797966|4000935|P6|Phase A+|Withdrawal by Subject|6
1219218|NCT00797966|4000936|P5|Phase A+|Withdrawal by Subject|0
1219219|NCT00797966|4000937|P4|Phase A+|Withdrawal by Subject|0
1219220|NCT00797966|4000938|P3|Phase A+|Withdrawal by Subject|0
1219221|NCT00797966|4000939|P2|Phase A+|Withdrawal by Subject|0
1219222|NCT00797966|4000940|P1|Phase A+|Withdrawal by Subject|0
1219223|NCT00797966|4000935|P6|Phase A+|Met withdrawal criteria|5
1219224|NCT00797966|4000936|P5|Phase A+|Met withdrawal criteria|0
1219225|NCT00797966|4000937|P4|Phase A+|Met withdrawal criteria|0
1219226|NCT00797966|4000938|P3|Phase A+|Met withdrawal criteria|0
1219227|NCT00797966|4000939|P2|Phase A+|Met withdrawal criteria|0
1219228|NCT00797966|4000940|P1|Phase A+|Met withdrawal criteria|0
1219229|NCT00797966|4000935|P6|Phase A+|Lost to Follow-up|9
1219230|NCT00797966|4000936|P5|Phase A+|Lost to Follow-up|0
1219231|NCT00797966|4000937|P4|Phase A+|Lost to Follow-up|0
1219232|NCT00797966|4000938|P3|Phase A+|Lost to Follow-up|0
1219233|NCT00797966|4000939|P2|Phase A+|Lost to Follow-up|0
1219234|NCT00797966|4000940|P1|Phase A+|Lost to Follow-up|0
1219235|NCT00797966|4000935|P6|Phase B|Lack of Efficacy|0
1219236|NCT00797966|4000936|P5|Phase B|Lack of Efficacy|0
1219237|NCT00797966|4000937|P4|Phase B|Lack of Efficacy|4
1219238|NCT00797966|4000938|P3|Phase B|Lack of Efficacy|1
1219239|NCT00797966|4000939|P2|Phase B|Lack of Efficacy|1
1219240|NCT00797966|4000940|P1|Phase B|Lack of Efficacy|0
1219241|NCT00797966|4000935|P6|Phase B|Protocol Deviation|0
1219242|NCT00797966|4000936|P5|Phase B|Protocol Deviation|0
1219243|NCT00797966|4000937|P4|Phase B|Protocol Deviation|6
1219244|NCT00797966|4000938|P3|Phase B|Protocol Deviation|2
1219245|NCT00797966|4000939|P2|Phase B|Protocol Deviation|8
1219246|NCT00797966|4000940|P1|Phase B|Protocol Deviation|4
1219247|NCT00797966|4000935|P6|Phase B|Withdrawal by Subject|0
1219248|NCT00797966|4000936|P5|Phase B|Withdrawal by Subject|0
1219249|NCT00797966|4000937|P4|Phase B|Withdrawal by Subject|3
1219250|NCT00797966|4000938|P3|Phase B|Withdrawal by Subject|3
1219251|NCT00797966|4000939|P2|Phase B|Withdrawal by Subject|4
1219252|NCT00797966|4000940|P1|Phase B|Withdrawal by Subject|1
1219253|NCT00797966|4000935|P6|Phase B|Physician Decision|0
1219254|NCT00797966|4000936|P5|Phase B|Physician Decision|0
1219255|NCT00797966|4000937|P4|Phase B|Physician Decision|1
1219256|NCT00797966|4000938|P3|Phase B|Physician Decision|3
1219257|NCT00797966|4000939|P2|Phase B|Physician Decision|0
1219258|NCT00797966|4000940|P1|Phase B|Physician Decision|1
1219259|NCT00797966|4000935|P6|Phase B|Met Withdrawal Criteria|0
1219260|NCT00797966|4000936|P5|Phase B|Met Withdrawal Criteria|0
1219261|NCT00797966|4000937|P4|Phase B|Met Withdrawal Criteria|1
1219262|NCT00797966|4000938|P3|Phase B|Met Withdrawal Criteria|6
1219263|NCT00797966|4000939|P2|Phase B|Met Withdrawal Criteria|3
1219264|NCT00797966|4000940|P1|Phase B|Met Withdrawal Criteria|3
1219265|NCT00797966|4000935|P6|Phase B|Adverse Event|0
1219266|NCT00797966|4000936|P5|Phase B|Adverse Event|0
1219267|NCT00797966|4000937|P4|Phase B|Adverse Event|1
1219268|NCT00797966|4000938|P3|Phase B|Adverse Event|3
1219269|NCT00797966|4000939|P2|Phase B|Adverse Event|1
1219270|NCT00797966|4000940|P1|Phase B|Adverse Event|2
1219271|NCT00797966|4000935|P6|Phase B|Lost to Follow-up|0
1219272|NCT00797966|4000936|P5|Phase B|Lost to Follow-up|0
1219273|NCT00797966|4000937|P4|Phase B|Lost to Follow-up|0
1219274|NCT00797966|4000938|P3|Phase B|Lost to Follow-up|3
1219275|NCT00797966|4000939|P2|Phase B|Lost to Follow-up|1
1219276|NCT00797966|4000940|P1|Phase B|Lost to Follow-up|0
1219277|NCT00797966|4000935|P6|Phase A|Protocol deviation|0
1219278|NCT00797966|4000936|P5|Phase A|Protocol deviation|56
1219279|NCT00797966|4000937|P4|Phase A|Protocol deviation|0
1219280|NCT00797966|4000938|P3|Phase A|Protocol deviation|0
1219281|NCT00797966|4000939|P2|Phase A|Protocol deviation|0
1219282|NCT00797966|4000940|P1|Phase A|Protocol deviation|0
1219283|NCT00797966|4000935|P6|Phase A|Withdrawal by Subject|0
1219284|NCT00797966|4000936|P5|Phase A|Withdrawal by Subject|33
1219285|NCT00797966|4000937|P4|Phase A|Withdrawal by Subject|0
1219286|NCT00797966|4000938|P3|Phase A|Withdrawal by Subject|0
1219287|NCT00797966|4000939|P2|Phase A|Withdrawal by Subject|0
1219288|NCT00797966|4000940|P1|Phase A|Withdrawal by Subject|0
1219289|NCT00797966|4000935|P6|Phase A|Physician Decision|0
1219290|NCT00797966|4000936|P5|Phase A|Physician Decision|13
1219291|NCT00797966|4000937|P4|Phase A|Physician Decision|0
1219292|NCT00797966|4000938|P3|Phase A|Physician Decision|0
1219293|NCT00797966|4000939|P2|Phase A|Physician Decision|0
1219294|NCT00797966|4000940|P1|Phase A|Physician Decision|0
1219295|NCT00797966|4000935|P6|Phase A|Met withdrawal criteria|0
1219296|NCT00797966|4000936|P5|Phase A|Met withdrawal criteria|4
1219297|NCT00797966|4000937|P4|Phase A|Met withdrawal criteria|0
1219298|NCT00797966|4000938|P3|Phase A|Met withdrawal criteria|0
1219299|NCT00797966|4000939|P2|Phase A|Met withdrawal criteria|0
1219300|NCT00797966|4000940|P1|Phase A|Met withdrawal criteria|0
1219301|NCT00797966|4000935|P6|Phase A|Adverse Event|0
1219302|NCT00797966|4000936|P5|Phase A|Adverse Event|46
1219303|NCT00797966|4000937|P4|Phase A|Adverse Event|0
1219304|NCT00797966|4000938|P3|Phase A|Adverse Event|0
1219305|NCT00797966|4000939|P2|Phase A|Adverse Event|0
1219306|NCT00797966|4000940|P1|Phase A|Adverse Event|0
1219307|NCT00797966|4000935|P6|Phase A|Lost to Follow-up|0
1219308|NCT00797966|4000936|P5|Phase A|Lost to Follow-up|33
1219309|NCT00797966|4000937|P4|Phase A|Lost to Follow-up|0
1219310|NCT00797966|4000938|P3|Phase A|Lost to Follow-up|0
1219311|NCT00797966|4000939|P2|Phase A|Lost to Follow-up|0
1219312|NCT00797966|4000940|P1|Phase A|Lost to Follow-up|0
1219313|NCT00797862|4001005|P3|Overall Study|Mis-randomized|1
1219314|NCT00797862|4001006|P2|Overall Study|Mis-randomized|3
1219315|NCT00797862|4001007|P1|Overall Study|Mis-randomized|3
1219316|NCT00797862|4001005|P3|Overall Study|Protocol Violation|8
1219317|NCT00797862|4001006|P2|Overall Study|Protocol Violation|6
1219318|NCT00797862|4001007|P1|Overall Study|Protocol Violation|4
1219319|NCT00797862|4001005|P3|Overall Study|Administrative Problem|0
1219320|NCT00797862|4001006|P2|Overall Study|Administrative Problem|0
1219321|NCT00797862|4001007|P1|Overall Study|Administrative Problem|4
1219322|NCT00797862|4001005|P3|Overall Study|Lost to Follow-up|5
1219323|NCT00797862|4001006|P2|Overall Study|Lost to Follow-up|0
1219324|NCT00797862|4001007|P1|Overall Study|Lost to Follow-up|11
1219325|NCT00797862|4001005|P3|Overall Study|Withdrawal by Subject|7
1219326|NCT00797862|4001006|P2|Overall Study|Withdrawal by Subject|7
1219327|NCT00797862|4001007|P1|Overall Study|Withdrawal by Subject|14
1219328|NCT00797862|4001005|P3|Overall Study|No longer required study medication|0
1219329|NCT00797862|4001006|P2|Overall Study|No longer required study medication|0
1219330|NCT00797862|4001007|P1|Overall Study|No longer required study medication|1
1219331|NCT00797862|4001005|P3|Overall Study|Lack of Efficacy|6
1219332|NCT00797862|4001006|P2|Overall Study|Lack of Efficacy|7
1219333|NCT00797862|4001007|P1|Overall Study|Lack of Efficacy|1
1219334|NCT00797862|4001005|P3|Overall Study|Abnormal Test Procedure Result|1
1219335|NCT00797862|4001006|P2|Overall Study|Abnormal Test Procedure Result|1
1219336|NCT00797862|4001007|P1|Overall Study|Abnormal Test Procedure Result|0
1219337|NCT00797862|4001005|P3|Overall Study|Adverse Event|58
1219338|NCT00797862|4001006|P2|Overall Study|Adverse Event|44
1219339|NCT00797862|4001007|P1|Overall Study|Adverse Event|86
1219340|NCT00797823|4001036|P3|First Period (Initial Randomization)|Physician Decision|0
1219341|NCT00797823|4001037|P2|First Period (Initial Randomization)|Physician Decision|0
1219342|NCT00797823|4001038|P1|First Period (Initial Randomization)|Physician Decision|1
1219343|NCT00797732|4001060|P3|Overall Study|Refused to Participate|123
1219344|NCT00797732|4001061|P2|Overall Study|Refused to Participate|0
1219345|NCT00797732|4001062|P1|Overall Study|Refused to Participate|0
1219346|NCT00797732|4001060|P3|Overall Study|Excluded due to time constraints|24
1219347|NCT00797732|4001061|P2|Overall Study|Excluded due to time constraints|0
1219348|NCT00797732|4001062|P1|Overall Study|Excluded due to time constraints|0
1219349|NCT00797732|4001060|P3|Overall Study|Not meet inclusion criteria|7
1219350|NCT00797732|4001061|P2|Overall Study|Not meet inclusion criteria|0
1219351|NCT00797732|4001062|P1|Overall Study|Not meet inclusion criteria|0
1219352|NCT00797732|4001060|P3|Overall Study|Death|0
1219353|NCT00797732|4001061|P2|Overall Study|Death|0
1219354|NCT00797732|4001062|P1|Overall Study|Death|1
1219355|NCT00797732|4001060|P3|Overall Study|Lost to Follow-up|0
1219356|NCT00797732|4001061|P2|Overall Study|Lost to Follow-up|0
1219357|NCT00797732|4001062|P1|Overall Study|Lost to Follow-up|1
1219358|NCT00797732|4001060|P3|Overall Study|Withdrawal by Subject|0
1219359|NCT00797732|4001061|P2|Overall Study|Withdrawal by Subject|3
1219360|NCT00797732|4001062|P1|Overall Study|Withdrawal by Subject|3
1219361|NCT00797667|4001077|P3|Overall Study|Adverse Event|8
1219362|NCT00797667|4001078|P2|Overall Study|Adverse Event|8
1219363|NCT00797667|4001079|P1|Overall Study|Adverse Event|19
1219364|NCT00797667|4001077|P3|Overall Study|Withdrawal by Subject|2
1219365|NCT00797667|4001078|P2|Overall Study|Withdrawal by Subject|14
1219366|NCT00797667|4001079|P1|Overall Study|Withdrawal by Subject|9
1219367|NCT00797667|4001077|P3|Overall Study|Study Terminated by Sponsor|115
1219368|NCT00797667|4001078|P2|Overall Study|Study Terminated by Sponsor|216
1219369|NCT00797667|4001079|P1|Overall Study|Study Terminated by Sponsor|217
1219370|NCT00797667|4001077|P3|Overall Study|Protocol Violation|0
1219371|NCT00797667|4001078|P2|Overall Study|Protocol Violation|7
1219372|NCT00797667|4001079|P1|Overall Study|Protocol Violation|2
1219373|NCT00797667|4001077|P3|Overall Study|Pregnancy|0
1219374|NCT00797667|4001078|P2|Overall Study|Pregnancy|0
1219375|NCT00797667|4001079|P1|Overall Study|Pregnancy|2
1219376|NCT00797667|4001077|P3|Overall Study|Physician Decision|0
1219377|NCT00797667|4001078|P2|Overall Study|Physician Decision|1
1219378|NCT00797667|4001079|P1|Overall Study|Physician Decision|3
1219379|NCT00797667|4001077|P3|Overall Study|Lost to Follow-up|2
1219380|NCT00797667|4001078|P2|Overall Study|Lost to Follow-up|12
1219381|NCT00797667|4001079|P1|Overall Study|Lost to Follow-up|8
1219382|NCT00797667|4001077|P3|Overall Study|Lack of Efficacy|0
1219383|NCT00797667|4001078|P2|Overall Study|Lack of Efficacy|1
1219384|NCT00797667|4001079|P1|Overall Study|Lack of Efficacy|0
1219385|NCT00797563|4001105|P1|Overall Study|Adverse Event|1
1219386|NCT00797511|4001111|P1|Overall Study|Withdrawal by Subject|1
1219387|NCT00797316|4001129|P2|Overall Study|Unsatisfactory therapeutic effect|13
1219388|NCT00797316|4001130|P1|Overall Study|Unsatisfactory therapeutic effect|0
1219389|NCT00797316|4001129|P2|Overall Study|Patient withdrew consent|6
1219390|NCT00797316|4001130|P1|Overall Study|Patient withdrew consent|12
1219391|NCT00797316|4001129|P2|Overall Study|Protocol Deviation|2
1219392|NCT00797316|4001130|P1|Overall Study|Protocol Deviation|1
1219393|NCT00797316|4001129|P2|Overall Study|Lost to Follow-up|8
1219394|NCT00797316|4001130|P1|Overall Study|Lost to Follow-up|4
1219395|NCT00797316|4001129|P2|Overall Study|Adverse Event|3
1219396|NCT00797316|4001130|P1|Overall Study|Adverse Event|5
1219397|NCT00797316|4001129|P2|Overall Study|Administrative problems|0
1219398|NCT00797316|4001130|P1|Overall Study|Administrative problems|1
1219399|NCT00797225|4001159|P8|Weeks 13 to 24|Sponsor Decision|0
1219400|NCT00797225|4001160|P7|Weeks 13 to 24|Sponsor Decision|1
1219401|NCT00797225|4001161|P6|Weeks 13 to 24|Sponsor Decision|0
1219402|NCT00797225|4001162|P5|Weeks 13 to 24|Sponsor Decision|0
1219403|NCT00797225|4001163|P4|Weeks 13 to 24|Sponsor Decision|0
1219404|NCT00797225|4001164|P3|Weeks 13 to 24|Sponsor Decision|0
1219405|NCT00797225|4001165|P2|Weeks 13 to 24|Sponsor Decision|0
1219406|NCT00797225|4001166|P1|Weeks 13 to 24|Sponsor Decision|0
1219407|NCT00797225|4001159|P8|Weeks 13 to 24|Adverse Event|0
1219408|NCT00797225|4001160|P7|Weeks 13 to 24|Adverse Event|1
1219409|NCT00797225|4001161|P6|Weeks 13 to 24|Adverse Event|0
1219410|NCT00797225|4001162|P5|Weeks 13 to 24|Adverse Event|0
1219411|NCT00797225|4001163|P4|Weeks 13 to 24|Adverse Event|0
1219412|NCT00797225|4001164|P3|Weeks 13 to 24|Adverse Event|0
1219413|NCT00797225|4001165|P2|Weeks 13 to 24|Adverse Event|1
1219414|NCT00797225|4001166|P1|Weeks 13 to 24|Adverse Event|0
1219415|NCT00797225|4001159|P8|Weeks 13 to 24|Lost to Follow-up|0
1219416|NCT00797225|4001160|P7|Weeks 13 to 24|Lost to Follow-up|0
1219417|NCT00797225|4001161|P6|Weeks 13 to 24|Lost to Follow-up|0
1219418|NCT00797225|4001162|P5|Weeks 13 to 24|Lost to Follow-up|1
1219419|NCT00797225|4001163|P4|Weeks 13 to 24|Lost to Follow-up|0
1219420|NCT00797225|4001164|P3|Weeks 13 to 24|Lost to Follow-up|1
1219421|NCT00797225|4001165|P2|Weeks 13 to 24|Lost to Follow-up|0
1219422|NCT00797225|4001166|P1|Weeks 13 to 24|Lost to Follow-up|0
1219423|NCT00797225|4001159|P8|Weeks 13 to 24|Withdrawal by Subject|0
1219424|NCT00797225|4001160|P7|Weeks 13 to 24|Withdrawal by Subject|0
1219425|NCT00797225|4001161|P6|Weeks 13 to 24|Withdrawal by Subject|0
1219426|NCT00797225|4001162|P5|Weeks 13 to 24|Withdrawal by Subject|0
1219427|NCT00797225|4001163|P4|Weeks 13 to 24|Withdrawal by Subject|0
1219428|NCT00797225|4001164|P3|Weeks 13 to 24|Withdrawal by Subject|1
1219429|NCT00797225|4001165|P2|Weeks 13 to 24|Withdrawal by Subject|1
1219430|NCT00797225|4001166|P1|Weeks 13 to 24|Withdrawal by Subject|0
1219431|NCT00797225|4001159|P8|Weeks 13 to 24|Non-compliance|0
1219432|NCT00797225|4001160|P7|Weeks 13 to 24|Non-compliance|0
1219433|NCT00797225|4001161|P6|Weeks 13 to 24|Non-compliance|0
1219434|NCT00797225|4001162|P5|Weeks 13 to 24|Non-compliance|0
1219435|NCT00797225|4001163|P4|Weeks 13 to 24|Non-compliance|0
1219436|NCT00797225|4001164|P3|Weeks 13 to 24|Non-compliance|0
1219437|NCT00797225|4001165|P2|Weeks 13 to 24|Non-compliance|2
1219438|NCT00797225|4001166|P1|Weeks 13 to 24|Non-compliance|0
1219439|NCT00797225|4001159|P8|Weeks 1 to 12|Sponsor Decision|0
1219440|NCT00797225|4001160|P7|Weeks 1 to 12|Sponsor Decision|0
1219441|NCT00797225|4001161|P6|Weeks 1 to 12|Sponsor Decision|0
1219442|NCT00797225|4001162|P5|Weeks 1 to 12|Sponsor Decision|0
1219443|NCT00797225|4001163|P4|Weeks 1 to 12|Sponsor Decision|0
1219444|NCT00797225|4001164|P3|Weeks 1 to 12|Sponsor Decision|0
1219445|NCT00797225|4001165|P2|Weeks 1 to 12|Sponsor Decision|0
1219446|NCT00797225|4001166|P1|Weeks 1 to 12|Sponsor Decision|1
1219447|NCT00797225|4001159|P8|Weeks 1 to 12|Lack of Efficacy|0
1219448|NCT00797225|4001160|P7|Weeks 1 to 12|Lack of Efficacy|0
1219449|NCT00797225|4001161|P6|Weeks 1 to 12|Lack of Efficacy|0
1219450|NCT00797225|4001162|P5|Weeks 1 to 12|Lack of Efficacy|0
1219451|NCT00797225|4001163|P4|Weeks 1 to 12|Lack of Efficacy|0
1219452|NCT00797225|4001164|P3|Weeks 1 to 12|Lack of Efficacy|0
1219453|NCT00797225|4001165|P2|Weeks 1 to 12|Lack of Efficacy|0
1219454|NCT00797225|4001166|P1|Weeks 1 to 12|Lack of Efficacy|1
1219455|NCT00797225|4001159|P8|Weeks 1 to 12|Non-compliance|0
1219456|NCT00797225|4001160|P7|Weeks 1 to 12|Non-compliance|0
1219457|NCT00797225|4001161|P6|Weeks 1 to 12|Non-compliance|0
1219458|NCT00797225|4001162|P5|Weeks 1 to 12|Non-compliance|0
1219459|NCT00797225|4001163|P4|Weeks 1 to 12|Non-compliance|0
1219460|NCT00797225|4001164|P3|Weeks 1 to 12|Non-compliance|0
1219461|NCT00797225|4001165|P2|Weeks 1 to 12|Non-compliance|1
1219462|NCT00797225|4001166|P1|Weeks 1 to 12|Non-compliance|0
1219463|NCT00797225|4001159|P8|Weeks 1 to 12|Adverse Event|0
1219464|NCT00797225|4001160|P7|Weeks 1 to 12|Adverse Event|0
1219465|NCT00797225|4001161|P6|Weeks 1 to 12|Adverse Event|0
1219466|NCT00797225|4001162|P5|Weeks 1 to 12|Adverse Event|0
1219467|NCT00797225|4001163|P4|Weeks 1 to 12|Adverse Event|0
1219468|NCT00797225|4001164|P3|Weeks 1 to 12|Adverse Event|1
1219469|NCT00797225|4001165|P2|Weeks 1 to 12|Adverse Event|0
1219470|NCT00797225|4001166|P1|Weeks 1 to 12|Adverse Event|0
1219471|NCT00797108|4001283|P3|Overall Study|Randomized but not Treated|0
1219472|NCT00797108|4001284|P2|Overall Study|Randomized but not Treated|0
1219473|NCT00797108|4001285|P1|Overall Study|Randomized but not Treated|2
1219474|NCT00797108|4001283|P3|Overall Study|Other|2
1219475|NCT00797108|4001284|P2|Overall Study|Other|0
1219476|NCT00797108|4001285|P1|Overall Study|Other|0
1219477|NCT00797108|4001283|P3|Overall Study|Lack of Efficacy|1
1219478|NCT00797108|4001284|P2|Overall Study|Lack of Efficacy|0
1219479|NCT00797108|4001285|P1|Overall Study|Lack of Efficacy|1
1219480|NCT00797108|4001283|P3|Overall Study|Global Deterioration of Health Status|0
1219481|NCT00797108|4001284|P2|Overall Study|Global Deterioration of Health Status|1
1219482|NCT00797108|4001285|P1|Overall Study|Global Deterioration of Health Status|0
1219483|NCT00797108|4001283|P3|Overall Study|Did Not Meet Entrance Criteria|0
1219484|NCT00797108|4001284|P2|Overall Study|Did Not Meet Entrance Criteria|1
1219485|NCT00797108|4001285|P1|Overall Study|Did Not Meet Entrance Criteria|0
1219486|NCT00797108|4001283|P3|Overall Study|Adverse Event|3
1219487|NCT00797108|4001284|P2|Overall Study|Adverse Event|0
1219488|NCT00797108|4001285|P1|Overall Study|Adverse Event|1
1219489|NCT00796991|4001320|P3|Overall Study|Withdrawal by Subject|1
1219490|NCT00796991|4001321|P2|Overall Study|Withdrawal by Subject|0
1219491|NCT00796991|4001322|P1|Overall Study|Withdrawal by Subject|0
1219492|NCT00796991|4001320|P3|Overall Study|Study Drug Toxicity|5
1219493|NCT00796991|4001321|P2|Overall Study|Study Drug Toxicity|3
1219494|NCT00796991|4001322|P1|Overall Study|Study Drug Toxicity|3
1219495|NCT00796991|4001320|P3|Overall Study|Disease Progression|7
1219496|NCT00796991|4001321|P2|Overall Study|Disease Progression|9
1219497|NCT00796991|4001322|P1|Overall Study|Disease Progression|10
1219498|NCT00796991|4001320|P3|Overall Study|Death|0
1219499|NCT00796991|4001321|P2|Overall Study|Death|0
1219500|NCT00796991|4001322|P1|Overall Study|Death|2
1219501|NCT00796991|4001320|P3|Overall Study|Adverse Event|1
1219502|NCT00796991|4001321|P2|Overall Study|Adverse Event|0
1219503|NCT00796991|4001322|P1|Overall Study|Adverse Event|0
1219504|NCT00796861|4001429|P1|Overall Study|Death|2
1219505|NCT00796861|4001429|P1|Overall Study|Withdrawal by Subject|2
1219506|NCT00796822|4001435|P2|Overall Study|Adverse Event|0
1219507|NCT00796822|4001436|P1|Overall Study|Adverse Event|1
1219508|NCT00796822|4001435|P2|Overall Study|Lost to Follow-up|0
1219509|NCT00796822|4001436|P1|Overall Study|Lost to Follow-up|2
1219510|NCT00796757|4001444|P1|Overall Study|Not specified|7
1219511|NCT00796757|4001444|P1|Overall Study|Investigator's decision|2
1219512|NCT00796757|4001444|P1|Overall Study|Participant noncompliance|1
1219513|NCT00796757|4001444|P1|Overall Study|Protocol Violation|1
1219514|NCT00796757|4001444|P1|Overall Study|Death|61
1219515|NCT00796757|4001444|P1|Overall Study|Withdrawal by Subject|14
1219516|NCT00796718|4001478|P1|Overall Study|Withdrawal by Informed Consent|1
1219517|NCT00796718|4001478|P1|Overall Study|Lost to Follow-up|5
1219518|NCT00796718|4001478|P1|Overall Study|Exclusion Criteria|1
1219519|NCT00796718|4001478|P1|Overall Study|Adverse Event|2
1219520|NCT00796666|4001530|P2|Overall Study|Randomized and not treated|0
1219521|NCT00796666|4001531|P1|Overall Study|Randomized and not treated|1
1219522|NCT00796666|4001530|P2|Overall Study|Terminated by sponsor|55
1219523|NCT00796666|4001531|P1|Overall Study|Terminated by sponsor|53
1219524|NCT00796666|4001530|P2|Overall Study|Other|0
1219525|NCT00796666|4001531|P1|Overall Study|Other|1
1219526|NCT00796666|4001530|P2|Overall Study|Protocol Violation|0
1219527|NCT00796666|4001531|P1|Overall Study|Protocol Violation|1
1219528|NCT00796666|4001530|P2|Overall Study|Adverse Event|5
1219529|NCT00796666|4001531|P1|Overall Study|Adverse Event|7
1219530|NCT00796666|4001530|P2|Overall Study|Withdrawal by Subject|0
1219531|NCT00796666|4001531|P1|Overall Study|Withdrawal by Subject|2
1219532|NCT00796666|4001530|P2|Overall Study|Death|4
1219533|NCT00796666|4001531|P1|Overall Study|Death|2
1219534|NCT00796653|4001565|P4|Overall Study|Other reason not described above|4
1219535|NCT00796653|4001566|P3|Overall Study|Other reason not described above|7
1219536|NCT00796653|4001567|P2|Overall Study|Other reason not described above|9
1219537|NCT00796653|4001568|P1|Overall Study|Other reason not described above|4
1219538|NCT00796653|4001565|P4|Overall Study|Non compliance with protocol|2
1219539|NCT00796653|4001566|P3|Overall Study|Non compliance with protocol|0
1219540|NCT00796653|4001567|P2|Overall Study|Non compliance with protocol|2
1219541|NCT00796653|4001568|P1|Overall Study|Non compliance with protocol|2
1219542|NCT00796653|4001565|P4|Overall Study|Lack of Efficacy|2
1219543|NCT00796653|4001566|P3|Overall Study|Lack of Efficacy|3
1219544|NCT00796653|4001567|P2|Overall Study|Lack of Efficacy|1
1219545|NCT00796653|4001568|P1|Overall Study|Lack of Efficacy|8
1219546|NCT00796653|4001565|P4|Overall Study|Withdrawal by Subject|13
1219547|NCT00796653|4001566|P3|Overall Study|Withdrawal by Subject|8
1219548|NCT00796653|4001567|P2|Overall Study|Withdrawal by Subject|8
1219549|NCT00796653|4001568|P1|Overall Study|Withdrawal by Subject|16
1219550|NCT00796653|4001565|P4|Overall Study|Lost to Follow-up|3
1219551|NCT00796653|4001566|P3|Overall Study|Lost to Follow-up|2
1219552|NCT00796653|4001567|P2|Overall Study|Lost to Follow-up|1
1219553|NCT00796653|4001568|P1|Overall Study|Lost to Follow-up|2
1219554|NCT00796653|4001565|P4|Overall Study|Adverse Event|16
1219555|NCT00796653|4001566|P3|Overall Study|Adverse Event|16
1219556|NCT00796653|4001567|P2|Overall Study|Adverse Event|16
1219557|NCT00796653|4001568|P1|Overall Study|Adverse Event|19
1219558|NCT00796614|4001853|P4|Overall Study|Other than stated|0
1219559|NCT00796614|4001854|P3|Overall Study|Other than stated|0
1219560|NCT00796614|4001855|P2|Overall Study|Other than stated|0
1219561|NCT00796614|4001856|P1|Overall Study|Other than stated|1
1219562|NCT00796614|4001853|P4|Overall Study|Withdrawal by Subject|1
1219563|NCT00796614|4001854|P3|Overall Study|Withdrawal by Subject|0
1219564|NCT00796614|4001855|P2|Overall Study|Withdrawal by Subject|0
1219565|NCT00796614|4001856|P1|Overall Study|Withdrawal by Subject|1
1219566|NCT00796614|4001853|P4|Overall Study|Lost to Follow-up|0
1219567|NCT00796614|4001854|P3|Overall Study|Lost to Follow-up|1
1219568|NCT00796614|4001855|P2|Overall Study|Lost to Follow-up|2
1219569|NCT00796614|4001856|P1|Overall Study|Lost to Follow-up|2
1219570|NCT00796614|4001853|P4|Overall Study|Protocol Violation|0
1219571|NCT00796614|4001854|P3|Overall Study|Protocol Violation|2
1219572|NCT00796614|4001855|P2|Overall Study|Protocol Violation|0
1219573|NCT00796614|4001856|P1|Overall Study|Protocol Violation|0
1219574|NCT00796614|4001853|P4|Overall Study|Adverse Event|0
1219575|NCT00796614|4001854|P3|Overall Study|Adverse Event|0
1219576|NCT00796614|4001855|P2|Overall Study|Adverse Event|2
1219577|NCT00796614|4001856|P1|Overall Study|Adverse Event|1
1219578|NCT00796549|4001898|P1|Overall Study|Progressive disease|56
1219579|NCT00796549|4001898|P1|Overall Study|Other|2
1219580|NCT00796549|4001898|P1|Overall Study|not entered|149
1219581|NCT00796549|4001898|P1|Overall Study|Adverse Event|11
1219582|NCT00796523|4001915|P2|Overall Study|Lost to Follow-up|7
1219583|NCT00796523|4001916|P1|Overall Study|Lost to Follow-up|9
1219584|NCT00796510|4001926|P2|Overall Study|Study Terminated|0
1219585|NCT00796510|4001927|P1|Overall Study|Study Terminated|2
1219586|NCT00796510|4001926|P2|Overall Study|Death|0
1219587|NCT00796510|4001927|P1|Overall Study|Death|1
1219588|NCT00796419|4001939|P2|Overall Study|Death|1
1219589|NCT00796419|4001940|P1|Overall Study|Death|0
1219590|NCT00796367|4001953|P3|Overall Study|other|3
1219591|NCT00796367|4001954|P2|Overall Study|other|4
1219592|NCT00796367|4001955|P1|Overall Study|other|2
1219593|NCT00796367|4001953|P3|Overall Study|Requirement for restricted medication|2
1219594|NCT00796367|4001954|P2|Overall Study|Requirement for restricted medication|0
1219595|NCT00796367|4001955|P1|Overall Study|Requirement for restricted medication|2
1219596|NCT00796367|4001953|P3|Overall Study|Pregnancy|1
1219597|NCT00796367|4001954|P2|Overall Study|Pregnancy|0
1219598|NCT00796367|4001955|P1|Overall Study|Pregnancy|1
1219599|NCT00796367|4001953|P3|Overall Study|non compliance|1
1219600|NCT00796367|4001954|P2|Overall Study|non compliance|1
1219601|NCT00796367|4001955|P1|Overall Study|non compliance|3
1219602|NCT00796367|4001953|P3|Overall Study|Lack of Efficacy|0
1219603|NCT00796367|4001954|P2|Overall Study|Lack of Efficacy|1
1219604|NCT00796367|4001955|P1|Overall Study|Lack of Efficacy|2
1219605|NCT00796367|4001953|P3|Overall Study|Withdrawal by Subject|12
1219606|NCT00796367|4001954|P2|Overall Study|Withdrawal by Subject|11
1219607|NCT00796367|4001955|P1|Overall Study|Withdrawal by Subject|9
1219608|NCT00796367|4001953|P3|Overall Study|Lost to Follow-up|21
1219609|NCT00796367|4001954|P2|Overall Study|Lost to Follow-up|4
1219610|NCT00796367|4001955|P1|Overall Study|Lost to Follow-up|5
1219611|NCT00796367|4001953|P3|Overall Study|Adverse Event|7
1219612|NCT00796367|4001954|P2|Overall Study|Adverse Event|4
1219613|NCT00796367|4001955|P1|Overall Study|Adverse Event|6
1219614|NCT00796328|4001966|P1|Overall Study|experienced hypotension requiring tx|6
1219615|NCT00796315|4001970|P3|Overall Study|Protocol Violation|0
1219616|NCT00796315|4001971|P2|Overall Study|Protocol Violation|1
1219617|NCT00796315|4001972|P1|Overall Study|Protocol Violation|0
1219618|NCT00796224|4002000|P2|Overall Study|Protocol Violation|1
1219619|NCT00796224|4002001|P1|Overall Study|Protocol Violation|0
1219620|NCT00796224|4002000|P2|Overall Study|Adverse Event|0
1219621|NCT00796224|4002001|P1|Overall Study|Adverse Event|1
1219622|NCT00796120|4002021|P2|Overall Study|Randomized but not treated|3
1219623|NCT00796120|4002022|P1|Overall Study|Randomized but not treated|0
1219624|NCT00796120|4002021|P2|Overall Study|Physician Decision|17
1219625|NCT00796120|4002022|P1|Overall Study|Physician Decision|16
1219626|NCT00796120|4002021|P2|Overall Study|Other|17
1219627|NCT00796120|4002022|P1|Overall Study|Other|6
1219628|NCT00796120|4002021|P2|Overall Study|Participant refusal|4
1219629|NCT00796120|4002022|P1|Overall Study|Participant refusal|3
1219630|NCT00796120|4002021|P2|Overall Study|Progressive disease|13
1219631|NCT00796120|4002022|P1|Overall Study|Progressive disease|22
1219632|NCT00796120|4002021|P2|Overall Study|Adverse Event|6
1219633|NCT00796120|4002022|P1|Overall Study|Adverse Event|11
1219634|NCT00796120|4002021|P2|Overall Study|Death|0
1219635|NCT00796120|4002022|P1|Overall Study|Death|3
1219636|NCT00796003|4002038|P2|Overall Study|Participants Not treated|2
1219637|NCT00796003|4002039|P1|Overall Study|Participants Not treated|0
1219638|NCT00796003|4002038|P2|Overall Study|Other|1
1219639|NCT00796003|4002039|P1|Overall Study|Other|0
1219640|NCT00796003|4002038|P2|Overall Study|Withdrawal by Subject|1
1219641|NCT00796003|4002039|P1|Overall Study|Withdrawal by Subject|0
1219642|NCT00796003|4002038|P2|Overall Study|Physician Decision|4
1219643|NCT00796003|4002039|P1|Overall Study|Physician Decision|0
1219644|NCT00796003|4002038|P2|Overall Study|Specified organ function not met|1
1219645|NCT00796003|4002039|P1|Overall Study|Specified organ function not met|0
1219646|NCT00796003|4002038|P2|Overall Study|Adverse Event|7
1219647|NCT00796003|4002039|P1|Overall Study|Adverse Event|1
1219648|NCT00796003|4002038|P2|Overall Study|Disease Progression|13
1219649|NCT00796003|4002039|P1|Overall Study|Disease Progression|2
1219650|NCT00795951|4002060|P1|Overall Study|Withdrawal by Subject|1
1219651|NCT00795951|4002060|P1|Overall Study|Lost to Follow-up|1
1219652|NCT00795886|4002097|P1|Overall Study|Death|10
1219653|NCT00795821|4002105|P2|Taper Phase|Withdrawal by Subject|0
1219654|NCT00795821|4002106|P1|Taper Phase|Withdrawal by Subject|4
1219655|NCT00795821|4002105|P2|Taper Phase|Physician Decision|0
1219656|NCT00795821|4002106|P1|Taper Phase|Physician Decision|2
1219657|NCT00795821|4002105|P2|Taper Phase|Lost to Follow-up|0
1219658|NCT00795821|4002106|P1|Taper Phase|Lost to Follow-up|1
1219659|NCT00795821|4002105|P2|Taper Phase|Adverse Event|0
1219660|NCT00795821|4002106|P1|Taper Phase|Adverse Event|2
1219661|NCT00795821|4002105|P2|Long-term Extension Phase|Withdrawal by Subject|25
1219662|NCT00795821|4002106|P1|Long-term Extension Phase|Withdrawal by Subject|25
1219663|NCT00795821|4002105|P2|Long-term Extension Phase|Protocol Violation|5
1219664|NCT00795821|4002106|P1|Long-term Extension Phase|Protocol Violation|3
1219665|NCT00795821|4002105|P2|Long-term Extension Phase|Physician Decision|2
1219666|NCT00795821|4002106|P1|Long-term Extension Phase|Physician Decision|1
1219667|NCT00795821|4002105|P2|Long-term Extension Phase|Lost to Follow-up|16
1219668|NCT00795821|4002106|P1|Long-term Extension Phase|Lost to Follow-up|20
1219669|NCT00795821|4002105|P2|Long-term Extension Phase|Lack of Efficacy|12
1219670|NCT00795821|4002106|P1|Long-term Extension Phase|Lack of Efficacy|16
1219671|NCT00795821|4002105|P2|Long-term Extension Phase|Adverse Event|32
1219672|NCT00795821|4002106|P1|Long-term Extension Phase|Adverse Event|25
1219673|NCT00795821|4002105|P2|Acute Treatment Phase|Withdrawal by Subject|10
1219674|NCT00795821|4002106|P1|Acute Treatment Phase|Withdrawal by Subject|16
1219675|NCT00795821|4002105|P2|Acute Treatment Phase|Protocol Violation|2
1219676|NCT00795821|4002106|P1|Acute Treatment Phase|Protocol Violation|1
1219677|NCT00795821|4002105|P2|Acute Treatment Phase|Physician Decision|1
1219678|NCT00795821|4002106|P1|Acute Treatment Phase|Physician Decision|1
1219679|NCT00795821|4002105|P2|Acute Treatment Phase|Lost to Follow-up|12
1219680|NCT00795821|4002106|P1|Acute Treatment Phase|Lost to Follow-up|9
1219681|NCT00795821|4002105|P2|Acute Treatment Phase|Lack of Efficacy|2
1219682|NCT00795821|4002106|P1|Acute Treatment Phase|Lack of Efficacy|5
1219683|NCT00795821|4002105|P2|Acute Treatment Phase|Death|0
1219684|NCT00795821|4002106|P1|Acute Treatment Phase|Death|1
1219685|NCT00795821|4002105|P2|Acute Treatment Phase|Adverse Event|4
1219686|NCT00795821|4002106|P1|Acute Treatment Phase|Adverse Event|23
1219687|NCT00795717|4002181|P2|Phase II|too busy|1
1219688|NCT00795717|4002182|P1|Phase II|too busy|0
1219689|NCT00795717|4002181|P2|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1
1219690|NCT00795717|4002182|P1|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0
1219691|NCT00795717|4002181|P2|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
1219692|NCT00795717|4002182|P1|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
1219693|NCT00795717|4002181|P2|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0
1219694|NCT00795717|4002182|P1|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1
1219695|NCT00795704|4002194|P2|Overall Study|Adverse Event|1
1219696|NCT00795704|4002195|P1|Overall Study|Adverse Event|1
1219697|NCT00795704|4002194|P2|Overall Study|Withdrawal by Subject|2
1219698|NCT00795704|4002195|P1|Overall Study|Withdrawal by Subject|3
1219699|NCT00795639|4002207|P2|Overall Study|Randomized and not treated|1
1219700|NCT00795639|4002208|P1|Overall Study|Randomized and not treated|0
1219701|NCT00795639|4002207|P2|Overall Study|Terminated by sponsor|12
1219702|NCT00795639|4002208|P1|Overall Study|Terminated by sponsor|13
1219703|NCT00795639|4002207|P2|Overall Study|Other|2
1219704|NCT00795639|4002208|P1|Overall Study|Other|0
1219705|NCT00795639|4002207|P2|Overall Study|Adverse Event|2
1219706|NCT00795639|4002208|P1|Overall Study|Adverse Event|5
1219707|NCT00795639|4002207|P2|Overall Study|Pregnancy|0
1219708|NCT00795639|4002208|P1|Overall Study|Pregnancy|1
1219709|NCT00795639|4002207|P2|Overall Study|Withdrawal by Subject|3
1219710|NCT00795639|4002208|P1|Overall Study|Withdrawal by Subject|1
1219711|NCT00795639|4002207|P2|Overall Study|Death|6
1219712|NCT00795639|4002208|P1|Overall Study|Death|1
1219713|NCT00795600|4002220|P2|Overall Study|Unclassified|1
1219714|NCT00795600|4002221|P1|Overall Study|Unclassified|1
1219715|NCT00795600|4002220|P2|Overall Study|Withdrawal by Subject|0
1219716|NCT00795600|4002221|P1|Overall Study|Withdrawal by Subject|1
1219717|NCT00795600|4002220|P2|Overall Study|Protocol Violation|2
1219718|NCT00795600|4002221|P1|Overall Study|Protocol Violation|1
1219719|NCT00795600|4002220|P2|Overall Study|Adverse Event|1
1219720|NCT00795600|4002221|P1|Overall Study|Adverse Event|1
1219721|NCT00795535|4002341|P1|Overall Study|incomplete data and technical problems|20
1219722|NCT00795509|4002348|P1|Overall Study|Protocol Violation|31
1219723|NCT00795184|4002404|P2|Overall Study|Tissue sampling incomplete/conclusive|13
1219724|NCT00795184|4002405|P1|Overall Study|Tissue sampling incomplete/conclusive|8
1219725|NCT00795132|4002466|P1|Overall Study|Relapse|2
1219726|NCT00795132|4002466|P1|Overall Study|Death|1
1219727|NCT00794963|4002493|P2|Overall Study|Withdrawal by Subject|4
1219728|NCT00794963|4002494|P1|Overall Study|Withdrawal by Subject|1
1219729|NCT00794924|4002502|P2|Overall Study|Adverse Event|2
1219730|NCT00794924|4002503|P1|Overall Study|Adverse Event|6
1219731|NCT00794924|4002502|P2|Overall Study|Withdrawal by Subject|60
1219732|NCT00794924|4002503|P1|Overall Study|Withdrawal by Subject|48
1219733|NCT00794924|4002502|P2|Overall Study|Lost to Follow-up|8
1219734|NCT00794924|4002503|P1|Overall Study|Lost to Follow-up|6
1219735|NCT00794820|4002507|P1|Overall Study|Ineligible/Screen Failure|1
1219736|NCT00794820|4002507|P1|Overall Study|Resistant Disease|2
1219737|NCT00794820|4002507|P1|Overall Study|Secondary Malignancies|2
1219738|NCT00794820|4002507|P1|Overall Study|Adverse Event|11
1219739|NCT00794677|4002515|P2|First Intervention|Withdrawal by Subject|0
1219740|NCT00794677|4002516|P1|First Intervention|Withdrawal by Subject|2
1219741|NCT00794664|4002538|P2|Follow-up Period|Protocol non-compliance|1
1219742|NCT00794664|4002539|P1|Follow-up Period|Protocol non-compliance|0
1219743|NCT00794664|4002538|P2|Follow-up Period|Withdrawal by Subject|2
1219744|NCT00794664|4002539|P1|Follow-up Period|Withdrawal by Subject|0
1219745|NCT00794664|4002538|P2|Follow-up Period|Not specified|2
1219746|NCT00794664|4002539|P1|Follow-up Period|Not specified|1
1219747|NCT00794664|4002538|P2|Treatment Period|Adverse Event|8
1219748|NCT00794664|4002539|P1|Treatment Period|Adverse Event|1
1219749|NCT00794664|4002538|P2|Treatment Period|Not specified|1
1219750|NCT00794664|4002539|P1|Treatment Period|Not specified|0
1219751|NCT00794664|4002538|P2|Treatment Period|Protocol non-compliance|1
1219752|NCT00794664|4002539|P1|Treatment Period|Protocol non-compliance|0
1219753|NCT00794664|4002538|P2|Treatment Period|Withdrawal by Subject|2
1219754|NCT00794664|4002539|P1|Treatment Period|Withdrawal by Subject|0
1219755|NCT00794365|4002624|P1|Overall Study|Lack of Efficacy|3
1219756|NCT00794365|4002624|P1|Overall Study|Adverse Event|10
1219757|NCT00794365|4002624|P1|Overall Study|Poor Compliance|11
1219758|NCT00794365|4002624|P1|Overall Study|Other|17
1219759|NCT00794365|4002624|P1|Overall Study|Lost to Follow-up|38
1219760|NCT00794196|4002645|P2|Overall Study|Lost to Follow-up|23
1219761|NCT00794196|4002646|P1|Overall Study|Lost to Follow-up|5
1219762|NCT00794157|4002666|P3|Overall Study|Protocol deviation|1
1219763|NCT00794157|4002667|P2|Overall Study|Protocol deviation|1
1219764|NCT00794157|4002668|P1|Overall Study|Protocol deviation|0
1219765|NCT00794157|4002666|P3|Overall Study|Abnormal test procedure result(s)|0
1219766|NCT00794157|4002667|P2|Overall Study|Abnormal test procedure result(s)|1
1219767|NCT00794157|4002668|P1|Overall Study|Abnormal test procedure result(s)|0
1219768|NCT00794157|4002666|P3|Overall Study|Administrative problems|4
1219769|NCT00794157|4002667|P2|Overall Study|Administrative problems|7
1219770|NCT00794157|4002668|P1|Overall Study|Administrative problems|1
1219771|NCT00794157|4002666|P3|Overall Study|Unsatisfactory therapeutic effect|2
1219772|NCT00794157|4002667|P2|Overall Study|Unsatisfactory therapeutic effect|0
1219773|NCT00794157|4002668|P1|Overall Study|Unsatisfactory therapeutic effect|1
1219774|NCT00794157|4002666|P3|Overall Study|Lost to Follow-up|1
1219775|NCT00794157|4002667|P2|Overall Study|Lost to Follow-up|0
1219776|NCT00794157|4002668|P1|Overall Study|Lost to Follow-up|2
1219777|NCT00794157|4002666|P3|Overall Study|Subject withdrew consent|3
1219778|NCT00794157|4002667|P2|Overall Study|Subject withdrew consent|0
1219779|NCT00794157|4002668|P1|Overall Study|Subject withdrew consent|2
1219780|NCT00794157|4002666|P3|Overall Study|Adverse Event|8
1219781|NCT00794157|4002667|P2|Overall Study|Adverse Event|1
1219782|NCT00794157|4002668|P1|Overall Study|Adverse Event|4
1219783|NCT00794118|4002697|P1|Overall Study|Changed hospital center|2
1219784|NCT00794118|4002697|P1|Overall Study|Withdrawal by Subject|9
1219785|NCT00794118|4002697|P1|Overall Study|Lost to Follow-up|16
1219786|NCT00793910|4002755|P2|Overall Study|Withdrawal by Subject|1
1219787|NCT00793910|4002756|P1|Overall Study|Withdrawal by Subject|0
1219788|NCT00793910|4002755|P2|Overall Study|decided to undergo LASIK instead of PRK|1
1219789|NCT00793910|4002756|P1|Overall Study|decided to undergo LASIK instead of PRK|2
1219790|NCT00793910|4002755|P2|Overall Study|ineligible based on entry criteria|3
1219791|NCT00793910|4002756|P1|Overall Study|ineligible based on entry criteria|2
1219792|NCT00793910|4002755|P2|Overall Study|did not pick up medications|1
1219793|NCT00793910|4002756|P1|Overall Study|did not pick up medications|1
1219794|NCT00793910|4002755|P2|Overall Study|discarded study pills|1
1219795|NCT00793910|4002756|P1|Overall Study|discarded study pills|0
1219796|NCT00793871|4002770|P1|Overall Study|Study terminated by the Sponsor|7
1219797|NCT00793871|4002770|P1|Overall Study|Lost to Follow-up|3
1219798|NCT00793871|4002770|P1|Overall Study|Death|50
1219799|NCT00793819|4002784|P2|Overall Study|Lost to Follow-up|1
1219800|NCT00793819|4002785|P1|Overall Study|Lost to Follow-up|1
1219801|NCT00793819|4002784|P2|Overall Study|Withdrawal by Subject|3
1219802|NCT00793819|4002785|P1|Overall Study|Withdrawal by Subject|4
1219803|NCT00793819|4002784|P2|Overall Study|Lack of Efficacy|1
1219804|NCT00793819|4002785|P1|Overall Study|Lack of Efficacy|1
1219805|NCT00793819|4002784|P2|Overall Study|Adverse Event|4
1219806|NCT00793819|4002785|P1|Overall Study|Adverse Event|8
1219807|NCT00793793|4002803|P12|Overall Study|reason not specified|4
1219808|NCT00793793|4002804|P11|Overall Study|reason not specified|2
1219809|NCT00793793|4002805|P10|Overall Study|reason not specified|6
1219810|NCT00793793|4002806|P9|Overall Study|reason not specified|7
1219811|NCT00793793|4002807|P8|Overall Study|reason not specified|0
1219812|NCT00793793|4002808|P7|Overall Study|reason not specified|2
1219813|NCT00793793|4002809|P6|Overall Study|reason not specified|1
1219814|NCT00793793|4002810|P5|Overall Study|reason not specified|1
1219815|NCT00793793|4002811|P4|Overall Study|reason not specified|1
1219816|NCT00793793|4002812|P3|Overall Study|reason not specified|0
1219817|NCT00793793|4002813|P2|Overall Study|reason not specified|1
1219818|NCT00793793|4002814|P1|Overall Study|reason not specified|0
1219819|NCT00793793|4002803|P12|Overall Study|Withdrawal by Subject|0
1219820|NCT00793793|4002804|P11|Overall Study|Withdrawal by Subject|0
1219821|NCT00793793|4002805|P10|Overall Study|Withdrawal by Subject|0
1219822|NCT00793793|4002806|P9|Overall Study|Withdrawal by Subject|1
1219823|NCT00793793|4002807|P8|Overall Study|Withdrawal by Subject|0
1219824|NCT00793793|4002808|P7|Overall Study|Withdrawal by Subject|0
1219825|NCT00793793|4002809|P6|Overall Study|Withdrawal by Subject|0
1219826|NCT00793793|4002810|P5|Overall Study|Withdrawal by Subject|1
1219827|NCT00793793|4002811|P4|Overall Study|Withdrawal by Subject|0
1219828|NCT00793793|4002812|P3|Overall Study|Withdrawal by Subject|0
1219829|NCT00793793|4002813|P2|Overall Study|Withdrawal by Subject|0
1219830|NCT00793793|4002814|P1|Overall Study|Withdrawal by Subject|0
1219831|NCT00793793|4002803|P12|Overall Study|Lost to Follow-up|0
1219832|NCT00793793|4002804|P11|Overall Study|Lost to Follow-up|1
1219833|NCT00793793|4002805|P10|Overall Study|Lost to Follow-up|3
1219834|NCT00793793|4002806|P9|Overall Study|Lost to Follow-up|1
1219835|NCT00793793|4002807|P8|Overall Study|Lost to Follow-up|0
1219836|NCT00793793|4002808|P7|Overall Study|Lost to Follow-up|0
1219837|NCT00793793|4002809|P6|Overall Study|Lost to Follow-up|0
1219838|NCT00793793|4002810|P5|Overall Study|Lost to Follow-up|0
1219839|NCT00793793|4002811|P4|Overall Study|Lost to Follow-up|0
1219840|NCT00793793|4002812|P3|Overall Study|Lost to Follow-up|1
1219841|NCT00793793|4002813|P2|Overall Study|Lost to Follow-up|0
1219842|NCT00793793|4002814|P1|Overall Study|Lost to Follow-up|0
1219843|NCT00793793|4002803|P12|Overall Study|Protocol Violation|0
1219844|NCT00793793|4002804|P11|Overall Study|Protocol Violation|0
1219845|NCT00793793|4002805|P10|Overall Study|Protocol Violation|0
1219846|NCT00793793|4002806|P9|Overall Study|Protocol Violation|0
1219847|NCT00793793|4002807|P8|Overall Study|Protocol Violation|0
1219848|NCT00793793|4002808|P7|Overall Study|Protocol Violation|0
1219849|NCT00793793|4002809|P6|Overall Study|Protocol Violation|0
1219850|NCT00793793|4002810|P5|Overall Study|Protocol Violation|0
1219851|NCT00793793|4002811|P4|Overall Study|Protocol Violation|1
1219852|NCT00793793|4002812|P3|Overall Study|Protocol Violation|0
1219853|NCT00793793|4002813|P2|Overall Study|Protocol Violation|0
1219854|NCT00793793|4002814|P1|Overall Study|Protocol Violation|0
1219855|NCT00793793|4002803|P12|Overall Study|Adverse Event|2
1219856|NCT00793793|4002804|P11|Overall Study|Adverse Event|0
1219857|NCT00793793|4002805|P10|Overall Study|Adverse Event|0
1219858|NCT00793793|4002806|P9|Overall Study|Adverse Event|0
1219859|NCT00793793|4002807|P8|Overall Study|Adverse Event|0
1219860|NCT00793793|4002808|P7|Overall Study|Adverse Event|2
1219861|NCT00793793|4002809|P6|Overall Study|Adverse Event|1
1219862|NCT00793793|4002810|P5|Overall Study|Adverse Event|0
1219863|NCT00793793|4002811|P4|Overall Study|Adverse Event|1
1219864|NCT00793793|4002812|P3|Overall Study|Adverse Event|1
1219865|NCT00793793|4002813|P2|Overall Study|Adverse Event|0
1219866|NCT00793793|4002814|P1|Overall Study|Adverse Event|0
1219867|NCT00793780|4003189|P2|Overall Study|Withdrawal by Subject|1
1219868|NCT00793780|4003190|P1|Overall Study|Withdrawal by Subject|2
1219869|NCT00793624|4003221|P4|Overall Study|Other reason not described above|3
1219870|NCT00793624|4003222|P3|Overall Study|Other reason not described above|6
1219871|NCT00793624|4003223|P2|Overall Study|Other reason not described above|4
1219872|NCT00793624|4003224|P1|Overall Study|Other reason not described above|6
1219873|NCT00793624|4003221|P4|Overall Study|Non compliance with protocol|3
1219874|NCT00793624|4003222|P3|Overall Study|Non compliance with protocol|2
1219875|NCT00793624|4003223|P2|Overall Study|Non compliance with protocol|3
1219876|NCT00793624|4003224|P1|Overall Study|Non compliance with protocol|2
1219877|NCT00793624|4003221|P4|Overall Study|Lack of Efficacy|3
1219878|NCT00793624|4003222|P3|Overall Study|Lack of Efficacy|1
1219879|NCT00793624|4003223|P2|Overall Study|Lack of Efficacy|2
1219880|NCT00793624|4003224|P1|Overall Study|Lack of Efficacy|9
1219881|NCT00793624|4003221|P4|Overall Study|Withdrawal by Subject|14
1219882|NCT00793624|4003222|P3|Overall Study|Withdrawal by Subject|11
1219883|NCT00793624|4003223|P2|Overall Study|Withdrawal by Subject|9
1219884|NCT00793624|4003224|P1|Overall Study|Withdrawal by Subject|20
1219885|NCT00793624|4003221|P4|Overall Study|Lost to Follow-up|0
1219886|NCT00793624|4003222|P3|Overall Study|Lost to Follow-up|4
1219887|NCT00793624|4003223|P2|Overall Study|Lost to Follow-up|2
1219888|NCT00793624|4003224|P1|Overall Study|Lost to Follow-up|2
1219889|NCT00793624|4003221|P4|Overall Study|Adverse Event|20
1219890|NCT00793624|4003222|P3|Overall Study|Adverse Event|15
1219891|NCT00793624|4003223|P2|Overall Study|Adverse Event|16
1219892|NCT00793624|4003224|P1|Overall Study|Adverse Event|18
1219893|NCT00793585|4003505|P2|Overall Study|Protocol Violation|2
1219894|NCT00793585|4003506|P1|Overall Study|Protocol Violation|1
1219895|NCT00793585|4003505|P2|Overall Study|Adverse Event|1
1219896|NCT00793585|4003506|P1|Overall Study|Adverse Event|1
1219897|NCT00793546|4003525|P2|Overall Study|Other|0
1219898|NCT00793546|4003526|P1|Overall Study|Other|1
1219899|NCT00793546|4003525|P2|Overall Study|Study Terminated by Sponsor|27
1219900|NCT00793546|4003526|P1|Overall Study|Study Terminated by Sponsor|8
1219901|NCT00793546|4003525|P2|Overall Study|Withdrawal by Subject|1
1219902|NCT00793546|4003526|P1|Overall Study|Withdrawal by Subject|1
1219903|NCT00793546|4003525|P2|Overall Study|Lost to Follow-up|0
1219904|NCT00793546|4003526|P1|Overall Study|Lost to Follow-up|1
1219905|NCT00793546|4003525|P2|Overall Study|Death|0
1219906|NCT00793546|4003526|P1|Overall Study|Death|3
1219907|NCT00793403|4003576|P1|Overall Study|Other|73
1219908|NCT00793325|4003623|P1|Overall Study|Lost to Follow-up|1
1219909|NCT00793325|4003623|P1|Overall Study|Protocol Violation|18
1219910|NCT00793104|4003655|P1|Overall Study|Lost to Follow-up|1
1219911|NCT00792948|4003663|P1|Overall Study|Protocol Violation|1
1219912|NCT00792948|4003663|P1|Overall Study|Physician Decision|11
1219913|NCT00792948|4003663|P1|Overall Study|Insurance denial - not treated|1
1219914|NCT00792948|4003663|P1|Overall Study|Ineligible|2
1219915|NCT00792948|4003663|P1|Overall Study|Withdrawal by Subject|3
1219916|NCT00792948|4003663|P1|Overall Study|Death|4
1219917|NCT00792948|4003663|P1|Overall Study|Adverse Event|6
1219918|NCT00792935|4003674|P2|Overall Study|Withdrawal by Subject|1
1219919|NCT00792935|4003675|P1|Overall Study|Withdrawal by Subject|0
1219920|NCT00792935|4003674|P2|Overall Study|Protocol Violation|0
1219921|NCT00792935|4003675|P1|Overall Study|Protocol Violation|2
1219922|NCT00792935|4003674|P2|Overall Study|Lost to Follow-up|1
1219923|NCT00792935|4003675|P1|Overall Study|Lost to Follow-up|0
1219924|NCT00792935|4003674|P2|Overall Study|Adverse Event|1
1219925|NCT00792935|4003675|P1|Overall Study|Adverse Event|2
1219926|NCT00792909|4003707|P3|Overall Study|Withdrawal by Subject|0
1219927|NCT00792909|4003708|P2|Overall Study|Withdrawal by Subject|1
1219928|NCT00792909|4003709|P1|Overall Study|Withdrawal by Subject|0
1219929|NCT00792805|4003765|P3|Overall Study|Protocol deviation|1
1219930|NCT00792805|4003766|P2|Overall Study|Protocol deviation|1
1219931|NCT00792805|4003767|P1|Overall Study|Protocol deviation|0
1219932|NCT00792805|4003765|P3|Overall Study|Abnormal laboratory value(s)|1
1219933|NCT00792805|4003766|P2|Overall Study|Abnormal laboratory value(s)|0
1219934|NCT00792805|4003767|P1|Overall Study|Abnormal laboratory value(s)|0
1219935|NCT00792805|4003765|P3|Overall Study|Lost to Follow-up|6
1219936|NCT00792805|4003766|P2|Overall Study|Lost to Follow-up|1
1219937|NCT00792805|4003767|P1|Overall Study|Lost to Follow-up|1
1219938|NCT00792805|4003765|P3|Overall Study|Unsatisfactory therapeutic effect|6
1219939|NCT00792805|4003766|P2|Overall Study|Unsatisfactory therapeutic effect|6
1219940|NCT00792805|4003767|P1|Overall Study|Unsatisfactory therapeutic effect|1
1219941|NCT00792805|4003765|P3|Overall Study|Abnormal test procedure result(s)|0
1219942|NCT00792805|4003766|P2|Overall Study|Abnormal test procedure result(s)|2
1219943|NCT00792805|4003767|P1|Overall Study|Abnormal test procedure result(s)|1
1219944|NCT00792805|4003765|P3|Overall Study|Administrative problems|4
1219945|NCT00792805|4003766|P2|Overall Study|Administrative problems|0
1219946|NCT00792805|4003767|P1|Overall Study|Administrative problems|2
1219947|NCT00792805|4003765|P3|Overall Study|Subject withdrew consent|5
1219948|NCT00792805|4003766|P2|Overall Study|Subject withdrew consent|6
1219949|NCT00792805|4003767|P1|Overall Study|Subject withdrew consent|5
1219950|NCT00792805|4003765|P3|Overall Study|Adverse Event|10
1219951|NCT00792805|4003766|P2|Overall Study|Adverse Event|10
1219952|NCT00792805|4003767|P1|Overall Study|Adverse Event|12
1219953|NCT00792701|4003777|P2|Overall Study|Not protocol specified|0
1219954|NCT00792701|4003778|P1|Overall Study|Not protocol specified|17
1219955|NCT00792701|4003777|P2|Overall Study|Withdrawal by Subject|19
1219956|NCT00792701|4003778|P1|Overall Study|Withdrawal by Subject|1
1219957|NCT00792701|4003777|P2|Overall Study|Ineligible|3
1219958|NCT00792701|4003778|P1|Overall Study|Ineligible|1
1219959|NCT00792701|4003777|P2|Overall Study|Adverse Event|22
1219960|NCT00792701|4003778|P1|Overall Study|Adverse Event|0
1219961|NCT00792636|4003808|P3|Overall Study|Investigator Discretion|2
1219962|NCT00792636|4003809|P2|Overall Study|Investigator Discretion|0
1219963|NCT00792636|4003810|P1|Overall Study|Investigator Discretion|2
1219964|NCT00792636|4003808|P3|Overall Study|Adverse Event|3
1219965|NCT00792636|4003809|P2|Overall Study|Adverse Event|2
1219966|NCT00792636|4003810|P1|Overall Study|Adverse Event|4
1219967|NCT00792636|4003808|P3|Overall Study|Lack of Efficacy|13
1219968|NCT00792636|4003809|P2|Overall Study|Lack of Efficacy|4
1219969|NCT00792636|4003810|P1|Overall Study|Lack of Efficacy|3
1219970|NCT00792636|4003808|P3|Overall Study|Withdrew Consent|9
1219971|NCT00792636|4003809|P2|Overall Study|Withdrew Consent|13
1219972|NCT00792636|4003810|P1|Overall Study|Withdrew Consent|10
1219973|NCT00792636|4003808|P3|Overall Study|Lost to Follow-up|14
1219974|NCT00792636|4003809|P2|Overall Study|Lost to Follow-up|19
1219975|NCT00792636|4003810|P1|Overall Study|Lost to Follow-up|13
1219976|NCT00792636|4003808|P3|Overall Study|Met Protocol-defined Stopping Criteria|20
1219977|NCT00792636|4003809|P2|Overall Study|Met Protocol-defined Stopping Criteria|20
1219978|NCT00792636|4003810|P1|Overall Study|Met Protocol-defined Stopping Criteria|19
1219979|NCT00792636|4003808|P3|Overall Study|Protocol Violation|20
1219980|NCT00792636|4003809|P2|Overall Study|Protocol Violation|23
1219981|NCT00792636|4003810|P1|Overall Study|Protocol Violation|17
1219982|NCT00792623|4003847|P1|Overall Study|Withdrawal by Subject|5
1219983|NCT00792623|4003847|P1|Overall Study|Adverse Event|2
1219984|NCT00792298|4003875|P8|Treatment Period 2|Withdrawal by Subject|2
1219985|NCT00792298|4003876|P7|Treatment Period 2|Withdrawal by Subject|0
1219986|NCT00792298|4003877|P6|Treatment Period 2|Withdrawal by Subject|0
1219987|NCT00792298|4003878|P5|Treatment Period 2|Withdrawal by Subject|1
1219988|NCT00792298|4003879|P4|Treatment Period 2|Withdrawal by Subject|2
1219989|NCT00792298|4003880|P3|Treatment Period 2|Withdrawal by Subject|0
1219990|NCT00792298|4003881|P2|Treatment Period 2|Withdrawal by Subject|1
1219991|NCT00792298|4003882|P1|Treatment Period 2|Withdrawal by Subject|1
1219992|NCT00792298|4003875|P8|Treatment Period 2|Pregnancy|0
1219993|NCT00792298|4003876|P7|Treatment Period 2|Pregnancy|0
1219994|NCT00792298|4003877|P6|Treatment Period 2|Pregnancy|0
1219995|NCT00792298|4003878|P5|Treatment Period 2|Pregnancy|0
1219996|NCT00792298|4003879|P4|Treatment Period 2|Pregnancy|0
1219997|NCT00792298|4003880|P3|Treatment Period 2|Pregnancy|1
1219998|NCT00792298|4003881|P2|Treatment Period 2|Pregnancy|0
1219999|NCT00792298|4003882|P1|Treatment Period 2|Pregnancy|0
1220000|NCT00792298|4003875|P8|Treatment Period 2|Physician Decision|0
1220001|NCT00792298|4003876|P7|Treatment Period 2|Physician Decision|1
1220002|NCT00792298|4003877|P6|Treatment Period 2|Physician Decision|0
1220003|NCT00792298|4003878|P5|Treatment Period 2|Physician Decision|0
1220004|NCT00792298|4003879|P4|Treatment Period 2|Physician Decision|0
1220005|NCT00792298|4003880|P3|Treatment Period 2|Physician Decision|0
1220006|NCT00792298|4003881|P2|Treatment Period 2|Physician Decision|0
1220007|NCT00792298|4003882|P1|Treatment Period 2|Physician Decision|0
1220008|NCT00792298|4003875|P8|Treatment Period 2|Lack of Efficacy|0
1220009|NCT00792298|4003876|P7|Treatment Period 2|Lack of Efficacy|0
1220010|NCT00792298|4003877|P6|Treatment Period 2|Lack of Efficacy|0
1220011|NCT00792298|4003878|P5|Treatment Period 2|Lack of Efficacy|1
1220012|NCT00792298|4003879|P4|Treatment Period 2|Lack of Efficacy|0
1220013|NCT00792298|4003880|P3|Treatment Period 2|Lack of Efficacy|0
1220014|NCT00792298|4003881|P2|Treatment Period 2|Lack of Efficacy|0
1220015|NCT00792298|4003882|P1|Treatment Period 2|Lack of Efficacy|0
1220016|NCT00792298|4003875|P8|Washout|Withdrawal by Subject|0
1220017|NCT00792298|4003876|P7|Washout|Withdrawal by Subject|0
1220018|NCT00792298|4003877|P6|Washout|Withdrawal by Subject|1
1220019|NCT00792298|4003878|P5|Washout|Withdrawal by Subject|0
1220020|NCT00792298|4003879|P4|Washout|Withdrawal by Subject|0
1220021|NCT00792298|4003880|P3|Washout|Withdrawal by Subject|1
1220022|NCT00792298|4003881|P2|Washout|Withdrawal by Subject|0
1220023|NCT00792298|4003882|P1|Washout|Withdrawal by Subject|0
1220024|NCT00792298|4003875|P8|Washout|Adverse Event|0
1220025|NCT00792298|4003876|P7|Washout|Adverse Event|0
1220026|NCT00792298|4003877|P6|Washout|Adverse Event|1
1220027|NCT00792298|4003878|P5|Washout|Adverse Event|0
1220028|NCT00792298|4003879|P4|Washout|Adverse Event|0
1220029|NCT00792298|4003880|P3|Washout|Adverse Event|0
1220030|NCT00792298|4003881|P2|Washout|Adverse Event|0
1220031|NCT00792298|4003882|P1|Washout|Adverse Event|0
1220032|NCT00792298|4003875|P8|Treatment Period 1|Protocol Violation|1
1220033|NCT00792298|4003876|P7|Treatment Period 1|Protocol Violation|0
1220034|NCT00792298|4003877|P6|Treatment Period 1|Protocol Violation|0
1220035|NCT00792298|4003878|P5|Treatment Period 1|Protocol Violation|0
1220036|NCT00792298|4003879|P4|Treatment Period 1|Protocol Violation|0
1220037|NCT00792298|4003880|P3|Treatment Period 1|Protocol Violation|0
1220038|NCT00792298|4003881|P2|Treatment Period 1|Protocol Violation|0
1220039|NCT00792298|4003882|P1|Treatment Period 1|Protocol Violation|0
1220040|NCT00792298|4003875|P8|Treatment Period 1|Physician Decision|0
1220041|NCT00792298|4003876|P7|Treatment Period 1|Physician Decision|1
1220042|NCT00792298|4003877|P6|Treatment Period 1|Physician Decision|0
1220043|NCT00792298|4003878|P5|Treatment Period 1|Physician Decision|0
1220044|NCT00792298|4003879|P4|Treatment Period 1|Physician Decision|1
1220045|NCT00792298|4003880|P3|Treatment Period 1|Physician Decision|0
1220046|NCT00792298|4003881|P2|Treatment Period 1|Physician Decision|0
1220047|NCT00792298|4003882|P1|Treatment Period 1|Physician Decision|0
1220048|NCT00792298|4003875|P8|Treatment Period 1|Lost to Follow-up|0
1220049|NCT00792298|4003876|P7|Treatment Period 1|Lost to Follow-up|1
1220050|NCT00792298|4003877|P6|Treatment Period 1|Lost to Follow-up|0
1220051|NCT00792298|4003878|P5|Treatment Period 1|Lost to Follow-up|0
1220052|NCT00792298|4003879|P4|Treatment Period 1|Lost to Follow-up|0
1220053|NCT00792298|4003880|P3|Treatment Period 1|Lost to Follow-up|0
1220054|NCT00792298|4003881|P2|Treatment Period 1|Lost to Follow-up|0
1220055|NCT00792298|4003882|P1|Treatment Period 1|Lost to Follow-up|0
1220056|NCT00792298|4003875|P8|Treatment Period 1|Withdrawal by Subject|0
1220057|NCT00792298|4003876|P7|Treatment Period 1|Withdrawal by Subject|1
1220058|NCT00792298|4003877|P6|Treatment Period 1|Withdrawal by Subject|2
1220059|NCT00792298|4003878|P5|Treatment Period 1|Withdrawal by Subject|0
1220060|NCT00792298|4003879|P4|Treatment Period 1|Withdrawal by Subject|2
1220061|NCT00792298|4003880|P3|Treatment Period 1|Withdrawal by Subject|1
1220062|NCT00792298|4003881|P2|Treatment Period 1|Withdrawal by Subject|0
1220063|NCT00792298|4003882|P1|Treatment Period 1|Withdrawal by Subject|1
1220064|NCT00792298|4003875|P8|Treatment Period 1|Lack of Efficacy|0
1220065|NCT00792298|4003876|P7|Treatment Period 1|Lack of Efficacy|0
1220066|NCT00792298|4003877|P6|Treatment Period 1|Lack of Efficacy|0
1220067|NCT00792298|4003878|P5|Treatment Period 1|Lack of Efficacy|0
1220068|NCT00792298|4003879|P4|Treatment Period 1|Lack of Efficacy|0
1220069|NCT00792298|4003880|P3|Treatment Period 1|Lack of Efficacy|1
1220070|NCT00792298|4003881|P2|Treatment Period 1|Lack of Efficacy|0
1220071|NCT00792298|4003882|P1|Treatment Period 1|Lack of Efficacy|0
1220072|NCT00792298|4003875|P8|Treatment Period 1|Adverse Event|0
1220073|NCT00792298|4003876|P7|Treatment Period 1|Adverse Event|1
1220074|NCT00792298|4003877|P6|Treatment Period 1|Adverse Event|1
1220075|NCT00792298|4003878|P5|Treatment Period 1|Adverse Event|0
1220076|NCT00792298|4003879|P4|Treatment Period 1|Adverse Event|1
1220077|NCT00792298|4003880|P3|Treatment Period 1|Adverse Event|0
1220078|NCT00792298|4003881|P2|Treatment Period 1|Adverse Event|1
1220079|NCT00792298|4003882|P1|Treatment Period 1|Adverse Event|0
1220080|NCT00792259|4003912|P3|Overall Study|Poor Quality Scans|0
1220081|NCT00792259|4003913|P2|Overall Study|Poor Quality Scans|0
1220082|NCT00792259|4003914|P1|Overall Study|Poor Quality Scans|1
1220083|NCT00792116|4003924|P2|Overall Study|Discontnued intervention|0
1220084|NCT00792116|4003925|P1|Overall Study|Discontnued intervention|1
1220085|NCT00792116|4003924|P2|Overall Study|Lost to Follow-up|1
1220086|NCT00792116|4003925|P1|Overall Study|Lost to Follow-up|0
1220087|NCT00792103|4003935|P1|Overall Study|Did not apply 6 patches in 1st 3 mths|14
1220088|NCT00792103|4003935|P1|Overall Study|Protocol Violation|10
1220089|NCT00792103|4003935|P1|Overall Study|Withdrawal by Subject|52
1220090|NCT00792103|4003935|P1|Overall Study|Adverse Event|25
1220091|NCT00792103|4003935|P1|Overall Study|Lost to Follow-up|17
1220092|NCT00792103|4003935|P1|Overall Study|Enrolled, not treated|15
1220093|NCT00791999|4003947|P4|Overall Study|Reason other than those above|0
1220094|NCT00791999|4003948|P3|Overall Study|Reason other than those above|1
1220095|NCT00791999|4003949|P2|Overall Study|Reason other than those above|0
1220096|NCT00791999|4003950|P1|Overall Study|Reason other than those above|1
1220097|NCT00791999|4003947|P4|Overall Study|Lack of Efficacy|2
1220098|NCT00791999|4003948|P3|Overall Study|Lack of Efficacy|0
1220099|NCT00791999|4003949|P2|Overall Study|Lack of Efficacy|1
1220100|NCT00791999|4003950|P1|Overall Study|Lack of Efficacy|0
1220101|NCT00791999|4003947|P4|Overall Study|Adverse Event|3
1220102|NCT00791999|4003948|P3|Overall Study|Adverse Event|7
1220103|NCT00791999|4003949|P2|Overall Study|Adverse Event|3
1220104|NCT00791999|4003950|P1|Overall Study|Adverse Event|3
1220105|NCT00791999|4003947|P4|Overall Study|Protocol Violation|0
1220106|NCT00791999|4003948|P3|Overall Study|Protocol Violation|1
1220107|NCT00791999|4003949|P2|Overall Study|Protocol Violation|0
1220108|NCT00791999|4003950|P1|Overall Study|Protocol Violation|3
1220109|NCT00791999|4003947|P4|Overall Study|Withdrawal by Subject|2
1220110|NCT00791999|4003948|P3|Overall Study|Withdrawal by Subject|0
1220111|NCT00791999|4003949|P2|Overall Study|Withdrawal by Subject|1
1220112|NCT00791999|4003950|P1|Overall Study|Withdrawal by Subject|0
1220113|NCT00791999|4003947|P4|Overall Study|Protocol planed withdrawal|45
1220114|NCT00791999|4003948|P3|Overall Study|Protocol planed withdrawal|11
1220115|NCT00791999|4003949|P2|Overall Study|Protocol planed withdrawal|11
1220116|NCT00791999|4003950|P1|Overall Study|Protocol planed withdrawal|14
1220117|NCT00791934|4003975|P1|Overall Study|Did not consent for extended follow-up|13
1220118|NCT00791934|4003975|P1|Overall Study|Withdrawal by Subject|2
1220119|NCT00791921|4003985|P2|Overall Study|Reason other than those above|1
1220120|NCT00791921|4003986|P1|Overall Study|Reason other than those above|0
1220121|NCT00791921|4003985|P2|Overall Study|Lack of study drug administration|1
1220122|NCT00791921|4003986|P1|Overall Study|Lack of study drug administration|1
1220123|NCT00791921|4003985|P2|Overall Study|Lack of Efficacy|2
1220124|NCT00791921|4003986|P1|Overall Study|Lack of Efficacy|0
1220125|NCT00791921|4003985|P2|Overall Study|Adverse Event|2
1220126|NCT00791921|4003986|P1|Overall Study|Adverse Event|8
1220127|NCT00791921|4003985|P2|Overall Study|Withdrawal by Subject|2
1220128|NCT00791921|4003986|P1|Overall Study|Withdrawal by Subject|1
1220129|NCT00791921|4003985|P2|Overall Study|Protocol planed|88
1220130|NCT00791921|4003986|P1|Overall Study|Protocol planed|24
1220131|NCT00791778|4004013|P2|Follow-up|Lost to Follow-up|1
1220132|NCT00791778|4004014|P1|Follow-up|Lost to Follow-up|2
1220133|NCT00791778|4004013|P2|Follow-up|Withdrawal by Subject|0
1220134|NCT00791778|4004014|P1|Follow-up|Withdrawal by Subject|3
1220135|NCT00791778|4004013|P2|Double-blind Treatment|Non-compliant with study medication|0
1220136|NCT00791778|4004014|P1|Double-blind Treatment|Non-compliant with study medication|2
1220137|NCT00791778|4004013|P2|Double-blind Treatment|Withdrawal by Subject|9
1220138|NCT00791778|4004014|P1|Double-blind Treatment|Withdrawal by Subject|20
1220139|NCT00791778|4004013|P2|Double-blind Treatment|Protocol Violation|4
1220140|NCT00791778|4004014|P1|Double-blind Treatment|Protocol Violation|0
1220141|NCT00791778|4004013|P2|Double-blind Treatment|Physician Decision|26
1220142|NCT00791778|4004014|P1|Double-blind Treatment|Physician Decision|6
1220143|NCT00791778|4004013|P2|Double-blind Treatment|Adverse Event|9
1220144|NCT00791778|4004014|P1|Double-blind Treatment|Adverse Event|49
1220145|NCT00791765|4004068|P2|Weeks 13 to 24|Other|1
1220146|NCT00791765|4004069|P1|Weeks 13 to 24|Other|0
1220147|NCT00791765|4004068|P2|Weeks 13 to 24|Lost to Follow-up|2
1220148|NCT00791765|4004069|P1|Weeks 13 to 24|Lost to Follow-up|1
1220149|NCT00791765|4004068|P2|Weeks 13 to 24|Disease progression|1
1220150|NCT00791765|4004069|P1|Weeks 13 to 24|Disease progression|0
1220151|NCT00791765|4004068|P2|Weeks 13 to 24|Withdrawal by Subject|1
1220152|NCT00791765|4004069|P1|Weeks 13 to 24|Withdrawal by Subject|2
1220153|NCT00791765|4004068|P2|Weeks 13 to 24|Adverse Event|3
1220154|NCT00791765|4004069|P1|Weeks 13 to 24|Adverse Event|0
1220155|NCT00791765|4004068|P2|Weeks 13 to 24|Protocol deviation|0
1220156|NCT00791765|4004069|P1|Weeks 13 to 24|Protocol deviation|2
1220157|NCT00791765|4004068|P2|Weeks 1 to 12|Ineligibility determined|3
1220158|NCT00791765|4004069|P1|Weeks 1 to 12|Ineligibility determined|0
1220159|NCT00791765|4004068|P2|Weeks 1 to 12|Disease progression|0
1220160|NCT00791765|4004069|P1|Weeks 1 to 12|Disease progression|3
1220161|NCT00791765|4004068|P2|Weeks 1 to 12|Physician Decision|0
1220162|NCT00791765|4004069|P1|Weeks 1 to 12|Physician Decision|1
1220163|NCT00791765|4004068|P2|Weeks 1 to 12|Withdrawal by Subject|0
1220164|NCT00791765|4004069|P1|Weeks 1 to 12|Withdrawal by Subject|3
1220165|NCT00791765|4004068|P2|Weeks 1 to 12|Lost to Follow-up|0
1220166|NCT00791765|4004069|P1|Weeks 1 to 12|Lost to Follow-up|1
1220167|NCT00791765|4004068|P2|Weeks 1 to 12|Adverse Event|1
1220168|NCT00791765|4004069|P1|Weeks 1 to 12|Adverse Event|0
1220169|NCT00791700|4004084|P4|Overall Study|Blood sampling not done before Stage 1|1
1220170|NCT00791700|4004085|P3|Overall Study|Blood sampling not done before Stage 1|0
1220171|NCT00791700|4004086|P2|Overall Study|Blood sampling not done before Stage 1|0
1220172|NCT00791700|4004087|P1|Overall Study|Blood sampling not done before Stage 1|0
1220173|NCT00791700|4004084|P4|Overall Study|Non-compliance with study treatment|2
1220174|NCT00791700|4004085|P3|Overall Study|Non-compliance with study treatment|0
1220175|NCT00791700|4004086|P2|Overall Study|Non-compliance with study treatment|0
1220176|NCT00791700|4004087|P1|Overall Study|Non-compliance with study treatment|1
1220177|NCT00791700|4004084|P4|Overall Study|No longer willing to participate|1
1220178|NCT00791700|4004085|P3|Overall Study|No longer willing to participate|0
1220179|NCT00791700|4004086|P2|Overall Study|No longer willing to participate|1
1220180|NCT00791700|4004087|P1|Overall Study|No longer willing to participate|0
1220181|NCT00791700|4004084|P4|Overall Study|Adverse Event|1
1220182|NCT00791700|4004085|P3|Overall Study|Adverse Event|1
1220183|NCT00791700|4004086|P2|Overall Study|Adverse Event|0
1220184|NCT00791700|4004087|P1|Overall Study|Adverse Event|0
1220185|NCT00791700|4004084|P4|Overall Study|Insufficient clinical response|13
1220186|NCT00791700|4004085|P3|Overall Study|Insufficient clinical response|3
1220187|NCT00791700|4004086|P2|Overall Study|Insufficient clinical response|4
1220188|NCT00791700|4004087|P1|Overall Study|Insufficient clinical response|3
1220189|NCT00791661|4004175|P3|7 Day Wash-out|Abnormal Clinical Laboratory Test|1
1220190|NCT00791661|4004176|P2|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
1220191|NCT00791661|4004177|P1|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
1220192|NCT00791661|4004175|P3|7 Day Wash-out|Adverse Event|1
1220193|NCT00791661|4004176|P2|7 Day Wash-out|Adverse Event|0
1220194|NCT00791661|4004177|P1|7 Day Wash-out|Adverse Event|0
1220195|NCT00791648|4004270|P2|Overall Study|Withdrawal by Subject|1
1220196|NCT00791648|4004271|P1|Overall Study|Withdrawal by Subject|0
1220197|NCT00791648|4004270|P2|Overall Study|Physician Decision|1
1220198|NCT00791648|4004271|P1|Overall Study|Physician Decision|0
1220199|NCT00791557|4004287|P1|Overall Study|Adverse Event|1
1220200|NCT00791518|4004291|P1|Overall Study|Protocol Violation|93
1220201|NCT00791492|4004319|P2|Overall Study|Liver transplantation|1
1220202|NCT00791492|4004320|P1|Overall Study|Liver transplantation|5
1220203|NCT00791492|4004319|P2|Overall Study|Withdrawal by Subject|2
1220204|NCT00791492|4004320|P1|Overall Study|Withdrawal by Subject|1
1220205|NCT00791479|4004368|P6|Overall Study|Withdrawal by Subject|1
1220206|NCT00791479|4004369|P5|Overall Study|Withdrawal by Subject|0
1220207|NCT00791479|4004370|P4|Overall Study|Withdrawal by Subject|1
1220208|NCT00791479|4004371|P3|Overall Study|Withdrawal by Subject|0
1220209|NCT00791479|4004372|P2|Overall Study|Withdrawal by Subject|0
1220210|NCT00791479|4004373|P1|Overall Study|Withdrawal by Subject|0
1220211|NCT00791479|4004368|P6|Overall Study|Protocol Violation|0
1220212|NCT00791479|4004369|P5|Overall Study|Protocol Violation|0
1220213|NCT00791479|4004370|P4|Overall Study|Protocol Violation|1
1220214|NCT00791479|4004371|P3|Overall Study|Protocol Violation|0
1220215|NCT00791479|4004372|P2|Overall Study|Protocol Violation|1
1220216|NCT00791479|4004373|P1|Overall Study|Protocol Violation|2
1220217|NCT00791479|4004368|P6|Overall Study|Lost to Follow-up|1
1220218|NCT00791479|4004369|P5|Overall Study|Lost to Follow-up|0
1220219|NCT00791479|4004370|P4|Overall Study|Lost to Follow-up|0
1220220|NCT00791479|4004371|P3|Overall Study|Lost to Follow-up|0
1220221|NCT00791479|4004372|P2|Overall Study|Lost to Follow-up|1
1220222|NCT00791479|4004373|P1|Overall Study|Lost to Follow-up|0
1220223|NCT00791479|4004368|P6|Overall Study|Adverse Event|1
1220224|NCT00791479|4004369|P5|Overall Study|Adverse Event|0
1220225|NCT00791479|4004370|P4|Overall Study|Adverse Event|2
1220226|NCT00791479|4004371|P3|Overall Study|Adverse Event|0
1220227|NCT00791479|4004372|P2|Overall Study|Adverse Event|1
1220228|NCT00791479|4004373|P1|Overall Study|Adverse Event|0
1220229|NCT00791479|4004368|P6|Overall Study|Dose Discontinued per Sponsor Decision|0
1220230|NCT00791479|4004369|P5|Overall Study|Dose Discontinued per Sponsor Decision|3
1220231|NCT00791479|4004370|P4|Overall Study|Dose Discontinued per Sponsor Decision|0
1220232|NCT00791479|4004371|P3|Overall Study|Dose Discontinued per Sponsor Decision|0
1220233|NCT00791479|4004372|P2|Overall Study|Dose Discontinued per Sponsor Decision|0
1220234|NCT00791479|4004373|P1|Overall Study|Dose Discontinued per Sponsor Decision|0
1220235|NCT00791388|4004472|P5|Period 4 - 400 mg Dose Group|Adverse Event|4
1220236|NCT00791388|4004473|P4|Period 4 - 400 mg Dose Group|Adverse Event|0
1220237|NCT00791388|4004474|P3|Period 4 - 400 mg Dose Group|Adverse Event|0
1220238|NCT00791388|4004475|P2|Period 4 - 400 mg Dose Group|Adverse Event|0
1220239|NCT00791388|4004476|P1|Period 4 - 400 mg Dose Group|Adverse Event|0
1220240|NCT00791388|4004472|P5|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
1220241|NCT00791388|4004473|P4|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
1220242|NCT00791388|4004474|P3|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
1220243|NCT00791388|4004475|P2|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
1220244|NCT00791388|4004476|P1|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1
1220245|NCT00791388|4004472|P5|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
1220246|NCT00791388|4004473|P4|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
1220247|NCT00791388|4004474|P3|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
1220248|NCT00791388|4004475|P2|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1
1220249|NCT00791388|4004476|P1|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
1220250|NCT00791258|4004518|P1|Overall Study|Lack of Efficacy|1
1220251|NCT00791258|4004518|P1|Overall Study|Subject required restricted medication|1
1220252|NCT00791258|4004518|P1|Overall Study|Subject incarcerated|1
1220253|NCT00791258|4004518|P1|Overall Study|non-compliance|3
1220254|NCT00791258|4004518|P1|Overall Study|subject left area|2
1220255|NCT00791258|4004518|P1|Overall Study|Did not take medication for >3 days|1
1220256|NCT00791258|4004518|P1|Overall Study|Withdrawal by Subject|40
1220257|NCT00791258|4004518|P1|Overall Study|Protocol Violation|109
1220258|NCT00791258|4004518|P1|Overall Study|Lost to Follow-up|18
1220259|NCT00791258|4004518|P1|Overall Study|Adverse Event|87
1220260|NCT00791128|4004580|P1|Overall Study|abdominal tumor, unrelated to device|1
1220261|NCT00791128|4004580|P1|Overall Study|non-compliance by subject|2
1220262|NCT00791128|4004580|P1|Overall Study|Device migration|2
1220263|NCT00791128|4004580|P1|Overall Study|Adverse Event|4
1220264|NCT00791076|4004611|P1|Overall Study|Study was terminated,PI left institution|8
1220265|NCT00790907|4004629|P3|Overall Study|Did Not Receive Study Drug|0
1220266|NCT00790907|4004630|P2|Overall Study|Did Not Receive Study Drug|0
1220267|NCT00790907|4004631|P1|Overall Study|Did Not Receive Study Drug|10
1220268|NCT00790907|4004629|P3|Overall Study|Verbatim Reason on the Case Report Form|29
1220269|NCT00790907|4004630|P2|Overall Study|Verbatim Reason on the Case Report Form|20
1220270|NCT00790907|4004631|P1|Overall Study|Verbatim Reason on the Case Report Form|74
1220271|NCT00790907|4004629|P3|Overall Study|Qualifying Condition Not Present|16
1220272|NCT00790907|4004630|P2|Overall Study|Qualifying Condition Not Present|14
1220273|NCT00790907|4004631|P1|Overall Study|Qualifying Condition Not Present|29
1220274|NCT00790907|4004629|P3|Overall Study|Required Protocol-prohibited Therapy|7
1220275|NCT00790907|4004630|P2|Overall Study|Required Protocol-prohibited Therapy|5
1220276|NCT00790907|4004631|P1|Overall Study|Required Protocol-prohibited Therapy|17
1220277|NCT00790907|4004629|P3|Overall Study|Bleeding Event|21
1220278|NCT00790907|4004630|P2|Overall Study|Bleeding Event|16
1220279|NCT00790907|4004631|P1|Overall Study|Bleeding Event|11
1220280|NCT00790907|4004629|P3|Overall Study|Withdrawal by Subject|5
1220281|NCT00790907|4004630|P2|Overall Study|Withdrawal by Subject|7
1220282|NCT00790907|4004631|P1|Overall Study|Withdrawal by Subject|1
1220283|NCT00790907|4004629|P3|Overall Study|Physician Decision|255
1220284|NCT00790907|4004630|P2|Overall Study|Physician Decision|271
1220285|NCT00790907|4004631|P1|Overall Study|Physician Decision|304
1220286|NCT00790907|4004629|P3|Overall Study|Adverse Event|6
1220287|NCT00790907|4004630|P2|Overall Study|Adverse Event|7
1220288|NCT00790907|4004631|P1|Overall Study|Adverse Event|9
1220289|NCT00790868|4004654|P2|Overall Study|Lost to Follow-up|12
1220290|NCT00790868|4004655|P1|Overall Study|Lost to Follow-up|2
1220291|NCT00790868|4004654|P2|Overall Study|Withdrawal by Subject|5
1220292|NCT00790868|4004655|P1|Overall Study|Withdrawal by Subject|4
1220293|NCT00790842|4004677|P11|Expansion Cohort|Study Closure|0
1220294|NCT00790842|4004678|P10|Expansion Cohort|Study Closure|0
1220295|NCT00790842|4004679|P9|Expansion Cohort|Study Closure|0
1220296|NCT00790842|4004680|P8|Expansion Cohort|Study Closure|0
1220297|NCT00790842|4004681|P7|Expansion Cohort|Study Closure|0
1220298|NCT00790842|4004682|P6|Expansion Cohort|Study Closure|0
1220299|NCT00790842|4004683|P5|Expansion Cohort|Study Closure|0
1220300|NCT00790842|4004684|P4|Expansion Cohort|Study Closure|0
1220301|NCT00790842|4004685|P3|Expansion Cohort|Study Closure|1
1220302|NCT00790842|4004686|P2|Expansion Cohort|Study Closure|0
1220303|NCT00790842|4004687|P1|Expansion Cohort|Study Closure|0
1220304|NCT00790842|4004677|P11|Expansion Cohort|Withdrawal by Subject|0
1220305|NCT00790842|4004678|P10|Expansion Cohort|Withdrawal by Subject|0
1220306|NCT00790842|4004679|P9|Expansion Cohort|Withdrawal by Subject|0
1220307|NCT00790842|4004680|P8|Expansion Cohort|Withdrawal by Subject|0
1220308|NCT00790842|4004681|P7|Expansion Cohort|Withdrawal by Subject|0
1220309|NCT00790842|4004682|P6|Expansion Cohort|Withdrawal by Subject|0
1220310|NCT00790842|4004683|P5|Expansion Cohort|Withdrawal by Subject|0
1220311|NCT00790842|4004684|P4|Expansion Cohort|Withdrawal by Subject|0
1220312|NCT00790842|4004685|P3|Expansion Cohort|Withdrawal by Subject|3
1220313|NCT00790842|4004686|P2|Expansion Cohort|Withdrawal by Subject|0
1220314|NCT00790842|4004687|P1|Expansion Cohort|Withdrawal by Subject|0
1220315|NCT00790842|4004677|P11|Expansion Cohort|Physician Decision|0
1220316|NCT00790842|4004678|P10|Expansion Cohort|Physician Decision|0
1220317|NCT00790842|4004679|P9|Expansion Cohort|Physician Decision|0
1220318|NCT00790842|4004680|P8|Expansion Cohort|Physician Decision|0
1220319|NCT00790842|4004681|P7|Expansion Cohort|Physician Decision|0
1220320|NCT00790842|4004682|P6|Expansion Cohort|Physician Decision|0
1220321|NCT00790842|4004683|P5|Expansion Cohort|Physician Decision|0
1220322|NCT00790842|4004684|P4|Expansion Cohort|Physician Decision|0
1220323|NCT00790842|4004685|P3|Expansion Cohort|Physician Decision|1
1220324|NCT00790842|4004686|P2|Expansion Cohort|Physician Decision|0
1220325|NCT00790842|4004687|P1|Expansion Cohort|Physician Decision|0
1220326|NCT00790842|4004677|P11|Expansion Cohort|Death|0
1220327|NCT00790842|4004678|P10|Expansion Cohort|Death|0
1220328|NCT00790842|4004679|P9|Expansion Cohort|Death|0
1220329|NCT00790842|4004680|P8|Expansion Cohort|Death|0
1220330|NCT00790842|4004681|P7|Expansion Cohort|Death|0
1220331|NCT00790842|4004682|P6|Expansion Cohort|Death|0
1220332|NCT00790842|4004683|P5|Expansion Cohort|Death|0
1220333|NCT00790842|4004684|P4|Expansion Cohort|Death|0
1220334|NCT00790842|4004685|P3|Expansion Cohort|Death|2
1220335|NCT00790842|4004686|P2|Expansion Cohort|Death|0
1220336|NCT00790842|4004687|P1|Expansion Cohort|Death|0
1220337|NCT00790842|4004677|P11|Expansion Cohort|Adverse Event|0
1220338|NCT00790842|4004678|P10|Expansion Cohort|Adverse Event|0
1220339|NCT00790842|4004679|P9|Expansion Cohort|Adverse Event|0
1220340|NCT00790842|4004680|P8|Expansion Cohort|Adverse Event|0
1220341|NCT00790842|4004681|P7|Expansion Cohort|Adverse Event|1
1220342|NCT00790842|4004682|P6|Expansion Cohort|Adverse Event|0
1220343|NCT00790842|4004683|P5|Expansion Cohort|Adverse Event|0
1220344|NCT00790842|4004684|P4|Expansion Cohort|Adverse Event|0
1220345|NCT00790842|4004685|P3|Expansion Cohort|Adverse Event|0
1220346|NCT00790842|4004686|P2|Expansion Cohort|Adverse Event|0
1220347|NCT00790842|4004687|P1|Expansion Cohort|Adverse Event|0
1220348|NCT00790842|4004677|P11|Dose Level 4|Withdrawal by Subject|1
1220349|NCT00790842|4004678|P10|Dose Level 4|Withdrawal by Subject|0
1220350|NCT00790842|4004679|P9|Dose Level 4|Withdrawal by Subject|0
1220351|NCT00790842|4004680|P8|Dose Level 4|Withdrawal by Subject|0
1220352|NCT00790842|4004681|P7|Dose Level 4|Withdrawal by Subject|0
1220353|NCT00790842|4004682|P6|Dose Level 4|Withdrawal by Subject|0
1220354|NCT00790842|4004683|P5|Dose Level 4|Withdrawal by Subject|0
1220355|NCT00790842|4004684|P4|Dose Level 4|Withdrawal by Subject|0
1220356|NCT00790842|4004685|P3|Dose Level 4|Withdrawal by Subject|0
1220357|NCT00790842|4004686|P2|Dose Level 4|Withdrawal by Subject|0
1220358|NCT00790842|4004687|P1|Dose Level 4|Withdrawal by Subject|0
1220359|NCT00790842|4004677|P11|Dose Level 4|Physician Decision|1
1220360|NCT00790842|4004678|P10|Dose Level 4|Physician Decision|0
1220361|NCT00790842|4004679|P9|Dose Level 4|Physician Decision|0
1220362|NCT00790842|4004680|P8|Dose Level 4|Physician Decision|0
1220363|NCT00790842|4004681|P7|Dose Level 4|Physician Decision|1
1220364|NCT00790842|4004682|P6|Dose Level 4|Physician Decision|0
1220365|NCT00790842|4004683|P5|Dose Level 4|Physician Decision|0
1220366|NCT00790842|4004684|P4|Dose Level 4|Physician Decision|0
1220367|NCT00790842|4004685|P3|Dose Level 4|Physician Decision|0
1220368|NCT00790842|4004686|P2|Dose Level 4|Physician Decision|0
1220369|NCT00790842|4004687|P1|Dose Level 4|Physician Decision|0
1220370|NCT00790842|4004677|P11|Dose Level 4|Adverse Event|0
1220371|NCT00790842|4004678|P10|Dose Level 4|Adverse Event|0
1220372|NCT00790842|4004679|P9|Dose Level 4|Adverse Event|0
1220373|NCT00790842|4004680|P8|Dose Level 4|Adverse Event|0
1220374|NCT00790842|4004681|P7|Dose Level 4|Adverse Event|1
1220375|NCT00790842|4004682|P6|Dose Level 4|Adverse Event|0
1220376|NCT00790842|4004683|P5|Dose Level 4|Adverse Event|0
1220377|NCT00790842|4004684|P4|Dose Level 4|Adverse Event|0
1220378|NCT00790842|4004685|P3|Dose Level 4|Adverse Event|0
1220379|NCT00790842|4004686|P2|Dose Level 4|Adverse Event|0
1220380|NCT00790842|4004687|P1|Dose Level 4|Adverse Event|0
1220381|NCT00790842|4004677|P11|Dose Level 3|Ineligible/Withdrew before Treatment|0
1220382|NCT00790842|4004678|P10|Dose Level 3|Ineligible/Withdrew before Treatment|0
1220383|NCT00790842|4004679|P9|Dose Level 3|Ineligible/Withdrew before Treatment|0
1220384|NCT00790842|4004680|P8|Dose Level 3|Ineligible/Withdrew before Treatment|0
1220385|NCT00790842|4004681|P7|Dose Level 3|Ineligible/Withdrew before Treatment|0
1220386|NCT00790842|4004682|P6|Dose Level 3|Ineligible/Withdrew before Treatment|0
1220387|NCT00790842|4004683|P5|Dose Level 3|Ineligible/Withdrew before Treatment|0
1220388|NCT00790842|4004684|P4|Dose Level 3|Ineligible/Withdrew before Treatment|0
1220389|NCT00790842|4004685|P3|Dose Level 3|Ineligible/Withdrew before Treatment|1
1220390|NCT00790842|4004686|P2|Dose Level 3|Ineligible/Withdrew before Treatment|0
1220391|NCT00790842|4004687|P1|Dose Level 3|Ineligible/Withdrew before Treatment|0
1220392|NCT00790842|4004677|P11|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
1220393|NCT00790842|4004678|P10|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
1220394|NCT00790842|4004679|P9|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
1220395|NCT00790842|4004680|P8|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
1220396|NCT00790842|4004681|P7|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
1220397|NCT00790842|4004682|P6|Dose Level 3|Intercurrent Illness/Alternative Therapy|1
1220398|NCT00790842|4004683|P5|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
1220399|NCT00790842|4004684|P4|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
1220400|NCT00790842|4004685|P3|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
1220401|NCT00790842|4004686|P2|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
1220402|NCT00790842|4004687|P1|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
1220403|NCT00790842|4004677|P11|Dose Level 3|Withdrawal by Subject|0
1220404|NCT00790842|4004678|P10|Dose Level 3|Withdrawal by Subject|2
1220405|NCT00790842|4004679|P9|Dose Level 3|Withdrawal by Subject|0
1220406|NCT00790842|4004680|P8|Dose Level 3|Withdrawal by Subject|0
1220407|NCT00790842|4004681|P7|Dose Level 3|Withdrawal by Subject|0
1220408|NCT00790842|4004682|P6|Dose Level 3|Withdrawal by Subject|0
1220409|NCT00790842|4004683|P5|Dose Level 3|Withdrawal by Subject|0
1220410|NCT00790842|4004684|P4|Dose Level 3|Withdrawal by Subject|0
1220411|NCT00790842|4004685|P3|Dose Level 3|Withdrawal by Subject|3
1220412|NCT00790842|4004686|P2|Dose Level 3|Withdrawal by Subject|0
1220413|NCT00790842|4004687|P1|Dose Level 3|Withdrawal by Subject|0
1220414|NCT00790842|4004677|P11|Dose Level 3|Adverse Event|0
1220415|NCT00790842|4004678|P10|Dose Level 3|Adverse Event|0
1220416|NCT00790842|4004679|P9|Dose Level 3|Adverse Event|0
1220417|NCT00790842|4004680|P8|Dose Level 3|Adverse Event|0
1220418|NCT00790842|4004681|P7|Dose Level 3|Adverse Event|0
1220419|NCT00790842|4004682|P6|Dose Level 3|Adverse Event|0
1220420|NCT00790842|4004683|P5|Dose Level 3|Adverse Event|0
1220421|NCT00790842|4004684|P4|Dose Level 3|Adverse Event|0
1220422|NCT00790842|4004685|P3|Dose Level 3|Adverse Event|1
1220423|NCT00790842|4004686|P2|Dose Level 3|Adverse Event|0
1220424|NCT00790842|4004687|P1|Dose Level 3|Adverse Event|0
1220425|NCT00790842|4004677|P11|Dose Level 2|Intercurrent Illness/Other Treatment|0
1220426|NCT00790842|4004678|P10|Dose Level 2|Intercurrent Illness/Other Treatment|0
1220427|NCT00790842|4004679|P9|Dose Level 2|Intercurrent Illness/Other Treatment|2
1220428|NCT00790842|4004680|P8|Dose Level 2|Intercurrent Illness/Other Treatment|0
1220429|NCT00790842|4004681|P7|Dose Level 2|Intercurrent Illness/Other Treatment|0
1220430|NCT00790842|4004682|P6|Dose Level 2|Intercurrent Illness/Other Treatment|0
1220431|NCT00790842|4004683|P5|Dose Level 2|Intercurrent Illness/Other Treatment|0
1220432|NCT00790842|4004684|P4|Dose Level 2|Intercurrent Illness/Other Treatment|0
1220433|NCT00790842|4004685|P3|Dose Level 2|Intercurrent Illness/Other Treatment|0
1220434|NCT00790842|4004686|P2|Dose Level 2|Intercurrent Illness/Other Treatment|0
1220435|NCT00790842|4004687|P1|Dose Level 2|Intercurrent Illness/Other Treatment|0
1220436|NCT00790842|4004677|P11|Dose Level 2|Withdrawal by Subject|0
1220437|NCT00790842|4004678|P10|Dose Level 2|Withdrawal by Subject|0
1220438|NCT00790842|4004679|P9|Dose Level 2|Withdrawal by Subject|0
1220439|NCT00790842|4004680|P8|Dose Level 2|Withdrawal by Subject|0
1220440|NCT00790842|4004681|P7|Dose Level 2|Withdrawal by Subject|0
1220441|NCT00790842|4004682|P6|Dose Level 2|Withdrawal by Subject|0
1220442|NCT00790842|4004683|P5|Dose Level 2|Withdrawal by Subject|0
1220443|NCT00790842|4004684|P4|Dose Level 2|Withdrawal by Subject|0
1220444|NCT00790842|4004685|P3|Dose Level 2|Withdrawal by Subject|0
1220445|NCT00790842|4004686|P2|Dose Level 2|Withdrawal by Subject|1
1220446|NCT00790842|4004687|P1|Dose Level 2|Withdrawal by Subject|0
1220447|NCT00790842|4004677|P11|Dose Level 2|Physician Decision|0
1220448|NCT00790842|4004678|P10|Dose Level 2|Physician Decision|0
1220449|NCT00790842|4004679|P9|Dose Level 2|Physician Decision|0
1220450|NCT00790842|4004680|P8|Dose Level 2|Physician Decision|0
1220451|NCT00790842|4004681|P7|Dose Level 2|Physician Decision|0
1220452|NCT00790842|4004682|P6|Dose Level 2|Physician Decision|0
1220453|NCT00790842|4004683|P5|Dose Level 2|Physician Decision|0
1220454|NCT00790842|4004684|P4|Dose Level 2|Physician Decision|0
1220455|NCT00790842|4004685|P3|Dose Level 2|Physician Decision|0
1220456|NCT00790842|4004686|P2|Dose Level 2|Physician Decision|1
1220457|NCT00790842|4004687|P1|Dose Level 2|Physician Decision|0
1220458|NCT00790842|4004677|P11|Dose Level 2|Death|0
1220459|NCT00790842|4004678|P10|Dose Level 2|Death|0
1220460|NCT00790842|4004679|P9|Dose Level 2|Death|0
1220461|NCT00790842|4004680|P8|Dose Level 2|Death|0
1220462|NCT00790842|4004681|P7|Dose Level 2|Death|0
1220463|NCT00790842|4004682|P6|Dose Level 2|Death|0
1220464|NCT00790842|4004683|P5|Dose Level 2|Death|1
1220465|NCT00790842|4004684|P4|Dose Level 2|Death|0
1220466|NCT00790842|4004685|P3|Dose Level 2|Death|0
1220467|NCT00790842|4004686|P2|Dose Level 2|Death|1
1220468|NCT00790842|4004687|P1|Dose Level 2|Death|0
1220469|NCT00790842|4004677|P11|Dose Level 1|Withdrawal by Subject|0
1220470|NCT00790842|4004678|P10|Dose Level 1|Withdrawal by Subject|0
1220471|NCT00790842|4004679|P9|Dose Level 1|Withdrawal by Subject|0
1220472|NCT00790842|4004680|P8|Dose Level 1|Withdrawal by Subject|0
1220473|NCT00790842|4004681|P7|Dose Level 1|Withdrawal by Subject|0
1220474|NCT00790842|4004682|P6|Dose Level 1|Withdrawal by Subject|0
1220475|NCT00790842|4004683|P5|Dose Level 1|Withdrawal by Subject|0
1220476|NCT00790842|4004684|P4|Dose Level 1|Withdrawal by Subject|0
1220477|NCT00790842|4004685|P3|Dose Level 1|Withdrawal by Subject|0
1220478|NCT00790842|4004686|P2|Dose Level 1|Withdrawal by Subject|0
1220479|NCT00790842|4004687|P1|Dose Level 1|Withdrawal by Subject|1
1220480|NCT00790842|4004677|P11|Dose Level 1|Physician Decision|0
1220481|NCT00790842|4004678|P10|Dose Level 1|Physician Decision|0
1220482|NCT00790842|4004679|P9|Dose Level 1|Physician Decision|0
1220483|NCT00790842|4004680|P8|Dose Level 1|Physician Decision|1
1220484|NCT00790842|4004681|P7|Dose Level 1|Physician Decision|0
1220485|NCT00790842|4004682|P6|Dose Level 1|Physician Decision|0
1220486|NCT00790842|4004683|P5|Dose Level 1|Physician Decision|0
1220487|NCT00790842|4004684|P4|Dose Level 1|Physician Decision|0
1220488|NCT00790842|4004685|P3|Dose Level 1|Physician Decision|0
1220489|NCT00790842|4004686|P2|Dose Level 1|Physician Decision|0
1220490|NCT00790842|4004687|P1|Dose Level 1|Physician Decision|1
1220491|NCT00790842|4004677|P11|Dose Level 1|Adverse Event|0
1220492|NCT00790842|4004678|P10|Dose Level 1|Adverse Event|0
1220493|NCT00790842|4004679|P9|Dose Level 1|Adverse Event|0
1220494|NCT00790842|4004680|P8|Dose Level 1|Adverse Event|1
1220495|NCT00790842|4004681|P7|Dose Level 1|Adverse Event|0
1220496|NCT00790842|4004682|P6|Dose Level 1|Adverse Event|0
1220497|NCT00790842|4004683|P5|Dose Level 1|Adverse Event|0
1220498|NCT00790842|4004684|P4|Dose Level 1|Adverse Event|2
1220499|NCT00790842|4004685|P3|Dose Level 1|Adverse Event|0
1220500|NCT00790842|4004686|P2|Dose Level 1|Adverse Event|0
1220501|NCT00790842|4004687|P1|Dose Level 1|Adverse Event|1
1220502|NCT00790790|4004755|P3|Study Period 2: Therapy Phase|Physician Decision|0
1220503|NCT00790790|4004756|P2|Study Period 2: Therapy Phase|Physician Decision|1
1220504|NCT00790790|4004757|P1|Study Period 2: Therapy Phase|Physician Decision|0
1220505|NCT00790790|4004755|P3|Study Period 2: Therapy Phase|Lack of Efficacy|3
1220506|NCT00790790|4004756|P2|Study Period 2: Therapy Phase|Lack of Efficacy|0
1220507|NCT00790790|4004757|P1|Study Period 2: Therapy Phase|Lack of Efficacy|1
1220508|NCT00790790|4004755|P3|Study Period 2: Therapy Phase|Withdrawal by Subject|2
1220509|NCT00790790|4004756|P2|Study Period 2: Therapy Phase|Withdrawal by Subject|0
1220510|NCT00790790|4004757|P1|Study Period 2: Therapy Phase|Withdrawal by Subject|7
1220511|NCT00790790|4004755|P3|Study Period 2: Therapy Phase|Protocol Violation|0
1220512|NCT00790790|4004756|P2|Study Period 2: Therapy Phase|Protocol Violation|1
1220513|NCT00790790|4004757|P1|Study Period 2: Therapy Phase|Protocol Violation|1
1220514|NCT00790790|4004755|P3|Study Period 2: Therapy Phase|Adverse Event|16
1220515|NCT00790790|4004756|P2|Study Period 2: Therapy Phase|Adverse Event|16
1220516|NCT00790790|4004757|P1|Study Period 2: Therapy Phase|Adverse Event|3
1220517|NCT00790751|4004834|P4|Overall Study|Physician Decision|1
1220518|NCT00790751|4004835|P3|Overall Study|Physician Decision|0
1220519|NCT00790751|4004836|P2|Overall Study|Physician Decision|0
1220520|NCT00790751|4004837|P1|Overall Study|Physician Decision|0
1220521|NCT00790751|4004834|P4|Overall Study|Death|0
1220522|NCT00790751|4004835|P3|Overall Study|Death|1
1220523|NCT00790751|4004836|P2|Overall Study|Death|0
1220524|NCT00790751|4004837|P1|Overall Study|Death|0
1220525|NCT00790751|4004834|P4|Overall Study|Requirement for restricted medication|0
1220526|NCT00790751|4004835|P3|Overall Study|Requirement for restricted medication|0
1220527|NCT00790751|4004836|P2|Overall Study|Requirement for restricted medication|2
1220528|NCT00790751|4004837|P1|Overall Study|Requirement for restricted medication|0
1220529|NCT00790751|4004834|P4|Overall Study|Adverse Event|4
1220530|NCT00790751|4004835|P3|Overall Study|Adverse Event|5
1220531|NCT00790751|4004836|P2|Overall Study|Adverse Event|3
1220532|NCT00790751|4004837|P1|Overall Study|Adverse Event|5
1220533|NCT00790751|4004834|P4|Overall Study|Lost to Follow-up|5
1220534|NCT00790751|4004835|P3|Overall Study|Lost to Follow-up|4
1220535|NCT00790751|4004836|P2|Overall Study|Lost to Follow-up|9
1220536|NCT00790751|4004837|P1|Overall Study|Lost to Follow-up|4
1220537|NCT00790751|4004834|P4|Overall Study|Protocol non-compliance|11
1220538|NCT00790751|4004835|P3|Overall Study|Protocol non-compliance|10
1220539|NCT00790751|4004836|P2|Overall Study|Protocol non-compliance|16
1220540|NCT00790751|4004837|P1|Overall Study|Protocol non-compliance|16
1220541|NCT00790647|4004885|P1|Overall Study|Adverse Event|1
1220542|NCT00790569|4004895|P3|End of Study (12 Month Interview)|Lost to Follow-up|50
1220543|NCT00790569|4004896|P2|End of Study (12 Month Interview)|Lost to Follow-up|19
1220544|NCT00790569|4004897|P1|End of Study (12 Month Interview)|Lost to Follow-up|66
1220545|NCT00790569|4004895|P3|End of Treatment (6 Month Interview)|Incarcerated|3
1220546|NCT00790569|4004896|P2|End of Treatment (6 Month Interview)|Incarcerated|0
1220547|NCT00790569|4004897|P1|End of Treatment (6 Month Interview)|Incarcerated|0
1220548|NCT00790569|4004895|P3|End of Treatment (6 Month Interview)|Residential Treatment|2
1220549|NCT00790569|4004896|P2|End of Treatment (6 Month Interview)|Residential Treatment|0
1220550|NCT00790569|4004897|P1|End of Treatment (6 Month Interview)|Residential Treatment|0
1220551|NCT00790569|4004895|P3|End of Treatment (6 Month Interview)|Hospitalized|0
1220552|NCT00790569|4004896|P2|End of Treatment (6 Month Interview)|Hospitalized|0
1220553|NCT00790569|4004897|P1|End of Treatment (6 Month Interview)|Hospitalized|2
1220554|NCT00790569|4004895|P3|End of Treatment (6 Month Interview)|Death|1
1220555|NCT00790569|4004896|P2|End of Treatment (6 Month Interview)|Death|2
1220556|NCT00790569|4004897|P1|End of Treatment (6 Month Interview)|Death|0
1220557|NCT00790569|4004895|P3|End of Treatment (6 Month Interview)|Lost to Follow-up|20
1220558|NCT00790569|4004896|P2|End of Treatment (6 Month Interview)|Lost to Follow-up|8
1220559|NCT00790569|4004897|P1|End of Treatment (6 Month Interview)|Lost to Follow-up|20
1220560|NCT00790556|4004938|P2|Treatment Period 1|Withdrawal by Subject|0
1220561|NCT00790556|4004939|P1|Treatment Period 1|Withdrawal by Subject|1
1220562|NCT00790556|4004938|P2|Treatment Period 1|Physician Decision|0
1220563|NCT00790556|4004939|P1|Treatment Period 1|Physician Decision|1
1220564|NCT00790452|4004951|P2|Overall Study|Drug supply issue|0
1220565|NCT00790452|4004952|P1|Overall Study|Drug supply issue|1
1220566|NCT00790400|4004960|P2|Everolimus Period (Core or Extension)|New treatment|0
1220567|NCT00790400|4004961|P1|Everolimus Period (Core or Extension)|New treatment|2
1220568|NCT00790400|4004960|P2|Everolimus Period (Core or Extension)|Protocol Violation|0
1220569|NCT00790400|4004961|P1|Everolimus Period (Core or Extension)|Protocol Violation|1
1220570|NCT00790400|4004960|P2|Everolimus Period (Core or Extension)|Disease progression|0
1220571|NCT00790400|4004961|P1|Everolimus Period (Core or Extension)|Disease progression|5
1220572|NCT00790400|4004960|P2|Everolimus Period (Core or Extension)|Death|0
1220573|NCT00790400|4004961|P1|Everolimus Period (Core or Extension)|Death|1
1220574|NCT00790400|4004960|P2|Everolimus Period (Core or Extension)|Administrative problems|0
1220575|NCT00790400|4004961|P1|Everolimus Period (Core or Extension)|Administrative problems|2
1220576|NCT00790400|4004960|P2|Everolimus Period (Core or Extension)|Lost to Follow-up|0
1220577|NCT00790400|4004961|P1|Everolimus Period (Core or Extension)|Lost to Follow-up|1
1220578|NCT00790400|4004960|P2|Everolimus Period (Core or Extension)|Withdrawal by Subject|0
1220579|NCT00790400|4004961|P1|Everolimus Period (Core or Extension)|Withdrawal by Subject|7
1220580|NCT00790400|4004960|P2|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0
1220581|NCT00790400|4004961|P1|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1
1220582|NCT00790400|4004960|P2|Everolimus Period (Core or Extension)|Adverse Event|0
1220583|NCT00790400|4004961|P1|Everolimus Period (Core or Extension)|Adverse Event|9
1220584|NCT00790400|4004960|P2|Double-blind Period (Core Phase)|Death|0
1220585|NCT00790400|4004961|P1|Double-blind Period (Core Phase)|Death|1
1220586|NCT00790400|4004960|P2|Double-blind Period (Core Phase)|Administrative problems|0
1220587|NCT00790400|4004961|P1|Double-blind Period (Core Phase)|Administrative problems|1
1220588|NCT00790400|4004960|P2|Double-blind Period (Core Phase)|Withdrawal by Subject|0
1220589|NCT00790400|4004961|P1|Double-blind Period (Core Phase)|Withdrawal by Subject|1
1220590|NCT00790400|4004960|P2|Double-blind Period (Core Phase)|Abnormal lab value (s)|0
1220591|NCT00790400|4004961|P1|Double-blind Period (Core Phase)|Abnormal lab value (s)|1
1220592|NCT00790400|4004960|P2|Double-blind Period (Core Phase)|Adverse Event|4
1220593|NCT00790400|4004961|P1|Double-blind Period (Core Phase)|Adverse Event|2
1220594|NCT00790400|4004960|P2|Double-blind Period (Core Phase)|Progressive disease|9
1220595|NCT00790400|4004961|P1|Double-blind Period (Core Phase)|Progressive disease|0
1220596|NCT00790400|4004960|P2|Double-blind Period (Core Phase)|Protocol Violation|0
1220597|NCT00790400|4004961|P1|Double-blind Period (Core Phase)|Protocol Violation|1
1220598|NCT00790296|4005051|P2|Overall Study|Adverse Event|1
1220599|NCT00790296|4005052|P1|Overall Study|Adverse Event|0
1220600|NCT00790296|4005051|P2|Overall Study|Did not meet study eligibility criteria|1
1220601|NCT00790296|4005052|P1|Overall Study|Did not meet study eligibility criteria|1
1220602|NCT00790218|4005074|P3|Overall Study|Death|0
1220603|NCT00790218|4005075|P2|Overall Study|Death|0
1220604|NCT00790218|4005076|P1|Overall Study|Death|1
1220605|NCT00790205|4005086|P2|Overall Study|Withdrawal by Subject|363
1220606|NCT00790205|4005087|P1|Overall Study|Withdrawal by Subject|299
1220607|NCT00790205|4005086|P2|Overall Study|Lost to Follow-up|71
1220608|NCT00790205|4005087|P1|Overall Study|Lost to Follow-up|61
1220609|NCT00790036|4005184|P2|Overall Study|Subject/guardian decision|7
1220610|NCT00790036|4005185|P1|Overall Study|Subject/guardian decision|20
1220611|NCT00790036|4005184|P2|Overall Study|Withdrawal by Subject|7
1220612|NCT00790036|4005185|P1|Overall Study|Withdrawal by Subject|18
1220613|NCT00790036|4005184|P2|Overall Study|Protocol Violation|2
1220614|NCT00790036|4005185|P1|Overall Study|Protocol Violation|10
1220615|NCT00790036|4005184|P2|Overall Study|Lost to Follow-up|2
1220616|NCT00790036|4005185|P1|Overall Study|Lost to Follow-up|1
1220617|NCT00790036|4005184|P2|Overall Study|Disease progression|48
1220618|NCT00790036|4005185|P1|Overall Study|Disease progression|24
1220619|NCT00790036|4005184|P2|Overall Study|Death|0
1220620|NCT00790036|4005185|P1|Overall Study|Death|1
1220621|NCT00790036|4005184|P2|Overall Study|Adverse Event|44
1220622|NCT00790036|4005185|P1|Overall Study|Adverse Event|113
1220623|NCT00790036|4005184|P2|Overall Study|Administrative problems|9
1220624|NCT00790036|4005185|P1|Overall Study|Administrative problems|5
1220625|NCT00790036|4005184|P2|Overall Study|Abnormal lab values|2
1220626|NCT00790036|4005185|P1|Overall Study|Abnormal lab values|3
1220627|NCT00790023|4005199|P3|Overall Study|Not specified|8
1220628|NCT00790023|4005200|P2|Overall Study|Not specified|5
1220629|NCT00790023|4005201|P1|Overall Study|Not specified|5
1220630|NCT00790023|4005199|P3|Overall Study|Lost to Follow-up|1
1220631|NCT00790023|4005200|P2|Overall Study|Lost to Follow-up|0
1220632|NCT00790023|4005201|P1|Overall Study|Lost to Follow-up|0
1220633|NCT00790023|4005199|P3|Overall Study|Withdrawal by Subject|6
1220634|NCT00790023|4005200|P2|Overall Study|Withdrawal by Subject|0
1220635|NCT00790023|4005201|P1|Overall Study|Withdrawal by Subject|2
1220636|NCT00790023|4005199|P3|Overall Study|Protocol Violation|2
1220637|NCT00790023|4005200|P2|Overall Study|Protocol Violation|4
1220638|NCT00790023|4005201|P1|Overall Study|Protocol Violation|2
1220639|NCT00790023|4005199|P3|Overall Study|Adverse Event|4
1220640|NCT00790023|4005200|P2|Overall Study|Adverse Event|1
1220641|NCT00790023|4005201|P1|Overall Study|Adverse Event|2
1220642|NCT00789958|4005300|P1|Overall Study|Not eligible/not analyzable|26
1220643|NCT00789958|4005300|P1|Overall Study|not protocol specified|1
1220644|NCT00789958|4005300|P1|Overall Study|Progression|3
1220645|NCT00789958|4005300|P1|Overall Study|Withdrawal by Subject|4
1220646|NCT00789958|4005300|P1|Overall Study|Adverse Event|3
1220647|NCT00789880|4005319|P6|Overall Study|Withdrawal by Subject|0
1220648|NCT00789880|4005320|P5|Overall Study|Withdrawal by Subject|2
1220649|NCT00789880|4005321|P4|Overall Study|Withdrawal by Subject|0
1220650|NCT00789880|4005322|P3|Overall Study|Withdrawal by Subject|0
1220651|NCT00789880|4005323|P2|Overall Study|Withdrawal by Subject|0
1220652|NCT00789880|4005324|P1|Overall Study|Withdrawal by Subject|1
1220653|NCT00789880|4005319|P6|Overall Study|Protocol Violation|0
1220654|NCT00789880|4005320|P5|Overall Study|Protocol Violation|0
1220655|NCT00789880|4005321|P4|Overall Study|Protocol Violation|1
1220656|NCT00789880|4005322|P3|Overall Study|Protocol Violation|0
1220657|NCT00789880|4005323|P2|Overall Study|Protocol Violation|1
1220658|NCT00789880|4005324|P1|Overall Study|Protocol Violation|0
1220659|NCT00789880|4005319|P6|Overall Study|Adverse Event|0
1220660|NCT00789880|4005320|P5|Overall Study|Adverse Event|1
1220661|NCT00789880|4005321|P4|Overall Study|Adverse Event|0
1220662|NCT00789880|4005322|P3|Overall Study|Adverse Event|0
1220663|NCT00789880|4005323|P2|Overall Study|Adverse Event|0
1220664|NCT00789880|4005324|P1|Overall Study|Adverse Event|0
1220665|NCT00789854|4005353|P3|Overall Study|Other|5
1220666|NCT00789854|4005354|P2|Overall Study|Other|0
1220667|NCT00789854|4005355|P1|Overall Study|Other|6
1220668|NCT00789854|4005353|P3|Overall Study|Safety reasons|2
1220669|NCT00789854|4005354|P2|Overall Study|Safety reasons|0
1220670|NCT00789854|4005355|P1|Overall Study|Safety reasons|0
1220671|NCT00789854|4005353|P3|Overall Study|Severe non-compliance to the protocol|0
1220672|NCT00789854|4005354|P2|Overall Study|Severe non-compliance to the protocol|0
1220673|NCT00789854|4005355|P1|Overall Study|Severe non-compliance to the protocol|3
1220674|NCT00789854|4005353|P3|Overall Study|Eligibility criteria not fulfilled|1
1220675|NCT00789854|4005354|P2|Overall Study|Eligibility criteria not fulfilled|5
1220676|NCT00789854|4005355|P1|Overall Study|Eligibility criteria not fulfilled|2
1220677|NCT00789854|4005353|P3|Overall Study|Withdrawal by Subject|17
1220678|NCT00789854|4005354|P2|Overall Study|Withdrawal by Subject|6
1220679|NCT00789854|4005355|P1|Overall Study|Withdrawal by Subject|9
1220680|NCT00789854|4005353|P3|Overall Study|Lost to Follow-up|4
1220681|NCT00789854|4005354|P2|Overall Study|Lost to Follow-up|1
1220682|NCT00789854|4005355|P1|Overall Study|Lost to Follow-up|1
1220683|NCT00789854|4005353|P3|Overall Study|Adverse Event|18
1220684|NCT00789854|4005354|P2|Overall Study|Adverse Event|23
1220685|NCT00789854|4005355|P1|Overall Study|Adverse Event|28
1220686|NCT00789828|4005452|P2|Open-label Extension Period (4 Years)|New treatment for indication under study|0
1220687|NCT00789828|4005453|P1|Open-label Extension Period (4 Years)|New treatment for indication under study|1
1220688|NCT00789828|4005452|P2|Open-label Extension Period (4 Years)|Disease progression|0
1220689|NCT00789828|4005453|P1|Open-label Extension Period (4 Years)|Disease progression|1
1220690|NCT00789828|4005452|P2|Open-label Extension Period (4 Years)|Death|0
1220691|NCT00789828|4005453|P1|Open-label Extension Period (4 Years)|Death|1
1220692|NCT00789828|4005452|P2|Open-label Extension Period (4 Years)|Administrative problems|0
1220693|NCT00789828|4005453|P1|Open-label Extension Period (4 Years)|Administrative problems|7
1220694|NCT00789828|4005452|P2|Open-label Extension Period (4 Years)|Lost to Follow-up|0
1220695|NCT00789828|4005453|P1|Open-label Extension Period (4 Years)|Lost to Follow-up|3
1220696|NCT00789828|4005452|P2|Open-label Extension Period (4 Years)|Withdrawal by Subject|0
1220697|NCT00789828|4005453|P1|Open-label Extension Period (4 Years)|Withdrawal by Subject|6
1220698|NCT00789828|4005452|P2|Open-label Extension Period (4 Years)|Adverse Event|0
1220699|NCT00789828|4005453|P1|Open-label Extension Period (4 Years)|Adverse Event|10
1220700|NCT00789828|4005452|P2|Core Period (48 Weeks)|Lost to Follow-up|1
1220701|NCT00789828|4005453|P1|Core Period (48 Weeks)|Lost to Follow-up|0
1220702|NCT00789828|4005452|P2|Core Period (48 Weeks)|Withdrawal by Subject|4
1220703|NCT00789828|4005453|P1|Core Period (48 Weeks)|Withdrawal by Subject|0
1220704|NCT00789828|4005452|P2|Core Period (48 Weeks)|Administrative problems|1
1220705|NCT00789828|4005453|P1|Core Period (48 Weeks)|Administrative problems|0
1220706|NCT00789815|4005487|P2|Overall Study|Intubation due to massive bleeding|0
1220707|NCT00789815|4005488|P1|Overall Study|Intubation due to massive bleeding|1
1220708|NCT00789815|4005487|P2|Overall Study|Protocol Violation|1
1220709|NCT00789815|4005488|P1|Overall Study|Protocol Violation|6
1220710|NCT00789737|4005598|P2|Overall Study|not specified|7
1220711|NCT00789737|4005599|P1|Overall Study|not specified|11
1220712|NCT00789737|4005598|P2|Overall Study|hyperglycemia that met protocol-specifie|4
1220713|NCT00789737|4005599|P1|Overall Study|hyperglycemia that met protocol-specifie|0
1220714|NCT00789737|4005598|P2|Overall Study|Lack of Efficacy|0
1220715|NCT00789737|4005599|P1|Overall Study|Lack of Efficacy|3
1220716|NCT00789737|4005598|P2|Overall Study|Protocol Violation|0
1220717|NCT00789737|4005599|P1|Overall Study|Protocol Violation|3
1220718|NCT00789737|4005598|P2|Overall Study|Adverse Event|8
1220719|NCT00789737|4005599|P1|Overall Study|Adverse Event|8
1220720|NCT00789737|4005598|P2|Overall Study|Lost to Follow-up|14
1220721|NCT00789737|4005599|P1|Overall Study|Lost to Follow-up|10
1220722|NCT00789737|4005598|P2|Overall Study|Withdrawal by Subject|22
1220723|NCT00789737|4005599|P1|Overall Study|Withdrawal by Subject|13
1220724|NCT00789698|4005642|P4|Overall Study|Administrative|1
1220725|NCT00789698|4005643|P3|Overall Study|Administrative|3
1220726|NCT00789698|4005644|P2|Overall Study|Administrative|3
1220727|NCT00789698|4005645|P1|Overall Study|Administrative|0
1220728|NCT00789698|4005642|P4|Overall Study|Withdrawal by Subject|19
1220729|NCT00789698|4005643|P3|Overall Study|Withdrawal by Subject|12
1220730|NCT00789698|4005644|P2|Overall Study|Withdrawal by Subject|15
1220731|NCT00789698|4005645|P1|Overall Study|Withdrawal by Subject|14
1220732|NCT00789698|4005642|P4|Overall Study|Protocol Violation|1
1220733|NCT00789698|4005643|P3|Overall Study|Protocol Violation|2
1220734|NCT00789698|4005644|P2|Overall Study|Protocol Violation|1
1220735|NCT00789698|4005645|P1|Overall Study|Protocol Violation|6
1220736|NCT00789698|4005642|P4|Overall Study|Lost to Follow-up|9
1220737|NCT00789698|4005643|P3|Overall Study|Lost to Follow-up|2
1220738|NCT00789698|4005644|P2|Overall Study|Lost to Follow-up|5
1220739|NCT00789698|4005645|P1|Overall Study|Lost to Follow-up|5
1220740|NCT00789698|4005642|P4|Overall Study|Adverse Event|4
1220741|NCT00789698|4005643|P3|Overall Study|Adverse Event|3
1220742|NCT00789698|4005644|P2|Overall Study|Adverse Event|5
1220743|NCT00789698|4005645|P1|Overall Study|Adverse Event|5
1220744|NCT00789698|4005642|P4|Overall Study|Lack of Efficacy|18
1220745|NCT00789698|4005643|P3|Overall Study|Lack of Efficacy|5
1220746|NCT00789698|4005644|P2|Overall Study|Lack of Efficacy|4
1220747|NCT00789698|4005645|P1|Overall Study|Lack of Efficacy|10
1220748|NCT00789581|4005700|P2|Adjuvant Therapy|Not Specified|1
1220749|NCT00789581|4005701|P1|Adjuvant Therapy|Not Specified|0
1220750|NCT00789581|4005700|P2|Adjuvant Therapy|Protocol Violation|1
1220751|NCT00789581|4005701|P1|Adjuvant Therapy|Protocol Violation|1
1220752|NCT00789581|4005700|P2|Adjuvant Therapy|Intercurrent Illness|3
1220753|NCT00789581|4005701|P1|Adjuvant Therapy|Intercurrent Illness|1
1220754|NCT00789581|4005700|P2|Adjuvant Therapy|Disease recurrence|1
1220755|NCT00789581|4005701|P1|Adjuvant Therapy|Disease recurrence|2
1220756|NCT00789581|4005700|P2|Adjuvant Therapy|Withdrawal by Subject|5
1220757|NCT00789581|4005701|P1|Adjuvant Therapy|Withdrawal by Subject|14
1220758|NCT00789581|4005700|P2|Adjuvant Therapy|Adverse Event|44
1220759|NCT00789581|4005701|P1|Adjuvant Therapy|Adverse Event|20
1220760|NCT00789581|4005700|P2|Adjuvant Therapy|Never treated|2
1220761|NCT00789581|4005701|P1|Adjuvant Therapy|Never treated|2
1220762|NCT00789581|4005700|P2|AC Therapy|Not specified|2
1220763|NCT00789581|4005701|P1|AC Therapy|Not specified|0
1220764|NCT00789581|4005700|P2|AC Therapy|Never Treated|4
1220765|NCT00789581|4005701|P1|AC Therapy|Never Treated|1
1220766|NCT00789581|4005700|P2|AC Therapy|Intercurrent Illness|0
1220767|NCT00789581|4005701|P1|AC Therapy|Intercurrent Illness|1
1220768|NCT00789581|4005700|P2|AC Therapy|Disease recurrence|1
1220769|NCT00789581|4005701|P1|AC Therapy|Disease recurrence|3
1220770|NCT00789581|4005700|P2|AC Therapy|Withdrawal by Subject|7
1220771|NCT00789581|4005701|P1|AC Therapy|Withdrawal by Subject|4
1220772|NCT00789581|4005700|P2|AC Therapy|Adverse Event|3
1220773|NCT00789581|4005701|P1|AC Therapy|Adverse Event|2
1220774|NCT00789555|4005712|P3|Overall Study|Protocol Violation|13
1220775|NCT00789555|4005713|P2|Overall Study|Protocol Violation|9
1220776|NCT00789555|4005714|P1|Overall Study|Protocol Violation|6
1220777|NCT00789555|4005712|P3|Overall Study|Treatment failure|12
1220778|NCT00789555|4005713|P2|Overall Study|Treatment failure|8
1220779|NCT00789555|4005714|P1|Overall Study|Treatment failure|11
1220780|NCT00789555|4005712|P3|Overall Study|Patient decision unnrelated to adv event|26
1220781|NCT00789555|4005713|P2|Overall Study|Patient decision unnrelated to adv event|29
1220782|NCT00789555|4005714|P1|Overall Study|Patient decision unnrelated to adv event|38
1220783|NCT00789555|4005712|P3|Overall Study|Lost to Follow-up|18
1220784|NCT00789555|4005713|P2|Overall Study|Lost to Follow-up|10
1220785|NCT00789555|4005714|P1|Overall Study|Lost to Follow-up|9
1220786|NCT00789555|4005712|P3|Overall Study|Adverse Event|10
1220787|NCT00789555|4005713|P2|Overall Study|Adverse Event|7
1220788|NCT00789555|4005714|P1|Overall Study|Adverse Event|17
1220789|NCT00789555|4005712|P3|Overall Study|Protocol Amendment|80
1220790|NCT00789555|4005713|P2|Overall Study|Protocol Amendment|76
1220791|NCT00789555|4005714|P1|Overall Study|Protocol Amendment|78
1220792|NCT00789529|4005739|P2|Overall Study|Other Reason|0
1220793|NCT00789529|4005740|P1|Overall Study|Other Reason|1
1220794|NCT00789529|4005739|P2|Overall Study|Withdrawal by Subject|1
1220795|NCT00789529|4005740|P1|Overall Study|Withdrawal by Subject|0
1220796|NCT00789477|4005753|P5|Overall Study|Other|0
1220797|NCT00789477|4005754|P4|Overall Study|Other|3
1220798|NCT00789477|4005755|P3|Overall Study|Other|1
1220799|NCT00789477|4005756|P2|Overall Study|Other|0
1220800|NCT00789477|4005757|P1|Overall Study|Other|2
1220801|NCT00789477|4005753|P5|Overall Study|Lack of Efficacy|0
1220802|NCT00789477|4005754|P4|Overall Study|Lack of Efficacy|0
1220803|NCT00789477|4005755|P3|Overall Study|Lack of Efficacy|0
1220804|NCT00789477|4005756|P2|Overall Study|Lack of Efficacy|0
1220805|NCT00789477|4005757|P1|Overall Study|Lack of Efficacy|2
1220806|NCT00789477|4005753|P5|Overall Study|Lost to Follow-up|4
1220807|NCT00789477|4005754|P4|Overall Study|Lost to Follow-up|2
1220808|NCT00789477|4005755|P3|Overall Study|Lost to Follow-up|4
1220809|NCT00789477|4005756|P2|Overall Study|Lost to Follow-up|1
1220810|NCT00789477|4005757|P1|Overall Study|Lost to Follow-up|0
1220811|NCT00789477|4005753|P5|Overall Study|Death|0
1220812|NCT00789477|4005754|P4|Overall Study|Death|2
1220813|NCT00789477|4005755|P3|Overall Study|Death|2
1220814|NCT00789477|4005756|P2|Overall Study|Death|1
1220815|NCT00789477|4005757|P1|Overall Study|Death|1
1220816|NCT00789477|4005753|P5|Overall Study|Adverse Event|0
1220817|NCT00789477|4005754|P4|Overall Study|Adverse Event|0
1220818|NCT00789477|4005755|P3|Overall Study|Adverse Event|1
1220819|NCT00789477|4005756|P2|Overall Study|Adverse Event|3
1220820|NCT00789477|4005757|P1|Overall Study|Adverse Event|3
1220821|NCT00789477|4005753|P5|Overall Study|Protocol Violation|0
1220822|NCT00789477|4005754|P4|Overall Study|Protocol Violation|1
1220823|NCT00789477|4005755|P3|Overall Study|Protocol Violation|0
1220824|NCT00789477|4005756|P2|Overall Study|Protocol Violation|0
1220825|NCT00789477|4005757|P1|Overall Study|Protocol Violation|1
1220826|NCT00789477|4005753|P5|Overall Study|Withdrawal by Subject|3
1220827|NCT00789477|4005754|P4|Overall Study|Withdrawal by Subject|2
1220828|NCT00789477|4005755|P3|Overall Study|Withdrawal by Subject|3
1220829|NCT00789477|4005756|P2|Overall Study|Withdrawal by Subject|1
1220830|NCT00789477|4005757|P1|Overall Study|Withdrawal by Subject|2
1220831|NCT00789373|4005802|P3|Maintenance|Participants On-Going at Data Cut-Off|0
1220832|NCT00789373|4005803|P2|Maintenance|Participants On-Going at Data Cut-Off|4
1220833|NCT00789373|4005804|P1|Maintenance|Participants On-Going at Data Cut-Off|0
1220834|NCT00789373|4005802|P3|Maintenance|Sponsor Decision|2
1220835|NCT00789373|4005803|P2|Maintenance|Sponsor Decision|0
1220836|NCT00789373|4005804|P1|Maintenance|Sponsor Decision|0
1220837|NCT00789373|4005802|P3|Maintenance|Withdrawal by Subject|8
1220838|NCT00789373|4005803|P2|Maintenance|Withdrawal by Subject|21
1220839|NCT00789373|4005804|P1|Maintenance|Withdrawal by Subject|0
1220840|NCT00789373|4005802|P3|Maintenance|Progressive Disease|152
1220841|NCT00789373|4005803|P2|Maintenance|Progressive Disease|253
1220842|NCT00789373|4005804|P1|Maintenance|Progressive Disease|0
1220843|NCT00789373|4005802|P3|Maintenance|Lost to Follow-up|0
1220844|NCT00789373|4005803|P2|Maintenance|Lost to Follow-up|2
1220845|NCT00789373|4005804|P1|Maintenance|Lost to Follow-up|0
1220846|NCT00789373|4005802|P3|Maintenance|Protocol entry criteria not met|0
1220847|NCT00789373|4005803|P2|Maintenance|Protocol entry criteria not met|2
1220848|NCT00789373|4005804|P1|Maintenance|Protocol entry criteria not met|0
1220849|NCT00789373|4005802|P3|Maintenance|Investigator Decision|2
1220850|NCT00789373|4005803|P2|Maintenance|Investigator Decision|4
1220851|NCT00789373|4005804|P1|Maintenance|Investigator Decision|0
1220852|NCT00789373|4005802|P3|Maintenance|Death due to toxicity|2
1220853|NCT00789373|4005803|P2|Maintenance|Death due to toxicity|1
1220854|NCT00789373|4005804|P1|Maintenance|Death due to toxicity|0
1220855|NCT00789373|4005802|P3|Maintenance|Death due to adverse event|1
1220856|NCT00789373|4005803|P2|Maintenance|Death due to adverse event|4
1220857|NCT00789373|4005804|P1|Maintenance|Death due to adverse event|0
1220858|NCT00789373|4005802|P3|Maintenance|Death due to study disease|1
1220859|NCT00789373|4005803|P2|Maintenance|Death due to study disease|3
1220860|NCT00789373|4005804|P1|Maintenance|Death due to study disease|0
1220861|NCT00789373|4005802|P3|Maintenance|Adverse Event|12
1220862|NCT00789373|4005803|P2|Maintenance|Adverse Event|65
1220863|NCT00789373|4005804|P1|Maintenance|Adverse Event|0
1220864|NCT00789373|4005802|P3|Induction|Withdrawal by Subject|0
1220865|NCT00789373|4005803|P2|Induction|Withdrawal by Subject|0
1220866|NCT00789373|4005804|P1|Induction|Withdrawal by Subject|37
1220867|NCT00789373|4005802|P3|Induction|Progressive Disease|0
1220868|NCT00789373|4005803|P2|Induction|Progressive Disease|0
1220869|NCT00789373|4005804|P1|Induction|Progressive Disease|220
1220870|NCT00789373|4005802|P3|Induction|Protocol Violation|0
1220871|NCT00789373|4005803|P2|Induction|Protocol Violation|0
1220872|NCT00789373|4005804|P1|Induction|Protocol Violation|1
1220873|NCT00789373|4005802|P3|Induction|Lost to Follow-up|0
1220874|NCT00789373|4005803|P2|Induction|Lost to Follow-up|0
1220875|NCT00789373|4005804|P1|Induction|Lost to Follow-up|6
1220876|NCT00789373|4005802|P3|Induction|Protocol entry criteria not met|0
1220877|NCT00789373|4005803|P2|Induction|Protocol entry criteria not met|0
1220878|NCT00789373|4005804|P1|Induction|Protocol entry criteria not met|9
1220879|NCT00789373|4005802|P3|Induction|Investigator decision|0
1220880|NCT00789373|4005803|P2|Induction|Investigator decision|0
1220881|NCT00789373|4005804|P1|Induction|Investigator decision|7
1220882|NCT00789373|4005802|P3|Induction|Death due to procedure|0
1220883|NCT00789373|4005803|P2|Induction|Death due to procedure|0
1220884|NCT00789373|4005804|P1|Induction|Death due to procedure|1
1220885|NCT00789373|4005802|P3|Induction|Death due to toxicity|0
1220886|NCT00789373|4005803|P2|Induction|Death due to toxicity|0
1220887|NCT00789373|4005804|P1|Induction|Death due to toxicity|11
1220888|NCT00789373|4005802|P3|Induction|Death due to adverse event|0
1220889|NCT00789373|4005803|P2|Induction|Death due to adverse event|0
1220890|NCT00789373|4005804|P1|Induction|Death due to adverse event|19
1220891|NCT00789373|4005802|P3|Induction|Death Due to study disease|0
1220892|NCT00789373|4005803|P2|Induction|Death Due to study disease|0
1220893|NCT00789373|4005804|P1|Induction|Death Due to study disease|24
1220894|NCT00789373|4005802|P3|Induction|Adverse Event|0
1220895|NCT00789373|4005803|P2|Induction|Adverse Event|0
1220896|NCT00789373|4005804|P1|Induction|Adverse Event|64
1220897|NCT00789321|4005831|P2|Overall Study|Adverse Event|1
1220898|NCT00789321|4005832|P1|Overall Study|Adverse Event|0
1220899|NCT00789191|4005854|P2|Overall Study|Unclassified|3
1220900|NCT00789191|4005855|P1|Overall Study|Unclassified|5
1220901|NCT00789191|4005854|P2|Overall Study|Withdrawal Criteria|4
1220902|NCT00789191|4005855|P1|Overall Study|Withdrawal Criteria|2
1220903|NCT00789191|4005854|P2|Overall Study|Protocol Violation|3
1220904|NCT00789191|4005855|P1|Overall Study|Protocol Violation|5
1220905|NCT00789191|4005854|P2|Overall Study|Lack of Efficacy|5
1220906|NCT00789191|4005855|P1|Overall Study|Lack of Efficacy|0
1220907|NCT00789191|4005854|P2|Overall Study|Adverse Event|4
1220908|NCT00789191|4005855|P1|Overall Study|Adverse Event|2
1220909|NCT00789035|4005912|P5|Overall Study|Other reason not defined above|1
1220910|NCT00789035|4005913|P4|Overall Study|Other reason not defined above|0
1220911|NCT00789035|4005914|P3|Overall Study|Other reason not defined above|1
1220912|NCT00789035|4005915|P2|Overall Study|Other reason not defined above|3
1220913|NCT00789035|4005916|P1|Overall Study|Other reason not defined above|2
1220914|NCT00789035|4005912|P5|Overall Study|Withdrawal by Subject|0
1220915|NCT00789035|4005913|P4|Overall Study|Withdrawal by Subject|0
1220916|NCT00789035|4005914|P3|Overall Study|Withdrawal by Subject|0
1220917|NCT00789035|4005915|P2|Overall Study|Withdrawal by Subject|2
1220918|NCT00789035|4005916|P1|Overall Study|Withdrawal by Subject|0
1220919|NCT00789035|4005912|P5|Overall Study|Protocol Violation|0
1220920|NCT00789035|4005913|P4|Overall Study|Protocol Violation|0
1220921|NCT00789035|4005914|P3|Overall Study|Protocol Violation|0
1220922|NCT00789035|4005915|P2|Overall Study|Protocol Violation|0
1220923|NCT00789035|4005916|P1|Overall Study|Protocol Violation|1
1220924|NCT00789035|4005912|P5|Overall Study|Lack of Efficacy|2
1220925|NCT00789035|4005913|P4|Overall Study|Lack of Efficacy|0
1220926|NCT00789035|4005914|P3|Overall Study|Lack of Efficacy|0
1220927|NCT00789035|4005915|P2|Overall Study|Lack of Efficacy|0
1220928|NCT00789035|4005916|P1|Overall Study|Lack of Efficacy|3
1220929|NCT00789035|4005912|P5|Overall Study|Adverse Event|3
1220930|NCT00789035|4005913|P4|Overall Study|Adverse Event|1
1220931|NCT00789035|4005914|P3|Overall Study|Adverse Event|0
1220932|NCT00789035|4005915|P2|Overall Study|Adverse Event|2
1220933|NCT00789035|4005916|P1|Overall Study|Adverse Event|0
1220934|NCT00788957|4005975|P6|Part 3|On-study at time of data cut-off|0
1220935|NCT00788957|4005976|P5|Part 3|On-study at time of data cut-off|1
1220936|NCT00788957|4005977|P4|Part 3|On-study at time of data cut-off|0
1220937|NCT00788957|4005978|P3|Part 3|On-study at time of data cut-off|0
1220938|NCT00788957|4005979|P2|Part 3|On-study at time of data cut-off|0
1220939|NCT00788957|4005980|P1|Part 3|On-study at time of data cut-off|0
1220940|NCT00788957|4005975|P6|Part 3|Death|9
1220941|NCT00788957|4005976|P5|Part 3|Death|8
1220942|NCT00788957|4005977|P4|Part 3|Death|0
1220943|NCT00788957|4005978|P3|Part 3|Death|0
1220944|NCT00788957|4005979|P2|Part 3|Death|0
1220945|NCT00788957|4005980|P1|Part 3|Death|0
1220946|NCT00788957|4005975|P6|Part 3|Withdrawal by Subject|2
1220947|NCT00788957|4005976|P5|Part 3|Withdrawal by Subject|0
1220948|NCT00788957|4005977|P4|Part 3|Withdrawal by Subject|0
1220949|NCT00788957|4005978|P3|Part 3|Withdrawal by Subject|0
1220950|NCT00788957|4005979|P2|Part 3|Withdrawal by Subject|0
1220951|NCT00788957|4005980|P1|Part 3|Withdrawal by Subject|0
1220952|NCT00788957|4005975|P6|Part 2|On-study at time of data cut-off|0
1220953|NCT00788957|4005976|P5|Part 2|On-study at time of data cut-off|0
1220954|NCT00788957|4005977|P4|Part 2|On-study at time of data cut-off|1
1220955|NCT00788957|4005978|P3|Part 2|On-study at time of data cut-off|1
1220956|NCT00788957|4005979|P2|Part 2|On-study at time of data cut-off|1
1220957|NCT00788957|4005980|P1|Part 2|On-study at time of data cut-off|0
1220958|NCT00788957|4005975|P6|Part 2|Lost to Follow-up|0
1220959|NCT00788957|4005976|P5|Part 2|Lost to Follow-up|0
1220960|NCT00788957|4005977|P4|Part 2|Lost to Follow-up|0
1220961|NCT00788957|4005978|P3|Part 2|Lost to Follow-up|3
1220962|NCT00788957|4005979|P2|Part 2|Lost to Follow-up|0
1220963|NCT00788957|4005980|P1|Part 2|Lost to Follow-up|0
1220964|NCT00788957|4005975|P6|Part 2|Death|0
1220965|NCT00788957|4005976|P5|Part 2|Death|0
1220966|NCT00788957|4005977|P4|Part 2|Death|37
1220967|NCT00788957|4005978|P3|Part 2|Death|35
1220968|NCT00788957|4005979|P2|Part 2|Death|32
1220969|NCT00788957|4005980|P1|Part 2|Death|0
1220970|NCT00788957|4005975|P6|Part 2|Withdrawal by Subject|0
1220971|NCT00788957|4005976|P5|Part 2|Withdrawal by Subject|0
1220972|NCT00788957|4005977|P4|Part 2|Withdrawal by Subject|3
1220973|NCT00788957|4005978|P3|Part 2|Withdrawal by Subject|5
1220974|NCT00788957|4005979|P2|Part 2|Withdrawal by Subject|9
1220975|NCT00788957|4005980|P1|Part 2|Withdrawal by Subject|0
1220976|NCT00788957|4005975|P6|Part 1|Lost to Follow-up|0
1220977|NCT00788957|4005976|P5|Part 1|Lost to Follow-up|0
1220978|NCT00788957|4005977|P4|Part 1|Lost to Follow-up|0
1220979|NCT00788957|4005978|P3|Part 1|Lost to Follow-up|0
1220980|NCT00788957|4005979|P2|Part 1|Lost to Follow-up|0
1220981|NCT00788957|4005980|P1|Part 1|Lost to Follow-up|1
1220982|NCT00788957|4005975|P6|Part 1|Death|0
1220983|NCT00788957|4005976|P5|Part 1|Death|0
1220984|NCT00788957|4005977|P4|Part 1|Death|0
1220985|NCT00788957|4005978|P3|Part 1|Death|0
1220986|NCT00788957|4005979|P2|Part 1|Death|0
1220987|NCT00788957|4005980|P1|Part 1|Death|8
1220988|NCT00788775|4006055|P2|Overall Study|Patient's measurable disease resected.|0
1220989|NCT00788775|4006056|P1|Overall Study|Patient's measurable disease resected.|1
1220990|NCT00788775|4006055|P2|Overall Study|Patient Non-Compliance|0
1220991|NCT00788775|4006056|P1|Overall Study|Patient Non-Compliance|1
1220992|NCT00788775|4006055|P2|Overall Study|Withdrawal by Subject|2
1220993|NCT00788775|4006056|P1|Overall Study|Withdrawal by Subject|0
1220994|NCT00788775|4006055|P2|Overall Study|Progressive Disease|6
1220995|NCT00788775|4006056|P1|Overall Study|Progressive Disease|8
1220996|NCT00788710|4006071|P3|Overall Study|Withdrawal by Subject|0
1220997|NCT00788710|4006072|P2|Overall Study|Withdrawal by Subject|2
1220998|NCT00788710|4006073|P1|Overall Study|Withdrawal by Subject|2
1220999|NCT00788710|4006071|P3|Overall Study|Protocol Violation|1
1221000|NCT00788710|4006072|P2|Overall Study|Protocol Violation|1
1221001|NCT00788710|4006073|P1|Overall Study|Protocol Violation|0
1221002|NCT00788710|4006071|P3|Overall Study|Physician Decision|0
1221003|NCT00788710|4006072|P2|Overall Study|Physician Decision|1
1221004|NCT00788710|4006073|P1|Overall Study|Physician Decision|2
1221005|NCT00788710|4006071|P3|Overall Study|Lost to Follow-up|0
1221006|NCT00788710|4006072|P2|Overall Study|Lost to Follow-up|1
1221007|NCT00788710|4006073|P1|Overall Study|Lost to Follow-up|0
1221008|NCT00788710|4006071|P3|Overall Study|Lack of Efficacy|1
1221009|NCT00788710|4006072|P2|Overall Study|Lack of Efficacy|0
1221010|NCT00788710|4006073|P1|Overall Study|Lack of Efficacy|0
1221011|NCT00788710|4006071|P3|Overall Study|Adverse Event|4
1221012|NCT00788710|4006072|P2|Overall Study|Adverse Event|3
1221013|NCT00788710|4006073|P1|Overall Study|Adverse Event|1
1221014|NCT00788697|4006087|P1|Overall Study|Indeterminate diagnosis from truth stand|17
1221015|NCT00788697|4006087|P1|Overall Study|Technically inadequate truth standard|1
1221016|NCT00788697|4006087|P1|Overall Study|no truth standard procedure available|5
1221017|NCT00788697|4006087|P1|Overall Study|Training Patients|74
1221018|NCT00788697|4006087|P1|Overall Study|No study drug administered|12
1221019|NCT00788593|4006134|P3|Second Intervention Period|Other|1
1221020|NCT00788593|4006135|P2|Second Intervention Period|Other|0
1221021|NCT00788593|4006136|P1|Second Intervention Period|Other|0
1221022|NCT00788593|4006134|P3|Second Intervention Period|Lost to Follow-up|0
1221023|NCT00788593|4006135|P2|Second Intervention Period|Lost to Follow-up|1
1221024|NCT00788593|4006136|P1|Second Intervention Period|Lost to Follow-up|0
1221025|NCT00788593|4006134|P3|First Intervention Period|Adverse Event|0
1221026|NCT00788593|4006135|P2|First Intervention Period|Adverse Event|1
1221027|NCT00788593|4006136|P1|First Intervention Period|Adverse Event|0
1221028|NCT00788593|4006134|P3|Placebo Run-in Phase|Protocol Violation|0
1221029|NCT00788593|4006135|P2|Placebo Run-in Phase|Protocol Violation|0
1221030|NCT00788593|4006136|P1|Placebo Run-in Phase|Protocol Violation|2
1221031|NCT00788593|4006134|P3|Placebo Run-in Phase|Withdrawal by Subject|0
1221032|NCT00788593|4006135|P2|Placebo Run-in Phase|Withdrawal by Subject|0
1221033|NCT00788593|4006136|P1|Placebo Run-in Phase|Withdrawal by Subject|2
1221034|NCT00788593|4006134|P3|Placebo Run-in Phase|Adverse Event|0
1221035|NCT00788593|4006135|P2|Placebo Run-in Phase|Adverse Event|0
1221036|NCT00788593|4006136|P1|Placebo Run-in Phase|Adverse Event|2
1221037|NCT00788372|4006153|P1|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1
1221038|NCT00788372|4006153|P1|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9
1221039|NCT00788372|4006153|P1|Period 2 (Week 4 to Week 52)|Physician Decision|9
1221040|NCT00788372|4006153|P1|Period 2 (Week 4 to Week 52)|Adverse Event|13
1221041|NCT00788372|4006153|P1|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4
1221042|NCT00788372|4006153|P1|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9
1221043|NCT00788372|4006153|P1|Period 1 (up to 4 Weeks)|Adverse Event|18
1221044|NCT00788073|4006182|P2|Placebo Then STX209|Protocol Violation|1
1221045|NCT00788073|4006183|P1|Placebo Then STX209|Protocol Violation|0
1221046|NCT00788073|4006182|P2|Placebo Then STX209|Adverse Event|0
1221047|NCT00788073|4006183|P1|Placebo Then STX209|Adverse Event|2
1221048|NCT00788073|4006182|P2|STX209 Then Placebo|unable to return due to travel|1
1221049|NCT00788073|4006183|P1|STX209 Then Placebo|unable to return due to travel|0
1221050|NCT00788073|4006182|P2|STX209 Then Placebo|Withdrawal by Subject|1
1221051|NCT00788073|4006183|P1|STX209 Then Placebo|Withdrawal by Subject|0
1221052|NCT00788073|4006182|P2|STX209 Then Placebo|Lost to Follow-up|1
1221053|NCT00788073|4006183|P1|STX209 Then Placebo|Lost to Follow-up|0
1221054|NCT00788073|4006182|P2|STX209 Then Placebo|Adverse Event|0
1221055|NCT00788073|4006183|P1|STX209 Then Placebo|Adverse Event|1
1221056|NCT00787930|4006208|P1|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3
1221057|NCT00787917|4006223|P2|Open Label|Administrative problems|0
1221058|NCT00787917|4006224|P1|Open Label|Administrative problems|3
1221059|NCT00787917|4006223|P2|Open Label|Unsatisfactory therapeutic effect|0
1221060|NCT00787917|4006224|P1|Open Label|Unsatisfactory therapeutic effect|1
1221061|NCT00787917|4006223|P2|Blinded Treatment|Administrative problems|2
1221062|NCT00787917|4006224|P1|Blinded Treatment|Administrative problems|3
1221063|NCT00787917|4006223|P2|Blinded Treatment|Lack of Efficacy|0
1221064|NCT00787917|4006224|P1|Blinded Treatment|Lack of Efficacy|1
1221065|NCT00787917|4006223|P2|Blinded Treatment|Adverse Event|0
1221066|NCT00787917|4006224|P1|Blinded Treatment|Adverse Event|1
1221067|NCT00787891|4006254|P2|Maintenance Double-blind Phase (Part 2)|Not specified|2
1221068|NCT00787891|4006255|P1|Maintenance Double-blind Phase (Part 2)|Not specified|5
1221069|NCT00787891|4006254|P2|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3
1221070|NCT00787891|4006255|P1|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1
1221071|NCT00787891|4006254|P2|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
1221072|NCT00787891|4006255|P1|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
1221073|NCT00787891|4006254|P2|Maintenance Double-blind Phase (Part 2)|Adverse Event|1
1221074|NCT00787891|4006255|P1|Maintenance Double-blind Phase (Part 2)|Adverse Event|0
1221075|NCT00787891|4006254|P2|Short-term Double-blind Phase (Part 1)|Not specified|2
1221076|NCT00787891|4006255|P1|Short-term Double-blind Phase (Part 1)|Not specified|0
1221077|NCT00787891|4006254|P2|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2
1221078|NCT00787891|4006255|P1|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6
1221079|NCT00787891|4006254|P2|Short-term Double-blind Phase (Part 1)|Physician Decision|0
1221080|NCT00787891|4006255|P1|Short-term Double-blind Phase (Part 1)|Physician Decision|1
1221081|NCT00787891|4006254|P2|Short-term Double-blind Phase (Part 1)|Protocol Violation|1
1221082|NCT00787891|4006255|P1|Short-term Double-blind Phase (Part 1)|Protocol Violation|0
1221083|NCT00787891|4006254|P2|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
1221084|NCT00787891|4006255|P1|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
1221085|NCT00787891|4006254|P2|Short-term Double-blind Phase (Part 1)|Adverse Event|2
1221086|NCT00787891|4006255|P1|Short-term Double-blind Phase (Part 1)|Adverse Event|1
1221087|NCT00787839|4006282|P1|Overall Study|Failure to have the OGTT was most common|404
1221088|NCT00787800|4006305|P2|Overall Study|Death|2
1221089|NCT00787800|4006306|P1|Overall Study|Death|0
1221090|NCT00787800|4006305|P2|Overall Study|Withdrawal by Subject|5
1221091|NCT00787800|4006306|P1|Overall Study|Withdrawal by Subject|3
1221092|NCT00787787|4006322|P1|Overall Study|Adverse Event|3
1221093|NCT00787787|4006322|P1|Overall Study|Lack of Efficacy|4
1221094|NCT00787644|4006341|P2|Overall Study|Withdrawal by Subject|1
1221095|NCT00787644|4006342|P1|Overall Study|Withdrawal by Subject|1
1221096|NCT00787644|4006341|P2|Overall Study|Lost to Follow-up|1
1221097|NCT00787644|4006342|P1|Overall Study|Lost to Follow-up|1
1221098|NCT00787605|4006363|P2|Overall Study|Lack of Efficacy|9
1221099|NCT00787605|4006364|P1|Overall Study|Lack of Efficacy|13
1221100|NCT00787605|4006363|P2|Overall Study|Withdrawal by Subject|13
1221101|NCT00787605|4006364|P1|Overall Study|Withdrawal by Subject|6
1221102|NCT00787605|4006363|P2|Overall Study|Protocol Violation|3
1221103|NCT00787605|4006364|P1|Overall Study|Protocol Violation|7
1221104|NCT00787605|4006363|P2|Overall Study|Lost to Follow-up|6
1221105|NCT00787605|4006364|P1|Overall Study|Lost to Follow-up|3
1221106|NCT00787605|4006363|P2|Overall Study|Adverse Event|25
1221107|NCT00787605|4006364|P1|Overall Study|Adverse Event|14
1221108|NCT00787605|4006363|P2|Overall Study|Administrative Problems|0
1221109|NCT00787605|4006364|P1|Overall Study|Administrative Problems|3
1221110|NCT00787566|4006383|P3|Overall Study|AE related to chemotherapy|0
1221111|NCT00787566|4006384|P2|Overall Study|AE related to chemotherapy|1
1221112|NCT00787566|4006385|P1|Overall Study|AE related to chemotherapy|0
1221113|NCT00787527|4006393|P1|Overall Study|Toxicity|3
1221114|NCT00787319|4006410|P1|Overall Study|Inactive disease|5
1221115|NCT00787319|4006410|P1|Overall Study|Stabilized disease findings|3
1221116|NCT00787319|4006410|P1|Overall Study|No health insurance reimbursement|2
1221117|NCT00787319|4006410|P1|Overall Study|Unresponsiveness to visit invitation|1
1221118|NCT00787319|4006410|P1|Overall Study|Budget exhausted/exceeded|1
1221119|NCT00787319|4006410|P1|Overall Study|Lack of Efficacy|1
1221120|NCT00787319|4006410|P1|Overall Study|Objective progression or relapse|30
1221121|NCT00787319|4006410|P1|Overall Study|Adverse Event|3
1221122|NCT00787319|4006410|P1|Overall Study|Withdrawal by Subject|15
1221123|NCT00787319|4006410|P1|Overall Study|Lost to Follow-up|2
1221124|NCT00787267|4006422|P1|Overall Study|Withdrawal by Subject|1
1221125|NCT00787267|4006422|P1|Overall Study|No Reason Provided|1
1221126|NCT00787267|4006422|P1|Overall Study|Screen failure/Ineligible|10
1221127|NCT00787254|4006432|P2|Overall Study|Physician Decision|8
1221128|NCT00787254|4006433|P1|Overall Study|Physician Decision|4
1221129|NCT00787254|4006432|P2|Overall Study|Institution closed|0
1221130|NCT00787254|4006433|P1|Overall Study|Institution closed|1
1221131|NCT00787254|4006432|P2|Overall Study|NSAIDs discontinuation|2
1221132|NCT00787254|4006433|P1|Overall Study|NSAIDs discontinuation|1
1221133|NCT00787254|4006432|P2|Overall Study|Lack of Efficacy|15
1221134|NCT00787254|4006433|P1|Overall Study|Lack of Efficacy|4
1221135|NCT00787254|4006432|P2|Overall Study|Withdrawal by Subject|11
1221136|NCT00787254|4006433|P1|Overall Study|Withdrawal by Subject|16
1221137|NCT00787254|4006432|P2|Overall Study|Protocol Violation|23
1221138|NCT00787254|4006433|P1|Overall Study|Protocol Violation|26
1221139|NCT00787254|4006432|P2|Overall Study|Adverse Event|23
1221140|NCT00787254|4006433|P1|Overall Study|Adverse Event|24
1221141|NCT00787202|4006557|P5|Overall Study|Randomized, not treated|0
1221142|NCT00787202|4006558|P4|Overall Study|Randomized, not treated|0
1221143|NCT00787202|4006559|P3|Overall Study|Randomized, not treated|0
1221144|NCT00787202|4006560|P2|Overall Study|Randomized, not treated|0
1221145|NCT00787202|4006561|P1|Overall Study|Randomized, not treated|1
1221146|NCT00787202|4006557|P5|Overall Study|Protocol Violation|1
1221147|NCT00787202|4006558|P4|Overall Study|Protocol Violation|0
1221148|NCT00787202|4006559|P3|Overall Study|Protocol Violation|0
1221149|NCT00787202|4006560|P2|Overall Study|Protocol Violation|1
1221150|NCT00787202|4006561|P1|Overall Study|Protocol Violation|2
1221151|NCT00787202|4006557|P5|Overall Study|Withdrawal by Subject|0
1221152|NCT00787202|4006558|P4|Overall Study|Withdrawal by Subject|0
1221153|NCT00787202|4006559|P3|Overall Study|Withdrawal by Subject|2
1221154|NCT00787202|4006560|P2|Overall Study|Withdrawal by Subject|2
1221155|NCT00787202|4006561|P1|Overall Study|Withdrawal by Subject|2
1221156|NCT00787202|4006557|P5|Overall Study|Lost to Follow-up|0
1221157|NCT00787202|4006558|P4|Overall Study|Lost to Follow-up|0
1221158|NCT00787202|4006559|P3|Overall Study|Lost to Follow-up|0
1221159|NCT00787202|4006560|P2|Overall Study|Lost to Follow-up|0
1221160|NCT00787202|4006561|P1|Overall Study|Lost to Follow-up|1
1221161|NCT00787202|4006557|P5|Overall Study|Lack of Efficacy|1
1221162|NCT00787202|4006558|P4|Overall Study|Lack of Efficacy|2
1221163|NCT00787202|4006559|P3|Overall Study|Lack of Efficacy|5
1221164|NCT00787202|4006560|P2|Overall Study|Lack of Efficacy|6
1221165|NCT00787202|4006561|P1|Overall Study|Lack of Efficacy|5
1221166|NCT00787202|4006557|P5|Overall Study|Adverse Event|2
1221167|NCT00787202|4006558|P4|Overall Study|Adverse Event|0
1221168|NCT00787202|4006559|P3|Overall Study|Adverse Event|0
1221169|NCT00787202|4006560|P2|Overall Study|Adverse Event|2
1221170|NCT00787202|4006561|P1|Overall Study|Adverse Event|3
1221171|NCT00787189|4006614|P2|Overall Study|Lost to Follow-up|2
1221172|NCT00787189|4006615|P1|Overall Study|Lost to Follow-up|2
1221173|NCT00787150|4006624|P3|Overall Study|Dosing incorrect study durg|0
1221174|NCT00787150|4006625|P2|Overall Study|Dosing incorrect study durg|0
1221175|NCT00787150|4006626|P1|Overall Study|Dosing incorrect study durg|2
1221176|NCT00787150|4006624|P3|Overall Study|Withdrawal by Subject|0
1221177|NCT00787150|4006625|P2|Overall Study|Withdrawal by Subject|1
1221178|NCT00787150|4006626|P1|Overall Study|Withdrawal by Subject|2
1221179|NCT00787150|4006624|P3|Overall Study|Physician Decision|1
1221180|NCT00787150|4006625|P2|Overall Study|Physician Decision|2
1221181|NCT00787150|4006626|P1|Overall Study|Physician Decision|1
1221182|NCT00787150|4006624|P3|Overall Study|Adverse Event|4
1221183|NCT00787150|4006625|P2|Overall Study|Adverse Event|4
1221184|NCT00787150|4006626|P1|Overall Study|Adverse Event|4
1221185|NCT00787137|4006671|P3|Overall Study|Study Termination|1
1221186|NCT00787137|4006672|P2|Overall Study|Study Termination|0
1221187|NCT00787137|4006673|P1|Overall Study|Study Termination|0
1221188|NCT00786864|4006748|P2|Overall Study|Sustained serious back injury|0
1221189|NCT00786864|4006749|P1|Overall Study|Sustained serious back injury|1
1221190|NCT00786864|4006748|P2|Overall Study|Lost to Follow-up|1
1221191|NCT00786864|4006749|P1|Overall Study|Lost to Follow-up|0
1221192|NCT00786838|4006761|P1|Overall Study|Withdrawal by Subject|4
1221193|NCT00786838|4006761|P1|Overall Study|Progressive disease|31
1221194|NCT00786838|4006761|P1|Overall Study|Adverse Event|6
1221195|NCT00786838|4006761|P1|Overall Study|Death|4
1221196|NCT00786838|4006761|P1|Overall Study|Physician Decision|4
1221197|NCT00786799|4006788|P2|Overall Study|Lost to Follow-up|1
1221198|NCT00786799|4006789|P1|Overall Study|Lost to Follow-up|1
1221199|NCT00786565|4006819|P1|Post Surgery|Adapt AO implanted posterior side up|1
1221200|NCT00786565|4006819|P1|Post Surgery|Abnormal macular pucker|1
1221201|NCT00786565|4006819|P1|Enrollment Prior to Surgery|Protocol Violation|3
1221202|NCT00786565|4006819|P1|Enrollment Prior to Surgery|Site Closed|3
1221203|NCT00786474|4006876|P2|Overall Study|Not Specified|4
1221204|NCT00786474|4006877|P1|Overall Study|Not Specified|4
1221205|NCT00786474|4006876|P2|Overall Study|Physician Decision|1
1221206|NCT00786474|4006877|P1|Overall Study|Physician Decision|2
1221207|NCT00786474|4006876|P2|Overall Study|Lost to Follow-up|3
1221208|NCT00786474|4006877|P1|Overall Study|Lost to Follow-up|3
1221209|NCT00786474|4006876|P2|Overall Study|Withdrawal by Subject|31
1221210|NCT00786474|4006877|P1|Overall Study|Withdrawal by Subject|23
1221211|NCT00786474|4006876|P2|Overall Study|Death|4
1221212|NCT00786474|4006877|P1|Overall Study|Death|5
1221213|NCT00786422|4006889|P1|Follow-up Period|End-of-study done up to 4 days early|2
1221214|NCT00786422|4006889|P1|Follow-up Period|Death|1
1221215|NCT00786422|4006889|P1|Rivaroxaban Treatment|Adverse Event|2
1221216|NCT00786422|4006889|P1|Rivaroxaban Treatment|Non-compliance with study drug treatment|1
1221217|NCT00786422|4006889|P1|Rivaroxaban Treatment|Withdrawal by Subject|1
1221218|NCT00786422|4006889|P1|Rivaroxaban Treatment|Physician Decision|1
1221219|NCT00786422|4006889|P1|Rivaroxaban Treatment|Lack of Efficacy|1
1221220|NCT00786422|4006889|P1|Rivaroxaban Treatment|Final visit earlier than planned|3
1221221|NCT00786422|4006889|P1|Rivaroxaban Treatment|Death|2
1221222|NCT00786409|4006905|P1|Overall Study|Lost to Follow-up|1
1221223|NCT00786409|4006905|P1|Overall Study|Pregnancy|2
1221224|NCT00786409|4006905|P1|Overall Study|Adverse Event|2
1221225|NCT00786409|4006905|P1|Overall Study|Withdrawal by Subject|2
1221226|NCT00786188|4006922|P2|Overall Study|Withdrawal by Subject|0
1221227|NCT00786188|4006923|P1|Overall Study|Withdrawal by Subject|2
1221228|NCT00786188|4006922|P2|Overall Study|Adverse Event|1
1221229|NCT00786188|4006923|P1|Overall Study|Adverse Event|3
1221230|NCT00786032|4006949|P1|Overall Study|Did not complete in the timeframe|6
1221231|NCT00786032|4006949|P1|Overall Study|Withdrawal by Subject|14
1221232|NCT00786032|4006949|P1|Overall Study|Death|4
1221233|NCT00785980|4006970|P1|7 Day Washout Period|Protocol Violation|3
1221234|NCT00785928|4006988|P7|Treatment Phase|Withdrawal by Subject|0
1221235|NCT00785928|4006989|P6|Treatment Phase|Withdrawal by Subject|0
1221236|NCT00785928|4006990|P5|Treatment Phase|Withdrawal by Subject|1
1221237|NCT00785928|4006991|P4|Treatment Phase|Withdrawal by Subject|0
1221238|NCT00785928|4006992|P3|Treatment Phase|Withdrawal by Subject|0
1221239|NCT00785928|4006993|P2|Treatment Phase|Withdrawal by Subject|2
1221240|NCT00785928|4006994|P1|Treatment Phase|Withdrawal by Subject|1
1221241|NCT00785928|4006988|P7|Treatment Phase|Sponsor Decision|1
1221242|NCT00785928|4006989|P6|Treatment Phase|Sponsor Decision|0
1221243|NCT00785928|4006990|P5|Treatment Phase|Sponsor Decision|0
1221244|NCT00785928|4006991|P4|Treatment Phase|Sponsor Decision|0
1221245|NCT00785928|4006992|P3|Treatment Phase|Sponsor Decision|0
1221246|NCT00785928|4006993|P2|Treatment Phase|Sponsor Decision|0
1221247|NCT00785928|4006994|P1|Treatment Phase|Sponsor Decision|1
1221248|NCT00785928|4006988|P7|Treatment Phase|Physician Decision|0
1221249|NCT00785928|4006989|P6|Treatment Phase|Physician Decision|0
1221250|NCT00785928|4006990|P5|Treatment Phase|Physician Decision|1
1221251|NCT00785928|4006991|P4|Treatment Phase|Physician Decision|0
1221252|NCT00785928|4006992|P3|Treatment Phase|Physician Decision|0
1221253|NCT00785928|4006993|P2|Treatment Phase|Physician Decision|0
1221254|NCT00785928|4006994|P1|Treatment Phase|Physician Decision|0
1221255|NCT00785928|4006988|P7|Treatment Phase|Lack of Efficacy|0
1221256|NCT00785928|4006989|P6|Treatment Phase|Lack of Efficacy|0
1221257|NCT00785928|4006990|P5|Treatment Phase|Lack of Efficacy|0
1221258|NCT00785928|4006991|P4|Treatment Phase|Lack of Efficacy|0
1221259|NCT00785928|4006992|P3|Treatment Phase|Lack of Efficacy|1
1221260|NCT00785928|4006993|P2|Treatment Phase|Lack of Efficacy|1
1221261|NCT00785928|4006994|P1|Treatment Phase|Lack of Efficacy|0
1221262|NCT00785928|4006988|P7|Treatment Phase|Inadequate Response|0
1221263|NCT00785928|4006989|P6|Treatment Phase|Inadequate Response|0
1221264|NCT00785928|4006990|P5|Treatment Phase|Inadequate Response|0
1221265|NCT00785928|4006991|P4|Treatment Phase|Inadequate Response|0
1221266|NCT00785928|4006992|P3|Treatment Phase|Inadequate Response|0
1221267|NCT00785928|4006993|P2|Treatment Phase|Inadequate Response|1
1221268|NCT00785928|4006994|P1|Treatment Phase|Inadequate Response|0
1221269|NCT00785928|4006988|P7|Treatment Phase|Adverse Event|2
1221270|NCT00785928|4006989|P6|Treatment Phase|Adverse Event|0
1221271|NCT00785928|4006990|P5|Treatment Phase|Adverse Event|0
1221272|NCT00785928|4006991|P4|Treatment Phase|Adverse Event|0
1221273|NCT00785928|4006992|P3|Treatment Phase|Adverse Event|2
1221274|NCT00785928|4006993|P2|Treatment Phase|Adverse Event|1
1221275|NCT00785928|4006994|P1|Treatment Phase|Adverse Event|1
1221276|NCT00785785|4007141|P2|Optional Extension Phase|Study terminated by sponsor|37
1221277|NCT00785785|4007142|P1|Optional Extension Phase|Study terminated by sponsor|3
1221278|NCT00785785|4007141|P2|Optional Extension Phase|Protocol deviation|2
1221279|NCT00785785|4007142|P1|Optional Extension Phase|Protocol deviation|0
1221280|NCT00785785|4007141|P2|Optional Extension Phase|Disease progression|70
1221281|NCT00785785|4007142|P1|Optional Extension Phase|Disease progression|22
1221282|NCT00785785|4007141|P2|Optional Extension Phase|Death|5
1221283|NCT00785785|4007142|P1|Optional Extension Phase|Death|1
1221284|NCT00785785|4007141|P2|Optional Extension Phase|Administrative problems|0
1221285|NCT00785785|4007142|P1|Optional Extension Phase|Administrative problems|2
1221286|NCT00785785|4007141|P2|Optional Extension Phase|Lost to Follow-up|0
1221287|NCT00785785|4007142|P1|Optional Extension Phase|Lost to Follow-up|1
1221288|NCT00785785|4007141|P2|Optional Extension Phase|Withdrawal by Subject|6
1221289|NCT00785785|4007142|P1|Optional Extension Phase|Withdrawal by Subject|6
1221290|NCT00785785|4007141|P2|Optional Extension Phase|Adverse Event|5
1221291|NCT00785785|4007142|P1|Optional Extension Phase|Adverse Event|4
1221292|NCT00785785|4007141|P2|Core Phase up to 36 Months|Study terminated by sponsor|133
1221293|NCT00785785|4007142|P1|Core Phase up to 36 Months|Study terminated by sponsor|116
1221294|NCT00785785|4007141|P2|Core Phase up to 36 Months|Protocol deviation|6
1221295|NCT00785785|4007142|P1|Core Phase up to 36 Months|Protocol deviation|5
1221296|NCT00785785|4007141|P2|Core Phase up to 36 Months|Disease progression|119
1221297|NCT00785785|4007142|P1|Core Phase up to 36 Months|Disease progression|139
1221298|NCT00785785|4007141|P2|Core Phase up to 36 Months|Death|8
1221299|NCT00785785|4007142|P1|Core Phase up to 36 Months|Death|5
1221300|NCT00785785|4007141|P2|Core Phase up to 36 Months|Administrative problems|3
1221301|NCT00785785|4007142|P1|Core Phase up to 36 Months|Administrative problems|3
1221302|NCT00785785|4007141|P2|Core Phase up to 36 Months|Lost to Follow-up|7
1221303|NCT00785785|4007142|P1|Core Phase up to 36 Months|Lost to Follow-up|3
1221304|NCT00785785|4007141|P2|Core Phase up to 36 Months|Withdrawal by Subject|17
1221305|NCT00785785|4007142|P1|Core Phase up to 36 Months|Withdrawal by Subject|16
1221306|NCT00785785|4007141|P2|Core Phase up to 36 Months|Abnormal test procedure result|2
1221307|NCT00785785|4007142|P1|Core Phase up to 36 Months|Abnormal test procedure result|2
1221308|NCT00785785|4007141|P2|Core Phase up to 36 Months|Abnormal laboratory value|0
1221309|NCT00785785|4007142|P1|Core Phase up to 36 Months|Abnormal laboratory value|1
1221310|NCT00785785|4007141|P2|Core Phase up to 36 Months|Adverse Event|21
1221311|NCT00785785|4007142|P1|Core Phase up to 36 Months|Adverse Event|31
1221312|NCT00785785|4007141|P2|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4
1221313|NCT00785785|4007142|P1|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3
1221314|NCT00785707|4007156|P1|Overall Study|Lost to Follow-up|7
1221315|NCT00785629|4007165|P4|Overall Study|Withdrawal by Subject|2
1221316|NCT00785629|4007166|P3|Overall Study|Withdrawal by Subject|2
1221317|NCT00785629|4007167|P2|Overall Study|Withdrawal by Subject|1
1221318|NCT00785629|4007168|P1|Overall Study|Withdrawal by Subject|0
1221319|NCT00785629|4007165|P4|Overall Study|administrative decision|4
1221320|NCT00785629|4007166|P3|Overall Study|administrative decision|3
1221321|NCT00785629|4007167|P2|Overall Study|administrative decision|1
1221322|NCT00785629|4007168|P1|Overall Study|administrative decision|5
1221323|NCT00785629|4007165|P4|Overall Study|Protocol Violation|5
1221324|NCT00785629|4007166|P3|Overall Study|Protocol Violation|4
1221325|NCT00785629|4007167|P2|Overall Study|Protocol Violation|2
1221326|NCT00785629|4007168|P1|Overall Study|Protocol Violation|1
1221327|NCT00785629|4007165|P4|Overall Study|Adverse Event|5
1221328|NCT00785629|4007166|P3|Overall Study|Adverse Event|1
1221329|NCT00785629|4007167|P2|Overall Study|Adverse Event|1
1221330|NCT00785629|4007168|P1|Overall Study|Adverse Event|2
1221331|NCT00785577|4007181|P5|Study Period 3: 1-Week Washout Phase|Death|1
1221332|NCT00785577|4007182|P4|Study Period 3: 1-Week Washout Phase|Death|0
1221333|NCT00785577|4007183|P3|Study Period 3: 1-Week Washout Phase|Death|0
1221334|NCT00785577|4007184|P2|Study Period 3: 1-Week Washout Phase|Death|0
1221335|NCT00785577|4007185|P1|Study Period 3: 1-Week Washout Phase|Death|0
1221336|NCT00785577|4007181|P5|Study Period 3: 1-Week Washout Phase|Adverse Event|0
1221337|NCT00785577|4007182|P4|Study Period 3: 1-Week Washout Phase|Adverse Event|1
1221338|NCT00785577|4007183|P3|Study Period 3: 1-Week Washout Phase|Adverse Event|0
1221339|NCT00785577|4007184|P2|Study Period 3: 1-Week Washout Phase|Adverse Event|0
1221340|NCT00785577|4007185|P1|Study Period 3: 1-Week Washout Phase|Adverse Event|0
1221341|NCT00785577|4007181|P5|Study Period 2: Therapy Phase|Sponsor Decision|0
1221342|NCT00785577|4007182|P4|Study Period 2: Therapy Phase|Sponsor Decision|1
1221343|NCT00785577|4007183|P3|Study Period 2: Therapy Phase|Sponsor Decision|1
1221344|NCT00785577|4007184|P2|Study Period 2: Therapy Phase|Sponsor Decision|0
1221345|NCT00785577|4007185|P1|Study Period 2: Therapy Phase|Sponsor Decision|1
1221346|NCT00785577|4007181|P5|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
1221347|NCT00785577|4007182|P4|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
1221348|NCT00785577|4007183|P3|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
1221349|NCT00785577|4007184|P2|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
1221350|NCT00785577|4007185|P1|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
1221351|NCT00785577|4007181|P5|Study Period 2: Therapy Phase|Withdrawal by Subject|1
1221352|NCT00785577|4007182|P4|Study Period 2: Therapy Phase|Withdrawal by Subject|0
1221353|NCT00785577|4007183|P3|Study Period 2: Therapy Phase|Withdrawal by Subject|1
1221354|NCT00785577|4007184|P2|Study Period 2: Therapy Phase|Withdrawal by Subject|1
1221355|NCT00785577|4007185|P1|Study Period 2: Therapy Phase|Withdrawal by Subject|2
1221356|NCT00785577|4007181|P5|Study Period 2: Therapy Phase|Protocol Violation|1
1221357|NCT00785577|4007182|P4|Study Period 2: Therapy Phase|Protocol Violation|0
1221358|NCT00785577|4007183|P3|Study Period 2: Therapy Phase|Protocol Violation|1
1221359|NCT00785577|4007184|P2|Study Period 2: Therapy Phase|Protocol Violation|1
1221360|NCT00785577|4007185|P1|Study Period 2: Therapy Phase|Protocol Violation|1
1221361|NCT00785577|4007181|P5|Study Period 2: Therapy Phase|Physician Decision|0
1221362|NCT00785577|4007182|P4|Study Period 2: Therapy Phase|Physician Decision|0
1221363|NCT00785577|4007183|P3|Study Period 2: Therapy Phase|Physician Decision|0
1221364|NCT00785577|4007184|P2|Study Period 2: Therapy Phase|Physician Decision|0
1221365|NCT00785577|4007185|P1|Study Period 2: Therapy Phase|Physician Decision|1
1221366|NCT00785577|4007181|P5|Study Period 2: Therapy Phase|Lost to Follow-up|0
1221367|NCT00785577|4007182|P4|Study Period 2: Therapy Phase|Lost to Follow-up|1
1221368|NCT00785577|4007183|P3|Study Period 2: Therapy Phase|Lost to Follow-up|0
1221369|NCT00785577|4007184|P2|Study Period 2: Therapy Phase|Lost to Follow-up|0
1221370|NCT00785577|4007185|P1|Study Period 2: Therapy Phase|Lost to Follow-up|0
1221371|NCT00785577|4007181|P5|Study Period 2: Therapy Phase|Lack of Efficacy|1
1221372|NCT00785577|4007182|P4|Study Period 2: Therapy Phase|Lack of Efficacy|0
1221373|NCT00785577|4007183|P3|Study Period 2: Therapy Phase|Lack of Efficacy|0
1221374|NCT00785577|4007184|P2|Study Period 2: Therapy Phase|Lack of Efficacy|0
1221375|NCT00785577|4007185|P1|Study Period 2: Therapy Phase|Lack of Efficacy|0
1221376|NCT00785577|4007181|P5|Study Period 2: Therapy Phase|Adverse Event|17
1221377|NCT00785577|4007182|P4|Study Period 2: Therapy Phase|Adverse Event|10
1221378|NCT00785577|4007183|P3|Study Period 2: Therapy Phase|Adverse Event|14
1221379|NCT00785577|4007184|P2|Study Period 2: Therapy Phase|Adverse Event|7
1221380|NCT00785577|4007185|P1|Study Period 2: Therapy Phase|Adverse Event|5
1221381|NCT00785538|4007325|P4|Treatment Period|Withdrawal by Subject|1
1221382|NCT00785538|4007326|P3|Treatment Period|Withdrawal by Subject|0
1221383|NCT00785538|4007327|P2|Treatment Period|Withdrawal by Subject|0
1221384|NCT00785538|4007328|P1|Treatment Period|Withdrawal by Subject|0
1221385|NCT00785538|4007325|P4|Treatment Period|Adverse Event|0
1221386|NCT00785538|4007326|P3|Treatment Period|Adverse Event|2
1221387|NCT00785538|4007327|P2|Treatment Period|Adverse Event|2
1221388|NCT00785538|4007328|P1|Treatment Period|Adverse Event|1
1221389|NCT00785512|4007376|P2|Overall Study|Lack of compliance|1
1221390|NCT00785512|4007377|P1|Overall Study|Lack of compliance|0
1221391|NCT00785512|4007376|P2|Overall Study|Physician Decision|0
1221392|NCT00785512|4007377|P1|Overall Study|Physician Decision|0
1221393|NCT00785512|4007376|P2|Overall Study|IVRS Programing Error|0
1221394|NCT00785512|4007377|P1|Overall Study|IVRS Programing Error|0
1221395|NCT00785512|4007376|P2|Overall Study|Precedure Refused|0
1221396|NCT00785512|4007377|P1|Overall Study|Precedure Refused|0
1221397|NCT00785512|4007376|P2|Overall Study|Lost to Follow-up|0
1221398|NCT00785512|4007377|P1|Overall Study|Lost to Follow-up|3
1221399|NCT00785512|4007376|P2|Overall Study|Withdrawal by Subject|1
1221400|NCT00785512|4007377|P1|Overall Study|Withdrawal by Subject|0
1221401|NCT00785512|4007376|P2|Overall Study|Lack of Efficacy|2
1221402|NCT00785512|4007377|P1|Overall Study|Lack of Efficacy|0
1221403|NCT00785512|4007376|P2|Overall Study|Adverse Event|0
1221404|NCT00785512|4007377|P1|Overall Study|Adverse Event|0
1221405|NCT00785512|4007376|P2|Overall Study|Inclusion/Exclusion not meet|0
1221406|NCT00785512|4007377|P1|Overall Study|Inclusion/Exclusion not meet|0
1221407|NCT00785486|4007386|P1|Midazolam Alone|Withdrawal by Subject|1
1221408|NCT00785356|4007410|P1|Overall Study|Study prematurely terminated|8
1221409|NCT00785291|4007421|P3|Overall Study|Other Medical Reasons|15
1221410|NCT00785291|4007422|P2|Overall Study|Other Medical Reasons|25
1221411|NCT00785291|4007423|P1|Overall Study|Other Medical Reasons|29
1221412|NCT00785291|4007421|P3|Overall Study|Complicating illness|4
1221413|NCT00785291|4007422|P2|Overall Study|Complicating illness|4
1221414|NCT00785291|4007423|P1|Overall Study|Complicating illness|6
1221415|NCT00785291|4007421|P3|Overall Study|Alternative Therapy|7
1221416|NCT00785291|4007422|P2|Overall Study|Alternative Therapy|6
1221417|NCT00785291|4007423|P1|Overall Study|Alternative Therapy|12
1221418|NCT00785291|4007421|P3|Overall Study|Withdrawal by Subject|17
1221419|NCT00785291|4007422|P2|Overall Study|Withdrawal by Subject|36
1221420|NCT00785291|4007423|P1|Overall Study|Withdrawal by Subject|35
1221421|NCT00785291|4007421|P3|Overall Study|Death|3
1221422|NCT00785291|4007422|P2|Overall Study|Death|4
1221423|NCT00785291|4007423|P1|Overall Study|Death|7
1221424|NCT00785291|4007421|P3|Overall Study|Adverse Event|56
1221425|NCT00785291|4007422|P2|Overall Study|Adverse Event|70
1221426|NCT00785291|4007423|P1|Overall Study|Adverse Event|39
1221427|NCT00785291|4007421|P3|Overall Study|Never began treatment|4
1221428|NCT00785291|4007422|P2|Overall Study|Never began treatment|4
1221429|NCT00785291|4007423|P1|Overall Study|Never began treatment|8
1221430|NCT00785213|4007443|P1|Rosiglitazone With Quinine Sulfate|Adverse Event|1
1221431|NCT00785213|4007443|P1|Quinine Sulfate Alone|Adverse Event|4
1221432|NCT00785044|4007454|P1|Overall Study|Withdrawal by Subject|1
1221433|NCT00785044|4007454|P1|Overall Study|Lost to Follow-up|266
1221434|NCT00785044|4007454|P1|Overall Study|Death|77
1221435|NCT00785044|4007454|P1|Overall Study|Dosed at non-participating sites|152
1221436|NCT00784979|4007459|P1|Overall Study|incomplete data|6
1221437|NCT00784927|4007463|P1|Overall Study|Ineligible|1
1221438|NCT00784927|4007463|P1|Overall Study|Protocol Violation|1
1221439|NCT00784927|4007463|P1|Overall Study|Cancel Prior to Initiating Treatment|1
1221440|NCT00784875|4007475|P4|Period D|Lost to Follow-up|1
1221441|NCT00784875|4007476|P3|Period D|Lost to Follow-up|1
1221442|NCT00784875|4007477|P2|Period D|Lost to Follow-up|0
1221443|NCT00784875|4007478|P1|Period D|Lost to Follow-up|1
1221444|NCT00784875|4007475|P4|Period D|Sponsor Decision|0
1221445|NCT00784875|4007476|P3|Period D|Sponsor Decision|1
1221446|NCT00784875|4007477|P2|Period D|Sponsor Decision|1
1221447|NCT00784875|4007478|P1|Period D|Sponsor Decision|1
1221448|NCT00784875|4007475|P4|Period D|Physician Decision|0
1221449|NCT00784875|4007476|P3|Period D|Physician Decision|0
1221450|NCT00784875|4007477|P2|Period D|Physician Decision|1
1221451|NCT00784875|4007478|P1|Period D|Physician Decision|0
1221452|NCT00784875|4007475|P4|Period D|Withdrawal by Subject|0
1221453|NCT00784875|4007476|P3|Period D|Withdrawal by Subject|2
1221454|NCT00784875|4007477|P2|Period D|Withdrawal by Subject|0
1221455|NCT00784875|4007478|P1|Period D|Withdrawal by Subject|2
1221456|NCT00784875|4007475|P4|Period D|Protocol Violation|0
1221457|NCT00784875|4007476|P3|Period D|Protocol Violation|0
1221458|NCT00784875|4007477|P2|Period D|Protocol Violation|0
1221459|NCT00784875|4007478|P1|Period D|Protocol Violation|1
1221460|NCT00784875|4007475|P4|Period D|Adverse Event|0
1221461|NCT00784875|4007476|P3|Period D|Adverse Event|2
1221462|NCT00784875|4007477|P2|Period D|Adverse Event|2
1221463|NCT00784875|4007478|P1|Period D|Adverse Event|0
1221464|NCT00784875|4007475|P4|Period C|Sponsor Decision|2
1221465|NCT00784875|4007476|P3|Period C|Sponsor Decision|4
1221466|NCT00784875|4007477|P2|Period C|Sponsor Decision|5
1221467|NCT00784875|4007478|P1|Period C|Sponsor Decision|5
1221468|NCT00784875|4007475|P4|Period C|Physician Decision|1
1221469|NCT00784875|4007476|P3|Period C|Physician Decision|1
1221470|NCT00784875|4007477|P2|Period C|Physician Decision|0
1221471|NCT00784875|4007478|P1|Period C|Physician Decision|0
1221472|NCT00784875|4007475|P4|Period C|Withdrawal by Subject|0
1221473|NCT00784875|4007476|P3|Period C|Withdrawal by Subject|2
1221474|NCT00784875|4007477|P2|Period C|Withdrawal by Subject|1
1221475|NCT00784875|4007478|P1|Period C|Withdrawal by Subject|1
1221476|NCT00784875|4007475|P4|Period C|Lack of Efficacy|0
1221477|NCT00784875|4007476|P3|Period C|Lack of Efficacy|1
1221478|NCT00784875|4007477|P2|Period C|Lack of Efficacy|0
1221479|NCT00784875|4007478|P1|Period C|Lack of Efficacy|0
1221480|NCT00784875|4007475|P4|Period C|Protocol Violation|2
1221481|NCT00784875|4007476|P3|Period C|Protocol Violation|1
1221482|NCT00784875|4007477|P2|Period C|Protocol Violation|0
1221483|NCT00784875|4007478|P1|Period C|Protocol Violation|0
1221484|NCT00784875|4007475|P4|Period C|Adverse Event|2
1221485|NCT00784875|4007476|P3|Period C|Adverse Event|4
1221486|NCT00784875|4007477|P2|Period C|Adverse Event|0
1221487|NCT00784875|4007478|P1|Period C|Adverse Event|1
1221488|NCT00784875|4007475|P4|Period B - Efficacy Endpoint|Lost to Follow-up|0
1221489|NCT00784875|4007476|P3|Period B - Efficacy Endpoint|Lost to Follow-up|1
1221490|NCT00784875|4007477|P2|Period B - Efficacy Endpoint|Lost to Follow-up|0
1221491|NCT00784875|4007478|P1|Period B - Efficacy Endpoint|Lost to Follow-up|0
1221492|NCT00784875|4007475|P4|Period B - Efficacy Endpoint|Sponsor Decision|12
1221493|NCT00784875|4007476|P3|Period B - Efficacy Endpoint|Sponsor Decision|12
1221494|NCT00784875|4007477|P2|Period B - Efficacy Endpoint|Sponsor Decision|6
1221495|NCT00784875|4007478|P1|Period B - Efficacy Endpoint|Sponsor Decision|9
1221496|NCT00784875|4007475|P4|Period B - Efficacy Endpoint|Physician Decision|0
1221497|NCT00784875|4007476|P3|Period B - Efficacy Endpoint|Physician Decision|1
1221498|NCT00784875|4007477|P2|Period B - Efficacy Endpoint|Physician Decision|0
1221499|NCT00784875|4007478|P1|Period B - Efficacy Endpoint|Physician Decision|0
1221500|NCT00784875|4007475|P4|Period B - Efficacy Endpoint|Withdrawal by Subject|2
1221501|NCT00784875|4007476|P3|Period B - Efficacy Endpoint|Withdrawal by Subject|1
1221502|NCT00784875|4007477|P2|Period B - Efficacy Endpoint|Withdrawal by Subject|1
1221503|NCT00784875|4007478|P1|Period B - Efficacy Endpoint|Withdrawal by Subject|4
1221504|NCT00784875|4007475|P4|Period B - Efficacy Endpoint|Lack of Efficacy|0
1221505|NCT00784875|4007476|P3|Period B - Efficacy Endpoint|Lack of Efficacy|0
1221506|NCT00784875|4007477|P2|Period B - Efficacy Endpoint|Lack of Efficacy|1
1221507|NCT00784875|4007478|P1|Period B - Efficacy Endpoint|Lack of Efficacy|0
1221508|NCT00784875|4007475|P4|Period B - Efficacy Endpoint|Protocol Violation|3
1221509|NCT00784875|4007476|P3|Period B - Efficacy Endpoint|Protocol Violation|2
1221510|NCT00784875|4007477|P2|Period B - Efficacy Endpoint|Protocol Violation|1
1221511|NCT00784875|4007478|P1|Period B - Efficacy Endpoint|Protocol Violation|1
1221512|NCT00784875|4007475|P4|Period B - Efficacy Endpoint|Adverse Event|1
1221513|NCT00784875|4007476|P3|Period B - Efficacy Endpoint|Adverse Event|2
1221514|NCT00784875|4007477|P2|Period B - Efficacy Endpoint|Adverse Event|3
1221515|NCT00784875|4007478|P1|Period B - Efficacy Endpoint|Adverse Event|0
1221516|NCT00784875|4007475|P4|Period B - Efficacy Endpoint|Entry Criteria Not Met|1
1221517|NCT00784875|4007476|P3|Period B - Efficacy Endpoint|Entry Criteria Not Met|2
1221518|NCT00784875|4007477|P2|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
1221519|NCT00784875|4007478|P1|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
1221520|NCT00784875|4007475|P4|Period A - Baseline|Lost to Follow-up|2
1221521|NCT00784875|4007476|P3|Period A - Baseline|Lost to Follow-up|0
1221522|NCT00784875|4007477|P2|Period A - Baseline|Lost to Follow-up|0
1221523|NCT00784875|4007478|P1|Period A - Baseline|Lost to Follow-up|0
1221524|NCT00784875|4007475|P4|Period A - Baseline|Sponsor Decision|113
1221525|NCT00784875|4007476|P3|Period A - Baseline|Sponsor Decision|0
1221526|NCT00784875|4007477|P2|Period A - Baseline|Sponsor Decision|0
1221527|NCT00784875|4007478|P1|Period A - Baseline|Sponsor Decision|0
1221528|NCT00784875|4007475|P4|Period A - Baseline|Physician Decision|2
1221529|NCT00784875|4007476|P3|Period A - Baseline|Physician Decision|0
1221530|NCT00784875|4007477|P2|Period A - Baseline|Physician Decision|0
1221531|NCT00784875|4007478|P1|Period A - Baseline|Physician Decision|0
1221532|NCT00784875|4007475|P4|Period A - Baseline|Withdrawal by Subject|27
1221533|NCT00784875|4007476|P3|Period A - Baseline|Withdrawal by Subject|0
1221534|NCT00784875|4007477|P2|Period A - Baseline|Withdrawal by Subject|0
1221535|NCT00784875|4007478|P1|Period A - Baseline|Withdrawal by Subject|0
1221536|NCT00784875|4007475|P4|Period A - Baseline|Protocol Violation|25
1221537|NCT00784875|4007476|P3|Period A - Baseline|Protocol Violation|0
1221538|NCT00784875|4007477|P2|Period A - Baseline|Protocol Violation|0
1221539|NCT00784875|4007478|P1|Period A - Baseline|Protocol Violation|0
1221540|NCT00784875|4007475|P4|Period A - Baseline|Adverse Event|8
1221541|NCT00784875|4007476|P3|Period A - Baseline|Adverse Event|0
1221542|NCT00784875|4007477|P2|Period A - Baseline|Adverse Event|0
1221543|NCT00784875|4007478|P1|Period A - Baseline|Adverse Event|0
1221544|NCT00784875|4007475|P4|Period A - Baseline|Entry Criteria Not Met|5
1221545|NCT00784875|4007476|P3|Period A - Baseline|Entry Criteria Not Met|0
1221546|NCT00784875|4007477|P2|Period A - Baseline|Entry Criteria Not Met|0
1221547|NCT00784875|4007478|P1|Period A - Baseline|Entry Criteria Not Met|0
1221548|NCT00784836|4007598|P1|Overall Study|Early Study Termination|3
1221549|NCT00784810|4007605|P2|Overall Study|Lost to Follow-up|1
1221550|NCT00784810|4007606|P1|Overall Study|Lost to Follow-up|1
1221551|NCT00784810|4007605|P2|Overall Study|Administrative|8
1221552|NCT00784810|4007606|P1|Overall Study|Administrative|5
1221553|NCT00784810|4007605|P2|Overall Study|Withdrawal by Subject|9
1221554|NCT00784810|4007606|P1|Overall Study|Withdrawal by Subject|11
1221555|NCT00784810|4007605|P2|Overall Study|Lack of Efficacy|11
1221556|NCT00784810|4007606|P1|Overall Study|Lack of Efficacy|14
1221557|NCT00784810|4007605|P2|Overall Study|Adverse Event|20
1221558|NCT00784810|4007606|P1|Overall Study|Adverse Event|32
1221559|NCT00784784|4007616|P2|Overall Study|Withdrawal by Subject|2
1221560|NCT00784784|4007617|P1|Overall Study|Withdrawal by Subject|2
1221561|NCT00784719|4007632|P7|Overall Study|Withdrawal by Subject|1
1221562|NCT00784719|4007633|P6|Overall Study|Withdrawal by Subject|0
1221563|NCT00784719|4007634|P5|Overall Study|Withdrawal by Subject|2
1221564|NCT00784719|4007635|P4|Overall Study|Withdrawal by Subject|0
1221565|NCT00784719|4007636|P3|Overall Study|Withdrawal by Subject|0
1221566|NCT00784719|4007637|P2|Overall Study|Withdrawal by Subject|0
1221567|NCT00784719|4007638|P1|Overall Study|Withdrawal by Subject|1
1221568|NCT00784719|4007632|P7|Overall Study|Other|3
1221569|NCT00784719|4007633|P6|Overall Study|Other|1
1221570|NCT00784719|4007634|P5|Overall Study|Other|2
1221571|NCT00784719|4007635|P4|Overall Study|Other|0
1221572|NCT00784719|4007636|P3|Overall Study|Other|1
1221573|NCT00784719|4007637|P2|Overall Study|Other|1
1221574|NCT00784719|4007638|P1|Overall Study|Other|2
1221575|NCT00784719|4007632|P7|Overall Study|Lost to Follow-up|0
1221576|NCT00784719|4007633|P6|Overall Study|Lost to Follow-up|1
1221577|NCT00784719|4007634|P5|Overall Study|Lost to Follow-up|1
1221578|NCT00784719|4007635|P4|Overall Study|Lost to Follow-up|0
1221579|NCT00784719|4007636|P3|Overall Study|Lost to Follow-up|0
1221580|NCT00784719|4007637|P2|Overall Study|Lost to Follow-up|0
1221581|NCT00784719|4007638|P1|Overall Study|Lost to Follow-up|0
1221582|NCT00784719|4007632|P7|Overall Study|Adverse Event|1
1221583|NCT00784719|4007633|P6|Overall Study|Adverse Event|1
1221584|NCT00784719|4007634|P5|Overall Study|Adverse Event|1
1221585|NCT00784719|4007635|P4|Overall Study|Adverse Event|0
1221586|NCT00784719|4007636|P3|Overall Study|Adverse Event|0
1221587|NCT00784719|4007637|P2|Overall Study|Adverse Event|2
1221588|NCT00784719|4007638|P1|Overall Study|Adverse Event|0
1221589|NCT00784654|4007808|P3|Randomized Withdrawal Period|Family reasons|1
1221590|NCT00784654|4007809|P2|Randomized Withdrawal Period|Family reasons|0
1221591|NCT00784654|4007810|P1|Randomized Withdrawal Period|Family reasons|0
1221592|NCT00784654|4007808|P3|Randomized Withdrawal Period|Did not complete a visit|0
1221593|NCT00784654|4007809|P2|Randomized Withdrawal Period|Did not complete a visit|1
1221594|NCT00784654|4007810|P1|Randomized Withdrawal Period|Did not complete a visit|0
1221595|NCT00784654|4007808|P3|Randomized Withdrawal Period|Adverse Event|1
1221596|NCT00784654|4007809|P2|Randomized Withdrawal Period|Adverse Event|1
1221597|NCT00784654|4007810|P1|Randomized Withdrawal Period|Adverse Event|0
1221598|NCT00784654|4007808|P3|Randomized Withdrawal Period|Protocol Violation|1
1221599|NCT00784654|4007809|P2|Randomized Withdrawal Period|Protocol Violation|2
1221600|NCT00784654|4007810|P1|Randomized Withdrawal Period|Protocol Violation|0
1221601|NCT00784654|4007808|P3|Randomized Withdrawal Period|Withdrawal by Subject|7
1221602|NCT00784654|4007809|P2|Randomized Withdrawal Period|Withdrawal by Subject|1
1221603|NCT00784654|4007810|P1|Randomized Withdrawal Period|Withdrawal by Subject|0
1221604|NCT00784654|4007808|P3|Randomized Withdrawal Period|Lack of Efficacy|18
1221605|NCT00784654|4007809|P2|Randomized Withdrawal Period|Lack of Efficacy|5
1221606|NCT00784654|4007810|P1|Randomized Withdrawal Period|Lack of Efficacy|0
1221607|NCT00784654|4007808|P3|Randomized Withdrawal Period|Met relapse criteria per investigator|35
1221608|NCT00784654|4007809|P2|Randomized Withdrawal Period|Met relapse criteria per investigator|8
1221609|NCT00784654|4007810|P1|Randomized Withdrawal Period|Met relapse criteria per investigator|0
1221610|NCT00784654|4007808|P3|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
1221611|NCT00784654|4007809|P2|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
1221612|NCT00784654|4007810|P1|Open-Label Period (Non-Randomized)|Did not provide end of study page|1
1221613|NCT00784654|4007808|P3|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
1221614|NCT00784654|4007809|P2|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
1221615|NCT00784654|4007810|P1|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1
1221616|NCT00784654|4007808|P3|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
1221617|NCT00784654|4007809|P2|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
1221618|NCT00784654|4007810|P1|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1
1221619|NCT00784654|4007808|P3|Open-Label Period (Non-Randomized)|Home situation intolerable|0
1221620|NCT00784654|4007809|P2|Open-Label Period (Non-Randomized)|Home situation intolerable|0
1221621|NCT00784654|4007810|P1|Open-Label Period (Non-Randomized)|Home situation intolerable|1
1221622|NCT00784654|4007808|P3|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
1221623|NCT00784654|4007809|P2|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
1221624|NCT00784654|4007810|P1|Open-Label Period (Non-Randomized)|Decision of medical monitor|1
1221625|NCT00784654|4007808|P3|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
1221626|NCT00784654|4007809|P2|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
1221627|NCT00784654|4007810|P1|Open-Label Period (Non-Randomized)|Mother is a drug addict|1
1221628|NCT00784654|4007808|P3|Open-Label Period (Non-Randomized)|Protocol Violation|0
1221629|NCT00784654|4007809|P2|Open-Label Period (Non-Randomized)|Protocol Violation|0
1221630|NCT00784654|4007810|P1|Open-Label Period (Non-Randomized)|Protocol Violation|7
1221631|NCT00784654|4007808|P3|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
1221632|NCT00784654|4007809|P2|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
1221633|NCT00784654|4007810|P1|Open-Label Period (Non-Randomized)|Lost to Follow-up|11
1221634|NCT00784654|4007808|P3|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
1221635|NCT00784654|4007809|P2|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
1221636|NCT00784654|4007810|P1|Open-Label Period (Non-Randomized)|Lack of Efficacy|21
1221637|NCT00784654|4007808|P3|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
1221638|NCT00784654|4007809|P2|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
1221639|NCT00784654|4007810|P1|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22
1221640|NCT00784654|4007808|P3|Open-Label Period (Non-Randomized)|Adverse Event|0
1221641|NCT00784654|4007809|P2|Open-Label Period (Non-Randomized)|Adverse Event|0
1221642|NCT00784654|4007810|P1|Open-Label Period (Non-Randomized)|Adverse Event|44
1221643|NCT00784563|4007845|P3|Year 3|Adverse Event|1
1221644|NCT00784563|4007846|P2|Year 3|Adverse Event|0
1221645|NCT00784563|4007847|P1|Year 3|Adverse Event|0
1221646|NCT00784563|4007845|P3|Year 3|Withdrawal by Subject|2
1221647|NCT00784563|4007846|P2|Year 3|Withdrawal by Subject|0
1221648|NCT00784563|4007847|P1|Year 3|Withdrawal by Subject|0
1221649|NCT00784563|4007845|P3|Years 1 & 2|Adverse Event|0
1221650|NCT00784563|4007846|P2|Years 1 & 2|Adverse Event|3
1221651|NCT00784563|4007847|P1|Years 1 & 2|Adverse Event|0
1221652|NCT00784563|4007845|P3|Years 1 & 2|Withdrawal by Subject|0
1221653|NCT00784563|4007846|P2|Years 1 & 2|Withdrawal by Subject|2
1221654|NCT00784563|4007847|P1|Years 1 & 2|Withdrawal by Subject|3
1221655|NCT00784550|4007865|P2|Overall Study|Withdrawal by Subject|13
1221656|NCT00784550|4007866|P1|Overall Study|Withdrawal by Subject|4
1221657|NCT00784550|4007865|P2|Overall Study|Physician Decision|3
1221658|NCT00784550|4007866|P1|Overall Study|Physician Decision|2
1221659|NCT00784550|4007865|P2|Overall Study|Lost to Follow-up|5
1221660|NCT00784550|4007866|P1|Overall Study|Lost to Follow-up|8
1221661|NCT00784550|4007865|P2|Overall Study|Protocol Violation|10
1221662|NCT00784550|4007866|P1|Overall Study|Protocol Violation|10
1221663|NCT00784550|4007865|P2|Overall Study|Lack of Efficacy|1
1221664|NCT00784550|4007866|P1|Overall Study|Lack of Efficacy|0
1221665|NCT00784550|4007865|P2|Overall Study|Adverse Event|10
1221666|NCT00784550|4007866|P1|Overall Study|Adverse Event|12
1221667|NCT00784459|4007884|P2|Overall Study|Adverse Event|2
1221668|NCT00784459|4007885|P1|Overall Study|Adverse Event|0
1221669|NCT00784368|4007896|P3|Overall Study|Withdrawal of informed consent|0
1221670|NCT00784368|4007897|P2|Overall Study|Withdrawal of informed consent|1
1221671|NCT00784368|4007898|P1|Overall Study|Withdrawal of informed consent|0
1221672|NCT00784368|4007896|P3|Overall Study|Worsening of symptoms|0
1221673|NCT00784368|4007897|P2|Overall Study|Worsening of symptoms|1
1221674|NCT00784368|4007898|P1|Overall Study|Worsening of symptoms|0
1221675|NCT00784368|4007896|P3|Overall Study|Worsening of complications|1
1221676|NCT00784368|4007897|P2|Overall Study|Worsening of complications|0
1221677|NCT00784368|4007898|P1|Overall Study|Worsening of complications|0
1221678|NCT00784368|4007896|P3|Overall Study|Diagnosis of fever|1
1221679|NCT00784368|4007897|P2|Overall Study|Diagnosis of fever|0
1221680|NCT00784368|4007898|P1|Overall Study|Diagnosis of fever|0
1221681|NCT00784368|4007896|P3|Overall Study|Adverse Event|2
1221682|NCT00784368|4007897|P2|Overall Study|Adverse Event|9
1221683|NCT00784368|4007898|P1|Overall Study|Adverse Event|6
1221684|NCT00784368|4007896|P3|Overall Study|Lack of Efficacy|1
1221685|NCT00784368|4007897|P2|Overall Study|Lack of Efficacy|0
1221686|NCT00784368|4007898|P1|Overall Study|Lack of Efficacy|2
1221687|NCT00784368|4007896|P3|Overall Study|Physician Decision|6
1221688|NCT00784368|4007897|P2|Overall Study|Physician Decision|0
1221689|NCT00784368|4007898|P1|Overall Study|Physician Decision|0
1221690|NCT00784277|4007936|P7|ER Treatment|Other|2
1221691|NCT00784277|4007937|P6|ER Treatment|Other|3
1221692|NCT00784277|4007938|P5|ER Treatment|Other|1
1221693|NCT00784277|4007939|P4|ER Treatment|Other|0
1221694|NCT00784277|4007940|P3|ER Treatment|Other|0
1221695|NCT00784277|4007941|P2|ER Treatment|Other|0
1221696|NCT00784277|4007942|P1|ER Treatment|Other|0
1221697|NCT00784277|4007936|P7|ER Treatment|Study Medication Non-Compliant|3
1221698|NCT00784277|4007937|P6|ER Treatment|Study Medication Non-Compliant|3
1221699|NCT00784277|4007938|P5|ER Treatment|Study Medication Non-Compliant|2
1221700|NCT00784277|4007939|P4|ER Treatment|Study Medication Non-Compliant|0
1221701|NCT00784277|4007940|P3|ER Treatment|Study Medication Non-Compliant|0
1221702|NCT00784277|4007941|P2|ER Treatment|Study Medication Non-Compliant|0
1221703|NCT00784277|4007942|P1|ER Treatment|Study Medication Non-Compliant|0
1221704|NCT00784277|4007936|P7|ER Treatment|Withdrawal by Subject|3
1221705|NCT00784277|4007937|P6|ER Treatment|Withdrawal by Subject|5
1221706|NCT00784277|4007938|P5|ER Treatment|Withdrawal by Subject|2
1221707|NCT00784277|4007939|P4|ER Treatment|Withdrawal by Subject|0
1221708|NCT00784277|4007940|P3|ER Treatment|Withdrawal by Subject|0
1221709|NCT00784277|4007941|P2|ER Treatment|Withdrawal by Subject|0
1221710|NCT00784277|4007942|P1|ER Treatment|Withdrawal by Subject|0
1221711|NCT00784277|4007936|P7|ER Treatment|Lost to Follow-up|0
1221712|NCT00784277|4007937|P6|ER Treatment|Lost to Follow-up|2
1221713|NCT00784277|4007938|P5|ER Treatment|Lost to Follow-up|0
1221714|NCT00784277|4007939|P4|ER Treatment|Lost to Follow-up|0
1221715|NCT00784277|4007940|P3|ER Treatment|Lost to Follow-up|0
1221716|NCT00784277|4007941|P2|ER Treatment|Lost to Follow-up|0
1221717|NCT00784277|4007942|P1|ER Treatment|Lost to Follow-up|0
1221718|NCT00784277|4007936|P7|ER Treatment|Lack of Efficacy|0
1221719|NCT00784277|4007937|P6|ER Treatment|Lack of Efficacy|4
1221720|NCT00784277|4007938|P5|ER Treatment|Lack of Efficacy|3
1221721|NCT00784277|4007939|P4|ER Treatment|Lack of Efficacy|0
1221722|NCT00784277|4007940|P3|ER Treatment|Lack of Efficacy|0
1221723|NCT00784277|4007941|P2|ER Treatment|Lack of Efficacy|0
1221724|NCT00784277|4007942|P1|ER Treatment|Lack of Efficacy|0
1221725|NCT00784277|4007936|P7|ER Treatment|Adverse Event|7
1221726|NCT00784277|4007937|P6|ER Treatment|Adverse Event|7
1221727|NCT00784277|4007938|P5|ER Treatment|Adverse Event|1
1221728|NCT00784277|4007939|P4|ER Treatment|Adverse Event|0
1221729|NCT00784277|4007940|P3|ER Treatment|Adverse Event|0
1221730|NCT00784277|4007941|P2|ER Treatment|Adverse Event|0
1221731|NCT00784277|4007942|P1|ER Treatment|Adverse Event|0
1221732|NCT00784277|4007936|P7|IR Treatment|Other|0
1221733|NCT00784277|4007937|P6|IR Treatment|Other|0
1221734|NCT00784277|4007938|P5|IR Treatment|Other|0
1221735|NCT00784277|4007939|P4|IR Treatment|Other|2
1221736|NCT00784277|4007940|P3|IR Treatment|Other|3
1221737|NCT00784277|4007941|P2|IR Treatment|Other|3
1221738|NCT00784277|4007942|P1|IR Treatment|Other|2
1221739|NCT00784277|4007936|P7|IR Treatment|Resolution Of Pain|0
1221740|NCT00784277|4007937|P6|IR Treatment|Resolution Of Pain|0
1221741|NCT00784277|4007938|P5|IR Treatment|Resolution Of Pain|0
1221742|NCT00784277|4007939|P4|IR Treatment|Resolution Of Pain|0
1221743|NCT00784277|4007940|P3|IR Treatment|Resolution Of Pain|0
1221744|NCT00784277|4007941|P2|IR Treatment|Resolution Of Pain|1
1221745|NCT00784277|4007942|P1|IR Treatment|Resolution Of Pain|0
1221746|NCT00784277|4007936|P7|IR Treatment|Withdrawal by Subject|0
1221747|NCT00784277|4007937|P6|IR Treatment|Withdrawal by Subject|0
1221748|NCT00784277|4007938|P5|IR Treatment|Withdrawal by Subject|0
1221749|NCT00784277|4007939|P4|IR Treatment|Withdrawal by Subject|6
1221750|NCT00784277|4007940|P3|IR Treatment|Withdrawal by Subject|4
1221751|NCT00784277|4007941|P2|IR Treatment|Withdrawal by Subject|1
1221752|NCT00784277|4007942|P1|IR Treatment|Withdrawal by Subject|5
1221753|NCT00784277|4007936|P7|IR Treatment|Lost to Follow-up|0
1221754|NCT00784277|4007937|P6|IR Treatment|Lost to Follow-up|0
1221755|NCT00784277|4007938|P5|IR Treatment|Lost to Follow-up|0
1221756|NCT00784277|4007939|P4|IR Treatment|Lost to Follow-up|0
1221757|NCT00784277|4007940|P3|IR Treatment|Lost to Follow-up|1
1221758|NCT00784277|4007941|P2|IR Treatment|Lost to Follow-up|0
1221759|NCT00784277|4007942|P1|IR Treatment|Lost to Follow-up|1
1221760|NCT00784277|4007936|P7|IR Treatment|Lack of Efficacy|0
1221761|NCT00784277|4007937|P6|IR Treatment|Lack of Efficacy|0
1221762|NCT00784277|4007938|P5|IR Treatment|Lack of Efficacy|0
1221763|NCT00784277|4007939|P4|IR Treatment|Lack of Efficacy|0
1221764|NCT00784277|4007940|P3|IR Treatment|Lack of Efficacy|1
1221765|NCT00784277|4007941|P2|IR Treatment|Lack of Efficacy|4
1221766|NCT00784277|4007942|P1|IR Treatment|Lack of Efficacy|4
1221767|NCT00784277|4007936|P7|IR Treatment|Adverse Event|0
1221768|NCT00784277|4007937|P6|IR Treatment|Adverse Event|0
1221769|NCT00784277|4007938|P5|IR Treatment|Adverse Event|0
1221770|NCT00784277|4007939|P4|IR Treatment|Adverse Event|35
1221771|NCT00784277|4007940|P3|IR Treatment|Adverse Event|19
1221772|NCT00784277|4007941|P2|IR Treatment|Adverse Event|8
1221773|NCT00784277|4007942|P1|IR Treatment|Adverse Event|4
1221774|NCT00784238|4007959|P1|Overall Study|Other|14
1221775|NCT00784238|4007959|P1|Overall Study|Withdrawal by Subject|26
1221776|NCT00784238|4007959|P1|Overall Study|Pregnancy|1
1221777|NCT00784238|4007959|P1|Overall Study|Lost to Follow-up|29
1221778|NCT00784238|4007959|P1|Overall Study|Lack of Efficacy|33
1221779|NCT00784238|4007959|P1|Overall Study|Death|2
1221780|NCT00784238|4007959|P1|Overall Study|Adverse Event|14
1221781|NCT00784147|4008002|P2|Overall Study|Death|0
1221782|NCT00784147|4008003|P1|Overall Study|Death|2
1221783|NCT00784147|4008002|P2|Overall Study|Protocol Violation|1
1221784|NCT00784147|4008003|P1|Overall Study|Protocol Violation|1
1221785|NCT00784147|4008002|P2|Overall Study|Physician Decision|1
1221786|NCT00784147|4008003|P1|Overall Study|Physician Decision|2
1221787|NCT00784147|4008002|P2|Overall Study|Withdrawal by Subject|3
1221788|NCT00784147|4008003|P1|Overall Study|Withdrawal by Subject|1
1221789|NCT00784147|4008002|P2|Overall Study|Lost to Follow-up|4
1221790|NCT00784147|4008003|P1|Overall Study|Lost to Follow-up|2
1221791|NCT00784134|4008023|P2|Overall Study|Lost to Follow-up|6
1221792|NCT00784134|4008024|P1|Overall Study|Lost to Follow-up|3
1221793|NCT00784043|4008147|P2|Overall Study|Protocol Terminated|1
1221794|NCT00784043|4008148|P1|Overall Study|Protocol Terminated|23
1221795|NCT00784043|4008147|P2|Overall Study|Withdrawal by Subject|5
1221796|NCT00784043|4008148|P1|Overall Study|Withdrawal by Subject|8
1221797|NCT00783835|4008183|P1|Overall Study|Participant not Adherent|3
1221798|NCT00783835|4008183|P1|Overall Study|Lost to Follow-up|1
1221799|NCT00783835|4008183|P1|Overall Study|Withdrawal by Subject|2
1221800|NCT00783835|4008183|P1|Overall Study|Medical Criteria|1
1221801|NCT00783835|4008183|P1|Overall Study|Adverse Event|3
1221802|NCT00783796|4008195|P1|Overall Study|Received commercial XIENCE V stent|1
1221803|NCT00783796|4008195|P1|Overall Study|Received non-XIENCE V stent|1
1221804|NCT00783796|4008195|P1|Overall Study|Did not receive any stent|4
1221805|NCT00783718|4008300|P7|Maintenance Phase|Lost to Follow-up|2
1221806|NCT00783718|4008301|P6|Maintenance Phase|Lost to Follow-up|0
1221807|NCT00783718|4008302|P5|Maintenance Phase|Lost to Follow-up|2
1221808|NCT00783718|4008303|P4|Maintenance Phase|Lost to Follow-up|0
1221809|NCT00783718|4008304|P3|Maintenance Phase|Lost to Follow-up|0
1221810|NCT00783718|4008305|P2|Maintenance Phase|Lost to Follow-up|0
1221811|NCT00783718|4008306|P1|Maintenance Phase|Lost to Follow-up|3
1221812|NCT00783718|4008300|P7|Maintenance Phase|Withdrawal by Subject|20
1221813|NCT00783718|4008301|P6|Maintenance Phase|Withdrawal by Subject|2
1221814|NCT00783718|4008302|P5|Maintenance Phase|Withdrawal by Subject|5
1221815|NCT00783718|4008303|P4|Maintenance Phase|Withdrawal by Subject|2
1221816|NCT00783718|4008304|P3|Maintenance Phase|Withdrawal by Subject|0
1221817|NCT00783718|4008305|P2|Maintenance Phase|Withdrawal by Subject|0
1221818|NCT00783718|4008306|P1|Maintenance Phase|Withdrawal by Subject|6
1221819|NCT00783718|4008300|P7|Maintenance Phase|Lack of Efficacy|155
1221820|NCT00783718|4008301|P6|Maintenance Phase|Lack of Efficacy|33
1221821|NCT00783718|4008302|P5|Maintenance Phase|Lack of Efficacy|31
1221822|NCT00783718|4008303|P4|Maintenance Phase|Lack of Efficacy|61
1221823|NCT00783718|4008304|P3|Maintenance Phase|Lack of Efficacy|0
1221824|NCT00783718|4008305|P2|Maintenance Phase|Lack of Efficacy|0
1221825|NCT00783718|4008306|P1|Maintenance Phase|Lack of Efficacy|83
1221826|NCT00783718|4008300|P7|Maintenance Phase|Protocol Violation|2
1221827|NCT00783718|4008301|P6|Maintenance Phase|Protocol Violation|0
1221828|NCT00783718|4008302|P5|Maintenance Phase|Protocol Violation|0
1221829|NCT00783718|4008303|P4|Maintenance Phase|Protocol Violation|0
1221830|NCT00783718|4008304|P3|Maintenance Phase|Protocol Violation|0
1221831|NCT00783718|4008305|P2|Maintenance Phase|Protocol Violation|0
1221832|NCT00783718|4008306|P1|Maintenance Phase|Protocol Violation|1
1221833|NCT00783718|4008300|P7|Maintenance Phase|Adverse Event|16
1221834|NCT00783718|4008301|P6|Maintenance Phase|Adverse Event|6
1221835|NCT00783718|4008302|P5|Maintenance Phase|Adverse Event|7
1221836|NCT00783718|4008303|P4|Maintenance Phase|Adverse Event|15
1221837|NCT00783718|4008304|P3|Maintenance Phase|Adverse Event|0
1221838|NCT00783718|4008305|P2|Maintenance Phase|Adverse Event|0
1221839|NCT00783718|4008306|P1|Maintenance Phase|Adverse Event|12
1221840|NCT00783718|4008300|P7|Induction Phase|Lost to Follow-up|0
1221841|NCT00783718|4008301|P6|Induction Phase|Lost to Follow-up|0
1221842|NCT00783718|4008302|P5|Induction Phase|Lost to Follow-up|0
1221843|NCT00783718|4008303|P4|Induction Phase|Lost to Follow-up|0
1221844|NCT00783718|4008304|P3|Induction Phase|Lost to Follow-up|1
1221845|NCT00783718|4008305|P2|Induction Phase|Lost to Follow-up|0
1221846|NCT00783718|4008306|P1|Induction Phase|Lost to Follow-up|1
1221847|NCT00783718|4008300|P7|Induction Phase|Withdrawal by Subject|0
1221848|NCT00783718|4008301|P6|Induction Phase|Withdrawal by Subject|0
1221849|NCT00783718|4008302|P5|Induction Phase|Withdrawal by Subject|0
1221850|NCT00783718|4008303|P4|Induction Phase|Withdrawal by Subject|0
1221851|NCT00783718|4008304|P3|Induction Phase|Withdrawal by Subject|8
1221852|NCT00783718|4008305|P2|Induction Phase|Withdrawal by Subject|4
1221853|NCT00783718|4008306|P1|Induction Phase|Withdrawal by Subject|3
1221854|NCT00783718|4008300|P7|Induction Phase|Lack of Efficacy|0
1221855|NCT00783718|4008301|P6|Induction Phase|Lack of Efficacy|0
1221856|NCT00783718|4008302|P5|Induction Phase|Lack of Efficacy|0
1221857|NCT00783718|4008303|P4|Induction Phase|Lack of Efficacy|0
1221858|NCT00783718|4008304|P3|Induction Phase|Lack of Efficacy|14
1221859|NCT00783718|4008305|P2|Induction Phase|Lack of Efficacy|2
1221860|NCT00783718|4008306|P1|Induction Phase|Lack of Efficacy|5
1221861|NCT00783718|4008300|P7|Induction Phase|Protocol Violation|0
1221862|NCT00783718|4008301|P6|Induction Phase|Protocol Violation|0
1221863|NCT00783718|4008302|P5|Induction Phase|Protocol Violation|0
1221864|NCT00783718|4008303|P4|Induction Phase|Protocol Violation|0
1221865|NCT00783718|4008304|P3|Induction Phase|Protocol Violation|6
1221866|NCT00783718|4008305|P2|Induction Phase|Protocol Violation|1
1221867|NCT00783718|4008306|P1|Induction Phase|Protocol Violation|1
1221868|NCT00783718|4008300|P7|Induction Phase|Adverse Event|0
1221869|NCT00783718|4008301|P6|Induction Phase|Adverse Event|0
1221870|NCT00783718|4008302|P5|Induction Phase|Adverse Event|0
1221871|NCT00783718|4008303|P4|Induction Phase|Adverse Event|0
1221872|NCT00783718|4008304|P3|Induction Phase|Adverse Event|7
1221873|NCT00783718|4008305|P2|Induction Phase|Adverse Event|0
1221874|NCT00783718|4008306|P1|Induction Phase|Adverse Event|4
1221875|NCT00783705|4008334|P2|Overall Study|Lost to Follow-up|3
1221876|NCT00783705|4008335|P1|Overall Study|Lost to Follow-up|1
1221877|NCT00783705|4008334|P2|Overall Study|Withdrawal by Subject|2
1221878|NCT00783705|4008335|P1|Overall Study|Withdrawal by Subject|3
1221879|NCT00783705|4008334|P2|Overall Study|Adverse Event|0
1221880|NCT00783705|4008335|P1|Overall Study|Adverse Event|2
1221881|NCT00783692|4008382|P7|Maintenance Phase|Other|1
1221882|NCT00783692|4008383|P6|Maintenance Phase|Other|1
1221883|NCT00783692|4008384|P5|Maintenance Phase|Other|0
1221884|NCT00783692|4008385|P4|Maintenance Phase|Other|1
1221885|NCT00783692|4008386|P3|Maintenance Phase|Other|0
1221886|NCT00783692|4008387|P2|Maintenance Phase|Other|0
1221887|NCT00783692|4008388|P1|Maintenance Phase|Other|0
1221888|NCT00783692|4008382|P7|Maintenance Phase|Lost to Follow-up|5
1221889|NCT00783692|4008383|P6|Maintenance Phase|Lost to Follow-up|2
1221890|NCT00783692|4008384|P5|Maintenance Phase|Lost to Follow-up|3
1221891|NCT00783692|4008385|P4|Maintenance Phase|Lost to Follow-up|1
1221892|NCT00783692|4008386|P3|Maintenance Phase|Lost to Follow-up|0
1221893|NCT00783692|4008387|P2|Maintenance Phase|Lost to Follow-up|0
1221894|NCT00783692|4008388|P1|Maintenance Phase|Lost to Follow-up|2
1221895|NCT00783692|4008382|P7|Maintenance Phase|Withdrawal by Subject|24
1221896|NCT00783692|4008383|P6|Maintenance Phase|Withdrawal by Subject|9
1221897|NCT00783692|4008384|P5|Maintenance Phase|Withdrawal by Subject|6
1221898|NCT00783692|4008385|P4|Maintenance Phase|Withdrawal by Subject|7
1221899|NCT00783692|4008386|P3|Maintenance Phase|Withdrawal by Subject|0
1221900|NCT00783692|4008387|P2|Maintenance Phase|Withdrawal by Subject|0
1221901|NCT00783692|4008388|P1|Maintenance Phase|Withdrawal by Subject|7
1221902|NCT00783692|4008382|P7|Maintenance Phase|Lack of Efficacy|177
1221903|NCT00783692|4008383|P6|Maintenance Phase|Lack of Efficacy|48
1221904|NCT00783692|4008384|P5|Maintenance Phase|Lack of Efficacy|58
1221905|NCT00783692|4008385|P4|Maintenance Phase|Lack of Efficacy|64
1221906|NCT00783692|4008386|P3|Maintenance Phase|Lack of Efficacy|0
1221907|NCT00783692|4008387|P2|Maintenance Phase|Lack of Efficacy|0
1221908|NCT00783692|4008388|P1|Maintenance Phase|Lack of Efficacy|79
1221909|NCT00783692|4008382|P7|Maintenance Phase|Protocol Violation|4
1221910|NCT00783692|4008383|P6|Maintenance Phase|Protocol Violation|3
1221911|NCT00783692|4008384|P5|Maintenance Phase|Protocol Violation|2
1221912|NCT00783692|4008385|P4|Maintenance Phase|Protocol Violation|1
1221913|NCT00783692|4008386|P3|Maintenance Phase|Protocol Violation|0
1221914|NCT00783692|4008387|P2|Maintenance Phase|Protocol Violation|0
1221915|NCT00783692|4008388|P1|Maintenance Phase|Protocol Violation|0
1221916|NCT00783692|4008382|P7|Maintenance Phase|Adverse Event|38
1221917|NCT00783692|4008383|P6|Maintenance Phase|Adverse Event|9
1221918|NCT00783692|4008384|P5|Maintenance Phase|Adverse Event|12
1221919|NCT00783692|4008385|P4|Maintenance Phase|Adverse Event|15
1221920|NCT00783692|4008386|P3|Maintenance Phase|Adverse Event|0
1221921|NCT00783692|4008387|P2|Maintenance Phase|Adverse Event|0
1221922|NCT00783692|4008388|P1|Maintenance Phase|Adverse Event|7
1221923|NCT00783692|4008382|P7|Induction Phase|Other|0
1221924|NCT00783692|4008383|P6|Induction Phase|Other|0
1221925|NCT00783692|4008384|P5|Induction Phase|Other|0
1221926|NCT00783692|4008385|P4|Induction Phase|Other|0
1221927|NCT00783692|4008386|P3|Induction Phase|Other|2
1221928|NCT00783692|4008387|P2|Induction Phase|Other|0
1221929|NCT00783692|4008388|P1|Induction Phase|Other|0
1221930|NCT00783692|4008382|P7|Induction Phase|Lost to Follow-up|0
1221931|NCT00783692|4008383|P6|Induction Phase|Lost to Follow-up|0
1221932|NCT00783692|4008384|P5|Induction Phase|Lost to Follow-up|0
1221933|NCT00783692|4008385|P4|Induction Phase|Lost to Follow-up|0
1221934|NCT00783692|4008386|P3|Induction Phase|Lost to Follow-up|3
1221935|NCT00783692|4008387|P2|Induction Phase|Lost to Follow-up|0
1221936|NCT00783692|4008388|P1|Induction Phase|Lost to Follow-up|0
1221937|NCT00783692|4008382|P7|Induction Phase|Withdrawal by Subject|0
1221938|NCT00783692|4008383|P6|Induction Phase|Withdrawal by Subject|0
1221939|NCT00783692|4008384|P5|Induction Phase|Withdrawal by Subject|0
1221940|NCT00783692|4008385|P4|Induction Phase|Withdrawal by Subject|0
1221941|NCT00783692|4008386|P3|Induction Phase|Withdrawal by Subject|16
1221942|NCT00783692|4008387|P2|Induction Phase|Withdrawal by Subject|9
1221943|NCT00783692|4008388|P1|Induction Phase|Withdrawal by Subject|3
1221944|NCT00783692|4008382|P7|Induction Phase|Lack of Efficacy|0
1221945|NCT00783692|4008383|P6|Induction Phase|Lack of Efficacy|0
1221946|NCT00783692|4008384|P5|Induction Phase|Lack of Efficacy|0
1221947|NCT00783692|4008385|P4|Induction Phase|Lack of Efficacy|0
1221948|NCT00783692|4008386|P3|Induction Phase|Lack of Efficacy|28
1221949|NCT00783692|4008387|P2|Induction Phase|Lack of Efficacy|3
1221950|NCT00783692|4008388|P1|Induction Phase|Lack of Efficacy|1
1221951|NCT00783692|4008382|P7|Induction Phase|Protocol Violation|0
1221952|NCT00783692|4008383|P6|Induction Phase|Protocol Violation|0
1221953|NCT00783692|4008384|P5|Induction Phase|Protocol Violation|0
1221954|NCT00783692|4008385|P4|Induction Phase|Protocol Violation|0
1221955|NCT00783692|4008386|P3|Induction Phase|Protocol Violation|1
1221956|NCT00783692|4008387|P2|Induction Phase|Protocol Violation|0
1221957|NCT00783692|4008388|P1|Induction Phase|Protocol Violation|0
1221958|NCT00783692|4008382|P7|Induction Phase|Adverse Event|0
1221959|NCT00783692|4008383|P6|Induction Phase|Adverse Event|0
1221960|NCT00783692|4008384|P5|Induction Phase|Adverse Event|0
1221961|NCT00783692|4008385|P4|Induction Phase|Adverse Event|0
1221962|NCT00783692|4008386|P3|Induction Phase|Adverse Event|24
1221963|NCT00783692|4008387|P2|Induction Phase|Adverse Event|9
1221964|NCT00783692|4008388|P1|Induction Phase|Adverse Event|7
1221965|NCT00783432|4008434|P2|Overall Study|Protocol Violation|9
1221966|NCT00783432|4008435|P1|Overall Study|Protocol Violation|6
1221967|NCT00783432|4008434|P2|Overall Study|subject moved|5
1221968|NCT00783432|4008435|P1|Overall Study|subject moved|3
1221969|NCT00783432|4008434|P2|Overall Study|Withdrawal by Subject|20
1221970|NCT00783432|4008435|P1|Overall Study|Withdrawal by Subject|23
1221971|NCT00783432|4008434|P2|Overall Study|Lost to Follow-up|6
1221972|NCT00783432|4008435|P1|Overall Study|Lost to Follow-up|11
1221973|NCT00783432|4008434|P2|Overall Study|Lack of Efficacy|21
1221974|NCT00783432|4008435|P1|Overall Study|Lack of Efficacy|20
1221975|NCT00783432|4008434|P2|Overall Study|Adverse Event|17
1221976|NCT00783432|4008435|P1|Overall Study|Adverse Event|22
1221977|NCT00783302|4008445|P1|Overall Study|Withdrawal by Subject|3
1221978|NCT00783302|4008445|P1|Overall Study|Physician Decision|1
1221979|NCT00783302|4008445|P1|Overall Study|Protocol Violation|3
1221980|NCT00783302|4008445|P1|Overall Study|Technical Problems|11
1221981|NCT00783302|4008445|P1|Overall Study|Lost to Follow-up|17
1221982|NCT00783263|4008467|P4|Overall Study|Withdrawal by Subject|2
1221983|NCT00783263|4008468|P3|Overall Study|Withdrawal by Subject|1
1221984|NCT00783263|4008469|P2|Overall Study|Withdrawal by Subject|1
1221985|NCT00783263|4008470|P1|Overall Study|Withdrawal by Subject|0
1221986|NCT00783263|4008467|P4|Overall Study|Lost to Follow-up|0
1221987|NCT00783263|4008468|P3|Overall Study|Lost to Follow-up|0
1221988|NCT00783263|4008469|P2|Overall Study|Lost to Follow-up|1
1221989|NCT00783263|4008470|P1|Overall Study|Lost to Follow-up|1
1221990|NCT00783263|4008467|P4|Overall Study|Adverse Event|1
1221991|NCT00783263|4008468|P3|Overall Study|Adverse Event|2
1221992|NCT00783263|4008469|P2|Overall Study|Adverse Event|0
1221993|NCT00783263|4008470|P1|Overall Study|Adverse Event|3
1221994|NCT00783224|4008500|P4|Overall Study|Inappropriate as a study subject|1
1221995|NCT00783224|4008501|P3|Overall Study|Inappropriate as a study subject|0
1221996|NCT00783224|4008502|P2|Overall Study|Inappropriate as a study subject|0
1221997|NCT00783224|4008503|P1|Overall Study|Inappropriate as a study subject|0
1221998|NCT00783224|4008500|P4|Overall Study|Discarded the Investigational Drug Used|1
1221999|NCT00783224|4008501|P3|Overall Study|Discarded the Investigational Drug Used|0
1222000|NCT00783224|4008502|P2|Overall Study|Discarded the Investigational Drug Used|0
1222001|NCT00783224|4008503|P1|Overall Study|Discarded the Investigational Drug Used|0
1222002|NCT00783224|4008500|P4|Overall Study|Adverse Event|0
1222003|NCT00783224|4008501|P3|Overall Study|Adverse Event|1
1222004|NCT00783224|4008502|P2|Overall Study|Adverse Event|0
1222005|NCT00783224|4008503|P1|Overall Study|Adverse Event|0
1222006|NCT00783198|4008515|P3|Overall Study|Administrative|2
1222007|NCT00783198|4008516|P2|Overall Study|Administrative|1
1222008|NCT00783198|4008517|P1|Overall Study|Administrative|2
1222009|NCT00783198|4008515|P3|Overall Study|Did not meet protocol eligibility|0
1222010|NCT00783198|4008516|P2|Overall Study|Did not meet protocol eligibility|1
1222011|NCT00783198|4008517|P1|Overall Study|Did not meet protocol eligibility|0
1222012|NCT00783198|4008515|P3|Overall Study|Noncompliance with protocol|10
1222013|NCT00783198|4008516|P2|Overall Study|Noncompliance with protocol|7
1222014|NCT00783198|4008517|P1|Overall Study|Noncompliance with protocol|7
1222015|NCT00783198|4008515|P3|Overall Study|Withdrawal by Subject|20
1222016|NCT00783198|4008516|P2|Overall Study|Withdrawal by Subject|14
1222017|NCT00783198|4008517|P1|Overall Study|Withdrawal by Subject|22
1222018|NCT00783198|4008515|P3|Overall Study|Lost to Follow-up|7
1222019|NCT00783198|4008516|P2|Overall Study|Lost to Follow-up|1
1222020|NCT00783198|4008517|P1|Overall Study|Lost to Follow-up|11
1222021|NCT00783198|4008515|P3|Overall Study|Adverse Event|3
1222022|NCT00783198|4008516|P2|Overall Study|Adverse Event|19
1222023|NCT00783198|4008517|P1|Overall Study|Adverse Event|15
1222024|NCT00783094|4008540|P3|Open-Label Extension Period|Lack of Efficacy|0
1222025|NCT00783094|4008541|P2|Open-Label Extension Period|Lack of Efficacy|4
1222026|NCT00783094|4008542|P1|Open-Label Extension Period|Lack of Efficacy|1
1222027|NCT00783094|4008540|P3|Open-Label Extension Period|Physician Decision|3
1222028|NCT00783094|4008541|P2|Open-Label Extension Period|Physician Decision|2
1222029|NCT00783094|4008542|P1|Open-Label Extension Period|Physician Decision|4
1222030|NCT00783094|4008540|P3|Open-Label Extension Period|Withdrawal by Subject|3
1222031|NCT00783094|4008541|P2|Open-Label Extension Period|Withdrawal by Subject|1
1222032|NCT00783094|4008542|P1|Open-Label Extension Period|Withdrawal by Subject|1
1222033|NCT00783094|4008540|P3|Open-Label Extension Period|Protocol Violation|7
1222034|NCT00783094|4008541|P2|Open-Label Extension Period|Protocol Violation|5
1222035|NCT00783094|4008542|P1|Open-Label Extension Period|Protocol Violation|4
1222036|NCT00783094|4008540|P3|Open-Label Extension Period|Death|1
1222037|NCT00783094|4008541|P2|Open-Label Extension Period|Death|0
1222038|NCT00783094|4008542|P1|Open-Label Extension Period|Death|0
1222039|NCT00783094|4008540|P3|Open-Label Extension Period|Adverse Event|16
1222040|NCT00783094|4008541|P2|Open-Label Extension Period|Adverse Event|7
1222041|NCT00783094|4008542|P1|Open-Label Extension Period|Adverse Event|12
1222042|NCT00783094|4008540|P3|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
1222043|NCT00783094|4008541|P2|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1
1222044|NCT00783094|4008542|P1|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
1222045|NCT00783094|4008540|P3|Randomized Double-Blind Treatment Period|Protocol Violation|1
1222046|NCT00783094|4008541|P2|Randomized Double-Blind Treatment Period|Protocol Violation|2
1222047|NCT00783094|4008542|P1|Randomized Double-Blind Treatment Period|Protocol Violation|1
1222048|NCT00783094|4008540|P3|Randomized Double-Blind Treatment Period|Physician Decision|0
1222049|NCT00783094|4008541|P2|Randomized Double-Blind Treatment Period|Physician Decision|2
1222050|NCT00783094|4008542|P1|Randomized Double-Blind Treatment Period|Physician Decision|0
1222051|NCT00783094|4008540|P3|Randomized Double-Blind Treatment Period|Lack of Efficacy|1
1222052|NCT00783094|4008541|P2|Randomized Double-Blind Treatment Period|Lack of Efficacy|2
1222053|NCT00783094|4008542|P1|Randomized Double-Blind Treatment Period|Lack of Efficacy|0
1222054|NCT00783094|4008540|P3|Randomized Double-Blind Treatment Period|Adverse Event|5
1222055|NCT00783094|4008541|P2|Randomized Double-Blind Treatment Period|Adverse Event|5
1222056|NCT00783094|4008542|P1|Randomized Double-Blind Treatment Period|Adverse Event|4
1222057|NCT00782834|4008618|P1|Treatment Phase|fibrous tumor not GIST|1
1222058|NCT00782795|4008658|P2|Overall Study|Withdrawal by Subject|2
1222059|NCT00782795|4008659|P1|Overall Study|Withdrawal by Subject|1
1222060|NCT00782717|4008699|P2|Overall Study|Exited in error|2
1222061|NCT00782717|4008700|P1|Overall Study|Exited in error|0
1222062|NCT00782717|4008699|P2|Overall Study|Did not meet entrance criteria|3
1222063|NCT00782717|4008700|P1|Overall Study|Did not meet entrance criteria|1
1222064|NCT00782717|4008699|P2|Overall Study|Enrollment close prior to surgery|0
1222065|NCT00782717|4008700|P1|Overall Study|Enrollment close prior to surgery|1
1222066|NCT00782717|4008699|P2|Overall Study|Treatment failure|14
1222067|NCT00782717|4008700|P1|Overall Study|Treatment failure|3
1222068|NCT00782717|4008699|P2|Overall Study|Noncompliance|1
1222069|NCT00782717|4008700|P1|Overall Study|Noncompliance|2
1222070|NCT00782717|4008699|P2|Overall Study|Patient decision unrelated to AE|3
1222071|NCT00782717|4008700|P1|Overall Study|Patient decision unrelated to AE|6
1222072|NCT00782717|4008699|P2|Overall Study|Adverse Event|5
1222073|NCT00782717|4008700|P1|Overall Study|Adverse Event|2
1222074|NCT00782626|4008727|P1|Overall Study|Other Complicating Disease|1
1222075|NCT00782626|4008727|P1|Overall Study|Progressive Disease|5
1222076|NCT00782626|4008727|P1|Overall Study|Adverse Event|1
1222077|NCT00782509|4008734|P3|Overall Study|Lack of Efficacy|2
1222078|NCT00782509|4008735|P2|Overall Study|Lack of Efficacy|5
1222079|NCT00782509|4008736|P1|Overall Study|Lack of Efficacy|10
1222080|NCT00782509|4008734|P3|Overall Study|Other reasons not stated above|3
1222081|NCT00782509|4008735|P2|Overall Study|Other reasons not stated above|2
1222082|NCT00782509|4008736|P1|Overall Study|Other reasons not stated above|5
1222083|NCT00782509|4008734|P3|Overall Study|Non compliance with protocol|0
1222084|NCT00782509|4008735|P2|Overall Study|Non compliance with protocol|0
1222085|NCT00782509|4008736|P1|Overall Study|Non compliance with protocol|2
1222086|NCT00782509|4008734|P3|Overall Study|Withdrawal by Subject|8
1222087|NCT00782509|4008735|P2|Overall Study|Withdrawal by Subject|5
1222088|NCT00782509|4008736|P1|Overall Study|Withdrawal by Subject|3
1222089|NCT00782509|4008734|P3|Overall Study|Lost to Follow-up|3
1222090|NCT00782509|4008735|P2|Overall Study|Lost to Follow-up|2
1222091|NCT00782509|4008736|P1|Overall Study|Lost to Follow-up|1
1222092|NCT00782509|4008734|P3|Overall Study|Adverse Event|20
1222093|NCT00782509|4008735|P2|Overall Study|Adverse Event|10
1222094|NCT00782509|4008736|P1|Overall Study|Adverse Event|20
1222095|NCT00782496|4008929|P2|Overall Study|Lost to Follow-up|15
1222096|NCT00782496|4008930|P1|Overall Study|Lost to Follow-up|14
1222097|NCT00782483|4008937|P1|Overall Study|Early Termination of Protocol - PI Reloc|6
1222098|NCT00782418|4008941|P7|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
1222099|NCT00782418|4008942|P6|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
1222100|NCT00782418|4008943|P5|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
1222101|NCT00782418|4008944|P4|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
1222102|NCT00782418|4008945|P3|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
1222103|NCT00782418|4008946|P2|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
1222104|NCT00782418|4008947|P1|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
1222105|NCT00782418|4008941|P7|Period 1 Procedure/Treatment Groups|Adverse Event|0
1222106|NCT00782418|4008942|P6|Period 1 Procedure/Treatment Groups|Adverse Event|0
1222107|NCT00782418|4008943|P5|Period 1 Procedure/Treatment Groups|Adverse Event|0
1222108|NCT00782418|4008944|P4|Period 1 Procedure/Treatment Groups|Adverse Event|0
1222109|NCT00782418|4008945|P3|Period 1 Procedure/Treatment Groups|Adverse Event|0
1222110|NCT00782418|4008946|P2|Period 1 Procedure/Treatment Groups|Adverse Event|0
1222111|NCT00782418|4008947|P1|Period 1 Procedure/Treatment Groups|Adverse Event|1
1222112|NCT00782340|4008984|P3|Open Label Titration|Randomized in error|0
1222113|NCT00782340|4008985|P2|Open Label Titration|Randomized in error|0
1222114|NCT00782340|4008986|P1|Open Label Titration|Randomized in error|6
1222115|NCT00782340|4008984|P3|Open Label Titration|Lost to Follow-up|0
1222116|NCT00782340|4008985|P2|Open Label Titration|Lost to Follow-up|0
1222117|NCT00782340|4008986|P1|Open Label Titration|Lost to Follow-up|5
1222118|NCT00782340|4008984|P3|Open Label Titration|Did not meet responder criteria|0
1222119|NCT00782340|4008985|P2|Open Label Titration|Did not meet responder criteria|0
1222120|NCT00782340|4008986|P1|Open Label Titration|Did not meet responder criteria|2
1222121|NCT00782340|4008984|P3|Open Label Titration|Enrollment capped|0
1222122|NCT00782340|4008985|P2|Open Label Titration|Enrollment capped|0
1222123|NCT00782340|4008986|P1|Open Label Titration|Enrollment capped|16
1222124|NCT00782340|4008984|P3|Open Label Titration|Withdrawal by Subject|0
1222125|NCT00782340|4008985|P2|Open Label Titration|Withdrawal by Subject|0
1222126|NCT00782340|4008986|P1|Open Label Titration|Withdrawal by Subject|5
1222127|NCT00782340|4008984|P3|Open Label Titration|Protocol Violation|0
1222128|NCT00782340|4008985|P2|Open Label Titration|Protocol Violation|0
1222129|NCT00782340|4008986|P1|Open Label Titration|Protocol Violation|5
1222130|NCT00782340|4008984|P3|Open Label Titration|Treatment failure|0
1222131|NCT00782340|4008985|P2|Open Label Titration|Treatment failure|0
1222132|NCT00782340|4008986|P1|Open Label Titration|Treatment failure|50
1222133|NCT00782340|4008984|P3|Open Label Titration|Adverse Event|0
1222134|NCT00782340|4008985|P2|Open Label Titration|Adverse Event|0
1222135|NCT00782340|4008986|P1|Open Label Titration|Adverse Event|12
1222136|NCT00782275|4009056|P1|Overall Study|Other|3
1222137|NCT00782275|4009056|P1|Overall Study|Not started treatment|1
1222138|NCT00782275|4009056|P1|Overall Study|Physician Decision|4
1222139|NCT00782275|4009056|P1|Overall Study|Progressive Disease|21
1222140|NCT00782275|4009056|P1|Overall Study|Withdrawal by Subject|1
1222141|NCT00782275|4009056|P1|Overall Study|Adverse Event|11
1222142|NCT00782210|4009065|P3|Overall Study|Other reason not described above|3
1222143|NCT00782210|4009066|P2|Overall Study|Other reason not described above|2
1222144|NCT00782210|4009067|P1|Overall Study|Other reason not described above|3
1222145|NCT00782210|4009065|P3|Overall Study|Lack of Efficacy|1
1222146|NCT00782210|4009066|P2|Overall Study|Lack of Efficacy|4
1222147|NCT00782210|4009067|P1|Overall Study|Lack of Efficacy|13
1222148|NCT00782210|4009065|P3|Overall Study|Non compliance with protocol|2
1222149|NCT00782210|4009066|P2|Overall Study|Non compliance with protocol|3
1222150|NCT00782210|4009067|P1|Overall Study|Non compliance with protocol|0
1222151|NCT00782210|4009065|P3|Overall Study|Withdrawal by Subject|11
1222152|NCT00782210|4009066|P2|Overall Study|Withdrawal by Subject|8
1222153|NCT00782210|4009067|P1|Overall Study|Withdrawal by Subject|11
1222154|NCT00782210|4009065|P3|Overall Study|Lost to Follow-up|2
1222155|NCT00782210|4009066|P2|Overall Study|Lost to Follow-up|1
1222156|NCT00782210|4009067|P1|Overall Study|Lost to Follow-up|2
1222157|NCT00782210|4009065|P3|Overall Study|Adverse Event|16
1222158|NCT00782210|4009066|P2|Overall Study|Adverse Event|17
1222159|NCT00782210|4009067|P1|Overall Study|Adverse Event|21
1222160|NCT00782184|4009260|P2|Overall Study|Withdrawal by Subject|2
1222161|NCT00782184|4009261|P1|Overall Study|Withdrawal by Subject|3
1222162|NCT00782184|4009260|P2|Overall Study|Protocol Violation|1
1222163|NCT00782184|4009261|P1|Overall Study|Protocol Violation|0
1222164|NCT00782184|4009260|P2|Overall Study|Adverse Event|2
1222165|NCT00782184|4009261|P1|Overall Study|Adverse Event|1
1222166|NCT00782171|4009298|P2|Overall Study|not eligible|6
1222167|NCT00782171|4009299|P1|Overall Study|not eligible|8
1222168|NCT00782171|4009298|P2|Overall Study|others|9
1222169|NCT00782171|4009299|P1|Overall Study|others|7
1222170|NCT00782171|4009298|P2|Overall Study|complications|1
1222171|NCT00782171|4009299|P1|Overall Study|complications|3
1222172|NCT00782171|4009298|P2|Overall Study|Withdrawal by Subject|1
1222173|NCT00782171|4009299|P1|Overall Study|Withdrawal by Subject|2
1222174|NCT00782171|4009298|P2|Overall Study|Lost to Follow-up|2
1222175|NCT00782171|4009299|P1|Overall Study|Lost to Follow-up|2
1222176|NCT00782067|4009331|P1|Overall Study|Protocol deviation|2
1222177|NCT00782067|4009331|P1|Overall Study|Disease progression|43
1222178|NCT00782067|4009331|P1|Overall Study|Death|9
1222179|NCT00782067|4009331|P1|Overall Study|Administrative problems|14
1222180|NCT00782067|4009331|P1|Overall Study|Lost to Follow-up|2
1222181|NCT00782067|4009331|P1|Overall Study|Subject withdrew consent|11
1222182|NCT00782067|4009331|P1|Overall Study|Adverse Event|35
1222183|NCT00781963|4009344|P3|Overall Study|Refused follow-up|0
1222184|NCT00781963|4009345|P2|Overall Study|Refused follow-up|5
1222185|NCT00781963|4009346|P1|Overall Study|Refused follow-up|4
1222186|NCT00781963|4009344|P3|Overall Study|Withdrawal by Subject|1
1222187|NCT00781963|4009345|P2|Overall Study|Withdrawal by Subject|3
1222188|NCT00781963|4009346|P1|Overall Study|Withdrawal by Subject|0
1222189|NCT00781963|4009344|P3|Overall Study|Lost to Follow-up|1
1222190|NCT00781963|4009345|P2|Overall Study|Lost to Follow-up|1
1222191|NCT00781963|4009346|P1|Overall Study|Lost to Follow-up|1
1222192|NCT00781963|4009344|P3|Overall Study|Death|0
1222193|NCT00781963|4009345|P2|Overall Study|Death|0
1222194|NCT00781963|4009346|P1|Overall Study|Death|3
1222195|NCT00781937|4009367|P2|Follow up Period (Week 56-68)|Unclassified|4
1222196|NCT00781937|4009368|P1|Follow up Period (Week 56-68)|Unclassified|5
1222197|NCT00781937|4009367|P2|Follow up Period (Week 56-68)|Protocol Violation|1
1222198|NCT00781937|4009368|P1|Follow up Period (Week 56-68)|Protocol Violation|1
1222199|NCT00781937|4009367|P2|Main Trial Period Through Week 56|Unclassified|15
1222200|NCT00781937|4009368|P1|Main Trial Period Through Week 56|Unclassified|10
1222201|NCT00781937|4009367|P2|Main Trial Period Through Week 56|Withdrawal by Subject|24
1222202|NCT00781937|4009368|P1|Main Trial Period Through Week 56|Withdrawal by Subject|17
1222203|NCT00781937|4009367|P2|Main Trial Period Through Week 56|Protocol Violation|5
1222204|NCT00781937|4009368|P1|Main Trial Period Through Week 56|Protocol Violation|8
1222205|NCT00781937|4009367|P2|Main Trial Period Through Week 56|Lack of Efficacy|2
1222206|NCT00781937|4009368|P1|Main Trial Period Through Week 56|Lack of Efficacy|0
1222207|NCT00781937|4009367|P2|Main Trial Period Through Week 56|Adverse Event|18
1222208|NCT00781937|4009368|P1|Main Trial Period Through Week 56|Adverse Event|18
1222209|NCT00781911|4009426|P2|Overall Study|Sponsor Decision|0
1222210|NCT00781911|4009427|P1|Overall Study|Sponsor Decision|1
1222211|NCT00781911|4009426|P2|Overall Study|Physician Decision|2
1222212|NCT00781911|4009427|P1|Overall Study|Physician Decision|0
1222213|NCT00781911|4009426|P2|Overall Study|Withdrawal by Subject|2
1222214|NCT00781911|4009427|P1|Overall Study|Withdrawal by Subject|1
1222215|NCT00781911|4009426|P2|Overall Study|Adverse Event|4
1222216|NCT00781911|4009427|P1|Overall Study|Adverse Event|4
1222217|NCT00781859|4009464|P2|Overall Study|Death|0
1222218|NCT00781859|4009465|P1|Overall Study|Death|3
1222219|NCT00781859|4009464|P2|Overall Study|Lost to Follow-up|3
1222220|NCT00781859|4009465|P1|Overall Study|Lost to Follow-up|6
1222221|NCT00781859|4009464|P2|Overall Study|Withdrawal by Subject|4
1222222|NCT00781859|4009465|P1|Overall Study|Withdrawal by Subject|8
1222223|NCT00781859|4009464|P2|Overall Study|Adverse Event|2
1222224|NCT00781859|4009465|P1|Overall Study|Adverse Event|2
1222225|NCT00781768|4009475|P2|Overall Study|Not transplanted.|2
1222226|NCT00781768|4009476|P1|Overall Study|Not transplanted.|0
1222227|NCT00781599|4009484|P2|Overall Study|Lost to Follow-up|4
1222228|NCT00781599|4009485|P1|Overall Study|Lost to Follow-up|7
1222229|NCT00781456|4009510|P2|Overall Study|Other Reason, Unknown|1
1222230|NCT00781456|4009511|P1|Overall Study|Other Reason, Unknown|0
1222231|NCT00781456|4009510|P2|Overall Study|Lost to Follow-up|5
1222232|NCT00781456|4009511|P1|Overall Study|Lost to Follow-up|10
1222233|NCT00781456|4009510|P2|Overall Study|Noncompliance With Protocol|1
1222234|NCT00781456|4009511|P1|Overall Study|Noncompliance With Protocol|1
1222235|NCT00781456|4009510|P2|Overall Study|Protocol Violation|1
1222236|NCT00781456|4009511|P1|Overall Study|Protocol Violation|4
1222237|NCT00781456|4009510|P2|Overall Study|Withdrawal by Subject|5
1222238|NCT00781456|4009511|P1|Overall Study|Withdrawal by Subject|3
1222239|NCT00781456|4009510|P2|Overall Study|Adverse Event|3
1222240|NCT00781456|4009511|P1|Overall Study|Adverse Event|3
1222241|NCT00781391|4009534|P3|Overall Study|Lost to Follow-up|1
1222242|NCT00781391|4009535|P2|Overall Study|Lost to Follow-up|0
1222243|NCT00781391|4009536|P1|Overall Study|Lost to Follow-up|0
1222244|NCT00781391|4009534|P3|Overall Study|Withdrawal by Subject|25
1222245|NCT00781391|4009535|P2|Overall Study|Withdrawal by Subject|37
1222246|NCT00781391|4009536|P1|Overall Study|Withdrawal by Subject|47
1222247|NCT00781391|4009534|P3|Overall Study|Death|706
1222248|NCT00781391|4009535|P2|Overall Study|Death|730
1222249|NCT00781391|4009536|P1|Overall Study|Death|789
1222250|NCT00781391|4009534|P3|Overall Study|Protocol Violation|20
1222251|NCT00781391|4009535|P2|Overall Study|Protocol Violation|17
1222252|NCT00781391|4009536|P1|Overall Study|Protocol Violation|19
1222253|NCT00781391|4009534|P3|Overall Study|never received study drug|32
1222254|NCT00781391|4009535|P2|Overall Study|never received study drug|23
1222255|NCT00781391|4009536|P1|Overall Study|never received study drug|24
1222256|NCT00781365|4009570|P2|Overall Study|Language barrier|0
1222257|NCT00781365|4009571|P1|Overall Study|Language barrier|1
1222258|NCT00781365|4009570|P2|Overall Study|Did Not Attend Visit|28
1222259|NCT00781365|4009571|P1|Overall Study|Did Not Attend Visit|20
1222260|NCT00781365|4009570|P2|Overall Study|Withdrawal by Subject|8
1222261|NCT00781365|4009571|P1|Overall Study|Withdrawal by Subject|13
1222262|NCT00781326|4009581|P1|Phase I|Physician Decision|2
1222263|NCT00781326|4009581|P1|Phase I|Withdrawal by Subject|1
1222264|NCT00781326|4009581|P1|Phase I|Adverse Event|1
1222265|NCT00781274|4009585|P1|Overall Study|Withdrawal by Subject|2
1222266|NCT00780910|4009617|P1|Overall Study|Adverse Event|2
1222267|NCT00780416|4009722|P2|Overall Study|Withdrawal by Subject|6
1222268|NCT00780416|4009723|P1|Overall Study|Withdrawal by Subject|8
1222269|NCT00780416|4009722|P2|Overall Study|Protocol Violation|0
1222270|NCT00780416|4009723|P1|Overall Study|Protocol Violation|1
1222271|NCT00780416|4009722|P2|Overall Study|Physician Decision|3
1222272|NCT00780416|4009723|P1|Overall Study|Physician Decision|3
1222273|NCT00780273|4009768|P1|Overall Study|Lost to Follow-up|1
1222274|NCT00780273|4009768|P1|Overall Study|Death|1
1222275|NCT00780143|4009782|P1|Overall Study|Adverse Event|1
1222276|NCT00780143|4009782|P1|Overall Study|Toxicity|1
1222277|NCT00780143|4009782|P1|Overall Study|Progressive disease|1
1222278|NCT00779909|4009813|P4|Overall Study|Withdrawal by Subject|0
1222279|NCT00779909|4009814|P3|Overall Study|Withdrawal by Subject|0
1222280|NCT00779909|4009815|P2|Overall Study|Withdrawal by Subject|1
1222281|NCT00779909|4009816|P1|Overall Study|Withdrawal by Subject|0
1222282|NCT00779909|4009813|P4|Overall Study|Lost to Follow-up|1
1222283|NCT00779909|4009814|P3|Overall Study|Lost to Follow-up|0
1222284|NCT00779909|4009815|P2|Overall Study|Lost to Follow-up|0
1222285|NCT00779909|4009816|P1|Overall Study|Lost to Follow-up|1
1222286|NCT00779857|4009858|P1|Overall Study|Missed Visit|2
1222287|NCT00779857|4009858|P1|Overall Study|Withdrawal by Subject|3
1222288|NCT00779857|4009858|P1|Overall Study|Death|1
1222289|NCT00779779|4009863|P1|Overall Study|Lost to Follow-up|5
1222290|NCT00779779|4009863|P1|Overall Study|Withdrawal by Subject|4
1222291|NCT00779779|4009863|P1|Overall Study|Protocol Violation|14
1222292|NCT00779779|4009863|P1|Overall Study|Adverse Event|1
1222293|NCT00779766|4009872|P2|Overall Study|Withdrawal by Subject|67
1222294|NCT00779766|4009873|P1|Overall Study|Withdrawal by Subject|84
1222295|NCT00779766|4009872|P2|Overall Study|Protocol Violation|1
1222296|NCT00779766|4009873|P1|Overall Study|Protocol Violation|1
1222297|NCT00779675|4009955|P1|Extended Treatment Period|Lost to Follow-up|6
1222298|NCT00779675|4009955|P1|Extended Treatment Period|Protocol defined clinical event|1
1222299|NCT00779675|4009955|P1|Extended Treatment Period|Treatment Failure|11
1222300|NCT00779675|4009955|P1|Extended Treatment Period|Adverse Event|6
1222301|NCT00779675|4009955|P1|Extended Treatment Period|Protocol Violation|13
1222302|NCT00779675|4009955|P1|Extended Treatment Period|Reasons unrelated to study treatment|9
1222303|NCT00779675|4009955|P1|Treatment Period|Administrative|3
1222304|NCT00779675|4009955|P1|Treatment Period|Did Not Meet Protocol Eligibility|1
1222305|NCT00779675|4009955|P1|Treatment Period|Protocol Violation|54
1222306|NCT00779675|4009955|P1|Treatment Period|Withdrawal by Subject|46
1222307|NCT00779675|4009955|P1|Treatment Period|Lost to Follow-up|23
1222308|NCT00779675|4009955|P1|Treatment Period|Transferred to Another Study|38
1222309|NCT00779675|4009955|P1|Treatment Period|Treatment Failure|80
1222310|NCT00779675|4009955|P1|Treatment Period|Adverse Event|87
1222311|NCT00779584|4009983|P9|Overall Study|Ongoing in Study|0
1222312|NCT00779584|4009984|P8|Overall Study|Ongoing in Study|0
1222313|NCT00779584|4009985|P7|Overall Study|Ongoing in Study|0
1222314|NCT00779584|4009986|P6|Overall Study|Ongoing in Study|1
1222315|NCT00779584|4009987|P5|Overall Study|Ongoing in Study|1
1222316|NCT00779584|4009988|P4|Overall Study|Ongoing in Study|0
1222317|NCT00779584|4009989|P3|Overall Study|Ongoing in Study|0
1222318|NCT00779584|4009990|P2|Overall Study|Ongoing in Study|0
1222319|NCT00779584|4009991|P1|Overall Study|Ongoing in Study|0
1222320|NCT00779584|4009983|P9|Overall Study|Symptomatic Deterioration|0
1222321|NCT00779584|4009984|P8|Overall Study|Symptomatic Deterioration|0
1222322|NCT00779584|4009985|P7|Overall Study|Symptomatic Deterioration|1
1222323|NCT00779584|4009986|P6|Overall Study|Symptomatic Deterioration|1
1222324|NCT00779584|4009987|P5|Overall Study|Symptomatic Deterioration|0
1222325|NCT00779584|4009988|P4|Overall Study|Symptomatic Deterioration|0
1222326|NCT00779584|4009989|P3|Overall Study|Symptomatic Deterioration|1
1222327|NCT00779584|4009990|P2|Overall Study|Symptomatic Deterioration|1
1222328|NCT00779584|4009991|P1|Overall Study|Symptomatic Deterioration|1
1222329|NCT00779584|4009983|P9|Overall Study|Adverse Event|1
1222330|NCT00779584|4009984|P8|Overall Study|Adverse Event|1
1222331|NCT00779584|4009985|P7|Overall Study|Adverse Event|2
1222332|NCT00779584|4009986|P6|Overall Study|Adverse Event|0
1222333|NCT00779584|4009987|P5|Overall Study|Adverse Event|0
1222334|NCT00779584|4009988|P4|Overall Study|Adverse Event|0
1222335|NCT00779584|4009989|P3|Overall Study|Adverse Event|2
1222336|NCT00779584|4009990|P2|Overall Study|Adverse Event|0
1222337|NCT00779584|4009991|P1|Overall Study|Adverse Event|1
1222338|NCT00779584|4009983|P9|Overall Study|Progression of Disease|1
1222339|NCT00779584|4009984|P8|Overall Study|Progression of Disease|2
1222340|NCT00779584|4009985|P7|Overall Study|Progression of Disease|4
1222341|NCT00779584|4009986|P6|Overall Study|Progression of Disease|1
1222342|NCT00779584|4009987|P5|Overall Study|Progression of Disease|5
1222343|NCT00779584|4009988|P4|Overall Study|Progression of Disease|6
1222344|NCT00779584|4009989|P3|Overall Study|Progression of Disease|2
1222345|NCT00779584|4009990|P2|Overall Study|Progression of Disease|1
1222346|NCT00779584|4009991|P1|Overall Study|Progression of Disease|0
1222347|NCT00779584|4009983|P9|Overall Study|Lost to Follow-up|0
1222348|NCT00779584|4009984|P8|Overall Study|Lost to Follow-up|0
1222349|NCT00779584|4009985|P7|Overall Study|Lost to Follow-up|0
1222350|NCT00779584|4009986|P6|Overall Study|Lost to Follow-up|0
1222351|NCT00779584|4009987|P5|Overall Study|Lost to Follow-up|1
1222352|NCT00779584|4009988|P4|Overall Study|Lost to Follow-up|0
1222353|NCT00779584|4009989|P3|Overall Study|Lost to Follow-up|0
1222354|NCT00779584|4009990|P2|Overall Study|Lost to Follow-up|0
1222355|NCT00779584|4009991|P1|Overall Study|Lost to Follow-up|0
1222356|NCT00779584|4009983|P9|Overall Study|Withdrawal by Subject|0
1222357|NCT00779584|4009984|P8|Overall Study|Withdrawal by Subject|0
1222358|NCT00779584|4009985|P7|Overall Study|Withdrawal by Subject|1
1222359|NCT00779584|4009986|P6|Overall Study|Withdrawal by Subject|2
1222360|NCT00779584|4009987|P5|Overall Study|Withdrawal by Subject|0
1222361|NCT00779584|4009988|P4|Overall Study|Withdrawal by Subject|0
1222362|NCT00779584|4009989|P3|Overall Study|Withdrawal by Subject|2
1222363|NCT00779584|4009990|P2|Overall Study|Withdrawal by Subject|1
1222364|NCT00779584|4009991|P1|Overall Study|Withdrawal by Subject|1
1222365|NCT00779584|4009983|P9|Overall Study|Protocol Violation|0
1222366|NCT00779584|4009984|P8|Overall Study|Protocol Violation|0
1222367|NCT00779584|4009985|P7|Overall Study|Protocol Violation|0
1222368|NCT00779584|4009986|P6|Overall Study|Protocol Violation|1
1222369|NCT00779584|4009987|P5|Overall Study|Protocol Violation|0
1222370|NCT00779584|4009988|P4|Overall Study|Protocol Violation|0
1222371|NCT00779584|4009989|P3|Overall Study|Protocol Violation|0
1222372|NCT00779584|4009990|P2|Overall Study|Protocol Violation|0
1222373|NCT00779584|4009991|P1|Overall Study|Protocol Violation|0
1222374|NCT00779506|4010082|P1|Overall Study|Lost to Follow-up|1
1222375|NCT00779506|4010082|P1|Overall Study|Withdrawal by Subject|6
1222376|NCT00779506|4010082|P1|Overall Study|Protocol Violation|5
1222377|NCT00779506|4010082|P1|Overall Study|Lack of Efficacy|11
1222378|NCT00779506|4010082|P1|Overall Study|Adverse Event|4
1222379|NCT00779506|4010082|P1|Overall Study|Screening Failed|2
1222380|NCT00779467|4010096|P4|Overall Study|unavailable research staff|1
1222381|NCT00779467|4010097|P3|Overall Study|unavailable research staff|0
1222382|NCT00779467|4010098|P2|Overall Study|unavailable research staff|0
1222383|NCT00779467|4010099|P1|Overall Study|unavailable research staff|0
1222384|NCT00779467|4010096|P4|Overall Study|technical issue|1
1222385|NCT00779467|4010097|P3|Overall Study|technical issue|2
1222386|NCT00779467|4010098|P2|Overall Study|technical issue|0
1222387|NCT00779467|4010099|P1|Overall Study|technical issue|0
1222388|NCT00779467|4010096|P4|Overall Study|missing data|4
1222389|NCT00779467|4010097|P3|Overall Study|missing data|1
1222390|NCT00779467|4010098|P2|Overall Study|missing data|0
1222391|NCT00779467|4010099|P1|Overall Study|missing data|1
1222392|NCT00779467|4010096|P4|Overall Study|failed inclusion criteria|2
1222393|NCT00779467|4010097|P3|Overall Study|failed inclusion criteria|1
1222394|NCT00779467|4010098|P2|Overall Study|failed inclusion criteria|3
1222395|NCT00779467|4010099|P1|Overall Study|failed inclusion criteria|3
1222396|NCT00779467|4010096|P4|Overall Study|Lack of Efficacy|11
1222397|NCT00779467|4010097|P3|Overall Study|Lack of Efficacy|6
1222398|NCT00779467|4010098|P2|Overall Study|Lack of Efficacy|2
1222399|NCT00779467|4010099|P1|Overall Study|Lack of Efficacy|11
1222400|NCT00779402|4010139|P2|Long-term Follow-up|Completed Protocol Visits|2
1222401|NCT00779402|4010140|P1|Long-term Follow-up|Completed Protocol Visits|6
1222402|NCT00779402|4010139|P2|Long-term Follow-up|Closure of Study|4
1222403|NCT00779402|4010140|P1|Long-term Follow-up|Closure of Study|8
1222404|NCT00779402|4010139|P2|Long-term Follow-up|Not specified|0
1222405|NCT00779402|4010140|P1|Long-term Follow-up|Not specified|5
1222406|NCT00779402|4010139|P2|Long-term Follow-up|Patient refused to continue|0
1222407|NCT00779402|4010140|P1|Long-term Follow-up|Patient refused to continue|2
1222408|NCT00779402|4010139|P2|Surveillance Phase|Completed Protocol Visits|2
1222409|NCT00779402|4010140|P1|Surveillance Phase|Completed Protocol Visits|3
1222410|NCT00779402|4010139|P2|Surveillance Phase|Closure of study|6
1222411|NCT00779402|4010140|P1|Surveillance Phase|Closure of study|5
1222412|NCT00779402|4010139|P2|Surveillance Phase|Withdrawal by Subject|1
1222413|NCT00779402|4010140|P1|Surveillance Phase|Withdrawal by Subject|4
1222414|NCT00779402|4010139|P2|Surveillance Phase|Not specified|5
1222415|NCT00779402|4010140|P1|Surveillance Phase|Not specified|5
1222416|NCT00779402|4010139|P2|Surveillance Phase|Intercurrent Illness|0
1222417|NCT00779402|4010140|P1|Surveillance Phase|Intercurrent Illness|2
1222418|NCT00779402|4010139|P2|Surveillance Phase|Death|1
1222419|NCT00779402|4010140|P1|Surveillance Phase|Death|0
1222420|NCT00779402|4010139|P2|Surveillance Phase|Lost to Follow-up|1
1222421|NCT00779402|4010140|P1|Surveillance Phase|Lost to Follow-up|2
1222422|NCT00779402|4010139|P2|Surveillance Phase|Patient refused to continue|14
1222423|NCT00779402|4010140|P1|Surveillance Phase|Patient refused to continue|22
1222424|NCT00779402|4010139|P2|Surveillance Phase|Protocol Violation|1
1222425|NCT00779402|4010140|P1|Surveillance Phase|Protocol Violation|0
1222426|NCT00779402|4010139|P2|Treatment Phase 1|Completed Protocol Visits|6
1222427|NCT00779402|4010140|P1|Treatment Phase 1|Completed Protocol Visits|3
1222428|NCT00779402|4010139|P2|Treatment Phase 1|Closure of Study|2
1222429|NCT00779402|4010140|P1|Treatment Phase 1|Closure of Study|3
1222430|NCT00779402|4010139|P2|Treatment Phase 1|Not Specified|2
1222431|NCT00779402|4010140|P1|Treatment Phase 1|Not Specified|4
1222432|NCT00779402|4010139|P2|Treatment Phase 1|Withdrawal by Subject|0
1222433|NCT00779402|4010140|P1|Treatment Phase 1|Withdrawal by Subject|1
1222434|NCT00779402|4010139|P2|Treatment Phase 1|Intercurrent Illness|1
1222435|NCT00779402|4010140|P1|Treatment Phase 1|Intercurrent Illness|1
1222436|NCT00779402|4010139|P2|Treatment Phase 1|Death|1
1222437|NCT00779402|4010140|P1|Treatment Phase 1|Death|0
1222438|NCT00779402|4010139|P2|Treatment Phase 1|Lost to Follow-up|1
1222439|NCT00779402|4010140|P1|Treatment Phase 1|Lost to Follow-up|0
1222440|NCT00779402|4010139|P2|Treatment Phase 1|Patient Refused to Continue|2
1222441|NCT00779402|4010140|P1|Treatment Phase 1|Patient Refused to Continue|17
1222442|NCT00779402|4010139|P2|Treatment Phase 1|Protocol Violation|0
1222443|NCT00779402|4010140|P1|Treatment Phase 1|Protocol Violation|1
1222444|NCT00779402|4010139|P2|Treatment Phase 1|Adverse Event|0
1222445|NCT00779402|4010140|P1|Treatment Phase 1|Adverse Event|2
1222446|NCT00779402|4010139|P2|Treatment Phase 1|Disease Progression|0
1222447|NCT00779402|4010140|P1|Treatment Phase 1|Disease Progression|1
1222448|NCT00779259|4010183|P1|Quinine Alone|Adverse Event|2
1222449|NCT00779246|4010204|P2|Overall Study|Missing sufficient data for analysis|53
1222450|NCT00779246|4010205|P1|Overall Study|Missing sufficient data for analysis|33
1222451|NCT00779142|4010224|P1|Overall Study|Screen Failures|3
1222452|NCT00779038|4010238|P1|Overall Study|Study Prematurely Terminated|13
1222453|NCT00779025|4010247|P1|Overall Study|Withdrawal by Subject|1
1222454|NCT00778999|4010258|P2|Overall Study|Did not receive recFSH|20
1222455|NCT00778999|4010259|P1|Overall Study|Did not receive recFSH|14
1222456|NCT00778999|4010258|P2|Overall Study|Discontinuation: no embryo transfer|14
1222457|NCT00778999|4010259|P1|Overall Study|Discontinuation: no embryo transfer|14
1222458|NCT00778921|4010268|P3|Overall Study|Not treated|2
1222459|NCT00778921|4010269|P2|Overall Study|Not treated|2
1222460|NCT00778921|4010270|P1|Overall Study|Not treated|0
1222461|NCT00778921|4010268|P3|Overall Study|Protocol Violation|2
1222462|NCT00778921|4010269|P2|Overall Study|Protocol Violation|0
1222463|NCT00778921|4010270|P1|Overall Study|Protocol Violation|3
1222464|NCT00778921|4010268|P3|Overall Study|Administrative Problems|0
1222465|NCT00778921|4010269|P2|Overall Study|Administrative Problems|2
1222466|NCT00778921|4010270|P1|Overall Study|Administrative Problems|1
1222467|NCT00778921|4010268|P3|Overall Study|Lost to Follow-up|1
1222468|NCT00778921|4010269|P2|Overall Study|Lost to Follow-up|2
1222469|NCT00778921|4010270|P1|Overall Study|Lost to Follow-up|0
1222470|NCT00778921|4010268|P3|Overall Study|Patient withdrew request|6
1222471|NCT00778921|4010269|P2|Overall Study|Patient withdrew request|1
1222472|NCT00778921|4010270|P1|Overall Study|Patient withdrew request|3
1222473|NCT00778921|4010268|P3|Overall Study|Patient No Longer Requires Study Drug|0
1222474|NCT00778921|4010269|P2|Overall Study|Patient No Longer Requires Study Drug|1
1222475|NCT00778921|4010270|P1|Overall Study|Patient No Longer Requires Study Drug|0
1222476|NCT00778921|4010268|P3|Overall Study|Unsatisfactory therapeutic response|1
1222477|NCT00778921|4010269|P2|Overall Study|Unsatisfactory therapeutic response|1
1222478|NCT00778921|4010270|P1|Overall Study|Unsatisfactory therapeutic response|1
1222479|NCT00778921|4010268|P3|Overall Study|Abnormal Test Procedure Result(s)|2
1222480|NCT00778921|4010269|P2|Overall Study|Abnormal Test Procedure Result(s)|0
1222481|NCT00778921|4010270|P1|Overall Study|Abnormal Test Procedure Result(s)|0
1222482|NCT00778921|4010268|P3|Overall Study|Abnormal Laboratory Value(s)|0
1222483|NCT00778921|4010269|P2|Overall Study|Abnormal Laboratory Value(s)|0
1222484|NCT00778921|4010270|P1|Overall Study|Abnormal Laboratory Value(s)|1
1222485|NCT00778921|4010268|P3|Overall Study|Adverse Event|14
1222486|NCT00778921|4010269|P2|Overall Study|Adverse Event|10
1222487|NCT00778921|4010270|P1|Overall Study|Adverse Event|9
1222488|NCT00778895|4010287|P3|ESFU Phase|Other|0
1222489|NCT00778895|4010288|P2|ESFU Phase|Other|0
1222490|NCT00778895|4010289|P1|ESFU Phase|Other|2
1222491|NCT00778895|4010287|P3|ESFU Phase|Lost to Follow-up|2
1222492|NCT00778895|4010288|P2|ESFU Phase|Lost to Follow-up|7
1222493|NCT00778895|4010289|P1|ESFU Phase|Lost to Follow-up|6
1222494|NCT00778895|4010287|P3|ESFU Phase|Withdrawal by Subject|0
1222495|NCT00778895|4010288|P2|ESFU Phase|Withdrawal by Subject|4
1222496|NCT00778895|4010289|P1|ESFU Phase|Withdrawal by Subject|1
1222497|NCT00778895|4010287|P3|ESFU Phase|Adverse Event|0
1222498|NCT00778895|4010288|P2|ESFU Phase|Adverse Event|1
1222499|NCT00778895|4010289|P1|ESFU Phase|Adverse Event|2
1222500|NCT00778895|4010287|P3|Active Phase|Other|0
1222501|NCT00778895|4010288|P2|Active Phase|Other|0
1222502|NCT00778895|4010289|P1|Active Phase|Other|2
1222503|NCT00778895|4010287|P3|Active Phase|Lost to Follow-up|0
1222504|NCT00778895|4010288|P2|Active Phase|Lost to Follow-up|1
1222505|NCT00778895|4010289|P1|Active Phase|Lost to Follow-up|1
1222506|NCT00778895|4010287|P3|Active Phase|Withdrawal by Subject|0
1222507|NCT00778895|4010288|P2|Active Phase|Withdrawal by Subject|4
1222508|NCT00778895|4010289|P1|Active Phase|Withdrawal by Subject|1
1222509|NCT00778895|4010287|P3|Active Phase|Adverse Event|0
1222510|NCT00778895|4010288|P2|Active Phase|Adverse Event|1
1222511|NCT00778895|4010289|P1|Active Phase|Adverse Event|3
1222512|NCT00778830|4010333|P2|Overall Study|Ongoing at data cut-off|1
1222513|NCT00778830|4010334|P1|Overall Study|Ongoing at data cut-off|0
1222514|NCT00778817|4010346|P1|Overall Study|Withdrawal by Subject|2
1222515|NCT00778817|4010346|P1|Overall Study|Adverse Event|2
1222516|NCT00778622|4010373|P3|Overall Study|Other|1
1222517|NCT00778622|4010374|P2|Overall Study|Other|0
1222518|NCT00778622|4010375|P1|Overall Study|Other|1
1222519|NCT00778622|4010373|P3|Overall Study|immigration|0
1222520|NCT00778622|4010374|P2|Overall Study|immigration|0
1222521|NCT00778622|4010375|P1|Overall Study|immigration|1
1222522|NCT00778622|4010373|P3|Overall Study|Lack of Efficacy|0
1222523|NCT00778622|4010374|P2|Overall Study|Lack of Efficacy|0
1222524|NCT00778622|4010375|P1|Overall Study|Lack of Efficacy|2
1222525|NCT00778622|4010373|P3|Overall Study|Protocol Violation|0
1222526|NCT00778622|4010374|P2|Overall Study|Protocol Violation|3
1222527|NCT00778622|4010375|P1|Overall Study|Protocol Violation|0
1222528|NCT00778622|4010373|P3|Overall Study|Lost to Follow-up|2
1222529|NCT00778622|4010374|P2|Overall Study|Lost to Follow-up|3
1222530|NCT00778622|4010375|P1|Overall Study|Lost to Follow-up|3
1222531|NCT00778622|4010373|P3|Overall Study|Withdrawal by Subject|5
1222532|NCT00778622|4010374|P2|Overall Study|Withdrawal by Subject|5
1222533|NCT00778622|4010375|P1|Overall Study|Withdrawal by Subject|4
1222534|NCT00778622|4010373|P3|Overall Study|Adverse Event|7
1222535|NCT00778622|4010374|P2|Overall Study|Adverse Event|4
1222536|NCT00778622|4010375|P1|Overall Study|Adverse Event|5
1222537|NCT00778375|4010428|P1|Overall Study|Ineligible|3
1222538|NCT00778336|4010442|P4|3 Month Follow Up|Death|0
1222539|NCT00778336|4010443|P3|3 Month Follow Up|Death|2
1222540|NCT00778336|4010444|P2|3 Month Follow Up|Death|3
1222541|NCT00778336|4010445|P1|3 Month Follow Up|Death|8
1222542|NCT00778336|4010442|P4|3 Month Follow Up|Lost to Follow-up|0
1222543|NCT00778336|4010443|P3|3 Month Follow Up|Lost to Follow-up|3
1222544|NCT00778336|4010444|P2|3 Month Follow Up|Lost to Follow-up|20
1222545|NCT00778336|4010445|P1|3 Month Follow Up|Lost to Follow-up|15
1222546|NCT00778336|4010442|P4|Index Procedure-Discharge|Death|0
1222547|NCT00778336|4010443|P3|Index Procedure-Discharge|Death|2
1222548|NCT00778336|4010444|P2|Index Procedure-Discharge|Death|3
1222549|NCT00778336|4010445|P1|Index Procedure-Discharge|Death|6
1222550|NCT00778258|4010483|P9|Overall Study|Other|0
1222551|NCT00778258|4010484|P8|Overall Study|Other|0
1222552|NCT00778258|4010485|P7|Overall Study|Other|1
1222553|NCT00778258|4010486|P6|Overall Study|Other|0
1222554|NCT00778258|4010487|P5|Overall Study|Other|0
1222555|NCT00778258|4010488|P4|Overall Study|Other|0
1222556|NCT00778258|4010489|P3|Overall Study|Other|0
1222557|NCT00778258|4010490|P2|Overall Study|Other|0
1222558|NCT00778258|4010491|P1|Overall Study|Other|0
1222559|NCT00778258|4010483|P9|Overall Study|Non-compliance|0
1222560|NCT00778258|4010484|P8|Overall Study|Non-compliance|0
1222561|NCT00778258|4010485|P7|Overall Study|Non-compliance|0
1222562|NCT00778258|4010486|P6|Overall Study|Non-compliance|0
1222563|NCT00778258|4010487|P5|Overall Study|Non-compliance|0
1222564|NCT00778258|4010488|P4|Overall Study|Non-compliance|1
1222565|NCT00778258|4010489|P3|Overall Study|Non-compliance|0
1222566|NCT00778258|4010490|P2|Overall Study|Non-compliance|0
1222567|NCT00778258|4010491|P1|Overall Study|Non-compliance|0
1222568|NCT00778258|4010483|P9|Overall Study|New Contraindication|0
1222569|NCT00778258|4010484|P8|Overall Study|New Contraindication|1
1222570|NCT00778258|4010485|P7|Overall Study|New Contraindication|0
1222571|NCT00778258|4010486|P6|Overall Study|New Contraindication|0
1222572|NCT00778258|4010487|P5|Overall Study|New Contraindication|0
1222573|NCT00778258|4010488|P4|Overall Study|New Contraindication|0
1222574|NCT00778258|4010489|P3|Overall Study|New Contraindication|0
1222575|NCT00778258|4010490|P2|Overall Study|New Contraindication|0
1222576|NCT00778258|4010491|P1|Overall Study|New Contraindication|0
1222577|NCT00778258|4010483|P9|Overall Study|Withdrawal by Subject|4
1222578|NCT00778258|4010484|P8|Overall Study|Withdrawal by Subject|12
1222579|NCT00778258|4010485|P7|Overall Study|Withdrawal by Subject|12
1222580|NCT00778258|4010486|P6|Overall Study|Withdrawal by Subject|6
1222581|NCT00778258|4010487|P5|Overall Study|Withdrawal by Subject|0
1222582|NCT00778258|4010488|P4|Overall Study|Withdrawal by Subject|2
1222583|NCT00778258|4010489|P3|Overall Study|Withdrawal by Subject|8
1222584|NCT00778258|4010490|P2|Overall Study|Withdrawal by Subject|2
1222585|NCT00778258|4010491|P1|Overall Study|Withdrawal by Subject|6
1222586|NCT00778258|4010483|P9|Overall Study|Lost to Follow-up|0
1222587|NCT00778258|4010484|P8|Overall Study|Lost to Follow-up|2
1222588|NCT00778258|4010485|P7|Overall Study|Lost to Follow-up|2
1222589|NCT00778258|4010486|P6|Overall Study|Lost to Follow-up|3
1222590|NCT00778258|4010487|P5|Overall Study|Lost to Follow-up|0
1222591|NCT00778258|4010488|P4|Overall Study|Lost to Follow-up|0
1222592|NCT00778258|4010489|P3|Overall Study|Lost to Follow-up|2
1222593|NCT00778258|4010490|P2|Overall Study|Lost to Follow-up|0
1222594|NCT00778258|4010491|P1|Overall Study|Lost to Follow-up|0
1222595|NCT00778258|4010483|P9|Overall Study|Adverse Event|0
1222596|NCT00778258|4010484|P8|Overall Study|Adverse Event|0
1222597|NCT00778258|4010485|P7|Overall Study|Adverse Event|0
1222598|NCT00778258|4010486|P6|Overall Study|Adverse Event|1
1222599|NCT00778258|4010487|P5|Overall Study|Adverse Event|0
1222600|NCT00778258|4010488|P4|Overall Study|Adverse Event|0
1222601|NCT00778258|4010489|P3|Overall Study|Adverse Event|0
1222602|NCT00778258|4010490|P2|Overall Study|Adverse Event|0
1222603|NCT00778258|4010491|P1|Overall Study|Adverse Event|1
1222604|NCT00778102|4010558|P2|Overall Study|Administrative Reason|10
1222605|NCT00778102|4010559|P1|Overall Study|Administrative Reason|7
1222606|NCT00778102|4010558|P2|Overall Study|Withdrawal by Subject|1
1222607|NCT00778102|4010559|P1|Overall Study|Withdrawal by Subject|1
1222608|NCT00778102|4010558|P2|Overall Study|Refused Treatment|3
1222609|NCT00778102|4010559|P1|Overall Study|Refused Treatment|2
1222610|NCT00778102|4010558|P2|Overall Study|Protocol Violation|1
1222611|NCT00778102|4010559|P1|Overall Study|Protocol Violation|0
1222612|NCT00778102|4010558|P2|Overall Study|Violation of Selection Criteria|1
1222613|NCT00778102|4010559|P1|Overall Study|Violation of Selection Criteria|1
1222614|NCT00778102|4010558|P2|Overall Study|Lost to Follow-up|0
1222615|NCT00778102|4010559|P1|Overall Study|Lost to Follow-up|1
1222616|NCT00778102|4010558|P2|Overall Study|Death|1
1222617|NCT00778102|4010559|P1|Overall Study|Death|1
1222618|NCT00778102|4010558|P2|Overall Study|Adverse Event|5
1222619|NCT00778102|4010559|P1|Overall Study|Adverse Event|8
1222620|NCT00777946|4010594|P3|Overall Study|Randomized in error|0
1222621|NCT00777946|4010595|P2|Overall Study|Randomized in error|1
1222622|NCT00777946|4010596|P1|Overall Study|Randomized in error|1
1222623|NCT00777946|4010594|P3|Overall Study|Protocol deviation|1
1222624|NCT00777946|4010595|P2|Overall Study|Protocol deviation|1
1222625|NCT00777946|4010596|P1|Overall Study|Protocol deviation|2
1222626|NCT00777946|4010594|P3|Overall Study|Lost to Follow-up|0
1222627|NCT00777946|4010595|P2|Overall Study|Lost to Follow-up|1
1222628|NCT00777946|4010596|P1|Overall Study|Lost to Follow-up|3
1222629|NCT00777946|4010594|P3|Overall Study|Patient withdrew consent|3
1222630|NCT00777946|4010595|P2|Overall Study|Patient withdrew consent|2
1222631|NCT00777946|4010596|P1|Overall Study|Patient withdrew consent|3
1222632|NCT00777946|4010594|P3|Overall Study|Condition no longer required study drug|0
1222633|NCT00777946|4010595|P2|Overall Study|Condition no longer required study drug|0
1222634|NCT00777946|4010596|P1|Overall Study|Condition no longer required study drug|1
1222635|NCT00777946|4010594|P3|Overall Study|Lack of Efficacy|9
1222636|NCT00777946|4010595|P2|Overall Study|Lack of Efficacy|0
1222637|NCT00777946|4010596|P1|Overall Study|Lack of Efficacy|0
1222638|NCT00777946|4010594|P3|Overall Study|Adverse Event|3
1222639|NCT00777946|4010595|P2|Overall Study|Adverse Event|1
1222640|NCT00777946|4010596|P1|Overall Study|Adverse Event|11
1222641|NCT00777803|4010631|P2|Overall Study|Non-compliance|2
1222642|NCT00777803|4010632|P1|Overall Study|Non-compliance|2
1222643|NCT00777803|4010631|P2|Overall Study|Adverse Event|0
1222644|NCT00777803|4010632|P1|Overall Study|Adverse Event|1
1222645|NCT00777803|4010631|P2|Overall Study|Lost to Follow-up|5
1222646|NCT00777803|4010632|P1|Overall Study|Lost to Follow-up|12
1222647|NCT00777608|4010711|P2|Overall Study|Investigator Decision|2
1222648|NCT00777608|4010712|P1|Overall Study|Investigator Decision|1
1222649|NCT00777608|4010711|P2|Overall Study|Protocol Violation|0
1222650|NCT00777608|4010712|P1|Overall Study|Protocol Violation|1
1222651|NCT00777608|4010711|P2|Overall Study|Withdrawal by Subject|3
1222652|NCT00777608|4010712|P1|Overall Study|Withdrawal by Subject|1
1222653|NCT00777608|4010711|P2|Overall Study|Lost to Follow-up|1
1222654|NCT00777608|4010712|P1|Overall Study|Lost to Follow-up|1
1222655|NCT00777556|4010722|P1|Overall Study|Did not complete all 3 follow-up visits|20
1222656|NCT00777556|4010722|P1|Overall Study|Dispensed but did not use product|12
1222657|NCT00777556|4010722|P1|Overall Study|Inappropriate self-selection|34
1222658|NCT00777257|4010743|P3|Overall Study|Withdrawal by Subject|5
1222659|NCT00777257|4010744|P2|Overall Study|Withdrawal by Subject|6
1222660|NCT00777257|4010745|P1|Overall Study|Withdrawal by Subject|3
1222661|NCT00777257|4010743|P3|Overall Study|Protocol Violation|2
1222662|NCT00777257|4010744|P2|Overall Study|Protocol Violation|2
1222663|NCT00777257|4010745|P1|Overall Study|Protocol Violation|2
1222664|NCT00777257|4010743|P3|Overall Study|Lost to Follow-up|2
1222665|NCT00777257|4010744|P2|Overall Study|Lost to Follow-up|3
1222666|NCT00777257|4010745|P1|Overall Study|Lost to Follow-up|3
1222667|NCT00777257|4010743|P3|Overall Study|Adverse Event|0
1222668|NCT00777257|4010744|P2|Overall Study|Adverse Event|1
1222669|NCT00777257|4010745|P1|Overall Study|Adverse Event|3
1222670|NCT00777205|4010764|P2|Overall Study|Protocol Violation|56
1222671|NCT00777205|4010765|P1|Overall Study|Protocol Violation|0
1222672|NCT00777205|4010764|P2|Overall Study|Death|2
1222673|NCT00777205|4010765|P1|Overall Study|Death|0
1222674|NCT00777205|4010764|P2|Overall Study|Withdrawal by Subject|4
1222675|NCT00777205|4010765|P1|Overall Study|Withdrawal by Subject|6
1222676|NCT00777205|4010764|P2|Overall Study|Lost to Follow-up|9
1222677|NCT00777205|4010765|P1|Overall Study|Lost to Follow-up|25
1222678|NCT00777153|4010799|P3|Overall Study|Incorrect enrol/elig crit not fulfilled|1
1222679|NCT00777153|4010800|P2|Overall Study|Incorrect enrol/elig crit not fulfilled|5
1222680|NCT00777153|4010801|P1|Overall Study|Incorrect enrol/elig crit not fulfilled|1
1222681|NCT00777153|4010799|P3|Overall Study|Withdrawal by Subject|3
1222682|NCT00777153|4010800|P2|Overall Study|Withdrawal by Subject|4
1222683|NCT00777153|4010801|P1|Overall Study|Withdrawal by Subject|3
1222684|NCT00777153|4010799|P3|Overall Study|Death|33
1222685|NCT00777153|4010800|P2|Overall Study|Death|73
1222686|NCT00777153|4010801|P1|Overall Study|Death|85
1222687|NCT00777153|4010799|P3|Overall Study|Lost to Follow-up|0
1222688|NCT00777153|4010800|P2|Overall Study|Lost to Follow-up|1
1222689|NCT00777153|4010801|P1|Overall Study|Lost to Follow-up|1
1222690|NCT00777101|4010826|P2|Overall Study|Failed to Return|1
1222691|NCT00777101|4010827|P1|Overall Study|Failed to Return|0
1222692|NCT00777101|4010826|P2|Overall Study|Discontinuation of Study by Sponsor|0
1222693|NCT00777101|4010827|P1|Overall Study|Discontinuation of Study by Sponsor|1
1222694|NCT00777101|4010826|P2|Overall Study|Lost to Follow-up|1
1222695|NCT00777101|4010827|P1|Overall Study|Lost to Follow-up|2
1222696|NCT00777101|4010826|P2|Overall Study|Withdrawal by Subject|6
1222697|NCT00777101|4010827|P1|Overall Study|Withdrawal by Subject|11
1222698|NCT00777101|4010826|P2|Overall Study|Death|43
1222699|NCT00777101|4010827|P1|Overall Study|Death|48
1222700|NCT00777088|4010845|P1|Overall Study|PED Treatment not attempted|1
1222701|NCT00777049|4010870|P2|Overall Study|No treatment (elevated liver enzymes)|1
1222702|NCT00777049|4010871|P1|Overall Study|No treatment (elevated liver enzymes)|0
1222703|NCT00777049|4010870|P2|Overall Study|Withdrawal by Subject|0
1222704|NCT00777049|4010871|P1|Overall Study|Withdrawal by Subject|1
1222705|NCT00777036|4010880|P3|Follow-Up|Death|0
1222706|NCT00777036|4010881|P2|Follow-Up|Death|8
1222707|NCT00777036|4010882|P1|Follow-Up|Death|1
1222708|NCT00777036|4010880|P3|Follow-Up|Withdrawal by Subject|4
1222709|NCT00777036|4010881|P2|Follow-Up|Withdrawal by Subject|0
1222710|NCT00777036|4010882|P1|Follow-Up|Withdrawal by Subject|1
1222711|NCT00777036|4010880|P3|Follow-Up|Reason Not Specified|0
1222712|NCT00777036|4010881|P2|Follow-Up|Reason Not Specified|0
1222713|NCT00777036|4010882|P1|Follow-Up|Reason Not Specified|2
1222714|NCT00777036|4010880|P3|Follow-Up|Lost to Follow-up|0
1222715|NCT00777036|4010881|P2|Follow-Up|Lost to Follow-up|0
1222716|NCT00777036|4010882|P1|Follow-Up|Lost to Follow-up|1
1222717|NCT00777036|4010880|P3|On Treatment|Progressive Disease|6
1222718|NCT00777036|4010881|P2|On Treatment|Progressive Disease|4
1222719|NCT00777036|4010882|P1|On Treatment|Progressive Disease|5
1222720|NCT00777036|4010880|P3|On Treatment|Study Drug Toxicity|1
1222721|NCT00777036|4010881|P2|On Treatment|Study Drug Toxicity|0
1222722|NCT00777036|4010882|P1|On Treatment|Study Drug Toxicity|0
1222723|NCT00777036|4010880|P3|On Treatment|Death|0
1222724|NCT00777036|4010881|P2|On Treatment|Death|2
1222725|NCT00777036|4010882|P1|On Treatment|Death|0
1222726|NCT00777036|4010880|P3|On Treatment|Withdrawal by Subject|3
1222727|NCT00777036|4010881|P2|On Treatment|Withdrawal by Subject|2
1222728|NCT00777036|4010882|P1|On Treatment|Withdrawal by Subject|3
1222729|NCT00777036|4010880|P3|On Treatment|Maximum Clinical Benefit|1
1222730|NCT00777036|4010881|P2|On Treatment|Maximum Clinical Benefit|0
1222731|NCT00777036|4010882|P1|On Treatment|Maximum Clinical Benefit|2
1222732|NCT00777036|4010880|P3|On Treatment|Non-compliance with Study Drug|0
1222733|NCT00777036|4010881|P2|On Treatment|Non-compliance with Study Drug|0
1222734|NCT00777036|4010882|P1|On Treatment|Non-compliance with Study Drug|1
1222735|NCT00777036|4010880|P3|On Treatment|Failure to Meet Study Criteria|0
1222736|NCT00777036|4010881|P2|On Treatment|Failure to Meet Study Criteria|1
1222737|NCT00777036|4010882|P1|On Treatment|Failure to Meet Study Criteria|0
1222738|NCT00777036|4010880|P3|On Treatment|Reason Not Specified|12
1222739|NCT00777036|4010881|P2|On Treatment|Reason Not Specified|7
1222740|NCT00777036|4010882|P1|On Treatment|Reason Not Specified|4
1222741|NCT00777023|4010978|P3|Overall Study|Last dose date unknown|1
1222742|NCT00777023|4010979|P2|Overall Study|Last dose date unknown|3
1222743|NCT00777023|4010980|P1|Overall Study|Last dose date unknown|3
1222744|NCT00777023|4010978|P3|Overall Study|Reasons not specified|2
1222745|NCT00777023|4010979|P2|Overall Study|Reasons not specified|4
1222746|NCT00777023|4010980|P1|Overall Study|Reasons not specified|4
1222747|NCT00777023|4010978|P3|Overall Study|Missing data|0
1222748|NCT00777023|4010979|P2|Overall Study|Missing data|1
1222749|NCT00777023|4010980|P1|Overall Study|Missing data|1
1222750|NCT00777023|4010978|P3|Overall Study|Withdrawal by Subject|8
1222751|NCT00777023|4010979|P2|Overall Study|Withdrawal by Subject|7
1222752|NCT00777023|4010980|P1|Overall Study|Withdrawal by Subject|7
1222753|NCT00777023|4010978|P3|Overall Study|Death|0
1222754|NCT00777023|4010979|P2|Overall Study|Death|1
1222755|NCT00777023|4010980|P1|Overall Study|Death|0
1222756|NCT00777023|4010978|P3|Overall Study|Lost to Follow-up|3
1222757|NCT00777023|4010979|P2|Overall Study|Lost to Follow-up|3
1222758|NCT00777023|4010980|P1|Overall Study|Lost to Follow-up|2
1222759|NCT00777023|4010978|P3|Overall Study|Protocol Violation|1
1222760|NCT00777023|4010979|P2|Overall Study|Protocol Violation|1
1222761|NCT00777023|4010980|P1|Overall Study|Protocol Violation|2
1222762|NCT00777023|4010978|P3|Overall Study|Lack of Efficacy|14
1222763|NCT00777023|4010979|P2|Overall Study|Lack of Efficacy|0
1222764|NCT00777023|4010980|P1|Overall Study|Lack of Efficacy|1
1222765|NCT00777023|4010978|P3|Overall Study|Adverse Event|8
1222766|NCT00777023|4010979|P2|Overall Study|Adverse Event|21
1222767|NCT00777023|4010980|P1|Overall Study|Adverse Event|15
1222768|NCT00776997|4010997|P1|Overall Study|Adverse Event|2
1222769|NCT00776984|4011006|P2|Overall Study|Other|9
1222770|NCT00776984|4011007|P1|Overall Study|Other|5
1222771|NCT00776984|4011006|P2|Overall Study|Lack of Efficacy|1
1222772|NCT00776984|4011007|P1|Overall Study|Lack of Efficacy|0
1222773|NCT00776984|4011006|P2|Overall Study|Withdrawal by Subject|7
1222774|NCT00776984|4011007|P1|Overall Study|Withdrawal by Subject|12
1222775|NCT00776984|4011006|P2|Overall Study|Lost to Follow-up|0
1222776|NCT00776984|4011007|P1|Overall Study|Lost to Follow-up|2
1222777|NCT00776984|4011006|P2|Overall Study|Protocol Violation|2
1222778|NCT00776984|4011007|P1|Overall Study|Protocol Violation|4
1222779|NCT00776984|4011006|P2|Overall Study|Adverse Event|2
1222780|NCT00776984|4011007|P1|Overall Study|Adverse Event|8
1222781|NCT00776919|4011081|P4|Overall Study|Other: Lack of Efficacy/Lost Medication|2
1222782|NCT00776919|4011082|P3|Overall Study|Other: Lack of Efficacy/Lost Medication|4
1222783|NCT00776919|4011083|P2|Overall Study|Other: Lack of Efficacy/Lost Medication|5
1222784|NCT00776919|4011084|P1|Overall Study|Other: Lack of Efficacy/Lost Medication|1
1222785|NCT00776919|4011081|P4|Overall Study|Protocol Violation|1
1222786|NCT00776919|4011082|P3|Overall Study|Protocol Violation|0
1222787|NCT00776919|4011083|P2|Overall Study|Protocol Violation|2
1222788|NCT00776919|4011084|P1|Overall Study|Protocol Violation|1
1222789|NCT00776919|4011081|P4|Overall Study|Adverse Event|2
1222790|NCT00776919|4011082|P3|Overall Study|Adverse Event|2
1222791|NCT00776919|4011083|P2|Overall Study|Adverse Event|0
1222792|NCT00776919|4011084|P1|Overall Study|Adverse Event|1
1222793|NCT00776919|4011081|P4|Overall Study|Lost to Follow-up|8
1222794|NCT00776919|4011082|P3|Overall Study|Lost to Follow-up|11
1222795|NCT00776919|4011083|P2|Overall Study|Lost to Follow-up|12
1222796|NCT00776919|4011084|P1|Overall Study|Lost to Follow-up|8
1222797|NCT00776919|4011081|P4|Overall Study|Withdrawal by Subject|26
1222798|NCT00776919|4011082|P3|Overall Study|Withdrawal by Subject|15
1222799|NCT00776919|4011083|P2|Overall Study|Withdrawal by Subject|14
1222800|NCT00776919|4011084|P1|Overall Study|Withdrawal by Subject|16
1222801|NCT00776789|4011148|P2|Overall Study|Poor quality video|1
1222802|NCT00776789|4011149|P1|Overall Study|Poor quality video|1
1222803|NCT00776789|4011148|P2|Overall Study|Consent refusal|2
1222804|NCT00776789|4011149|P1|Overall Study|Consent refusal|2
1222805|NCT00776659|4011161|P1|Overall Study|Study Terminated by Sponsor|1
1222806|NCT00776659|4011161|P1|Overall Study|Withdrawal by Subject|10
1222807|NCT00776659|4011161|P1|Overall Study|Lost to Follow-up|15
1222808|NCT00776555|4011188|P2|Overall Study|Study terminated|0
1222809|NCT00776555|4011189|P1|Overall Study|Study terminated|3
1222810|NCT00776230|4011207|P3|Overall Study|Subject missed Visit 4|0
1222811|NCT00776230|4011208|P2|Overall Study|Subject missed Visit 4|1
1222812|NCT00776230|4011209|P1|Overall Study|Subject missed Visit 4|0
1222813|NCT00776230|4011207|P3|Overall Study|Withdrawal by Subject|0
1222814|NCT00776230|4011208|P2|Overall Study|Withdrawal by Subject|1
1222815|NCT00776230|4011209|P1|Overall Study|Withdrawal by Subject|0
1222816|NCT00776230|4011207|P3|Overall Study|Not vaccinated at Day 0|0
1222817|NCT00776230|4011208|P2|Overall Study|Not vaccinated at Day 0|0
1222818|NCT00776230|4011209|P1|Overall Study|Not vaccinated at Day 0|1
1222819|NCT00776230|4011207|P3|Overall Study|Lost to Follow-up|5
1222820|NCT00776230|4011208|P2|Overall Study|Lost to Follow-up|1
1222821|NCT00776230|4011209|P1|Overall Study|Lost to Follow-up|2
1222822|NCT00776100|4011219|P2|Overall Study|Disease Progression|0
1222823|NCT00776100|4011220|P1|Overall Study|Disease Progression|1
1222824|NCT00776009|4011242|P6|Period 3: Third Intervention|Withdrawal by Subject|0
1222825|NCT00776009|4011243|P5|Period 3: Third Intervention|Withdrawal by Subject|0
1222826|NCT00776009|4011244|P4|Period 3: Third Intervention|Withdrawal by Subject|0
1222827|NCT00776009|4011245|P3|Period 3: Third Intervention|Withdrawal by Subject|0
1222828|NCT00776009|4011246|P2|Period 3: Third Intervention|Withdrawal by Subject|0
1222829|NCT00776009|4011247|P1|Period 3: Third Intervention|Withdrawal by Subject|1
1222830|NCT00776009|4011242|P6|Period 2: Second Intervention|Protocol Violation|0
1222831|NCT00776009|4011243|P5|Period 2: Second Intervention|Protocol Violation|0
1222832|NCT00776009|4011244|P4|Period 2: Second Intervention|Protocol Violation|0
1222833|NCT00776009|4011245|P3|Period 2: Second Intervention|Protocol Violation|1
1222834|NCT00776009|4011246|P2|Period 2: Second Intervention|Protocol Violation|0
1222835|NCT00776009|4011247|P1|Period 2: Second Intervention|Protocol Violation|1
1222836|NCT00776009|4011242|P6|Period 2: Second Intervention|Withdrawal by Subject|1
1222837|NCT00776009|4011243|P5|Period 2: Second Intervention|Withdrawal by Subject|0
1222838|NCT00776009|4011244|P4|Period 2: Second Intervention|Withdrawal by Subject|0
1222839|NCT00776009|4011245|P3|Period 2: Second Intervention|Withdrawal by Subject|0
1222840|NCT00776009|4011246|P2|Period 2: Second Intervention|Withdrawal by Subject|0
1222841|NCT00776009|4011247|P1|Period 2: Second Intervention|Withdrawal by Subject|0
1222842|NCT00776009|4011242|P6|Period 1: First Intervention|Protocol Violation|0
1222843|NCT00776009|4011243|P5|Period 1: First Intervention|Protocol Violation|1
1222844|NCT00776009|4011244|P4|Period 1: First Intervention|Protocol Violation|0
1222845|NCT00776009|4011245|P3|Period 1: First Intervention|Protocol Violation|0
1222846|NCT00776009|4011246|P2|Period 1: First Intervention|Protocol Violation|1
1222847|NCT00776009|4011247|P1|Period 1: First Intervention|Protocol Violation|0
1222848|NCT00776009|4011242|P6|Period 1: First Intervention|Withdrawal by Subject|0
1222849|NCT00776009|4011243|P5|Period 1: First Intervention|Withdrawal by Subject|1
1222850|NCT00776009|4011244|P4|Period 1: First Intervention|Withdrawal by Subject|0
1222851|NCT00776009|4011245|P3|Period 1: First Intervention|Withdrawal by Subject|1
1222852|NCT00776009|4011246|P2|Period 1: First Intervention|Withdrawal by Subject|0
1222853|NCT00776009|4011247|P1|Period 1: First Intervention|Withdrawal by Subject|0
1222854|NCT00775983|4011269|P2|Overall Study|Protocol Violation|2
1222855|NCT00775983|4011270|P1|Overall Study|Protocol Violation|1
1222856|NCT00775606|4011381|P2|Overall Study|Study sponsor terminated funding|0
1222857|NCT00775606|4011382|P1|Overall Study|Study sponsor terminated funding|3
1222858|NCT00775593|4011392|P1|Overall Study|Death|1
1222859|NCT00775593|4011392|P1|Overall Study|Unmet eligibility criteria|6
1222860|NCT00775528|4011399|P1|Overall Study|Protocol Violation|1
1222861|NCT00775463|4011408|P2|Overall Study|Lack of Efficacy|1
1222862|NCT00775463|4011409|P1|Overall Study|Lack of Efficacy|1
1222863|NCT00775463|4011408|P2|Overall Study|Lost to Follow-up|0
1222864|NCT00775463|4011409|P1|Overall Study|Lost to Follow-up|1
1222865|NCT00775463|4011408|P2|Overall Study|Protocol Violation|2
1222866|NCT00775463|4011409|P1|Overall Study|Protocol Violation|2
1222867|NCT00775463|4011408|P2|Overall Study|Adverse Event|9
1222868|NCT00775463|4011409|P1|Overall Study|Adverse Event|7
1222869|NCT00775463|4011408|P2|Overall Study|Withdrawal by Subject|1
1222870|NCT00775463|4011409|P1|Overall Study|Withdrawal by Subject|0
1222871|NCT00775450|4011446|P5|Overall Study|Withdrawal by Subject|1
1222872|NCT00775450|4011447|P4|Overall Study|Withdrawal by Subject|0
1222873|NCT00775450|4011448|P3|Overall Study|Withdrawal by Subject|0
1222874|NCT00775450|4011449|P2|Overall Study|Withdrawal by Subject|0
1222875|NCT00775450|4011450|P1|Overall Study|Withdrawal by Subject|1
1222876|NCT00775450|4011446|P5|Overall Study|Protocol Violation|1
1222877|NCT00775450|4011447|P4|Overall Study|Protocol Violation|0
1222878|NCT00775450|4011448|P3|Overall Study|Protocol Violation|0
1222879|NCT00775450|4011449|P2|Overall Study|Protocol Violation|0
1222880|NCT00775450|4011450|P1|Overall Study|Protocol Violation|0
1222881|NCT00775450|4011446|P5|Overall Study|Serious Adverse Event|0
1222882|NCT00775450|4011447|P4|Overall Study|Serious Adverse Event|0
1222883|NCT00775450|4011448|P3|Overall Study|Serious Adverse Event|0
1222884|NCT00775450|4011449|P2|Overall Study|Serious Adverse Event|0
1222885|NCT00775450|4011450|P1|Overall Study|Serious Adverse Event|2
1222886|NCT00775437|4011477|P1|Overall Study|Lost to Follow-up|1
1222887|NCT00775437|4011477|P1|Overall Study|Withdrawal by Subject|3
1222888|NCT00775437|4011477|P1|Overall Study|Loss of efficacy|2
1222889|NCT00775203|4011552|P2|Overall Study|Physician Decision|1
1222890|NCT00775203|4011553|P1|Overall Study|Physician Decision|0
1222891|NCT00775203|4011552|P2|Overall Study|Entered other study|0
1222892|NCT00775203|4011553|P1|Overall Study|Entered other study|1
1222893|NCT00775203|4011552|P2|Overall Study|Protocol Violation|1
1222894|NCT00775203|4011553|P1|Overall Study|Protocol Violation|0
1222895|NCT00775203|4011552|P2|Overall Study|Noncompliance|2
1222896|NCT00775203|4011553|P1|Overall Study|Noncompliance|4
1222897|NCT00775203|4011552|P2|Overall Study|Administrative reason|0
1222898|NCT00775203|4011553|P1|Overall Study|Administrative reason|2
1222899|NCT00775203|4011552|P2|Overall Study|Lost to Follow-up|15
1222900|NCT00775203|4011553|P1|Overall Study|Lost to Follow-up|11
1222901|NCT00775203|4011552|P2|Overall Study|Withdrawal by Subject|9
1222902|NCT00775203|4011553|P1|Overall Study|Withdrawal by Subject|11
1222903|NCT00775203|4011552|P2|Overall Study|Lack of Efficacy|9
1222904|NCT00775203|4011553|P1|Overall Study|Lack of Efficacy|8
1222905|NCT00775203|4011552|P2|Overall Study|Adverse Event|6
1222906|NCT00775203|4011553|P1|Overall Study|Adverse Event|25
1222907|NCT00775190|4011587|P2|Overall Study|Protocol Violation|0
1222908|NCT00775190|4011588|P1|Overall Study|Protocol Violation|1
1222909|NCT00775190|4011587|P2|Overall Study|Withdrawal by Subject|2
1222910|NCT00775190|4011588|P1|Overall Study|Withdrawal by Subject|1
1222911|NCT00775190|4011587|P2|Overall Study|Lost to Follow-up|3
1222912|NCT00775190|4011588|P1|Overall Study|Lost to Follow-up|2
1222913|NCT00775021|4011610|P2|Second Intervention|Adverse Event|1
1222914|NCT00775021|4011611|P1|Second Intervention|Adverse Event|0
1222915|NCT00775021|4011610|P2|First Intervention|Lost to Follow-up|0
1222916|NCT00775021|4011611|P1|First Intervention|Lost to Follow-up|1
1222917|NCT00774995|4011629|P4|Overall Study|Protocol Violation|0
1222918|NCT00774995|4011630|P3|Overall Study|Protocol Violation|1
1222919|NCT00774995|4011631|P2|Overall Study|Protocol Violation|0
1222920|NCT00774995|4011632|P1|Overall Study|Protocol Violation|0
1222921|NCT00774930|4011672|P2|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1
1222922|NCT00774930|4011673|P1|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0
1222923|NCT00774930|4011672|P2|LTOLE Phase|Tumour Progression of Hepatic Metastases|1
1222924|NCT00774930|4011673|P1|LTOLE Phase|Tumour Progression of Hepatic Metastases|0
1222925|NCT00774930|4011672|P2|LTOLE Phase|Disease Progression|5
1222926|NCT00774930|4011673|P1|LTOLE Phase|Disease Progression|2
1222927|NCT00774930|4011672|P2|LTOLE Phase|Sponsor decision|1
1222928|NCT00774930|4011673|P1|LTOLE Phase|Sponsor decision|2
1222929|NCT00774930|4011672|P2|LTOLE Phase|Physician Decision|1
1222930|NCT00774930|4011673|P1|LTOLE Phase|Physician Decision|4
1222931|NCT00774930|4011672|P2|LTOLE Phase|Subject decision|5
1222932|NCT00774930|4011673|P1|LTOLE Phase|Subject decision|0
1222933|NCT00774930|4011672|P2|LTOLE Phase|Adverse Event|3
1222934|NCT00774930|4011673|P1|LTOLE Phase|Adverse Event|7
1222935|NCT00774930|4011672|P2|IOL Phase|Brain radiation|1
1222936|NCT00774930|4011673|P1|IOL Phase|Brain radiation|0
1222937|NCT00774930|4011672|P2|IOL Phase|Other|0
1222938|NCT00774930|4011673|P1|IOL Phase|Other|1
1222939|NCT00774930|4011672|P2|IOL Phase|Peptide Receptor Radionuclide Therapy|1
1222940|NCT00774930|4011673|P1|IOL Phase|Peptide Receptor Radionuclide Therapy|0
1222941|NCT00774930|4011672|P2|IOL Phase|Subject Consumed Prohibited Medication|0
1222942|NCT00774930|4011673|P1|IOL Phase|Subject Consumed Prohibited Medication|1
1222943|NCT00774930|4011672|P2|IOL Phase|Disease Progression|1
1222944|NCT00774930|4011673|P1|IOL Phase|Disease Progression|2
1222945|NCT00774930|4011672|P2|IOL Phase|Sponsor Decision|0
1222946|NCT00774930|4011673|P1|IOL Phase|Sponsor Decision|1
1222947|NCT00774930|4011672|P2|IOL Phase|Physician Decision|2
1222948|NCT00774930|4011673|P1|IOL Phase|Physician Decision|3
1222949|NCT00774930|4011672|P2|IOL Phase|Subject Decision|3
1222950|NCT00774930|4011673|P1|IOL Phase|Subject Decision|4
1222951|NCT00774930|4011672|P2|IOL Phase|Adverse Event|1
1222952|NCT00774930|4011673|P1|IOL Phase|Adverse Event|1
1222953|NCT00774930|4011672|P2|DB Phase|Started Nonprotocol Radiation therapy|1
1222954|NCT00774930|4011673|P1|DB Phase|Started Nonprotocol Radiation therapy|0
1222955|NCT00774930|4011672|P2|DB Phase|Disease Progression|1
1222956|NCT00774930|4011673|P1|DB Phase|Disease Progression|1
1222957|NCT00774930|4011672|P2|DB Phase|Sponsor Decision|1
1222958|NCT00774930|4011673|P1|DB Phase|Sponsor Decision|0
1222959|NCT00774930|4011672|P2|DB Phase|Subject Decision|5
1222960|NCT00774930|4011673|P1|DB Phase|Subject Decision|1
1222961|NCT00774930|4011672|P2|DB Phase|Adverse Event|2
1222962|NCT00774930|4011673|P1|DB Phase|Adverse Event|1
1222963|NCT00774930|4011672|P2|DB Phase|Early Roll Over (ERO) to IOL phase|12
1222964|NCT00774930|4011673|P1|DB Phase|Early Roll Over (ERO) to IOL phase|11
1222965|NCT00774852|4011701|P2|Overall Study|Subject received prohibited medication|0
1222966|NCT00774852|4011702|P1|Overall Study|Subject received prohibited medication|1
1222967|NCT00774852|4011701|P2|Overall Study|Protocol Violation|0
1222968|NCT00774852|4011702|P1|Overall Study|Protocol Violation|1
1222969|NCT00774852|4011701|P2|Overall Study|Subject non-compliance|1
1222970|NCT00774852|4011702|P1|Overall Study|Subject non-compliance|0
1222971|NCT00774852|4011701|P2|Overall Study|Non-responder|11
1222972|NCT00774852|4011702|P1|Overall Study|Non-responder|15
1222973|NCT00774852|4011701|P2|Overall Study|Withdrawal by Subject|2
1222974|NCT00774852|4011702|P1|Overall Study|Withdrawal by Subject|2
1222975|NCT00774852|4011701|P2|Overall Study|Pregnancy|2
1222976|NCT00774852|4011702|P1|Overall Study|Pregnancy|1
1222977|NCT00774852|4011701|P2|Overall Study|Physician Decision|6
1222978|NCT00774852|4011702|P1|Overall Study|Physician Decision|2
1222979|NCT00774852|4011701|P2|Overall Study|Lost to Follow-up|5
1222980|NCT00774852|4011702|P1|Overall Study|Lost to Follow-up|9
1222981|NCT00774852|4011701|P2|Overall Study|Lack of Efficacy|7
1222982|NCT00774852|4011702|P1|Overall Study|Lack of Efficacy|3
1222983|NCT00774852|4011701|P2|Overall Study|Death|1
1222984|NCT00774852|4011702|P1|Overall Study|Death|2
1222985|NCT00774852|4011701|P2|Overall Study|Adverse Event|6
1222986|NCT00774852|4011702|P1|Overall Study|Adverse Event|9
1222987|NCT00774800|4011750|P1|Intervention 4|Withdrawal by Subject|1
1222988|NCT00774787|4011772|P1|Overall Study|Lost to Follow-up|1
1222989|NCT00774748|4011779|P1|Overall Study|Lost to Follow-up|3
1222990|NCT00774397|4011794|P7|Overall Study|Other than those stated above|1
1222991|NCT00774397|4011795|P6|Overall Study|Other than those stated above|0
1222992|NCT00774397|4011796|P5|Overall Study|Other than those stated above|2
1222993|NCT00774397|4011797|P4|Overall Study|Other than those stated above|2
1222994|NCT00774397|4011798|P3|Overall Study|Other than those stated above|3
1222995|NCT00774397|4011799|P2|Overall Study|Other than those stated above|1
1222996|NCT00774397|4011800|P1|Overall Study|Other than those stated above|1
1222997|NCT00774397|4011794|P7|Overall Study|Not treated|1
1222998|NCT00774397|4011795|P6|Overall Study|Not treated|0
1222999|NCT00774397|4011796|P5|Overall Study|Not treated|1
1223000|NCT00774397|4011797|P4|Overall Study|Not treated|0
1223001|NCT00774397|4011798|P3|Overall Study|Not treated|0
1223002|NCT00774397|4011799|P2|Overall Study|Not treated|0
1223003|NCT00774397|4011800|P1|Overall Study|Not treated|0
1223004|NCT00774397|4011794|P7|Overall Study|Refused to continue trial medication|3
1223005|NCT00774397|4011795|P6|Overall Study|Refused to continue trial medication|2
1223006|NCT00774397|4011796|P5|Overall Study|Refused to continue trial medication|6
1223007|NCT00774397|4011797|P4|Overall Study|Refused to continue trial medication|2
1223008|NCT00774397|4011798|P3|Overall Study|Refused to continue trial medication|2
1223009|NCT00774397|4011799|P2|Overall Study|Refused to continue trial medication|3
1223010|NCT00774397|4011800|P1|Overall Study|Refused to continue trial medication|1
1223011|NCT00774397|4011794|P7|Overall Study|Lost to Follow-up|0
1223012|NCT00774397|4011795|P6|Overall Study|Lost to Follow-up|1
1223013|NCT00774397|4011796|P5|Overall Study|Lost to Follow-up|0
1223014|NCT00774397|4011797|P4|Overall Study|Lost to Follow-up|1
1223015|NCT00774397|4011798|P3|Overall Study|Lost to Follow-up|1
1223016|NCT00774397|4011799|P2|Overall Study|Lost to Follow-up|1
1223017|NCT00774397|4011800|P1|Overall Study|Lost to Follow-up|0
1223018|NCT00774397|4011794|P7|Overall Study|Protocol Violation|0
1223019|NCT00774397|4011795|P6|Overall Study|Protocol Violation|1
1223020|NCT00774397|4011796|P5|Overall Study|Protocol Violation|2
1223021|NCT00774397|4011797|P4|Overall Study|Protocol Violation|1
1223022|NCT00774397|4011798|P3|Overall Study|Protocol Violation|3
1223023|NCT00774397|4011799|P2|Overall Study|Protocol Violation|1
1223024|NCT00774397|4011800|P1|Overall Study|Protocol Violation|0
1223025|NCT00774397|4011794|P7|Overall Study|Lack of Efficacy|9
1223026|NCT00774397|4011795|P6|Overall Study|Lack of Efficacy|15
1223027|NCT00774397|4011796|P5|Overall Study|Lack of Efficacy|27
1223028|NCT00774397|4011797|P4|Overall Study|Lack of Efficacy|3
1223029|NCT00774397|4011798|P3|Overall Study|Lack of Efficacy|5
1223030|NCT00774397|4011799|P2|Overall Study|Lack of Efficacy|4
1223031|NCT00774397|4011800|P1|Overall Study|Lack of Efficacy|11
1223032|NCT00774397|4011794|P7|Overall Study|Adverse Event|16
1223033|NCT00774397|4011795|P6|Overall Study|Adverse Event|3
1223034|NCT00774397|4011796|P5|Overall Study|Adverse Event|8
1223035|NCT00774397|4011797|P4|Overall Study|Adverse Event|8
1223036|NCT00774397|4011798|P3|Overall Study|Adverse Event|16
1223037|NCT00774397|4011799|P2|Overall Study|Adverse Event|3
1223038|NCT00774397|4011800|P1|Overall Study|Adverse Event|1
1223039|NCT00774306|4012036|P4|Overall Study|Death|0
1223040|NCT00774306|4012037|P3|Overall Study|Death|0
1223041|NCT00774306|4012038|P2|Overall Study|Death|1
1223042|NCT00774306|4012039|P1|Overall Study|Death|1
1223043|NCT00774306|4012036|P4|Overall Study|Lost to Follow-up|5
1223044|NCT00774306|4012037|P3|Overall Study|Lost to Follow-up|4
1223045|NCT00774306|4012038|P2|Overall Study|Lost to Follow-up|0
1223046|NCT00774306|4012039|P1|Overall Study|Lost to Follow-up|6
1223047|NCT00774306|4012036|P4|Overall Study|Withdrawal by Subject|0
1223048|NCT00774306|4012037|P3|Overall Study|Withdrawal by Subject|1
1223049|NCT00774306|4012038|P2|Overall Study|Withdrawal by Subject|1
1223050|NCT00774306|4012039|P1|Overall Study|Withdrawal by Subject|6
1223051|NCT00774306|4012036|P4|Overall Study|Protocol Violation|0
1223052|NCT00774306|4012037|P3|Overall Study|Protocol Violation|3
1223053|NCT00774306|4012038|P2|Overall Study|Protocol Violation|0
1223054|NCT00774306|4012039|P1|Overall Study|Protocol Violation|2
1223055|NCT00774306|4012036|P4|Overall Study|Adverse Event|0
1223056|NCT00774306|4012037|P3|Overall Study|Adverse Event|0
1223057|NCT00774306|4012038|P2|Overall Study|Adverse Event|0
1223058|NCT00774306|4012039|P1|Overall Study|Adverse Event|3
1223059|NCT00774046|4012120|P1|Stem Cell Mobilization|Count too low (2), sudden death (1)|3
1223060|NCT00774046|4012120|P1|Enrollment|Desired other therapy/refused|28
1223061|NCT00774046|4012120|P1|Screening|Not eligible|56
1223062|NCT00773968|4012130|P1|Overall Study|Other|8
1223063|NCT00773968|4012130|P1|Overall Study|Screen Failure|17
1223064|NCT00773968|4012130|P1|Overall Study|Withdrawal by Subject|11
1223065|NCT00773968|4012130|P1|Overall Study|Protocol Violation|1
1223066|NCT00773968|4012130|P1|Overall Study|Lack of Efficacy|3
1223067|NCT00773968|4012130|P1|Overall Study|Failure to Return|2
1223068|NCT00773968|4012130|P1|Overall Study|Death|1
1223069|NCT00773968|4012130|P1|Overall Study|Adverse Event|2
1223070|NCT00773734|4012161|P6|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
1223071|NCT00773734|4012162|P5|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
1223072|NCT00773734|4012163|P4|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
1223073|NCT00773734|4012164|P3|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
1223074|NCT00773734|4012165|P2|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
1223075|NCT00773734|4012166|P1|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
1223076|NCT00773734|4012161|P6|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
1223077|NCT00773734|4012162|P5|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
1223078|NCT00773734|4012163|P4|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3
1223079|NCT00773734|4012164|P3|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6
1223080|NCT00773734|4012165|P2|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
1223081|NCT00773734|4012166|P1|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
1223082|NCT00773734|4012161|P6|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
1223083|NCT00773734|4012162|P5|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
1223084|NCT00773734|4012163|P4|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4
1223085|NCT00773734|4012164|P3|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2
1223086|NCT00773734|4012165|P2|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
1223087|NCT00773734|4012166|P1|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
1223088|NCT00773734|4012161|P6|LTE Period: Week 52 to 6 Years|Adverse Event|0
1223089|NCT00773734|4012162|P5|LTE Period: Week 52 to 6 Years|Adverse Event|0
1223090|NCT00773734|4012163|P4|LTE Period: Week 52 to 6 Years|Adverse Event|1
1223091|NCT00773734|4012164|P3|LTE Period: Week 52 to 6 Years|Adverse Event|0
1223092|NCT00773734|4012165|P2|LTE Period: Week 52 to 6 Years|Adverse Event|0
1223093|NCT00773734|4012166|P1|LTE Period: Week 52 to 6 Years|Adverse Event|0
1223094|NCT00773734|4012161|P6|Extension: Active Treatment Week 24-52|Other|1
1223095|NCT00773734|4012162|P5|Extension: Active Treatment Week 24-52|Other|0
1223096|NCT00773734|4012163|P4|Extension: Active Treatment Week 24-52|Other|2
1223097|NCT00773734|4012164|P3|Extension: Active Treatment Week 24-52|Other|1
1223098|NCT00773734|4012165|P2|Extension: Active Treatment Week 24-52|Other|0
1223099|NCT00773734|4012166|P1|Extension: Active Treatment Week 24-52|Other|0
1223100|NCT00773734|4012161|P6|Extension: Active Treatment Week 24-52|Lost to Follow-up|1
1223101|NCT00773734|4012162|P5|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
1223102|NCT00773734|4012163|P4|Extension: Active Treatment Week 24-52|Lost to Follow-up|3
1223103|NCT00773734|4012164|P3|Extension: Active Treatment Week 24-52|Lost to Follow-up|5
1223104|NCT00773734|4012165|P2|Extension: Active Treatment Week 24-52|Lost to Follow-up|2
1223105|NCT00773734|4012166|P1|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
1223106|NCT00773734|4012161|P6|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
1223107|NCT00773734|4012162|P5|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
1223108|NCT00773734|4012163|P4|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
1223109|NCT00773734|4012164|P3|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1
1223110|NCT00773734|4012165|P2|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
1223111|NCT00773734|4012166|P1|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0
1223112|NCT00773734|4012161|P6|Extension: Active Treatment Week 24-52|Lack of Efficacy|2
1223113|NCT00773734|4012162|P5|Extension: Active Treatment Week 24-52|Lack of Efficacy|1
1223114|NCT00773734|4012163|P4|Extension: Active Treatment Week 24-52|Lack of Efficacy|3
1223115|NCT00773734|4012164|P3|Extension: Active Treatment Week 24-52|Lack of Efficacy|10
1223116|NCT00773734|4012165|P2|Extension: Active Treatment Week 24-52|Lack of Efficacy|8
1223117|NCT00773734|4012166|P1|Extension: Active Treatment Week 24-52|Lack of Efficacy|0
1223118|NCT00773734|4012161|P6|Extension: Active Treatment Week 24-52|Adverse Event|1
1223119|NCT00773734|4012162|P5|Extension: Active Treatment Week 24-52|Adverse Event|2
1223120|NCT00773734|4012163|P4|Extension: Active Treatment Week 24-52|Adverse Event|0
1223121|NCT00773734|4012164|P3|Extension: Active Treatment Week 24-52|Adverse Event|0
1223122|NCT00773734|4012165|P2|Extension: Active Treatment Week 24-52|Adverse Event|0
1223123|NCT00773734|4012166|P1|Extension: Active Treatment Week 24-52|Adverse Event|0
1223124|NCT00773734|4012161|P6|Core: Active Treatment Phase Week 16-24|Other|0
1223125|NCT00773734|4012162|P5|Core: Active Treatment Phase Week 16-24|Other|0
1223126|NCT00773734|4012163|P4|Core: Active Treatment Phase Week 16-24|Other|0
1223127|NCT00773734|4012164|P3|Core: Active Treatment Phase Week 16-24|Other|0
1223128|NCT00773734|4012165|P2|Core: Active Treatment Phase Week 16-24|Other|1
1223129|NCT00773734|4012166|P1|Core: Active Treatment Phase Week 16-24|Other|0
1223130|NCT00773734|4012161|P6|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
1223131|NCT00773734|4012162|P5|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
1223132|NCT00773734|4012163|P4|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
1223133|NCT00773734|4012164|P3|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
1223134|NCT00773734|4012165|P2|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
1223135|NCT00773734|4012166|P1|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
1223136|NCT00773734|4012161|P6|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
1223137|NCT00773734|4012162|P5|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
1223138|NCT00773734|4012163|P4|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
1223139|NCT00773734|4012164|P3|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
1223140|NCT00773734|4012165|P2|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
1223141|NCT00773734|4012166|P1|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
1223142|NCT00773734|4012161|P6|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2
1223143|NCT00773734|4012162|P5|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
1223144|NCT00773734|4012163|P4|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
1223145|NCT00773734|4012164|P3|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
1223146|NCT00773734|4012165|P2|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
1223147|NCT00773734|4012166|P1|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
1223148|NCT00773734|4012161|P6|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
1223149|NCT00773734|4012162|P5|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
1223150|NCT00773734|4012163|P4|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1
1223151|NCT00773734|4012164|P3|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
1223152|NCT00773734|4012165|P2|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
1223153|NCT00773734|4012166|P1|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
1223154|NCT00773734|4012161|P6|Core: Active Treatment Phase Week 16-24|Adverse Event|2
1223155|NCT00773734|4012162|P5|Core: Active Treatment Phase Week 16-24|Adverse Event|1
1223156|NCT00773734|4012163|P4|Core: Active Treatment Phase Week 16-24|Adverse Event|0
1223157|NCT00773734|4012164|P3|Core: Active Treatment Phase Week 16-24|Adverse Event|0
1223158|NCT00773734|4012165|P2|Core: Active Treatment Phase Week 16-24|Adverse Event|4
1223159|NCT00773734|4012166|P1|Core: Active Treatment Phase Week 16-24|Adverse Event|0
1223160|NCT00773734|4012161|P6|Core: Placebo Controlled Phase Week 0-16|Other|0
1223161|NCT00773734|4012162|P5|Core: Placebo Controlled Phase Week 0-16|Other|0
1223162|NCT00773734|4012163|P4|Core: Placebo Controlled Phase Week 0-16|Other|1
1223163|NCT00773734|4012164|P3|Core: Placebo Controlled Phase Week 0-16|Other|1
1223164|NCT00773734|4012165|P2|Core: Placebo Controlled Phase Week 0-16|Other|1
1223165|NCT00773734|4012166|P1|Core: Placebo Controlled Phase Week 0-16|Other|1
1223166|NCT00773734|4012161|P6|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
1223167|NCT00773734|4012162|P5|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
1223168|NCT00773734|4012163|P4|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
1223169|NCT00773734|4012164|P3|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4
1223170|NCT00773734|4012165|P2|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3
1223171|NCT00773734|4012166|P1|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1
1223172|NCT00773734|4012161|P6|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
1223173|NCT00773734|4012162|P5|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
1223174|NCT00773734|4012163|P4|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1
1223175|NCT00773734|4012164|P3|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
1223176|NCT00773734|4012165|P2|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
1223177|NCT00773734|4012166|P1|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2
1223178|NCT00773734|4012161|P6|Core: Placebo Controlled Phase Week 0-16|Death|0
1223179|NCT00773734|4012162|P5|Core: Placebo Controlled Phase Week 0-16|Death|0
1223180|NCT00773734|4012163|P4|Core: Placebo Controlled Phase Week 0-16|Death|0
1223181|NCT00773734|4012164|P3|Core: Placebo Controlled Phase Week 0-16|Death|0
1223182|NCT00773734|4012165|P2|Core: Placebo Controlled Phase Week 0-16|Death|0
1223183|NCT00773734|4012166|P1|Core: Placebo Controlled Phase Week 0-16|Death|1
1223184|NCT00773734|4012161|P6|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
1223185|NCT00773734|4012162|P5|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
1223186|NCT00773734|4012163|P4|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4
1223187|NCT00773734|4012164|P3|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6
1223188|NCT00773734|4012165|P2|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
1223189|NCT00773734|4012166|P1|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
1223190|NCT00773734|4012161|P6|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
1223191|NCT00773734|4012162|P5|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
1223192|NCT00773734|4012163|P4|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
1223193|NCT00773734|4012164|P3|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
1223194|NCT00773734|4012165|P2|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3
1223195|NCT00773734|4012166|P1|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4
1223196|NCT00773734|4012161|P6|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
1223197|NCT00773734|4012162|P5|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
1223198|NCT00773734|4012163|P4|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10
1223199|NCT00773734|4012164|P3|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8
1223200|NCT00773734|4012165|P2|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1
1223201|NCT00773734|4012166|P1|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5
1223202|NCT00773513|4012730|P2|Overall Study|Death|545
1223203|NCT00773513|4012731|P1|Overall Study|Death|531
1223204|NCT00773513|4012730|P2|Overall Study|Reason Not Specified|126
1223205|NCT00773513|4012731|P1|Overall Study|Reason Not Specified|159
1223206|NCT00773513|4012730|P2|Overall Study|Insufficient Therapeutic Response|18
1223207|NCT00773513|4012731|P1|Overall Study|Insufficient Therapeutic Response|1
1223208|NCT00773513|4012730|P2|Overall Study|Failure to Return|8
1223209|NCT00773513|4012731|P1|Overall Study|Failure to Return|22
1223210|NCT00773513|4012730|P2|Overall Study|Refused Treatment / Did not Cooperate|32
1223211|NCT00773513|4012731|P1|Overall Study|Refused Treatment / Did not Cooperate|26
1223212|NCT00773513|4012730|P2|Overall Study|Withdrew Consent|69
1223213|NCT00773513|4012731|P1|Overall Study|Withdrew Consent|68
1223214|NCT00773513|4012730|P2|Overall Study|Adverse Event / Intercurrent Illness|48
1223215|NCT00773513|4012731|P1|Overall Study|Adverse Event / Intercurrent Illness|40
1223216|NCT00773513|4012730|P2|Overall Study|Renal Transplant|263
1223217|NCT00773513|4012731|P1|Overall Study|Renal Transplant|254
1223218|NCT00773461|4012760|P2|Overall Study|Withdrawal by Subject|1
1223219|NCT00773461|4012761|P1|Overall Study|Withdrawal by Subject|4
1223220|NCT00773461|4012760|P2|Overall Study|Adverse Event|3
1223221|NCT00773461|4012761|P1|Overall Study|Adverse Event|1
1223222|NCT00773383|4012815|P1|Overall Study|No study dose received|1
1223223|NCT00773383|4012815|P1|Overall Study|not specified|2
1223224|NCT00773383|4012815|P1|Overall Study|Progression of Disease|23
1223225|NCT00773383|4012815|P1|Overall Study|Death|1
1223226|NCT00773383|4012815|P1|Overall Study|Adverse Event|4
1223227|NCT00773279|4012850|P2|Period 2|Unclassified|2
1223228|NCT00773279|4012851|P1|Period 2|Unclassified|2
1223229|NCT00773279|4012850|P2|Period 2|Protocol Violation|3
1223230|NCT00773279|4012851|P1|Period 2|Protocol Violation|0
1223231|NCT00773279|4012850|P2|Period 2|Lack of Efficacy|0
1223232|NCT00773279|4012851|P1|Period 2|Lack of Efficacy|1
1223233|NCT00773279|4012850|P2|Period 2|Adverse Event|1
1223234|NCT00773279|4012851|P1|Period 2|Adverse Event|0
1223235|NCT00773279|4012850|P2|Period 1|Unclassified|1
1223236|NCT00773279|4012851|P1|Period 1|Unclassified|5
1223237|NCT00773279|4012850|P2|Period 1|Lack of Efficacy|2
1223238|NCT00773279|4012851|P1|Period 1|Lack of Efficacy|0
1223239|NCT00773279|4012850|P2|Period 1|Adverse Event|1
1223240|NCT00773279|4012851|P1|Period 1|Adverse Event|2
1223241|NCT00773253|4012872|P2|First Intervention (Week 0-24)|Frontalis Test Negative|1
1223242|NCT00773253|4012873|P1|First Intervention (Week 0-24)|Frontalis Test Negative|0
1223243|NCT00773175|4012881|P2|Overall Study|Consent Withdrawn|2
1223244|NCT00773175|4012882|P1|Overall Study|Consent Withdrawn|0
1223245|NCT00773175|4012881|P2|Overall Study|Adverse Event|0
1223246|NCT00773175|4012882|P1|Overall Study|Adverse Event|2
1223247|NCT00773136|4012974|P1|Overall Study|Physician Decision|2
1223248|NCT00773097|4012979|P1|Overall Study|Physician Decision|6
1223249|NCT00773097|4012979|P1|Overall Study|Withdrawal by Subject|1
1223250|NCT00772967|4012985|P6|Crossover Treatment 3|Adverse Event|0
1223251|NCT00772967|4012986|P5|Crossover Treatment 3|Adverse Event|1
1223252|NCT00772967|4012987|P4|Crossover Treatment 3|Adverse Event|0
1223253|NCT00772967|4012988|P3|Crossover Treatment 3|Adverse Event|0
1223254|NCT00772967|4012989|P2|Crossover Treatment 3|Adverse Event|0
1223255|NCT00772967|4012990|P1|Crossover Treatment 3|Adverse Event|0
1223256|NCT00772967|4012985|P6|Break 1 (4-7 Days)|Withdrawal by Subject|0
1223257|NCT00772967|4012986|P5|Break 1 (4-7 Days)|Withdrawal by Subject|0
1223258|NCT00772967|4012987|P4|Break 1 (4-7 Days)|Withdrawal by Subject|0
1223259|NCT00772967|4012988|P3|Break 1 (4-7 Days)|Withdrawal by Subject|0
1223260|NCT00772967|4012989|P2|Break 1 (4-7 Days)|Withdrawal by Subject|1
1223261|NCT00772967|4012990|P1|Break 1 (4-7 Days)|Withdrawal by Subject|0
1223262|NCT00772967|4012985|P6|Crossover Treatment 1|Adverse Event (Pain)|0
1223263|NCT00772967|4012986|P5|Crossover Treatment 1|Adverse Event (Pain)|0
1223264|NCT00772967|4012987|P4|Crossover Treatment 1|Adverse Event (Pain)|1
1223265|NCT00772967|4012988|P3|Crossover Treatment 1|Adverse Event (Pain)|0
1223266|NCT00772967|4012989|P2|Crossover Treatment 1|Adverse Event (Pain)|0
1223267|NCT00772967|4012990|P1|Crossover Treatment 1|Adverse Event (Pain)|0
1223268|NCT00772954|4013010|P3|Overall Study|Adverse Event|1
1223269|NCT00772954|4013011|P2|Overall Study|Adverse Event|0
1223270|NCT00772954|4013012|P1|Overall Study|Adverse Event|0
1223271|NCT00772941|4013020|P1|Overall Study|GPSP Violation|90
1223272|NCT00772941|4013020|P1|Overall Study|Poor Compliance|7
1223273|NCT00772941|4013020|P1|Overall Study|Missed Visits|374
1223274|NCT00772941|4013020|P1|Overall Study|Study not completed|16
1223275|NCT00772941|4013020|P1|Overall Study|CRFs not available|195
1223276|NCT00772928|4013051|P2|Overall Study|Did not receive vaccine|1
1223277|NCT00772928|4013052|P1|Overall Study|Did not receive vaccine|0
1223278|NCT00772928|4013051|P2|Overall Study|Withdrawal by Subject|22
1223279|NCT00772928|4013052|P1|Overall Study|Withdrawal by Subject|25
1223280|NCT00772928|4013051|P2|Overall Study|Protocol Violation|12
1223281|NCT00772928|4013052|P1|Overall Study|Protocol Violation|10
1223282|NCT00772928|4013051|P2|Overall Study|Lost to Follow-up|6
1223283|NCT00772928|4013052|P1|Overall Study|Lost to Follow-up|9
1223284|NCT00772889|4013069|P3|Overall Study|Lost to Follow-up|7
1223285|NCT00772889|4013070|P2|Overall Study|Lost to Follow-up|6
1223286|NCT00772889|4013071|P1|Overall Study|Lost to Follow-up|6
1223287|NCT00772889|4013069|P3|Overall Study|Withdrawal by Subject|9
1223288|NCT00772889|4013070|P2|Overall Study|Withdrawal by Subject|8
1223289|NCT00772889|4013071|P1|Overall Study|Withdrawal by Subject|9
1223290|NCT00772889|4013069|P3|Overall Study|Adverse Event|0
1223291|NCT00772889|4013070|P2|Overall Study|Adverse Event|4
1223292|NCT00772889|4013071|P1|Overall Study|Adverse Event|7
1223293|NCT00772707|4013129|P1|Overall Study|Withdrawn|3
1223294|NCT00772668|4013134|P1|Overall Study|Physician Decision|3
1223295|NCT00772629|4013143|P2|Overall Study|Subject was not vaccinated|0
1223296|NCT00772629|4013144|P1|Overall Study|Subject was not vaccinated|1
1223297|NCT00772603|4013153|P3|Overall Study|Other|2
1223298|NCT00772603|4013154|P2|Overall Study|Other|0
1223299|NCT00772603|4013155|P1|Overall Study|Other|2
1223300|NCT00772603|4013153|P3|Overall Study|Physician Decision|1
1223301|NCT00772603|4013154|P2|Overall Study|Physician Decision|0
1223302|NCT00772603|4013155|P1|Overall Study|Physician Decision|0
1223303|NCT00772603|4013153|P3|Overall Study|Lost to Follow-up|2
1223304|NCT00772603|4013154|P2|Overall Study|Lost to Follow-up|5
1223305|NCT00772603|4013155|P1|Overall Study|Lost to Follow-up|1
1223306|NCT00772603|4013153|P3|Overall Study|Protocol Violation|1
1223307|NCT00772603|4013154|P2|Overall Study|Protocol Violation|1
1223308|NCT00772603|4013155|P1|Overall Study|Protocol Violation|0
1223309|NCT00772603|4013153|P3|Overall Study|Subject Non-compliance|4
1223310|NCT00772603|4013154|P2|Overall Study|Subject Non-compliance|6
1223311|NCT00772603|4013155|P1|Overall Study|Subject Non-compliance|1
1223312|NCT00772603|4013153|P3|Overall Study|Adverse Event|10
1223313|NCT00772603|4013154|P2|Overall Study|Adverse Event|18
1223314|NCT00772603|4013155|P1|Overall Study|Adverse Event|37
1223315|NCT00772603|4013153|P3|Overall Study|Withdrawal by Subject|6
1223316|NCT00772603|4013154|P2|Overall Study|Withdrawal by Subject|10
1223317|NCT00772603|4013155|P1|Overall Study|Withdrawal by Subject|11
1223318|NCT00772577|4013194|P2|Overall Study|Protocol Deviation|2
1223319|NCT00772577|4013195|P1|Overall Study|Protocol Deviation|3
1223320|NCT00772577|4013194|P2|Overall Study|Administrative problems|1
1223321|NCT00772577|4013195|P1|Overall Study|Administrative problems|2
1223322|NCT00772577|4013194|P2|Overall Study|Lost to Follow-up|3
1223323|NCT00772577|4013195|P1|Overall Study|Lost to Follow-up|4
1223324|NCT00772577|4013194|P2|Overall Study|Patient withdrew consent|5
1223325|NCT00772577|4013195|P1|Overall Study|Patient withdrew consent|8
1223326|NCT00772577|4013194|P2|Overall Study|Unsatisfactory therapeutic effect|8
1223327|NCT00772577|4013195|P1|Overall Study|Unsatisfactory therapeutic effect|0
1223328|NCT00772577|4013194|P2|Overall Study|Abnormal laboratory values|1
1223329|NCT00772577|4013195|P1|Overall Study|Abnormal laboratory values|0
1223330|NCT00772577|4013194|P2|Overall Study|Adverse Event|3
1223331|NCT00772577|4013195|P1|Overall Study|Adverse Event|6
1223332|NCT00772538|4013211|P2|Overall Study|Other|7
1223333|NCT00772538|4013212|P1|Overall Study|Other|7
1223334|NCT00772538|4013211|P2|Overall Study|Lack of Efficacy|1
1223335|NCT00772538|4013212|P1|Overall Study|Lack of Efficacy|0
1223336|NCT00772538|4013211|P2|Overall Study|Withdrawal by Subject|8
1223337|NCT00772538|4013212|P1|Overall Study|Withdrawal by Subject|3
1223338|NCT00772538|4013211|P2|Overall Study|Lost to Follow-up|1
1223339|NCT00772538|4013212|P1|Overall Study|Lost to Follow-up|1
1223340|NCT00772538|4013211|P2|Overall Study|Protocol Violation|3
1223341|NCT00772538|4013212|P1|Overall Study|Protocol Violation|3
1223342|NCT00772538|4013211|P2|Overall Study|Adverse Event|6
1223343|NCT00772538|4013212|P1|Overall Study|Adverse Event|6
1223344|NCT00772447|4013284|P2|Overall Study|all others|2
1223345|NCT00772447|4013285|P1|Overall Study|all others|2
1223346|NCT00772447|4013284|P2|Overall Study|Protocol Violation|1
1223347|NCT00772447|4013285|P1|Overall Study|Protocol Violation|0
1223348|NCT00772447|4013284|P2|Overall Study|incorrect enrolment|4
1223349|NCT00772447|4013285|P1|Overall Study|incorrect enrolment|3
1223350|NCT00772447|4013284|P2|Overall Study|Lost to Follow-up|4
1223351|NCT00772447|4013285|P1|Overall Study|Lost to Follow-up|2
1223352|NCT00772447|4013284|P2|Overall Study|Physician Decision|8
1223353|NCT00772447|4013285|P1|Overall Study|Physician Decision|4
1223354|NCT00772447|4013284|P2|Overall Study|Withdrawal by Subject|5
1223355|NCT00772447|4013285|P1|Overall Study|Withdrawal by Subject|9
1223356|NCT00772382|4013313|P1|Overall Study|Other Reasons|10
1223357|NCT00772382|4013313|P1|Overall Study|Withdrawal by Subject|10
1223358|NCT00772382|4013313|P1|Overall Study|Protocol Violation|1
1223359|NCT00772382|4013313|P1|Overall Study|Physician Decision|5
1223360|NCT00772382|4013313|P1|Overall Study|Lack of Efficacy|4
1223361|NCT00772382|4013313|P1|Overall Study|Death|6
1223362|NCT00772382|4013313|P1|Overall Study|Adverse Event|19
1223363|NCT00772369|4013318|P1|Overall Study|Did not return record release form|1
1223364|NCT00772148|4013329|P2|Maintenance Phase (Week 52)|Administrative/other|2
1223365|NCT00772148|4013330|P1|Maintenance Phase (Week 52)|Administrative/other|1
1223366|NCT00772148|4013329|P2|Maintenance Phase (Week 52)|Withdrawal by Subject|1
1223367|NCT00772148|4013330|P1|Maintenance Phase (Week 52)|Withdrawal by Subject|0
1223368|NCT00772148|4013329|P2|Maintenance Phase (Week 52)|Adverse Event|0
1223369|NCT00772148|4013330|P1|Maintenance Phase (Week 52)|Adverse Event|1
1223370|NCT00772148|4013329|P2|Maintenance Phase (Week 52)|Death|2
1223371|NCT00772148|4013330|P1|Maintenance Phase (Week 52)|Death|2
1223372|NCT00772148|4013329|P2|Pharmacokinetic Phase (14 Days)|Administrative/other|0
1223373|NCT00772148|4013330|P1|Pharmacokinetic Phase (14 Days)|Administrative/other|2
1223374|NCT00772148|4013329|P2|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5
1223375|NCT00772148|4013330|P1|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3
1223376|NCT00772148|4013329|P2|Pharmacokinetic Phase (14 Days)|Adverse Event|1
1223377|NCT00772148|4013330|P1|Pharmacokinetic Phase (14 Days)|Adverse Event|3
1223378|NCT00772109|4013350|P4|Overall Study|Withdrawal by Subject|16
1223379|NCT00772109|4013351|P3|Overall Study|Withdrawal by Subject|6
1223380|NCT00772109|4013352|P2|Overall Study|Withdrawal by Subject|8
1223381|NCT00772109|4013353|P1|Overall Study|Withdrawal by Subject|8
1223382|NCT00772109|4013350|P4|Overall Study|Lost to Follow-up|9
1223383|NCT00772109|4013351|P3|Overall Study|Lost to Follow-up|5
1223384|NCT00772109|4013352|P2|Overall Study|Lost to Follow-up|3
1223385|NCT00772109|4013353|P1|Overall Study|Lost to Follow-up|7
1223386|NCT00772109|4013350|P4|Overall Study|Protocol Violation|6
1223387|NCT00772109|4013351|P3|Overall Study|Protocol Violation|7
1223388|NCT00772109|4013352|P2|Overall Study|Protocol Violation|8
1223389|NCT00772109|4013353|P1|Overall Study|Protocol Violation|5
1223390|NCT00772109|4013350|P4|Overall Study|Serious adverse event|0
1223391|NCT00772109|4013351|P3|Overall Study|Serious adverse event|1
1223392|NCT00772109|4013352|P2|Overall Study|Serious adverse event|0
1223393|NCT00772109|4013353|P1|Overall Study|Serious adverse event|1
1223394|NCT00772070|4013377|P2|Overall Study|Vaccination error-wrong dose/expired lot|0
1223395|NCT00772070|4013378|P1|Overall Study|Vaccination error-wrong dose/expired lot|2
1223396|NCT00772070|4013377|P2|Overall Study|Withdrawal by Subject|2
1223397|NCT00772070|4013378|P1|Overall Study|Withdrawal by Subject|0
1223398|NCT00772070|4013377|P2|Overall Study|Lost to Follow-up|8
1223399|NCT00772070|4013378|P1|Overall Study|Lost to Follow-up|0
1223400|NCT00772031|4013390|P2|Overall Study|Lost to Follow-up|33
1223401|NCT00772031|4013391|P1|Overall Study|Lost to Follow-up|20
1223402|NCT00772031|4013390|P2|Overall Study|Early termination of trial|10
1223403|NCT00772031|4013391|P1|Overall Study|Early termination of trial|12
1223404|NCT00772005|4013417|P4|Overall Study|Non-compliance with drug administration|1
1223405|NCT00772005|4013418|P3|Overall Study|Non-compliance with drug administration|1
1223406|NCT00772005|4013419|P2|Overall Study|Non-compliance with drug administration|0
1223407|NCT00772005|4013420|P1|Overall Study|Non-compliance with drug administration|3
1223408|NCT00772005|4013417|P4|Overall Study|Non-compliance with study procedures|1
1223409|NCT00772005|4013418|P3|Overall Study|Non-compliance with study procedures|0
1223410|NCT00772005|4013419|P2|Overall Study|Non-compliance with study procedures|1
1223411|NCT00772005|4013420|P1|Overall Study|Non-compliance with study procedures|1
1223412|NCT00772005|4013417|P4|Overall Study|Lost to Follow-up|3
1223413|NCT00772005|4013418|P3|Overall Study|Lost to Follow-up|6
1223414|NCT00772005|4013419|P2|Overall Study|Lost to Follow-up|3
1223415|NCT00772005|4013420|P1|Overall Study|Lost to Follow-up|7
1223416|NCT00772005|4013417|P4|Overall Study|Protocol Violation|6
1223417|NCT00772005|4013418|P3|Overall Study|Protocol Violation|1
1223418|NCT00772005|4013419|P2|Overall Study|Protocol Violation|4
1223419|NCT00772005|4013420|P1|Overall Study|Protocol Violation|2
1223420|NCT00772005|4013417|P4|Overall Study|Withdrawal by Subject|2
1223421|NCT00772005|4013418|P3|Overall Study|Withdrawal by Subject|10
1223422|NCT00772005|4013419|P2|Overall Study|Withdrawal by Subject|7
1223423|NCT00772005|4013420|P1|Overall Study|Withdrawal by Subject|3
1223424|NCT00772005|4013417|P4|Overall Study|Lack of Efficacy|0
1223425|NCT00772005|4013418|P3|Overall Study|Lack of Efficacy|0
1223426|NCT00772005|4013419|P2|Overall Study|Lack of Efficacy|1
1223427|NCT00772005|4013420|P1|Overall Study|Lack of Efficacy|0
1223428|NCT00772005|4013417|P4|Overall Study|Adverse Event|13
1223429|NCT00772005|4013418|P3|Overall Study|Adverse Event|10
1223430|NCT00772005|4013419|P2|Overall Study|Adverse Event|14
1223431|NCT00772005|4013420|P1|Overall Study|Adverse Event|9
1223432|NCT00771953|4014108|P2|Overall Study|Withdrawal by Subject|3
1223433|NCT00771953|4014109|P1|Overall Study|Withdrawal by Subject|0
1223434|NCT00771953|4014108|P2|Overall Study|Other complicating disease|0
1223435|NCT00771953|4014109|P1|Overall Study|Other complicating disease|1
1223436|NCT00771953|4014108|P2|Overall Study|Sponsor decision|0
1223437|NCT00771953|4014109|P1|Overall Study|Sponsor decision|1
1223438|NCT00771953|4014108|P2|Overall Study|Progression before active Tx|2
1223439|NCT00771953|4014109|P1|Overall Study|Progression before active Tx|1
1223440|NCT00771953|4014108|P2|Overall Study|Death|2
1223441|NCT00771953|4014109|P1|Overall Study|Death|2
1223442|NCT00771953|4014108|P2|Overall Study|Adverse Event|3
1223443|NCT00771953|4014109|P1|Overall Study|Adverse Event|5
1223444|NCT00771927|4014119|P2|Overall Study|Other reason|27
1223445|NCT00771927|4014120|P1|Overall Study|Other reason|23
1223446|NCT00771927|4014119|P2|Overall Study|Withdrawal by Subject|17
1223447|NCT00771927|4014120|P1|Overall Study|Withdrawal by Subject|16
1223448|NCT00771927|4014119|P2|Overall Study|Lost to Follow-up|46
1223449|NCT00771927|4014120|P1|Overall Study|Lost to Follow-up|46
1223450|NCT00771927|4014119|P2|Overall Study|Lack of Efficacy|42
1223451|NCT00771927|4014120|P1|Overall Study|Lack of Efficacy|70
1223452|NCT00771927|4014119|P2|Overall Study|Adverse Event|105
1223453|NCT00771927|4014120|P1|Overall Study|Adverse Event|100
1223454|NCT00771914|4014132|P4|Overall Study|Lost to Follow-up|1
1223455|NCT00771914|4014133|P3|Overall Study|Lost to Follow-up|0
1223456|NCT00771914|4014134|P2|Overall Study|Lost to Follow-up|0
1223457|NCT00771914|4014135|P1|Overall Study|Lost to Follow-up|0
1223458|NCT00771914|4014132|P4|Overall Study|Physician Decision|1
1223459|NCT00771914|4014133|P3|Overall Study|Physician Decision|0
1223460|NCT00771914|4014134|P2|Overall Study|Physician Decision|0
1223461|NCT00771914|4014135|P1|Overall Study|Physician Decision|0
1223462|NCT00771901|4014148|P3|Overall Study|Dissat w/# of study medication (40/day)|4
1223463|NCT00771901|4014149|P2|Overall Study|Dissat w/# of study medication (40/day)|0
1223464|NCT00771901|4014150|P1|Overall Study|Dissat w/# of study medication (40/day)|0
1223465|NCT00771849|4014197|P2|Overall Study|Not vaccinated|1
1223466|NCT00771849|4014198|P1|Overall Study|Not vaccinated|0
1223467|NCT00771849|4014197|P2|Overall Study|Withdrawal by Subject|1
1223468|NCT00771849|4014198|P1|Overall Study|Withdrawal by Subject|1
1223469|NCT00771849|4014197|P2|Overall Study|Lost to Follow-up|2
1223470|NCT00771849|4014198|P1|Overall Study|Lost to Follow-up|1
1223471|NCT00771810|4014209|P3|Overall Study|Other|1
1223472|NCT00771810|4014210|P2|Overall Study|Other|0
1223473|NCT00771810|4014211|P1|Overall Study|Other|0
1223474|NCT00771810|4014209|P3|Overall Study|Withdrawal by Subject|0
1223475|NCT00771810|4014210|P2|Overall Study|Withdrawal by Subject|2
1223476|NCT00771810|4014211|P1|Overall Study|Withdrawal by Subject|1
1223477|NCT00771810|4014209|P3|Overall Study|Protocol Violation|1
1223478|NCT00771810|4014210|P2|Overall Study|Protocol Violation|1
1223479|NCT00771810|4014211|P1|Overall Study|Protocol Violation|0
1223480|NCT00771810|4014209|P3|Overall Study|Physician Decision|2
1223481|NCT00771810|4014210|P2|Overall Study|Physician Decision|2
1223482|NCT00771810|4014211|P1|Overall Study|Physician Decision|1
1223483|NCT00771810|4014209|P3|Overall Study|Lost to Follow-up|1
1223484|NCT00771810|4014210|P2|Overall Study|Lost to Follow-up|0
1223485|NCT00771810|4014211|P1|Overall Study|Lost to Follow-up|0
1223486|NCT00771810|4014209|P3|Overall Study|Adverse Event|2
1223487|NCT00771810|4014210|P2|Overall Study|Adverse Event|0
1223488|NCT00771810|4014211|P1|Overall Study|Adverse Event|3
1223489|NCT00771758|4014249|P3|Overall Study|Other|0
1223490|NCT00771758|4014250|P2|Overall Study|Other|2
1223491|NCT00771758|4014251|P1|Overall Study|Other|3
1223492|NCT00771758|4014249|P3|Overall Study|Withdrawal by Subject|0
1223493|NCT00771758|4014250|P2|Overall Study|Withdrawal by Subject|0
1223494|NCT00771758|4014251|P1|Overall Study|Withdrawal by Subject|1
1223495|NCT00771758|4014249|P3|Overall Study|Protocol Violation|0
1223496|NCT00771758|4014250|P2|Overall Study|Protocol Violation|0
1223497|NCT00771758|4014251|P1|Overall Study|Protocol Violation|1
1223498|NCT00771758|4014249|P3|Overall Study|Lost to Follow-up|0
1223499|NCT00771758|4014250|P2|Overall Study|Lost to Follow-up|0
1223500|NCT00771758|4014251|P1|Overall Study|Lost to Follow-up|1
1223501|NCT00771758|4014249|P3|Overall Study|Lack of Efficacy|1
1223502|NCT00771758|4014250|P2|Overall Study|Lack of Efficacy|2
1223503|NCT00771758|4014251|P1|Overall Study|Lack of Efficacy|0
1223504|NCT00771758|4014249|P3|Overall Study|Adverse Event|1
1223505|NCT00771758|4014250|P2|Overall Study|Adverse Event|8
1223506|NCT00771758|4014251|P1|Overall Study|Adverse Event|2
1223507|NCT00771667|4014412|P10|Maintenance Phase|Other|3
1223508|NCT00771667|4014413|P9|Maintenance Phase|Other|3
1223509|NCT00771667|4014414|P8|Maintenance Phase|Other|2
1223510|NCT00771667|4014415|P7|Maintenance Phase|Other|2
1223511|NCT00771667|4014416|P6|Maintenance Phase|Other|1
1223512|NCT00771667|4014417|P5|Maintenance Phase|Other|0
1223513|NCT00771667|4014418|P4|Maintenance Phase|Other|0
1223514|NCT00771667|4014419|P3|Maintenance Phase|Other|0
1223515|NCT00771667|4014420|P2|Maintenance Phase|Other|0
1223516|NCT00771667|4014421|P1|Maintenance Phase|Other|0
1223517|NCT00771667|4014412|P10|Maintenance Phase|Lack of Efficacy|7
1223518|NCT00771667|4014413|P9|Maintenance Phase|Lack of Efficacy|11
1223519|NCT00771667|4014414|P8|Maintenance Phase|Lack of Efficacy|2
1223520|NCT00771667|4014415|P7|Maintenance Phase|Lack of Efficacy|3
1223521|NCT00771667|4014416|P6|Maintenance Phase|Lack of Efficacy|3
1223522|NCT00771667|4014417|P5|Maintenance Phase|Lack of Efficacy|1
1223523|NCT00771667|4014418|P4|Maintenance Phase|Lack of Efficacy|0
1223524|NCT00771667|4014419|P3|Maintenance Phase|Lack of Efficacy|0
1223525|NCT00771667|4014420|P2|Maintenance Phase|Lack of Efficacy|0
1223526|NCT00771667|4014421|P1|Maintenance Phase|Lack of Efficacy|0
1223527|NCT00771667|4014412|P10|Maintenance Phase|Adverse Event|7
1223528|NCT00771667|4014413|P9|Maintenance Phase|Adverse Event|8
1223529|NCT00771667|4014414|P8|Maintenance Phase|Adverse Event|1
1223530|NCT00771667|4014415|P7|Maintenance Phase|Adverse Event|5
1223531|NCT00771667|4014416|P6|Maintenance Phase|Adverse Event|3
1223532|NCT00771667|4014417|P5|Maintenance Phase|Adverse Event|1
1223533|NCT00771667|4014418|P4|Maintenance Phase|Adverse Event|0
1223534|NCT00771667|4014419|P3|Maintenance Phase|Adverse Event|0
1223535|NCT00771667|4014420|P2|Maintenance Phase|Adverse Event|0
1223536|NCT00771667|4014421|P1|Maintenance Phase|Adverse Event|0
1223537|NCT00771667|4014412|P10|Induction Phase|Other|0
1223538|NCT00771667|4014413|P9|Induction Phase|Other|0
1223539|NCT00771667|4014414|P8|Induction Phase|Other|0
1223540|NCT00771667|4014415|P7|Induction Phase|Other|0
1223541|NCT00771667|4014416|P6|Induction Phase|Other|0
1223542|NCT00771667|4014417|P5|Induction Phase|Other|0
1223543|NCT00771667|4014418|P4|Induction Phase|Other|4
1223544|NCT00771667|4014419|P3|Induction Phase|Other|3
1223545|NCT00771667|4014420|P2|Induction Phase|Other|6
1223546|NCT00771667|4014421|P1|Induction Phase|Other|4
1223547|NCT00771667|4014412|P10|Induction Phase|Lost to Follow-up|0
1223548|NCT00771667|4014413|P9|Induction Phase|Lost to Follow-up|0
1223549|NCT00771667|4014414|P8|Induction Phase|Lost to Follow-up|0
1223550|NCT00771667|4014415|P7|Induction Phase|Lost to Follow-up|0
1223551|NCT00771667|4014416|P6|Induction Phase|Lost to Follow-up|0
1223552|NCT00771667|4014417|P5|Induction Phase|Lost to Follow-up|0
1223553|NCT00771667|4014418|P4|Induction Phase|Lost to Follow-up|0
1223554|NCT00771667|4014419|P3|Induction Phase|Lost to Follow-up|1
1223555|NCT00771667|4014420|P2|Induction Phase|Lost to Follow-up|0
1223556|NCT00771667|4014421|P1|Induction Phase|Lost to Follow-up|1
1223557|NCT00771667|4014412|P10|Induction Phase|Lack of Efficacy|0
1223558|NCT00771667|4014413|P9|Induction Phase|Lack of Efficacy|0
1223559|NCT00771667|4014414|P8|Induction Phase|Lack of Efficacy|0
1223560|NCT00771667|4014415|P7|Induction Phase|Lack of Efficacy|0
1223561|NCT00771667|4014416|P6|Induction Phase|Lack of Efficacy|0
1223562|NCT00771667|4014417|P5|Induction Phase|Lack of Efficacy|0
1223563|NCT00771667|4014418|P4|Induction Phase|Lack of Efficacy|3
1223564|NCT00771667|4014419|P3|Induction Phase|Lack of Efficacy|4
1223565|NCT00771667|4014420|P2|Induction Phase|Lack of Efficacy|2
1223566|NCT00771667|4014421|P1|Induction Phase|Lack of Efficacy|9
1223567|NCT00771667|4014412|P10|Induction Phase|Adverse Event|0
1223568|NCT00771667|4014413|P9|Induction Phase|Adverse Event|0
1223569|NCT00771667|4014414|P8|Induction Phase|Adverse Event|0
1223570|NCT00771667|4014415|P7|Induction Phase|Adverse Event|0
1223571|NCT00771667|4014416|P6|Induction Phase|Adverse Event|0
1223572|NCT00771667|4014417|P5|Induction Phase|Adverse Event|0
1223573|NCT00771667|4014418|P4|Induction Phase|Adverse Event|1
1223574|NCT00771667|4014419|P3|Induction Phase|Adverse Event|4
1223575|NCT00771667|4014420|P2|Induction Phase|Adverse Event|2
1223576|NCT00771667|4014421|P1|Induction Phase|Adverse Event|5
1223577|NCT00771615|4014466|P9|Overall Study|Lost to Follow-up|0
1223578|NCT00771615|4014467|P8|Overall Study|Lost to Follow-up|0
1223579|NCT00771615|4014468|P7|Overall Study|Lost to Follow-up|1
1223580|NCT00771615|4014469|P6|Overall Study|Lost to Follow-up|1
1223581|NCT00771615|4014470|P5|Overall Study|Lost to Follow-up|0
1223582|NCT00771615|4014471|P4|Overall Study|Lost to Follow-up|1
1223583|NCT00771615|4014472|P3|Overall Study|Lost to Follow-up|1
1223584|NCT00771615|4014473|P2|Overall Study|Lost to Follow-up|1
1223585|NCT00771615|4014474|P1|Overall Study|Lost to Follow-up|1
1223586|NCT00771615|4014466|P9|Overall Study|Withdrawal by Subject|0
1223587|NCT00771615|4014467|P8|Overall Study|Withdrawal by Subject|1
1223588|NCT00771615|4014468|P7|Overall Study|Withdrawal by Subject|0
1223589|NCT00771615|4014469|P6|Overall Study|Withdrawal by Subject|0
1223590|NCT00771615|4014470|P5|Overall Study|Withdrawal by Subject|0
1223591|NCT00771615|4014471|P4|Overall Study|Withdrawal by Subject|0
1223592|NCT00771615|4014472|P3|Overall Study|Withdrawal by Subject|0
1223593|NCT00771615|4014473|P2|Overall Study|Withdrawal by Subject|1
1223594|NCT00771615|4014474|P1|Overall Study|Withdrawal by Subject|0
1223595|NCT00771472|4014735|P2|Overall Study|Protocol Violation|0
1223596|NCT00771472|4014736|P1|Overall Study|Protocol Violation|1
1223597|NCT00771472|4014735|P2|Overall Study|Progressive Disease|1
1223598|NCT00771472|4014736|P1|Overall Study|Progressive Disease|3
1223599|NCT00771472|4014735|P2|Overall Study|Physician Decision|3
1223600|NCT00771472|4014736|P1|Overall Study|Physician Decision|2
1223601|NCT00771316|4014756|P2|Overall Study|Discontinued due to early termination|0
1223602|NCT00771316|4014757|P1|Overall Study|Discontinued due to early termination|1
1223603|NCT00771316|4014756|P2|Overall Study|Patient withdrew consent|0
1223604|NCT00771316|4014757|P1|Overall Study|Patient withdrew consent|1
1223605|NCT00771316|4014756|P2|Overall Study|Adverse Event|1
1223606|NCT00771316|4014757|P1|Overall Study|Adverse Event|0
1223607|NCT00770991|4014809|P2|Overall Study|Pregnancy|0
1223608|NCT00770991|4014810|P1|Overall Study|Pregnancy|1
1223609|NCT00770991|4014809|P2|Overall Study|Adverse Event|5
1223610|NCT00770991|4014810|P1|Overall Study|Adverse Event|1
1223611|NCT00770991|4014809|P2|Overall Study|Withdrawal by Subject|0
1223612|NCT00770991|4014810|P1|Overall Study|Withdrawal by Subject|1
1223613|NCT00770991|4014809|P2|Overall Study|Physician Decision|0
1223614|NCT00770991|4014810|P1|Overall Study|Physician Decision|2
1223615|NCT00770965|4014826|P4|Excluded Set|Withdrawal by Subject|3
1223616|NCT00770965|4014827|P3|Excluded Set|Withdrawal by Subject|2
1223617|NCT00770965|4014828|P2|Excluded Set|Withdrawal by Subject|1
1223618|NCT00770965|4014829|P1|Excluded Set|Withdrawal by Subject|1
1223619|NCT00770965|4014826|P4|Excluded Set|Administrative problems|10
1223620|NCT00770965|4014827|P3|Excluded Set|Administrative problems|12
1223621|NCT00770965|4014828|P2|Excluded Set|Administrative problems|12
1223622|NCT00770965|4014829|P1|Excluded Set|Administrative problems|14
1223623|NCT00770965|4014826|P4|Safety Set|Protocol deviation|0
1223624|NCT00770965|4014827|P3|Safety Set|Protocol deviation|1
1223625|NCT00770965|4014828|P2|Safety Set|Protocol deviation|0
1223626|NCT00770965|4014829|P1|Safety Set|Protocol deviation|0
1223627|NCT00770965|4014826|P4|Safety Set|Withdrawal by Subject|1
1223628|NCT00770965|4014827|P3|Safety Set|Withdrawal by Subject|0
1223629|NCT00770965|4014828|P2|Safety Set|Withdrawal by Subject|0
1223630|NCT00770965|4014829|P1|Safety Set|Withdrawal by Subject|0
1223631|NCT00770913|4014850|P3|Overall Study|Incorrect drug was allocated|0
1223632|NCT00770913|4014851|P2|Overall Study|Incorrect drug was allocated|0
1223633|NCT00770913|4014852|P1|Overall Study|Incorrect drug was allocated|1
1223634|NCT00770913|4014850|P3|Overall Study|Protocol Violation|1
1223635|NCT00770913|4014851|P2|Overall Study|Protocol Violation|0
1223636|NCT00770913|4014852|P1|Overall Study|Protocol Violation|3
1223637|NCT00770913|4014850|P3|Overall Study|Physician Decision|1
1223638|NCT00770913|4014851|P2|Overall Study|Physician Decision|1
1223639|NCT00770913|4014852|P1|Overall Study|Physician Decision|0
1223640|NCT00770913|4014850|P3|Overall Study|Refusal to continue participation|5
1223641|NCT00770913|4014851|P2|Overall Study|Refusal to continue participation|4
1223642|NCT00770913|4014852|P1|Overall Study|Refusal to continue participation|6
1223643|NCT00770913|4014850|P3|Overall Study|Adverse Event|6
1223644|NCT00770913|4014851|P2|Overall Study|Adverse Event|3
1223645|NCT00770913|4014852|P1|Overall Study|Adverse Event|1
1223646|NCT00770809|4014874|P3|Overall Study|Other Medical Reasons|3
1223647|NCT00770809|4014875|P2|Overall Study|Other Medical Reasons|4
1223648|NCT00770809|4014876|P1|Overall Study|Other Medical Reasons|2
1223649|NCT00770809|4014874|P3|Overall Study|Complicating illness|1
1223650|NCT00770809|4014875|P2|Overall Study|Complicating illness|0
1223651|NCT00770809|4014876|P1|Overall Study|Complicating illness|0
1223652|NCT00770809|4014874|P3|Overall Study|Progression|0
1223653|NCT00770809|4014875|P2|Overall Study|Progression|2
1223654|NCT00770809|4014876|P1|Overall Study|Progression|2
1223655|NCT00770809|4014874|P3|Overall Study|Withdrawal by Subject|7
1223656|NCT00770809|4014875|P2|Overall Study|Withdrawal by Subject|3
1223657|NCT00770809|4014876|P1|Overall Study|Withdrawal by Subject|3
1223658|NCT00770809|4014874|P3|Overall Study|Death|0
1223659|NCT00770809|4014875|P2|Overall Study|Death|0
1223660|NCT00770809|4014876|P1|Overall Study|Death|1
1223661|NCT00770809|4014874|P3|Overall Study|Adverse Event|12
1223662|NCT00770809|4014875|P2|Overall Study|Adverse Event|1
1223663|NCT00770809|4014876|P1|Overall Study|Adverse Event|9
1223664|NCT00770770|4014886|P2|Overall Study|Study Terminated|0
1223665|NCT00770770|4014887|P1|Overall Study|Study Terminated|8
1223666|NCT00770770|4014886|P2|Overall Study|Death|1
1223667|NCT00770770|4014887|P1|Overall Study|Death|0
1223668|NCT00770770|4014886|P2|Overall Study|Withdrawal by Subject|0
1223669|NCT00770770|4014887|P1|Overall Study|Withdrawal by Subject|1
1223670|NCT00770770|4014886|P2|Overall Study|Lost to Follow-up|0
1223671|NCT00770770|4014887|P1|Overall Study|Lost to Follow-up|1
1223672|NCT00770692|4014905|P4|Overall Study|Investigator judgment|1
1223673|NCT00770692|4014906|P3|Overall Study|Investigator judgment|1
1223674|NCT00770692|4014907|P2|Overall Study|Investigator judgment|0
1223675|NCT00770692|4014908|P1|Overall Study|Investigator judgment|2
1223676|NCT00770692|4014905|P4|Overall Study|Adverse Event|4
1223677|NCT00770692|4014906|P3|Overall Study|Adverse Event|4
1223678|NCT00770692|4014907|P2|Overall Study|Adverse Event|0
1223679|NCT00770692|4014908|P1|Overall Study|Adverse Event|3
1223680|NCT00770692|4014905|P4|Overall Study|Withdrawal by Subject|6
1223681|NCT00770692|4014906|P3|Overall Study|Withdrawal by Subject|9
1223682|NCT00770692|4014907|P2|Overall Study|Withdrawal by Subject|9
1223683|NCT00770692|4014908|P1|Overall Study|Withdrawal by Subject|7
1223684|NCT00770679|4014934|P1|Overall Study|Follow-up LDL measurement not collected|3
1223685|NCT00770679|4014934|P1|Overall Study|Lost to Follow-up|3
1223686|NCT00770653|4014942|P2|Overall Study|Physician Decision|0
1223687|NCT00770653|4014943|P1|Overall Study|Physician Decision|1
1223688|NCT00770653|4014942|P2|Overall Study|Lost to Follow-up|2
1223689|NCT00770653|4014943|P1|Overall Study|Lost to Follow-up|1
1223690|NCT00770653|4014942|P2|Overall Study|> Three Moderate Hypoglycemic Episodes|2
1223691|NCT00770653|4014943|P1|Overall Study|> Three Moderate Hypoglycemic Episodes|0
1223692|NCT00770653|4014942|P2|Overall Study|Fasting Glucose > 240 mg/dL|1
1223693|NCT00770653|4014943|P1|Overall Study|Fasting Glucose > 240 mg/dL|2
1223694|NCT00770653|4014942|P2|Overall Study|Worsening of Glycosolated Hemoglobin|2
1223695|NCT00770653|4014943|P1|Overall Study|Worsening of Glycosolated Hemoglobin|2
1223696|NCT00770653|4014942|P2|Overall Study|Lack of Compliance|4
1223697|NCT00770653|4014943|P1|Overall Study|Lack of Compliance|1
1223698|NCT00770653|4014942|P2|Overall Study|Withdrawal by Subject|7
1223699|NCT00770653|4014943|P1|Overall Study|Withdrawal by Subject|4
1223700|NCT00770653|4014942|P2|Overall Study|Protocol Violation|6
1223701|NCT00770653|4014943|P1|Overall Study|Protocol Violation|8
1223702|NCT00770653|4014942|P2|Overall Study|Adverse Event|5
1223703|NCT00770653|4014943|P1|Overall Study|Adverse Event|13
1223704|NCT00770588|4015013|P2|Overall Study|Withdrawal by Subject|1
1223705|NCT00770588|4015014|P1|Overall Study|Withdrawal by Subject|1
1223706|NCT00770588|4015013|P2|Overall Study|Lost to Follow-up|1
1223707|NCT00770588|4015014|P1|Overall Study|Lost to Follow-up|1
1223708|NCT00770588|4015013|P2|Overall Study|Death caused by progression of disease|91
1223709|NCT00770588|4015014|P1|Overall Study|Death caused by progression of disease|70
1223710|NCT00770588|4015013|P2|Overall Study|Adverse Event|2
1223711|NCT00770588|4015014|P1|Overall Study|Adverse Event|9
1223712|NCT00770562|4015030|P2|Overall Study|Did not take treatment|1
1223713|NCT00770562|4015031|P1|Overall Study|Did not take treatment|1
1223714|NCT00770510|4015042|P1|Overall Study|Withdrawal by Subject|2
1223715|NCT00770510|4015042|P1|Overall Study|Pregnancy|1
1223716|NCT00770510|4015042|P1|Overall Study|Lost to Follow-up|2
1223717|NCT00770484|4015081|P2|Overall Study|Withdrawal by Subject|0
1223718|NCT00770484|4015082|P1|Overall Study|Withdrawal by Subject|1
1223719|NCT00770432|4015090|P2|Overall Study|Non-compliance|1
1223720|NCT00770432|4015091|P1|Overall Study|Non-compliance|0
1223721|NCT00770432|4015090|P2|Overall Study|Not specified|6
1223722|NCT00770432|4015091|P1|Overall Study|Not specified|4
1223723|NCT00770367|4015099|P2|Second Intervention|Lost to Follow-up|0
1223724|NCT00770367|4015100|P1|Second Intervention|Lost to Follow-up|2
1223725|NCT00770367|4015099|P2|Washout Period of 4 Weeks|Withdrawal by Subject|1
1223726|NCT00770367|4015100|P1|Washout Period of 4 Weeks|Withdrawal by Subject|0
1223727|NCT00770367|4015099|P2|First Intervention|Withdrawal by Subject|2
1223728|NCT00770367|4015100|P1|First Intervention|Withdrawal by Subject|0
1223729|NCT00770341|4015111|P3|Overall Study|Not treated|0
1223730|NCT00770341|4015112|P2|Overall Study|Not treated|0
1223731|NCT00770341|4015113|P1|Overall Study|Not treated|1
1223732|NCT00770341|4015111|P3|Overall Study|Not specified|0
1223733|NCT00770341|4015112|P2|Overall Study|Not specified|0
1223734|NCT00770341|4015113|P1|Overall Study|Not specified|1
1223735|NCT00770341|4015111|P3|Overall Study|Lack of Efficacy|1
1223736|NCT00770341|4015112|P2|Overall Study|Lack of Efficacy|0
1223737|NCT00770341|4015113|P1|Overall Study|Lack of Efficacy|3
1223738|NCT00770341|4015111|P3|Overall Study|Laboratory adverse event|0
1223739|NCT00770341|4015112|P2|Overall Study|Laboratory adverse event|3
1223740|NCT00770341|4015113|P1|Overall Study|Laboratory adverse event|3
1223741|NCT00770341|4015111|P3|Overall Study|Clinical Adverse Event|2
1223742|NCT00770341|4015112|P2|Overall Study|Clinical Adverse Event|1
1223743|NCT00770341|4015113|P1|Overall Study|Clinical Adverse Event|3
1223744|NCT00770341|4015111|P3|Overall Study|Withdrawal by Subject|0
1223745|NCT00770341|4015112|P2|Overall Study|Withdrawal by Subject|1
1223746|NCT00770341|4015113|P1|Overall Study|Withdrawal by Subject|0
1223747|NCT00770341|4015111|P3|Overall Study|Did not meet eligibility criteria|0
1223748|NCT00770341|4015112|P2|Overall Study|Did not meet eligibility criteria|0
1223749|NCT00770341|4015113|P1|Overall Study|Did not meet eligibility criteria|1
1223750|NCT00770328|4015139|P2|Overall Study|Lost to Follow-up|2
1223751|NCT00770328|4015140|P1|Overall Study|Lost to Follow-up|2
1223752|NCT00770328|4015139|P2|Overall Study|Adverse Event|2
1223753|NCT00770328|4015140|P1|Overall Study|Adverse Event|11
1223754|NCT00770315|4015156|P4|Overall Study|Noncompliance with Protocol|9
1223755|NCT00770315|4015157|P3|Overall Study|Noncompliance with Protocol|7
1223756|NCT00770315|4015158|P2|Overall Study|Noncompliance with Protocol|4
1223757|NCT00770315|4015159|P1|Overall Study|Noncompliance with Protocol|7
1223758|NCT00770315|4015156|P4|Overall Study|Withdrawal by Subject|20
1223759|NCT00770315|4015157|P3|Overall Study|Withdrawal by Subject|24
1223760|NCT00770315|4015158|P2|Overall Study|Withdrawal by Subject|17
1223761|NCT00770315|4015159|P1|Overall Study|Withdrawal by Subject|13
1223762|NCT00770315|4015156|P4|Overall Study|Lost to Follow-up|3
1223763|NCT00770315|4015157|P3|Overall Study|Lost to Follow-up|10
1223764|NCT00770315|4015158|P2|Overall Study|Lost to Follow-up|5
1223765|NCT00770315|4015159|P1|Overall Study|Lost to Follow-up|9
1223766|NCT00770315|4015156|P4|Overall Study|Adverse Event|6
1223767|NCT00770315|4015157|P3|Overall Study|Adverse Event|16
1223768|NCT00770315|4015158|P2|Overall Study|Adverse Event|17
1223769|NCT00770315|4015159|P1|Overall Study|Adverse Event|11
1223770|NCT00770289|4015185|P1|Overall Study|Other|6
1223771|NCT00770224|4015194|P2|Step 2: Maintenance|Ineligible|2
1223772|NCT00770224|4015195|P1|Step 2: Maintenance|Ineligible|0
1223773|NCT00770224|4015194|P2|Step 2: Maintenance|Other reason not protocol specified|7
1223774|NCT00770224|4015195|P1|Step 2: Maintenance|Other reason not protocol specified|0
1223775|NCT00770224|4015194|P2|Step 2: Maintenance|Death|2
1223776|NCT00770224|4015195|P1|Step 2: Maintenance|Death|0
1223777|NCT00770224|4015194|P2|Step 2: Maintenance|Progression/relapse|1
1223778|NCT00770224|4015195|P1|Step 2: Maintenance|Progression/relapse|0
1223779|NCT00770224|4015194|P2|Step 2: Maintenance|Refusal unrelated to adverse event|8
1223780|NCT00770224|4015195|P1|Step 2: Maintenance|Refusal unrelated to adverse event|0
1223781|NCT00770224|4015194|P2|Step 2: Maintenance|Adverse Event|10
1223782|NCT00770224|4015195|P1|Step 2: Maintenance|Adverse Event|0
1223783|NCT00770224|4015194|P2|Step 1: Induction|No protocol treatment given|0
1223784|NCT00770224|4015195|P1|Step 1: Induction|No protocol treatment given|1
1223785|NCT00770224|4015194|P2|Step 1: Induction|Ineligible|0
1223786|NCT00770224|4015195|P1|Step 1: Induction|Ineligible|2
1223787|NCT00770224|4015194|P2|Step 1: Induction|Other reason not protocol specified|0
1223788|NCT00770224|4015195|P1|Step 1: Induction|Other reason not protocol specified|2
1223789|NCT00770224|4015194|P2|Step 1: Induction|Refusal unrelated to adverse event|0
1223790|NCT00770224|4015195|P1|Step 1: Induction|Refusal unrelated to adverse event|6
1223791|NCT00770224|4015194|P2|Step 1: Induction|Adverse Event|0
1223792|NCT00770224|4015195|P1|Step 1: Induction|Adverse Event|3
1223793|NCT00770211|4015207|P2|Overall Study|Withdrawal by Subject|2
1223794|NCT00770211|4015208|P1|Overall Study|Withdrawal by Subject|0
1223795|NCT00770211|4015207|P2|Overall Study|Lost to Follow-up|0
1223796|NCT00770211|4015208|P1|Overall Study|Lost to Follow-up|1
1223797|NCT00770146|4015224|P2|Follow-up Period|Other|5
1223798|NCT00770146|4015225|P1|Follow-up Period|Other|4
1223799|NCT00770146|4015224|P2|Follow-up Period|Adverse Event|2
1223800|NCT00770146|4015225|P1|Follow-up Period|Adverse Event|0
1223801|NCT00770146|4015224|P2|Follow-up Period|Withdrawal by Subject|13
1223802|NCT00770146|4015225|P1|Follow-up Period|Withdrawal by Subject|7
1223803|NCT00770146|4015224|P2|Treatment Period|Protocol non-compliance|1
1223804|NCT00770146|4015225|P1|Treatment Period|Protocol non-compliance|0
1223805|NCT00770146|4015224|P2|Treatment Period|Other|5
1223806|NCT00770146|4015225|P1|Treatment Period|Other|1
1223807|NCT00770146|4015224|P2|Treatment Period|Adverse Event|26
1223808|NCT00770146|4015225|P1|Treatment Period|Adverse Event|2
1223809|NCT00770146|4015224|P2|Treatment Period|Withdrawal by Subject|13
1223810|NCT00770146|4015225|P1|Treatment Period|Withdrawal by Subject|6
1223811|NCT00770120|4015269|P1|Overall Study|Reason under Review|1
1223812|NCT00770120|4015269|P1|Overall Study|Never Received Treatment/Not Analyzable|1
1223813|NCT00770120|4015269|P1|Overall Study|Ineligible|1
1223814|NCT00770120|4015269|P1|Overall Study|Withdrawal by Subject|2
1223815|NCT00770120|4015269|P1|Overall Study|Death|3
1223816|NCT00770120|4015269|P1|Overall Study|Not Protocol Specified|11
1223817|NCT00770120|4015269|P1|Overall Study|Adverse Event|11
1223818|NCT00770120|4015269|P1|Overall Study|Progression|31
1223819|NCT00770029|4015278|P2|Overall Study|Adverse Event|0
1223820|NCT00770029|4015279|P1|Overall Study|Adverse Event|1
1223821|NCT00770029|4015278|P2|Overall Study|Withdrawal by Subject|3
1223822|NCT00770029|4015279|P1|Overall Study|Withdrawal by Subject|3
1223823|NCT00770029|4015278|P2|Overall Study|Lost to Follow-up|0
1223824|NCT00770029|4015279|P1|Overall Study|Lost to Follow-up|2
1223825|NCT00769860|4015295|P2|Overall Study|Withdrawal by Subject|0
1223826|NCT00769860|4015296|P1|Overall Study|Withdrawal by Subject|2
1223827|NCT00769704|4015324|P2|Overall Study|Other|2
1223828|NCT00769704|4015325|P1|Overall Study|Other|1
1223829|NCT00769704|4015324|P2|Overall Study|Withdrawal by Subject|5
1223830|NCT00769704|4015325|P1|Overall Study|Withdrawal by Subject|12
1223831|NCT00769704|4015324|P2|Overall Study|Death|190
1223832|NCT00769704|4015325|P1|Overall Study|Death|95
1223833|NCT00769704|4015324|P2|Overall Study|Lost to Follow-up|2
1223834|NCT00769704|4015325|P1|Overall Study|Lost to Follow-up|3
1223835|NCT00769561|4015358|P2|Overall Study|Lost to Follow-up|3
1223836|NCT00769561|4015359|P1|Overall Study|Lost to Follow-up|1
1223837|NCT00769561|4015358|P2|Overall Study|Withdrawal by Subject|2
1223838|NCT00769561|4015359|P1|Overall Study|Withdrawal by Subject|2
1223839|NCT00769184|4015408|P2|No Treatment (6 Weeks)|Adverse Event|1
1223840|NCT00769184|4015409|P1|No Treatment (6 Weeks)|Adverse Event|1
1223841|NCT00769184|4015408|P2|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1
1223842|NCT00769184|4015409|P1|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0
1223843|NCT00769184|4015408|P2|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0
1223844|NCT00769184|4015409|P1|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1
1223845|NCT00769132|4015417|P4|Period 4|Withdrawal by Subject|0
1223846|NCT00769132|4015418|P3|Period 4|Withdrawal by Subject|0
1223847|NCT00769132|4015419|P2|Period 4|Withdrawal by Subject|1
1223848|NCT00769132|4015420|P1|Period 4|Withdrawal by Subject|0
1223849|NCT00769132|4015417|P4|Period 3|Withdrawal by Subject|0
1223850|NCT00769132|4015418|P3|Period 3|Withdrawal by Subject|0
1223851|NCT00769132|4015419|P2|Period 3|Withdrawal by Subject|0
1223852|NCT00769132|4015420|P1|Period 3|Withdrawal by Subject|1
1223853|NCT00769132|4015417|P4|Period 2|Withdrawal by Subject|1
1223854|NCT00769132|4015418|P3|Period 2|Withdrawal by Subject|0
1223855|NCT00769132|4015419|P2|Period 2|Withdrawal by Subject|0
1223856|NCT00769132|4015420|P1|Period 2|Withdrawal by Subject|0
1223857|NCT00769132|4015417|P4|Period 1|Adverse Event|1
1223858|NCT00769132|4015418|P3|Period 1|Adverse Event|0
1223859|NCT00769132|4015419|P2|Period 1|Adverse Event|0
1223860|NCT00769132|4015420|P1|Period 1|Adverse Event|1
1223861|NCT00769119|4015436|P2|Overall Study|Disallowed medication|0
1223862|NCT00769119|4015437|P1|Overall Study|Disallowed medication|1
1223863|NCT00769119|4015436|P2|Overall Study|Adverse Event|1
1223864|NCT00769119|4015437|P1|Overall Study|Adverse Event|1
1223865|NCT00769119|4015436|P2|Overall Study|Voluntary discontinuation|2
1223866|NCT00769119|4015437|P1|Overall Study|Voluntary discontinuation|0
1223867|NCT00769067|4015483|P2|Overall Study|Withdrawal by Subject|1
1223868|NCT00769067|4015484|P1|Overall Study|Withdrawal by Subject|0
1223869|NCT00769067|4015483|P2|Overall Study|Other|3
1223870|NCT00769067|4015484|P1|Overall Study|Other|1
1223871|NCT00769067|4015483|P2|Overall Study|Study terminated by sponsor|3
1223872|NCT00769067|4015484|P1|Overall Study|Study terminated by sponsor|1
1223873|NCT00769067|4015483|P2|Overall Study|Lost to Follow-up|1
1223874|NCT00769067|4015484|P1|Overall Study|Lost to Follow-up|3
1223875|NCT00769067|4015483|P2|Overall Study|Death|86
1223876|NCT00769067|4015484|P1|Overall Study|Death|89
1223877|NCT00768989|4015532|P2|On or After Week 36|Sponsor Termination|26
1223878|NCT00768989|4015533|P1|On or After Week 36|Sponsor Termination|45
1223879|NCT00768989|4015532|P2|On or After Week 36|Did not attend termination visit|0
1223880|NCT00768989|4015533|P1|On or After Week 36|Did not attend termination visit|2
1223881|NCT00768989|4015532|P2|On or After Week 36|Protocol Violation|0
1223882|NCT00768989|4015533|P1|On or After Week 36|Protocol Violation|1
1223883|NCT00768989|4015532|P2|On or After Week 36|Poor Compliance|0
1223884|NCT00768989|4015533|P1|On or After Week 36|Poor Compliance|1
1223885|NCT00768989|4015532|P2|On or After Week 36|Lost to Follow-up|0
1223886|NCT00768989|4015533|P1|On or After Week 36|Lost to Follow-up|1
1223887|NCT00768989|4015532|P2|On or After Week 36|Adverse Event|1
1223888|NCT00768989|4015533|P1|On or After Week 36|Adverse Event|0
1223889|NCT00768989|4015532|P2|On or After Week 36|Lack of Efficacy|0
1223890|NCT00768989|4015533|P1|On or After Week 36|Lack of Efficacy|1
1223891|NCT00768989|4015532|P2|Week 24 to Prior to Week 36|Withdrawal by Subject|0
1223892|NCT00768989|4015533|P1|Week 24 to Prior to Week 36|Withdrawal by Subject|1
1223893|NCT00768989|4015532|P2|Week 24 to Prior to Week 36|Lack of Efficacy|0
1223894|NCT00768989|4015533|P1|Week 24 to Prior to Week 36|Lack of Efficacy|6
1223895|NCT00768989|4015532|P2|Week 24 to Prior to Week 36|Adverse Event|0
1223896|NCT00768989|4015533|P1|Week 24 to Prior to Week 36|Adverse Event|1
1223897|NCT00768989|4015532|P2|Prior to Week 24|Protocol Violation|2
1223898|NCT00768989|4015533|P1|Prior to Week 24|Protocol Violation|0
1223899|NCT00768989|4015532|P2|Prior to Week 24|Lost to Follow-up|1
1223900|NCT00768989|4015533|P1|Prior to Week 24|Lost to Follow-up|0
1223901|NCT00768989|4015532|P2|Prior to Week 24|Adverse Event|0
1223902|NCT00768989|4015533|P1|Prior to Week 24|Adverse Event|3
1223903|NCT00768989|4015532|P2|Prior to Week 24|Withdrawal by Subject|0
1223904|NCT00768989|4015533|P1|Prior to Week 24|Withdrawal by Subject|1
1223905|NCT00768898|4015581|P1|Overall Study|Headache|1
1223906|NCT00768898|4015581|P1|Overall Study|Unrelated injury|1
1223907|NCT00768755|4015605|P4|Phase 2|Randomized but not treated|2
1223908|NCT00768755|4015606|P3|Phase 2|Randomized but not treated|0
1223909|NCT00768755|4015607|P2|Phase 2|Randomized but not treated|0
1223910|NCT00768755|4015608|P1|Phase 2|Randomized but not treated|0
1223911|NCT00768755|4015605|P4|Phase 2|Study Terminated by Sponsor|14
1223912|NCT00768755|4015606|P3|Phase 2|Study Terminated by Sponsor|7
1223913|NCT00768755|4015607|P2|Phase 2|Study Terminated by Sponsor|13
1223914|NCT00768755|4015608|P1|Phase 2|Study Terminated by Sponsor|0
1223915|NCT00768755|4015605|P4|Phase 2|Other|4
1223916|NCT00768755|4015606|P3|Phase 2|Other|2
1223917|NCT00768755|4015607|P2|Phase 2|Other|1
1223918|NCT00768755|4015608|P1|Phase 2|Other|0
1223919|NCT00768755|4015605|P4|Phase 2|Withdrawal by Subject|1
1223920|NCT00768755|4015606|P3|Phase 2|Withdrawal by Subject|0
1223921|NCT00768755|4015607|P2|Phase 2|Withdrawal by Subject|1
1223922|NCT00768755|4015608|P1|Phase 2|Withdrawal by Subject|0
1223923|NCT00768755|4015605|P4|Phase 2|Lost to Follow-up|4
1223924|NCT00768755|4015606|P3|Phase 2|Lost to Follow-up|1
1223925|NCT00768755|4015607|P2|Phase 2|Lost to Follow-up|1
1223926|NCT00768755|4015608|P1|Phase 2|Lost to Follow-up|0
1223927|NCT00768755|4015605|P4|Phase 2|Protocol Violation|1
1223928|NCT00768755|4015606|P3|Phase 2|Protocol Violation|0
1223929|NCT00768755|4015607|P2|Phase 2|Protocol Violation|2
1223930|NCT00768755|4015608|P1|Phase 2|Protocol Violation|0
1223931|NCT00768755|4015605|P4|Phase 2|Death|31
1223932|NCT00768755|4015606|P3|Phase 2|Death|48
1223933|NCT00768755|4015607|P2|Phase 2|Death|37
1223934|NCT00768755|4015608|P1|Phase 2|Death|0
1223935|NCT00768755|4015605|P4|Phase 1|Other|0
1223936|NCT00768755|4015606|P3|Phase 1|Other|0
1223937|NCT00768755|4015607|P2|Phase 1|Other|0
1223938|NCT00768755|4015608|P1|Phase 1|Other|4
1223939|NCT00768755|4015605|P4|Phase 1|Death|0
1223940|NCT00768755|4015606|P3|Phase 1|Death|0
1223941|NCT00768755|4015607|P2|Phase 1|Death|0
1223942|NCT00768755|4015608|P1|Phase 1|Death|6
1223943|NCT00768651|4015632|P1|Overall Study|Withdrawal by Subject|1
1223944|NCT00768560|4015671|P6|Intervention Set 1|Adverse Event|0
1223945|NCT00768560|4015672|P5|Intervention Set 1|Adverse Event|0
1223946|NCT00768560|4015673|P4|Intervention Set 1|Adverse Event|0
1223947|NCT00768560|4015674|P3|Intervention Set 1|Adverse Event|0
1223948|NCT00768560|4015675|P2|Intervention Set 1|Adverse Event|1
1223949|NCT00768560|4015676|P1|Intervention Set 1|Adverse Event|0
1223950|NCT00768469|4015713|P2|Overall Study|Withdrawal by Subject|1
1223951|NCT00768469|4015714|P1|Overall Study|Withdrawal by Subject|0
1223952|NCT00768469|4015713|P2|Overall Study|Disease Progression|4
1223953|NCT00768469|4015714|P1|Overall Study|Disease Progression|3
1223954|NCT00768469|4015713|P2|Overall Study|Adverse Event|2
1223955|NCT00768469|4015714|P1|Overall Study|Adverse Event|0
1223956|NCT00768430|4015729|P2|7 Day Endpoint|Withdrawal by Subject|3
1223957|NCT00768430|4015730|P1|7 Day Endpoint|Withdrawal by Subject|2
1223958|NCT00768300|4015738|P2|Overall Study|Missing data|0
1223959|NCT00768300|4015739|P1|Overall Study|Missing data|1
1223960|NCT00768300|4015738|P2|Overall Study|Treated but never dosed with Study drug|0
1223961|NCT00768300|4015739|P1|Overall Study|Treated but never dosed with Study drug|1
1223962|NCT00768300|4015738|P2|Overall Study|Began prohibited concomitant medication|1
1223963|NCT00768300|4015739|P1|Overall Study|Began prohibited concomitant medication|0
1223964|NCT00768300|4015738|P2|Overall Study|Lost to Follow-up|1
1223965|NCT00768300|4015739|P1|Overall Study|Lost to Follow-up|0
1223966|NCT00768300|4015738|P2|Overall Study|Received lung transplant|1
1223967|NCT00768300|4015739|P1|Overall Study|Received lung transplant|1
1223968|NCT00768300|4015738|P2|Overall Study|Screen failure following randomization|0
1223969|NCT00768300|4015739|P1|Overall Study|Screen failure following randomization|1
1223970|NCT00768300|4015738|P2|Overall Study|Subject moved to pursue lung transplant|1
1223971|NCT00768300|4015739|P1|Overall Study|Subject moved to pursue lung transplant|1
1223972|NCT00768300|4015738|P2|Overall Study|Death|5
1223973|NCT00768300|4015739|P1|Overall Study|Death|21
1223974|NCT00768300|4015738|P2|Overall Study|Study discontinued by Sponsor|140
1223975|NCT00768300|4015739|P1|Overall Study|Study discontinued by Sponsor|271
1223976|NCT00768300|4015738|P2|Overall Study|Physician Decision|3
1223977|NCT00768300|4015739|P1|Overall Study|Physician Decision|2
1223978|NCT00768300|4015738|P2|Overall Study|Withdrawal by Subject|7
1223979|NCT00768300|4015739|P1|Overall Study|Withdrawal by Subject|13
1223980|NCT00768300|4015738|P2|Overall Study|Protocol Violation|1
1223981|NCT00768300|4015739|P1|Overall Study|Protocol Violation|6
1223982|NCT00768300|4015738|P2|Overall Study|Adverse Event|2
1223983|NCT00768300|4015739|P1|Overall Study|Adverse Event|10
1223984|NCT00768300|4015738|P2|Overall Study|Randomized but not treated|1
1223985|NCT00768300|4015739|P1|Overall Study|Randomized but not treated|1
1223986|NCT00768222|4015823|P2|Overall Study|Protocol Violation|2
1223987|NCT00768222|4015824|P1|Overall Study|Protocol Violation|0
1223988|NCT00768222|4015823|P2|Overall Study|Withdrawal by Subject|1
1223989|NCT00768222|4015824|P1|Overall Study|Withdrawal by Subject|3
1223990|NCT00768222|4015823|P2|Overall Study|Lost to Follow-up|1
1223991|NCT00768222|4015824|P1|Overall Study|Lost to Follow-up|1
1223992|NCT00768144|4015846|P1|Overall Study|Pt Withdrew Consent|1
1223993|NCT00768144|4015846|P1|Overall Study|Patient or MD Decision to End Treatment|1
1223994|NCT00768144|4015846|P1|Overall Study|Progressive Disease|21
1223995|NCT00768144|4015846|P1|Overall Study|Adverse Event|13
1223996|NCT00768066|4015859|P3|Overall Study|Did not receive study product injection.|0
1223997|NCT00768066|4015860|P2|Overall Study|Did not receive study product injection.|3
1223998|NCT00768066|4015861|P1|Overall Study|Did not receive study product injection.|3
1223999|NCT00768053|4015893|P1|Overall Study|Lost to Follow-up|1
1224000|NCT00768053|4015893|P1|Overall Study|Adverse Event|10
1224001|NCT00768040|4015924|P2|Overall Study|Abnormal laboratory value|1
1224002|NCT00768040|4015925|P1|Overall Study|Abnormal laboratory value|1
1224003|NCT00768040|4015924|P2|Overall Study|Adverse Event|2
1224004|NCT00768040|4015925|P1|Overall Study|Adverse Event|3
1224005|NCT00767806|4015933|P2|Overall Study|Sponsor Decision|1
1224006|NCT00767806|4015934|P1|Overall Study|Sponsor Decision|0
1224007|NCT00767806|4015933|P2|Overall Study|Entry Criteria Not Met|1
1224008|NCT00767806|4015934|P1|Overall Study|Entry Criteria Not Met|1
1224009|NCT00767806|4015933|P2|Overall Study|Lost to Follow-up|4
1224010|NCT00767806|4015934|P1|Overall Study|Lost to Follow-up|1
1224011|NCT00767806|4015933|P2|Overall Study|Physician Decision|3
1224012|NCT00767806|4015934|P1|Overall Study|Physician Decision|4
1224013|NCT00767806|4015933|P2|Overall Study|Lack of Efficacy|9
1224014|NCT00767806|4015934|P1|Overall Study|Lack of Efficacy|1
1224015|NCT00767806|4015933|P2|Overall Study|Protocol Violation|5
1224016|NCT00767806|4015934|P1|Overall Study|Protocol Violation|6
1224017|NCT00767806|4015933|P2|Overall Study|Withdrawal by Subject|13
1224018|NCT00767806|4015934|P1|Overall Study|Withdrawal by Subject|8
1224019|NCT00767806|4015933|P2|Overall Study|Adverse Event|11
1224020|NCT00767806|4015934|P1|Overall Study|Adverse Event|30
1224021|NCT00767676|4016011|P1|Overall Study|Investigator error|54
1224022|NCT00767520|4016034|P2|Overall Study|Randomized in error and Never treated|2
1224023|NCT00767520|4016035|P1|Overall Study|Randomized in error and Never treated|0
1224024|NCT00767520|4016034|P2|Overall Study|Participants still on treatment|15
1224025|NCT00767520|4016035|P1|Overall Study|Participants still on treatment|11
1224026|NCT00767455|4016088|P1|Overall Study|Investigator error|19
1224027|NCT00767325|4016122|P1|Overall Study|Missed visit due to family reasons|1
1224028|NCT00767325|4016122|P1|Overall Study|No longer met study criteria|2
1224029|NCT00767325|4016122|P1|Overall Study|Lost to Follow-up|3
1224030|NCT00767325|4016122|P1|Overall Study|Adverse Event|7
1224031|NCT00767325|4016122|P1|Overall Study|Lack of Efficacy|2
1224032|NCT00767104|4016133|P2|Overall Study|Lost to Follow-up|2
1224033|NCT00767104|4016134|P1|Overall Study|Lost to Follow-up|1
1224034|NCT00767039|4016144|P2|Overall Study|Death|2
1224035|NCT00767039|4016145|P1|Overall Study|Death|5
1224036|NCT00767000|4016176|P5|Optional 104-week Extension|Study terminated by sponsor|4
1224037|NCT00767000|4016177|P4|Optional 104-week Extension|Study terminated by sponsor|2
1224038|NCT00767000|4016178|P3|Optional 104-week Extension|Study terminated by sponsor|7
1224039|NCT00767000|4016179|P2|Optional 104-week Extension|Study terminated by sponsor|3
1224040|NCT00767000|4016180|P1|Optional 104-week Extension|Study terminated by sponsor|7
1224041|NCT00767000|4016176|P5|54-week Study|Reason not reported|0
1224042|NCT00767000|4016177|P4|54-week Study|Reason not reported|1
1224043|NCT00767000|4016178|P3|54-week Study|Reason not reported|0
1224044|NCT00767000|4016179|P2|54-week Study|Reason not reported|0
1224045|NCT00767000|4016180|P1|54-week Study|Reason not reported|0
1224046|NCT00767000|4016176|P5|54-week Study|Study terminated by sponsor|194
1224047|NCT00767000|4016177|P4|54-week Study|Study terminated by sponsor|196
1224048|NCT00767000|4016178|P3|54-week Study|Study terminated by sponsor|89
1224049|NCT00767000|4016179|P2|54-week Study|Study terminated by sponsor|102
1224050|NCT00767000|4016180|P1|54-week Study|Study terminated by sponsor|90
1224051|NCT00767000|4016176|P5|54-week Study|Withdrawal by Subject|13
1224052|NCT00767000|4016177|P4|54-week Study|Withdrawal by Subject|11
1224053|NCT00767000|4016178|P3|54-week Study|Withdrawal by Subject|5
1224054|NCT00767000|4016179|P2|54-week Study|Withdrawal by Subject|3
1224055|NCT00767000|4016180|P1|54-week Study|Withdrawal by Subject|2
1224056|NCT00767000|4016176|P5|54-week Study|Protocol Violation|0
1224057|NCT00767000|4016177|P4|54-week Study|Protocol Violation|2
1224058|NCT00767000|4016178|P3|54-week Study|Protocol Violation|1
1224059|NCT00767000|4016179|P2|54-week Study|Protocol Violation|0
1224060|NCT00767000|4016180|P1|54-week Study|Protocol Violation|0
1224061|NCT00767000|4016176|P5|54-week Study|Progressive disease|0
1224062|NCT00767000|4016177|P4|54-week Study|Progressive disease|0
1224063|NCT00767000|4016178|P3|54-week Study|Progressive disease|1
1224064|NCT00767000|4016179|P2|54-week Study|Progressive disease|0
1224065|NCT00767000|4016180|P1|54-week Study|Progressive disease|0
1224066|NCT00767000|4016176|P5|54-week Study|Physician Decision|1
1224067|NCT00767000|4016177|P4|54-week Study|Physician Decision|1
1224068|NCT00767000|4016178|P3|54-week Study|Physician Decision|1
1224069|NCT00767000|4016179|P2|54-week Study|Physician Decision|0
1224070|NCT00767000|4016180|P1|54-week Study|Physician Decision|4
1224071|NCT00767000|4016176|P5|54-week Study|Lost to Follow-up|2
1224072|NCT00767000|4016177|P4|54-week Study|Lost to Follow-up|4
1224073|NCT00767000|4016178|P3|54-week Study|Lost to Follow-up|1
1224074|NCT00767000|4016179|P2|54-week Study|Lost to Follow-up|0
1224075|NCT00767000|4016180|P1|54-week Study|Lost to Follow-up|4
1224076|NCT00767000|4016176|P5|54-week Study|Lack of Efficacy|5
1224077|NCT00767000|4016177|P4|54-week Study|Lack of Efficacy|0
1224078|NCT00767000|4016178|P3|54-week Study|Lack of Efficacy|1
1224079|NCT00767000|4016179|P2|54-week Study|Lack of Efficacy|0
1224080|NCT00767000|4016180|P1|54-week Study|Lack of Efficacy|2
1224081|NCT00767000|4016176|P5|54-week Study|Interruption of study medication|0
1224324|NCT00765817|4016583|P1|Overall Study|Adverse Event|13
1224082|NCT00767000|4016177|P4|54-week Study|Interruption of study medication|0
1224083|NCT00767000|4016178|P3|54-week Study|Interruption of study medication|1
1224084|NCT00767000|4016179|P2|54-week Study|Interruption of study medication|0
1224085|NCT00767000|4016180|P1|54-week Study|Interruption of study medication|0
1224086|NCT00767000|4016176|P5|54-week Study|Hypoglycemia|0
1224087|NCT00767000|4016177|P4|54-week Study|Hypoglycemia|0
1224088|NCT00767000|4016178|P3|54-week Study|Hypoglycemia|0
1224089|NCT00767000|4016179|P2|54-week Study|Hypoglycemia|1
1224090|NCT00767000|4016180|P1|54-week Study|Hypoglycemia|0
1224091|NCT00767000|4016176|P5|54-week Study|Hyperglycemia|1
1224092|NCT00767000|4016177|P4|54-week Study|Hyperglycemia|0
1224093|NCT00767000|4016178|P3|54-week Study|Hyperglycemia|1
1224094|NCT00767000|4016179|P2|54-week Study|Hyperglycemia|0
1224095|NCT00767000|4016180|P1|54-week Study|Hyperglycemia|0
1224096|NCT00767000|4016176|P5|54-week Study|Creaninine/creatinine clearance|4
1224097|NCT00767000|4016177|P4|54-week Study|Creaninine/creatinine clearance|2
1224098|NCT00767000|4016178|P3|54-week Study|Creaninine/creatinine clearance|2
1224099|NCT00767000|4016179|P2|54-week Study|Creaninine/creatinine clearance|1
1224100|NCT00767000|4016180|P1|54-week Study|Creaninine/creatinine clearance|2
1224101|NCT00767000|4016176|P5|54-week Study|Adverse Event|4
1224102|NCT00767000|4016177|P4|54-week Study|Adverse Event|8
1224103|NCT00767000|4016178|P3|54-week Study|Adverse Event|6
1224104|NCT00767000|4016179|P2|54-week Study|Adverse Event|6
1224105|NCT00767000|4016180|P1|54-week Study|Adverse Event|4
1224106|NCT00766831|4016222|P1|Overall Study|Not specified|28
1224107|NCT00766831|4016222|P1|Overall Study|Non cooperation by participants|14
1224108|NCT00766831|4016222|P1|Overall Study|Withdrawal of consent|26
1224109|NCT00766831|4016222|P1|Overall Study|Physician Decision|5
1224110|NCT00766831|4016222|P1|Overall Study|Protocol Violation|15
1224111|NCT00766831|4016222|P1|Overall Study|Adverse Event|20
1224112|NCT00766831|4016222|P1|Overall Study|Lost to Follow-up|3
1224113|NCT00766831|4016222|P1|Overall Study|Withdrawal by Subject|4
1224114|NCT00766675|4016252|P1|Overall Study|Insufficient therapy|1
1224115|NCT00766675|4016252|P1|Overall Study|Receive other anti-neoplastic treatment|1
1224116|NCT00766675|4016252|P1|Overall Study|Participant took prohibited medication|1
1224117|NCT00766675|4016252|P1|Overall Study|Protocol Violation|8
1224118|NCT00766675|4016252|P1|Overall Study|Withdrawal by Subject|11
1224119|NCT00766675|4016252|P1|Overall Study|Lost to Follow-up|2
1224120|NCT00766675|4016252|P1|Overall Study|Adverse Event|16
1224121|NCT00766636|4016279|P2|Overall Study|Disease Progression|0
1224122|NCT00766636|4016280|P1|Overall Study|Disease Progression|1
1224123|NCT00766636|4016279|P2|Overall Study|Adverse Event|0
1224124|NCT00766636|4016280|P1|Overall Study|Adverse Event|1
1224125|NCT00766636|4016279|P2|Overall Study|Incomplete Treatment|1
1224126|NCT00766636|4016280|P1|Overall Study|Incomplete Treatment|0
1224127|NCT00766636|4016279|P2|Overall Study|Withdrawal by Subject|1
1224128|NCT00766636|4016280|P1|Overall Study|Withdrawal by Subject|1
1224129|NCT00766597|4016286|P1|Overall Study|Without CCR5-tropic virus|5
1224130|NCT00766597|4016286|P1|Overall Study|Unexpected closure of study|4
1224131|NCT00766532|4016298|P1|Overall Study|Protocol Violation|2
1224132|NCT00766506|4016304|P2|Overall Study|Other|2
1224133|NCT00766506|4016305|P1|Overall Study|Other|2
1224134|NCT00766506|4016304|P2|Overall Study|Use rescue medication after 3 hours|0
1224135|NCT00766506|4016305|P1|Overall Study|Use rescue medication after 3 hours|3
1224136|NCT00766493|4016329|P1|30 Days Post-Procedure|Missed Visit - No Phone Contact|1
1224137|NCT00766493|4016329|P1|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4
1224138|NCT00766493|4016329|P1|30 Days Post-Procedure|Discontinued|7
1224139|NCT00766467|4016339|P2|Overall Study|Physician Decision|0
1224140|NCT00766467|4016340|P1|Overall Study|Physician Decision|1
1224141|NCT00766467|4016339|P2|Overall Study|Tumor Progression on Study|1
1224142|NCT00766467|4016340|P1|Overall Study|Tumor Progression on Study|0
1224143|NCT00766467|4016339|P2|Overall Study|Protocol Violation|4
1224144|NCT00766467|4016340|P1|Overall Study|Protocol Violation|2
1224145|NCT00766467|4016339|P2|Overall Study|Adverse Event|1
1224146|NCT00766467|4016340|P1|Overall Study|Adverse Event|1
1224147|NCT00766467|4016339|P2|Overall Study|Withdrawal by Subject|2
1224148|NCT00766467|4016340|P1|Overall Study|Withdrawal by Subject|7
1224149|NCT00766415|4016352|P2|Overall Study|Withdrawal by Subject|1
1224150|NCT00766415|4016353|P1|Overall Study|Withdrawal by Subject|0
1224151|NCT00766376|4016401|P1|Overall Study|Withdrawal by Subject|27
1224152|NCT00766363|4016410|P4|Overall Study|Adverse Event Prior to Randomization|0
1224153|NCT00766363|4016411|P3|Overall Study|Adverse Event Prior to Randomization|0
1224154|NCT00766363|4016412|P2|Overall Study|Adverse Event Prior to Randomization|1
1224155|NCT00766363|4016413|P1|Overall Study|Adverse Event Prior to Randomization|0
1224156|NCT00766363|4016410|P4|Overall Study|Withdrawal by Subject|0
1224157|NCT00766363|4016411|P3|Overall Study|Withdrawal by Subject|0
1224158|NCT00766363|4016412|P2|Overall Study|Withdrawal by Subject|0
1224159|NCT00766363|4016413|P1|Overall Study|Withdrawal by Subject|1
1224160|NCT00766090|4016452|P12|Treatment Period 3 (28 Days)|Lost to Follow-up|0
1224161|NCT00766090|4016453|P11|Treatment Period 3 (28 Days)|Lost to Follow-up|0
1224162|NCT00766090|4016454|P10|Treatment Period 3 (28 Days)|Lost to Follow-up|0
1224163|NCT00766090|4016455|P9|Treatment Period 3 (28 Days)|Lost to Follow-up|0
1224164|NCT00766090|4016456|P8|Treatment Period 3 (28 Days)|Lost to Follow-up|0
1224165|NCT00766090|4016457|P7|Treatment Period 3 (28 Days)|Lost to Follow-up|0
1224166|NCT00766090|4016458|P6|Treatment Period 3 (28 Days)|Lost to Follow-up|0
1224167|NCT00766090|4016459|P5|Treatment Period 3 (28 Days)|Lost to Follow-up|1
1224168|NCT00766090|4016460|P4|Treatment Period 3 (28 Days)|Lost to Follow-up|0
1224169|NCT00766090|4016461|P3|Treatment Period 3 (28 Days)|Lost to Follow-up|0
1224170|NCT00766090|4016462|P2|Treatment Period 3 (28 Days)|Lost to Follow-up|0
1224171|NCT00766090|4016463|P1|Treatment Period 3 (28 Days)|Lost to Follow-up|0
1224172|NCT00766090|4016452|P12|Treatment Period 3 (28 Days)|Lack of Efficacy|1
1224173|NCT00766090|4016453|P11|Treatment Period 3 (28 Days)|Lack of Efficacy|0
1224174|NCT00766090|4016454|P10|Treatment Period 3 (28 Days)|Lack of Efficacy|0
1224175|NCT00766090|4016455|P9|Treatment Period 3 (28 Days)|Lack of Efficacy|0
1224176|NCT00766090|4016456|P8|Treatment Period 3 (28 Days)|Lack of Efficacy|0
1224177|NCT00766090|4016457|P7|Treatment Period 3 (28 Days)|Lack of Efficacy|0
1224178|NCT00766090|4016458|P6|Treatment Period 3 (28 Days)|Lack of Efficacy|0
1224179|NCT00766090|4016459|P5|Treatment Period 3 (28 Days)|Lack of Efficacy|0
1224180|NCT00766090|4016460|P4|Treatment Period 3 (28 Days)|Lack of Efficacy|1
1224181|NCT00766090|4016461|P3|Treatment Period 3 (28 Days)|Lack of Efficacy|0
1224182|NCT00766090|4016462|P2|Treatment Period 3 (28 Days)|Lack of Efficacy|1
1224183|NCT00766090|4016463|P1|Treatment Period 3 (28 Days)|Lack of Efficacy|0
1224184|NCT00766090|4016452|P12|Treatment Period 3 (28 Days)|Protocol Violation|0
1224185|NCT00766090|4016453|P11|Treatment Period 3 (28 Days)|Protocol Violation|0
1224186|NCT00766090|4016454|P10|Treatment Period 3 (28 Days)|Protocol Violation|0
1224187|NCT00766090|4016455|P9|Treatment Period 3 (28 Days)|Protocol Violation|0
1224188|NCT00766090|4016456|P8|Treatment Period 3 (28 Days)|Protocol Violation|0
1224189|NCT00766090|4016457|P7|Treatment Period 3 (28 Days)|Protocol Violation|0
1224190|NCT00766090|4016458|P6|Treatment Period 3 (28 Days)|Protocol Violation|1
1224191|NCT00766090|4016459|P5|Treatment Period 3 (28 Days)|Protocol Violation|0
1224192|NCT00766090|4016460|P4|Treatment Period 3 (28 Days)|Protocol Violation|0
1224193|NCT00766090|4016461|P3|Treatment Period 3 (28 Days)|Protocol Violation|0
1224194|NCT00766090|4016462|P2|Treatment Period 3 (28 Days)|Protocol Violation|0
1224195|NCT00766090|4016463|P1|Treatment Period 3 (28 Days)|Protocol Violation|0
1224196|NCT00766090|4016452|P12|Washout Period 2 (14 Days)|Physician Decision|0
1224197|NCT00766090|4016453|P11|Washout Period 2 (14 Days)|Physician Decision|0
1224198|NCT00766090|4016454|P10|Washout Period 2 (14 Days)|Physician Decision|0
1224199|NCT00766090|4016455|P9|Washout Period 2 (14 Days)|Physician Decision|0
1224200|NCT00766090|4016456|P8|Washout Period 2 (14 Days)|Physician Decision|0
1224201|NCT00766090|4016457|P7|Washout Period 2 (14 Days)|Physician Decision|0
1224202|NCT00766090|4016458|P6|Washout Period 2 (14 Days)|Physician Decision|0
1224203|NCT00766090|4016459|P5|Washout Period 2 (14 Days)|Physician Decision|0
1224204|NCT00766090|4016460|P4|Washout Period 2 (14 Days)|Physician Decision|0
1224205|NCT00766090|4016461|P3|Washout Period 2 (14 Days)|Physician Decision|1
1224206|NCT00766090|4016462|P2|Washout Period 2 (14 Days)|Physician Decision|0
1224207|NCT00766090|4016463|P1|Washout Period 2 (14 Days)|Physician Decision|0
1224208|NCT00766090|4016452|P12|Treatment Period 2 (28 Days)|Lack of Efficacy|0
1224209|NCT00766090|4016453|P11|Treatment Period 2 (28 Days)|Lack of Efficacy|0
1224210|NCT00766090|4016454|P10|Treatment Period 2 (28 Days)|Lack of Efficacy|0
1224211|NCT00766090|4016455|P9|Treatment Period 2 (28 Days)|Lack of Efficacy|0
1224212|NCT00766090|4016456|P8|Treatment Period 2 (28 Days)|Lack of Efficacy|0
1224213|NCT00766090|4016457|P7|Treatment Period 2 (28 Days)|Lack of Efficacy|0
1224214|NCT00766090|4016458|P6|Treatment Period 2 (28 Days)|Lack of Efficacy|0
1224215|NCT00766090|4016459|P5|Treatment Period 2 (28 Days)|Lack of Efficacy|0
1224216|NCT00766090|4016460|P4|Treatment Period 2 (28 Days)|Lack of Efficacy|0
1224217|NCT00766090|4016461|P3|Treatment Period 2 (28 Days)|Lack of Efficacy|1
1224218|NCT00766090|4016462|P2|Treatment Period 2 (28 Days)|Lack of Efficacy|0
1224219|NCT00766090|4016463|P1|Treatment Period 2 (28 Days)|Lack of Efficacy|0
1224220|NCT00766090|4016452|P12|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1224221|NCT00766090|4016453|P11|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1224222|NCT00766090|4016454|P10|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1224223|NCT00766090|4016455|P9|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1224224|NCT00766090|4016456|P8|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1224225|NCT00766090|4016457|P7|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1224226|NCT00766090|4016458|P6|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1224227|NCT00766090|4016459|P5|Treatment Period 2 (28 Days)|Lost to Follow-up|2
1224228|NCT00766090|4016460|P4|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1224229|NCT00766090|4016461|P3|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1224230|NCT00766090|4016462|P2|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1224231|NCT00766090|4016463|P1|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1224232|NCT00766090|4016452|P12|Washout Period 1 (14 Days)|Protocol Violation|0
1224233|NCT00766090|4016453|P11|Washout Period 1 (14 Days)|Protocol Violation|0
1224234|NCT00766090|4016454|P10|Washout Period 1 (14 Days)|Protocol Violation|0
1224235|NCT00766090|4016455|P9|Washout Period 1 (14 Days)|Protocol Violation|0
1224236|NCT00766090|4016456|P8|Washout Period 1 (14 Days)|Protocol Violation|0
1224237|NCT00766090|4016457|P7|Washout Period 1 (14 Days)|Protocol Violation|0
1224238|NCT00766090|4016458|P6|Washout Period 1 (14 Days)|Protocol Violation|0
1224239|NCT00766090|4016459|P5|Washout Period 1 (14 Days)|Protocol Violation|0
1224240|NCT00766090|4016460|P4|Washout Period 1 (14 Days)|Protocol Violation|0
1224241|NCT00766090|4016461|P3|Washout Period 1 (14 Days)|Protocol Violation|1
1224242|NCT00766090|4016462|P2|Washout Period 1 (14 Days)|Protocol Violation|0
1224243|NCT00766090|4016463|P1|Washout Period 1 (14 Days)|Protocol Violation|0
1224244|NCT00766090|4016452|P12|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1224245|NCT00766090|4016453|P11|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1224246|NCT00766090|4016454|P10|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1224247|NCT00766090|4016455|P9|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1224248|NCT00766090|4016456|P8|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1224249|NCT00766090|4016457|P7|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1224250|NCT00766090|4016458|P6|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1224251|NCT00766090|4016459|P5|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1224252|NCT00766090|4016460|P4|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
1224253|NCT00766090|4016461|P3|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1224254|NCT00766090|4016462|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1224255|NCT00766090|4016463|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
1224256|NCT00766090|4016452|P12|Treatment Period 1 (28 Days)|Lack of Efficacy|0
1224257|NCT00766090|4016453|P11|Treatment Period 1 (28 Days)|Lack of Efficacy|0
1224258|NCT00766090|4016454|P10|Treatment Period 1 (28 Days)|Lack of Efficacy|0
1224259|NCT00766090|4016455|P9|Treatment Period 1 (28 Days)|Lack of Efficacy|0
1224260|NCT00766090|4016456|P8|Treatment Period 1 (28 Days)|Lack of Efficacy|0
1224261|NCT00766090|4016457|P7|Treatment Period 1 (28 Days)|Lack of Efficacy|0
1224262|NCT00766090|4016458|P6|Treatment Period 1 (28 Days)|Lack of Efficacy|0
1224263|NCT00766090|4016459|P5|Treatment Period 1 (28 Days)|Lack of Efficacy|0
1224264|NCT00766090|4016460|P4|Treatment Period 1 (28 Days)|Lack of Efficacy|0
1224265|NCT00766090|4016461|P3|Treatment Period 1 (28 Days)|Lack of Efficacy|0
1224266|NCT00766090|4016462|P2|Treatment Period 1 (28 Days)|Lack of Efficacy|0
1224267|NCT00766090|4016463|P1|Treatment Period 1 (28 Days)|Lack of Efficacy|2
1224268|NCT00766090|4016452|P12|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1224269|NCT00766090|4016453|P11|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1224270|NCT00766090|4016454|P10|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1224271|NCT00766090|4016455|P9|Treatment Period 1 (28 Days)|Lost to Follow-up|1
1224272|NCT00766090|4016456|P8|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1224273|NCT00766090|4016457|P7|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1224274|NCT00766090|4016458|P6|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1224275|NCT00766090|4016459|P5|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1224276|NCT00766090|4016460|P4|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1224277|NCT00766090|4016461|P3|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1224278|NCT00766090|4016462|P2|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1224279|NCT00766090|4016463|P1|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1224280|NCT00766051|4016504|P2|Overall Study|Withdrawal by Subject|0
1224281|NCT00766051|4016505|P1|Overall Study|Withdrawal by Subject|2
1224282|NCT00765882|4016536|P3|Overall Study|Other Reason|2
1224283|NCT00765882|4016537|P2|Overall Study|Other Reason|1
1224284|NCT00765882|4016538|P1|Overall Study|Other Reason|3
1224285|NCT00765882|4016536|P3|Overall Study|Lost to Follow-up|6
1224286|NCT00765882|4016537|P2|Overall Study|Lost to Follow-up|9
1224287|NCT00765882|4016538|P1|Overall Study|Lost to Follow-up|1
1224288|NCT00765882|4016536|P3|Overall Study|Withdrawal by Subject|6
1224289|NCT00765882|4016537|P2|Overall Study|Withdrawal by Subject|6
1224290|NCT00765882|4016538|P1|Overall Study|Withdrawal by Subject|2
1224291|NCT00765882|4016536|P3|Overall Study|Protocol Violation|1
1224292|NCT00765882|4016537|P2|Overall Study|Protocol Violation|3
1224293|NCT00765882|4016538|P1|Overall Study|Protocol Violation|4
1224294|NCT00765882|4016536|P3|Overall Study|Lack of Efficacy|1
1224295|NCT00765882|4016537|P2|Overall Study|Lack of Efficacy|0
1224296|NCT00765882|4016538|P1|Overall Study|Lack of Efficacy|4
1224297|NCT00765882|4016536|P3|Overall Study|Adverse Event|20
1224298|NCT00765882|4016537|P2|Overall Study|Adverse Event|21
1224299|NCT00765882|4016538|P1|Overall Study|Adverse Event|10
1224300|NCT00765843|4016570|P3|Overall Study|Adverse Event|1
1224301|NCT00765843|4016571|P2|Overall Study|Adverse Event|0
1224302|NCT00765843|4016572|P1|Overall Study|Adverse Event|0
1224303|NCT00765843|4016570|P3|Overall Study|did not return to receive intervention|0
1224304|NCT00765843|4016571|P2|Overall Study|did not return to receive intervention|1
1224305|NCT00765843|4016572|P1|Overall Study|did not return to receive intervention|0
1224306|NCT00765843|4016570|P3|Overall Study|Lost to Follow-up|2
1224307|NCT00765843|4016571|P2|Overall Study|Lost to Follow-up|3
1224308|NCT00765843|4016572|P1|Overall Study|Lost to Follow-up|1
1224309|NCT00765817|4016582|P2|Overall Study|Subject decision|11
1224310|NCT00765817|4016583|P1|Overall Study|Subject decision|7
1224311|NCT00765817|4016582|P2|Overall Study|Protocol Violation|1
1224312|NCT00765817|4016583|P1|Overall Study|Protocol Violation|1
1224313|NCT00765817|4016582|P2|Overall Study|Physician Decision|1
1224314|NCT00765817|4016583|P1|Overall Study|Physician Decision|2
1224315|NCT00765817|4016582|P2|Overall Study|Lost to Follow-up|3
1224316|NCT00765817|4016583|P1|Overall Study|Lost to Follow-up|1
1224317|NCT00765817|4016582|P2|Overall Study|Loss of glucose control|2
1224318|NCT00765817|4016583|P1|Overall Study|Loss of glucose control|0
1224319|NCT00765817|4016582|P2|Overall Study|Entry criteria not met|2
1224320|NCT00765817|4016583|P1|Overall Study|Entry criteria not met|2
1224321|NCT00765817|4016582|P2|Overall Study|Death|1
1224322|NCT00765817|4016583|P1|Overall Study|Death|0
1224323|NCT00765817|4016582|P2|Overall Study|Adverse Event|1
1224325|NCT00765726|4016631|P1|Overall Study|Discontinuation of study by sponsor|8
1224326|NCT00765726|4016631|P1|Overall Study|Withdrawal by Subject|1
1224327|NCT00765674|4016639|P4|Overall Study|Randomized in Error - No Study Drug|1
1224328|NCT00765674|4016640|P3|Overall Study|Randomized in Error - No Study Drug|0
1224329|NCT00765674|4016641|P2|Overall Study|Randomized in Error - No Study Drug|1
1224330|NCT00765674|4016642|P1|Overall Study|Randomized in Error - No Study Drug|0
1224331|NCT00765674|4016639|P4|Overall Study|Lost to Follow-up|1
1224332|NCT00765674|4016640|P3|Overall Study|Lost to Follow-up|2
1224333|NCT00765674|4016641|P2|Overall Study|Lost to Follow-up|6
1224334|NCT00765674|4016642|P1|Overall Study|Lost to Follow-up|4
1224335|NCT00765674|4016639|P4|Overall Study|Withdrawal by Subject|8
1224336|NCT00765674|4016640|P3|Overall Study|Withdrawal by Subject|3
1224337|NCT00765674|4016641|P2|Overall Study|Withdrawal by Subject|7
1224338|NCT00765674|4016642|P1|Overall Study|Withdrawal by Subject|5
1224339|NCT00765674|4016639|P4|Overall Study|Protocol Violation|0
1224340|NCT00765674|4016640|P3|Overall Study|Protocol Violation|1
1224341|NCT00765674|4016641|P2|Overall Study|Protocol Violation|0
1224342|NCT00765674|4016642|P1|Overall Study|Protocol Violation|2
1224343|NCT00765674|4016639|P4|Overall Study|Lack of Efficacy|2
1224344|NCT00765674|4016640|P3|Overall Study|Lack of Efficacy|1
1224345|NCT00765674|4016641|P2|Overall Study|Lack of Efficacy|3
1224346|NCT00765674|4016642|P1|Overall Study|Lack of Efficacy|2
1224347|NCT00765674|4016639|P4|Overall Study|Abnormal Test Procedure Result(s)|2
1224348|NCT00765674|4016640|P3|Overall Study|Abnormal Test Procedure Result(s)|1
1224349|NCT00765674|4016641|P2|Overall Study|Abnormal Test Procedure Result(s)|3
1224350|NCT00765674|4016642|P1|Overall Study|Abnormal Test Procedure Result(s)|1
1224351|NCT00765674|4016639|P4|Overall Study|Abnormal Laboratory Value(s)|0
1224352|NCT00765674|4016640|P3|Overall Study|Abnormal Laboratory Value(s)|1
1224353|NCT00765674|4016641|P2|Overall Study|Abnormal Laboratory Value(s)|0
1224354|NCT00765674|4016642|P1|Overall Study|Abnormal Laboratory Value(s)|0
1224355|NCT00765674|4016639|P4|Overall Study|Adverse Event|11
1224356|NCT00765674|4016640|P3|Overall Study|Adverse Event|8
1224357|NCT00765674|4016641|P2|Overall Study|Adverse Event|2
1224358|NCT00765674|4016642|P1|Overall Study|Adverse Event|7
1224359|NCT00765388|4016709|P2|Period 1|Hip operation|1
1224360|NCT00765388|4016710|P1|Period 1|Hip operation|0
1224361|NCT00765388|4016709|P2|Period 1|Herpes Zoster|1
1224362|NCT00765388|4016710|P1|Period 1|Herpes Zoster|0
1224363|NCT00765388|4016709|P2|Period 1|Lost to Follow-up|1
1224364|NCT00765388|4016710|P1|Period 1|Lost to Follow-up|0
1224365|NCT00765388|4016709|P2|Period 1|Lack of Efficacy|2
1224366|NCT00765388|4016710|P1|Period 1|Lack of Efficacy|1
1224367|NCT00765362|4016744|P1|Overall Study|Lost to Follow-up|95
1224368|NCT00765362|4016744|P1|Overall Study|Withdrawal by Subject|13
1224369|NCT00765362|4016744|P1|Overall Study|Protocol Violation|18
1224370|NCT00765362|4016744|P1|Overall Study|Adverse Event|2
1224371|NCT00765362|4016744|P1|Overall Study|Death|9
1224372|NCT00765336|4016752|P2|Overall Study|Adverse Event|1
1224373|NCT00765336|4016753|P1|Overall Study|Adverse Event|2
1224374|NCT00765336|4016752|P2|Overall Study|Lost to Follow-up|9
1224375|NCT00765336|4016753|P1|Overall Study|Lost to Follow-up|7
1224376|NCT00765336|4016752|P2|Overall Study|Withdrawal by Subject|4
1224377|NCT00765336|4016753|P1|Overall Study|Withdrawal by Subject|6
1224378|NCT00765336|4016752|P2|Overall Study|Protocol Violation|2
1224379|NCT00765336|4016753|P1|Overall Study|Protocol Violation|4
1224380|NCT00765245|4016761|P2|Overall Study|Death|0
1224381|NCT00765245|4016762|P1|Overall Study|Death|1
1224382|NCT00765245|4016761|P2|Overall Study|Physician Decision|0
1224383|NCT00765245|4016762|P1|Overall Study|Physician Decision|1
1224384|NCT00765245|4016761|P2|Overall Study|Adverse Event|0
1224385|NCT00765245|4016762|P1|Overall Study|Adverse Event|5
1224386|NCT00765245|4016761|P2|Overall Study|Withdrawal by Subject|0
1224387|NCT00765245|4016762|P1|Overall Study|Withdrawal by Subject|3
1224388|NCT00765245|4016761|P2|Overall Study|disease progression|2
1224389|NCT00765245|4016762|P1|Overall Study|disease progression|3
1224390|NCT00765102|4016808|P1|Overall Study|Protocol Violation|1
1224391|NCT00765102|4016808|P1|Overall Study|Withdrawal by Subject|2
1224392|NCT00765102|4016808|P1|Overall Study|Physician Decision|4
1224393|NCT00765102|4016808|P1|Overall Study|Adverse Event|6
1224394|NCT00765102|4016808|P1|Overall Study|Progressive disease|18
1224395|NCT00765076|4016833|P3|Overall Study|Withdrawal by Subject|1
1224396|NCT00765076|4016834|P2|Overall Study|Withdrawal by Subject|0
1224397|NCT00765076|4016835|P1|Overall Study|Withdrawal by Subject|0
1224398|NCT00765076|4016833|P3|Overall Study|Adverse Event|0
1224399|NCT00765076|4016834|P2|Overall Study|Adverse Event|0
1224400|NCT00765076|4016835|P1|Overall Study|Adverse Event|1
1224401|NCT00765063|4016888|P1|Overall Study|Adverse Event|4
1224402|NCT00765063|4016888|P1|Overall Study|Protocol Violation|6
1224403|NCT00765063|4016888|P1|Overall Study|Other|16
1224404|NCT00765063|4016888|P1|Overall Study|Withdrawal by Subject|1
1224405|NCT00765063|4016888|P1|Overall Study|Lack of Efficacy|5
1224406|NCT00765037|4016904|P1|Overall Study|Adverse Event|1
1224407|NCT00765037|4016904|P1|Overall Study|Lost to Follow-up|5
1224408|NCT00764946|4016911|P3|Overall Study|Never Treated|1
1224409|NCT00764946|4016912|P2|Overall Study|Never Treated|1
1224410|NCT00764946|4016913|P1|Overall Study|Never Treated|1
1224411|NCT00764946|4016911|P3|Overall Study|Withdrawal by Subject|2
1224412|NCT00764946|4016912|P2|Overall Study|Withdrawal by Subject|6
1224413|NCT00764946|4016913|P1|Overall Study|Withdrawal by Subject|3
1224414|NCT00764946|4016911|P3|Overall Study|Adverse Event|1
1224415|NCT00764946|4016912|P2|Overall Study|Adverse Event|2
1224416|NCT00764946|4016913|P1|Overall Study|Adverse Event|3
1224417|NCT00764946|4016911|P3|Overall Study|Physician Decision|0
1224418|NCT00764946|4016912|P2|Overall Study|Physician Decision|4
1224419|NCT00764946|4016913|P1|Overall Study|Physician Decision|2
1224420|NCT00764946|4016911|P3|Overall Study|Lost to Follow-up|0
1224421|NCT00764946|4016912|P2|Overall Study|Lost to Follow-up|4
1224422|NCT00764946|4016913|P1|Overall Study|Lost to Follow-up|3
1224423|NCT00764946|4016911|P3|Overall Study|Lack of Efficacy|0
1224424|NCT00764946|4016912|P2|Overall Study|Lack of Efficacy|0
1224425|NCT00764946|4016913|P1|Overall Study|Lack of Efficacy|1
1224426|NCT00764881|4016941|P2|Overall Study|no treatment or no observation|2
1224427|NCT00764881|4016942|P1|Overall Study|no treatment or no observation|2
1224428|NCT00764881|4016941|P2|Overall Study|Possibly noncompliant (study drug)|2
1224429|NCT00764881|4016942|P1|Overall Study|Possibly noncompliant (study drug)|0
1224430|NCT00764881|4016941|P2|Overall Study|Carcinoma detected|0
1224431|NCT00764881|4016942|P1|Overall Study|Carcinoma detected|1
1224432|NCT00764881|4016941|P2|Overall Study|Wished to become pregnant|0
1224433|NCT00764881|4016942|P1|Overall Study|Wished to become pregnant|1
1224434|NCT00764881|4016941|P2|Overall Study|Accidentally discontinued study drug|0
1224435|NCT00764881|4016942|P1|Overall Study|Accidentally discontinued study drug|1
1224436|NCT00764881|4016941|P2|Overall Study|Noncompliant|0
1224437|NCT00764881|4016942|P1|Overall Study|Noncompliant|1
1224438|NCT00764881|4016941|P2|Overall Study|Lost to Follow-up|0
1224439|NCT00764881|4016942|P1|Overall Study|Lost to Follow-up|2
1224440|NCT00764881|4016941|P2|Overall Study|Protocol Violation|2
1224441|NCT00764881|4016942|P1|Overall Study|Protocol Violation|2
1224442|NCT00764881|4016941|P2|Overall Study|Withdrawal by Subject|3
1224443|NCT00764881|4016942|P1|Overall Study|Withdrawal by Subject|1
1224444|NCT00764881|4016941|P2|Overall Study|Adverse Event|1
1224445|NCT00764881|4016942|P1|Overall Study|Adverse Event|5
1224446|NCT00764868|4017166|P1|Overall Study|Sponsor requested withdrawal|1
1224447|NCT00764868|4017166|P1|Overall Study|Positive drug screen|2
1224448|NCT00764868|4017166|P1|Overall Study|Met an exclusion criteria|1
1224449|NCT00764868|4017166|P1|Overall Study|Subject sent to boarding school|1
1224450|NCT00764868|4017166|P1|Overall Study|Misuse and compliance of study drug|1
1224451|NCT00764868|4017166|P1|Overall Study|Out of town|1
1224452|NCT00764868|4017166|P1|Overall Study|Prohibited medication|1
1224453|NCT00764868|4017166|P1|Overall Study|Pregnancy|3
1224454|NCT00764868|4017166|P1|Overall Study|Subject moved|7
1224455|NCT00764868|4017166|P1|Overall Study|Lack of Efficacy|5
1224456|NCT00764868|4017166|P1|Overall Study|Lost to Follow-up|25
1224457|NCT00764868|4017166|P1|Overall Study|Non-compliance|16
1224458|NCT00764868|4017166|P1|Overall Study|Withdrawal by Subject|31
1224459|NCT00764868|4017166|P1|Overall Study|Adverse Event|18
1224460|NCT00764790|4017175|P3|Overall Study|Lost to Follow-up|23
1224461|NCT00764790|4017176|P2|Overall Study|Lost to Follow-up|29
1224462|NCT00764790|4017177|P1|Overall Study|Lost to Follow-up|28
1224463|NCT00764790|4017175|P3|Overall Study|Withdrawal by Subject|6
1224464|NCT00764790|4017176|P2|Overall Study|Withdrawal by Subject|12
1224465|NCT00764790|4017177|P1|Overall Study|Withdrawal by Subject|10
1224466|NCT00764790|4017175|P3|Overall Study|Protocol Violation|1
1224467|NCT00764790|4017176|P2|Overall Study|Protocol Violation|0
1224468|NCT00764790|4017177|P1|Overall Study|Protocol Violation|0
1224469|NCT00764699|4017209|P1|Overall Study|PI left and study terminated|3
1224470|NCT00764673|4017213|P1|Overall Study|Revision of Device|2
1224471|NCT00764673|4017213|P1|Overall Study|Withdrawal by Subject|6
1224472|NCT00764673|4017213|P1|Overall Study|Lost to Follow-up|3
1224473|NCT00764673|4017213|P1|Overall Study|Death|1
1224474|NCT00764660|4017223|P2|Overall Study|Did Not Meet Protocol Eligibility|0
1224475|NCT00764660|4017224|P1|Overall Study|Did Not Meet Protocol Eligibility|1
1224476|NCT00764660|4017223|P2|Overall Study|Noncompliance With Protocol|1
1224477|NCT00764660|4017224|P1|Overall Study|Noncompliance With Protocol|5
1224478|NCT00764660|4017223|P2|Overall Study|Withdrawal by Subject|3
1224479|NCT00764660|4017224|P1|Overall Study|Withdrawal by Subject|7
1224480|NCT00764660|4017223|P2|Overall Study|Lost to Follow-up|4
1224481|NCT00764660|4017224|P1|Overall Study|Lost to Follow-up|3
1224482|NCT00764660|4017223|P2|Overall Study|Adverse Event|3
1224483|NCT00764660|4017224|P1|Overall Study|Adverse Event|6
1224484|NCT00764517|4017258|P2|Overall Study|Physician Decision|0
1224485|NCT00764517|4017259|P1|Overall Study|Physician Decision|3
1224486|NCT00764517|4017258|P2|Overall Study|Death|11
1224487|NCT00764517|4017259|P1|Overall Study|Death|3
1224488|NCT00764517|4017258|P2|Overall Study|Adverse Event|3
1224489|NCT00764517|4017259|P1|Overall Study|Adverse Event|9
1224490|NCT00764504|4017280|P3|Overall Study|Lost to Follow-up|72
1224491|NCT00764504|4017281|P2|Overall Study|Lost to Follow-up|34
1224492|NCT00764504|4017282|P1|Overall Study|Lost to Follow-up|40
1224493|NCT00764504|4017280|P3|Overall Study|Withdrawal by Subject|4
1224494|NCT00764504|4017281|P2|Overall Study|Withdrawal by Subject|7
1224495|NCT00764504|4017282|P1|Overall Study|Withdrawal by Subject|1
1224496|NCT00764504|4017280|P3|Overall Study|Physician Decision|0
1224497|NCT00764504|4017281|P2|Overall Study|Physician Decision|0
1224498|NCT00764504|4017282|P1|Overall Study|Physician Decision|1
1224499|NCT00764504|4017280|P3|Overall Study|Revision of Device|14
1224500|NCT00764504|4017281|P2|Overall Study|Revision of Device|23
1224501|NCT00764504|4017282|P1|Overall Study|Revision of Device|12
1224502|NCT00764504|4017280|P3|Overall Study|Death|13
1224503|NCT00764504|4017281|P2|Overall Study|Death|6
1224504|NCT00764504|4017282|P1|Overall Study|Death|12
1224505|NCT00764478|4017311|P3|Overall Study|Protocol Violation|1
1224506|NCT00764478|4017312|P2|Overall Study|Protocol Violation|1
1224507|NCT00764478|4017313|P1|Overall Study|Protocol Violation|0
1224508|NCT00764478|4017311|P3|Overall Study|Lost to Follow-up|5
1224509|NCT00764478|4017312|P2|Overall Study|Lost to Follow-up|8
1224510|NCT00764478|4017313|P1|Overall Study|Lost to Follow-up|7
1224511|NCT00764478|4017311|P3|Overall Study|Withdrawal by Subject|1
1224512|NCT00764478|4017312|P2|Overall Study|Withdrawal by Subject|12
1224513|NCT00764478|4017313|P1|Overall Study|Withdrawal by Subject|7
1224514|NCT00764478|4017311|P3|Overall Study|Adverse Event|1
1224515|NCT00764478|4017312|P2|Overall Study|Adverse Event|1
1224516|NCT00764478|4017313|P1|Overall Study|Adverse Event|1
1224517|NCT00764465|4017393|P6|Overall Study|Withdrawal by Subject|0
1224518|NCT00764465|4017394|P5|Overall Study|Withdrawal by Subject|0
1224519|NCT00764465|4017395|P4|Overall Study|Withdrawal by Subject|0
1224520|NCT00764465|4017396|P3|Overall Study|Withdrawal by Subject|1
1224521|NCT00764465|4017397|P2|Overall Study|Withdrawal by Subject|1
1224522|NCT00764465|4017398|P1|Overall Study|Withdrawal by Subject|0
1224523|NCT00764465|4017393|P6|Overall Study|Adverse Event|1
1224524|NCT00764465|4017394|P5|Overall Study|Adverse Event|1
1224525|NCT00764465|4017395|P4|Overall Study|Adverse Event|1
1224526|NCT00764465|4017396|P3|Overall Study|Adverse Event|0
1224527|NCT00764465|4017397|P2|Overall Study|Adverse Event|0
1224528|NCT00764465|4017398|P1|Overall Study|Adverse Event|2
1224529|NCT00764361|4017426|P2|Overall Study|Adverse Event|1
1224530|NCT00764361|4017427|P1|Overall Study|Adverse Event|0
1224531|NCT00764361|4017426|P2|Overall Study|Withdrawal by Subject|3
1224532|NCT00764361|4017427|P1|Overall Study|Withdrawal by Subject|2
1224533|NCT00764322|4017435|P1|Overall Study|No CYP2D6 genotyping|9
1224534|NCT00764322|4017435|P1|Overall Study|Withdrawal by Subject|11
1224535|NCT00763971|4017462|P3|Overall Study|Participation in 489-326 required|0
1224536|NCT00763971|4017463|P2|Overall Study|Participation in 489-326 required|0
1224537|NCT00763971|4017464|P1|Overall Study|Participation in 489-326 required|1
1224538|NCT00763971|4017462|P3|Overall Study|Performed final visit on phone|0
1224539|NCT00763971|4017463|P2|Overall Study|Performed final visit on phone|1
1224540|NCT00763971|4017464|P1|Overall Study|Performed final visit on phone|0
1224541|NCT00763971|4017462|P3|Overall Study|Lack of availability|0
1224542|NCT00763971|4017463|P2|Overall Study|Lack of availability|1
1224543|NCT00763971|4017464|P1|Overall Study|Lack of availability|0
1224544|NCT00763971|4017462|P3|Overall Study|Subject wanted dose reduction|0
1224545|NCT00763971|4017463|P2|Overall Study|Subject wanted dose reduction|1
1224546|NCT00763971|4017464|P1|Overall Study|Subject wanted dose reduction|0
1224547|NCT00763971|4017462|P3|Overall Study|Moved to another country|0
1224548|NCT00763971|4017463|P2|Overall Study|Moved to another country|1
1224549|NCT00763971|4017464|P1|Overall Study|Moved to another country|0
1224550|NCT00763971|4017462|P3|Overall Study|Medical monitor decision|1
1224551|NCT00763971|4017463|P2|Overall Study|Medical monitor decision|0
1224552|NCT00763971|4017464|P1|Overall Study|Medical monitor decision|0
1224553|NCT00763971|4017462|P3|Overall Study|Randomization error|1
1224554|NCT00763971|4017463|P2|Overall Study|Randomization error|0
1224555|NCT00763971|4017464|P1|Overall Study|Randomization error|0
1224556|NCT00763971|4017462|P3|Overall Study|Due to holiday season|1
1224557|NCT00763971|4017463|P2|Overall Study|Due to holiday season|0
1224558|NCT00763971|4017464|P1|Overall Study|Due to holiday season|2
1224559|NCT00763971|4017462|P3|Overall Study|Sponsor decision|0
1224560|NCT00763971|4017463|P2|Overall Study|Sponsor decision|0
1224561|NCT00763971|4017464|P1|Overall Study|Sponsor decision|1
1224562|NCT00763971|4017462|P3|Overall Study|Exclusion criteria met|0
1224563|NCT00763971|4017463|P2|Overall Study|Exclusion criteria met|0
1224564|NCT00763971|4017464|P1|Overall Study|Exclusion criteria met|1
1224565|NCT00763971|4017462|P3|Overall Study|Personal reason|0
1224566|NCT00763971|4017463|P2|Overall Study|Personal reason|0
1224567|NCT00763971|4017464|P1|Overall Study|Personal reason|3
1224568|NCT00763971|4017462|P3|Overall Study|Unable to swallow capsule|1
1224569|NCT00763971|4017463|P2|Overall Study|Unable to swallow capsule|1
1224570|NCT00763971|4017464|P1|Overall Study|Unable to swallow capsule|2
1224571|NCT00763971|4017462|P3|Overall Study|Lack of Efficacy|54
1224572|NCT00763971|4017463|P2|Overall Study|Lack of Efficacy|22
1224573|NCT00763971|4017464|P1|Overall Study|Lack of Efficacy|11
1224574|NCT00763971|4017462|P3|Overall Study|Lost to Follow-up|0
1224575|NCT00763971|4017463|P2|Overall Study|Lost to Follow-up|1
1224576|NCT00763971|4017464|P1|Overall Study|Lost to Follow-up|0
1224577|NCT00763971|4017462|P3|Overall Study|Withdrawal by Subject|5
1224578|NCT00763971|4017463|P2|Overall Study|Withdrawal by Subject|5
1224579|NCT00763971|4017464|P1|Overall Study|Withdrawal by Subject|4
1224580|NCT00763971|4017462|P3|Overall Study|Protocol Violation|2
1224581|NCT00763971|4017463|P2|Overall Study|Protocol Violation|3
1224582|NCT00763971|4017464|P1|Overall Study|Protocol Violation|3
1224583|NCT00763971|4017462|P3|Overall Study|Adverse Event|4
1224584|NCT00763971|4017463|P2|Overall Study|Adverse Event|2
1224585|NCT00763971|4017464|P1|Overall Study|Adverse Event|5
1224586|NCT00763958|4017495|P2|Overall Study|Believed they were receiving placebo|5
1224587|NCT00763958|4017496|P1|Overall Study|Believed they were receiving placebo|0
1224588|NCT00763958|4017495|P2|Overall Study|Lost to Follow-up|2
1224589|NCT00763958|4017496|P1|Overall Study|Lost to Follow-up|10
1224590|NCT00763958|4017495|P2|Overall Study|did not meet final criteria|4
1224591|NCT00763958|4017496|P1|Overall Study|did not meet final criteria|4
1224592|NCT00763815|4017631|P2|Overall Study|Sponsor's Decision|1
1224593|NCT00763815|4017632|P1|Overall Study|Sponsor's Decision|0
1224594|NCT00763815|4017631|P2|Overall Study|Protocol Violation|5
1224595|NCT00763815|4017632|P1|Overall Study|Protocol Violation|2
1224596|NCT00763815|4017631|P2|Overall Study|Withdrawal by Subject|12
1224597|NCT00763815|4017632|P1|Overall Study|Withdrawal by Subject|7
1224598|NCT00763815|4017631|P2|Overall Study|Physician Decision|0
1224599|NCT00763815|4017632|P1|Overall Study|Physician Decision|1
1224600|NCT00763815|4017631|P2|Overall Study|Familial and Personal Reasons|16
1224601|NCT00763815|4017632|P1|Overall Study|Familial and Personal Reasons|9
1224602|NCT00763815|4017631|P2|Overall Study|Early Termination|0
1224603|NCT00763815|4017632|P1|Overall Study|Early Termination|1
1224604|NCT00763815|4017631|P2|Overall Study|Lost to Follow-up|4
1224605|NCT00763815|4017632|P1|Overall Study|Lost to Follow-up|2
1224606|NCT00763815|4017631|P2|Overall Study|Poor Compliance to Protocol|6
1224607|NCT00763815|4017632|P1|Overall Study|Poor Compliance to Protocol|6
1224608|NCT00763815|4017631|P2|Overall Study|Lack of Efficacy|11
1224609|NCT00763815|4017632|P1|Overall Study|Lack of Efficacy|10
1224610|NCT00763815|4017631|P2|Overall Study|Adverse Event|29
1224611|NCT00763815|4017632|P1|Overall Study|Adverse Event|14
1224612|NCT00763698|4017660|P1|Overall Study|Withdrawal by Subject|1
1224613|NCT00763698|4017660|P1|Overall Study|Death|4
1224614|NCT00763698|4017660|P1|Overall Study|Unsuccessful Implant|5
1224615|NCT00763451|4017677|P4|Overall Study|Study Site Reason|1
1224616|NCT00763451|4017678|P3|Overall Study|Study Site Reason|1
1224617|NCT00763451|4017679|P2|Overall Study|Study Site Reason|1
1224618|NCT00763451|4017680|P1|Overall Study|Study Site Reason|0
1224619|NCT00763451|4017677|P4|Overall Study|Randomized but not Treated|0
1224620|NCT00763451|4017678|P3|Overall Study|Randomized but not Treated|0
1224621|NCT00763451|4017679|P2|Overall Study|Randomized but not Treated|1
1224622|NCT00763451|4017680|P1|Overall Study|Randomized but not Treated|1
1224623|NCT00763451|4017677|P4|Overall Study|Familial and Personal Reasons|4
1224624|NCT00763451|4017678|P3|Overall Study|Familial and Personal Reasons|5
1224625|NCT00763451|4017679|P2|Overall Study|Familial and Personal Reasons|3
1224626|NCT00763451|4017680|P1|Overall Study|Familial and Personal Reasons|5
1224627|NCT00763451|4017677|P4|Overall Study|Poor Compliance to Protocol|2
1224628|NCT00763451|4017678|P3|Overall Study|Poor Compliance to Protocol|2
1224629|NCT00763451|4017679|P2|Overall Study|Poor Compliance to Protocol|1
1224630|NCT00763451|4017680|P1|Overall Study|Poor Compliance to Protocol|1
1224631|NCT00763451|4017677|P4|Overall Study|Protocol Violation|0
1224632|NCT00763451|4017678|P3|Overall Study|Protocol Violation|1
1224633|NCT00763451|4017679|P2|Overall Study|Protocol Violation|0
1224634|NCT00763451|4017680|P1|Overall Study|Protocol Violation|0
1224635|NCT00763451|4017677|P4|Overall Study|Withdrawal by Subject|7
1224636|NCT00763451|4017678|P3|Overall Study|Withdrawal by Subject|9
1224637|NCT00763451|4017679|P2|Overall Study|Withdrawal by Subject|6
1224638|NCT00763451|4017680|P1|Overall Study|Withdrawal by Subject|1
1224639|NCT00763451|4017677|P4|Overall Study|Lack of Efficacy|2
1224640|NCT00763451|4017678|P3|Overall Study|Lack of Efficacy|3
1224641|NCT00763451|4017679|P2|Overall Study|Lack of Efficacy|4
1224642|NCT00763451|4017680|P1|Overall Study|Lack of Efficacy|1
1224643|NCT00763451|4017677|P4|Overall Study|Adverse Event|14
1224644|NCT00763451|4017678|P3|Overall Study|Adverse Event|19
1224645|NCT00763451|4017679|P2|Overall Study|Adverse Event|6
1224646|NCT00763451|4017680|P1|Overall Study|Adverse Event|4
1224647|NCT00763386|4017739|P2|Overall Study|Study Prosthesis Removed|0
1224648|NCT00763386|4017740|P1|Overall Study|Study Prosthesis Removed|1
1224649|NCT00763386|4017739|P2|Overall Study|CRF missing|1
1224650|NCT00763386|4017740|P1|Overall Study|CRF missing|0
1224651|NCT00763386|4017739|P2|Overall Study|Withdrawal by Subject|1
1224652|NCT00763386|4017740|P1|Overall Study|Withdrawal by Subject|0
1224653|NCT00763386|4017739|P2|Overall Study|Lost to Follow-up|3
1224654|NCT00763386|4017740|P1|Overall Study|Lost to Follow-up|3
1224655|NCT00763386|4017739|P2|Overall Study|Death|2
1224656|NCT00763386|4017740|P1|Overall Study|Death|1
1224657|NCT00763386|4017739|P2|Overall Study|Adverse Event|33
1224658|NCT00763386|4017740|P1|Overall Study|Adverse Event|43
1224659|NCT00763321|4017773|P3|Double-blind Period|Not specified|3
1224660|NCT00763321|4017774|P2|Double-blind Period|Not specified|2
1224661|NCT00763321|4017775|P1|Double-blind Period|Not specified|0
1224662|NCT00763321|4017773|P3|Double-blind Period|Withdrawal by Subject|3
1224663|NCT00763321|4017774|P2|Double-blind Period|Withdrawal by Subject|2
1224664|NCT00763321|4017775|P1|Double-blind Period|Withdrawal by Subject|0
1224665|NCT00763321|4017773|P3|Double-blind Period|Lost to Follow-up|2
1224666|NCT00763321|4017774|P2|Double-blind Period|Lost to Follow-up|4
1224667|NCT00763321|4017775|P1|Double-blind Period|Lost to Follow-up|0
1224668|NCT00763321|4017773|P3|Double-blind Period|Adverse Event|4
1224669|NCT00763321|4017774|P2|Double-blind Period|Adverse Event|4
1224670|NCT00763321|4017775|P1|Double-blind Period|Adverse Event|0
1224671|NCT00763321|4017773|P3|Double-blind Period|Lack of Efficacy|17
1224672|NCT00763321|4017774|P2|Double-blind Period|Lack of Efficacy|9
1224673|NCT00763321|4017775|P1|Double-blind Period|Lack of Efficacy|0
1224674|NCT00763321|4017773|P3|Open-label Period|Not specified|0
1224675|NCT00763321|4017774|P2|Open-label Period|Not specified|0
1224676|NCT00763321|4017775|P1|Open-label Period|Not specified|4
1224677|NCT00763321|4017773|P3|Open-label Period|Lack of Efficacy|0
1224678|NCT00763321|4017774|P2|Open-label Period|Lack of Efficacy|0
1224679|NCT00763321|4017775|P1|Open-label Period|Lack of Efficacy|2
1224680|NCT00763321|4017773|P3|Open-label Period|Did not meet DB randomization criteria|0
1224681|NCT00763321|4017774|P2|Open-label Period|Did not meet DB randomization criteria|0
1224682|NCT00763321|4017775|P1|Open-label Period|Did not meet DB randomization criteria|5
1224683|NCT00763321|4017773|P3|Open-label Period|Subject noncompliant|0
1224684|NCT00763321|4017774|P2|Open-label Period|Subject noncompliant|0
1224685|NCT00763321|4017775|P1|Open-label Period|Subject noncompliant|7
1224686|NCT00763321|4017773|P3|Open-label Period|Withdrawal by Subject|0
1224687|NCT00763321|4017774|P2|Open-label Period|Withdrawal by Subject|0
1224688|NCT00763321|4017775|P1|Open-label Period|Withdrawal by Subject|7
1224689|NCT00763321|4017773|P3|Open-label Period|Lost to Follow-up|0
1224690|NCT00763321|4017774|P2|Open-label Period|Lost to Follow-up|0
1224691|NCT00763321|4017775|P1|Open-label Period|Lost to Follow-up|14
1224692|NCT00763321|4017773|P3|Open-label Period|Adverse Event|0
1224693|NCT00763321|4017774|P2|Open-label Period|Adverse Event|0
1224694|NCT00763321|4017775|P1|Open-label Period|Adverse Event|24
1224695|NCT00763282|4017786|P2|Overall Study|Lost to Follow-up|26
1224696|NCT00763282|4017787|P1|Overall Study|Lost to Follow-up|22
1224697|NCT00763282|4017786|P2|Overall Study|Death|3
1224698|NCT00763282|4017787|P1|Overall Study|Death|4
1224699|NCT00763282|4017786|P2|Overall Study|Withdrawal by Subject|5
1224700|NCT00763282|4017787|P1|Overall Study|Withdrawal by Subject|6
1224701|NCT00763269|4017803|P2|Overall Study|Lost to Follow-up|13
1224702|NCT00763269|4017804|P1|Overall Study|Lost to Follow-up|12
1224703|NCT00763256|4017818|P2|Overall Study|Didn't return for appointments|10
1224704|NCT00763256|4017819|P1|Overall Study|Didn't return for appointments|7
1224705|NCT00763139|4017855|P2|Overall Study|med change not allowed by protocol|0
1224706|NCT00763139|4017856|P1|Overall Study|med change not allowed by protocol|1
1224707|NCT00763139|4017855|P2|Overall Study|Withdrawal by Subject|1
1224708|NCT00763139|4017856|P1|Overall Study|Withdrawal by Subject|0
1224709|NCT00763139|4017855|P2|Overall Study|Adverse Event|2
1224710|NCT00763139|4017856|P1|Overall Study|Adverse Event|4
1224711|NCT00763035|4017918|P2|Second Intervention|Physician Decision|0
1224712|NCT00763035|4017919|P1|Second Intervention|Physician Decision|2
1224713|NCT00763035|4017918|P2|Second Intervention|Adverse Event|0
1224714|NCT00763035|4017919|P1|Second Intervention|Adverse Event|1
1224715|NCT00763035|4017918|P2|First Intervention|Adverse Event|1
1224716|NCT00763035|4017919|P1|First Intervention|Adverse Event|0
1224717|NCT00763035|4017918|P2|First Intervention|Did not meeting inclusion/exclusion|0
1224718|NCT00763035|4017919|P1|First Intervention|Did not meeting inclusion/exclusion|1
1224719|NCT00763009|4017937|P1|Overall Study|Coronary Anatomy unsuitable|1
1224720|NCT00762996|4017942|P4|Period One|Withdrawal by Subject|0
1224721|NCT00762996|4017943|P3|Period One|Withdrawal by Subject|1
1224722|NCT00762996|4017944|P2|Period One|Withdrawal by Subject|0
1224723|NCT00762996|4017945|P1|Period One|Withdrawal by Subject|0
1224724|NCT00762996|4017942|P4|Period One|Adverse Event|0
1224725|NCT00762996|4017943|P3|Period One|Adverse Event|1
1224726|NCT00762996|4017944|P2|Period One|Adverse Event|0
1224727|NCT00762996|4017945|P1|Period One|Adverse Event|0
1224728|NCT00762996|4017942|P4|Period One|ineligible|1
1224729|NCT00762996|4017943|P3|Period One|ineligible|1
1224730|NCT00762996|4017944|P2|Period One|ineligible|0
1224731|NCT00762996|4017945|P1|Period One|ineligible|0
1224732|NCT00762996|4017942|P4|Period One|Protocol Violation|0
1224733|NCT00762996|4017943|P3|Period One|Protocol Violation|1
1224734|NCT00762996|4017944|P2|Period One|Protocol Violation|0
1224735|NCT00762996|4017945|P1|Period One|Protocol Violation|0
1224736|NCT00762970|4017958|P3|Overall Study|Difficulty of handling lens|0
1224737|NCT00762970|4017959|P2|Overall Study|Difficulty of handling lens|2
1224738|NCT00762970|4017960|P1|Overall Study|Difficulty of handling lens|1
1224739|NCT00762970|4017958|P3|Overall Study|Lost to Follow-up|0
1224740|NCT00762970|4017959|P2|Overall Study|Lost to Follow-up|2
1224741|NCT00762970|4017960|P1|Overall Study|Lost to Follow-up|1
1224742|NCT00762970|4017958|P3|Overall Study|Protocol Violation|1
1224743|NCT00762970|4017959|P2|Overall Study|Protocol Violation|1
1224744|NCT00762970|4017960|P1|Overall Study|Protocol Violation|3
1224745|NCT00762970|4017958|P3|Overall Study|Withdrawal by Subject|0
1224746|NCT00762970|4017959|P2|Overall Study|Withdrawal by Subject|4
1224747|NCT00762970|4017960|P1|Overall Study|Withdrawal by Subject|7
1224748|NCT00762892|4017978|P2|Overall Study|Incarceration|0
1224749|NCT00762892|4017979|P1|Overall Study|Incarceration|1
1224750|NCT00762892|4017978|P2|Overall Study|Pregnancy|0
1224751|NCT00762892|4017979|P1|Overall Study|Pregnancy|1
1224752|NCT00762892|4017978|P2|Overall Study|Death|0
1224753|NCT00762892|4017979|P1|Overall Study|Death|1
1224754|NCT00762892|4017978|P2|Overall Study|Withdrawal by Subject|1
1224755|NCT00762892|4017979|P1|Overall Study|Withdrawal by Subject|0
1224756|NCT00762892|4017978|P2|Overall Study|Lost to Follow-up|5
1224757|NCT00762892|4017979|P1|Overall Study|Lost to Follow-up|2
1224758|NCT00762788|4018008|P6|Overall Study|Lost to Follow-up|21
1224759|NCT00762788|4018009|P5|Overall Study|Lost to Follow-up|13
1224760|NCT00762788|4018010|P4|Overall Study|Lost to Follow-up|26
1224761|NCT00762788|4018011|P3|Overall Study|Lost to Follow-up|21
1224762|NCT00762788|4018012|P2|Overall Study|Lost to Follow-up|37
1224763|NCT00762788|4018013|P1|Overall Study|Lost to Follow-up|26
1224764|NCT00762762|4018035|P2|Overall Study|Did not report for appointments|10
1224765|NCT00762762|4018036|P1|Overall Study|Did not report for appointments|8
1224766|NCT00762723|4018053|P3|Overall Study|Study Terminated slow enrollement|3
1224767|NCT00762723|4018054|P2|Overall Study|Study Terminated slow enrollement|5
1224768|NCT00762723|4018055|P1|Overall Study|Study Terminated slow enrollement|5
1224769|NCT00762606|4018219|P2|Overall Study|Lost to Follow-up|13
1224770|NCT00762606|4018220|P1|Overall Study|Lost to Follow-up|18
1224771|NCT00762502|4018265|P3|Month 3 to Month 6 (Period 2)|Pregnancy|0
1224772|NCT00762502|4018266|P2|Month 3 to Month 6 (Period 2)|Pregnancy|1
1224773|NCT00762502|4018267|P1|Month 3 to Month 6 (Period 2)|Pregnancy|0
1224774|NCT00762502|4018265|P3|Baseline to Month 3 (Period 1)|Lost to Follow-up|13
1224775|NCT00762502|4018266|P2|Baseline to Month 3 (Period 1)|Lost to Follow-up|3
1224776|NCT00762502|4018267|P1|Baseline to Month 3 (Period 1)|Lost to Follow-up|6
1224777|NCT00762502|4018265|P3|Baseline to Month 3 (Period 1)|Adverse Event|6
1224778|NCT00762502|4018266|P2|Baseline to Month 3 (Period 1)|Adverse Event|3
1224779|NCT00762502|4018267|P1|Baseline to Month 3 (Period 1)|Adverse Event|4
1224780|NCT00762476|4018281|P2|Overall Study|Seasonal allergies|0
1224781|NCT00762476|4018282|P1|Overall Study|Seasonal allergies|1
1224782|NCT00762476|4018281|P2|Overall Study|non-compliance with study visits|2
1224783|NCT00762476|4018282|P1|Overall Study|non-compliance with study visits|0
1224784|NCT00762476|4018281|P2|Overall Study|antibiotic use|1
1224785|NCT00762476|4018282|P1|Overall Study|antibiotic use|0
1224786|NCT00762476|4018281|P2|Overall Study|Withdrawal by Subject|12
1224787|NCT00762476|4018282|P1|Overall Study|Withdrawal by Subject|6
1224788|NCT00762476|4018281|P2|Overall Study|Physician Decision|14
1224789|NCT00762476|4018282|P1|Overall Study|Physician Decision|2
1224790|NCT00762476|4018281|P2|Overall Study|Protocol Violation|6
1224791|NCT00762476|4018282|P1|Overall Study|Protocol Violation|5
1224792|NCT00762476|4018281|P2|Overall Study|Lost to Follow-up|0
1224793|NCT00762476|4018282|P1|Overall Study|Lost to Follow-up|2
1224794|NCT00762476|4018281|P2|Overall Study|Adverse Event|1
1224795|NCT00762476|4018282|P1|Overall Study|Adverse Event|7
1224796|NCT00762463|4018294|P4|Extension Phase (Week 6 to Week 12)|Not specified|1
1224797|NCT00762463|4018295|P3|Extension Phase (Week 6 to Week 12)|Not specified|0
1224798|NCT00762463|4018296|P2|Extension Phase (Week 6 to Week 12)|Not specified|0
1224799|NCT00762463|4018297|P1|Extension Phase (Week 6 to Week 12)|Not specified|0
1224800|NCT00762463|4018294|P4|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
1224801|NCT00762463|4018295|P3|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3
1224802|NCT00762463|4018296|P2|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
1224803|NCT00762463|4018297|P1|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1
1224804|NCT00762463|4018294|P4|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
1224805|NCT00762463|4018295|P3|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0
1224806|NCT00762463|4018296|P2|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
1224807|NCT00762463|4018297|P1|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
1224808|NCT00762463|4018294|P4|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
1224809|NCT00762463|4018295|P3|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
1224810|NCT00762463|4018296|P2|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
1224811|NCT00762463|4018297|P1|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
1224812|NCT00762463|4018294|P4|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
1224813|NCT00762463|4018295|P3|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
1224814|NCT00762463|4018296|P2|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1
1224815|NCT00762463|4018297|P1|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4
1224816|NCT00762463|4018294|P4|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
1224817|NCT00762463|4018295|P3|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
1224818|NCT00762463|4018296|P2|Double-blind Phase (Baseline to Week 6)|Adverse Event|4
1224819|NCT00762463|4018297|P1|Double-blind Phase (Baseline to Week 6)|Adverse Event|2
1224820|NCT00762463|4018294|P4|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
1224821|NCT00762463|4018295|P3|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
1224822|NCT00762463|4018296|P2|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4
1224823|NCT00762463|4018297|P1|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3
1224824|NCT00762463|4018294|P4|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
1224825|NCT00762463|4018295|P3|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
1224826|NCT00762463|4018296|P2|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
1224827|NCT00762463|4018297|P1|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
1224828|NCT00762411|4018403|P2|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54
1224829|NCT00762411|4018404|P1|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48
1224830|NCT00762411|4018403|P2|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
1224831|NCT00762411|4018404|P1|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
1224832|NCT00762411|4018403|P2|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
1224833|NCT00762411|4018404|P1|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6
1224834|NCT00762411|4018403|P2|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46
1224835|NCT00762411|4018404|P1|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21
1224836|NCT00762411|4018403|P2|Safety Follow Up (SFU)-Optional|Adverse Event|1
1224837|NCT00762411|4018404|P1|Safety Follow Up (SFU)-Optional|Adverse Event|0
1224838|NCT00762411|4018403|P2|Safety Follow Up (SFU)-Optional|Death|8
1224839|NCT00762411|4018404|P1|Safety Follow Up (SFU)-Optional|Death|1
1224840|NCT00762411|4018403|P2|Delayed Start|Caregiver Decision|1
1224841|NCT00762411|4018404|P1|Delayed Start|Caregiver Decision|1
1224842|NCT00762411|4018403|P2|Delayed Start|Sponsor Decision|20
1224843|NCT00762411|4018404|P1|Delayed Start|Sponsor Decision|16
1224844|NCT00762411|4018403|P2|Delayed Start|Protocol Violation|1
1224845|NCT00762411|4018404|P1|Delayed Start|Protocol Violation|0
1224846|NCT00762411|4018403|P2|Delayed Start|Adverse Event|4
1224847|NCT00762411|4018404|P1|Delayed Start|Adverse Event|0
1224848|NCT00762411|4018403|P2|Initial Treatment|Entry Criteria Exclusion|1
1224849|NCT00762411|4018404|P1|Initial Treatment|Entry Criteria Exclusion|0
1224850|NCT00762411|4018403|P2|Initial Treatment|Abnormal Lab/ECG Result|4
1224851|NCT00762411|4018404|P1|Initial Treatment|Abnormal Lab/ECG Result|6
1224852|NCT00762411|4018403|P2|Initial Treatment|Caregiver Decision|16
1224853|NCT00762411|4018404|P1|Initial Treatment|Caregiver Decision|21
1224854|NCT00762411|4018403|P2|Initial Treatment|Lost to Follow-up|0
1224855|NCT00762411|4018404|P1|Initial Treatment|Lost to Follow-up|5
1224856|NCT00762411|4018403|P2|Initial Treatment|Sponsor Decision|401
1224857|NCT00762411|4018404|P1|Initial Treatment|Sponsor Decision|293
1224858|NCT00762411|4018403|P2|Initial Treatment|Physician Decision|0
1224859|NCT00762411|4018404|P1|Initial Treatment|Physician Decision|1
1224860|NCT00762411|4018403|P2|Initial Treatment|Withdrawal by Subject|52
1224861|NCT00762411|4018404|P1|Initial Treatment|Withdrawal by Subject|65
1224862|NCT00762411|4018403|P2|Initial Treatment|Protocol Violation|1
1224863|NCT00762411|4018404|P1|Initial Treatment|Protocol Violation|4
1224864|NCT00762411|4018403|P2|Initial Treatment|Adverse Event|40
1224865|NCT00762411|4018404|P1|Initial Treatment|Adverse Event|132
1224866|NCT00762411|4018403|P2|Initial Treatment|Death|6
1224867|NCT00762411|4018404|P1|Initial Treatment|Death|7
1224868|NCT00762385|4018468|P2|Second Intervention|Protocol Violation|3
1224869|NCT00762385|4018469|P1|Second Intervention|Protocol Violation|3
1224870|NCT00762385|4018468|P2|First Intervention|Protocol Violation|1
1224871|NCT00762385|4018469|P1|First Intervention|Protocol Violation|0
1224872|NCT00762385|4018468|P2|First Intervention|Ineligible|0
1224873|NCT00762385|4018469|P1|First Intervention|Ineligible|1
1224874|NCT00762385|4018468|P2|First Intervention|Lost to Follow-up|2
1224875|NCT00762385|4018469|P1|First Intervention|Lost to Follow-up|0
1224876|NCT00762385|4018468|P2|First Intervention|Lens Issue|1
1224877|NCT00762385|4018469|P1|First Intervention|Lens Issue|1
1224878|NCT00762359|4018481|P2|Overall Study|Withdrew consent|0
1224879|NCT00762359|4018482|P1|Overall Study|Withdrew consent|1
1224880|NCT00762359|4018481|P2|Overall Study|Removal|1
1224881|NCT00762359|4018482|P1|Overall Study|Removal|0
1224882|NCT00762359|4018481|P2|Overall Study|Physician Decision|3
1224883|NCT00762359|4018482|P1|Overall Study|Physician Decision|2
1224884|NCT00762359|4018481|P2|Overall Study|Institution closed|3
1224885|NCT00762359|4018482|P1|Overall Study|Institution closed|2
1224886|NCT00762359|4018481|P2|Overall Study|Lack of Efficacy|4
1224887|NCT00762359|4018482|P1|Overall Study|Lack of Efficacy|0
1224888|NCT00762359|4018481|P2|Overall Study|Withdrawal by Subject|10
1224889|NCT00762359|4018482|P1|Overall Study|Withdrawal by Subject|13
1224890|NCT00762359|4018481|P2|Overall Study|Protocol Violation|13
1224891|NCT00762359|4018482|P1|Overall Study|Protocol Violation|21
1224892|NCT00762359|4018481|P2|Overall Study|Adverse Event|23
1224893|NCT00762359|4018482|P1|Overall Study|Adverse Event|20
1224894|NCT00762268|4018599|P2|Overall Study|Protocol Violation|2
1224895|NCT00762268|4018600|P1|Overall Study|Protocol Violation|1
1224896|NCT00762229|4018608|P2|Overall Study|did not recveive intervention|1
1224897|NCT00762229|4018609|P1|Overall Study|did not recveive intervention|0
1224898|NCT00762229|4018608|P2|Overall Study|Lost to Follow-up|1
1224899|NCT00762229|4018609|P1|Overall Study|Lost to Follow-up|1
1224900|NCT00762164|4018706|P2|Overall Study|Withdrawal by Subject|1
1224901|NCT00762164|4018707|P1|Overall Study|Withdrawal by Subject|0
1224902|NCT00762164|4018706|P2|Overall Study|Discontinued medication|0
1224903|NCT00762164|4018707|P1|Overall Study|Discontinued medication|2
1224904|NCT00762164|4018706|P2|Overall Study|Lost to Follow-up|1
1224905|NCT00762164|4018707|P1|Overall Study|Lost to Follow-up|1
1224906|NCT00762086|4018717|P2|Overall Study|Ineligible to participate in the study|0
1224907|NCT00762086|4018718|P1|Overall Study|Ineligible to participate in the study|1
1224908|NCT00762086|4018717|P2|Overall Study|Withdrawal by Subject|2
1224909|NCT00762086|4018718|P1|Overall Study|Withdrawal by Subject|2
1224910|NCT00762086|4018717|P2|Overall Study|Non compliance|0
1224911|NCT00762086|4018718|P1|Overall Study|Non compliance|1
1224912|NCT00762086|4018717|P2|Overall Study|Lost to Follow-up|2
1224913|NCT00762086|4018718|P1|Overall Study|Lost to Follow-up|0
1224914|NCT00762086|4018717|P2|Overall Study|Adverse Event|0
1224915|NCT00762086|4018718|P1|Overall Study|Adverse Event|2
1224916|NCT00762073|4018728|P4|Overall Study|Not on treatment for >/= 77 days|0
1224917|NCT00762073|4018729|P3|Overall Study|Not on treatment for >/= 77 days|0
1224918|NCT00762073|4018730|P2|Overall Study|Not on treatment for >/= 77 days|0
1224919|NCT00762073|4018731|P1|Overall Study|Not on treatment for >/= 77 days|1
1224920|NCT00762073|4018728|P4|Overall Study|Withdrawal by Subject|1
1224921|NCT00762073|4018729|P3|Overall Study|Withdrawal by Subject|1
1224922|NCT00762073|4018730|P2|Overall Study|Withdrawal by Subject|2
1224923|NCT00762073|4018731|P1|Overall Study|Withdrawal by Subject|1
1224924|NCT00762073|4018728|P4|Overall Study|Significant Subject Noncompliance|1
1224925|NCT00762073|4018729|P3|Overall Study|Significant Subject Noncompliance|0
1224926|NCT00762073|4018730|P2|Overall Study|Significant Subject Noncompliance|1
1224927|NCT00762073|4018731|P1|Overall Study|Significant Subject Noncompliance|0
1224928|NCT00762073|4018728|P4|Overall Study|Adverse Event|1
1224929|NCT00762073|4018729|P3|Overall Study|Adverse Event|1
1224930|NCT00762073|4018730|P2|Overall Study|Adverse Event|0
1224931|NCT00762073|4018731|P1|Overall Study|Adverse Event|1
1224932|NCT00762073|4018728|P4|Overall Study|Lack of Efficacy|0
1224933|NCT00762073|4018729|P3|Overall Study|Lack of Efficacy|0
1224934|NCT00762073|4018730|P2|Overall Study|Lack of Efficacy|1
1224935|NCT00762073|4018731|P1|Overall Study|Lack of Efficacy|1
1224936|NCT00762034|4018795|P2|Maintenance Period|Other|1
1224937|NCT00762034|4018796|P1|Maintenance Period|Other|1
1224938|NCT00762034|4018795|P2|Maintenance Period|Death due to study disease|3
1224939|NCT00762034|4018796|P1|Maintenance Period|Death due to study disease|3
1224940|NCT00762034|4018795|P2|Maintenance Period|Death not due to study disease|5
1224941|NCT00762034|4018796|P1|Maintenance Period|Death not due to study disease|2
1224942|NCT00762034|4018795|P2|Maintenance Period|Withdrawal by Subject|14
1224943|NCT00762034|4018796|P1|Maintenance Period|Withdrawal by Subject|34
1224944|NCT00762034|4018795|P2|Maintenance Period|Physician Decision|20
1224945|NCT00762034|4018796|P1|Maintenance Period|Physician Decision|25
1224946|NCT00762034|4018795|P2|Maintenance Period|Progressive Disease|224
1224947|NCT00762034|4018796|P1|Maintenance Period|Progressive Disease|186
1224948|NCT00762034|4018795|P2|Maintenance Period|Adverse Event|26
1224949|NCT00762034|4018796|P1|Maintenance Period|Adverse Event|42
1224950|NCT00762034|4018795|P2|Maintenance Period|Entry Criterion Not Met|2
1224951|NCT00762034|4018796|P1|Maintenance Period|Entry Criterion Not Met|0
1224952|NCT00762034|4018795|P2|Maintenance Period|Protocol Violation|3
1224953|NCT00762034|4018796|P1|Maintenance Period|Protocol Violation|1
1224954|NCT00762034|4018795|P2|Induction Period|Deaths Due to Study Disease|9
1224955|NCT00762034|4018796|P1|Induction Period|Deaths Due to Study Disease|9
1224956|NCT00762034|4018795|P2|Induction Period|Deaths Not Due to Study Disease|14
1224957|NCT00762034|4018796|P1|Induction Period|Deaths Not Due to Study Disease|19
1224958|NCT00762034|4018795|P2|Induction Period|Withdrawal by Subject|19
1224959|NCT00762034|4018796|P1|Induction Period|Withdrawal by Subject|15
1224960|NCT00762034|4018795|P2|Induction Period|Physician Decision|20
1224961|NCT00762034|4018796|P1|Induction Period|Physician Decision|21
1224962|NCT00762034|4018795|P2|Induction Period|Progressive Disease|55
1224963|NCT00762034|4018796|P1|Induction Period|Progressive Disease|73
1224964|NCT00762034|4018795|P2|Induction Period|Lost to Follow-up|1
1224965|NCT00762034|4018796|P1|Induction Period|Lost to Follow-up|1
1224966|NCT00762034|4018795|P2|Induction Period|Adverse Event|38
1224967|NCT00762034|4018796|P1|Induction Period|Adverse Event|27
1224968|NCT00762034|4018795|P2|Induction Period|Entry Criterion Not Met|11
1224969|NCT00762034|4018796|P1|Induction Period|Entry Criterion Not Met|12
1224970|NCT00762034|4018795|P2|Induction Period|Protocol Violation|2
1224971|NCT00762034|4018796|P1|Induction Period|Protocol Violation|1
1224972|NCT00761969|4018868|P2|Overall Study|Lost to Follow-up|93
1224973|NCT00761969|4018869|P1|Overall Study|Lost to Follow-up|88
1224974|NCT00761969|4018868|P2|Overall Study|Death|47
1224975|NCT00761969|4018869|P1|Overall Study|Death|112
1224976|NCT00761956|4018879|P2|Overall Study|Adverse Event|34
1224977|NCT00761956|4018880|P1|Overall Study|Adverse Event|26
1224978|NCT00761956|4018879|P2|Overall Study|Death|1
1224979|NCT00761956|4018880|P1|Overall Study|Death|0
1224980|NCT00761956|4018879|P2|Overall Study|Withdrawal by Subject|8
1224981|NCT00761956|4018880|P1|Overall Study|Withdrawal by Subject|3
1224982|NCT00761956|4018879|P2|Overall Study|Lost to Follow-up|11
1224983|NCT00761956|4018880|P1|Overall Study|Lost to Follow-up|6
1224984|NCT00761865|4018909|P2|Overall Study|Lost to Follow-up|7
1224985|NCT00761865|4018910|P1|Overall Study|Lost to Follow-up|8
1224986|NCT00761774|4018931|P1|Overall Study|IP stopped by hospital physician|1
1224987|NCT00761774|4018931|P1|Overall Study|Subject IP non-compliance|1
1224988|NCT00761774|4018931|P1|Overall Study|Coordinator leaving site|1
1224989|NCT00761774|4018931|P1|Overall Study|Patient moved out of study area|1
1224990|NCT00761774|4018931|P1|Overall Study|Investigator clinical judgement|1
1224991|NCT00761774|4018931|P1|Overall Study|Sponsor decision|1
1224992|NCT00761774|4018931|P1|Overall Study|Medical decision to read SUSAR reports|1
1224993|NCT00761774|4018931|P1|Overall Study|Reclassification of seizures|1
1224994|NCT00761774|4018931|P1|Overall Study|End of study|2
1224995|NCT00761774|4018931|P1|Overall Study|Non-compliance|4
1224996|NCT00761774|4018931|P1|Overall Study|Withdrawal by Subject|9
1224997|NCT00761774|4018931|P1|Overall Study|Lost to Follow-up|2
1224998|NCT00761774|4018931|P1|Overall Study|Lack of Efficacy|37
1224999|NCT00761774|4018931|P1|Overall Study|Adverse Event|17
1225000|NCT00761761|4018942|P2|Overall Study|Withdrawal by Subject|0
1225001|NCT00761761|4018943|P1|Overall Study|Withdrawal by Subject|3
1225002|NCT00761761|4018942|P2|Overall Study|Lost to Follow-up|1
1225003|NCT00761761|4018943|P1|Overall Study|Lost to Follow-up|3
1225004|NCT00761748|4018955|P2|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3
1225005|NCT00761748|4018956|P1|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0
1225006|NCT00761748|4018955|P2|First Intervention (21 +/- 3 Days)|Adverse Event|0
1225007|NCT00761748|4018956|P1|First Intervention (21 +/- 3 Days)|Adverse Event|3
1225008|NCT00761735|4018962|P1|Overall Study|Administrative|1
1225009|NCT00761735|4018962|P1|Overall Study|Non-compliance with protocol|1
1225010|NCT00761735|4018962|P1|Overall Study|Withdrawal by Subject|6
1225011|NCT00761735|4018962|P1|Overall Study|Lost to Follow-up|6
1225012|NCT00761631|4018978|P6|Overall Study|Other|1
1225013|NCT00761631|4018979|P5|Overall Study|Other|1
1225014|NCT00761631|4018980|P4|Overall Study|Other|0
1225015|NCT00761631|4018981|P3|Overall Study|Other|0
1225016|NCT00761631|4018982|P2|Overall Study|Other|0
1225017|NCT00761631|4018983|P1|Overall Study|Other|0
1225018|NCT00761631|4018978|P6|Overall Study|Physician Decision|0
1225019|NCT00761631|4018979|P5|Overall Study|Physician Decision|0
1225020|NCT00761631|4018980|P4|Overall Study|Physician Decision|0
1225021|NCT00761631|4018981|P3|Overall Study|Physician Decision|0
1225022|NCT00761631|4018982|P2|Overall Study|Physician Decision|0
1225023|NCT00761631|4018983|P1|Overall Study|Physician Decision|1
1225024|NCT00761631|4018978|P6|Overall Study|Failed to return|2
1225025|NCT00761631|4018979|P5|Overall Study|Failed to return|5
1225026|NCT00761631|4018980|P4|Overall Study|Failed to return|1
1225027|NCT00761631|4018981|P3|Overall Study|Failed to return|1
1225028|NCT00761631|4018982|P2|Overall Study|Failed to return|0
1225029|NCT00761631|4018983|P1|Overall Study|Failed to return|1
1225030|NCT00761631|4018978|P6|Overall Study|Randomized, not treated|0
1225031|NCT00761631|4018979|P5|Overall Study|Randomized, not treated|0
1225032|NCT00761631|4018980|P4|Overall Study|Randomized, not treated|0
1225033|NCT00761631|4018981|P3|Overall Study|Randomized, not treated|0
1225034|NCT00761631|4018982|P2|Overall Study|Randomized, not treated|0
1225035|NCT00761631|4018983|P1|Overall Study|Randomized, not treated|1
1225036|NCT00761631|4018978|P6|Overall Study|Protocol Violation|1
1225037|NCT00761631|4018979|P5|Overall Study|Protocol Violation|5
1225038|NCT00761631|4018980|P4|Overall Study|Protocol Violation|1
1225039|NCT00761631|4018981|P3|Overall Study|Protocol Violation|0
1225040|NCT00761631|4018982|P2|Overall Study|Protocol Violation|0
1225041|NCT00761631|4018983|P1|Overall Study|Protocol Violation|2
1225042|NCT00761631|4018978|P6|Overall Study|Lost to Follow-up|1
1225043|NCT00761631|4018979|P5|Overall Study|Lost to Follow-up|6
1225044|NCT00761631|4018980|P4|Overall Study|Lost to Follow-up|1
1225045|NCT00761631|4018981|P3|Overall Study|Lost to Follow-up|7
1225046|NCT00761631|4018982|P2|Overall Study|Lost to Follow-up|4
1225047|NCT00761631|4018983|P1|Overall Study|Lost to Follow-up|2
1225048|NCT00761631|4018978|P6|Overall Study|Parent/legal guardian request|0
1225049|NCT00761631|4018979|P5|Overall Study|Parent/legal guardian request|5
1225050|NCT00761631|4018980|P4|Overall Study|Parent/legal guardian request|0
1225051|NCT00761631|4018981|P3|Overall Study|Parent/legal guardian request|8
1225052|NCT00761631|4018982|P2|Overall Study|Parent/legal guardian request|3
1225053|NCT00761631|4018983|P1|Overall Study|Parent/legal guardian request|8
1225054|NCT00761605|4019018|P1|Overall Study|Other|21
1225055|NCT00761605|4019018|P1|Overall Study|Withdrawal by Subject|37
1225056|NCT00761605|4019018|P1|Overall Study|Lost to Follow-up|29
1225057|NCT00761605|4019018|P1|Overall Study|Lack of Efficacy|26
1225058|NCT00761605|4019018|P1|Overall Study|Death|2
1225059|NCT00761605|4019018|P1|Overall Study|Adverse Event|26
1225060|NCT00761579|4019062|P1|Overall Study|Intake of prohibited concomitant drug|1
1225061|NCT00761579|4019062|P1|Overall Study|Lost survey form|1
1225062|NCT00761579|4019062|P1|Overall Study|Aggravation of symptoms by changing drug|1
1225063|NCT00761579|4019062|P1|Overall Study|Aggravation of depression|1
1225064|NCT00761579|4019062|P1|Overall Study|Drug overdose|1
1225065|NCT00761579|4019062|P1|Overall Study|Protocol deviation|1
1225066|NCT00761579|4019062|P1|Overall Study|Lack of compliance|2
1225067|NCT00761579|4019062|P1|Overall Study|Withdrawal by Subject|34
1225068|NCT00761579|4019062|P1|Overall Study|Pregnancy|1
1225069|NCT00761579|4019062|P1|Overall Study|Lost to Follow-up|16
1225070|NCT00761579|4019062|P1|Overall Study|Lack of Efficacy|21
1225071|NCT00761579|4019062|P1|Overall Study|Death|2
1225072|NCT00761579|4019062|P1|Overall Study|Adverse Event|10
1225073|NCT00761527|4019095|P1|Overall Study|Unknown reason|2
1225074|NCT00761527|4019095|P1|Overall Study|Lost to Follow-up|9
1225075|NCT00761527|4019095|P1|Overall Study|Poor Compliance|8
1225076|NCT00761527|4019095|P1|Overall Study|Adverse Event|3
1225077|NCT00761514|4019102|P1|Overall Study|Unable to pay for medications|1
1225078|NCT00761514|4019102|P1|Overall Study|Problem complying with study visit|1
1225079|NCT00761514|4019102|P1|Overall Study|Health insurance didn't cover study drug|1
1225080|NCT00761514|4019102|P1|Overall Study|Lost to Follow-up|1
1225081|NCT00761514|4019102|P1|Overall Study|Withdrawal by Subject|2
1225082|NCT00761514|4019102|P1|Overall Study|Adverse Event|1
1225083|NCT00761462|4019109|P2|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21
1225084|NCT00761462|4019110|P1|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75
1225085|NCT00761462|4019109|P2|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30
1225086|NCT00761462|4019110|P1|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75
1225087|NCT00761462|4019109|P2|2 or 5 Years Long-term Safety Follow-up|Death|0
1225088|NCT00761462|4019110|P1|2 or 5 Years Long-term Safety Follow-up|Death|4
1225089|NCT00761462|4019109|P2|Treatment|Subjects never received study medication|12
1225090|NCT00761462|4019110|P1|Treatment|Subjects never received study medication|23
1225091|NCT00761319|4019124|P2|Overall Study|Missing|0
1225092|NCT00761319|4019125|P1|Overall Study|Missing|1
1225093|NCT00761319|4019124|P2|Overall Study|Nonspecified|2
1225094|NCT00761319|4019125|P1|Overall Study|Nonspecified|2
1225095|NCT00761319|4019124|P2|Overall Study|Lost to Follow-up|1
1225096|NCT00761319|4019125|P1|Overall Study|Lost to Follow-up|1
1225097|NCT00761319|4019124|P2|Overall Study|Noncompliance|3
1225098|NCT00761319|4019125|P1|Overall Study|Noncompliance|4
1225099|NCT00761319|4019124|P2|Overall Study|Withdrawal by Subject|7
1225100|NCT00761319|4019125|P1|Overall Study|Withdrawal by Subject|8
1225101|NCT00761319|4019124|P2|Overall Study|Adverse Event|7
1225102|NCT00761319|4019125|P1|Overall Study|Adverse Event|11
1225103|NCT00761319|4019124|P2|Overall Study|Protocol Violation|14
1225104|NCT00761319|4019125|P1|Overall Study|Protocol Violation|21
1225105|NCT00761306|4019133|P1|Overall Study|Administrative or Other Reasons|5
1225106|NCT00761306|4019133|P1|Overall Study|Lost to Follow-up|1
1225107|NCT00761306|4019133|P1|Overall Study|Withdrawal of Consent|3
1225108|NCT00761306|4019133|P1|Overall Study|Protocol Violation|2
1225109|NCT00761306|4019133|P1|Overall Study|Lack of Efficacy|4
1225110|NCT00761306|4019133|P1|Overall Study|Adverse Event|5
1225111|NCT00761280|4019144|P2|First Dose to End of Study|Lost to Follow-up|1
1225112|NCT00761280|4019145|P1|First Dose to End of Study|Lost to Follow-up|0
1225113|NCT00761280|4019144|P2|First Dose to End of Study|Death|0
1225114|NCT00761280|4019145|P1|First Dose to End of Study|Death|1
1225115|NCT00761280|4019144|P2|First Dose to End of Study|Sponsor decision|2
1225116|NCT00761280|4019145|P1|First Dose to End of Study|Sponsor decision|1
1225117|NCT00761280|4019144|P2|First Dose to End of Study|Progressive disease|3
1225118|NCT00761280|4019145|P1|First Dose to End of Study|Progressive disease|5
1225119|NCT00761280|4019144|P2|First Dose to End of Study|End of trial|5
1225120|NCT00761280|4019145|P1|First Dose to End of Study|End of trial|5
1225121|NCT00761280|4019144|P2|Randomization to First Dose|Other|0
1225122|NCT00761280|4019145|P1|Randomization to First Dose|Other|1
1225123|NCT00761280|4019144|P2|Randomization to First Dose|Sponsor decision|0
1225124|NCT00761280|4019145|P1|Randomization to First Dose|Sponsor decision|1
1225125|NCT00761280|4019144|P2|Randomization to First Dose|Withdrawal by Subject|2
1225126|NCT00761280|4019145|P1|Randomization to First Dose|Withdrawal by Subject|0
1225127|NCT00761267|4019176|P3|Overall Study|Withdrawal by Subject|0
1225128|NCT00761267|4019177|P2|Overall Study|Withdrawal by Subject|1
1225129|NCT00761267|4019178|P1|Overall Study|Withdrawal by Subject|0
1225130|NCT00761267|4019176|P3|Overall Study|Randomized but not treated|0
1225131|NCT00761267|4019177|P2|Overall Study|Randomized but not treated|1
1225132|NCT00761267|4019178|P1|Overall Study|Randomized but not treated|1
1225133|NCT00761267|4019176|P3|Overall Study|Lost to Follow-up|1
1225134|NCT00761267|4019177|P2|Overall Study|Lost to Follow-up|0
1225135|NCT00761267|4019178|P1|Overall Study|Lost to Follow-up|0
1225136|NCT00761267|4019176|P3|Overall Study|Death|5
1225137|NCT00761267|4019177|P2|Overall Study|Death|2
1225138|NCT00761267|4019178|P1|Overall Study|Death|1
1225139|NCT00761215|4019208|P3|Overall Study|Bacteremia|0
1225140|NCT00761215|4019209|P2|Overall Study|Bacteremia|0
1225141|NCT00761215|4019210|P1|Overall Study|Bacteremia|1
1225142|NCT00761215|4019208|P3|Overall Study|Withdrawal by Subject|0
1225143|NCT00761215|4019209|P2|Overall Study|Withdrawal by Subject|0
1225144|NCT00761215|4019210|P1|Overall Study|Withdrawal by Subject|1
1225145|NCT00761215|4019208|P3|Overall Study|Lost to Follow-up|6
1225146|NCT00761215|4019209|P2|Overall Study|Lost to Follow-up|3
1225147|NCT00761215|4019210|P1|Overall Study|Lost to Follow-up|6
1225148|NCT00761215|4019208|P3|Overall Study|Randomized but didn't receive drug|2
1225149|NCT00761215|4019209|P2|Overall Study|Randomized but didn't receive drug|1
1225150|NCT00761215|4019210|P1|Overall Study|Randomized but didn't receive drug|1
1225151|NCT00761189|4019252|P1|Overall Study|Other|13
1225152|NCT00761189|4019252|P1|Overall Study|Withdrawal by Subject|49
1225153|NCT00761189|4019252|P1|Overall Study|Lost to Follow-up|36
1225154|NCT00761189|4019252|P1|Overall Study|Lack of Efficacy|45
1225155|NCT00761189|4019252|P1|Overall Study|Adverse Event|42
1225156|NCT00761176|4019269|P2|Overall Study|Withdrawal by Subject|1
1225157|NCT00761176|4019270|P1|Overall Study|Withdrawal by Subject|1
1225158|NCT00761176|4019269|P2|Overall Study|Death|0
1225159|NCT00761176|4019270|P1|Overall Study|Death|1
1225160|NCT00761150|4019279|P3|Double-blind Period|Not specified|3
1225161|NCT00761150|4019280|P2|Double-blind Period|Not specified|3
1225162|NCT00761150|4019281|P1|Double-blind Period|Not specified|0
1225163|NCT00761150|4019279|P3|Double-blind Period|Noncompliance|0
1225164|NCT00761150|4019280|P2|Double-blind Period|Noncompliance|1
1225165|NCT00761150|4019281|P1|Double-blind Period|Noncompliance|0
1225166|NCT00761150|4019279|P3|Double-blind Period|Did not meet DB randomization criteria|1
1225167|NCT00761150|4019280|P2|Double-blind Period|Did not meet DB randomization criteria|0
1225168|NCT00761150|4019281|P1|Double-blind Period|Did not meet DB randomization criteria|0
1225169|NCT00761150|4019279|P3|Double-blind Period|Lost to Follow-up|1
1225170|NCT00761150|4019280|P2|Double-blind Period|Lost to Follow-up|2
1225171|NCT00761150|4019281|P1|Double-blind Period|Lost to Follow-up|0
1225172|NCT00761150|4019279|P3|Double-blind Period|Withdrawal by Subject|2
1225173|NCT00761150|4019280|P2|Double-blind Period|Withdrawal by Subject|3
1225174|NCT00761150|4019281|P1|Double-blind Period|Withdrawal by Subject|0
1225175|NCT00761150|4019279|P3|Double-blind Period|Adverse Event|3
1225176|NCT00761150|4019280|P2|Double-blind Period|Adverse Event|3
1225177|NCT00761150|4019281|P1|Double-blind Period|Adverse Event|0
1225178|NCT00761150|4019279|P3|Double-blind Period|Lack of Efficacy|19
1225179|NCT00761150|4019280|P2|Double-blind Period|Lack of Efficacy|2
1225180|NCT00761150|4019281|P1|Double-blind Period|Lack of Efficacy|0
1225181|NCT00761150|4019279|P3|Open-label Period|Not specified|0
1225182|NCT00761150|4019280|P2|Open-label Period|Not specified|0
1225183|NCT00761150|4019281|P1|Open-label Period|Not specified|5
1225184|NCT00761150|4019279|P3|Open-label Period|Noncompliance|0
1225185|NCT00761150|4019280|P2|Open-label Period|Noncompliance|0
1225186|NCT00761150|4019281|P1|Open-label Period|Noncompliance|2
1225187|NCT00761150|4019279|P3|Open-label Period|Withdrawal by Subject|0
1225188|NCT00761150|4019280|P2|Open-label Period|Withdrawal by Subject|0
1225189|NCT00761150|4019281|P1|Open-label Period|Withdrawal by Subject|5
1225190|NCT00761150|4019279|P3|Open-label Period|Lack of Efficacy|0
1225191|NCT00761150|4019280|P2|Open-label Period|Lack of Efficacy|0
1225192|NCT00761150|4019281|P1|Open-label Period|Lack of Efficacy|4
1225193|NCT00761150|4019279|P3|Open-label Period|Lost to Follow-up|0
1225194|NCT00761150|4019280|P2|Open-label Period|Lost to Follow-up|0
1225195|NCT00761150|4019281|P1|Open-label Period|Lost to Follow-up|7
1225196|NCT00761150|4019279|P3|Open-label Period|Did not meet DB randomization criteria|0
1225197|NCT00761150|4019280|P2|Open-label Period|Did not meet DB randomization criteria|0
1225198|NCT00761150|4019281|P1|Open-label Period|Did not meet DB randomization criteria|11
1225199|NCT00761150|4019279|P3|Open-label Period|Adverse Event|0
1225200|NCT00761150|4019280|P2|Open-label Period|Adverse Event|0
1225201|NCT00761150|4019281|P1|Open-label Period|Adverse Event|36
1225202|NCT00760877|4019332|P2|Overall Study|Treatment failure|0
1225203|NCT00760877|4019333|P1|Overall Study|Treatment failure|1
1225204|NCT00760877|4019332|P2|Overall Study|Participants transferred to AMN107A2408|1
1225205|NCT00760877|4019333|P1|Overall Study|Participants transferred to AMN107A2408|11
1225206|NCT00760877|4019332|P2|Overall Study|Physician Decision|2
1225207|NCT00760877|4019333|P1|Overall Study|Physician Decision|1
1225208|NCT00760877|4019332|P2|Overall Study|Participant not eligible to cross-over|1
1225209|NCT00760877|4019333|P1|Overall Study|Participant not eligible to cross-over|0
1225210|NCT00760877|4019332|P2|Overall Study|Participant diagnosed with AML|1
1225211|NCT00760877|4019333|P1|Overall Study|Participant diagnosed with AML|0
1225212|NCT00760877|4019332|P2|Overall Study|Adverse Event|12
1225213|NCT00760877|4019333|P1|Overall Study|Adverse Event|19
1225214|NCT00760877|4019332|P2|Overall Study|Withdrawal by Subject|3
1225215|NCT00760877|4019333|P1|Overall Study|Withdrawal by Subject|7
1225216|NCT00760877|4019332|P2|Overall Study|Death|1
1225217|NCT00760877|4019333|P1|Overall Study|Death|2
1225218|NCT00760877|4019332|P2|Overall Study|Pregnancy|4
1225219|NCT00760877|4019333|P1|Overall Study|Pregnancy|1
1225220|NCT00760877|4019332|P2|Overall Study|Non-compliance with protocol treatment|1
1225221|NCT00760877|4019333|P1|Overall Study|Non-compliance with protocol treatment|2
1225222|NCT00760877|4019332|P2|Overall Study|Protocol Violation|0
1225223|NCT00760877|4019333|P1|Overall Study|Protocol Violation|1
1225224|NCT00760838|4019351|P2|Overall Study|Withdrawal by Subject|1
1225225|NCT00760838|4019352|P1|Overall Study|Withdrawal by Subject|1
1225226|NCT00760838|4019351|P2|Overall Study|Lost to Follow-up|0
1225227|NCT00760838|4019352|P1|Overall Study|Lost to Follow-up|2
1225228|NCT00760838|4019351|P2|Overall Study|Lack of Efficacy|0
1225229|NCT00760838|4019352|P1|Overall Study|Lack of Efficacy|1
1225230|NCT00760838|4019351|P2|Overall Study|Adverse Event|1
1225231|NCT00760838|4019352|P1|Overall Study|Adverse Event|1
1225232|NCT00760747|4019370|P2|Study Period III|Physician Decision|1
1225233|NCT00760747|4019371|P1|Study Period III|Physician Decision|0
1225234|NCT00760747|4019370|P2|Study Period III|Protocol Violation|1
1225235|NCT00760747|4019371|P1|Study Period III|Protocol Violation|1
1225236|NCT00760747|4019370|P2|Study Period III|Parent/Caregiver Decision|1
1225237|NCT00760747|4019371|P1|Study Period III|Parent/Caregiver Decision|0
1225238|NCT00760747|4019370|P2|Study Period III|Lack of Efficacy|0
1225239|NCT00760747|4019371|P1|Study Period III|Lack of Efficacy|1
1225240|NCT00760747|4019370|P2|Study Period III|Adverse Event|0
1225241|NCT00760747|4019371|P1|Study Period III|Adverse Event|1
1225242|NCT00760747|4019370|P2|Study Period II|No drug administered|1
1225243|NCT00760747|4019371|P1|Study Period II|No drug administered|0
1225244|NCT00760747|4019370|P2|Study Period II|Withdrawal by Subject|0
1225245|NCT00760747|4019371|P1|Study Period II|Withdrawal by Subject|1
1225246|NCT00760747|4019370|P2|Study Period II|Protocol Violation|3
1225247|NCT00760747|4019371|P1|Study Period II|Protocol Violation|6
1225248|NCT00760747|4019370|P2|Study Period II|Parent/Caregiver Decision|0
1225249|NCT00760747|4019371|P1|Study Period II|Parent/Caregiver Decision|3
1225250|NCT00760747|4019370|P2|Study Period II|Lack of Efficacy|6
1225251|NCT00760747|4019371|P1|Study Period II|Lack of Efficacy|0
1225252|NCT00760747|4019370|P2|Study Period II|Adverse Event|4
1225253|NCT00760747|4019371|P1|Study Period II|Adverse Event|3
1225254|NCT00760669|4019399|P1|Overall Study|Took drug before entering in contract|5
1225255|NCT00760669|4019399|P1|Overall Study|Participants with overlapping cases|1
1225256|NCT00760669|4019399|P1|Overall Study|Participants missing efficacy assessment|6
1225257|NCT00760669|4019399|P1|Overall Study|Not assessed for overall improvement|18
1225258|NCT00760617|4019416|P3|Overall Study|Lost to Follow-up|5
1225259|NCT00760617|4019417|P2|Overall Study|Lost to Follow-up|0
1225260|NCT00760617|4019418|P1|Overall Study|Lost to Follow-up|0
1225261|NCT00760617|4019416|P3|Overall Study|Adverse Event|0
1225262|NCT00760617|4019417|P2|Overall Study|Adverse Event|2
1225263|NCT00760617|4019418|P1|Overall Study|Adverse Event|5
1225264|NCT00760552|4019532|P2|Overall Study|Lost to Follow-up|10
1225265|NCT00760552|4019533|P1|Overall Study|Lost to Follow-up|11
1225266|NCT00760552|4019532|P2|Overall Study|Death|0
1225267|NCT00760552|4019533|P1|Overall Study|Death|2
1225268|NCT00760487|4019567|P1|Overall Study|Unilateral implantation|3
1225269|NCT00760474|4019573|P2|Period 2 (P2)|Adverse Event|1
1225270|NCT00760474|4019574|P1|Period 2 (P2)|Adverse Event|0
1225271|NCT00760474|4019573|P2|Period 2 (P2)|Lost to Follow-up|0
1225272|NCT00760474|4019574|P1|Period 2 (P2)|Lost to Follow-up|1
1225273|NCT00760474|4019573|P2|Placebo Washout Period|Other|1
1225274|NCT00760474|4019574|P1|Placebo Washout Period|Other|0
1225275|NCT00760474|4019573|P2|Period 1 (P1)|Discontinued then re-entered|1
1225276|NCT00760474|4019574|P1|Period 1 (P1)|Discontinued then re-entered|1
1225277|NCT00760383|4019631|P2|Overall Study|moved away; withdrew; medical reasons|7
1225278|NCT00760383|4019632|P1|Overall Study|moved away; withdrew; medical reasons|5
1225279|NCT00760266|4019644|P2|Overall Study|Administrative Problems|1
1225280|NCT00760266|4019645|P1|Overall Study|Administrative Problems|0
1225281|NCT00760266|4019644|P2|Overall Study|Lost to Follow-up|1
1225282|NCT00760266|4019645|P1|Overall Study|Lost to Follow-up|2
1225283|NCT00760266|4019644|P2|Overall Study|Patient withdrew consent|3
1225284|NCT00760266|4019645|P1|Overall Study|Patient withdrew consent|3
1225285|NCT00760266|4019644|P2|Overall Study|Protocol deviation|4
1225286|NCT00760266|4019645|P1|Overall Study|Protocol deviation|2
1225287|NCT00760266|4019644|P2|Overall Study|Lack of Efficacy|2
1225288|NCT00760266|4019645|P1|Overall Study|Lack of Efficacy|2
1225289|NCT00760266|4019644|P2|Overall Study|Abnormal test procedure result(s)|0
1225290|NCT00760266|4019645|P1|Overall Study|Abnormal test procedure result(s)|1
1225291|NCT00760266|4019644|P2|Overall Study|Abnormal laboratory value(s)|0
1225292|NCT00760266|4019645|P1|Overall Study|Abnormal laboratory value(s)|1
1225293|NCT00760266|4019644|P2|Overall Study|Adverse Event|7
1225294|NCT00760266|4019645|P1|Overall Study|Adverse Event|13
1225295|NCT00760214|4019662|P3|Overall Study|Other|6
1225296|NCT00760214|4019663|P2|Overall Study|Other|4
1225297|NCT00760214|4019664|P1|Overall Study|Other|3
1225298|NCT00760214|4019662|P3|Overall Study|Physician Decision|1
1225299|NCT00760214|4019663|P2|Overall Study|Physician Decision|1
1225300|NCT00760214|4019664|P1|Overall Study|Physician Decision|1
1225301|NCT00760214|4019662|P3|Overall Study|Pregnancy|1
1225302|NCT00760214|4019663|P2|Overall Study|Pregnancy|0
1225303|NCT00760214|4019664|P1|Overall Study|Pregnancy|0
1225304|NCT00760214|4019662|P3|Overall Study|Lack of Efficacy|4
1225305|NCT00760214|4019663|P2|Overall Study|Lack of Efficacy|2
1225306|NCT00760214|4019664|P1|Overall Study|Lack of Efficacy|3
1225307|NCT00760214|4019662|P3|Overall Study|Withdrawal by Subject|13
1225308|NCT00760214|4019663|P2|Overall Study|Withdrawal by Subject|14
1225309|NCT00760214|4019664|P1|Overall Study|Withdrawal by Subject|12
1225310|NCT00760214|4019662|P3|Overall Study|Lost to Follow-up|1
1225311|NCT00760214|4019663|P2|Overall Study|Lost to Follow-up|0
1225312|NCT00760214|4019664|P1|Overall Study|Lost to Follow-up|0
1225313|NCT00760214|4019662|P3|Overall Study|Protocol Violation|3
1225314|NCT00760214|4019663|P2|Overall Study|Protocol Violation|0
1225315|NCT00760214|4019664|P1|Overall Study|Protocol Violation|3
1225316|NCT00760214|4019662|P3|Overall Study|Adverse Event|12
1225317|NCT00760214|4019663|P2|Overall Study|Adverse Event|9
1225318|NCT00760214|4019664|P1|Overall Study|Adverse Event|8
1225319|NCT00760084|4019705|P1|Overall Study|Progressive Disease|3
1225320|NCT00760084|4019705|P1|Overall Study|Withdrawal by Subject|2
1225321|NCT00760084|4019705|P1|Overall Study|Physician Decision|5
1225322|NCT00759954|4019748|P2|Overall Study|Adverse Event|2
1225323|NCT00759954|4019749|P1|Overall Study|Adverse Event|1
1225324|NCT00759954|4019748|P2|Overall Study|Personal reason|0
1225325|NCT00759954|4019749|P1|Overall Study|Personal reason|1
1225326|NCT00759941|4019763|P2|Overall Study|Exited in error by site|1
1225327|NCT00759941|4019764|P1|Overall Study|Exited in error by site|1
1225328|NCT00759941|4019763|P2|Overall Study|Adverse Event|0
1225329|NCT00759941|4019764|P1|Overall Study|Adverse Event|1
1225330|NCT00759941|4019763|P2|Overall Study|Use of medication|0
1225331|NCT00759941|4019764|P1|Overall Study|Use of medication|1
1225332|NCT00759915|4019778|P2|Overall Study|Adverse Event|1
1225333|NCT00759915|4019779|P1|Overall Study|Adverse Event|0
1225334|NCT00759915|4019778|P2|Overall Study|Withdrawal by Subject|0
1225335|NCT00759915|4019779|P1|Overall Study|Withdrawal by Subject|1
1225336|NCT00759902|4019793|P2|Overall Study|Adverse Event|1
1225337|NCT00759902|4019794|P1|Overall Study|Adverse Event|0
1225338|NCT00759863|4019808|P2|Overall Study|Death, moved, or lost contact|18
1225339|NCT00759863|4019809|P1|Overall Study|Death, moved, or lost contact|20
1225340|NCT00759785|4019830|P2|Overall Study|Withdrawal by Subject|1
1225341|NCT00759785|4019831|P1|Overall Study|Withdrawal by Subject|0
1225342|NCT00759785|4019830|P2|Overall Study|Physician Decision|1
1225343|NCT00759785|4019831|P1|Overall Study|Physician Decision|0
1225344|NCT00759785|4019830|P2|Overall Study|Protocol Violation|0
1225345|NCT00759785|4019831|P1|Overall Study|Protocol Violation|1
1225346|NCT00759785|4019830|P2|Overall Study|Participant sample lost|1
1225347|NCT00759785|4019831|P1|Overall Study|Participant sample lost|0
1225348|NCT00759785|4019830|P2|Overall Study|Participant sample not evaluable|2
1225349|NCT00759785|4019831|P1|Overall Study|Participant sample not evaluable|11
1225350|NCT00759759|4019854|P2|Overall Study|Withdrawal by Subject|1
1225351|NCT00759759|4019855|P1|Overall Study|Withdrawal by Subject|2
1225352|NCT00759759|4019854|P2|Overall Study|Didn't receive drug in period 2|0
1225353|NCT00759759|4019855|P1|Overall Study|Didn't receive drug in period 2|1
1225354|NCT00759759|4019854|P2|Overall Study|didn't return for period 2|0
1225355|NCT00759759|4019855|P1|Overall Study|didn't return for period 2|1
1225356|NCT00759681|4019873|P2|Overall Study|Lost to Follow-up|5
1225357|NCT00759681|4019874|P1|Overall Study|Lost to Follow-up|8
1225358|NCT00759681|4019873|P2|Overall Study|Death|5
1225359|NCT00759681|4019874|P1|Overall Study|Death|2
1225360|NCT00759655|4019901|P1|Overall Study|Termination of the study by sponsor|1
1225361|NCT00759564|4019929|P5|Washout Period (at Least 14 Days)|Adverse Event|1
1225362|NCT00759564|4019930|P4|Washout Period (at Least 14 Days)|Adverse Event|0
1225363|NCT00759564|4019931|P3|Washout Period (at Least 14 Days)|Adverse Event|0
1225364|NCT00759564|4019932|P2|Washout Period (at Least 14 Days)|Adverse Event|0
1225365|NCT00759564|4019933|P1|Washout Period (at Least 14 Days)|Adverse Event|0
1225366|NCT00759395|4020110|P2|Overall Study|Lack of Efficacy|2
1225367|NCT00759395|4020111|P1|Overall Study|Lack of Efficacy|0
1225368|NCT00759395|4020110|P2|Overall Study|Withdrawal by Subject|0
1225369|NCT00759395|4020111|P1|Overall Study|Withdrawal by Subject|1
1225370|NCT00759395|4020110|P2|Overall Study|Adverse Event|0
1225371|NCT00759395|4020111|P1|Overall Study|Adverse Event|1
1225372|NCT00759356|4020127|P2|Overall Study|Subject was unable to return|0
1225373|NCT00759356|4020128|P1|Overall Study|Subject was unable to return|1
1225374|NCT00759356|4020127|P2|Overall Study|Withdrawal by Subject|2
1225375|NCT00759356|4020128|P1|Overall Study|Withdrawal by Subject|0
1225376|NCT00759356|4020127|P2|Overall Study|Adverse Event|1
1225377|NCT00759356|4020128|P1|Overall Study|Adverse Event|0
1225378|NCT00759174|4020208|P2|Overall Study|Other|2
1225379|NCT00759174|4020209|P1|Overall Study|Other|0
1225380|NCT00759148|4020233|P2|Overall Study|Reason not given|0
1225381|NCT00759148|4020234|P1|Overall Study|Reason not given|1
1225382|NCT00759148|4020233|P2|Overall Study|Treatment Failure|10
1225383|NCT00759148|4020234|P1|Overall Study|Treatment Failure|6
1225384|NCT00759148|4020233|P2|Overall Study|Lost to Follow-up|9
1225385|NCT00759148|4020234|P1|Overall Study|Lost to Follow-up|3
1225386|NCT00759148|4020233|P2|Overall Study|Withdrawal by Subject|7
1225387|NCT00759148|4020234|P1|Overall Study|Withdrawal by Subject|3
1225388|NCT00759148|4020233|P2|Overall Study|Adverse Event|6
1225389|NCT00759148|4020234|P1|Overall Study|Adverse Event|1
1225390|NCT00759109|4020244|P2|Overall Study|Lost during study|0
1225391|NCT00759109|4020245|P1|Overall Study|Lost during study|1
1225392|NCT00759109|4020244|P2|Overall Study|Participant had a liver transplant|1
1225393|NCT00759109|4020245|P1|Overall Study|Participant had a liver transplant|0
1225394|NCT00759109|4020244|P2|Overall Study|Participant moved to a different city|1
1225395|NCT00759109|4020245|P1|Overall Study|Participant moved to a different city|0
1225396|NCT00759109|4020244|P2|Overall Study|HCV RNA negative|0
1225397|NCT00759109|4020245|P1|Overall Study|HCV RNA negative|1
1225398|NCT00759109|4020244|P2|Overall Study|Started new therapy|6
1225399|NCT00759109|4020245|P1|Overall Study|Started new therapy|2
1225400|NCT00759109|4020244|P2|Overall Study|Lost to Follow-up|6
1225401|NCT00759109|4020245|P1|Overall Study|Lost to Follow-up|4
1225402|NCT00759109|4020244|P2|Overall Study|Death|3
1225403|NCT00759109|4020245|P1|Overall Study|Death|4
1225404|NCT00759109|4020244|P2|Overall Study|Withdrawal by Subject|5
1225405|NCT00759109|4020245|P1|Overall Study|Withdrawal by Subject|9
1225406|NCT00759109|4020244|P2|Overall Study|Inability to comply|1
1225407|NCT00759109|4020245|P1|Overall Study|Inability to comply|1
1225408|NCT00759109|4020244|P2|Overall Study|Adverse Event|12
1225409|NCT00759109|4020245|P1|Overall Study|Adverse Event|17
1225410|NCT00759031|4020267|P2|First Intervention (1 Day)|Screening failure|0
1225411|NCT00759031|4020268|P1|First Intervention (1 Day)|Screening failure|1
1225412|NCT00759031|4020267|P2|First Intervention (1 Day)|Withdrawal by Subject|1
1225413|NCT00759031|4020268|P1|First Intervention (1 Day)|Withdrawal by Subject|0
1225414|NCT00759031|4020267|P2|First Intervention (1 Day)|Physician Decision|0
1225415|NCT00759031|4020268|P1|First Intervention (1 Day)|Physician Decision|1
1225416|NCT00758771|4020321|P2|Overall Study|Did not meet eligibility criteria|4
1225417|NCT00758771|4020322|P1|Overall Study|Did not meet eligibility criteria|2
1225418|NCT00758771|4020321|P2|Overall Study|Withdrawal by Subject|1
1225419|NCT00758771|4020322|P1|Overall Study|Withdrawal by Subject|1
1225420|NCT00758706|4020380|P2|Overall Study|Adverse Event|4
1225421|NCT00758706|4020381|P1|Overall Study|Adverse Event|4
1225422|NCT00758680|4020417|P10|Overall Study|Withdrawal by Subject|0
1225423|NCT00758680|4020418|P9|Overall Study|Withdrawal by Subject|1
1225424|NCT00758680|4020419|P8|Overall Study|Withdrawal by Subject|0
1225425|NCT00758680|4020420|P7|Overall Study|Withdrawal by Subject|1
1225426|NCT00758680|4020421|P6|Overall Study|Withdrawal by Subject|0
1225427|NCT00758680|4020422|P5|Overall Study|Withdrawal by Subject|0
1225428|NCT00758680|4020423|P4|Overall Study|Withdrawal by Subject|0
1225429|NCT00758680|4020424|P3|Overall Study|Withdrawal by Subject|0
1225430|NCT00758680|4020425|P2|Overall Study|Withdrawal by Subject|0
1225431|NCT00758680|4020426|P1|Overall Study|Withdrawal by Subject|0
1225432|NCT00758680|4020417|P10|Overall Study|Laboratory Adverse Event|0
1225433|NCT00758680|4020418|P9|Overall Study|Laboratory Adverse Event|1
1225434|NCT00758680|4020419|P8|Overall Study|Laboratory Adverse Event|0
1225435|NCT00758680|4020420|P7|Overall Study|Laboratory Adverse Event|0
1225436|NCT00758680|4020421|P6|Overall Study|Laboratory Adverse Event|0
1225437|NCT00758680|4020422|P5|Overall Study|Laboratory Adverse Event|0
1225438|NCT00758680|4020423|P4|Overall Study|Laboratory Adverse Event|0
1225439|NCT00758680|4020424|P3|Overall Study|Laboratory Adverse Event|0
1225440|NCT00758680|4020425|P2|Overall Study|Laboratory Adverse Event|0
1225441|NCT00758680|4020426|P1|Overall Study|Laboratory Adverse Event|0
1225442|NCT00758680|4020417|P10|Overall Study|Adverse Event|1
1225443|NCT00758680|4020418|P9|Overall Study|Adverse Event|0
1225444|NCT00758680|4020419|P8|Overall Study|Adverse Event|1
1225445|NCT00758680|4020420|P7|Overall Study|Adverse Event|0
1225446|NCT00758680|4020421|P6|Overall Study|Adverse Event|0
1225447|NCT00758680|4020422|P5|Overall Study|Adverse Event|0
1225448|NCT00758680|4020423|P4|Overall Study|Adverse Event|0
1225449|NCT00758680|4020424|P3|Overall Study|Adverse Event|0
1225450|NCT00758680|4020425|P2|Overall Study|Adverse Event|0
1225451|NCT00758680|4020426|P1|Overall Study|Adverse Event|0
1225452|NCT00758602|4020479|P2|Overall Study|Reason not specified|3
1225453|NCT00758602|4020480|P1|Overall Study|Reason not specified|3
1225454|NCT00758602|4020479|P2|Overall Study|Death|1
1225455|NCT00758602|4020480|P1|Overall Study|Death|0
1225456|NCT00758602|4020479|P2|Overall Study|Protocol Violation|2
1225457|NCT00758602|4020480|P1|Overall Study|Protocol Violation|0
1225458|NCT00758602|4020479|P2|Overall Study|Withdrawal by Subject|3
1225459|NCT00758602|4020480|P1|Overall Study|Withdrawal by Subject|1
1225460|NCT00758602|4020479|P2|Overall Study|Lost to Follow-up|3
1225461|NCT00758602|4020480|P1|Overall Study|Lost to Follow-up|4
1225462|NCT00758602|4020479|P2|Overall Study|Adverse Event|10
1225463|NCT00758602|4020480|P1|Overall Study|Adverse Event|11
1225464|NCT00758589|4020506|P4|Overall Study|Palm stopped to work|1
1225465|NCT00758589|4020507|P3|Overall Study|Palm stopped to work|0
1225466|NCT00758589|4020508|P2|Overall Study|Palm stopped to work|0
1225467|NCT00758589|4020509|P1|Overall Study|Palm stopped to work|0
1225468|NCT00758589|4020506|P4|Overall Study|Withdrawal by Subject|1
1225469|NCT00758589|4020507|P3|Overall Study|Withdrawal by Subject|1
1225470|NCT00758589|4020508|P2|Overall Study|Withdrawal by Subject|1
1225471|NCT00758589|4020509|P1|Overall Study|Withdrawal by Subject|0
1225472|NCT00758589|4020506|P4|Overall Study|Adverse Event|4
1225473|NCT00758589|4020507|P3|Overall Study|Adverse Event|5
1225474|NCT00758589|4020508|P2|Overall Study|Adverse Event|2
1225475|NCT00758589|4020509|P1|Overall Study|Adverse Event|3
1225476|NCT00758498|4020602|P3|Overall Study|Noncompliance to study procedures|1
1225477|NCT00758498|4020603|P2|Overall Study|Noncompliance to study procedures|0
1225478|NCT00758498|4020604|P1|Overall Study|Noncompliance to study procedures|0
1225479|NCT00758498|4020602|P3|Overall Study|Withdrawal by Subject|1
1225480|NCT00758498|4020603|P2|Overall Study|Withdrawal by Subject|0
1225481|NCT00758498|4020604|P1|Overall Study|Withdrawal by Subject|0
1225482|NCT00758498|4020602|P3|Overall Study|Subject legally detained out of state|0
1225483|NCT00758498|4020603|P2|Overall Study|Subject legally detained out of state|0
1225484|NCT00758498|4020604|P1|Overall Study|Subject legally detained out of state|1
1225485|NCT00758498|4020602|P3|Overall Study|Adverse Event|3
1225486|NCT00758498|4020603|P2|Overall Study|Adverse Event|2
1225487|NCT00758498|4020604|P1|Overall Study|Adverse Event|2
1225488|NCT00758485|4020689|P2|Overall Study|Not Treated|2
1225489|NCT00758485|4020690|P1|Overall Study|Not Treated|1
1225490|NCT00758485|4020689|P2|Overall Study|Lost to Follow-up|1
1225491|NCT00758485|4020690|P1|Overall Study|Lost to Follow-up|0
1225492|NCT00758459|4020702|P2|Overall Study|Withdrawal by Subject|1
1225493|NCT00758459|4020703|P1|Overall Study|Withdrawal by Subject|0
1225494|NCT00758459|4020702|P2|Overall Study|Protocol Violation|1
1225495|NCT00758459|4020703|P1|Overall Study|Protocol Violation|0
1225496|NCT00758459|4020702|P2|Overall Study|Adverse Event|2
1225497|NCT00758459|4020703|P1|Overall Study|Adverse Event|3
1225498|NCT00758394|4020748|P4|3rd Intervention|Lost to Follow-up|1
1225499|NCT00758394|4020749|P3|3rd Intervention|Lost to Follow-up|0
1225500|NCT00758394|4020750|P2|3rd Intervention|Lost to Follow-up|0
1225501|NCT00758394|4020751|P1|3rd Intervention|Lost to Follow-up|1
1225502|NCT00758394|4020748|P4|2nd Intervention Order|Lost to Follow-up|0
1225503|NCT00758394|4020749|P3|2nd Intervention Order|Lost to Follow-up|0
1225504|NCT00758394|4020750|P2|2nd Intervention Order|Lost to Follow-up|1
1225505|NCT00758394|4020751|P1|2nd Intervention Order|Lost to Follow-up|0
1225506|NCT00758264|4020780|P3|Active Phase|Not specified|4
1225507|NCT00758264|4020781|P2|Active Phase|Not specified|0
1225508|NCT00758264|4020782|P1|Active Phase|Not specified|0
1225509|NCT00758264|4020780|P3|Active Phase|Lost to Follow-up|0
1225510|NCT00758264|4020781|P2|Active Phase|Lost to Follow-up|0
1225511|NCT00758264|4020782|P1|Active Phase|Lost to Follow-up|1
1225512|NCT00758264|4020780|P3|Active Phase|Withdrawal by Subject|1
1225513|NCT00758264|4020781|P2|Active Phase|Withdrawal by Subject|0
1225514|NCT00758264|4020782|P1|Active Phase|Withdrawal by Subject|0
1225515|NCT00758160|4020841|P1|Overall Study|Withdrawal by Subject|8
1225516|NCT00758160|4020841|P1|Overall Study|Protocol Violation|12
1225517|NCT00758160|4020841|P1|Overall Study|Lost to Follow-up|14
1225518|NCT00758160|4020841|P1|Overall Study|Lack of Efficacy|10
1225519|NCT00758160|4020841|P1|Overall Study|Adverse Event|15
1225520|NCT00758160|4020841|P1|Overall Study|Administration Problems|3
1225521|NCT00758160|4020841|P1|Overall Study|No Longer Requires Study Medication|4
1225522|NCT00758069|4020862|P3|Overall Study|Incorrect Study Drug|0
1225523|NCT00758069|4020863|P2|Overall Study|Incorrect Study Drug|0
1225524|NCT00758069|4020864|P1|Overall Study|Incorrect Study Drug|1
1225525|NCT00758069|4020862|P3|Overall Study|Lack of Efficacy|1
1225526|NCT00758069|4020863|P2|Overall Study|Lack of Efficacy|0
1225527|NCT00758069|4020864|P1|Overall Study|Lack of Efficacy|0
1225528|NCT00758043|4020879|P4|Overall Study|Other Reasons|5
1225529|NCT00758043|4020880|P3|Overall Study|Other Reasons|0
1225530|NCT00758043|4020881|P2|Overall Study|Other Reasons|1
1225531|NCT00758043|4020882|P1|Overall Study|Other Reasons|0
1225532|NCT00758043|4020879|P4|Overall Study|Non-Compliant With study Drug|1
1225533|NCT00758043|4020880|P3|Overall Study|Non-Compliant With study Drug|0
1225534|NCT00758043|4020881|P2|Overall Study|Non-Compliant With study Drug|0
1225535|NCT00758043|4020882|P1|Overall Study|Non-Compliant With study Drug|0
1225536|NCT00758043|4020879|P4|Overall Study|Required Prohibited Medication|3
1225537|NCT00758043|4020880|P3|Overall Study|Required Prohibited Medication|1
1225538|NCT00758043|4020881|P2|Overall Study|Required Prohibited Medication|0
1225539|NCT00758043|4020882|P1|Overall Study|Required Prohibited Medication|0
1225540|NCT00758043|4020879|P4|Overall Study|Withdrawal by Subject|4
1225541|NCT00758043|4020880|P3|Overall Study|Withdrawal by Subject|1
1225542|NCT00758043|4020881|P2|Overall Study|Withdrawal by Subject|1
1225543|NCT00758043|4020882|P1|Overall Study|Withdrawal by Subject|0
1225544|NCT00758043|4020879|P4|Overall Study|Lost to Follow-up|5
1225545|NCT00758043|4020880|P3|Overall Study|Lost to Follow-up|2
1225546|NCT00758043|4020881|P2|Overall Study|Lost to Follow-up|2
1225547|NCT00758043|4020882|P1|Overall Study|Lost to Follow-up|0
1225548|NCT00758043|4020879|P4|Overall Study|Refused Further Treatment|8
1225549|NCT00758043|4020880|P3|Overall Study|Refused Further Treatment|5
1225550|NCT00758043|4020881|P2|Overall Study|Refused Further Treatment|11
1225551|NCT00758043|4020882|P1|Overall Study|Refused Further Treatment|0
1225552|NCT00758043|4020879|P4|Overall Study|Lack of Efficacy|12
1225553|NCT00758043|4020880|P3|Overall Study|Lack of Efficacy|18
1225554|NCT00758043|4020881|P2|Overall Study|Lack of Efficacy|6
1225555|NCT00758043|4020882|P1|Overall Study|Lack of Efficacy|0
1225556|NCT00758043|4020879|P4|Overall Study|Adverse Event|62
1225557|NCT00758043|4020880|P3|Overall Study|Adverse Event|12
1225558|NCT00758043|4020881|P2|Overall Study|Adverse Event|20
1225559|NCT00758043|4020882|P1|Overall Study|Adverse Event|1
1225560|NCT00757848|4020910|P2|Overall Study|Incorrect enrolment|0
1225561|NCT00757848|4020911|P1|Overall Study|Incorrect enrolment|1
1225562|NCT00757848|4020910|P2|Overall Study|Adverse Event|2
1225563|NCT00757848|4020911|P1|Overall Study|Adverse Event|1
1225564|NCT00757848|4020910|P2|Overall Study|Voluntary discontinuation|0
1225565|NCT00757848|4020911|P1|Overall Study|Voluntary discontinuation|1
1225566|NCT00757783|4020980|P2|Overall Study|Other|2
1225567|NCT00757783|4020981|P1|Overall Study|Other|1
1225568|NCT00757783|4020980|P2|Overall Study|Withdrawal by Subject|1
1225569|NCT00757783|4020981|P1|Overall Study|Withdrawal by Subject|2
1225570|NCT00757783|4020980|P2|Overall Study|Protocol Violation|0
1225571|NCT00757783|4020981|P1|Overall Study|Protocol Violation|1
1225572|NCT00757783|4020980|P2|Overall Study|Lost to Follow-up|1
1225573|NCT00757783|4020981|P1|Overall Study|Lost to Follow-up|1
1225574|NCT00757783|4020980|P2|Overall Study|Adverse Event|2
1225575|NCT00757783|4020981|P1|Overall Study|Adverse Event|0
1225576|NCT00757705|4021017|P1|Overall Study|Other|18
1225577|NCT00757705|4021017|P1|Overall Study|Non-compliant|9
1225578|NCT00757705|4021017|P1|Overall Study|Ineligible to continue|8
1225579|NCT00757705|4021017|P1|Overall Study|Insufficient Response|26
1225580|NCT00757705|4021017|P1|Overall Study|Withdrawal by Subject|25
1225581|NCT00757705|4021017|P1|Overall Study|Lost to Follow-up|16
1225582|NCT00757705|4021017|P1|Overall Study|Adverse Event|19
1225583|NCT00757627|4021046|P1|Overall Study|Other|1
1225584|NCT00757627|4021046|P1|Overall Study|Withdrawal by Subject|27
1225585|NCT00757627|4021046|P1|Overall Study|Lost to Follow-up|28
1225586|NCT00757627|4021046|P1|Overall Study|Lack of Efficacy|10
1225587|NCT00757627|4021046|P1|Overall Study|Adverse Event|15
1225588|NCT00757588|4021181|P2|Period 2: Long-term (52-week) Phase|Not specified|0
1225589|NCT00757588|4021182|P1|Period 2: Long-term (52-week) Phase|Not specified|1
1225590|NCT00757588|4021181|P2|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4
1225591|NCT00757588|4021182|P1|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5
1225592|NCT00757588|4021181|P2|Period 2: Long-term (52-week) Phase|Pregnancy|0
1225593|NCT00757588|4021182|P1|Period 2: Long-term (52-week) Phase|Pregnancy|1
1225594|NCT00757588|4021181|P2|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2
1225595|NCT00757588|4021182|P1|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5
1225596|NCT00757588|4021181|P2|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
1225597|NCT00757588|4021182|P1|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
1225598|NCT00757588|4021181|P2|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2
1225599|NCT00757588|4021182|P1|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4
1225600|NCT00757588|4021181|P2|Period 2: Long-term (52-week) Phase|Adverse Event|0
1225601|NCT00757588|4021182|P1|Period 2: Long-term (52-week) Phase|Adverse Event|4
1225602|NCT00757588|4021181|P2|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0
1225603|NCT00757588|4021182|P1|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1
1225604|NCT00757588|4021181|P2|Period 1: Short-term (24-week) Phase|Not specified|1
1225605|NCT00757588|4021182|P1|Period 1: Short-term (24-week) Phase|Not specified|0
1225606|NCT00757588|4021181|P2|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0
1225607|NCT00757588|4021182|P1|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5
1225608|NCT00757588|4021181|P2|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1
1225609|NCT00757588|4021182|P1|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5
1225610|NCT00757588|4021181|P2|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5
1225611|NCT00757588|4021182|P1|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3
1225612|NCT00757588|4021181|P2|Period 1: Short-term (24-week) Phase|Death|0
1225613|NCT00757588|4021182|P1|Period 1: Short-term (24-week) Phase|Death|1
1225614|NCT00757588|4021181|P2|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5
1225615|NCT00757588|4021182|P1|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13
1225616|NCT00757588|4021181|P2|Period 1: Short-term (24-week) Phase|Adverse Event|3
1225617|NCT00757588|4021182|P1|Period 1: Short-term (24-week) Phase|Adverse Event|6
1225618|NCT00757588|4021181|P2|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2
1225619|NCT00757588|4021182|P1|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3
1225620|NCT00757237|4021223|P2|Overall Study|Other|2
1225621|NCT00757237|4021224|P1|Overall Study|Other|0
1225622|NCT00757237|4021223|P2|Overall Study|Safety or Tolerability|5
1225623|NCT00757237|4021224|P1|Overall Study|Safety or Tolerability|3
1225624|NCT00757237|4021223|P2|Overall Study|Withdrawal by Subject|12
1225625|NCT00757237|4021224|P1|Overall Study|Withdrawal by Subject|8
1225626|NCT00757237|4021223|P2|Overall Study|Physician Decision|3
1225627|NCT00757237|4021224|P1|Overall Study|Physician Decision|2
1225628|NCT00757237|4021223|P2|Overall Study|Protocol Violation|2
1225629|NCT00757237|4021224|P1|Overall Study|Protocol Violation|0
1225630|NCT00757237|4021223|P2|Overall Study|Lost to Follow-up|1
1225631|NCT00757237|4021224|P1|Overall Study|Lost to Follow-up|0
1225632|NCT00757172|4021252|P1|Overall Study|Progression|4
1225633|NCT00757172|4021252|P1|Overall Study|Physician Decision|3
1225634|NCT00757172|4021252|P1|Overall Study|Withdrawal by Subject|4
1225635|NCT00757003|4021260|P1|Overall Study|Not implanted|1
1225636|NCT00757003|4021260|P1|Overall Study|Surgically explanted|2
1225637|NCT00757003|4021260|P1|Overall Study|Withdrawal by Subject|4
1225638|NCT00757003|4021260|P1|Overall Study|Lost to Follow-up|9
1225639|NCT00757003|4021260|P1|Overall Study|Death|33
1225640|NCT00756938|4021307|P4|Optional Extension|Adverse Event|1
1225641|NCT00756938|4021308|P3|Optional Extension|Adverse Event|0
1225642|NCT00756938|4021309|P2|Optional Extension|Adverse Event|0
1225643|NCT00756938|4021310|P1|Optional Extension|Adverse Event|0
1225644|NCT00756938|4021307|P4|Optional Extension|Withdrawal by Subject|10
1225645|NCT00756938|4021308|P3|Optional Extension|Withdrawal by Subject|0
1225646|NCT00756938|4021309|P2|Optional Extension|Withdrawal by Subject|0
1225647|NCT00756938|4021310|P1|Optional Extension|Withdrawal by Subject|0
1225648|NCT00756938|4021307|P4|Optional Extension|Protocol Violation|1
1225649|NCT00756938|4021308|P3|Optional Extension|Protocol Violation|0
1225650|NCT00756938|4021309|P2|Optional Extension|Protocol Violation|0
1225651|NCT00756938|4021310|P1|Optional Extension|Protocol Violation|0
1225652|NCT00756938|4021307|P4|Optional Extension|Lost to Follow-up|1
1225653|NCT00756938|4021308|P3|Optional Extension|Lost to Follow-up|0
1225654|NCT00756938|4021309|P2|Optional Extension|Lost to Follow-up|0
1225655|NCT00756938|4021310|P1|Optional Extension|Lost to Follow-up|0
1225656|NCT00756938|4021307|P4|Optional Extension|Physician Decision|3
1225657|NCT00756938|4021308|P3|Optional Extension|Physician Decision|0
1225658|NCT00756938|4021309|P2|Optional Extension|Physician Decision|0
1225659|NCT00756938|4021310|P1|Optional Extension|Physician Decision|0
1225660|NCT00756938|4021307|P4|Optional Extension|Protocol-specific criteria met|9
1225661|NCT00756938|4021308|P3|Optional Extension|Protocol-specific criteria met|0
1225662|NCT00756938|4021309|P2|Optional Extension|Protocol-specific criteria met|0
1225663|NCT00756938|4021310|P1|Optional Extension|Protocol-specific criteria met|0
1225664|NCT00756938|4021307|P4|Optional Extension|End of Study|11
1225665|NCT00756938|4021308|P3|Optional Extension|End of Study|0
1225666|NCT00756938|4021309|P2|Optional Extension|End of Study|0
1225667|NCT00756938|4021310|P1|Optional Extension|End of Study|0
1225668|NCT00756938|4021307|P4|Optional Extension|Lack of Efficacy|1
1225669|NCT00756938|4021308|P3|Optional Extension|Lack of Efficacy|0
1225670|NCT00756938|4021309|P2|Optional Extension|Lack of Efficacy|0
1225671|NCT00756938|4021310|P1|Optional Extension|Lack of Efficacy|0
1225672|NCT00756938|4021307|P4|12-week Base Study|Lost to Follow-up|0
1225673|NCT00756938|4021308|P3|12-week Base Study|Lost to Follow-up|0
1225674|NCT00756938|4021309|P2|12-week Base Study|Lost to Follow-up|0
1225675|NCT00756938|4021310|P1|12-week Base Study|Lost to Follow-up|1
1225676|NCT00756938|4021307|P4|12-week Base Study|Protocol Violation|0
1225677|NCT00756938|4021308|P3|12-week Base Study|Protocol Violation|1
1225678|NCT00756938|4021309|P2|12-week Base Study|Protocol Violation|0
1225679|NCT00756938|4021310|P1|12-week Base Study|Protocol Violation|0
1225680|NCT00756938|4021307|P4|12-week Base Study|Protocol-specific Criteria Met|0
1225681|NCT00756938|4021308|P3|12-week Base Study|Protocol-specific Criteria Met|1
1225682|NCT00756938|4021309|P2|12-week Base Study|Protocol-specific Criteria Met|0
1225683|NCT00756938|4021310|P1|12-week Base Study|Protocol-specific Criteria Met|1
1225684|NCT00756886|4021338|P2|Overall Study|Ineligible|4
1225685|NCT00756886|4021339|P1|Overall Study|Ineligible|9
1225686|NCT00756886|4021338|P2|Overall Study|Lack of Efficacy|0
1225687|NCT00756886|4021339|P1|Overall Study|Lack of Efficacy|1
1225688|NCT00756886|4021338|P2|Overall Study|Adverse Event|3
1225689|NCT00756886|4021339|P1|Overall Study|Adverse Event|0
1225690|NCT00756886|4021338|P2|Overall Study|Lost to Follow-up|0
1225691|NCT00756886|4021339|P1|Overall Study|Lost to Follow-up|1
1225692|NCT00756730|4021347|P2|Overall Study|persistent low-level viremmia|1
1225693|NCT00756730|4021348|P1|Overall Study|persistent low-level viremmia|0
1225694|NCT00756730|4021347|P2|Overall Study|discontinued due to rash prior to week 4|1
1225695|NCT00756730|4021348|P1|Overall Study|discontinued due to rash prior to week 4|0
1225696|NCT00756574|4021381|P2|Overall Study|Lost to Follow-up|4
1225697|NCT00756574|4021382|P1|Overall Study|Lost to Follow-up|4
1225698|NCT00756574|4021381|P2|Overall Study|Withdrawal by Subject|7
1225699|NCT00756574|4021382|P1|Overall Study|Withdrawal by Subject|9
1225700|NCT00756470|4021426|P1|Overall Study|Adverse Event|4
1225701|NCT00756470|4021426|P1|Overall Study|Withdrawal by Subject|1
1225702|NCT00756457|4021433|P2|Overall Study|Lost to Follow-up|2
1225703|NCT00756457|4021434|P1|Overall Study|Lost to Follow-up|1
1225704|NCT00756444|4021464|P2|Overall Study|Ineligibility Determined|0
1225705|NCT00756444|4021465|P1|Overall Study|Ineligibility Determined|1
1225706|NCT00756444|4021464|P2|Overall Study|Disease Progression|7
1225707|NCT00756444|4021465|P1|Overall Study|Disease Progression|2
1225708|NCT00756444|4021464|P2|Overall Study|Death|4
1225709|NCT00756444|4021465|P1|Overall Study|Death|5
1225710|NCT00756444|4021464|P2|Overall Study|Lost to Follow-up|1
1225711|NCT00756444|4021465|P1|Overall Study|Lost to Follow-up|0
1225712|NCT00756444|4021464|P2|Overall Study|Withdrawal by Subject|8
1225713|NCT00756444|4021465|P1|Overall Study|Withdrawal by Subject|6
1225714|NCT00756444|4021464|P2|Overall Study|Adverse Event|1
1225715|NCT00756444|4021465|P1|Overall Study|Adverse Event|1
1225716|NCT00756314|4021476|P2|Overall Study|Lost to Follow-up|59
1225717|NCT00756314|4021477|P1|Overall Study|Lost to Follow-up|2
1225718|NCT00756275|4021493|P2|Overall Study|Withdrawal by Subject|7
1225719|NCT00756275|4021494|P1|Overall Study|Withdrawal by Subject|4
1225720|NCT00756275|4021493|P2|Overall Study|Lost to Follow-up|21
1225721|NCT00756275|4021494|P1|Overall Study|Lost to Follow-up|25
1225722|NCT00756002|4021546|P2|Double-Blind Treatment Period|Not Specified|2
1225723|NCT00756002|4021547|P1|Double-Blind Treatment Period|Not Specified|2
1225724|NCT00756002|4021546|P2|Double-Blind Treatment Period|Protocol Violation|5
1225725|NCT00756002|4021547|P1|Double-Blind Treatment Period|Protocol Violation|6
1225726|NCT00756002|4021546|P2|Double-Blind Treatment Period|Withdrawal by Subject|6
1225727|NCT00756002|4021547|P1|Double-Blind Treatment Period|Withdrawal by Subject|6
1225728|NCT00756002|4021546|P2|Double-Blind Treatment Period|Lost to Follow-up|1
1225729|NCT00756002|4021547|P1|Double-Blind Treatment Period|Lost to Follow-up|0
1225730|NCT00756002|4021546|P2|Double-Blind Treatment Period|Lack of Efficacy|1
1225731|NCT00756002|4021547|P1|Double-Blind Treatment Period|Lack of Efficacy|1
1225732|NCT00755937|4021641|P1|Observational Follow-up|Lost to Follow-up|148
1225733|NCT00755937|4021641|P1|Recruitment|Unknown if infliximab received|164
1225734|NCT00755846|4021668|P6|Overall Study|Participant Non-compliance|0
1225735|NCT00755846|4021669|P5|Overall Study|Participant Non-compliance|1
1225736|NCT00755846|4021670|P4|Overall Study|Participant Non-compliance|0
1225737|NCT00755846|4021671|P3|Overall Study|Participant Non-compliance|0
1225738|NCT00755846|4021672|P2|Overall Study|Participant Non-compliance|0
1225739|NCT00755846|4021673|P1|Overall Study|Participant Non-compliance|0
1225740|NCT00755846|4021668|P6|Overall Study|Administrative Error|0
1225741|NCT00755846|4021669|P5|Overall Study|Administrative Error|0
1225742|NCT00755846|4021670|P4|Overall Study|Administrative Error|0
1225743|NCT00755846|4021671|P3|Overall Study|Administrative Error|0
1225744|NCT00755846|4021672|P2|Overall Study|Administrative Error|1
1225745|NCT00755846|4021673|P1|Overall Study|Administrative Error|0
1225746|NCT00755846|4021668|P6|Overall Study|Physician Decision|1
1225747|NCT00755846|4021669|P5|Overall Study|Physician Decision|0
1225748|NCT00755846|4021670|P4|Overall Study|Physician Decision|1
1225749|NCT00755846|4021671|P3|Overall Study|Physician Decision|0
1225750|NCT00755846|4021672|P2|Overall Study|Physician Decision|3
1225751|NCT00755846|4021673|P1|Overall Study|Physician Decision|1
1225752|NCT00755846|4021668|P6|Overall Study|Hyperglycemic Rescue|7
1225753|NCT00755846|4021669|P5|Overall Study|Hyperglycemic Rescue|8
1225754|NCT00755846|4021670|P4|Overall Study|Hyperglycemic Rescue|8
1225755|NCT00755846|4021671|P3|Overall Study|Hyperglycemic Rescue|5
1225756|NCT00755846|4021672|P2|Overall Study|Hyperglycemic Rescue|7
1225757|NCT00755846|4021673|P1|Overall Study|Hyperglycemic Rescue|21
1225758|NCT00755846|4021668|P6|Overall Study|Withdrawal by Subject|1
1225759|NCT00755846|4021669|P5|Overall Study|Withdrawal by Subject|0
1225760|NCT00755846|4021670|P4|Overall Study|Withdrawal by Subject|2
1225761|NCT00755846|4021671|P3|Overall Study|Withdrawal by Subject|5
1225762|NCT00755846|4021672|P2|Overall Study|Withdrawal by Subject|3
1225763|NCT00755846|4021673|P1|Overall Study|Withdrawal by Subject|2
1225764|NCT00755846|4021668|P6|Overall Study|Lost to Follow-up|2
1225765|NCT00755846|4021669|P5|Overall Study|Lost to Follow-up|4
1225766|NCT00755846|4021670|P4|Overall Study|Lost to Follow-up|0
1225767|NCT00755846|4021671|P3|Overall Study|Lost to Follow-up|1
1225768|NCT00755846|4021672|P2|Overall Study|Lost to Follow-up|2
1225769|NCT00755846|4021673|P1|Overall Study|Lost to Follow-up|0
1225770|NCT00755846|4021668|P6|Overall Study|Protocol Violation|1
1225771|NCT00755846|4021669|P5|Overall Study|Protocol Violation|1
1225772|NCT00755846|4021670|P4|Overall Study|Protocol Violation|1
1225773|NCT00755846|4021671|P3|Overall Study|Protocol Violation|1
1225774|NCT00755846|4021672|P2|Overall Study|Protocol Violation|1
1225775|NCT00755846|4021673|P1|Overall Study|Protocol Violation|1
1225776|NCT00755846|4021668|P6|Overall Study|Adverse Event|2
1225777|NCT00755846|4021669|P5|Overall Study|Adverse Event|3
1225778|NCT00755846|4021670|P4|Overall Study|Adverse Event|1
1225779|NCT00755846|4021671|P3|Overall Study|Adverse Event|0
1225780|NCT00755846|4021672|P2|Overall Study|Adverse Event|0
1225781|NCT00755846|4021673|P1|Overall Study|Adverse Event|0
1225782|NCT00755807|4021773|P2|Open-label Extension Phase|Sponsor Decision|1
1225783|NCT00755807|4021774|P1|Open-label Extension Phase|Sponsor Decision|0
1225784|NCT00755807|4021773|P2|Open-label Extension Phase|Lost to Follow-up|0
1225785|NCT00755807|4021774|P1|Open-label Extension Phase|Lost to Follow-up|2
1225786|NCT00755807|4021773|P2|Open-label Extension Phase|Withdrawal by Subject|3
1225787|NCT00755807|4021774|P1|Open-label Extension Phase|Withdrawal by Subject|1
1225788|NCT00755807|4021773|P2|Open-label Extension Phase|Lack of Efficacy|3
1225789|NCT00755807|4021774|P1|Open-label Extension Phase|Lack of Efficacy|3
1225790|NCT00755807|4021773|P2|Open-label Extension Phase|Protocol Violation|2
1225791|NCT00755807|4021774|P1|Open-label Extension Phase|Protocol Violation|5
1225792|NCT00755807|4021773|P2|Open-label Extension Phase|Adverse Event|7
1225793|NCT00755807|4021774|P1|Open-label Extension Phase|Adverse Event|7
1225794|NCT00755807|4021773|P2|Acute Phase|Physician Decision|1
1225795|NCT00755807|4021774|P1|Acute Phase|Physician Decision|0
1225796|NCT00755807|4021773|P2|Acute Phase|Lack of Efficacy|1
1225797|NCT00755807|4021774|P1|Acute Phase|Lack of Efficacy|0
1225798|NCT00755807|4021773|P2|Acute Phase|Withdrawal by Subject|2
1225799|NCT00755807|4021774|P1|Acute Phase|Withdrawal by Subject|1
1225800|NCT00755807|4021773|P2|Acute Phase|Protocol Violation|3
1225801|NCT00755807|4021774|P1|Acute Phase|Protocol Violation|1
1225802|NCT00755807|4021773|P2|Acute Phase|Adverse Event|5
1225803|NCT00755807|4021774|P1|Acute Phase|Adverse Event|16
1225804|NCT00755716|4021854|P3|Overall Study|work schedule issues|1
1225805|NCT00755716|4021855|P2|Overall Study|work schedule issues|1
1225806|NCT00755716|4021856|P1|Overall Study|work schedule issues|0
1225807|NCT00755716|4021854|P3|Overall Study|Lost to Follow-up|1
1225808|NCT00755716|4021855|P2|Overall Study|Lost to Follow-up|3
1225809|NCT00755716|4021856|P1|Overall Study|Lost to Follow-up|5
1225810|NCT00755716|4021854|P3|Overall Study|Lack of Efficacy|0
1225811|NCT00755716|4021855|P2|Overall Study|Lack of Efficacy|0
1225812|NCT00755716|4021856|P1|Overall Study|Lack of Efficacy|2
1225813|NCT00755716|4021854|P3|Overall Study|Adverse Event|1
1225814|NCT00755716|4021855|P2|Overall Study|Adverse Event|4
1225815|NCT00755716|4021856|P1|Overall Study|Adverse Event|1
1225816|NCT00755417|4021870|P3|Overall Study|Not specified or missing data|12
1225817|NCT00755417|4021871|P2|Overall Study|Not specified or missing data|18
1225818|NCT00755417|4021872|P1|Overall Study|Not specified or missing data|9
1225819|NCT00755417|4021870|P3|Overall Study|Withdrawal by Subject|12
1225820|NCT00755417|4021871|P2|Overall Study|Withdrawal by Subject|12
1225821|NCT00755417|4021872|P1|Overall Study|Withdrawal by Subject|12
1225822|NCT00755417|4021870|P3|Overall Study|Lost to Follow-up|1
1225823|NCT00755417|4021871|P2|Overall Study|Lost to Follow-up|0
1225824|NCT00755417|4021872|P1|Overall Study|Lost to Follow-up|3
1225825|NCT00755417|4021870|P3|Overall Study|Protocol Violation|1
1225826|NCT00755417|4021871|P2|Overall Study|Protocol Violation|1
1225827|NCT00755417|4021872|P1|Overall Study|Protocol Violation|2
1225828|NCT00755417|4021870|P3|Overall Study|Lack of Efficacy|9
1225829|NCT00755417|4021871|P2|Overall Study|Lack of Efficacy|4
1225830|NCT00755417|4021872|P1|Overall Study|Lack of Efficacy|8
1225831|NCT00755417|4021870|P3|Overall Study|Adverse Event|7
1225832|NCT00755417|4021871|P2|Overall Study|Adverse Event|20
1225833|NCT00755417|4021872|P1|Overall Study|Adverse Event|28
1225834|NCT00755222|4021929|P2|Overall Study|Protocol Violation|0
1225835|NCT00755222|4021930|P1|Overall Study|Protocol Violation|2
1225836|NCT00755222|4021929|P2|Overall Study|Adverse Event|0
1225837|NCT00755222|4021930|P1|Overall Study|Adverse Event|2
1225838|NCT00755222|4021929|P2|Overall Study|Withdrawal by Subject|2
1225839|NCT00755222|4021930|P1|Overall Study|Withdrawal by Subject|4
1225840|NCT00755196|4021944|P1|Overall Study|Lack of Efficiency|1
1225841|NCT00755196|4021944|P1|Overall Study|Lost to Follow-up|1
1225842|NCT00755105|4021965|P3|Overall Study|Withdrawal by Subject|4
1225843|NCT00755105|4021966|P2|Overall Study|Withdrawal by Subject|11
1225844|NCT00755105|4021967|P1|Overall Study|Withdrawal by Subject|9
1225845|NCT00755079|4021977|P2|Overall Study|Withdrawal by Subject|2
1225846|NCT00755079|4021978|P1|Overall Study|Withdrawal by Subject|0
1225847|NCT00755079|4021977|P2|Overall Study|Adverse Event|1
1225848|NCT00755079|4021978|P1|Overall Study|Adverse Event|0
1225849|NCT00755079|4021977|P2|Overall Study|Lost to Follow-up|3
1225850|NCT00755079|4021978|P1|Overall Study|Lost to Follow-up|1
1225851|NCT00754793|4022030|P2|Overall Study|voluntary withdrawn from study|1
1225852|NCT00754793|4022031|P1|Overall Study|voluntary withdrawn from study|0
1225853|NCT00754741|4022049|P3|Overall Study|Died or disenrolled|54
1225854|NCT00754741|4022050|P2|Overall Study|Died or disenrolled|69
1225855|NCT00754741|4022051|P1|Overall Study|Died or disenrolled|57
1225856|NCT00754650|4022098|P1|Overall Study|Disease Progression|2
1225857|NCT00754624|4022103|P1|Overall Study|Lost to Follow-up|3
1225858|NCT00754624|4022103|P1|Overall Study|Various|12
1225859|NCT00754624|4022103|P1|Overall Study|Withdrawal by Subject|28
1225860|NCT00754624|4022103|P1|Overall Study|Protocol Violation|1
1225861|NCT00754624|4022103|P1|Overall Study|Physician Decision|8
1225862|NCT00754624|4022103|P1|Overall Study|Death|1
1225863|NCT00754624|4022103|P1|Overall Study|Adverse Event|16
1225864|NCT00754572|4022113|P1|Overall Study|Lost to Follow-up|1
1225865|NCT00754572|4022113|P1|Overall Study|Administrative Reason|3
1225866|NCT00754572|4022113|P1|Overall Study|Death|1
1225867|NCT00754572|4022113|P1|Overall Study|Lack of Efficacy|2
1225868|NCT00754572|4022113|P1|Overall Study|Withdrawal by Subject|3
1225869|NCT00754572|4022113|P1|Overall Study|Protocol Violation|3
1225870|NCT00754572|4022113|P1|Overall Study|Other|39
1225871|NCT00754572|4022113|P1|Overall Study|Adverse Event|19
1225872|NCT00754559|4022140|P1|Overall Study|Withdrawal by Subject|3
1225873|NCT00754559|4022140|P1|Overall Study|Other|5
1225874|NCT00754559|4022140|P1|Overall Study|Administrative reason|1
1225875|NCT00754559|4022140|P1|Overall Study|Lost to Follow-up|2
1225876|NCT00754559|4022140|P1|Overall Study|Lack of Efficacy|10
1225877|NCT00754559|4022140|P1|Overall Study|Protocol Violation|11
1225878|NCT00754559|4022140|P1|Overall Study|Adverse Event|15
1225879|NCT00754442|4022240|P2|Overall Study|Withdrawal by Subject|3
1225880|NCT00754442|4022241|P1|Overall Study|Withdrawal by Subject|5
1225881|NCT00754390|4022248|P1|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1
1225882|NCT00754390|4022248|P1|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1
1225883|NCT00754390|4022248|P1|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2
1225884|NCT00754390|4022248|P1|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3
1225885|NCT00754338|4022270|P4|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
1225886|NCT00754338|4022271|P3|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
1225887|NCT00754338|4022272|P2|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
1225888|NCT00754338|4022273|P1|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
1225889|NCT00754338|4022270|P4|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
1225890|NCT00754338|4022271|P3|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
1225891|NCT00754338|4022272|P2|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
1225892|NCT00754338|4022273|P1|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
1225893|NCT00754325|4022305|P2|Initial Treatment|Disease Progression|35
1225894|NCT00754325|4022306|P1|Initial Treatment|Disease Progression|35
1225895|NCT00754325|4022305|P2|Initial Treatment|Sponsor Request|1
1225896|NCT00754325|4022306|P1|Initial Treatment|Sponsor Request|0
1225897|NCT00754325|4022305|P2|Initial Treatment|Physician Decision|0
1225898|NCT00754325|4022306|P1|Initial Treatment|Physician Decision|2
1225899|NCT00754325|4022305|P2|Initial Treatment|Withdrawal by Subject|2
1225900|NCT00754325|4022306|P1|Initial Treatment|Withdrawal by Subject|2
1225901|NCT00754325|4022305|P2|Initial Treatment|Adverse Event|6
1225902|NCT00754325|4022306|P1|Initial Treatment|Adverse Event|7
1225903|NCT00754325|4022305|P2|Initial Treatment|Continuing Active Treatment|5
1225904|NCT00754325|4022306|P1|Initial Treatment|Continuing Active Treatment|4
1225905|NCT00754234|4022325|P1|Overall Study|Withdrawal by Subject|3
1225906|NCT00754065|4022411|P2|Overall Study|Reason not specified or unknown, etc.|27
1225907|NCT00754065|4022412|P1|Overall Study|Reason not specified or unknown, etc.|21
1225908|NCT00754065|4022411|P2|Overall Study|Pregnancy|0
1225909|NCT00754065|4022412|P1|Overall Study|Pregnancy|6
1225910|NCT00754065|4022411|P2|Overall Study|Withdrawal by Subject|5
1225911|NCT00754065|4022412|P1|Overall Study|Withdrawal by Subject|4
1225912|NCT00754065|4022411|P2|Overall Study|Protocol Violation|10
1225913|NCT00754065|4022412|P1|Overall Study|Protocol Violation|12
1225914|NCT00754065|4022411|P2|Overall Study|Lost to Follow-up|11
1225915|NCT00754065|4022412|P1|Overall Study|Lost to Follow-up|7
1225916|NCT00754065|4022411|P2|Overall Study|Adverse Event|25
1225917|NCT00754065|4022412|P1|Overall Study|Adverse Event|19
1225918|NCT00754065|4022411|P2|Overall Study|Never received treatment|2
1225919|NCT00754065|4022412|P1|Overall Study|Never received treatment|12
1225920|NCT00754052|4022652|P2|Overall Study|Study terminated by Sponsor|3
1225921|NCT00754052|4022653|P1|Overall Study|Study terminated by Sponsor|5
1225922|NCT00754013|4022667|P2|Overall Study|didn't return after study termed|4
1225923|NCT00754013|4022668|P1|Overall Study|didn't return after study termed|3
1225924|NCT00754013|4022667|P2|Overall Study|Lost to Follow-up|1
1225925|NCT00754013|4022668|P1|Overall Study|Lost to Follow-up|1
1225926|NCT00753922|4022702|P4|Overall Study|Discontinuation Due to Explantation|4
1225927|NCT00753922|4022703|P3|Overall Study|Discontinuation Due to Explantation|14
1225928|NCT00753922|4022704|P2|Overall Study|Discontinuation Due to Explantation|14
1225929|NCT00753922|4022705|P1|Overall Study|Discontinuation Due to Explantation|14
1225930|NCT00753922|4022702|P4|Overall Study|Death|1
1225931|NCT00753922|4022703|P3|Overall Study|Death|2
1225932|NCT00753922|4022704|P2|Overall Study|Death|23
1225933|NCT00753922|4022705|P1|Overall Study|Death|2
1225934|NCT00753922|4022702|P4|Overall Study|Patients Not Completing Visit|0
1225935|NCT00753922|4022703|P3|Overall Study|Patients Not Completing Visit|1
1225936|NCT00753922|4022704|P2|Overall Study|Patients Not Completing Visit|0
1225937|NCT00753922|4022705|P1|Overall Study|Patients Not Completing Visit|11
1225938|NCT00753922|4022702|P4|Overall Study|Patient Non-compliance|11
1225939|NCT00753922|4022703|P3|Overall Study|Patient Non-compliance|14
1225940|NCT00753922|4022704|P2|Overall Study|Patient Non-compliance|22
1225941|NCT00753922|4022705|P1|Overall Study|Patient Non-compliance|55
1225942|NCT00753922|4022702|P4|Overall Study|Withdrawal by Subject|2
1225943|NCT00753922|4022703|P3|Overall Study|Withdrawal by Subject|4
1225944|NCT00753922|4022704|P2|Overall Study|Withdrawal by Subject|11
1225945|NCT00753922|4022705|P1|Overall Study|Withdrawal by Subject|9
1225946|NCT00753922|4022702|P4|Overall Study|Lost to Follow-up|5
1225947|NCT00753922|4022703|P3|Overall Study|Lost to Follow-up|28
1225948|NCT00753922|4022704|P2|Overall Study|Lost to Follow-up|24
1225949|NCT00753922|4022705|P1|Overall Study|Lost to Follow-up|155
1225950|NCT00753896|4022735|P1|Overall Study|Entry Criteria Not Met|4
1225951|NCT00753896|4022735|P1|Overall Study|Withdrawal by Subject|4
1225952|NCT00753896|4022735|P1|Overall Study|Protocol Violation|1
1225953|NCT00753896|4022735|P1|Overall Study|Lost to Follow-up|2
1225954|NCT00753896|4022735|P1|Overall Study|Death|1
1225955|NCT00753896|4022735|P1|Overall Study|Adverse Event|4
1225956|NCT00753766|4022751|P2|Overall Study|Physician Decision|0
1225957|NCT00753766|4022752|P1|Overall Study|Physician Decision|1
1225958|NCT00753714|4022762|P2|Overall Study|not specified|5
1225959|NCT00753714|4022763|P1|Overall Study|not specified|7
1225960|NCT00753714|4022762|P2|Overall Study|Death|3
1225961|NCT00753714|4022763|P1|Overall Study|Death|3
1225962|NCT00753714|4022762|P2|Overall Study|Withdrawal by Subject|1
1225963|NCT00753714|4022763|P1|Overall Study|Withdrawal by Subject|2
1225964|NCT00753714|4022762|P2|Overall Study|Lost to Follow-up|1
1225965|NCT00753714|4022763|P1|Overall Study|Lost to Follow-up|0
1225966|NCT00753714|4022762|P2|Overall Study|Protocol Violation|0
1225967|NCT00753714|4022763|P1|Overall Study|Protocol Violation|1
1225968|NCT00753714|4022762|P2|Overall Study|Adverse Event|18
1225969|NCT00753714|4022763|P1|Overall Study|Adverse Event|26
1225970|NCT00753714|4022762|P2|Overall Study|Lack of Efficacy|34
1225971|NCT00753714|4022763|P1|Overall Study|Lack of Efficacy|21
1225972|NCT00753688|4022779|P2|Overall Study|Adverse Event|1
1225973|NCT00753688|4022780|P1|Overall Study|Adverse Event|0
1225974|NCT00753688|4022779|P2|Overall Study|Ongoing - in Follow-up|31
1225975|NCT00753688|4022780|P1|Overall Study|Ongoing - in Follow-up|15
1225976|NCT00753688|4022779|P2|Overall Study|Participant Withdrew Consent|2
1225977|NCT00753688|4022780|P1|Overall Study|Participant Withdrew Consent|2
1225978|NCT00753688|4022779|P2|Overall Study|Missing|9
1225979|NCT00753688|4022780|P1|Overall Study|Missing|4
1225980|NCT00753688|4022779|P2|Overall Study|Death|203
1225981|NCT00753688|4022780|P1|Overall Study|Death|102
1225982|NCT00753675|4022809|P3|Overall Study|Lost to Follow-up|0
1225983|NCT00753675|4022810|P2|Overall Study|Lost to Follow-up|0
1225984|NCT00753675|4022811|P1|Overall Study|Lost to Follow-up|1
1225985|NCT00753675|4022809|P3|Overall Study|Withdrawal by Subject|0
1225986|NCT00753675|4022810|P2|Overall Study|Withdrawal by Subject|1
1225987|NCT00753675|4022811|P1|Overall Study|Withdrawal by Subject|0
1225988|NCT00753675|4022809|P3|Overall Study|Objective progression of disease|35
1225989|NCT00753675|4022810|P2|Overall Study|Objective progression of disease|35
1225990|NCT00753675|4022811|P1|Overall Study|Objective progression of disease|35
1225991|NCT00753675|4022809|P3|Overall Study|Adverse Event|4
1225992|NCT00753675|4022810|P2|Overall Study|Adverse Event|9
1225993|NCT00753675|4022811|P1|Overall Study|Adverse Event|11
1225994|NCT00753675|4022809|P3|Overall Study|Death|4
1225995|NCT00753675|4022810|P2|Overall Study|Death|2
1225996|NCT00753675|4022811|P1|Overall Study|Death|1
1225997|NCT00753675|4022809|P3|Overall Study|other reason|13
1225998|NCT00753675|4022810|P2|Overall Study|other reason|12
1225999|NCT00753675|4022811|P1|Overall Study|other reason|11
1226000|NCT00753649|4022833|P2|Overall Study|Protocol Violation|0
1226001|NCT00753649|4022834|P1|Overall Study|Protocol Violation|2
1226002|NCT00753649|4022833|P2|Overall Study|Lost to follow-up-complete vaccination|0
1226003|NCT00753649|4022834|P1|Overall Study|Lost to follow-up-complete vaccination|1
1226004|NCT00753649|4022833|P2|Overall Study|Lost to follow-up-incomplete vaccination|0
1226005|NCT00753649|4022834|P1|Overall Study|Lost to follow-up-incomplete vaccination|3
1226006|NCT00753649|4022833|P2|Overall Study|Migrated/moved from study area|0
1226007|NCT00753649|4022834|P1|Overall Study|Migrated/moved from study area|1
1226008|NCT00753623|4022866|P2|Phase II (14 Days)|Physician Decision|1
1226009|NCT00753623|4022867|P1|Phase II (14 Days)|Physician Decision|0
1226010|NCT00753623|4022866|P2|Washout (7 Days)|Physician Decision|0
1226011|NCT00753623|4022867|P1|Washout (7 Days)|Physician Decision|1
1226012|NCT00753623|4022866|P2|Phase I (14 Days)|Adverse Event|1
1226013|NCT00753623|4022867|P1|Phase I (14 Days)|Adverse Event|0
1226014|NCT00753623|4022866|P2|Phase I (14 Days)|Physician Decision|2
1226015|NCT00753623|4022867|P1|Phase I (14 Days)|Physician Decision|1
1226016|NCT00753623|4022866|P2|Phase I (14 Days)|Withdrawal by Subject|1
1226017|NCT00753623|4022867|P1|Phase I (14 Days)|Withdrawal by Subject|1
1226018|NCT00753545|4022875|P2|Overall Study|Voluntary Discontinuation of Patient|3
1226019|NCT00753545|4022876|P1|Overall Study|Voluntary Discontinuation of Patient|7
1226020|NCT00753545|4022875|P2|Overall Study|Protocol Violation|0
1226021|NCT00753545|4022876|P1|Overall Study|Protocol Violation|1
1226022|NCT00753545|4022875|P2|Overall Study|Lost to Follow-up|3
1226023|NCT00753545|4022876|P1|Overall Study|Lost to Follow-up|2
1226024|NCT00753545|4022875|P2|Overall Study|Death|112
1226025|NCT00753545|4022876|P1|Overall Study|Death|98
1226026|NCT00753519|4022914|P2|Overall Study|Withdrawal by Subject|2
1226027|NCT00753519|4022915|P1|Overall Study|Withdrawal by Subject|0
1226028|NCT00753506|4022937|P2|Overall Study|Other reason|1
1226029|NCT00753506|4022938|P1|Overall Study|Other reason|1
1226030|NCT00753506|4022937|P2|Overall Study|Lost to Follow-up|0
1226031|NCT00753506|4022938|P1|Overall Study|Lost to Follow-up|2
1226032|NCT00753506|4022937|P2|Overall Study|Withdrawal by Subject|1
1226033|NCT00753506|4022938|P1|Overall Study|Withdrawal by Subject|4
1226034|NCT00753454|4022944|P1|Overall Study|Investigator Decision|1
1226035|NCT00753454|4022944|P1|Overall Study|Withdrawal by Subject|5
1226036|NCT00753454|4022944|P1|Overall Study|Lost to Follow-up|3
1226037|NCT00753454|4022944|P1|Overall Study|Lack of Efficacy|1
1226038|NCT00753454|4022944|P1|Overall Study|Adverse Event|4
1226039|NCT00753415|4022978|P10|Part B|Disease progression|1
1226040|NCT00753415|4022979|P9|Part B|Disease progression|2
1226041|NCT00753415|4022980|P8|Part B|Disease progression|0
1226042|NCT00753415|4022981|P7|Part B|Disease progression|0
1226043|NCT00753415|4022982|P6|Part B|Disease progression|0
1226044|NCT00753415|4022983|P5|Part B|Disease progression|0
1226045|NCT00753415|4022984|P4|Part B|Disease progression|0
1226046|NCT00753415|4022985|P3|Part B|Disease progression|0
1226047|NCT00753415|4022986|P2|Part B|Disease progression|0
1226048|NCT00753415|4022987|P1|Part B|Disease progression|0
1226049|NCT00753415|4022978|P10|Part B|Lost to Follow-up|0
1226050|NCT00753415|4022979|P9|Part B|Lost to Follow-up|1
1226051|NCT00753415|4022980|P8|Part B|Lost to Follow-up|1
1226052|NCT00753415|4022981|P7|Part B|Lost to Follow-up|0
1226053|NCT00753415|4022982|P6|Part B|Lost to Follow-up|0
1226054|NCT00753415|4022983|P5|Part B|Lost to Follow-up|0
1226055|NCT00753415|4022984|P4|Part B|Lost to Follow-up|0
1226056|NCT00753415|4022985|P3|Part B|Lost to Follow-up|0
1226057|NCT00753415|4022986|P2|Part B|Lost to Follow-up|0
1226058|NCT00753415|4022987|P1|Part B|Lost to Follow-up|0
1226059|NCT00753415|4022978|P10|Part A|Withdrawal by Subject|0
1226060|NCT00753415|4022979|P9|Part A|Withdrawal by Subject|0
1226061|NCT00753415|4022980|P8|Part A|Withdrawal by Subject|0
1226062|NCT00753415|4022981|P7|Part A|Withdrawal by Subject|0
1226063|NCT00753415|4022982|P6|Part A|Withdrawal by Subject|0
1226064|NCT00753415|4022983|P5|Part A|Withdrawal by Subject|0
1226065|NCT00753415|4022984|P4|Part A|Withdrawal by Subject|0
1226066|NCT00753415|4022985|P3|Part A|Withdrawal by Subject|1
1226067|NCT00753415|4022986|P2|Part A|Withdrawal by Subject|0
1226068|NCT00753415|4022987|P1|Part A|Withdrawal by Subject|0
1226069|NCT00753415|4022978|P10|Part A|Disease progression|0
1226070|NCT00753415|4022979|P9|Part A|Disease progression|0
1226071|NCT00753415|4022980|P8|Part A|Disease progression|0
1226072|NCT00753415|4022981|P7|Part A|Disease progression|0
1226073|NCT00753415|4022982|P6|Part A|Disease progression|0
1226074|NCT00753415|4022983|P5|Part A|Disease progression|0
1226075|NCT00753415|4022984|P4|Part A|Disease progression|2
1226076|NCT00753415|4022985|P3|Part A|Disease progression|1
1226077|NCT00753415|4022986|P2|Part A|Disease progression|0
1226078|NCT00753415|4022987|P1|Part A|Disease progression|1
1226079|NCT00753272|4023077|P2|Overall Study|Other|1088
1226080|NCT00753272|4023078|P1|Overall Study|Other|1104
1226081|NCT00753272|4023077|P2|Overall Study|Lost to Follow-up|497
1226082|NCT00753272|4023078|P1|Overall Study|Lost to Follow-up|491
1226083|NCT00753272|4023077|P2|Overall Study|Withdrawal by Subject|2407
1226084|NCT00753272|4023078|P1|Overall Study|Withdrawal by Subject|2481
1226085|NCT00753272|4023077|P2|Overall Study|Protocol Violation|46
1226086|NCT00753272|4023078|P1|Overall Study|Protocol Violation|28
1226087|NCT00753272|4023077|P2|Overall Study|Adverse Event|869
1226088|NCT00753272|4023078|P1|Overall Study|Adverse Event|878
1226089|NCT00753012|4023162|P2|Overall Study|Confounded endpoint data|0
1226090|NCT00753012|4023163|P1|Overall Study|Confounded endpoint data|1
1226091|NCT00753012|4023162|P2|Overall Study|Lost to Follow-up|0
1226092|NCT00753012|4023163|P1|Overall Study|Lost to Follow-up|4
1226093|NCT00753012|4023162|P2|Overall Study|Withdrawal by Subject|1
1226094|NCT00753012|4023163|P1|Overall Study|Withdrawal by Subject|0
1226095|NCT00753012|4023162|P2|Overall Study|Adverse Event|0
1226096|NCT00753012|4023163|P1|Overall Study|Adverse Event|2
1226097|NCT00753012|4023162|P2|Overall Study|Ineligible, abnormal cardiac histo|0
1226098|NCT00753012|4023163|P1|Overall Study|Ineligible, abnormal cardiac histo|1
1226099|NCT00752986|4023176|P3|Overall Study|Protocol Violation|0
1226100|NCT00752986|4023177|P2|Overall Study|Protocol Violation|0
1226101|NCT00752986|4023178|P1|Overall Study|Protocol Violation|3
1226102|NCT00752986|4023176|P3|Overall Study|Withdrawal by Subject|2
1226103|NCT00752986|4023177|P2|Overall Study|Withdrawal by Subject|1
1226104|NCT00752986|4023178|P1|Overall Study|Withdrawal by Subject|2
1226105|NCT00752895|4023207|P2|Overall Study|Withdrawal by Subject|3
1226106|NCT00752895|4023208|P1|Overall Study|Withdrawal by Subject|8
1226107|NCT00752791|4023216|P1|Overall Study|Protocol deviation|1
1226108|NCT00752791|4023216|P1|Overall Study|Switched to hemodialysis|2
1226109|NCT00752791|4023216|P1|Overall Study|Renal transplant|3
1226110|NCT00752791|4023216|P1|Overall Study|Death|1
1226111|NCT00752791|4023216|P1|Overall Study|Physician Decision|1
1226112|NCT00752791|4023216|P1|Overall Study|Withdrawal by Subject|1
1226113|NCT00752791|4023216|P1|Overall Study|Adverse Event|7
1226114|NCT00752726|4023228|P2|Overall Study|Other Reason|2
1226115|NCT00752726|4023229|P1|Overall Study|Other Reason|1
1226116|NCT00752726|4023228|P2|Overall Study|Withdrawal by Subject|10
1226117|NCT00752726|4023229|P1|Overall Study|Withdrawal by Subject|5
1226118|NCT00752726|4023228|P2|Overall Study|Adverse Event|0
1226119|NCT00752726|4023229|P1|Overall Study|Adverse Event|3
1226120|NCT00752726|4023228|P2|Overall Study|Lost to Follow-up|1
1226121|NCT00752726|4023229|P1|Overall Study|Lost to Follow-up|2
1226122|NCT00752622|4023254|P1|Interventional Phase|Premature Study Termination|5
1226123|NCT00752622|4023254|P1|Interventional Phase|Physician Decision|1
1226124|NCT00752622|4023254|P1|Interventional Phase|Non-responder|2
1226125|NCT00752622|4023254|P1|Observational Phase|Other|2
1226126|NCT00752622|4023254|P1|Observational Phase|Adverse Event|1
1226127|NCT00752622|4023254|P1|Observational Phase|Withdrawal by Subject|2
1226128|NCT00752622|4023254|P1|Observational Phase|Non-responder|2
1226129|NCT00752622|4023254|P1|Observational Phase|Premature Study Termination|36
1226130|NCT00752622|4023254|P1|Induction Phase|Premature study termination|14
1226131|NCT00752622|4023254|P1|Induction Phase|Withdrawal by Subject|1
1226132|NCT00752622|4023254|P1|Induction Phase|Non-responder|14
1226133|NCT00752622|4023254|P1|Induction Phase|Other|3
1226134|NCT00752622|4023254|P1|Induction Phase|Adverse Event|3
1226135|NCT00752609|4023267|P2|Overall Study|Received Aranesp in error|0
1226136|NCT00752609|4023268|P1|Overall Study|Received Aranesp in error|1
1226137|NCT00752609|4023267|P2|Overall Study|Met exclusion criteria|0
1226138|NCT00752609|4023268|P1|Overall Study|Met exclusion criteria|1
1226139|NCT00752609|4023267|P2|Overall Study|Death|0
1226140|NCT00752609|4023268|P1|Overall Study|Death|1
1226141|NCT00752609|4023267|P2|Overall Study|Physician Decision|0
1226142|NCT00752609|4023268|P1|Overall Study|Physician Decision|1
1226143|NCT00752609|4023267|P2|Overall Study|Withdrawal by Subject|0
1226144|NCT00752609|4023268|P1|Overall Study|Withdrawal by Subject|3
1226145|NCT00752609|4023267|P2|Overall Study|Adverse Event|2
1226146|NCT00752609|4023268|P1|Overall Study|Adverse Event|2
1226147|NCT00752232|4023294|P7|Overall Study|Caregiver could not attend the subject|0
1226148|NCT00752232|4023295|P6|Overall Study|Caregiver could not attend the subject|0
1226149|NCT00752232|4023296|P5|Overall Study|Caregiver could not attend the subject|1
1226150|NCT00752232|4023297|P4|Overall Study|Caregiver could not attend the subject|0
1226151|NCT00752232|4023298|P3|Overall Study|Caregiver could not attend the subject|0
1226152|NCT00752232|4023299|P2|Overall Study|Caregiver could not attend the subject|0
1226153|NCT00752232|4023300|P1|Overall Study|Caregiver could not attend the subject|0
1226154|NCT00752232|4023294|P7|Overall Study|Group home admission|0
1226155|NCT00752232|4023295|P6|Overall Study|Group home admission|0
1226156|NCT00752232|4023296|P5|Overall Study|Group home admission|0
1226157|NCT00752232|4023297|P4|Overall Study|Group home admission|1
1226158|NCT00752232|4023298|P3|Overall Study|Group home admission|0
1226159|NCT00752232|4023299|P2|Overall Study|Group home admission|0
1226160|NCT00752232|4023300|P1|Overall Study|Group home admission|0
1226161|NCT00752232|4023294|P7|Overall Study|Subject request|0
1226162|NCT00752232|4023295|P6|Overall Study|Subject request|0
1226163|NCT00752232|4023296|P5|Overall Study|Subject request|0
1226164|NCT00752232|4023297|P4|Overall Study|Subject request|0
1226165|NCT00752232|4023298|P3|Overall Study|Subject request|1
1226166|NCT00752232|4023299|P2|Overall Study|Subject request|0
1226167|NCT00752232|4023300|P1|Overall Study|Subject request|0
1226168|NCT00752232|4023294|P7|Overall Study|Investigator request|0
1226169|NCT00752232|4023295|P6|Overall Study|Investigator request|0
1226170|NCT00752232|4023296|P5|Overall Study|Investigator request|1
1226171|NCT00752232|4023297|P4|Overall Study|Investigator request|0
1226172|NCT00752232|4023298|P3|Overall Study|Investigator request|0
1226173|NCT00752232|4023299|P2|Overall Study|Investigator request|0
1226174|NCT00752232|4023300|P1|Overall Study|Investigator request|0
1226175|NCT00752232|4023294|P7|Overall Study|Caregiver request|0
1226176|NCT00752232|4023295|P6|Overall Study|Caregiver request|0
1226177|NCT00752232|4023296|P5|Overall Study|Caregiver request|1
1226178|NCT00752232|4023297|P4|Overall Study|Caregiver request|0
1226179|NCT00752232|4023298|P3|Overall Study|Caregiver request|0
1226180|NCT00752232|4023299|P2|Overall Study|Caregiver request|0
1226181|NCT00752232|4023300|P1|Overall Study|Caregiver request|2
1226182|NCT00752232|4023294|P7|Overall Study|Protocol Violation|0
1226183|NCT00752232|4023295|P6|Overall Study|Protocol Violation|1
1226184|NCT00752232|4023296|P5|Overall Study|Protocol Violation|0
1226185|NCT00752232|4023297|P4|Overall Study|Protocol Violation|0
1226186|NCT00752232|4023298|P3|Overall Study|Protocol Violation|0
1226187|NCT00752232|4023299|P2|Overall Study|Protocol Violation|0
1226188|NCT00752232|4023300|P1|Overall Study|Protocol Violation|0
1226189|NCT00752219|4023374|P2|Overall Study|Other|0
1226190|NCT00752219|4023375|P1|Overall Study|Other|3
1226191|NCT00752219|4023374|P2|Overall Study|Randomized but not treated|0
1226192|NCT00752219|4023375|P1|Overall Study|Randomized but not treated|1
1226193|NCT00752219|4023374|P2|Overall Study|Lost to Follow-up|2
1226194|NCT00752219|4023375|P1|Overall Study|Lost to Follow-up|1
1226195|NCT00752219|4023374|P2|Overall Study|Protocol deviation|0
1226196|NCT00752219|4023375|P1|Overall Study|Protocol deviation|1
1226197|NCT00752219|4023374|P2|Overall Study|Adverse Event|3
1226198|NCT00752219|4023375|P1|Overall Study|Adverse Event|5
1226199|NCT00752219|4023374|P2|Overall Study|Clinical failure|1
1226200|NCT00752219|4023375|P1|Overall Study|Clinical failure|0
1226201|NCT00752128|4023399|P1|Overall Study|Withdrawal by Subject|4
1226202|NCT00752089|4023413|P1|Overall Study|Cannot continue the study|1
1226203|NCT00752089|4023413|P1|Overall Study|Not capable of wearing partial denture|1
1226204|NCT00752089|4023413|P1|Overall Study|Could not attend visit 9|1
1226205|NCT00752089|4023413|P1|Overall Study|Protocol Deviation|2
1226206|NCT00752089|4023413|P1|Overall Study|Adverse Event|1
1226207|NCT00751998|4023427|P1|Overall Study|Withdrawal by Subject|2
1226208|NCT00751998|4023427|P1|Overall Study|Death|11
1226209|NCT00751998|4023427|P1|Overall Study|Lost to Follow-up|7
1226210|NCT00751933|4023446|P4|Overall Study|Physician Decision|1
1226211|NCT00751933|4023447|P3|Overall Study|Physician Decision|1
1226212|NCT00751933|4023448|P2|Overall Study|Physician Decision|0
1226213|NCT00751933|4023449|P1|Overall Study|Physician Decision|0
1226214|NCT00751933|4023446|P4|Overall Study|Withdrawal by Subject|0
1226215|NCT00751933|4023447|P3|Overall Study|Withdrawal by Subject|0
1226216|NCT00751933|4023448|P2|Overall Study|Withdrawal by Subject|1
1226217|NCT00751933|4023449|P1|Overall Study|Withdrawal by Subject|0
1226218|NCT00751881|4023457|P3|Extension Study Period|Other than specified above|18
1226219|NCT00751881|4023458|P2|Extension Study Period|Other than specified above|30
1226220|NCT00751881|4023459|P1|Extension Study Period|Other than specified above|26
1226221|NCT00751881|4023457|P3|Extension Study Period|Poor Compliance to Protocol|1
1226222|NCT00751881|4023458|P2|Extension Study Period|Poor Compliance to Protocol|2
1226223|NCT00751881|4023459|P1|Extension Study Period|Poor Compliance to Protocol|3
1226224|NCT00751881|4023457|P3|Extension Study Period|Lost to Follow-up|6
1226225|NCT00751881|4023458|P2|Extension Study Period|Lost to Follow-up|9
1226226|NCT00751881|4023459|P1|Extension Study Period|Lost to Follow-up|4
1226227|NCT00751881|4023457|P3|Extension Study Period|Lack of Efficacy|20
1226228|NCT00751881|4023458|P2|Extension Study Period|Lack of Efficacy|10
1226229|NCT00751881|4023459|P1|Extension Study Period|Lack of Efficacy|14
1226230|NCT00751881|4023457|P3|Extension Study Period|Adverse Event|21
1226231|NCT00751881|4023458|P2|Extension Study Period|Adverse Event|20
1226232|NCT00751881|4023459|P1|Extension Study Period|Adverse Event|18
1226233|NCT00751881|4023457|P3|Core Treatment Period|Other:participant's decision/unspecified|16
1226234|NCT00751881|4023458|P2|Core Treatment Period|Other:participant's decision/unspecified|22
1226235|NCT00751881|4023459|P1|Core Treatment Period|Other:participant's decision/unspecified|19
1226236|NCT00751881|4023457|P3|Core Treatment Period|Other: tolerability complaints|0
1226237|NCT00751881|4023458|P2|Core Treatment Period|Other: tolerability complaints|0
1226238|NCT00751881|4023459|P1|Core Treatment Period|Other: tolerability complaints|2
1226239|NCT00751881|4023457|P3|Core Treatment Period|Other: MS treatment change|4
1226240|NCT00751881|4023458|P2|Core Treatment Period|Other: MS treatment change|4
1226241|NCT00751881|4023459|P1|Core Treatment Period|Other: MS treatment change|6
1226242|NCT00751881|4023457|P3|Core Treatment Period|Other: personal/family constraints|10
1226243|NCT00751881|4023458|P2|Core Treatment Period|Other: personal/family constraints|7
1226244|NCT00751881|4023459|P1|Core Treatment Period|Other: personal/family constraints|6
1226245|NCT00751881|4023457|P3|Core Treatment Period|Other: wish to parent|4
1226246|NCT00751881|4023458|P2|Core Treatment Period|Other: wish to parent|7
1226247|NCT00751881|4023459|P1|Core Treatment Period|Other: wish to parent|5
1226248|NCT00751881|4023457|P3|Core Treatment Period|Other: protocol deviation|7
1226249|NCT00751881|4023458|P2|Core Treatment Period|Other: protocol deviation|3
1226250|NCT00751881|4023459|P1|Core Treatment Period|Other: protocol deviation|3
1226251|NCT00751881|4023457|P3|Core Treatment Period|Lost to Follow-up|3
1226252|NCT00751881|4023458|P2|Core Treatment Period|Lost to Follow-up|4
1226253|NCT00751881|4023459|P1|Core Treatment Period|Lost to Follow-up|6
1226254|NCT00751881|4023457|P3|Core Treatment Period|Poor compliance to protocol|4
1226255|NCT00751881|4023458|P2|Core Treatment Period|Poor compliance to protocol|3
1226256|NCT00751881|4023459|P1|Core Treatment Period|Poor compliance to protocol|15
1226257|NCT00751881|4023457|P3|Core Treatment Period|Lack of Efficacy|20
1226258|NCT00751881|4023458|P2|Core Treatment Period|Lack of Efficacy|30
1226259|NCT00751881|4023459|P1|Core Treatment Period|Lack of Efficacy|37
1226260|NCT00751881|4023457|P3|Core Treatment Period|Adverse Event|58
1226261|NCT00751881|4023458|P2|Core Treatment Period|Adverse Event|54
1226262|NCT00751881|4023459|P1|Core Treatment Period|Adverse Event|26
1226263|NCT00751881|4023457|P3|Core Treatment Period|Not treated|2
1226264|NCT00751881|4023458|P2|Core Treatment Period|Not treated|1
1226265|NCT00751881|4023459|P1|Core Treatment Period|Not treated|1
1226266|NCT00751790|4023506|P1|Overall Study|Withdrawal by Subject|1
1226267|NCT00751790|4023506|P1|Overall Study|Death|3
1226268|NCT00751790|4023506|P1|Overall Study|Lost to Follow-up|1
1226269|NCT00751621|4023531|P1|Overall Study|Poor adherence to asthma treatment|1
1226270|NCT00751621|4023531|P1|Overall Study|Subject moved to another country|1
1226271|NCT00751621|4023531|P1|Overall Study|Withdrawal by Subject|1
1226272|NCT00751621|4023531|P1|Overall Study|Adverse Event|1
1226273|NCT00751400|4023565|P1|Overall Study|Lost to Follow-up|10
1226274|NCT00751348|4023580|P2|Overall Study|Migration from study area|0
1226275|NCT00751348|4023581|P1|Overall Study|Migration from study area|1
1226276|NCT00751348|4023580|P2|Overall Study|Withdrawal by Subject|2
1226277|NCT00751348|4023581|P1|Overall Study|Withdrawal by Subject|5
1226278|NCT00751296|4023603|P1|Overall Study|Adverse Event|2
1226279|NCT00751140|4023631|P1|Overall Study|benign angioma excluded from analysis|1
1226280|NCT00751114|4023641|P2|Overall Study|Move to another city|0
1226281|NCT00751114|4023642|P1|Overall Study|Move to another city|1
1226282|NCT00751114|4023641|P2|Overall Study|Out of country for 2 months|0
1226283|NCT00751114|4023642|P1|Overall Study|Out of country for 2 months|1
1226284|NCT00751114|4023641|P2|Overall Study|Not Treated|1
1226285|NCT00751114|4023642|P1|Overall Study|Not Treated|13
1226286|NCT00751114|4023641|P2|Overall Study|Lack of Efficacy|7
1226287|NCT00751114|4023642|P1|Overall Study|Lack of Efficacy|0
1226288|NCT00751114|4023641|P2|Overall Study|Lost to Follow-up|7
1226289|NCT00751114|4023642|P1|Overall Study|Lost to Follow-up|4
1226290|NCT00751114|4023641|P2|Overall Study|Withdrawal by Subject|4
1226291|NCT00751114|4023642|P1|Overall Study|Withdrawal by Subject|9
1226292|NCT00751114|4023641|P2|Overall Study|Protocol Violation|9
1226293|NCT00751114|4023642|P1|Overall Study|Protocol Violation|8
1226294|NCT00751114|4023641|P2|Overall Study|Adverse Event|4
1226295|NCT00751114|4023642|P1|Overall Study|Adverse Event|2
1226296|NCT00751036|4023667|P2|Overall Study|Missing end of Treatment Page|3
1226297|NCT00751036|4023668|P1|Overall Study|Missing end of Treatment Page|2
1226298|NCT00751036|4023667|P2|Overall Study|Protocol Violation|0
1226299|NCT00751036|4023668|P1|Overall Study|Protocol Violation|1
1226300|NCT00751036|4023667|P2|Overall Study|Lost to Follow-up|1
1226301|NCT00751036|4023668|P1|Overall Study|Lost to Follow-up|0
1226302|NCT00751036|4023667|P2|Overall Study|Death|3
1226303|NCT00751036|4023668|P1|Overall Study|Death|3
1226304|NCT00751036|4023667|P2|Overall Study|Withdrawal by Subject|2
1226305|NCT00751036|4023668|P1|Overall Study|Withdrawal by Subject|5
1226306|NCT00751036|4023667|P2|Overall Study|Administrative Problems|4
1226307|NCT00751036|4023668|P1|Overall Study|Administrative Problems|3
1226308|NCT00751036|4023667|P2|Overall Study|Adverse Event|4
1226309|NCT00751036|4023668|P1|Overall Study|Adverse Event|6
1226310|NCT00751036|4023667|P2|Overall Study|Disease Progression|29
1226311|NCT00751036|4023668|P1|Overall Study|Disease Progression|28
1226312|NCT00750919|4023680|P1|Overall Study|Other|36
1226313|NCT00750919|4023680|P1|Overall Study|Could not cooperate, unrelated to trial|4
1226314|NCT00750919|4023680|P1|Overall Study|Lack of Efficacy|8
1226315|NCT00750919|4023680|P1|Overall Study|Withdrawal by Subject|1
1226316|NCT00750919|4023680|P1|Overall Study|Adverse Event|9
1226317|NCT00750893|4023688|P1|Overall Study|Other|17
1226318|NCT00750893|4023688|P1|Overall Study|Lost to Follow-up|510
1226319|NCT00750893|4023688|P1|Overall Study|Withdrawal by Subject|10
1226320|NCT00750893|4023688|P1|Overall Study|Adverse Event|5
1226321|NCT00750880|4023703|P1|Overall Study|Administrative|11
1226322|NCT00750880|4023703|P1|Overall Study|Physician Decision|20
1226323|NCT00750880|4023703|P1|Overall Study|Withdrawal by Subject|33
1226324|NCT00750880|4023703|P1|Overall Study|Protocol Violation|15
1226325|NCT00750880|4023703|P1|Overall Study|Lost to Follow-up|10
1226326|NCT00750880|4023703|P1|Overall Study|Lack of Efficacy|46
1226327|NCT00750880|4023703|P1|Overall Study|Death|4
1226328|NCT00750880|4023703|P1|Overall Study|Adverse Event|76
1226329|NCT00750867|4023726|P1|Overall Study|Adverse Event|2
1226330|NCT00750737|4023747|P2|Overall Study|Withdrawal by Subject|3
1226331|NCT00750737|4023748|P1|Overall Study|Withdrawal by Subject|3
1226332|NCT00750308|4023808|P12|Third Treatment|Withdrawal by Subject|0
1226333|NCT00750308|4023809|P11|Third Treatment|Withdrawal by Subject|0
1226334|NCT00750308|4023810|P10|Third Treatment|Withdrawal by Subject|0
1226335|NCT00750308|4023811|P9|Third Treatment|Withdrawal by Subject|0
1226336|NCT00750308|4023812|P8|Third Treatment|Withdrawal by Subject|0
1226337|NCT00750308|4023813|P7|Third Treatment|Withdrawal by Subject|0
1226338|NCT00750308|4023814|P6|Third Treatment|Withdrawal by Subject|0
1226339|NCT00750308|4023815|P5|Third Treatment|Withdrawal by Subject|0
1226340|NCT00750308|4023816|P4|Third Treatment|Withdrawal by Subject|0
1226341|NCT00750308|4023817|P3|Third Treatment|Withdrawal by Subject|0
1226342|NCT00750308|4023818|P2|Third Treatment|Withdrawal by Subject|1
1226343|NCT00750308|4023819|P1|Third Treatment|Withdrawal by Subject|0
1226344|NCT00750308|4023808|P12|Second Treatment|Withdrawal by Subject|0
1226345|NCT00750308|4023809|P11|Second Treatment|Withdrawal by Subject|0
1226346|NCT00750308|4023810|P10|Second Treatment|Withdrawal by Subject|0
1226347|NCT00750308|4023811|P9|Second Treatment|Withdrawal by Subject|0
1226348|NCT00750308|4023812|P8|Second Treatment|Withdrawal by Subject|0
1226349|NCT00750308|4023813|P7|Second Treatment|Withdrawal by Subject|0
1226350|NCT00750308|4023814|P6|Second Treatment|Withdrawal by Subject|0
1226351|NCT00750308|4023815|P5|Second Treatment|Withdrawal by Subject|1
1226352|NCT00750308|4023816|P4|Second Treatment|Withdrawal by Subject|0
1226353|NCT00750308|4023817|P3|Second Treatment|Withdrawal by Subject|0
1226354|NCT00750308|4023818|P2|Second Treatment|Withdrawal by Subject|0
1226355|NCT00750308|4023819|P1|Second Treatment|Withdrawal by Subject|0
1226356|NCT00750308|4023808|P12|Second Treatment|Adverse Event|0
1226357|NCT00750308|4023809|P11|Second Treatment|Adverse Event|0
1226358|NCT00750308|4023810|P10|Second Treatment|Adverse Event|0
1226359|NCT00750308|4023811|P9|Second Treatment|Adverse Event|1
1226360|NCT00750308|4023812|P8|Second Treatment|Adverse Event|0
1226361|NCT00750308|4023813|P7|Second Treatment|Adverse Event|0
1226362|NCT00750308|4023814|P6|Second Treatment|Adverse Event|1
1226363|NCT00750308|4023815|P5|Second Treatment|Adverse Event|0
1226364|NCT00750308|4023816|P4|Second Treatment|Adverse Event|0
1226365|NCT00750308|4023817|P3|Second Treatment|Adverse Event|0
1226366|NCT00750308|4023818|P2|Second Treatment|Adverse Event|0
1226367|NCT00750308|4023819|P1|Second Treatment|Adverse Event|0
1226368|NCT00750308|4023808|P12|First Treatment|Withdrawal by Subject|0
1226369|NCT00750308|4023809|P11|First Treatment|Withdrawal by Subject|0
1226370|NCT00750308|4023810|P10|First Treatment|Withdrawal by Subject|0
1226371|NCT00750308|4023811|P9|First Treatment|Withdrawal by Subject|0
1226372|NCT00750308|4023812|P8|First Treatment|Withdrawal by Subject|1
1226373|NCT00750308|4023813|P7|First Treatment|Withdrawal by Subject|0
1226374|NCT00750308|4023814|P6|First Treatment|Withdrawal by Subject|0
1226375|NCT00750308|4023815|P5|First Treatment|Withdrawal by Subject|0
1226376|NCT00750308|4023816|P4|First Treatment|Withdrawal by Subject|1
1226377|NCT00750308|4023817|P3|First Treatment|Withdrawal by Subject|0
1226378|NCT00750308|4023818|P2|First Treatment|Withdrawal by Subject|0
1226379|NCT00750308|4023819|P1|First Treatment|Withdrawal by Subject|0
1226380|NCT00750308|4023808|P12|First Treatment|Adverse Event|1
1226381|NCT00750308|4023809|P11|First Treatment|Adverse Event|1
1226382|NCT00750308|4023810|P10|First Treatment|Adverse Event|0
1226383|NCT00750308|4023811|P9|First Treatment|Adverse Event|0
1226384|NCT00750308|4023812|P8|First Treatment|Adverse Event|0
1226385|NCT00750308|4023813|P7|First Treatment|Adverse Event|0
1226386|NCT00750308|4023814|P6|First Treatment|Adverse Event|0
1226387|NCT00750308|4023815|P5|First Treatment|Adverse Event|0
1226388|NCT00750308|4023816|P4|First Treatment|Adverse Event|0
1226389|NCT00750308|4023817|P3|First Treatment|Adverse Event|0
1226390|NCT00750308|4023818|P2|First Treatment|Adverse Event|1
1226391|NCT00750308|4023819|P1|First Treatment|Adverse Event|0
1226392|NCT00750269|4023869|P5|Overall Study|Fiducials could not be placed|1
1226393|NCT00750269|4023870|P4|Overall Study|Fiducials could not be placed|0
1226394|NCT00750269|4023871|P3|Overall Study|Fiducials could not be placed|0
1226395|NCT00750269|4023872|P2|Overall Study|Fiducials could not be placed|0
1226396|NCT00750269|4023873|P1|Overall Study|Fiducials could not be placed|0
1226397|NCT00750269|4023869|P5|Overall Study|SBRT plan could not be drawn|1
1226398|NCT00750269|4023870|P4|Overall Study|SBRT plan could not be drawn|0
1226399|NCT00750269|4023871|P3|Overall Study|SBRT plan could not be drawn|0
1226400|NCT00750269|4023872|P2|Overall Study|SBRT plan could not be drawn|0
1226401|NCT00750269|4023873|P1|Overall Study|SBRT plan could not be drawn|0
1226402|NCT00750269|4023869|P5|Overall Study|Site error|0
1226403|NCT00750269|4023870|P4|Overall Study|Site error|1
1226404|NCT00750269|4023871|P3|Overall Study|Site error|0
1226405|NCT00750269|4023872|P2|Overall Study|Site error|0
1226406|NCT00750269|4023873|P1|Overall Study|Site error|0
1226407|NCT00750269|4023869|P5|Overall Study|Patient too large for positioning|0
1226408|NCT00750269|4023870|P4|Overall Study|Patient too large for positioning|0
1226409|NCT00750269|4023871|P3|Overall Study|Patient too large for positioning|1
1226410|NCT00750269|4023872|P2|Overall Study|Patient too large for positioning|0
1226411|NCT00750269|4023873|P1|Overall Study|Patient too large for positioning|0
1226412|NCT00750269|4023869|P5|Overall Study|Physician Decision|2
1226413|NCT00750269|4023870|P4|Overall Study|Physician Decision|0
1226414|NCT00750269|4023871|P3|Overall Study|Physician Decision|0
1226415|NCT00750269|4023872|P2|Overall Study|Physician Decision|0
1226416|NCT00750269|4023873|P1|Overall Study|Physician Decision|0
1226417|NCT00750269|4023869|P5|Overall Study|Withdrawal by Subject|2
1226418|NCT00750269|4023870|P4|Overall Study|Withdrawal by Subject|2
1226419|NCT00750269|4023871|P3|Overall Study|Withdrawal by Subject|2
1226420|NCT00750269|4023872|P2|Overall Study|Withdrawal by Subject|0
1226421|NCT00750269|4023873|P1|Overall Study|Withdrawal by Subject|0
1226422|NCT00750269|4023869|P5|Overall Study|Protocol Violation|4
1226423|NCT00750269|4023870|P4|Overall Study|Protocol Violation|2
1226424|NCT00750269|4023871|P3|Overall Study|Protocol Violation|1
1226425|NCT00750269|4023872|P2|Overall Study|Protocol Violation|1
1226426|NCT00750269|4023873|P1|Overall Study|Protocol Violation|0
1226427|NCT00750204|4023920|P2|Overall Study|study halted prematurely|1
1226428|NCT00750204|4023921|P1|Overall Study|study halted prematurely|1
1226429|NCT00750152|4023944|P2|Overall Study|Not specified|8
1226430|NCT00750152|4023945|P1|Overall Study|Not specified|7
1226431|NCT00750152|4023944|P2|Overall Study|Termination by sponsor|0
1226432|NCT00750152|4023945|P1|Overall Study|Termination by sponsor|1
1226433|NCT00750152|4023944|P2|Overall Study|Non-compliance|1
1226434|NCT00750152|4023945|P1|Overall Study|Non-compliance|0
1226435|NCT00750152|4023944|P2|Overall Study|Physician Decision|1
1226436|NCT00750152|4023945|P1|Overall Study|Physician Decision|1
1226437|NCT00750152|4023944|P2|Overall Study|Withdrawal by Subject|3
1226438|NCT00750152|4023945|P1|Overall Study|Withdrawal by Subject|3
1226439|NCT00750152|4023944|P2|Overall Study|Lost to Follow-up|13
1226440|NCT00750152|4023945|P1|Overall Study|Lost to Follow-up|8
1226441|NCT00750152|4023944|P2|Overall Study|Adverse Event|1
1226442|NCT00750152|4023945|P1|Overall Study|Adverse Event|2
1226443|NCT00750139|4023957|P4|Overall Study|Non-specific|33
1226444|NCT00750139|4023958|P3|Overall Study|Non-specific|79
1226445|NCT00750139|4023959|P2|Overall Study|Non-specific|42
1226446|NCT00750139|4023960|P1|Overall Study|Non-specific|62
1226447|NCT00750139|4023957|P4|Overall Study|Termination by sponsor|1
1226448|NCT00750139|4023958|P3|Overall Study|Termination by sponsor|0
1226449|NCT00750139|4023959|P2|Overall Study|Termination by sponsor|0
1226450|NCT00750139|4023960|P1|Overall Study|Termination by sponsor|4
1226451|NCT00750139|4023957|P4|Overall Study|Non-compliance|3
1226452|NCT00750139|4023958|P3|Overall Study|Non-compliance|1
1226453|NCT00750139|4023959|P2|Overall Study|Non-compliance|0
1226454|NCT00750139|4023960|P1|Overall Study|Non-compliance|1
1226455|NCT00750139|4023957|P4|Overall Study|Physician Decision|0
1226456|NCT00750139|4023958|P3|Overall Study|Physician Decision|0
1226457|NCT00750139|4023959|P2|Overall Study|Physician Decision|1
1226458|NCT00750139|4023960|P1|Overall Study|Physician Decision|1
1226459|NCT00750139|4023957|P4|Overall Study|Withdrawal by Subject|2
1226460|NCT00750139|4023958|P3|Overall Study|Withdrawal by Subject|6
1226461|NCT00750139|4023959|P2|Overall Study|Withdrawal by Subject|2
1226462|NCT00750139|4023960|P1|Overall Study|Withdrawal by Subject|3
1226463|NCT00750139|4023957|P4|Overall Study|Lost to Follow-up|6
1226464|NCT00750139|4023958|P3|Overall Study|Lost to Follow-up|15
1226465|NCT00750139|4023959|P2|Overall Study|Lost to Follow-up|12
1226466|NCT00750139|4023960|P1|Overall Study|Lost to Follow-up|17
1226467|NCT00750139|4023957|P4|Overall Study|Adverse Event|1
1226468|NCT00750139|4023958|P3|Overall Study|Adverse Event|0
1226469|NCT00750139|4023959|P2|Overall Study|Adverse Event|2
1226470|NCT00750139|4023960|P1|Overall Study|Adverse Event|1
1226471|NCT00750061|4023976|P2|Overall Study|Physician Decision|1
1226472|NCT00750061|4023977|P1|Overall Study|Physician Decision|0
1226473|NCT00750061|4023976|P2|Overall Study|Withdrawal by Subject|1
1226474|NCT00750061|4023977|P1|Overall Study|Withdrawal by Subject|0
1226475|NCT00750061|4023976|P2|Overall Study|Adverse Event|0
1226476|NCT00750061|4023977|P1|Overall Study|Adverse Event|2
1226477|NCT00749996|4023987|P2|Overall Study|Death|0
1226478|NCT00749996|4023988|P1|Overall Study|Death|1
1226479|NCT00749996|4023987|P2|Overall Study|Adverse Event|0
1226480|NCT00749996|4023988|P1|Overall Study|Adverse Event|1
1226481|NCT00749996|4023987|P2|Overall Study|Pregnancy|2
1226482|NCT00749996|4023988|P1|Overall Study|Pregnancy|0
1226483|NCT00749996|4023987|P2|Overall Study|Physician Decision|0
1226484|NCT00749996|4023988|P1|Overall Study|Physician Decision|2
1226485|NCT00749996|4023987|P2|Overall Study|Protocol Violation|3
1226486|NCT00749996|4023988|P1|Overall Study|Protocol Violation|2
1226487|NCT00749996|4023987|P2|Overall Study|Withdrawal by Subject|4
1226488|NCT00749996|4023988|P1|Overall Study|Withdrawal by Subject|5
1226489|NCT00749996|4023987|P2|Overall Study|Lost to Follow-up|4
1226490|NCT00749996|4023988|P1|Overall Study|Lost to Follow-up|7
1226491|NCT00749944|4024011|P2|Overall Study|Withdrawal by Subject|0
1226492|NCT00749944|4024012|P1|Overall Study|Withdrawal by Subject|2
1226493|NCT00749944|4024011|P2|Overall Study|Not specified|0
1226494|NCT00749944|4024012|P1|Overall Study|Not specified|1
1226495|NCT00749944|4024011|P2|Overall Study|Lost to Follow-up|1
1226496|NCT00749944|4024012|P1|Overall Study|Lost to Follow-up|2
1226497|NCT00749775|4024091|P1|Overall Study|No drug administration|3
1226498|NCT00749775|4024091|P1|Overall Study|No visit after first day of treatment|44
1226499|NCT00749775|4024091|P1|Overall Study|Lost to Follow-up|36
1226500|NCT00749775|4024091|P1|Overall Study|Protocol Violation|24
1226501|NCT00749684|4024107|P1|Overall Study|Missing|9
1226502|NCT00749684|4024107|P1|Overall Study|AE+discontinuation on participants wish|1
1226503|NCT00749684|4024107|P1|Overall Study|Therapy according to protocol + AE|2
1226504|NCT00749684|4024107|P1|Overall Study|Progressive Desease|31
1226505|NCT00749684|4024107|P1|Overall Study|Not Documented|1
1226506|NCT00749684|4024107|P1|Overall Study|Participant's Wish|10
1226507|NCT00749684|4024107|P1|Overall Study|Adverse Event|27
1226508|NCT00749684|4024107|P1|Overall Study|Death|1
1226509|NCT00749580|4024146|P2|Overall Study|Adverse Event|1
1226510|NCT00749580|4024147|P1|Overall Study|Adverse Event|0
1226511|NCT00749580|4024146|P2|Overall Study|Lost to Follow-up|8
1226512|NCT00749580|4024147|P1|Overall Study|Lost to Follow-up|4
1226513|NCT00749463|4024162|P3|Overall Study|Withdrawal by Subject|0
1226514|NCT00749463|4024163|P2|Overall Study|Withdrawal by Subject|0
1226515|NCT00749463|4024164|P1|Overall Study|Withdrawal by Subject|1
1226516|NCT00749463|4024162|P3|Overall Study|Adverse Event|1
1226517|NCT00749463|4024163|P2|Overall Study|Adverse Event|4
1226518|NCT00749463|4024164|P1|Overall Study|Adverse Event|0
1226519|NCT00749398|4024190|P1|Overall Study|Unknown reason|1
1226520|NCT00749398|4024190|P1|Overall Study|Reason not specified|2
1226521|NCT00749398|4024190|P1|Overall Study|Lost to Follow-up|11
1226522|NCT00749398|4024190|P1|Overall Study|Withdrawal by Subject|17
1226523|NCT00749398|4024190|P1|Overall Study|Serious adverse event|11
1226524|NCT00749398|4024190|P1|Overall Study|Adverse Event|4
1226525|NCT00749398|4024190|P1|Overall Study|Lack of Efficacy|7
1226526|NCT00749203|4024233|P2|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1
1226527|NCT00749203|4024234|P1|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0
1226528|NCT00749203|4024233|P2|Second Infusion at 2 Weeks|Protocol Violation|1
1226529|NCT00749203|4024234|P1|Second Infusion at 2 Weeks|Protocol Violation|0
1226530|NCT00749203|4024233|P2|no Infusion at Week 1|low baseline PTSD symptoms level|1
1226531|NCT00749203|4024234|P1|no Infusion at Week 1|low baseline PTSD symptoms level|0
1226532|NCT00749203|4024233|P2|no Infusion at Week 1|delayed-onset sedation|1
1226533|NCT00749203|4024234|P1|no Infusion at Week 1|delayed-onset sedation|0
1226534|NCT00749203|4024233|P2|no Infusion at Week 1|Withdrawal by Subject|1
1226535|NCT00749203|4024234|P1|no Infusion at Week 1|Withdrawal by Subject|0
1226536|NCT00749203|4024233|P2|no Infusion at Week 1|Lost to Follow-up|1
1226537|NCT00749203|4024234|P1|no Infusion at Week 1|Lost to Follow-up|0
1226538|NCT00749190|4024255|P7|Overall Study|Other reason not defined above|0
1226539|NCT00749190|4024256|P6|Overall Study|Other reason not defined above|0
1226540|NCT00749190|4024257|P5|Overall Study|Other reason not defined above|0
1226541|NCT00749190|4024258|P4|Overall Study|Other reason not defined above|1
1226542|NCT00749190|4024259|P3|Overall Study|Other reason not defined above|0
1226543|NCT00749190|4024260|P2|Overall Study|Other reason not defined above|0
1226544|NCT00749190|4024261|P1|Overall Study|Other reason not defined above|0
1226545|NCT00749190|4024255|P7|Overall Study|Protocol Violation|1
1226546|NCT00749190|4024256|P6|Overall Study|Protocol Violation|0
1226547|NCT00749190|4024257|P5|Overall Study|Protocol Violation|0
1226548|NCT00749190|4024258|P4|Overall Study|Protocol Violation|0
1226549|NCT00749190|4024259|P3|Overall Study|Protocol Violation|0
1226550|NCT00749190|4024260|P2|Overall Study|Protocol Violation|1
1226551|NCT00749190|4024261|P1|Overall Study|Protocol Violation|0
1226552|NCT00749190|4024255|P7|Overall Study|Withdrawal by Subject|0
1226553|NCT00749190|4024256|P6|Overall Study|Withdrawal by Subject|1
1226554|NCT00749190|4024257|P5|Overall Study|Withdrawal by Subject|0
1226555|NCT00749190|4024258|P4|Overall Study|Withdrawal by Subject|0
1226556|NCT00749190|4024259|P3|Overall Study|Withdrawal by Subject|0
1226557|NCT00749190|4024260|P2|Overall Study|Withdrawal by Subject|1
1226558|NCT00749190|4024261|P1|Overall Study|Withdrawal by Subject|2
1226559|NCT00749190|4024255|P7|Overall Study|Lack of Efficacy|0
1226560|NCT00749190|4024256|P6|Overall Study|Lack of Efficacy|1
1226561|NCT00749190|4024257|P5|Overall Study|Lack of Efficacy|0
1226562|NCT00749190|4024258|P4|Overall Study|Lack of Efficacy|0
1226563|NCT00749190|4024259|P3|Overall Study|Lack of Efficacy|1
1226564|NCT00749190|4024260|P2|Overall Study|Lack of Efficacy|1
1226565|NCT00749190|4024261|P1|Overall Study|Lack of Efficacy|3
1226566|NCT00749190|4024255|P7|Overall Study|Adverse Event|0
1226567|NCT00749190|4024256|P6|Overall Study|Adverse Event|3
1226568|NCT00749190|4024257|P5|Overall Study|Adverse Event|0
1226569|NCT00749190|4024258|P4|Overall Study|Adverse Event|4
1226570|NCT00749190|4024259|P3|Overall Study|Adverse Event|0
1226571|NCT00749190|4024260|P2|Overall Study|Adverse Event|2
1226572|NCT00749190|4024261|P1|Overall Study|Adverse Event|0
1226573|NCT00748969|4024370|P2|Overall Study|Withdrawal by Subject|1
1226574|NCT00748969|4024371|P1|Overall Study|Withdrawal by Subject|0
1226575|NCT00748969|4024370|P2|Overall Study|Withdrawal by Subject|0
1226576|NCT00748969|4024371|P1|Overall Study|Withdrawal by Subject|1
1226577|NCT00748709|4024421|P1|Overall Study|Other Reasons|1
1226578|NCT00748709|4024421|P1|Overall Study|Withdrawal by Subject|1
1226579|NCT00748709|4024421|P1|Overall Study|Other Adverse Event|1
1226580|NCT00748709|4024421|P1|Overall Study|Drug reducing Toxity|2
1226581|NCT00748709|4024421|P1|Overall Study|Progressive disease|15
1226582|NCT00748566|4024454|P1|Overall Study|Other|9
1226583|NCT00748566|4024454|P1|Overall Study|Study terminated by sponsor|5
1226584|NCT00748566|4024454|P1|Overall Study|Withdrawal by Subject|22
1226585|NCT00748566|4024454|P1|Overall Study|Protocol Violation|13
1226586|NCT00748566|4024454|P1|Overall Study|Lost to Follow-up|1
1226587|NCT00748566|4024454|P1|Overall Study|Lack of Efficacy|12
1226588|NCT00748566|4024454|P1|Overall Study|Death|1
1226589|NCT00748566|4024454|P1|Overall Study|Adverse Event|49
1226590|NCT00748553|4024484|P2|Overall Study|noncompliance|0
1226591|NCT00748553|4024485|P1|Overall Study|noncompliance|1
1226592|NCT00748553|4024484|P2|Overall Study|disease progression|0
1226593|NCT00748553|4024485|P1|Overall Study|disease progression|2
1226594|NCT00748553|4024484|P2|Overall Study|Adverse Event|1
1226595|NCT00748553|4024485|P1|Overall Study|Adverse Event|0
1226596|NCT00748540|4024492|P1|Overall Study|Physician Decision|1
1226597|NCT00748241|4024518|P1|Overall Study|Death|2
1226598|NCT00748241|4024518|P1|Overall Study|Lost to Follow-up|5
1226599|NCT00748241|4024518|P1|Overall Study|Implant failure|1
1226600|NCT00748189|4024528|P2|Overall Study|Ongoing|162
1226601|NCT00748189|4024529|P1|Overall Study|Ongoing|155
1226602|NCT00748189|4024528|P2|Overall Study|Study terminated by Sponsor|1
1226603|NCT00748189|4024529|P1|Overall Study|Study terminated by Sponsor|0
1226604|NCT00748189|4024528|P2|Overall Study|Lost to Follow-up|4
1226605|NCT00748189|4024529|P1|Overall Study|Lost to Follow-up|2
1226606|NCT00748189|4024528|P2|Overall Study|Physician Decision|4
1226607|NCT00748189|4024529|P1|Overall Study|Physician Decision|13
1226608|NCT00748189|4024528|P2|Overall Study|Withdrawal by Subject|16
1226609|NCT00748189|4024529|P1|Overall Study|Withdrawal by Subject|15
1226610|NCT00748189|4024528|P2|Overall Study|Death|34
1226611|NCT00748189|4024529|P1|Overall Study|Death|40
1226612|NCT00748098|4024583|P2|Second Treatment Intervention Period|Withdrawal by Subject|1
1226613|NCT00748098|4024584|P1|Second Treatment Intervention Period|Withdrawal by Subject|1
1226614|NCT00748098|4024583|P2|Second Treatment Intervention Period|Lost to Follow-up|1
1226615|NCT00748098|4024584|P1|Second Treatment Intervention Period|Lost to Follow-up|1
1226616|NCT00748098|4024583|P2|Second Treatment Intervention Period|Adverse Event|1
1226617|NCT00748098|4024584|P1|Second Treatment Intervention Period|Adverse Event|4
1226618|NCT00748098|4024583|P2|1-Week Washout Period|Withdrawal by Subject|0
1226619|NCT00748098|4024584|P1|1-Week Washout Period|Withdrawal by Subject|2
1226620|NCT00748098|4024583|P2|1-Week Washout Period|Adverse Event|1
1226621|NCT00748098|4024584|P1|1-Week Washout Period|Adverse Event|0
1226622|NCT00748098|4024583|P2|First Taper Period|Protocol Stopping Criteria Met|1
1226623|NCT00748098|4024584|P1|First Taper Period|Protocol Stopping Criteria Met|0
1226624|NCT00748098|4024583|P2|First Taper Period|Withdrawal by Subject|0
1226625|NCT00748098|4024584|P1|First Taper Period|Withdrawal by Subject|2
1226626|NCT00748098|4024583|P2|First Taper Period|Protocol Violation|0
1226627|NCT00748098|4024584|P1|First Taper Period|Protocol Violation|1
1226628|NCT00748098|4024583|P2|First Treatment Intervention Period|Withdrawal by Subject|0
1226629|NCT00748098|4024584|P1|First Treatment Intervention Period|Withdrawal by Subject|2
1226630|NCT00748098|4024583|P2|First Treatment Intervention Period|Lost to Follow-up|0
1226631|NCT00748098|4024584|P1|First Treatment Intervention Period|Lost to Follow-up|1
1226632|NCT00748098|4024583|P2|First Treatment Intervention Period|Protocol Violation|0
1226633|NCT00748098|4024584|P1|First Treatment Intervention Period|Protocol Violation|1
1226634|NCT00748098|4024583|P2|First Treatment Intervention Period|Adverse Event|1
1226635|NCT00748098|4024584|P1|First Treatment Intervention Period|Adverse Event|1
1226636|NCT00747812|4024665|P2|Overall Study|Research Site Staff Relocation|3
1226637|NCT00747812|4024666|P1|Overall Study|Research Site Staff Relocation|5
1226638|NCT00747643|4024704|P2|Overall Study|Withdrawal by Subject|27
1226639|NCT00747643|4024705|P1|Overall Study|Withdrawal by Subject|36
1226640|NCT00747617|4024719|P2|Overall Study|Lost to Follow-up|1
1226641|NCT00747617|4024720|P1|Overall Study|Lost to Follow-up|3
1226642|NCT00747565|4024730|P2|Overall Study|Lost to Follow-up|1
1226643|NCT00747565|4024731|P1|Overall Study|Lost to Follow-up|4
1226644|NCT00747565|4024730|P2|Overall Study|Withdrawal by Subject|6
1226645|NCT00747565|4024731|P1|Overall Study|Withdrawal by Subject|10
1226646|NCT00747474|4024744|P12|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
1226647|NCT00747474|4024745|P11|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
1226648|NCT00747474|4024746|P10|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
1226649|NCT00747474|4024747|P9|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
1226650|NCT00747474|4024748|P8|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1
1226651|NCT00747474|4024749|P7|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
1226652|NCT00747474|4024750|P6|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
1226653|NCT00747474|4024751|P5|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
1226654|NCT00747474|4024752|P4|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
1226655|NCT00747474|4024753|P3|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
1226656|NCT00747474|4024754|P2|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
1226657|NCT00747474|4024755|P1|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
1226658|NCT00747461|4024781|P1|Overall Study|study terminated by sponsor|5
1226659|NCT00747435|4024786|P1|Overall Study|Still undergoing follow up|1
1226660|NCT00747435|4024786|P1|Overall Study|Withdrawal by Subject|3
1226661|NCT00747435|4024786|P1|Overall Study|Lost to Follow-up|2
1226662|NCT00747344|4024796|P4|After Controlled Period|Adverse Event|1
1226663|NCT00747344|4024797|P3|After Controlled Period|Adverse Event|0
1226664|NCT00747344|4024798|P2|After Controlled Period|Adverse Event|0
1226665|NCT00747344|4024799|P1|After Controlled Period|Adverse Event|0
1226666|NCT00747344|4024796|P4|Controlled Period|Other|0
1226667|NCT00747344|4024797|P3|Controlled Period|Other|0
1226668|NCT00747344|4024798|P2|Controlled Period|Other|3
1226669|NCT00747344|4024799|P1|Controlled Period|Other|0
1226670|NCT00747344|4024796|P4|Controlled Period|Lack of Efficacy|0
1226671|NCT00747344|4024797|P3|Controlled Period|Lack of Efficacy|0
1226672|NCT00747344|4024798|P2|Controlled Period|Lack of Efficacy|1
1226673|NCT00747344|4024799|P1|Controlled Period|Lack of Efficacy|2
1226674|NCT00747344|4024796|P4|Controlled Period|Adverse Event|0
1226675|NCT00747344|4024797|P3|Controlled Period|Adverse Event|0
1226676|NCT00747344|4024798|P2|Controlled Period|Adverse Event|0
1226677|NCT00747344|4024799|P1|Controlled Period|Adverse Event|3
1226678|NCT00747227|4024813|P2|Overall Study|Illness|1
1226679|NCT00747227|4024814|P1|Overall Study|Illness|1
1226680|NCT00747227|4024813|P2|Overall Study|Lost to Follow-up|2
1226681|NCT00747227|4024814|P1|Overall Study|Lost to Follow-up|1
1226682|NCT00747227|4024813|P2|Overall Study|Withdrawal by Subject|0
1226683|NCT00747227|4024814|P1|Overall Study|Withdrawal by Subject|1
1226684|NCT00747227|4024813|P2|Overall Study|Death|1
1226685|NCT00747227|4024814|P1|Overall Study|Death|3
1226686|NCT00747149|4024843|P2|Overall Study|Not reported|4
1226687|NCT00747149|4024844|P1|Overall Study|Not reported|1
1226688|NCT00747149|4024843|P2|Overall Study|Severe non-compliance to protocol|1
1226689|NCT00747149|4024844|P1|Overall Study|Severe non-compliance to protocol|0
1226690|NCT00747149|4024843|P2|Overall Study|Incorrect enrollment|6
1226691|NCT00747149|4024844|P1|Overall Study|Incorrect enrollment|0
1226692|NCT00747149|4024843|P2|Overall Study|Did not receive treatment|1
1226693|NCT00747149|4024844|P1|Overall Study|Did not receive treatment|0
1226694|NCT00747149|4024843|P2|Overall Study|Withdrawal by Subject|6
1226695|NCT00747149|4024844|P1|Overall Study|Withdrawal by Subject|0
1226696|NCT00747149|4024843|P2|Overall Study|Lost to Follow-up|10
1226697|NCT00747149|4024844|P1|Overall Study|Lost to Follow-up|0
1226698|NCT00747149|4024843|P2|Overall Study|Adverse Event|15
1226699|NCT00747149|4024844|P1|Overall Study|Adverse Event|0
1226700|NCT00747006|4024859|P3|Overall Study|Physician Decision|1
1226701|NCT00747006|4024860|P2|Overall Study|Physician Decision|0
1226702|NCT00747006|4024861|P1|Overall Study|Physician Decision|2
1226703|NCT00747006|4024859|P3|Overall Study|Lost to Follow-up|0
1226704|NCT00747006|4024860|P2|Overall Study|Lost to Follow-up|1
1226705|NCT00747006|4024861|P1|Overall Study|Lost to Follow-up|0
1226706|NCT00747006|4024859|P3|Overall Study|Adverse Event|0
1226707|NCT00747006|4024860|P2|Overall Study|Adverse Event|0
1226708|NCT00747006|4024861|P1|Overall Study|Adverse Event|1
1226709|NCT00746941|4024939|P4|Overall Study|Adverse Event|1
1226710|NCT00746941|4024940|P3|Overall Study|Adverse Event|0
1226711|NCT00746941|4024941|P2|Overall Study|Adverse Event|0
1226712|NCT00746941|4024942|P1|Overall Study|Adverse Event|0
1226713|NCT00746941|4024939|P4|Overall Study|Other, reason not provided|4
1226714|NCT00746941|4024940|P3|Overall Study|Other, reason not provided|0
1226715|NCT00746941|4024941|P2|Overall Study|Other, reason not provided|4
1226716|NCT00746941|4024942|P1|Overall Study|Other, reason not provided|2
1226717|NCT00746941|4024939|P4|Overall Study|Withdrawal by Subject|2
1226718|NCT00746941|4024940|P3|Overall Study|Withdrawal by Subject|0
1226719|NCT00746941|4024941|P2|Overall Study|Withdrawal by Subject|0
1226720|NCT00746941|4024942|P1|Overall Study|Withdrawal by Subject|3
1226721|NCT00746941|4024939|P4|Overall Study|Physician Decision|0
1226722|NCT00746941|4024940|P3|Overall Study|Physician Decision|2
1226723|NCT00746941|4024941|P2|Overall Study|Physician Decision|0
1226724|NCT00746941|4024942|P1|Overall Study|Physician Decision|0
1226725|NCT00746941|4024939|P4|Overall Study|Death|6
1226726|NCT00746941|4024940|P3|Overall Study|Death|0
1226727|NCT00746941|4024941|P2|Overall Study|Death|0
1226728|NCT00746941|4024942|P1|Overall Study|Death|2
1226729|NCT00746798|4025000|P4|Overall Study|Participant unable to return for visit|0
1226730|NCT00746798|4025001|P3|Overall Study|Participant unable to return for visit|0
1226731|NCT00746798|4025002|P2|Overall Study|Participant unable to return for visit|0
1226732|NCT00746798|4025003|P1|Overall Study|Participant unable to return for visit|1
1226733|NCT00746798|4025000|P4|Overall Study|Death|0
1226734|NCT00746798|4025001|P3|Overall Study|Death|2
1226735|NCT00746798|4025002|P2|Overall Study|Death|0
1226736|NCT00746798|4025003|P1|Overall Study|Death|0
1226737|NCT00746798|4025000|P4|Overall Study|Withdrawal by Subject|0
1226738|NCT00746798|4025001|P3|Overall Study|Withdrawal by Subject|1
1226739|NCT00746798|4025002|P2|Overall Study|Withdrawal by Subject|1
1226740|NCT00746798|4025003|P1|Overall Study|Withdrawal by Subject|0
1226741|NCT00746798|4025000|P4|Overall Study|Protocol Violation|0
1226742|NCT00746798|4025001|P3|Overall Study|Protocol Violation|0
1226743|NCT00746798|4025002|P2|Overall Study|Protocol Violation|1
1226744|NCT00746798|4025003|P1|Overall Study|Protocol Violation|0
1226745|NCT00746785|4025028|P3|Overall Study|Lost to Follow-up|27
1226746|NCT00746785|4025029|P2|Overall Study|Lost to Follow-up|25
1226747|NCT00746785|4025030|P1|Overall Study|Lost to Follow-up|29
1226748|NCT00746733|4025038|P2|Third Intervention|Withdrawal by Subject|1
1226749|NCT00746733|4025039|P1|Third Intervention|Withdrawal by Subject|1
1226750|NCT00746733|4025038|P2|Second Intervention|Adverse Event|0
1226751|NCT00746733|4025039|P1|Second Intervention|Adverse Event|1
1226752|NCT00746590|4025123|P1|Overall Study|Death|1
1226753|NCT00746564|4025127|P1|Overall Study|Required Pacemaker/ICD Implant|2
1226754|NCT00746551|4025142|P2|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8
1226755|NCT00746551|4025143|P1|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6
1226756|NCT00746551|4025142|P2|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7
1226757|NCT00746551|4025143|P1|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9
1226758|NCT00746551|4025142|P2|At Gestational Age of 36 Weeks|Lost to Follow-up|4
1226759|NCT00746551|4025143|P1|At Gestational Age of 36 Weeks|Lost to Follow-up|2
1226760|NCT00746356|4025194|P2|Overall Study|Patient relocated|0
1226761|NCT00746356|4025195|P1|Overall Study|Patient relocated|1
1226762|NCT00746356|4025194|P2|Overall Study|Removal of Device|1
1226763|NCT00746356|4025195|P1|Overall Study|Removal of Device|0
1226764|NCT00746356|4025194|P2|Overall Study|Lost to Follow-up|0
1226765|NCT00746356|4025195|P1|Overall Study|Lost to Follow-up|1
1226766|NCT00746356|4025194|P2|Overall Study|Death|3
1226767|NCT00746356|4025195|P1|Overall Study|Death|7
1226768|NCT00746356|4025194|P2|Overall Study|Withdrawal by Subject|3
1226769|NCT00746356|4025195|P1|Overall Study|Withdrawal by Subject|2
1226770|NCT00746330|4025207|P4|Period 1|Abnormal test procedure result|0
1226771|NCT00746330|4025208|P3|Period 1|Abnormal test procedure result|1
1226772|NCT00746330|4025209|P2|Period 1|Abnormal test procedure result|0
1226773|NCT00746330|4025210|P1|Period 1|Abnormal test procedure result|0
1226774|NCT00746252|4025240|P2|Overall Study|weight gain >7.5 %|2
1226775|NCT00746252|4025241|P1|Overall Study|weight gain >7.5 %|1
1226776|NCT00746096|4025263|P2|Overall Study|No study drug treatment|1
1226777|NCT00746096|4025264|P1|Overall Study|No study drug treatment|1
1226778|NCT00746096|4025263|P2|Overall Study|Protocol Violation|0
1226779|NCT00746096|4025264|P1|Overall Study|Protocol Violation|1
1226780|NCT00746096|4025263|P2|Overall Study|Lost to Follow-up|1
1226781|NCT00746096|4025264|P1|Overall Study|Lost to Follow-up|2
1226782|NCT00746096|4025263|P2|Overall Study|Withdrawal by Subject|1
1226783|NCT00746096|4025264|P1|Overall Study|Withdrawal by Subject|5
1226784|NCT00746096|4025263|P2|Overall Study|Adverse Event|0
1226785|NCT00746096|4025264|P1|Overall Study|Adverse Event|1
1226786|NCT00745901|4025295|P2|Overall Study|Patient didn't take any study medication|3
1226787|NCT00745901|4025296|P1|Overall Study|Patient didn't take any study medication|7
1226788|NCT00745901|4025295|P2|Overall Study|Chlamydia test at Visit 1 was positive|1
1226789|NCT00745901|4025296|P1|Overall Study|Chlamydia test at Visit 1 was positive|1
1226790|NCT00745901|4025295|P2|Overall Study|Results of Pap smear at Vis 1 malignant|2
1226791|NCT00745901|4025296|P1|Overall Study|Results of Pap smear at Vis 1 malignant|0
1226792|NCT00745901|4025295|P2|Overall Study|Patient's next menses did not start with|0
1226793|NCT00745901|4025296|P1|Overall Study|Patient's next menses did not start with|1
1226794|NCT00745901|4025295|P2|Overall Study|Lack of compliance|2
1226795|NCT00745901|4025296|P1|Overall Study|Lack of compliance|2
1226796|NCT00745901|4025295|P2|Overall Study|Pregnancy|4
1226797|NCT00745901|4025296|P1|Overall Study|Pregnancy|2
1226798|NCT00745901|4025295|P2|Overall Study|Lost to Follow-up|4
1226799|NCT00745901|4025296|P1|Overall Study|Lost to Follow-up|7
1226800|NCT00745901|4025295|P2|Overall Study|Withdrawal by Subject|0
1226801|NCT00745901|4025296|P1|Overall Study|Withdrawal by Subject|1
1226802|NCT00745901|4025295|P2|Overall Study|Protocol Violation|1
1226803|NCT00745901|4025296|P1|Overall Study|Protocol Violation|0
1226804|NCT00745901|4025295|P2|Overall Study|Adverse Event|4
1226805|NCT00745901|4025296|P1|Overall Study|Adverse Event|3
1226806|NCT00745875|4025342|P2|Overall Study|Continuing study treatment|4
1226807|NCT00745875|4025343|P1|Overall Study|Continuing study treatment|4
1226808|NCT00745823|4025353|P2|Overall Study|Study Terminated by Sponsor|349
1226809|NCT00745823|4025354|P1|Overall Study|Study Terminated by Sponsor|326
1226810|NCT00745823|4025353|P2|Overall Study|Withdrawal by Subject|8
1226811|NCT00745823|4025354|P1|Overall Study|Withdrawal by Subject|14
1226812|NCT00745823|4025353|P2|Overall Study|Pregnancy|4
1226813|NCT00745823|4025354|P1|Overall Study|Pregnancy|0
1226814|NCT00745823|4025353|P2|Overall Study|Physician Decision|5
1226815|NCT00745823|4025354|P1|Overall Study|Physician Decision|10
1226816|NCT00745823|4025353|P2|Overall Study|Lost to Follow-up|11
1226817|NCT00745823|4025354|P1|Overall Study|Lost to Follow-up|10
1226818|NCT00745823|4025353|P2|Overall Study|Lack of Efficacy|6
1226819|NCT00745823|4025354|P1|Overall Study|Lack of Efficacy|20
1226820|NCT00745823|4025353|P2|Overall Study|Adverse Event|3
1226821|NCT00745823|4025354|P1|Overall Study|Adverse Event|5
1226822|NCT00745498|4025381|P3|Overall Study|Edophthalmitis after preoperative IVB|0
1226823|NCT00745498|4025382|P2|Overall Study|Edophthalmitis after preoperative IVB|0
1226824|NCT00745498|4025383|P1|Overall Study|Edophthalmitis after preoperative IVB|1
1226825|NCT00745498|4025381|P3|Overall Study|Non-PDR related VH|1
1226826|NCT00745498|4025382|P2|Overall Study|Non-PDR related VH|1
1226827|NCT00745498|4025383|P1|Overall Study|Non-PDR related VH|0
1226828|NCT00745498|4025381|P3|Overall Study|Injection of intravitreal silicone oil o|4
1226829|NCT00745498|4025382|P2|Overall Study|Injection of intravitreal silicone oil o|4
1226830|NCT00745498|4025383|P1|Overall Study|Injection of intravitreal silicone oil o|3
1226831|NCT00745498|4025381|P3|Overall Study|Lost to Follow-up|3
1226832|NCT00745498|4025382|P2|Overall Study|Lost to Follow-up|1
1226833|NCT00745498|4025383|P1|Overall Study|Lost to Follow-up|1
1226834|NCT00745420|4025397|P1|Overall Study|Ineligible|1
1226835|NCT00745368|4025414|P1|Overall Study|Unable to provide sample|3
1226836|NCT00745251|4025436|P2|Overall Study|Withdrawal by Subject|1
1226837|NCT00745251|4025437|P1|Overall Study|Withdrawal by Subject|1
1226838|NCT00745251|4025436|P2|Overall Study|Adverse Event|2
1226839|NCT00745251|4025437|P1|Overall Study|Adverse Event|1
1226840|NCT00745095|4025451|P6|Overall Study|Ineligible due to GFR criteria|28
1226841|NCT00745095|4025452|P5|Overall Study|Ineligible due to GFR criteria|30
1226842|NCT00745095|4025453|P4|Overall Study|Ineligible due to GFR criteria|3
1226843|NCT00745095|4025454|P3|Overall Study|Ineligible due to GFR criteria|3
1226844|NCT00745095|4025455|P2|Overall Study|Ineligible due to GFR criteria|2
1226845|NCT00745095|4025456|P1|Overall Study|Ineligible due to GFR criteria|0
1226846|NCT00745095|4025451|P6|Overall Study|Declined to participate|95
1226847|NCT00745095|4025452|P5|Overall Study|Declined to participate|92
1226848|NCT00745095|4025453|P4|Overall Study|Declined to participate|0
1226849|NCT00745095|4025454|P3|Overall Study|Declined to participate|0
1226850|NCT00745095|4025455|P2|Overall Study|Declined to participate|0
1226851|NCT00745095|4025456|P1|Overall Study|Declined to participate|1
1226852|NCT00744978|4025487|P2|Period 2|Adverse Event|1
1226853|NCT00744978|4025488|P1|Period 2|Adverse Event|0
1226854|NCT00744978|4025487|P2|Period 1|Randomized but not Treated|1
1226855|NCT00744978|4025488|P1|Period 1|Randomized but not Treated|1
1226856|NCT00744978|4025487|P2|Period 1|Adverse Event|0
1226857|NCT00744978|4025488|P1|Period 1|Adverse Event|4
1226858|NCT00744978|4025487|P2|Period 1|Other|2
1226859|NCT00744978|4025488|P1|Period 1|Other|0
1226860|NCT00744978|4025487|P2|Period 1|Withdrawal by Subject|2
1226861|NCT00744978|4025488|P1|Period 1|Withdrawal by Subject|0
1226862|NCT00744978|4025487|P2|Period 1|Lost to Follow-up|0
1226863|NCT00744978|4025488|P1|Period 1|Lost to Follow-up|1
1226864|NCT00744939|4025540|P1|Overall Study|incorrect race|1
1226865|NCT00744939|4025540|P1|Overall Study|coma|1
1226866|NCT00744939|4025540|P1|Overall Study|Failed inclusion/exclusion criteria|19
1226867|NCT00744939|4025540|P1|Overall Study|Did not receive Magnevist|7
1226868|NCT00744939|4025540|P1|Overall Study|Medical history exclusionary|1
1226869|NCT00744939|4025540|P1|Overall Study|Lost to Follow-up|12
1226870|NCT00744939|4025540|P1|Overall Study|distance|4
1226871|NCT00744939|4025540|P1|Overall Study|Death|24
1226872|NCT00744939|4025540|P1|Overall Study|Protocol Violation|13
1226873|NCT00744939|4025540|P1|Overall Study|Withdrawal by Subject|9
1226874|NCT00744874|4025576|P1|Overall Study|Unable to accomodate schedule|1
1226875|NCT00744874|4025576|P1|Overall Study|Study Device not available at procedure|1
1226876|NCT00744874|4025576|P1|Overall Study|Withdrawal by Subject|1
1226877|NCT00744874|4025576|P1|Overall Study|Lost to Follow-up|1
1226878|NCT00744757|4025601|P1|Overall Study|Adverse Event|2
1226879|NCT00744757|4025601|P1|Overall Study|Death|6
1226880|NCT00744757|4025601|P1|Overall Study|Withdrawal by Subject|1
1226881|NCT00744757|4025601|P1|Overall Study|Physician Decision|5
1226882|NCT00744757|4025601|P1|Overall Study|Objective disease progression|7
1226883|NCT00744653|4025626|P1|Overall Study|Physician Decision|3
1226884|NCT00744653|4025626|P1|Overall Study|Lost to Follow-up|1
1226885|NCT00744653|4025626|P1|Overall Study|Death|1
1226886|NCT00744653|4025626|P1|Overall Study|antineoplastic treatment|11
1226887|NCT00744627|4025634|P2|Overall Study|Other|0
1226888|NCT00744627|4025635|P1|Overall Study|Other|1
1226889|NCT00744627|4025634|P2|Overall Study|Lost to Follow-up|1
1226890|NCT00744627|4025635|P1|Overall Study|Lost to Follow-up|2
1226891|NCT00744627|4025634|P2|Overall Study|Voluntary Withdrawal|6
1226892|NCT00744627|4025635|P1|Overall Study|Voluntary Withdrawal|9
1226893|NCT00744627|4025634|P2|Overall Study|Protocol Deviations|2
1226894|NCT00744627|4025635|P1|Overall Study|Protocol Deviations|0
1226895|NCT00744627|4025634|P2|Overall Study|Noncompliance|1
1226896|NCT00744627|4025635|P1|Overall Study|Noncompliance|0
1226897|NCT00744627|4025634|P2|Overall Study|Lack of Efficacy|3
1226898|NCT00744627|4025635|P1|Overall Study|Lack of Efficacy|7
1226899|NCT00744627|4025634|P2|Overall Study|Adverse Event|9
1226900|NCT00744627|4025635|P1|Overall Study|Adverse Event|6
1226901|NCT00744523|4025691|P2|30 Days After the Procedure|Insufficient follow-up|5
1226902|NCT00744523|4025692|P1|30 Days After the Procedure|Insufficient follow-up|0
1226903|NCT00744497|4025712|P2|Overall Study|Not defined|13
1226904|NCT00744497|4025713|P1|Overall Study|Not defined|19
1226905|NCT00744497|4025712|P2|Overall Study|Maximum clinical benefit|142
1226906|NCT00744497|4025713|P1|Overall Study|Maximum clinical benefit|141
1226907|NCT00744497|4025712|P2|Overall Study|Patient requested to stop study drug|80
1226908|NCT00744497|4025713|P1|Overall Study|Patient requested to stop study drug|65
1226909|NCT00744497|4025712|P2|Overall Study|Adverse event unrelated to study drug|122
1226910|NCT00744497|4025713|P1|Overall Study|Adverse event unrelated to study drug|78
1226911|NCT00744497|4025712|P2|Overall Study|Study drug toxicity|141
1226912|NCT00744497|4025713|P1|Overall Study|Study drug toxicity|68
1226913|NCT00744497|4025712|P2|Overall Study|Disease progression|219
1226914|NCT00744497|4025713|P1|Overall Study|Disease progression|312
1226915|NCT00744497|4025712|P2|Overall Study|Administrative Reason By Sponsor|8
1226916|NCT00744497|4025713|P1|Overall Study|Administrative Reason By Sponsor|25
1226917|NCT00744497|4025712|P2|Overall Study|No longer meets study criteria|3
1226918|NCT00744497|4025713|P1|Overall Study|No longer meets study criteria|7
1226919|NCT00744497|4025712|P2|Overall Study|Poor compliance/noncompliance|5
1226920|NCT00744497|4025713|P1|Overall Study|Poor compliance/noncompliance|9
1226921|NCT00744497|4025712|P2|Overall Study|Lost to Follow-up|2
1226922|NCT00744497|4025713|P1|Overall Study|Lost to Follow-up|4
1226923|NCT00744497|4025712|P2|Overall Study|Death|9
1226924|NCT00744497|4025713|P1|Overall Study|Death|11
1226925|NCT00744497|4025712|P2|Overall Study|Withdrawal by Subject|18
1226926|NCT00744497|4025713|P1|Overall Study|Withdrawal by Subject|21
1226927|NCT00744328|4025773|P3|Overall Study|Found ineligible after randomization|1
1226928|NCT00744328|4025774|P2|Overall Study|Found ineligible after randomization|0
1226929|NCT00744328|4025775|P1|Overall Study|Found ineligible after randomization|0
1226930|NCT00744328|4025773|P3|Overall Study|Withdrawal by Subject|4
1226931|NCT00744328|4025774|P2|Overall Study|Withdrawal by Subject|3
1226932|NCT00744328|4025775|P1|Overall Study|Withdrawal by Subject|5
1226933|NCT00744328|4025773|P3|Overall Study|Lost to Follow-up|3
1226934|NCT00744328|4025774|P2|Overall Study|Lost to Follow-up|5
1226935|NCT00744328|4025775|P1|Overall Study|Lost to Follow-up|2
1226936|NCT00744263|4025785|P2|Overall Study|Other|2
1226937|NCT00744263|4025786|P1|Overall Study|Other|2
1226938|NCT00744263|4025785|P2|Overall Study|Adverse Event|0
1226939|NCT00744263|4025786|P1|Overall Study|Adverse Event|1
1226940|NCT00744263|4025785|P2|Overall Study|Protocol Violation|5
1226941|NCT00744263|4025786|P1|Overall Study|Protocol Violation|3
1226942|NCT00744263|4025785|P2|Overall Study|Physician Decision|23
1226943|NCT00744263|4025786|P1|Overall Study|Physician Decision|20
1226944|NCT00744263|4025785|P2|Overall Study|Withdrawal by Subject|150
1226945|NCT00744263|4025786|P1|Overall Study|Withdrawal by Subject|166
1226946|NCT00744263|4025785|P2|Overall Study|Lost to Follow-up|2135
1226947|NCT00744263|4025786|P1|Overall Study|Lost to Follow-up|2038
1226948|NCT00744263|4025785|P2|Overall Study|Death|3005
1226949|NCT00744263|4025786|P1|Overall Study|Death|3006
1226950|NCT00744237|4025809|P3|Overall Study|Adverse Event|5
1226951|NCT00744237|4025810|P2|Overall Study|Adverse Event|13
1226952|NCT00744237|4025811|P1|Overall Study|Adverse Event|9
1226953|NCT00744237|4025809|P3|Overall Study|Administrative. Site Closed|1
1226954|NCT00744237|4025810|P2|Overall Study|Administrative. Site Closed|1
1226955|NCT00744237|4025811|P1|Overall Study|Administrative. Site Closed|1
1226956|NCT00744237|4025809|P3|Overall Study|Poor Compliance|0
1226957|NCT00744237|4025810|P2|Overall Study|Poor Compliance|2
1226958|NCT00744237|4025811|P1|Overall Study|Poor Compliance|0
1226959|NCT00744237|4025809|P3|Overall Study|Prohibited Concomitant Medication|1
1226960|NCT00744237|4025810|P2|Overall Study|Prohibited Concomitant Medication|0
1226961|NCT00744237|4025811|P1|Overall Study|Prohibited Concomitant Medication|0
1226962|NCT00744237|4025809|P3|Overall Study|Study Drug Error|0
1226963|NCT00744237|4025810|P2|Overall Study|Study Drug Error|0
1226964|NCT00744237|4025811|P1|Overall Study|Study Drug Error|1
1226965|NCT00744237|4025809|P3|Overall Study|Dosing Error|1
1226966|NCT00744237|4025810|P2|Overall Study|Dosing Error|0
1226967|NCT00744237|4025811|P1|Overall Study|Dosing Error|1
1226968|NCT00744237|4025809|P3|Overall Study|Inclusion/Exclusion criteria not met|0
1226969|NCT00744237|4025810|P2|Overall Study|Inclusion/Exclusion criteria not met|0
1226970|NCT00744237|4025811|P1|Overall Study|Inclusion/Exclusion criteria not met|1
1226971|NCT00744237|4025809|P3|Overall Study|Protocol Violation|3
1226972|NCT00744237|4025810|P2|Overall Study|Protocol Violation|4
1226973|NCT00744237|4025811|P1|Overall Study|Protocol Violation|3
1226974|NCT00744237|4025809|P3|Overall Study|Lost to Follow-up|1
1226975|NCT00744237|4025810|P2|Overall Study|Lost to Follow-up|1
1226976|NCT00744237|4025811|P1|Overall Study|Lost to Follow-up|1
1226977|NCT00744237|4025809|P3|Overall Study|Withdrawal by Subject|3
1226978|NCT00744237|4025810|P2|Overall Study|Withdrawal by Subject|5
1226979|NCT00744237|4025811|P1|Overall Study|Withdrawal by Subject|9
1226980|NCT00744237|4025809|P3|Overall Study|Lack of Efficacy|0
1226981|NCT00744237|4025810|P2|Overall Study|Lack of Efficacy|1
1226982|NCT00744237|4025811|P1|Overall Study|Lack of Efficacy|1
1226983|NCT00744055|4025845|P2|Overall Study|Lost to Follow-up|1
1226984|NCT00744055|4025846|P1|Overall Study|Lost to Follow-up|0
1226985|NCT00744055|4025845|P2|Overall Study|Protocol Violation|1
1226986|NCT00744055|4025846|P1|Overall Study|Protocol Violation|1
1226987|NCT00744055|4025845|P2|Overall Study|Physician Decision|2
1226988|NCT00744055|4025846|P1|Overall Study|Physician Decision|0
1226989|NCT00744055|4025845|P2|Overall Study|Lack of Efficacy|1
1226990|NCT00744055|4025846|P1|Overall Study|Lack of Efficacy|0
1226991|NCT00744055|4025845|P2|Overall Study|Withdrawal by Subject|9
1226992|NCT00744055|4025846|P1|Overall Study|Withdrawal by Subject|6
1226993|NCT00744042|4025854|P1|Overall Study|Withdrawal by Subject|1
1226994|NCT00743652|4025900|P5|Overall Study|Lost to Follow-up|0
1226995|NCT00743652|4025901|P4|Overall Study|Lost to Follow-up|0
1226996|NCT00743652|4025902|P3|Overall Study|Lost to Follow-up|0
1226997|NCT00743652|4025903|P2|Overall Study|Lost to Follow-up|0
1226998|NCT00743652|4025904|P1|Overall Study|Lost to Follow-up|1
1226999|NCT00743652|4025900|P5|Overall Study|Other|0
1227000|NCT00743652|4025901|P4|Overall Study|Other|0
1227001|NCT00743652|4025902|P3|Overall Study|Other|0
1227002|NCT00743652|4025903|P2|Overall Study|Other|1
1227003|NCT00743652|4025904|P1|Overall Study|Other|1
1227004|NCT00743652|4025900|P5|Overall Study|Investigator Request|0
1227005|NCT00743652|4025901|P4|Overall Study|Investigator Request|2
1227006|NCT00743652|4025902|P3|Overall Study|Investigator Request|0
1227007|NCT00743652|4025903|P2|Overall Study|Investigator Request|0
1227008|NCT00743652|4025904|P1|Overall Study|Investigator Request|0
1227009|NCT00743652|4025900|P5|Overall Study|Death|0
1227010|NCT00743652|4025901|P4|Overall Study|Death|0
1227011|NCT00743652|4025902|P3|Overall Study|Death|0
1227012|NCT00743652|4025903|P2|Overall Study|Death|0
1227013|NCT00743652|4025904|P1|Overall Study|Death|2
1227014|NCT00743652|4025900|P5|Overall Study|Adverse Event|0
1227015|NCT00743652|4025901|P4|Overall Study|Adverse Event|0
1227016|NCT00743652|4025902|P3|Overall Study|Adverse Event|0
1227017|NCT00743652|4025903|P2|Overall Study|Adverse Event|0
1227018|NCT00743652|4025904|P1|Overall Study|Adverse Event|3
1227019|NCT00743652|4025900|P5|Overall Study|Parent/Legal Guardian Request|0
1227020|NCT00743652|4025901|P4|Overall Study|Parent/Legal Guardian Request|2
1227021|NCT00743652|4025902|P3|Overall Study|Parent/Legal Guardian Request|2
1227022|NCT00743652|4025903|P2|Overall Study|Parent/Legal Guardian Request|2
1227023|NCT00743652|4025904|P1|Overall Study|Parent/Legal Guardian Request|3
1227024|NCT00743509|4025988|P1|Overall Study|Withdrawal by Subject|2
1227025|NCT00743483|4025993|P1|Treatment Period|Adverse Event|1
1227026|NCT00743483|4025993|P1|Baseline Period|Physician Decision|1
1227027|NCT00743444|4025997|P2|Washout Period|Adverse Event|1
1227028|NCT00743444|4025998|P1|Washout Period|Adverse Event|0
1227029|NCT00743444|4025997|P2|First Intervention|Catheter placement problems|1
1227030|NCT00743444|4025998|P1|First Intervention|Catheter placement problems|0
1227031|NCT00743431|4026007|P1|Overall Study|No documentation available|13
1227032|NCT00743431|4026007|P1|Overall Study|Reason for discontinuation not specified|29
1227033|NCT00743431|4026007|P1|Overall Study|Death|9
1227034|NCT00743431|4026007|P1|Overall Study|Withdrawal by Subject|13
1227035|NCT00743431|4026007|P1|Overall Study|Tumor progression|56
1227036|NCT00743431|4026007|P1|Overall Study|Toxicity|6
1227037|NCT00743366|4026011|P2|Intervention 1 (8 Days)|Withdrawal by Subject|3
1227038|NCT00743366|4026012|P1|Intervention 1 (8 Days)|Withdrawal by Subject|3
1227039|NCT00743340|4026018|P1|Overall Study|Participant Relocated|1
1227040|NCT00743340|4026018|P1|Overall Study|Rolled over to other Gilead Study|23
1227041|NCT00743340|4026018|P1|Overall Study|Pregnancy|1
1227042|NCT00743340|4026018|P1|Overall Study|Virologic failure|8
1227043|NCT00743340|4026018|P1|Overall Study|Protocol Violation|1
1227044|NCT00743340|4026018|P1|Overall Study|Withdrawal from the Study|5
1227045|NCT00743340|4026018|P1|Overall Study|Lost to Follow-up|1
1227046|NCT00743340|4026018|P1|Overall Study|Study medication non-compliance|1
1227047|NCT00743288|4026022|P7|Overall Study|Worsening of condition (Not PD)|0
1227048|NCT00743288|4026023|P6|Overall Study|Worsening of condition (Not PD)|0
1227049|NCT00743288|4026024|P5|Overall Study|Worsening of condition (Not PD)|0
1227050|NCT00743288|4026025|P4|Overall Study|Worsening of condition (Not PD)|1
1227051|NCT00743288|4026026|P3|Overall Study|Worsening of condition (Not PD)|1
1227052|NCT00743288|4026027|P2|Overall Study|Worsening of condition (Not PD)|2
1227053|NCT00743288|4026028|P1|Overall Study|Worsening of condition (Not PD)|0
1227054|NCT00743288|4026022|P7|Overall Study|Progressive disease (PD)|6
1227055|NCT00743288|4026023|P6|Overall Study|Progressive disease (PD)|3
1227056|NCT00743288|4026024|P5|Overall Study|Progressive disease (PD)|5
1227057|NCT00743288|4026025|P4|Overall Study|Progressive disease (PD)|4
1227058|NCT00743288|4026026|P3|Overall Study|Progressive disease (PD)|1
1227059|NCT00743288|4026027|P2|Overall Study|Progressive disease (PD)|0
1227060|NCT00743288|4026028|P1|Overall Study|Progressive disease (PD)|2
1227061|NCT00743288|4026022|P7|Overall Study|Withdrawal by Subject|1
1227062|NCT00743288|4026023|P6|Overall Study|Withdrawal by Subject|1
1227063|NCT00743288|4026024|P5|Overall Study|Withdrawal by Subject|0
1227064|NCT00743288|4026025|P4|Overall Study|Withdrawal by Subject|0
1227065|NCT00743288|4026026|P3|Overall Study|Withdrawal by Subject|1
1227066|NCT00743288|4026027|P2|Overall Study|Withdrawal by Subject|0
1227067|NCT00743288|4026028|P1|Overall Study|Withdrawal by Subject|0
1227068|NCT00743288|4026022|P7|Overall Study|Adverse Event|2
1227069|NCT00743288|4026023|P6|Overall Study|Adverse Event|1
1227070|NCT00743288|4026024|P5|Overall Study|Adverse Event|1
1227071|NCT00743288|4026025|P4|Overall Study|Adverse Event|2
1227072|NCT00743288|4026026|P3|Overall Study|Adverse Event|2
1227073|NCT00743288|4026027|P2|Overall Study|Adverse Event|1
1227074|NCT00743288|4026028|P1|Overall Study|Adverse Event|1
1227075|NCT00743275|4026042|P2|Overall Study|Protocol Violation|1
1227076|NCT00743275|4026043|P1|Overall Study|Protocol Violation|0
1227077|NCT00743249|4026063|P2|Overall Study|Unsuccessful insertion of stent|1
1227078|NCT00743249|4026064|P1|Overall Study|Unsuccessful insertion of stent|2
1227079|NCT00743249|4026063|P2|Overall Study|Patient Decision Unrelated to Ad Event|1
1227080|NCT00743249|4026064|P1|Overall Study|Patient Decision Unrelated to Ad Event|0
1227081|NCT00743249|4026063|P2|Overall Study|Adverse Event|4
1227082|NCT00743249|4026064|P1|Overall Study|Adverse Event|0
1227083|NCT00743197|4026074|P2|Overall Study|Study terminated due to departure of PI.|2
1227084|NCT00743197|4026075|P1|Overall Study|Study terminated due to departure of PI.|1
1227085|NCT00743145|4026081|P1|Overall Study|Pregnancy|1
1227086|NCT00743145|4026081|P1|Overall Study|Adverse Event|2
1227087|NCT00743145|4026081|P1|Overall Study|Withdrawal by Subject|1
1227088|NCT00743119|4026095|P1|Overall Study|Withdrawal by Subject|1
1227089|NCT00743119|4026095|P1|Overall Study|unreliable|3
1227090|NCT00743106|4026109|P2|Overall Study|Met intraoperative exclusion criterion|5
1227091|NCT00743106|4026110|P1|Overall Study|Met intraoperative exclusion criterion|8
1227092|NCT00742924|4026137|P4|Overall Study|Withdrawal by Subject|0
1227093|NCT00742924|4026138|P3|Overall Study|Withdrawal by Subject|1
1227094|NCT00742924|4026139|P2|Overall Study|Withdrawal by Subject|1
1227095|NCT00742924|4026140|P1|Overall Study|Withdrawal by Subject|0
1227096|NCT00742924|4026137|P4|Overall Study|Physician Decision|1
1227097|NCT00742924|4026138|P3|Overall Study|Physician Decision|0
1227098|NCT00742924|4026139|P2|Overall Study|Physician Decision|0
1227099|NCT00742924|4026140|P1|Overall Study|Physician Decision|0
1227100|NCT00742924|4026137|P4|Overall Study|Lack of Efficacy|4
1227101|NCT00742924|4026138|P3|Overall Study|Lack of Efficacy|2
1227102|NCT00742924|4026139|P2|Overall Study|Lack of Efficacy|1
1227103|NCT00742924|4026140|P1|Overall Study|Lack of Efficacy|5
1227104|NCT00742924|4026137|P4|Overall Study|Adverse Event|1
1227105|NCT00742924|4026138|P3|Overall Study|Adverse Event|1
1227106|NCT00742924|4026139|P2|Overall Study|Adverse Event|0
1227107|NCT00742924|4026140|P1|Overall Study|Adverse Event|0
1227108|NCT00742885|4026152|P2|Overall Study|Lost to Follow-up|0
1227109|NCT00742885|4026153|P1|Overall Study|Lost to Follow-up|1
1227110|NCT00742859|4026212|P4|Overall Study|Site error|1
1227111|NCT00742859|4026213|P3|Overall Study|Site error|1
1227112|NCT00742859|4026214|P2|Overall Study|Site error|0
1227113|NCT00742859|4026215|P1|Overall Study|Site error|0
1227114|NCT00742859|4026212|P4|Overall Study|Sponsor request patient out of town|1
1227115|NCT00742859|4026213|P3|Overall Study|Sponsor request patient out of town|1
1227116|NCT00742859|4026214|P2|Overall Study|Sponsor request patient out of town|0
1227117|NCT00742859|4026215|P1|Overall Study|Sponsor request patient out of town|0
1227118|NCT00742859|4026212|P4|Overall Study|Sponsor req visit schedule noncompliance|1
1227119|NCT00742859|4026213|P3|Overall Study|Sponsor req visit schedule noncompliance|0
1227120|NCT00742859|4026214|P2|Overall Study|Sponsor req visit schedule noncompliance|0
1227121|NCT00742859|4026215|P1|Overall Study|Sponsor req visit schedule noncompliance|0
1227122|NCT00742859|4026212|P4|Overall Study|Amendment 2 patient off study drug >4wks|0
1227123|NCT00742859|4026213|P3|Overall Study|Amendment 2 patient off study drug >4wks|1
1227124|NCT00742859|4026214|P2|Overall Study|Amendment 2 patient off study drug >4wks|1
1227125|NCT00742859|4026215|P1|Overall Study|Amendment 2 patient off study drug >4wks|0
1227126|NCT00742859|4026212|P4|Overall Study|Endpoint|2
1227127|NCT00742859|4026213|P3|Overall Study|Endpoint|1
1227128|NCT00742859|4026214|P2|Overall Study|Endpoint|1
1227129|NCT00742859|4026215|P1|Overall Study|Endpoint|0
1227130|NCT00742859|4026212|P4|Overall Study|Withdrawal by Subject|1
1227131|NCT00742859|4026213|P3|Overall Study|Withdrawal by Subject|4
1227132|NCT00742859|4026214|P2|Overall Study|Withdrawal by Subject|2
1227133|NCT00742859|4026215|P1|Overall Study|Withdrawal by Subject|4
1227134|NCT00742859|4026212|P4|Overall Study|Physician Decision|0
1227135|NCT00742859|4026213|P3|Overall Study|Physician Decision|0
1227136|NCT00742859|4026214|P2|Overall Study|Physician Decision|2
1227137|NCT00742859|4026215|P1|Overall Study|Physician Decision|1
1227138|NCT00742859|4026212|P4|Overall Study|Death|1
1227139|NCT00742859|4026213|P3|Overall Study|Death|0
1227140|NCT00742859|4026214|P2|Overall Study|Death|0
1227141|NCT00742859|4026215|P1|Overall Study|Death|1
1227142|NCT00742859|4026212|P4|Overall Study|Adverse Event|1
1227143|NCT00742859|4026213|P3|Overall Study|Adverse Event|3
1227144|NCT00742859|4026214|P2|Overall Study|Adverse Event|6
1227145|NCT00742859|4026215|P1|Overall Study|Adverse Event|5
1227146|NCT00742781|4026229|P1|Overall Study|Withdrawal by Subject|3
1227147|NCT00742625|4026238|P1|Consolidation|Non protocol therapy|13
1227148|NCT00742625|4026238|P1|Consolidation|Refused|1
1227149|NCT00742625|4026238|P1|Consolidation|Death|1
1227150|NCT00742625|4026238|P1|Consolidation|Adverse Event|1
1227151|NCT00742625|4026238|P1|Consolidation|Progression|5
1227152|NCT00742625|4026238|P1|Remission Induction|Other, not specified|5
1227153|NCT00742625|4026238|P1|Remission Induction|Non protocol treatment|17
1227154|NCT00742625|4026238|P1|Remission Induction|Refusal|5
1227155|NCT00742625|4026238|P1|Remission Induction|Death|10
1227156|NCT00742625|4026238|P1|Remission Induction|Adverse Event|3
1227157|NCT00742625|4026238|P1|Remission Induction|Failed induction|8
1227158|NCT00742625|4026238|P1|Remission Induction|Progression|6
1227159|NCT00742560|4026252|P5|Overall Study|MIssing|1
1227160|NCT00742560|4026253|P4|Overall Study|MIssing|0
1227161|NCT00742560|4026254|P3|Overall Study|MIssing|0
1227162|NCT00742560|4026255|P2|Overall Study|MIssing|0
1227163|NCT00742560|4026256|P1|Overall Study|MIssing|0
1227164|NCT00742560|4026252|P5|Overall Study|Not Specified|9
1227165|NCT00742560|4026253|P4|Overall Study|Not Specified|9
1227166|NCT00742560|4026254|P3|Overall Study|Not Specified|8
1227167|NCT00742560|4026255|P2|Overall Study|Not Specified|1
1227168|NCT00742560|4026256|P1|Overall Study|Not Specified|0
1227169|NCT00742560|4026252|P5|Overall Study|New Multiple Myeloma Therapy|4
1227170|NCT00742560|4026253|P4|Overall Study|New Multiple Myeloma Therapy|3
1227171|NCT00742560|4026254|P3|Overall Study|New Multiple Myeloma Therapy|2
1227172|NCT00742560|4026255|P2|Overall Study|New Multiple Myeloma Therapy|0
1227173|NCT00742560|4026256|P1|Overall Study|New Multiple Myeloma Therapy|1
1227174|NCT00742560|4026252|P5|Overall Study|Disease Progression|16
1227175|NCT00742560|4026253|P4|Overall Study|Disease Progression|17
1227176|NCT00742560|4026254|P3|Overall Study|Disease Progression|5
1227177|NCT00742560|4026255|P2|Overall Study|Disease Progression|0
1227178|NCT00742560|4026256|P1|Overall Study|Disease Progression|1
1227179|NCT00742560|4026252|P5|Overall Study|Investigator's Decision|0
1227180|NCT00742560|4026253|P4|Overall Study|Investigator's Decision|1
1227181|NCT00742560|4026254|P3|Overall Study|Investigator's Decision|4
1227182|NCT00742560|4026255|P2|Overall Study|Investigator's Decision|0
1227183|NCT00742560|4026256|P1|Overall Study|Investigator's Decision|0
1227184|NCT00742560|4026252|P5|Overall Study|Subject's Decision|3
1227185|NCT00742560|4026253|P4|Overall Study|Subject's Decision|3
1227186|NCT00742560|4026254|P3|Overall Study|Subject's Decision|2
1227187|NCT00742560|4026255|P2|Overall Study|Subject's Decision|0
1227188|NCT00742560|4026256|P1|Overall Study|Subject's Decision|1
1227189|NCT00742560|4026252|P5|Overall Study|Death|3
1227190|NCT00742560|4026253|P4|Overall Study|Death|2
1227191|NCT00742560|4026254|P3|Overall Study|Death|0
1227192|NCT00742560|4026255|P2|Overall Study|Death|2
1227193|NCT00742560|4026256|P1|Overall Study|Death|0
1227194|NCT00742560|4026252|P5|Overall Study|Adverse Event|1
1227195|NCT00742560|4026253|P4|Overall Study|Adverse Event|1
1227196|NCT00742560|4026254|P3|Overall Study|Adverse Event|1
1227197|NCT00742560|4026255|P2|Overall Study|Adverse Event|0
1227198|NCT00742560|4026256|P1|Overall Study|Adverse Event|0
1227199|NCT00742508|4026330|P2|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1
1227200|NCT00742508|4026331|P1|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0
1227201|NCT00742508|4026330|P2|8-Week Primary Evaluation Period|Withdrawal by Subject|2
1227202|NCT00742508|4026331|P1|8-Week Primary Evaluation Period|Withdrawal by Subject|0
1227203|NCT00742508|4026330|P2|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5
1227204|NCT00742508|4026331|P1|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8
1227205|NCT00742508|4026330|P2|8-Week Primary Evaluation Period|Protocol Violation|0
1227206|NCT00742508|4026331|P1|8-Week Primary Evaluation Period|Protocol Violation|1
1227207|NCT00742508|4026330|P2|8-Week Primary Evaluation Period|Adverse Event|4
1227208|NCT00742508|4026331|P1|8-Week Primary Evaluation Period|Adverse Event|2
1227209|NCT00742417|4026395|P2|Intensive Period|Adverse Event|0
1227210|NCT00742417|4026396|P1|Intensive Period|Adverse Event|2
1227211|NCT00742417|4026395|P2|Intensive Period|Withdrawal by Subject|1
1227212|NCT00742417|4026396|P1|Intensive Period|Withdrawal by Subject|1
1227213|NCT00742417|4026395|P2|Randomized|Physician Decision|0
1227214|NCT00742417|4026396|P1|Randomized|Physician Decision|1
1227215|NCT00742417|4026395|P2|Randomized|Withdrawal by Subject|0
1227216|NCT00742417|4026396|P1|Randomized|Withdrawal by Subject|1
1227217|NCT00742417|4026395|P2|Randomized|Withdrawal by legal representative|1
1227218|NCT00742417|4026396|P1|Randomized|Withdrawal by legal representative|0
1227219|NCT00742391|4026420|P2|Overall Study|Protocol Violation|0
1227220|NCT00742391|4026421|P1|Overall Study|Protocol Violation|1
1227221|NCT00742391|4026420|P2|Overall Study|Lost to Follow-up|0
1227222|NCT00742391|4026421|P1|Overall Study|Lost to Follow-up|1
1227223|NCT00742391|4026420|P2|Overall Study|Adverse Event|1
1227224|NCT00742391|4026421|P1|Overall Study|Adverse Event|2
1227225|NCT00742326|4026431|P2|Overall Study|Physician Decision|1
1227226|NCT00742326|4026432|P1|Overall Study|Physician Decision|0
1227227|NCT00742274|4026451|P2|Overall Study|Removed for medical reasons|1
1227228|NCT00742274|4026452|P1|Overall Study|Removed for medical reasons|1
1227229|NCT00742274|4026451|P2|Overall Study|Withdrawal by Subject|2
1227230|NCT00742274|4026452|P1|Overall Study|Withdrawal by Subject|1
1227231|NCT00742274|4026451|P2|Overall Study|Death|0
1227232|NCT00742274|4026452|P1|Overall Study|Death|1
1227233|NCT00742235|4026460|P2|Overall Study|Lost to Follow-up|31
1227234|NCT00742235|4026461|P1|Overall Study|Lost to Follow-up|0
1227235|NCT00742209|4026474|P5|Overall Study|Investigator Discretion|1
1227236|NCT00742209|4026475|P4|Overall Study|Investigator Discretion|1
1227237|NCT00742209|4026476|P3|Overall Study|Investigator Discretion|5
1227238|NCT00742209|4026477|P2|Overall Study|Investigator Discretion|0
1227239|NCT00742209|4026478|P1|Overall Study|Investigator Discretion|0
1227240|NCT00742209|4026474|P5|Overall Study|Lack of Efficacy|1
1227241|NCT00742209|4026475|P4|Overall Study|Lack of Efficacy|3
1227242|NCT00742209|4026476|P3|Overall Study|Lack of Efficacy|1
1227243|NCT00742209|4026477|P2|Overall Study|Lack of Efficacy|1
1227244|NCT00742209|4026478|P1|Overall Study|Lack of Efficacy|6
1227245|NCT00742209|4026474|P5|Overall Study|Lost to Follow-up|3
1227246|NCT00742209|4026475|P4|Overall Study|Lost to Follow-up|5
1227247|NCT00742209|4026476|P3|Overall Study|Lost to Follow-up|5
1227248|NCT00742209|4026477|P2|Overall Study|Lost to Follow-up|4
1227249|NCT00742209|4026478|P1|Overall Study|Lost to Follow-up|3
1227250|NCT00742209|4026474|P5|Overall Study|Protocol Violation|3
1227251|NCT00742209|4026475|P4|Overall Study|Protocol Violation|5
1227252|NCT00742209|4026476|P3|Overall Study|Protocol Violation|4
1227253|NCT00742209|4026477|P2|Overall Study|Protocol Violation|5
1227254|NCT00742209|4026478|P1|Overall Study|Protocol Violation|6
1227255|NCT00742209|4026474|P5|Overall Study|Participant Withdrew Consent|4
1227256|NCT00742209|4026475|P4|Overall Study|Participant Withdrew Consent|7
1227257|NCT00742209|4026476|P3|Overall Study|Participant Withdrew Consent|14
1227258|NCT00742209|4026477|P2|Overall Study|Participant Withdrew Consent|4
1227259|NCT00742209|4026478|P1|Overall Study|Participant Withdrew Consent|8
1227260|NCT00742209|4026474|P5|Overall Study|Adverse Event|13
1227261|NCT00742209|4026475|P4|Overall Study|Adverse Event|16
1227262|NCT00742209|4026476|P3|Overall Study|Adverse Event|17
1227263|NCT00742209|4026477|P2|Overall Study|Adverse Event|4
1227264|NCT00742209|4026478|P1|Overall Study|Adverse Event|11
1227265|NCT00742183|4026581|P2|Overall Study|Lack of Efficacy|3
1227266|NCT00742183|4026582|P1|Overall Study|Lack of Efficacy|0
1227267|NCT00742183|4026581|P2|Overall Study|Withdrawal by Subject|0
1227268|NCT00742183|4026582|P1|Overall Study|Withdrawal by Subject|1
1227269|NCT00742183|4026581|P2|Overall Study|Required skin-graft|1
1227270|NCT00742183|4026582|P1|Overall Study|Required skin-graft|1
1227271|NCT00742183|4026581|P2|Overall Study|Lost to Follow-up|4
1227272|NCT00742183|4026582|P1|Overall Study|Lost to Follow-up|4
1227273|NCT00742183|4026581|P2|Overall Study|Physician Decision|2
1227274|NCT00742183|4026582|P1|Overall Study|Physician Decision|0
1227275|NCT00742183|4026581|P2|Overall Study|Death|0
1227276|NCT00742183|4026582|P1|Overall Study|Death|1
1227277|NCT00742183|4026581|P2|Overall Study|Adverse Event|2
1227278|NCT00742183|4026582|P1|Overall Study|Adverse Event|2
1227279|NCT00742079|4026601|P2|Overall Study|Lost to Follow-up|1
1227280|NCT00742079|4026602|P1|Overall Study|Lost to Follow-up|0
1227281|NCT00741988|4026622|P2|Overall Study|Lack of Efficacy|0
1227282|NCT00741988|4026623|P1|Overall Study|Lack of Efficacy|2
1227283|NCT00741988|4026622|P2|Overall Study|Adverse Event|4
1227284|NCT00741988|4026623|P1|Overall Study|Adverse Event|2
1227285|NCT00741936|4026635|P2|Overall Study|Low compliance|0
1227286|NCT00741936|4026636|P1|Overall Study|Low compliance|3
1227287|NCT00741936|4026635|P2|Overall Study|Lack of Efficacy|2
1227288|NCT00741936|4026636|P1|Overall Study|Lack of Efficacy|0
1227289|NCT00741936|4026635|P2|Overall Study|Protocol Violation|0
1227290|NCT00741936|4026636|P1|Overall Study|Protocol Violation|2
1227291|NCT00741936|4026635|P2|Overall Study|Pregnancy|1
1227292|NCT00741936|4026636|P1|Overall Study|Pregnancy|0
1227293|NCT00741936|4026635|P2|Overall Study|Adverse Event|4
1227294|NCT00741936|4026636|P1|Overall Study|Adverse Event|3
1227295|NCT00741936|4026635|P2|Overall Study|Lost to Follow-up|1
1227296|NCT00741936|4026636|P1|Overall Study|Lost to Follow-up|1
1227297|NCT00741819|4026671|P1|Overall Study|Disease progression|1
1227298|NCT00741819|4026671|P1|Overall Study|Death|1
1227299|NCT00741819|4026671|P1|Overall Study|Withdrawal by Subject|3
1227300|NCT00741819|4026671|P1|Overall Study|Adverse Event|3
1227301|NCT00741611|4026685|P3|Overall Study|Withdrawal by Subject|2
1227302|NCT00741611|4026686|P2|Overall Study|Withdrawal by Subject|2
1227303|NCT00741611|4026687|P1|Overall Study|Withdrawal by Subject|0
1227304|NCT00741611|4026685|P3|Overall Study|Death|1
1227305|NCT00741611|4026686|P2|Overall Study|Death|0
1227306|NCT00741611|4026687|P1|Overall Study|Death|0
1227307|NCT00741598|4026706|P2|Overall Study|Withdrawal by Subject|2
1227308|NCT00741598|4026707|P1|Overall Study|Withdrawal by Subject|3
1227309|NCT00741598|4026706|P2|Overall Study|Pregnancy|0
1227310|NCT00741598|4026707|P1|Overall Study|Pregnancy|1
1227311|NCT00741598|4026706|P2|Overall Study|Physician Decision|1
1227312|NCT00741598|4026707|P1|Overall Study|Physician Decision|1
1227313|NCT00741598|4026706|P2|Overall Study|Lack of Efficacy|2
1227314|NCT00741598|4026707|P1|Overall Study|Lack of Efficacy|1
1227315|NCT00741598|4026706|P2|Overall Study|Lost to Follow-up|4
1227316|NCT00741598|4026707|P1|Overall Study|Lost to Follow-up|3
1227317|NCT00741338|4026753|P2|Overall Study|Adverse Event|1
1227318|NCT00741338|4026754|P1|Overall Study|Adverse Event|0
1227319|NCT00741286|4026764|P2|Overall Study|Primary Outcome|1
1227320|NCT00741286|4026765|P1|Overall Study|Primary Outcome|1
1227321|NCT00741286|4026764|P2|Overall Study|Protocol Violation|2
1227322|NCT00741286|4026765|P1|Overall Study|Protocol Violation|3
1227323|NCT00741286|4026764|P2|Overall Study|Adverse Event|6
1227324|NCT00741286|4026765|P1|Overall Study|Adverse Event|1
1227325|NCT00741286|4026764|P2|Overall Study|Lost to Follow-up|10
1227326|NCT00741286|4026765|P1|Overall Study|Lost to Follow-up|15
1227327|NCT00741260|4026799|P7|Overall Study|Not Specified|1
1227328|NCT00741260|4026800|P6|Overall Study|Not Specified|3
1227329|NCT00741260|4026801|P5|Overall Study|Not Specified|1
1227330|NCT00741260|4026802|P4|Overall Study|Not Specified|2
1227331|NCT00741260|4026803|P3|Overall Study|Not Specified|1
1227332|NCT00741260|4026804|P2|Overall Study|Not Specified|1
1227333|NCT00741260|4026805|P1|Overall Study|Not Specified|2
1227334|NCT00741260|4026799|P7|Overall Study|Physician Decision|0
1227335|NCT00741260|4026800|P6|Overall Study|Physician Decision|0
1227336|NCT00741260|4026801|P5|Overall Study|Physician Decision|0
1227337|NCT00741260|4026802|P4|Overall Study|Physician Decision|0
1227338|NCT00741260|4026803|P3|Overall Study|Physician Decision|0
1227339|NCT00741260|4026804|P2|Overall Study|Physician Decision|1
1227340|NCT00741260|4026805|P1|Overall Study|Physician Decision|1
1227341|NCT00741260|4026799|P7|Overall Study|Withdrawal by Subject|1
1227342|NCT00741260|4026800|P6|Overall Study|Withdrawal by Subject|3
1227343|NCT00741260|4026801|P5|Overall Study|Withdrawal by Subject|1
1227344|NCT00741260|4026802|P4|Overall Study|Withdrawal by Subject|0
1227345|NCT00741260|4026803|P3|Overall Study|Withdrawal by Subject|0
1227346|NCT00741260|4026804|P2|Overall Study|Withdrawal by Subject|0
1227347|NCT00741260|4026805|P1|Overall Study|Withdrawal by Subject|0
1227348|NCT00741260|4026799|P7|Overall Study|Death|1
1227349|NCT00741260|4026800|P6|Overall Study|Death|2
1227350|NCT00741260|4026801|P5|Overall Study|Death|2
1227351|NCT00741260|4026802|P4|Overall Study|Death|1
1227352|NCT00741260|4026803|P3|Overall Study|Death|0
1227353|NCT00741260|4026804|P2|Overall Study|Death|1
1227354|NCT00741260|4026805|P1|Overall Study|Death|0
1227355|NCT00741260|4026799|P7|Overall Study|Disease Progression|4
1227356|NCT00741260|4026800|P6|Overall Study|Disease Progression|37
1227357|NCT00741260|4026801|P5|Overall Study|Disease Progression|5
1227358|NCT00741260|4026802|P4|Overall Study|Disease Progression|3
1227359|NCT00741260|4026803|P3|Overall Study|Disease Progression|3
1227360|NCT00741260|4026804|P2|Overall Study|Disease Progression|5
1227361|NCT00741260|4026805|P1|Overall Study|Disease Progression|3
1227362|NCT00741091|4026854|P1|Overall Study|Missed Visit|22
1227363|NCT00741091|4026854|P1|Overall Study|Withdrawal by Subject|6
1227364|NCT00741091|4026854|P1|Overall Study|Lost to Follow-up|16
1227365|NCT00741091|4026854|P1|Overall Study|Death|13
1227366|NCT00741039|4026864|P2|Overall Study|Patient non-compliance|0
1227367|NCT00741039|4026865|P1|Overall Study|Patient non-compliance|2
1227368|NCT00741013|4026902|P3|Overall Study|Discovered failed screen after enrolled|0
1227369|NCT00741013|4026903|P2|Overall Study|Discovered failed screen after enrolled|2
1227370|NCT00741013|4026904|P1|Overall Study|Discovered failed screen after enrolled|0
1227371|NCT00741013|4026902|P3|Overall Study|Withdrawal by Subject|1
1227372|NCT00741013|4026903|P2|Overall Study|Withdrawal by Subject|0
1227373|NCT00741013|4026904|P1|Overall Study|Withdrawal by Subject|0
1227374|NCT00741013|4026902|P3|Overall Study|Adverse Event|0
1227375|NCT00741013|4026903|P2|Overall Study|Adverse Event|0
1227376|NCT00741013|4026904|P1|Overall Study|Adverse Event|1
1227377|NCT00740870|4026915|P1|Overall Study|Further testing contraindicated implant|17
1227378|NCT00740870|4026915|P1|Overall Study|Not Catheterized|4
1227379|NCT00740857|4026930|P3|Overall Study|Withdrawal by Subject|0
1227380|NCT00740857|4026931|P2|Overall Study|Withdrawal by Subject|0
1227381|NCT00740857|4026932|P1|Overall Study|Withdrawal by Subject|1
1227382|NCT00740792|4026987|P4|Overall Study|administrative|2
1227383|NCT00740792|4026988|P3|Overall Study|administrative|8
1227384|NCT00740792|4026989|P2|Overall Study|administrative|3
1227385|NCT00740792|4026990|P1|Overall Study|administrative|3
1227386|NCT00740792|4026987|P4|Overall Study|Withdrawal by Subject|0
1227387|NCT00740792|4026988|P3|Overall Study|Withdrawal by Subject|0
1227388|NCT00740792|4026989|P2|Overall Study|Withdrawal by Subject|1
1227389|NCT00740792|4026990|P1|Overall Study|Withdrawal by Subject|1
1227390|NCT00740792|4026987|P4|Overall Study|Protocol Violation|2
1227391|NCT00740792|4026988|P3|Overall Study|Protocol Violation|0
1227392|NCT00740792|4026989|P2|Overall Study|Protocol Violation|1
1227393|NCT00740792|4026990|P1|Overall Study|Protocol Violation|0
1227394|NCT00740792|4026987|P4|Overall Study|Lost to Follow-up|0
1227395|NCT00740792|4026988|P3|Overall Study|Lost to Follow-up|0
1227396|NCT00740792|4026989|P2|Overall Study|Lost to Follow-up|1
1227397|NCT00740792|4026990|P1|Overall Study|Lost to Follow-up|2
1227398|NCT00740792|4026987|P4|Overall Study|Lack of Efficacy|3
1227399|NCT00740792|4026988|P3|Overall Study|Lack of Efficacy|0
1227400|NCT00740792|4026989|P2|Overall Study|Lack of Efficacy|1
1227401|NCT00740792|4026990|P1|Overall Study|Lack of Efficacy|1
1227402|NCT00740792|4026987|P4|Overall Study|Adverse Event|3
1227403|NCT00740792|4026988|P3|Overall Study|Adverse Event|1
1227404|NCT00740792|4026989|P2|Overall Study|Adverse Event|1
1227405|NCT00740792|4026990|P1|Overall Study|Adverse Event|3
1227406|NCT00740779|4027011|P3|Overall Study|Lost to Follow-up|5
1227407|NCT00740779|4027012|P2|Overall Study|Lost to Follow-up|3
1227408|NCT00740779|4027013|P1|Overall Study|Lost to Follow-up|2
1227409|NCT00740779|4027011|P3|Overall Study|Withdrawal by Subject|2
1227410|NCT00740779|4027012|P2|Overall Study|Withdrawal by Subject|4
1227411|NCT00740779|4027013|P1|Overall Study|Withdrawal by Subject|2
1227412|NCT00740779|4027011|P3|Overall Study|Lack of Efficacy|2
1227413|NCT00740779|4027012|P2|Overall Study|Lack of Efficacy|0
1227414|NCT00740779|4027013|P1|Overall Study|Lack of Efficacy|0
1227415|NCT00740779|4027011|P3|Overall Study|Protocol Violation|1
1227416|NCT00740779|4027012|P2|Overall Study|Protocol Violation|1
1227417|NCT00740779|4027013|P1|Overall Study|Protocol Violation|1
1227418|NCT00740779|4027011|P3|Overall Study|Adverse Event|3
1227419|NCT00740779|4027012|P2|Overall Study|Adverse Event|6
1227420|NCT00740779|4027013|P1|Overall Study|Adverse Event|4
1227421|NCT00740714|4027030|P3|Overall Study|Withdrawal by Subject|29
1227422|NCT00740714|4027031|P2|Overall Study|Withdrawal by Subject|19
1227423|NCT00740714|4027032|P1|Overall Study|Withdrawal by Subject|17
1227424|NCT00740636|4027108|P2|Overall Study|Death|0
1227425|NCT00740636|4027109|P1|Overall Study|Death|1
1227426|NCT00740636|4027108|P2|Overall Study|Progressive Disease|0
1227427|NCT00740636|4027109|P1|Overall Study|Progressive Disease|1
1227428|NCT00740636|4027108|P2|Overall Study|Patient Not Treated|1
1227429|NCT00740636|4027109|P1|Overall Study|Patient Not Treated|0
1227430|NCT00740636|4027108|P2|Overall Study|Patient Ineligible|1
1227431|NCT00740636|4027109|P1|Overall Study|Patient Ineligible|0
1227432|NCT00740636|4027108|P2|Overall Study|Adverse Event|2
1227433|NCT00740636|4027109|P1|Overall Study|Adverse Event|0
1227434|NCT00740597|4027115|P1|Overall Study|insurance would not cover treatment|1
1227435|NCT00740584|4027119|P1|Overall Study|Withdrawal by Subject|1
1227436|NCT00740480|4027124|P1|Overall Study|Physician Decision|1
1227437|NCT00740480|4027124|P1|Overall Study|Adverse Event|1
1227438|NCT00740220|4027128|P1|Overall Study|screen failures (non-COPD patients)|9
1227439|NCT00740051|4027153|P2|Overall Study|Other reason (not specified)|1
1227440|NCT00740051|4027154|P1|Overall Study|Other reason (not specified)|4
1227441|NCT00740051|4027153|P2|Overall Study|Withdrawal by Subject|8
1227442|NCT00740051|4027154|P1|Overall Study|Withdrawal by Subject|6
1227443|NCT00740051|4027153|P2|Overall Study|Lost to Follow-up|8
1227444|NCT00740051|4027154|P1|Overall Study|Lost to Follow-up|3
1227445|NCT00740051|4027153|P2|Overall Study|Protocol Violation|6
1227446|NCT00740051|4027154|P1|Overall Study|Protocol Violation|2
1227447|NCT00740051|4027153|P2|Overall Study|Adverse Event|4
1227448|NCT00740051|4027154|P1|Overall Study|Adverse Event|1
1227449|NCT00740051|4027153|P2|Overall Study|Lack of Efficacy|5
1227450|NCT00740051|4027154|P1|Overall Study|Lack of Efficacy|2
1227451|NCT00739973|4027257|P9|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
1227452|NCT00739973|4027258|P8|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
1227453|NCT00739973|4027259|P7|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2
1227454|NCT00739973|4027260|P6|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
1227455|NCT00739973|4027261|P5|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
1227456|NCT00739973|4027262|P4|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
1227457|NCT00739973|4027263|P3|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
1227458|NCT00739973|4027264|P2|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1
1227459|NCT00739973|4027265|P1|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
1227460|NCT00739973|4027257|P9|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
1227461|NCT00739973|4027258|P8|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
1227462|NCT00739973|4027259|P7|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
1227463|NCT00739973|4027260|P6|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
1227464|NCT00739973|4027261|P5|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
1227465|NCT00739973|4027262|P4|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
1227466|NCT00739973|4027263|P3|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
1227467|NCT00739973|4027264|P2|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
1227468|NCT00739973|4027265|P1|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5
1227469|NCT00739973|4027257|P9|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
1227470|NCT00739973|4027258|P8|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
1227471|NCT00739973|4027259|P7|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1
1227472|NCT00739973|4027260|P6|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
1227473|NCT00739973|4027261|P5|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
1227474|NCT00739973|4027262|P4|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
1227475|NCT00739973|4027263|P3|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
1227476|NCT00739973|4027264|P2|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
1227477|NCT00739973|4027265|P1|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
1227478|NCT00739973|4027257|P9|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
1227479|NCT00739973|4027258|P8|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3
1227480|NCT00739973|4027259|P7|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
1227481|NCT00739973|4027260|P6|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
1227482|NCT00739973|4027261|P5|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
1227483|NCT00739973|4027262|P4|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
1227484|NCT00739973|4027263|P3|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4
1227485|NCT00739973|4027264|P2|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
1227486|NCT00739973|4027265|P1|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
1227487|NCT00739973|4027257|P9|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
1227488|NCT00739973|4027258|P8|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
1227489|NCT00739973|4027259|P7|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
1227490|NCT00739973|4027260|P6|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
1227491|NCT00739973|4027261|P5|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
1227492|NCT00739973|4027262|P4|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
1227493|NCT00739973|4027263|P3|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
1227494|NCT00739973|4027264|P2|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
1227495|NCT00739973|4027265|P1|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
1227496|NCT00739973|4027257|P9|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
1227497|NCT00739973|4027258|P8|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
1227498|NCT00739973|4027259|P7|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
1227499|NCT00739973|4027260|P6|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
1227500|NCT00739973|4027261|P5|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
1227501|NCT00739973|4027262|P4|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
1227502|NCT00739973|4027263|P3|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1
1227503|NCT00739973|4027264|P2|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
1227504|NCT00739973|4027265|P1|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
1227505|NCT00739973|4027257|P9|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
1227506|NCT00739973|4027258|P8|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
1227507|NCT00739973|4027259|P7|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
1227508|NCT00739973|4027260|P6|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
1227509|NCT00739973|4027261|P5|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
1227510|NCT00739973|4027262|P4|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4
1227511|NCT00739973|4027263|P3|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
1227512|NCT00739973|4027264|P2|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
1227513|NCT00739973|4027265|P1|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17
1227514|NCT00739973|4027257|P9|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
1227515|NCT00739973|4027258|P8|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
1227516|NCT00739973|4027259|P7|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
1227517|NCT00739973|4027260|P6|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
1227518|NCT00739973|4027261|P5|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
1227519|NCT00739973|4027262|P4|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
1227520|NCT00739973|4027263|P3|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
1227521|NCT00739973|4027264|P2|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
1227522|NCT00739973|4027265|P1|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
1227523|NCT00739973|4027257|P9|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
1227524|NCT00739973|4027258|P8|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
1227525|NCT00739973|4027259|P7|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
1227526|NCT00739973|4027260|P6|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
1227527|NCT00739973|4027261|P5|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
1227528|NCT00739973|4027262|P4|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
1227529|NCT00739973|4027263|P3|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
1227530|NCT00739973|4027264|P2|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
1227531|NCT00739973|4027265|P1|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
1227532|NCT00739973|4027257|P9|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
1227533|NCT00739973|4027258|P8|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
1227534|NCT00739973|4027259|P7|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
1227535|NCT00739973|4027260|P6|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
1227536|NCT00739973|4027261|P5|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7
1227537|NCT00739973|4027262|P4|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2
1227538|NCT00739973|4027263|P3|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
1227539|NCT00739973|4027264|P2|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
1227540|NCT00739973|4027265|P1|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
1227541|NCT00739973|4027257|P9|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
1227542|NCT00739973|4027258|P8|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
1227543|NCT00739973|4027259|P7|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
1227544|NCT00739973|4027260|P6|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
1227545|NCT00739973|4027261|P5|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
1227546|NCT00739973|4027262|P4|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
1227547|NCT00739973|4027263|P3|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
1227548|NCT00739973|4027264|P2|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
1227549|NCT00739973|4027265|P1|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11
1227550|NCT00739973|4027257|P9|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
1227551|NCT00739973|4027258|P8|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
1227552|NCT00739973|4027259|P7|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
1227553|NCT00739973|4027260|P6|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
1227554|NCT00739973|4027261|P5|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
1227555|NCT00739973|4027262|P4|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
1227556|NCT00739973|4027263|P3|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
1227557|NCT00739973|4027264|P2|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
1227558|NCT00739973|4027265|P1|Single-blind Period (2 to 4 Weeks)|Administrative problems|12
1227559|NCT00739973|4027257|P9|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
1227560|NCT00739973|4027258|P8|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
1227561|NCT00739973|4027259|P7|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
1227562|NCT00739973|4027260|P6|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
1227563|NCT00739973|4027261|P5|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
1227564|NCT00739973|4027262|P4|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
1227565|NCT00739973|4027263|P3|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
1227566|NCT00739973|4027264|P2|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
1227567|NCT00739973|4027265|P1|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17
1227568|NCT00739973|4027257|P9|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
1227569|NCT00739973|4027258|P8|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
1227570|NCT00739973|4027259|P7|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
1227571|NCT00739973|4027260|P6|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
1227572|NCT00739973|4027261|P5|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
1227573|NCT00739973|4027262|P4|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
1227574|NCT00739973|4027263|P3|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
1227575|NCT00739973|4027264|P2|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
1227576|NCT00739973|4027265|P1|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86
1227577|NCT00739973|4027257|P9|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
1227578|NCT00739973|4027258|P8|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
1227579|NCT00739973|4027259|P7|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
1227580|NCT00739973|4027260|P6|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
1227581|NCT00739973|4027261|P5|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
1227582|NCT00739973|4027262|P4|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
1227583|NCT00739973|4027263|P3|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
1227584|NCT00739973|4027264|P2|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
1227585|NCT00739973|4027265|P1|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810
1227586|NCT00739973|4027257|P9|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
1227587|NCT00739973|4027258|P8|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
1227588|NCT00739973|4027259|P7|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
1227589|NCT00739973|4027260|P6|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
1227590|NCT00739973|4027261|P5|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
1227591|NCT00739973|4027262|P4|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
1227592|NCT00739973|4027263|P3|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
1227593|NCT00739973|4027264|P2|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
1227594|NCT00739973|4027265|P1|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38
1227595|NCT00739973|4027257|P9|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
1227596|NCT00739973|4027258|P8|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
1227597|NCT00739973|4027259|P7|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
1227598|NCT00739973|4027260|P6|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
1227599|NCT00739973|4027261|P5|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
1227600|NCT00739973|4027262|P4|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
1227601|NCT00739973|4027263|P3|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
1227602|NCT00739973|4027264|P2|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
1227603|NCT00739973|4027265|P1|Single-blind Period (2 to 4 Weeks)|Adverse Event|35
1227604|NCT00739934|4027351|P1|Voriconazole Oral|Other|3
1227605|NCT00739934|4027351|P1|Voriconazole IV|Adverse Event|6
1227606|NCT00739908|4027373|P2|Overall Study|Relocation|1
1227607|NCT00739908|4027374|P1|Overall Study|Relocation|0
1227608|NCT00739908|4027373|P2|Overall Study|Lack of Efficacy|1
1227609|NCT00739908|4027374|P1|Overall Study|Lack of Efficacy|0
1227610|NCT00739908|4027373|P2|Overall Study|Non-Compliance With Study Medication|3
1227611|NCT00739908|4027374|P1|Overall Study|Non-Compliance With Study Medication|0
1227612|NCT00739908|4027373|P2|Overall Study|Non-Compliance With Study Procedures|3
1227613|NCT00739908|4027374|P1|Overall Study|Non-Compliance With Study Procedures|2
1227614|NCT00739908|4027373|P2|Overall Study|Lost to Follow-up|9
1227615|NCT00739908|4027374|P1|Overall Study|Lost to Follow-up|14
1227616|NCT00739908|4027373|P2|Overall Study|Withdrawal by Subject|2
1227617|NCT00739908|4027374|P1|Overall Study|Withdrawal by Subject|4
1227618|NCT00739908|4027373|P2|Overall Study|Adverse Event|6
1227619|NCT00739908|4027374|P1|Overall Study|Adverse Event|5
1227620|NCT00739882|4027394|P2|Open-label Period|Other|5
1227621|NCT00739882|4027395|P1|Open-label Period|Other|9
1227622|NCT00739882|4027394|P2|Open-label Period|Adverse Event|0
1227623|NCT00739882|4027395|P1|Open-label Period|Adverse Event|1
1227624|NCT00739882|4027394|P2|Double-blind Period|Not specified|8
1227625|NCT00739882|4027395|P1|Double-blind Period|Not specified|16
1227626|NCT00739882|4027394|P2|Double-blind Period|Lack of Efficacy|1
1227627|NCT00739882|4027395|P1|Double-blind Period|Lack of Efficacy|1
1227628|NCT00739882|4027394|P2|Double-blind Period|Protocol Violation|0
1227629|NCT00739882|4027395|P1|Double-blind Period|Protocol Violation|1
1227630|NCT00739882|4027394|P2|Double-blind Period|Adverse Event|2
1227631|NCT00739882|4027395|P1|Double-blind Period|Adverse Event|1
1227632|NCT00739674|4027456|P2|Overall Study|Erectile dysfunction|1
1227633|NCT00739674|4027457|P1|Overall Study|Erectile dysfunction|0
1227634|NCT00739674|4027456|P2|Overall Study|Home monitoring off meds|0
1227635|NCT00739674|4027457|P1|Overall Study|Home monitoring off meds|1
1227636|NCT00739674|4027456|P2|Overall Study|Unable to attend visit|1
1227637|NCT00739674|4027457|P1|Overall Study|Unable to attend visit|3
1227638|NCT00739674|4027456|P2|Overall Study|Non compliant|0
1227639|NCT00739674|4027457|P1|Overall Study|Non compliant|4
1227640|NCT00739674|4027456|P2|Overall Study|Patient moved|2
1227641|NCT00739674|4027457|P1|Overall Study|Patient moved|3
1227642|NCT00739674|4027456|P2|Overall Study|Clinic closed|4
1227643|NCT00739674|4027457|P1|Overall Study|Clinic closed|6
1227644|NCT00739674|4027456|P2|Overall Study|Reason missing|0
1227645|NCT00739674|4027457|P1|Overall Study|Reason missing|2
1227646|NCT00739674|4027456|P2|Overall Study|Withdrawal by Subject|9
1227647|NCT00739674|4027457|P1|Overall Study|Withdrawal by Subject|9
1227648|NCT00739674|4027456|P2|Overall Study|Protocol Violation|5
1227649|NCT00739674|4027457|P1|Overall Study|Protocol Violation|5
1227650|NCT00739674|4027456|P2|Overall Study|Lost to Follow-up|30
1227651|NCT00739674|4027457|P1|Overall Study|Lost to Follow-up|52
1227652|NCT00739674|4027456|P2|Overall Study|Lack of Efficacy|0
1227653|NCT00739674|4027457|P1|Overall Study|Lack of Efficacy|1
1227654|NCT00739674|4027456|P2|Overall Study|Death|0
1227655|NCT00739674|4027457|P1|Overall Study|Death|1
1227656|NCT00739674|4027456|P2|Overall Study|Adverse Event|13
1227657|NCT00739674|4027457|P1|Overall Study|Adverse Event|22
1227658|NCT00739674|4027456|P2|Overall Study|Dietician consultation >30 days|9
1227659|NCT00739674|4027457|P1|Overall Study|Dietician consultation >30 days|1
1227660|NCT00739674|4027456|P2|Overall Study|No follow-up data|18
1227661|NCT00739674|4027457|P1|Overall Study|No follow-up data|33
1227662|NCT00739674|4027456|P2|Overall Study|Site 212 removal|13
1227663|NCT00739674|4027457|P1|Overall Study|Site 212 removal|19
1227664|NCT00739674|4027456|P2|Overall Study|Screening failures|17
1227665|NCT00739674|4027457|P1|Overall Study|Screening failures|19
1227666|NCT00739661|4027485|P2|Overall Study|Reason for discontinuation not available|1
1227667|NCT00739661|4027486|P1|Overall Study|Reason for discontinuation not available|1
1227668|NCT00739661|4027485|P2|Overall Study|Disease progression, radiographic|37
1227669|NCT00739661|4027486|P1|Overall Study|Disease progression, radiographic|33
1227670|NCT00739661|4027485|P2|Overall Study|Patient decision to withdraw|4
1227671|NCT00739661|4027486|P1|Overall Study|Patient decision to withdraw|9
1227672|NCT00739661|4027485|P2|Overall Study|Physician decision to withdraw patient|0
1227673|NCT00739661|4027486|P1|Overall Study|Physician decision to withdraw patient|1
1227674|NCT00739661|4027485|P2|Overall Study|Adverse Event|0
1227675|NCT00739661|4027486|P1|Overall Study|Adverse Event|2
1227676|NCT00739648|4027498|P2|Overall Study|Do not know|6
1227677|NCT00739648|4027499|P1|Overall Study|Do not know|4
1227678|NCT00739648|4027498|P2|Overall Study|Death|0
1227679|NCT00739648|4027499|P1|Overall Study|Death|2
1227680|NCT00739648|4027498|P2|Overall Study|Lost to Follow-up|7
1227681|NCT00739648|4027499|P1|Overall Study|Lost to Follow-up|4
1227682|NCT00739648|4027498|P2|Overall Study|Withdrawal by Subject|25
1227683|NCT00739648|4027499|P1|Overall Study|Withdrawal by Subject|13
1227684|NCT00739648|4027498|P2|Overall Study|Adverse Event|15
1227685|NCT00739648|4027499|P1|Overall Study|Adverse Event|3
1227686|NCT00739596|4027513|P2|Overall Study|Protocol Deviation|1
1227687|NCT00739596|4027514|P1|Overall Study|Protocol Deviation|1
1227688|NCT00739596|4027513|P2|Overall Study|Lost to Follow-up|2
1227689|NCT00739596|4027514|P1|Overall Study|Lost to Follow-up|0
1227690|NCT00739596|4027513|P2|Overall Study|Patient Withdrew Consent|8
1227691|NCT00739596|4027514|P1|Overall Study|Patient Withdrew Consent|8
1227692|NCT00739596|4027513|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
1227693|NCT00739596|4027514|P1|Overall Study|Unsatisfactory Therapeutic Effect|4
1227694|NCT00739596|4027513|P2|Overall Study|Adverse Event|6
1227695|NCT00739596|4027514|P1|Overall Study|Adverse Event|12
1227696|NCT00739310|4027556|P1|Overall Study|Lost to Follow-up|2
1227697|NCT00739310|4027556|P1|Overall Study|Withdrawal by Subject|1
1227698|NCT00739310|4027556|P1|Overall Study|Poor adherance to prescribed therapy|4
1227699|NCT00739297|4027561|P7|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
1227700|NCT00739297|4027562|P6|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
1227701|NCT00739297|4027563|P5|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
1227702|NCT00739297|4027564|P4|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
1227703|NCT00739297|4027565|P3|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
1227704|NCT00739297|4027566|P2|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
1227705|NCT00739297|4027567|P1|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
1227706|NCT00739297|4027561|P7|First Washout Period of 4-7 Days|Adverse Event|2
1227707|NCT00739297|4027562|P6|First Washout Period of 4-7 Days|Adverse Event|0
1227708|NCT00739297|4027563|P5|First Washout Period of 4-7 Days|Adverse Event|0
1227709|NCT00739297|4027564|P4|First Washout Period of 4-7 Days|Adverse Event|2
1227710|NCT00739297|4027565|P3|First Washout Period of 4-7 Days|Adverse Event|0
1227711|NCT00739297|4027566|P2|First Washout Period of 4-7 Days|Adverse Event|0
1227712|NCT00739297|4027567|P1|First Washout Period of 4-7 Days|Adverse Event|0
1227713|NCT00739102|4027595|P1|Overall Study|Withdrawal by Subject|10
1227714|NCT00739102|4027595|P1|Overall Study|Death|5
1227715|NCT00739063|4027611|P1|Overall Study|Screen failures|8
1227716|NCT00738894|4027656|P2|Overall Study|Death|0
1227717|NCT00738894|4027657|P1|Overall Study|Death|2
1227718|NCT00738894|4027656|P2|Overall Study|Physician Decision|5
1227719|NCT00738894|4027657|P1|Overall Study|Physician Decision|4
1227720|NCT00738894|4027656|P2|Overall Study|Withdrawal by Subject|15
1227721|NCT00738894|4027657|P1|Overall Study|Withdrawal by Subject|10
1227722|NCT00738894|4027656|P2|Overall Study|Lost to Follow-up|13
1227723|NCT00738894|4027657|P1|Overall Study|Lost to Follow-up|23
1227724|NCT00738881|4027670|P2|Overall Study|Withdrawal by Subject|2
1227725|NCT00738881|4027671|P1|Overall Study|Withdrawal by Subject|0
1227726|NCT00738699|4027685|P2|Overall Study|Not specified|0
1227727|NCT00738699|4027686|P1|Overall Study|Not specified|2
1227728|NCT00738699|4027685|P2|Overall Study|Discontinuation of study by Sponsor|72
1227729|NCT00738699|4027686|P1|Overall Study|Discontinuation of study by Sponsor|123
1227730|NCT00738699|4027685|P2|Overall Study|Death|68
1227731|NCT00738699|4027686|P1|Overall Study|Death|144
1227732|NCT00738699|4027685|P2|Overall Study|Lost to Follow-up|0
1227733|NCT00738699|4027686|P1|Overall Study|Lost to Follow-up|1
1227734|NCT00738699|4027685|P2|Overall Study|Withdrawal by Subject|0
1227735|NCT00738699|4027686|P1|Overall Study|Withdrawal by Subject|5
1227736|NCT00738673|4027704|P2|Overall Study|Withdrawal by Subject|1
1227737|NCT00738673|4027705|P1|Overall Study|Withdrawal by Subject|3
1227738|NCT00738673|4027704|P2|Overall Study|Protocol Violation|2
1227739|NCT00738673|4027705|P1|Overall Study|Protocol Violation|1
1227740|NCT00738673|4027704|P2|Overall Study|Lack of Efficacy|8
1227741|NCT00738673|4027705|P1|Overall Study|Lack of Efficacy|19
1227742|NCT00738673|4027704|P2|Overall Study|Adverse Event|0
1227743|NCT00738673|4027705|P1|Overall Study|Adverse Event|1
1227744|NCT00738530|4027743|P2|Overall Study|Withdrawal by Subject|8
1227745|NCT00738530|4027744|P1|Overall Study|Withdrawal by Subject|6
1227746|NCT00738530|4027743|P2|Overall Study|Lost to Follow-up|6
1227747|NCT00738530|4027744|P1|Overall Study|Lost to Follow-up|8
1227748|NCT00738530|4027743|P2|Overall Study|Death|224
1227749|NCT00738530|4027744|P1|Overall Study|Death|220
1227750|NCT00738400|4027779|P2|Overall Study|Non-compliant with study medication|1
1227751|NCT00738400|4027780|P1|Overall Study|Non-compliant with study medication|0
1227752|NCT00738400|4027779|P2|Overall Study|Protocol Violation|0
1227753|NCT00738400|4027780|P1|Overall Study|Protocol Violation|1
1227754|NCT00738400|4027779|P2|Overall Study|Lost to Follow-up|3
1227755|NCT00738400|4027780|P1|Overall Study|Lost to Follow-up|0
1227756|NCT00738400|4027779|P2|Overall Study|Lack of Efficacy|1
1227757|NCT00738400|4027780|P1|Overall Study|Lack of Efficacy|0
1227758|NCT00738400|4027779|P2|Overall Study|Withdrawal by Subject|1
1227759|NCT00738400|4027780|P1|Overall Study|Withdrawal by Subject|0
1227760|NCT00738400|4027779|P2|Overall Study|Adverse Event|1
1227761|NCT00738400|4027780|P1|Overall Study|Adverse Event|3
1227762|NCT00738374|4027801|P4|Maintenance Treatment/Observation Phase|Not Specified|0
1227763|NCT00738374|4027802|P3|Maintenance Treatment/Observation Phase|Not Specified|0
1227764|NCT00738374|4027803|P2|Maintenance Treatment/Observation Phase|Not Specified|1
1227765|NCT00738374|4027804|P1|Maintenance Treatment/Observation Phase|Not Specified|0
1227766|NCT00738374|4027801|P4|Maintenance Treatment/Observation Phase|Protocol Violation|0
1227767|NCT00738374|4027802|P3|Maintenance Treatment/Observation Phase|Protocol Violation|0
1227768|NCT00738374|4027803|P2|Maintenance Treatment/Observation Phase|Protocol Violation|1
1227769|NCT00738374|4027804|P1|Maintenance Treatment/Observation Phase|Protocol Violation|0
1227770|NCT00738374|4027801|P4|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1
1227771|NCT00738374|4027802|P3|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
1227772|NCT00738374|4027803|P2|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
1227773|NCT00738374|4027804|P1|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
1227774|NCT00738374|4027801|P4|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11
1227775|NCT00738374|4027802|P3|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5
1227776|NCT00738374|4027803|P2|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4
1227777|NCT00738374|4027804|P1|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0
1227778|NCT00738374|4027801|P4|Maintenance Treatment/Observation Phase|Adverse Event|0
1227779|NCT00738374|4027802|P3|Maintenance Treatment/Observation Phase|Adverse Event|2
1227780|NCT00738374|4027803|P2|Maintenance Treatment/Observation Phase|Adverse Event|1
1227781|NCT00738374|4027804|P1|Maintenance Treatment/Observation Phase|Adverse Event|0
1227782|NCT00738374|4027801|P4|Induction Treatment Phase|Withdrawal by Subject|0
1227783|NCT00738374|4027802|P3|Induction Treatment Phase|Withdrawal by Subject|0
1227784|NCT00738374|4027803|P2|Induction Treatment Phase|Withdrawal by Subject|0
1227785|NCT00738374|4027804|P1|Induction Treatment Phase|Withdrawal by Subject|1
1227786|NCT00738374|4027801|P4|Induction Treatment Phase|Non-compliance|0
1227787|NCT00738374|4027802|P3|Induction Treatment Phase|Non-compliance|0
1227788|NCT00738374|4027803|P2|Induction Treatment Phase|Non-compliance|0
1227789|NCT00738374|4027804|P1|Induction Treatment Phase|Non-compliance|1
1227790|NCT00738374|4027801|P4|Induction Treatment Phase|Protocol Violation|0
1227791|NCT00738374|4027802|P3|Induction Treatment Phase|Protocol Violation|0
1227792|NCT00738374|4027803|P2|Induction Treatment Phase|Protocol Violation|0
1227793|NCT00738374|4027804|P1|Induction Treatment Phase|Protocol Violation|2
1227794|NCT00738374|4027801|P4|Induction Treatment Phase|Physician Decision|0
1227795|NCT00738374|4027802|P3|Induction Treatment Phase|Physician Decision|0
1227796|NCT00738374|4027803|P2|Induction Treatment Phase|Physician Decision|0
1227797|NCT00738374|4027804|P1|Induction Treatment Phase|Physician Decision|2
1227798|NCT00738374|4027801|P4|Induction Treatment Phase|Disease progression/relapse/stable|0
1227799|NCT00738374|4027802|P3|Induction Treatment Phase|Disease progression/relapse/stable|0
1227800|NCT00738374|4027803|P2|Induction Treatment Phase|Disease progression/relapse/stable|0
1227801|NCT00738374|4027804|P1|Induction Treatment Phase|Disease progression/relapse/stable|4
1227802|NCT00738374|4027801|P4|Induction Treatment Phase|Adverse Event|0
1227803|NCT00738374|4027802|P3|Induction Treatment Phase|Adverse Event|0
1227804|NCT00738374|4027803|P2|Induction Treatment Phase|Adverse Event|0
1227805|NCT00738374|4027804|P1|Induction Treatment Phase|Adverse Event|14
1227806|NCT00738283|4027842|P1|Overall Study|Discharge home prior to end of study|1
1227807|NCT00738283|4027842|P1|Overall Study|Transfer to another facility|2
1227808|NCT00738283|4027842|P1|Overall Study|Death|1
1227809|NCT00738062|4027849|P3|Open-Label Extension|Study Terminated|0
1227810|NCT00738062|4027850|P2|Open-Label Extension|Study Terminated|0
1227811|NCT00738062|4027851|P1|Open-Label Extension|Study Terminated|2
1227812|NCT00738062|4027849|P3|Open-Label Extension|Protocol Violation|0
1227813|NCT00738062|4027850|P2|Open-Label Extension|Protocol Violation|0
1227814|NCT00738062|4027851|P1|Open-Label Extension|Protocol Violation|1
1227815|NCT00738062|4027849|P3|Open-Label Extension|Withdrawal by Subject|0
1227816|NCT00738062|4027850|P2|Open-Label Extension|Withdrawal by Subject|0
1227817|NCT00738062|4027851|P1|Open-Label Extension|Withdrawal by Subject|6
1227818|NCT00738062|4027849|P3|Open-Label Extension|Lack of Efficacy|0
1227819|NCT00738062|4027850|P2|Open-Label Extension|Lack of Efficacy|0
1227820|NCT00738062|4027851|P1|Open-Label Extension|Lack of Efficacy|2
1227821|NCT00738062|4027849|P3|Open-Label Extension|Physician Decision|0
1227822|NCT00738062|4027850|P2|Open-Label Extension|Physician Decision|0
1227823|NCT00738062|4027851|P1|Open-Label Extension|Physician Decision|1
1227824|NCT00738062|4027849|P3|Open-Label Extension|Adverse Event|0
1227825|NCT00738062|4027850|P2|Open-Label Extension|Adverse Event|0
1227826|NCT00738062|4027851|P1|Open-Label Extension|Adverse Event|5
1227827|NCT00738062|4027849|P3|Open Label Treatment|Investigator Decision|0
1227828|NCT00738062|4027850|P2|Open Label Treatment|Investigator Decision|0
1227829|NCT00738062|4027851|P1|Open Label Treatment|Investigator Decision|1
1227830|NCT00738062|4027849|P3|Open Label Treatment|Withdrawal by Subject|0
1227831|NCT00738062|4027850|P2|Open Label Treatment|Withdrawal by Subject|0
1227832|NCT00738062|4027851|P1|Open Label Treatment|Withdrawal by Subject|9
1227833|NCT00738062|4027849|P3|Open Label Treatment|Protocol Violation|0
1227834|NCT00738062|4027850|P2|Open Label Treatment|Protocol Violation|0
1227835|NCT00738062|4027851|P1|Open Label Treatment|Protocol Violation|2
1227836|NCT00738062|4027849|P3|Open Label Treatment|Adverse Event|0
1227837|NCT00738062|4027850|P2|Open Label Treatment|Adverse Event|0
1227838|NCT00738062|4027851|P1|Open Label Treatment|Adverse Event|11
1227839|NCT00738062|4027849|P3|Open Label Treatment|Lack of Efficacy|0
1227840|NCT00738062|4027850|P2|Open Label Treatment|Lack of Efficacy|0
1227841|NCT00738062|4027851|P1|Open Label Treatment|Lack of Efficacy|5
1227842|NCT00737711|4027913|P1|Overall Study|Other|5
1227843|NCT00737711|4027913|P1|Overall Study|Blood transfusion|6
1227844|NCT00737711|4027913|P1|Overall Study|Withdrawal by Subject|5
1227845|NCT00737711|4027913|P1|Overall Study|Protocol Violation|1
1227846|NCT00737711|4027913|P1|Overall Study|Failure to return|4
1227847|NCT00737711|4027913|P1|Overall Study|Death|8
1227848|NCT00737711|4027913|P1|Overall Study|Adverse Event|2
1227849|NCT00737672|4027946|P2|Overall Study|Physician Decision|2
1227850|NCT00737672|4027947|P1|Overall Study|Physician Decision|0
1227851|NCT00737672|4027946|P2|Overall Study|Miscellaneous|1
1227852|NCT00737672|4027947|P1|Overall Study|Miscellaneous|7
1227853|NCT00737672|4027946|P2|Overall Study|Lost to Follow-up|0
1227854|NCT00737672|4027947|P1|Overall Study|Lost to Follow-up|1
1227855|NCT00737672|4027946|P2|Overall Study|Withdrawal by Subject|2
1227856|NCT00737672|4027947|P1|Overall Study|Withdrawal by Subject|1
1227857|NCT00737672|4027946|P2|Overall Study|Death|22
1227858|NCT00737672|4027947|P1|Overall Study|Death|23
1227859|NCT00737672|4027946|P2|Overall Study|Graft Abandonment|56
1227860|NCT00737672|4027947|P1|Overall Study|Graft Abandonment|48
1227861|NCT00737633|4027985|P2|Overall Study|protocol non-compliance|1
1227862|NCT00737633|4027986|P1|Overall Study|protocol non-compliance|0
1227863|NCT00737633|4027985|P2|Overall Study|Lost to Follow-up|1
1227864|NCT00737633|4027986|P1|Overall Study|Lost to Follow-up|0
1227865|NCT00737633|4027985|P2|Overall Study|Study terminated by sponsor|55
1227866|NCT00737633|4027986|P1|Overall Study|Study terminated by sponsor|44
1227867|NCT00737568|4028009|P2|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0
1227868|NCT00737568|4028010|P1|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1
1227869|NCT00737568|4028009|P2|Treatment-Free Follow-up (TFFU) Period|Death|1
1227870|NCT00737568|4028010|P1|Treatment-Free Follow-up (TFFU) Period|Death|0
1227871|NCT00737568|4028009|P2|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17
1227872|NCT00737568|4028010|P1|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25
1227873|NCT00737568|4028009|P2|Treatment Period Through Week 240|Study Discontinued by Sponsor|0
1227874|NCT00737568|4028010|P1|Treatment Period Through Week 240|Study Discontinued by Sponsor|1
1227875|NCT00737568|4028009|P2|Treatment Period Through Week 240|Protocol Violation|3
1227876|NCT00737568|4028010|P1|Treatment Period Through Week 240|Protocol Violation|2
1227877|NCT00737568|4028009|P2|Treatment Period Through Week 240|Lost to Follow-up|3
1227878|NCT00737568|4028010|P1|Treatment Period Through Week 240|Lost to Follow-up|3
1227879|NCT00737568|4028009|P2|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4
1227880|NCT00737568|4028010|P1|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3
1227881|NCT00737568|4028009|P2|Treatment Period Through Week 240|Withdrew Consent|6
1227882|NCT00737568|4028010|P1|Treatment Period Through Week 240|Withdrew Consent|5
1227883|NCT00737568|4028009|P2|Treatment Period Through Week 240|Investigator’s Discretion|5
1227884|NCT00737568|4028010|P1|Treatment Period Through Week 240|Investigator’s Discretion|6
1227885|NCT00737529|4028040|P1|Overall Study|Other|4
1227886|NCT00737529|4028040|P1|Overall Study|Protocol Violation|1
1227887|NCT00737529|4028040|P1|Overall Study|Death|4
1227888|NCT00737529|4028040|P1|Overall Study|Withdrawal by Subject|5
1227889|NCT00737529|4028040|P1|Overall Study|Adverse Event|24
1227890|NCT00737529|4028040|P1|Overall Study|Disease Progression|95
1227891|NCT00737477|4028054|P1|Overall Study|Not Specified|4
1227892|NCT00737477|4028054|P1|Overall Study|Renal Transplantation|10
1227893|NCT00737477|4028054|P1|Overall Study|Withdrawal by Subject|1
1227894|NCT00737477|4028054|P1|Overall Study|Treatment Refusal|1
1227895|NCT00737477|4028054|P1|Overall Study|Death|9
1227896|NCT00737477|4028054|P1|Overall Study|Adverse Event|9
1227897|NCT00737464|4028070|P1|Overall Study|Other reasons|4
1227898|NCT00737464|4028070|P1|Overall Study|Refused Treatment / Withdrew Consent|6
1227899|NCT00737464|4028070|P1|Overall Study|Other - Failure to Return|1
1227900|NCT00737464|4028070|P1|Overall Study|Death|6
1227901|NCT00737464|4028070|P1|Overall Study|Adverse Event|1
1227902|NCT00737438|4028091|P1|Overall Study|Patient ineligible|1
1227903|NCT00737438|4028091|P1|Overall Study|Withdrawal by Subject|2
1227904|NCT00737282|4028104|P1|Overall Study|Study prematurely terminated|175
1227905|NCT00737100|4028147|P3|Overall Study|Reason discontinued not explained above|1
1227906|NCT00737100|4028148|P2|Overall Study|Reason discontinued not explained above|1
1227907|NCT00737100|4028149|P1|Overall Study|Reason discontinued not explained above|1
1227908|NCT00737100|4028147|P3|Overall Study|Withdrawal by Subject|3
1227909|NCT00737100|4028148|P2|Overall Study|Withdrawal by Subject|0
1227910|NCT00737100|4028149|P1|Overall Study|Withdrawal by Subject|0
1227911|NCT00737100|4028147|P3|Overall Study|Lost to Follow-up|0
1227912|NCT00737100|4028148|P2|Overall Study|Lost to Follow-up|1
1227913|NCT00737100|4028149|P1|Overall Study|Lost to Follow-up|0
1227914|NCT00737100|4028147|P3|Overall Study|Adverse Event|3
1227915|NCT00737100|4028148|P2|Overall Study|Adverse Event|5
1227916|NCT00737100|4028149|P1|Overall Study|Adverse Event|6
1227917|NCT00737061|4028193|P1|1 Year Wearing Period|Terminated for protocol non-compliance|1
1227918|NCT00737061|4028193|P1|1 Year Wearing Period|Discontinued reilance|3
1227919|NCT00737061|4028193|P1|1 Year Wearing Period|Withdrawal by Subject|2
1227920|NCT00737061|4028193|P1|1 Year Wearing Period|Lost to Follow-up|11
1227921|NCT00737061|4028193|P1|Waiting Period|Elected surgical tubal ligation|5
1227922|NCT00737061|4028193|P1|Waiting Period|Alternative contraception failure|3
1227923|NCT00737061|4028193|P1|Waiting Period|Deemed patent following HSG|26
1227924|NCT00737061|4028193|P1|Waiting Period|Bilateral placement failure|34
1227925|NCT00737061|4028193|P1|Waiting Period|Withdrawal by Subject|1
1227926|NCT00737061|4028193|P1|Waiting Period|Lost to Follow-up|6
1227927|NCT00737048|4028210|P3|Overall Study|Worsening of the symptoms|3
1227928|NCT00737048|4028211|P2|Overall Study|Worsening of the symptoms|5
1227929|NCT00737048|4028212|P1|Overall Study|Worsening of the symptoms|3
1227930|NCT00737048|4028210|P3|Overall Study|Adverse Event|0
1227931|NCT00737048|4028211|P2|Overall Study|Adverse Event|1
1227932|NCT00737048|4028212|P1|Overall Study|Adverse Event|0
1227933|NCT00737048|4028210|P3|Overall Study|Physician Decision|1
1227934|NCT00737048|4028211|P2|Overall Study|Physician Decision|0
1227935|NCT00737048|4028212|P1|Overall Study|Physician Decision|0
1227936|NCT00736996|4028256|P3|Overall Study|Lost to Follow-up|2
1227937|NCT00736996|4028257|P2|Overall Study|Lost to Follow-up|9
1227938|NCT00736996|4028258|P1|Overall Study|Lost to Follow-up|1
1227939|NCT00736957|4028272|P1|Overall Study|Physician Decision|5
1227940|NCT00736957|4028272|P1|Overall Study|not eligible for Treatment Period I|22
1227941|NCT00736957|4028272|P1|Overall Study|did not attend hospital appointments|1
1227942|NCT00736957|4028272|P1|Overall Study|violation of eligibility criteria|2
1227943|NCT00736957|4028272|P1|Overall Study|Withdrawal by Subject|49
1227944|NCT00736957|4028272|P1|Overall Study|Adverse Event|43
1227945|NCT00736944|4028282|P1|Definitive Treatment|Physician Decision|1
1227946|NCT00736944|4028282|P1|Induction|Death|1
1227947|NCT00736879|4028313|P4|Follow up Period - No Drug Treatment|non-specified|0
1227948|NCT00736879|4028314|P3|Follow up Period - No Drug Treatment|non-specified|0
1227949|NCT00736879|4028315|P2|Follow up Period - No Drug Treatment|non-specified|2
1227950|NCT00736879|4028316|P1|Follow up Period - No Drug Treatment|non-specified|1
1227951|NCT00736879|4028313|P4|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
1227952|NCT00736879|4028314|P3|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
1227953|NCT00736879|4028315|P2|Follow up Period - No Drug Treatment|Withdrawal by Subject|1
1227954|NCT00736879|4028316|P1|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
1227955|NCT00736879|4028313|P4|Double Blind Treatment Period|non-specified|0
1227956|NCT00736879|4028314|P3|Double Blind Treatment Period|non-specified|0
1227957|NCT00736879|4028315|P2|Double Blind Treatment Period|non-specified|1
1227958|NCT00736879|4028316|P1|Double Blind Treatment Period|non-specified|0
1227959|NCT00736879|4028313|P4|Double Blind Treatment Period|No longer met criteria|0
1227960|NCT00736879|4028314|P3|Double Blind Treatment Period|No longer met criteria|0
1227961|NCT00736879|4028315|P2|Double Blind Treatment Period|No longer met criteria|1
1227962|NCT00736879|4028316|P1|Double Blind Treatment Period|No longer met criteria|0
1227963|NCT00736879|4028313|P4|Double Blind Treatment Period|Poor non-compliance|1
1227964|NCT00736879|4028314|P3|Double Blind Treatment Period|Poor non-compliance|1
1227965|NCT00736879|4028315|P2|Double Blind Treatment Period|Poor non-compliance|0
1227966|NCT00736879|4028316|P1|Double Blind Treatment Period|Poor non-compliance|0
1227967|NCT00736879|4028313|P4|Double Blind Treatment Period|Lost to Follow-up|1
1227968|NCT00736879|4028314|P3|Double Blind Treatment Period|Lost to Follow-up|2
1227969|NCT00736879|4028315|P2|Double Blind Treatment Period|Lost to Follow-up|0
1227970|NCT00736879|4028316|P1|Double Blind Treatment Period|Lost to Follow-up|0
1227971|NCT00736879|4028313|P4|Double Blind Treatment Period|Withdrawal by Subject|3
1227972|NCT00736879|4028314|P3|Double Blind Treatment Period|Withdrawal by Subject|3
1227973|NCT00736879|4028315|P2|Double Blind Treatment Period|Withdrawal by Subject|1
1227974|NCT00736879|4028316|P1|Double Blind Treatment Period|Withdrawal by Subject|2
1227975|NCT00736879|4028313|P4|Double Blind Treatment Period|Adverse Event|0
1227976|NCT00736879|4028314|P3|Double Blind Treatment Period|Adverse Event|1
1227977|NCT00736879|4028315|P2|Double Blind Treatment Period|Adverse Event|1
1227978|NCT00736879|4028316|P1|Double Blind Treatment Period|Adverse Event|0
1227979|NCT00736879|4028313|P4|Double Blind Treatment Period|Lack of Efficacy|0
1227980|NCT00736879|4028314|P3|Double Blind Treatment Period|Lack of Efficacy|0
1227981|NCT00736879|4028315|P2|Double Blind Treatment Period|Lack of Efficacy|0
1227982|NCT00736879|4028316|P1|Double Blind Treatment Period|Lack of Efficacy|1
1227983|NCT00736853|4028370|P3|Double-Blind Period|Ineligible to participate the study|0
1227984|NCT00736853|4028371|P2|Double-Blind Period|Ineligible to participate the study|1
1227985|NCT00736853|4028372|P1|Double-Blind Period|Ineligible to participate the study|0
1227986|NCT00736853|4028370|P3|Double-Blind Period|Withdrawal by Subject|4
1227987|NCT00736853|4028371|P2|Double-Blind Period|Withdrawal by Subject|1
1227988|NCT00736853|4028372|P1|Double-Blind Period|Withdrawal by Subject|0
1227989|NCT00736853|4028370|P3|Double-Blind Period|Adverse Event|2
1227990|NCT00736853|4028371|P2|Double-Blind Period|Adverse Event|3
1227991|NCT00736853|4028372|P1|Double-Blind Period|Adverse Event|0
1227992|NCT00736853|4028370|P3|Double-Blind Period|Lack of Efficacy|42
1227993|NCT00736853|4028371|P2|Double-Blind Period|Lack of Efficacy|19
1227994|NCT00736853|4028372|P1|Double-Blind Period|Lack of Efficacy|0
1227995|NCT00736853|4028370|P3|Open-Label Period|Unable to attend hospital appointments|0
1227996|NCT00736853|4028371|P2|Open-Label Period|Unable to attend hospital appointments|0
1227997|NCT00736853|4028372|P1|Open-Label Period|Unable to attend hospital appointments|1
1227998|NCT00736853|4028370|P3|Open-Label Period|Failed to meet the transfer criteria|0
1227999|NCT00736853|4028371|P2|Open-Label Period|Failed to meet the transfer criteria|0
1228000|NCT00736853|4028372|P1|Open-Label Period|Failed to meet the transfer criteria|40
1228001|NCT00736853|4028370|P3|Open-Label Period|Started but not treated|0
1228002|NCT00736853|4028371|P2|Open-Label Period|Started but not treated|0
1228003|NCT00736853|4028372|P1|Open-Label Period|Started but not treated|42
1228004|NCT00736853|4028370|P3|Open-Label Period|Withdrawal by Subject|0
1228005|NCT00736853|4028371|P2|Open-Label Period|Withdrawal by Subject|0
1228006|NCT00736853|4028372|P1|Open-Label Period|Withdrawal by Subject|16
1228007|NCT00736853|4028370|P3|Open-Label Period|Adverse Event|0
1228008|NCT00736853|4028371|P2|Open-Label Period|Adverse Event|0
1228009|NCT00736853|4028372|P1|Open-Label Period|Adverse Event|31
1228010|NCT00736853|4028370|P3|Open-Label Period|Physician Decision|0
1228011|NCT00736853|4028371|P2|Open-Label Period|Physician Decision|0
1228012|NCT00736853|4028372|P1|Open-Label Period|Physician Decision|2
1228013|NCT00736840|4028412|P1|Overall Study|Lost to Follow-up|13
1228014|NCT00736723|4028419|P2|Overall Study|Withdrawal by Subject|3
1228015|NCT00736723|4028420|P1|Overall Study|Withdrawal by Subject|4
1228016|NCT00736645|4028430|P4|Overall Study|Adverse Event|0
1228017|NCT00736645|4028431|P3|Overall Study|Adverse Event|0
1228018|NCT00736645|4028432|P2|Overall Study|Adverse Event|2
1228019|NCT00736645|4028433|P1|Overall Study|Adverse Event|0
1228020|NCT00736502|4028456|P1|Overall Study|Lost to Follow-up|27
1228021|NCT00736502|4028456|P1|Overall Study|Lack of Efficacy|16
1228022|NCT00736502|4028456|P1|Overall Study|Adverse Event|22
1228023|NCT00736489|4028462|P6|Period 1|Withdrawal by Subject|1
1228024|NCT00736489|4028463|P5|Period 1|Withdrawal by Subject|0
1228025|NCT00736489|4028464|P4|Period 1|Withdrawal by Subject|0
1228026|NCT00736489|4028465|P3|Period 1|Withdrawal by Subject|0
1228027|NCT00736489|4028466|P2|Period 1|Withdrawal by Subject|0
1228028|NCT00736489|4028467|P1|Period 1|Withdrawal by Subject|0
1228029|NCT00736489|4028462|P6|Period 1|Lost to Follow-up|0
1228030|NCT00736489|4028463|P5|Period 1|Lost to Follow-up|0
1228031|NCT00736489|4028464|P4|Period 1|Lost to Follow-up|0
1228032|NCT00736489|4028465|P3|Period 1|Lost to Follow-up|0
1228033|NCT00736489|4028466|P2|Period 1|Lost to Follow-up|0
1228034|NCT00736489|4028467|P1|Period 1|Lost to Follow-up|1
1228035|NCT00736476|4028621|P2|Overall Study|Adverse Event|0
1228036|NCT00736476|4028622|P1|Overall Study|Adverse Event|1
1228037|NCT00736450|4028642|P1|Overall Study|Physician Decision|1
1228038|NCT00736450|4028642|P1|Overall Study|Withdrawal by Subject|5
1228039|NCT00736450|4028642|P1|Overall Study|Not ABC gene eligible|19
1228040|NCT00736385|4028650|P2|Overall Study|Adverse Event|1
1228041|NCT00736385|4028651|P1|Overall Study|Adverse Event|0
1228042|NCT00736385|4028650|P2|Overall Study|Withdrawal by Subject|2
1228043|NCT00736385|4028651|P1|Overall Study|Withdrawal by Subject|2
1228044|NCT00736333|4028663|P1|Overall Study|Not Specified|4
1228045|NCT00736333|4028663|P1|Overall Study|Death|7
1228046|NCT00736333|4028663|P1|Overall Study|Withdrawal by Subject|10
1228047|NCT00736333|4028663|P1|Overall Study|Toxicity|6
1228048|NCT00736333|4028663|P1|Overall Study|Tumor Progression|75
1228049|NCT00736333|4028663|P1|Overall Study|Data Missing|2
1228050|NCT00736333|4028663|P1|Overall Study|Did Not Receive Drug or Not Documented|7
1228051|NCT00736255|4028674|P2|Overall Study|Non-compliance|1
1228052|NCT00736255|4028675|P1|Overall Study|Non-compliance|1
1228053|NCT00736255|4028674|P2|Overall Study|Physician Decision|0
1228054|NCT00736255|4028675|P1|Overall Study|Physician Decision|1
1228055|NCT00736255|4028674|P2|Overall Study|Adverse Event|0
1228056|NCT00736255|4028675|P1|Overall Study|Adverse Event|1
1228057|NCT00736190|4028722|P1|Overall Study|Adverse Event|1
1228058|NCT00736190|4028722|P1|Overall Study|Withdrawal by Subject|1
1228059|NCT00736190|4028722|P1|Overall Study|Pregnancy|1
1228060|NCT00736099|4028748|P2|Overall Study|Other reason|10
1228061|NCT00736099|4028749|P1|Overall Study|Other reason|43
1228062|NCT00736099|4028748|P2|Overall Study|Lack of Efficacy|8
1228063|NCT00736099|4028749|P1|Overall Study|Lack of Efficacy|15
1228064|NCT00736099|4028748|P2|Overall Study|Withdrawal by Subject|13
1228065|NCT00736099|4028749|P1|Overall Study|Withdrawal by Subject|42
1228066|NCT00736099|4028748|P2|Overall Study|Lost to Follow-up|5
1228067|NCT00736099|4028749|P1|Overall Study|Lost to Follow-up|12
1228068|NCT00736099|4028748|P2|Overall Study|Protocol Violation|4
1228069|NCT00736099|4028749|P1|Overall Study|Protocol Violation|10
1228070|NCT00736099|4028748|P2|Overall Study|Adverse Event|18
1228071|NCT00736099|4028749|P1|Overall Study|Adverse Event|61
1228072|NCT00736034|4028858|P1|Overall Study|Adverse Event|2
1228073|NCT00735943|4028866|P1|Overall Study|Adverse Event|1
1228074|NCT00735943|4028866|P1|Overall Study|Lost to Follow-up|1
1228075|NCT00735904|4028891|P1|Overall Study|Other|8
1228076|NCT00735904|4028891|P1|Overall Study|Study Terminated by Sponsor|5
1228077|NCT00735904|4028891|P1|Overall Study|Withdrawal by Subject|1
1228078|NCT00735904|4028891|P1|Overall Study|Protocol Violation|1
1228079|NCT00735904|4028891|P1|Overall Study|Death|20
1228080|NCT00735904|4028891|P1|Overall Study|Adverse Event|3
1228081|NCT00735878|4028901|P3|Phase I- Dose Determination|Withdrawal by Subject|1
1228082|NCT00735878|4028902|P2|Phase I- Dose Determination|Withdrawal by Subject|0
1228083|NCT00735878|4028903|P1|Phase I- Dose Determination|Withdrawal by Subject|0
1228084|NCT00735709|4028982|P4|Overall Study|Excluded medication|1
1228085|NCT00735709|4028983|P3|Overall Study|Excluded medication|0
1228086|NCT00735709|4028984|P2|Overall Study|Excluded medication|0
1228087|NCT00735709|4028985|P1|Overall Study|Excluded medication|1
1228088|NCT00735709|4028982|P4|Overall Study|Lost to Follow-up|1
1228089|NCT00735709|4028983|P3|Overall Study|Lost to Follow-up|1
1228090|NCT00735709|4028984|P2|Overall Study|Lost to Follow-up|1
1228091|NCT00735709|4028985|P1|Overall Study|Lost to Follow-up|0
1228092|NCT00735709|4028982|P4|Overall Study|Voluntary Withdrawal|7
1228093|NCT00735709|4028983|P3|Overall Study|Voluntary Withdrawal|5
1228094|NCT00735709|4028984|P2|Overall Study|Voluntary Withdrawal|3
1228095|NCT00735709|4028985|P1|Overall Study|Voluntary Withdrawal|1
1228096|NCT00735709|4028982|P4|Overall Study|Protocol deviations|1
1228097|NCT00735709|4028983|P3|Overall Study|Protocol deviations|1
1228098|NCT00735709|4028984|P2|Overall Study|Protocol deviations|2
1228099|NCT00735709|4028985|P1|Overall Study|Protocol deviations|1
1228100|NCT00735709|4028982|P4|Overall Study|Noncompliance|0
1228101|NCT00735709|4028983|P3|Overall Study|Noncompliance|1
1228102|NCT00735709|4028984|P2|Overall Study|Noncompliance|0
1228103|NCT00735709|4028985|P1|Overall Study|Noncompliance|0
1228104|NCT00735709|4028982|P4|Overall Study|Lack of Efficacy|3
1228105|NCT00735709|4028983|P3|Overall Study|Lack of Efficacy|2
1228106|NCT00735709|4028984|P2|Overall Study|Lack of Efficacy|4
1228107|NCT00735709|4028985|P1|Overall Study|Lack of Efficacy|8
1228108|NCT00735709|4028982|P4|Overall Study|Adverse Event|5
1228109|NCT00735709|4028983|P3|Overall Study|Adverse Event|1
1228110|NCT00735709|4028984|P2|Overall Study|Adverse Event|3
1228111|NCT00735709|4028985|P1|Overall Study|Adverse Event|2
1228112|NCT00735696|4029095|P1|Overall Study|Enrolled but never Treated|1
1228113|NCT00735696|4029095|P1|Overall Study|Withdrawal by Subject|1
1228114|NCT00735644|4029123|P5|Overall Study|Withdrawal by Subject|0
1228115|NCT00735644|4029124|P4|Overall Study|Withdrawal by Subject|1
1228116|NCT00735644|4029125|P3|Overall Study|Withdrawal by Subject|1
1228117|NCT00735644|4029126|P2|Overall Study|Withdrawal by Subject|1
1228118|NCT00735644|4029127|P1|Overall Study|Withdrawal by Subject|0
1228119|NCT00735644|4029123|P5|Overall Study|Did not receive study vaccine|0
1228120|NCT00735644|4029124|P4|Overall Study|Did not receive study vaccine|0
1228121|NCT00735644|4029125|P3|Overall Study|Did not receive study vaccine|0
1228122|NCT00735644|4029126|P2|Overall Study|Did not receive study vaccine|1
1228123|NCT00735644|4029127|P1|Overall Study|Did not receive study vaccine|0
1228124|NCT00735553|4029171|P1|Overall Study|Study prematurely terminated|77
1228125|NCT00735475|4029181|P2|Overall Study|Withdrawal by Subject|5
1228126|NCT00735475|4029182|P1|Overall Study|Withdrawal by Subject|4
1228127|NCT00735475|4029181|P2|Overall Study|Physician Decision|1
1228128|NCT00735475|4029182|P1|Overall Study|Physician Decision|0
1228129|NCT00735475|4029181|P2|Overall Study|Lost to Follow-up|3
1228130|NCT00735475|4029182|P1|Overall Study|Lost to Follow-up|3
1228131|NCT00735475|4029181|P2|Overall Study|Death|1
1228132|NCT00735475|4029182|P1|Overall Study|Death|1
1228133|NCT00735475|4029181|P2|Overall Study|Adverse Event|1
1228134|NCT00735475|4029182|P1|Overall Study|Adverse Event|0
1228135|NCT00735397|4029242|P1|Overall Study|Administrative/Other|502
1228136|NCT00735397|4029242|P1|Overall Study|Inadequate therapeutic effect|202
1228137|NCT00735397|4029242|P1|Overall Study|Participant choice|252
1228138|NCT00735397|4029242|P1|Overall Study|Lost to Follow-up|33
1228139|NCT00735397|4029242|P1|Overall Study|Adverse Event|194
1228140|NCT00735371|4029256|P4|Overall Study|Exclusion criteria|0
1228141|NCT00735371|4029257|P3|Overall Study|Exclusion criteria|0
1228142|NCT00735371|4029258|P2|Overall Study|Exclusion criteria|0
1228143|NCT00735371|4029259|P1|Overall Study|Exclusion criteria|1
1228144|NCT00735371|4029256|P4|Overall Study|Prior Vyvanse Exposure|0
1228145|NCT00735371|4029257|P3|Overall Study|Prior Vyvanse Exposure|0
1228146|NCT00735371|4029258|P2|Overall Study|Prior Vyvanse Exposure|1
1228147|NCT00735371|4029259|P1|Overall Study|Prior Vyvanse Exposure|1
1228148|NCT00735371|4029256|P4|Overall Study|Protocol Violation|0
1228149|NCT00735371|4029257|P3|Overall Study|Protocol Violation|2
1228150|NCT00735371|4029258|P2|Overall Study|Protocol Violation|1
1228151|NCT00735371|4029259|P1|Overall Study|Protocol Violation|0
1228152|NCT00735371|4029256|P4|Overall Study|Sponsor Decision|1
1228153|NCT00735371|4029257|P3|Overall Study|Sponsor Decision|0
1228154|NCT00735371|4029258|P2|Overall Study|Sponsor Decision|1
1228155|NCT00735371|4029259|P1|Overall Study|Sponsor Decision|3
1228156|NCT00735371|4029256|P4|Overall Study|Lack of Efficacy|4
1228157|NCT00735371|4029257|P3|Overall Study|Lack of Efficacy|0
1228158|NCT00735371|4029258|P2|Overall Study|Lack of Efficacy|2
1228159|NCT00735371|4029259|P1|Overall Study|Lack of Efficacy|4
1228160|NCT00735371|4029256|P4|Overall Study|Lost to Follow-up|1
1228161|NCT00735371|4029257|P3|Overall Study|Lost to Follow-up|3
1228162|NCT00735371|4029258|P2|Overall Study|Lost to Follow-up|1
1228163|NCT00735371|4029259|P1|Overall Study|Lost to Follow-up|1
1228164|NCT00735371|4029256|P4|Overall Study|Withdrawal by Subject|0
1228165|NCT00735371|4029257|P3|Overall Study|Withdrawal by Subject|2
1228166|NCT00735371|4029258|P2|Overall Study|Withdrawal by Subject|2
1228167|NCT00735371|4029259|P1|Overall Study|Withdrawal by Subject|0
1228168|NCT00735371|4029256|P4|Overall Study|Protocol Violation|3
1228169|NCT00735371|4029257|P3|Overall Study|Protocol Violation|0
1228170|NCT00735371|4029258|P2|Overall Study|Protocol Violation|2
1228171|NCT00735371|4029259|P1|Overall Study|Protocol Violation|2
1228172|NCT00735371|4029256|P4|Overall Study|Adverse Event|1
1228173|NCT00735371|4029257|P3|Overall Study|Adverse Event|4
1228174|NCT00735371|4029258|P2|Overall Study|Adverse Event|3
1228175|NCT00735371|4029259|P1|Overall Study|Adverse Event|3
1228176|NCT00735254|4029287|P4|Overall Study|Protocol Violation|0
1228177|NCT00735254|4029288|P3|Overall Study|Protocol Violation|1
1228178|NCT00735254|4029289|P2|Overall Study|Protocol Violation|1
1228179|NCT00735254|4029290|P1|Overall Study|Protocol Violation|1
1228180|NCT00735072|4029302|P2|Overall Study|Subject interrupted ARVs (non-adherence)|1
1228181|NCT00735072|4029303|P1|Overall Study|Subject interrupted ARVs (non-adherence)|0
1228182|NCT00735072|4029302|P2|Overall Study|interrupted study med during ARV change|0
1228183|NCT00735072|4029303|P1|Overall Study|interrupted study med during ARV change|1
1228184|NCT00735007|4029309|P1|Overall Study|Protocol Violation|1
1228185|NCT00735007|4029309|P1|Overall Study|Adverse Event|4
1228186|NCT00734994|4029334|P1|Overall Study|Withdrawal by Subject|1
1228187|NCT00734929|4029354|P2|Overall Study|No intervention/ screen fail|3
1228188|NCT00734929|4029355|P1|Overall Study|No intervention/ screen fail|5
1228189|NCT00734929|4029354|P2|Overall Study|Lost to Follow-up|2
1228190|NCT00734929|4029355|P1|Overall Study|Lost to Follow-up|1
1228191|NCT00734851|4029412|P1|Overall Study|Physician Decision|18
1228192|NCT00734851|4029412|P1|Overall Study|Lost to Follow-up|1
1228193|NCT00734851|4029412|P1|Overall Study|Withdrawal by Subject|2
1228194|NCT00734747|4029433|P1|6 Month Follow-up|Did not meet inclusion criteria|3
1228195|NCT00734747|4029433|P1|SRS Procedure|No staples placed|3
1228196|NCT00734656|4029447|P4|Lab Session 4|Withdrawal by Subject|1
1228197|NCT00734656|4029448|P3|Lab Session 4|Withdrawal by Subject|0
1228198|NCT00734656|4029449|P2|Lab Session 4|Withdrawal by Subject|0
1228199|NCT00734656|4029450|P1|Lab Session 4|Withdrawal by Subject|0
1228200|NCT00734656|4029447|P4|Washout 3|Withdrawal by Subject|1
1228201|NCT00734656|4029448|P3|Washout 3|Withdrawal by Subject|0
1228202|NCT00734656|4029449|P2|Washout 3|Withdrawal by Subject|0
1228203|NCT00734656|4029450|P1|Washout 3|Withdrawal by Subject|1
1228204|NCT00734656|4029447|P4|Washout 2|Withdrawal by Subject|0
1228205|NCT00734656|4029448|P3|Washout 2|Withdrawal by Subject|1
1228206|NCT00734656|4029449|P2|Washout 2|Withdrawal by Subject|1
1228207|NCT00734656|4029450|P1|Washout 2|Withdrawal by Subject|1
1228208|NCT00734656|4029447|P4|Lab Session 2|Withdrawal by Subject|1
1228209|NCT00734656|4029448|P3|Lab Session 2|Withdrawal by Subject|0
1228210|NCT00734656|4029449|P2|Lab Session 2|Withdrawal by Subject|0
1228211|NCT00734656|4029450|P1|Lab Session 2|Withdrawal by Subject|1
1228212|NCT00734656|4029447|P4|Washout 1|Withdrawal by Subject|3
1228213|NCT00734656|4029448|P3|Washout 1|Withdrawal by Subject|2
1228214|NCT00734656|4029449|P2|Washout 1|Withdrawal by Subject|5
1228215|NCT00734656|4029450|P1|Washout 1|Withdrawal by Subject|1
1228216|NCT00734656|4029447|P4|Lab Session 1|Withdrawal by Subject|0
1228217|NCT00734656|4029448|P3|Lab Session 1|Withdrawal by Subject|0
1228218|NCT00734656|4029449|P2|Lab Session 1|Withdrawal by Subject|0
1228219|NCT00734656|4029450|P1|Lab Session 1|Withdrawal by Subject|2
1228220|NCT00734630|4029474|P2|Overall Study|Poor Compliance|1
1228221|NCT00734630|4029475|P1|Overall Study|Poor Compliance|1
1228222|NCT00734630|4029474|P2|Overall Study|Tested Positive for Illegal Drug Use|1
1228223|NCT00734630|4029475|P1|Overall Study|Tested Positive for Illegal Drug Use|1
1228224|NCT00734630|4029474|P2|Overall Study|Randomized in Error|1
1228225|NCT00734630|4029475|P1|Overall Study|Randomized in Error|0
1228226|NCT00734630|4029474|P2|Overall Study|Adverse Event|6
1228227|NCT00734630|4029475|P1|Overall Study|Adverse Event|3
1228228|NCT00734630|4029474|P2|Overall Study|Inclusion/Exclusion criteria not met|1
1228229|NCT00734630|4029475|P1|Overall Study|Inclusion/Exclusion criteria not met|0
1228230|NCT00734630|4029474|P2|Overall Study|Protocol Violation|3
1228231|NCT00734630|4029475|P1|Overall Study|Protocol Violation|0
1228232|NCT00734630|4029474|P2|Overall Study|Lost to Follow-up|7
1228233|NCT00734630|4029475|P1|Overall Study|Lost to Follow-up|13
1228234|NCT00734630|4029474|P2|Overall Study|Withdrawal by Subject|9
1228235|NCT00734630|4029475|P1|Overall Study|Withdrawal by Subject|7
1228236|NCT00734630|4029474|P2|Overall Study|Lack of Efficacy|4
1228237|NCT00734630|4029475|P1|Overall Study|Lack of Efficacy|4
1228238|NCT00734617|4029485|P2|Overall Study|Withdrawal by Subject|95
1228239|NCT00734617|4029486|P1|Overall Study|Withdrawal by Subject|103
1228240|NCT00734617|4029485|P2|Overall Study|Adverse Event|7
1228241|NCT00734617|4029486|P1|Overall Study|Adverse Event|4
1228242|NCT00734604|4029498|P6|Overall Study|Lack of Efficacy|0
1228243|NCT00734604|4029499|P5|Overall Study|Lack of Efficacy|0
1228244|NCT00734604|4029500|P4|Overall Study|Lack of Efficacy|0
1228245|NCT00734604|4029501|P3|Overall Study|Lack of Efficacy|1
1228246|NCT00734604|4029502|P2|Overall Study|Lack of Efficacy|1
1228247|NCT00734604|4029503|P1|Overall Study|Lack of Efficacy|0
1228248|NCT00734604|4029498|P6|Overall Study|Withdrawal by Subject|1
1228249|NCT00734604|4029499|P5|Overall Study|Withdrawal by Subject|2
1228250|NCT00734604|4029500|P4|Overall Study|Withdrawal by Subject|1
1228251|NCT00734604|4029501|P3|Overall Study|Withdrawal by Subject|0
1228252|NCT00734604|4029502|P2|Overall Study|Withdrawal by Subject|2
1228253|NCT00734604|4029503|P1|Overall Study|Withdrawal by Subject|0
1228254|NCT00734604|4029498|P6|Overall Study|Sponsor Decision|0
1228255|NCT00734604|4029499|P5|Overall Study|Sponsor Decision|2
1228256|NCT00734604|4029500|P4|Overall Study|Sponsor Decision|0
1228257|NCT00734604|4029501|P3|Overall Study|Sponsor Decision|1
1228258|NCT00734604|4029502|P2|Overall Study|Sponsor Decision|2
1228259|NCT00734604|4029503|P1|Overall Study|Sponsor Decision|1
1228260|NCT00734604|4029498|P6|Overall Study|Protocol Violation|0
1228261|NCT00734604|4029499|P5|Overall Study|Protocol Violation|1
1228262|NCT00734604|4029500|P4|Overall Study|Protocol Violation|0
1228263|NCT00734604|4029501|P3|Overall Study|Protocol Violation|0
1228264|NCT00734604|4029502|P2|Overall Study|Protocol Violation|2
1228265|NCT00734604|4029503|P1|Overall Study|Protocol Violation|0
1228266|NCT00734604|4029498|P6|Overall Study|Physician Decision|0
1228267|NCT00734604|4029499|P5|Overall Study|Physician Decision|0
1228268|NCT00734604|4029500|P4|Overall Study|Physician Decision|0
1228269|NCT00734604|4029501|P3|Overall Study|Physician Decision|1
1228270|NCT00734604|4029502|P2|Overall Study|Physician Decision|1
1228271|NCT00734604|4029503|P1|Overall Study|Physician Decision|0
1228272|NCT00734604|4029498|P6|Overall Study|Lost to Follow-up|3
1228273|NCT00734604|4029499|P5|Overall Study|Lost to Follow-up|2
1228274|NCT00734604|4029500|P4|Overall Study|Lost to Follow-up|4
1228275|NCT00734604|4029501|P3|Overall Study|Lost to Follow-up|2
1228276|NCT00734604|4029502|P2|Overall Study|Lost to Follow-up|2
1228277|NCT00734604|4029503|P1|Overall Study|Lost to Follow-up|1
1228278|NCT00734604|4029498|P6|Overall Study|Serious Adverse Event|1
1228279|NCT00734604|4029499|P5|Overall Study|Serious Adverse Event|0
1228280|NCT00734604|4029500|P4|Overall Study|Serious Adverse Event|2
1228281|NCT00734604|4029501|P3|Overall Study|Serious Adverse Event|1
1228282|NCT00734604|4029502|P2|Overall Study|Serious Adverse Event|0
1228283|NCT00734604|4029503|P1|Overall Study|Serious Adverse Event|1
1228284|NCT00734604|4029498|P6|Overall Study|Adverse Event|1
1228285|NCT00734604|4029499|P5|Overall Study|Adverse Event|1
1228286|NCT00734604|4029500|P4|Overall Study|Adverse Event|2
1228287|NCT00734604|4029501|P3|Overall Study|Adverse Event|0
1228288|NCT00734604|4029502|P2|Overall Study|Adverse Event|2
1228289|NCT00734604|4029503|P1|Overall Study|Adverse Event|0
1228290|NCT00734591|4029553|P2|Prospective Period|Other|2
1228291|NCT00734591|4029554|P1|Prospective Period|Other|2
1228292|NCT00734591|4029553|P2|Prospective Period|Study Terminated|0
1228293|NCT00734591|4029554|P1|Prospective Period|Study Terminated|1
1228294|NCT00734591|4029553|P2|Prospective Period|Lost to Follow-up|33
1228295|NCT00734591|4029554|P1|Prospective Period|Lost to Follow-up|37
1228296|NCT00734591|4029553|P2|Prospective Period|Withdrawal by Subject|9
1228297|NCT00734591|4029554|P1|Prospective Period|Withdrawal by Subject|11
1228298|NCT00734591|4029553|P2|Screening for Prospective Period|Patient at partic. site not enrolled|803
1228299|NCT00734591|4029554|P1|Screening for Prospective Period|Patient at partic. site not enrolled|913
1228300|NCT00734591|4029553|P2|Screening for Prospective Period|Site did not participate|1488
1228301|NCT00734591|4029554|P1|Screening for Prospective Period|Site did not participate|1604
1228302|NCT00734578|4029569|P3|Overall Study|Exclusion criteria|0
1228303|NCT00734578|4029570|P2|Overall Study|Exclusion criteria|0
1228304|NCT00734578|4029571|P1|Overall Study|Exclusion criteria|1
1228305|NCT00734578|4029569|P3|Overall Study|Randomized in error|0
1228306|NCT00734578|4029570|P2|Overall Study|Randomized in error|0
1228307|NCT00734578|4029571|P1|Overall Study|Randomized in error|1
1228308|NCT00734578|4029569|P3|Overall Study|Lack of Efficacy|5
1228309|NCT00734578|4029570|P2|Overall Study|Lack of Efficacy|2
1228310|NCT00734578|4029571|P1|Overall Study|Lack of Efficacy|3
1228311|NCT00734578|4029569|P3|Overall Study|Lost to Follow-up|5
1228312|NCT00734578|4029570|P2|Overall Study|Lost to Follow-up|3
1228313|NCT00734578|4029571|P1|Overall Study|Lost to Follow-up|9
1228314|NCT00734578|4029569|P3|Overall Study|Withdrawal by Subject|11
1228315|NCT00734578|4029570|P2|Overall Study|Withdrawal by Subject|8
1228316|NCT00734578|4029571|P1|Overall Study|Withdrawal by Subject|7
1228317|NCT00734578|4029569|P3|Overall Study|Protocol Violation|3
1228318|NCT00734578|4029570|P2|Overall Study|Protocol Violation|6
1228319|NCT00734578|4029571|P1|Overall Study|Protocol Violation|8
1228320|NCT00734578|4029569|P3|Overall Study|Adverse Event|1
1228321|NCT00734578|4029570|P2|Overall Study|Adverse Event|6
1228322|NCT00734578|4029571|P1|Overall Study|Adverse Event|4
1228323|NCT00734539|4029605|P2|Main Study|Enrolled in error; ineligible|0
1228324|NCT00734539|4029606|P1|Main Study|Enrolled in error; ineligible|1
1228325|NCT00734539|4029605|P2|Main Study|Withdrawal by Subject|3
1228326|NCT00734539|4029606|P1|Main Study|Withdrawal by Subject|1
1228327|NCT00734539|4029605|P2|Main Study|Physician Decision|0
1228328|NCT00734539|4029606|P1|Main Study|Physician Decision|2
1228329|NCT00734539|4029605|P2|Main Study|Death|32
1228330|NCT00734539|4029606|P1|Main Study|Death|33
1228331|NCT00734474|4029648|P9|Overall Study|Lack of Efficacy|6
1228332|NCT00734474|4029649|P8|Overall Study|Lack of Efficacy|4
1228333|NCT00734474|4029650|P7|Overall Study|Lack of Efficacy|0
1228334|NCT00734474|4029651|P6|Overall Study|Lack of Efficacy|0
1228335|NCT00734474|4029652|P5|Overall Study|Lack of Efficacy|0
1228336|NCT00734474|4029653|P4|Overall Study|Lack of Efficacy|0
1228337|NCT00734474|4029654|P3|Overall Study|Lack of Efficacy|4
1228338|NCT00734474|4029655|P2|Overall Study|Lack of Efficacy|0
1228339|NCT00734474|4029656|P1|Overall Study|Lack of Efficacy|0
1228340|NCT00734474|4029648|P9|Overall Study|Death|1
1228341|NCT00734474|4029649|P8|Overall Study|Death|2
1228342|NCT00734474|4029650|P7|Overall Study|Death|0
1228343|NCT00734474|4029651|P6|Overall Study|Death|0
1228344|NCT00734474|4029652|P5|Overall Study|Death|0
1228345|NCT00734474|4029653|P4|Overall Study|Death|0
1228346|NCT00734474|4029654|P3|Overall Study|Death|1
1228347|NCT00734474|4029655|P2|Overall Study|Death|0
1228348|NCT00734474|4029656|P1|Overall Study|Death|0
1228349|NCT00734474|4029648|P9|Overall Study|Sponsor Decision|0
1228350|NCT00734474|4029649|P8|Overall Study|Sponsor Decision|0
1228351|NCT00734474|4029650|P7|Overall Study|Sponsor Decision|0
1228352|NCT00734474|4029651|P6|Overall Study|Sponsor Decision|0
1228353|NCT00734474|4029652|P5|Overall Study|Sponsor Decision|2
1228354|NCT00734474|4029653|P4|Overall Study|Sponsor Decision|0
1228355|NCT00734474|4029654|P3|Overall Study|Sponsor Decision|0
1228356|NCT00734474|4029655|P2|Overall Study|Sponsor Decision|0
1228357|NCT00734474|4029656|P1|Overall Study|Sponsor Decision|0
1228358|NCT00734474|4029648|P9|Overall Study|Sponsor Decision, Arm Discontinued|0
1228359|NCT00734474|4029649|P8|Overall Study|Sponsor Decision, Arm Discontinued|0
1228360|NCT00734474|4029650|P7|Overall Study|Sponsor Decision, Arm Discontinued|23
1228361|NCT00734474|4029651|P6|Overall Study|Sponsor Decision, Arm Discontinued|21
1228362|NCT00734474|4029652|P5|Overall Study|Sponsor Decision, Arm Discontinued|0
1228363|NCT00734474|4029653|P4|Overall Study|Sponsor Decision, Arm Discontinued|8
1228364|NCT00734474|4029654|P3|Overall Study|Sponsor Decision, Arm Discontinued|0
1228365|NCT00734474|4029655|P2|Overall Study|Sponsor Decision, Arm Discontinued|25
1228366|NCT00734474|4029656|P1|Overall Study|Sponsor Decision, Arm Discontinued|8
1228367|NCT00734474|4029648|P9|Overall Study|Protocol Violation|1
1228368|NCT00734474|4029649|P8|Overall Study|Protocol Violation|3
1228369|NCT00734474|4029650|P7|Overall Study|Protocol Violation|0
1228370|NCT00734474|4029651|P6|Overall Study|Protocol Violation|0
1228371|NCT00734474|4029652|P5|Overall Study|Protocol Violation|3
1228372|NCT00734474|4029653|P4|Overall Study|Protocol Violation|0
1228373|NCT00734474|4029654|P3|Overall Study|Protocol Violation|4
1228374|NCT00734474|4029655|P2|Overall Study|Protocol Violation|0
1228375|NCT00734474|4029656|P1|Overall Study|Protocol Violation|0
1228376|NCT00734474|4029648|P9|Overall Study|Adverse Event|39
1228377|NCT00734474|4029649|P8|Overall Study|Adverse Event|65
1228378|NCT00734474|4029650|P7|Overall Study|Adverse Event|1
1228379|NCT00734474|4029651|P6|Overall Study|Adverse Event|0
1228380|NCT00734474|4029652|P5|Overall Study|Adverse Event|64
1228381|NCT00734474|4029653|P4|Overall Study|Adverse Event|1
1228382|NCT00734474|4029654|P3|Overall Study|Adverse Event|63
1228383|NCT00734474|4029655|P2|Overall Study|Adverse Event|4
1228384|NCT00734474|4029656|P1|Overall Study|Adverse Event|4
1228385|NCT00734474|4029648|P9|Overall Study|Physician Decision|9
1228386|NCT00734474|4029649|P8|Overall Study|Physician Decision|9
1228387|NCT00734474|4029650|P7|Overall Study|Physician Decision|0
1228388|NCT00734474|4029651|P6|Overall Study|Physician Decision|0
1228389|NCT00734474|4029652|P5|Overall Study|Physician Decision|11
1228390|NCT00734474|4029653|P4|Overall Study|Physician Decision|1
1228391|NCT00734474|4029654|P3|Overall Study|Physician Decision|4
1228392|NCT00734474|4029655|P2|Overall Study|Physician Decision|0
1228393|NCT00734474|4029656|P1|Overall Study|Physician Decision|0
1228394|NCT00734474|4029648|P9|Overall Study|Withdrawal by Subject|21
1228395|NCT00734474|4029649|P8|Overall Study|Withdrawal by Subject|36
1228396|NCT00734474|4029650|P7|Overall Study|Withdrawal by Subject|0
1228397|NCT00734474|4029651|P6|Overall Study|Withdrawal by Subject|2
1228398|NCT00734474|4029652|P5|Overall Study|Withdrawal by Subject|24
1228399|NCT00734474|4029653|P4|Overall Study|Withdrawal by Subject|0
1228400|NCT00734474|4029654|P3|Overall Study|Withdrawal by Subject|18
1228401|NCT00734474|4029655|P2|Overall Study|Withdrawal by Subject|1
1228402|NCT00734474|4029656|P1|Overall Study|Withdrawal by Subject|2
1228403|NCT00734474|4029648|P9|Overall Study|Lost to Follow-up|4
1228404|NCT00734474|4029649|P8|Overall Study|Lost to Follow-up|9
1228405|NCT00734474|4029650|P7|Overall Study|Lost to Follow-up|0
1228406|NCT00734474|4029651|P6|Overall Study|Lost to Follow-up|1
1228407|NCT00734474|4029652|P5|Overall Study|Lost to Follow-up|11
1228408|NCT00734474|4029653|P4|Overall Study|Lost to Follow-up|0
1228409|NCT00734474|4029654|P3|Overall Study|Lost to Follow-up|13
1228410|NCT00734474|4029655|P2|Overall Study|Lost to Follow-up|0
1228411|NCT00734474|4029656|P1|Overall Study|Lost to Follow-up|1
1228412|NCT00734474|4029648|P9|Overall Study|Entry Criteria Not Met|1
1228413|NCT00734474|4029649|P8|Overall Study|Entry Criteria Not Met|1
1228414|NCT00734474|4029650|P7|Overall Study|Entry Criteria Not Met|0
1228415|NCT00734474|4029651|P6|Overall Study|Entry Criteria Not Met|1
1228416|NCT00734474|4029652|P5|Overall Study|Entry Criteria Not Met|3
1228417|NCT00734474|4029653|P4|Overall Study|Entry Criteria Not Met|0
1228418|NCT00734474|4029654|P3|Overall Study|Entry Criteria Not Met|5
1228419|NCT00734474|4029655|P2|Overall Study|Entry Criteria Not Met|0
1228420|NCT00734474|4029656|P1|Overall Study|Entry Criteria Not Met|0
1228421|NCT00734214|4029946|P2|Overall Study|MD withdrawal|0
1228422|NCT00734214|4029947|P1|Overall Study|MD withdrawal|1
1228423|NCT00734214|4029946|P2|Overall Study|Withdrawal by Subject|4
1228424|NCT00734214|4029947|P1|Overall Study|Withdrawal by Subject|3
1228425|NCT00734162|4029957|P4|Open-Label Phase|Did Not Meet Entrance Criteria|1
1228426|NCT00734162|4029958|P3|Open-Label Phase|Did Not Meet Entrance Criteria|0
1228427|NCT00734162|4029959|P2|Open-Label Phase|Did Not Meet Entrance Criteria|0
1228428|NCT00734162|4029960|P1|Open-Label Phase|Did Not Meet Entrance Criteria|0
1228429|NCT00734162|4029957|P4|Open-Label Phase|Lost to Follow-up|1
1228430|NCT00734162|4029958|P3|Open-Label Phase|Lost to Follow-up|0
1228431|NCT00734162|4029959|P2|Open-Label Phase|Lost to Follow-up|2
1228432|NCT00734162|4029960|P1|Open-Label Phase|Lost to Follow-up|1
1228433|NCT00734162|4029957|P4|Open-Label Phase|Withdrew Consent|1
1228434|NCT00734162|4029958|P3|Open-Label Phase|Withdrew Consent|1
1228435|NCT00734162|4029959|P2|Open-Label Phase|Withdrew Consent|0
1228436|NCT00734162|4029960|P1|Open-Label Phase|Withdrew Consent|1
1228437|NCT00734162|4029957|P4|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
1228438|NCT00734162|4029958|P3|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
1228439|NCT00734162|4029959|P2|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
1228440|NCT00734162|4029960|P1|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1
1228441|NCT00734162|4029957|P4|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2
1228442|NCT00734162|4029958|P3|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
1228443|NCT00734162|4029959|P2|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
1228444|NCT00734162|4029960|P1|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
1228445|NCT00734162|4029957|P4|Randomized Phase (Through Week 72)|Investigator's Discretion|2
1228446|NCT00734162|4029958|P3|Randomized Phase (Through Week 72)|Investigator's Discretion|0
1228447|NCT00734162|4029959|P2|Randomized Phase (Through Week 72)|Investigator's Discretion|1
1228448|NCT00734162|4029960|P1|Randomized Phase (Through Week 72)|Investigator's Discretion|0
1228449|NCT00734149|4030184|P1|Overall Study|Withdrawal by Subject|1
1228450|NCT00734097|4030191|P1|Open Label|Protocol Violation|4
1228451|NCT00734097|4030191|P1|Open Label|Withdrawal by Subject|5
1228452|NCT00734097|4030191|P1|Open Label|Lost to Follow-up|7
1228453|NCT00734097|4030191|P1|Screening|Unconfirmed pregnancy|1
1228454|NCT00734097|4030191|P1|Screening|Lost to Follow-up|2
1228455|NCT00734097|4030191|P1|Screening|Withdrawal by Subject|5
1228456|NCT00734097|4030191|P1|Screening|Protocol Violation|12
1228457|NCT00734071|4030208|P2|Overall Study|Other|2
1228458|NCT00734071|4030209|P1|Overall Study|Other|1
1228459|NCT00734071|4030208|P2|Overall Study|Lost to Follow-up|8
1228460|NCT00734071|4030209|P1|Overall Study|Lost to Follow-up|16
1228461|NCT00734071|4030208|P2|Overall Study|Voluntary Withdrawal|7
1228462|NCT00734071|4030209|P1|Overall Study|Voluntary Withdrawal|9
1228463|NCT00734071|4030208|P2|Overall Study|Protocol Deviations|4
1228464|NCT00734071|4030209|P1|Overall Study|Protocol Deviations|3
1228465|NCT00734071|4030208|P2|Overall Study|Noncompliance|2
1228466|NCT00734071|4030209|P1|Overall Study|Noncompliance|2
1228467|NCT00734071|4030208|P2|Overall Study|Lack of Efficacy|1
1228468|NCT00734071|4030209|P1|Overall Study|Lack of Efficacy|3
1228469|NCT00734071|4030208|P2|Overall Study|Adverse Event|3
1228470|NCT00734071|4030209|P1|Overall Study|Adverse Event|4
1228471|NCT00734032|4030267|P4|Overall Study|Adverse Event|0
1228472|NCT00734032|4030268|P3|Overall Study|Adverse Event|0
1228473|NCT00734032|4030269|P2|Overall Study|Adverse Event|1
1228474|NCT00734032|4030270|P1|Overall Study|Adverse Event|0
1228475|NCT00733980|4030326|P2|Overall Study|Withdrawal by Subject|2
1228476|NCT00733980|4030327|P1|Overall Study|Withdrawal by Subject|6
1228477|NCT00733980|4030326|P2|Overall Study|Physician Decision|3
1228478|NCT00733980|4030327|P1|Overall Study|Physician Decision|2
1228479|NCT00733980|4030326|P2|Overall Study|Lost to Follow-up|11
1228480|NCT00733980|4030327|P1|Overall Study|Lost to Follow-up|6
1228481|NCT00733980|4030326|P2|Overall Study|Protocol defined stopping criteria reach|1
1228482|NCT00733980|4030327|P1|Overall Study|Protocol defined stopping criteria reach|1
1228483|NCT00733980|4030326|P2|Overall Study|Protocol Violation|1
1228484|NCT00733980|4030327|P1|Overall Study|Protocol Violation|2
1228485|NCT00733980|4030326|P2|Overall Study|Lack of Efficacy|1
1228486|NCT00733980|4030327|P1|Overall Study|Lack of Efficacy|0
1228487|NCT00733980|4030326|P2|Overall Study|Adverse Event|2
1228488|NCT00733980|4030327|P1|Overall Study|Adverse Event|5
1228489|NCT00733954|4030371|P2|Overall Study|Withdrawal by Subject|0
1228490|NCT00733954|4030372|P1|Overall Study|Withdrawal by Subject|2
1228491|NCT00733954|4030371|P2|Overall Study|Protocol Violation|0
1228492|NCT00733954|4030372|P1|Overall Study|Protocol Violation|1
1228493|NCT00733954|4030371|P2|Overall Study|Lost to Follow-up|2
1228494|NCT00733954|4030372|P1|Overall Study|Lost to Follow-up|5
1228495|NCT00733824|4030419|P5|Phase I|Withdrawal by Subject|0
1228496|NCT00733824|4030420|P4|Phase I|Withdrawal by Subject|0
1228497|NCT00733824|4030421|P3|Phase I|Withdrawal by Subject|0
1228498|NCT00733824|4030422|P2|Phase I|Withdrawal by Subject|0
1228499|NCT00733824|4030423|P1|Phase I|Withdrawal by Subject|1
1228500|NCT00733746|4030442|P1|Overall Study|Ineligible|5
1228501|NCT00733499|4030457|P2|24 Months Follow-up|Death|1
1228502|NCT00733499|4030458|P1|24 Months Follow-up|Death|0
1228503|NCT00733499|4030457|P2|12 Months Follow-up|Death|1
1228504|NCT00733499|4030458|P1|12 Months Follow-up|Death|2
1228505|NCT00733499|4030457|P2|6 Months Follow-up|Adverse Event|1
1228506|NCT00733499|4030458|P1|6 Months Follow-up|Adverse Event|0
1228507|NCT00733499|4030457|P2|6 Months Follow-up|Death|2
1228508|NCT00733499|4030458|P1|6 Months Follow-up|Death|0
1228509|NCT00733499|4030457|P2|3 Months Follow-up|Death|2
1228510|NCT00733499|4030458|P1|3 Months Follow-up|Death|1
1228511|NCT00733499|4030457|P2|Pre-operative|Protocol Violation|1
1228512|NCT00733499|4030458|P1|Pre-operative|Protocol Violation|0
1228513|NCT00733421|4030466|P2|Overall Study|Withdrawal by Subject|1
1228514|NCT00733421|4030467|P1|Overall Study|Withdrawal by Subject|1
1228515|NCT00733408|4030489|P1|Overall Study|Adverse Event|4
1228516|NCT00733369|4030501|P2|Overall Study|Protocol Violation|4
1228517|NCT00733369|4030502|P1|Overall Study|Protocol Violation|4
1228518|NCT00733369|4030501|P2|Overall Study|Adverse Event|4
1228519|NCT00733369|4030502|P1|Overall Study|Adverse Event|4
1228520|NCT00733369|4030501|P2|Overall Study|Lost to Follow-up|1
1228521|NCT00733369|4030502|P1|Overall Study|Lost to Follow-up|2
1228522|NCT00733304|4030710|P3|Overall Study|Withdrawal by Subject|0
1228523|NCT00733304|4030711|P2|Overall Study|Withdrawal by Subject|1
1228524|NCT00733304|4030712|P1|Overall Study|Withdrawal by Subject|1
1228525|NCT00733304|4030710|P3|Overall Study|Physician Decision|3
1228526|NCT00733304|4030711|P2|Overall Study|Physician Decision|1
1228527|NCT00733304|4030712|P1|Overall Study|Physician Decision|3
1228528|NCT00733304|4030710|P3|Overall Study|Lost to Follow-up|0
1228529|NCT00733304|4030711|P2|Overall Study|Lost to Follow-up|1
1228530|NCT00733304|4030712|P1|Overall Study|Lost to Follow-up|0
1228531|NCT00733304|4030710|P3|Overall Study|Lack of Efficacy|2
1228532|NCT00733304|4030711|P2|Overall Study|Lack of Efficacy|0
1228533|NCT00733304|4030712|P1|Overall Study|Lack of Efficacy|0
1228534|NCT00733304|4030710|P3|Overall Study|Adverse Event|0
1228535|NCT00733304|4030711|P2|Overall Study|Adverse Event|0
1228536|NCT00733304|4030712|P1|Overall Study|Adverse Event|3
1228537|NCT00733291|4030794|P4|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
1228538|NCT00733291|4030795|P3|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
1228539|NCT00733291|4030796|P2|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
1228540|NCT00733291|4030797|P1|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1
1228541|NCT00733226|4030826|P2|Overall Study|moved to another place|0
1228542|NCT00733226|4030827|P1|Overall Study|moved to another place|2
1228543|NCT00733226|4030826|P2|Overall Study|Lost to Follow-up|0
1228544|NCT00733226|4030827|P1|Overall Study|Lost to Follow-up|2
1228545|NCT00733226|4030826|P2|Overall Study|Withdrawal by Subject|0
1228546|NCT00733226|4030827|P1|Overall Study|Withdrawal by Subject|1
1228547|NCT00733005|4030876|P2|Overall Study|Protocol Violation|0
1228548|NCT00733005|4030877|P1|Overall Study|Protocol Violation|2
1228549|NCT00733005|4030876|P2|Overall Study|Withdrawal by Subject|1
1228550|NCT00733005|4030877|P1|Overall Study|Withdrawal by Subject|0
1228551|NCT00733005|4030876|P2|Overall Study|Treatment Failure|1
1228552|NCT00733005|4030877|P1|Overall Study|Treatment Failure|0
1228553|NCT00733005|4030876|P2|Overall Study|Adverse Event|1
1228554|NCT00733005|4030877|P1|Overall Study|Adverse Event|0
1228555|NCT00732992|4030887|P2|Overall Study|Withdrawal by Subject|0
1228556|NCT00732992|4030888|P1|Overall Study|Withdrawal by Subject|1
1228557|NCT00732992|4030887|P2|Overall Study|Global Deterioration of Health Status|0
1228558|NCT00732992|4030888|P1|Overall Study|Global Deterioration of Health Status|1
1228559|NCT00732992|4030887|P2|Overall Study|Objective Progression or Relapse|5
1228560|NCT00732992|4030888|P1|Overall Study|Objective Progression or Relapse|3
1228561|NCT00732992|4030887|P2|Overall Study|Adverse Event|1
1228562|NCT00732992|4030888|P1|Overall Study|Adverse Event|1
1228563|NCT00732940|4030907|P2|Overall Study|Lost to Follow-up|0
1228564|NCT00732940|4030908|P1|Overall Study|Lost to Follow-up|1
1228565|NCT00732940|4030907|P2|Overall Study|Adverse Event|1
1228566|NCT00732940|4030908|P1|Overall Study|Adverse Event|0
1228567|NCT00732940|4030907|P2|Overall Study|Withdrawal by Subject|2
1228568|NCT00732940|4030908|P1|Overall Study|Withdrawal by Subject|1
1228569|NCT00732875|4030989|P1|Overall Study|Lack of Efficacy|13
1228570|NCT00732875|4030989|P1|Overall Study|Withdrawal by Subject|6
1228571|NCT00732875|4030989|P1|Overall Study|Adverse Event|16
1228572|NCT00732758|4030997|P2|Overall Study|Lost to Follow-up|16
1228573|NCT00732758|4030998|P1|Overall Study|Lost to Follow-up|8
1228574|NCT00732641|4031038|P2|Overall Study|Not Specified|5
1228575|NCT00732641|4031039|P1|Overall Study|Not Specified|18
1228576|NCT00732641|4031038|P2|Overall Study|Unable to Complete|1
1228577|NCT00732641|4031039|P1|Overall Study|Unable to Complete|1
1228578|NCT00732641|4031038|P2|Overall Study|Withdrawal by Subject|2
1228579|NCT00732641|4031039|P1|Overall Study|Withdrawal by Subject|4
1228580|NCT00732641|4031038|P2|Overall Study|Physician Decision|0
1228581|NCT00732641|4031039|P1|Overall Study|Physician Decision|6
1228582|NCT00732641|4031038|P2|Overall Study|Serious Adverse Events|3
1228583|NCT00732641|4031039|P1|Overall Study|Serious Adverse Events|12
1228584|NCT00732641|4031038|P2|Overall Study|Relapse or Progressive Disease|101
1228585|NCT00732641|4031039|P1|Overall Study|Relapse or Progressive Disease|65
1228586|NCT00732615|4031059|P2|Overall Study|Non-Compliance, Subject/Physician Dec.|1
1228587|NCT00732615|4031060|P1|Overall Study|Non-Compliance, Subject/Physician Dec.|1
1228588|NCT00732615|4031059|P2|Overall Study|Physician Decision|0
1228589|NCT00732615|4031060|P1|Overall Study|Physician Decision|3
1228590|NCT00732615|4031059|P2|Overall Study|Adverse Event|2
1228591|NCT00732615|4031060|P1|Overall Study|Adverse Event|0
1228592|NCT00732615|4031059|P2|Overall Study|Lost to Follow-up|1
1228593|NCT00732615|4031060|P1|Overall Study|Lost to Follow-up|0
1228594|NCT00732615|4031059|P2|Overall Study|Withdrawal by Subject|1
1228595|NCT00732615|4031060|P1|Overall Study|Withdrawal by Subject|3
1228596|NCT00732472|4031076|P4|Overall Study|Withdrawal by Subject|1
1228597|NCT00732472|4031077|P3|Overall Study|Withdrawal by Subject|0
1228598|NCT00732472|4031078|P2|Overall Study|Withdrawal by Subject|2
1228599|NCT00732472|4031079|P1|Overall Study|Withdrawal by Subject|0
1228600|NCT00732472|4031076|P4|Overall Study|Protocol Violation|1
1228601|NCT00732472|4031077|P3|Overall Study|Protocol Violation|0
1228602|NCT00732472|4031078|P2|Overall Study|Protocol Violation|0
1228603|NCT00732472|4031079|P1|Overall Study|Protocol Violation|0
1228604|NCT00732472|4031076|P4|Overall Study|Adverse Event|1
1228605|NCT00732472|4031077|P3|Overall Study|Adverse Event|1
1228606|NCT00732472|4031078|P2|Overall Study|Adverse Event|1
1228607|NCT00732472|4031079|P1|Overall Study|Adverse Event|0
1228608|NCT00732381|4031179|P2|Overall Study|Treatment Failure|1
1228609|NCT00732381|4031180|P1|Overall Study|Treatment Failure|1
1228610|NCT00732381|4031179|P2|Overall Study|Adverse Event|0
1228611|NCT00732381|4031180|P1|Overall Study|Adverse Event|1
1228612|NCT00732303|4031188|P1|Overall Study|Study Terminated|2
1228613|NCT00732251|4031194|P1|Overall Study|Early Term due to Site Closure|1
1228614|NCT00732251|4031194|P1|Overall Study|Withdrawal by Subject|3
1228615|NCT00732251|4031194|P1|Overall Study|Lost to Follow-up|3
1228616|NCT00732238|4031200|P2|Overall Study|Asymptomatic bacteriuria|0
1228617|NCT00732238|4031201|P1|Overall Study|Asymptomatic bacteriuria|1
1228618|NCT00732238|4031200|P2|Overall Study|Bacteremia|1
1228619|NCT00732238|4031201|P1|Overall Study|Bacteremia|4
1228620|NCT00732199|4031302|P2|Overall Study|sleep apnea, inadequate signals/sleep|8
1228621|NCT00732199|4031303|P1|Overall Study|sleep apnea, inadequate signals/sleep|9
1228622|NCT00732199|4031302|P2|Overall Study|Withdrawal by Subject|18
1228623|NCT00732199|4031303|P1|Overall Study|Withdrawal by Subject|25
1228624|NCT00732160|4031318|P4|Overall Study|scheduling|1
1228625|NCT00732160|4031319|P3|Overall Study|scheduling|2
1228626|NCT00732160|4031320|P2|Overall Study|scheduling|4
1228627|NCT00732160|4031321|P1|Overall Study|scheduling|4
1228628|NCT00732160|4031318|P4|Overall Study|Adverse Event|1
1228629|NCT00732160|4031319|P3|Overall Study|Adverse Event|1
1228630|NCT00732160|4031320|P2|Overall Study|Adverse Event|0
1228631|NCT00732160|4031321|P1|Overall Study|Adverse Event|1
1228632|NCT00732069|4031335|P6|Washout After First Study Drug|Adverse Event|0
1228633|NCT00732069|4031336|P5|Washout After First Study Drug|Adverse Event|0
1228634|NCT00732069|4031337|P4|Washout After First Study Drug|Adverse Event|0
1228635|NCT00732069|4031338|P3|Washout After First Study Drug|Adverse Event|0
1228636|NCT00732069|4031339|P2|Washout After First Study Drug|Adverse Event|0
1228637|NCT00732069|4031340|P1|Washout After First Study Drug|Adverse Event|1
1228638|NCT00731939|4031358|P1|Overall Study|Did not meet enrollment criteria|2
1228639|NCT00731939|4031358|P1|Overall Study|Withdrawal by Subject|2
1228640|NCT00731939|4031358|P1|Overall Study|Not implanted with study device|9
1228641|NCT00731939|4031358|P1|Overall Study|Lost to Follow-up|15
1228642|NCT00731939|4031358|P1|Overall Study|Adverse Event|6
1228643|NCT00731822|4031435|P2|Overall Study|Lost to Follow-up|0
1228644|NCT00731822|4031436|P1|Overall Study|Lost to Follow-up|1
1228645|NCT00731822|4031435|P2|Overall Study|Protocol Violation|0
1228646|NCT00731822|4031436|P1|Overall Study|Protocol Violation|1
1228647|NCT00731822|4031435|P2|Overall Study|Adverse Event|1
1228648|NCT00731822|4031436|P1|Overall Study|Adverse Event|2
1228649|NCT00731783|4031450|P2|12 Month Follow-Up Visit|Lost to Follow-up|7
1228650|NCT00731783|4031451|P1|12 Month Follow-Up Visit|Lost to Follow-up|6
1228651|NCT00731783|4031450|P2|Six Month Follow-Up Visit|Lost to Follow-up|3
1228652|NCT00731783|4031451|P1|Six Month Follow-Up Visit|Lost to Follow-up|6
1228653|NCT00731783|4031450|P2|Three Month Follow-Up Visit|Lost to Follow-up|16
1228654|NCT00731783|4031451|P1|Three Month Follow-Up Visit|Lost to Follow-up|7
1228655|NCT00731783|4031450|P2|One Month Follow-Up Visit|Lost to Follow-up|22
1228656|NCT00731783|4031451|P1|One Month Follow-Up Visit|Lost to Follow-up|14
1228657|NCT00731731|4031474|P3|Overall Study|Cancel prior to treatment|2
1228658|NCT00731731|4031475|P2|Overall Study|Cancel prior to treatment|0
1228659|NCT00731731|4031476|P1|Overall Study|Cancel prior to treatment|0
1228660|NCT00731731|4031474|P3|Overall Study|Protocol Violation|1
1228661|NCT00731731|4031475|P2|Overall Study|Protocol Violation|0
1228662|NCT00731731|4031476|P1|Overall Study|Protocol Violation|0
1228663|NCT00731692|4031494|P3|Extension Phase|Adverse Event|15
1228664|NCT00731692|4031495|P2|Extension Phase|Adverse Event|1
1228665|NCT00731692|4031496|P1|Extension Phase|Adverse Event|1
1228666|NCT00731692|4031494|P3|Extension Phase|Withdrawal by Subject|3
1228667|NCT00731692|4031495|P2|Extension Phase|Withdrawal by Subject|5
1228668|NCT00731692|4031496|P1|Extension Phase|Withdrawal by Subject|4
1228669|NCT00731692|4031494|P3|Extension Phase|Lost to Follow-up|4
1228670|NCT00731692|4031495|P2|Extension Phase|Lost to Follow-up|1
1228671|NCT00731692|4031496|P1|Extension Phase|Lost to Follow-up|0
1228672|NCT00731692|4031494|P3|Extension Phase|Abnormal lab values|1
1228673|NCT00731692|4031495|P2|Extension Phase|Abnormal lab values|0
1228674|NCT00731692|4031496|P1|Extension Phase|Abnormal lab values|0
1228675|NCT00731692|4031494|P3|Extension Phase|Abnormal test procedure|1
1228676|NCT00731692|4031495|P2|Extension Phase|Abnormal test procedure|0
1228677|NCT00731692|4031496|P1|Extension Phase|Abnormal test procedure|0
1228678|NCT00731692|4031494|P3|Extension Phase|Admin Problems: Terminated # patients|277
1228679|NCT00731692|4031495|P2|Extension Phase|Admin Problems: Terminated # patients|189
1228680|NCT00731692|4031496|P1|Extension Phase|Admin Problems: Terminated # patients|69
1228681|NCT00731692|4031494|P3|Core Study (36 Months)|Withdrawal by Subject|46
1228682|NCT00731692|4031495|P2|Core Study (36 Months)|Withdrawal by Subject|32
1228683|NCT00731692|4031496|P1|Core Study (36 Months)|Withdrawal by Subject|12
1228684|NCT00731692|4031494|P3|Core Study (36 Months)|Adverse Event|29
1228685|NCT00731692|4031495|P2|Core Study (36 Months)|Adverse Event|28
1228686|NCT00731692|4031496|P1|Core Study (36 Months)|Adverse Event|25
1228687|NCT00731692|4031494|P3|Core Study (36 Months)|Abnormal Lab values|5
1228688|NCT00731692|4031495|P2|Core Study (36 Months)|Abnormal Lab values|19
1228689|NCT00731692|4031496|P1|Core Study (36 Months)|Abnormal Lab values|6
1228690|NCT00731692|4031494|P3|Core Study (36 Months)|Protocol Violation|8
1228691|NCT00731692|4031495|P2|Core Study (36 Months)|Protocol Violation|5
1228692|NCT00731692|4031496|P1|Core Study (36 Months)|Protocol Violation|4
1228693|NCT00731692|4031494|P3|Core Study (36 Months)|Abnormal Test Procedure Result|5
1228694|NCT00731692|4031495|P2|Core Study (36 Months)|Abnormal Test Procedure Result|3
1228695|NCT00731692|4031496|P1|Core Study (36 Months)|Abnormal Test Procedure Result|4
1228696|NCT00731692|4031494|P3|Core Study (36 Months)|Administrative|6
1228697|NCT00731692|4031495|P2|Core Study (36 Months)|Administrative|2
1228698|NCT00731692|4031496|P1|Core Study (36 Months)|Administrative|2
1228699|NCT00731692|4031494|P3|Core Study (36 Months)|Lost to Follow-up|3
1228700|NCT00731692|4031495|P2|Core Study (36 Months)|Lost to Follow-up|3
1228701|NCT00731692|4031496|P1|Core Study (36 Months)|Lost to Follow-up|1
1228702|NCT00731692|4031494|P3|Core Study (36 Months)|Death|2
1228703|NCT00731692|4031495|P2|Core Study (36 Months)|Death|1
1228704|NCT00731692|4031496|P1|Core Study (36 Months)|Death|2
1228705|NCT00731692|4031494|P3|Core Study (36 Months)|Physician Decision|2
1228706|NCT00731692|4031495|P2|Core Study (36 Months)|Physician Decision|0
1228707|NCT00731692|4031496|P1|Core Study (36 Months)|Physician Decision|1
1228708|NCT00731692|4031494|P3|Core Study (36 Months)|Lack of Efficacy|64
1228709|NCT00731692|4031495|P2|Core Study (36 Months)|Lack of Efficacy|23
1228710|NCT00731692|4031496|P1|Core Study (36 Months)|Lack of Efficacy|11
1228711|NCT00731679|4031542|P2|Overall Study|Pregnancy|1
1228712|NCT00731679|4031543|P1|Overall Study|Pregnancy|0
1228713|NCT00731679|4031542|P2|Overall Study|Noncompliance|1
1228714|NCT00731679|4031543|P1|Overall Study|Noncompliance|0
1228715|NCT00731679|4031542|P2|Overall Study|Lost to Follow-up|8
1228716|NCT00731679|4031543|P1|Overall Study|Lost to Follow-up|7
1228717|NCT00731679|4031542|P2|Overall Study|Withdrawal by Subject|8
1228718|NCT00731679|4031543|P1|Overall Study|Withdrawal by Subject|8
1228719|NCT00731679|4031542|P2|Overall Study|Adverse Event|8
1228720|NCT00731679|4031543|P1|Overall Study|Adverse Event|7
1228721|NCT00731666|4031551|P1|Overall Study|Withdrawal by Subject|2
1228722|NCT00731666|4031551|P1|Overall Study|Lost to Follow-up|8
1228723|NCT00731666|4031551|P1|Overall Study|Adverse Event|2
1228724|NCT00731549|4031585|P1|Overall Study|Lack of efficacy without AE|6
1228725|NCT00731549|4031585|P1|Overall Study|Lack of efficacy with AE|37
1228726|NCT00731549|4031585|P1|Overall Study|Adverse Event|31
1228727|NCT00731549|4031585|P1|Overall Study|Protocol deviation|1
1228728|NCT00731549|4031585|P1|Overall Study|Withdrawal by Subject|89
1228729|NCT00731549|4031585|P1|Overall Study|Physician Decision|16
1228730|NCT00731549|4031585|P1|Overall Study|Met withdrawal criteria|24
1228731|NCT00731549|4031585|P1|Overall Study|Lost to Follow-up|19
1228732|NCT00731133|4031625|P1|Overall Study|Withdrawal by Subject|10
1228733|NCT00731120|4031633|P3|Overall Study|Other|1
1228734|NCT00731120|4031634|P2|Overall Study|Other|0
1228735|NCT00731120|4031635|P1|Overall Study|Other|4
1228736|NCT00731120|4031633|P3|Overall Study|Lost to Follow-up|17
1228737|NCT00731120|4031634|P2|Overall Study|Lost to Follow-up|15
1228738|NCT00731120|4031635|P1|Overall Study|Lost to Follow-up|10
1228739|NCT00731120|4031633|P3|Overall Study|Withdrawal of Consent|4
1228740|NCT00731120|4031634|P2|Overall Study|Withdrawal of Consent|8
1228741|NCT00731120|4031635|P1|Overall Study|Withdrawal of Consent|13
1228742|NCT00731120|4031633|P3|Overall Study|Protocol Deviations|1
1228743|NCT00731120|4031634|P2|Overall Study|Protocol Deviations|6
1228744|NCT00731120|4031635|P1|Overall Study|Protocol Deviations|1
1228745|NCT00731120|4031633|P3|Overall Study|Noncompliance with Study Drug|1
1228746|NCT00731120|4031634|P2|Overall Study|Noncompliance with Study Drug|3
1228747|NCT00731120|4031635|P1|Overall Study|Noncompliance with Study Drug|3
1228748|NCT00731120|4031633|P3|Overall Study|Lack of Efficacy|4
1228749|NCT00731120|4031634|P2|Overall Study|Lack of Efficacy|5
1228750|NCT00731120|4031635|P1|Overall Study|Lack of Efficacy|4
1228751|NCT00731120|4031633|P3|Overall Study|Adverse Event|8
1228752|NCT00731120|4031634|P2|Overall Study|Adverse Event|6
1228753|NCT00731120|4031635|P1|Overall Study|Adverse Event|7
1228754|NCT00731042|4031752|P2|Second Intervention|Did not meet inclusion criteria|2
1228755|NCT00731042|4031753|P1|Second Intervention|Did not meet inclusion criteria|0
1228756|NCT00730925|4031764|P1|Overall Study|Other|1
1228757|NCT00730925|4031764|P1|Overall Study|Switch to combination therapy|8
1228758|NCT00730925|4031764|P1|Overall Study|Withdrawal by Subject|1
1228759|NCT00730925|4031764|P1|Overall Study|Protocol Violation|1
1228760|NCT00730925|4031764|P1|Overall Study|Other Averse Event|7
1228761|NCT00730925|4031764|P1|Overall Study|Dose reducing Event|2
1228762|NCT00730925|4031764|P1|Overall Study|Progressive Disease|21
1228763|NCT00730912|4031774|P3|Overall Study|Discontinued|1
1228764|NCT00730912|4031775|P2|Overall Study|Discontinued|0
1228765|NCT00730912|4031776|P1|Overall Study|Discontinued|0
1228766|NCT00730886|4031789|P2|Overall Study|Physician Decision|0
1228767|NCT00730886|4031790|P1|Overall Study|Physician Decision|1
1228768|NCT00730886|4031789|P2|Overall Study|Lost to Follow-up|0
1228769|NCT00730886|4031790|P1|Overall Study|Lost to Follow-up|1
1228770|NCT00730847|4031814|P1|Overall Study|Other|24
1228771|NCT00730847|4031814|P1|Overall Study|Unknown completion status|21
1228772|NCT00730847|4031814|P1|Overall Study|Lost to Follow-up|67
1228773|NCT00730847|4031814|P1|Overall Study|Withdrawal by Subject|16
1228774|NCT00730847|4031814|P1|Overall Study|Protocol Violation|2
1228775|NCT00730847|4031814|P1|Overall Study|Adverse Event|1
1228776|NCT00730756|4031823|P2|Overall Study|Withdrew Consent|1
1228777|NCT00730756|4031824|P1|Overall Study|Withdrew Consent|0
1228778|NCT00730756|4031823|P2|Overall Study|Lost to Follow-up|1
1228779|NCT00730756|4031824|P1|Overall Study|Lost to Follow-up|0
1228780|NCT00730756|4031823|P2|Overall Study|Protocol Deviation|2
1228781|NCT00730756|4031824|P1|Overall Study|Protocol Deviation|1
1228782|NCT00730756|4031823|P2|Overall Study|Lack of Efficacy|1
1228783|NCT00730756|4031824|P1|Overall Study|Lack of Efficacy|1
1228784|NCT00730756|4031823|P2|Overall Study|Adverse Event|0
1228785|NCT00730756|4031824|P1|Overall Study|Adverse Event|2
1228786|NCT00730691|4031858|P5|Overall Study|Other|2
1228787|NCT00730691|4031859|P4|Overall Study|Other|2
1228788|NCT00730691|4031860|P3|Overall Study|Other|1
1228789|NCT00730691|4031861|P2|Overall Study|Other|1
1228790|NCT00730691|4031862|P1|Overall Study|Other|1
1228791|NCT00730691|4031858|P5|Overall Study|Lost to Follow-up|13
1228792|NCT00730691|4031859|P4|Overall Study|Lost to Follow-up|15
1228793|NCT00730691|4031860|P3|Overall Study|Lost to Follow-up|13
1228794|NCT00730691|4031861|P2|Overall Study|Lost to Follow-up|8
1228795|NCT00730691|4031862|P1|Overall Study|Lost to Follow-up|11
1228796|NCT00730691|4031858|P5|Overall Study|Withdrawal of Consent|3
1228797|NCT00730691|4031859|P4|Overall Study|Withdrawal of Consent|6
1228798|NCT00730691|4031860|P3|Overall Study|Withdrawal of Consent|3
1228799|NCT00730691|4031861|P2|Overall Study|Withdrawal of Consent|9
1228800|NCT00730691|4031862|P1|Overall Study|Withdrawal of Consent|7
1228801|NCT00730691|4031858|P5|Overall Study|Protocol Deviations|5
1228802|NCT00730691|4031859|P4|Overall Study|Protocol Deviations|7
1228803|NCT00730691|4031860|P3|Overall Study|Protocol Deviations|3
1228804|NCT00730691|4031861|P2|Overall Study|Protocol Deviations|5
1228805|NCT00730691|4031862|P1|Overall Study|Protocol Deviations|3
1228806|NCT00730691|4031858|P5|Overall Study|Non-compliance with Study Drug|3
1228807|NCT00730691|4031859|P4|Overall Study|Non-compliance with Study Drug|3
1228808|NCT00730691|4031860|P3|Overall Study|Non-compliance with Study Drug|6
1228809|NCT00730691|4031861|P2|Overall Study|Non-compliance with Study Drug|1
1228810|NCT00730691|4031862|P1|Overall Study|Non-compliance with Study Drug|6
1228811|NCT00730691|4031858|P5|Overall Study|Lack of Efficacy|1
1228812|NCT00730691|4031859|P4|Overall Study|Lack of Efficacy|1
1228813|NCT00730691|4031860|P3|Overall Study|Lack of Efficacy|2
1228814|NCT00730691|4031861|P2|Overall Study|Lack of Efficacy|4
1228815|NCT00730691|4031862|P1|Overall Study|Lack of Efficacy|4
1228816|NCT00730691|4031858|P5|Overall Study|Adverse Event|23
1228817|NCT00730691|4031859|P4|Overall Study|Adverse Event|11
1228818|NCT00730691|4031860|P3|Overall Study|Adverse Event|11
1228819|NCT00730691|4031861|P2|Overall Study|Adverse Event|8
1228820|NCT00730691|4031862|P1|Overall Study|Adverse Event|4
1228821|NCT00730639|4031954|P5|Overall Study|Treatment on-going|4
1228822|NCT00730639|4031955|P4|Overall Study|Treatment on-going|4
1228823|NCT00730639|4031956|P3|Overall Study|Treatment on-going|5
1228824|NCT00730639|4031957|P2|Overall Study|Treatment on-going|5
1228825|NCT00730639|4031958|P1|Overall Study|Treatment on-going|2
1228826|NCT00730639|4031954|P5|Overall Study|Withdrawal by Subject|4
1228827|NCT00730639|4031955|P4|Overall Study|Withdrawal by Subject|3
1228828|NCT00730639|4031956|P3|Overall Study|Withdrawal by Subject|6
1228829|NCT00730639|4031957|P2|Overall Study|Withdrawal by Subject|0
1228830|NCT00730639|4031958|P1|Overall Study|Withdrawal by Subject|0
1228831|NCT00730639|4031954|P5|Overall Study|Protocol Violation|0
1228832|NCT00730639|4031955|P4|Overall Study|Protocol Violation|0
1228833|NCT00730639|4031956|P3|Overall Study|Protocol Violation|1
1228834|NCT00730639|4031957|P2|Overall Study|Protocol Violation|0
1228835|NCT00730639|4031958|P1|Overall Study|Protocol Violation|0
1228836|NCT00730639|4031954|P5|Overall Study|non-specified|3
1228837|NCT00730639|4031955|P4|Overall Study|non-specified|2
1228838|NCT00730639|4031956|P3|Overall Study|non-specified|4
1228839|NCT00730639|4031957|P2|Overall Study|non-specified|0
1228840|NCT00730639|4031958|P1|Overall Study|non-specified|0
1228841|NCT00730639|4031954|P5|Overall Study|Disease Progression|88
1228842|NCT00730639|4031955|P4|Overall Study|Disease Progression|32
1228843|NCT00730639|4031956|P3|Overall Study|Disease Progression|48
1228844|NCT00730639|4031957|P2|Overall Study|Disease Progression|13
1228845|NCT00730639|4031958|P1|Overall Study|Disease Progression|12
1228846|NCT00730639|4031954|P5|Overall Study|Death|2
1228847|NCT00730639|4031955|P4|Overall Study|Death|0
1228848|NCT00730639|4031956|P3|Overall Study|Death|0
1228849|NCT00730639|4031957|P2|Overall Study|Death|0
1228850|NCT00730639|4031958|P1|Overall Study|Death|0
1228851|NCT00730639|4031954|P5|Overall Study|Completed Maximum Cycles|6
1228852|NCT00730639|4031955|P4|Overall Study|Completed Maximum Cycles|3
1228853|NCT00730639|4031956|P3|Overall Study|Completed Maximum Cycles|11
1228854|NCT00730639|4031957|P2|Overall Study|Completed Maximum Cycles|0
1228855|NCT00730639|4031958|P1|Overall Study|Completed Maximum Cycles|0
1228856|NCT00730639|4031954|P5|Overall Study|Complete Response|1
1228857|NCT00730639|4031955|P4|Overall Study|Complete Response|2
1228858|NCT00730639|4031956|P3|Overall Study|Complete Response|2
1228859|NCT00730639|4031957|P2|Overall Study|Complete Response|0
1228860|NCT00730639|4031958|P1|Overall Study|Complete Response|0
1228861|NCT00730639|4031954|P5|Overall Study|Adverse Event|23
1228862|NCT00730639|4031955|P4|Overall Study|Adverse Event|8
1228863|NCT00730639|4031956|P3|Overall Study|Adverse Event|9
1228864|NCT00730639|4031957|P2|Overall Study|Adverse Event|0
1228865|NCT00730639|4031958|P1|Overall Study|Adverse Event|3
1228866|NCT00730405|4032035|P5|Overall Study-follow-up Phase|Atrial fibrillation history|0
1228867|NCT00730405|4032036|P4|Overall Study-follow-up Phase|Atrial fibrillation history|0
1228868|NCT00730405|4032037|P3|Overall Study-follow-up Phase|Atrial fibrillation history|0
1228869|NCT00730405|4032038|P2|Overall Study-follow-up Phase|Atrial fibrillation history|0
1228870|NCT00730405|4032039|P1|Overall Study-follow-up Phase|Atrial fibrillation history|1
1228871|NCT00730405|4032035|P5|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
1228872|NCT00730405|4032036|P4|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1
1228873|NCT00730405|4032037|P3|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
1228874|NCT00730405|4032038|P2|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
1228875|NCT00730405|4032039|P1|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
1228876|NCT00730405|4032035|P5|Overall Study-follow-up Phase|Other Protocol violation|0
1228877|NCT00730405|4032036|P4|Overall Study-follow-up Phase|Other Protocol violation|0
1228878|NCT00730405|4032037|P3|Overall Study-follow-up Phase|Other Protocol violation|1
1228879|NCT00730405|4032038|P2|Overall Study-follow-up Phase|Other Protocol violation|0
1228880|NCT00730405|4032039|P1|Overall Study-follow-up Phase|Other Protocol violation|0
1228881|NCT00730405|4032035|P5|Overall Study-follow-up Phase|Mis-randomized|0
1228882|NCT00730405|4032036|P4|Overall Study-follow-up Phase|Mis-randomized|0
1228883|NCT00730405|4032037|P3|Overall Study-follow-up Phase|Mis-randomized|0
1228884|NCT00730405|4032038|P2|Overall Study-follow-up Phase|Mis-randomized|1
1228885|NCT00730405|4032039|P1|Overall Study-follow-up Phase|Mis-randomized|0
1228886|NCT00730405|4032035|P5|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
1228887|NCT00730405|4032036|P4|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
1228888|NCT00730405|4032037|P3|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1
1228889|NCT00730405|4032038|P2|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
1228890|NCT00730405|4032039|P1|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
1228891|NCT00730405|4032035|P5|Overall Study-follow-up Phase|Use an exclusionary medication|1
1228892|NCT00730405|4032036|P4|Overall Study-follow-up Phase|Use an exclusionary medication|0
1228893|NCT00730405|4032037|P3|Overall Study-follow-up Phase|Use an exclusionary medication|0
1228894|NCT00730405|4032038|P2|Overall Study-follow-up Phase|Use an exclusionary medication|0
1228895|NCT00730405|4032039|P1|Overall Study-follow-up Phase|Use an exclusionary medication|0
1228896|NCT00730405|4032035|P5|Overall Study-follow-up Phase|Missing|0
1228897|NCT00730405|4032036|P4|Overall Study-follow-up Phase|Missing|0
1228898|NCT00730405|4032037|P3|Overall Study-follow-up Phase|Missing|2
1228899|NCT00730405|4032038|P2|Overall Study-follow-up Phase|Missing|0
1228900|NCT00730405|4032039|P1|Overall Study-follow-up Phase|Missing|0
1228901|NCT00730405|4032035|P5|Overall Study-follow-up Phase|Non-compliance|0
1228902|NCT00730405|4032036|P4|Overall Study-follow-up Phase|Non-compliance|0
1228903|NCT00730405|4032037|P3|Overall Study-follow-up Phase|Non-compliance|2
1228904|NCT00730405|4032038|P2|Overall Study-follow-up Phase|Non-compliance|0
1228905|NCT00730405|4032039|P1|Overall Study-follow-up Phase|Non-compliance|1
1228906|NCT00730405|4032035|P5|Overall Study-follow-up Phase|Use of restricted medication|0
1228907|NCT00730405|4032036|P4|Overall Study-follow-up Phase|Use of restricted medication|0
1228908|NCT00730405|4032037|P3|Overall Study-follow-up Phase|Use of restricted medication|0
1228909|NCT00730405|4032038|P2|Overall Study-follow-up Phase|Use of restricted medication|1
1228910|NCT00730405|4032039|P1|Overall Study-follow-up Phase|Use of restricted medication|0
1228911|NCT00730405|4032035|P5|Overall Study-follow-up Phase|Declined to continue with follow-up|0
1228912|NCT00730405|4032036|P4|Overall Study-follow-up Phase|Declined to continue with follow-up|0
1228913|NCT00730405|4032037|P3|Overall Study-follow-up Phase|Declined to continue with follow-up|0
1228914|NCT00730405|4032038|P2|Overall Study-follow-up Phase|Declined to continue with follow-up|1
1228915|NCT00730405|4032039|P1|Overall Study-follow-up Phase|Declined to continue with follow-up|1
1228916|NCT00730405|4032035|P5|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
1228917|NCT00730405|4032036|P4|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
1228918|NCT00730405|4032037|P3|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
1228919|NCT00730405|4032038|P2|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
1228920|NCT00730405|4032039|P1|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
1228921|NCT00730405|4032035|P5|Overall Study-follow-up Phase|Refused follow-up due to AE|0
1228922|NCT00730405|4032036|P4|Overall Study-follow-up Phase|Refused follow-up due to AE|1
1228923|NCT00730405|4032037|P3|Overall Study-follow-up Phase|Refused follow-up due to AE|0
1228924|NCT00730405|4032038|P2|Overall Study-follow-up Phase|Refused follow-up due to AE|0
1228925|NCT00730405|4032039|P1|Overall Study-follow-up Phase|Refused follow-up due to AE|0
1228926|NCT00730405|4032035|P5|Overall Study-follow-up Phase|Prohibited concomitant medication|0
1228927|NCT00730405|4032036|P4|Overall Study-follow-up Phase|Prohibited concomitant medication|0
1228928|NCT00730405|4032037|P3|Overall Study-follow-up Phase|Prohibited concomitant medication|0
1228929|NCT00730405|4032038|P2|Overall Study-follow-up Phase|Prohibited concomitant medication|0
1228930|NCT00730405|4032039|P1|Overall Study-follow-up Phase|Prohibited concomitant medication|1
1228931|NCT00730405|4032035|P5|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1
1228932|NCT00730405|4032036|P4|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
1228933|NCT00730405|4032037|P3|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
1228934|NCT00730405|4032038|P2|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
1228935|NCT00730405|4032039|P1|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
1228936|NCT00730405|4032035|P5|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
1228937|NCT00730405|4032036|P4|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
1228938|NCT00730405|4032037|P3|Overall Study-follow-up Phase|Participant meets exclusion criteria|1
1228939|NCT00730405|4032038|P2|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
1228940|NCT00730405|4032039|P1|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
1228941|NCT00730405|4032035|P5|Overall Study-follow-up Phase|Non-compliance with study treatment|0
1228942|NCT00730405|4032036|P4|Overall Study-follow-up Phase|Non-compliance with study treatment|0
1228943|NCT00730405|4032037|P3|Overall Study-follow-up Phase|Non-compliance with study treatment|1
1228944|NCT00730405|4032038|P2|Overall Study-follow-up Phase|Non-compliance with study treatment|0
1228945|NCT00730405|4032039|P1|Overall Study-follow-up Phase|Non-compliance with study treatment|0
1228946|NCT00730405|4032035|P5|Overall Study-follow-up Phase|Did not met eligibility|0
1228947|NCT00730405|4032036|P4|Overall Study-follow-up Phase|Did not met eligibility|0
1228948|NCT00730405|4032037|P3|Overall Study-follow-up Phase|Did not met eligibility|1
1228949|NCT00730405|4032038|P2|Overall Study-follow-up Phase|Did not met eligibility|0
1228950|NCT00730405|4032039|P1|Overall Study-follow-up Phase|Did not met eligibility|0
1228951|NCT00730405|4032035|P5|Overall Study-follow-up Phase|Change of location|0
1228952|NCT00730405|4032036|P4|Overall Study-follow-up Phase|Change of location|1
1228953|NCT00730405|4032037|P3|Overall Study-follow-up Phase|Change of location|0
1228954|NCT00730405|4032038|P2|Overall Study-follow-up Phase|Change of location|1
1228955|NCT00730405|4032039|P1|Overall Study-follow-up Phase|Change of location|1
1228956|NCT00730405|4032035|P5|Overall Study-follow-up Phase|Death|0
1228957|NCT00730405|4032036|P4|Overall Study-follow-up Phase|Death|1
1228958|NCT00730405|4032037|P3|Overall Study-follow-up Phase|Death|0
1228959|NCT00730405|4032038|P2|Overall Study-follow-up Phase|Death|1
1228960|NCT00730405|4032039|P1|Overall Study-follow-up Phase|Death|0
1228961|NCT00730405|4032035|P5|Overall Study-follow-up Phase|Withdrawal by Subject|10
1228962|NCT00730405|4032036|P4|Overall Study-follow-up Phase|Withdrawal by Subject|6
1228963|NCT00730405|4032037|P3|Overall Study-follow-up Phase|Withdrawal by Subject|3
1228964|NCT00730405|4032038|P2|Overall Study-follow-up Phase|Withdrawal by Subject|3
1228965|NCT00730405|4032039|P1|Overall Study-follow-up Phase|Withdrawal by Subject|7
1228966|NCT00730405|4032035|P5|Overall Study-follow-up Phase|Lost to Follow-up|6
1228967|NCT00730405|4032036|P4|Overall Study-follow-up Phase|Lost to Follow-up|4
1228968|NCT00730405|4032037|P3|Overall Study-follow-up Phase|Lost to Follow-up|8
1228969|NCT00730405|4032038|P2|Overall Study-follow-up Phase|Lost to Follow-up|6
1228970|NCT00730405|4032039|P1|Overall Study-follow-up Phase|Lost to Follow-up|7
1228971|NCT00730405|4032035|P5|Overall Study-follow-up Phase|Adverse Event|4
1228972|NCT00730405|4032036|P4|Overall Study-follow-up Phase|Adverse Event|3
1228973|NCT00730405|4032037|P3|Overall Study-follow-up Phase|Adverse Event|2
1228974|NCT00730405|4032038|P2|Overall Study-follow-up Phase|Adverse Event|6
1228975|NCT00730405|4032039|P1|Overall Study-follow-up Phase|Adverse Event|2
1228976|NCT00730405|4032035|P5|Overall Study-Treatment Phase|Atrial fibrillation history|0
1228977|NCT00730405|4032036|P4|Overall Study-Treatment Phase|Atrial fibrillation history|0
1228978|NCT00730405|4032037|P3|Overall Study-Treatment Phase|Atrial fibrillation history|0
1228979|NCT00730405|4032038|P2|Overall Study-Treatment Phase|Atrial fibrillation history|0
1228980|NCT00730405|4032039|P1|Overall Study-Treatment Phase|Atrial fibrillation history|1
1228981|NCT00730405|4032035|P5|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1
1228982|NCT00730405|4032036|P4|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
1228983|NCT00730405|4032037|P3|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
1228984|NCT00730405|4032038|P2|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
1228985|NCT00730405|4032039|P1|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
1228986|NCT00730405|4032035|P5|Overall Study-Treatment Phase|Pregnancy|0
1228987|NCT00730405|4032036|P4|Overall Study-Treatment Phase|Pregnancy|0
1228988|NCT00730405|4032037|P3|Overall Study-Treatment Phase|Pregnancy|0
1228989|NCT00730405|4032038|P2|Overall Study-Treatment Phase|Pregnancy|1
1228990|NCT00730405|4032039|P1|Overall Study-Treatment Phase|Pregnancy|0
1228991|NCT00730405|4032035|P5|Overall Study-Treatment Phase|Change of location|0
1228992|NCT00730405|4032036|P4|Overall Study-Treatment Phase|Change of location|1
1228993|NCT00730405|4032037|P3|Overall Study-Treatment Phase|Change of location|0
1228994|NCT00730405|4032038|P2|Overall Study-Treatment Phase|Change of location|0
1228995|NCT00730405|4032039|P1|Overall Study-Treatment Phase|Change of location|0
1228996|NCT00730405|4032035|P5|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
1228997|NCT00730405|4032036|P4|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
1228998|NCT00730405|4032037|P3|Overall Study-Treatment Phase|Protocol violation due to eligibility|1
1228999|NCT00730405|4032038|P2|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
1229000|NCT00730405|4032039|P1|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
1229001|NCT00730405|4032035|P5|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
1229002|NCT00730405|4032036|P4|Overall Study-Treatment Phase|Due to in-vitro fertilization|1
1229003|NCT00730405|4032037|P3|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
1229004|NCT00730405|4032038|P2|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
1229005|NCT00730405|4032039|P1|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
1229006|NCT00730405|4032035|P5|Overall Study-Treatment Phase|Study drug interrupted|0
1229007|NCT00730405|4032036|P4|Overall Study-Treatment Phase|Study drug interrupted|0
1229008|NCT00730405|4032037|P3|Overall Study-Treatment Phase|Study drug interrupted|0
1229009|NCT00730405|4032038|P2|Overall Study-Treatment Phase|Study drug interrupted|1
1229010|NCT00730405|4032039|P1|Overall Study-Treatment Phase|Study drug interrupted|0
1229011|NCT00730405|4032035|P5|Overall Study-Treatment Phase|Misrandomized|0
1229012|NCT00730405|4032036|P4|Overall Study-Treatment Phase|Misrandomized|0
1229013|NCT00730405|4032037|P3|Overall Study-Treatment Phase|Misrandomized|0
1229014|NCT00730405|4032038|P2|Overall Study-Treatment Phase|Misrandomized|1
1229015|NCT00730405|4032039|P1|Overall Study-Treatment Phase|Misrandomized|0
1229016|NCT00730405|4032035|P5|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
1229017|NCT00730405|4032036|P4|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
1229018|NCT00730405|4032037|P3|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1
1229019|NCT00730405|4032038|P2|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
1229020|NCT00730405|4032039|P1|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
1229021|NCT00730405|4032035|P5|Overall Study-Treatment Phase|Use of prohibited medication|2
1229022|NCT00730405|4032036|P4|Overall Study-Treatment Phase|Use of prohibited medication|0
1229023|NCT00730405|4032037|P3|Overall Study-Treatment Phase|Use of prohibited medication|0
1229024|NCT00730405|4032038|P2|Overall Study-Treatment Phase|Use of prohibited medication|1
1229025|NCT00730405|4032039|P1|Overall Study-Treatment Phase|Use of prohibited medication|0
1229026|NCT00730405|4032035|P5|Overall Study-Treatment Phase|Withdrew from study treatment|0
1229027|NCT00730405|4032036|P4|Overall Study-Treatment Phase|Withdrew from study treatment|0
1229028|NCT00730405|4032037|P3|Overall Study-Treatment Phase|Withdrew from study treatment|0
1229029|NCT00730405|4032038|P2|Overall Study-Treatment Phase|Withdrew from study treatment|1
1229030|NCT00730405|4032039|P1|Overall Study-Treatment Phase|Withdrew from study treatment|0
1229031|NCT00730405|4032035|P5|Overall Study-Treatment Phase|Prohibited concomitant medication|0
1229032|NCT00730405|4032036|P4|Overall Study-Treatment Phase|Prohibited concomitant medication|0
1229033|NCT00730405|4032037|P3|Overall Study-Treatment Phase|Prohibited concomitant medication|0
1229034|NCT00730405|4032038|P2|Overall Study-Treatment Phase|Prohibited concomitant medication|0
1229035|NCT00730405|4032039|P1|Overall Study-Treatment Phase|Prohibited concomitant medication|1
1229036|NCT00730405|4032035|P5|Overall Study-Treatment Phase|Participant meets exclusion|0
1229037|NCT00730405|4032036|P4|Overall Study-Treatment Phase|Participant meets exclusion|0
1229038|NCT00730405|4032037|P3|Overall Study-Treatment Phase|Participant meets exclusion|1
1229039|NCT00730405|4032038|P2|Overall Study-Treatment Phase|Participant meets exclusion|0
1229040|NCT00730405|4032039|P1|Overall Study-Treatment Phase|Participant meets exclusion|0
1229041|NCT00730405|4032035|P5|Overall Study-Treatment Phase|Did not met eligibility|0
1229042|NCT00730405|4032036|P4|Overall Study-Treatment Phase|Did not met eligibility|0
1229043|NCT00730405|4032037|P3|Overall Study-Treatment Phase|Did not met eligibility|1
1229044|NCT00730405|4032038|P2|Overall Study-Treatment Phase|Did not met eligibility|0
1229045|NCT00730405|4032039|P1|Overall Study-Treatment Phase|Did not met eligibility|0
1229046|NCT00730405|4032035|P5|Overall Study-Treatment Phase|Withdrawal by Subject|8
1229047|NCT00730405|4032036|P4|Overall Study-Treatment Phase|Withdrawal by Subject|5
1229048|NCT00730405|4032037|P3|Overall Study-Treatment Phase|Withdrawal by Subject|2
1229049|NCT00730405|4032038|P2|Overall Study-Treatment Phase|Withdrawal by Subject|1
1229050|NCT00730405|4032039|P1|Overall Study-Treatment Phase|Withdrawal by Subject|7
1229051|NCT00730405|4032035|P5|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
1229052|NCT00730405|4032036|P4|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
1229053|NCT00730405|4032037|P3|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5
1229054|NCT00730405|4032038|P2|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
1229055|NCT00730405|4032039|P1|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
1229056|NCT00730405|4032035|P5|Overall Study-Treatment Phase|Lost to Follow-up|4
1229057|NCT00730405|4032036|P4|Overall Study-Treatment Phase|Lost to Follow-up|4
1229058|NCT00730405|4032037|P3|Overall Study-Treatment Phase|Lost to Follow-up|6
1229059|NCT00730405|4032038|P2|Overall Study-Treatment Phase|Lost to Follow-up|5
1229060|NCT00730405|4032039|P1|Overall Study-Treatment Phase|Lost to Follow-up|4
1229061|NCT00730405|4032035|P5|Overall Study-Treatment Phase|Adverse Event|4
1229062|NCT00730405|4032036|P4|Overall Study-Treatment Phase|Adverse Event|8
1229063|NCT00730405|4032037|P3|Overall Study-Treatment Phase|Adverse Event|4
1229064|NCT00730405|4032038|P2|Overall Study-Treatment Phase|Adverse Event|10
1229065|NCT00730405|4032039|P1|Overall Study-Treatment Phase|Adverse Event|5
1229066|NCT00730327|4032086|P2|Overall Study|Subject withdrew (reason not specified)|7
1229067|NCT00730327|4032087|P1|Overall Study|Subject withdrew (reason not specified)|2
1229068|NCT00730327|4032086|P2|Overall Study|Withdrawal by Subject|13
1229069|NCT00730327|4032087|P1|Overall Study|Withdrawal by Subject|3
1229070|NCT00730327|4032086|P2|Overall Study|Adverse Event|1
1229071|NCT00730327|4032087|P1|Overall Study|Adverse Event|8
1229072|NCT00730327|4032086|P2|Overall Study|Lost to Follow-up|16
1229073|NCT00730327|4032087|P1|Overall Study|Lost to Follow-up|14
1229074|NCT00730275|4032112|P4|Overall Study|Withdrawal by Subject|1
1229075|NCT00730275|4032113|P3|Overall Study|Withdrawal by Subject|0
1229076|NCT00730275|4032114|P2|Overall Study|Withdrawal by Subject|0
1229077|NCT00730275|4032115|P1|Overall Study|Withdrawal by Subject|0
1229078|NCT00730236|4032141|P1|Overall Study|Non-compliance|1
1229079|NCT00730236|4032141|P1|Overall Study|Withdrawal by Subject|1
1229080|NCT00730236|4032141|P1|Overall Study|Adverse Event|4
1229081|NCT00730171|4032156|P1|Overall Study|Not Specified|61
1229082|NCT00730171|4032156|P1|Overall Study|Insufficient Therapeutic Response|141
1229083|NCT00730171|4032156|P1|Overall Study|Lost to Follow-up|121
1229084|NCT00730171|4032156|P1|Overall Study|Withdrawal by Subject|202
1229085|NCT00730171|4032156|P1|Overall Study|Protocol Violation|48
1229086|NCT00730171|4032156|P1|Overall Study|Adverse Event|193
1229087|NCT00730171|4032156|P1|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5
1229088|NCT00730132|4032164|P1|Overall Study|Death|1
1229089|NCT00730132|4032164|P1|Overall Study|Protocol Violation|154
1229090|NCT00730041|4032182|P2|Overall Study|Lost to Follow-up|2
1229091|NCT00730041|4032183|P1|Overall Study|Lost to Follow-up|0
1229092|NCT00730028|4032206|P5|Overall Study|Randomization Error|2
1229093|NCT00730028|4032207|P4|Overall Study|Randomization Error|0
1229094|NCT00730028|4032208|P3|Overall Study|Randomization Error|0
1229095|NCT00730028|4032209|P2|Overall Study|Randomization Error|0
1229096|NCT00730028|4032210|P1|Overall Study|Randomization Error|1
1229097|NCT00730028|4032206|P5|Overall Study|Treatment Failure|1
1229098|NCT00730028|4032207|P4|Overall Study|Treatment Failure|0
1229099|NCT00730028|4032208|P3|Overall Study|Treatment Failure|0
1229100|NCT00730028|4032209|P2|Overall Study|Treatment Failure|5
1229101|NCT00730028|4032210|P1|Overall Study|Treatment Failure|5
1229102|NCT00730028|4032206|P5|Overall Study|Physician Decision|2
1229103|NCT00730028|4032207|P4|Overall Study|Physician Decision|3
1229104|NCT00730028|4032208|P3|Overall Study|Physician Decision|2
1229105|NCT00730028|4032209|P2|Overall Study|Physician Decision|3
1229106|NCT00730028|4032210|P1|Overall Study|Physician Decision|3
1229107|NCT00730028|4032206|P5|Overall Study|Withdrawal by Subject|9
1229108|NCT00730028|4032207|P4|Overall Study|Withdrawal by Subject|5
1229109|NCT00730028|4032208|P3|Overall Study|Withdrawal by Subject|4
1229110|NCT00730028|4032209|P2|Overall Study|Withdrawal by Subject|5
1229111|NCT00730028|4032210|P1|Overall Study|Withdrawal by Subject|9
1229112|NCT00730028|4032206|P5|Overall Study|Protocol Violation|0
1229113|NCT00730028|4032207|P4|Overall Study|Protocol Violation|2
1229114|NCT00730028|4032208|P3|Overall Study|Protocol Violation|1
1229115|NCT00730028|4032209|P2|Overall Study|Protocol Violation|1
1229116|NCT00730028|4032210|P1|Overall Study|Protocol Violation|6
1229117|NCT00730028|4032206|P5|Overall Study|Lost to Follow-up|25
1229118|NCT00730028|4032207|P4|Overall Study|Lost to Follow-up|26
1229119|NCT00730028|4032208|P3|Overall Study|Lost to Follow-up|22
1229120|NCT00730028|4032209|P2|Overall Study|Lost to Follow-up|26
1229121|NCT00730028|4032210|P1|Overall Study|Lost to Follow-up|13
1229122|NCT00730028|4032206|P5|Overall Study|Adverse Event|43
1229123|NCT00730028|4032207|P4|Overall Study|Adverse Event|20
1229124|NCT00730028|4032208|P3|Overall Study|Adverse Event|16
1229125|NCT00730028|4032209|P2|Overall Study|Adverse Event|26
1229126|NCT00730028|4032210|P1|Overall Study|Adverse Event|23
1229127|NCT00730015|4032260|P3|Overall Study|Other Reason|1
1229128|NCT00730015|4032261|P2|Overall Study|Other Reason|0
1229129|NCT00730015|4032262|P1|Overall Study|Other Reason|1
1229130|NCT00730015|4032260|P3|Overall Study|Lack of Efficacy|8
1229131|NCT00730015|4032261|P2|Overall Study|Lack of Efficacy|2
1229132|NCT00730015|4032262|P1|Overall Study|Lack of Efficacy|1
1229133|NCT00730015|4032260|P3|Overall Study|Lost to Follow-up|3
1229134|NCT00730015|4032261|P2|Overall Study|Lost to Follow-up|10
1229135|NCT00730015|4032262|P1|Overall Study|Lost to Follow-up|4
1229136|NCT00730015|4032260|P3|Overall Study|Withdrawal by Subject|8
1229137|NCT00730015|4032261|P2|Overall Study|Withdrawal by Subject|12
1229138|NCT00730015|4032262|P1|Overall Study|Withdrawal by Subject|12
1229139|NCT00730015|4032260|P3|Overall Study|Protocol Violation|4
1229140|NCT00730015|4032261|P2|Overall Study|Protocol Violation|6
1229141|NCT00730015|4032262|P1|Overall Study|Protocol Violation|2
1229142|NCT00730015|4032260|P3|Overall Study|Adverse Event|8
1229143|NCT00730015|4032261|P2|Overall Study|Adverse Event|10
1229144|NCT00730015|4032262|P1|Overall Study|Adverse Event|11
1229145|NCT00729937|4032302|P6|Overall Study|Incarcerated|0
1229146|NCT00729937|4032303|P5|Overall Study|Incarcerated|0
1229147|NCT00729937|4032304|P4|Overall Study|Incarcerated|1
1229148|NCT00729937|4032305|P3|Overall Study|Incarcerated|1
1229149|NCT00729937|4032306|P2|Overall Study|Incarcerated|2
1229150|NCT00729937|4032307|P1|Overall Study|Incarcerated|0
1229151|NCT00729937|4032302|P6|Overall Study|Did not meet eligibility criteria|0
1229152|NCT00729937|4032303|P5|Overall Study|Did not meet eligibility criteria|0
1229153|NCT00729937|4032304|P4|Overall Study|Did not meet eligibility criteria|0
1229154|NCT00729937|4032305|P3|Overall Study|Did not meet eligibility criteria|0
1229155|NCT00729937|4032306|P2|Overall Study|Did not meet eligibility criteria|1
1229156|NCT00729937|4032307|P1|Overall Study|Did not meet eligibility criteria|2
1229157|NCT00729937|4032302|P6|Overall Study|Randomized but not treated|3
1229158|NCT00729937|4032303|P5|Overall Study|Randomized but not treated|1
1229159|NCT00729937|4032304|P4|Overall Study|Randomized but not treated|0
1229160|NCT00729937|4032305|P3|Overall Study|Randomized but not treated|1
1229161|NCT00729937|4032306|P2|Overall Study|Randomized but not treated|6
1229162|NCT00729937|4032307|P1|Overall Study|Randomized but not treated|12
1229163|NCT00729937|4032302|P6|Overall Study|Withdrawal by Subject|2
1229164|NCT00729937|4032303|P5|Overall Study|Withdrawal by Subject|4
1229165|NCT00729937|4032304|P4|Overall Study|Withdrawal by Subject|0
1229166|NCT00729937|4032305|P3|Overall Study|Withdrawal by Subject|6
1229167|NCT00729937|4032306|P2|Overall Study|Withdrawal by Subject|5
1229168|NCT00729937|4032307|P1|Overall Study|Withdrawal by Subject|3
1229169|NCT00729937|4032302|P6|Overall Study|Death|1
1229170|NCT00729937|4032303|P5|Overall Study|Death|0
1229171|NCT00729937|4032304|P4|Overall Study|Death|0
1229172|NCT00729937|4032305|P3|Overall Study|Death|1
1229173|NCT00729937|4032306|P2|Overall Study|Death|0
1229174|NCT00729937|4032307|P1|Overall Study|Death|1
1229175|NCT00729937|4032302|P6|Overall Study|Physician Decision|8
1229176|NCT00729937|4032303|P5|Overall Study|Physician Decision|5
1229177|NCT00729937|4032304|P4|Overall Study|Physician Decision|0
1229178|NCT00729937|4032305|P3|Overall Study|Physician Decision|2
1229179|NCT00729937|4032306|P2|Overall Study|Physician Decision|16
1229180|NCT00729937|4032307|P1|Overall Study|Physician Decision|7
1229181|NCT00729937|4032302|P6|Overall Study|Lost to Follow-up|23
1229182|NCT00729937|4032303|P5|Overall Study|Lost to Follow-up|18
1229183|NCT00729937|4032304|P4|Overall Study|Lost to Follow-up|33
1229184|NCT00729937|4032305|P3|Overall Study|Lost to Follow-up|18
1229185|NCT00729937|4032306|P2|Overall Study|Lost to Follow-up|58
1229186|NCT00729937|4032307|P1|Overall Study|Lost to Follow-up|49
1229187|NCT00729859|4032511|P3|Overall Study|Withdrawal by Subject|0
1229188|NCT00729859|4032512|P2|Overall Study|Withdrawal by Subject|1
1229189|NCT00729859|4032513|P1|Overall Study|Withdrawal by Subject|0
1229190|NCT00729859|4032511|P3|Overall Study|Adverse Event|0
1229191|NCT00729859|4032512|P2|Overall Study|Adverse Event|1
1229192|NCT00729859|4032513|P1|Overall Study|Adverse Event|0
1229193|NCT00729833|4032557|P4|Overall Study|Unspecified Reasons|1
1229194|NCT00729833|4032558|P3|Overall Study|Unspecified Reasons|5
1229195|NCT00729833|4032559|P2|Overall Study|Unspecified Reasons|5
1229196|NCT00729833|4032560|P1|Overall Study|Unspecified Reasons|11
1229197|NCT00729833|4032557|P4|Overall Study|Withdrawal by Subject|0
1229198|NCT00729833|4032558|P3|Overall Study|Withdrawal by Subject|3
1229199|NCT00729833|4032559|P2|Overall Study|Withdrawal by Subject|1
1229200|NCT00729833|4032560|P1|Overall Study|Withdrawal by Subject|3
1229201|NCT00729833|4032557|P4|Overall Study|Lost to Follow-up|0
1229202|NCT00729833|4032558|P3|Overall Study|Lost to Follow-up|0
1229203|NCT00729833|4032559|P2|Overall Study|Lost to Follow-up|0
1229204|NCT00729833|4032560|P1|Overall Study|Lost to Follow-up|1
1229205|NCT00729833|4032557|P4|Overall Study|Study Terminated by Sponsor|0
1229206|NCT00729833|4032558|P3|Overall Study|Study Terminated by Sponsor|1
1229207|NCT00729833|4032559|P2|Overall Study|Study Terminated by Sponsor|0
1229208|NCT00729833|4032560|P1|Overall Study|Study Terminated by Sponsor|0
1229209|NCT00729833|4032557|P4|Overall Study|Death|5
1229210|NCT00729833|4032558|P3|Overall Study|Death|3
1229211|NCT00729833|4032559|P2|Overall Study|Death|1
1229212|NCT00729833|4032560|P1|Overall Study|Death|5
1229213|NCT00729690|4032612|P3|Overall Study|IT Catheter Malfunction|2
1229214|NCT00729690|4032613|P2|Overall Study|IT Catheter Malfunction|2
1229215|NCT00729690|4032614|P1|Overall Study|IT Catheter Malfunction|0
1229216|NCT00729651|4032644|P2|Overall Study|Subject’s private reason|0
1229217|NCT00729651|4032645|P1|Overall Study|Subject’s private reason|2
1229218|NCT00729651|4032644|P2|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4
1229219|NCT00729651|4032645|P1|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0
1229220|NCT00729651|4032644|P2|Overall Study|Adverse Event|3
1229221|NCT00729651|4032645|P1|Overall Study|Adverse Event|7
1229222|NCT00729651|4032644|P2|Overall Study|Protocol Violation|1
1229223|NCT00729651|4032645|P1|Overall Study|Protocol Violation|0
1229224|NCT00729651|4032644|P2|Overall Study|Lost to Follow-up|4
1229225|NCT00729651|4032645|P1|Overall Study|Lost to Follow-up|5
1229226|NCT00729651|4032644|P2|Overall Study|Withdrawal by Subject|6
1229227|NCT00729651|4032645|P1|Overall Study|Withdrawal by Subject|5
1229228|NCT00729612|4032657|P1|Overall Study|Non evaluable for response|10
1229229|NCT00729586|4032666|P2|Overall Study|never treated|0
1229230|NCT00729586|4032667|P1|Overall Study|never treated|1
1229231|NCT00729586|4032666|P2|Overall Study|Ineligible|1
1229232|NCT00729586|4032667|P1|Overall Study|Ineligible|0
1229233|NCT00729560|4032680|P1|Overall Study|Withdrawal by Subject|3
1229234|NCT00729469|4032706|P2|Overall Study|Other-Not mentioned|4
1229235|NCT00729469|4032707|P1|Overall Study|Other-Not mentioned|9
1229236|NCT00729469|4032706|P2|Overall Study|Withdrawal by Subject|8
1229237|NCT00729469|4032707|P1|Overall Study|Withdrawal by Subject|19
1229238|NCT00729469|4032706|P2|Overall Study|Protocol Violation|1
1229239|NCT00729469|4032707|P1|Overall Study|Protocol Violation|2
1229240|NCT00729469|4032706|P2|Overall Study|Lost to Follow-up|9
1229241|NCT00729469|4032707|P1|Overall Study|Lost to Follow-up|9
1229242|NCT00729469|4032706|P2|Overall Study|Adverse Event|25
1229243|NCT00729469|4032707|P1|Overall Study|Adverse Event|14
1229244|NCT00729378|4032760|P2|36-months|Lost to Follow-up|6
1229245|NCT00729378|4032761|P1|36-months|Lost to Follow-up|15
1229246|NCT00729378|4032760|P2|24-months|Lost to Follow-up|51
1229247|NCT00729378|4032761|P1|24-months|Lost to Follow-up|72
1229248|NCT00729378|4032760|P2|12-months|Lost to Follow-up|65
1229249|NCT00729378|4032761|P1|12-months|Lost to Follow-up|100
1229250|NCT00729378|4032760|P2|Baseline|Withdrawal by Subject|59
1229251|NCT00729378|4032761|P1|Baseline|Withdrawal by Subject|66
1229252|NCT00729378|4032760|P2|Baseline|Did not complete study measurements|33
1229253|NCT00729378|4032761|P1|Baseline|Did not complete study measurements|72
1229254|NCT00729365|4032960|P3|Overall Study|Physician Decision|7
1229255|NCT00729365|4032961|P2|Overall Study|Physician Decision|6
1229256|NCT00729365|4032962|P1|Overall Study|Physician Decision|33
1229257|NCT00729326|4032975|P2|Overall Study|Sponsor Decision|2
1229258|NCT00729326|4032976|P1|Overall Study|Sponsor Decision|1
1229259|NCT00729326|4032975|P2|Overall Study|Subject Decision|4
1229260|NCT00729326|4032976|P1|Overall Study|Subject Decision|4
1229261|NCT00729326|4032975|P2|Overall Study|Protocol Violation|2
1229262|NCT00729326|4032976|P1|Overall Study|Protocol Violation|3
1229263|NCT00729326|4032975|P2|Overall Study|Physician Decision|1
1229264|NCT00729326|4032976|P1|Overall Study|Physician Decision|0
1229265|NCT00729326|4032975|P2|Overall Study|Lost to Follow-up|0
1229266|NCT00729326|4032976|P1|Overall Study|Lost to Follow-up|2
1229267|NCT00729248|4033018|P1|Overall Study|Physician Decision|2
1229268|NCT00729183|4033025|P2|Overall Study|Withdrawal by Subject|7
1229269|NCT00729183|4033026|P1|Overall Study|Withdrawal by Subject|9
1229270|NCT00729183|4033025|P2|Overall Study|Protocol Violation|0
1229271|NCT00729183|4033026|P1|Overall Study|Protocol Violation|1
1229272|NCT00729183|4033025|P2|Overall Study|Physician Decision|1
1229273|NCT00729183|4033026|P1|Overall Study|Physician Decision|1
1229274|NCT00729183|4033025|P2|Overall Study|Lost to Follow-up|1
1229275|NCT00729183|4033026|P1|Overall Study|Lost to Follow-up|3
1229276|NCT00729183|4033025|P2|Overall Study|Lack of Efficacy|1
1229277|NCT00729183|4033026|P1|Overall Study|Lack of Efficacy|0
1229278|NCT00729183|4033025|P2|Overall Study|Adverse Event|5
1229279|NCT00729183|4033026|P1|Overall Study|Adverse Event|11
1229280|NCT00729157|4033058|P1|Overall Study|Withdrawal by Subject|1
1229281|NCT00728988|4033101|P2|Overall Study|Withdrawal by Subject|6
1229282|NCT00728988|4033102|P1|Overall Study|Withdrawal by Subject|2
1229283|NCT00728988|4033101|P2|Overall Study|Other|77
1229284|NCT00728988|4033102|P1|Overall Study|Other|85
1229285|NCT00728988|4033101|P2|Overall Study|Adverse Event|2
1229286|NCT00728988|4033102|P1|Overall Study|Adverse Event|3
1229287|NCT00728988|4033101|P2|Overall Study|Death|1
1229288|NCT00728988|4033102|P1|Overall Study|Death|1
1229289|NCT00728988|4033101|P2|Overall Study|Not Treated|2
1229290|NCT00728988|4033102|P1|Overall Study|Not Treated|2
1229291|NCT00728962|4033120|P1|Two Year Post Placement Follow-up|Lost to Follow-up|3
1229292|NCT00728962|4033120|P1|Permanent Prosthesis Placement|Adverse Event|3
1229293|NCT00728962|4033120|P1|Implant Placement Surgery|Protocol Violation|1
1229294|NCT00728962|4033120|P1|Implant Placement Surgery|Lost to Follow-up|1
1229295|NCT00728962|4033120|P1|Implant Placement Surgery|Adverse Event|8
1229296|NCT00728949|4033126|P2|Overall Study|On treatment at cutoff date|0
1229297|NCT00728949|4033127|P1|Overall Study|On treatment at cutoff date|1
1229298|NCT00728949|4033126|P2|Overall Study|Abnormal Lab Results|2
1229299|NCT00728949|4033127|P1|Overall Study|Abnormal Lab Results|0
1229300|NCT00728949|4033126|P2|Overall Study|Withdrawal by Subject|2
1229301|NCT00728949|4033127|P1|Overall Study|Withdrawal by Subject|2
1229302|NCT00728949|4033126|P2|Overall Study|Adverse Event|0
1229303|NCT00728949|4033127|P1|Overall Study|Adverse Event|8
1229304|NCT00728884|4033162|P1|One Year Post Placement Follow-up|Lost to Follow-up|4
1229305|NCT00728884|4033162|P1|Permanent Prosthesis Placement|Lost to Follow-up|13
1229306|NCT00728754|4033198|P2|One Year Post Placement Follow-up|Adverse Event|0
1229307|NCT00728754|4033199|P1|One Year Post Placement Follow-up|Adverse Event|1
1229308|NCT00728754|4033198|P2|Permanent Prosthesis Placement|Lost to Follow-up|3
1229309|NCT00728754|4033199|P1|Permanent Prosthesis Placement|Lost to Follow-up|3
1229310|NCT00728754|4033198|P2|Permanent Prosthesis Placement|Adverse Event|1
1229311|NCT00728754|4033199|P1|Permanent Prosthesis Placement|Adverse Event|1
1229312|NCT00728689|4033228|P2|Washout Period (Days 4 - 10)|Death in family|0
1229313|NCT00728689|4033229|P1|Washout Period (Days 4 - 10)|Death in family|1
1229314|NCT00728494|4033258|P2|Overall Study|No data available|1
1229315|NCT00728494|4033259|P1|Overall Study|No data available|0
1229316|NCT00728494|4033258|P2|Overall Study|Lack of Efficacy|4
1229317|NCT00728494|4033259|P1|Overall Study|Lack of Efficacy|2
1229318|NCT00728494|4033258|P2|Overall Study|Withdrawal by Subject|2
1229319|NCT00728494|4033259|P1|Overall Study|Withdrawal by Subject|0
1229320|NCT00728494|4033258|P2|Overall Study|Adverse Event|0
1229321|NCT00728494|4033259|P1|Overall Study|Adverse Event|7
1229322|NCT00728481|4033277|P2|Overall Study|Incorrectly assigned to opposite arm|0
1229323|NCT00728481|4033278|P1|Overall Study|Incorrectly assigned to opposite arm|1
1229324|NCT00728481|4033277|P2|Overall Study|Study medication non-compliance|2
1229325|NCT00728481|4033278|P1|Overall Study|Study medication non-compliance|0
1229326|NCT00728481|4033277|P2|Overall Study|Adverse Event|1
1229327|NCT00728481|4033278|P1|Overall Study|Adverse Event|0
1229328|NCT00728481|4033277|P2|Overall Study|Withdrawal by Subject|1
1229329|NCT00728481|4033278|P1|Overall Study|Withdrawal by Subject|0
1229330|NCT00728468|4033294|P1|Overall Study|Study terminated by sponsor|1
1229331|NCT00728468|4033294|P1|Overall Study|Objective progression or relapse|9
1229332|NCT00728468|4033294|P1|Overall Study|Protocol Violation|4
1229333|NCT00728468|4033294|P1|Overall Study|Death|1
1229334|NCT00728468|4033294|P1|Overall Study|Enrolled but not treated|1
1229335|NCT00728416|4033318|P2|Overall Study|Withdrawal by Subject|0
1229336|NCT00728416|4033319|P1|Overall Study|Withdrawal by Subject|1
1229337|NCT00728416|4033318|P2|Overall Study|Treatment Failure|1
1229338|NCT00728416|4033319|P1|Overall Study|Treatment Failure|0
1229339|NCT00728416|4033318|P2|Overall Study|Adverse Event|1
1229340|NCT00728416|4033319|P1|Overall Study|Adverse Event|1
1229341|NCT00728182|4033335|P2|Overall Study|Protocol Noncompliance|1
1229342|NCT00728182|4033336|P1|Overall Study|Protocol Noncompliance|0
1229343|NCT00728182|4033335|P2|Overall Study|Death|2
1229344|NCT00728182|4033336|P1|Overall Study|Death|0
1229345|NCT00728182|4033335|P2|Overall Study|Lost to Follow-up|0
1229346|NCT00728182|4033336|P1|Overall Study|Lost to Follow-up|2
1229347|NCT00728182|4033335|P2|Overall Study|Adverse Event|0
1229348|NCT00728182|4033336|P1|Overall Study|Adverse Event|1
1229349|NCT00728130|4033364|P1|Overall Study|Physician Decision|1
1229350|NCT00728130|4033364|P1|Overall Study|Paperwork not completed in time|1
1229351|NCT00728130|4033364|P1|Overall Study|Withdrawal by Subject|1
1229352|NCT00727961|4033369|P1|Overall Study|Progression|30
1229353|NCT00727961|4033369|P1|Overall Study|Patient's refusal|2
1229354|NCT00727961|4033369|P1|Overall Study|Adverse Event|4
1229355|NCT00727961|4033369|P1|Overall Study|Lost to Follow-up|1
1229356|NCT00727909|4033379|P4|Overall Study|Death|0
1229357|NCT00727909|4033380|P3|Overall Study|Death|1
1229358|NCT00727909|4033381|P2|Overall Study|Death|0
1229359|NCT00727909|4033382|P1|Overall Study|Death|0
1229360|NCT00727909|4033379|P4|Overall Study|Withdrawal by Subject|5
1229361|NCT00727909|4033380|P3|Overall Study|Withdrawal by Subject|8
1229362|NCT00727909|4033381|P2|Overall Study|Withdrawal by Subject|11
1229363|NCT00727909|4033382|P1|Overall Study|Withdrawal by Subject|5
1229364|NCT00727844|4033479|P4|Initial Randomization|Physician Decision|0
1229365|NCT00727844|4033480|P3|Initial Randomization|Physician Decision|0
1229366|NCT00727844|4033481|P2|Initial Randomization|Physician Decision|0
1229367|NCT00727844|4033482|P1|Initial Randomization|Physician Decision|2
1229368|NCT00727714|4033496|P1|Overall Study|Lost to Follow-up|2
1229369|NCT00727649|4033506|P2|Second Intervention (4-weeks)|Withdrawal by Subject|2
1229370|NCT00727649|4033507|P1|Second Intervention (4-weeks)|Withdrawal by Subject|0
1229371|NCT00727649|4033506|P2|Second Intervention (4-weeks)|Lost to Follow-up|1
1229372|NCT00727649|4033507|P1|Second Intervention (4-weeks)|Lost to Follow-up|0
1229373|NCT00727649|4033506|P2|Second Intervention (4-weeks)|Death|0
1229374|NCT00727649|4033507|P1|Second Intervention (4-weeks)|Death|1
1229375|NCT00727649|4033506|P2|Wash-out (2-weeks)|Withdrawal by Subject|2
1229376|NCT00727649|4033507|P1|Wash-out (2-weeks)|Withdrawal by Subject|1
1229377|NCT00727649|4033506|P2|Wash-out (2-weeks)|Lost to Follow-up|1
1229378|NCT00727649|4033507|P1|Wash-out (2-weeks)|Lost to Follow-up|3
1229379|NCT00727649|4033506|P2|First Intervention (4-weeks)|Withdrawal by Subject|1
1229380|NCT00727649|4033507|P1|First Intervention (4-weeks)|Withdrawal by Subject|2
1229381|NCT00727649|4033506|P2|First Intervention (4-weeks)|Lost to Follow-up|2
1229382|NCT00727649|4033507|P1|First Intervention (4-weeks)|Lost to Follow-up|1
1229383|NCT00727571|4033549|P4|Overall Study|Other|0
1229384|NCT00727571|4033550|P3|Overall Study|Other|6
1229385|NCT00727571|4033551|P2|Overall Study|Other|4
1229386|NCT00727571|4033552|P1|Overall Study|Other|0
1229387|NCT00727571|4033549|P4|Overall Study|AE not leading to hospitalization|0
1229388|NCT00727571|4033550|P3|Overall Study|AE not leading to hospitalization|2
1229389|NCT00727571|4033551|P2|Overall Study|AE not leading to hospitalization|0
1229390|NCT00727571|4033552|P1|Overall Study|AE not leading to hospitalization|0
1229391|NCT00727571|4033549|P4|Overall Study|Hospitalization|1
1229392|NCT00727571|4033550|P3|Overall Study|Hospitalization|0
1229393|NCT00727571|4033551|P2|Overall Study|Hospitalization|1
1229394|NCT00727571|4033552|P1|Overall Study|Hospitalization|0
1229395|NCT00727571|4033549|P4|Overall Study|Dismissed from nursing home|0
1229396|NCT00727571|4033550|P3|Overall Study|Dismissed from nursing home|5
1229397|NCT00727571|4033551|P2|Overall Study|Dismissed from nursing home|9
1229398|NCT00727571|4033552|P1|Overall Study|Dismissed from nursing home|0
1229399|NCT00727571|4033549|P4|Overall Study|Subject Non Compliance|4
1229400|NCT00727571|4033550|P3|Overall Study|Subject Non Compliance|0
1229401|NCT00727571|4033551|P2|Overall Study|Subject Non Compliance|6
1229402|NCT00727571|4033552|P1|Overall Study|Subject Non Compliance|0
1229403|NCT00727571|4033549|P4|Overall Study|Withdrawal by Subject|0
1229404|NCT00727571|4033550|P3|Overall Study|Withdrawal by Subject|11
1229405|NCT00727571|4033551|P2|Overall Study|Withdrawal by Subject|10
1229406|NCT00727571|4033552|P1|Overall Study|Withdrawal by Subject|0
1229407|NCT00727571|4033549|P4|Overall Study|Physician Decision|0
1229408|NCT00727571|4033550|P3|Overall Study|Physician Decision|0
1229409|NCT00727571|4033551|P2|Overall Study|Physician Decision|5
1229410|NCT00727571|4033552|P1|Overall Study|Physician Decision|0
1229411|NCT00727571|4033549|P4|Overall Study|Death|1
1229412|NCT00727571|4033550|P3|Overall Study|Death|5
1229413|NCT00727571|4033551|P2|Overall Study|Death|19
1229414|NCT00727571|4033552|P1|Overall Study|Death|0
1229415|NCT00727571|4033549|P4|Overall Study|Ineligibility determined|0
1229416|NCT00727571|4033550|P3|Overall Study|Ineligibility determined|1
1229417|NCT00727571|4033551|P2|Overall Study|Ineligibility determined|1
1229418|NCT00727571|4033552|P1|Overall Study|Ineligibility determined|1
1229419|NCT00727558|4033579|P2|Overall Study|Lost to Follow-up|0
1229420|NCT00727558|4033580|P1|Overall Study|Lost to Follow-up|1
1229421|NCT00727558|4033579|P2|Overall Study|Subject unable to return for follow-up|1
1229422|NCT00727558|4033580|P1|Overall Study|Subject unable to return for follow-up|1
1229423|NCT00727558|4033579|P2|Overall Study|Adverse Event|1
1229424|NCT00727558|4033580|P1|Overall Study|Adverse Event|0
1229425|NCT00727558|4033579|P2|Overall Study|Lens issue|1
1229426|NCT00727558|4033580|P1|Overall Study|Lens issue|0
1229427|NCT00727506|4033604|P6|Overall Study|Other reason not described above|1
1229428|NCT00727506|4033605|P5|Overall Study|Other reason not described above|1
1229429|NCT00727506|4033606|P4|Overall Study|Other reason not described above|4
1229430|NCT00727506|4033607|P3|Overall Study|Other reason not described above|1
1229431|NCT00727506|4033608|P2|Overall Study|Other reason not described above|0
1229432|NCT00727506|4033609|P1|Overall Study|Other reason not described above|0
1229433|NCT00727506|4033604|P6|Overall Study|Refused to continue medication|2
1229434|NCT00727506|4033605|P5|Overall Study|Refused to continue medication|1
1229435|NCT00727506|4033606|P4|Overall Study|Refused to continue medication|3
1229436|NCT00727506|4033607|P3|Overall Study|Refused to continue medication|2
1229437|NCT00727506|4033608|P2|Overall Study|Refused to continue medication|1
1229438|NCT00727506|4033609|P1|Overall Study|Refused to continue medication|0
1229439|NCT00727506|4033604|P6|Overall Study|Progressive disease|28
1229440|NCT00727506|4033605|P5|Overall Study|Progressive disease|38
1229441|NCT00727506|4033606|P4|Overall Study|Progressive disease|28
1229442|NCT00727506|4033607|P3|Overall Study|Progressive disease|9
1229443|NCT00727506|4033608|P2|Overall Study|Progressive disease|7
1229444|NCT00727506|4033609|P1|Overall Study|Progressive disease|4
1229445|NCT00727506|4033604|P6|Overall Study|Dose Limiting Toxicity (DLT)|0
1229446|NCT00727506|4033605|P5|Overall Study|Dose Limiting Toxicity (DLT)|0
1229447|NCT00727506|4033606|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
1229448|NCT00727506|4033607|P3|Overall Study|Dose Limiting Toxicity (DLT)|2
1229449|NCT00727506|4033608|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
1229450|NCT00727506|4033609|P1|Overall Study|Dose Limiting Toxicity (DLT)|2
1229451|NCT00727506|4033604|P6|Overall Study|Adverse Event|8
1229452|NCT00727506|4033605|P5|Overall Study|Adverse Event|1
1229453|NCT00727506|4033606|P4|Overall Study|Adverse Event|4
1229454|NCT00727506|4033607|P3|Overall Study|Adverse Event|4
1229455|NCT00727506|4033608|P2|Overall Study|Adverse Event|0
1229456|NCT00727506|4033609|P1|Overall Study|Adverse Event|0
1229457|NCT00727402|4033702|P1|Overall Study|Physician Decision|116
1229458|NCT00727311|4033731|P1|Overall Study|Multiple reasons|39
1229459|NCT00727311|4033731|P1|Overall Study|not specified|97
1229460|NCT00727311|4033731|P1|Overall Study|Withdrawal by Subject|77
1229461|NCT00727311|4033731|P1|Overall Study|Lost to Follow-up|73
1229462|NCT00727311|4033731|P1|Overall Study|Lack of Efficacy|242
1229463|NCT00727311|4033731|P1|Overall Study|Adverse Event|58
1229464|NCT00727311|4033731|P1|Overall Study|Missing end of therapy data|205
1229465|NCT00727311|4033731|P1|Overall Study|Did not receive drug|316
1229466|NCT00727272|4033744|P3|Washout Period B|Withdrawal by Subject|1
1229467|NCT00727272|4033745|P2|Washout Period B|Withdrawal by Subject|0
1229468|NCT00727272|4033746|P1|Washout Period B|Withdrawal by Subject|0
1229469|NCT00727272|4033744|P3|Washout Period A|Adverse Event|1
1229470|NCT00727272|4033745|P2|Washout Period A|Adverse Event|0
1229471|NCT00727272|4033746|P1|Washout Period A|Adverse Event|0
1229472|NCT00727259|4033763|P1|Overall Study|Not all questionnaires completed|1055
1229473|NCT00727246|4033772|P4|Overall Study|withdrawn|0
1229474|NCT00727246|4033773|P3|Overall Study|withdrawn|1
1229475|NCT00727246|4033774|P2|Overall Study|withdrawn|0
1229476|NCT00727246|4033775|P1|Overall Study|withdrawn|0
1229477|NCT00727246|4033772|P4|Overall Study|incidental finding|1
1229478|NCT00727246|4033773|P3|Overall Study|incidental finding|0
1229479|NCT00727246|4033774|P2|Overall Study|incidental finding|0
1229480|NCT00727246|4033775|P1|Overall Study|incidental finding|0
1229481|NCT00727246|4033772|P4|Overall Study|could not complete MRI|1
1229482|NCT00727246|4033773|P3|Overall Study|could not complete MRI|0
1229483|NCT00727246|4033774|P2|Overall Study|could not complete MRI|1
1229484|NCT00727246|4033775|P1|Overall Study|could not complete MRI|0
1229485|NCT00727194|4033798|P3|Treatment Period 2|Lack of Efficacy|0
1229486|NCT00727194|4033799|P2|Treatment Period 2|Lack of Efficacy|1
1229487|NCT00727194|4033800|P1|Treatment Period 2|Lack of Efficacy|0
1229488|NCT00727194|4033798|P3|Screening Period|History of thymoma|1
1229489|NCT00727194|4033799|P2|Screening Period|History of thymoma|0
1229490|NCT00727194|4033800|P1|Screening Period|History of thymoma|0
1229491|NCT00727194|4033798|P3|Screening Period|Severe infections|2
1229492|NCT00727194|4033799|P2|Screening Period|Severe infections|0
1229493|NCT00727194|4033800|P1|Screening Period|Severe infections|0
1229494|NCT00727194|4033798|P3|Screening Period|Not stable on concomitant MG therapy|2
1229495|NCT00727194|4033799|P2|Screening Period|Not stable on concomitant MG therapy|0
1229496|NCT00727194|4033800|P1|Screening Period|Not stable on concomitant MG therapy|0
1229497|NCT00727194|4033798|P3|Screening Period|Lacked AChR antibodies|5
1229498|NCT00727194|4033799|P2|Screening Period|Lacked AChR antibodies|0
1229499|NCT00727194|4033800|P1|Screening Period|Lacked AChR antibodies|0
1229500|NCT00727194|4033798|P3|Screening Period|Low QMG scores|6
1229501|NCT00727194|4033799|P2|Screening Period|Low QMG scores|0
1229502|NCT00727194|4033800|P1|Screening Period|Low QMG scores|0
1229503|NCT00727025|4033872|P1|Overall Study|Physician Decision|23
1229504|NCT00726999|4033884|P2|Overall Study|Protocol Violation|0
1229505|NCT00726999|4033885|P1|Overall Study|Protocol Violation|1
1229506|NCT00726999|4033884|P2|Overall Study|Withdrawal by Subject|0
1229507|NCT00726999|4033885|P1|Overall Study|Withdrawal by Subject|2
1229508|NCT00726999|4033884|P2|Overall Study|Physician Decision|1
1229509|NCT00726999|4033885|P1|Overall Study|Physician Decision|0
1229510|NCT00726986|4033895|P1|Maintenance Phase|Lack of Efficacy|2
1229511|NCT00726986|4033895|P1|Maintenance Phase|Adverse Event|1
1229512|NCT00726986|4033895|P1|Induction Phase|Secondary Disease|2
1229513|NCT00726986|4033895|P1|Induction Phase|Lack of Efficacy|5
1229514|NCT00726986|4033895|P1|Induction Phase|Death|2
1229515|NCT00726986|4033895|P1|Induction Phase|Withdrawal by Subject|2
1229516|NCT00726986|4033895|P1|Induction Phase|Adverse Event|4
1229517|NCT00726895|4033902|P2|Washout Period of 7 Days|Withdrawal by Subject|1
1229518|NCT00726895|4033903|P1|Washout Period of 7 Days|Withdrawal by Subject|0
1229519|NCT00726882|4033916|P1|Overall Study|Not Specified|10
1229520|NCT00726882|4033916|P1|Overall Study|Lost to Follow-up|7
1229521|NCT00726882|4033916|P1|Overall Study|Withdrawal by Subject|5
1229522|NCT00726752|4033931|P1|Overall Study|Lack of Efficacy|6
1229523|NCT00726661|4033993|P2|Overall Study|Not specified|35
1229524|NCT00726661|4033994|P1|Overall Study|Not specified|47
1229525|NCT00726661|4033993|P2|Overall Study|Physician Decision|13
1229526|NCT00726661|4033994|P1|Overall Study|Physician Decision|25
1229527|NCT00726661|4033993|P2|Overall Study|Death|159
1229528|NCT00726661|4033994|P1|Overall Study|Death|475
1229529|NCT00726661|4033993|P2|Overall Study|Trial terminated by sponsor|187
1229530|NCT00726661|4033994|P1|Overall Study|Trial terminated by sponsor|214
1229531|NCT00726661|4033993|P2|Overall Study|Withdrawal by Subject|13
1229532|NCT00726661|4033994|P1|Overall Study|Withdrawal by Subject|17
1229533|NCT00726661|4033993|P2|Overall Study|Lost to Follow-up|11
1229534|NCT00726661|4033994|P1|Overall Study|Lost to Follow-up|36
1229535|NCT00726622|4034011|P2|Overall Study|Metastasis|0
1229536|NCT00726622|4034012|P1|Overall Study|Metastasis|2
1229537|NCT00726622|4034011|P2|Overall Study|Physician Decision|1
1229538|NCT00726622|4034012|P1|Overall Study|Physician Decision|0
1229539|NCT00726622|4034011|P2|Overall Study|Withdrawal by Subject|2
1229540|NCT00726622|4034012|P1|Overall Study|Withdrawal by Subject|16
1229541|NCT00726609|4034030|P1|Overall Study|Other|3
1229542|NCT00726609|4034030|P1|Overall Study|Missing|42
1229543|NCT00726609|4034030|P1|Overall Study|Not specified|16
1229544|NCT00726609|4034030|P1|Overall Study|Lack of Efficacy|25
1229545|NCT00726609|4034030|P1|Overall Study|Withdrawal by Subject|2
1229546|NCT00726609|4034030|P1|Overall Study|Adverse Event|10
1229547|NCT00726557|4034034|P1|Overall Study|Inclusion criteria not met|15
1229548|NCT00726557|4034034|P1|Overall Study|Treatment less than 3 months|17
1229549|NCT00726557|4034034|P1|Overall Study|No follow-up documentation available|55
1229550|NCT00726557|4034034|P1|Overall Study|No end of treatment documentation|37
1229551|NCT00726557|4034034|P1|Overall Study|Screening failure|4
1229552|NCT00726453|4034041|P2|38 mm Length Group|Death|3
1229553|NCT00726453|4034042|P1|38 mm Length Group|Death|0
1229554|NCT00726453|4034041|P2|Primary Enrollment Group|Withdrawal by Subject|0
1229555|NCT00726453|4034042|P1|Primary Enrollment Group|Withdrawal by Subject|13
1229556|NCT00726453|4034041|P2|Primary Enrollment Group|Death|0
1229557|NCT00726453|4034042|P1|Primary Enrollment Group|Death|18
1229558|NCT00726323|4034070|P2|Overall Study|Metastatic lesions inferred cyst|1
1229559|NCT00726323|4034071|P1|Overall Study|Metastatic lesions inferred cyst|0
1229560|NCT00726323|4034070|P2|Overall Study|Participant wished to discontinue|1
1229561|NCT00726323|4034071|P1|Overall Study|Participant wished to discontinue|0
1229562|NCT00726323|4034070|P2|Overall Study|Death|0
1229563|NCT00726323|4034071|P1|Overall Study|Death|1
1229564|NCT00726323|4034070|P2|Overall Study|Adverse Event|9
1229565|NCT00726323|4034071|P1|Overall Study|Adverse Event|9
1229566|NCT00726323|4034070|P2|Overall Study|Clinical progression|3
1229567|NCT00726323|4034071|P1|Overall Study|Clinical progression|0
1229568|NCT00726323|4034070|P2|Overall Study|Progressive disease|16
1229569|NCT00726323|4034071|P1|Overall Study|Progressive disease|23
1229570|NCT00726323|4034070|P2|Overall Study|Physician Decision|0
1229571|NCT00726323|4034071|P1|Overall Study|Physician Decision|1
1229572|NCT00726323|4034070|P2|Overall Study|Withdrawal by Subject|1
1229573|NCT00726323|4034071|P1|Overall Study|Withdrawal by Subject|3
1229574|NCT00726232|4034101|P6|Overall Study|No response|1
1229575|NCT00726232|4034102|P5|Overall Study|No response|3
1229576|NCT00726232|4034103|P4|Overall Study|No response|0
1229577|NCT00726232|4034104|P3|Overall Study|No response|0
1229578|NCT00726232|4034105|P2|Overall Study|No response|0
1229579|NCT00726232|4034106|P1|Overall Study|No response|1
1229580|NCT00726232|4034101|P6|Overall Study|Disease progression|0
1229581|NCT00726232|4034102|P5|Overall Study|Disease progression|0
1229582|NCT00726232|4034103|P4|Overall Study|Disease progression|0
1229583|NCT00726232|4034104|P3|Overall Study|Disease progression|0
1229584|NCT00726232|4034105|P2|Overall Study|Disease progression|0
1229585|NCT00726232|4034106|P1|Overall Study|Disease progression|1
1229586|NCT00726232|4034101|P6|Overall Study|Adverse Event|1
1229587|NCT00726232|4034102|P5|Overall Study|Adverse Event|2
1229588|NCT00726232|4034103|P4|Overall Study|Adverse Event|1
1229589|NCT00726232|4034104|P3|Overall Study|Adverse Event|0
1229590|NCT00726232|4034105|P2|Overall Study|Adverse Event|1
1229591|NCT00726232|4034106|P1|Overall Study|Adverse Event|1
1229592|NCT00726232|4034101|P6|Overall Study|Withdrawal by Subject|2
1229593|NCT00726232|4034102|P5|Overall Study|Withdrawal by Subject|0
1229594|NCT00726232|4034103|P4|Overall Study|Withdrawal by Subject|0
1229595|NCT00726232|4034104|P3|Overall Study|Withdrawal by Subject|0
1229596|NCT00726232|4034105|P2|Overall Study|Withdrawal by Subject|0
1229597|NCT00726232|4034106|P1|Overall Study|Withdrawal by Subject|2
1229598|NCT00726063|4034156|P2|Overall Study|Adverse Event|7
1229599|NCT00726063|4034157|P1|Overall Study|Adverse Event|9
1229600|NCT00725985|4034171|P12|LTFU (No Cladribine Treatment)|Other|14
1229601|NCT00725985|4034172|P11|LTFU (No Cladribine Treatment)|Other|36
1229602|NCT00725985|4034173|P10|LTFU (No Cladribine Treatment)|Other|34
1229603|NCT00725985|4034174|P9|LTFU (No Cladribine Treatment)|Other|0
1229604|NCT00725985|4034175|P8|LTFU (No Cladribine Treatment)|Other|0
1229605|NCT00725985|4034176|P7|LTFU (No Cladribine Treatment)|Other|0
1229606|NCT00725985|4034177|P6|LTFU (No Cladribine Treatment)|Other|0
1229607|NCT00725985|4034178|P5|LTFU (No Cladribine Treatment)|Other|0
1229608|NCT00725985|4034179|P4|LTFU (No Cladribine Treatment)|Other|0
1229609|NCT00725985|4034180|P3|LTFU (No Cladribine Treatment)|Other|0
1229610|NCT00725985|4034181|P2|LTFU (No Cladribine Treatment)|Other|0
1229611|NCT00725985|4034182|P1|LTFU (No Cladribine Treatment)|Other|0
1229612|NCT00725985|4034171|P12|LTFU (With Cladribine Treatment)|Other|0
1229613|NCT00725985|4034172|P11|LTFU (With Cladribine Treatment)|Other|0
1229614|NCT00725985|4034173|P10|LTFU (With Cladribine Treatment)|Other|0
1229615|NCT00725985|4034174|P9|LTFU (With Cladribine Treatment)|Other|16
1229616|NCT00725985|4034175|P8|LTFU (With Cladribine Treatment)|Other|8
1229617|NCT00725985|4034176|P7|LTFU (With Cladribine Treatment)|Other|9
1229618|NCT00725985|4034177|P6|LTFU (With Cladribine Treatment)|Other|0
1229619|NCT00725985|4034178|P5|LTFU (With Cladribine Treatment)|Other|0
1229620|NCT00725985|4034179|P4|LTFU (With Cladribine Treatment)|Other|0
1229621|NCT00725985|4034180|P3|LTFU (With Cladribine Treatment)|Other|0
1229622|NCT00725985|4034181|P2|LTFU (With Cladribine Treatment)|Other|0
1229623|NCT00725985|4034182|P1|LTFU (With Cladribine Treatment)|Other|0
1229624|NCT00725985|4034171|P12|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
1229625|NCT00725985|4034172|P11|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
1229626|NCT00725985|4034173|P10|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
1229627|NCT00725985|4034174|P9|LTFU (With Cladribine Treatment)|Lost to Follow-up|1
1229628|NCT00725985|4034175|P8|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
1229629|NCT00725985|4034176|P7|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
1229630|NCT00725985|4034177|P6|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
1229631|NCT00725985|4034178|P5|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
1229632|NCT00725985|4034179|P4|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
1229633|NCT00725985|4034180|P3|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
1229634|NCT00725985|4034181|P2|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
1229635|NCT00725985|4034182|P1|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
1229636|NCT00725985|4034171|P12|LTFU (With Cladribine Treatment)|Adverse Event|0
1229637|NCT00725985|4034172|P11|LTFU (With Cladribine Treatment)|Adverse Event|0
1229638|NCT00725985|4034173|P10|LTFU (With Cladribine Treatment)|Adverse Event|0
1229639|NCT00725985|4034174|P9|LTFU (With Cladribine Treatment)|Adverse Event|0
1229640|NCT00725985|4034175|P8|LTFU (With Cladribine Treatment)|Adverse Event|1
1229641|NCT00725985|4034176|P7|LTFU (With Cladribine Treatment)|Adverse Event|0
1229642|NCT00725985|4034177|P6|LTFU (With Cladribine Treatment)|Adverse Event|0
1229643|NCT00725985|4034178|P5|LTFU (With Cladribine Treatment)|Adverse Event|0
1229644|NCT00725985|4034179|P4|LTFU (With Cladribine Treatment)|Adverse Event|0
1229645|NCT00725985|4034180|P3|LTFU (With Cladribine Treatment)|Adverse Event|0
1229646|NCT00725985|4034181|P2|LTFU (With Cladribine Treatment)|Adverse Event|0
1229647|NCT00725985|4034182|P1|LTFU (With Cladribine Treatment)|Adverse Event|0
1229648|NCT00725985|4034171|P12|OLMP|Other|0
1229649|NCT00725985|4034172|P11|OLMP|Other|0
1229650|NCT00725985|4034173|P10|OLMP|Other|0
1229651|NCT00725985|4034174|P9|OLMP|Other|0
1229652|NCT00725985|4034175|P8|OLMP|Other|0
1229653|NCT00725985|4034176|P7|OLMP|Other|0
1229654|NCT00725985|4034177|P6|OLMP|Other|44
1229655|NCT00725985|4034178|P5|OLMP|Other|20
1229656|NCT00725985|4034179|P4|OLMP|Other|15
1229657|NCT00725985|4034180|P3|OLMP|Other|0
1229658|NCT00725985|4034181|P2|OLMP|Other|0
1229659|NCT00725985|4034182|P1|OLMP|Other|0
1229660|NCT00725985|4034171|P12|OLMP|Disease progression|0
1229661|NCT00725985|4034172|P11|OLMP|Disease progression|0
1229662|NCT00725985|4034173|P10|OLMP|Disease progression|0
1229663|NCT00725985|4034174|P9|OLMP|Disease progression|0
1229664|NCT00725985|4034175|P8|OLMP|Disease progression|0
1229665|NCT00725985|4034176|P7|OLMP|Disease progression|0
1229666|NCT00725985|4034177|P6|OLMP|Disease progression|4
1229667|NCT00725985|4034178|P5|OLMP|Disease progression|0
1229668|NCT00725985|4034179|P4|OLMP|Disease progression|0
1229669|NCT00725985|4034180|P3|OLMP|Disease progression|0
1229670|NCT00725985|4034181|P2|OLMP|Disease progression|0
1229671|NCT00725985|4034182|P1|OLMP|Disease progression|0
1229672|NCT00725985|4034171|P12|OLMP|Lost to Follow-up|0
1229673|NCT00725985|4034172|P11|OLMP|Lost to Follow-up|0
1229674|NCT00725985|4034173|P10|OLMP|Lost to Follow-up|0
1229675|NCT00725985|4034174|P9|OLMP|Lost to Follow-up|0
1229676|NCT00725985|4034175|P8|OLMP|Lost to Follow-up|0
1229677|NCT00725985|4034176|P7|OLMP|Lost to Follow-up|0
1229678|NCT00725985|4034177|P6|OLMP|Lost to Follow-up|0
1229679|NCT00725985|4034178|P5|OLMP|Lost to Follow-up|0
1229680|NCT00725985|4034179|P4|OLMP|Lost to Follow-up|1
1229681|NCT00725985|4034180|P3|OLMP|Lost to Follow-up|0
1229682|NCT00725985|4034181|P2|OLMP|Lost to Follow-up|0
1229683|NCT00725985|4034182|P1|OLMP|Lost to Follow-up|0
1229684|NCT00725985|4034171|P12|OLMP|Death|0
1229685|NCT00725985|4034172|P11|OLMP|Death|0
1229686|NCT00725985|4034173|P10|OLMP|Death|0
1229687|NCT00725985|4034174|P9|OLMP|Death|0
1229688|NCT00725985|4034175|P8|OLMP|Death|0
1229689|NCT00725985|4034176|P7|OLMP|Death|0
1229690|NCT00725985|4034177|P6|OLMP|Death|0
1229691|NCT00725985|4034178|P5|OLMP|Death|1
1229692|NCT00725985|4034179|P4|OLMP|Death|0
1229693|NCT00725985|4034180|P3|OLMP|Death|0
1229694|NCT00725985|4034181|P2|OLMP|Death|0
1229695|NCT00725985|4034182|P1|OLMP|Death|0
1229696|NCT00725985|4034171|P12|OLMP|Adverse Event|0
1229697|NCT00725985|4034172|P11|OLMP|Adverse Event|0
1229698|NCT00725985|4034173|P10|OLMP|Adverse Event|0
1229699|NCT00725985|4034174|P9|OLMP|Adverse Event|0
1229700|NCT00725985|4034175|P8|OLMP|Adverse Event|0
1229701|NCT00725985|4034176|P7|OLMP|Adverse Event|0
1229702|NCT00725985|4034177|P6|OLMP|Adverse Event|5
1229703|NCT00725985|4034178|P5|OLMP|Adverse Event|2
1229704|NCT00725985|4034179|P4|OLMP|Adverse Event|2
1229705|NCT00725985|4034180|P3|OLMP|Adverse Event|0
1229706|NCT00725985|4034181|P2|OLMP|Adverse Event|0
1229707|NCT00725985|4034182|P1|OLMP|Adverse Event|0
1229708|NCT00725985|4034171|P12|ITP (Up to 96 Weeks)|Other|0
1229709|NCT00725985|4034172|P11|ITP (Up to 96 Weeks)|Other|0
1229710|NCT00725985|4034173|P10|ITP (Up to 96 Weeks)|Other|0
1229711|NCT00725985|4034174|P9|ITP (Up to 96 Weeks)|Other|0
1229712|NCT00725985|4034175|P8|ITP (Up to 96 Weeks)|Other|0
1229713|NCT00725985|4034176|P7|ITP (Up to 96 Weeks)|Other|0
1229714|NCT00725985|4034177|P6|ITP (Up to 96 Weeks)|Other|0
1229715|NCT00725985|4034178|P5|ITP (Up to 96 Weeks)|Other|0
1229716|NCT00725985|4034179|P4|ITP (Up to 96 Weeks)|Other|0
1229717|NCT00725985|4034180|P3|ITP (Up to 96 Weeks)|Other|24
1229718|NCT00725985|4034181|P2|ITP (Up to 96 Weeks)|Other|38
1229719|NCT00725985|4034182|P1|ITP (Up to 96 Weeks)|Other|50
1229720|NCT00725985|4034171|P12|ITP (Up to 96 Weeks)|Converted to CDMS|0
1229721|NCT00725985|4034172|P11|ITP (Up to 96 Weeks)|Converted to CDMS|0
1229722|NCT00725985|4034173|P10|ITP (Up to 96 Weeks)|Converted to CDMS|0
1229723|NCT00725985|4034174|P9|ITP (Up to 96 Weeks)|Converted to CDMS|0
1229724|NCT00725985|4034175|P8|ITP (Up to 96 Weeks)|Converted to CDMS|0
1229725|NCT00725985|4034176|P7|ITP (Up to 96 Weeks)|Converted to CDMS|0
1229726|NCT00725985|4034177|P6|ITP (Up to 96 Weeks)|Converted to CDMS|0
1229727|NCT00725985|4034178|P5|ITP (Up to 96 Weeks)|Converted to CDMS|0
1229728|NCT00725985|4034179|P4|ITP (Up to 96 Weeks)|Converted to CDMS|0
1229729|NCT00725985|4034180|P3|ITP (Up to 96 Weeks)|Converted to CDMS|71
1229730|NCT00725985|4034181|P2|ITP (Up to 96 Weeks)|Converted to CDMS|27
1229731|NCT00725985|4034182|P1|ITP (Up to 96 Weeks)|Converted to CDMS|30
1229732|NCT00725985|4034171|P12|ITP (Up to 96 Weeks)|Randomized but not treated|0
1229733|NCT00725985|4034172|P11|ITP (Up to 96 Weeks)|Randomized but not treated|0
1229734|NCT00725985|4034173|P10|ITP (Up to 96 Weeks)|Randomized but not treated|0
1229735|NCT00725985|4034174|P9|ITP (Up to 96 Weeks)|Randomized but not treated|0
1229736|NCT00725985|4034175|P8|ITP (Up to 96 Weeks)|Randomized but not treated|0
1229737|NCT00725985|4034176|P7|ITP (Up to 96 Weeks)|Randomized but not treated|0
1229738|NCT00725985|4034177|P6|ITP (Up to 96 Weeks)|Randomized but not treated|0
1229739|NCT00725985|4034178|P5|ITP (Up to 96 Weeks)|Randomized but not treated|0
1229740|NCT00725985|4034179|P4|ITP (Up to 96 Weeks)|Randomized but not treated|0
1229741|NCT00725985|4034180|P3|ITP (Up to 96 Weeks)|Randomized but not treated|0
1229742|NCT00725985|4034181|P2|ITP (Up to 96 Weeks)|Randomized but not treated|0
1229743|NCT00725985|4034182|P1|ITP (Up to 96 Weeks)|Randomized but not treated|1
1229744|NCT00725985|4034171|P12|ITP (Up to 96 Weeks)|Lost to Follow-up|0
1229745|NCT00725985|4034172|P11|ITP (Up to 96 Weeks)|Lost to Follow-up|0
1229746|NCT00725985|4034173|P10|ITP (Up to 96 Weeks)|Lost to Follow-up|0
1229747|NCT00725985|4034174|P9|ITP (Up to 96 Weeks)|Lost to Follow-up|0
1229748|NCT00725985|4034175|P8|ITP (Up to 96 Weeks)|Lost to Follow-up|0
1229749|NCT00725985|4034176|P7|ITP (Up to 96 Weeks)|Lost to Follow-up|0
1229750|NCT00725985|4034177|P6|ITP (Up to 96 Weeks)|Lost to Follow-up|0
1229751|NCT00725985|4034178|P5|ITP (Up to 96 Weeks)|Lost to Follow-up|0
1229752|NCT00725985|4034179|P4|ITP (Up to 96 Weeks)|Lost to Follow-up|0
1229753|NCT00725985|4034180|P3|ITP (Up to 96 Weeks)|Lost to Follow-up|2
1229754|NCT00725985|4034181|P2|ITP (Up to 96 Weeks)|Lost to Follow-up|0
1229755|NCT00725985|4034182|P1|ITP (Up to 96 Weeks)|Lost to Follow-up|0
1229756|NCT00725985|4034171|P12|ITP (Up to 96 Weeks)|Adverse Event|0
1229757|NCT00725985|4034172|P11|ITP (Up to 96 Weeks)|Adverse Event|0
1229758|NCT00725985|4034173|P10|ITP (Up to 96 Weeks)|Adverse Event|0
1229759|NCT00725985|4034174|P9|ITP (Up to 96 Weeks)|Adverse Event|0
1229760|NCT00725985|4034175|P8|ITP (Up to 96 Weeks)|Adverse Event|0
1229761|NCT00725985|4034176|P7|ITP (Up to 96 Weeks)|Adverse Event|0
1229762|NCT00725985|4034177|P6|ITP (Up to 96 Weeks)|Adverse Event|0
1229763|NCT00725985|4034178|P5|ITP (Up to 96 Weeks)|Adverse Event|0
1229764|NCT00725985|4034179|P4|ITP (Up to 96 Weeks)|Adverse Event|0
1229765|NCT00725985|4034180|P3|ITP (Up to 96 Weeks)|Adverse Event|5
1229766|NCT00725985|4034181|P2|ITP (Up to 96 Weeks)|Adverse Event|10
1229767|NCT00725985|4034182|P1|ITP (Up to 96 Weeks)|Adverse Event|20
1229768|NCT00725920|4034219|P2|Overall Study|Lack of Efficacy|6
1229769|NCT00725920|4034220|P1|Overall Study|Lack of Efficacy|3
1229770|NCT00725842|4034226|P1|Overall Study|No Visit 1 data|1
1229771|NCT00725842|4034226|P1|Overall Study|Inclusion criterion not met|1
1229772|NCT00725842|4034226|P1|Overall Study|Consent date prior to study start date|5
1229773|NCT00725842|4034226|P1|Overall Study|Positive HCV-RNA at Visit 2|13
1229774|NCT00725842|4034226|P1|Overall Study|Death|1
1229775|NCT00725842|4034226|P1|Overall Study|Lost to Follow-up|19
1229776|NCT00725764|4034233|P1|Overall Study|Decline in performance status|1
1229777|NCT00725764|4034233|P1|Overall Study|Participant non compliant with protocol|1
1229778|NCT00725764|4034233|P1|Overall Study|Death|1
1229779|NCT00725764|4034233|P1|Overall Study|Lost to Follow-up|1
1229780|NCT00725764|4034233|P1|Overall Study|Progressive Disease|7
1229781|NCT00725764|4034233|P1|Overall Study|Physician Decision|1
1229782|NCT00725764|4034233|P1|Overall Study|Withdrawal by Subject|2
1229783|NCT00725725|4034266|P3|Overall Study|Protocol Violation|0
1229784|NCT00725725|4034267|P2|Overall Study|Protocol Violation|1
1229785|NCT00725725|4034268|P1|Overall Study|Protocol Violation|0
1229786|NCT00725725|4034266|P3|Overall Study|Withdrawal by Subject|1
1229787|NCT00725725|4034267|P2|Overall Study|Withdrawal by Subject|0
1229788|NCT00725725|4034268|P1|Overall Study|Withdrawal by Subject|1
1229789|NCT00725725|4034266|P3|Overall Study|Lost to Follow-up|2
1229790|NCT00725725|4034267|P2|Overall Study|Lost to Follow-up|0
1229791|NCT00725725|4034268|P1|Overall Study|Lost to Follow-up|2
1229792|NCT00725725|4034266|P3|Overall Study|Adverse Event|2
1229793|NCT00725725|4034267|P2|Overall Study|Adverse Event|3
1229794|NCT00725725|4034268|P1|Overall Study|Adverse Event|1
1229795|NCT00725712|4034311|P2|Overall Study|Hospitalized, unable to continue|1
1229796|NCT00725712|4034312|P1|Overall Study|Hospitalized, unable to continue|0
1229797|NCT00725712|4034311|P2|Overall Study|Other: Death|0
1229798|NCT00725712|4034312|P1|Overall Study|Other: Death|1
1229799|NCT00725712|4034311|P2|Overall Study|Death|0
1229800|NCT00725712|4034312|P1|Overall Study|Death|2
1229801|NCT00725712|4034311|P2|Overall Study|Adverse Event|5
1229802|NCT00725712|4034312|P1|Overall Study|Adverse Event|5
1229803|NCT00725712|4034311|P2|Overall Study|Clinical progression not based on RECIST|3
1229804|NCT00725712|4034312|P1|Overall Study|Clinical progression not based on RECIST|0
1229805|NCT00725712|4034311|P2|Overall Study|Progressive disease|16
1229806|NCT00725712|4034312|P1|Overall Study|Progressive disease|37
1229807|NCT00725712|4034311|P2|Overall Study|Protocol Violation|0
1229808|NCT00725712|4034312|P1|Overall Study|Protocol Violation|1
1229809|NCT00725712|4034311|P2|Overall Study|Withdrawal by Subject|1
1229810|NCT00725712|4034312|P1|Overall Study|Withdrawal by Subject|2
1229811|NCT00725621|4034348|P1|Overall Study|Reason not specified|55
1229812|NCT00725621|4034348|P1|Overall Study|Prepared for elective surgery|1
1229813|NCT00725621|4034348|P1|Overall Study|Switched to other drug|1
1229814|NCT00725621|4034348|P1|Overall Study|Switched to other study|1
1229815|NCT00725621|4034348|P1|Overall Study|Continued treatment by other physician|6
1229816|NCT00725621|4034348|P1|Overall Study|Non-compliance|8
1229817|NCT00725621|4034348|P1|Overall Study|Lost to Follow-up|52
1229818|NCT00725621|4034348|P1|Overall Study|Physician Decision|19
1229819|NCT00725621|4034348|P1|Overall Study|Withdrawal by Subject|57
1229820|NCT00725621|4034348|P1|Overall Study|Lack of Efficacy|46
1229821|NCT00725621|4034348|P1|Overall Study|Adverse Event|25
1229822|NCT00725608|4034371|P1|Overall Study|Other|7
1229823|NCT00725608|4034371|P1|Overall Study|Individual reasons|86
1229824|NCT00725608|4034371|P1|Overall Study|Adverse Event|14
1229825|NCT00725608|4034371|P1|Overall Study|Lost to Follow-up|60
1229826|NCT00725543|4034377|P1|Overall Study|Not specified|119
1229827|NCT00725543|4034377|P1|Overall Study|Non-compliance|2
1229828|NCT00725543|4034377|P1|Overall Study|Lost to Follow-up|4
1229829|NCT00725543|4034377|P1|Overall Study|Physician Decision|5
1229830|NCT00725543|4034377|P1|Overall Study|Withdrawal by Subject|10
1229831|NCT00725543|4034377|P1|Overall Study|Lack of Efficacy|3
1229832|NCT00725543|4034377|P1|Overall Study|Adverse Event|10
1229833|NCT00725491|4034402|P2|Overall Study|No/too few embryos/ bad quality embryos|2
1229834|NCT00725491|4034403|P1|Overall Study|No/too few embryos/ bad quality embryos|3
1229835|NCT00725491|4034402|P2|Overall Study|Fertilization failure|1
1229836|NCT00725491|4034403|P1|Overall Study|Fertilization failure|0
1229837|NCT00725491|4034402|P2|Overall Study|No/too few oocytes/bad quality oocytes|1
1229838|NCT00725491|4034403|P1|Overall Study|No/too few oocytes/bad quality oocytes|1
1229839|NCT00725491|4034402|P2|Overall Study|Risk for hyperstimulation|9
1229840|NCT00725491|4034403|P1|Overall Study|Risk for hyperstimulation|2
1229841|NCT00725491|4034402|P2|Overall Study|Pregnancy|3
1229842|NCT00725491|4034403|P1|Overall Study|Pregnancy|0
1229843|NCT00725491|4034402|P2|Overall Study|Adverse Event|2
1229844|NCT00725491|4034403|P1|Overall Study|Adverse Event|3
1229845|NCT00725452|4034409|P1|Overall Study|Lost to Follow-up|1
1229846|NCT00725452|4034409|P1|Overall Study|Withdrawal by Subject|3
1229847|NCT00725452|4034409|P1|Overall Study|Physician Decision|1
1229848|NCT00725452|4034409|P1|Overall Study|Reason not specified|1
1229849|NCT00725452|4034409|P1|Overall Study|Lack of Efficacy|2
1229850|NCT00725452|4034409|P1|Overall Study|Adverse Event|3
1229851|NCT00725322|4034428|P2|Washout (28 Days)|Protocol Violation|1
1229852|NCT00725322|4034429|P1|Washout (28 Days)|Protocol Violation|0
1229853|NCT00725322|4034428|P2|Washout (28 Days)|Withdrawal by Subject|0
1229854|NCT00725322|4034429|P1|Washout (28 Days)|Withdrawal by Subject|2
1229855|NCT00725296|4034437|P1|Overall Study|Not Specified|38
1229856|NCT00725296|4034437|P1|Overall Study|Lost to Follow-up|1
1229857|NCT00725296|4034437|P1|Overall Study|Non-Compliance|2
1229858|NCT00725296|4034437|P1|Overall Study|Withdrawal by Subject|3
1229859|NCT00725296|4034437|P1|Overall Study|Lack of Efficacy|7
1229860|NCT00725296|4034437|P1|Overall Study|Adverse Event|11
1229861|NCT00725283|4034446|P1|Overall Study|Withdrawal by Subject|10
1229862|NCT00725283|4034446|P1|Overall Study|Not specified|6
1229863|NCT00725283|4034446|P1|Overall Study|Death|5
1229864|NCT00725283|4034446|P1|Overall Study|Missing Code|3
1229865|NCT00725205|4034467|P1|Overall Study|Treatment Failure|41
1229866|NCT00725205|4034467|P1|Overall Study|Protocol Defined Clinical Event|1
1229867|NCT00725205|4034467|P1|Overall Study|Other|8
1229868|NCT00725205|4034467|P1|Overall Study|Non-compliance With Protocol|14
1229869|NCT00725205|4034467|P1|Overall Study|Investigator Discontinued|1
1229870|NCT00725205|4034467|P1|Overall Study|Adverse Event|22
1229871|NCT00725101|4034480|P1|Overall Study|not specified/no reason given|11
1229872|NCT00725101|4034480|P1|Overall Study|Withdrawal by Subject|127
1229873|NCT00725101|4034480|P1|Overall Study|Protocol Violation|1
1229874|NCT00725101|4034480|P1|Overall Study|Lost to Follow-up|353
1229875|NCT00725101|4034480|P1|Overall Study|Death|3
1229876|NCT00725075|4034503|P3|Overall Study|Other|0
1229877|NCT00725075|4034504|P2|Overall Study|Other|0
1229878|NCT00725075|4034505|P1|Overall Study|Other|1
1229879|NCT00725075|4034503|P3|Overall Study|Inclusion/Exclusion Criteria|1
1229880|NCT00725075|4034504|P2|Overall Study|Inclusion/Exclusion Criteria|0
1229881|NCT00725075|4034505|P1|Overall Study|Inclusion/Exclusion Criteria|1
1229882|NCT00725075|4034503|P3|Overall Study|Worsening of Disease|2
1229883|NCT00725075|4034504|P2|Overall Study|Worsening of Disease|1
1229884|NCT00725075|4034505|P1|Overall Study|Worsening of Disease|2
1229885|NCT00725075|4034503|P3|Overall Study|Adverse Event|1
1229886|NCT00725075|4034504|P2|Overall Study|Adverse Event|1
1229887|NCT00725075|4034505|P1|Overall Study|Adverse Event|2
1229888|NCT00725075|4034503|P3|Overall Study|Withdrawal by Subject|4
1229889|NCT00725075|4034504|P2|Overall Study|Withdrawal by Subject|5
1229890|NCT00725075|4034505|P1|Overall Study|Withdrawal by Subject|4
1229891|NCT00725075|4034503|P3|Overall Study|Lost to Follow-up|0
1229892|NCT00725075|4034504|P2|Overall Study|Lost to Follow-up|0
1229893|NCT00725075|4034505|P1|Overall Study|Lost to Follow-up|1
1229894|NCT00725075|4034503|P3|Overall Study|Protocol Violation|1
1229895|NCT00725075|4034504|P2|Overall Study|Protocol Violation|0
1229896|NCT00725075|4034505|P1|Overall Study|Protocol Violation|0
1229897|NCT00725075|4034503|P3|Overall Study|Use of Excluded Medication|0
1229898|NCT00725075|4034504|P2|Overall Study|Use of Excluded Medication|1
1229899|NCT00725075|4034505|P1|Overall Study|Use of Excluded Medication|0
1229900|NCT00725010|4034558|P1|Overall Study|Intensified treatment scheme: 3 on 1 off|2
1229901|NCT00725010|4034558|P1|Overall Study|No further documentation|1
1229902|NCT00725010|4034558|P1|Overall Study|Suspect lymph nodes neck thorax abdomen|1
1229903|NCT00725010|4034558|P1|Overall Study|Hepatopathy probably not Temodal-related|1
1229904|NCT00725010|4034558|P1|Overall Study|Lost to Follow-up|1
1229905|NCT00725010|4034558|P1|Overall Study|Death|1
1229906|NCT00725010|4034558|P1|Overall Study|Withdrawal by Subject|2
1229907|NCT00725010|4034558|P1|Overall Study|Tumor Progression|7
1229908|NCT00725010|4034558|P1|Overall Study|Toxicity|9
1229909|NCT00724958|4034591|P1|Overall Study|No documentation for end of therapy|13
1229910|NCT00724958|4034591|P1|Overall Study|Other Reason|76
1229911|NCT00724958|4034591|P1|Overall Study|Remission|7
1229912|NCT00724958|4034591|P1|Overall Study|No Response|18
1229913|NCT00724958|4034591|P1|Overall Study|Loss of Response|40
1229914|NCT00724958|4034591|P1|Overall Study|Adverse Event|28
1229915|NCT00724945|4034600|P2|Period 2|lens physiology issue|0
1229916|NCT00724945|4034601|P1|Period 2|lens physiology issue|1
1229917|NCT00724945|4034600|P2|Period 2|lens comfort issue|0
1229918|NCT00724945|4034601|P1|Period 2|lens comfort issue|3
1229919|NCT00724945|4034600|P2|Period 1|Lost to Follow-up|0
1229920|NCT00724945|4034601|P1|Period 1|Lost to Follow-up|1
1229921|NCT00724945|4034600|P2|Period 1|Adverse Event|1
1229922|NCT00724945|4034601|P1|Period 1|Adverse Event|1
1229923|NCT00724945|4034600|P2|Period 1|non-compliance|0
1229924|NCT00724945|4034601|P1|Period 1|non-compliance|1
1229925|NCT00724932|4034613|P2|Overall Study|Not treated|3
1229926|NCT00724932|4034614|P1|Overall Study|Not treated|4
1229927|NCT00724932|4034613|P2|Overall Study|Lost to Follow-up|0
1229928|NCT00724932|4034614|P1|Overall Study|Lost to Follow-up|1
1229929|NCT00724893|4034685|P2|Overall Study|Unknown, missing data|1
1229930|NCT00724893|4034686|P1|Overall Study|Unknown, missing data|1
1229931|NCT00724893|4034685|P2|Overall Study|Lost to Follow-up|52
1229932|NCT00724893|4034686|P1|Overall Study|Lost to Follow-up|0
1229933|NCT00724893|4034685|P2|Overall Study|Assigned shorter treatment|2
1229934|NCT00724893|4034686|P1|Overall Study|Assigned shorter treatment|0
1229935|NCT00724893|4034685|P2|Overall Study|Financial reasons|2
1229936|NCT00724893|4034686|P1|Overall Study|Financial reasons|0
1229937|NCT00724893|4034685|P2|Overall Study|Substance abuse|3
1229938|NCT00724893|4034686|P1|Overall Study|Substance abuse|0
1229939|NCT00724893|4034685|P2|Overall Study|Incarceration|9
1229940|NCT00724893|4034686|P1|Overall Study|Incarceration|0
1229941|NCT00724893|4034685|P2|Overall Study|Geographic reasons|11
1229942|NCT00724893|4034686|P1|Overall Study|Geographic reasons|0
1229943|NCT00724893|4034685|P2|Overall Study|Patient choice|26
1229944|NCT00724893|4034686|P1|Overall Study|Patient choice|0
1229945|NCT00724893|4034685|P2|Overall Study|Reason not specified|7
1229946|NCT00724893|4034686|P1|Overall Study|Reason not specified|193
1229947|NCT00724893|4034685|P2|Overall Study|Lack of virologic response|202
1229948|NCT00724893|4034686|P1|Overall Study|Lack of virologic response|94
1229949|NCT00724893|4034685|P2|Overall Study|Withdrawal by Subject|1
1229950|NCT00724893|4034686|P1|Overall Study|Withdrawal by Subject|0
1229951|NCT00724893|4034685|P2|Overall Study|Adverse Event|142
1229952|NCT00724893|4034686|P1|Overall Study|Adverse Event|76
1229953|NCT00724867|4034754|P1|Overall Study|Elected to exit due to site closure|2
1229954|NCT00724867|4034754|P1|Overall Study|Subject moved out of state|1
1229955|NCT00724867|4034754|P1|Overall Study|Developed withdrawal criteria- pregnancy|4
1229956|NCT00724867|4034754|P1|Overall Study|Subject incarcerated|1
1229957|NCT00724867|4034754|P1|Overall Study|Sponsor decision to end study|14
1229958|NCT00724867|4034754|P1|Overall Study|Withdrawal by Subject|31
1229959|NCT00724867|4034754|P1|Overall Study|Protocol Violation|1
1229960|NCT00724867|4034754|P1|Overall Study|Physician Decision|17
1229961|NCT00724867|4034754|P1|Overall Study|Non-compliance with study drug|6
1229962|NCT00724867|4034754|P1|Overall Study|Lost to Follow-up|12
1229963|NCT00724867|4034754|P1|Overall Study|Lack of Efficacy|14
1229964|NCT00724867|4034754|P1|Overall Study|Adverse Event|25
1229965|NCT00724854|4034794|P2|Overall Study|Adverse event + lack of efficacy|1
1229966|NCT00724854|4034795|P1|Overall Study|Adverse event + lack of efficacy|2
1229967|NCT00724854|4034794|P2|Overall Study|Withdrawal by Subject|0
1229968|NCT00724854|4034795|P1|Overall Study|Withdrawal by Subject|5
1229969|NCT00724854|4034794|P2|Overall Study|Change of treatment|0
1229970|NCT00724854|4034795|P1|Overall Study|Change of treatment|7
1229971|NCT00724854|4034794|P2|Overall Study|Death|0
1229972|NCT00724854|4034795|P1|Overall Study|Death|11
1229973|NCT00724854|4034794|P2|Overall Study|Not specified|3
1229974|NCT00724854|4034795|P1|Overall Study|Not specified|42
1229975|NCT00724854|4034794|P2|Overall Study|Adverse Event|4
1229976|NCT00724854|4034795|P1|Overall Study|Adverse Event|62
1229977|NCT00724854|4034794|P2|Overall Study|Lost to Follow-up|10
1229978|NCT00724854|4034795|P1|Overall Study|Lost to Follow-up|87
1229979|NCT00724854|4034794|P2|Overall Study|Lack of Efficacy|13
1229980|NCT00724854|4034795|P1|Overall Study|Lack of Efficacy|187
1229981|NCT00724815|4034812|P2|Overall Study|Other Various|5
1229982|NCT00724815|4034813|P1|Overall Study|Other Various|3
1229983|NCT00724815|4034812|P2|Overall Study|Lost to Follow-up|1
1229984|NCT00724815|4034813|P1|Overall Study|Lost to Follow-up|4
1229985|NCT00724815|4034812|P2|Overall Study|Adverse Event|3
1229986|NCT00724815|4034813|P1|Overall Study|Adverse Event|5
1229987|NCT00724815|4034812|P2|Overall Study|Randomized, not treated|30
1229988|NCT00724815|4034813|P1|Overall Study|Randomized, not treated|31
1229989|NCT00724711|4034846|P2|Overall Study|Protocol Violation|0
1229990|NCT00724711|4034847|P1|Overall Study|Protocol Violation|1
1229991|NCT00724711|4034846|P2|Overall Study|Lost to Follow-up|5
1229992|NCT00724711|4034847|P1|Overall Study|Lost to Follow-up|4
1229993|NCT00724711|4034846|P2|Overall Study|Withdrawal by Subject|4
1229994|NCT00724711|4034847|P1|Overall Study|Withdrawal by Subject|5
1229995|NCT00724711|4034846|P2|Overall Study|Physician Decision|3
1229996|NCT00724711|4034847|P1|Overall Study|Physician Decision|0
1229997|NCT00724711|4034846|P2|Overall Study|Lack of Efficacy|1
1229998|NCT00724711|4034847|P1|Overall Study|Lack of Efficacy|0
1229999|NCT00724711|4034846|P2|Overall Study|Pregnancy|1
1230000|NCT00724711|4034847|P1|Overall Study|Pregnancy|0
1230001|NCT00724711|4034846|P2|Overall Study|Adverse Event|3
1230002|NCT00724711|4034847|P1|Overall Study|Adverse Event|7
1230003|NCT00724698|4034879|P1|Overall Study|No Info|25
1230004|NCT00724698|4034879|P1|Overall Study|Lost to Follow-up|36
1230005|NCT00724698|4034879|P1|Overall Study|Poor Compliance|16
1230006|NCT00724698|4034879|P1|Overall Study|Failure of Therapy|4
1230007|NCT00724698|4034879|P1|Overall Study|Adverse Event|9
1230008|NCT00724451|4034946|P1|Overall Study|Investigator + Participant Decision|13
1230009|NCT00724451|4034946|P1|Overall Study|Withdrawal by Subject|45
1230010|NCT00724451|4034946|P1|Overall Study|Physician Decision|116
1230011|NCT00724451|4034946|P1|Overall Study|Unknown; No Data Sources Available|9
1230012|NCT00724451|4034946|P1|Overall Study|Never Started Treatment|89
1230013|NCT00724451|4034946|P1|Overall Study|Participant Refused Treatment|89
1230014|NCT00724451|4034946|P1|Overall Study|Not Eligible for Treatment|431
1230015|NCT00724451|4034946|P1|Overall Study|Excluded - Hepatitis C Virus Negative|3
1230016|NCT00724451|4034946|P1|Overall Study|Excluded - Prior Use of Peginterferon|7
1230017|NCT00724373|4034952|P1|Overall Study|Tolerability|23
1230018|NCT00724373|4034952|P1|Overall Study|Drug Relapse|1
1230019|NCT00724373|4034952|P1|Overall Study|Acute HCV infection|1
1230020|NCT00724373|4034952|P1|Overall Study|Viral Relapse|1
1230021|NCT00724373|4034952|P1|Overall Study|Only to have 24 week regimen|1
1230022|NCT00724373|4034952|P1|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2
1230023|NCT00724373|4034952|P1|Overall Study|Participant moved away|1
1230024|NCT00724373|4034952|P1|Overall Study|HCV RNA negative after 4 weeks|9
1230025|NCT00724373|4034952|P1|Overall Study|Non-compliance|2
1230026|NCT00724373|4034952|P1|Overall Study|Lost to Follow-up|7
1230027|NCT00724373|4034952|P1|Overall Study|Lack of Efficacy|82
1230028|NCT00724373|4034952|P1|Overall Study|Adverse Event|41
1230029|NCT00724282|4034969|P1|Overall Study|Physician Decision|1
1230030|NCT00724282|4034969|P1|Overall Study|Withdrawal by Subject|3
1230031|NCT00724243|4034973|P1|Overall Study|Adverse Event|5
1230032|NCT00724243|4034973|P1|Overall Study|Lack of Efficacy|10
1230033|NCT00724152|4034983|P3|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
1230034|NCT00724152|4034984|P2|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2
1230035|NCT00724152|4034985|P1|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
1230036|NCT00724152|4034983|P3|Two-arm Study Period|Withdrawal by Subject|0
1230037|NCT00724152|4034984|P2|Two-arm Study Period|Withdrawal by Subject|2
1230038|NCT00724152|4034985|P1|Two-arm Study Period|Withdrawal by Subject|3
1230039|NCT00724126|4035002|P2|Overall Study|Subject had to leave vicinity of site|1
1230040|NCT00724126|4035003|P1|Overall Study|Subject had to leave vicinity of site|0
1230041|NCT00724126|4035002|P2|Overall Study|Subject randomized although ineligible|1
1230042|NCT00724126|4035003|P1|Overall Study|Subject randomized although ineligible|1
1230043|NCT00724126|4035002|P2|Overall Study|Noncompliance|1
1230044|NCT00724126|4035003|P1|Overall Study|Noncompliance|2
1230045|NCT00724126|4035002|P2|Overall Study|Lost to Follow-up|6
1230046|NCT00724126|4035003|P1|Overall Study|Lost to Follow-up|6
1230047|NCT00724126|4035002|P2|Overall Study|Withdrawal by Subject|6
1230048|NCT00724126|4035003|P1|Overall Study|Withdrawal by Subject|8
1230049|NCT00724126|4035002|P2|Overall Study|Adverse Event|0
1230050|NCT00724126|4035003|P1|Overall Study|Adverse Event|2
1230051|NCT00724061|4035011|P1|Dose Escalation Phase|Disease Progression|3
1230052|NCT00724061|4035011|P1|Dose Escalation Phase|Adverse Event|2
1230053|NCT00723957|4035031|P2|Overall Study|Never received treatment|3
1230054|NCT00723957|4035032|P1|Overall Study|Never received treatment|3
1230055|NCT00723957|4035031|P2|Overall Study|Reason not analyzed|0
1230056|NCT00723957|4035032|P1|Overall Study|Reason not analyzed|1
1230057|NCT00723957|4035031|P2|Overall Study|Withdrawal by Subject|5
1230058|NCT00723957|4035032|P1|Overall Study|Withdrawal by Subject|7
1230059|NCT00723957|4035031|P2|Overall Study|Study drug toxicity|6
1230060|NCT00723957|4035032|P1|Overall Study|Study drug toxicity|4
1230061|NCT00723957|4035031|P2|Overall Study|Investigator decision|1
1230062|NCT00723957|4035032|P1|Overall Study|Investigator decision|1
1230063|NCT00723957|4035031|P2|Overall Study|Maximum clinical benefit|5
1230064|NCT00723957|4035032|P1|Overall Study|Maximum clinical benefit|4
1230065|NCT00723957|4035031|P2|Overall Study|Disease progression|25
1230066|NCT00723957|4035032|P1|Overall Study|Disease progression|27
1230067|NCT00723957|4035031|P2|Overall Study|Death|4
1230068|NCT00723957|4035032|P1|Overall Study|Death|3
1230069|NCT00723957|4035031|P2|Overall Study|Adverse event unrelated to study drug|4
1230070|NCT00723957|4035032|P1|Overall Study|Adverse event unrelated to study drug|1
1230071|NCT00723944|4035056|P2|One Year Post Placement Follow-up|Lost to Follow-up|4
1230072|NCT00723944|4035057|P1|One Year Post Placement Follow-up|Lost to Follow-up|1
1230073|NCT00723944|4035056|P2|Permanent Prosthesis Placement|Lost to Follow-up|2
1230074|NCT00723944|4035057|P1|Permanent Prosthesis Placement|Lost to Follow-up|2
1230075|NCT00723944|4035056|P2|Permanent Prosthesis Placement|Adverse Event|7
1230076|NCT00723944|4035057|P1|Permanent Prosthesis Placement|Adverse Event|1
1230077|NCT00723892|4035070|P2|Overall Study|Drug addiction|0
1230078|NCT00723892|4035071|P1|Overall Study|Drug addiction|1
1230079|NCT00723892|4035070|P2|Overall Study|Intercurrent infection|0
1230080|NCT00723892|4035071|P1|Overall Study|Intercurrent infection|2
1230081|NCT00723892|4035070|P2|Overall Study|Alcohol abuse|1
1230082|NCT00723892|4035071|P1|Overall Study|Alcohol abuse|0
1230083|NCT00723892|4035070|P2|Overall Study|Weight loss|3
1230084|NCT00723892|4035071|P1|Overall Study|Weight loss|1
1230085|NCT00723892|4035070|P2|Overall Study|Study end|3
1230086|NCT00723892|4035071|P1|Overall Study|Study end|1
1230087|NCT00723892|4035070|P2|Overall Study|Not specified|3
1230088|NCT00723892|4035071|P1|Overall Study|Not specified|6
1230089|NCT00723892|4035070|P2|Overall Study|Multiple reasons|12
1230090|NCT00723892|4035071|P1|Overall Study|Multiple reasons|17
1230091|NCT00723892|4035070|P2|Overall Study|Bad tolerance|5
1230092|NCT00723892|4035071|P1|Overall Study|Bad tolerance|5
1230093|NCT00723892|4035070|P2|Overall Study|End planned|7
1230094|NCT00723892|4035071|P1|Overall Study|End planned|11
1230095|NCT00723892|4035070|P2|Overall Study|Withdrawal by Subject|9
1230096|NCT00723892|4035071|P1|Overall Study|Withdrawal by Subject|6
1230097|NCT00723892|4035070|P2|Overall Study|Virological criterion|9
1230098|NCT00723892|4035071|P1|Overall Study|Virological criterion|24
1230099|NCT00723892|4035070|P2|Overall Study|Participant not tracked|35
1230100|NCT00723892|4035071|P1|Overall Study|Participant not tracked|33
1230101|NCT00723840|4035078|P1|Overall Study|Unspecified reason|2
1230102|NCT00723840|4035078|P1|Overall Study|Other Medical Event|2
1230103|NCT00723840|4035078|P1|Overall Study|Serious Adverse Events|3
1230104|NCT00723840|4035078|P1|Overall Study|Withdrawal by Subject|55
1230105|NCT00723840|4035078|P1|Overall Study|Failure to return|18
1230106|NCT00723840|4035078|P1|Overall Study|Lost to Follow-up|2
1230107|NCT00723801|4035099|P2|Overall Study|Protocol Violation|1
1230108|NCT00723801|4035100|P1|Overall Study|Protocol Violation|2
1230109|NCT00723801|4035099|P2|Overall Study|Lost to Follow-up|2
1230110|NCT00723801|4035100|P1|Overall Study|Lost to Follow-up|1
1230111|NCT00723710|4035125|P1|Overall Study|Physician Decision|2
1230112|NCT00723710|4035125|P1|Overall Study|Withdrawal by Subject|36
1230113|NCT00723710|4035125|P1|Overall Study|Adverse Event|88
1230114|NCT00723710|4035125|P1|Overall Study|Disease progression|48
1230115|NCT00723697|4035129|P1|Overall Study|Other exclusion criteria applied|6
1230116|NCT00723697|4035129|P1|Overall Study|Missing Informed Consent Form|10
1230117|NCT00723697|4035129|P1|Overall Study|Physician questionnaires not received|2
1230118|NCT00723606|4035150|P2|Overall Study|Withdrawal by Subject|2
1230119|NCT00723606|4035151|P1|Overall Study|Withdrawal by Subject|0
1230120|NCT00723606|4035150|P2|Overall Study|Other|0
1230121|NCT00723606|4035151|P1|Overall Study|Other|2
1230122|NCT00723606|4035150|P2|Overall Study|Adverse Event|5
1230123|NCT00723606|4035151|P1|Overall Study|Adverse Event|2
1230124|NCT00723554|4035171|P1|Overall Study|Non-compliance|1
1230125|NCT00723554|4035171|P1|Overall Study|Lost to Follow-up|1
1230126|NCT00723554|4035171|P1|Overall Study|Not specified|3
1230127|NCT00723554|4035171|P1|Overall Study|Withdrawal of consent|3
1230128|NCT00723554|4035171|P1|Overall Study|Inhaled medication other than iloprost|4
1230129|NCT00723554|4035171|P1|Overall Study|Investigator's judgement|5
1230130|NCT00723554|4035171|P1|Overall Study|Adverse Event|12
1230131|NCT00723528|4035221|P7|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1
1230132|NCT00723528|4035222|P6|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
1230133|NCT00723528|4035223|P5|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
1230134|NCT00723528|4035224|P4|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
1230291|NCT00723398|4035371|P2|Overall Study|Withdrawal by Subject|6
1230135|NCT00723528|4035225|P3|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
1230136|NCT00723528|4035226|P2|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
1230137|NCT00723528|4035227|P1|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
1230138|NCT00723528|4035221|P7|Period 2: After Controlled Period|Use of prohibited concomitant medication|1
1230139|NCT00723528|4035222|P6|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
1230140|NCT00723528|4035223|P5|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
1230141|NCT00723528|4035224|P4|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
1230142|NCT00723528|4035225|P3|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
1230143|NCT00723528|4035226|P2|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
1230144|NCT00723528|4035227|P1|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
1230145|NCT00723528|4035221|P7|Period 2: After Controlled Period|Adverse Event|1
1230146|NCT00723528|4035222|P6|Period 2: After Controlled Period|Adverse Event|0
1230147|NCT00723528|4035223|P5|Period 2: After Controlled Period|Adverse Event|1
1230148|NCT00723528|4035224|P4|Period 2: After Controlled Period|Adverse Event|0
1230149|NCT00723528|4035225|P3|Period 2: After Controlled Period|Adverse Event|0
1230150|NCT00723528|4035226|P2|Period 2: After Controlled Period|Adverse Event|0
1230151|NCT00723528|4035227|P1|Period 2: After Controlled Period|Adverse Event|0
1230152|NCT00723528|4035221|P7|Period 2: After Controlled Period|Other|0
1230153|NCT00723528|4035222|P6|Period 2: After Controlled Period|Other|4
1230154|NCT00723528|4035223|P5|Period 2: After Controlled Period|Other|1
1230155|NCT00723528|4035224|P4|Period 2: After Controlled Period|Other|0
1230156|NCT00723528|4035225|P3|Period 2: After Controlled Period|Other|0
1230157|NCT00723528|4035226|P2|Period 2: After Controlled Period|Other|0
1230158|NCT00723528|4035227|P1|Period 2: After Controlled Period|Other|0
1230159|NCT00723528|4035221|P7|Period 2: After Controlled Period|Onset of tuberculosis infection|0
1230160|NCT00723528|4035222|P6|Period 2: After Controlled Period|Onset of tuberculosis infection|1
1230161|NCT00723528|4035223|P5|Period 2: After Controlled Period|Onset of tuberculosis infection|0
1230162|NCT00723528|4035224|P4|Period 2: After Controlled Period|Onset of tuberculosis infection|0
1230163|NCT00723528|4035225|P3|Period 2: After Controlled Period|Onset of tuberculosis infection|0
1230164|NCT00723528|4035226|P2|Period 2: After Controlled Period|Onset of tuberculosis infection|0
1230165|NCT00723528|4035227|P1|Period 2: After Controlled Period|Onset of tuberculosis infection|0
1230166|NCT00723528|4035221|P7|Period 2: After Controlled Period|Withdrawal by Subject|1
1230167|NCT00723528|4035222|P6|Period 2: After Controlled Period|Withdrawal by Subject|1
1230168|NCT00723528|4035223|P5|Period 2: After Controlled Period|Withdrawal by Subject|0
1230169|NCT00723528|4035224|P4|Period 2: After Controlled Period|Withdrawal by Subject|1
1230170|NCT00723528|4035225|P3|Period 2: After Controlled Period|Withdrawal by Subject|0
1230171|NCT00723528|4035226|P2|Period 2: After Controlled Period|Withdrawal by Subject|0
1230172|NCT00723528|4035227|P1|Period 2: After Controlled Period|Withdrawal by Subject|0
1230173|NCT00723528|4035221|P7|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
1230174|NCT00723528|4035222|P6|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
1230175|NCT00723528|4035223|P5|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
1230176|NCT00723528|4035224|P4|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
1230177|NCT00723528|4035225|P3|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1
1230178|NCT00723528|4035226|P2|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
1230179|NCT00723528|4035227|P1|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2
1230180|NCT00723528|4035221|P7|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
1230181|NCT00723528|4035222|P6|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
1230182|NCT00723528|4035223|P5|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
1230183|NCT00723528|4035224|P4|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
1230184|NCT00723528|4035225|P3|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1
1230185|NCT00723528|4035226|P2|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
1230186|NCT00723528|4035227|P1|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
1230187|NCT00723528|4035221|P7|Period 1: Controlled Period (CP)|Physician Decision|0
1230188|NCT00723528|4035222|P6|Period 1: Controlled Period (CP)|Physician Decision|0
1230189|NCT00723528|4035223|P5|Period 1: Controlled Period (CP)|Physician Decision|0
1230190|NCT00723528|4035224|P4|Period 1: Controlled Period (CP)|Physician Decision|0
1230191|NCT00723528|4035225|P3|Period 1: Controlled Period (CP)|Physician Decision|1
1230192|NCT00723528|4035226|P2|Period 1: Controlled Period (CP)|Physician Decision|0
1230193|NCT00723528|4035227|P1|Period 1: Controlled Period (CP)|Physician Decision|0
1230194|NCT00723528|4035221|P7|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
1230195|NCT00723528|4035222|P6|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
1230196|NCT00723528|4035223|P5|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
1230197|NCT00723528|4035224|P4|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
1230198|NCT00723528|4035225|P3|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
1230199|NCT00723528|4035226|P2|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
1230200|NCT00723528|4035227|P1|Period 1: Controlled Period (CP)|Withdrawal by Subject|2
1230201|NCT00723528|4035221|P7|Period 1: Controlled Period (CP)|Adverse Event|0
1230202|NCT00723528|4035222|P6|Period 1: Controlled Period (CP)|Adverse Event|0
1230203|NCT00723528|4035223|P5|Period 1: Controlled Period (CP)|Adverse Event|0
1230204|NCT00723528|4035224|P4|Period 1: Controlled Period (CP)|Adverse Event|0
1230205|NCT00723528|4035225|P3|Period 1: Controlled Period (CP)|Adverse Event|1
1230206|NCT00723528|4035226|P2|Period 1: Controlled Period (CP)|Adverse Event|0
1230207|NCT00723528|4035227|P1|Period 1: Controlled Period (CP)|Adverse Event|0
1230208|NCT00723489|4035289|P4|Overall Study|Samples Collected Out of Window|0
1230209|NCT00723489|4035290|P3|Overall Study|Samples Collected Out of Window|0
1230210|NCT00723489|4035291|P2|Overall Study|Samples Collected Out of Window|3
1230211|NCT00723489|4035292|P1|Overall Study|Samples Collected Out of Window|0
1230212|NCT00723489|4035289|P4|Overall Study|Prohibited Medication|1
1230213|NCT00723489|4035290|P3|Overall Study|Prohibited Medication|0
1230214|NCT00723489|4035291|P2|Overall Study|Prohibited Medication|0
1230215|NCT00723489|4035292|P1|Overall Study|Prohibited Medication|0
1230216|NCT00723489|4035289|P4|Overall Study|Seropositive at baseline|0
1230217|NCT00723489|4035290|P3|Overall Study|Seropositive at baseline|0
1230218|NCT00723489|4035291|P2|Overall Study|Seropositive at baseline|0
1230219|NCT00723489|4035292|P1|Overall Study|Seropositive at baseline|1
1230220|NCT00723489|4035289|P4|Overall Study|Withdrawal by Subject|1
1230221|NCT00723489|4035290|P3|Overall Study|Withdrawal by Subject|0
1230222|NCT00723489|4035291|P2|Overall Study|Withdrawal by Subject|0
1230223|NCT00723489|4035292|P1|Overall Study|Withdrawal by Subject|0
1230224|NCT00723489|4035289|P4|Overall Study|Pregnancy|1
1230225|NCT00723489|4035290|P3|Overall Study|Pregnancy|0
1230226|NCT00723489|4035291|P2|Overall Study|Pregnancy|0
1230227|NCT00723489|4035292|P1|Overall Study|Pregnancy|0
1230228|NCT00723489|4035289|P4|Overall Study|Physician Decision|0
1230229|NCT00723489|4035290|P3|Overall Study|Physician Decision|0
1230230|NCT00723489|4035291|P2|Overall Study|Physician Decision|1
1230231|NCT00723489|4035292|P1|Overall Study|Physician Decision|0
1230232|NCT00723450|4035320|P3|Randomized Phase|Withdrawal by Subject|22
1230233|NCT00723450|4035321|P2|Randomized Phase|Withdrawal by Subject|14
1230234|NCT00723450|4035322|P1|Randomized Phase|Withdrawal by Subject|0
1230235|NCT00723450|4035320|P3|Randomized Phase|Physician Decision|1
1230236|NCT00723450|4035321|P2|Randomized Phase|Physician Decision|3
1230237|NCT00723450|4035322|P1|Randomized Phase|Physician Decision|0
1230238|NCT00723450|4035320|P3|Randomized Phase|Lost to Follow-up|3
1230239|NCT00723450|4035321|P2|Randomized Phase|Lost to Follow-up|2
1230240|NCT00723450|4035322|P1|Randomized Phase|Lost to Follow-up|0
1230241|NCT00723450|4035320|P3|Randomized Phase|Protocol Violation|13
1230242|NCT00723450|4035321|P2|Randomized Phase|Protocol Violation|9
1230243|NCT00723450|4035322|P1|Randomized Phase|Protocol Violation|0
1230244|NCT00723450|4035320|P3|Randomized Phase|Lack of Efficacy|11
1230245|NCT00723450|4035321|P2|Randomized Phase|Lack of Efficacy|11
1230246|NCT00723450|4035322|P1|Randomized Phase|Lack of Efficacy|0
1230247|NCT00723450|4035320|P3|Randomized Phase|Adverse Event|17
1230248|NCT00723450|4035321|P2|Randomized Phase|Adverse Event|26
1230249|NCT00723450|4035322|P1|Randomized Phase|Adverse Event|0
1230250|NCT00723450|4035320|P3|Open-Label Phase|Withdrawal by Subject|0
1230251|NCT00723450|4035321|P2|Open-Label Phase|Withdrawal by Subject|0
1230252|NCT00723450|4035322|P1|Open-Label Phase|Withdrawal by Subject|37
1230253|NCT00723450|4035320|P3|Open-Label Phase|Physician Decision|0
1230254|NCT00723450|4035321|P2|Open-Label Phase|Physician Decision|0
1230255|NCT00723450|4035322|P1|Open-Label Phase|Physician Decision|2
1230256|NCT00723450|4035320|P3|Open-Label Phase|Lost to Follow-up|0
1230257|NCT00723450|4035321|P2|Open-Label Phase|Lost to Follow-up|0
1230258|NCT00723450|4035322|P1|Open-Label Phase|Lost to Follow-up|7
1230259|NCT00723450|4035320|P3|Open-Label Phase|Protocol Violation|0
1230260|NCT00723450|4035321|P2|Open-Label Phase|Protocol Violation|0
1230261|NCT00723450|4035322|P1|Open-Label Phase|Protocol Violation|35
1230262|NCT00723450|4035320|P3|Open-Label Phase|Lack of Efficacy|0
1230263|NCT00723450|4035321|P2|Open-Label Phase|Lack of Efficacy|0
1230264|NCT00723450|4035322|P1|Open-Label Phase|Lack of Efficacy|18
1230265|NCT00723450|4035320|P3|Open-Label Phase|Adverse Event|0
1230266|NCT00723450|4035321|P2|Open-Label Phase|Adverse Event|0
1230267|NCT00723450|4035322|P1|Open-Label Phase|Adverse Event|26
1230268|NCT00723398|4035368|P5|Overall Study|Lost to Follow-up|0
1230269|NCT00723398|4035369|P4|Overall Study|Lost to Follow-up|0
1230270|NCT00723398|4035370|P3|Overall Study|Lost to Follow-up|0
1230271|NCT00723398|4035371|P2|Overall Study|Lost to Follow-up|1
1230272|NCT00723398|4035372|P1|Overall Study|Lost to Follow-up|0
1230273|NCT00723398|4035368|P5|Overall Study|Adverse Event|4
1230274|NCT00723398|4035369|P4|Overall Study|Adverse Event|1
1230275|NCT00723398|4035370|P3|Overall Study|Adverse Event|3
1230276|NCT00723398|4035371|P2|Overall Study|Adverse Event|5
1230277|NCT00723398|4035372|P1|Overall Study|Adverse Event|0
1230278|NCT00723398|4035368|P5|Overall Study|Physician Decision|1
1230279|NCT00723398|4035369|P4|Overall Study|Physician Decision|0
1230280|NCT00723398|4035370|P3|Overall Study|Physician Decision|5
1230281|NCT00723398|4035371|P2|Overall Study|Physician Decision|2
1230282|NCT00723398|4035372|P1|Overall Study|Physician Decision|2
1230283|NCT00723398|4035368|P5|Overall Study|Protocol Violation|0
1230284|NCT00723398|4035369|P4|Overall Study|Protocol Violation|0
1230285|NCT00723398|4035370|P3|Overall Study|Protocol Violation|5
1230286|NCT00723398|4035371|P2|Overall Study|Protocol Violation|1
1230287|NCT00723398|4035372|P1|Overall Study|Protocol Violation|2
1230288|NCT00723398|4035368|P5|Overall Study|Withdrawal by Subject|4
1230289|NCT00723398|4035369|P4|Overall Study|Withdrawal by Subject|4
1230290|NCT00723398|4035370|P3|Overall Study|Withdrawal by Subject|4
1230292|NCT00723398|4035372|P1|Overall Study|Withdrawal by Subject|2
1230293|NCT00723294|4035434|P1|Overall Study|No treatment due to probe failure|1
1230294|NCT00723294|4035434|P1|Overall Study|Withdrawal by Subject|1
1230295|NCT00723294|4035434|P1|Overall Study|Benign lesion|1
1230296|NCT00723294|4035434|P1|Overall Study|Treated by non-credentialed surgeon|1
1230297|NCT00723294|4035434|P1|Overall Study|Treated prior to registration|1
1230298|NCT00723294|4035434|P1|Overall Study|Did not undergo surgery|1
1230299|NCT00723294|4035434|P1|Overall Study|No cryoabalation|2
1230300|NCT00723294|4035434|P1|Overall Study|1.0-Tesla MRI|1
1230301|NCT00723294|4035434|P1|Overall Study|No MRI tumor enhancement|1
1230302|NCT00723294|4035434|P1|Overall Study|>25% intraductal component|1
1230303|NCT00723294|4035434|P1|Overall Study|Lobular histology|2
1230304|NCT00723255|4035439|P1|Overall Study|Ineligible: Wrong Primary|2
1230305|NCT00723255|4035439|P1|Overall Study|Ineligible: Second primary|1
1230306|NCT00723255|4035439|P1|Overall Study|Ineligible: Inadequate pathology|1
1230307|NCT00723229|4035466|P2|First Intervention|Lost to Follow-up|3
1230308|NCT00723229|4035467|P1|First Intervention|Lost to Follow-up|7
1230309|NCT00723203|4035479|P1|Overall Study|Withdrawal by Subject|3
1230310|NCT00723190|4035483|P1|Overall Study|Other-Not included in safety population|2
1230311|NCT00723190|4035483|P1|Overall Study|Other-Premature Discontinuation|9
1230312|NCT00723190|4035483|P1|Overall Study|Protocol Violation|15
1230313|NCT00723190|4035483|P1|Overall Study|Lack of Efficacy|16
1230314|NCT00723190|4035483|P1|Overall Study|Adverse Event|18
1230315|NCT00723190|4035483|P1|Overall Study|Lost to Follow-up|37
1230316|NCT00723190|4035483|P1|Overall Study|Withdrawal by Subject|45
1230317|NCT00723125|4035516|P2|Overall Study|Adverse Event|0
1230318|NCT00723125|4035517|P1|Overall Study|Adverse Event|2
1230319|NCT00723125|4035516|P2|Overall Study|Withdrawal by Subject|6
1230320|NCT00723125|4035517|P1|Overall Study|Withdrawal by Subject|15
1230321|NCT00723125|4035516|P2|Overall Study|Met Dx|0
1230322|NCT00723125|4035517|P1|Overall Study|Met Dx|1
1230323|NCT00723021|4035554|P5|Intervention Period 4|Adverse Event|1
1230324|NCT00723021|4035555|P4|Intervention Period 4|Adverse Event|0
1230325|NCT00723021|4035556|P3|Intervention Period 4|Adverse Event|0
1230326|NCT00723021|4035557|P2|Intervention Period 4|Adverse Event|0
1230327|NCT00723021|4035558|P1|Intervention Period 4|Adverse Event|0
1230328|NCT00723008|4035612|P2|4-Week Unblinded Treatment|Lost to Follow-up|1
1230329|NCT00723008|4035613|P1|4-Week Unblinded Treatment|Lost to Follow-up|0
1230330|NCT00723008|4035612|P2|4-Week Unblinded Treatment|Adverse Event|0
1230331|NCT00723008|4035613|P1|4-Week Unblinded Treatment|Adverse Event|1
1230332|NCT00723008|4035612|P2|4-Week Double Blinded|Lost to Follow-up|3
1230333|NCT00723008|4035613|P1|4-Week Double Blinded|Lost to Follow-up|4
1230334|NCT00723008|4035612|P2|4-Week Double Blinded|Withdrawal by Subject|1
1230335|NCT00723008|4035613|P1|4-Week Double Blinded|Withdrawal by Subject|1
1230336|NCT00723008|4035612|P2|4-Week Double Blinded|Lack of Efficacy|1
1230337|NCT00723008|4035613|P1|4-Week Double Blinded|Lack of Efficacy|0
1230338|NCT00723008|4035612|P2|Enrollment|Lost to Follow-up|0
1230339|NCT00723008|4035613|P1|Enrollment|Lost to Follow-up|1
1230340|NCT00722800|4035645|P2|Overall Study|Physician Decision|0
1230341|NCT00722800|4035646|P1|Overall Study|Physician Decision|1
1230342|NCT00722800|4035645|P2|Overall Study|Withdrawal by Subject|0
1230343|NCT00722800|4035646|P1|Overall Study|Withdrawal by Subject|1
1230344|NCT00722761|4035658|P2|Overall Study|Withdrawal by Subject|2
1230345|NCT00722761|4035659|P1|Overall Study|Withdrawal by Subject|5
1230346|NCT00722761|4035658|P2|Overall Study|Lost to Follow-up|4
1230347|NCT00722761|4035659|P1|Overall Study|Lost to Follow-up|1
1230348|NCT00722423|4035716|P2|Overall Study|Protocol Violation|1
1230349|NCT00722423|4035717|P1|Overall Study|Protocol Violation|0
1230350|NCT00722371|4035732|P7|Overall Study|Withdrawal by Subject|26
1230351|NCT00722371|4035733|P6|Overall Study|Withdrawal by Subject|18
1230352|NCT00722371|4035734|P5|Overall Study|Withdrawal by Subject|19
1230353|NCT00722371|4035735|P4|Overall Study|Withdrawal by Subject|23
1230354|NCT00722371|4035736|P3|Overall Study|Withdrawal by Subject|19
1230355|NCT00722371|4035737|P2|Overall Study|Withdrawal by Subject|27
1230356|NCT00722371|4035738|P1|Overall Study|Withdrawal by Subject|18
1230357|NCT00722371|4035732|P7|Overall Study|Protocol Violation|1
1230358|NCT00722371|4035733|P6|Overall Study|Protocol Violation|2
1230359|NCT00722371|4035734|P5|Overall Study|Protocol Violation|4
1230360|NCT00722371|4035735|P4|Overall Study|Protocol Violation|1
1230361|NCT00722371|4035736|P3|Overall Study|Protocol Violation|0
1230362|NCT00722371|4035737|P2|Overall Study|Protocol Violation|1
1230363|NCT00722371|4035738|P1|Overall Study|Protocol Violation|6
1230364|NCT00722371|4035732|P7|Overall Study|Pregnancy|0
1230365|NCT00722371|4035733|P6|Overall Study|Pregnancy|1
1230366|NCT00722371|4035734|P5|Overall Study|Pregnancy|0
1230367|NCT00722371|4035735|P4|Overall Study|Pregnancy|0
1230368|NCT00722371|4035736|P3|Overall Study|Pregnancy|0
1230369|NCT00722371|4035737|P2|Overall Study|Pregnancy|1
1230370|NCT00722371|4035738|P1|Overall Study|Pregnancy|1
1230371|NCT00722371|4035732|P7|Overall Study|Physician Decision|4
1230372|NCT00722371|4035733|P6|Overall Study|Physician Decision|3
1230373|NCT00722371|4035734|P5|Overall Study|Physician Decision|2
1230374|NCT00722371|4035735|P4|Overall Study|Physician Decision|5
1230375|NCT00722371|4035736|P3|Overall Study|Physician Decision|2
1230376|NCT00722371|4035737|P2|Overall Study|Physician Decision|2
1230377|NCT00722371|4035738|P1|Overall Study|Physician Decision|5
1230378|NCT00722371|4035732|P7|Overall Study|Lost to Follow-up|13
1230379|NCT00722371|4035733|P6|Overall Study|Lost to Follow-up|16
1230380|NCT00722371|4035734|P5|Overall Study|Lost to Follow-up|8
1230381|NCT00722371|4035735|P4|Overall Study|Lost to Follow-up|13
1230382|NCT00722371|4035736|P3|Overall Study|Lost to Follow-up|21
1230383|NCT00722371|4035737|P2|Overall Study|Lost to Follow-up|14
1230384|NCT00722371|4035738|P1|Overall Study|Lost to Follow-up|11
1230385|NCT00722371|4035732|P7|Overall Study|Lack of Efficacy|0
1230386|NCT00722371|4035733|P6|Overall Study|Lack of Efficacy|3
1230387|NCT00722371|4035734|P5|Overall Study|Lack of Efficacy|2
1230388|NCT00722371|4035735|P4|Overall Study|Lack of Efficacy|6
1230389|NCT00722371|4035736|P3|Overall Study|Lack of Efficacy|6
1230390|NCT00722371|4035737|P2|Overall Study|Lack of Efficacy|6
1230391|NCT00722371|4035738|P1|Overall Study|Lack of Efficacy|4
1230392|NCT00722371|4035732|P7|Overall Study|Hypoglycemia|0
1230393|NCT00722371|4035733|P6|Overall Study|Hypoglycemia|0
1230394|NCT00722371|4035734|P5|Overall Study|Hypoglycemia|0
1230395|NCT00722371|4035735|P4|Overall Study|Hypoglycemia|0
1230396|NCT00722371|4035736|P3|Overall Study|Hypoglycemia|0
1230397|NCT00722371|4035737|P2|Overall Study|Hypoglycemia|0
1230398|NCT00722371|4035738|P1|Overall Study|Hypoglycemia|1
1230399|NCT00722371|4035732|P7|Overall Study|Hyperglycemia|1
1230400|NCT00722371|4035733|P6|Overall Study|Hyperglycemia|1
1230401|NCT00722371|4035734|P5|Overall Study|Hyperglycemia|5
1230402|NCT00722371|4035735|P4|Overall Study|Hyperglycemia|2
1230403|NCT00722371|4035736|P3|Overall Study|Hyperglycemia|4
1230404|NCT00722371|4035737|P2|Overall Study|Hyperglycemia|6
1230405|NCT00722371|4035738|P1|Overall Study|Hyperglycemia|2
1230406|NCT00722371|4035732|P7|Overall Study|Excluded medication|1
1230407|NCT00722371|4035733|P6|Overall Study|Excluded medication|0
1230408|NCT00722371|4035734|P5|Overall Study|Excluded medication|0
1230409|NCT00722371|4035735|P4|Overall Study|Excluded medication|0
1230410|NCT00722371|4035736|P3|Overall Study|Excluded medication|1
1230411|NCT00722371|4035737|P2|Overall Study|Excluded medication|1
1230412|NCT00722371|4035738|P1|Overall Study|Excluded medication|0
1230413|NCT00722371|4035732|P7|Overall Study|Creatinine / Creatinine clearance|1
1230414|NCT00722371|4035733|P6|Overall Study|Creatinine / Creatinine clearance|1
1230415|NCT00722371|4035734|P5|Overall Study|Creatinine / Creatinine clearance|2
1230416|NCT00722371|4035735|P4|Overall Study|Creatinine / Creatinine clearance|3
1230417|NCT00722371|4035736|P3|Overall Study|Creatinine / Creatinine clearance|2
1230418|NCT00722371|4035737|P2|Overall Study|Creatinine / Creatinine clearance|1
1230419|NCT00722371|4035738|P1|Overall Study|Creatinine / Creatinine clearance|2
1230420|NCT00722371|4035732|P7|Overall Study|Contraindication|0
1230421|NCT00722371|4035733|P6|Overall Study|Contraindication|0
1230422|NCT00722371|4035734|P5|Overall Study|Contraindication|0
1230423|NCT00722371|4035735|P4|Overall Study|Contraindication|0
1230424|NCT00722371|4035736|P3|Overall Study|Contraindication|1
1230425|NCT00722371|4035737|P2|Overall Study|Contraindication|0
1230426|NCT00722371|4035738|P1|Overall Study|Contraindication|0
1230427|NCT00722371|4035732|P7|Overall Study|Adverse Event|4
1230428|NCT00722371|4035733|P6|Overall Study|Adverse Event|8
1230429|NCT00722371|4035734|P5|Overall Study|Adverse Event|6
1230430|NCT00722371|4035735|P4|Overall Study|Adverse Event|10
1230431|NCT00722371|4035736|P3|Overall Study|Adverse Event|9
1230432|NCT00722371|4035737|P2|Overall Study|Adverse Event|13
1230433|NCT00722371|4035738|P1|Overall Study|Adverse Event|6
1230434|NCT00722137|4035791|P2|Overall Study|Randomized But Not Treated|3
1230435|NCT00722137|4035792|P1|Overall Study|Randomized But Not Treated|2
1230436|NCT00722137|4035791|P2|Overall Study|Other Reason Unknown|4
1230437|NCT00722137|4035792|P1|Overall Study|Other Reason Unknown|3
1230438|NCT00722137|4035791|P2|Overall Study|Withdrawal by Subject|9
1230439|NCT00722137|4035792|P1|Overall Study|Withdrawal by Subject|6
1230440|NCT00722137|4035791|P2|Overall Study|Death|7
1230441|NCT00722137|4035792|P1|Overall Study|Death|12
1230442|NCT00722137|4035791|P2|Overall Study|Adverse Event|21
1230443|NCT00722137|4035792|P1|Overall Study|Adverse Event|17
1230444|NCT00722137|4035791|P2|Overall Study|Overt Disease Progression|4
1230445|NCT00722137|4035792|P1|Overall Study|Overt Disease Progression|5
1230446|NCT00721968|4035862|P2|Overall Study|Lost to Follow-up|0
1230447|NCT00721968|4035863|P1|Overall Study|Lost to Follow-up|2
1230448|NCT00721955|4035874|P3|Overall Study|Adverse Event|2
1230449|NCT00721955|4035875|P2|Overall Study|Adverse Event|0
1230450|NCT00721955|4035876|P1|Overall Study|Adverse Event|0
1230451|NCT00721799|4035890|P1|Overall Study|withdraw by subject after scan 1|1
1230452|NCT00721799|4035890|P1|Overall Study|Withdrawal by Subject|7
1230453|NCT00721734|4035930|P5|Overall Study|Other|0
1230454|NCT00721734|4035931|P4|Overall Study|Other|1
1230455|NCT00721734|4035932|P3|Overall Study|Other|0
1230456|NCT00721734|4035933|P2|Overall Study|Other|0
1230457|NCT00721734|4035934|P1|Overall Study|Other|0
1230458|NCT00721734|4035930|P5|Overall Study|Withdrawal by Subject|1
1230459|NCT00721734|4035931|P4|Overall Study|Withdrawal by Subject|0
1230460|NCT00721734|4035932|P3|Overall Study|Withdrawal by Subject|0
1230461|NCT00721734|4035933|P2|Overall Study|Withdrawal by Subject|1
1230462|NCT00721734|4035934|P1|Overall Study|Withdrawal by Subject|2
1230463|NCT00721734|4035930|P5|Overall Study|Adverse Event|3
1230464|NCT00721734|4035931|P4|Overall Study|Adverse Event|0
1230465|NCT00721734|4035932|P3|Overall Study|Adverse Event|4
1230466|NCT00721734|4035933|P2|Overall Study|Adverse Event|1
1230467|NCT00721734|4035934|P1|Overall Study|Adverse Event|3
1230468|NCT00721734|4035930|P5|Overall Study|Progressive Disease|2
1230469|NCT00721734|4035931|P4|Overall Study|Progressive Disease|5
1230470|NCT00721734|4035932|P3|Overall Study|Progressive Disease|4
1230471|NCT00721734|4035933|P2|Overall Study|Progressive Disease|10
1230472|NCT00721734|4035934|P1|Overall Study|Progressive Disease|3
1230473|NCT00721630|4036046|P1|Overall Study|Participant found to be ineligible|1
1230474|NCT00721578|4036075|P2|Overall Study|Withdrawal by Subject|1
1230475|NCT00721578|4036076|P1|Overall Study|Withdrawal by Subject|1
1230476|NCT00721578|4036075|P2|Overall Study|Death|1
1230477|NCT00721578|4036076|P1|Overall Study|Death|1
1230478|NCT00721409|4036119|P3|Overall Study|Objective progression or relapse|62
1230479|NCT00721409|4036120|P2|Overall Study|Objective progression or relapse|55
1230480|NCT00721409|4036121|P1|Overall Study|Objective progression or relapse|8
1230481|NCT00721409|4036119|P3|Overall Study|Withdrawal by Subject|5
1230482|NCT00721409|4036120|P2|Overall Study|Withdrawal by Subject|6
1230483|NCT00721409|4036121|P1|Overall Study|Withdrawal by Subject|1
1230484|NCT00721409|4036119|P3|Overall Study|Lost to Follow-up|1
1230485|NCT00721409|4036120|P2|Overall Study|Lost to Follow-up|0
1230486|NCT00721409|4036121|P1|Overall Study|Lost to Follow-up|0
1230487|NCT00721409|4036119|P3|Overall Study|Adverse Event|2
1230488|NCT00721409|4036120|P2|Overall Study|Adverse Event|13
1230489|NCT00721409|4036121|P1|Overall Study|Adverse Event|0
1230490|NCT00721409|4036119|P3|Overall Study|Reason not specified|2
1230491|NCT00721409|4036120|P2|Overall Study|Reason not specified|0
1230492|NCT00721409|4036121|P1|Overall Study|Reason not specified|1
1230493|NCT00721409|4036119|P3|Overall Study|Randomized not Treated|4
1230494|NCT00721409|4036120|P2|Overall Study|Randomized not Treated|1
1230495|NCT00721409|4036121|P1|Overall Study|Randomized not Treated|0
1230496|NCT00721409|4036119|P3|Overall Study|Death|0
1230497|NCT00721409|4036120|P2|Overall Study|Death|1
1230498|NCT00721409|4036121|P1|Overall Study|Death|0
1230499|NCT00721409|4036119|P3|Overall Study|Global deterioration of health status|3
1230500|NCT00721409|4036120|P2|Overall Study|Global deterioration of health status|6
1230501|NCT00721409|4036121|P1|Overall Study|Global deterioration of health status|2
1230502|NCT00721396|4036248|P4|Overall Study|Administrative reason|0
1230503|NCT00721396|4036249|P3|Overall Study|Administrative reason|1
1230504|NCT00721396|4036250|P2|Overall Study|Administrative reason|0
1230505|NCT00721396|4036251|P1|Overall Study|Administrative reason|3
1230506|NCT00721396|4036248|P4|Overall Study|Inappropriate enrollment|0
1230507|NCT00721396|4036249|P3|Overall Study|Inappropriate enrollment|0
1230508|NCT00721396|4036250|P2|Overall Study|Inappropriate enrollment|2
1230509|NCT00721396|4036251|P1|Overall Study|Inappropriate enrollment|0
1230510|NCT00721396|4036248|P4|Overall Study|Protocol Violation|0
1230511|NCT00721396|4036249|P3|Overall Study|Protocol Violation|1
1230512|NCT00721396|4036250|P2|Overall Study|Protocol Violation|3
1230513|NCT00721396|4036251|P1|Overall Study|Protocol Violation|4
1230514|NCT00721396|4036248|P4|Overall Study|Lost to Follow-up|3
1230515|NCT00721396|4036249|P3|Overall Study|Lost to Follow-up|3
1230516|NCT00721396|4036250|P2|Overall Study|Lost to Follow-up|9
1230517|NCT00721396|4036251|P1|Overall Study|Lost to Follow-up|7
1230518|NCT00721396|4036248|P4|Overall Study|Withdrawal by Subject|7
1230519|NCT00721396|4036249|P3|Overall Study|Withdrawal by Subject|3
1230520|NCT00721396|4036250|P2|Overall Study|Withdrawal by Subject|15
1230521|NCT00721396|4036251|P1|Overall Study|Withdrawal by Subject|12
1230522|NCT00721396|4036248|P4|Overall Study|Adverse Event|0
1230523|NCT00721396|4036249|P3|Overall Study|Adverse Event|2
1230524|NCT00721396|4036250|P2|Overall Study|Adverse Event|7
1230525|NCT00721396|4036251|P1|Overall Study|Adverse Event|4
1230526|NCT00721279|4036298|P2|Overall Study|Other|16
1230527|NCT00721279|4036299|P1|Overall Study|Other|12
1230528|NCT00721279|4036298|P2|Overall Study|Withdrawal by Subject|3
1230529|NCT00721279|4036299|P1|Overall Study|Withdrawal by Subject|13
1230530|NCT00721279|4036298|P2|Overall Study|Tolerability insufficient|2
1230531|NCT00721279|4036299|P1|Overall Study|Tolerability insufficient|5
1230532|NCT00721279|4036298|P2|Overall Study|Lack of Efficacy|3
1230533|NCT00721279|4036299|P1|Overall Study|Lack of Efficacy|6
1230534|NCT00721227|4036327|P2|Overall Study|Noncompliance with scheduled visits.|0
1230535|NCT00721227|4036328|P1|Overall Study|Noncompliance with scheduled visits.|1
1230536|NCT00721227|4036327|P2|Overall Study|Lost to Follow-up|0
1230537|NCT00721227|4036328|P1|Overall Study|Lost to Follow-up|3
1230538|NCT00721214|4036338|P1|Overall Study|Death|3
1230539|NCT00721214|4036338|P1|Overall Study|Chose another center for transplant|1
1230540|NCT00721149|4036388|P1|Overall Study|Physician Decision|1
1230541|NCT00721123|4036422|P1|Overall Study|Withdrawal by Subject|5
1230542|NCT00721123|4036422|P1|Overall Study|Failure to Return|9
1230543|NCT00721123|4036422|P1|Overall Study|Refused Treatment|41
1230544|NCT00721123|4036422|P1|Overall Study|Protocol Violation|1
1230545|NCT00721123|4036422|P1|Overall Study|Insufficient Therapeutic Response|21
1230546|NCT00721123|4036422|P1|Overall Study|Death|10
1230547|NCT00721123|4036422|P1|Overall Study|Adverse Event|96
1230548|NCT00721110|4036500|P4|Overall Study|vertical incision|0
1230549|NCT00721110|4036501|P3|Overall Study|vertical incision|1
1230550|NCT00721110|4036502|P2|Overall Study|vertical incision|0
1230551|NCT00721110|4036503|P1|Overall Study|vertical incision|0
1230552|NCT00721110|4036500|P4|Overall Study|Ultram use|0
1230553|NCT00721110|4036501|P3|Overall Study|Ultram use|0
1230554|NCT00721110|4036502|P2|Overall Study|Ultram use|0
1230555|NCT00721110|4036503|P1|Overall Study|Ultram use|1
1230556|NCT00720941|4036531|P2|Overall Study|Ongoing|23
1230557|NCT00720941|4036532|P1|Overall Study|Ongoing|34
1230558|NCT00720941|4036531|P2|Overall Study|Withdrawal by Subject|35
1230559|NCT00720941|4036532|P1|Overall Study|Withdrawal by Subject|27
1230560|NCT00720941|4036531|P2|Overall Study|Physician Decision|5
1230561|NCT00720941|4036532|P1|Overall Study|Physician Decision|1
1230562|NCT00720941|4036531|P2|Overall Study|Lost to Follow-up|15
1230563|NCT00720941|4036532|P1|Overall Study|Lost to Follow-up|17
1230564|NCT00720941|4036531|P2|Overall Study|Protocol Violation|2
1230565|NCT00720941|4036532|P1|Overall Study|Protocol Violation|0
1230566|NCT00720941|4036531|P2|Overall Study|Death|335
1230567|NCT00720941|4036532|P1|Overall Study|Death|334
1230568|NCT00720876|4036572|P1|Overall Study|found to be ineligible after starting tx|2
1230569|NCT00720798|4036578|P1|Overall Study|Reason not Specified|83
1230570|NCT00720798|4036578|P1|Overall Study|Failure to Return|46
1230571|NCT00720798|4036578|P1|Overall Study|Refused Treatment|151
1230572|NCT00720798|4036578|P1|Overall Study|Protocol Violation|4
1230573|NCT00720798|4036578|P1|Overall Study|Insufficient Therapeutic Response|129
1230574|NCT00720798|4036578|P1|Overall Study|Death|39
1230575|NCT00720798|4036578|P1|Overall Study|Adverse Event|304
1230576|NCT00720759|4036601|P4|Overall Study|Lost to Follow-up|0
1230577|NCT00720759|4036602|P3|Overall Study|Lost to Follow-up|1
1230578|NCT00720759|4036603|P2|Overall Study|Lost to Follow-up|1
1230579|NCT00720759|4036604|P1|Overall Study|Lost to Follow-up|0
1230580|NCT00720499|4036624|P2|Treatment Period 2 (4 Weeks)|Adverse Event|3
1230581|NCT00720499|4036625|P1|Treatment Period 2 (4 Weeks)|Adverse Event|2
1230582|NCT00720499|4036624|P2|Treatment Period 1 (4 Weeks)|Protocol Violation|2
1230583|NCT00720499|4036625|P1|Treatment Period 1 (4 Weeks)|Protocol Violation|1
1230584|NCT00720499|4036624|P2|Treatment Period 1 (4 Weeks)|Adverse Event|0
1230585|NCT00720499|4036625|P1|Treatment Period 1 (4 Weeks)|Adverse Event|2
1230586|NCT00720434|4036718|P4|Open-Label Period (Week 5-72)|Other|2
1230587|NCT00720434|4036719|P3|Open-Label Period (Week 5-72)|Other|3
1230588|NCT00720434|4036720|P2|Open-Label Period (Week 5-72)|Other|3
1230589|NCT00720434|4036721|P1|Open-Label Period (Week 5-72)|Other|4
1230590|NCT00720434|4036718|P4|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
1230591|NCT00720434|4036719|P3|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
1230592|NCT00720434|4036720|P2|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
1230593|NCT00720434|4036721|P1|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
1230594|NCT00720434|4036718|P4|Open-Label Period (Week 5-72)|Lost to Follow-up|0
1230595|NCT00720434|4036719|P3|Open-Label Period (Week 5-72)|Lost to Follow-up|0
1230596|NCT00720434|4036720|P2|Open-Label Period (Week 5-72)|Lost to Follow-up|0
1230597|NCT00720434|4036721|P1|Open-Label Period (Week 5-72)|Lost to Follow-up|1
1230598|NCT00720434|4036718|P4|Open-Label Period (Week 5-72)|Adverse Event|2
1230599|NCT00720434|4036719|P3|Open-Label Period (Week 5-72)|Adverse Event|0
1230600|NCT00720434|4036720|P2|Open-Label Period (Week 5-72)|Adverse Event|0
1230601|NCT00720434|4036721|P1|Open-Label Period (Week 5-72)|Adverse Event|0
1230602|NCT00720434|4036718|P4|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
1230603|NCT00720434|4036719|P3|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
1230604|NCT00720434|4036720|P2|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1
1230605|NCT00720434|4036721|P1|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
1230606|NCT00720382|4036745|P2|Overall Study|administrative|5
1230607|NCT00720382|4036746|P1|Overall Study|administrative|14
1230608|NCT00720382|4036745|P2|Overall Study|Lost to Follow-up|14
1230609|NCT00720382|4036746|P1|Overall Study|Lost to Follow-up|28
1230610|NCT00720382|4036745|P2|Overall Study|Withdrawal by Subject|11
1230611|NCT00720382|4036746|P1|Overall Study|Withdrawal by Subject|47
1230612|NCT00720382|4036745|P2|Overall Study|Non-Compliance|5
1230613|NCT00720382|4036746|P1|Overall Study|Non-Compliance|15
1230614|NCT00720382|4036745|P2|Overall Study|Lack of Efficacy|7
1230615|NCT00720382|4036746|P1|Overall Study|Lack of Efficacy|18
1230616|NCT00720382|4036745|P2|Overall Study|Adverse Event|17
1230617|NCT00720382|4036746|P1|Overall Study|Adverse Event|54
1230618|NCT00720356|4036765|P1|Follow up Until Death|Alive at last data collection|4
1230619|NCT00720356|4036765|P1|Follow up Until Death|Withdrawal by Subject|1
1230620|NCT00720356|4036765|P1|Went on to be Treated Cycle 3|Physician Decision|1
1230621|NCT00720356|4036765|P1|Went on to be Treated Cycle 3|Adverse Event|1
1230622|NCT00720356|4036765|P1|Reached 1st Response/2 Cycles|Withdrawal by Subject|1
1230623|NCT00720356|4036765|P1|Reached 1st Response/2 Cycles|Progressive Disease|1
1230624|NCT00720356|4036765|P1|Registration to Study|Determined to have methylated MGMT|67
1230625|NCT00720343|4036779|P1|Overall Study|No data|3
1230626|NCT00720343|4036779|P1|Overall Study|Physician Decision|3
1230627|NCT00720278|4036813|P3|Overall Study|eligibility criteria violation|1
1230628|NCT00720278|4036814|P2|Overall Study|eligibility criteria violation|0
1230629|NCT00720278|4036815|P1|Overall Study|eligibility criteria violation|1
1230630|NCT00720278|4036813|P3|Overall Study|Non-compliance|0
1230631|NCT00720278|4036814|P2|Overall Study|Non-compliance|0
1230632|NCT00720278|4036815|P1|Overall Study|Non-compliance|1
1230633|NCT00720278|4036813|P3|Overall Study|Lost to Follow-up|1
1230634|NCT00720278|4036814|P2|Overall Study|Lost to Follow-up|0
1230635|NCT00720278|4036815|P1|Overall Study|Lost to Follow-up|0
1230636|NCT00720278|4036813|P3|Overall Study|Withdrawal by Subject|0
1230637|NCT00720278|4036814|P2|Overall Study|Withdrawal by Subject|1
1230638|NCT00720278|4036815|P1|Overall Study|Withdrawal by Subject|0
1230639|NCT00720278|4036813|P3|Overall Study|Adverse Event|4
1230640|NCT00720278|4036814|P2|Overall Study|Adverse Event|3
1230641|NCT00720278|4036815|P1|Overall Study|Adverse Event|5
1230642|NCT00720226|4036837|P2|Overall Study|Withdrawal by Subject|4
1230643|NCT00720226|4036838|P1|Overall Study|Withdrawal by Subject|7
1230644|NCT00720122|4036846|P1|Overall Study|Withdrawal by Subject|7
1230645|NCT00720122|4036846|P1|Overall Study|Physician Decision|1
1230646|NCT00720122|4036846|P1|Overall Study|Lost to Follow-up|1
1230647|NCT00720109|4036850|P3|Risk Stratification Period|Development of second malignant neoplasm|0
1230648|NCT00720109|4036851|P2|Risk Stratification Period|Development of second malignant neoplasm|1
1230649|NCT00720109|4036852|P1|Risk Stratification Period|Development of second malignant neoplasm|0
1230650|NCT00720109|4036850|P3|Risk Stratification Period|Disease progression or relapse|0
1230651|NCT00720109|4036851|P2|Risk Stratification Period|Disease progression or relapse|2
1230652|NCT00720109|4036852|P1|Risk Stratification Period|Disease progression or relapse|0
1230653|NCT00720109|4036850|P3|Risk Stratification Period|Bone marrow transplant|7
1230654|NCT00720109|4036851|P2|Risk Stratification Period|Bone marrow transplant|9
1230655|NCT00720109|4036852|P1|Risk Stratification Period|Bone marrow transplant|0
1230656|NCT00720109|4036850|P3|Risk Stratification Period|Physician Decision|1
1230657|NCT00720109|4036851|P2|Risk Stratification Period|Physician Decision|2
1230658|NCT00720109|4036852|P1|Risk Stratification Period|Physician Decision|0
1230659|NCT00720109|4036850|P3|Risk Stratification Period|Adverse Event|0
1230660|NCT00720109|4036851|P2|Risk Stratification Period|Adverse Event|1
1230661|NCT00720109|4036852|P1|Risk Stratification Period|Adverse Event|0
1230662|NCT00720109|4036850|P3|Induction Period|Physician Decision|0
1230663|NCT00720109|4036851|P2|Induction Period|Physician Decision|0
1230664|NCT00720109|4036852|P1|Induction Period|Physician Decision|1
1230665|NCT00720109|4036850|P3|Induction Period|Bone Marrow Transplant|0
1230666|NCT00720109|4036851|P2|Induction Period|Bone Marrow Transplant|0
1230667|NCT00720109|4036852|P1|Induction Period|Bone Marrow Transplant|2
1230668|NCT00720109|4036850|P3|Induction Period|Did not meet eligibility criteria|0
1230669|NCT00720109|4036851|P2|Induction Period|Did not meet eligibility criteria|0
1230670|NCT00720109|4036852|P1|Induction Period|Did not meet eligibility criteria|3
1230671|NCT00720096|4036872|P2|Overall Study|Withdrawal by Subject|2
1230672|NCT00720096|4036873|P1|Overall Study|Withdrawal by Subject|0
1230673|NCT00720083|4036885|P2|Overall Study|Ineligible|2
1230674|NCT00720083|4036886|P1|Overall Study|Ineligible|1
1230675|NCT00720057|4036894|P2|Overall Study|Withdrawal by Subject|1
1230676|NCT00720057|4036895|P1|Overall Study|Withdrawal by Subject|0
1230677|NCT00720057|4036894|P2|Overall Study|Protocol Violation|0
1230678|NCT00720057|4036895|P1|Overall Study|Protocol Violation|1
1230679|NCT00720057|4036894|P2|Overall Study|Lost to Follow-up|2
1230680|NCT00720057|4036895|P1|Overall Study|Lost to Follow-up|0
1230681|NCT00719953|4036911|P1|Overall Study|Adverse Event|4
1230682|NCT00719901|4036924|P1|Overall Study|Availability of Study Drug|1
1230683|NCT00719901|4036924|P1|Overall Study|Disease Progression|3
1230684|NCT00719901|4036924|P1|Overall Study|Alternate Treatment|1
1230685|NCT00719901|4036924|P1|Overall Study|Withdrawal by Subject|1
1230686|NCT00719901|4036924|P1|Overall Study|Adverse Event|5
1230687|NCT00719862|4036936|P2|Overall Study|Other|3
1230688|NCT00719862|4036937|P1|Overall Study|Other|2
1230689|NCT00719862|4036936|P2|Overall Study|Lost to Follow-up|1
1230690|NCT00719862|4036937|P1|Overall Study|Lost to Follow-up|0
1230691|NCT00719862|4036936|P2|Overall Study|Withdrawal by Subject|0
1230692|NCT00719862|4036937|P1|Overall Study|Withdrawal by Subject|1
1230693|NCT00719862|4036936|P2|Overall Study|Non-Compliance|0
1230694|NCT00719862|4036937|P1|Overall Study|Non-Compliance|1
1230695|NCT00719862|4036936|P2|Overall Study|Lack of Efficacy|0
1230696|NCT00719862|4036937|P1|Overall Study|Lack of Efficacy|3
1230697|NCT00719862|4036936|P2|Overall Study|Adverse Event|2
1230698|NCT00719862|4036937|P1|Overall Study|Adverse Event|1
1230699|NCT00719849|4036955|P2|Overall Study|Death|1
1230700|NCT00719849|4036956|P1|Overall Study|Death|0
1230701|NCT00719810|4036995|P3|Overall Study|Withdrawal by Subject|2
1230702|NCT00719810|4036996|P2|Overall Study|Withdrawal by Subject|1
1230703|NCT00719810|4036997|P1|Overall Study|Withdrawal by Subject|1
1230704|NCT00719810|4036995|P3|Overall Study|Physician Decision|0
1230705|NCT00719810|4036996|P2|Overall Study|Physician Decision|1
1230706|NCT00719810|4036997|P1|Overall Study|Physician Decision|0
1230707|NCT00719810|4036995|P3|Overall Study|Lost to Follow-up|3
1230708|NCT00719810|4036996|P2|Overall Study|Lost to Follow-up|0
1230709|NCT00719810|4036997|P1|Overall Study|Lost to Follow-up|2
1230710|NCT00719810|4036995|P3|Overall Study|Adverse Event|3
1230711|NCT00719810|4036996|P2|Overall Study|Adverse Event|2
1230712|NCT00719810|4036997|P1|Overall Study|Adverse Event|0
1230713|NCT00719732|4037008|P1|Overall Study|Illness not associated with device|1
1230714|NCT00719732|4037008|P1|Overall Study|Unilateral (not bilateral) implantation|1
1230715|NCT00719732|4037008|P1|Overall Study|Lost to Follow-up|20
1230716|NCT00719706|4037014|P2|Overall Study|Protocol Violation|0
1230717|NCT00719706|4037015|P1|Overall Study|Protocol Violation|3
1230718|NCT00719706|4037014|P2|Overall Study|Withdrawal by Subject|2
1230719|NCT00719706|4037015|P1|Overall Study|Withdrawal by Subject|1
1230720|NCT00719706|4037014|P2|Overall Study|Adverse Event|4
1230721|NCT00719706|4037015|P1|Overall Study|Adverse Event|5
1230722|NCT00719680|4037029|P1|Overall Study|Withdrawal by Subject|3
1230723|NCT00719680|4037029|P1|Overall Study|Lost to Follow-up|1
1230724|NCT00719680|4037029|P1|Overall Study|Adverse Event|1
1230725|NCT00719563|4037085|P2|Overall Study|Lost to Follow-up|3
1230726|NCT00719563|4037086|P1|Overall Study|Lost to Follow-up|5
1230727|NCT00719563|4037085|P2|Overall Study|Noncompliant|1
1230728|NCT00719563|4037086|P1|Overall Study|Noncompliant|1
1230729|NCT00719563|4037085|P2|Overall Study|Unknown reasons|6
1230730|NCT00719563|4037086|P1|Overall Study|Unknown reasons|4
1230731|NCT00719563|4037085|P2|Overall Study|Personal reasons|7
1230732|NCT00719563|4037086|P1|Overall Study|Personal reasons|6
1230733|NCT00719563|4037085|P2|Overall Study|Lack of Efficacy|7
1230734|NCT00719563|4037086|P1|Overall Study|Lack of Efficacy|3
1230735|NCT00719563|4037085|P2|Overall Study|Medical condition changed|5
1230736|NCT00719563|4037086|P1|Overall Study|Medical condition changed|3
1230737|NCT00719563|4037085|P2|Overall Study|Adverse Event|13
1230738|NCT00719563|4037086|P1|Overall Study|Adverse Event|16
1230739|NCT00719537|4037118|P2|Overall Study|Lost to Follow-up|1
1230740|NCT00719537|4037119|P1|Overall Study|Lost to Follow-up|0
1230741|NCT00719537|4037118|P2|Overall Study|Withdrawal by Subject|0
1230742|NCT00719537|4037119|P1|Overall Study|Withdrawal by Subject|1
1230743|NCT00719472|4037125|P1|Received Cycle 2 Treatment|Various Reasons|25
1230744|NCT00719472|4037125|P1|Received Cycle 2 Treatment|Subject decision to withdraw|6
1230745|NCT00719472|4037125|P1|Received Cycle 2 Treatment|Physician decision to withdraw patient|13
1230746|NCT00719472|4037125|P1|Received Cycle 2 Treatment|Lost to Follow-up|3
1230747|NCT00719472|4037125|P1|Received Cycle 2 Treatment|Disease progression|3
1230748|NCT00719472|4037125|P1|Received Cycle 2 Treatment|Death|6
1230749|NCT00719472|4037125|P1|Received Cycle 2 Treatment|Adverse Event|12
1230750|NCT00719472|4037125|P1|Received Cycle 1 Treatment|Various Reasons|13
1230751|NCT00719472|4037125|P1|Received Cycle 1 Treatment|Subject decision to withdraw|9
1230752|NCT00719472|4037125|P1|Received Cycle 1 Treatment|Physician decision to withdraw patient|7
1230753|NCT00719472|4037125|P1|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11
1230754|NCT00719472|4037125|P1|Received Cycle 1 Treatment|Death|5
1230755|NCT00719472|4037125|P1|Received Cycle 1 Treatment|Adverse Event|8
1230756|NCT00719472|4037125|P1|Enrolled in Study|Various Reasons|17
1230757|NCT00719472|4037125|P1|Enrolled in Study|Subject decision to withdraw|8
1230758|NCT00719472|4037125|P1|Enrolled in Study|Physician decision to withdraw patient|1
1230759|NCT00719355|4037136|P2|Overall Study|Moved|1
1230760|NCT00719355|4037137|P1|Overall Study|Moved|0
1230761|NCT00719355|4037136|P2|Overall Study|Compliance|6
1230762|NCT00719355|4037137|P1|Overall Study|Compliance|4
1230763|NCT00719355|4037136|P2|Overall Study|Medical|5
1230764|NCT00719355|4037137|P1|Overall Study|Medical|14
1230765|NCT00719355|4037136|P2|Overall Study|Death|1
1230766|NCT00719355|4037137|P1|Overall Study|Death|0
1230767|NCT00719264|4037166|P2|Overall Study|Disease Progression|107
1230768|NCT00719264|4037167|P1|Overall Study|Disease Progression|104
1230769|NCT00719264|4037166|P2|Overall Study|New Cancer Therapy|2
1230770|NCT00719264|4037167|P1|Overall Study|New Cancer Therapy|4
1230771|NCT00719264|4037166|P2|Overall Study|Protocol Deviation|3
1230772|NCT00719264|4037167|P1|Overall Study|Protocol Deviation|1
1230773|NCT00719264|4037166|P2|Overall Study|Withdrawal by Subject|7
1230774|NCT00719264|4037167|P1|Overall Study|Withdrawal by Subject|12
1230775|NCT00719264|4037166|P2|Overall Study|Lost to Follow-up|1
1230776|NCT00719264|4037167|P1|Overall Study|Lost to Follow-up|1
1230777|NCT00719264|4037166|P2|Overall Study|Administrative Problems|4
1230778|NCT00719264|4037167|P1|Overall Study|Administrative Problems|6
1230779|NCT00719264|4037166|P2|Overall Study|Death|10
1230780|NCT00719264|4037167|P1|Overall Study|Death|13
1230781|NCT00719264|4037166|P2|Overall Study|Adverse Event|49
1230782|NCT00719264|4037167|P1|Overall Study|Adverse Event|41
1230783|NCT00719212|4037186|P1|Overall Study|Withdrawal by Subject|1
1230784|NCT00719212|4037186|P1|Overall Study|Lost to Follow-up|2
1230785|NCT00719212|4037186|P1|Overall Study|Death|41
1230786|NCT00719043|4037234|P7|Overall Study|Withdrawal by Subject|14
1230787|NCT00719043|4037235|P6|Overall Study|Withdrawal by Subject|18
1230788|NCT00719043|4037236|P5|Overall Study|Withdrawal by Subject|16
1230789|NCT00719043|4037237|P4|Overall Study|Withdrawal by Subject|10
1230790|NCT00719043|4037238|P3|Overall Study|Withdrawal by Subject|9
1230791|NCT00719043|4037239|P2|Overall Study|Withdrawal by Subject|14
1230792|NCT00719043|4037240|P1|Overall Study|Withdrawal by Subject|12
1230793|NCT00719043|4037234|P7|Overall Study|Other|1
1230794|NCT00719043|4037235|P6|Overall Study|Other|2
1230795|NCT00719043|4037236|P5|Overall Study|Other|0
1230796|NCT00719043|4037237|P4|Overall Study|Other|2
1230797|NCT00719043|4037238|P3|Overall Study|Other|1
1230798|NCT00719043|4037239|P2|Overall Study|Other|0
1230799|NCT00719043|4037240|P1|Overall Study|Other|1
1230800|NCT00719043|4037234|P7|Overall Study|Protocol Violation|0
1230801|NCT00719043|4037235|P6|Overall Study|Protocol Violation|1
1230802|NCT00719043|4037236|P5|Overall Study|Protocol Violation|0
1230803|NCT00719043|4037237|P4|Overall Study|Protocol Violation|0
1230804|NCT00719043|4037238|P3|Overall Study|Protocol Violation|0
1230805|NCT00719043|4037239|P2|Overall Study|Protocol Violation|0
1230806|NCT00719043|4037240|P1|Overall Study|Protocol Violation|0
1230807|NCT00719043|4037234|P7|Overall Study|Lost to Follow-up|9
1230808|NCT00719043|4037235|P6|Overall Study|Lost to Follow-up|9
1230809|NCT00719043|4037236|P5|Overall Study|Lost to Follow-up|10
1230810|NCT00719043|4037237|P4|Overall Study|Lost to Follow-up|9
1230811|NCT00719043|4037238|P3|Overall Study|Lost to Follow-up|8
1230812|NCT00719043|4037239|P2|Overall Study|Lost to Follow-up|10
1230813|NCT00719043|4037240|P1|Overall Study|Lost to Follow-up|14
1230814|NCT00719043|4037234|P7|Overall Study|Adverse Event|4
1230815|NCT00719043|4037235|P6|Overall Study|Adverse Event|4
1230816|NCT00719043|4037236|P5|Overall Study|Adverse Event|1
1230817|NCT00719043|4037237|P4|Overall Study|Adverse Event|2
1230818|NCT00719043|4037238|P3|Overall Study|Adverse Event|2
1230819|NCT00719043|4037239|P2|Overall Study|Adverse Event|1
1230820|NCT00719043|4037240|P1|Overall Study|Adverse Event|5
1230821|NCT00718887|4037364|P2|Overall Study|Not identified|7
1230822|NCT00718887|4037365|P1|Overall Study|Not identified|2
1230823|NCT00718887|4037364|P2|Overall Study|Withdrawal by Subject|2
1230824|NCT00718887|4037365|P1|Overall Study|Withdrawal by Subject|3
1230825|NCT00718861|4037389|P2|Overall Study|Death|5
1230826|NCT00718861|4037390|P1|Overall Study|Death|1
1230827|NCT00718861|4037389|P2|Overall Study|Administrative Problems|1
1230828|NCT00718861|4037390|P1|Overall Study|Administrative Problems|1
1230829|NCT00718861|4037389|P2|Overall Study|Lost to Follow-up|1
1230830|NCT00718861|4037390|P1|Overall Study|Lost to Follow-up|2
1230831|NCT00718861|4037389|P2|Overall Study|Adverse Event|1
1230832|NCT00718861|4037390|P1|Overall Study|Adverse Event|2
1230833|NCT00718861|4037389|P2|Overall Study|Withdrawal by Subject|10
1230834|NCT00718861|4037390|P1|Overall Study|Withdrawal by Subject|15
1230835|NCT00718809|4037418|P2|Overall Study|Noncompliance|0
1230836|NCT00718809|4037419|P1|Overall Study|Noncompliance|1
1230837|NCT00718809|4037418|P2|Overall Study|Lost to Follow-up|0
1230838|NCT00718809|4037419|P1|Overall Study|Lost to Follow-up|1
1230839|NCT00718809|4037418|P2|Overall Study|Withdrawal by Subject|1
1230840|NCT00718809|4037419|P1|Overall Study|Withdrawal by Subject|0
1230841|NCT00718809|4037418|P2|Overall Study|Adverse Event|1
1230842|NCT00718809|4037419|P1|Overall Study|Adverse Event|1
1230843|NCT00718809|4037418|P2|Overall Study|Disease progression|7
1230844|NCT00718809|4037419|P1|Overall Study|Disease progression|9
1230845|NCT00718770|4037433|P1|Overall Study|Adverse Event|1
1230846|NCT00718770|4037433|P1|Overall Study|Lack of Efficacy|1
1230847|NCT00718770|4037433|P1|Overall Study|Adverse Event|1
1230848|NCT00718770|4037433|P1|Overall Study|Lack of Efficacy|1
1230849|NCT00718770|4037433|P1|Overall Study|Adverse Event|1
1230850|NCT00718770|4037433|P1|Overall Study|Lack of Efficacy|1
1230851|NCT00718770|4037433|P1|Overall Study|Lack of Efficacy|1
1230852|NCT00718770|4037433|P1|Overall Study|Adverse Event|1
1230853|NCT00718718|4037444|P10|Week 12 to End of Study|Other|0
1230854|NCT00718718|4037445|P9|Week 12 to End of Study|Other|0
1230855|NCT00718718|4037446|P8|Week 12 to End of Study|Other|0
1230856|NCT00718718|4037447|P7|Week 12 to End of Study|Other|1
1230857|NCT00718718|4037448|P6|Week 12 to End of Study|Other|0
1230858|NCT00718718|4037449|P5|Week 12 to End of Study|Other|0
1230859|NCT00718718|4037450|P4|Week 12 to End of Study|Other|1
1230860|NCT00718718|4037451|P3|Week 12 to End of Study|Other|0
1230861|NCT00718718|4037452|P2|Week 12 to End of Study|Other|1
1230862|NCT00718718|4037453|P1|Week 12 to End of Study|Other|0
1230863|NCT00718718|4037444|P10|Week 12 to End of Study|Lost to Follow-up|0
1230864|NCT00718718|4037445|P9|Week 12 to End of Study|Lost to Follow-up|1
1230865|NCT00718718|4037446|P8|Week 12 to End of Study|Lost to Follow-up|0
1230866|NCT00718718|4037447|P7|Week 12 to End of Study|Lost to Follow-up|0
1230867|NCT00718718|4037448|P6|Week 12 to End of Study|Lost to Follow-up|0
1230868|NCT00718718|4037449|P5|Week 12 to End of Study|Lost to Follow-up|0
1230869|NCT00718718|4037450|P4|Week 12 to End of Study|Lost to Follow-up|0
1230870|NCT00718718|4037451|P3|Week 12 to End of Study|Lost to Follow-up|0
1230871|NCT00718718|4037452|P2|Week 12 to End of Study|Lost to Follow-up|0
1230872|NCT00718718|4037453|P1|Week 12 to End of Study|Lost to Follow-up|0
1230873|NCT00718718|4037444|P10|Week 12 to End of Study|Withdrawal by Subject|0
1230874|NCT00718718|4037445|P9|Week 12 to End of Study|Withdrawal by Subject|0
1230875|NCT00718718|4037446|P8|Week 12 to End of Study|Withdrawal by Subject|0
1230876|NCT00718718|4037447|P7|Week 12 to End of Study|Withdrawal by Subject|1
1230877|NCT00718718|4037448|P6|Week 12 to End of Study|Withdrawal by Subject|2
1230878|NCT00718718|4037449|P5|Week 12 to End of Study|Withdrawal by Subject|0
1230879|NCT00718718|4037450|P4|Week 12 to End of Study|Withdrawal by Subject|0
1230880|NCT00718718|4037451|P3|Week 12 to End of Study|Withdrawal by Subject|0
1230881|NCT00718718|4037452|P2|Week 12 to End of Study|Withdrawal by Subject|0
1230882|NCT00718718|4037453|P1|Week 12 to End of Study|Withdrawal by Subject|0
1230883|NCT00718718|4037444|P10|Week 12 to End of Study|Death|0
1230884|NCT00718718|4037445|P9|Week 12 to End of Study|Death|0
1230885|NCT00718718|4037446|P8|Week 12 to End of Study|Death|0
1230886|NCT00718718|4037447|P7|Week 12 to End of Study|Death|0
1230887|NCT00718718|4037448|P6|Week 12 to End of Study|Death|1
1230888|NCT00718718|4037449|P5|Week 12 to End of Study|Death|0
1230889|NCT00718718|4037450|P4|Week 12 to End of Study|Death|0
1230890|NCT00718718|4037451|P3|Week 12 to End of Study|Death|0
1230891|NCT00718718|4037452|P2|Week 12 to End of Study|Death|0
1230892|NCT00718718|4037453|P1|Week 12 to End of Study|Death|0
1230893|NCT00718718|4037444|P10|Week 12 to End of Study|Adverse Event|0
1230894|NCT00718718|4037445|P9|Week 12 to End of Study|Adverse Event|0
1230895|NCT00718718|4037446|P8|Week 12 to End of Study|Adverse Event|1
1230896|NCT00718718|4037447|P7|Week 12 to End of Study|Adverse Event|0
1230897|NCT00718718|4037448|P6|Week 12 to End of Study|Adverse Event|0
1230898|NCT00718718|4037449|P5|Week 12 to End of Study|Adverse Event|0
1230899|NCT00718718|4037450|P4|Week 12 to End of Study|Adverse Event|0
1230900|NCT00718718|4037451|P3|Week 12 to End of Study|Adverse Event|0
1230901|NCT00718718|4037452|P2|Week 12 to End of Study|Adverse Event|0
1230902|NCT00718718|4037453|P1|Week 12 to End of Study|Adverse Event|0
1230903|NCT00718718|4037444|P10|Prior to Week 12|Other|0
1230904|NCT00718718|4037445|P9|Prior to Week 12|Other|0
1230905|NCT00718718|4037446|P8|Prior to Week 12|Other|0
1230906|NCT00718718|4037447|P7|Prior to Week 12|Other|0
1230907|NCT00718718|4037448|P6|Prior to Week 12|Other|0
1230908|NCT00718718|4037449|P5|Prior to Week 12|Other|0
1230909|NCT00718718|4037450|P4|Prior to Week 12|Other|0
1230910|NCT00718718|4037451|P3|Prior to Week 12|Other|1
1230911|NCT00718718|4037452|P2|Prior to Week 12|Other|0
1230912|NCT00718718|4037453|P1|Prior to Week 12|Other|1
1230913|NCT00718718|4037444|P10|Prior to Week 12|Withdrawal by Subject|0
1230914|NCT00718718|4037445|P9|Prior to Week 12|Withdrawal by Subject|1
1230915|NCT00718718|4037446|P8|Prior to Week 12|Withdrawal by Subject|1
1230916|NCT00718718|4037447|P7|Prior to Week 12|Withdrawal by Subject|1
1230917|NCT00718718|4037448|P6|Prior to Week 12|Withdrawal by Subject|0
1230918|NCT00718718|4037449|P5|Prior to Week 12|Withdrawal by Subject|3
1230919|NCT00718718|4037450|P4|Prior to Week 12|Withdrawal by Subject|0
1230920|NCT00718718|4037451|P3|Prior to Week 12|Withdrawal by Subject|0
1230921|NCT00718718|4037452|P2|Prior to Week 12|Withdrawal by Subject|0
1230922|NCT00718718|4037453|P1|Prior to Week 12|Withdrawal by Subject|0
1230923|NCT00718718|4037444|P10|Prior to Week 12|Adverse Event|0
1230924|NCT00718718|4037445|P9|Prior to Week 12|Adverse Event|1
1230925|NCT00718718|4037446|P8|Prior to Week 12|Adverse Event|1
1230926|NCT00718718|4037447|P7|Prior to Week 12|Adverse Event|0
1230927|NCT00718718|4037448|P6|Prior to Week 12|Adverse Event|0
1230928|NCT00718718|4037449|P5|Prior to Week 12|Adverse Event|0
1230929|NCT00718718|4037450|P4|Prior to Week 12|Adverse Event|0
1230930|NCT00718718|4037451|P3|Prior to Week 12|Adverse Event|0
1230931|NCT00718718|4037452|P2|Prior to Week 12|Adverse Event|0
1230932|NCT00718718|4037453|P1|Prior to Week 12|Adverse Event|0
1230933|NCT00718666|4037496|P3|Booster Phase Year 5|Lost to Follow-up|4
1230934|NCT00718666|4037497|P2|Booster Phase Year 5|Lost to Follow-up|0
1230935|NCT00718666|4037498|P1|Booster Phase Year 5|Lost to Follow-up|1
1230936|NCT00718666|4037496|P3|Booster Phase Year 5|Withdrawal by Subject|1
1230937|NCT00718666|4037497|P2|Booster Phase Year 5|Withdrawal by Subject|0
1230938|NCT00718666|4037498|P1|Booster Phase Year 5|Withdrawal by Subject|0
1230939|NCT00718666|4037496|P3|Booster Phase Year 5|Declined v-4 serology|0
1230940|NCT00718666|4037497|P2|Booster Phase Year 5|Declined v-4 serology|0
1230941|NCT00718666|4037498|P1|Booster Phase Year 5|Declined v-4 serology|1
1230942|NCT00718666|4037496|P3|Booster Phase Year 5|No active participation request|1
1230943|NCT00718666|4037497|P2|Booster Phase Year 5|No active participation request|0
1230944|NCT00718666|4037498|P1|Booster Phase Year 5|No active participation request|0
1230945|NCT00718640|4037582|P1|Overall Study|Unresolved toxicity after 2 weeks|2
1230946|NCT00718640|4037582|P1|Overall Study|Death|1
1230947|NCT00718640|4037582|P1|Overall Study|Adverse Event|4
1230948|NCT00718549|4037594|P3|Maintenance/ Observation Phase|Relapse|2
1230949|NCT00718549|4037595|P2|Maintenance/ Observation Phase|Relapse|3
1230950|NCT00718549|4037596|P1|Maintenance/ Observation Phase|Relapse|0
1230951|NCT00718549|4037594|P3|Maintenance/ Observation Phase|Progression|14
1230952|NCT00718549|4037595|P2|Maintenance/ Observation Phase|Progression|5
1230953|NCT00718549|4037596|P1|Maintenance/ Observation Phase|Progression|0
1230954|NCT00718549|4037594|P3|Maintenance/ Observation Phase|Lost to Follow-up|4
1230955|NCT00718549|4037595|P2|Maintenance/ Observation Phase|Lost to Follow-up|4
1230956|NCT00718549|4037596|P1|Maintenance/ Observation Phase|Lost to Follow-up|0
1230957|NCT00718549|4037594|P3|Maintenance/ Observation Phase|Death|2
1230958|NCT00718549|4037595|P2|Maintenance/ Observation Phase|Death|1
1230959|NCT00718549|4037596|P1|Maintenance/ Observation Phase|Death|0
1230960|NCT00718549|4037594|P3|Maintenance/ Observation Phase|Early Termination - No Additional Info|8
1230961|NCT00718549|4037595|P2|Maintenance/ Observation Phase|Early Termination - No Additional Info|15
1230962|NCT00718549|4037596|P1|Maintenance/ Observation Phase|Early Termination - No Additional Info|0
1230963|NCT00718549|4037594|P3|Induction Phase|Early Termination - No Additional Info|0
1230964|NCT00718549|4037595|P2|Induction Phase|Early Termination - No Additional Info|0
1230965|NCT00718549|4037596|P1|Induction Phase|Early Termination - No Additional Info|59
1230966|NCT00718549|4037594|P3|Induction Phase|Eligibility Criteria Violation|0
1230967|NCT00718549|4037595|P2|Induction Phase|Eligibility Criteria Violation|0
1230968|NCT00718549|4037596|P1|Induction Phase|Eligibility Criteria Violation|2
1230969|NCT00718549|4037594|P3|Induction Phase|Disease Progression|0
1230970|NCT00718549|4037595|P2|Induction Phase|Disease Progression|0
1230971|NCT00718549|4037596|P1|Induction Phase|Disease Progression|1
1230972|NCT00718523|4037621|P2|Overall Study|Death|17
1230973|NCT00718523|4037622|P1|Overall Study|Death|13
1230974|NCT00718523|4037621|P2|Overall Study|Withdrawal by Subject|7
1230975|NCT00718523|4037622|P1|Overall Study|Withdrawal by Subject|5
1230976|NCT00718510|4037634|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|0
1230977|NCT00718510|4037635|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|1
1230978|NCT00718510|4037634|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
1230979|NCT00718510|4037635|P1|First Intervention (3 Weeks)|Withdrawal by Subject|0
1230980|NCT00718328|4037647|P2|Overall Study|Lost to Follow-up|0
1230981|NCT00718328|4037648|P1|Overall Study|Lost to Follow-up|1
1230982|NCT00718315|4037657|P3|Overall Study|Use of ATB and Corticoids|2
1230983|NCT00718315|4037658|P2|Overall Study|Use of ATB and Corticoids|1
1230984|NCT00718315|4037659|P1|Overall Study|Use of ATB and Corticoids|0
1230985|NCT00718315|4037657|P3|Overall Study|Other|1
1230986|NCT00718315|4037658|P2|Overall Study|Other|0
1230987|NCT00718315|4037659|P1|Overall Study|Other|0
1230988|NCT00718315|4037657|P3|Overall Study|Disease progression|1
1230989|NCT00718315|4037658|P2|Overall Study|Disease progression|1
1230990|NCT00718315|4037659|P1|Overall Study|Disease progression|0
1230991|NCT00718315|4037657|P3|Overall Study|Use of Minocyclin|1
1230992|NCT00718315|4037658|P2|Overall Study|Use of Minocyclin|1
1230993|NCT00718315|4037659|P1|Overall Study|Use of Minocyclin|1
1230994|NCT00718315|4037657|P3|Overall Study|Erlotinib dose decreased|1
1230995|NCT00718315|4037658|P2|Overall Study|Erlotinib dose decreased|3
1230996|NCT00718315|4037659|P1|Overall Study|Erlotinib dose decreased|4
1230997|NCT00718315|4037657|P3|Overall Study|Protocol Violation|3
1230998|NCT00718315|4037658|P2|Overall Study|Protocol Violation|5
1230999|NCT00718315|4037659|P1|Overall Study|Protocol Violation|5
1231000|NCT00718315|4037657|P3|Overall Study|Lost to Follow-up|4
1231001|NCT00718315|4037658|P2|Overall Study|Lost to Follow-up|3
1231002|NCT00718315|4037659|P1|Overall Study|Lost to Follow-up|2
1231003|NCT00718315|4037657|P3|Overall Study|Death|5
1231004|NCT00718315|4037658|P2|Overall Study|Death|6
1231005|NCT00718315|4037659|P1|Overall Study|Death|6
1231006|NCT00718315|4037657|P3|Overall Study|Adverse Event|3
1231007|NCT00718315|4037658|P2|Overall Study|Adverse Event|2
1231008|NCT00718315|4037659|P1|Overall Study|Adverse Event|1
1231009|NCT00718237|4037710|P2|Overall Study|Withdrawal by Subject|10
1231010|NCT00718237|4037711|P1|Overall Study|Withdrawal by Subject|9
1231011|NCT00718237|4037710|P2|Overall Study|Physician Decision|0
1231012|NCT00718237|4037711|P1|Overall Study|Physician Decision|1
1231013|NCT00718237|4037710|P2|Overall Study|Lost to Follow-up|2
1231014|NCT00718237|4037711|P1|Overall Study|Lost to Follow-up|2
1231015|NCT00718237|4037710|P2|Overall Study|Adverse Event|3
1231016|NCT00718237|4037711|P1|Overall Study|Adverse Event|1
1231017|NCT00718159|4037728|P7|Overall Study|Investigator Decision|1
1231018|NCT00718159|4037729|P6|Overall Study|Investigator Decision|1
1231019|NCT00718159|4037730|P5|Overall Study|Investigator Decision|0
1231020|NCT00718159|4037731|P4|Overall Study|Investigator Decision|0
1231021|NCT00718159|4037732|P3|Overall Study|Investigator Decision|0
1231022|NCT00718159|4037733|P2|Overall Study|Investigator Decision|0
1231023|NCT00718159|4037734|P1|Overall Study|Investigator Decision|0
1231024|NCT00718159|4037728|P7|Overall Study|Death due to Study Drug Toxicity|0
1231025|NCT00718159|4037729|P6|Overall Study|Death due to Study Drug Toxicity|0
1231026|NCT00718159|4037730|P5|Overall Study|Death due to Study Drug Toxicity|0
1231027|NCT00718159|4037731|P4|Overall Study|Death due to Study Drug Toxicity|2
1231028|NCT00718159|4037732|P3|Overall Study|Death due to Study Drug Toxicity|1
1231029|NCT00718159|4037733|P2|Overall Study|Death due to Study Drug Toxicity|0
1231030|NCT00718159|4037734|P1|Overall Study|Death due to Study Drug Toxicity|0
1231031|NCT00718159|4037728|P7|Overall Study|Death due to Adverse Event|0
1231032|NCT00718159|4037729|P6|Overall Study|Death due to Adverse Event|0
1231033|NCT00718159|4037730|P5|Overall Study|Death due to Adverse Event|2
1231034|NCT00718159|4037731|P4|Overall Study|Death due to Adverse Event|2
1231035|NCT00718159|4037732|P3|Overall Study|Death due to Adverse Event|0
1231036|NCT00718159|4037733|P2|Overall Study|Death due to Adverse Event|0
1231037|NCT00718159|4037734|P1|Overall Study|Death due to Adverse Event|0
1231038|NCT00718159|4037728|P7|Overall Study|Progressive Disease|0
1231039|NCT00718159|4037729|P6|Overall Study|Progressive Disease|0
1231040|NCT00718159|4037730|P5|Overall Study|Progressive Disease|6
1231041|NCT00718159|4037731|P4|Overall Study|Progressive Disease|0
1231042|NCT00718159|4037732|P3|Overall Study|Progressive Disease|2
1231043|NCT00718159|4037733|P2|Overall Study|Progressive Disease|3
1231044|NCT00718159|4037734|P1|Overall Study|Progressive Disease|3
1231045|NCT00718081|4037791|P3|Overall Study|Lack of Efficacy|21
1231046|NCT00718081|4037792|P2|Overall Study|Lack of Efficacy|3
1231047|NCT00718081|4037793|P1|Overall Study|Lack of Efficacy|7
1231048|NCT00718081|4037791|P3|Overall Study|Adverse Event|0
1231049|NCT00718081|4037792|P2|Overall Study|Adverse Event|1
1231050|NCT00718081|4037793|P1|Overall Study|Adverse Event|0
1231051|NCT00718042|4037810|P6|Donor Follow-up|Lost to Follow-up|0
1231052|NCT00718042|4037811|P5|Donor Follow-up|Lost to Follow-up|19
1231053|NCT00718042|4037812|P4|Donor Follow-up|Lost to Follow-up|0
1231054|NCT00718042|4037813|P3|Donor Follow-up|Lost to Follow-up|0
1231055|NCT00718042|4037814|P2|Donor Follow-up|Lost to Follow-up|0
1231056|NCT00718042|4037815|P1|Donor Follow-up|Lost to Follow-up|13
1231057|NCT00718042|4037810|P6|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
1231058|NCT00718042|4037811|P5|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
1231059|NCT00718042|4037812|P4|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
1231060|NCT00718042|4037813|P3|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
1231061|NCT00718042|4037814|P2|ABBOTT PRISM Chagas Testing|No result on comparator assay|1
1231062|NCT00718042|4037815|P1|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
1231063|NCT00718042|4037810|P6|ABBOTT PRISM Chagas Testing|Insufficient sample|0
1231064|NCT00718042|4037811|P5|ABBOTT PRISM Chagas Testing|Insufficient sample|0
1231065|NCT00718042|4037812|P4|ABBOTT PRISM Chagas Testing|Insufficient sample|0
1231066|NCT00718042|4037813|P3|ABBOTT PRISM Chagas Testing|Insufficient sample|1
1231067|NCT00718042|4037814|P2|ABBOTT PRISM Chagas Testing|Insufficient sample|1
1231068|NCT00718042|4037815|P1|ABBOTT PRISM Chagas Testing|Insufficient sample|0
1231069|NCT00718042|4037810|P6|ABBOTT PRISM Chagas Testing|Protocol Violation|0
1231070|NCT00718042|4037811|P5|ABBOTT PRISM Chagas Testing|Protocol Violation|36
1231071|NCT00718042|4037812|P4|ABBOTT PRISM Chagas Testing|Protocol Violation|0
1231072|NCT00718042|4037813|P3|ABBOTT PRISM Chagas Testing|Protocol Violation|0
1231073|NCT00718042|4037814|P2|ABBOTT PRISM Chagas Testing|Protocol Violation|0
1231074|NCT00718042|4037815|P1|ABBOTT PRISM Chagas Testing|Protocol Violation|64
1231075|NCT00718042|4037810|P6|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
1231076|NCT00718042|4037811|P5|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2
1231077|NCT00718042|4037812|P4|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
1231078|NCT00718042|4037813|P3|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
1231079|NCT00718042|4037814|P2|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
1231080|NCT00718042|4037815|P1|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
1231081|NCT00717886|4037871|P1|Overall Study|Treatment Failure|1
1231082|NCT00717886|4037871|P1|Overall Study|Withdrawal by Subject|3
1231083|NCT00717860|4037886|P2|Overall Study|Withdrew consent|3
1231084|NCT00717860|4037887|P1|Overall Study|Withdrew consent|7
1231085|NCT00717860|4037886|P2|Overall Study|Discontinued for other reason|1
1231086|NCT00717860|4037887|P1|Overall Study|Discontinued for other reason|6
1231087|NCT00717860|4037886|P2|Overall Study|Lack of Efficacy|13
1231088|NCT00717860|4037887|P1|Overall Study|Lack of Efficacy|7
1231089|NCT00717860|4037886|P2|Overall Study|Laboratory adverse experience|2
1231090|NCT00717860|4037887|P1|Overall Study|Laboratory adverse experience|2
1231091|NCT00717860|4037886|P2|Overall Study|Clinical adverse experience|9
1231092|NCT00717860|4037887|P1|Overall Study|Clinical adverse experience|5
1231093|NCT00717756|4037897|P1|Overall Study|Withdrawal by Subject|1
1231094|NCT00717522|4037910|P1|Overall Study|Death|1
1231095|NCT00717522|4037910|P1|Overall Study|Adverse Event|1
1231096|NCT00717522|4037910|P1|Overall Study|Disease Progression|5
1231097|NCT00717366|4037946|P2|Extension Period (52 Weeks)|Withdrew consent|1
1231098|NCT00717366|4037947|P1|Extension Period (52 Weeks)|Withdrew consent|1
1231099|NCT00717366|4037946|P2|Extension Period (52 Weeks)|Admin/Other than specified|2
1231100|NCT00717366|4037947|P1|Extension Period (52 Weeks)|Admin/Other than specified|0
1231101|NCT00717366|4037946|P2|Extension Period (52 Weeks)|Renal transplant|13
1231102|NCT00717366|4037947|P1|Extension Period (52 Weeks)|Renal transplant|3
1231103|NCT00717366|4037946|P2|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1
1231104|NCT00717366|4037947|P1|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0
1231105|NCT00717366|4037946|P2|Core Study Period (20 Weeks)|Death|1
1231106|NCT00717366|4037947|P1|Core Study Period (20 Weeks)|Death|0
1231107|NCT00717366|4037946|P2|Core Study Period (20 Weeks)|Admin/Other than specified|2
1231108|NCT00717366|4037947|P1|Core Study Period (20 Weeks)|Admin/Other than specified|0
1231109|NCT00717366|4037946|P2|Core Study Period (20 Weeks)|Renal transplant|9
1231110|NCT00717366|4037947|P1|Core Study Period (20 Weeks)|Renal transplant|4
1231111|NCT00717314|4037971|P2|Overall Study|Withdrawal by Subject|3
1231112|NCT00717314|4037972|P1|Overall Study|Withdrawal by Subject|1
1231113|NCT00717314|4037971|P2|Overall Study|Lost to Follow-up|5
1231114|NCT00717314|4037972|P1|Overall Study|Lost to Follow-up|1
1231115|NCT00717314|4037971|P2|Overall Study|Protocol Violation|0
1231116|NCT00717314|4037972|P1|Overall Study|Protocol Violation|1
1231117|NCT00717314|4037971|P2|Overall Study|Adverse Event|2
1231118|NCT00717314|4037972|P1|Overall Study|Adverse Event|3
1231119|NCT00717275|4038009|P1|Overall Study|Premature study termination.|3
1231120|NCT00717249|4038015|P2|Overall Study|Headaches|0
1231121|NCT00717249|4038016|P1|Overall Study|Headaches|1
1231122|NCT00717249|4038015|P2|Overall Study|Subject relocated|0
1231123|NCT00717249|4038016|P1|Overall Study|Subject relocated|1
1231124|NCT00717249|4038015|P2|Overall Study|Diagnosed with Multiple Scletosis|0
1231125|NCT00717249|4038016|P1|Overall Study|Diagnosed with Multiple Scletosis|1
1231126|NCT00717249|4038015|P2|Overall Study|Diagnosed with Diabetes|0
1231127|NCT00717249|4038016|P1|Overall Study|Diagnosed with Diabetes|1
1231128|NCT00717249|4038015|P2|Overall Study|Gastric Surgery|1
1231129|NCT00717249|4038016|P1|Overall Study|Gastric Surgery|0
1231130|NCT00717249|4038015|P2|Overall Study|Unsatisfactory Physiological Response|1
1231131|NCT00717249|4038016|P1|Overall Study|Unsatisfactory Physiological Response|0
1231132|NCT00717249|4038015|P2|Overall Study|Subject became Ineligible|1
1231133|NCT00717249|4038016|P1|Overall Study|Subject became Ineligible|1
1231134|NCT00717249|4038015|P2|Overall Study|Protocol Violation|2
1231135|NCT00717249|4038016|P1|Overall Study|Protocol Violation|0
1231136|NCT00717249|4038015|P2|Overall Study|Pregnancy|3
1231137|NCT00717249|4038016|P1|Overall Study|Pregnancy|6
1231138|NCT00717249|4038015|P2|Overall Study|Withdrawal by Subject|2
1231139|NCT00717249|4038016|P1|Overall Study|Withdrawal by Subject|1
1231140|NCT00717249|4038015|P2|Overall Study|Lost to Follow-up|0
1231141|NCT00717249|4038016|P1|Overall Study|Lost to Follow-up|2
1231142|NCT00717249|4038015|P2|Overall Study|Adverse Event|2
1231143|NCT00717249|4038016|P1|Overall Study|Adverse Event|4
1231144|NCT00717249|4038015|P2|Overall Study|Unsatisfactory visual Response|2
1231145|NCT00717249|4038016|P1|Overall Study|Unsatisfactory visual Response|0
1231146|NCT00717249|4038015|P2|Overall Study|Lens Discomfort|1
1231147|NCT00717249|4038016|P1|Overall Study|Lens Discomfort|4
1231148|NCT00717236|4038030|P2|Open-Label Period|Other: Medical Monitor Recommendation|0
1231149|NCT00717236|4038031|P1|Open-Label Period|Other: Medical Monitor Recommendation|1
1231150|NCT00717236|4038030|P2|Open-Label Period|Other: Completion Accidently Performed|0
1231151|NCT00717236|4038031|P1|Open-Label Period|Other: Completion Accidently Performed|1
1231152|NCT00717236|4038030|P2|Open-Label Period|Other: Administration of Golimumab|0
1231153|NCT00717236|4038031|P1|Open-Label Period|Other: Administration of Golimumab|1
1231154|NCT00717236|4038030|P2|Open-Label Period|Other: Cataract Surgery|0
1231155|NCT00717236|4038031|P1|Open-Label Period|Other: Cataract Surgery|1
1231156|NCT00717236|4038030|P2|Open-Label Period|Other: Sponsor Request|0
1231157|NCT00717236|4038031|P1|Open-Label Period|Other: Sponsor Request|3
1231158|NCT00717236|4038030|P2|Open-Label Period|Other: Loss of Staff (unblinded)|0
1231159|NCT00717236|4038031|P1|Open-Label Period|Other: Loss of Staff (unblinded)|1
1231160|NCT00717236|4038030|P2|Open-Label Period|Other: Investigator Decision|0
1231161|NCT00717236|4038031|P1|Open-Label Period|Other: Investigator Decision|1
1231162|NCT00717236|4038030|P2|Open-Label Period|Other: Moved|0
1231163|NCT00717236|4038031|P1|Open-Label Period|Other: Moved|1
1231164|NCT00717236|4038030|P2|Open-Label Period|Other: History of Basal Cell Carcinoma|0
1231165|NCT00717236|4038031|P1|Open-Label Period|Other: History of Basal Cell Carcinoma|1
1231166|NCT00717236|4038030|P2|Open-Label Period|Other: Lack of Compliance|1
1231167|NCT00717236|4038031|P1|Open-Label Period|Other: Lack of Compliance|1
1231168|NCT00717236|4038030|P2|Open-Label Period|Other: Peripheral Neuropathy|1
1231169|NCT00717236|4038031|P1|Open-Label Period|Other: Peripheral Neuropathy|0
1231170|NCT00717236|4038030|P2|Open-Label Period|Loss of Efficacy|1
1231171|NCT00717236|4038031|P1|Open-Label Period|Loss of Efficacy|6
1231172|NCT00717236|4038030|P2|Open-Label Period|Withdrawal by Subject|2
1231173|NCT00717236|4038031|P1|Open-Label Period|Withdrawal by Subject|20
1231174|NCT00717236|4038030|P2|Open-Label Period|Lost to Follow-up|4
1231175|NCT00717236|4038031|P1|Open-Label Period|Lost to Follow-up|28
1231176|NCT00717236|4038030|P2|Open-Label Period|Lack of Efficacy|8
1231177|NCT00717236|4038031|P1|Open-Label Period|Lack of Efficacy|30
1231178|NCT00717236|4038030|P2|Open-Label Period|Adverse Event|4
1231179|NCT00717236|4038031|P1|Open-Label Period|Adverse Event|29
1231180|NCT00717236|4038030|P2|Double-Blind Period|Other: Investigator Decision|1
1231181|NCT00717236|4038031|P1|Double-Blind Period|Other: Investigator Decision|0
1231182|NCT00717236|4038030|P2|Double-Blind Period|Other: Transportation problems|1
1231183|NCT00717236|4038031|P1|Double-Blind Period|Other: Transportation problems|0
1231184|NCT00717236|4038030|P2|Double-Blind Period|Other: Prohibited medication taken|2
1231185|NCT00717236|4038031|P1|Double-Blind Period|Other: Prohibited medication taken|2
1231186|NCT00717236|4038030|P2|Double-Blind Period|Other: Stopped taking DMARD|0
1231187|NCT00717236|4038031|P1|Double-Blind Period|Other: Stopped taking DMARD|1
1231188|NCT00717236|4038030|P2|Double-Blind Period|Other: Subject moved|1
1231189|NCT00717236|4038031|P1|Double-Blind Period|Other: Subject moved|1
1231190|NCT00717236|4038030|P2|Double-Blind Period|Other: Detection of Hepatitis C Virus|0
1231191|NCT00717236|4038031|P1|Double-Blind Period|Other: Detection of Hepatitis C Virus|1
1231192|NCT00717236|4038030|P2|Double-Blind Period|Other: Inappropriate randomization|0
1231193|NCT00717236|4038031|P1|Double-Blind Period|Other: Inappropriate randomization|1
1231194|NCT00717236|4038030|P2|Double-Blind Period|Other: Sponsor request|0
1231195|NCT00717236|4038031|P1|Double-Blind Period|Other: Sponsor request|1
1231196|NCT00717236|4038030|P2|Double-Blind Period|Other: History of cancer|0
1231197|NCT00717236|4038031|P1|Double-Blind Period|Other: History of cancer|1
1231198|NCT00717236|4038030|P2|Double-Blind Period|Other: History of adenoid grown|0
1231199|NCT00717236|4038031|P1|Double-Blind Period|Other: History of adenoid grown|1
1231200|NCT00717236|4038030|P2|Double-Blind Period|Other: Abnormal chest X-ray|1
1231201|NCT00717236|4038031|P1|Double-Blind Period|Other: Abnormal chest X-ray|2
1231202|NCT00717236|4038030|P2|Double-Blind Period|Other: subject withdrew consent|1
1231203|NCT00717236|4038031|P1|Double-Blind Period|Other: subject withdrew consent|1
1231204|NCT00717236|4038030|P2|Double-Blind Period|Other: Screening failure|0
1231205|NCT00717236|4038031|P1|Double-Blind Period|Other: Screening failure|1
1231206|NCT00717236|4038030|P2|Double-Blind Period|Other: Site withdrew|0
1231207|NCT00717236|4038031|P1|Double-Blind Period|Other: Site withdrew|2
1231208|NCT00717236|4038030|P2|Double-Blind Period|Other: Inclusion/Exclusion criteria|2
1231209|NCT00717236|4038031|P1|Double-Blind Period|Other: Inclusion/Exclusion criteria|6
1231210|NCT00717236|4038030|P2|Double-Blind Period|Other: Protocol Violation|0
1231211|NCT00717236|4038031|P1|Double-Blind Period|Other: Protocol Violation|2
1231212|NCT00717236|4038030|P2|Double-Blind Period|Other: Pregnancy|0
1231213|NCT00717236|4038031|P1|Double-Blind Period|Other: Pregnancy|1
1231214|NCT00717236|4038030|P2|Double-Blind Period|Other: Death|0
1231215|NCT00717236|4038031|P1|Double-Blind Period|Other: Death|1
1231216|NCT00717236|4038030|P2|Double-Blind Period|Loss of efficacy|0
1231217|NCT00717236|4038031|P1|Double-Blind Period|Loss of efficacy|3
1231218|NCT00717236|4038030|P2|Double-Blind Period|Withdrawal by Subject|2
1231219|NCT00717236|4038031|P1|Double-Blind Period|Withdrawal by Subject|10
1231220|NCT00717236|4038030|P2|Double-Blind Period|Lost to Follow-up|5
1231221|NCT00717236|4038031|P1|Double-Blind Period|Lost to Follow-up|3
1231222|NCT00717236|4038030|P2|Double-Blind Period|Lack of Efficacy|6
1231223|NCT00717236|4038031|P1|Double-Blind Period|Lack of Efficacy|6
1231224|NCT00717236|4038030|P2|Double-Blind Period|Adverse Event|6
1231225|NCT00717236|4038031|P1|Double-Blind Period|Adverse Event|33
1231226|NCT00717197|4038100|P1|Overall Study|Physician Decision|1
1231227|NCT00717197|4038100|P1|Overall Study|Tumor Progression|1
1231228|NCT00717197|4038100|P1|Overall Study|Unable to purchase study drug|5
1231229|NCT00717093|4038106|P2|Overall Study|Randomized but not treated|0
1231230|NCT00717093|4038107|P1|Overall Study|Randomized but not treated|1
1231231|NCT00717093|4038106|P2|Overall Study|Other|1
1231232|NCT00717093|4038107|P1|Overall Study|Other|0
1231233|NCT00717093|4038106|P2|Overall Study|Withdrawal by Subject|19
1231234|NCT00717093|4038107|P1|Overall Study|Withdrawal by Subject|12
1231235|NCT00717093|4038106|P2|Overall Study|Lost to Follow-up|6
1231236|NCT00717093|4038107|P1|Overall Study|Lost to Follow-up|9
1231237|NCT00717093|4038106|P2|Overall Study|Lack of Efficacy|13
1231238|NCT00717093|4038107|P1|Overall Study|Lack of Efficacy|3
1231239|NCT00717093|4038106|P2|Overall Study|Adverse Event|9
1231240|NCT00717093|4038107|P1|Overall Study|Adverse Event|19
1231241|NCT00717067|4038124|P5|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
1231242|NCT00717067|4038125|P4|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
1231243|NCT00717067|4038126|P3|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1
1231244|NCT00717067|4038127|P2|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
1231245|NCT00717067|4038128|P1|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
1231246|NCT00716976|4038235|P2|Overall Study|Ineligibles|2
1231247|NCT00716976|4038236|P1|Overall Study|Ineligibles|4
1231248|NCT00716976|4038235|P2|Overall Study|Radiation during protocol|0
1231249|NCT00716976|4038236|P1|Overall Study|Radiation during protocol|1
1231250|NCT00716976|4038235|P2|Overall Study|Premature discontinuation cisplatin|4
1231251|NCT00716976|4038236|P1|Overall Study|Premature discontinuation cisplatin|5
1231252|NCT00716976|4038235|P2|Overall Study|Withdrawal by Subject|1
1231253|NCT00716976|4038236|P1|Overall Study|Withdrawal by Subject|5
1231254|NCT00716976|4038235|P2|Overall Study|Physician Decision|2
1231255|NCT00716976|4038236|P1|Overall Study|Physician Decision|2
1231256|NCT00716976|4038235|P2|Overall Study|Death|0
1231257|NCT00716976|4038236|P1|Overall Study|Death|1
1231258|NCT00716976|4038235|P2|Overall Study|Adverse Event|0
1231259|NCT00716976|4038236|P1|Overall Study|Adverse Event|2
1231260|NCT00716859|4038276|P2|Overall Study|Not treated|1
1231261|NCT00716859|4038277|P1|Overall Study|Not treated|1
1231262|NCT00716859|4038276|P2|Overall Study|Withdrawal by Subject|3
1231263|NCT00716859|4038277|P1|Overall Study|Withdrawal by Subject|1
1231264|NCT00716859|4038276|P2|Overall Study|Lack of Efficacy|0
1231265|NCT00716859|4038277|P1|Overall Study|Lack of Efficacy|3
1231266|NCT00716859|4038276|P2|Overall Study|Adverse Event|1
1231267|NCT00716859|4038277|P1|Overall Study|Adverse Event|4
1231268|NCT00716625|4038362|P1|Overall Study|Safety was not Assessable|1
1231269|NCT00716482|4038387|P1|Overall Study|inclusion/exclusion criteria not met|25
1231270|NCT00716482|4038387|P1|Overall Study|technical/machine error|28
1231271|NCT00716482|4038387|P1|Overall Study|no pathology obtained|10
1231272|NCT00716482|4038387|P1|Overall Study|Inadequate acquisition or analysis|50
1231273|NCT00716482|4038387|P1|Overall Study|Lost to Follow-up|6
1231274|NCT00716456|4038400|P3|Overall Study|Adverse Event|0
1231275|NCT00716456|4038401|P2|Overall Study|Adverse Event|2
1231276|NCT00716456|4038402|P1|Overall Study|Adverse Event|0
1231277|NCT00716417|4038453|P10|Overall Study|On patient request due to toxicities|0
1231278|NCT00716417|4038454|P9|Overall Study|On patient request due to toxicities|0
1231279|NCT00716417|4038455|P8|Overall Study|On patient request due to toxicities|1
1231280|NCT00716417|4038456|P7|Overall Study|On patient request due to toxicities|0
1231281|NCT00716417|4038457|P6|Overall Study|On patient request due to toxicities|0
1231282|NCT00716417|4038458|P5|Overall Study|On patient request due to toxicities|0
1231283|NCT00716417|4038459|P4|Overall Study|On patient request due to toxicities|0
1231284|NCT00716417|4038460|P3|Overall Study|On patient request due to toxicities|0
1231285|NCT00716417|4038461|P2|Overall Study|On patient request due to toxicities|0
1231286|NCT00716417|4038462|P1|Overall Study|On patient request due to toxicities|0
1231287|NCT00716417|4038453|P10|Overall Study|Dose limiting toxicity (DLT)|0
1231288|NCT00716417|4038454|P9|Overall Study|Dose limiting toxicity (DLT)|0
1231289|NCT00716417|4038455|P8|Overall Study|Dose limiting toxicity (DLT)|0
1231290|NCT00716417|4038456|P7|Overall Study|Dose limiting toxicity (DLT)|0
1231291|NCT00716417|4038457|P6|Overall Study|Dose limiting toxicity (DLT)|0
1231292|NCT00716417|4038458|P5|Overall Study|Dose limiting toxicity (DLT)|1
1231293|NCT00716417|4038459|P4|Overall Study|Dose limiting toxicity (DLT)|0
1231294|NCT00716417|4038460|P3|Overall Study|Dose limiting toxicity (DLT)|0
1231295|NCT00716417|4038461|P2|Overall Study|Dose limiting toxicity (DLT)|0
1231296|NCT00716417|4038462|P1|Overall Study|Dose limiting toxicity (DLT)|0
1231297|NCT00716417|4038453|P10|Overall Study|Progressive disease|0
1231298|NCT00716417|4038454|P9|Overall Study|Progressive disease|5
1231299|NCT00716417|4038455|P8|Overall Study|Progressive disease|1
1231300|NCT00716417|4038456|P7|Overall Study|Progressive disease|3
1231301|NCT00716417|4038457|P6|Overall Study|Progressive disease|3
1231302|NCT00716417|4038458|P5|Overall Study|Progressive disease|0
1231303|NCT00716417|4038459|P4|Overall Study|Progressive disease|8
1231304|NCT00716417|4038460|P3|Overall Study|Progressive disease|3
1231305|NCT00716417|4038461|P2|Overall Study|Progressive disease|5
1231306|NCT00716417|4038462|P1|Overall Study|Progressive disease|3
1231307|NCT00716417|4038453|P10|Overall Study|Withdrawal by Subject|0
1231308|NCT00716417|4038454|P9|Overall Study|Withdrawal by Subject|0
1231309|NCT00716417|4038455|P8|Overall Study|Withdrawal by Subject|0
1231310|NCT00716417|4038456|P7|Overall Study|Withdrawal by Subject|1
1231311|NCT00716417|4038457|P6|Overall Study|Withdrawal by Subject|0
1231312|NCT00716417|4038458|P5|Overall Study|Withdrawal by Subject|0
1231313|NCT00716417|4038459|P4|Overall Study|Withdrawal by Subject|2
1231314|NCT00716417|4038460|P3|Overall Study|Withdrawal by Subject|0
1231315|NCT00716417|4038461|P2|Overall Study|Withdrawal by Subject|1
1231316|NCT00716417|4038462|P1|Overall Study|Withdrawal by Subject|0
1231317|NCT00716417|4038453|P10|Overall Study|Adverse Event|3
1231318|NCT00716417|4038454|P9|Overall Study|Adverse Event|0
1231319|NCT00716417|4038455|P8|Overall Study|Adverse Event|1
1231320|NCT00716417|4038456|P7|Overall Study|Adverse Event|3
1231321|NCT00716417|4038457|P6|Overall Study|Adverse Event|0
1231322|NCT00716417|4038458|P5|Overall Study|Adverse Event|0
1231323|NCT00716417|4038459|P4|Overall Study|Adverse Event|1
1231324|NCT00716417|4038460|P3|Overall Study|Adverse Event|2
1231325|NCT00716417|4038461|P2|Overall Study|Adverse Event|0
1231326|NCT00716417|4038462|P1|Overall Study|Adverse Event|0
1231327|NCT00716274|4038509|P6|Study Period III (16-Weeks)|Adverse Event|0
1231328|NCT00716274|4038510|P5|Study Period III (16-Weeks)|Adverse Event|1
1231329|NCT00716274|4038511|P4|Study Period III (16-Weeks)|Adverse Event|0
1231330|NCT00716274|4038512|P3|Study Period III (16-Weeks)|Adverse Event|0
1231331|NCT00716274|4038513|P2|Study Period III (16-Weeks)|Adverse Event|0
1231332|NCT00716274|4038514|P1|Study Period III (16-Weeks)|Adverse Event|0
1231333|NCT00716274|4038509|P6|Study Period III (16-Weeks)|Parent Caregiver Decision|0
1231334|NCT00716274|4038510|P5|Study Period III (16-Weeks)|Parent Caregiver Decision|1
1231335|NCT00716274|4038511|P4|Study Period III (16-Weeks)|Parent Caregiver Decision|1
1231336|NCT00716274|4038512|P3|Study Period III (16-Weeks)|Parent Caregiver Decision|0
1231337|NCT00716274|4038513|P2|Study Period III (16-Weeks)|Parent Caregiver Decision|0
1231338|NCT00716274|4038514|P1|Study Period III (16-Weeks)|Parent Caregiver Decision|0
1231339|NCT00716274|4038509|P6|Study Period III (16-Weeks)|Physician Decision|0
1231340|NCT00716274|4038510|P5|Study Period III (16-Weeks)|Physician Decision|1
1231341|NCT00716274|4038511|P4|Study Period III (16-Weeks)|Physician Decision|0
1231342|NCT00716274|4038512|P3|Study Period III (16-Weeks)|Physician Decision|0
1231343|NCT00716274|4038513|P2|Study Period III (16-Weeks)|Physician Decision|0
1231344|NCT00716274|4038514|P1|Study Period III (16-Weeks)|Physician Decision|0
1231345|NCT00716274|4038509|P6|Study Period III (16-Weeks)|Withdrawal by Subject|0
1231346|NCT00716274|4038510|P5|Study Period III (16-Weeks)|Withdrawal by Subject|0
1231347|NCT00716274|4038511|P4|Study Period III (16-Weeks)|Withdrawal by Subject|0
1231348|NCT00716274|4038512|P3|Study Period III (16-Weeks)|Withdrawal by Subject|2
1231349|NCT00716274|4038513|P2|Study Period III (16-Weeks)|Withdrawal by Subject|0
1231350|NCT00716274|4038514|P1|Study Period III (16-Weeks)|Withdrawal by Subject|0
1231351|NCT00716274|4038509|P6|Study Period II (16-Weeks)|Lost to Follow-up|0
1231352|NCT00716274|4038510|P5|Study Period II (16-Weeks)|Lost to Follow-up|0
1231353|NCT00716274|4038511|P4|Study Period II (16-Weeks)|Lost to Follow-up|0
1231354|NCT00716274|4038512|P3|Study Period II (16-Weeks)|Lost to Follow-up|0
1231355|NCT00716274|4038513|P2|Study Period II (16-Weeks)|Lost to Follow-up|2
1231356|NCT00716274|4038514|P1|Study Period II (16-Weeks)|Lost to Follow-up|0
1231357|NCT00716274|4038509|P6|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
1231358|NCT00716274|4038510|P5|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
1231359|NCT00716274|4038511|P4|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
1231360|NCT00716274|4038512|P3|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
1231361|NCT00716274|4038513|P2|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
1231362|NCT00716274|4038514|P1|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
1231363|NCT00716274|4038509|P6|Study Period II (16-Weeks)|Physician Decision|1
1231364|NCT00716274|4038510|P5|Study Period II (16-Weeks)|Physician Decision|0
1231365|NCT00716274|4038511|P4|Study Period II (16-Weeks)|Physician Decision|0
1231366|NCT00716274|4038512|P3|Study Period II (16-Weeks)|Physician Decision|0
1231367|NCT00716274|4038513|P2|Study Period II (16-Weeks)|Physician Decision|1
1231368|NCT00716274|4038514|P1|Study Period II (16-Weeks)|Physician Decision|3
1231369|NCT00716274|4038509|P6|Study Period II (16-Weeks)|Withdrawal by Subject|0
1231370|NCT00716274|4038510|P5|Study Period II (16-Weeks)|Withdrawal by Subject|0
1231371|NCT00716274|4038511|P4|Study Period II (16-Weeks)|Withdrawal by Subject|0
1231372|NCT00716274|4038512|P3|Study Period II (16-Weeks)|Withdrawal by Subject|0
1231373|NCT00716274|4038513|P2|Study Period II (16-Weeks)|Withdrawal by Subject|0
1231374|NCT00716274|4038514|P1|Study Period II (16-Weeks)|Withdrawal by Subject|1
1231375|NCT00716274|4038509|P6|Study Period II (16-Weeks)|Protocol Violation|1
1231376|NCT00716274|4038510|P5|Study Period II (16-Weeks)|Protocol Violation|0
1231377|NCT00716274|4038511|P4|Study Period II (16-Weeks)|Protocol Violation|0
1231378|NCT00716274|4038512|P3|Study Period II (16-Weeks)|Protocol Violation|0
1231379|NCT00716274|4038513|P2|Study Period II (16-Weeks)|Protocol Violation|3
1231380|NCT00716274|4038514|P1|Study Period II (16-Weeks)|Protocol Violation|0
1231381|NCT00716274|4038509|P6|Study Period II (16-Weeks)|Entry Criteria Not Met|0
1231382|NCT00716274|4038510|P5|Study Period II (16-Weeks)|Entry Criteria Not Met|0
1231383|NCT00716274|4038511|P4|Study Period II (16-Weeks)|Entry Criteria Not Met|0
1231384|NCT00716274|4038512|P3|Study Period II (16-Weeks)|Entry Criteria Not Met|0
1231385|NCT00716274|4038513|P2|Study Period II (16-Weeks)|Entry Criteria Not Met|0
1231386|NCT00716274|4038514|P1|Study Period II (16-Weeks)|Entry Criteria Not Met|2
1231387|NCT00716144|4038648|P4|Overall Study|Clinical Depression|0
1231388|NCT00716144|4038649|P3|Overall Study|Clinical Depression|0
1231389|NCT00716144|4038650|P2|Overall Study|Clinical Depression|1
1231390|NCT00716144|4038651|P1|Overall Study|Clinical Depression|0
1231391|NCT00716144|4038648|P4|Overall Study|Adverse event: left foot pain|0
1231392|NCT00716144|4038649|P3|Overall Study|Adverse event: left foot pain|0
1231393|NCT00716144|4038650|P2|Overall Study|Adverse event: left foot pain|1
1231394|NCT00716144|4038651|P1|Overall Study|Adverse event: left foot pain|0
1231395|NCT00716144|4038648|P4|Overall Study|Withdrew consent, allowed use of data|0
1231396|NCT00716144|4038649|P3|Overall Study|Withdrew consent, allowed use of data|1
1231397|NCT00716144|4038650|P2|Overall Study|Withdrew consent, allowed use of data|0
1231398|NCT00716144|4038651|P1|Overall Study|Withdrew consent, allowed use of data|0
1231399|NCT00716144|4038648|P4|Overall Study|Intercurrent illness|0
1231400|NCT00716144|4038649|P3|Overall Study|Intercurrent illness|1
1231401|NCT00716144|4038650|P2|Overall Study|Intercurrent illness|0
1231402|NCT00716144|4038651|P1|Overall Study|Intercurrent illness|0
1231403|NCT00716144|4038648|P4|Overall Study|Physician Decision|2
1231404|NCT00716144|4038649|P3|Overall Study|Physician Decision|2
1231405|NCT00716144|4038650|P2|Overall Study|Physician Decision|1
1231406|NCT00716144|4038651|P1|Overall Study|Physician Decision|0
1231407|NCT00716144|4038648|P4|Overall Study|Protocol Violation|0
1231408|NCT00716144|4038649|P3|Overall Study|Protocol Violation|1
1231409|NCT00716144|4038650|P2|Overall Study|Protocol Violation|0
1231410|NCT00716144|4038651|P1|Overall Study|Protocol Violation|2
1231411|NCT00716144|4038648|P4|Overall Study|Non-compliance|0
1231412|NCT00716144|4038649|P3|Overall Study|Non-compliance|0
1231413|NCT00716144|4038650|P2|Overall Study|Non-compliance|0
1231414|NCT00716144|4038651|P1|Overall Study|Non-compliance|1
1231415|NCT00716144|4038648|P4|Overall Study|Adverse Event|2
1231416|NCT00716144|4038649|P3|Overall Study|Adverse Event|0
1231417|NCT00716144|4038650|P2|Overall Study|Adverse Event|0
1231418|NCT00716144|4038651|P1|Overall Study|Adverse Event|0
1231419|NCT00716144|4038648|P4|Overall Study|Lost to Follow-up|2
1231420|NCT00716144|4038649|P3|Overall Study|Lost to Follow-up|1
1231421|NCT00716144|4038650|P2|Overall Study|Lost to Follow-up|2
1231422|NCT00716144|4038651|P1|Overall Study|Lost to Follow-up|2
1231423|NCT00716144|4038648|P4|Overall Study|Withdrawal by Subject|6
1231424|NCT00716144|4038649|P3|Overall Study|Withdrawal by Subject|6
1231425|NCT00716144|4038650|P2|Overall Study|Withdrawal by Subject|2
1231426|NCT00716144|4038651|P1|Overall Study|Withdrawal by Subject|4
1231427|NCT00716092|4038676|P3|Overall Study|Other incl. Lack of Efficacy|0
1231428|NCT00716092|4038677|P2|Overall Study|Other incl. Lack of Efficacy|1
1231429|NCT00716092|4038678|P1|Overall Study|Other incl. Lack of Efficacy|2
1231430|NCT00715949|4038731|P1|Overall Study|could not finish first test|4
1231431|NCT00715910|4038739|P6|Booster and ESFU Phase|Other|0
1231432|NCT00715910|4038740|P5|Booster and ESFU Phase|Other|1
1231433|NCT00715910|4038741|P4|Booster and ESFU Phase|Other|5
1231434|NCT00715910|4038742|P3|Booster and ESFU Phase|Other|0
1231435|NCT00715910|4038743|P2|Booster and ESFU Phase|Other|0
1231436|NCT00715910|4038744|P1|Booster and ESFU Phase|Other|0
1231437|NCT00715910|4038739|P6|Booster and ESFU Phase|Lost to Follow-up|13
1231438|NCT00715910|4038740|P5|Booster and ESFU Phase|Lost to Follow-up|1
1231439|NCT00715910|4038741|P4|Booster and ESFU Phase|Lost to Follow-up|6
1231440|NCT00715910|4038742|P3|Booster and ESFU Phase|Lost to Follow-up|0
1231441|NCT00715910|4038743|P2|Booster and ESFU Phase|Lost to Follow-up|0
1231442|NCT00715910|4038744|P1|Booster and ESFU Phase|Lost to Follow-up|0
1231443|NCT00715793|4038863|P2|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2
1231444|NCT00715793|4038864|P1|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0
1231445|NCT00715793|4038863|P2|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0
1231446|NCT00715793|4038864|P1|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1
1231447|NCT00715676|4038925|P3|Overall Study|Elevated Blood Glucose|0
1231448|NCT00715676|4038926|P2|Overall Study|Elevated Blood Glucose|1
1231449|NCT00715676|4038927|P1|Overall Study|Elevated Blood Glucose|0
1231450|NCT00715676|4038925|P3|Overall Study|Use of Exclusionary Medication|1
1231451|NCT00715676|4038926|P2|Overall Study|Use of Exclusionary Medication|0
1231452|NCT00715676|4038927|P1|Overall Study|Use of Exclusionary Medication|0
1231453|NCT00715676|4038925|P3|Overall Study|Did Not Meet Entry Criteria|1
1231454|NCT00715676|4038926|P2|Overall Study|Did Not Meet Entry Criteria|0
1231455|NCT00715676|4038927|P1|Overall Study|Did Not Meet Entry Criteria|0
1231456|NCT00715676|4038925|P3|Overall Study|Terminated by Sponsor|0
1231457|NCT00715676|4038926|P2|Overall Study|Terminated by Sponsor|0
1231458|NCT00715676|4038927|P1|Overall Study|Terminated by Sponsor|1
1231459|NCT00715676|4038925|P3|Overall Study|Lost to Follow-up|1
1231460|NCT00715676|4038926|P2|Overall Study|Lost to Follow-up|2
1231461|NCT00715676|4038927|P1|Overall Study|Lost to Follow-up|1
1231462|NCT00715676|4038925|P3|Overall Study|Withdrawal by Subject|8
1231463|NCT00715676|4038926|P2|Overall Study|Withdrawal by Subject|3
1231464|NCT00715676|4038927|P1|Overall Study|Withdrawal by Subject|1
1231465|NCT00715676|4038925|P3|Overall Study|Adverse Event|21
1231466|NCT00715676|4038926|P2|Overall Study|Adverse Event|5
1231467|NCT00715676|4038927|P1|Overall Study|Adverse Event|3
1231468|NCT00715624|4038970|P2|Overall Study|Other|1
1231469|NCT00715624|4038971|P1|Overall Study|Other|0
1231470|NCT00715624|4038970|P2|Overall Study|Incorrect randomization (not treated)|1
1231471|NCT00715624|4038971|P1|Overall Study|Incorrect randomization (not treated)|0
1231472|NCT00715624|4038970|P2|Overall Study|Sponsor decision|4
1231473|NCT00715624|4038971|P1|Overall Study|Sponsor decision|0
1231474|NCT00715624|4038970|P2|Overall Study|Poor compliance|13
1231475|NCT00715624|4038971|P1|Overall Study|Poor compliance|6
1231476|NCT00715624|4038970|P2|Overall Study|Familial and personal reasons|22
1231477|NCT00715624|4038971|P1|Overall Study|Familial and personal reasons|10
1231478|NCT00715624|4038970|P2|Overall Study|Withdrawal by Subject|25
1231479|NCT00715624|4038971|P1|Overall Study|Withdrawal by Subject|11
1231480|NCT00715624|4038970|P2|Overall Study|Protocol Violation|0
1231481|NCT00715624|4038971|P1|Overall Study|Protocol Violation|1
1231482|NCT00715624|4038970|P2|Overall Study|Lost to Follow-up|2
1231483|NCT00715624|4038971|P1|Overall Study|Lost to Follow-up|1
1231484|NCT00715624|4038970|P2|Overall Study|Lack of Efficacy|11
1231485|NCT00715624|4038971|P1|Overall Study|Lack of Efficacy|11
1231486|NCT00715624|4038970|P2|Overall Study|Adverse Event|37
1231487|NCT00715624|4038971|P1|Overall Study|Adverse Event|12
1231488|NCT00715559|4038999|P1|Overall Study|medication not tolerated - nausea|1
1231489|NCT00715520|4039009|P3|Overall Study|Withdrawal by Subject|1
1231490|NCT00715520|4039010|P2|Overall Study|Withdrawal by Subject|0
1231491|NCT00715520|4039011|P1|Overall Study|Withdrawal by Subject|2
1231492|NCT00715520|4039009|P3|Overall Study|Screen failure|1
1231493|NCT00715520|4039010|P2|Overall Study|Screen failure|1
1231494|NCT00715520|4039011|P1|Overall Study|Screen failure|8
1231495|NCT00715403|4039031|P7|Overall Study|Other reason not defined above|0
1231496|NCT00715403|4039032|P6|Overall Study|Other reason not defined above|1
1231497|NCT00715403|4039033|P5|Overall Study|Other reason not defined above|1
1231498|NCT00715403|4039034|P4|Overall Study|Other reason not defined above|0
1231499|NCT00715403|4039035|P3|Overall Study|Other reason not defined above|1
1231500|NCT00715403|4039036|P2|Overall Study|Other reason not defined above|0
1231501|NCT00715403|4039037|P1|Overall Study|Other reason not defined above|0
1231502|NCT00715403|4039031|P7|Overall Study|Protocol Violation|0
1231503|NCT00715403|4039032|P6|Overall Study|Protocol Violation|1
1231504|NCT00715403|4039033|P5|Overall Study|Protocol Violation|0
1231505|NCT00715403|4039034|P4|Overall Study|Protocol Violation|0
1231506|NCT00715403|4039035|P3|Overall Study|Protocol Violation|0
1231507|NCT00715403|4039036|P2|Overall Study|Protocol Violation|0
1231508|NCT00715403|4039037|P1|Overall Study|Protocol Violation|0
1231509|NCT00715403|4039031|P7|Overall Study|Other Adverse Event than DLT|0
1231510|NCT00715403|4039032|P6|Overall Study|Other Adverse Event than DLT|2
1231511|NCT00715403|4039033|P5|Overall Study|Other Adverse Event than DLT|0
1231512|NCT00715403|4039034|P4|Overall Study|Other Adverse Event than DLT|0
1231513|NCT00715403|4039035|P3|Overall Study|Other Adverse Event than DLT|0
1231514|NCT00715403|4039036|P2|Overall Study|Other Adverse Event than DLT|0
1231515|NCT00715403|4039037|P1|Overall Study|Other Adverse Event than DLT|1
1231516|NCT00715403|4039031|P7|Overall Study|Dose limiting Toxicity (DLT)|0
1231517|NCT00715403|4039032|P6|Overall Study|Dose limiting Toxicity (DLT)|1
1231518|NCT00715403|4039033|P5|Overall Study|Dose limiting Toxicity (DLT)|0
1231519|NCT00715403|4039034|P4|Overall Study|Dose limiting Toxicity (DLT)|0
1231520|NCT00715403|4039035|P3|Overall Study|Dose limiting Toxicity (DLT)|0
1231521|NCT00715403|4039036|P2|Overall Study|Dose limiting Toxicity (DLT)|0
1231522|NCT00715403|4039037|P1|Overall Study|Dose limiting Toxicity (DLT)|0
1231523|NCT00715403|4039031|P7|Overall Study|Progressive disease|1
1231524|NCT00715403|4039032|P6|Overall Study|Progressive disease|14
1231525|NCT00715403|4039033|P5|Overall Study|Progressive disease|5
1231526|NCT00715403|4039034|P4|Overall Study|Progressive disease|9
1231527|NCT00715403|4039035|P3|Overall Study|Progressive disease|3
1231528|NCT00715403|4039036|P2|Overall Study|Progressive disease|1
1231529|NCT00715403|4039037|P1|Overall Study|Progressive disease|0
1231530|NCT00715299|4039176|P1|Overall Study|failed the pre-screen exercise test|2
1231531|NCT00715299|4039176|P1|Overall Study|Adverse Event|3
1231532|NCT00715299|4039176|P1|Overall Study|Withdrawal by Subject|1
1231533|NCT00715208|4039182|P2|Overall Study|Lack of Efficacy|2
1231534|NCT00715208|4039183|P1|Overall Study|Lack of Efficacy|0
1231535|NCT00715208|4039182|P2|Overall Study|Adverse Event|6
1231536|NCT00715208|4039183|P1|Overall Study|Adverse Event|0
1231537|NCT00715208|4039182|P2|Overall Study|Withdrawal by Subject|1
1231538|NCT00715208|4039183|P1|Overall Study|Withdrawal by Subject|1
1231539|NCT00715117|4039199|P2|Overall Study|Crohn's flare and rescue with steroids|1
1231540|NCT00715117|4039200|P1|Overall Study|Crohn's flare and rescue with steroids|0
1231541|NCT00715078|4039268|P3|Overall Study|Unable to start due to disease prog.|1
1231542|NCT00715078|4039269|P2|Overall Study|Unable to start due to disease prog.|0
1231543|NCT00715078|4039270|P1|Overall Study|Unable to start due to disease prog.|0
1231544|NCT00715078|4039268|P3|Overall Study|Withdrawal by Subject|1
1231545|NCT00715078|4039269|P2|Overall Study|Withdrawal by Subject|0
1231546|NCT00715078|4039270|P1|Overall Study|Withdrawal by Subject|1
1231547|NCT00715078|4039268|P3|Overall Study|Death|36
1231548|NCT00715078|4039269|P2|Overall Study|Death|36
1231549|NCT00715078|4039270|P1|Overall Study|Death|29
1231550|NCT00715026|4039278|P1|Overall Study|Surgery done on non-study consented hip|1
1231551|NCT00715026|4039278|P1|Overall Study|Protocol Violation|1
1231552|NCT00715026|4039278|P1|Overall Study|Lost to Follow-up|3
1231553|NCT00715026|4039278|P1|Overall Study|Withdrawal by Subject|5
1231554|NCT00714948|4039283|P1|Overall Study|Adverse Event|2
1231555|NCT00714870|4039289|P2|Overall Study|did not attend minimum of 4 sessions|0
1231556|NCT00714870|4039290|P1|Overall Study|did not attend minimum of 4 sessions|4
1231557|NCT00714870|4039289|P2|Overall Study|patient unable to come b/c back pain|0
1231558|NCT00714870|4039290|P1|Overall Study|patient unable to come b/c back pain|1
1231559|NCT00714870|4039289|P2|Overall Study|Lost to Follow-up|5
1231560|NCT00714870|4039290|P1|Overall Study|Lost to Follow-up|22
1231561|NCT00714714|4039314|P1|Overall Study|Adverse Event|1
1231562|NCT00714688|4039323|P3|Overall Study|Other|5
1231563|NCT00714688|4039324|P2|Overall Study|Other|6
1231564|NCT00714688|4039325|P1|Overall Study|Other|1
1231565|NCT00714688|4039323|P3|Overall Study|Sponsor's Decision|0
1231566|NCT00714688|4039324|P2|Overall Study|Sponsor's Decision|2
1231567|NCT00714688|4039325|P1|Overall Study|Sponsor's Decision|0
1231568|NCT00714688|4039323|P3|Overall Study|Ineligible to Continue the Study|1
1231569|NCT00714688|4039324|P2|Overall Study|Ineligible to Continue the Study|1
1231570|NCT00714688|4039325|P1|Overall Study|Ineligible to Continue the Study|0
1231571|NCT00714688|4039323|P3|Overall Study|Subject Non-compliant|5
1231572|NCT00714688|4039324|P2|Overall Study|Subject Non-compliant|5
1231573|NCT00714688|4039325|P1|Overall Study|Subject Non-compliant|3
1231574|NCT00714688|4039323|P3|Overall Study|Adverse Event|19
1231575|NCT00714688|4039324|P2|Overall Study|Adverse Event|15
1231576|NCT00714688|4039325|P1|Overall Study|Adverse Event|2
1231577|NCT00714688|4039323|P3|Overall Study|Lost to Follow-up|0
1231578|NCT00714688|4039324|P2|Overall Study|Lost to Follow-up|2
1231579|NCT00714688|4039325|P1|Overall Study|Lost to Follow-up|5
1231580|NCT00714688|4039323|P3|Overall Study|Withdrawal by Subject|3
1231581|NCT00714688|4039324|P2|Overall Study|Withdrawal by Subject|3
1231582|NCT00714688|4039325|P1|Overall Study|Withdrawal by Subject|4
1231583|NCT00714688|4039323|P3|Overall Study|Lack of Efficacy|4
1231584|NCT00714688|4039324|P2|Overall Study|Lack of Efficacy|1
1231585|NCT00714688|4039325|P1|Overall Study|Lack of Efficacy|14
1231586|NCT00714493|4039367|P1|Overall Study|OTHER|2
1231587|NCT00714493|4039367|P1|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8
1231588|NCT00714493|4039367|P1|Overall Study|Protocol Violation|12
1231589|NCT00714493|4039367|P1|Overall Study|Lost to Follow-up|3
1231590|NCT00714493|4039367|P1|Overall Study|Lack of Efficacy|10
1231591|NCT00714493|4039367|P1|Overall Study|Death|3
1231592|NCT00714493|4039367|P1|Overall Study|Adverse Event|11
1231593|NCT00714415|4039379|P2|Overall Study|Death|0
1231594|NCT00714415|4039380|P1|Overall Study|Death|1
1231595|NCT00714415|4039379|P2|Overall Study|Lack of Efficacy|0
1231596|NCT00714415|4039380|P1|Overall Study|Lack of Efficacy|1
1231597|NCT00714285|4039430|P4|Overall Study|Migrated/moved from study area|0
1231598|NCT00714285|4039431|P3|Overall Study|Migrated/moved from study area|0
1231599|NCT00714285|4039432|P2|Overall Study|Migrated/moved from study area|1
1231600|NCT00714285|4039433|P1|Overall Study|Migrated/moved from study area|0
1231601|NCT00714285|4039430|P4|Overall Study|Lost to Follow-up|1
1231602|NCT00714285|4039431|P3|Overall Study|Lost to Follow-up|0
1231603|NCT00714285|4039432|P2|Overall Study|Lost to Follow-up|2
1231604|NCT00714285|4039433|P1|Overall Study|Lost to Follow-up|0
1231605|NCT00714259|4039483|P1|Overall Study|Death|2
1231606|NCT00714168|4039529|P2|Overall Study|Non-study medical condition|2
1231607|NCT00714168|4039530|P1|Overall Study|Non-study medical condition|3
1231608|NCT00714168|4039529|P2|Overall Study|Relocation|3
1231609|NCT00714168|4039530|P1|Overall Study|Relocation|4
1231610|NCT00714168|4039529|P2|Overall Study|Lost to Follow-up|50
1231611|NCT00714168|4039530|P1|Overall Study|Lost to Follow-up|32
1231612|NCT00714168|4039529|P2|Overall Study|Pregnancy|4
1231613|NCT00714168|4039530|P1|Overall Study|Pregnancy|5
1231614|NCT00714051|4039546|P2|Overall Study|Death|1
1231615|NCT00714051|4039547|P1|Overall Study|Death|0
1231616|NCT00714051|4039546|P2|Overall Study|Withdrawal by Subject|0
1231617|NCT00714051|4039547|P1|Overall Study|Withdrawal by Subject|1
1231618|NCT00713830|4039555|P2|Overall Study|Sponsor Decision|10
1231619|NCT00713830|4039556|P1|Overall Study|Sponsor Decision|4
1231620|NCT00713830|4039555|P2|Overall Study|Familial and Personal Reasons|34
1231621|NCT00713830|4039556|P1|Overall Study|Familial and Personal Reasons|9
1231622|NCT00713830|4039555|P2|Overall Study|Poor Compliance to Protocol|14
1231623|NCT00713830|4039556|P1|Overall Study|Poor Compliance to Protocol|7
1231624|NCT00713830|4039555|P2|Overall Study|Withdrawal by Subject|23
1231625|NCT00713830|4039556|P1|Overall Study|Withdrawal by Subject|13
1231626|NCT00713830|4039555|P2|Overall Study|Lost to Follow-up|9
1231627|NCT00713830|4039556|P1|Overall Study|Lost to Follow-up|2
1231628|NCT00713830|4039555|P2|Overall Study|Lack of Efficacy|16
1231629|NCT00713830|4039556|P1|Overall Study|Lack of Efficacy|24
1231630|NCT00713830|4039555|P2|Overall Study|Adverse Event|71
1231631|NCT00713830|4039556|P1|Overall Study|Adverse Event|23
1231632|NCT00713700|4039613|P1|Overall Study|Withdrawal by Subject|1
1231633|NCT00713700|4039613|P1|Overall Study|Lost to Follow-up|3
1231634|NCT00713648|4039639|P1|Overall Study|Development of antibodies|3
1231635|NCT00713648|4039639|P1|Overall Study|According to Protocol|2
1231636|NCT00713648|4039639|P1|Overall Study|Unclassified|2
1231637|NCT00713648|4039639|P1|Overall Study|Adverse Event|1
1231638|NCT00713609|4039652|P6|Overall Study|Protocol Violation|0
1231639|NCT00713609|4039653|P5|Overall Study|Protocol Violation|2
1231640|NCT00713609|4039654|P4|Overall Study|Protocol Violation|1
1231641|NCT00713609|4039655|P3|Overall Study|Protocol Violation|1
1231642|NCT00713609|4039656|P2|Overall Study|Protocol Violation|3
1231643|NCT00713609|4039657|P1|Overall Study|Protocol Violation|6
1231644|NCT00713609|4039652|P6|Overall Study|Withdrawal by Subject|7
1231645|NCT00713609|4039653|P5|Overall Study|Withdrawal by Subject|5
1231646|NCT00713609|4039654|P4|Overall Study|Withdrawal by Subject|1
1231647|NCT00713609|4039655|P3|Overall Study|Withdrawal by Subject|5
1231648|NCT00713609|4039656|P2|Overall Study|Withdrawal by Subject|1
1231649|NCT00713609|4039657|P1|Overall Study|Withdrawal by Subject|6
1231650|NCT00713609|4039652|P6|Overall Study|Non-Compliance with Study Treatment|0
1231651|NCT00713609|4039653|P5|Overall Study|Non-Compliance with Study Treatment|1
1231652|NCT00713609|4039654|P4|Overall Study|Non-Compliance with Study Treatment|0
1231653|NCT00713609|4039655|P3|Overall Study|Non-Compliance with Study Treatment|2
1231654|NCT00713609|4039656|P2|Overall Study|Non-Compliance with Study Treatment|1
1231655|NCT00713609|4039657|P1|Overall Study|Non-Compliance with Study Treatment|1
1231656|NCT00713609|4039652|P6|Overall Study|Lack of Efficacy|0
1231657|NCT00713609|4039653|P5|Overall Study|Lack of Efficacy|1
1231658|NCT00713609|4039654|P4|Overall Study|Lack of Efficacy|0
1231659|NCT00713609|4039655|P3|Overall Study|Lack of Efficacy|0
1231660|NCT00713609|4039656|P2|Overall Study|Lack of Efficacy|3
1231661|NCT00713609|4039657|P1|Overall Study|Lack of Efficacy|1
1231662|NCT00713609|4039652|P6|Overall Study|Lost to Follow-up|0
1231663|NCT00713609|4039653|P5|Overall Study|Lost to Follow-up|7
1231664|NCT00713609|4039654|P4|Overall Study|Lost to Follow-up|5
1231665|NCT00713609|4039655|P3|Overall Study|Lost to Follow-up|5
1231666|NCT00713609|4039656|P2|Overall Study|Lost to Follow-up|7
1231667|NCT00713609|4039657|P1|Overall Study|Lost to Follow-up|5
1231668|NCT00713609|4039652|P6|Overall Study|Adverse Event|1
1231669|NCT00713609|4039653|P5|Overall Study|Adverse Event|3
1231670|NCT00713609|4039654|P4|Overall Study|Adverse Event|2
1231671|NCT00713609|4039655|P3|Overall Study|Adverse Event|2
1231672|NCT00713609|4039656|P2|Overall Study|Adverse Event|0
1231673|NCT00713609|4039657|P1|Overall Study|Adverse Event|2
1231674|NCT00713596|4039692|P3|Overall Study|Study was terminated|2
1231675|NCT00713596|4039693|P2|Overall Study|Study was terminated|3
1231676|NCT00713596|4039694|P1|Overall Study|Study was terminated|2
1231677|NCT00713544|4039720|P6|Overall Study|Hepatotoxicity - not an AE|0
1231678|NCT00713544|4039721|P5|Overall Study|Hepatotoxicity - not an AE|1
1231679|NCT00713544|4039722|P4|Overall Study|Hepatotoxicity - not an AE|0
1231680|NCT00713544|4039723|P3|Overall Study|Hepatotoxicity - not an AE|0
1231681|NCT00713544|4039724|P2|Overall Study|Hepatotoxicity - not an AE|0
1231682|NCT00713544|4039725|P1|Overall Study|Hepatotoxicity - not an AE|0
1231683|NCT00713544|4039720|P6|Overall Study|Incorrect enrollment|0
1231684|NCT00713544|4039721|P5|Overall Study|Incorrect enrollment|0
1231685|NCT00713544|4039722|P4|Overall Study|Incorrect enrollment|0
1231686|NCT00713544|4039723|P3|Overall Study|Incorrect enrollment|0
1231687|NCT00713544|4039724|P2|Overall Study|Incorrect enrollment|1
1231688|NCT00713544|4039725|P1|Overall Study|Incorrect enrollment|0
1231689|NCT00713544|4039720|P6|Overall Study|AZ decision - Hepatitis C ab reactive|0
1231690|NCT00713544|4039721|P5|Overall Study|AZ decision - Hepatitis C ab reactive|0
1231691|NCT00713544|4039722|P4|Overall Study|AZ decision - Hepatitis C ab reactive|0
1231692|NCT00713544|4039723|P3|Overall Study|AZ decision - Hepatitis C ab reactive|0
1231693|NCT00713544|4039724|P2|Overall Study|AZ decision - Hepatitis C ab reactive|1
1231694|NCT00713544|4039725|P1|Overall Study|AZ decision - Hepatitis C ab reactive|0
1231695|NCT00713544|4039720|P6|Overall Study|Lost to Follow-up|0
1231696|NCT00713544|4039721|P5|Overall Study|Lost to Follow-up|0
1231697|NCT00713544|4039722|P4|Overall Study|Lost to Follow-up|0
1231698|NCT00713544|4039723|P3|Overall Study|Lost to Follow-up|1
1231699|NCT00713544|4039724|P2|Overall Study|Lost to Follow-up|0
1231700|NCT00713544|4039725|P1|Overall Study|Lost to Follow-up|0
1231701|NCT00713544|4039720|P6|Overall Study|Lack of Efficacy|0
1231702|NCT00713544|4039721|P5|Overall Study|Lack of Efficacy|1
1231703|NCT00713544|4039722|P4|Overall Study|Lack of Efficacy|1
1231704|NCT00713544|4039723|P3|Overall Study|Lack of Efficacy|0
1231705|NCT00713544|4039724|P2|Overall Study|Lack of Efficacy|1
1231706|NCT00713544|4039725|P1|Overall Study|Lack of Efficacy|0
1231707|NCT00713544|4039720|P6|Overall Study|Physician Decision|2
1231708|NCT00713544|4039721|P5|Overall Study|Physician Decision|0
1231709|NCT00713544|4039722|P4|Overall Study|Physician Decision|0
1231710|NCT00713544|4039723|P3|Overall Study|Physician Decision|0
1231711|NCT00713544|4039724|P2|Overall Study|Physician Decision|0
1231712|NCT00713544|4039725|P1|Overall Study|Physician Decision|0
1231713|NCT00713544|4039720|P6|Overall Study|Protocol Violation|1
1231714|NCT00713544|4039721|P5|Overall Study|Protocol Violation|0
1231715|NCT00713544|4039722|P4|Overall Study|Protocol Violation|0
1231716|NCT00713544|4039723|P3|Overall Study|Protocol Violation|0
1231717|NCT00713544|4039724|P2|Overall Study|Protocol Violation|0
1231718|NCT00713544|4039725|P1|Overall Study|Protocol Violation|0
1231719|NCT00713544|4039720|P6|Overall Study|Withdrawal by Subject|1
1231720|NCT00713544|4039721|P5|Overall Study|Withdrawal by Subject|3
1231721|NCT00713544|4039722|P4|Overall Study|Withdrawal by Subject|2
1231722|NCT00713544|4039723|P3|Overall Study|Withdrawal by Subject|3
1231723|NCT00713544|4039724|P2|Overall Study|Withdrawal by Subject|0
1231724|NCT00713544|4039725|P1|Overall Study|Withdrawal by Subject|2
1231725|NCT00713544|4039720|P6|Overall Study|Adverse Event|5
1231726|NCT00713544|4039721|P5|Overall Study|Adverse Event|3
1231727|NCT00713544|4039722|P4|Overall Study|Adverse Event|7
1231728|NCT00713544|4039723|P3|Overall Study|Adverse Event|7
1231729|NCT00713544|4039724|P2|Overall Study|Adverse Event|3
1231730|NCT00713544|4039725|P1|Overall Study|Adverse Event|5
1231731|NCT00713349|4039776|P1|Overall Study|Protocol Violation|1
1231732|NCT00713323|4039782|P1|Overall Study|Treatment that may interact with Sativex|1
1231733|NCT00713323|4039782|P1|Overall Study|Subject travelling to Dominica Republic|1
1231734|NCT00713323|4039782|P1|Overall Study|Subject travelling to USA|1
1231735|NCT00713323|4039782|P1|Overall Study|Pain resolved|1
1231736|NCT00713323|4039782|P1|Overall Study|Non-compliance|1
1231737|NCT00713323|4039782|P1|Overall Study|Pain free|1
1231738|NCT00713323|4039782|P1|Overall Study|Surgery cured allodynic pain|1
1231739|NCT00713323|4039782|P1|Overall Study|Withdrawn due to exclusion criteria 11|1
1231740|NCT00713323|4039782|P1|Overall Study|Low creatine clearance at screening|1
1231741|NCT00713323|4039782|P1|Overall Study|Lack of Efficacy|36
1231742|NCT00713323|4039782|P1|Overall Study|Lost to Follow-up|11
1231743|NCT00713323|4039782|P1|Overall Study|Withdrawal by Subject|15
1231744|NCT00713323|4039782|P1|Overall Study|Adverse Event|75
1231745|NCT00713310|4039795|P2|Overall Study|Withdrawal by Subject|2
1231746|NCT00713310|4039796|P1|Overall Study|Withdrawal by Subject|0
1231747|NCT00713310|4039795|P2|Overall Study|Lack of Efficacy|2
1231748|NCT00713310|4039796|P1|Overall Study|Lack of Efficacy|0
1231749|NCT00713310|4039795|P2|Overall Study|Adverse Event|2
1231750|NCT00713310|4039796|P1|Overall Study|Adverse Event|5
1231751|NCT00713258|4039806|P2|Overall Study|Other|1
1231752|NCT00713258|4039807|P1|Overall Study|Other|1
1231753|NCT00713258|4039806|P2|Overall Study|Non-Compliance|1
1231754|NCT00713258|4039807|P1|Overall Study|Non-Compliance|2
1231755|NCT00713258|4039806|P2|Overall Study|Adverse Event|4
1231756|NCT00713258|4039807|P1|Overall Study|Adverse Event|2
1231757|NCT00713219|4039815|P1|Overall Study|Protocol Violation|1
1231758|NCT00713219|4039815|P1|Overall Study|Death|1
1231759|NCT00713206|4039821|P2|Overall Study|Adverse Event|1
1231760|NCT00713206|4039822|P1|Overall Study|Adverse Event|2
1231761|NCT00713206|4039821|P2|Overall Study|Lost to Follow-up|2
1231762|NCT00713206|4039822|P1|Overall Study|Lost to Follow-up|5
1231763|NCT00712985|4039828|P1|Overall Study|Lack of Efficacy|3
1231764|NCT00712985|4039828|P1|Overall Study|1 patient moved out of state|1
1231765|NCT00712985|4039828|P1|Overall Study|1 withdrew prior to start of drug|1
1231766|NCT00712959|4039834|P2|Overall Study|Withdrawal by Subject|0
1231767|NCT00712959|4039835|P1|Overall Study|Withdrawal by Subject|3
1231768|NCT00712959|4039834|P2|Overall Study|Lost to Follow-up|2
1231769|NCT00712959|4039835|P1|Overall Study|Lost to Follow-up|13
1231770|NCT00712959|4039834|P2|Overall Study|Protocol Violation|1
1231771|NCT00712959|4039835|P1|Overall Study|Protocol Violation|3
1231772|NCT00712933|4039853|P1|Overall Study|Withdrawal by Subject|151
1231773|NCT00712933|4039853|P1|Overall Study|Protocol Violation|4
1231774|NCT00712933|4039853|P1|Overall Study|Physician Decision|36
1231775|NCT00712933|4039853|P1|Overall Study|Participant received medication|1
1231776|NCT00712933|4039853|P1|Overall Study|Not committed to contraception|1
1231777|NCT00712933|4039853|P1|Overall Study|Other Physician decision|1
1231778|NCT00712933|4039853|P1|Overall Study|Death of patient|1
1231779|NCT00712933|4039853|P1|Overall Study|Participant travelled overseas|2
1231780|NCT00712933|4039853|P1|Overall Study|Participant hospitalized|1
1231781|NCT00712933|4039853|P1|Overall Study|Involved in Clinical research|3
1231782|NCT00712933|4039853|P1|Overall Study|Hip replacement surgery|1
1231783|NCT00712933|4039853|P1|Overall Study|Withdrew consent|4
1231784|NCT00712933|4039853|P1|Overall Study|Sponsor decision|14
1231785|NCT00712933|4039853|P1|Overall Study|Other Pregnancy|37
1231786|NCT00712933|4039853|P1|Overall Study|Non-compliance with study drug|13
1231787|NCT00712933|4039853|P1|Overall Study|Lost to Follow-up|22
1231788|NCT00712933|4039853|P1|Overall Study|Lack of Efficacy|6
1231789|NCT00712933|4039853|P1|Overall Study|Adverse Event|69
1231790|NCT00712920|4039883|P3|Overall Study|Non-compliance|0
1231791|NCT00712920|4039884|P2|Overall Study|Non-compliance|0
1231792|NCT00712920|4039885|P1|Overall Study|Non-compliance|3
1231793|NCT00712920|4039883|P3|Overall Study|Other|3
1231794|NCT00712920|4039884|P2|Overall Study|Other|7
1231795|NCT00712920|4039885|P1|Overall Study|Other|5
1231796|NCT00712920|4039883|P3|Overall Study|Lack of Efficacy|1
1231797|NCT00712920|4039884|P2|Overall Study|Lack of Efficacy|0
1231798|NCT00712920|4039885|P1|Overall Study|Lack of Efficacy|1
1231799|NCT00712920|4039883|P3|Overall Study|Lost to Follow-up|0
1231800|NCT00712920|4039884|P2|Overall Study|Lost to Follow-up|4
1231801|NCT00712920|4039885|P1|Overall Study|Lost to Follow-up|1
1231802|NCT00712920|4039883|P3|Overall Study|Withdrawal by Subject|1
1231803|NCT00712920|4039884|P2|Overall Study|Withdrawal by Subject|2
1231804|NCT00712920|4039885|P1|Overall Study|Withdrawal by Subject|4
1231805|NCT00712920|4039883|P3|Overall Study|Adverse Event|7
1231806|NCT00712920|4039884|P2|Overall Study|Adverse Event|4
1231807|NCT00712920|4039885|P1|Overall Study|Adverse Event|3
1231808|NCT00712725|4039913|P8|Overall Study|Protocol Specified Criteria|1
1231809|NCT00712725|4039914|P7|Overall Study|Protocol Specified Criteria|2
1231810|NCT00712725|4039915|P6|Overall Study|Protocol Specified Criteria|0
1231811|NCT00712725|4039916|P5|Overall Study|Protocol Specified Criteria|1
1231812|NCT00712725|4039917|P4|Overall Study|Protocol Specified Criteria|2
1231813|NCT00712725|4039918|P3|Overall Study|Protocol Specified Criteria|1
1231814|NCT00712725|4039919|P2|Overall Study|Protocol Specified Criteria|0
1231815|NCT00712725|4039920|P1|Overall Study|Protocol Specified Criteria|3
1231816|NCT00712725|4039913|P8|Overall Study|Lack of Qualifying Event|6
1231817|NCT00712725|4039914|P7|Overall Study|Lack of Qualifying Event|11
1231818|NCT00712725|4039915|P6|Overall Study|Lack of Qualifying Event|13
1231819|NCT00712725|4039916|P5|Overall Study|Lack of Qualifying Event|11
1231820|NCT00712725|4039917|P4|Overall Study|Lack of Qualifying Event|8
1231821|NCT00712725|4039918|P3|Overall Study|Lack of Qualifying Event|6
1231822|NCT00712725|4039919|P2|Overall Study|Lack of Qualifying Event|2
1231823|NCT00712725|4039920|P1|Overall Study|Lack of Qualifying Event|16
1231824|NCT00712725|4039913|P8|Overall Study|Withdrawal by Subject|2
1231825|NCT00712725|4039914|P7|Overall Study|Withdrawal by Subject|1
1231826|NCT00712725|4039915|P6|Overall Study|Withdrawal by Subject|1
1231827|NCT00712725|4039916|P5|Overall Study|Withdrawal by Subject|1
1231828|NCT00712725|4039917|P4|Overall Study|Withdrawal by Subject|2
1231829|NCT00712725|4039918|P3|Overall Study|Withdrawal by Subject|1
1231830|NCT00712725|4039919|P2|Overall Study|Withdrawal by Subject|1
1231831|NCT00712725|4039920|P1|Overall Study|Withdrawal by Subject|2
1231832|NCT00712725|4039913|P8|Overall Study|Protocol Violation|1
1231833|NCT00712725|4039914|P7|Overall Study|Protocol Violation|1
1231834|NCT00712725|4039915|P6|Overall Study|Protocol Violation|0
1231835|NCT00712725|4039916|P5|Overall Study|Protocol Violation|2
1231836|NCT00712725|4039917|P4|Overall Study|Protocol Violation|3
1231837|NCT00712725|4039918|P3|Overall Study|Protocol Violation|1
1231838|NCT00712725|4039919|P2|Overall Study|Protocol Violation|0
1231839|NCT00712725|4039920|P1|Overall Study|Protocol Violation|2
1231840|NCT00712725|4039913|P8|Overall Study|Pregnancy|0
1231841|NCT00712725|4039914|P7|Overall Study|Pregnancy|2
1231842|NCT00712725|4039915|P6|Overall Study|Pregnancy|0
1231843|NCT00712725|4039916|P5|Overall Study|Pregnancy|1
1231844|NCT00712725|4039917|P4|Overall Study|Pregnancy|0
1231845|NCT00712725|4039918|P3|Overall Study|Pregnancy|0
1231846|NCT00712725|4039919|P2|Overall Study|Pregnancy|1
1231847|NCT00712725|4039920|P1|Overall Study|Pregnancy|0
1231848|NCT00712725|4039913|P8|Overall Study|Physician Decision|0
1231849|NCT00712725|4039914|P7|Overall Study|Physician Decision|2
1231850|NCT00712725|4039915|P6|Overall Study|Physician Decision|0
1231851|NCT00712725|4039916|P5|Overall Study|Physician Decision|1
1231852|NCT00712725|4039917|P4|Overall Study|Physician Decision|0
1231853|NCT00712725|4039918|P3|Overall Study|Physician Decision|0
1231854|NCT00712725|4039919|P2|Overall Study|Physician Decision|0
1231855|NCT00712725|4039920|P1|Overall Study|Physician Decision|2
1231856|NCT00712725|4039913|P8|Overall Study|Lost to Follow-up|1
1231857|NCT00712725|4039914|P7|Overall Study|Lost to Follow-up|3
1231858|NCT00712725|4039915|P6|Overall Study|Lost to Follow-up|2
1231859|NCT00712725|4039916|P5|Overall Study|Lost to Follow-up|2
1231860|NCT00712725|4039917|P4|Overall Study|Lost to Follow-up|1
1231861|NCT00712725|4039918|P3|Overall Study|Lost to Follow-up|1
1231862|NCT00712725|4039919|P2|Overall Study|Lost to Follow-up|2
1231863|NCT00712725|4039920|P1|Overall Study|Lost to Follow-up|3
1231864|NCT00712725|4039913|P8|Overall Study|Adverse Event|0
1231865|NCT00712725|4039914|P7|Overall Study|Adverse Event|0
1231866|NCT00712725|4039915|P6|Overall Study|Adverse Event|0
1231867|NCT00712725|4039916|P5|Overall Study|Adverse Event|0
1231868|NCT00712725|4039917|P4|Overall Study|Adverse Event|1
1231869|NCT00712725|4039918|P3|Overall Study|Adverse Event|0
1231870|NCT00712725|4039919|P2|Overall Study|Adverse Event|0
1231871|NCT00712725|4039920|P1|Overall Study|Adverse Event|1
1231872|NCT00712673|4039981|P4|Overall Study|Protocol Violation|0
1231873|NCT00712673|4039982|P3|Overall Study|Protocol Violation|2
1231874|NCT00712673|4039983|P2|Overall Study|Protocol Violation|0
1231875|NCT00712673|4039984|P1|Overall Study|Protocol Violation|0
1231876|NCT00712673|4039981|P4|Overall Study|Investigator's Decision|0
1231877|NCT00712673|4039982|P3|Overall Study|Investigator's Decision|0
1231878|NCT00712673|4039983|P2|Overall Study|Investigator's Decision|0
1231879|NCT00712673|4039984|P1|Overall Study|Investigator's Decision|1
1231880|NCT00712673|4039981|P4|Overall Study|Familial and Personal Reasons|2
1231881|NCT00712673|4039982|P3|Overall Study|Familial and Personal Reasons|5
1231882|NCT00712673|4039983|P2|Overall Study|Familial and Personal Reasons|0
1231883|NCT00712673|4039984|P1|Overall Study|Familial and Personal Reasons|5
1231884|NCT00712673|4039981|P4|Overall Study|Withdrawal by Subject|20
1231885|NCT00712673|4039982|P3|Overall Study|Withdrawal by Subject|15
1231886|NCT00712673|4039983|P2|Overall Study|Withdrawal by Subject|7
1231887|NCT00712673|4039984|P1|Overall Study|Withdrawal by Subject|6
1231888|NCT00712673|4039981|P4|Overall Study|Lost to Follow-up|0
1231889|NCT00712673|4039982|P3|Overall Study|Lost to Follow-up|2
1231890|NCT00712673|4039983|P2|Overall Study|Lost to Follow-up|0
1231891|NCT00712673|4039984|P1|Overall Study|Lost to Follow-up|1
1231892|NCT00712673|4039981|P4|Overall Study|Poor Compliance to Protocol|16
1231893|NCT00712673|4039982|P3|Overall Study|Poor Compliance to Protocol|4
1231894|NCT00712673|4039983|P2|Overall Study|Poor Compliance to Protocol|3
1231895|NCT00712673|4039984|P1|Overall Study|Poor Compliance to Protocol|3
1231896|NCT00712673|4039981|P4|Overall Study|Lack of Efficacy|6
1231897|NCT00712673|4039982|P3|Overall Study|Lack of Efficacy|8
1231898|NCT00712673|4039983|P2|Overall Study|Lack of Efficacy|8
1231899|NCT00712673|4039984|P1|Overall Study|Lack of Efficacy|2
1231900|NCT00712673|4039981|P4|Overall Study|Adverse Event|26
1231901|NCT00712673|4039982|P3|Overall Study|Adverse Event|21
1231902|NCT00712673|4039983|P2|Overall Study|Adverse Event|3
1231903|NCT00712673|4039984|P1|Overall Study|Adverse Event|3
1231904|NCT00712543|4040048|P2|Day 8-14|Lost to Follow-up|2
1231905|NCT00712543|4040049|P1|Day 8-14|Lost to Follow-up|0
1231906|NCT00712348|4040083|P1|Overall Study|Withdrawal by Subject|1
1231907|NCT00712335|4040095|P5|Overall Study|Other Reason|0
1231908|NCT00712335|4040096|P4|Overall Study|Other Reason|0
1231909|NCT00712335|4040097|P3|Overall Study|Other Reason|1
1231910|NCT00712335|4040098|P2|Overall Study|Other Reason|3
1231911|NCT00712335|4040099|P1|Overall Study|Other Reason|0
1231912|NCT00712335|4040095|P5|Overall Study|Lack of Efficacy|0
1231913|NCT00712335|4040096|P4|Overall Study|Lack of Efficacy|1
1231914|NCT00712335|4040097|P3|Overall Study|Lack of Efficacy|1
1231915|NCT00712335|4040098|P2|Overall Study|Lack of Efficacy|0
1231916|NCT00712335|4040099|P1|Overall Study|Lack of Efficacy|0
1231917|NCT00712335|4040095|P5|Overall Study|Protocol Violation|0
1231918|NCT00712335|4040096|P4|Overall Study|Protocol Violation|0
1231919|NCT00712335|4040097|P3|Overall Study|Protocol Violation|1
1231920|NCT00712335|4040098|P2|Overall Study|Protocol Violation|2
1231921|NCT00712335|4040099|P1|Overall Study|Protocol Violation|1
1231922|NCT00712335|4040095|P5|Overall Study|Lost to Follow-up|0
1231923|NCT00712335|4040096|P4|Overall Study|Lost to Follow-up|1
1231924|NCT00712335|4040097|P3|Overall Study|Lost to Follow-up|0
1231925|NCT00712335|4040098|P2|Overall Study|Lost to Follow-up|5
1231926|NCT00712335|4040099|P1|Overall Study|Lost to Follow-up|2
1231927|NCT00712335|4040095|P5|Overall Study|Withdrawal by Subject|0
1231928|NCT00712335|4040096|P4|Overall Study|Withdrawal by Subject|3
1231929|NCT00712335|4040097|P3|Overall Study|Withdrawal by Subject|2
1231930|NCT00712335|4040098|P2|Overall Study|Withdrawal by Subject|7
1231931|NCT00712335|4040099|P1|Overall Study|Withdrawal by Subject|0
1231932|NCT00712270|4040144|P1|Overall Study|Screen Failure|3
1231933|NCT00712270|4040144|P1|Overall Study|Withdrawal by Subject|11
1231934|NCT00712166|4040208|P2|Overall Study|Noncompliance|1
1231935|NCT00712166|4040209|P1|Overall Study|Noncompliance|0
1231936|NCT00712010|4040252|P1|Washout (7 Days)|Withdrawal by Subject|1
1231937|NCT00711971|4040291|P3|Overall Study|Lost to Follow-up|1
1231938|NCT00711971|4040292|P2|Overall Study|Lost to Follow-up|4
1231939|NCT00711971|4040293|P1|Overall Study|Lost to Follow-up|3
1231940|NCT00711958|4040327|P2|Overall Study|Progression of disease|0
1231941|NCT00711958|4040328|P1|Overall Study|Progression of disease|1
1231942|NCT00711958|4040327|P2|Overall Study|Death|5
1231943|NCT00711958|4040328|P1|Overall Study|Death|10
1231944|NCT00711958|4040327|P2|Overall Study|Lost to Follow-up|2
1231945|NCT00711958|4040328|P1|Overall Study|Lost to Follow-up|2
1231946|NCT00711958|4040327|P2|Overall Study|Protocol Violation|0
1231947|NCT00711958|4040328|P1|Overall Study|Protocol Violation|1
1231948|NCT00711958|4040327|P2|Overall Study|Adverse Event|7
1231949|NCT00711958|4040328|P1|Overall Study|Adverse Event|9
1231950|NCT00711958|4040327|P2|Overall Study|Clinical deterioration|0
1231951|NCT00711958|4040328|P1|Overall Study|Clinical deterioration|1
1231952|NCT00711958|4040327|P2|Overall Study|Lack of Efficacy|1
1231953|NCT00711958|4040328|P1|Overall Study|Lack of Efficacy|3
1231954|NCT00711958|4040327|P2|Overall Study|Withdrawal by Subject|8
1231955|NCT00711958|4040328|P1|Overall Study|Withdrawal by Subject|6
1231956|NCT00711880|4040336|P2|Overall Study|Lack of Efficacy|5
1231957|NCT00711880|4040337|P1|Overall Study|Lack of Efficacy|1
1231958|NCT00711880|4040336|P2|Overall Study|Patient non-compliance|0
1231959|NCT00711880|4040337|P1|Overall Study|Patient non-compliance|1
1231960|NCT00711880|4040336|P2|Overall Study|Adverse Event|2
1231961|NCT00711880|4040337|P1|Overall Study|Adverse Event|11
1231962|NCT00711802|4040399|P8|Overall Study|Reason not reported|0
1231963|NCT00711802|4040400|P7|Overall Study|Reason not reported|1
1231964|NCT00711802|4040401|P6|Overall Study|Reason not reported|0
1231965|NCT00711802|4040402|P5|Overall Study|Reason not reported|1
1231966|NCT00711802|4040403|P4|Overall Study|Reason not reported|0
1231967|NCT00711802|4040404|P3|Overall Study|Reason not reported|1
1231968|NCT00711802|4040405|P2|Overall Study|Reason not reported|1
1231969|NCT00711802|4040406|P1|Overall Study|Reason not reported|0
1231970|NCT00711802|4040399|P8|Overall Study|Lost to Follow-up|2
1231971|NCT00711802|4040400|P7|Overall Study|Lost to Follow-up|4
1231972|NCT00711802|4040401|P6|Overall Study|Lost to Follow-up|6
1231973|NCT00711802|4040402|P5|Overall Study|Lost to Follow-up|10
1231974|NCT00711802|4040403|P4|Overall Study|Lost to Follow-up|1
1231975|NCT00711802|4040404|P3|Overall Study|Lost to Follow-up|3
1231976|NCT00711802|4040405|P2|Overall Study|Lost to Follow-up|0
1231977|NCT00711802|4040406|P1|Overall Study|Lost to Follow-up|0
1231978|NCT00711802|4040399|P8|Overall Study|Withdrawal by Subject|0
1231979|NCT00711802|4040400|P7|Overall Study|Withdrawal by Subject|0
1231980|NCT00711802|4040401|P6|Overall Study|Withdrawal by Subject|0
1231981|NCT00711802|4040402|P5|Overall Study|Withdrawal by Subject|0
1231982|NCT00711802|4040403|P4|Overall Study|Withdrawal by Subject|1
1231983|NCT00711802|4040404|P3|Overall Study|Withdrawal by Subject|0
1231984|NCT00711802|4040405|P2|Overall Study|Withdrawal by Subject|1
1231985|NCT00711802|4040406|P1|Overall Study|Withdrawal by Subject|0
1231986|NCT00711802|4040399|P8|Overall Study|Physician Decision|0
1231987|NCT00711802|4040400|P7|Overall Study|Physician Decision|0
1231988|NCT00711802|4040401|P6|Overall Study|Physician Decision|0
1231989|NCT00711802|4040402|P5|Overall Study|Physician Decision|0
1231990|NCT00711802|4040403|P4|Overall Study|Physician Decision|0
1231991|NCT00711802|4040404|P3|Overall Study|Physician Decision|0
1231992|NCT00711802|4040405|P2|Overall Study|Physician Decision|2
1231993|NCT00711802|4040406|P1|Overall Study|Physician Decision|0
1231994|NCT00711802|4040399|P8|Overall Study|Protocol Violation|0
1231995|NCT00711802|4040400|P7|Overall Study|Protocol Violation|0
1231996|NCT00711802|4040401|P6|Overall Study|Protocol Violation|0
1231997|NCT00711802|4040402|P5|Overall Study|Protocol Violation|0
1231998|NCT00711802|4040403|P4|Overall Study|Protocol Violation|1
1231999|NCT00711802|4040404|P3|Overall Study|Protocol Violation|0
1232000|NCT00711802|4040405|P2|Overall Study|Protocol Violation|0
1232001|NCT00711802|4040406|P1|Overall Study|Protocol Violation|0
1232002|NCT00711802|4040399|P8|Overall Study|Microbiological failure|0
1232003|NCT00711802|4040400|P7|Overall Study|Microbiological failure|0
1232004|NCT00711802|4040401|P6|Overall Study|Microbiological failure|1
1232005|NCT00711802|4040402|P5|Overall Study|Microbiological failure|0
1232006|NCT00711802|4040403|P4|Overall Study|Microbiological failure|0
1232007|NCT00711802|4040404|P3|Overall Study|Microbiological failure|0
1232008|NCT00711802|4040405|P2|Overall Study|Microbiological failure|1
1232009|NCT00711802|4040406|P1|Overall Study|Microbiological failure|0
1232010|NCT00711802|4040399|P8|Overall Study|Adverse Event|0
1232011|NCT00711802|4040400|P7|Overall Study|Adverse Event|0
1232012|NCT00711802|4040401|P6|Overall Study|Adverse Event|1
1232013|NCT00711802|4040402|P5|Overall Study|Adverse Event|1
1232014|NCT00711802|4040403|P4|Overall Study|Adverse Event|0
1232015|NCT00711802|4040404|P3|Overall Study|Adverse Event|0
1232016|NCT00711802|4040405|P2|Overall Study|Adverse Event|0
1232017|NCT00711802|4040406|P1|Overall Study|Adverse Event|0
1232018|NCT00711802|4040399|P8|Overall Study|Not treated (no further detail)|0
1232019|NCT00711802|4040400|P7|Overall Study|Not treated (no further detail)|0
1232020|NCT00711802|4040401|P6|Overall Study|Not treated (no further detail)|0
1232021|NCT00711802|4040402|P5|Overall Study|Not treated (no further detail)|2
1232022|NCT00711802|4040403|P4|Overall Study|Not treated (no further detail)|0
1232023|NCT00711802|4040404|P3|Overall Study|Not treated (no further detail)|2
1232024|NCT00711802|4040405|P2|Overall Study|Not treated (no further detail)|1
1232025|NCT00711802|4040406|P1|Overall Study|Not treated (no further detail)|2
1232026|NCT00711646|4040438|P2|Overall Study|patient non-compliance|0
1232027|NCT00711646|4040439|P1|Overall Study|patient non-compliance|1
1232028|NCT00711646|4040438|P2|Overall Study|administrative decision|1
1232029|NCT00711646|4040439|P1|Overall Study|administrative decision|0
1232030|NCT00711646|4040438|P2|Overall Study|Lost to Follow-up|0
1232031|NCT00711646|4040439|P1|Overall Study|Lost to Follow-up|1
1232032|NCT00711646|4040438|P2|Overall Study|Protocol Violation|1
1232033|NCT00711646|4040439|P1|Overall Study|Protocol Violation|0
1232034|NCT00711646|4040438|P2|Overall Study|Withdrawal by Subject|0
1232035|NCT00711646|4040439|P1|Overall Study|Withdrawal by Subject|4
1232036|NCT00711646|4040438|P2|Overall Study|Adverse Event|1
1232037|NCT00711646|4040439|P1|Overall Study|Adverse Event|6
1232038|NCT00711594|4040461|P4|Overall Study|Withdrawal by Subject|2
1232039|NCT00711594|4040462|P3|Overall Study|Withdrawal by Subject|0
1232040|NCT00711594|4040463|P2|Overall Study|Withdrawal by Subject|1
1232041|NCT00711594|4040464|P1|Overall Study|Withdrawal by Subject|0
1232042|NCT00711594|4040461|P4|Overall Study|Other Adverse Event|16
1232043|NCT00711594|4040462|P3|Overall Study|Other Adverse Event|0
1232044|NCT00711594|4040463|P2|Overall Study|Other Adverse Event|0
1232045|NCT00711594|4040464|P1|Overall Study|Other Adverse Event|1
1232046|NCT00711594|4040461|P4|Overall Study|Progressive disease|44
1232047|NCT00711594|4040462|P3|Overall Study|Progressive disease|6
1232048|NCT00711594|4040463|P2|Overall Study|Progressive disease|2
1232049|NCT00711594|4040464|P1|Overall Study|Progressive disease|2
1232050|NCT00711555|4040501|P1|Overall Study|Adverse Event|3
1232051|NCT00711529|4040510|P2|Overall Study|Withdrawal by Subject|6
1232052|NCT00711529|4040511|P1|Overall Study|Withdrawal by Subject|2
1232053|NCT00711529|4040510|P2|Overall Study|Protocol Violation|0
1232054|NCT00711529|4040511|P1|Overall Study|Protocol Violation|2
1232055|NCT00711516|4040535|P2|Overall Study|Protocol Violation|1
1232056|NCT00711516|4040536|P1|Overall Study|Protocol Violation|0
1232057|NCT00711516|4040535|P2|Overall Study|Withdrawal by Subject|1
1232058|NCT00711516|4040536|P1|Overall Study|Withdrawal by Subject|0
1232059|NCT00711516|4040535|P2|Overall Study|Adverse Event|1
1232060|NCT00711516|4040536|P1|Overall Study|Adverse Event|1
1232061|NCT00711477|4040643|P2|Overall Study|Noncompliance|1
1232062|NCT00711477|4040644|P1|Overall Study|Noncompliance|0
1232063|NCT00711477|4040643|P2|Overall Study|Lost to Follow-up|1
1232064|NCT00711477|4040644|P1|Overall Study|Lost to Follow-up|0
1232065|NCT00711477|4040643|P2|Overall Study|Adverse Event|1
1232066|NCT00711477|4040644|P1|Overall Study|Adverse Event|3
1232067|NCT00711425|4040690|P1|Overall Study|Lost to Follow-up|1
1232068|NCT00711425|4040690|P1|Overall Study|Death|2
1232069|NCT00711425|4040690|P1|Overall Study|Protocol Violation|1
1232070|NCT00711412|4040696|P1|Survival Follow up Until Death|Other|12
1232071|NCT00711412|4040696|P1|Evaluation for Response and Surgery|Death|1
1232072|NCT00711412|4040696|P1|Evaluation for Response and Surgery|Withdrawal by Subject|1
1232073|NCT00711412|4040696|P1|Evaluation for Response and Surgery|Too high risk for surgery|2
1232074|NCT00711412|4040696|P1|Evaluation for Response and Surgery|Progressive Disease|2
1232075|NCT00711412|4040696|P1|Combination Treatment|Progressive Disease|1
1232076|NCT00711412|4040696|P1|Evaluated for Combination Treatment|Progressive disease|2
1232077|NCT00711412|4040696|P1|Evaluated for Combination Treatment|Withdrawal by Subject|1
1232078|NCT00711412|4040696|P1|Evaluated for Combination Treatment|Death|1
1232079|NCT00711412|4040696|P1|Evaluated for Combination Treatment|Adverse Event|2
1232080|NCT00711412|4040696|P1|Induction Treatment|Other|1
1232081|NCT00711412|4040696|P1|Induction Treatment|Adverse Event|1
1232082|NCT00711412|4040696|P1|Induction Treatment|Death|2
1232083|NCT00711243|4040774|P6|Follow up Every 3 Months Until Death|Lost to Follow-up|2
1232084|NCT00711243|4040775|P5|Follow up Every 3 Months Until Death|Lost to Follow-up|0
1232085|NCT00711243|4040776|P4|Follow up Every 3 Months Until Death|Lost to Follow-up|0
1232086|NCT00711243|4040777|P3|Follow up Every 3 Months Until Death|Lost to Follow-up|0
1232087|NCT00711243|4040778|P2|Follow up Every 3 Months Until Death|Lost to Follow-up|0
1232088|NCT00711243|4040779|P1|Follow up Every 3 Months Until Death|Lost to Follow-up|0
1232089|NCT00711243|4040774|P6|Treated Cycle 5 After First Response|Decline in performance status|1
1232090|NCT00711243|4040775|P5|Treated Cycle 5 After First Response|Decline in performance status|0
1232091|NCT00711243|4040776|P4|Treated Cycle 5 After First Response|Decline in performance status|0
1232092|NCT00711243|4040777|P3|Treated Cycle 5 After First Response|Decline in performance status|0
1232093|NCT00711243|4040778|P2|Treated Cycle 5 After First Response|Decline in performance status|0
1232094|NCT00711243|4040779|P1|Treated Cycle 5 After First Response|Decline in performance status|0
1232095|NCT00711243|4040774|P6|Treated Cycle 5 After First Response|Death|2
1232096|NCT00711243|4040775|P5|Treated Cycle 5 After First Response|Death|0
1232097|NCT00711243|4040776|P4|Treated Cycle 5 After First Response|Death|0
1232098|NCT00711243|4040777|P3|Treated Cycle 5 After First Response|Death|0
1232099|NCT00711243|4040778|P2|Treated Cycle 5 After First Response|Death|0
1232100|NCT00711243|4040779|P1|Treated Cycle 5 After First Response|Death|0
1232101|NCT00711243|4040774|P6|Treated Cycle 5 After First Response|Progressive disease|1
1232102|NCT00711243|4040775|P5|Treated Cycle 5 After First Response|Progressive disease|1
1232103|NCT00711243|4040776|P4|Treated Cycle 5 After First Response|Progressive disease|0
1232104|NCT00711243|4040777|P3|Treated Cycle 5 After First Response|Progressive disease|0
1232105|NCT00711243|4040778|P2|Treated Cycle 5 After First Response|Progressive disease|2
1232106|NCT00711243|4040779|P1|Treated Cycle 5 After First Response|Progressive disease|1
1232107|NCT00711243|4040774|P6|Reached First Response/4 Cycles|Progressive disease|0
1232108|NCT00711243|4040775|P5|Reached First Response/4 Cycles|Progressive disease|0
1232109|NCT00711243|4040776|P4|Reached First Response/4 Cycles|Progressive disease|1
1232110|NCT00711243|4040777|P3|Reached First Response/4 Cycles|Progressive disease|0
1232111|NCT00711243|4040778|P2|Reached First Response/4 Cycles|Progressive disease|0
1232112|NCT00711243|4040779|P1|Reached First Response/4 Cycles|Progressive disease|0
1232113|NCT00711243|4040774|P6|Reached First Response/4 Cycles|Death|2
1232114|NCT00711243|4040775|P5|Reached First Response/4 Cycles|Death|0
1232115|NCT00711243|4040776|P4|Reached First Response/4 Cycles|Death|0
1232116|NCT00711243|4040777|P3|Reached First Response/4 Cycles|Death|0
1232117|NCT00711243|4040778|P2|Reached First Response/4 Cycles|Death|0
1232118|NCT00711243|4040779|P1|Reached First Response/4 Cycles|Death|0
1232119|NCT00711243|4040774|P6|Registed and Started Treatment|Withdrawal by Subject|1
1232120|NCT00711243|4040775|P5|Registed and Started Treatment|Withdrawal by Subject|0
1232121|NCT00711243|4040776|P4|Registed and Started Treatment|Withdrawal by Subject|0
1232122|NCT00711243|4040777|P3|Registed and Started Treatment|Withdrawal by Subject|0
1232123|NCT00711243|4040778|P2|Registed and Started Treatment|Withdrawal by Subject|0
1232124|NCT00711243|4040779|P1|Registed and Started Treatment|Withdrawal by Subject|0
1232125|NCT00711191|4040802|P3|Overall Study|Withdrawal by Subject|3
1232126|NCT00711191|4040803|P2|Overall Study|Withdrawal by Subject|1
1232127|NCT00711191|4040804|P1|Overall Study|Withdrawal by Subject|0
1232128|NCT00711191|4040802|P3|Overall Study|Objective progression or relapse|7
1232129|NCT00711191|4040803|P2|Overall Study|Objective progression or relapse|3
1232130|NCT00711191|4040804|P1|Overall Study|Objective progression or relapse|2
1232131|NCT00711191|4040802|P3|Overall Study|Adverse Event|2
1232132|NCT00711191|4040803|P2|Overall Study|Adverse Event|1
1232133|NCT00711191|4040804|P1|Overall Study|Adverse Event|1
1232134|NCT00711113|4040841|P1|Overall Study|Implant lost|2
1232135|NCT00711113|4040841|P1|Overall Study|Lost to Follow-up|9
1232136|NCT00711100|4040847|P1|Overall Study|Withdrawal by Subject|8
1232137|NCT00711100|4040847|P1|Overall Study|Lack of Efficacy|5
1232138|NCT00711087|4040865|P2|Overall Study|Lost to Follow-up|0
1232139|NCT00711087|4040866|P1|Overall Study|Lost to Follow-up|1
1232140|NCT00711009|4040878|P2|Overall Study|Dose adjustment|0
1232141|NCT00711009|4040879|P1|Overall Study|Dose adjustment|1
1232142|NCT00711009|4040878|P2|Overall Study|Site closing|1
1232143|NCT00711009|4040879|P1|Overall Study|Site closing|0
1232144|NCT00711009|4040878|P2|Overall Study|Pregnancy|0
1232145|NCT00711009|4040879|P1|Overall Study|Pregnancy|1
1232146|NCT00711009|4040878|P2|Overall Study|Virologic Failure|1
1232147|NCT00711009|4040879|P1|Overall Study|Virologic Failure|2
1232148|NCT00711009|4040878|P2|Overall Study|Participant Noncompliant|1
1232149|NCT00711009|4040879|P1|Overall Study|Participant Noncompliant|0
1232150|NCT00711009|4040878|P2|Overall Study|Lost to Follow-up|9
1232151|NCT00711009|4040879|P1|Overall Study|Lost to Follow-up|3
1232152|NCT00711009|4040878|P2|Overall Study|Withdrawal by Subject|2
1232153|NCT00711009|4040879|P1|Overall Study|Withdrawal by Subject|4
1232154|NCT00711009|4040878|P2|Overall Study|Adverse Event/HIV-Related Event|5
1232155|NCT00711009|4040879|P1|Overall Study|Adverse Event/HIV-Related Event|4
1232156|NCT00710970|4041060|P1|Overall Study|Never took drug|2
1232157|NCT00710970|4041060|P1|Overall Study|Lost to Follow-up|8
1232158|NCT00710879|4041087|P2|Overall Study|Protocol Violation|3
1232159|NCT00710879|4041088|P1|Overall Study|Protocol Violation|0
1232160|NCT00710879|4041087|P2|Overall Study|Lost to Follow-up|1
1232161|NCT00710879|4041088|P1|Overall Study|Lost to Follow-up|2
1232162|NCT00710866|4041100|P2|Overall Study|Failed to meet eligibility|1
1232163|NCT00710866|4041101|P1|Overall Study|Failed to meet eligibility|1
1232164|NCT00710866|4041100|P2|Overall Study|Lost to Follow-up|0
1232165|NCT00710866|4041101|P1|Overall Study|Lost to Follow-up|1
1232166|NCT00710866|4041100|P2|Overall Study|Withdrawal by Subject|1
1232167|NCT00710866|4041101|P1|Overall Study|Withdrawal by Subject|2
1232168|NCT00710866|4041100|P2|Overall Study|Protocol Violation|4
1232169|NCT00710866|4041101|P1|Overall Study|Protocol Violation|5
1232170|NCT00710762|4041147|P2|Overall Study|Reason other than listed above|2
1232171|NCT00710762|4041148|P1|Overall Study|Reason other than listed above|2
1232172|NCT00710762|4041147|P2|Overall Study|Lost to Follow-up|0
1232173|NCT00710762|4041148|P1|Overall Study|Lost to Follow-up|1
1232174|NCT00710762|4041147|P2|Overall Study|Other Adverse Event|7
1232175|NCT00710762|4041148|P1|Overall Study|Other Adverse Event|7
1232176|NCT00710762|4041147|P2|Overall Study|Adverse Event other disease worsening|1
1232177|NCT00710762|4041148|P1|Overall Study|Adverse Event other disease worsening|2
1232178|NCT00710762|4041147|P2|Overall Study|Progressive disease|30
1232179|NCT00710762|4041148|P1|Overall Study|Progressive disease|27
1232180|NCT00710749|4041164|P2|First Intervention|Withdrawal by Subject|0
1232181|NCT00710749|4041165|P1|First Intervention|Withdrawal by Subject|1
1232182|NCT00710684|4041176|P3|Overall Study|Did not continue after week 24|16
1232183|NCT00710684|4041177|P2|Overall Study|Did not continue after week 24|21
1232184|NCT00710684|4041178|P1|Overall Study|Did not continue after week 24|25
1232185|NCT00710684|4041176|P3|Overall Study|Missing|0
1232186|NCT00710684|4041177|P2|Overall Study|Missing|0
1232187|NCT00710684|4041178|P1|Overall Study|Missing|1
1232188|NCT00710684|4041176|P3|Overall Study|Withdrawal by Subject|11
1232189|NCT00710684|4041177|P2|Overall Study|Withdrawal by Subject|18
1232190|NCT00710684|4041178|P1|Overall Study|Withdrawal by Subject|24
1232191|NCT00710684|4041176|P3|Overall Study|Physician Decision|4
1232192|NCT00710684|4041177|P2|Overall Study|Physician Decision|2
1232193|NCT00710684|4041178|P1|Overall Study|Physician Decision|0
1232194|NCT00710684|4041176|P3|Overall Study|Lost to Follow-up|7
1232195|NCT00710684|4041177|P2|Overall Study|Lost to Follow-up|6
1232196|NCT00710684|4041178|P1|Overall Study|Lost to Follow-up|4
1232197|NCT00710684|4041176|P3|Overall Study|Protocol Violation|5
1232198|NCT00710684|4041177|P2|Overall Study|Protocol Violation|5
1232199|NCT00710684|4041178|P1|Overall Study|Protocol Violation|5
1232200|NCT00710684|4041176|P3|Overall Study|Lack of Efficacy|5
1232201|NCT00710684|4041177|P2|Overall Study|Lack of Efficacy|3
1232202|NCT00710684|4041178|P1|Overall Study|Lack of Efficacy|4
1232203|NCT00710684|4041176|P3|Overall Study|Adverse Event|16
1232204|NCT00710684|4041177|P2|Overall Study|Adverse Event|19
1232205|NCT00710684|4041178|P1|Overall Study|Adverse Event|11
1232206|NCT00710606|4041235|P2|Overall Study|Adverse Event|2
1232207|NCT00710606|4041236|P1|Overall Study|Adverse Event|0
1232208|NCT00710593|4041248|P2|Overall Study|Prem disc vaccine, completed all visits|2
1232209|NCT00710593|4041249|P1|Overall Study|Prem disc vaccine, completed all visits|6
1232210|NCT00710593|4041248|P2|Overall Study|Protocol Violation|1
1232211|NCT00710593|4041249|P1|Overall Study|Protocol Violation|1
1232212|NCT00710593|4041248|P2|Overall Study|Failure to adhere or complete study eval|1
1232213|NCT00710593|4041249|P1|Overall Study|Failure to adhere or complete study eval|1
1232214|NCT00710593|4041248|P2|Overall Study|Moved out of area|0
1232215|NCT00710593|4041249|P1|Overall Study|Moved out of area|1
1232216|NCT00710593|4041248|P2|Overall Study|Lost to Follow-up|1
1232217|NCT00710593|4041249|P1|Overall Study|Lost to Follow-up|3
1232218|NCT00710593|4041248|P2|Overall Study|Unable to complete Wk 48 within window|0
1232219|NCT00710593|4041249|P1|Overall Study|Unable to complete Wk 48 within window|2
1232220|NCT00710593|4041248|P2|Overall Study|Incarceration|0
1232221|NCT00710593|4041249|P1|Overall Study|Incarceration|1
1232222|NCT00710554|4041292|P2|Overall Study|Receiving radiotherapy - prostate cancer|1
1232223|NCT00710554|4041293|P1|Overall Study|Receiving radiotherapy - prostate cancer|0
1232224|NCT00710554|4041292|P2|Overall Study|Lack of Efficacy|12
1232225|NCT00710554|4041293|P1|Overall Study|Lack of Efficacy|11
1232226|NCT00710554|4041292|P2|Overall Study|Lost to Follow-up|1
1232227|NCT00710554|4041293|P1|Overall Study|Lost to Follow-up|7
1232228|NCT00710554|4041292|P2|Overall Study|Withdrawal by Subject|3
1232229|NCT00710554|4041293|P1|Overall Study|Withdrawal by Subject|7
1232230|NCT00710554|4041292|P2|Overall Study|Adverse Event|7
1232231|NCT00710554|4041293|P1|Overall Study|Adverse Event|24
1232232|NCT00710424|4041321|P2|Overall Study|Felt good so stopped treatment|1
1232233|NCT00710424|4041322|P1|Overall Study|Felt good so stopped treatment|0
1232234|NCT00710424|4041321|P2|Overall Study|Subject preferred paracetamol|1
1232235|NCT00710424|4041322|P1|Overall Study|Subject preferred paracetamol|0
1232236|NCT00710424|4041321|P2|Overall Study|Ceased treatment due to travel|0
1232237|NCT00710424|4041322|P1|Overall Study|Ceased treatment due to travel|1
1232238|NCT00710424|4041321|P2|Overall Study|Subject thought medication changed|0
1232239|NCT00710424|4041322|P1|Overall Study|Subject thought medication changed|1
1232240|NCT00710424|4041321|P2|Overall Study|Did not meet entry criteria at visit 1|0
1232241|NCT00710424|4041322|P1|Overall Study|Did not meet entry criteria at visit 1|1
1232242|NCT00710424|4041321|P2|Overall Study|Non-compliance with stable analgesia|0
1232243|NCT00710424|4041322|P1|Overall Study|Non-compliance with stable analgesia|1
1232244|NCT00710424|4041321|P2|Overall Study|Refused medication, no side effects|0
1232245|NCT00710424|4041322|P1|Overall Study|Refused medication, no side effects|1
1232246|NCT00710424|4041321|P2|Overall Study|Lost to Follow-up|1
1232247|NCT00710424|4041322|P1|Overall Study|Lost to Follow-up|0
1232248|NCT00710424|4041321|P2|Overall Study|Withdrawal by Subject|3
1232249|NCT00710424|4041322|P1|Overall Study|Withdrawal by Subject|5
1232250|NCT00710424|4041321|P2|Overall Study|Lack of Efficacy|5
1232251|NCT00710424|4041322|P1|Overall Study|Lack of Efficacy|4
1232252|NCT00710424|4041321|P2|Overall Study|Adverse Event|12
1232253|NCT00710424|4041322|P1|Overall Study|Adverse Event|30
1232254|NCT00710385|4041346|P1|Overall Study|Undisclosed excessive methadone use|1
1232255|NCT00710385|4041346|P1|Overall Study|Physician Decision|1
1232256|NCT00710385|4041346|P1|Overall Study|Undisclosed back pain|1
1232257|NCT00710385|4041346|P1|Overall Study|Withdrawal by Subject|1
1232258|NCT00710385|4041346|P1|Overall Study|Did not qualify|1
1232259|NCT00710034|4041391|P2|Completed 12 Weeks of Treatment|Withdrawal by Subject|2
1232260|NCT00710034|4041392|P1|Completed 12 Weeks of Treatment|Withdrawal by Subject|8
1232261|NCT00710034|4041391|P2|Completed 12 Weeks of Treatment|Product Dissatisfaction|1
1232262|NCT00710034|4041392|P1|Completed 12 Weeks of Treatment|Product Dissatisfaction|0
1232263|NCT00710034|4041391|P2|Completed 12 Weeks of Treatment|Lost to Follow-up|5
1232264|NCT00710034|4041392|P1|Completed 12 Weeks of Treatment|Lost to Follow-up|5
1232265|NCT00710034|4041391|P2|Completed 12 Weeks of Treatment|Lack of Efficacy|2
1232266|NCT00710034|4041392|P1|Completed 12 Weeks of Treatment|Lack of Efficacy|0
1232267|NCT00710034|4041391|P2|Completed 12 Weeks of Treatment|Adverse Event|1
1232268|NCT00710034|4041392|P1|Completed 12 Weeks of Treatment|Adverse Event|0
1232269|NCT00710034|4041391|P2|Completed 6 Weeks of Treatment|Physician Decision|0
1232270|NCT00710034|4041392|P1|Completed 6 Weeks of Treatment|Physician Decision|1
1232271|NCT00710034|4041391|P2|Completed 6 Weeks of Treatment|Withdrawal by Subject|4
1232272|NCT00710034|4041392|P1|Completed 6 Weeks of Treatment|Withdrawal by Subject|6
1232273|NCT00710034|4041391|P2|Completed 6 Weeks of Treatment|Product dissatisfaction|6
1232274|NCT00710034|4041392|P1|Completed 6 Weeks of Treatment|Product dissatisfaction|2
1232275|NCT00710034|4041391|P2|Completed 6 Weeks of Treatment|Lost to Follow-up|17
1232276|NCT00710034|4041392|P1|Completed 6 Weeks of Treatment|Lost to Follow-up|15
1232277|NCT00710034|4041391|P2|Completed 6 Weeks of Treatment|Lack of Efficacy|8
1232278|NCT00710034|4041392|P1|Completed 6 Weeks of Treatment|Lack of Efficacy|12
1232279|NCT00710034|4041391|P2|Completed 6 Weeks of Treatment|Adverse Event|12
1232280|NCT00710034|4041392|P1|Completed 6 Weeks of Treatment|Adverse Event|5
1232281|NCT00710021|4041409|P3|Overall Study|Physician Decision|0
1232282|NCT00710021|4041410|P2|Overall Study|Physician Decision|1
1232283|NCT00710021|4041411|P1|Overall Study|Physician Decision|0
1232284|NCT00710021|4041409|P3|Overall Study|Subject misrandomized|1
1232285|NCT00710021|4041410|P2|Overall Study|Subject misrandomized|1
1232286|NCT00710021|4041411|P1|Overall Study|Subject misrandomized|0
1232287|NCT00710021|4041409|P3|Overall Study|Subject's Decision|0
1232288|NCT00710021|4041410|P2|Overall Study|Subject's Decision|1
1232289|NCT00710021|4041411|P1|Overall Study|Subject's Decision|0
1232290|NCT00710021|4041409|P3|Overall Study|Lost to Follow-up|0
1232291|NCT00710021|4041410|P2|Overall Study|Lost to Follow-up|0
1232292|NCT00710021|4041411|P1|Overall Study|Lost to Follow-up|1
1232293|NCT00709956|4041526|P2|Overall Study|Inclusion/exclusion criteria violation|3
1232294|NCT00709956|4041527|P1|Overall Study|Inclusion/exclusion criteria violation|2
1232295|NCT00709956|4041526|P2|Overall Study|Withdrawal by Subject|1
1232296|NCT00709956|4041527|P1|Overall Study|Withdrawal by Subject|1
1232297|NCT00709852|4041557|P2|Period 2|No 72-hour follow-up|0
1232298|NCT00709852|4041558|P1|Period 2|No 72-hour follow-up|3
1232299|NCT00709852|4041557|P2|Period 2|Lost to Follow-up|0
1232300|NCT00709852|4041558|P1|Period 2|Lost to Follow-up|1
1232301|NCT00709852|4041557|P2|Period 2|Adverse Event|1
1232302|NCT00709852|4041558|P1|Period 2|Adverse Event|1
1232303|NCT00709852|4041557|P2|Period 2|Protocol Violation|1
1232304|NCT00709852|4041558|P1|Period 2|Protocol Violation|4
1232305|NCT00709852|4041557|P2|Period 1|Lost to Follow-up|0
1232306|NCT00709852|4041558|P1|Period 1|Lost to Follow-up|1
1232307|NCT00709852|4041557|P2|Period 1|Defective scanner|1
1232308|NCT00709852|4041558|P1|Period 1|Defective scanner|0
1232309|NCT00709852|4041557|P2|Period 1|Protocol Violation|0
1232310|NCT00709852|4041558|P1|Period 1|Protocol Violation|1
1232311|NCT00709852|4041557|P2|Period 1|Withdrawal by Subject|2
1232312|NCT00709852|4041558|P1|Period 1|Withdrawal by Subject|4
1232313|NCT00709852|4041557|P2|Period 1|Adverse Event|0
1232314|NCT00709852|4041558|P1|Period 1|Adverse Event|2
1232315|NCT00709761|4041722|P1|Overall Study|Ongoing|40
1232316|NCT00709761|4041722|P1|Overall Study|Withdrawal by Subject|7
1232317|NCT00709735|4041733|P2|Overall Study|Did not meet PTSD Diagnostic Criteria|0
1232318|NCT00709735|4041734|P1|Overall Study|Did not meet PTSD Diagnostic Criteria|2
1232319|NCT00709735|4041733|P2|Overall Study|Relapse into Opioid Abuse|1
1232320|NCT00709735|4041734|P1|Overall Study|Relapse into Opioid Abuse|0
1232321|NCT00709735|4041733|P2|Overall Study|Lost to Follow-up|1
1232322|NCT00709735|4041734|P1|Overall Study|Lost to Follow-up|1
1232323|NCT00709722|4041742|P1|Overall Study|Adverse Event|1
1232324|NCT00709618|4041757|P1|Overall Study|Study Closed/Terminated|25
1232325|NCT00709618|4041757|P1|Overall Study|Lost to Follow-up|1
1232326|NCT00709618|4041757|P1|Overall Study|Withdrawal by Subject|4
1232327|NCT00709592|4041769|P2|Overall Study|Unable to proceed to transplant|1
1232328|NCT00709592|4041770|P1|Overall Study|Unable to proceed to transplant|0
1232329|NCT00709319|4041792|P1|Overall Study|Withdrawal by Subject|2
1232330|NCT00709319|4041792|P1|Overall Study|Death|4
1232331|NCT00709228|4041821|P1|Overall Study|Non-compliance|5
1232332|NCT00709228|4041821|P1|Overall Study|Lost to Follow-up|6
1232333|NCT00709228|4041821|P1|Overall Study|Disease progression|1
1232334|NCT00709228|4041821|P1|Overall Study|Discontinued follow-up|5
1232335|NCT00709228|4041821|P1|Overall Study|Did not enter follow-up|4
1232336|NCT00709228|4041821|P1|Overall Study|Discontinued treatment|14
1232337|NCT00709228|4041821|P1|Overall Study|Adverse events|2
1232338|NCT00709228|4041821|P1|Overall Study|Eligibility criteria not met|281
1232339|NCT00709228|4041821|P1|Overall Study|Not treated|14
1232340|NCT00709124|4041827|P2|Overall Study|encephalopathy; can't do assessment|0
1232341|NCT00709124|4041828|P1|Overall Study|encephalopathy; can't do assessment|1
1232342|NCT00709124|4041827|P2|Overall Study|Death|1
1232343|NCT00709124|4041828|P1|Overall Study|Death|3
1232344|NCT00709111|4041862|P1|Overall Study|Unable to attend clinic visits|1
1232345|NCT00709111|4041862|P1|Overall Study|Withdrawal by Subject|1
1232346|NCT00709098|4041903|P3|Open-label Period|Lost to Follow-up|1
1232347|NCT00709098|4041904|P2|Open-label Period|Lost to Follow-up|0
1232348|NCT00709098|4041905|P1|Open-label Period|Lost to Follow-up|0
1232349|NCT00709098|4041903|P3|Open-label Period|Death|1
1232350|NCT00709098|4041904|P2|Open-label Period|Death|0
1232351|NCT00709098|4041905|P1|Open-label Period|Death|0
1232352|NCT00709098|4041903|P3|Open-label Period|Administrative reason|5
1232353|NCT00709098|4041904|P2|Open-label Period|Administrative reason|0
1232354|NCT00709098|4041905|P1|Open-label Period|Administrative reason|0
1232355|NCT00709098|4041903|P3|Open-label Period|Withdrawal of consent|7
1232356|NCT00709098|4041904|P2|Open-label Period|Withdrawal of consent|0
1232357|NCT00709098|4041905|P1|Open-label Period|Withdrawal of consent|0
1232358|NCT00709098|4041903|P3|Double-blind Period|Lost to Follow-up|0
1232359|NCT00709098|4041904|P2|Double-blind Period|Lost to Follow-up|1
1232360|NCT00709098|4041905|P1|Double-blind Period|Lost to Follow-up|1
1232361|NCT00709098|4041903|P3|Double-blind Period|Death|0
1232362|NCT00709098|4041904|P2|Double-blind Period|Death|1
1232363|NCT00709098|4041905|P1|Double-blind Period|Death|1
1232364|NCT00709098|4041903|P3|Double-blind Period|Administrative reason|0
1232365|NCT00709098|4041904|P2|Double-blind Period|Administrative reason|3
1232366|NCT00709098|4041905|P1|Double-blind Period|Administrative reason|1
1232367|NCT00709098|4041903|P3|Double-blind Period|Withdrawal of consent|0
1232368|NCT00709098|4041904|P2|Double-blind Period|Withdrawal of consent|3
1232369|NCT00709098|4041905|P1|Double-blind Period|Withdrawal of consent|3
1232370|NCT00709059|4041924|P1|Overall Study|Serious side effects|11
1232371|NCT00709059|4041924|P1|Overall Study|Side effects|20
1232372|NCT00709059|4041924|P1|Overall Study|Disease complication|3
1232373|NCT00709059|4041924|P1|Overall Study|Physician Decision|7
1232374|NCT00709059|4041924|P1|Overall Study|Withdrawal by Subject|19
1232375|NCT00709059|4041924|P1|Overall Study|Lost to Follow-up|34
1232376|NCT00708734|4041971|P1|Overall Study|leg fracture|1
1232377|NCT00708734|4041971|P1|Overall Study|vertigo|1
1232378|NCT00708734|4041971|P1|Overall Study|knee replacement|1
1232379|NCT00708734|4041971|P1|Overall Study|leg injury|1
1232380|NCT00708734|4041971|P1|Overall Study|moved|1
1232381|NCT00708734|4041971|P1|Overall Study|scheduling conflict|2
1232382|NCT00708708|4041991|P1|Overall Study|Missing values|392
1232383|NCT00708708|4041991|P1|Overall Study|Adverse Event|3
1232384|NCT00708708|4041991|P1|Overall Study|Pregnancy|3
1232385|NCT00708708|4041991|P1|Overall Study|Lack of compliance|3
1232386|NCT00708708|4041991|P1|Overall Study|Lack of effectiveness|4
1232387|NCT00708708|4041991|P1|Overall Study|Administrative reasons|7
1232388|NCT00708708|4041991|P1|Overall Study|Ineffectiveness (no systemic therapy)|9
1232389|NCT00708708|4041991|P1|Overall Study|Good effectiveness|9
1232390|NCT00708708|4041991|P1|Overall Study|Other unspecified|11
1232391|NCT00708708|4041991|P1|Overall Study|Another therapy along with Enbrel|15
1232392|NCT00708708|4041991|P1|Overall Study|Intolerance|42
1232393|NCT00708708|4041991|P1|Overall Study|Withdrawal by Subject|51
1232394|NCT00708708|4041991|P1|Overall Study|Lost to Follow-up|52
1232395|NCT00708708|4041991|P1|Overall Study|Another therapy instead of Enbrel|141
1232396|NCT00708682|4042039|P1|Toddler Dose|Failed to Return|4
1232397|NCT00708682|4042039|P1|Toddler Dose|Lost to Follow-up|3
1232398|NCT00708682|4042039|P1|Toddler Dose|Parent/Legal Guardian Request|1
1232399|NCT00708682|4042039|P1|After Infant Series|Parent/Legal Guardian Request|1
1232400|NCT00708682|4042039|P1|Infant Series|Not Specified|19
1232401|NCT00708682|4042039|P1|Infant Series|Failed to return|2
1232402|NCT00708682|4042039|P1|Infant Series|Parent/legal guardian request|6
1232403|NCT00708682|4042039|P1|Infant Series|Protocol Violation|1
1232404|NCT00708682|4042039|P1|Infant Series|Lost to Follow-up|4
1232405|NCT00708682|4042039|P1|Infant Series|Adverse Event|1
1232406|NCT00708643|4042060|P2|Overall Study|Adverse Event|1
1232407|NCT00708643|4042061|P1|Overall Study|Adverse Event|0
1232408|NCT00708552|4042081|P4|Overall Study|Withdrawal by Subject|10
1232409|NCT00708552|4042082|P3|Overall Study|Withdrawal by Subject|8
1232410|NCT00708552|4042083|P2|Overall Study|Withdrawal by Subject|7
1232411|NCT00708552|4042084|P1|Overall Study|Withdrawal by Subject|12
1232412|NCT00708552|4042081|P4|Overall Study|Physician Decision|0
1232413|NCT00708552|4042082|P3|Overall Study|Physician Decision|0
1232414|NCT00708552|4042083|P2|Overall Study|Physician Decision|2
1232415|NCT00708552|4042084|P1|Overall Study|Physician Decision|1
1232416|NCT00708552|4042081|P4|Overall Study|Lost to Follow-up|1
1232417|NCT00708552|4042082|P3|Overall Study|Lost to Follow-up|0
1232418|NCT00708552|4042083|P2|Overall Study|Lost to Follow-up|2
1232419|NCT00708552|4042084|P1|Overall Study|Lost to Follow-up|4
1232420|NCT00708552|4042081|P4|Overall Study|Protocol Violation|4
1232421|NCT00708552|4042082|P3|Overall Study|Protocol Violation|2
1232422|NCT00708552|4042083|P2|Overall Study|Protocol Violation|0
1232423|NCT00708552|4042084|P1|Overall Study|Protocol Violation|0
1232424|NCT00708552|4042081|P4|Overall Study|Lack of Efficacy|0
1232425|NCT00708552|4042082|P3|Overall Study|Lack of Efficacy|1
1232426|NCT00708552|4042083|P2|Overall Study|Lack of Efficacy|4
1232427|NCT00708552|4042084|P1|Overall Study|Lack of Efficacy|0
1232428|NCT00708552|4042081|P4|Overall Study|Adverse Event|6
1232429|NCT00708552|4042082|P3|Overall Study|Adverse Event|4
1232430|NCT00708552|4042083|P2|Overall Study|Adverse Event|3
1232431|NCT00708552|4042084|P1|Overall Study|Adverse Event|10
1232432|NCT00708500|4042246|P3|FOLLOWUP|Non-compliance with protocol|1
1232433|NCT00708500|4042247|P2|FOLLOWUP|Non-compliance with protocol|0
1232434|NCT00708500|4042248|P1|FOLLOWUP|Non-compliance with protocol|5
1232435|NCT00708500|4042246|P3|FOLLOWUP|Subject withdrew consent|5
1232436|NCT00708500|4042247|P2|FOLLOWUP|Subject withdrew consent|4
1232437|NCT00708500|4042248|P1|FOLLOWUP|Subject withdrew consent|31
1232438|NCT00708500|4042246|P3|FOLLOWUP|Subject withdrawal unrelated to Tx|5
1232439|NCT00708500|4042247|P2|FOLLOWUP|Subject withdrawal unrelated to Tx|4
1232440|NCT00708500|4042248|P1|FOLLOWUP|Subject withdrawal unrelated to Tx|3
1232441|NCT00708500|4042246|P3|FOLLOWUP|Lost to Follow-up|4
1232442|NCT00708500|4042247|P2|FOLLOWUP|Lost to Follow-up|6
1232443|NCT00708500|4042248|P1|FOLLOWUP|Lost to Follow-up|1
1232444|NCT00708500|4042246|P3|FOLLOWUP|Adverse Event|0
1232445|NCT00708500|4042247|P2|FOLLOWUP|Adverse Event|1
1232446|NCT00708500|4042248|P1|FOLLOWUP|Adverse Event|0
1232447|NCT00708500|4042246|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
1232448|NCT00708500|4042247|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1
1232449|NCT00708500|4042248|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
1232450|NCT00708500|4042246|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
1232451|NCT00708500|4042247|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
1232452|NCT00708500|4042248|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0
1232453|NCT00708500|4042246|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1
1232454|NCT00708500|4042247|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2
1232455|NCT00708500|4042248|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0
1232456|NCT00708500|4042246|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1
1232457|NCT00708500|4042247|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0
1232458|NCT00708500|4042248|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2
1232459|NCT00708500|4042246|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4
1232460|NCT00708500|4042247|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1
1232461|NCT00708500|4042248|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3
1232462|NCT00708500|4042246|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
1232463|NCT00708500|4042247|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1
1232464|NCT00708500|4042248|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
1232465|NCT00708500|4042246|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29
1232466|NCT00708500|4042247|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36
1232467|NCT00708500|4042248|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49
1232468|NCT00708500|4042246|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19
1232469|NCT00708500|4042247|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10
1232470|NCT00708500|4042248|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1
1232471|NCT00708500|4042246|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1
1232472|NCT00708500|4042247|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
1232473|NCT00708500|4042248|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
1232474|NCT00708500|4042246|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
1232475|NCT00708500|4042247|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2
1232476|NCT00708500|4042248|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
1232477|NCT00708500|4042246|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
1232478|NCT00708500|4042247|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1
1232479|NCT00708500|4042248|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
1232480|NCT00708500|4042246|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
1232481|NCT00708500|4042247|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
1232482|NCT00708500|4042248|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1
1232483|NCT00708500|4042246|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
1232484|NCT00708500|4042247|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3
1232485|NCT00708500|4042248|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
1232486|NCT00708461|4042267|P2|Overall Study|left workforce|180
1232487|NCT00708461|4042268|P1|Overall Study|left workforce|115
1232488|NCT00708461|4042267|P2|Overall Study|Withdrawal by Subject|9
1232489|NCT00708461|4042268|P1|Overall Study|Withdrawal by Subject|8
1232490|NCT00708461|4042267|P2|Overall Study|Lost to Follow-up|11
1232491|NCT00708461|4042268|P1|Overall Study|Lost to Follow-up|18
1232492|NCT00708435|4042276|P2|Overall Study|Refused hospitalization|0
1232493|NCT00708435|4042277|P1|Overall Study|Refused hospitalization|1
1232494|NCT00708435|4042276|P2|Overall Study|Intervention by primary care physician|0
1232495|NCT00708435|4042277|P1|Overall Study|Intervention by primary care physician|1
1232496|NCT00708435|4042276|P2|Overall Study|Protocol Violation|1
1232497|NCT00708435|4042277|P1|Overall Study|Protocol Violation|0
1232498|NCT00708435|4042276|P2|Overall Study|Adverse Event|0
1232499|NCT00708435|4042277|P1|Overall Study|Adverse Event|1
1232500|NCT00708435|4042276|P2|Overall Study|Withdrawal by Subject|7
1232501|NCT00708435|4042277|P1|Overall Study|Withdrawal by Subject|3
1232502|NCT00708435|4042276|P2|Overall Study|Lost to Follow-up|4
1232503|NCT00708435|4042277|P1|Overall Study|Lost to Follow-up|9
1232504|NCT00708435|4042276|P2|Overall Study|Death / Serious Adverse Event|5
1232505|NCT00708435|4042277|P1|Overall Study|Death / Serious Adverse Event|10
1232506|NCT00708422|4042304|P2|Overall Study|Withdrawal by Subject|0
1232507|NCT00708422|4042305|P1|Overall Study|Withdrawal by Subject|1
1232508|NCT00708422|4042304|P2|Overall Study|Adverse Event|1
1232509|NCT00708422|4042305|P1|Overall Study|Adverse Event|3
1232510|NCT00708305|4042313|P4|Period 3|Other Reason|0
1232511|NCT00708305|4042314|P3|Period 3|Other Reason|0
1232512|NCT00708305|4042315|P2|Period 3|Other Reason|0
1232513|NCT00708305|4042316|P1|Period 3|Other Reason|1
1232514|NCT00708305|4042313|P4|Period 3|Protocol Violation|0
1232515|NCT00708305|4042314|P3|Period 3|Protocol Violation|0
1232516|NCT00708305|4042315|P2|Period 3|Protocol Violation|2
1232517|NCT00708305|4042316|P1|Period 3|Protocol Violation|0
1232518|NCT00708305|4042313|P4|Period 2|Other Reason|1
1232519|NCT00708305|4042314|P3|Period 2|Other Reason|0
1232520|NCT00708305|4042315|P2|Period 2|Other Reason|0
1232521|NCT00708305|4042316|P1|Period 2|Other Reason|1
1232522|NCT00708305|4042313|P4|Period 2|Protocol Violation|0
1232523|NCT00708305|4042314|P3|Period 2|Protocol Violation|0
1232524|NCT00708305|4042315|P2|Period 2|Protocol Violation|1
1232525|NCT00708305|4042316|P1|Period 2|Protocol Violation|0
1232526|NCT00708305|4042313|P4|Period 2|Lost to Follow-up|0
1232527|NCT00708305|4042314|P3|Period 2|Lost to Follow-up|0
1232528|NCT00708305|4042315|P2|Period 2|Lost to Follow-up|1
1232529|NCT00708305|4042316|P1|Period 2|Lost to Follow-up|0
1232530|NCT00708305|4042313|P4|Period 1|Other Reason|2
1232531|NCT00708305|4042314|P3|Period 1|Other Reason|0
1232532|NCT00708305|4042315|P2|Period 1|Other Reason|0
1232533|NCT00708305|4042316|P1|Period 1|Other Reason|0
1232534|NCT00708305|4042313|P4|Period 1|Protocol Violation|0
1232535|NCT00708305|4042314|P3|Period 1|Protocol Violation|1
1232536|NCT00708305|4042315|P2|Period 1|Protocol Violation|0
1232537|NCT00708305|4042316|P1|Period 1|Protocol Violation|1
1232538|NCT00708227|4042352|P4|Overall Study|Withdrawal by Subject|1
1232539|NCT00708227|4042353|P3|Overall Study|Withdrawal by Subject|0
1232540|NCT00708227|4042354|P2|Overall Study|Withdrawal by Subject|2
1232541|NCT00708227|4042355|P1|Overall Study|Withdrawal by Subject|1
1232542|NCT00708227|4042352|P4|Overall Study|Physician Decision|2
1232543|NCT00708227|4042353|P3|Overall Study|Physician Decision|1
1232544|NCT00708227|4042354|P2|Overall Study|Physician Decision|3
1232545|NCT00708227|4042355|P1|Overall Study|Physician Decision|0
1232546|NCT00708214|4042388|P3|Overall Study|Progressive Disease|5
1232547|NCT00708214|4042389|P2|Overall Study|Progressive Disease|6
1232548|NCT00708214|4042390|P1|Overall Study|Progressive Disease|4
1232549|NCT00708214|4042388|P3|Overall Study|Other|1
1232550|NCT00708214|4042389|P2|Overall Study|Other|1
1232551|NCT00708214|4042390|P1|Overall Study|Other|0
1232552|NCT00708214|4042388|P3|Overall Study|Other Adverse Event|2
1232553|NCT00708214|4042389|P2|Overall Study|Other Adverse Event|6
1232554|NCT00708214|4042390|P1|Overall Study|Other Adverse Event|3
1232555|NCT00708201|4042433|P2|Overall Study|Protocol Violation|1
1232556|NCT00708201|4042434|P1|Overall Study|Protocol Violation|0
1232557|NCT00708201|4042433|P2|Overall Study|Lost to Follow-up|0
1232558|NCT00708201|4042434|P1|Overall Study|Lost to Follow-up|2
1232559|NCT00708201|4042433|P2|Overall Study|Withdrawal by Subject|1
1232560|NCT00708201|4042434|P1|Overall Study|Withdrawal by Subject|1
1232561|NCT00708201|4042433|P2|Overall Study|Adverse Event|4
1232562|NCT00708201|4042434|P1|Overall Study|Adverse Event|4
1232563|NCT00708175|4042458|P2|Overall Study|BMD loss >7%|3
1232564|NCT00708175|4042459|P1|Overall Study|BMD loss >7%|2
1232565|NCT00708175|4042458|P2|Overall Study|Withdrawal by Subject|7
1232566|NCT00708175|4042459|P1|Overall Study|Withdrawal by Subject|5
1232567|NCT00708175|4042458|P2|Overall Study|Lost to Follow-up|3
1232568|NCT00708175|4042459|P1|Overall Study|Lost to Follow-up|5
1232569|NCT00708175|4042458|P2|Overall Study|Protocol Violation|3
1232570|NCT00708175|4042459|P1|Overall Study|Protocol Violation|2
1232571|NCT00708175|4042458|P2|Overall Study|Adverse Event|5
1232572|NCT00708175|4042459|P1|Overall Study|Adverse Event|4
1232573|NCT00708162|4042475|P2|Open-Label Phase|Other|0
1232574|NCT00708162|4042476|P1|Open-Label Phase|Other|1
1232575|NCT00708162|4042475|P2|Open-Label Phase|Adverse Event|2
1232576|NCT00708162|4042476|P1|Open-Label Phase|Adverse Event|1
1232577|NCT00708162|4042475|P2|Open-Label Phase|Death|1
1232578|NCT00708162|4042476|P1|Open-Label Phase|Death|3
1232579|NCT00708162|4042475|P2|Open-Label Phase|Investigator's Discretion|2
1232580|NCT00708162|4042476|P1|Open-Label Phase|Investigator's Discretion|3
1232581|NCT00708162|4042475|P2|Open-Label Phase|Lack of Efficacy|4
1232582|NCT00708162|4042476|P1|Open-Label Phase|Lack of Efficacy|7
1232583|NCT00708162|4042475|P2|Open-Label Phase|Participant Noncompliance|7
1232584|NCT00708162|4042476|P1|Open-Label Phase|Participant Noncompliance|7
1232585|NCT00708162|4042475|P2|Open-Label Phase|Withdrew Consent|6
1232586|NCT00708162|4042476|P1|Open-Label Phase|Withdrew Consent|12
1232587|NCT00708162|4042475|P2|Open-Label Phase|Lost to Follow-up|8
1232588|NCT00708162|4042476|P1|Open-Label Phase|Lost to Follow-up|10
1232589|NCT00708162|4042475|P2|Randomized Phase|Pregnancy|0
1232590|NCT00708162|4042476|P1|Randomized Phase|Pregnancy|3
1232591|NCT00708162|4042475|P2|Randomized Phase|Death|9
1232592|NCT00708162|4042476|P1|Randomized Phase|Death|2
1232593|NCT00708162|4042475|P2|Randomized Phase|Investigator’s Discretion|10
1232594|NCT00708162|4042476|P1|Randomized Phase|Investigator’s Discretion|7
1232595|NCT00708162|4042475|P2|Randomized Phase|Adverse Event|12
1232596|NCT00708162|4042476|P1|Randomized Phase|Adverse Event|8
1232597|NCT00708162|4042475|P2|Randomized Phase|Protocol Violation|11
1232598|NCT00708162|4042476|P1|Randomized Phase|Protocol Violation|10
1232599|NCT00708162|4042475|P2|Randomized Phase|Lack of Efficacy|19
1232600|NCT00708162|4042476|P1|Randomized Phase|Lack of Efficacy|14
1232601|NCT00708162|4042475|P2|Randomized Phase|Withdrew Consent|22
1232602|NCT00708162|4042476|P1|Randomized Phase|Withdrew Consent|31
1232603|NCT00708162|4042475|P2|Randomized Phase|Lost to Follow-up|34
1232604|NCT00708162|4042476|P1|Randomized Phase|Lost to Follow-up|34
1232605|NCT00708162|4042475|P2|Randomized Phase|Participant Noncompliance|32
1232606|NCT00708162|4042476|P1|Randomized Phase|Participant Noncompliance|40
1232607|NCT00708162|4042475|P2|Randomized Phase|Randomized but Not Treated|5
1232608|NCT00708162|4042476|P1|Randomized Phase|Randomized but Not Treated|7
1232609|NCT00708123|4042517|P5|Period 4|Protocol Violation|0
1232610|NCT00708123|4042518|P4|Period 4|Protocol Violation|0
1232611|NCT00708123|4042519|P3|Period 4|Protocol Violation|0
1232612|NCT00708123|4042520|P2|Period 4|Protocol Violation|1
1232613|NCT00708123|4042521|P1|Period 4|Protocol Violation|0
1232614|NCT00708123|4042517|P5|Period 3|Lost to Follow-up|0
1232615|NCT00708123|4042518|P4|Period 3|Lost to Follow-up|1
1232616|NCT00708123|4042519|P3|Period 3|Lost to Follow-up|1
1232617|NCT00708123|4042520|P2|Period 3|Lost to Follow-up|0
1232618|NCT00708123|4042521|P1|Period 3|Lost to Follow-up|0
1232619|NCT00708123|4042517|P5|Period 2|Other Reason|0
1232620|NCT00708123|4042518|P4|Period 2|Other Reason|0
1232621|NCT00708123|4042519|P3|Period 2|Other Reason|0
1232622|NCT00708123|4042520|P2|Period 2|Other Reason|0
1232623|NCT00708123|4042521|P1|Period 2|Other Reason|1
1232624|NCT00708123|4042517|P5|Period 2|Protocol Violation|0
1232625|NCT00708123|4042518|P4|Period 2|Protocol Violation|1
1232626|NCT00708123|4042519|P3|Period 2|Protocol Violation|0
1232627|NCT00708123|4042520|P2|Period 2|Protocol Violation|0
1232628|NCT00708123|4042521|P1|Period 2|Protocol Violation|0
1232629|NCT00708123|4042517|P5|Period 1|Adverse Event|0
1232630|NCT00708123|4042518|P4|Period 1|Adverse Event|0
1232631|NCT00708123|4042519|P3|Period 1|Adverse Event|1
1232632|NCT00708123|4042520|P2|Period 1|Adverse Event|0
1232633|NCT00708123|4042521|P1|Period 1|Adverse Event|0
1232634|NCT00708123|4042517|P5|Period 1|Protocol Violation|0
1232635|NCT00708123|4042518|P4|Period 1|Protocol Violation|1
1232636|NCT00708123|4042519|P3|Period 1|Protocol Violation|0
1232637|NCT00708123|4042520|P2|Period 1|Protocol Violation|1
1232638|NCT00708123|4042521|P1|Period 1|Protocol Violation|0
1232639|NCT00708097|4042654|P5|Period 2|Protocol Violation|0
1232640|NCT00708097|4042655|P4|Period 2|Protocol Violation|1
1232641|NCT00708097|4042656|P3|Period 2|Protocol Violation|1
1232642|NCT00708097|4042657|P2|Period 2|Protocol Violation|1
1232643|NCT00708097|4042658|P1|Period 2|Protocol Violation|0
1232644|NCT00708097|4042654|P5|Period 1|Other Reason|1
1232645|NCT00708097|4042655|P4|Period 1|Other Reason|0
1232646|NCT00708097|4042656|P3|Period 1|Other Reason|0
1232647|NCT00708097|4042657|P2|Period 1|Other Reason|0
1232648|NCT00708097|4042658|P1|Period 1|Other Reason|0
1232649|NCT00708097|4042654|P5|Period 1|Protocol Violation|0
1232650|NCT00708097|4042655|P4|Period 1|Protocol Violation|2
1232651|NCT00708097|4042656|P3|Period 1|Protocol Violation|0
1232652|NCT00708097|4042657|P2|Period 1|Protocol Violation|1
1232653|NCT00708097|4042658|P1|Period 1|Protocol Violation|0
1232654|NCT00708032|4042768|P2|Overall Study|Withdrawal by Subject|1
1232655|NCT00708032|4042769|P1|Overall Study|Withdrawal by Subject|0
1232656|NCT00708032|4042768|P2|Overall Study|Protocol Violation|1
1232657|NCT00708032|4042769|P1|Overall Study|Protocol Violation|4
1232658|NCT00708032|4042768|P2|Overall Study|Did not meet protocol criteria|2
1232659|NCT00708032|4042769|P1|Overall Study|Did not meet protocol criteria|1
1232660|NCT00708032|4042768|P2|Overall Study|Visit out of range at month 12|1
1232661|NCT00708032|4042769|P1|Overall Study|Visit out of range at month 12|4
1232662|NCT00708032|4042768|P2|Overall Study|Poor vision|6
1232663|NCT00708032|4042769|P1|Overall Study|Poor vision|0
1232664|NCT00708032|4042768|P2|Overall Study|Pregnancy|1
1232665|NCT00708032|4042769|P1|Overall Study|Pregnancy|0
1232666|NCT00708032|4042768|P2|Overall Study|Lost to Follow-up|2
1232667|NCT00708032|4042769|P1|Overall Study|Lost to Follow-up|1
1232668|NCT00708032|4042768|P2|Overall Study|Adverse Event|2
1232669|NCT00708032|4042769|P1|Overall Study|Adverse Event|0
1232670|NCT00707993|4042796|P2|Overall Study|Other|0
1232671|NCT00707993|4042797|P1|Overall Study|Other|2
1232672|NCT00707993|4042796|P2|Overall Study|Hyperglycemic Rescue|47
1232673|NCT00707993|4042797|P1|Overall Study|Hyperglycemic Rescue|55
1232674|NCT00707993|4042796|P2|Overall Study|Withdrawal by Subject|16
1232675|NCT00707993|4042797|P1|Overall Study|Withdrawal by Subject|12
1232676|NCT00707993|4042796|P2|Overall Study|Lost to Follow-up|4
1232677|NCT00707993|4042797|P1|Overall Study|Lost to Follow-up|0
1232678|NCT00707993|4042796|P2|Overall Study|Protocol Violation|7
1232679|NCT00707993|4042797|P1|Overall Study|Protocol Violation|4
1232680|NCT00707993|4042796|P2|Overall Study|Adverse Event|20
1232681|NCT00707993|4042797|P1|Overall Study|Adverse Event|16
1232682|NCT00707980|4042839|P1|Overall Study|Other|39
1232683|NCT00707980|4042839|P1|Overall Study|Lost to Follow-up|59
1232684|NCT00707980|4042839|P1|Overall Study|Withdrawal of Consent|81
1232685|NCT00707980|4042839|P1|Overall Study|Protocol Deviations|19
1232686|NCT00707980|4042839|P1|Overall Study|Non-Compliance with Study Drug|28
1232687|NCT00707980|4042839|P1|Overall Study|Lack of Efficacy|35
1232688|NCT00707980|4042839|P1|Overall Study|Adverse Event|49
1232689|NCT00707954|4042923|P5|Overall Study|Physician Decision|1
1232690|NCT00707954|4042924|P4|Overall Study|Physician Decision|0
1232691|NCT00707954|4042925|P3|Overall Study|Physician Decision|0
1232692|NCT00707954|4042926|P2|Overall Study|Physician Decision|0
1232693|NCT00707954|4042927|P1|Overall Study|Physician Decision|0
1232694|NCT00707746|4042968|P2|Treatment Period|Ineligibility|1
1232695|NCT00707746|4042969|P1|Treatment Period|Ineligibility|0
1232696|NCT00707746|4042968|P2|Treatment Period|Adverse Event|4
1232697|NCT00707746|4042969|P1|Treatment Period|Adverse Event|2
1232698|NCT00707577|4043030|P2|Overall Study|Pregnancy|1
1232699|NCT00707577|4043031|P1|Overall Study|Pregnancy|4
1232700|NCT00707577|4043030|P2|Overall Study|Left employment|10
1232701|NCT00707577|4043031|P1|Overall Study|Left employment|13
1232702|NCT00707577|4043030|P2|Overall Study|Lost to Follow-up|25
1232703|NCT00707577|4043031|P1|Overall Study|Lost to Follow-up|34
1232704|NCT00707577|4043030|P2|Overall Study|Withdrawal by Subject|2
1232705|NCT00707577|4043031|P1|Overall Study|Withdrawal by Subject|3
1232706|NCT00707486|4043037|P1|Overall Study|Withdrawal by Subject|1
1232707|NCT00707239|4043080|P3|Overall Study|Other|5
1232708|NCT00707239|4043081|P2|Overall Study|Other|3
1232709|NCT00707239|4043082|P1|Overall Study|Other|8
1232710|NCT00707239|4043080|P3|Overall Study|Randomized, but not treated|1
1232711|NCT00707239|4043081|P2|Overall Study|Randomized, but not treated|1
1232712|NCT00707239|4043082|P1|Overall Study|Randomized, but not treated|1
1232713|NCT00707239|4043080|P3|Overall Study|Lack of Efficacy|0
1232714|NCT00707239|4043081|P2|Overall Study|Lack of Efficacy|2
1232715|NCT00707239|4043082|P1|Overall Study|Lack of Efficacy|1
1232716|NCT00707239|4043080|P3|Overall Study|Protocol Violation|1
1232717|NCT00707239|4043081|P2|Overall Study|Protocol Violation|0
1232718|NCT00707239|4043082|P1|Overall Study|Protocol Violation|0
1232719|NCT00707239|4043080|P3|Overall Study|Physician Decision|2
1232720|NCT00707239|4043081|P2|Overall Study|Physician Decision|1
1232721|NCT00707239|4043082|P1|Overall Study|Physician Decision|1
1232722|NCT00707239|4043080|P3|Overall Study|Death|3
1232723|NCT00707239|4043081|P2|Overall Study|Death|1
1232724|NCT00707239|4043082|P1|Overall Study|Death|3
1232725|NCT00707239|4043080|P3|Overall Study|Adverse Event|2
1232726|NCT00707239|4043081|P2|Overall Study|Adverse Event|3
1232727|NCT00707239|4043082|P1|Overall Study|Adverse Event|5
1232728|NCT00707174|4043130|P2|Overall Study|Withdrawal by Subject|1
1232729|NCT00707174|4043131|P1|Overall Study|Withdrawal by Subject|4
1232730|NCT00707174|4043130|P2|Overall Study|Adverse Event|6
1232731|NCT00707174|4043131|P1|Overall Study|Adverse Event|1
1232732|NCT00707161|4043137|P1|Overall Study|Physician Decision|6
1232733|NCT00707057|4043143|P2|Overall Study|Dosed incorrectly|1
1232734|NCT00707057|4043144|P1|Overall Study|Dosed incorrectly|0
1232735|NCT00707057|4043143|P2|Overall Study|Withdrawal by Subject|3
1232736|NCT00707057|4043144|P1|Overall Study|Withdrawal by Subject|8
1232737|NCT00707031|4043178|P2|Overall Study|Sponsor Decision|8
1232738|NCT00707031|4043179|P1|Overall Study|Sponsor Decision|9
1232739|NCT00707031|4043178|P2|Overall Study|Serious Noncompliance|3
1232740|NCT00707031|4043179|P1|Overall Study|Serious Noncompliance|2
1232741|NCT00707031|4043178|P2|Overall Study|Familial or Personal Reasons|15
1232742|NCT00707031|4043179|P1|Overall Study|Familial or Personal Reasons|12
1232743|NCT00707031|4043178|P2|Overall Study|Poor Compliance to Protocol|13
1232744|NCT00707031|4043179|P1|Overall Study|Poor Compliance to Protocol|7
1232745|NCT00707031|4043178|P2|Overall Study|Withdrawal by Subject|8
1232746|NCT00707031|4043179|P1|Overall Study|Withdrawal by Subject|7
1232747|NCT00707031|4043178|P2|Overall Study|Protocol Violation|0
1232748|NCT00707031|4043179|P1|Overall Study|Protocol Violation|1
1232749|NCT00707031|4043178|P2|Overall Study|Lost to Follow-up|1
1232750|NCT00707031|4043179|P1|Overall Study|Lost to Follow-up|2
1232751|NCT00707031|4043178|P2|Overall Study|Lack of Efficacy|6
1232752|NCT00707031|4043179|P1|Overall Study|Lack of Efficacy|19
1232753|NCT00707031|4043178|P2|Overall Study|Adverse Event|45
1232754|NCT00707031|4043179|P1|Overall Study|Adverse Event|45
1232755|NCT00706992|4043208|P7|Overall Study|Disease progression before treatment|0
1232756|NCT00706992|4043209|P6|Overall Study|Disease progression before treatment|0
1232757|NCT00706992|4043210|P5|Overall Study|Disease progression before treatment|1
1232758|NCT00706992|4043211|P4|Overall Study|Disease progression before treatment|0
1232759|NCT00706992|4043212|P3|Overall Study|Disease progression before treatment|0
1232760|NCT00706992|4043213|P2|Overall Study|Disease progression before treatment|0
1232761|NCT00706992|4043214|P1|Overall Study|Disease progression before treatment|0
1232762|NCT00706992|4043208|P7|Overall Study|Study termination|3
1232763|NCT00706992|4043209|P6|Overall Study|Study termination|2
1232764|NCT00706992|4043210|P5|Overall Study|Study termination|3
1232765|NCT00706992|4043211|P4|Overall Study|Study termination|2
1232766|NCT00706992|4043212|P3|Overall Study|Study termination|6
1232767|NCT00706992|4043213|P2|Overall Study|Study termination|5
1232768|NCT00706992|4043214|P1|Overall Study|Study termination|5
1232769|NCT00706966|4043246|P1|Overall Study|Adverse Event|1
1232770|NCT00706914|4043282|P3|Overall Study|Protocol Violation|1
1232771|NCT00706914|4043283|P2|Overall Study|Protocol Violation|1
1232772|NCT00706914|4043284|P1|Overall Study|Protocol Violation|3
1232773|NCT00706914|4043282|P3|Overall Study|Adverse Event|0
1232774|NCT00706914|4043283|P2|Overall Study|Adverse Event|2
1232775|NCT00706914|4043284|P1|Overall Study|Adverse Event|2
1232776|NCT00706914|4043282|P3|Overall Study|Lost to Follow-up|0
1232777|NCT00706914|4043283|P2|Overall Study|Lost to Follow-up|0
1232778|NCT00706914|4043284|P1|Overall Study|Lost to Follow-up|1
1232779|NCT00706914|4043282|P3|Overall Study|Lack of Efficacy|0
1232780|NCT00706914|4043283|P2|Overall Study|Lack of Efficacy|1
1232781|NCT00706914|4043284|P1|Overall Study|Lack of Efficacy|0
1232782|NCT00706901|4043307|P3|Overall Study|Death|0
1232783|NCT00706901|4043308|P2|Overall Study|Death|0
1232784|NCT00706901|4043309|P1|Overall Study|Death|1
1232785|NCT00706901|4043307|P3|Overall Study|In Jail|1
1232786|NCT00706901|4043308|P2|Overall Study|In Jail|0
1232787|NCT00706901|4043309|P1|Overall Study|In Jail|1
1232788|NCT00706901|4043307|P3|Overall Study|Withdrawal by Subject|5
1232789|NCT00706901|4043308|P2|Overall Study|Withdrawal by Subject|2
1232790|NCT00706901|4043309|P1|Overall Study|Withdrawal by Subject|4
1232791|NCT00706901|4043307|P3|Overall Study|Lost to Follow-up|2
1232792|NCT00706901|4043308|P2|Overall Study|Lost to Follow-up|3
1232793|NCT00706901|4043309|P1|Overall Study|Lost to Follow-up|2
1232794|NCT00706849|4043334|P2|Follow-up Period|Protocol non-compliance|1
1232795|NCT00706849|4043335|P1|Follow-up Period|Protocol non-compliance|0
1232796|NCT00706849|4043334|P2|Follow-up Period|Withdrawal by Subject|2
1232797|NCT00706849|4043335|P1|Follow-up Period|Withdrawal by Subject|0
1232798|NCT00706849|4043334|P2|Treatment Period|Other|1
1232799|NCT00706849|4043335|P1|Treatment Period|Other|0
1232800|NCT00706849|4043334|P2|Treatment Period|Adverse Event|9
1232801|NCT00706849|4043335|P1|Treatment Period|Adverse Event|0
1232802|NCT00706797|4043413|P2|Overall Study|Other|0
1232803|NCT00706797|4043414|P1|Overall Study|Other|1
1232804|NCT00706797|4043413|P2|Overall Study|Lost to Follow-up|2
1232805|NCT00706797|4043414|P1|Overall Study|Lost to Follow-up|1
1232806|NCT00706797|4043413|P2|Overall Study|Protocol Violation|2
1232807|NCT00706797|4043414|P1|Overall Study|Protocol Violation|3
1232808|NCT00706797|4043413|P2|Overall Study|Discontinuation of study by sponsor|63
1232809|NCT00706797|4043414|P1|Overall Study|Discontinuation of study by sponsor|52
1232810|NCT00706797|4043413|P2|Overall Study|Death|0
1232811|NCT00706797|4043414|P1|Overall Study|Death|1
1232812|NCT00706797|4043413|P2|Overall Study|Withdrawal by Subject|1
1232813|NCT00706797|4043414|P1|Overall Study|Withdrawal by Subject|8
1232814|NCT00706797|4043413|P2|Overall Study|Adverse Event|3
1232815|NCT00706797|4043414|P1|Overall Study|Adverse Event|0
1232816|NCT00706797|4043413|P2|Overall Study|Lack of Efficacy|0
1232817|NCT00706797|4043414|P1|Overall Study|Lack of Efficacy|3
1232818|NCT00706706|4043483|P1|Overall Study|Study endpoint had reached|45
1232819|NCT00706706|4043483|P1|Overall Study|Lost to Follow-up|7
1232820|NCT00706706|4043483|P1|Overall Study|Death|53
1232821|NCT00706654|4043493|P4|Depot Maintenance Phase|Impending Relapse without Adverse Event|12
1232822|NCT00706654|4043494|P3|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
1232823|NCT00706654|4043495|P2|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
1232824|NCT00706654|4043496|P1|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
1232825|NCT00706654|4043493|P4|Depot Maintenance Phase|Impending Relapse with Adverse Event|17
1232826|NCT00706654|4043494|P3|Depot Maintenance Phase|Impending Relapse with Adverse Event|12
1232827|NCT00706654|4043495|P2|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
1232828|NCT00706654|4043496|P1|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
1232829|NCT00706654|4043493|P4|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
1232830|NCT00706654|4043494|P3|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
1232831|NCT00706654|4043495|P2|Depot Maintenance Phase|Adverse Event without Impending Relapse|8
1232832|NCT00706654|4043496|P1|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
1232833|NCT00706654|4043493|P4|Depot Maintenance Phase|Protocol Deviation|1
1232834|NCT00706654|4043494|P3|Depot Maintenance Phase|Protocol Deviation|3
1232835|NCT00706654|4043495|P2|Depot Maintenance Phase|Protocol Deviation|2
1232836|NCT00706654|4043496|P1|Depot Maintenance Phase|Protocol Deviation|0
1232837|NCT00706654|4043493|P4|Depot Maintenance Phase|Withdrew Consent|14
1232838|NCT00706654|4043494|P3|Depot Maintenance Phase|Withdrew Consent|29
1232839|NCT00706654|4043495|P2|Depot Maintenance Phase|Withdrew Consent|21
1232840|NCT00706654|4043496|P1|Depot Maintenance Phase|Withdrew Consent|0
1232841|NCT00706654|4043493|P4|Depot Maintenance Phase|Withdrawn by Investigator|8
1232842|NCT00706654|4043494|P3|Depot Maintenance Phase|Withdrawn by Investigator|12
1232843|NCT00706654|4043495|P2|Depot Maintenance Phase|Withdrawn by Investigator|8
1232844|NCT00706654|4043496|P1|Depot Maintenance Phase|Withdrawn by Investigator|0
1232845|NCT00706654|4043493|P4|Depot Maintenance Phase|Met Withdrawal Criteria|5
1232846|NCT00706654|4043494|P3|Depot Maintenance Phase|Met Withdrawal Criteria|6
1232847|NCT00706654|4043495|P2|Depot Maintenance Phase|Met Withdrawal Criteria|4
1232848|NCT00706654|4043496|P1|Depot Maintenance Phase|Met Withdrawal Criteria|0
1232849|NCT00706654|4043493|P4|Depot Maintenance Phase|Lost to Follow-up|6
1232850|NCT00706654|4043494|P3|Depot Maintenance Phase|Lost to Follow-up|10
1232851|NCT00706654|4043495|P2|Depot Maintenance Phase|Lost to Follow-up|4
1232852|NCT00706654|4043496|P1|Depot Maintenance Phase|Lost to Follow-up|0
1232853|NCT00706654|4043493|P4|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
1232854|NCT00706654|4043494|P3|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
1232855|NCT00706654|4043495|P2|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
1232856|NCT00706654|4043496|P1|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10
1232857|NCT00706654|4043493|P4|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
1232858|NCT00706654|4043494|P3|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
1232859|NCT00706654|4043495|P2|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
1232860|NCT00706654|4043496|P1|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20
1232861|NCT00706654|4043493|P4|Oral Stabilization Phase|Adverse Event|0
1232862|NCT00706654|4043494|P3|Oral Stabilization Phase|Adverse Event|0
1232863|NCT00706654|4043495|P2|Oral Stabilization Phase|Adverse Event|0
1232864|NCT00706654|4043496|P1|Oral Stabilization Phase|Adverse Event|21
1232865|NCT00706654|4043493|P4|Oral Stabilization Phase|Protocol Deviation|0
1232866|NCT00706654|4043494|P3|Oral Stabilization Phase|Protocol Deviation|0
1232867|NCT00706654|4043495|P2|Oral Stabilization Phase|Protocol Deviation|0
1232868|NCT00706654|4043496|P1|Oral Stabilization Phase|Protocol Deviation|2
1232869|NCT00706654|4043493|P4|Oral Stabilization Phase|Withdrew consent|0
1232870|NCT00706654|4043494|P3|Oral Stabilization Phase|Withdrew consent|0
1232871|NCT00706654|4043495|P2|Oral Stabilization Phase|Withdrew consent|0
1232872|NCT00706654|4043496|P1|Oral Stabilization Phase|Withdrew consent|55
1232873|NCT00706654|4043493|P4|Oral Stabilization Phase|Withdrawn by Investigator|0
1232874|NCT00706654|4043494|P3|Oral Stabilization Phase|Withdrawn by Investigator|0
1232875|NCT00706654|4043495|P2|Oral Stabilization Phase|Withdrawn by Investigator|0
1232876|NCT00706654|4043496|P1|Oral Stabilization Phase|Withdrawn by Investigator|21
1232877|NCT00706654|4043493|P4|Oral Stabilization Phase|Met Withdrawal Criteria|0
1232878|NCT00706654|4043494|P3|Oral Stabilization Phase|Met Withdrawal Criteria|0
1232879|NCT00706654|4043495|P2|Oral Stabilization Phase|Met Withdrawal Criteria|0
1232880|NCT00706654|4043496|P1|Oral Stabilization Phase|Met Withdrawal Criteria|15
1232881|NCT00706654|4043493|P4|Oral Stabilization Phase|Sponsor Discontinue Trial|0
1232882|NCT00706654|4043494|P3|Oral Stabilization Phase|Sponsor Discontinue Trial|0
1232883|NCT00706654|4043495|P2|Oral Stabilization Phase|Sponsor Discontinue Trial|0
1232884|NCT00706654|4043496|P1|Oral Stabilization Phase|Sponsor Discontinue Trial|19
1232885|NCT00706654|4043493|P4|Oral Stabilization Phase|Lost to Follow-up|0
1232886|NCT00706654|4043494|P3|Oral Stabilization Phase|Lost to Follow-up|0
1232887|NCT00706654|4043495|P2|Oral Stabilization Phase|Lost to Follow-up|0
1232888|NCT00706654|4043496|P1|Oral Stabilization Phase|Lost to Follow-up|17
1232889|NCT00706654|4043493|P4|Conversion Phase|Lack of Efficacy without Adverse Event|0
1232890|NCT00706654|4043494|P3|Conversion Phase|Lack of Efficacy without Adverse Event|0
1232891|NCT00706654|4043495|P2|Conversion Phase|Lack of Efficacy without Adverse Event|0
1232892|NCT00706654|4043496|P1|Conversion Phase|Lack of Efficacy without Adverse Event|2
1232893|NCT00706654|4043493|P4|Conversion Phase|Lack of Efficacy with Adverse Event|0
1232894|NCT00706654|4043494|P3|Conversion Phase|Lack of Efficacy with Adverse Event|0
1232895|NCT00706654|4043495|P2|Conversion Phase|Lack of Efficacy with Adverse Event|0
1232896|NCT00706654|4043496|P1|Conversion Phase|Lack of Efficacy with Adverse Event|9
1232897|NCT00706654|4043493|P4|Conversion Phase|Adverse Event|0
1232898|NCT00706654|4043494|P3|Conversion Phase|Adverse Event|0
1232899|NCT00706654|4043495|P2|Conversion Phase|Adverse Event|0
1232900|NCT00706654|4043496|P1|Conversion Phase|Adverse Event|18
1232901|NCT00706654|4043493|P4|Conversion Phase|Withdrew Consent|0
1232902|NCT00706654|4043494|P3|Conversion Phase|Withdrew Consent|0
1232903|NCT00706654|4043495|P2|Conversion Phase|Withdrew Consent|0
1232904|NCT00706654|4043496|P1|Conversion Phase|Withdrew Consent|38
1232905|NCT00706654|4043493|P4|Conversion Phase|Withdrawn by Investigator|0
1232906|NCT00706654|4043494|P3|Conversion Phase|Withdrawn by Investigator|0
1232907|NCT00706654|4043495|P2|Conversion Phase|Withdrawn by Investigator|0
1232908|NCT00706654|4043496|P1|Conversion Phase|Withdrawn by Investigator|14
1232909|NCT00706654|4043493|P4|Conversion Phase|Met Withdrawal Criteria|0
1232910|NCT00706654|4043494|P3|Conversion Phase|Met Withdrawal Criteria|0
1232911|NCT00706654|4043495|P2|Conversion Phase|Met Withdrawal Criteria|0
1232912|NCT00706654|4043496|P1|Conversion Phase|Met Withdrawal Criteria|2
1232913|NCT00706654|4043493|P4|Conversion Phase|Sponsor Discontinued Trial|0
1232914|NCT00706654|4043494|P3|Conversion Phase|Sponsor Discontinued Trial|0
1232915|NCT00706654|4043495|P2|Conversion Phase|Sponsor Discontinued Trial|0
1232916|NCT00706654|4043496|P1|Conversion Phase|Sponsor Discontinued Trial|8
1232917|NCT00706654|4043493|P4|Conversion Phase|Lost to Follow-up|0
1232918|NCT00706654|4043494|P3|Conversion Phase|Lost to Follow-up|0
1232919|NCT00706654|4043495|P2|Conversion Phase|Lost to Follow-up|0
1232920|NCT00706654|4043496|P1|Conversion Phase|Lost to Follow-up|4
1232921|NCT00706641|4043515|P1|Radical Cystectomy|Deemed unresectable upon exploration|1
1232922|NCT00706641|4043515|P1|Dasatinib Administration|Ineligible after start of therapy|1
1232923|NCT00706641|4043515|P1|Dasatinib Administration|Withdrawal by Subject|1
1232924|NCT00706628|4043529|P4|Overall Study|Not treated|0
1232925|NCT00706628|4043530|P3|Overall Study|Not treated|0
1232926|NCT00706628|4043531|P2|Overall Study|Not treated|1
1232927|NCT00706628|4043532|P1|Overall Study|Not treated|1
1232928|NCT00706628|4043529|P4|Overall Study|Other than those stated above|0
1232929|NCT00706628|4043530|P3|Overall Study|Other than those stated above|0
1232930|NCT00706628|4043531|P2|Overall Study|Other than those stated above|0
1232931|NCT00706628|4043532|P1|Overall Study|Other than those stated above|4
1232932|NCT00706628|4043529|P4|Overall Study|Progressive disease|1
1232933|NCT00706628|4043530|P3|Overall Study|Progressive disease|8
1232934|NCT00706628|4043531|P2|Overall Study|Progressive disease|13
1232935|NCT00706628|4043532|P1|Overall Study|Progressive disease|20
1232936|NCT00706628|4043529|P4|Overall Study|Consent withdrawn|0
1232937|NCT00706628|4043530|P3|Overall Study|Consent withdrawn|3
1232938|NCT00706628|4043531|P2|Overall Study|Consent withdrawn|1
1232939|NCT00706628|4043532|P1|Overall Study|Consent withdrawn|6
1232940|NCT00706628|4043529|P4|Overall Study|Non compliant with protocol|0
1232941|NCT00706628|4043530|P3|Overall Study|Non compliant with protocol|0
1232942|NCT00706628|4043531|P2|Overall Study|Non compliant with protocol|1
1232943|NCT00706628|4043532|P1|Overall Study|Non compliant with protocol|0
1232944|NCT00706628|4043529|P4|Overall Study|Other Adverse Event|2
1232945|NCT00706628|4043530|P3|Overall Study|Other Adverse Event|5
1232946|NCT00706628|4043531|P2|Overall Study|Other Adverse Event|5
1232947|NCT00706628|4043532|P1|Overall Study|Other Adverse Event|16
1232948|NCT00706433|4043692|P4|Overall Study|new job|1
1232949|NCT00706433|4043693|P3|Overall Study|new job|0
1232950|NCT00706433|4043694|P2|Overall Study|new job|0
1232951|NCT00706433|4043695|P1|Overall Study|new job|0
1232952|NCT00706433|4043692|P4|Overall Study|Protocol Violation|0
1232953|NCT00706433|4043693|P3|Overall Study|Protocol Violation|0
1232954|NCT00706433|4043694|P2|Overall Study|Protocol Violation|0
1232955|NCT00706433|4043695|P1|Overall Study|Protocol Violation|1
1232956|NCT00706433|4043692|P4|Overall Study|Adverse Event|0
1232957|NCT00706433|4043693|P3|Overall Study|Adverse Event|1
1232958|NCT00706433|4043694|P2|Overall Study|Adverse Event|0
1232959|NCT00706433|4043695|P1|Overall Study|Adverse Event|0
1232960|NCT00706433|4043692|P4|Overall Study|Withdrawal by Subject|1
1232961|NCT00706433|4043693|P3|Overall Study|Withdrawal by Subject|3
1232962|NCT00706433|4043694|P2|Overall Study|Withdrawal by Subject|2
1232963|NCT00706433|4043695|P1|Overall Study|Withdrawal by Subject|1
1232964|NCT00706433|4043692|P4|Overall Study|Lost to Follow-up|0
1232965|NCT00706433|4043693|P3|Overall Study|Lost to Follow-up|6
1232966|NCT00706433|4043694|P2|Overall Study|Lost to Follow-up|1
1232967|NCT00706433|4043695|P1|Overall Study|Lost to Follow-up|3
1232968|NCT00706355|4044022|P4|Period 4: PF-04217903 150 mg|Objective progression or relapse|2
1232969|NCT00706355|4044023|P3|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
1232970|NCT00706355|4044024|P2|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
1232971|NCT00706355|4044025|P1|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
1232972|NCT00706355|4044022|P4|Period 4: PF-04217903 150 mg|Adverse Event|2
1232973|NCT00706355|4044023|P3|Period 4: PF-04217903 150 mg|Adverse Event|0
1232974|NCT00706355|4044024|P2|Period 4: PF-04217903 150 mg|Adverse Event|0
1232975|NCT00706355|4044025|P1|Period 4: PF-04217903 150 mg|Adverse Event|0
1232976|NCT00706355|4044022|P4|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
1232977|NCT00706355|4044023|P3|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1
1232978|NCT00706355|4044024|P2|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
1232979|NCT00706355|4044025|P1|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
1232980|NCT00706355|4044022|P4|Period 3: PF-04217903 200 mg|Adverse Event|0
1232981|NCT00706355|4044023|P3|Period 3: PF-04217903 200 mg|Adverse Event|1
1232982|NCT00706355|4044024|P2|Period 3: PF-04217903 200 mg|Adverse Event|0
1232983|NCT00706355|4044025|P1|Period 3: PF-04217903 200 mg|Adverse Event|0
1232984|NCT00706355|4044022|P4|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
1232985|NCT00706355|4044023|P3|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
1232986|NCT00706355|4044024|P2|Period 2: PF-04217903 100 mg|Objective progression or relapse|5
1232987|NCT00706355|4044025|P1|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
1232988|NCT00706355|4044022|P4|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
1232989|NCT00706355|4044023|P3|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
1232990|NCT00706355|4044024|P2|Period 2: PF-04217903 100 mg|Global deterioration of health status|1
1232991|NCT00706355|4044025|P1|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
1232992|NCT00706355|4044022|P4|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
1232993|NCT00706355|4044023|P3|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
1232994|NCT00706355|4044024|P2|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1
1232995|NCT00706355|4044025|P1|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
1232996|NCT00706355|4044022|P4|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
1232997|NCT00706355|4044023|P3|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
1232998|NCT00706355|4044024|P2|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
1232999|NCT00706355|4044025|P1|Period 1: PF-04217903 50 mg|Objective progression or relapse|2
1233000|NCT00706355|4044022|P4|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
1233001|NCT00706355|4044023|P3|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
1233002|NCT00706355|4044024|P2|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
1233003|NCT00706355|4044025|P1|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1
1233004|NCT00706342|4044077|P1|Overall Study|WIthdrawal of consent|1
1233005|NCT00706342|4044077|P1|Overall Study|Ongoing|6
1233006|NCT00706342|4044077|P1|Overall Study|Non-responder Week 12|1
1233007|NCT00706342|4044077|P1|Overall Study|Investigator discretion|2
1233008|NCT00706342|4044077|P1|Overall Study|Withdrew from the study on his own.|1
1233009|NCT00706342|4044077|P1|Overall Study|Death|1
1233010|NCT00706342|4044077|P1|Overall Study|Withdrawn due to failure to respond|1
1233011|NCT00706342|4044077|P1|Overall Study|Not responding to treatment|2
1233012|NCT00706342|4044077|P1|Overall Study|Adverse Event|3
1233013|NCT00706134|4044094|P4|Overall Study|Did not meet study criteria|0
1233014|NCT00706134|4044095|P3|Overall Study|Did not meet study criteria|0
1233015|NCT00706134|4044096|P2|Overall Study|Did not meet study criteria|0
1233016|NCT00706134|4044097|P1|Overall Study|Did not meet study criteria|2
1233017|NCT00706134|4044094|P4|Overall Study|Unsatisfactory therapeutic effect|5
1233018|NCT00706134|4044095|P3|Overall Study|Unsatisfactory therapeutic effect|3
1233019|NCT00706134|4044096|P2|Overall Study|Unsatisfactory therapeutic effect|3
1233020|NCT00706134|4044097|P1|Overall Study|Unsatisfactory therapeutic effect|9
1233021|NCT00706134|4044094|P4|Overall Study|Withdrawal by Subject|0
1233022|NCT00706134|4044095|P3|Overall Study|Withdrawal by Subject|1
1233023|NCT00706134|4044096|P2|Overall Study|Withdrawal by Subject|2
1233024|NCT00706134|4044097|P1|Overall Study|Withdrawal by Subject|1
1233025|NCT00706134|4044094|P4|Overall Study|Protocol Violation|3
1233026|NCT00706134|4044095|P3|Overall Study|Protocol Violation|0
1233027|NCT00706134|4044096|P2|Overall Study|Protocol Violation|6
1233028|NCT00706134|4044097|P1|Overall Study|Protocol Violation|0
1233029|NCT00706134|4044094|P4|Overall Study|Lost to Follow-up|0
1233030|NCT00706134|4044095|P3|Overall Study|Lost to Follow-up|0
1233031|NCT00706134|4044096|P2|Overall Study|Lost to Follow-up|1
1233032|NCT00706134|4044097|P1|Overall Study|Lost to Follow-up|0
1233033|NCT00706134|4044094|P4|Overall Study|Adverse Event|3
1233034|NCT00706134|4044095|P3|Overall Study|Adverse Event|2
1233035|NCT00706134|4044096|P2|Overall Study|Adverse Event|7
1233036|NCT00706134|4044097|P1|Overall Study|Adverse Event|8
1233037|NCT00706095|4044163|P3|Overall Study|Withdrawal by Subject|0
1233038|NCT00706095|4044164|P2|Overall Study|Withdrawal by Subject|0
1233039|NCT00706095|4044165|P1|Overall Study|Withdrawal by Subject|1
1233040|NCT00706095|4044163|P3|Overall Study|Clinical Progression|2
1233041|NCT00706095|4044164|P2|Overall Study|Clinical Progression|2
1233042|NCT00706095|4044165|P1|Overall Study|Clinical Progression|1
1233043|NCT00706095|4044163|P3|Overall Study|Progressive Disease|3
1233044|NCT00706095|4044164|P2|Overall Study|Progressive Disease|5
1233045|NCT00706095|4044165|P1|Overall Study|Progressive Disease|4
1233046|NCT00706030|4044183|P4|Overall Study|Death|0
1233047|NCT00706030|4044184|P3|Overall Study|Death|1
1233048|NCT00706030|4044185|P2|Overall Study|Death|0
1233049|NCT00706030|4044186|P1|Overall Study|Death|0
1233050|NCT00706030|4044183|P4|Overall Study|No treatment received|1
1233051|NCT00706030|4044184|P3|Overall Study|No treatment received|0
1233052|NCT00706030|4044185|P2|Overall Study|No treatment received|0
1233053|NCT00706030|4044186|P1|Overall Study|No treatment received|0
1233054|NCT00706030|4044183|P4|Overall Study|Symptomatic Deterioration|0
1233055|NCT00706030|4044184|P3|Overall Study|Symptomatic Deterioration|1
1233056|NCT00706030|4044185|P2|Overall Study|Symptomatic Deterioration|0
1233057|NCT00706030|4044186|P1|Overall Study|Symptomatic Deterioration|0
1233058|NCT00706030|4044183|P4|Overall Study|Failed to return|0
1233059|NCT00706030|4044184|P3|Overall Study|Failed to return|1
1233060|NCT00706030|4044185|P2|Overall Study|Failed to return|0
1233061|NCT00706030|4044186|P1|Overall Study|Failed to return|0
1233062|NCT00706030|4044183|P4|Overall Study|Protocol Violation|1
1233063|NCT00706030|4044184|P3|Overall Study|Protocol Violation|1
1233064|NCT00706030|4044185|P2|Overall Study|Protocol Violation|0
1233065|NCT00706030|4044186|P1|Overall Study|Protocol Violation|0
1233066|NCT00706030|4044183|P4|Overall Study|Not recorded|0
1233067|NCT00706030|4044184|P3|Overall Study|Not recorded|2
1233068|NCT00706030|4044185|P2|Overall Study|Not recorded|0
1233069|NCT00706030|4044186|P1|Overall Study|Not recorded|0
1233070|NCT00706030|4044183|P4|Overall Study|Physician Decision|0
1233071|NCT00706030|4044184|P3|Overall Study|Physician Decision|2
1233072|NCT00706030|4044185|P2|Overall Study|Physician Decision|0
1233073|NCT00706030|4044186|P1|Overall Study|Physician Decision|0
1233074|NCT00706030|4044183|P4|Overall Study|Withdrawal by Subject|0
1233075|NCT00706030|4044184|P3|Overall Study|Withdrawal by Subject|2
1233076|NCT00706030|4044185|P2|Overall Study|Withdrawal by Subject|0
1233077|NCT00706030|4044186|P1|Overall Study|Withdrawal by Subject|1
1233078|NCT00706030|4044183|P4|Overall Study|Adverse Event|2
1233079|NCT00706030|4044184|P3|Overall Study|Adverse Event|4
1233080|NCT00706030|4044185|P2|Overall Study|Adverse Event|0
1233081|NCT00706030|4044186|P1|Overall Study|Adverse Event|1
1233082|NCT00706030|4044183|P4|Overall Study|Disease Progression|12
1233083|NCT00706030|4044184|P3|Overall Study|Disease Progression|46
1233084|NCT00706030|4044185|P2|Overall Study|Disease Progression|6
1233085|NCT00706030|4044186|P1|Overall Study|Disease Progression|4
1233086|NCT00706004|4044201|P1|Overall Study|Did not meet eligibility criteria|2
1233087|NCT00705939|4044229|P3|Overall Study|Physician Decision|0
1233088|NCT00705939|4044230|P2|Overall Study|Physician Decision|1
1233089|NCT00705939|4044231|P1|Overall Study|Physician Decision|0
1233090|NCT00705939|4044229|P3|Overall Study|Withdrawal by Subject|3
1233091|NCT00705939|4044230|P2|Overall Study|Withdrawal by Subject|1
1233092|NCT00705939|4044231|P1|Overall Study|Withdrawal by Subject|0
1233093|NCT00705939|4044229|P3|Overall Study|Protocol Violation|1
1233094|NCT00705939|4044230|P2|Overall Study|Protocol Violation|0
1233095|NCT00705939|4044231|P1|Overall Study|Protocol Violation|0
1233096|NCT00705783|4044285|P3|Depot Maintenance Phase|Impending Relapse without Adverse Event|40
1233097|NCT00705783|4044286|P2|Depot Maintenance Phase|Impending Relapse without Adverse Event|16
1233098|NCT00705783|4044287|P1|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
1233099|NCT00705783|4044285|P3|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
1233100|NCT00705783|4044286|P2|Depot Maintenance Phase|Impending Relapse with Adverse Event|11
1233101|NCT00705783|4044287|P1|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
1233102|NCT00705783|4044285|P3|Depot Maintenance Phase|Adverse Event without Impending Relapse|5
1233103|NCT00705783|4044286|P2|Depot Maintenance Phase|Adverse Event without Impending Relapse|9
1233104|NCT00705783|4044287|P1|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
1233105|NCT00705783|4044285|P3|Depot Maintenance Phase|Protocol Deviation|0
1233106|NCT00705783|4044286|P2|Depot Maintenance Phase|Protocol Deviation|2
1233107|NCT00705783|4044287|P1|Depot Maintenance Phase|Protocol Deviation|0
1233108|NCT00705783|4044285|P3|Depot Maintenance Phase|Withdrew Consent|4
1233109|NCT00705783|4044286|P2|Depot Maintenance Phase|Withdrew Consent|14
1233110|NCT00705783|4044287|P1|Depot Maintenance Phase|Withdrew Consent|0
1233111|NCT00705783|4044285|P3|Depot Maintenance Phase|Withdrawn by Investigator|6
1233112|NCT00705783|4044286|P2|Depot Maintenance Phase|Withdrawn by Investigator|8
1233113|NCT00705783|4044287|P1|Depot Maintenance Phase|Withdrawn by Investigator|0
1233191|NCT00705783|4044287|P1|Conversion Phase|Met Withdrawal Criteria|4
1233114|NCT00705783|4044285|P3|Depot Maintenance Phase|Met Withdrawal Criteria|2
1233115|NCT00705783|4044286|P2|Depot Maintenance Phase|Met Withdrawal Criteria|2
1233116|NCT00705783|4044287|P1|Depot Maintenance Phase|Met Withdrawal Criteria|0
1233117|NCT00705783|4044285|P3|Depot Maintenance Phase|Lost to Follow-up|3
1233118|NCT00705783|4044286|P2|Depot Maintenance Phase|Lost to Follow-up|5
1233119|NCT00705783|4044287|P1|Depot Maintenance Phase|Lost to Follow-up|0
1233120|NCT00705783|4044285|P3|Depot Maintenance Phase|Sponsor Discontinued Study|58
1233121|NCT00705783|4044286|P2|Depot Maintenance Phase|Sponsor Discontinued Study|179
1233122|NCT00705783|4044287|P1|Depot Maintenance Phase|Sponsor Discontinued Study|0
1233123|NCT00705783|4044285|P3|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
1233124|NCT00705783|4044286|P2|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
1233125|NCT00705783|4044287|P1|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1
1233126|NCT00705783|4044285|P3|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
1233127|NCT00705783|4044286|P2|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
1233128|NCT00705783|4044287|P1|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12
1233129|NCT00705783|4044285|P3|Depot Stabilization Phase|Adverse Event|0
1233130|NCT00705783|4044286|P2|Depot Stabilization Phase|Adverse Event|0
1233131|NCT00705783|4044287|P1|Depot Stabilization Phase|Adverse Event|17
1233132|NCT00705783|4044285|P3|Depot Stabilization Phase|Withdrew Consent|0
1233133|NCT00705783|4044286|P2|Depot Stabilization Phase|Withdrew Consent|0
1233134|NCT00705783|4044287|P1|Depot Stabilization Phase|Withdrew Consent|29
1233135|NCT00705783|4044285|P3|Depot Stabilization Phase|Withdrawn by Investigator|0
1233136|NCT00705783|4044286|P2|Depot Stabilization Phase|Withdrawn by Investigator|0
1233137|NCT00705783|4044287|P1|Depot Stabilization Phase|Withdrawn by Investigator|9
1233138|NCT00705783|4044285|P3|Depot Stabilization Phase|Met Withdrawal Criteria|0
1233139|NCT00705783|4044286|P2|Depot Stabilization Phase|Met Withdrawal Criteria|0
1233140|NCT00705783|4044287|P1|Depot Stabilization Phase|Met Withdrawal Criteria|8
1233141|NCT00705783|4044285|P3|Depot Stabilization Phase|Lost to Follow-up|0
1233142|NCT00705783|4044286|P2|Depot Stabilization Phase|Lost to Follow-up|0
1233143|NCT00705783|4044287|P1|Depot Stabilization Phase|Lost to Follow-up|11
1233144|NCT00705783|4044285|P3|Depot Stabilization Phase|Sponsor Discontinued Study|0
1233145|NCT00705783|4044286|P2|Depot Stabilization Phase|Sponsor Discontinued Study|0
1233146|NCT00705783|4044287|P1|Depot Stabilization Phase|Sponsor Discontinued Study|86
1233147|NCT00705783|4044285|P3|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
1233148|NCT00705783|4044286|P2|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
1233149|NCT00705783|4044287|P1|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4
1233150|NCT00705783|4044285|P3|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
1233151|NCT00705783|4044286|P2|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
1233152|NCT00705783|4044287|P1|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7
1233153|NCT00705783|4044285|P3|Oral Stabilization Phase|Adverse Event|0
1233154|NCT00705783|4044286|P2|Oral Stabilization Phase|Adverse Event|0
1233155|NCT00705783|4044287|P1|Oral Stabilization Phase|Adverse Event|14
1233156|NCT00705783|4044285|P3|Oral Stabilization Phase|Withdrew Consent|0
1233157|NCT00705783|4044286|P2|Oral Stabilization Phase|Withdrew Consent|0
1233158|NCT00705783|4044287|P1|Oral Stabilization Phase|Withdrew Consent|29
1233159|NCT00705783|4044285|P3|Oral Stabilization Phase|Withdrawn by Investigator|0
1233160|NCT00705783|4044286|P2|Oral Stabilization Phase|Withdrawn by Investigator|0
1233161|NCT00705783|4044287|P1|Oral Stabilization Phase|Withdrawn by Investigator|12
1233162|NCT00705783|4044285|P3|Oral Stabilization Phase|Met Withdrawal Criteria|0
1233163|NCT00705783|4044286|P2|Oral Stabilization Phase|Met Withdrawal Criteria|0
1233164|NCT00705783|4044287|P1|Oral Stabilization Phase|Met Withdrawal Criteria|19
1233165|NCT00705783|4044285|P3|Oral Stabilization Phase|Lost to Follow-up|0
1233166|NCT00705783|4044286|P2|Oral Stabilization Phase|Lost to Follow-up|0
1233167|NCT00705783|4044287|P1|Oral Stabilization Phase|Lost to Follow-up|7
1233168|NCT00705783|4044285|P3|Oral Stabilization Phase|Sponsor Discontinue Study|0
1233169|NCT00705783|4044286|P2|Oral Stabilization Phase|Sponsor Discontinue Study|0
1233170|NCT00705783|4044287|P1|Oral Stabilization Phase|Sponsor Discontinue Study|42
1233171|NCT00705783|4044285|P3|Conversion Phase|Lack of Efficacy without Adverse Event|0
1233172|NCT00705783|4044286|P2|Conversion Phase|Lack of Efficacy without Adverse Event|0
1233173|NCT00705783|4044287|P1|Conversion Phase|Lack of Efficacy without Adverse Event|8
1233174|NCT00705783|4044285|P3|Conversion Phase|Lack of Efficacy with Adverse Event|0
1233175|NCT00705783|4044286|P2|Conversion Phase|Lack of Efficacy with Adverse Event|0
1233176|NCT00705783|4044287|P1|Conversion Phase|Lack of Efficacy with Adverse Event|13
1233177|NCT00705783|4044285|P3|Conversion Phase|Adverse Event|0
1233178|NCT00705783|4044286|P2|Conversion Phase|Adverse Event|0
1233179|NCT00705783|4044287|P1|Conversion Phase|Adverse Event|11
1233180|NCT00705783|4044285|P3|Conversion Phase|Protocol Deviation|0
1233181|NCT00705783|4044286|P2|Conversion Phase|Protocol Deviation|0
1233182|NCT00705783|4044287|P1|Conversion Phase|Protocol Deviation|2
1233183|NCT00705783|4044285|P3|Conversion Phase|Withdrew Consent|0
1233184|NCT00705783|4044286|P2|Conversion Phase|Withdrew Consent|0
1233185|NCT00705783|4044287|P1|Conversion Phase|Withdrew Consent|24
1233186|NCT00705783|4044285|P3|Conversion Phase|Withdrawn by Investigator|0
1233187|NCT00705783|4044286|P2|Conversion Phase|Withdrawn by Investigator|0
1233188|NCT00705783|4044287|P1|Conversion Phase|Withdrawn by Investigator|4
1233189|NCT00705783|4044285|P3|Conversion Phase|Met Withdrawal Criteria|0
1233190|NCT00705783|4044286|P2|Conversion Phase|Met Withdrawal Criteria|0
1233192|NCT00705783|4044285|P3|Conversion Phase|Lost to Follow-up|0
1233193|NCT00705783|4044286|P2|Conversion Phase|Lost to Follow-up|0
1233194|NCT00705783|4044287|P1|Conversion Phase|Lost to Follow-up|13
1233195|NCT00705783|4044285|P3|Conversion Phase|Sponsor Discontinued Study|0
1233196|NCT00705783|4044286|P2|Conversion Phase|Sponsor Discontinued Study|0
1233197|NCT00705783|4044287|P1|Conversion Phase|Sponsor Discontinued Study|54
1233198|NCT00705757|4044317|P3|Overall Study|Withdrawal by Subject|2
1233199|NCT00705757|4044318|P2|Overall Study|Withdrawal by Subject|1
1233200|NCT00705757|4044319|P1|Overall Study|Withdrawal by Subject|1
1233201|NCT00705757|4044317|P3|Overall Study|Lost to Follow-up|6
1233202|NCT00705757|4044318|P2|Overall Study|Lost to Follow-up|6
1233203|NCT00705757|4044319|P1|Overall Study|Lost to Follow-up|7
1233204|NCT00705757|4044317|P3|Overall Study|Lack of Efficacy|3
1233205|NCT00705757|4044318|P2|Overall Study|Lack of Efficacy|1
1233206|NCT00705757|4044319|P1|Overall Study|Lack of Efficacy|5
1233207|NCT00705718|4044329|P2|Overall Study|Follow up not done|4
1233208|NCT00705718|4044330|P1|Overall Study|Follow up not done|1
1233209|NCT00705718|4044329|P2|Overall Study|Not due for Visit|12
1233210|NCT00705718|4044330|P1|Overall Study|Not due for Visit|0
1233211|NCT00705718|4044329|P2|Overall Study|Death|6
1233212|NCT00705718|4044330|P1|Overall Study|Death|6
1233213|NCT00705679|4044351|P5|Overall Study|Withdrawal by Subject|33
1233214|NCT00705679|4044352|P4|Overall Study|Withdrawal by Subject|47
1233215|NCT00705679|4044353|P3|Overall Study|Withdrawal by Subject|68
1233216|NCT00705679|4044354|P2|Overall Study|Withdrawal by Subject|77
1233217|NCT00705679|4044355|P1|Overall Study|Withdrawal by Subject|32
1233218|NCT00705679|4044351|P5|Overall Study|Physician Decision|0
1233219|NCT00705679|4044352|P4|Overall Study|Physician Decision|1
1233220|NCT00705679|4044353|P3|Overall Study|Physician Decision|0
1233221|NCT00705679|4044354|P2|Overall Study|Physician Decision|1
1233222|NCT00705679|4044355|P1|Overall Study|Physician Decision|0
1233223|NCT00705679|4044351|P5|Overall Study|Lost to Follow-up|35
1233224|NCT00705679|4044352|P4|Overall Study|Lost to Follow-up|30
1233225|NCT00705679|4044353|P3|Overall Study|Lost to Follow-up|44
1233226|NCT00705679|4044354|P2|Overall Study|Lost to Follow-up|60
1233227|NCT00705679|4044355|P1|Overall Study|Lost to Follow-up|32
1233228|NCT00705679|4044351|P5|Overall Study|Death|1
1233229|NCT00705679|4044352|P4|Overall Study|Death|2
1233230|NCT00705679|4044353|P3|Overall Study|Death|3
1233231|NCT00705679|4044354|P2|Overall Study|Death|0
1233232|NCT00705679|4044355|P1|Overall Study|Death|0
1233233|NCT00705679|4044351|P5|Overall Study|Adverse Event|0
1233234|NCT00705679|4044352|P4|Overall Study|Adverse Event|0
1233235|NCT00705679|4044353|P3|Overall Study|Adverse Event|0
1233236|NCT00705679|4044354|P2|Overall Study|Adverse Event|1
1233237|NCT00705679|4044355|P1|Overall Study|Adverse Event|1
1233238|NCT00705666|4044390|P1|Overall Study|Untreated|5
1233239|NCT00705666|4044390|P1|Overall Study|Lack of data|3
1233240|NCT00705666|4044390|P1|Overall Study|Other|2
1233241|NCT00705666|4044390|P1|Overall Study|Not specified|12
1233242|NCT00705666|4044390|P1|Overall Study|Adverse Event|4
1233243|NCT00705666|4044390|P1|Overall Study|Death|1
1233244|NCT00705666|4044390|P1|Overall Study|Lost to Follow-up|5
1233245|NCT00705666|4044390|P1|Overall Study|Physician Decision|7
1233246|NCT00705666|4044390|P1|Overall Study|Withdrawal by Subject|21
1233247|NCT00705666|4044390|P1|Overall Study|No post-treatment questionnaire|279
1233248|NCT00705614|4044401|P2|Switch to Remicade|Administrative Reason|9
1233249|NCT00705614|4044402|P1|Switch to Remicade|Administrative Reason|0
1233250|NCT00705614|4044401|P2|Switch to Remicade|Withdrawal by Subject|12
1233251|NCT00705614|4044402|P1|Switch to Remicade|Withdrawal by Subject|0
1233252|NCT00705614|4044401|P2|Switch to Remicade|Lost to Follow-up|23
1233253|NCT00705614|4044402|P1|Switch to Remicade|Lost to Follow-up|0
1233254|NCT00705614|4044401|P2|Switch to Remicade|Adverse Event|5
1233255|NCT00705614|4044402|P1|Switch to Remicade|Adverse Event|0
1233256|NCT00705614|4044401|P2|Initial Intervention|Status completion unknown|0
1233257|NCT00705614|4044402|P1|Initial Intervention|Status completion unknown|3
1233258|NCT00705614|4044401|P2|Initial Intervention|Administrative Reason|38
1233259|NCT00705614|4044402|P1|Initial Intervention|Administrative Reason|51
1233260|NCT00705614|4044401|P2|Initial Intervention|Withdrawal by Subject|71
1233261|NCT00705614|4044402|P1|Initial Intervention|Withdrawal by Subject|114
1233262|NCT00705614|4044401|P2|Initial Intervention|Lost to Follow-up|191
1233263|NCT00705614|4044402|P1|Initial Intervention|Lost to Follow-up|310
1233264|NCT00705614|4044401|P2|Initial Intervention|Adverse Event|21
1233265|NCT00705614|4044402|P1|Initial Intervention|Adverse Event|40
1233266|NCT00705575|4044451|P2|Overall Study|Withdrawal by Subject|10
1233267|NCT00705575|4044452|P1|Overall Study|Withdrawal by Subject|5
1233268|NCT00705575|4044451|P2|Overall Study|Protocol Violation|2
1233269|NCT00705575|4044452|P1|Overall Study|Protocol Violation|2
1233270|NCT00705575|4044451|P2|Overall Study|Lost to Follow-up|4
1233271|NCT00705575|4044452|P1|Overall Study|Lost to Follow-up|3
1233272|NCT00705575|4044451|P2|Overall Study|Adverse Event|15
1233273|NCT00705575|4044452|P1|Overall Study|Adverse Event|11
1233274|NCT00705575|4044451|P2|Overall Study|Abnormal test procedure result(s)|12
1233275|NCT00705575|4044452|P1|Overall Study|Abnormal test procedure result(s)|2
1233276|NCT00705575|4044451|P2|Overall Study|Abnormal laboratory value(s)|3
1233277|NCT00705575|4044452|P1|Overall Study|Abnormal laboratory value(s)|0
1233278|NCT00705536|4044466|P4|Start Period 1|Withdrawal by Subject|1
1233279|NCT00705536|4044467|P3|Start Period 1|Withdrawal by Subject|0
1233280|NCT00705536|4044468|P2|Start Period 1|Withdrawal by Subject|0
1233281|NCT00705536|4044469|P1|Start Period 1|Withdrawal by Subject|0
1233282|NCT00705523|4044530|P2|Overall Study|Lost to Follow-up|3
1233283|NCT00705523|4044531|P1|Overall Study|Lost to Follow-up|2
1233284|NCT00705484|4044541|P2|Overall Study|Administrative|59
1233285|NCT00705484|4044542|P1|Overall Study|Administrative|89
1233286|NCT00705484|4044541|P2|Overall Study|Withdrawal by Subject|72
1233287|NCT00705484|4044542|P1|Overall Study|Withdrawal by Subject|96
1233288|NCT00705484|4044541|P2|Overall Study|Lost to Follow-up|250
1233289|NCT00705484|4044542|P1|Overall Study|Lost to Follow-up|169
1233290|NCT00705484|4044541|P2|Overall Study|Adverse Event|27
1233291|NCT00705484|4044542|P1|Overall Study|Adverse Event|28
1233292|NCT00705432|4044556|P6|Follow-up Period (Upto Week 72)|Non medical reason|7
1233293|NCT00705432|4044557|P5|Follow-up Period (Upto Week 72)|Non medical reason|6
1233294|NCT00705432|4044558|P4|Follow-up Period (Upto Week 72)|Non medical reason|14
1233295|NCT00705432|4044559|P3|Follow-up Period (Upto Week 72)|Non medical reason|24
1233296|NCT00705432|4044560|P2|Follow-up Period (Upto Week 72)|Non medical reason|42
1233297|NCT00705432|4044561|P1|Follow-up Period (Upto Week 72)|Non medical reason|69
1233298|NCT00705432|4044556|P6|Follow-up Period (Upto Week 72)|Adverse Event|0
1233299|NCT00705432|4044557|P5|Follow-up Period (Upto Week 72)|Adverse Event|0
1233300|NCT00705432|4044558|P4|Follow-up Period (Upto Week 72)|Adverse Event|0
1233301|NCT00705432|4044559|P3|Follow-up Period (Upto Week 72)|Adverse Event|1
1233302|NCT00705432|4044560|P2|Follow-up Period (Upto Week 72)|Adverse Event|1
1233303|NCT00705432|4044561|P1|Follow-up Period (Upto Week 72)|Adverse Event|2
1233304|NCT00705432|4044556|P6|Treatment Period|Non medical reason|7
1233305|NCT00705432|4044557|P5|Treatment Period|Non medical reason|7
1233306|NCT00705432|4044558|P4|Treatment Period|Non medical reason|4
1233307|NCT00705432|4044559|P3|Treatment Period|Non medical reason|37
1233308|NCT00705432|4044560|P2|Treatment Period|Non medical reason|32
1233309|NCT00705432|4044561|P1|Treatment Period|Non medical reason|26
1233310|NCT00705432|4044556|P6|Treatment Period|Treatment failure|14
1233311|NCT00705432|4044557|P5|Treatment Period|Treatment failure|13
1233312|NCT00705432|4044558|P4|Treatment Period|Treatment failure|25
1233313|NCT00705432|4044559|P3|Treatment Period|Treatment failure|33
1233314|NCT00705432|4044560|P2|Treatment Period|Treatment failure|42
1233315|NCT00705432|4044561|P1|Treatment Period|Treatment failure|92
1233316|NCT00705432|4044556|P6|Treatment Period|Adverse Event|9
1233317|NCT00705432|4044557|P5|Treatment Period|Adverse Event|8
1233318|NCT00705432|4044558|P4|Treatment Period|Adverse Event|12
1233319|NCT00705432|4044559|P3|Treatment Period|Adverse Event|51
1233320|NCT00705432|4044560|P2|Treatment Period|Adverse Event|37
1233321|NCT00705432|4044561|P1|Treatment Period|Adverse Event|45
1233322|NCT00705406|4044598|P2|Overall Study|Did not receive study drug|2
1233323|NCT00705406|4044599|P1|Overall Study|Did not receive study drug|1
1233324|NCT00705406|4044598|P2|Overall Study|Lost to Follow-up|3
1233325|NCT00705406|4044599|P1|Overall Study|Lost to Follow-up|3
1233326|NCT00705367|4044623|P2|Long-term Extension Period|Administrative reason by sponsor|0
1233327|NCT00705367|4044624|P1|Long-term Extension Period|Administrative reason by sponsor|3
1233328|NCT00705367|4044623|P2|Long-term Extension Period|No longer met study criteria|0
1233329|NCT00705367|4044624|P1|Long-term Extension Period|No longer met study criteria|1
1233330|NCT00705367|4044623|P2|Long-term Extension Period|Lack of Efficacy|0
1233331|NCT00705367|4044624|P1|Long-term Extension Period|Lack of Efficacy|1
1233332|NCT00705367|4044623|P2|Long-term Extension Period|Withdrawal by Subject|0
1233333|NCT00705367|4044624|P1|Long-term Extension Period|Withdrawal by Subject|2
1233334|NCT00705367|4044623|P2|Long-term Extension Period|Adverse Event|0
1233335|NCT00705367|4044624|P1|Long-term Extension Period|Adverse Event|2
1233336|NCT00705341|4044651|P4|Phase 2: Trial|Did not meet post-diluent threshold|0
1233337|NCT00705341|4044652|P3|Phase 2: Trial|Did not meet post-diluent threshold|1
1233338|NCT00705341|4044653|P2|Phase 2: Trial|Did not meet post-diluent threshold|0
1233339|NCT00705341|4044654|P1|Phase 2: Trial|Did not meet post-diluent threshold|0
1233340|NCT00705341|4044651|P4|Phase 2: Trial|Withdrawal by Subject|4
1233341|NCT00705341|4044652|P3|Phase 2: Trial|Withdrawal by Subject|6
1233342|NCT00705341|4044653|P2|Phase 2: Trial|Withdrawal by Subject|0
1233343|NCT00705341|4044654|P1|Phase 2: Trial|Withdrawal by Subject|0
1233344|NCT00705289|4044662|P1|Overall Study|Subject or treating physician's choice|131
1233345|NCT00705263|4044686|P1|Overall Study|Withdrawal by Subject|2
1233346|NCT00705250|4044690|P1|Overall Study|Patient died in car accident|1
1233347|NCT00705250|4044690|P1|Overall Study|Withdrawal by Subject|1
1233348|NCT00705224|4044694|P1|Overall Study|Lost to Follow-up|5
1233349|NCT00705224|4044694|P1|Overall Study|Withdrawal by Subject|3
1233350|NCT00705224|4044694|P1|Overall Study|Lack of Efficacy|2
1233351|NCT00705224|4044694|P1|Overall Study|Adverse Event|1
1233352|NCT00705159|4044710|P4|Overall Study|Screen Failure|1
1233353|NCT00705159|4044711|P3|Overall Study|Screen Failure|0
1233354|NCT00705159|4044712|P2|Overall Study|Screen Failure|0
1233355|NCT00705159|4044713|P1|Overall Study|Screen Failure|0
1233356|NCT00705159|4044710|P4|Overall Study|Lost to Follow-up|2
1233357|NCT00705159|4044711|P3|Overall Study|Lost to Follow-up|3
1233358|NCT00705159|4044712|P2|Overall Study|Lost to Follow-up|0
1233359|NCT00705159|4044713|P1|Overall Study|Lost to Follow-up|0
1233360|NCT00705159|4044710|P4|Overall Study|Adverse Event|0
1233361|NCT00705159|4044711|P3|Overall Study|Adverse Event|1
1233362|NCT00705159|4044712|P2|Overall Study|Adverse Event|0
1233363|NCT00705159|4044713|P1|Overall Study|Adverse Event|0
1233364|NCT00705159|4044710|P4|Overall Study|Protocol Violation|0
1233365|NCT00705159|4044711|P3|Overall Study|Protocol Violation|0
1233366|NCT00705159|4044712|P2|Overall Study|Protocol Violation|1
1233367|NCT00705159|4044713|P1|Overall Study|Protocol Violation|0
1233368|NCT00705159|4044710|P4|Overall Study|Withdrawal by Subject|1
1233369|NCT00705159|4044711|P3|Overall Study|Withdrawal by Subject|1
1233370|NCT00705159|4044712|P2|Overall Study|Withdrawal by Subject|1
1233371|NCT00705159|4044713|P1|Overall Study|Withdrawal by Subject|0
1233372|NCT00705146|4044733|P2|Overall Study|Lost to Follow-up|1
1233373|NCT00705146|4044734|P1|Overall Study|Lost to Follow-up|1
1233374|NCT00705016|4044763|P3|Overall Study|Other|6
1233375|NCT00705016|4044764|P2|Overall Study|Other|6
1233376|NCT00705016|4044765|P1|Overall Study|Other|9
1233377|NCT00705016|4044763|P3|Overall Study|Symptomatic Deterioration|1
1233378|NCT00705016|4044764|P2|Overall Study|Symptomatic Deterioration|1
1233379|NCT00705016|4044765|P1|Overall Study|Symptomatic Deterioration|3
1233380|NCT00705016|4044763|P3|Overall Study|Progressive Disease|33
1233381|NCT00705016|4044764|P2|Overall Study|Progressive Disease|29
1233382|NCT00705016|4044765|P1|Overall Study|Progressive Disease|33
1233383|NCT00705016|4044763|P3|Overall Study|Withdrawal by Subject|2
1233384|NCT00705016|4044764|P2|Overall Study|Withdrawal by Subject|3
1233385|NCT00705016|4044765|P1|Overall Study|Withdrawal by Subject|4
1233386|NCT00705016|4044763|P3|Overall Study|Protocol Violation|1
1233387|NCT00705016|4044764|P2|Overall Study|Protocol Violation|1
1233388|NCT00705016|4044765|P1|Overall Study|Protocol Violation|0
1233389|NCT00705016|4044763|P3|Overall Study|Death|5
1233390|NCT00705016|4044764|P2|Overall Study|Death|7
1233391|NCT00705016|4044765|P1|Overall Study|Death|5
1233392|NCT00705016|4044763|P3|Overall Study|Adverse Event|10
1233393|NCT00705016|4044764|P2|Overall Study|Adverse Event|11
1233394|NCT00705016|4044765|P1|Overall Study|Adverse Event|6
1233395|NCT00704964|4044816|P1|Overall Study|Not completed on time|328
1233396|NCT00704808|4044865|P1|Overall Study|Treatment change|1
1233397|NCT00704808|4044865|P1|Overall Study|Lost to Follow-up|1
1233398|NCT00704808|4044865|P1|Overall Study|Adverse Event|1
1233399|NCT00704808|4044865|P1|Overall Study|Early therapy discontinuation|16
1233400|NCT00704808|4044865|P1|Overall Study|Patient's decision|11
1233401|NCT00704808|4044865|P1|Overall Study|Tumor progression|80
1233402|NCT00704808|4044865|P1|Overall Study|Death|7
1233403|NCT00704808|4044865|P1|Overall Study|Discontinued prior to starting treatment|14
1233404|NCT00704730|4044876|P2|Overall Study|Withdrawal by Subject|13
1233405|NCT00704730|4044877|P1|Overall Study|Withdrawal by Subject|9
1233406|NCT00704730|4044876|P2|Overall Study|data unavailable|0
1233407|NCT00704730|4044877|P1|Overall Study|data unavailable|1
1233408|NCT00704730|4044876|P2|Overall Study|Disease progression per PI|67
1233409|NCT00704730|4044877|P1|Overall Study|Disease progression per PI|58
1233410|NCT00704730|4044876|P2|Overall Study|Did not receive drug|2
1233411|NCT00704730|4044877|P1|Overall Study|Did not receive drug|5
1233412|NCT00704730|4044876|P2|Overall Study|Physician Decision|0
1233413|NCT00704730|4044877|P1|Overall Study|Physician Decision|2
1233414|NCT00704730|4044876|P2|Overall Study|Death|5
1233415|NCT00704730|4044877|P1|Overall Study|Death|11
1233416|NCT00704730|4044876|P2|Overall Study|Adverse Event|9
1233417|NCT00704730|4044877|P1|Overall Study|Adverse Event|35
1233418|NCT00704535|4044897|P1|Overall Study|Completed status not on Case Report Form|124
1233419|NCT00704535|4044897|P1|Overall Study|Protocol Violation|10
1233420|NCT00704535|4044897|P1|Overall Study|Lost to Follow-up|8
1233421|NCT00704535|4044897|P1|Overall Study|Death|2
1233422|NCT00704535|4044897|P1|Overall Study|Adverse Event|2
1233423|NCT00704522|4044910|P2|Overall Study|No information on therapy end|2
1233424|NCT00704522|4044911|P1|Overall Study|No information on therapy end|27
1233425|NCT00704522|4044910|P2|Overall Study|Undefined causes|7
1233426|NCT00704522|4044911|P1|Overall Study|Undefined causes|9
1233427|NCT00704522|4044910|P2|Overall Study|Adverse Event|1
1233428|NCT00704522|4044911|P1|Overall Study|Adverse Event|9
1233429|NCT00704522|4044910|P2|Overall Study|Withdrawal by Subject|8
1233430|NCT00704522|4044911|P1|Overall Study|Withdrawal by Subject|17
1233431|NCT00704522|4044910|P2|Overall Study|Failure to appear again at hospital|10
1233432|NCT00704522|4044911|P1|Overall Study|Failure to appear again at hospital|56
1233433|NCT00704522|4044910|P2|Overall Study|Lack of Efficacy|17
1233434|NCT00704522|4044911|P1|Overall Study|Lack of Efficacy|65
1233435|NCT00704418|4044931|P2|Overall Study|Over-enrolled/surgery postponed|6
1233436|NCT00704418|4044932|P1|Overall Study|Over-enrolled/surgery postponed|3
1233437|NCT00704418|4044931|P2|Overall Study|Withdrawal by Subject|0
1233438|NCT00704418|4044932|P1|Overall Study|Withdrawal by Subject|2
1233439|NCT00704405|4044945|P5|Overall Study (C Population)|Lost to Follow-up|0
1233440|NCT00704405|4044946|P4|Overall Study (C Population)|Lost to Follow-up|0
1233441|NCT00704405|4044947|P3|Overall Study (C Population)|Lost to Follow-up|0
1233442|NCT00704405|4044948|P2|Overall Study (C Population)|Lost to Follow-up|2
1233443|NCT00704405|4044949|P1|Overall Study (C Population)|Lost to Follow-up|0
1233444|NCT00704405|4044945|P5|Overall Study (C Population)|Withdrawal by Subject|0
1233445|NCT00704405|4044946|P4|Overall Study (C Population)|Withdrawal by Subject|1
1233446|NCT00704405|4044947|P3|Overall Study (C Population)|Withdrawal by Subject|1
1233447|NCT00704405|4044948|P2|Overall Study (C Population)|Withdrawal by Subject|1
1233448|NCT00704405|4044949|P1|Overall Study (C Population)|Withdrawal by Subject|1
1233449|NCT00704405|4044945|P5|Overall Study (NC Population)|Other|1
1233450|NCT00704405|4044946|P4|Overall Study (NC Population)|Other|0
1233451|NCT00704405|4044947|P3|Overall Study (NC Population)|Other|0
1233452|NCT00704405|4044948|P2|Overall Study (NC Population)|Other|0
1233453|NCT00704405|4044949|P1|Overall Study (NC Population)|Other|0
1233454|NCT00704405|4044945|P5|Overall Study (NC Population)|Withdrawal by Subject|2
1233455|NCT00704405|4044946|P4|Overall Study (NC Population)|Withdrawal by Subject|2
1233456|NCT00704405|4044947|P3|Overall Study (NC Population)|Withdrawal by Subject|2
1233457|NCT00704405|4044948|P2|Overall Study (NC Population)|Withdrawal by Subject|3
1233458|NCT00704405|4044949|P1|Overall Study (NC Population)|Withdrawal by Subject|2
1233459|NCT00704405|4044945|P5|Overall Study (NC Population)|Lost to Follow-up|2
1233460|NCT00704405|4044946|P4|Overall Study (NC Population)|Lost to Follow-up|2
1233461|NCT00704405|4044947|P3|Overall Study (NC Population)|Lost to Follow-up|1
1233462|NCT00704405|4044948|P2|Overall Study (NC Population)|Lost to Follow-up|1
1233463|NCT00704405|4044949|P1|Overall Study (NC Population)|Lost to Follow-up|2
1233464|NCT00704405|4044945|P5|Overall Study (NC Population)|Adverse Event|0
1233465|NCT00704405|4044946|P4|Overall Study (NC Population)|Adverse Event|0
1233466|NCT00704405|4044947|P3|Overall Study (NC Population)|Adverse Event|0
1233467|NCT00704405|4044948|P2|Overall Study (NC Population)|Adverse Event|0
1233468|NCT00704405|4044949|P1|Overall Study (NC Population)|Adverse Event|1
1233469|NCT00704340|4045007|P2|Overall Study|Death|1
1233470|NCT00704340|4045008|P1|Overall Study|Death|0
1233471|NCT00704340|4045007|P2|Overall Study|Lost to Follow-up|1
1233472|NCT00704340|4045008|P1|Overall Study|Lost to Follow-up|2
1233473|NCT00704184|4045023|P5|Open-Label Treatment|Withdrawal by Subject|0
1233474|NCT00704184|4045024|P4|Open-Label Treatment|Withdrawal by Subject|3
1233475|NCT00704184|4045025|P3|Open-Label Treatment|Withdrawal by Subject|0
1233476|NCT00704184|4045026|P2|Open-Label Treatment|Withdrawal by Subject|0
1233477|NCT00704184|4045027|P1|Open-Label Treatment|Withdrawal by Subject|1
1233478|NCT00704184|4045023|P5|Open-Label Treatment|Physician Decision|1
1233479|NCT00704184|4045024|P4|Open-Label Treatment|Physician Decision|0
1233480|NCT00704184|4045025|P3|Open-Label Treatment|Physician Decision|0
1233481|NCT00704184|4045026|P2|Open-Label Treatment|Physician Decision|0
1233482|NCT00704184|4045027|P1|Open-Label Treatment|Physician Decision|0
1233483|NCT00704184|4045023|P5|Open-Label Treatment|Lack of Efficacy|1
1233484|NCT00704184|4045024|P4|Open-Label Treatment|Lack of Efficacy|2
1233485|NCT00704184|4045025|P3|Open-Label Treatment|Lack of Efficacy|2
1233486|NCT00704184|4045026|P2|Open-Label Treatment|Lack of Efficacy|2
1233487|NCT00704184|4045027|P1|Open-Label Treatment|Lack of Efficacy|0
1233488|NCT00704184|4045023|P5|Open-Label Treatment|Adverse Event|1
1233489|NCT00704184|4045024|P4|Open-Label Treatment|Adverse Event|0
1233490|NCT00704184|4045025|P3|Open-Label Treatment|Adverse Event|2
1233491|NCT00704184|4045026|P2|Open-Label Treatment|Adverse Event|0
1233492|NCT00704184|4045027|P1|Open-Label Treatment|Adverse Event|0
1233493|NCT00704184|4045023|P5|Double-Blind Treatment|Withdrawal by Subject|0
1233494|NCT00704184|4045024|P4|Double-Blind Treatment|Withdrawal by Subject|0
1233495|NCT00704184|4045025|P3|Double-Blind Treatment|Withdrawal by Subject|0
1233496|NCT00704184|4045026|P2|Double-Blind Treatment|Withdrawal by Subject|0
1233497|NCT00704184|4045027|P1|Double-Blind Treatment|Withdrawal by Subject|1
1233498|NCT00704171|4045066|P2|Overall Study|Withdrawal by Subject|0
1233499|NCT00704171|4045067|P1|Overall Study|Withdrawal by Subject|1
1233500|NCT00704132|4045085|P2|Overall Study|Withdrawal by Subject|1
1233501|NCT00704132|4045086|P1|Overall Study|Withdrawal by Subject|0
1233502|NCT00704132|4045085|P2|Overall Study|Lack of Efficacy|1
1233503|NCT00704132|4045086|P1|Overall Study|Lack of Efficacy|0
1233504|NCT00704132|4045085|P2|Overall Study|Clinical Adverse Experience|0
1233505|NCT00704132|4045086|P1|Overall Study|Clinical Adverse Experience|1
1233506|NCT00703963|4045114|P2|Overall Study|Physician Decision|1
1233507|NCT00703963|4045115|P1|Overall Study|Physician Decision|0
1233508|NCT00703963|4045114|P2|Overall Study|Withdrawal by Subject|13
1233509|NCT00703963|4045115|P1|Overall Study|Withdrawal by Subject|7
1233510|NCT00703924|4045136|P2|Overall Study|Withdrawal by Subject|1
1233511|NCT00703924|4045137|P1|Overall Study|Withdrawal by Subject|1
1233512|NCT00703911|4045153|P1|Overall Study|Withdrawal by Subject|2
1233513|NCT00703911|4045153|P1|Overall Study|Lost to Follow-up|1
1233514|NCT00703911|4045153|P1|Overall Study|Physician Decision|6
1233515|NCT00703911|4045153|P1|Overall Study|Death|1
1233516|NCT00703846|4045186|P1|Overall Study|Did Not Receive Study Drug|2
1233517|NCT00703846|4045186|P1|Overall Study|Other|14
1233518|NCT00703846|4045186|P1|Overall Study|Death|1
1233519|NCT00703846|4045186|P1|Overall Study|Withdrawal by Subject|40
1233520|NCT00703846|4045186|P1|Overall Study|Noncompliance with Study Treatment|2
1233521|NCT00703846|4045186|P1|Overall Study|Lack of Efficacy|15
1233522|NCT00703846|4045186|P1|Overall Study|Lost to Follow-up|55
1233523|NCT00703846|4045186|P1|Overall Study|Adverse Event|8
1233524|NCT00703820|4045202|P2|Overall Study|Withdrawal by Subject|1
1233525|NCT00703820|4045203|P1|Overall Study|Withdrawal by Subject|2
1233526|NCT00703820|4045202|P2|Overall Study|Physician Decision|5
1233527|NCT00703820|4045203|P1|Overall Study|Physician Decision|4
1233528|NCT00703820|4045202|P2|Overall Study|Received non-protocol therapy|0
1233529|NCT00703820|4045203|P1|Overall Study|Received non-protocol therapy|1
1233530|NCT00703820|4045202|P2|Overall Study|Lack of Efficacy|11
1233531|NCT00703820|4045203|P1|Overall Study|Lack of Efficacy|11
1233532|NCT00703820|4045202|P2|Overall Study|Death|0
1233533|NCT00703820|4045203|P1|Overall Study|Death|5
1233534|NCT00703820|4045202|P2|Overall Study|Adverse Event|17
1233535|NCT00703820|4045203|P1|Overall Study|Adverse Event|12
1233536|NCT00703781|4045212|P2|Overall Study|Cancelled surgery|0
1233537|NCT00703781|4045213|P1|Overall Study|Cancelled surgery|1
1233538|NCT00703781|4045212|P2|Overall Study|Withdrawal by Subject|2
1233539|NCT00703781|4045213|P1|Overall Study|Withdrawal by Subject|1
1233540|NCT00703677|4045258|P1|Overall Study|Dropout-withdrawal not related to drug|3
1233541|NCT00703534|4045298|P2|Overall Study|Severe Non Compliance|5
1233542|NCT00703534|4045299|P1|Overall Study|Severe Non Compliance|1
1233543|NCT00703534|4045298|P2|Overall Study|Lost to Follow-up|4
1233544|NCT00703534|4045299|P1|Overall Study|Lost to Follow-up|1
1233545|NCT00703534|4045298|P2|Overall Study|Incorrect Enrollment|6
1233546|NCT00703534|4045299|P1|Overall Study|Incorrect Enrollment|6
1233547|NCT00703534|4045298|P2|Overall Study|Withdrawal by Subject|7
1233548|NCT00703534|4045299|P1|Overall Study|Withdrawal by Subject|8
1233549|NCT00703534|4045298|P2|Overall Study|Adverse Event|3
1233550|NCT00703534|4045299|P1|Overall Study|Adverse Event|14
1233551|NCT00703326|4045371|P2|Overall Study|Withdrawal by Subject|20
1233552|NCT00703326|4045372|P1|Overall Study|Withdrawal by Subject|42
1233553|NCT00703326|4045371|P2|Overall Study|Lost to Follow-up|8
1233554|NCT00703326|4045372|P1|Overall Study|Lost to Follow-up|25
1233555|NCT00703326|4045371|P2|Overall Study|Still on study|197
1233556|NCT00703326|4045372|P1|Overall Study|Still on study|380
1233557|NCT00703157|4045404|P2|Overall Study|source data permanently lost/ other|1
1233558|NCT00703157|4045405|P1|Overall Study|source data permanently lost/ other|4
1233559|NCT00703157|4045404|P2|Overall Study|Lost to Follow-up|1
1233560|NCT00703157|4045405|P1|Overall Study|Lost to Follow-up|0
1233561|NCT00703118|4045439|P3|Overall Study|Not specified|1
1233562|NCT00703118|4045440|P2|Overall Study|Not specified|0
1233563|NCT00703118|4045441|P1|Overall Study|Not specified|0
1233564|NCT00703118|4045439|P3|Overall Study|Withdrawal by Subject|13
1233565|NCT00703118|4045440|P2|Overall Study|Withdrawal by Subject|7
1233566|NCT00703118|4045441|P1|Overall Study|Withdrawal by Subject|8
1233567|NCT00703118|4045439|P3|Overall Study|Lost to Follow-up|4
1233568|NCT00703118|4045440|P2|Overall Study|Lost to Follow-up|4
1233569|NCT00703118|4045441|P1|Overall Study|Lost to Follow-up|6
1233570|NCT00703118|4045439|P3|Overall Study|Subject Ineligible To Continue The Trial|2
1233571|NCT00703118|4045440|P2|Overall Study|Subject Ineligible To Continue The Trial|3
1233572|NCT00703118|4045441|P1|Overall Study|Subject Ineligible To Continue The Trial|6
1233573|NCT00703118|4045439|P3|Overall Study|Adverse Event|2
1233574|NCT00703118|4045440|P2|Overall Study|Adverse Event|2
1233575|NCT00703118|4045441|P1|Overall Study|Adverse Event|1
1233576|NCT00703092|4045472|P1|Overall Study|Withdrawal by Subject|2
1233577|NCT00703014|4045680|P4|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42
1233578|NCT00703014|4045681|P3|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47
1233579|NCT00703014|4045682|P2|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
1233580|NCT00703014|4045683|P1|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
1233581|NCT00703014|4045680|P4|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
1233582|NCT00703014|4045681|P3|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
1233583|NCT00703014|4045682|P2|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32
1233584|NCT00703014|4045683|P1|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33
1233585|NCT00702962|4045703|P2|Overall Study|Hospitalized for other health disorder|0
1233586|NCT00702962|4045704|P1|Overall Study|Hospitalized for other health disorder|1
1233587|NCT00702962|4045703|P2|Overall Study|Progressive disease|1
1233588|NCT00702962|4045704|P1|Overall Study|Progressive disease|0
1233589|NCT00702949|4045715|P3|Overall Study|Other Medical Reason/unknown|3
1233590|NCT00702949|4045716|P2|Overall Study|Other Medical Reason/unknown|1
1233591|NCT00702949|4045717|P1|Overall Study|Other Medical Reason/unknown|1
1233592|NCT00702949|4045715|P3|Overall Study|Adverse Event|3
1233593|NCT00702949|4045716|P2|Overall Study|Adverse Event|6
1233594|NCT00702949|4045717|P1|Overall Study|Adverse Event|1
1233595|NCT00702949|4045715|P3|Overall Study|Refusal|2
1233596|NCT00702949|4045716|P2|Overall Study|Refusal|2
1233597|NCT00702949|4045717|P1|Overall Study|Refusal|3
1233598|NCT00702923|4045742|P1|Overall Study|Adverse Event|1
1233599|NCT00702845|4045765|P2|Overall Study|Not randomized|1
1233600|NCT00702845|4045766|P1|Overall Study|Not randomized|0
1233601|NCT00702845|4045765|P2|Overall Study|Patient's decision|1
1233602|NCT00702845|4045766|P1|Overall Study|Patient's decision|2
1233603|NCT00702845|4045765|P2|Overall Study|No or abnormal fertilization|2
1233604|NCT00702845|4045766|P1|Overall Study|No or abnormal fertilization|4
1233605|NCT00702845|4045765|P2|Overall Study|No/too few/bad quality embryos retrieved|1
1233606|NCT00702845|4045766|P1|Overall Study|No/too few/bad quality embryos retrieved|7
1233607|NCT00702845|4045765|P2|Overall Study|Insufficient ovarian response|0
1233608|NCT00702845|4045766|P1|Overall Study|Insufficient ovarian response|1
1233609|NCT00702845|4045765|P2|Overall Study|Risk of ovarian hyperstimulation synd.|0
1233610|NCT00702845|4045766|P1|Overall Study|Risk of ovarian hyperstimulation synd.|1
1233611|NCT00702845|4045765|P2|Overall Study|Too high ovarian response|1
1233612|NCT00702845|4045766|P1|Overall Study|Too high ovarian response|5
1233613|NCT00702845|4045765|P2|Overall Study|No/too few/bad quality oocytes retrieved|2
1233614|NCT00702845|4045766|P1|Overall Study|No/too few/bad quality oocytes retrieved|2
1233615|NCT00702715|4045828|P2|Overall Study|Lost to Follow-up|0
1233616|NCT00702715|4045829|P1|Overall Study|Lost to Follow-up|1
1233617|NCT00702702|4045842|P1|Overall Study|Study prematurely terminated|56
1233618|NCT00702689|4045850|P1|Overall Study|Adverse Event|1
1233619|NCT00702689|4045850|P1|Overall Study|Recurrent malignancy|1
1233620|NCT00702689|4045850|P1|Overall Study|Withdrawal by Subject|4
1233621|NCT00702650|4045861|P1|Overall Study|Adverse Event|3
1233622|NCT00702650|4045861|P1|Overall Study|Screening Testosterone Levels >300 ng/dL|1
1233623|NCT00702650|4045861|P1|Overall Study|Sponsor Request|1
1233624|NCT00702650|4045861|P1|Overall Study|Non-Compliance with Site Directives|1
1233625|NCT00702650|4045861|P1|Overall Study|Lost to Follow-up|2
1233626|NCT00702650|4045861|P1|Overall Study|Non-Compliance of Study Drug|3
1233627|NCT00702650|4045861|P1|Overall Study|Withdrawal by Subject|9
1233628|NCT00702520|4045923|P4|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
1233629|NCT00702520|4045924|P3|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
1233630|NCT00702520|4045925|P2|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10
1233631|NCT00702520|4045926|P1|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15
1233632|NCT00702520|4045923|P4|Base Study P05788 - Embryo Transfer|No embryo transfer|0
1233633|NCT00702520|4045924|P3|Base Study P05788 - Embryo Transfer|No embryo transfer|0
1233634|NCT00702520|4045925|P2|Base Study P05788 - Embryo Transfer|No embryo transfer|6
1233635|NCT00702520|4045926|P1|Base Study P05788 - Embryo Transfer|No embryo transfer|3
1233636|NCT00702520|4045923|P4|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
1233637|NCT00702520|4045924|P3|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
1233638|NCT00702520|4045925|P2|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1
1233639|NCT00702520|4045926|P1|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
1233640|NCT00702507|4045942|P1|Follow-up Phase|Late Enrollment|1
1233641|NCT00702507|4045942|P1|Follow-up Phase|Lost to Follow-up|23
1233642|NCT00702507|4045942|P1|Follow-up Phase|Protocol Violation|2
1233643|NCT00702507|4045942|P1|Follow-up Phase|Participant's Caretaker Withdrew Consent|1
1233644|NCT00702507|4045942|P1|Initial Treatment Phase|Negative Candida Culture|34
1233645|NCT00702507|4045942|P1|Initial Treatment Phase|Lost to Follow-up|2
1233646|NCT00702507|4045942|P1|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3
1233647|NCT00702507|4045942|P1|Initial Treatment Phase|Adverse Event|2
1233648|NCT00702403|4045979|P1|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5
1233649|NCT00702403|4045979|P1|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1
1233650|NCT00702403|4045979|P1|From Engraftment to Study Completion|Acute respiratory distress syndrome|1
1233651|NCT00702403|4045979|P1|From Engraftment to Study Completion|Suicide|1
1233652|NCT00702403|4045979|P1|From Engraftment to Study Completion|Liver GVHD|1
1233653|NCT00702403|4045979|P1|From Engraftment to Study Completion|Adenocarcinoma|1
1233654|NCT00702403|4045979|P1|From Engraftment to Study Completion|Non-compliance|2
1233655|NCT00702403|4045979|P1|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4
1233656|NCT00702403|4045979|P1|From Engraftment to Study Completion|Failed pre-1st dose criteria|11
1233657|NCT00702403|4045979|P1|From Consent to Engraftment|Miscellaneous (unanticipated) other|2
1233658|NCT00702403|4045979|P1|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4
1233659|NCT00702403|4045979|P1|From Consent to Engraftment|Myocardial infarction|1
1233660|NCT00702403|4045979|P1|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2
1233661|NCT00702403|4045979|P1|From Consent to Engraftment|Critically ill|2
1233662|NCT00702403|4045979|P1|From Consent to Engraftment|Progressive leukemia|6
1233663|NCT00702325|4046033|P2|Overall Study|Incorrectly Discontinued|1
1233664|NCT00702325|4046034|P1|Overall Study|Incorrectly Discontinued|0
1233665|NCT00702325|4046033|P2|Overall Study|Withdrew consent|1
1233666|NCT00702325|4046034|P1|Overall Study|Withdrew consent|0
1233667|NCT00702325|4046033|P2|Overall Study|Didn't follow study medication dosage|2
1233668|NCT00702325|4046034|P1|Overall Study|Didn't follow study medication dosage|0
1233669|NCT00702325|4046033|P2|Overall Study|Termination due to lab results|0
1233670|NCT00702325|4046034|P1|Overall Study|Termination due to lab results|1
1233671|NCT00702325|4046033|P2|Overall Study|Severe noncompliance to protocol|3
1233672|NCT00702325|4046034|P1|Overall Study|Severe noncompliance to protocol|3
1233673|NCT00702325|4046033|P2|Overall Study|Developed study discontinuation criteria|28
1233674|NCT00702325|4046034|P1|Overall Study|Developed study discontinuation criteria|18
1233675|NCT00702325|4046033|P2|Overall Study|Incorrect enrollment|7
1233676|NCT00702325|4046034|P1|Overall Study|Incorrect enrollment|5
1233677|NCT00702325|4046033|P2|Overall Study|Lost to Follow-up|4
1233678|NCT00702325|4046034|P1|Overall Study|Lost to Follow-up|3
1233679|NCT00702325|4046033|P2|Overall Study|Withdrawal by Subject|7
1233680|NCT00702325|4046034|P1|Overall Study|Withdrawal by Subject|7
1233681|NCT00702325|4046033|P2|Overall Study|Adverse Event|0
1233682|NCT00702325|4046034|P1|Overall Study|Adverse Event|1
1233683|NCT00702221|4046130|P2|Overall Study|Adverse Event|3
1233684|NCT00702221|4046131|P1|Overall Study|Adverse Event|4
1233685|NCT00702208|4046137|P1|Overall Study|Unsatisfactory colposcopy|2
1233686|NCT00702208|4046137|P1|Overall Study|Did not self-lavage|1
1233687|NCT00702208|4046137|P1|Overall Study|Lost to Follow-up|28
1233688|NCT00702143|4046146|P3|Overall Study|Lost to Follow-up|1
1233689|NCT00702143|4046147|P2|Overall Study|Lost to Follow-up|0
1233690|NCT00702143|4046148|P1|Overall Study|Lost to Follow-up|0
1233691|NCT00701805|4046197|P4|Overall Study|Resumption criteria were not met|0
1233692|NCT00701805|4046198|P3|Overall Study|Resumption criteria were not met|0
1233693|NCT00701805|4046199|P2|Overall Study|Resumption criteria were not met|1
1233694|NCT00701805|4046200|P1|Overall Study|Resumption criteria were not met|0
1233695|NCT00701805|4046197|P4|Overall Study|Difficult to travel to dialysis site|0
1233696|NCT00701805|4046198|P3|Overall Study|Difficult to travel to dialysis site|1
1233697|NCT00701805|4046199|P2|Overall Study|Difficult to travel to dialysis site|0
1233698|NCT00701805|4046200|P1|Overall Study|Difficult to travel to dialysis site|0
1233699|NCT00701805|4046197|P4|Overall Study|Physician decision, change of therapy|1
1233700|NCT00701805|4046198|P3|Overall Study|Physician decision, change of therapy|0
1233701|NCT00701805|4046199|P2|Overall Study|Physician decision, change of therapy|0
1233702|NCT00701805|4046200|P1|Overall Study|Physician decision, change of therapy|0
1233703|NCT00701805|4046197|P4|Overall Study|Admitted to hospital for 2 weeks|0
1233704|NCT00701805|4046198|P3|Overall Study|Admitted to hospital for 2 weeks|1
1233705|NCT00701805|4046199|P2|Overall Study|Admitted to hospital for 2 weeks|0
1233706|NCT00701805|4046200|P1|Overall Study|Admitted to hospital for 2 weeks|0
1233707|NCT00701805|4046197|P4|Overall Study|Missed 7 consecutive doses|0
1233708|NCT00701805|4046198|P3|Overall Study|Missed 7 consecutive doses|0
1233709|NCT00701805|4046199|P2|Overall Study|Missed 7 consecutive doses|1
1233710|NCT00701805|4046200|P1|Overall Study|Missed 7 consecutive doses|0
1233711|NCT00701805|4046197|P4|Overall Study|Adverse Event|0
1233712|NCT00701805|4046198|P3|Overall Study|Adverse Event|1
1233713|NCT00701805|4046199|P2|Overall Study|Adverse Event|1
1233714|NCT00701805|4046200|P1|Overall Study|Adverse Event|0
1233715|NCT00701805|4046197|P4|Overall Study|Withdrawal by Subject|3
1233716|NCT00701805|4046198|P3|Overall Study|Withdrawal by Subject|4
1233717|NCT00701805|4046199|P2|Overall Study|Withdrawal by Subject|1
1233718|NCT00701805|4046200|P1|Overall Study|Withdrawal by Subject|3
1233719|NCT00701779|4046250|P1|Overall Study|Withdrawal by Subject|2
1233720|NCT00701779|4046250|P1|Overall Study|Lost to Follow-up|1
1233721|NCT00701779|4046250|P1|Overall Study|Adverse Event|6
1233722|NCT00701727|4046262|P2|Second Treatment Period|Withdrawal by Subject|0
1233723|NCT00701727|4046263|P1|Second Treatment Period|Withdrawal by Subject|2
1233724|NCT00701727|4046262|P2|First Treatment Period|Lost to Follow-up|1
1233725|NCT00701727|4046263|P1|First Treatment Period|Lost to Follow-up|0
1233726|NCT00701727|4046262|P2|First Treatment Period|sponsor decision|1
1233727|NCT00701727|4046263|P1|First Treatment Period|sponsor decision|0
1233728|NCT00701727|4046262|P2|First Treatment Period|Withdrawal by Subject|0
1233729|NCT00701727|4046263|P1|First Treatment Period|Withdrawal by Subject|1
1233730|NCT00701727|4046262|P2|First Treatment Period|Adverse Event|0
1233731|NCT00701727|4046263|P1|First Treatment Period|Adverse Event|0
1233732|NCT00701662|4046309|P1|Overall Study|Lack of Efficacy|1
1233733|NCT00701558|4046334|P1|Overall Study|Lost to Follow-up|8
1233734|NCT00701558|4046334|P1|Overall Study|Death|7
1233735|NCT00701441|4046342|P2|Overall Study|failure in cpap compliance|4
1233736|NCT00701441|4046343|P1|Overall Study|failure in cpap compliance|0
1233737|NCT00701415|4046355|P2|Overall Study|Social/family issues and needle phobia|0
1233738|NCT00701415|4046356|P1|Overall Study|Social/family issues and needle phobia|1
1233739|NCT00701415|4046355|P2|Overall Study|Adverse Event|1
1233740|NCT00701415|4046356|P1|Overall Study|Adverse Event|0
1233741|NCT00701363|4046391|P4|Treatment Phase 2|Withdrawal by Subject|0
1233742|NCT00701363|4046392|P3|Treatment Phase 2|Withdrawal by Subject|1
1233743|NCT00701363|4046393|P2|Treatment Phase 2|Withdrawal by Subject|0
1233744|NCT00701363|4046394|P1|Treatment Phase 2|Withdrawal by Subject|0
1233745|NCT00701363|4046391|P4|Treatment Phase 2|Adverse Event|0
1233746|NCT00701363|4046392|P3|Treatment Phase 2|Adverse Event|1
1233747|NCT00701363|4046393|P2|Treatment Phase 2|Adverse Event|0
1233748|NCT00701363|4046394|P1|Treatment Phase 2|Adverse Event|0
1233749|NCT00701363|4046391|P4|Treatment Phase 1|Lack of Efficacy|0
1233750|NCT00701363|4046392|P3|Treatment Phase 1|Lack of Efficacy|0
1233751|NCT00701363|4046393|P2|Treatment Phase 1|Lack of Efficacy|0
1233752|NCT00701363|4046394|P1|Treatment Phase 1|Lack of Efficacy|1
1233753|NCT00701363|4046391|P4|Treatment Phase 1|Withdrawal by Subject|0
1233754|NCT00701363|4046392|P3|Treatment Phase 1|Withdrawal by Subject|0
1233755|NCT00701363|4046393|P2|Treatment Phase 1|Withdrawal by Subject|0
1233756|NCT00701363|4046394|P1|Treatment Phase 1|Withdrawal by Subject|5
1233757|NCT00701363|4046391|P4|Treatment Phase 1|Protocol Violation|0
1233758|NCT00701363|4046392|P3|Treatment Phase 1|Protocol Violation|0
1233759|NCT00701363|4046393|P2|Treatment Phase 1|Protocol Violation|0
1233760|NCT00701363|4046394|P1|Treatment Phase 1|Protocol Violation|1
1233761|NCT00701363|4046391|P4|Treatment Phase 1|Adverse Event|0
1233762|NCT00701363|4046392|P3|Treatment Phase 1|Adverse Event|0
1233763|NCT00701363|4046393|P2|Treatment Phase 1|Adverse Event|0
1233764|NCT00701363|4046394|P1|Treatment Phase 1|Adverse Event|7
1233765|NCT00701363|4046391|P4|Treatment Phase 1|Does not meet entry Criteria|0
1233766|NCT00701363|4046392|P3|Treatment Phase 1|Does not meet entry Criteria|0
1233767|NCT00701363|4046393|P2|Treatment Phase 1|Does not meet entry Criteria|0
1233768|NCT00701363|4046394|P1|Treatment Phase 1|Does not meet entry Criteria|1
1233769|NCT00701363|4046391|P4|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
1233770|NCT00701363|4046392|P3|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
1233771|NCT00701363|4046393|P2|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
1233772|NCT00701363|4046394|P1|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4
1233773|NCT00701311|4046434|P1|Overall Study|Withdrawal by Subject|2
1233774|NCT00701311|4046434|P1|Overall Study|Adverse Event|3
1233775|NCT00701311|4046434|P1|Overall Study|Lack of Efficacy|3
1233776|NCT00701129|4046438|P1|Overall Study|Death|2
1233777|NCT00701103|4046460|P11|Overall Study|Other|0
1233778|NCT00701103|4046461|P10|Overall Study|Other|1
1233779|NCT00701103|4046462|P9|Overall Study|Other|1
1233780|NCT00701103|4046463|P8|Overall Study|Other|0
1233781|NCT00701103|4046464|P7|Overall Study|Other|0
1233782|NCT00701103|4046465|P6|Overall Study|Other|0
1233783|NCT00701103|4046466|P5|Overall Study|Other|0
1233784|NCT00701103|4046467|P4|Overall Study|Other|0
1233785|NCT00701103|4046468|P3|Overall Study|Other|0
1233786|NCT00701103|4046469|P2|Overall Study|Other|0
1233787|NCT00701103|4046470|P1|Overall Study|Other|0
1233788|NCT00701103|4046460|P11|Overall Study|Withdrawal by Subject|0
1233789|NCT00701103|4046461|P10|Overall Study|Withdrawal by Subject|0
1233790|NCT00701103|4046462|P9|Overall Study|Withdrawal by Subject|0
1233791|NCT00701103|4046463|P8|Overall Study|Withdrawal by Subject|0
1233792|NCT00701103|4046464|P7|Overall Study|Withdrawal by Subject|0
1233793|NCT00701103|4046465|P6|Overall Study|Withdrawal by Subject|0
1233794|NCT00701103|4046466|P5|Overall Study|Withdrawal by Subject|0
1233795|NCT00701103|4046467|P4|Overall Study|Withdrawal by Subject|0
1233796|NCT00701103|4046468|P3|Overall Study|Withdrawal by Subject|1
1233797|NCT00701103|4046469|P2|Overall Study|Withdrawal by Subject|1
1233798|NCT00701103|4046470|P1|Overall Study|Withdrawal by Subject|0
1233799|NCT00701103|4046460|P11|Overall Study|Progressive Disease|11
1233800|NCT00701103|4046461|P10|Overall Study|Progressive Disease|8
1233801|NCT00701103|4046462|P9|Overall Study|Progressive Disease|8
1233802|NCT00701103|4046463|P8|Overall Study|Progressive Disease|7
1233803|NCT00701103|4046464|P7|Overall Study|Progressive Disease|7
1233804|NCT00701103|4046465|P6|Overall Study|Progressive Disease|5
1233805|NCT00701103|4046466|P5|Overall Study|Progressive Disease|6
1233806|NCT00701103|4046467|P4|Overall Study|Progressive Disease|5
1233807|NCT00701103|4046468|P3|Overall Study|Progressive Disease|6
1233808|NCT00701103|4046469|P2|Overall Study|Progressive Disease|2
1233809|NCT00701103|4046470|P1|Overall Study|Progressive Disease|5
1233810|NCT00701103|4046460|P11|Overall Study|Adverse Event|0
1233811|NCT00701103|4046461|P10|Overall Study|Adverse Event|2
1233812|NCT00701103|4046462|P9|Overall Study|Adverse Event|0
1233813|NCT00701103|4046463|P8|Overall Study|Adverse Event|0
1233814|NCT00701103|4046464|P7|Overall Study|Adverse Event|1
1233815|NCT00701103|4046465|P6|Overall Study|Adverse Event|1
1233816|NCT00701103|4046466|P5|Overall Study|Adverse Event|0
1233817|NCT00701103|4046467|P4|Overall Study|Adverse Event|1
1233818|NCT00701103|4046468|P3|Overall Study|Adverse Event|1
1233819|NCT00701103|4046469|P2|Overall Study|Adverse Event|0
1233820|NCT00701103|4046470|P1|Overall Study|Adverse Event|0
1233821|NCT00701090|4046576|P2|Overall Study|Other|12
1233822|NCT00701090|4046577|P1|Overall Study|Other|7
1233823|NCT00701090|4046576|P2|Overall Study|Withdrawal by Subject|16
1233824|NCT00701090|4046577|P1|Overall Study|Withdrawal by Subject|11
1233825|NCT00701090|4046576|P2|Overall Study|Protocol Violation|3
1233826|NCT00701090|4046577|P1|Overall Study|Protocol Violation|2
1233827|NCT00701090|4046576|P2|Overall Study|Physician Decision|4
1233828|NCT00701090|4046577|P1|Overall Study|Physician Decision|3
1233829|NCT00701090|4046576|P2|Overall Study|Lost to Follow-up|9
1233830|NCT00701090|4046577|P1|Overall Study|Lost to Follow-up|9
1233831|NCT00701090|4046576|P2|Overall Study|Lack of Efficacy|4
1233832|NCT00701090|4046577|P1|Overall Study|Lack of Efficacy|5
1233833|NCT00701090|4046576|P2|Overall Study|Death|1
1233834|NCT00701090|4046577|P1|Overall Study|Death|0
1233835|NCT00701090|4046576|P2|Overall Study|Adverse Event|2
1233836|NCT00701090|4046577|P1|Overall Study|Adverse Event|11
1233837|NCT00701064|4046595|P2|Overall Study|initiated other PTSD treatment|2
1233838|NCT00701064|4046596|P1|Overall Study|initiated other PTSD treatment|2
1233839|NCT00701064|4046595|P2|Overall Study|Withdrawal by Subject|1
1233840|NCT00701064|4046596|P1|Overall Study|Withdrawal by Subject|1
1233841|NCT00701064|4046595|P2|Overall Study|Protocol Violation|1
1233842|NCT00701064|4046596|P1|Overall Study|Protocol Violation|1
1233843|NCT00701051|4046608|P3|Exercise Intervention|time conflict; non-study related illness|3
1233844|NCT00701051|4046609|P2|Exercise Intervention|time conflict; non-study related illness|5
1233845|NCT00701051|4046610|P1|Exercise Intervention|time conflict; non-study related illness|0
1233846|NCT00701051|4046608|P3|Screening|Time conflicts|0
1233847|NCT00701051|4046609|P2|Screening|Time conflicts|0
1233848|NCT00701051|4046610|P1|Screening|Time conflicts|19
1233849|NCT00701051|4046608|P3|Screening|Failed Screening|0
1233850|NCT00701051|4046609|P2|Screening|Failed Screening|0
1233851|NCT00701051|4046610|P1|Screening|Failed Screening|40
1233852|NCT00701038|4046628|P2|Overall Study|study amended pilot group of patients|4
1233853|NCT00701038|4046629|P1|Overall Study|study amended pilot group of patients|4
1233854|NCT00700999|4046637|P2|Overall Study|Withdrawal by Subject|1
1233855|NCT00700999|4046638|P1|Overall Study|Withdrawal by Subject|8
1233856|NCT00700999|4046637|P2|Overall Study|Excluded - did not meet study criteria|1
1233857|NCT00700999|4046638|P1|Overall Study|Excluded - did not meet study criteria|0
1233858|NCT00700999|4046637|P2|Overall Study|Lost to Follow-up|7
1233859|NCT00700999|4046638|P1|Overall Study|Lost to Follow-up|7
1233860|NCT00700817|4046658|P5|Week 52-78 (Extension Period 2)|Unclassified|1
1233861|NCT00700817|4046659|P4|Week 52-78 (Extension Period 2)|Unclassified|0
1233862|NCT00700817|4046660|P3|Week 52-78 (Extension Period 2)|Unclassified|0
1233863|NCT00700817|4046661|P2|Week 52-78 (Extension Period 2)|Unclassified|4
1233864|NCT00700817|4046662|P1|Week 52-78 (Extension Period 2)|Unclassified|2
1233865|NCT00700817|4046658|P5|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
1233866|NCT00700817|4046659|P4|Week 52-78 (Extension Period 2)|Withdrawal criteria|1
1233867|NCT00700817|4046660|P3|Week 52-78 (Extension Period 2)|Withdrawal criteria|0
1233868|NCT00700817|4046661|P2|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
1233869|NCT00700817|4046662|P1|Week 52-78 (Extension Period 2)|Withdrawal criteria|4
1233870|NCT00700817|4046658|P5|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
1233871|NCT00700817|4046659|P4|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
1233872|NCT00700817|4046660|P3|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
1233873|NCT00700817|4046661|P2|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
1233874|NCT00700817|4046662|P1|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
1233875|NCT00700817|4046658|P5|Week 52-78 (Extension Period 2)|Protocol Violation|1
1233876|NCT00700817|4046659|P4|Week 52-78 (Extension Period 2)|Protocol Violation|1
1233877|NCT00700817|4046660|P3|Week 52-78 (Extension Period 2)|Protocol Violation|0
1233878|NCT00700817|4046661|P2|Week 52-78 (Extension Period 2)|Protocol Violation|2
1233879|NCT00700817|4046662|P1|Week 52-78 (Extension Period 2)|Protocol Violation|1
1233880|NCT00700817|4046658|P5|Week 52-78 (Extension Period 2)|Adverse Event|0
1233881|NCT00700817|4046659|P4|Week 52-78 (Extension Period 2)|Adverse Event|6
1233882|NCT00700817|4046660|P3|Week 52-78 (Extension Period 2)|Adverse Event|0
1233883|NCT00700817|4046661|P2|Week 52-78 (Extension Period 2)|Adverse Event|3
1233884|NCT00700817|4046662|P1|Week 52-78 (Extension Period 2)|Adverse Event|0
1233885|NCT00700817|4046658|P5|Week 26-52 (Extension Period 1)|Unclassified|0
1233886|NCT00700817|4046659|P4|Week 26-52 (Extension Period 1)|Unclassified|0
1233887|NCT00700817|4046660|P3|Week 26-52 (Extension Period 1)|Unclassified|1
1233888|NCT00700817|4046661|P2|Week 26-52 (Extension Period 1)|Unclassified|3
1233889|NCT00700817|4046662|P1|Week 26-52 (Extension Period 1)|Unclassified|4
1233890|NCT00700817|4046658|P5|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
1233891|NCT00700817|4046659|P4|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
1233892|NCT00700817|4046660|P3|Week 26-52 (Extension Period 1)|Withdrawal criteria|2
1233893|NCT00700817|4046661|P2|Week 26-52 (Extension Period 1)|Withdrawal criteria|8
1233894|NCT00700817|4046662|P1|Week 26-52 (Extension Period 1)|Withdrawal criteria|6
1233895|NCT00700817|4046658|P5|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
1233896|NCT00700817|4046659|P4|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
1233897|NCT00700817|4046660|P3|Week 26-52 (Extension Period 1)|Lack of Efficacy|7
1233898|NCT00700817|4046661|P2|Week 26-52 (Extension Period 1)|Lack of Efficacy|3
1233899|NCT00700817|4046662|P1|Week 26-52 (Extension Period 1)|Lack of Efficacy|2
1233900|NCT00700817|4046658|P5|Week 26-52 (Extension Period 1)|Protocol Violation|0
1233901|NCT00700817|4046659|P4|Week 26-52 (Extension Period 1)|Protocol Violation|0
1233902|NCT00700817|4046660|P3|Week 26-52 (Extension Period 1)|Protocol Violation|2
1233903|NCT00700817|4046661|P2|Week 26-52 (Extension Period 1)|Protocol Violation|2
1233904|NCT00700817|4046662|P1|Week 26-52 (Extension Period 1)|Protocol Violation|3
1233905|NCT00700817|4046658|P5|Week 26-52 (Extension Period 1)|Adverse Event|0
1233906|NCT00700817|4046659|P4|Week 26-52 (Extension Period 1)|Adverse Event|0
1233907|NCT00700817|4046660|P3|Week 26-52 (Extension Period 1)|Adverse Event|3
1233908|NCT00700817|4046661|P2|Week 26-52 (Extension Period 1)|Adverse Event|10
1233909|NCT00700817|4046662|P1|Week 26-52 (Extension Period 1)|Adverse Event|5
1233910|NCT00700817|4046658|P5|Week 0-26 (Main Period)|Unclassified|0
1233911|NCT00700817|4046659|P4|Week 0-26 (Main Period)|Unclassified|0
1233912|NCT00700817|4046660|P3|Week 0-26 (Main Period)|Unclassified|8
1233913|NCT00700817|4046661|P2|Week 0-26 (Main Period)|Unclassified|4
1233914|NCT00700817|4046662|P1|Week 0-26 (Main Period)|Unclassified|14
1233915|NCT00700817|4046658|P5|Week 0-26 (Main Period)|Withdrawal criteria|0
1233916|NCT00700817|4046659|P4|Week 0-26 (Main Period)|Withdrawal criteria|0
1233917|NCT00700817|4046660|P3|Week 0-26 (Main Period)|Withdrawal criteria|5
1233918|NCT00700817|4046661|P2|Week 0-26 (Main Period)|Withdrawal criteria|7
1233919|NCT00700817|4046662|P1|Week 0-26 (Main Period)|Withdrawal criteria|10
1233920|NCT00700817|4046658|P5|Week 0-26 (Main Period)|Protocol Violation|0
1233921|NCT00700817|4046659|P4|Week 0-26 (Main Period)|Protocol Violation|0
1233922|NCT00700817|4046660|P3|Week 0-26 (Main Period)|Protocol Violation|4
1233923|NCT00700817|4046661|P2|Week 0-26 (Main Period)|Protocol Violation|4
1233924|NCT00700817|4046662|P1|Week 0-26 (Main Period)|Protocol Violation|14
1233925|NCT00700817|4046658|P5|Week 0-26 (Main Period)|Lack of Efficacy|0
1233926|NCT00700817|4046659|P4|Week 0-26 (Main Period)|Lack of Efficacy|0
1233927|NCT00700817|4046660|P3|Week 0-26 (Main Period)|Lack of Efficacy|4
1233928|NCT00700817|4046661|P2|Week 0-26 (Main Period)|Lack of Efficacy|0
1233929|NCT00700817|4046662|P1|Week 0-26 (Main Period)|Lack of Efficacy|4
1233930|NCT00700817|4046658|P5|Week 0-26 (Main Period)|Adverse Event|0
1233931|NCT00700817|4046659|P4|Week 0-26 (Main Period)|Adverse Event|0
1233932|NCT00700817|4046660|P3|Week 0-26 (Main Period)|Adverse Event|4
1233933|NCT00700817|4046661|P2|Week 0-26 (Main Period)|Adverse Event|15
1233934|NCT00700817|4046662|P1|Week 0-26 (Main Period)|Adverse Event|14
1233935|NCT00700804|4047044|P2|Overall Study|Loose Stools|1
1233936|NCT00700804|4047045|P1|Overall Study|Loose Stools|1
1233937|NCT00700804|4047044|P2|Overall Study|Protocol Violation|1
1233938|NCT00700804|4047045|P1|Overall Study|Protocol Violation|1
1233939|NCT00700804|4047044|P2|Overall Study|Withdrawal by Subject|2
1233940|NCT00700804|4047045|P1|Overall Study|Withdrawal by Subject|1
1233941|NCT00700752|4047053|P2|First Intervention|Withdrawal by Subject|2
1233942|NCT00700752|4047054|P1|First Intervention|Withdrawal by Subject|0
1233943|NCT00700739|4047062|P2|Overall Study|Lost to Follow-up|4
1233944|NCT00700739|4047063|P1|Overall Study|Lost to Follow-up|4
1233945|NCT00700713|4047102|P3|Overall Study|Withdrawal by Subject|1
1233946|NCT00700713|4047103|P2|Overall Study|Withdrawal by Subject|0
1233947|NCT00700713|4047104|P1|Overall Study|Withdrawal by Subject|0
1233948|NCT00700713|4047102|P3|Overall Study|Protocol Violation|1
1233949|NCT00700713|4047103|P2|Overall Study|Protocol Violation|0
1233950|NCT00700713|4047104|P1|Overall Study|Protocol Violation|1
1233951|NCT00700635|4047121|P3|Overall Study|Withdrawal by Subject|1
1233952|NCT00700635|4047122|P2|Overall Study|Withdrawal by Subject|3
1233953|NCT00700635|4047123|P1|Overall Study|Withdrawal by Subject|7
1233954|NCT00700635|4047121|P3|Overall Study|Protocol Violation|0
1233955|NCT00700635|4047122|P2|Overall Study|Protocol Violation|2
1233956|NCT00700635|4047123|P1|Overall Study|Protocol Violation|2
1233957|NCT00700635|4047121|P3|Overall Study|Lost to Follow-up|0
1233958|NCT00700635|4047122|P2|Overall Study|Lost to Follow-up|3
1233959|NCT00700635|4047123|P1|Overall Study|Lost to Follow-up|1
1233960|NCT00700635|4047121|P3|Overall Study|Adverse Event|0
1233961|NCT00700635|4047122|P2|Overall Study|Adverse Event|0
1233962|NCT00700635|4047123|P1|Overall Study|Adverse Event|1
1233963|NCT00700622|4047145|P2|Overall Study|Other|1
1233964|NCT00700622|4047146|P1|Overall Study|Other|3
1233965|NCT00700622|4047145|P2|Overall Study|Withdrawal by Subject|1
1233966|NCT00700622|4047146|P1|Overall Study|Withdrawal by Subject|4
1233967|NCT00700622|4047145|P2|Overall Study|Protocol Violation|1
1233968|NCT00700622|4047146|P1|Overall Study|Protocol Violation|0
1233969|NCT00700622|4047145|P2|Overall Study|Physician Decision|1
1233970|NCT00700622|4047146|P1|Overall Study|Physician Decision|2
1233971|NCT00700622|4047145|P2|Overall Study|Lost to Follow-up|1
1233972|NCT00700622|4047146|P1|Overall Study|Lost to Follow-up|0
1233973|NCT00700622|4047145|P2|Overall Study|Adverse Event|0
1233974|NCT00700622|4047146|P1|Overall Study|Adverse Event|4
1233975|NCT00700570|4047154|P2|Overall Study|Withdrawal by Subject|6
1233976|NCT00700570|4047155|P1|Overall Study|Withdrawal by Subject|1
1233977|NCT00700570|4047154|P2|Overall Study|Disease Progression|11
1233978|NCT00700570|4047155|P1|Overall Study|Disease Progression|8
1233979|NCT00700570|4047154|P2|Overall Study|Discretion of Investigator or Sponsor|3
1233980|NCT00700570|4047155|P1|Overall Study|Discretion of Investigator or Sponsor|0
1233981|NCT00700570|4047154|P2|Overall Study|Adverse Event|6
1233982|NCT00700570|4047155|P1|Overall Study|Adverse Event|2
1233983|NCT00700427|4047171|P5|Study Period 4 (Open-Label Extension)|Clinical Relapse|1
1233984|NCT00700427|4047172|P4|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
1233985|NCT00700427|4047173|P3|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
1233986|NCT00700427|4047174|P2|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
1233987|NCT00700427|4047175|P1|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
1233988|NCT00700427|4047171|P5|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11
1233989|NCT00700427|4047172|P4|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
1233990|NCT00700427|4047173|P3|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
1233991|NCT00700427|4047174|P2|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
1233992|NCT00700427|4047175|P1|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
1233993|NCT00700427|4047171|P5|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1
1233994|NCT00700427|4047172|P4|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
1233995|NCT00700427|4047173|P3|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
1233996|NCT00700427|4047174|P2|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
1233997|NCT00700427|4047175|P1|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
1233998|NCT00700427|4047171|P5|Study Period 4 (Open-Label Extension)|Sponsor Decision|2
1233999|NCT00700427|4047172|P4|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
1234000|NCT00700427|4047173|P3|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
1234001|NCT00700427|4047174|P2|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
1234002|NCT00700427|4047175|P1|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
1234003|NCT00700427|4047171|P5|Study Period 4 (Open-Label Extension)|Physician Decision|2
1234004|NCT00700427|4047172|P4|Study Period 4 (Open-Label Extension)|Physician Decision|0
1234005|NCT00700427|4047173|P3|Study Period 4 (Open-Label Extension)|Physician Decision|0
1234006|NCT00700427|4047174|P2|Study Period 4 (Open-Label Extension)|Physician Decision|0
1234007|NCT00700427|4047175|P1|Study Period 4 (Open-Label Extension)|Physician Decision|0
1234008|NCT00700427|4047171|P5|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38
1234009|NCT00700427|4047172|P4|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
1234010|NCT00700427|4047173|P3|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
1234011|NCT00700427|4047174|P2|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
1234012|NCT00700427|4047175|P1|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
1234013|NCT00700427|4047171|P5|Study Period 4 (Open-Label Extension)|Protocol Violation|12
1234014|NCT00700427|4047172|P4|Study Period 4 (Open-Label Extension)|Protocol Violation|0
1234015|NCT00700427|4047173|P3|Study Period 4 (Open-Label Extension)|Protocol Violation|0
1234016|NCT00700427|4047174|P2|Study Period 4 (Open-Label Extension)|Protocol Violation|0
1234017|NCT00700427|4047175|P1|Study Period 4 (Open-Label Extension)|Protocol Violation|0
1234018|NCT00700427|4047171|P5|Study Period 4 (Open-Label Extension)|Death|1
1234019|NCT00700427|4047172|P4|Study Period 4 (Open-Label Extension)|Death|0
1234020|NCT00700427|4047173|P3|Study Period 4 (Open-Label Extension)|Death|0
1234021|NCT00700427|4047174|P2|Study Period 4 (Open-Label Extension)|Death|0
1234022|NCT00700427|4047175|P1|Study Period 4 (Open-Label Extension)|Death|0
1234023|NCT00700427|4047171|P5|Study Period 4 (Open-Label Extension)|Adverse Event|16
1234024|NCT00700427|4047172|P4|Study Period 4 (Open-Label Extension)|Adverse Event|0
1234025|NCT00700427|4047173|P3|Study Period 4 (Open-Label Extension)|Adverse Event|0
1234026|NCT00700427|4047174|P2|Study Period 4 (Open-Label Extension)|Adverse Event|0
1234027|NCT00700427|4047175|P1|Study Period 4 (Open-Label Extension)|Adverse Event|0
1234028|NCT00700427|4047171|P5|Study Period 3B (Randomized Withdrawal)|Death|0
1234029|NCT00700427|4047172|P4|Study Period 3B (Randomized Withdrawal)|Death|0
1234030|NCT00700427|4047173|P3|Study Period 3B (Randomized Withdrawal)|Death|1
1234031|NCT00700427|4047174|P2|Study Period 3B (Randomized Withdrawal)|Death|0
1234032|NCT00700427|4047175|P1|Study Period 3B (Randomized Withdrawal)|Death|0
1234033|NCT00700427|4047171|P5|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
1234034|NCT00700427|4047172|P4|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
1234035|NCT00700427|4047173|P3|Study Period 3B (Randomized Withdrawal)|Physician Decision|2
1234036|NCT00700427|4047174|P2|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
1234037|NCT00700427|4047175|P1|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
1234038|NCT00700427|4047171|P5|Study Period 3B (Randomized Withdrawal)|Missing|0
1234039|NCT00700427|4047172|P4|Study Period 3B (Randomized Withdrawal)|Missing|1
1234040|NCT00700427|4047173|P3|Study Period 3B (Randomized Withdrawal)|Missing|1
1234041|NCT00700427|4047174|P2|Study Period 3B (Randomized Withdrawal)|Missing|0
1234042|NCT00700427|4047175|P1|Study Period 3B (Randomized Withdrawal)|Missing|0
1234043|NCT00700427|4047171|P5|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
1234044|NCT00700427|4047172|P4|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3
1234045|NCT00700427|4047173|P3|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
1234046|NCT00700427|4047174|P2|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
1234047|NCT00700427|4047175|P1|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
1234048|NCT00700427|4047171|P5|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
1234049|NCT00700427|4047172|P4|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5
1234050|NCT00700427|4047173|P3|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
1234051|NCT00700427|4047174|P2|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
1234052|NCT00700427|4047175|P1|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
1234053|NCT00700427|4047171|P5|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
1234054|NCT00700427|4047172|P4|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11
1234055|NCT00700427|4047173|P3|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3
1234056|NCT00700427|4047174|P2|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
1234057|NCT00700427|4047175|P1|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
1234058|NCT00700427|4047171|P5|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
1234059|NCT00700427|4047172|P4|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9
1234060|NCT00700427|4047173|P3|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19
1234061|NCT00700427|4047174|P2|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
1234062|NCT00700427|4047175|P1|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
1234063|NCT00700427|4047171|P5|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
1234064|NCT00700427|4047172|P4|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25
1234065|NCT00700427|4047173|P3|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23
1234066|NCT00700427|4047174|P2|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
1234067|NCT00700427|4047175|P1|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
1234068|NCT00700427|4047171|P5|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
1234069|NCT00700427|4047172|P4|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34
1234070|NCT00700427|4047173|P3|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25
1234071|NCT00700427|4047174|P2|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
1234072|NCT00700427|4047175|P1|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
1234073|NCT00700427|4047171|P5|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
1234074|NCT00700427|4047172|P4|Study Period 3B (Randomized Withdrawal)|Adverse Event|5
1234075|NCT00700427|4047173|P3|Study Period 3B (Randomized Withdrawal)|Adverse Event|8
1234076|NCT00700427|4047174|P2|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
1234077|NCT00700427|4047175|P1|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
1234078|NCT00700427|4047171|P5|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
1234079|NCT00700427|4047172|P4|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
1234080|NCT00700427|4047173|P3|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
1234081|NCT00700427|4047174|P2|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5
1234082|NCT00700427|4047175|P1|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
1234083|NCT00700427|4047171|P5|Study Period 3A (Blinded Maintenance)|Physician Decision|0
1234084|NCT00700427|4047172|P4|Study Period 3A (Blinded Maintenance)|Physician Decision|0
1234085|NCT00700427|4047173|P3|Study Period 3A (Blinded Maintenance)|Physician Decision|0
1234086|NCT00700427|4047174|P2|Study Period 3A (Blinded Maintenance)|Physician Decision|2
1234087|NCT00700427|4047175|P1|Study Period 3A (Blinded Maintenance)|Physician Decision|0
1234088|NCT00700427|4047171|P5|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
1234089|NCT00700427|4047172|P4|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
1234090|NCT00700427|4047173|P3|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
1234091|NCT00700427|4047174|P2|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3
1234092|NCT00700427|4047175|P1|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
1234093|NCT00700427|4047171|P5|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
1234094|NCT00700427|4047172|P4|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
1234095|NCT00700427|4047173|P3|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
1234096|NCT00700427|4047174|P2|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32
1234097|NCT00700427|4047175|P1|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
1234098|NCT00700427|4047171|P5|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
1234099|NCT00700427|4047172|P4|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
1234100|NCT00700427|4047173|P3|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
1234101|NCT00700427|4047174|P2|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41
1234102|NCT00700427|4047175|P1|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
1234103|NCT00700427|4047171|P5|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
1234104|NCT00700427|4047172|P4|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
1234105|NCT00700427|4047173|P3|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
1234106|NCT00700427|4047174|P2|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49
1234107|NCT00700427|4047175|P1|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
1234108|NCT00700427|4047171|P5|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
1234109|NCT00700427|4047172|P4|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
1234110|NCT00700427|4047173|P3|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
1234111|NCT00700427|4047174|P2|Study Period 3A (Blinded Maintenance)|Protocol Violation|56
1234112|NCT00700427|4047175|P1|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
1234113|NCT00700427|4047171|P5|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
1234114|NCT00700427|4047172|P4|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
1234115|NCT00700427|4047173|P3|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
1234116|NCT00700427|4047174|P2|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81
1234117|NCT00700427|4047175|P1|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
1234118|NCT00700427|4047171|P5|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
1234119|NCT00700427|4047172|P4|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
1234120|NCT00700427|4047173|P3|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
1234121|NCT00700427|4047174|P2|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162
1234122|NCT00700427|4047175|P1|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
1234123|NCT00700427|4047171|P5|Study Period 3A (Blinded Maintenance)|Adverse Event|0
1234124|NCT00700427|4047172|P4|Study Period 3A (Blinded Maintenance)|Adverse Event|0
1234125|NCT00700427|4047173|P3|Study Period 3A (Blinded Maintenance)|Adverse Event|0
1234126|NCT00700427|4047174|P2|Study Period 3A (Blinded Maintenance)|Adverse Event|50
1234127|NCT00700427|4047175|P1|Study Period 3A (Blinded Maintenance)|Adverse Event|0
1234128|NCT00700427|4047171|P5|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
1234129|NCT00700427|4047172|P4|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
1234130|NCT00700427|4047173|P3|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
1234131|NCT00700427|4047174|P2|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
1234132|NCT00700427|4047175|P1|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2
1234133|NCT00700427|4047171|P5|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
1234134|NCT00700427|4047172|P4|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
1234135|NCT00700427|4047173|P3|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
1234136|NCT00700427|4047174|P2|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
1234137|NCT00700427|4047175|P1|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7
1234138|NCT00700427|4047171|P5|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
1234139|NCT00700427|4047172|P4|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
1234140|NCT00700427|4047173|P3|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
1234141|NCT00700427|4047174|P2|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
1234142|NCT00700427|4047175|P1|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8
1234143|NCT00700427|4047171|P5|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
1234144|NCT00700427|4047172|P4|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
1234145|NCT00700427|4047173|P3|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
1234146|NCT00700427|4047174|P2|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
1234147|NCT00700427|4047175|P1|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90
1234148|NCT00700427|4047171|P5|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
1234149|NCT00700427|4047172|P4|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
1234150|NCT00700427|4047173|P3|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
1234151|NCT00700427|4047174|P2|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
1234152|NCT00700427|4047175|P1|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108
1234153|NCT00700427|4047171|P5|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
1234154|NCT00700427|4047172|P4|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
1234155|NCT00700427|4047173|P3|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
1234156|NCT00700427|4047174|P2|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
1234157|NCT00700427|4047175|P1|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161
1234158|NCT00700427|4047171|P5|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
1234159|NCT00700427|4047172|P4|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
1234160|NCT00700427|4047173|P3|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
1234161|NCT00700427|4047174|P2|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
1234162|NCT00700427|4047175|P1|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164
1234163|NCT00700427|4047171|P5|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
1234164|NCT00700427|4047172|P4|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
1234165|NCT00700427|4047173|P3|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
1234166|NCT00700427|4047174|P2|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
1234167|NCT00700427|4047175|P1|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173
1234168|NCT00700427|4047171|P5|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
1234169|NCT00700427|4047172|P4|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
1234170|NCT00700427|4047173|P3|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
1234171|NCT00700427|4047174|P2|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
1234172|NCT00700427|4047175|P1|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298
1234173|NCT00700401|4047197|P1|Overall Study|Withdrawal by Subject|2
1234174|NCT00700401|4047197|P1|Overall Study|HCV RNA not detected at baseline and SAE|1
1234175|NCT00700401|4047197|P1|Overall Study|Treatment never started|1
1234176|NCT00700401|4047197|P1|Overall Study|Lost to Follow-up|1
1234177|NCT00700401|4047197|P1|Overall Study|Refused Treatment|2
1234178|NCT00700401|4047197|P1|Overall Study|Adverse Event|5
1234179|NCT00700401|4047197|P1|Overall Study|Detectable HCV RNA after Week 4|82
1234180|NCT00700310|4047221|P4|Overall Study|Randomized, Not Treated|2
1234181|NCT00700310|4047222|P3|Overall Study|Randomized, Not Treated|2
1234182|NCT00700310|4047223|P2|Overall Study|Randomized, Not Treated|0
1234183|NCT00700310|4047224|P1|Overall Study|Randomized, Not Treated|2
1234184|NCT00700310|4047221|P4|Overall Study|Administrative/Other|3
1234185|NCT00700310|4047222|P3|Overall Study|Administrative/Other|1
1234186|NCT00700310|4047223|P2|Overall Study|Administrative/Other|3
1234187|NCT00700310|4047224|P1|Overall Study|Administrative/Other|1
1234188|NCT00700310|4047221|P4|Overall Study|Lack of Efficacy|1
1234189|NCT00700310|4047222|P3|Overall Study|Lack of Efficacy|0
1234190|NCT00700310|4047223|P2|Overall Study|Lack of Efficacy|3
1234191|NCT00700310|4047224|P1|Overall Study|Lack of Efficacy|0
1234192|NCT00700310|4047221|P4|Overall Study|Withdrawal by Subject|8
1234193|NCT00700310|4047222|P3|Overall Study|Withdrawal by Subject|8
1234194|NCT00700310|4047223|P2|Overall Study|Withdrawal by Subject|9
1234195|NCT00700310|4047224|P1|Overall Study|Withdrawal by Subject|8
1234196|NCT00700310|4047221|P4|Overall Study|Lost to Follow-up|1
1234197|NCT00700310|4047222|P3|Overall Study|Lost to Follow-up|0
1234198|NCT00700310|4047223|P2|Overall Study|Lost to Follow-up|1
1234199|NCT00700310|4047224|P1|Overall Study|Lost to Follow-up|4
1234200|NCT00700310|4047221|P4|Overall Study|Adverse Event|11
1234201|NCT00700310|4047222|P3|Overall Study|Adverse Event|5
1234202|NCT00700310|4047223|P2|Overall Study|Adverse Event|10
1234203|NCT00700310|4047224|P1|Overall Study|Adverse Event|6
1234204|NCT00700271|4047244|P2|Overall Study|Lost to Follow-up|2
1234205|NCT00700271|4047245|P1|Overall Study|Lost to Follow-up|2
1234206|NCT00700271|4047244|P2|Overall Study|Withdrawal by Subject|4
1234207|NCT00700271|4047245|P1|Overall Study|Withdrawal by Subject|6
1234208|NCT00700271|4047244|P2|Overall Study|Administrative Reasons|0
1234209|NCT00700271|4047245|P1|Overall Study|Administrative Reasons|1
1234210|NCT00700271|4047244|P2|Overall Study|Protocol Violation|0
1234211|NCT00700271|4047245|P1|Overall Study|Protocol Violation|1
1234212|NCT00700271|4047244|P2|Overall Study|Adverse Event|6
1234213|NCT00700271|4047245|P1|Overall Study|Adverse Event|4
1234214|NCT00700180|4047273|P2|Overall Study|Lost to Follow-up|5
1234215|NCT00700180|4047274|P1|Overall Study|Lost to Follow-up|4
1234216|NCT00700180|4047273|P2|Overall Study|Alive in follow-up|27
1234217|NCT00700180|4047274|P1|Overall Study|Alive in follow-up|46
1234218|NCT00700180|4047273|P2|Overall Study|Alive on treatment|3
1234219|NCT00700180|4047274|P1|Overall Study|Alive on treatment|5
1234220|NCT00700180|4047273|P2|Overall Study|Death|114
1234221|NCT00700180|4047274|P1|Overall Study|Death|99
1234222|NCT00700115|4047303|P2|Overall Study|Lost to Follow-up|1
1234223|NCT00700115|4047304|P1|Overall Study|Lost to Follow-up|0
1234224|NCT00700115|4047303|P2|Overall Study|Withdrawal by Subject|0
1234225|NCT00700115|4047304|P1|Overall Study|Withdrawal by Subject|1
1234226|NCT00700102|4047314|P2|Overall Study|Lost to Follow-up|10
1234227|NCT00700102|4047315|P1|Overall Study|Lost to Follow-up|8
1234228|NCT00700102|4047314|P2|Overall Study|Died|385
1234229|NCT00700102|4047315|P1|Overall Study|Died|394
1234230|NCT00700011|4047454|P2|Overall Study|Death|1
1234231|NCT00700011|4047455|P1|Overall Study|Death|0
1234232|NCT00699998|4047471|P4|Overall Study|Lost to Follow-up|1
1234233|NCT00699998|4047472|P3|Overall Study|Lost to Follow-up|3
1234234|NCT00699998|4047473|P2|Overall Study|Lost to Follow-up|1
1234235|NCT00699998|4047474|P1|Overall Study|Lost to Follow-up|2
1234236|NCT00699998|4047471|P4|Overall Study|Physician Decision|1
1234237|NCT00699998|4047472|P3|Overall Study|Physician Decision|1
1234238|NCT00699998|4047473|P2|Overall Study|Physician Decision|2
1234239|NCT00699998|4047474|P1|Overall Study|Physician Decision|3
1234240|NCT00699998|4047471|P4|Overall Study|Withdrawal by Subject|80
1234241|NCT00699998|4047472|P3|Overall Study|Withdrawal by Subject|202
1234242|NCT00699998|4047473|P2|Overall Study|Withdrawal by Subject|83
1234243|NCT00699998|4047474|P1|Overall Study|Withdrawal by Subject|194
1234244|NCT00699972|4047519|P3|Overall Study|Randomized, Not Treated|1
1234245|NCT00699972|4047520|P2|Overall Study|Randomized, Not Treated|0
1234246|NCT00699972|4047521|P1|Overall Study|Randomized, Not Treated|1
1234247|NCT00699972|4047519|P3|Overall Study|Administrative/Other|4
1234248|NCT00699972|4047520|P2|Overall Study|Administrative/Other|1
1234249|NCT00699972|4047521|P1|Overall Study|Administrative/Other|3
1234250|NCT00699972|4047519|P3|Overall Study|Lack of Efficacy|2
1234251|NCT00699972|4047520|P2|Overall Study|Lack of Efficacy|0
1234252|NCT00699972|4047521|P1|Overall Study|Lack of Efficacy|2
1234253|NCT00699972|4047519|P3|Overall Study|Withdrawal by Subject|4
1234254|NCT00699972|4047520|P2|Overall Study|Withdrawal by Subject|7
1234255|NCT00699972|4047521|P1|Overall Study|Withdrawal by Subject|3
1234256|NCT00699972|4047519|P3|Overall Study|Lost to Follow-up|0
1234257|NCT00699972|4047520|P2|Overall Study|Lost to Follow-up|2
1234258|NCT00699972|4047521|P1|Overall Study|Lost to Follow-up|0
1234259|NCT00699972|4047519|P3|Overall Study|Adverse Event|24
1234260|NCT00699972|4047520|P2|Overall Study|Adverse Event|9
1234261|NCT00699972|4047521|P1|Overall Study|Adverse Event|7
1234262|NCT00699907|4047538|P3|Overall Study|No usable sample|8
1234263|NCT00699907|4047539|P2|Overall Study|No usable sample|9
1234264|NCT00699907|4047540|P1|Overall Study|No usable sample|0
1234265|NCT00699907|4047538|P3|Overall Study|Withdrawal by Subject|0
1234266|NCT00699907|4047539|P2|Overall Study|Withdrawal by Subject|1
1234267|NCT00699907|4047540|P1|Overall Study|Withdrawal by Subject|2
1234268|NCT00699842|4047575|P3|Overall Study|Death|0
1234269|NCT00699842|4047576|P2|Overall Study|Death|1
1234270|NCT00699842|4047577|P1|Overall Study|Death|0
1234271|NCT00699816|4047590|P2|Overall Study|Protocol Violation|3
1234272|NCT00699816|4047591|P1|Overall Study|Protocol Violation|1
1234273|NCT00699751|4047609|P2|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4
1234274|NCT00699751|4047610|P1|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0
1234275|NCT00699751|4047609|P2|Period 2:Switched From Placebo to Xofigo|Investigator Request|1
1234276|NCT00699751|4047610|P1|Period 2:Switched From Placebo to Xofigo|Investigator Request|0
1234277|NCT00699751|4047609|P2|Period 2:Switched From Placebo to Xofigo|Adverse Event|4
1234278|NCT00699751|4047610|P1|Period 2:Switched From Placebo to Xofigo|Adverse Event|0
1234279|NCT00699751|4047609|P2|Period 1: Without/Before Drug Switch|Adverse Event|63
1234280|NCT00699751|4047610|P1|Period 1: Without/Before Drug Switch|Adverse Event|97
1234281|NCT00699751|4047609|P2|Period 1: Without/Before Drug Switch|Other|20
1234282|NCT00699751|4047610|P1|Period 1: Without/Before Drug Switch|Other|30
1234283|NCT00699751|4047609|P2|Period 1: Without/Before Drug Switch|Subject Request|23
1234284|NCT00699751|4047610|P1|Period 1: Without/Before Drug Switch|Subject Request|43
1234285|NCT00699751|4047609|P2|Period 1: Without/Before Drug Switch|Death|29
1234286|NCT00699751|4047610|P1|Period 1: Without/Before Drug Switch|Death|28
1234287|NCT00699751|4047609|P2|Period 1: Without/Before Drug Switch|Investigator Request|27
1234288|NCT00699751|4047610|P1|Period 1: Without/Before Drug Switch|Investigator Request|27
1234289|NCT00699699|4047695|P1|Overall Study|Individual different reasons|21
1234290|NCT00699699|4047695|P1|Overall Study|Adverse Event|36
1234291|NCT00699660|4047704|P2|Overall Study|missing reports and recording failures|6
1234292|NCT00699660|4047705|P1|Overall Study|missing reports and recording failures|10
1234293|NCT00699660|4047704|P2|Overall Study|Lost to Follow-up|2
1234294|NCT00699660|4047705|P1|Overall Study|Lost to Follow-up|4
1234295|NCT00699608|4047717|P6|Second Intervention|Withdrawal by Subject|0
1234296|NCT00699608|4047718|P5|Second Intervention|Withdrawal by Subject|0
1234297|NCT00699608|4047719|P4|Second Intervention|Withdrawal by Subject|1
1234298|NCT00699608|4047720|P3|Second Intervention|Withdrawal by Subject|0
1234299|NCT00699608|4047721|P2|Second Intervention|Withdrawal by Subject|0
1234300|NCT00699608|4047722|P1|Second Intervention|Withdrawal by Subject|0
1234301|NCT00699608|4047717|P6|Second Intervention|Adverse Event|0
1234302|NCT00699608|4047718|P5|Second Intervention|Adverse Event|0
1234303|NCT00699608|4047719|P4|Second Intervention|Adverse Event|0
1234304|NCT00699608|4047720|P3|Second Intervention|Adverse Event|1
1234305|NCT00699608|4047721|P2|Second Intervention|Adverse Event|0
1234306|NCT00699608|4047722|P1|Second Intervention|Adverse Event|0
1234307|NCT00699608|4047717|P6|First Intervention|Protocol Violation|0
1234308|NCT00699608|4047718|P5|First Intervention|Protocol Violation|1
1234309|NCT00699608|4047719|P4|First Intervention|Protocol Violation|0
1234310|NCT00699608|4047720|P3|First Intervention|Protocol Violation|0
1234311|NCT00699608|4047721|P2|First Intervention|Protocol Violation|0
1234312|NCT00699608|4047722|P1|First Intervention|Protocol Violation|0
1234313|NCT00699608|4047717|P6|First Intervention|Withdrawal by Subject|0
1234314|NCT00699608|4047718|P5|First Intervention|Withdrawal by Subject|0
1234315|NCT00699608|4047719|P4|First Intervention|Withdrawal by Subject|0
1234316|NCT00699608|4047720|P3|First Intervention|Withdrawal by Subject|1
1234317|NCT00699608|4047721|P2|First Intervention|Withdrawal by Subject|0
1234318|NCT00699608|4047722|P1|First Intervention|Withdrawal by Subject|0
1234319|NCT00699582|4047775|P3|Overall Study|Randomized, Not Treated|0
1234320|NCT00699582|4047776|P2|Overall Study|Randomized, Not Treated|1
1234321|NCT00699582|4047777|P1|Overall Study|Randomized, Not Treated|2
1234322|NCT00699582|4047775|P3|Overall Study|Administrative/Other|0
1234323|NCT00699582|4047776|P2|Overall Study|Administrative/Other|3
1234324|NCT00699582|4047777|P1|Overall Study|Administrative/Other|4
1234325|NCT00699582|4047775|P3|Overall Study|Progressive Disease|0
1234326|NCT00699582|4047776|P2|Overall Study|Progressive Disease|0
1234327|NCT00699582|4047777|P1|Overall Study|Progressive Disease|1
1234328|NCT00699582|4047775|P3|Overall Study|Lack of Efficacy|1
1234329|NCT00699582|4047776|P2|Overall Study|Lack of Efficacy|0
1234330|NCT00699582|4047777|P1|Overall Study|Lack of Efficacy|1
1234331|NCT00699582|4047775|P3|Overall Study|Withdrawal by Subject|4
1234332|NCT00699582|4047776|P2|Overall Study|Withdrawal by Subject|7
1234333|NCT00699582|4047777|P1|Overall Study|Withdrawal by Subject|6
1234334|NCT00699582|4047775|P3|Overall Study|Adverse Event|23
1234335|NCT00699582|4047776|P2|Overall Study|Adverse Event|11
1234336|NCT00699582|4047777|P1|Overall Study|Adverse Event|4
1234337|NCT00699374|4047881|P2|Overall Study|Died 28 days after last dose|9
1234338|NCT00699374|4047882|P1|Overall Study|Died 28 days after last dose|5
1234339|NCT00699374|4047881|P2|Overall Study|Randomized but not treated|2
1234340|NCT00699374|4047882|P1|Overall Study|Randomized but not treated|4
1234341|NCT00699374|4047881|P2|Overall Study|Study terminated by sponsor|28
1234342|NCT00699374|4047882|P1|Overall Study|Study terminated by sponsor|13
1234343|NCT00699374|4047881|P2|Overall Study|Protocol Violation|6
1234344|NCT00699374|4047882|P1|Overall Study|Protocol Violation|2
1234345|NCT00699374|4047881|P2|Overall Study|Other|15
1234346|NCT00699374|4047882|P1|Overall Study|Other|18
1234347|NCT00699374|4047881|P2|Overall Study|Objective progression or relapse|277
1234348|NCT00699374|4047882|P1|Overall Study|Objective progression or relapse|281
1234349|NCT00699374|4047881|P2|Overall Study|Withdrawal by Subject|44
1234350|NCT00699374|4047882|P1|Overall Study|Withdrawal by Subject|34
1234351|NCT00699374|4047881|P2|Overall Study|Lost to Follow-up|5
1234352|NCT00699374|4047882|P1|Overall Study|Lost to Follow-up|3
1234353|NCT00699374|4047881|P2|Overall Study|Global deterioration of health status|8
1234354|NCT00699374|4047882|P1|Overall Study|Global deterioration of health status|7
1234355|NCT00699374|4047881|P2|Overall Study|Adverse Event|67
1234356|NCT00699374|4047882|P1|Overall Study|Adverse Event|70
1234357|NCT00699374|4047881|P2|Overall Study|Death|83
1234358|NCT00699374|4047882|P1|Overall Study|Death|93
1234359|NCT00699348|4047894|P1|Overall Study|Other|5
1234360|NCT00699348|4047894|P1|Overall Study|Renal transplantation|10
1234361|NCT00699348|4047894|P1|Overall Study|Blood transfusion|24
1234362|NCT00699348|4047894|P1|Overall Study|Failure to return|1
1234363|NCT00699348|4047894|P1|Overall Study|Lack of Efficacy|8
1234364|NCT00699348|4047894|P1|Overall Study|Protocol Violation|10
1234365|NCT00699348|4047894|P1|Overall Study|Withdrawal by Subject|11
1234366|NCT00699348|4047894|P1|Overall Study|Adverse Event|15
1234367|NCT00699348|4047894|P1|Overall Study|Death|6
1234368|NCT00699335|4047903|P1|Overall Study|Missing data|52
1234369|NCT00699335|4047903|P1|Overall Study|Combination of multiple reasons|176
1234370|NCT00699283|4047936|P2|Overall Study|AE of unknown type|0
1234371|NCT00699283|4047937|P1|Overall Study|AE of unknown type|1
1234372|NCT00699283|4047936|P2|Overall Study|AE, non-serious non-fatal|1
1234373|NCT00699283|4047937|P1|Overall Study|AE, non-serious non-fatal|8
1234374|NCT00699283|4047936|P2|Overall Study|SAE, non-fatal|1
1234375|NCT00699283|4047937|P1|Overall Study|SAE, non-fatal|1
1234376|NCT00699283|4047936|P2|Overall Study|Other Reason|1
1234377|NCT00699283|4047937|P1|Overall Study|Other Reason|5
1234378|NCT00699283|4047936|P2|Overall Study|Withdrawal by Subject|0
1234379|NCT00699283|4047937|P1|Overall Study|Withdrawal by Subject|1
1234380|NCT00699283|4047936|P2|Overall Study|Lost to Follow-up|0
1234381|NCT00699283|4047937|P1|Overall Study|Lost to Follow-up|2
1234382|NCT00699283|4047936|P2|Overall Study|Lack of Efficacy|5
1234383|NCT00699283|4047937|P1|Overall Study|Lack of Efficacy|15
1234384|NCT00699192|4047950|P3|Overall Study|Protocol Violation|0
1234385|NCT00699192|4047951|P2|Overall Study|Protocol Violation|2
1234386|NCT00699192|4047952|P1|Overall Study|Protocol Violation|2
1234387|NCT00699192|4047950|P3|Overall Study|Administrative problems|1
1234388|NCT00699192|4047951|P2|Overall Study|Administrative problems|3
1234389|NCT00699192|4047952|P1|Overall Study|Administrative problems|1
1234390|NCT00699192|4047950|P3|Overall Study|Withdrawal by Subject|4
1234391|NCT00699192|4047951|P2|Overall Study|Withdrawal by Subject|2
1234392|NCT00699192|4047952|P1|Overall Study|Withdrawal by Subject|3
1234393|NCT00699192|4047950|P3|Overall Study|Lack of Efficacy|1
1234394|NCT00699192|4047951|P2|Overall Study|Lack of Efficacy|0
1234395|NCT00699192|4047952|P1|Overall Study|Lack of Efficacy|0
1234396|NCT00699192|4047950|P3|Overall Study|Abnormal test procedure result(s)|1
1234397|NCT00699192|4047951|P2|Overall Study|Abnormal test procedure result(s)|0
1234398|NCT00699192|4047952|P1|Overall Study|Abnormal test procedure result(s)|0
1234399|NCT00699192|4047950|P3|Overall Study|Adverse Event|3
1234400|NCT00699192|4047951|P2|Overall Study|Adverse Event|4
1234401|NCT00699192|4047952|P1|Overall Study|Adverse Event|9
1234402|NCT00699192|4047950|P3|Overall Study|Missing|1
1234403|NCT00699192|4047951|P2|Overall Study|Missing|1
1234404|NCT00699192|4047952|P1|Overall Study|Missing|1
1234405|NCT00699153|4047974|P2|Overall Study|Travel Problem|0
1234406|NCT00699153|4047975|P1|Overall Study|Travel Problem|1
1234407|NCT00699153|4047974|P2|Overall Study|Protocol Violation|0
1234408|NCT00699153|4047975|P1|Overall Study|Protocol Violation|1
1234409|NCT00699153|4047974|P2|Overall Study|Adverse Event|2
1234410|NCT00699153|4047975|P1|Overall Study|Adverse Event|0
1234411|NCT00699153|4047974|P2|Overall Study|Lost to Follow-up|0
1234412|NCT00699153|4047975|P1|Overall Study|Lost to Follow-up|1
1234413|NCT00698932|4048010|P2|Overall Study|Death|0
1234414|NCT00698932|4048011|P1|Overall Study|Death|1
1234415|NCT00698932|4048010|P2|Overall Study|Safety reasons|2
1234416|NCT00698932|4048011|P1|Overall Study|Safety reasons|0
1234417|NCT00698932|4048010|P2|Overall Study|Severe non-compliance to protocol|2
1234418|NCT00698932|4048011|P1|Overall Study|Severe non-compliance to protocol|1
1234419|NCT00698932|4048010|P2|Overall Study|Lost to Follow-up|1
1234420|NCT00698932|4048011|P1|Overall Study|Lost to Follow-up|6
1234421|NCT00698932|4048010|P2|Overall Study|Withdrawal by Subject|23
1234422|NCT00698932|4048011|P1|Overall Study|Withdrawal by Subject|11
1234423|NCT00698932|4048010|P2|Overall Study|Study specific discontinuation criteria|4
1234424|NCT00698932|4048011|P1|Overall Study|Study specific discontinuation criteria|3
1234425|NCT00698932|4048010|P2|Overall Study|Incorrect enrollment|2
1234426|NCT00698932|4048011|P1|Overall Study|Incorrect enrollment|0
1234427|NCT00698932|4048010|P2|Overall Study|Adverse Event|2
1234428|NCT00698932|4048011|P1|Overall Study|Adverse Event|0
1234429|NCT00698841|4048037|P1|Overall Study|Other|2
1234430|NCT00698841|4048037|P1|Overall Study|Study drug toxicity|2
1234431|NCT00698841|4048037|P1|Overall Study|Failure to meet eligibility criteria|2
1234432|NCT00698841|4048037|P1|Overall Study|Disease progression|7
1234433|NCT00698841|4048037|P1|Overall Study|Adverse Event|3
1234434|NCT00698841|4048037|P1|Overall Study|Withdrawal by Subject|2
1234435|NCT00698815|4048051|P3|Overall Study|Did not receive protocol treatment|2
1234436|NCT00698815|4048052|P2|Overall Study|Did not receive protocol treatment|2
1234437|NCT00698815|4048053|P1|Overall Study|Did not receive protocol treatment|1
1234438|NCT00698815|4048051|P3|Overall Study|MD discretion|2
1234439|NCT00698815|4048052|P2|Overall Study|MD discretion|7
1234440|NCT00698815|4048053|P1|Overall Study|MD discretion|2
1234441|NCT00698815|4048051|P3|Overall Study|Withdrawal by Subject|2
1234442|NCT00698815|4048052|P2|Overall Study|Withdrawal by Subject|3
1234443|NCT00698815|4048053|P1|Overall Study|Withdrawal by Subject|6
1234444|NCT00698815|4048051|P3|Overall Study|Death|4
1234445|NCT00698815|4048052|P2|Overall Study|Death|2
1234446|NCT00698815|4048053|P1|Overall Study|Death|1
1234447|NCT00698685|4048070|P1|Overall Study|Off study pre transplant by clinic MD|1
1234448|NCT00698685|4048070|P1|Overall Study|Sister withdrew as donor|1
1234449|NCT00698646|4048078|P3|Overall Study|Administrative problems|1
1234450|NCT00698646|4048079|P2|Overall Study|Administrative problems|0
1234451|NCT00698646|4048080|P1|Overall Study|Administrative problems|1
1234452|NCT00698646|4048078|P3|Overall Study|Lost to Follow-up|2
1234453|NCT00698646|4048079|P2|Overall Study|Lost to Follow-up|0
1234454|NCT00698646|4048080|P1|Overall Study|Lost to Follow-up|0
1234455|NCT00698646|4048078|P3|Overall Study|Withdrawal by Subject|8
1234456|NCT00698646|4048079|P2|Overall Study|Withdrawal by Subject|11
1234457|NCT00698646|4048080|P1|Overall Study|Withdrawal by Subject|10
1234458|NCT00698646|4048078|P3|Overall Study|Protocol Deviation|3
1234459|NCT00698646|4048079|P2|Overall Study|Protocol Deviation|2
1234460|NCT00698646|4048080|P1|Overall Study|Protocol Deviation|6
1234461|NCT00698646|4048078|P3|Overall Study|Unsatisfactory Therapeutic Effect|7
1234462|NCT00698646|4048079|P2|Overall Study|Unsatisfactory Therapeutic Effect|11
1234463|NCT00698646|4048080|P1|Overall Study|Unsatisfactory Therapeutic Effect|11
1234464|NCT00698646|4048078|P3|Overall Study|Adverse Event|8
1234465|NCT00698646|4048079|P2|Overall Study|Adverse Event|7
1234466|NCT00698646|4048080|P1|Overall Study|Adverse Event|8
1234467|NCT00698581|4048105|P2|Overall Study|AE of unknown type|0
1234468|NCT00698581|4048106|P1|Overall Study|AE of unknown type|1
1234469|NCT00698581|4048105|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
1234470|NCT00698581|4048106|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
1234471|NCT00698581|4048105|P2|Overall Study|AE, non-serious non-fatal|0
1234472|NCT00698581|4048106|P1|Overall Study|AE, non-serious non-fatal|4
1234473|NCT00698581|4048105|P2|Overall Study|SAE, non-fatal|0
1234474|NCT00698581|4048106|P1|Overall Study|SAE, non-fatal|1
1234475|NCT00698581|4048105|P2|Overall Study|Other reason|1
1234476|NCT00698581|4048106|P1|Overall Study|Other reason|9
1234477|NCT00698581|4048105|P2|Overall Study|Withdrawal by Subject|0
1234478|NCT00698581|4048106|P1|Overall Study|Withdrawal by Subject|6
1234479|NCT00698581|4048105|P2|Overall Study|Lack of Efficacy|11
1234480|NCT00698581|4048106|P1|Overall Study|Lack of Efficacy|23
1234481|NCT00698516|4048117|P1|Overall Study|Withdrawal by Subject|3
1234482|NCT00698516|4048117|P1|Overall Study|Study Termination|2
1234483|NCT00698451|4048135|P1|Overall Study|Disease progression|3
1234484|NCT00698451|4048135|P1|Overall Study|Withdrawal by Subject|6
1234485|NCT00698451|4048135|P1|Overall Study|Protocol Violation|6
1234486|NCT00698451|4048135|P1|Overall Study|Physician Decision|2
1234487|NCT00698451|4048135|P1|Overall Study|Adverse Event|22
1234488|NCT00698204|4048142|P2|Overall Study|Withdrawal by Subject|0
1234489|NCT00698204|4048143|P1|Overall Study|Withdrawal by Subject|1
1234490|NCT00698009|4048203|P1|Overall Study|Withdrawal by Subject|1
1234491|NCT00697827|4048209|P2|Overall Study|enrolled but not treated|1
1234492|NCT00697827|4048210|P1|Overall Study|enrolled but not treated|2
1234493|NCT00697788|4048237|P8|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
1234494|NCT00697788|4048238|P7|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
1234495|NCT00697788|4048239|P6|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
1234496|NCT00697788|4048240|P5|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1
1234497|NCT00697788|4048241|P4|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
1234498|NCT00697788|4048242|P3|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
1234499|NCT00697788|4048243|P2|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
1234500|NCT00697788|4048244|P1|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
1234501|NCT00697788|4048237|P8|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
1234502|NCT00697788|4048238|P7|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
1234503|NCT00697788|4048239|P6|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
1234504|NCT00697788|4048240|P5|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
1234505|NCT00697788|4048241|P4|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
1234506|NCT00697788|4048242|P3|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
1234507|NCT00697788|4048243|P2|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2
1234590|NCT00696787|4048595|P1|Overall Study|Lost to Follow-up|4
1234508|NCT00697788|4048244|P1|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
1234509|NCT00697619|4048299|P2|Overall Study|Adverse Event|6
1234510|NCT00697619|4048300|P1|Overall Study|Adverse Event|4
1234511|NCT00697619|4048299|P2|Overall Study|Lack of Efficacy|2
1234512|NCT00697619|4048300|P1|Overall Study|Lack of Efficacy|2
1234513|NCT00697593|4048306|P1|Overall Study|Suspension of the study by sponsor|12
1234514|NCT00697593|4048306|P1|Overall Study|Lack of Efficacy|3
1234515|NCT00697593|4048306|P1|Overall Study|Protocol Violation|1
1234516|NCT00697593|4048306|P1|Overall Study|Adverse Event|3
1234517|NCT00697515|4048350|P2|Second Intervention (Crossover Period)|Withdrawal by Subject|1
1234518|NCT00697515|4048351|P1|Second Intervention (Crossover Period)|Withdrawal by Subject|1
1234519|NCT00697515|4048350|P2|First Intervention (Crossover Period)|Withdrawal by Subject|1
1234520|NCT00697515|4048351|P1|First Intervention (Crossover Period)|Withdrawal by Subject|2
1234521|NCT00697515|4048350|P2|First Intervention (Crossover Period)|Adverse Event|2
1234522|NCT00697515|4048351|P1|First Intervention (Crossover Period)|Adverse Event|0
1234523|NCT00697515|4048350|P2|First Intervention (Crossover Period)|Natural disaster|9
1234524|NCT00697515|4048351|P1|First Intervention (Crossover Period)|Natural disaster|8
1234525|NCT00697515|4048350|P2|Dose Optimization Period|elevated QTc|0
1234526|NCT00697515|4048351|P1|Dose Optimization Period|elevated QTc|1
1234527|NCT00697515|4048350|P2|Dose Optimization Period|called to active duty|0
1234528|NCT00697515|4048351|P1|Dose Optimization Period|called to active duty|1
1234529|NCT00697515|4048350|P2|Dose Optimization Period|sponsor request|0
1234530|NCT00697515|4048351|P1|Dose Optimization Period|sponsor request|2
1234531|NCT00697515|4048350|P2|Dose Optimization Period|Lost to Follow-up|0
1234532|NCT00697515|4048351|P1|Dose Optimization Period|Lost to Follow-up|2
1234533|NCT00697515|4048350|P2|Dose Optimization Period|Withdrawal by Subject|0
1234534|NCT00697515|4048351|P1|Dose Optimization Period|Withdrawal by Subject|5
1234535|NCT00697515|4048350|P2|Dose Optimization Period|Adverse Event|0
1234536|NCT00697515|4048351|P1|Dose Optimization Period|Adverse Event|4
1234537|NCT00697463|4048379|P1|Overall Study|Withdrawal by Subject|1
1234538|NCT00697255|4048385|P2|Stage 1b|Insufficient ovarian response|1
1234539|NCT00697255|4048386|P1|Stage 1b|Insufficient ovarian response|0
1234540|NCT00697255|4048385|P2|Stage 1b|Not growing of dominant follicle|1
1234541|NCT00697255|4048386|P1|Stage 1b|Not growing of dominant follicle|0
1234542|NCT00697255|4048385|P2|Stage 1a|Not growing of dominant follicle|0
1234543|NCT00697255|4048386|P1|Stage 1a|Not growing of dominant follicle|1
1234544|NCT00697255|4048385|P2|Stage 1a|Multifollicular growth|0
1234545|NCT00697255|4048386|P1|Stage 1a|Multifollicular growth|1
1234546|NCT00697255|4048385|P2|Stage 1a|Insufficient ovarian response|0
1234547|NCT00697255|4048386|P1|Stage 1a|Insufficient ovarian response|1
1234548|NCT00697112|4048437|P1|Overall Study|Did not meet inclusion criteria|1
1234549|NCT00697112|4048437|P1|Overall Study|Lost to Follow-up|1
1234550|NCT00697112|4048437|P1|Overall Study|Adverse Event|8
1234551|NCT00697073|4048461|P1|Overall Study|non compliance and other|6
1234552|NCT00697073|4048461|P1|Overall Study|Pregnancy|1
1234553|NCT00697073|4048461|P1|Overall Study|Withdrawal by Subject|2
1234554|NCT00696878|4048465|P1|Overall Study|Other reason (not specified)|55
1234555|NCT00696878|4048465|P1|Overall Study|Trial stopped|32
1234556|NCT00696878|4048465|P1|Overall Study|Pregnant prior to Treat Cycle 3|304
1234557|NCT00696878|4048465|P1|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18
1234558|NCT00696878|4048465|P1|Overall Study|Withdrawal by Subject|87
1234559|NCT00696878|4048465|P1|Overall Study|Adverse Event|8
1234560|NCT00696800|4048539|P2|Overall Study|Not treated|2
1234561|NCT00696800|4048540|P1|Overall Study|Not treated|1
1234562|NCT00696800|4048539|P2|Overall Study|Other Reasons|3
1234563|NCT00696800|4048540|P1|Overall Study|Other Reasons|5
1234564|NCT00696800|4048539|P2|Overall Study|No/too few/bad quality embryos|18
1234565|NCT00696800|4048540|P1|Overall Study|No/too few/bad quality embryos|24
1234566|NCT00696800|4048539|P2|Overall Study|No/abnormal fertilization|13
1234567|NCT00696800|4048540|P1|Overall Study|No/abnormal fertilization|11
1234568|NCT00696800|4048539|P2|Overall Study|No/too few/bad quality oocytes|3
1234569|NCT00696800|4048540|P1|Overall Study|No/too few/bad quality oocytes|4
1234570|NCT00696800|4048539|P2|Overall Study|Too high ovarian response|1
1234571|NCT00696800|4048540|P1|Overall Study|Too high ovarian response|6
1234572|NCT00696800|4048539|P2|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2
1234573|NCT00696800|4048540|P1|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8
1234574|NCT00696800|4048539|P2|Overall Study|Insufficient ovarian response|1
1234575|NCT00696800|4048540|P1|Overall Study|Insufficient ovarian response|4
1234576|NCT00696800|4048539|P2|Overall Study|Insufficient ovarian response on Day 8|1
1234577|NCT00696800|4048540|P1|Overall Study|Insufficient ovarian response on Day 8|4
1234578|NCT00696800|4048539|P2|Overall Study|Insufficient compliance with medication|1
1234579|NCT00696800|4048540|P1|Overall Study|Insufficient compliance with medication|2
1234580|NCT00696800|4048539|P2|Overall Study|Adverse Event|3
1234581|NCT00696800|4048540|P1|Overall Study|Adverse Event|16
1234582|NCT00696787|4048593|P3|Overall Study|Failed to return|1
1234583|NCT00696787|4048594|P2|Overall Study|Failed to return|3
1234584|NCT00696787|4048595|P1|Overall Study|Failed to return|1
1234585|NCT00696787|4048593|P3|Overall Study|Withdrawal by Subject|2
1234586|NCT00696787|4048594|P2|Overall Study|Withdrawal by Subject|3
1234587|NCT00696787|4048595|P1|Overall Study|Withdrawal by Subject|0
1234588|NCT00696787|4048593|P3|Overall Study|Lost to Follow-up|3
1234589|NCT00696787|4048594|P2|Overall Study|Lost to Follow-up|0
1234591|NCT00696787|4048593|P3|Overall Study|Lack of Efficacy|0
1234592|NCT00696787|4048594|P2|Overall Study|Lack of Efficacy|1
1234593|NCT00696787|4048595|P1|Overall Study|Lack of Efficacy|0
1234594|NCT00696787|4048593|P3|Overall Study|Discontinuation by Sponsor|14
1234595|NCT00696787|4048594|P2|Overall Study|Discontinuation by Sponsor|13
1234596|NCT00696787|4048595|P1|Overall Study|Discontinuation by Sponsor|9
1234597|NCT00696787|4048593|P3|Overall Study|Adverse Event|6
1234598|NCT00696787|4048594|P2|Overall Study|Adverse Event|0
1234599|NCT00696787|4048595|P1|Overall Study|Adverse Event|1
1234600|NCT00696774|4048609|P3|Period III|Lack of Efficacy|0
1234601|NCT00696774|4048610|P2|Period III|Lack of Efficacy|2
1234602|NCT00696774|4048611|P1|Period III|Lack of Efficacy|0
1234603|NCT00696774|4048609|P3|Period III|Sponsor Decision|0
1234604|NCT00696774|4048610|P2|Period III|Sponsor Decision|0
1234605|NCT00696774|4048611|P1|Period III|Sponsor Decision|2
1234606|NCT00696774|4048609|P3|Period III|Withdrawal by Subject|0
1234607|NCT00696774|4048610|P2|Period III|Withdrawal by Subject|2
1234608|NCT00696774|4048611|P1|Period III|Withdrawal by Subject|1
1234609|NCT00696774|4048609|P3|Period III|Protocol Violation|0
1234610|NCT00696774|4048610|P2|Period III|Protocol Violation|1
1234611|NCT00696774|4048611|P1|Period III|Protocol Violation|1
1234612|NCT00696774|4048609|P3|Period III|Lost to Follow-up|0
1234613|NCT00696774|4048610|P2|Period III|Lost to Follow-up|1
1234614|NCT00696774|4048611|P1|Period III|Lost to Follow-up|2
1234615|NCT00696774|4048609|P3|Period III|Adverse Event|0
1234616|NCT00696774|4048610|P2|Period III|Adverse Event|1
1234617|NCT00696774|4048611|P1|Period III|Adverse Event|1
1234618|NCT00696774|4048609|P3|Period II|Lack of Efficacy|2
1234619|NCT00696774|4048610|P2|Period II|Lack of Efficacy|0
1234620|NCT00696774|4048611|P1|Period II|Lack of Efficacy|0
1234621|NCT00696774|4048609|P3|Period II|Sponsor Decision|0
1234622|NCT00696774|4048610|P2|Period II|Sponsor Decision|0
1234623|NCT00696774|4048611|P1|Period II|Sponsor Decision|0
1234624|NCT00696774|4048609|P3|Period II|Withdrawal by Subject|4
1234625|NCT00696774|4048610|P2|Period II|Withdrawal by Subject|0
1234626|NCT00696774|4048611|P1|Period II|Withdrawal by Subject|0
1234627|NCT00696774|4048609|P3|Period II|Protocol Violation|11
1234628|NCT00696774|4048610|P2|Period II|Protocol Violation|0
1234629|NCT00696774|4048611|P1|Period II|Protocol Violation|0
1234630|NCT00696774|4048609|P3|Period II|Lost to Follow-up|4
1234631|NCT00696774|4048610|P2|Period II|Lost to Follow-up|0
1234632|NCT00696774|4048611|P1|Period II|Lost to Follow-up|0
1234633|NCT00696774|4048609|P3|Period II|Adverse Event|15
1234634|NCT00696774|4048610|P2|Period II|Adverse Event|0
1234635|NCT00696774|4048611|P1|Period II|Adverse Event|0
1234636|NCT00696696|4048666|P1|Overall Study|Death|3
1234637|NCT00696696|4048666|P1|Overall Study|Physician Decision|2
1234638|NCT00696696|4048666|P1|Overall Study|Withdrawal by Subject|8
1234639|NCT00696696|4048666|P1|Overall Study|Adverse Event|5
1234640|NCT00696657|4048681|P9|Overall Study|Adverse Event|5
1234641|NCT00696657|4048682|P8|Overall Study|Adverse Event|2
1234642|NCT00696657|4048683|P7|Overall Study|Adverse Event|14
1234643|NCT00696657|4048684|P6|Overall Study|Adverse Event|9
1234644|NCT00696657|4048685|P5|Overall Study|Adverse Event|6
1234645|NCT00696657|4048686|P4|Overall Study|Adverse Event|7
1234646|NCT00696657|4048687|P3|Overall Study|Adverse Event|3
1234647|NCT00696657|4048688|P2|Overall Study|Adverse Event|0
1234648|NCT00696657|4048689|P1|Overall Study|Adverse Event|0
1234649|NCT00696657|4048681|P9|Overall Study|Unclassified|1
1234650|NCT00696657|4048682|P8|Overall Study|Unclassified|0
1234651|NCT00696657|4048683|P7|Overall Study|Unclassified|0
1234652|NCT00696657|4048684|P6|Overall Study|Unclassified|2
1234653|NCT00696657|4048685|P5|Overall Study|Unclassified|4
1234654|NCT00696657|4048686|P4|Overall Study|Unclassified|2
1234655|NCT00696657|4048687|P3|Overall Study|Unclassified|3
1234656|NCT00696657|4048688|P2|Overall Study|Unclassified|1
1234657|NCT00696657|4048689|P1|Overall Study|Unclassified|0
1234658|NCT00696657|4048681|P9|Overall Study|Withdrawal criteria|2
1234659|NCT00696657|4048682|P8|Overall Study|Withdrawal criteria|1
1234660|NCT00696657|4048683|P7|Overall Study|Withdrawal criteria|1
1234661|NCT00696657|4048684|P6|Overall Study|Withdrawal criteria|0
1234662|NCT00696657|4048685|P5|Overall Study|Withdrawal criteria|0
1234663|NCT00696657|4048686|P4|Overall Study|Withdrawal criteria|2
1234664|NCT00696657|4048687|P3|Overall Study|Withdrawal criteria|2
1234665|NCT00696657|4048688|P2|Overall Study|Withdrawal criteria|3
1234666|NCT00696657|4048689|P1|Overall Study|Withdrawal criteria|1
1234667|NCT00696657|4048681|P9|Overall Study|Lack of Efficacy|0
1234668|NCT00696657|4048682|P8|Overall Study|Lack of Efficacy|0
1234669|NCT00696657|4048683|P7|Overall Study|Lack of Efficacy|0
1234670|NCT00696657|4048684|P6|Overall Study|Lack of Efficacy|0
1234671|NCT00696657|4048685|P5|Overall Study|Lack of Efficacy|0
1234672|NCT00696657|4048686|P4|Overall Study|Lack of Efficacy|0
1234673|NCT00696657|4048687|P3|Overall Study|Lack of Efficacy|0
1234674|NCT00696657|4048688|P2|Overall Study|Lack of Efficacy|1
1234675|NCT00696657|4048689|P1|Overall Study|Lack of Efficacy|0
1234676|NCT00696657|4048681|P9|Overall Study|Protocol Violation|1
1234677|NCT00696657|4048682|P8|Overall Study|Protocol Violation|0
1234678|NCT00696657|4048683|P7|Overall Study|Protocol Violation|0
1234679|NCT00696657|4048684|P6|Overall Study|Protocol Violation|1
1234680|NCT00696657|4048685|P5|Overall Study|Protocol Violation|0
1234681|NCT00696657|4048686|P4|Overall Study|Protocol Violation|0
1234682|NCT00696657|4048687|P3|Overall Study|Protocol Violation|0
1242238|NCT00632931|4075306|P1|Part 2|Death|0
1234683|NCT00696657|4048688|P2|Overall Study|Protocol Violation|0
1234684|NCT00696657|4048689|P1|Overall Study|Protocol Violation|0
1234685|NCT00696436|4049058|P5|Overall Study|Missing|0
1234686|NCT00696436|4049059|P4|Overall Study|Missing|0
1234687|NCT00696436|4049060|P3|Overall Study|Missing|1
1234688|NCT00696436|4049061|P2|Overall Study|Missing|1
1234689|NCT00696436|4049062|P1|Overall Study|Missing|0
1234690|NCT00696436|4049058|P5|Overall Study|Administrative Decision|0
1234691|NCT00696436|4049059|P4|Overall Study|Administrative Decision|0
1234692|NCT00696436|4049060|P3|Overall Study|Administrative Decision|0
1234693|NCT00696436|4049061|P2|Overall Study|Administrative Decision|0
1234694|NCT00696436|4049062|P1|Overall Study|Administrative Decision|1
1234695|NCT00696436|4049058|P5|Overall Study|Participant Non-compliance|0
1234696|NCT00696436|4049059|P4|Overall Study|Participant Non-compliance|2
1234697|NCT00696436|4049060|P3|Overall Study|Participant Non-compliance|1
1234698|NCT00696436|4049061|P2|Overall Study|Participant Non-compliance|0
1234699|NCT00696436|4049062|P1|Overall Study|Participant Non-compliance|0
1234700|NCT00696436|4049058|P5|Overall Study|Administrative Error|0
1234701|NCT00696436|4049059|P4|Overall Study|Administrative Error|0
1234702|NCT00696436|4049060|P3|Overall Study|Administrative Error|2
1234703|NCT00696436|4049061|P2|Overall Study|Administrative Error|0
1234704|NCT00696436|4049062|P1|Overall Study|Administrative Error|2
1234705|NCT00696436|4049058|P5|Overall Study|Participant Unavailability|0
1234706|NCT00696436|4049059|P4|Overall Study|Participant Unavailability|1
1234707|NCT00696436|4049060|P3|Overall Study|Participant Unavailability|2
1234708|NCT00696436|4049061|P2|Overall Study|Participant Unavailability|0
1234709|NCT00696436|4049062|P1|Overall Study|Participant Unavailability|2
1234710|NCT00696436|4049058|P5|Overall Study|Lack of Efficacy|4
1234711|NCT00696436|4049059|P4|Overall Study|Lack of Efficacy|2
1234712|NCT00696436|4049060|P3|Overall Study|Lack of Efficacy|5
1234713|NCT00696436|4049061|P2|Overall Study|Lack of Efficacy|1
1234714|NCT00696436|4049062|P1|Overall Study|Lack of Efficacy|3
1234715|NCT00696436|4049058|P5|Overall Study|Withdrawal by Subject|1
1234716|NCT00696436|4049059|P4|Overall Study|Withdrawal by Subject|7
1234717|NCT00696436|4049060|P3|Overall Study|Withdrawal by Subject|5
1234718|NCT00696436|4049061|P2|Overall Study|Withdrawal by Subject|11
1234719|NCT00696436|4049062|P1|Overall Study|Withdrawal by Subject|4
1234720|NCT00696436|4049058|P5|Overall Study|Lost to Follow-up|3
1234721|NCT00696436|4049059|P4|Overall Study|Lost to Follow-up|4
1234722|NCT00696436|4049060|P3|Overall Study|Lost to Follow-up|2
1234723|NCT00696436|4049061|P2|Overall Study|Lost to Follow-up|6
1234724|NCT00696436|4049062|P1|Overall Study|Lost to Follow-up|1
1234725|NCT00696436|4049058|P5|Overall Study|Protocol Violation|1
1234726|NCT00696436|4049059|P4|Overall Study|Protocol Violation|0
1234727|NCT00696436|4049060|P3|Overall Study|Protocol Violation|2
1234728|NCT00696436|4049061|P2|Overall Study|Protocol Violation|2
1234729|NCT00696436|4049062|P1|Overall Study|Protocol Violation|3
1234730|NCT00696436|4049058|P5|Overall Study|Adverse Event|4
1234731|NCT00696436|4049059|P4|Overall Study|Adverse Event|6
1234732|NCT00696436|4049060|P3|Overall Study|Adverse Event|8
1234733|NCT00696436|4049061|P2|Overall Study|Adverse Event|9
1234734|NCT00696436|4049062|P1|Overall Study|Adverse Event|7
1234735|NCT00696423|4049146|P2|Overall Study|Lost to Follow-up|5
1234736|NCT00696423|4049147|P1|Overall Study|Lost to Follow-up|0
1234737|NCT00696410|4049179|P2|Overall Study|Physician Decision|0
1234738|NCT00696410|4049180|P1|Overall Study|Physician Decision|3
1234739|NCT00696410|4049179|P2|Overall Study|Withdrawal by Subject|0
1234740|NCT00696410|4049180|P1|Overall Study|Withdrawal by Subject|8
1234741|NCT00696410|4049179|P2|Overall Study|Lost to Follow-up|0
1234742|NCT00696410|4049180|P1|Overall Study|Lost to Follow-up|2
1234743|NCT00696384|4049194|P3|Double Blind Phase|Physician Decision|0
1234744|NCT00696384|4049195|P2|Double Blind Phase|Physician Decision|2
1234745|NCT00696384|4049196|P1|Double Blind Phase|Physician Decision|0
1234746|NCT00696384|4049194|P3|Double Blind Phase|Lack of Efficacy|0
1234747|NCT00696384|4049195|P2|Double Blind Phase|Lack of Efficacy|1
1234748|NCT00696384|4049196|P1|Double Blind Phase|Lack of Efficacy|0
1234749|NCT00696384|4049194|P3|Double Blind Phase|Withdrawal by Subject|3
1234750|NCT00696384|4049195|P2|Double Blind Phase|Withdrawal by Subject|4
1234751|NCT00696384|4049196|P1|Double Blind Phase|Withdrawal by Subject|0
1234752|NCT00696384|4049194|P3|Double Blind Phase|Lost to Follow-up|1
1234753|NCT00696384|4049195|P2|Double Blind Phase|Lost to Follow-up|2
1234754|NCT00696384|4049196|P1|Double Blind Phase|Lost to Follow-up|0
1234755|NCT00696384|4049194|P3|Double Blind Phase|Adverse Event|2
1234756|NCT00696384|4049195|P2|Double Blind Phase|Adverse Event|2
1234757|NCT00696384|4049196|P1|Double Blind Phase|Adverse Event|0
1234758|NCT00696384|4049194|P3|Open Label Phase|Physician Decision|0
1234759|NCT00696384|4049195|P2|Open Label Phase|Physician Decision|0
1234760|NCT00696384|4049196|P1|Open Label Phase|Physician Decision|4
1234761|NCT00696384|4049194|P3|Open Label Phase|Lack of Efficacy|0
1234762|NCT00696384|4049195|P2|Open Label Phase|Lack of Efficacy|0
1234763|NCT00696384|4049196|P1|Open Label Phase|Lack of Efficacy|3
1234764|NCT00696384|4049194|P3|Open Label Phase|Other|0
1234765|NCT00696384|4049195|P2|Open Label Phase|Other|0
1234766|NCT00696384|4049196|P1|Open Label Phase|Other|6
1234767|NCT00696384|4049194|P3|Open Label Phase|Withdrawal by Subject|0
1234768|NCT00696384|4049195|P2|Open Label Phase|Withdrawal by Subject|0
1234769|NCT00696384|4049196|P1|Open Label Phase|Withdrawal by Subject|37
1234770|NCT00696384|4049194|P3|Open Label Phase|Lost to Follow-up|0
1234771|NCT00696384|4049195|P2|Open Label Phase|Lost to Follow-up|0
1234772|NCT00696384|4049196|P1|Open Label Phase|Lost to Follow-up|24
1234773|NCT00696384|4049194|P3|Open Label Phase|Protocol Violation|0
1234774|NCT00696384|4049195|P2|Open Label Phase|Protocol Violation|0
1234775|NCT00696384|4049196|P1|Open Label Phase|Protocol Violation|18
1234776|NCT00696384|4049194|P3|Open Label Phase|Adverse Event|0
1234777|NCT00696384|4049195|P2|Open Label Phase|Adverse Event|0
1234778|NCT00696384|4049196|P1|Open Label Phase|Adverse Event|27
1234779|NCT00696241|4049220|P5|Overall Study|Other|1
1234780|NCT00696241|4049221|P4|Overall Study|Other|2
1234781|NCT00696241|4049222|P3|Overall Study|Other|5
1234782|NCT00696241|4049223|P2|Overall Study|Other|1
1234783|NCT00696241|4049224|P1|Overall Study|Other|6
1234784|NCT00696241|4049220|P5|Overall Study|Lack of Efficacy|3
1234785|NCT00696241|4049221|P4|Overall Study|Lack of Efficacy|5
1234786|NCT00696241|4049222|P3|Overall Study|Lack of Efficacy|4
1234787|NCT00696241|4049223|P2|Overall Study|Lack of Efficacy|5
1234788|NCT00696241|4049224|P1|Overall Study|Lack of Efficacy|1
1234789|NCT00696241|4049220|P5|Overall Study|Withdrawal by Subject|0
1234790|NCT00696241|4049221|P4|Overall Study|Withdrawal by Subject|1
1234791|NCT00696241|4049222|P3|Overall Study|Withdrawal by Subject|6
1234792|NCT00696241|4049223|P2|Overall Study|Withdrawal by Subject|8
1234793|NCT00696241|4049224|P1|Overall Study|Withdrawal by Subject|4
1234794|NCT00696241|4049220|P5|Overall Study|Lost to Follow-up|0
1234795|NCT00696241|4049221|P4|Overall Study|Lost to Follow-up|2
1234796|NCT00696241|4049222|P3|Overall Study|Lost to Follow-up|1
1234797|NCT00696241|4049223|P2|Overall Study|Lost to Follow-up|4
1234798|NCT00696241|4049224|P1|Overall Study|Lost to Follow-up|1
1234799|NCT00696241|4049220|P5|Overall Study|Protocol Violation|3
1234800|NCT00696241|4049221|P4|Overall Study|Protocol Violation|0
1234801|NCT00696241|4049222|P3|Overall Study|Protocol Violation|2
1234802|NCT00696241|4049223|P2|Overall Study|Protocol Violation|1
1234803|NCT00696241|4049224|P1|Overall Study|Protocol Violation|1
1234804|NCT00696241|4049220|P5|Overall Study|Adverse Event|5
1234805|NCT00696241|4049221|P4|Overall Study|Adverse Event|4
1234806|NCT00696241|4049222|P3|Overall Study|Adverse Event|6
1234807|NCT00696241|4049223|P2|Overall Study|Adverse Event|3
1234808|NCT00696241|4049224|P1|Overall Study|Adverse Event|11
1234809|NCT00696137|4049306|P1|Overall Study|Withdrawal by Subject|2
1234810|NCT00696072|4049312|P2|Overall Study|Non-specified|2
1234811|NCT00696072|4049313|P1|Overall Study|Non-specified|1
1234812|NCT00696072|4049312|P2|Overall Study|Disease Progression|30
1234813|NCT00696072|4049313|P1|Overall Study|Disease Progression|32
1234814|NCT00696072|4049312|P2|Overall Study|Sponsor Request|1
1234815|NCT00696072|4049313|P1|Overall Study|Sponsor Request|0
1234816|NCT00696072|4049312|P2|Overall Study|Investigator Request|4
1234817|NCT00696072|4049313|P1|Overall Study|Investigator Request|1
1234818|NCT00696072|4049312|P2|Overall Study|Patient Request|7
1234819|NCT00696072|4049313|P1|Overall Study|Patient Request|3
1234820|NCT00696072|4049312|P2|Overall Study|Adverse Event|6
1234821|NCT00696072|4049313|P1|Overall Study|Adverse Event|10
1234822|NCT00696072|4049312|P2|Overall Study|continuing active treatment|13
1234823|NCT00696072|4049313|P1|Overall Study|continuing active treatment|10
1234824|NCT00696020|4049334|P4|Overall Study|Other not stated above|1
1234825|NCT00696020|4049335|P3|Overall Study|Other not stated above|1
1234826|NCT00696020|4049336|P2|Overall Study|Other not stated above|0
1234827|NCT00696020|4049337|P1|Overall Study|Other not stated above|0
1234828|NCT00696020|4049334|P4|Overall Study|Withdrawal by Subject|1
1234829|NCT00696020|4049335|P3|Overall Study|Withdrawal by Subject|0
1234830|NCT00696020|4049336|P2|Overall Study|Withdrawal by Subject|1
1234831|NCT00696020|4049337|P1|Overall Study|Withdrawal by Subject|0
1234832|NCT00696020|4049334|P4|Overall Study|Protocol Violation|1
1234833|NCT00696020|4049335|P3|Overall Study|Protocol Violation|0
1234834|NCT00696020|4049336|P2|Overall Study|Protocol Violation|0
1234835|NCT00696020|4049337|P1|Overall Study|Protocol Violation|0
1234836|NCT00696020|4049334|P4|Overall Study|Lack of Efficacy|0
1234837|NCT00696020|4049335|P3|Overall Study|Lack of Efficacy|0
1234838|NCT00696020|4049336|P2|Overall Study|Lack of Efficacy|0
1234839|NCT00696020|4049337|P1|Overall Study|Lack of Efficacy|1
1234840|NCT00696020|4049334|P4|Overall Study|Adverse Event|1
1234841|NCT00696020|4049335|P3|Overall Study|Adverse Event|2
1234842|NCT00696020|4049336|P2|Overall Study|Adverse Event|1
1234843|NCT00696020|4049337|P1|Overall Study|Adverse Event|3
1234844|NCT00695955|4049445|P1|Cohort 2|Other|5
1234845|NCT00695955|4049445|P1|Cohort 2|Lack of Efficacy|4
1234846|NCT00695955|4049445|P1|Cohort 2|Withdrawal by Subject|28
1234847|NCT00695955|4049445|P1|Cohort 2|Lost to Follow-up|38
1234848|NCT00695955|4049445|P1|Cohort 2|Protocol Violation|5
1234849|NCT00695955|4049445|P1|Cohort 2|Adverse Event|24
1234850|NCT00695955|4049445|P1|Cohort 1|Other|16
1234851|NCT00695955|4049445|P1|Cohort 1|Lack of Efficacy|3
1234852|NCT00695955|4049445|P1|Cohort 1|Withdrawal by Subject|25
1234853|NCT00695955|4049445|P1|Cohort 1|Lost to Follow-up|30
1234854|NCT00695955|4049445|P1|Cohort 1|Protocol Violation|2
1234855|NCT00695955|4049445|P1|Cohort 1|Adverse Event|26
1234856|NCT00695903|4049457|P2|Had Test of Cure (TOC) Assessment|Adverse Event|1
1234857|NCT00695903|4049458|P1|Had Test of Cure (TOC) Assessment|Adverse Event|0
1234858|NCT00695903|4049457|P2|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0
1234859|NCT00695903|4049458|P1|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1
1234860|NCT00695903|4049457|P2|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0
1234861|NCT00695903|4049458|P1|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1
1234862|NCT00695903|4049457|P2|Had End of Therapy (EOT) Assessment|Protocol Violation|2
1234863|NCT00695903|4049458|P1|Had End of Therapy (EOT) Assessment|Protocol Violation|1
1234864|NCT00695903|4049457|P2|Had End of Therapy (EOT) Assessment|Physician Decision|1
1234865|NCT00695903|4049458|P1|Had End of Therapy (EOT) Assessment|Physician Decision|0
1234866|NCT00695903|4049457|P2|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
1234867|NCT00695903|4049458|P1|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
1234868|NCT00695903|4049457|P2|Had End of Therapy (EOT) Assessment|Adverse Event|0
1234869|NCT00695903|4049458|P1|Had End of Therapy (EOT) Assessment|Adverse Event|1
1234870|NCT00695903|4049457|P2|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
1234871|NCT00695903|4049458|P1|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
1234872|NCT00695903|4049457|P2|Had End of Therapy (EOT) Assessment|Randomized not treated|2
1234873|NCT00695903|4049458|P1|Had End of Therapy (EOT) Assessment|Randomized not treated|0
1234874|NCT00695864|4049470|P1|Placebo|Physician Decision|4
1234875|NCT00695864|4049470|P1|Placebo|Withdrawal by Subject|1
1234876|NCT00695669|4049480|P4|Overall Study|Lost to Follow-up|4
1234877|NCT00695669|4049481|P3|Overall Study|Lost to Follow-up|1
1234878|NCT00695669|4049482|P2|Overall Study|Lost to Follow-up|4
1234879|NCT00695669|4049483|P1|Overall Study|Lost to Follow-up|4
1234880|NCT00695669|4049480|P4|Overall Study|Adverse Event|0
1234881|NCT00695669|4049481|P3|Overall Study|Adverse Event|2
1234882|NCT00695669|4049482|P2|Overall Study|Adverse Event|0
1234883|NCT00695669|4049483|P1|Overall Study|Adverse Event|0
1234884|NCT00695565|4049568|P2|Overall Study|Subject did not follow instructions|1
1234885|NCT00695565|4049569|P1|Overall Study|Subject did not follow instructions|1
1234886|NCT00695565|4049568|P2|Overall Study|Lack of Efficacy|1
1234887|NCT00695565|4049569|P1|Overall Study|Lack of Efficacy|1
1234888|NCT00695565|4049568|P2|Overall Study|Withdrawal by Subject|1
1234889|NCT00695565|4049569|P1|Overall Study|Withdrawal by Subject|1
1234890|NCT00695565|4049568|P2|Overall Study|Protocol Violation|1
1234891|NCT00695565|4049569|P1|Overall Study|Protocol Violation|3
1234892|NCT00695565|4049568|P2|Overall Study|Adverse Event|1
1234893|NCT00695565|4049569|P1|Overall Study|Adverse Event|3
1234894|NCT00695565|4049568|P2|Overall Study|Lost to Follow-up|4
1234895|NCT00695565|4049569|P1|Overall Study|Lost to Follow-up|4
1234896|NCT00695396|4049642|P3|Overall Study|Withdrawal by Subject|0
1234897|NCT00695396|4049643|P2|Overall Study|Withdrawal by Subject|2
1234898|NCT00695396|4049644|P1|Overall Study|Withdrawal by Subject|2
1234899|NCT00695396|4049642|P3|Overall Study|Study Closed Prematurely|8
1234900|NCT00695396|4049643|P2|Overall Study|Study Closed Prematurely|6
1234901|NCT00695396|4049644|P1|Overall Study|Study Closed Prematurely|5
1234902|NCT00695318|4049660|P2|Overall Study|Study Terminated|0
1234903|NCT00695318|4049661|P1|Overall Study|Study Terminated|1
1234904|NCT00695318|4049660|P2|Overall Study|Death|1
1234905|NCT00695318|4049661|P1|Overall Study|Death|1
1234906|NCT00695318|4049660|P2|Overall Study|Withdrawal by Subject|0
1234907|NCT00695318|4049661|P1|Overall Study|Withdrawal by Subject|2
1234908|NCT00695318|4049660|P2|Overall Study|Lost to Follow-up|0
1234909|NCT00695318|4049661|P1|Overall Study|Lost to Follow-up|1
1234910|NCT00695136|4049686|P1|Overall Study|unrelated adverse event|1
1234911|NCT00695136|4049686|P1|Overall Study|Withdrawal by Subject|1
1234912|NCT00695019|4049702|P3|Overall Study|Various|4
1234913|NCT00695019|4049703|P2|Overall Study|Various|5
1234914|NCT00695019|4049704|P1|Overall Study|Various|4
1234915|NCT00695019|4049702|P3|Overall Study|Lack of Efficacy|1
1234916|NCT00695019|4049703|P2|Overall Study|Lack of Efficacy|0
1234917|NCT00695019|4049704|P1|Overall Study|Lack of Efficacy|0
1234918|NCT00695019|4049702|P3|Overall Study|Protocol Violation|1
1234919|NCT00695019|4049703|P2|Overall Study|Protocol Violation|3
1234920|NCT00695019|4049704|P1|Overall Study|Protocol Violation|1
1234921|NCT00695019|4049702|P3|Overall Study|Withdrawal by Subject|4
1234922|NCT00695019|4049703|P2|Overall Study|Withdrawal by Subject|6
1234923|NCT00695019|4049704|P1|Overall Study|Withdrawal by Subject|8
1234924|NCT00694551|4049745|P3|Overall Study|Disease Progression|1
1234925|NCT00694551|4049746|P2|Overall Study|Disease Progression|0
1234926|NCT00694551|4049747|P1|Overall Study|Disease Progression|1
1234927|NCT00694369|4049776|P5|Overall Study|Withdrawal by Subject|2
1234928|NCT00694369|4049777|P4|Overall Study|Withdrawal by Subject|1
1234929|NCT00694369|4049778|P3|Overall Study|Withdrawal by Subject|1
1234930|NCT00694369|4049779|P2|Overall Study|Withdrawal by Subject|1
1234931|NCT00694369|4049780|P1|Overall Study|Withdrawal by Subject|1
1234932|NCT00694369|4049776|P5|Overall Study|Protocol Violation|0
1234933|NCT00694369|4049777|P4|Overall Study|Protocol Violation|0
1234934|NCT00694369|4049778|P3|Overall Study|Protocol Violation|0
1234935|NCT00694369|4049779|P2|Overall Study|Protocol Violation|1
1234936|NCT00694369|4049780|P1|Overall Study|Protocol Violation|0
1234937|NCT00694369|4049776|P5|Overall Study|Physician Decision|1
1234938|NCT00694369|4049777|P4|Overall Study|Physician Decision|0
1234939|NCT00694369|4049778|P3|Overall Study|Physician Decision|0
1234940|NCT00694369|4049779|P2|Overall Study|Physician Decision|0
1234941|NCT00694369|4049780|P1|Overall Study|Physician Decision|0
1234942|NCT00694369|4049776|P5|Overall Study|Lost to Follow-up|0
1234943|NCT00694369|4049777|P4|Overall Study|Lost to Follow-up|1
1234944|NCT00694369|4049778|P3|Overall Study|Lost to Follow-up|1
1234945|NCT00694369|4049779|P2|Overall Study|Lost to Follow-up|0
1234946|NCT00694369|4049780|P1|Overall Study|Lost to Follow-up|0
1234947|NCT00694369|4049776|P5|Overall Study|Adverse Event|3
1234948|NCT00694369|4049777|P4|Overall Study|Adverse Event|1
1234949|NCT00694369|4049778|P3|Overall Study|Adverse Event|0
1234950|NCT00694369|4049779|P2|Overall Study|Adverse Event|1
1234951|NCT00694369|4049780|P1|Overall Study|Adverse Event|0
1234952|NCT00694356|4049800|P3|Overall Study|Progressive Disease|6
1234953|NCT00694356|4049801|P2|Overall Study|Progressive Disease|6
1234954|NCT00694356|4049802|P1|Overall Study|Progressive Disease|2
1234955|NCT00694356|4049800|P3|Overall Study|Adverse Event|0
1234956|NCT00694356|4049801|P2|Overall Study|Adverse Event|0
1234957|NCT00694356|4049802|P1|Overall Study|Adverse Event|1
1234958|NCT00694304|4049837|P1|Overall Study|Administrative or Other Reasons|32
1234959|NCT00694304|4049837|P1|Overall Study|Lost to Follow-up|15
1234960|NCT00694304|4049837|P1|Overall Study|Withdrawal of Consent|61
1234961|NCT00694304|4049837|P1|Overall Study|Protocol Violation|6
1234962|NCT00694304|4049837|P1|Overall Study|Non-compliance With Study Product|16
1234963|NCT00694304|4049837|P1|Overall Study|Lack of Efficacy|35
1234964|NCT00694304|4049837|P1|Overall Study|Adverse Event|42
1234965|NCT00694161|4049850|P1|Part 2 (After Week 6 up to Month 12)|Death|1
1234966|NCT00694161|4049850|P1|Part 2 (After Week 6 up to Month 12)|Physician Decision|1
1234967|NCT00694161|4049850|P1|Part 2 (After Week 6 up to Month 12)|Adverse Event|1
1234968|NCT00694122|4049889|P2|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1
1234969|NCT00694122|4049890|P1|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2
1234970|NCT00694122|4049889|P2|First Intervention (3-4 Weeks)|Lost to Follow-up|1
1234971|NCT00694122|4049890|P1|First Intervention (3-4 Weeks)|Lost to Follow-up|1
1234972|NCT00694122|4049889|P2|First Intervention (3-4 Weeks)|Withdrawal by Subject|0
1234973|NCT00694122|4049890|P1|First Intervention (3-4 Weeks)|Withdrawal by Subject|7
1234974|NCT00694109|4049906|P1|Overall Study|Consented but no additional treatment|3
1234975|NCT00694109|4049906|P1|Overall Study|Other|2
1234976|NCT00694109|4049906|P1|Overall Study|Enrolled but not treated|1
1234977|NCT00694109|4049906|P1|Overall Study|Pregnancy|1
1234978|NCT00694109|4049906|P1|Overall Study|Withdrawal by Subject|13
1234979|NCT00694109|4049906|P1|Overall Study|Lack of Efficacy|2
1234980|NCT00694109|4049906|P1|Overall Study|Not consent of more 2 years of treatment|18
1234981|NCT00694109|4049906|P1|Overall Study|Adverse Event|74
1234982|NCT00694109|4049906|P1|Overall Study|Physician Decision|3
1234983|NCT00694096|4049930|P1|Overall Study|Withdrawal by Subject|5
1234984|NCT00693784|4049970|P1|Overall Study|Withdrawal by Subject|2
1234985|NCT00693784|4049970|P1|Overall Study|Lost to Follow-up|2
1234986|NCT00693706|4049983|P2|Overall Study|Protocol Violation|1
1234987|NCT00693706|4049984|P1|Overall Study|Protocol Violation|0
1234988|NCT00693693|4050011|P3|Overall Study|Lost to Follow-up|2
1234989|NCT00693693|4050012|P2|Overall Study|Lost to Follow-up|1
1234990|NCT00693693|4050013|P1|Overall Study|Lost to Follow-up|1
1234991|NCT00693472|4050072|P4|Part 2|Withdrew - reason unrelated to treatment|2
1234992|NCT00693472|4050073|P3|Part 2|Withdrew - reason unrelated to treatment|1
1234993|NCT00693472|4050074|P2|Part 2|Withdrew - reason unrelated to treatment|0
1234994|NCT00693472|4050075|P1|Part 2|Withdrew - reason unrelated to treatment|0
1234995|NCT00693472|4050072|P4|Part 2|Adverse Event|0
1234996|NCT00693472|4050073|P3|Part 2|Adverse Event|1
1234997|NCT00693472|4050074|P2|Part 2|Adverse Event|0
1234998|NCT00693472|4050075|P1|Part 2|Adverse Event|0
1234999|NCT00693472|4050072|P4|Part 1|Withdrew - reason unrelated to treatment|0
1235000|NCT00693472|4050073|P3|Part 1|Withdrew - reason unrelated to treatment|0
1235001|NCT00693472|4050074|P2|Part 1|Withdrew - reason unrelated to treatment|2
1235002|NCT00693472|4050075|P1|Part 1|Withdrew - reason unrelated to treatment|5
1235003|NCT00693472|4050072|P4|Part 1|Lost to Follow-up|0
1235004|NCT00693472|4050073|P3|Part 1|Lost to Follow-up|0
1235005|NCT00693472|4050074|P2|Part 1|Lost to Follow-up|1
1235006|NCT00693472|4050075|P1|Part 1|Lost to Follow-up|0
1235007|NCT00693472|4050072|P4|Part 1|Adverse Event|0
1235008|NCT00693472|4050073|P3|Part 1|Adverse Event|0
1235009|NCT00693472|4050074|P2|Part 1|Adverse Event|1
1235010|NCT00693472|4050075|P1|Part 1|Adverse Event|1
1235011|NCT00693420|4050095|P2|Overall Study|Personal Reasons|4
1235012|NCT00693420|4050096|P1|Overall Study|Personal Reasons|1
1235013|NCT00693420|4050095|P2|Overall Study|Sponsor Request - Conflict of Interest|2
1235014|NCT00693420|4050096|P1|Overall Study|Sponsor Request - Conflict of Interest|0
1235015|NCT00693420|4050095|P2|Overall Study|Protocol Violation|2
1235016|NCT00693420|4050096|P1|Overall Study|Protocol Violation|0
1235017|NCT00693420|4050095|P2|Overall Study|Withdrawal by Subject|0
1235018|NCT00693420|4050096|P1|Overall Study|Withdrawal by Subject|1
1235019|NCT00693420|4050095|P2|Overall Study|Lost to Follow-up|3
1235020|NCT00693420|4050096|P1|Overall Study|Lost to Follow-up|0
1235021|NCT00693420|4050095|P2|Overall Study|Adverse Event|4
1235022|NCT00693420|4050096|P1|Overall Study|Adverse Event|4
1235023|NCT00693225|4050135|P2|Overall Study|Adverse Event|3
1235024|NCT00693225|4050136|P1|Overall Study|Adverse Event|1
1235025|NCT00693225|4050135|P2|Overall Study|Lost to Follow-up|2
1235026|NCT00693225|4050136|P1|Overall Study|Lost to Follow-up|1
1235027|NCT00693017|4050159|P2|Overall Study|Death|1
1235028|NCT00693017|4050160|P1|Overall Study|Death|0
1235029|NCT00693017|4050159|P2|Overall Study|Sponsor Decision|1
1235030|NCT00693017|4050160|P1|Overall Study|Sponsor Decision|2
1235031|NCT00692913|4050170|P2|Overall Study|Withdrawal by Subject|20
1235032|NCT00692913|4050171|P1|Overall Study|Withdrawal by Subject|15
1235033|NCT00692913|4050170|P2|Overall Study|Protocol Violation|1
1235034|NCT00692913|4050171|P1|Overall Study|Protocol Violation|1
1235035|NCT00692913|4050170|P2|Overall Study|Physician Decision|0
1235036|NCT00692913|4050171|P1|Overall Study|Physician Decision|2
1235037|NCT00692913|4050170|P2|Overall Study|Lost to Follow-up|5
1235038|NCT00692913|4050171|P1|Overall Study|Lost to Follow-up|3
1235039|NCT00692913|4050170|P2|Overall Study|Adverse Event|4
1235040|NCT00692913|4050171|P1|Overall Study|Adverse Event|8
1235041|NCT00692770|4050193|P2|Overall Study|Randomized but not treated|4
1235042|NCT00692770|4050194|P1|Overall Study|Randomized but not treated|3
1235043|NCT00692770|4050193|P2|Overall Study|Study terminated by sponsor|2
1235044|NCT00692770|4050194|P1|Overall Study|Study terminated by sponsor|2
1235045|NCT00692770|4050193|P2|Overall Study|Clinical endpoint reached|43
1235046|NCT00692770|4050194|P1|Overall Study|Clinical endpoint reached|16
1235047|NCT00692770|4050193|P2|Overall Study|Radiological and clinical progression|8
1235048|NCT00692770|4050194|P1|Overall Study|Radiological and clinical progression|8
1235049|NCT00692770|4050193|P2|Overall Study|Completed all planned assessments|101
1235050|NCT00692770|4050194|P1|Overall Study|Completed all planned assessments|79
1235051|NCT00692770|4050193|P2|Overall Study|Protocol driven decision point|7
1235052|NCT00692770|4050194|P1|Overall Study|Protocol driven decision point|3
1235053|NCT00692770|4050193|P2|Overall Study|Disease progression, recurrence/relapse|279
1235054|NCT00692770|4050194|P1|Overall Study|Disease progression, recurrence/relapse|170
1235055|NCT00692770|4050193|P2|Overall Study|Physician decision not protocol driven|14
1235056|NCT00692770|4050194|P1|Overall Study|Physician decision not protocol driven|10
1235057|NCT00692770|4050193|P2|Overall Study|Progression by clinical judgment|3
1235058|NCT00692770|4050194|P1|Overall Study|Progression by clinical judgment|2
1235059|NCT00692770|4050193|P2|Overall Study|Non-compliant with study medication|5
1235060|NCT00692770|4050194|P1|Overall Study|Non-compliant with study medication|11
1235061|NCT00692770|4050193|P2|Overall Study|Lost to Follow-up|3
1235062|NCT00692770|4050194|P1|Overall Study|Lost to Follow-up|7
1235063|NCT00692770|4050193|P2|Overall Study|Death|5
1235064|NCT00692770|4050194|P1|Overall Study|Death|10
1235065|NCT00692770|4050193|P2|Overall Study|Adverse Event|41
1235066|NCT00692770|4050194|P1|Overall Study|Adverse Event|136
1235067|NCT00692770|4050193|P2|Overall Study|Withdrawal by Subject|36
1235068|NCT00692770|4050194|P1|Overall Study|Withdrawal by Subject|97
1235069|NCT00692770|4050193|P2|Overall Study|Protocol Violation|7
1235070|NCT00692770|4050194|P1|Overall Study|Protocol Violation|2
1235071|NCT00692406|4050240|P1|Overall Study|PI dropped, bad data|57
1235072|NCT00692237|4050302|P2|Overall Study|Adverse Event|1
1235073|NCT00692237|4050303|P1|Overall Study|Adverse Event|0
1235074|NCT00692237|4050302|P2|Overall Study|Withdrawal by Subject|3
1235075|NCT00692237|4050303|P1|Overall Study|Withdrawal by Subject|1
1235076|NCT00692003|4050367|P2|Overall Study|Sponsor Decision|1
1235077|NCT00692003|4050368|P1|Overall Study|Sponsor Decision|5
1235078|NCT00691938|4050383|P7|Overall Study|QTc prolongation|0
1235079|NCT00691938|4050384|P6|Overall Study|QTc prolongation|0
1235080|NCT00691938|4050385|P5|Overall Study|QTc prolongation|0
1235081|NCT00691938|4050386|P4|Overall Study|QTc prolongation|0
1235082|NCT00691938|4050387|P3|Overall Study|QTc prolongation|0
1235083|NCT00691938|4050388|P2|Overall Study|QTc prolongation|0
1235084|NCT00691938|4050389|P1|Overall Study|QTc prolongation|1
1235085|NCT00691704|4050456|P1|Two Years of Maintenance Therapy|Withdrawal by Subject|1
1235086|NCT00691704|4050456|P1|Two Years of Maintenance Therapy|Physician Decision|4
1235087|NCT00691704|4050456|P1|Two Years of Maintenance Therapy|Disease Progression|8
1235088|NCT00691704|4050456|P1|Induction Therapy|Active Hepatitis|1
1235089|NCT00691704|4050456|P1|Induction Therapy|Disease Progression|1
1235090|NCT00691483|4050485|P2|Overall Study|Randomized by not treated|1
1235091|NCT00691483|4050486|P1|Overall Study|Randomized by not treated|7
1235092|NCT00691483|4050485|P2|Overall Study|Other known cause|1
1235093|NCT00691483|4050486|P1|Overall Study|Other known cause|6
1235094|NCT00691483|4050485|P2|Overall Study|Withdrawal by Subject|7
1235095|NCT00691483|4050486|P1|Overall Study|Withdrawal by Subject|24
1235096|NCT00691483|4050485|P2|Overall Study|Lost to Follow-up|10
1235097|NCT00691483|4050486|P1|Overall Study|Lost to Follow-up|17
1235098|NCT00691483|4050485|P2|Overall Study|Adverse Event|6
1235099|NCT00691483|4050486|P1|Overall Study|Adverse Event|14
1235100|NCT00691301|4050513|P1|Overall Study|Did not initiate study treatment|1
1235101|NCT00691301|4050513|P1|Overall Study|other reason|3
1235102|NCT00691301|4050513|P1|Overall Study|Concurrent illness|2
1235103|NCT00691301|4050513|P1|Overall Study|Withdrawal by Subject|4
1235104|NCT00691301|4050513|P1|Overall Study|Lack of Efficacy|32
1235105|NCT00691301|4050513|P1|Overall Study|Death|2
1235106|NCT00691301|4050513|P1|Overall Study|Adverse Event|10
1235107|NCT00691210|4050533|P8|Overall Study|Lack of Efficacy|0
1235108|NCT00691210|4050534|P7|Overall Study|Lack of Efficacy|0
1235109|NCT00691210|4050535|P6|Overall Study|Lack of Efficacy|1
1235110|NCT00691210|4050536|P5|Overall Study|Lack of Efficacy|0
1235111|NCT00691210|4050537|P4|Overall Study|Lack of Efficacy|1
1235112|NCT00691210|4050538|P3|Overall Study|Lack of Efficacy|0
1235113|NCT00691210|4050539|P2|Overall Study|Lack of Efficacy|0
1235114|NCT00691210|4050540|P1|Overall Study|Lack of Efficacy|0
1235115|NCT00691210|4050533|P8|Overall Study|Progression of Disease|0
1235116|NCT00691210|4050534|P7|Overall Study|Progression of Disease|0
1235117|NCT00691210|4050535|P6|Overall Study|Progression of Disease|0
1235118|NCT00691210|4050536|P5|Overall Study|Progression of Disease|0
1235119|NCT00691210|4050537|P4|Overall Study|Progression of Disease|2
1235120|NCT00691210|4050538|P3|Overall Study|Progression of Disease|0
1235121|NCT00691210|4050539|P2|Overall Study|Progression of Disease|0
1235122|NCT00691210|4050540|P1|Overall Study|Progression of Disease|0
1235123|NCT00691132|4050575|P2|Overall Study|Withdrawal by Subject|10
1235124|NCT00691132|4050576|P1|Overall Study|Withdrawal by Subject|10
1235125|NCT00691132|4050575|P2|Overall Study|Adverse Event|3
1235126|NCT00691132|4050576|P1|Overall Study|Adverse Event|2
1235127|NCT00691093|4050595|P1|Overall Study|Ongoing at Date of Cut-Off|4
1235128|NCT00691093|4050595|P1|Overall Study|Lack of Efficacy|1
1235129|NCT00691093|4050595|P1|Overall Study|Lost to Follow-up|1
1235130|NCT00691093|4050595|P1|Overall Study|Adverse Event|1
1235131|NCT00691054|4050629|P1|Overall Study|Withdrawal by Subject|1
1235132|NCT00691028|4050641|P4|Double-blind Period|not come to a hospital.|0
1235133|NCT00691028|4050642|P3|Double-blind Period|not come to a hospital.|0
1235134|NCT00691028|4050643|P2|Double-blind Period|not come to a hospital.|1
1235135|NCT00691028|4050644|P1|Double-blind Period|not come to a hospital.|0
1235136|NCT00691028|4050641|P4|Double-blind Period|Withdrawal by Subject|0
1235137|NCT00691028|4050642|P3|Double-blind Period|Withdrawal by Subject|1
1235138|NCT00691028|4050643|P2|Double-blind Period|Withdrawal by Subject|0
1235139|NCT00691028|4050644|P1|Double-blind Period|Withdrawal by Subject|1
1235140|NCT00691028|4050641|P4|Double-blind Period|Lack of Efficacy|0
1235141|NCT00691028|4050642|P3|Double-blind Period|Lack of Efficacy|2
1235142|NCT00691028|4050643|P2|Double-blind Period|Lack of Efficacy|3
1235143|NCT00691028|4050644|P1|Double-blind Period|Lack of Efficacy|4
1235144|NCT00691028|4050641|P4|Double-blind Period|Adverse Event|0
1235145|NCT00691028|4050642|P3|Double-blind Period|Adverse Event|6
1235146|NCT00691028|4050643|P2|Double-blind Period|Adverse Event|9
1235147|NCT00691028|4050644|P1|Double-blind Period|Adverse Event|8
1235148|NCT00691028|4050641|P4|Open-label Period|not come to a hospital|1
1235149|NCT00691028|4050642|P3|Open-label Period|not come to a hospital|0
1235150|NCT00691028|4050643|P2|Open-label Period|not come to a hospital|0
1235151|NCT00691028|4050644|P1|Open-label Period|not come to a hospital|0
1235152|NCT00691028|4050641|P4|Open-label Period|Withdrawal by Subject|3
1235153|NCT00691028|4050642|P3|Open-label Period|Withdrawal by Subject|0
1235154|NCT00691028|4050643|P2|Open-label Period|Withdrawal by Subject|0
1235155|NCT00691028|4050644|P1|Open-label Period|Withdrawal by Subject|0
1235156|NCT00691028|4050641|P4|Open-label Period|Adverse Event|16
1235157|NCT00691028|4050642|P3|Open-label Period|Adverse Event|0
1235158|NCT00691028|4050643|P2|Open-label Period|Adverse Event|0
1235159|NCT00691028|4050644|P1|Open-label Period|Adverse Event|0
1235160|NCT00691015|4050677|P1|Overall Study|Refused further treatment|1
1235161|NCT00690898|4050692|P1|TREATMENT|Other (not otherwise specified)|1
1235162|NCT00690898|4050692|P1|TREATMENT|Withdrawal by Subject|4
1235163|NCT00690898|4050692|P1|TREATMENT|Lack of Efficacy|18
1235164|NCT00690898|4050692|P1|TREATMENT|Adverse Event|3
1235165|NCT00690898|4050692|P1|SCREENING|Screen failure|18
1235166|NCT00690820|4050712|P2|Period 1|Withdrawal by Subject|1
1235167|NCT00690820|4050713|P1|Period 1|Withdrawal by Subject|0
1235168|NCT00690794|4050735|P2|Overall Study|Other not specified|3
1235169|NCT00690794|4050736|P1|Overall Study|Other not specified|1
1235170|NCT00690794|4050735|P2|Overall Study|Noncompliance|2
1235171|NCT00690794|4050736|P1|Overall Study|Noncompliance|1
1235172|NCT00690794|4050735|P2|Overall Study|Protocol Violation|7
1235173|NCT00690794|4050736|P1|Overall Study|Protocol Violation|6
1235174|NCT00690794|4050735|P2|Overall Study|Withdrawal by Subject|9
1235175|NCT00690794|4050736|P1|Overall Study|Withdrawal by Subject|0
1235176|NCT00690794|4050735|P2|Overall Study|Lost to Follow-up|4
1235177|NCT00690794|4050736|P1|Overall Study|Lost to Follow-up|1
1235178|NCT00690794|4050735|P2|Overall Study|Adverse Event|10
1235179|NCT00690794|4050736|P1|Overall Study|Adverse Event|12
1235180|NCT00690755|4050751|P7|Overall Study|Physician Decision|0
1235181|NCT00690755|4050752|P6|Overall Study|Physician Decision|4
1235182|NCT00690755|4050753|P5|Overall Study|Physician Decision|0
1235183|NCT00690755|4050754|P4|Overall Study|Physician Decision|5
1235184|NCT00690755|4050755|P3|Overall Study|Physician Decision|46
1235185|NCT00690755|4050756|P2|Overall Study|Physician Decision|0
1235186|NCT00690755|4050757|P1|Overall Study|Physician Decision|2
1235187|NCT00690612|4050773|P1|Overall Study|Withdrawal by Subject|2
1235188|NCT00690612|4050773|P1|Overall Study|Adverse Event|1
1235189|NCT00690573|4050778|P1|Overall Study|Withdrawal by Subject|1
1235190|NCT00690573|4050778|P1|Overall Study|Lack of Efficacy|8
1235191|NCT00690482|4050797|P2|Overall Study|withdrew consent at rand.day|1
1235192|NCT00690482|4050798|P1|Overall Study|withdrew consent at rand.day|0
1235193|NCT00690482|4050797|P2|Overall Study|Intake of prohibited medicine|0
1235194|NCT00690482|4050798|P1|Overall Study|Intake of prohibited medicine|1
1235195|NCT00690482|4050797|P2|Overall Study|Study-specific discontinuation criteria|0
1235196|NCT00690482|4050798|P1|Overall Study|Study-specific discontinuation criteria|1
1235197|NCT00690482|4050797|P2|Overall Study|Incorrect enrolment|1
1235198|NCT00690482|4050798|P1|Overall Study|Incorrect enrolment|0
1235199|NCT00690482|4050797|P2|Overall Study|Adverse Event|1
1235200|NCT00690482|4050798|P1|Overall Study|Adverse Event|2
1235201|NCT00690443|4050832|P2|Overall Study|Adverse Event|2
1235202|NCT00690443|4050833|P1|Overall Study|Adverse Event|1
1235203|NCT00690430|4050843|P3|Extension Phase|Early Termination|3
1235204|NCT00690430|4050844|P2|Extension Phase|Early Termination|1
1235205|NCT00690430|4050845|P1|Extension Phase|Early Termination|10
1235206|NCT00690430|4050843|P3|Extension Phase|Withdrawal by Subject|2
1235207|NCT00690430|4050844|P2|Extension Phase|Withdrawal by Subject|0
1235208|NCT00690430|4050845|P1|Extension Phase|Withdrawal by Subject|0
1235209|NCT00690430|4050843|P3|Extension Phase|Death|1
1235210|NCT00690430|4050844|P2|Extension Phase|Death|1
1235211|NCT00690430|4050845|P1|Extension Phase|Death|1
1235212|NCT00690430|4050843|P3|Extension Phase|Adverse Event|2
1235213|NCT00690430|4050844|P2|Extension Phase|Adverse Event|1
1235214|NCT00690430|4050845|P1|Extension Phase|Adverse Event|2
1235215|NCT00690430|4050843|P3|Extension Phase|Administrative Problems|1
1235216|NCT00690430|4050844|P2|Extension Phase|Administrative Problems|1
1235217|NCT00690430|4050845|P1|Extension Phase|Administrative Problems|0
1235218|NCT00690430|4050843|P3|Extension Phase|Abnormal test procedure results|0
1235219|NCT00690430|4050844|P2|Extension Phase|Abnormal test procedure results|0
1235220|NCT00690430|4050845|P1|Extension Phase|Abnormal test procedure results|1
1235221|NCT00690430|4050843|P3|Extension Phase|Abnormal Lab Values|0
1235222|NCT00690430|4050844|P2|Extension Phase|Abnormal Lab Values|0
1235223|NCT00690430|4050845|P1|Extension Phase|Abnormal Lab Values|1
1235224|NCT00690430|4050843|P3|Extension Phase|Lack of Efficacy|4
1235225|NCT00690430|4050844|P2|Extension Phase|Lack of Efficacy|1
1235226|NCT00690430|4050845|P1|Extension Phase|Lack of Efficacy|3
1235227|NCT00690430|4050843|P3|Core Phase|Early Termination|0
1235228|NCT00690430|4050844|P2|Core Phase|Early Termination|5
1235229|NCT00690430|4050845|P1|Core Phase|Early Termination|0
1235230|NCT00690430|4050843|P3|Core Phase|Administrative Problems|0
1235231|NCT00690430|4050844|P2|Core Phase|Administrative Problems|1
1235232|NCT00690430|4050845|P1|Core Phase|Administrative Problems|0
1235233|NCT00690430|4050843|P3|Core Phase|Lack of Efficacy|0
1235234|NCT00690430|4050844|P2|Core Phase|Lack of Efficacy|10
1235235|NCT00690430|4050845|P1|Core Phase|Lack of Efficacy|8
1235236|NCT00690430|4050843|P3|Core Phase|Subject no longer requires study drug|0
1235237|NCT00690430|4050844|P2|Core Phase|Subject no longer requires study drug|0
1235238|NCT00690430|4050845|P1|Core Phase|Subject no longer requires study drug|1
1235239|NCT00690430|4050843|P3|Core Phase|Withdrawal by Subject|0
1235240|NCT00690430|4050844|P2|Core Phase|Withdrawal by Subject|3
1235241|NCT00690430|4050845|P1|Core Phase|Withdrawal by Subject|3
1235242|NCT00690430|4050843|P3|Core Phase|Protocol Violation|0
1235243|NCT00690430|4050844|P2|Core Phase|Protocol Violation|0
1235244|NCT00690430|4050845|P1|Core Phase|Protocol Violation|1
1235245|NCT00690430|4050843|P3|Core Phase|Death|0
1235246|NCT00690430|4050844|P2|Core Phase|Death|2
1235247|NCT00690430|4050845|P1|Core Phase|Death|0
1235248|NCT00690430|4050843|P3|Core Phase|Adverse Event|0
1235249|NCT00690430|4050844|P2|Core Phase|Adverse Event|1
1235250|NCT00690430|4050845|P1|Core Phase|Adverse Event|5
1235251|NCT00690430|4050843|P3|Core Phase|Abnormal Laboratory value|0
1235252|NCT00690430|4050844|P2|Core Phase|Abnormal Laboratory value|1
1235253|NCT00690430|4050845|P1|Core Phase|Abnormal Laboratory value|0
1235254|NCT00690378|4050874|P2|Overall Study|Social problem|0
1235255|NCT00690378|4050875|P1|Overall Study|Social problem|1
1235256|NCT00690378|4050874|P2|Overall Study|Did not meet inc/exc criteria|11
1235257|NCT00690378|4050875|P1|Overall Study|Did not meet inc/exc criteria|13
1235258|NCT00690378|4050874|P2|Overall Study|Lost to Follow-up|3
1235259|NCT00690378|4050875|P1|Overall Study|Lost to Follow-up|2
1235260|NCT00690378|4050874|P2|Overall Study|Protocol Violation|0
1235261|NCT00690378|4050875|P1|Overall Study|Protocol Violation|1
1235262|NCT00690378|4050874|P2|Overall Study|Withdrawal by Subject|0
1235263|NCT00690378|4050875|P1|Overall Study|Withdrawal by Subject|2
1235264|NCT00690378|4050874|P2|Overall Study|Adverse Event|0
1235265|NCT00690378|4050875|P1|Overall Study|Adverse Event|1
1235266|NCT00689936|4050961|P3|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144
1235267|NCT00689936|4050962|P2|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188
1235268|NCT00689936|4050963|P1|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127
1235269|NCT00689936|4050961|P3|Active Treatment Phase|Miscellaneous|47
1235270|NCT00689936|4050962|P2|Active Treatment Phase|Miscellaneous|34
1235271|NCT00689936|4050963|P1|Active Treatment Phase|Miscellaneous|52
1235272|NCT00689936|4050961|P3|Active Treatment Phase|Study Close Out|21
1235273|NCT00689936|4050962|P2|Active Treatment Phase|Study Close Out|26
1235274|NCT00689936|4050963|P1|Active Treatment Phase|Study Close Out|64
1235275|NCT00689936|4050961|P3|Active Treatment Phase|Protocol Violation|4
1235276|NCT00689936|4050962|P2|Active Treatment Phase|Protocol Violation|2
1235277|NCT00689936|4050963|P1|Active Treatment Phase|Protocol Violation|2
1235278|NCT00689936|4050961|P3|Active Treatment Phase|Lost to Follow-up|2
1235279|NCT00689936|4050962|P2|Active Treatment Phase|Lost to Follow-up|2
1235280|NCT00689936|4050963|P1|Active Treatment Phase|Lost to Follow-up|0
1235281|NCT00689936|4050961|P3|Active Treatment Phase|Death|37
1235282|NCT00689936|4050962|P2|Active Treatment Phase|Death|28
1235283|NCT00689936|4050963|P1|Active Treatment Phase|Death|60
1235284|NCT00689936|4050961|P3|Active Treatment Phase|Withdrawal by Subject|21
1235285|NCT00689936|4050962|P2|Active Treatment Phase|Withdrawal by Subject|16
1235286|NCT00689936|4050963|P1|Active Treatment Phase|Withdrawal by Subject|16
1235287|NCT00689936|4050961|P3|Active Treatment Phase|Disease Progression|339
1235288|NCT00689936|4050962|P2|Active Treatment Phase|Disease Progression|362
1235289|NCT00689936|4050963|P1|Active Treatment Phase|Disease Progression|273
1235290|NCT00689936|4050961|P3|Active Treatment Phase|Adverse Event|76
1235291|NCT00689936|4050962|P2|Active Treatment Phase|Adverse Event|71
1235292|NCT00689936|4050963|P1|Active Treatment Phase|Adverse Event|68
1235293|NCT00689871|4051112|P4|Overall Study|Physician Decision|0
1235294|NCT00689871|4051113|P3|Overall Study|Physician Decision|1
1235295|NCT00689871|4051114|P2|Overall Study|Physician Decision|1
1235296|NCT00689871|4051115|P1|Overall Study|Physician Decision|2
1235297|NCT00689871|4051112|P4|Overall Study|Death|2
1235298|NCT00689871|4051113|P3|Overall Study|Death|2
1235299|NCT00689871|4051114|P2|Overall Study|Death|10
1235300|NCT00689871|4051115|P1|Overall Study|Death|1
1235301|NCT00689871|4051112|P4|Overall Study|Withdrawal by Subject|1
1235302|NCT00689871|4051113|P3|Overall Study|Withdrawal by Subject|4
1235303|NCT00689871|4051114|P2|Overall Study|Withdrawal by Subject|3
1235304|NCT00689871|4051115|P1|Overall Study|Withdrawal by Subject|13
1235305|NCT00689871|4051112|P4|Overall Study|Explanted of All Study Devices|3
1235306|NCT00689871|4051113|P3|Overall Study|Explanted of All Study Devices|29
1235307|NCT00689871|4051114|P2|Overall Study|Explanted of All Study Devices|25
1235308|NCT00689871|4051115|P1|Overall Study|Explanted of All Study Devices|36
1235309|NCT00689871|4051112|P4|Overall Study|Lost to Follow-up|1
1235310|NCT00689871|4051113|P3|Overall Study|Lost to Follow-up|37
1235311|NCT00689871|4051114|P2|Overall Study|Lost to Follow-up|13
1235312|NCT00689871|4051115|P1|Overall Study|Lost to Follow-up|123
1235313|NCT00689793|4051142|P2|Overall Study|Lost to Follow-up|5
1235314|NCT00689793|4051143|P1|Overall Study|Lost to Follow-up|4
1235315|NCT00689728|4051162|P3|Optional Follow-Up|Withdrawal by Subject|3
1235316|NCT00689728|4051163|P2|Optional Follow-Up|Withdrawal by Subject|4
1235317|NCT00689728|4051164|P1|Optional Follow-Up|Withdrawal by Subject|2
1235318|NCT00689728|4051162|P3|Optional Follow-Up|Protocol Violation|1
1235319|NCT00689728|4051163|P2|Optional Follow-Up|Protocol Violation|0
1235320|NCT00689728|4051164|P1|Optional Follow-Up|Protocol Violation|0
1235321|NCT00689728|4051162|P3|Optional Follow-Up|Lost to Follow-up|1
1235322|NCT00689728|4051163|P2|Optional Follow-Up|Lost to Follow-up|1
1235323|NCT00689728|4051164|P1|Optional Follow-Up|Lost to Follow-up|0
1235324|NCT00689728|4051162|P3|Optional Follow-Up|Lack of Efficacy|1
1235325|NCT00689728|4051163|P2|Optional Follow-Up|Lack of Efficacy|1
1235326|NCT00689728|4051164|P1|Optional Follow-Up|Lack of Efficacy|0
1235327|NCT00689728|4051162|P3|Optional Follow-Up|Adverse Event|0
1235328|NCT00689728|4051163|P2|Optional Follow-Up|Adverse Event|0
1235329|NCT00689728|4051164|P1|Optional Follow-Up|Adverse Event|1
1235330|NCT00689728|4051162|P3|Rescue|Withdrawal by Subject|1
1235331|NCT00689728|4051163|P2|Rescue|Withdrawal by Subject|1
1235332|NCT00689728|4051164|P1|Rescue|Withdrawal by Subject|1
1235333|NCT00689728|4051162|P3|Rescue|Adverse Event|0
1235334|NCT00689728|4051163|P2|Rescue|Adverse Event|1
1235335|NCT00689728|4051164|P1|Rescue|Adverse Event|0
1235336|NCT00689728|4051162|P3|Double-Blind Treatment|Lack of Efficacy|2
1235337|NCT00689728|4051163|P2|Double-Blind Treatment|Lack of Efficacy|1
1235338|NCT00689728|4051164|P1|Double-Blind Treatment|Lack of Efficacy|0
1235339|NCT00689728|4051162|P3|Double-Blind Treatment|Withdrawal by Subject|2
1235340|NCT00689728|4051163|P2|Double-Blind Treatment|Withdrawal by Subject|3
1235341|NCT00689728|4051164|P1|Double-Blind Treatment|Withdrawal by Subject|3
1235342|NCT00689728|4051162|P3|Double-Blind Treatment|Protocol Violation|1
1235343|NCT00689728|4051163|P2|Double-Blind Treatment|Protocol Violation|0
1235344|NCT00689728|4051164|P1|Double-Blind Treatment|Protocol Violation|0
1235345|NCT00689728|4051162|P3|Double-Blind Treatment|Adverse Event|0
1235346|NCT00689728|4051163|P2|Double-Blind Treatment|Adverse Event|0
1235347|NCT00689728|4051164|P1|Double-Blind Treatment|Adverse Event|1
1235348|NCT00689611|4051247|P2|Overall Study|Lost to Follow-up|28
1235349|NCT00689611|4051248|P1|Overall Study|Lost to Follow-up|27
1235350|NCT00689611|4051247|P2|Overall Study|Withdrawal by Subject|9
1235351|NCT00689611|4051248|P1|Overall Study|Withdrawal by Subject|8
1235352|NCT00689611|4051247|P2|Overall Study|Death|9
1235353|NCT00689611|4051248|P1|Overall Study|Death|6
1235354|NCT00689481|4051258|P2|Overall Study|Subject early term, left on vacation|1
1235355|NCT00689481|4051259|P1|Overall Study|Subject early term, left on vacation|0
1235356|NCT00689481|4051258|P2|Overall Study|Excluded medication started during study|1
1235357|NCT00689481|4051259|P1|Overall Study|Excluded medication started during study|0
1235358|NCT00689481|4051258|P2|Overall Study|Withdrawal by Subject|4
1235359|NCT00689481|4051259|P1|Overall Study|Withdrawal by Subject|8
1235360|NCT00689481|4051258|P2|Overall Study|Non-compliance with study treatment|1
1235361|NCT00689481|4051259|P1|Overall Study|Non-compliance with study treatment|1
1235362|NCT00689481|4051258|P2|Overall Study|Lack of Efficacy|3
1235363|NCT00689481|4051259|P1|Overall Study|Lack of Efficacy|4
1235364|NCT00689481|4051258|P2|Overall Study|Lost to Follow-up|3
1235365|NCT00689481|4051259|P1|Overall Study|Lost to Follow-up|4
1235366|NCT00689481|4051258|P2|Overall Study|Adverse Event|1
1235367|NCT00689481|4051259|P1|Overall Study|Adverse Event|7
1235368|NCT00689390|4051277|P2|Overall Study|Administrative|0
1235369|NCT00689390|4051278|P1|Overall Study|Administrative|37
1235370|NCT00689390|4051277|P2|Overall Study|Did Not Meet Protocol Eligibility|0
1235371|NCT00689390|4051278|P1|Overall Study|Did Not Meet Protocol Eligibility|1
1235372|NCT00689390|4051277|P2|Overall Study|Non-Compliance With Protocol|0
1235373|NCT00689390|4051278|P1|Overall Study|Non-Compliance With Protocol|21
1235374|NCT00689390|4051277|P2|Overall Study|Withdrew Consent-Retreatment Opportunity|0
1235375|NCT00689390|4051278|P1|Overall Study|Withdrew Consent-Retreatment Opportunity|52
1235376|NCT00689390|4051277|P2|Overall Study|Withdrawal by Subject|3
1235377|NCT00689390|4051278|P1|Overall Study|Withdrawal by Subject|117
1235378|NCT00689390|4051277|P2|Overall Study|Lost to Follow-up|7
1235379|NCT00689390|4051278|P1|Overall Study|Lost to Follow-up|179
1235380|NCT00689390|4051277|P2|Overall Study|Adverse Event|0
1235381|NCT00689390|4051278|P1|Overall Study|Adverse Event|19
1235382|NCT00689351|4051296|P2|After Infant Series|Parent/legal guardian request|0
1235383|NCT00689351|4051297|P1|After Infant Series|Parent/legal guardian request|1
1235384|NCT00689351|4051296|P2|Infant Series of Dosing|Lost to Follow-up|1
1235385|NCT00689351|4051297|P1|Infant Series of Dosing|Lost to Follow-up|0
1235386|NCT00689351|4051296|P2|Infant Series of Dosing|Adverse Event|0
1235387|NCT00689351|4051297|P1|Infant Series of Dosing|Adverse Event|1
1235388|NCT00689351|4051296|P2|Infant Series of Dosing|Parent/legal guardian request|0
1235389|NCT00689351|4051297|P1|Infant Series of Dosing|Parent/legal guardian request|5
1235390|NCT00689338|4051329|P1|Overall Study|Protocol Violation|15
1235391|NCT00689338|4051329|P1|Overall Study|Withdrawal by Subject|3
1235392|NCT00689338|4051329|P1|Overall Study|Lost to Follow-up|5
1235393|NCT00689338|4051329|P1|Overall Study|Did not Meet Entrance Criteria|27
1235394|NCT00689338|4051329|P1|Overall Study|Other|8
1235395|NCT00689338|4051329|P1|Overall Study|Lack of Efficacy|6
1235396|NCT00689338|4051329|P1|Overall Study|Insufficient Clinical Response|1
1235397|NCT00689338|4051329|P1|Overall Study|Adverse Event|13
1235398|NCT00689338|4051329|P1|Overall Study|Death|65
1235399|NCT00689299|4051342|P3|Overall Study|Protocol Violation|0
1235400|NCT00689299|4051343|P2|Overall Study|Protocol Violation|0
1235401|NCT00689299|4051344|P1|Overall Study|Protocol Violation|1
1235402|NCT00689299|4051342|P3|Overall Study|Withdrawal by Subject|3
1235403|NCT00689299|4051343|P2|Overall Study|Withdrawal by Subject|1
1235404|NCT00689299|4051344|P1|Overall Study|Withdrawal by Subject|4
1235405|NCT00689299|4051342|P3|Overall Study|Lost to Follow-up|1
1235406|NCT00689299|4051343|P2|Overall Study|Lost to Follow-up|1
1235407|NCT00689299|4051344|P1|Overall Study|Lost to Follow-up|0
1235408|NCT00689299|4051342|P3|Overall Study|Adverse Event|1
1235409|NCT00689299|4051343|P2|Overall Study|Adverse Event|1
1235410|NCT00689299|4051344|P1|Overall Study|Adverse Event|2
1235411|NCT00689221|4051373|P2|Overall Study|Ongoing at cut-off date|36
1235412|NCT00689221|4051374|P1|Overall Study|Ongoing at cut-off date|39
1235413|NCT00689117|4051403|P4|Overall Study|Dispensing Error|0
1235414|NCT00689117|4051404|P3|Overall Study|Dispensing Error|0
1235415|NCT00689117|4051405|P2|Overall Study|Dispensing Error|1
1235416|NCT00689117|4051406|P1|Overall Study|Dispensing Error|0
1235417|NCT00689117|4051403|P4|Overall Study|Personal Reason|0
1235418|NCT00689117|4051404|P3|Overall Study|Personal Reason|0
1235419|NCT00689117|4051405|P2|Overall Study|Personal Reason|1
1235420|NCT00689117|4051406|P1|Overall Study|Personal Reason|0
1235421|NCT00689117|4051403|P4|Overall Study|Patient Withdrew from Study|1
1235422|NCT00689117|4051404|P3|Overall Study|Patient Withdrew from Study|0
1235423|NCT00689117|4051405|P2|Overall Study|Patient Withdrew from Study|0
1235424|NCT00689117|4051406|P1|Overall Study|Patient Withdrew from Study|0
1235425|NCT00689117|4051403|P4|Overall Study|Transportation|0
1235426|NCT00689117|4051404|P3|Overall Study|Transportation|0
1235427|NCT00689117|4051405|P2|Overall Study|Transportation|0
1235428|NCT00689117|4051406|P1|Overall Study|Transportation|1
1235429|NCT00689117|4051403|P4|Overall Study|Fear of Birth Defects|0
1235430|NCT00689117|4051404|P3|Overall Study|Fear of Birth Defects|1
1235431|NCT00689117|4051405|P2|Overall Study|Fear of Birth Defects|0
1235432|NCT00689117|4051406|P1|Overall Study|Fear of Birth Defects|0
1235433|NCT00689117|4051403|P4|Overall Study|Incarceration|0
1235434|NCT00689117|4051404|P3|Overall Study|Incarceration|0
1235435|NCT00689117|4051405|P2|Overall Study|Incarceration|0
1235436|NCT00689117|4051406|P1|Overall Study|Incarceration|2
1235437|NCT00689117|4051403|P4|Overall Study|Pregnancy|2
1235438|NCT00689117|4051404|P3|Overall Study|Pregnancy|0
1235439|NCT00689117|4051405|P2|Overall Study|Pregnancy|2
1235440|NCT00689117|4051406|P1|Overall Study|Pregnancy|0
1235441|NCT00689117|4051403|P4|Overall Study|Use of Prohibitive Medication|0
1235442|NCT00689117|4051404|P3|Overall Study|Use of Prohibitive Medication|3
1235443|NCT00689117|4051405|P2|Overall Study|Use of Prohibitive Medication|1
1235444|NCT00689117|4051406|P1|Overall Study|Use of Prohibitive Medication|2
1235445|NCT00689117|4051403|P4|Overall Study|Change/Discontinuation of Birth Control|0
1235446|NCT00689117|4051404|P3|Overall Study|Change/Discontinuation of Birth Control|1
1235447|NCT00689117|4051405|P2|Overall Study|Change/Discontinuation of Birth Control|1
1235448|NCT00689117|4051406|P1|Overall Study|Change/Discontinuation of Birth Control|1
1235449|NCT00689117|4051403|P4|Overall Study|Non-compliance with Treatment Regimen|0
1235450|NCT00689117|4051404|P3|Overall Study|Non-compliance with Treatment Regimen|0
1235451|NCT00689117|4051405|P2|Overall Study|Non-compliance with Treatment Regimen|1
1235452|NCT00689117|4051406|P1|Overall Study|Non-compliance with Treatment Regimen|0
1235453|NCT00689117|4051403|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1235454|NCT00689117|4051404|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1235455|NCT00689117|4051405|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|2
1235456|NCT00689117|4051406|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
1235457|NCT00689117|4051403|P4|Overall Study|Unable to Comply with Visit Schedule|1
1235458|NCT00689117|4051404|P3|Overall Study|Unable to Comply with Visit Schedule|1
1235459|NCT00689117|4051405|P2|Overall Study|Unable to Comply with Visit Schedule|0
1235460|NCT00689117|4051406|P1|Overall Study|Unable to Comply with Visit Schedule|0
1235461|NCT00689117|4051403|P4|Overall Study|Withdrawal by Subject|13
1235462|NCT00689117|4051404|P3|Overall Study|Withdrawal by Subject|26
1235463|NCT00689117|4051405|P2|Overall Study|Withdrawal by Subject|18
1235464|NCT00689117|4051406|P1|Overall Study|Withdrawal by Subject|19
1235465|NCT00689117|4051403|P4|Overall Study|Non-Compliance with Study Treatment|1
1235466|NCT00689117|4051404|P3|Overall Study|Non-Compliance with Study Treatment|3
1235467|NCT00689117|4051405|P2|Overall Study|Non-Compliance with Study Treatment|3
1235468|NCT00689117|4051406|P1|Overall Study|Non-Compliance with Study Treatment|3
1235469|NCT00689117|4051403|P4|Overall Study|Lack of Efficacy|2
1235470|NCT00689117|4051404|P3|Overall Study|Lack of Efficacy|2
1235471|NCT00689117|4051405|P2|Overall Study|Lack of Efficacy|2
1235472|NCT00689117|4051406|P1|Overall Study|Lack of Efficacy|1
1235473|NCT00689117|4051403|P4|Overall Study|Lost to Follow-up|11
1235474|NCT00689117|4051404|P3|Overall Study|Lost to Follow-up|17
1235475|NCT00689117|4051405|P2|Overall Study|Lost to Follow-up|19
1235476|NCT00689117|4051406|P1|Overall Study|Lost to Follow-up|26
1235477|NCT00689117|4051403|P4|Overall Study|Adverse Event|0
1235478|NCT00689117|4051404|P3|Overall Study|Adverse Event|5
1235479|NCT00689117|4051405|P2|Overall Study|Adverse Event|0
1235480|NCT00689117|4051406|P1|Overall Study|Adverse Event|6
1235481|NCT00689104|4051436|P4|Overall Study|Non-compliance with study procedures|0
1235482|NCT00689104|4051437|P3|Overall Study|Non-compliance with study procedures|1
1235483|NCT00689104|4051438|P2|Overall Study|Non-compliance with study procedures|0
1235484|NCT00689104|4051439|P1|Overall Study|Non-compliance with study procedures|0
1235485|NCT00689104|4051436|P4|Overall Study|Physician Decision|0
1235486|NCT00689104|4051437|P3|Overall Study|Physician Decision|0
1235487|NCT00689104|4051438|P2|Overall Study|Physician Decision|0
1235488|NCT00689104|4051439|P1|Overall Study|Physician Decision|1
1235489|NCT00689104|4051436|P4|Overall Study|Randomized but never received study drug|0
1235490|NCT00689104|4051437|P3|Overall Study|Randomized but never received study drug|1
1235491|NCT00689104|4051438|P2|Overall Study|Randomized but never received study drug|1
1235492|NCT00689104|4051439|P1|Overall Study|Randomized but never received study drug|2
1235493|NCT00689104|4051436|P4|Overall Study|Protocol Violation|3
1235494|NCT00689104|4051437|P3|Overall Study|Protocol Violation|5
1235495|NCT00689104|4051438|P2|Overall Study|Protocol Violation|3
1235496|NCT00689104|4051439|P1|Overall Study|Protocol Violation|2
1235497|NCT00689104|4051436|P4|Overall Study|Lost to Follow-up|5
1235498|NCT00689104|4051437|P3|Overall Study|Lost to Follow-up|2
1235499|NCT00689104|4051438|P2|Overall Study|Lost to Follow-up|3
1235500|NCT00689104|4051439|P1|Overall Study|Lost to Follow-up|4
1235501|NCT00689104|4051436|P4|Overall Study|Withdrawal by Subject|11
1235502|NCT00689104|4051437|P3|Overall Study|Withdrawal by Subject|18
1235503|NCT00689104|4051438|P2|Overall Study|Withdrawal by Subject|11
1235504|NCT00689104|4051439|P1|Overall Study|Withdrawal by Subject|12
1235505|NCT00689104|4051436|P4|Overall Study|Lack of Efficacy|3
1235506|NCT00689104|4051437|P3|Overall Study|Lack of Efficacy|2
1235507|NCT00689104|4051438|P2|Overall Study|Lack of Efficacy|6
1235508|NCT00689104|4051439|P1|Overall Study|Lack of Efficacy|5
1235509|NCT00689104|4051436|P4|Overall Study|Adverse Event|24
1235510|NCT00689104|4051437|P3|Overall Study|Adverse Event|16
1235511|NCT00689104|4051438|P2|Overall Study|Adverse Event|25
1235512|NCT00689104|4051439|P1|Overall Study|Adverse Event|13
1235513|NCT00689104|4051436|P4|Overall Study|Eligibility criterion not met|4
1235514|NCT00689104|4051437|P3|Overall Study|Eligibility criterion not met|0
1235515|NCT00689104|4051438|P2|Overall Study|Eligibility criterion not met|8
1235516|NCT00689104|4051439|P1|Overall Study|Eligibility criterion not met|5
1235517|NCT00689052|4051645|P2|Overall Study|Early termination of the trial|24
1235518|NCT00689052|4051646|P1|Overall Study|Early termination of the trial|22
1235519|NCT00689052|4051645|P2|Overall Study|Withdrawal by Subject|0
1235520|NCT00689052|4051646|P1|Overall Study|Withdrawal by Subject|2
1235521|NCT00689052|4051645|P2|Overall Study|Lost to Follow-up|0
1235522|NCT00689052|4051646|P1|Overall Study|Lost to Follow-up|2
1235523|NCT00689052|4051645|P2|Overall Study|Protocol Violation|0
1235524|NCT00689052|4051646|P1|Overall Study|Protocol Violation|1
1235525|NCT00689052|4051645|P2|Overall Study|Adverse Event|6
1235526|NCT00689052|4051646|P1|Overall Study|Adverse Event|4
1235527|NCT00689026|4051678|P2|Overall Study|Withdrawal by Subject|6
1235528|NCT00689026|4051679|P1|Overall Study|Withdrawal by Subject|13
1235529|NCT00688870|4051687|P2|Infant Series|Parent or legal guardian request|0
1235530|NCT00688870|4051688|P1|Infant Series|Parent or legal guardian request|4
1235531|NCT00688844|4051720|P1|Overall Study|Lost to Follow-up|10
1235532|NCT00688753|4051730|P1|Overall Study|Lost to Follow-up|3
1235533|NCT00688753|4051730|P1|Overall Study|Protocol Violation|1
1235534|NCT00688753|4051730|P1|Overall Study|Adverse Event|20
1235535|NCT00688753|4051730|P1|Overall Study|Withdrawal by Subject|3
1235536|NCT00688753|4051730|P1|Overall Study|Death|9
1235537|NCT00688753|4051730|P1|Overall Study|Missing|1
1235538|NCT00688753|4051730|P1|Overall Study|Disease progression|55
1235539|NCT00688740|4051741|P2|Overall Study|Violation of Inclusion Criteria|3
1235540|NCT00688740|4051742|P1|Overall Study|Violation of Inclusion Criteria|1
1235541|NCT00688740|4051741|P2|Overall Study|Breast Cancer Relapse|4
1235542|NCT00688740|4051742|P1|Overall Study|Breast Cancer Relapse|1
1235543|NCT00688740|4051741|P2|Overall Study|Consent Withdrawn|17
1235544|NCT00688740|4051742|P1|Overall Study|Consent Withdrawn|17
1235545|NCT00688740|4051741|P2|Overall Study|Lost to Follow-up|1
1235546|NCT00688740|4051742|P1|Overall Study|Lost to Follow-up|0
1235547|NCT00688740|4051741|P2|Overall Study|Death|2
1235548|NCT00688740|4051742|P1|Overall Study|Death|2
1235549|NCT00688740|4051741|P2|Overall Study|Adverse Event|8
1235550|NCT00688740|4051742|P1|Overall Study|Adverse Event|45
1235551|NCT00688701|4051755|P4|Overall Study|Poor compliance to protocol|0
1235552|NCT00688701|4051756|P3|Overall Study|Poor compliance to protocol|1
1235553|NCT00688701|4051757|P2|Overall Study|Poor compliance to protocol|1
1235554|NCT00688701|4051758|P1|Overall Study|Poor compliance to protocol|0
1235555|NCT00688701|4051755|P4|Overall Study|Withdrawal by Subject|8
1235556|NCT00688701|4051756|P3|Overall Study|Withdrawal by Subject|4
1235557|NCT00688701|4051757|P2|Overall Study|Withdrawal by Subject|3
1235558|NCT00688701|4051758|P1|Overall Study|Withdrawal by Subject|3
1235559|NCT00688701|4051755|P4|Overall Study|Lack of Efficacy|0
1235560|NCT00688701|4051756|P3|Overall Study|Lack of Efficacy|0
1235561|NCT00688701|4051757|P2|Overall Study|Lack of Efficacy|1
1235562|NCT00688701|4051758|P1|Overall Study|Lack of Efficacy|0
1235563|NCT00688701|4051755|P4|Overall Study|Adverse Event|3
1235564|NCT00688701|4051756|P3|Overall Study|Adverse Event|5
1235565|NCT00688701|4051757|P2|Overall Study|Adverse Event|0
1235566|NCT00688701|4051758|P1|Overall Study|Adverse Event|1
1235567|NCT00688688|4051799|P3|Overall Study|Violation of exclusion criterion|0
1235568|NCT00688688|4051800|P2|Overall Study|Violation of exclusion criterion|1
1235569|NCT00688688|4051801|P1|Overall Study|Violation of exclusion criterion|0
1235570|NCT00688688|4051799|P3|Overall Study|Site closure|0
1235571|NCT00688688|4051800|P2|Overall Study|Site closure|1
1235572|NCT00688688|4051801|P1|Overall Study|Site closure|0
1235573|NCT00688688|4051799|P3|Overall Study|Taking exclusionary medications|0
1235574|NCT00688688|4051800|P2|Overall Study|Taking exclusionary medications|0
1235575|NCT00688688|4051801|P1|Overall Study|Taking exclusionary medications|1
1235576|NCT00688688|4051799|P3|Overall Study|Non-compliance with study procedures|4
1235577|NCT00688688|4051800|P2|Overall Study|Non-compliance with study procedures|3
1235578|NCT00688688|4051801|P1|Overall Study|Non-compliance with study procedures|5
1235579|NCT00688688|4051799|P3|Overall Study|Randomized but never received study drug|0
1235580|NCT00688688|4051800|P2|Overall Study|Randomized but never received study drug|0
1235581|NCT00688688|4051801|P1|Overall Study|Randomized but never received study drug|1
1235582|NCT00688688|4051799|P3|Overall Study|Protocol Violation|11
1235583|NCT00688688|4051800|P2|Overall Study|Protocol Violation|9
1235584|NCT00688688|4051801|P1|Overall Study|Protocol Violation|6
1235585|NCT00688688|4051799|P3|Overall Study|Lost to Follow-up|7
1235586|NCT00688688|4051800|P2|Overall Study|Lost to Follow-up|7
1235587|NCT00688688|4051801|P1|Overall Study|Lost to Follow-up|14
1235588|NCT00688688|4051799|P3|Overall Study|Withdrawal by Subject|65
1235589|NCT00688688|4051800|P2|Overall Study|Withdrawal by Subject|75
1235590|NCT00688688|4051801|P1|Overall Study|Withdrawal by Subject|66
1235591|NCT00688688|4051799|P3|Overall Study|Lack of Efficacy|45
1235592|NCT00688688|4051800|P2|Overall Study|Lack of Efficacy|25
1235593|NCT00688688|4051801|P1|Overall Study|Lack of Efficacy|34
1235594|NCT00688688|4051799|P3|Overall Study|Adverse Event|50
1235595|NCT00688688|4051800|P2|Overall Study|Adverse Event|51
1235596|NCT00688688|4051801|P1|Overall Study|Adverse Event|52
1235597|NCT00688688|4051799|P3|Overall Study|Eligibility criterion not met|10
1235598|NCT00688688|4051800|P2|Overall Study|Eligibility criterion not met|7
1235599|NCT00688688|4051801|P1|Overall Study|Eligibility criterion not met|7
1235600|NCT00688636|4051903|P2|Overall Study|Adverse Event|1
1235601|NCT00688636|4051904|P1|Overall Study|Adverse Event|2
1235602|NCT00688597|4051921|P3|Overall Study|Physician Decision|0
1235603|NCT00688597|4051922|P2|Overall Study|Physician Decision|0
1235604|NCT00688597|4051923|P1|Overall Study|Physician Decision|1
1235605|NCT00688597|4051921|P3|Overall Study|Adverse Event|0
1235606|NCT00688597|4051922|P2|Overall Study|Adverse Event|0
1235607|NCT00688597|4051923|P1|Overall Study|Adverse Event|2
1235608|NCT00688545|4051936|P2|Overall Study|Unspecified, unrelated to AE/Toxicity|7
1235609|NCT00688545|4051937|P1|Overall Study|Unspecified, unrelated to AE/Toxicity|2
1235610|NCT00688545|4051936|P2|Overall Study|Withdrawal by Subject|3
1235611|NCT00688545|4051937|P1|Overall Study|Withdrawal by Subject|2
1235612|NCT00688545|4051936|P2|Overall Study|Insurance/cost of drug|1
1235613|NCT00688545|4051937|P1|Overall Study|Insurance/cost of drug|0
1235614|NCT00688545|4051936|P2|Overall Study|Lost to Follow-up|4
1235615|NCT00688545|4051937|P1|Overall Study|Lost to Follow-up|1
1235616|NCT00688519|4051947|P2|Overall Study|Pregnancy|1
1235617|NCT00688519|4051948|P1|Overall Study|Pregnancy|0
1235618|NCT00688519|4051947|P2|Overall Study|Subject moved out of area|0
1235619|NCT00688519|4051948|P1|Overall Study|Subject moved out of area|1
1235620|NCT00688519|4051947|P2|Overall Study|Investigator decision|0
1235621|NCT00688519|4051948|P1|Overall Study|Investigator decision|1
1235622|NCT00688519|4051947|P2|Overall Study|Subject moved out of state|0
1235623|NCT00688519|4051948|P1|Overall Study|Subject moved out of state|1
1235624|NCT00688519|4051947|P2|Overall Study|Non-compliance|1
1235625|NCT00688519|4051948|P1|Overall Study|Non-compliance|0
1235626|NCT00688519|4051947|P2|Overall Study|Prohibited medication|0
1235627|NCT00688519|4051948|P1|Overall Study|Prohibited medication|1
1235628|NCT00688519|4051947|P2|Overall Study|Withdrawal by Subject|6
1235629|NCT00688519|4051948|P1|Overall Study|Withdrawal by Subject|7
1235630|NCT00688519|4051947|P2|Overall Study|Lack of Efficacy|1
1235631|NCT00688519|4051948|P1|Overall Study|Lack of Efficacy|3
1235632|NCT00688519|4051947|P2|Overall Study|Lost to Follow-up|3
1235633|NCT00688519|4051948|P1|Overall Study|Lost to Follow-up|3
1235634|NCT00688519|4051947|P2|Overall Study|Adverse Event|3
1235635|NCT00688519|4051948|P1|Overall Study|Adverse Event|2
1235636|NCT00688467|4051966|P2|Treatment Period 2|Adverse Event|1
1235637|NCT00688467|4051967|P1|Treatment Period 2|Adverse Event|0
1235638|NCT00688467|4051966|P2|Treatment Period 2|Protocol Violation|1
1235639|NCT00688467|4051967|P1|Treatment Period 2|Protocol Violation|0
1235640|NCT00688467|4051966|P2|Treatment Period 1|Did not meet protocol eligibility|1
1235641|NCT00688467|4051967|P1|Treatment Period 1|Did not meet protocol eligibility|0
1235642|NCT00688467|4051966|P2|Treatment Period 1|Adverse Event|1
1235643|NCT00688467|4051967|P1|Treatment Period 1|Adverse Event|2
1235644|NCT00688324|4051997|P1|Overall Study|Lost to Follow-up|1
1235645|NCT00688324|4051997|P1|Overall Study|Physician Decision|5
1235646|NCT00688324|4051997|P1|Overall Study|Withdrawal by Subject|2
1235647|NCT00688259|4052042|P2|Overall Study|Hospitalized at Follow-up|1
1235648|NCT00688259|4052043|P1|Overall Study|Hospitalized at Follow-up|0
1235649|NCT00688259|4052042|P2|Overall Study|Declined Interview|3
1235650|NCT00688259|4052043|P1|Overall Study|Declined Interview|2
1235651|NCT00688259|4052042|P2|Overall Study|Withdrawal by Subject|0
1235652|NCT00688259|4052043|P1|Overall Study|Withdrawal by Subject|2
1235653|NCT00688259|4052042|P2|Overall Study|Physician Decision|0
1235654|NCT00688259|4052043|P1|Overall Study|Physician Decision|1
1235655|NCT00688259|4052042|P2|Overall Study|Lost to Follow-up|4
1235656|NCT00688259|4052043|P1|Overall Study|Lost to Follow-up|2
1235657|NCT00688155|4052063|P4|Overall Study|Withdrawal by Subject|1
1235658|NCT00688155|4052064|P3|Overall Study|Withdrawal by Subject|1
1235659|NCT00688155|4052065|P2|Overall Study|Withdrawal by Subject|2
1235660|NCT00688155|4052066|P1|Overall Study|Withdrawal by Subject|2
1235661|NCT00688103|4052086|P2|Overall Study|complex reasons|9
1235662|NCT00688103|4052087|P1|Overall Study|complex reasons|11
1235663|NCT00688103|4052086|P2|Overall Study|Withdrawal by Subject|2
1235664|NCT00688103|4052087|P1|Overall Study|Withdrawal by Subject|4
1235665|NCT00688103|4052086|P2|Overall Study|Lack of Efficacy|1
1235666|NCT00688103|4052087|P1|Overall Study|Lack of Efficacy|11
1235667|NCT00688103|4052086|P2|Overall Study|Adverse Event|1
1235668|NCT00688103|4052087|P1|Overall Study|Adverse Event|4
1235669|NCT00688064|4052099|P2|Overall Study|Any other reasons|3
1235670|NCT00688064|4052100|P1|Overall Study|Any other reasons|1
1235671|NCT00688064|4052099|P2|Overall Study|Pregnancy|0
1235672|NCT00688064|4052100|P1|Overall Study|Pregnancy|1
1235673|NCT00688064|4052099|P2|Overall Study|Lack of Efficacy|1
1235674|NCT00688064|4052100|P1|Overall Study|Lack of Efficacy|0
1235675|NCT00688064|4052099|P2|Overall Study|Lost to Follow-up|10
1235676|NCT00688064|4052100|P1|Overall Study|Lost to Follow-up|10
1235677|NCT00688064|4052099|P2|Overall Study|Withdrawal by Subject|7
1235678|NCT00688064|4052100|P1|Overall Study|Withdrawal by Subject|7
1235679|NCT00688064|4052099|P2|Overall Study|Adverse Event|4
1235680|NCT00688064|4052100|P1|Overall Study|Adverse Event|2
1235681|NCT00688064|4052099|P2|Overall Study|Protocol Violation|1
1235682|NCT00688064|4052100|P1|Overall Study|Protocol Violation|0
1235683|NCT00687973|4052116|P2|Overall Study|Withdrawal by Subject|3
1235684|NCT00687973|4052117|P1|Overall Study|Withdrawal by Subject|3
1235685|NCT00687973|4052116|P2|Overall Study|Administrative Reasons|2
1235686|NCT00687973|4052117|P1|Overall Study|Administrative Reasons|0
1235687|NCT00687973|4052116|P2|Overall Study|Protocol Violation|2
1235688|NCT00687973|4052117|P1|Overall Study|Protocol Violation|1
1235689|NCT00687973|4052116|P2|Overall Study|Lack of Efficacy|3
1235690|NCT00687973|4052117|P1|Overall Study|Lack of Efficacy|2
1235691|NCT00687973|4052116|P2|Overall Study|Adverse Event|28
1235692|NCT00687973|4052117|P1|Overall Study|Adverse Event|18
1235693|NCT00687804|4052179|P3|Open-Label Extension Study|Death|3
1235694|NCT00687804|4052180|P2|Open-Label Extension Study|Death|3
1235695|NCT00687804|4052181|P1|Open-Label Extension Study|Death|2
1235696|NCT00687804|4052179|P3|Open-Label Extension Study|Administrative problems|0
1235697|NCT00687804|4052180|P2|Open-Label Extension Study|Administrative problems|1
1235698|NCT00687804|4052181|P1|Open-Label Extension Study|Administrative problems|1
1235699|NCT00687804|4052179|P3|Open-Label Extension Study|Lost to Follow-up|2
1235700|NCT00687804|4052180|P2|Open-Label Extension Study|Lost to Follow-up|1
1235701|NCT00687804|4052181|P1|Open-Label Extension Study|Lost to Follow-up|2
1235702|NCT00687804|4052179|P3|Open-Label Extension Study|Subject withdrew consent|4
1235703|NCT00687804|4052180|P2|Open-Label Extension Study|Subject withdrew consent|4
1235704|NCT00687804|4052181|P1|Open-Label Extension Study|Subject withdrew consent|3
1235705|NCT00687804|4052179|P3|Open-Label Extension Study|Adverse Event|2
1235706|NCT00687804|4052180|P2|Open-Label Extension Study|Adverse Event|2
1235707|NCT00687804|4052181|P1|Open-Label Extension Study|Adverse Event|2
1235708|NCT00687804|4052179|P3|Core Study|Protocol Violation|0
1235709|NCT00687804|4052180|P2|Core Study|Protocol Violation|1
1235710|NCT00687804|4052181|P1|Core Study|Protocol Violation|1
1235711|NCT00687804|4052179|P3|Core Study|Death|2
1235712|NCT00687804|4052180|P2|Core Study|Death|2
1235713|NCT00687804|4052181|P1|Core Study|Death|2
1235714|NCT00687804|4052179|P3|Core Study|Lost to Follow-up|0
1235715|NCT00687804|4052180|P2|Core Study|Lost to Follow-up|1
1235716|NCT00687804|4052181|P1|Core Study|Lost to Follow-up|0
1235717|NCT00687804|4052179|P3|Core Study|Withdrawal by Subject|7
1235718|NCT00687804|4052180|P2|Core Study|Withdrawal by Subject|7
1235719|NCT00687804|4052181|P1|Core Study|Withdrawal by Subject|4
1235720|NCT00687804|4052179|P3|Core Study|Lack of Efficacy|1
1235721|NCT00687804|4052180|P2|Core Study|Lack of Efficacy|1
1235722|NCT00687804|4052181|P1|Core Study|Lack of Efficacy|1
1235723|NCT00687804|4052179|P3|Core Study|Abnormal laboratory value(s)|0
1235724|NCT00687804|4052180|P2|Core Study|Abnormal laboratory value(s)|0
1235725|NCT00687804|4052181|P1|Core Study|Abnormal laboratory value(s)|1
1235726|NCT00687804|4052179|P3|Core Study|Adverse Event|3
1235727|NCT00687804|4052180|P2|Core Study|Adverse Event|3
1235728|NCT00687804|4052181|P1|Core Study|Adverse Event|5
1235729|NCT00687609|4052242|P1|Overall Study|Withdrawal by Subject|2
1235730|NCT00687609|4052242|P1|Overall Study|Physician Decision|1
1235731|NCT00687531|4052265|P1|Overall Study|Lost to Follow-up|26
1235732|NCT00687531|4052265|P1|Overall Study|Adverse Event|5
1235733|NCT00687531|4052265|P1|Overall Study|Did not meet protocol eligibility|104
1235734|NCT00687440|4052288|P1|Overall Study|Missing|1
1235735|NCT00687440|4052288|P1|Overall Study|Not specified|1
1235736|NCT00687440|4052288|P1|Overall Study|Death|2
1235737|NCT00687440|4052288|P1|Overall Study|Lack of Efficacy|2
1235738|NCT00687440|4052288|P1|Overall Study|Lost to Follow-up|3
1235739|NCT00687440|4052288|P1|Overall Study|Adverse Event|3
1235740|NCT00687401|4052292|P1|Overall Study|For reasons different from those above|4
1235741|NCT00687401|4052292|P1|Overall Study|Did not return for visit|3
1235742|NCT00687401|4052292|P1|Overall Study|Withdrawal by Subject|4
1235743|NCT00687401|4052292|P1|Overall Study|Lack of Efficacy|6
1235744|NCT00687401|4052292|P1|Overall Study|Adverse Event|6
1235745|NCT00687401|4052292|P1|Overall Study|Protocol Violation|7
1235746|NCT00687362|4052297|P1|Overall Study|Withdrawal by Subject|1
1235747|NCT00687362|4052297|P1|Overall Study|Protocol Violation|2
1235748|NCT00687323|4052301|P1|Overall Study|Screen failure|148
1235749|NCT00687323|4052301|P1|Overall Study|Excluded from efficacy evaluations|6
1235750|NCT00687323|4052301|P1|Overall Study|Withdrawal by Subject|1
1235751|NCT00687323|4052301|P1|Overall Study|Death|25
1235752|NCT00687297|4052317|P2|Induction|Other|1
1235753|NCT00687297|4052318|P1|Induction|Other|0
1235754|NCT00687297|4052317|P2|Induction|Physician Decision|2
1235755|NCT00687297|4052318|P1|Induction|Physician Decision|0
1235756|NCT00687297|4052317|P2|Induction|Patient Noncompliance|0
1235757|NCT00687297|4052318|P1|Induction|Patient Noncompliance|1
1235758|NCT00687297|4052317|P2|Induction|Ineligible|1
1235759|NCT00687297|4052318|P1|Induction|Ineligible|0
1235760|NCT00687297|4052317|P2|Induction|Lack of Efficacy|21
1235761|NCT00687297|4052318|P1|Induction|Lack of Efficacy|17
1235762|NCT00687297|4052317|P2|Induction|Death|11
1235763|NCT00687297|4052318|P1|Induction|Death|7
1235764|NCT00687297|4052317|P2|Induction|Adverse Event|15
1235765|NCT00687297|4052318|P1|Induction|Adverse Event|16
1235766|NCT00687297|4052317|P2|Induction|Withdrawal by Subject|4
1235767|NCT00687297|4052318|P1|Induction|Withdrawal by Subject|4
1235768|NCT00687297|4052317|P2|Randomization|Withdrew before treatment, ineligible|1
1235769|NCT00687297|4052318|P1|Randomization|Withdrew before treatment, ineligible|1
1235770|NCT00687297|4052317|P2|Randomization|Withdrawal by Subject|0
1235771|NCT00687297|4052318|P1|Randomization|Withdrawal by Subject|2
1235772|NCT00687271|4052332|P4|Overall Study|Withdrawal by Subject|0
1235773|NCT00687271|4052333|P3|Overall Study|Withdrawal by Subject|3
1235774|NCT00687271|4052334|P2|Overall Study|Withdrawal by Subject|1
1235775|NCT00687271|4052335|P1|Overall Study|Withdrawal by Subject|0
1235776|NCT00687271|4052332|P4|Overall Study|Protocol Violation|0
1235777|NCT00687271|4052333|P3|Overall Study|Protocol Violation|1
1235778|NCT00687271|4052334|P2|Overall Study|Protocol Violation|1
1235779|NCT00687271|4052335|P1|Overall Study|Protocol Violation|2
1235780|NCT00687271|4052332|P4|Overall Study|Lost to Follow-up|0
1235781|NCT00687271|4052333|P3|Overall Study|Lost to Follow-up|0
1235782|NCT00687271|4052334|P2|Overall Study|Lost to Follow-up|1
1235783|NCT00687271|4052335|P1|Overall Study|Lost to Follow-up|0
1235784|NCT00687271|4052332|P4|Overall Study|Adverse Event|0
1235785|NCT00687271|4052333|P3|Overall Study|Adverse Event|1
1235786|NCT00687271|4052334|P2|Overall Study|Adverse Event|3
1235787|NCT00687271|4052335|P1|Overall Study|Adverse Event|1
1235788|NCT00687219|4052373|P1|Overall Study|Lack of Efficacy|1
1235789|NCT00687219|4052373|P1|Overall Study|Withdrawal by Subject|1
1235790|NCT00687219|4052373|P1|Overall Study|HCV-RNA positive conversion|34
1235791|NCT00687219|4052373|P1|Overall Study|Discontinuance criteria met|7
1235792|NCT00687219|4052373|P1|Overall Study|Adverse Event|8
1235793|NCT00687193|4052385|P6|Overall Study|Protocol Violation|0
1235794|NCT00687193|4052386|P5|Overall Study|Protocol Violation|2
1235795|NCT00687193|4052387|P4|Overall Study|Protocol Violation|1
1235796|NCT00687193|4052388|P3|Overall Study|Protocol Violation|0
1235797|NCT00687193|4052389|P2|Overall Study|Protocol Violation|2
1235798|NCT00687193|4052390|P1|Overall Study|Protocol Violation|1
1235799|NCT00687193|4052385|P6|Overall Study|Lack of Efficacy|2
1235800|NCT00687193|4052386|P5|Overall Study|Lack of Efficacy|0
1235801|NCT00687193|4052387|P4|Overall Study|Lack of Efficacy|0
1235802|NCT00687193|4052388|P3|Overall Study|Lack of Efficacy|0
1235803|NCT00687193|4052389|P2|Overall Study|Lack of Efficacy|1
1235804|NCT00687193|4052390|P1|Overall Study|Lack of Efficacy|1
1235805|NCT00687193|4052385|P6|Overall Study|Adverse Event|2
1235806|NCT00687193|4052386|P5|Overall Study|Adverse Event|0
1235807|NCT00687193|4052387|P4|Overall Study|Adverse Event|3
1235808|NCT00687193|4052388|P3|Overall Study|Adverse Event|2
1235809|NCT00687193|4052389|P2|Overall Study|Adverse Event|1
1235810|NCT00687193|4052390|P1|Overall Study|Adverse Event|0
1235811|NCT00686998|4052600|P3|Overall Study|Safety Reasons|0
1235812|NCT00686998|4052601|P2|Overall Study|Safety Reasons|0
1235813|NCT00686998|4052602|P1|Overall Study|Safety Reasons|1
1235814|NCT00686998|4052600|P3|Overall Study|Not specified|1
1235815|NCT00686998|4052601|P2|Overall Study|Not specified|0
1235816|NCT00686998|4052602|P1|Overall Study|Not specified|0
1235817|NCT00686998|4052600|P3|Overall Study|Lack of Efficacy|0
1235818|NCT00686998|4052601|P2|Overall Study|Lack of Efficacy|5
1235819|NCT00686998|4052602|P1|Overall Study|Lack of Efficacy|7
1235820|NCT00686998|4052600|P3|Overall Study|Withdrawal by Subject|2
1235821|NCT00686998|4052601|P2|Overall Study|Withdrawal by Subject|1
1235822|NCT00686998|4052602|P1|Overall Study|Withdrawal by Subject|2
1235823|NCT00686998|4052600|P3|Overall Study|Adverse Event|1
1235824|NCT00686998|4052601|P2|Overall Study|Adverse Event|2
1235825|NCT00686998|4052602|P1|Overall Study|Adverse Event|3
1235826|NCT00686972|4052610|P1|Overall Study|P.I, Left institution. Study terminated|51
1235827|NCT00686959|4052616|P2|Overall Study|Participants censored (no death events)|117
1235828|NCT00686959|4052617|P1|Overall Study|Participants censored (no death events)|124
1235829|NCT00686894|4052635|P1|Overall Study|Protocol Violation|4
1235830|NCT00686894|4052635|P1|Overall Study|Relapse|2
1235831|NCT00686881|4052641|P2|Overall Study|Never received study drug|6
1235832|NCT00686881|4052642|P1|Overall Study|Never received study drug|2
1235833|NCT00686881|4052641|P2|Overall Study|Study discontinuation|32
1235834|NCT00686881|4052642|P1|Overall Study|Study discontinuation|35
1235835|NCT00686881|4052641|P2|Overall Study|Irregular visits|0
1235836|NCT00686881|4052642|P1|Overall Study|Irregular visits|1
1235837|NCT00686881|4052641|P2|Overall Study|Did not meet protocol eligibility|0
1235838|NCT00686881|4052642|P1|Overall Study|Did not meet protocol eligibility|1
1235839|NCT00686881|4052641|P2|Overall Study|Circumstances of site|1
1235840|NCT00686881|4052642|P1|Overall Study|Circumstances of site|1
1235841|NCT00686881|4052641|P2|Overall Study|Physician Decision|0
1235842|NCT00686881|4052642|P1|Overall Study|Physician Decision|1
1235843|NCT00686881|4052641|P2|Overall Study|Lack of Efficacy|3
1235844|NCT00686881|4052642|P1|Overall Study|Lack of Efficacy|4
1235845|NCT00686881|4052641|P2|Overall Study|Onset of malignant tumor|11
1235846|NCT00686881|4052642|P1|Overall Study|Onset of malignant tumor|11
1235847|NCT00686881|4052641|P2|Overall Study|Met discontinuation criteria|0
1235848|NCT00686881|4052642|P1|Overall Study|Met discontinuation criteria|5
1235849|NCT00686881|4052641|P2|Overall Study|Treatment-related adverse event|9
1235850|NCT00686881|4052642|P1|Overall Study|Treatment-related adverse event|10
1235851|NCT00686881|4052641|P2|Overall Study|Lost to Follow-up|1
1235852|NCT00686881|4052642|P1|Overall Study|Lost to Follow-up|0
1235853|NCT00686881|4052641|P2|Overall Study|Withdrawal by Subject|18
1235854|NCT00686881|4052642|P1|Overall Study|Withdrawal by Subject|11
1235855|NCT00686855|4052654|P2|Overall Study|Progressive GVHD|1
1235856|NCT00686855|4052655|P1|Overall Study|Progressive GVHD|0
1235857|NCT00686855|4052654|P2|Overall Study|Lost to Follow-up|0
1235858|NCT00686855|4052655|P1|Overall Study|Lost to Follow-up|1
1235859|NCT00686790|4052681|P1|Overall Study|Lost to Follow-up|12
1235860|NCT00686790|4052681|P1|Overall Study|Death|1
1235861|NCT00686790|4052681|P1|Overall Study|Withdrawal by Subject|1
1235862|NCT00686790|4052681|P1|Overall Study|Adverse Event|2
1235863|NCT00686777|4052689|P1|Overall Study|No Visit|1
1235864|NCT00686777|4052689|P1|Overall Study|Discontinuance Criteria (specified AEs)|4
1235865|NCT00686777|4052689|P1|Overall Study|Withdrawal by Subject|2
1235866|NCT00686777|4052689|P1|Overall Study|Pregnancy|1
1235867|NCT00686777|4052689|P1|Overall Study|Adverse Event|2
1235868|NCT00686725|4052697|P2|Overall Study|Not Specified|3
1235869|NCT00686725|4052698|P1|Overall Study|Not Specified|1
1235870|NCT00686725|4052697|P2|Overall Study|Protocol Violation|3
1235871|NCT00686725|4052698|P1|Overall Study|Protocol Violation|1
1235872|NCT00686725|4052697|P2|Overall Study|Withdrawal by Subject|4
1235873|NCT00686725|4052698|P1|Overall Study|Withdrawal by Subject|13
1235874|NCT00686725|4052697|P2|Overall Study|Death|3
1235875|NCT00686725|4052698|P1|Overall Study|Death|6
1235876|NCT00686725|4052697|P2|Overall Study|Lost to Follow-up|5
1235877|NCT00686725|4052698|P1|Overall Study|Lost to Follow-up|7
1235878|NCT00686725|4052697|P2|Overall Study|Progressive Disease|23
1235879|NCT00686725|4052698|P1|Overall Study|Progressive Disease|17
1235880|NCT00686725|4052697|P2|Overall Study|Adverse Event|1
1235881|NCT00686725|4052698|P1|Overall Study|Adverse Event|1
1235882|NCT00686712|4052723|P3|Overall Study|Adverse Event|0
1235883|NCT00686712|4052724|P2|Overall Study|Adverse Event|1
1235884|NCT00686712|4052725|P1|Overall Study|Adverse Event|1
1235885|NCT00686712|4052723|P3|Overall Study|Lost to Follow-up|3
1235886|NCT00686712|4052724|P2|Overall Study|Lost to Follow-up|2
1235887|NCT00686712|4052725|P1|Overall Study|Lost to Follow-up|1
1235888|NCT00686712|4052723|P3|Overall Study|Protocol Violation|10
1235889|NCT00686712|4052724|P2|Overall Study|Protocol Violation|8
1235890|NCT00686712|4052725|P1|Overall Study|Protocol Violation|8
1235891|NCT00686699|4052753|P2|Treatment Period 1|Adverse Event|2
1235892|NCT00686699|4052754|P1|Treatment Period 1|Adverse Event|0
1235893|NCT00686686|4052778|P1|Overall Study|Lost to Follow-up|3
1235894|NCT00686686|4052778|P1|Overall Study|Adverse Event|2
1235895|NCT00686686|4052778|P1|Overall Study|Non-compliance|1
1235896|NCT00686647|4052786|P1|Overall Study|Death|1
1235897|NCT00686647|4052786|P1|Overall Study|Lost to Follow-up|1
1235898|NCT00686634|4052792|P1|Overall Study|Protocol Violation|6
1235899|NCT00686595|4052799|P1|Overall Study|Poor Compliance|1
1235900|NCT00686595|4052799|P1|Overall Study|Lack of Efficacy|1
1235901|NCT00686595|4052799|P1|Overall Study|Lost to Follow-up|1
1235902|NCT00686595|4052799|P1|Overall Study|Protocol Violation|1
1235903|NCT00686595|4052799|P1|Overall Study|Adverse Event|3
1235904|NCT00686543|4052828|P4|Overall Study|Protocol Violation|1
1235905|NCT00686543|4052829|P3|Overall Study|Protocol Violation|2
1235906|NCT00686543|4052830|P2|Overall Study|Protocol Violation|0
1235907|NCT00686543|4052831|P1|Overall Study|Protocol Violation|3
1235908|NCT00686543|4052828|P4|Overall Study|Withdrawal by Subject|0
1235909|NCT00686543|4052829|P3|Overall Study|Withdrawal by Subject|0
1235910|NCT00686543|4052830|P2|Overall Study|Withdrawal by Subject|0
1235911|NCT00686543|4052831|P1|Overall Study|Withdrawal by Subject|2
1235912|NCT00686543|4052828|P4|Overall Study|Adverse Event|2
1235913|NCT00686543|4052829|P3|Overall Study|Adverse Event|3
1235914|NCT00686543|4052830|P2|Overall Study|Adverse Event|1
1235915|NCT00686543|4052831|P1|Overall Study|Adverse Event|9
1235916|NCT00686517|4052852|P3|Treatment|Protocol Violation|0
1235917|NCT00686517|4052853|P2|Treatment|Protocol Violation|1
1235918|NCT00686517|4052854|P1|Treatment|Protocol Violation|2
1235919|NCT00686517|4052852|P3|Treatment|Poor Protocol Compliance|0
1235920|NCT00686517|4052853|P2|Treatment|Poor Protocol Compliance|0
1235921|NCT00686517|4052854|P1|Treatment|Poor Protocol Compliance|1
1235922|NCT00686517|4052852|P3|Treatment|Adverse Event|0
1235923|NCT00686517|4052853|P2|Treatment|Adverse Event|0
1235924|NCT00686517|4052854|P1|Treatment|Adverse Event|2
1235925|NCT00686517|4052852|P3|Treatment|Serious Adverse Event|1
1235926|NCT00686517|4052853|P2|Treatment|Serious Adverse Event|2
1235927|NCT00686517|4052854|P1|Treatment|Serious Adverse Event|1
1235928|NCT00686374|4052877|P1|Overall Study|Other, not specified|4
1235929|NCT00686374|4052877|P1|Overall Study|Missing reason|33
1235930|NCT00686374|4052877|P1|Overall Study|Lost to Follow-up|1
1235931|NCT00686374|4052877|P1|Overall Study|Withdrew consent|5
1235932|NCT00686374|4052877|P1|Overall Study|Adverse Event|8
1235933|NCT00686374|4052877|P1|Overall Study|Lack of Efficacy|10
1235934|NCT00686335|4052888|P1|Run-in Period|violation of inclusion/exclusion criteri|3
1235935|NCT00686335|4052888|P1|Run-in Period|asthma exacerbation|1
1235936|NCT00686335|4052888|P1|Run-in Period|Adverse Event|1
1235937|NCT00686205|4052932|P2|Overall Study|Specimens not confirmed HIV positive|981
1235938|NCT00686205|4052933|P1|Overall Study|Specimens not confirmed HIV positive|0
1235939|NCT00686205|4052932|P2|Overall Study|Specimen handling procedure altered|0
1235940|NCT00686205|4052933|P1|Overall Study|Specimen handling procedure altered|5878
1235941|NCT00686205|4052932|P2|Overall Study|Withdrawal by Subject|0
1235942|NCT00686205|4052933|P1|Overall Study|Withdrawal by Subject|2
1235943|NCT00686205|4052932|P2|Overall Study|Protocol Violation|0
1235944|NCT00686205|4052933|P1|Overall Study|Protocol Violation|127
1235945|NCT00686166|4052939|P1|Overall Study|Did not begin protocol therapy|4
1235946|NCT00686166|4052939|P1|Overall Study|Ineligible|5
1235947|NCT00686166|4052939|P1|Overall Study|Not Protocol Specified|1
1235948|NCT00686166|4052939|P1|Overall Study|Death|1
1235949|NCT00686166|4052939|P1|Overall Study|Progression/Relapse|1
1235950|NCT00686166|4052939|P1|Overall Study|Withdrawal by Subject|1
1235951|NCT00686166|4052939|P1|Overall Study|Adverse Event|7
1235952|NCT00686127|4052951|P2|Overall Study|Withdrawal by Subject|6
1235953|NCT00686127|4052952|P1|Overall Study|Withdrawal by Subject|14
1235954|NCT00686075|4052968|P10|Overall Study|Other|1
1235955|NCT00686075|4052969|P9|Overall Study|Other|0
1235956|NCT00686075|4052970|P8|Overall Study|Other|0
1235957|NCT00686075|4052971|P7|Overall Study|Other|0
1235958|NCT00686075|4052972|P6|Overall Study|Other|0
1235959|NCT00686075|4052973|P5|Overall Study|Other|0
1235960|NCT00686075|4052974|P4|Overall Study|Other|0
1235961|NCT00686075|4052975|P3|Overall Study|Other|0
1235962|NCT00686075|4052976|P2|Overall Study|Other|1
1235963|NCT00686075|4052977|P1|Overall Study|Other|1
1235964|NCT00686075|4052968|P10|Overall Study|Lost to Follow-up|3
1235965|NCT00686075|4052969|P9|Overall Study|Lost to Follow-up|2
1235966|NCT00686075|4052970|P8|Overall Study|Lost to Follow-up|0
1235967|NCT00686075|4052971|P7|Overall Study|Lost to Follow-up|0
1235968|NCT00686075|4052972|P6|Overall Study|Lost to Follow-up|3
1235969|NCT00686075|4052973|P5|Overall Study|Lost to Follow-up|3
1235970|NCT00686075|4052974|P4|Overall Study|Lost to Follow-up|2
1235971|NCT00686075|4052975|P3|Overall Study|Lost to Follow-up|3
1235972|NCT00686075|4052976|P2|Overall Study|Lost to Follow-up|6
1235973|NCT00686075|4052977|P1|Overall Study|Lost to Follow-up|3
1235974|NCT00686075|4052968|P10|Overall Study|Withdrawal by Subject|6
1235975|NCT00686075|4052969|P9|Overall Study|Withdrawal by Subject|4
1235976|NCT00686075|4052970|P8|Overall Study|Withdrawal by Subject|2
1235977|NCT00686075|4052971|P7|Overall Study|Withdrawal by Subject|0
1235978|NCT00686075|4052972|P6|Overall Study|Withdrawal by Subject|0
1235979|NCT00686075|4052973|P5|Overall Study|Withdrawal by Subject|1
1235980|NCT00686075|4052974|P4|Overall Study|Withdrawal by Subject|7
1235981|NCT00686075|4052975|P3|Overall Study|Withdrawal by Subject|3
1235982|NCT00686075|4052976|P2|Overall Study|Withdrawal by Subject|3
1235983|NCT00686075|4052977|P1|Overall Study|Withdrawal by Subject|4
1235984|NCT00686036|4053171|P2|Overall Study|Other reasons not identified|4
1235985|NCT00686036|4053172|P1|Overall Study|Other reasons not identified|0
1235986|NCT00686036|4053171|P2|Overall Study|PSA ≥ 10ng/mL|0
1235987|NCT00686036|4053172|P1|Overall Study|PSA ≥ 10ng/mL|1
1235988|NCT00686036|4053171|P2|Overall Study|Study terminated by AstraZeneca|1
1235989|NCT00686036|4053172|P1|Overall Study|Study terminated by AstraZeneca|2
1235990|NCT00686036|4053171|P2|Overall Study|Withdrawal by Subject|1
1235991|NCT00686036|4053172|P1|Overall Study|Withdrawal by Subject|3
1235992|NCT00686036|4053171|P2|Overall Study|Adverse Event|0
1235993|NCT00686036|4053172|P1|Overall Study|Adverse Event|3
1235994|NCT00685945|4053184|P1|L-NMMA + Bradykinin|Physician Decision|1
1235995|NCT00685802|4053219|P2|Washout Period of 7 Days|Withdrawal by Subject|1
1235996|NCT00685802|4053220|P1|Washout Period of 7 Days|Withdrawal by Subject|0
1235997|NCT00685802|4053219|P2|Washout Period of 7 Days|Protocol Violation|0
1235998|NCT00685802|4053220|P1|Washout Period of 7 Days|Protocol Violation|2
1235999|NCT00685763|4053230|P1|Overall Study|Protocol Violation|1
1236000|NCT00685763|4053230|P1|Overall Study|Intercurrent death-incomplete treatment|1
1236001|NCT00685698|4053234|P1|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1
1236002|NCT00685698|4053234|P1|Overall Study|CULTURE RESULTS: GRAM-VE|1
1236003|NCT00685698|4053234|P1|Overall Study|CULTURE GRAM NEG SPECIES|1
1236004|NCT00685698|4053234|P1|Overall Study|Adverse Event|3
1236005|NCT00685698|4053234|P1|Overall Study|Protocol Violation|6
1236006|NCT00685698|4053234|P1|Overall Study|Withdrawal by Subject|1
1236007|NCT00685685|4053269|P2|Washout Period of 7 Days|Withdrawal by Subject|1
1236008|NCT00685685|4053270|P1|Washout Period of 7 Days|Withdrawal by Subject|0
1236009|NCT00685685|4053269|P2|Washout Period of 7 Days|Adverse Event|0
1236010|NCT00685685|4053270|P1|Washout Period of 7 Days|Adverse Event|2
1236011|NCT00685399|4053423|P8|Extension|Adverse Event|0
1236012|NCT00685399|4053424|P7|Extension|Adverse Event|0
1236013|NCT00685399|4053425|P6|Extension|Adverse Event|0
1236014|NCT00685399|4053426|P5|Extension|Adverse Event|0
1236015|NCT00685399|4053427|P4|Extension|Adverse Event|2
1236016|NCT00685399|4053428|P3|Extension|Adverse Event|0
1236017|NCT00685399|4053429|P2|Extension|Adverse Event|0
1236018|NCT00685399|4053430|P1|Extension|Adverse Event|0
1236019|NCT00685399|4053423|P8|Extension|Lack of Efficacy|0
1236020|NCT00685399|4053424|P7|Extension|Lack of Efficacy|0
1236021|NCT00685399|4053425|P6|Extension|Lack of Efficacy|0
1236022|NCT00685399|4053426|P5|Extension|Lack of Efficacy|0
1236023|NCT00685399|4053427|P4|Extension|Lack of Efficacy|2
1236024|NCT00685399|4053428|P3|Extension|Lack of Efficacy|0
1236025|NCT00685399|4053429|P2|Extension|Lack of Efficacy|0
1236026|NCT00685399|4053430|P1|Extension|Lack of Efficacy|0
1236027|NCT00685399|4053423|P8|Extension|Protocol Violation|0
1236028|NCT00685399|4053424|P7|Extension|Protocol Violation|0
1236029|NCT00685399|4053425|P6|Extension|Protocol Violation|0
1236030|NCT00685399|4053426|P5|Extension|Protocol Violation|0
1236031|NCT00685399|4053427|P4|Extension|Protocol Violation|1
1236032|NCT00685399|4053428|P3|Extension|Protocol Violation|0
1236033|NCT00685399|4053429|P2|Extension|Protocol Violation|0
1236034|NCT00685399|4053430|P1|Extension|Protocol Violation|0
1236035|NCT00685399|4053423|P8|Extension|Withdrawal by Subject|0
1236036|NCT00685399|4053424|P7|Extension|Withdrawal by Subject|0
1236037|NCT00685399|4053425|P6|Extension|Withdrawal by Subject|0
1236038|NCT00685399|4053426|P5|Extension|Withdrawal by Subject|0
1236039|NCT00685399|4053427|P4|Extension|Withdrawal by Subject|1
1236040|NCT00685399|4053428|P3|Extension|Withdrawal by Subject|0
1236041|NCT00685399|4053429|P2|Extension|Withdrawal by Subject|0
1236042|NCT00685399|4053430|P1|Extension|Withdrawal by Subject|0
1236043|NCT00685399|4053423|P8|Extension|Administrative Issues|0
1236044|NCT00685399|4053424|P7|Extension|Administrative Issues|0
1236045|NCT00685399|4053425|P6|Extension|Administrative Issues|0
1236046|NCT00685399|4053426|P5|Extension|Administrative Issues|0
1236047|NCT00685399|4053427|P4|Extension|Administrative Issues|1
1236048|NCT00685399|4053428|P3|Extension|Administrative Issues|0
1236049|NCT00685399|4053429|P2|Extension|Administrative Issues|0
1236050|NCT00685399|4053430|P1|Extension|Administrative Issues|0
1236051|NCT00685399|4053423|P8|Treatment Period 2|Lack of Efficacy|0
1236052|NCT00685399|4053424|P7|Treatment Period 2|Lack of Efficacy|0
1236053|NCT00685399|4053425|P6|Treatment Period 2|Lack of Efficacy|1
1236054|NCT00685399|4053426|P5|Treatment Period 2|Lack of Efficacy|0
1236055|NCT00685399|4053427|P4|Treatment Period 2|Lack of Efficacy|0
1236056|NCT00685399|4053428|P3|Treatment Period 2|Lack of Efficacy|2
1236057|NCT00685399|4053429|P2|Treatment Period 2|Lack of Efficacy|10
1236058|NCT00685399|4053430|P1|Treatment Period 2|Lack of Efficacy|0
1236059|NCT00685399|4053423|P8|Treatment Period 2|Adverse Event|0
1236060|NCT00685399|4053424|P7|Treatment Period 2|Adverse Event|0
1236061|NCT00685399|4053425|P6|Treatment Period 2|Adverse Event|1
1236062|NCT00685399|4053426|P5|Treatment Period 2|Adverse Event|0
1236063|NCT00685399|4053427|P4|Treatment Period 2|Adverse Event|0
1236064|NCT00685399|4053428|P3|Treatment Period 2|Adverse Event|0
1236065|NCT00685399|4053429|P2|Treatment Period 2|Adverse Event|0
1236066|NCT00685399|4053430|P1|Treatment Period 2|Adverse Event|0
1236067|NCT00685399|4053423|P8|Treatment Period 2|Withdrawal by Subject|2
1236068|NCT00685399|4053424|P7|Treatment Period 2|Withdrawal by Subject|0
1236069|NCT00685399|4053425|P6|Treatment Period 2|Withdrawal by Subject|0
1236070|NCT00685399|4053426|P5|Treatment Period 2|Withdrawal by Subject|0
1236071|NCT00685399|4053427|P4|Treatment Period 2|Withdrawal by Subject|0
1236072|NCT00685399|4053428|P3|Treatment Period 2|Withdrawal by Subject|0
1236073|NCT00685399|4053429|P2|Treatment Period 2|Withdrawal by Subject|0
1236074|NCT00685399|4053430|P1|Treatment Period 2|Withdrawal by Subject|0
1236075|NCT00685399|4053423|P8|Treatment Period 2|Administrative Problems|0
1236076|NCT00685399|4053424|P7|Treatment Period 2|Administrative Problems|0
1236077|NCT00685399|4053425|P6|Treatment Period 2|Administrative Problems|0
1236078|NCT00685399|4053426|P5|Treatment Period 2|Administrative Problems|0
1236079|NCT00685399|4053427|P4|Treatment Period 2|Administrative Problems|0
1236080|NCT00685399|4053428|P3|Treatment Period 2|Administrative Problems|1
1236081|NCT00685399|4053429|P2|Treatment Period 2|Administrative Problems|2
1236082|NCT00685399|4053430|P1|Treatment Period 2|Administrative Problems|0
1236083|NCT00685399|4053423|P8|Treatment Period 1|Lack of Efficacy|0
1236084|NCT00685399|4053424|P7|Treatment Period 1|Lack of Efficacy|0
1236085|NCT00685399|4053425|P6|Treatment Period 1|Lack of Efficacy|0
1236086|NCT00685399|4053426|P5|Treatment Period 1|Lack of Efficacy|0
1236087|NCT00685399|4053427|P4|Treatment Period 1|Lack of Efficacy|0
1236088|NCT00685399|4053428|P3|Treatment Period 1|Lack of Efficacy|0
1236089|NCT00685399|4053429|P2|Treatment Period 1|Lack of Efficacy|0
1236090|NCT00685399|4053430|P1|Treatment Period 1|Lack of Efficacy|1
1236091|NCT00685399|4053423|P8|Treatment Period 1|Administrative|0
1236092|NCT00685399|4053424|P7|Treatment Period 1|Administrative|0
1236093|NCT00685399|4053425|P6|Treatment Period 1|Administrative|0
1236094|NCT00685399|4053426|P5|Treatment Period 1|Administrative|0
1236095|NCT00685399|4053427|P4|Treatment Period 1|Administrative|0
1236096|NCT00685399|4053428|P3|Treatment Period 1|Administrative|0
1236097|NCT00685399|4053429|P2|Treatment Period 1|Administrative|0
1236098|NCT00685399|4053430|P1|Treatment Period 1|Administrative|2
1236099|NCT00685399|4053423|P8|Treatment Period 1|Protocol Violation|0
1236100|NCT00685399|4053424|P7|Treatment Period 1|Protocol Violation|0
1236101|NCT00685399|4053425|P6|Treatment Period 1|Protocol Violation|0
1236102|NCT00685399|4053426|P5|Treatment Period 1|Protocol Violation|0
1236103|NCT00685399|4053427|P4|Treatment Period 1|Protocol Violation|0
1236104|NCT00685399|4053428|P3|Treatment Period 1|Protocol Violation|0
1236105|NCT00685399|4053429|P2|Treatment Period 1|Protocol Violation|0
1236106|NCT00685399|4053430|P1|Treatment Period 1|Protocol Violation|1
1236107|NCT00685399|4053423|P8|Treatment Period 1|Withdrawal by Subject|0
1236108|NCT00685399|4053424|P7|Treatment Period 1|Withdrawal by Subject|0
1236109|NCT00685399|4053425|P6|Treatment Period 1|Withdrawal by Subject|0
1236110|NCT00685399|4053426|P5|Treatment Period 1|Withdrawal by Subject|0
1236111|NCT00685399|4053427|P4|Treatment Period 1|Withdrawal by Subject|0
1236112|NCT00685399|4053428|P3|Treatment Period 1|Withdrawal by Subject|0
1236113|NCT00685399|4053429|P2|Treatment Period 1|Withdrawal by Subject|0
1236114|NCT00685399|4053430|P1|Treatment Period 1|Withdrawal by Subject|2
1236115|NCT00685373|4053463|P1|Overall Study|Protocol Violation|1
1236116|NCT00685373|4053463|P1|Overall Study|Lost to Follow-up|2
1236117|NCT00685373|4053463|P1|Overall Study|Condition no longer requires study drug|1
1236118|NCT00685373|4053463|P1|Overall Study|Lack of Efficacy|3
1236119|NCT00685373|4053463|P1|Overall Study|Withdrawal by Subject|5
1236120|NCT00685373|4053463|P1|Overall Study|Adverse Event|3
1236121|NCT00685334|4053472|P2|Overall Study|Chose to enter hospital|1
1236122|NCT00685334|4053473|P1|Overall Study|Chose to enter hospital|1
1236123|NCT00685334|4053472|P2|Overall Study|Lost to Follow-up|0
1236124|NCT00685334|4053473|P1|Overall Study|Lost to Follow-up|4
1236125|NCT00685334|4053472|P2|Overall Study|Withdrawal by Subject|6
1236126|NCT00685334|4053473|P1|Overall Study|Withdrawal by Subject|5
1236127|NCT00685178|4053498|P4|Overall Study|Pregnancy|1
1236128|NCT00685178|4053499|P3|Overall Study|Pregnancy|0
1236129|NCT00685178|4053500|P2|Overall Study|Pregnancy|0
1236130|NCT00685178|4053501|P1|Overall Study|Pregnancy|0
1236131|NCT00685178|4053498|P4|Overall Study|administrative (disciplinary) discharge|2
1236132|NCT00685178|4053499|P3|Overall Study|administrative (disciplinary) discharge|0
1236133|NCT00685178|4053500|P2|Overall Study|administrative (disciplinary) discharge|1
1236134|NCT00685178|4053501|P1|Overall Study|administrative (disciplinary) discharge|0
1236135|NCT00685178|4053498|P4|Overall Study|incarcerated|0
1236136|NCT00685178|4053499|P3|Overall Study|incarcerated|7
1236137|NCT00685178|4053500|P2|Overall Study|incarcerated|3
1236138|NCT00685178|4053501|P1|Overall Study|incarcerated|1
1236139|NCT00685178|4053498|P4|Overall Study|voluntary study discharge|1
1236140|NCT00685178|4053499|P3|Overall Study|voluntary study discharge|1
1236141|NCT00685178|4053500|P2|Overall Study|voluntary study discharge|5
1236142|NCT00685178|4053501|P1|Overall Study|voluntary study discharge|4
1236143|NCT00685178|4053498|P4|Overall Study|missed 3 consecutive methadone clin days|6
1236144|NCT00685178|4053499|P3|Overall Study|missed 3 consecutive methadone clin days|2
1236145|NCT00685178|4053500|P2|Overall Study|missed 3 consecutive methadone clin days|5
1236146|NCT00685178|4053501|P1|Overall Study|missed 3 consecutive methadone clin days|7
1236147|NCT00685178|4053498|P4|Overall Study|Adverse Event|4
1236148|NCT00685178|4053499|P3|Overall Study|Adverse Event|2
1236149|NCT00685178|4053500|P2|Overall Study|Adverse Event|5
1236150|NCT00685178|4053501|P1|Overall Study|Adverse Event|1
1236151|NCT00685165|4053515|P2|Washout Period of 14 Days|Adverse Event|0
1236152|NCT00685165|4053516|P1|Washout Period of 14 Days|Adverse Event|1
1236153|NCT00685035|4053535|P2|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0
1236154|NCT00685035|4053536|P1|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1
1236155|NCT00684996|4053560|P1|Overall Study|Other reasons not protocol specified|1
1236156|NCT00684996|4053560|P1|Overall Study|Progression/relapse|2
1236157|NCT00684996|4053560|P1|Overall Study|Refusal unrelated to adverse event|1
1236158|NCT00684996|4053560|P1|Overall Study|Adverse Event|1
1236159|NCT00684814|4053592|P2|Second Intervention|Adverse Event|0
1236160|NCT00684814|4053593|P1|Second Intervention|Adverse Event|1
1236161|NCT00684814|4053592|P2|Washout Period of 7 Days|Withdrawal by Subject|2
1236162|NCT00684814|4053593|P1|Washout Period of 7 Days|Withdrawal by Subject|1
1236163|NCT00684814|4053592|P2|Washout Period of 7 Days|Adverse Event|2
1236164|NCT00684814|4053593|P1|Washout Period of 7 Days|Adverse Event|1
1236165|NCT00684762|4053645|P2|Washout Period of 7 Days|Withdrawal by Subject|2
1236166|NCT00684762|4053646|P1|Washout Period of 7 Days|Withdrawal by Subject|2
1236167|NCT00684671|4053674|P3|Overall Study|Alcoholic dependance|0
1236168|NCT00684671|4053675|P2|Overall Study|Alcoholic dependance|0
1236169|NCT00684671|4053676|P1|Overall Study|Alcoholic dependance|1
1236170|NCT00684671|4053674|P3|Overall Study|Lost to Follow-up|0
1236171|NCT00684671|4053675|P2|Overall Study|Lost to Follow-up|0
1236172|NCT00684671|4053676|P1|Overall Study|Lost to Follow-up|1
1236173|NCT00684671|4053674|P3|Overall Study|Adverse Event|0
1236174|NCT00684671|4053675|P2|Overall Study|Adverse Event|0
1236175|NCT00684671|4053676|P1|Overall Study|Adverse Event|1
1236176|NCT00684645|4053705|P1|Overall Study|Not specified|15
1236177|NCT00684645|4053705|P1|Overall Study|Lost to Follow-up|3
1236178|NCT00684645|4053705|P1|Overall Study|Adverse Event|27
1236179|NCT00684645|4053705|P1|Overall Study|Progressive disease|67
1236180|NCT00684645|4053705|P1|Overall Study|Death|2
1236181|NCT00684593|4053725|P2|Overall Study|Adverse Event|2
1236182|NCT00684593|4053726|P1|Overall Study|Adverse Event|0
1236183|NCT00684567|4053738|P1|Monotherapy Period|Progression of primary disease|11
1236184|NCT00684567|4053738|P1|Monotherapy Period|Death|1
1236185|NCT00684567|4053738|P1|Monotherapy Period|Adverse Event|2
1236186|NCT00684567|4053738|P1|Concomitant Radiotherapy Period|Adverse Event|2
1236187|NCT00684515|4053771|P3|Overall Study|Protocol-Defined Clinical Event|0
1236188|NCT00684515|4053772|P2|Overall Study|Protocol-Defined Clinical Event|0
1236189|NCT00684515|4053773|P1|Overall Study|Protocol-Defined Clinical Event|1
1236190|NCT00684515|4053771|P3|Overall Study|Adverse Event|1
1236191|NCT00684515|4053772|P2|Overall Study|Adverse Event|3
1236192|NCT00684515|4053773|P1|Overall Study|Adverse Event|3
1236193|NCT00684424|4053796|P1|Overall Study|Not Specified|2
1236194|NCT00684424|4053796|P1|Overall Study|Lost to Follow-up|2
1236195|NCT00684424|4053796|P1|Overall Study|Adverse Event|1
1236196|NCT00684411|4053811|P1|Overall Study|Adverse Event|1
1236197|NCT00684411|4053811|P1|Overall Study|Disease Progression|10
1236198|NCT00684411|4053811|P1|Overall Study|New Primary Cancer|1
1236199|NCT00684307|4053833|P5|Overall Study|Criteria from the CSR|3
1236200|NCT00684307|4053834|P4|Overall Study|Criteria from the CSR|3
1236201|NCT00684307|4053835|P3|Overall Study|Criteria from the CSR|1
1236202|NCT00684307|4053836|P2|Overall Study|Criteria from the CSR|0
1236203|NCT00684307|4053837|P1|Overall Study|Criteria from the CSR|0
1236204|NCT00684307|4053833|P5|Overall Study|Participant not willing to continue|8
1236205|NCT00684307|4053834|P4|Overall Study|Participant not willing to continue|5
1236206|NCT00684307|4053835|P3|Overall Study|Participant not willing to continue|11
1236207|NCT00684307|4053836|P2|Overall Study|Participant not willing to continue|10
1236208|NCT00684307|4053837|P1|Overall Study|Participant not willing to continue|7
1236209|NCT00684307|4053833|P5|Overall Study|Severe non compliance to protocol|2
1236210|NCT00684307|4053834|P4|Overall Study|Severe non compliance to protocol|1
1236211|NCT00684307|4053835|P3|Overall Study|Severe non compliance to protocol|0
1236212|NCT00684307|4053836|P2|Overall Study|Severe non compliance to protocol|0
1236213|NCT00684307|4053837|P1|Overall Study|Severe non compliance to protocol|1
1236214|NCT00684307|4053833|P5|Overall Study|Interupted IP for more than 7 days|3
1236215|NCT00684307|4053834|P4|Overall Study|Interupted IP for more than 7 days|3
1236216|NCT00684307|4053835|P3|Overall Study|Interupted IP for more than 7 days|1
1236217|NCT00684307|4053836|P2|Overall Study|Interupted IP for more than 7 days|4
1236218|NCT00684307|4053837|P1|Overall Study|Interupted IP for more than 7 days|0
1236219|NCT00684307|4053833|P5|Overall Study|Incorrect enrolment or randomization|0
1236220|NCT00684307|4053834|P4|Overall Study|Incorrect enrolment or randomization|0
1236221|NCT00684307|4053835|P3|Overall Study|Incorrect enrolment or randomization|0
1236222|NCT00684307|4053836|P2|Overall Study|Incorrect enrolment or randomization|0
1236223|NCT00684307|4053837|P1|Overall Study|Incorrect enrolment or randomization|4
1236224|NCT00684307|4053833|P5|Overall Study|Fullfillment of exclusion criteria|1
1236225|NCT00684307|4053834|P4|Overall Study|Fullfillment of exclusion criteria|3
1236226|NCT00684307|4053835|P3|Overall Study|Fullfillment of exclusion criteria|0
1236227|NCT00684307|4053836|P2|Overall Study|Fullfillment of exclusion criteria|0
1236228|NCT00684307|4053837|P1|Overall Study|Fullfillment of exclusion criteria|1
1236229|NCT00684307|4053833|P5|Overall Study|Development of increasing Liver Function|0
1236230|NCT00684307|4053834|P4|Overall Study|Development of increasing Liver Function|1
1236231|NCT00684307|4053835|P3|Overall Study|Development of increasing Liver Function|0
1236232|NCT00684307|4053836|P2|Overall Study|Development of increasing Liver Function|2
1236233|NCT00684307|4053837|P1|Overall Study|Development of increasing Liver Function|0
1236234|NCT00684307|4053833|P5|Overall Study|Adverse Event|8
1236235|NCT00684307|4053834|P4|Overall Study|Adverse Event|16
1236236|NCT00684307|4053835|P3|Overall Study|Adverse Event|15
1236237|NCT00684307|4053836|P2|Overall Study|Adverse Event|6
1236238|NCT00684307|4053837|P1|Overall Study|Adverse Event|11
1236239|NCT00684203|4053919|P6|Overall Study|Did not meet protocol eligibility|0
1236240|NCT00684203|4053920|P5|Overall Study|Did not meet protocol eligibility|0
1236241|NCT00684203|4053921|P4|Overall Study|Did not meet protocol eligibility|0
1236242|NCT00684203|4053922|P3|Overall Study|Did not meet protocol eligibility|0
1236243|NCT00684203|4053923|P2|Overall Study|Did not meet protocol eligibility|1
1236244|NCT00684203|4053924|P1|Overall Study|Did not meet protocol eligibility|0
1236245|NCT00684203|4053919|P6|Overall Study|Withdrawal by Subject|0
1236246|NCT00684203|4053920|P5|Overall Study|Withdrawal by Subject|0
1236247|NCT00684203|4053921|P4|Overall Study|Withdrawal by Subject|0
1236248|NCT00684203|4053922|P3|Overall Study|Withdrawal by Subject|1
1236249|NCT00684203|4053923|P2|Overall Study|Withdrawal by Subject|2
1236250|NCT00684203|4053924|P1|Overall Study|Withdrawal by Subject|0
1236251|NCT00684203|4053919|P6|Overall Study|Protocol-defined clinical event|0
1236252|NCT00684203|4053920|P5|Overall Study|Protocol-defined clinical event|0
1236253|NCT00684203|4053921|P4|Overall Study|Protocol-defined clinical event|0
1236254|NCT00684203|4053922|P3|Overall Study|Protocol-defined clinical event|0
1236255|NCT00684203|4053923|P2|Overall Study|Protocol-defined clinical event|1
1236256|NCT00684203|4053924|P1|Overall Study|Protocol-defined clinical event|3
1236257|NCT00684203|4053919|P6|Overall Study|Adverse Event|0
1236258|NCT00684203|4053920|P5|Overall Study|Adverse Event|0
1236259|NCT00684203|4053921|P4|Overall Study|Adverse Event|0
1236260|NCT00684203|4053922|P3|Overall Study|Adverse Event|8
1236261|NCT00684203|4053923|P2|Overall Study|Adverse Event|4
1236262|NCT00684203|4053924|P1|Overall Study|Adverse Event|6
1236263|NCT00684177|4053985|P2|Overall Study|Other|2
1236264|NCT00684177|4053986|P1|Overall Study|Other|1
1236265|NCT00684177|4053985|P2|Overall Study|Withdrawal by Subject|2
1236266|NCT00684177|4053986|P1|Overall Study|Withdrawal by Subject|1
1236267|NCT00684177|4053985|P2|Overall Study|Physician Decision|0
1236268|NCT00684177|4053986|P1|Overall Study|Physician Decision|2
1236269|NCT00684177|4053985|P2|Overall Study|Lost to Follow-up|1
1236270|NCT00684177|4053986|P1|Overall Study|Lost to Follow-up|2
1236271|NCT00684177|4053985|P2|Overall Study|Protocol Violation|0
1236272|NCT00684177|4053986|P1|Overall Study|Protocol Violation|1
1236273|NCT00684177|4053985|P2|Overall Study|Lack of Efficacy|15
1236274|NCT00684177|4053986|P1|Overall Study|Lack of Efficacy|10
1236275|NCT00684177|4053985|P2|Overall Study|Adverse Event|3
1236276|NCT00684177|4053986|P1|Overall Study|Adverse Event|4
1236277|NCT00684073|4054021|P1|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1
1236278|NCT00684073|4054021|P1|Selection|request of the sponsor|1
1236279|NCT00684073|4054021|P1|Selection|Lost to Follow-up|1
1236280|NCT00684073|4054021|P1|Selection|noncompliance|1
1236281|NCT00684073|4054021|P1|Selection|Death|1
1236282|NCT00684073|4054021|P1|Selection|Selection/non-selection criteria|3
1236283|NCT00684060|4054031|P2|Overall Study|Death|1
1236284|NCT00684060|4054032|P1|Overall Study|Death|0
1236285|NCT00684060|4054031|P2|Overall Study|Unable to collect MRI|2
1236286|NCT00684060|4054032|P1|Overall Study|Unable to collect MRI|1
1236287|NCT00684060|4054031|P2|Overall Study|New stenosis identified|0
1236288|NCT00684060|4054032|P1|Overall Study|New stenosis identified|1
1236289|NCT00684060|4054031|P2|Overall Study|Lost to Follow-up|0
1236290|NCT00684060|4054032|P1|Overall Study|Lost to Follow-up|1
1236291|NCT00684021|4054071|P4|Overall Study|Death|0
1236292|NCT00684021|4054072|P3|Overall Study|Death|0
1236293|NCT00684021|4054073|P2|Overall Study|Death|0
1236294|NCT00684021|4054074|P1|Overall Study|Death|1
1236295|NCT00684021|4054071|P4|Overall Study|MRI not performed|2
1236296|NCT00684021|4054072|P3|Overall Study|MRI not performed|1
1236297|NCT00684021|4054073|P2|Overall Study|MRI not performed|1
1236298|NCT00684021|4054074|P1|Overall Study|MRI not performed|0
1236299|NCT00684021|4054071|P4|Overall Study|MRI Contraindicated|0
1236300|NCT00684021|4054072|P3|Overall Study|MRI Contraindicated|1
1236301|NCT00684021|4054073|P2|Overall Study|MRI Contraindicated|1
1236302|NCT00684021|4054074|P1|Overall Study|MRI Contraindicated|1
1236303|NCT00683917|4054135|P1|Overall Study|Study prematurely terminated|10
1236304|NCT00683904|4054145|P2|Dose Level 2|Adverse Event|2
1236305|NCT00683904|4054146|P1|Dose Level 2|Adverse Event|0
1236306|NCT00683904|4054145|P2|Dose Level 1|Adverse Event|0
1236307|NCT00683904|4054146|P1|Dose Level 1|Adverse Event|1
1236308|NCT00683904|4054145|P2|Dose Level 1|Disease progression|0
1236309|NCT00683904|4054146|P1|Dose Level 1|Disease progression|2
1236310|NCT00683878|4054182|P3|Overall Study|Non-compliance, not met criteria etc.|0
1236311|NCT00683878|4054183|P2|Overall Study|Non-compliance, not met criteria etc.|2
1236312|NCT00683878|4054184|P1|Overall Study|Non-compliance, not met criteria etc.|3
1236313|NCT00683878|4054182|P3|Overall Study|Lost to Follow-up|4
1236314|NCT00683878|4054183|P2|Overall Study|Lost to Follow-up|2
1236315|NCT00683878|4054184|P1|Overall Study|Lost to Follow-up|4
1236316|NCT00683878|4054182|P3|Overall Study|Death|0
1236317|NCT00683878|4054183|P2|Overall Study|Death|1
1236318|NCT00683878|4054184|P1|Overall Study|Death|0
1236319|NCT00683878|4054182|P3|Overall Study|Withdrawal by Subject|6
1236320|NCT00683878|4054183|P2|Overall Study|Withdrawal by Subject|8
1236321|NCT00683878|4054184|P1|Overall Study|Withdrawal by Subject|9
1236322|NCT00683878|4054182|P3|Overall Study|Adverse Event|3
1236323|NCT00683878|4054183|P2|Overall Study|Adverse Event|3
1236324|NCT00683878|4054184|P1|Overall Study|Adverse Event|4
1236325|NCT00683878|4054182|P3|Overall Study|Lack of Efficacy|1
1236326|NCT00683878|4054183|P2|Overall Study|Lack of Efficacy|0
1236327|NCT00683878|4054184|P1|Overall Study|Lack of Efficacy|3
1236328|NCT00683800|4054258|P2|Overall Study|Randomized, not treated|33
1236329|NCT00683800|4054259|P1|Overall Study|Randomized, not treated|35
1236330|NCT00683800|4054258|P2|Overall Study|Lack of Efficacy|104
1236331|NCT00683800|4054259|P1|Overall Study|Lack of Efficacy|61
1236332|NCT00683800|4054258|P2|Overall Study|Withdrawal by Subject|64
1236333|NCT00683800|4054259|P1|Overall Study|Withdrawal by Subject|66
1236334|NCT00683800|4054258|P2|Overall Study|Protocol Violation|16
1236335|NCT00683800|4054259|P1|Overall Study|Protocol Violation|13
1236336|NCT00683800|4054258|P2|Overall Study|Other|2
1236337|NCT00683800|4054259|P1|Overall Study|Other|5
1236338|NCT00683800|4054258|P2|Overall Study|Lost to Follow-up|44
1236339|NCT00683800|4054259|P1|Overall Study|Lost to Follow-up|57
1236340|NCT00683800|4054258|P2|Overall Study|Death|1
1236341|NCT00683800|4054259|P1|Overall Study|Death|0
1236342|NCT00683800|4054258|P2|Overall Study|Adverse Event|102
1236343|NCT00683800|4054259|P1|Overall Study|Adverse Event|195
1236344|NCT00683787|4054326|P3|Overall Study|Adverse Event|2
1236345|NCT00683787|4054327|P2|Overall Study|Adverse Event|0
1236346|NCT00683787|4054328|P1|Overall Study|Adverse Event|0
1236347|NCT00683787|4054326|P3|Overall Study|Progression|0
1236348|NCT00683787|4054327|P2|Overall Study|Progression|3
1236349|NCT00683787|4054328|P1|Overall Study|Progression|3
1236350|NCT00683774|4054347|P2|Overall Study|Physician Decision|0
1236351|NCT00683774|4054348|P1|Overall Study|Physician Decision|3
1236352|NCT00683774|4054347|P2|Overall Study|Withdrawal by Subject|1
1236353|NCT00683774|4054348|P1|Overall Study|Withdrawal by Subject|0
1236354|NCT00683696|4054358|P2|Overall Study|Death|30
1236355|NCT00683696|4054359|P1|Overall Study|Death|46
1236356|NCT00683696|4054358|P2|Overall Study|Vital status follow-up only|3
1236357|NCT00683696|4054359|P1|Overall Study|Vital status follow-up only|3
1236358|NCT00683696|4054358|P2|Overall Study|Lost to Follow-up|6
1236359|NCT00683696|4054359|P1|Overall Study|Lost to Follow-up|5
1236360|NCT00683696|4054358|P2|Overall Study|Withdrawn prior to study closure|28
1236361|NCT00683696|4054359|P1|Overall Study|Withdrawn prior to study closure|13
1236362|NCT00683696|4054358|P2|Overall Study|Withdrawn due to study closure|338
1236363|NCT00683696|4054359|P1|Overall Study|Withdrawn due to study closure|337
1236364|NCT00683657|4054378|P2|Overall Study|Subject Withdrew Consent|0
1236365|NCT00683657|4054379|P1|Overall Study|Subject Withdrew Consent|1
1236366|NCT00683657|4054378|P2|Overall Study|Adverse Event|1
1236367|NCT00683657|4054379|P1|Overall Study|Adverse Event|0
1236368|NCT00683644|4054395|P2|Overall Study|Low copper, other health problems,|6
1236369|NCT00683644|4054396|P1|Overall Study|Low copper, other health problems,|7
1236370|NCT00683644|4054395|P2|Overall Study|Adverse Event|2
1236371|NCT00683644|4054396|P1|Overall Study|Adverse Event|1
1236372|NCT00683644|4054395|P2|Overall Study|Lost to Follow-up|4
1236373|NCT00683644|4054396|P1|Overall Study|Lost to Follow-up|1
1236374|NCT00683644|4054395|P2|Overall Study|Withdrawal by Subject|2
1236375|NCT00683644|4054396|P1|Overall Study|Withdrawal by Subject|4
1236376|NCT00683618|4054409|P3|Extension Treatment Period|Protocol Violation|0
1236377|NCT00683618|4054410|P2|Extension Treatment Period|Protocol Violation|0
1236378|NCT00683618|4054411|P1|Extension Treatment Period|Protocol Violation|1
1236379|NCT00683618|4054409|P3|Extension Treatment Period|Adverse Event|0
1236380|NCT00683618|4054410|P2|Extension Treatment Period|Adverse Event|0
1236381|NCT00683618|4054411|P1|Extension Treatment Period|Adverse Event|1
1236382|NCT00683618|4054409|P3|Extension Treatment Period|Withdrawal by Subject|0
1236383|NCT00683618|4054410|P2|Extension Treatment Period|Withdrawal by Subject|0
1236384|NCT00683618|4054411|P1|Extension Treatment Period|Withdrawal by Subject|1
1236385|NCT00683618|4054409|P3|Randomised Treatment Period|Reason not provided|2
1236386|NCT00683618|4054410|P2|Randomised Treatment Period|Reason not provided|0
1236387|NCT00683618|4054411|P1|Randomised Treatment Period|Reason not provided|0
1236388|NCT00683618|4054409|P3|Randomised Treatment Period|Adverse Event|2
1236389|NCT00683618|4054410|P2|Randomised Treatment Period|Adverse Event|0
1236390|NCT00683618|4054411|P1|Randomised Treatment Period|Adverse Event|2
1236391|NCT00683618|4054409|P3|Randomised Treatment Period|Protocol Violation|0
1236392|NCT00683618|4054410|P2|Randomised Treatment Period|Protocol Violation|1
1236393|NCT00683618|4054411|P1|Randomised Treatment Period|Protocol Violation|0
1236394|NCT00683618|4054409|P3|Randomised Treatment Period|Withdrawal by Subject|2
1236395|NCT00683618|4054410|P2|Randomised Treatment Period|Withdrawal by Subject|1
1236396|NCT00683618|4054411|P1|Randomised Treatment Period|Withdrawal by Subject|4
1236397|NCT00683592|4054461|P2|Overall Study|Other|1
1236398|NCT00683592|4054462|P1|Overall Study|Other|1
1236399|NCT00683592|4054461|P2|Overall Study|Non-compliance|5
1236400|NCT00683592|4054462|P1|Overall Study|Non-compliance|3
1236401|NCT00683592|4054461|P2|Overall Study|Physician Decision|1
1236402|NCT00683592|4054462|P1|Overall Study|Physician Decision|0
1236403|NCT00683592|4054461|P2|Overall Study|Lack of Efficacy|7
1236404|NCT00683592|4054462|P1|Overall Study|Lack of Efficacy|3
1236405|NCT00683592|4054461|P2|Overall Study|Lost to Follow-up|17
1236406|NCT00683592|4054462|P1|Overall Study|Lost to Follow-up|17
1236407|NCT00683592|4054461|P2|Overall Study|Withdrawal by Subject|11
1236408|NCT00683592|4054462|P1|Overall Study|Withdrawal by Subject|11
1236409|NCT00683592|4054461|P2|Overall Study|Adverse Event|4
1236410|NCT00683592|4054462|P1|Overall Study|Adverse Event|12
1236411|NCT00683475|4054480|P2|Overall Study|Never Treated: Progressive Disease|0
1236412|NCT00683475|4054481|P1|Overall Study|Never Treated: Progressive Disease|1
1236413|NCT00683475|4054480|P2|Overall Study|Never Treated: Adverse Event|3
1236414|NCT00683475|4054481|P1|Overall Study|Never Treated: Adverse Event|2
1236415|NCT00683475|4054480|P2|Overall Study|Withdrawal by Subject|0
1236416|NCT00683475|4054481|P1|Overall Study|Withdrawal by Subject|1
1236417|NCT00683449|4054516|P5|Overall Study|Lost to Follow-up|0
1236418|NCT00683449|4054517|P4|Overall Study|Lost to Follow-up|0
1236419|NCT00683449|4054518|P3|Overall Study|Lost to Follow-up|0
1236420|NCT00683449|4054519|P2|Overall Study|Lost to Follow-up|1
1236421|NCT00683449|4054520|P1|Overall Study|Lost to Follow-up|0
1236422|NCT00683384|4054546|P1|Overall Study|Adverse Event|1
1236423|NCT00683384|4054546|P1|Overall Study|Death|1
1236424|NCT00683293|4054556|P2|Overall Study|Withdrawal by Subject|3
1236425|NCT00683293|4054557|P1|Overall Study|Withdrawal by Subject|2
1236426|NCT00682929|4054620|P3|Overall Study|lag in DEA renewal|0
1236427|NCT00682929|4054621|P2|Overall Study|lag in DEA renewal|0
1236428|NCT00682929|4054622|P1|Overall Study|lag in DEA renewal|1
1236429|NCT00682929|4054620|P3|Overall Study|dosing compliance < 80%|0
1236430|NCT00682929|4054621|P2|Overall Study|dosing compliance < 80%|2
1236431|NCT00682929|4054622|P1|Overall Study|dosing compliance < 80%|0
1236432|NCT00682929|4054620|P3|Overall Study|Withdrawal by Subject|1
1236433|NCT00682929|4054621|P2|Overall Study|Withdrawal by Subject|2
1236434|NCT00682929|4054622|P1|Overall Study|Withdrawal by Subject|1
1236435|NCT00682929|4054620|P3|Overall Study|Adverse Event|1
1236436|NCT00682929|4054621|P2|Overall Study|Adverse Event|1
1236437|NCT00682929|4054622|P1|Overall Study|Adverse Event|4
1236438|NCT00682890|4054791|P2|Overall Study|heavy menstrual bleeding|0
1236439|NCT00682890|4054792|P1|Overall Study|heavy menstrual bleeding|1
1236440|NCT00682890|4054791|P2|Overall Study|subject moved away|1
1236441|NCT00682890|4054792|P1|Overall Study|subject moved away|0
1236442|NCT00682890|4054791|P2|Overall Study|Lost to Follow-up|1
1236443|NCT00682890|4054792|P1|Overall Study|Lost to Follow-up|1
1236444|NCT00682786|4054834|P2|Overall Study|Did not receive irinotecan|1
1236445|NCT00682786|4054835|P1|Overall Study|Did not receive irinotecan|0
1236446|NCT00682786|4054834|P2|Overall Study|Withdrawal by Subject|2
1236447|NCT00682786|4054835|P1|Overall Study|Withdrawal by Subject|2
1236448|NCT00682643|4054884|P2|Overall Study|Did Not Receive Study Drug|1
1236449|NCT00682643|4054885|P1|Overall Study|Did Not Receive Study Drug|1
1236450|NCT00682643|4054884|P2|Overall Study|Withdrawal by Subject|53
1236451|NCT00682643|4054885|P1|Overall Study|Withdrawal by Subject|19
1236452|NCT00682643|4054884|P2|Overall Study|Physician Decision|6
1236453|NCT00682643|4054885|P1|Overall Study|Physician Decision|2
1236454|NCT00682643|4054884|P2|Overall Study|Lost to Follow-up|6
1236455|NCT00682643|4054885|P1|Overall Study|Lost to Follow-up|1
1236456|NCT00682643|4054884|P2|Overall Study|Met Protocol-defined Stopping Criteria|4
1236457|NCT00682643|4054885|P1|Overall Study|Met Protocol-defined Stopping Criteria|3
1236458|NCT00682643|4054884|P2|Overall Study|Protocol Violation|76
1236459|NCT00682643|4054885|P1|Overall Study|Protocol Violation|38
1236460|NCT00682643|4054884|P2|Overall Study|Lack of Efficacy|0
1236461|NCT00682643|4054885|P1|Overall Study|Lack of Efficacy|2
1236462|NCT00682643|4054884|P2|Overall Study|Adverse Event|23
1236463|NCT00682643|4054885|P1|Overall Study|Adverse Event|12
1236464|NCT00682539|4054946|P3|Ranibizumab vs Triamcinolone|Lost to Follow-up|8
1236465|NCT00682539|4054947|P2|Ranibizumab vs Triamcinolone|Lost to Follow-up|3
1236466|NCT00682539|4054948|P1|Ranibizumab vs Triamcinolone|Lost to Follow-up|0
1236467|NCT00682539|4054946|P3|Bevacizumab vs Triamcinolone|Lost to Follow-up|0
1236468|NCT00682539|4054947|P2|Bevacizumab vs Triamcinolone|Lost to Follow-up|1
1236469|NCT00682539|4054948|P1|Bevacizumab vs Triamcinolone|Lost to Follow-up|3
1236470|NCT00682461|4054961|P2|Overall Study|Withdrawal by Subject|19
1236471|NCT00682461|4054962|P1|Overall Study|Withdrawal by Subject|12
1236472|NCT00682461|4054961|P2|Overall Study|Lost to Follow-up|5
1236473|NCT00682461|4054962|P1|Overall Study|Lost to Follow-up|8
1236474|NCT00682461|4054961|P2|Overall Study|Adverse Event|7
1236475|NCT00682461|4054962|P1|Overall Study|Adverse Event|5
1236476|NCT00682435|4054976|P1|Overall Study|Erroneously enrolled twice|2
1236477|NCT00682435|4054976|P1|Overall Study|Insufficient data|5
1236478|NCT00681863|4055009|P1|Overall Study|not specified|18
1236479|NCT00681863|4055009|P1|Overall Study|Lack of Efficacy|2
1236480|NCT00681863|4055009|P1|Overall Study|Lost to Follow-up|2
1236481|NCT00681863|4055009|P1|Overall Study|Adverse Event|1
1236482|NCT00681824|4055057|P3|Overall Study|Death|0
1236483|NCT00681824|4055058|P2|Overall Study|Death|1
1236484|NCT00681824|4055059|P1|Overall Study|Death|0
1236485|NCT00681824|4055057|P3|Overall Study|scheduling conflict|0
1236486|NCT00681824|4055058|P2|Overall Study|scheduling conflict|0
1236487|NCT00681824|4055059|P1|Overall Study|scheduling conflict|1
1236488|NCT00681824|4055057|P3|Overall Study|withdrawn by investigator|1
1236489|NCT00681824|4055058|P2|Overall Study|withdrawn by investigator|0
1236490|NCT00681824|4055059|P1|Overall Study|withdrawn by investigator|0
1236491|NCT00681811|4055077|P2|Overall Study|Non-compliance|1
1236492|NCT00681811|4055078|P1|Overall Study|Non-compliance|0
1236493|NCT00681811|4055077|P2|Overall Study|Withdrawal by Subject|2
1236494|NCT00681811|4055078|P1|Overall Study|Withdrawal by Subject|2
1236495|NCT00681811|4055077|P2|Overall Study|Adverse Event|1
1236496|NCT00681811|4055078|P1|Overall Study|Adverse Event|1
1236497|NCT00681668|4055106|P1|Overall Study|Withdrawal by Subject|1
1236498|NCT00681668|4055106|P1|Overall Study|Protocol Violation|1
1236499|NCT00681629|4055115|P2|Overall Study|Adverse Event|0
1236500|NCT00681629|4055116|P1|Overall Study|Adverse Event|1
1236501|NCT00681629|4055115|P2|Overall Study|Study termination|2
1236502|NCT00681629|4055116|P1|Overall Study|Study termination|4
1236503|NCT00681590|4055162|P2|Overall Study|Withdrawal by Subject|12
1236504|NCT00681590|4055163|P1|Overall Study|Withdrawal by Subject|2
1236505|NCT00681564|4055173|P2|Overall Study|Death|1
1236506|NCT00681564|4055174|P1|Overall Study|Death|0
1236507|NCT00681564|4055173|P2|Overall Study|Withdrawal by Subject|1
1236508|NCT00681564|4055174|P1|Overall Study|Withdrawal by Subject|0
1236509|NCT00681564|4055173|P2|Overall Study|Lost to Follow-up|6
1236510|NCT00681564|4055174|P1|Overall Study|Lost to Follow-up|6
1236511|NCT00681187|4055266|P2|Overall Study|Adverse Event|1
1236512|NCT00681187|4055267|P1|Overall Study|Adverse Event|0
1236513|NCT00681187|4055266|P2|Overall Study|Death|1
1236514|NCT00681187|4055267|P1|Overall Study|Death|0
1236515|NCT00681187|4055266|P2|Overall Study|Withdrawal by Subject|0
1236516|NCT00681187|4055267|P1|Overall Study|Withdrawal by Subject|1
1236517|NCT00681109|4055302|P3|Overall Study|Lost to Follow-up|0
1236518|NCT00681109|4055303|P2|Overall Study|Lost to Follow-up|6
1236519|NCT00681109|4055304|P1|Overall Study|Lost to Follow-up|2
1236520|NCT00680992|4055336|P3|Overall Study|Ineligibility Determined|0
1236521|NCT00680992|4055337|P2|Overall Study|Ineligibility Determined|1
1236522|NCT00680992|4055338|P1|Overall Study|Ineligibility Determined|0
1236523|NCT00680992|4055336|P3|Overall Study|Death|0
1236524|NCT00680992|4055337|P2|Overall Study|Death|1
1236525|NCT00680992|4055338|P1|Overall Study|Death|5
1236526|NCT00680992|4055336|P3|Overall Study|Pregnancy|1
1236527|NCT00680992|4055337|P2|Overall Study|Pregnancy|0
1236528|NCT00680992|4055338|P1|Overall Study|Pregnancy|5
1236529|NCT00680992|4055336|P3|Overall Study|Requirement for Alternative Therapy|0
1236530|NCT00680992|4055337|P2|Overall Study|Requirement for Alternative Therapy|2
1236531|NCT00680992|4055338|P1|Overall Study|Requirement for Alternative Therapy|8
1236532|NCT00680992|4055336|P3|Overall Study|Noncompliance|0
1236533|NCT00680992|4055337|P2|Overall Study|Noncompliance|6
1236534|NCT00680992|4055338|P1|Overall Study|Noncompliance|4
1236535|NCT00680992|4055336|P3|Overall Study|Lost to Follow-up|0
1236536|NCT00680992|4055337|P2|Overall Study|Lost to Follow-up|14
1236537|NCT00680992|4055338|P1|Overall Study|Lost to Follow-up|12
1236538|NCT00680992|4055336|P3|Overall Study|Disease Progression|0
1236539|NCT00680992|4055337|P2|Overall Study|Disease Progression|9
1236540|NCT00680992|4055338|P1|Overall Study|Disease Progression|21
1236541|NCT00680992|4055336|P3|Overall Study|Other|1
1236542|NCT00680992|4055337|P2|Overall Study|Other|14
1236543|NCT00680992|4055338|P1|Overall Study|Other|19
1236544|NCT00680992|4055336|P3|Overall Study|Adverse Event|1
1236545|NCT00680992|4055337|P2|Overall Study|Adverse Event|19
1236546|NCT00680992|4055338|P1|Overall Study|Adverse Event|21
1236547|NCT00680992|4055336|P3|Overall Study|Withdrawal by Subject|1
1236548|NCT00680992|4055337|P2|Overall Study|Withdrawal by Subject|11
1236549|NCT00680992|4055338|P1|Overall Study|Withdrawal by Subject|33
1236550|NCT00680992|4055336|P3|Overall Study|End of Trial|3
1236551|NCT00680992|4055337|P2|Overall Study|End of Trial|12
1236552|NCT00680992|4055338|P1|Overall Study|End of Trial|32
1236553|NCT00680992|4055336|P3|Overall Study|Administrative Decision|5
1236554|NCT00680992|4055337|P2|Overall Study|Administrative Decision|42
1236555|NCT00680992|4055338|P1|Overall Study|Administrative Decision|83
1236556|NCT00680992|4055336|P3|Overall Study|Complete Resection (as per protocol)|0
1236557|NCT00680992|4055337|P2|Overall Study|Complete Resection (as per protocol)|121
1236558|NCT00680992|4055338|P1|Overall Study|Complete Resection (as per protocol)|25
1236559|NCT00680914|4055372|P2|Overall Study|serious adverse event (SAE)|1
1236560|NCT00680914|4055373|P1|Overall Study|serious adverse event (SAE)|0
1236561|NCT00680914|4055372|P2|Overall Study|Lost to Follow-up|0
1236562|NCT00680914|4055373|P1|Overall Study|Lost to Follow-up|4
1236563|NCT00680914|4055372|P2|Overall Study|Consent withdrawal|3
1236564|NCT00680914|4055373|P1|Overall Study|Consent withdrawal|6
1236565|NCT00680901|4055407|P2|Overall Study|Ongoing: In Follow Up|41
1236566|NCT00680901|4055408|P1|Overall Study|Ongoing: In Follow Up|45
1236567|NCT00680901|4055407|P2|Overall Study|Ongoing: On Study Treatment|13
1236568|NCT00680901|4055408|P1|Overall Study|Ongoing: On Study Treatment|16
1236569|NCT00680901|4055407|P2|Overall Study|Physician Decision|1
1236570|NCT00680901|4055408|P1|Overall Study|Physician Decision|0
1236571|NCT00680901|4055407|P2|Overall Study|Withdrawal by Subject|13
1236572|NCT00680901|4055408|P1|Overall Study|Withdrawal by Subject|4
1236573|NCT00680901|4055407|P2|Overall Study|Lost to Follow-up|8
1236574|NCT00680901|4055408|P1|Overall Study|Lost to Follow-up|8
1236575|NCT00680836|4055446|P2|Overall Study|Physician Decision|1
1236576|NCT00680836|4055447|P1|Overall Study|Physician Decision|2
1236577|NCT00680836|4055446|P2|Overall Study|Lost to Follow-up|1
1236578|NCT00680836|4055447|P1|Overall Study|Lost to Follow-up|3
1236579|NCT00680836|4055446|P2|Overall Study|Withdrawal by Subject|0
1236580|NCT00680836|4055447|P1|Overall Study|Withdrawal by Subject|3
1236581|NCT00680771|4055501|P2|Overall Study|Prior Exposure to Hepatitus B Vaccine|2
1236582|NCT00680771|4055502|P1|Overall Study|Prior Exposure to Hepatitus B Vaccine|4
1236583|NCT00680771|4055501|P2|Overall Study|Sleep Apnea suspected after PSG|0
1236584|NCT00680771|4055502|P1|Overall Study|Sleep Apnea suspected after PSG|1
1236585|NCT00680771|4055501|P2|Overall Study|Withdrawal by Subject|0
1236586|NCT00680771|4055502|P1|Overall Study|Withdrawal by Subject|1
1236587|NCT00680745|4055512|P4|Overall Study|False Treatment|0
1236588|NCT00680745|4055513|P3|Overall Study|False Treatment|3
1236589|NCT00680745|4055514|P2|Overall Study|False Treatment|1
1236590|NCT00680745|4055515|P1|Overall Study|False Treatment|0
1236591|NCT00680745|4055512|P4|Overall Study|Subject No Longer Meets Study Criteria|2
1236592|NCT00680745|4055513|P3|Overall Study|Subject No Longer Meets Study Criteria|0
1236593|NCT00680745|4055514|P2|Overall Study|Subject No Longer Meets Study Criteria|2
1236594|NCT00680745|4055515|P1|Overall Study|Subject No Longer Meets Study Criteria|0
1236595|NCT00680745|4055512|P4|Overall Study|Poor/Non-compliance|0
1236596|NCT00680745|4055513|P3|Overall Study|Poor/Non-compliance|0
1236597|NCT00680745|4055514|P2|Overall Study|Poor/Non-compliance|3
1236598|NCT00680745|4055515|P1|Overall Study|Poor/Non-compliance|0
1236599|NCT00680745|4055512|P4|Overall Study|Adverse Event|3
1236600|NCT00680745|4055513|P3|Overall Study|Adverse Event|3
1236601|NCT00680745|4055514|P2|Overall Study|Adverse Event|3
1236602|NCT00680745|4055515|P1|Overall Study|Adverse Event|5
1236603|NCT00680745|4055512|P4|Overall Study|Death|0
1236604|NCT00680745|4055513|P3|Overall Study|Death|1
1236605|NCT00680745|4055514|P2|Overall Study|Death|0
1236606|NCT00680745|4055515|P1|Overall Study|Death|1
1236607|NCT00680745|4055512|P4|Overall Study|Lost to Follow-up|0
1236608|NCT00680745|4055513|P3|Overall Study|Lost to Follow-up|1
1236609|NCT00680745|4055514|P2|Overall Study|Lost to Follow-up|1
1236610|NCT00680745|4055515|P1|Overall Study|Lost to Follow-up|0
1236611|NCT00680745|4055512|P4|Overall Study|Withdrawal by Subject|8
1236612|NCT00680745|4055513|P3|Overall Study|Withdrawal by Subject|2
1236613|NCT00680745|4055514|P2|Overall Study|Withdrawal by Subject|3
1236614|NCT00680745|4055515|P1|Overall Study|Withdrawal by Subject|8
1236615|NCT00680407|4055589|P3|Overall Study|Withdrawal by Subject|2
1236616|NCT00680407|4055590|P2|Overall Study|Withdrawal by Subject|2
1236617|NCT00680407|4055591|P1|Overall Study|Withdrawal by Subject|5
1236618|NCT00680407|4055589|P3|Overall Study|Lost to Follow-up|1
1236619|NCT00680407|4055590|P2|Overall Study|Lost to Follow-up|3
1236620|NCT00680407|4055591|P1|Overall Study|Lost to Follow-up|3
1236621|NCT00680368|4055605|P1|Overall Study|not supervised, not eligible|15
1236622|NCT00680186|4055633|P2|Overall Study|Other|1
1236623|NCT00680186|4055634|P1|Overall Study|Other|4
1236624|NCT00680186|4055633|P2|Overall Study|Withdrawal by Subject|39
1236625|NCT00680186|4055634|P1|Overall Study|Withdrawal by Subject|32
1236626|NCT00680186|4055633|P2|Overall Study|Lost to Follow-up|6
1236627|NCT00680186|4055634|P1|Overall Study|Lost to Follow-up|11
1236628|NCT00680186|4055633|P2|Overall Study|Protocol Violation|26
1236629|NCT00680186|4055634|P1|Overall Study|Protocol Violation|31
1236630|NCT00680186|4055633|P2|Overall Study|Adverse Event|44
1236631|NCT00680186|4055634|P1|Overall Study|Adverse Event|47
1236632|NCT00680121|4055660|P2|Overall Study|Lost to Follow-up|23
1236633|NCT00680121|4055661|P1|Overall Study|Lost to Follow-up|27
1236634|NCT00680056|4055675|P2|Second Intervention|Protocol Violation|1
1236635|NCT00680056|4055676|P1|Second Intervention|Protocol Violation|3
1236636|NCT00680056|4055675|P2|First Intervention|Mainly Exacerbation of COPD|2
1236637|NCT00680056|4055676|P1|First Intervention|Mainly Exacerbation of COPD|1
1236638|NCT00680043|4055687|P3|Overall Study|Renal Transplant|4
1236639|NCT00680043|4055688|P2|Overall Study|Renal Transplant|0
1236640|NCT00680043|4055689|P1|Overall Study|Renal Transplant|1
1236641|NCT00680043|4055687|P3|Overall Study|Patient Not Compliant With Study Reqs.|0
1236642|NCT00680043|4055688|P2|Overall Study|Patient Not Compliant With Study Reqs.|1
1236643|NCT00680043|4055689|P1|Overall Study|Patient Not Compliant With Study Reqs.|0
1236644|NCT00680043|4055687|P3|Overall Study|Withdrawal by Subject|0
1236645|NCT00680043|4055688|P2|Overall Study|Withdrawal by Subject|0
1236646|NCT00680043|4055689|P1|Overall Study|Withdrawal by Subject|1
1236647|NCT00680017|4055705|P2|Overall Study|Lost to Follow-up|0
1236648|NCT00680017|4055706|P1|Overall Study|Lost to Follow-up|2
1236649|NCT00680017|4055705|P2|Overall Study|Withdrawal by Subject|5
1236650|NCT00680017|4055706|P1|Overall Study|Withdrawal by Subject|2
1236651|NCT00680017|4055705|P2|Overall Study|Adverse Event|7
1236652|NCT00680017|4055706|P1|Overall Study|Adverse Event|13
1236653|NCT00679939|4055725|P2|24-Week Open-Label (OL) Period|Withdrawal by Subject|1
1236654|NCT00679939|4055726|P1|24-Week Open-Label (OL) Period|Withdrawal by Subject|2
1236655|NCT00679939|4055725|P2|24-Week Open-Label (OL) Period|Physician Decision|0
1236656|NCT00679939|4055726|P1|24-Week Open-Label (OL) Period|Physician Decision|1
1236657|NCT00679939|4055725|P2|24-Week Open-Label (OL) Period|Met Stopping Criteria|1
1236658|NCT00679939|4055726|P1|24-Week Open-Label (OL) Period|Met Stopping Criteria|3
1236659|NCT00679939|4055725|P2|24-Week Open-Label (OL) Period|Protocol Violation|1
1236660|NCT00679939|4055726|P1|24-Week Open-Label (OL) Period|Protocol Violation|1
1236661|NCT00679939|4055725|P2|24-Week Open-Label (OL) Period|Adverse Event|1
1236662|NCT00679939|4055726|P1|24-Week Open-Label (OL) Period|Adverse Event|0
1236663|NCT00679939|4055725|P2|52-Week Double-Blind (DB) Period|Lost to Follow-up|2
1236664|NCT00679939|4055726|P1|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
1236665|NCT00679939|4055725|P2|52-Week Double-Blind (DB) Period|Protocol Violation|0
1236666|NCT00679939|4055726|P1|52-Week Double-Blind (DB) Period|Protocol Violation|1
1236667|NCT00679939|4055725|P2|52-Week Double-Blind (DB) Period|Investigator Discretion|0
1236668|NCT00679939|4055726|P1|52-Week Double-Blind (DB) Period|Investigator Discretion|5
1236669|NCT00679939|4055725|P2|52-Week Double-Blind (DB) Period|Adverse Event|12
1236670|NCT00679939|4055726|P1|52-Week Double-Blind (DB) Period|Adverse Event|14
1236671|NCT00679939|4055725|P2|52-Week Double-Blind (DB) Period|Withdrew Consent|13
1236672|NCT00679939|4055726|P1|52-Week Double-Blind (DB) Period|Withdrew Consent|17
1236673|NCT00679913|4055877|P2|Overall Study|Protocol Violation|13
1236674|NCT00679913|4055878|P1|Overall Study|Protocol Violation|18
1236675|NCT00679783|4055893|P7|Overall Study|Ongoing at data cut-off|0
1236676|NCT00679783|4055894|P6|Overall Study|Ongoing at data cut-off|0
1236677|NCT00679783|4055895|P5|Overall Study|Ongoing at data cut-off|1
1236678|NCT00679783|4055896|P4|Overall Study|Ongoing at data cut-off|9
1236679|NCT00679783|4055897|P3|Overall Study|Ongoing at data cut-off|0
1236680|NCT00679783|4055898|P2|Overall Study|Ongoing at data cut-off|2
1236681|NCT00679783|4055899|P1|Overall Study|Ongoing at data cut-off|2
1236682|NCT00679783|4055893|P7|Overall Study|Not Captured|0
1236683|NCT00679783|4055894|P6|Overall Study|Not Captured|0
1236684|NCT00679783|4055895|P5|Overall Study|Not Captured|0
1236685|NCT00679783|4055896|P4|Overall Study|Not Captured|5
1236686|NCT00679783|4055897|P3|Overall Study|Not Captured|0
1236687|NCT00679783|4055898|P2|Overall Study|Not Captured|0
1236688|NCT00679783|4055899|P1|Overall Study|Not Captured|0
1236689|NCT00679783|4055893|P7|Overall Study|Withdrawal by Subject|0
1236690|NCT00679783|4055894|P6|Overall Study|Withdrawal by Subject|0
1236691|NCT00679783|4055895|P5|Overall Study|Withdrawal by Subject|0
1236692|NCT00679783|4055896|P4|Overall Study|Withdrawal by Subject|1
1236693|NCT00679783|4055897|P3|Overall Study|Withdrawal by Subject|1
1236694|NCT00679783|4055898|P2|Overall Study|Withdrawal by Subject|0
1236695|NCT00679783|4055899|P1|Overall Study|Withdrawal by Subject|0
1236696|NCT00679783|4055893|P7|Overall Study|Lack of Efficacy|0
1236697|NCT00679783|4055894|P6|Overall Study|Lack of Efficacy|0
1236698|NCT00679783|4055895|P5|Overall Study|Lack of Efficacy|0
1236699|NCT00679783|4055896|P4|Overall Study|Lack of Efficacy|2
1236700|NCT00679783|4055897|P3|Overall Study|Lack of Efficacy|0
1236701|NCT00679783|4055898|P2|Overall Study|Lack of Efficacy|1
1236702|NCT00679783|4055899|P1|Overall Study|Lack of Efficacy|0
1236703|NCT00679783|4055893|P7|Overall Study|Adverse Event|1
1236704|NCT00679783|4055894|P6|Overall Study|Adverse Event|0
1236705|NCT00679783|4055895|P5|Overall Study|Adverse Event|0
1236706|NCT00679783|4055896|P4|Overall Study|Adverse Event|3
1236707|NCT00679783|4055897|P3|Overall Study|Adverse Event|0
1236708|NCT00679783|4055898|P2|Overall Study|Adverse Event|0
1236709|NCT00679783|4055899|P1|Overall Study|Adverse Event|0
1236710|NCT00679627|4055952|P2|Overall Study|Early Study Closure|405
1236711|NCT00679627|4055953|P1|Overall Study|Early Study Closure|425
1236712|NCT00679627|4055952|P2|Overall Study|Lost to Follow-up|26
1236713|NCT00679627|4055953|P1|Overall Study|Lost to Follow-up|22
1236714|NCT00679627|4055952|P2|Overall Study|Withdrawal by Subject|172
1236715|NCT00679627|4055953|P1|Overall Study|Withdrawal by Subject|168
1236716|NCT00679627|4055952|P2|Overall Study|Adverse Event|53
1236717|NCT00679627|4055953|P1|Overall Study|Adverse Event|43
1236718|NCT00679627|4055952|P2|Overall Study|Death|29
1236719|NCT00679627|4055953|P1|Overall Study|Death|41
1236720|NCT00679432|4055979|P4|Overall Study|Randomization error, return to prior Rx|0
1236721|NCT00679432|4055980|P3|Overall Study|Randomization error, return to prior Rx|3
1236722|NCT00679432|4055981|P2|Overall Study|Randomization error, return to prior Rx|0
1236723|NCT00679432|4055982|P1|Overall Study|Randomization error, return to prior Rx|0
1236724|NCT00679432|4055979|P4|Overall Study|Infectious colitis, normal histology|3
1236725|NCT00679432|4055980|P3|Overall Study|Infectious colitis, normal histology|8
1236726|NCT00679432|4055981|P2|Overall Study|Infectious colitis, normal histology|4
1236727|NCT00679432|4055982|P1|Overall Study|Infectious colitis, normal histology|5
1236728|NCT00679432|4055979|P4|Overall Study|Lack of Efficacy|8
1236729|NCT00679432|4055980|P3|Overall Study|Lack of Efficacy|14
1236730|NCT00679432|4055981|P2|Overall Study|Lack of Efficacy|9
1236731|NCT00679432|4055982|P1|Overall Study|Lack of Efficacy|13
1236732|NCT00679432|4055979|P4|Overall Study|Sponsor decision|0
1236733|NCT00679432|4055980|P3|Overall Study|Sponsor decision|0
1236734|NCT00679432|4055981|P2|Overall Study|Sponsor decision|0
1236735|NCT00679432|4055982|P1|Overall Study|Sponsor decision|1
1236736|NCT00679432|4055979|P4|Overall Study|Physician Decision|2
1236737|NCT00679432|4055980|P3|Overall Study|Physician Decision|2
1236738|NCT00679432|4055981|P2|Overall Study|Physician Decision|2
1236739|NCT00679432|4055982|P1|Overall Study|Physician Decision|3
1236740|NCT00679432|4055979|P4|Overall Study|Lost to Follow-up|2
1236741|NCT00679432|4055980|P3|Overall Study|Lost to Follow-up|4
1236742|NCT00679432|4055981|P2|Overall Study|Lost to Follow-up|5
1236743|NCT00679432|4055982|P1|Overall Study|Lost to Follow-up|1
1236744|NCT00679432|4055979|P4|Overall Study|Withdrawal by Subject|9
1236745|NCT00679432|4055980|P3|Overall Study|Withdrawal by Subject|10
1236746|NCT00679432|4055981|P2|Overall Study|Withdrawal by Subject|11
1236747|NCT00679432|4055982|P1|Overall Study|Withdrawal by Subject|8
1236748|NCT00679432|4055979|P4|Overall Study|Protocol Violation|1
1236749|NCT00679432|4055980|P3|Overall Study|Protocol Violation|2
1236750|NCT00679432|4055981|P2|Overall Study|Protocol Violation|1
1236751|NCT00679432|4055982|P1|Overall Study|Protocol Violation|1
1236752|NCT00679432|4055979|P4|Overall Study|Adverse Event|7
1236753|NCT00679432|4055980|P3|Overall Study|Adverse Event|10
1236754|NCT00679432|4055981|P2|Overall Study|Adverse Event|6
1236755|NCT00679432|4055982|P1|Overall Study|Adverse Event|5
1236756|NCT00679367|4056025|P1|Overall Study|Withdrawal by Subject|1
1236757|NCT00679367|4056025|P1|Overall Study|Lack of Efficacy|3
1236758|NCT00679367|4056025|P1|Overall Study|inability to swallow oral drugs|1
1236759|NCT00679367|4056025|P1|Overall Study|Adverse Event|7
1236760|NCT00679354|4056031|P1|Overall Study|Ineligible|1
1236761|NCT00679354|4056031|P1|Overall Study|Physician Decision|4
1236762|NCT00679354|4056031|P1|Overall Study|Lack of Efficacy|22
1236763|NCT00679354|4056031|P1|Overall Study|Death|3
1236764|NCT00679341|4056049|P2|Overall Study|Physician/patient decision to withdraw|6
1236765|NCT00679341|4056050|P1|Overall Study|Physician/patient decision to withdraw|0
1236766|NCT00679341|4056049|P2|Overall Study|Not treated|2
1236767|NCT00679341|4056050|P1|Overall Study|Not treated|0
1236768|NCT00679341|4056049|P2|Overall Study|Physician Decision|0
1236769|NCT00679341|4056050|P1|Overall Study|Physician Decision|1
1236770|NCT00679341|4056049|P2|Overall Study|Not specified|0
1236771|NCT00679341|4056050|P1|Overall Study|Not specified|1
1236772|NCT00679341|4056049|P2|Overall Study|Death|1
1236773|NCT00679341|4056050|P1|Overall Study|Death|1
1236774|NCT00679341|4056049|P2|Overall Study|Subject/guardian decision to discontinue|0
1236775|NCT00679341|4056050|P1|Overall Study|Subject/guardian decision to discontinue|3
1236776|NCT00679341|4056049|P2|Overall Study|Adverse Event|6
1236777|NCT00679341|4056050|P1|Overall Study|Adverse Event|5
1236778|NCT00679341|4056049|P2|Overall Study|Disease progression|36
1236779|NCT00679341|4056050|P1|Overall Study|Disease progression|42
1236780|NCT00679302|4056070|P2|Overall Study|Lost to Follow-up|4
1236781|NCT00679302|4056071|P1|Overall Study|Lost to Follow-up|8
1236782|NCT00679289|4056082|P3|Overall Study|Physician Decision|1
1236783|NCT00679289|4056083|P2|Overall Study|Physician Decision|0
1236784|NCT00679289|4056084|P1|Overall Study|Physician Decision|1
1236785|NCT00679289|4056082|P3|Overall Study|Adverse Event|3
1236786|NCT00679289|4056083|P2|Overall Study|Adverse Event|0
1236787|NCT00679289|4056084|P1|Overall Study|Adverse Event|0
1236788|NCT00679289|4056082|P3|Overall Study|Withdrawal by Subject|1
1236789|NCT00679289|4056083|P2|Overall Study|Withdrawal by Subject|1
1236790|NCT00679289|4056084|P1|Overall Study|Withdrawal by Subject|0
1236791|NCT00679289|4056082|P3|Overall Study|Progressive disease|18
1236792|NCT00679289|4056083|P2|Overall Study|Progressive disease|5
1236793|NCT00679289|4056084|P1|Overall Study|Progressive disease|4
1236794|NCT00679263|4056106|P3|Visit 2/Dose 1|subject not compliance|0
1236795|NCT00679263|4056107|P2|Visit 2/Dose 1|subject not compliance|1
1236796|NCT00679263|4056108|P1|Visit 2/Dose 1|subject not compliance|1
1236797|NCT00679263|4056106|P3|Visit 2/Dose 1|Adverse Event|0
1236798|NCT00679263|4056107|P2|Visit 2/Dose 1|Adverse Event|0
1236799|NCT00679263|4056108|P1|Visit 2/Dose 1|Adverse Event|1
1236800|NCT00679211|4056119|P1|Overall Study|Other|1
1236801|NCT00679211|4056119|P1|Overall Study|Transferred to extension study TDM4529g|12
1236802|NCT00679211|4056119|P1|Overall Study|Refused to undergo protocol procedures|1
1236803|NCT00679211|4056119|P1|Overall Study|Physician Decision|5
1236804|NCT00679211|4056119|P1|Overall Study|Withdrawal by Subject|2
1236805|NCT00679211|4056119|P1|Overall Study|Adverse Event|7
1236806|NCT00679211|4056119|P1|Overall Study|Progressive disease|82
1236807|NCT00679172|4056136|P5|Overall Study|Other not specified|0
1236808|NCT00679172|4056137|P4|Overall Study|Other not specified|0
1236809|NCT00679172|4056138|P3|Overall Study|Other not specified|1
1236810|NCT00679172|4056139|P2|Overall Study|Other not specified|0
1236811|NCT00679172|4056140|P1|Overall Study|Other not specified|0
1236812|NCT00679172|4056136|P5|Overall Study|Non-compliance|0
1236813|NCT00679172|4056137|P4|Overall Study|Non-compliance|1
1236814|NCT00679172|4056138|P3|Overall Study|Non-compliance|0
1236815|NCT00679172|4056139|P2|Overall Study|Non-compliance|1
1236816|NCT00679172|4056140|P1|Overall Study|Non-compliance|1
1236817|NCT00679081|4056203|P1|Overall Study|Lost to Follow-up|1
1236818|NCT00679055|4056213|P2|Overall Study|Study Terminated|1
1236819|NCT00679055|4056214|P1|Overall Study|Study Terminated|2
1236820|NCT00679055|4056213|P2|Overall Study|Other|3
1236821|NCT00679055|4056214|P1|Overall Study|Other|0
1236822|NCT00679055|4056213|P2|Overall Study|Adverse Event|1
1236823|NCT00679055|4056214|P1|Overall Study|Adverse Event|0
1236824|NCT00679029|4056224|P1|Overall Study|Lost to Follow-up|1
1236825|NCT00679029|4056224|P1|Overall Study|Withdrawal by Subject|1
1236826|NCT00679029|4056224|P1|Overall Study|Adverse Event|3
1236827|NCT00678899|4056231|P1|Overall Study|Adverse Event|1
1236828|NCT00678886|4056240|P4|Overall Study|Other|0
1236829|NCT00678886|4056241|P3|Overall Study|Other|1
1236830|NCT00678886|4056242|P2|Overall Study|Other|0
1236831|NCT00678886|4056243|P1|Overall Study|Other|0
1236832|NCT00678886|4056240|P4|Overall Study|Lost to Follow-up|2
1236833|NCT00678886|4056241|P3|Overall Study|Lost to Follow-up|3
1236834|NCT00678886|4056242|P2|Overall Study|Lost to Follow-up|0
1236835|NCT00678886|4056243|P1|Overall Study|Lost to Follow-up|0
1236836|NCT00678886|4056240|P4|Overall Study|Physician Decision|1
1236837|NCT00678886|4056241|P3|Overall Study|Physician Decision|1
1236838|NCT00678886|4056242|P2|Overall Study|Physician Decision|0
1236839|NCT00678886|4056243|P1|Overall Study|Physician Decision|0
1236840|NCT00678886|4056240|P4|Overall Study|Withdrawal by Subject|6
1236841|NCT00678886|4056241|P3|Overall Study|Withdrawal by Subject|4
1236842|NCT00678886|4056242|P2|Overall Study|Withdrawal by Subject|0
1236843|NCT00678886|4056243|P1|Overall Study|Withdrawal by Subject|0
1236844|NCT00678795|4056312|P2|Overall Study|Lack of Efficacy|1
1236845|NCT00678795|4056313|P1|Overall Study|Lack of Efficacy|1
1236846|NCT00678795|4056312|P2|Overall Study|Lost to Follow-up|1
1236847|NCT00678795|4056313|P1|Overall Study|Lost to Follow-up|0
1236848|NCT00678795|4056312|P2|Overall Study|Protocol Violation|1
1236849|NCT00678795|4056313|P1|Overall Study|Protocol Violation|0
1236850|NCT00678795|4056312|P2|Overall Study|Withdrawal by Subject|0
1236851|NCT00678795|4056313|P1|Overall Study|Withdrawal by Subject|3
1236852|NCT00678795|4056312|P2|Overall Study|Adverse Event|3
1236853|NCT00678795|4056313|P1|Overall Study|Adverse Event|7
1236854|NCT00678691|4056335|P2|Overall Study|Adverse Event|4
1236855|NCT00678691|4056336|P1|Overall Study|Adverse Event|6
1236856|NCT00678652|4056346|P4|Overall Study|Relocation|0
1236857|NCT00678652|4056347|P3|Overall Study|Relocation|0
1236858|NCT00678652|4056348|P2|Overall Study|Relocation|0
1236859|NCT00678652|4056349|P1|Overall Study|Relocation|1
1236860|NCT00678652|4056346|P4|Overall Study|Pregnancy|0
1236861|NCT00678652|4056347|P3|Overall Study|Pregnancy|1
1236862|NCT00678652|4056348|P2|Overall Study|Pregnancy|0
1236863|NCT00678652|4056349|P1|Overall Study|Pregnancy|0
1236864|NCT00678652|4056346|P4|Overall Study|Protocol Violation|0
1236865|NCT00678652|4056347|P3|Overall Study|Protocol Violation|0
1236866|NCT00678652|4056348|P2|Overall Study|Protocol Violation|0
1236867|NCT00678652|4056349|P1|Overall Study|Protocol Violation|2
1236868|NCT00678639|4056373|P2|Overall Study|Lost to Follow-up at 30 days|0
1236869|NCT00678639|4056374|P1|Overall Study|Lost to Follow-up at 30 days|2
1236870|NCT00678587|4056389|P2|Overall Study|Withdrew Consent|3
1236871|NCT00678587|4056390|P1|Overall Study|Withdrew Consent|8
1236872|NCT00678587|4056389|P2|Overall Study|Investigator Discretion|6
1236873|NCT00678587|4056390|P1|Overall Study|Investigator Discretion|2
1236874|NCT00678587|4056389|P2|Overall Study|Lost to Follow-up|5
1236875|NCT00678587|4056390|P1|Overall Study|Lost to Follow-up|3
1236876|NCT00678587|4056389|P2|Overall Study|Study Closed/Terminated|0
1236877|NCT00678587|4056390|P1|Overall Study|Study Closed/Terminated|1
1236878|NCT00678587|4056389|P2|Overall Study|Protocol Violation|1
1236879|NCT00678587|4056390|P1|Overall Study|Protocol Violation|2
1236880|NCT00678587|4056389|P2|Overall Study|Lack of Efficacy|0
1236881|NCT00678587|4056390|P1|Overall Study|Lack of Efficacy|1
1236882|NCT00678587|4056389|P2|Overall Study|Adverse Event|3
1236883|NCT00678587|4056390|P1|Overall Study|Adverse Event|3
1236884|NCT00678392|4056484|P2|Overall Study|Other|53
1236885|NCT00678392|4056485|P1|Overall Study|Other|56
1236886|NCT00678392|4056484|P2|Overall Study|Randomized But Not Treated|7
1236887|NCT00678392|4056485|P1|Overall Study|Randomized But Not Treated|2
1236888|NCT00678392|4056484|P2|Overall Study|Withdrawal by Subject|4
1236889|NCT00678392|4056485|P1|Overall Study|Withdrawal by Subject|4
1236890|NCT00678392|4056484|P2|Overall Study|Sponsor's Decision|2
1236891|NCT00678392|4056485|P1|Overall Study|Sponsor's Decision|1
1236892|NCT00678392|4056484|P2|Overall Study|Objective Progression or Relapse|8
1236893|NCT00678392|4056485|P1|Overall Study|Objective Progression or Relapse|3
1236894|NCT00678392|4056484|P2|Overall Study|Lost to Follow-up|13
1236895|NCT00678392|4056485|P1|Overall Study|Lost to Follow-up|15
1236896|NCT00678392|4056484|P2|Overall Study|Death|269
1236897|NCT00678392|4056485|P1|Overall Study|Death|280
1236898|NCT00678392|4056484|P2|Overall Study|Adverse Event|6
1236899|NCT00678392|4056485|P1|Overall Study|Adverse Event|0
1236900|NCT00678379|4056520|P3|Overall Study|Incomplete Data|3
1236901|NCT00678379|4056521|P2|Overall Study|Incomplete Data|3
1236902|NCT00678379|4056522|P1|Overall Study|Incomplete Data|4
1236903|NCT00678379|4056520|P3|Overall Study|Injection performed after tonsillectomy|1
1236904|NCT00678379|4056521|P2|Overall Study|Injection performed after tonsillectomy|0
1236905|NCT00678379|4056522|P1|Overall Study|Injection performed after tonsillectomy|2
1236906|NCT00678301|4056550|P2|Overall Study|Lost to Follow-up|1
1236907|NCT00678301|4056551|P1|Overall Study|Lost to Follow-up|3
1236908|NCT00678301|4056550|P2|Overall Study|Withdrawal by Subject|0
1236909|NCT00678301|4056551|P1|Overall Study|Withdrawal by Subject|4
1236910|NCT00678301|4056550|P2|Overall Study|Adverse Event|0
1236911|NCT00678301|4056551|P1|Overall Study|Adverse Event|1
1236912|NCT00678301|4056550|P2|Overall Study|Non-compliance with study procedures|1
1236913|NCT00678301|4056551|P1|Overall Study|Non-compliance with study procedures|0
1236914|NCT00678288|4056609|P2|Overall Study|Disease progression/recurrence/relapse|1
1236915|NCT00678288|4056610|P1|Overall Study|Disease progression/recurrence/relapse|6
1236916|NCT00678288|4056609|P2|Overall Study|Reason not reported|0
1236917|NCT00678288|4056610|P1|Overall Study|Reason not reported|1
1236918|NCT00678288|4056609|P2|Overall Study|Switch to commercial drug|1
1236919|NCT00678288|4056610|P1|Overall Study|Switch to commercial drug|0
1236920|NCT00678288|4056609|P2|Overall Study|Not compliant with study medication|1
1236921|NCT00678288|4056610|P1|Overall Study|Not compliant with study medication|0
1236922|NCT00678288|4056609|P2|Overall Study|Study terminated by the sponsor|0
1236923|NCT00678288|4056610|P1|Overall Study|Study terminated by the sponsor|2
1236924|NCT00678288|4056609|P2|Overall Study|Withdrawal by Subject|1
1236925|NCT00678288|4056610|P1|Overall Study|Withdrawal by Subject|1
1236926|NCT00678288|4056609|P2|Overall Study|Adverse Event|2
1236927|NCT00678288|4056610|P1|Overall Study|Adverse Event|0
1236928|NCT00678210|4056665|P4|Overall Study|Other|0
1236929|NCT00678210|4056666|P3|Overall Study|Other|1
1236930|NCT00678210|4056667|P2|Overall Study|Other|0
1236931|NCT00678210|4056668|P1|Overall Study|Other|1
1236932|NCT00678210|4056665|P4|Overall Study|Withdrawal by Subject|7
1236933|NCT00678210|4056666|P3|Overall Study|Withdrawal by Subject|1
1236934|NCT00678210|4056667|P2|Overall Study|Withdrawal by Subject|4
1236935|NCT00678210|4056668|P1|Overall Study|Withdrawal by Subject|3
1236936|NCT00678210|4056665|P4|Overall Study|Lost to Follow-up|1
1236937|NCT00678210|4056666|P3|Overall Study|Lost to Follow-up|0
1236938|NCT00678210|4056667|P2|Overall Study|Lost to Follow-up|2
1236939|NCT00678210|4056668|P1|Overall Study|Lost to Follow-up|4
1236940|NCT00678210|4056665|P4|Overall Study|Lack of Efficacy|9
1236941|NCT00678210|4056666|P3|Overall Study|Lack of Efficacy|1
1236942|NCT00678210|4056667|P2|Overall Study|Lack of Efficacy|3
1236943|NCT00678210|4056668|P1|Overall Study|Lack of Efficacy|2
1236944|NCT00678210|4056665|P4|Overall Study|Adverse Event|3
1236945|NCT00678210|4056666|P3|Overall Study|Adverse Event|3
1236946|NCT00678210|4056667|P2|Overall Study|Adverse Event|2
1236947|NCT00678210|4056668|P1|Overall Study|Adverse Event|1
1236948|NCT00678080|4056704|P2|Overall Study|Withdrawal by Subject|1
1236949|NCT00678080|4056705|P1|Overall Study|Withdrawal by Subject|0
1236950|NCT00678080|4056704|P2|Overall Study|Lost to Follow-up|0
1236951|NCT00678080|4056705|P1|Overall Study|Lost to Follow-up|1
1236952|NCT00678080|4056704|P2|Overall Study|Physician Decision|0
1236953|NCT00678080|4056705|P1|Overall Study|Physician Decision|2
1236954|NCT00678041|4056731|P2|Overall Study|Physician Decision|5
1236955|NCT00678041|4056732|P1|Overall Study|Physician Decision|5
1236956|NCT00677833|4056785|P4|Overall Study|Lost to Follow-up|0
1236957|NCT00677833|4056786|P3|Overall Study|Lost to Follow-up|1
1236958|NCT00677833|4056787|P2|Overall Study|Lost to Follow-up|0
1236959|NCT00677833|4056788|P1|Overall Study|Lost to Follow-up|0
1236960|NCT00677833|4056785|P4|Overall Study|Withdrawal by Subject|3
1236961|NCT00677833|4056786|P3|Overall Study|Withdrawal by Subject|1
1236962|NCT00677833|4056787|P2|Overall Study|Withdrawal by Subject|0
1236963|NCT00677833|4056788|P1|Overall Study|Withdrawal by Subject|4
1236964|NCT00677820|4056838|P2|Overall Study|Lost to Follow-up|0
1236965|NCT00677820|4056839|P1|Overall Study|Lost to Follow-up|1
1236966|NCT00677807|4056860|P3|Overall Study|Protocol Deviation|0
1236967|NCT00677807|4056861|P2|Overall Study|Protocol Deviation|3
1236968|NCT00677807|4056862|P1|Overall Study|Protocol Deviation|1
1236969|NCT00677807|4056860|P3|Overall Study|Death|1
1236970|NCT00677807|4056861|P2|Overall Study|Death|1
1236971|NCT00677807|4056862|P1|Overall Study|Death|0
1236972|NCT00677807|4056860|P3|Overall Study|Administrative problems|2
1236973|NCT00677807|4056861|P2|Overall Study|Administrative problems|1
1236974|NCT00677807|4056862|P1|Overall Study|Administrative problems|1
1236975|NCT00677807|4056860|P3|Overall Study|Lost to Follow-up|2
1236976|NCT00677807|4056861|P2|Overall Study|Lost to Follow-up|2
1236977|NCT00677807|4056862|P1|Overall Study|Lost to Follow-up|2
1236978|NCT00677807|4056860|P3|Overall Study|Withdrawal by Subject|6
1236979|NCT00677807|4056861|P2|Overall Study|Withdrawal by Subject|3
1236980|NCT00677807|4056862|P1|Overall Study|Withdrawal by Subject|10
1236981|NCT00677807|4056860|P3|Overall Study|Participant no longer needs study drug|1
1236982|NCT00677807|4056861|P2|Overall Study|Participant no longer needs study drug|0
1236983|NCT00677807|4056862|P1|Overall Study|Participant no longer needs study drug|0
1236984|NCT00677807|4056860|P3|Overall Study|Lack of Efficacy|2
1236985|NCT00677807|4056861|P2|Overall Study|Lack of Efficacy|0
1236986|NCT00677807|4056862|P1|Overall Study|Lack of Efficacy|0
1236987|NCT00677807|4056860|P3|Overall Study|Adverse Event|6
1236988|NCT00677807|4056861|P2|Overall Study|Adverse Event|1
1236989|NCT00677807|4056862|P1|Overall Study|Adverse Event|4
1236990|NCT00677534|4056908|P1|Washout (Weeks 1-4)|Withdrawal by Subject|1
1236991|NCT00677534|4056908|P1|Washout (Weeks 1-4)|Withdrawal by Subject|1
1236992|NCT00677534|4056908|P1|Washout (Weeks 1-4)|did not qualify after signing consent|1
1236993|NCT00677365|4056916|P4|Overall Study|Other reason|1
1236994|NCT00677365|4056917|P3|Overall Study|Other reason|0
1236995|NCT00677365|4056918|P2|Overall Study|Other reason|0
1236996|NCT00677365|4056919|P1|Overall Study|Other reason|0
1236997|NCT00677365|4056916|P4|Overall Study|Withdrawal by Subject|0
1236998|NCT00677365|4056917|P3|Overall Study|Withdrawal by Subject|1
1236999|NCT00677365|4056918|P2|Overall Study|Withdrawal by Subject|0
1237000|NCT00677365|4056919|P1|Overall Study|Withdrawal by Subject|0
1237001|NCT00677365|4056916|P4|Overall Study|Adverse Event|2
1237002|NCT00677365|4056917|P3|Overall Study|Adverse Event|1
1237003|NCT00677365|4056918|P2|Overall Study|Adverse Event|1
1237004|NCT00677365|4056919|P1|Overall Study|Adverse Event|2
1237005|NCT00677352|4056951|P2|Tapering Phase|Job transfer|1
1237006|NCT00677352|4056952|P1|Tapering Phase|Job transfer|0
1237007|NCT00677352|4056951|P2|Tapering Phase|Pregnancy|1
1237008|NCT00677352|4056952|P1|Tapering Phase|Pregnancy|0
1237009|NCT00677352|4056951|P2|Tapering Phase|Withdrawal by Subject|3
1237010|NCT00677352|4056952|P1|Tapering Phase|Withdrawal by Subject|5
1237011|NCT00677352|4056951|P2|Tapering Phase|Adverse Event|5
1237012|NCT00677352|4056952|P1|Tapering Phase|Adverse Event|1
1237013|NCT00677352|4056951|P2|Treatment Phase|Not treated|2
1237014|NCT00677352|4056952|P1|Treatment Phase|Not treated|0
1237015|NCT00677352|4056951|P2|Treatment Phase|Transference or work related matter|5
1237016|NCT00677352|4056952|P1|Treatment Phase|Transference or work related matter|0
1237017|NCT00677352|4056951|P2|Treatment Phase|Protocol Violation|1
1237018|NCT00677352|4056952|P1|Treatment Phase|Protocol Violation|1
1237019|NCT00677352|4056951|P2|Treatment Phase|Pregnancy|1
1237020|NCT00677352|4056952|P1|Treatment Phase|Pregnancy|0
1237021|NCT00677352|4056951|P2|Treatment Phase|Physician Decision|0
1237022|NCT00677352|4056952|P1|Treatment Phase|Physician Decision|1
1237023|NCT00677352|4056951|P2|Treatment Phase|Withdrawal by Subject|7
1237024|NCT00677352|4056952|P1|Treatment Phase|Withdrawal by Subject|7
1237025|NCT00677352|4056951|P2|Treatment Phase|Lost to Follow-up|1
1237026|NCT00677352|4056952|P1|Treatment Phase|Lost to Follow-up|0
1237027|NCT00677352|4056951|P2|Treatment Phase|Lack of Efficacy|3
1237028|NCT00677352|4056952|P1|Treatment Phase|Lack of Efficacy|2
1237029|NCT00677352|4056951|P2|Treatment Phase|Adverse Event|22
1237030|NCT00677352|4056952|P1|Treatment Phase|Adverse Event|14
1237031|NCT00677235|4056972|P2|Overall Study|Adverse Experience|0
1237032|NCT00677235|4056973|P1|Overall Study|Adverse Experience|1
1237033|NCT00677235|4056972|P2|Overall Study|Death|36
1237034|NCT00677235|4056973|P1|Overall Study|Death|37
1237035|NCT00677235|4056972|P2|Overall Study|Lost to Follow-up|1
1237036|NCT00677235|4056973|P1|Overall Study|Lost to Follow-up|2
1237037|NCT00677235|4056972|P2|Overall Study|Withdrawal by Subject|1
1237038|NCT00677235|4056973|P1|Overall Study|Withdrawal by Subject|1
1237039|NCT00677092|4057013|P1|Overall Study|Death Prior to Receiving Treatment|1
1237040|NCT00677092|4057013|P1|Overall Study|Withdrawal by Subject|3
1237041|NCT00677092|4057013|P1|Overall Study|Lost to Follow-up|1
1237042|NCT00677092|4057013|P1|Overall Study|Adverse Event|1
1237043|NCT00677014|4057030|P3|Overall Study|Unavailable or unreadable 6 month LVESV|18
1237044|NCT00677014|4057031|P2|Overall Study|Unavailable or unreadable 6 month LVESV|14
1237045|NCT00677014|4057032|P1|Overall Study|Unavailable or unreadable 6 month LVESV|18
1237046|NCT00677014|4057030|P3|Overall Study|Death|7
1237047|NCT00677014|4057031|P2|Overall Study|Death|15
1237048|NCT00677014|4057032|P1|Overall Study|Death|6
1237049|NCT00677014|4057030|P3|Overall Study|Lost to Follow-up|24
1237050|NCT00677014|4057031|P2|Overall Study|Lost to Follow-up|12
1237051|NCT00677014|4057032|P1|Overall Study|Lost to Follow-up|20
1237052|NCT00676715|4057085|P4|Overall Study|Participants Ongoing|24
1237053|NCT00676715|4057086|P3|Overall Study|Participants Ongoing|17
1237054|NCT00676715|4057087|P2|Overall Study|Participants Ongoing|29
1237055|NCT00676715|4057088|P1|Overall Study|Participants Ongoing|29
1237056|NCT00676715|4057085|P4|Overall Study|Adverse Event|0
1237057|NCT00676715|4057086|P3|Overall Study|Adverse Event|2
1237058|NCT00676715|4057087|P2|Overall Study|Adverse Event|1
1237059|NCT00676715|4057088|P1|Overall Study|Adverse Event|0
1237060|NCT00676715|4057085|P4|Overall Study|Death|0
1237061|NCT00676715|4057086|P3|Overall Study|Death|1
1237062|NCT00676715|4057087|P2|Overall Study|Death|1
1237063|NCT00676715|4057088|P1|Overall Study|Death|1
1237064|NCT00676715|4057085|P4|Overall Study|Lost to Follow-up|3
1237065|NCT00676715|4057086|P3|Overall Study|Lost to Follow-up|7
1237066|NCT00676715|4057087|P2|Overall Study|Lost to Follow-up|1
1237067|NCT00676715|4057088|P1|Overall Study|Lost to Follow-up|1
1237068|NCT00676715|4057085|P4|Overall Study|Other|3
1237069|NCT00676715|4057086|P3|Overall Study|Other|4
1237070|NCT00676715|4057087|P2|Overall Study|Other|6
1237071|NCT00676715|4057088|P1|Overall Study|Other|2
1237072|NCT00676715|4057085|P4|Overall Study|Withdrawal by Subject|10
1237073|NCT00676715|4057086|P3|Overall Study|Withdrawal by Subject|10
1237074|NCT00676715|4057087|P2|Overall Study|Withdrawal by Subject|9
1237075|NCT00676715|4057088|P1|Overall Study|Withdrawal by Subject|7
1237076|NCT00676689|4057118|P1|Overall Study|Continuing FU|49
1237077|NCT00676689|4057118|P1|Overall Study|Withdrawal by Subject|3
1237078|NCT00676689|4057118|P1|Overall Study|Physician Decision|1
1237079|NCT00676689|4057118|P1|Overall Study|Lost to Follow-up|4
1237080|NCT00676689|4057118|P1|Overall Study|Death|2
1237081|NCT00676689|4057118|P1|Overall Study|Screen Failure|2
1237082|NCT00676650|4057130|P2|Overall Study|Randomized but not treated|4
1237083|NCT00676650|4057131|P1|Overall Study|Randomized but not treated|3
1237084|NCT00676650|4057130|P2|Overall Study|Withdrawal by Subject|24
1237085|NCT00676650|4057131|P1|Overall Study|Withdrawal by Subject|48
1237086|NCT00676650|4057130|P2|Overall Study|Study terminated by sponsor|43
1237087|NCT00676650|4057131|P1|Overall Study|Study terminated by sponsor|57
1237088|NCT00676650|4057130|P2|Overall Study|Protocol Violation|1
1237089|NCT00676650|4057131|P1|Overall Study|Protocol Violation|3
1237090|NCT00676650|4057130|P2|Overall Study|Other|10
1237091|NCT00676650|4057131|P1|Overall Study|Other|14
1237092|NCT00676650|4057130|P2|Overall Study|Objective progression or relapse|140
1237093|NCT00676650|4057131|P1|Overall Study|Objective progression or relapse|189
1237094|NCT00676650|4057130|P2|Overall Study|Lost to Follow-up|1
1237095|NCT00676650|4057131|P1|Overall Study|Lost to Follow-up|0
1237096|NCT00676650|4057130|P2|Overall Study|Global deterioration of health status|31
1237097|NCT00676650|4057131|P1|Overall Study|Global deterioration of health status|66
1237098|NCT00676650|4057130|P2|Overall Study|Adverse Event|21
1237099|NCT00676650|4057131|P1|Overall Study|Adverse Event|159
1237100|NCT00676650|4057130|P2|Overall Study|Death|14
1237101|NCT00676650|4057131|P1|Overall Study|Death|45
1237102|NCT00676520|4057162|P1|Overall Study|Other Reason|18
1237103|NCT00676520|4057162|P1|Overall Study|Ineligible for Randomization to DAPT|209
1237104|NCT00676520|4057162|P1|Overall Study|Physician Decision|20
1237105|NCT00676520|4057162|P1|Overall Study|Death|159
1237106|NCT00676520|4057162|P1|Overall Study|Lost to Follow-up|162
1237107|NCT00676520|4057162|P1|Overall Study|Withdrawal by Subject|163
1237108|NCT00676494|4057219|P1|Overall Study|Withdrawal by Subject|6
1237109|NCT00676494|4057219|P1|Overall Study|Missed Visit|8
1237110|NCT00676403|4057236|P6|Overall Study|Withdrawal by Subject|1
1237111|NCT00676403|4057237|P5|Overall Study|Withdrawal by Subject|0
1237112|NCT00676403|4057238|P4|Overall Study|Withdrawal by Subject|0
1237113|NCT00676403|4057239|P3|Overall Study|Withdrawal by Subject|0
1237114|NCT00676403|4057240|P2|Overall Study|Withdrawal by Subject|0
1237115|NCT00676403|4057241|P1|Overall Study|Withdrawal by Subject|0
1237116|NCT00676403|4057236|P6|Overall Study|Reason Unspecified|1
1237117|NCT00676403|4057237|P5|Overall Study|Reason Unspecified|0
1237118|NCT00676403|4057238|P4|Overall Study|Reason Unspecified|0
1237119|NCT00676403|4057239|P3|Overall Study|Reason Unspecified|1
1237120|NCT00676403|4057240|P2|Overall Study|Reason Unspecified|0
1237121|NCT00676403|4057241|P1|Overall Study|Reason Unspecified|1
1237122|NCT00676403|4057236|P6|Overall Study|Lost to Follow-up|1
1237123|NCT00676403|4057237|P5|Overall Study|Lost to Follow-up|0
1237124|NCT00676403|4057238|P4|Overall Study|Lost to Follow-up|0
1237125|NCT00676403|4057239|P3|Overall Study|Lost to Follow-up|0
1237126|NCT00676403|4057240|P2|Overall Study|Lost to Follow-up|0
1237127|NCT00676403|4057241|P1|Overall Study|Lost to Follow-up|0
1237128|NCT00676403|4057236|P6|Overall Study|Adverse Event|2
1237129|NCT00676403|4057237|P5|Overall Study|Adverse Event|1
1237130|NCT00676403|4057238|P4|Overall Study|Adverse Event|5
1237131|NCT00676403|4057239|P3|Overall Study|Adverse Event|0
1237132|NCT00676403|4057240|P2|Overall Study|Adverse Event|2
1237133|NCT00676403|4057241|P1|Overall Study|Adverse Event|1
1237134|NCT00676338|4057384|P4|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
1237135|NCT00676338|4057385|P3|Overall Study|Lack of Efficacy-Loss of Glucose Control|5
1237136|NCT00676338|4057386|P2|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
1237137|NCT00676338|4057387|P1|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
1237138|NCT00676338|4057384|P4|Overall Study|Entry Criteria Not Met|1
1237139|NCT00676338|4057385|P3|Overall Study|Entry Criteria Not Met|1
1237140|NCT00676338|4057386|P2|Overall Study|Entry Criteria Not Met|2
1237141|NCT00676338|4057387|P1|Overall Study|Entry Criteria Not Met|0
1237142|NCT00676338|4057384|P4|Overall Study|Withdrawal by Subject|6
1237143|NCT00676338|4057385|P3|Overall Study|Withdrawal by Subject|12
1237144|NCT00676338|4057386|P2|Overall Study|Withdrawal by Subject|9
1237145|NCT00676338|4057387|P1|Overall Study|Withdrawal by Subject|17
1237146|NCT00676338|4057384|P4|Overall Study|Protocol Violation|5
1237147|NCT00676338|4057385|P3|Overall Study|Protocol Violation|2
1237148|NCT00676338|4057386|P2|Overall Study|Protocol Violation|9
1237149|NCT00676338|4057387|P1|Overall Study|Protocol Violation|5
1237150|NCT00676338|4057384|P4|Overall Study|Physician Decision|3
1237151|NCT00676338|4057385|P3|Overall Study|Physician Decision|2
1237152|NCT00676338|4057386|P2|Overall Study|Physician Decision|3
1237153|NCT00676338|4057387|P1|Overall Study|Physician Decision|3
1237154|NCT00676338|4057384|P4|Overall Study|Lost to Follow-up|4
1237155|NCT00676338|4057385|P3|Overall Study|Lost to Follow-up|3
1237156|NCT00676338|4057386|P2|Overall Study|Lost to Follow-up|1
1237157|NCT00676338|4057387|P1|Overall Study|Lost to Follow-up|4
1237158|NCT00676338|4057384|P4|Overall Study|Adverse Event|1
1237159|NCT00676338|4057385|P3|Overall Study|Adverse Event|5
1237160|NCT00676338|4057386|P2|Overall Study|Adverse Event|6
1237161|NCT00676338|4057387|P1|Overall Study|Adverse Event|6
1237162|NCT00676208|4057439|P2|Overall Study|Incomplete data|4
1237163|NCT00676208|4057440|P1|Overall Study|Incomplete data|2
1237164|NCT00676208|4057439|P2|Overall Study|Lost to Follow-up|2
1237165|NCT00676208|4057440|P1|Overall Study|Lost to Follow-up|0
1237166|NCT00676195|4057448|P1|Overall Study|Physician Decision|1
1237167|NCT00676195|4057448|P1|Overall Study|Adverse Event|1
1237168|NCT00676195|4057448|P1|Overall Study|Lost to Follow-up|1
1237169|NCT00676143|4057473|P2|Overall Study|Vasogenic edema recurrence|3
1237170|NCT00676143|4057474|P1|Overall Study|Vasogenic edema recurrence|1
1237171|NCT00676143|4057473|P2|Overall Study|Participant participation unknown|4
1237172|NCT00676143|4057474|P1|Overall Study|Participant participation unknown|1
1237173|NCT00676143|4057473|P2|Overall Study|Not specified|20
1237174|NCT00676143|4057474|P1|Overall Study|Not specified|11
1237175|NCT00676143|4057473|P2|Overall Study|Loss of caregiver|3
1237176|NCT00676143|4057474|P1|Overall Study|Loss of caregiver|5
1237177|NCT00676143|4057473|P2|Overall Study|Failed to return|1
1237178|NCT00676143|4057474|P1|Overall Study|Failed to return|2
1237179|NCT00676143|4057473|P2|Overall Study|Discontinuation of study by sponsor|88
1237180|NCT00676143|4057474|P1|Overall Study|Discontinuation of study by sponsor|65
1237181|NCT00676143|4057473|P2|Overall Study|Withdrawal by Subject|42
1237182|NCT00676143|4057474|P1|Overall Study|Withdrawal by Subject|24
1237183|NCT00676143|4057473|P2|Overall Study|Protocol Violation|8
1237184|NCT00676143|4057474|P1|Overall Study|Protocol Violation|4
1237185|NCT00676143|4057473|P2|Overall Study|Physician Decision|8
1237186|NCT00676143|4057474|P1|Overall Study|Physician Decision|5
1237187|NCT00676143|4057473|P2|Overall Study|Lost to Follow-up|13
1237188|NCT00676143|4057474|P1|Overall Study|Lost to Follow-up|0
1237189|NCT00676143|4057473|P2|Overall Study|Lack of Efficacy|6
1237190|NCT00676143|4057474|P1|Overall Study|Lack of Efficacy|0
1237191|NCT00676143|4057473|P2|Overall Study|Death|4
1237192|NCT00676143|4057474|P1|Overall Study|Death|4
1237193|NCT00676143|4057473|P2|Overall Study|Adverse Event|60
1237194|NCT00676143|4057474|P1|Overall Study|Adverse Event|34
1237195|NCT00676130|4057514|P2|Overall Study|Withdrawal by Subject|1
1237196|NCT00676130|4057515|P1|Overall Study|Withdrawal by Subject|0
1237197|NCT00676130|4057514|P2|Overall Study|Found ineligible|2
1237198|NCT00676130|4057515|P1|Overall Study|Found ineligible|3
1237199|NCT00676130|4057514|P2|Overall Study|Lost to Follow-up|1
1237200|NCT00676130|4057515|P1|Overall Study|Lost to Follow-up|0
1237201|NCT00676091|4057525|P2|Toddler Dose|Parent or legal guardian request|0
1237202|NCT00676091|4057526|P1|Toddler Dose|Parent or legal guardian request|1
1237203|NCT00676091|4057525|P2|Toddler Dose|Failed to return|0
1237204|NCT00676091|4057526|P1|Toddler Dose|Failed to return|2
1237205|NCT00676091|4057525|P2|After Infant Series|Failed to return|1
1237206|NCT00676091|4057526|P1|After Infant Series|Failed to return|1
1237207|NCT00676091|4057525|P2|After Infant Series|Protocol Violation|1
1237208|NCT00676091|4057526|P1|After Infant Series|Protocol Violation|0
1237209|NCT00676091|4057525|P2|After Infant Series|Adverse Event|1
1237210|NCT00676091|4057526|P1|After Infant Series|Adverse Event|0
1237211|NCT00676091|4057525|P2|Infant Series|Died prior to receiving 7vPnC|1
1237212|NCT00676091|4057526|P1|Infant Series|Died prior to receiving 7vPnC|0
1237213|NCT00676091|4057525|P2|Infant Series|Lost to Follow-up|0
1237214|NCT00676091|4057526|P1|Infant Series|Lost to Follow-up|1
1237215|NCT00676091|4057525|P2|Infant Series|Failed to return|3
1237216|NCT00676091|4057526|P1|Infant Series|Failed to return|1
1237217|NCT00676091|4057525|P2|Infant Series|Adverse Event|3
1237218|NCT00676091|4057526|P1|Infant Series|Adverse Event|2
1237219|NCT00676091|4057525|P2|Infant Series|Protocol Violation|3
1237220|NCT00676091|4057526|P1|Infant Series|Protocol Violation|6
1237221|NCT00676091|4057525|P2|Infant Series|Parent or legal guardian request|8
1237222|NCT00676091|4057526|P1|Infant Series|Parent or legal guardian request|10
1237223|NCT00676052|4057583|P6|Overall Study|Withdrawal by Subject|0
1237224|NCT00676052|4057584|P5|Overall Study|Withdrawal by Subject|0
1237225|NCT00676052|4057585|P4|Overall Study|Withdrawal by Subject|0
1237226|NCT00676052|4057586|P3|Overall Study|Withdrawal by Subject|1
1237227|NCT00676052|4057587|P2|Overall Study|Withdrawal by Subject|0
1237228|NCT00676052|4057588|P1|Overall Study|Withdrawal by Subject|1
1237229|NCT00676052|4057583|P6|Overall Study|Physician Decision|1
1237230|NCT00676052|4057584|P5|Overall Study|Physician Decision|0
1237231|NCT00676052|4057585|P4|Overall Study|Physician Decision|0
1237232|NCT00676052|4057586|P3|Overall Study|Physician Decision|1
1237233|NCT00676052|4057587|P2|Overall Study|Physician Decision|1
1237234|NCT00676052|4057588|P1|Overall Study|Physician Decision|1
1237235|NCT00676052|4057583|P6|Overall Study|Lost to Follow-up|0
1237236|NCT00676052|4057584|P5|Overall Study|Lost to Follow-up|1
1237237|NCT00676052|4057585|P4|Overall Study|Lost to Follow-up|0
1237238|NCT00676052|4057586|P3|Overall Study|Lost to Follow-up|0
1237239|NCT00676052|4057587|P2|Overall Study|Lost to Follow-up|0
1237240|NCT00676052|4057588|P1|Overall Study|Lost to Follow-up|0
1237241|NCT00676052|4057583|P6|Overall Study|Protocol Violation|2
1237242|NCT00676052|4057584|P5|Overall Study|Protocol Violation|1
1237243|NCT00676052|4057585|P4|Overall Study|Protocol Violation|2
1237244|NCT00676052|4057586|P3|Overall Study|Protocol Violation|2
1237245|NCT00676052|4057587|P2|Overall Study|Protocol Violation|3
1237246|NCT00676052|4057588|P1|Overall Study|Protocol Violation|5
1237247|NCT00676052|4057583|P6|Overall Study|Lack of Efficacy|1
1237248|NCT00676052|4057584|P5|Overall Study|Lack of Efficacy|2
1237249|NCT00676052|4057585|P4|Overall Study|Lack of Efficacy|1
1237250|NCT00676052|4057586|P3|Overall Study|Lack of Efficacy|1
1237251|NCT00676052|4057587|P2|Overall Study|Lack of Efficacy|2
1237252|NCT00676052|4057588|P1|Overall Study|Lack of Efficacy|2
1237253|NCT00676052|4057583|P6|Overall Study|Adverse Event|2
1237254|NCT00676052|4057584|P5|Overall Study|Adverse Event|2
1237255|NCT00676052|4057585|P4|Overall Study|Adverse Event|2
1237256|NCT00676052|4057586|P3|Overall Study|Adverse Event|1
1237257|NCT00676052|4057587|P2|Overall Study|Adverse Event|1
1237258|NCT00676052|4057588|P1|Overall Study|Adverse Event|0
1237259|NCT00675948|4057651|P2|Overall Study|Patient feels unable to take medication|1
1237260|NCT00675948|4057652|P1|Overall Study|Patient feels unable to take medication|0
1237261|NCT00675948|4057651|P2|Overall Study|Patient unable to comply with diaries|0
1237262|NCT00675948|4057652|P1|Overall Study|Patient unable to comply with diaries|1
1237263|NCT00675948|4057651|P2|Overall Study|Patient died|0
1237264|NCT00675948|4057652|P1|Overall Study|Patient died|1
1237265|NCT00675948|4057651|P2|Overall Study|Sponsor decision|1
1237266|NCT00675948|4057652|P1|Overall Study|Sponsor decision|0
1237267|NCT00675948|4057651|P2|Overall Study|Pain under control|0
1237268|NCT00675948|4057652|P1|Overall Study|Pain under control|1
1237269|NCT00675948|4057651|P2|Overall Study|Protocol Violation|0
1237270|NCT00675948|4057652|P1|Overall Study|Protocol Violation|1
1237271|NCT00675948|4057651|P2|Overall Study|Lost to Follow-up|0
1237272|NCT00675948|4057652|P1|Overall Study|Lost to Follow-up|2
1237273|NCT00675948|4057651|P2|Overall Study|Withdrawal by Subject|0
1237274|NCT00675948|4057652|P1|Overall Study|Withdrawal by Subject|7
1237275|NCT00675948|4057651|P2|Overall Study|Lack of Efficacy|0
1237276|NCT00675948|4057652|P1|Overall Study|Lack of Efficacy|3
1237277|NCT00675948|4057651|P2|Overall Study|Adverse Event|1
1237278|NCT00675948|4057652|P1|Overall Study|Adverse Event|23
1237279|NCT00675766|4057715|P4|Overall Study|Lost to Follow-up|26
1237280|NCT00675766|4057716|P3|Overall Study|Lost to Follow-up|21
1237281|NCT00675766|4057717|P2|Overall Study|Lost to Follow-up|5
1237282|NCT00675766|4057718|P1|Overall Study|Lost to Follow-up|6
1237283|NCT00675597|4057728|P1|Overall Study|Withdrawal by Subject|3
1237284|NCT00675506|4057782|P2|Overall Study|Schedule conflict|1
1237285|NCT00675506|4057783|P1|Overall Study|Schedule conflict|0
1237286|NCT00675506|4057782|P2|Overall Study|Declined participation|0
1237287|NCT00675506|4057783|P1|Overall Study|Declined participation|1
1237288|NCT00675506|4057782|P2|Overall Study|Disclosed history of cancer|0
1237289|NCT00675506|4057783|P1|Overall Study|Disclosed history of cancer|1
1237290|NCT00675506|4057782|P2|Overall Study|Hypersensitivity Reaction|0
1237291|NCT00675506|4057783|P1|Overall Study|Hypersensitivity Reaction|1
1237292|NCT00675506|4057782|P2|Overall Study|Elevated IGF-1|0
1237293|NCT00675506|4057783|P1|Overall Study|Elevated IGF-1|2
1237294|NCT00675506|4057782|P2|Overall Study|Elevated IGF-1 prior to treatment|0
1237295|NCT00675506|4057783|P1|Overall Study|Elevated IGF-1 prior to treatment|1
1237296|NCT00675506|4057782|P2|Overall Study|Elevated fasting glucose|1
1237297|NCT00675506|4057783|P1|Overall Study|Elevated fasting glucose|2
1237298|NCT00675506|4057782|P2|Overall Study|Lost interest|5
1237299|NCT00675506|4057783|P1|Overall Study|Lost interest|3
1237300|NCT00675506|4057782|P2|Overall Study|Lost to Follow-up|5
1237301|NCT00675506|4057783|P1|Overall Study|Lost to Follow-up|1
1237302|NCT00675441|4057799|P1|Overall Study|Death|1
1237303|NCT00675441|4057799|P1|Overall Study|Withdrawal by Subject|2
1237304|NCT00675428|4057805|P2|Overall Study|Physician Decision|0
1237305|NCT00675428|4057806|P1|Overall Study|Physician Decision|1
1237306|NCT00675428|4057805|P2|Overall Study|No Disease Response After Cycle 6|1
1237307|NCT00675428|4057806|P1|Overall Study|No Disease Response After Cycle 6|0
1237308|NCT00675428|4057805|P2|Overall Study|Disease Progression|2
1237309|NCT00675428|4057806|P1|Overall Study|Disease Progression|2
1237310|NCT00675103|4057848|P1|Overall Study|Adverse Event|1
1237311|NCT00675103|4057848|P1|Overall Study|Lack of Efficacy|2
1237312|NCT00674986|4057855|P2|Overall Study|Other reasons|8
1237313|NCT00674986|4057856|P1|Overall Study|Other reasons|4
1237314|NCT00674986|4057855|P2|Overall Study|Lost to Follow-up|53
1237315|NCT00674986|4057856|P1|Overall Study|Lost to Follow-up|25
1237316|NCT00674986|4057855|P2|Overall Study|Subject withdrew consent|19
1237317|NCT00674986|4057856|P1|Overall Study|Subject withdrew consent|12
1237318|NCT00674986|4057855|P2|Overall Study|Adverse Event|1
1237319|NCT00674986|4057856|P1|Overall Study|Adverse Event|2
1237320|NCT00674973|4057877|P2|Overall Study|Protocol Violation|1
1237321|NCT00674973|4057878|P1|Overall Study|Protocol Violation|0
1237322|NCT00674973|4057877|P2|Overall Study|Death|15
1237323|NCT00674973|4057878|P1|Overall Study|Death|19
1237324|NCT00674973|4057877|P2|Overall Study|Adverse Event|9
1237325|NCT00674973|4057878|P1|Overall Study|Adverse Event|2
1237326|NCT00674973|4057877|P2|Overall Study|Failure to Return|0
1237327|NCT00674973|4057878|P1|Overall Study|Failure to Return|1
1237328|NCT00674973|4057877|P2|Overall Study|Refused Treatment|5
1237329|NCT00674973|4057878|P1|Overall Study|Refused Treatment|1
1237330|NCT00674973|4057877|P2|Overall Study|Insufficient Therapeutic Response|72
1237331|NCT00674973|4057878|P1|Overall Study|Insufficient Therapeutic Response|77
1237332|NCT00674817|4057892|P1|Period 4|Adverse Event|1
1237333|NCT00674817|4057892|P1|Period 3|Protocol Violation|1
1237334|NCT00674817|4057892|P1|Period 3|Adverse Event|1
1237335|NCT00674817|4057892|P1|Period 1|Protocol Violation|1
1237336|NCT00674817|4057892|P1|Period 1|Withdrawal by Subject|2
1237337|NCT00674700|4058069|P3|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7
1237338|NCT00674700|4058070|P2|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10
1237339|NCT00674700|4058071|P1|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5
1237340|NCT00674700|4058069|P3|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4
1237341|NCT00674700|4058070|P2|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
1237342|NCT00674700|4058071|P1|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
1237343|NCT00674700|4058069|P3|Year 2 Follow-up Without Treatment|Adverse Event|1
1237344|NCT00674700|4058070|P2|Year 2 Follow-up Without Treatment|Adverse Event|1
1237345|NCT00674700|4058071|P1|Year 2 Follow-up Without Treatment|Adverse Event|0
1237346|NCT00674700|4058069|P3|Year 1|Any other reason not above-mentioned|6
1237347|NCT00674700|4058070|P2|Year 1|Any other reason not above-mentioned|7
1237348|NCT00674700|4058071|P1|Year 1|Any other reason not above-mentioned|7
1237349|NCT00674700|4058069|P3|Year 1|Withdrawal by Subject|6
1237350|NCT00674700|4058070|P2|Year 1|Withdrawal by Subject|7
1237351|NCT00674700|4058071|P1|Year 1|Withdrawal by Subject|7
1237352|NCT00674700|4058069|P3|Year 1|Adverse Event|5
1237353|NCT00674700|4058070|P2|Year 1|Adverse Event|20
1237354|NCT00674700|4058071|P1|Year 1|Adverse Event|17
1237355|NCT00674661|4058084|P2|Overall Study|Withdrawal by Subject|5
1237356|NCT00674661|4058085|P1|Overall Study|Withdrawal by Subject|0
1237357|NCT00674661|4058084|P2|Overall Study|Lost to Follow-up|3
1237358|NCT00674661|4058085|P1|Overall Study|Lost to Follow-up|6
1237359|NCT00674661|4058084|P2|Overall Study|not specified|7
1237360|NCT00674661|4058085|P1|Overall Study|not specified|5
1237361|NCT00674362|4058205|P2|Open Label|Other: Subject moved to extension study|0
1237362|NCT00674362|4058206|P1|Open Label|Other: Subject moved to extension study|1
1237363|NCT00674362|4058205|P2|Open Label|Adverse Event|0
1237364|NCT00674362|4058206|P1|Open Label|Adverse Event|1
1237365|NCT00674362|4058205|P2|Double Blind|Other: Surgery|1
1237366|NCT00674362|4058206|P1|Double Blind|Other: Surgery|0
1237367|NCT00674362|4058205|P2|Double Blind|Other: Loss of Patient Compliance|1
1237368|NCT00674362|4058206|P1|Double Blind|Other: Loss of Patient Compliance|0
1237369|NCT00674362|4058205|P2|Double Blind|Withdrawal by Subject|3
1237370|NCT00674362|4058206|P1|Double Blind|Withdrawal by Subject|4
1237371|NCT00674362|4058205|P2|Double Blind|Loss of efficacy|1
1237372|NCT00674362|4058206|P1|Double Blind|Loss of efficacy|0
1237373|NCT00674362|4058205|P2|Double Blind|Lack of Efficacy|6
1237374|NCT00674362|4058206|P1|Double Blind|Lack of Efficacy|2
1237375|NCT00674362|4058205|P2|Double Blind|Adverse Event|6
1237376|NCT00674362|4058206|P1|Double Blind|Adverse Event|6
1237377|NCT00674323|4058274|P3|Overall Study|Protocol Violation|0
1237378|NCT00674323|4058275|P2|Overall Study|Protocol Violation|0
1237379|NCT00674323|4058276|P1|Overall Study|Protocol Violation|1
1237380|NCT00674323|4058274|P3|Overall Study|Adverse Event|0
1237381|NCT00674323|4058275|P2|Overall Study|Adverse Event|1
1237382|NCT00674323|4058276|P1|Overall Study|Adverse Event|0
1237383|NCT00674154|4058318|P2|Overall Study|Did not want parathyroidectomy|2
1237384|NCT00674154|4058319|P1|Overall Study|Did not want parathyroidectomy|0
1237385|NCT00674154|4058318|P2|Overall Study|Withdrawal by Subject|1
1237386|NCT00674154|4058319|P1|Overall Study|Withdrawal by Subject|3
1237387|NCT00674128|4058327|P2|Overall Study|Withdrawal by Subject|23
1237388|NCT00674128|4058328|P1|Overall Study|Withdrawal by Subject|25
1237389|NCT00673933|4058353|P1|Overall Study|Lost to Follow-up|1
1237390|NCT00673933|4058353|P1|Overall Study|Withdrawal by Subject|2
1237391|NCT00673881|4058369|P1|Overall Study|Withdrawal by Subject|1
1237392|NCT00673816|4058383|P1|Overall Study|Withdrawal by Subject|1
1237393|NCT00673816|4058383|P1|Overall Study|Adverse Event|1
1237394|NCT00673673|4058418|P1|Overall Study|Investigators' discretion|2
1237395|NCT00673673|4058418|P1|Overall Study|Withdrawal by Subject|3
1237396|NCT00673673|4058418|P1|Overall Study|Adverse Event|4
1237397|NCT00673673|4058418|P1|Overall Study|Progressive disease|27
1237398|NCT00673660|4058424|P1|Overall Study|Lost to Follow-up|107
1237399|NCT00673465|4058446|P12|Part 1/Period 2 (United States)|Protocol Violation|0
1237400|NCT00673465|4058447|P11|Part 1/Period 2 (United States)|Protocol Violation|0
1237401|NCT00673465|4058448|P10|Part 1/Period 2 (United States)|Protocol Violation|0
1237402|NCT00673465|4058449|P9|Part 1/Period 2 (United States)|Protocol Violation|0
1237403|NCT00673465|4058450|P8|Part 1/Period 2 (United States)|Protocol Violation|0
1237404|NCT00673465|4058451|P7|Part 1/Period 2 (United States)|Protocol Violation|0
1237405|NCT00673465|4058452|P6|Part 1/Period 2 (United States)|Protocol Violation|0
1237406|NCT00673465|4058453|P5|Part 1/Period 2 (United States)|Protocol Violation|1
1237407|NCT00673465|4058454|P4|Part 1/Period 2 (United States)|Protocol Violation|0
1237408|NCT00673465|4058455|P3|Part 1/Period 2 (United States)|Protocol Violation|0
1237409|NCT00673465|4058456|P2|Part 1/Period 2 (United States)|Protocol Violation|0
1237410|NCT00673465|4058457|P1|Part 1/Period 2 (United States)|Protocol Violation|0
1237411|NCT00673465|4058446|P12|Part 1/Period 1 (United States)|Protocol Violation|0
1237412|NCT00673465|4058447|P11|Part 1/Period 1 (United States)|Protocol Violation|0
1237413|NCT00673465|4058448|P10|Part 1/Period 1 (United States)|Protocol Violation|0
1237414|NCT00673465|4058449|P9|Part 1/Period 1 (United States)|Protocol Violation|0
1237415|NCT00673465|4058450|P8|Part 1/Period 1 (United States)|Protocol Violation|0
1237416|NCT00673465|4058451|P7|Part 1/Period 1 (United States)|Protocol Violation|0
1237417|NCT00673465|4058452|P6|Part 1/Period 1 (United States)|Protocol Violation|1
1237418|NCT00673465|4058453|P5|Part 1/Period 1 (United States)|Protocol Violation|1
1237419|NCT00673465|4058454|P4|Part 1/Period 1 (United States)|Protocol Violation|0
1237420|NCT00673465|4058455|P3|Part 1/Period 1 (United States)|Protocol Violation|0
1237421|NCT00673465|4058456|P2|Part 1/Period 1 (United States)|Protocol Violation|0
1237422|NCT00673465|4058457|P1|Part 1/Period 1 (United States)|Protocol Violation|0
1237423|NCT00673452|4058506|P2|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0
1237424|NCT00673452|4058507|P1|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1
1237425|NCT00673452|4058506|P2|Continuation Double-Blind Phase|Physician Decision|0
1237426|NCT00673452|4058507|P1|Continuation Double-Blind Phase|Physician Decision|2
1237427|NCT00673452|4058506|P2|Continuation Double-Blind Phase|Sponsor Decision|3
1237428|NCT00673452|4058507|P1|Continuation Double-Blind Phase|Sponsor Decision|0
1237429|NCT00673452|4058506|P2|Continuation Double-Blind Phase|Protocol Violation|3
1237430|NCT00673452|4058507|P1|Continuation Double-Blind Phase|Protocol Violation|2
1237431|NCT00673452|4058506|P2|Continuation Double-Blind Phase|Lack of Efficacy|5
1237432|NCT00673452|4058507|P1|Continuation Double-Blind Phase|Lack of Efficacy|2
1237433|NCT00673452|4058506|P2|Continuation Double-Blind Phase|Lost to Follow-up|5
1237434|NCT00673452|4058507|P1|Continuation Double-Blind Phase|Lost to Follow-up|4
1237435|NCT00673452|4058506|P2|Continuation Double-Blind Phase|Withdrawal by Subject|5
1237436|NCT00673452|4058507|P1|Continuation Double-Blind Phase|Withdrawal by Subject|9
1237437|NCT00673452|4058506|P2|Continuation Double-Blind Phase|Adverse Event|13
1237438|NCT00673452|4058507|P1|Continuation Double-Blind Phase|Adverse Event|5
1237439|NCT00673452|4058506|P2|Acute Double-Blind Phase|Withdrawal by Subject|13
1237440|NCT00673452|4058507|P1|Acute Double-Blind Phase|Withdrawal by Subject|16
1237441|NCT00673452|4058506|P2|Acute Double-Blind Phase|Sponsor Decision|1
1237442|NCT00673452|4058507|P1|Acute Double-Blind Phase|Sponsor Decision|0
1237443|NCT00673452|4058506|P2|Acute Double-Blind Phase|Protocol Violation|3
1237444|NCT00673452|4058507|P1|Acute Double-Blind Phase|Protocol Violation|5
1237445|NCT00673452|4058506|P2|Acute Double-Blind Phase|Physician Decision|6
1237446|NCT00673452|4058507|P1|Acute Double-Blind Phase|Physician Decision|0
1237447|NCT00673452|4058506|P2|Acute Double-Blind Phase|Lost to Follow-up|19
1237448|NCT00673452|4058507|P1|Acute Double-Blind Phase|Lost to Follow-up|16
1237449|NCT00673452|4058506|P2|Acute Double-Blind Phase|Lack of Efficacy|14
1237450|NCT00673452|4058507|P1|Acute Double-Blind Phase|Lack of Efficacy|9
1237451|NCT00673452|4058506|P2|Acute Double-Blind Phase|Adverse Event|24
1237452|NCT00673452|4058507|P1|Acute Double-Blind Phase|Adverse Event|41
1237453|NCT00673387|4058570|P8|Overall Study|Lost to Follow-up|5
1237454|NCT00673387|4058571|P7|Overall Study|Lost to Follow-up|8
1237455|NCT00673387|4058572|P6|Overall Study|Lost to Follow-up|5
1237456|NCT00673387|4058573|P5|Overall Study|Lost to Follow-up|6
1237457|NCT00673387|4058574|P4|Overall Study|Lost to Follow-up|6
1237458|NCT00673387|4058575|P3|Overall Study|Lost to Follow-up|5
1237459|NCT00673387|4058576|P2|Overall Study|Lost to Follow-up|6
1237460|NCT00673387|4058577|P1|Overall Study|Lost to Follow-up|8
1237461|NCT00673387|4058570|P8|Overall Study|Protocol Violation|3
1237462|NCT00673387|4058571|P7|Overall Study|Protocol Violation|1
1237463|NCT00673387|4058572|P6|Overall Study|Protocol Violation|1
1237464|NCT00673387|4058573|P5|Overall Study|Protocol Violation|0
1237465|NCT00673387|4058574|P4|Overall Study|Protocol Violation|2
1237466|NCT00673387|4058575|P3|Overall Study|Protocol Violation|1
1237467|NCT00673387|4058576|P2|Overall Study|Protocol Violation|0
1237468|NCT00673387|4058577|P1|Overall Study|Protocol Violation|3
1237469|NCT00673387|4058570|P8|Overall Study|Physician Decision|1
1237470|NCT00673387|4058571|P7|Overall Study|Physician Decision|1
1237471|NCT00673387|4058572|P6|Overall Study|Physician Decision|5
1237472|NCT00673387|4058573|P5|Overall Study|Physician Decision|0
1237473|NCT00673387|4058574|P4|Overall Study|Physician Decision|0
1237474|NCT00673387|4058575|P3|Overall Study|Physician Decision|0
1237475|NCT00673387|4058576|P2|Overall Study|Physician Decision|0
1237476|NCT00673387|4058577|P1|Overall Study|Physician Decision|0
1237477|NCT00673387|4058570|P8|Overall Study|Adverse Event|5
1237478|NCT00673387|4058571|P7|Overall Study|Adverse Event|5
1237479|NCT00673387|4058572|P6|Overall Study|Adverse Event|2
1237480|NCT00673387|4058573|P5|Overall Study|Adverse Event|6
1237481|NCT00673387|4058574|P4|Overall Study|Adverse Event|2
1237482|NCT00673387|4058575|P3|Overall Study|Adverse Event|5
1237483|NCT00673387|4058576|P2|Overall Study|Adverse Event|1
1237484|NCT00673387|4058577|P1|Overall Study|Adverse Event|3
1237485|NCT00673387|4058570|P8|Overall Study|Withdrawal by Subject|21
1237486|NCT00673387|4058571|P7|Overall Study|Withdrawal by Subject|15
1237487|NCT00673387|4058572|P6|Overall Study|Withdrawal by Subject|21
1237488|NCT00673387|4058573|P5|Overall Study|Withdrawal by Subject|18
1237489|NCT00673387|4058574|P4|Overall Study|Withdrawal by Subject|16
1237490|NCT00673387|4058575|P3|Overall Study|Withdrawal by Subject|20
1237491|NCT00673387|4058576|P2|Overall Study|Withdrawal by Subject|16
1237492|NCT00673387|4058577|P1|Overall Study|Withdrawal by Subject|15
1237493|NCT00673361|4058793|P1|Overall Study|Screen Failure|2
1237494|NCT00673257|4058797|P1|Overall Study|Unable to obtain specimen|1
1237495|NCT00673257|4058797|P1|Overall Study|Withdrawal by Subject|4
1237496|NCT00673231|4058806|P4|Overall Study|Study criteria,compliance,safety, other|4
1237497|NCT00673231|4058807|P3|Overall Study|Study criteria,compliance,safety, other|7
1237498|NCT00673231|4058808|P2|Overall Study|Study criteria,compliance,safety, other|5
1237499|NCT00673231|4058809|P1|Overall Study|Study criteria,compliance,safety, other|8
1237500|NCT00673231|4058806|P4|Overall Study|Death|0
1237501|NCT00673231|4058807|P3|Overall Study|Death|1
1237502|NCT00673231|4058808|P2|Overall Study|Death|0
1237503|NCT00673231|4058809|P1|Overall Study|Death|0
1237504|NCT00673231|4058806|P4|Overall Study|Lost to Follow-up|2
1237505|NCT00673231|4058807|P3|Overall Study|Lost to Follow-up|1
1237506|NCT00673231|4058808|P2|Overall Study|Lost to Follow-up|2
1237507|NCT00673231|4058809|P1|Overall Study|Lost to Follow-up|1
1237508|NCT00673231|4058806|P4|Overall Study|Adverse Event|6
1237509|NCT00673231|4058807|P3|Overall Study|Adverse Event|9
1237510|NCT00673231|4058808|P2|Overall Study|Adverse Event|5
1237511|NCT00673231|4058809|P1|Overall Study|Adverse Event|6
1237512|NCT00673231|4058806|P4|Overall Study|Withdrawal by Subject|6
1237513|NCT00673231|4058807|P3|Overall Study|Withdrawal by Subject|8
1237514|NCT00673231|4058808|P2|Overall Study|Withdrawal by Subject|10
1237515|NCT00673231|4058809|P1|Overall Study|Withdrawal by Subject|14
1237516|NCT00673179|4058841|P2|Overall Study|Toxicity/Complications|0
1237517|NCT00673179|4058842|P1|Overall Study|Toxicity/Complications|3
1237518|NCT00673049|4058891|P4|After Progression on Erlotinib|study terminated by sponsor|4
1237519|NCT00673049|4058892|P3|After Progression on Erlotinib|study terminated by sponsor|0
1237520|NCT00673049|4058893|P2|After Progression on Erlotinib|study terminated by sponsor|0
1237521|NCT00673049|4058894|P1|After Progression on Erlotinib|study terminated by sponsor|0
1237522|NCT00673049|4058891|P4|After Progression on Erlotinib|Withdrawal by Subject|5
1237523|NCT00673049|4058892|P3|After Progression on Erlotinib|Withdrawal by Subject|0
1237524|NCT00673049|4058893|P2|After Progression on Erlotinib|Withdrawal by Subject|0
1237525|NCT00673049|4058894|P1|After Progression on Erlotinib|Withdrawal by Subject|0
1237526|NCT00673049|4058891|P4|After Progression on Erlotinib|Lost to Follow-up|3
1237527|NCT00673049|4058892|P3|After Progression on Erlotinib|Lost to Follow-up|0
1237528|NCT00673049|4058893|P2|After Progression on Erlotinib|Lost to Follow-up|0
1237529|NCT00673049|4058894|P1|After Progression on Erlotinib|Lost to Follow-up|0
1237530|NCT00673049|4058891|P4|After Progression on Erlotinib|Death|71
1237531|NCT00673049|4058892|P3|After Progression on Erlotinib|Death|0
1237532|NCT00673049|4058893|P2|After Progression on Erlotinib|Death|0
1237533|NCT00673049|4058894|P1|After Progression on Erlotinib|Death|0
1237534|NCT00673049|4058891|P4|Before Progression on Erlotinib|Switched to figitumumab|0
1237535|NCT00673049|4058892|P3|Before Progression on Erlotinib|Switched to figitumumab|0
1237536|NCT00673049|4058893|P2|Before Progression on Erlotinib|Switched to figitumumab|83
1237537|NCT00673049|4058894|P1|Before Progression on Erlotinib|Switched to figitumumab|0
1237538|NCT00673049|4058891|P4|Before Progression on Erlotinib|study terminated by sponsor|0
1237539|NCT00673049|4058892|P3|Before Progression on Erlotinib|study terminated by sponsor|0
1237540|NCT00673049|4058893|P2|Before Progression on Erlotinib|study terminated by sponsor|14
1237541|NCT00673049|4058894|P1|Before Progression on Erlotinib|study terminated by sponsor|18
1237542|NCT00673049|4058891|P4|Before Progression on Erlotinib|Other|0
1237543|NCT00673049|4058892|P3|Before Progression on Erlotinib|Other|0
1237544|NCT00673049|4058893|P2|Before Progression on Erlotinib|Other|2
1237545|NCT00673049|4058894|P1|Before Progression on Erlotinib|Other|1
1237546|NCT00673049|4058891|P4|Before Progression on Erlotinib|Withdrawal by Subject|0
1237547|NCT00673049|4058892|P3|Before Progression on Erlotinib|Withdrawal by Subject|0
1237548|NCT00673049|4058893|P2|Before Progression on Erlotinib|Withdrawal by Subject|18
1237549|NCT00673049|4058894|P1|Before Progression on Erlotinib|Withdrawal by Subject|26
1237550|NCT00673049|4058891|P4|Before Progression on Erlotinib|Lost to Follow-up|0
1237551|NCT00673049|4058892|P3|Before Progression on Erlotinib|Lost to Follow-up|0
1237552|NCT00673049|4058893|P2|Before Progression on Erlotinib|Lost to Follow-up|5
1237553|NCT00673049|4058894|P1|Before Progression on Erlotinib|Lost to Follow-up|9
1237554|NCT00673049|4058891|P4|Before Progression on Erlotinib|Death|0
1237555|NCT00673049|4058892|P3|Before Progression on Erlotinib|Death|1
1237556|NCT00673049|4058893|P2|Before Progression on Erlotinib|Death|167
1237557|NCT00673049|4058894|P1|Before Progression on Erlotinib|Death|235
1237558|NCT00673049|4058891|P4|Before Progression on Erlotinib|Randomized but not treated|0
1237559|NCT00673049|4058892|P3|Before Progression on Erlotinib|Randomized but not treated|0
1237560|NCT00673049|4058893|P2|Before Progression on Erlotinib|Randomized but not treated|1
1237561|NCT00673049|4058894|P1|Before Progression on Erlotinib|Randomized but not treated|3
1237562|NCT00672984|4058918|P3|Third Intervention|Adverse Event|1
1237563|NCT00672984|4058919|P2|Third Intervention|Adverse Event|0
1237564|NCT00672984|4058920|P1|Third Intervention|Adverse Event|1
1237565|NCT00672984|4058918|P3|Second Intervention|Protocol Violation|1
1237566|NCT00672984|4058919|P2|Second Intervention|Protocol Violation|1
1237567|NCT00672984|4058920|P1|Second Intervention|Protocol Violation|0
1237568|NCT00672984|4058918|P3|Second Intervention|Withdrawal by Subject|0
1237569|NCT00672984|4058919|P2|Second Intervention|Withdrawal by Subject|3
1237570|NCT00672984|4058920|P1|Second Intervention|Withdrawal by Subject|0
1237571|NCT00672984|4058918|P3|Second Intervention|Non-compliance with facility policies|0
1237572|NCT00672984|4058919|P2|Second Intervention|Non-compliance with facility policies|2
1237573|NCT00672984|4058920|P1|Second Intervention|Non-compliance with facility policies|0
1237574|NCT00672984|4058918|P3|First Intervention|Sponsor decision|0
1237575|NCT00672984|4058919|P2|First Intervention|Sponsor decision|0
1237576|NCT00672984|4058920|P1|First Intervention|Sponsor decision|3
1237577|NCT00672984|4058918|P3|First Intervention|Withdrawal by Subject|2
1237578|NCT00672984|4058919|P2|First Intervention|Withdrawal by Subject|2
1237579|NCT00672984|4058920|P1|First Intervention|Withdrawal by Subject|1
1237580|NCT00672984|4058918|P3|First Intervention|Adverse Event|0
1237581|NCT00672984|4058919|P2|First Intervention|Adverse Event|0
1237582|NCT00672984|4058920|P1|First Intervention|Adverse Event|5
1237583|NCT00672958|4058971|P2|Overall Study|Reason not specified|3
1237584|NCT00672958|4058972|P1|Overall Study|Reason not specified|0
1237585|NCT00672958|4058971|P2|Overall Study|Lost to Follow-up|17
1237586|NCT00672958|4058972|P1|Overall Study|Lost to Follow-up|22
1237587|NCT00672958|4058971|P2|Overall Study|Voluntary withdrawal|8
1237588|NCT00672958|4058972|P1|Overall Study|Voluntary withdrawal|12
1237589|NCT00672958|4058971|P2|Overall Study|Protocol deviations|5
1237590|NCT00672958|4058972|P1|Overall Study|Protocol deviations|11
1237591|NCT00672958|4058971|P2|Overall Study|Non-compliance with study drug|3
1237592|NCT00672958|4058972|P1|Overall Study|Non-compliance with study drug|2
1237593|NCT00672958|4058971|P2|Overall Study|Lack of Efficacy|11
1237594|NCT00672958|4058972|P1|Overall Study|Lack of Efficacy|6
1237595|NCT00672958|4058971|P2|Overall Study|Adverse Event|9
1237596|NCT00672958|4058972|P1|Overall Study|Adverse Event|11
1237597|NCT00672841|4059038|P2|Overall Study|Pregnancy|1
1237598|NCT00672841|4059039|P1|Overall Study|Pregnancy|0
1237599|NCT00672841|4059038|P2|Overall Study|Adverse Event|3
1237600|NCT00672841|4059039|P1|Overall Study|Adverse Event|0
1237601|NCT00672841|4059038|P2|Overall Study|Antifungal therapy, negative glucan|4
1237602|NCT00672841|4059039|P1|Overall Study|Antifungal therapy, negative glucan|0
1237603|NCT00672841|4059038|P2|Overall Study|icteric specimens|3
1237604|NCT00672841|4059039|P1|Overall Study|icteric specimens|0
1237605|NCT00672841|4059038|P2|Overall Study|Comfort care|4
1237606|NCT00672841|4059039|P1|Overall Study|Comfort care|1
1237607|NCT00672646|4059061|P3|Overall Study|Withdrawal by Subject|1
1237608|NCT00672646|4059062|P2|Overall Study|Withdrawal by Subject|0
1237609|NCT00672646|4059063|P1|Overall Study|Withdrawal by Subject|0
1237610|NCT00672646|4059061|P3|Overall Study|Lost to Follow-up|2
1237611|NCT00672646|4059062|P2|Overall Study|Lost to Follow-up|1
1237612|NCT00672646|4059063|P1|Overall Study|Lost to Follow-up|0
1237613|NCT00672633|4059088|P2|Overall Study|Withdrawal by Subject|1
1237614|NCT00672633|4059089|P1|Overall Study|Withdrawal by Subject|0
1237615|NCT00672620|4059103|P4|Overall Study|Reason not Specified|1
1237616|NCT00672620|4059104|P3|Overall Study|Reason not Specified|2
1237617|NCT00672620|4059105|P2|Overall Study|Reason not Specified|3
1237618|NCT00672620|4059106|P1|Overall Study|Reason not Specified|3
1237619|NCT00672620|4059103|P4|Overall Study|Lost to Follow-up|11
1237620|NCT00672620|4059104|P3|Overall Study|Lost to Follow-up|8
1237621|NCT00672620|4059105|P2|Overall Study|Lost to Follow-up|19
1237622|NCT00672620|4059106|P1|Overall Study|Lost to Follow-up|8
1237623|NCT00672620|4059103|P4|Overall Study|Withdrawal of Consent|6
1237624|NCT00672620|4059104|P3|Overall Study|Withdrawal of Consent|5
1237625|NCT00672620|4059105|P2|Overall Study|Withdrawal of Consent|12
1237626|NCT00672620|4059106|P1|Overall Study|Withdrawal of Consent|6
1237627|NCT00672620|4059103|P4|Overall Study|Protocol Deviations|5
1237628|NCT00672620|4059104|P3|Overall Study|Protocol Deviations|2
1237629|NCT00672620|4059105|P2|Overall Study|Protocol Deviations|7
1237630|NCT00672620|4059106|P1|Overall Study|Protocol Deviations|5
1237631|NCT00672620|4059103|P4|Overall Study|Noncompliance with Study Drug|2
1237632|NCT00672620|4059104|P3|Overall Study|Noncompliance with Study Drug|0
1237633|NCT00672620|4059105|P2|Overall Study|Noncompliance with Study Drug|4
1237634|NCT00672620|4059106|P1|Overall Study|Noncompliance with Study Drug|3
1237635|NCT00672620|4059103|P4|Overall Study|Lack of Efficacy|0
1237636|NCT00672620|4059104|P3|Overall Study|Lack of Efficacy|2
1237637|NCT00672620|4059105|P2|Overall Study|Lack of Efficacy|2
1237638|NCT00672620|4059106|P1|Overall Study|Lack of Efficacy|1
1237639|NCT00672620|4059103|P4|Overall Study|Adverse Event|17
1237640|NCT00672620|4059104|P3|Overall Study|Adverse Event|12
1237641|NCT00672620|4059105|P2|Overall Study|Adverse Event|7
1237642|NCT00672620|4059106|P1|Overall Study|Adverse Event|7
1237643|NCT00672555|4059171|P1|Overall Study|Did not want to answer questionnaire|2
1237644|NCT00672555|4059171|P1|Overall Study|Lost to Follow-up|4
1237645|NCT00672490|4059182|P2|Overall Study|No reason was provided|2
1237646|NCT00672490|4059183|P1|Overall Study|No reason was provided|6
1237647|NCT00672490|4059182|P2|Overall Study|Lost to Follow-up|5
1237648|NCT00672490|4059183|P1|Overall Study|Lost to Follow-up|1
1237649|NCT00672490|4059182|P2|Overall Study|Intolerance|2
1237650|NCT00672490|4059183|P1|Overall Study|Intolerance|0
1237651|NCT00672490|4059182|P2|Overall Study|Violation of Concomitant Medicine|0
1237652|NCT00672490|4059183|P1|Overall Study|Violation of Concomitant Medicine|1
1237653|NCT00672490|4059182|P2|Overall Study|Adverse Event|8
1237654|NCT00672490|4059183|P1|Overall Study|Adverse Event|5
1237655|NCT00672490|4059182|P2|Overall Study|Mismatch Include/Exclude Criteria|0
1237656|NCT00672490|4059183|P1|Overall Study|Mismatch Include/Exclude Criteria|1
1237657|NCT00672490|4059182|P2|Overall Study|Lack of Compliance|7
1237658|NCT00672490|4059183|P1|Overall Study|Lack of Compliance|2
1237659|NCT00672490|4059182|P2|Overall Study|Withdrawal by Subject|8
1237660|NCT00672490|4059183|P1|Overall Study|Withdrawal by Subject|8
1237661|NCT00672477|4059207|P2|Overall Study|no study drug for low GFR, health cond.|3
1237662|NCT00672477|4059208|P1|Overall Study|no study drug for low GFR, health cond.|1
1237663|NCT00672477|4059207|P2|Overall Study|Lack of Efficacy|1
1237664|NCT00672477|4059208|P1|Overall Study|Lack of Efficacy|1
1237665|NCT00672477|4059207|P2|Overall Study|Withdrawal by Subject|3
1237666|NCT00672477|4059208|P1|Overall Study|Withdrawal by Subject|5
1237667|NCT00672477|4059207|P2|Overall Study|Protocol Violation|1
1237668|NCT00672477|4059208|P1|Overall Study|Protocol Violation|1
1237669|NCT00672477|4059207|P2|Overall Study|Physician Decision|0
1237670|NCT00672477|4059208|P1|Overall Study|Physician Decision|2
1237671|NCT00672477|4059207|P2|Overall Study|Death|11
1237672|NCT00672477|4059208|P1|Overall Study|Death|7
1237673|NCT00672477|4059207|P2|Overall Study|Adverse Event|7
1237674|NCT00672477|4059208|P1|Overall Study|Adverse Event|10
1237675|NCT00672256|4059261|P1|Overall Study|PI dropped, bad data|44
1237676|NCT00672139|4059286|P2|Overall Study|hospice discharge, caregiver requests|2
1237677|NCT00672139|4059287|P1|Overall Study|hospice discharge, caregiver requests|3
1237678|NCT00672139|4059286|P2|Overall Study|Protocol Violation|1
1237679|NCT00672139|4059287|P1|Overall Study|Protocol Violation|1
1237680|NCT00672139|4059286|P2|Overall Study|Lack of Efficacy|1
1237681|NCT00672139|4059287|P1|Overall Study|Lack of Efficacy|4
1237682|NCT00672139|4059286|P2|Overall Study|Physician Decision|0
1237683|NCT00672139|4059287|P1|Overall Study|Physician Decision|2
1237684|NCT00672139|4059286|P2|Overall Study|Adverse Event|7
1237685|NCT00672139|4059287|P1|Overall Study|Adverse Event|4
1237686|NCT00672139|4059286|P2|Overall Study|Withdrawal by Subject|11
1237687|NCT00672139|4059287|P1|Overall Study|Withdrawal by Subject|2
1237688|NCT00672139|4059286|P2|Overall Study|Death|23
1237689|NCT00672139|4059287|P1|Overall Study|Death|14
1237690|NCT00671931|4059344|P5|Overall Study|Physician Decision|1
1237691|NCT00671931|4059345|P4|Overall Study|Physician Decision|2
1237692|NCT00671931|4059346|P3|Overall Study|Physician Decision|0
1237693|NCT00671931|4059347|P2|Overall Study|Physician Decision|0
1237694|NCT00671931|4059348|P1|Overall Study|Physician Decision|1
1237695|NCT00671879|4059368|P3|Overall Study|Withdrawal by Subject|6
1237696|NCT00671879|4059369|P2|Overall Study|Withdrawal by Subject|4
1237697|NCT00671879|4059370|P1|Overall Study|Withdrawal by Subject|0
1237698|NCT00671853|4059383|P2|Overall Study|Non-adherence with study procedures|4
1237699|NCT00671853|4059384|P1|Overall Study|Non-adherence with study procedures|1
1237700|NCT00671853|4059383|P2|Overall Study|Physician Decision|2
1237701|NCT00671853|4059384|P1|Overall Study|Physician Decision|0
1237702|NCT00671853|4059383|P2|Overall Study|Lost to Follow-up|8
1237703|NCT00671853|4059384|P1|Overall Study|Lost to Follow-up|8
1237704|NCT00671853|4059383|P2|Overall Study|Withdrawal by Subject|5
1237705|NCT00671853|4059384|P1|Overall Study|Withdrawal by Subject|1
1237706|NCT00671853|4059383|P2|Overall Study|Adverse Event|1
1237707|NCT00671853|4059384|P1|Overall Study|Adverse Event|7
1237708|NCT00671853|4059383|P2|Overall Study|Lack of Efficacy|7
1237709|NCT00671853|4059384|P1|Overall Study|Lack of Efficacy|3
1237710|NCT00671788|4059400|P1|Overall Study|Other|1
1237711|NCT00671788|4059400|P1|Overall Study|MD Decision|1
1237712|NCT00671788|4059400|P1|Overall Study|Ineligible|1
1237713|NCT00671788|4059400|P1|Overall Study|Refused further treatment|3
1237714|NCT00671788|4059400|P1|Overall Study|Adverse Event|8
1237715|NCT00671749|4059407|P1|Overall Study|Lost to Follow-up|1
1237716|NCT00671749|4059407|P1|Overall Study|Protocol Violation|1
1237717|NCT00671749|4059407|P1|Overall Study|Withdrawal by Subject|4
1237718|NCT00671749|4059407|P1|Overall Study|Adverse Event|2
1237719|NCT00671554|4059466|P1|Overall Study|Disease progression|3
1237720|NCT00671437|4059505|P1|Overall Study|Ineligible post-hoc|1
1237721|NCT00671437|4059505|P1|Overall Study|Adverse Event|3
1237722|NCT00671437|4059505|P1|Overall Study|Cutaneous SCC of head and neck|3
1237723|NCT00671437|4059505|P1|Overall Study|Progressive disease before C1 week 8|8
1237724|NCT00671060|4059539|P2|Overall Study|Physician Decision|1
1237725|NCT00671060|4059540|P1|Overall Study|Physician Decision|0
1237726|NCT00671060|4059539|P2|Overall Study|Protocol Violation|0
1237727|NCT00671060|4059540|P1|Overall Study|Protocol Violation|1
1237728|NCT00671034|4059549|P3|Overall Study|includes Alternative therapy, etc.|7
1237729|NCT00671034|4059550|P2|Overall Study|includes Alternative therapy, etc.|1
1237730|NCT00671034|4059551|P1|Overall Study|includes Alternative therapy, etc.|6
1237731|NCT00671034|4059549|P3|Overall Study|Refusal|5
1237732|NCT00671034|4059550|P2|Overall Study|Refusal|3
1237733|NCT00671034|4059551|P1|Overall Study|Refusal|5
1237734|NCT00671034|4059549|P3|Overall Study|VHR ALL feature|5
1237735|NCT00671034|4059550|P2|Overall Study|VHR ALL feature|3
1237736|NCT00671034|4059551|P1|Overall Study|VHR ALL feature|8
1237737|NCT00671034|4059549|P3|Overall Study|Physician Decision|5
1237738|NCT00671034|4059550|P2|Overall Study|Physician Decision|4
1237739|NCT00671034|4059551|P1|Overall Study|Physician Decision|12
1237740|NCT00671034|4059549|P3|Overall Study|Death|1
1237741|NCT00671034|4059550|P2|Overall Study|Death|2
1237742|NCT00671034|4059551|P1|Overall Study|Death|3
1237743|NCT00671034|4059549|P3|Overall Study|Adverse Event|1
1237744|NCT00671034|4059550|P2|Overall Study|Adverse Event|7
1237745|NCT00671034|4059551|P1|Overall Study|Adverse Event|5
1237746|NCT00670930|4059606|P2|Overall Study|Lost to Follow-up|0
1237747|NCT00670930|4059607|P1|Overall Study|Lost to Follow-up|1
1237748|NCT00670930|4059606|P2|Overall Study|Adminstrative Problem|1
1237749|NCT00670930|4059607|P1|Overall Study|Adminstrative Problem|0
1237750|NCT00670800|4059623|P2|Overall Study|2 controls were insulin resistant|2
1237751|NCT00670800|4059624|P1|Overall Study|2 controls were insulin resistant|0
1237752|NCT00670748|4059655|P4|Overall Study|Not off study|1
1237753|NCT00670748|4059656|P3|Overall Study|Not off study|1
1237754|NCT00670748|4059657|P2|Overall Study|Not off study|1
1237755|NCT00670748|4059658|P1|Overall Study|Not off study|2
1237756|NCT00670748|4059655|P4|Overall Study|Death during treatment|0
1237757|NCT00670748|4059656|P3|Overall Study|Death during treatment|1
1237758|NCT00670748|4059657|P2|Overall Study|Death during treatment|1
1237759|NCT00670748|4059658|P1|Overall Study|Death during treatment|1
1237760|NCT00670540|4059693|P1|Overall Study|missing information inclusion criteria|1
1237761|NCT00670540|4059693|P1|Overall Study|controls randomised for no follow up|2770
1237762|NCT00670540|4059693|P1|Overall Study|refused to participate|189
1237763|NCT00670540|4059693|P1|Overall Study|not living in France|348
1237764|NCT00670540|4059693|P1|Overall Study|ineligible|17
1237765|NCT00670449|4059738|P4|Overall Study|Abnormal Laboratory Value(s)|0
1237766|NCT00670449|4059739|P3|Overall Study|Abnormal Laboratory Value(s)|0
1237767|NCT00670449|4059740|P2|Overall Study|Abnormal Laboratory Value(s)|2
1237768|NCT00670449|4059741|P1|Overall Study|Abnormal Laboratory Value(s)|0
1237769|NCT00670449|4059738|P4|Overall Study|Unsatisfactory Therapeutic Effect|0
1237770|NCT00670449|4059739|P3|Overall Study|Unsatisfactory Therapeutic Effect|1
1237771|NCT00670449|4059740|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
1237772|NCT00670449|4059741|P1|Overall Study|Unsatisfactory Therapeutic Effect|2
1237773|NCT00670449|4059738|P4|Overall Study|Subject Withdrew Consent|1
1237774|NCT00670449|4059739|P3|Overall Study|Subject Withdrew Consent|0
1237775|NCT00670449|4059740|P2|Overall Study|Subject Withdrew Consent|2
1237776|NCT00670449|4059741|P1|Overall Study|Subject Withdrew Consent|0
1237777|NCT00670449|4059738|P4|Overall Study|Administrative Problems|1
1237778|NCT00670449|4059739|P3|Overall Study|Administrative Problems|0
1237779|NCT00670449|4059740|P2|Overall Study|Administrative Problems|2
1237780|NCT00670449|4059741|P1|Overall Study|Administrative Problems|0
1237781|NCT00670449|4059738|P4|Overall Study|Protocol Deviation|1
1237782|NCT00670449|4059739|P3|Overall Study|Protocol Deviation|0
1237783|NCT00670449|4059740|P2|Overall Study|Protocol Deviation|2
1237784|NCT00670449|4059741|P1|Overall Study|Protocol Deviation|1
1237785|NCT00670449|4059738|P4|Overall Study|Adverse Event|5
1237786|NCT00670449|4059739|P3|Overall Study|Adverse Event|8
1237787|NCT00670449|4059740|P2|Overall Study|Adverse Event|2
1237788|NCT00670449|4059741|P1|Overall Study|Adverse Event|6
1237789|NCT00670306|4059765|P1|Overall Study|incl/excl criterias did not meet|19
1237790|NCT00670306|4059765|P1|Overall Study|Lost to Follow-up|8
1237791|NCT00670306|4059765|P1|Overall Study|Physician Decision|1
1237792|NCT00670306|4059765|P1|Overall Study|Withdrawal by Subject|9
1237793|NCT00670306|4059765|P1|Overall Study|Lack of Efficacy|10
1237794|NCT00670306|4059765|P1|Overall Study|Adverse Event|8
1237795|NCT00670228|4059804|P2|Overall Study|Not meeting the selection criteria|0
1237796|NCT00670228|4059805|P1|Overall Study|Not meeting the selection criteria|2
1237797|NCT00670228|4059804|P2|Overall Study|Not treated|2
1237798|NCT00670228|4059805|P1|Overall Study|Not treated|2
1237799|NCT00670228|4059804|P2|Overall Study|Death or MACE|1
1237800|NCT00670228|4059805|P1|Overall Study|Death or MACE|0
1237801|NCT00670228|4059804|P2|Overall Study|Adverse Event|0
1237802|NCT00670228|4059805|P1|Overall Study|Adverse Event|1
1237803|NCT00670111|4059829|P3|Enrollment to One Month|Physician Decision|0
1237804|NCT00670111|4059830|P2|Enrollment to One Month|Physician Decision|0
1237805|NCT00670111|4059831|P1|Enrollment to One Month|Physician Decision|1
1237806|NCT00670111|4059829|P3|Enrollment to One Month|Ebrolled Patients but not Implanted|6
1237807|NCT00670111|4059830|P2|Enrollment to One Month|Ebrolled Patients but not Implanted|0
1237808|NCT00670111|4059831|P1|Enrollment to One Month|Ebrolled Patients but not Implanted|0
1237809|NCT00670111|4059829|P3|Enrollment to One Month|Testing Failure|13
1237810|NCT00670111|4059830|P2|Enrollment to One Month|Testing Failure|0
1237811|NCT00670111|4059831|P1|Enrollment to One Month|Testing Failure|0
1237812|NCT00670046|4059841|P2|Overall Study|Withdrawal by Subject|1
1237813|NCT00670046|4059842|P1|Overall Study|Withdrawal by Subject|0
1237814|NCT00670046|4059841|P2|Overall Study|Lost to Follow-up|1
1237815|NCT00670046|4059842|P1|Overall Study|Lost to Follow-up|1
1237816|NCT00670007|4059856|P1|Overall Study|Withdrawal by Subject|4
1237817|NCT00670007|4059856|P1|Overall Study|Adverse Event|1
1237818|NCT00670007|4059856|P1|Overall Study|Adverse event, serious fatal|1
1237819|NCT00670007|4059856|P1|Overall Study|Travel/Vacation|1
1237820|NCT00670007|4059856|P1|Overall Study|Lung transplant|1
1237821|NCT00670007|4059856|P1|Overall Study|Drug abuse|1
1237822|NCT00669955|4059883|P2|Overall Study|not compliant with study drug/visit|3
1237823|NCT00669955|4059884|P1|Overall Study|not compliant with study drug/visit|2
1237824|NCT00669955|4059883|P2|Overall Study|Investigator Sponsor Judgement|1
1237825|NCT00669955|4059884|P1|Overall Study|Investigator Sponsor Judgement|0
1237826|NCT00669955|4059883|P2|Overall Study|Protocol Violation|7
1237827|NCT00669955|4059884|P1|Overall Study|Protocol Violation|2
1237828|NCT00669955|4059883|P2|Overall Study|Lost to Follow-up|7
1237829|NCT00669955|4059884|P1|Overall Study|Lost to Follow-up|5
1237830|NCT00669955|4059883|P2|Overall Study|Withdrawal by Subject|3
1237831|NCT00669955|4059884|P1|Overall Study|Withdrawal by Subject|2
1237832|NCT00669955|4059883|P2|Overall Study|Death|1
1237833|NCT00669955|4059884|P1|Overall Study|Death|0
1237834|NCT00669955|4059883|P2|Overall Study|Adverse Event|5
1237835|NCT00669955|4059884|P1|Overall Study|Adverse Event|3
1237836|NCT00669942|4059914|P12|Parts 2 and 3|Protocol Violation|0
1237837|NCT00669942|4059915|P11|Parts 2 and 3|Protocol Violation|0
1237838|NCT00669942|4059916|P10|Parts 2 and 3|Protocol Violation|0
1237839|NCT00669942|4059917|P9|Parts 2 and 3|Protocol Violation|0
1237840|NCT00669942|4059918|P8|Parts 2 and 3|Protocol Violation|0
1237841|NCT00669942|4059919|P7|Parts 2 and 3|Protocol Violation|0
1237842|NCT00669942|4059920|P6|Parts 2 and 3|Protocol Violation|1
1237843|NCT00669942|4059921|P5|Parts 2 and 3|Protocol Violation|0
1237844|NCT00669942|4059922|P4|Parts 2 and 3|Protocol Violation|0
1237845|NCT00669942|4059923|P3|Parts 2 and 3|Protocol Violation|0
1237846|NCT00669942|4059924|P2|Parts 2 and 3|Protocol Violation|0
1237847|NCT00669942|4059925|P1|Parts 2 and 3|Protocol Violation|0
1237848|NCT00669942|4059914|P12|Parts 2 and 3|Withdrawal by Subject|0
1237849|NCT00669942|4059915|P11|Parts 2 and 3|Withdrawal by Subject|0
1237850|NCT00669942|4059916|P10|Parts 2 and 3|Withdrawal by Subject|0
1237851|NCT00669942|4059917|P9|Parts 2 and 3|Withdrawal by Subject|2
1237852|NCT00669942|4059918|P8|Parts 2 and 3|Withdrawal by Subject|0
1237853|NCT00669942|4059919|P7|Parts 2 and 3|Withdrawal by Subject|0
1237854|NCT00669942|4059920|P6|Parts 2 and 3|Withdrawal by Subject|1
1237855|NCT00669942|4059921|P5|Parts 2 and 3|Withdrawal by Subject|0
1237856|NCT00669942|4059922|P4|Parts 2 and 3|Withdrawal by Subject|0
1237857|NCT00669942|4059923|P3|Parts 2 and 3|Withdrawal by Subject|0
1237858|NCT00669942|4059924|P2|Parts 2 and 3|Withdrawal by Subject|0
1237859|NCT00669942|4059925|P1|Parts 2 and 3|Withdrawal by Subject|0
1237860|NCT00669942|4059914|P12|Parts 2 and 3|Adverse Event|0
1237861|NCT00669942|4059915|P11|Parts 2 and 3|Adverse Event|0
1237862|NCT00669942|4059916|P10|Parts 2 and 3|Adverse Event|0
1237863|NCT00669942|4059917|P9|Parts 2 and 3|Adverse Event|1
1237864|NCT00669942|4059918|P8|Parts 2 and 3|Adverse Event|2
1237865|NCT00669942|4059919|P7|Parts 2 and 3|Adverse Event|0
1237866|NCT00669942|4059920|P6|Parts 2 and 3|Adverse Event|0
1237867|NCT00669942|4059921|P5|Parts 2 and 3|Adverse Event|0
1237868|NCT00669942|4059922|P4|Parts 2 and 3|Adverse Event|0
1237869|NCT00669942|4059923|P3|Parts 2 and 3|Adverse Event|0
1237870|NCT00669942|4059924|P2|Parts 2 and 3|Adverse Event|0
1237871|NCT00669942|4059925|P1|Parts 2 and 3|Adverse Event|0
1237872|NCT00669903|4060008|P4|Overall Study|Protocol Violation|0
1237873|NCT00669903|4060009|P3|Overall Study|Protocol Violation|0
1237874|NCT00669903|4060010|P2|Overall Study|Protocol Violation|1
1237875|NCT00669903|4060011|P1|Overall Study|Protocol Violation|0
1237876|NCT00669903|4060008|P4|Overall Study|Lost to Follow-up|1
1237877|NCT00669903|4060009|P3|Overall Study|Lost to Follow-up|0
1237878|NCT00669903|4060010|P2|Overall Study|Lost to Follow-up|1
1237879|NCT00669903|4060011|P1|Overall Study|Lost to Follow-up|1
1237880|NCT00669903|4060008|P4|Overall Study|Withdrawal by Subject|2
1237881|NCT00669903|4060009|P3|Overall Study|Withdrawal by Subject|2
1237882|NCT00669903|4060010|P2|Overall Study|Withdrawal by Subject|2
1237883|NCT00669903|4060011|P1|Overall Study|Withdrawal by Subject|0
1237884|NCT00669903|4060008|P4|Overall Study|Adverse Event|1
1237885|NCT00669903|4060009|P3|Overall Study|Adverse Event|3
1237886|NCT00669903|4060010|P2|Overall Study|Adverse Event|1
1237887|NCT00669903|4060011|P1|Overall Study|Adverse Event|0
1237888|NCT00669877|4060041|P1|Overall Study|Disease Progression/Death|4
1237889|NCT00669864|4060046|P1|Overall Study|Other|2
1237890|NCT00669864|4060046|P1|Overall Study|Withdrawal by Subject|3
1237891|NCT00669864|4060046|P1|Overall Study|Protocol Violation|2
1237892|NCT00669864|4060046|P1|Overall Study|Lost to Follow-up|2
1237893|NCT00669669|4060060|P1|Overall Study|To late to start treatment|1
1237894|NCT00669617|4060065|P5|Period 3|Lost to Follow-up|0
1237895|NCT00669617|4060066|P4|Period 3|Lost to Follow-up|0
1237896|NCT00669617|4060067|P3|Period 3|Lost to Follow-up|0
1237897|NCT00669617|4060068|P2|Period 3|Lost to Follow-up|0
1237898|NCT00669617|4060069|P1|Period 3|Lost to Follow-up|1
1237899|NCT00669617|4060065|P5|Period 1|Protocol Deviation|1
1237900|NCT00669617|4060066|P4|Period 1|Protocol Deviation|0
1237901|NCT00669617|4060067|P3|Period 1|Protocol Deviation|0
1237902|NCT00669617|4060068|P2|Period 1|Protocol Deviation|0
1237903|NCT00669617|4060069|P1|Period 1|Protocol Deviation|0
1237904|NCT00669617|4060065|P5|Period 1|Withdrawal by Subject|0
1237905|NCT00669617|4060066|P4|Period 1|Withdrawal by Subject|0
1237906|NCT00669617|4060067|P3|Period 1|Withdrawal by Subject|1
1237907|NCT00669617|4060068|P2|Period 1|Withdrawal by Subject|0
1237908|NCT00669617|4060069|P1|Period 1|Withdrawal by Subject|0
1237909|NCT00669396|4060117|P2|Overall Study|Lost to Follow-up|12
1237910|NCT00669396|4060118|P1|Overall Study|Lost to Follow-up|10
1237911|NCT00669331|4060132|P2|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
1237912|NCT00669331|4060133|P1|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
1237913|NCT00669331|4060132|P2|Blinded Treatment Period|Physician Decision|3
1237914|NCT00669331|4060133|P1|Blinded Treatment Period|Physician Decision|3
1237915|NCT00669331|4060132|P2|Blinded Treatment Period|Death|2
1237916|NCT00669331|4060133|P1|Blinded Treatment Period|Death|0
1237917|NCT00669331|4060132|P2|Blinded Treatment Period|Lost to Follow-up|2
1237918|NCT00669331|4060133|P1|Blinded Treatment Period|Lost to Follow-up|3
1237919|NCT00669331|4060132|P2|Blinded Treatment Period|Withdrawal by Subject|19
1237920|NCT00669331|4060133|P1|Blinded Treatment Period|Withdrawal by Subject|17
1237921|NCT00669331|4060132|P2|Blinded Treatment Period|Protocol Violation|1
1237922|NCT00669331|4060133|P1|Blinded Treatment Period|Protocol Violation|1
1237923|NCT00669331|4060132|P2|Blinded Treatment Period|Adverse Event|10
1237924|NCT00669331|4060133|P1|Blinded Treatment Period|Adverse Event|16
1237925|NCT00669331|4060132|P2|Randomisation to First Dose|Randomised in error|10
1237926|NCT00669331|4060133|P1|Randomisation to First Dose|Randomised in error|3
1237927|NCT00669331|4060132|P2|Randomisation to First Dose|Sponsor decision|1
1237928|NCT00669331|4060133|P1|Randomisation to First Dose|Sponsor decision|0
1237929|NCT00669331|4060132|P2|Randomisation to First Dose|Death|0
1237930|NCT00669331|4060133|P1|Randomisation to First Dose|Death|1
1237931|NCT00669331|4060132|P2|Randomisation to First Dose|Lost to Follow-up|0
1237932|NCT00669331|4060133|P1|Randomisation to First Dose|Lost to Follow-up|2
1237933|NCT00669331|4060132|P2|Randomisation to First Dose|Withdrawal by Subject|2
1237934|NCT00669331|4060133|P1|Randomisation to First Dose|Withdrawal by Subject|3
1237935|NCT00669331|4060132|P2|Randomisation to First Dose|Protocol Violation|0
1237936|NCT00669331|4060133|P1|Randomisation to First Dose|Protocol Violation|1
1237937|NCT00669331|4060132|P2|Randomisation to First Dose|Adverse Event|0
1237938|NCT00669331|4060133|P1|Randomisation to First Dose|Adverse Event|1
1237939|NCT00669318|4060175|P1|Overall Study|Withdrawal by Subject|2
1237940|NCT00669240|4060192|P1|Overall Study|Enrolled but no dosing record|1
1237941|NCT00669240|4060192|P1|Overall Study|Enrolled but not treated|15
1237942|NCT00669240|4060192|P1|Overall Study|Other|19
1237943|NCT00669240|4060192|P1|Overall Study|Adverse Event|21
1237944|NCT00669240|4060192|P1|Overall Study|Lost to Follow-up|34
1237945|NCT00669240|4060192|P1|Overall Study|Withdrawal by Subject|42
1237946|NCT00669240|4060192|P1|Overall Study|Lack of Efficacy|33
1237947|NCT00669110|4060243|P2|Overall Study|Withdrawal by Subject|2
1237948|NCT00669110|4060244|P1|Overall Study|Withdrawal by Subject|0
1237949|NCT00669110|4060243|P2|Overall Study|Protocol Violation|5
1237950|NCT00669110|4060244|P1|Overall Study|Protocol Violation|0
1237951|NCT00669110|4060243|P2|Overall Study|Lost to Follow-up|0
1237952|NCT00669110|4060244|P1|Overall Study|Lost to Follow-up|1
1237953|NCT00669110|4060243|P2|Overall Study|Physician Decision|1
1237954|NCT00669110|4060244|P1|Overall Study|Physician Decision|0
1237955|NCT00669110|4060243|P2|Overall Study|Caregiver request|2
1237956|NCT00669110|4060244|P1|Overall Study|Caregiver request|3
1237957|NCT00669110|4060243|P2|Overall Study|Adverse Event|3
1237958|NCT00669110|4060244|P1|Overall Study|Adverse Event|4
1237959|NCT00669071|4060280|P1|Overall Study|Final visit 40 days out of window|1
1237960|NCT00669071|4060280|P1|Overall Study|Lost to Follow-up|3
1237961|NCT00669032|4060301|P2|Overall Study|No fulfilment of the selection criteria|5
1237962|NCT00669032|4060302|P1|Overall Study|No fulfilment of the selection criteria|5
1237963|NCT00669032|4060301|P2|Overall Study|Physician Decision|1
1237964|NCT00669032|4060302|P1|Overall Study|Physician Decision|1
1237965|NCT00669032|4060301|P2|Overall Study|Adverse Event|16
1237966|NCT00669032|4060302|P1|Overall Study|Adverse Event|12
1237967|NCT00669032|4060301|P2|Overall Study|Withdrawal by Subject|13
1237968|NCT00669032|4060302|P1|Overall Study|Withdrawal by Subject|12
1237969|NCT00669032|4060301|P2|Overall Study|Lack of Efficacy|19
1237970|NCT00669032|4060302|P1|Overall Study|Lack of Efficacy|8
1237971|NCT00669032|4060301|P2|Overall Study|Lost to Follow-up|5
1237972|NCT00669032|4060302|P1|Overall Study|Lost to Follow-up|6
1237973|NCT00668863|4060348|P1|Overall Study|Physician Decision|1
1237974|NCT00668863|4060348|P1|Overall Study|Subject’s work scheduling problem|1
1237975|NCT00668863|4060348|P1|Overall Study|Surgery|1
1237976|NCT00668863|4060348|P1|Overall Study|Withdrawal by Subject|1
1237977|NCT00668863|4060348|P1|Overall Study|Global Deterioration of Health Status|4
1237978|NCT00668863|4060348|P1|Overall Study|Study Terminated by Sponsor|8
1237979|NCT00668863|4060348|P1|Overall Study|Adverse Event|13
1237980|NCT00668863|4060348|P1|Overall Study|Objective Progression or Relapse|42
1237981|NCT00668746|4060380|P2|Overall Study|Lost to Follow-up|1
1237982|NCT00668746|4060381|P1|Overall Study|Lost to Follow-up|2
1237983|NCT00668733|4060401|P2|Overall Study|Withdrawal by Subject|4
1237984|NCT00668733|4060402|P1|Overall Study|Withdrawal by Subject|0
1237985|NCT00668733|4060401|P2|Overall Study|Lost to Follow-up|3
1237986|NCT00668733|4060402|P1|Overall Study|Lost to Follow-up|2
1237987|NCT00668395|4060447|P3|Overall Study|Physician Decision|0
1237988|NCT00668395|4060448|P2|Overall Study|Physician Decision|1
1237989|NCT00668395|4060449|P1|Overall Study|Physician Decision|1
1237990|NCT00668395|4060447|P3|Overall Study|Adverse Event|0
1237991|NCT00668395|4060448|P2|Overall Study|Adverse Event|1
1237992|NCT00668395|4060449|P1|Overall Study|Adverse Event|1
1237993|NCT00668395|4060447|P3|Overall Study|Withdrawal by Subject|1
1237994|NCT00668395|4060448|P2|Overall Study|Withdrawal by Subject|4
1237995|NCT00668395|4060449|P1|Overall Study|Withdrawal by Subject|4
1237996|NCT00668317|4060461|P1|Overall Study|Adverse Event|2
1237997|NCT00668200|4060476|P1|Overall Study|Lost to Follow-up|1
1237998|NCT00668200|4060476|P1|Overall Study|Withdrawal by Subject|2
1237999|NCT00668148|4060482|P1|Overall Study|Withdrawal of Consent|2
1238000|NCT00668148|4060482|P1|Overall Study|Progressive Disease Before Treatment|2
1238001|NCT00668148|4060482|P1|Overall Study|Subject Non-compliance|1
1238002|NCT00668148|4060482|P1|Overall Study|Adverse Event|5
1238003|NCT00667992|4060521|P2|Third Intervention 100 Mcg Twice Daily|Adverse Event|1
1238004|NCT00667992|4060522|P1|Third Intervention 100 Mcg Twice Daily|Adverse Event|0
1238005|NCT00667992|4060521|P2|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
1238006|NCT00667992|4060522|P1|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1
1238007|NCT00667992|4060521|P2|Wash-out|Withdrawal by Subject|0
1238008|NCT00667992|4060522|P1|Wash-out|Withdrawal by Subject|1
1238009|NCT00667992|4060521|P2|Wash-out|Failure to wash-out|2
1238010|NCT00667992|4060522|P1|Wash-out|Failure to wash-out|2
1238011|NCT00667992|4060521|P2|Wash-out|Not within one doubling dilution|3
1238012|NCT00667992|4060522|P1|Wash-out|Not within one doubling dilution|4
1238013|NCT00667992|4060521|P2|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1
1238014|NCT00667992|4060522|P1|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0
1238015|NCT00667992|4060521|P2|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3
1238016|NCT00667992|4060522|P1|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2
1238017|NCT00667992|4060521|P2|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0
1238018|NCT00667992|4060522|P1|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1
1238019|NCT00667992|4060521|P2|First Intervention 100 Mcg Twice Daily|Adverse Event|1
1238020|NCT00667992|4060522|P1|First Intervention 100 Mcg Twice Daily|Adverse Event|0
1238021|NCT00667992|4060521|P2|First Intervention 100 Mcg Twice Daily|Pregnancy|0
1238022|NCT00667992|4060522|P1|First Intervention 100 Mcg Twice Daily|Pregnancy|1
1238023|NCT00667992|4060521|P2|First Intervention 100 Mcg Twice Daily|Adverse Event|1
1238024|NCT00667992|4060522|P1|First Intervention 100 Mcg Twice Daily|Adverse Event|0
1238025|NCT00667992|4060521|P2|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
1238026|NCT00667992|4060522|P1|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2
1238027|NCT00667992|4060521|P2|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3
1238028|NCT00667992|4060522|P1|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2
1238029|NCT00667875|4060579|P3|Overall Study|Withdrawal by Subject|7
1238030|NCT00667875|4060580|P2|Overall Study|Withdrawal by Subject|9
1238031|NCT00667875|4060581|P1|Overall Study|Withdrawal by Subject|10
1238032|NCT00667875|4060579|P3|Overall Study|Adverse Event|6
1238033|NCT00667875|4060580|P2|Overall Study|Adverse Event|2
1238034|NCT00667875|4060581|P1|Overall Study|Adverse Event|0
1238035|NCT00667810|4060615|P4|Overall Study|Not specified|0
1238036|NCT00667810|4060616|P3|Overall Study|Not specified|5
1238037|NCT00667810|4060617|P2|Overall Study|Not specified|6
1238038|NCT00667810|4060618|P1|Overall Study|Not specified|6
1238039|NCT00667810|4060615|P4|Overall Study|Vasogenic Edema Recurrence|0
1238040|NCT00667810|4060616|P3|Overall Study|Vasogenic Edema Recurrence|0
1238041|NCT00667810|4060617|P2|Overall Study|Vasogenic Edema Recurrence|3
1238042|NCT00667810|4060618|P1|Overall Study|Vasogenic Edema Recurrence|0
1238043|NCT00667810|4060615|P4|Overall Study|Loss of Caregiver|0
1238044|NCT00667810|4060616|P3|Overall Study|Loss of Caregiver|3
1238045|NCT00667810|4060617|P2|Overall Study|Loss of Caregiver|1
1238046|NCT00667810|4060618|P1|Overall Study|Loss of Caregiver|0
1238047|NCT00667810|4060615|P4|Overall Study|Failed to Return|0
1238048|NCT00667810|4060616|P3|Overall Study|Failed to Return|2
1238049|NCT00667810|4060617|P2|Overall Study|Failed to Return|0
1238050|NCT00667810|4060618|P1|Overall Study|Failed to Return|0
1238051|NCT00667810|4060615|P4|Overall Study|Discontinuation of Study by Sponsor|0
1238052|NCT00667810|4060616|P3|Overall Study|Discontinuation of Study by Sponsor|155
1238053|NCT00667810|4060617|P2|Overall Study|Discontinuation of Study by Sponsor|118
1238054|NCT00667810|4060618|P1|Overall Study|Discontinuation of Study by Sponsor|130
1238055|NCT00667810|4060615|P4|Overall Study|Withdrawal by Subject|1
1238056|NCT00667810|4060616|P3|Overall Study|Withdrawal by Subject|29
1238057|NCT00667810|4060617|P2|Overall Study|Withdrawal by Subject|20
1238058|NCT00667810|4060618|P1|Overall Study|Withdrawal by Subject|14
1238059|NCT00667810|4060615|P4|Overall Study|Protocol Violation|0
1238060|NCT00667810|4060616|P3|Overall Study|Protocol Violation|0
1238061|NCT00667810|4060617|P2|Overall Study|Protocol Violation|2
1238062|NCT00667810|4060618|P1|Overall Study|Protocol Violation|0
1238063|NCT00667810|4060615|P4|Overall Study|Physician Decision|0
1238064|NCT00667810|4060616|P3|Overall Study|Physician Decision|2
1238065|NCT00667810|4060617|P2|Overall Study|Physician Decision|1
1238066|NCT00667810|4060618|P1|Overall Study|Physician Decision|1
1238067|NCT00667810|4060615|P4|Overall Study|Lost to Follow-up|0
1238068|NCT00667810|4060616|P3|Overall Study|Lost to Follow-up|2
1238069|NCT00667810|4060617|P2|Overall Study|Lost to Follow-up|4
1238070|NCT00667810|4060618|P1|Overall Study|Lost to Follow-up|1
1238071|NCT00667810|4060615|P4|Overall Study|Lack of Efficacy|0
1238072|NCT00667810|4060616|P3|Overall Study|Lack of Efficacy|2
1238073|NCT00667810|4060617|P2|Overall Study|Lack of Efficacy|0
1238074|NCT00667810|4060618|P1|Overall Study|Lack of Efficacy|1
1238075|NCT00667810|4060615|P4|Overall Study|Death|0
1238076|NCT00667810|4060616|P3|Overall Study|Death|3
1238077|NCT00667810|4060617|P2|Overall Study|Death|1
1238078|NCT00667810|4060618|P1|Overall Study|Death|1
1238079|NCT00667810|4060615|P4|Overall Study|Adverse Event|1
1238080|NCT00667810|4060616|P3|Overall Study|Adverse Event|19
1238081|NCT00667810|4060617|P2|Overall Study|Adverse Event|14
1238082|NCT00667810|4060618|P1|Overall Study|Adverse Event|13
1238083|NCT00667732|4060694|P3|Randomization (24 Weeks)|Withdrawal by Subject|0
1238084|NCT00667732|4060695|P2|Randomization (24 Weeks)|Withdrawal by Subject|1
1238085|NCT00667732|4060696|P1|Randomization (24 Weeks)|Withdrawal by Subject|0
1238086|NCT00667732|4060694|P3|Run -In (8 Weeks)|Withdrawal by Subject|0
1238087|NCT00667732|4060695|P2|Run -In (8 Weeks)|Withdrawal by Subject|0
1238088|NCT00667732|4060696|P1|Run -In (8 Weeks)|Withdrawal by Subject|3
1238089|NCT00667732|4060694|P3|Run -In (8 Weeks)|Adverse Event|0
1238090|NCT00667732|4060695|P2|Run -In (8 Weeks)|Adverse Event|0
1238091|NCT00667732|4060696|P1|Run -In (8 Weeks)|Adverse Event|4
1238092|NCT00667602|4060732|P3|Overall Study|Protocol Violation|0
1238093|NCT00667602|4060733|P2|Overall Study|Protocol Violation|1
1238094|NCT00667602|4060734|P1|Overall Study|Protocol Violation|0
1238095|NCT00667602|4060732|P3|Overall Study|Administrative reason|2
1238096|NCT00667602|4060733|P2|Overall Study|Administrative reason|0
1238097|NCT00667602|4060734|P1|Overall Study|Administrative reason|0
1238098|NCT00667602|4060732|P3|Overall Study|Lost to Follow-up|6
1238099|NCT00667602|4060733|P2|Overall Study|Lost to Follow-up|5
1238100|NCT00667602|4060734|P1|Overall Study|Lost to Follow-up|4
1238101|NCT00667602|4060732|P3|Overall Study|Withdrawal by Subject|10
1238102|NCT00667602|4060733|P2|Overall Study|Withdrawal by Subject|9
1238103|NCT00667602|4060734|P1|Overall Study|Withdrawal by Subject|4
1238104|NCT00667576|4060802|P5|Overall Study|Missed Visit|0
1238105|NCT00667576|4060803|P4|Overall Study|Missed Visit|1
1238106|NCT00667576|4060804|P3|Overall Study|Missed Visit|0
1238107|NCT00667576|4060805|P2|Overall Study|Missed Visit|0
1238108|NCT00667576|4060806|P1|Overall Study|Missed Visit|0
1238109|NCT00667576|4060802|P5|Overall Study|Physician Decision|0
1238110|NCT00667576|4060803|P4|Overall Study|Physician Decision|1
1238111|NCT00667576|4060804|P3|Overall Study|Physician Decision|0
1238112|NCT00667576|4060805|P2|Overall Study|Physician Decision|0
1238113|NCT00667576|4060806|P1|Overall Study|Physician Decision|0
1238114|NCT00667576|4060802|P5|Overall Study|Protocol Violation|0
1238115|NCT00667576|4060803|P4|Overall Study|Protocol Violation|1
1238116|NCT00667576|4060804|P3|Overall Study|Protocol Violation|0
1238117|NCT00667576|4060805|P2|Overall Study|Protocol Violation|0
1238118|NCT00667576|4060806|P1|Overall Study|Protocol Violation|0
1238119|NCT00667576|4060802|P5|Overall Study|Lost to Follow-up|0
1238120|NCT00667576|4060803|P4|Overall Study|Lost to Follow-up|0
1238121|NCT00667576|4060804|P3|Overall Study|Lost to Follow-up|1
1238122|NCT00667576|4060805|P2|Overall Study|Lost to Follow-up|0
1238123|NCT00667576|4060806|P1|Overall Study|Lost to Follow-up|0
1238124|NCT00667576|4060802|P5|Overall Study|Adverse Event|0
1238125|NCT00667576|4060803|P4|Overall Study|Adverse Event|0
1238126|NCT00667576|4060804|P3|Overall Study|Adverse Event|0
1238127|NCT00667576|4060805|P2|Overall Study|Adverse Event|1
1238128|NCT00667576|4060806|P1|Overall Study|Adverse Event|1
1238129|NCT00667576|4060802|P5|Overall Study|Withdrawal by Subject|1
1238130|NCT00667576|4060803|P4|Overall Study|Withdrawal by Subject|1
1238131|NCT00667576|4060804|P3|Overall Study|Withdrawal by Subject|1
1238132|NCT00667576|4060805|P2|Overall Study|Withdrawal by Subject|0
1238133|NCT00667576|4060806|P1|Overall Study|Withdrawal by Subject|1
1238134|NCT00667563|4060853|P1|Overall Study|Protocol Violation|24
1238135|NCT00667459|4060873|P2|Overall Study|Lost to Follow-up|43
1238136|NCT00667459|4060874|P1|Overall Study|Lost to Follow-up|8
1238137|NCT00667459|4060873|P2|Overall Study|Death|2
1238138|NCT00667459|4060874|P1|Overall Study|Death|0
1238139|NCT00667446|4060916|P2|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1
1238140|NCT00667446|4060917|P1|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0
1238141|NCT00667446|4060916|P2|Treatment Period (36 Months)|Therapeutic Failure|1
1238142|NCT00667446|4060917|P1|Treatment Period (36 Months)|Therapeutic Failure|1
1238143|NCT00667446|4060916|P2|Treatment Period (36 Months)|Protocol Violation|1
1238144|NCT00667446|4060917|P1|Treatment Period (36 Months)|Protocol Violation|1
1238145|NCT00667446|4060916|P2|Treatment Period (36 Months)|Lost to Follow-up|0
1238146|NCT00667446|4060917|P1|Treatment Period (36 Months)|Lost to Follow-up|1
1238147|NCT00667446|4060916|P2|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0
1238148|NCT00667446|4060917|P1|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3
1238149|NCT00667446|4060916|P2|Treatment Period (36 Months)|Withdrawal by Subject|4
1238150|NCT00667446|4060917|P1|Treatment Period (36 Months)|Withdrawal by Subject|0
1238151|NCT00667446|4060916|P2|Treatment Period (36 Months)|Personal reasons|2
1238152|NCT00667446|4060917|P1|Treatment Period (36 Months)|Personal reasons|2
1238153|NCT00667446|4060916|P2|Treatment Period (36 Months)|Other|2
1238154|NCT00667446|4060917|P1|Treatment Period (36 Months)|Other|2
1238155|NCT00667446|4060916|P2|Treatment Period (36 Months)|Ready to enter puberty based on age|15
1238156|NCT00667446|4060917|P1|Treatment Period (36 Months)|Ready to enter puberty based on age|13
1238157|NCT00667420|4060939|P1|Overall Study|Withdrawal by Subject|2
1238158|NCT00667420|4060939|P1|Overall Study|Physician Decision|1
1238159|NCT00667420|4060939|P1|Overall Study|Lack of Efficacy|5
1238160|NCT00667420|4060939|P1|Overall Study|Adverse Event|2
1238161|NCT00667394|4060949|P2|Overall Study|Progressive disease|0
1238162|NCT00667394|4060950|P1|Overall Study|Progressive disease|1
1238163|NCT00667394|4060949|P2|Overall Study|Adverse Event|0
1238164|NCT00667394|4060950|P1|Overall Study|Adverse Event|3
1238165|NCT00667368|4060977|P2|Overall Study|Discontinued early|17
1238166|NCT00667368|4060978|P1|Overall Study|Discontinued early|24
1238167|NCT00667368|4060977|P2|Overall Study|Lost to Follow-up|155
1238168|NCT00667368|4060978|P1|Overall Study|Lost to Follow-up|176
1238169|NCT00667355|4060986|P1|Overall Study|Other reason was not specified|5
1238170|NCT00667355|4060986|P1|Overall Study|Lost to Follow-up|1
1238171|NCT00667355|4060986|P1|Overall Study|Adverse Event|5
1238172|NCT00667342|4061011|P3|Overall Study|Ineligible|1
1238173|NCT00667342|4061012|P2|Overall Study|Ineligible|0
1238174|NCT00667342|4061013|P1|Overall Study|Ineligible|0
1238175|NCT00667342|4061011|P3|Overall Study|Adverse Event|1
1238176|NCT00667342|4061012|P2|Overall Study|Adverse Event|0
1238177|NCT00667342|4061013|P1|Overall Study|Adverse Event|0
1238178|NCT00667342|4061011|P3|Overall Study|Relapse or tumor progression|7
1238179|NCT00667342|4061012|P2|Overall Study|Relapse or tumor progression|0
1238180|NCT00667342|4061013|P1|Overall Study|Relapse or tumor progression|9
1238181|NCT00667342|4061011|P3|Overall Study|Physician Decision|0
1238182|NCT00667342|4061012|P2|Overall Study|Physician Decision|0
1238183|NCT00667342|4061013|P1|Overall Study|Physician Decision|3
1238184|NCT00667342|4061011|P3|Overall Study|Withdrawal by Subject|0
1238185|NCT00667342|4061012|P2|Overall Study|Withdrawal by Subject|0
1238186|NCT00667342|4061013|P1|Overall Study|Withdrawal by Subject|1
1238187|NCT00667342|4061011|P3|Overall Study|Protocol Violation|0
1238188|NCT00667342|4061012|P2|Overall Study|Protocol Violation|0
1238189|NCT00667342|4061013|P1|Overall Study|Protocol Violation|1
1238190|NCT00667277|4061051|P1|Overall Study|Withdrawal by Subject|2
1238191|NCT00667251|4061058|P2|Overall Study|Symptomatic progression|2
1238192|NCT00667251|4061059|P1|Overall Study|Symptomatic progression|1
1238193|NCT00667251|4061058|P2|Overall Study|Intercurrent Illness|3
1238194|NCT00667251|4061059|P1|Overall Study|Intercurrent Illness|4
1238195|NCT00667251|4061058|P2|Overall Study|Other/missing|84
1238196|NCT00667251|4061059|P1|Overall Study|Other/missing|46
1238197|NCT00667251|4061058|P2|Overall Study|Withdrawal by Subject|2
1238198|NCT00667251|4061059|P1|Overall Study|Withdrawal by Subject|6
1238199|NCT00667251|4061058|P2|Overall Study|Adverse Event|4
1238200|NCT00667251|4061059|P1|Overall Study|Adverse Event|13
1238201|NCT00667225|4061085|P2|Overall Study|Lost to Follow-up|1
1238202|NCT00667225|4061086|P1|Overall Study|Lost to Follow-up|0
1238203|NCT00667225|4061085|P2|Overall Study|Subject had no more lesions to treat.|0
1238204|NCT00667225|4061086|P1|Overall Study|Subject had no more lesions to treat.|1
1238205|NCT00667095|4061107|P2|Overall Study|Withdrawal by Subject|1
1238206|NCT00667095|4061108|P1|Overall Study|Withdrawal by Subject|0
1238207|NCT00667017|4061124|P1|Overall Study|Withdrawal by Subject|1
1238208|NCT00666965|4061144|P4|Overall Study|Withdrawal by Subject|2
1238209|NCT00666965|4061145|P3|Overall Study|Withdrawal by Subject|0
1238210|NCT00666965|4061146|P2|Overall Study|Withdrawal by Subject|0
1238211|NCT00666965|4061147|P1|Overall Study|Withdrawal by Subject|0
1238212|NCT00666965|4061144|P4|Overall Study|Discontinuation criteria|2
1238213|NCT00666965|4061145|P3|Overall Study|Discontinuation criteria|1
1238214|NCT00666965|4061146|P2|Overall Study|Discontinuation criteria|1
1238215|NCT00666965|4061147|P1|Overall Study|Discontinuation criteria|2
1238216|NCT00666965|4061144|P4|Overall Study|Protocol Violation|2
1238217|NCT00666965|4061145|P3|Overall Study|Protocol Violation|0
1238218|NCT00666965|4061146|P2|Overall Study|Protocol Violation|0
1238219|NCT00666965|4061147|P1|Overall Study|Protocol Violation|0
1238220|NCT00666965|4061144|P4|Overall Study|Lack of Efficacy|0
1238221|NCT00666965|4061145|P3|Overall Study|Lack of Efficacy|0
1238222|NCT00666965|4061146|P2|Overall Study|Lack of Efficacy|1
1238223|NCT00666965|4061147|P1|Overall Study|Lack of Efficacy|1
1238224|NCT00666965|4061144|P4|Overall Study|Adverse Event|9
1238225|NCT00666965|4061145|P3|Overall Study|Adverse Event|1
1238226|NCT00666965|4061146|P2|Overall Study|Adverse Event|2
1238227|NCT00666965|4061147|P1|Overall Study|Adverse Event|0
1238228|NCT00666926|4061177|P16|Overall Study|Death|0
1238229|NCT00666926|4061178|P15|Overall Study|Death|0
1238230|NCT00666926|4061179|P14|Overall Study|Death|0
1238231|NCT00666926|4061180|P13|Overall Study|Death|0
1238232|NCT00666926|4061181|P12|Overall Study|Death|1
1238233|NCT00666926|4061182|P11|Overall Study|Death|0
1238234|NCT00666926|4061183|P10|Overall Study|Death|0
1238235|NCT00666926|4061184|P9|Overall Study|Death|0
1238236|NCT00666926|4061185|P8|Overall Study|Death|0
1238237|NCT00666926|4061186|P7|Overall Study|Death|0
1238238|NCT00666926|4061187|P6|Overall Study|Death|0
1238239|NCT00666926|4061188|P5|Overall Study|Death|0
1238240|NCT00666926|4061189|P4|Overall Study|Death|0
1238241|NCT00666926|4061190|P3|Overall Study|Death|0
1238242|NCT00666926|4061191|P2|Overall Study|Death|0
1238243|NCT00666926|4061192|P1|Overall Study|Death|0
1238244|NCT00666926|4061177|P16|Overall Study|Withdrawal by Subject|3
1238245|NCT00666926|4061178|P15|Overall Study|Withdrawal by Subject|3
1238246|NCT00666926|4061179|P14|Overall Study|Withdrawal by Subject|1
1238247|NCT00666926|4061180|P13|Overall Study|Withdrawal by Subject|0
1238248|NCT00666926|4061181|P12|Overall Study|Withdrawal by Subject|3
1238249|NCT00666926|4061182|P11|Overall Study|Withdrawal by Subject|0
1238250|NCT00666926|4061183|P10|Overall Study|Withdrawal by Subject|3
1238251|NCT00666926|4061184|P9|Overall Study|Withdrawal by Subject|0
1238252|NCT00666926|4061185|P8|Overall Study|Withdrawal by Subject|1
1238253|NCT00666926|4061186|P7|Overall Study|Withdrawal by Subject|0
1238254|NCT00666926|4061187|P6|Overall Study|Withdrawal by Subject|0
1238255|NCT00666926|4061188|P5|Overall Study|Withdrawal by Subject|0
1238256|NCT00666926|4061189|P4|Overall Study|Withdrawal by Subject|0
1238257|NCT00666926|4061190|P3|Overall Study|Withdrawal by Subject|0
1238258|NCT00666926|4061191|P2|Overall Study|Withdrawal by Subject|0
1238259|NCT00666926|4061192|P1|Overall Study|Withdrawal by Subject|0
1238260|NCT00666926|4061177|P16|Overall Study|Other|4
1238261|NCT00666926|4061178|P15|Overall Study|Other|4
1238262|NCT00666926|4061179|P14|Overall Study|Other|2
1238263|NCT00666926|4061180|P13|Overall Study|Other|3
1238264|NCT00666926|4061181|P12|Overall Study|Other|26
1238265|NCT00666926|4061182|P11|Overall Study|Other|3
1238266|NCT00666926|4061183|P10|Overall Study|Other|5
1238267|NCT00666926|4061184|P9|Overall Study|Other|3
1238268|NCT00666926|4061185|P8|Overall Study|Other|0
1238269|NCT00666926|4061186|P7|Overall Study|Other|4
1238270|NCT00666926|4061187|P6|Overall Study|Other|3
1238271|NCT00666926|4061188|P5|Overall Study|Other|3
1238272|NCT00666926|4061189|P4|Overall Study|Other|3
1238273|NCT00666926|4061190|P3|Overall Study|Other|3
1238274|NCT00666926|4061191|P2|Overall Study|Other|4
1238275|NCT00666926|4061192|P1|Overall Study|Other|2
1238276|NCT00666926|4061177|P16|Overall Study|Lost to Follow-up|0
1238277|NCT00666926|4061178|P15|Overall Study|Lost to Follow-up|0
1238278|NCT00666926|4061179|P14|Overall Study|Lost to Follow-up|0
1238279|NCT00666926|4061180|P13|Overall Study|Lost to Follow-up|0
1238280|NCT00666926|4061181|P12|Overall Study|Lost to Follow-up|0
1238281|NCT00666926|4061182|P11|Overall Study|Lost to Follow-up|0
1238282|NCT00666926|4061183|P10|Overall Study|Lost to Follow-up|0
1238283|NCT00666926|4061184|P9|Overall Study|Lost to Follow-up|0
1238284|NCT00666926|4061185|P8|Overall Study|Lost to Follow-up|0
1238285|NCT00666926|4061186|P7|Overall Study|Lost to Follow-up|0
1238286|NCT00666926|4061187|P6|Overall Study|Lost to Follow-up|0
1238287|NCT00666926|4061188|P5|Overall Study|Lost to Follow-up|0
1238288|NCT00666926|4061189|P4|Overall Study|Lost to Follow-up|1
1238289|NCT00666926|4061190|P3|Overall Study|Lost to Follow-up|0
1238290|NCT00666926|4061191|P2|Overall Study|Lost to Follow-up|0
1238291|NCT00666926|4061192|P1|Overall Study|Lost to Follow-up|0
1238292|NCT00666926|4061177|P16|Overall Study|Lack of Efficacy|0
1238293|NCT00666926|4061178|P15|Overall Study|Lack of Efficacy|0
1238294|NCT00666926|4061179|P14|Overall Study|Lack of Efficacy|0
1238295|NCT00666926|4061180|P13|Overall Study|Lack of Efficacy|0
1238296|NCT00666926|4061181|P12|Overall Study|Lack of Efficacy|1
1238297|NCT00666926|4061182|P11|Overall Study|Lack of Efficacy|0
1238298|NCT00666926|4061183|P10|Overall Study|Lack of Efficacy|0
1238299|NCT00666926|4061184|P9|Overall Study|Lack of Efficacy|0
1238300|NCT00666926|4061185|P8|Overall Study|Lack of Efficacy|0
1238301|NCT00666926|4061186|P7|Overall Study|Lack of Efficacy|0
1238302|NCT00666926|4061187|P6|Overall Study|Lack of Efficacy|1
1238303|NCT00666926|4061188|P5|Overall Study|Lack of Efficacy|0
1238304|NCT00666926|4061189|P4|Overall Study|Lack of Efficacy|0
1238305|NCT00666926|4061190|P3|Overall Study|Lack of Efficacy|0
1238306|NCT00666926|4061191|P2|Overall Study|Lack of Efficacy|0
1238307|NCT00666926|4061192|P1|Overall Study|Lack of Efficacy|0
1238308|NCT00666926|4061177|P16|Overall Study|Laboratory abnormality|1
1238309|NCT00666926|4061178|P15|Overall Study|Laboratory abnormality|0
1238310|NCT00666926|4061179|P14|Overall Study|Laboratory abnormality|0
1238311|NCT00666926|4061180|P13|Overall Study|Laboratory abnormality|0
1238312|NCT00666926|4061181|P12|Overall Study|Laboratory abnormality|0
1238313|NCT00666926|4061182|P11|Overall Study|Laboratory abnormality|1
1238314|NCT00666926|4061183|P10|Overall Study|Laboratory abnormality|0
1238315|NCT00666926|4061184|P9|Overall Study|Laboratory abnormality|0
1238316|NCT00666926|4061185|P8|Overall Study|Laboratory abnormality|0
1238317|NCT00666926|4061186|P7|Overall Study|Laboratory abnormality|0
1238318|NCT00666926|4061187|P6|Overall Study|Laboratory abnormality|0
1238319|NCT00666926|4061188|P5|Overall Study|Laboratory abnormality|0
1238320|NCT00666926|4061189|P4|Overall Study|Laboratory abnormality|0
1238321|NCT00666926|4061190|P3|Overall Study|Laboratory abnormality|0
1238322|NCT00666926|4061191|P2|Overall Study|Laboratory abnormality|0
1238323|NCT00666926|4061192|P1|Overall Study|Laboratory abnormality|0
1238324|NCT00666926|4061177|P16|Overall Study|Adverse Event|0
1238325|NCT00666926|4061178|P15|Overall Study|Adverse Event|0
1238326|NCT00666926|4061179|P14|Overall Study|Adverse Event|1
1238327|NCT00666926|4061180|P13|Overall Study|Adverse Event|0
1238328|NCT00666926|4061181|P12|Overall Study|Adverse Event|2
1238329|NCT00666926|4061182|P11|Overall Study|Adverse Event|2
1238330|NCT00666926|4061183|P10|Overall Study|Adverse Event|2
1238331|NCT00666926|4061184|P9|Overall Study|Adverse Event|0
1238332|NCT00666926|4061185|P8|Overall Study|Adverse Event|0
1238333|NCT00666926|4061186|P7|Overall Study|Adverse Event|0
1238334|NCT00666926|4061187|P6|Overall Study|Adverse Event|0
1238335|NCT00666926|4061188|P5|Overall Study|Adverse Event|0
1238336|NCT00666926|4061189|P4|Overall Study|Adverse Event|0
1238337|NCT00666926|4061190|P3|Overall Study|Adverse Event|0
1238338|NCT00666926|4061191|P2|Overall Study|Adverse Event|0
1238339|NCT00666926|4061192|P1|Overall Study|Adverse Event|0
1238340|NCT00666835|4061501|P2|Overall Study|Physician Decision|2
1238341|NCT00666835|4061502|P1|Overall Study|Physician Decision|1
1238342|NCT00666835|4061501|P2|Overall Study|Planned operation|0
1238343|NCT00666835|4061502|P1|Overall Study|Planned operation|2
1238344|NCT00666835|4061501|P2|Overall Study|Hemoglobulin concentration|3
1238345|NCT00666835|4061502|P1|Overall Study|Hemoglobulin concentration|4
1238346|NCT00666835|4061501|P2|Overall Study|Kidney Transplantation (NTX)|2
1238347|NCT00666835|4061502|P1|Overall Study|Kidney Transplantation (NTX)|10
1238348|NCT00666835|4061501|P2|Overall Study|Death|4
1238349|NCT00666835|4061502|P1|Overall Study|Death|15
1238350|NCT00666835|4061501|P2|Overall Study|Protocol Violation|0
1238351|NCT00666835|4061502|P1|Overall Study|Protocol Violation|2
1238352|NCT00666835|4061501|P2|Overall Study|Adverse Event|6
1238353|NCT00666835|4061502|P1|Overall Study|Adverse Event|7
1238354|NCT00666835|4061501|P2|Overall Study|Incl./excl. not fulfilled|2
1238355|NCT00666835|4061502|P1|Overall Study|Incl./excl. not fulfilled|7
1238356|NCT00666835|4061501|P2|Overall Study|Lack of Efficacy|1
1238357|NCT00666835|4061502|P1|Overall Study|Lack of Efficacy|0
1238358|NCT00666835|4061501|P2|Overall Study|Withdrawal by Subject|2
1238359|NCT00666835|4061502|P1|Overall Study|Withdrawal by Subject|5
1238360|NCT00666757|4061512|P2|Overall Study|Sponsor decision|1
1238361|NCT00666757|4061513|P1|Overall Study|Sponsor decision|0
1238362|NCT00666757|4061512|P2|Overall Study|Physician Decision|2
1238363|NCT00666757|4061513|P1|Overall Study|Physician Decision|0
1238364|NCT00666757|4061512|P2|Overall Study|Lack of Efficacy|6
1238365|NCT00666757|4061513|P1|Overall Study|Lack of Efficacy|3
1238366|NCT00666757|4061512|P2|Overall Study|Withdrawal by Subject|17
1238367|NCT00666757|4061513|P1|Overall Study|Withdrawal by Subject|13
1238368|NCT00666757|4061512|P2|Overall Study|Adverse Event|12
1238369|NCT00666757|4061513|P1|Overall Study|Adverse Event|22
1238370|NCT00666757|4061512|P2|Overall Study|Protocol Violation|24
1238371|NCT00666757|4061513|P1|Overall Study|Protocol Violation|23
1238372|NCT00666757|4061512|P2|Overall Study|Lost to Follow-up|35
1238373|NCT00666757|4061513|P1|Overall Study|Lost to Follow-up|39
1238374|NCT00666718|4061572|P2|Overall Study|Physician Decision|2
1238375|NCT00666718|4061573|P1|Overall Study|Physician Decision|0
1238376|NCT00666718|4061572|P2|Overall Study|Withdrawal by Subject|12
1238377|NCT00666718|4061573|P1|Overall Study|Withdrawal by Subject|7
1238378|NCT00666718|4061572|P2|Overall Study|Protocol Violation|3
1238379|NCT00666718|4061573|P1|Overall Study|Protocol Violation|1
1238380|NCT00666718|4061572|P2|Overall Study|Entry Criteria Not Met|0
1238381|NCT00666718|4061573|P1|Overall Study|Entry Criteria Not Met|2
1238382|NCT00666718|4061572|P2|Overall Study|Lost to Follow-up|0
1238383|NCT00666718|4061573|P1|Overall Study|Lost to Follow-up|1
1238384|NCT00666718|4061572|P2|Overall Study|Death|0
1238385|NCT00666718|4061573|P1|Overall Study|Death|1
1238386|NCT00666718|4061572|P2|Overall Study|Adverse Event|1
1238387|NCT00666718|4061573|P1|Overall Study|Adverse Event|0
1238388|NCT00666705|4061599|P1|Overall Study|Withdrawal by Subject|1
1238389|NCT00666679|4061618|P2|Second Intervention|Death|1
1238390|NCT00666679|4061619|P1|Second Intervention|Death|0
1238391|NCT00666679|4061618|P2|Second Intervention|Adverse Event|0
1238392|NCT00666679|4061619|P1|Second Intervention|Adverse Event|1
1238393|NCT00666679|4061618|P2|Washout Period of 1 Week|Protocol Violation|1
1238394|NCT00666679|4061619|P1|Washout Period of 1 Week|Protocol Violation|0
1238395|NCT00666679|4061618|P2|Washout Period of 1 Week|Lost to Follow-up|1
1238396|NCT00666679|4061619|P1|Washout Period of 1 Week|Lost to Follow-up|0
1238397|NCT00666679|4061618|P2|First Intervention|Randomized did not start treatment|1
1238398|NCT00666679|4061619|P1|First Intervention|Randomized did not start treatment|1
1238399|NCT00666679|4061618|P2|First Intervention|Withdrawal by Subject|0
1238400|NCT00666679|4061619|P1|First Intervention|Withdrawal by Subject|1
1238401|NCT00666679|4061618|P2|First Intervention|Protocol Violation|0
1238402|NCT00666679|4061619|P1|First Intervention|Protocol Violation|1
1238403|NCT00666679|4061618|P2|First Intervention|Lost to Follow-up|0
1238404|NCT00666679|4061619|P1|First Intervention|Lost to Follow-up|1
1238405|NCT00666588|4061649|P4|Overall Study|inevaluable|0
1238406|NCT00666588|4061650|P3|Overall Study|inevaluable|0
1238407|NCT00666588|4061651|P2|Overall Study|inevaluable|0
1238408|NCT00666588|4061652|P1|Overall Study|inevaluable|2
1238409|NCT00666588|4061649|P4|Overall Study|ineligible|2
1238410|NCT00666588|4061650|P3|Overall Study|ineligible|0
1238411|NCT00666588|4061651|P2|Overall Study|ineligible|0
1238412|NCT00666588|4061652|P1|Overall Study|ineligible|2
1238413|NCT00666562|4061685|P3|Overall Study|Concomitant Medication|0
1238414|NCT00666562|4061686|P2|Overall Study|Concomitant Medication|1
1238415|NCT00666562|4061687|P1|Overall Study|Concomitant Medication|0
1238416|NCT00666562|4061685|P3|Overall Study|Withdrawal by Subject|0
1238417|NCT00666562|4061686|P2|Overall Study|Withdrawal by Subject|1
1238418|NCT00666562|4061687|P1|Overall Study|Withdrawal by Subject|0
1238419|NCT00666536|4061734|P2|Overall Study|Lost to Follow-up|3
1238420|NCT00666536|4061735|P1|Overall Study|Lost to Follow-up|4
1238421|NCT00666536|4061734|P2|Overall Study|Withdrawal by Subject|9
1238422|NCT00666536|4061735|P1|Overall Study|Withdrawal by Subject|10
1238423|NCT00666536|4061734|P2|Overall Study|Protocol deviation(s)|6
1238424|NCT00666536|4061735|P1|Overall Study|Protocol deviation(s)|8
1238425|NCT00666536|4061734|P2|Overall Study|Unsatisfactory therapeutic effect|0
1238426|NCT00666536|4061735|P1|Overall Study|Unsatisfactory therapeutic effect|2
1238427|NCT00666536|4061734|P2|Overall Study|Adverse Event|19
1238428|NCT00666536|4061735|P1|Overall Study|Adverse Event|9
1238429|NCT00666458|4061753|P2|Overall Study|Medical history of anemia|0
1238430|NCT00666458|4061754|P1|Overall Study|Medical history of anemia|1
1238431|NCT00666458|4061753|P2|Overall Study|Safety reasons|0
1238432|NCT00666458|4061754|P1|Overall Study|Safety reasons|1
1238433|NCT00666458|4061753|P2|Overall Study|Severe non-compliance to the protocol|1
1238434|NCT00666458|4061754|P1|Overall Study|Severe non-compliance to the protocol|1
1238435|NCT00666458|4061753|P2|Overall Study|Study specific discontinuation criteria|7
1238436|NCT00666458|4061754|P1|Overall Study|Study specific discontinuation criteria|14
1238437|NCT00666458|4061753|P2|Overall Study|Incorrect enrollment|1
1238438|NCT00666458|4061754|P1|Overall Study|Incorrect enrollment|7
1238439|NCT00666458|4061753|P2|Overall Study|Administrative reason by sponsor|1
1238440|NCT00666458|4061754|P1|Overall Study|Administrative reason by sponsor|1
1238441|NCT00666458|4061753|P2|Overall Study|Lost to Follow-up|3
1238442|NCT00666458|4061754|P1|Overall Study|Lost to Follow-up|0
1238443|NCT00666458|4061753|P2|Overall Study|Withdrawal by Subject|4
1238444|NCT00666458|4061754|P1|Overall Study|Withdrawal by Subject|5
1238445|NCT00666458|4061753|P2|Overall Study|Adverse Event|7
1238446|NCT00666458|4061754|P1|Overall Study|Adverse Event|8
1238447|NCT00666328|4061842|P1|Overall Study|No longer met eligibility criteria|1
1238448|NCT00666328|4061842|P1|Overall Study|Lost to Follow-up|2
1238449|NCT00666328|4061842|P1|Overall Study|Death|2
1238450|NCT00666276|4061855|P1|Overall Study|Protocol Violation|34
1238451|NCT00666263|4061879|P2|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1
1238452|NCT00666263|4061880|P1|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0
1238453|NCT00666263|4061879|P2|Study Part 4 (Cross-over Period 2)|Adverse Event|0
1238454|NCT00666263|4061880|P1|Study Part 4 (Cross-over Period 2)|Adverse Event|1
1238455|NCT00666263|4061879|P2|Study Part 1 (Stabilization Phase 1)|Adverse Event|1
1238456|NCT00666263|4061880|P1|Study Part 1 (Stabilization Phase 1)|Adverse Event|0
1238457|NCT00666224|4062024|P2|Open-Label|Undefined/Unknown|1
1238458|NCT00666224|4062025|P1|Open-Label|Undefined/Unknown|1
1238459|NCT00666224|4062024|P2|Open-Label|Noncompliance|1
1238460|NCT00666224|4062025|P1|Open-Label|Noncompliance|2
1238461|NCT00666224|4062024|P2|Open-Label|Pregnancy|5
1238462|NCT00666224|4062025|P1|Open-Label|Pregnancy|1
1238463|NCT00666224|4062024|P2|Open-Label|Physician Decision|5
1238464|NCT00666224|4062025|P1|Open-Label|Physician Decision|7
1238465|NCT00666224|4062024|P2|Open-Label|Withdrawal by Subject|25
1238466|NCT00666224|4062025|P1|Open-Label|Withdrawal by Subject|12
1238467|NCT00666224|4062024|P2|Open-Label|Lost to Follow-up|5
1238468|NCT00666224|4062025|P1|Open-Label|Lost to Follow-up|4
1238469|NCT00666224|4062024|P2|Open-Label|Adverse Event|43
1238470|NCT00666224|4062025|P1|Open-Label|Adverse Event|8
1238471|NCT00666224|4062024|P2|Double-Blind|Undefined/Unknown|1
1238472|NCT00666224|4062025|P1|Double-Blind|Undefined/Unknown|4
1238473|NCT00666224|4062024|P2|Double-Blind|Death|0
1238474|NCT00666224|4062025|P1|Double-Blind|Death|1
1238475|NCT00666224|4062024|P2|Double-Blind|Noncompliance|0
1238476|NCT00666224|4062025|P1|Double-Blind|Noncompliance|1
1238477|NCT00666224|4062024|P2|Double-Blind|Pregnancy|2
1238478|NCT00666224|4062025|P1|Double-Blind|Pregnancy|3
1238479|NCT00666224|4062024|P2|Double-Blind|Sponsor decision|0
1238480|NCT00666224|4062025|P1|Double-Blind|Sponsor decision|1
1238481|NCT00666224|4062024|P2|Double-Blind|Physician Decision|3
1238482|NCT00666224|4062025|P1|Double-Blind|Physician Decision|0
1238483|NCT00666224|4062024|P2|Double-Blind|Withdrawal by Subject|14
1238484|NCT00666224|4062025|P1|Double-Blind|Withdrawal by Subject|18
1238485|NCT00666224|4062024|P2|Double-Blind|Lost to Follow-up|2
1238486|NCT00666224|4062025|P1|Double-Blind|Lost to Follow-up|2
1238487|NCT00666224|4062024|P2|Double-Blind|Adverse Event|5
1238488|NCT00666224|4062025|P1|Double-Blind|Adverse Event|15
1238489|NCT00666211|4062044|P2|Overall Study|Physician Decision|1
1238490|NCT00666211|4062045|P1|Overall Study|Physician Decision|0
1238491|NCT00666211|4062044|P2|Overall Study|off tx for other complicating disease|1
1238492|NCT00666211|4062045|P1|Overall Study|off tx for other complicating disease|0
1238493|NCT00666211|4062044|P2|Overall Study|Death|2
1238494|NCT00666211|4062045|P1|Overall Study|Death|0
1238495|NCT00666211|4062044|P2|Overall Study|hospital admission|5
1238496|NCT00666211|4062045|P1|Overall Study|hospital admission|0
1238497|NCT00666211|4062044|P2|Overall Study|toxicity|2
1238498|NCT00666211|4062045|P1|Overall Study|toxicity|0
1238499|NCT00666211|4062044|P2|Overall Study|Lost to Follow-up|0
1238500|NCT00666211|4062045|P1|Overall Study|Lost to Follow-up|2
1238501|NCT00666211|4062044|P2|Overall Study|disease progression|8
1238502|NCT00666211|4062045|P1|Overall Study|disease progression|1
1238503|NCT00666211|4062044|P2|Overall Study|patient non-compliant|6
1238504|NCT00666211|4062045|P1|Overall Study|patient non-compliant|6
1238505|NCT00666211|4062044|P2|Overall Study|went off medication, no more pain|0
1238506|NCT00666211|4062045|P1|Overall Study|went off medication, no more pain|1
1238507|NCT00666211|4062044|P2|Overall Study|Withdrawal by Subject|13
1238508|NCT00666211|4062045|P1|Overall Study|Withdrawal by Subject|10
1238509|NCT00666198|4062063|P1|Overall Study|No Drug Administration|4
1238510|NCT00666198|4062063|P1|Overall Study|Safety Not Assessable|6
1238511|NCT00666198|4062063|P1|Overall Study|No Visit After First Day of Treatment|13
1238512|NCT00666198|4062063|P1|Overall Study|Protocol Violation|10
1238513|NCT00665925|4062091|P4|Overall Study|Due to exclusion criteria|0
1238514|NCT00665925|4062092|P3|Overall Study|Due to exclusion criteria|0
1238515|NCT00665925|4062093|P2|Overall Study|Due to exclusion criteria|0
1238516|NCT00665925|4062094|P1|Overall Study|Due to exclusion criteria|1
1238517|NCT00665925|4062091|P4|Overall Study|Enrolled by mistake|1
1238518|NCT00665925|4062092|P3|Overall Study|Enrolled by mistake|0
1238519|NCT00665925|4062093|P2|Overall Study|Enrolled by mistake|0
1238520|NCT00665925|4062094|P1|Overall Study|Enrolled by mistake|0
1238521|NCT00665925|4062091|P4|Overall Study|Adverse Event|5
1238522|NCT00665925|4062092|P3|Overall Study|Adverse Event|10
1238523|NCT00665925|4062093|P2|Overall Study|Adverse Event|5
1238524|NCT00665925|4062094|P1|Overall Study|Adverse Event|1
1238525|NCT00665925|4062091|P4|Overall Study|Severe Non-Compliance to Protocol|1
1238526|NCT00665925|4062092|P3|Overall Study|Severe Non-Compliance to Protocol|1
1238527|NCT00665925|4062093|P2|Overall Study|Severe Non-Compliance to Protocol|0
1238528|NCT00665925|4062094|P1|Overall Study|Severe Non-Compliance to Protocol|0
1238529|NCT00665925|4062091|P4|Overall Study|Physician Decision|2
1238530|NCT00665925|4062092|P3|Overall Study|Physician Decision|1
1238531|NCT00665925|4062093|P2|Overall Study|Physician Decision|0
1238532|NCT00665925|4062094|P1|Overall Study|Physician Decision|0
1238533|NCT00665925|4062091|P4|Overall Study|Withdrawal by Subject|2
1238534|NCT00665925|4062092|P3|Overall Study|Withdrawal by Subject|3
1238535|NCT00665925|4062093|P2|Overall Study|Withdrawal by Subject|2
1238536|NCT00665925|4062094|P1|Overall Study|Withdrawal by Subject|2
1238537|NCT00665925|4062091|P4|Overall Study|Lost to Follow-up|2
1238538|NCT00665925|4062092|P3|Overall Study|Lost to Follow-up|2
1238539|NCT00665925|4062093|P2|Overall Study|Lost to Follow-up|2
1238540|NCT00665925|4062094|P1|Overall Study|Lost to Follow-up|1
1238541|NCT00665925|4062091|P4|Overall Study|Lack of Efficacy|8
1238542|NCT00665925|4062092|P3|Overall Study|Lack of Efficacy|9
1238543|NCT00665925|4062093|P2|Overall Study|Lack of Efficacy|8
1238544|NCT00665925|4062094|P1|Overall Study|Lack of Efficacy|10
1238545|NCT00665847|4062505|P1|Overall Study|Switch to Commercial Medication|1
1238546|NCT00665847|4062505|P1|Overall Study|Subject ineligible to continue the trial|1
1238547|NCT00665847|4062505|P1|Overall Study|Resistance to TMC125|1
1238548|NCT00665847|4062505|P1|Overall Study|Subject reached a virologic endpoint|4
1238549|NCT00665847|4062505|P1|Overall Study|Subject non-compliant|8
1238550|NCT00665847|4062505|P1|Overall Study|Withdrawal by Subject|2
1238551|NCT00665847|4062505|P1|Overall Study|Adverse Event|8
1238552|NCT00665652|4062522|P1|Overall Study|No longer met inclusion criteria.|1
1238553|NCT00665652|4062522|P1|Overall Study|Death|1
1238554|NCT00665652|4062522|P1|Overall Study|Adverse Event|4
1238555|NCT00665626|4062528|P2|Overall Study|Death|0
1238556|NCT00665626|4062529|P1|Overall Study|Death|1
1238557|NCT00665626|4062528|P2|Overall Study|Unably to comply with dosing regimen|1
1238558|NCT00665626|4062529|P1|Overall Study|Unably to comply with dosing regimen|0
1238559|NCT00665626|4062528|P2|Overall Study|Did not fulfil inclusion criteria|1
1238560|NCT00665626|4062529|P1|Overall Study|Did not fulfil inclusion criteria|0
1238561|NCT00665626|4062528|P2|Overall Study|Due to exclusion criteria|1
1238562|NCT00665626|4062529|P1|Overall Study|Due to exclusion criteria|0
1238563|NCT00665626|4062528|P2|Overall Study|Adverse Event|9
1238564|NCT00665626|4062529|P1|Overall Study|Adverse Event|1
1238565|NCT00665626|4062528|P2|Overall Study|Protocol Violation|2
1238566|NCT00665626|4062529|P1|Overall Study|Protocol Violation|0
1238567|NCT00665626|4062528|P2|Overall Study|Withdrawal by Subject|1
1238568|NCT00665626|4062529|P1|Overall Study|Withdrawal by Subject|0
1238569|NCT00665626|4062528|P2|Overall Study|Lost to Follow-up|2
1238570|NCT00665626|4062529|P1|Overall Study|Lost to Follow-up|0
1238571|NCT00665626|4062528|P2|Overall Study|Lack of Efficacy|5
1238572|NCT00665626|4062529|P1|Overall Study|Lack of Efficacy|8
1238573|NCT00665444|4062611|P1|Overall Study|Study Terminated by Study Sponsor|1
1238574|NCT00665444|4062611|P1|Overall Study|Physician Decision|1
1238575|NCT00665431|4062623|P3|Overall Study|Other|2
1238576|NCT00665431|4062624|P2|Overall Study|Other|7
1238577|NCT00665431|4062625|P1|Overall Study|Other|4
1238578|NCT00665431|4062623|P3|Overall Study|Lost to Follow-up|1
1238579|NCT00665431|4062624|P2|Overall Study|Lost to Follow-up|3
1238580|NCT00665431|4062625|P1|Overall Study|Lost to Follow-up|3
1238581|NCT00665431|4062623|P3|Overall Study|Withdrawal by Subject|15
1238582|NCT00665431|4062624|P2|Overall Study|Withdrawal by Subject|25
1238583|NCT00665431|4062625|P1|Overall Study|Withdrawal by Subject|17
1238584|NCT00665431|4062623|P3|Overall Study|Adverse Event|6
1238585|NCT00665431|4062624|P2|Overall Study|Adverse Event|22
1238586|NCT00665431|4062625|P1|Overall Study|Adverse Event|16
1238587|NCT00665366|4062668|P2|Overall Study|Other reasons|1
1238588|NCT00665366|4062669|P1|Overall Study|Other reasons|4
1238589|NCT00665366|4062668|P2|Overall Study|No longer meets study criteria|1
1238590|NCT00665366|4062669|P1|Overall Study|No longer meets study criteria|0
1238591|NCT00665366|4062668|P2|Overall Study|Pregnancy|0
1238592|NCT00665366|4062669|P1|Overall Study|Pregnancy|1
1238593|NCT00665366|4062668|P2|Overall Study|Poor compliance/noncompliance|5
1238594|NCT00665366|4062669|P1|Overall Study|Poor compliance/noncompliance|3
1238595|NCT00665366|4062668|P2|Overall Study|Lost to Follow-up|5
1238596|NCT00665366|4062669|P1|Overall Study|Lost to Follow-up|3
1238597|NCT00665366|4062668|P2|Overall Study|Withdrawal by Subject|14
1238598|NCT00665366|4062669|P1|Overall Study|Withdrawal by Subject|11
1238599|NCT00665366|4062668|P2|Overall Study|Adverse Event|23
1238600|NCT00665366|4062669|P1|Overall Study|Adverse Event|25
1238601|NCT00665366|4062668|P2|Overall Study|Lack of Efficacy|10
1238602|NCT00665366|4062669|P1|Overall Study|Lack of Efficacy|11
1238603|NCT00665353|4062697|P1|Study Step 2|Lack of Efficacy|12
1238604|NCT00665353|4062697|P1|Study Step 2|Lost to Follow-up|2
1238605|NCT00665353|4062697|P1|Study Step 1|Withdrawal by Subject|2
1238606|NCT00665353|4062697|P1|Study Step 1|Adverse Event|1
1238607|NCT00665002|4062714|P1|Overall Study|Cytogenetic resistance|1
1238608|NCT00665002|4062714|P1|Overall Study|Progression/relapse during treatment|11
1238609|NCT00664742|4062728|P1|Overall Study|Lost to Follow-up|92
1238610|NCT00664742|4062728|P1|Overall Study|Withdrawal by Subject|31
1238611|NCT00664742|4062728|P1|Overall Study|Withdrawn due to adverse events|3
1238612|NCT00664560|4062736|P3|Overall Study|Other|5
1238613|NCT00664560|4062737|P2|Overall Study|Other|4
1238614|NCT00664560|4062738|P1|Overall Study|Other|11
1238615|NCT00664560|4062736|P3|Overall Study|Lost to Follow-up|0
1238616|NCT00664560|4062737|P2|Overall Study|Lost to Follow-up|2
1238617|NCT00664560|4062738|P1|Overall Study|Lost to Follow-up|0
1238618|NCT00664560|4062736|P3|Overall Study|Withdrawal by Subject|7
1238619|NCT00664560|4062737|P2|Overall Study|Withdrawal by Subject|13
1238620|NCT00664560|4062738|P1|Overall Study|Withdrawal by Subject|9
1238621|NCT00664560|4062736|P3|Overall Study|Adverse Event|7
1238622|NCT00664560|4062737|P2|Overall Study|Adverse Event|16
1238623|NCT00664560|4062738|P1|Overall Study|Adverse Event|19
1238624|NCT00664534|4062781|P2|Overall Study|Sponsor decision|6
1238625|NCT00664534|4062782|P1|Overall Study|Sponsor decision|8
1238626|NCT00664534|4062781|P2|Overall Study|Physician Decision|0
1238627|NCT00664534|4062782|P1|Overall Study|Physician Decision|8
1238628|NCT00664534|4062781|P2|Overall Study|Withdrawal by Subject|6
1238629|NCT00664534|4062782|P1|Overall Study|Withdrawal by Subject|7
1238630|NCT00664534|4062781|P2|Overall Study|Protocol Violation|8
1238631|NCT00664534|4062782|P1|Overall Study|Protocol Violation|10
1238632|NCT00664534|4062781|P2|Overall Study|Lost to Follow-up|10
1238633|NCT00664534|4062782|P1|Overall Study|Lost to Follow-up|6
1238634|NCT00664534|4062781|P2|Overall Study|Adverse Event|3
1238635|NCT00664534|4062782|P1|Overall Study|Adverse Event|2
1238636|NCT00664521|4062810|P2|Overall Study|Other|0
1238637|NCT00664521|4062811|P1|Overall Study|Other|1
1238638|NCT00664521|4062810|P2|Overall Study|Lost to Follow-up|0
1238639|NCT00664521|4062811|P1|Overall Study|Lost to Follow-up|1
1238640|NCT00664521|4062810|P2|Overall Study|Adverse Event|1
1238641|NCT00664521|4062811|P1|Overall Study|Adverse Event|4
1238642|NCT00664326|4062837|P1|Overall Study|ongoing with treatment|6
1238643|NCT00664326|4062837|P1|Overall Study|Physician Decision|1
1238644|NCT00664326|4062837|P1|Overall Study|Withdrawal by Subject|1
1238645|NCT00664326|4062837|P1|Overall Study|Noncompliance with study medication|3
1238646|NCT00664326|4062837|P1|Overall Study|Adverse Event|13
1238647|NCT00664209|4062856|P1|Study Treatment Period|Withdrawal by Subject|2
1238648|NCT00664209|4062856|P1|Study Treatment Period|Physician Decision|4
1238649|NCT00664209|4062856|P1|Motor Fluctuations Screen|Negative for motor fluctuation|7
1238650|NCT00664105|4062864|P1|Overall Study|Disease progression|7
1238651|NCT00664105|4062864|P1|Overall Study|Adverse Event|9
1238652|NCT00664105|4062864|P1|Overall Study|Withdrawal by Subject|5
1238653|NCT00664105|4062864|P1|Overall Study|Death|3
1238654|NCT00664066|4062871|P1|Overall Study|Study terminated|3
1238655|NCT00663962|4062877|P2|Overall Study|somnolence|0
1238656|NCT00663962|4062878|P1|Overall Study|somnolence|1
1238657|NCT00663923|4062884|P1|Overall Study|Lost to Follow-up|2
1238658|NCT00663858|4062901|P3|Overall Study|Other|4
1238659|NCT00663858|4062902|P2|Overall Study|Other|2
1238660|NCT00663858|4062903|P1|Overall Study|Other|8
1238661|NCT00663858|4062901|P3|Overall Study|Protocol Violation|4
1238662|NCT00663858|4062902|P2|Overall Study|Protocol Violation|3
1238663|NCT00663858|4062903|P1|Overall Study|Protocol Violation|5
1238664|NCT00663858|4062901|P3|Overall Study|Withdrawal by Subject|3
1238665|NCT00663858|4062902|P2|Overall Study|Withdrawal by Subject|3
1238666|NCT00663858|4062903|P1|Overall Study|Withdrawal by Subject|7
1238667|NCT00663858|4062901|P3|Overall Study|Lack of Efficacy|3
1238668|NCT00663858|4062902|P2|Overall Study|Lack of Efficacy|1
1238669|NCT00663858|4062903|P1|Overall Study|Lack of Efficacy|5
1238670|NCT00663858|4062901|P3|Overall Study|Adverse Event|6
1238671|NCT00663858|4062902|P2|Overall Study|Adverse Event|1
1238672|NCT00663858|4062903|P1|Overall Study|Adverse Event|9
1238673|NCT00663702|4062941|P2|Overall Study|Lack of Efficacy|3
1238674|NCT00663702|4062942|P1|Overall Study|Lack of Efficacy|3
1238675|NCT00663702|4062941|P2|Overall Study|Death|1
1238676|NCT00663702|4062942|P1|Overall Study|Death|1
1238677|NCT00663702|4062941|P2|Overall Study|Lost to Follow-up|0
1238678|NCT00663702|4062942|P1|Overall Study|Lost to Follow-up|3
1238679|NCT00663702|4062941|P2|Overall Study|Pregnancy|1
1238680|NCT00663702|4062942|P1|Overall Study|Pregnancy|0
1238681|NCT00663702|4062941|P2|Overall Study|Withdrawal by Subject|1
1238682|NCT00663702|4062942|P1|Overall Study|Withdrawal by Subject|3
1238683|NCT00663702|4062941|P2|Overall Study|Adverse Event|4
1238684|NCT00663702|4062942|P1|Overall Study|Adverse Event|8
1238685|NCT00663260|4062978|P3|Overall Study|non-compliance, not met criteria, etc.|3
1238686|NCT00663260|4062979|P2|Overall Study|non-compliance, not met criteria, etc.|2
1238687|NCT00663260|4062980|P1|Overall Study|non-compliance, not met criteria, etc.|3
1238688|NCT00663260|4062978|P3|Overall Study|Lost to Follow-up|0
1238689|NCT00663260|4062979|P2|Overall Study|Lost to Follow-up|1
1238690|NCT00663260|4062980|P1|Overall Study|Lost to Follow-up|0
1238691|NCT00663260|4062978|P3|Overall Study|Death|1
1238692|NCT00663260|4062979|P2|Overall Study|Death|0
1238693|NCT00663260|4062980|P1|Overall Study|Death|1
1238694|NCT00663260|4062978|P3|Overall Study|Withdrawal by Subject|6
1238695|NCT00663260|4062979|P2|Overall Study|Withdrawal by Subject|1
1238696|NCT00663260|4062980|P1|Overall Study|Withdrawal by Subject|3
1238697|NCT00663260|4062978|P3|Overall Study|Adverse Event|6
1238698|NCT00663260|4062979|P2|Overall Study|Adverse Event|7
1238699|NCT00663260|4062980|P1|Overall Study|Adverse Event|12
1238700|NCT00663260|4062978|P3|Overall Study|Lack of Efficacy|0
1238701|NCT00663260|4062979|P2|Overall Study|Lack of Efficacy|0
1238702|NCT00663260|4062980|P1|Overall Study|Lack of Efficacy|2
1238703|NCT00663234|4062994|P1|Overall Study|Not willing to adhere to requirements|1
1238704|NCT00663208|4063027|P7|Follow-up Period|Other reason|1
1238705|NCT00663208|4063028|P6|Follow-up Period|Other reason|0
1238706|NCT00663208|4063029|P5|Follow-up Period|Other reason|0
1238707|NCT00663208|4063030|P4|Follow-up Period|Other reason|0
1238708|NCT00663208|4063031|P3|Follow-up Period|Other reason|0
1238709|NCT00663208|4063032|P2|Follow-up Period|Other reason|0
1238710|NCT00663208|4063033|P1|Follow-up Period|Other reason|1
1238711|NCT00663208|4063027|P7|Follow-up Period|Lost to Follow-up|0
1238712|NCT00663208|4063028|P6|Follow-up Period|Lost to Follow-up|0
1238713|NCT00663208|4063029|P5|Follow-up Period|Lost to Follow-up|0
1238714|NCT00663208|4063030|P4|Follow-up Period|Lost to Follow-up|2
1238715|NCT00663208|4063031|P3|Follow-up Period|Lost to Follow-up|3
1238716|NCT00663208|4063032|P2|Follow-up Period|Lost to Follow-up|0
1238717|NCT00663208|4063033|P1|Follow-up Period|Lost to Follow-up|2
1238718|NCT00663208|4063027|P7|Treatment Period|Lost to Follow-up|0
1238719|NCT00663208|4063028|P6|Treatment Period|Lost to Follow-up|0
1238720|NCT00663208|4063029|P5|Treatment Period|Lost to Follow-up|0
1238721|NCT00663208|4063030|P4|Treatment Period|Lost to Follow-up|0
1238722|NCT00663208|4063031|P3|Treatment Period|Lost to Follow-up|0
1238723|NCT00663208|4063032|P2|Treatment Period|Lost to Follow-up|1
1238724|NCT00663208|4063033|P1|Treatment Period|Lost to Follow-up|0
1238725|NCT00663117|4063211|P2|Overall Study|Lack of Efficacy|0
1238726|NCT00663117|4063212|P1|Overall Study|Lack of Efficacy|1
1238727|NCT00663052|4063226|P2|Overall Study|Other|1
1238728|NCT00663052|4063227|P1|Overall Study|Other|0
1238729|NCT00663052|4063226|P2|Overall Study|Unsatisfactory Response - Efficacy|1
1238730|NCT00663052|4063227|P1|Overall Study|Unsatisfactory Response - Efficacy|1
1238731|NCT00663052|4063226|P2|Overall Study|Withdrawal by Subject|5
1238732|NCT00663052|4063227|P1|Overall Study|Withdrawal by Subject|2
1238733|NCT00663052|4063226|P2|Overall Study|Protocol Violation|0
1238734|NCT00663052|4063227|P1|Overall Study|Protocol Violation|1
1238735|NCT00663052|4063226|P2|Overall Study|Discontinuation of Study by Sponsor|0
1238736|NCT00663052|4063227|P1|Overall Study|Discontinuation of Study by Sponsor|2
1238737|NCT00663052|4063226|P2|Overall Study|Adverse Event|3
1238738|NCT00663052|4063227|P1|Overall Study|Adverse Event|6
1238739|NCT00663026|4063333|P3|Overall Study|Withdrawal by Subject|1
1238740|NCT00663026|4063334|P2|Overall Study|Withdrawal by Subject|0
1238741|NCT00663026|4063335|P1|Overall Study|Withdrawal by Subject|0
1238742|NCT00663026|4063333|P3|Overall Study|Caregiver Request|0
1238743|NCT00663026|4063334|P2|Overall Study|Caregiver Request|2
1238744|NCT00663026|4063335|P1|Overall Study|Caregiver Request|0
1238745|NCT00663026|4063333|P3|Overall Study|Adverse Event|3
1238746|NCT00663026|4063334|P2|Overall Study|Adverse Event|2
1238747|NCT00663026|4063335|P1|Overall Study|Adverse Event|0
1238748|NCT00663026|4063333|P3|Overall Study|Other|0
1238749|NCT00663026|4063334|P2|Overall Study|Other|2
1238750|NCT00663026|4063335|P1|Overall Study|Other|1
1238751|NCT00663026|4063333|P3|Overall Study|Lost to Follow-up|0
1238752|NCT00663026|4063334|P2|Overall Study|Lost to Follow-up|0
1238753|NCT00663026|4063335|P1|Overall Study|Lost to Follow-up|1
1238754|NCT00662909|4063358|P3|Overall Study|Eligibility criterion not met|1
1238755|NCT00662909|4063359|P2|Overall Study|Eligibility criterion not met|1
1238756|NCT00662909|4063360|P1|Overall Study|Eligibility criterion not met|0
1238757|NCT00662909|4063358|P3|Overall Study|Physician Decision|2
1238758|NCT00662909|4063359|P2|Overall Study|Physician Decision|1
1238759|NCT00662909|4063360|P1|Overall Study|Physician Decision|1
1238760|NCT00662909|4063358|P3|Overall Study|Non-compliance with study procedures|2
1238761|NCT00662909|4063359|P2|Overall Study|Non-compliance with study procedures|3
1238762|NCT00662909|4063360|P1|Overall Study|Non-compliance with study procedures|3
1238763|NCT00662909|4063358|P3|Overall Study|Randomized- never received study drug|0
1238764|NCT00662909|4063359|P2|Overall Study|Randomized- never received study drug|0
1238765|NCT00662909|4063360|P1|Overall Study|Randomized- never received study drug|1
1238766|NCT00662909|4063358|P3|Overall Study|Protocol Violation|5
1238767|NCT00662909|4063359|P2|Overall Study|Protocol Violation|4
1238768|NCT00662909|4063360|P1|Overall Study|Protocol Violation|7
1238769|NCT00662909|4063358|P3|Overall Study|Lost to Follow-up|3
1238770|NCT00662909|4063359|P2|Overall Study|Lost to Follow-up|9
1238771|NCT00662909|4063360|P1|Overall Study|Lost to Follow-up|2
1238772|NCT00662909|4063358|P3|Overall Study|Withdrawal by Subject|16
1238773|NCT00662909|4063359|P2|Overall Study|Withdrawal by Subject|22
1238774|NCT00662909|4063360|P1|Overall Study|Withdrawal by Subject|29
1238775|NCT00662909|4063358|P3|Overall Study|Lack of Efficacy|5
1238776|NCT00662909|4063359|P2|Overall Study|Lack of Efficacy|1
1238777|NCT00662909|4063360|P1|Overall Study|Lack of Efficacy|9
1238778|NCT00662909|4063358|P3|Overall Study|Adverse Event|19
1238779|NCT00662909|4063359|P2|Overall Study|Adverse Event|18
1238780|NCT00662909|4063360|P1|Overall Study|Adverse Event|17
1238781|NCT00662857|4063458|P2|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0
1238782|NCT00662857|4063459|P1|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1
1238783|NCT00662857|4063458|P2|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1
1238784|NCT00662857|4063459|P1|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0
1238785|NCT00662857|4063458|P2|Washout 1 (3 - 14 Days)|Physician Decision|1
1238786|NCT00662857|4063459|P1|Washout 1 (3 - 14 Days)|Physician Decision|0
1238787|NCT00662831|4063474|P2|Overall Study|Adverse Event|16
1238788|NCT00662831|4063475|P1|Overall Study|Adverse Event|23
1238789|NCT00662831|4063474|P2|Overall Study|Protocol Violation|4
1238790|NCT00662831|4063475|P1|Overall Study|Protocol Violation|8
1238791|NCT00662831|4063474|P2|Overall Study|Other|31
1238792|NCT00662831|4063475|P1|Overall Study|Other|62
1238793|NCT00662831|4063474|P2|Overall Study|Withdrawal by Subject|1
1238794|NCT00662831|4063475|P1|Overall Study|Withdrawal by Subject|2
1238795|NCT00662831|4063474|P2|Overall Study|Lost to Follow-up|0
1238796|NCT00662831|4063475|P1|Overall Study|Lost to Follow-up|1
1238797|NCT00662831|4063474|P2|Overall Study|Lack of Efficacy|6
1238798|NCT00662831|4063475|P1|Overall Study|Lack of Efficacy|6
1238799|NCT00662831|4063474|P2|Overall Study|Death|1
1238800|NCT00662831|4063475|P1|Overall Study|Death|4
1238801|NCT00662649|4063555|P5|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
1238802|NCT00662649|4063556|P4|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
1238803|NCT00662649|4063557|P3|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0
1238804|NCT00662649|4063558|P2|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
1238805|NCT00662649|4063559|P1|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
1238806|NCT00662649|4063555|P5|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
1238807|NCT00662649|4063556|P4|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
1238808|NCT00662649|4063557|P3|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
1238809|NCT00662649|4063558|P2|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1
1238810|NCT00662649|4063559|P1|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
1238811|NCT00662649|4063555|P5|Extension Study (Month 24 to 60)|Subject withdrew consent|9
1238812|NCT00662649|4063556|P4|Extension Study (Month 24 to 60)|Subject withdrew consent|15
1238813|NCT00662649|4063557|P3|Extension Study (Month 24 to 60)|Subject withdrew consent|0
1238814|NCT00662649|4063558|P2|Extension Study (Month 24 to 60)|Subject withdrew consent|23
1238815|NCT00662649|4063559|P1|Extension Study (Month 24 to 60)|Subject withdrew consent|19
1238816|NCT00662649|4063555|P5|Extension Study (Month 24 to 60)|Protocol Violation|0
1238817|NCT00662649|4063556|P4|Extension Study (Month 24 to 60)|Protocol Violation|0
1238818|NCT00662649|4063557|P3|Extension Study (Month 24 to 60)|Protocol Violation|0
1238819|NCT00662649|4063558|P2|Extension Study (Month 24 to 60)|Protocol Violation|1
1238820|NCT00662649|4063559|P1|Extension Study (Month 24 to 60)|Protocol Violation|1
1238821|NCT00662649|4063555|P5|Extension Study (Month 24 to 60)|Lost to Follow-up|1
1238822|NCT00662649|4063556|P4|Extension Study (Month 24 to 60)|Lost to Follow-up|1
1238823|NCT00662649|4063557|P3|Extension Study (Month 24 to 60)|Lost to Follow-up|0
1238824|NCT00662649|4063558|P2|Extension Study (Month 24 to 60)|Lost to Follow-up|0
1238825|NCT00662649|4063559|P1|Extension Study (Month 24 to 60)|Lost to Follow-up|2
1238826|NCT00662649|4063555|P5|Extension Study (Month 24 to 60)|Adverse Event|10
1238827|NCT00662649|4063556|P4|Extension Study (Month 24 to 60)|Adverse Event|6
1238828|NCT00662649|4063557|P3|Extension Study (Month 24 to 60)|Adverse Event|0
1238829|NCT00662649|4063558|P2|Extension Study (Month 24 to 60)|Adverse Event|9
1238830|NCT00662649|4063559|P1|Extension Study (Month 24 to 60)|Adverse Event|6
1238831|NCT00662649|4063555|P5|Extension Study (Month 24 to 60)|Administrative problems|0
1238832|NCT00662649|4063556|P4|Extension Study (Month 24 to 60)|Administrative problems|1
1238833|NCT00662649|4063557|P3|Extension Study (Month 24 to 60)|Administrative problems|0
1238834|NCT00662649|4063558|P2|Extension Study (Month 24 to 60)|Administrative problems|0
1238835|NCT00662649|4063559|P1|Extension Study (Month 24 to 60)|Administrative problems|0
1238836|NCT00662649|4063555|P5|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
1238837|NCT00662649|4063556|P4|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
1238838|NCT00662649|4063557|P3|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0
1238839|NCT00662649|4063558|P2|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
1238840|NCT00662649|4063559|P1|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
1238841|NCT00662649|4063555|P5|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3
1238842|NCT00662649|4063556|P4|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8
1238843|NCT00662649|4063557|P3|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0
1238844|NCT00662649|4063558|P2|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5
1238845|NCT00662649|4063559|P1|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10
1238846|NCT00662649|4063555|P5|Core Study (24 Months)|Death|0
1238847|NCT00662649|4063556|P4|Core Study (24 Months)|Death|0
1238848|NCT00662649|4063557|P3|Core Study (24 Months)|Death|2
1238849|NCT00662649|4063558|P2|Core Study (24 Months)|Death|0
1238850|NCT00662649|4063559|P1|Core Study (24 Months)|Death|1
1238851|NCT00662649|4063555|P5|Core Study (24 Months)|Abnormal test procedure result(s)|0
1238852|NCT00662649|4063556|P4|Core Study (24 Months)|Abnormal test procedure result(s)|0
1238853|NCT00662649|4063557|P3|Core Study (24 Months)|Abnormal test procedure result(s)|1
1238854|NCT00662649|4063558|P2|Core Study (24 Months)|Abnormal test procedure result(s)|1
1238855|NCT00662649|4063559|P1|Core Study (24 Months)|Abnormal test procedure result(s)|2
1238856|NCT00662649|4063555|P5|Core Study (24 Months)|Protocol Violation|0
1238857|NCT00662649|4063556|P4|Core Study (24 Months)|Protocol Violation|0
1238858|NCT00662649|4063557|P3|Core Study (24 Months)|Protocol Violation|4
1238859|NCT00662649|4063558|P2|Core Study (24 Months)|Protocol Violation|5
1238860|NCT00662649|4063559|P1|Core Study (24 Months)|Protocol Violation|5
1238861|NCT00662649|4063555|P5|Core Study (24 Months)|Lost to Follow-up|0
1238862|NCT00662649|4063556|P4|Core Study (24 Months)|Lost to Follow-up|0
1238863|NCT00662649|4063557|P3|Core Study (24 Months)|Lost to Follow-up|7
1238864|NCT00662649|4063558|P2|Core Study (24 Months)|Lost to Follow-up|5
1238865|NCT00662649|4063559|P1|Core Study (24 Months)|Lost to Follow-up|3
1238866|NCT00662649|4063555|P5|Core Study (24 Months)|Abnormal laboratory value(s)|0
1238867|NCT00662649|4063556|P4|Core Study (24 Months)|Abnormal laboratory value(s)|0
1238868|NCT00662649|4063557|P3|Core Study (24 Months)|Abnormal laboratory value(s)|1
1238869|NCT00662649|4063558|P2|Core Study (24 Months)|Abnormal laboratory value(s)|9
1238870|NCT00662649|4063559|P1|Core Study (24 Months)|Abnormal laboratory value(s)|20
1238871|NCT00662649|4063555|P5|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
1238872|NCT00662649|4063556|P4|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
1238873|NCT00662649|4063557|P3|Core Study (24 Months)|Unsatisfactory therapeutic effect|25
1238874|NCT00662649|4063558|P2|Core Study (24 Months)|Unsatisfactory therapeutic effect|6
1238875|NCT00662649|4063559|P1|Core Study (24 Months)|Unsatisfactory therapeutic effect|13
1238876|NCT00662649|4063555|P5|Core Study (24 Months)|Adverse Event|0
1238877|NCT00662649|4063556|P4|Core Study (24 Months)|Adverse Event|0
1238878|NCT00662649|4063557|P3|Core Study (24 Months)|Adverse Event|18
1238879|NCT00662649|4063558|P2|Core Study (24 Months)|Adverse Event|13
1238880|NCT00662649|4063559|P1|Core Study (24 Months)|Adverse Event|22
1238881|NCT00662649|4063555|P5|Core Study (24 Months)|Withdrawal by Subject|0
1238882|NCT00662649|4063556|P4|Core Study (24 Months)|Withdrawal by Subject|0
1238883|NCT00662649|4063557|P3|Core Study (24 Months)|Withdrawal by Subject|28
1238884|NCT00662649|4063558|P2|Core Study (24 Months)|Withdrawal by Subject|17
1238885|NCT00662649|4063559|P1|Core Study (24 Months)|Withdrawal by Subject|31
1238886|NCT00662558|4063599|P2|Overall Study|Randomized But Did Not Receive Treatment|8
1238887|NCT00662558|4063600|P1|Overall Study|Randomized But Did Not Receive Treatment|2
1238888|NCT00662558|4063599|P2|Overall Study|Withdrawal by Subject|12
1238889|NCT00662558|4063600|P1|Overall Study|Withdrawal by Subject|7
1238890|NCT00662558|4063599|P2|Overall Study|Other|14
1238891|NCT00662558|4063600|P1|Overall Study|Other|9
1238892|NCT00662558|4063599|P2|Overall Study|Lost to Follow-up|10
1238893|NCT00662558|4063600|P1|Overall Study|Lost to Follow-up|13
1238894|NCT00662558|4063599|P2|Overall Study|Lack of Efficacy|7
1238895|NCT00662558|4063600|P1|Overall Study|Lack of Efficacy|4
1238896|NCT00662558|4063599|P2|Overall Study|Adverse Event|59
1238897|NCT00662558|4063600|P1|Overall Study|Adverse Event|21
1238898|NCT00662532|4063651|P2|Overall Study|Lost to Follow-up|1
1238899|NCT00662532|4063652|P1|Overall Study|Lost to Follow-up|0
1238900|NCT00662532|4063651|P2|Overall Study|Adverse Event|1
1238901|NCT00662532|4063652|P1|Overall Study|Adverse Event|0
1238902|NCT00662363|4063667|P2|Overall Study|Protocol Violation|1
1238903|NCT00662363|4063668|P1|Overall Study|Protocol Violation|1
1238904|NCT00662363|4063667|P2|Overall Study|Discharged early from rehab|1
1238905|NCT00662363|4063668|P1|Overall Study|Discharged early from rehab|4
1238906|NCT00662363|4063667|P2|Overall Study|Adverse Event|3
1238907|NCT00662363|4063668|P1|Overall Study|Adverse Event|0
1238908|NCT00662363|4063667|P2|Overall Study|Withdrawal by Subject|5
1238909|NCT00662363|4063668|P1|Overall Study|Withdrawal by Subject|6
1238910|NCT00662311|4063679|P3|Overall Study|Respiratory Infection|0
1238911|NCT00662311|4063680|P2|Overall Study|Respiratory Infection|0
1238912|NCT00662311|4063681|P1|Overall Study|Respiratory Infection|1
1238913|NCT00662129|4063732|P1|Overall Study|Ineligible|1
1238914|NCT00662129|4063732|P1|Overall Study|Cancel prior to beginning treatment|1
1238915|NCT00662129|4063732|P1|Overall Study|Protocol Violation|1
1238916|NCT00662038|4063742|P1|Overall Study|Continued treatment|5
1238917|NCT00662038|4063742|P1|Overall Study|Adverse Event|358
1238918|NCT00662038|4063742|P1|Overall Study|Death|95
1238919|NCT00662038|4063742|P1|Overall Study|Lost to Follow-up|1
1238920|NCT00662038|4063742|P1|Overall Study|Lung transplantation|44
1238921|NCT00662038|4063742|P1|Overall Study|Physician Decision|19
1238922|NCT00662038|4063742|P1|Overall Study|Sponsor decision|1
1238923|NCT00662038|4063742|P1|Overall Study|Withdrawal by Subject|83
1238924|NCT00662038|4063742|P1|Overall Study|Withdrawn consent|22
1238925|NCT00662038|4063742|P1|Overall Study|Reason not specified|3
1238926|NCT00662025|4063746|P1|Overall Study|Domestic circumstances|1
1238927|NCT00662025|4063746|P1|Overall Study|Target lesion cannot be evaluated|1
1238928|NCT00662025|4063746|P1|Overall Study|Results of other clinical study|2
1238929|NCT00662025|4063746|P1|Overall Study|Withdrawal by Subject|1
1238930|NCT00662025|4063746|P1|Overall Study|Adverse Event|7
1238931|NCT00662025|4063746|P1|Overall Study|Objective progression or relapse|51
1238932|NCT00662012|4063766|P1|Overall Study|Withdrawal by Subject|1
1238933|NCT00662012|4063766|P1|Overall Study|Death|1
1238934|NCT00662012|4063766|P1|Overall Study|Lost to Follow-up|85
1238935|NCT00661999|4063774|P3|Overall Study|Other Medical Problems|9
1238936|NCT00661999|4063775|P2|Overall Study|Other Medical Problems|4
1238937|NCT00661999|4063776|P1|Overall Study|Other Medical Problems|4
1238938|NCT00661999|4063774|P3|Overall Study|Alternative Treatment|0
1238939|NCT00661999|4063775|P2|Overall Study|Alternative Treatment|0
1238940|NCT00661999|4063776|P1|Overall Study|Alternative Treatment|1
1238941|NCT00661999|4063774|P3|Overall Study|Withdrawal by Subject|14
1238942|NCT00661999|4063775|P2|Overall Study|Withdrawal by Subject|23
1238943|NCT00661999|4063776|P1|Overall Study|Withdrawal by Subject|30
1238944|NCT00661999|4063774|P3|Overall Study|Other Reasons|23
1238945|NCT00661999|4063775|P2|Overall Study|Other Reasons|12
1238946|NCT00661999|4063776|P1|Overall Study|Other Reasons|5
1238947|NCT00661999|4063774|P3|Overall Study|Death|3
1238948|NCT00661999|4063775|P2|Overall Study|Death|6
1238949|NCT00661999|4063776|P1|Overall Study|Death|8
1238950|NCT00661999|4063774|P3|Overall Study|Adverse Event|8
1238951|NCT00661999|4063775|P2|Overall Study|Adverse Event|5
1238952|NCT00661999|4063776|P1|Overall Study|Adverse Event|11
1238953|NCT00661830|4063853|P2|Overall Study|Other reason|5
1238954|NCT00661830|4063854|P1|Overall Study|Other reason|1
1238955|NCT00661830|4063853|P2|Overall Study|Withdrawal by Subject|1
1238956|NCT00661830|4063854|P1|Overall Study|Withdrawal by Subject|1
1238957|NCT00661830|4063853|P2|Overall Study|Lost to Follow-up|3
1238958|NCT00661830|4063854|P1|Overall Study|Lost to Follow-up|1
1238959|NCT00661830|4063853|P2|Overall Study|Death|33
1238960|NCT00661830|4063854|P1|Overall Study|Death|37
1238961|NCT00661778|4063866|P1|Overall Study|Withdrawal of Consent|1
1238962|NCT00661778|4063866|P1|Overall Study|Protocol Violation|2
1238963|NCT00661778|4063866|P1|Overall Study|Reason not Specified|6
1238964|NCT00661778|4063866|P1|Overall Study|Adverse Event|18
1238965|NCT00661778|4063866|P1|Overall Study|Disease Progression|23
1238966|NCT00661726|4063873|P1|Overall Study|Adverse Event|1
1238967|NCT00661713|4063896|P8|Overall Study|Inappropriate Enrollment|0
1238968|NCT00661713|4063897|P7|Overall Study|Inappropriate Enrollment|1
1238969|NCT00661713|4063898|P6|Overall Study|Inappropriate Enrollment|0
1238970|NCT00661713|4063899|P5|Overall Study|Inappropriate Enrollment|0
1238971|NCT00661713|4063900|P4|Overall Study|Inappropriate Enrollment|0
1238972|NCT00661713|4063901|P3|Overall Study|Inappropriate Enrollment|0
1238973|NCT00661713|4063902|P2|Overall Study|Inappropriate Enrollment|0
1238974|NCT00661713|4063903|P1|Overall Study|Inappropriate Enrollment|0
1238975|NCT00661713|4063896|P8|Overall Study|Adverse Event|0
1238976|NCT00661713|4063897|P7|Overall Study|Adverse Event|1
1238977|NCT00661713|4063898|P6|Overall Study|Adverse Event|0
1238978|NCT00661713|4063899|P5|Overall Study|Adverse Event|0
1238979|NCT00661713|4063900|P4|Overall Study|Adverse Event|0
1238980|NCT00661713|4063901|P3|Overall Study|Adverse Event|0
1238981|NCT00661713|4063902|P2|Overall Study|Adverse Event|0
1238982|NCT00661713|4063903|P1|Overall Study|Adverse Event|0
1238983|NCT00661713|4063896|P8|Overall Study|Administrative Reason|0
1238984|NCT00661713|4063897|P7|Overall Study|Administrative Reason|1
1238985|NCT00661713|4063898|P6|Overall Study|Administrative Reason|2
1238986|NCT00661713|4063899|P5|Overall Study|Administrative Reason|2
1238987|NCT00661713|4063900|P4|Overall Study|Administrative Reason|2
1238988|NCT00661713|4063901|P3|Overall Study|Administrative Reason|0
1238989|NCT00661713|4063902|P2|Overall Study|Administrative Reason|1
1238990|NCT00661713|4063903|P1|Overall Study|Administrative Reason|0
1238991|NCT00661713|4063896|P8|Overall Study|Lost to Follow-up|1
1238992|NCT00661713|4063897|P7|Overall Study|Lost to Follow-up|14
1238993|NCT00661713|4063898|P6|Overall Study|Lost to Follow-up|7
1238994|NCT00661713|4063899|P5|Overall Study|Lost to Follow-up|5
1238995|NCT00661713|4063900|P4|Overall Study|Lost to Follow-up|2
1238996|NCT00661713|4063901|P3|Overall Study|Lost to Follow-up|2
1238997|NCT00661713|4063902|P2|Overall Study|Lost to Follow-up|7
1238998|NCT00661713|4063903|P1|Overall Study|Lost to Follow-up|2
1238999|NCT00661713|4063896|P8|Overall Study|Withdrawal by Subject|9
1239000|NCT00661713|4063897|P7|Overall Study|Withdrawal by Subject|45
1239001|NCT00661713|4063898|P6|Overall Study|Withdrawal by Subject|26
1239002|NCT00661713|4063899|P5|Overall Study|Withdrawal by Subject|12
1239003|NCT00661713|4063900|P4|Overall Study|Withdrawal by Subject|21
1239004|NCT00661713|4063901|P3|Overall Study|Withdrawal by Subject|12
1239005|NCT00661713|4063902|P2|Overall Study|Withdrawal by Subject|25
1239006|NCT00661713|4063903|P1|Overall Study|Withdrawal by Subject|11
1239007|NCT00661713|4063896|P8|Overall Study|Protocol Violation|1
1239008|NCT00661713|4063897|P7|Overall Study|Protocol Violation|2
1239009|NCT00661713|4063898|P6|Overall Study|Protocol Violation|2
1239010|NCT00661713|4063899|P5|Overall Study|Protocol Violation|0
1239011|NCT00661713|4063900|P4|Overall Study|Protocol Violation|3
1239012|NCT00661713|4063901|P3|Overall Study|Protocol Violation|3
1239013|NCT00661713|4063902|P2|Overall Study|Protocol Violation|6
1239014|NCT00661713|4063903|P1|Overall Study|Protocol Violation|1
1239015|NCT00661713|4063896|P8|Overall Study|Unable to Classify|0
1239016|NCT00661713|4063897|P7|Overall Study|Unable to Classify|0
1239017|NCT00661713|4063898|P6|Overall Study|Unable to Classify|0
1239018|NCT00661713|4063899|P5|Overall Study|Unable to Classify|0
1239019|NCT00661713|4063900|P4|Overall Study|Unable to Classify|0
1239020|NCT00661713|4063901|P3|Overall Study|Unable to Classify|0
1239021|NCT00661713|4063902|P2|Overall Study|Unable to Classify|0
1239022|NCT00661713|4063903|P1|Overall Study|Unable to Classify|1
1239023|NCT00661713|4063896|P8|Overall Study|Death|0
1239024|NCT00661713|4063897|P7|Overall Study|Death|0
1239025|NCT00661713|4063898|P6|Overall Study|Death|0
1239026|NCT00661713|4063899|P5|Overall Study|Death|1
1239027|NCT00661713|4063900|P4|Overall Study|Death|0
1239028|NCT00661713|4063901|P3|Overall Study|Death|0
1239029|NCT00661713|4063902|P2|Overall Study|Death|0
1239030|NCT00661713|4063903|P1|Overall Study|Death|1
1239031|NCT00661687|4063993|P1|Overall Study|Adverse Event|2
1239032|NCT00661687|4063993|P1|Overall Study|Physician Decision|1
1239033|NCT00661687|4063993|P1|Overall Study|Inability to maintain wearing schedule|3
1239034|NCT00661687|4063993|P1|Overall Study|Positive slit lamp findings|4
1239035|NCT00661687|4063993|P1|Overall Study|Study related symptoms and complaints|5
1239036|NCT00661661|4064021|P2|Overall Study|Not assigned treatment|0
1239037|NCT00661661|4064022|P1|Overall Study|Not assigned treatment|1
1239038|NCT00661661|4064021|P2|Overall Study|Other|7
1239039|NCT00661661|4064022|P1|Overall Study|Other|22
1239040|NCT00661661|4064021|P2|Overall Study|Withdrawal by Subject|5
1239041|NCT00661661|4064022|P1|Overall Study|Withdrawal by Subject|15
1239042|NCT00661661|4064021|P2|Overall Study|Lost to Follow-up|1
1239043|NCT00661661|4064022|P1|Overall Study|Lost to Follow-up|0
1239044|NCT00661661|4064021|P2|Overall Study|Lack of Efficacy|2
1239045|NCT00661661|4064022|P1|Overall Study|Lack of Efficacy|3
1239046|NCT00661661|4064021|P2|Overall Study|Adverse Event|24
1239047|NCT00661661|4064022|P1|Overall Study|Adverse Event|99
1239048|NCT00661622|4064098|P2|Overall Study|Protocol Violation|0
1239049|NCT00661622|4064099|P1|Overall Study|Protocol Violation|1
1239050|NCT00661609|4064113|P1|Overall Study|Disease progression|3
1239051|NCT00661609|4064113|P1|Overall Study|Survival follow up stage discontinued|11
1239052|NCT00661609|4064113|P1|Overall Study|PI Decision|1
1239053|NCT00661609|4064113|P1|Overall Study|Withdrawal by Subject|2
1239054|NCT00661609|4064113|P1|Overall Study|Death|20
1239055|NCT00661609|4064113|P1|Overall Study|Adverse Event|4
1239056|NCT00661531|4064180|P1|Overall Study|Withdrawal by Subject|3
1239057|NCT00661505|4064185|P1|Overall Study|Not Specified|2
1239058|NCT00661505|4064185|P1|Overall Study|Lost to Follow-up|3
1239059|NCT00661505|4064185|P1|Overall Study|Withdrawal by Subject|8
1239060|NCT00661505|4064185|P1|Overall Study|Protocol Violation|14
1239061|NCT00661505|4064185|P1|Overall Study|Adverse Event|3
1239062|NCT00661492|4064213|P2|Overall Study|Other|0
1239063|NCT00661492|4064214|P1|Overall Study|Other|1
1239064|NCT00661492|4064213|P2|Overall Study|Lost to Follow-up|1
1239065|NCT00661492|4064214|P1|Overall Study|Lost to Follow-up|0
1239066|NCT00661492|4064213|P2|Overall Study|Investigator Request|0
1239067|NCT00661492|4064214|P1|Overall Study|Investigator Request|1
1239068|NCT00661492|4064213|P2|Overall Study|Patient Request|1
1239069|NCT00661492|4064214|P1|Overall Study|Patient Request|6
1239070|NCT00661492|4064213|P2|Overall Study|Disease Progression|14
1239071|NCT00661492|4064214|P1|Overall Study|Disease Progression|44
1239072|NCT00661492|4064213|P2|Overall Study|Adverse Event|13
1239073|NCT00661492|4064214|P1|Overall Study|Adverse Event|16
1239074|NCT00661427|4064260|P2|Overall Study|Patient not treated|2
1239075|NCT00661427|4064261|P1|Overall Study|Patient not treated|0
1239076|NCT00661427|4064260|P2|Overall Study|Adverse Event|5
1239077|NCT00661427|4064261|P1|Overall Study|Adverse Event|5
1239078|NCT00661388|4064269|P1|Overall Study|Administrative reasons|1
1239079|NCT00661388|4064269|P1|Overall Study|Dialysis initiation|1
1239080|NCT00661388|4064269|P1|Overall Study|Renal transplantation|1
1239081|NCT00661388|4064269|P1|Overall Study|Protocol Violation|7
1239082|NCT00661388|4064269|P1|Overall Study|Adverse Event|14
1239083|NCT00661362|4064292|P2|Overall Study|Metformin dose haven't decreasd to 2.5 g|0
1239084|NCT00661362|4064293|P1|Overall Study|Metformin dose haven't decreasd to 2.5 g|1
1239085|NCT00661362|4064292|P2|Overall Study|Safety reasons|0
1239086|NCT00661362|4064293|P1|Overall Study|Safety reasons|1
1239087|NCT00661362|4064292|P2|Overall Study|Severe non-compliance to protocol|1
1239088|NCT00661362|4064293|P1|Overall Study|Severe non-compliance to protocol|0
1239089|NCT00661362|4064292|P2|Overall Study|Lost to Follow-up|1
1239090|NCT00661362|4064293|P1|Overall Study|Lost to Follow-up|3
1239091|NCT00661362|4064292|P2|Overall Study|Withdrawal by Subject|23
1239092|NCT00661362|4064293|P1|Overall Study|Withdrawal by Subject|13
1239093|NCT00661362|4064292|P2|Overall Study|Study specific discontinuation criteria|11
1239094|NCT00661362|4064293|P1|Overall Study|Study specific discontinuation criteria|4
1239095|NCT00661362|4064292|P2|Overall Study|Incorrect enrollment|0
1239096|NCT00661362|4064293|P1|Overall Study|Incorrect enrollment|2
1239097|NCT00661362|4064292|P2|Overall Study|Adverse Event|4
1239098|NCT00661362|4064293|P1|Overall Study|Adverse Event|5
1239099|NCT00661271|4064311|P2|Overall Study|Lost to Follow-up|25
1239100|NCT00661271|4064312|P1|Overall Study|Lost to Follow-up|28
1239101|NCT00661258|4064322|P2|Overall Study|caught by police and in detox center|1
1239102|NCT00661258|4064323|P1|Overall Study|caught by police and in detox center|2
1239103|NCT00661258|4064322|P2|Overall Study|Death|0
1239104|NCT00661258|4064323|P1|Overall Study|Death|1
1239105|NCT00661193|4064333|P2|Overall Study|Not protocol specified|0
1239106|NCT00661193|4064334|P1|Overall Study|Not protocol specified|1
1239107|NCT00661193|4064333|P2|Overall Study|Progression|24
1239108|NCT00661193|4064334|P1|Overall Study|Progression|27
1239109|NCT00661193|4064333|P2|Overall Study|Withdrawal by Subject|1
1239110|NCT00661193|4064334|P1|Overall Study|Withdrawal by Subject|3
1239111|NCT00661193|4064333|P2|Overall Study|Adverse Event|1
1239112|NCT00661193|4064334|P1|Overall Study|Adverse Event|2
1239113|NCT00661089|4064559|P2|Overall Study|death at 8 weeks due to new stroke|1
1239114|NCT00661089|4064560|P1|Overall Study|death at 8 weeks due to new stroke|0
1239115|NCT00661089|4064559|P2|Overall Study|1 subject withdrawal|1
1239116|NCT00661089|4064560|P1|Overall Study|1 subject withdrawal|0
1239117|NCT00660907|4064608|P2|Overall Study|Various|8
1239118|NCT00660907|4064609|P1|Overall Study|Various|11
1239119|NCT00660907|4064608|P2|Overall Study|Death|3
1239120|NCT00660907|4064609|P1|Overall Study|Death|1
1239121|NCT00660907|4064608|P2|Overall Study|Safety|0
1239122|NCT00660907|4064609|P1|Overall Study|Safety|1
1239123|NCT00660907|4064608|P2|Overall Study|Poor/Non-Compliance|1
1239124|NCT00660907|4064609|P1|Overall Study|Poor/Non-Compliance|5
1239125|NCT00660907|4064608|P2|Overall Study|Lost to Follow-up|3
1239126|NCT00660907|4064609|P1|Overall Study|Lost to Follow-up|3
1239127|NCT00660907|4064608|P2|Overall Study|Withdrawal by Subject|32
1239128|NCT00660907|4064609|P1|Overall Study|Withdrawal by Subject|23
1239129|NCT00660907|4064608|P2|Overall Study|Subject No Longer Meets Study Criteria|27
1239130|NCT00660907|4064609|P1|Overall Study|Subject No Longer Meets Study Criteria|6
1239131|NCT00660907|4064608|P2|Overall Study|Adverse Event|19
1239132|NCT00660907|4064609|P1|Overall Study|Adverse Event|33
1239133|NCT00660907|4064608|P2|Overall Study|Incorrect Enrollment|1
1239134|NCT00660907|4064609|P1|Overall Study|Incorrect Enrollment|1
1239135|NCT00660829|4064623|P2|Overall Study|Other|4
1239136|NCT00660829|4064624|P1|Overall Study|Other|9
1239137|NCT00660829|4064623|P2|Overall Study|Lost to Follow-up|2
1239138|NCT00660829|4064624|P1|Overall Study|Lost to Follow-up|3
1239139|NCT00660829|4064623|P2|Overall Study|Withdrawal by Subject|2
1239140|NCT00660829|4064624|P1|Overall Study|Withdrawal by Subject|1
1239141|NCT00660829|4064623|P2|Overall Study|Non-Compliance|4
1239142|NCT00660829|4064624|P1|Overall Study|Non-Compliance|0
1239143|NCT00660829|4064623|P2|Overall Study|Lack of Efficacy|3
1239144|NCT00660829|4064624|P1|Overall Study|Lack of Efficacy|2
1239145|NCT00660829|4064623|P2|Overall Study|Adverse Event|4
1239146|NCT00660829|4064624|P1|Overall Study|Adverse Event|3
1239147|NCT00660816|4064642|P2|Overall Study|Complicating Disease|1
1239148|NCT00660816|4064643|P1|Overall Study|Complicating Disease|0
1239149|NCT00660816|4064642|P2|Overall Study|Disease Progression|12
1239150|NCT00660816|4064643|P1|Overall Study|Disease Progression|16
1239151|NCT00660816|4064642|P2|Overall Study|Protocol Violation|0
1239152|NCT00660816|4064643|P1|Overall Study|Protocol Violation|1
1239153|NCT00660816|4064642|P2|Overall Study|Physician Decision|2
1239154|NCT00660816|4064643|P1|Overall Study|Physician Decision|0
1239155|NCT00660816|4064642|P2|Overall Study|Lack of Efficacy|0
1239156|NCT00660816|4064643|P1|Overall Study|Lack of Efficacy|1
1239157|NCT00660816|4064642|P2|Overall Study|Death|2
1239158|NCT00660816|4064643|P1|Overall Study|Death|0
1239159|NCT00660816|4064642|P2|Overall Study|Withdrawal by Subject|0
1239160|NCT00660816|4064643|P1|Overall Study|Withdrawal by Subject|1
1239161|NCT00660816|4064642|P2|Overall Study|Adverse Event|2
1239162|NCT00660816|4064643|P1|Overall Study|Adverse Event|1
1239163|NCT00660699|4064655|P1|Overall Study|Withdrawal by Subject|2
1239164|NCT00660660|4064671|P2|Overall Study|New medication after randomization|0
1239165|NCT00660660|4064672|P1|Overall Study|New medication after randomization|1
1239166|NCT00660660|4064671|P2|Overall Study|Incorrect enrollment and other|1
1239167|NCT00660660|4064672|P1|Overall Study|Incorrect enrollment and other|0
1239168|NCT00660660|4064671|P2|Overall Study|Withdrawal by Subject|0
1239169|NCT00660660|4064672|P1|Overall Study|Withdrawal by Subject|3
1239170|NCT00660660|4064671|P2|Overall Study|Lack of Efficacy|2
1239171|NCT00660660|4064672|P1|Overall Study|Lack of Efficacy|0
1239172|NCT00660660|4064671|P2|Overall Study|Lost to Follow-up|6
1239173|NCT00660660|4064672|P1|Overall Study|Lost to Follow-up|0
1239174|NCT00660660|4064671|P2|Overall Study|Adverse Event|0
1239175|NCT00660660|4064672|P1|Overall Study|Adverse Event|1
1239176|NCT00660595|4064772|P2|Overall Study|Non Specified reasons|0
1239177|NCT00660595|4064773|P1|Overall Study|Non Specified reasons|5
1239178|NCT00660595|4064772|P2|Overall Study|Participant left hospital|0
1239179|NCT00660595|4064773|P1|Overall Study|Participant left hospital|1
1239180|NCT00660595|4064772|P2|Overall Study|Did not consent to participate in study|8
1239181|NCT00660595|4064773|P1|Overall Study|Did not consent to participate in study|12
1239182|NCT00660595|4064772|P2|Overall Study|Lost to Follow-up|1
1239183|NCT00660595|4064773|P1|Overall Study|Lost to Follow-up|0
1239184|NCT00660400|4064834|P1|Overall Study|Withdrawal by Subject|1
1239185|NCT00660400|4064834|P1|Overall Study|Intracranial hemorrhage|1
1239186|NCT00660400|4064834|P1|Overall Study|Suboptimal organ function|1
1239187|NCT00660400|4064834|P1|Overall Study|Lack of insurance approval|1
1239188|NCT00660387|4064843|P2|Overall Study|Protocol Violation|0
1239189|NCT00660387|4064844|P1|Overall Study|Protocol Violation|1
1239190|NCT00660387|4064843|P2|Overall Study|Lack of Efficacy|1
1239191|NCT00660387|4064844|P1|Overall Study|Lack of Efficacy|0
1239192|NCT00660387|4064843|P2|Overall Study|Adverse Event|2
1239193|NCT00660387|4064844|P1|Overall Study|Adverse Event|1
1239194|NCT00660348|4064898|P2|Overall Study|Withdrawal by Subject|0
1239195|NCT00660348|4064899|P1|Overall Study|Withdrawal by Subject|1
1239196|NCT00660309|4064907|P2|Overall Study|Withdrawal by Subject|3
1239197|NCT00660309|4064908|P1|Overall Study|Withdrawal by Subject|0
1239198|NCT00660309|4064907|P2|Overall Study|Adverse Event|0
1239199|NCT00660309|4064908|P1|Overall Study|Adverse Event|2
1239200|NCT00660192|4064949|P2|Overall Study|Lost to Follow-up|3
1239201|NCT00660192|4064950|P1|Overall Study|Lost to Follow-up|2
1239202|NCT00660179|4064961|P3|Overall Study|Incorrect randomization|0
1239203|NCT00660179|4064962|P2|Overall Study|Incorrect randomization|0
1239204|NCT00660179|4064963|P1|Overall Study|Incorrect randomization|1
1239205|NCT00660179|4064961|P3|Overall Study|Administrative reason|1
1239206|NCT00660179|4064962|P2|Overall Study|Administrative reason|0
1239207|NCT00660179|4064963|P1|Overall Study|Administrative reason|0
1239208|NCT00660179|4064961|P3|Overall Study|Lost to Follow-up|2
1239209|NCT00660179|4064962|P2|Overall Study|Lost to Follow-up|5
1239210|NCT00660179|4064963|P1|Overall Study|Lost to Follow-up|7
1239211|NCT00660179|4064961|P3|Overall Study|Withdrawal of consent|4
1239212|NCT00660179|4064962|P2|Overall Study|Withdrawal of consent|6
1239213|NCT00660179|4064963|P1|Overall Study|Withdrawal of consent|4
1239214|NCT00660179|4064961|P3|Overall Study|Death|34
1239215|NCT00660179|4064962|P2|Overall Study|Death|47
1239216|NCT00660179|4064963|P1|Overall Study|Death|44
1239217|NCT00660023|4065008|P1|Overall Study|Other Screening Failure|9
1239218|NCT00660023|4065008|P1|Overall Study|Missed Pregnancy Test|1
1239219|NCT00660023|4065008|P1|Overall Study|Withdrawal by Subject|1
1239220|NCT00660023|4065008|P1|Overall Study|Renal Transplantation|3
1239221|NCT00660023|4065008|P1|Overall Study|Blood Transfusion|5
1239222|NCT00660023|4065008|P1|Overall Study|Death|8
1239223|NCT00660023|4065008|P1|Overall Study|Adverse Event|2
1239224|NCT00660010|4065019|P1|Overall Study|Noncompliance with visit schedule|3
1239225|NCT00660010|4065019|P1|Overall Study|Adverse Event|1
1239226|NCT00660010|4065019|P1|Overall Study|Lost to Follow-up|3
1239227|NCT00660010|4065019|P1|Overall Study|Withdrawal by Subject|2
1239228|NCT00659984|4065033|P1|Overall Study|Adverse Event|1
1239229|NCT00659880|4065053|P1|Overall Study|Lost to Follow-up|5
1239230|NCT00659815|4065060|P2|Overall Study|Withdrawal by Subject|1
1239231|NCT00659815|4065061|P1|Overall Study|Withdrawal by Subject|1
1239232|NCT00659815|4065060|P2|Overall Study|Inability to maintain wearing schedule|2
1239233|NCT00659815|4065061|P1|Overall Study|Inability to maintain wearing schedule|1
1239234|NCT00659815|4065060|P2|Overall Study|Study related symptoms and complaints|1
1239235|NCT00659815|4065061|P1|Overall Study|Study related symptoms and complaints|2
1239236|NCT00659607|4065121|P1|Overall Study|Inconsistent BP measuring date|2
1239237|NCT00659607|4065121|P1|Overall Study|No recorded efficacy data|15
1239238|NCT00659607|4065121|P1|Overall Study|‘Unable to evaluate’ for the final asses|67
1239239|NCT00659607|4065121|P1|Overall Study|Unknown measuring date of blood pressure|85
1239240|NCT00659607|4065121|P1|Overall Study|No blood pressure recorded|147
1239241|NCT00659581|4065139|P1|Overall Study|Other|6393
1239242|NCT00659581|4065139|P1|Overall Study|Lack of Efficacy|1183
1239243|NCT00659581|4065139|P1|Overall Study|Adverse Event|1006
1239244|NCT00659529|4065151|P1|Overall Study|Screen failure|9
1239245|NCT00659529|4065151|P1|Overall Study|Protocol Violation|3
1239246|NCT00659529|4065151|P1|Overall Study|Withdrawal by Subject|4
1239247|NCT00659490|4065158|P3|Overall Study|Lost to Follow-up|1
1239248|NCT00659490|4065159|P2|Overall Study|Lost to Follow-up|0
1239249|NCT00659490|4065160|P1|Overall Study|Lost to Follow-up|2
1239250|NCT00659438|4065233|P2|Overall Study|Lost to Follow-up|0
1239251|NCT00659438|4065234|P1|Overall Study|Lost to Follow-up|1
1239252|NCT00659438|4065233|P2|Overall Study|Death|6
1239253|NCT00659438|4065234|P1|Overall Study|Death|11
1239254|NCT00659438|4065233|P2|Overall Study|Withdrawal by Subject|2
1239255|NCT00659438|4065234|P1|Overall Study|Withdrawal by Subject|2
1239256|NCT00659425|4065266|P10|Overall Study|Other|6
1239257|NCT00659425|4065267|P9|Overall Study|Other|0
1239258|NCT00659425|4065268|P8|Overall Study|Other|2
1239259|NCT00659425|4065269|P7|Overall Study|Other|3
1239260|NCT00659425|4065270|P6|Overall Study|Other|0
1239261|NCT00659425|4065271|P5|Overall Study|Other|4
1239262|NCT00659425|4065272|P4|Overall Study|Other|2
1239263|NCT00659425|4065273|P3|Overall Study|Other|1
1239264|NCT00659425|4065274|P2|Overall Study|Other|1
1239265|NCT00659425|4065275|P1|Overall Study|Other|0
1239266|NCT00659425|4065266|P10|Overall Study|Investigator Discretion|0
1239267|NCT00659425|4065267|P9|Overall Study|Investigator Discretion|0
1239268|NCT00659425|4065268|P8|Overall Study|Investigator Discretion|3
1239269|NCT00659425|4065269|P7|Overall Study|Investigator Discretion|0
1239270|NCT00659425|4065270|P6|Overall Study|Investigator Discretion|1
1239271|NCT00659425|4065271|P5|Overall Study|Investigator Discretion|0
1239272|NCT00659425|4065272|P4|Overall Study|Investigator Discretion|0
1239273|NCT00659425|4065273|P3|Overall Study|Investigator Discretion|0
1239274|NCT00659425|4065274|P2|Overall Study|Investigator Discretion|0
1239275|NCT00659425|4065275|P1|Overall Study|Investigator Discretion|0
1239276|NCT00659425|4065266|P10|Overall Study|Adverse Event|4
1239277|NCT00659425|4065267|P9|Overall Study|Adverse Event|1
1239278|NCT00659425|4065268|P8|Overall Study|Adverse Event|3
1239279|NCT00659425|4065269|P7|Overall Study|Adverse Event|0
1239280|NCT00659425|4065270|P6|Overall Study|Adverse Event|1
1239281|NCT00659425|4065271|P5|Overall Study|Adverse Event|0
1239282|NCT00659425|4065272|P4|Overall Study|Adverse Event|0
1239283|NCT00659425|4065273|P3|Overall Study|Adverse Event|0
1239284|NCT00659425|4065274|P2|Overall Study|Adverse Event|0
1239285|NCT00659425|4065275|P1|Overall Study|Adverse Event|0
1239286|NCT00659425|4065266|P10|Overall Study|Death|0
1239287|NCT00659425|4065267|P9|Overall Study|Death|0
1239288|NCT00659425|4065268|P8|Overall Study|Death|0
1239289|NCT00659425|4065269|P7|Overall Study|Death|1
1239290|NCT00659425|4065270|P6|Overall Study|Death|0
1239291|NCT00659425|4065271|P5|Overall Study|Death|0
1239292|NCT00659425|4065272|P4|Overall Study|Death|1
1239293|NCT00659425|4065273|P3|Overall Study|Death|0
1239294|NCT00659425|4065274|P2|Overall Study|Death|0
1239295|NCT00659425|4065275|P1|Overall Study|Death|0
1239296|NCT00659425|4065266|P10|Overall Study|Disease progression|3
1239297|NCT00659425|4065267|P9|Overall Study|Disease progression|5
1239298|NCT00659425|4065268|P8|Overall Study|Disease progression|3
1239299|NCT00659425|4065269|P7|Overall Study|Disease progression|4
1239300|NCT00659425|4065270|P6|Overall Study|Disease progression|2
1239301|NCT00659425|4065271|P5|Overall Study|Disease progression|0
1239302|NCT00659425|4065272|P4|Overall Study|Disease progression|1
1239303|NCT00659425|4065273|P3|Overall Study|Disease progression|0
1239304|NCT00659425|4065274|P2|Overall Study|Disease progression|0
1239305|NCT00659425|4065275|P1|Overall Study|Disease progression|1
1239306|NCT00659373|4065506|P2|Overall Study|Assessment Missed|2
1239307|NCT00659373|4065507|P1|Overall Study|Assessment Missed|2
1239308|NCT00659373|4065506|P2|Overall Study|Withdrawal by Subject|5
1239309|NCT00659373|4065507|P1|Overall Study|Withdrawal by Subject|3
1239310|NCT00659334|4065529|P7|Overall Study|Screen Failure|1
1239311|NCT00659334|4065530|P6|Overall Study|Screen Failure|0
1239312|NCT00659334|4065531|P5|Overall Study|Screen Failure|0
1239313|NCT00659334|4065532|P4|Overall Study|Screen Failure|0
1239314|NCT00659334|4065533|P3|Overall Study|Screen Failure|0
1239315|NCT00659334|4065534|P2|Overall Study|Screen Failure|5
1239316|NCT00659334|4065535|P1|Overall Study|Screen Failure|8
1239317|NCT00659269|4065562|P2|Overall Study|Physician Decision|1
1239318|NCT00659269|4065563|P1|Overall Study|Physician Decision|1
1239319|NCT00659230|4065593|P2|Overall Study|Did not return post-randomization|3
1239320|NCT00659230|4065594|P1|Overall Study|Did not return post-randomization|2
1239321|NCT00659230|4065593|P2|Overall Study|Lost source documentation|4
1239322|NCT00659230|4065594|P1|Overall Study|Lost source documentation|5
1239323|NCT00659230|4065593|P2|Overall Study|Lost to Follow-up|5
1239324|NCT00659230|4065594|P1|Overall Study|Lost to Follow-up|2
1239325|NCT00659061|4065617|P2|Overall Study|Migration due to political unrest|15
1239326|NCT00659061|4065618|P1|Overall Study|Migration due to political unrest|21
1239327|NCT00658996|4065636|P2|Second Intervention|Positive slit lamp finding|1
1239328|NCT00658996|4065637|P1|Second Intervention|Positive slit lamp finding|0
1239329|NCT00658996|4065636|P2|Second Intervention|Developed a stye on upper lid|0
1239330|NCT00658996|4065637|P1|Second Intervention|Developed a stye on upper lid|1
1239331|NCT00658996|4065636|P2|Crossover Period|Ineligible|1
1239332|NCT00658996|4065637|P1|Crossover Period|Ineligible|1
1239333|NCT00658996|4065636|P2|Crossover Period|Physician Decision|0
1239334|NCT00658996|4065637|P1|Crossover Period|Physician Decision|1
1239335|NCT00658996|4065636|P2|First Intervention|Lack of lenses|1
1239336|NCT00658996|4065637|P1|First Intervention|Lack of lenses|0
1239337|NCT00658996|4065636|P2|First Intervention|Positive slit lamp finding|0
1239338|NCT00658996|4065637|P1|First Intervention|Positive slit lamp finding|1
1239339|NCT00658814|4065649|P2|Maintenance Therapy|Not eligible|0
1239340|NCT00658814|4065650|P1|Maintenance Therapy|Not eligible|1
1239341|NCT00658814|4065649|P2|Maintenance Therapy|Not protocol specified|0
1239342|NCT00658814|4065650|P1|Maintenance Therapy|Not protocol specified|1
1239343|NCT00658814|4065649|P2|Maintenance Therapy|Adverse Event|1
1239344|NCT00658814|4065650|P1|Maintenance Therapy|Adverse Event|1
1239345|NCT00658814|4065649|P2|Consolidation Therapy|Not eligible|2
1239346|NCT00658814|4065650|P1|Consolidation Therapy|Not eligible|2
1239347|NCT00658814|4065649|P2|Consolidation Therapy|Not protocol specified|1
1239348|NCT00658814|4065650|P1|Consolidation Therapy|Not protocol specified|0
1239349|NCT00658814|4065649|P2|Remission Induction Chemotherapy|Not eligible|2
1239350|NCT00658814|4065650|P1|Remission Induction Chemotherapy|Not eligible|1
1239351|NCT00658814|4065649|P2|Remission Induction Chemotherapy|Not protocol specified|4
1239352|NCT00658814|4065650|P1|Remission Induction Chemotherapy|Not protocol specified|2
1239353|NCT00658814|4065649|P2|Remission Induction Chemotherapy|Death|4
1239354|NCT00658814|4065650|P1|Remission Induction Chemotherapy|Death|1
1239355|NCT00658814|4065649|P2|Remission Induction Chemotherapy|Progression/Relapse|1
1239356|NCT00658814|4065650|P1|Remission Induction Chemotherapy|Progression/Relapse|0
1239357|NCT00658814|4065649|P2|Remission Induction Chemotherapy|Withdrawal by Subject|4
1239358|NCT00658814|4065650|P1|Remission Induction Chemotherapy|Withdrawal by Subject|3
1239359|NCT00658814|4065649|P2|Remission Induction Chemotherapy|Adverse Event|3
1239360|NCT00658814|4065650|P1|Remission Induction Chemotherapy|Adverse Event|1
1239361|NCT00658788|4065664|P1|Overall Study|Treatment Discontinuation|32
1239362|NCT00658788|4065664|P1|Overall Study|Lost to Follow-up|18
1239363|NCT00658788|4065664|P1|Overall Study|Withdrawal by Subject|13
1239364|NCT00658788|4065664|P1|Overall Study|Adverse Event|11
1239365|NCT00658775|4065719|P2|Overall Study|Not specified|8
1239366|NCT00658775|4065720|P1|Overall Study|Not specified|7
1239367|NCT00658775|4065719|P2|Overall Study|Withdrawal of consent|7
1239368|NCT00658775|4065720|P1|Overall Study|Withdrawal of consent|8
1239369|NCT00658775|4065719|P2|Overall Study|Withdrawal by Subject|4
1239370|NCT00658775|4065720|P1|Overall Study|Withdrawal by Subject|6
1239371|NCT00658775|4065719|P2|Overall Study|Lost to Follow-up|18
1239372|NCT00658775|4065720|P1|Overall Study|Lost to Follow-up|17
1239373|NCT00658775|4065719|P2|Overall Study|Adverse Event|6
1239374|NCT00658775|4065720|P1|Overall Study|Adverse Event|4
1239375|NCT00658723|4065743|P3|Overall Study|Withdrawal by Subject|1
1239376|NCT00658723|4065744|P2|Overall Study|Withdrawal by Subject|0
1239377|NCT00658723|4065745|P1|Overall Study|Withdrawal by Subject|1
1239378|NCT00658723|4065743|P3|Overall Study|Scheduling Issue|0
1239379|NCT00658723|4065744|P2|Overall Study|Scheduling Issue|1
1239380|NCT00658723|4065745|P1|Overall Study|Scheduling Issue|1
1239381|NCT00658723|4065743|P3|Overall Study|Death|4
1239382|NCT00658723|4065744|P2|Overall Study|Death|1
1239383|NCT00658723|4065745|P1|Overall Study|Death|2
1239384|NCT00658723|4065743|P3|Overall Study|Lost to Follow-up|2
1239385|NCT00658723|4065744|P2|Overall Study|Lost to Follow-up|2
1239386|NCT00658723|4065745|P1|Overall Study|Lost to Follow-up|0
1239387|NCT00658684|4065783|P4|Overall Study|Pregnancy|0
1239388|NCT00658684|4065784|P3|Overall Study|Pregnancy|0
1239389|NCT00658684|4065785|P2|Overall Study|Pregnancy|1
1239390|NCT00658684|4065786|P1|Overall Study|Pregnancy|1
1239391|NCT00658684|4065783|P4|Overall Study|Protocol Violation|0
1239392|NCT00658684|4065784|P3|Overall Study|Protocol Violation|0
1239393|NCT00658684|4065785|P2|Overall Study|Protocol Violation|1
1239394|NCT00658684|4065786|P1|Overall Study|Protocol Violation|1
1239395|NCT00658684|4065783|P4|Overall Study|Lack of Efficacy|0
1239396|NCT00658684|4065784|P3|Overall Study|Lack of Efficacy|0
1239397|NCT00658684|4065785|P2|Overall Study|Lack of Efficacy|1
1239398|NCT00658684|4065786|P1|Overall Study|Lack of Efficacy|1
1239399|NCT00658684|4065783|P4|Overall Study|Withdrawal by Subject|1
1239400|NCT00658684|4065784|P3|Overall Study|Withdrawal by Subject|1
1239401|NCT00658684|4065785|P2|Overall Study|Withdrawal by Subject|4
1239402|NCT00658684|4065786|P1|Overall Study|Withdrawal by Subject|6
1239403|NCT00658684|4065783|P4|Overall Study|Adverse Event|0
1239404|NCT00658684|4065784|P3|Overall Study|Adverse Event|2
1239405|NCT00658684|4065785|P2|Overall Study|Adverse Event|8
1239406|NCT00658684|4065786|P1|Overall Study|Adverse Event|10
1239407|NCT00658658|4065841|P5|Overall Study|Other|1
1239408|NCT00658658|4065842|P4|Overall Study|Other|0
1239409|NCT00658658|4065843|P3|Overall Study|Other|0
1239410|NCT00658658|4065844|P2|Overall Study|Other|0
1239411|NCT00658658|4065845|P1|Overall Study|Other|0
1239412|NCT00658658|4065841|P5|Overall Study|Protocol-specified Criteria|0
1239413|NCT00658658|4065842|P4|Overall Study|Protocol-specified Criteria|0
1239414|NCT00658658|4065843|P3|Overall Study|Protocol-specified Criteria|0
1239415|NCT00658658|4065844|P2|Overall Study|Protocol-specified Criteria|0
1239416|NCT00658658|4065845|P1|Overall Study|Protocol-specified Criteria|1
1239417|NCT00658658|4065841|P5|Overall Study|Disease Progression|3
1239418|NCT00658658|4065842|P4|Overall Study|Disease Progression|1
1239419|NCT00658658|4065843|P3|Overall Study|Disease Progression|0
1239420|NCT00658658|4065844|P2|Overall Study|Disease Progression|1
1239421|NCT00658658|4065845|P1|Overall Study|Disease Progression|0
1239422|NCT00658658|4065841|P5|Overall Study|Death|1
1239423|NCT00658658|4065842|P4|Overall Study|Death|1
1239424|NCT00658658|4065843|P3|Overall Study|Death|0
1239425|NCT00658658|4065844|P2|Overall Study|Death|0
1239426|NCT00658658|4065845|P1|Overall Study|Death|4
1239427|NCT00658658|4065841|P5|Overall Study|Withdrawal by Subject|0
1239428|NCT00658658|4065842|P4|Overall Study|Withdrawal by Subject|0
1239429|NCT00658658|4065843|P3|Overall Study|Withdrawal by Subject|0
1239430|NCT00658658|4065844|P2|Overall Study|Withdrawal by Subject|1
1239431|NCT00658658|4065845|P1|Overall Study|Withdrawal by Subject|0
1239432|NCT00658632|4065904|P2|Overall Study|Not specified|8
1239433|NCT00658632|4065905|P1|Overall Study|Not specified|7
1239434|NCT00658632|4065904|P2|Overall Study|Pregnancy|1
1239435|NCT00658632|4065905|P1|Overall Study|Pregnancy|1
1239436|NCT00658632|4065904|P2|Overall Study|Withdrawal of consent|14
1239437|NCT00658632|4065905|P1|Overall Study|Withdrawal of consent|8
1239438|NCT00658632|4065904|P2|Overall Study|Lack of Efficacy|1
1239439|NCT00658632|4065905|P1|Overall Study|Lack of Efficacy|0
1239440|NCT00658632|4065904|P2|Overall Study|Withdrawal by Subject|7
1239441|NCT00658632|4065905|P1|Overall Study|Withdrawal by Subject|10
1239442|NCT00658632|4065904|P2|Overall Study|Lost to Follow-up|23
1239443|NCT00658632|4065905|P1|Overall Study|Lost to Follow-up|25
1239444|NCT00658632|4065904|P2|Overall Study|Adverse Event|11
1239445|NCT00658632|4065905|P1|Overall Study|Adverse Event|13
1239446|NCT00658606|4065946|P2|Overall Study|Lack of Compliance|3
1239447|NCT00658606|4065947|P1|Overall Study|Lack of Compliance|0
1239448|NCT00658606|4065946|P2|Overall Study|Withdrawal by Subject|16
1239449|NCT00658606|4065947|P1|Overall Study|Withdrawal by Subject|7
1239450|NCT00658606|4065946|P2|Overall Study|Lost to Follow-up|0
1239451|NCT00658606|4065947|P1|Overall Study|Lost to Follow-up|1
1239452|NCT00658606|4065946|P2|Overall Study|Lack of Efficacy|3
1239453|NCT00658606|4065947|P1|Overall Study|Lack of Efficacy|6
1239454|NCT00658606|4065946|P2|Overall Study|Adverse Event|1
1239455|NCT00658606|4065947|P1|Overall Study|Adverse Event|2
1239456|NCT00658567|4065976|P3|Overall Study|At Discretion of Sponsor|1
1239457|NCT00658567|4065977|P2|Overall Study|At Discretion of Sponsor|1
1239458|NCT00658567|4065978|P1|Overall Study|At Discretion of Sponsor|1
1239459|NCT00658567|4065976|P3|Overall Study|Physician Decision|0
1239460|NCT00658567|4065977|P2|Overall Study|Physician Decision|1
1239461|NCT00658567|4065978|P1|Overall Study|Physician Decision|0
1239462|NCT00658567|4065976|P3|Overall Study|Voluntary Withdrawal of Consent|2
1239463|NCT00658567|4065977|P2|Overall Study|Voluntary Withdrawal of Consent|0
1239464|NCT00658567|4065978|P1|Overall Study|Voluntary Withdrawal of Consent|2
1239465|NCT00658567|4065976|P3|Overall Study|Adverse Event|3
1239466|NCT00658567|4065977|P2|Overall Study|Adverse Event|2
1239467|NCT00658567|4065978|P1|Overall Study|Adverse Event|5
1239468|NCT00658541|4065989|P2|Washout Period of 7 Days|Withdrawal by Subject|1
1239469|NCT00658541|4065990|P1|Washout Period of 7 Days|Withdrawal by Subject|0
1239470|NCT00658541|4065989|P2|Washout Period of 7 Days|Withdrawal by Subject|1
1239471|NCT00658541|4065990|P1|Washout Period of 7 Days|Withdrawal by Subject|1
1239472|NCT00658528|4066002|P2|Overall Study|Not specified|4
1239473|NCT00658528|4066003|P1|Overall Study|Not specified|8
1239474|NCT00658528|4066002|P2|Overall Study|Withdrawal of consent|6
1239475|NCT00658528|4066003|P1|Overall Study|Withdrawal of consent|5
1239476|NCT00658528|4066002|P2|Overall Study|Withdrawal by Subject|6
1239477|NCT00658528|4066003|P1|Overall Study|Withdrawal by Subject|8
1239478|NCT00658528|4066002|P2|Overall Study|Lost to Follow-up|22
1239479|NCT00658528|4066003|P1|Overall Study|Lost to Follow-up|14
1239480|NCT00658528|4066002|P2|Overall Study|Adverse Event|7
1239481|NCT00658528|4066003|P1|Overall Study|Adverse Event|5
1239482|NCT00658359|4066028|P3|Overall Study|Lack of Efficacy|0
1239483|NCT00658359|4066029|P2|Overall Study|Lack of Efficacy|1
1239484|NCT00658359|4066030|P1|Overall Study|Lack of Efficacy|0
1239485|NCT00658359|4066028|P3|Overall Study|Lost to Follow-up|4
1239486|NCT00658359|4066029|P2|Overall Study|Lost to Follow-up|2
1239487|NCT00658359|4066030|P1|Overall Study|Lost to Follow-up|2
1239488|NCT00658359|4066028|P3|Overall Study|Withdrawal by Subject|2
1239489|NCT00658359|4066029|P2|Overall Study|Withdrawal by Subject|4
1239490|NCT00658359|4066030|P1|Overall Study|Withdrawal by Subject|7
1239491|NCT00658359|4066028|P3|Overall Study|Includes protocol Amendments 3 and 4|29
1239492|NCT00658359|4066029|P2|Overall Study|Includes protocol Amendments 3 and 4|31
1239493|NCT00658359|4066030|P1|Overall Study|Includes protocol Amendments 3 and 4|2
1239494|NCT00658359|4066028|P3|Overall Study|Protocol Violation|0
1239495|NCT00658359|4066029|P2|Overall Study|Protocol Violation|0
1239496|NCT00658359|4066030|P1|Overall Study|Protocol Violation|1
1239497|NCT00658359|4066028|P3|Overall Study|Adverse Event|9
1239498|NCT00658359|4066029|P2|Overall Study|Adverse Event|6
1239499|NCT00658359|4066030|P1|Overall Study|Adverse Event|13
1239500|NCT00658359|4066028|P3|Overall Study|Death|2
1239501|NCT00658359|4066029|P2|Overall Study|Death|1
1239502|NCT00658359|4066030|P1|Overall Study|Death|3
1239503|NCT00658333|4066118|P2|Overall Study|Adverse Event|1
1239504|NCT00658333|4066119|P1|Overall Study|Adverse Event|2
1239505|NCT00658320|4066129|P2|Extension Study: After Month 24|Subject withdrew consent|0
1239506|NCT00658320|4066130|P1|Extension Study: After Month 24|Subject withdrew consent|2
1239507|NCT00658320|4066129|P2|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7
1239508|NCT00658320|4066130|P1|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3
1239509|NCT00658320|4066129|P2|Extension Study: Month 12 to Month 24|Subject withdrew consent|0
1239510|NCT00658320|4066130|P1|Extension Study: Month 12 to Month 24|Subject withdrew consent|3
1239511|NCT00658320|4066129|P2|Core Study: 12 Months|Subject withdrew consent|3
1239512|NCT00658320|4066130|P1|Core Study: 12 Months|Subject withdrew consent|5
1239513|NCT00657709|4066167|P5|Overall Study|Protocol Violation|2
1239514|NCT00657709|4066168|P4|Overall Study|Protocol Violation|1
1239515|NCT00657709|4066169|P3|Overall Study|Protocol Violation|0
1239516|NCT00657709|4066170|P2|Overall Study|Protocol Violation|2
1239517|NCT00657709|4066171|P1|Overall Study|Protocol Violation|0
1239518|NCT00657709|4066167|P5|Overall Study|Lost to Follow-up|21
1239519|NCT00657709|4066168|P4|Overall Study|Lost to Follow-up|1
1239520|NCT00657709|4066169|P3|Overall Study|Lost to Follow-up|7
1239521|NCT00657709|4066170|P2|Overall Study|Lost to Follow-up|9
1239522|NCT00657709|4066171|P1|Overall Study|Lost to Follow-up|9
1239523|NCT00657709|4066167|P5|Overall Study|Withdrawal by Subject|9
1239524|NCT00657709|4066168|P4|Overall Study|Withdrawal by Subject|5
1239525|NCT00657709|4066169|P3|Overall Study|Withdrawal by Subject|15
1239526|NCT00657709|4066170|P2|Overall Study|Withdrawal by Subject|15
1239527|NCT00657709|4066171|P1|Overall Study|Withdrawal by Subject|7
1239528|NCT00657709|4066167|P5|Overall Study|AE or Death|1
1239529|NCT00657709|4066168|P4|Overall Study|AE or Death|7
1239530|NCT00657709|4066169|P3|Overall Study|AE or Death|6
1239531|NCT00657709|4066170|P2|Overall Study|AE or Death|7
1239532|NCT00657709|4066171|P1|Overall Study|AE or Death|7
1239533|NCT00657618|4066220|P1|Overall Study|didn't start due to schedule conflicts|1
1239534|NCT00657618|4066220|P1|Overall Study|negative for leishmaniasis|2
1239535|NCT00657618|4066220|P1|Overall Study|Withdrawal by Subject|8
1239536|NCT00657618|4066220|P1|Overall Study|Adverse Event|32
1239537|NCT00657553|4066227|P2|Overall Study|low accrual, no analysis run|5
1239538|NCT00657553|4066228|P1|Overall Study|low accrual, no analysis run|5
1239539|NCT00657540|4066236|P2|Overall Study|Lost to Follow-up|4
1239540|NCT00657540|4066237|P1|Overall Study|Lost to Follow-up|1
1239541|NCT00657371|4066251|P1|Overall Study|Pre-existing medical condition|4
1239542|NCT00657371|4066251|P1|Overall Study|Device- related reasons|13
1239543|NCT00657371|4066251|P1|Overall Study|Protocol Violation|2
1239544|NCT00657371|4066251|P1|Overall Study|Unable to intubate the cecum|5
1239545|NCT00657371|4066251|P1|Overall Study|Poor bowel preparation|15
1239546|NCT00657358|4066256|P1|Overall Study|Lack of Efficacy|6
1239547|NCT00657267|4066268|P1|Overall Study|Adverse Event|9
1239548|NCT00657267|4066268|P1|Overall Study|Progressive disease|45
1239549|NCT00657150|4066278|P2|Treatment|Not Specified|15
1239550|NCT00657150|4066279|P1|Treatment|Not Specified|13
1239551|NCT00657150|4066278|P2|Treatment|Withdrawal by Subject|20
1239552|NCT00657150|4066279|P1|Treatment|Withdrawal by Subject|23
1239553|NCT00657150|4066278|P2|Treatment|Lost to Follow-up|0
1239554|NCT00657150|4066279|P1|Treatment|Lost to Follow-up|1
1239555|NCT00657150|4066278|P2|Treatment|Non-compliant with protocol|9
1239556|NCT00657150|4066279|P1|Treatment|Non-compliant with protocol|10
1239557|NCT00657150|4066278|P2|Treatment|Adverse Event|53
1239558|NCT00657150|4066279|P1|Treatment|Adverse Event|60
1239559|NCT00657150|4066278|P2|Overall Study|Not Specified|38
1239560|NCT00657150|4066279|P1|Overall Study|Not Specified|38
1239561|NCT00657150|4066278|P2|Overall Study|Withdrawal by Subject|36
1239562|NCT00657150|4066279|P1|Overall Study|Withdrawal by Subject|51
1239563|NCT00657150|4066278|P2|Overall Study|Lost to Follow-up|0
1239564|NCT00657150|4066279|P1|Overall Study|Lost to Follow-up|2
1239565|NCT00657150|4066278|P2|Overall Study|Non-compliant with protocol|9
1239566|NCT00657150|4066279|P1|Overall Study|Non-compliant with protocol|5
1239567|NCT00657150|4066278|P2|Overall Study|Adverse Event|10
1239568|NCT00657150|4066279|P1|Overall Study|Adverse Event|19
1239569|NCT00657046|4066310|P3|Overall Study|Surgery|1
1239570|NCT00657046|4066311|P2|Overall Study|Surgery|0
1239571|NCT00657046|4066312|P1|Overall Study|Surgery|0
1239572|NCT00657046|4066310|P3|Overall Study|Death|1
1239573|NCT00657046|4066311|P2|Overall Study|Death|0
1239574|NCT00657046|4066312|P1|Overall Study|Death|0
1239575|NCT00657046|4066310|P3|Overall Study|Withdrawal by Subject|0
1239576|NCT00657046|4066311|P2|Overall Study|Withdrawal by Subject|0
1239577|NCT00657046|4066312|P1|Overall Study|Withdrawal by Subject|1
1239578|NCT00657046|4066310|P3|Overall Study|Protocol Violation|0
1239579|NCT00657046|4066311|P2|Overall Study|Protocol Violation|2
1239580|NCT00657046|4066312|P1|Overall Study|Protocol Violation|2
1239581|NCT00657046|4066310|P3|Overall Study|Adverse Event|0
1239582|NCT00657046|4066311|P2|Overall Study|Adverse Event|1
1239583|NCT00657046|4066312|P1|Overall Study|Adverse Event|1
1239584|NCT00657020|4066344|P2|PERIOD 1|Adverse Event|1
1239585|NCT00657020|4066345|P1|PERIOD 1|Adverse Event|0
1239586|NCT00656851|4066395|P2|Overall Study|Withdrawal by Subject|4
1239587|NCT00656851|4066396|P1|Overall Study|Withdrawal by Subject|0
1239588|NCT00656799|4066418|P1|Overall Study|Death|2
1239589|NCT00656669|4066440|P1|AC (Cycles 6-9)|Did not start segment 3|1
1239590|NCT00656669|4066440|P1|AC (Cycles 6-9)|Adverse Event|1
1239591|NCT00656669|4066440|P1|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2
1239592|NCT00656669|4066440|P1|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4
1239593|NCT00656617|4066479|P1|Overall Study|Move to different clinical trial|2
1239594|NCT00656617|4066479|P1|Overall Study|Insurance Issues|2
1239595|NCT00656617|4066479|P1|Overall Study|Death|2
1239596|NCT00656617|4066479|P1|Overall Study|Adverse Event|1
1239597|NCT00656513|4066488|P3|Overall Study|Missing baseline form|5
1239598|NCT00656513|4066489|P2|Overall Study|Missing baseline form|5
1239599|NCT00656513|4066490|P1|Overall Study|Missing baseline form|0
1239600|NCT00656513|4066488|P3|Overall Study|Treatment completed outside of timeframe|1
1239601|NCT00656513|4066489|P2|Overall Study|Treatment completed outside of timeframe|3
1239602|NCT00656513|4066490|P1|Overall Study|Treatment completed outside of timeframe|0
1239603|NCT00656513|4066488|P3|Overall Study|Incomplete treatment|0
1239604|NCT00656513|4066489|P2|Overall Study|Incomplete treatment|0
1239605|NCT00656513|4066490|P1|Overall Study|Incomplete treatment|3
1239606|NCT00656513|4066488|P3|Overall Study|Missing data|9
1239607|NCT00656513|4066489|P2|Overall Study|Missing data|11
1239608|NCT00656513|4066490|P1|Overall Study|Missing data|0
1239609|NCT00656513|4066488|P3|Overall Study|Death|1
1239610|NCT00656513|4066489|P2|Overall Study|Death|0
1239611|NCT00656513|4066490|P1|Overall Study|Death|0
1239612|NCT00656513|4066488|P3|Overall Study|Withdrawal by Subject|4
1239613|NCT00656513|4066489|P2|Overall Study|Withdrawal by Subject|11
1239614|NCT00656513|4066490|P1|Overall Study|Withdrawal by Subject|0
1239615|NCT00656513|4066488|P3|Overall Study|Protocol Violation|2
1239616|NCT00656513|4066489|P2|Overall Study|Protocol Violation|0
1239617|NCT00656513|4066490|P1|Overall Study|Protocol Violation|1
1239618|NCT00656474|4066537|P1|Overall Study|Other Reason|1
1239619|NCT00656370|4066555|P1|Overall Study|Alternates|3
1239620|NCT00656370|4066555|P1|Overall Study|Screen Failures|7
1239621|NCT00656292|4066584|P2|Overall Study|Screen failure|2
1239622|NCT00656292|4066585|P1|Overall Study|Screen failure|1
1239623|NCT00656292|4066584|P2|Overall Study|Withdrawal by Subject|3
1239624|NCT00656292|4066585|P1|Overall Study|Withdrawal by Subject|2
1239625|NCT00656175|4066612|P2|Overall Study|Transportation issues|1
1239626|NCT00656175|4066613|P1|Overall Study|Transportation issues|0
1239627|NCT00656175|4066612|P2|Overall Study|Adverse Event|0
1239628|NCT00656175|4066613|P1|Overall Study|Adverse Event|1
1239629|NCT00656136|4066621|P2|Overall Study|Unknown and others|4
1239630|NCT00656136|4066622|P1|Overall Study|Unknown and others|4
1239631|NCT00656136|4066621|P2|Overall Study|Patient refused to take study medication|10
1239632|NCT00656136|4066622|P1|Overall Study|Patient refused to take study medication|7
1239633|NCT00656136|4066621|P2|Overall Study|Protocol Violation|3
1239634|NCT00656136|4066622|P1|Overall Study|Protocol Violation|2
1239635|NCT00656136|4066621|P2|Overall Study|Other Adverse Event|51
1239636|NCT00656136|4066622|P1|Overall Study|Other Adverse Event|5
1239637|NCT00656136|4066621|P2|Overall Study|Progressive disease|322
1239638|NCT00656136|4066622|P1|Overall Study|Progressive disease|177
1239639|NCT00656084|4066632|P1|Overall Study|Investigator Request|1
1239640|NCT00656084|4066632|P1|Overall Study|Patient Request|1
1239641|NCT00656084|4066632|P1|Overall Study|Withdrawal by Subject|1
1239642|NCT00656084|4066632|P1|Overall Study|Adverse Event|4
1239643|NCT00656058|4066639|P1|Overall Study|Withdrawal by Subject|4
1239644|NCT00656058|4066639|P1|Overall Study|Withdrawal by Subject|2
1239645|NCT00656019|4066652|P4|Overall Study|Lost to Follow-up|0
1239646|NCT00656019|4066653|P3|Overall Study|Lost to Follow-up|0
1239647|NCT00656019|4066654|P2|Overall Study|Lost to Follow-up|1
1239648|NCT00656019|4066655|P1|Overall Study|Lost to Follow-up|2
1239649|NCT00656019|4066652|P4|Overall Study|Withdrawal by Subject|0
1239650|NCT00656019|4066653|P3|Overall Study|Withdrawal by Subject|0
1239651|NCT00656019|4066654|P2|Overall Study|Withdrawal by Subject|0
1239652|NCT00656019|4066655|P1|Overall Study|Withdrawal by Subject|2
1239653|NCT00656019|4066652|P4|Overall Study|Not Eligible|0
1239654|NCT00656019|4066653|P3|Overall Study|Not Eligible|0
1239655|NCT00656019|4066654|P2|Overall Study|Not Eligible|0
1239656|NCT00656019|4066655|P1|Overall Study|Not Eligible|10
1239657|NCT00655889|4066665|P1|Overall Study|Protocol Violation|1
1239658|NCT00655889|4066665|P1|Overall Study|Inadequate cell growth|1
1239659|NCT00655876|4066672|P2|Overall Study|Protocol Violation|7
1239660|NCT00655876|4066673|P1|Overall Study|Protocol Violation|9
1239661|NCT00655863|4066692|P3|Overall Study|Lost to Follow-up|1
1239662|NCT00655863|4066693|P2|Overall Study|Lost to Follow-up|0
1239663|NCT00655863|4066694|P1|Overall Study|Lost to Follow-up|0
1239664|NCT00655850|4066753|P1|Overall Study|Withdrawal by Subject|1
1239665|NCT00655850|4066753|P1|Overall Study|Death|2
1239666|NCT00655824|4066760|P1|Overall Study|Deterioration of Trial Disease|2
1239667|NCT00655824|4066760|P1|Overall Study|Withdrawal by Subject|4
1239668|NCT00655824|4066760|P1|Overall Study|Protocol Violation|1
1239669|NCT00655824|4066760|P1|Overall Study|Early Termination of Study by Sponsor|74
1239670|NCT00655824|4066760|P1|Overall Study|Adverse Event|3
1239671|NCT00655746|4066808|P1|Overall Study|Withdrawal by Subject|1
1239672|NCT00655733|4066827|P2|Overall Study|Physician Decision|1
1239673|NCT00655733|4066828|P1|Overall Study|Physician Decision|0
1239674|NCT00655733|4066827|P2|Overall Study|Withdrawal by Subject|3
1239675|NCT00655733|4066828|P1|Overall Study|Withdrawal by Subject|3
1239676|NCT00655733|4066827|P2|Overall Study|Adverse Event|2
1239677|NCT00655733|4066828|P1|Overall Study|Adverse Event|2
1239678|NCT00655733|4066827|P2|Overall Study|Lost to Follow-up|2
1239679|NCT00655733|4066828|P1|Overall Study|Lost to Follow-up|2
1239680|NCT00655668|4066834|P1|Overall Study|Withdrawal by Subject|2
1239681|NCT00655668|4066834|P1|Overall Study|New Lymphoma Treatment Started|4
1239682|NCT00655668|4066834|P1|Overall Study|Other|1
1239683|NCT00655668|4066834|P1|Overall Study|Study Terminated|9
1239684|NCT00655668|4066834|P1|Overall Study|Disease Progression|27
1239685|NCT00655668|4066834|P1|Overall Study|Death|5
1239686|NCT00655668|4066834|P1|Overall Study|Adverse Event|6
1239687|NCT00655629|4066861|P2|Overall Study|consent withdrawn|4
1239688|NCT00655629|4066862|P1|Overall Study|consent withdrawn|6
1239689|NCT00655629|4066861|P2|Overall Study|Protocol Violation|3
1239690|NCT00655629|4066862|P1|Overall Study|Protocol Violation|5
1239691|NCT00655629|4066861|P2|Overall Study|Lost to Follow-up|3
1239692|NCT00655629|4066862|P1|Overall Study|Lost to Follow-up|4
1239693|NCT00655629|4066861|P2|Overall Study|Lack of Efficacy|12
1239694|NCT00655629|4066862|P1|Overall Study|Lack of Efficacy|2
1239695|NCT00655629|4066861|P2|Overall Study|Adverse Event|1
1239696|NCT00655629|4066862|P1|Overall Study|Adverse Event|4
1239697|NCT00655564|4066898|P1|Overall Study|Desired Alternate Therapy|1
1239698|NCT00655564|4066898|P1|Overall Study|Lost to Follow-up|1
1239699|NCT00655564|4066898|P1|Overall Study|Adverse Event|1
1239700|NCT00655551|4066906|P3|Period 4 (up to 7 Days)|Adverse Event|0
1239701|NCT00655551|4066907|P2|Period 4 (up to 7 Days)|Adverse Event|2
1239702|NCT00655551|4066908|P1|Period 4 (up to 7 Days)|Adverse Event|0
1239703|NCT00655551|4066906|P3|Period 3 (up to 7 Days)|Adverse Event|4
1239704|NCT00655551|4066907|P2|Period 3 (up to 7 Days)|Adverse Event|0
1239705|NCT00655551|4066908|P1|Period 3 (up to 7 Days)|Adverse Event|0
1239706|NCT00655551|4066906|P3|Period 2 (up to 7 Days)|Adverse Event|0
1239707|NCT00655551|4066907|P2|Period 2 (up to 7 Days)|Adverse Event|1
1239708|NCT00655551|4066908|P1|Period 2 (up to 7 Days)|Adverse Event|0
1239709|NCT00655551|4066906|P3|All Periods Combined|Adverse Event|4
1239710|NCT00655551|4066907|P2|All Periods Combined|Adverse Event|3
1239711|NCT00655551|4066908|P1|All Periods Combined|Adverse Event|0
1239712|NCT00655486|4066922|P1|Overall Study|Other: Abnormal electrocardiogram (ECG)|1
1239713|NCT00655486|4066922|P1|Overall Study|Other: Could not tolerate BID dosing|1
1239714|NCT00655486|4066922|P1|Overall Study|Other: Pregnancy|1
1239715|NCT00655486|4066922|P1|Overall Study|Unsatisfactory compliance|2
1239716|NCT00655486|4066922|P1|Overall Study|Protocol Violation|1
1239717|NCT00655486|4066922|P1|Overall Study|Withdrawal by Subject|4
1239718|NCT00655486|4066922|P1|Overall Study|Lack of Efficacy|8
1239719|NCT00655486|4066922|P1|Overall Study|Adverse Event|10
1239720|NCT00655356|4066929|P2|Overall Study|Other Reason|0
1239721|NCT00655356|4066930|P1|Overall Study|Other Reason|1
1239722|NCT00655356|4066929|P2|Overall Study|Protocol Violation|1
1239723|NCT00655356|4066930|P1|Overall Study|Protocol Violation|2
1239724|NCT00655356|4066929|P2|Overall Study|Adverse Event|1
1239725|NCT00655356|4066930|P1|Overall Study|Adverse Event|1
1239726|NCT00655356|4066929|P2|Overall Study|Sponsor Request|4
1239727|NCT00655356|4066930|P1|Overall Study|Sponsor Request|10
1239728|NCT00655356|4066929|P2|Overall Study|Withdrawal by Subject|4
1239729|NCT00655356|4066930|P1|Overall Study|Withdrawal by Subject|3
1239730|NCT00654940|4066981|P2|Period 1|Intolerable Pain Level|0
1239731|NCT00654940|4066982|P1|Period 1|Intolerable Pain Level|1
1239732|NCT00654940|4066981|P2|Period 1|Adverse Event|1
1239733|NCT00654940|4066982|P1|Period 1|Adverse Event|0
1239734|NCT00654901|4067006|P4|Overall Study|Withdrawal by Subject|0
1239735|NCT00654901|4067007|P3|Overall Study|Withdrawal by Subject|1
1239736|NCT00654901|4067008|P2|Overall Study|Withdrawal by Subject|0
1239737|NCT00654901|4067009|P1|Overall Study|Withdrawal by Subject|3
1239738|NCT00654901|4067006|P4|Overall Study|Lost to Follow-up|0
1239739|NCT00654901|4067007|P3|Overall Study|Lost to Follow-up|1
1239740|NCT00654901|4067008|P2|Overall Study|Lost to Follow-up|0
1239741|NCT00654901|4067009|P1|Overall Study|Lost to Follow-up|1
1239742|NCT00654875|4067029|P2|Overall Study|Administrative Problems|0
1239743|NCT00654875|4067030|P1|Overall Study|Administrative Problems|1
1239744|NCT00654875|4067029|P2|Overall Study|Abnormal Test Procedure Result(s)|0
1239745|NCT00654875|4067030|P1|Overall Study|Abnormal Test Procedure Result(s)|1
1239746|NCT00654875|4067029|P2|Overall Study|Lost to Follow-up|3
1239747|NCT00654875|4067030|P1|Overall Study|Lost to Follow-up|1
1239748|NCT00654875|4067029|P2|Overall Study|Lack of Efficacy|2
1239749|NCT00654875|4067030|P1|Overall Study|Lack of Efficacy|2
1239750|NCT00654875|4067029|P2|Overall Study|Protocol Violation|3
1239751|NCT00654875|4067030|P1|Overall Study|Protocol Violation|3
1239752|NCT00654875|4067029|P2|Overall Study|Withdrawal by Subject|4
1239753|NCT00654875|4067030|P1|Overall Study|Withdrawal by Subject|4
1239754|NCT00654875|4067029|P2|Overall Study|Adverse Event|5
1239755|NCT00654875|4067030|P1|Overall Study|Adverse Event|5
1239756|NCT00654745|4067063|P1|Overall Study|poor ABPM, noncompliance, lab MAs|3
1239757|NCT00654745|4067063|P1|Overall Study|Withdrawal by Subject|10
1239758|NCT00654745|4067063|P1|Overall Study|Protocol Violation|11
1239759|NCT00654745|4067063|P1|Overall Study|Lost to Follow-up|7
1239760|NCT00654745|4067063|P1|Overall Study|Adverse Event|12
1239761|NCT00654641|4067108|P2|Overall Study|Lost to Follow-up|3
1239762|NCT00654641|4067109|P1|Overall Study|Lost to Follow-up|2
1239763|NCT00654628|4067115|P1|6 –Week Extension Period (Single Site)|Lost to Follow-up|1
1239764|NCT00654628|4067115|P1|6 –Week Extension Period (Single Site)|Adverse Event|4
1239765|NCT00654628|4067115|P1|6-week Active Treatment Period|Out of window period|1
1239766|NCT00654628|4067115|P1|6-week Active Treatment Period|Transferred to branch hospital|1
1239767|NCT00654628|4067115|P1|6-week Active Treatment Period|Lost to Follow-up|10
1239768|NCT00654628|4067115|P1|6-week Active Treatment Period|Adverse Event|9
1239769|NCT00654498|4067164|P2|Overall Study|Other reason not defined above|5
1239770|NCT00654498|4067165|P1|Overall Study|Other reason not defined above|4
1239771|NCT00654498|4067164|P2|Overall Study|Withdrawal by Subject|0
1239772|NCT00654498|4067165|P1|Overall Study|Withdrawal by Subject|1
1239773|NCT00654498|4067164|P2|Overall Study|Lost to Follow-up|5
1239774|NCT00654498|4067165|P1|Overall Study|Lost to Follow-up|1
1239775|NCT00654498|4067164|P2|Overall Study|Protocol Violation|1
1239776|NCT00654498|4067165|P1|Overall Study|Protocol Violation|1
1239777|NCT00654498|4067164|P2|Overall Study|Adverse Event|1
1239778|NCT00654498|4067165|P1|Overall Study|Adverse Event|6
1239779|NCT00654498|4067164|P2|Overall Study|Not Treated|0
1239780|NCT00654498|4067165|P1|Overall Study|Not Treated|1
1239781|NCT00654420|4067197|P4|Phase II|Missing Disposition Record|0
1239782|NCT00654420|4067198|P3|Phase II|Missing Disposition Record|1
1239783|NCT00654420|4067199|P2|Phase II|Missing Disposition Record|0
1239784|NCT00654420|4067200|P1|Phase II|Missing Disposition Record|0
1239785|NCT00654420|4067197|P4|Phase II|Withdrawal by Subject|1
1239786|NCT00654420|4067198|P3|Phase II|Withdrawal by Subject|4
1239787|NCT00654420|4067199|P2|Phase II|Withdrawal by Subject|0
1239788|NCT00654420|4067200|P1|Phase II|Withdrawal by Subject|0
1239789|NCT00654420|4067197|P4|Phase II|Progressive Disease|29
1239790|NCT00654420|4067198|P3|Phase II|Progressive Disease|29
1239791|NCT00654420|4067199|P2|Phase II|Progressive Disease|0
1239792|NCT00654420|4067200|P1|Phase II|Progressive Disease|0
1239793|NCT00654420|4067197|P4|Phase II|Physician Decision|4
1239794|NCT00654420|4067198|P3|Phase II|Physician Decision|0
1239795|NCT00654420|4067199|P2|Phase II|Physician Decision|0
1239796|NCT00654420|4067200|P1|Phase II|Physician Decision|0
1239797|NCT00654420|4067197|P4|Phase II|Lost to Follow-up|1
1239798|NCT00654420|4067198|P3|Phase II|Lost to Follow-up|0
1239799|NCT00654420|4067199|P2|Phase II|Lost to Follow-up|0
1239800|NCT00654420|4067200|P1|Phase II|Lost to Follow-up|0
1239801|NCT00654420|4067197|P4|Phase II|Adverse Event|3
1239802|NCT00654420|4067198|P3|Phase II|Adverse Event|3
1239803|NCT00654420|4067199|P2|Phase II|Adverse Event|0
1239804|NCT00654420|4067200|P1|Phase II|Adverse Event|0
1239805|NCT00654420|4067197|P4|Phase I (Dose Escalation)|Progressive Disease|0
1239806|NCT00654420|4067198|P3|Phase I (Dose Escalation)|Progressive Disease|0
1239807|NCT00654420|4067199|P2|Phase I (Dose Escalation)|Progressive Disease|15
1239808|NCT00654420|4067200|P1|Phase I (Dose Escalation)|Progressive Disease|4
1239809|NCT00654420|4067197|P4|Phase I (Dose Escalation)|Adverse Event|0
1239810|NCT00654420|4067198|P3|Phase I (Dose Escalation)|Adverse Event|0
1239811|NCT00654420|4067199|P2|Phase I (Dose Escalation)|Adverse Event|1
1239812|NCT00654420|4067200|P1|Phase I (Dose Escalation)|Adverse Event|0
1239813|NCT00654381|4067226|P6|Extension Stage|Closure of the trial site|1
1239814|NCT00654381|4067227|P5|Extension Stage|Closure of the trial site|1
1239815|NCT00654381|4067228|P4|Extension Stage|Closure of the trial site|0
1239816|NCT00654381|4067229|P3|Extension Stage|Closure of the trial site|0
1239817|NCT00654381|4067230|P2|Extension Stage|Closure of the trial site|0
1239818|NCT00654381|4067231|P1|Extension Stage|Closure of the trial site|0
1239819|NCT00654381|4067226|P6|Extension Stage|Withdrawal by Subject|1
1239820|NCT00654381|4067227|P5|Extension Stage|Withdrawal by Subject|1
1239821|NCT00654381|4067228|P4|Extension Stage|Withdrawal by Subject|1
1239822|NCT00654381|4067229|P3|Extension Stage|Withdrawal by Subject|1
1239823|NCT00654381|4067230|P2|Extension Stage|Withdrawal by Subject|0
1239824|NCT00654381|4067231|P1|Extension Stage|Withdrawal by Subject|0
1239825|NCT00654381|4067226|P6|Extension Stage|Lack of Efficacy|0
1239826|NCT00654381|4067227|P5|Extension Stage|Lack of Efficacy|0
1239827|NCT00654381|4067228|P4|Extension Stage|Lack of Efficacy|0
1239828|NCT00654381|4067229|P3|Extension Stage|Lack of Efficacy|1
1239829|NCT00654381|4067230|P2|Extension Stage|Lack of Efficacy|0
1239830|NCT00654381|4067231|P1|Extension Stage|Lack of Efficacy|0
1239831|NCT00654381|4067226|P6|Extension Stage|Protocol Violation|0
1239832|NCT00654381|4067227|P5|Extension Stage|Protocol Violation|0
1239833|NCT00654381|4067228|P4|Extension Stage|Protocol Violation|1
1239834|NCT00654381|4067229|P3|Extension Stage|Protocol Violation|0
1239835|NCT00654381|4067230|P2|Extension Stage|Protocol Violation|0
1239836|NCT00654381|4067231|P1|Extension Stage|Protocol Violation|0
1239837|NCT00654381|4067226|P6|Extension Stage|Adverse Event|1
1239838|NCT00654381|4067227|P5|Extension Stage|Adverse Event|1
1239839|NCT00654381|4067228|P4|Extension Stage|Adverse Event|7
1239840|NCT00654381|4067229|P3|Extension Stage|Adverse Event|9
1239841|NCT00654381|4067230|P2|Extension Stage|Adverse Event|2
1239842|NCT00654381|4067231|P1|Extension Stage|Adverse Event|1
1239843|NCT00654381|4067226|P6|2nd Stage|Investigator's decision|0
1239844|NCT00654381|4067227|P5|2nd Stage|Investigator's decision|0
1239845|NCT00654381|4067228|P4|2nd Stage|Investigator's decision|1
1239846|NCT00654381|4067229|P3|2nd Stage|Investigator's decision|1
1239847|NCT00654381|4067230|P2|2nd Stage|Investigator's decision|0
1239848|NCT00654381|4067231|P1|2nd Stage|Investigator's decision|0
1239849|NCT00654381|4067226|P6|2nd Stage|Withdrawal by Subject|1
1239850|NCT00654381|4067227|P5|2nd Stage|Withdrawal by Subject|1
1239851|NCT00654381|4067228|P4|2nd Stage|Withdrawal by Subject|0
1239852|NCT00654381|4067229|P3|2nd Stage|Withdrawal by Subject|0
1239853|NCT00654381|4067230|P2|2nd Stage|Withdrawal by Subject|0
1239854|NCT00654381|4067231|P1|2nd Stage|Withdrawal by Subject|0
1239855|NCT00654381|4067226|P6|2nd Stage|Adverse Event|2
1239856|NCT00654381|4067227|P5|2nd Stage|Adverse Event|7
1239857|NCT00654381|4067228|P4|2nd Stage|Adverse Event|3
1239858|NCT00654381|4067229|P3|2nd Stage|Adverse Event|2
1239859|NCT00654381|4067230|P2|2nd Stage|Adverse Event|0
1239860|NCT00654381|4067231|P1|2nd Stage|Adverse Event|2
1239861|NCT00654381|4067226|P6|1st Stage|Investigator's decision|0
1239862|NCT00654381|4067227|P5|1st Stage|Investigator's decision|0
1239863|NCT00654381|4067228|P4|1st Stage|Investigator's decision|1
1239864|NCT00654381|4067229|P3|1st Stage|Investigator's decision|0
1239865|NCT00654381|4067230|P2|1st Stage|Investigator's decision|0
1239866|NCT00654381|4067231|P1|1st Stage|Investigator's decision|0
1239867|NCT00654381|4067226|P6|1st Stage|Withdrawal by Subject|1
1239868|NCT00654381|4067227|P5|1st Stage|Withdrawal by Subject|0
1239869|NCT00654381|4067228|P4|1st Stage|Withdrawal by Subject|1
1239870|NCT00654381|4067229|P3|1st Stage|Withdrawal by Subject|0
1239871|NCT00654381|4067230|P2|1st Stage|Withdrawal by Subject|0
1239872|NCT00654381|4067231|P1|1st Stage|Withdrawal by Subject|0
1239873|NCT00654381|4067226|P6|1st Stage|Adverse Event|1
1239874|NCT00654381|4067227|P5|1st Stage|Adverse Event|2
1239875|NCT00654381|4067228|P4|1st Stage|Adverse Event|3
1239876|NCT00654381|4067229|P3|1st Stage|Adverse Event|3
1239877|NCT00654381|4067230|P2|1st Stage|Adverse Event|3
1239878|NCT00654381|4067231|P1|1st Stage|Adverse Event|3
1239879|NCT00654368|4067268|P3|Overall Study|Adverse Event|6
1239880|NCT00654368|4067269|P2|Overall Study|Adverse Event|9
1239881|NCT00654368|4067270|P1|Overall Study|Adverse Event|14
1239882|NCT00654368|4067268|P3|Overall Study|Other|3
1239883|NCT00654368|4067269|P2|Overall Study|Other|2
1239884|NCT00654368|4067270|P1|Overall Study|Other|0
1239885|NCT00654368|4067268|P3|Overall Study|Pregnancy|2
1239886|NCT00654368|4067269|P2|Overall Study|Pregnancy|0
1239887|NCT00654368|4067270|P1|Overall Study|Pregnancy|0
1239888|NCT00654368|4067268|P3|Overall Study|Death|0
1239889|NCT00654368|4067269|P2|Overall Study|Death|0
1239890|NCT00654368|4067270|P1|Overall Study|Death|1
1239891|NCT00654368|4067268|P3|Overall Study|Physician Decision|2
1239892|NCT00654368|4067269|P2|Overall Study|Physician Decision|0
1239893|NCT00654368|4067270|P1|Overall Study|Physician Decision|0
1239894|NCT00654368|4067268|P3|Overall Study|Requirement for alternative therapy|1
1239895|NCT00654368|4067269|P2|Overall Study|Requirement for alternative therapy|1
1239896|NCT00654368|4067270|P1|Overall Study|Requirement for alternative therapy|1
1239897|NCT00654368|4067268|P3|Overall Study|Disease progression|13
1239898|NCT00654368|4067269|P2|Overall Study|Disease progression|31
1239899|NCT00654368|4067270|P1|Overall Study|Disease progression|21
1239900|NCT00654368|4067268|P3|Overall Study|Withdrawal by Subject|2
1239901|NCT00654368|4067269|P2|Overall Study|Withdrawal by Subject|2
1239902|NCT00654368|4067270|P1|Overall Study|Withdrawal by Subject|5
1239903|NCT00654368|4067268|P3|Overall Study|Non-compliance|2
1239904|NCT00654368|4067269|P2|Overall Study|Non-compliance|1
1239905|NCT00654368|4067270|P1|Overall Study|Non-compliance|2
1239906|NCT00654368|4067268|P3|Overall Study|Protocol deviation|1
1239907|NCT00654368|4067269|P2|Overall Study|Protocol deviation|2
1239908|NCT00654368|4067270|P1|Overall Study|Protocol deviation|3
1239909|NCT00654368|4067268|P3|Overall Study|Ineligibility determined|0
1239910|NCT00654368|4067269|P2|Overall Study|Ineligibility determined|0
1239911|NCT00654368|4067270|P1|Overall Study|Ineligibility determined|6
1239912|NCT00654355|4067303|P2|Overall Study|Lost to Follow-up|2
1239913|NCT00654355|4067304|P1|Overall Study|Lost to Follow-up|2
1239914|NCT00654186|4067335|P1|Overall Study|Withdrawal by Subject|5
1239915|NCT00654095|4067360|P1|Overall Study|Did not meet inclusion criteria|1
1239916|NCT00654095|4067360|P1|Overall Study|Adverse reaction did not improve (5)|4
1239917|NCT00654095|4067360|P1|Overall Study|Elevated alanine aminotransferase (4)|7
1239918|NCT00654095|4067360|P1|Overall Study|Withdrawal by Subject|5
1239919|NCT00654095|4067360|P1|Overall Study|Adverse Event|11
1239920|NCT00654095|4067360|P1|Overall Study|Elevated alanine aminotransferase (3)|1
1239921|NCT00654095|4067360|P1|Overall Study|Elevated triglyceride level (2)|1
1239922|NCT00654095|4067360|P1|Overall Study|Drop in low density lipoprotein (1)|2
1239923|NCT00654004|4067383|P2|Overall Study|Lost to Follow-up|0
1239924|NCT00654004|4067384|P1|Overall Study|Lost to Follow-up|1
1239925|NCT00653939|4067400|P2|Overall Study|Not Specified|6
1239926|NCT00653939|4067401|P1|Overall Study|Not Specified|2
1239927|NCT00653939|4067400|P2|Overall Study|Disease Progression|3
1239928|NCT00653939|4067401|P1|Overall Study|Disease Progression|2
1239929|NCT00653939|4067400|P2|Overall Study|Physician Decision|0
1239930|NCT00653939|4067401|P1|Overall Study|Physician Decision|4
1239931|NCT00653939|4067400|P2|Overall Study|Withdrawal by Subject|3
1239932|NCT00653939|4067401|P1|Overall Study|Withdrawal by Subject|3
1239933|NCT00653939|4067400|P2|Overall Study|Adverse Event|3
1239934|NCT00653939|4067401|P1|Overall Study|Adverse Event|1
1239935|NCT00653523|4067426|P1|Overall Study|Adverse reaction did not improve (4)|1
1239936|NCT00653523|4067426|P1|Overall Study|Elevated alanine aminotransferase (3)|2
1239937|NCT00653523|4067426|P1|Overall Study|Withdrawal by Subject|6
1239938|NCT00653523|4067426|P1|Overall Study|Adverse Event|7
1239939|NCT00653523|4067426|P1|Overall Study|Elevated creatine phosphokinase (2)|1
1239940|NCT00653523|4067426|P1|Overall Study|Drop in low density lipoprotein (1)|2
1239941|NCT00653328|4067430|P1|Overall Study|Drug manufacturer no longing making drug|2
1239942|NCT00653328|4067430|P1|Overall Study|Disease progression|10
1239943|NCT00653328|4067430|P1|Overall Study|Adverse Event|2
1239944|NCT00653328|4067430|P1|Overall Study|Withdrawal by Subject|1
1239945|NCT00653263|4067437|P1|Overall Study|Physician Decision|1
1239946|NCT00653263|4067437|P1|Overall Study|Withdrawal by Subject|1
1239947|NCT00653224|4067445|P2|Overall Study|Other|4
1239948|NCT00653224|4067446|P1|Overall Study|Other|2
1239949|NCT00653224|4067445|P2|Overall Study|Lost to Follow-up|0
1239950|NCT00653224|4067446|P1|Overall Study|Lost to Follow-up|1
1239951|NCT00653224|4067445|P2|Overall Study|Loss of efficacy|0
1239952|NCT00653224|4067446|P1|Overall Study|Loss of efficacy|1
1239953|NCT00653224|4067445|P2|Overall Study|Lack of Efficacy|2
1239954|NCT00653224|4067446|P1|Overall Study|Lack of Efficacy|1
1239955|NCT00653224|4067445|P2|Overall Study|Adverse Event|1
1239956|NCT00653224|4067446|P1|Overall Study|Adverse Event|2
1239957|NCT00653159|4067632|P2|Overall Study|Lost to Follow-up|2
1239958|NCT00653159|4067633|P1|Overall Study|Lost to Follow-up|1
1239959|NCT00653159|4067632|P2|Overall Study|Adverse Event|1
1239960|NCT00653159|4067633|P1|Overall Study|Adverse Event|4
1239961|NCT00653068|4067660|P1|Overall Study|Ineligible|2
1239962|NCT00653068|4067660|P1|Overall Study|Withdrawal by Subject|1
1239963|NCT00653068|4067660|P1|Overall Study|Physician Decision|4
1239964|NCT00653068|4067660|P1|Overall Study|Lack of Efficacy|34
1239965|NCT00653068|4067660|P1|Overall Study|Death|9
1239966|NCT00652951|4067674|P3|Booster Phase|Not specified|0
1239967|NCT00652951|4067675|P2|Booster Phase|Not specified|0
1239968|NCT00652951|4067676|P1|Booster Phase|Not specified|1
1239969|NCT00652951|4067674|P3|Booster Phase|Adverse event, non-fatal|0
1239970|NCT00652951|4067675|P2|Booster Phase|Adverse event, non-fatal|1
1239971|NCT00652951|4067676|P1|Booster Phase|Adverse event, non-fatal|0
1239972|NCT00652938|4067813|P3|Overall Study|fear of blood sampling|0
1239973|NCT00652938|4067814|P2|Overall Study|fear of blood sampling|1
1239974|NCT00652938|4067815|P1|Overall Study|fear of blood sampling|0
1239975|NCT00652938|4067813|P3|Overall Study|Lost to Follow-up|2
1239976|NCT00652938|4067814|P2|Overall Study|Lost to Follow-up|0
1239977|NCT00652938|4067815|P1|Overall Study|Lost to Follow-up|0
1239978|NCT00652938|4067813|P3|Overall Study|Withdrawal by Subject|1
1239979|NCT00652938|4067814|P2|Overall Study|Withdrawal by Subject|6
1239980|NCT00652938|4067815|P1|Overall Study|Withdrawal by Subject|0
1239981|NCT00652938|4067813|P3|Overall Study|Adverse Event|2
1239982|NCT00652938|4067814|P2|Overall Study|Adverse Event|0
1239983|NCT00652938|4067815|P1|Overall Study|Adverse Event|1
1239984|NCT00652899|4067880|P1|Overall Study|Treating physician decision|1
1239985|NCT00652899|4067880|P1|Overall Study|Death|1
1239986|NCT00652834|4067890|P1|Overall Study|Lost to Follow-up|2
1239987|NCT00652834|4067890|P1|Overall Study|Withdrawal by Subject|3
1239988|NCT00652743|4067897|P3|Months 36-42|Other|8
1239989|NCT00652743|4067898|P2|Months 36-42|Other|2
1239990|NCT00652743|4067899|P1|Months 36-42|Other|4
1239991|NCT00652743|4067897|P3|Months 36-42|Migrated/moved from study area|0
1239992|NCT00652743|4067898|P2|Months 36-42|Migrated/moved from study area|0
1239993|NCT00652743|4067899|P1|Months 36-42|Migrated/moved from study area|1
1239994|NCT00652743|4067897|P3|Months 36-42|Lost to Follow-up|0
1239995|NCT00652743|4067898|P2|Months 36-42|Lost to Follow-up|1
1239996|NCT00652743|4067899|P1|Months 36-42|Lost to Follow-up|0
1239997|NCT00652743|4067897|P3|Months 36-42|Withdrawal by Subject|0
1239998|NCT00652743|4067898|P2|Months 36-42|Withdrawal by Subject|1
1239999|NCT00652743|4067899|P1|Months 36-42|Withdrawal by Subject|1
1240000|NCT00652743|4067897|P3|Months 36-42|Serious Adverse Events|1
1240001|NCT00652743|4067898|P2|Months 36-42|Serious Adverse Events|1
1240002|NCT00652743|4067899|P1|Months 36-42|Serious Adverse Events|0
1240003|NCT00652743|4067897|P3|Months 24-30|Other|11
1240004|NCT00652743|4067898|P2|Months 24-30|Other|1
1240005|NCT00652743|4067899|P1|Months 24-30|Other|5
1240006|NCT00652743|4067897|P3|Months 12-18|Lost to Follow-up|7
1240007|NCT00652743|4067898|P2|Months 12-18|Lost to Follow-up|2
1240008|NCT00652743|4067899|P1|Months 12-18|Lost to Follow-up|1
1240009|NCT00652626|4067981|P7|Extension Phase|Death|1
1240010|NCT00652626|4067982|P6|Extension Phase|Death|1
1240011|NCT00652626|4067983|P5|Extension Phase|Death|0
1240012|NCT00652626|4067984|P4|Extension Phase|Death|0
1240013|NCT00652626|4067985|P3|Extension Phase|Death|0
1240014|NCT00652626|4067986|P2|Extension Phase|Death|0
1240015|NCT00652626|4067987|P1|Extension Phase|Death|0
1240016|NCT00652626|4067981|P7|Extension Phase|Physician Decision|1
1240017|NCT00652626|4067982|P6|Extension Phase|Physician Decision|1
1240018|NCT00652626|4067983|P5|Extension Phase|Physician Decision|0
1240019|NCT00652626|4067984|P4|Extension Phase|Physician Decision|0
1240020|NCT00652626|4067985|P3|Extension Phase|Physician Decision|0
1240021|NCT00652626|4067986|P2|Extension Phase|Physician Decision|0
1240022|NCT00652626|4067987|P1|Extension Phase|Physician Decision|0
1240023|NCT00652626|4067981|P7|Extension Phase|No Longer Receiving Clinical Benefit|0
1240024|NCT00652626|4067982|P6|Extension Phase|No Longer Receiving Clinical Benefit|6
1240025|NCT00652626|4067983|P5|Extension Phase|No Longer Receiving Clinical Benefit|0
1240026|NCT00652626|4067984|P4|Extension Phase|No Longer Receiving Clinical Benefit|0
1240027|NCT00652626|4067985|P3|Extension Phase|No Longer Receiving Clinical Benefit|0
1240028|NCT00652626|4067986|P2|Extension Phase|No Longer Receiving Clinical Benefit|0
1240029|NCT00652626|4067987|P1|Extension Phase|No Longer Receiving Clinical Benefit|0
1240030|NCT00652626|4067981|P7|Extension Phase|Adverse Event|1
1240031|NCT00652626|4067982|P6|Extension Phase|Adverse Event|2
1240032|NCT00652626|4067983|P5|Extension Phase|Adverse Event|0
1240033|NCT00652626|4067984|P4|Extension Phase|Adverse Event|0
1240034|NCT00652626|4067985|P3|Extension Phase|Adverse Event|0
1240035|NCT00652626|4067986|P2|Extension Phase|Adverse Event|0
1240036|NCT00652626|4067987|P1|Extension Phase|Adverse Event|0
1240037|NCT00652626|4067981|P7|Extension Phase|Withdrawal by Subject|0
1240038|NCT00652626|4067982|P6|Extension Phase|Withdrawal by Subject|2
1240039|NCT00652626|4067983|P5|Extension Phase|Withdrawal by Subject|0
1240040|NCT00652626|4067984|P4|Extension Phase|Withdrawal by Subject|0
1240041|NCT00652626|4067985|P3|Extension Phase|Withdrawal by Subject|0
1240042|NCT00652626|4067986|P2|Extension Phase|Withdrawal by Subject|0
1240043|NCT00652626|4067987|P1|Extension Phase|Withdrawal by Subject|0
1240044|NCT00652626|4067981|P7|Initial Treatment Phase|Lost to Follow-up|0
1240045|NCT00652626|4067982|P6|Initial Treatment Phase|Lost to Follow-up|0
1240046|NCT00652626|4067983|P5|Initial Treatment Phase|Lost to Follow-up|1
1240047|NCT00652626|4067984|P4|Initial Treatment Phase|Lost to Follow-up|0
1240048|NCT00652626|4067985|P3|Initial Treatment Phase|Lost to Follow-up|0
1240049|NCT00652626|4067986|P2|Initial Treatment Phase|Lost to Follow-up|0
1240050|NCT00652626|4067987|P1|Initial Treatment Phase|Lost to Follow-up|0
1240051|NCT00652626|4067981|P7|Initial Treatment Phase|Sponsor Request|0
1240052|NCT00652626|4067982|P6|Initial Treatment Phase|Sponsor Request|0
1240053|NCT00652626|4067983|P5|Initial Treatment Phase|Sponsor Request|0
1240054|NCT00652626|4067984|P4|Initial Treatment Phase|Sponsor Request|0
1240055|NCT00652626|4067985|P3|Initial Treatment Phase|Sponsor Request|1
1240056|NCT00652626|4067986|P2|Initial Treatment Phase|Sponsor Request|0
1240057|NCT00652626|4067987|P1|Initial Treatment Phase|Sponsor Request|0
1240058|NCT00652626|4067981|P7|Initial Treatment Phase|Physician Decision|0
1240059|NCT00652626|4067982|P6|Initial Treatment Phase|Physician Decision|0
1240060|NCT00652626|4067983|P5|Initial Treatment Phase|Physician Decision|1
1240061|NCT00652626|4067984|P4|Initial Treatment Phase|Physician Decision|0
1240062|NCT00652626|4067985|P3|Initial Treatment Phase|Physician Decision|0
1240063|NCT00652626|4067986|P2|Initial Treatment Phase|Physician Decision|0
1240064|NCT00652626|4067987|P1|Initial Treatment Phase|Physician Decision|0
1240065|NCT00652626|4067981|P7|Initial Treatment Phase|Protocol Violation|0
1240066|NCT00652626|4067982|P6|Initial Treatment Phase|Protocol Violation|0
1240067|NCT00652626|4067983|P5|Initial Treatment Phase|Protocol Violation|0
1240068|NCT00652626|4067984|P4|Initial Treatment Phase|Protocol Violation|1
1240069|NCT00652626|4067985|P3|Initial Treatment Phase|Protocol Violation|0
1240070|NCT00652626|4067986|P2|Initial Treatment Phase|Protocol Violation|0
1240071|NCT00652626|4067987|P1|Initial Treatment Phase|Protocol Violation|0
1240072|NCT00652626|4067981|P7|Initial Treatment Phase|Adverse Event|0
1240073|NCT00652626|4067982|P6|Initial Treatment Phase|Adverse Event|0
1240074|NCT00652626|4067983|P5|Initial Treatment Phase|Adverse Event|1
1240075|NCT00652626|4067984|P4|Initial Treatment Phase|Adverse Event|0
1240076|NCT00652626|4067985|P3|Initial Treatment Phase|Adverse Event|0
1240077|NCT00652626|4067986|P2|Initial Treatment Phase|Adverse Event|0
1240078|NCT00652626|4067987|P1|Initial Treatment Phase|Adverse Event|0
1240079|NCT00652366|4068056|P5|Overall Study|Not specified|0
1240080|NCT00652366|4068057|P4|Overall Study|Not specified|4
1240081|NCT00652366|4068058|P3|Overall Study|Not specified|3
1240082|NCT00652366|4068059|P2|Overall Study|Not specified|2
1240083|NCT00652366|4068060|P1|Overall Study|Not specified|5
1240084|NCT00652366|4068056|P5|Overall Study|Refused treatment|5
1240085|NCT00652366|4068057|P4|Overall Study|Refused treatment|17
1240086|NCT00652366|4068058|P3|Overall Study|Refused treatment|6
1240087|NCT00652366|4068059|P2|Overall Study|Refused treatment|7
1240088|NCT00652366|4068060|P1|Overall Study|Refused treatment|3
1240089|NCT00652366|4068056|P5|Overall Study|Protocol Violation|0
1240090|NCT00652366|4068057|P4|Overall Study|Protocol Violation|0
1240091|NCT00652366|4068058|P3|Overall Study|Protocol Violation|0
1240092|NCT00652366|4068059|P2|Overall Study|Protocol Violation|0
1240093|NCT00652366|4068060|P1|Overall Study|Protocol Violation|1
1240094|NCT00652366|4068056|P5|Overall Study|Violation of Selection Criteria|0
1240095|NCT00652366|4068057|P4|Overall Study|Violation of Selection Criteria|0
1240096|NCT00652366|4068058|P3|Overall Study|Violation of Selection Criteria|1
1240097|NCT00652366|4068059|P2|Overall Study|Violation of Selection Criteria|0
1240098|NCT00652366|4068060|P1|Overall Study|Violation of Selection Criteria|0
1240099|NCT00652366|4068056|P5|Overall Study|Lack of Efficacy|13
1240100|NCT00652366|4068057|P4|Overall Study|Lack of Efficacy|133
1240101|NCT00652366|4068058|P3|Overall Study|Lack of Efficacy|53
1240102|NCT00652366|4068059|P2|Overall Study|Lack of Efficacy|58
1240103|NCT00652366|4068060|P1|Overall Study|Lack of Efficacy|84
1240104|NCT00652366|4068056|P5|Overall Study|Death|5
1240105|NCT00652366|4068057|P4|Overall Study|Death|8
1240106|NCT00652366|4068058|P3|Overall Study|Death|1
1240107|NCT00652366|4068059|P2|Overall Study|Death|4
1240108|NCT00652366|4068060|P1|Overall Study|Death|5
1240109|NCT00652366|4068056|P5|Overall Study|Adverse Event|13
1240110|NCT00652366|4068057|P4|Overall Study|Adverse Event|17
1240111|NCT00652366|4068058|P3|Overall Study|Adverse Event|7
1240112|NCT00652366|4068059|P2|Overall Study|Adverse Event|4
1240113|NCT00652366|4068060|P1|Overall Study|Adverse Event|8
1240114|NCT00652340|4068095|P2|Overall Study|Had not progressed.|3
1240115|NCT00652340|4068096|P1|Overall Study|Had not progressed.|4
1240116|NCT00652327|4068106|P2|Overall Study|Lost to Follow-up|3
1240117|NCT00652327|4068107|P1|Overall Study|Lost to Follow-up|0
1240118|NCT00652327|4068106|P2|Overall Study|Adverse Event|2
1240119|NCT00652327|4068107|P1|Overall Study|Adverse Event|0
1240120|NCT00652093|4068149|P6|Overall Study|Physician Decision|0
1240121|NCT00652093|4068150|P5|Overall Study|Physician Decision|1
1240122|NCT00652093|4068151|P4|Overall Study|Physician Decision|0
1240123|NCT00652093|4068152|P3|Overall Study|Physician Decision|0
1240124|NCT00652093|4068153|P2|Overall Study|Physician Decision|0
1240125|NCT00652093|4068154|P1|Overall Study|Physician Decision|0
1240126|NCT00652093|4068149|P6|Overall Study|Withdrawal by Subject|0
1240127|NCT00652093|4068150|P5|Overall Study|Withdrawal by Subject|1
1240128|NCT00652093|4068151|P4|Overall Study|Withdrawal by Subject|0
1240129|NCT00652093|4068152|P3|Overall Study|Withdrawal by Subject|1
1240130|NCT00652093|4068153|P2|Overall Study|Withdrawal by Subject|0
1240131|NCT00652093|4068154|P1|Overall Study|Withdrawal by Subject|0
1240132|NCT00652028|4068238|P4|Overall Study|Physician Decision|0
1240133|NCT00652028|4068239|P3|Overall Study|Physician Decision|1
1240134|NCT00652028|4068240|P2|Overall Study|Physician Decision|0
1240135|NCT00652028|4068241|P1|Overall Study|Physician Decision|0
1240136|NCT00652028|4068238|P4|Overall Study|No Longer Meets Entry Criteria|0
1240137|NCT00652028|4068239|P3|Overall Study|No Longer Meets Entry Criteria|0
1240138|NCT00652028|4068240|P2|Overall Study|No Longer Meets Entry Criteria|1
1240139|NCT00652028|4068241|P1|Overall Study|No Longer Meets Entry Criteria|0
1240140|NCT00652028|4068238|P4|Overall Study|Adverse Event|0
1240141|NCT00652028|4068239|P3|Overall Study|Adverse Event|0
1240142|NCT00652028|4068240|P2|Overall Study|Adverse Event|0
1240143|NCT00652028|4068241|P1|Overall Study|Adverse Event|1
1240144|NCT00651924|4068285|P2|Overall Study|Withdrawal by Subject|5
1240145|NCT00651924|4068286|P1|Overall Study|Withdrawal by Subject|0
1240146|NCT00651924|4068285|P2|Overall Study|Withdrawal by PI|2
1240147|NCT00651924|4068286|P1|Overall Study|Withdrawal by PI|0
1240148|NCT00651820|4068292|P1|Overall Study|Lost to Follow-up|2
1240149|NCT00651755|4068324|P2|Cycle 2 (Second 21 Days)|Not Evaluable|1
1240150|NCT00651755|4068325|P1|Cycle 2 (Second 21 Days)|Not Evaluable|0
1240151|NCT00651755|4068324|P2|Cycle 1 (First 21 Days)|Withdrawal by Subject|0
1240152|NCT00651755|4068325|P1|Cycle 1 (First 21 Days)|Withdrawal by Subject|1
1240153|NCT00651313|4068370|P2|Overall Study|Adminstrative Discontinuation|3
1240154|NCT00651313|4068371|P1|Overall Study|Adminstrative Discontinuation|2
1240155|NCT00651313|4068370|P2|Overall Study|Lost to Follow-up|1
1240156|NCT00651313|4068371|P1|Overall Study|Lost to Follow-up|1
1240157|NCT00651313|4068370|P2|Overall Study|Withdrawal by Subject|1
1240158|NCT00651313|4068371|P1|Overall Study|Withdrawal by Subject|3
1240159|NCT00651313|4068370|P2|Overall Study|Adverse Event|1
1240160|NCT00651313|4068371|P1|Overall Study|Adverse Event|0
1240161|NCT00651261|4068379|P2|Overall Study|Never treated|3
1240162|NCT00651261|4068380|P1|Overall Study|Never treated|5
1240163|NCT00651261|4068379|P2|Overall Study|Other disease or participant decisions|23
1240164|NCT00651261|4068380|P1|Overall Study|Other disease or participant decisions|23
1240165|NCT00651261|4068379|P2|Overall Study|Alternative therapy|107
1240166|NCT00651261|4068380|P1|Overall Study|Alternative therapy|109
1240167|NCT00651261|4068379|P2|Overall Study|Disease progression|58
1240168|NCT00651261|4068380|P1|Overall Study|Disease progression|58
1240169|NCT00651261|4068379|P2|Overall Study|Induction failure|35
1240170|NCT00651261|4068380|P1|Overall Study|Induction failure|24
1240171|NCT00651261|4068379|P2|Overall Study|Withdrawal by Subject|40
1240172|NCT00651261|4068380|P1|Overall Study|Withdrawal by Subject|22
1240173|NCT00651261|4068379|P2|Overall Study|Death|18
1240174|NCT00651261|4068380|P1|Overall Study|Death|18
1240175|NCT00651261|4068379|P2|Overall Study|Adverse Event|22
1240176|NCT00651261|4068380|P1|Overall Study|Adverse Event|32
1240177|NCT00651183|4068396|P2|Overall Study|missing|0
1240178|NCT00651183|4068397|P1|Overall Study|missing|1
1240179|NCT00651183|4068396|P2|Overall Study|Other reasons|2
1240180|NCT00651183|4068397|P1|Overall Study|Other reasons|4
1240181|NCT00651183|4068396|P2|Overall Study|Lost to Follow-up|1
1240182|NCT00651183|4068397|P1|Overall Study|Lost to Follow-up|3
1240183|NCT00651183|4068396|P2|Overall Study|Withdrawal by Subject|3
1240184|NCT00651183|4068397|P1|Overall Study|Withdrawal by Subject|6
1240185|NCT00651183|4068396|P2|Overall Study|Tolerability insufficient +Patients wish|1
1240186|NCT00651183|4068397|P1|Overall Study|Tolerability insufficient +Patients wish|0
1240187|NCT00651183|4068396|P2|Overall Study|Tolerability insufficient|2
1240188|NCT00651183|4068397|P1|Overall Study|Tolerability insufficient|5
1240189|NCT00651183|4068396|P2|Overall Study|Efficacy insufficient + patients wish|1
1240190|NCT00651183|4068397|P1|Overall Study|Efficacy insufficient + patients wish|0
1240191|NCT00651183|4068396|P2|Overall Study|Lack of Efficacy|0
1240192|NCT00651183|4068397|P1|Overall Study|Lack of Efficacy|1
1240193|NCT00651157|4068409|P1|Overall Study|Protocol Violation|1
1240194|NCT00651157|4068409|P1|Overall Study|Death|1
1240195|NCT00651118|4068419|P4|Overall Study|Withdrawal by Subject|1
1240196|NCT00651118|4068420|P3|Overall Study|Withdrawal by Subject|1
1240197|NCT00651118|4068421|P2|Overall Study|Withdrawal by Subject|1
1240198|NCT00651118|4068422|P1|Overall Study|Withdrawal by Subject|0
1240199|NCT00651118|4068419|P4|Overall Study|administrative|1
1240200|NCT00651118|4068420|P3|Overall Study|administrative|2
1240201|NCT00651118|4068421|P2|Overall Study|administrative|4
1240202|NCT00651118|4068422|P1|Overall Study|administrative|1
1240203|NCT00651118|4068419|P4|Overall Study|Lost to Follow-up|2
1240204|NCT00651118|4068420|P3|Overall Study|Lost to Follow-up|1
1240205|NCT00651118|4068421|P2|Overall Study|Lost to Follow-up|0
1240206|NCT00651118|4068422|P1|Overall Study|Lost to Follow-up|2
1240207|NCT00651118|4068419|P4|Overall Study|Protocol Violation|2
1240208|NCT00651118|4068420|P3|Overall Study|Protocol Violation|6
1240209|NCT00651118|4068421|P2|Overall Study|Protocol Violation|2
1240210|NCT00651118|4068422|P1|Overall Study|Protocol Violation|2
1240211|NCT00651118|4068419|P4|Overall Study|Adverse Event|1
1240212|NCT00651118|4068420|P3|Overall Study|Adverse Event|1
1240213|NCT00651118|4068421|P2|Overall Study|Adverse Event|0
1240214|NCT00651118|4068422|P1|Overall Study|Adverse Event|4
1240215|NCT00650845|4068485|P2|Overall Study|Protocol Violation|13
1240216|NCT00650845|4068486|P1|Overall Study|Protocol Violation|0
1240217|NCT00650845|4068485|P2|Overall Study|Withdrawal by Subject|0
1240218|NCT00650845|4068486|P1|Overall Study|Withdrawal by Subject|5
1240219|NCT00650806|4068506|P4|Overall Study|Not specified|0
1240220|NCT00650806|4068507|P3|Overall Study|Not specified|2
1240221|NCT00650806|4068508|P2|Overall Study|Not specified|1
1240222|NCT00650806|4068509|P1|Overall Study|Not specified|1
1240223|NCT00650806|4068506|P4|Overall Study|Study terminated by sponsor|4
1240224|NCT00650806|4068507|P3|Overall Study|Study terminated by sponsor|5
1240225|NCT00650806|4068508|P2|Overall Study|Study terminated by sponsor|3
1240226|NCT00650806|4068509|P1|Overall Study|Study terminated by sponsor|2
1240227|NCT00650806|4068506|P4|Overall Study|Noncompliance with study drug regimen|0
1240228|NCT00650806|4068507|P3|Overall Study|Noncompliance with study drug regimen|0
1240229|NCT00650806|4068508|P2|Overall Study|Noncompliance with study drug regimen|1
1240230|NCT00650806|4068509|P1|Overall Study|Noncompliance with study drug regimen|1
1240231|NCT00650806|4068506|P4|Overall Study|Withdrawal by Subject|6
1240232|NCT00650806|4068507|P3|Overall Study|Withdrawal by Subject|8
1240233|NCT00650806|4068508|P2|Overall Study|Withdrawal by Subject|5
1240234|NCT00650806|4068509|P1|Overall Study|Withdrawal by Subject|7
1240235|NCT00650806|4068506|P4|Overall Study|Pregnancy|1
1240236|NCT00650806|4068507|P3|Overall Study|Pregnancy|0
1240237|NCT00650806|4068508|P2|Overall Study|Pregnancy|0
1240238|NCT00650806|4068509|P1|Overall Study|Pregnancy|0
1240239|NCT00650806|4068506|P4|Overall Study|Protocol Violation|1
1240240|NCT00650806|4068507|P3|Overall Study|Protocol Violation|0
1240241|NCT00650806|4068508|P2|Overall Study|Protocol Violation|0
1240242|NCT00650806|4068509|P1|Overall Study|Protocol Violation|0
1240243|NCT00650806|4068506|P4|Overall Study|Lost to Follow-up|10
1240244|NCT00650806|4068507|P3|Overall Study|Lost to Follow-up|11
1240245|NCT00650806|4068508|P2|Overall Study|Lost to Follow-up|6
1240246|NCT00650806|4068509|P1|Overall Study|Lost to Follow-up|7
1240247|NCT00650806|4068506|P4|Overall Study|Adverse Event|4
1240248|NCT00650806|4068507|P3|Overall Study|Adverse Event|3
1240249|NCT00650806|4068508|P2|Overall Study|Adverse Event|5
1240250|NCT00650806|4068509|P1|Overall Study|Adverse Event|0
1240251|NCT00650767|4068551|P4|Overall Study|Other|0
1240252|NCT00650767|4068552|P3|Overall Study|Other|0
1240253|NCT00650767|4068553|P2|Overall Study|Other|1
1240254|NCT00650767|4068554|P1|Overall Study|Other|1
1240255|NCT00650767|4068551|P4|Overall Study|Lost to Follow-up|0
1240256|NCT00650767|4068552|P3|Overall Study|Lost to Follow-up|1
1240257|NCT00650767|4068553|P2|Overall Study|Lost to Follow-up|1
1240258|NCT00650767|4068554|P1|Overall Study|Lost to Follow-up|1
1240259|NCT00650767|4068551|P4|Overall Study|Withdrawal by Subject|3
1240260|NCT00650767|4068552|P3|Overall Study|Withdrawal by Subject|3
1240261|NCT00650767|4068553|P2|Overall Study|Withdrawal by Subject|4
1240262|NCT00650767|4068554|P1|Overall Study|Withdrawal by Subject|2
1240263|NCT00650767|4068551|P4|Overall Study|Death|0
1240264|NCT00650767|4068552|P3|Overall Study|Death|0
1240265|NCT00650767|4068553|P2|Overall Study|Death|0
1240266|NCT00650767|4068554|P1|Overall Study|Death|1
1240267|NCT00650767|4068551|P4|Overall Study|Adverse Event|8
1240268|NCT00650767|4068552|P3|Overall Study|Adverse Event|10
1240269|NCT00650767|4068553|P2|Overall Study|Adverse Event|3
1240270|NCT00650767|4068554|P1|Overall Study|Adverse Event|0
1240271|NCT00650585|4069058|P2|Overall Study|Excluded/ruled ineligible|129
1240272|NCT00650585|4069059|P1|Overall Study|Excluded/ruled ineligible|357
1240273|NCT00650585|4069058|P2|Overall Study|No parental consent|866
1240274|NCT00650585|4069059|P1|Overall Study|No parental consent|935
1240275|NCT00650585|4069058|P2|Overall Study|Lost to Follow-up|482
1240276|NCT00650585|4069059|P1|Overall Study|Lost to Follow-up|505
1240277|NCT00650104|4069103|P1|Overall Study|Sponsor Terminated Dosing|1
1240278|NCT00650104|4069103|P1|Overall Study|Non-compliance|2
1240279|NCT00650104|4069103|P1|Overall Study|Lost to Follow-up|1
1240280|NCT00650104|4069103|P1|Overall Study|Physician Decision|7
1240281|NCT00650104|4069103|P1|Overall Study|Withdrawal by Subject|11
1240282|NCT00650104|4069103|P1|Overall Study|Death|2
1240283|NCT00650104|4069103|P1|Overall Study|Adverse Event|17
1240284|NCT00650091|4069118|P3|Amended Study Design|Not specified|0
1240285|NCT00650091|4069119|P2|Amended Study Design|Not specified|3
1240286|NCT00650091|4069120|P1|Amended Study Design|Not specified|1
1240287|NCT00650091|4069118|P3|Amended Study Design|Lung transplantation|0
1240288|NCT00650091|4069119|P2|Amended Study Design|Lung transplantation|2
1240289|NCT00650091|4069120|P1|Amended Study Design|Lung transplantation|4
1240290|NCT00650091|4069118|P3|Amended Study Design|Adverse Event|0
1240291|NCT00650091|4069119|P2|Amended Study Design|Adverse Event|4
1240292|NCT00650091|4069120|P1|Amended Study Design|Adverse Event|1
1240293|NCT00650091|4069118|P3|Amended Study Design|Physician Decision|0
1240294|NCT00650091|4069119|P2|Amended Study Design|Physician Decision|0
1240295|NCT00650091|4069120|P1|Amended Study Design|Physician Decision|5
1240296|NCT00650091|4069118|P3|Amended Study Design|Withdrawal by Subject|0
1240297|NCT00650091|4069119|P2|Amended Study Design|Withdrawal by Subject|11
1240298|NCT00650091|4069120|P1|Amended Study Design|Withdrawal by Subject|12
1240299|NCT00649428|4069163|P2|Overall Study|Physician Decision|1
1240300|NCT00649428|4069164|P1|Overall Study|Physician Decision|0
1240301|NCT00649428|4069163|P2|Overall Study|Protocol Violation|2
1240302|NCT00649428|4069164|P1|Overall Study|Protocol Violation|6
1240303|NCT00649428|4069163|P2|Overall Study|Insufficient manufacturing yield|1
1240304|NCT00649428|4069164|P1|Overall Study|Insufficient manufacturing yield|5
1240305|NCT00649428|4069163|P2|Overall Study|Lost to Follow-up|3
1240306|NCT00649428|4069164|P1|Overall Study|Lost to Follow-up|1
1240307|NCT00649428|4069163|P2|Overall Study|Withdrawal by Subject|6
1240308|NCT00649428|4069164|P1|Overall Study|Withdrawal by Subject|6
1240309|NCT00649428|4069163|P2|Overall Study|Adverse Event|2
1240310|NCT00649428|4069164|P1|Overall Study|Adverse Event|2
1240311|NCT00649389|4069180|P4|Overall Study|Other|6
1240312|NCT00649389|4069181|P3|Overall Study|Other|1
1240313|NCT00649389|4069182|P2|Overall Study|Other|9
1240314|NCT00649389|4069183|P1|Overall Study|Other|3
1240315|NCT00649389|4069180|P4|Overall Study|Withdrawal by Subject|23
1240316|NCT00649389|4069181|P3|Overall Study|Withdrawal by Subject|19
1240317|NCT00649389|4069182|P2|Overall Study|Withdrawal by Subject|21
1240318|NCT00649389|4069183|P1|Overall Study|Withdrawal by Subject|20
1240319|NCT00649389|4069180|P4|Overall Study|Protocol Violation|8
1240320|NCT00649389|4069181|P3|Overall Study|Protocol Violation|9
1240321|NCT00649389|4069182|P2|Overall Study|Protocol Violation|13
1240322|NCT00649389|4069183|P1|Overall Study|Protocol Violation|11
1240323|NCT00649389|4069180|P4|Overall Study|Lost to Follow-up|26
1240324|NCT00649389|4069181|P3|Overall Study|Lost to Follow-up|21
1240325|NCT00649389|4069182|P2|Overall Study|Lost to Follow-up|17
1240326|NCT00649389|4069183|P1|Overall Study|Lost to Follow-up|15
1240327|NCT00649389|4069180|P4|Overall Study|Adverse Event|48
1240328|NCT00649389|4069181|P3|Overall Study|Adverse Event|38
1240329|NCT00649389|4069182|P2|Overall Study|Adverse Event|46
1240330|NCT00649389|4069183|P1|Overall Study|Adverse Event|22
1240331|NCT00649220|4069205|P1|Overall Study|Withdrawal by Subject|1
1240332|NCT00649220|4069205|P1|Overall Study|Adverse Event|2
1240333|NCT00648895|4069226|P2|Overall Study|Lack of Efficacy|1
1240334|NCT00648895|4069227|P1|Overall Study|Lack of Efficacy|0
1240335|NCT00648167|4069233|P1|Overall Study|unable to swallow tablets|1
1240336|NCT00648167|4069233|P1|Overall Study|Adverse Event|6
1240337|NCT00648037|4069253|P1|Overall Study|Other|1
1240338|NCT00648037|4069253|P1|Overall Study|Relapse|2
1240339|NCT00648037|4069253|P1|Overall Study|Adverse Event|11
1240340|NCT00648037|4069253|P1|Overall Study|Withdrawal by Subject|1
1240341|NCT00648037|4069253|P1|Overall Study|Not Treated|1
1240342|NCT00647699|4069272|P2|Overall Study|Withdrawal by Subject|8
1240343|NCT00647699|4069273|P1|Overall Study|Withdrawal by Subject|3
1240344|NCT00647699|4069272|P2|Overall Study|Lost to Follow-up|4
1240345|NCT00647699|4069273|P1|Overall Study|Lost to Follow-up|5
1240346|NCT00647556|4069281|P2|Overall Study|Surgery for pre-existing neck pain|0
1240347|NCT00647556|4069282|P1|Overall Study|Surgery for pre-existing neck pain|1
1240348|NCT00647556|4069281|P2|Overall Study|Withdrawal by Subject|0
1240349|NCT00647556|4069282|P1|Overall Study|Withdrawal by Subject|1
1240350|NCT00647556|4069281|P2|Overall Study|Protocol Violation|1
1240351|NCT00647556|4069282|P1|Overall Study|Protocol Violation|0
1240352|NCT00647556|4069281|P2|Overall Study|Lost to Follow-up|0
1240353|NCT00647556|4069282|P1|Overall Study|Lost to Follow-up|1
1240354|NCT00647556|4069281|P2|Overall Study|Adverse Event|1
1240355|NCT00647556|4069282|P1|Overall Study|Adverse Event|0
1240356|NCT00647270|4069312|P3|Period 2, Placebo Switched to Adalimumab|Other|0
1240357|NCT00647270|4069313|P2|Period 2, Placebo Switched to Adalimumab|Other|6
1240358|NCT00647270|4069314|P1|Period 2, Placebo Switched to Adalimumab|Other|2
1240359|NCT00647270|4069312|P3|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4
1240360|NCT00647270|4069313|P2|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
1240361|NCT00647270|4069314|P1|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
1240362|NCT00647270|4069312|P3|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
1240363|NCT00647270|4069313|P2|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
1240364|NCT00647270|4069314|P1|Period 2, Placebo Switched to Adalimumab|Adverse Event|1
1240365|NCT00647270|4069312|P3|Period 1, Placebo-control (12 Weeks)|Other|8
1240366|NCT00647270|4069313|P2|Period 1, Placebo-control (12 Weeks)|Other|4
1240367|NCT00647270|4069314|P1|Period 1, Placebo-control (12 Weeks)|Other|4
1240368|NCT00647270|4069312|P3|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7
1240369|NCT00647270|4069313|P2|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1
1240370|NCT00647270|4069314|P1|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2
1240371|NCT00647270|4069312|P3|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
1240372|NCT00647270|4069313|P2|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
1240373|NCT00647270|4069314|P1|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0
1240374|NCT00647270|4069312|P3|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
1240375|NCT00647270|4069313|P2|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
1240376|NCT00647270|4069314|P1|Period 1, Placebo-control (12 Weeks)|Adverse Event|2
1240377|NCT00646958|4069340|P3|Overall Study|Did not receive study drug|2
1240378|NCT00646958|4069341|P2|Overall Study|Did not receive study drug|0
1240379|NCT00646958|4069342|P1|Overall Study|Did not receive study drug|2
1240380|NCT00646958|4069340|P3|Overall Study|Withdrawal by Subject|0
1240381|NCT00646958|4069341|P2|Overall Study|Withdrawal by Subject|2
1240382|NCT00646958|4069342|P1|Overall Study|Withdrawal by Subject|1
1240383|NCT00646958|4069340|P3|Overall Study|Abnormal screening lab tests|0
1240384|NCT00646958|4069341|P2|Overall Study|Abnormal screening lab tests|1
1240385|NCT00646958|4069342|P1|Overall Study|Abnormal screening lab tests|1
1240386|NCT00646958|4069340|P3|Overall Study|Protocol Violation|0
1240387|NCT00646958|4069341|P2|Overall Study|Protocol Violation|1
1240388|NCT00646958|4069342|P1|Overall Study|Protocol Violation|1
1240389|NCT00646958|4069340|P3|Overall Study|Lost to Follow-up|7
1240390|NCT00646958|4069341|P2|Overall Study|Lost to Follow-up|5
1240391|NCT00646958|4069342|P1|Overall Study|Lost to Follow-up|1
1240392|NCT00646958|4069340|P3|Overall Study|Adverse Event|0
1240393|NCT00646958|4069341|P2|Overall Study|Adverse Event|0
1240394|NCT00646958|4069342|P1|Overall Study|Adverse Event|4
1240395|NCT00646958|4069340|P3|Overall Study|Lack of Efficacy|0
1240396|NCT00646958|4069341|P2|Overall Study|Lack of Efficacy|0
1240397|NCT00646958|4069342|P1|Overall Study|Lack of Efficacy|1
1240398|NCT00646776|4069355|P2|Overall Study|Investigator discretion|4
1240399|NCT00646776|4069356|P1|Overall Study|Investigator discretion|0
1240400|NCT00646776|4069355|P2|Overall Study|Adverse Event|9
1240401|NCT00646776|4069356|P1|Overall Study|Adverse Event|1
1240402|NCT00646399|4069454|P2|Overall Study|Other Reason|11
1240403|NCT00646399|4069455|P1|Overall Study|Other Reason|11
1240404|NCT00646399|4069454|P2|Overall Study|Withdrawal by Subject|10
1240405|NCT00646399|4069455|P1|Overall Study|Withdrawal by Subject|9
1240406|NCT00646399|4069454|P2|Overall Study|Death|53
1240407|NCT00646399|4069455|P1|Overall Study|Death|63
1240408|NCT00646282|4069463|P2|Overall Study|Protocol terminated|4
1240409|NCT00646282|4069464|P1|Overall Study|Protocol terminated|4
1240410|NCT00645944|4069487|P2|Received Medication|Protocol Violation|1
1240411|NCT00645944|4069488|P1|Received Medication|Protocol Violation|2
1240412|NCT00645944|4069487|P2|Received Medication|Lost to Follow-up|0
1240413|NCT00645944|4069488|P1|Received Medication|Lost to Follow-up|1
1240414|NCT00645944|4069487|P2|Received Medication|Withdrawal by Subject|1
1240415|NCT00645944|4069488|P1|Received Medication|Withdrawal by Subject|1
1240416|NCT00645944|4069487|P2|Received Medication|Adverse Event|1
1240417|NCT00645944|4069488|P1|Received Medication|Adverse Event|2
1240418|NCT00645944|4069487|P2|Randomized|Withdrawal by Subject|2
1240419|NCT00645944|4069488|P1|Randomized|Withdrawal by Subject|1
1240420|NCT00645853|4069496|P2|Overall Study|recall of ICF, planned operation, death|4
1240421|NCT00645853|4069497|P1|Overall Study|recall of ICF, planned operation, death|7
1240422|NCT00645853|4069496|P2|Overall Study|Discontinuation criteria|2
1240423|NCT00645853|4069497|P1|Overall Study|Discontinuation criteria|2
1240424|NCT00645853|4069496|P2|Overall Study|Protocol Violation|2
1240425|NCT00645853|4069497|P1|Overall Study|Protocol Violation|0
1240426|NCT00645853|4069496|P2|Overall Study|Withdrawal by Subject|2
1240427|NCT00645853|4069497|P1|Overall Study|Withdrawal by Subject|5
1240428|NCT00645853|4069496|P2|Overall Study|AZ study closure in Hungary|40
1240429|NCT00645853|4069497|P1|Overall Study|AZ study closure in Hungary|60
1240430|NCT00645853|4069496|P2|Overall Study|Adverse Event|7
1240431|NCT00645853|4069497|P1|Overall Study|Adverse Event|18
1240432|NCT00645788|4069528|P4|Overall Study|Pulmonary exacerbation|9
1240433|NCT00645788|4069529|P3|Overall Study|Pulmonary exacerbation|11
1240434|NCT00645788|4069530|P2|Overall Study|Pulmonary exacerbation|16
1240435|NCT00645788|4069531|P1|Overall Study|Pulmonary exacerbation|13
1240436|NCT00645788|4069528|P4|Overall Study|Withdrawal by Subject|2
1240437|NCT00645788|4069529|P3|Overall Study|Withdrawal by Subject|0
1240438|NCT00645788|4069530|P2|Overall Study|Withdrawal by Subject|1
1240439|NCT00645788|4069531|P1|Overall Study|Withdrawal by Subject|0
1240440|NCT00645788|4069528|P4|Overall Study|Protocol Violation|0
1240441|NCT00645788|4069529|P3|Overall Study|Protocol Violation|2
1240442|NCT00645788|4069530|P2|Overall Study|Protocol Violation|0
1240443|NCT00645788|4069531|P1|Overall Study|Protocol Violation|1
1240444|NCT00645788|4069528|P4|Overall Study|Lost to Follow-up|0
1240445|NCT00645788|4069529|P3|Overall Study|Lost to Follow-up|0
1240446|NCT00645788|4069530|P2|Overall Study|Lost to Follow-up|0
1240447|NCT00645788|4069531|P1|Overall Study|Lost to Follow-up|1
1240448|NCT00645788|4069528|P4|Overall Study|Adverse Event|3
1240449|NCT00645788|4069529|P3|Overall Study|Adverse Event|5
1240450|NCT00645788|4069530|P2|Overall Study|Adverse Event|9
1240451|NCT00645788|4069531|P1|Overall Study|Adverse Event|4
1240452|NCT00645788|4069528|P4|Overall Study|Did not receive study drug|0
1240453|NCT00645788|4069529|P3|Overall Study|Did not receive study drug|0
1240454|NCT00645788|4069530|P2|Overall Study|Did not receive study drug|1
1240455|NCT00645788|4069531|P1|Overall Study|Did not receive study drug|1
1240456|NCT00645671|4069589|P2|Overall Study|Physician Decision|1
1240457|NCT00645671|4069590|P1|Overall Study|Physician Decision|0
1240458|NCT00645671|4069589|P2|Overall Study|Adverse Event|1
1240459|NCT00645671|4069590|P1|Overall Study|Adverse Event|0
1240460|NCT00645671|4069589|P2|Overall Study|Withdrawal by Subject|4
1240461|NCT00645671|4069590|P1|Overall Study|Withdrawal by Subject|0
1240462|NCT00645671|4069589|P2|Overall Study|Protocol Violation|0
1240463|NCT00645671|4069590|P1|Overall Study|Protocol Violation|1
1240464|NCT00645593|4069604|P2|Overall Study|Later found to be ineligible|0
1240465|NCT00645593|4069605|P1|Overall Study|Later found to be ineligible|1
1240466|NCT00645567|4069617|P1|Overall Study|Adverse Event|1
1240467|NCT00645528|4069625|P1|Overall Study|Did not show up for Visit 2|7
1240468|NCT00645411|4069638|P4|Overall Study|Unable to classify|4
1240469|NCT00645411|4069639|P3|Overall Study|Unable to classify|3
1240470|NCT00645411|4069640|P2|Overall Study|Unable to classify|0
1240471|NCT00645411|4069641|P1|Overall Study|Unable to classify|0
1240472|NCT00645411|4069638|P4|Overall Study|Inappropriate enrollment|1
1240473|NCT00645411|4069639|P3|Overall Study|Inappropriate enrollment|4
1240474|NCT00645411|4069640|P2|Overall Study|Inappropriate enrollment|0
1240475|NCT00645411|4069641|P1|Overall Study|Inappropriate enrollment|0
1240476|NCT00645411|4069638|P4|Overall Study|Protocol Violation|0
1240477|NCT00645411|4069639|P3|Overall Study|Protocol Violation|1
1240478|NCT00645411|4069640|P2|Overall Study|Protocol Violation|0
1240479|NCT00645411|4069641|P1|Overall Study|Protocol Violation|1
1240480|NCT00645411|4069638|P4|Overall Study|Lost to Follow-up|75
1240481|NCT00645411|4069639|P3|Overall Study|Lost to Follow-up|124
1240482|NCT00645411|4069640|P2|Overall Study|Lost to Follow-up|5
1240483|NCT00645411|4069641|P1|Overall Study|Lost to Follow-up|10
1240484|NCT00645411|4069638|P4|Overall Study|Withdrawal by Subject|21
1240485|NCT00645411|4069639|P3|Overall Study|Withdrawal by Subject|19
1240486|NCT00645411|4069640|P2|Overall Study|Withdrawal by Subject|1
1240487|NCT00645411|4069641|P1|Overall Study|Withdrawal by Subject|2
1240488|NCT00645411|4069638|P4|Overall Study|Adverse Event|2
1240489|NCT00645411|4069639|P3|Overall Study|Adverse Event|0
1240490|NCT00645411|4069640|P2|Overall Study|Adverse Event|0
1240491|NCT00645411|4069641|P1|Overall Study|Adverse Event|0
1240492|NCT00645164|4069683|P1|Overall Study|Protocol Violation|1
1240493|NCT00645164|4069683|P1|Overall Study|Withdrawal by Subject|4
1240494|NCT00645164|4069683|P1|Overall Study|Lost to Follow-up|2
1240495|NCT00645099|4069689|P2|Overall Study|Other|5
1240496|NCT00645099|4069690|P1|Overall Study|Other|9
1240497|NCT00645099|4069689|P2|Overall Study|Adverse Event|5
1240498|NCT00645099|4069690|P1|Overall Study|Adverse Event|11
1240499|NCT00645099|4069689|P2|Overall Study|Lost to Follow-up|4
1240500|NCT00645099|4069690|P1|Overall Study|Lost to Follow-up|6
1240501|NCT00645099|4069689|P2|Overall Study|Withdrawal by Subject|22
1240502|NCT00645099|4069690|P1|Overall Study|Withdrawal by Subject|30
1240503|NCT00645099|4069689|P2|Overall Study|Lack of Efficacy|6
1240504|NCT00645099|4069690|P1|Overall Study|Lack of Efficacy|15
1240505|NCT00644995|4069759|P2|Overall Study|Refused|0
1240506|NCT00644995|4069760|P1|Overall Study|Refused|1
1240507|NCT00644995|4069759|P2|Overall Study|Lost to Follow-up|4
1240508|NCT00644995|4069760|P1|Overall Study|Lost to Follow-up|1
1240509|NCT00644969|4069780|P2|Post Treatment Phase|Other|0
1240510|NCT00644969|4069781|P1|Post Treatment Phase|Other|1
1240511|NCT00644969|4069780|P2|Post Treatment Phase|Lost to Follow-up|1
1240512|NCT00644969|4069781|P1|Post Treatment Phase|Lost to Follow-up|4
1240513|NCT00644969|4069780|P2|Post Treatment Phase|Withdrawal by Subject|2
1240514|NCT00644969|4069781|P1|Post Treatment Phase|Withdrawal by Subject|4
1240515|NCT00644969|4069780|P2|Post Treatment Phase|Death|0
1240516|NCT00644969|4069781|P1|Post Treatment Phase|Death|1
1240517|NCT00644969|4069780|P2|Treatment Phase|Other|1
1240518|NCT00644969|4069781|P1|Treatment Phase|Other|4
1240519|NCT00644969|4069780|P2|Treatment Phase|Lost to Follow-up|2
1240520|NCT00644969|4069781|P1|Treatment Phase|Lost to Follow-up|2
1240521|NCT00644969|4069780|P2|Treatment Phase|Withdrawal by Subject|0
1240522|NCT00644969|4069781|P1|Treatment Phase|Withdrawal by Subject|4
1240523|NCT00644969|4069780|P2|Treatment Phase|Adverse Event|0
1240524|NCT00644969|4069781|P1|Treatment Phase|Adverse Event|3
1240525|NCT00644969|4069780|P2|Treatment Phase|Randomized, not treated|0
1240526|NCT00644969|4069781|P1|Treatment Phase|Randomized, not treated|1
1240527|NCT00644917|4069827|P1|Overall Study|Withdrawal by Subject|2
1240528|NCT00644787|4069835|P3|Period 2: Double Blind Phase|Worsening of symptoms|1
1240529|NCT00644787|4069836|P2|Period 2: Double Blind Phase|Worsening of symptoms|0
1240530|NCT00644787|4069837|P1|Period 2: Double Blind Phase|Worsening of symptoms|0
1240531|NCT00644787|4069835|P3|Period 2: Double Blind Phase|Worsening of underlying disease|2
1240532|NCT00644787|4069836|P2|Period 2: Double Blind Phase|Worsening of underlying disease|6
1240533|NCT00644787|4069837|P1|Period 2: Double Blind Phase|Worsening of underlying disease|0
1240534|NCT00644787|4069835|P3|Period 2: Double Blind Phase|Withdrawal by Subject|0
1240535|NCT00644787|4069836|P2|Period 2: Double Blind Phase|Withdrawal by Subject|1
1240536|NCT00644787|4069837|P1|Period 2: Double Blind Phase|Withdrawal by Subject|0
1240537|NCT00644787|4069835|P3|Period 2: Double Blind Phase|Adverse Event|4
1240538|NCT00644787|4069836|P2|Period 2: Double Blind Phase|Adverse Event|2
1240539|NCT00644787|4069837|P1|Period 2: Double Blind Phase|Adverse Event|0
1240540|NCT00644787|4069835|P3|Period 1: Titration Phase|Participant was judged as ineligible|0
1240541|NCT00644787|4069836|P2|Period 1: Titration Phase|Participant was judged as ineligible|0
1240542|NCT00644787|4069837|P1|Period 1: Titration Phase|Participant was judged as ineligible|3
1240543|NCT00644787|4069835|P3|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
1240544|NCT00644787|4069836|P2|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
1240545|NCT00644787|4069837|P1|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3
1240546|NCT00644787|4069835|P3|Period 1: Titration Phase|Worsening of symptoms|0
1240547|NCT00644787|4069836|P2|Period 1: Titration Phase|Worsening of symptoms|0
1240548|NCT00644787|4069837|P1|Period 1: Titration Phase|Worsening of symptoms|1
1240549|NCT00644787|4069835|P3|Period 1: Titration Phase|Worsening of complications|0
1240550|NCT00644787|4069836|P2|Period 1: Titration Phase|Worsening of complications|0
1240551|NCT00644787|4069837|P1|Period 1: Titration Phase|Worsening of complications|1
1240552|NCT00644787|4069835|P3|Period 1: Titration Phase|Worsening of underlying disease|0
1240553|NCT00644787|4069836|P2|Period 1: Titration Phase|Worsening of underlying disease|0
1240554|NCT00644787|4069837|P1|Period 1: Titration Phase|Worsening of underlying disease|5
1240555|NCT00644787|4069835|P3|Period 1: Titration Phase|Physician Decision|0
1240556|NCT00644787|4069836|P2|Period 1: Titration Phase|Physician Decision|0
1240557|NCT00644787|4069837|P1|Period 1: Titration Phase|Physician Decision|1
1240558|NCT00644787|4069835|P3|Period 1: Titration Phase|Withdrawal by Subject|0
1240559|NCT00644787|4069836|P2|Period 1: Titration Phase|Withdrawal by Subject|0
1240560|NCT00644787|4069837|P1|Period 1: Titration Phase|Withdrawal by Subject|2
1240561|NCT00644787|4069835|P3|Period 1: Titration Phase|Adverse Event|0
1240562|NCT00644787|4069836|P2|Period 1: Titration Phase|Adverse Event|0
1240563|NCT00644787|4069837|P1|Period 1: Titration Phase|Adverse Event|11
1240564|NCT00644358|4069879|P1|Overall Study|Other Unspecified|11
1240565|NCT00644358|4069879|P1|Overall Study|Noncompliance|14
1240566|NCT00644358|4069879|P1|Overall Study|Protocol Violation|5
1240567|NCT00644358|4069879|P1|Overall Study|Lack of Effectiveness|39
1240568|NCT00644358|4069879|P1|Overall Study|Consent Withdrawal|64
1240569|NCT00644358|4069879|P1|Overall Study|Lost to Follow-up|105
1240570|NCT00644358|4069879|P1|Overall Study|Adverse Event|124
1240571|NCT00644332|4069886|P1|Overall Study|Could Not Attend Scheduled Visits|1
1240572|NCT00644332|4069886|P1|Overall Study|Did Not Meet Eligibility Requirements|1
1240573|NCT00644332|4069886|P1|Overall Study|Completion Status Unknown|2
1240574|NCT00644332|4069886|P1|Overall Study|Withdrawal by Subject|6
1240575|NCT00644332|4069886|P1|Overall Study|Adverse Event|11
1240576|NCT00644228|4069912|P2|Maintenance|On Treatment|40
1240577|NCT00644228|4069913|P1|Maintenance|On Treatment|26
1240578|NCT00644228|4069912|P2|Maintenance|Not Protocol-Specified|15
1240579|NCT00644228|4069913|P1|Maintenance|Not Protocol-Specified|14
1240580|NCT00644228|4069912|P2|Maintenance|Death|3
1240581|NCT00644228|4069913|P1|Maintenance|Death|3
1240582|NCT00644228|4069912|P2|Maintenance|Progression/Relapse|42
1240583|NCT00644228|4069913|P1|Maintenance|Progression/Relapse|67
1240584|NCT00644228|4069912|P2|Maintenance|Withdrawal by Subject|4
1240585|NCT00644228|4069913|P1|Maintenance|Withdrawal by Subject|6
1240586|NCT00644228|4069912|P2|Maintenance|Adverse Event|31
1240587|NCT00644228|4069913|P1|Maintenance|Adverse Event|27
1240588|NCT00644228|4069912|P2|Induction Therapy|Not Protocol-Specified|28
1240589|NCT00644228|4069913|P1|Induction Therapy|Not Protocol-Specified|24
1240590|NCT00644228|4069912|P2|Induction Therapy|Death|7
1240591|NCT00644228|4069913|P1|Induction Therapy|Death|3
1240592|NCT00644228|4069912|P2|Induction Therapy|Progression/Relapse|12
1240593|NCT00644228|4069913|P1|Induction Therapy|Progression/Relapse|24
1240594|NCT00644228|4069912|P2|Induction Therapy|Withdrawal by Subject|3
1240595|NCT00644228|4069913|P1|Induction Therapy|Withdrawal by Subject|10
1240596|NCT00644228|4069912|P2|Induction Therapy|Adverse Event|55
1240597|NCT00644228|4069913|P1|Induction Therapy|Adverse Event|22
1240598|NCT00644228|4069912|P2|Randomization & Eligibility|Invalid Consent|1
1240599|NCT00644228|4069913|P1|Randomization & Eligibility|Invalid Consent|0
1240600|NCT00644228|4069912|P2|Randomization & Eligibility|Withdrew Consent prior to therapy start|0
1240601|NCT00644228|4069913|P1|Randomization & Eligibility|Withdrew Consent prior to therapy start|1
1240602|NCT00644228|4069912|P2|Randomization & Eligibility|Ineligible|21
1240603|NCT00644228|4069913|P1|Randomization & Eligibility|Ineligible|31
1240604|NCT00644059|4069942|P3|Overall Study|Unable to classify|3
1240605|NCT00644059|4069943|P2|Overall Study|Unable to classify|2
1240606|NCT00644059|4069944|P1|Overall Study|Unable to classify|6
1240607|NCT00644059|4069942|P3|Overall Study|Protocol Deviation/violation|15
1240608|NCT00644059|4069943|P2|Overall Study|Protocol Deviation/violation|19
1240609|NCT00644059|4069944|P1|Overall Study|Protocol Deviation/violation|20
1240610|NCT00644059|4069942|P3|Overall Study|Inappropriate Enrollment|0
1240611|NCT00644059|4069943|P2|Overall Study|Inappropriate Enrollment|3
1240612|NCT00644059|4069944|P1|Overall Study|Inappropriate Enrollment|1
1240613|NCT00644059|4069942|P3|Overall Study|Adverse Event|1
1240614|NCT00644059|4069943|P2|Overall Study|Adverse Event|5
1240615|NCT00644059|4069944|P1|Overall Study|Adverse Event|8
1240616|NCT00644059|4069942|P3|Overall Study|Withdrawal by Subject|30
1240617|NCT00644059|4069943|P2|Overall Study|Withdrawal by Subject|60
1240618|NCT00644059|4069944|P1|Overall Study|Withdrawal by Subject|52
1240619|NCT00644059|4069942|P3|Overall Study|Lost to Follow-up|16
1240620|NCT00644059|4069943|P2|Overall Study|Lost to Follow-up|34
1240621|NCT00644059|4069944|P1|Overall Study|Lost to Follow-up|37
1240622|NCT00643916|4070034|P6|Overall Study|Not Vaccinated|0
1240623|NCT00643916|4070035|P5|Overall Study|Not Vaccinated|2
1240624|NCT00643916|4070036|P4|Overall Study|Not Vaccinated|0
1240625|NCT00643916|4070037|P3|Overall Study|Not Vaccinated|3
1240626|NCT00643916|4070038|P2|Overall Study|Not Vaccinated|2
1240627|NCT00643916|4070039|P1|Overall Study|Not Vaccinated|2
1240628|NCT00643916|4070034|P6|Overall Study|Withdrawal by Subject|1
1240629|NCT00643916|4070035|P5|Overall Study|Withdrawal by Subject|0
1240630|NCT00643916|4070036|P4|Overall Study|Withdrawal by Subject|1
1240631|NCT00643916|4070037|P3|Overall Study|Withdrawal by Subject|2
1240632|NCT00643916|4070038|P2|Overall Study|Withdrawal by Subject|2
1240633|NCT00643916|4070039|P1|Overall Study|Withdrawal by Subject|2
1240634|NCT00643916|4070034|P6|Overall Study|Lost to Follow-up|0
1240635|NCT00643916|4070035|P5|Overall Study|Lost to Follow-up|0
1240636|NCT00643916|4070036|P4|Overall Study|Lost to Follow-up|0
1240637|NCT00643916|4070037|P3|Overall Study|Lost to Follow-up|0
1240638|NCT00643916|4070038|P2|Overall Study|Lost to Follow-up|1
1240639|NCT00643916|4070039|P1|Overall Study|Lost to Follow-up|0
1240640|NCT00643916|4070034|P6|Overall Study|Protocol Violation|0
1240641|NCT00643916|4070035|P5|Overall Study|Protocol Violation|0
1240642|NCT00643916|4070036|P4|Overall Study|Protocol Violation|1
1240643|NCT00643916|4070037|P3|Overall Study|Protocol Violation|1
1240644|NCT00643916|4070038|P2|Overall Study|Protocol Violation|1
1240645|NCT00643916|4070039|P1|Overall Study|Protocol Violation|0
1240646|NCT00643851|4070062|P3|Overall Study|Non-compl., not met criteria, etc.|6
1240647|NCT00643851|4070063|P2|Overall Study|Non-compl., not met criteria, etc.|4
1240648|NCT00643851|4070064|P1|Overall Study|Non-compl., not met criteria, etc.|3
1240649|NCT00643851|4070062|P3|Overall Study|Withdrawal by Subject|9
1240650|NCT00643851|4070063|P2|Overall Study|Withdrawal by Subject|15
1240651|NCT00643851|4070064|P1|Overall Study|Withdrawal by Subject|8
1240652|NCT00643851|4070062|P3|Overall Study|Lost to Follow-up|9
1240653|NCT00643851|4070063|P2|Overall Study|Lost to Follow-up|6
1240654|NCT00643851|4070064|P1|Overall Study|Lost to Follow-up|4
1240655|NCT00643851|4070062|P3|Overall Study|Adverse Event|6
1240656|NCT00643851|4070063|P2|Overall Study|Adverse Event|6
1240657|NCT00643851|4070064|P1|Overall Study|Adverse Event|2
1240658|NCT00643851|4070062|P3|Overall Study|Lack of Efficacy|0
1240659|NCT00643851|4070063|P2|Overall Study|Lack of Efficacy|1
1240660|NCT00643851|4070064|P1|Overall Study|Lack of Efficacy|0
1240661|NCT00643851|4070062|P3|Overall Study|Death|0
1240662|NCT00643851|4070063|P2|Overall Study|Death|1
1240663|NCT00643851|4070064|P1|Overall Study|Death|0
1240664|NCT00643760|4070092|P5|Overall Study|Withdrawal by Subject|1
1240665|NCT00643760|4070093|P4|Overall Study|Withdrawal by Subject|4
1240666|NCT00643760|4070094|P3|Overall Study|Withdrawal by Subject|2
1240667|NCT00643760|4070095|P2|Overall Study|Withdrawal by Subject|1
1240668|NCT00643760|4070096|P1|Overall Study|Withdrawal by Subject|3
1240669|NCT00643760|4070092|P5|Overall Study|Investigator Discretion|0
1240670|NCT00643760|4070093|P4|Overall Study|Investigator Discretion|2
1240671|NCT00643760|4070094|P3|Overall Study|Investigator Discretion|0
1240672|NCT00643760|4070095|P2|Overall Study|Investigator Discretion|0
1240673|NCT00643760|4070096|P1|Overall Study|Investigator Discretion|0
1240674|NCT00643760|4070092|P5|Overall Study|Lost to Follow-up|3
1240675|NCT00643760|4070093|P4|Overall Study|Lost to Follow-up|3
1240676|NCT00643760|4070094|P3|Overall Study|Lost to Follow-up|1
1240677|NCT00643760|4070095|P2|Overall Study|Lost to Follow-up|2
1240678|NCT00643760|4070096|P1|Overall Study|Lost to Follow-up|6
1240679|NCT00643760|4070092|P5|Overall Study|Protocol Violation|6
1240680|NCT00643760|4070093|P4|Overall Study|Protocol Violation|4
1240681|NCT00643760|4070094|P3|Overall Study|Protocol Violation|4
1240682|NCT00643760|4070095|P2|Overall Study|Protocol Violation|6
1240683|NCT00643760|4070096|P1|Overall Study|Protocol Violation|7
1240684|NCT00643760|4070092|P5|Overall Study|Lack of Efficacy|3
1240685|NCT00643760|4070093|P4|Overall Study|Lack of Efficacy|4
1240686|NCT00643760|4070094|P3|Overall Study|Lack of Efficacy|0
1240687|NCT00643760|4070095|P2|Overall Study|Lack of Efficacy|1
1240688|NCT00643760|4070096|P1|Overall Study|Lack of Efficacy|3
1240689|NCT00643760|4070092|P5|Overall Study|Adverse Event|6
1240690|NCT00643760|4070093|P4|Overall Study|Adverse Event|21
1240691|NCT00643760|4070094|P3|Overall Study|Adverse Event|12
1240692|NCT00643760|4070095|P2|Overall Study|Adverse Event|5
1240693|NCT00643760|4070096|P1|Overall Study|Adverse Event|11
1240694|NCT00643682|4070200|P2|Overall Study|did not keep appointment|509
1240695|NCT00643682|4070201|P1|Overall Study|did not keep appointment|522
1240696|NCT00643604|4070213|P1|Overall Study|Death|1
1240697|NCT00643565|4070241|P2|Overall Study|Lost to Follow-up|0
1240698|NCT00643565|4070242|P1|Overall Study|Lost to Follow-up|2
1240699|NCT00643565|4070241|P2|Overall Study|Withdrawal by Subject|1
1240700|NCT00643565|4070242|P1|Overall Study|Withdrawal by Subject|2
1240701|NCT00643565|4070241|P2|Overall Study|Ongoing in Follow-up|39
1240702|NCT00643565|4070242|P1|Overall Study|Ongoing in Follow-up|39
1240703|NCT00643565|4070241|P2|Overall Study|Death|34
1240704|NCT00643565|4070242|P1|Overall Study|Death|37
1240705|NCT00643487|4070264|P1|Overall Study|Technical difficulty|3
1240706|NCT00643448|4070271|P3|Overall Study|QTcF>550 ms|0
1240707|NCT00643448|4070272|P2|Overall Study|QTcF>550 ms|3
1240708|NCT00643448|4070273|P1|Overall Study|QTcF>550 ms|0
1240709|NCT00643448|4070271|P3|Overall Study|Adverse Event|2
1240710|NCT00643448|4070272|P2|Overall Study|Adverse Event|2
1240711|NCT00643448|4070273|P1|Overall Study|Adverse Event|2
1240712|NCT00643448|4070271|P3|Overall Study|Lack of Efficacy|4
1240713|NCT00643448|4070272|P2|Overall Study|Lack of Efficacy|0
1240714|NCT00643448|4070273|P1|Overall Study|Lack of Efficacy|2
1240715|NCT00643201|4070290|P2|Completed Study Follow Up|non-specified|0
1240716|NCT00643201|4070291|P1|Completed Study Follow Up|non-specified|1
1240717|NCT00643201|4070290|P2|Completed Study Follow Up|Lost to Follow-up|16
1240718|NCT00643201|4070291|P1|Completed Study Follow Up|Lost to Follow-up|18
1240719|NCT00643201|4070290|P2|Completed Study Follow Up|Withdrawal by Subject|29
1240720|NCT00643201|4070291|P1|Completed Study Follow Up|Withdrawal by Subject|23
1240721|NCT00643201|4070290|P2|Completed Study Follow Up|Death|34
1240722|NCT00643201|4070291|P1|Completed Study Follow Up|Death|28
1240723|NCT00643201|4070290|P2|Randomized, Completed 6 Months of Study|not specified|107
1240724|NCT00643201|4070291|P1|Randomized, Completed 6 Months of Study|not specified|107
1240725|NCT00643201|4070290|P2|Randomized, Completed 6 Months of Study|Administrative reason|1
1240726|NCT00643201|4070291|P1|Randomized, Completed 6 Months of Study|Administrative reason|1
1240727|NCT00643201|4070290|P2|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9
1240728|NCT00643201|4070291|P1|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13
1240729|NCT00643201|4070290|P2|Randomized, Completed 6 Months of Study|Pregnancy|2
1240730|NCT00643201|4070291|P1|Randomized, Completed 6 Months of Study|Pregnancy|3
1240731|NCT00643201|4070290|P2|Randomized, Completed 6 Months of Study|Poor or non-compliance|23
1240732|NCT00643201|4070291|P1|Randomized, Completed 6 Months of Study|Poor or non-compliance|20
1240733|NCT00643201|4070290|P2|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
1240734|NCT00643201|4070291|P1|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
1240735|NCT00643201|4070290|P2|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
1240736|NCT00643201|4070291|P1|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
1240737|NCT00643201|4070290|P2|Randomized, Completed 6 Months of Study|Adverse Event|182
1240738|NCT00643201|4070291|P1|Randomized, Completed 6 Months of Study|Adverse Event|150
1240739|NCT00643201|4070290|P2|Randomized, Completed 6 Months of Study|Death|26
1240740|NCT00643201|4070291|P1|Randomized, Completed 6 Months of Study|Death|20
1240741|NCT00643123|4070339|P2|Overall Study|Withdrawal by Subject|1
1240742|NCT00643123|4070340|P1|Overall Study|Withdrawal by Subject|1
1240743|NCT00643123|4070339|P2|Overall Study|Lost to Follow-up|0
1240744|NCT00643123|4070340|P1|Overall Study|Lost to Follow-up|4
1240745|NCT00643006|4070370|P2|Overall Study|Lost to Follow-up|4
1240746|NCT00643006|4070371|P1|Overall Study|Lost to Follow-up|5
1240747|NCT00642993|4070381|P2|Overall Study|Administrative|0
1240748|NCT00642993|4070382|P1|Overall Study|Administrative|1
1240749|NCT00642993|4070381|P2|Overall Study|Did not meet protocol eligibility|1
1240750|NCT00642993|4070382|P1|Overall Study|Did not meet protocol eligibility|0
1240751|NCT00642993|4070381|P2|Overall Study|Protocol Violation|4
1240752|NCT00642993|4070382|P1|Overall Study|Protocol Violation|1
1240753|NCT00642993|4070381|P2|Overall Study|Withdrew - reason unrelated to treatment|3
1240754|NCT00642993|4070382|P1|Overall Study|Withdrew - reason unrelated to treatment|11
1240755|NCT00642993|4070381|P2|Overall Study|Lost to Follow-up|4
1240756|NCT00642993|4070382|P1|Overall Study|Lost to Follow-up|8
1240757|NCT00642993|4070381|P2|Overall Study|Adverse Event|4
1240758|NCT00642993|4070382|P1|Overall Study|Adverse Event|85
1240759|NCT00642902|4070400|P4|Overall Study|Other|4
1240760|NCT00642902|4070401|P3|Overall Study|Other|1
1240761|NCT00642902|4070402|P2|Overall Study|Other|5
1240762|NCT00642902|4070403|P1|Overall Study|Other|1
1240763|NCT00642902|4070400|P4|Overall Study|Randomized, but not treated|0
1240764|NCT00642902|4070401|P3|Overall Study|Randomized, but not treated|1
1240765|NCT00642902|4070402|P2|Overall Study|Randomized, but not treated|0
1240766|NCT00642902|4070403|P1|Overall Study|Randomized, but not treated|0
1240767|NCT00642902|4070400|P4|Overall Study|Premature termination of clinical trial|35
1240768|NCT00642902|4070401|P3|Overall Study|Premature termination of clinical trial|35
1240769|NCT00642902|4070402|P2|Overall Study|Premature termination of clinical trial|32
1240770|NCT00642902|4070403|P1|Overall Study|Premature termination of clinical trial|37
1240771|NCT00642902|4070400|P4|Overall Study|Death|0
1240772|NCT00642902|4070401|P3|Overall Study|Death|0
1240773|NCT00642902|4070402|P2|Overall Study|Death|0
1240774|NCT00642902|4070403|P1|Overall Study|Death|1
1240775|NCT00642902|4070400|P4|Overall Study|Lack of Efficacy|0
1240776|NCT00642902|4070401|P3|Overall Study|Lack of Efficacy|3
1240777|NCT00642902|4070402|P2|Overall Study|Lack of Efficacy|3
1240778|NCT00642902|4070403|P1|Overall Study|Lack of Efficacy|0
1240779|NCT00642902|4070400|P4|Overall Study|Lost to Follow-up|0
1240780|NCT00642902|4070401|P3|Overall Study|Lost to Follow-up|0
1240781|NCT00642902|4070402|P2|Overall Study|Lost to Follow-up|1
1240782|NCT00642902|4070403|P1|Overall Study|Lost to Follow-up|1
1240783|NCT00642902|4070400|P4|Overall Study|Adverse Event|1
1240784|NCT00642902|4070401|P3|Overall Study|Adverse Event|3
1240785|NCT00642902|4070402|P2|Overall Study|Adverse Event|1
1240786|NCT00642902|4070403|P1|Overall Study|Adverse Event|0
1240787|NCT00642850|4070425|P1|Overall Study|Other reasons|7
1240788|NCT00642850|4070425|P1|Overall Study|Blood transfusion|6
1240789|NCT00642850|4070425|P1|Overall Study|Kidney transplantation|8
1240790|NCT00642850|4070425|P1|Overall Study|Protocol Violation|2
1240791|NCT00642850|4070425|P1|Overall Study|Lack of Efficacy|1
1240792|NCT00642850|4070425|P1|Overall Study|Adverse Event|2
1240793|NCT00642850|4070425|P1|Overall Study|Death|7
1240794|NCT00642811|4070441|P6|Overall Study|Other|0
1240795|NCT00642811|4070442|P5|Overall Study|Other|0
1240796|NCT00642811|4070443|P4|Overall Study|Other|1
1240797|NCT00642811|4070444|P3|Overall Study|Other|0
1240798|NCT00642811|4070445|P2|Overall Study|Other|1
1240799|NCT00642811|4070446|P1|Overall Study|Other|0
1240800|NCT00642811|4070441|P6|Overall Study|Severe Non-compliance to protocol|0
1240801|NCT00642811|4070442|P5|Overall Study|Severe Non-compliance to protocol|0
1240802|NCT00642811|4070443|P4|Overall Study|Severe Non-compliance to protocol|0
1240803|NCT00642811|4070444|P3|Overall Study|Severe Non-compliance to protocol|0
1240804|NCT00642811|4070445|P2|Overall Study|Severe Non-compliance to protocol|0
1240805|NCT00642811|4070446|P1|Overall Study|Severe Non-compliance to protocol|1
1240806|NCT00642811|4070441|P6|Overall Study|Developement of discontinuation criteria|0
1240807|NCT00642811|4070442|P5|Overall Study|Developement of discontinuation criteria|1
1240808|NCT00642811|4070443|P4|Overall Study|Developement of discontinuation criteria|0
1240809|NCT00642811|4070444|P3|Overall Study|Developement of discontinuation criteria|0
1240810|NCT00642811|4070445|P2|Overall Study|Developement of discontinuation criteria|0
1240811|NCT00642811|4070446|P1|Overall Study|Developement of discontinuation criteria|0
1240812|NCT00642811|4070441|P6|Overall Study|Adverse Event|1
1240813|NCT00642811|4070442|P5|Overall Study|Adverse Event|0
1240814|NCT00642811|4070443|P4|Overall Study|Adverse Event|0
1240815|NCT00642811|4070444|P3|Overall Study|Adverse Event|0
1240816|NCT00642811|4070445|P2|Overall Study|Adverse Event|3
1240817|NCT00642811|4070446|P1|Overall Study|Adverse Event|2
1240818|NCT00642772|4070468|P1|Overall Study|Withdrawal by Subject|7
1240819|NCT00642772|4070468|P1|Overall Study|Lost to Follow-up|3
1240820|NCT00642759|4070472|P1|Overall Study|Protocol Violation|1
1240821|NCT00642746|4070481|P2|Overall Study|Patient unevaluable|0
1240822|NCT00642746|4070482|P1|Overall Study|Patient unevaluable|1
1240823|NCT00642707|4070496|P4|Overall Study|Withdrawal by Subject|0
1240824|NCT00642707|4070497|P3|Overall Study|Withdrawal by Subject|0
1240825|NCT00642707|4070498|P2|Overall Study|Withdrawal by Subject|0
1240826|NCT00642707|4070499|P1|Overall Study|Withdrawal by Subject|1
1240827|NCT00642707|4070496|P4|Overall Study|Adverse Event|2
1240828|NCT00642707|4070497|P3|Overall Study|Adverse Event|0
1240829|NCT00642707|4070498|P2|Overall Study|Adverse Event|0
1240830|NCT00642707|4070499|P1|Overall Study|Adverse Event|0
1240831|NCT00642668|4070520|P1|Overall Study|Blood Transfusion|2
1240832|NCT00642668|4070520|P1|Overall Study|Dialysis Initiation|5
1240833|NCT00642668|4070520|P1|Overall Study|Failure to Return|1
1240834|NCT00642668|4070520|P1|Overall Study|Insufficient Therapeutic Response|1
1240835|NCT00642668|4070520|P1|Overall Study|Death|2
1240836|NCT00642668|4070520|P1|Overall Study|Adverse Event|2
1240837|NCT00642668|4070520|P1|Overall Study|Lost to Follow-up|1
1240838|NCT00642642|4070528|P1|Treatment & Follow Up|Lost to Follow-up|10
1240839|NCT00642642|4070528|P1|Treatment & Follow Up|Withdrawal by Subject|5
1240840|NCT00642642|4070528|P1|Treatment & Follow Up|Adverse Event|2
1240841|NCT00642616|4070545|P4|Overall Study|Physician Decision|1
1240842|NCT00642616|4070546|P3|Overall Study|Physician Decision|1
1240843|NCT00642616|4070547|P2|Overall Study|Physician Decision|0
1240844|NCT00642616|4070548|P1|Overall Study|Physician Decision|0
1240845|NCT00642616|4070545|P4|Overall Study|Protocol Violation|0
1240846|NCT00642616|4070546|P3|Overall Study|Protocol Violation|2
1240847|NCT00642616|4070547|P2|Overall Study|Protocol Violation|0
1240848|NCT00642616|4070548|P1|Overall Study|Protocol Violation|0
1240849|NCT00642616|4070545|P4|Overall Study|Withdrawal by Subject|1
1240850|NCT00642616|4070546|P3|Overall Study|Withdrawal by Subject|1
1240851|NCT00642616|4070547|P2|Overall Study|Withdrawal by Subject|1
1240852|NCT00642616|4070548|P1|Overall Study|Withdrawal by Subject|0
1240853|NCT00642616|4070545|P4|Overall Study|Study Terminated by Sponsor|5
1240854|NCT00642616|4070546|P3|Overall Study|Study Terminated by Sponsor|4
1240855|NCT00642616|4070547|P2|Overall Study|Study Terminated by Sponsor|6
1240856|NCT00642616|4070548|P1|Overall Study|Study Terminated by Sponsor|7
1240857|NCT00642616|4070545|P4|Overall Study|Adverse Event|0
1240858|NCT00642616|4070546|P3|Overall Study|Adverse Event|1
1240859|NCT00642616|4070547|P2|Overall Study|Adverse Event|0
1240860|NCT00642616|4070548|P1|Overall Study|Adverse Event|2
1240861|NCT00642473|4070581|P2|Overall Study|Other|2
1240862|NCT00642473|4070582|P1|Overall Study|Other|2
1240863|NCT00642473|4070581|P2|Overall Study|Progression or death|4
1240864|NCT00642473|4070582|P1|Overall Study|Progression or death|2
1240865|NCT00642473|4070581|P2|Overall Study|Withdrawal by Subject|5
1240866|NCT00642473|4070582|P1|Overall Study|Withdrawal by Subject|0
1240867|NCT00642460|4070596|P6|Part III: Open-Label Up to Week 260|Refused treatment|3
1240868|NCT00642460|4070597|P5|Part III: Open-Label Up to Week 260|Refused treatment|8
1240869|NCT00642460|4070598|P4|Part III: Open-Label Up to Week 260|Refused treatment|0
1240870|NCT00642460|4070599|P3|Part III: Open-Label Up to Week 260|Refused treatment|0
1240871|NCT00642460|4070600|P2|Part III: Open-Label Up to Week 260|Refused treatment|0
1240872|NCT00642460|4070601|P1|Part III: Open-Label Up to Week 260|Refused treatment|0
1240873|NCT00642460|4070596|P6|Part III: Open-Label Up to Week 260|Administrative reason|1
1240874|NCT00642460|4070597|P5|Part III: Open-Label Up to Week 260|Administrative reason|0
1240875|NCT00642460|4070598|P4|Part III: Open-Label Up to Week 260|Administrative reason|0
1240876|NCT00642460|4070599|P3|Part III: Open-Label Up to Week 260|Administrative reason|0
1240877|NCT00642460|4070600|P2|Part III: Open-Label Up to Week 260|Administrative reason|0
1240878|NCT00642460|4070601|P1|Part III: Open-Label Up to Week 260|Administrative reason|0
1240879|NCT00642460|4070596|P6|Part III: Open-Label Up to Week 260|Death|3
1240880|NCT00642460|4070597|P5|Part III: Open-Label Up to Week 260|Death|0
1240881|NCT00642460|4070598|P4|Part III: Open-Label Up to Week 260|Death|0
1240882|NCT00642460|4070599|P3|Part III: Open-Label Up to Week 260|Death|0
1240883|NCT00642460|4070600|P2|Part III: Open-Label Up to Week 260|Death|0
1240884|NCT00642460|4070601|P1|Part III: Open-Label Up to Week 260|Death|0
1240885|NCT00642460|4070596|P6|Part III: Open-Label Up to Week 260|Other|2
1240886|NCT00642460|4070597|P5|Part III: Open-Label Up to Week 260|Other|2
1240887|NCT00642460|4070598|P4|Part III: Open-Label Up to Week 260|Other|0
1240888|NCT00642460|4070599|P3|Part III: Open-Label Up to Week 260|Other|0
1240889|NCT00642460|4070600|P2|Part III: Open-Label Up to Week 260|Other|0
1240890|NCT00642460|4070601|P1|Part III: Open-Label Up to Week 260|Other|0
1240891|NCT00642460|4070596|P6|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
1240892|NCT00642460|4070597|P5|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
1240893|NCT00642460|4070598|P4|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
1240894|NCT00642460|4070599|P3|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
1240895|NCT00642460|4070600|P2|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
1240896|NCT00642460|4070601|P1|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
1240897|NCT00642460|4070596|P6|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1
1240898|NCT00642460|4070597|P5|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4
1240899|NCT00642460|4070598|P4|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
1240900|NCT00642460|4070599|P3|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
1240901|NCT00642460|4070600|P2|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
1240902|NCT00642460|4070601|P1|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
1240903|NCT00642460|4070596|P6|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4
1240904|NCT00642460|4070597|P5|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3
1240905|NCT00642460|4070598|P4|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
1240906|NCT00642460|4070599|P3|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
1240907|NCT00642460|4070600|P2|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
1240908|NCT00642460|4070601|P1|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
1240909|NCT00642460|4070596|P6|Part III: Open-Label Up to Week 260|Adverse Event|6
1240910|NCT00642460|4070597|P5|Part III: Open-Label Up to Week 260|Adverse Event|7
1240911|NCT00642460|4070598|P4|Part III: Open-Label Up to Week 260|Adverse Event|0
1240912|NCT00642460|4070599|P3|Part III: Open-Label Up to Week 260|Adverse Event|0
1240913|NCT00642460|4070600|P2|Part III: Open-Label Up to Week 260|Adverse Event|0
1240914|NCT00642460|4070601|P1|Part III: Open-Label Up to Week 260|Adverse Event|0
1240915|NCT00642460|4070596|P6|Part II: Open-Label Up to Week 92|Administrative reasons|0
1240916|NCT00642460|4070597|P5|Part II: Open-Label Up to Week 92|Administrative reasons|0
1240917|NCT00642460|4070598|P4|Part II: Open-Label Up to Week 92|Administrative reasons|1
1240918|NCT00642460|4070599|P3|Part II: Open-Label Up to Week 92|Administrative reasons|0
1240919|NCT00642460|4070600|P2|Part II: Open-Label Up to Week 92|Administrative reasons|0
1240920|NCT00642460|4070601|P1|Part II: Open-Label Up to Week 92|Administrative reasons|0
1240921|NCT00642460|4070596|P6|Part II: Open-Label Up to Week 92|Failure to return|0
1240922|NCT00642460|4070597|P5|Part II: Open-Label Up to Week 92|Failure to return|0
1240923|NCT00642460|4070598|P4|Part II: Open-Label Up to Week 92|Failure to return|0
1240924|NCT00642460|4070599|P3|Part II: Open-Label Up to Week 92|Failure to return|0
1240925|NCT00642460|4070600|P2|Part II: Open-Label Up to Week 92|Failure to return|1
1240926|NCT00642460|4070601|P1|Part II: Open-Label Up to Week 92|Failure to return|0
1240927|NCT00642460|4070596|P6|Part II: Open-Label Up to Week 92|Refused treatment|0
1240928|NCT00642460|4070597|P5|Part II: Open-Label Up to Week 92|Refused treatment|0
1240929|NCT00642460|4070598|P4|Part II: Open-Label Up to Week 92|Refused treatment|0
1240930|NCT00642460|4070599|P3|Part II: Open-Label Up to Week 92|Refused treatment|0
1240931|NCT00642460|4070600|P2|Part II: Open-Label Up to Week 92|Refused treatment|1
1240932|NCT00642460|4070601|P1|Part II: Open-Label Up to Week 92|Refused treatment|3
1240933|NCT00642460|4070596|P6|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
1240934|NCT00642460|4070597|P5|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
1240935|NCT00642460|4070598|P4|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
1240936|NCT00642460|4070599|P3|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
1240937|NCT00642460|4070600|P2|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3
1240938|NCT00642460|4070601|P1|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2
1240939|NCT00642460|4070596|P6|Part II: Open-Label Up to Week 92|Death|0
1240940|NCT00642460|4070597|P5|Part II: Open-Label Up to Week 92|Death|0
1240941|NCT00642460|4070598|P4|Part II: Open-Label Up to Week 92|Death|2
1240942|NCT00642460|4070599|P3|Part II: Open-Label Up to Week 92|Death|0
1240943|NCT00642460|4070600|P2|Part II: Open-Label Up to Week 92|Death|1
1240944|NCT00642460|4070601|P1|Part II: Open-Label Up to Week 92|Death|0
1240945|NCT00642460|4070596|P6|Part II: Open-Label Up to Week 92|Adverse Event|0
1240946|NCT00642460|4070597|P5|Part II: Open-Label Up to Week 92|Adverse Event|0
1240947|NCT00642460|4070598|P4|Part II: Open-Label Up to Week 92|Adverse Event|0
1240948|NCT00642460|4070599|P3|Part II: Open-Label Up to Week 92|Adverse Event|0
1240949|NCT00642460|4070600|P2|Part II: Open-Label Up to Week 92|Adverse Event|2
1240950|NCT00642460|4070601|P1|Part II: Open-Label Up to Week 92|Adverse Event|4
1240951|NCT00642460|4070596|P6|Part I: 12 Week Double-Blind|Refused Treatment|0
1240952|NCT00642460|4070597|P5|Part I: 12 Week Double-Blind|Refused Treatment|0
1240953|NCT00642460|4070598|P4|Part I: 12 Week Double-Blind|Refused Treatment|0
1240954|NCT00642460|4070599|P3|Part I: 12 Week Double-Blind|Refused Treatment|0
1240955|NCT00642460|4070600|P2|Part I: 12 Week Double-Blind|Refused Treatment|0
1240956|NCT00642460|4070601|P1|Part I: 12 Week Double-Blind|Refused Treatment|1
1240957|NCT00642460|4070596|P6|Part I: 12 Week Double-Blind|Adverse Event|0
1240958|NCT00642460|4070597|P5|Part I: 12 Week Double-Blind|Adverse Event|0
1240959|NCT00642460|4070598|P4|Part I: 12 Week Double-Blind|Adverse Event|0
1240960|NCT00642460|4070599|P3|Part I: 12 Week Double-Blind|Adverse Event|1
1240961|NCT00642460|4070600|P2|Part I: 12 Week Double-Blind|Adverse Event|1
1240962|NCT00642460|4070601|P1|Part I: 12 Week Double-Blind|Adverse Event|0
1240963|NCT00642369|4070676|P2|Overall Study|Lack of Efficacy|2
1240964|NCT00642369|4070677|P1|Overall Study|Lack of Efficacy|2
1240965|NCT00642369|4070676|P2|Overall Study|misdiagnosis|1
1240966|NCT00642369|4070677|P1|Overall Study|misdiagnosis|0
1240967|NCT00642369|4070676|P2|Overall Study|Withdrawal by Subject|0
1240968|NCT00642369|4070677|P1|Overall Study|Withdrawal by Subject|1
1240969|NCT00642369|4070676|P2|Overall Study|Adverse Event|3
1240970|NCT00642369|4070677|P1|Overall Study|Adverse Event|2
1240971|NCT00642356|4070687|P2|Overall Study|Lack of Efficacy|0
1240972|NCT00642356|4070688|P1|Overall Study|Lack of Efficacy|1
1240973|NCT00642356|4070687|P2|Overall Study|Protocol Violation|3
1240974|NCT00642356|4070688|P1|Overall Study|Protocol Violation|0
1240975|NCT00642356|4070687|P2|Overall Study|Adverse Event|0
1240976|NCT00642356|4070688|P1|Overall Study|Adverse Event|1
1240977|NCT00642304|4070696|P1|Overall Study|Transplantation|1
1240978|NCT00642304|4070696|P1|Overall Study|Erythropoiesis Stimulating Agent Use.|1
1240979|NCT00642304|4070696|P1|Overall Study|Blood transfusion|2
1240980|NCT00642304|4070696|P1|Overall Study|Death|1
1240981|NCT00642304|4070696|P1|Overall Study|Adverse Event|1
1240982|NCT00642278|4070712|P7|Overall Study|Not specified|0
1240983|NCT00642278|4070713|P6|Overall Study|Not specified|1
1240984|NCT00642278|4070714|P5|Overall Study|Not specified|0
1240985|NCT00642278|4070715|P4|Overall Study|Not specified|1
1240986|NCT00642278|4070716|P3|Overall Study|Not specified|0
1240987|NCT00642278|4070717|P2|Overall Study|Not specified|1
1240988|NCT00642278|4070718|P1|Overall Study|Not specified|2
1240989|NCT00642278|4070712|P7|Overall Study|Noncompliance with study drug regimen|0
1240990|NCT00642278|4070713|P6|Overall Study|Noncompliance with study drug regimen|0
1240991|NCT00642278|4070714|P5|Overall Study|Noncompliance with study drug regimen|0
1240992|NCT00642278|4070715|P4|Overall Study|Noncompliance with study drug regimen|1
1240993|NCT00642278|4070716|P3|Overall Study|Noncompliance with study drug regimen|0
1240994|NCT00642278|4070717|P2|Overall Study|Noncompliance with study drug regimen|0
1240995|NCT00642278|4070718|P1|Overall Study|Noncompliance with study drug regimen|0
1240996|NCT00642278|4070712|P7|Overall Study|Withdrawal by Subject|2
1240997|NCT00642278|4070713|P6|Overall Study|Withdrawal by Subject|2
1240998|NCT00642278|4070714|P5|Overall Study|Withdrawal by Subject|6
1240999|NCT00642278|4070715|P4|Overall Study|Withdrawal by Subject|3
1241000|NCT00642278|4070716|P3|Overall Study|Withdrawal by Subject|1
1241001|NCT00642278|4070717|P2|Overall Study|Withdrawal by Subject|1
1241002|NCT00642278|4070718|P1|Overall Study|Withdrawal by Subject|1
1241003|NCT00642278|4070712|P7|Overall Study|Protocol Violation|2
1241004|NCT00642278|4070713|P6|Overall Study|Protocol Violation|1
1241005|NCT00642278|4070714|P5|Overall Study|Protocol Violation|0
1241006|NCT00642278|4070715|P4|Overall Study|Protocol Violation|1
1241007|NCT00642278|4070716|P3|Overall Study|Protocol Violation|1
1241008|NCT00642278|4070717|P2|Overall Study|Protocol Violation|0
1241009|NCT00642278|4070718|P1|Overall Study|Protocol Violation|0
1241010|NCT00642278|4070712|P7|Overall Study|Physician Decision|0
1241011|NCT00642278|4070713|P6|Overall Study|Physician Decision|0
1241012|NCT00642278|4070714|P5|Overall Study|Physician Decision|0
1241013|NCT00642278|4070715|P4|Overall Study|Physician Decision|1
1241014|NCT00642278|4070716|P3|Overall Study|Physician Decision|0
1241015|NCT00642278|4070717|P2|Overall Study|Physician Decision|0
1241016|NCT00642278|4070718|P1|Overall Study|Physician Decision|0
1241017|NCT00642278|4070712|P7|Overall Study|Lost to Follow-up|1
1241018|NCT00642278|4070713|P6|Overall Study|Lost to Follow-up|1
1241019|NCT00642278|4070714|P5|Overall Study|Lost to Follow-up|0
1241020|NCT00642278|4070715|P4|Overall Study|Lost to Follow-up|1
1241021|NCT00642278|4070716|P3|Overall Study|Lost to Follow-up|0
1241022|NCT00642278|4070717|P2|Overall Study|Lost to Follow-up|1
1241023|NCT00642278|4070718|P1|Overall Study|Lost to Follow-up|5
1241024|NCT00642278|4070712|P7|Overall Study|Lack of Efficacy|0
1241025|NCT00642278|4070713|P6|Overall Study|Lack of Efficacy|0
1241026|NCT00642278|4070714|P5|Overall Study|Lack of Efficacy|0
1241027|NCT00642278|4070715|P4|Overall Study|Lack of Efficacy|0
1241028|NCT00642278|4070716|P3|Overall Study|Lack of Efficacy|0
1241029|NCT00642278|4070717|P2|Overall Study|Lack of Efficacy|1
1241030|NCT00642278|4070718|P1|Overall Study|Lack of Efficacy|0
1241031|NCT00642278|4070712|P7|Overall Study|Adverse Event|0
1241032|NCT00642278|4070713|P6|Overall Study|Adverse Event|2
1241033|NCT00642278|4070714|P5|Overall Study|Adverse Event|2
1241034|NCT00642278|4070715|P4|Overall Study|Adverse Event|1
1241035|NCT00642278|4070716|P3|Overall Study|Adverse Event|3
1241036|NCT00642278|4070717|P2|Overall Study|Adverse Event|1
1241037|NCT00642278|4070718|P1|Overall Study|Adverse Event|2
1241038|NCT00642174|4070771|P2|Period 1 - Initial Drug|Entry Criteria Not Met|1
1241039|NCT00642174|4070772|P1|Period 1 - Initial Drug|Entry Criteria Not Met|0
1241040|NCT00641719|4070815|P2|Overall Study|Reason Not Specified|2
1241041|NCT00641719|4070816|P1|Overall Study|Reason Not Specified|1
1241042|NCT00641719|4070815|P2|Overall Study|Withdrawal by Subject|4
1241043|NCT00641719|4070816|P1|Overall Study|Withdrawal by Subject|4
1241044|NCT00641719|4070815|P2|Overall Study|Adverse Event|29
1241045|NCT00641719|4070816|P1|Overall Study|Adverse Event|24
1241046|NCT00641719|4070815|P2|Overall Study|Lack of Efficacy|2
1241047|NCT00641719|4070816|P1|Overall Study|Lack of Efficacy|1
1241048|NCT00641706|4070840|P2|Overall Study|Lead Investigator Decision|1
1241049|NCT00641706|4070841|P1|Overall Study|Lead Investigator Decision|0
1241050|NCT00641706|4070840|P2|Overall Study|Clinical Decline|0
1241051|NCT00641706|4070841|P1|Overall Study|Clinical Decline|1
1241052|NCT00641706|4070840|P2|Overall Study|Withdrawal by Subject|1
1241053|NCT00641706|4070841|P1|Overall Study|Withdrawal by Subject|6
1241054|NCT00641706|4070840|P2|Overall Study|Adverse Event|1
1241055|NCT00641706|4070841|P1|Overall Study|Adverse Event|2
1241056|NCT00641667|4070853|P1|Overall Study|Worsening of underlying disease|3
1241057|NCT00641667|4070853|P1|Overall Study|Physician Decision|1
1241058|NCT00641667|4070853|P1|Overall Study|Adverse Event|1
1241059|NCT00641667|4070853|P1|Overall Study|Withdrawal by Subject|1
1241060|NCT00641537|4070881|P8|24-Week Supplemental Follow-up Period|Other|1
1241061|NCT00641537|4070882|P7|24-Week Supplemental Follow-up Period|Other|1
1241062|NCT00641537|4070883|P6|24-Week Supplemental Follow-up Period|Other|0
1241063|NCT00641537|4070884|P5|24-Week Supplemental Follow-up Period|Other|3
1241064|NCT00641537|4070885|P4|24-Week Supplemental Follow-up Period|Other|1
1241065|NCT00641537|4070886|P3|24-Week Supplemental Follow-up Period|Other|2
1241066|NCT00641537|4070887|P2|24-Week Supplemental Follow-up Period|Other|2
1241067|NCT00641537|4070888|P1|24-Week Supplemental Follow-up Period|Other|0
1241068|NCT00641537|4070881|P8|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
1241069|NCT00641537|4070882|P7|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
1241070|NCT00641537|4070883|P6|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
1241071|NCT00641537|4070884|P5|24-Week Supplemental Follow-up Period|Lost to Follow-up|2
1241072|NCT00641537|4070885|P4|24-Week Supplemental Follow-up Period|Lost to Follow-up|3
1241073|NCT00641537|4070886|P3|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
1241074|NCT00641537|4070887|P2|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
1241075|NCT00641537|4070888|P1|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
1241076|NCT00641537|4070881|P8|96-week Period|Other|6
1241077|NCT00641537|4070882|P7|96-week Period|Other|4
1241078|NCT00641537|4070883|P6|96-week Period|Other|6
1241079|NCT00641537|4070884|P5|96-week Period|Other|12
1241080|NCT00641537|4070885|P4|96-week Period|Other|9
1241081|NCT00641537|4070886|P3|96-week Period|Other|14
1241082|NCT00641537|4070887|P2|96-week Period|Other|7
1241083|NCT00641537|4070888|P1|96-week Period|Other|4
1241084|NCT00641537|4070881|P8|96-week Period|Death|0
1241085|NCT00641537|4070882|P7|96-week Period|Death|0
1241086|NCT00641537|4070883|P6|96-week Period|Death|0
1241087|NCT00641537|4070884|P5|96-week Period|Death|0
1241088|NCT00641537|4070885|P4|96-week Period|Death|0
1241089|NCT00641537|4070886|P3|96-week Period|Death|1
1241090|NCT00641537|4070887|P2|96-week Period|Death|0
1241091|NCT00641537|4070888|P1|96-week Period|Death|2
1241092|NCT00641537|4070881|P8|96-week Period|Protocol Violation|0
1241093|NCT00641537|4070882|P7|96-week Period|Protocol Violation|0
1241094|NCT00641537|4070883|P6|96-week Period|Protocol Violation|1
1241095|NCT00641537|4070884|P5|96-week Period|Protocol Violation|0
1241096|NCT00641537|4070885|P4|96-week Period|Protocol Violation|1
1241097|NCT00641537|4070886|P3|96-week Period|Protocol Violation|0
1241098|NCT00641537|4070887|P2|96-week Period|Protocol Violation|1
1241099|NCT00641537|4070888|P1|96-week Period|Protocol Violation|0
1241100|NCT00641537|4070881|P8|96-week Period|Lost to Follow-up|0
1241101|NCT00641537|4070882|P7|96-week Period|Lost to Follow-up|1
1241102|NCT00641537|4070883|P6|96-week Period|Lost to Follow-up|0
1241103|NCT00641537|4070884|P5|96-week Period|Lost to Follow-up|4
1241104|NCT00641537|4070885|P4|96-week Period|Lost to Follow-up|2
1241105|NCT00641537|4070886|P3|96-week Period|Lost to Follow-up|2
1241106|NCT00641537|4070887|P2|96-week Period|Lost to Follow-up|1
1241107|NCT00641537|4070888|P1|96-week Period|Lost to Follow-up|3
1241108|NCT00641537|4070881|P8|96-week Period|Adverse Event|0
1241109|NCT00641537|4070882|P7|96-week Period|Adverse Event|0
1241110|NCT00641537|4070883|P6|96-week Period|Adverse Event|0
1241111|NCT00641537|4070884|P5|96-week Period|Adverse Event|2
1241112|NCT00641537|4070885|P4|96-week Period|Adverse Event|0
1241113|NCT00641537|4070886|P3|96-week Period|Adverse Event|3
1241114|NCT00641537|4070887|P2|96-week Period|Adverse Event|1
1241115|NCT00641537|4070888|P1|96-week Period|Adverse Event|0
1241116|NCT00641147|4070943|P2|Completed 16 Months.|Lost to Follow-up|0
1241117|NCT00641147|4070944|P1|Completed 16 Months.|Lost to Follow-up|1
1241118|NCT00641147|4070943|P2|Completed 16 Months.|Physician Decision|0
1241119|NCT00641147|4070944|P1|Completed 16 Months.|Physician Decision|1
1241120|NCT00641147|4070943|P2|Completed 12 Months.|Withdrawal by Subject|1
1241121|NCT00641147|4070944|P1|Completed 12 Months.|Withdrawal by Subject|0
1241122|NCT00641147|4070943|P2|Completed 12 Months.|Physician Decision|1
1241123|NCT00641147|4070944|P1|Completed 12 Months.|Physician Decision|1
1241124|NCT00641147|4070943|P2|Completed 8 Months.|Withdrawal by Subject|1
1241125|NCT00641147|4070944|P1|Completed 8 Months.|Withdrawal by Subject|0
1241126|NCT00641147|4070943|P2|Completed 8 Months.|non compliance|0
1241127|NCT00641147|4070944|P1|Completed 8 Months.|non compliance|1
1241128|NCT00641147|4070943|P2|Completed 8 Months.|Physician Decision|1
1241129|NCT00641147|4070944|P1|Completed 8 Months.|Physician Decision|2
1241130|NCT00641147|4070943|P2|Completed 4 Months.|Adverse Event|0
1241131|NCT00641147|4070944|P1|Completed 4 Months.|Adverse Event|1
1241132|NCT00641147|4070943|P2|Completed 4 Months.|Physician Decision|0
1241133|NCT00641147|4070944|P1|Completed 4 Months.|Physician Decision|1
1241134|NCT00641056|4070988|P2|Overall Study|Sponsor Decision|2
1241135|NCT00641056|4070989|P1|Overall Study|Sponsor Decision|1
1241136|NCT00641056|4070988|P2|Overall Study|Subject Decision|19
1241137|NCT00641056|4070989|P1|Overall Study|Subject Decision|6
1241138|NCT00641056|4070988|P2|Overall Study|Entry Criteria Not Met|0
1241139|NCT00641056|4070989|P1|Overall Study|Entry Criteria Not Met|3
1241140|NCT00641056|4070988|P2|Overall Study|Protocol Violation|0
1241141|NCT00641056|4070989|P1|Overall Study|Protocol Violation|2
1241142|NCT00641056|4070988|P2|Overall Study|Physician Decision|1
1241143|NCT00641056|4070989|P1|Overall Study|Physician Decision|3
1241144|NCT00641056|4070988|P2|Overall Study|Lost to Follow-up|1
1241145|NCT00641056|4070989|P1|Overall Study|Lost to Follow-up|2
1241146|NCT00641056|4070988|P2|Overall Study|Adverse Event|2
1241147|NCT00641056|4070989|P1|Overall Study|Adverse Event|12
1241148|NCT00641043|4071017|P2|Overall Study|Other incl. lack of efficacy|2
1241149|NCT00641043|4071018|P1|Overall Study|Other incl. lack of efficacy|4
1241150|NCT00641043|4071017|P2|Overall Study|Withdrawal by Subject|4
1241151|NCT00641043|4071018|P1|Overall Study|Withdrawal by Subject|4
1241152|NCT00641043|4071017|P2|Overall Study|Lost to Follow-up|2
1241153|NCT00641043|4071018|P1|Overall Study|Lost to Follow-up|3
1241154|NCT00641043|4071017|P2|Overall Study|Protocol Violation|3
1241155|NCT00641043|4071018|P1|Overall Study|Protocol Violation|2
1241156|NCT00641043|4071017|P2|Overall Study|Adverse Event|4
1241157|NCT00641043|4071018|P1|Overall Study|Adverse Event|6
1241158|NCT00640926|4071055|P3|Overall Study|Withdrawal by Subject|1
1241159|NCT00640926|4071056|P2|Overall Study|Withdrawal by Subject|0
1241160|NCT00640926|4071057|P1|Overall Study|Withdrawal by Subject|1
1241161|NCT00640926|4071055|P3|Overall Study|Lost to Follow-up|2
1241162|NCT00640926|4071056|P2|Overall Study|Lost to Follow-up|1
1241163|NCT00640926|4071057|P1|Overall Study|Lost to Follow-up|3
1241164|NCT00640926|4071055|P3|Overall Study|Protocol Violation|2
1241165|NCT00640926|4071056|P2|Overall Study|Protocol Violation|0
1241166|NCT00640926|4071057|P1|Overall Study|Protocol Violation|2
1241167|NCT00640926|4071055|P3|Overall Study|Lack of Efficacy|1
1241168|NCT00640926|4071056|P2|Overall Study|Lack of Efficacy|2
1241169|NCT00640926|4071057|P1|Overall Study|Lack of Efficacy|0
1241170|NCT00640926|4071055|P3|Overall Study|Adverse Event|2
1241171|NCT00640926|4071056|P2|Overall Study|Adverse Event|3
1241172|NCT00640926|4071057|P1|Overall Study|Adverse Event|2
1241173|NCT00640835|4071070|P2|Overall Study|Other Reason|4
1241174|NCT00640835|4071071|P1|Overall Study|Other Reason|19
1241175|NCT00640835|4071070|P2|Overall Study|Lost to Follow-up|13
1241176|NCT00640835|4071071|P1|Overall Study|Lost to Follow-up|17
1241177|NCT00640835|4071070|P2|Overall Study|Protocol Violation|2
1241178|NCT00640835|4071071|P1|Overall Study|Protocol Violation|2
1241179|NCT00640835|4071070|P2|Overall Study|Sponsor's Decision|7
1241180|NCT00640835|4071071|P1|Overall Study|Sponsor's Decision|11
1241181|NCT00640835|4071070|P2|Overall Study|Physician Decision|14
1241182|NCT00640835|4071071|P1|Overall Study|Physician Decision|10
1241183|NCT00640835|4071070|P2|Overall Study|Withdrawal by Subject|14
1241184|NCT00640835|4071071|P1|Overall Study|Withdrawal by Subject|12
1241185|NCT00640835|4071070|P2|Overall Study|Adverse Event|3
1241186|NCT00640835|4071071|P1|Overall Study|Adverse Event|5
1241187|NCT00640614|4071135|P2|Overall Study|Lost to Follow-up|0
1241188|NCT00640614|4071136|P1|Overall Study|Lost to Follow-up|1
1241189|NCT00640601|4071178|P1|Overall Study|treatment naive, combination therapy|10
1241190|NCT00640601|4071178|P1|Overall Study|Physician Decision|8
1241191|NCT00640601|4071178|P1|Overall Study|Lost to Follow-up|9
1241192|NCT00640601|4071178|P1|Overall Study|Lack of Efficacy|16
1241193|NCT00640601|4071178|P1|Overall Study|Protocol Violation|6
1241194|NCT00640601|4071178|P1|Overall Study|Withdrawal by Subject|20
1241195|NCT00640601|4071178|P1|Overall Study|Adverse Event|43
1241196|NCT00640562|4071194|P2|Overall Study|Glycosylated Hemoglobin >8|0
1241197|NCT00640562|4071195|P1|Overall Study|Glycosylated Hemoglobin >8|1
1241198|NCT00640562|4071194|P2|Overall Study|Low study drug dose|1
1241199|NCT00640562|4071195|P1|Overall Study|Low study drug dose|0
1241200|NCT00640562|4071194|P2|Overall Study|Past use of Seroquel -stopped due to AE|1
1241201|NCT00640562|4071195|P1|Overall Study|Past use of Seroquel -stopped due to AE|0
1241202|NCT00640562|4071194|P2|Overall Study|Known risperidone intolerance|1
1241203|NCT00640562|4071195|P1|Overall Study|Known risperidone intolerance|0
1241204|NCT00640562|4071194|P2|Overall Study|Withdrawal by Subject|10
1241205|NCT00640562|4071195|P1|Overall Study|Withdrawal by Subject|6
1241206|NCT00640562|4071194|P2|Overall Study|Protocol Violation|4
1241207|NCT00640562|4071195|P1|Overall Study|Protocol Violation|2
1241208|NCT00640562|4071194|P2|Overall Study|Lack of Efficacy|4
1241209|NCT00640562|4071195|P1|Overall Study|Lack of Efficacy|1
1241210|NCT00640562|4071194|P2|Overall Study|Adverse Event|5
1241211|NCT00640562|4071195|P1|Overall Study|Adverse Event|8
1241212|NCT00640510|4071223|P2|Overall Study|Physician Decision|1
1241213|NCT00640510|4071224|P1|Overall Study|Physician Decision|0
1241214|NCT00640510|4071223|P2|Overall Study|Protocol Violation|0
1241215|NCT00640510|4071224|P1|Overall Study|Protocol Violation|1
1241216|NCT00640510|4071223|P2|Overall Study|Lack of Efficacy|1
1241217|NCT00640510|4071224|P1|Overall Study|Lack of Efficacy|0
1241218|NCT00640393|4071236|P3|Part 2|Adverse Event|0
1241219|NCT00640393|4071237|P2|Part 2|Adverse Event|1
1241220|NCT00640393|4071238|P1|Part 2|Adverse Event|0
1241221|NCT00640393|4071236|P3|Part 2|Non-adherence|0
1241222|NCT00640393|4071237|P2|Part 2|Non-adherence|1
1241223|NCT00640393|4071238|P1|Part 2|Non-adherence|0
1241224|NCT00640393|4071236|P3|Part 2|Withdrawal by Subject|1
1241225|NCT00640393|4071237|P2|Part 2|Withdrawal by Subject|6
1241226|NCT00640393|4071238|P1|Part 2|Withdrawal by Subject|0
1241227|NCT00640393|4071236|P3|Part 2|Lost to Follow-up|2
1241228|NCT00640393|4071237|P2|Part 2|Lost to Follow-up|2
1241229|NCT00640393|4071238|P1|Part 2|Lost to Follow-up|0
1241230|NCT00640393|4071236|P3|Randomization|Never randomized by site|0
1241231|NCT00640393|4071237|P2|Randomization|Never randomized by site|0
1241232|NCT00640393|4071238|P1|Randomization|Never randomized by site|2
1241233|NCT00640393|4071236|P3|Randomization|Withdrawn per protocol|0
1241234|NCT00640393|4071237|P2|Randomization|Withdrawn per protocol|0
1241235|NCT00640393|4071238|P1|Randomization|Withdrawn per protocol|17
1241236|NCT00640393|4071236|P3|Part 1|Withdrawal by Subject|0
1241237|NCT00640393|4071237|P2|Part 1|Withdrawal by Subject|0
1241238|NCT00640393|4071238|P1|Part 1|Withdrawal by Subject|3
1241239|NCT00640393|4071236|P3|Part 1|Lost to Follow-up|0
1241240|NCT00640393|4071237|P2|Part 1|Lost to Follow-up|0
1241241|NCT00640393|4071238|P1|Part 1|Lost to Follow-up|2
1241242|NCT00640341|4071303|P3|Overall Study|Adverse event and positive slit lamp|0
1241243|NCT00640341|4071304|P2|Overall Study|Adverse event and positive slit lamp|0
1241244|NCT00640341|4071305|P1|Overall Study|Adverse event and positive slit lamp|1
1241245|NCT00640341|4071303|P3|Overall Study|Ineligable at Baseline|2
1241246|NCT00640341|4071304|P2|Overall Study|Ineligable at Baseline|3
1241247|NCT00640341|4071305|P1|Overall Study|Ineligable at Baseline|5
1241248|NCT00640341|4071303|P3|Overall Study|Poor fit/Uncomfortable|0
1241249|NCT00640341|4071304|P2|Overall Study|Poor fit/Uncomfortable|0
1241250|NCT00640341|4071305|P1|Overall Study|Poor fit/Uncomfortable|4
1241251|NCT00640341|4071303|P3|Overall Study|Unacceptable Lens Movement|0
1241252|NCT00640341|4071304|P2|Overall Study|Unacceptable Lens Movement|0
1241253|NCT00640341|4071305|P1|Overall Study|Unacceptable Lens Movement|1
1241254|NCT00640341|4071303|P3|Overall Study|Withdrawal by Subject|1
1241255|NCT00640341|4071304|P2|Overall Study|Withdrawal by Subject|0
1241256|NCT00640341|4071305|P1|Overall Study|Withdrawal by Subject|4
1241257|NCT00640341|4071303|P3|Overall Study|Lost to Follow-up|0
1241258|NCT00640341|4071304|P2|Overall Study|Lost to Follow-up|0
1241259|NCT00640341|4071305|P1|Overall Study|Lost to Follow-up|2
1241260|NCT00640341|4071303|P3|Overall Study|Failure to Follow Subject Instructions|0
1241261|NCT00640341|4071304|P2|Overall Study|Failure to Follow Subject Instructions|0
1241262|NCT00640341|4071305|P1|Overall Study|Failure to Follow Subject Instructions|1
1241263|NCT00640341|4071303|P3|Overall Study|Inability to Maintain Wearing Schedule|0
1241264|NCT00640341|4071304|P2|Overall Study|Inability to Maintain Wearing Schedule|1
1241265|NCT00640341|4071305|P1|Overall Study|Inability to Maintain Wearing Schedule|1
1241266|NCT00640341|4071303|P3|Overall Study|Study Related Symptoms/Complaints|2
1241267|NCT00640341|4071304|P2|Overall Study|Study Related Symptoms/Complaints|1
1241268|NCT00640341|4071305|P1|Overall Study|Study Related Symptoms/Complaints|2
1241269|NCT00640341|4071303|P3|Overall Study|Positive Slit Lamp Findings|1
1241270|NCT00640341|4071304|P2|Overall Study|Positive Slit Lamp Findings|0
1241271|NCT00640341|4071305|P1|Overall Study|Positive Slit Lamp Findings|0
1241272|NCT00640341|4071303|P3|Overall Study|Adverse Event|1
1241273|NCT00640341|4071304|P2|Overall Study|Adverse Event|0
1241274|NCT00640341|4071305|P1|Overall Study|Adverse Event|0
1241275|NCT00640328|4071325|P6|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
1241276|NCT00640328|4071326|P5|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
1241277|NCT00640328|4071327|P4|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
1241278|NCT00640328|4071328|P3|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
1241279|NCT00640328|4071329|P2|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
1241280|NCT00640328|4071330|P1|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
1241281|NCT00640328|4071325|P6|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
1241282|NCT00640328|4071326|P5|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
1241283|NCT00640328|4071327|P4|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
1241284|NCT00640328|4071328|P3|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1
1241285|NCT00640328|4071329|P2|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
1241286|NCT00640328|4071330|P1|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
1241287|NCT00640328|4071325|P6|Second Treatment Period (Weeks 24-48)|Adverse Event|0
1241288|NCT00640328|4071326|P5|Second Treatment Period (Weeks 24-48)|Adverse Event|1
1241289|NCT00640328|4071327|P4|Second Treatment Period (Weeks 24-48)|Adverse Event|0
1241290|NCT00640328|4071328|P3|Second Treatment Period (Weeks 24-48)|Adverse Event|0
1241291|NCT00640328|4071329|P2|Second Treatment Period (Weeks 24-48)|Adverse Event|0
1241292|NCT00640328|4071330|P1|Second Treatment Period (Weeks 24-48)|Adverse Event|0
1241293|NCT00640328|4071325|P6|First Treatment Period (Weeks 0-24)|Adverse Event|0
1241294|NCT00640328|4071326|P5|First Treatment Period (Weeks 0-24)|Adverse Event|0
1241295|NCT00640328|4071327|P4|First Treatment Period (Weeks 0-24)|Adverse Event|0
1241296|NCT00640328|4071328|P3|First Treatment Period (Weeks 0-24)|Adverse Event|0
1241297|NCT00640328|4071329|P2|First Treatment Period (Weeks 0-24)|Adverse Event|1
1241298|NCT00640328|4071330|P1|First Treatment Period (Weeks 0-24)|Adverse Event|0
1241299|NCT00640315|4071496|P2|Overall Study|Withdrawal by Subject|1
1241300|NCT00640315|4071497|P1|Overall Study|Withdrawal by Subject|0
1241301|NCT00640289|4071623|P1|Overall Study|Missing status|5
1241302|NCT00640289|4071623|P1|Overall Study|Transferred to another center|1
1241303|NCT00640289|4071623|P1|Overall Study|Data collected under different amendment|2
1241304|NCT00640289|4071623|P1|Overall Study|Lost to Follow-up|1
1241305|NCT00640289|4071623|P1|Overall Study|Withdrawal by Subject|1
1241306|NCT00640289|4071623|P1|Overall Study|Death|3
1241307|NCT00640224|4071735|P4|Overall Study|Headaches|0
1241308|NCT00640224|4071736|P3|Overall Study|Headaches|0
1241309|NCT00640224|4071737|P2|Overall Study|Headaches|1
1241310|NCT00640224|4071738|P1|Overall Study|Headaches|0
1241311|NCT00640224|4071735|P4|Overall Study|Withdrawal by Subject|0
1241312|NCT00640224|4071736|P3|Overall Study|Withdrawal by Subject|0
1241313|NCT00640224|4071737|P2|Overall Study|Withdrawal by Subject|0
1241314|NCT00640224|4071738|P1|Overall Study|Withdrawal by Subject|1
1241315|NCT00640224|4071735|P4|Overall Study|Lost to Follow-up|0
1241316|NCT00640224|4071736|P3|Overall Study|Lost to Follow-up|0
1241317|NCT00640224|4071737|P2|Overall Study|Lost to Follow-up|2
1241318|NCT00640224|4071738|P1|Overall Study|Lost to Follow-up|5
1241319|NCT00640042|4071836|P1|Enrollment|Did not receive study drug|83
1241320|NCT00640016|4071852|P4|Overall Study|Adverse Event|1
1241321|NCT00640016|4071853|P3|Overall Study|Adverse Event|0
1241322|NCT00640016|4071854|P2|Overall Study|Adverse Event|0
1241323|NCT00640016|4071855|P1|Overall Study|Adverse Event|0
1241324|NCT00640016|4071852|P4|Overall Study|Study termination|2
1241325|NCT00640016|4071853|P3|Overall Study|Study termination|3
1241326|NCT00640016|4071854|P2|Overall Study|Study termination|1
1241327|NCT00640016|4071855|P1|Overall Study|Study termination|2
1241328|NCT00640016|4071852|P4|Overall Study|Withdrawal by Subject|0
1241329|NCT00640016|4071853|P3|Overall Study|Withdrawal by Subject|0
1241330|NCT00640016|4071854|P2|Overall Study|Withdrawal by Subject|1
1241331|NCT00640016|4071855|P1|Overall Study|Withdrawal by Subject|0
1241332|NCT00639769|4071907|P1|Overall Study|Withdrawal by Subject|4
1241333|NCT00639769|4071907|P1|Overall Study|Disease progression|26
1241334|NCT00639769|4071907|P1|Overall Study|Lack of Efficacy|1
1241335|NCT00639769|4071907|P1|Overall Study|Adverse Event|7
1241336|NCT00639769|4071907|P1|Overall Study|Death|2
1241337|NCT00639678|4071924|P4|Overall Study|Lack of Compliance|0
1241338|NCT00639678|4071925|P3|Overall Study|Lack of Compliance|1
1241339|NCT00639678|4071926|P2|Overall Study|Lack of Compliance|0
1241340|NCT00639678|4071927|P1|Overall Study|Lack of Compliance|0
1241341|NCT00639678|4071924|P4|Overall Study|Adverse Event|0
1241342|NCT00639678|4071925|P3|Overall Study|Adverse Event|0
1241343|NCT00639678|4071926|P2|Overall Study|Adverse Event|1
1241344|NCT00639678|4071927|P1|Overall Study|Adverse Event|0
1241345|NCT00639678|4071924|P4|Overall Study|Lost to Follow-up|0
1241346|NCT00639678|4071925|P3|Overall Study|Lost to Follow-up|6
1241347|NCT00639678|4071926|P2|Overall Study|Lost to Follow-up|0
1241348|NCT00639678|4071927|P1|Overall Study|Lost to Follow-up|1
1241349|NCT00639678|4071924|P4|Overall Study|Withdrawal by Subject|0
1241350|NCT00639678|4071925|P3|Overall Study|Withdrawal by Subject|4
1241351|NCT00639678|4071926|P2|Overall Study|Withdrawal by Subject|0
1241352|NCT00639678|4071927|P1|Overall Study|Withdrawal by Subject|3
1241353|NCT00639509|4071992|P1|Overall Study|Death|1
1241354|NCT00639457|4072000|P2|Overall Study|Withdrawal by Subject|3
1241355|NCT00639457|4072001|P1|Overall Study|Withdrawal by Subject|2
1241356|NCT00639379|4072060|P2|Period 1 - 2 Weeks|lens issue|0
1241357|NCT00639379|4072061|P1|Period 1 - 2 Weeks|lens issue|3
1241358|NCT00639379|4072060|P2|Period 1 - 2 Weeks|Lost to Follow-up|0
1241359|NCT00639379|4072061|P1|Period 1 - 2 Weeks|Lost to Follow-up|2
1241360|NCT00639223|4072077|P2|Overall Study|Lost to Follow-up|2
1241361|NCT00639223|4072078|P1|Overall Study|Lost to Follow-up|0
1241362|NCT00639002|4072118|P1|Overall Study|Lack of Efficacy|1
1241363|NCT00639002|4072118|P1|Overall Study|Physician Decision|6
1241364|NCT00639002|4072118|P1|Overall Study|Disease progression|3
1241365|NCT00639002|4072118|P1|Overall Study|Protocol Violation|1
1241366|NCT00639002|4072118|P1|Overall Study|Adverse Event|1
1241367|NCT00639002|4072118|P1|Overall Study|Death|1
1241368|NCT00638989|4072127|P3|Overall Study|Lost to Follow-up|1
1241369|NCT00638989|4072128|P2|Overall Study|Lost to Follow-up|0
1241370|NCT00638989|4072129|P1|Overall Study|Lost to Follow-up|0
1241371|NCT00638963|4072169|P2|Overall Study|Withdrawal by Subject|0
1241372|NCT00638963|4072170|P1|Overall Study|Withdrawal by Subject|1
1241373|NCT00638846|4072211|P2|Overall Study|lens issue|3
1241374|NCT00638846|4072212|P1|Overall Study|lens issue|1
1241375|NCT00638846|4072211|P2|Overall Study|Lost to Follow-up|2
1241376|NCT00638846|4072212|P1|Overall Study|Lost to Follow-up|3
1241377|NCT00638846|4072211|P2|Overall Study|Adverse Event|1
1241378|NCT00638846|4072212|P1|Overall Study|Adverse Event|0
1241379|NCT00638690|4072256|P2|Overall Study|Lost to Follow-up|2
1241380|NCT00638690|4072257|P1|Overall Study|Lost to Follow-up|4
1241381|NCT00638690|4072256|P2|Overall Study|Withdrawal by Subject|5
1241382|NCT00638690|4072257|P1|Overall Study|Withdrawal by Subject|22
1241383|NCT00638690|4072256|P2|Overall Study|Death|335
1241384|NCT00638690|4072257|P1|Overall Study|Death|655
1241385|NCT00638508|4072277|P2|Overall Study|Physician Decision|2
1241386|NCT00638508|4072278|P1|Overall Study|Physician Decision|5
1241387|NCT00638443|4072322|P2|First Intervention|Adverse Event|1
1241388|NCT00638443|4072323|P1|First Intervention|Adverse Event|2
1241389|NCT00638404|4072353|P2|Overall Study|Physician Decision|0
1241390|NCT00638404|4072354|P1|Overall Study|Physician Decision|8
1241391|NCT00638378|4072366|P1|Overall Study|Physician Decision|4
1241392|NCT00638378|4072366|P1|Overall Study|Disease progression|15
1241393|NCT00638378|4072366|P1|Overall Study|Adverse Event|1
1241394|NCT00638378|4072366|P1|Overall Study|Death|2
1241395|NCT00638235|4072406|P9|Overall Study|Lost to Follow-up|18
1241396|NCT00638235|4072407|P8|Overall Study|Lost to Follow-up|1
1241397|NCT00638235|4072408|P7|Overall Study|Lost to Follow-up|0
1241398|NCT00638235|4072409|P6|Overall Study|Lost to Follow-up|26
1241399|NCT00638235|4072410|P5|Overall Study|Lost to Follow-up|13
1241400|NCT00638235|4072411|P4|Overall Study|Lost to Follow-up|10
1241401|NCT00638235|4072412|P3|Overall Study|Lost to Follow-up|18
1241402|NCT00638235|4072413|P2|Overall Study|Lost to Follow-up|3
1241403|NCT00638235|4072414|P1|Overall Study|Lost to Follow-up|31
1241404|NCT00638183|4072824|P1|Overall Study|Other reason not defined above|27
1241405|NCT00638183|4072824|P1|Overall Study|Lost to Follow-up|46
1241406|NCT00638183|4072824|P1|Overall Study|Physician Decision|9
1241407|NCT00638183|4072824|P1|Overall Study|Lack of Efficacy|14
1241408|NCT00638183|4072824|P1|Overall Study|Adverse Event|23
1241409|NCT00638157|4072833|P2|Overall Study|Randomized, not treated|0
1241410|NCT00638157|4072834|P1|Overall Study|Randomized, not treated|2
1241411|NCT00638157|4072833|P2|Overall Study|Not Specified|2
1241412|NCT00638157|4072834|P1|Overall Study|Not Specified|1
1241413|NCT00638157|4072833|P2|Overall Study|Physician Decision|0
1241414|NCT00638157|4072834|P1|Overall Study|Physician Decision|1
1241415|NCT00638157|4072833|P2|Overall Study|Lost to Follow-up|0
1241416|NCT00638157|4072834|P1|Overall Study|Lost to Follow-up|1
1241417|NCT00638157|4072833|P2|Overall Study|Microbiological failure|0
1241418|NCT00638157|4072834|P1|Overall Study|Microbiological failure|1
1241419|NCT00638157|4072833|P2|Overall Study|Clinical (symptomatic) failure|1
1241420|NCT00638157|4072834|P1|Overall Study|Clinical (symptomatic) failure|1
1241421|NCT00638157|4072833|P2|Overall Study|Adverse Event|1
1241422|NCT00638157|4072834|P1|Overall Study|Adverse Event|0
1241423|NCT00638027|4072844|P2|Overall Study|Adverse Event|2
1241424|NCT00638027|4072845|P1|Overall Study|Adverse Event|0
1241425|NCT00637806|4072892|P4|Extension Phase|Study Discontinued|1
1241426|NCT00637806|4072893|P3|Extension Phase|Study Discontinued|0
1241427|NCT00637806|4072894|P2|Extension Phase|Study Discontinued|0
1241428|NCT00637806|4072895|P1|Extension Phase|Study Discontinued|0
1241429|NCT00637806|4072892|P4|Double-blind Phase|Study Discontinued|0
1241430|NCT00637806|4072893|P3|Double-blind Phase|Study Discontinued|1
1241431|NCT00637806|4072894|P2|Double-blind Phase|Study Discontinued|0
1241432|NCT00637806|4072895|P1|Double-blind Phase|Study Discontinued|2
1241433|NCT00637728|4072930|P3|Double-blind Phase|Study Discontinued|0
1241434|NCT00637728|4072931|P2|Double-blind Phase|Study Discontinued|1
1241435|NCT00637728|4072932|P1|Double-blind Phase|Study Discontinued|1
1241436|NCT00637728|4072930|P3|Double-blind Phase|Non-compliance|0
1241437|NCT00637728|4072931|P2|Double-blind Phase|Non-compliance|0
1241438|NCT00637728|4072932|P1|Double-blind Phase|Non-compliance|2
1241439|NCT00637728|4072930|P3|Double-blind Phase|Adverse Event|0
1241440|NCT00637728|4072931|P2|Double-blind Phase|Adverse Event|0
1241441|NCT00637728|4072932|P1|Double-blind Phase|Adverse Event|1
1241442|NCT00637572|4072947|P2|Overall Study|Illicit Drug Use|0
1241443|NCT00637572|4072948|P1|Overall Study|Illicit Drug Use|1
1241444|NCT00637572|4072947|P2|Overall Study|Withdrawal by Subject|2
1241445|NCT00637572|4072948|P1|Overall Study|Withdrawal by Subject|0
1241446|NCT00637572|4072947|P2|Overall Study|Physician Decision|1
1241447|NCT00637572|4072948|P1|Overall Study|Physician Decision|1
1241448|NCT00637572|4072947|P2|Overall Study|Lost to Follow-up|1
1241449|NCT00637572|4072948|P1|Overall Study|Lost to Follow-up|0
1241450|NCT00637572|4072947|P2|Overall Study|Death|1
1241451|NCT00637572|4072948|P1|Overall Study|Death|0
1241452|NCT00637572|4072947|P2|Overall Study|Adverse Event|2
1241453|NCT00637572|4072948|P1|Overall Study|Adverse Event|1
1241454|NCT00637416|4072987|P2|Overall Study|Unable to take study drug|1
1241455|NCT00637416|4072988|P1|Overall Study|Unable to take study drug|0
1241456|NCT00637416|4072987|P2|Overall Study|Lost to Follow-up|1
1241457|NCT00637416|4072988|P1|Overall Study|Lost to Follow-up|1
1241458|NCT00637377|4072998|P4|Overall Study|Other (no further information available)|5
1241459|NCT00637377|4072999|P3|Overall Study|Other (no further information available)|10
1241460|NCT00637377|4073000|P2|Overall Study|Other (no further information available)|6
1241461|NCT00637377|4073001|P1|Overall Study|Other (no further information available)|7
1241462|NCT00637377|4072998|P4|Overall Study|Withdrawal by Subject|11
1241463|NCT00637377|4072999|P3|Overall Study|Withdrawal by Subject|13
1241464|NCT00637377|4073000|P2|Overall Study|Withdrawal by Subject|15
1241465|NCT00637377|4073001|P1|Overall Study|Withdrawal by Subject|11
1241466|NCT00637377|4072998|P4|Overall Study|Protocol Violation|0
1241467|NCT00637377|4072999|P3|Overall Study|Protocol Violation|1
1241468|NCT00637377|4073000|P2|Overall Study|Protocol Violation|1
1241469|NCT00637377|4073001|P1|Overall Study|Protocol Violation|2
1241470|NCT00637377|4072998|P4|Overall Study|Lost to Follow-up|2
1241471|NCT00637377|4072999|P3|Overall Study|Lost to Follow-up|2
1241472|NCT00637377|4073000|P2|Overall Study|Lost to Follow-up|1
1241473|NCT00637377|4073001|P1|Overall Study|Lost to Follow-up|4
1241474|NCT00637377|4072998|P4|Overall Study|Lack of Efficacy|1
1241475|NCT00637377|4072999|P3|Overall Study|Lack of Efficacy|1
1241476|NCT00637377|4073000|P2|Overall Study|Lack of Efficacy|0
1241477|NCT00637377|4073001|P1|Overall Study|Lack of Efficacy|0
1241478|NCT00637377|4072998|P4|Overall Study|Death|1
1241479|NCT00637377|4072999|P3|Overall Study|Death|2
1241480|NCT00637377|4073000|P2|Overall Study|Death|3
1241481|NCT00637377|4073001|P1|Overall Study|Death|1
1241482|NCT00637377|4072998|P4|Overall Study|Adverse Event|9
1241483|NCT00637377|4072999|P3|Overall Study|Adverse Event|8
1241484|NCT00637377|4073000|P2|Overall Study|Adverse Event|6
1241485|NCT00637377|4073001|P1|Overall Study|Adverse Event|2
1241486|NCT00637273|4073050|P3|Overall Study|Loss of Glucose Control|1
1241487|NCT00637273|4073051|P2|Overall Study|Loss of Glucose Control|1
1241488|NCT00637273|4073052|P1|Overall Study|Loss of Glucose Control|1
1241489|NCT00637273|4073050|P3|Overall Study|Administrative|0
1241490|NCT00637273|4073051|P2|Overall Study|Administrative|0
1241491|NCT00637273|4073052|P1|Overall Study|Administrative|2
1241492|NCT00637273|4073050|P3|Overall Study|Investigator Decision|1
1241493|NCT00637273|4073051|P2|Overall Study|Investigator Decision|3
1241494|NCT00637273|4073052|P1|Overall Study|Investigator Decision|1
1241495|NCT00637273|4073050|P3|Overall Study|Withdrawal of Consent|18
1241496|NCT00637273|4073051|P2|Overall Study|Withdrawal of Consent|6
1241497|NCT00637273|4073052|P1|Overall Study|Withdrawal of Consent|18
1241498|NCT00637273|4073050|P3|Overall Study|Protocol Violation|1
1241499|NCT00637273|4073051|P2|Overall Study|Protocol Violation|4
1241500|NCT00637273|4073052|P1|Overall Study|Protocol Violation|2
1241501|NCT00637273|4073050|P3|Overall Study|Lost to Follow-up|13
1241502|NCT00637273|4073051|P2|Overall Study|Lost to Follow-up|9
1241503|NCT00637273|4073052|P1|Overall Study|Lost to Follow-up|8
1241504|NCT00637273|4073050|P3|Overall Study|Adverse Event|7
1241505|NCT00637273|4073051|P2|Overall Study|Adverse Event|5
1241506|NCT00637273|4073052|P1|Overall Study|Adverse Event|11
1241507|NCT00637195|4073108|P2|Overall Study|Withdrawal by Subject|1
1241508|NCT00637195|4073109|P1|Overall Study|Withdrawal by Subject|0
1241509|NCT00637195|4073108|P2|Overall Study|Other|0
1241510|NCT00637195|4073109|P1|Overall Study|Other|2
1241511|NCT00637195|4073108|P2|Overall Study|Lost to Follow-up|0
1241512|NCT00637195|4073109|P1|Overall Study|Lost to Follow-up|1
1241513|NCT00637156|4073145|P2|Overall Study|Lost to Follow-up|16
1241514|NCT00637156|4073146|P1|Overall Study|Lost to Follow-up|10
1241515|NCT00637156|4073145|P2|Overall Study|Death|1
1241516|NCT00637156|4073146|P1|Overall Study|Death|0
1241517|NCT00637156|4073145|P2|Overall Study|Withdrawal by Subject|7
1241518|NCT00637156|4073146|P1|Overall Study|Withdrawal by Subject|0
1241519|NCT00637000|4073188|P2|Overall Study|Withdrawal by Subject|3
1241520|NCT00637000|4073189|P1|Overall Study|Withdrawal by Subject|4
1241521|NCT00636987|4073229|P1|Overall Study|5 year visit window not complete|69
1241522|NCT00636987|4073229|P1|Overall Study|Lost to Follow-up|63
1241523|NCT00636987|4073229|P1|Overall Study|Explanted|13
1241524|NCT00636987|4073229|P1|Overall Study|Death|44
1241525|NCT00636961|4073239|P2|Period 2|Adverse Event|0
1241526|NCT00636961|4073240|P1|Period 2|Adverse Event|1
1241527|NCT00636961|4073239|P2|Period 1|Administrative problems|1
1241528|NCT00636961|4073240|P1|Period 1|Administrative problems|1
1241529|NCT00636818|4073254|P1|Overall Study|Withdrawal by Subject|4
1241530|NCT00636818|4073254|P1|Overall Study|Protocol Violation|1
1241531|NCT00636818|4073254|P1|Overall Study|Entry Criteria Exclusion|3
1241532|NCT00636818|4073254|P1|Overall Study|Lost to Follow-up|2
1241533|NCT00636818|4073254|P1|Overall Study|Adverse Event|1
1241534|NCT00636792|4073279|P1|Overall Study|Other|3
1241535|NCT00636792|4073279|P1|Overall Study|Withdrawal by Subject|3
1241536|NCT00636792|4073279|P1|Overall Study|Progressive Disease|4
1241537|NCT00636792|4073279|P1|Overall Study|Physician Decision|7
1241538|NCT00636792|4073279|P1|Overall Study|Adverse Event|16
1241539|NCT00636675|4073295|P2|Overall Study|Withdrawal by Subject|10
1241540|NCT00636675|4073296|P1|Overall Study|Withdrawal by Subject|19
1241541|NCT00636675|4073295|P2|Overall Study|Lost to Follow-up|31
1241542|NCT00636675|4073296|P1|Overall Study|Lost to Follow-up|121
1241543|NCT00636636|4073339|P2|Overall Study|Withdrawal by Subject|9
1241544|NCT00636636|4073340|P1|Overall Study|Withdrawal by Subject|4
1241545|NCT00636636|4073339|P2|Overall Study|Death|1
1241546|NCT00636636|4073340|P1|Overall Study|Death|0
1241547|NCT00636636|4073339|P2|Overall Study|Lost to Follow-up|1
1241548|NCT00636636|4073340|P1|Overall Study|Lost to Follow-up|0
1241549|NCT00636636|4073339|P2|Overall Study|Protocol Violation|2
1241550|NCT00636636|4073340|P1|Overall Study|Protocol Violation|2
1241551|NCT00636636|4073339|P2|Overall Study|Lack of Efficacy|12
1241552|NCT00636636|4073340|P1|Overall Study|Lack of Efficacy|7
1241553|NCT00636636|4073339|P2|Overall Study|Adverse Event|8
1241554|NCT00636636|4073340|P1|Overall Study|Adverse Event|19
1241555|NCT00636636|4073339|P2|Overall Study|Other reason|6
1241556|NCT00636636|4073340|P1|Overall Study|Other reason|4
1241557|NCT00636610|4073356|P2|Overall Study|Reason for discontinuation not available|2
1241558|NCT00636610|4073357|P1|Overall Study|Reason for discontinuation not available|3
1241559|NCT00636610|4073356|P2|Overall Study|Disease progression - clinical|3
1241560|NCT00636610|4073357|P1|Overall Study|Disease progression - clinical|8
1241561|NCT00636610|4073356|P2|Overall Study|Disease progression - radiographic|51
1241562|NCT00636610|4073357|P1|Overall Study|Disease progression - radiographic|41
1241563|NCT00636610|4073356|P2|Overall Study|Subject decision to withdraw|11
1241564|NCT00636610|4073357|P1|Overall Study|Subject decision to withdraw|15
1241565|NCT00636610|4073356|P2|Overall Study|Physician decision to withdraw patient|9
1241566|NCT00636610|4073357|P1|Overall Study|Physician decision to withdraw patient|15
1241567|NCT00636610|4073356|P2|Overall Study|Death|3
1241568|NCT00636610|4073357|P1|Overall Study|Death|6
1241569|NCT00636610|4073356|P2|Overall Study|Adverse Event|4
1241570|NCT00636610|4073357|P1|Overall Study|Adverse Event|4
1241571|NCT00636441|4073374|P7|Overall Study|Screen Failure|17
1241572|NCT00636441|4073375|P6|Overall Study|Screen Failure|0
1241573|NCT00636441|4073376|P5|Overall Study|Screen Failure|0
1241574|NCT00636441|4073377|P4|Overall Study|Screen Failure|0
1241575|NCT00636441|4073378|P3|Overall Study|Screen Failure|0
1241576|NCT00636441|4073379|P2|Overall Study|Screen Failure|0
1241577|NCT00636441|4073380|P1|Overall Study|Screen Failure|0
1241578|NCT00636441|4073374|P7|Overall Study|Late, ineligible|1
1241579|NCT00636441|4073375|P6|Overall Study|Late, ineligible|0
1241580|NCT00636441|4073376|P5|Overall Study|Late, ineligible|0
1241581|NCT00636441|4073377|P4|Overall Study|Late, ineligible|0
1241582|NCT00636441|4073378|P3|Overall Study|Late, ineligible|0
1241583|NCT00636441|4073379|P2|Overall Study|Late, ineligible|0
1241584|NCT00636441|4073380|P1|Overall Study|Late, ineligible|0
1241585|NCT00636441|4073374|P7|Overall Study|Adverse Event|0
1241586|NCT00636441|4073375|P6|Overall Study|Adverse Event|1
1241587|NCT00636441|4073376|P5|Overall Study|Adverse Event|0
1241588|NCT00636441|4073377|P4|Overall Study|Adverse Event|0
1241589|NCT00636441|4073378|P3|Overall Study|Adverse Event|1
1241590|NCT00636441|4073379|P2|Overall Study|Adverse Event|1
1241591|NCT00636441|4073380|P1|Overall Study|Adverse Event|0
1241592|NCT00636363|4073423|P3|Overall Study|Withdrawal by Subject|2
1241593|NCT00636363|4073424|P2|Overall Study|Withdrawal by Subject|3
1241594|NCT00636363|4073425|P1|Overall Study|Withdrawal by Subject|1
1241595|NCT00636363|4073423|P3|Overall Study|Lost to Follow-up|2
1241596|NCT00636363|4073424|P2|Overall Study|Lost to Follow-up|4
1241597|NCT00636363|4073425|P1|Overall Study|Lost to Follow-up|3
1241598|NCT00636363|4073423|P3|Overall Study|Protocol Violation|0
1241599|NCT00636363|4073424|P2|Overall Study|Protocol Violation|3
1241600|NCT00636363|4073425|P1|Overall Study|Protocol Violation|0
1241601|NCT00636363|4073423|P3|Overall Study|Lack of motivation|1
1241602|NCT00636363|4073424|P2|Overall Study|Lack of motivation|0
1241603|NCT00636363|4073425|P1|Overall Study|Lack of motivation|1
1241604|NCT00636363|4073423|P3|Overall Study|Missed > 1 visit|3
1241605|NCT00636363|4073424|P2|Overall Study|Missed > 1 visit|1
1241606|NCT00636363|4073425|P1|Overall Study|Missed > 1 visit|0
1241607|NCT00636363|4073423|P3|Overall Study|Met ineligibility criteria|3
1241608|NCT00636363|4073424|P2|Overall Study|Met ineligibility criteria|0
1241609|NCT00636363|4073425|P1|Overall Study|Met ineligibility criteria|0
1241610|NCT00636363|4073423|P3|Overall Study|Study related symptoms/complaints|4
1241611|NCT00636363|4073424|P2|Overall Study|Study related symptoms/complaints|7
1241612|NCT00636363|4073425|P1|Overall Study|Study related symptoms/complaints|8
1241613|NCT00636363|4073423|P3|Overall Study|Positive slit lamp finding|1
1241614|NCT00636363|4073424|P2|Overall Study|Positive slit lamp finding|2
1241615|NCT00636363|4073425|P1|Overall Study|Positive slit lamp finding|0
1241616|NCT00636363|4073423|P3|Overall Study|Adverse Event|1
1241617|NCT00636363|4073424|P2|Overall Study|Adverse Event|0
1241618|NCT00636363|4073425|P1|Overall Study|Adverse Event|0
1241619|NCT00636363|4073423|P3|Overall Study|Conjunctivitis|1
1241620|NCT00636363|4073424|P2|Overall Study|Conjunctivitis|0
1241621|NCT00636363|4073425|P1|Overall Study|Conjunctivitis|0
1241622|NCT00636207|4073446|P7|Overall Study|Withdrawal by Subject|0
1241623|NCT00636207|4073447|P6|Overall Study|Withdrawal by Subject|0
1241624|NCT00636207|4073448|P5|Overall Study|Withdrawal by Subject|1
1241625|NCT00636207|4073449|P4|Overall Study|Withdrawal by Subject|0
1241626|NCT00636207|4073450|P3|Overall Study|Withdrawal by Subject|0
1241627|NCT00636207|4073451|P2|Overall Study|Withdrawal by Subject|1
1241628|NCT00636207|4073452|P1|Overall Study|Withdrawal by Subject|0
1241629|NCT00636207|4073446|P7|Overall Study|Adverse Event|0
1241630|NCT00636207|4073447|P6|Overall Study|Adverse Event|0
1241631|NCT00636207|4073448|P5|Overall Study|Adverse Event|0
1241632|NCT00636207|4073449|P4|Overall Study|Adverse Event|0
1241633|NCT00636207|4073450|P3|Overall Study|Adverse Event|0
1241634|NCT00636207|4073451|P2|Overall Study|Adverse Event|0
1241635|NCT00636207|4073452|P1|Overall Study|Adverse Event|1
1241636|NCT00636194|4073516|P2|Overall Study|Protocol Violation|0
1241637|NCT00636194|4073517|P1|Overall Study|Protocol Violation|2
1241638|NCT00636194|4073516|P2|Overall Study|Study related symptoms and complaints|0
1241639|NCT00636194|4073517|P1|Overall Study|Study related symptoms and complaints|1
1241640|NCT00636168|4073529|P2|Treated With Study Drug|Still remains on treatment|94
1241641|NCT00636168|4073530|P1|Treated With Study Drug|Still remains on treatment|48
1241642|NCT00636168|4073529|P2|Treated With Study Drug|non-specified|1
1241643|NCT00636168|4073530|P1|Treated With Study Drug|non-specified|1
1241644|NCT00636168|4073529|P2|Treated With Study Drug|No longer meets criteria|0
1241645|NCT00636168|4073530|P1|Treated With Study Drug|No longer meets criteria|1
1241646|NCT00636168|4073529|P2|Treated With Study Drug|Pregnancy|0
1241647|NCT00636168|4073530|P1|Treated With Study Drug|Pregnancy|1
1241648|NCT00636168|4073529|P2|Treated With Study Drug|Death|0
1241649|NCT00636168|4073530|P1|Treated With Study Drug|Death|3
1241650|NCT00636168|4073529|P2|Treated With Study Drug|Poor or non-compliance|3
1241651|NCT00636168|4073530|P1|Treated With Study Drug|Poor or non-compliance|1
1241652|NCT00636168|4073529|P2|Treated With Study Drug|Withdrawal by Subject|20
1241653|NCT00636168|4073530|P1|Treated With Study Drug|Withdrawal by Subject|16
1241654|NCT00636168|4073529|P2|Treated With Study Drug|Adverse Event|20
1241655|NCT00636168|4073530|P1|Treated With Study Drug|Adverse Event|244
1241656|NCT00636168|4073529|P2|Treated With Study Drug|Recurrence of disease|273
1241657|NCT00636168|4073530|P1|Treated With Study Drug|Recurrence of disease|132
1241658|NCT00636168|4073529|P2|Randomized to Study Drug|No longer met study criteria|0
1241659|NCT00636168|4073530|P1|Randomized to Study Drug|No longer met study criteria|1
1241660|NCT00636168|4073529|P2|Randomized to Study Drug|Adverse Event|0
1241661|NCT00636168|4073530|P1|Randomized to Study Drug|Adverse Event|1
1241662|NCT00636168|4073529|P2|Randomized to Study Drug|Withdrawal by Subject|2
1241663|NCT00636168|4073530|P1|Randomized to Study Drug|Withdrawal by Subject|2
1241664|NCT00636155|4073550|P1|Overall Study|Physician Decision|5
1241665|NCT00636155|4073550|P1|Overall Study|Stem cell transplant|1
1241666|NCT00636155|4073550|P1|Overall Study|Withdrawal by Subject|3
1241667|NCT00636155|4073550|P1|Overall Study|Lack of Efficacy|1
1241668|NCT00636155|4073550|P1|Overall Study|Adverse Event|8
1241669|NCT00635999|4073592|P3|Overall Study|Withdrawal by Subject|1
1241670|NCT00635999|4073593|P2|Overall Study|Withdrawal by Subject|2
1241671|NCT00635999|4073594|P1|Overall Study|Withdrawal by Subject|4
1241672|NCT00635882|4073611|P6|Overall Study|Protocol Violation|0
1241673|NCT00635882|4073612|P5|Overall Study|Protocol Violation|0
1241674|NCT00635882|4073613|P4|Overall Study|Protocol Violation|0
1241675|NCT00635882|4073614|P3|Overall Study|Protocol Violation|0
1241676|NCT00635882|4073615|P2|Overall Study|Protocol Violation|0
1241677|NCT00635882|4073616|P1|Overall Study|Protocol Violation|1
1241678|NCT00635804|4073746|P8|Overall Study|Withdrawal by Subject|0
1241679|NCT00635804|4073747|P7|Overall Study|Withdrawal by Subject|0
1241680|NCT00635804|4073748|P6|Overall Study|Withdrawal by Subject|0
1241681|NCT00635804|4073749|P5|Overall Study|Withdrawal by Subject|0
1241682|NCT00635804|4073750|P4|Overall Study|Withdrawal by Subject|0
1241683|NCT00635804|4073751|P3|Overall Study|Withdrawal by Subject|0
1241684|NCT00635804|4073752|P2|Overall Study|Withdrawal by Subject|0
1241685|NCT00635804|4073753|P1|Overall Study|Withdrawal by Subject|1
1241686|NCT00635804|4073746|P8|Overall Study|Adverse Event|0
1241687|NCT00635804|4073747|P7|Overall Study|Adverse Event|0
1241688|NCT00635804|4073748|P6|Overall Study|Adverse Event|1
1241689|NCT00635804|4073749|P5|Overall Study|Adverse Event|0
1241690|NCT00635804|4073750|P4|Overall Study|Adverse Event|0
1241691|NCT00635804|4073751|P3|Overall Study|Adverse Event|0
1241692|NCT00635804|4073752|P2|Overall Study|Adverse Event|0
1241693|NCT00635804|4073753|P1|Overall Study|Adverse Event|0
1241694|NCT00635778|4073857|P7|Overall Study|Progressive disease|4
1241695|NCT00635778|4073858|P6|Overall Study|Progressive disease|14
1241696|NCT00635778|4073859|P5|Overall Study|Progressive disease|5
1241697|NCT00635778|4073860|P4|Overall Study|Progressive disease|4
1241698|NCT00635778|4073861|P3|Overall Study|Progressive disease|3
1241699|NCT00635778|4073862|P2|Overall Study|Progressive disease|3
1241700|NCT00635778|4073863|P1|Overall Study|Progressive disease|0
1241701|NCT00635778|4073857|P7|Overall Study|Withdrawal by Subject|1
1241702|NCT00635778|4073858|P6|Overall Study|Withdrawal by Subject|1
1241703|NCT00635778|4073859|P5|Overall Study|Withdrawal by Subject|0
1241704|NCT00635778|4073860|P4|Overall Study|Withdrawal by Subject|1
1241705|NCT00635778|4073861|P3|Overall Study|Withdrawal by Subject|0
1241706|NCT00635778|4073862|P2|Overall Study|Withdrawal by Subject|0
1241707|NCT00635778|4073863|P1|Overall Study|Withdrawal by Subject|0
1241708|NCT00635778|4073857|P7|Overall Study|Adverse Event|1
1241709|NCT00635778|4073858|P6|Overall Study|Adverse Event|6
1241710|NCT00635778|4073859|P5|Overall Study|Adverse Event|3
1241711|NCT00635778|4073860|P4|Overall Study|Adverse Event|3
1241712|NCT00635778|4073861|P3|Overall Study|Adverse Event|0
1241713|NCT00635778|4073862|P2|Overall Study|Adverse Event|0
1241714|NCT00635778|4073863|P1|Overall Study|Adverse Event|1
1241715|NCT00635661|4073923|P1|Overall Study|Withdrawal by Subject|4
1241716|NCT00635648|4073927|P1|Overall Study|Other reason|2
1241717|NCT00635648|4073927|P1|Overall Study|Noncompliance with protocol|1
1241718|NCT00635648|4073927|P1|Overall Study|No improvement after 7-10 days treatment|4
1241719|NCT00635648|4073927|P1|Overall Study|Use of other antifungal agent needed|1
1241720|NCT00635648|4073927|P1|Overall Study|Rapid progression of baseline disease|4
1241721|NCT00635648|4073927|P1|Overall Study|Physician Decision|4
1241722|NCT00635648|4073927|P1|Overall Study|Withdrawal by Subject|9
1241723|NCT00635648|4073927|P1|Overall Study|Adverse Event|12
1241724|NCT00635570|4073949|P2|Overall Study|Early termination(No sexual activity)|1
1241725|NCT00635570|4073950|P1|Overall Study|Early termination(No sexual activity)|1
1241726|NCT00635570|4073949|P2|Overall Study|Did not complete survey|1
1241727|NCT00635570|4073950|P1|Overall Study|Did not complete survey|2
1241728|NCT00635570|4073949|P2|Overall Study|Physician Decision|0
1241729|NCT00635570|4073950|P1|Overall Study|Physician Decision|1
1241730|NCT00635570|4073949|P2|Overall Study|Adverse Event|0
1241731|NCT00635570|4073950|P1|Overall Study|Adverse Event|2
1241732|NCT00635570|4073949|P2|Overall Study|Withdrawal by Subject|1
1241733|NCT00635570|4073950|P1|Overall Study|Withdrawal by Subject|1
1241734|NCT00635570|4073949|P2|Overall Study|Lost to Follow-up|8
1241735|NCT00635570|4073950|P1|Overall Study|Lost to Follow-up|8
1241736|NCT00635492|4073964|P2|Overall Study|Withdrawal by Subject|45
1241737|NCT00635492|4073965|P1|Overall Study|Withdrawal by Subject|82
1241738|NCT00635492|4073964|P2|Overall Study|Sponsor decision|3
1241739|NCT00635492|4073965|P1|Overall Study|Sponsor decision|2
1241740|NCT00635492|4073964|P2|Overall Study|Physician Decision|22
1241741|NCT00635492|4073965|P1|Overall Study|Physician Decision|32
1241742|NCT00635492|4073964|P2|Overall Study|Lost to Follow-up|172
1241743|NCT00635492|4073965|P1|Overall Study|Lost to Follow-up|151
1241744|NCT00635492|4073964|P2|Overall Study|Death|40
1241745|NCT00635492|4073965|P1|Overall Study|Death|12
1241746|NCT00635427|4074023|P5|Overall Study|Withdrawal Of Consent|2
1241747|NCT00635427|4074024|P4|Overall Study|Withdrawal Of Consent|2
1241748|NCT00635427|4074025|P3|Overall Study|Withdrawal Of Consent|0
1241749|NCT00635427|4074026|P2|Overall Study|Withdrawal Of Consent|0
1241750|NCT00635427|4074027|P1|Overall Study|Withdrawal Of Consent|0
1241751|NCT00635427|4074023|P5|Overall Study|Termination Of Study By Sponsor|6
1241752|NCT00635427|4074024|P4|Overall Study|Termination Of Study By Sponsor|6
1241753|NCT00635427|4074025|P3|Overall Study|Termination Of Study By Sponsor|10
1241754|NCT00635427|4074026|P2|Overall Study|Termination Of Study By Sponsor|6
1241755|NCT00635427|4074027|P1|Overall Study|Termination Of Study By Sponsor|12
1241756|NCT00635427|4074023|P5|Overall Study|Death|0
1241757|NCT00635427|4074024|P4|Overall Study|Death|1
1241758|NCT00635427|4074025|P3|Overall Study|Death|0
1241759|NCT00635427|4074026|P2|Overall Study|Death|0
1241760|NCT00635427|4074027|P1|Overall Study|Death|0
1241761|NCT00635427|4074023|P5|Overall Study|Refusal Of Required DiagnosticEvaluation|0
1241762|NCT00635427|4074024|P4|Overall Study|Refusal Of Required DiagnosticEvaluation|0
1241763|NCT00635427|4074025|P3|Overall Study|Refusal Of Required DiagnosticEvaluation|1
1241764|NCT00635427|4074026|P2|Overall Study|Refusal Of Required DiagnosticEvaluation|0
1241765|NCT00635427|4074027|P1|Overall Study|Refusal Of Required DiagnosticEvaluation|0
1241766|NCT00635349|4074066|P2|Overall Study|Adverse Event|9
1241767|NCT00635349|4074067|P1|Overall Study|Adverse Event|11
1241768|NCT00635349|4074066|P2|Overall Study|Lost to Follow-up|3
1241769|NCT00635349|4074067|P1|Overall Study|Lost to Follow-up|4
1241770|NCT00635349|4074066|P2|Overall Study|Withdrawal by Subject|8
1241771|NCT00635349|4074067|P1|Overall Study|Withdrawal by Subject|3
1241772|NCT00635349|4074066|P2|Overall Study|Protocol Violation|22
1241773|NCT00635349|4074067|P1|Overall Study|Protocol Violation|18
1241774|NCT00635349|4074066|P2|Overall Study|Other|6
1241775|NCT00635349|4074067|P1|Overall Study|Other|8
1241776|NCT00635219|4074121|P5|Overall Study|Administrative or Other Reasons|1
1241777|NCT00635219|4074122|P4|Overall Study|Administrative or Other Reasons|0
1241778|NCT00635219|4074123|P3|Overall Study|Administrative or Other Reasons|1
1241779|NCT00635219|4074124|P2|Overall Study|Administrative or Other Reasons|1
1241780|NCT00635219|4074125|P1|Overall Study|Administrative or Other Reasons|0
1241781|NCT00635219|4074121|P5|Overall Study|Lost to Follow-up|3
1241782|NCT00635219|4074122|P4|Overall Study|Lost to Follow-up|0
1241783|NCT00635219|4074123|P3|Overall Study|Lost to Follow-up|2
1241784|NCT00635219|4074124|P2|Overall Study|Lost to Follow-up|0
1241785|NCT00635219|4074125|P1|Overall Study|Lost to Follow-up|0
1241786|NCT00635219|4074121|P5|Overall Study|Withdrawal of Consent|8
1241787|NCT00635219|4074122|P4|Overall Study|Withdrawal of Consent|11
1241788|NCT00635219|4074123|P3|Overall Study|Withdrawal of Consent|8
1241789|NCT00635219|4074124|P2|Overall Study|Withdrawal of Consent|6
1241790|NCT00635219|4074125|P1|Overall Study|Withdrawal of Consent|8
1241791|NCT00635219|4074121|P5|Overall Study|Protocol Violation|4
1241792|NCT00635219|4074122|P4|Overall Study|Protocol Violation|2
1241793|NCT00635219|4074123|P3|Overall Study|Protocol Violation|3
1241794|NCT00635219|4074124|P2|Overall Study|Protocol Violation|2
1241795|NCT00635219|4074125|P1|Overall Study|Protocol Violation|0
1241796|NCT00635219|4074121|P5|Overall Study|Non-compliance With Study Product|1
1241797|NCT00635219|4074122|P4|Overall Study|Non-compliance With Study Product|2
1241798|NCT00635219|4074123|P3|Overall Study|Non-compliance With Study Product|0
1241799|NCT00635219|4074124|P2|Overall Study|Non-compliance With Study Product|0
1241800|NCT00635219|4074125|P1|Overall Study|Non-compliance With Study Product|0
1241801|NCT00635219|4074121|P5|Overall Study|Lack of Efficacy|6
1241802|NCT00635219|4074122|P4|Overall Study|Lack of Efficacy|4
1241803|NCT00635219|4074123|P3|Overall Study|Lack of Efficacy|3
1241804|NCT00635219|4074124|P2|Overall Study|Lack of Efficacy|6
1241805|NCT00635219|4074125|P1|Overall Study|Lack of Efficacy|5
1241806|NCT00635219|4074121|P5|Overall Study|Adverse Event|19
1241807|NCT00635219|4074122|P4|Overall Study|Adverse Event|15
1241808|NCT00635219|4074123|P3|Overall Study|Adverse Event|18
1241809|NCT00635219|4074124|P2|Overall Study|Adverse Event|10
1241810|NCT00635219|4074125|P1|Overall Study|Adverse Event|12
1241811|NCT00635154|4074188|P1|Overall Study|Still on treatment|21
1241812|NCT00635154|4074188|P1|Overall Study|Other|4
1241813|NCT00635154|4074188|P1|Overall Study|Alternative Treatment|8
1241814|NCT00635102|4074231|P2|Overall Study|Withdrawal by Subject|8
1241815|NCT00635102|4074232|P1|Overall Study|Withdrawal by Subject|7
1241816|NCT00635089|4074326|P1|Overall Study|Not Specified|31
1241817|NCT00635089|4074326|P1|Overall Study|Lost to Follow-up|8
1241818|NCT00635089|4074326|P1|Overall Study|Protocol Deviation|4
1241819|NCT00635089|4074326|P1|Overall Study|Lack of Efficacy|28
1241820|NCT00635089|4074326|P1|Overall Study|Adverse Event|7
1241821|NCT00635050|4074353|P1|Overall Study|Withdrawal by Subject|1
1241822|NCT00635024|4074360|P1|Overall Study|Adverse Event|1
1241823|NCT00634933|4074371|P5|Part B: Week 24 to Week 52|Other|1
1241824|NCT00634933|4074372|P4|Part B: Week 24 to Week 52|Other|0
1241825|NCT00634933|4074373|P3|Part B: Week 24 to Week 52|Other|5
1241826|NCT00634933|4074374|P2|Part B: Week 24 to Week 52|Other|0
1241827|NCT00634933|4074375|P1|Part B: Week 24 to Week 52|Other|0
1241828|NCT00634933|4074371|P5|Part B: Week 24 to Week 52|Lack of Efficacy|0
1241829|NCT00634933|4074372|P4|Part B: Week 24 to Week 52|Lack of Efficacy|0
1241830|NCT00634933|4074373|P3|Part B: Week 24 to Week 52|Lack of Efficacy|1
1241831|NCT00634933|4074374|P2|Part B: Week 24 to Week 52|Lack of Efficacy|1
1241832|NCT00634933|4074375|P1|Part B: Week 24 to Week 52|Lack of Efficacy|0
1241833|NCT00634933|4074371|P5|Part B: Week 24 to Week 52|Withdrawal by Subject|1
1241834|NCT00634933|4074372|P4|Part B: Week 24 to Week 52|Withdrawal by Subject|2
1241835|NCT00634933|4074373|P3|Part B: Week 24 to Week 52|Withdrawal by Subject|0
1241836|NCT00634933|4074374|P2|Part B: Week 24 to Week 52|Withdrawal by Subject|0
1241837|NCT00634933|4074375|P1|Part B: Week 24 to Week 52|Withdrawal by Subject|0
1241838|NCT00634933|4074371|P5|Part B: Week 24 to Week 52|Protocol Violation|1
1241839|NCT00634933|4074372|P4|Part B: Week 24 to Week 52|Protocol Violation|0
1241840|NCT00634933|4074373|P3|Part B: Week 24 to Week 52|Protocol Violation|0
1241841|NCT00634933|4074374|P2|Part B: Week 24 to Week 52|Protocol Violation|0
1241842|NCT00634933|4074375|P1|Part B: Week 24 to Week 52|Protocol Violation|0
1241843|NCT00634933|4074371|P5|Part B: Week 24 to Week 52|Physician Decision|0
1241844|NCT00634933|4074372|P4|Part B: Week 24 to Week 52|Physician Decision|0
1241845|NCT00634933|4074373|P3|Part B: Week 24 to Week 52|Physician Decision|1
1241846|NCT00634933|4074374|P2|Part B: Week 24 to Week 52|Physician Decision|1
1241847|NCT00634933|4074375|P1|Part B: Week 24 to Week 52|Physician Decision|0
1241848|NCT00634933|4074371|P5|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7
1241849|NCT00634933|4074372|P4|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3
1241850|NCT00634933|4074373|P3|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14
1241851|NCT00634933|4074374|P2|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11
1241852|NCT00634933|4074375|P1|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0
1241853|NCT00634933|4074371|P5|Part B: Week 24 to Week 52|Adverse Event|0
1241854|NCT00634933|4074372|P4|Part B: Week 24 to Week 52|Adverse Event|1
1241855|NCT00634933|4074373|P3|Part B: Week 24 to Week 52|Adverse Event|1
1241856|NCT00634933|4074374|P2|Part B: Week 24 to Week 52|Adverse Event|1
1241857|NCT00634933|4074375|P1|Part B: Week 24 to Week 52|Adverse Event|0
1241858|NCT00634933|4074371|P5|Between Part A and Part B|Physician Decision|0
1241859|NCT00634933|4074372|P4|Between Part A and Part B|Physician Decision|0
1241860|NCT00634933|4074373|P3|Between Part A and Part B|Physician Decision|0
1241861|NCT00634933|4074374|P2|Between Part A and Part B|Physician Decision|1
1241862|NCT00634933|4074375|P1|Between Part A and Part B|Physician Decision|0
1241863|NCT00634933|4074371|P5|Part A: Baseline to Week 24|Other|0
1241864|NCT00634933|4074372|P4|Part A: Baseline to Week 24|Other|0
1241865|NCT00634933|4074373|P3|Part A: Baseline to Week 24|Other|5
1241866|NCT00634933|4074374|P2|Part A: Baseline to Week 24|Other|8
1241867|NCT00634933|4074375|P1|Part A: Baseline to Week 24|Other|1
1241868|NCT00634933|4074371|P5|Part A: Baseline to Week 24|Lack of Efficacy|0
1241869|NCT00634933|4074372|P4|Part A: Baseline to Week 24|Lack of Efficacy|0
1241870|NCT00634933|4074373|P3|Part A: Baseline to Week 24|Lack of Efficacy|0
1241871|NCT00634933|4074374|P2|Part A: Baseline to Week 24|Lack of Efficacy|1
1241872|NCT00634933|4074375|P1|Part A: Baseline to Week 24|Lack of Efficacy|3
1241873|NCT00634933|4074371|P5|Part A: Baseline to Week 24|Withdrawal by Subject|0
1241874|NCT00634933|4074372|P4|Part A: Baseline to Week 24|Withdrawal by Subject|0
1241875|NCT00634933|4074373|P3|Part A: Baseline to Week 24|Withdrawal by Subject|3
1241876|NCT00634933|4074374|P2|Part A: Baseline to Week 24|Withdrawal by Subject|3
1241877|NCT00634933|4074375|P1|Part A: Baseline to Week 24|Withdrawal by Subject|0
1241878|NCT00634933|4074371|P5|Part A: Baseline to Week 24|Lost to Follow-up|0
1241879|NCT00634933|4074372|P4|Part A: Baseline to Week 24|Lost to Follow-up|0
1241880|NCT00634933|4074373|P3|Part A: Baseline to Week 24|Lost to Follow-up|1
1241881|NCT00634933|4074374|P2|Part A: Baseline to Week 24|Lost to Follow-up|1
1241882|NCT00634933|4074375|P1|Part A: Baseline to Week 24|Lost to Follow-up|0
1241883|NCT00634933|4074371|P5|Part A: Baseline to Week 24|Investigator Request|0
1241884|NCT00634933|4074372|P4|Part A: Baseline to Week 24|Investigator Request|0
1241885|NCT00634933|4074373|P3|Part A: Baseline to Week 24|Investigator Request|1
1241886|NCT00634933|4074374|P2|Part A: Baseline to Week 24|Investigator Request|1
1241887|NCT00634933|4074375|P1|Part A: Baseline to Week 24|Investigator Request|1
1241888|NCT00634933|4074371|P5|Part A: Baseline to Week 24|Failed to Return|0
1241889|NCT00634933|4074372|P4|Part A: Baseline to Week 24|Failed to Return|0
1241890|NCT00634933|4074373|P3|Part A: Baseline to Week 24|Failed to Return|0
1241891|NCT00634933|4074374|P2|Part A: Baseline to Week 24|Failed to Return|0
1241892|NCT00634933|4074375|P1|Part A: Baseline to Week 24|Failed to Return|1
1241893|NCT00634933|4074371|P5|Part A: Baseline to Week 24|Death|0
1241894|NCT00634933|4074372|P4|Part A: Baseline to Week 24|Death|0
1241895|NCT00634933|4074373|P3|Part A: Baseline to Week 24|Death|0
1241896|NCT00634933|4074374|P2|Part A: Baseline to Week 24|Death|0
1241897|NCT00634933|4074375|P1|Part A: Baseline to Week 24|Death|1
1241898|NCT00634933|4074371|P5|Part A: Baseline to Week 24|Adverse Event|0
1241899|NCT00634933|4074372|P4|Part A: Baseline to Week 24|Adverse Event|0
1241900|NCT00634933|4074373|P3|Part A: Baseline to Week 24|Adverse Event|8
1241901|NCT00634933|4074374|P2|Part A: Baseline to Week 24|Adverse Event|4
1241902|NCT00634933|4074375|P1|Part A: Baseline to Week 24|Adverse Event|4
1241903|NCT00634920|4074444|P3|Period 2 - Post-Randomization|Patients did not receive study drug|0
1241904|NCT00634920|4074445|P2|Period 2 - Post-Randomization|Patients did not receive study drug|0
1241905|NCT00634920|4074446|P1|Period 2 - Post-Randomization|Patients did not receive study drug|2
1241906|NCT00634920|4074444|P3|Period 2 - Post-Randomization|consent withdrawal, non compliance|0
1241907|NCT00634920|4074445|P2|Period 2 - Post-Randomization|consent withdrawal, non compliance|13
1241908|NCT00634920|4074446|P1|Period 2 - Post-Randomization|consent withdrawal, non compliance|9
1241909|NCT00634920|4074444|P3|Period 2 - Post-Randomization|Death|0
1241910|NCT00634920|4074445|P2|Period 2 - Post-Randomization|Death|5
1241911|NCT00634920|4074446|P1|Period 2 - Post-Randomization|Death|2
1241912|NCT00634920|4074444|P3|Period 2 - Post-Randomization|Rejection|0
1241913|NCT00634920|4074445|P2|Period 2 - Post-Randomization|Rejection|5
1241914|NCT00634920|4074446|P1|Period 2 - Post-Randomization|Rejection|11
1241915|NCT00634920|4074444|P3|Period 2 - Post-Randomization|Adverse Event|0
1241916|NCT00634920|4074445|P2|Period 2 - Post-Randomization|Adverse Event|9
1241917|NCT00634920|4074446|P1|Period 2 - Post-Randomization|Adverse Event|37
1241918|NCT00634920|4074444|P3|Period 1 - Pre-Randomization|Other issues|6
1241919|NCT00634920|4074445|P2|Period 1 - Pre-Randomization|Other issues|0
1241920|NCT00634920|4074446|P1|Period 1 - Pre-Randomization|Other issues|0
1241921|NCT00634920|4074444|P3|Period 1 - Pre-Randomization|Non-Compliance|3
1241922|NCT00634920|4074445|P2|Period 1 - Pre-Randomization|Non-Compliance|0
1241923|NCT00634920|4074446|P1|Period 1 - Pre-Randomization|Non-Compliance|0
1241924|NCT00634920|4074444|P3|Period 1 - Pre-Randomization|Withdrawal by Subject|21
1241925|NCT00634920|4074445|P2|Period 1 - Pre-Randomization|Withdrawal by Subject|0
1241926|NCT00634920|4074446|P1|Period 1 - Pre-Randomization|Withdrawal by Subject|0
1241927|NCT00634920|4074444|P3|Period 1 - Pre-Randomization|Rejections|55
1241928|NCT00634920|4074445|P2|Period 1 - Pre-Randomization|Rejections|0
1241929|NCT00634920|4074446|P1|Period 1 - Pre-Randomization|Rejections|0
1241930|NCT00634920|4074444|P3|Period 1 - Pre-Randomization|Wound healing problems|16
1241931|NCT00634920|4074445|P2|Period 1 - Pre-Randomization|Wound healing problems|0
1241932|NCT00634920|4074446|P1|Period 1 - Pre-Randomization|Wound healing problems|0
1241933|NCT00634920|4074444|P3|Period 1 - Pre-Randomization|Adverse Event|36
1241934|NCT00634920|4074445|P2|Period 1 - Pre-Randomization|Adverse Event|0
1241935|NCT00634920|4074446|P1|Period 1 - Pre-Randomization|Adverse Event|0
1241936|NCT00634907|4074490|P2|Overall Study|Withdrawal by Subject|8
1241937|NCT00634907|4074491|P1|Overall Study|Withdrawal by Subject|11
1241938|NCT00634907|4074490|P2|Overall Study|Physician Decision|9
1241939|NCT00634907|4074491|P1|Overall Study|Physician Decision|3
1241940|NCT00634907|4074490|P2|Overall Study|Withdrawal by Subject|0
1241941|NCT00634907|4074491|P1|Overall Study|Withdrawal by Subject|3
1241942|NCT00634842|4074515|P2|Overall Study|Subject off study drug for too long|1
1241943|NCT00634842|4074516|P1|Overall Study|Subject off study drug for too long|0
1241944|NCT00634842|4074515|P2|Overall Study|No wish to keep taking Avandia|1
1241945|NCT00634842|4074516|P1|Overall Study|No wish to keep taking Avandia|0
1241946|NCT00634842|4074515|P2|Overall Study|No need of study drug to treat diabetes|1
1241947|NCT00634842|4074516|P1|Overall Study|No need of study drug to treat diabetes|0
1241948|NCT00634842|4074515|P2|Overall Study|Discontinued due to injection|2
1241949|NCT00634842|4074516|P1|Overall Study|Discontinued due to injection|0
1241950|NCT00634842|4074515|P2|Overall Study|Lack of time and intolerance to drug|1
1241951|NCT00634842|4074516|P1|Overall Study|Lack of time and intolerance to drug|0
1241952|NCT00634842|4074515|P2|Overall Study|Withdrawal by Subject|3
1241953|NCT00634842|4074516|P1|Overall Study|Withdrawal by Subject|1
1241954|NCT00634842|4074515|P2|Overall Study|Physician Decision|0
1241955|NCT00634842|4074516|P1|Overall Study|Physician Decision|1
1241956|NCT00634842|4074515|P2|Overall Study|Lost to Follow-up|2
1241957|NCT00634842|4074516|P1|Overall Study|Lost to Follow-up|1
1241958|NCT00634842|4074515|P2|Overall Study|Inclusion criteria were not met|0
1241959|NCT00634842|4074516|P1|Overall Study|Inclusion criteria were not met|1
1241960|NCT00634842|4074515|P2|Overall Study|Move to another state|0
1241961|NCT00634842|4074516|P1|Overall Study|Move to another state|1
1241962|NCT00634842|4074515|P2|Overall Study|Protocol Violation|4
1241963|NCT00634842|4074516|P1|Overall Study|Protocol Violation|8
1241964|NCT00634842|4074515|P2|Overall Study|Adverse Event|3
1241965|NCT00634842|4074516|P1|Overall Study|Adverse Event|2
1241966|NCT00634751|4074532|P4|Pancreatic and Bilial Tract Cancer|Death|1
1241967|NCT00634751|4074533|P3|Pancreatic and Bilial Tract Cancer|Death|1
1241968|NCT00634751|4074534|P2|Pancreatic and Bilial Tract Cancer|Death|0
1241969|NCT00634751|4074535|P1|Pancreatic and Bilial Tract Cancer|Death|0
1241970|NCT00634751|4074532|P4|Phase I: 400mg Sorafenib BID+2DOC|Death|0
1241971|NCT00634751|4074533|P3|Phase I: 400mg Sorafenib BID+2DOC|Death|0
1241972|NCT00634751|4074534|P2|Phase I: 400mg Sorafenib BID+2DOC|Death|1
1241973|NCT00634751|4074535|P1|Phase I: 400mg Sorafenib BID+2DOC|Death|0
1241974|NCT00634751|4074532|P4|Phase I: 200mg Sorafenib+2DOC|Death|0
1241975|NCT00634751|4074533|P3|Phase I: 200mg Sorafenib+2DOC|Death|0
1241976|NCT00634751|4074534|P2|Phase I: 200mg Sorafenib+2DOC|Death|0
1241977|NCT00634751|4074535|P1|Phase I: 200mg Sorafenib+2DOC|Death|1
1241978|NCT00634647|4074553|P1|Overall Study|declined to participate before treatment|1
1241979|NCT00634647|4074553|P1|Overall Study|refused further treatment|3
1241980|NCT00634647|4074553|P1|Overall Study|death on study|3
1241981|NCT00634569|4074573|P2|Overall Study|Physician Decision|1
1241982|NCT00634569|4074574|P1|Overall Study|Physician Decision|0
1241983|NCT00634569|4074573|P2|Overall Study|Withdrawal by Subject|4
1241984|NCT00634569|4074574|P1|Overall Study|Withdrawal by Subject|0
1241985|NCT00634543|4074588|P2|Overall Study|Lost to Follow-up|1
1241986|NCT00634543|4074589|P1|Overall Study|Lost to Follow-up|0
1241987|NCT00634543|4074588|P2|Overall Study|Withdrawal by Subject|4
1241988|NCT00634543|4074589|P1|Overall Study|Withdrawal by Subject|4
1241989|NCT00634543|4074588|P2|Overall Study|Adverse Event|11
1241990|NCT00634543|4074589|P1|Overall Study|Adverse Event|11
1241991|NCT00634543|4074588|P2|Overall Study|Protocol Violation|3
1241992|NCT00634543|4074589|P1|Overall Study|Protocol Violation|3
1241993|NCT00634543|4074588|P2|Overall Study|Other|2
1241994|NCT00634543|4074589|P1|Overall Study|Other|1
1241995|NCT00634504|4074607|P2|Overall Study|Protocol Violation|0
1241996|NCT00634504|4074608|P1|Overall Study|Protocol Violation|1
1241997|NCT00634244|4074659|P3|Overall Study|Other complicating disease|0
1241998|NCT00634244|4074660|P2|Overall Study|Other complicating disease|1
1241999|NCT00634244|4074661|P1|Overall Study|Other complicating disease|0
1242000|NCT00634244|4074659|P3|Overall Study|Disease progression/relapse|0
1242001|NCT00634244|4074660|P2|Overall Study|Disease progression/relapse|1
1242002|NCT00634244|4074661|P1|Overall Study|Disease progression/relapse|0
1242003|NCT00634244|4074659|P3|Overall Study|Physician Decision|0
1242004|NCT00634244|4074660|P2|Overall Study|Physician Decision|1
1242005|NCT00634244|4074661|P1|Overall Study|Physician Decision|0
1242006|NCT00634244|4074659|P3|Overall Study|Withdrawal by Subject|0
1242007|NCT00634244|4074660|P2|Overall Study|Withdrawal by Subject|1
1242008|NCT00634244|4074661|P1|Overall Study|Withdrawal by Subject|0
1242009|NCT00634244|4074659|P3|Overall Study|Adverse Event|0
1242010|NCT00634244|4074660|P2|Overall Study|Adverse Event|2
1242011|NCT00634244|4074661|P1|Overall Study|Adverse Event|0
1242012|NCT00634244|4074659|P3|Overall Study|Death|0
1242013|NCT00634244|4074660|P2|Overall Study|Death|6
1242014|NCT00634244|4074661|P1|Overall Study|Death|1
1242015|NCT00634244|4074659|P3|Overall Study|Never started treatment|0
1242016|NCT00634244|4074660|P2|Overall Study|Never started treatment|1
1242017|NCT00634244|4074661|P1|Overall Study|Never started treatment|0
1242018|NCT00634179|4074672|P1|Phase II: Maintenance|Diagnosis changed after re-review|1
1242019|NCT00634114|4074691|P3|Overall Study|Other reason|1
1242020|NCT00634114|4074692|P2|Overall Study|Other reason|1
1242021|NCT00634114|4074693|P1|Overall Study|Other reason|1
1242022|NCT00634114|4074691|P3|Overall Study|Difficult to continue|1
1242023|NCT00634114|4074692|P2|Overall Study|Difficult to continue|1
1242024|NCT00634114|4074693|P1|Overall Study|Difficult to continue|3
1242025|NCT00634114|4074691|P3|Overall Study|Recurrence of reflux esophagitis|21
1242026|NCT00634114|4074692|P2|Overall Study|Recurrence of reflux esophagitis|15
1242027|NCT00634114|4074693|P1|Overall Study|Recurrence of reflux esophagitis|5
1242028|NCT00634114|4074691|P3|Overall Study|Incorrect enrolment|0
1242029|NCT00634114|4074692|P2|Overall Study|Incorrect enrolment|1
1242030|NCT00634114|4074693|P1|Overall Study|Incorrect enrolment|0
1242031|NCT00634114|4074691|P3|Overall Study|Pregnancy|0
1242032|NCT00634114|4074692|P2|Overall Study|Pregnancy|0
1242033|NCT00634114|4074693|P1|Overall Study|Pregnancy|1
1242034|NCT00634114|4074691|P3|Overall Study|Protocol Violation|1
1242035|NCT00634114|4074692|P2|Overall Study|Protocol Violation|3
1242036|NCT00634114|4074693|P1|Overall Study|Protocol Violation|3
1242037|NCT00634114|4074691|P3|Overall Study|Lost to Follow-up|1
1242038|NCT00634114|4074692|P2|Overall Study|Lost to Follow-up|0
1242039|NCT00634114|4074693|P1|Overall Study|Lost to Follow-up|0
1242040|NCT00634114|4074691|P3|Overall Study|Withdrawal by Subject|11
1242041|NCT00634114|4074692|P2|Overall Study|Withdrawal by Subject|6
1242042|NCT00634114|4074693|P1|Overall Study|Withdrawal by Subject|9
1242043|NCT00634114|4074691|P3|Overall Study|Adverse Event|3
1242044|NCT00634114|4074692|P2|Overall Study|Adverse Event|8
1242045|NCT00634114|4074693|P1|Overall Study|Adverse Event|6
1242046|NCT00634088|4074711|P4|Time Period 3: Dose Level 3|Progressive disease|0
1242047|NCT00634088|4074712|P3|Time Period 3: Dose Level 3|Progressive disease|1
1242048|NCT00634088|4074713|P2|Time Period 3: Dose Level 3|Progressive disease|0
1242049|NCT00634088|4074714|P1|Time Period 3: Dose Level 3|Progressive disease|0
1242050|NCT00634088|4074711|P4|Time Period 2: Dose Level 2|Progressive disease|0
1242051|NCT00634088|4074712|P3|Time Period 2: Dose Level 2|Progressive disease|0
1242052|NCT00634088|4074713|P2|Time Period 2: Dose Level 2|Progressive disease|1
1242053|NCT00634088|4074714|P1|Time Period 2: Dose Level 2|Progressive disease|0
1242054|NCT00634088|4074711|P4|Time Period 2: Dose Level 2|Adverse Event|0
1242055|NCT00634088|4074712|P3|Time Period 2: Dose Level 2|Adverse Event|0
1242056|NCT00634088|4074713|P2|Time Period 2: Dose Level 2|Adverse Event|2
1242057|NCT00634088|4074714|P1|Time Period 2: Dose Level 2|Adverse Event|0
1242058|NCT00634088|4074711|P4|Time Period 1: Dose Level 1|Adverse Event|0
1242059|NCT00634088|4074712|P3|Time Period 1: Dose Level 1|Adverse Event|0
1242060|NCT00634088|4074713|P2|Time Period 1: Dose Level 1|Adverse Event|0
1242061|NCT00634088|4074714|P1|Time Period 1: Dose Level 1|Adverse Event|3
1242062|NCT00634088|4074711|P4|Time Period 1: Dose Level 1|Physician Decision|0
1242063|NCT00634088|4074712|P3|Time Period 1: Dose Level 1|Physician Decision|0
1242064|NCT00634088|4074713|P2|Time Period 1: Dose Level 1|Physician Decision|0
1242065|NCT00634088|4074714|P1|Time Period 1: Dose Level 1|Physician Decision|1
1242066|NCT00634088|4074711|P4|Time Period 1: Dose Level 1|Disease progression|0
1242067|NCT00634088|4074712|P3|Time Period 1: Dose Level 1|Disease progression|0
1242068|NCT00634088|4074713|P2|Time Period 1: Dose Level 1|Disease progression|0
1242069|NCT00634088|4074714|P1|Time Period 1: Dose Level 1|Disease progression|2
1242070|NCT00634049|4074765|P1|Overall Study|Screening failure|1
1242071|NCT00634049|4074765|P1|Overall Study|Died prior to receiving study drug|1
1242072|NCT00634049|4074765|P1|Overall Study|Never received study drug|1
1242073|NCT00634036|4074844|P2|Overall Study|Withdrawal by Subject|1
1242074|NCT00634036|4074845|P1|Overall Study|Withdrawal by Subject|1
1242075|NCT00634036|4074844|P2|Overall Study|Lost to Follow-up|1
1242076|NCT00634036|4074845|P1|Overall Study|Lost to Follow-up|1
1242077|NCT00634010|4074859|P2|Overall Study|Non-Compliant|1
1242078|NCT00634010|4074860|P1|Overall Study|Non-Compliant|1
1242079|NCT00634010|4074859|P2|Overall Study|Disease Progression|1
1242080|NCT00634010|4074860|P1|Overall Study|Disease Progression|1
1242081|NCT00634010|4074859|P2|Overall Study|Physician Decision|1
1242082|NCT00634010|4074860|P1|Overall Study|Physician Decision|1
1242083|NCT00634010|4074859|P2|Overall Study|Withdrawal by Subject|6
1242084|NCT00634010|4074860|P1|Overall Study|Withdrawal by Subject|5
1242085|NCT00634010|4074859|P2|Overall Study|Adverse Event|5
1242086|NCT00634010|4074860|P1|Overall Study|Adverse Event|2
1242087|NCT00633984|4074868|P2|Overall Study|Hospitalized|0
1242088|NCT00633984|4074869|P1|Overall Study|Hospitalized|1
1242089|NCT00633984|4074868|P2|Overall Study|Withdrawal by Subject|7
1242090|NCT00633984|4074869|P1|Overall Study|Withdrawal by Subject|8
1242091|NCT00633984|4074868|P2|Overall Study|Lost to Follow-up|6
1242092|NCT00633984|4074869|P1|Overall Study|Lost to Follow-up|0
1242093|NCT00633932|4074880|P3|Overall Study|Moved Away|0
1242094|NCT00633932|4074881|P2|Overall Study|Moved Away|0
1242095|NCT00633932|4074882|P1|Overall Study|Moved Away|1
1242096|NCT00633932|4074880|P3|Overall Study|Doctor's judgement|0
1242097|NCT00633932|4074881|P2|Overall Study|Doctor's judgement|0
1242098|NCT00633932|4074882|P1|Overall Study|Doctor's judgement|1
1242099|NCT00633932|4074880|P3|Overall Study|Physician Decision|1
1242100|NCT00633932|4074881|P2|Overall Study|Physician Decision|0
1242101|NCT00633932|4074882|P1|Overall Study|Physician Decision|0
1242102|NCT00633932|4074880|P3|Overall Study|Protocol Violation|3
1242103|NCT00633932|4074881|P2|Overall Study|Protocol Violation|2
1242104|NCT00633932|4074882|P1|Overall Study|Protocol Violation|5
1242105|NCT00633932|4074880|P3|Overall Study|Lost to Follow-up|2
1242106|NCT00633932|4074881|P2|Overall Study|Lost to Follow-up|0
1242107|NCT00633932|4074882|P1|Overall Study|Lost to Follow-up|1
1242108|NCT00633932|4074880|P3|Overall Study|Withdrawal by Subject|1
1242109|NCT00633932|4074881|P2|Overall Study|Withdrawal by Subject|9
1242110|NCT00633932|4074882|P1|Overall Study|Withdrawal by Subject|3
1242111|NCT00633932|4074880|P3|Overall Study|Adverse Event|4
1242112|NCT00633932|4074881|P2|Overall Study|Adverse Event|3
1242113|NCT00633932|4074882|P1|Overall Study|Adverse Event|1
1242114|NCT00633893|4074913|P3|Overall Study|not specified|31
1242115|NCT00633893|4074914|P2|Overall Study|not specified|33
1242116|NCT00633893|4074915|P1|Overall Study|not specified|28
1242117|NCT00633893|4074913|P3|Overall Study|Not meet/no longer meets criteria|4
1242118|NCT00633893|4074914|P2|Overall Study|Not meet/no longer meets criteria|6
1242119|NCT00633893|4074915|P1|Overall Study|Not meet/no longer meets criteria|4
1242120|NCT00633893|4074913|P3|Overall Study|Pregnancy|1
1242121|NCT00633893|4074914|P2|Overall Study|Pregnancy|1
1242122|NCT00633893|4074915|P1|Overall Study|Pregnancy|2
1242123|NCT00633893|4074913|P3|Overall Study|Poor/non-compliance|3
1242124|NCT00633893|4074914|P2|Overall Study|Poor/non-compliance|12
1242125|NCT00633893|4074915|P1|Overall Study|Poor/non-compliance|5
1242126|NCT00633893|4074913|P3|Overall Study|Lost to Follow-up|8
1242127|NCT00633893|4074914|P2|Overall Study|Lost to Follow-up|4
1242128|NCT00633893|4074915|P1|Overall Study|Lost to Follow-up|2
1242129|NCT00633893|4074913|P3|Overall Study|Withdrawal by Subject|6
1242130|NCT00633893|4074914|P2|Overall Study|Withdrawal by Subject|12
1242131|NCT00633893|4074915|P1|Overall Study|Withdrawal by Subject|7
1242132|NCT00633893|4074913|P3|Overall Study|Adverse Event|126
1242133|NCT00633893|4074914|P2|Overall Study|Adverse Event|58
1242134|NCT00633893|4074915|P1|Overall Study|Adverse Event|65
1242135|NCT00633893|4074913|P3|Overall Study|Death|9
1242136|NCT00633893|4074914|P2|Overall Study|Death|3
1242137|NCT00633893|4074915|P1|Overall Study|Death|1
1242138|NCT00633880|4074989|P3|Open Label Titration|Withdrawal by Subject|0
1242139|NCT00633880|4074990|P2|Open Label Titration|Withdrawal by Subject|0
1242140|NCT00633880|4074991|P1|Open Label Titration|Withdrawal by Subject|4
1242141|NCT00633880|4074989|P3|Open Label Titration|Physician Decision|0
1242142|NCT00633880|4074990|P2|Open Label Titration|Physician Decision|0
1242143|NCT00633880|4074991|P1|Open Label Titration|Physician Decision|1
1242144|NCT00633880|4074989|P3|Open Label Titration|Protocol Violation|0
1242145|NCT00633880|4074990|P2|Open Label Titration|Protocol Violation|0
1242146|NCT00633880|4074991|P1|Open Label Titration|Protocol Violation|6
1242147|NCT00633880|4074989|P3|Open Label Titration|Treatment Failure|0
1242148|NCT00633880|4074990|P2|Open Label Titration|Treatment Failure|0
1242149|NCT00633880|4074991|P1|Open Label Titration|Treatment Failure|55
1242150|NCT00633880|4074989|P3|Open Label Titration|Adverse Event|0
1242151|NCT00633880|4074990|P2|Open Label Titration|Adverse Event|0
1242152|NCT00633880|4074991|P1|Open Label Titration|Adverse Event|13
1242153|NCT00633880|4074989|P3|Open Label Titration|Lack of Efficacy|0
1242154|NCT00633880|4074990|P2|Open Label Titration|Lack of Efficacy|0
1242155|NCT00633880|4074991|P1|Open Label Titration|Lack of Efficacy|1
1242156|NCT00633750|4075027|P1|Overall Study|Withdrawal by Subject|3
1242157|NCT00633750|4075027|P1|Overall Study|Adverse Event|2
1242158|NCT00633594|4075036|P3|Overall Study|Disease Progression|1
1242159|NCT00633594|4075037|P2|Overall Study|Disease Progression|0
1242160|NCT00633594|4075038|P1|Overall Study|Disease Progression|0
1242161|NCT00633594|4075036|P3|Overall Study|Death|2
1242162|NCT00633594|4075037|P2|Overall Study|Death|1
1242163|NCT00633594|4075038|P1|Overall Study|Death|0
1242164|NCT00633594|4075036|P3|Overall Study|Adverse Event|7
1242165|NCT00633594|4075037|P2|Overall Study|Adverse Event|4
1242166|NCT00633594|4075038|P1|Overall Study|Adverse Event|0
1242167|NCT00633477|4075067|P2|Overall Study|Randomized but not treated|0
1242168|NCT00633477|4075068|P1|Overall Study|Randomized but not treated|1
1242169|NCT00633477|4075067|P2|Overall Study|Death|0
1242170|NCT00633477|4075068|P1|Overall Study|Death|1
1242171|NCT00633464|4075084|P2|Overall Study|Never Treated (Randomized in error)|1
1242172|NCT00633464|4075085|P1|Overall Study|Never Treated (Randomized in error)|0
1242173|NCT00633464|4075084|P2|Overall Study|Never Treated (Not met study criteria)|1
1242174|NCT00633464|4075085|P1|Overall Study|Never Treated (Not met study criteria)|0
1242175|NCT00633360|4075120|P2|Overall Study|Protocol Violation|1
1242176|NCT00633360|4075121|P1|Overall Study|Protocol Violation|0
1242177|NCT00633360|4075120|P2|Overall Study|Adverse Event|1
1242178|NCT00633360|4075121|P1|Overall Study|Adverse Event|3
1242179|NCT00633360|4075120|P2|Overall Study|Lost to Follow-up|1
1242180|NCT00633360|4075121|P1|Overall Study|Lost to Follow-up|1
1242181|NCT00633243|4075144|P2|Overall Study|Couldn't tolerate side-effects|1
1242182|NCT00633243|4075145|P1|Overall Study|Couldn't tolerate side-effects|1
1242183|NCT00633243|4075144|P2|Overall Study|Mental Health--Depression|1
1242184|NCT00633243|4075145|P1|Overall Study|Mental Health--Depression|0
1242185|NCT00633243|4075144|P2|Overall Study|Not comfortable with self-injecting|1
1242186|NCT00633243|4075145|P1|Overall Study|Not comfortable with self-injecting|0
1242187|NCT00633243|4075144|P2|Overall Study|Homeless--no refrigeration for meds|1
1242188|NCT00633243|4075145|P1|Overall Study|Homeless--no refrigeration for meds|0
1242189|NCT00633243|4075144|P2|Overall Study|incarceration|2
1242190|NCT00633243|4075145|P1|Overall Study|incarceration|0
1242191|NCT00633243|4075144|P2|Overall Study|Withdrawal by Subject|1
1242192|NCT00633243|4075145|P1|Overall Study|Withdrawal by Subject|0
1242193|NCT00633217|4075153|P2|Overall Study|Withdrew Consent|3
1242194|NCT00633217|4075154|P1|Overall Study|Withdrew Consent|3
1242195|NCT00633217|4075153|P2|Overall Study|Investigator Discretion|0
1242196|NCT00633217|4075154|P1|Overall Study|Investigator Discretion|2
1242197|NCT00633217|4075153|P2|Overall Study|Lost to Follow-up|2
1242198|NCT00633217|4075154|P1|Overall Study|Lost to Follow-up|2
1242199|NCT00633217|4075153|P2|Overall Study|Protocol Violation|7
1242200|NCT00633217|4075154|P1|Overall Study|Protocol Violation|3
1242201|NCT00633217|4075153|P2|Overall Study|Lack of Efficacy|2
1242202|NCT00633217|4075154|P1|Overall Study|Lack of Efficacy|0
1242203|NCT00633217|4075153|P2|Overall Study|Adverse Event|9
1242204|NCT00633217|4075154|P1|Overall Study|Adverse Event|5
1242205|NCT00633152|4075166|P2|Overall Study|Miscellaneous Other|2
1242206|NCT00633152|4075167|P1|Overall Study|Miscellaneous Other|3
1242207|NCT00633152|4075166|P2|Overall Study|Lost to Follow-up|1
1242208|NCT00633152|4075167|P1|Overall Study|Lost to Follow-up|4
1242209|NCT00633152|4075166|P2|Overall Study|Withdrawal by Subject|1
1242210|NCT00633152|4075167|P1|Overall Study|Withdrawal by Subject|1
1242211|NCT00633152|4075166|P2|Overall Study|Randomized, did not receive study drug|2
1242212|NCT00633152|4075167|P1|Overall Study|Randomized, did not receive study drug|5
1242213|NCT00633152|4075166|P2|Overall Study|Adverse Event|0
1242214|NCT00633152|4075167|P1|Overall Study|Adverse Event|1
1242215|NCT00633139|4075178|P3|Overall Study|Withdrawal by Subject|0
1242216|NCT00633139|4075179|P2|Overall Study|Withdrawal by Subject|1
1242217|NCT00633139|4075180|P1|Overall Study|Withdrawal by Subject|0
1242218|NCT00633139|4075178|P3|Overall Study|Non compliance|1
1242219|NCT00633139|4075179|P2|Overall Study|Non compliance|0
1242220|NCT00633139|4075180|P1|Overall Study|Non compliance|0
1242221|NCT00633126|4075194|P1|Overall Study|Did not receive full dose|1
1242222|NCT00633074|4075208|P2|Overall Study|Adverse Event|0
1242223|NCT00633074|4075209|P1|Overall Study|Adverse Event|1
1242224|NCT00633022|4075240|P3|Overall Study|Physician Decision|0
1242225|NCT00633022|4075241|P2|Overall Study|Physician Decision|1
1242226|NCT00633022|4075242|P1|Overall Study|Physician Decision|0
1242227|NCT00633022|4075240|P3|Overall Study|Adverse Event|5
1242228|NCT00633022|4075241|P2|Overall Study|Adverse Event|0
1242229|NCT00633022|4075242|P1|Overall Study|Adverse Event|1
1242230|NCT00632931|4075304|P3|Part 2|Withdrawal by Subject|3
1242231|NCT00632931|4075305|P2|Part 2|Withdrawal by Subject|0
1242232|NCT00632931|4075306|P1|Part 2|Withdrawal by Subject|0
1242233|NCT00632931|4075304|P3|Part 2|Lack of Efficacy|17
1242234|NCT00632931|4075305|P2|Part 2|Lack of Efficacy|0
1242235|NCT00632931|4075306|P1|Part 2|Lack of Efficacy|0
1242236|NCT00632931|4075304|P3|Part 2|Death|1
1242237|NCT00632931|4075305|P2|Part 2|Death|0
1242239|NCT00632931|4075304|P3|Part 2|Adverse Event|3
1242240|NCT00632931|4075305|P2|Part 2|Adverse Event|0
1242241|NCT00632931|4075306|P1|Part 2|Adverse Event|0
1242242|NCT00632931|4075304|P3|Part 1, Period 1|Withdrawal by Subject|0
1242243|NCT00632931|4075305|P2|Part 1, Period 1|Withdrawal by Subject|0
1242244|NCT00632931|4075306|P1|Part 1, Period 1|Withdrawal by Subject|1
1242245|NCT00632931|4075304|P3|Part 1, Period 1|Protocol Violation|0
1242246|NCT00632931|4075305|P2|Part 1, Period 1|Protocol Violation|0
1242247|NCT00632931|4075306|P1|Part 1, Period 1|Protocol Violation|1
1242248|NCT00632749|4075376|P14|Overall Study|Reason other than those specified above|2
1242249|NCT00632749|4075377|P13|Overall Study|Reason other than those specified above|0
1242250|NCT00632749|4075378|P12|Overall Study|Reason other than those specified above|1
1242251|NCT00632749|4075379|P11|Overall Study|Reason other than those specified above|2
1242252|NCT00632749|4075380|P10|Overall Study|Reason other than those specified above|0
1242253|NCT00632749|4075381|P9|Overall Study|Reason other than those specified above|0
1242254|NCT00632749|4075382|P8|Overall Study|Reason other than those specified above|0
1242255|NCT00632749|4075383|P7|Overall Study|Reason other than those specified above|1
1242256|NCT00632749|4075384|P6|Overall Study|Reason other than those specified above|0
1242257|NCT00632749|4075385|P5|Overall Study|Reason other than those specified above|1
1242258|NCT00632749|4075386|P4|Overall Study|Reason other than those specified above|0
1242259|NCT00632749|4075387|P3|Overall Study|Reason other than those specified above|0
1242260|NCT00632749|4075388|P2|Overall Study|Reason other than those specified above|2
1242261|NCT00632749|4075389|P1|Overall Study|Reason other than those specified above|0
1242262|NCT00632749|4075376|P14|Overall Study|Refuse to continue medication|0
1242263|NCT00632749|4075377|P13|Overall Study|Refuse to continue medication|0
1242264|NCT00632749|4075378|P12|Overall Study|Refuse to continue medication|0
1242265|NCT00632749|4075379|P11|Overall Study|Refuse to continue medication|0
1242266|NCT00632749|4075380|P10|Overall Study|Refuse to continue medication|1
1242267|NCT00632749|4075381|P9|Overall Study|Refuse to continue medication|0
1242268|NCT00632749|4075382|P8|Overall Study|Refuse to continue medication|0
1242269|NCT00632749|4075383|P7|Overall Study|Refuse to continue medication|0
1242270|NCT00632749|4075384|P6|Overall Study|Refuse to continue medication|0
1242271|NCT00632749|4075385|P5|Overall Study|Refuse to continue medication|0
1242272|NCT00632749|4075386|P4|Overall Study|Refuse to continue medication|1
1242273|NCT00632749|4075387|P3|Overall Study|Refuse to continue medication|0
1242274|NCT00632749|4075388|P2|Overall Study|Refuse to continue medication|0
1242275|NCT00632749|4075389|P1|Overall Study|Refuse to continue medication|0
1242276|NCT00632749|4075376|P14|Overall Study|Other Adverse event|0
1242277|NCT00632749|4075377|P13|Overall Study|Other Adverse event|1
1242278|NCT00632749|4075378|P12|Overall Study|Other Adverse event|0
1242279|NCT00632749|4075379|P11|Overall Study|Other Adverse event|1
1242280|NCT00632749|4075380|P10|Overall Study|Other Adverse event|0
1242281|NCT00632749|4075381|P9|Overall Study|Other Adverse event|2
1242282|NCT00632749|4075382|P8|Overall Study|Other Adverse event|2
1242283|NCT00632749|4075383|P7|Overall Study|Other Adverse event|1
1242284|NCT00632749|4075384|P6|Overall Study|Other Adverse event|4
1242285|NCT00632749|4075385|P5|Overall Study|Other Adverse event|2
1242286|NCT00632749|4075386|P4|Overall Study|Other Adverse event|1
1242287|NCT00632749|4075387|P3|Overall Study|Other Adverse event|1
1242288|NCT00632749|4075388|P2|Overall Study|Other Adverse event|1
1242289|NCT00632749|4075389|P1|Overall Study|Other Adverse event|1
1242290|NCT00632749|4075376|P14|Overall Study|Progressive disease|4
1242291|NCT00632749|4075377|P13|Overall Study|Progressive disease|2
1242292|NCT00632749|4075378|P12|Overall Study|Progressive disease|3
1242293|NCT00632749|4075379|P11|Overall Study|Progressive disease|4
1242294|NCT00632749|4075380|P10|Overall Study|Progressive disease|2
1242295|NCT00632749|4075381|P9|Overall Study|Progressive disease|3
1242296|NCT00632749|4075382|P8|Overall Study|Progressive disease|2
1242297|NCT00632749|4075383|P7|Overall Study|Progressive disease|3
1242298|NCT00632749|4075384|P6|Overall Study|Progressive disease|4
1242299|NCT00632749|4075385|P5|Overall Study|Progressive disease|4
1242300|NCT00632749|4075386|P4|Overall Study|Progressive disease|2
1242301|NCT00632749|4075387|P3|Overall Study|Progressive disease|2
1242302|NCT00632749|4075388|P2|Overall Study|Progressive disease|2
1242303|NCT00632749|4075389|P1|Overall Study|Progressive disease|3
1242304|NCT00632736|4075683|P1|Overall Study|Other|16
1242305|NCT00632736|4075683|P1|Overall Study|Non-compliance|10
1242306|NCT00632736|4075683|P1|Overall Study|Sponsor terminated study|5
1242307|NCT00632736|4075683|P1|Overall Study|Lack of Efficacy|5
1242308|NCT00632736|4075683|P1|Overall Study|Withdrawal by Subject|99
1242309|NCT00632736|4075683|P1|Overall Study|Protocol Violation|14
1242310|NCT00632736|4075683|P1|Overall Study|Lost to Follow-up|15
1242311|NCT00632736|4075683|P1|Overall Study|Adverse Event|104
1242312|NCT00632541|4075718|P1|Overall Study|Adverse Event|7
1242313|NCT00632502|4075727|P2|Overall Study|Randomized not treated|0
1242314|NCT00632502|4075728|P1|Overall Study|Randomized not treated|3
1242315|NCT00632502|4075727|P2|Overall Study|Adverse Event|1
1242316|NCT00632502|4075728|P1|Overall Study|Adverse Event|0
1242317|NCT00632463|4075772|P3|Overall Study|Adverse Event|0
1242318|NCT00632463|4075773|P2|Overall Study|Adverse Event|1
1242319|NCT00632463|4075774|P1|Overall Study|Adverse Event|0
1242320|NCT00632424|4075791|P1|Overall Study|Study Drug Toxicity|1
1242321|NCT00632424|4075791|P1|Overall Study|Disease Progression|17
1242322|NCT00632229|4075829|P2|Overall Study|Undisclosed reasons within the first wee|1
1242323|NCT00632229|4075830|P1|Overall Study|Undisclosed reasons within the first wee|0
1242324|NCT00632229|4075829|P2|Overall Study|Lack of Efficacy|2
1242325|NCT00632229|4075830|P1|Overall Study|Lack of Efficacy|0
1242326|NCT00632229|4075829|P2|Overall Study|Lost to Follow-up|3
1242327|NCT00632229|4075830|P1|Overall Study|Lost to Follow-up|0
1242328|NCT00632229|4075829|P2|Overall Study|Adverse Event|0
1242329|NCT00632229|4075830|P1|Overall Study|Adverse Event|6
1242330|NCT00632203|4075840|P2|Overall Study|Did not start study treatment|0
1242331|NCT00632203|4075841|P1|Overall Study|Did not start study treatment|1
1242332|NCT00632125|4075859|P1|Overall Study|Moved to other dialysis unit, etc.|102
1242333|NCT00632125|4075859|P1|Overall Study|Development of uncontrolled hypertension|5
1242334|NCT00632125|4075859|P1|Overall Study|Non-compliance|8
1242335|NCT00632125|4075859|P1|Overall Study|Need for systemic immunosuppressive medi|8
1242336|NCT00632125|4075859|P1|Overall Study|Renal transplantation|17
1242337|NCT00632125|4075859|P1|Overall Study|Adverse Event|36
1242338|NCT00632125|4075859|P1|Overall Study|Withdrawal by Subject|44
1242339|NCT00632125|4075859|P1|Overall Study|Death|82
1242340|NCT00632099|4075865|P2|Overall Study|Lost to Follow-up|3
1242341|NCT00632099|4075866|P1|Overall Study|Lost to Follow-up|3
1242342|NCT00632021|4075874|P2|Overall Study|Withdrawal/death|7
1242343|NCT00632021|4075875|P1|Overall Study|Withdrawal/death|4
1242344|NCT00631969|4075885|P2|Overall Study|No Drug Exposure|2
1242345|NCT00631969|4075886|P1|Overall Study|No Drug Exposure|2
1242346|NCT00631969|4075885|P2|Overall Study|Noncompliant With Study Medication|1
1242347|NCT00631969|4075886|P1|Overall Study|Noncompliant With Study Medication|0
1242348|NCT00631969|4075885|P2|Overall Study|Consent Withdrawn|7
1242349|NCT00631969|4075886|P1|Overall Study|Consent Withdrawn|5
1242350|NCT00631969|4075885|P2|Overall Study|Protocol Violation|1
1242351|NCT00631969|4075886|P1|Overall Study|Protocol Violation|1
1242352|NCT00631969|4075885|P2|Overall Study|Lost to Follow-up|1
1242353|NCT00631969|4075886|P1|Overall Study|Lost to Follow-up|2
1242354|NCT00631969|4075885|P2|Overall Study|Lack of Efficacy|8
1242355|NCT00631969|4075886|P1|Overall Study|Lack of Efficacy|2
1242356|NCT00631969|4075885|P2|Overall Study|Adverse Event|1
1242357|NCT00631969|4075886|P1|Overall Study|Adverse Event|3
1242358|NCT00631917|4075932|P2|Overall Study|Death|0
1242359|NCT00631917|4075933|P1|Overall Study|Death|1
1242360|NCT00631917|4075932|P2|Overall Study|Administrative problems|0
1242361|NCT00631917|4075933|P1|Overall Study|Administrative problems|2
1242362|NCT00631917|4075932|P2|Overall Study|Lost to Follow-up|7
1242363|NCT00631917|4075933|P1|Overall Study|Lost to Follow-up|7
1242364|NCT00631917|4075932|P2|Overall Study|Subject withdrew consent|33
1242365|NCT00631917|4075933|P1|Overall Study|Subject withdrew consent|25
1242366|NCT00631917|4075932|P2|Overall Study|Protocol deviation|5
1242367|NCT00631917|4075933|P1|Overall Study|Protocol deviation|6
1242368|NCT00631917|4075932|P2|Overall Study|No longer required study drug|1
1242369|NCT00631917|4075933|P1|Overall Study|No longer required study drug|0
1242370|NCT00631917|4075932|P2|Overall Study|Unsatisfactory therapeutic effect|14
1242371|NCT00631917|4075933|P1|Overall Study|Unsatisfactory therapeutic effect|8
1242372|NCT00631917|4075932|P2|Overall Study|Abnormal test procedure result(s)|2
1242373|NCT00631917|4075933|P1|Overall Study|Abnormal test procedure result(s)|3
1242374|NCT00631917|4075932|P2|Overall Study|Abnormal laboratory value(s)|1
1242375|NCT00631917|4075933|P1|Overall Study|Abnormal laboratory value(s)|2
1242376|NCT00631917|4075932|P2|Overall Study|Adverse Event|45
1242377|NCT00631917|4075933|P1|Overall Study|Adverse Event|34
1242378|NCT00631696|4075960|P2|Overall Study|Adverse Event|0
1242379|NCT00631696|4075961|P1|Overall Study|Adverse Event|5
1242380|NCT00631696|4075960|P2|Overall Study|Study terminated by sponsor|3
1242381|NCT00631696|4075961|P1|Overall Study|Study terminated by sponsor|3
1242382|NCT00631696|4075960|P2|Overall Study|Protocol Violation|9
1242383|NCT00631696|4075961|P1|Overall Study|Protocol Violation|9
1242384|NCT00631696|4075960|P2|Overall Study|Other|8
1242385|NCT00631696|4075961|P1|Overall Study|Other|8
1242386|NCT00631696|4075960|P2|Overall Study|Withdrawal by Subject|9
1242387|NCT00631696|4075961|P1|Overall Study|Withdrawal by Subject|2
1242388|NCT00631696|4075960|P2|Overall Study|Lost to Follow-up|10
1242389|NCT00631696|4075961|P1|Overall Study|Lost to Follow-up|7
1242390|NCT00631696|4075960|P2|Overall Study|Follow up after database release date|0
1242391|NCT00631696|4075961|P1|Overall Study|Follow up after database release date|1
1242392|NCT00631696|4075960|P2|Overall Study|Discontinued after database release date|0
1242393|NCT00631696|4075961|P1|Overall Study|Discontinued after database release date|1
1242394|NCT00631696|4075960|P2|Overall Study|Entered, not randomized to treatment|1
1242395|NCT00631696|4075961|P1|Overall Study|Entered, not randomized to treatment|1
1242396|NCT00631657|4076004|P3|7-Day Discontinuation Period|Other|0
1242397|NCT00631657|4076005|P2|7-Day Discontinuation Period|Other|0
1242398|NCT00631657|4076006|P1|7-Day Discontinuation Period|Other|1
1242399|NCT00631657|4076004|P3|7-Day Discontinuation Period|Not Treated|1
1242400|NCT00631657|4076005|P2|7-Day Discontinuation Period|Not Treated|1
1242401|NCT00631657|4076006|P1|7-Day Discontinuation Period|Not Treated|1
1242402|NCT00631657|4076004|P3|6-Month Treatment Period|Not Treated|1
1242403|NCT00631657|4076005|P2|6-Month Treatment Period|Not Treated|0
1242404|NCT00631657|4076006|P1|6-Month Treatment Period|Not Treated|2
1242405|NCT00631657|4076004|P3|6-Month Treatment Period|Other|4
1242406|NCT00631657|4076005|P2|6-Month Treatment Period|Other|0
1242407|NCT00631657|4076006|P1|6-Month Treatment Period|Other|16
1242408|NCT00631657|4076004|P3|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6
1242409|NCT00631657|4076005|P2|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0
1242410|NCT00631657|4076006|P1|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21
1242411|NCT00631657|4076004|P3|6-Month Treatment Period|Lost to Follow-up|2
1242412|NCT00631657|4076005|P2|6-Month Treatment Period|Lost to Follow-up|0
1242413|NCT00631657|4076006|P1|6-Month Treatment Period|Lost to Follow-up|7
1242414|NCT00631657|4076004|P3|6-Month Treatment Period|Lack of Efficacy|25
1242415|NCT00631657|4076005|P2|6-Month Treatment Period|Lack of Efficacy|0
1242416|NCT00631657|4076006|P1|6-Month Treatment Period|Lack of Efficacy|34
1242417|NCT00631657|4076004|P3|6-Month Treatment Period|Withdrawal by Subject|5
1242418|NCT00631657|4076005|P2|6-Month Treatment Period|Withdrawal by Subject|0
1242419|NCT00631657|4076006|P1|6-Month Treatment Period|Withdrawal by Subject|14
1242420|NCT00631657|4076004|P3|6-Month Treatment Period|Adverse Event|7
1242421|NCT00631657|4076005|P2|6-Month Treatment Period|Adverse Event|0
1242422|NCT00631657|4076006|P1|6-Month Treatment Period|Adverse Event|47
1242423|NCT00631540|4076055|P1|Overall Study|Core Lab Data Unavailable|3
1242424|NCT00631540|4076055|P1|Overall Study|Lost to Follow-up|2
1242425|NCT00631540|4076055|P1|Overall Study|Death|4
1242426|NCT00631540|4076055|P1|Overall Study|Withdrawal by Subject|5
1242427|NCT00631488|4076067|P3|Overall Study|Protocol Violation|1
1242428|NCT00631488|4076068|P2|Overall Study|Protocol Violation|0
1242429|NCT00631488|4076069|P1|Overall Study|Protocol Violation|0
1242430|NCT00631488|4076067|P3|Overall Study|Physician Decision|1
1242431|NCT00631488|4076068|P2|Overall Study|Physician Decision|0
1242432|NCT00631488|4076069|P1|Overall Study|Physician Decision|1
1242433|NCT00631488|4076067|P3|Overall Study|Lost to Follow-up|0
1242434|NCT00631488|4076068|P2|Overall Study|Lost to Follow-up|2
1242435|NCT00631488|4076069|P1|Overall Study|Lost to Follow-up|2
1242436|NCT00631488|4076067|P3|Overall Study|Adverse Event|0
1242437|NCT00631488|4076068|P2|Overall Study|Adverse Event|0
1242438|NCT00631488|4076069|P1|Overall Study|Adverse Event|1
1242439|NCT00631475|4076089|P1|Overall Study|Preparation for lung transplant|8
1242440|NCT00631475|4076089|P1|Overall Study|Withdrew consent|5
1242441|NCT00631475|4076089|P1|Overall Study|Adverse Event|14
1242442|NCT00631475|4076089|P1|Overall Study|Death|18
1242443|NCT00631410|4076108|P2|Overall Study|Surgery|0
1242444|NCT00631410|4076109|P1|Overall Study|Surgery|1
1242445|NCT00631410|4076108|P2|Overall Study|Objective Progression or Relapse|3
1242446|NCT00631410|4076109|P1|Overall Study|Objective Progression or Relapse|4
1242447|NCT00631410|4076108|P2|Overall Study|Adverse Event|3
1242448|NCT00631410|4076109|P1|Overall Study|Adverse Event|1
1242449|NCT00631371|4076128|P2|Overall Study|Death|239
1242450|NCT00631371|4076129|P1|Overall Study|Death|263
1242451|NCT00631371|4076128|P2|Overall Study|Discontinuation of study by Sponsor|76
1242452|NCT00631371|4076129|P1|Overall Study|Discontinuation of study by Sponsor|70
1242453|NCT00631371|4076128|P2|Overall Study|subject request|45
1242454|NCT00631371|4076129|P1|Overall Study|subject request|38
1242455|NCT00631371|4076128|P2|Overall Study|Other reason|12
1242456|NCT00631371|4076129|P1|Overall Study|Other reason|5
1242457|NCT00631371|4076128|P2|Overall Study|Lost to Follow-up|19
1242458|NCT00631371|4076129|P1|Overall Study|Lost to Follow-up|24
1242459|NCT00631189|4076162|P4|Treatment Phase|patient did not take pravastatin|0
1242460|NCT00631189|4076163|P3|Treatment Phase|patient did not take pravastatin|1
1242461|NCT00631189|4076164|P2|Treatment Phase|patient did not take pravastatin|0
1242462|NCT00631189|4076165|P1|Treatment Phase|patient did not take pravastatin|0
1242463|NCT00631189|4076162|P4|Treatment Phase|Pregnancy|0
1242464|NCT00631189|4076163|P3|Treatment Phase|Pregnancy|1
1242465|NCT00631189|4076164|P2|Treatment Phase|Pregnancy|0
1242466|NCT00631189|4076165|P1|Treatment Phase|Pregnancy|0
1242467|NCT00631189|4076162|P4|Treatment Phase|Lost to Follow-up|0
1242468|NCT00631189|4076163|P3|Treatment Phase|Lost to Follow-up|0
1242469|NCT00631189|4076164|P2|Treatment Phase|Lost to Follow-up|1
1242470|NCT00631189|4076165|P1|Treatment Phase|Lost to Follow-up|0
1242471|NCT00631189|4076162|P4|Treatment Phase|Adverse Event|4
1242472|NCT00631189|4076163|P3|Treatment Phase|Adverse Event|2
1242473|NCT00631189|4076164|P2|Treatment Phase|Adverse Event|3
1242474|NCT00631189|4076165|P1|Treatment Phase|Adverse Event|0
1242475|NCT00631189|4076162|P4|Treatment Phase|Protocol Violation|2
1242476|NCT00631189|4076163|P3|Treatment Phase|Protocol Violation|6
1242477|NCT00631189|4076164|P2|Treatment Phase|Protocol Violation|1
1242478|NCT00631189|4076165|P1|Treatment Phase|Protocol Violation|0
1242479|NCT00631189|4076162|P4|Treatment Phase|Withdrawal by Subject|1
1242480|NCT00631189|4076163|P3|Treatment Phase|Withdrawal by Subject|1
1242481|NCT00631189|4076164|P2|Treatment Phase|Withdrawal by Subject|2
1242482|NCT00631189|4076165|P1|Treatment Phase|Withdrawal by Subject|0
1242483|NCT00631189|4076162|P4|Initial Phase|Withdrawal by Subject|0
1242484|NCT00631189|4076163|P3|Initial Phase|Withdrawal by Subject|0
1242485|NCT00631189|4076164|P2|Initial Phase|Withdrawal by Subject|0
1242486|NCT00631189|4076165|P1|Initial Phase|Withdrawal by Subject|4
1242487|NCT00631189|4076162|P4|Initial Phase|Protocol Violation|0
1242488|NCT00631189|4076163|P3|Initial Phase|Protocol Violation|0
1242489|NCT00631189|4076164|P2|Initial Phase|Protocol Violation|0
1242490|NCT00631189|4076165|P1|Initial Phase|Protocol Violation|347
1242491|NCT00631137|4076209|P2|Overall Study|Withdrawal by Subject|0
1242492|NCT00631137|4076210|P1|Overall Study|Withdrawal by Subject|1
1242493|NCT00631020|4076228|P1|Overall Study|Incarcerated|1
1242494|NCT00631020|4076228|P1|Overall Study|Lost to Follow-up|7
1242495|NCT00631007|4076243|P6|Overall Study|Other|0
1242496|NCT00631007|4076244|P5|Overall Study|Other|1
1242497|NCT00631007|4076245|P4|Overall Study|Other|0
1242498|NCT00631007|4076246|P3|Overall Study|Other|0
1242499|NCT00631007|4076247|P2|Overall Study|Other|1
1242500|NCT00631007|4076248|P1|Overall Study|Other|2
1242501|NCT00631007|4076243|P6|Overall Study|Withdrawal by Subject|3
1242502|NCT00631007|4076244|P5|Overall Study|Withdrawal by Subject|1
1242503|NCT00631007|4076245|P4|Overall Study|Withdrawal by Subject|2
1242504|NCT00631007|4076246|P3|Overall Study|Withdrawal by Subject|2
1242505|NCT00631007|4076247|P2|Overall Study|Withdrawal by Subject|5
1242506|NCT00631007|4076248|P1|Overall Study|Withdrawal by Subject|4
1242507|NCT00631007|4076243|P6|Overall Study|Persistent Hyperglycemia|5
1242508|NCT00631007|4076244|P5|Overall Study|Persistent Hyperglycemia|2
1242509|NCT00631007|4076245|P4|Overall Study|Persistent Hyperglycemia|1
1242510|NCT00631007|4076246|P3|Overall Study|Persistent Hyperglycemia|5
1242511|NCT00631007|4076247|P2|Overall Study|Persistent Hyperglycemia|2
1242512|NCT00631007|4076248|P1|Overall Study|Persistent Hyperglycemia|2
1242513|NCT00631007|4076243|P6|Overall Study|Physician Decision|2
1242514|NCT00631007|4076244|P5|Overall Study|Physician Decision|0
1242515|NCT00631007|4076245|P4|Overall Study|Physician Decision|0
1242516|NCT00631007|4076246|P3|Overall Study|Physician Decision|1
1242517|NCT00631007|4076247|P2|Overall Study|Physician Decision|0
1242518|NCT00631007|4076248|P1|Overall Study|Physician Decision|1
1242519|NCT00631007|4076243|P6|Overall Study|Lost to Follow-up|3
1242520|NCT00631007|4076244|P5|Overall Study|Lost to Follow-up|5
1242521|NCT00631007|4076245|P4|Overall Study|Lost to Follow-up|4
1242522|NCT00631007|4076246|P3|Overall Study|Lost to Follow-up|2
1242523|NCT00631007|4076247|P2|Overall Study|Lost to Follow-up|1
1242524|NCT00631007|4076248|P1|Overall Study|Lost to Follow-up|2
1242525|NCT00631007|4076243|P6|Overall Study|Adverse Event|2
1242526|NCT00631007|4076244|P5|Overall Study|Adverse Event|3
1242527|NCT00631007|4076245|P4|Overall Study|Adverse Event|2
1242528|NCT00631007|4076246|P3|Overall Study|Adverse Event|0
1242529|NCT00631007|4076247|P2|Overall Study|Adverse Event|2
1242530|NCT00631007|4076248|P1|Overall Study|Adverse Event|0
1242531|NCT00630994|4076268|P1|Overall Study|Other|1
1242532|NCT00630994|4076268|P1|Overall Study|Lack of Efficacy|1
1242533|NCT00630994|4076268|P1|Overall Study|Disease Progression|1
1242534|NCT00630994|4076268|P1|Overall Study|Adverse Event|1
1242535|NCT00630916|4076298|P1|Overall Study|Lack of Efficacy|3
1242536|NCT00630916|4076298|P1|Overall Study|Physician Decision|47
1242537|NCT00630916|4076298|P1|Overall Study|Protocol Violation|7
1242538|NCT00630916|4076298|P1|Overall Study|Withdrawal by Subject|30
1242539|NCT00630916|4076298|P1|Overall Study|Lost to Follow-up|5
1242540|NCT00630916|4076298|P1|Overall Study|Explant|8
1242541|NCT00630916|4076298|P1|Overall Study|Death|110
1242542|NCT00630877|4076308|P3|Overall Study|Personal reasons|1
1242543|NCT00630877|4076309|P2|Overall Study|Personal reasons|0
1242544|NCT00630877|4076310|P1|Overall Study|Personal reasons|0
1242545|NCT00630877|4076308|P3|Overall Study|Protocol violation|1
1242546|NCT00630877|4076309|P2|Overall Study|Protocol violation|0
1242547|NCT00630877|4076310|P1|Overall Study|Protocol violation|1
1242548|NCT00630877|4076308|P3|Overall Study|Noncompliance|1
1242549|NCT00630877|4076309|P2|Overall Study|Noncompliance|3
1242550|NCT00630877|4076310|P1|Overall Study|Noncompliance|2
1242551|NCT00630877|4076308|P3|Overall Study|Lost to Follow-up|0
1242552|NCT00630877|4076309|P2|Overall Study|Lost to Follow-up|0
1242553|NCT00630877|4076310|P1|Overall Study|Lost to Follow-up|2
1242554|NCT00630877|4076308|P3|Overall Study|Withdrawal by Subject|0
1242555|NCT00630877|4076309|P2|Overall Study|Withdrawal by Subject|4
1242556|NCT00630877|4076310|P1|Overall Study|Withdrawal by Subject|3
1242557|NCT00630877|4076308|P3|Overall Study|Adverse Event|7
1242558|NCT00630877|4076309|P2|Overall Study|Adverse Event|8
1242559|NCT00630877|4076310|P1|Overall Study|Adverse Event|11
1242560|NCT00630864|4076328|P1|Part 2 (After Week 6 up to Month 12)|Liver transplant|2
1242561|NCT00630864|4076328|P1|Part 1 (up to Week 6)|Adverse Event|1
1242562|NCT00630838|4076367|P2|Overall Study|Lost to Follow-up|1
1242563|NCT00630838|4076368|P1|Overall Study|Lost to Follow-up|0
1242564|NCT00630838|4076367|P2|Overall Study|Death|1
1242565|NCT00630838|4076368|P1|Overall Study|Death|0
1242566|NCT00630825|4076380|P4|Overall Study|Withdrawal by Subject|3
1242567|NCT00630825|4076381|P3|Overall Study|Withdrawal by Subject|2
1242568|NCT00630825|4076382|P2|Overall Study|Withdrawal by Subject|2
1242569|NCT00630825|4076383|P1|Overall Study|Withdrawal by Subject|2
1242570|NCT00630825|4076380|P4|Overall Study|Physician Decision|0
1242571|NCT00630825|4076381|P3|Overall Study|Physician Decision|0
1242572|NCT00630825|4076382|P2|Overall Study|Physician Decision|0
1242573|NCT00630825|4076383|P1|Overall Study|Physician Decision|1
1242574|NCT00630825|4076380|P4|Overall Study|Lost to Follow-up|1
1242575|NCT00630825|4076381|P3|Overall Study|Lost to Follow-up|1
1242576|NCT00630825|4076382|P2|Overall Study|Lost to Follow-up|1
1242577|NCT00630825|4076383|P1|Overall Study|Lost to Follow-up|1
1242578|NCT00630825|4076380|P4|Overall Study|Entry Criteria Not Met|1
1242579|NCT00630825|4076381|P3|Overall Study|Entry Criteria Not Met|2
1242580|NCT00630825|4076382|P2|Overall Study|Entry Criteria Not Met|0
1242581|NCT00630825|4076383|P1|Overall Study|Entry Criteria Not Met|1
1242582|NCT00630825|4076380|P4|Overall Study|Adverse Event|1
1242583|NCT00630825|4076381|P3|Overall Study|Adverse Event|3
1242584|NCT00630825|4076382|P2|Overall Study|Adverse Event|4
1242585|NCT00630825|4076383|P1|Overall Study|Adverse Event|4
1242586|NCT00630786|4076455|P3|Overall Study|Not specified|0
1242587|NCT00630786|4076456|P2|Overall Study|Not specified|0
1242588|NCT00630786|4076457|P1|Overall Study|Not specified|1
1242589|NCT00630786|4076455|P3|Overall Study|Lost to Follow-up|0
1242590|NCT00630786|4076456|P2|Overall Study|Lost to Follow-up|1
1242591|NCT00630786|4076457|P1|Overall Study|Lost to Follow-up|0
1242592|NCT00630786|4076455|P3|Overall Study|Withdrawal by Subject|1
1242593|NCT00630786|4076456|P2|Overall Study|Withdrawal by Subject|1
1242594|NCT00630786|4076457|P1|Overall Study|Withdrawal by Subject|0
1242595|NCT00630786|4076455|P3|Overall Study|Physician Decision|1
1242596|NCT00630786|4076456|P2|Overall Study|Physician Decision|0
1242597|NCT00630786|4076457|P1|Overall Study|Physician Decision|0
1242598|NCT00630747|4076476|P1|Overall Study|Returned to country of origin|1
1242599|NCT00630747|4076476|P1|Overall Study|Transferred to Study TKT031NPU|7
1242600|NCT00630747|4076476|P1|Overall Study|Death|1
1242601|NCT00630539|4076529|P4|Overall Study|Withdrawal by Subject|1
1242602|NCT00630539|4076530|P3|Overall Study|Withdrawal by Subject|0
1242603|NCT00630539|4076531|P2|Overall Study|Withdrawal by Subject|1
1242604|NCT00630539|4076532|P1|Overall Study|Withdrawal by Subject|0
1242605|NCT00630539|4076529|P4|Overall Study|Adverse Event|2
1242606|NCT00630539|4076530|P3|Overall Study|Adverse Event|1
1242607|NCT00630539|4076531|P2|Overall Study|Adverse Event|3
1242608|NCT00630539|4076532|P1|Overall Study|Adverse Event|1
1242609|NCT00630396|4076628|P1|Overall Study|Lost to Follow-up|3
1242610|NCT00630396|4076628|P1|Overall Study|Death|4
1242611|NCT00630344|4076634|P1|Overall Study|Other|1
1242612|NCT00630344|4076634|P1|Overall Study|Intercurrent Illness|1
1242613|NCT00630344|4076634|P1|Overall Study|Withdrawal by Subject|1
1242614|NCT00630344|4076634|P1|Overall Study|Physician Decision|9
1242615|NCT00630344|4076634|P1|Overall Study|Progressive Disease|19
1242616|NCT00630344|4076634|P1|Overall Study|Adverse Event|5
1242617|NCT00630331|4076646|P3|Overall Study|Protocol Violation|6
1242618|NCT00630331|4076647|P2|Overall Study|Protocol Violation|5
1242619|NCT00630331|4076648|P1|Overall Study|Protocol Violation|4
1242620|NCT00630331|4076646|P3|Overall Study|Unable to classify|3
1242621|NCT00630331|4076647|P2|Overall Study|Unable to classify|4
1242622|NCT00630331|4076648|P1|Overall Study|Unable to classify|9
1242623|NCT00630331|4076646|P3|Overall Study|Inappropriate enrollment|3
1242624|NCT00630331|4076647|P2|Overall Study|Inappropriate enrollment|6
1242625|NCT00630331|4076648|P1|Overall Study|Inappropriate enrollment|3
1242626|NCT00630331|4076646|P3|Overall Study|Lost to Follow-up|170
1242627|NCT00630331|4076647|P2|Overall Study|Lost to Follow-up|143
1242628|NCT00630331|4076648|P1|Overall Study|Lost to Follow-up|175
1242629|NCT00630331|4076646|P3|Overall Study|Withdrawal by Subject|5
1242630|NCT00630331|4076647|P2|Overall Study|Withdrawal by Subject|7
1242631|NCT00630331|4076648|P1|Overall Study|Withdrawal by Subject|12
1242632|NCT00630331|4076646|P3|Overall Study|Adverse Event|0
1242633|NCT00630331|4076647|P2|Overall Study|Adverse Event|0
1242634|NCT00630331|4076648|P1|Overall Study|Adverse Event|1
1242635|NCT00630331|4076646|P3|Overall Study|Death|1
1242636|NCT00630331|4076647|P2|Overall Study|Death|1
1242637|NCT00630331|4076648|P1|Overall Study|Death|2
1242638|NCT00630305|4076689|P1|Overall Study|Inability to insert contact lens|1
1242639|NCT00630305|4076689|P1|Overall Study|Withdrawal by Subject|1
1242640|NCT00630292|4076711|P1|Overall Study|Withdrawal by Subject|1
1242641|NCT00630058|4076717|P2|Overall Study|stopping criteria|2
1242642|NCT00630058|4076718|P1|Overall Study|stopping criteria|3
1242643|NCT00630058|4076717|P2|Overall Study|Withdrawal by Subject|1
1242644|NCT00630058|4076718|P1|Overall Study|Withdrawal by Subject|0
1242645|NCT00630058|4076717|P2|Overall Study|Adverse Event|1
1242646|NCT00630058|4076718|P1|Overall Study|Adverse Event|1
1242647|NCT00629772|4076749|P2|Second Intervention Week 14 - Week 26|Lack of Efficacy|1
1242648|NCT00629772|4076750|P1|Second Intervention Week 14 - Week 26|Lack of Efficacy|0
1242649|NCT00629772|4076749|P2|Second Intervention Week 14 - Week 26|Adverse Event|1
1242650|NCT00629772|4076750|P1|Second Intervention Week 14 - Week 26|Adverse Event|1
1242651|NCT00629707|4076770|P2|Overall Study|Physician Decision|1
1242652|NCT00629707|4076771|P1|Overall Study|Physician Decision|0
1242653|NCT00629707|4076770|P2|Overall Study|Withdrawal by Subject|1
1242654|NCT00629707|4076771|P1|Overall Study|Withdrawal by Subject|0
1242655|NCT00629265|4076791|P2|Overall Study|Unknown Reason|2
1242656|NCT00629265|4076792|P1|Overall Study|Unknown Reason|2
1242657|NCT00629265|4076791|P2|Overall Study|Unrelated Medical Complications|1
1242658|NCT00629265|4076792|P1|Overall Study|Unrelated Medical Complications|3
1242659|NCT00629265|4076791|P2|Overall Study|Needed Esophageal Dilation|1
1242660|NCT00629265|4076792|P1|Overall Study|Needed Esophageal Dilation|4
1242661|NCT00629265|4076791|P2|Overall Study|Other CA Requiring Treatment|3
1242662|NCT00629265|4076792|P1|Overall Study|Other CA Requiring Treatment|1
1242663|NCT00629265|4076791|P2|Overall Study|HNC Recurrence|0
1242664|NCT00629265|4076792|P1|Overall Study|HNC Recurrence|4
1242665|NCT00629265|4076791|P2|Overall Study|Adverse Event|0
1242666|NCT00629265|4076792|P1|Overall Study|Adverse Event|2
1242667|NCT00629265|4076791|P2|Overall Study|Death|0
1242668|NCT00629265|4076792|P1|Overall Study|Death|1
1242669|NCT00629265|4076791|P2|Overall Study|Withdrawal by Subject|8
1242670|NCT00629265|4076792|P1|Overall Study|Withdrawal by Subject|11
1242671|NCT00629265|4076791|P2|Overall Study|Lost to Follow-up|5
1242672|NCT00629265|4076792|P1|Overall Study|Lost to Follow-up|4
1242673|NCT00629239|4076802|P2|Overall Study|Physician Decision|0
1242674|NCT00629239|4076803|P1|Overall Study|Physician Decision|1
1242675|NCT00629239|4076802|P2|Overall Study|Adverse Event|4
1242676|NCT00629239|4076803|P1|Overall Study|Adverse Event|7
1242677|NCT00628927|4076867|P2|Overall Study|Equipment failure|0
1242678|NCT00628927|4076868|P1|Overall Study|Equipment failure|1
1242679|NCT00628927|4076867|P2|Overall Study|Lost to Follow-up|0
1242680|NCT00628927|4076868|P1|Overall Study|Lost to Follow-up|1
1242681|NCT00628927|4076867|P2|Overall Study|Problems performing blood draw|0
1242682|NCT00628927|4076868|P1|Overall Study|Problems performing blood draw|6
1242683|NCT00628862|4076913|P3|Overall Study|COPD Exacerbation|0
1242684|NCT00628862|4076914|P2|Overall Study|COPD Exacerbation|1
1242685|NCT00628862|4076915|P1|Overall Study|COPD Exacerbation|0
1242686|NCT00628862|4076913|P3|Overall Study|Protocol Violation|0
1242687|NCT00628862|4076914|P2|Overall Study|Protocol Violation|0
1242688|NCT00628862|4076915|P1|Overall Study|Protocol Violation|1
1242689|NCT00628862|4076913|P3|Overall Study|Lost to Follow-up|1
1242690|NCT00628862|4076914|P2|Overall Study|Lost to Follow-up|2
1242691|NCT00628862|4076915|P1|Overall Study|Lost to Follow-up|0
1242692|NCT00628862|4076913|P3|Overall Study|Withdrawal by Subject|11
1242693|NCT00628862|4076914|P2|Overall Study|Withdrawal by Subject|6
1242694|NCT00628862|4076915|P1|Overall Study|Withdrawal by Subject|4
1242695|NCT00628862|4076913|P3|Overall Study|Adverse Event|10
1242696|NCT00628862|4076914|P2|Overall Study|Adverse Event|8
1242697|NCT00628862|4076915|P1|Overall Study|Adverse Event|6
1242698|NCT00628758|4076961|P2|Overall Study|Treatment Failure|2
1242699|NCT00628758|4076962|P1|Overall Study|Treatment Failure|0
1242700|NCT00628758|4076961|P2|Overall Study|Investigator Moved|0
1242701|NCT00628758|4076962|P1|Overall Study|Investigator Moved|3
1242702|NCT00628758|4076961|P2|Overall Study|Pregnancy|2
1242703|NCT00628758|4076962|P1|Overall Study|Pregnancy|2
1242704|NCT00628758|4076961|P2|Overall Study|Lost to Follow-up|31
1242705|NCT00628758|4076962|P1|Overall Study|Lost to Follow-up|25
1242706|NCT00628758|4076961|P2|Overall Study|Protocol Violation|1
1242707|NCT00628758|4076962|P1|Overall Study|Protocol Violation|5
1242708|NCT00628758|4076961|P2|Overall Study|Death|0
1242709|NCT00628758|4076962|P1|Overall Study|Death|1
1242710|NCT00628758|4076961|P2|Overall Study|Withdrawal by Subject|3
1242711|NCT00628758|4076962|P1|Overall Study|Withdrawal by Subject|6
1242712|NCT00628758|4076961|P2|Overall Study|Adverse Event|3
1242713|NCT00628758|4076962|P1|Overall Study|Adverse Event|2
1242714|NCT00628446|4077006|P1|Overall Study|Protocol Violation|3
1242715|NCT00628446|4077006|P1|Overall Study|Withdrawal by Subject|1
1242716|NCT00628446|4077006|P1|Overall Study|Lost to Follow-up|3
1242717|NCT00628355|4077017|P2|Overall Study|Withdrawal by Subject|1
1242718|NCT00628355|4077018|P1|Overall Study|Withdrawal by Subject|1
1242719|NCT00628251|4077029|P3|Cross-over/ Continuation of Olaparib|Other|0
1242720|NCT00628251|4077030|P2|Cross-over/ Continuation of Olaparib|Other|1
1242721|NCT00628251|4077031|P1|Cross-over/ Continuation of Olaparib|Other|1
1242722|NCT00628251|4077029|P3|Cross-over/ Continuation of Olaparib|Withdrawal by Subject|4
1242723|NCT00628251|4077030|P2|Cross-over/ Continuation of Olaparib|Withdrawal by Subject|2
1242724|NCT00628251|4077031|P1|Cross-over/ Continuation of Olaparib|Withdrawal by Subject|1
1242725|NCT00628251|4077029|P3|Cross-over/ Continuation of Olaparib|Condition under investigation worsened|13
1242726|NCT00628251|4077030|P2|Cross-over/ Continuation of Olaparib|Condition under investigation worsened|21
1242727|NCT00628251|4077031|P1|Cross-over/ Continuation of Olaparib|Condition under investigation worsened|24
1242728|NCT00628251|4077029|P3|Cross-over/ Continuation of Olaparib|Adverse Event|0
1242729|NCT00628251|4077030|P2|Cross-over/ Continuation of Olaparib|Adverse Event|2
1242730|NCT00628251|4077031|P1|Cross-over/ Continuation of Olaparib|Adverse Event|1
1242731|NCT00628251|4077029|P3|Randomised Part|Did not receive cross over treatment|8
1242732|NCT00628251|4077030|P2|Randomised Part|Did not receive cross over treatment|0
1242733|NCT00628251|4077031|P1|Randomised Part|Did not receive cross over treatment|0
1242734|NCT00628212|4077074|P4|Overall Study|Physician Decision|3
1242735|NCT00628212|4077075|P3|Overall Study|Physician Decision|2
1242736|NCT00628212|4077076|P2|Overall Study|Physician Decision|1
1242737|NCT00628212|4077077|P1|Overall Study|Physician Decision|1
1242738|NCT00628212|4077074|P4|Overall Study|Adverse Event|2
1242739|NCT00628212|4077075|P3|Overall Study|Adverse Event|1
1242740|NCT00628212|4077076|P2|Overall Study|Adverse Event|0
1242741|NCT00628212|4077077|P1|Overall Study|Adverse Event|2
1242742|NCT00628108|4077125|P2|Overall Study|Withdrawal by Subject|0
1242743|NCT00628108|4077126|P1|Overall Study|Withdrawal by Subject|1
1242744|NCT00628108|4077125|P2|Overall Study|Adverse Event|3
1242745|NCT00628108|4077126|P1|Overall Study|Adverse Event|0
1242746|NCT00628030|4077158|P2|Post to 6 Month Follow-up|Lost to Follow-up|30
1242747|NCT00628030|4077159|P1|Post to 6 Month Follow-up|Lost to Follow-up|32
1242748|NCT00628030|4077158|P2|Baseline to Post-Assessment|Withdrawal by Subject|0
1242749|NCT00628030|4077159|P1|Baseline to Post-Assessment|Withdrawal by Subject|5
1242750|NCT00628030|4077158|P2|Baseline to Post-Assessment|Lost to Follow-up|29
1242751|NCT00628030|4077159|P1|Baseline to Post-Assessment|Lost to Follow-up|28
1242752|NCT00627926|4077185|P3|Overall Study|Noncompliance/unspecified|17
1242753|NCT00627926|4077186|P2|Overall Study|Noncompliance/unspecified|23
1242754|NCT00627926|4077187|P1|Overall Study|Noncompliance/unspecified|8
1242755|NCT00627926|4077185|P3|Overall Study|Lack of Efficacy|38
1242756|NCT00627926|4077186|P2|Overall Study|Lack of Efficacy|40
1242757|NCT00627926|4077187|P1|Overall Study|Lack of Efficacy|118
1242758|NCT00627926|4077185|P3|Overall Study|Withdrawal by Subject|0
1242759|NCT00627926|4077186|P2|Overall Study|Withdrawal by Subject|1
1242760|NCT00627926|4077187|P1|Overall Study|Withdrawal by Subject|2
1242761|NCT00627926|4077185|P3|Overall Study|Lost to Follow-up|4
1242762|NCT00627926|4077186|P2|Overall Study|Lost to Follow-up|3
1242763|NCT00627926|4077187|P1|Overall Study|Lost to Follow-up|4
1242764|NCT00627926|4077185|P3|Overall Study|Death|0
1242765|NCT00627926|4077186|P2|Overall Study|Death|0
1242766|NCT00627926|4077187|P1|Overall Study|Death|1
1242767|NCT00627926|4077185|P3|Overall Study|Adverse Event|36
1242768|NCT00627926|4077186|P2|Overall Study|Adverse Event|37
1242769|NCT00627926|4077187|P1|Overall Study|Adverse Event|26
1242770|NCT00627705|4077239|P2|Overall Study|Lost to Follow-up|1
1242771|NCT00627705|4077240|P1|Overall Study|Lost to Follow-up|0
1242772|NCT00627705|4077239|P2|Overall Study|Withdrawal by Subject|2
1242773|NCT00627705|4077240|P1|Overall Study|Withdrawal by Subject|0
1242774|NCT00627705|4077239|P2|Overall Study|Adverse Event|0
1242775|NCT00627705|4077240|P1|Overall Study|Adverse Event|1
1242776|NCT00627705|4077239|P2|Overall Study|Unwilling to take the compound (taste)|3
1242777|NCT00627705|4077240|P1|Overall Study|Unwilling to take the compound (taste)|1
1242778|NCT00627523|4077291|P2|Overall Study|Not specified|0
1242779|NCT00627523|4077292|P1|Overall Study|Not specified|1
1242780|NCT00627523|4077291|P2|Overall Study|Withdrawal by Subject|2
1242781|NCT00627523|4077292|P1|Overall Study|Withdrawal by Subject|0
1242782|NCT00627523|4077291|P2|Overall Study|Lack of Efficacy|0
1242783|NCT00627523|4077292|P1|Overall Study|Lack of Efficacy|1
1242784|NCT00627497|4077320|P4|Overall Study|Lost to Follow-up|0
1242785|NCT00627497|4077321|P3|Overall Study|Lost to Follow-up|0
1242786|NCT00627497|4077322|P2|Overall Study|Lost to Follow-up|1
1242787|NCT00627497|4077323|P1|Overall Study|Lost to Follow-up|1
1242788|NCT00627458|4077384|P3|Overall Study|Lost to Follow-up|0
1242789|NCT00627458|4077385|P2|Overall Study|Lost to Follow-up|1
1242790|NCT00627458|4077386|P1|Overall Study|Lost to Follow-up|1
1242791|NCT00627458|4077384|P3|Overall Study|Withdrawal by Subject|5
1242792|NCT00627458|4077385|P2|Overall Study|Withdrawal by Subject|6
1242793|NCT00627458|4077386|P1|Overall Study|Withdrawal by Subject|2
1242794|NCT00627458|4077384|P3|Overall Study|Migrated from study area|1
1242795|NCT00627458|4077385|P2|Overall Study|Migrated from study area|0
1242796|NCT00627458|4077386|P1|Overall Study|Migrated from study area|1
1242797|NCT00627445|4077461|P2|Overall Study|Other|8
1242798|NCT00627445|4077462|P1|Overall Study|Other|6
1242799|NCT00627445|4077461|P2|Overall Study|Lack of Efficacy|1
1242800|NCT00627445|4077462|P1|Overall Study|Lack of Efficacy|0
1242801|NCT00627445|4077461|P2|Overall Study|Adverse Event|3
1242802|NCT00627445|4077462|P1|Overall Study|Adverse Event|3
1242803|NCT00627393|4077505|P2|Per-Protocol Analysis|Withdrawal by patient/family/physician|10
1242804|NCT00627393|4077506|P1|Per-Protocol Analysis|Withdrawal by patient/family/physician|4
1242805|NCT00627393|4077505|P2|Per-Protocol Analysis|Received unstimulated/no granulocytes|3
1242806|NCT00627393|4077506|P1|Per-Protocol Analysis|Received unstimulated/no granulocytes|6
1242807|NCT00627393|4077505|P2|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5
1242808|NCT00627393|4077506|P1|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4
1242809|NCT00627393|4077505|P2|Intention-To-Treat Analysis|Adjudication indeterminate|3
1242810|NCT00627393|4077506|P1|Intention-To-Treat Analysis|Adjudication indeterminate|5
1242811|NCT00627094|4077542|P2|Overall Study|Other reason|0
1242812|NCT00627094|4077543|P1|Overall Study|Other reason|1
1242813|NCT00627094|4077542|P2|Overall Study|ulcer healed|7
1242814|NCT00627094|4077543|P1|Overall Study|ulcer healed|1
1242815|NCT00627094|4077542|P2|Overall Study|Withdrawal by Subject|1
1242816|NCT00627094|4077543|P1|Overall Study|Withdrawal by Subject|1
1242817|NCT00627094|4077542|P2|Overall Study|Lost to Follow-up|0
1242818|NCT00627094|4077543|P1|Overall Study|Lost to Follow-up|1
1242819|NCT00627094|4077542|P2|Overall Study|Adverse Event|7
1242820|NCT00627094|4077543|P1|Overall Study|Adverse Event|8
1242821|NCT00627042|4077555|P1|Overall Study|Withdrawal by Subject|2
1242822|NCT00627016|4077567|P2|Overall Study|Pregnancy|0
1242823|NCT00627016|4077568|P1|Overall Study|Pregnancy|1
1242824|NCT00627016|4077567|P2|Overall Study|Placed on Excluded Drugs|0
1242825|NCT00627016|4077568|P1|Overall Study|Placed on Excluded Drugs|1
1242826|NCT00627016|4077567|P2|Overall Study|Lack of Efficacy|0
1242827|NCT00627016|4077568|P1|Overall Study|Lack of Efficacy|1
1242828|NCT00627016|4077567|P2|Overall Study|Failed Inclusion/Exclusion Criteria|1
1242829|NCT00627016|4077568|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
1242830|NCT00627016|4077567|P2|Overall Study|Withdrawal by Subject|1
1242831|NCT00627016|4077568|P1|Overall Study|Withdrawal by Subject|2
1242832|NCT00627016|4077567|P2|Overall Study|Lost to Follow-up|1
1242833|NCT00627016|4077568|P1|Overall Study|Lost to Follow-up|0
1242834|NCT00627016|4077567|P2|Overall Study|Protocol Violation|2
1242835|NCT00627016|4077568|P1|Overall Study|Protocol Violation|0
1242836|NCT00627016|4077567|P2|Overall Study|Adverse Event|1
1242837|NCT00627016|4077568|P1|Overall Study|Adverse Event|1
1242838|NCT00626925|4077580|P2|Overall Study|Time constraints|1
1242839|NCT00626925|4077581|P1|Overall Study|Time constraints|3
1242840|NCT00626925|4077580|P2|Overall Study|Lack of Efficacy|4
1242841|NCT00626925|4077581|P1|Overall Study|Lack of Efficacy|1
1242842|NCT00626925|4077580|P2|Overall Study|Adverse effect|2
1242843|NCT00626925|4077581|P1|Overall Study|Adverse effect|6
1242844|NCT00626925|4077580|P2|Overall Study|relapse|0
1242845|NCT00626925|4077581|P1|Overall Study|relapse|1
1242846|NCT00626925|4077580|P2|Overall Study|Lost to Follow-up|2
1242847|NCT00626925|4077581|P1|Overall Study|Lost to Follow-up|1
1242848|NCT00626821|4077613|P1|Overall Study|other/unknown reason|104
1242849|NCT00626821|4077613|P1|Overall Study|Product dysfunction|21
1242850|NCT00626821|4077613|P1|Overall Study|Physician Decision|9
1242851|NCT00626821|4077613|P1|Overall Study|Withdrawal by Subject|10
1242852|NCT00626821|4077613|P1|Overall Study|Protocol Violation|33
1242853|NCT00626821|4077613|P1|Overall Study|Adverse Event|44
1242854|NCT00626795|4077693|P3|Blinded Treatment|Missing reason for withdrawal|5
1242855|NCT00626795|4077694|P2|Blinded Treatment|Missing reason for withdrawal|3
1242856|NCT00626795|4077695|P1|Blinded Treatment|Missing reason for withdrawal|5
1242857|NCT00626795|4077693|P3|Blinded Treatment|Other reasons|2
1242858|NCT00626795|4077694|P2|Blinded Treatment|Other reasons|0
1242859|NCT00626795|4077695|P1|Blinded Treatment|Other reasons|2
1242860|NCT00626795|4077693|P3|Blinded Treatment|Withdrawal by Subject|0
1242861|NCT00626795|4077694|P2|Blinded Treatment|Withdrawal by Subject|1
1242862|NCT00626795|4077695|P1|Blinded Treatment|Withdrawal by Subject|1
1242863|NCT00626795|4077693|P3|Blinded Treatment|Protocol Violation|1
1242864|NCT00626795|4077694|P2|Blinded Treatment|Protocol Violation|1
1242865|NCT00626795|4077695|P1|Blinded Treatment|Protocol Violation|0
1242866|NCT00626795|4077693|P3|Blinded Treatment|Unacceptable adverse event|1
1242867|NCT00626795|4077694|P2|Blinded Treatment|Unacceptable adverse event|0
1242868|NCT00626795|4077695|P1|Blinded Treatment|Unacceptable adverse event|0
1242869|NCT00626795|4077693|P3|Blinded Treatment|Lack of Efficacy|0
1242870|NCT00626795|4077694|P2|Blinded Treatment|Lack of Efficacy|0
1242871|NCT00626795|4077695|P1|Blinded Treatment|Lack of Efficacy|2
1242872|NCT00626795|4077693|P3|Open-label TD1414 Cream TID Treatment|Adverse Event|0
1242873|NCT00626795|4077694|P2|Open-label TD1414 Cream TID Treatment|Adverse Event|1
1242874|NCT00626795|4077695|P1|Open-label TD1414 Cream TID Treatment|Adverse Event|0
1242875|NCT00626639|4077746|P2|Overall Study|Occurrence of grade 3 oral mucositis|2
1242876|NCT00626639|4077747|P1|Overall Study|Occurrence of grade 3 oral mucositis|2
1242877|NCT00626561|4077793|P1|Overall Study|Disease Progression|2
1242878|NCT00626561|4077793|P1|Overall Study|Withdrawal by Subject|2
1242879|NCT00626548|4077799|P2|Overall Study|Other termination reason|613
1242880|NCT00626548|4077800|P1|Overall Study|Other termination reason|493
1242881|NCT00626548|4077799|P2|Overall Study|Lost to Follow-up|2
1242882|NCT00626548|4077800|P1|Overall Study|Lost to Follow-up|2
1242883|NCT00626548|4077799|P2|Overall Study|Protocol Violation|11
1242884|NCT00626548|4077800|P1|Overall Study|Protocol Violation|4
1242885|NCT00626548|4077799|P2|Overall Study|Withdrawal by Subject|46
1242886|NCT00626548|4077800|P1|Overall Study|Withdrawal by Subject|42
1242887|NCT00626548|4077799|P2|Overall Study|Adverse Event|44
1242888|NCT00626548|4077800|P1|Overall Study|Adverse Event|164
1242889|NCT00626522|4077814|P6|Overall Study|Non-fulfilment of in/exclusion criteria|0
1242890|NCT00626522|4077815|P5|Overall Study|Non-fulfilment of in/exclusion criteria|0
1242891|NCT00626522|4077816|P4|Overall Study|Non-fulfilment of in/exclusion criteria|1
1242892|NCT00626522|4077817|P3|Overall Study|Non-fulfilment of in/exclusion criteria|1
1242893|NCT00626522|4077818|P2|Overall Study|Non-fulfilment of in/exclusion criteria|0
1242894|NCT00626522|4077819|P1|Overall Study|Non-fulfilment of in/exclusion criteria|1
1242895|NCT00626522|4077814|P6|Overall Study|Inconsistent reason reported|0
1242896|NCT00626522|4077815|P5|Overall Study|Inconsistent reason reported|0
1242897|NCT00626522|4077816|P4|Overall Study|Inconsistent reason reported|0
1242898|NCT00626522|4077817|P3|Overall Study|Inconsistent reason reported|0
1242899|NCT00626522|4077818|P2|Overall Study|Inconsistent reason reported|0
1242900|NCT00626522|4077819|P1|Overall Study|Inconsistent reason reported|1
1242901|NCT00626522|4077814|P6|Overall Study|Lost to Follow-up|0
1242902|NCT00626522|4077815|P5|Overall Study|Lost to Follow-up|0
1242903|NCT00626522|4077816|P4|Overall Study|Lost to Follow-up|0
1242904|NCT00626522|4077817|P3|Overall Study|Lost to Follow-up|0
1242905|NCT00626522|4077818|P2|Overall Study|Lost to Follow-up|1
1242906|NCT00626522|4077819|P1|Overall Study|Lost to Follow-up|0
1242907|NCT00626522|4077814|P6|Overall Study|COPD exacerbation|0
1242908|NCT00626522|4077815|P5|Overall Study|COPD exacerbation|1
1242909|NCT00626522|4077816|P4|Overall Study|COPD exacerbation|1
1242910|NCT00626522|4077817|P3|Overall Study|COPD exacerbation|0
1242911|NCT00626522|4077818|P2|Overall Study|COPD exacerbation|0
1242912|NCT00626522|4077819|P1|Overall Study|COPD exacerbation|0
1242913|NCT00626522|4077814|P6|Overall Study|Withdrawal by Subject|1
1242914|NCT00626522|4077815|P5|Overall Study|Withdrawal by Subject|4
1242915|NCT00626522|4077816|P4|Overall Study|Withdrawal by Subject|0
1242916|NCT00626522|4077817|P3|Overall Study|Withdrawal by Subject|5
1242917|NCT00626522|4077818|P2|Overall Study|Withdrawal by Subject|5
1242918|NCT00626522|4077819|P1|Overall Study|Withdrawal by Subject|2
1242919|NCT00626522|4077814|P6|Overall Study|Adverse Event|1
1242920|NCT00626522|4077815|P5|Overall Study|Adverse Event|1
1242921|NCT00626522|4077816|P4|Overall Study|Adverse Event|0
1242922|NCT00626522|4077817|P3|Overall Study|Adverse Event|2
1242923|NCT00626522|4077818|P2|Overall Study|Adverse Event|1
1242924|NCT00626522|4077819|P1|Overall Study|Adverse Event|2
1242925|NCT00626522|4077814|P6|Overall Study|Protocol Violation|0
1242926|NCT00626522|4077815|P5|Overall Study|Protocol Violation|1
1242927|NCT00626522|4077816|P4|Overall Study|Protocol Violation|0
1242928|NCT00626522|4077817|P3|Overall Study|Protocol Violation|0
1242929|NCT00626522|4077818|P2|Overall Study|Protocol Violation|0
1242930|NCT00626522|4077819|P1|Overall Study|Protocol Violation|0
1242931|NCT00626405|4077882|P2|Overall Study|Withdrawal by Subject|1
1242932|NCT00626405|4077883|P1|Overall Study|Withdrawal by Subject|0
1242933|NCT00626405|4077882|P2|Overall Study|Deemed Ineligible|0
1242934|NCT00626405|4077883|P1|Overall Study|Deemed Ineligible|1
1242935|NCT00626392|4077899|P6|Coadministration Period|Other|1
1242936|NCT00626392|4077900|P5|Coadministration Period|Other|1
1242937|NCT00626392|4077901|P4|Coadministration Period|Other|1
1242938|NCT00626392|4077902|P3|Coadministration Period|Other|3
1242939|NCT00626392|4077903|P2|Coadministration Period|Other|2
1242940|NCT00626392|4077904|P1|Coadministration Period|Other|0
1242941|NCT00626392|4077899|P6|Coadministration Period|Protocol Violation|0
1242942|NCT00626392|4077900|P5|Coadministration Period|Protocol Violation|1
1242943|NCT00626392|4077901|P4|Coadministration Period|Protocol Violation|1
1242944|NCT00626392|4077902|P3|Coadministration Period|Protocol Violation|0
1242945|NCT00626392|4077903|P2|Coadministration Period|Protocol Violation|1
1242946|NCT00626392|4077904|P1|Coadministration Period|Protocol Violation|0
1242947|NCT00626392|4077899|P6|Coadministration Period|Withdrawal by Subject|1
1242948|NCT00626392|4077900|P5|Coadministration Period|Withdrawal by Subject|0
1242949|NCT00626392|4077901|P4|Coadministration Period|Withdrawal by Subject|1
1242950|NCT00626392|4077902|P3|Coadministration Period|Withdrawal by Subject|0
1242951|NCT00626392|4077903|P2|Coadministration Period|Withdrawal by Subject|1
1242952|NCT00626392|4077904|P1|Coadministration Period|Withdrawal by Subject|1
1242953|NCT00626392|4077899|P6|Coadministration Period|Adverse Event|4
1242954|NCT00626392|4077900|P5|Coadministration Period|Adverse Event|3
1242955|NCT00626392|4077901|P4|Coadministration Period|Adverse Event|4
1242956|NCT00626392|4077902|P3|Coadministration Period|Adverse Event|7
1242957|NCT00626392|4077903|P2|Coadministration Period|Adverse Event|1
1242958|NCT00626392|4077904|P1|Coadministration Period|Adverse Event|3
1242959|NCT00626392|4077899|P6|Run-in Period|Noncompliance|0
1242960|NCT00626392|4077900|P5|Run-in Period|Noncompliance|0
1242961|NCT00626392|4077901|P4|Run-in Period|Noncompliance|0
1242962|NCT00626392|4077902|P3|Run-in Period|Noncompliance|1
1242963|NCT00626392|4077903|P2|Run-in Period|Noncompliance|0
1242964|NCT00626392|4077904|P1|Run-in Period|Noncompliance|1
1242965|NCT00626392|4077899|P6|Run-in Period|Withdrawal by Subject|1
1242966|NCT00626392|4077900|P5|Run-in Period|Withdrawal by Subject|3
1242967|NCT00626392|4077901|P4|Run-in Period|Withdrawal by Subject|1
1242968|NCT00626392|4077902|P3|Run-in Period|Withdrawal by Subject|1
1242969|NCT00626392|4077903|P2|Run-in Period|Withdrawal by Subject|1
1242970|NCT00626392|4077904|P1|Run-in Period|Withdrawal by Subject|0
1242971|NCT00626392|4077899|P6|Run-in Period|Adverse Event|0
1242972|NCT00626392|4077900|P5|Run-in Period|Adverse Event|1
1242973|NCT00626392|4077901|P4|Run-in Period|Adverse Event|0
1242974|NCT00626392|4077902|P3|Run-in Period|Adverse Event|1
1242975|NCT00626392|4077903|P2|Run-in Period|Adverse Event|0
1242976|NCT00626392|4077904|P1|Run-in Period|Adverse Event|0
1242977|NCT00626327|4077923|P3|Overall Study|Protocol Violation|26
1242978|NCT00626327|4077924|P2|Overall Study|Protocol Violation|4
1242979|NCT00626327|4077925|P1|Overall Study|Protocol Violation|26
1242980|NCT00626327|4077923|P3|Overall Study|Administrative Reason|6
1242981|NCT00626327|4077924|P2|Overall Study|Administrative Reason|0
1242982|NCT00626327|4077925|P1|Overall Study|Administrative Reason|2
1242983|NCT00626327|4077923|P3|Overall Study|Inappropriate enrollment|3
1242984|NCT00626327|4077924|P2|Overall Study|Inappropriate enrollment|5
1242985|NCT00626327|4077925|P1|Overall Study|Inappropriate enrollment|4
1242986|NCT00626327|4077923|P3|Overall Study|Lost to Follow-up|23
1242987|NCT00626327|4077924|P2|Overall Study|Lost to Follow-up|21
1242988|NCT00626327|4077925|P1|Overall Study|Lost to Follow-up|24
1242989|NCT00626327|4077923|P3|Overall Study|Adverse Event|0
1242990|NCT00626327|4077924|P2|Overall Study|Adverse Event|0
1242991|NCT00626327|4077925|P1|Overall Study|Adverse Event|1
1242992|NCT00626327|4077923|P3|Overall Study|Withdrawal by Subject|30
1242993|NCT00626327|4077924|P2|Overall Study|Withdrawal by Subject|29
1242994|NCT00626327|4077925|P1|Overall Study|Withdrawal by Subject|21
1242995|NCT00626275|4077951|P8|Part B|Withdrawal by Subject|1
1242996|NCT00626275|4077952|P7|Part B|Withdrawal by Subject|0
1242997|NCT00626275|4077953|P6|Part B|Withdrawal by Subject|0
1242998|NCT00626275|4077954|P5|Part B|Withdrawal by Subject|0
1242999|NCT00626275|4077955|P4|Part B|Withdrawal by Subject|0
1243000|NCT00626275|4077956|P3|Part B|Withdrawal by Subject|0
1243001|NCT00626275|4077957|P2|Part B|Withdrawal by Subject|0
1243002|NCT00626275|4077958|P1|Part B|Withdrawal by Subject|0
1243003|NCT00626275|4077951|P8|Part B|Lost to Follow-up|0
1243004|NCT00626275|4077952|P7|Part B|Lost to Follow-up|1
1243005|NCT00626275|4077953|P6|Part B|Lost to Follow-up|0
1243006|NCT00626275|4077954|P5|Part B|Lost to Follow-up|0
1243007|NCT00626275|4077955|P4|Part B|Lost to Follow-up|0
1243008|NCT00626275|4077956|P3|Part B|Lost to Follow-up|0
1243009|NCT00626275|4077957|P2|Part B|Lost to Follow-up|0
1243010|NCT00626275|4077958|P1|Part B|Lost to Follow-up|0
1243011|NCT00626275|4077951|P8|Part A - Treatment Period 1|Withdrawal by Subject|0
1243012|NCT00626275|4077952|P7|Part A - Treatment Period 1|Withdrawal by Subject|0
1243013|NCT00626275|4077953|P6|Part A - Treatment Period 1|Withdrawal by Subject|0
1243014|NCT00626275|4077954|P5|Part A - Treatment Period 1|Withdrawal by Subject|0
1243015|NCT00626275|4077955|P4|Part A - Treatment Period 1|Withdrawal by Subject|0
1243016|NCT00626275|4077956|P3|Part A - Treatment Period 1|Withdrawal by Subject|1
1243017|NCT00626275|4077957|P2|Part A - Treatment Period 1|Withdrawal by Subject|0
1243018|NCT00626275|4077958|P1|Part A - Treatment Period 1|Withdrawal by Subject|0
1243019|NCT00626275|4077951|P8|Part A - Treatment Period 1|Adverse Event|0
1243020|NCT00626275|4077952|P7|Part A - Treatment Period 1|Adverse Event|0
1243021|NCT00626275|4077953|P6|Part A - Treatment Period 1|Adverse Event|0
1243022|NCT00626275|4077954|P5|Part A - Treatment Period 1|Adverse Event|0
1243023|NCT00626275|4077955|P4|Part A - Treatment Period 1|Adverse Event|0
1243024|NCT00626275|4077956|P3|Part A - Treatment Period 1|Adverse Event|0
1243025|NCT00626275|4077957|P2|Part A - Treatment Period 1|Adverse Event|0
1243026|NCT00626275|4077958|P1|Part A - Treatment Period 1|Adverse Event|1
1243027|NCT00626093|4078002|P1|Overall Study|One of the required devices not implante|6
1243028|NCT00626093|4078002|P1|Overall Study|Protocol Violation|1
1243029|NCT00626093|4078002|P1|Overall Study|Withdrawal by Subject|6
1243030|NCT00626093|4078002|P1|Overall Study|Physician Decision|4
1243031|NCT00626093|4078002|P1|Overall Study|Death|1
1243032|NCT00626093|4078002|P1|Overall Study|Lost to Follow-up|5
1243033|NCT00626028|4078009|P2|Treatment 1 NO First, O2 Last|Inclusion/Exclusion Criteria|6
1243034|NCT00626028|4078010|P1|Treatment 1 NO First, O2 Last|Inclusion/Exclusion Criteria|3
1243035|NCT00626028|4078009|P2|Treatment 1 NO First, O2 Last|Physician Decision|1
1243036|NCT00626028|4078010|P1|Treatment 1 NO First, O2 Last|Physician Decision|2
1243037|NCT00626028|4078009|P2|Treatment 1 NO First, O2 Last|Device Failure|1
1243038|NCT00626028|4078010|P1|Treatment 1 NO First, O2 Last|Device Failure|0
1243039|NCT00626028|4078009|P2|Treatment 1 NO First, O2 Last|Adverse Event|1
1243040|NCT00626028|4078010|P1|Treatment 1 NO First, O2 Last|Adverse Event|1
1243041|NCT00625872|4078030|P2|Overall Study|Randomized but not treated|1
1243042|NCT00625872|4078031|P1|Overall Study|Randomized but not treated|0
1243043|NCT00625872|4078030|P2|Overall Study|Terminated by sponsor|5
1243044|NCT00625872|4078031|P1|Overall Study|Terminated by sponsor|2
1243045|NCT00625872|4078030|P2|Overall Study|Does not meet inclusion criteria|0
1243046|NCT00625872|4078031|P1|Overall Study|Does not meet inclusion criteria|1
1243047|NCT00625872|4078030|P2|Overall Study|Withdrawal by Subject|0
1243048|NCT00625872|4078031|P1|Overall Study|Withdrawal by Subject|1
1243049|NCT00625820|4078141|P1|Overall Study|Withdrawal by Subject|1
1243050|NCT00625807|4078149|P2|Overall Study|schedule conflict|8
1243051|NCT00625807|4078150|P1|Overall Study|schedule conflict|2
1243052|NCT00625742|4078166|P1|Overall Study|Ineligible|1
1243053|NCT00625742|4078166|P1|Overall Study|Lost to Follow-up|4
1243054|NCT00625742|4078166|P1|Overall Study|Adverse Event|4
1243055|NCT00625742|4078166|P1|Overall Study|Withdrawal by Subject|1
1243056|NCT00625742|4078166|P1|Overall Study|Disease Progression|2
1243057|NCT00625586|4078180|P1|Overall Study|Adverse Event|1
1243058|NCT00625443|4078193|P3|Overall Study|Not specified|1
1243059|NCT00625443|4078194|P2|Overall Study|Not specified|1
1243060|NCT00625443|4078195|P1|Overall Study|Not specified|0
1243061|NCT00625443|4078193|P3|Overall Study|Physician Decision|2
1243062|NCT00625443|4078194|P2|Overall Study|Physician Decision|4
1243063|NCT00625443|4078195|P1|Overall Study|Physician Decision|0
1243064|NCT00625443|4078193|P3|Overall Study|Withdrawal by Subject|2
1243065|NCT00625443|4078194|P2|Overall Study|Withdrawal by Subject|1
1243066|NCT00625443|4078195|P1|Overall Study|Withdrawal by Subject|0
1243067|NCT00625443|4078193|P3|Overall Study|Platelet count increase >=500,000/mm3|0
1243068|NCT00625443|4078194|P2|Overall Study|Platelet count increase >=500,000/mm3|0
1243069|NCT00625443|4078195|P1|Overall Study|Platelet count increase >=500,000/mm3|1
1243070|NCT00625443|4078193|P3|Overall Study|Non-compliance with protocol|0
1243071|NCT00625443|4078194|P2|Overall Study|Non-compliance with protocol|1
1243072|NCT00625443|4078195|P1|Overall Study|Non-compliance with protocol|0
1243073|NCT00625443|4078193|P3|Overall Study|Adverse Event|0
1243074|NCT00625443|4078194|P2|Overall Study|Adverse Event|4
1243075|NCT00625443|4078195|P1|Overall Study|Adverse Event|1
1243076|NCT00625365|4078275|P1|Overall Study|VSD|1
1243077|NCT00625365|4078275|P1|Overall Study|No IV access|5
1243078|NCT00625365|4078275|P1|Overall Study|Withdrawal by Subject|1
1243079|NCT00625183|4078281|P1|Overall Study|Disease Progression|1
1243080|NCT00625131|4078292|P3|Overall Study|Withdrawal by Subject|5
1243081|NCT00625131|4078293|P2|Overall Study|Withdrawal by Subject|0
1243082|NCT00625131|4078294|P1|Overall Study|Withdrawal by Subject|1
1243083|NCT00625131|4078292|P3|Overall Study|Lost to Follow-up|0
1243084|NCT00625131|4078293|P2|Overall Study|Lost to Follow-up|2
1243085|NCT00625131|4078294|P1|Overall Study|Lost to Follow-up|3
1243086|NCT00624832|4078317|P4|Overall Study|Abnormal Laboratory Value|0
1243087|NCT00624832|4078318|P3|Overall Study|Abnormal Laboratory Value|0
1243088|NCT00624832|4078319|P2|Overall Study|Abnormal Laboratory Value|0
1243089|NCT00624832|4078320|P1|Overall Study|Abnormal Laboratory Value|2
1243090|NCT00624832|4078317|P4|Overall Study|Adverse Event|1
1243091|NCT00624832|4078318|P3|Overall Study|Adverse Event|0
1243092|NCT00624832|4078319|P2|Overall Study|Adverse Event|1
1243093|NCT00624832|4078320|P1|Overall Study|Adverse Event|0
1243094|NCT00624780|4078351|P6|Follow-up (Week 26)|Other|0
1243095|NCT00624780|4078352|P5|Follow-up (Week 26)|Other|0
1243096|NCT00624780|4078353|P4|Follow-up (Week 26)|Other|0
1243097|NCT00624780|4078354|P3|Follow-up (Week 26)|Other|0
1243098|NCT00624780|4078355|P2|Follow-up (Week 26)|Other|1
1243099|NCT00624780|4078356|P1|Follow-up (Week 26)|Other|1
1243100|NCT00624780|4078351|P6|Follow-up (Week 26)|Withdrawal by Subject|0
1243101|NCT00624780|4078352|P5|Follow-up (Week 26)|Withdrawal by Subject|0
1243102|NCT00624780|4078353|P4|Follow-up (Week 26)|Withdrawal by Subject|0
1243103|NCT00624780|4078354|P3|Follow-up (Week 26)|Withdrawal by Subject|0
1243104|NCT00624780|4078355|P2|Follow-up (Week 26)|Withdrawal by Subject|0
1243105|NCT00624780|4078356|P1|Follow-up (Week 26)|Withdrawal by Subject|1
1243106|NCT00624780|4078351|P6|Follow-up (Week 26)|Lost to Follow-up|0
1243107|NCT00624780|4078352|P5|Follow-up (Week 26)|Lost to Follow-up|1
1243108|NCT00624780|4078353|P4|Follow-up (Week 26)|Lost to Follow-up|0
1243109|NCT00624780|4078354|P3|Follow-up (Week 26)|Lost to Follow-up|1
1243110|NCT00624780|4078355|P2|Follow-up (Week 26)|Lost to Follow-up|0
1243111|NCT00624780|4078356|P1|Follow-up (Week 26)|Lost to Follow-up|0
1243112|NCT00624780|4078351|P6|Follow-up (Week 26)|Adverse Event|0
1243113|NCT00624780|4078352|P5|Follow-up (Week 26)|Adverse Event|1
1243114|NCT00624780|4078353|P4|Follow-up (Week 26)|Adverse Event|0
1243115|NCT00624780|4078354|P3|Follow-up (Week 26)|Adverse Event|0
1243116|NCT00624780|4078355|P2|Follow-up (Week 26)|Adverse Event|0
1243117|NCT00624780|4078356|P1|Follow-up (Week 26)|Adverse Event|0
1243118|NCT00624780|4078351|P6|Follow-up (Week 26)|Death|0
1243119|NCT00624780|4078352|P5|Follow-up (Week 26)|Death|0
1243120|NCT00624780|4078353|P4|Follow-up (Week 26)|Death|0
1243121|NCT00624780|4078354|P3|Follow-up (Week 26)|Death|1
1243122|NCT00624780|4078355|P2|Follow-up (Week 26)|Death|0
1243123|NCT00624780|4078356|P1|Follow-up (Week 26)|Death|0
1243124|NCT00624780|4078351|P6|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
1243125|NCT00624780|4078352|P5|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
1243126|NCT00624780|4078353|P4|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
1243127|NCT00624780|4078354|P3|Treatment Discontinuation (Week 25)|Lost to Follow-up|1
1243128|NCT00624780|4078355|P2|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
1243129|NCT00624780|4078356|P1|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
1243130|NCT00624780|4078351|P6|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
1243131|NCT00624780|4078352|P5|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
1243132|NCT00624780|4078353|P4|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
1243133|NCT00624780|4078354|P3|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
1243134|NCT00624780|4078355|P2|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
1243135|NCT00624780|4078356|P1|Treatment Discontinuation (Week 25)|Lack of Efficacy|1
1243136|NCT00624780|4078351|P6|Treatment Discontinuation (Week 25)|Adverse Event|1
1243137|NCT00624780|4078352|P5|Treatment Discontinuation (Week 25)|Adverse Event|0
1243138|NCT00624780|4078353|P4|Treatment Discontinuation (Week 25)|Adverse Event|1
1243139|NCT00624780|4078354|P3|Treatment Discontinuation (Week 25)|Adverse Event|2
1243140|NCT00624780|4078355|P2|Treatment Discontinuation (Week 25)|Adverse Event|0
1243141|NCT00624780|4078356|P1|Treatment Discontinuation (Week 25)|Adverse Event|1
1243142|NCT00624780|4078351|P6|Fixed Dosing (Week 13 to Week 24)|Other|3
1243143|NCT00624780|4078352|P5|Fixed Dosing (Week 13 to Week 24)|Other|4
1243144|NCT00624780|4078353|P4|Fixed Dosing (Week 13 to Week 24)|Other|1
1243145|NCT00624780|4078354|P3|Fixed Dosing (Week 13 to Week 24)|Other|4
1243146|NCT00624780|4078355|P2|Fixed Dosing (Week 13 to Week 24)|Other|3
1243147|NCT00624780|4078356|P1|Fixed Dosing (Week 13 to Week 24)|Other|5
1243148|NCT00624780|4078351|P6|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
1243149|NCT00624780|4078352|P5|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
1243150|NCT00624780|4078353|P4|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
1243151|NCT00624780|4078354|P3|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
1243152|NCT00624780|4078355|P2|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
1243153|NCT00624780|4078356|P1|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
1243154|NCT00624780|4078351|P6|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
1243155|NCT00624780|4078352|P5|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
1243156|NCT00624780|4078353|P4|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
1243157|NCT00624780|4078354|P3|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
1243158|NCT00624780|4078355|P2|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
1243159|NCT00624780|4078356|P1|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
1243160|NCT00624780|4078351|P6|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
1243161|NCT00624780|4078352|P5|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
1243162|NCT00624780|4078353|P4|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
1243163|NCT00624780|4078354|P3|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
1243164|NCT00624780|4078355|P2|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1
1243165|NCT00624780|4078356|P1|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
1243166|NCT00624780|4078351|P6|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1
1243167|NCT00624780|4078352|P5|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3
1243168|NCT00624780|4078353|P4|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2
1243169|NCT00624780|4078354|P3|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
1243170|NCT00624780|4078355|P2|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4
1243171|NCT00624780|4078356|P1|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
1243172|NCT00624780|4078351|P6|Treatment Optimization (Up to Week 12)|Other|0
1243173|NCT00624780|4078352|P5|Treatment Optimization (Up to Week 12)|Other|9
1243174|NCT00624780|4078353|P4|Treatment Optimization (Up to Week 12)|Other|2
1243175|NCT00624780|4078354|P3|Treatment Optimization (Up to Week 12)|Other|8
1243176|NCT00624780|4078355|P2|Treatment Optimization (Up to Week 12)|Other|4
1243177|NCT00624780|4078356|P1|Treatment Optimization (Up to Week 12)|Other|10
1243178|NCT00624780|4078351|P6|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
1243179|NCT00624780|4078352|P5|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
1243180|NCT00624780|4078353|P4|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
1243181|NCT00624780|4078354|P3|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7
1243182|NCT00624780|4078355|P2|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2
1243183|NCT00624780|4078356|P1|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
1243184|NCT00624780|4078351|P6|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
1243185|NCT00624780|4078352|P5|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
1243186|NCT00624780|4078353|P4|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
1243187|NCT00624780|4078354|P3|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
1243188|NCT00624780|4078355|P2|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
1243189|NCT00624780|4078356|P1|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
1243190|NCT00624780|4078351|P6|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1
1243191|NCT00624780|4078352|P5|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9
1243192|NCT00624780|4078353|P4|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
1243193|NCT00624780|4078354|P3|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10
1243194|NCT00624780|4078355|P2|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2
1243195|NCT00624780|4078356|P1|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
1243196|NCT00624780|4078351|P6|Treatment Optimization (Up to Week 12)|Adverse Event|5
1243197|NCT00624780|4078352|P5|Treatment Optimization (Up to Week 12)|Adverse Event|9
1243198|NCT00624780|4078353|P4|Treatment Optimization (Up to Week 12)|Adverse Event|3
1243199|NCT00624780|4078354|P3|Treatment Optimization (Up to Week 12)|Adverse Event|15
1243200|NCT00624780|4078355|P2|Treatment Optimization (Up to Week 12)|Adverse Event|5
1243201|NCT00624780|4078356|P1|Treatment Optimization (Up to Week 12)|Adverse Event|7
1243202|NCT00624585|4078538|P1|Overall Study|Adverse Event|3
1243203|NCT00624585|4078538|P1|Overall Study|Disease Progression|6
1243204|NCT00624585|4078538|P1|Overall Study|Death|3
1243205|NCT00624520|4078568|P2|Overall Study|Death|1
1243206|NCT00624520|4078569|P1|Overall Study|Death|0
1243207|NCT00624520|4078568|P2|Overall Study|Withdrawal by Subject|7
1243208|NCT00624520|4078569|P1|Overall Study|Withdrawal by Subject|12
1243209|NCT00624468|4078596|P4|Safety Follow-up (SFU) Period|Other|1
1243210|NCT00624468|4078597|P3|Safety Follow-up (SFU) Period|Other|1
1243211|NCT00624468|4078598|P2|Safety Follow-up (SFU) Period|Other|0
1243212|NCT00624468|4078599|P1|Safety Follow-up (SFU) Period|Other|0
1243213|NCT00624468|4078596|P4|Safety Follow-up (SFU) Period|Lost to Follow-up|2
1243214|NCT00624468|4078597|P3|Safety Follow-up (SFU) Period|Lost to Follow-up|1
1243215|NCT00624468|4078598|P2|Safety Follow-up (SFU) Period|Lost to Follow-up|0
1243216|NCT00624468|4078599|P1|Safety Follow-up (SFU) Period|Lost to Follow-up|0
1243217|NCT00624468|4078596|P4|Double-blind Period|Withdrew Prematurely|0
1243218|NCT00624468|4078597|P3|Double-blind Period|Withdrew Prematurely|0
1243219|NCT00624468|4078598|P2|Double-blind Period|Withdrew Prematurely|1
1243220|NCT00624468|4078599|P1|Double-blind Period|Withdrew Prematurely|1
1243221|NCT00624468|4078596|P4|Double-blind Period|Early Termination Initiated by Sponsor|0
1243222|NCT00624468|4078597|P3|Double-blind Period|Early Termination Initiated by Sponsor|0
1243223|NCT00624468|4078598|P2|Double-blind Period|Early Termination Initiated by Sponsor|12
1243224|NCT00624468|4078599|P1|Double-blind Period|Early Termination Initiated by Sponsor|13
1243225|NCT00624377|4078666|P1|Overall Study|Non-evaluable population|84
1243226|NCT00624377|4078666|P1|Overall Study|Other|91
1243227|NCT00624377|4078666|P1|Overall Study|Adverse Event|14
1243228|NCT00624377|4078666|P1|Overall Study|Withdrawal by Subject|100
1243229|NCT00624377|4078666|P1|Overall Study|Lost to Follow-up|355
1243230|NCT00624338|4078680|P3|Overall Study|Randomized but not treated|3
1243231|NCT00624338|4078681|P2|Overall Study|Randomized but not treated|1
1243232|NCT00624338|4078682|P1|Overall Study|Randomized but not treated|2
1243233|NCT00624338|4078680|P3|Overall Study|Other|9
1243234|NCT00624338|4078681|P2|Overall Study|Other|5
1243235|NCT00624338|4078682|P1|Overall Study|Other|15
1243236|NCT00624338|4078680|P3|Overall Study|Termination of 150 mg group by Sponsor|0
1243237|NCT00624338|4078681|P2|Overall Study|Termination of 150 mg group by Sponsor|55
1243238|NCT00624338|4078682|P1|Overall Study|Termination of 150 mg group by Sponsor|0
1243239|NCT00624338|4078680|P3|Overall Study|Immunoglobulin less than 3gram per liter|0
1243240|NCT00624338|4078681|P2|Overall Study|Immunoglobulin less than 3gram per liter|0
1243241|NCT00624338|4078682|P1|Overall Study|Immunoglobulin less than 3gram per liter|1
1243242|NCT00624338|4078680|P3|Overall Study|Death|0
1243243|NCT00624338|4078681|P2|Overall Study|Death|2
1243244|NCT00624338|4078682|P1|Overall Study|Death|0
1243245|NCT00624338|4078680|P3|Overall Study|Protocol Violation|2
1243246|NCT00624338|4078681|P2|Overall Study|Protocol Violation|3
1243247|NCT00624338|4078682|P1|Overall Study|Protocol Violation|3
1243248|NCT00624338|4078680|P3|Overall Study|Lack of Efficacy|14
1243249|NCT00624338|4078681|P2|Overall Study|Lack of Efficacy|3
1243250|NCT00624338|4078682|P1|Overall Study|Lack of Efficacy|11
1243251|NCT00624338|4078680|P3|Overall Study|Lost to Follow-up|0
1243252|NCT00624338|4078681|P2|Overall Study|Lost to Follow-up|0
1243253|NCT00624338|4078682|P1|Overall Study|Lost to Follow-up|1
1243254|NCT00624338|4078680|P3|Overall Study|Adverse Event|18
1243255|NCT00624338|4078681|P2|Overall Study|Adverse Event|14
1243256|NCT00624338|4078682|P1|Overall Study|Adverse Event|14
1243257|NCT00624286|4078704|P2|Overall Study|Death|1
1243258|NCT00624286|4078705|P1|Overall Study|Death|0
1243259|NCT00624286|4078704|P2|Overall Study|Abnormal test procedure result(s)|1
1243260|NCT00624286|4078705|P1|Overall Study|Abnormal test procedure result(s)|0
1243261|NCT00624286|4078704|P2|Overall Study|Not stated|1
1243262|NCT00624286|4078705|P1|Overall Study|Not stated|0
1243263|NCT00624286|4078704|P2|Overall Study|Lack of Efficacy|6
1243264|NCT00624286|4078705|P1|Overall Study|Lack of Efficacy|1
1243265|NCT00624286|4078704|P2|Overall Study|Administrative problems|0
1243266|NCT00624286|4078705|P1|Overall Study|Administrative problems|3
1243267|NCT00624286|4078704|P2|Overall Study|Lost to Follow-up|2
1243268|NCT00624286|4078705|P1|Overall Study|Lost to Follow-up|3
1243269|NCT00624286|4078704|P2|Overall Study|Withdrawal by Subject|4
1243270|NCT00624286|4078705|P1|Overall Study|Withdrawal by Subject|5
1243271|NCT00624286|4078704|P2|Overall Study|Adverse Event|3
1243272|NCT00624286|4078705|P1|Overall Study|Adverse Event|6
1243273|NCT00624286|4078704|P2|Overall Study|Protocol Deviation|9
1243274|NCT00624286|4078705|P1|Overall Study|Protocol Deviation|7
1243275|NCT00624065|4078758|P2|Overall Study|Met protocol-defined stopping criteria|9
1243276|NCT00624065|4078759|P1|Overall Study|Met protocol-defined stopping criteria|4
1243277|NCT00624065|4078758|P2|Overall Study|Lack of Efficacy|3
1243278|NCT00624065|4078759|P1|Overall Study|Lack of Efficacy|0
1243279|NCT00624065|4078758|P2|Overall Study|Consent withdrawn|5
1243280|NCT00624065|4078759|P1|Overall Study|Consent withdrawn|6
1243281|NCT00624065|4078758|P2|Overall Study|Lost to Follow-up|1
1243282|NCT00624065|4078759|P1|Overall Study|Lost to Follow-up|4
1243283|NCT00624065|4078758|P2|Overall Study|Adverse Event|6
1243284|NCT00624065|4078759|P1|Overall Study|Adverse Event|5
1243285|NCT00624052|4078771|P4|Overall Study|Changed job/ran out if meds|0
1243286|NCT00624052|4078772|P3|Overall Study|Changed job/ran out if meds|0
1243287|NCT00624052|4078773|P2|Overall Study|Changed job/ran out if meds|2
1243288|NCT00624052|4078774|P1|Overall Study|Changed job/ran out if meds|0
1243289|NCT00624052|4078771|P4|Overall Study|Consent withdrawn|0
1243290|NCT00624052|4078772|P3|Overall Study|Consent withdrawn|1
1243291|NCT00624052|4078773|P2|Overall Study|Consent withdrawn|1
1243292|NCT00624052|4078774|P1|Overall Study|Consent withdrawn|3
1243293|NCT00624052|4078771|P4|Overall Study|Non compliant with the protocol|1
1243294|NCT00624052|4078772|P3|Overall Study|Non compliant with the protocol|1
1243295|NCT00624052|4078773|P2|Overall Study|Non compliant with the protocol|1
1243296|NCT00624052|4078774|P1|Overall Study|Non compliant with the protocol|2
1243297|NCT00624052|4078771|P4|Overall Study|Lost to Follow-up|0
1243298|NCT00624052|4078772|P3|Overall Study|Lost to Follow-up|1
1243299|NCT00624052|4078773|P2|Overall Study|Lost to Follow-up|3
1243300|NCT00624052|4078774|P1|Overall Study|Lost to Follow-up|2
1243301|NCT00624052|4078771|P4|Overall Study|Lack of Efficacy|0
1243302|NCT00624052|4078772|P3|Overall Study|Lack of Efficacy|0
1243303|NCT00624052|4078773|P2|Overall Study|Lack of Efficacy|1
1243304|NCT00624052|4078774|P1|Overall Study|Lack of Efficacy|1
1243305|NCT00624052|4078771|P4|Overall Study|Adverse Event|3
1243306|NCT00624052|4078772|P3|Overall Study|Adverse Event|0
1243307|NCT00624052|4078773|P2|Overall Study|Adverse Event|6
1243308|NCT00624052|4078774|P1|Overall Study|Adverse Event|7
1243309|NCT00623935|4078851|P1|Overall Study|Patient Declined Transplant|1
1243310|NCT00623935|4078851|P1|Overall Study|Death|1
1243311|NCT00623831|4078858|P2|Overall Study|Progressive Disease|1
1243312|NCT00623831|4078859|P1|Overall Study|Progressive Disease|0
1243313|NCT00623831|4078858|P2|Overall Study|Withdrawal by Subject|0
1243314|NCT00623831|4078859|P1|Overall Study|Withdrawal by Subject|1
1243315|NCT00623805|4078871|P2|Overall Study|Reason not Specified|6
1243316|NCT00623805|4078872|P1|Overall Study|Reason not Specified|3
1243317|NCT00623805|4078871|P2|Overall Study|Protocol Violation|1
1243318|NCT00623805|4078872|P1|Overall Study|Protocol Violation|1
1243319|NCT00623805|4078871|P2|Overall Study|Lost to Follow-up|2
1243320|NCT00623805|4078872|P1|Overall Study|Lost to Follow-up|2
1243321|NCT00623805|4078871|P2|Overall Study|Lack of Efficacy|7
1243322|NCT00623805|4078872|P1|Overall Study|Lack of Efficacy|3
1243323|NCT00623805|4078871|P2|Overall Study|Death|0
1243324|NCT00623805|4078872|P1|Overall Study|Death|2
1243325|NCT00623805|4078871|P2|Overall Study|Adverse Event|6
1243326|NCT00623805|4078872|P1|Overall Study|Adverse Event|9
1243327|NCT00623779|4078889|P3|Overall Study|Criteria from CSR|1
1243328|NCT00623779|4078890|P2|Overall Study|Criteria from CSR|0
1243329|NCT00623779|4078891|P1|Overall Study|Criteria from CSR|2
1243330|NCT00623779|4078889|P3|Overall Study|Adverse Event|0
1243331|NCT00623779|4078890|P2|Overall Study|Adverse Event|3
1243332|NCT00623779|4078891|P1|Overall Study|Adverse Event|1
1243333|NCT00623766|4078940|P2|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0
1243334|NCT00623766|4078941|P1|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1
1243335|NCT00623766|4078940|P2|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2
1243336|NCT00623766|4078941|P1|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1
1243337|NCT00623766|4078940|P2|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0
1243338|NCT00623766|4078941|P1|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4
1243339|NCT00623766|4078940|P2|Maintenance Phase (Week 24 to Year 2)|Disease progression|0
1243340|NCT00623766|4078941|P1|Maintenance Phase (Week 24 to Year 2)|Disease progression|4
1243341|NCT00623766|4078940|P2|Induction Phase (Day 1 to Week 24)|Off treatment|16
1243342|NCT00623766|4078941|P1|Induction Phase (Day 1 to Week 24)|Off treatment|36
1243343|NCT00623727|4078965|P2|Open Label Follow-up|Participant convenience|1
1243344|NCT00623727|4078966|P1|Open Label Follow-up|Participant convenience|0
1243345|NCT00623727|4078965|P2|Open Label Follow-up|Study termination|6
1243346|NCT00623727|4078966|P1|Open Label Follow-up|Study termination|0
1243347|NCT00623727|4078965|P2|Open Label Follow-up|Withdrawal by Subject|1
1243348|NCT00623727|4078966|P1|Open Label Follow-up|Withdrawal by Subject|0
1243349|NCT00623727|4078965|P2|Double Blind (DB)|Protocol Violation|2
1243350|NCT00623727|4078966|P1|Double Blind (DB)|Protocol Violation|2
1243351|NCT00623727|4078965|P2|Double Blind (DB)|Lost to Follow-up|1
1243352|NCT00623727|4078966|P1|Double Blind (DB)|Lost to Follow-up|1
1243353|NCT00623727|4078965|P2|Double Blind (DB)|Termination of the double-blind period|21
1243354|NCT00623727|4078966|P1|Double Blind (DB)|Termination of the double-blind period|22
1243355|NCT00623727|4078965|P2|Double Blind (DB)|Lack of Efficacy|2
1243356|NCT00623727|4078966|P1|Double Blind (DB)|Lack of Efficacy|2
1243357|NCT00623727|4078965|P2|Double Blind (DB)|Withdrawal by Subject|2
1243358|NCT00623727|4078966|P1|Double Blind (DB)|Withdrawal by Subject|8
1243359|NCT00623727|4078965|P2|Double Blind (DB)|Physician Decision|1
1243360|NCT00623727|4078966|P1|Double Blind (DB)|Physician Decision|0
1243361|NCT00623727|4078965|P2|Double Blind (DB)|Adverse Event|3
1243362|NCT00623727|4078966|P1|Double Blind (DB)|Adverse Event|1
1243363|NCT00623597|4079021|P2|Overall Study|Failed to return|0
1243364|NCT00623597|4079022|P1|Overall Study|Failed to return|1
1243365|NCT00623545|4079085|P1|Overall Study|Withdrawal by Subject|4
1243366|NCT00623545|4079085|P1|Overall Study|Adverse Event|6
1243367|NCT00623480|4079105|P2|Overall Study|Site closed by sponsor|1
1243368|NCT00623480|4079106|P1|Overall Study|Site closed by sponsor|0
1243369|NCT00623480|4079105|P2|Overall Study|Protocol Violation|1
1243370|NCT00623480|4079106|P1|Overall Study|Protocol Violation|0
1243371|NCT00623480|4079105|P2|Overall Study|Non-compliant with study medication|0
1243372|NCT00623480|4079106|P1|Overall Study|Non-compliant with study medication|4
1243373|NCT00623480|4079105|P2|Overall Study|Lack of Efficacy|0
1243374|NCT00623480|4079106|P1|Overall Study|Lack of Efficacy|1
1243375|NCT00623480|4079105|P2|Overall Study|Withdrawal by Subject|4
1243376|NCT00623480|4079106|P1|Overall Study|Withdrawal by Subject|2
1243377|NCT00623480|4079105|P2|Overall Study|Lost to Follow-up|1
1243378|NCT00623480|4079106|P1|Overall Study|Lost to Follow-up|0
1243379|NCT00623467|4079118|P1|Overall Study|Withdrawal by Subject|2
1243380|NCT00623467|4079118|P1|Overall Study|Protocol Violation|4
1243381|NCT00623467|4079118|P1|Overall Study|Lost to Follow-up|1
1243382|NCT00623428|4079188|P2|Follow-up Period|Death|1
1243383|NCT00623428|4079189|P1|Follow-up Period|Death|0
1243384|NCT00623428|4079188|P2|Follow-up Period|Reason not specified|1
1243385|NCT00623428|4079189|P1|Follow-up Period|Reason not specified|1
1243386|NCT00623428|4079188|P2|Follow-up Period|Did not cooperate|3
1243387|NCT00623428|4079189|P1|Follow-up Period|Did not cooperate|0
1243388|NCT00623428|4079188|P2|Follow-up Period|HCV-RNA detectable at end of treatment|1
1243389|NCT00623428|4079189|P1|Follow-up Period|HCV-RNA detectable at end of treatment|2
1243390|NCT00623428|4079188|P2|Follow-up Period|Patient withdrew consent|4
1243391|NCT00623428|4079189|P1|Follow-up Period|Patient withdrew consent|5
1243392|NCT00623428|4079188|P2|Follow-up Period|Failure to return|2
1243393|NCT00623428|4079189|P1|Follow-up Period|Failure to return|10
1243394|NCT00623428|4079188|P2|Follow-up Period|Relapse post-treatment|3
1243395|NCT00623428|4079189|P1|Follow-up Period|Relapse post-treatment|11
1243396|NCT00623428|4079188|P2|Treatment Period|Withdrawal by Subject|1
1243397|NCT00623428|4079189|P1|Treatment Period|Withdrawal by Subject|0
1243398|NCT00623428|4079188|P2|Treatment Period|Other|1
1243399|NCT00623428|4079189|P1|Treatment Period|Other|0
1243400|NCT00623428|4079188|P2|Treatment Period|Insufficient therapeutic response|2
1243401|NCT00623428|4079189|P1|Treatment Period|Insufficient therapeutic response|0
1243402|NCT00623428|4079188|P2|Treatment Period|Did not cooperate / refused treatment|13
1243403|NCT00623428|4079189|P1|Treatment Period|Did not cooperate / refused treatment|0
1243404|NCT00623428|4079188|P2|Treatment Period|Death|1
1243405|NCT00623428|4079189|P1|Treatment Period|Death|0
1243406|NCT00623428|4079188|P2|Treatment Period|Adverse event/intercurrent illness|9
1243407|NCT00623428|4079189|P1|Treatment Period|Adverse event/intercurrent illness|0
1243408|NCT00623233|4079207|P1|Overall Study|Withdrawal by Subject|3
1243409|NCT00623233|4079207|P1|Overall Study|Lost to Follow-up|1
1243410|NCT00623233|4079207|P1|Overall Study|Physician Decision|10
1243411|NCT00623233|4079207|P1|Overall Study|Adverse Event|10
1243412|NCT00623194|4079214|P1|Overall Study|Unclassified|1
1243413|NCT00623194|4079214|P1|Overall Study|Protocol Violation|3
1243414|NCT00623194|4079214|P1|Overall Study|Lack of Efficacy|1
1243415|NCT00623103|4079251|P2|Overall Study|Protocol deviation|1
1243416|NCT00623103|4079252|P1|Overall Study|Protocol deviation|2
1243417|NCT00623103|4079251|P2|Overall Study|Death|11
1243418|NCT00623103|4079252|P1|Overall Study|Death|11
1243419|NCT00623103|4079251|P2|Overall Study|Administrative problems|4
1243420|NCT00623103|4079252|P1|Overall Study|Administrative problems|2
1243421|NCT00623103|4079251|P2|Overall Study|Lost to Follow-up|1
1243422|NCT00623103|4079252|P1|Overall Study|Lost to Follow-up|4
1243423|NCT00623103|4079251|P2|Overall Study|Withdrawal by Subject|24
1243424|NCT00623103|4079252|P1|Overall Study|Withdrawal by Subject|18
1243425|NCT00623103|4079251|P2|Overall Study|Unsatisfactory therapeutic effect|12
1243426|NCT00623103|4079252|P1|Overall Study|Unsatisfactory therapeutic effect|4
1243427|NCT00623103|4079251|P2|Overall Study|Adverse Event|60
1243428|NCT00623103|4079252|P1|Overall Study|Adverse Event|70
1243429|NCT00622908|4079280|P2|Overall Study|Termination by study sponser|1
1243430|NCT00622908|4079281|P1|Overall Study|Termination by study sponser|0
1243431|NCT00622908|4079280|P2|Overall Study|Refusal|1
1243432|NCT00622908|4079281|P1|Overall Study|Refusal|0
1243433|NCT00622908|4079280|P2|Overall Study|Lost to Follow-up|0
1243434|NCT00622908|4079281|P1|Overall Study|Lost to Follow-up|1
1243435|NCT00622908|4079280|P2|Overall Study|Lack of Efficacy|7
1243436|NCT00622908|4079281|P1|Overall Study|Lack of Efficacy|1
1243437|NCT00622908|4079280|P2|Overall Study|Adverse Event|1
1243438|NCT00622908|4079281|P1|Overall Study|Adverse Event|0
1243439|NCT00622908|4079280|P2|Overall Study|Protocol Violation|0
1243440|NCT00622908|4079281|P1|Overall Study|Protocol Violation|1
1243441|NCT00622869|4079311|P3|Overall Study|Missing|1
1243442|NCT00622869|4079312|P2|Overall Study|Missing|1
1243443|NCT00622869|4079313|P1|Overall Study|Missing|0
1243444|NCT00622869|4079311|P3|Overall Study|Graft Loss|2
1243445|NCT00622869|4079312|P2|Overall Study|Graft Loss|3
1243446|NCT00622869|4079313|P1|Overall Study|Graft Loss|5
1243447|NCT00622869|4079311|P3|Overall Study|Lost to Follow-up|2
1243448|NCT00622869|4079312|P2|Overall Study|Lost to Follow-up|4
1243449|NCT00622869|4079313|P1|Overall Study|Lost to Follow-up|2
1243450|NCT00622869|4079311|P3|Overall Study|Death|10
1243451|NCT00622869|4079312|P2|Overall Study|Death|15
1243452|NCT00622869|4079313|P1|Overall Study|Death|12
1243453|NCT00622869|4079311|P3|Overall Study|Administrative Problems|13
1243454|NCT00622869|4079312|P2|Overall Study|Administrative Problems|17
1243455|NCT00622869|4079313|P1|Overall Study|Administrative Problems|11
1243456|NCT00622869|4079311|P3|Overall Study|Subject Withdrew Consent|11
1243457|NCT00622869|4079312|P2|Overall Study|Subject Withdrew Consent|17
1243458|NCT00622869|4079313|P1|Overall Study|Subject Withdrew Consent|13
1243459|NCT00622739|4079332|P2|Overall Study|Lost to Follow-up|1
1243460|NCT00622739|4079333|P1|Overall Study|Lost to Follow-up|0
1243461|NCT00622739|4079332|P2|Overall Study|Withdrawal by Subject|1
1243462|NCT00622739|4079333|P1|Overall Study|Withdrawal by Subject|0
1243463|NCT00622739|4079332|P2|Overall Study|Lack of Efficacy|2
1243464|NCT00622739|4079333|P1|Overall Study|Lack of Efficacy|0
1243465|NCT00622739|4079332|P2|Overall Study|Adverse Event|2
1243466|NCT00622739|4079333|P1|Overall Study|Adverse Event|1
1243467|NCT00622739|4079332|P2|Overall Study|Physician Decision|0
1243468|NCT00622739|4079333|P1|Overall Study|Physician Decision|1
1243469|NCT00622726|4079341|P2|August, 2010 to April, 2013|Death|5
1243470|NCT00622726|4079342|P1|August, 2010 to April, 2013|Death|1
1243471|NCT00622726|4079341|P2|March, 2008 to August, 2010|Death|2
1243472|NCT00622726|4079342|P1|March, 2008 to August, 2010|Death|5
1243473|NCT00622713|4079352|P1|Overall Study|Did not meet eligibility criteria|1
1243474|NCT00622713|4079352|P1|Overall Study|Subject no longer required study drug|1
1243475|NCT00622713|4079352|P1|Overall Study|Death|2
1243476|NCT00622713|4079352|P1|Overall Study|Lost to Follow-up|5
1243477|NCT00622713|4079352|P1|Overall Study|Withdrawal by Subject|11
1243478|NCT00622713|4079352|P1|Overall Study|Administrative problems|4
1243479|NCT00622713|4079352|P1|Overall Study|Adverse Event|35
1243480|NCT00622700|4079363|P7|Extension Treatment Period|Other than specified above|1
1243481|NCT00622700|4079364|P6|Extension Treatment Period|Other than specified above|1
1243482|NCT00622700|4079365|P5|Extension Treatment Period|Other than specified above|0
1243483|NCT00622700|4079366|P4|Extension Treatment Period|Other than specified above|0
1243484|NCT00622700|4079367|P3|Extension Treatment Period|Other than specified above|0
1243485|NCT00622700|4079368|P2|Extension Treatment Period|Other than specified above|0
1243486|NCT00622700|4079369|P1|Extension Treatment Period|Other than specified above|0
1243487|NCT00622700|4079363|P7|Extension Treatment Period|Missing|0
1243488|NCT00622700|4079364|P6|Extension Treatment Period|Missing|1
1243489|NCT00622700|4079365|P5|Extension Treatment Period|Missing|3
1243490|NCT00622700|4079366|P4|Extension Treatment Period|Missing|2
1243491|NCT00622700|4079367|P3|Extension Treatment Period|Missing|0
1243492|NCT00622700|4079368|P2|Extension Treatment Period|Missing|0
1243493|NCT00622700|4079369|P1|Extension Treatment Period|Missing|0
1243494|NCT00622700|4079363|P7|Extension Treatment Period|Withdrawal by Subject|10
1243495|NCT00622700|4079364|P6|Extension Treatment Period|Withdrawal by Subject|6
1243496|NCT00622700|4079365|P5|Extension Treatment Period|Withdrawal by Subject|16
1243497|NCT00622700|4079366|P4|Extension Treatment Period|Withdrawal by Subject|11
1243498|NCT00622700|4079367|P3|Extension Treatment Period|Withdrawal by Subject|0
1243499|NCT00622700|4079368|P2|Extension Treatment Period|Withdrawal by Subject|0
1243500|NCT00622700|4079369|P1|Extension Treatment Period|Withdrawal by Subject|0
1243501|NCT00622700|4079363|P7|Extension Treatment Period|Progressive Disease|2
1243502|NCT00622700|4079364|P6|Extension Treatment Period|Progressive Disease|0
1243503|NCT00622700|4079365|P5|Extension Treatment Period|Progressive Disease|2
1243504|NCT00622700|4079366|P4|Extension Treatment Period|Progressive Disease|1
1243505|NCT00622700|4079367|P3|Extension Treatment Period|Progressive Disease|0
1243506|NCT00622700|4079368|P2|Extension Treatment Period|Progressive Disease|0
1243507|NCT00622700|4079369|P1|Extension Treatment Period|Progressive Disease|0
1243508|NCT00622700|4079363|P7|Extension Treatment Period|Lost to Follow-up|0
1243509|NCT00622700|4079364|P6|Extension Treatment Period|Lost to Follow-up|0
1243510|NCT00622700|4079365|P5|Extension Treatment Period|Lost to Follow-up|1
1243511|NCT00622700|4079366|P4|Extension Treatment Period|Lost to Follow-up|0
1243512|NCT00622700|4079367|P3|Extension Treatment Period|Lost to Follow-up|0
1243513|NCT00622700|4079368|P2|Extension Treatment Period|Lost to Follow-up|0
1243514|NCT00622700|4079369|P1|Extension Treatment Period|Lost to Follow-up|0
1243515|NCT00622700|4079363|P7|Extension Treatment Period|Protocol Violation|0
1243516|NCT00622700|4079364|P6|Extension Treatment Period|Protocol Violation|2
1243517|NCT00622700|4079365|P5|Extension Treatment Period|Protocol Violation|0
1243518|NCT00622700|4079366|P4|Extension Treatment Period|Protocol Violation|0
1243519|NCT00622700|4079367|P3|Extension Treatment Period|Protocol Violation|0
1243520|NCT00622700|4079368|P2|Extension Treatment Period|Protocol Violation|0
1243521|NCT00622700|4079369|P1|Extension Treatment Period|Protocol Violation|0
1243522|NCT00622700|4079363|P7|Extension Treatment Period|Lack of Efficacy|9
1243523|NCT00622700|4079364|P6|Extension Treatment Period|Lack of Efficacy|1
1243524|NCT00622700|4079365|P5|Extension Treatment Period|Lack of Efficacy|8
1243525|NCT00622700|4079366|P4|Extension Treatment Period|Lack of Efficacy|2
1243526|NCT00622700|4079367|P3|Extension Treatment Period|Lack of Efficacy|0
1243527|NCT00622700|4079368|P2|Extension Treatment Period|Lack of Efficacy|0
1243528|NCT00622700|4079369|P1|Extension Treatment Period|Lack of Efficacy|0
1243529|NCT00622700|4079363|P7|Extension Treatment Period|Adverse Event|8
1243530|NCT00622700|4079364|P6|Extension Treatment Period|Adverse Event|6
1243531|NCT00622700|4079365|P5|Extension Treatment Period|Adverse Event|9
1243532|NCT00622700|4079366|P4|Extension Treatment Period|Adverse Event|5
1243533|NCT00622700|4079367|P3|Extension Treatment Period|Adverse Event|0
1243534|NCT00622700|4079368|P2|Extension Treatment Period|Adverse Event|0
1243535|NCT00622700|4079369|P1|Extension Treatment Period|Adverse Event|0
1243536|NCT00622700|4079363|P7|Core Treatment Period|Other than specified above|0
1243537|NCT00622700|4079364|P6|Core Treatment Period|Other than specified above|0
1243538|NCT00622700|4079365|P5|Core Treatment Period|Other than specified above|0
1243539|NCT00622700|4079366|P4|Core Treatment Period|Other than specified above|0
1243540|NCT00622700|4079367|P3|Core Treatment Period|Other than specified above|5
1243541|NCT00622700|4079368|P2|Core Treatment Period|Other than specified above|2
1243542|NCT00622700|4079369|P1|Core Treatment Period|Other than specified above|2
1243543|NCT00622700|4079363|P7|Core Treatment Period|Withdrawal by Subject|0
1243544|NCT00622700|4079364|P6|Core Treatment Period|Withdrawal by Subject|0
1243545|NCT00622700|4079365|P5|Core Treatment Period|Withdrawal by Subject|0
1243546|NCT00622700|4079366|P4|Core Treatment Period|Withdrawal by Subject|0
1243547|NCT00622700|4079367|P3|Core Treatment Period|Withdrawal by Subject|15
1243548|NCT00622700|4079368|P2|Core Treatment Period|Withdrawal by Subject|18
1243549|NCT00622700|4079369|P1|Core Treatment Period|Withdrawal by Subject|12
1243550|NCT00622700|4079363|P7|Core Treatment Period|Progressive Disease|0
1243551|NCT00622700|4079364|P6|Core Treatment Period|Progressive Disease|0
1243552|NCT00622700|4079365|P5|Core Treatment Period|Progressive Disease|0
1243553|NCT00622700|4079366|P4|Core Treatment Period|Progressive Disease|0
1243554|NCT00622700|4079367|P3|Core Treatment Period|Progressive Disease|0
1243555|NCT00622700|4079368|P2|Core Treatment Period|Progressive Disease|1
1243556|NCT00622700|4079369|P1|Core Treatment Period|Progressive Disease|3
1243557|NCT00622700|4079363|P7|Core Treatment Period|Death|0
1243558|NCT00622700|4079364|P6|Core Treatment Period|Death|0
1243559|NCT00622700|4079365|P5|Core Treatment Period|Death|0
1243560|NCT00622700|4079366|P4|Core Treatment Period|Death|0
1243561|NCT00622700|4079367|P3|Core Treatment Period|Death|0
1243562|NCT00622700|4079368|P2|Core Treatment Period|Death|0
1243563|NCT00622700|4079369|P1|Core Treatment Period|Death|1
1243564|NCT00622700|4079363|P7|Core Treatment Period|Lost to Follow-up|0
1243565|NCT00622700|4079364|P6|Core Treatment Period|Lost to Follow-up|0
1243566|NCT00622700|4079365|P5|Core Treatment Period|Lost to Follow-up|0
1243567|NCT00622700|4079366|P4|Core Treatment Period|Lost to Follow-up|0
1243568|NCT00622700|4079367|P3|Core Treatment Period|Lost to Follow-up|1
1243569|NCT00622700|4079368|P2|Core Treatment Period|Lost to Follow-up|1
1243570|NCT00622700|4079369|P1|Core Treatment Period|Lost to Follow-up|1
1243571|NCT00622700|4079363|P7|Core Treatment Period|Lack of Efficacy|0
1243572|NCT00622700|4079364|P6|Core Treatment Period|Lack of Efficacy|0
1243573|NCT00622700|4079365|P5|Core Treatment Period|Lack of Efficacy|0
1243574|NCT00622700|4079366|P4|Core Treatment Period|Lack of Efficacy|0
1243575|NCT00622700|4079367|P3|Core Treatment Period|Lack of Efficacy|12
1243576|NCT00622700|4079368|P2|Core Treatment Period|Lack of Efficacy|6
1243577|NCT00622700|4079369|P1|Core Treatment Period|Lack of Efficacy|19
1243578|NCT00622700|4079363|P7|Core Treatment Period|Adverse Event|0
1243579|NCT00622700|4079364|P6|Core Treatment Period|Adverse Event|0
1243580|NCT00622700|4079365|P5|Core Treatment Period|Adverse Event|0
1243581|NCT00622700|4079366|P4|Core Treatment Period|Adverse Event|0
1243582|NCT00622700|4079367|P3|Core Treatment Period|Adverse Event|18
1243583|NCT00622700|4079368|P2|Core Treatment Period|Adverse Event|25
1243584|NCT00622700|4079369|P1|Core Treatment Period|Adverse Event|18
1243585|NCT00622700|4079363|P7|Core Treatment Period|Randomized but Not Treated|0
1243586|NCT00622700|4079364|P6|Core Treatment Period|Randomized but Not Treated|0
1243587|NCT00622700|4079365|P5|Core Treatment Period|Randomized but Not Treated|0
1243588|NCT00622700|4079366|P4|Core Treatment Period|Randomized but Not Treated|0
1243589|NCT00622700|4079367|P3|Core Treatment Period|Randomized but Not Treated|2
1243590|NCT00622700|4079368|P2|Core Treatment Period|Randomized but Not Treated|2
1243591|NCT00622700|4079369|P1|Core Treatment Period|Randomized but Not Treated|0
1243592|NCT00622635|4079428|P6|Treatment Period 3|Withdrawal by Subject|0
1243593|NCT00622635|4079429|P5|Treatment Period 3|Withdrawal by Subject|0
1243594|NCT00622635|4079430|P4|Treatment Period 3|Withdrawal by Subject|1
1243595|NCT00622635|4079431|P3|Treatment Period 3|Withdrawal by Subject|0
1243596|NCT00622635|4079432|P2|Treatment Period 3|Withdrawal by Subject|0
1243597|NCT00622635|4079433|P1|Treatment Period 3|Withdrawal by Subject|0
1243598|NCT00622635|4079428|P6|Treatment Period 3|Adverse Event|0
1243599|NCT00622635|4079429|P5|Treatment Period 3|Adverse Event|0
1243600|NCT00622635|4079430|P4|Treatment Period 3|Adverse Event|2
1243601|NCT00622635|4079431|P3|Treatment Period 3|Adverse Event|0
1243602|NCT00622635|4079432|P2|Treatment Period 3|Adverse Event|0
1243603|NCT00622635|4079433|P1|Treatment Period 3|Adverse Event|0
1243604|NCT00622635|4079428|P6|Treatment Period 2|Adverse Event|0
1243605|NCT00622635|4079429|P5|Treatment Period 2|Adverse Event|0
1243606|NCT00622635|4079430|P4|Treatment Period 2|Adverse Event|0
1243607|NCT00622635|4079431|P3|Treatment Period 2|Adverse Event|0
1243608|NCT00622635|4079432|P2|Treatment Period 2|Adverse Event|0
1243609|NCT00622635|4079433|P1|Treatment Period 2|Adverse Event|1
1243610|NCT00622635|4079428|P6|Treatment Period 1|Abnormal test procedure result(s)|0
1243611|NCT00622635|4079429|P5|Treatment Period 1|Abnormal test procedure result(s)|1
1243612|NCT00622635|4079430|P4|Treatment Period 1|Abnormal test procedure result(s)|0
1243613|NCT00622635|4079431|P3|Treatment Period 1|Abnormal test procedure result(s)|0
1243614|NCT00622635|4079432|P2|Treatment Period 1|Abnormal test procedure result(s)|0
1243615|NCT00622635|4079433|P1|Treatment Period 1|Abnormal test procedure result(s)|0
1243616|NCT00622635|4079428|P6|Treatment Period 1|Withdrawal by Subject|0
1243617|NCT00622635|4079429|P5|Treatment Period 1|Withdrawal by Subject|0
1243618|NCT00622635|4079430|P4|Treatment Period 1|Withdrawal by Subject|0
1243619|NCT00622635|4079431|P3|Treatment Period 1|Withdrawal by Subject|0
1243620|NCT00622635|4079432|P2|Treatment Period 1|Withdrawal by Subject|1
1243621|NCT00622635|4079433|P1|Treatment Period 1|Withdrawal by Subject|0
1243622|NCT00622635|4079428|P6|Treatment Period 1|Adverse Event|0
1243623|NCT00622635|4079429|P5|Treatment Period 1|Adverse Event|0
1243624|NCT00622635|4079430|P4|Treatment Period 1|Adverse Event|0
1243625|NCT00622635|4079431|P3|Treatment Period 1|Adverse Event|1
1243626|NCT00622635|4079432|P2|Treatment Period 1|Adverse Event|0
1243627|NCT00622635|4079433|P1|Treatment Period 1|Adverse Event|0
1243628|NCT00622440|4079516|P2|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1
1243629|NCT00622440|4079517|P1|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0
1243630|NCT00622440|4079516|P2|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1
1243631|NCT00622440|4079517|P1|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0
1243632|NCT00622440|4079516|P2|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5
1243633|NCT00622440|4079517|P1|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3
1243634|NCT00622440|4079516|P2|Baseline - Week 12 (Treatment)|Received cream but did not return|1
1243635|NCT00622440|4079517|P1|Baseline - Week 12 (Treatment)|Received cream but did not return|4
1243636|NCT00622401|4079543|P3|Overall Study|Disease progression prior to treatment|0
1243637|NCT00622401|4079544|P2|Overall Study|Disease progression prior to treatment|2
1243638|NCT00622401|4079545|P1|Overall Study|Disease progression prior to treatment|3
1243639|NCT00622388|4079552|P1|Overall Study|Insurance Expired|1
1243640|NCT00622388|4079552|P1|Overall Study|Withdrew Consent|1
1243641|NCT00622388|4079552|P1|Overall Study|Took Prohibited Medication|2
1243642|NCT00622388|4079552|P1|Overall Study|Received Alternate Anticancer Therapy|8
1243643|NCT00622388|4079552|P1|Overall Study|Death|3
1243644|NCT00622388|4079552|P1|Overall Study|Participant Refusal|1
1243645|NCT00622388|4079552|P1|Overall Study|Protocol Violation|3
1243646|NCT00622388|4079552|P1|Overall Study|Adverse Event|6
1243647|NCT00622388|4079552|P1|Overall Study|Disease Progression|47
1243648|NCT00622336|4079570|P1|Extension Phase|Other|9
1243649|NCT00622336|4079570|P1|Extension Phase|Lost to Follow-up|1
1243650|NCT00622336|4079570|P1|Extension Phase|Withdrawal by Subject|1
1243651|NCT00622336|4079570|P1|Extension Phase|Lack of therapeutic effect|2
1243652|NCT00622336|4079570|P1|Extension Phase|Progressive Disease|6
1243653|NCT00622336|4079570|P1|Extension Phase|Adverse Event|2
1243654|NCT00622336|4079570|P1|Treatment Phase|Lost to Follow-up|2
1243655|NCT00622336|4079570|P1|Treatment Phase|Withdrawal by Subject|13
1243656|NCT00622336|4079570|P1|Treatment Phase|Lack of therapeutic effect|13
1243657|NCT00622336|4079570|P1|Treatment Phase|Death|14
1243658|NCT00622336|4079570|P1|Treatment Phase|Other|40
1243659|NCT00622336|4079570|P1|Treatment Phase|Adverse Event|46
1243660|NCT00622336|4079570|P1|Treatment Phase|Progression of Disease|181
1243661|NCT00622284|4079581|P2|Overall Study|Other reason (not specified)|24
1243662|NCT00622284|4079582|P1|Overall Study|Other reason (not specified)|33
1243663|NCT00622284|4079581|P2|Overall Study|Withdrawal by Subject|24
1243664|NCT00622284|4079582|P1|Overall Study|Withdrawal by Subject|27
1243665|NCT00622284|4079581|P2|Overall Study|Lost to Follow-up|13
1243666|NCT00622284|4079582|P1|Overall Study|Lost to Follow-up|11
1243667|NCT00622284|4079581|P2|Overall Study|Protocol Violation|5
1243668|NCT00622284|4079582|P1|Overall Study|Protocol Violation|12
1243669|NCT00622284|4079581|P2|Overall Study|Adverse Event|90
1243670|NCT00622284|4079582|P1|Overall Study|Adverse Event|61
1243671|NCT00622284|4079581|P2|Overall Study|Lack of Efficacy|15
1243672|NCT00622284|4079582|P1|Overall Study|Lack of Efficacy|45
1243673|NCT00622167|4079644|P1|Overall Study|Did not meet angiographic criteria|20
1243674|NCT00621985|4079648|P1|Dexamethasone Admission|Adverse Event|1
1243675|NCT00621959|4079656|P2|Overall Study|Other|3
1243676|NCT00621959|4079657|P1|Overall Study|Other|1
1243677|NCT00621959|4079656|P2|Overall Study|Withdrawal by Subject|1
1243678|NCT00621959|4079657|P1|Overall Study|Withdrawal by Subject|1
1243679|NCT00621959|4079656|P2|Overall Study|Lost to Follow-up|2
1243680|NCT00621959|4079657|P1|Overall Study|Lost to Follow-up|0
1243681|NCT00621959|4079656|P2|Overall Study|Lack of Efficacy|1
1243682|NCT00621959|4079657|P1|Overall Study|Lack of Efficacy|1
1243683|NCT00621959|4079656|P2|Overall Study|Adverse Event|2
1243684|NCT00621959|4079657|P1|Overall Study|Adverse Event|4
1243685|NCT00621855|4079696|P5|Overall Study|Patients did not receive study drug|2
1243686|NCT00621855|4079697|P4|Overall Study|Patients did not receive study drug|4
1243687|NCT00621855|4079698|P3|Overall Study|Patients did not receive study drug|5
1243688|NCT00621855|4079699|P2|Overall Study|Patients did not receive study drug|3
1243689|NCT00621855|4079700|P1|Overall Study|Patients did not receive study drug|3
1243690|NCT00621855|4079696|P5|Overall Study|Other|4
1243691|NCT00621855|4079697|P4|Overall Study|Other|5
1243692|NCT00621855|4079698|P3|Overall Study|Other|6
1243693|NCT00621855|4079699|P2|Overall Study|Other|7
1243694|NCT00621855|4079700|P1|Overall Study|Other|9
1243695|NCT00621855|4079696|P5|Overall Study|Withdrawal by Subject|9
1243696|NCT00621855|4079697|P4|Overall Study|Withdrawal by Subject|13
1243697|NCT00621855|4079698|P3|Overall Study|Withdrawal by Subject|13
1243698|NCT00621855|4079699|P2|Overall Study|Withdrawal by Subject|11
1243699|NCT00621855|4079700|P1|Overall Study|Withdrawal by Subject|16
1243700|NCT00621855|4079696|P5|Overall Study|Protocol Violation|8
1243701|NCT00621855|4079697|P4|Overall Study|Protocol Violation|7
1243702|NCT00621855|4079698|P3|Overall Study|Protocol Violation|6
1243703|NCT00621855|4079699|P2|Overall Study|Protocol Violation|8
1243704|NCT00621855|4079700|P1|Overall Study|Protocol Violation|16
1243705|NCT00621855|4079696|P5|Overall Study|Lost to Follow-up|1
1243706|NCT00621855|4079697|P4|Overall Study|Lost to Follow-up|4
1243707|NCT00621855|4079698|P3|Overall Study|Lost to Follow-up|3
1243708|NCT00621855|4079699|P2|Overall Study|Lost to Follow-up|1
1243709|NCT00621855|4079700|P1|Overall Study|Lost to Follow-up|0
1243710|NCT00621855|4079696|P5|Overall Study|Adverse Event|31
1243711|NCT00621855|4079697|P4|Overall Study|Adverse Event|34
1243712|NCT00621855|4079698|P3|Overall Study|Adverse Event|48
1243713|NCT00621855|4079699|P2|Overall Study|Adverse Event|31
1243714|NCT00621855|4079700|P1|Overall Study|Adverse Event|32
1243715|NCT00621842|4079742|P1|Overall Study|Lack of Efficacy|2
1243716|NCT00621842|4079742|P1|Overall Study|Protocol Violation|4
1243717|NCT00621842|4079742|P1|Overall Study|Withdrawal by Subject|7
1243718|NCT00621842|4079742|P1|Overall Study|Adverse Event|6
1243719|NCT00621777|4079759|P2|Randomized Phase|Death|1
1243720|NCT00621777|4079760|P1|Randomized Phase|Death|0
1243721|NCT00621777|4079759|P2|Randomized Phase|administrative|3
1243722|NCT00621777|4079760|P1|Randomized Phase|administrative|0
1243723|NCT00621777|4079759|P2|Randomized Phase|Withdrawal by Subject|9
1243724|NCT00621777|4079760|P1|Randomized Phase|Withdrawal by Subject|1
1243725|NCT00621777|4079759|P2|Randomized Phase|Lost to Follow-up|3
1243726|NCT00621777|4079760|P1|Randomized Phase|Lost to Follow-up|3
1243727|NCT00621777|4079759|P2|Randomized Phase|Adverse Event|3
1243728|NCT00621777|4079760|P1|Randomized Phase|Adverse Event|3
1243729|NCT00621777|4079759|P2|Open Phase|Lost to Follow-up|0
1243730|NCT00621777|4079760|P1|Open Phase|Lost to Follow-up|10
1243731|NCT00621777|4079759|P2|Open Phase|administrative|0
1243732|NCT00621777|4079760|P1|Open Phase|administrative|13
1243733|NCT00621777|4079759|P2|Open Phase|Withdrawal by Subject|0
1243734|NCT00621777|4079760|P1|Open Phase|Withdrawal by Subject|17
1243735|NCT00621777|4079759|P2|Open Phase|Did not abstain during open phase|0
1243736|NCT00621777|4079760|P1|Open Phase|Did not abstain during open phase|56
1243737|NCT00621777|4079759|P2|Open Phase|Adverse Event|0
1243738|NCT00621777|4079760|P1|Open Phase|Adverse Event|20
1243739|NCT00621764|4079775|P4|Overall Study|Protocol Violation|1
1243740|NCT00621764|4079776|P3|Overall Study|Protocol Violation|0
1243741|NCT00621764|4079777|P2|Overall Study|Protocol Violation|0
1243742|NCT00621764|4079778|P1|Overall Study|Protocol Violation|0
1243743|NCT00621621|4079824|P2|Overall Study|Subjects were exited at EP study|0
1243744|NCT00621621|4079825|P1|Overall Study|Subjects were exited at EP study|30
1243745|NCT00621582|4079833|P1|Overall Study|issues not identified by investigators|18
1243746|NCT00621582|4079833|P1|Overall Study|Lost to Follow-up|24
1243747|NCT00621582|4079833|P1|Overall Study|Protocol Violation|57
1243748|NCT00621582|4079833|P1|Overall Study|Adverse Event|7
1243749|NCT00621543|4079840|P1|Overall Study|Lost to Follow-up|23
1243750|NCT00621517|4079864|P2|Overall Study|Adverse Event|0
1243751|NCT00621517|4079865|P1|Overall Study|Adverse Event|1
1243752|NCT00621517|4079864|P2|Overall Study|Withdrawal by Subject|4
1243753|NCT00621517|4079865|P1|Overall Study|Withdrawal by Subject|3
1243754|NCT00621517|4079864|P2|Overall Study|Lost to Follow-up|3
1243755|NCT00621517|4079865|P1|Overall Study|Lost to Follow-up|3
1243756|NCT00621504|4079873|P2|Overall Study|Death|6
1243757|NCT00621504|4079874|P1|Overall Study|Death|6
1243758|NCT00621504|4079873|P2|Overall Study|Other|0
1243759|NCT00621504|4079874|P1|Overall Study|Other|1
1243760|NCT00621504|4079873|P2|Overall Study|Lost to Follow-up|10
1243761|NCT00621504|4079874|P1|Overall Study|Lost to Follow-up|8
1243762|NCT00621504|4079873|P2|Overall Study|Withdrew consent|6
1243763|NCT00621504|4079874|P1|Overall Study|Withdrew consent|9
1243764|NCT00621504|4079873|P2|Overall Study|At the request of sponsor/investigator|0
1243765|NCT00621504|4079874|P1|Overall Study|At the request of sponsor/investigator|1
1243766|NCT00621504|4079873|P2|Overall Study|Adverse Event|3
1243767|NCT00621504|4079874|P1|Overall Study|Adverse Event|1
1243768|NCT00621322|4079908|P6|Overall Study|Migrated/moved from study area|2
1243769|NCT00621322|4079909|P5|Overall Study|Migrated/moved from study area|0
1243770|NCT00621322|4079910|P4|Overall Study|Migrated/moved from study area|1
1243771|NCT00621322|4079911|P3|Overall Study|Migrated/moved from study area|1
1243772|NCT00621322|4079912|P2|Overall Study|Migrated/moved from study area|0
1243773|NCT00621322|4079913|P1|Overall Study|Migrated/moved from study area|1
1243774|NCT00621322|4079908|P6|Overall Study|Withdrawal by Subject|2
1243775|NCT00621322|4079909|P5|Overall Study|Withdrawal by Subject|0
1243776|NCT00621322|4079910|P4|Overall Study|Withdrawal by Subject|1
1243777|NCT00621322|4079911|P3|Overall Study|Withdrawal by Subject|0
1243778|NCT00621322|4079912|P2|Overall Study|Withdrawal by Subject|0
1243779|NCT00621322|4079913|P1|Overall Study|Withdrawal by Subject|0
1243780|NCT00621322|4079908|P6|Overall Study|Physician Decision|0
1243781|NCT00621322|4079909|P5|Overall Study|Physician Decision|0
1243782|NCT00621322|4079910|P4|Overall Study|Physician Decision|1
1243783|NCT00621322|4079911|P3|Overall Study|Physician Decision|1
1243784|NCT00621322|4079912|P2|Overall Study|Physician Decision|0
1243785|NCT00621322|4079913|P1|Overall Study|Physician Decision|0
1243786|NCT00621322|4079908|P6|Overall Study|Lost to Follow-up|0
1243787|NCT00621322|4079909|P5|Overall Study|Lost to Follow-up|1
1243788|NCT00621322|4079910|P4|Overall Study|Lost to Follow-up|0
1243789|NCT00621322|4079911|P3|Overall Study|Lost to Follow-up|0
1243790|NCT00621322|4079912|P2|Overall Study|Lost to Follow-up|0
1243791|NCT00621322|4079913|P1|Overall Study|Lost to Follow-up|0
1243792|NCT00621296|4079993|P1|Overall Study|Stopping Criteria|3
1243793|NCT00621296|4079993|P1|Overall Study|Unmatch Criteria|1
1243794|NCT00621296|4079993|P1|Overall Study|Physician Decision|7
1243795|NCT00621296|4079993|P1|Overall Study|Lack of Efficacy|1
1243796|NCT00621296|4079993|P1|Overall Study|Adverse Event|2
1243797|NCT00621257|4080002|P5|Overall Study|Withdrawal by Subject|1
1243798|NCT00621257|4080003|P4|Overall Study|Withdrawal by Subject|1
1243799|NCT00621257|4080004|P3|Overall Study|Withdrawal by Subject|0
1243800|NCT00621257|4080005|P2|Overall Study|Withdrawal by Subject|0
1243801|NCT00621257|4080006|P1|Overall Study|Withdrawal by Subject|0
1243802|NCT00621257|4080002|P5|Overall Study|Physician Decision|1
1243803|NCT00621257|4080003|P4|Overall Study|Physician Decision|1
1243804|NCT00621257|4080004|P3|Overall Study|Physician Decision|0
1243805|NCT00621257|4080005|P2|Overall Study|Physician Decision|2
1243806|NCT00621257|4080006|P1|Overall Study|Physician Decision|0
1243807|NCT00621257|4080002|P5|Overall Study|Adverse Event|0
1243808|NCT00621257|4080003|P4|Overall Study|Adverse Event|0
1243809|NCT00621257|4080004|P3|Overall Study|Adverse Event|1
1243810|NCT00621257|4080005|P2|Overall Study|Adverse Event|1
1243811|NCT00621257|4080006|P1|Overall Study|Adverse Event|0
1243812|NCT00621257|4080002|P5|Overall Study|Lost to Follow-up|7
1243813|NCT00621257|4080003|P4|Overall Study|Lost to Follow-up|4
1243814|NCT00621257|4080004|P3|Overall Study|Lost to Follow-up|2
1243815|NCT00621257|4080005|P2|Overall Study|Lost to Follow-up|0
1243816|NCT00621257|4080006|P1|Overall Study|Lost to Follow-up|4
1243817|NCT00621244|4080022|P4|Overall Study|Administrative problems|2
1243818|NCT00621244|4080023|P3|Overall Study|Administrative problems|0
1243819|NCT00621244|4080024|P2|Overall Study|Administrative problems|1
1243820|NCT00621244|4080025|P1|Overall Study|Administrative problems|5
1243821|NCT00621244|4080022|P4|Overall Study|Adverse Event|2
1243822|NCT00621244|4080023|P3|Overall Study|Adverse Event|9
1243823|NCT00621244|4080024|P2|Overall Study|Adverse Event|7
1243824|NCT00621244|4080025|P1|Overall Study|Adverse Event|27
1243825|NCT00621244|4080022|P4|Overall Study|Death|1
1243826|NCT00621244|4080023|P3|Overall Study|Death|1
1243827|NCT00621244|4080024|P2|Overall Study|Death|3
1243828|NCT00621244|4080025|P1|Overall Study|Death|3
1243829|NCT00621244|4080022|P4|Overall Study|Disease progression|15
1243830|NCT00621244|4080023|P3|Overall Study|Disease progression|20
1243831|NCT00621244|4080024|P2|Overall Study|Disease progression|20
1243832|NCT00621244|4080025|P1|Overall Study|Disease progression|44
1243833|NCT00621244|4080022|P4|Overall Study|Withdrawal by Subject|3
1243834|NCT00621244|4080023|P3|Overall Study|Withdrawal by Subject|3
1243835|NCT00621244|4080024|P2|Overall Study|Withdrawal by Subject|3
1243836|NCT00621244|4080025|P1|Overall Study|Withdrawal by Subject|7
1243837|NCT00621192|4080129|P4|Overall Study|Final Assessments not Completed|1
1243838|NCT00621192|4080130|P3|Overall Study|Final Assessments not Completed|3
1243839|NCT00621192|4080131|P2|Overall Study|Final Assessments not Completed|0
1243840|NCT00621192|4080132|P1|Overall Study|Final Assessments not Completed|0
1243841|NCT00621192|4080129|P4|Overall Study|Death|0
1243842|NCT00621192|4080130|P3|Overall Study|Death|0
1243843|NCT00621192|4080131|P2|Overall Study|Death|5
1243844|NCT00621192|4080132|P1|Overall Study|Death|2
1243845|NCT00621192|4080129|P4|Overall Study|Adverse Event|1
1243846|NCT00621192|4080130|P3|Overall Study|Adverse Event|0
1243847|NCT00621192|4080131|P2|Overall Study|Adverse Event|1
1243848|NCT00621192|4080132|P1|Overall Study|Adverse Event|0
1243849|NCT00621192|4080129|P4|Overall Study|Protocol Violation|1
1243850|NCT00621192|4080130|P3|Overall Study|Protocol Violation|0
1243851|NCT00621192|4080131|P2|Overall Study|Protocol Violation|0
1243852|NCT00621192|4080132|P1|Overall Study|Protocol Violation|1
1243853|NCT00621192|4080129|P4|Overall Study|Physician Decision|0
1243854|NCT00621192|4080130|P3|Overall Study|Physician Decision|0
1243855|NCT00621192|4080131|P2|Overall Study|Physician Decision|3
1243856|NCT00621192|4080132|P1|Overall Study|Physician Decision|1
1243857|NCT00621192|4080129|P4|Overall Study|Withdrawal by Subject|0
1243858|NCT00621192|4080130|P3|Overall Study|Withdrawal by Subject|2
1243859|NCT00621192|4080131|P2|Overall Study|Withdrawal by Subject|0
1243860|NCT00621192|4080132|P1|Overall Study|Withdrawal by Subject|0
1243861|NCT00621153|4080156|P2|Overall Study|Withdrawal by Subject|5
1243862|NCT00621153|4080157|P1|Overall Study|Withdrawal by Subject|4
1243863|NCT00621153|4080156|P2|Overall Study|Lost to Follow-up|1
1243864|NCT00621153|4080157|P1|Overall Study|Lost to Follow-up|5
1243865|NCT00621153|4080156|P2|Overall Study|Adverse Event|2
1243866|NCT00621153|4080157|P1|Overall Study|Adverse Event|3
1243867|NCT00621153|4080156|P2|Overall Study|Safety Reason|7
1243868|NCT00621153|4080157|P1|Overall Study|Safety Reason|8
1243869|NCT00621140|4080165|P2|Overall Study|Other incl. lack of efficacy|5
1243870|NCT00621140|4080166|P1|Overall Study|Other incl. lack of efficacy|6
1243871|NCT00621140|4080165|P2|Overall Study|Withdrawal by Subject|6
1243872|NCT00621140|4080166|P1|Overall Study|Withdrawal by Subject|4
1243873|NCT00621140|4080165|P2|Overall Study|Lost to Follow-up|2
1243874|NCT00621140|4080166|P1|Overall Study|Lost to Follow-up|1
1243875|NCT00621140|4080165|P2|Overall Study|Adverse Event|5
1243876|NCT00621140|4080166|P1|Overall Study|Adverse Event|4
1243877|NCT00621023|4080213|P1|Overall Study|Follow up discontinued|1
1243878|NCT00621023|4080213|P1|Overall Study|Death|5
1243879|NCT00620854|4080230|P6|Washout 1|Withdrawal by Subject|0
1243880|NCT00620854|4080231|P5|Washout 1|Withdrawal by Subject|0
1243881|NCT00620854|4080232|P4|Washout 1|Withdrawal by Subject|1
1243882|NCT00620854|4080233|P3|Washout 1|Withdrawal by Subject|1
1243883|NCT00620854|4080234|P2|Washout 1|Withdrawal by Subject|0
1243884|NCT00620854|4080235|P1|Washout 1|Withdrawal by Subject|0
1243885|NCT00620815|4080266|P3|Overall Study|Protocol Violation|1
1243886|NCT00620815|4080267|P2|Overall Study|Protocol Violation|2
1243887|NCT00620815|4080268|P1|Overall Study|Protocol Violation|1
1243888|NCT00620815|4080266|P3|Overall Study|Inappropriate enrolment|1
1243889|NCT00620815|4080267|P2|Overall Study|Inappropriate enrolment|0
1243890|NCT00620815|4080268|P1|Overall Study|Inappropriate enrolment|0
1243891|NCT00620815|4080266|P3|Overall Study|Lost to Follow-up|3
1243892|NCT00620815|4080267|P2|Overall Study|Lost to Follow-up|6
1243893|NCT00620815|4080268|P1|Overall Study|Lost to Follow-up|1
1243894|NCT00620815|4080266|P3|Overall Study|Withdrawal by Subject|0
1243895|NCT00620815|4080267|P2|Overall Study|Withdrawal by Subject|2
1243896|NCT00620815|4080268|P1|Overall Study|Withdrawal by Subject|1
1243897|NCT00620815|4080266|P3|Overall Study|Adverse Event|2
1243898|NCT00620815|4080267|P2|Overall Study|Adverse Event|1
1243899|NCT00620815|4080268|P1|Overall Study|Adverse Event|1
1243900|NCT00620776|4080308|P2|Overall Study|Withdrawal by Subject|2
1243901|NCT00620776|4080309|P1|Overall Study|Withdrawal by Subject|3
1243902|NCT00620776|4080308|P2|Overall Study|Lost to Follow-up|5
1243903|NCT00620776|4080309|P1|Overall Study|Lost to Follow-up|2
1243904|NCT00620776|4080308|P2|Overall Study|Lack of Efficacy|1
1243905|NCT00620776|4080309|P1|Overall Study|Lack of Efficacy|2
1243906|NCT00620776|4080308|P2|Overall Study|Adverse Event|3
1243907|NCT00620776|4080309|P1|Overall Study|Adverse Event|2
1243908|NCT00620776|4080308|P2|Overall Study|Did not receive treatment|5
1243909|NCT00620776|4080309|P1|Overall Study|Did not receive treatment|3
1243910|NCT00620763|4080337|P2|Period: Second Intervention|Withdrawal by Subject|0
1243911|NCT00620763|4080338|P1|Period: Second Intervention|Withdrawal by Subject|1
1243912|NCT00620763|4080337|P2|Period: First Intervention|Protocol Violation|3
1243913|NCT00620763|4080338|P1|Period: First Intervention|Protocol Violation|0
1243914|NCT00620763|4080337|P2|Period: First Intervention|Withdrawal by Subject|2
1243915|NCT00620763|4080338|P1|Period: First Intervention|Withdrawal by Subject|0
1243916|NCT00620750|4080344|P1|Overall Study|Lost to Follow-up|25
1243917|NCT00620659|4080359|P6|Treatment Period 3|Withdrawal by Subject|0
1243918|NCT00620659|4080360|P5|Treatment Period 3|Withdrawal by Subject|0
1243919|NCT00620659|4080361|P4|Treatment Period 3|Withdrawal by Subject|1
1243920|NCT00620659|4080362|P3|Treatment Period 3|Withdrawal by Subject|0
1243921|NCT00620659|4080363|P2|Treatment Period 3|Withdrawal by Subject|0
1243922|NCT00620659|4080364|P1|Treatment Period 3|Withdrawal by Subject|0
1243923|NCT00620659|4080359|P6|Treatment Period 3|Adverse Event|0
1243924|NCT00620659|4080360|P5|Treatment Period 3|Adverse Event|0
1243925|NCT00620659|4080361|P4|Treatment Period 3|Adverse Event|0
1243926|NCT00620659|4080362|P3|Treatment Period 3|Adverse Event|0
1243927|NCT00620659|4080363|P2|Treatment Period 3|Adverse Event|2
1243928|NCT00620659|4080364|P1|Treatment Period 3|Adverse Event|0
1243929|NCT00620659|4080359|P6|Placebo Washout Period 2|Adverse Event|0
1243930|NCT00620659|4080360|P5|Placebo Washout Period 2|Adverse Event|0
1243931|NCT00620659|4080361|P4|Placebo Washout Period 2|Adverse Event|0
1243932|NCT00620659|4080362|P3|Placebo Washout Period 2|Adverse Event|0
1243933|NCT00620659|4080363|P2|Placebo Washout Period 2|Adverse Event|0
1243934|NCT00620659|4080364|P1|Placebo Washout Period 2|Adverse Event|2
1243935|NCT00620659|4080359|P6|Treatment Period 2|Withdrawal by Subject|0
1243936|NCT00620659|4080360|P5|Treatment Period 2|Withdrawal by Subject|3
1243937|NCT00620659|4080361|P4|Treatment Period 2|Withdrawal by Subject|0
1243938|NCT00620659|4080362|P3|Treatment Period 2|Withdrawal by Subject|1
1243939|NCT00620659|4080363|P2|Treatment Period 2|Withdrawal by Subject|0
1243940|NCT00620659|4080364|P1|Treatment Period 2|Withdrawal by Subject|0
1243941|NCT00620659|4080359|P6|Treatment Period 2|Adverse Event|0
1243942|NCT00620659|4080360|P5|Treatment Period 2|Adverse Event|2
1243943|NCT00620659|4080361|P4|Treatment Period 2|Adverse Event|0
1243944|NCT00620659|4080362|P3|Treatment Period 2|Adverse Event|0
1243945|NCT00620659|4080363|P2|Treatment Period 2|Adverse Event|3
1243946|NCT00620659|4080364|P1|Treatment Period 2|Adverse Event|0
1243947|NCT00620659|4080359|P6|Placebo Washout Period 1|Withdrawal by Subject|0
1243948|NCT00620659|4080360|P5|Placebo Washout Period 1|Withdrawal by Subject|0
1243949|NCT00620659|4080361|P4|Placebo Washout Period 1|Withdrawal by Subject|1
1243950|NCT00620659|4080362|P3|Placebo Washout Period 1|Withdrawal by Subject|0
1243951|NCT00620659|4080363|P2|Placebo Washout Period 1|Withdrawal by Subject|0
1243952|NCT00620659|4080364|P1|Placebo Washout Period 1|Withdrawal by Subject|0
1243953|NCT00620659|4080359|P6|Treatment Period 1|Withdrawal by Subject|0
1243954|NCT00620659|4080360|P5|Treatment Period 1|Withdrawal by Subject|1
1243955|NCT00620659|4080361|P4|Treatment Period 1|Withdrawal by Subject|0
1243956|NCT00620659|4080362|P3|Treatment Period 1|Withdrawal by Subject|1
1243957|NCT00620659|4080363|P2|Treatment Period 1|Withdrawal by Subject|0
1243958|NCT00620659|4080364|P1|Treatment Period 1|Withdrawal by Subject|1
1243959|NCT00620659|4080359|P6|Treatment Period 1|Protocol Violation|0
1243960|NCT00620659|4080360|P5|Treatment Period 1|Protocol Violation|0
1243961|NCT00620659|4080361|P4|Treatment Period 1|Protocol Violation|0
1243962|NCT00620659|4080362|P3|Treatment Period 1|Protocol Violation|0
1243963|NCT00620659|4080363|P2|Treatment Period 1|Protocol Violation|0
1243964|NCT00620659|4080364|P1|Treatment Period 1|Protocol Violation|1
1243965|NCT00620659|4080359|P6|Treatment Period 1|Adverse Event|0
1243966|NCT00620659|4080360|P5|Treatment Period 1|Adverse Event|0
1243967|NCT00620659|4080361|P4|Treatment Period 1|Adverse Event|3
1243968|NCT00620659|4080362|P3|Treatment Period 1|Adverse Event|0
1243969|NCT00620659|4080363|P2|Treatment Period 1|Adverse Event|0
1243970|NCT00620659|4080364|P1|Treatment Period 1|Adverse Event|1
1243971|NCT00620555|4080382|P1|Overall Study|Visit failure against planned|1
1243972|NCT00620555|4080382|P1|Overall Study|Choice of other treatment|1
1243973|NCT00620555|4080382|P1|Overall Study|Withdrawal by Subject|1
1243974|NCT00620555|4080382|P1|Overall Study|Lack of Efficacy|12
1243975|NCT00620555|4080382|P1|Overall Study|Protocol Violation|2
1243976|NCT00620555|4080382|P1|Overall Study|Adverse Event|4
1243977|NCT00620542|4080391|P4|Part B (2 Year Core Study)|IVUS not available|2
1243978|NCT00620542|4080392|P3|Part B (2 Year Core Study)|IVUS not available|3
1243979|NCT00620542|4080393|P2|Part B (2 Year Core Study)|IVUS not available|0
1243980|NCT00620542|4080394|P1|Part B (2 Year Core Study)|IVUS not available|0
1243981|NCT00620542|4080391|P4|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
1243982|NCT00620542|4080392|P3|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
1243983|NCT00620542|4080393|P2|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
1243984|NCT00620542|4080394|P1|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
1243985|NCT00620542|4080391|P4|Part B (2 Year Core Study)|Safety reasons|3
1243986|NCT00620542|4080392|P3|Part B (2 Year Core Study)|Safety reasons|2
1243987|NCT00620542|4080393|P2|Part B (2 Year Core Study)|Safety reasons|0
1243988|NCT00620542|4080394|P1|Part B (2 Year Core Study)|Safety reasons|0
1243989|NCT00620542|4080391|P4|Part B (2 Year Core Study)|Protocol Violation|16
1243990|NCT00620542|4080392|P3|Part B (2 Year Core Study)|Protocol Violation|13
1243991|NCT00620542|4080393|P2|Part B (2 Year Core Study)|Protocol Violation|0
1243992|NCT00620542|4080394|P1|Part B (2 Year Core Study)|Protocol Violation|0
1243993|NCT00620542|4080391|P4|Part B (2 Year Core Study)|Lost to Follow-up|9
1243994|NCT00620542|4080392|P3|Part B (2 Year Core Study)|Lost to Follow-up|20
1243995|NCT00620542|4080393|P2|Part B (2 Year Core Study)|Lost to Follow-up|0
1243996|NCT00620542|4080394|P1|Part B (2 Year Core Study)|Lost to Follow-up|0
1243997|NCT00620542|4080391|P4|Part B (2 Year Core Study)|Withdrawal by Subject|54
1243998|NCT00620542|4080392|P3|Part B (2 Year Core Study)|Withdrawal by Subject|55
1243999|NCT00620542|4080393|P2|Part B (2 Year Core Study)|Withdrawal by Subject|0
1244000|NCT00620542|4080394|P1|Part B (2 Year Core Study)|Withdrawal by Subject|0
1244001|NCT00620542|4080391|P4|Part B (2 Year Core Study)|Protocol Violation|5
1244002|NCT00620542|4080392|P3|Part B (2 Year Core Study)|Protocol Violation|3
1244003|NCT00620542|4080393|P2|Part B (2 Year Core Study)|Protocol Violation|0
1244004|NCT00620542|4080394|P1|Part B (2 Year Core Study)|Protocol Violation|0
1244005|NCT00620542|4080391|P4|Part B (2 Year Core Study)|Adverse Event|49
1244006|NCT00620542|4080392|P3|Part B (2 Year Core Study)|Adverse Event|46
1244007|NCT00620542|4080393|P2|Part B (2 Year Core Study)|Adverse Event|0
1244008|NCT00620542|4080394|P1|Part B (2 Year Core Study)|Adverse Event|0
1244009|NCT00620542|4080391|P4|Part A (Run-in - 2 Weeks)|IVUS not available|0
1244010|NCT00620542|4080392|P3|Part A (Run-in - 2 Weeks)|IVUS not available|0
1244011|NCT00620542|4080393|P2|Part A (Run-in - 2 Weeks)|IVUS not available|4
1244012|NCT00620542|4080394|P1|Part A (Run-in - 2 Weeks)|IVUS not available|4
1244013|NCT00620542|4080391|P4|Part A (Run-in - 2 Weeks)|Safety reasons|0
1244014|NCT00620542|4080392|P3|Part A (Run-in - 2 Weeks)|Safety reasons|0
1244015|NCT00620542|4080393|P2|Part A (Run-in - 2 Weeks)|Safety reasons|1
1244016|NCT00620542|4080394|P1|Part A (Run-in - 2 Weeks)|Safety reasons|0
1244017|NCT00620542|4080391|P4|Part A (Run-in - 2 Weeks)|Protocol Violation|0
1244018|NCT00620542|4080392|P3|Part A (Run-in - 2 Weeks)|Protocol Violation|0
1244019|NCT00620542|4080393|P2|Part A (Run-in - 2 Weeks)|Protocol Violation|1
1244020|NCT00620542|4080394|P1|Part A (Run-in - 2 Weeks)|Protocol Violation|0
1244021|NCT00620542|4080391|P4|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
1244022|NCT00620542|4080392|P3|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
1244023|NCT00620542|4080393|P2|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6
1244024|NCT00620542|4080394|P1|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7
1244025|NCT00620542|4080391|P4|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
1244026|NCT00620542|4080392|P3|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
1244027|NCT00620542|4080393|P2|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40
1244028|NCT00620542|4080394|P1|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43
1244029|NCT00620542|4080391|P4|Part A (Run-in - 2 Weeks)|Protocol Violation|0
1244030|NCT00620542|4080392|P3|Part A (Run-in - 2 Weeks)|Protocol Violation|0
1244031|NCT00620542|4080393|P2|Part A (Run-in - 2 Weeks)|Protocol Violation|409
1244032|NCT00620542|4080394|P1|Part A (Run-in - 2 Weeks)|Protocol Violation|406
1244033|NCT00620542|4080391|P4|Part A (Run-in - 2 Weeks)|Adverse Event|0
1244034|NCT00620542|4080392|P3|Part A (Run-in - 2 Weeks)|Adverse Event|0
1244035|NCT00620542|4080393|P2|Part A (Run-in - 2 Weeks)|Adverse Event|15
1244036|NCT00620542|4080394|P1|Part A (Run-in - 2 Weeks)|Adverse Event|12
1244037|NCT00620464|4080434|P2|Overall Study|Used prohibited medication|0
1244038|NCT00620464|4080435|P1|Overall Study|Used prohibited medication|1
1244039|NCT00620464|4080434|P2|Overall Study|Personal|2
1244040|NCT00620464|4080435|P1|Overall Study|Personal|2
1244041|NCT00620464|4080434|P2|Overall Study|Planning Pregnancy|4
1244042|NCT00620464|4080435|P1|Overall Study|Planning Pregnancy|1
1244043|NCT00620464|4080434|P2|Overall Study|Lost to Follow-up|1
1244044|NCT00620464|4080435|P1|Overall Study|Lost to Follow-up|1
1244045|NCT00620464|4080434|P2|Overall Study|Adverse Event|17
1244046|NCT00620464|4080435|P1|Overall Study|Adverse Event|15
1244047|NCT00620373|4080454|P1|Overall Study|Unverified cancer status|33
1244048|NCT00620282|4080473|P3|Overall Study|Withdrawal by Subject|0
1244049|NCT00620282|4080474|P2|Overall Study|Withdrawal by Subject|1
1244050|NCT00620282|4080475|P1|Overall Study|Withdrawal by Subject|0
1244051|NCT00620282|4080473|P3|Overall Study|Arterial line unable to be placed|1
1244052|NCT00620282|4080474|P2|Overall Study|Arterial line unable to be placed|0
1244053|NCT00620282|4080475|P1|Overall Study|Arterial line unable to be placed|0
1244054|NCT00620282|4080473|P3|Overall Study|Adverse Event|0
1244055|NCT00620282|4080474|P2|Overall Study|Adverse Event|1
1244056|NCT00620282|4080475|P1|Overall Study|Adverse Event|0
1244057|NCT00620113|4080539|P4|Overall Study|Withdrawal by Subject|5
1244058|NCT00620113|4080540|P3|Overall Study|Withdrawal by Subject|3
1244059|NCT00620113|4080541|P2|Overall Study|Withdrawal by Subject|1
1244060|NCT00620113|4080542|P1|Overall Study|Withdrawal by Subject|5
1244061|NCT00620113|4080539|P4|Overall Study|Protocol Violation|0
1244062|NCT00620113|4080540|P3|Overall Study|Protocol Violation|0
1244063|NCT00620113|4080541|P2|Overall Study|Protocol Violation|1
1244064|NCT00620113|4080542|P1|Overall Study|Protocol Violation|2
1244065|NCT00620113|4080539|P4|Overall Study|Physician Decision|2
1244066|NCT00620113|4080540|P3|Overall Study|Physician Decision|0
1244067|NCT00620113|4080541|P2|Overall Study|Physician Decision|0
1244068|NCT00620113|4080542|P1|Overall Study|Physician Decision|1
1244069|NCT00620113|4080539|P4|Overall Study|Lack of Efficacy|2
1244070|NCT00620113|4080540|P3|Overall Study|Lack of Efficacy|0
1244071|NCT00620113|4080541|P2|Overall Study|Lack of Efficacy|3
1244072|NCT00620113|4080542|P1|Overall Study|Lack of Efficacy|2
1244073|NCT00620113|4080539|P4|Overall Study|Adverse Event|1
1244074|NCT00620113|4080540|P3|Overall Study|Adverse Event|2
1244075|NCT00620113|4080541|P2|Overall Study|Adverse Event|2
1244076|NCT00620113|4080542|P1|Overall Study|Adverse Event|3
1244077|NCT00620074|4080592|P1|Overall Study|Adverse Event|1
1244078|NCT00620035|4080600|P1|Overall Study|Other Reason|38
1244079|NCT00620035|4080600|P1|Overall Study|Withdrawal of Informed Consent|1
1244080|NCT00620035|4080600|P1|Overall Study|Adverse Event|106
1244081|NCT00620022|4080610|P2|Treatment Period 2|Adverse Event|2
1244082|NCT00620022|4080611|P1|Treatment Period 2|Adverse Event|2
1244083|NCT00620022|4080610|P2|Treatment Period 1|Subject withdrew consent|0
1244084|NCT00620022|4080611|P1|Treatment Period 1|Subject withdrew consent|1
1244085|NCT00620022|4080610|P2|Treatment Period 1|Adverse Event|6
1244086|NCT00620022|4080611|P1|Treatment Period 1|Adverse Event|4
1244087|NCT00619983|4080623|P4|Test Drug Alone|Failure of daily diary device|2
1244088|NCT00619983|4080624|P3|Test Drug Alone|Failure of daily diary device|2
1244089|NCT00619983|4080625|P2|Test Drug Alone|Failure of daily diary device|1
1244090|NCT00619983|4080626|P1|Test Drug Alone|Failure of daily diary device|1
1244091|NCT00619983|4080623|P4|Test Drug Alone|Withdrawal by Subject|1
1244092|NCT00619983|4080624|P3|Test Drug Alone|Withdrawal by Subject|0
1244093|NCT00619983|4080625|P2|Test Drug Alone|Withdrawal by Subject|0
1244094|NCT00619983|4080626|P1|Test Drug Alone|Withdrawal by Subject|1
1244095|NCT00619957|4080653|P2|Month 48 Open-Label|Withdrawal by Subject|9
1244096|NCT00619957|4080654|P1|Month 48 Open-Label|Withdrawal by Subject|6
1244097|NCT00619957|4080653|P2|Month 48 Open-Label|Lost to Follow-up|4
1244098|NCT00619957|4080654|P1|Month 48 Open-Label|Lost to Follow-up|2
1244099|NCT00619957|4080653|P2|Month 48 Open-Label|Adverse Event|4
1244100|NCT00619957|4080654|P1|Month 48 Open-Label|Adverse Event|4
1244101|NCT00619957|4080653|P2|Month 24 Double-Blind|Did not take any study medication|1
1244102|NCT00619957|4080654|P1|Month 24 Double-Blind|Did not take any study medication|0
1244103|NCT00619957|4080653|P2|Month 24 Double-Blind|Lost to Follow-up|0
1244104|NCT00619957|4080654|P1|Month 24 Double-Blind|Lost to Follow-up|1
1244105|NCT00619957|4080653|P2|Month 24 Double-Blind|Withdrawal by Subject|9
1244106|NCT00619957|4080654|P1|Month 24 Double-Blind|Withdrawal by Subject|7
1244107|NCT00619957|4080653|P2|Month 24 Double-Blind|Protocol Violation|0
1244108|NCT00619957|4080654|P1|Month 24 Double-Blind|Protocol Violation|1
1244109|NCT00619957|4080653|P2|Month 24 Double-Blind|Adverse Event|7
1244110|NCT00619957|4080654|P1|Month 24 Double-Blind|Adverse Event|9
1244111|NCT00619918|4080736|P2|Overall Study|Left before receiving first dose|8
1244112|NCT00619918|4080737|P1|Overall Study|Left before receiving first dose|5
1244113|NCT00619918|4080736|P2|Overall Study|Transfer to outside facility|3
1244114|NCT00619918|4080737|P1|Overall Study|Transfer to outside facility|3
1244115|NCT00619918|4080736|P2|Overall Study|Physician Decision|8
1244116|NCT00619918|4080737|P1|Overall Study|Physician Decision|8
1244117|NCT00619918|4080736|P2|Overall Study|Withdrawal by Subject|3
1244118|NCT00619918|4080737|P1|Overall Study|Withdrawal by Subject|4
1244119|NCT00619892|4080747|P2|Overall Study|Intercurrent illness|1
1244120|NCT00619892|4080748|P1|Overall Study|Intercurrent illness|0
1244121|NCT00619892|4080747|P2|Overall Study|Lost to Follow-up|1
1244122|NCT00619892|4080748|P1|Overall Study|Lost to Follow-up|0
1244123|NCT00619892|4080747|P2|Overall Study|Adverse Event|0
1244124|NCT00619892|4080748|P1|Overall Study|Adverse Event|3
1244125|NCT00619866|4080759|P5|Weeks 13 - 24|Lost to Follow-up|0
1244126|NCT00619866|4080760|P4|Weeks 13 - 24|Lost to Follow-up|0
1244127|NCT00619866|4080761|P3|Weeks 13 - 24|Lost to Follow-up|0
1244128|NCT00619866|4080762|P2|Weeks 13 - 24|Lost to Follow-up|3
1244129|NCT00619866|4080763|P1|Weeks 13 - 24|Lost to Follow-up|0
1244130|NCT00619866|4080759|P5|Weeks 13 - 24|Non-compliance|0
1244131|NCT00619866|4080760|P4|Weeks 13 - 24|Non-compliance|0
1244132|NCT00619866|4080761|P3|Weeks 13 - 24|Non-compliance|1
1244133|NCT00619866|4080762|P2|Weeks 13 - 24|Non-compliance|1
1244134|NCT00619866|4080763|P1|Weeks 13 - 24|Non-compliance|0
1244135|NCT00619866|4080759|P5|Weeks 13 - 24|Withdrawal by Subject|2
1244136|NCT00619866|4080760|P4|Weeks 13 - 24|Withdrawal by Subject|2
1244137|NCT00619866|4080761|P3|Weeks 13 - 24|Withdrawal by Subject|2
1244138|NCT00619866|4080762|P2|Weeks 13 - 24|Withdrawal by Subject|3
1244139|NCT00619866|4080763|P1|Weeks 13 - 24|Withdrawal by Subject|0
1244140|NCT00619866|4080759|P5|Weeks 13 - 24|Protocol Deviation|0
1244141|NCT00619866|4080760|P4|Weeks 13 - 24|Protocol Deviation|1
1244142|NCT00619866|4080761|P3|Weeks 13 - 24|Protocol Deviation|0
1244143|NCT00619866|4080762|P2|Weeks 13 - 24|Protocol Deviation|0
1244144|NCT00619866|4080763|P1|Weeks 13 - 24|Protocol Deviation|0
1244145|NCT00619866|4080759|P5|Weeks 13 - 24|Adverse Event|0
1244146|NCT00619866|4080760|P4|Weeks 13 - 24|Adverse Event|1
1244147|NCT00619866|4080761|P3|Weeks 13 - 24|Adverse Event|2
1244148|NCT00619866|4080762|P2|Weeks 13 - 24|Adverse Event|0
1244149|NCT00619866|4080763|P1|Weeks 13 - 24|Adverse Event|0
1244150|NCT00619866|4080759|P5|Weeks 1 - 12|Sponsor Decision|0
1244151|NCT00619866|4080760|P4|Weeks 1 - 12|Sponsor Decision|0
1244152|NCT00619866|4080761|P3|Weeks 1 - 12|Sponsor Decision|0
1244153|NCT00619866|4080762|P2|Weeks 1 - 12|Sponsor Decision|1
1244154|NCT00619866|4080763|P1|Weeks 1 - 12|Sponsor Decision|0
1244155|NCT00619866|4080759|P5|Weeks 1 - 12|Lost to Follow-up|0
1244156|NCT00619866|4080760|P4|Weeks 1 - 12|Lost to Follow-up|0
1244157|NCT00619866|4080761|P3|Weeks 1 - 12|Lost to Follow-up|2
1244158|NCT00619866|4080762|P2|Weeks 1 - 12|Lost to Follow-up|0
1244159|NCT00619866|4080763|P1|Weeks 1 - 12|Lost to Follow-up|4
1244160|NCT00619866|4080759|P5|Weeks 1 - 12|Lack of Efficacy|0
1244161|NCT00619866|4080760|P4|Weeks 1 - 12|Lack of Efficacy|0
1244162|NCT00619866|4080761|P3|Weeks 1 - 12|Lack of Efficacy|1
1244163|NCT00619866|4080762|P2|Weeks 1 - 12|Lack of Efficacy|2
1244164|NCT00619866|4080763|P1|Weeks 1 - 12|Lack of Efficacy|3
1244165|NCT00619866|4080759|P5|Weeks 1 - 12|Withdrawal by Subject|0
1244166|NCT00619866|4080760|P4|Weeks 1 - 12|Withdrawal by Subject|0
1244167|NCT00619866|4080761|P3|Weeks 1 - 12|Withdrawal by Subject|4
1244168|NCT00619866|4080762|P2|Weeks 1 - 12|Withdrawal by Subject|2
1244169|NCT00619866|4080763|P1|Weeks 1 - 12|Withdrawal by Subject|7
1244170|NCT00619866|4080759|P5|Weeks 1 - 12|Non-compliance|0
1244171|NCT00619866|4080760|P4|Weeks 1 - 12|Non-compliance|0
1244172|NCT00619866|4080761|P3|Weeks 1 - 12|Non-compliance|1
1244173|NCT00619866|4080762|P2|Weeks 1 - 12|Non-compliance|0
1244174|NCT00619866|4080763|P1|Weeks 1 - 12|Non-compliance|0
1244175|NCT00619866|4080759|P5|Weeks 1 - 12|Adverse Event|0
1244176|NCT00619866|4080760|P4|Weeks 1 - 12|Adverse Event|0
1244177|NCT00619866|4080761|P3|Weeks 1 - 12|Adverse Event|2
1244178|NCT00619866|4080762|P2|Weeks 1 - 12|Adverse Event|1
1244179|NCT00619866|4080763|P1|Weeks 1 - 12|Adverse Event|0
1244180|NCT00619827|4080850|P2|Overall Study|Withdrawal by Subject|2
1244181|NCT00619827|4080851|P1|Overall Study|Withdrawal by Subject|2
1244182|NCT00619827|4080850|P2|Overall Study|Adverse Event|2
1244183|NCT00619827|4080851|P1|Overall Study|Adverse Event|1
1244184|NCT00619801|4080859|P2|Overall Study|Loss of efficacy|1
1244185|NCT00619801|4080860|P1|Overall Study|Loss of efficacy|0
1244186|NCT00619801|4080859|P2|Overall Study|Withdrawal by Subject|1
1244187|NCT00619801|4080860|P1|Overall Study|Withdrawal by Subject|1
1244188|NCT00619801|4080859|P2|Overall Study|Lack of Efficacy|1
1244189|NCT00619801|4080860|P1|Overall Study|Lack of Efficacy|0
1244190|NCT00619645|4080917|P1|Overall Study|Adverse Event|1
1244191|NCT00619619|4080931|P8|Overall Study|Adverse Event|2
1244192|NCT00619619|4080932|P7|Overall Study|Adverse Event|0
1244193|NCT00619619|4080933|P6|Overall Study|Adverse Event|0
1244194|NCT00619619|4080934|P5|Overall Study|Adverse Event|2
1244195|NCT00619619|4080935|P4|Overall Study|Adverse Event|0
1244196|NCT00619619|4080936|P3|Overall Study|Adverse Event|0
1244197|NCT00619619|4080937|P2|Overall Study|Adverse Event|0
1244198|NCT00619619|4080938|P1|Overall Study|Adverse Event|0
1244199|NCT00619619|4080931|P8|Overall Study|Protocol Violation|1
1244200|NCT00619619|4080932|P7|Overall Study|Protocol Violation|1
1244201|NCT00619619|4080933|P6|Overall Study|Protocol Violation|0
1244202|NCT00619619|4080934|P5|Overall Study|Protocol Violation|0
1244203|NCT00619619|4080935|P4|Overall Study|Protocol Violation|1
1244204|NCT00619619|4080936|P3|Overall Study|Protocol Violation|0
1244205|NCT00619619|4080937|P2|Overall Study|Protocol Violation|0
1244206|NCT00619619|4080938|P1|Overall Study|Protocol Violation|0
1244207|NCT00619619|4080931|P8|Overall Study|Physician Decision|0
1244208|NCT00619619|4080932|P7|Overall Study|Physician Decision|0
1244209|NCT00619619|4080933|P6|Overall Study|Physician Decision|0
1244210|NCT00619619|4080934|P5|Overall Study|Physician Decision|0
1244211|NCT00619619|4080935|P4|Overall Study|Physician Decision|0
1244212|NCT00619619|4080936|P3|Overall Study|Physician Decision|1
1244213|NCT00619619|4080937|P2|Overall Study|Physician Decision|0
1244214|NCT00619619|4080938|P1|Overall Study|Physician Decision|0
1244215|NCT00619502|4081025|P2|Overall Study|Lost to Follow-up|10
1244216|NCT00619502|4081026|P1|Overall Study|Lost to Follow-up|8
1244217|NCT00619489|4081038|P2|Overall Study|Rolled over to Study C13008 (NCT00790933|15
1244218|NCT00619489|4081039|P1|Overall Study|Rolled over to Study C13008 (NCT00790933|22
1244219|NCT00619489|4081038|P2|Overall Study|Lack of Efficacy|11
1244220|NCT00619489|4081039|P1|Overall Study|Lack of Efficacy|0
1244221|NCT00619489|4081038|P2|Overall Study|Withdrawal by Subject|1
1244222|NCT00619489|4081039|P1|Overall Study|Withdrawal by Subject|1
1244223|NCT00619489|4081038|P2|Overall Study|Adverse Event|7
1244224|NCT00619489|4081039|P1|Overall Study|Adverse Event|0
1244225|NCT00619476|4081061|P4|Overall Study|Withdrawal by Subject|4
1244226|NCT00619476|4081062|P3|Overall Study|Withdrawal by Subject|5
1244227|NCT00619476|4081063|P2|Overall Study|Withdrawal by Subject|7
1244228|NCT00619476|4081064|P1|Overall Study|Withdrawal by Subject|5
1244229|NCT00619476|4081061|P4|Overall Study|Investigator Discretion|0
1244230|NCT00619476|4081062|P3|Overall Study|Investigator Discretion|2
1244231|NCT00619476|4081063|P2|Overall Study|Investigator Discretion|2
1244232|NCT00619476|4081064|P1|Overall Study|Investigator Discretion|2
1244233|NCT00619476|4081061|P4|Overall Study|Lost to Follow-up|1
1244234|NCT00619476|4081062|P3|Overall Study|Lost to Follow-up|0
1244235|NCT00619476|4081063|P2|Overall Study|Lost to Follow-up|2
1244236|NCT00619476|4081064|P1|Overall Study|Lost to Follow-up|1
1244237|NCT00619476|4081061|P4|Overall Study|Protocol Violation|9
1244238|NCT00619476|4081062|P3|Overall Study|Protocol Violation|4
1244239|NCT00619476|4081063|P2|Overall Study|Protocol Violation|4
1244240|NCT00619476|4081064|P1|Overall Study|Protocol Violation|5
1244241|NCT00619476|4081061|P4|Overall Study|Lack of Efficacy|4
1244242|NCT00619476|4081062|P3|Overall Study|Lack of Efficacy|1
1244243|NCT00619476|4081063|P2|Overall Study|Lack of Efficacy|1
1244244|NCT00619476|4081064|P1|Overall Study|Lack of Efficacy|6
1244245|NCT00619476|4081061|P4|Overall Study|Adverse Event|16
1244246|NCT00619476|4081062|P3|Overall Study|Adverse Event|12
1244247|NCT00619476|4081063|P2|Overall Study|Adverse Event|6
1244248|NCT00619476|4081064|P1|Overall Study|Adverse Event|12
1244249|NCT00619385|4081149|P3|Overall Study|Other|1
1244250|NCT00619385|4081150|P2|Overall Study|Other|2
1244251|NCT00619385|4081151|P1|Overall Study|Other|1
1244252|NCT00619385|4081149|P3|Overall Study|Adverse Event|3
1244253|NCT00619385|4081150|P2|Overall Study|Adverse Event|0
1244254|NCT00619385|4081151|P1|Overall Study|Adverse Event|0
1244255|NCT00619359|4081166|P2|Overall Study|Progressive Disease|1
1244256|NCT00619359|4081167|P1|Overall Study|Progressive Disease|3
1244257|NCT00619359|4081166|P2|Overall Study|Withdrawal by Subject|20
1244258|NCT00619359|4081167|P1|Overall Study|Withdrawal by Subject|19
1244259|NCT00619359|4081166|P2|Overall Study|Protocol Violation|1
1244260|NCT00619359|4081167|P1|Overall Study|Protocol Violation|1
1244261|NCT00619359|4081166|P2|Overall Study|Physician Decision|7
1244262|NCT00619359|4081167|P1|Overall Study|Physician Decision|0
1244263|NCT00619359|4081166|P2|Overall Study|Lost to Follow-up|16
1244264|NCT00619359|4081167|P1|Overall Study|Lost to Follow-up|12
1244265|NCT00619359|4081166|P2|Overall Study|Adverse Event|36
1244266|NCT00619359|4081167|P1|Overall Study|Adverse Event|32
1244267|NCT00619307|4081179|P2|Overall Study|MS attack plus steroids|1
1244268|NCT00619307|4081180|P1|Overall Study|MS attack plus steroids|0
1244269|NCT00619307|4081179|P2|Overall Study|Severe migraine|1
1244270|NCT00619307|4081180|P1|Overall Study|Severe migraine|0
1244271|NCT00619307|4081179|P2|Overall Study|Withdrew consent|0
1244272|NCT00619307|4081180|P1|Overall Study|Withdrew consent|1
1244273|NCT00619307|4081179|P2|Overall Study|Protocol Violation|0
1244274|NCT00619307|4081180|P1|Overall Study|Protocol Violation|3
1244275|NCT00619307|4081179|P2|Overall Study|Lost to Follow-up|1
1244276|NCT00619307|4081180|P1|Overall Study|Lost to Follow-up|0
1244277|NCT00619307|4081179|P2|Overall Study|Adverse Event|1
1244278|NCT00619307|4081180|P1|Overall Study|Adverse Event|0
1244279|NCT00619229|4081217|P2|Overall Study|Investigator planned Cataract Operation|0
1244280|NCT00619229|4081218|P1|Overall Study|Investigator planned Cataract Operation|1
1244281|NCT00619229|4081217|P2|Overall Study|Termination of the Study by the Sponsor|1
1244282|NCT00619229|4081218|P1|Overall Study|Termination of the Study by the Sponsor|1
1244283|NCT00619229|4081217|P2|Overall Study|Lost to Follow-up|0
1244284|NCT00619229|4081218|P1|Overall Study|Lost to Follow-up|1
1244285|NCT00619229|4081217|P2|Overall Study|Withdrawal by Subject|1
1244286|NCT00619229|4081218|P1|Overall Study|Withdrawal by Subject|1
1244287|NCT00619177|4081257|P1|Overall Study|Not specified reasons|6
1244288|NCT00619177|4081257|P1|Overall Study|Missing termination information|481
1244289|NCT00619177|4081257|P1|Overall Study|Lack of Efficacy|1
1244290|NCT00619177|4081257|P1|Overall Study|Lost to Follow-up|2
1244291|NCT00619177|4081257|P1|Overall Study|Adverse Event|18
1244292|NCT00619151|4081267|P2|Overall Study|Study terminated prior to followup|0
1244293|NCT00619151|4081268|P1|Overall Study|Study terminated prior to followup|1
1244294|NCT00619112|4081278|P2|Overall Study|Adverse Event|2
1244295|NCT00619112|4081279|P1|Overall Study|Adverse Event|1
1244296|NCT00619099|4081300|P2|Overall Study|Physician Decision|6
1244297|NCT00619099|4081301|P1|Overall Study|Physician Decision|9
1244298|NCT00619099|4081300|P2|Overall Study|Withdrawal by Subject|2
1244299|NCT00619099|4081301|P1|Overall Study|Withdrawal by Subject|10
1244300|NCT00619099|4081300|P2|Overall Study|Emergence of Clinically Significant Lab|2
1244301|NCT00619099|4081301|P1|Overall Study|Emergence of Clinically Significant Lab|1
1244302|NCT00619099|4081300|P2|Overall Study|Adverse Event|3
1244303|NCT00619099|4081301|P1|Overall Study|Adverse Event|4
1244304|NCT00619099|4081300|P2|Overall Study|Allogeneic Bone Marrow Transplantation|1
1244305|NCT00619099|4081301|P1|Overall Study|Allogeneic Bone Marrow Transplantation|2
1244306|NCT00619099|4081300|P2|Overall Study|Progressive Disease|5
1244307|NCT00619099|4081301|P1|Overall Study|Progressive Disease|7
1244308|NCT00618995|4081323|P4|Period 4|Adverse Event|0
1244309|NCT00618995|4081324|P3|Period 4|Adverse Event|0
1244310|NCT00618995|4081325|P2|Period 4|Adverse Event|0
1244311|NCT00618995|4081326|P1|Period 4|Adverse Event|1
1244312|NCT00618995|4081323|P4|Period 2|Protocol Violation|0
1244313|NCT00618995|4081324|P3|Period 2|Protocol Violation|1
1244314|NCT00618995|4081325|P2|Period 2|Protocol Violation|0
1244315|NCT00618995|4081326|P1|Period 2|Protocol Violation|0
1244316|NCT00618995|4081323|P4|Period 1|Protocol Violation|0
1244317|NCT00618995|4081324|P3|Period 1|Protocol Violation|1
1244318|NCT00618995|4081325|P2|Period 1|Protocol Violation|1
1244319|NCT00618995|4081326|P1|Period 1|Protocol Violation|0
1244320|NCT00618995|4081323|P4|Period 1|Adverse Event|0
1244321|NCT00618995|4081324|P3|Period 1|Adverse Event|1
1244322|NCT00618995|4081325|P2|Period 1|Adverse Event|0
1244323|NCT00618995|4081326|P1|Period 1|Adverse Event|0
1244324|NCT00618982|4081340|P1|Overall Study|ongoing, still treated with study med.|25
1244325|NCT00618982|4081340|P1|Overall Study|Protocol Violation|1
1244326|NCT00618982|4081340|P1|Overall Study|Withdrawal by Subject|1
1244327|NCT00618982|4081340|P1|Overall Study|Adverse Event|23
1244328|NCT00618956|4081363|P2|Overall Study|did not meet criteria, non-compliance|1
1244329|NCT00618956|4081364|P1|Overall Study|did not meet criteria, non-compliance|2
1244330|NCT00618956|4081363|P2|Overall Study|Protocol Violation|2
1244331|NCT00618956|4081364|P1|Overall Study|Protocol Violation|2
1244332|NCT00618956|4081363|P2|Overall Study|Lost to Follow-up|5
1244333|NCT00618956|4081364|P1|Overall Study|Lost to Follow-up|4
1244334|NCT00618956|4081363|P2|Overall Study|Withdrawal by Subject|7
1244335|NCT00618956|4081364|P1|Overall Study|Withdrawal by Subject|5
1244336|NCT00618956|4081363|P2|Overall Study|Lack of Efficacy|1
1244337|NCT00618956|4081364|P1|Overall Study|Lack of Efficacy|2
1244338|NCT00618956|4081363|P2|Overall Study|Adverse Event|34
1244339|NCT00618956|4081364|P1|Overall Study|Adverse Event|10
1244340|NCT00618826|4081389|P1|Overall Study|Adverse Event|1
1244341|NCT00618813|4081394|P1|Overall Study|Withdrawal by Subject|1
1244342|NCT00618813|4081394|P1|Overall Study|Physician Decision|2
1244343|NCT00618813|4081394|P1|Overall Study|Lack of Efficacy|1
1244344|NCT00618787|4081404|P2|Overall Study|Lost to Follow-up|0
1244345|NCT00618787|4081405|P1|Overall Study|Lost to Follow-up|1
1244346|NCT00618787|4081404|P2|Overall Study|Withdrawal by Subject|1
1244347|NCT00618787|4081405|P1|Overall Study|Withdrawal by Subject|2
1244348|NCT00618787|4081404|P2|Overall Study|Adverse Event|1
1244349|NCT00618787|4081405|P1|Overall Study|Adverse Event|0
1244350|NCT00618774|4081413|P2|Overall Study|Withdrawal by Subject|0
1244351|NCT00618774|4081414|P1|Overall Study|Withdrawal by Subject|1
1244352|NCT00618774|4081413|P2|Overall Study|Adverse Event|3
1244353|NCT00618774|4081414|P1|Overall Study|Adverse Event|5
1244354|NCT00618748|4081447|P3|Overall Study|Withdrawal by Subject|5
1244355|NCT00618748|4081448|P2|Overall Study|Withdrawal by Subject|1
1244356|NCT00618748|4081449|P1|Overall Study|Withdrawal by Subject|4
1244357|NCT00618748|4081447|P3|Overall Study|Physician Decision|1
1244358|NCT00618748|4081448|P2|Overall Study|Physician Decision|1
1244359|NCT00618748|4081449|P1|Overall Study|Physician Decision|3
1244360|NCT00618748|4081447|P3|Overall Study|Adverse Event|8
1244361|NCT00618748|4081448|P2|Overall Study|Adverse Event|3
1244362|NCT00618748|4081449|P1|Overall Study|Adverse Event|4
1244363|NCT00618722|4081494|P4|Overall Study|Miscellaneous Reasons|1
1244364|NCT00618722|4081495|P3|Overall Study|Miscellaneous Reasons|1
1244365|NCT00618722|4081496|P2|Overall Study|Miscellaneous Reasons|0
1244366|NCT00618722|4081497|P1|Overall Study|Miscellaneous Reasons|0
1244367|NCT00618722|4081494|P4|Overall Study|Lost to Follow-up|2
1244368|NCT00618722|4081495|P3|Overall Study|Lost to Follow-up|0
1244369|NCT00618722|4081496|P2|Overall Study|Lost to Follow-up|0
1244370|NCT00618722|4081497|P1|Overall Study|Lost to Follow-up|2
1244371|NCT00618722|4081494|P4|Overall Study|Inability to Complete Study Procedure|0
1244372|NCT00618722|4081495|P3|Overall Study|Inability to Complete Study Procedure|0
1244373|NCT00618722|4081496|P2|Overall Study|Inability to Complete Study Procedure|1
1244374|NCT00618722|4081497|P1|Overall Study|Inability to Complete Study Procedure|0
1244375|NCT00618722|4081494|P4|Overall Study|Patient Request|1
1244376|NCT00618722|4081495|P3|Overall Study|Patient Request|1
1244377|NCT00618722|4081496|P2|Overall Study|Patient Request|1
1244378|NCT00618722|4081497|P1|Overall Study|Patient Request|1
1244379|NCT00618722|4081494|P4|Overall Study|Refusal of Treatment|0
1244380|NCT00618722|4081495|P3|Overall Study|Refusal of Treatment|1
1244381|NCT00618722|4081496|P2|Overall Study|Refusal of Treatment|0
1244382|NCT00618722|4081497|P1|Overall Study|Refusal of Treatment|0
1244383|NCT00618618|4081535|P4|Overall Study|Death|0
1244384|NCT00618618|4081536|P3|Overall Study|Death|0
1244385|NCT00618618|4081537|P2|Overall Study|Death|1
1244386|NCT00618618|4081538|P1|Overall Study|Death|0
1244387|NCT00618618|4081535|P4|Overall Study|Did Not Meet Entry Criteria|0
1244388|NCT00618618|4081536|P3|Overall Study|Did Not Meet Entry Criteria|1
1244389|NCT00618618|4081537|P2|Overall Study|Did Not Meet Entry Criteria|0
1244390|NCT00618618|4081538|P1|Overall Study|Did Not Meet Entry Criteria|0
1244391|NCT00618618|4081535|P4|Overall Study|Non-compliance|0
1244392|NCT00618618|4081536|P3|Overall Study|Non-compliance|0
1244393|NCT00618618|4081537|P2|Overall Study|Non-compliance|1
1244394|NCT00618618|4081538|P1|Overall Study|Non-compliance|1
1244395|NCT00618618|4081535|P4|Overall Study|Lost to Follow-up|1
1244396|NCT00618618|4081536|P3|Overall Study|Lost to Follow-up|0
1244397|NCT00618618|4081537|P2|Overall Study|Lost to Follow-up|0
1244398|NCT00618618|4081538|P1|Overall Study|Lost to Follow-up|3
1244399|NCT00618618|4081535|P4|Overall Study|Inability to Complete Study Procedures|0
1244400|NCT00618618|4081536|P3|Overall Study|Inability to Complete Study Procedures|0
1244401|NCT00618618|4081537|P2|Overall Study|Inability to Complete Study Procedures|1
1244402|NCT00618618|4081538|P1|Overall Study|Inability to Complete Study Procedures|0
1244403|NCT00618618|4081535|P4|Overall Study|Patient Request|0
1244404|NCT00618618|4081536|P3|Overall Study|Patient Request|2
1244405|NCT00618618|4081537|P2|Overall Study|Patient Request|0
1244406|NCT00618618|4081538|P1|Overall Study|Patient Request|0
1244407|NCT00618514|4081597|P3|Overall Study|Lost to Follow-up|4
1244408|NCT00618514|4081598|P2|Overall Study|Lost to Follow-up|12
1244409|NCT00618514|4081599|P1|Overall Study|Lost to Follow-up|11
1244410|NCT00618449|4081619|P2|Overall Study|Lost to Follow-up|110
1244411|NCT00618449|4081620|P1|Overall Study|Lost to Follow-up|98
1244412|NCT00618410|4081639|P2|Washout Period (2 Weeks)|Physician Decision|1
1244413|NCT00618410|4081640|P1|Washout Period (2 Weeks)|Physician Decision|0
1244414|NCT00618371|4081656|P1|Overall Study|Withdrawal by Subject|2
1244415|NCT00618072|4081689|P3|Overall Study|Physician Decision|1
1244416|NCT00618072|4081690|P2|Overall Study|Physician Decision|1
1244417|NCT00618072|4081691|P1|Overall Study|Physician Decision|0
1244418|NCT00618072|4081689|P3|Overall Study|Lost to Follow-up|3
1244419|NCT00618072|4081690|P2|Overall Study|Lost to Follow-up|0
1244420|NCT00618072|4081691|P1|Overall Study|Lost to Follow-up|2
1244421|NCT00617929|4081747|P1|Overall Study|Physician Decision|1
1244422|NCT00617903|4081759|P2|Overall Study|noncompliance|1
1244423|NCT00617903|4081760|P1|Overall Study|noncompliance|0
1244424|NCT00617903|4081759|P2|Overall Study|Adverse Event|1
1244425|NCT00617903|4081760|P1|Overall Study|Adverse Event|0
1244426|NCT00617903|4081759|P2|Overall Study|Lack of Efficacy|1
1244427|NCT00617903|4081760|P1|Overall Study|Lack of Efficacy|0
1244428|NCT00617903|4081759|P2|Overall Study|Lost to Follow-up|1
1244429|NCT00617903|4081760|P1|Overall Study|Lost to Follow-up|1
1244430|NCT00617903|4081759|P2|Overall Study|Withdrawal by Subject|3
1244431|NCT00617903|4081760|P1|Overall Study|Withdrawal by Subject|2
1244432|NCT00617890|4081806|P4|Overall Study|Not treated|1
1244433|NCT00617890|4081807|P3|Overall Study|Not treated|1
1244434|NCT00617890|4081808|P2|Overall Study|Not treated|0
1244435|NCT00617890|4081809|P1|Overall Study|Not treated|1
1244436|NCT00617890|4081806|P4|Overall Study|Adverse Event|8
1244437|NCT00617890|4081807|P3|Overall Study|Adverse Event|3
1244438|NCT00617890|4081808|P2|Overall Study|Adverse Event|0
1244439|NCT00617890|4081809|P1|Overall Study|Adverse Event|1
1244440|NCT00617890|4081806|P4|Overall Study|Protocol Violation|0
1244441|NCT00617890|4081807|P3|Overall Study|Protocol Violation|0
1244442|NCT00617890|4081808|P2|Overall Study|Protocol Violation|1
1244443|NCT00617890|4081809|P1|Overall Study|Protocol Violation|2
1244444|NCT00617890|4081806|P4|Overall Study|Withdrawal by Subject|2
1244445|NCT00617890|4081807|P3|Overall Study|Withdrawal by Subject|0
1244446|NCT00617890|4081808|P2|Overall Study|Withdrawal by Subject|1
1244447|NCT00617890|4081809|P1|Overall Study|Withdrawal by Subject|4
1244448|NCT00617890|4081806|P4|Overall Study|Lost to Follow-up|2
1244449|NCT00617890|4081807|P3|Overall Study|Lost to Follow-up|1
1244450|NCT00617890|4081808|P2|Overall Study|Lost to Follow-up|0
1244451|NCT00617890|4081809|P1|Overall Study|Lost to Follow-up|0
1244452|NCT00617890|4081806|P4|Overall Study|Lack of Efficacy|97
1244453|NCT00617890|4081807|P3|Overall Study|Lack of Efficacy|30
1244454|NCT00617890|4081808|P2|Overall Study|Lack of Efficacy|26
1244455|NCT00617890|4081809|P1|Overall Study|Lack of Efficacy|23
1244456|NCT00617890|4081806|P4|Overall Study|Treatment ongoing at data cut-off|5
1244457|NCT00617890|4081807|P3|Overall Study|Treatment ongoing at data cut-off|0
1244458|NCT00617890|4081808|P2|Overall Study|Treatment ongoing at data cut-off|0
1244459|NCT00617890|4081809|P1|Overall Study|Treatment ongoing at data cut-off|0
1244460|NCT00617851|4081845|P4|Overall Study|Unable to classify|0
1244461|NCT00617851|4081846|P3|Overall Study|Unable to classify|1
1244462|NCT00617851|4081847|P2|Overall Study|Unable to classify|0
1244463|NCT00617851|4081848|P1|Overall Study|Unable to classify|1
1244464|NCT00617851|4081845|P4|Overall Study|Inappropriate Enrollment|1
1244465|NCT00617851|4081846|P3|Overall Study|Inappropriate Enrollment|1
1244466|NCT00617851|4081847|P2|Overall Study|Inappropriate Enrollment|4
1244467|NCT00617851|4081848|P1|Overall Study|Inappropriate Enrollment|5
1244468|NCT00617851|4081845|P4|Overall Study|Lost to Follow-up|19
1244469|NCT00617851|4081846|P3|Overall Study|Lost to Follow-up|31
1244470|NCT00617851|4081847|P2|Overall Study|Lost to Follow-up|29
1244471|NCT00617851|4081848|P1|Overall Study|Lost to Follow-up|27
1244472|NCT00617851|4081845|P4|Overall Study|Withdrawal by Subject|4
1244473|NCT00617851|4081846|P3|Overall Study|Withdrawal by Subject|12
1244474|NCT00617851|4081847|P2|Overall Study|Withdrawal by Subject|7
1244475|NCT00617851|4081848|P1|Overall Study|Withdrawal by Subject|14
1244476|NCT00617851|4081845|P4|Overall Study|Death|1
1244477|NCT00617851|4081846|P3|Overall Study|Death|0
1244478|NCT00617851|4081847|P2|Overall Study|Death|0
1244479|NCT00617851|4081848|P1|Overall Study|Death|0
1244480|NCT00617773|4081886|P1|Overall Study|Protocol Violation|1
1244481|NCT00617773|4081886|P1|Overall Study|Progressive disease|19
1244482|NCT00617773|4081886|P1|Overall Study|Death|1
1244483|NCT00617773|4081886|P1|Overall Study|Withdrawal by Subject|1
1244484|NCT00617773|4081886|P1|Overall Study|Lack of compliance with the protocol|1
1244485|NCT00617773|4081886|P1|Overall Study|Physician Decision|1
1244486|NCT00617734|4081903|P2|Overall Study|Lost to Follow-up|1
1244487|NCT00617734|4081904|P1|Overall Study|Lost to Follow-up|0
1244488|NCT00617734|4081903|P2|Overall Study|Found Ineligible After Randomization|4
1244489|NCT00617734|4081904|P1|Overall Study|Found Ineligible After Randomization|1
1244490|NCT00617734|4081903|P2|Overall Study|Protocol Violation|0
1244491|NCT00617734|4081904|P1|Overall Study|Protocol Violation|1
1244492|NCT00617734|4081903|P2|Overall Study|Adverse Event|1
1244493|NCT00617734|4081904|P1|Overall Study|Adverse Event|4
1244494|NCT00617734|4081903|P2|Overall Study|Withdrew Consent|0
1244495|NCT00617734|4081904|P1|Overall Study|Withdrew Consent|2
1244496|NCT00617708|4081925|P3|Overall Study|Not eligible|5
1244497|NCT00617708|4081926|P2|Overall Study|Not eligible|3
1244498|NCT00617708|4081927|P1|Overall Study|Not eligible|1
1244499|NCT00617708|4081925|P3|Overall Study|Not protocol specified|2
1244500|NCT00617708|4081926|P2|Overall Study|Not protocol specified|4
1244501|NCT00617708|4081927|P1|Overall Study|Not protocol specified|1
1244502|NCT00617708|4081925|P3|Overall Study|Progression/Relapse|36
1244503|NCT00617708|4081926|P2|Overall Study|Progression/Relapse|40
1244504|NCT00617708|4081927|P1|Overall Study|Progression/Relapse|7
1244505|NCT00617708|4081925|P3|Overall Study|Death|5
1244506|NCT00617708|4081926|P2|Overall Study|Death|6
1244507|NCT00617708|4081927|P1|Overall Study|Death|0
1244508|NCT00617708|4081925|P3|Overall Study|Withdrawal by Subject|7
1244509|NCT00617708|4081926|P2|Overall Study|Withdrawal by Subject|1
1244510|NCT00617708|4081927|P1|Overall Study|Withdrawal by Subject|1
1244511|NCT00617708|4081925|P3|Overall Study|Adverse Event|9
1244512|NCT00617708|4081926|P2|Overall Study|Adverse Event|6
1244513|NCT00617708|4081927|P1|Overall Study|Adverse Event|0
1244514|NCT00617669|4081944|P2|Overall Study|Patients randomized but not treated|3
1244515|NCT00617669|4081945|P1|Overall Study|Patients randomized but not treated|2
1244516|NCT00617669|4081944|P2|Overall Study|Reason not otherwise captured, eg; death|290
1244517|NCT00617669|4081945|P1|Overall Study|Reason not otherwise captured, eg; death|265
1244518|NCT00617669|4081944|P2|Overall Study|Protocol Violation|3
1244519|NCT00617669|4081945|P1|Overall Study|Protocol Violation|2
1244520|NCT00617669|4081944|P2|Overall Study|Adverse Event|76
1244521|NCT00617669|4081945|P1|Overall Study|Adverse Event|87
1244522|NCT00617669|4081944|P2|Overall Study|Lost to Follow-up|2
1244523|NCT00617669|4081945|P1|Overall Study|Lost to Follow-up|3
1244524|NCT00617669|4081944|P2|Overall Study|Withdrawal by Subject|77
1244525|NCT00617669|4081945|P1|Overall Study|Withdrawal by Subject|71
1244526|NCT00617604|4081967|P2|Overall Study|Randomized but Never Received Study Drug|3
1244527|NCT00617604|4081968|P1|Overall Study|Randomized but Never Received Study Drug|3
1244528|NCT00617604|4081967|P2|Overall Study|Withdrawal by Subject|6
1244529|NCT00617604|4081968|P1|Overall Study|Withdrawal by Subject|4
1244530|NCT00617604|4081967|P2|Overall Study|Miscellaneous Reasons|10
1244531|NCT00617604|4081968|P1|Overall Study|Miscellaneous Reasons|8
1244532|NCT00617604|4081967|P2|Overall Study|Lost to Follow-up|0
1244533|NCT00617604|4081968|P1|Overall Study|Lost to Follow-up|1
1244534|NCT00617604|4081967|P2|Overall Study|Death|1
1244535|NCT00617604|4081968|P1|Overall Study|Death|2
1244536|NCT00617591|4082012|P1|Overall Study|Withdrew consent during Maintenance|6
1244537|NCT00617591|4082012|P1|Overall Study|Withdrew consent during Induction|4
1244538|NCT00617461|4082028|P2|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2
1244539|NCT00617461|4082029|P1|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1
1244540|NCT00617461|4082028|P2|6-Day Down-Titration Period|Withdrawal by Subject|0
1244541|NCT00617461|4082029|P1|6-Day Down-Titration Period|Withdrawal by Subject|1
1244542|NCT00617461|4082028|P2|Second Treatment Intervention Period|Lack of Efficacy|3
1244543|NCT00617461|4082029|P1|Second Treatment Intervention Period|Lack of Efficacy|0
1244544|NCT00617461|4082028|P2|Second Treatment Intervention Period|Adverse Event|1
1244545|NCT00617461|4082029|P1|Second Treatment Intervention Period|Adverse Event|0
1244546|NCT00617461|4082028|P2|4-Day Crossover Period|Withdrawal by Subject|0
1244547|NCT00617461|4082029|P1|4-Day Crossover Period|Withdrawal by Subject|1
1244548|NCT00617461|4082028|P2|First Treatment Intervention Period|Withdrawal by Subject|0
1244549|NCT00617461|4082029|P1|First Treatment Intervention Period|Withdrawal by Subject|4
1244550|NCT00617461|4082028|P2|First Treatment Intervention Period|Investigator Discretion|1
1244551|NCT00617461|4082029|P1|First Treatment Intervention Period|Investigator Discretion|1
1244552|NCT00617461|4082028|P2|First Treatment Intervention Period|Lost to Follow-up|1
1244553|NCT00617461|4082029|P1|First Treatment Intervention Period|Lost to Follow-up|0
1244554|NCT00617461|4082028|P2|First Treatment Intervention Period|Protocol Violation|1
1244555|NCT00617461|4082029|P1|First Treatment Intervention Period|Protocol Violation|2
1244556|NCT00617461|4082028|P2|First Treatment Intervention Period|Lack of Efficacy|0
1244557|NCT00617461|4082029|P1|First Treatment Intervention Period|Lack of Efficacy|1
1244558|NCT00617461|4082028|P2|First Treatment Intervention Period|Adverse Event|0
1244559|NCT00617461|4082029|P1|First Treatment Intervention Period|Adverse Event|2
1244560|NCT00617409|4082085|P3|Overall Study|Alternative Therapy|0
1244561|NCT00617409|4082086|P2|Overall Study|Alternative Therapy|2
1244562|NCT00617409|4082087|P1|Overall Study|Alternative Therapy|1
1244563|NCT00617409|4082085|P3|Overall Study|Death|4
1244564|NCT00617409|4082086|P2|Overall Study|Death|5
1244565|NCT00617409|4082087|P1|Overall Study|Death|3
1244566|NCT00617409|4082085|P3|Overall Study|Disease Progression|18
1244567|NCT00617409|4082086|P2|Overall Study|Disease Progression|8
1244568|NCT00617409|4082087|P1|Overall Study|Disease Progression|8
1244569|NCT00617409|4082085|P3|Overall Study|Adverse Event|3
1244570|NCT00617409|4082086|P2|Overall Study|Adverse Event|2
1244571|NCT00617409|4082087|P1|Overall Study|Adverse Event|0
1244572|NCT00617409|4082085|P3|Overall Study|Withdrawal by Subject|2
1244573|NCT00617409|4082086|P2|Overall Study|Withdrawal by Subject|1
1244574|NCT00617409|4082087|P1|Overall Study|Withdrawal by Subject|4
1244575|NCT00617357|4082102|P1|Overall Study|Physician Decision|1
1244576|NCT00617357|4082102|P1|Overall Study|Withdrawal by Subject|1
1244577|NCT00617357|4082102|P1|Overall Study|insurance concerns|2
1244578|NCT00617357|4082102|P1|Overall Study|Death|5
1244579|NCT00617357|4082102|P1|Overall Study|Lost to Follow-up|7
1244580|NCT00617305|4082115|P3|Overall Study|Withdrawal by Subject|0
1244581|NCT00617305|4082116|P2|Overall Study|Withdrawal by Subject|0
1244582|NCT00617305|4082117|P1|Overall Study|Withdrawal by Subject|1
1244583|NCT00617305|4082115|P3|Overall Study|Protocol Violation|1
1244584|NCT00617305|4082116|P2|Overall Study|Protocol Violation|0
1244585|NCT00617305|4082117|P1|Overall Study|Protocol Violation|1
1244586|NCT00617305|4082115|P3|Overall Study|Physician Decision|0
1244587|NCT00617305|4082116|P2|Overall Study|Physician Decision|0
1244588|NCT00617305|4082117|P1|Overall Study|Physician Decision|1
1244589|NCT00617305|4082115|P3|Overall Study|Death|0
1244590|NCT00617305|4082116|P2|Overall Study|Death|0
1244591|NCT00617305|4082117|P1|Overall Study|Death|1
1244592|NCT00617305|4082115|P3|Overall Study|Adverse Event|0
1244593|NCT00617305|4082116|P2|Overall Study|Adverse Event|0
1244594|NCT00617305|4082117|P1|Overall Study|Adverse Event|4
1244595|NCT00617279|4082173|P2|Overall Study|Death|2
1244596|NCT00617279|4082174|P1|Overall Study|Death|1
1244597|NCT00617279|4082173|P2|Overall Study|Lost to Follow-up|0
1244598|NCT00617279|4082174|P1|Overall Study|Lost to Follow-up|1
1244599|NCT00617279|4082173|P2|Overall Study|Graft abandonment|0
1244600|NCT00617279|4082174|P1|Overall Study|Graft abandonment|2
1244601|NCT00617279|4082173|P2|Overall Study|Study terminated by Sponsor|15
1244602|NCT00617279|4082174|P1|Overall Study|Study terminated by Sponsor|10
1244603|NCT00617240|4082230|P2|Overall Study|Lack of Efficacy|0
1244604|NCT00617240|4082231|P1|Overall Study|Lack of Efficacy|1
1244605|NCT00617201|4082251|P2|Overall Study|Lost to Follow-up|13
1244606|NCT00617201|4082252|P1|Overall Study|Lost to Follow-up|9
1244607|NCT00617123|4082280|P2|Study Treatment Period|Noncompliance with Protocol|1
1244608|NCT00617123|4082281|P1|Study Treatment Period|Noncompliance with Protocol|0
1244609|NCT00617123|4082280|P2|Study Treatment Period|Did Not Meet Protocol Eligibility|0
1244610|NCT00617123|4082281|P1|Study Treatment Period|Did Not Meet Protocol Eligibility|2
1244611|NCT00617123|4082280|P2|Study Treatment Period|Adverse Event|3
1244612|NCT00617123|4082281|P1|Study Treatment Period|Adverse Event|7
1244613|NCT00617123|4082280|P2|Study Treatment Period|Withdrawal by Subject|12
1244614|NCT00617123|4082281|P1|Study Treatment Period|Withdrawal by Subject|8
1244615|NCT00617123|4082280|P2|Referral Screening Period|Adverse Event|1
1244616|NCT00617123|4082281|P1|Referral Screening Period|Adverse Event|0
1244617|NCT00617123|4082280|P2|Referral Screening Period|Did Not Wish To Continue|1
1244618|NCT00617123|4082281|P1|Referral Screening Period|Did Not Wish To Continue|3
1244619|NCT00617123|4082280|P2|Referral Screening Period|Did Not Meet Protocol Eligibility|24
1244620|NCT00617123|4082281|P1|Referral Screening Period|Did Not Meet Protocol Eligibility|36
1244621|NCT00617084|4082312|P2|Overall Study|Missed 12 Months visit|19
1244622|NCT00617084|4082313|P1|Overall Study|Missed 12 Months visit|16
1244623|NCT00617084|4082312|P2|Overall Study|Withdrawal by Subject|7
1244624|NCT00617084|4082313|P1|Overall Study|Withdrawal by Subject|5
1244625|NCT00616967|4082366|P3|Overall Study|Withdrawal by Subject|1
1244626|NCT00616967|4082367|P2|Overall Study|Withdrawal by Subject|0
1244627|NCT00616967|4082368|P1|Overall Study|Withdrawal by Subject|0
1244628|NCT00616941|4082380|P3|Overall Study|Vaccination Suspended|3
1244629|NCT00616941|4082381|P2|Overall Study|Vaccination Suspended|0
1244630|NCT00616941|4082382|P1|Overall Study|Vaccination Suspended|0
1244631|NCT00616941|4082380|P3|Overall Study|Unrelated Medical Illness/Complication|0
1244632|NCT00616941|4082381|P2|Overall Study|Unrelated Medical Illness/Complication|2
1244633|NCT00616941|4082382|P1|Overall Study|Unrelated Medical Illness/Complication|0
1244634|NCT00616941|4082380|P3|Overall Study|Subject Non-compliance|1
1244635|NCT00616941|4082381|P2|Overall Study|Subject Non-compliance|0
1244636|NCT00616941|4082382|P1|Overall Study|Subject Non-compliance|0
1244637|NCT00616941|4082380|P3|Overall Study|Adverse Event|1
1244638|NCT00616941|4082381|P2|Overall Study|Adverse Event|1
1244639|NCT00616941|4082382|P1|Overall Study|Adverse Event|0
1244640|NCT00616941|4082380|P3|Overall Study|Progressive Disease|1
1244641|NCT00616941|4082381|P2|Overall Study|Progressive Disease|2
1244642|NCT00616941|4082382|P1|Overall Study|Progressive Disease|1
1244643|NCT00616928|4082409|P4|Overall Study|Lost to Follow-up|0
1244644|NCT00616928|4082410|P3|Overall Study|Lost to Follow-up|0
1244645|NCT00616928|4082411|P2|Overall Study|Lost to Follow-up|7
1244646|NCT00616928|4082412|P1|Overall Study|Lost to Follow-up|5
1244647|NCT00616928|4082409|P4|Overall Study|Other|5
1244648|NCT00616928|4082410|P3|Overall Study|Other|15
1244649|NCT00616928|4082411|P2|Overall Study|Other|8
1244650|NCT00616928|4082412|P1|Overall Study|Other|51
1244651|NCT00616928|4082409|P4|Overall Study|Adverse Event|2
1244652|NCT00616928|4082410|P3|Overall Study|Adverse Event|2
1244653|NCT00616928|4082411|P2|Overall Study|Adverse Event|3
1244654|NCT00616928|4082412|P1|Overall Study|Adverse Event|6
1244655|NCT00616902|4082476|P2|Overall Study|Termination of study|6
1244656|NCT00616902|4082477|P1|Overall Study|Termination of study|6
1244657|NCT00616759|4082520|P2|Overall Study|Withdrawal by Subject|2
1244658|NCT00616759|4082521|P1|Overall Study|Withdrawal by Subject|1
1244659|NCT00616759|4082520|P2|Overall Study|Physician Decision|0
1244660|NCT00616759|4082521|P1|Overall Study|Physician Decision|2
1244661|NCT00616655|4082530|P3|Overall Study|Other|5
1244662|NCT00616655|4082531|P2|Overall Study|Other|6
1244663|NCT00616655|4082532|P1|Overall Study|Other|6
1244664|NCT00616655|4082530|P3|Overall Study|Does not meet in/ex criteria|2
1244665|NCT00616655|4082531|P2|Overall Study|Does not meet in/ex criteria|0
1244666|NCT00616655|4082532|P1|Overall Study|Does not meet in/ex criteria|0
1244667|NCT00616655|4082530|P3|Overall Study|Withdrawal by Subject|11
1244668|NCT00616655|4082531|P2|Overall Study|Withdrawal by Subject|7
1244669|NCT00616655|4082532|P1|Overall Study|Withdrawal by Subject|9
1244670|NCT00616655|4082530|P3|Overall Study|Protocol Violation|3
1244671|NCT00616655|4082531|P2|Overall Study|Protocol Violation|4
1244672|NCT00616655|4082532|P1|Overall Study|Protocol Violation|2
1244673|NCT00616655|4082530|P3|Overall Study|Lost to Follow-up|10
1244674|NCT00616655|4082531|P2|Overall Study|Lost to Follow-up|12
1244675|NCT00616655|4082532|P1|Overall Study|Lost to Follow-up|3
1244676|NCT00616655|4082530|P3|Overall Study|Lack of Efficacy|5
1244677|NCT00616655|4082531|P2|Overall Study|Lack of Efficacy|5
1244678|NCT00616655|4082532|P1|Overall Study|Lack of Efficacy|5
1244679|NCT00616655|4082530|P3|Overall Study|Adverse Event|12
1244680|NCT00616655|4082531|P2|Overall Study|Adverse Event|7
1244681|NCT00616655|4082532|P1|Overall Study|Adverse Event|10
1244682|NCT00616642|4082572|P2|Overall Study|Withdrawal by Subject|1
1244683|NCT00616642|4082573|P1|Overall Study|Withdrawal by Subject|0
1244684|NCT00616629|4082584|P5|Overall Study|AV-block|0
1244685|NCT00616629|4082585|P4|Overall Study|AV-block|0
1244686|NCT00616629|4082586|P3|Overall Study|AV-block|0
1244687|NCT00616629|4082587|P2|Overall Study|AV-block|0
1244688|NCT00616629|4082588|P1|Overall Study|AV-block|1
1244689|NCT00616629|4082584|P5|Overall Study|Protocol Violation|0
1244690|NCT00616629|4082585|P4|Overall Study|Protocol Violation|0
1244691|NCT00616629|4082586|P3|Overall Study|Protocol Violation|1
1244692|NCT00616629|4082587|P2|Overall Study|Protocol Violation|2
1244693|NCT00616629|4082588|P1|Overall Study|Protocol Violation|1
1244694|NCT00616603|4082633|P3|Overall Study|Physician Decision|2
1244695|NCT00616603|4082634|P2|Overall Study|Physician Decision|0
1244696|NCT00616603|4082635|P1|Overall Study|Physician Decision|2
1244697|NCT00616434|4082658|P2|Overall Study|Protocol deviation|1
1244698|NCT00616434|4082659|P1|Overall Study|Protocol deviation|0
1244699|NCT00616434|4082658|P2|Overall Study|Withdrawal by Subject|1
1244700|NCT00616434|4082659|P1|Overall Study|Withdrawal by Subject|1
1244701|NCT00616434|4082658|P2|Overall Study|Physician Decision|4
1244702|NCT00616434|4082659|P1|Overall Study|Physician Decision|0
1244703|NCT00616434|4082658|P2|Overall Study|Adverse Event|2
1244704|NCT00616434|4082659|P1|Overall Study|Adverse Event|5
1244705|NCT00616421|4082672|P3|Overall Study|Unable to classify|0
1244706|NCT00616421|4082673|P2|Overall Study|Unable to classify|0
1244707|NCT00616421|4082674|P1|Overall Study|Unable to classify|1
1244708|NCT00616421|4082672|P3|Overall Study|Protocol Violation|2
1244709|NCT00616421|4082673|P2|Overall Study|Protocol Violation|1
1244710|NCT00616421|4082674|P1|Overall Study|Protocol Violation|0
1244711|NCT00616421|4082672|P3|Overall Study|Administrative reason|0
1244712|NCT00616421|4082673|P2|Overall Study|Administrative reason|0
1244713|NCT00616421|4082674|P1|Overall Study|Administrative reason|1
1244714|NCT00616421|4082672|P3|Overall Study|Inappropriate enrollment|1
1244715|NCT00616421|4082673|P2|Overall Study|Inappropriate enrollment|0
1244716|NCT00616421|4082674|P1|Overall Study|Inappropriate enrollment|3
1244717|NCT00616421|4082672|P3|Overall Study|Lost to Follow-up|30
1244718|NCT00616421|4082673|P2|Overall Study|Lost to Follow-up|26
1244719|NCT00616421|4082674|P1|Overall Study|Lost to Follow-up|12
1244720|NCT00616421|4082672|P3|Overall Study|Withdrawal by Subject|8
1244721|NCT00616421|4082673|P2|Overall Study|Withdrawal by Subject|11
1244722|NCT00616421|4082674|P1|Overall Study|Withdrawal by Subject|9
1244723|NCT00616239|4082715|P1|Overall Study|Withdrawal by Subject|2
1244724|NCT00616018|4082739|P1|Overall Study|Protocol Violation|3
1244725|NCT00615992|4082744|P1|Overall Study|Protocol Violation|67
1244726|NCT00615914|4082770|P1|Overall Study|Irregularly enrolled patients|10
1244727|NCT00615914|4082770|P1|Overall Study|No treatment|2
1244728|NCT00615914|4082770|P1|Overall Study|No data was collected.|65
1244729|NCT00615914|4082770|P1|Overall Study|Physician Decision|4
1244730|NCT00615914|4082770|P1|Overall Study|Withdrawal by Subject|16
1244731|NCT00615914|4082770|P1|Overall Study|Lost to Follow-up|187
1244732|NCT00615914|4082770|P1|Overall Study|Lack of Efficacy|59
1244733|NCT00615914|4082770|P1|Overall Study|Death|20
1244734|NCT00615914|4082770|P1|Overall Study|Adverse Event|274
1244735|NCT00615901|4082777|P1|Overall Study|Adverse Event|7
1244736|NCT00615901|4082777|P1|Overall Study|Withdrawal by Subject|2
1244737|NCT00615836|4082785|P5|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
1244738|NCT00615836|4082786|P4|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
1244739|NCT00615836|4082787|P3|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
1244740|NCT00615836|4082788|P2|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
1244741|NCT00615836|4082789|P1|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65
1244742|NCT00615836|4082785|P5|Extension Study (FE992026 CS31)|Not reported|0
1244743|NCT00615836|4082786|P4|Extension Study (FE992026 CS31)|Not reported|4
1244744|NCT00615836|4082787|P3|Extension Study (FE992026 CS31)|Not reported|1
1244745|NCT00615836|4082788|P2|Extension Study (FE992026 CS31)|Not reported|4
1244746|NCT00615836|4082789|P1|Extension Study (FE992026 CS31)|Not reported|6
1244747|NCT00615836|4082785|P5|Extension Study (FE992026 CS31)|Not specified|0
1244748|NCT00615836|4082786|P4|Extension Study (FE992026 CS31)|Not specified|8
1244749|NCT00615836|4082787|P3|Extension Study (FE992026 CS31)|Not specified|8
1244750|NCT00615836|4082788|P2|Extension Study (FE992026 CS31)|Not specified|7
1244751|NCT00615836|4082789|P1|Extension Study (FE992026 CS31)|Not specified|10
1244752|NCT00615836|4082785|P5|Extension Study (FE992026 CS31)|Lost to Follow-up|0
1244753|NCT00615836|4082786|P4|Extension Study (FE992026 CS31)|Lost to Follow-up|10
1244754|NCT00615836|4082787|P3|Extension Study (FE992026 CS31)|Lost to Follow-up|5
1244755|NCT00615836|4082788|P2|Extension Study (FE992026 CS31)|Lost to Follow-up|14
1244756|NCT00615836|4082789|P1|Extension Study (FE992026 CS31)|Lost to Follow-up|10
1244757|NCT00615836|4082785|P5|Extension Study (FE992026 CS31)|Withdrawal by Subject|0
1244758|NCT00615836|4082786|P4|Extension Study (FE992026 CS31)|Withdrawal by Subject|43
1244759|NCT00615836|4082787|P3|Extension Study (FE992026 CS31)|Withdrawal by Subject|38
1244760|NCT00615836|4082788|P2|Extension Study (FE992026 CS31)|Withdrawal by Subject|42
1244761|NCT00615836|4082789|P1|Extension Study (FE992026 CS31)|Withdrawal by Subject|37
1244762|NCT00615836|4082785|P5|Extension Study (FE992026 CS31)|Protocol Violation|0
1244763|NCT00615836|4082786|P4|Extension Study (FE992026 CS31)|Protocol Violation|3
1244764|NCT00615836|4082787|P3|Extension Study (FE992026 CS31)|Protocol Violation|2
1244765|NCT00615836|4082788|P2|Extension Study (FE992026 CS31)|Protocol Violation|5
1244766|NCT00615836|4082789|P1|Extension Study (FE992026 CS31)|Protocol Violation|4
1244767|NCT00615836|4082785|P5|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
1244768|NCT00615836|4082786|P4|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
1244769|NCT00615836|4082787|P3|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
1244770|NCT00615836|4082788|P2|Extension Study (FE992026 CS31)|Use of exclusionary medication|2
1244771|NCT00615836|4082789|P1|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
1244772|NCT00615836|4082785|P5|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
1244773|NCT00615836|4082786|P4|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
1244774|NCT00615836|4082787|P3|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
1244775|NCT00615836|4082788|P2|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
1244776|NCT00615836|4082789|P1|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1
1244777|NCT00615836|4082785|P5|Extension Study (FE992026 CS31)|Adverse Event|0
1244778|NCT00615836|4082786|P4|Extension Study (FE992026 CS31)|Adverse Event|13
1244779|NCT00615836|4082787|P3|Extension Study (FE992026 CS31)|Adverse Event|15
1244780|NCT00615836|4082788|P2|Extension Study (FE992026 CS31)|Adverse Event|12
1244781|NCT00615836|4082789|P1|Extension Study (FE992026 CS31)|Adverse Event|7
1244782|NCT00615719|4082849|P1|Overall Study|Physician Decision|5
1244783|NCT00615550|4082863|P2|Overall Study|Lost to Follow-up|1
1244784|NCT00615550|4082864|P1|Overall Study|Lost to Follow-up|6
1244785|NCT00615459|4082887|P4|Period III|Unsatisfactory therapeutic effect|0
1244786|NCT00615459|4082888|P3|Period III|Unsatisfactory therapeutic effect|0
1244787|NCT00615459|4082889|P2|Period III|Unsatisfactory therapeutic effect|1
1244788|NCT00615459|4082890|P1|Period III|Unsatisfactory therapeutic effect|0
1244789|NCT00615459|4082887|P4|Period III|Administrative problems|0
1244790|NCT00615459|4082888|P3|Period III|Administrative problems|1
1244791|NCT00615459|4082889|P2|Period III|Administrative problems|1
1244792|NCT00615459|4082890|P1|Period III|Administrative problems|0
1244793|NCT00615459|4082887|P4|Period III|Adverse Event|0
1244794|NCT00615459|4082888|P3|Period III|Adverse Event|0
1244795|NCT00615459|4082889|P2|Period III|Adverse Event|1
1244796|NCT00615459|4082890|P1|Period III|Adverse Event|0
1244797|NCT00615459|4082887|P4|Period II|Lost to Follow-up|1
1244798|NCT00615459|4082888|P3|Period II|Lost to Follow-up|0
1244799|NCT00615459|4082889|P2|Period II|Lost to Follow-up|0
1244800|NCT00615459|4082890|P1|Period II|Lost to Follow-up|0
1244801|NCT00615459|4082887|P4|Period II|Adverse Event|0
1244802|NCT00615459|4082888|P3|Period II|Adverse Event|0
1244803|NCT00615459|4082889|P2|Period II|Adverse Event|0
1244804|NCT00615459|4082890|P1|Period II|Adverse Event|1
1244805|NCT00615459|4082887|P4|Period I|Abnormal test procedure results|0
1244806|NCT00615459|4082888|P3|Period I|Abnormal test procedure results|1
1244807|NCT00615459|4082889|P2|Period I|Abnormal test procedure results|1
1244808|NCT00615459|4082890|P1|Period I|Abnormal test procedure results|1
1244809|NCT00615459|4082887|P4|Period I|Subject withdrew consent|1
1244810|NCT00615459|4082888|P3|Period I|Subject withdrew consent|0
1244811|NCT00615459|4082889|P2|Period I|Subject withdrew consent|0
1244812|NCT00615459|4082890|P1|Period I|Subject withdrew consent|1
1244813|NCT00615459|4082887|P4|Period I|Adverse Event|0
1244814|NCT00615459|4082888|P3|Period I|Adverse Event|1
1244815|NCT00615459|4082889|P2|Period I|Adverse Event|0
1244816|NCT00615459|4082890|P1|Period I|Adverse Event|2
1244817|NCT00615290|4082925|P1|Overall Study|Other|2
1244818|NCT00615290|4082925|P1|Overall Study|Withdrawal by Subject|1
1244819|NCT00615290|4082925|P1|Overall Study|Lost to Follow-up|3
1244820|NCT00615290|4082925|P1|Overall Study|Adverse Event|2
1244821|NCT00615264|4082939|P2|Overall Study|Dermal Hypersensitivity|3
1244822|NCT00615264|4082940|P1|Overall Study|Dermal Hypersensitivity|0
1244823|NCT00615264|4082939|P2|Overall Study|Not defined|4
1244824|NCT00615264|4082940|P1|Overall Study|Not defined|7
1244825|NCT00615264|4082939|P2|Overall Study|Protocol Violation|7
1244826|NCT00615264|4082940|P1|Overall Study|Protocol Violation|11
1244827|NCT00615264|4082939|P2|Overall Study|Death|1
1244828|NCT00615264|4082940|P1|Overall Study|Death|1
1244829|NCT00615264|4082939|P2|Overall Study|Adverse Event|5
1244830|NCT00615264|4082940|P1|Overall Study|Adverse Event|8
1244831|NCT00615264|4082939|P2|Overall Study|Lost to Follow-up|13
1244832|NCT00615264|4082940|P1|Overall Study|Lost to Follow-up|6
1244833|NCT00615264|4082939|P2|Overall Study|Withdrawal by Subject|19
1244834|NCT00615264|4082940|P1|Overall Study|Withdrawal by Subject|17
1244835|NCT00615199|4082952|P4|Overall Study|Withdrawal by Subject|0
1244836|NCT00615199|4082953|P3|Overall Study|Withdrawal by Subject|0
1244837|NCT00615199|4082954|P2|Overall Study|Withdrawal by Subject|1
1244838|NCT00615199|4082955|P1|Overall Study|Withdrawal by Subject|2
1244839|NCT00615199|4082952|P4|Overall Study|Other|1
1244840|NCT00615199|4082953|P3|Overall Study|Other|0
1244841|NCT00615199|4082954|P2|Overall Study|Other|0
1244842|NCT00615199|4082955|P1|Overall Study|Other|0
1244843|NCT00615199|4082952|P4|Overall Study|Lost to Follow-up|0
1244844|NCT00615199|4082953|P3|Overall Study|Lost to Follow-up|0
1244845|NCT00615199|4082954|P2|Overall Study|Lost to Follow-up|0
1244846|NCT00615199|4082955|P1|Overall Study|Lost to Follow-up|1
1244847|NCT00615199|4082952|P4|Overall Study|Lack of Efficacy|1
1244848|NCT00615199|4082953|P3|Overall Study|Lack of Efficacy|0
1244849|NCT00615199|4082954|P2|Overall Study|Lack of Efficacy|0
1244850|NCT00615199|4082955|P1|Overall Study|Lack of Efficacy|2
1244851|NCT00615199|4082952|P4|Overall Study|Adverse Event|0
1244852|NCT00615199|4082953|P3|Overall Study|Adverse Event|1
1244853|NCT00615199|4082954|P2|Overall Study|Adverse Event|1
1244854|NCT00615199|4082955|P1|Overall Study|Adverse Event|3
1244855|NCT00615108|4082989|P1|Overall Study|Lost to Follow-up|15
1244856|NCT00615108|4082989|P1|Overall Study|Other|370
1244857|NCT00615108|4082989|P1|Overall Study|Adverse Event|122
1244858|NCT00615069|4083004|P1|Overall Study|Withdrawal by Subject|4
1244859|NCT00615069|4083004|P1|Overall Study|Physician Decision|2
1244860|NCT00615069|4083004|P1|Overall Study|Death|10
1244861|NCT00615056|4083013|P4|Overall Study|Randomized but not treated|0
1244862|NCT00615056|4083014|P3|Overall Study|Randomized but not treated|0
1244863|NCT00615056|4083015|P2|Overall Study|Randomized but not treated|0
1244864|NCT00615056|4083016|P1|Overall Study|Randomized but not treated|3
1244865|NCT00615056|4083013|P4|Overall Study|Discontinued by Sponsor|0
1244866|NCT00615056|4083014|P3|Overall Study|Discontinued by Sponsor|0
1244867|NCT00615056|4083015|P2|Overall Study|Discontinued by Sponsor|0
1244868|NCT00615056|4083016|P1|Overall Study|Discontinued by Sponsor|1
1244869|NCT00615056|4083013|P4|Overall Study|Withdrawal by Subject|0
1244870|NCT00615056|4083014|P3|Overall Study|Withdrawal by Subject|1
1244871|NCT00615056|4083015|P2|Overall Study|Withdrawal by Subject|1
1244872|NCT00615056|4083016|P1|Overall Study|Withdrawal by Subject|0
1244873|NCT00615056|4083013|P4|Overall Study|Objective progression or relapse|0
1244874|NCT00615056|4083014|P3|Overall Study|Objective progression or relapse|0
1244875|NCT00615056|4083015|P2|Overall Study|Objective progression or relapse|2
1244876|NCT00615056|4083016|P1|Overall Study|Objective progression or relapse|0
1244877|NCT00615056|4083013|P4|Overall Study|Other|7
1244878|NCT00615056|4083014|P3|Overall Study|Other|10
1244879|NCT00615056|4083015|P2|Overall Study|Other|15
1244880|NCT00615056|4083016|P1|Overall Study|Other|13
1244881|NCT00615056|4083013|P4|Overall Study|Lost to Follow-up|5
1244882|NCT00615056|4083014|P3|Overall Study|Lost to Follow-up|4
1244883|NCT00615056|4083015|P2|Overall Study|Lost to Follow-up|2
1244884|NCT00615056|4083016|P1|Overall Study|Lost to Follow-up|1
1244885|NCT00615056|4083013|P4|Overall Study|Death|23
1244886|NCT00615056|4083014|P3|Overall Study|Death|21
1244887|NCT00615056|4083015|P2|Overall Study|Death|31
1244888|NCT00615056|4083016|P1|Overall Study|Death|31
1244889|NCT00615030|4083046|P12|Period III|Administrative problems|0
1244890|NCT00615030|4083047|P11|Period III|Administrative problems|0
1244891|NCT00615030|4083048|P10|Period III|Administrative problems|0
1244892|NCT00615030|4083049|P9|Period III|Administrative problems|0
1244893|NCT00615030|4083050|P8|Period III|Administrative problems|0
1244894|NCT00615030|4083051|P7|Period III|Administrative problems|0
1244895|NCT00615030|4083052|P6|Period III|Administrative problems|0
1244896|NCT00615030|4083053|P5|Period III|Administrative problems|0
1244897|NCT00615030|4083054|P4|Period III|Administrative problems|1
1244898|NCT00615030|4083055|P3|Period III|Administrative problems|0
1244899|NCT00615030|4083056|P2|Period III|Administrative problems|0
1244900|NCT00615030|4083057|P1|Period III|Administrative problems|1
1244901|NCT00615030|4083046|P12|Period II|Subject withdrew consent|0
1244902|NCT00615030|4083047|P11|Period II|Subject withdrew consent|0
1244903|NCT00615030|4083048|P10|Period II|Subject withdrew consent|0
1244904|NCT00615030|4083049|P9|Period II|Subject withdrew consent|0
1244905|NCT00615030|4083050|P8|Period II|Subject withdrew consent|0
1244906|NCT00615030|4083051|P7|Period II|Subject withdrew consent|1
1244907|NCT00615030|4083052|P6|Period II|Subject withdrew consent|0
1244908|NCT00615030|4083053|P5|Period II|Subject withdrew consent|0
1244909|NCT00615030|4083054|P4|Period II|Subject withdrew consent|1
1244910|NCT00615030|4083055|P3|Period II|Subject withdrew consent|0
1244911|NCT00615030|4083056|P2|Period II|Subject withdrew consent|0
1244912|NCT00615030|4083057|P1|Period II|Subject withdrew consent|0
1244913|NCT00615030|4083046|P12|Period II|Adverse Event|0
1244914|NCT00615030|4083047|P11|Period II|Adverse Event|0
1244915|NCT00615030|4083048|P10|Period II|Adverse Event|0
1244916|NCT00615030|4083049|P9|Period II|Adverse Event|1
1244917|NCT00615030|4083050|P8|Period II|Adverse Event|0
1244918|NCT00615030|4083051|P7|Period II|Adverse Event|0
1244919|NCT00615030|4083052|P6|Period II|Adverse Event|0
1244920|NCT00615030|4083053|P5|Period II|Adverse Event|0
1244921|NCT00615030|4083054|P4|Period II|Adverse Event|0
1244922|NCT00615030|4083055|P3|Period II|Adverse Event|1
1244923|NCT00615030|4083056|P2|Period II|Adverse Event|0
1244924|NCT00615030|4083057|P1|Period II|Adverse Event|0
1244925|NCT00615030|4083046|P12|Period I|Abnormal laboratory value(s)|0
1244926|NCT00615030|4083047|P11|Period I|Abnormal laboratory value(s)|0
1244927|NCT00615030|4083048|P10|Period I|Abnormal laboratory value(s)|0
1244928|NCT00615030|4083049|P9|Period I|Abnormal laboratory value(s)|0
1244929|NCT00615030|4083050|P8|Period I|Abnormal laboratory value(s)|0
1244930|NCT00615030|4083051|P7|Period I|Abnormal laboratory value(s)|0
1244931|NCT00615030|4083052|P6|Period I|Abnormal laboratory value(s)|1
1244932|NCT00615030|4083053|P5|Period I|Abnormal laboratory value(s)|0
1244933|NCT00615030|4083054|P4|Period I|Abnormal laboratory value(s)|0
1244934|NCT00615030|4083055|P3|Period I|Abnormal laboratory value(s)|0
1244935|NCT00615030|4083056|P2|Period I|Abnormal laboratory value(s)|0
1244936|NCT00615030|4083057|P1|Period I|Abnormal laboratory value(s)|0
1244937|NCT00615030|4083046|P12|Period I|Subject withdrew consent|1
1244938|NCT00615030|4083047|P11|Period I|Subject withdrew consent|1
1244939|NCT00615030|4083048|P10|Period I|Subject withdrew consent|0
1244940|NCT00615030|4083049|P9|Period I|Subject withdrew consent|1
1244941|NCT00615030|4083050|P8|Period I|Subject withdrew consent|0
1244942|NCT00615030|4083051|P7|Period I|Subject withdrew consent|0
1244943|NCT00615030|4083052|P6|Period I|Subject withdrew consent|0
1244944|NCT00615030|4083053|P5|Period I|Subject withdrew consent|0
1244945|NCT00615030|4083054|P4|Period I|Subject withdrew consent|0
1244946|NCT00615030|4083055|P3|Period I|Subject withdrew consent|0
1244947|NCT00615030|4083056|P2|Period I|Subject withdrew consent|0
1244948|NCT00615030|4083057|P1|Period I|Subject withdrew consent|0
1244949|NCT00615030|4083046|P12|Period I|Protocol deviation|0
1244950|NCT00615030|4083047|P11|Period I|Protocol deviation|0
1244951|NCT00615030|4083048|P10|Period I|Protocol deviation|0
1244952|NCT00615030|4083049|P9|Period I|Protocol deviation|0
1244953|NCT00615030|4083050|P8|Period I|Protocol deviation|0
1244954|NCT00615030|4083051|P7|Period I|Protocol deviation|0
1244955|NCT00615030|4083052|P6|Period I|Protocol deviation|0
1244956|NCT00615030|4083053|P5|Period I|Protocol deviation|0
1244957|NCT00615030|4083054|P4|Period I|Protocol deviation|0
1244958|NCT00615030|4083055|P3|Period I|Protocol deviation|0
1244959|NCT00615030|4083056|P2|Period I|Protocol deviation|0
1244960|NCT00615030|4083057|P1|Period I|Protocol deviation|1
1244961|NCT00615030|4083046|P12|Period I|Administrative problem|0
1244962|NCT00615030|4083047|P11|Period I|Administrative problem|0
1244963|NCT00615030|4083048|P10|Period I|Administrative problem|0
1244964|NCT00615030|4083049|P9|Period I|Administrative problem|0
1244965|NCT00615030|4083050|P8|Period I|Administrative problem|0
1244966|NCT00615030|4083051|P7|Period I|Administrative problem|0
1244967|NCT00615030|4083052|P6|Period I|Administrative problem|0
1244968|NCT00615030|4083053|P5|Period I|Administrative problem|1
1244969|NCT00615030|4083054|P4|Period I|Administrative problem|0
1244970|NCT00615030|4083055|P3|Period I|Administrative problem|0
1244971|NCT00615030|4083056|P2|Period I|Administrative problem|0
1244972|NCT00615030|4083057|P1|Period I|Administrative problem|0
1244973|NCT00615017|4083077|P6|Overall Study|Physician discontinued drug|1
1244974|NCT00615017|4083078|P5|Overall Study|Physician discontinued drug|0
1244975|NCT00615017|4083079|P4|Overall Study|Physician discontinued drug|0
1244976|NCT00615017|4083080|P3|Overall Study|Physician discontinued drug|0
1244977|NCT00615017|4083081|P2|Overall Study|Physician discontinued drug|0
1244978|NCT00615017|4083082|P1|Overall Study|Physician discontinued drug|0
1244979|NCT00615017|4083077|P6|Overall Study|Transferred out of Intensive Care Unit|0
1244980|NCT00615017|4083078|P5|Overall Study|Transferred out of Intensive Care Unit|0
1244981|NCT00615017|4083079|P4|Overall Study|Transferred out of Intensive Care Unit|1
1244982|NCT00615017|4083080|P3|Overall Study|Transferred out of Intensive Care Unit|0
1244983|NCT00615017|4083081|P2|Overall Study|Transferred out of Intensive Care Unit|0
1244984|NCT00615017|4083082|P1|Overall Study|Transferred out of Intensive Care Unit|0
1244985|NCT00615017|4083077|P6|Overall Study|Sepsis resolved|0
1244986|NCT00615017|4083078|P5|Overall Study|Sepsis resolved|0
1244987|NCT00615017|4083079|P4|Overall Study|Sepsis resolved|0
1244988|NCT00615017|4083080|P3|Overall Study|Sepsis resolved|1
1244989|NCT00615017|4083081|P2|Overall Study|Sepsis resolved|0
1244990|NCT00615017|4083082|P1|Overall Study|Sepsis resolved|0
1244991|NCT00615017|4083077|P6|Overall Study|Death|1
1244992|NCT00615017|4083078|P5|Overall Study|Death|1
1244993|NCT00615017|4083079|P4|Overall Study|Death|0
1244994|NCT00615017|4083080|P3|Overall Study|Death|2
1244995|NCT00615017|4083081|P2|Overall Study|Death|0
1244996|NCT00615017|4083082|P1|Overall Study|Death|0
1244997|NCT00615017|4083077|P6|Overall Study|Adverse Event|1
1244998|NCT00615017|4083078|P5|Overall Study|Adverse Event|0
1244999|NCT00615017|4083079|P4|Overall Study|Adverse Event|0
1245000|NCT00615017|4083080|P3|Overall Study|Adverse Event|2
1245001|NCT00615017|4083081|P2|Overall Study|Adverse Event|1
1245002|NCT00615017|4083082|P1|Overall Study|Adverse Event|0
1245003|NCT00614991|4083240|P6|Overall Study|Adverse Event|0
1245004|NCT00614991|4083241|P5|Overall Study|Adverse Event|1
1245005|NCT00614991|4083242|P4|Overall Study|Adverse Event|0
1245006|NCT00614991|4083243|P3|Overall Study|Adverse Event|0
1245007|NCT00614991|4083244|P2|Overall Study|Adverse Event|3
1245008|NCT00614991|4083245|P1|Overall Study|Adverse Event|3
1245009|NCT00614939|4083279|P2|Overall Study|Hospitalized due to kidney transplant|0
1245010|NCT00614939|4083280|P1|Overall Study|Hospitalized due to kidney transplant|1
1245011|NCT00614939|4083279|P2|Overall Study|Poor/non-compliance|0
1245012|NCT00614939|4083280|P1|Overall Study|Poor/non-compliance|4
1245013|NCT00614939|4083279|P2|Overall Study|Death|3
1245014|NCT00614939|4083280|P1|Overall Study|Death|4
1245015|NCT00614939|4083279|P2|Overall Study|Incorrect enrollment|2
1245016|NCT00614939|4083280|P1|Overall Study|Incorrect enrollment|1
1245017|NCT00614939|4083279|P2|Overall Study|Adverse Event|5
1245018|NCT00614939|4083280|P1|Overall Study|Adverse Event|2
1245019|NCT00614939|4083279|P2|Overall Study|Study specific discontinuation criteris|16
1245020|NCT00614939|4083280|P1|Overall Study|Study specific discontinuation criteris|13
1245021|NCT00614939|4083279|P2|Overall Study|Withdrawal by Subject|17
1245022|NCT00614939|4083280|P1|Overall Study|Withdrawal by Subject|10
1245023|NCT00614926|4083314|P2|Overall Study|Adverse Event|0
1245024|NCT00614926|4083315|P1|Overall Study|Adverse Event|3
1245025|NCT00614926|4083314|P2|Overall Study|Burden of travel|0
1245026|NCT00614926|4083315|P1|Overall Study|Burden of travel|1
1245027|NCT00614874|4083328|P1|Overall Study|Withdrawal by Subject|1
1245028|NCT00614874|4083328|P1|Overall Study|Protocol Violation|1
1245029|NCT00614744|4083337|P2|Overall Study|Incomplete for Behavior Issues|2
1245030|NCT00614744|4083338|P1|Overall Study|Incomplete for Behavior Issues|0
1245031|NCT00614744|4083337|P2|Overall Study|Lost to Follow-up|4
1245032|NCT00614744|4083338|P1|Overall Study|Lost to Follow-up|5
1245033|NCT00614614|4083364|P5|Booster Vaccination Phase|Other|1
1245034|NCT00614614|4083365|P4|Booster Vaccination Phase|Other|2
1245035|NCT00614614|4083366|P3|Booster Vaccination Phase|Other|3
1245036|NCT00614614|4083367|P2|Booster Vaccination Phase|Other|1
1245037|NCT00614614|4083368|P1|Booster Vaccination Phase|Other|0
1245038|NCT00614614|4083364|P5|Booster Vaccination Phase|Protocol Violation|0
1245039|NCT00614614|4083365|P4|Booster Vaccination Phase|Protocol Violation|3
1245040|NCT00614614|4083366|P3|Booster Vaccination Phase|Protocol Violation|2
1245041|NCT00614614|4083367|P2|Booster Vaccination Phase|Protocol Violation|0
1245042|NCT00614614|4083368|P1|Booster Vaccination Phase|Protocol Violation|0
1245043|NCT00614614|4083364|P5|Booster Vaccination Phase|Lost to Follow-up|8
1245044|NCT00614614|4083365|P4|Booster Vaccination Phase|Lost to Follow-up|10
1245045|NCT00614614|4083366|P3|Booster Vaccination Phase|Lost to Follow-up|17
1245046|NCT00614614|4083367|P2|Booster Vaccination Phase|Lost to Follow-up|5
1245047|NCT00614614|4083368|P1|Booster Vaccination Phase|Lost to Follow-up|0
1245048|NCT00614614|4083364|P5|Booster Vaccination Phase|Withdrawal by Subject|4
1245049|NCT00614614|4083365|P4|Booster Vaccination Phase|Withdrawal by Subject|3
1245050|NCT00614614|4083366|P3|Booster Vaccination Phase|Withdrawal by Subject|4
1245051|NCT00614614|4083367|P2|Booster Vaccination Phase|Withdrawal by Subject|0
1245052|NCT00614614|4083368|P1|Booster Vaccination Phase|Withdrawal by Subject|0
1245053|NCT00614614|4083364|P5|Booster Vaccination Phase|Adverse Event|0
1245054|NCT00614614|4083365|P4|Booster Vaccination Phase|Adverse Event|1
1245055|NCT00614614|4083366|P3|Booster Vaccination Phase|Adverse Event|1
1245056|NCT00614614|4083367|P2|Booster Vaccination Phase|Adverse Event|0
1245057|NCT00614614|4083368|P1|Booster Vaccination Phase|Adverse Event|0
1245058|NCT00614614|4083364|P5|Primary Vaccination Phase|Other|0
1245059|NCT00614614|4083365|P4|Primary Vaccination Phase|Other|0
1245060|NCT00614614|4083366|P3|Primary Vaccination Phase|Other|0
1245061|NCT00614614|4083367|P2|Primary Vaccination Phase|Other|0
1245062|NCT00614614|4083368|P1|Primary Vaccination Phase|Other|4
1245063|NCT00614614|4083364|P5|Primary Vaccination Phase|Protocol Violation|0
1245064|NCT00614614|4083365|P4|Primary Vaccination Phase|Protocol Violation|0
1245065|NCT00614614|4083366|P3|Primary Vaccination Phase|Protocol Violation|0
1245066|NCT00614614|4083367|P2|Primary Vaccination Phase|Protocol Violation|3
1245067|NCT00614614|4083368|P1|Primary Vaccination Phase|Protocol Violation|9
1245068|NCT00614614|4083364|P5|Primary Vaccination Phase|Lost to Follow-up|0
1245069|NCT00614614|4083365|P4|Primary Vaccination Phase|Lost to Follow-up|0
1245070|NCT00614614|4083366|P3|Primary Vaccination Phase|Lost to Follow-up|0
1245071|NCT00614614|4083367|P2|Primary Vaccination Phase|Lost to Follow-up|8
1245072|NCT00614614|4083368|P1|Primary Vaccination Phase|Lost to Follow-up|26
1245073|NCT00614614|4083364|P5|Primary Vaccination Phase|Withdrawal by Subject|0
1245074|NCT00614614|4083365|P4|Primary Vaccination Phase|Withdrawal by Subject|0
1245075|NCT00614614|4083366|P3|Primary Vaccination Phase|Withdrawal by Subject|0
1245076|NCT00614614|4083367|P2|Primary Vaccination Phase|Withdrawal by Subject|6
1245077|NCT00614614|4083368|P1|Primary Vaccination Phase|Withdrawal by Subject|45
1245078|NCT00614614|4083364|P5|Primary Vaccination Phase|Adverse Event|0
1245079|NCT00614614|4083365|P4|Primary Vaccination Phase|Adverse Event|0
1245080|NCT00614614|4083366|P3|Primary Vaccination Phase|Adverse Event|0
1245081|NCT00614614|4083367|P2|Primary Vaccination Phase|Adverse Event|0
1245082|NCT00614614|4083368|P1|Primary Vaccination Phase|Adverse Event|6
1245083|NCT00614575|4083491|P1|Overall Study|No treatment|1
1245084|NCT00614575|4083491|P1|Overall Study|Irregularly enrolled patients|23
1245085|NCT00614575|4083491|P1|Overall Study|No data were collected.|18
1245086|NCT00614575|4083491|P1|Overall Study|Physician Decision|2
1245087|NCT00614575|4083491|P1|Overall Study|Death|3
1245088|NCT00614575|4083491|P1|Overall Study|Withdrawal by Subject|6
1245089|NCT00614575|4083491|P1|Overall Study|Lack of Efficacy|14
1245090|NCT00614575|4083491|P1|Overall Study|Lost to Follow-up|55
1245091|NCT00614575|4083491|P1|Overall Study|Adverse Event|106
1245092|NCT00614523|4083502|P2|Overall Study|Administrative Decision|46
1245093|NCT00614523|4083503|P1|Overall Study|Administrative Decision|23
1245094|NCT00614523|4083502|P2|Overall Study|Disease Progression|8
1245095|NCT00614523|4083503|P1|Overall Study|Disease Progression|0
1245096|NCT00614523|4083502|P2|Overall Study|Ineligibility Determined|2
1245097|NCT00614523|4083503|P1|Overall Study|Ineligibility Determined|1
1245098|NCT00614523|4083502|P2|Overall Study|Other|11
1245099|NCT00614523|4083503|P1|Overall Study|Other|6
1245100|NCT00614523|4083502|P2|Overall Study|Withdrawal by Subject|22
1245101|NCT00614523|4083503|P1|Overall Study|Withdrawal by Subject|12
1245102|NCT00614523|4083502|P2|Overall Study|Protocol Violation|2
1245103|NCT00614523|4083503|P1|Overall Study|Protocol Violation|3
1245104|NCT00614523|4083502|P2|Overall Study|Lost to Follow-up|1
1245105|NCT00614523|4083503|P1|Overall Study|Lost to Follow-up|0
1245106|NCT00614523|4083502|P2|Overall Study|Lack of Efficacy|11
1245107|NCT00614523|4083503|P1|Overall Study|Lack of Efficacy|9
1245108|NCT00614523|4083502|P2|Overall Study|Death|8
1245109|NCT00614523|4083503|P1|Overall Study|Death|5
1245110|NCT00614523|4083502|P2|Overall Study|Adverse Event|20
1245111|NCT00614523|4083503|P1|Overall Study|Adverse Event|4
1245112|NCT00614393|4083568|P5|Overall Study|Not Treated|2
1245113|NCT00614393|4083569|P4|Overall Study|Not Treated|0
1245114|NCT00614393|4083570|P3|Overall Study|Not Treated|0
1245115|NCT00614393|4083571|P2|Overall Study|Not Treated|0
1245116|NCT00614393|4083572|P1|Overall Study|Not Treated|0
1245117|NCT00614393|4083568|P5|Overall Study|Other|2
1245118|NCT00614393|4083569|P4|Overall Study|Other|4
1245119|NCT00614393|4083570|P3|Overall Study|Other|0
1245120|NCT00614393|4083571|P2|Overall Study|Other|0
1245121|NCT00614393|4083572|P1|Overall Study|Other|4
1245122|NCT00614393|4083568|P5|Overall Study|Withdrawal by Subject|13
1245123|NCT00614393|4083569|P4|Overall Study|Withdrawal by Subject|16
1245124|NCT00614393|4083570|P3|Overall Study|Withdrawal by Subject|1
1245125|NCT00614393|4083571|P2|Overall Study|Withdrawal by Subject|1
1245126|NCT00614393|4083572|P1|Overall Study|Withdrawal by Subject|20
1245127|NCT00614393|4083568|P5|Overall Study|Terminated by Sponsor|1
1245128|NCT00614393|4083569|P4|Overall Study|Terminated by Sponsor|0
1245129|NCT00614393|4083570|P3|Overall Study|Terminated by Sponsor|0
1245130|NCT00614393|4083571|P2|Overall Study|Terminated by Sponsor|0
1245131|NCT00614393|4083572|P1|Overall Study|Terminated by Sponsor|0
1245132|NCT00614393|4083568|P5|Overall Study|Protocol Violation|0
1245133|NCT00614393|4083569|P4|Overall Study|Protocol Violation|0
1245134|NCT00614393|4083570|P3|Overall Study|Protocol Violation|0
1245135|NCT00614393|4083571|P2|Overall Study|Protocol Violation|0
1245136|NCT00614393|4083572|P1|Overall Study|Protocol Violation|1
1245137|NCT00614393|4083568|P5|Overall Study|Progressive Disease|130
1245138|NCT00614393|4083569|P4|Overall Study|Progressive Disease|138
1245139|NCT00614393|4083570|P3|Overall Study|Progressive Disease|5
1245140|NCT00614393|4083571|P2|Overall Study|Progressive Disease|5
1245141|NCT00614393|4083572|P1|Overall Study|Progressive Disease|118
1245142|NCT00614393|4083568|P5|Overall Study|Physician Decision|9
1245143|NCT00614393|4083569|P4|Overall Study|Physician Decision|8
1245144|NCT00614393|4083570|P3|Overall Study|Physician Decision|1
1245145|NCT00614393|4083571|P2|Overall Study|Physician Decision|0
1245146|NCT00614393|4083572|P1|Overall Study|Physician Decision|17
1245147|NCT00614393|4083568|P5|Overall Study|Lost to Follow-up|2
1245148|NCT00614393|4083569|P4|Overall Study|Lost to Follow-up|1
1245149|NCT00614393|4083570|P3|Overall Study|Lost to Follow-up|0
1245150|NCT00614393|4083571|P2|Overall Study|Lost to Follow-up|0
1245151|NCT00614393|4083572|P1|Overall Study|Lost to Follow-up|0
1245152|NCT00614393|4083568|P5|Overall Study|Adverse Event|21
1245153|NCT00614393|4083569|P4|Overall Study|Adverse Event|13
1245154|NCT00614393|4083570|P3|Overall Study|Adverse Event|3
1245155|NCT00614393|4083571|P2|Overall Study|Adverse Event|2
1245156|NCT00614393|4083572|P1|Overall Study|Adverse Event|20
1245157|NCT00614380|4083618|P4|Overall Study|Consent withdrawn|0
1245158|NCT00614380|4083619|P3|Overall Study|Consent withdrawn|0
1245159|NCT00614380|4083620|P2|Overall Study|Consent withdrawn|1
1245160|NCT00614380|4083621|P1|Overall Study|Consent withdrawn|3
1245161|NCT00614380|4083618|P4|Overall Study|Non compliant with the protocol|2
1245162|NCT00614380|4083619|P3|Overall Study|Non compliant with the protocol|1
1245163|NCT00614380|4083620|P2|Overall Study|Non compliant with the protocol|2
1245164|NCT00614380|4083621|P1|Overall Study|Non compliant with the protocol|12
1245165|NCT00614380|4083618|P4|Overall Study|Lost to Follow-up|0
1245166|NCT00614380|4083619|P3|Overall Study|Lost to Follow-up|0
1245167|NCT00614380|4083620|P2|Overall Study|Lost to Follow-up|1
1245168|NCT00614380|4083621|P1|Overall Study|Lost to Follow-up|6
1245169|NCT00614380|4083618|P4|Overall Study|Adverse Event|0
1245170|NCT00614380|4083619|P3|Overall Study|Adverse Event|0
1245171|NCT00614380|4083620|P2|Overall Study|Adverse Event|4
1245172|NCT00614380|4083621|P1|Overall Study|Adverse Event|14
1245173|NCT00614120|4083688|P4|Overall Study|Lost to Follow-up|4
1245174|NCT00614120|4083689|P3|Overall Study|Lost to Follow-up|3
1245175|NCT00614120|4083690|P2|Overall Study|Lost to Follow-up|2
1245176|NCT00614120|4083691|P1|Overall Study|Lost to Follow-up|1
1245177|NCT00614120|4083688|P4|Overall Study|Taken inhibition medication eg Prandin|1
1245178|NCT00614120|4083689|P3|Overall Study|Taken inhibition medication eg Prandin|1
1245179|NCT00614120|4083690|P2|Overall Study|Taken inhibition medication eg Prandin|0
1245180|NCT00614120|4083691|P1|Overall Study|Taken inhibition medication eg Prandin|0
1245181|NCT00614120|4083688|P4|Overall Study|Late syphilis, latent|0
1245182|NCT00614120|4083689|P3|Overall Study|Late syphilis, latent|0
1245183|NCT00614120|4083690|P2|Overall Study|Late syphilis, latent|0
1245184|NCT00614120|4083691|P1|Overall Study|Late syphilis, latent|1
1245185|NCT00614120|4083688|P4|Overall Study|Lack of trial product|0
1245186|NCT00614120|4083689|P3|Overall Study|Lack of trial product|2
1245187|NCT00614120|4083690|P2|Overall Study|Lack of trial product|3
1245188|NCT00614120|4083691|P1|Overall Study|Lack of trial product|3
1245189|NCT00614120|4083688|P4|Overall Study|Hypoglycaemia|1
1245190|NCT00614120|4083689|P3|Overall Study|Hypoglycaemia|0
1245191|NCT00614120|4083690|P2|Overall Study|Hypoglycaemia|0
1245192|NCT00614120|4083691|P1|Overall Study|Hypoglycaemia|0
1245193|NCT00614120|4083688|P4|Overall Study|hCG positive (not pregnant)|0
1245194|NCT00614120|4083689|P3|Overall Study|hCG positive (not pregnant)|1
1245195|NCT00614120|4083690|P2|Overall Study|hCG positive (not pregnant)|0
1245196|NCT00614120|4083691|P1|Overall Study|hCG positive (not pregnant)|0
1245197|NCT00614120|4083688|P4|Overall Study|Did not meet trial criteria|1
1245198|NCT00614120|4083689|P3|Overall Study|Did not meet trial criteria|1
1245199|NCT00614120|4083690|P2|Overall Study|Did not meet trial criteria|1
1245200|NCT00614120|4083691|P1|Overall Study|Did not meet trial criteria|0
1245201|NCT00614120|4083688|P4|Overall Study|Withdrawal by Subject|3
1245202|NCT00614120|4083689|P3|Overall Study|Withdrawal by Subject|16
1245203|NCT00614120|4083690|P2|Overall Study|Withdrawal by Subject|10
1245204|NCT00614120|4083691|P1|Overall Study|Withdrawal by Subject|9
1245205|NCT00614120|4083688|P4|Overall Study|Withdrawal criteria|0
1245206|NCT00614120|4083689|P3|Overall Study|Withdrawal criteria|0
1245207|NCT00614120|4083690|P2|Overall Study|Withdrawal criteria|0
1245208|NCT00614120|4083691|P1|Overall Study|Withdrawal criteria|1
1245209|NCT00614120|4083688|P4|Overall Study|Protocol Violation|1
1245210|NCT00614120|4083689|P3|Overall Study|Protocol Violation|3
1245211|NCT00614120|4083690|P2|Overall Study|Protocol Violation|5
1245212|NCT00614120|4083691|P1|Overall Study|Protocol Violation|2
1245213|NCT00614120|4083688|P4|Overall Study|Lack of Efficacy|2
1245214|NCT00614120|4083689|P3|Overall Study|Lack of Efficacy|2
1245215|NCT00614120|4083690|P2|Overall Study|Lack of Efficacy|3
1245216|NCT00614120|4083691|P1|Overall Study|Lack of Efficacy|3
1245217|NCT00614120|4083688|P4|Overall Study|Adverse Event|3
1245218|NCT00614120|4083689|P3|Overall Study|Adverse Event|30
1245219|NCT00614120|4083690|P2|Overall Study|Adverse Event|22
1245220|NCT00614120|4083691|P1|Overall Study|Adverse Event|9
1245221|NCT00614055|4083732|P3|Overall Study|Unclassified|2
1245222|NCT00614055|4083733|P2|Overall Study|Unclassified|4
1245223|NCT00614055|4083734|P1|Overall Study|Unclassified|1
1245224|NCT00614055|4083732|P3|Overall Study|Lack of Efficacy|2
1245225|NCT00614055|4083733|P2|Overall Study|Lack of Efficacy|0
1245226|NCT00614055|4083734|P1|Overall Study|Lack of Efficacy|0
1245227|NCT00614055|4083732|P3|Overall Study|Protocol Violation|1
1245228|NCT00614055|4083733|P2|Overall Study|Protocol Violation|2
1245229|NCT00614055|4083734|P1|Overall Study|Protocol Violation|2
1245230|NCT00614055|4083732|P3|Overall Study|Adverse Event|0
1245231|NCT00614055|4083733|P2|Overall Study|Adverse Event|0
1245232|NCT00614055|4083734|P1|Overall Study|Adverse Event|1
1245233|NCT00613951|4083781|P3|Overall Study|Unclassified|2
1245234|NCT00613951|4083782|P2|Overall Study|Unclassified|3
1245235|NCT00613951|4083783|P1|Overall Study|Unclassified|5
1245236|NCT00613951|4083781|P3|Overall Study|Protocol Violation|1
1245237|NCT00613951|4083782|P2|Overall Study|Protocol Violation|1
1245238|NCT00613951|4083783|P1|Overall Study|Protocol Violation|1
1245239|NCT00613951|4083781|P3|Overall Study|Lack of Efficacy|1
1245240|NCT00613951|4083782|P2|Overall Study|Lack of Efficacy|1
1245241|NCT00613951|4083783|P1|Overall Study|Lack of Efficacy|0
1245242|NCT00613951|4083781|P3|Overall Study|Adverse Event|1
1245243|NCT00613951|4083782|P2|Overall Study|Adverse Event|0
1245244|NCT00613951|4083783|P1|Overall Study|Adverse Event|1
1245245|NCT00613938|4083828|P4|Overall Study|Other|3
1245246|NCT00613938|4083829|P3|Overall Study|Other|1
1245247|NCT00613938|4083830|P2|Overall Study|Other|2
1245248|NCT00613938|4083831|P1|Overall Study|Other|1
1245249|NCT00613938|4083828|P4|Overall Study|Lack of Efficacy|9
1245250|NCT00613938|4083829|P3|Overall Study|Lack of Efficacy|5
1245251|NCT00613938|4083830|P2|Overall Study|Lack of Efficacy|18
1245252|NCT00613938|4083831|P1|Overall Study|Lack of Efficacy|16
1245253|NCT00613938|4083828|P4|Overall Study|Adverse Event|5
1245254|NCT00613938|4083829|P3|Overall Study|Adverse Event|8
1245255|NCT00613938|4083830|P2|Overall Study|Adverse Event|4
1245256|NCT00613938|4083831|P1|Overall Study|Adverse Event|1
1245257|NCT00613938|4083828|P4|Overall Study|Withdrawal by Subject|9
1245258|NCT00613938|4083829|P3|Overall Study|Withdrawal by Subject|9
1245259|NCT00613938|4083830|P2|Overall Study|Withdrawal by Subject|4
1245260|NCT00613938|4083831|P1|Overall Study|Withdrawal by Subject|2
1245261|NCT00613925|4083863|P2|Overall Study|1 did not tolerate outpatient biopsy|1
1245262|NCT00613925|4083864|P1|Overall Study|1 did not tolerate outpatient biopsy|0
1245263|NCT00613821|4083874|P2|Overall Study|Physician Decision|1
1245264|NCT00613821|4083875|P1|Overall Study|Physician Decision|1
1245265|NCT00613821|4083874|P2|Overall Study|Withdrawal by Subject|0
1245266|NCT00613821|4083875|P1|Overall Study|Withdrawal by Subject|1
1245267|NCT00613730|4083881|P1|Overall Study|Administrative decision|1
1245268|NCT00613730|4083881|P1|Overall Study|Disease progression|2
1245269|NCT00613626|4083890|P3|Overall Study|Ineligible|0
1245270|NCT00613626|4083891|P2|Overall Study|Ineligible|1
1245271|NCT00613626|4083892|P1|Overall Study|Ineligible|0
1245272|NCT00613574|4083908|P1|Overall Study|Other|1
1245273|NCT00613574|4083908|P1|Overall Study|Lost to Follow-up|2
1245274|NCT00613574|4083908|P1|Overall Study|Adverse Event|3
1245275|NCT00613509|4083920|P2|Cycle 1|Other administrative reason|1
1245276|NCT00613509|4083921|P1|Cycle 1|Other administrative reason|0
1245277|NCT00613509|4083920|P2|Cycle 1|Unacceptable Toxicity|0
1245278|NCT00613509|4083921|P1|Cycle 1|Unacceptable Toxicity|1
1245279|NCT00613509|4083920|P2|Cycle 1|Disease Progression|6
1245280|NCT00613509|4083921|P1|Cycle 1|Disease Progression|2
1245281|NCT00613509|4083920|P2|Cycle 1|Adverse Event|1
1245282|NCT00613509|4083921|P1|Cycle 1|Adverse Event|2
1245283|NCT00613366|4083967|P2|Overall Study|Withdrawal by Subject|2
1245284|NCT00613366|4083968|P1|Overall Study|Withdrawal by Subject|3
1245285|NCT00613327|4083976|P1|Overall Study|Other|47
1245286|NCT00613327|4083976|P1|Overall Study|Protocol Violation|2
1245287|NCT00613327|4083976|P1|Overall Study|Withdrawal by Subject|6
1245288|NCT00613327|4083976|P1|Overall Study|Lost to Follow-up|8
1245289|NCT00613327|4083976|P1|Overall Study|Adverse Event|38
1245290|NCT00613314|4083995|P1|Overall Study|Other reason not defined above|90
1245291|NCT00613314|4083995|P1|Overall Study|Lost to Follow-up|46
1245292|NCT00613314|4083995|P1|Overall Study|Protocol Violation|14
1245293|NCT00613314|4083995|P1|Overall Study|Adverse Event|5
1245294|NCT00613301|4084003|P1|Overall Study|Irregularly enrolled patients|12
1245295|NCT00613301|4084003|P1|Overall Study|No data was collected|53
1245296|NCT00613301|4084003|P1|Overall Study|Physician Decision|2
1245297|NCT00613301|4084003|P1|Overall Study|Lack of Efficacy|13
1245298|NCT00613301|4084003|P1|Overall Study|Death|6
1245299|NCT00613301|4084003|P1|Overall Study|Withdrawal by Subject|5
1245300|NCT00613301|4084003|P1|Overall Study|Lost to Follow-up|88
1245301|NCT00613301|4084003|P1|Overall Study|Adverse Event|49
1245302|NCT00613106|4084012|P2|Overall Study|misc|3
1245303|NCT00613106|4084013|P1|Overall Study|misc|4
1245304|NCT00613106|4084012|P2|Overall Study|Lost to Follow-up|2
1245305|NCT00613106|4084013|P1|Overall Study|Lost to Follow-up|7
1245306|NCT00613106|4084012|P2|Overall Study|Withdrawal by Subject|3
1245307|NCT00613106|4084013|P1|Overall Study|Withdrawal by Subject|6
1245308|NCT00613106|4084012|P2|Overall Study|Adverse Event|1
1245309|NCT00613106|4084013|P1|Overall Study|Adverse Event|3
1245310|NCT00613080|4084019|P1|Overall Study|Ineligible / no protocol treatment|11
1245311|NCT00613015|4084054|P6|Overall Study|Lost to Follow-up|3
1245312|NCT00613015|4084055|P5|Overall Study|Lost to Follow-up|2
1245313|NCT00613015|4084056|P4|Overall Study|Lost to Follow-up|3
1245314|NCT00613015|4084057|P3|Overall Study|Lost to Follow-up|3
1245315|NCT00613015|4084058|P2|Overall Study|Lost to Follow-up|1
1245316|NCT00613015|4084059|P1|Overall Study|Lost to Follow-up|0
1245317|NCT00612807|4084095|P2|Overall Study|Withdrawal by Subject|0
1245318|NCT00612807|4084096|P1|Overall Study|Withdrawal by Subject|2
1245319|NCT00612690|4084131|P2|Overall Study|Withdrawal by Site|0
1245320|NCT00612690|4084132|P1|Overall Study|Withdrawal by Site|11
1245321|NCT00612690|4084131|P2|Overall Study|Withdrawal by Subject|20
1245322|NCT00612690|4084132|P1|Overall Study|Withdrawal by Subject|32
1245323|NCT00612690|4084131|P2|Overall Study|Lost to Follow-up|98
1245324|NCT00612690|4084132|P1|Overall Study|Lost to Follow-up|72
1245325|NCT00612677|4084140|P1|Overall Study|study closed before treatment started|1
1245326|NCT00612534|4084208|P4|Overall Study|Other Reason|0
1245327|NCT00612534|4084209|P3|Overall Study|Other Reason|0
1245328|NCT00612534|4084210|P2|Overall Study|Other Reason|1
1245329|NCT00612534|4084211|P1|Overall Study|Other Reason|0
1245330|NCT00612534|4084208|P4|Overall Study|Lack of Efficacy|16
1245331|NCT00612534|4084209|P3|Overall Study|Lack of Efficacy|5
1245332|NCT00612534|4084210|P2|Overall Study|Lack of Efficacy|12
1245333|NCT00612534|4084211|P1|Overall Study|Lack of Efficacy|13
1245334|NCT00612534|4084208|P4|Overall Study|Adverse Event|1
1245335|NCT00612534|4084209|P3|Overall Study|Adverse Event|2
1245336|NCT00612534|4084210|P2|Overall Study|Adverse Event|4
1245337|NCT00612534|4084211|P1|Overall Study|Adverse Event|0
1245338|NCT00612508|4084223|P2|Overall Study|Withdrawal by Subject|4
1245339|NCT00612508|4084224|P1|Overall Study|Withdrawal by Subject|3
1245340|NCT00612456|4084235|P3|Overall Study|Withdrawal by Subject|0
1245341|NCT00612456|4084236|P2|Overall Study|Withdrawal by Subject|1
1245342|NCT00612456|4084237|P1|Overall Study|Withdrawal by Subject|0
1245343|NCT00612456|4084235|P3|Overall Study|Lack of Efficacy|0
1245344|NCT00612456|4084236|P2|Overall Study|Lack of Efficacy|1
1245345|NCT00612456|4084237|P1|Overall Study|Lack of Efficacy|1
1245346|NCT00612456|4084235|P3|Overall Study|Adverse Event|0
1245347|NCT00612456|4084236|P2|Overall Study|Adverse Event|0
1245348|NCT00612456|4084237|P1|Overall Study|Adverse Event|1
1245349|NCT00612352|4084300|P2|Overall Study|didn't return calls/show up on test date|1
1245350|NCT00612352|4084301|P1|Overall Study|didn't return calls/show up on test date|4
1245351|NCT00612352|4084300|P2|Overall Study|moved out of state|0
1245352|NCT00612352|4084301|P1|Overall Study|moved out of state|1
1245353|NCT00612352|4084300|P2|Overall Study|Withdrawal by Subject|5
1245354|NCT00612352|4084301|P1|Overall Study|Withdrawal by Subject|3
1245355|NCT00612352|4084300|P2|Overall Study|Adverse Event|0
1245356|NCT00612352|4084301|P1|Overall Study|Adverse Event|1
1245357|NCT00612313|4084421|P2|Overall Study|Lost to Follow-up|4
1245358|NCT00612313|4084422|P1|Overall Study|Lost to Follow-up|11
1245359|NCT00612313|4084421|P2|Overall Study|Withdrawal by Subject|9
1245360|NCT00612313|4084422|P1|Overall Study|Withdrawal by Subject|6
1245361|NCT00612105|4084464|P2|Period Title 3: 3-Week Taper Phase|Other|0
1245362|NCT00612105|4084465|P1|Period Title 3: 3-Week Taper Phase|Other|1
1245363|NCT00612105|4084464|P2|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0
1245364|NCT00612105|4084465|P1|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1
1245365|NCT00612105|4084464|P2|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
1245366|NCT00612105|4084465|P1|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
1245367|NCT00612105|4084464|P2|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1
1245368|NCT00612105|4084465|P1|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9
1245369|NCT00612105|4084464|P2|Period Title 1: 6-Week Titration Phase|Other|1
1245370|NCT00612105|4084465|P1|Period Title 1: 6-Week Titration Phase|Other|0
1245371|NCT00612105|4084464|P2|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0
1245372|NCT00612105|4084465|P1|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5
1245373|NCT00612105|4084464|P2|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1
1245374|NCT00612105|4084465|P1|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3
1245375|NCT00612105|4084464|P2|Period Title 1: 6-Week Titration Phase|Protocol Violation|0
1245376|NCT00612105|4084465|P1|Period Title 1: 6-Week Titration Phase|Protocol Violation|1
1245377|NCT00612105|4084464|P2|Period Title 1: 6-Week Titration Phase|Physician Decision|1
1245378|NCT00612105|4084465|P1|Period Title 1: 6-Week Titration Phase|Physician Decision|1
1245379|NCT00612105|4084464|P2|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0
1245380|NCT00612105|4084465|P1|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2
1245381|NCT00612105|4084464|P2|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1
1245382|NCT00612105|4084465|P1|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6
1245383|NCT00612105|4084464|P2|Period Title 1: 6-Week Titration Phase|Adverse Event|1
1245384|NCT00612105|4084465|P1|Period Title 1: 6-Week Titration Phase|Adverse Event|18
1245385|NCT00612066|4084515|P1|Overall Study|Adverse Event|1
1245386|NCT00612040|4084522|P3|Overall Study|Unclassified|5
1245387|NCT00612040|4084523|P2|Overall Study|Unclassified|2
1245388|NCT00612040|4084524|P1|Overall Study|Unclassified|2
1245389|NCT00612040|4084522|P3|Overall Study|Lack of Efficacy|0
1245390|NCT00612040|4084523|P2|Overall Study|Lack of Efficacy|1
1245391|NCT00612040|4084524|P1|Overall Study|Lack of Efficacy|2
1245392|NCT00612040|4084522|P3|Overall Study|Protocol Violation|1
1245393|NCT00612040|4084523|P2|Overall Study|Protocol Violation|2
1245394|NCT00612040|4084524|P1|Overall Study|Protocol Violation|1
1245395|NCT00612040|4084522|P3|Overall Study|Adverse Event|1
1245396|NCT00612040|4084523|P2|Overall Study|Adverse Event|2
1245397|NCT00612040|4084524|P1|Overall Study|Adverse Event|0
1245398|NCT00611884|4084597|P4|Overall Study|Unclassified|3
1245399|NCT00611884|4084598|P3|Overall Study|Unclassified|2
1245400|NCT00611884|4084599|P2|Overall Study|Unclassified|4
1245401|NCT00611884|4084600|P1|Overall Study|Unclassified|7
1245402|NCT00611884|4084597|P4|Overall Study|Lack of Efficacy|0
1245403|NCT00611884|4084598|P3|Overall Study|Lack of Efficacy|0
1245404|NCT00611884|4084599|P2|Overall Study|Lack of Efficacy|1
1245405|NCT00611884|4084600|P1|Overall Study|Lack of Efficacy|0
1245406|NCT00611884|4084597|P4|Overall Study|Non-Compliance|2
1245407|NCT00611884|4084598|P3|Overall Study|Non-Compliance|2
1245408|NCT00611884|4084599|P2|Overall Study|Non-Compliance|4
1245409|NCT00611884|4084600|P1|Overall Study|Non-Compliance|1
1245410|NCT00611884|4084597|P4|Overall Study|Adverse Event|1
1245411|NCT00611884|4084598|P3|Overall Study|Adverse Event|0
1245412|NCT00611884|4084599|P2|Overall Study|Adverse Event|0
1245413|NCT00611884|4084600|P1|Overall Study|Adverse Event|1
1245414|NCT00611858|4084654|P1|Overall Study|Withdrawal by Subject|2
1245415|NCT00611858|4084654|P1|Overall Study|Adverse Event|2
1245416|NCT00611806|4084666|P2|Overall Study|Lost to Follow-up|0
1245417|NCT00611806|4084667|P1|Overall Study|Lost to Follow-up|6
1245418|NCT00611806|4084666|P2|Overall Study|Adverse Event|1
1245419|NCT00611806|4084667|P1|Overall Study|Adverse Event|2
1245420|NCT00611806|4084666|P2|Overall Study|Withdrawal by Subject|2
1245421|NCT00611806|4084667|P1|Overall Study|Withdrawal by Subject|8
1245422|NCT00611767|4084681|P2|Overall Study|Physician Decision|0
1245423|NCT00611767|4084682|P1|Overall Study|Physician Decision|1
1245424|NCT00611767|4084681|P2|Overall Study|didn't like the medication|1
1245425|NCT00611767|4084682|P1|Overall Study|didn't like the medication|1
1245426|NCT00611767|4084681|P2|Overall Study|Thiopental not available|0
1245427|NCT00611767|4084682|P1|Overall Study|Thiopental not available|3
1245428|NCT00611767|4084681|P2|Overall Study|Withdrawal by Subject|1
1245429|NCT00611767|4084682|P1|Overall Study|Withdrawal by Subject|4
1245430|NCT00611715|4084844|P2|Overall Study|two patients are still on treatment|0
1245431|NCT00611715|4084845|P1|Overall Study|two patients are still on treatment|2
1245432|NCT00611715|4084844|P2|Overall Study|Death|0
1245433|NCT00611715|4084845|P1|Overall Study|Death|1
1245434|NCT00611715|4084844|P2|Overall Study|Adverse Event|1
1245435|NCT00611715|4084845|P1|Overall Study|Adverse Event|9
1245436|NCT00611715|4084844|P2|Overall Study|Withdrawal by Subject|1
1245437|NCT00611715|4084845|P1|Overall Study|Withdrawal by Subject|5
1245438|NCT00611715|4084844|P2|Overall Study|Disease Progression|4
1245439|NCT00611715|4084845|P1|Overall Study|Disease Progression|24
1245440|NCT00611559|4084865|P3|Overall Study|Protocol Violation|1
1245441|NCT00611559|4084866|P2|Overall Study|Protocol Violation|0
1245442|NCT00611559|4084867|P1|Overall Study|Protocol Violation|1
1245443|NCT00611559|4084865|P3|Overall Study|Lost to Follow-up|0
1245444|NCT00611559|4084866|P2|Overall Study|Lost to Follow-up|1
1245445|NCT00611559|4084867|P1|Overall Study|Lost to Follow-up|0
1245446|NCT00611533|4084926|P2|Second Intervention (6 Weeks)|Adverse Event|2
1245447|NCT00611533|4084927|P1|Second Intervention (6 Weeks)|Adverse Event|0
1245448|NCT00611533|4084926|P2|First Intervention (6 Weeks)|Adverse Event|1
1245449|NCT00611533|4084927|P1|First Intervention (6 Weeks)|Adverse Event|0
1245450|NCT00611533|4084926|P2|First Intervention (6 Weeks)|Never started study|1
1245451|NCT00611533|4084927|P1|First Intervention (6 Weeks)|Never started study|0
1245452|NCT00611455|4084961|P3|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49
1245453|NCT00611455|4084962|P2|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
1245454|NCT00611455|4084963|P1|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
1245455|NCT00611455|4084961|P3|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13
1245456|NCT00611455|4084962|P2|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
1245457|NCT00611455|4084963|P1|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
1245458|NCT00611455|4084961|P3|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80
1245459|NCT00611455|4084962|P2|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
1245460|NCT00611455|4084963|P1|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
1245461|NCT00611455|4084961|P3|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23
1245462|NCT00611455|4084962|P2|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
1245463|NCT00611455|4084963|P1|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
1245464|NCT00611455|4084961|P3|Follow-up Period (Approximately 2 Years)|Protocol Violation|4
1245465|NCT00611455|4084962|P2|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
1245466|NCT00611455|4084963|P1|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
1245467|NCT00611455|4084961|P3|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12
1245468|NCT00611455|4084962|P2|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
1245469|NCT00611455|4084963|P1|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
1245470|NCT00611455|4084961|P3|Follow-up Period (Approximately 2 Years)|Adverse Event|30
1245471|NCT00611455|4084962|P2|Follow-up Period (Approximately 2 Years)|Adverse Event|0
1245472|NCT00611455|4084963|P1|Follow-up Period (Approximately 2 Years)|Adverse Event|0
1245473|NCT00611455|4084961|P3|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
1245474|NCT00611455|4084962|P2|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18
1245475|NCT00611455|4084963|P1|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
1245476|NCT00611455|4084961|P3|OL Treatment Period (120 Weeks)|Physician Decision|0
1245477|NCT00611455|4084962|P2|OL Treatment Period (120 Weeks)|Physician Decision|5
1245478|NCT00611455|4084963|P1|OL Treatment Period (120 Weeks)|Physician Decision|0
1245479|NCT00611455|4084961|P3|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
1245480|NCT00611455|4084962|P2|OL Treatment Period (120 Weeks)|Lost to Follow-up|5
1245481|NCT00611455|4084963|P1|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
1245482|NCT00611455|4084961|P3|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
1245483|NCT00611455|4084962|P2|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110
1245484|NCT00611455|4084963|P1|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
1245485|NCT00611455|4084961|P3|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
1245486|NCT00611455|4084962|P2|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12
1245487|NCT00611455|4084963|P1|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
1245488|NCT00611455|4084961|P3|OL Treatment Period (120 Weeks)|Protocol Violation|0
1245489|NCT00611455|4084962|P2|OL Treatment Period (120 Weeks)|Protocol Violation|3
1245490|NCT00611455|4084963|P1|OL Treatment Period (120 Weeks)|Protocol Violation|0
1245491|NCT00611455|4084961|P3|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
1245492|NCT00611455|4084962|P2|OL Treatment Period (120 Weeks)|Lack of Efficacy|9
1245493|NCT00611455|4084963|P1|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
1245494|NCT00611455|4084961|P3|OL Treatment Period (120 Weeks)|Adverse Event|0
1245495|NCT00611455|4084962|P2|OL Treatment Period (120 Weeks)|Adverse Event|17
1245496|NCT00611455|4084963|P1|OL Treatment Period (120 Weeks)|Adverse Event|0
1245497|NCT00611455|4084961|P3|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
1245498|NCT00611455|4084962|P2|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
1245499|NCT00611455|4084963|P1|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1
1245500|NCT00611455|4084961|P3|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0
1245501|NCT00611455|4084962|P2|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
1245502|NCT00611455|4084963|P1|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
1245503|NCT00611455|4084961|P3|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
1245504|NCT00611455|4084962|P2|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3
1245505|NCT00611455|4084963|P1|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2
1245506|NCT00611455|4084961|P3|DB Treatment Period (24 Weeks)|Protocol Violation|0
1245507|NCT00611455|4084962|P2|DB Treatment Period (24 Weeks)|Protocol Violation|1
1245508|NCT00611455|4084963|P1|DB Treatment Period (24 Weeks)|Protocol Violation|4
1245509|NCT00611455|4084961|P3|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
1245510|NCT00611455|4084962|P2|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
1245511|NCT00611455|4084963|P1|DB Treatment Period (24 Weeks)|Lack of Efficacy|2
1245512|NCT00611455|4084961|P3|DB Treatment Period (24 Weeks)|Adverse Event|0
1245513|NCT00611455|4084962|P2|DB Treatment Period (24 Weeks)|Adverse Event|8
1245514|NCT00611455|4084963|P1|DB Treatment Period (24 Weeks)|Adverse Event|2
1245515|NCT00611247|4085143|P2|Overall Study|Lack of Efficacy|16
1245516|NCT00611247|4085144|P1|Overall Study|Lack of Efficacy|1
1245517|NCT00611247|4085143|P2|Overall Study|Death|5
1245518|NCT00611247|4085144|P1|Overall Study|Death|1
1245519|NCT00611130|4085156|P2|Overall Study|Death|0
1245520|NCT00611130|4085157|P1|Overall Study|Death|1
1245521|NCT00611130|4085156|P2|Overall Study|Adverse Event|0
1245522|NCT00611130|4085157|P1|Overall Study|Adverse Event|1
1245523|NCT00611130|4085156|P2|Overall Study|Administrative|1
1245524|NCT00611130|4085157|P1|Overall Study|Administrative|1
1245525|NCT00611130|4085156|P2|Overall Study|Incarceration|2
1245526|NCT00611130|4085157|P1|Overall Study|Incarceration|3
1245527|NCT00611130|4085156|P2|Overall Study|Other|4
1245528|NCT00611130|4085157|P1|Overall Study|Other|5
1245529|NCT00611130|4085156|P2|Overall Study|Withdrawal by Subject|5
1245530|NCT00611130|4085157|P1|Overall Study|Withdrawal by Subject|6
1245531|NCT00611130|4085156|P2|Overall Study|Protocol noncompliance|6
1245532|NCT00611130|4085157|P1|Overall Study|Protocol noncompliance|7
1245533|NCT00611130|4085156|P2|Overall Study|Lost to Follow-up|29
1245534|NCT00611130|4085157|P1|Overall Study|Lost to Follow-up|25
1245535|NCT00611026|4085167|P3|Double-blind Treatment Period|Other|18
1245536|NCT00611026|4085168|P2|Double-blind Treatment Period|Other|20
1245537|NCT00611026|4085169|P1|Double-blind Treatment Period|Other|13
1245538|NCT00611026|4085167|P3|Double-blind Treatment Period|Withdrawal by Subject|16
1245539|NCT00611026|4085168|P2|Double-blind Treatment Period|Withdrawal by Subject|19
1245540|NCT00611026|4085169|P1|Double-blind Treatment Period|Withdrawal by Subject|7
1245541|NCT00611026|4085167|P3|Double-blind Treatment Period|Lost to Follow-up|14
1245542|NCT00611026|4085168|P2|Double-blind Treatment Period|Lost to Follow-up|11
1245543|NCT00611026|4085169|P1|Double-blind Treatment Period|Lost to Follow-up|6
1245544|NCT00611026|4085167|P3|Double-blind Treatment Period|Lack of Efficacy|4
1245545|NCT00611026|4085168|P2|Double-blind Treatment Period|Lack of Efficacy|10
1245546|NCT00611026|4085169|P1|Double-blind Treatment Period|Lack of Efficacy|11
1245547|NCT00611026|4085167|P3|Double-blind Treatment Period|Adverse Event|46
1245548|NCT00611026|4085168|P2|Double-blind Treatment Period|Adverse Event|28
1245549|NCT00611026|4085169|P1|Double-blind Treatment Period|Adverse Event|9
1245550|NCT00611026|4085167|P3|Double-blind Treatment Period|Death|0
1245551|NCT00611026|4085168|P2|Double-blind Treatment Period|Death|0
1245552|NCT00611026|4085169|P1|Double-blind Treatment Period|Death|1
1245553|NCT00611026|4085167|P3|Randomized to Double-blind Treatment|Not treated|3
1245554|NCT00611026|4085168|P2|Randomized to Double-blind Treatment|Not treated|1
1245555|NCT00611026|4085169|P1|Randomized to Double-blind Treatment|Not treated|2
1245556|NCT00610857|4085246|P1|Overall Study|Not evaluable for response|2
1245557|NCT00610714|4085290|P2|Overall Study|Study completion at 120 PFS events|2
1245558|NCT00610714|4085291|P1|Overall Study|Study completion at 120 PFS events|2
1245559|NCT00610714|4085290|P2|Overall Study|Withdrawal by Subject|3
1245560|NCT00610714|4085291|P1|Overall Study|Withdrawal by Subject|9
1245561|NCT00610714|4085290|P2|Overall Study|Death|18
1245562|NCT00610714|4085291|P1|Overall Study|Death|12
1245563|NCT00610714|4085290|P2|Overall Study|Adverse Event|1
1245564|NCT00610714|4085291|P1|Overall Study|Adverse Event|3
1245565|NCT00610675|4085329|P1|Overall Study|Other reason (not specified)|25
1245566|NCT00610675|4085329|P1|Overall Study|Lost to Follow-up|31
1245567|NCT00610675|4085329|P1|Overall Study|Lack of Compliance|7
1245568|NCT00610675|4085329|P1|Overall Study|Reasons unrelated to trial|27
1245569|NCT00610675|4085329|P1|Overall Study|Withdrawal by Subject|28
1245570|NCT00610675|4085329|P1|Overall Study|Insufficient Effect|31
1245571|NCT00610675|4085329|P1|Overall Study|Adverse Event|67
1245572|NCT00610675|4085329|P1|Overall Study|Untreated|4
1245573|NCT00610649|4085351|P11|Overall Study|Withdrawal by Subject|0
1245574|NCT00610649|4085352|P10|Overall Study|Withdrawal by Subject|1
1245575|NCT00610649|4085353|P9|Overall Study|Withdrawal by Subject|0
1245576|NCT00610649|4085354|P8|Overall Study|Withdrawal by Subject|0
1245577|NCT00610649|4085355|P7|Overall Study|Withdrawal by Subject|0
1245578|NCT00610649|4085356|P6|Overall Study|Withdrawal by Subject|0
1245579|NCT00610649|4085357|P5|Overall Study|Withdrawal by Subject|0
1245580|NCT00610649|4085358|P4|Overall Study|Withdrawal by Subject|0
1245581|NCT00610649|4085359|P3|Overall Study|Withdrawal by Subject|0
1245582|NCT00610649|4085360|P2|Overall Study|Withdrawal by Subject|0
1245583|NCT00610649|4085361|P1|Overall Study|Withdrawal by Subject|0
1245584|NCT00610649|4085351|P11|Overall Study|Family Emergency|0
1245585|NCT00610649|4085352|P10|Overall Study|Family Emergency|0
1245586|NCT00610649|4085353|P9|Overall Study|Family Emergency|0
1245587|NCT00610649|4085354|P8|Overall Study|Family Emergency|0
1245588|NCT00610649|4085355|P7|Overall Study|Family Emergency|0
1245589|NCT00610649|4085356|P6|Overall Study|Family Emergency|0
1245590|NCT00610649|4085357|P5|Overall Study|Family Emergency|0
1245591|NCT00610649|4085358|P4|Overall Study|Family Emergency|0
1245592|NCT00610649|4085359|P3|Overall Study|Family Emergency|0
1245593|NCT00610649|4085360|P2|Overall Study|Family Emergency|1
1245594|NCT00610649|4085361|P1|Overall Study|Family Emergency|0
1245595|NCT00610649|4085351|P11|Overall Study|Adverse Event|1
1245596|NCT00610649|4085352|P10|Overall Study|Adverse Event|0
1245597|NCT00610649|4085353|P9|Overall Study|Adverse Event|0
1245598|NCT00610649|4085354|P8|Overall Study|Adverse Event|0
1245599|NCT00610649|4085355|P7|Overall Study|Adverse Event|0
1245600|NCT00610649|4085356|P6|Overall Study|Adverse Event|0
1245601|NCT00610649|4085357|P5|Overall Study|Adverse Event|0
1245602|NCT00610649|4085358|P4|Overall Study|Adverse Event|0
1245603|NCT00610649|4085359|P3|Overall Study|Adverse Event|0
1245604|NCT00610649|4085360|P2|Overall Study|Adverse Event|0
1245605|NCT00610649|4085361|P1|Overall Study|Adverse Event|1
1245606|NCT00610441|4085425|P4|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
1245607|NCT00610441|4085426|P3|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
1245608|NCT00610441|4085427|P2|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
1245609|NCT00610441|4085428|P1|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1
1245610|NCT00610441|4085425|P4|Treatment Period 2 - 3 Weeks|Adverse Event|1
1245611|NCT00610441|4085426|P3|Treatment Period 2 - 3 Weeks|Adverse Event|0
1245612|NCT00610441|4085427|P2|Treatment Period 2 - 3 Weeks|Adverse Event|0
1245613|NCT00610441|4085428|P1|Treatment Period 2 - 3 Weeks|Adverse Event|0
1245614|NCT00610441|4085425|P4|Treatment Period 2 - 3 Weeks|Other|1
1245615|NCT00610441|4085426|P3|Treatment Period 2 - 3 Weeks|Other|0
1245616|NCT00610441|4085427|P2|Treatment Period 2 - 3 Weeks|Other|1
1245617|NCT00610441|4085428|P1|Treatment Period 2 - 3 Weeks|Other|1
1245618|NCT00610441|4085425|P4|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
1245619|NCT00610441|4085426|P3|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
1245620|NCT00610441|4085427|P2|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1
1245621|NCT00610441|4085428|P1|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
1245622|NCT00610441|4085425|P4|Placebo Washout Period - 2 Weeks|Adverse Event|0
1245623|NCT00610441|4085426|P3|Placebo Washout Period - 2 Weeks|Adverse Event|2
1245624|NCT00610441|4085427|P2|Placebo Washout Period - 2 Weeks|Adverse Event|0
1245625|NCT00610441|4085428|P1|Placebo Washout Period - 2 Weeks|Adverse Event|0
1245626|NCT00610441|4085425|P4|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
1245627|NCT00610441|4085426|P3|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
1245628|NCT00610441|4085427|P2|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0
1245629|NCT00610441|4085428|P1|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
1245630|NCT00610441|4085425|P4|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0
1245631|NCT00610441|4085426|P3|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
1245632|NCT00610441|4085427|P2|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
1245633|NCT00610441|4085428|P1|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
1245634|NCT00610441|4085425|P4|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
1245635|NCT00610441|4085426|P3|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1
1245636|NCT00610441|4085427|P2|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
1245637|NCT00610441|4085428|P1|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
1245638|NCT00610441|4085425|P4|Treatment Period 1 - 3 Weeks|Adverse Event|1
1245639|NCT00610441|4085426|P3|Treatment Period 1 - 3 Weeks|Adverse Event|4
1245640|NCT00610441|4085427|P2|Treatment Period 1 - 3 Weeks|Adverse Event|1
1245641|NCT00610441|4085428|P1|Treatment Period 1 - 3 Weeks|Adverse Event|1
1245642|NCT00610363|4085537|P2|Overall Study|Other than specified above|1
1245643|NCT00610363|4085538|P1|Overall Study|Other than specified above|1
1245644|NCT00610363|4085537|P2|Overall Study|Withdrawal by Subject|0
1245645|NCT00610363|4085538|P1|Overall Study|Withdrawal by Subject|1
1245646|NCT00610363|4085537|P2|Overall Study|Lost to Follow-up|0
1245647|NCT00610363|4085538|P1|Overall Study|Lost to Follow-up|4
1245648|NCT00610363|4085537|P2|Overall Study|Lack of Efficacy|0
1245649|NCT00610363|4085538|P1|Overall Study|Lack of Efficacy|2
1245650|NCT00610363|4085537|P2|Overall Study|Adverse Event|1
1245651|NCT00610363|4085538|P1|Overall Study|Adverse Event|3
1245652|NCT00610363|4085537|P2|Overall Study|Non-compliance with protocol|1
1245653|NCT00610363|4085538|P1|Overall Study|Non-compliance with protocol|0
1245654|NCT00610207|4085563|P1|Overall Study|Lost to Follow-up|3
1245655|NCT00610168|4085570|P2|Overall Study|Withdrawal by Subject|0
1245656|NCT00610168|4085571|P1|Overall Study|Withdrawal by Subject|2
1245657|NCT00610155|4085590|P6|Period 3|Adverse Event|0
1245658|NCT00610155|4085591|P5|Period 3|Adverse Event|0
1245659|NCT00610155|4085592|P4|Period 3|Adverse Event|0
1245660|NCT00610155|4085593|P3|Period 3|Adverse Event|0
1245661|NCT00610155|4085594|P2|Period 3|Adverse Event|0
1245662|NCT00610155|4085595|P1|Period 3|Adverse Event|1
1245663|NCT00610155|4085590|P6|Period 1|Withdrawal by Subject|0
1245664|NCT00610155|4085591|P5|Period 1|Withdrawal by Subject|0
1245665|NCT00610155|4085592|P4|Period 1|Withdrawal by Subject|0
1245666|NCT00610155|4085593|P3|Period 1|Withdrawal by Subject|1
1245667|NCT00610155|4085594|P2|Period 1|Withdrawal by Subject|0
1245668|NCT00610155|4085595|P1|Period 1|Withdrawal by Subject|0
1245669|NCT00610129|4085642|P1|Overall Study|Not treated since patients ineligible|3
1245670|NCT00609986|4085648|P2|Overall Study|Did not receive transplant or treatment|3
1245671|NCT00609986|4085649|P1|Overall Study|Did not receive transplant or treatment|8
1245672|NCT00609973|4085663|P2|Overall Study|Withdrawal by Subject|1
1245673|NCT00609973|4085664|P1|Overall Study|Withdrawal by Subject|0
1245674|NCT00609973|4085663|P2|Overall Study|Lost to Follow-up|1
1245675|NCT00609973|4085664|P1|Overall Study|Lost to Follow-up|2
1245676|NCT00609973|4085663|P2|Overall Study|Protocol Violation|3
1245677|NCT00609973|4085664|P1|Overall Study|Protocol Violation|4
1245678|NCT00609973|4085663|P2|Overall Study|Adverse Event|1
1245679|NCT00609973|4085664|P1|Overall Study|Adverse Event|2
1245680|NCT00609947|4085672|P1|Overall Study|Death|1
1245681|NCT00609869|4085677|P1|Overall Study|Mantle cell: not evaluable|4
1245682|NCT00609869|4085677|P1|Overall Study|Rituximab reaction prior to lenalidomide|1
1245683|NCT00609869|4085677|P1|Overall Study|Hepatitis B infection|1
1245684|NCT00609869|4085677|P1|Overall Study|Severe tumor flare reaction|1
1245685|NCT00609869|4085677|P1|Overall Study|Seizures|1
1245686|NCT00609869|4085677|P1|Overall Study|Withdrawal by Subject|1
1245687|NCT00609869|4085677|P1|Overall Study|Severe hematologic toxicity|1
1245688|NCT00609869|4085677|P1|Overall Study|Withdrawn, ischemic stroke|1
1245689|NCT00609765|4085696|P1|Overall Study|Study ended prior to 12 months|1
1245690|NCT00609674|4085710|P2|Overall Study|Withdrew consent|1
1245691|NCT00609674|4085711|P1|Overall Study|Withdrew consent|2
1245692|NCT00609674|4085710|P2|Overall Study|Lost to Follow-up|0
1245693|NCT00609674|4085711|P1|Overall Study|Lost to Follow-up|1
1245694|NCT00609674|4085710|P2|Overall Study|Protocol Violation|5
1245695|NCT00609674|4085711|P1|Overall Study|Protocol Violation|3
1245696|NCT00609674|4085710|P2|Overall Study|Adverse Event|1
1245697|NCT00609674|4085711|P1|Overall Study|Adverse Event|1
1245698|NCT00609622|4085747|P2|Overall Study|Global deterioration of health status|2
1245699|NCT00609622|4085748|P1|Overall Study|Global deterioration of health status|6
1245700|NCT00609622|4085747|P2|Overall Study|Other|14
1245701|NCT00609622|4085748|P1|Overall Study|Other|7
1245702|NCT00609622|4085747|P2|Overall Study|Study terminated by sponsor|3
1245703|NCT00609622|4085748|P1|Overall Study|Study terminated by sponsor|16
1245704|NCT00609622|4085747|P2|Overall Study|Objective progression or relapse|41
1245705|NCT00609622|4085748|P1|Overall Study|Objective progression or relapse|47
1245706|NCT00609622|4085747|P2|Overall Study|Protocol Violation|1
1245707|NCT00609622|4085748|P1|Overall Study|Protocol Violation|1
1245708|NCT00609622|4085747|P2|Overall Study|Death|4
1245709|NCT00609622|4085748|P1|Overall Study|Death|1
1245710|NCT00609622|4085747|P2|Overall Study|Withdrawal by Subject|20
1245711|NCT00609622|4085748|P1|Overall Study|Withdrawal by Subject|4
1245712|NCT00609622|4085747|P2|Overall Study|Adverse Event|10
1245713|NCT00609622|4085748|P1|Overall Study|Adverse Event|14
1245714|NCT00609609|4085770|P2|Overall Study|Progression|2
1245715|NCT00609609|4085771|P1|Overall Study|Progression|4
1245716|NCT00609609|4085770|P2|Overall Study|Withdrawal by Subject|0
1245717|NCT00609609|4085771|P1|Overall Study|Withdrawal by Subject|2
1245718|NCT00609518|4085783|P2|Overall Study|Death from Adverse Event|2
1245719|NCT00609518|4085784|P1|Overall Study|Death from Adverse Event|2
1245720|NCT00609518|4085783|P2|Overall Study|Physician Decision|3
1245721|NCT00609518|4085784|P1|Overall Study|Physician Decision|1
1245722|NCT00609518|4085783|P2|Overall Study|Lost to Follow-up|0
1245723|NCT00609518|4085784|P1|Overall Study|Lost to Follow-up|3
1245724|NCT00609518|4085783|P2|Overall Study|Withdrawal by Subject|3
1245725|NCT00609518|4085784|P1|Overall Study|Withdrawal by Subject|5
1245726|NCT00609518|4085783|P2|Overall Study|Death from Study Disease|32
1245727|NCT00609518|4085784|P1|Overall Study|Death from Study Disease|32
1245728|NCT00609492|4085799|P3|Overall Study|Lost to Follow-up|4
1245729|NCT00609492|4085800|P2|Overall Study|Lost to Follow-up|1
1245730|NCT00609492|4085801|P1|Overall Study|Lost to Follow-up|1
1245731|NCT00609492|4085799|P3|Overall Study|Withdrawal by Subject|3
1245732|NCT00609492|4085800|P2|Overall Study|Withdrawal by Subject|2
1245733|NCT00609492|4085801|P1|Overall Study|Withdrawal by Subject|0
1245734|NCT00609466|4085886|P3|Overall Study|Lack of Efficacy|2
1245735|NCT00609466|4085887|P2|Overall Study|Lack of Efficacy|2
1245736|NCT00609466|4085888|P1|Overall Study|Lack of Efficacy|0
1245737|NCT00609466|4085886|P3|Overall Study|Adverse Event|1
1245738|NCT00609466|4085887|P2|Overall Study|Adverse Event|3
1245739|NCT00609466|4085888|P1|Overall Study|Adverse Event|2
1245740|NCT00609466|4085886|P3|Overall Study|Withdrawal by Subject|1
1245741|NCT00609466|4085887|P2|Overall Study|Withdrawal by Subject|1
1245742|NCT00609466|4085888|P1|Overall Study|Withdrawal by Subject|0
1245743|NCT00609362|4085916|P2|Overall Study|Adverse Event|0
1245744|NCT00609362|4085917|P1|Overall Study|Adverse Event|1
1245745|NCT00609362|4085916|P2|Overall Study|Withdrawal by Subject|1
1245746|NCT00609362|4085917|P1|Overall Study|Withdrawal by Subject|2
1245747|NCT00609336|4085927|P1|Overall Study|LA or Met at Surgery|9
1245748|NCT00609336|4085927|P1|Overall Study|Death|1
1245749|NCT00609336|4085927|P1|Overall Study|Protocol Violation|3
1245750|NCT00609245|4085978|P1|Overall Study|Adverse Event|1
1245751|NCT00609167|4085986|P2|Overall Study|Stem Cell Transplant|6
1245752|NCT00609167|4085987|P1|Overall Study|Stem Cell Transplant|0
1245753|NCT00609167|4085986|P2|Overall Study|Disease Progression|0
1245754|NCT00609167|4085987|P1|Overall Study|Disease Progression|1
1245755|NCT00609167|4085986|P2|Overall Study|Adverse Event|1
1245756|NCT00609167|4085987|P1|Overall Study|Adverse Event|5
1245757|NCT00609167|4085986|P2|Overall Study|Lack of Efficacy|0
1245758|NCT00609167|4085987|P1|Overall Study|Lack of Efficacy|1
1245759|NCT00609167|4085986|P2|Overall Study|Withdrawal by Subject|0
1245760|NCT00609167|4085987|P1|Overall Study|Withdrawal by Subject|1
1245761|NCT00608985|4086018|P4|Overall Study|Lost to Follow-up|0
1245762|NCT00608985|4086019|P3|Overall Study|Lost to Follow-up|0
1245763|NCT00608985|4086020|P2|Overall Study|Lost to Follow-up|1
1245764|NCT00608985|4086021|P1|Overall Study|Lost to Follow-up|2
1245765|NCT00608985|4086018|P4|Overall Study|Withdrawal of Consent|1
1245766|NCT00608985|4086019|P3|Overall Study|Withdrawal of Consent|1
1245767|NCT00608985|4086020|P2|Overall Study|Withdrawal of Consent|1
1245768|NCT00608985|4086021|P1|Overall Study|Withdrawal of Consent|5
1245769|NCT00608985|4086018|P4|Overall Study|Administrative/Other|2
1245770|NCT00608985|4086019|P3|Overall Study|Administrative/Other|1
1245771|NCT00608985|4086020|P2|Overall Study|Administrative/Other|4
1245772|NCT00608985|4086021|P1|Overall Study|Administrative/Other|7
1245773|NCT00608985|4086018|P4|Overall Study|Adverse Event|6
1245774|NCT00608985|4086019|P3|Overall Study|Adverse Event|4
1245775|NCT00608985|4086020|P2|Overall Study|Adverse Event|7
1245776|NCT00608985|4086021|P1|Overall Study|Adverse Event|2
1245777|NCT00608959|4086053|P1|Part 1|Did not meet eligibility criteria|1
1245778|NCT00608907|4086066|P3|Overall Study|Progressive Disease|0
1245779|NCT00608907|4086067|P2|Overall Study|Progressive Disease|0
1245780|NCT00608907|4086068|P1|Overall Study|Progressive Disease|1
1245781|NCT00608907|4086066|P3|Overall Study|Withdrawal by Subject|0
1245782|NCT00608907|4086067|P2|Overall Study|Withdrawal by Subject|0
1245783|NCT00608907|4086068|P1|Overall Study|Withdrawal by Subject|4
1245784|NCT00608907|4086066|P3|Overall Study|Death|0
1245785|NCT00608907|4086067|P2|Overall Study|Death|0
1245786|NCT00608907|4086068|P1|Overall Study|Death|1
1245787|NCT00608907|4086066|P3|Overall Study|Adverse Event|1
1245788|NCT00608907|4086067|P2|Overall Study|Adverse Event|0
1245789|NCT00608907|4086068|P1|Overall Study|Adverse Event|6
1245790|NCT00608881|4086078|P2|Overall Study|Institutionalized|2
1245791|NCT00608881|4086079|P1|Overall Study|Institutionalized|1
1245792|NCT00608881|4086078|P2|Overall Study|Physician Decision|5
1245793|NCT00608881|4086079|P1|Overall Study|Physician Decision|5
1245794|NCT00608881|4086078|P2|Overall Study|Withdrawal by Subject|29
1245795|NCT00608881|4086079|P1|Overall Study|Withdrawal by Subject|18
1245796|NCT00608881|4086078|P2|Overall Study|Lost to Follow-up|14
1245797|NCT00608881|4086079|P1|Overall Study|Lost to Follow-up|28
1245798|NCT00608881|4086078|P2|Overall Study|Adverse Event|3
1245799|NCT00608881|4086079|P1|Overall Study|Adverse Event|5
1245800|NCT00608881|4086078|P2|Overall Study|Death|13
1245801|NCT00608881|4086079|P1|Overall Study|Death|22
1245802|NCT00608868|4086113|P1|Overall Study|Physician Decision|2
1245803|NCT00608868|4086113|P1|Overall Study|Adverse Event|1
1245804|NCT00608868|4086113|P1|Overall Study|Lost to Follow-up|2
1245805|NCT00608868|4086113|P1|Overall Study|Protocol Violation|3
1245806|NCT00608868|4086113|P1|Overall Study|Withdrawal by Subject|7
1245807|NCT00608842|4086124|P4|Overall Study|Lost to Follow-up|0
1245808|NCT00608842|4086125|P3|Overall Study|Lost to Follow-up|0
1245809|NCT00608842|4086126|P2|Overall Study|Lost to Follow-up|0
1245810|NCT00608842|4086127|P1|Overall Study|Lost to Follow-up|1
1245811|NCT00608842|4086124|P4|Overall Study|Participant's Request|1
1245812|NCT00608842|4086125|P3|Overall Study|Participant's Request|2
1245813|NCT00608842|4086126|P2|Overall Study|Participant's Request|1
1245814|NCT00608842|4086127|P1|Overall Study|Participant's Request|0
1245815|NCT00608829|4086161|P1|Overall Study|Subject refuses to follow up or return.|5
1245816|NCT00608829|4086161|P1|Overall Study|Withdrawal by Subject|4
1245817|NCT00608829|4086161|P1|Overall Study|Death|6
1245818|NCT00608582|4086187|P2|Overall Study|Early stage Design Change|3
1245819|NCT00608582|4086188|P1|Overall Study|Early stage Design Change|0
1245820|NCT00608582|4086187|P2|Overall Study|Illicit Drug Use|0
1245821|NCT00608582|4086188|P1|Overall Study|Illicit Drug Use|1
1245822|NCT00608582|4086187|P2|Overall Study|No Best Response in Phase 1 located|1
1245823|NCT00608582|4086188|P1|Overall Study|No Best Response in Phase 1 located|1
1245824|NCT00608582|4086187|P2|Overall Study|Lost to Follow-up|0
1245825|NCT00608582|4086188|P1|Overall Study|Lost to Follow-up|2
1245826|NCT00608569|4086198|P2|Overall Study|Unable to adhere with study requirements|1
1245827|NCT00608569|4086199|P1|Overall Study|Unable to adhere with study requirements|0
1245828|NCT00608569|4086198|P2|Overall Study|Adverse Event|0
1245829|NCT00608569|4086199|P1|Overall Study|Adverse Event|1
1245830|NCT00608569|4086198|P2|Overall Study|Withdrawal by Subject|0
1245831|NCT00608569|4086199|P1|Overall Study|Withdrawal by Subject|1
1245832|NCT00608569|4086198|P2|Overall Study|Lost to Follow-up|5
1245833|NCT00608569|4086199|P1|Overall Study|Lost to Follow-up|4
1245834|NCT00608569|4086198|P2|Overall Study|Death|3
1245835|NCT00608569|4086199|P1|Overall Study|Death|4
1245836|NCT00608543|4086219|P1|Overall Study|Adverse Event|4
1245837|NCT00608530|4086232|P4|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
1245838|NCT00608530|4086233|P3|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1
1245839|NCT00608530|4086234|P2|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
1245840|NCT00608530|4086235|P1|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
1245841|NCT00608530|4086232|P4|Study 2 Nurse-delivered Treatments|Time demands of study|1
1245842|NCT00608530|4086233|P3|Study 2 Nurse-delivered Treatments|Time demands of study|4
1245843|NCT00608530|4086234|P2|Study 2 Nurse-delivered Treatments|Time demands of study|0
1245844|NCT00608530|4086235|P1|Study 2 Nurse-delivered Treatments|Time demands of study|0
1245845|NCT00608530|4086232|P4|Study 2 Nurse-delivered Treatments|Protocol Violation|0
1245846|NCT00608530|4086233|P3|Study 2 Nurse-delivered Treatments|Protocol Violation|2
1245847|NCT00608530|4086234|P2|Study 2 Nurse-delivered Treatments|Protocol Violation|0
1245848|NCT00608530|4086235|P1|Study 2 Nurse-delivered Treatments|Protocol Violation|0
1245849|NCT00608530|4086232|P4|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3
1245850|NCT00608530|4086233|P3|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2
1245851|NCT00608530|4086234|P2|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
1245852|NCT00608530|4086235|P1|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
1245853|NCT00608530|4086232|P4|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
1245854|NCT00608530|4086233|P3|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
1245855|NCT00608530|4086234|P2|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
1245856|NCT00608530|4086235|P1|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
1245857|NCT00608530|4086232|P4|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
1245858|NCT00608530|4086233|P3|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
1245859|NCT00608530|4086234|P2|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5
1245860|NCT00608530|4086235|P1|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11
1245861|NCT00608517|4086256|P3|Overall Study|Death|0
1245862|NCT00608517|4086257|P2|Overall Study|Death|0
1245863|NCT00608517|4086258|P1|Overall Study|Death|1
1245864|NCT00608426|4086438|P2|Overall Study|refused, health issues, wrong address|348
1245865|NCT00608426|4086439|P1|Overall Study|refused, health issues, wrong address|319
1245866|NCT00608426|4086438|P2|Overall Study|Lost to Follow-up|521
1245867|NCT00608426|4086439|P1|Overall Study|Lost to Follow-up|485
1245868|NCT00608426|4086438|P2|Overall Study|Death|36
1245869|NCT00608426|4086439|P1|Overall Study|Death|32
1245870|NCT00608322|4086451|P2|Overall Study|Death|1
1245871|NCT00608322|4086452|P1|Overall Study|Death|2
1245872|NCT00608244|4086458|P1|Overall Study|Low trough levels|1
1245873|NCT00608244|4086458|P1|Overall Study|Adverse Event|1
1245874|NCT00608205|4086469|P2|Overall Study|Patient non-compliant|1
1245875|NCT00608205|4086470|P1|Overall Study|Patient non-compliant|0
1245876|NCT00608205|4086469|P2|Overall Study|Adverse Event|2
1245877|NCT00608205|4086470|P1|Overall Study|Adverse Event|3
1245878|NCT00608023|4086587|P3|Overall Study|Unknown reason|0
1245879|NCT00608023|4086588|P2|Overall Study|Unknown reason|3
1245880|NCT00608023|4086589|P1|Overall Study|Unknown reason|0
1245881|NCT00608023|4086587|P3|Overall Study|Protocol Violation|1
1245882|NCT00608023|4086588|P2|Overall Study|Protocol Violation|3
1245883|NCT00608023|4086589|P1|Overall Study|Protocol Violation|1
1245884|NCT00608023|4086587|P3|Overall Study|Lost to Follow-up|1
1245885|NCT00608023|4086588|P2|Overall Study|Lost to Follow-up|2
1245886|NCT00608023|4086589|P1|Overall Study|Lost to Follow-up|2
1245887|NCT00608023|4086587|P3|Overall Study|Adverse Event|5
1245888|NCT00608023|4086588|P2|Overall Study|Adverse Event|4
1245889|NCT00608023|4086589|P1|Overall Study|Adverse Event|1
1245890|NCT00608023|4086587|P3|Overall Study|Withdrawal by Subject|7
1245891|NCT00608023|4086588|P2|Overall Study|Withdrawal by Subject|10
1245892|NCT00608023|4086589|P1|Overall Study|Withdrawal by Subject|8
1245893|NCT00607997|4086613|P4|Overall Study|Other without explanation|1
1245894|NCT00607997|4086614|P3|Overall Study|Other without explanation|4
1245895|NCT00607997|4086615|P2|Overall Study|Other without explanation|0
1245896|NCT00607997|4086616|P1|Overall Study|Other without explanation|2
1245897|NCT00607997|4086613|P4|Overall Study|Relapse, recurrent illness|0
1245898|NCT00607997|4086614|P3|Overall Study|Relapse, recurrent illness|2
1245899|NCT00607997|4086615|P2|Overall Study|Relapse, recurrent illness|0
1245900|NCT00607997|4086616|P1|Overall Study|Relapse, recurrent illness|4
1245901|NCT00607997|4086613|P4|Overall Study|Physician Decision|0
1245902|NCT00607997|4086614|P3|Overall Study|Physician Decision|0
1245903|NCT00607997|4086615|P2|Overall Study|Physician Decision|1
1245904|NCT00607997|4086616|P1|Overall Study|Physician Decision|4
1245905|NCT00607997|4086613|P4|Overall Study|Adverse Event|0
1245906|NCT00607997|4086614|P3|Overall Study|Adverse Event|2
1245907|NCT00607997|4086615|P2|Overall Study|Adverse Event|1
1245908|NCT00607997|4086616|P1|Overall Study|Adverse Event|3
1245909|NCT00607997|4086613|P4|Overall Study|Death|5
1245910|NCT00607997|4086614|P3|Overall Study|Death|2
1245911|NCT00607997|4086615|P2|Overall Study|Death|5
1245912|NCT00607997|4086616|P1|Overall Study|Death|8
1245913|NCT00607997|4086613|P4|Overall Study|Lack of Efficacy|10
1245914|NCT00607997|4086614|P3|Overall Study|Lack of Efficacy|14
1245915|NCT00607997|4086615|P2|Overall Study|Lack of Efficacy|20
1245916|NCT00607997|4086616|P1|Overall Study|Lack of Efficacy|6
1245917|NCT00607919|4086674|P2|Open-Label Phase|Parent/Caregiver Decision|2
1245918|NCT00607919|4086675|P1|Open-Label Phase|Parent/Caregiver Decision|1
1245919|NCT00607919|4086674|P2|Open-Label Phase|Withdrawal by Subject|2
1245920|NCT00607919|4086675|P1|Open-Label Phase|Withdrawal by Subject|2
1245921|NCT00607919|4086674|P2|Open-Label Phase|Protocol Violation|2
1245922|NCT00607919|4086675|P1|Open-Label Phase|Protocol Violation|2
1245923|NCT00607919|4086674|P2|Open-Label Phase|Lost to Follow-up|1
1245924|NCT00607919|4086675|P1|Open-Label Phase|Lost to Follow-up|4
1245925|NCT00607919|4086674|P2|Open-Label Phase|Adverse Event|5
1245926|NCT00607919|4086675|P1|Open-Label Phase|Adverse Event|1
1245927|NCT00607919|4086674|P2|Acute Phase|Withdrawal by Subject|3
1245928|NCT00607919|4086675|P1|Acute Phase|Withdrawal by Subject|3
1245929|NCT00607919|4086674|P2|Acute Phase|Protocol Violation|1
1245930|NCT00607919|4086675|P1|Acute Phase|Protocol Violation|5
1245931|NCT00607919|4086674|P2|Acute Phase|Parent/Caregiver Decision|4
1245932|NCT00607919|4086675|P1|Acute Phase|Parent/Caregiver Decision|6
1245933|NCT00607919|4086674|P2|Acute Phase|Lost to Follow-up|3
1245934|NCT00607919|4086675|P1|Acute Phase|Lost to Follow-up|9
1245935|NCT00607919|4086674|P2|Acute Phase|Lack of Efficacy|2
1245936|NCT00607919|4086675|P1|Acute Phase|Lack of Efficacy|1
1245937|NCT00607919|4086674|P2|Acute Phase|Entry Criteria Not Met|1
1245938|NCT00607919|4086675|P1|Acute Phase|Entry Criteria Not Met|1
1245939|NCT00607919|4086674|P2|Acute Phase|Adverse Event|2
1245940|NCT00607919|4086675|P1|Acute Phase|Adverse Event|9
1245941|NCT00607893|4086733|P2|Overall Study|Withdrew due to hypertensive urgency|1
1245942|NCT00607893|4086734|P1|Overall Study|Withdrew due to hypertensive urgency|1
1245943|NCT00607893|4086733|P2|Overall Study|Declined to be treated|0
1245944|NCT00607893|4086734|P1|Overall Study|Declined to be treated|1
1245945|NCT00607893|4086733|P2|Overall Study|withdrew could not tolerate CPAP|1
1245946|NCT00607893|4086734|P1|Overall Study|withdrew could not tolerate CPAP|0
1245947|NCT00607893|4086733|P2|Overall Study|Withdrew due to osteomyelitis surgery|1
1245948|NCT00607893|4086734|P1|Overall Study|Withdrew due to osteomyelitis surgery|0
1245949|NCT00607893|4086733|P2|Overall Study|withdrew due to loss of interest|1
1245950|NCT00607893|4086734|P1|Overall Study|withdrew due to loss of interest|0
1245951|NCT00607893|4086733|P2|Overall Study|Lost to Follow-up|0
1245952|NCT00607893|4086734|P1|Overall Study|Lost to Follow-up|4
1245953|NCT00607880|4086762|P2|Overall Study|Unable to place port due to occlusion|0
1245954|NCT00607880|4086763|P1|Overall Study|Unable to place port due to occlusion|1
1245955|NCT00607789|4086813|P2|Overall Study|Withdrawal by Subject|0
1245956|NCT00607789|4086814|P1|Overall Study|Withdrawal by Subject|1
1245957|NCT00607789|4086813|P2|Overall Study|Lost to Follow-up|5
1245958|NCT00607789|4086814|P1|Overall Study|Lost to Follow-up|0
1245959|NCT00607789|4086813|P2|Overall Study|Inadequate adherence|0
1245960|NCT00607789|4086814|P1|Overall Study|Inadequate adherence|3
1245961|NCT00607789|4086813|P2|Overall Study|Lack of Efficacy|1
1245962|NCT00607789|4086814|P1|Overall Study|Lack of Efficacy|0
1245963|NCT00607789|4086813|P2|Overall Study|Adverse Event|0
1245964|NCT00607789|4086814|P1|Overall Study|Adverse Event|3
1245965|NCT00607724|4086829|P7|Stage 2: Expanded Cohort|Withdrawal by Subject|0
1245966|NCT00607724|4086830|P6|Stage 2: Expanded Cohort|Withdrawal by Subject|0
1245967|NCT00607724|4086831|P5|Stage 2: Expanded Cohort|Withdrawal by Subject|0
1245968|NCT00607724|4086832|P4|Stage 2: Expanded Cohort|Withdrawal by Subject|1
1245969|NCT00607724|4086833|P3|Stage 2: Expanded Cohort|Withdrawal by Subject|0
1245970|NCT00607724|4086834|P2|Stage 2: Expanded Cohort|Withdrawal by Subject|0
1245971|NCT00607724|4086835|P1|Stage 2: Expanded Cohort|Withdrawal by Subject|0
1245972|NCT00607724|4086829|P7|Stage 2: Expanded Cohort|Physician Decision|0
1245973|NCT00607724|4086830|P6|Stage 2: Expanded Cohort|Physician Decision|1
1245974|NCT00607724|4086831|P5|Stage 2: Expanded Cohort|Physician Decision|1
1245975|NCT00607724|4086832|P4|Stage 2: Expanded Cohort|Physician Decision|0
1245976|NCT00607724|4086833|P3|Stage 2: Expanded Cohort|Physician Decision|0
1245977|NCT00607724|4086834|P2|Stage 2: Expanded Cohort|Physician Decision|0
1245978|NCT00607724|4086835|P1|Stage 2: Expanded Cohort|Physician Decision|0
1245979|NCT00607724|4086829|P7|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|10
1245980|NCT00607724|4086830|P6|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|11
1245981|NCT00607724|4086831|P5|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|8
1245982|NCT00607724|4086832|P4|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|4
1245983|NCT00607724|4086833|P3|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
1245984|NCT00607724|4086834|P2|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
1245985|NCT00607724|4086835|P1|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
1245986|NCT00607724|4086829|P7|Stage 2: Expanded Cohort|Adverse Event|1
1245987|NCT00607724|4086830|P6|Stage 2: Expanded Cohort|Adverse Event|0
1245988|NCT00607724|4086831|P5|Stage 2: Expanded Cohort|Adverse Event|0
1245989|NCT00607724|4086832|P4|Stage 2: Expanded Cohort|Adverse Event|0
1245990|NCT00607724|4086833|P3|Stage 2: Expanded Cohort|Adverse Event|0
1245991|NCT00607724|4086834|P2|Stage 2: Expanded Cohort|Adverse Event|0
1245992|NCT00607724|4086835|P1|Stage 2: Expanded Cohort|Adverse Event|0
1245993|NCT00607724|4086829|P7|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
1245994|NCT00607724|4086830|P6|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
1245995|NCT00607724|4086831|P5|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
1245996|NCT00607724|4086832|P4|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
1245997|NCT00607724|4086833|P3|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|4
1245998|NCT00607724|4086834|P2|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|8
1245999|NCT00607724|4086835|P1|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|7
1246000|NCT00607386|4086998|P1|Overall Study|Physician Decision|1
1246001|NCT00607373|4087013|P2|Follow-up Period|Withdrawal by Subject|3
1246002|NCT00607373|4087014|P1|Follow-up Period|Withdrawal by Subject|1
1246003|NCT00607373|4087013|P2|Follow-up Period|Protocol Violation|1
1246004|NCT00607373|4087014|P1|Follow-up Period|Protocol Violation|0
1246005|NCT00607373|4087013|P2|Follow-up Period|Not specified|1
1246006|NCT00607373|4087014|P1|Follow-up Period|Not specified|0
1246007|NCT00607373|4087013|P2|Treatment Period|Withdrawal by Subject|1
1246008|NCT00607373|4087014|P1|Treatment Period|Withdrawal by Subject|0
1246009|NCT00607373|4087013|P2|Treatment Period|Physician Decision|1
1246010|NCT00607373|4087014|P1|Treatment Period|Physician Decision|0
1246011|NCT00607373|4087013|P2|Treatment Period|Adverse Event|4
1246012|NCT00607373|4087014|P1|Treatment Period|Adverse Event|0
1246013|NCT00607087|4087116|P3|Period 3|Adverse Event|0
1246014|NCT00607087|4087117|P2|Period 3|Adverse Event|1
1246015|NCT00607087|4087118|P1|Period 3|Adverse Event|0
1246016|NCT00607087|4087116|P3|Period 3|Withdrawal by Subject|0
1246017|NCT00607087|4087117|P2|Period 3|Withdrawal by Subject|1
1246018|NCT00607087|4087118|P1|Period 3|Withdrawal by Subject|2
1246019|NCT00607087|4087116|P3|Period 2|Poor compliance to protocol|1
1246020|NCT00607087|4087117|P2|Period 2|Poor compliance to protocol|0
1246021|NCT00607087|4087118|P1|Period 2|Poor compliance to protocol|0
1246022|NCT00607087|4087116|P3|Period 2|Adverse Event|3
1246023|NCT00607087|4087117|P2|Period 2|Adverse Event|1
1246024|NCT00607087|4087118|P1|Period 2|Adverse Event|0
1246025|NCT00607087|4087116|P3|Period 2|Other reason|0
1246026|NCT00607087|4087117|P2|Period 2|Other reason|1
1246027|NCT00607087|4087118|P1|Period 2|Other reason|1
1246028|NCT00607087|4087116|P3|Period 2|Withdrawal by Subject|1
1246029|NCT00607087|4087117|P2|Period 2|Withdrawal by Subject|1
1246030|NCT00607087|4087118|P1|Period 2|Withdrawal by Subject|0
1246031|NCT00607087|4087116|P3|Period 1|Other reason|2
1246032|NCT00607087|4087117|P2|Period 1|Other reason|4
1246033|NCT00607087|4087118|P1|Period 1|Other reason|0
1246034|NCT00607087|4087116|P3|Period 1|Lost to Follow-up|0
1246035|NCT00607087|4087117|P2|Period 1|Lost to Follow-up|0
1246036|NCT00607087|4087118|P1|Period 1|Lost to Follow-up|1
1246037|NCT00607087|4087116|P3|Period 1|Poor compliance to protocol|0
1246038|NCT00607087|4087117|P2|Period 1|Poor compliance to protocol|0
1246039|NCT00607087|4087118|P1|Period 1|Poor compliance to protocol|1
1246040|NCT00607087|4087116|P3|Period 1|Adverse Event|0
1246041|NCT00607087|4087117|P2|Period 1|Adverse Event|0
1246042|NCT00607087|4087118|P1|Period 1|Adverse Event|3
1246043|NCT00607087|4087116|P3|Period 1|Withdrawal by Subject|3
1246044|NCT00607087|4087117|P2|Period 1|Withdrawal by Subject|2
1246045|NCT00607087|4087118|P1|Period 1|Withdrawal by Subject|7
1246046|NCT00607087|4087116|P3|Overall Study|Lost to Follow-up|0
1246047|NCT00607087|4087117|P2|Overall Study|Lost to Follow-up|0
1246048|NCT00607087|4087118|P1|Overall Study|Lost to Follow-up|1
1246049|NCT00607087|4087116|P3|Overall Study|Poor compliance to protocol|1
1246050|NCT00607087|4087117|P2|Overall Study|Poor compliance to protocol|0
1246051|NCT00607087|4087118|P1|Overall Study|Poor compliance to protocol|1
1246052|NCT00607087|4087116|P3|Overall Study|Other reason|2
1246053|NCT00607087|4087117|P2|Overall Study|Other reason|5
1246054|NCT00607087|4087118|P1|Overall Study|Other reason|1
1246055|NCT00607087|4087116|P3|Overall Study|Adverse Event|3
1246056|NCT00607087|4087117|P2|Overall Study|Adverse Event|2
1246057|NCT00607087|4087118|P1|Overall Study|Adverse Event|3
1246058|NCT00607087|4087116|P3|Overall Study|Withdrawal by Subject|4
1246059|NCT00607087|4087117|P2|Overall Study|Withdrawal by Subject|4
1246060|NCT00607087|4087118|P1|Overall Study|Withdrawal by Subject|9
1246061|NCT00607048|4087176|P6|Overall Study|Other|1
1246062|NCT00607048|4087177|P5|Overall Study|Other|0
1246063|NCT00607048|4087178|P4|Overall Study|Other|0
1246064|NCT00607048|4087179|P3|Overall Study|Other|0
1246065|NCT00607048|4087180|P2|Overall Study|Other|1
1246066|NCT00607048|4087181|P1|Overall Study|Other|1
1246067|NCT00607048|4087176|P6|Overall Study|Withdrawal by Subject|2
1246068|NCT00607048|4087177|P5|Overall Study|Withdrawal by Subject|0
1246069|NCT00607048|4087178|P4|Overall Study|Withdrawal by Subject|1
1246070|NCT00607048|4087179|P3|Overall Study|Withdrawal by Subject|0
1246071|NCT00607048|4087180|P2|Overall Study|Withdrawal by Subject|0
1246072|NCT00607048|4087181|P1|Overall Study|Withdrawal by Subject|0
1246073|NCT00607048|4087176|P6|Overall Study|Objective disease progression - relapse|2
1246074|NCT00607048|4087177|P5|Overall Study|Objective disease progression - relapse|2
1246075|NCT00607048|4087178|P4|Overall Study|Objective disease progression - relapse|2
1246076|NCT00607048|4087179|P3|Overall Study|Objective disease progression - relapse|4
1246077|NCT00607048|4087180|P2|Overall Study|Objective disease progression - relapse|2
1246078|NCT00607048|4087181|P1|Overall Study|Objective disease progression - relapse|1
1246079|NCT00607048|4087176|P6|Overall Study|Global deterioration of health|0
1246080|NCT00607048|4087177|P5|Overall Study|Global deterioration of health|0
1246081|NCT00607048|4087178|P4|Overall Study|Global deterioration of health|0
1246082|NCT00607048|4087179|P3|Overall Study|Global deterioration of health|0
1246083|NCT00607048|4087180|P2|Overall Study|Global deterioration of health|0
1246084|NCT00607048|4087181|P1|Overall Study|Global deterioration of health|1
1246085|NCT00607048|4087176|P6|Overall Study|Adverse Event|0
1246086|NCT00607048|4087177|P5|Overall Study|Adverse Event|4
1246087|NCT00607048|4087178|P4|Overall Study|Adverse Event|0
1246088|NCT00607048|4087179|P3|Overall Study|Adverse Event|0
1246089|NCT00607048|4087180|P2|Overall Study|Adverse Event|1
1246090|NCT00607048|4087181|P1|Overall Study|Adverse Event|0
1246091|NCT00607022|4087266|P3|Overall Study|Withdrawal by Subject|0
1246092|NCT00607022|4087267|P2|Overall Study|Withdrawal by Subject|0
1246093|NCT00607022|4087268|P1|Overall Study|Withdrawal by Subject|1
1246094|NCT00606931|4087285|P1|Overall Study|Withdrawal by Subject|3
1246095|NCT00606905|4087293|P2|Overall Study|Withdrew|5
1246096|NCT00606905|4087294|P1|Overall Study|Withdrew|5
1246097|NCT00606905|4087293|P2|Overall Study|Non-Index Pregnancy|4
1246098|NCT00606905|4087294|P1|Overall Study|Non-Index Pregnancy|1
1246099|NCT00606905|4087293|P2|Overall Study|No Pregnancy|6
1246100|NCT00606905|4087294|P1|Overall Study|No Pregnancy|9
1246101|NCT00606892|4087300|P2|First Intervention|Protocol Violation|4
1246102|NCT00606892|4087301|P1|First Intervention|Protocol Violation|1
1246103|NCT00606801|4087335|P2|Intervention|Protocol Violation|3
1246104|NCT00606801|4087336|P1|Intervention|Protocol Violation|3
1246105|NCT00606684|4087364|P7|Double-Blind Treatment Period|Withdrawal by Subject|0
1246106|NCT00606684|4087365|P6|Double-Blind Treatment Period|Withdrawal by Subject|2
1246107|NCT00606684|4087366|P5|Double-Blind Treatment Period|Withdrawal by Subject|1
1246108|NCT00606684|4087367|P4|Double-Blind Treatment Period|Withdrawal by Subject|2
1246109|NCT00606684|4087368|P3|Double-Blind Treatment Period|Withdrawal by Subject|1
1246110|NCT00606684|4087369|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
1246111|NCT00606684|4087370|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
1246112|NCT00606684|4087364|P7|Double-Blind Treatment Period|Physician Decision|2
1246113|NCT00606684|4087365|P6|Double-Blind Treatment Period|Physician Decision|1
1246114|NCT00606684|4087366|P5|Double-Blind Treatment Period|Physician Decision|3
1246115|NCT00606684|4087367|P4|Double-Blind Treatment Period|Physician Decision|0
1246116|NCT00606684|4087368|P3|Double-Blind Treatment Period|Physician Decision|1
1246117|NCT00606684|4087369|P2|Double-Blind Treatment Period|Physician Decision|5
1246118|NCT00606684|4087370|P1|Double-Blind Treatment Period|Physician Decision|0
1246119|NCT00606684|4087364|P7|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
1246120|NCT00606684|4087365|P6|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3
1246121|NCT00606684|4087366|P5|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
1246122|NCT00606684|4087367|P4|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
1246123|NCT00606684|4087368|P3|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
1246124|NCT00606684|4087369|P2|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
1246125|NCT00606684|4087370|P1|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0
1246126|NCT00606684|4087364|P7|Double-Blind Treatment Period|Protocol Violation|4
1246127|NCT00606684|4087365|P6|Double-Blind Treatment Period|Protocol Violation|3
1246128|NCT00606684|4087366|P5|Double-Blind Treatment Period|Protocol Violation|0
1246129|NCT00606684|4087367|P4|Double-Blind Treatment Period|Protocol Violation|3
1246130|NCT00606684|4087368|P3|Double-Blind Treatment Period|Protocol Violation|5
1246131|NCT00606684|4087369|P2|Double-Blind Treatment Period|Protocol Violation|5
1246132|NCT00606684|4087370|P1|Double-Blind Treatment Period|Protocol Violation|0
1246133|NCT00606684|4087364|P7|Double-Blind Treatment Period|Lack of Efficacy|0
1246134|NCT00606684|4087365|P6|Double-Blind Treatment Period|Lack of Efficacy|0
1246135|NCT00606684|4087366|P5|Double-Blind Treatment Period|Lack of Efficacy|1
1246136|NCT00606684|4087367|P4|Double-Blind Treatment Period|Lack of Efficacy|0
1246137|NCT00606684|4087368|P3|Double-Blind Treatment Period|Lack of Efficacy|0
1246138|NCT00606684|4087369|P2|Double-Blind Treatment Period|Lack of Efficacy|1
1246139|NCT00606684|4087370|P1|Double-Blind Treatment Period|Lack of Efficacy|0
1246140|NCT00606684|4087364|P7|Double-Blind Treatment Period|Adverse Event|1
1246141|NCT00606684|4087365|P6|Double-Blind Treatment Period|Adverse Event|0
1246142|NCT00606684|4087366|P5|Double-Blind Treatment Period|Adverse Event|2
1246143|NCT00606684|4087367|P4|Double-Blind Treatment Period|Adverse Event|4
1246144|NCT00606684|4087368|P3|Double-Blind Treatment Period|Adverse Event|2
1246145|NCT00606684|4087369|P2|Double-Blind Treatment Period|Adverse Event|3
1246146|NCT00606684|4087370|P1|Double-Blind Treatment Period|Adverse Event|0
1246147|NCT00606684|4087364|P7|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
1246148|NCT00606684|4087365|P6|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
1246149|NCT00606684|4087366|P5|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
1246150|NCT00606684|4087367|P4|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
1246151|NCT00606684|4087368|P3|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
1246152|NCT00606684|4087369|P2|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
1246153|NCT00606684|4087370|P1|2-week Single-Blind Run-in Period|Received Study Medication in Error|1
1246154|NCT00606684|4087364|P7|2-week Single-Blind Run-in Period|Adverse Event|0
1246155|NCT00606684|4087365|P6|2-week Single-Blind Run-in Period|Adverse Event|0
1246156|NCT00606684|4087366|P5|2-week Single-Blind Run-in Period|Adverse Event|0
1246157|NCT00606684|4087367|P4|2-week Single-Blind Run-in Period|Adverse Event|0
1246158|NCT00606684|4087368|P3|2-week Single-Blind Run-in Period|Adverse Event|0
1246159|NCT00606684|4087369|P2|2-week Single-Blind Run-in Period|Adverse Event|0
1246160|NCT00606684|4087370|P1|2-week Single-Blind Run-in Period|Adverse Event|2
1246161|NCT00606684|4087364|P7|2-week Single-Blind Run-in Period|Lost to Follow-up|0
1246162|NCT00606684|4087365|P6|2-week Single-Blind Run-in Period|Lost to Follow-up|0
1246163|NCT00606684|4087366|P5|2-week Single-Blind Run-in Period|Lost to Follow-up|0
1246164|NCT00606684|4087367|P4|2-week Single-Blind Run-in Period|Lost to Follow-up|0
1246165|NCT00606684|4087368|P3|2-week Single-Blind Run-in Period|Lost to Follow-up|0
1246166|NCT00606684|4087369|P2|2-week Single-Blind Run-in Period|Lost to Follow-up|0
1246167|NCT00606684|4087370|P1|2-week Single-Blind Run-in Period|Lost to Follow-up|5
1246168|NCT00606684|4087364|P7|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
1246169|NCT00606684|4087365|P6|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
1246170|NCT00606684|4087366|P5|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
1246171|NCT00606684|4087367|P4|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
1246172|NCT00606684|4087368|P3|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
1246173|NCT00606684|4087369|P2|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
1246174|NCT00606684|4087370|P1|2-week Single-Blind Run-in Period|Withdrawal by Subject|15
1246257|NCT00606281|4087543|P1|Overall Study|Protocol Violation|3
1246175|NCT00606684|4087364|P7|2-week Single-Blind Run-in Period|Physician Decision|0
1246176|NCT00606684|4087365|P6|2-week Single-Blind Run-in Period|Physician Decision|0
1246177|NCT00606684|4087366|P5|2-week Single-Blind Run-in Period|Physician Decision|0
1246178|NCT00606684|4087367|P4|2-week Single-Blind Run-in Period|Physician Decision|0
1246179|NCT00606684|4087368|P3|2-week Single-Blind Run-in Period|Physician Decision|0
1246180|NCT00606684|4087369|P2|2-week Single-Blind Run-in Period|Physician Decision|0
1246181|NCT00606684|4087370|P1|2-week Single-Blind Run-in Period|Physician Decision|18
1246182|NCT00606684|4087364|P7|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
1246183|NCT00606684|4087365|P6|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
1246184|NCT00606684|4087366|P5|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
1246185|NCT00606684|4087367|P4|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
1246186|NCT00606684|4087368|P3|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
1246187|NCT00606684|4087369|P2|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
1246188|NCT00606684|4087370|P1|2-week Single-Blind Run-in Period|Study Closed/Terminated|32
1246189|NCT00606684|4087364|P7|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
1246190|NCT00606684|4087365|P6|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
1246191|NCT00606684|4087366|P5|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
1246192|NCT00606684|4087367|P4|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
1246193|NCT00606684|4087368|P3|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
1246194|NCT00606684|4087369|P2|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
1246195|NCT00606684|4087370|P1|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173
1246196|NCT00606632|4087402|P1|Overall Study|Miscellaneous reasons|9
1246197|NCT00606632|4087402|P1|Overall Study|Withdrawal by Subject|13
1246198|NCT00606593|4087415|P10|Overall Study|Administrative/Other|0
1246199|NCT00606593|4087416|P9|Overall Study|Administrative/Other|0
1246200|NCT00606593|4087417|P8|Overall Study|Administrative/Other|0
1246201|NCT00606593|4087418|P7|Overall Study|Administrative/Other|0
1246202|NCT00606593|4087419|P6|Overall Study|Administrative/Other|0
1246203|NCT00606593|4087420|P5|Overall Study|Administrative/Other|0
1246204|NCT00606593|4087421|P4|Overall Study|Administrative/Other|0
1246205|NCT00606593|4087422|P3|Overall Study|Administrative/Other|1
1246206|NCT00606593|4087423|P2|Overall Study|Administrative/Other|0
1246207|NCT00606593|4087424|P1|Overall Study|Administrative/Other|0
1246208|NCT00606593|4087415|P10|Overall Study|Withdrawal of consent|0
1246209|NCT00606593|4087416|P9|Overall Study|Withdrawal of consent|0
1246210|NCT00606593|4087417|P8|Overall Study|Withdrawal of consent|0
1246211|NCT00606593|4087418|P7|Overall Study|Withdrawal of consent|0
1246212|NCT00606593|4087419|P6|Overall Study|Withdrawal of consent|0
1246213|NCT00606593|4087420|P5|Overall Study|Withdrawal of consent|0
1246214|NCT00606593|4087421|P4|Overall Study|Withdrawal of consent|0
1246215|NCT00606593|4087422|P3|Overall Study|Withdrawal of consent|1
1246216|NCT00606593|4087423|P2|Overall Study|Withdrawal of consent|0
1246217|NCT00606593|4087424|P1|Overall Study|Withdrawal of consent|1
1246218|NCT00606593|4087415|P10|Overall Study|Adverse Event|0
1246219|NCT00606593|4087416|P9|Overall Study|Adverse Event|1
1246220|NCT00606593|4087417|P8|Overall Study|Adverse Event|2
1246221|NCT00606593|4087418|P7|Overall Study|Adverse Event|1
1246222|NCT00606593|4087419|P6|Overall Study|Adverse Event|0
1246223|NCT00606593|4087420|P5|Overall Study|Adverse Event|1
1246224|NCT00606593|4087421|P4|Overall Study|Adverse Event|1
1246225|NCT00606593|4087422|P3|Overall Study|Adverse Event|0
1246226|NCT00606593|4087423|P2|Overall Study|Adverse Event|0
1246227|NCT00606593|4087424|P1|Overall Study|Adverse Event|0
1246228|NCT00606580|4087445|P3|Overall Study|Withdrawal by Subject|0
1246229|NCT00606580|4087446|P2|Overall Study|Withdrawal by Subject|1
1246230|NCT00606580|4087447|P1|Overall Study|Withdrawal by Subject|0
1246231|NCT00606580|4087445|P3|Overall Study|Withdrawal by investigator|6
1246232|NCT00606580|4087446|P2|Overall Study|Withdrawal by investigator|1
1246233|NCT00606580|4087447|P1|Overall Study|Withdrawal by investigator|0
1246234|NCT00606580|4087445|P3|Overall Study|Clinical failures|12
1246235|NCT00606580|4087446|P2|Overall Study|Clinical failures|0
1246236|NCT00606580|4087447|P1|Overall Study|Clinical failures|1
1246237|NCT00606580|4087445|P3|Overall Study|Lost to Follow-up|4
1246238|NCT00606580|4087446|P2|Overall Study|Lost to Follow-up|1
1246239|NCT00606580|4087447|P1|Overall Study|Lost to Follow-up|1
1246240|NCT00606502|4087513|P2|Treatment|Treatment ongoing at time of data cutoff|3
1246241|NCT00606502|4087514|P1|Treatment|Treatment ongoing at time of data cutoff|0
1246242|NCT00606502|4087513|P2|Randomization|Randomized but not treated|0
1246243|NCT00606502|4087514|P1|Randomization|Randomized but not treated|3
1246244|NCT00606320|4087535|P1|Overall Study|Progression to depressive phase|4
1246245|NCT00606320|4087535|P1|Overall Study|Withdrawal by Subject|10
1246246|NCT00606320|4087535|P1|Overall Study|Protocol Violation|8
1246247|NCT00606320|4087535|P1|Overall Study|Physician Decision|7
1246248|NCT00606320|4087535|P1|Overall Study|Lack of Efficacy|5
1246249|NCT00606320|4087535|P1|Overall Study|Adverse Event|3
1246250|NCT00606281|4087542|P2|Overall Study|Change of residence or other commitments|1
1246251|NCT00606281|4087543|P1|Overall Study|Change of residence or other commitments|1
1246252|NCT00606281|4087542|P2|Overall Study|Progression to depressive phase|1
1246253|NCT00606281|4087543|P1|Overall Study|Progression to depressive phase|1
1246254|NCT00606281|4087542|P2|Overall Study|Withdrawal by Subject|13
1246255|NCT00606281|4087543|P1|Overall Study|Withdrawal by Subject|11
1246256|NCT00606281|4087542|P2|Overall Study|Protocol Violation|3
1246258|NCT00606281|4087542|P2|Overall Study|Physician Decision|1
1246259|NCT00606281|4087543|P1|Overall Study|Physician Decision|0
1246260|NCT00606281|4087542|P2|Overall Study|Lack of Efficacy|35
1246261|NCT00606281|4087543|P1|Overall Study|Lack of Efficacy|28
1246262|NCT00606281|4087542|P2|Overall Study|Death|0
1246263|NCT00606281|4087543|P1|Overall Study|Death|1
1246264|NCT00606281|4087542|P2|Overall Study|Adverse Event|12
1246265|NCT00606281|4087543|P1|Overall Study|Adverse Event|11
1246266|NCT00606229|4087551|P1|Overall Study|change of residence or other commitments|2
1246267|NCT00606229|4087551|P1|Overall Study|does not meet inclusion criterion 1-3|4
1246268|NCT00606229|4087551|P1|Overall Study|Withdrawal by Subject|4
1246269|NCT00606229|4087551|P1|Overall Study|Lack of Efficacy|1
1246270|NCT00606229|4087551|P1|Overall Study|Adverse Event|11
1246271|NCT00606177|4087558|P2|Overall Study|Change of residence or other commitments|1
1246272|NCT00606177|4087559|P1|Overall Study|Change of residence or other commitments|1
1246273|NCT00606177|4087558|P2|Overall Study|Diabetic blood glucose level/ High HbA1c|1
1246274|NCT00606177|4087559|P1|Overall Study|Diabetic blood glucose level/ High HbA1c|1
1246275|NCT00606177|4087558|P2|Overall Study|Progression to depressive phase|1
1246276|NCT00606177|4087559|P1|Overall Study|Progression to depressive phase|6
1246277|NCT00606177|4087558|P2|Overall Study|Withdrawal by Subject|6
1246278|NCT00606177|4087559|P1|Overall Study|Withdrawal by Subject|5
1246279|NCT00606177|4087558|P2|Overall Study|Protocol Violation|4
1246280|NCT00606177|4087559|P1|Overall Study|Protocol Violation|1
1246281|NCT00606177|4087558|P2|Overall Study|Physician Decision|0
1246282|NCT00606177|4087559|P1|Overall Study|Physician Decision|1
1246283|NCT00606177|4087558|P2|Overall Study|Lack of Efficacy|7
1246284|NCT00606177|4087559|P1|Overall Study|Lack of Efficacy|3
1246285|NCT00606177|4087558|P2|Overall Study|Adverse Event|5
1246286|NCT00606177|4087559|P1|Overall Study|Adverse Event|9
1246287|NCT00606086|4087586|P2|Overall Study|Randomized, not treated|2
1246288|NCT00606086|4087587|P1|Overall Study|Randomized, not treated|1
1246289|NCT00606086|4087586|P2|Overall Study|Non-compliance|1
1246290|NCT00606086|4087587|P1|Overall Study|Non-compliance|0
1246291|NCT00606086|4087586|P2|Overall Study|Withdrawal by Subject|3
1246292|NCT00606086|4087587|P1|Overall Study|Withdrawal by Subject|5
1246293|NCT00606086|4087586|P2|Overall Study|Protocol Violation|0
1246294|NCT00606086|4087587|P1|Overall Study|Protocol Violation|1
1246295|NCT00606086|4087586|P2|Overall Study|Lost to Follow-up|8
1246296|NCT00606086|4087587|P1|Overall Study|Lost to Follow-up|4
1246297|NCT00606086|4087586|P2|Overall Study|Adverse Event|1
1246298|NCT00606086|4087587|P1|Overall Study|Adverse Event|1
1246299|NCT00606034|4087593|P1|Overall Study|incarceration|1
1246300|NCT00606021|4087601|P3|Maintenance Phase|Lost to Follow-up|2
1246301|NCT00606021|4087602|P2|Maintenance Phase|Lost to Follow-up|5
1246302|NCT00606021|4087603|P1|Maintenance Phase|Lost to Follow-up|0
1246303|NCT00606021|4087601|P3|Maintenance Phase|Physician Decision|0
1246304|NCT00606021|4087602|P2|Maintenance Phase|Physician Decision|1
1246305|NCT00606021|4087603|P1|Maintenance Phase|Physician Decision|0
1246306|NCT00606021|4087601|P3|Maintenance Phase|Death|15
1246307|NCT00606021|4087602|P2|Maintenance Phase|Death|17
1246308|NCT00606021|4087603|P1|Maintenance Phase|Death|0
1246309|NCT00606021|4087601|P3|Induction Phase|Lost to Follow-up|0
1246310|NCT00606021|4087602|P2|Induction Phase|Lost to Follow-up|0
1246311|NCT00606021|4087603|P1|Induction Phase|Lost to Follow-up|10
1246312|NCT00606021|4087601|P3|Induction Phase|Withdrawal by Subject|0
1246313|NCT00606021|4087602|P2|Induction Phase|Withdrawal by Subject|0
1246314|NCT00606021|4087603|P1|Induction Phase|Withdrawal by Subject|2
1246315|NCT00606021|4087601|P3|Induction Phase|Physician Decision|0
1246316|NCT00606021|4087602|P2|Induction Phase|Physician Decision|0
1246317|NCT00606021|4087603|P1|Induction Phase|Physician Decision|2
1246318|NCT00606021|4087601|P3|Induction Phase|Death|0
1246319|NCT00606021|4087602|P2|Induction Phase|Death|0
1246320|NCT00606021|4087603|P1|Induction Phase|Death|73
1246321|NCT00606008|4087621|P1|Overall Study|Withdrawal by Subject|4
1246322|NCT00606008|4087621|P1|Overall Study|Adverse Event|1
1246323|NCT00605917|4087635|P1|Overall Study|Protocol Violation|79
1246324|NCT00605865|4087687|P1|Overall Study|Protocol Violation|115
1246325|NCT00605839|4087729|P3|Overall Study|Protocol Violation|0
1246326|NCT00605839|4087730|P2|Overall Study|Protocol Violation|0
1246327|NCT00605839|4087731|P1|Overall Study|Protocol Violation|1
1246328|NCT00605813|4087739|P1|Overall Study|Protocol Violation|25
1246329|NCT00605722|4087752|P1|Overall Study|Failure to return|1
1246330|NCT00605722|4087752|P1|Overall Study|Insufficient therapeutic response|44
1246331|NCT00605722|4087752|P1|Overall Study|Adverse Event|6
1246332|NCT00605657|4087773|P1|Overall Study|Protocol Violation|1
1246333|NCT00605657|4087773|P1|Overall Study|Adverse Event|1
1246334|NCT00605540|4087778|P1|Overall Study|Lost to Follow-up|23
1246335|NCT00605540|4087778|P1|Overall Study|Death|15
1246336|NCT00605475|4087796|P10|Overall Study|Withdrawal by Subject|1
1246337|NCT00605475|4087797|P9|Overall Study|Withdrawal by Subject|0
1246338|NCT00605475|4087798|P8|Overall Study|Withdrawal by Subject|0
1246339|NCT00605475|4087799|P7|Overall Study|Withdrawal by Subject|0
1246340|NCT00605475|4087800|P6|Overall Study|Withdrawal by Subject|2
1246341|NCT00605475|4087801|P5|Overall Study|Withdrawal by Subject|0
1246342|NCT00605475|4087802|P4|Overall Study|Withdrawal by Subject|0
1246343|NCT00605475|4087803|P3|Overall Study|Withdrawal by Subject|0
1246344|NCT00605475|4087804|P2|Overall Study|Withdrawal by Subject|0
1246345|NCT00605475|4087805|P1|Overall Study|Withdrawal by Subject|0
1246346|NCT00605475|4087796|P10|Overall Study|Protocol Violation|0
1246347|NCT00605475|4087797|P9|Overall Study|Protocol Violation|0
1246348|NCT00605475|4087798|P8|Overall Study|Protocol Violation|0
1246349|NCT00605475|4087799|P7|Overall Study|Protocol Violation|0
1246350|NCT00605475|4087800|P6|Overall Study|Protocol Violation|0
1246351|NCT00605475|4087801|P5|Overall Study|Protocol Violation|1
1246352|NCT00605475|4087802|P4|Overall Study|Protocol Violation|0
1246353|NCT00605475|4087803|P3|Overall Study|Protocol Violation|0
1246354|NCT00605475|4087804|P2|Overall Study|Protocol Violation|0
1246355|NCT00605475|4087805|P1|Overall Study|Protocol Violation|0
1246356|NCT00605475|4087796|P10|Overall Study|Lost to Follow-up|1
1246357|NCT00605475|4087797|P9|Overall Study|Lost to Follow-up|1
1246358|NCT00605475|4087798|P8|Overall Study|Lost to Follow-up|0
1246359|NCT00605475|4087799|P7|Overall Study|Lost to Follow-up|0
1246360|NCT00605475|4087800|P6|Overall Study|Lost to Follow-up|0
1246361|NCT00605475|4087801|P5|Overall Study|Lost to Follow-up|0
1246362|NCT00605475|4087802|P4|Overall Study|Lost to Follow-up|0
1246363|NCT00605475|4087803|P3|Overall Study|Lost to Follow-up|0
1246364|NCT00605475|4087804|P2|Overall Study|Lost to Follow-up|0
1246365|NCT00605475|4087805|P1|Overall Study|Lost to Follow-up|0
1246366|NCT00605475|4087796|P10|Overall Study|Administrative problems|0
1246367|NCT00605475|4087797|P9|Overall Study|Administrative problems|0
1246368|NCT00605475|4087798|P8|Overall Study|Administrative problems|0
1246369|NCT00605475|4087799|P7|Overall Study|Administrative problems|1
1246370|NCT00605475|4087800|P6|Overall Study|Administrative problems|0
1246371|NCT00605475|4087801|P5|Overall Study|Administrative problems|0
1246372|NCT00605475|4087802|P4|Overall Study|Administrative problems|0
1246373|NCT00605475|4087803|P3|Overall Study|Administrative problems|0
1246374|NCT00605475|4087804|P2|Overall Study|Administrative problems|0
1246375|NCT00605475|4087805|P1|Overall Study|Administrative problems|0
1246376|NCT00605475|4087796|P10|Overall Study|Abnormal Laboratory Values|0
1246377|NCT00605475|4087797|P9|Overall Study|Abnormal Laboratory Values|1
1246378|NCT00605475|4087798|P8|Overall Study|Abnormal Laboratory Values|0
1246379|NCT00605475|4087799|P7|Overall Study|Abnormal Laboratory Values|0
1246380|NCT00605475|4087800|P6|Overall Study|Abnormal Laboratory Values|0
1246381|NCT00605475|4087801|P5|Overall Study|Abnormal Laboratory Values|0
1246382|NCT00605475|4087802|P4|Overall Study|Abnormal Laboratory Values|0
1246383|NCT00605475|4087803|P3|Overall Study|Abnormal Laboratory Values|0
1246384|NCT00605475|4087804|P2|Overall Study|Abnormal Laboratory Values|0
1246385|NCT00605475|4087805|P1|Overall Study|Abnormal Laboratory Values|0
1246386|NCT00605345|4087982|P2|Overall Study|Protocol Violation|2
1246387|NCT00605345|4087983|P1|Overall Study|Protocol Violation|0
1246388|NCT00605345|4087982|P2|Overall Study|Adverse Event|1
1246389|NCT00605345|4087983|P1|Overall Study|Adverse Event|0
1246390|NCT00605345|4087982|P2|Overall Study|Withdrawal by Subject|0
1246391|NCT00605345|4087983|P1|Overall Study|Withdrawal by Subject|1
1246392|NCT00605319|4087999|P1|Overall Study|Adverse Event|6
1246393|NCT00605306|4088011|P2|Overall Study|Adverse Event|1
1246394|NCT00605306|4088012|P1|Overall Study|Adverse Event|0
1246395|NCT00605293|4088026|P2|Overall Study|Principal Investigator Decision|1
1246396|NCT00605293|4088027|P1|Overall Study|Principal Investigator Decision|0
1246397|NCT00605293|4088026|P2|Overall Study|Dialysis Out of Centre for 3 Months|1
1246398|NCT00605293|4088027|P1|Overall Study|Dialysis Out of Centre for 3 Months|0
1246399|NCT00605293|4088026|P2|Overall Study|Incorrect Epoetin Beta Administration|0
1246400|NCT00605293|4088027|P1|Overall Study|Incorrect Epoetin Beta Administration|1
1246401|NCT00605293|4088026|P2|Overall Study|Renal Transplantation|1
1246402|NCT00605293|4088027|P1|Overall Study|Renal Transplantation|3
1246403|NCT00605293|4088026|P2|Overall Study|Blood Transfusion|1
1246404|NCT00605293|4088027|P1|Overall Study|Blood Transfusion|7
1246405|NCT00605293|4088026|P2|Overall Study|Holidays Dialysis Out|0
1246406|NCT00605293|4088027|P1|Overall Study|Holidays Dialysis Out|1
1246407|NCT00605293|4088026|P2|Overall Study|Adverse Event|0
1246408|NCT00605293|4088027|P1|Overall Study|Adverse Event|1
1246409|NCT00605293|4088026|P2|Overall Study|Insufficient Therapeutic Response|0
1246410|NCT00605293|4088027|P1|Overall Study|Insufficient Therapeutic Response|2
1246411|NCT00605293|4088026|P2|Overall Study|Death|1
1246412|NCT00605293|4088027|P1|Overall Study|Death|2
1246413|NCT00605280|4088047|P4|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
1246414|NCT00605280|4088048|P3|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
1246415|NCT00605280|4088049|P2|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
1246416|NCT00605280|4088050|P1|Year 3 Extension|Lost to Follow-up or Patient non-comply|2
1246417|NCT00605280|4088047|P4|Year 3 Extension|Other|0
1246418|NCT00605280|4088048|P3|Year 3 Extension|Other|0
1246419|NCT00605280|4088049|P2|Year 3 Extension|Other|0
1246420|NCT00605280|4088050|P1|Year 3 Extension|Other|2
1246421|NCT00605280|4088047|P4|Year 3 Extension|Withdrawal by Subject|5
1246422|NCT00605280|4088048|P3|Year 3 Extension|Withdrawal by Subject|0
1246423|NCT00605280|4088049|P2|Year 3 Extension|Withdrawal by Subject|0
1246424|NCT00605280|4088050|P1|Year 3 Extension|Withdrawal by Subject|2
1246425|NCT00605280|4088047|P4|Year 3 Extension|Physician Decision|2
1246426|NCT00605280|4088048|P3|Year 3 Extension|Physician Decision|0
1246427|NCT00605280|4088049|P2|Year 3 Extension|Physician Decision|0
1246428|NCT00605280|4088050|P1|Year 3 Extension|Physician Decision|0
1246429|NCT00605280|4088047|P4|Year 3 Extension|Adverse Event|2
1246430|NCT00605280|4088048|P3|Year 3 Extension|Adverse Event|0
1246431|NCT00605280|4088049|P2|Year 3 Extension|Adverse Event|0
1246432|NCT00605280|4088050|P1|Year 3 Extension|Adverse Event|2
1246433|NCT00605280|4088047|P4|Year 2|Lost to Follow-up or Patient non-comply|2
1246434|NCT00605280|4088048|P3|Year 2|Lost to Follow-up or Patient non-comply|0
1246435|NCT00605280|4088049|P2|Year 2|Lost to Follow-up or Patient non-comply|0
1246436|NCT00605280|4088050|P1|Year 2|Lost to Follow-up or Patient non-comply|4
1246437|NCT00605280|4088047|P4|Year 2|Other|1
1246438|NCT00605280|4088048|P3|Year 2|Other|0
1246439|NCT00605280|4088049|P2|Year 2|Other|0
1246440|NCT00605280|4088050|P1|Year 2|Other|1
1246441|NCT00605280|4088047|P4|Year 2|Withdrawal by Subject|4
1246442|NCT00605280|4088048|P3|Year 2|Withdrawal by Subject|0
1246443|NCT00605280|4088049|P2|Year 2|Withdrawal by Subject|0
1246444|NCT00605280|4088050|P1|Year 2|Withdrawal by Subject|4
1246445|NCT00605280|4088047|P4|Year 2|Physician Decision|11
1246446|NCT00605280|4088048|P3|Year 2|Physician Decision|4
1246447|NCT00605280|4088049|P2|Year 2|Physician Decision|6
1246448|NCT00605280|4088050|P1|Year 2|Physician Decision|11
1246449|NCT00605280|4088047|P4|Year 2|Adverse Event|4
1246450|NCT00605280|4088048|P3|Year 2|Adverse Event|2
1246451|NCT00605280|4088049|P2|Year 2|Adverse Event|0
1246452|NCT00605280|4088050|P1|Year 2|Adverse Event|4
1246453|NCT00605280|4088047|P4|Year 1|Lost to Follow-up or Patient non-comply|2
1246454|NCT00605280|4088048|P3|Year 1|Lost to Follow-up or Patient non-comply|0
1246455|NCT00605280|4088049|P2|Year 1|Lost to Follow-up or Patient non-comply|1
1246456|NCT00605280|4088050|P1|Year 1|Lost to Follow-up or Patient non-comply|5
1246457|NCT00605280|4088047|P4|Year 1|Other|1
1246458|NCT00605280|4088048|P3|Year 1|Other|0
1246459|NCT00605280|4088049|P2|Year 1|Other|1
1246460|NCT00605280|4088050|P1|Year 1|Other|2
1246461|NCT00605280|4088047|P4|Year 1|Withdrawal by Subject|4
1246462|NCT00605280|4088048|P3|Year 1|Withdrawal by Subject|0
1246463|NCT00605280|4088049|P2|Year 1|Withdrawal by Subject|4
1246464|NCT00605280|4088050|P1|Year 1|Withdrawal by Subject|2
1246465|NCT00605280|4088047|P4|Year 1|Physician Decision|6
1246466|NCT00605280|4088048|P3|Year 1|Physician Decision|0
1246467|NCT00605280|4088049|P2|Year 1|Physician Decision|4
1246468|NCT00605280|4088050|P1|Year 1|Physician Decision|7
1246469|NCT00605280|4088047|P4|Year 1|Adverse Event|5
1246470|NCT00605280|4088048|P3|Year 1|Adverse Event|1
1246471|NCT00605280|4088049|P2|Year 1|Adverse Event|1
1246472|NCT00605280|4088050|P1|Year 1|Adverse Event|3
1246473|NCT00605280|4088047|P4|Year 1|Protocol Violation|1
1246474|NCT00605280|4088048|P3|Year 1|Protocol Violation|0
1246475|NCT00605280|4088049|P2|Year 1|Protocol Violation|0
1246476|NCT00605280|4088050|P1|Year 1|Protocol Violation|0
1246477|NCT00605267|4088084|P2|Overall Study|Withdrawal by Subject|3
1246478|NCT00605267|4088085|P1|Overall Study|Withdrawal by Subject|2
1246479|NCT00605267|4088084|P2|Overall Study|Lack of Efficacy|5
1246480|NCT00605267|4088085|P1|Overall Study|Lack of Efficacy|1
1246481|NCT00605267|4088084|P2|Overall Study|Adverse Event|1
1246482|NCT00605267|4088085|P1|Overall Study|Adverse Event|0
1246483|NCT00605189|4088133|P3|Overall Study|Not specified|0
1246484|NCT00605189|4088134|P2|Overall Study|Not specified|2
1246485|NCT00605189|4088135|P1|Overall Study|Not specified|2
1246486|NCT00605189|4088133|P3|Overall Study|Adverse Event|0
1246487|NCT00605189|4088134|P2|Overall Study|Adverse Event|0
1246488|NCT00605189|4088135|P1|Overall Study|Adverse Event|1
1246489|NCT00605176|4088146|P3|Overall Study|Other (not due to AE)|0
1246490|NCT00605176|4088147|P2|Overall Study|Other (not due to AE)|1
1246491|NCT00605176|4088148|P1|Overall Study|Other (not due to AE)|1
1246492|NCT00605176|4088146|P3|Overall Study|Use of concomitant therapy|1
1246493|NCT00605176|4088147|P2|Overall Study|Use of concomitant therapy|0
1246494|NCT00605176|4088148|P1|Overall Study|Use of concomitant therapy|1
1246495|NCT00605176|4088146|P3|Overall Study|Non-complicance with study procedures|0
1246496|NCT00605176|4088147|P2|Overall Study|Non-complicance with study procedures|0
1246497|NCT00605176|4088148|P1|Overall Study|Non-complicance with study procedures|1
1246498|NCT00605176|4088146|P3|Overall Study|Lost to Follow-up|1
1246499|NCT00605176|4088147|P2|Overall Study|Lost to Follow-up|2
1246500|NCT00605176|4088148|P1|Overall Study|Lost to Follow-up|2
1246501|NCT00605176|4088146|P3|Overall Study|Withdrawal by Subject|4
1246502|NCT00605176|4088147|P2|Overall Study|Withdrawal by Subject|2
1246503|NCT00605176|4088148|P1|Overall Study|Withdrawal by Subject|4
1246504|NCT00605176|4088146|P3|Overall Study|Adverse Event|3
1246505|NCT00605176|4088147|P2|Overall Study|Adverse Event|1
1246506|NCT00605176|4088148|P1|Overall Study|Adverse Event|2
1246507|NCT00605085|4088171|P2|Overall Study|administrative reasons|8
1246508|NCT00605085|4088172|P1|Overall Study|administrative reasons|18
1246509|NCT00605085|4088171|P2|Overall Study|Lost to Follow-up|5
1246510|NCT00605085|4088172|P1|Overall Study|Lost to Follow-up|10
1246511|NCT00605085|4088171|P2|Overall Study|Protocol Violation|2
1246512|NCT00605085|4088172|P1|Overall Study|Protocol Violation|3
1246513|NCT00605085|4088171|P2|Overall Study|Pregnancy|0
1246514|NCT00605085|4088172|P1|Overall Study|Pregnancy|2
1246515|NCT00605085|4088171|P2|Overall Study|Adverse Event|5
1246516|NCT00605085|4088172|P1|Overall Study|Adverse Event|9
1246517|NCT00605085|4088171|P2|Overall Study|Withdrawal by Subject|5
1246518|NCT00605085|4088172|P1|Overall Study|Withdrawal by Subject|8
1246519|NCT00605033|4088205|P2|Overall Study|Protocol Violation|1
1246520|NCT00605033|4088206|P1|Overall Study|Protocol Violation|1
1246521|NCT00605033|4088205|P2|Overall Study|Withdrawal by Subject|4
1246522|NCT00605033|4088206|P1|Overall Study|Withdrawal by Subject|3
1246523|NCT00605033|4088205|P2|Overall Study|Lost to Follow-up|1
1246524|NCT00605033|4088206|P1|Overall Study|Lost to Follow-up|1
1246525|NCT00605033|4088205|P2|Overall Study|Adverse Event|2
1246526|NCT00605033|4088206|P1|Overall Study|Adverse Event|2
1246527|NCT00604825|4088229|P4|Overall Study|Exclusion criterion met|1
1246528|NCT00604825|4088230|P3|Overall Study|Exclusion criterion met|0
1246529|NCT00604825|4088231|P2|Overall Study|Exclusion criterion met|0
1246530|NCT00604825|4088232|P1|Overall Study|Exclusion criterion met|0
1246531|NCT00604825|4088229|P4|Overall Study|Physician Decision|1
1246532|NCT00604825|4088230|P3|Overall Study|Physician Decision|0
1246533|NCT00604825|4088231|P2|Overall Study|Physician Decision|0
1246534|NCT00604825|4088232|P1|Overall Study|Physician Decision|0
1246535|NCT00604825|4088229|P4|Overall Study|Did not meet eligibility criteria|0
1246536|NCT00604825|4088230|P3|Overall Study|Did not meet eligibility criteria|2
1246537|NCT00604825|4088231|P2|Overall Study|Did not meet eligibility criteria|0
1246538|NCT00604825|4088232|P1|Overall Study|Did not meet eligibility criteria|0
1246539|NCT00604825|4088229|P4|Overall Study|Lack of Efficacy|0
1246540|NCT00604825|4088230|P3|Overall Study|Lack of Efficacy|1
1246541|NCT00604825|4088231|P2|Overall Study|Lack of Efficacy|2
1246542|NCT00604825|4088232|P1|Overall Study|Lack of Efficacy|3
1246543|NCT00604825|4088229|P4|Overall Study|Withdrawal by Subject|5
1246544|NCT00604825|4088230|P3|Overall Study|Withdrawal by Subject|5
1246545|NCT00604825|4088231|P2|Overall Study|Withdrawal by Subject|3
1246546|NCT00604825|4088232|P1|Overall Study|Withdrawal by Subject|4
1246547|NCT00604825|4088229|P4|Overall Study|Protocol Violation|0
1246548|NCT00604825|4088230|P3|Overall Study|Protocol Violation|0
1246549|NCT00604825|4088231|P2|Overall Study|Protocol Violation|1
1246550|NCT00604825|4088232|P1|Overall Study|Protocol Violation|0
1246551|NCT00604825|4088229|P4|Overall Study|Lost to Follow-up|0
1246552|NCT00604825|4088230|P3|Overall Study|Lost to Follow-up|1
1246553|NCT00604825|4088231|P2|Overall Study|Lost to Follow-up|3
1246554|NCT00604825|4088232|P1|Overall Study|Lost to Follow-up|0
1246555|NCT00604825|4088229|P4|Overall Study|Adverse Event|4
1246556|NCT00604825|4088230|P3|Overall Study|Adverse Event|7
1246557|NCT00604825|4088231|P2|Overall Study|Adverse Event|6
1246558|NCT00604825|4088232|P1|Overall Study|Adverse Event|2
1246559|NCT00604786|4088460|P2|Overall Study|Lost to Follow-up|0
1246560|NCT00604786|4088461|P1|Overall Study|Lost to Follow-up|2
1246561|NCT00604721|4088467|P1|Overall Study|Withdrawal by Subject|1
1246562|NCT00604721|4088467|P1|Overall Study|Physician Decision|1
1246563|NCT00604708|4088475|P2|Overall Study|Adverse Event|6
1246564|NCT00604708|4088476|P1|Overall Study|Adverse Event|6
1246565|NCT00604708|4088475|P2|Overall Study|administrative reasons|11
1246566|NCT00604708|4088476|P1|Overall Study|administrative reasons|9
1246567|NCT00604708|4088475|P2|Overall Study|Lost to Follow-up|5
1246568|NCT00604708|4088476|P1|Overall Study|Lost to Follow-up|5
1246569|NCT00604708|4088475|P2|Overall Study|Protocol Violation|8
1246570|NCT00604708|4088476|P1|Overall Study|Protocol Violation|2
1246571|NCT00604708|4088475|P2|Overall Study|Withdrawal by Subject|10
1246572|NCT00604708|4088476|P1|Overall Study|Withdrawal by Subject|9
1246573|NCT00604695|4088486|P2|Overall Study|Did not receive first bolus.|4
1246574|NCT00604695|4088487|P1|Overall Study|Did not receive first bolus.|0
1246575|NCT00604669|4088509|P1|Overall Study|lack of information in chart|7
1246576|NCT00604565|4088515|P2|Overall Study|Study terminated|3
1246577|NCT00604565|4088516|P1|Overall Study|Study terminated|0
1246578|NCT00604500|4088535|P1|Overall Study|Did not meet protocol eligibility|1
1246579|NCT00604500|4088535|P1|Overall Study|Administrative|1
1246580|NCT00604500|4088535|P1|Overall Study|Withdrawal by Subject|4
1246581|NCT00604500|4088535|P1|Overall Study|Treatment Failure|1
1246582|NCT00604500|4088535|P1|Overall Study|Protocol Violation|2
1246583|NCT00604500|4088535|P1|Overall Study|Adverse Event|2
1246584|NCT00604383|4088549|P2|Overall Study|Physician Decision|3
1246585|NCT00604383|4088550|P1|Overall Study|Physician Decision|0
1246586|NCT00604383|4088549|P2|Overall Study|Adverse Event|9
1246587|NCT00604383|4088550|P1|Overall Study|Adverse Event|16
1246588|NCT00604383|4088549|P2|Overall Study|Death|22
1246589|NCT00604383|4088550|P1|Overall Study|Death|14
1246590|NCT00604383|4088549|P2|Overall Study|Lost to Follow-up|19
1246591|NCT00604383|4088550|P1|Overall Study|Lost to Follow-up|24
1246592|NCT00604383|4088549|P2|Overall Study|Withdrawal by Subject|31
1246593|NCT00604383|4088550|P1|Overall Study|Withdrawal by Subject|33
1246594|NCT00604279|4088566|P2|Overall Study|Other|4
1246595|NCT00604279|4088567|P1|Overall Study|Other|8
1246596|NCT00604279|4088566|P2|Overall Study|Adverse Event|5
1246597|NCT00604279|4088567|P1|Overall Study|Adverse Event|4
1246598|NCT00604279|4088566|P2|Overall Study|Withdrawal by Subject|5
1246599|NCT00604279|4088567|P1|Overall Study|Withdrawal by Subject|16
1246600|NCT00604279|4088566|P2|Overall Study|Protocol Violation|1
1246601|NCT00604279|4088567|P1|Overall Study|Protocol Violation|3
1246602|NCT00604279|4088566|P2|Overall Study|Pregnancy|0
1246603|NCT00604279|4088567|P1|Overall Study|Pregnancy|2
1246604|NCT00604279|4088566|P2|Overall Study|Lost to Follow-up|14
1246605|NCT00604279|4088567|P1|Overall Study|Lost to Follow-up|9
1246606|NCT00604279|4088566|P2|Overall Study|Lack of Efficacy|9
1246607|NCT00604279|4088567|P1|Overall Study|Lack of Efficacy|22
1246608|NCT00604214|4088583|P2|Day 91 to Day 180|Withdrawal by Subject|1
1246609|NCT00604214|4088584|P1|Day 91 to Day 180|Withdrawal by Subject|1
1246610|NCT00604214|4088583|P2|Day 91 to Day 180|Lost to Follow-up|8
1246611|NCT00604214|4088584|P1|Day 91 to Day 180|Lost to Follow-up|6
1246612|NCT00604214|4088583|P2|Day 91 to Day 180|Death|23
1246613|NCT00604214|4088584|P1|Day 91 to Day 180|Death|19
1246614|NCT00604214|4088583|P2|Day 29 to Day 90|Withdrawal by Subject|6
1246615|NCT00604214|4088584|P1|Day 29 to Day 90|Withdrawal by Subject|0
1246616|NCT00604214|4088583|P2|Day 29 to Day 90|Lost to Follow-up|6
1246617|NCT00604214|4088584|P1|Day 29 to Day 90|Lost to Follow-up|4
1246618|NCT00604214|4088583|P2|Day 29 to Day 90|Death|67
1246619|NCT00604214|4088584|P1|Day 29 to Day 90|Death|64
1246620|NCT00604214|4088583|P2|Baseline to Day 28|Withdrawal by Subject|7
1246621|NCT00604214|4088584|P1|Baseline to Day 28|Withdrawal by Subject|3
1246622|NCT00604214|4088583|P2|Baseline to Day 28|Lost to Follow-up|4
1246623|NCT00604214|4088584|P1|Baseline to Day 28|Lost to Follow-up|2
1246624|NCT00604214|4088583|P2|Baseline to Day 28|Death|202
1246625|NCT00604214|4088584|P1|Baseline to Day 28|Death|223
1246626|NCT00604188|4088616|P2|Overall Study|Did not receive study drug|1
1246627|NCT00604188|4088617|P1|Overall Study|Did not receive study drug|0
1246628|NCT00604188|4088616|P2|Overall Study|Non-compliance with protocol|4
1246629|NCT00604188|4088617|P1|Overall Study|Non-compliance with protocol|4
1246630|NCT00604188|4088616|P2|Overall Study|Withdrawal by Subject|1
1246631|NCT00604188|4088617|P1|Overall Study|Withdrawal by Subject|5
1246632|NCT00604188|4088616|P2|Overall Study|Lost to Follow-up|15
1246633|NCT00604188|4088617|P1|Overall Study|Lost to Follow-up|17
1246634|NCT00604188|4088616|P2|Overall Study|Adverse Event|4
1246635|NCT00604188|4088617|P1|Overall Study|Adverse Event|1
1246636|NCT00604175|4088640|P3|Week 29 Through Week 72|Non-adherence to study requirements|1
1246637|NCT00604175|4088641|P2|Week 29 Through Week 72|Non-adherence to study requirements|0
1246638|NCT00604175|4088642|P1|Week 29 Through Week 72|Non-adherence to study requirements|0
1246639|NCT00604175|4088640|P3|Week 29 Through Week 72|Site closure|0
1246640|NCT00604175|4088641|P2|Week 29 Through Week 72|Site closure|1
1246641|NCT00604175|4088642|P1|Week 29 Through Week 72|Site closure|0
1246642|NCT00604175|4088640|P3|Week 29 Through Week 72|Lost to Follow-up|2
1246643|NCT00604175|4088641|P2|Week 29 Through Week 72|Lost to Follow-up|6
1246644|NCT00604175|4088642|P1|Week 29 Through Week 72|Lost to Follow-up|12
1246645|NCT00604175|4088640|P3|Week 29 Through Week 72|Death|1
1246646|NCT00604175|4088641|P2|Week 29 Through Week 72|Death|0
1246647|NCT00604175|4088642|P1|Week 29 Through Week 72|Death|0
1246648|NCT00604175|4088640|P3|Entry Through Week 28|Did not start intervention|1
1246649|NCT00604175|4088641|P2|Entry Through Week 28|Did not start intervention|0
1246650|NCT00604175|4088642|P1|Entry Through Week 28|Did not start intervention|2
1246651|NCT00604175|4088640|P3|Entry Through Week 28|Ineligible|0
1246652|NCT00604175|4088641|P2|Entry Through Week 28|Ineligible|0
1246653|NCT00604175|4088642|P1|Entry Through Week 28|Ineligible|1
1246654|NCT00604175|4088640|P3|Entry Through Week 28|Lost to Follow-up|0
1246655|NCT00604175|4088641|P2|Entry Through Week 28|Lost to Follow-up|3
1246656|NCT00604175|4088642|P1|Entry Through Week 28|Lost to Follow-up|4
1246657|NCT00604175|4088640|P3|Entry Through Week 28|Withdrawal by Subject|0
1246658|NCT00604175|4088641|P2|Entry Through Week 28|Withdrawal by Subject|0
1246659|NCT00604175|4088642|P1|Entry Through Week 28|Withdrawal by Subject|1
1246660|NCT00604175|4088640|P3|Entry Through Week 28|Death|0
1246661|NCT00604175|4088641|P2|Entry Through Week 28|Death|0
1246662|NCT00604175|4088642|P1|Entry Through Week 28|Death|2
1246663|NCT00604162|4088695|P1|Overall Study|Withdrawal by Subject|1
1246664|NCT00604162|4088695|P1|Overall Study|Physician Decision|3
1246665|NCT00603915|4088737|P1|Overall Study|Physician Decision|1
1246666|NCT00603837|4088767|P2|Overall Study|Physician Decision|0
1246667|NCT00603837|4088768|P1|Overall Study|Physician Decision|3
1246668|NCT00603798|4088777|P3|Overall Study|Not due to AE|4
1246669|NCT00603798|4088778|P2|Overall Study|Not due to AE|1
1246670|NCT00603798|4088779|P1|Overall Study|Not due to AE|1
1246671|NCT00603798|4088777|P3|Overall Study|Non-compliance with study procedures|0
1246672|NCT00603798|4088778|P2|Overall Study|Non-compliance with study procedures|1
1246673|NCT00603798|4088779|P1|Overall Study|Non-compliance with study procedures|0
1246674|NCT00603798|4088777|P3|Overall Study|Lost to Follow-up|1
1246675|NCT00603798|4088778|P2|Overall Study|Lost to Follow-up|0
1246676|NCT00603798|4088779|P1|Overall Study|Lost to Follow-up|1
1246677|NCT00603798|4088777|P3|Overall Study|Withdrawal by Subject|4
1246678|NCT00603798|4088778|P2|Overall Study|Withdrawal by Subject|3
1246679|NCT00603798|4088779|P1|Overall Study|Withdrawal by Subject|4
1246680|NCT00603798|4088777|P3|Overall Study|Adverse Event|1
1246681|NCT00603798|4088778|P2|Overall Study|Adverse Event|2
1246682|NCT00603798|4088779|P1|Overall Study|Adverse Event|4
1246683|NCT00603746|4088802|P6|Overall Study|Withdrawal by Subject|1
1246684|NCT00603746|4088803|P5|Overall Study|Withdrawal by Subject|3
1246685|NCT00603746|4088804|P4|Overall Study|Withdrawal by Subject|1
1246686|NCT00603746|4088805|P3|Overall Study|Withdrawal by Subject|0
1246687|NCT00603746|4088806|P2|Overall Study|Withdrawal by Subject|0
1246688|NCT00603746|4088807|P1|Overall Study|Withdrawal by Subject|1
1246689|NCT00603746|4088802|P6|Overall Study|Physician Decision|0
1246690|NCT00603746|4088803|P5|Overall Study|Physician Decision|1
1246691|NCT00603746|4088804|P4|Overall Study|Physician Decision|0
1246692|NCT00603746|4088805|P3|Overall Study|Physician Decision|0
1246693|NCT00603746|4088806|P2|Overall Study|Physician Decision|0
1246694|NCT00603746|4088807|P1|Overall Study|Physician Decision|1
1246695|NCT00603746|4088802|P6|Overall Study|Lost to Follow-up|0
1246696|NCT00603746|4088803|P5|Overall Study|Lost to Follow-up|0
1246697|NCT00603746|4088804|P4|Overall Study|Lost to Follow-up|0
1246698|NCT00603746|4088805|P3|Overall Study|Lost to Follow-up|1
1246699|NCT00603746|4088806|P2|Overall Study|Lost to Follow-up|1
1246700|NCT00603746|4088807|P1|Overall Study|Lost to Follow-up|0
1246701|NCT00603746|4088802|P6|Overall Study|Protocol Violation|0
1246702|NCT00603746|4088803|P5|Overall Study|Protocol Violation|1
1246703|NCT00603746|4088804|P4|Overall Study|Protocol Violation|0
1246704|NCT00603746|4088805|P3|Overall Study|Protocol Violation|1
1246705|NCT00603746|4088806|P2|Overall Study|Protocol Violation|3
1246706|NCT00603746|4088807|P1|Overall Study|Protocol Violation|0
1246707|NCT00603746|4088802|P6|Overall Study|Lack of Efficacy|8
1246708|NCT00603746|4088803|P5|Overall Study|Lack of Efficacy|12
1246709|NCT00603746|4088804|P4|Overall Study|Lack of Efficacy|11
1246710|NCT00603746|4088805|P3|Overall Study|Lack of Efficacy|6
1246711|NCT00603746|4088806|P2|Overall Study|Lack of Efficacy|11
1246712|NCT00603746|4088807|P1|Overall Study|Lack of Efficacy|34
1246713|NCT00603746|4088802|P6|Overall Study|Adverse Event|4
1246714|NCT00603746|4088803|P5|Overall Study|Adverse Event|0
1246715|NCT00603746|4088804|P4|Overall Study|Adverse Event|1
1246716|NCT00603746|4088805|P3|Overall Study|Adverse Event|0
1246717|NCT00603746|4088806|P2|Overall Study|Adverse Event|3
1246718|NCT00603746|4088807|P1|Overall Study|Adverse Event|2
1246719|NCT00603733|4088955|P2|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5
1246720|NCT00603733|4088956|P1|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3
1246721|NCT00603733|4088955|P2|Maintenance Phase ITT|Physician Decision|1
1246722|NCT00603733|4088956|P1|Maintenance Phase ITT|Physician Decision|0
1246723|NCT00603733|4088955|P2|Maintenance Phase ITT|Lack of Efficacy|2
1246724|NCT00603733|4088956|P1|Maintenance Phase ITT|Lack of Efficacy|2
1246725|NCT00603733|4088955|P2|Maintenance Phase ITT|Lost to Follow-up|1
1246726|NCT00603733|4088956|P1|Maintenance Phase ITT|Lost to Follow-up|0
1246727|NCT00603733|4088955|P2|Maintenance Phase ITT|Protocol Violation|1
1246728|NCT00603733|4088956|P1|Maintenance Phase ITT|Protocol Violation|1
1246729|NCT00603733|4088955|P2|Maintenance Phase ITT|Withdrawal by Subject|0
1246730|NCT00603733|4088956|P1|Maintenance Phase ITT|Withdrawal by Subject|1
1246731|NCT00603733|4088955|P2|Maintenance Phase ITT|Adverse Event|6
1246732|NCT00603733|4088956|P1|Maintenance Phase ITT|Adverse Event|3
1246733|NCT00603733|4088955|P2|Run-In Phase - 4 Weeks|Lack of Efficacy|1
1246734|NCT00603733|4088956|P1|Run-In Phase - 4 Weeks|Lack of Efficacy|2
1246735|NCT00603733|4088955|P2|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10
1246736|NCT00603733|4088956|P1|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5
1246737|NCT00603733|4088955|P2|Run-In Phase - 4 Weeks|Lost to Follow-up|0
1246738|NCT00603733|4088956|P1|Run-In Phase - 4 Weeks|Lost to Follow-up|1
1246739|NCT00603733|4088955|P2|Run-In Phase - 4 Weeks|Withdrawal by Subject|1
1246740|NCT00603733|4088956|P1|Run-In Phase - 4 Weeks|Withdrawal by Subject|4
1246741|NCT00603733|4088955|P2|Run-In Phase - 4 Weeks|Adverse Event|1
1246742|NCT00603733|4088956|P1|Run-In Phase - 4 Weeks|Adverse Event|2
1246743|NCT00603733|4088955|P2|Active Phase ITT|Subject moved, site closed|1
1246744|NCT00603733|4088956|P1|Active Phase ITT|Subject moved, site closed|1
1246745|NCT00603733|4088955|P2|Active Phase ITT|Lack of Efficacy|2
1246746|NCT00603733|4088956|P1|Active Phase ITT|Lack of Efficacy|1
1246747|NCT00603733|4088955|P2|Active Phase ITT|Did not meet inclusion/exclusion|3
1246748|NCT00603733|4088956|P1|Active Phase ITT|Did not meet inclusion/exclusion|1
1246749|NCT00603733|4088955|P2|Active Phase ITT|Lost to Follow-up|1
1246750|NCT00603733|4088956|P1|Active Phase ITT|Lost to Follow-up|0
1246751|NCT00603733|4088955|P2|Active Phase ITT|Withdrawal by Subject|3
1246752|NCT00603733|4088956|P1|Active Phase ITT|Withdrawal by Subject|0
1246753|NCT00603733|4088955|P2|Active Phase ITT|Adverse Event|7
1246754|NCT00603733|4088956|P1|Active Phase ITT|Adverse Event|8
1246755|NCT00603590|4089006|P2|Overall Study|Cardiovascular event|1
1246756|NCT00603590|4089007|P1|Overall Study|Cardiovascular event|0
1246757|NCT00603590|4089006|P2|Overall Study|Lost to Follow-up|4
1246758|NCT00603590|4089007|P1|Overall Study|Lost to Follow-up|8
1246759|NCT00603590|4089006|P2|Overall Study|Adverse Event|0
1246760|NCT00603590|4089007|P1|Overall Study|Adverse Event|2
1246761|NCT00603590|4089006|P2|Overall Study|Patient discontinued study drug|15
1246762|NCT00603590|4089007|P1|Overall Study|Patient discontinued study drug|22
1246763|NCT00603590|4089006|P2|Overall Study|Refused blood test|1
1246764|NCT00603590|4089007|P1|Overall Study|Refused blood test|5
1246765|NCT00603590|4089006|P2|Overall Study|Did not attend study clinic|30
1246766|NCT00603590|4089007|P1|Overall Study|Did not attend study clinic|39
1246767|NCT00603538|4089031|P3|Overall Study|Objective progression or relapse|0
1246768|NCT00603538|4089032|P2|Overall Study|Objective progression or relapse|0
1246769|NCT00603538|4089033|P1|Overall Study|Objective progression or relapse|3
1246770|NCT00603538|4089031|P3|Overall Study|Adverse Event|2
1246771|NCT00603538|4089032|P2|Overall Study|Adverse Event|4
1246772|NCT00603538|4089033|P1|Overall Study|Adverse Event|0
1246773|NCT00603525|4089073|P3|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111
1246774|NCT00603525|4089074|P2|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
1246775|NCT00603525|4089075|P1|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
1246776|NCT00603525|4089073|P3|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
1246777|NCT00603525|4089074|P2|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8
1246778|NCT00603525|4089075|P1|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
1246779|NCT00603525|4089073|P3|OL Treatment Period (120 Weeks)|Physician Decision|0
1246780|NCT00603525|4089074|P2|OL Treatment Period (120 Weeks)|Physician Decision|2
1246864|NCT00603447|4089370|P3|Overall Study|Adverse Event|1
1246781|NCT00603525|4089075|P1|OL Treatment Period (120 Weeks)|Physician Decision|0
1246782|NCT00603525|4089073|P3|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
1246783|NCT00603525|4089074|P2|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71
1246784|NCT00603525|4089075|P1|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
1246785|NCT00603525|4089073|P3|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
1246786|NCT00603525|4089074|P2|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5
1246787|NCT00603525|4089075|P1|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
1246788|NCT00603525|4089073|P3|OL Treatment Period (120 Weeks)|Protocol Violation|0
1246789|NCT00603525|4089074|P2|OL Treatment Period (120 Weeks)|Protocol Violation|1
1246790|NCT00603525|4089075|P1|OL Treatment Period (120 Weeks)|Protocol Violation|0
1246791|NCT00603525|4089073|P3|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
1246792|NCT00603525|4089074|P2|OL Treatment Period (120 Weeks)|Lack of Efficacy|13
1246793|NCT00603525|4089075|P1|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
1246794|NCT00603525|4089073|P3|OL Treatment Period (120 Weeks)|Adverse Event|0
1246795|NCT00603525|4089074|P2|OL Treatment Period (120 Weeks)|Adverse Event|12
1246796|NCT00603525|4089075|P1|OL Treatment Period (120 Weeks)|Adverse Event|0
1246797|NCT00603525|4089073|P3|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
1246798|NCT00603525|4089074|P2|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1
1246799|NCT00603525|4089075|P1|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
1246800|NCT00603525|4089073|P3|DB Treatment Period (24 Weeks)|Physician Decision|0
1246801|NCT00603525|4089074|P2|DB Treatment Period (24 Weeks)|Physician Decision|1
1246802|NCT00603525|4089075|P1|DB Treatment Period (24 Weeks)|Physician Decision|0
1246803|NCT00603525|4089073|P3|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
1246804|NCT00603525|4089074|P2|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6
1246805|NCT00603525|4089075|P1|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5
1246806|NCT00603525|4089073|P3|DB Treatment Period (24 Weeks)|Lost to Follow-up|0
1246807|NCT00603525|4089074|P2|DB Treatment Period (24 Weeks)|Lost to Follow-up|3
1246808|NCT00603525|4089075|P1|DB Treatment Period (24 Weeks)|Lost to Follow-up|1
1246809|NCT00603525|4089073|P3|DB Treatment Period (24 Weeks)|Protocol Violation|0
1246810|NCT00603525|4089074|P2|DB Treatment Period (24 Weeks)|Protocol Violation|2
1246811|NCT00603525|4089075|P1|DB Treatment Period (24 Weeks)|Protocol Violation|1
1246812|NCT00603525|4089073|P3|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
1246813|NCT00603525|4089074|P2|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
1246814|NCT00603525|4089075|P1|DB Treatment Period (24 Weeks)|Lack of Efficacy|7
1246815|NCT00603525|4089073|P3|DB Treatment Period (24 Weeks)|Adverse Event|0
1246816|NCT00603525|4089074|P2|DB Treatment Period (24 Weeks)|Adverse Event|9
1246817|NCT00603525|4089075|P1|DB Treatment Period (24 Weeks)|Adverse Event|3
1246818|NCT00603512|4089207|P5|Overall Study|Randomized but not treated|0
1246819|NCT00603512|4089208|P4|Overall Study|Randomized but not treated|2
1246820|NCT00603512|4089209|P3|Overall Study|Randomized but not treated|1
1246821|NCT00603512|4089210|P2|Overall Study|Randomized but not treated|1
1246822|NCT00603512|4089211|P1|Overall Study|Randomized but not treated|0
1246823|NCT00603512|4089207|P5|Overall Study|Withdrawal by Subject|1
1246824|NCT00603512|4089208|P4|Overall Study|Withdrawal by Subject|0
1246825|NCT00603512|4089209|P3|Overall Study|Withdrawal by Subject|0
1246826|NCT00603512|4089210|P2|Overall Study|Withdrawal by Subject|0
1246827|NCT00603512|4089211|P1|Overall Study|Withdrawal by Subject|0
1246828|NCT00603512|4089207|P5|Overall Study|Other|1
1246829|NCT00603512|4089208|P4|Overall Study|Other|1
1246830|NCT00603512|4089209|P3|Overall Study|Other|0
1246831|NCT00603512|4089210|P2|Overall Study|Other|1
1246832|NCT00603512|4089211|P1|Overall Study|Other|2
1246833|NCT00603512|4089207|P5|Overall Study|Lack of Efficacy|1
1246834|NCT00603512|4089208|P4|Overall Study|Lack of Efficacy|0
1246835|NCT00603512|4089209|P3|Overall Study|Lack of Efficacy|0
1246836|NCT00603512|4089210|P2|Overall Study|Lack of Efficacy|1
1246837|NCT00603512|4089211|P1|Overall Study|Lack of Efficacy|0
1246838|NCT00603512|4089207|P5|Overall Study|Adverse Event|2
1246839|NCT00603512|4089208|P4|Overall Study|Adverse Event|4
1246840|NCT00603512|4089209|P3|Overall Study|Adverse Event|4
1246841|NCT00603512|4089210|P2|Overall Study|Adverse Event|2
1246842|NCT00603512|4089211|P1|Overall Study|Adverse Event|0
1246843|NCT00603473|4089353|P1|Overall Study|Protocol Violation|1
1246844|NCT00603473|4089353|P1|Overall Study|Lack of Efficacy|4
1246845|NCT00603473|4089353|P1|Overall Study|Adverse Event|4
1246846|NCT00603447|4089366|P7|Overall Study|Withdrew Consent|1
1246847|NCT00603447|4089367|P6|Overall Study|Withdrew Consent|0
1246848|NCT00603447|4089368|P5|Overall Study|Withdrew Consent|1
1246849|NCT00603447|4089369|P4|Overall Study|Withdrew Consent|0
1246850|NCT00603447|4089370|P3|Overall Study|Withdrew Consent|0
1246851|NCT00603447|4089371|P2|Overall Study|Withdrew Consent|2
1246852|NCT00603447|4089372|P1|Overall Study|Withdrew Consent|0
1246853|NCT00603447|4089366|P7|Overall Study|Other|13
1246854|NCT00603447|4089367|P6|Overall Study|Other|0
1246855|NCT00603447|4089368|P5|Overall Study|Other|3
1246856|NCT00603447|4089369|P4|Overall Study|Other|0
1246857|NCT00603447|4089370|P3|Overall Study|Other|1
1246858|NCT00603447|4089371|P2|Overall Study|Other|0
1246859|NCT00603447|4089372|P1|Overall Study|Other|0
1246860|NCT00603447|4089366|P7|Overall Study|Adverse Event|10
1246861|NCT00603447|4089367|P6|Overall Study|Adverse Event|2
1246862|NCT00603447|4089368|P5|Overall Study|Adverse Event|1
1246863|NCT00603447|4089369|P4|Overall Study|Adverse Event|2
1246865|NCT00603447|4089371|P2|Overall Study|Adverse Event|1
1246866|NCT00603447|4089372|P1|Overall Study|Adverse Event|0
1246867|NCT00603382|4089411|P6|Overall Study|Withdrawal by Subject|1
1246868|NCT00603382|4089412|P5|Overall Study|Withdrawal by Subject|0
1246869|NCT00603382|4089413|P4|Overall Study|Withdrawal by Subject|1
1246870|NCT00603382|4089414|P3|Overall Study|Withdrawal by Subject|1
1246871|NCT00603382|4089415|P2|Overall Study|Withdrawal by Subject|3
1246872|NCT00603382|4089416|P1|Overall Study|Withdrawal by Subject|3
1246873|NCT00603382|4089411|P6|Overall Study|Physician Decision|3
1246874|NCT00603382|4089412|P5|Overall Study|Physician Decision|1
1246875|NCT00603382|4089413|P4|Overall Study|Physician Decision|0
1246876|NCT00603382|4089414|P3|Overall Study|Physician Decision|2
1246877|NCT00603382|4089415|P2|Overall Study|Physician Decision|0
1246878|NCT00603382|4089416|P1|Overall Study|Physician Decision|0
1246879|NCT00603382|4089411|P6|Overall Study|Lost to Follow-up|1
1246880|NCT00603382|4089412|P5|Overall Study|Lost to Follow-up|0
1246881|NCT00603382|4089413|P4|Overall Study|Lost to Follow-up|1
1246882|NCT00603382|4089414|P3|Overall Study|Lost to Follow-up|1
1246883|NCT00603382|4089415|P2|Overall Study|Lost to Follow-up|1
1246884|NCT00603382|4089416|P1|Overall Study|Lost to Follow-up|0
1246885|NCT00603382|4089411|P6|Overall Study|Protocol Violation|0
1246886|NCT00603382|4089412|P5|Overall Study|Protocol Violation|1
1246887|NCT00603382|4089413|P4|Overall Study|Protocol Violation|2
1246888|NCT00603382|4089414|P3|Overall Study|Protocol Violation|1
1246889|NCT00603382|4089415|P2|Overall Study|Protocol Violation|0
1246890|NCT00603382|4089416|P1|Overall Study|Protocol Violation|1
1246891|NCT00603382|4089411|P6|Overall Study|Lack of Efficacy|11
1246892|NCT00603382|4089412|P5|Overall Study|Lack of Efficacy|6
1246893|NCT00603382|4089413|P4|Overall Study|Lack of Efficacy|6
1246894|NCT00603382|4089414|P3|Overall Study|Lack of Efficacy|3
1246895|NCT00603382|4089415|P2|Overall Study|Lack of Efficacy|9
1246896|NCT00603382|4089416|P1|Overall Study|Lack of Efficacy|14
1246897|NCT00603382|4089411|P6|Overall Study|Adverse Event|2
1246898|NCT00603382|4089412|P5|Overall Study|Adverse Event|1
1246899|NCT00603382|4089413|P4|Overall Study|Adverse Event|2
1246900|NCT00603382|4089414|P3|Overall Study|Adverse Event|1
1246901|NCT00603382|4089415|P2|Overall Study|Adverse Event|1
1246902|NCT00603382|4089416|P1|Overall Study|Adverse Event|0
1246903|NCT00603304|4089564|P2|Overall Study|Patient Decision|0
1246904|NCT00603304|4089565|P1|Overall Study|Patient Decision|2
1246905|NCT00603304|4089564|P2|Overall Study|Not Specified|0
1246906|NCT00603304|4089565|P1|Overall Study|Not Specified|2
1246907|NCT00603304|4089564|P2|Overall Study|Moved Away|2
1246908|NCT00603304|4089565|P1|Overall Study|Moved Away|0
1246909|NCT00603304|4089564|P2|Overall Study|Non-Compliant|1
1246910|NCT00603304|4089565|P1|Overall Study|Non-Compliant|0
1246911|NCT00603304|4089564|P2|Overall Study|Exclusionary Medication|3
1246912|NCT00603304|4089565|P1|Overall Study|Exclusionary Medication|2
1246913|NCT00603304|4089564|P2|Overall Study|Crossed Over to Open Label Therapy|3
1246914|NCT00603304|4089565|P1|Overall Study|Crossed Over to Open Label Therapy|3
1246915|NCT00603304|4089564|P2|Overall Study|Unacceptable Treatment Toxicity|8
1246916|NCT00603304|4089565|P1|Overall Study|Unacceptable Treatment Toxicity|5
1246917|NCT00603304|4089564|P2|Overall Study|Adverse Event|2
1246918|NCT00603304|4089565|P1|Overall Study|Adverse Event|4
1246919|NCT00603304|4089564|P2|Overall Study|Protocol Violation|0
1246920|NCT00603304|4089565|P1|Overall Study|Protocol Violation|1
1246921|NCT00603304|4089564|P2|Overall Study|Withdrawal by Subject|5
1246922|NCT00603304|4089565|P1|Overall Study|Withdrawal by Subject|8
1246923|NCT00603304|4089564|P2|Overall Study|Lost to Follow-up|7
1246924|NCT00603304|4089565|P1|Overall Study|Lost to Follow-up|5
1246925|NCT00603278|4089621|P6|Overall Study|Lost to Follow-up|0
1246926|NCT00603278|4089622|P5|Overall Study|Lost to Follow-up|1
1246927|NCT00603278|4089623|P4|Overall Study|Lost to Follow-up|0
1246928|NCT00603278|4089624|P3|Overall Study|Lost to Follow-up|0
1246929|NCT00603278|4089625|P2|Overall Study|Lost to Follow-up|0
1246930|NCT00603278|4089626|P1|Overall Study|Lost to Follow-up|1
1246931|NCT00603278|4089621|P6|Overall Study|Physician Decision|1
1246932|NCT00603278|4089622|P5|Overall Study|Physician Decision|2
1246933|NCT00603278|4089623|P4|Overall Study|Physician Decision|0
1246934|NCT00603278|4089624|P3|Overall Study|Physician Decision|0
1246935|NCT00603278|4089625|P2|Overall Study|Physician Decision|1
1246936|NCT00603278|4089626|P1|Overall Study|Physician Decision|0
1246937|NCT00603278|4089621|P6|Overall Study|Protocol Violation|1
1246938|NCT00603278|4089622|P5|Overall Study|Protocol Violation|0
1246939|NCT00603278|4089623|P4|Overall Study|Protocol Violation|1
1246940|NCT00603278|4089624|P3|Overall Study|Protocol Violation|1
1246941|NCT00603278|4089625|P2|Overall Study|Protocol Violation|0
1246942|NCT00603278|4089626|P1|Overall Study|Protocol Violation|3
1246943|NCT00603278|4089621|P6|Overall Study|Withdrawal by Subject|2
1246944|NCT00603278|4089622|P5|Overall Study|Withdrawal by Subject|1
1246945|NCT00603278|4089623|P4|Overall Study|Withdrawal by Subject|2
1246946|NCT00603278|4089624|P3|Overall Study|Withdrawal by Subject|1
1246947|NCT00603278|4089625|P2|Overall Study|Withdrawal by Subject|3
1246948|NCT00603278|4089626|P1|Overall Study|Withdrawal by Subject|2
1246949|NCT00603278|4089621|P6|Overall Study|Adverse Event|1
1246950|NCT00603278|4089622|P5|Overall Study|Adverse Event|2
1246951|NCT00603278|4089623|P4|Overall Study|Adverse Event|0
1246952|NCT00603278|4089624|P3|Overall Study|Adverse Event|1
1246953|NCT00603278|4089625|P2|Overall Study|Adverse Event|3
1246954|NCT00603278|4089626|P1|Overall Study|Adverse Event|0
1246955|NCT00603278|4089621|P6|Overall Study|Lack of Efficacy|14
1246956|NCT00603278|4089622|P5|Overall Study|Lack of Efficacy|7
1246957|NCT00603278|4089623|P4|Overall Study|Lack of Efficacy|8
1246958|NCT00603278|4089624|P3|Overall Study|Lack of Efficacy|11
1246959|NCT00603278|4089625|P2|Overall Study|Lack of Efficacy|10
1246960|NCT00603278|4089626|P1|Overall Study|Lack of Efficacy|35
1246961|NCT00603265|4089775|P3|Overall Study|Protocol Violation|0
1246962|NCT00603265|4089776|P2|Overall Study|Protocol Violation|0
1246963|NCT00603265|4089777|P1|Overall Study|Protocol Violation|1
1246964|NCT00603265|4089775|P3|Overall Study|Participant Left Country, No Responses|0
1246965|NCT00603265|4089776|P2|Overall Study|Participant Left Country, No Responses|1
1246966|NCT00603265|4089777|P1|Overall Study|Participant Left Country, No Responses|0
1246967|NCT00603265|4089775|P3|Overall Study|Out of Town, Ran Out of Study Drug|0
1246968|NCT00603265|4089776|P2|Overall Study|Out of Town, Ran Out of Study Drug|1
1246969|NCT00603265|4089777|P1|Overall Study|Out of Town, Ran Out of Study Drug|0
1246970|NCT00603265|4089775|P3|Overall Study|Lost to Follow-up|0
1246971|NCT00603265|4089776|P2|Overall Study|Lost to Follow-up|1
1246972|NCT00603265|4089777|P1|Overall Study|Lost to Follow-up|0
1246973|NCT00603265|4089775|P3|Overall Study|Lack of Efficacy|3
1246974|NCT00603265|4089776|P2|Overall Study|Lack of Efficacy|0
1246975|NCT00603265|4089777|P1|Overall Study|Lack of Efficacy|3
1246976|NCT00603265|4089775|P3|Overall Study|Withdrawal by Subject|1
1246977|NCT00603265|4089776|P2|Overall Study|Withdrawal by Subject|2
1246978|NCT00603265|4089777|P1|Overall Study|Withdrawal by Subject|1
1246979|NCT00603265|4089775|P3|Overall Study|Adverse Event|1
1246980|NCT00603265|4089776|P2|Overall Study|Adverse Event|11
1246981|NCT00603265|4089777|P1|Overall Study|Adverse Event|2
1246982|NCT00603239|4089805|P2|Overall Study|Subject decision|1
1246983|NCT00603239|4089806|P1|Overall Study|Subject decision|2
1246984|NCT00603239|4089805|P2|Overall Study|Protocol Violation|0
1246985|NCT00603239|4089806|P1|Overall Study|Protocol Violation|2
1246986|NCT00603239|4089805|P2|Overall Study|Physician Decision|0
1246987|NCT00603239|4089806|P1|Overall Study|Physician Decision|2
1246988|NCT00603239|4089805|P2|Overall Study|Lost to Follow-up|1
1246989|NCT00603239|4089806|P1|Overall Study|Lost to Follow-up|2
1246990|NCT00603239|4089805|P2|Overall Study|Loss of glucose control|0
1246991|NCT00603239|4089806|P1|Overall Study|Loss of glucose control|3
1246992|NCT00603239|4089805|P2|Overall Study|Entry criteria not met|1
1246993|NCT00603239|4089806|P1|Overall Study|Entry criteria not met|0
1246994|NCT00603239|4089805|P2|Overall Study|Adverse Event|1
1246995|NCT00603239|4089806|P1|Overall Study|Adverse Event|4
1246996|NCT00602979|4089867|P5|Overall Study|Failed Intubation|0
1246997|NCT00602979|4089868|P4|Overall Study|Failed Intubation|1
1246998|NCT00602979|4089869|P3|Overall Study|Failed Intubation|0
1246999|NCT00602979|4089870|P2|Overall Study|Failed Intubation|1
1247000|NCT00602979|4089871|P1|Overall Study|Failed Intubation|0
1247001|NCT00602979|4089867|P5|Overall Study|Lost to Follow-up|3
1247002|NCT00602979|4089868|P4|Overall Study|Lost to Follow-up|2
1247003|NCT00602979|4089869|P3|Overall Study|Lost to Follow-up|3
1247004|NCT00602979|4089870|P2|Overall Study|Lost to Follow-up|2
1247005|NCT00602979|4089871|P1|Overall Study|Lost to Follow-up|3
1247006|NCT00602927|4089921|P2|Period 3: 13 Days|MRI data quality|2
1247007|NCT00602927|4089922|P1|Period 3: 13 Days|MRI data quality|2
1247008|NCT00602927|4089921|P2|Period 3: 13 Days|Protocol Violation|1
1247009|NCT00602927|4089922|P1|Period 3: 13 Days|Protocol Violation|0
1247010|NCT00602927|4089921|P2|Period 2: 14 Days|Protocol Violation|2
1247011|NCT00602927|4089922|P1|Period 2: 14 Days|Protocol Violation|0
1247012|NCT00602927|4089921|P2|Period 1: 13 Days|Claustrophobia|1
1247013|NCT00602927|4089922|P1|Period 1: 13 Days|Claustrophobia|0
1247014|NCT00602927|4089921|P2|Period 1: 13 Days|Time|0
1247015|NCT00602927|4089922|P1|Period 1: 13 Days|Time|1
1247016|NCT00602927|4089921|P2|Period 1: 13 Days|MRI scanner technical issue|0
1247017|NCT00602927|4089922|P1|Period 1: 13 Days|MRI scanner technical issue|1
1247018|NCT00602927|4089921|P2|Period 1: 13 Days|Protocol Violation|4
1247019|NCT00602927|4089922|P1|Period 1: 13 Days|Protocol Violation|2
1247020|NCT00602797|4089934|P1|Overall Study|Adverse Event|1
1247021|NCT00602641|4089951|P2|Overall Study|Other|1
1247022|NCT00602641|4089952|P1|Overall Study|Other|3
1247023|NCT00602641|4089951|P2|Overall Study|Administrative Closure|1
1247024|NCT00602641|4089952|P1|Overall Study|Administrative Closure|1
1247025|NCT00602641|4089951|P2|Overall Study|Physician Decision|4
1247026|NCT00602641|4089952|P1|Overall Study|Physician Decision|5
1247027|NCT00602641|4089951|P2|Overall Study|Other Complicating Disease|2
1247028|NCT00602641|4089952|P1|Overall Study|Other Complicating Disease|5
1247029|NCT00602641|4089951|P2|Overall Study|Alternative therapy|2
1247030|NCT00602641|4089952|P1|Overall Study|Alternative therapy|5
1247031|NCT00602641|4089951|P2|Overall Study|Withdrawal by Subject|12
1247032|NCT00602641|4089952|P1|Overall Study|Withdrawal by Subject|15
1247033|NCT00602641|4089951|P2|Overall Study|Death|5
1247034|NCT00602641|4089952|P1|Overall Study|Death|6
1247035|NCT00602641|4089951|P2|Overall Study|Disease progression|55
1247036|NCT00602641|4089952|P1|Overall Study|Disease progression|38
1247037|NCT00602641|4089951|P2|Overall Study|Adverse Event|53
1247038|NCT00602641|4089952|P1|Overall Study|Adverse Event|62
1247039|NCT00602641|4089951|P2|Overall Study|Still on treatment at time of analysis|15
1247040|NCT00602641|4089952|P1|Overall Study|Still on treatment at time of analysis|8
1247041|NCT00602641|4089951|P2|Overall Study|Never started protocol therapy|2
1247042|NCT00602641|4089952|P1|Overall Study|Never started protocol therapy|6
1247043|NCT00602537|4089966|P2|Follow Up Study Comparison|Withdrawal by Subject|2
1247044|NCT00602537|4089967|P1|Follow Up Study Comparison|Withdrawal by Subject|2
1247045|NCT00602537|4089966|P2|Follow Up Study Comparison|Lost to Follow-up|1
1247046|NCT00602537|4089967|P1|Follow Up Study Comparison|Lost to Follow-up|8
1247047|NCT00602537|4089966|P2|Follow Up Study Comparison|Adverse Event|0
1247048|NCT00602537|4089967|P1|Follow Up Study Comparison|Adverse Event|1
1247049|NCT00602537|4089966|P2|12 Week Double Blind Comparison|Withdrawal by Subject|13
1247050|NCT00602537|4089967|P1|12 Week Double Blind Comparison|Withdrawal by Subject|3
1247051|NCT00602537|4089966|P2|12 Week Double Blind Comparison|Lost to Follow-up|6
1247052|NCT00602537|4089967|P1|12 Week Double Blind Comparison|Lost to Follow-up|5
1247053|NCT00602537|4089966|P2|12 Week Double Blind Comparison|Lack of Efficacy|23
1247054|NCT00602537|4089967|P1|12 Week Double Blind Comparison|Lack of Efficacy|13
1247055|NCT00602537|4089966|P2|12 Week Double Blind Comparison|Adverse Event|5
1247056|NCT00602537|4089967|P1|12 Week Double Blind Comparison|Adverse Event|2
1247057|NCT00602472|4089977|P2|Overall Study|Other incl. lack of efficacy|2
1247058|NCT00602472|4089978|P1|Overall Study|Other incl. lack of efficacy|4
1247059|NCT00602472|4089977|P2|Overall Study|Withdrawal by Subject|14
1247060|NCT00602472|4089978|P1|Overall Study|Withdrawal by Subject|8
1247061|NCT00602472|4089977|P2|Overall Study|Protocol Violation|19
1247062|NCT00602472|4089978|P1|Overall Study|Protocol Violation|4
1247063|NCT00602472|4089977|P2|Overall Study|Adverse Event|23
1247064|NCT00602472|4089978|P1|Overall Study|Adverse Event|5
1247065|NCT00602420|4090043|P2|Overall Study|Adverse Event|0
1247066|NCT00602420|4090044|P1|Overall Study|Adverse Event|1
1247067|NCT00602420|4090043|P2|Overall Study|Withdrawal by Subject|17
1247068|NCT00602420|4090044|P1|Overall Study|Withdrawal by Subject|18
1247069|NCT00602420|4090043|P2|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3
1247070|NCT00602420|4090044|P1|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5
1247071|NCT00602420|4090043|P2|Overall Study|Death|4
1247072|NCT00602420|4090044|P1|Overall Study|Death|1
1247073|NCT00601900|4090152|P2|Overall Study|Withdrawal by Subject|3
1247074|NCT00601900|4090153|P1|Overall Study|Withdrawal by Subject|0
1247075|NCT00601835|4090169|P2|Overall Study|Relocate|2
1247076|NCT00601835|4090170|P1|Overall Study|Relocate|12
1247077|NCT00601835|4090169|P2|Overall Study|Adverse Event|1
1247078|NCT00601835|4090170|P1|Overall Study|Adverse Event|1
1247079|NCT00601835|4090169|P2|Overall Study|Lost to Follow-up|5
1247080|NCT00601835|4090170|P1|Overall Study|Lost to Follow-up|37
1247081|NCT00601835|4090169|P2|Overall Study|Physician Decision|0
1247082|NCT00601835|4090170|P1|Overall Study|Physician Decision|1
1247083|NCT00601835|4090169|P2|Overall Study|Withdrawal by Subject|6
1247084|NCT00601835|4090170|P1|Overall Study|Withdrawal by Subject|9
1247085|NCT00601640|4090262|P3|Overall Study|change in eligibility status|1
1247086|NCT00601640|4090263|P2|Overall Study|change in eligibility status|1
1247087|NCT00601640|4090264|P1|Overall Study|change in eligibility status|0
1247088|NCT00601640|4090262|P3|Overall Study|intercurrent illness|0
1247089|NCT00601640|4090263|P2|Overall Study|intercurrent illness|0
1247090|NCT00601640|4090264|P1|Overall Study|intercurrent illness|1
1247091|NCT00601640|4090262|P3|Overall Study|Adverse Event|2
1247092|NCT00601640|4090263|P2|Overall Study|Adverse Event|4
1247093|NCT00601640|4090264|P1|Overall Study|Adverse Event|0
1247094|NCT00601640|4090262|P3|Overall Study|Death|0
1247095|NCT00601640|4090263|P2|Overall Study|Death|0
1247096|NCT00601640|4090264|P1|Overall Study|Death|1
1247097|NCT00601640|4090262|P3|Overall Study|Withdrawal by Subject|7
1247098|NCT00601640|4090263|P2|Overall Study|Withdrawal by Subject|0
1247099|NCT00601640|4090264|P1|Overall Study|Withdrawal by Subject|3
1247100|NCT00601523|4090289|P2|Overall Study|not specified|1
1247101|NCT00601523|4090290|P1|Overall Study|not specified|9
1247102|NCT00601523|4090289|P2|Overall Study|Withdrawal by Subject|9
1247103|NCT00601523|4090290|P1|Overall Study|Withdrawal by Subject|18
1247104|NCT00601523|4090289|P2|Overall Study|Lost to Follow-up|1
1247105|NCT00601523|4090290|P1|Overall Study|Lost to Follow-up|0
1247106|NCT00601523|4090289|P2|Overall Study|Protocol Violation|1
1247107|NCT00601523|4090290|P1|Overall Study|Protocol Violation|5
1247108|NCT00601523|4090289|P2|Overall Study|Lack of Efficacy|0
1247109|NCT00601523|4090290|P1|Overall Study|Lack of Efficacy|3
1247110|NCT00601523|4090289|P2|Overall Study|Adverse Event|14
1247111|NCT00601523|4090290|P1|Overall Study|Adverse Event|42
1247112|NCT00601458|4090325|P3|Overall Study|Early Termination|1
1247113|NCT00601458|4090326|P2|Overall Study|Early Termination|1
1247114|NCT00601458|4090327|P1|Overall Study|Early Termination|0
1247115|NCT00601458|4090325|P3|Overall Study|Protocol Violation|1
1247116|NCT00601458|4090326|P2|Overall Study|Protocol Violation|2
1247117|NCT00601458|4090327|P1|Overall Study|Protocol Violation|3
1247118|NCT00601458|4090325|P3|Overall Study|Incomplete Data|0
1247119|NCT00601458|4090326|P2|Overall Study|Incomplete Data|2
1247120|NCT00601458|4090327|P1|Overall Study|Incomplete Data|0
1247121|NCT00601458|4090325|P3|Overall Study|Dosing Error|0
1247122|NCT00601458|4090326|P2|Overall Study|Dosing Error|0
1247123|NCT00601458|4090327|P1|Overall Study|Dosing Error|1
1247124|NCT00601419|4090338|P1|Overall Study|Missed Visits|1
1247125|NCT00601419|4090338|P1|Overall Study|Lost to Follow-up|3
1247126|NCT00601354|4090368|P2|Overall Study|Lost to Follow-up|5
1247127|NCT00601354|4090369|P1|Overall Study|Lost to Follow-up|4
1247128|NCT00601250|4090381|P2|Overall Study|Other incl. lack of efficacy|9
1247129|NCT00601250|4090382|P1|Overall Study|Other incl. lack of efficacy|2
1247130|NCT00601250|4090381|P2|Overall Study|Withdrawal by Subject|13
1247131|NCT00601250|4090382|P1|Overall Study|Withdrawal by Subject|4
1247132|NCT00601250|4090381|P2|Overall Study|Lost to Follow-up|6
1247133|NCT00601250|4090382|P1|Overall Study|Lost to Follow-up|2
1247134|NCT00601250|4090381|P2|Overall Study|Protocol Violation|2
1247135|NCT00601250|4090382|P1|Overall Study|Protocol Violation|3
1247136|NCT00601250|4090381|P2|Overall Study|Adverse Event|9
1247137|NCT00601250|4090382|P1|Overall Study|Adverse Event|3
1247138|NCT00601172|4090418|P2|Overall Study|Did not meet continuation criteria|20
1247139|NCT00601172|4090419|P1|Overall Study|Did not meet continuation criteria|19
1247140|NCT00601172|4090418|P2|Overall Study|Withdrawal by Subject|27
1247141|NCT00601172|4090419|P1|Overall Study|Withdrawal by Subject|35
1247142|NCT00601172|4090418|P2|Overall Study|Physician Decision|28
1247143|NCT00601172|4090419|P1|Overall Study|Physician Decision|27
1247144|NCT00601172|4090418|P2|Overall Study|Lost to Follow-up|3
1247145|NCT00601172|4090419|P1|Overall Study|Lost to Follow-up|4
1247146|NCT00601172|4090418|P2|Overall Study|Protocol Violation|5
1247147|NCT00601172|4090419|P1|Overall Study|Protocol Violation|2
1247148|NCT00601172|4090418|P2|Overall Study|Lack of Efficacy|12
1247149|NCT00601172|4090419|P1|Overall Study|Lack of Efficacy|11
1247150|NCT00601172|4090418|P2|Overall Study|Adverse Event|32
1247151|NCT00601172|4090419|P1|Overall Study|Adverse Event|43
1247152|NCT00601107|4090476|P4|Overall Study|Undefined|0
1247153|NCT00601107|4090477|P3|Overall Study|Undefined|1
1247154|NCT00601107|4090478|P2|Overall Study|Undefined|0
1247155|NCT00601107|4090479|P1|Overall Study|Undefined|1
1247156|NCT00601107|4090476|P4|Overall Study|Worsening of Psoriasis|4
1247157|NCT00601107|4090477|P3|Overall Study|Worsening of Psoriasis|1
1247158|NCT00601107|4090478|P2|Overall Study|Worsening of Psoriasis|1
1247159|NCT00601107|4090479|P1|Overall Study|Worsening of Psoriasis|4
1247160|NCT00601107|4090476|P4|Overall Study|Serum Calcium >11.5 milligram/deciliter|1
1247161|NCT00601107|4090477|P3|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
1247162|NCT00601107|4090478|P2|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
1247163|NCT00601107|4090479|P1|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
1247164|NCT00601107|4090476|P4|Overall Study|Lost to Follow-up|3
1247165|NCT00601107|4090477|P3|Overall Study|Lost to Follow-up|0
1247166|NCT00601107|4090478|P2|Overall Study|Lost to Follow-up|3
1247167|NCT00601107|4090479|P1|Overall Study|Lost to Follow-up|3
1247168|NCT00601107|4090476|P4|Overall Study|Withdrawal by Subject|4
1247169|NCT00601107|4090477|P3|Overall Study|Withdrawal by Subject|7
1247170|NCT00601107|4090478|P2|Overall Study|Withdrawal by Subject|4
1247171|NCT00601107|4090479|P1|Overall Study|Withdrawal by Subject|5
1247172|NCT00601107|4090476|P4|Overall Study|Adverse Event|0
1247173|NCT00601107|4090477|P3|Overall Study|Adverse Event|3
1247174|NCT00601107|4090478|P2|Overall Study|Adverse Event|1
1247175|NCT00601107|4090479|P1|Overall Study|Adverse Event|0
1247176|NCT00600938|4090499|P4|Extension Study|Death|0
1247177|NCT00600938|4090500|P3|Extension Study|Death|0
1247178|NCT00600938|4090501|P2|Extension Study|Death|0
1247179|NCT00600938|4090502|P1|Extension Study|Death|1
1247180|NCT00600938|4090499|P4|Extension Study|Lost to Follow-up|0
1247181|NCT00600938|4090500|P3|Extension Study|Lost to Follow-up|2
1247182|NCT00600938|4090501|P2|Extension Study|Lost to Follow-up|1
1247183|NCT00600938|4090502|P1|Extension Study|Lost to Follow-up|1
1247184|NCT00600938|4090499|P4|Extension Study|Withdrawal by Subject|0
1247185|NCT00600938|4090500|P3|Extension Study|Withdrawal by Subject|3
1247186|NCT00600938|4090501|P2|Extension Study|Withdrawal by Subject|2
1247187|NCT00600938|4090502|P1|Extension Study|Withdrawal by Subject|2
1247188|NCT00600938|4090499|P4|Extension Study|Unsatisfactory therapeutic effect|0
1247189|NCT00600938|4090500|P3|Extension Study|Unsatisfactory therapeutic effect|1
1247190|NCT00600938|4090501|P2|Extension Study|Unsatisfactory therapeutic effect|1
1247191|NCT00600938|4090502|P1|Extension Study|Unsatisfactory therapeutic effect|4
1247192|NCT00600938|4090499|P4|Extension Study|Abnormal test procedure results|1
1247193|NCT00600938|4090500|P3|Extension Study|Abnormal test procedure results|1
1247194|NCT00600938|4090501|P2|Extension Study|Abnormal test procedure results|1
1247195|NCT00600938|4090502|P1|Extension Study|Abnormal test procedure results|0
1247196|NCT00600938|4090499|P4|Extension Study|Adverse Event|0
1247197|NCT00600938|4090500|P3|Extension Study|Adverse Event|2
1247198|NCT00600938|4090501|P2|Extension Study|Adverse Event|0
1247199|NCT00600938|4090502|P1|Extension Study|Adverse Event|1
1247200|NCT00600938|4090499|P4|Core Study|Protocol Violation|0
1247201|NCT00600938|4090500|P3|Core Study|Protocol Violation|0
1247202|NCT00600938|4090501|P2|Core Study|Protocol Violation|2
1247203|NCT00600938|4090502|P1|Core Study|Protocol Violation|1
1247204|NCT00600938|4090499|P4|Core Study|Death|0
1247205|NCT00600938|4090500|P3|Core Study|Death|0
1247206|NCT00600938|4090501|P2|Core Study|Death|1
1247207|NCT00600938|4090502|P1|Core Study|Death|1
1247208|NCT00600938|4090499|P4|Core Study|Lost to Follow-up|0
1247209|NCT00600938|4090500|P3|Core Study|Lost to Follow-up|0
1247210|NCT00600938|4090501|P2|Core Study|Lost to Follow-up|2
1247211|NCT00600938|4090502|P1|Core Study|Lost to Follow-up|3
1247212|NCT00600938|4090499|P4|Core Study|Patient withdrew consent|0
1247213|NCT00600938|4090500|P3|Core Study|Patient withdrew consent|0
1247214|NCT00600938|4090501|P2|Core Study|Patient withdrew consent|12
1247215|NCT00600938|4090502|P1|Core Study|Patient withdrew consent|7
1247216|NCT00600938|4090499|P4|Core Study|Unsatisfactory therapeutic effect|0
1247217|NCT00600938|4090500|P3|Core Study|Unsatisfactory therapeutic effect|0
1247218|NCT00600938|4090501|P2|Core Study|Unsatisfactory therapeutic effect|2
1247219|NCT00600938|4090502|P1|Core Study|Unsatisfactory therapeutic effect|1
1247220|NCT00600938|4090499|P4|Core Study|Abnormal test procedure result(s)|0
1247221|NCT00600938|4090500|P3|Core Study|Abnormal test procedure result(s)|0
1247222|NCT00600938|4090501|P2|Core Study|Abnormal test procedure result(s)|2
1247223|NCT00600938|4090502|P1|Core Study|Abnormal test procedure result(s)|3
1247224|NCT00600886|4090566|P2|Extension - After Crossover (CAS)|Death|0
1247225|NCT00600886|4090567|P1|Extension - After Crossover (CAS)|Death|1
1247226|NCT00600886|4090566|P2|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0
1247227|NCT00600886|4090567|P1|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3
1247228|NCT00600886|4090566|P2|Extension - After Crossover (CAS)|Subject no longer requires study drug|0
1247229|NCT00600886|4090567|P1|Extension - After Crossover (CAS)|Subject no longer requires study drug|3
1247230|NCT00600886|4090566|P2|Extension - After Crossover (CAS)|Administrative Problems|4
1247231|NCT00600886|4090567|P1|Extension - After Crossover (CAS)|Administrative Problems|4
1247232|NCT00600886|4090566|P2|Extension - After Crossover (CAS)|Lack of Efficacy|4
1247233|NCT00600886|4090567|P1|Extension - After Crossover (CAS)|Lack of Efficacy|13
1247234|NCT00600886|4090566|P2|Extension - After Crossover (CAS)|Withdrawal by Subject|4
1247235|NCT00600886|4090567|P1|Extension - After Crossover (CAS)|Withdrawal by Subject|19
1247236|NCT00600886|4090566|P2|Extension - After Crossover (CAS)|Adverse Event|1
1247237|NCT00600886|4090567|P1|Extension - After Crossover (CAS)|Adverse Event|19
1247238|NCT00600886|4090566|P2|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0
1247239|NCT00600886|4090567|P1|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6
1247240|NCT00600886|4090566|P2|Extension - Same Treatment (FAS)|Death|1
1247241|NCT00600886|4090567|P1|Extension - Same Treatment (FAS)|Death|1
1247242|NCT00600886|4090566|P2|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0
1247243|NCT00600886|4090567|P1|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4
1247244|NCT00600886|4090566|P2|Extension - Same Treatment (FAS)|Adverse Event|1
1247245|NCT00600886|4090567|P1|Extension - Same Treatment (FAS)|Adverse Event|4
1247246|NCT00600886|4090566|P2|Extension - Same Treatment (FAS)|Lost to Follow-up|1
1247247|NCT00600886|4090567|P1|Extension - Same Treatment (FAS)|Lost to Follow-up|3
1247248|NCT00600886|4090566|P2|Extension - Same Treatment (FAS)|Administrative Problems|3
1247249|NCT00600886|4090567|P1|Extension - Same Treatment (FAS)|Administrative Problems|9
1247250|NCT00600886|4090566|P2|Extension - Same Treatment (FAS)|Lack of Efficacy|3
1247251|NCT00600886|4090567|P1|Extension - Same Treatment (FAS)|Lack of Efficacy|3
1247252|NCT00600886|4090566|P2|Extension - Same Treatment (FAS)|Withdrawal by Subject|2
1247253|NCT00600886|4090567|P1|Extension - Same Treatment (FAS)|Withdrawal by Subject|16
1247254|NCT00600886|4090566|P2|Core Phase - Full Analysis Set (FAS)|Death|1
1247255|NCT00600886|4090567|P1|Core Phase - Full Analysis Set (FAS)|Death|0
1247256|NCT00600886|4090566|P2|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0
1247257|NCT00600886|4090567|P1|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1
1247258|NCT00600886|4090566|P2|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0
1247259|NCT00600886|4090567|P1|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1
1247260|NCT00600886|4090566|P2|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0
1247261|NCT00600886|4090567|P1|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2
1247262|NCT00600886|4090566|P2|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3
1247263|NCT00600886|4090567|P1|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5
1247264|NCT00600886|4090566|P2|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8
1247265|NCT00600886|4090567|P1|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5
1247266|NCT00600886|4090566|P2|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8
1247267|NCT00600886|4090567|P1|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7
1247268|NCT00600886|4090566|P2|Core Phase - Full Analysis Set (FAS)|Adverse Event|6
1247269|NCT00600886|4090567|P1|Core Phase - Full Analysis Set (FAS)|Adverse Event|14
1247270|NCT00600821|4090631|P2|Overall Study|Other|3
1247271|NCT00600821|4090632|P1|Overall Study|Other|2
1247272|NCT00600821|4090631|P2|Overall Study|Randomized but not treated|1
1247273|NCT00600821|4090632|P1|Overall Study|Randomized but not treated|0
1247274|NCT00600821|4090631|P2|Overall Study|Objective progression or relapse|1
1247275|NCT00600821|4090632|P1|Overall Study|Objective progression or relapse|0
1247276|NCT00600821|4090631|P2|Overall Study|Terminated by sponsor|6
1247277|NCT00600821|4090632|P1|Overall Study|Terminated by sponsor|8
1247278|NCT00600821|4090631|P2|Overall Study|Withdrawal by Subject|1
1247279|NCT00600821|4090632|P1|Overall Study|Withdrawal by Subject|1
1247280|NCT00600821|4090631|P2|Overall Study|Lost to Follow-up|2
1247281|NCT00600821|4090632|P1|Overall Study|Lost to Follow-up|2
1247282|NCT00600821|4090631|P2|Overall Study|Death|46
1247283|NCT00600821|4090632|P1|Overall Study|Death|45
1247284|NCT00600756|4090660|P2|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
1247285|NCT00600756|4090661|P1|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
1247286|NCT00600756|4090660|P2|Overall Study Analysis After 12 Months|Lost to Follow-up|13
1247287|NCT00600756|4090661|P1|Overall Study Analysis After 12 Months|Lost to Follow-up|16
1247288|NCT00600756|4090660|P2|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20
1247289|NCT00600756|4090661|P1|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16
1247290|NCT00600756|4090660|P2|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20
1247291|NCT00600756|4090661|P1|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17
1247292|NCT00600756|4090660|P2|Overall Study Analysis After 12 Months|Incorrect enrollment|29
1247293|NCT00600756|4090661|P1|Overall Study Analysis After 12 Months|Incorrect enrollment|21
1247294|NCT00600756|4090660|P2|Overall Study Analysis After 12 Months|Withdrawal by Subject|41
1247295|NCT00600756|4090661|P1|Overall Study Analysis After 12 Months|Withdrawal by Subject|51
1247296|NCT00600756|4090660|P2|Overall Study Analysis After 12 Months|Adverse Event|44
1247297|NCT00600756|4090661|P1|Overall Study Analysis After 12 Months|Adverse Event|53
1247298|NCT00600756|4090660|P2|Analysis After 6 Months|Study-specific discontinuation criteria|3
1247299|NCT00600756|4090661|P1|Analysis After 6 Months|Study-specific discontinuation criteria|6
1247300|NCT00600756|4090660|P2|Analysis After 6 Months|Lost to Follow-up|8
1247301|NCT00600756|4090661|P1|Analysis After 6 Months|Lost to Follow-up|10
1247302|NCT00600756|4090660|P2|Analysis After 6 Months|Severe non-compliance to protocol|11
1247303|NCT00600756|4090661|P1|Analysis After 6 Months|Severe non-compliance to protocol|11
1247304|NCT00600756|4090660|P2|Analysis After 6 Months|worsening symptom, lack of efficacy|14
1247305|NCT00600756|4090661|P1|Analysis After 6 Months|worsening symptom, lack of efficacy|11
1247306|NCT00600756|4090660|P2|Analysis After 6 Months|Incorrect Enrollment|21
1247307|NCT00600756|4090661|P1|Analysis After 6 Months|Incorrect Enrollment|12
1247308|NCT00600756|4090660|P2|Analysis After 6 Months|Withdrawal by Subject|30
1247309|NCT00600756|4090661|P1|Analysis After 6 Months|Withdrawal by Subject|38
1247310|NCT00600756|4090660|P2|Analysis After 6 Months|Adverse Event|33
1247311|NCT00600756|4090661|P1|Analysis After 6 Months|Adverse Event|43
1247312|NCT00600613|4090770|P1|Overall Study|Protocol Deviation|1
1247313|NCT00600353|4090776|P2|Overall Study|History of prepartive regimen|1
1247314|NCT00600353|4090777|P1|Overall Study|History of prepartive regimen|0
1247315|NCT00600353|4090776|P2|Overall Study|history of malignancy within 5 years|0
1247316|NCT00600353|4090777|P1|Overall Study|history of malignancy within 5 years|1
1247317|NCT00600171|4090795|P6|Overall Study|Lost to Follow-up|0
1247318|NCT00600171|4090796|P5|Overall Study|Lost to Follow-up|0
1247319|NCT00600171|4090797|P4|Overall Study|Lost to Follow-up|1
1247320|NCT00600171|4090798|P3|Overall Study|Lost to Follow-up|0
1247321|NCT00600171|4090799|P2|Overall Study|Lost to Follow-up|0
1247322|NCT00600171|4090800|P1|Overall Study|Lost to Follow-up|0
1247323|NCT00600171|4090795|P6|Overall Study|Physician Decision|2
1247324|NCT00600171|4090796|P5|Overall Study|Physician Decision|0
1247325|NCT00600171|4090797|P4|Overall Study|Physician Decision|1
1247326|NCT00600171|4090798|P3|Overall Study|Physician Decision|0
1247327|NCT00600171|4090799|P2|Overall Study|Physician Decision|1
1247328|NCT00600171|4090800|P1|Overall Study|Physician Decision|0
1247329|NCT00600171|4090795|P6|Overall Study|Withdrawal by Subject|1
1247330|NCT00600171|4090796|P5|Overall Study|Withdrawal by Subject|1
1247331|NCT00600171|4090797|P4|Overall Study|Withdrawal by Subject|1
1247332|NCT00600171|4090798|P3|Overall Study|Withdrawal by Subject|0
1247333|NCT00600171|4090799|P2|Overall Study|Withdrawal by Subject|0
1247334|NCT00600171|4090800|P1|Overall Study|Withdrawal by Subject|3
1247335|NCT00600171|4090795|P6|Overall Study|Met Protocol-defined Stopping Criteria|2
1247336|NCT00600171|4090796|P5|Overall Study|Met Protocol-defined Stopping Criteria|2
1247337|NCT00600171|4090797|P4|Overall Study|Met Protocol-defined Stopping Criteria|3
1247338|NCT00600171|4090798|P3|Overall Study|Met Protocol-defined Stopping Criteria|7
1247339|NCT00600171|4090799|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
1247340|NCT00600171|4090800|P1|Overall Study|Met Protocol-defined Stopping Criteria|3
1247341|NCT00600171|4090795|P6|Overall Study|Protocol Violation|0
1247342|NCT00600171|4090796|P5|Overall Study|Protocol Violation|0
1247343|NCT00600171|4090797|P4|Overall Study|Protocol Violation|1
1247344|NCT00600171|4090798|P3|Overall Study|Protocol Violation|0
1247345|NCT00600171|4090799|P2|Overall Study|Protocol Violation|2
1247346|NCT00600171|4090800|P1|Overall Study|Protocol Violation|1
1247347|NCT00600171|4090795|P6|Overall Study|Lack of Efficacy|0
1247348|NCT00600171|4090796|P5|Overall Study|Lack of Efficacy|4
1247349|NCT00600171|4090797|P4|Overall Study|Lack of Efficacy|5
1247350|NCT00600171|4090798|P3|Overall Study|Lack of Efficacy|3
1247351|NCT00600171|4090799|P2|Overall Study|Lack of Efficacy|12
1247352|NCT00600171|4090800|P1|Overall Study|Lack of Efficacy|9
1247353|NCT00600171|4090795|P6|Overall Study|Adverse Event|0
1247354|NCT00600171|4090796|P5|Overall Study|Adverse Event|1
1247355|NCT00600171|4090797|P4|Overall Study|Adverse Event|0
1247356|NCT00600171|4090798|P3|Overall Study|Adverse Event|0
1247357|NCT00600171|4090799|P2|Overall Study|Adverse Event|1
1247358|NCT00600171|4090800|P1|Overall Study|Adverse Event|0
1247359|NCT00600119|4090874|P6|Follow-up Period|Other|0
1247360|NCT00600119|4090875|P5|Follow-up Period|Other|0
1247361|NCT00600119|4090876|P4|Follow-up Period|Other|0
1247362|NCT00600119|4090877|P3|Follow-up Period|Other|0
1247363|NCT00600119|4090878|P2|Follow-up Period|Other|0
1247364|NCT00600119|4090879|P1|Follow-up Period|Other|1
1247365|NCT00600119|4090874|P6|Follow-up Period|Adverse Event|1
1247366|NCT00600119|4090875|P5|Follow-up Period|Adverse Event|0
1247367|NCT00600119|4090876|P4|Follow-up Period|Adverse Event|0
1247368|NCT00600119|4090877|P3|Follow-up Period|Adverse Event|0
1247369|NCT00600119|4090878|P2|Follow-up Period|Adverse Event|0
1247370|NCT00600119|4090879|P1|Follow-up Period|Adverse Event|0
1247371|NCT00600119|4090874|P6|Double-blind Treatment Period|Adverse Event|10
1247372|NCT00600119|4090875|P5|Double-blind Treatment Period|Adverse Event|2
1247373|NCT00600119|4090876|P4|Double-blind Treatment Period|Adverse Event|1
1247374|NCT00600119|4090877|P3|Double-blind Treatment Period|Adverse Event|0
1247375|NCT00600119|4090878|P2|Double-blind Treatment Period|Adverse Event|1
1247376|NCT00600119|4090879|P1|Double-blind Treatment Period|Adverse Event|1
1247377|NCT00600119|4090874|P6|Double-blind Treatment Period|Lost to Follow-up|0
1247378|NCT00600119|4090875|P5|Double-blind Treatment Period|Lost to Follow-up|0
1247379|NCT00600119|4090876|P4|Double-blind Treatment Period|Lost to Follow-up|0
1247380|NCT00600119|4090877|P3|Double-blind Treatment Period|Lost to Follow-up|0
1247381|NCT00600119|4090878|P2|Double-blind Treatment Period|Lost to Follow-up|1
1247382|NCT00600119|4090879|P1|Double-blind Treatment Period|Lost to Follow-up|0
1247383|NCT00600119|4090874|P6|Double-blind Treatment Period|Physician Decision|0
1247384|NCT00600119|4090875|P5|Double-blind Treatment Period|Physician Decision|0
1247385|NCT00600119|4090876|P4|Double-blind Treatment Period|Physician Decision|0
1247386|NCT00600119|4090877|P3|Double-blind Treatment Period|Physician Decision|0
1247387|NCT00600119|4090878|P2|Double-blind Treatment Period|Physician Decision|0
1247388|NCT00600119|4090879|P1|Double-blind Treatment Period|Physician Decision|2
1247389|NCT00600119|4090874|P6|Double-blind Treatment Period|Sponsor Decision|0
1247390|NCT00600119|4090875|P5|Double-blind Treatment Period|Sponsor Decision|1
1247391|NCT00600119|4090876|P4|Double-blind Treatment Period|Sponsor Decision|0
1247392|NCT00600119|4090877|P3|Double-blind Treatment Period|Sponsor Decision|0
1247393|NCT00600119|4090878|P2|Double-blind Treatment Period|Sponsor Decision|1
1247394|NCT00600119|4090879|P1|Double-blind Treatment Period|Sponsor Decision|0
1247395|NCT00600119|4090874|P6|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
1247396|NCT00600119|4090875|P5|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
1247397|NCT00600119|4090876|P4|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
1247398|NCT00600119|4090877|P3|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
1247399|NCT00600119|4090878|P2|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1
1247400|NCT00600119|4090879|P1|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
1247401|NCT00600119|4090874|P6|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
1247402|NCT00600119|4090875|P5|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
1247403|NCT00600119|4090876|P4|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
1247404|NCT00600119|4090877|P3|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
1247405|NCT00600119|4090878|P2|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
1247406|NCT00600119|4090879|P1|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
1247407|NCT00600119|4090874|P6|Double-blind Treatment Period|Other|1
1247408|NCT00600119|4090875|P5|Double-blind Treatment Period|Other|2
1247409|NCT00600119|4090876|P4|Double-blind Treatment Period|Other|0
1247410|NCT00600119|4090877|P3|Double-blind Treatment Period|Other|0
1247411|NCT00600119|4090878|P2|Double-blind Treatment Period|Other|0
1247412|NCT00600119|4090879|P1|Double-blind Treatment Period|Other|0
1247413|NCT00600119|4090874|P6|Double-blind Treatment Period|Withdrawal by Subject|3
1247414|NCT00600119|4090875|P5|Double-blind Treatment Period|Withdrawal by Subject|0
1247415|NCT00600119|4090876|P4|Double-blind Treatment Period|Withdrawal by Subject|1
1247416|NCT00600119|4090877|P3|Double-blind Treatment Period|Withdrawal by Subject|0
1247417|NCT00600119|4090878|P2|Double-blind Treatment Period|Withdrawal by Subject|0
1247418|NCT00600119|4090879|P1|Double-blind Treatment Period|Withdrawal by Subject|2
1247419|NCT00600119|4090874|P6|Single-blind Placebo run-in Period|Withdrawal by Subject|0
1247420|NCT00600119|4090875|P5|Single-blind Placebo run-in Period|Withdrawal by Subject|0
1247421|NCT00600119|4090876|P4|Single-blind Placebo run-in Period|Withdrawal by Subject|0
1247422|NCT00600119|4090877|P3|Single-blind Placebo run-in Period|Withdrawal by Subject|0
1247423|NCT00600119|4090878|P2|Single-blind Placebo run-in Period|Withdrawal by Subject|1
1247424|NCT00600119|4090879|P1|Single-blind Placebo run-in Period|Withdrawal by Subject|2
1247425|NCT00600119|4090874|P6|Single-blind Placebo run-in Period|Adverse Event|1
1247426|NCT00600119|4090875|P5|Single-blind Placebo run-in Period|Adverse Event|0
1247427|NCT00600119|4090876|P4|Single-blind Placebo run-in Period|Adverse Event|1
1247428|NCT00600119|4090877|P3|Single-blind Placebo run-in Period|Adverse Event|0
1247429|NCT00600119|4090878|P2|Single-blind Placebo run-in Period|Adverse Event|0
1247430|NCT00600119|4090879|P1|Single-blind Placebo run-in Period|Adverse Event|0
1247431|NCT00600119|4090874|P6|Single-blind Placebo run-in Period|Lost to Follow-up|0
1247432|NCT00600119|4090875|P5|Single-blind Placebo run-in Period|Lost to Follow-up|0
1247433|NCT00600119|4090876|P4|Single-blind Placebo run-in Period|Lost to Follow-up|0
1247434|NCT00600119|4090877|P3|Single-blind Placebo run-in Period|Lost to Follow-up|0
1247435|NCT00600119|4090878|P2|Single-blind Placebo run-in Period|Lost to Follow-up|0
1247436|NCT00600119|4090879|P1|Single-blind Placebo run-in Period|Lost to Follow-up|1
1247437|NCT00600119|4090874|P6|Single-blind Placebo run-in Period|Sponsor Decision|0
1247438|NCT00600119|4090875|P5|Single-blind Placebo run-in Period|Sponsor Decision|1
1247439|NCT00600119|4090876|P4|Single-blind Placebo run-in Period|Sponsor Decision|0
1247440|NCT00600119|4090877|P3|Single-blind Placebo run-in Period|Sponsor Decision|1
1247441|NCT00600119|4090878|P2|Single-blind Placebo run-in Period|Sponsor Decision|0
1247442|NCT00600119|4090879|P1|Single-blind Placebo run-in Period|Sponsor Decision|0
1247443|NCT00600119|4090874|P6|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
1247444|NCT00600119|4090875|P5|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
1247445|NCT00600119|4090876|P4|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
1247446|NCT00600119|4090877|P3|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
1247447|NCT00600119|4090878|P2|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
1247448|NCT00600119|4090879|P1|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
1247449|NCT00600119|4090874|P6|Single-blind Placebo run-in Period|Other - Not specified|1
1247450|NCT00600119|4090875|P5|Single-blind Placebo run-in Period|Other - Not specified|1
1247451|NCT00600119|4090876|P4|Single-blind Placebo run-in Period|Other - Not specified|0
1247452|NCT00600119|4090877|P3|Single-blind Placebo run-in Period|Other - Not specified|0
1247453|NCT00600119|4090878|P2|Single-blind Placebo run-in Period|Other - Not specified|0
1247454|NCT00600119|4090879|P1|Single-blind Placebo run-in Period|Other - Not specified|1
1247455|NCT00600106|4090913|P2|Overall Study|Withdrawal by Subject|1
1247456|NCT00600106|4090914|P1|Overall Study|Withdrawal by Subject|1
1247457|NCT00600067|4090961|P2|Overall Study|Lack of Efficacy|0
1247458|NCT00600067|4090962|P1|Overall Study|Lack of Efficacy|1
1247459|NCT00600067|4090961|P2|Overall Study|protocol non-compliance|3
1247460|NCT00600067|4090962|P1|Overall Study|protocol non-compliance|0
1247461|NCT00600067|4090961|P2|Overall Study|Lost to Follow-up|3
1247462|NCT00600067|4090962|P1|Overall Study|Lost to Follow-up|2
1247463|NCT00600067|4090961|P2|Overall Study|Adverse Event|1
1247464|NCT00600067|4090962|P1|Overall Study|Adverse Event|0
1247465|NCT00600028|4090972|P2|Second Intervention (12 Weeks)|Adverse Event|2
1247466|NCT00600028|4090973|P1|Second Intervention (12 Weeks)|Adverse Event|0
1247467|NCT00600028|4090972|P2|First Intervention (12 Weeks)|Adverse Event|1
1247468|NCT00600028|4090973|P1|First Intervention (12 Weeks)|Adverse Event|0
1247469|NCT00600028|4090972|P2|First Intervention (12 Weeks)|Withdrawal by Subject|0
1247470|NCT00600028|4090973|P1|First Intervention (12 Weeks)|Withdrawal by Subject|1
1247471|NCT00599924|4091003|P7|Overall Study|Other|2
1247472|NCT00599924|4091004|P6|Overall Study|Other|0
1247473|NCT00599924|4091005|P5|Overall Study|Other|2
1247474|NCT00599924|4091006|P4|Overall Study|Other|1
1247475|NCT00599924|4091007|P3|Overall Study|Other|0
1247476|NCT00599924|4091008|P2|Overall Study|Other|0
1247477|NCT00599924|4091009|P1|Overall Study|Other|0
1247478|NCT00599924|4091003|P7|Overall Study|Withdrawal by Subject|0
1247479|NCT00599924|4091004|P6|Overall Study|Withdrawal by Subject|0
1247480|NCT00599924|4091005|P5|Overall Study|Withdrawal by Subject|1
1247481|NCT00599924|4091006|P4|Overall Study|Withdrawal by Subject|0
1247482|NCT00599924|4091007|P3|Overall Study|Withdrawal by Subject|1
1247483|NCT00599924|4091008|P2|Overall Study|Withdrawal by Subject|0
1247484|NCT00599924|4091009|P1|Overall Study|Withdrawal by Subject|0
1247485|NCT00599924|4091003|P7|Overall Study|Protocol Violation|0
1247486|NCT00599924|4091004|P6|Overall Study|Protocol Violation|0
1247487|NCT00599924|4091005|P5|Overall Study|Protocol Violation|0
1247488|NCT00599924|4091006|P4|Overall Study|Protocol Violation|1
1247489|NCT00599924|4091007|P3|Overall Study|Protocol Violation|0
1247490|NCT00599924|4091008|P2|Overall Study|Protocol Violation|0
1247491|NCT00599924|4091009|P1|Overall Study|Protocol Violation|0
1247492|NCT00599924|4091003|P7|Overall Study|Death|1
1247493|NCT00599924|4091004|P6|Overall Study|Death|2
1247494|NCT00599924|4091005|P5|Overall Study|Death|0
1247495|NCT00599924|4091006|P4|Overall Study|Death|2
1247496|NCT00599924|4091007|P3|Overall Study|Death|0
1247497|NCT00599924|4091008|P2|Overall Study|Death|0
1247498|NCT00599924|4091009|P1|Overall Study|Death|0
1247499|NCT00599924|4091003|P7|Overall Study|Adverse Event|2
1247500|NCT00599924|4091004|P6|Overall Study|Adverse Event|0
1247501|NCT00599924|4091005|P5|Overall Study|Adverse Event|0
1247502|NCT00599924|4091006|P4|Overall Study|Adverse Event|2
1247503|NCT00599924|4091007|P3|Overall Study|Adverse Event|0
1247504|NCT00599924|4091008|P2|Overall Study|Adverse Event|0
1247505|NCT00599924|4091009|P1|Overall Study|Adverse Event|0
1247506|NCT00599924|4091003|P7|Overall Study|Lack of Efficacy|0
1247507|NCT00599924|4091004|P6|Overall Study|Lack of Efficacy|2
1247508|NCT00599924|4091005|P5|Overall Study|Lack of Efficacy|3
1247509|NCT00599924|4091006|P4|Overall Study|Lack of Efficacy|2
1247510|NCT00599924|4091007|P3|Overall Study|Lack of Efficacy|1
1247511|NCT00599924|4091008|P2|Overall Study|Lack of Efficacy|5
1247512|NCT00599924|4091009|P1|Overall Study|Lack of Efficacy|3
1247513|NCT00599755|4091113|P1|Overall Study|No data available|1
1247514|NCT00599755|4091113|P1|Overall Study|Other Reason|2
1247515|NCT00599755|4091113|P1|Overall Study|Progression of Disease|3
1247516|NCT00599755|4091113|P1|Overall Study|Withdrawal by Subject|2
1247517|NCT00599755|4091113|P1|Overall Study|Adverse Event|11
1247518|NCT00599521|4091124|P2|Overall Study|Pregnancy|2
1247519|NCT00599521|4091125|P1|Overall Study|Pregnancy|0
1247520|NCT00599521|4091124|P2|Overall Study|Lost to Follow-up|23
1247521|NCT00599521|4091125|P1|Overall Study|Lost to Follow-up|23
1247522|NCT00599521|4091124|P2|Overall Study|Protocol Violation|1
1247523|NCT00599521|4091125|P1|Overall Study|Protocol Violation|1
1247524|NCT00599521|4091124|P2|Overall Study|Withdrawal by Subject|34
1247525|NCT00599521|4091125|P1|Overall Study|Withdrawal by Subject|28
1247526|NCT00599521|4091124|P2|Overall Study|Adverse Event|1
1247527|NCT00599521|4091125|P1|Overall Study|Adverse Event|4
1247528|NCT00599521|4091124|P2|Overall Study|Lack of Efficacy|8
1247529|NCT00599521|4091125|P1|Overall Study|Lack of Efficacy|4
1247530|NCT00599339|4091139|P1|Overall Study|Study Termination Status Unknown|12
1247531|NCT00599339|4091139|P1|Overall Study|No valid data consent|36
1247532|NCT00599339|4091139|P1|Overall Study|Lost to Follow-up|221
1247533|NCT00599339|4091139|P1|Overall Study|Other Reason|179
1247534|NCT00599339|4091139|P1|Overall Study|Withdrawal by Subject|137
1247535|NCT00599339|4091139|P1|Overall Study|Adverse Event|79
1247536|NCT00599326|4091241|P1|Overall Study|Noncompliant|1
1247537|NCT00599326|4091241|P1|Overall Study|Lost to Follow-up|1
1247538|NCT00599313|4091246|P1|Overall Study|Ineligible|1
1247539|NCT00599313|4091246|P1|Overall Study|Patient Request|4
1247540|NCT00599313|4091246|P1|Overall Study|Disease Progression|12
1247541|NCT00599313|4091246|P1|Overall Study|Adverse Event|19
1247542|NCT00599196|4091288|P1|Overall Study|Other: Inv Switched Dopamine Agonist|1
1247543|NCT00599196|4091288|P1|Overall Study|Other: Patient Stopped Due To Moving|1
1247544|NCT00599196|4091288|P1|Overall Study|Other: Pt Moved To Australia|1
1247545|NCT00599196|4091288|P1|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1
1247546|NCT00599196|4091288|P1|Overall Study|Other: Spouse Withdrew Consent|1
1247547|NCT00599196|4091288|P1|Overall Study|Other: Patient Leaving For Israel|1
1247548|NCT00599196|4091288|P1|Overall Study|Lost to Follow-up|17
1247549|NCT00599196|4091288|P1|Overall Study|Study ended per sponsor|197
1247550|NCT00599196|4091288|P1|Overall Study|Subject withdrew consent|43
1247551|NCT00599196|4091288|P1|Overall Study|Unsatisfactory compliance of subject|3
1247552|NCT00599196|4091288|P1|Overall Study|Adverse Event|93
1247553|NCT00599196|4091288|P1|Overall Study|Lack of Efficacy|22
1247554|NCT00599027|4091319|P2|Overall Study|Treatment Failure|1
1247555|NCT00599027|4091320|P1|Overall Study|Treatment Failure|0
1247556|NCT00599027|4091319|P2|Overall Study|Adverse Event|1
1247557|NCT00599027|4091320|P1|Overall Study|Adverse Event|0
1247558|NCT00599027|4091319|P2|Overall Study|Withdrawal by Subject|1
1247559|NCT00599027|4091320|P1|Overall Study|Withdrawal by Subject|1
1247560|NCT00598871|4091333|P2|Overall Study|Adverse Event|1
1247561|NCT00598871|4091334|P1|Overall Study|Adverse Event|0
1247562|NCT00598832|4091344|P2|Overall Study|Non compliance|0
1247563|NCT00598832|4091345|P1|Overall Study|Non compliance|1
1247564|NCT00598832|4091344|P2|Overall Study|Physician Decision|4
1247565|NCT00598832|4091345|P1|Overall Study|Physician Decision|1
1247566|NCT00598832|4091344|P2|Overall Study|Pregnancy|2
1247567|NCT00598832|4091345|P1|Overall Study|Pregnancy|2
1247568|NCT00598832|4091344|P2|Overall Study|Lost to Follow-up|29
1247569|NCT00598832|4091345|P1|Overall Study|Lost to Follow-up|24
1247570|NCT00598832|4091344|P2|Overall Study|Protocol Violation|2
1247571|NCT00598832|4091345|P1|Overall Study|Protocol Violation|0
1247572|NCT00598832|4091344|P2|Overall Study|Withdrawal by Subject|36
1247573|NCT00598832|4091345|P1|Overall Study|Withdrawal by Subject|25
1247574|NCT00598832|4091344|P2|Overall Study|Adverse Event|2
1247575|NCT00598832|4091345|P1|Overall Study|Adverse Event|6
1247576|NCT00598832|4091344|P2|Overall Study|Lack of Efficacy|7
1247577|NCT00598832|4091345|P1|Overall Study|Lack of Efficacy|3
1247578|NCT00598702|4091398|P8|Overall Study|Dose limiting toxicity|0
1247579|NCT00598702|4091399|P7|Overall Study|Dose limiting toxicity|0
1247580|NCT00598702|4091400|P6|Overall Study|Dose limiting toxicity|1
1247581|NCT00598702|4091401|P5|Overall Study|Dose limiting toxicity|1
1247582|NCT00598702|4091402|P4|Overall Study|Dose limiting toxicity|1
1247583|NCT00598702|4091403|P3|Overall Study|Dose limiting toxicity|0
1247584|NCT00598702|4091404|P2|Overall Study|Dose limiting toxicity|0
1247585|NCT00598702|4091405|P1|Overall Study|Dose limiting toxicity|0
1247586|NCT00598702|4091398|P8|Overall Study|Physician Decision|0
1247587|NCT00598702|4091399|P7|Overall Study|Physician Decision|0
1247588|NCT00598702|4091400|P6|Overall Study|Physician Decision|0
1247589|NCT00598702|4091401|P5|Overall Study|Physician Decision|1
1247590|NCT00598702|4091402|P4|Overall Study|Physician Decision|0
1247591|NCT00598702|4091403|P3|Overall Study|Physician Decision|0
1247592|NCT00598702|4091404|P2|Overall Study|Physician Decision|0
1247593|NCT00598702|4091405|P1|Overall Study|Physician Decision|0
1247594|NCT00598702|4091398|P8|Overall Study|Withdrawal by Subject|0
1247595|NCT00598702|4091399|P7|Overall Study|Withdrawal by Subject|0
1247596|NCT00598702|4091400|P6|Overall Study|Withdrawal by Subject|0
1247597|NCT00598702|4091401|P5|Overall Study|Withdrawal by Subject|1
1247598|NCT00598702|4091402|P4|Overall Study|Withdrawal by Subject|1
1247599|NCT00598702|4091403|P3|Overall Study|Withdrawal by Subject|0
1247600|NCT00598702|4091404|P2|Overall Study|Withdrawal by Subject|0
1247601|NCT00598702|4091405|P1|Overall Study|Withdrawal by Subject|0
1247602|NCT00598702|4091398|P8|Overall Study|Adverse Event|0
1247603|NCT00598702|4091399|P7|Overall Study|Adverse Event|0
1247604|NCT00598702|4091400|P6|Overall Study|Adverse Event|0
1247605|NCT00598702|4091401|P5|Overall Study|Adverse Event|0
1247606|NCT00598702|4091402|P4|Overall Study|Adverse Event|1
1247607|NCT00598702|4091403|P3|Overall Study|Adverse Event|0
1247608|NCT00598702|4091404|P2|Overall Study|Adverse Event|0
1247609|NCT00598702|4091405|P1|Overall Study|Adverse Event|0
1247610|NCT00598702|4091398|P8|Overall Study|Early discharge from hospital|0
1247611|NCT00598702|4091399|P7|Overall Study|Early discharge from hospital|1
1247612|NCT00598702|4091400|P6|Overall Study|Early discharge from hospital|10
1247613|NCT00598702|4091401|P5|Overall Study|Early discharge from hospital|0
1247614|NCT00598702|4091402|P4|Overall Study|Early discharge from hospital|5
1247615|NCT00598702|4091403|P3|Overall Study|Early discharge from hospital|2
1247616|NCT00598702|4091404|P2|Overall Study|Early discharge from hospital|0
1247617|NCT00598702|4091405|P1|Overall Study|Early discharge from hospital|0
1247618|NCT00598702|4091398|P8|Overall Study|Not specified|0
1247619|NCT00598702|4091399|P7|Overall Study|Not specified|0
1247620|NCT00598702|4091400|P6|Overall Study|Not specified|1
1247621|NCT00598702|4091401|P5|Overall Study|Not specified|0
1247622|NCT00598702|4091402|P4|Overall Study|Not specified|0
1247623|NCT00598702|4091403|P3|Overall Study|Not specified|0
1247624|NCT00598702|4091404|P2|Overall Study|Not specified|2
1247625|NCT00598702|4091405|P1|Overall Study|Not specified|0
1247626|NCT00598650|4091460|P1|Overall Study|Physician Decision|2
1247627|NCT00598650|4091460|P1|Overall Study|Prohibited Concomitant Medication|2
1247628|NCT00598650|4091460|P1|Overall Study|Not eligible|1
1247629|NCT00598650|4091460|P1|Overall Study|No treatment for 3 weeks|1
1247630|NCT00598650|4091460|P1|Overall Study|Adverse Event|18
1247631|NCT00598650|4091460|P1|Overall Study|Withdrawal by Subject|3
1247632|NCT00598585|4091469|P2|Overall Study|Lost to Follow-up|0
1247633|NCT00598585|4091470|P1|Overall Study|Lost to Follow-up|1
1247634|NCT00598559|4091479|P3|Overall Study|Subject unable/unwilling to attend visit|0
1247635|NCT00598559|4091480|P2|Overall Study|Subject unable/unwilling to attend visit|7
1247636|NCT00598559|4091481|P1|Overall Study|Subject unable/unwilling to attend visit|4
1247637|NCT00598559|4091479|P3|Overall Study|Early discharge from hospital|3
1247638|NCT00598559|4091480|P2|Overall Study|Early discharge from hospital|12
1247639|NCT00598559|4091481|P1|Overall Study|Early discharge from hospital|9
1247640|NCT00598559|4091479|P3|Overall Study|Protocol Non-compliance|0
1247641|NCT00598559|4091480|P2|Overall Study|Protocol Non-compliance|0
1247642|NCT00598559|4091481|P1|Overall Study|Protocol Non-compliance|1
1247643|NCT00598559|4091479|P3|Overall Study|Withdrawal by Subject|0
1247644|NCT00598559|4091480|P2|Overall Study|Withdrawal by Subject|2
1247645|NCT00598559|4091481|P1|Overall Study|Withdrawal by Subject|2
1247646|NCT00598559|4091479|P3|Overall Study|Adverse Event|0
1247647|NCT00598559|4091480|P2|Overall Study|Adverse Event|7
1247648|NCT00598559|4091481|P1|Overall Study|Adverse Event|11
1247649|NCT00598442|4091508|P3|Overall Study|Started dialysis|0
1247650|NCT00598442|4091509|P2|Overall Study|Started dialysis|0
1247651|NCT00598442|4091510|P1|Overall Study|Started dialysis|1
1247652|NCT00598442|4091508|P3|Overall Study|Site closed by sponsor|1
1247653|NCT00598442|4091509|P2|Overall Study|Site closed by sponsor|2
1247654|NCT00598442|4091510|P1|Overall Study|Site closed by sponsor|5
1247655|NCT00598442|4091508|P3|Overall Study|Renal transplant|1
1247656|NCT00598442|4091509|P2|Overall Study|Renal transplant|0
1247657|NCT00598442|4091510|P1|Overall Study|Renal transplant|0
1247658|NCT00598442|4091508|P3|Overall Study|Relocation|0
1247659|NCT00598442|4091509|P2|Overall Study|Relocation|4
1247660|NCT00598442|4091510|P1|Overall Study|Relocation|1
1247661|NCT00598442|4091508|P3|Overall Study|Noncompliance|1
1247662|NCT00598442|4091509|P2|Overall Study|Noncompliance|2
1247663|NCT00598442|4091510|P1|Overall Study|Noncompliance|0
1247664|NCT00598442|4091508|P3|Overall Study|Withdrawal by Subject|6
1247665|NCT00598442|4091509|P2|Overall Study|Withdrawal by Subject|16
1247666|NCT00598442|4091510|P1|Overall Study|Withdrawal by Subject|8
1247667|NCT00598442|4091508|P3|Overall Study|Physician Decision|1
1247668|NCT00598442|4091509|P2|Overall Study|Physician Decision|1
1247669|NCT00598442|4091510|P1|Overall Study|Physician Decision|2
1247670|NCT00598442|4091508|P3|Overall Study|Lost to Follow-up|3
1247671|NCT00598442|4091509|P2|Overall Study|Lost to Follow-up|3
1247672|NCT00598442|4091510|P1|Overall Study|Lost to Follow-up|4
1247673|NCT00598442|4091508|P3|Overall Study|Death|11
1247674|NCT00598442|4091509|P2|Overall Study|Death|11
1247675|NCT00598442|4091510|P1|Overall Study|Death|19
1247676|NCT00598442|4091508|P3|Overall Study|Adverse Event|0
1247677|NCT00598442|4091509|P2|Overall Study|Adverse Event|0
1247678|NCT00598442|4091510|P1|Overall Study|Adverse Event|3
1247679|NCT00598273|4091527|P3|Overall Study|Started dialysis|5
1247680|NCT00598273|4091528|P2|Overall Study|Started dialysis|4
1247681|NCT00598273|4091529|P1|Overall Study|Started dialysis|6
1247682|NCT00598273|4091527|P3|Overall Study|Site elected to close|0
1247683|NCT00598273|4091528|P2|Overall Study|Site elected to close|0
1247684|NCT00598273|4091529|P1|Overall Study|Site elected to close|1
1247685|NCT00598273|4091527|P3|Overall Study|Renal transplant|1
1247686|NCT00598273|4091528|P2|Overall Study|Renal transplant|0
1247687|NCT00598273|4091529|P1|Overall Study|Renal transplant|1
1247688|NCT00598273|4091527|P3|Overall Study|Relocation|4
1247689|NCT00598273|4091528|P2|Overall Study|Relocation|2
1247690|NCT00598273|4091529|P1|Overall Study|Relocation|0
1247691|NCT00598273|4091527|P3|Overall Study|Noncompliance|3
1247692|NCT00598273|4091528|P2|Overall Study|Noncompliance|2
1247693|NCT00598273|4091529|P1|Overall Study|Noncompliance|3
1247694|NCT00598273|4091527|P3|Overall Study|Withdrawal by Subject|10
1247695|NCT00598273|4091528|P2|Overall Study|Withdrawal by Subject|10
1247696|NCT00598273|4091529|P1|Overall Study|Withdrawal by Subject|12
1247697|NCT00598273|4091527|P3|Overall Study|Physician Decision|1
1247698|NCT00598273|4091528|P2|Overall Study|Physician Decision|0
1247699|NCT00598273|4091529|P1|Overall Study|Physician Decision|0
1247700|NCT00598273|4091527|P3|Overall Study|Lost to Follow-up|5
1247701|NCT00598273|4091528|P2|Overall Study|Lost to Follow-up|3
1247702|NCT00598273|4091529|P1|Overall Study|Lost to Follow-up|8
1247703|NCT00598273|4091527|P3|Overall Study|Death|8
1247704|NCT00598273|4091528|P2|Overall Study|Death|12
1247705|NCT00598273|4091529|P1|Overall Study|Death|6
1247706|NCT00598273|4091527|P3|Overall Study|Adverse Event|2
1247707|NCT00598273|4091528|P2|Overall Study|Adverse Event|5
1247708|NCT00598273|4091529|P1|Overall Study|Adverse Event|4
1247709|NCT00598078|4091543|P2|Period 2 (Day 2)|Adverse Event|0
1247710|NCT00598078|4091544|P1|Period 2 (Day 2)|Adverse Event|1
1247711|NCT00597766|4091597|P3|Follow-up 2, Week 8|Lost to Follow-up|1
1247712|NCT00597766|4091598|P2|Follow-up 2, Week 8|Lost to Follow-up|0
1247713|NCT00597766|4091599|P1|Follow-up 2, Week 8|Lost to Follow-up|0
1247714|NCT00597766|4091597|P3|Follow-up 1, Week 4|Withdrawal by Subject|0
1247715|NCT00597766|4091598|P2|Follow-up 1, Week 4|Withdrawal by Subject|0
1247716|NCT00597766|4091599|P1|Follow-up 1, Week 4|Withdrawal by Subject|1
1247717|NCT00597753|4091618|P2|Overall Study|Site elected to close|4
1247718|NCT00597753|4091619|P1|Overall Study|Site elected to close|2
1247719|NCT00597753|4091618|P2|Overall Study|Site closed by sponsor|7
1247720|NCT00597753|4091619|P1|Overall Study|Site closed by sponsor|19
1247721|NCT00597753|4091618|P2|Overall Study|Renal transplant|3
1247722|NCT00597753|4091619|P1|Overall Study|Renal transplant|10
1247723|NCT00597753|4091618|P2|Overall Study|Relocation|6
1247724|NCT00597753|4091619|P1|Overall Study|Relocation|17
1247725|NCT00597753|4091618|P2|Overall Study|Noncompliance|1
1247726|NCT00597753|4091619|P1|Overall Study|Noncompliance|2
1247727|NCT00597753|4091618|P2|Overall Study|Never dosed|0
1247728|NCT00597753|4091619|P1|Overall Study|Never dosed|2
1247729|NCT00597753|4091618|P2|Overall Study|Discontinued Dialysis|1
1247730|NCT00597753|4091619|P1|Overall Study|Discontinued Dialysis|0
1247731|NCT00597753|4091618|P2|Overall Study|Withdrawal by Subject|12
1247732|NCT00597753|4091619|P1|Overall Study|Withdrawal by Subject|35
1247733|NCT00597753|4091618|P2|Overall Study|Pregnancy|0
1247734|NCT00597753|4091619|P1|Overall Study|Pregnancy|1
1247735|NCT00597753|4091618|P2|Overall Study|Physician Decision|1
1247736|NCT00597753|4091619|P1|Overall Study|Physician Decision|5
1247737|NCT00597753|4091618|P2|Overall Study|Lost to Follow-up|3
1247738|NCT00597753|4091619|P1|Overall Study|Lost to Follow-up|10
1247739|NCT00597753|4091618|P2|Overall Study|Lack of Efficacy|0
1247740|NCT00597753|4091619|P1|Overall Study|Lack of Efficacy|2
1247741|NCT00597753|4091618|P2|Overall Study|Death|29
1247742|NCT00597753|4091619|P1|Overall Study|Death|55
1247743|NCT00597753|4091618|P2|Overall Study|Adverse Event|2
1247744|NCT00597753|4091619|P1|Overall Study|Adverse Event|6
1247745|NCT00597714|4091653|P3|Overall Study|Recipient death|10
1247746|NCT00597714|4091654|P2|Overall Study|Recipient death|0
1247747|NCT00597714|4091655|P1|Overall Study|Recipient death|0
1247748|NCT00597714|4091653|P3|Overall Study|Death|0
1247749|NCT00597714|4091654|P2|Overall Study|Death|46
1247750|NCT00597714|4091655|P1|Overall Study|Death|56
1247751|NCT00597701|4091667|P2|Overall Study|Did not start intervention (pharmacy er)|2
1247752|NCT00597701|4091668|P1|Overall Study|Did not start intervention (pharmacy er)|0
1247753|NCT00597701|4091667|P2|Overall Study|Physician Decision|0
1247754|NCT00597701|4091668|P1|Overall Study|Physician Decision|2
1247755|NCT00597701|4091667|P2|Overall Study|Death|1
1247756|NCT00597701|4091668|P1|Overall Study|Death|0
1247757|NCT00597701|4091667|P2|Overall Study|Withdrawal by Subject|5
1247758|NCT00597701|4091668|P1|Overall Study|Withdrawal by Subject|5
1247759|NCT00597584|4091690|P2|Overall Study|Renal transplant|7
1247760|NCT00597584|4091691|P1|Overall Study|Renal transplant|9
1247761|NCT00597584|4091690|P2|Overall Study|Relocation|6
1247762|NCT00597584|4091691|P1|Overall Study|Relocation|8
1247763|NCT00597584|4091690|P2|Overall Study|Never dosed|0
1247764|NCT00597584|4091691|P1|Overall Study|Never dosed|1
1247765|NCT00597584|4091690|P2|Overall Study|Lost ability to consent|1
1247766|NCT00597584|4091691|P1|Overall Study|Lost ability to consent|1
1247767|NCT00597584|4091690|P2|Overall Study|Discontinued Dialysis|1
1247768|NCT00597584|4091691|P1|Overall Study|Discontinued Dialysis|0
1247769|NCT00597584|4091690|P2|Overall Study|Withdrawal by Subject|12
1247770|NCT00597584|4091691|P1|Overall Study|Withdrawal by Subject|44
1247771|NCT00597584|4091690|P2|Overall Study|Pregnancy|0
1247772|NCT00597584|4091691|P1|Overall Study|Pregnancy|2
1247773|NCT00597584|4091690|P2|Overall Study|Physician Decision|0
1247774|NCT00597584|4091691|P1|Overall Study|Physician Decision|3
1247775|NCT00597584|4091690|P2|Overall Study|Lost to Follow-up|4
1247776|NCT00597584|4091691|P1|Overall Study|Lost to Follow-up|2
1247777|NCT00597584|4091690|P2|Overall Study|Lack of Efficacy|0
1247778|NCT00597584|4091691|P1|Overall Study|Lack of Efficacy|1
1247779|NCT00597584|4091690|P2|Overall Study|Death|30
1247780|NCT00597584|4091691|P1|Overall Study|Death|53
1247781|NCT00597584|4091690|P2|Overall Study|Adverse Event|2
1247782|NCT00597584|4091691|P1|Overall Study|Adverse Event|4
1247783|NCT00597519|4091716|P1|Overall Study|Death|1
1247784|NCT00597506|4091720|P1|Overall Study|Subject is being followed for survival|1
1247785|NCT00597376|4091770|P2|Overall Study|Adverse Event|1
1247786|NCT00597376|4091771|P1|Overall Study|Adverse Event|4
1247787|NCT00597376|4091770|P2|Overall Study|Withdrawal by Subject|3
1247788|NCT00597376|4091771|P1|Overall Study|Withdrawal by Subject|4
1247789|NCT00597207|4091812|P2|Overall Study|Lost to Follow-up|7
1247790|NCT00597207|4091813|P1|Overall Study|Lost to Follow-up|5
1247791|NCT00597116|4091821|P2|Overall Study|Progressive disease|6
1247792|NCT00597116|4091822|P1|Overall Study|Progressive disease|11
1247793|NCT00597116|4091821|P2|Overall Study|Lost to Follow-up|0
1247794|NCT00597116|4091822|P1|Overall Study|Lost to Follow-up|1
1247795|NCT00597116|4091821|P2|Overall Study|Death|1
1247796|NCT00597116|4091822|P1|Overall Study|Death|0
1247797|NCT00597116|4091821|P2|Overall Study|Physician Decision|1
1247798|NCT00597116|4091822|P1|Overall Study|Physician Decision|0
1247799|NCT00597116|4091821|P2|Overall Study|Withdrawal by Subject|2
1247800|NCT00597116|4091822|P1|Overall Study|Withdrawal by Subject|0
1247801|NCT00597116|4091821|P2|Overall Study|Adverse Event|1
1247802|NCT00597116|4091822|P1|Overall Study|Adverse Event|2
1247803|NCT00597012|4091848|P2|Overall Study|Lost to Follow-up|2
1247804|NCT00597012|4091849|P1|Overall Study|Lost to Follow-up|0
1247805|NCT00597012|4091848|P2|Overall Study|Ineligible|0
1247806|NCT00597012|4091849|P1|Overall Study|Ineligible|2
1247807|NCT00597012|4091848|P2|Overall Study|Withdrawal by Subject|4
1247808|NCT00597012|4091849|P1|Overall Study|Withdrawal by Subject|7
1247809|NCT00597012|4091848|P2|Overall Study|Underwent Total Knee Replacement (TKR)|1
1247810|NCT00597012|4091849|P1|Overall Study|Underwent Total Knee Replacement (TKR)|3
1247811|NCT00597012|4091848|P2|Overall Study|Death|1
1247812|NCT00597012|4091849|P1|Overall Study|Death|1
1247813|NCT00596960|4091861|P2|Overall Study|No alcohol use data|1
1247814|NCT00596960|4091862|P1|Overall Study|No alcohol use data|0
1247815|NCT00596960|4091861|P2|Overall Study|Protocol Violation|1
1247816|NCT00596960|4091862|P1|Overall Study|Protocol Violation|0
1247817|NCT00596960|4091861|P2|Overall Study|Physician Decision|0
1247818|NCT00596960|4091862|P1|Overall Study|Physician Decision|1
1247819|NCT00596960|4091861|P2|Overall Study|Incarcerated|0
1247820|NCT00596960|4091862|P1|Overall Study|Incarcerated|2
1247821|NCT00596960|4091861|P2|Overall Study|Withdrawal by Subject|0
1247822|NCT00596960|4091862|P1|Overall Study|Withdrawal by Subject|1
1247823|NCT00596960|4091861|P2|Overall Study|Lost to Follow-up|5
1247824|NCT00596960|4091862|P1|Overall Study|Lost to Follow-up|6
1247825|NCT00596960|4091861|P2|Overall Study|Death|2
1247826|NCT00596960|4091862|P1|Overall Study|Death|1
1247827|NCT00596947|4091874|P2|Overall Study|Lost to Follow-up|0
1247828|NCT00596947|4091875|P1|Overall Study|Lost to Follow-up|1
1247829|NCT00596947|4091874|P2|Overall Study|study halted due to low enrollment|3
1247830|NCT00596947|4091875|P1|Overall Study|study halted due to low enrollment|5
1247831|NCT00596934|4091915|P1|Overall Study|Withdrawal by Subject|1
1247832|NCT00596934|4091915|P1|Overall Study|Protocol Violation|1
1247833|NCT00596830|4091928|P2|Overall Study|Randomized but not treated|7
1247834|NCT00596830|4091929|P1|Overall Study|Randomized but not treated|3
1247835|NCT00596830|4091928|P2|Overall Study|Follow-up was discontinued|0
1247836|NCT00596830|4091929|P1|Overall Study|Follow-up was discontinued|1
1247837|NCT00596830|4091928|P2|Overall Study|Study terminated by sponsor|62
1247838|NCT00596830|4091929|P1|Overall Study|Study terminated by sponsor|51
1247839|NCT00596830|4091928|P2|Overall Study|Withdrawal by Subject|12
1247840|NCT00596830|4091929|P1|Overall Study|Withdrawal by Subject|22
1247841|NCT00596830|4091928|P2|Overall Study|Lost to Follow-up|11
1247842|NCT00596830|4091929|P1|Overall Study|Lost to Follow-up|7
1247843|NCT00596830|4091928|P2|Overall Study|Death|247
1247844|NCT00596830|4091929|P1|Overall Study|Death|258
1247845|NCT00596817|4091955|P2|Double-blind Period|Other Reasons|18
1247846|NCT00596817|4091956|P1|Double-blind Period|Other Reasons|10
1247847|NCT00596817|4091955|P2|Double-blind Period|Lost to Follow-up|2
1247848|NCT00596817|4091956|P1|Double-blind Period|Lost to Follow-up|0
1247849|NCT00596817|4091955|P2|Double-blind Period|Withdrawal of Consent|3
1247850|NCT00596817|4091956|P1|Double-blind Period|Withdrawal of Consent|7
1247851|NCT00596817|4091955|P2|Double-blind Period|Protocol Violation|8
1247852|NCT00596817|4091956|P1|Double-blind Period|Protocol Violation|11
1247853|NCT00596817|4091955|P2|Double-blind Period|Non-compliance With Study Product|4
1247854|NCT00596817|4091956|P1|Double-blind Period|Non-compliance With Study Product|3
1247855|NCT00596817|4091955|P2|Double-blind Period|Lack of Efficacy|28
1247856|NCT00596817|4091956|P1|Double-blind Period|Lack of Efficacy|52
1247857|NCT00596817|4091955|P2|Double-blind Period|Adverse Event|16
1247858|NCT00596817|4091956|P1|Double-blind Period|Adverse Event|5
1247859|NCT00596817|4091955|P2|Open-label Period to Double-blind Period|Other Reasons|14
1247860|NCT00596817|4091956|P1|Open-label Period to Double-blind Period|Other Reasons|0
1247861|NCT00596817|4091955|P2|Open-label Period to Double-blind Period|Not Eligible|49
1247862|NCT00596817|4091956|P1|Open-label Period to Double-blind Period|Not Eligible|0
1247863|NCT00596817|4091955|P2|Open-label Period to Double-blind Period|Lack of Efficacy|24
1247864|NCT00596817|4091956|P1|Open-label Period to Double-blind Period|Lack of Efficacy|0
1247865|NCT00596817|4091955|P2|Open-label Period to Double-blind Period|Adverse Event|5
1247866|NCT00596817|4091956|P1|Open-label Period to Double-blind Period|Adverse Event|0
1247867|NCT00596817|4091955|P2|Open-label Period|Other Reasons|65
1247868|NCT00596817|4091956|P1|Open-label Period|Other Reasons|0
1247869|NCT00596817|4091955|P2|Open-label Period|Lack of Efficacy|33
1247870|NCT00596817|4091956|P1|Open-label Period|Lack of Efficacy|0
1247871|NCT00596817|4091955|P2|Open-label Period|Adverse Event|49
1247872|NCT00596817|4091956|P1|Open-label Period|Adverse Event|0
1247873|NCT00596752|4091981|P2|Overall Study|Protocol Violation|0
1247874|NCT00596752|4091982|P1|Overall Study|Protocol Violation|1
1247875|NCT00596752|4091981|P2|Overall Study|Lack of Efficacy|7
1247876|NCT00596752|4091982|P1|Overall Study|Lack of Efficacy|4
1247877|NCT00596752|4091981|P2|Overall Study|Unsatisfactory Compliance|6
1247878|NCT00596752|4091982|P1|Overall Study|Unsatisfactory Compliance|9
1247879|NCT00596752|4091981|P2|Overall Study|Withdrawal by Subject|9
1247880|NCT00596752|4091982|P1|Overall Study|Withdrawal by Subject|12
1247881|NCT00596752|4091981|P2|Overall Study|Lost to Follow-up|38
1247882|NCT00596752|4091982|P1|Overall Study|Lost to Follow-up|22
1247883|NCT00596752|4091981|P2|Overall Study|Adverse Event|34
1247884|NCT00596752|4091982|P1|Overall Study|Adverse Event|34
1247885|NCT00596752|4091981|P2|Overall Study|Other Reason|49
1247886|NCT00596752|4091982|P1|Overall Study|Other Reason|44
1247887|NCT00596687|4092012|P2|Overall Study|cancelled surgery|1
1247888|NCT00596687|4092013|P1|Overall Study|cancelled surgery|1
1247889|NCT00596687|4092012|P2|Overall Study|Withdrawal by Subject|1
1247890|NCT00596687|4092013|P1|Overall Study|Withdrawal by Subject|3
1247891|NCT00596687|4092012|P2|Overall Study|continuous insulin infusion during TPN|1
1247892|NCT00596687|4092013|P1|Overall Study|continuous insulin infusion during TPN|2
1247893|NCT00596687|4092012|P2|Overall Study|< 24 hours of insulin treatment|6
1247894|NCT00596687|4092013|P1|Overall Study|< 24 hours of insulin treatment|8
1247895|NCT00596635|4092024|P3|Overall Study|Could not provide urine specimen|2
1247896|NCT00596635|4092025|P2|Overall Study|Could not provide urine specimen|2
1247897|NCT00596635|4092026|P1|Overall Study|Could not provide urine specimen|1
1247898|NCT00596635|4092024|P3|Overall Study|Hip fracture|3
1247899|NCT00596635|4092025|P2|Overall Study|Hip fracture|3
1247900|NCT00596635|4092026|P1|Overall Study|Hip fracture|2
1247901|NCT00596635|4092024|P3|Overall Study|Treatment for symptomatic UTI|3
1247902|NCT00596635|4092025|P2|Overall Study|Treatment for symptomatic UTI|6
1247903|NCT00596635|4092026|P1|Overall Study|Treatment for symptomatic UTI|4
1247904|NCT00596635|4092024|P3|Overall Study|Lost to Follow-up|0
1247905|NCT00596635|4092025|P2|Overall Study|Lost to Follow-up|2
1247906|NCT00596635|4092026|P1|Overall Study|Lost to Follow-up|0
1247907|NCT00596466|4092052|P1|Overall Study|Enrolled, not treated|2
1247908|NCT00596466|4092052|P1|Overall Study|Unpecified|2
1247909|NCT00596466|4092052|P1|Overall Study|Protocol Violation|2
1247910|NCT00596466|4092052|P1|Overall Study|Withdrawal by Subject|2
1247911|NCT00596466|4092052|P1|Overall Study|Adverse Event|4
1247912|NCT00596466|4092052|P1|Overall Study|Lack of Efficacy|5
1247913|NCT00596427|4092082|P2|Overall Study|Protocol Violation|0
1247914|NCT00596427|4092083|P1|Overall Study|Protocol Violation|1
1247915|NCT00596427|4092082|P2|Overall Study|Increased Fasting Triacylglycerol level|0
1247916|NCT00596427|4092083|P1|Overall Study|Increased Fasting Triacylglycerol level|1
1247917|NCT00596427|4092082|P2|Overall Study|Withdrawal by Subject|2
1247918|NCT00596427|4092083|P1|Overall Study|Withdrawal by Subject|2
1247919|NCT00596362|4092111|P1|Overall Study|Progressive Disease|1
1247920|NCT00596011|4092147|P2|Overall Study|Adverse Event|7
1247921|NCT00596011|4092148|P1|Overall Study|Adverse Event|11
1247922|NCT00596011|4092147|P2|Overall Study|Withdrawal by Subject|3
1247923|NCT00596011|4092148|P1|Overall Study|Withdrawal by Subject|2
1247924|NCT00595959|4092164|P1|Overall Study|Lost to Follow-up|1
1247925|NCT00595959|4092164|P1|Overall Study|Withdrawal by Subject|1
1247926|NCT00595920|4092198|P1|Overall Study|The OLTERMS study was discontinued by th|116
1247927|NCT00595868|4092209|P2|Overall Study|Lost to Follow-up|50
1247928|NCT00595868|4092210|P1|Overall Study|Lost to Follow-up|45
1247929|NCT00595764|4092233|P2|Overall Study|Withdrawal by Subject|0
1247930|NCT00595764|4092234|P1|Overall Study|Withdrawal by Subject|4
1247931|NCT00595764|4092233|P2|Overall Study|Missed 3 PM visits|7
1247932|NCT00595764|4092234|P1|Overall Study|Missed 3 PM visits|1
1247933|NCT00595764|4092233|P2|Overall Study|Missed Medication >1 week|17
1247934|NCT00595764|4092234|P1|Overall Study|Missed Medication >1 week|10
1247935|NCT00595764|4092233|P2|Overall Study|Protocol Violation|19
1247936|NCT00595764|4092234|P1|Overall Study|Protocol Violation|24
1247937|NCT00595582|4092248|P1|Overall Study|Physician Decision|5
1247938|NCT00595582|4092248|P1|Overall Study|Adverse Event|2
1247939|NCT00595582|4092248|P1|Overall Study|Lost to Follow-up|1
1247940|NCT00595582|4092248|P1|Overall Study|Pilot study that PI terminated|2
1247941|NCT00595517|4092273|P1|Overall Study|No intention to attend regularly|1
1247942|NCT00595517|4092273|P1|Overall Study|usage of prohibited treatment|1
1247943|NCT00595517|4092273|P1|Overall Study|Recurrence of ulcer|5
1247944|NCT00595517|4092273|P1|Overall Study|Protocol Violation|2
1247945|NCT00595517|4092273|P1|Overall Study|Withdrawal by Subject|4
1247946|NCT00595517|4092273|P1|Overall Study|Adverse Event|6
1247947|NCT00595504|4092282|P2|Overall Study|Physician Decision|0
1247948|NCT00595504|4092283|P1|Overall Study|Physician Decision|1
1247949|NCT00595504|4092282|P2|Overall Study|Withdrawal by Subject|3
1247950|NCT00595504|4092283|P1|Overall Study|Withdrawal by Subject|1
1247951|NCT00595478|4092295|P2|36-week Follow-up Period|Withdrawal by Subject|4
1247952|NCT00595478|4092296|P1|36-week Follow-up Period|Withdrawal by Subject|4
1247953|NCT00595478|4092295|P2|36-week Follow-up Period|Lost to Follow-up|4
1247954|NCT00595478|4092296|P1|36-week Follow-up Period|Lost to Follow-up|5
1247955|NCT00595465|4092307|P3|Overall Study|administrative reason|1
1247956|NCT00595465|4092308|P2|Overall Study|administrative reason|0
1247957|NCT00595465|4092309|P1|Overall Study|administrative reason|0
1247958|NCT00595465|4092307|P3|Overall Study|Lost to Follow-up|2
1247959|NCT00595465|4092308|P2|Overall Study|Lost to Follow-up|0
1247960|NCT00595465|4092309|P1|Overall Study|Lost to Follow-up|0
1247961|NCT00595465|4092307|P3|Overall Study|Protocol Violation|0
1247962|NCT00595465|4092308|P2|Overall Study|Protocol Violation|1
1247963|NCT00595465|4092309|P1|Overall Study|Protocol Violation|2
1247964|NCT00595465|4092307|P3|Overall Study|Pregnancy|1
1247965|NCT00595465|4092308|P2|Overall Study|Pregnancy|0
1247966|NCT00595465|4092309|P1|Overall Study|Pregnancy|0
1247967|NCT00595465|4092307|P3|Overall Study|Adverse Event|3
1247968|NCT00595465|4092308|P2|Overall Study|Adverse Event|3
1247969|NCT00595465|4092309|P1|Overall Study|Adverse Event|4
1247970|NCT00595413|4092321|P4|Overall Study|Other|0
1247971|NCT00595413|4092322|P3|Overall Study|Other|5
1247972|NCT00595413|4092323|P2|Overall Study|Other|1
1247973|NCT00595413|4092324|P1|Overall Study|Other|5
1247974|NCT00595413|4092321|P4|Overall Study|Death|0
1247975|NCT00595413|4092322|P3|Overall Study|Death|1
1247976|NCT00595413|4092323|P2|Overall Study|Death|0
1247977|NCT00595413|4092324|P1|Overall Study|Death|0
1247978|NCT00595413|4092321|P4|Overall Study|Lost to Follow-up|3
1247979|NCT00595413|4092322|P3|Overall Study|Lost to Follow-up|1
1247980|NCT00595413|4092323|P2|Overall Study|Lost to Follow-up|2
1247981|NCT00595413|4092324|P1|Overall Study|Lost to Follow-up|2
1247982|NCT00595413|4092321|P4|Overall Study|Adverse Event|1
1247983|NCT00595413|4092322|P3|Overall Study|Adverse Event|1
1247984|NCT00595413|4092323|P2|Overall Study|Adverse Event|2
1247985|NCT00595413|4092324|P1|Overall Study|Adverse Event|0
1247986|NCT00595335|4092365|P2|Six Months to Twelve Months|Disease Progression|0
1247987|NCT00595335|4092366|P1|Six Months to Twelve Months|Disease Progression|1
1247988|NCT00595335|4092365|P2|Six Months to Twelve Months|Withdrawal by Subject|1
1247989|NCT00595335|4092366|P1|Six Months to Twelve Months|Withdrawal by Subject|0
1247990|NCT00595335|4092365|P2|Baseline to Six Months|Adverse Event|0
1247991|NCT00595335|4092366|P1|Baseline to Six Months|Adverse Event|1
1247992|NCT00595335|4092365|P2|Baseline to Six Months|Disease Progression|1
1247993|NCT00595335|4092366|P1|Baseline to Six Months|Disease Progression|1
1247994|NCT00595335|4092365|P2|Baseline to Six Months|Withdrawal by Subject|1
1247995|NCT00595335|4092366|P1|Baseline to Six Months|Withdrawal by Subject|0
1247996|NCT00595309|4092386|P1|Overall Study|personal reason|1
1247997|NCT00595309|4092386|P1|Overall Study|acute infection after V0|1
1247998|NCT00595309|4092386|P1|Overall Study|planned vaccination against yellow fever|1
1247999|NCT00595309|4092386|P1|Overall Study|Lost to Follow-up|1
1248000|NCT00595127|4092416|P1|Overall Study|joined another trial|1
1248001|NCT00595127|4092416|P1|Overall Study|Relapsed|3
1248002|NCT00595127|4092416|P1|Overall Study|Death|6
1248003|NCT00595075|4092438|P2|Overall Study|Withdrawal by Subject|0
1248004|NCT00595075|4092439|P1|Overall Study|Withdrawal by Subject|1
1248005|NCT00594958|4092460|P3|Overall Study|administrative|2
1248006|NCT00594958|4092461|P2|Overall Study|administrative|0
1248007|NCT00594958|4092462|P1|Overall Study|administrative|3
1248008|NCT00594958|4092460|P3|Overall Study|Lost to Follow-up|3
1248009|NCT00594958|4092461|P2|Overall Study|Lost to Follow-up|0
1248010|NCT00594958|4092462|P1|Overall Study|Lost to Follow-up|5
1248011|NCT00594958|4092460|P3|Overall Study|Protocol Violation|2
1248012|NCT00594958|4092461|P2|Overall Study|Protocol Violation|0
1248013|NCT00594958|4092462|P1|Overall Study|Protocol Violation|1
1248014|NCT00594958|4092460|P3|Overall Study|Pregnancy|0
1248015|NCT00594958|4092461|P2|Overall Study|Pregnancy|2
1248016|NCT00594958|4092462|P1|Overall Study|Pregnancy|0
1248017|NCT00594958|4092460|P3|Overall Study|Adverse Event|2
1248018|NCT00594958|4092461|P2|Overall Study|Adverse Event|1
1248019|NCT00594958|4092462|P1|Overall Study|Adverse Event|4
1248020|NCT00594958|4092460|P3|Overall Study|Withdrawal by Subject|1
1248021|NCT00594958|4092461|P2|Overall Study|Withdrawal by Subject|0
1248022|NCT00594958|4092462|P1|Overall Study|Withdrawal by Subject|1
1248023|NCT00594906|4092483|P2|Overall Study|Death|1
1248024|NCT00594906|4092484|P1|Overall Study|Death|0
1248025|NCT00594906|4092483|P2|Overall Study|Physician Decision|1
1248026|NCT00594906|4092484|P1|Overall Study|Physician Decision|0
1248027|NCT00594906|4092483|P2|Overall Study|Physician Decision|0
1248028|NCT00594906|4092484|P1|Overall Study|Physician Decision|1
1248029|NCT00594880|4092492|P2|Overall Study|Lost to Follow-up|0
1248030|NCT00594880|4092493|P1|Overall Study|Lost to Follow-up|1
1248031|NCT00594880|4092492|P2|Overall Study|Withdrawal by Subject|1
1248032|NCT00594880|4092493|P1|Overall Study|Withdrawal by Subject|1
1248033|NCT00594854|4092505|P2|Overall Study|Study terminated|10
1248034|NCT00594854|4092506|P1|Overall Study|Study terminated|7
1248035|NCT00594815|4092516|P1|Overall Study|Toxicity|4
1248036|NCT00594815|4092516|P1|Overall Study|Withdrawal by Subject|2
1248037|NCT00594815|4092516|P1|Overall Study|Never Treated|3
1248038|NCT00594659|4092541|P3|Overall Study|Lost to Follow-up|7
1248039|NCT00594659|4092542|P2|Overall Study|Lost to Follow-up|9
1248040|NCT00594659|4092543|P1|Overall Study|Lost to Follow-up|13
1248041|NCT00594646|4092554|P1|Overall Study|Lost to Follow-up|15
1248042|NCT00594646|4092554|P1|Overall Study|Withdrawal by Subject|1
1248043|NCT00594568|4092562|P3|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18
1248044|NCT00594568|4092563|P2|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22
1248045|NCT00594568|4092564|P1|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25
1248046|NCT00594568|4092562|P3|Safety Follow Up (SFU)-Optional|Caregiver Decision|9
1248047|NCT00594568|4092563|P2|Safety Follow Up (SFU)-Optional|Caregiver Decision|16
1248048|NCT00594568|4092564|P1|Safety Follow Up (SFU)-Optional|Caregiver Decision|17
1248049|NCT00594568|4092562|P3|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
1248050|NCT00594568|4092563|P2|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
1248051|NCT00594568|4092564|P1|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
1248052|NCT00594568|4092562|P3|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13
1248053|NCT00594568|4092563|P2|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15
1248054|NCT00594568|4092564|P1|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12
1248055|NCT00594568|4092562|P3|Safety Follow Up (SFU)-Optional|Adverse Event|0
1248056|NCT00594568|4092563|P2|Safety Follow Up (SFU)-Optional|Adverse Event|0
1248057|NCT00594568|4092564|P1|Safety Follow Up (SFU)-Optional|Adverse Event|5
1248058|NCT00594568|4092562|P3|Safety Follow Up (SFU)-Optional|Death|0
1248059|NCT00594568|4092563|P2|Safety Follow Up (SFU)-Optional|Death|1
1248060|NCT00594568|4092564|P1|Safety Follow Up (SFU)-Optional|Death|0
1248061|NCT00594568|4092562|P3|Delayed Start|Sponsor Decision|59
1248062|NCT00594568|4092563|P2|Delayed Start|Sponsor Decision|66
1248063|NCT00594568|4092564|P1|Delayed Start|Sponsor Decision|77
1248064|NCT00594568|4092562|P3|Delayed Start|Caregiver Decision|2
1248065|NCT00594568|4092563|P2|Delayed Start|Caregiver Decision|6
1248066|NCT00594568|4092564|P1|Delayed Start|Caregiver Decision|5
1248067|NCT00594568|4092562|P3|Delayed Start|Lost to Follow-up|1
1248068|NCT00594568|4092563|P2|Delayed Start|Lost to Follow-up|0
1248069|NCT00594568|4092564|P1|Delayed Start|Lost to Follow-up|0
1248070|NCT00594568|4092562|P3|Delayed Start|Physician Decision|1
1248071|NCT00594568|4092563|P2|Delayed Start|Physician Decision|0
1248072|NCT00594568|4092564|P1|Delayed Start|Physician Decision|0
1248073|NCT00594568|4092562|P3|Delayed Start|Withdrawal by Subject|0
1248074|NCT00594568|4092563|P2|Delayed Start|Withdrawal by Subject|3
1248075|NCT00594568|4092564|P1|Delayed Start|Withdrawal by Subject|4
1248076|NCT00594568|4092562|P3|Delayed Start|Adverse Event|2
1248077|NCT00594568|4092563|P2|Delayed Start|Adverse Event|2
1248078|NCT00594568|4092564|P1|Delayed Start|Adverse Event|12
1248079|NCT00594568|4092562|P3|Delayed Start|Death|1
1248080|NCT00594568|4092563|P2|Delayed Start|Death|0
1248081|NCT00594568|4092564|P1|Delayed Start|Death|0
1248082|NCT00594568|4092562|P3|Initial Treatment|Entry criteria exclusion|1
1248083|NCT00594568|4092563|P2|Initial Treatment|Entry criteria exclusion|1
1248084|NCT00594568|4092564|P1|Initial Treatment|Entry criteria exclusion|0
1248085|NCT00594568|4092562|P3|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6
1248086|NCT00594568|4092563|P2|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
1248087|NCT00594568|4092564|P1|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
1248088|NCT00594568|4092562|P3|Initial Treatment|Caregiver decision|36
1248089|NCT00594568|4092563|P2|Initial Treatment|Caregiver decision|36
1248090|NCT00594568|4092564|P1|Initial Treatment|Caregiver decision|21
1248091|NCT00594568|4092562|P3|Initial Treatment|Sponsor decision|147
1248092|NCT00594568|4092563|P2|Initial Treatment|Sponsor decision|142
1248093|NCT00594568|4092564|P1|Initial Treatment|Sponsor decision|193
1248094|NCT00594568|4092562|P3|Initial Treatment|Withdrawal by Subject|46
1248095|NCT00594568|4092563|P2|Initial Treatment|Withdrawal by Subject|31
1248096|NCT00594568|4092564|P1|Initial Treatment|Withdrawal by Subject|25
1248097|NCT00594568|4092562|P3|Initial Treatment|Protocol Violation|5
1248098|NCT00594568|4092563|P2|Initial Treatment|Protocol Violation|2
1248099|NCT00594568|4092564|P1|Initial Treatment|Protocol Violation|2
1248100|NCT00594568|4092562|P3|Initial Treatment|Physician Decision|4
1248101|NCT00594568|4092563|P2|Initial Treatment|Physician Decision|2
1248102|NCT00594568|4092564|P1|Initial Treatment|Physician Decision|3
1248103|NCT00594568|4092562|P3|Initial Treatment|Lost to Follow-up|4
1248104|NCT00594568|4092563|P2|Initial Treatment|Lost to Follow-up|1
1248105|NCT00594568|4092564|P1|Initial Treatment|Lost to Follow-up|4
1248106|NCT00594568|4092562|P3|Initial Treatment|Death|15
1248107|NCT00594568|4092563|P2|Initial Treatment|Death|11
1248108|NCT00594568|4092564|P1|Initial Treatment|Death|6
1248109|NCT00594568|4092562|P3|Initial Treatment|Adverse Event|144
1248110|NCT00594568|4092563|P2|Initial Treatment|Adverse Event|121
1248111|NCT00594568|4092564|P1|Initial Treatment|Adverse Event|51
1248112|NCT00594516|4092652|P3|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2
1248113|NCT00594516|4092653|P2|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
1248114|NCT00594516|4092654|P1|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
1248115|NCT00594516|4092652|P3|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
1248116|NCT00594516|4092653|P2|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
1248117|NCT00594516|4092654|P1|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0
1248118|NCT00594516|4092652|P3|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2
1248119|NCT00594516|4092653|P2|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3
1248120|NCT00594516|4092654|P1|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0
1248121|NCT00594516|4092652|P3|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
1248122|NCT00594516|4092653|P2|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
1248123|NCT00594516|4092654|P1|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0
1248124|NCT00594516|4092652|P3|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
1248125|NCT00594516|4092653|P2|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
1248126|NCT00594516|4092654|P1|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6
1248127|NCT00594516|4092652|P3|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
1248128|NCT00594516|4092653|P2|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
1248129|NCT00594516|4092654|P1|Open Label (OL): Tapentadol IR|Lack of Efficacy|1
1248130|NCT00594516|4092652|P3|Open Label (OL): Tapentadol IR|Adverse Event|0
1248131|NCT00594516|4092653|P2|Open Label (OL): Tapentadol IR|Adverse Event|0
1248132|NCT00594516|4092654|P1|Open Label (OL): Tapentadol IR|Adverse Event|16
1248133|NCT00594516|4092652|P3|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
1248134|NCT00594516|4092653|P2|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
1248135|NCT00594516|4092654|P1|Open Label (OL): Tapentadol IR|Lost to Follow-up|2
1248136|NCT00594516|4092652|P3|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
1248137|NCT00594516|4092653|P2|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
1248138|NCT00594516|4092654|P1|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4
1248139|NCT00594464|4092662|P1|Overall Study|Delay in operation|2
1248140|NCT00594464|4092662|P1|Overall Study|Withdrawal by Subject|1
1248141|NCT00594399|4092791|P3|Rerandomization Arm 1 Only|Withdrawal by Subject|0
1248142|NCT00594399|4092792|P2|Rerandomization Arm 1 Only|Withdrawal by Subject|3
1248143|NCT00594399|4092793|P1|Rerandomization Arm 1 Only|Withdrawal by Subject|0
1248144|NCT00594399|4092791|P3|Rerandomization Arm 1 Only|Death|0
1248145|NCT00594399|4092792|P2|Rerandomization Arm 1 Only|Death|1
1248146|NCT00594399|4092793|P1|Rerandomization Arm 1 Only|Death|2
1248147|NCT00594399|4092791|P3|Initial 3 Month Counseling|Family illness|0
1248148|NCT00594399|4092792|P2|Initial 3 Month Counseling|Family illness|0
1248149|NCT00594399|4092793|P1|Initial 3 Month Counseling|Family illness|1
1248150|NCT00594399|4092791|P3|Initial 3 Month Counseling|Moved|0
1248151|NCT00594399|4092792|P2|Initial 3 Month Counseling|Moved|0
1248152|NCT00594399|4092793|P1|Initial 3 Month Counseling|Moved|1
1248153|NCT00594399|4092791|P3|Initial 3 Month Counseling|Pain|0
1248154|NCT00594399|4092792|P2|Initial 3 Month Counseling|Pain|0
1248155|NCT00594399|4092793|P1|Initial 3 Month Counseling|Pain|2
1248156|NCT00594399|4092791|P3|Initial 3 Month Counseling|Too busy|0
1248157|NCT00594399|4092792|P2|Initial 3 Month Counseling|Too busy|1
1248158|NCT00594399|4092793|P1|Initial 3 Month Counseling|Too busy|7
1248159|NCT00594399|4092791|P3|Initial 3 Month Counseling|Personal issues|0
1248160|NCT00594399|4092792|P2|Initial 3 Month Counseling|Personal issues|0
1248161|NCT00594399|4092793|P1|Initial 3 Month Counseling|Personal issues|2
1248162|NCT00594399|4092791|P3|Initial 3 Month Counseling|Lack of Interest|0
1248163|NCT00594399|4092792|P2|Initial 3 Month Counseling|Lack of Interest|3
1248164|NCT00594399|4092793|P1|Initial 3 Month Counseling|Lack of Interest|3
1248165|NCT00594399|4092791|P3|Initial 3 Month Counseling|Not ready to exercise|0
1248166|NCT00594399|4092792|P2|Initial 3 Month Counseling|Not ready to exercise|0
1248167|NCT00594399|4092793|P1|Initial 3 Month Counseling|Not ready to exercise|1
1248168|NCT00594386|4092815|P1|Overall Study|Other: Loss of drivers license|1
1248169|NCT00594386|4092815|P1|Overall Study|Other: Patient wants prescription Neupro|1
1248170|NCT00594386|4092815|P1|Overall Study|Other: Site terminated participation|1
1248171|NCT00594386|4092815|P1|Overall Study|Other: Sponsor closure of study|1
1248172|NCT00594386|4092815|P1|Overall Study|Other: Study terminated per investigator|2
1248173|NCT00594386|4092815|P1|Overall Study|Other: Subject admitted to nursing home|1
1248174|NCT00594386|4092815|P1|Overall Study|Other: Subject moved to Seattle|1
1248175|NCT00594386|4092815|P1|Overall Study|Other: Patient went off patch (hospital)|1
1248176|NCT00594386|4092815|P1|Overall Study|Lost to Follow-up|6
1248177|NCT00594386|4092815|P1|Overall Study|Study ended per sponsor|115
1248178|NCT00594386|4092815|P1|Overall Study|Subject withdrew consent|35
1248179|NCT00594386|4092815|P1|Overall Study|Unsatisfactory compliance of subject|11
1248180|NCT00594386|4092815|P1|Overall Study|Adverse Event|68
1248181|NCT00594386|4092815|P1|Overall Study|Lack of Efficacy|12
1248182|NCT00594386|4092815|P1|Overall Study|Major protocol violation|2
1248183|NCT00594204|4092848|P2|Overall Study|Randomized but not treated|1
1248184|NCT00594204|4092849|P1|Overall Study|Randomized but not treated|4
1248185|NCT00594204|4092848|P2|Overall Study|Lack of Efficacy|4
1248186|NCT00594204|4092849|P1|Overall Study|Lack of Efficacy|3
1248187|NCT00594204|4092848|P2|Overall Study|Other|3
1248188|NCT00594204|4092849|P1|Overall Study|Other|4
1248189|NCT00594204|4092848|P2|Overall Study|Withdrawal by Subject|29
1248190|NCT00594204|4092849|P1|Overall Study|Withdrawal by Subject|23
1248191|NCT00594204|4092848|P2|Overall Study|Lost to Follow-up|5
1248192|NCT00594204|4092849|P1|Overall Study|Lost to Follow-up|9
1248193|NCT00594204|4092848|P2|Overall Study|Adverse Event|3
1248194|NCT00594204|4092849|P1|Overall Study|Adverse Event|15
1248195|NCT00594178|4092859|P1|Overall Study|Physician Decision|5
1248196|NCT00594165|4092864|P1|Overall Study|Other: Site terminated participation|2
1248197|NCT00594165|4092864|P1|Overall Study|Other: Subject enrolled in other trial|1
1248198|NCT00594165|4092864|P1|Overall Study|Other: House bound; can't get to clinic|1
1248199|NCT00594165|4092864|P1|Overall Study|Other: Brain surgery controlled symptoms|1
1248200|NCT00594165|4092864|P1|Overall Study|Other: Subject moving|3
1248201|NCT00594165|4092864|P1|Overall Study|Other: PI discretion|5
1248202|NCT00594165|4092864|P1|Overall Study|Lost to Follow-up|4
1248203|NCT00594165|4092864|P1|Overall Study|Study ended per sponsor|102
1248204|NCT00594165|4092864|P1|Overall Study|Subject withdrew consent|27
1248205|NCT00594165|4092864|P1|Overall Study|Unsatisfactory compliance of subject|6
1248206|NCT00594165|4092864|P1|Overall Study|Adverse Event|52
1248207|NCT00594165|4092864|P1|Overall Study|Lack of Efficacy|12
1248208|NCT00594165|4092864|P1|Overall Study|Major protocol violation|1
1248209|NCT00594100|4092870|P1|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4
1248210|NCT00594100|4092870|P1|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6
1248211|NCT00594100|4092870|P1|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2
1248212|NCT00594100|4092870|P1|Procedure|Technical Failure|9
1248213|NCT00594035|4092886|P2|Overall Study|Subject couldn't return due to job|1
1248214|NCT00594035|4092887|P1|Overall Study|Subject couldn't return due to job|0
1248215|NCT00594035|4092886|P2|Overall Study|Subject transferred to nursing home|1
1248216|NCT00594035|4092887|P1|Overall Study|Subject transferred to nursing home|0
1248217|NCT00594035|4092886|P2|Overall Study|Withdrawal by Subject|0
1248218|NCT00594035|4092887|P1|Overall Study|Withdrawal by Subject|1
1248219|NCT00594035|4092886|P2|Overall Study|Lost to Follow-up|1
1248220|NCT00594035|4092887|P1|Overall Study|Lost to Follow-up|1
1248221|NCT00593957|4092913|P3|Overall Study|Physician Decision|2
1248222|NCT00593957|4092914|P2|Overall Study|Physician Decision|1
1248223|NCT00593957|4092915|P1|Overall Study|Physician Decision|0
1248224|NCT00593918|4092939|P2|Overall Study|Withdrawal by Subject|24
1248225|NCT00593918|4092940|P1|Overall Study|Withdrawal by Subject|5
1248226|NCT00593840|4092953|P1|Overall Study|Withdrawal by Subject|1
1248227|NCT00593827|4092965|P2|Overall Study|On Active Treatment/Pending|2
1248228|NCT00593827|4092966|P1|Overall Study|On Active Treatment/Pending|0
1248229|NCT00593814|4092990|P2|Overall Study|Physician Decision|0
1248230|NCT00593814|4092991|P1|Overall Study|Physician Decision|3
1248231|NCT00593814|4092990|P2|Overall Study|Lost to Follow-up|0
1248232|NCT00593814|4092991|P1|Overall Study|Lost to Follow-up|7
1248233|NCT00593814|4092990|P2|Overall Study|Withdrawal by Subject|0
1248234|NCT00593814|4092991|P1|Overall Study|Withdrawal by Subject|7
1248235|NCT00593814|4092990|P2|Overall Study|Death|0
1248236|NCT00593814|4092991|P1|Overall Study|Death|7
1248237|NCT00593736|4093003|P4|Treatment Period and Placebo Run-out|Various|0
1248238|NCT00593736|4093004|P3|Treatment Period and Placebo Run-out|Various|1
1248239|NCT00593736|4093005|P2|Treatment Period and Placebo Run-out|Various|1
1248240|NCT00593736|4093006|P1|Treatment Period and Placebo Run-out|Various|1
1248241|NCT00593736|4093003|P4|Treatment Period and Placebo Run-out|Withdrawal by Subject|3
1248242|NCT00593736|4093004|P3|Treatment Period and Placebo Run-out|Withdrawal by Subject|1
1248243|NCT00593736|4093005|P2|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
1248244|NCT00593736|4093006|P1|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
1248245|NCT00593736|4093003|P4|Treatment Period and Placebo Run-out|Protocol Violation|1
1248246|NCT00593736|4093004|P3|Treatment Period and Placebo Run-out|Protocol Violation|1
1248247|NCT00593736|4093005|P2|Treatment Period and Placebo Run-out|Protocol Violation|0
1248248|NCT00593736|4093006|P1|Treatment Period and Placebo Run-out|Protocol Violation|0
1248249|NCT00593736|4093003|P4|Treatment Period and Placebo Run-out|Lost to Follow-up|0
1248250|NCT00593736|4093004|P3|Treatment Period and Placebo Run-out|Lost to Follow-up|2
1248251|NCT00593736|4093005|P2|Treatment Period and Placebo Run-out|Lost to Follow-up|1
1248252|NCT00593736|4093006|P1|Treatment Period and Placebo Run-out|Lost to Follow-up|2
1248253|NCT00593736|4093003|P4|Screening Period and Placebo Run-in|Various|25
1248254|NCT00593736|4093004|P3|Screening Period and Placebo Run-in|Various|0
1248255|NCT00593736|4093005|P2|Screening Period and Placebo Run-in|Various|0
1248256|NCT00593736|4093006|P1|Screening Period and Placebo Run-in|Various|0
1248257|NCT00593736|4093003|P4|Screening Period and Placebo Run-in|Did Not Meet Criteria|322
1248258|NCT00593736|4093004|P3|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
1248259|NCT00593736|4093005|P2|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
1248260|NCT00593736|4093006|P1|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
1248261|NCT00593736|4093003|P4|Screening Period and Placebo Run-in|Study Termination|15
1248262|NCT00593736|4093004|P3|Screening Period and Placebo Run-in|Study Termination|0
1248263|NCT00593736|4093005|P2|Screening Period and Placebo Run-in|Study Termination|0
1248264|NCT00593736|4093006|P1|Screening Period and Placebo Run-in|Study Termination|0
1248265|NCT00593736|4093003|P4|Screening Period and Placebo Run-in|Withdrawal by Subject|43
1248266|NCT00593736|4093004|P3|Screening Period and Placebo Run-in|Withdrawal by Subject|0
1248267|NCT00593736|4093005|P2|Screening Period and Placebo Run-in|Withdrawal by Subject|0
1248268|NCT00593736|4093006|P1|Screening Period and Placebo Run-in|Withdrawal by Subject|0
1248269|NCT00593736|4093003|P4|Screening Period and Placebo Run-in|Lost to Follow-up|9
1248270|NCT00593736|4093004|P3|Screening Period and Placebo Run-in|Lost to Follow-up|0
1248271|NCT00593736|4093005|P2|Screening Period and Placebo Run-in|Lost to Follow-up|0
1248272|NCT00593736|4093006|P1|Screening Period and Placebo Run-in|Lost to Follow-up|0
1248273|NCT00593736|4093003|P4|Screening Period and Placebo Run-in|Adverse Event|3
1248274|NCT00593736|4093004|P3|Screening Period and Placebo Run-in|Adverse Event|0
1248275|NCT00593736|4093005|P2|Screening Period and Placebo Run-in|Adverse Event|0
1248276|NCT00593736|4093006|P1|Screening Period and Placebo Run-in|Adverse Event|0
1248277|NCT00593684|4093254|P2|Overall Study|Death|1
1248278|NCT00593684|4093255|P1|Overall Study|Death|2
1248279|NCT00593606|4093281|P1|Overall Study|Screen Failure|3
1248280|NCT00593606|4093281|P1|Overall Study|Run-In Failure|5
1248281|NCT00593606|4093281|P1|Overall Study|Lost to Follow-up|2
1248282|NCT00593606|4093281|P1|Overall Study|Protocol Violation|3
1248283|NCT00593606|4093281|P1|Overall Study|Withdrawal by Subject|1
1248284|NCT00593606|4093281|P1|Overall Study|Adverse Event|13
1248285|NCT00593554|4093379|P2|Overall Study|Disease Progression|2
1248286|NCT00593554|4093380|P1|Overall Study|Disease Progression|1
1248287|NCT00593554|4093379|P2|Overall Study|Withdrawal by Subject|0
1248288|NCT00593554|4093380|P1|Overall Study|Withdrawal by Subject|1
1248289|NCT00593554|4093379|P2|Overall Study|Physician Decision|1
1248290|NCT00593554|4093380|P1|Overall Study|Physician Decision|0
1248291|NCT00593554|4093379|P2|Overall Study|Death|2
1248292|NCT00593554|4093380|P1|Overall Study|Death|1
1248293|NCT00593385|4093475|P1|Overall Study|Withdrawal by Subject|9
1248294|NCT00593385|4093475|P1|Overall Study|Lost to Follow-up|17
1248295|NCT00593385|4093475|P1|Overall Study|Death|14
1248296|NCT00593333|4093536|P2|Overall Study|Lost to Follow-up|11
1248297|NCT00593333|4093537|P1|Overall Study|Lost to Follow-up|10
1248298|NCT00593112|4093560|P2|Overall Study|Withdrawal by Subject|0
1248299|NCT00593112|4093561|P1|Overall Study|Withdrawal by Subject|5
1248300|NCT00593112|4093560|P2|Overall Study|Unreadable Scan|0
1248301|NCT00593112|4093561|P1|Overall Study|Unreadable Scan|1
1248302|NCT00593112|4093560|P2|Overall Study|Abnormal Scan|0
1248303|NCT00593112|4093561|P1|Overall Study|Abnormal Scan|1
1248304|NCT00593112|4093560|P2|Overall Study|Scan Anxiety|0
1248305|NCT00593112|4093561|P1|Overall Study|Scan Anxiety|3
1248306|NCT00592904|4093588|P4|Overall Study|Not specified|0
1248307|NCT00592904|4093589|P3|Overall Study|Not specified|0
1248308|NCT00592904|4093590|P2|Overall Study|Not specified|3
1248309|NCT00592904|4093591|P1|Overall Study|Not specified|3
1248310|NCT00592904|4093588|P4|Overall Study|Physician Decision|0
1248311|NCT00592904|4093589|P3|Overall Study|Physician Decision|1
1248312|NCT00592904|4093590|P2|Overall Study|Physician Decision|3
1248313|NCT00592904|4093591|P1|Overall Study|Physician Decision|0
1248314|NCT00592904|4093588|P4|Overall Study|Lack of Efficacy|3
1248315|NCT00592904|4093589|P3|Overall Study|Lack of Efficacy|2
1248316|NCT00592904|4093590|P2|Overall Study|Lack of Efficacy|7
1248317|NCT00592904|4093591|P1|Overall Study|Lack of Efficacy|2
1248318|NCT00592904|4093588|P4|Overall Study|Withdrawal by Subject|2
1248319|NCT00592904|4093589|P3|Overall Study|Withdrawal by Subject|1
1248320|NCT00592904|4093590|P2|Overall Study|Withdrawal by Subject|16
1248321|NCT00592904|4093591|P1|Overall Study|Withdrawal by Subject|4
1248322|NCT00592904|4093588|P4|Overall Study|Protocol Violation|1
1248323|NCT00592904|4093589|P3|Overall Study|Protocol Violation|0
1248324|NCT00592904|4093590|P2|Overall Study|Protocol Violation|1
1248325|NCT00592904|4093591|P1|Overall Study|Protocol Violation|1
1248326|NCT00592904|4093588|P4|Overall Study|Adverse Event|5
1248327|NCT00592904|4093589|P3|Overall Study|Adverse Event|13
1248328|NCT00592904|4093590|P2|Overall Study|Adverse Event|25
1248329|NCT00592904|4093591|P1|Overall Study|Adverse Event|15
1248330|NCT00592852|4093617|P1|Overall Study|Withdrawal by Subject|1
1248331|NCT00592852|4093617|P1|Overall Study|Found ineligible|1
1248332|NCT00592852|4093617|P1|Overall Study|Adverse Event|3
1248333|NCT00592852|4093617|P1|Overall Study|Non-compliance|1
1248334|NCT00592839|4093625|P3|Overall Study|Lost to Follow-up|1
1248335|NCT00592839|4093626|P2|Overall Study|Lost to Follow-up|1
1248336|NCT00592839|4093627|P1|Overall Study|Lost to Follow-up|0
1248337|NCT00592839|4093625|P3|Overall Study|Adverse Event|0
1248338|NCT00592839|4093626|P2|Overall Study|Adverse Event|1
1248339|NCT00592839|4093627|P1|Overall Study|Adverse Event|0
1248340|NCT00592839|4093625|P3|Overall Study|Protocol Violation|2
1248341|NCT00592839|4093626|P2|Overall Study|Protocol Violation|1
1248342|NCT00592839|4093627|P1|Overall Study|Protocol Violation|1
1248343|NCT00592839|4093625|P3|Overall Study|Withdrawal by Subject|3
1248344|NCT00592839|4093626|P2|Overall Study|Withdrawal by Subject|1
1248345|NCT00592839|4093627|P1|Overall Study|Withdrawal by Subject|1
1248346|NCT00592774|4093655|P5|Overall Study|Not specified|2
1248347|NCT00592774|4093656|P4|Overall Study|Not specified|0
1248348|NCT00592774|4093657|P3|Overall Study|Not specified|1
1248349|NCT00592774|4093658|P2|Overall Study|Not specified|1
1248350|NCT00592774|4093659|P1|Overall Study|Not specified|0
1248351|NCT00592774|4093655|P5|Overall Study|Physician Decision|1
1248352|NCT00592774|4093656|P4|Overall Study|Physician Decision|0
1248353|NCT00592774|4093657|P3|Overall Study|Physician Decision|1
1248354|NCT00592774|4093658|P2|Overall Study|Physician Decision|1
1248355|NCT00592774|4093659|P1|Overall Study|Physician Decision|0
1248356|NCT00592774|4093655|P5|Overall Study|Lack of Efficacy|2
1248357|NCT00592774|4093656|P4|Overall Study|Lack of Efficacy|0
1248358|NCT00592774|4093657|P3|Overall Study|Lack of Efficacy|0
1248359|NCT00592774|4093658|P2|Overall Study|Lack of Efficacy|3
1248360|NCT00592774|4093659|P1|Overall Study|Lack of Efficacy|3
1248361|NCT00592774|4093655|P5|Overall Study|Withdrawal by Subject|0
1248362|NCT00592774|4093656|P4|Overall Study|Withdrawal by Subject|0
1248363|NCT00592774|4093657|P3|Overall Study|Withdrawal by Subject|0
1248364|NCT00592774|4093658|P2|Overall Study|Withdrawal by Subject|7
1248365|NCT00592774|4093659|P1|Overall Study|Withdrawal by Subject|3
1248366|NCT00592774|4093655|P5|Overall Study|Protocol Violation|1
1248367|NCT00592774|4093656|P4|Overall Study|Protocol Violation|0
1248368|NCT00592774|4093657|P3|Overall Study|Protocol Violation|0
1248369|NCT00592774|4093658|P2|Overall Study|Protocol Violation|1
1248370|NCT00592774|4093659|P1|Overall Study|Protocol Violation|0
1248371|NCT00592774|4093655|P5|Overall Study|Adverse Event|8
1248372|NCT00592774|4093656|P4|Overall Study|Adverse Event|14
1248373|NCT00592774|4093657|P3|Overall Study|Adverse Event|2
1248374|NCT00592774|4093658|P2|Overall Study|Adverse Event|19
1248375|NCT00592774|4093659|P1|Overall Study|Adverse Event|5
1248376|NCT00592683|4093731|P2|Overall Study|Lost to Follow-up|1
1248377|NCT00592683|4093732|P1|Overall Study|Lost to Follow-up|0
1248378|NCT00592683|4093731|P2|Overall Study|Other|0
1248379|NCT00592683|4093732|P1|Overall Study|Other|1
1248380|NCT00592683|4093731|P2|Overall Study|Study drug expired|0
1248381|NCT00592683|4093732|P1|Overall Study|Study drug expired|1
1248382|NCT00592683|4093731|P2|Overall Study|Protocol Violation|0
1248383|NCT00592683|4093732|P1|Overall Study|Protocol Violation|1
1248384|NCT00592683|4093731|P2|Overall Study|Adverse Event|2
1248385|NCT00592683|4093732|P1|Overall Study|Adverse Event|0
1248386|NCT00592683|4093731|P2|Overall Study|Withdrawal by Subject|0
1248387|NCT00592683|4093732|P1|Overall Study|Withdrawal by Subject|1
1248388|NCT00592683|4093731|P2|Overall Study|Found ineligible|1
1248389|NCT00592683|4093732|P1|Overall Study|Found ineligible|0
1248390|NCT00592631|4093742|P2|Overall Study|Lost to Follow-up|2
1248391|NCT00592631|4093743|P1|Overall Study|Lost to Follow-up|0
1248392|NCT00592384|4093792|P2|Overall Study|Withdrawal by Subject|6
1248393|NCT00592384|4093793|P1|Overall Study|Withdrawal by Subject|5
1248394|NCT00592358|4093801|P1|Overall Study|Inability to swallow pills|1
1248395|NCT00592358|4093801|P1|Overall Study|Lack of Efficacy|2
1248396|NCT00592358|4093801|P1|Overall Study|Adverse Event|1
1248397|NCT00592358|4093801|P1|Overall Study|Withdrawal by Subject|2
1248398|NCT00592319|4093808|P2|Overall Study|Lost to Follow-up|3
1248399|NCT00592319|4093809|P1|Overall Study|Lost to Follow-up|0
1248400|NCT00592072|4093884|P2|Wash Out Period|Lost to Follow-up|1
1248401|NCT00592072|4093885|P1|Wash Out Period|Lost to Follow-up|1
1248402|NCT00592007|4093907|P1|Overall Study|patient ineligible (out of lab range)|1
1248403|NCT00592007|4093907|P1|Overall Study|Withdrawal by Subject|1
1248404|NCT00591864|4093919|P1|Overall Study|Incomplete Imaging|5
1248405|NCT00591851|4093925|P1|Overall Study|Progressive Disease|1
1248406|NCT00591851|4093925|P1|Overall Study|Adverse Event|2
1248407|NCT00591851|4093925|P1|Overall Study|Withdrawal by Subject|3
1248408|NCT00591773|4093965|P3|Overall Study|Other|4
1248409|NCT00591773|4093966|P2|Overall Study|Other|1
1248410|NCT00591773|4093967|P1|Overall Study|Other|1
1248411|NCT00591773|4093965|P3|Overall Study|Lack of Efficacy|2
1248412|NCT00591773|4093966|P2|Overall Study|Lack of Efficacy|2
1248413|NCT00591773|4093967|P1|Overall Study|Lack of Efficacy|1
1248414|NCT00591773|4093965|P3|Overall Study|Withdrawal by Subject|3
1248415|NCT00591773|4093966|P2|Overall Study|Withdrawal by Subject|5
1248416|NCT00591773|4093967|P1|Overall Study|Withdrawal by Subject|2
1248417|NCT00591773|4093965|P3|Overall Study|Lost to Follow-up|1
1248418|NCT00591773|4093966|P2|Overall Study|Lost to Follow-up|4
1248419|NCT00591773|4093967|P1|Overall Study|Lost to Follow-up|1
1248420|NCT00591773|4093965|P3|Overall Study|Protocol Violation|0
1248421|NCT00591773|4093966|P2|Overall Study|Protocol Violation|3
1248422|NCT00591773|4093967|P1|Overall Study|Protocol Violation|2
1248423|NCT00591773|4093965|P3|Overall Study|Adverse Event|6
1248424|NCT00591773|4093966|P2|Overall Study|Adverse Event|9
1248425|NCT00591773|4093967|P1|Overall Study|Adverse Event|9
1248426|NCT00591734|4094026|P1|Overall Study|Intercurrent Illness|8
1248427|NCT00591734|4094026|P1|Overall Study|Physician Decision|5
1248428|NCT00591734|4094026|P1|Overall Study|Adverse Event|5
1248429|NCT00591734|4094026|P1|Overall Study|Lack of Efficacy|35
1248430|NCT00591721|4094032|P2|Overall Study|Intervention not received|8
1248431|NCT00591721|4094033|P1|Overall Study|Intervention not received|10
1248432|NCT00591721|4094032|P2|Overall Study|Lost to Follow-up|4
1248433|NCT00591721|4094033|P1|Overall Study|Lost to Follow-up|1
1248434|NCT00591721|4094032|P2|Overall Study|Withdrawal by Subject|10
1248435|NCT00591721|4094033|P1|Overall Study|Withdrawal by Subject|10
1248436|NCT00591591|4094041|P2|Overall Study|Lack of Efficacy|2
1248437|NCT00591591|4094042|P1|Overall Study|Lack of Efficacy|10
1248438|NCT00591591|4094041|P2|Overall Study|Withdrawal by Subject|37
1248439|NCT00591591|4094042|P1|Overall Study|Withdrawal by Subject|1
1248440|NCT00591578|4094059|P3|Open-Label Extension Phase|Other|0
1248441|NCT00591578|4094060|P2|Open-Label Extension Phase|Other|0
1248442|NCT00591578|4094061|P1|Open-Label Extension Phase|Other|1
1248443|NCT00591578|4094059|P3|Open-Label Extension Phase|Withdrawal by Subject|0
1248444|NCT00591578|4094060|P2|Open-Label Extension Phase|Withdrawal by Subject|1
1248445|NCT00591578|4094061|P1|Open-Label Extension Phase|Withdrawal by Subject|1
1248446|NCT00591578|4094059|P3|Open-Label Extension Phase|Lost to Follow-up|0
1248447|NCT00591578|4094060|P2|Open-Label Extension Phase|Lost to Follow-up|4
1248448|NCT00591578|4094061|P1|Open-Label Extension Phase|Lost to Follow-up|1
1248449|NCT00591578|4094059|P3|Open-Label Extension Phase|Adverse Event|0
1248450|NCT00591578|4094060|P2|Open-Label Extension Phase|Adverse Event|5
1248451|NCT00591578|4094061|P1|Open-Label Extension Phase|Adverse Event|3
1248452|NCT00591578|4094059|P3|Double-Blind Treatment Phase|Other|4
1248453|NCT00591578|4094060|P2|Double-Blind Treatment Phase|Other|9
1248454|NCT00591578|4094061|P1|Double-Blind Treatment Phase|Other|4
1248455|NCT00591578|4094059|P3|Double-Blind Treatment Phase|Lack of Efficacy|25
1248456|NCT00591578|4094060|P2|Double-Blind Treatment Phase|Lack of Efficacy|9
1248457|NCT00591578|4094061|P1|Double-Blind Treatment Phase|Lack of Efficacy|16
1248458|NCT00591578|4094059|P3|Double-Blind Treatment Phase|Pregnancy|0
1248459|NCT00591578|4094060|P2|Double-Blind Treatment Phase|Pregnancy|0
1248460|NCT00591578|4094061|P1|Double-Blind Treatment Phase|Pregnancy|1
1248461|NCT00591578|4094059|P3|Double-Blind Treatment Phase|Withdrawal by Subject|22
1248462|NCT00591578|4094060|P2|Double-Blind Treatment Phase|Withdrawal by Subject|22
1248463|NCT00591578|4094061|P1|Double-Blind Treatment Phase|Withdrawal by Subject|22
1248464|NCT00591578|4094059|P3|Double-Blind Treatment Phase|Lost to Follow-up|11
1248465|NCT00591578|4094060|P2|Double-Blind Treatment Phase|Lost to Follow-up|12
1248466|NCT00591578|4094061|P1|Double-Blind Treatment Phase|Lost to Follow-up|12
1248467|NCT00591578|4094059|P3|Double-Blind Treatment Phase|Protocol Violation|3
1248468|NCT00591578|4094060|P2|Double-Blind Treatment Phase|Protocol Violation|2
1248469|NCT00591578|4094061|P1|Double-Blind Treatment Phase|Protocol Violation|3
1248470|NCT00591578|4094059|P3|Double-Blind Treatment Phase|Adverse Event|19
1248471|NCT00591578|4094060|P2|Double-Blind Treatment Phase|Adverse Event|26
1248472|NCT00591578|4094061|P1|Double-Blind Treatment Phase|Adverse Event|20
1248473|NCT00591565|4094112|P1|Overall Study|lost follow up, withdrawn|5
1248474|NCT00591370|4094116|P1|Overall Study|Not Treated|2
1248475|NCT00591344|4094124|P2|Overall Study|Did not want to come off medication|1
1248476|NCT00591344|4094125|P1|Overall Study|Did not want to come off medication|0
1248477|NCT00591344|4094124|P2|Overall Study|Lost to Follow-up|1
1248478|NCT00591344|4094125|P1|Overall Study|Lost to Follow-up|0
1248479|NCT00591344|4094124|P2|Overall Study|Death|1
1248480|NCT00591344|4094125|P1|Overall Study|Death|0
1248481|NCT00591344|4094124|P2|Overall Study|Underwent DBS|2
1248482|NCT00591344|4094125|P1|Overall Study|Underwent DBS|2
1248483|NCT00591344|4094124|P2|Overall Study|Medical complications|3
1248484|NCT00591344|4094125|P1|Overall Study|Medical complications|1
1248485|NCT00591344|4094124|P2|Overall Study|Moved out of state|0
1248486|NCT00591344|4094125|P1|Overall Study|Moved out of state|1
1248487|NCT00591344|4094124|P2|Overall Study|Transportation issues|0
1248488|NCT00591344|4094125|P1|Overall Study|Transportation issues|1
1248489|NCT00591266|4094151|P3|Overall Study|Other|5
1248490|NCT00591266|4094152|P2|Overall Study|Other|4
1248491|NCT00591266|4094153|P1|Overall Study|Other|1
1248492|NCT00591266|4094151|P3|Overall Study|Lack of Efficacy|0
1248493|NCT00591266|4094152|P2|Overall Study|Lack of Efficacy|2
1248494|NCT00591266|4094153|P1|Overall Study|Lack of Efficacy|0
1248495|NCT00591266|4094151|P3|Overall Study|Withdrawal by Subject|5
1248496|NCT00591266|4094152|P2|Overall Study|Withdrawal by Subject|2
1248497|NCT00591266|4094153|P1|Overall Study|Withdrawal by Subject|6
1248498|NCT00591266|4094151|P3|Overall Study|Protocol Violation|1
1248499|NCT00591266|4094152|P2|Overall Study|Protocol Violation|0
1248500|NCT00591266|4094153|P1|Overall Study|Protocol Violation|0
1248501|NCT00591266|4094151|P3|Overall Study|Lost to Follow-up|0
1248502|NCT00591266|4094152|P2|Overall Study|Lost to Follow-up|1
1248503|NCT00591266|4094153|P1|Overall Study|Lost to Follow-up|0
1248504|NCT00591266|4094151|P3|Overall Study|Adverse Event|3
1248505|NCT00591266|4094152|P2|Overall Study|Adverse Event|2
1248506|NCT00591266|4094153|P1|Overall Study|Adverse Event|2
1248507|NCT00591253|4094206|P3|Overall Study|Other|3
1248508|NCT00591253|4094207|P2|Overall Study|Other|5
1248509|NCT00591253|4094208|P1|Overall Study|Other|5
1248510|NCT00591253|4094206|P3|Overall Study|Lack of Efficacy|3
1248511|NCT00591253|4094207|P2|Overall Study|Lack of Efficacy|0
1248512|NCT00591253|4094208|P1|Overall Study|Lack of Efficacy|1
1248513|NCT00591253|4094206|P3|Overall Study|Withdrawal by Subject|6
1248514|NCT00591253|4094207|P2|Overall Study|Withdrawal by Subject|7
1248515|NCT00591253|4094208|P1|Overall Study|Withdrawal by Subject|1
1248516|NCT00591253|4094206|P3|Overall Study|Lost to Follow-up|0
1248517|NCT00591253|4094207|P2|Overall Study|Lost to Follow-up|4
1248518|NCT00591253|4094208|P1|Overall Study|Lost to Follow-up|2
1248519|NCT00591253|4094206|P3|Overall Study|Protocol Violation|2
1248520|NCT00591253|4094207|P2|Overall Study|Protocol Violation|2
1248521|NCT00591253|4094208|P1|Overall Study|Protocol Violation|2
1248522|NCT00591253|4094206|P3|Overall Study|Adverse Event|1
1248523|NCT00591253|4094207|P2|Overall Study|Adverse Event|3
1248524|NCT00591253|4094208|P1|Overall Study|Adverse Event|3
1248525|NCT00591214|4094276|P1|Overall Study|Withdrawal by Subject|1
1248526|NCT00591214|4094276|P1|Overall Study|Physician Decision|7
1248527|NCT00591149|4094285|P1|Overall Study|Withdrawal by Subject|1
1248528|NCT00591149|4094285|P1|Overall Study|Adverse Event|4
1248529|NCT00591006|4094301|P24|Overall Study|Adverse Event|0
1248530|NCT00591006|4094302|P23|Overall Study|Adverse Event|1
1248531|NCT00591006|4094303|P22|Overall Study|Adverse Event|0
1248532|NCT00591006|4094304|P21|Overall Study|Adverse Event|0
1248533|NCT00591006|4094305|P20|Overall Study|Adverse Event|0
1248534|NCT00591006|4094306|P19|Overall Study|Adverse Event|0
1248535|NCT00591006|4094307|P18|Overall Study|Adverse Event|0
1248536|NCT00591006|4094308|P17|Overall Study|Adverse Event|0
1248537|NCT00591006|4094309|P16|Overall Study|Adverse Event|0
1248538|NCT00591006|4094310|P15|Overall Study|Adverse Event|0
1248539|NCT00591006|4094311|P14|Overall Study|Adverse Event|0
1248540|NCT00591006|4094312|P13|Overall Study|Adverse Event|0
1248541|NCT00591006|4094313|P12|Overall Study|Adverse Event|0
1248542|NCT00591006|4094314|P11|Overall Study|Adverse Event|0
1248543|NCT00591006|4094315|P10|Overall Study|Adverse Event|0
1248544|NCT00591006|4094316|P9|Overall Study|Adverse Event|0
1248545|NCT00591006|4094317|P8|Overall Study|Adverse Event|0
1248546|NCT00591006|4094318|P7|Overall Study|Adverse Event|0
1248547|NCT00591006|4094319|P6|Overall Study|Adverse Event|0
1248548|NCT00591006|4094320|P5|Overall Study|Adverse Event|0
1248549|NCT00591006|4094321|P4|Overall Study|Adverse Event|0
1248550|NCT00591006|4094322|P3|Overall Study|Adverse Event|0
1248551|NCT00591006|4094323|P2|Overall Study|Adverse Event|0
1248552|NCT00591006|4094324|P1|Overall Study|Adverse Event|0
1248553|NCT00591006|4094301|P24|Overall Study|Withdrawal by Subject|1
1248554|NCT00591006|4094302|P23|Overall Study|Withdrawal by Subject|0
1248555|NCT00591006|4094303|P22|Overall Study|Withdrawal by Subject|0
1248556|NCT00591006|4094304|P21|Overall Study|Withdrawal by Subject|0
1248557|NCT00591006|4094305|P20|Overall Study|Withdrawal by Subject|0
1248558|NCT00591006|4094306|P19|Overall Study|Withdrawal by Subject|0
1248559|NCT00591006|4094307|P18|Overall Study|Withdrawal by Subject|0
1248560|NCT00591006|4094308|P17|Overall Study|Withdrawal by Subject|0
1248561|NCT00591006|4094309|P16|Overall Study|Withdrawal by Subject|1
1248562|NCT00591006|4094310|P15|Overall Study|Withdrawal by Subject|0
1248563|NCT00591006|4094311|P14|Overall Study|Withdrawal by Subject|0
1248564|NCT00591006|4094312|P13|Overall Study|Withdrawal by Subject|0
1248565|NCT00591006|4094313|P12|Overall Study|Withdrawal by Subject|0
1248566|NCT00591006|4094314|P11|Overall Study|Withdrawal by Subject|0
1248567|NCT00591006|4094315|P10|Overall Study|Withdrawal by Subject|0
1248568|NCT00591006|4094316|P9|Overall Study|Withdrawal by Subject|0
1248569|NCT00591006|4094317|P8|Overall Study|Withdrawal by Subject|0
1248570|NCT00591006|4094318|P7|Overall Study|Withdrawal by Subject|0
1248571|NCT00591006|4094319|P6|Overall Study|Withdrawal by Subject|0
1248572|NCT00591006|4094320|P5|Overall Study|Withdrawal by Subject|0
1248573|NCT00591006|4094321|P4|Overall Study|Withdrawal by Subject|0
1248574|NCT00591006|4094322|P3|Overall Study|Withdrawal by Subject|0
1248575|NCT00591006|4094323|P2|Overall Study|Withdrawal by Subject|0
1248576|NCT00591006|4094324|P1|Overall Study|Withdrawal by Subject|0
1248577|NCT00590980|4094342|P1|Overall Study|Did not meet all inclusion criteria|10
1248578|NCT00590967|4094348|P2|Overall Study|Did not receive chemo per protocol|0
1248579|NCT00590967|4094349|P1|Overall Study|Did not receive chemo per protocol|1
1248580|NCT00590967|4094348|P2|Overall Study|Did not sign consent form|1
1248581|NCT00590967|4094349|P1|Overall Study|Did not sign consent form|0
1248582|NCT00590967|4094348|P2|Overall Study|Non-compliant|2
1248583|NCT00590967|4094349|P1|Overall Study|Non-compliant|0
1248584|NCT00590967|4094348|P2|Overall Study|Poor performance status|1
1248585|NCT00590967|4094349|P1|Overall Study|Poor performance status|0
1248586|NCT00590967|4094348|P2|Overall Study|Ineligible|0
1248587|NCT00590967|4094349|P1|Overall Study|Ineligible|1
1248588|NCT00590967|4094348|P2|Overall Study|Withdrawal by Subject|1
1248589|NCT00590967|4094349|P1|Overall Study|Withdrawal by Subject|1
1248590|NCT00590902|4094361|P1|Overall Study|Death|1
1248591|NCT00590759|4094396|P1|Overall Study|Lost to Follow-up|28
1248592|NCT00590759|4094396|P1|Overall Study|Death|52
1248593|NCT00590720|4094403|P2|Overall Study|Withdrawal by Subject|1
1248594|NCT00590720|4094404|P1|Overall Study|Withdrawal by Subject|0
1248595|NCT00590720|4094403|P2|Overall Study|Lost to Follow-up|0
1248596|NCT00590720|4094404|P1|Overall Study|Lost to Follow-up|1
1248597|NCT00590590|4094466|P3|Overall Study|Did not complete study|0
1248598|NCT00590590|4094467|P2|Overall Study|Did not complete study|1
1248599|NCT00590590|4094468|P1|Overall Study|Did not complete study|0
1248600|NCT00590590|4094466|P3|Overall Study|Did not complete due to study closure|1
1248601|NCT00590590|4094467|P2|Overall Study|Did not complete due to study closure|1
1248602|NCT00590590|4094468|P1|Overall Study|Did not complete due to study closure|1
1248603|NCT00590590|4094466|P3|Overall Study|Withdrawal by Subject|1
1248604|NCT00590590|4094467|P2|Overall Study|Withdrawal by Subject|1
1248605|NCT00590590|4094468|P1|Overall Study|Withdrawal by Subject|0
1248606|NCT00590590|4094466|P3|Overall Study|Lost to Follow-up|2
1248607|NCT00590590|4094467|P2|Overall Study|Lost to Follow-up|1
1248608|NCT00590590|4094468|P1|Overall Study|Lost to Follow-up|4
1248609|NCT00590590|4094466|P3|Overall Study|Protocol Violation|2
1248610|NCT00590590|4094467|P2|Overall Study|Protocol Violation|0
1248611|NCT00590590|4094468|P1|Overall Study|Protocol Violation|0
1248612|NCT00590590|4094466|P3|Overall Study|Adverse Event|0
1248613|NCT00590590|4094467|P2|Overall Study|Adverse Event|0
1248614|NCT00590590|4094468|P1|Overall Study|Adverse Event|1
1248615|NCT00590590|4094466|P3|Overall Study|Lack of Efficacy|0
1248616|NCT00590590|4094467|P2|Overall Study|Lack of Efficacy|2
1248617|NCT00590590|4094468|P1|Overall Study|Lack of Efficacy|1
1248618|NCT00590577|4094495|P4|Overall Study|Various reasons|2
1248619|NCT00590577|4094496|P3|Overall Study|Various reasons|1
1248620|NCT00590577|4094497|P2|Overall Study|Various reasons|3
1248621|NCT00590577|4094498|P1|Overall Study|Various reasons|1
1248622|NCT00590577|4094495|P4|Overall Study|Pregnancy|0
1248623|NCT00590577|4094496|P3|Overall Study|Pregnancy|0
1248624|NCT00590577|4094497|P2|Overall Study|Pregnancy|1
1248625|NCT00590577|4094498|P1|Overall Study|Pregnancy|0
1248626|NCT00590577|4094495|P4|Overall Study|Lost to Follow-up|9
1248627|NCT00590577|4094496|P3|Overall Study|Lost to Follow-up|6
1248628|NCT00590577|4094497|P2|Overall Study|Lost to Follow-up|6
1248629|NCT00590577|4094498|P1|Overall Study|Lost to Follow-up|12
1248630|NCT00590577|4094495|P4|Overall Study|Adverse Event|11
1248631|NCT00590577|4094496|P3|Overall Study|Adverse Event|13
1248632|NCT00590577|4094497|P2|Overall Study|Adverse Event|10
1248633|NCT00590577|4094498|P1|Overall Study|Adverse Event|10
1248634|NCT00590577|4094495|P4|Overall Study|Withdrawal by Subject|26
1248635|NCT00590577|4094496|P3|Overall Study|Withdrawal by Subject|30
1248636|NCT00590577|4094497|P2|Overall Study|Withdrawal by Subject|28
1248637|NCT00590577|4094498|P1|Overall Study|Withdrawal by Subject|23
1248638|NCT00590577|4094495|P4|Overall Study|Lack of Efficacy|45
1248639|NCT00590577|4094496|P3|Overall Study|Lack of Efficacy|23
1248640|NCT00590577|4094497|P2|Overall Study|Lack of Efficacy|28
1248641|NCT00590577|4094498|P1|Overall Study|Lack of Efficacy|31
1248642|NCT00590564|4094516|P1|Overall Study|Patient Non-compliance|6
1248643|NCT00590564|4094516|P1|Overall Study|Patient Found to be Ineligible|1
1248644|NCT00590564|4094516|P1|Overall Study|Protocol Violation|1
1248645|NCT00590564|4094516|P1|Overall Study|Lost to Follow-up|6
1248646|NCT00590564|4094516|P1|Overall Study|Withdrawal by Subject|4
1248647|NCT00590538|4094520|P1|Overall Study|Study terminated before completed|2
1248648|NCT00590317|4094562|P2|Overall Study|Lack of Efficacy|5
1248649|NCT00590317|4094563|P1|Overall Study|Lack of Efficacy|1
1248650|NCT00590135|4094593|P1|Overall Study|Primary endpoint measure not obtainable|59
1248651|NCT00590044|4094603|P2|Overall Study|Protocol Violation|0
1248652|NCT00590044|4094604|P1|Overall Study|Protocol Violation|1
1248653|NCT00590044|4094603|P2|Overall Study|wrong insulin arm assigned|0
1248654|NCT00590044|4094604|P1|Overall Study|wrong insulin arm assigned|1
1248655|NCT00590044|4094603|P2|Overall Study|Withdrawal by Subject|2
1248656|NCT00590044|4094604|P1|Overall Study|Withdrawal by Subject|2
1248657|NCT00590031|4094616|P1|Overall Study|Admin Hold|1
1248658|NCT00590031|4094616|P1|Overall Study|Metastatic Disease|1
1248659|NCT00590031|4094616|P1|Overall Study|Withdrawal by Subject|1
1248660|NCT00590031|4094616|P1|Overall Study|Adverse Event|3
1248661|NCT00589979|4094643|P3|Double-Blind Treatment Period 3|Withdrawal by Subject|1
1248662|NCT00589979|4094644|P2|Double-Blind Treatment Period 3|Withdrawal by Subject|0
1248663|NCT00589979|4094645|P1|Double-Blind Treatment Period 3|Withdrawal by Subject|0
1248664|NCT00589979|4094643|P3|Double-Blind Treatment Period 3|Protocol Violation|0
1248665|NCT00589979|4094644|P2|Double-Blind Treatment Period 3|Protocol Violation|1
1248666|NCT00589979|4094645|P1|Double-Blind Treatment Period 3|Protocol Violation|0
1248667|NCT00589979|4094643|P3|Double-Blind Treatment Period 2|Other|1
1248668|NCT00589979|4094644|P2|Double-Blind Treatment Period 2|Other|0
1248669|NCT00589979|4094645|P1|Double-Blind Treatment Period 2|Other|0
1248670|NCT00589979|4094643|P3|Double-Blind Treatment Period 2|Withdrawal by Subject|1
1248671|NCT00589979|4094644|P2|Double-Blind Treatment Period 2|Withdrawal by Subject|0
1248672|NCT00589979|4094645|P1|Double-Blind Treatment Period 2|Withdrawal by Subject|0
1248673|NCT00589979|4094643|P3|Double-Blind Treatment Period 2|Adverse Event|0
1248674|NCT00589979|4094644|P2|Double-Blind Treatment Period 2|Adverse Event|1
1248675|NCT00589979|4094645|P1|Double-Blind Treatment Period 2|Adverse Event|0
1248676|NCT00589979|4094643|P3|Double-Blind Treatment Period 1|Withdrawal by Subject|1
1248677|NCT00589979|4094644|P2|Double-Blind Treatment Period 1|Withdrawal by Subject|0
1248678|NCT00589979|4094645|P1|Double-Blind Treatment Period 1|Withdrawal by Subject|0
1248679|NCT00589979|4094643|P3|Double-Blind Treatment Period 1|Protocol Violation|1
1248680|NCT00589979|4094644|P2|Double-Blind Treatment Period 1|Protocol Violation|1
1248681|NCT00589979|4094645|P1|Double-Blind Treatment Period 1|Protocol Violation|0
1248682|NCT00589979|4094643|P3|Double-Blind Treatment Period 1|Adverse Event|0
1248683|NCT00589979|4094644|P2|Double-Blind Treatment Period 1|Adverse Event|1
1248684|NCT00589979|4094645|P1|Double-Blind Treatment Period 1|Adverse Event|0
1248685|NCT00589979|4094643|P3|Run-In Period|Informed Consent Withdrawn|0
1248686|NCT00589979|4094644|P2|Run-In Period|Informed Consent Withdrawn|0
1248687|NCT00589979|4094645|P1|Run-In Period|Informed Consent Withdrawn|4
1248688|NCT00589979|4094643|P3|Run-In Period|Withdrawal by Subject|0
1248689|NCT00589979|4094644|P2|Run-In Period|Withdrawal by Subject|0
1248690|NCT00589979|4094645|P1|Run-In Period|Withdrawal by Subject|10
1248691|NCT00589979|4094643|P3|Run-In Period|Did not qualify for randomization|0
1248692|NCT00589979|4094644|P2|Run-In Period|Did not qualify for randomization|0
1248693|NCT00589979|4094645|P1|Run-In Period|Did not qualify for randomization|54
1248694|NCT00589979|4094643|P3|Run-In Period|Protocol Violation|0
1248695|NCT00589979|4094644|P2|Run-In Period|Protocol Violation|0
1248696|NCT00589979|4094645|P1|Run-In Period|Protocol Violation|3
1248697|NCT00589979|4094643|P3|Run-In Period|Adverse Event|0
1248698|NCT00589979|4094644|P2|Run-In Period|Adverse Event|0
1248699|NCT00589979|4094645|P1|Run-In Period|Adverse Event|5
1248700|NCT00589914|4094684|P2|Overall Study|Other|17
1248701|NCT00589914|4094685|P1|Overall Study|Other|22
1248702|NCT00589914|4094684|P2|Overall Study|Withdrawal by Subject|49
1248703|NCT00589914|4094685|P1|Overall Study|Withdrawal by Subject|55
1248704|NCT00589914|4094684|P2|Overall Study|Pregnancy|0
1248705|NCT00589914|4094685|P1|Overall Study|Pregnancy|1
1248706|NCT00589914|4094684|P2|Overall Study|Lost to Follow-up|18
1248707|NCT00589914|4094685|P1|Overall Study|Lost to Follow-up|11
1248708|NCT00589914|4094684|P2|Overall Study|Lack of Efficacy|43
1248709|NCT00589914|4094685|P1|Overall Study|Lack of Efficacy|40
1248710|NCT00589914|4094684|P2|Overall Study|Death|0
1248711|NCT00589914|4094685|P1|Overall Study|Death|2
1248712|NCT00589914|4094684|P2|Overall Study|Adverse Event|10
1248713|NCT00589914|4094685|P1|Overall Study|Adverse Event|19
1248714|NCT00589797|4094741|P2|Overall Study|Non-Randomized Training Subjects|6
1248715|NCT00589797|4094742|P1|Overall Study|Non-Randomized Training Subjects|46
1248716|NCT00589797|4094741|P2|Overall Study|Withdrawal by Subject|5
1248717|NCT00589797|4094742|P1|Overall Study|Withdrawal by Subject|6
1248718|NCT00589797|4094741|P2|Overall Study|Physician Decision|3
1248719|NCT00589797|4094742|P1|Overall Study|Physician Decision|8
1248720|NCT00589797|4094741|P2|Overall Study|Lost to Follow-up|9
1248721|NCT00589797|4094742|P1|Overall Study|Lost to Follow-up|12
1248722|NCT00589797|4094741|P2|Overall Study|Death|0
1248723|NCT00589797|4094742|P1|Overall Study|Death|1
1248724|NCT00589784|4094766|P2|Overall Study|Adverse Event|4
1248725|NCT00589784|4094767|P1|Overall Study|Adverse Event|0
1248726|NCT00589784|4094766|P2|Overall Study|Patient inevaluable|0
1248727|NCT00589784|4094767|P1|Overall Study|Patient inevaluable|1
1248728|NCT00589784|4094766|P2|Overall Study|Withdrawal by Subject|6
1248729|NCT00589784|4094767|P1|Overall Study|Withdrawal by Subject|0
1248730|NCT00589693|4094774|P2|Overall Study|Protocol Violation|1
1248731|NCT00589693|4094775|P1|Overall Study|Protocol Violation|1
1248732|NCT00589693|4094774|P2|Overall Study|Physician Decision|1
1248733|NCT00589693|4094775|P1|Overall Study|Physician Decision|0
1248734|NCT00589693|4094774|P2|Overall Study|Lost to Follow-up|0
1248735|NCT00589693|4094775|P1|Overall Study|Lost to Follow-up|1
1248736|NCT00589693|4094774|P2|Overall Study|Lack of Efficacy|1
1248737|NCT00589693|4094775|P1|Overall Study|Lack of Efficacy|0
1248738|NCT00589693|4094774|P2|Overall Study|Death|16
1248739|NCT00589693|4094775|P1|Overall Study|Death|26
1248740|NCT00589693|4094774|P2|Overall Study|Adverse Event|4
1248741|NCT00589693|4094775|P1|Overall Study|Adverse Event|4
1248742|NCT00589693|4094774|P2|Overall Study|randomized in error|6
1248743|NCT00589693|4094775|P1|Overall Study|randomized in error|12
1248744|NCT00589667|4094789|P1|Overall Study|Withdrawal by Subject|1
1248745|NCT00589667|4094789|P1|Overall Study|Adverse Event|2
1248746|NCT00589628|4094796|P2|Overall Study|Lost to Follow-up|1
1248747|NCT00589628|4094797|P1|Overall Study|Lost to Follow-up|0
1248748|NCT00589602|4094803|P1|Overall Study|Did not collect enough CD34+ cells|1
1248749|NCT00589472|4094838|P1|Overall Study|Adverse Event|1
1248750|NCT00589303|4094850|P2|Overall Study|Withdrawal by Subject|1
1248751|NCT00589303|4094851|P1|Overall Study|Withdrawal by Subject|2
1248752|NCT00589290|4094857|P1|Overall Study|Withdrawal by Subject|1
1248753|NCT00589121|4094880|P2|Overall Study|No protocol treatment received|1
1248754|NCT00589121|4094881|P1|Overall Study|No protocol treatment received|0
1248755|NCT00589121|4094880|P2|Overall Study|Protocol Violation|6
1248756|NCT00589121|4094881|P1|Overall Study|Protocol Violation|2
1248757|NCT00589108|4094901|P3|Overall Study|Death|4
1248758|NCT00589108|4094902|P2|Overall Study|Death|3
1248759|NCT00589108|4094903|P1|Overall Study|Death|3
1248760|NCT00589108|4094901|P3|Overall Study|Lost to Follow-up|1
1248761|NCT00589108|4094902|P2|Overall Study|Lost to Follow-up|1
1248762|NCT00589108|4094903|P1|Overall Study|Lost to Follow-up|1
1248763|NCT00588952|4094933|P2|Overall Study|Withdrawal by Subject|5
1248764|NCT00588952|4094934|P1|Overall Study|Withdrawal by Subject|3
1248765|NCT00588952|4094933|P2|Overall Study|Adverse Event|2
1248766|NCT00588952|4094934|P1|Overall Study|Adverse Event|0
1248767|NCT00588861|4094962|P2|10 Years|Incomplete due to study termination|114
1248768|NCT00588861|4094963|P1|10 Years|Incomplete due to study termination|107
1248769|NCT00588861|4094962|P2|8 Years|Patients did not return for follow-up|114
1248770|NCT00588861|4094963|P1|8 Years|Patients did not return for follow-up|105
1248771|NCT00588861|4094962|P2|6 Years|Patients did not return for follow-up|109
1248772|NCT00588861|4094963|P1|6 Years|Patients did not return for follow-up|104
1248773|NCT00588861|4094962|P2|4 Years|Patients did not return for follow-up|103
1248774|NCT00588861|4094963|P1|4 Years|Patients did not return for follow-up|91
1248775|NCT00588861|4094962|P2|2 Years|Patients did not return for follow-up|87
1248776|NCT00588861|4094963|P1|2 Years|Patients did not return for follow-up|92
1248777|NCT00588861|4094962|P2|1 Year|Patients did not return for follow-up|82
1248778|NCT00588861|4094963|P1|1 Year|Patients did not return for follow-up|89
1248779|NCT00588861|4094962|P2|6 Months|Patients did not return for follow-up|73
1248780|NCT00588861|4094963|P1|6 Months|Patients did not return for follow-up|98
1248781|NCT00588861|4094962|P2|Pre-Operative|Patients Did Not Complete Preop Data|86
1248782|NCT00588861|4094963|P1|Pre-Operative|Patients Did Not Complete Preop Data|95
1248783|NCT00588822|4094984|P1|Overall Study|progression of disease|8
1248784|NCT00588731|4095004|P2|Overall Study|Withdrawal by Subject|2
1248785|NCT00588731|4095005|P1|Overall Study|Withdrawal by Subject|3
1248786|NCT00588692|4095015|P2|Overall Study|Death|0
1248787|NCT00588692|4095016|P1|Overall Study|Death|1
1248788|NCT00588692|4095015|P2|Overall Study|Cancer|0
1248789|NCT00588692|4095016|P1|Overall Study|Cancer|1
1248790|NCT00588692|4095015|P2|Overall Study|Severe Peptic Ulcer Disease|0
1248791|NCT00588692|4095016|P1|Overall Study|Severe Peptic Ulcer Disease|1
1248792|NCT00588692|4095015|P2|Overall Study|Hip Surgery|1
1248793|NCT00588692|4095016|P1|Overall Study|Hip Surgery|0
1248794|NCT00588692|4095015|P2|Overall Study|Withdrawal by Subject|2
1248795|NCT00588692|4095016|P1|Overall Study|Withdrawal by Subject|4
1248796|NCT00588666|4095052|P1|Overall Study|Adverse Event|4
1248797|NCT00588640|4095057|P1|Overall Study|Ineligible Patient|1
1248798|NCT00588640|4095057|P1|Overall Study|Physician Decision|1
1248799|NCT00588445|4095076|P1|Overall Study|Not Treated|10
1248800|NCT00588445|4095076|P1|Overall Study|Disease Progression|1
1248801|NCT00588445|4095076|P1|Overall Study|Withdrawal by Subject|3
1248802|NCT00588445|4095076|P1|Overall Study|Protocol Violation|1
1248803|NCT00588354|4095100|P2|Baseline to 4 Weeks|Lost to Follow-up|1
1248804|NCT00588354|4095101|P1|Baseline to 4 Weeks|Lost to Follow-up|0
1248805|NCT00588354|4095100|P2|Baseline to 2 Weeks|Lack of Efficacy|0
1248806|NCT00588354|4095101|P1|Baseline to 2 Weeks|Lack of Efficacy|1
1248807|NCT00588354|4095100|P2|Baseline to 2 Weeks|Adverse Event|0
1248808|NCT00588354|4095101|P1|Baseline to 2 Weeks|Adverse Event|1
1248809|NCT00588341|4095121|P1|Overall Study|Patient ineligible|1
1248810|NCT00588341|4095121|P1|Overall Study|Not treated due to metastatic disease|1
1248811|NCT00588341|4095121|P1|Overall Study|Withdrawal by Subject|3
1248812|NCT00588237|4095125|P1|Overall Study|Patien not treated|1
1248813|NCT00588237|4095125|P1|Overall Study|Evaluable for toxicity only|3
1248814|NCT00588146|4095148|P2|First Intervention (Baseline to 6 mo)|Adverse Event|3
1248815|NCT00588146|4095149|P1|First Intervention (Baseline to 6 mo)|Adverse Event|4
1248816|NCT00588094|4095155|P1|Overall Study|Progression of Disease|2
1248817|NCT00588094|4095155|P1|Overall Study|Adverse Event|3
1248818|NCT00587964|4095178|P1|Overall Study|Progression of Disease|4
1248819|NCT00587964|4095178|P1|Overall Study|Patient did not receive intervention|5
1248820|NCT00587964|4095178|P1|Overall Study|Patient found to be ineligible|1
1248821|NCT00587964|4095178|P1|Overall Study|Lost to Follow-up|1
1248822|NCT00587964|4095178|P1|Overall Study|Withdrawal by Subject|1
1248823|NCT00587860|4095184|P2|Overall Study|Withdrawal by Subject|3
1248824|NCT00587860|4095185|P1|Overall Study|Withdrawal by Subject|3
1248825|NCT00587860|4095184|P2|Overall Study|Lost to Follow-up|2
1248826|NCT00587860|4095185|P1|Overall Study|Lost to Follow-up|2
1248827|NCT00587847|4095205|P1|Overall Study|Adverse Event|2
1248828|NCT00587847|4095205|P1|Overall Study|Lack of Efficacy|5
1248829|NCT00587795|4095228|P2|Overall Study|Withdrawal by Subject|0
1248830|NCT00587795|4095229|P1|Overall Study|Withdrawal by Subject|1
1248831|NCT00587639|4095283|P1|Overall Study|Withdrawal by Subject|1
1248832|NCT00587587|4095290|P2|Overall Study|Lost to Follow-up|1
1248833|NCT00587587|4095291|P1|Overall Study|Lost to Follow-up|6
1248834|NCT00587457|4095345|P3|Overall Study|Development of neutralizing Abs|1
1248835|NCT00587457|4095346|P2|Overall Study|Development of neutralizing Abs|0
1248836|NCT00587457|4095347|P1|Overall Study|Development of neutralizing Abs|0
1248837|NCT00587457|4095345|P3|Overall Study|Undefined|1
1248838|NCT00587457|4095346|P2|Overall Study|Undefined|0
1248839|NCT00587457|4095347|P1|Overall Study|Undefined|0
1248840|NCT00587457|4095345|P3|Overall Study|Initiation of alternative therapy|0
1248841|NCT00587457|4095346|P2|Overall Study|Initiation of alternative therapy|1
1248842|NCT00587457|4095347|P1|Overall Study|Initiation of alternative therapy|0
1248843|NCT00587457|4095345|P3|Overall Study|Disease progression|2
1248844|NCT00587457|4095346|P2|Overall Study|Disease progression|0
1248845|NCT00587457|4095347|P1|Overall Study|Disease progression|2
1248846|NCT00587457|4095345|P3|Overall Study|Adverse Event|1
1248847|NCT00587457|4095346|P2|Overall Study|Adverse Event|2
1248848|NCT00587457|4095347|P1|Overall Study|Adverse Event|1
1248849|NCT00587431|4095384|P2|Overall Study|Withdrawal by Subject|1
1248850|NCT00587431|4095385|P1|Overall Study|Withdrawal by Subject|0
1248851|NCT00587431|4095384|P2|Overall Study|Adverse Event|0
1248852|NCT00587431|4095385|P1|Overall Study|Adverse Event|1
1248853|NCT00587288|4095396|P2|Overall Study|Protocol Violation|0
1248854|NCT00587288|4095397|P1|Overall Study|Protocol Violation|1
1248855|NCT00587288|4095396|P2|Overall Study|Lack of Efficacy|8
1248856|NCT00587288|4095397|P1|Overall Study|Lack of Efficacy|2
1248857|NCT00587288|4095396|P2|Overall Study|Adverse Event|1
1248858|NCT00587288|4095397|P1|Overall Study|Adverse Event|0
1248859|NCT00587223|4095415|P1|Overall Study|Adverse Event|1
1248860|NCT00587171|4095432|P2|Overall Study|Lost to Follow-up|1
1248861|NCT00587171|4095433|P1|Overall Study|Lost to Follow-up|1
1248862|NCT00587158|4095463|P2|Overall Study|Subject did not want to take study med|1
1248863|NCT00587158|4095464|P1|Overall Study|Subject did not want to take study med|0
1248864|NCT00587158|4095463|P2|Overall Study|Death|1
1248865|NCT00587158|4095464|P1|Overall Study|Death|0
1248866|NCT00587158|4095463|P2|Overall Study|Lost to Follow-up|2
1248867|NCT00587158|4095464|P1|Overall Study|Lost to Follow-up|1
1248868|NCT00587158|4095463|P2|Overall Study|Physician Decision|1
1248869|NCT00587158|4095464|P1|Overall Study|Physician Decision|0
1248870|NCT00587158|4095463|P2|Overall Study|Did not want to do 24 hr urine collect.|3
1248871|NCT00587158|4095464|P1|Overall Study|Did not want to do 24 hr urine collect.|4
1248872|NCT00587054|4095517|P1|Overall Study|Patient not treated|9
1248873|NCT00586898|4095537|P1|Overall Study|Evaluable for Toxicity Only|5
1248874|NCT00586898|4095537|P1|Overall Study|Patiemt Non-compliance|1
1248875|NCT00586898|4095537|P1|Overall Study|Adverse Event|1
1248876|NCT00586846|4095541|P1|Overall Study|Evaluable for Toxicity Only|4
1248877|NCT00586846|4095541|P1|Overall Study|Death|1
1248878|NCT00586846|4095541|P1|Overall Study|Physician Decision|1
1248879|NCT00586820|4095547|P2|Overall Study|Unsuccessful PCI|0
1248880|NCT00586820|4095548|P1|Overall Study|Unsuccessful PCI|1
1248881|NCT00586703|4095579|P1|Overall Study|Death|12
1248882|NCT00586690|4095586|P2|Overall Study|Lab can't accommodate|0
1248883|NCT00586690|4095587|P1|Overall Study|Lab can't accommodate|1
1248884|NCT00586690|4095586|P2|Overall Study|Lack of Efficacy|0
1248885|NCT00586690|4095587|P1|Overall Study|Lack of Efficacy|2
1248886|NCT00586690|4095586|P2|Overall Study|Adverse Event|0
1248887|NCT00586690|4095587|P1|Overall Study|Adverse Event|1
1248888|NCT00586690|4095586|P2|Overall Study|Disease Progression|0
1248889|NCT00586690|4095587|P1|Overall Study|Disease Progression|10
1248890|NCT00586690|4095586|P2|Overall Study|Death|0
1248891|NCT00586690|4095587|P1|Overall Study|Death|2
1248892|NCT00586664|4095597|P3|Overall Study|Exclusion criteria met|0
1248893|NCT00586664|4095598|P2|Overall Study|Exclusion criteria met|0
1248894|NCT00586664|4095599|P1|Overall Study|Exclusion criteria met|2
1248895|NCT00586664|4095597|P3|Overall Study|Withdrawal by Subject|1
1248896|NCT00586664|4095598|P2|Overall Study|Withdrawal by Subject|7
1248897|NCT00586664|4095599|P1|Overall Study|Withdrawal by Subject|3
1248898|NCT00586625|4095645|P2|Overall Study|Subject unable to return for visit|0
1248899|NCT00586625|4095646|P1|Overall Study|Subject unable to return for visit|2
1248900|NCT00586625|4095645|P2|Overall Study|Subject non-compliance|1
1248901|NCT00586625|4095646|P1|Overall Study|Subject non-compliance|0
1248902|NCT00586625|4095645|P2|Overall Study|Withdrawal by Subject|10
1248903|NCT00586625|4095646|P1|Overall Study|Withdrawal by Subject|32
1248904|NCT00586625|4095645|P2|Overall Study|Protocol Violation|0
1248905|NCT00586625|4095646|P1|Overall Study|Protocol Violation|3
1248906|NCT00586625|4095645|P2|Overall Study|Adverse Event|6
1248907|NCT00586625|4095646|P1|Overall Study|Adverse Event|6
1248908|NCT00586612|4095654|P2|Booster Phase|Lost to Follow-up|1
1248909|NCT00586612|4095655|P1|Booster Phase|Lost to Follow-up|3
1248910|NCT00586612|4095654|P2|Primary Phase|Withdrawal by Subject|2
1248911|NCT00586612|4095655|P1|Primary Phase|Withdrawal by Subject|0
1248912|NCT00586612|4095654|P2|Primary Phase|Lost to Follow-up|1
1248913|NCT00586612|4095655|P1|Primary Phase|Lost to Follow-up|0
1248914|NCT00586612|4095654|P2|Primary Phase|Protocol Violation|0
1248915|NCT00586612|4095655|P1|Primary Phase|Protocol Violation|1
1248916|NCT00586521|4095725|P1|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1
1248917|NCT00586495|4095732|P1|Follow-up|Switch to commercial drug|10
1248918|NCT00586495|4095732|P1|Follow-up|Protocol driven decision point|37
1248919|NCT00586495|4095732|P1|Follow-up|Withdrawal by Subject|4
1248920|NCT00586495|4095732|P1|Follow-up|Lost to Follow-up|1
1248921|NCT00586495|4095732|P1|Follow-up|Death|40
1248922|NCT00586495|4095732|P1|Treatment Period|Switch to commercial drug|10
1248923|NCT00586495|4095732|P1|Treatment Period|Disease progression, recurrence/relapse|71
1248924|NCT00586495|4095732|P1|Treatment Period|Withdrawal by Subject|1
1248925|NCT00586495|4095732|P1|Treatment Period|Protocol Violation|1
1248926|NCT00586495|4095732|P1|Treatment Period|Death|1
1248927|NCT00586495|4095732|P1|Treatment Period|Adverse Event|11
1248928|NCT00586469|4095761|P2|Overall Study|Adverse Event|1
1248929|NCT00586469|4095762|P1|Overall Study|Adverse Event|0
1248930|NCT00586339|4095789|P3|Overall Study|Withdrawal by Subject|1
1248931|NCT00586339|4095790|P2|Overall Study|Withdrawal by Subject|3
1248932|NCT00586339|4095791|P1|Overall Study|Withdrawal by Subject|1
1248933|NCT00586339|4095789|P3|Overall Study|Lost to Follow-up|5
1248934|NCT00586339|4095790|P2|Overall Study|Lost to Follow-up|4
1248935|NCT00586339|4095791|P1|Overall Study|Lost to Follow-up|6
1248936|NCT00586326|4095889|P1|Treated Through 5-yr Follow Up-Treated|Other|2
1248937|NCT00586326|4095889|P1|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14
1248938|NCT00586326|4095889|P1|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5
1248939|NCT00586326|4095889|P1|Treated Through 5-yr Follow Up-Treated|Medical Reason|2
1248940|NCT00586326|4095889|P1|Treated Through 5-yr Follow Up-Treated|Death|2
1248941|NCT00586326|4095889|P1|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1
1248942|NCT00586326|4095889|P1|Device Placed toTreatment-ITT|Physician Decision|1
1248943|NCT00586326|4095889|P1|Device Placed toTreatment-ITT|Positive Margins|3
1248944|NCT00586326|4095889|P1|Device Placed toTreatment-ITT|Microinvasion|1
1248945|NCT00586326|4095889|P1|Device Placed toTreatment-ITT|Cavity Conformance|6
1248946|NCT00586326|4095889|P1|Device Placed toTreatment-ITT|Skin Distance|7
1248947|NCT00586326|4095889|P1|Enrollment to Device Placement-Enrolled|Other|1
1248948|NCT00586326|4095889|P1|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1
1248949|NCT00586326|4095889|P1|Enrollment to Device Placement-Enrolled|Physician Decision|1
1248950|NCT00586326|4095889|P1|Enrollment to Device Placement-Enrolled|Microinvasion|2
1248951|NCT00586326|4095889|P1|Enrollment to Device Placement-Enrolled|Cavity Conformance|4
1248952|NCT00586326|4095889|P1|Enrollment to Device Placement-Enrolled|Skin Distance|6
1248953|NCT00586313|4095900|P1|Overall Study|Lack of Efficacy|2
1248954|NCT00586157|4095936|P2|Second Intervention|Adverse Event|1
1248955|NCT00586157|4095937|P1|Second Intervention|Adverse Event|0
1248956|NCT00586157|4095936|P2|Second Intervention|Worsening behavior|0
1248957|NCT00586157|4095937|P1|Second Intervention|Worsening behavior|1
1248958|NCT00586157|4095936|P2|Second Intervention|Withdrawal by Subject|0
1248959|NCT00586157|4095937|P1|Second Intervention|Withdrawal by Subject|1
1248960|NCT00586157|4095936|P2|First Intervention|Worsening behavior|0
1248961|NCT00586157|4095937|P1|First Intervention|Worsening behavior|1
1248962|NCT00586105|4095947|P1|Overall Study|Reason not reported|1
1248963|NCT00586105|4095947|P1|Overall Study|Switched to commercial drug|9
1248964|NCT00586105|4095947|P1|Overall Study|Disease progression|19
1248965|NCT00586105|4095947|P1|Overall Study|Withdrawal by Subject|3
1248966|NCT00586105|4095947|P1|Overall Study|Protocol Violation|1
1248967|NCT00586105|4095947|P1|Overall Study|Death|2
1248968|NCT00586105|4095947|P1|Overall Study|Adverse Event|4
1248969|NCT00586066|4095962|P2|Overall Study|Withdrawal of consent|2
1248970|NCT00586066|4095963|P1|Overall Study|Withdrawal of consent|4
1248971|NCT00586066|4095962|P2|Overall Study|Physician Decision|0
1248972|NCT00586066|4095963|P1|Overall Study|Physician Decision|1
1248973|NCT00586066|4095962|P2|Overall Study|Adverse Event|2
1248974|NCT00586066|4095963|P1|Overall Study|Adverse Event|2
1248975|NCT00586066|4095962|P2|Overall Study|Lack of Efficacy|3
1248976|NCT00586066|4095963|P1|Overall Study|Lack of Efficacy|5
1248977|NCT00586066|4095962|P2|Overall Study|Lost to Follow-up|3
1248978|NCT00586066|4095963|P1|Overall Study|Lost to Follow-up|6
1248979|NCT00585975|4096020|P2|Overall Study|Enrollment met/over-enrolled|9
1248980|NCT00585975|4096021|P1|Overall Study|Enrollment met/over-enrolled|10
1248981|NCT00585975|4096020|P2|Overall Study|Lost to Follow-up|1
1248982|NCT00585975|4096021|P1|Overall Study|Lost to Follow-up|2
1248983|NCT00585975|4096020|P2|Overall Study|Withdrawal by Subject|3
1248984|NCT00585975|4096021|P1|Overall Study|Withdrawal by Subject|3
1248985|NCT00585923|4096031|P2|Overall Study|Physician decided not to continue|33
1248986|NCT00585923|4096032|P1|Overall Study|Physician decided not to continue|31
1248987|NCT00585689|4096063|P1|Overall Study|Death|1
1248988|NCT00585689|4096063|P1|Overall Study|Patient had unresectable disease|1
1248989|NCT00585689|4096063|P1|Overall Study|Patient Declined Surgery|1
1248990|NCT00585689|4096063|P1|Overall Study|Adverse Event|1
1248991|NCT00585689|4096063|P1|Overall Study|Received different ABI-007 schedule|3
1248992|NCT00585585|4096109|P1|Overall Study|Adverse Event|1
1248993|NCT00585546|4096113|P1|Clenbuterol Treatment - up to 12 Months|Adverse Event|3
1248994|NCT00585546|4096113|P1|Clenbuterol Treatment - up to 12 Months|Death|1
1248995|NCT00585533|4096127|P1|Overall Study|objective or symptomatic progression|9
1248996|NCT00585468|4096136|P2|First Intervention|Withdrawal by Subject|1
1248997|NCT00585468|4096137|P1|First Intervention|Withdrawal by Subject|1
1248998|NCT00585351|4096169|P8|Enrollment Period (Intervention)|Unknown if alive or deceased|0
1248999|NCT00585351|4096170|P7|Enrollment Period (Intervention)|Unknown if alive or deceased|0
1249000|NCT00585351|4096171|P6|Enrollment Period (Intervention)|Unknown if alive or deceased|2
1249001|NCT00585351|4096172|P5|Enrollment Period (Intervention)|Unknown if alive or deceased|1
1249002|NCT00585351|4096173|P4|Enrollment Period (Intervention)|Unknown if alive or deceased|0
1249003|NCT00585351|4096174|P3|Enrollment Period (Intervention)|Unknown if alive or deceased|0
1249004|NCT00585351|4096175|P2|Enrollment Period (Intervention)|Unknown if alive or deceased|0
1249005|NCT00585351|4096176|P1|Enrollment Period (Intervention)|Unknown if alive or deceased|0
1249006|NCT00585351|4096169|P8|Enrollment Period (Intervention)|Death|0
1249007|NCT00585351|4096170|P7|Enrollment Period (Intervention)|Death|1
1249008|NCT00585351|4096171|P6|Enrollment Period (Intervention)|Death|0
1249009|NCT00585351|4096172|P5|Enrollment Period (Intervention)|Death|1
1249010|NCT00585351|4096173|P4|Enrollment Period (Intervention)|Death|0
1249011|NCT00585351|4096174|P3|Enrollment Period (Intervention)|Death|0
1249012|NCT00585351|4096175|P2|Enrollment Period (Intervention)|Death|0
1249013|NCT00585351|4096176|P1|Enrollment Period (Intervention)|Death|0
1249014|NCT00585351|4096169|P8|Enrollment Period (Intervention)|Lost to Follow-up|1
1249015|NCT00585351|4096170|P7|Enrollment Period (Intervention)|Lost to Follow-up|1
1249016|NCT00585351|4096171|P6|Enrollment Period (Intervention)|Lost to Follow-up|0
1249017|NCT00585351|4096172|P5|Enrollment Period (Intervention)|Lost to Follow-up|0
1249018|NCT00585351|4096173|P4|Enrollment Period (Intervention)|Lost to Follow-up|0
1249019|NCT00585351|4096174|P3|Enrollment Period (Intervention)|Lost to Follow-up|0
1249020|NCT00585351|4096175|P2|Enrollment Period (Intervention)|Lost to Follow-up|0
1249021|NCT00585351|4096176|P1|Enrollment Period (Intervention)|Lost to Follow-up|0
1249022|NCT00585351|4096169|P8|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
1249023|NCT00585351|4096170|P7|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
1249024|NCT00585351|4096171|P6|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
1249025|NCT00585351|4096172|P5|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
1249026|NCT00585351|4096173|P4|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
1249027|NCT00585351|4096174|P3|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
1249028|NCT00585351|4096175|P2|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
1249029|NCT00585351|4096176|P1|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
1249030|NCT00585351|4096169|P8|Notification Period (Informed Consent)|No study medication on flight|0
1249031|NCT00585351|4096170|P7|Notification Period (Informed Consent)|No study medication on flight|0
1249032|NCT00585351|4096171|P6|Notification Period (Informed Consent)|No study medication on flight|0
1249033|NCT00585351|4096172|P5|Notification Period (Informed Consent)|No study medication on flight|0
1249034|NCT00585351|4096173|P4|Notification Period (Informed Consent)|No study medication on flight|0
1249035|NCT00585351|4096174|P3|Notification Period (Informed Consent)|No study medication on flight|0
1249036|NCT00585351|4096175|P2|Notification Period (Informed Consent)|No study medication on flight|1
1249037|NCT00585351|4096176|P1|Notification Period (Informed Consent)|No study medication on flight|0
1249038|NCT00585351|4096169|P8|Notification Period (Informed Consent)|Flight aborted|0
1249039|NCT00585351|4096170|P7|Notification Period (Informed Consent)|Flight aborted|0
1249040|NCT00585351|4096171|P6|Notification Period (Informed Consent)|Flight aborted|0
1249041|NCT00585351|4096172|P5|Notification Period (Informed Consent)|Flight aborted|0
1249042|NCT00585351|4096173|P4|Notification Period (Informed Consent)|Flight aborted|0
1249043|NCT00585351|4096174|P3|Notification Period (Informed Consent)|Flight aborted|0
1249044|NCT00585351|4096175|P2|Notification Period (Informed Consent)|Flight aborted|1
1249045|NCT00585351|4096176|P1|Notification Period (Informed Consent)|Flight aborted|2
1249046|NCT00585351|4096169|P8|Notification Period (Informed Consent)|Physician Decision|0
1249047|NCT00585351|4096170|P7|Notification Period (Informed Consent)|Physician Decision|0
1249048|NCT00585351|4096171|P6|Notification Period (Informed Consent)|Physician Decision|0
1249049|NCT00585351|4096172|P5|Notification Period (Informed Consent)|Physician Decision|0
1249050|NCT00585351|4096173|P4|Notification Period (Informed Consent)|Physician Decision|0
1249051|NCT00585351|4096174|P3|Notification Period (Informed Consent)|Physician Decision|0
1249052|NCT00585351|4096175|P2|Notification Period (Informed Consent)|Physician Decision|2
1249053|NCT00585351|4096176|P1|Notification Period (Informed Consent)|Physician Decision|0
1249054|NCT00585325|4096192|P2|Overall Study|Withdrawal by Subject|1
1249055|NCT00585325|4096193|P1|Overall Study|Withdrawal by Subject|1
1249056|NCT00585312|4096201|P2|Overall Study|Study terminated by the sponsor|31
1249057|NCT00585312|4096202|P1|Overall Study|Study terminated by the sponsor|34
1249058|NCT00585312|4096201|P2|Overall Study|Withdrawal by Subject|1
1249059|NCT00585312|4096202|P1|Overall Study|Withdrawal by Subject|5
1249060|NCT00585312|4096201|P2|Overall Study|Reason not specified|0
1249061|NCT00585312|4096202|P1|Overall Study|Reason not specified|2
1249062|NCT00585312|4096201|P2|Overall Study|Lost to Follow-up|1
1249063|NCT00585312|4096202|P1|Overall Study|Lost to Follow-up|1
1249064|NCT00585312|4096201|P2|Overall Study|Lack of Efficacy|11
1249065|NCT00585312|4096202|P1|Overall Study|Lack of Efficacy|6
1249066|NCT00585312|4096201|P2|Overall Study|Adverse Event|0
1249067|NCT00585312|4096202|P1|Overall Study|Adverse Event|3
1249068|NCT00585286|4096214|P1|Overall Study|Lost to Follow-up|1
1249069|NCT00585221|4096230|P1|Overall Study|Protocol Violation|8
1249070|NCT00585169|4096240|P1|Overall Study|Withdrawal by Subject|1
1249071|NCT00585078|4096250|P1|Overall Study|Death|1
1249072|NCT00585078|4096250|P1|Overall Study|Adverse Event|10
1249073|NCT00585078|4096250|P1|Overall Study|Disease Progression|24
1249074|NCT00585078|4096250|P1|Overall Study|Poor performance status|1
1249075|NCT00585078|4096250|P1|Overall Study|Withdrawal by Subject|4
1249076|NCT00585052|4096257|P1|Overall Study|Withdrawal by Subject|1
1249077|NCT00585039|4096264|P2|Overall Study|medication spilled|0
1249078|NCT00585039|4096265|P1|Overall Study|medication spilled|2
1249079|NCT00584987|4096294|P4|Overall Study|Adverse Event|1
1249080|NCT00584987|4096295|P3|Overall Study|Adverse Event|0
1249081|NCT00584987|4096296|P2|Overall Study|Adverse Event|0
1249082|NCT00584987|4096297|P1|Overall Study|Adverse Event|0
1249083|NCT00584987|4096294|P4|Overall Study|Protocol Violation|0
1249084|NCT00584987|4096295|P3|Overall Study|Protocol Violation|1
1249085|NCT00584987|4096296|P2|Overall Study|Protocol Violation|1
1249086|NCT00584987|4096297|P1|Overall Study|Protocol Violation|1
1249087|NCT00584909|4096345|P1|Overall Study|Adverse Event|4
1249088|NCT00584844|4096355|P1|Overall Study|Screen Failure|20
1249089|NCT00584844|4096355|P1|Overall Study|Withdrawal by Subject|59
1249090|NCT00584740|4096407|P2|Overall Study|Lost to Follow-up|1
1249091|NCT00584740|4096408|P1|Overall Study|Lost to Follow-up|0
1249092|NCT00584740|4096407|P2|Overall Study|Withdrawal by Subject|2
1249093|NCT00584740|4096408|P1|Overall Study|Withdrawal by Subject|3
1249094|NCT00584740|4096407|P2|Overall Study|Lack of Efficacy|2
1249095|NCT00584740|4096408|P1|Overall Study|Lack of Efficacy|8
1249096|NCT00584740|4096407|P2|Overall Study|Adverse Event|1
1249097|NCT00584740|4096408|P1|Overall Study|Adverse Event|1
1249098|NCT00584727|4096426|P6|Third Intervention|Protocol Violation|2
1249099|NCT00584727|4096427|P5|Third Intervention|Protocol Violation|4
1249100|NCT00584727|4096428|P4|Third Intervention|Protocol Violation|0
1249101|NCT00584727|4096429|P3|Third Intervention|Protocol Violation|1
1249102|NCT00584727|4096430|P2|Third Intervention|Protocol Violation|0
1249103|NCT00584727|4096431|P1|Third Intervention|Protocol Violation|0
1249104|NCT00584727|4096426|P6|First Intervention|Discontinuation|0
1249105|NCT00584727|4096427|P5|First Intervention|Discontinuation|0
1249106|NCT00584727|4096428|P4|First Intervention|Discontinuation|0
1249107|NCT00584727|4096429|P3|First Intervention|Discontinuation|1
1249108|NCT00584727|4096430|P2|First Intervention|Discontinuation|0
1249109|NCT00584727|4096431|P1|First Intervention|Discontinuation|0
1249110|NCT00584454|4096469|P1|Overall Study|Clinical Hold|2
1249111|NCT00584454|4096469|P1|Overall Study|Relocation|1
1249112|NCT00584454|4096469|P1|Overall Study|Adverse Event|1
1249113|NCT00584415|4096473|P1|Overall Study|Adverse Event|7
1249114|NCT00584194|4096496|P1|Overall Study|Not specified|135
1249115|NCT00584012|4096509|P1|Overall Study|Withdrawal by Subject|1
1249116|NCT00583947|4096515|P2|Cross-over Period|not specified|1
1249117|NCT00583947|4096516|P1|Cross-over Period|not specified|1
1249118|NCT00583947|4096515|P2|Cross-over Period|Did not meet-no longer met entry criteri|1
1249119|NCT00583947|4096516|P1|Cross-over Period|Did not meet-no longer met entry criteri|0
1249120|NCT00583947|4096515|P2|Cross-over Period|Withdrawal by Subject|0
1249121|NCT00583947|4096516|P1|Cross-over Period|Withdrawal by Subject|2
1249122|NCT00583947|4096515|P2|Cross-over Period|Adverse Event|0
1249123|NCT00583947|4096516|P1|Cross-over Period|Adverse Event|2
1249124|NCT00583596|4096688|P1|Overall Study|Outside f-up window|26
1249125|NCT00583596|4096688|P1|Overall Study|Not consented|15
1249126|NCT00583596|4096688|P1|Overall Study|Data not complete|1
1249127|NCT00583596|4096688|P1|Overall Study|Lost to Follow-up|94
1249128|NCT00583596|4096688|P1|Overall Study|Withdrawal by Subject|6
1249129|NCT00583596|4096688|P1|Overall Study|Death|2
1249130|NCT00583596|4096688|P1|Overall Study|Excluded due to Hurricane Katrina|30
1249131|NCT00583596|4096688|P1|Overall Study|Lost to Follow-up|110
1249132|NCT00583557|4096693|P1|Overall Study|Did not receive belimumab in LBRA99|2
1249133|NCT00583557|4096693|P1|Overall Study|Other|5
1249134|NCT00583557|4096693|P1|Overall Study|Lack of Compliance|5
1249135|NCT00583557|4096693|P1|Overall Study|Lack of Efficacy|31
1249136|NCT00583557|4096693|P1|Overall Study|Adverse Event|9
1249137|NCT00583557|4096693|P1|Overall Study|Withdrawal by Subject|18
1249138|NCT00583453|4096724|P2|Overall Study|discontinued intervention|2
1249139|NCT00583453|4096725|P1|Overall Study|discontinued intervention|0
1249140|NCT00583362|4096758|P1|Overall Study|Withdrawal by Subject|57
1249141|NCT00583362|4096758|P1|Overall Study|Protocol Violation|2
1249142|NCT00583362|4096758|P1|Overall Study|Physician Decision|19
1249143|NCT00583362|4096758|P1|Overall Study|Sponsor request due to missed doses|1
1249144|NCT00583362|4096758|P1|Overall Study|Behavioral problems and non-compliance|1
1249145|NCT00583362|4096758|P1|Overall Study|Misunderstanding of protocol|1
1249146|NCT00583362|4096758|P1|Overall Study|Missed visits due to staff changes|1
1249147|NCT00583362|4096758|P1|Overall Study|Subject moved out of the country/state|2
1249148|NCT00583362|4096758|P1|Overall Study|Subject not dosed in LBSL99|1
1249149|NCT00583362|4096758|P1|Overall Study|Current site closed|7
1249150|NCT00583362|4096758|P1|Overall Study|Miscommunication of visit window|5
1249151|NCT00583362|4096758|P1|Overall Study|Pregnancy|7
1249152|NCT00583362|4096758|P1|Overall Study|Non-compliance with study drug|28
1249153|NCT00583362|4096758|P1|Overall Study|Lost to Follow-up|4
1249154|NCT00583362|4096758|P1|Overall Study|Lack of Efficacy|22
1249155|NCT00583362|4096758|P1|Overall Study|Adverse Event|44
1249156|NCT00583219|4096782|P1|Phase 2|Withdrawal by Subject|1
1249157|NCT00583115|4096799|P1|Overall Study|Death|1
1249158|NCT00583102|4096804|P1|Overall Study|Adverse Event|3
1249159|NCT00582972|4096808|P1|Overall Study|Protocol Violation|2
1249160|NCT00582933|4096817|P1|Overall Study|Physician Decision|3
1249161|NCT00582907|4096821|P4|2nd Course|Lack of Efficacy|0
1249162|NCT00582907|4096822|P3|2nd Course|Lack of Efficacy|0
1249163|NCT00582907|4096823|P2|2nd Course|Lack of Efficacy|0
1249164|NCT00582907|4096824|P1|2nd Course|Lack of Efficacy|1
1249165|NCT00582907|4096821|P4|1st Course|Lost to Follow-up|1
1249166|NCT00582907|4096822|P3|1st Course|Lost to Follow-up|0
1249167|NCT00582907|4096823|P2|1st Course|Lost to Follow-up|0
1249168|NCT00582907|4096824|P1|1st Course|Lost to Follow-up|0
1249169|NCT00582907|4096821|P4|1st Course|Withdrawal by Subject|0
1249170|NCT00582907|4096822|P3|1st Course|Withdrawal by Subject|0
1249171|NCT00582907|4096823|P2|1st Course|Withdrawal by Subject|0
1249172|NCT00582907|4096824|P1|1st Course|Withdrawal by Subject|1
1249173|NCT00582816|4096863|P1|Overall Study|Engraftment Failure|3
1249174|NCT00582790|4096873|P1|Overall Study|Rapid progression of disease|1
1249175|NCT00582738|4096882|P2|Overall Study|Withdrawal by Subject|3
1249176|NCT00582738|4096883|P1|Overall Study|Withdrawal by Subject|0
1249177|NCT00582738|4096882|P2|Overall Study|Protocol Violation|1
1249178|NCT00582738|4096883|P1|Overall Study|Protocol Violation|1
1249179|NCT00582738|4096882|P2|Overall Study|Other|0
1249180|NCT00582738|4096883|P1|Overall Study|Other|1
1249181|NCT00582738|4096882|P2|Overall Study|Graft Lost|1
1249182|NCT00582738|4096883|P1|Overall Study|Graft Lost|0
1249183|NCT00582738|4096882|P2|Overall Study|Adverse Event|5
1249184|NCT00582738|4096883|P1|Overall Study|Adverse Event|0
1249185|NCT00582738|4096882|P2|Overall Study|Administrative Problems|8
1249186|NCT00582738|4096883|P1|Overall Study|Administrative Problems|7
1249187|NCT00582712|4096907|P1|Overall Study|Complicating disease requiring treatment|1
1249188|NCT00582712|4096907|P1|Overall Study|Withdrawal by Subject|1
1249189|NCT00582712|4096907|P1|Overall Study|Lack of Efficacy|1
1249190|NCT00582712|4096907|P1|Overall Study|Adverse Event|1
1249191|NCT00582608|4096922|P1|Overall Study|Lack of accrual|4
1249192|NCT00582608|4096922|P1|Overall Study|Patient Ineligible|1
1249193|NCT00582608|4096922|P1|Overall Study|Not Treated|7
1249194|NCT00582556|4096929|P3|Overall Study|Physician Decision|1
1249195|NCT00582556|4096930|P2|Overall Study|Physician Decision|0
1249196|NCT00582556|4096931|P1|Overall Study|Physician Decision|0
1249197|NCT00582556|4096929|P3|Overall Study|Withdrawal by Subject|1
1249198|NCT00582556|4096930|P2|Overall Study|Withdrawal by Subject|1
1249199|NCT00582556|4096931|P1|Overall Study|Withdrawal by Subject|0
1249200|NCT00582491|4096959|P2|Overall Study|Withdrawal by Subject|0
1249201|NCT00582491|4096960|P1|Overall Study|Withdrawal by Subject|1
1249202|NCT00582426|4096984|P2|Overall Study|Use of illicit drugs|0
1249203|NCT00582426|4096985|P1|Overall Study|Use of illicit drugs|1
1249204|NCT00582426|4096984|P2|Overall Study|Disease Progression|2
1249205|NCT00582426|4096985|P1|Overall Study|Disease Progression|2
1249206|NCT00582426|4096984|P2|Overall Study|Withdrawal by Subject|2
1249207|NCT00582426|4096985|P1|Overall Study|Withdrawal by Subject|3
1249208|NCT00582426|4096984|P2|Overall Study|Death|3
1249209|NCT00582426|4096985|P1|Overall Study|Death|4
1249210|NCT00582426|4096984|P2|Overall Study|Protocol Violation|2
1249211|NCT00582426|4096985|P1|Overall Study|Protocol Violation|6
1249212|NCT00582426|4096984|P2|Overall Study|Adverse Event|2
1249213|NCT00582426|4096985|P1|Overall Study|Adverse Event|4
1249214|NCT00582426|4096984|P2|Overall Study|Lost to Follow-up|2
1249215|NCT00582426|4096985|P1|Overall Study|Lost to Follow-up|0
1249216|NCT00582309|4097032|P3|Overall Study|Protocol Violation|2
1249217|NCT00582309|4097033|P2|Overall Study|Protocol Violation|0
1249218|NCT00582309|4097034|P1|Overall Study|Protocol Violation|0
1249219|NCT00582166|4097047|P1|Overall Study|Ineligible pathology|1
1249220|NCT00582166|4097047|P1|Overall Study|Death|1
1249221|NCT00582114|4097057|P2|Overall Study|Stopped by data safety monitoring board|20
1249222|NCT00582114|4097058|P1|Overall Study|Stopped by data safety monitoring board|19
1249223|NCT00582114|4097057|P2|Overall Study|Physician Decision|6
1249224|NCT00582114|4097058|P1|Overall Study|Physician Decision|0
1249225|NCT00582114|4097057|P2|Overall Study|Adverse Event|1
1249226|NCT00582114|4097058|P1|Overall Study|Adverse Event|1
1249227|NCT00582114|4097057|P2|Overall Study|Withdrawal by Subject|16
1249228|NCT00582114|4097058|P1|Overall Study|Withdrawal by Subject|8
1249229|NCT00582114|4097057|P2|Overall Study|Lost to Follow-up|6
1249230|NCT00582114|4097058|P1|Overall Study|Lost to Follow-up|7
1249231|NCT00582114|4097057|P2|Overall Study|Kidney Transplant|1
1249232|NCT00582114|4097058|P1|Overall Study|Kidney Transplant|3
1249233|NCT00582114|4097057|P2|Overall Study|Death|4
1249234|NCT00582114|4097058|P1|Overall Study|Death|4
1249235|NCT00582036|4097073|P2|Overall Study|Withdrawal by Subject|1
1249236|NCT00582036|4097074|P1|Overall Study|Withdrawal by Subject|0
1249237|NCT00582010|4097082|P2|Overall Study|Death|1
1249238|NCT00582010|4097083|P1|Overall Study|Death|0
1249239|NCT00581945|4097112|P2|Overall Study|Death|0
1249240|NCT00581945|4097113|P1|Overall Study|Death|1
1249241|NCT00581945|4097112|P2|Overall Study|Withdrawal by Subject|6
1249242|NCT00581945|4097113|P1|Overall Study|Withdrawal by Subject|2
1249243|NCT00581945|4097112|P2|Overall Study|Unsatisfactory therapeutic effect|0
1249244|NCT00581945|4097113|P1|Overall Study|Unsatisfactory therapeutic effect|2
1249245|NCT00581945|4097112|P2|Overall Study|Adverse Event|4
1249246|NCT00581945|4097113|P1|Overall Study|Adverse Event|4
1249247|NCT00581919|4097129|P1|Overall Study|Withdrawal by Subject|1
1249248|NCT00581919|4097129|P1|Overall Study|Started Non-Protocol Therapy|2
1249249|NCT00581919|4097129|P1|Overall Study|Other Complicating Disease|1
1249250|NCT00581919|4097129|P1|Overall Study|Physician Decision|1
1249251|NCT00581919|4097129|P1|Overall Study|Disease Progression|10
1249252|NCT00581919|4097129|P1|Overall Study|Death|1
1249253|NCT00581919|4097129|P1|Overall Study|Adverse Event|8
1249254|NCT00581828|4097148|P1|Overall Study|Protocol Violation|1
1249255|NCT00581776|4097152|P1|Overall Study|Disease progression or no response|3
1249256|NCT00581555|4097170|P2|Overall Study|Other reasons|4
1249257|NCT00581555|4097171|P1|Overall Study|Other reasons|16
1249258|NCT00581555|4097170|P2|Overall Study|Lost to Follow-up|2
1249259|NCT00581555|4097171|P1|Overall Study|Lost to Follow-up|2
1249260|NCT00581555|4097170|P2|Overall Study|Withdrawal by Subject|9
1249261|NCT00581555|4097171|P1|Overall Study|Withdrawal by Subject|18
1249262|NCT00581555|4097170|P2|Overall Study|Physician Decision|2
1249263|NCT00581555|4097171|P1|Overall Study|Physician Decision|3
1249264|NCT00581555|4097170|P2|Overall Study|Adverse Event|3
1249265|NCT00581555|4097171|P1|Overall Study|Adverse Event|4
1249266|NCT00581542|4097195|P2|Overall Study|Lost to Follow-up|21
1249267|NCT00581542|4097196|P1|Overall Study|Lost to Follow-up|9
1249268|NCT00581542|4097195|P2|Overall Study|they met an exclusion criteria|2
1249269|NCT00581542|4097196|P1|Overall Study|they met an exclusion criteria|2
1249270|NCT00581360|4097250|P1|Overall Study|Withdrawal by Subject|1
1249271|NCT00581308|4097269|P1|Month 12|Other|1
1249272|NCT00581308|4097269|P1|Month 12|Device Removed|1
1249273|NCT00581308|4097269|P1|Month 12|Withdrawal by Subject|3
1249274|NCT00581308|4097269|P1|Month 12|Lost to Follow-up|14
1249275|NCT00581308|4097269|P1|Month 12|Death|1
1249276|NCT00581308|4097269|P1|Month 6|Withdrawal by Subject|2
1249277|NCT00581308|4097269|P1|Month 6|Lost to Follow-up|1
1249278|NCT00581308|4097269|P1|Month 1|Uknown|1
1249279|NCT00581308|4097269|P1|Month 1|Device Removed|2
1249280|NCT00581308|4097269|P1|Month 1|Withdrawal by Subject|2
1249281|NCT00581308|4097269|P1|Month 1|Lost to Follow-up|3
1249282|NCT00581308|4097269|P1|Pre Discharge|Device Removed|1
1249283|NCT00581308|4097269|P1|Pre Discharge|Lost to Follow-up|1
1249284|NCT00581113|4097300|P2|Overall Study|Withdrawal by Subject|1
1249285|NCT00581113|4097301|P1|Overall Study|Withdrawal by Subject|0
1249286|NCT00581100|4097311|P2|Overall Study|Other|0
1249287|NCT00581100|4097312|P1|Overall Study|Other|3
1249288|NCT00581100|4097311|P2|Overall Study|Withdrawal by Subject|4
1249289|NCT00581100|4097312|P1|Overall Study|Withdrawal by Subject|1
1249290|NCT00581100|4097311|P2|Overall Study|Adverse Event|1
1249291|NCT00581100|4097312|P1|Overall Study|Adverse Event|2
1249292|NCT00581100|4097311|P2|Overall Study|Death|0
1249293|NCT00581100|4097312|P1|Overall Study|Death|1
1249294|NCT00580983|4097365|P1|Overall Study|Did not complete 12 mon post RT studies|7
1249295|NCT00580970|4097372|P1|Treatment (Lovastatin)|Death|1
1249296|NCT00580970|4097372|P1|Treatment (Lovastatin)|Development of metastatic second primary|1
1249297|NCT00580970|4097372|P1|Treatment (Lovastatin)|Physician Decision|4
1249298|NCT00580970|4097372|P1|Treatment (Lovastatin)|Intolerance of Lovastatin|7
1249299|NCT00580970|4097372|P1|Treatment (Lovastatin)|Non-compliance|6
1249300|NCT00580970|4097372|P1|Pre-treatment|Non-compliance|1
1249301|NCT00580866|4097387|P2|Overall Study|Lost to Follow-up|2
1249302|NCT00580866|4097388|P1|Overall Study|Lost to Follow-up|2
1249303|NCT00580840|4097412|P4|Double-Blind|Other: Forbidden Medication|0
1249304|NCT00580840|4097413|P3|Double-Blind|Other: Forbidden Medication|1
1249305|NCT00580840|4097414|P2|Double-Blind|Other: Forbidden Medication|0
1249306|NCT00580840|4097415|P1|Double-Blind|Other: Forbidden Medication|0
1249307|NCT00580840|4097412|P4|Double-Blind|Other: Discontinued Methotrexate|0
1249308|NCT00580840|4097413|P3|Double-Blind|Other: Discontinued Methotrexate|0
1249309|NCT00580840|4097414|P2|Double-Blind|Other: Discontinued Methotrexate|1
1249310|NCT00580840|4097415|P1|Double-Blind|Other: Discontinued Methotrexate|0
1249311|NCT00580840|4097412|P4|Double-Blind|Withdrawal by Subject|2
1249312|NCT00580840|4097413|P3|Double-Blind|Withdrawal by Subject|2
1249313|NCT00580840|4097414|P2|Double-Blind|Withdrawal by Subject|1
1249314|NCT00580840|4097415|P1|Double-Blind|Withdrawal by Subject|0
1249315|NCT00580840|4097412|P4|Double-Blind|Lost to Follow-up|2
1249316|NCT00580840|4097413|P3|Double-Blind|Lost to Follow-up|0
1249317|NCT00580840|4097414|P2|Double-Blind|Lost to Follow-up|1
1249318|NCT00580840|4097415|P1|Double-Blind|Lost to Follow-up|0
1249319|NCT00580840|4097412|P4|Double-Blind|Loss of Efficacy|10
1249320|NCT00580840|4097413|P3|Double-Blind|Loss of Efficacy|2
1249321|NCT00580840|4097414|P2|Double-Blind|Loss of Efficacy|1
1249322|NCT00580840|4097415|P1|Double-Blind|Loss of Efficacy|0
1249323|NCT00580840|4097412|P4|Double-Blind|Adverse Event|1
1249324|NCT00580840|4097413|P3|Double-Blind|Adverse Event|4
1249325|NCT00580840|4097414|P2|Double-Blind|Adverse Event|3
1249326|NCT00580840|4097415|P1|Double-Blind|Adverse Event|0
1249327|NCT00580840|4097412|P4|Run-in|Other: Exclusionary Lab Value|0
1249328|NCT00580840|4097413|P3|Run-in|Other: Exclusionary Lab Value|0
1249329|NCT00580840|4097414|P2|Run-in|Other: Exclusionary Lab Value|0
1249330|NCT00580840|4097415|P1|Run-in|Other: Exclusionary Lab Value|1
1249331|NCT00580840|4097412|P4|Run-in|Other: Did Not Meet Joint Count Criteria|0
1249332|NCT00580840|4097413|P3|Run-in|Other: Did Not Meet Joint Count Criteria|0
1249333|NCT00580840|4097414|P2|Run-in|Other: Did Not Meet Joint Count Criteria|0
1249334|NCT00580840|4097415|P1|Run-in|Other: Did Not Meet Joint Count Criteria|1
1249335|NCT00580840|4097412|P4|Run-in|Other: Per Sponsor Request|0
1249336|NCT00580840|4097413|P3|Run-in|Other: Per Sponsor Request|0
1249337|NCT00580840|4097414|P2|Run-in|Other: Per Sponsor Request|0
1249338|NCT00580840|4097415|P1|Run-in|Other: Per Sponsor Request|2
1249339|NCT00580840|4097412|P4|Run-in|Withdrawal by Subject|0
1249340|NCT00580840|4097413|P3|Run-in|Withdrawal by Subject|0
1249341|NCT00580840|4097414|P2|Run-in|Withdrawal by Subject|0
1249342|NCT00580840|4097415|P1|Run-in|Withdrawal by Subject|5
1249343|NCT00580840|4097412|P4|Run-in|Lost to Follow-up|0
1249344|NCT00580840|4097413|P3|Run-in|Lost to Follow-up|0
1249345|NCT00580840|4097414|P2|Run-in|Lost to Follow-up|0
1249346|NCT00580840|4097415|P1|Run-in|Lost to Follow-up|4
1249347|NCT00580840|4097412|P4|Run-in|Loss of Efficacy|0
1249348|NCT00580840|4097413|P3|Run-in|Loss of Efficacy|0
1249349|NCT00580840|4097414|P2|Run-in|Loss of Efficacy|0
1249350|NCT00580840|4097415|P1|Run-in|Loss of Efficacy|1
1249351|NCT00580840|4097412|P4|Run-in|Lack of Efficacy|0
1249352|NCT00580840|4097413|P3|Run-in|Lack of Efficacy|0
1249353|NCT00580840|4097414|P2|Run-in|Lack of Efficacy|0
1249354|NCT00580840|4097415|P1|Run-in|Lack of Efficacy|93
1249355|NCT00580840|4097412|P4|Run-in|Adverse Event|0
1249356|NCT00580840|4097413|P3|Run-in|Adverse Event|0
1249357|NCT00580840|4097414|P2|Run-in|Adverse Event|0
1249358|NCT00580840|4097415|P1|Run-in|Adverse Event|17
1249359|NCT00580801|4097523|P3|Overall Study|Travel|0
1249360|NCT00580801|4097524|P2|Overall Study|Travel|0
1249361|NCT00580801|4097525|P1|Overall Study|Travel|1
1249362|NCT00580801|4097523|P3|Overall Study|Participant non-compliant|1
1249363|NCT00580801|4097524|P2|Overall Study|Participant non-compliant|0
1249364|NCT00580801|4097525|P1|Overall Study|Participant non-compliant|0
1249365|NCT00580801|4097523|P3|Overall Study|Reached a virologic endpoint|2
1249366|NCT00580801|4097524|P2|Overall Study|Reached a virologic endpoint|1
1249367|NCT00580801|4097525|P1|Overall Study|Reached a virologic endpoint|0
1249368|NCT00580801|4097523|P3|Overall Study|Lost to Follow-up|0
1249369|NCT00580801|4097524|P2|Overall Study|Lost to Follow-up|0
1249370|NCT00580801|4097525|P1|Overall Study|Lost to Follow-up|2
1249371|NCT00580801|4097523|P3|Overall Study|Adverse Event|0
1249372|NCT00580801|4097524|P2|Overall Study|Adverse Event|0
1249373|NCT00580801|4097525|P1|Overall Study|Adverse Event|2
1249374|NCT00580801|4097523|P3|Overall Study|Physician Decision|0
1249375|NCT00580801|4097524|P2|Overall Study|Physician Decision|0
1249376|NCT00580801|4097525|P1|Overall Study|Physician Decision|1
1249377|NCT00580788|4097564|P4|Overall Study|Adverse Event|1
1249378|NCT00580788|4097565|P3|Overall Study|Adverse Event|0
1249379|NCT00580788|4097566|P2|Overall Study|Adverse Event|0
1249380|NCT00580788|4097567|P1|Overall Study|Adverse Event|0
1249381|NCT00580723|4097625|P1|Overall Study|Lost to Follow-up|5
1249382|NCT00580723|4097625|P1|Overall Study|Did not want to participate in extension|3
1249383|NCT00580606|4097668|P2|Open Label (OL)|Needed Prohibited Medication|1
1249384|NCT00580606|4097669|P1|Open Label (OL)|Needed Prohibited Medication|0
1249385|NCT00580606|4097668|P2|Open Label (OL)|Physician Decision|1
1249386|NCT00580606|4097669|P1|Open Label (OL)|Physician Decision|1
1249387|NCT00580606|4097668|P2|Open Label (OL)|Non-compliance|0
1249388|NCT00580606|4097669|P1|Open Label (OL)|Non-compliance|2
1249389|NCT00580606|4097668|P2|Open Label (OL)|Pregnancy|1
1249390|NCT00580606|4097669|P1|Open Label (OL)|Pregnancy|0
1249391|NCT00580606|4097668|P2|Open Label (OL)|Lost to Follow-up|1
1249392|NCT00580606|4097669|P1|Open Label (OL)|Lost to Follow-up|0
1249393|NCT00580606|4097668|P2|Open Label (OL)|Dosing Symptoms|1
1249394|NCT00580606|4097669|P1|Open Label (OL)|Dosing Symptoms|0
1249395|NCT00580606|4097668|P2|Open Label (OL)|Withdrawal by Subject|6
1249396|NCT00580606|4097669|P1|Open Label (OL)|Withdrawal by Subject|4
1249397|NCT00580606|4097668|P2|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1
1249398|NCT00580606|4097669|P1|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2
1249399|NCT00580047|4097750|P3|Overall Study|Withdrawal by Subject|0
1249400|NCT00580047|4097751|P2|Overall Study|Withdrawal by Subject|0
1249401|NCT00580047|4097752|P1|Overall Study|Withdrawal by Subject|1
1249402|NCT00580047|4097750|P3|Overall Study|Withdrawal by Subject|2
1249403|NCT00580047|4097751|P2|Overall Study|Withdrawal by Subject|1
1249404|NCT00580047|4097752|P1|Overall Study|Withdrawal by Subject|1
1249405|NCT00580047|4097750|P3|Overall Study|Lost to Follow-up|0
1249406|NCT00580047|4097751|P2|Overall Study|Lost to Follow-up|1
1249407|NCT00580047|4097752|P1|Overall Study|Lost to Follow-up|1
1249408|NCT00580034|4097763|P2|Overall Study|Toxicity|0
1249409|NCT00580034|4097764|P1|Overall Study|Toxicity|10
1249410|NCT00579982|4097770|P1|Overall Study|Protocol Violation|4
1249411|NCT00579982|4097770|P1|Overall Study|Adverse Event|4
1249412|NCT00579826|4097791|P2|Overall Study|Withdrawal by Subject|3
1249413|NCT00579826|4097792|P1|Overall Study|Withdrawal by Subject|5
1249414|NCT00579670|4097826|P5|Overall Study|Withdrawal by Subject|0
1249415|NCT00579670|4097827|P4|Overall Study|Withdrawal by Subject|0
1249416|NCT00579670|4097828|P3|Overall Study|Withdrawal by Subject|1
1249417|NCT00579670|4097829|P2|Overall Study|Withdrawal by Subject|0
1249418|NCT00579670|4097830|P1|Overall Study|Withdrawal by Subject|0
1249419|NCT00579670|4097826|P5|Overall Study|Other|0
1249420|NCT00579670|4097827|P4|Overall Study|Other|2
1249421|NCT00579670|4097828|P3|Overall Study|Other|1
1249422|NCT00579670|4097829|P2|Overall Study|Other|0
1249423|NCT00579670|4097830|P1|Overall Study|Other|0
1249424|NCT00579670|4097826|P5|Overall Study|Lost to Follow-up|0
1249425|NCT00579670|4097827|P4|Overall Study|Lost to Follow-up|4
1249426|NCT00579670|4097828|P3|Overall Study|Lost to Follow-up|0
1249427|NCT00579670|4097829|P2|Overall Study|Lost to Follow-up|1
1249428|NCT00579670|4097830|P1|Overall Study|Lost to Follow-up|0
1249429|NCT00579670|4097826|P5|Overall Study|Lack of Efficacy|0
1249430|NCT00579670|4097827|P4|Overall Study|Lack of Efficacy|14
1249431|NCT00579670|4097828|P3|Overall Study|Lack of Efficacy|1
1249432|NCT00579670|4097829|P2|Overall Study|Lack of Efficacy|0
1249433|NCT00579670|4097830|P1|Overall Study|Lack of Efficacy|0
1249434|NCT00579670|4097826|P5|Overall Study|Adverse Event|0
1249435|NCT00579670|4097827|P4|Overall Study|Adverse Event|2
1249436|NCT00579670|4097828|P3|Overall Study|Adverse Event|1
1249437|NCT00579670|4097829|P2|Overall Study|Adverse Event|0
1249438|NCT00579670|4097830|P1|Overall Study|Adverse Event|1
1249439|NCT00579670|4097826|P5|Overall Study|Death|0
1249440|NCT00579670|4097827|P4|Overall Study|Death|0
1249441|NCT00579670|4097828|P3|Overall Study|Death|0
1249442|NCT00579670|4097829|P2|Overall Study|Death|0
1249443|NCT00579670|4097830|P1|Overall Study|Death|1
1249444|NCT00579501|4098042|P1|Overall Study|Radiation therapy before surgery|1
1249445|NCT00579501|4098042|P1|Overall Study|Secondary lesion|1
1249446|NCT00579501|4098042|P1|Overall Study|toxicity|1
1249447|NCT00579501|4098042|P1|Overall Study|End of neoadjuvant therapy|25
1249448|NCT00579501|4098042|P1|Overall Study|Death|1
1249449|NCT00579345|4098070|P8|Overall Study|Death|0
1249450|NCT00579345|4098071|P7|Overall Study|Death|0
1249451|NCT00579345|4098072|P6|Overall Study|Death|0
1249452|NCT00579345|4098073|P5|Overall Study|Death|0
1249453|NCT00579345|4098074|P4|Overall Study|Death|1
1249454|NCT00579345|4098075|P3|Overall Study|Death|1
1249455|NCT00579345|4098076|P2|Overall Study|Death|1
1249456|NCT00579345|4098077|P1|Overall Study|Death|1
1249457|NCT00579345|4098070|P8|Overall Study|Protocol Violation|1
1249458|NCT00579345|4098071|P7|Overall Study|Protocol Violation|0
1249459|NCT00579345|4098072|P6|Overall Study|Protocol Violation|0
1249460|NCT00579345|4098073|P5|Overall Study|Protocol Violation|0
1249461|NCT00579345|4098074|P4|Overall Study|Protocol Violation|0
1249462|NCT00579345|4098075|P3|Overall Study|Protocol Violation|0
1249463|NCT00579345|4098076|P2|Overall Study|Protocol Violation|0
1249464|NCT00579345|4098077|P1|Overall Study|Protocol Violation|1
1249465|NCT00579345|4098070|P8|Overall Study|Adverse Event|0
1249466|NCT00579345|4098071|P7|Overall Study|Adverse Event|0
1249467|NCT00579345|4098072|P6|Overall Study|Adverse Event|0
1249468|NCT00579345|4098073|P5|Overall Study|Adverse Event|0
1249469|NCT00579345|4098074|P4|Overall Study|Adverse Event|0
1249470|NCT00579345|4098075|P3|Overall Study|Adverse Event|1
1249471|NCT00579345|4098076|P2|Overall Study|Adverse Event|0
1249472|NCT00579345|4098077|P1|Overall Study|Adverse Event|0
1249473|NCT00579345|4098070|P8|Overall Study|Lost to Follow-up|0
1249474|NCT00579345|4098071|P7|Overall Study|Lost to Follow-up|0
1249475|NCT00579345|4098072|P6|Overall Study|Lost to Follow-up|0
1249476|NCT00579345|4098073|P5|Overall Study|Lost to Follow-up|0
1249477|NCT00579345|4098074|P4|Overall Study|Lost to Follow-up|0
1249478|NCT00579345|4098075|P3|Overall Study|Lost to Follow-up|0
1249479|NCT00579345|4098076|P2|Overall Study|Lost to Follow-up|0
1249480|NCT00579345|4098077|P1|Overall Study|Lost to Follow-up|1
1249481|NCT00579345|4098070|P8|Overall Study|Withdrawal by Subject|1
1249482|NCT00579345|4098071|P7|Overall Study|Withdrawal by Subject|0
1249483|NCT00579345|4098072|P6|Overall Study|Withdrawal by Subject|0
1249484|NCT00579345|4098073|P5|Overall Study|Withdrawal by Subject|0
1249485|NCT00579345|4098074|P4|Overall Study|Withdrawal by Subject|0
1249486|NCT00579345|4098075|P3|Overall Study|Withdrawal by Subject|0
1249487|NCT00579345|4098076|P2|Overall Study|Withdrawal by Subject|0
1249488|NCT00579345|4098077|P1|Overall Study|Withdrawal by Subject|2
1249489|NCT00579254|4098109|P1|Overall Study|Discontinued when study terminated|73
1249490|NCT00579254|4098109|P1|Overall Study|Lost to Follow-up|39
1249491|NCT00579098|4098133|P2|Overall Study|AF returned after ablation|2
1249492|NCT00579098|4098134|P1|Overall Study|AF returned after ablation|3
1249493|NCT00579098|4098133|P2|Overall Study|Withdrawal by Subject|3
1249494|NCT00579098|4098134|P1|Overall Study|Withdrawal by Subject|2
1249495|NCT00579098|4098133|P2|Overall Study|Adverse Event|3
1249496|NCT00579098|4098134|P1|Overall Study|Adverse Event|2
1249497|NCT00579098|4098133|P2|Overall Study|Lost to Follow-up|0
1249498|NCT00579098|4098134|P1|Overall Study|Lost to Follow-up|2
1249499|NCT00579059|4098150|P2|Overall Study|Study Canceled at 1 Year|10
1249500|NCT00579059|4098151|P1|Overall Study|Study Canceled at 1 Year|21
1249501|NCT00578942|4098225|P1|Overall Study|Lost to Follow-up|1
1249502|NCT00578877|4098264|P2|Overall Study|did not provide follow-up data|17
1249503|NCT00578877|4098265|P1|Overall Study|did not provide follow-up data|12
1249504|NCT00578877|4098264|P2|Overall Study|early discontinue|101
1249505|NCT00578877|4098265|P1|Overall Study|early discontinue|61
1249506|NCT00578877|4098264|P2|Overall Study|Lost to Follow-up|10
1249507|NCT00578877|4098265|P1|Overall Study|Lost to Follow-up|8
1249508|NCT00578864|4098273|P2|Overall Study|Death|0
1249509|NCT00578864|4098274|P1|Overall Study|Death|1
1249510|NCT00578812|4098290|P2|Overall Study|Not treated|7
1249511|NCT00578812|4098291|P1|Overall Study|Not treated|6
1249512|NCT00578786|4098330|P3|Overall Study|Qualified but Not Enrolled in Extension|0
1249513|NCT00578786|4098331|P2|Overall Study|Qualified but Not Enrolled in Extension|3
1249514|NCT00578786|4098332|P1|Overall Study|Qualified but Not Enrolled in Extension|0
1249515|NCT00578786|4098330|P3|Overall Study|Not Otherwise Specified|1
1249516|NCT00578786|4098331|P2|Overall Study|Not Otherwise Specified|4
1249517|NCT00578786|4098332|P1|Overall Study|Not Otherwise Specified|0
1249518|NCT00578786|4098330|P3|Overall Study|Pregnancy|0
1249519|NCT00578786|4098331|P2|Overall Study|Pregnancy|1
1249520|NCT00578786|4098332|P1|Overall Study|Pregnancy|0
1249521|NCT00578786|4098330|P3|Overall Study|Lost to Follow-up|0
1249522|NCT00578786|4098331|P2|Overall Study|Lost to Follow-up|4
1249523|NCT00578786|4098332|P1|Overall Study|Lost to Follow-up|0
1249524|NCT00578786|4098330|P3|Overall Study|Sponsor Decision|1
1249525|NCT00578786|4098331|P2|Overall Study|Sponsor Decision|0
1249526|NCT00578786|4098332|P1|Overall Study|Sponsor Decision|0
1249527|NCT00578786|4098330|P3|Overall Study|Physician Decision|1
1249528|NCT00578786|4098331|P2|Overall Study|Physician Decision|0
1249529|NCT00578786|4098332|P1|Overall Study|Physician Decision|1
1249530|NCT00578786|4098330|P3|Overall Study|Protocol Violation|1
1249531|NCT00578786|4098331|P2|Overall Study|Protocol Violation|3
1249532|NCT00578786|4098332|P1|Overall Study|Protocol Violation|0
1249533|NCT00578786|4098330|P3|Overall Study|Withdrawal by Subject|5
1249534|NCT00578786|4098331|P2|Overall Study|Withdrawal by Subject|8
1249535|NCT00578786|4098332|P1|Overall Study|Withdrawal by Subject|7
1249536|NCT00578786|4098330|P3|Overall Study|Early Escape from Prior Study|2
1249537|NCT00578786|4098331|P2|Overall Study|Early Escape from Prior Study|1
1249538|NCT00578786|4098332|P1|Overall Study|Early Escape from Prior Study|2
1249539|NCT00578786|4098330|P3|Overall Study|Lack of Efficacy|2
1249540|NCT00578786|4098331|P2|Overall Study|Lack of Efficacy|5
1249541|NCT00578786|4098332|P1|Overall Study|Lack of Efficacy|2
1249542|NCT00578786|4098330|P3|Overall Study|Adverse Event|17
1249543|NCT00578786|4098331|P2|Overall Study|Adverse Event|37
1249544|NCT00578786|4098332|P1|Overall Study|Adverse Event|27
1249545|NCT00578643|4098433|P1|Overall Study|Lost to Follow-up|1
1249546|NCT00578643|4098433|P1|Overall Study|Death|1
1249547|NCT00578565|4098449|P1|Overall Study|Adverse Event|3
1249548|NCT00578448|4098479|P1|1 Year Long Term Extension (LTE)|Adverse Event|1
1249549|NCT00578448|4098479|P1|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1
1249550|NCT00578448|4098479|P1|Day 1 up to 3 Years of Planned Study|Adverse Event|1
1249551|NCT00578448|4098479|P1|Day 1 up to 3 Years of Planned Study|Death|1
1249552|NCT00578318|4098543|P2|Overall Study|Physician Decision|0
1249553|NCT00578318|4098544|P1|Overall Study|Physician Decision|1
1249554|NCT00578318|4098543|P2|Overall Study|Lost to Follow-up|0
1249555|NCT00578318|4098544|P1|Overall Study|Lost to Follow-up|2
1249556|NCT00578227|4098626|P3|Overall Study|Withdrawal by Subject|3
1249557|NCT00578227|4098627|P2|Overall Study|Withdrawal by Subject|1
1249558|NCT00578227|4098628|P1|Overall Study|Withdrawal by Subject|5
1249559|NCT00578227|4098626|P3|Overall Study|Lost to Follow-up|1
1249560|NCT00578227|4098627|P2|Overall Study|Lost to Follow-up|1
1249561|NCT00578227|4098628|P1|Overall Study|Lost to Follow-up|0
1249562|NCT00578175|4098753|P3|Overall Study|Other reasons|23
1249563|NCT00578175|4098754|P2|Overall Study|Other reasons|42
1249564|NCT00578175|4098755|P1|Overall Study|Other reasons|70
1249565|NCT00578175|4098753|P3|Overall Study|Adverse Event|1
1249566|NCT00578175|4098754|P2|Overall Study|Adverse Event|1
1249567|NCT00578175|4098755|P1|Overall Study|Adverse Event|0
1249568|NCT00578136|4098834|P2|Overall Study|Not given intervention|1
1249569|NCT00578136|4098835|P1|Overall Study|Not given intervention|1
1249570|NCT00577889|4098853|P3|Overall Study|Withdrawal by Subject|0
1249571|NCT00577889|4098854|P2|Overall Study|Withdrawal by Subject|0
1249572|NCT00577889|4098855|P1|Overall Study|Withdrawal by Subject|1
1249573|NCT00577863|4098874|P2|Overall Study|Did Not Receive at Least One Injection|1
1249574|NCT00577863|4098875|P1|Overall Study|Did Not Receive at Least One Injection|0
1249575|NCT00577863|4098874|P2|Overall Study|Sponsor Decision|7
1249576|NCT00577863|4098875|P1|Overall Study|Sponsor Decision|2
1249577|NCT00577863|4098874|P2|Overall Study|Withdrawal by Subject|2
1249578|NCT00577863|4098875|P1|Overall Study|Withdrawal by Subject|0
1249579|NCT00577863|4098874|P2|Overall Study|Entry Criteria Exclusion|0
1249580|NCT00577863|4098875|P1|Overall Study|Entry Criteria Exclusion|1
1249581|NCT00577863|4098874|P2|Overall Study|Lost to Follow-up|2
1249582|NCT00577863|4098875|P1|Overall Study|Lost to Follow-up|2
1249583|NCT00577863|4098874|P2|Overall Study|Death|0
1249584|NCT00577863|4098875|P1|Overall Study|Death|1
1249585|NCT00577863|4098874|P2|Overall Study|Adverse Event|2
1249586|NCT00577863|4098875|P1|Overall Study|Adverse Event|4
1249587|NCT00577824|4098917|P3|Overall Study|Protocol Violation|0
1249588|NCT00577824|4098918|P2|Overall Study|Protocol Violation|1
1249589|NCT00577824|4098919|P1|Overall Study|Protocol Violation|1
1249590|NCT00577824|4098917|P3|Overall Study|Patient decision|1
1249591|NCT00577824|4098918|P2|Overall Study|Patient decision|1
1249592|NCT00577824|4098919|P1|Overall Study|Patient decision|0
1249593|NCT00577824|4098917|P3|Overall Study|Adverse Event|1
1249594|NCT00577824|4098918|P2|Overall Study|Adverse Event|18
1249595|NCT00577824|4098919|P1|Overall Study|Adverse Event|6
1249596|NCT00577772|4098977|P2|Overall Study|Lost to Follow-up|1
1249597|NCT00577772|4098978|P1|Overall Study|Lost to Follow-up|0
1249598|NCT00577720|4098988|P4|Overall Study|Withdrawal by Subject|2
1249599|NCT00577720|4098989|P3|Overall Study|Withdrawal by Subject|0
1249600|NCT00577720|4098990|P2|Overall Study|Withdrawal by Subject|0
1249601|NCT00577720|4098991|P1|Overall Study|Withdrawal by Subject|2
1249602|NCT00577720|4098988|P4|Overall Study|Protocol Violation|1
1249603|NCT00577720|4098989|P3|Overall Study|Protocol Violation|0
1249604|NCT00577720|4098990|P2|Overall Study|Protocol Violation|0
1249605|NCT00577720|4098991|P1|Overall Study|Protocol Violation|0
1249606|NCT00577720|4098988|P4|Overall Study|Lost to Follow-up|0
1249607|NCT00577720|4098989|P3|Overall Study|Lost to Follow-up|1
1249608|NCT00577720|4098990|P2|Overall Study|Lost to Follow-up|0
1249609|NCT00577720|4098991|P1|Overall Study|Lost to Follow-up|0
1249610|NCT00577720|4098988|P4|Overall Study|Adverse Event|4
1249611|NCT00577720|4098989|P3|Overall Study|Adverse Event|0
1249612|NCT00577720|4098990|P2|Overall Study|Adverse Event|1
1249613|NCT00577720|4098991|P1|Overall Study|Adverse Event|2
1249614|NCT00577707|4099009|P1|Overall Study|Withdrawal by Subject|3
1249615|NCT00577655|4099017|P2|Overall Study|Lost to Follow-up|1
1249616|NCT00577655|4099018|P1|Overall Study|Lost to Follow-up|1
1249617|NCT00577655|4099017|P2|Overall Study|Protocol Violation|1
1249618|NCT00577655|4099018|P1|Overall Study|Protocol Violation|0
1249619|NCT00577655|4099017|P2|Overall Study|Patient Request|2
1249620|NCT00577655|4099018|P1|Overall Study|Patient Request|0
1249621|NCT00577642|4099056|P1|Overall Study|Clinical Disease Progression|1
1249622|NCT00577629|4099060|P1|Long Term Follow-Up|Physician Decision|1
1249623|NCT00577629|4099060|P1|Long Term Follow-Up|Withdrawal by Subject|4
1249624|NCT00577629|4099060|P1|Long Term Follow-Up|Lost to Follow-up|5
1249625|NCT00577629|4099060|P1|Long Term Follow-Up|Death|15
1249626|NCT00577629|4099060|P1|Treatment Period|Death|1
1249627|NCT00577473|4099087|P2|Overall Study|Lack of Efficacy|7
1249628|NCT00577473|4099088|P1|Overall Study|Lack of Efficacy|8
1249629|NCT00577473|4099087|P2|Overall Study|Physician Decision|2
1249630|NCT00577473|4099088|P1|Overall Study|Physician Decision|2
1249631|NCT00577473|4099087|P2|Overall Study|Withdrawal by Subject|6
1249632|NCT00577473|4099088|P1|Overall Study|Withdrawal by Subject|2
1249633|NCT00577473|4099087|P2|Overall Study|Adverse Event|5
1249634|NCT00577473|4099088|P1|Overall Study|Adverse Event|8
1249635|NCT00577473|4099087|P2|Overall Study|Protocol Violation|4
1249636|NCT00577473|4099088|P1|Overall Study|Protocol Violation|1
1249637|NCT00577460|4099119|P3|Overall Study|not specified|2
1249638|NCT00577460|4099120|P2|Overall Study|not specified|3
1249639|NCT00577460|4099121|P1|Overall Study|not specified|0
1249640|NCT00577460|4099119|P3|Overall Study|Withdrawal by Subject|6
1249641|NCT00577460|4099120|P2|Overall Study|Withdrawal by Subject|5
1249642|NCT00577460|4099121|P1|Overall Study|Withdrawal by Subject|5
1249643|NCT00577460|4099119|P3|Overall Study|Lost to Follow-up|4
1249644|NCT00577460|4099120|P2|Overall Study|Lost to Follow-up|3
1249645|NCT00577460|4099121|P1|Overall Study|Lost to Follow-up|0
1249646|NCT00577460|4099119|P3|Overall Study|Protocol Violation|1
1249647|NCT00577460|4099120|P2|Overall Study|Protocol Violation|1
1249648|NCT00577460|4099121|P1|Overall Study|Protocol Violation|0
1249649|NCT00577460|4099119|P3|Overall Study|Adverse Event|14
1249650|NCT00577460|4099120|P2|Overall Study|Adverse Event|7
1249651|NCT00577460|4099121|P1|Overall Study|Adverse Event|11
1249652|NCT00577408|4099230|P2|Overall Study|Psychiatric hospitalization|1
1249653|NCT00577408|4099231|P1|Overall Study|Psychiatric hospitalization|0
1249654|NCT00577408|4099230|P2|Overall Study|Death|1
1249655|NCT00577408|4099231|P1|Overall Study|Death|0
1249656|NCT00577408|4099230|P2|Overall Study|Scheduling Issues|3
1249657|NCT00577408|4099231|P1|Overall Study|Scheduling Issues|0
1249658|NCT00577408|4099230|P2|Overall Study|Moved out of state|1
1249659|NCT00577408|4099231|P1|Overall Study|Moved out of state|0
1249660|NCT00577408|4099230|P2|Overall Study|Refused Oral Naltrexone|1
1249661|NCT00577408|4099231|P1|Overall Study|Refused Oral Naltrexone|0
1249662|NCT00577408|4099230|P2|Overall Study|Non-compliance with study meds|3
1249663|NCT00577408|4099231|P1|Overall Study|Non-compliance with study meds|0
1249664|NCT00577408|4099230|P2|Overall Study|Continued opioid use|2
1249665|NCT00577408|4099231|P1|Overall Study|Continued opioid use|3
1249666|NCT00577408|4099230|P2|Overall Study|Stopped attending study visits|11
1249667|NCT00577408|4099231|P1|Overall Study|Stopped attending study visits|9
1249668|NCT00577395|4099239|P2|Overall Study|Study was terminated early by Sponsor|6
1249669|NCT00577395|4099240|P1|Overall Study|Study was terminated early by Sponsor|7
1249670|NCT00577382|4099250|P2|Overall Study|Lost to Follow-up|2
1249671|NCT00577382|4099251|P1|Overall Study|Lost to Follow-up|2
1249672|NCT00577382|4099250|P2|Overall Study|Death|1
1249673|NCT00577382|4099251|P1|Overall Study|Death|1
1249674|NCT00577382|4099250|P2|Overall Study|Intercurrent Illness|2
1249675|NCT00577382|4099251|P1|Overall Study|Intercurrent Illness|1
1249676|NCT00577382|4099250|P2|Overall Study|Progressive Disease|19
1249677|NCT00577382|4099251|P1|Overall Study|Progressive Disease|17
1249678|NCT00577382|4099250|P2|Overall Study|Withdrawal by Subject|1
1249679|NCT00577382|4099251|P1|Overall Study|Withdrawal by Subject|0
1249680|NCT00577382|4099250|P2|Overall Study|Adverse Event|6
1249681|NCT00577382|4099251|P1|Overall Study|Adverse Event|0
1249682|NCT00577122|4099394|P2|Overall Study|Alternative Therapy|1
1249683|NCT00577122|4099395|P1|Overall Study|Alternative Therapy|0
1249684|NCT00577122|4099394|P2|Overall Study|Prog, refract disease during active trt|5
1249685|NCT00577122|4099395|P1|Overall Study|Prog, refract disease during active trt|8
1249686|NCT00577122|4099394|P2|Overall Study|Progression, relapse during active trt|8
1249687|NCT00577122|4099395|P1|Overall Study|Progression, relapse during active trt|6
1249688|NCT00577122|4099394|P2|Overall Study|Adverse Event|2
1249689|NCT00577122|4099395|P1|Overall Study|Adverse Event|0
1249690|NCT00577096|4099409|P2|Short Term Participation|Death|1
1249691|NCT00577096|4099410|P1|Short Term Participation|Death|1
1249692|NCT00577096|4099409|P2|Short Term Participation|Withdrawal by Subject|5
1249693|NCT00577096|4099410|P1|Short Term Participation|Withdrawal by Subject|3
1249694|NCT00577096|4099409|P2|Short Term Participation|withdrew from multiple myeloma treatment|2
1249695|NCT00577096|4099410|P1|Short Term Participation|withdrew from multiple myeloma treatment|3
1249696|NCT00577031|4099449|P1|Overall Study|Death|6
1249697|NCT00577031|4099449|P1|Overall Study|Medical decision|14
1249698|NCT00577031|4099449|P1|Overall Study|Need for surgery|17
1249699|NCT00577031|4099449|P1|Overall Study|Participant non-compliance|5
1249700|NCT00577031|4099449|P1|Overall Study|Participant withdrew consent|13
1249701|NCT00577031|4099449|P1|Overall Study|Protocol Violation|5
1249702|NCT00577031|4099449|P1|Overall Study|Progression of disease|93
1249703|NCT00577031|4099449|P1|Overall Study|Adverse Event|52
1249704|NCT00577005|4099470|P2|Overall Study|Withdrawal by Subject|1
1249705|NCT00577005|4099471|P1|Overall Study|Withdrawal by Subject|2
1249706|NCT00577005|4099470|P2|Overall Study|Lost to Follow-up|2
1249707|NCT00577005|4099471|P1|Overall Study|Lost to Follow-up|3
1249708|NCT00576927|4099485|P1|Sleep Hygiene With the Placebo|Withdrawal by Subject|1
1249709|NCT00576927|4099485|P1|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1
1249710|NCT00576927|4099485|P1|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1
1249711|NCT00576927|4099485|P1|Sleep Hygiene Behavioral Intervention|Death|1
1249712|NCT00576927|4099485|P1|Sleep Hygiene Behavioral Intervention|Responded to intervention|4
1249713|NCT00576927|4099485|P1|Baseline|Withdrawal by Subject|3
1249714|NCT00576927|4099485|P1|Baseline|Medication Change by PCP of subject|1
1249715|NCT00576927|4099485|P1|Baseline|Physician Decision|9
1249716|NCT00576927|4099485|P1|Clinical Assessment|Physician Decision|1
1249717|NCT00576927|4099485|P1|Clinical Assessment|Withdrawal by Subject|10
1249718|NCT00576927|4099485|P1|Clinical Assessment|Death|1
1249719|NCT00576927|4099485|P1|Clinical Assessment|Lack of Efficacy|24
1249720|NCT00576901|4099497|P1|Overall Study|Protocol Violation|1
1249721|NCT00576901|4099497|P1|Overall Study|Disease course|1
1249722|NCT00576901|4099497|P1|Overall Study|Withdrawal by Subject|1
1249723|NCT00576823|4099508|P3|40-week Safety Extension Phase|Lack of Efficacy|0
1249724|NCT00576823|4099509|P2|40-week Safety Extension Phase|Lack of Efficacy|0
1249725|NCT00576823|4099510|P1|40-week Safety Extension Phase|Lack of Efficacy|1
1249726|NCT00576823|4099508|P3|12-week Efficacy Phase|Parentʼs schedule issue|0
1249727|NCT00576823|4099509|P2|12-week Efficacy Phase|Parentʼs schedule issue|0
1249728|NCT00576823|4099510|P1|12-week Efficacy Phase|Parentʼs schedule issue|1
1249729|NCT00576758|4099526|P2|Follow-up Period|Withdrew consent|1
1249730|NCT00576758|4099527|P1|Follow-up Period|Withdrew consent|2
1249731|NCT00576758|4099526|P2|Follow-up Period|Insufficient therapeutic response|5
1249732|NCT00576758|4099527|P1|Follow-up Period|Insufficient therapeutic response|16
1249733|NCT00576758|4099526|P2|Follow-up Period|Death|3
1249734|NCT00576758|4099527|P1|Follow-up Period|Death|3
1249735|NCT00576758|4099526|P2|Follow-up Period|Administrative/Other|8
1249736|NCT00576758|4099527|P1|Follow-up Period|Administrative/Other|6
1249737|NCT00576758|4099526|P2|Extension Treatment Period|Administrative/Other|1
1249738|NCT00576758|4099527|P1|Extension Treatment Period|Administrative/Other|3
1249739|NCT00576758|4099526|P2|Extension Treatment Period|Insufficient therapeutic response|33
1249740|NCT00576758|4099527|P1|Extension Treatment Period|Insufficient therapeutic response|30
1249741|NCT00576758|4099526|P2|Extension Treatment Period|Refused treatment/did not cooperate|1
1249742|NCT00576758|4099527|P1|Extension Treatment Period|Refused treatment/did not cooperate|2
1249743|NCT00576758|4099526|P2|Extension Treatment Period|Death|1
1249744|NCT00576758|4099527|P1|Extension Treatment Period|Death|1
1249745|NCT00576758|4099526|P2|Extension Treatment Period|Adverse event or Intercurrent illness|7
1249746|NCT00576758|4099527|P1|Extension Treatment Period|Adverse event or Intercurrent illness|6
1249747|NCT00576758|4099526|P2|Induction Treatment Period|Withdrew consent|0
1249748|NCT00576758|4099527|P1|Induction Treatment Period|Withdrew consent|1
1249749|NCT00576758|4099526|P2|Induction Treatment Period|Refused treatment/ Did not Cooperate|1
1249750|NCT00576758|4099527|P1|Induction Treatment Period|Refused treatment/ Did not Cooperate|0
1249751|NCT00576758|4099526|P2|Induction Treatment Period|Death|0
1249752|NCT00576758|4099527|P1|Induction Treatment Period|Death|1
1249753|NCT00576758|4099526|P2|Induction Treatment Period|Violation of selection criteria at entry|1
1249754|NCT00576758|4099527|P1|Induction Treatment Period|Violation of selection criteria at entry|1
1249755|NCT00576758|4099526|P2|Induction Treatment Period|Insufficient therapeutic response|0
1249756|NCT00576758|4099527|P1|Induction Treatment Period|Insufficient therapeutic response|2
1249757|NCT00576758|4099526|P2|Induction Treatment Period|Adverse event or Intercurrent illness|3
1249758|NCT00576758|4099527|P1|Induction Treatment Period|Adverse event or Intercurrent illness|3
1249759|NCT00576732|4099573|P6|OPEN LABEL|Protocol Violation|0
1249760|NCT00576732|4099574|P5|OPEN LABEL|Protocol Violation|1
1249761|NCT00576732|4099575|P4|OPEN LABEL|Protocol Violation|2
1249762|NCT00576732|4099576|P3|OPEN LABEL|Protocol Violation|0
1249763|NCT00576732|4099577|P2|OPEN LABEL|Protocol Violation|0
1249764|NCT00576732|4099578|P1|OPEN LABEL|Protocol Violation|0
1249765|NCT00576732|4099573|P6|OPEN LABEL|Lack of Efficacy|3
1249766|NCT00576732|4099574|P5|OPEN LABEL|Lack of Efficacy|2
1249767|NCT00576732|4099575|P4|OPEN LABEL|Lack of Efficacy|2
1249768|NCT00576732|4099576|P3|OPEN LABEL|Lack of Efficacy|0
1249769|NCT00576732|4099577|P2|OPEN LABEL|Lack of Efficacy|0
1249770|NCT00576732|4099578|P1|OPEN LABEL|Lack of Efficacy|0
1249771|NCT00576732|4099573|P6|OPEN LABEL|OTHER|2
1249772|NCT00576732|4099574|P5|OPEN LABEL|OTHER|0
1249773|NCT00576732|4099575|P4|OPEN LABEL|OTHER|0
1249774|NCT00576732|4099576|P3|OPEN LABEL|OTHER|0
1249775|NCT00576732|4099577|P2|OPEN LABEL|OTHER|0
1249776|NCT00576732|4099578|P1|OPEN LABEL|OTHER|0
1249777|NCT00576732|4099573|P6|OPEN LABEL|Withdrawal by Subject|1
1249778|NCT00576732|4099574|P5|OPEN LABEL|Withdrawal by Subject|0
1249779|NCT00576732|4099575|P4|OPEN LABEL|Withdrawal by Subject|1
1249780|NCT00576732|4099576|P3|OPEN LABEL|Withdrawal by Subject|0
1249781|NCT00576732|4099577|P2|OPEN LABEL|Withdrawal by Subject|0
1249782|NCT00576732|4099578|P1|OPEN LABEL|Withdrawal by Subject|0
1249783|NCT00576732|4099573|P6|OPEN LABEL|Lost to Follow-up|1
1249784|NCT00576732|4099574|P5|OPEN LABEL|Lost to Follow-up|1
1249785|NCT00576732|4099575|P4|OPEN LABEL|Lost to Follow-up|2
1249786|NCT00576732|4099576|P3|OPEN LABEL|Lost to Follow-up|0
1249787|NCT00576732|4099577|P2|OPEN LABEL|Lost to Follow-up|0
1249788|NCT00576732|4099578|P1|OPEN LABEL|Lost to Follow-up|0
1249789|NCT00576732|4099573|P6|OPEN LABEL|Adverse Event|1
1249790|NCT00576732|4099574|P5|OPEN LABEL|Adverse Event|0
1249791|NCT00576732|4099575|P4|OPEN LABEL|Adverse Event|4
1249792|NCT00576732|4099576|P3|OPEN LABEL|Adverse Event|0
1249793|NCT00576732|4099577|P2|OPEN LABEL|Adverse Event|0
1249794|NCT00576732|4099578|P1|OPEN LABEL|Adverse Event|0
1249795|NCT00576732|4099573|P6|DOUBLE BLIND|Protocol Violation|0
1249796|NCT00576732|4099574|P5|DOUBLE BLIND|Protocol Violation|0
1249797|NCT00576732|4099575|P4|DOUBLE BLIND|Protocol Violation|0
1249798|NCT00576732|4099576|P3|DOUBLE BLIND|Protocol Violation|0
1249799|NCT00576732|4099577|P2|DOUBLE BLIND|Protocol Violation|0
1249800|NCT00576732|4099578|P1|DOUBLE BLIND|Protocol Violation|1
1249801|NCT00576732|4099573|P6|DOUBLE BLIND|Lack of Efficacy|0
1249802|NCT00576732|4099574|P5|DOUBLE BLIND|Lack of Efficacy|0
1249803|NCT00576732|4099575|P4|DOUBLE BLIND|Lack of Efficacy|0
1249804|NCT00576732|4099576|P3|DOUBLE BLIND|Lack of Efficacy|0
1249805|NCT00576732|4099577|P2|DOUBLE BLIND|Lack of Efficacy|1
1249806|NCT00576732|4099578|P1|DOUBLE BLIND|Lack of Efficacy|6
1249807|NCT00576732|4099573|P6|DOUBLE BLIND|OTHER|0
1249808|NCT00576732|4099574|P5|DOUBLE BLIND|OTHER|0
1249809|NCT00576732|4099575|P4|DOUBLE BLIND|OTHER|0
1249810|NCT00576732|4099576|P3|DOUBLE BLIND|OTHER|1
1249811|NCT00576732|4099577|P2|DOUBLE BLIND|OTHER|2
1249812|NCT00576732|4099578|P1|DOUBLE BLIND|OTHER|0
1249813|NCT00576732|4099573|P6|DOUBLE BLIND|Withdrawal by Subject|0
1249814|NCT00576732|4099574|P5|DOUBLE BLIND|Withdrawal by Subject|0
1249815|NCT00576732|4099575|P4|DOUBLE BLIND|Withdrawal by Subject|0
1249816|NCT00576732|4099576|P3|DOUBLE BLIND|Withdrawal by Subject|3
1249817|NCT00576732|4099577|P2|DOUBLE BLIND|Withdrawal by Subject|1
1249818|NCT00576732|4099578|P1|DOUBLE BLIND|Withdrawal by Subject|1
1249819|NCT00576732|4099573|P6|DOUBLE BLIND|Lost to Follow-up|0
1249820|NCT00576732|4099574|P5|DOUBLE BLIND|Lost to Follow-up|0
1249821|NCT00576732|4099575|P4|DOUBLE BLIND|Lost to Follow-up|0
1249822|NCT00576732|4099576|P3|DOUBLE BLIND|Lost to Follow-up|1
1249823|NCT00576732|4099577|P2|DOUBLE BLIND|Lost to Follow-up|1
1249824|NCT00576732|4099578|P1|DOUBLE BLIND|Lost to Follow-up|0
1249825|NCT00576732|4099573|P6|DOUBLE BLIND|Adverse Event|0
1249826|NCT00576732|4099574|P5|DOUBLE BLIND|Adverse Event|0
1249827|NCT00576732|4099575|P4|DOUBLE BLIND|Adverse Event|0
1249828|NCT00576732|4099576|P3|DOUBLE BLIND|Adverse Event|1
1249829|NCT00576732|4099577|P2|DOUBLE BLIND|Adverse Event|0
1249830|NCT00576732|4099578|P1|DOUBLE BLIND|Adverse Event|0
1249831|NCT00576693|4099610|P2|Overall Study|Withdrawal by Subject|13
1249832|NCT00576693|4099611|P1|Overall Study|Withdrawal by Subject|3
1249833|NCT00576693|4099610|P2|Overall Study|Lost to Follow-up|11
1249834|NCT00576693|4099611|P1|Overall Study|Lost to Follow-up|7
1249835|NCT00576628|4099617|P1|Overall Study|Dialysis|15
1249836|NCT00576628|4099617|P1|Overall Study|Transplantation|1
1249837|NCT00576628|4099617|P1|Overall Study|The patient move into other town|1
1249838|NCT00576628|4099617|P1|Overall Study|Progression of Renal Failure|1
1249839|NCT00576628|4099617|P1|Overall Study|Progression of Kidney Disease|1
1249840|NCT00576628|4099617|P1|Overall Study|RBC transfusion|1
1249841|NCT00576628|4099617|P1|Overall Study|Pregnancy|1
1249842|NCT00576628|4099617|P1|Overall Study|Refused Treatment|8
1249843|NCT00576628|4099617|P1|Overall Study|Failure to return|1
1249844|NCT00576628|4099617|P1|Overall Study|Death|2
1249845|NCT00576628|4099617|P1|Overall Study|Adverse Event|11
1249846|NCT00576576|4099637|P1|Overall Study|Protocol Violation|1
1249847|NCT00576576|4099637|P1|Overall Study|Lost to Follow-up|6
1249848|NCT00576472|4099671|P15|MPH Home Maintenance Phase|Lost to Follow-up|3
1249849|NCT00576472|4099672|P14|MPH Home Maintenance Phase|Lost to Follow-up|0
1249850|NCT00576472|4099673|P13|MPH Home Maintenance Phase|Lost to Follow-up|0
1249851|NCT00576472|4099674|P12|MPH Home Maintenance Phase|Lost to Follow-up|0
1249852|NCT00576472|4099675|P11|MPH Home Maintenance Phase|Lost to Follow-up|0
1249853|NCT00576472|4099676|P10|MPH Home Maintenance Phase|Lost to Follow-up|0
1249854|NCT00576472|4099677|P9|MPH Home Maintenance Phase|Lost to Follow-up|0
1249855|NCT00576472|4099678|P8|MPH Home Maintenance Phase|Lost to Follow-up|0
1249856|NCT00576472|4099679|P7|MPH Home Maintenance Phase|Lost to Follow-up|0
1249857|NCT00576472|4099680|P6|MPH Home Maintenance Phase|Lost to Follow-up|0
1249858|NCT00576472|4099681|P5|MPH Home Maintenance Phase|Lost to Follow-up|0
1249859|NCT00576472|4099682|P4|MPH Home Maintenance Phase|Lost to Follow-up|0
1249860|NCT00576472|4099683|P3|MPH Home Maintenance Phase|Lost to Follow-up|0
1249861|NCT00576472|4099684|P2|MPH Home Maintenance Phase|Lost to Follow-up|0
1249862|NCT00576472|4099685|P1|MPH Home Maintenance Phase|Lost to Follow-up|0
1249863|NCT00576472|4099671|P15|MPH Home Maintenance Phase|Medical reasons|6
1249864|NCT00576472|4099672|P14|MPH Home Maintenance Phase|Medical reasons|0
1249865|NCT00576472|4099673|P13|MPH Home Maintenance Phase|Medical reasons|0
1249866|NCT00576472|4099674|P12|MPH Home Maintenance Phase|Medical reasons|0
1249867|NCT00576472|4099675|P11|MPH Home Maintenance Phase|Medical reasons|0
1249868|NCT00576472|4099676|P10|MPH Home Maintenance Phase|Medical reasons|0
1249869|NCT00576472|4099677|P9|MPH Home Maintenance Phase|Medical reasons|0
1249870|NCT00576472|4099678|P8|MPH Home Maintenance Phase|Medical reasons|0
1249871|NCT00576472|4099679|P7|MPH Home Maintenance Phase|Medical reasons|0
1249872|NCT00576472|4099680|P6|MPH Home Maintenance Phase|Medical reasons|0
1249873|NCT00576472|4099681|P5|MPH Home Maintenance Phase|Medical reasons|0
1249874|NCT00576472|4099682|P4|MPH Home Maintenance Phase|Medical reasons|0
1249875|NCT00576472|4099683|P3|MPH Home Maintenance Phase|Medical reasons|0
1249876|NCT00576472|4099684|P2|MPH Home Maintenance Phase|Medical reasons|0
1249877|NCT00576472|4099685|P1|MPH Home Maintenance Phase|Medical reasons|0
1249878|NCT00576472|4099671|P15|MPH Home Maintenance Phase|Withdrawal by Subject|6
1249879|NCT00576472|4099672|P14|MPH Home Maintenance Phase|Withdrawal by Subject|0
1249880|NCT00576472|4099673|P13|MPH Home Maintenance Phase|Withdrawal by Subject|0
1249881|NCT00576472|4099674|P12|MPH Home Maintenance Phase|Withdrawal by Subject|0
1249882|NCT00576472|4099675|P11|MPH Home Maintenance Phase|Withdrawal by Subject|0
1249883|NCT00576472|4099676|P10|MPH Home Maintenance Phase|Withdrawal by Subject|0
1249884|NCT00576472|4099677|P9|MPH Home Maintenance Phase|Withdrawal by Subject|0
1249885|NCT00576472|4099678|P8|MPH Home Maintenance Phase|Withdrawal by Subject|0
1249886|NCT00576472|4099679|P7|MPH Home Maintenance Phase|Withdrawal by Subject|0
1249887|NCT00576472|4099680|P6|MPH Home Maintenance Phase|Withdrawal by Subject|0
1249888|NCT00576472|4099681|P5|MPH Home Maintenance Phase|Withdrawal by Subject|0
1249889|NCT00576472|4099682|P4|MPH Home Maintenance Phase|Withdrawal by Subject|0
1249890|NCT00576472|4099683|P3|MPH Home Maintenance Phase|Withdrawal by Subject|0
1249891|NCT00576472|4099684|P2|MPH Home Maintenance Phase|Withdrawal by Subject|0
1249892|NCT00576472|4099685|P1|MPH Home Maintenance Phase|Withdrawal by Subject|0
1249893|NCT00576472|4099671|P15|MPH Home Maintenance Phase|Side effects|8
1249894|NCT00576472|4099672|P14|MPH Home Maintenance Phase|Side effects|0
1249895|NCT00576472|4099673|P13|MPH Home Maintenance Phase|Side effects|0
1249896|NCT00576472|4099674|P12|MPH Home Maintenance Phase|Side effects|0
1249897|NCT00576472|4099675|P11|MPH Home Maintenance Phase|Side effects|0
1249898|NCT00576472|4099676|P10|MPH Home Maintenance Phase|Side effects|0
1249899|NCT00576472|4099677|P9|MPH Home Maintenance Phase|Side effects|0
1249900|NCT00576472|4099678|P8|MPH Home Maintenance Phase|Side effects|0
1249901|NCT00576472|4099679|P7|MPH Home Maintenance Phase|Side effects|0
1249902|NCT00576472|4099680|P6|MPH Home Maintenance Phase|Side effects|0
1249903|NCT00576472|4099681|P5|MPH Home Maintenance Phase|Side effects|0
1249904|NCT00576472|4099682|P4|MPH Home Maintenance Phase|Side effects|0
1249905|NCT00576472|4099683|P3|MPH Home Maintenance Phase|Side effects|0
1249906|NCT00576472|4099684|P2|MPH Home Maintenance Phase|Side effects|0
1249907|NCT00576472|4099685|P1|MPH Home Maintenance Phase|Side effects|0
1249908|NCT00576472|4099671|P15|MPH Home Maintenance Phase|Insufficient data|0
1249909|NCT00576472|4099672|P14|MPH Home Maintenance Phase|Insufficient data|4
1249910|NCT00576472|4099673|P13|MPH Home Maintenance Phase|Insufficient data|0
1249911|NCT00576472|4099674|P12|MPH Home Maintenance Phase|Insufficient data|0
1249912|NCT00576472|4099675|P11|MPH Home Maintenance Phase|Insufficient data|0
1249913|NCT00576472|4099676|P10|MPH Home Maintenance Phase|Insufficient data|0
1249914|NCT00576472|4099677|P9|MPH Home Maintenance Phase|Insufficient data|0
1249915|NCT00576472|4099678|P8|MPH Home Maintenance Phase|Insufficient data|0
1249916|NCT00576472|4099679|P7|MPH Home Maintenance Phase|Insufficient data|0
1249917|NCT00576472|4099680|P6|MPH Home Maintenance Phase|Insufficient data|0
1249918|NCT00576472|4099681|P5|MPH Home Maintenance Phase|Insufficient data|0
1249919|NCT00576472|4099682|P4|MPH Home Maintenance Phase|Insufficient data|0
1249920|NCT00576472|4099683|P3|MPH Home Maintenance Phase|Insufficient data|0
1249921|NCT00576472|4099684|P2|MPH Home Maintenance Phase|Insufficient data|0
1249922|NCT00576472|4099685|P1|MPH Home Maintenance Phase|Insufficient data|0
1249923|NCT00576472|4099671|P15|MPH Home Maintenance Phase|Declined to participate|0
1249924|NCT00576472|4099672|P14|MPH Home Maintenance Phase|Declined to participate|7
1249925|NCT00576472|4099673|P13|MPH Home Maintenance Phase|Declined to participate|0
1249926|NCT00576472|4099674|P12|MPH Home Maintenance Phase|Declined to participate|0
1249927|NCT00576472|4099675|P11|MPH Home Maintenance Phase|Declined to participate|0
1249928|NCT00576472|4099676|P10|MPH Home Maintenance Phase|Declined to participate|0
1249929|NCT00576472|4099677|P9|MPH Home Maintenance Phase|Declined to participate|0
1249930|NCT00576472|4099678|P8|MPH Home Maintenance Phase|Declined to participate|0
1249931|NCT00576472|4099679|P7|MPH Home Maintenance Phase|Declined to participate|0
1249932|NCT00576472|4099680|P6|MPH Home Maintenance Phase|Declined to participate|0
1249933|NCT00576472|4099681|P5|MPH Home Maintenance Phase|Declined to participate|0
1249934|NCT00576472|4099682|P4|MPH Home Maintenance Phase|Declined to participate|0
1249935|NCT00576472|4099683|P3|MPH Home Maintenance Phase|Declined to participate|0
1249936|NCT00576472|4099684|P2|MPH Home Maintenance Phase|Declined to participate|0
1249937|NCT00576472|4099685|P1|MPH Home Maintenance Phase|Declined to participate|0
1249938|NCT00576472|4099671|P15|MPH Home Maintenance Phase|Did not meet response criteria|0
1249939|NCT00576472|4099672|P14|MPH Home Maintenance Phase|Did not meet response criteria|16
1249940|NCT00576472|4099673|P13|MPH Home Maintenance Phase|Did not meet response criteria|0
1249941|NCT00576472|4099674|P12|MPH Home Maintenance Phase|Did not meet response criteria|0
1249942|NCT00576472|4099675|P11|MPH Home Maintenance Phase|Did not meet response criteria|0
1249943|NCT00576472|4099676|P10|MPH Home Maintenance Phase|Did not meet response criteria|0
1249944|NCT00576472|4099677|P9|MPH Home Maintenance Phase|Did not meet response criteria|0
1249945|NCT00576472|4099678|P8|MPH Home Maintenance Phase|Did not meet response criteria|0
1249946|NCT00576472|4099679|P7|MPH Home Maintenance Phase|Did not meet response criteria|0
1249947|NCT00576472|4099680|P6|MPH Home Maintenance Phase|Did not meet response criteria|0
1249948|NCT00576472|4099681|P5|MPH Home Maintenance Phase|Did not meet response criteria|0
1249949|NCT00576472|4099682|P4|MPH Home Maintenance Phase|Did not meet response criteria|0
1249950|NCT00576472|4099683|P3|MPH Home Maintenance Phase|Did not meet response criteria|0
1249951|NCT00576472|4099684|P2|MPH Home Maintenance Phase|Did not meet response criteria|0
1249952|NCT00576472|4099685|P1|MPH Home Maintenance Phase|Did not meet response criteria|0
1249953|NCT00576472|4099671|P15|MPH Cross Over Phase|Did not complete cross over phase|0
1249954|NCT00576472|4099672|P14|MPH Cross Over Phase|Did not complete cross over phase|0
1249955|NCT00576472|4099673|P13|MPH Cross Over Phase|Did not complete cross over phase|0
1249956|NCT00576472|4099674|P12|MPH Cross Over Phase|Did not complete cross over phase|1
1249957|NCT00576472|4099675|P11|MPH Cross Over Phase|Did not complete cross over phase|1
1249958|NCT00576472|4099676|P10|MPH Cross Over Phase|Did not complete cross over phase|0
1249959|NCT00576472|4099677|P9|MPH Cross Over Phase|Did not complete cross over phase|2
1249960|NCT00576472|4099678|P8|MPH Cross Over Phase|Did not complete cross over phase|0
1249961|NCT00576472|4099679|P7|MPH Cross Over Phase|Did not complete cross over phase|0
1249962|NCT00576472|4099680|P6|MPH Cross Over Phase|Did not complete cross over phase|0
1249963|NCT00576472|4099681|P5|MPH Cross Over Phase|Did not complete cross over phase|0
1249964|NCT00576472|4099682|P4|MPH Cross Over Phase|Did not complete cross over phase|0
1249965|NCT00576472|4099683|P3|MPH Cross Over Phase|Did not complete cross over phase|0
1249966|NCT00576472|4099684|P2|MPH Cross Over Phase|Did not complete cross over phase|0
1249967|NCT00576472|4099685|P1|MPH Cross Over Phase|Did not complete cross over phase|0
1249968|NCT00576472|4099671|P15|MPH Cross Over Phase|Physician Decision|0
1249969|NCT00576472|4099672|P14|MPH Cross Over Phase|Physician Decision|0
1249970|NCT00576472|4099673|P13|MPH Cross Over Phase|Physician Decision|0
1249971|NCT00576472|4099674|P12|MPH Cross Over Phase|Physician Decision|0
1249972|NCT00576472|4099675|P11|MPH Cross Over Phase|Physician Decision|0
1249973|NCT00576472|4099676|P10|MPH Cross Over Phase|Physician Decision|0
1249974|NCT00576472|4099677|P9|MPH Cross Over Phase|Physician Decision|0
1249975|NCT00576472|4099678|P8|MPH Cross Over Phase|Physician Decision|0
1249976|NCT00576472|4099679|P7|MPH Cross Over Phase|Physician Decision|4
1249977|NCT00576472|4099680|P6|MPH Cross Over Phase|Physician Decision|0
1249978|NCT00576472|4099681|P5|MPH Cross Over Phase|Physician Decision|0
1249979|NCT00576472|4099682|P4|MPH Cross Over Phase|Physician Decision|0
1249980|NCT00576472|4099683|P3|MPH Cross Over Phase|Physician Decision|0
1249981|NCT00576472|4099684|P2|MPH Cross Over Phase|Physician Decision|0
1249982|NCT00576472|4099685|P1|MPH Cross Over Phase|Physician Decision|0
1249983|NCT00576472|4099671|P15|MPH Cross Over Phase|Ineligible due to disease|0
1249984|NCT00576472|4099672|P14|MPH Cross Over Phase|Ineligible due to disease|0
1249985|NCT00576472|4099673|P13|MPH Cross Over Phase|Ineligible due to disease|0
1249986|NCT00576472|4099674|P12|MPH Cross Over Phase|Ineligible due to disease|0
1249987|NCT00576472|4099675|P11|MPH Cross Over Phase|Ineligible due to disease|0
1249988|NCT00576472|4099676|P10|MPH Cross Over Phase|Ineligible due to disease|0
1249989|NCT00576472|4099677|P9|MPH Cross Over Phase|Ineligible due to disease|0
1249990|NCT00576472|4099678|P8|MPH Cross Over Phase|Ineligible due to disease|0
1249991|NCT00576472|4099679|P7|MPH Cross Over Phase|Ineligible due to disease|2
1249992|NCT00576472|4099680|P6|MPH Cross Over Phase|Ineligible due to disease|0
1249993|NCT00576472|4099681|P5|MPH Cross Over Phase|Ineligible due to disease|0
1249994|NCT00576472|4099682|P4|MPH Cross Over Phase|Ineligible due to disease|0
1249995|NCT00576472|4099683|P3|MPH Cross Over Phase|Ineligible due to disease|0
1249996|NCT00576472|4099684|P2|MPH Cross Over Phase|Ineligible due to disease|0
1249997|NCT00576472|4099685|P1|MPH Cross Over Phase|Ineligible due to disease|0
1249998|NCT00576472|4099671|P15|MPH Cross Over Phase|Withdrawal by Subject|0
1249999|NCT00576472|4099672|P14|MPH Cross Over Phase|Withdrawal by Subject|0
1250000|NCT00576472|4099673|P13|MPH Cross Over Phase|Withdrawal by Subject|0
1250001|NCT00576472|4099674|P12|MPH Cross Over Phase|Withdrawal by Subject|0
1250002|NCT00576472|4099675|P11|MPH Cross Over Phase|Withdrawal by Subject|0
1250003|NCT00576472|4099676|P10|MPH Cross Over Phase|Withdrawal by Subject|0
1250004|NCT00576472|4099677|P9|MPH Cross Over Phase|Withdrawal by Subject|0
1250005|NCT00576472|4099678|P8|MPH Cross Over Phase|Withdrawal by Subject|0
1250006|NCT00576472|4099679|P7|MPH Cross Over Phase|Withdrawal by Subject|6
1250007|NCT00576472|4099680|P6|MPH Cross Over Phase|Withdrawal by Subject|0
1250008|NCT00576472|4099681|P5|MPH Cross Over Phase|Withdrawal by Subject|0
1250009|NCT00576472|4099682|P4|MPH Cross Over Phase|Withdrawal by Subject|0
1250010|NCT00576472|4099683|P3|MPH Cross Over Phase|Withdrawal by Subject|0
1250011|NCT00576472|4099684|P2|MPH Cross Over Phase|Withdrawal by Subject|0
1250012|NCT00576472|4099685|P1|MPH Cross Over Phase|Withdrawal by Subject|0
1250013|NCT00576472|4099671|P15|MPH In-Lab Phase|Psychiatric exclusion|0
1250014|NCT00576472|4099672|P14|MPH In-Lab Phase|Psychiatric exclusion|0
1250015|NCT00576472|4099673|P13|MPH In-Lab Phase|Psychiatric exclusion|0
1250016|NCT00576472|4099674|P12|MPH In-Lab Phase|Psychiatric exclusion|0
1250017|NCT00576472|4099675|P11|MPH In-Lab Phase|Psychiatric exclusion|0
1250018|NCT00576472|4099676|P10|MPH In-Lab Phase|Psychiatric exclusion|0
1250019|NCT00576472|4099677|P9|MPH In-Lab Phase|Psychiatric exclusion|0
1250020|NCT00576472|4099678|P8|MPH In-Lab Phase|Psychiatric exclusion|0
1250021|NCT00576472|4099679|P7|MPH In-Lab Phase|Psychiatric exclusion|0
1250022|NCT00576472|4099680|P6|MPH In-Lab Phase|Psychiatric exclusion|0
1250023|NCT00576472|4099681|P5|MPH In-Lab Phase|Psychiatric exclusion|0
1250024|NCT00576472|4099682|P4|MPH In-Lab Phase|Psychiatric exclusion|10
1250025|NCT00576472|4099683|P3|MPH In-Lab Phase|Psychiatric exclusion|0
1250026|NCT00576472|4099684|P2|MPH In-Lab Phase|Psychiatric exclusion|0
1250027|NCT00576472|4099685|P1|MPH In-Lab Phase|Psychiatric exclusion|0
1250028|NCT00576472|4099671|P15|MPH In-Lab Phase|No attention/academic problems|0
1250029|NCT00576472|4099672|P14|MPH In-Lab Phase|No attention/academic problems|0
1250030|NCT00576472|4099673|P13|MPH In-Lab Phase|No attention/academic problems|0
1250031|NCT00576472|4099674|P12|MPH In-Lab Phase|No attention/academic problems|0
1250032|NCT00576472|4099675|P11|MPH In-Lab Phase|No attention/academic problems|0
1250033|NCT00576472|4099676|P10|MPH In-Lab Phase|No attention/academic problems|0
1250034|NCT00576472|4099677|P9|MPH In-Lab Phase|No attention/academic problems|0
1250035|NCT00576472|4099678|P8|MPH In-Lab Phase|No attention/academic problems|0
1250036|NCT00576472|4099679|P7|MPH In-Lab Phase|No attention/academic problems|0
1250037|NCT00576472|4099680|P6|MPH In-Lab Phase|No attention/academic problems|0
1250038|NCT00576472|4099681|P5|MPH In-Lab Phase|No attention/academic problems|0
1250039|NCT00576472|4099682|P4|MPH In-Lab Phase|No attention/academic problems|245
1250040|NCT00576472|4099683|P3|MPH In-Lab Phase|No attention/academic problems|0
1250041|NCT00576472|4099684|P2|MPH In-Lab Phase|No attention/academic problems|0
1250042|NCT00576472|4099685|P1|MPH In-Lab Phase|No attention/academic problems|0
1250043|NCT00576472|4099671|P15|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1250044|NCT00576472|4099672|P14|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1250045|NCT00576472|4099673|P13|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1250046|NCT00576472|4099674|P12|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1250047|NCT00576472|4099675|P11|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1250048|NCT00576472|4099676|P10|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1250049|NCT00576472|4099677|P9|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1250050|NCT00576472|4099678|P8|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1250051|NCT00576472|4099679|P7|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1250052|NCT00576472|4099680|P6|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1250053|NCT00576472|4099681|P5|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1250054|NCT00576472|4099682|P4|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4
1250055|NCT00576472|4099683|P3|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1250056|NCT00576472|4099684|P2|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1250057|NCT00576472|4099685|P1|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1250058|NCT00576472|4099671|P15|MPH In-Lab Phase|Lost to Follow-up|0
1250059|NCT00576472|4099672|P14|MPH In-Lab Phase|Lost to Follow-up|0
1250060|NCT00576472|4099673|P13|MPH In-Lab Phase|Lost to Follow-up|0
1250061|NCT00576472|4099674|P12|MPH In-Lab Phase|Lost to Follow-up|0
1250062|NCT00576472|4099675|P11|MPH In-Lab Phase|Lost to Follow-up|0
1250063|NCT00576472|4099676|P10|MPH In-Lab Phase|Lost to Follow-up|0
1250064|NCT00576472|4099677|P9|MPH In-Lab Phase|Lost to Follow-up|0
1250065|NCT00576472|4099678|P8|MPH In-Lab Phase|Lost to Follow-up|0
1250066|NCT00576472|4099679|P7|MPH In-Lab Phase|Lost to Follow-up|0
1250067|NCT00576472|4099680|P6|MPH In-Lab Phase|Lost to Follow-up|0
1250068|NCT00576472|4099681|P5|MPH In-Lab Phase|Lost to Follow-up|0
1250069|NCT00576472|4099682|P4|MPH In-Lab Phase|Lost to Follow-up|1
1250070|NCT00576472|4099683|P3|MPH In-Lab Phase|Lost to Follow-up|0
1250071|NCT00576472|4099684|P2|MPH In-Lab Phase|Lost to Follow-up|0
1250072|NCT00576472|4099685|P1|MPH In-Lab Phase|Lost to Follow-up|0
1250073|NCT00576472|4099671|P15|MPH In-Lab Phase|Declined participation in medication pha|0
1250074|NCT00576472|4099672|P14|MPH In-Lab Phase|Declined participation in medication pha|0
1250075|NCT00576472|4099673|P13|MPH In-Lab Phase|Declined participation in medication pha|0
1250076|NCT00576472|4099674|P12|MPH In-Lab Phase|Declined participation in medication pha|0
1250077|NCT00576472|4099675|P11|MPH In-Lab Phase|Declined participation in medication pha|0
1250078|NCT00576472|4099676|P10|MPH In-Lab Phase|Declined participation in medication pha|0
1250079|NCT00576472|4099677|P9|MPH In-Lab Phase|Declined participation in medication pha|0
1250080|NCT00576472|4099678|P8|MPH In-Lab Phase|Declined participation in medication pha|0
1250081|NCT00576472|4099679|P7|MPH In-Lab Phase|Declined participation in medication pha|0
1250082|NCT00576472|4099680|P6|MPH In-Lab Phase|Declined participation in medication pha|0
1250083|NCT00576472|4099681|P5|MPH In-Lab Phase|Declined participation in medication pha|0
1250084|NCT00576472|4099682|P4|MPH In-Lab Phase|Declined participation in medication pha|75
1250085|NCT00576472|4099683|P3|MPH In-Lab Phase|Declined participation in medication pha|0
1250086|NCT00576472|4099684|P2|MPH In-Lab Phase|Declined participation in medication pha|0
1250087|NCT00576472|4099685|P1|MPH In-Lab Phase|Declined participation in medication pha|0
1250088|NCT00576420|4099778|P3|Overall Study|Death|1
1250089|NCT00576420|4099779|P2|Overall Study|Death|0
1250090|NCT00576420|4099780|P1|Overall Study|Death|0
1250091|NCT00576381|4099945|P1|Overall Study|Adverse Event|4
1250092|NCT00576381|4099945|P1|Overall Study|Reoperation|3
1250093|NCT00576316|4099949|P1|Overall Study|Protocol Violation|9
1250094|NCT00576316|4099949|P1|Overall Study|Withdrawal by Subject|2
1250095|NCT00576316|4099949|P1|Overall Study|Adverse Event|9
1250096|NCT00576303|4099954|P1|Long Term Safety Period|Early withdrawal|16
1250097|NCT00576303|4099954|P1|Efficacy Evaluation Period|Early withdrawal|5
1250098|NCT00576303|4099954|P1|Dose Titration Period|Early withdrawal|17
1250099|NCT00576199|4099972|P1|Overall Study|Reason Unspecified|2
1250100|NCT00576199|4099972|P1|Overall Study|Refused Treatment|2
1250101|NCT00576199|4099972|P1|Overall Study|Insufficient Therapeutic Response|14
1250102|NCT00576199|4099972|P1|Overall Study|Adverse Event|12
1250103|NCT00576056|4099985|P1|Overall Study|Physician Decision|1
1250104|NCT00576056|4099985|P1|Overall Study|did not meet eligibility criteria|8
1250105|NCT00576056|4099985|P1|Overall Study|Withdrawal by Subject|2
1250106|NCT00576056|4099985|P1|Overall Study|Lack of Efficacy|1
1250107|NCT00576056|4099985|P1|Overall Study|Death|1
1250108|NCT00576056|4099985|P1|Overall Study|Adverse Event|1
1250109|NCT00575666|4100001|P2|Overall Study|Physician Decision|1
1250110|NCT00575666|4100002|P1|Overall Study|Physician Decision|1
1250111|NCT00575666|4100001|P2|Overall Study|Withdrawal by Subject|2
1250112|NCT00575666|4100002|P1|Overall Study|Withdrawal by Subject|3
1250113|NCT00575588|4100042|P2|Overall Study|Impossible to determine HbA1c|1
1250114|NCT00575588|4100043|P1|Overall Study|Impossible to determine HbA1c|0
1250115|NCT00575588|4100042|P2|Overall Study|Patient moved|3
1250116|NCT00575588|4100043|P1|Overall Study|Patient moved|1
1250117|NCT00575588|4100042|P2|Overall Study|Elevated triglyceride|0
1250118|NCT00575588|4100043|P1|Overall Study|Elevated triglyceride|1
1250119|NCT00575588|4100042|P2|Overall Study|Safety reasons|1
1250120|NCT00575588|4100043|P1|Overall Study|Safety reasons|2
1250121|NCT00575588|4100042|P2|Overall Study|Severe non-compliance to protocol|7
1250122|NCT00575588|4100043|P1|Overall Study|Severe non-compliance to protocol|5
1250123|NCT00575588|4100042|P2|Overall Study|Study specific discontinuation criteria|218
1250124|NCT00575588|4100043|P1|Overall Study|Study specific discontinuation criteria|203
1250125|NCT00575588|4100042|P2|Overall Study|Incorrect enrollment|4
1250126|NCT00575588|4100043|P1|Overall Study|Incorrect enrollment|8
1250127|NCT00575588|4100042|P2|Overall Study|Death|2
1250128|NCT00575588|4100043|P1|Overall Study|Death|4
1250129|NCT00575588|4100042|P2|Overall Study|Lost to Follow-up|3
1250130|NCT00575588|4100043|P1|Overall Study|Lost to Follow-up|1
1250131|NCT00575588|4100042|P2|Overall Study|Withdrawal by Subject|31
1250132|NCT00575588|4100043|P1|Overall Study|Withdrawal by Subject|27
1250133|NCT00575588|4100042|P2|Overall Study|Adverse Event|13
1250134|NCT00575588|4100043|P1|Overall Study|Adverse Event|11
1250135|NCT00575510|4100066|P3|Overall Study|Pregnancy|1
1250136|NCT00575510|4100067|P2|Overall Study|Pregnancy|0
1250137|NCT00575510|4100068|P1|Overall Study|Pregnancy|0
1250138|NCT00575510|4100066|P3|Overall Study|Clinic Called Patient|7
1250139|NCT00575510|4100067|P2|Overall Study|Clinic Called Patient|7
1250140|NCT00575510|4100068|P1|Overall Study|Clinic Called Patient|7
1250141|NCT00575510|4100066|P3|Overall Study|Withdrawal by Subject|0
1250142|NCT00575510|4100067|P2|Overall Study|Withdrawal by Subject|0
1250143|NCT00575510|4100068|P1|Overall Study|Withdrawal by Subject|1
1250144|NCT00575510|4100066|P3|Overall Study|Lost to Follow-up|9
1250145|NCT00575510|4100067|P2|Overall Study|Lost to Follow-up|6
1250146|NCT00575510|4100068|P1|Overall Study|Lost to Follow-up|4
1250147|NCT00575380|4100081|P2|Overall Study|Various|2
1250148|NCT00575380|4100082|P1|Overall Study|Various|0
1250149|NCT00575380|4100081|P2|Overall Study|Adverse Event|1
1250150|NCT00575380|4100082|P1|Overall Study|Adverse Event|0
1250151|NCT00575380|4100081|P2|Overall Study|Withdrawal by Subject|0
1250152|NCT00575380|4100082|P1|Overall Study|Withdrawal by Subject|1
1250153|NCT00575094|4100224|P1|Overall Study|Withdrawal by Subject|1
1250154|NCT00575094|4100224|P1|Overall Study|Adverse Event|2
1250155|NCT00575042|4100228|P1|Overall Study|Lost to Follow-up|1
1250156|NCT00575042|4100228|P1|Overall Study|Adverse Event|2
1250157|NCT00574951|4100279|P1|Overall Study|Ineligible - improper prior treatment|1
1250158|NCT00574912|4100287|P1|Overall Study|Physician Decision|2
1250159|NCT00574912|4100287|P1|Overall Study|scheduling conflicts|3
1250160|NCT00574912|4100287|P1|Overall Study|Could not place IV lines.|3
1250161|NCT00574873|4100301|P2|Overall Study|Extension Study|0
1250162|NCT00574873|4100302|P1|Overall Study|Extension Study|126
1250163|NCT00574873|4100301|P2|Overall Study|Blank, site closed per local regulations|2
1250164|NCT00574873|4100302|P1|Overall Study|Blank, site closed per local regulations|2
1250165|NCT00574873|4100301|P2|Overall Study|Discontinuation of study by sponsor|199
1250166|NCT00574873|4100302|P1|Overall Study|Discontinuation of study by sponsor|5
1250167|NCT00574873|4100301|P2|Overall Study|Other|4
1250168|NCT00574873|4100302|P1|Overall Study|Other|40
1250169|NCT00574873|4100301|P2|Overall Study|Lost to Follow-up|5
1250170|NCT00574873|4100302|P1|Overall Study|Lost to Follow-up|14
1250171|NCT00574873|4100301|P2|Overall Study|Death|14
1250172|NCT00574873|4100302|P1|Overall Study|Death|15
1250173|NCT00574873|4100301|P2|Overall Study|Investigator request|8
1250174|NCT00574873|4100302|P1|Overall Study|Investigator request|18
1250175|NCT00574873|4100301|P2|Overall Study|Withdrawal by Subject|19
1250176|NCT00574873|4100302|P1|Overall Study|Withdrawal by Subject|18
1250177|NCT00574847|4100320|P2|Overall Study|Did not receive medication (declined)|5
1250178|NCT00574847|4100321|P1|Overall Study|Did not receive medication (declined)|2
1250179|NCT00574847|4100320|P2|Overall Study|Physician Decision|0
1250180|NCT00574847|4100321|P1|Overall Study|Physician Decision|1
1250181|NCT00574847|4100320|P2|Overall Study|Withdrawal by Subject|2
1250182|NCT00574847|4100321|P1|Overall Study|Withdrawal by Subject|2
1250183|NCT00574847|4100320|P2|Overall Study|Death|0
1250184|NCT00574847|4100321|P1|Overall Study|Death|1
1250185|NCT00574847|4100320|P2|Overall Study|Adverse Event|0
1250186|NCT00574847|4100321|P1|Overall Study|Adverse Event|2
1250187|NCT00574795|4100366|P1|Toddler Dose|Withdrawal by Subject|1
1250188|NCT00574795|4100366|P1|After Infant Series|Adverse Event|2
1250189|NCT00574795|4100366|P1|After Infant Series|Withdrawal by Subject|1
1250190|NCT00574795|4100366|P1|Infant Series|Adverse Event|1
1250191|NCT00574795|4100366|P1|Infant Series|Protocol Violation|2
1250192|NCT00574795|4100366|P1|Infant Series|Withdrawal by Subject|2
1250193|NCT00574405|4100449|P2|Overall Study|Withdrawal by Subject|2
1250194|NCT00574405|4100450|P1|Overall Study|Withdrawal by Subject|3
1250195|NCT00574288|4100470|P7|Overall Study|Other|0
1250196|NCT00574288|4100471|P6|Overall Study|Other|0
1250197|NCT00574288|4100472|P5|Overall Study|Other|0
1250198|NCT00574288|4100473|P4|Overall Study|Other|0
1250199|NCT00574288|4100474|P3|Overall Study|Other|0
1250200|NCT00574288|4100475|P2|Overall Study|Other|1
1250201|NCT00574288|4100476|P1|Overall Study|Other|1
1250202|NCT00574288|4100470|P7|Overall Study|Progressive Disease|0
1250203|NCT00574288|4100471|P6|Overall Study|Progressive Disease|0
1250204|NCT00574288|4100472|P5|Overall Study|Progressive Disease|1
1250205|NCT00574288|4100473|P4|Overall Study|Progressive Disease|2
1250206|NCT00574288|4100474|P3|Overall Study|Progressive Disease|3
1250207|NCT00574288|4100475|P2|Overall Study|Progressive Disease|2
1250208|NCT00574288|4100476|P1|Overall Study|Progressive Disease|17
1250209|NCT00574288|4100470|P7|Overall Study|Study Terminated By Sponsor|5
1250210|NCT00574288|4100471|P6|Overall Study|Study Terminated By Sponsor|0
1250211|NCT00574288|4100472|P5|Overall Study|Study Terminated By Sponsor|0
1250212|NCT00574288|4100473|P4|Overall Study|Study Terminated By Sponsor|0
1250213|NCT00574288|4100474|P3|Overall Study|Study Terminated By Sponsor|0
1250214|NCT00574288|4100475|P2|Overall Study|Study Terminated By Sponsor|0
1250215|NCT00574288|4100476|P1|Overall Study|Study Terminated By Sponsor|0
1250216|NCT00574288|4100470|P7|Overall Study|Lost to Follow-up|2
1250217|NCT00574288|4100471|P6|Overall Study|Lost to Follow-up|1
1250218|NCT00574288|4100472|P5|Overall Study|Lost to Follow-up|0
1250219|NCT00574288|4100473|P4|Overall Study|Lost to Follow-up|0
1250220|NCT00574288|4100474|P3|Overall Study|Lost to Follow-up|0
1250221|NCT00574288|4100475|P2|Overall Study|Lost to Follow-up|0
1250222|NCT00574288|4100476|P1|Overall Study|Lost to Follow-up|0
1250223|NCT00574288|4100470|P7|Overall Study|Death|21
1250224|NCT00574288|4100471|P6|Overall Study|Death|25
1250225|NCT00574288|4100472|P5|Overall Study|Death|0
1250226|NCT00574288|4100473|P4|Overall Study|Death|0
1250227|NCT00574288|4100474|P3|Overall Study|Death|0
1250228|NCT00574288|4100475|P2|Overall Study|Death|0
1250229|NCT00574288|4100476|P1|Overall Study|Death|0
1250230|NCT00574288|4100470|P7|Overall Study|Adverse Event|0
1250231|NCT00574288|4100471|P6|Overall Study|Adverse Event|0
1250232|NCT00574288|4100472|P5|Overall Study|Adverse Event|1
1250233|NCT00574288|4100473|P4|Overall Study|Adverse Event|0
1250234|NCT00574288|4100474|P3|Overall Study|Adverse Event|0
1250235|NCT00574288|4100475|P2|Overall Study|Adverse Event|0
1250236|NCT00574288|4100476|P1|Overall Study|Adverse Event|2
1250237|NCT00574275|4100514|P2|Overall Study|Operation for curative intent|1
1250238|NCT00574275|4100515|P1|Overall Study|Operation for curative intent|0
1250239|NCT00574275|4100514|P2|Overall Study|Insurance change|1
1250240|NCT00574275|4100515|P1|Overall Study|Insurance change|0
1250241|NCT00574275|4100514|P2|Overall Study|Patient and Investigator decision|1
1250242|NCT00574275|4100515|P1|Overall Study|Patient and Investigator decision|0
1250243|NCT00574275|4100514|P2|Overall Study|Protocol Violation|1
1250244|NCT00574275|4100515|P1|Overall Study|Protocol Violation|0
1250245|NCT00574275|4100514|P2|Overall Study|Physician Decision|1
1250246|NCT00574275|4100515|P1|Overall Study|Physician Decision|1
1250247|NCT00574275|4100514|P2|Overall Study|Error calculating tumor measurement|0
1250248|NCT00574275|4100515|P1|Overall Study|Error calculating tumor measurement|1
1250249|NCT00574275|4100514|P2|Overall Study|Withdrawal by Subject|17
1250250|NCT00574275|4100515|P1|Overall Study|Withdrawal by Subject|15
1250251|NCT00574275|4100514|P2|Overall Study|Study stopped based on DMC decision|23
1250252|NCT00574275|4100515|P1|Overall Study|Study stopped based on DMC decision|62
1250253|NCT00574275|4100514|P2|Overall Study|Lost to Follow-up|1
1250254|NCT00574275|4100515|P1|Overall Study|Lost to Follow-up|2
1250255|NCT00574275|4100514|P2|Overall Study|Disease progression|146
1250256|NCT00574275|4100515|P1|Overall Study|Disease progression|160
1250257|NCT00574275|4100514|P2|Overall Study|Adverse Event|76
1250258|NCT00574275|4100515|P1|Overall Study|Adverse Event|32
1250259|NCT00574275|4100514|P2|Overall Study|Randomized but not treated|3
1250260|NCT00574275|4100515|P1|Overall Study|Randomized but not treated|2
1250261|NCT00574249|4100533|P2|Overall Study|PPD test taken twice|1
1250262|NCT00574249|4100534|P1|Overall Study|PPD test taken twice|0
1250263|NCT00574249|4100533|P2|Overall Study|Excluded by company|1
1250264|NCT00574249|4100534|P1|Overall Study|Excluded by company|0
1250265|NCT00574249|4100533|P2|Overall Study|Pregnancy|0
1250266|NCT00574249|4100534|P1|Overall Study|Pregnancy|1
1250267|NCT00574249|4100533|P2|Overall Study|Physician Decision|0
1250268|NCT00574249|4100534|P1|Overall Study|Physician Decision|1
1250269|NCT00574249|4100533|P2|Overall Study|Withdrawal by Subject|0
1250270|NCT00574249|4100534|P1|Overall Study|Withdrawal by Subject|3
1250271|NCT00574249|4100533|P2|Overall Study|History of carcinoma|0
1250272|NCT00574249|4100534|P1|Overall Study|History of carcinoma|1
1250273|NCT00574249|4100533|P2|Overall Study|Protocol Violation|2
1250274|NCT00574249|4100534|P1|Overall Study|Protocol Violation|5
1250275|NCT00574249|4100533|P2|Overall Study|Lost to Follow-up|3
1250276|NCT00574249|4100534|P1|Overall Study|Lost to Follow-up|4
1250277|NCT00574249|4100533|P2|Overall Study|Lack of Efficacy|3
1250278|NCT00574249|4100534|P1|Overall Study|Lack of Efficacy|5
1250279|NCT00574249|4100533|P2|Overall Study|Adverse Event|18
1250280|NCT00574249|4100534|P1|Overall Study|Adverse Event|6
1250281|NCT00574145|4100585|P2|Overall Study|Withdrawal by Subject|1
1250282|NCT00574145|4100586|P1|Overall Study|Withdrawal by Subject|2
1250283|NCT00574080|4100598|P2|Overall Study|Death|10
1250284|NCT00574080|4100599|P1|Overall Study|Death|10
1250285|NCT00573937|4100668|P2|Overall Study|Study Terminated|1
1250286|NCT00573937|4100669|P1|Overall Study|Study Terminated|0
1250287|NCT00573859|4100683|P1|Smoking Versus Abstinence|Scheduling conflicts|12
1250288|NCT00573859|4100683|P1|Medication Versus Placebo|Scheduling conflicts|12
1250289|NCT00573833|4100689|P1|Overall Study|Not Treated|2
1250290|NCT00573794|4100696|P1|Overall Study|Not Specified|46
1250291|NCT00573794|4100696|P1|Overall Study|Lack of Efficacy|94
1250292|NCT00573794|4100696|P1|Overall Study|Protocol Violation|6
1250293|NCT00573794|4100696|P1|Overall Study|Lost to Follow-up|13
1250294|NCT00573794|4100696|P1|Overall Study|Withdrew Consent|90
1250295|NCT00573794|4100696|P1|Overall Study|Adverse Event|81
1250296|NCT00573768|4100727|P3|Overall Study|Lost to Follow-up|1
1250297|NCT00573768|4100728|P2|Overall Study|Lost to Follow-up|0
1250298|NCT00573768|4100729|P1|Overall Study|Lost to Follow-up|0
1250299|NCT00573768|4100727|P3|Overall Study|Withdrawal by Subject|0
1250300|NCT00573768|4100728|P2|Overall Study|Withdrawal by Subject|1
1250301|NCT00573768|4100729|P1|Overall Study|Withdrawal by Subject|0
1250302|NCT00573768|4100727|P3|Overall Study|Protocol Violation|1
1250303|NCT00573768|4100728|P2|Overall Study|Protocol Violation|0
1250304|NCT00573768|4100729|P1|Overall Study|Protocol Violation|1
1250305|NCT00573768|4100727|P3|Overall Study|Adverse Event|2
1250306|NCT00573768|4100728|P2|Overall Study|Adverse Event|1
1250307|NCT00573768|4100729|P1|Overall Study|Adverse Event|1
1250308|NCT00573755|4100739|P2|Overall Study|Still receiving treatment|0
1250309|NCT00573755|4100740|P1|Overall Study|Still receiving treatment|1
1250310|NCT00573534|4100756|P1|Overall Study|oppositional behavior|3
1250311|NCT00573469|4100797|P3|Overall Study|Not Specified|3
1250312|NCT00573469|4100798|P2|Overall Study|Not Specified|1
1250313|NCT00573469|4100799|P1|Overall Study|Not Specified|5
1250314|NCT00573469|4100797|P3|Overall Study|Withdrawal by Subject|0
1250315|NCT00573469|4100798|P2|Overall Study|Withdrawal by Subject|2
1250316|NCT00573469|4100799|P1|Overall Study|Withdrawal by Subject|0
1250317|NCT00573469|4100797|P3|Overall Study|Adverse Event|1
1250318|NCT00573469|4100798|P2|Overall Study|Adverse Event|1
1250319|NCT00573469|4100799|P1|Overall Study|Adverse Event|1
1250320|NCT00573443|4100822|P3|Open-Label Extension Phase|Not Specified|0
1250321|NCT00573443|4100823|P2|Open-Label Extension Phase|Not Specified|0
1250322|NCT00573443|4100824|P1|Open-Label Extension Phase|Not Specified|2
1250323|NCT00573443|4100822|P3|Open-Label Extension Phase|Protocol Violation|0
1250324|NCT00573443|4100823|P2|Open-Label Extension Phase|Protocol Violation|0
1250325|NCT00573443|4100824|P1|Open-Label Extension Phase|Protocol Violation|2
1250326|NCT00573443|4100822|P3|Open-Label Extension Phase|Withdrawal by Subject|0
1250327|NCT00573443|4100823|P2|Open-Label Extension Phase|Withdrawal by Subject|0
1250328|NCT00573443|4100824|P1|Open-Label Extension Phase|Withdrawal by Subject|3
1250329|NCT00573443|4100822|P3|Open-Label Extension Phase|Serious Adverse Event|0
1250330|NCT00573443|4100823|P2|Open-Label Extension Phase|Serious Adverse Event|0
1250331|NCT00573443|4100824|P1|Open-Label Extension Phase|Serious Adverse Event|5
1250332|NCT00573443|4100822|P3|Open-Label Extension Phase|Adverse Event|0
1250333|NCT00573443|4100823|P2|Open-Label Extension Phase|Adverse Event|0
1250334|NCT00573443|4100824|P1|Open-Label Extension Phase|Adverse Event|3
1250335|NCT00573443|4100822|P3|Open-Label Extension Phase|Exacerbation of MS symptoms|0
1250336|NCT00573443|4100823|P2|Open-Label Extension Phase|Exacerbation of MS symptoms|0
1250337|NCT00573443|4100824|P1|Open-Label Extension Phase|Exacerbation of MS symptoms|2
1250338|NCT00573443|4100822|P3|Open-Label Extension Phase|Lost to Follow-up|0
1250339|NCT00573443|4100823|P2|Open-Label Extension Phase|Lost to Follow-up|0
1250340|NCT00573443|4100824|P1|Open-Label Extension Phase|Lost to Follow-up|1
1250341|NCT00573443|4100822|P3|Double-Blind Phase|Not specified|3
1250342|NCT00573443|4100823|P2|Double-Blind Phase|Not specified|2
1250343|NCT00573443|4100824|P1|Double-Blind Phase|Not specified|0
1250344|NCT00573443|4100822|P3|Double-Blind Phase|Protocol Violation|1
1250345|NCT00573443|4100823|P2|Double-Blind Phase|Protocol Violation|2
1250346|NCT00573443|4100824|P1|Double-Blind Phase|Protocol Violation|0
1250347|NCT00573443|4100822|P3|Double-Blind Phase|Withdrawal by Subject|7
1250348|NCT00573443|4100823|P2|Double-Blind Phase|Withdrawal by Subject|2
1250349|NCT00573443|4100824|P1|Double-Blind Phase|Withdrawal by Subject|2
1250350|NCT00573443|4100822|P3|Double-Blind Phase|Medication refusal due to AE|0
1250351|NCT00573443|4100823|P2|Double-Blind Phase|Medication refusal due to AE|2
1250352|NCT00573443|4100824|P1|Double-Blind Phase|Medication refusal due to AE|2
1250353|NCT00573443|4100822|P3|Double-Blind Phase|Serious Adverse Event (AE)|1
1250354|NCT00573443|4100823|P2|Double-Blind Phase|Serious Adverse Event (AE)|3
1250355|NCT00573443|4100824|P1|Double-Blind Phase|Serious Adverse Event (AE)|2
1250356|NCT00573443|4100822|P3|Double-Blind Phase|Adverse Event|0
1250357|NCT00573443|4100823|P2|Double-Blind Phase|Adverse Event|5
1250358|NCT00573443|4100824|P1|Double-Blind Phase|Adverse Event|1
1250359|NCT00573443|4100822|P3|Double-Blind Phase|Exacerbation of MS symptoms|1
1250360|NCT00573443|4100823|P2|Double-Blind Phase|Exacerbation of MS symptoms|0
1250361|NCT00573443|4100824|P1|Double-Blind Phase|Exacerbation of MS symptoms|1
1250362|NCT00573443|4100822|P3|Double-Blind Phase|Lost to Follow-up|2
1250363|NCT00573443|4100823|P2|Double-Blind Phase|Lost to Follow-up|3
1250364|NCT00573443|4100824|P1|Double-Blind Phase|Lost to Follow-up|1
1250365|NCT00573430|4100854|P3|Overall Study|Eligibility criteria not fulfilled|3
1250366|NCT00573430|4100855|P2|Overall Study|Eligibility criteria not fulfilled|0
1250367|NCT00573430|4100856|P1|Overall Study|Eligibility criteria not fulfilled|0
1250368|NCT00573430|4100854|P3|Overall Study|Protocol Violation|1
1250369|NCT00573430|4100855|P2|Overall Study|Protocol Violation|1
1250370|NCT00573430|4100856|P1|Overall Study|Protocol Violation|0
1250371|NCT00573430|4100854|P3|Overall Study|Withdrawal by Subject|1
1250372|NCT00573430|4100855|P2|Overall Study|Withdrawal by Subject|0
1250373|NCT00573430|4100856|P1|Overall Study|Withdrawal by Subject|1
1250374|NCT00573430|4100854|P3|Overall Study|Adverse Event|2
1250375|NCT00573430|4100855|P2|Overall Study|Adverse Event|0
1250376|NCT00573430|4100856|P1|Overall Study|Adverse Event|0
1250377|NCT00573430|4100854|P3|Overall Study|Incorrect enrollment of randomization|3
1250378|NCT00573430|4100855|P2|Overall Study|Incorrect enrollment of randomization|4
1250379|NCT00573430|4100856|P1|Overall Study|Incorrect enrollment of randomization|0
1250380|NCT00573391|4100878|P2|Overall Study|Death|0
1250381|NCT00573391|4100879|P1|Overall Study|Death|1
1250382|NCT00573391|4100878|P2|Overall Study|study stopped|2
1250383|NCT00573391|4100879|P1|Overall Study|study stopped|2
1250384|NCT00573313|4100889|P4|Overall Study|Protocol Violation|0
1250385|NCT00573313|4100890|P3|Overall Study|Protocol Violation|6
1250386|NCT00573313|4100891|P2|Overall Study|Protocol Violation|0
1250387|NCT00573313|4100892|P1|Overall Study|Protocol Violation|5
1250388|NCT00573248|4100942|P2|Overall Study|scheduling conflicts|11
1250389|NCT00573248|4100943|P1|Overall Study|scheduling conflicts|15
1250390|NCT00573183|4100957|P2|Overall Study|Other|2
1250391|NCT00573183|4100958|P1|Overall Study|Other|5
1250392|NCT00573183|4100957|P2|Overall Study|Incarceration|8
1250393|NCT00573183|4100958|P1|Overall Study|Incarceration|5
1250394|NCT00573183|4100957|P2|Overall Study|Adverse Event|0
1250395|NCT00573183|4100958|P1|Overall Study|Adverse Event|2
1250396|NCT00573183|4100957|P2|Overall Study|Death|1
1250397|NCT00573183|4100958|P1|Overall Study|Death|0
1250398|NCT00573183|4100957|P2|Overall Study|Withdrawal by Subject|2
1250399|NCT00573183|4100958|P1|Overall Study|Withdrawal by Subject|8
1250400|NCT00573183|4100957|P2|Overall Study|Lost to Follow-up|50
1250401|NCT00573183|4100958|P1|Overall Study|Lost to Follow-up|52
1250402|NCT00573170|4100966|P6|Third Treatment Period|Lost to Follow-up|2
1250403|NCT00573170|4100967|P5|Third Treatment Period|Lost to Follow-up|0
1250404|NCT00573170|4100968|P4|Third Treatment Period|Lost to Follow-up|0
1250405|NCT00573170|4100969|P3|Third Treatment Period|Lost to Follow-up|0
1250406|NCT00573170|4100970|P2|Third Treatment Period|Lost to Follow-up|0
1250407|NCT00573170|4100971|P1|Third Treatment Period|Lost to Follow-up|0
1250408|NCT00573170|4100966|P6|Third Treatment Period|Withdrawal by Subject|0
1250409|NCT00573170|4100967|P5|Third Treatment Period|Withdrawal by Subject|0
1250410|NCT00573170|4100968|P4|Third Treatment Period|Withdrawal by Subject|0
1250411|NCT00573170|4100969|P3|Third Treatment Period|Withdrawal by Subject|0
1250412|NCT00573170|4100970|P2|Third Treatment Period|Withdrawal by Subject|0
1250413|NCT00573170|4100971|P1|Third Treatment Period|Withdrawal by Subject|1
1250414|NCT00573170|4100966|P6|Second Washout Period|Other|2
1250415|NCT00573170|4100967|P5|Second Washout Period|Other|6
1250416|NCT00573170|4100968|P4|Second Washout Period|Other|4
1250417|NCT00573170|4100969|P3|Second Washout Period|Other|1
1250418|NCT00573170|4100970|P2|Second Washout Period|Other|2
1250419|NCT00573170|4100971|P1|Second Washout Period|Other|1
1250420|NCT00573170|4100966|P6|Second Washout Period|Lost to Follow-up|0
1250421|NCT00573170|4100967|P5|Second Washout Period|Lost to Follow-up|0
1250422|NCT00573170|4100968|P4|Second Washout Period|Lost to Follow-up|1
1250423|NCT00573170|4100969|P3|Second Washout Period|Lost to Follow-up|0
1250424|NCT00573170|4100970|P2|Second Washout Period|Lost to Follow-up|0
1250425|NCT00573170|4100971|P1|Second Washout Period|Lost to Follow-up|0
1250426|NCT00573170|4100966|P6|Second Washout Period|Withdrawal by Subject|0
1250427|NCT00573170|4100967|P5|Second Washout Period|Withdrawal by Subject|1
1250428|NCT00573170|4100968|P4|Second Washout Period|Withdrawal by Subject|0
1250429|NCT00573170|4100969|P3|Second Washout Period|Withdrawal by Subject|2
1250430|NCT00573170|4100970|P2|Second Washout Period|Withdrawal by Subject|1
1250431|NCT00573170|4100971|P1|Second Washout Period|Withdrawal by Subject|1
1250432|NCT00573170|4100966|P6|Second Washout Period|Protocol Violation|0
1250433|NCT00573170|4100967|P5|Second Washout Period|Protocol Violation|0
1250434|NCT00573170|4100968|P4|Second Washout Period|Protocol Violation|0
1250435|NCT00573170|4100969|P3|Second Washout Period|Protocol Violation|1
1250436|NCT00573170|4100970|P2|Second Washout Period|Protocol Violation|1
1250437|NCT00573170|4100971|P1|Second Washout Period|Protocol Violation|2
1250438|NCT00573170|4100966|P6|Second Washout Period|Adverse Event|0
1250439|NCT00573170|4100967|P5|Second Washout Period|Adverse Event|1
1250440|NCT00573170|4100968|P4|Second Washout Period|Adverse Event|0
1250441|NCT00573170|4100969|P3|Second Washout Period|Adverse Event|0
1250442|NCT00573170|4100970|P2|Second Washout Period|Adverse Event|0
1250443|NCT00573170|4100971|P1|Second Washout Period|Adverse Event|1
1250444|NCT00573170|4100966|P6|First Washout Period|Other|0
1250445|NCT00573170|4100967|P5|First Washout Period|Other|0
1250446|NCT00573170|4100968|P4|First Washout Period|Other|1
1250447|NCT00573170|4100969|P3|First Washout Period|Other|1
1250448|NCT00573170|4100970|P2|First Washout Period|Other|0
1250449|NCT00573170|4100971|P1|First Washout Period|Other|4
1250450|NCT00573170|4100966|P6|First Washout Period|Withdrawal by Subject|3
1250451|NCT00573170|4100967|P5|First Washout Period|Withdrawal by Subject|3
1250452|NCT00573170|4100968|P4|First Washout Period|Withdrawal by Subject|2
1250453|NCT00573170|4100969|P3|First Washout Period|Withdrawal by Subject|0
1250454|NCT00573170|4100970|P2|First Washout Period|Withdrawal by Subject|0
1250455|NCT00573170|4100971|P1|First Washout Period|Withdrawal by Subject|2
1250456|NCT00573170|4100966|P6|First Washout Period|Lost to Follow-up|2
1250457|NCT00573170|4100967|P5|First Washout Period|Lost to Follow-up|0
1250458|NCT00573170|4100968|P4|First Washout Period|Lost to Follow-up|2
1250459|NCT00573170|4100969|P3|First Washout Period|Lost to Follow-up|0
1250460|NCT00573170|4100970|P2|First Washout Period|Lost to Follow-up|1
1250461|NCT00573170|4100971|P1|First Washout Period|Lost to Follow-up|1
1250462|NCT00573170|4100966|P6|First Washout Period|Lack of Efficacy|1
1250463|NCT00573170|4100967|P5|First Washout Period|Lack of Efficacy|0
1250464|NCT00573170|4100968|P4|First Washout Period|Lack of Efficacy|0
1250465|NCT00573170|4100969|P3|First Washout Period|Lack of Efficacy|0
1250466|NCT00573170|4100970|P2|First Washout Period|Lack of Efficacy|0
1250467|NCT00573170|4100971|P1|First Washout Period|Lack of Efficacy|0
1250468|NCT00573170|4100966|P6|First Washout Period|Adverse Event|1
1250469|NCT00573170|4100967|P5|First Washout Period|Adverse Event|0
1250470|NCT00573170|4100968|P4|First Washout Period|Adverse Event|0
1250471|NCT00573170|4100969|P3|First Washout Period|Adverse Event|0
1250472|NCT00573170|4100970|P2|First Washout Period|Adverse Event|1
1250473|NCT00573170|4100971|P1|First Washout Period|Adverse Event|1
1250474|NCT00573170|4100966|P6|First Treatment Period|Did Not Treat Attack 1|0
1250475|NCT00573170|4100967|P5|First Treatment Period|Did Not Treat Attack 1|1
1250476|NCT00573170|4100968|P4|First Treatment Period|Did Not Treat Attack 1|0
1250477|NCT00573170|4100969|P3|First Treatment Period|Did Not Treat Attack 1|0
1250478|NCT00573170|4100970|P2|First Treatment Period|Did Not Treat Attack 1|0
1250479|NCT00573170|4100971|P1|First Treatment Period|Did Not Treat Attack 1|0
1250480|NCT00573157|4101047|P2|Overall Study|Other|1
1250481|NCT00573157|4101048|P1|Overall Study|Other|1
1250482|NCT00573157|4101047|P2|Overall Study|Adverse Event|1
1250483|NCT00573157|4101048|P1|Overall Study|Adverse Event|3
1250484|NCT00573144|4101060|P2|Overall Study|Withdrawal by Subject|3
1250485|NCT00573144|4101061|P1|Overall Study|Withdrawal by Subject|2
1250486|NCT00573131|4101073|P2|Overall Study|Withdrawal by Subject|8
1250487|NCT00573131|4101074|P1|Overall Study|Withdrawal by Subject|10
1250488|NCT00573066|4101080|P1|Overall Study|Postoperative bleeding|1
1250489|NCT00573066|4101080|P1|Overall Study|IV malfunction|1
1250490|NCT00573066|4101080|P1|Overall Study|Exclusion criteria|18
1250491|NCT00572910|4101124|P11|Overall Study|Withdrawal by Subject|1
1250492|NCT00572910|4101125|P10|Overall Study|Withdrawal by Subject|2
1250493|NCT00572910|4101126|P9|Overall Study|Withdrawal by Subject|2
1250494|NCT00572910|4101127|P8|Overall Study|Withdrawal by Subject|2
1250495|NCT00572910|4101128|P7|Overall Study|Withdrawal by Subject|0
1250496|NCT00572910|4101129|P6|Overall Study|Withdrawal by Subject|3
1250497|NCT00572910|4101130|P5|Overall Study|Withdrawal by Subject|1
1250498|NCT00572910|4101131|P4|Overall Study|Withdrawal by Subject|0
1250499|NCT00572910|4101132|P3|Overall Study|Withdrawal by Subject|1
1250500|NCT00572910|4101133|P2|Overall Study|Withdrawal by Subject|0
1250501|NCT00572910|4101134|P1|Overall Study|Withdrawal by Subject|3
1250502|NCT00572910|4101124|P11|Overall Study|Lost to Follow-up|0
1250503|NCT00572910|4101125|P10|Overall Study|Lost to Follow-up|1
1250504|NCT00572910|4101126|P9|Overall Study|Lost to Follow-up|0
1250505|NCT00572910|4101127|P8|Overall Study|Lost to Follow-up|0
1250506|NCT00572910|4101128|P7|Overall Study|Lost to Follow-up|0
1250507|NCT00572910|4101129|P6|Overall Study|Lost to Follow-up|0
1250508|NCT00572910|4101130|P5|Overall Study|Lost to Follow-up|1
1250509|NCT00572910|4101131|P4|Overall Study|Lost to Follow-up|2
1250510|NCT00572910|4101132|P3|Overall Study|Lost to Follow-up|1
1250511|NCT00572910|4101133|P2|Overall Study|Lost to Follow-up|1
1250512|NCT00572910|4101134|P1|Overall Study|Lost to Follow-up|0
1250513|NCT00572910|4101124|P11|Overall Study|Adverse Event|2
1250514|NCT00572910|4101125|P10|Overall Study|Adverse Event|3
1250515|NCT00572910|4101126|P9|Overall Study|Adverse Event|1
1250516|NCT00572910|4101127|P8|Overall Study|Adverse Event|2
1250517|NCT00572910|4101128|P7|Overall Study|Adverse Event|4
1250518|NCT00572910|4101129|P6|Overall Study|Adverse Event|0
1250519|NCT00572910|4101130|P5|Overall Study|Adverse Event|0
1250520|NCT00572910|4101131|P4|Overall Study|Adverse Event|2
1250521|NCT00572910|4101132|P3|Overall Study|Adverse Event|0
1250522|NCT00572910|4101133|P2|Overall Study|Adverse Event|2
1250523|NCT00572910|4101134|P1|Overall Study|Adverse Event|1
1250524|NCT00572832|4101201|P2|Overall Study|Pregnancy|1
1250525|NCT00572832|4101202|P1|Overall Study|Pregnancy|0
1250526|NCT00572832|4101201|P2|Overall Study|Lost to Follow-up|11
1250527|NCT00572832|4101202|P1|Overall Study|Lost to Follow-up|0
1250528|NCT00572728|4101208|P1|Overall Study|Pathology missing|1
1250529|NCT00572728|4101208|P1|Overall Study|FLT2 after second chemotherapy initiated|7
1250530|NCT00572728|4101208|P1|Overall Study|Second chemotherapy not initiated|1
1250531|NCT00572728|4101208|P1|Overall Study|FLT2 not completed|5
1250532|NCT00572728|4101208|P1|Overall Study|First Chemotherapy not initiated|2
1250533|NCT00572728|4101208|P1|Overall Study|FLT1 not completed|4
1250534|NCT00572728|4101208|P1|Overall Study|Offstudy due to complicating disease|1
1250535|NCT00572728|4101208|P1|Overall Study|Enrolled under Amendment 4|5
1250536|NCT00572728|4101208|P1|Overall Study|Ineligible|3
1250537|NCT00572728|4101208|P1|Overall Study|Withdrawal by Subject|10
1250538|NCT00572624|4101222|P2|Overall Study|Health issues unrelated to the study|0
1250539|NCT00572624|4101223|P1|Overall Study|Health issues unrelated to the study|1
1250540|NCT00572624|4101222|P2|Overall Study|Problem with vascular access|0
1250541|NCT00572624|4101223|P1|Overall Study|Problem with vascular access|1
1250542|NCT00572624|4101222|P2|Overall Study|Refused to do the stress test|0
1250543|NCT00572624|4101223|P1|Overall Study|Refused to do the stress test|1
1250544|NCT00572624|4101222|P2|Overall Study|Admitted to being a smoker|0
1250545|NCT00572624|4101223|P1|Overall Study|Admitted to being a smoker|1
1250546|NCT00572624|4101222|P2|Overall Study|Started a new job-- no time for study|0
1250547|NCT00572624|4101223|P1|Overall Study|Started a new job-- no time for study|1
1250548|NCT00572624|4101222|P2|Overall Study|Medication change|0
1250549|NCT00572624|4101223|P1|Overall Study|Medication change|1
1250550|NCT00572624|4101222|P2|Overall Study|Wanted to do a different diet program|0
1250551|NCT00572624|4101223|P1|Overall Study|Wanted to do a different diet program|1
1250552|NCT00572624|4101222|P2|Overall Study|Lost to Follow-up|4
1250553|NCT00572624|4101223|P1|Overall Study|Lost to Follow-up|10
1250554|NCT00572572|4101251|P2|Overall Study|Withdrawal by Subject|6
1250555|NCT00572572|4101252|P1|Overall Study|Withdrawal by Subject|3
1250556|NCT00572533|4101270|P2|Overall Study|Transfer out of Facility|1
1250557|NCT00572533|4101271|P1|Overall Study|Transfer out of Facility|0
1250558|NCT00572533|4101270|P2|Overall Study|Social Issues|0
1250559|NCT00572533|4101271|P1|Overall Study|Social Issues|1
1250560|NCT00572533|4101270|P2|Overall Study|Received Kidney Transplant|1
1250561|NCT00572533|4101271|P1|Overall Study|Received Kidney Transplant|2
1250562|NCT00572533|4101270|P2|Overall Study|Death|1
1250563|NCT00572533|4101271|P1|Overall Study|Death|4
1250564|NCT00572156|4101310|P4|Overall Study|Sponsor Decision|19
1250565|NCT00572156|4101311|P3|Overall Study|Sponsor Decision|17
1250566|NCT00572156|4101312|P2|Overall Study|Sponsor Decision|16
1250567|NCT00572156|4101313|P1|Overall Study|Sponsor Decision|20
1250568|NCT00572156|4101310|P4|Overall Study|Patient/Parent Decision|3
1250569|NCT00572156|4101311|P3|Overall Study|Patient/Parent Decision|4
1250570|NCT00572156|4101312|P2|Overall Study|Patient/Parent Decision|6
1250571|NCT00572156|4101313|P1|Overall Study|Patient/Parent Decision|1
1250572|NCT00572156|4101310|P4|Overall Study|Protocol Violation|2
1250573|NCT00572156|4101311|P3|Overall Study|Protocol Violation|0
1250574|NCT00572156|4101312|P2|Overall Study|Protocol Violation|2
1250575|NCT00572156|4101313|P1|Overall Study|Protocol Violation|1
1250576|NCT00572156|4101310|P4|Overall Study|Lost to Follow-up|0
1250577|NCT00572156|4101311|P3|Overall Study|Lost to Follow-up|1
1250578|NCT00572156|4101312|P2|Overall Study|Lost to Follow-up|1
1250579|NCT00572156|4101313|P1|Overall Study|Lost to Follow-up|1
1250580|NCT00572156|4101310|P4|Overall Study|Adverse Event|1
1250581|NCT00572156|4101311|P3|Overall Study|Adverse Event|5
1250582|NCT00572156|4101312|P2|Overall Study|Adverse Event|1
1250583|NCT00572156|4101313|P1|Overall Study|Adverse Event|3
1250584|NCT00572039|4101384|P2|Overall Study|Ill|1
1250585|NCT00572039|4101385|P1|Overall Study|Ill|5
1250586|NCT00572039|4101384|P2|Overall Study|Death|3
1250587|NCT00572039|4101385|P1|Overall Study|Death|2
1250588|NCT00572039|4101384|P2|Overall Study|Withdrawal by Subject|6
1250589|NCT00572039|4101385|P1|Overall Study|Withdrawal by Subject|9
1250590|NCT00571948|4101417|P2|Overall Study|Parent were afraid of blood colection|5
1250591|NCT00571948|4101418|P1|Overall Study|Parent were afraid of blood colection|2
1250592|NCT00571948|4101417|P2|Overall Study|infant refused study meal|4
1250593|NCT00571948|4101418|P1|Overall Study|infant refused study meal|3
1250594|NCT00571948|4101417|P2|Overall Study|Protocol Violation|3
1250595|NCT00571948|4101418|P1|Overall Study|Protocol Violation|3
1250596|NCT00571948|4101417|P2|Overall Study|Withdrawal by Subject|2
1250597|NCT00571948|4101418|P1|Overall Study|Withdrawal by Subject|1
1250598|NCT00571948|4101417|P2|Overall Study|Lost to Follow-up|0
1250599|NCT00571948|4101418|P1|Overall Study|Lost to Follow-up|2
1250600|NCT00571922|4101426|P2|Overall Study|Completion unknown|36
1250601|NCT00571922|4101427|P1|Overall Study|Completion unknown|36
1250602|NCT00571701|4101437|P2|Second Intervention 12 Months|Withdrawal by Subject|0
1250603|NCT00571701|4101438|P1|Second Intervention 12 Months|Withdrawal by Subject|3
1250604|NCT00571701|4101437|P2|Second Intervention 12 Months|Adverse Event|1
1250605|NCT00571701|4101438|P1|Second Intervention 12 Months|Adverse Event|0
1250606|NCT00571701|4101437|P2|First Intervention 12 Months|Death|0
1250607|NCT00571701|4101438|P1|First Intervention 12 Months|Death|1
1250608|NCT00571701|4101437|P2|First Intervention 12 Months|Withdrawal by Subject|1
1250609|NCT00571701|4101438|P1|First Intervention 12 Months|Withdrawal by Subject|2
1250610|NCT00571688|4101464|P2|Overall Study|subject moved out of the area|0
1250611|NCT00571688|4101465|P1|Overall Study|subject moved out of the area|1
1250612|NCT00571688|4101464|P2|Overall Study|subject did not tolerate Consta|0
1250613|NCT00571688|4101465|P1|Overall Study|subject did not tolerate Consta|1
1250614|NCT00571688|4101464|P2|Overall Study|Lost to Follow-up|6
1250615|NCT00571688|4101465|P1|Overall Study|Lost to Follow-up|3
1250616|NCT00571662|4101471|P1|Overall Study|Adverse Event|5
1250617|NCT00571662|4101471|P1|Overall Study|psychiatric instability|1
1250618|NCT00571662|4101471|P1|Overall Study|Withdrawal by Subject|2
1250619|NCT00571649|4101482|P2|Follow-up Period|Protocol Violation|12
1250620|NCT00571649|4101483|P1|Follow-up Period|Protocol Violation|5
1250621|NCT00571649|4101482|P2|Follow-up Period|Patient convenience|121
1250622|NCT00571649|4101483|P1|Follow-up Period|Patient convenience|136
1250623|NCT00571649|4101482|P2|Follow-up Period|Lost to Follow-up|92
1250624|NCT00571649|4101483|P1|Follow-up Period|Lost to Follow-up|95
1250625|NCT00571649|4101482|P2|Follow-up Period|Physician Decision|13
1250626|NCT00571649|4101483|P1|Follow-up Period|Physician Decision|7
1250627|NCT00571649|4101482|P2|Follow-up Period|Death|133
1250628|NCT00571649|4101483|P1|Follow-up Period|Death|132
1250629|NCT00571649|4101482|P2|Follow-up Period|Withdrawal by Subject|115
1250630|NCT00571649|4101483|P1|Follow-up Period|Withdrawal by Subject|119
1250631|NCT00571649|4101482|P2|Follow-up Period|Clinical endpoint reached|2
1250632|NCT00571649|4101483|P1|Follow-up Period|Clinical endpoint reached|5
1250633|NCT00571649|4101482|P2|Follow-up Period|Adverse Event|40
1250634|NCT00571649|4101483|P1|Follow-up Period|Adverse Event|46
1250635|NCT00571649|4101482|P2|Treatment Period|Technical problems|5
1250636|NCT00571649|4101483|P1|Treatment Period|Technical problems|3
1250637|NCT00571649|4101482|P2|Treatment Period|Protocol Violation|92
1250638|NCT00571649|4101483|P1|Treatment Period|Protocol Violation|90
1250639|NCT00571649|4101482|P2|Treatment Period|Patient convenience|13
1250640|NCT00571649|4101483|P1|Treatment Period|Patient convenience|11
1250641|NCT00571649|4101482|P2|Treatment Period|Non-compliant with study medication|89
1250642|NCT00571649|4101483|P1|Treatment Period|Non-compliant with study medication|88
1250643|NCT00571649|4101482|P2|Treatment Period|Lost to Follow-up|41
1250644|NCT00571649|4101483|P1|Treatment Period|Lost to Follow-up|43
1250645|NCT00571649|4101482|P2|Treatment Period|Physician Decision|9
1250646|NCT00571649|4101483|P1|Treatment Period|Physician Decision|8
1250647|NCT00571649|4101482|P2|Treatment Period|Death|59
1250648|NCT00571649|4101483|P1|Treatment Period|Death|76
1250649|NCT00571649|4101482|P2|Treatment Period|Withdrawal by Subject|255
1250650|NCT00571649|4101483|P1|Treatment Period|Withdrawal by Subject|285
1250651|NCT00571649|4101482|P2|Treatment Period|Clinical endpoint reached|56
1250652|NCT00571649|4101483|P1|Treatment Period|Clinical endpoint reached|50
1250653|NCT00571649|4101482|P2|Treatment Period|Adverse Event|385
1250654|NCT00571649|4101483|P1|Treatment Period|Adverse Event|438
1250655|NCT00571103|4101581|P1|Overall Study|Lost to Follow-up|1
1250656|NCT00571103|4101581|P1|Overall Study|Withdrawal by Subject|1
1250657|NCT00571064|4101586|P1|Overall Study|Not specified|2
1250658|NCT00571064|4101586|P1|Overall Study|Withdrawal by Subject|2
1250659|NCT00571064|4101586|P1|Overall Study|Protocol Violation|4
1250660|NCT00571064|4101586|P1|Overall Study|Adverse Event|13
1250661|NCT00571038|4101601|P2|Overall Study|Moved out of state|2
1250662|NCT00571038|4101602|P1|Overall Study|Moved out of state|2
1250663|NCT00571038|4101601|P2|Overall Study|Withdrawal by Subject|3
1250664|NCT00571038|4101602|P1|Overall Study|Withdrawal by Subject|1
1250665|NCT00571038|4101601|P2|Overall Study|Death|5
1250666|NCT00571038|4101602|P1|Overall Study|Death|7
1250667|NCT00571038|4101601|P2|Overall Study|Lost to Follow-up|4
1250668|NCT00571038|4101602|P1|Overall Study|Lost to Follow-up|1
1250669|NCT00570921|4101657|P1|Overall Study|Physician Decision|1
1250670|NCT00570921|4101657|P1|Overall Study|Protocol Violation|1
1250671|NCT00570908|4101663|P1|Overall Study|Withdrawal by Subject|2
1250672|NCT00570908|4101663|P1|Overall Study|Adverse Event|5
1250673|NCT00570778|4101667|P4|Overall Study|Subject no longer requires study drug|0
1250674|NCT00570778|4101668|P3|Overall Study|Subject no longer requires study drug|0
1250675|NCT00570778|4101669|P2|Overall Study|Subject no longer requires study drug|1
1250676|NCT00570778|4101670|P1|Overall Study|Subject no longer requires study drug|0
1250677|NCT00570778|4101667|P4|Overall Study|Lost to Follow-up|0
1250678|NCT00570778|4101668|P3|Overall Study|Lost to Follow-up|1
1250679|NCT00570778|4101669|P2|Overall Study|Lost to Follow-up|0
1250680|NCT00570778|4101670|P1|Overall Study|Lost to Follow-up|0
1250681|NCT00570778|4101667|P4|Overall Study|Unsatisfactory therapeutic effect|0
1250682|NCT00570778|4101668|P3|Overall Study|Unsatisfactory therapeutic effect|0
1250683|NCT00570778|4101669|P2|Overall Study|Unsatisfactory therapeutic effect|0
1250684|NCT00570778|4101670|P1|Overall Study|Unsatisfactory therapeutic effect|1
1250685|NCT00570778|4101667|P4|Overall Study|Abnormal test procedure|0
1250686|NCT00570778|4101668|P3|Overall Study|Abnormal test procedure|0
1250687|NCT00570778|4101669|P2|Overall Study|Abnormal test procedure|0
1250688|NCT00570778|4101670|P1|Overall Study|Abnormal test procedure|1
1250689|NCT00570778|4101667|P4|Overall Study|Subject withdrew consent|1
1250690|NCT00570778|4101668|P3|Overall Study|Subject withdrew consent|0
1250691|NCT00570778|4101669|P2|Overall Study|Subject withdrew consent|1
1250692|NCT00570778|4101670|P1|Overall Study|Subject withdrew consent|0
1250693|NCT00570778|4101667|P4|Overall Study|Adverse Event|1
1250694|NCT00570778|4101668|P3|Overall Study|Adverse Event|4
1250695|NCT00570778|4101669|P2|Overall Study|Adverse Event|1
1250696|NCT00570778|4101670|P1|Overall Study|Adverse Event|0
1250697|NCT00570778|4101667|P4|Overall Study|Protocol deviation|2
1250698|NCT00570778|4101668|P3|Overall Study|Protocol deviation|2
1250699|NCT00570778|4101669|P2|Overall Study|Protocol deviation|1
1250700|NCT00570778|4101670|P1|Overall Study|Protocol deviation|2
1250701|NCT00570739|4101711|P4|Overall Study|Not specified|3
1250702|NCT00570739|4101712|P3|Overall Study|Not specified|5
1250703|NCT00570739|4101713|P2|Overall Study|Not specified|2
1250704|NCT00570739|4101714|P1|Overall Study|Not specified|0
1250705|NCT00570739|4101711|P4|Overall Study|Met discontinuation criteria|1
1250706|NCT00570739|4101712|P3|Overall Study|Met discontinuation criteria|1
1250707|NCT00570739|4101713|P2|Overall Study|Met discontinuation criteria|0
1250708|NCT00570739|4101714|P1|Overall Study|Met discontinuation criteria|1
1250709|NCT00570739|4101711|P4|Overall Study|Required restricted medication|0
1250710|NCT00570739|4101712|P3|Overall Study|Required restricted medication|1
1250711|NCT00570739|4101713|P2|Overall Study|Required restricted medication|0
1250712|NCT00570739|4101714|P1|Overall Study|Required restricted medication|0
1250713|NCT00570739|4101711|P4|Overall Study|Withdrawal by Subject|5
1250714|NCT00570739|4101712|P3|Overall Study|Withdrawal by Subject|3
1250715|NCT00570739|4101713|P2|Overall Study|Withdrawal by Subject|7
1250716|NCT00570739|4101714|P1|Overall Study|Withdrawal by Subject|7
1250717|NCT00570739|4101711|P4|Overall Study|Physician Decision|0
1250718|NCT00570739|4101712|P3|Overall Study|Physician Decision|0
1250719|NCT00570739|4101713|P2|Overall Study|Physician Decision|1
1250720|NCT00570739|4101714|P1|Overall Study|Physician Decision|1
1250721|NCT00570739|4101711|P4|Overall Study|Lost to Follow-up|1
1250722|NCT00570739|4101712|P3|Overall Study|Lost to Follow-up|4
1250723|NCT00570739|4101713|P2|Overall Study|Lost to Follow-up|5
1250724|NCT00570739|4101714|P1|Overall Study|Lost to Follow-up|4
1250725|NCT00570739|4101711|P4|Overall Study|Adverse Event|2
1250726|NCT00570739|4101712|P3|Overall Study|Adverse Event|2
1250727|NCT00570739|4101713|P2|Overall Study|Adverse Event|6
1250728|NCT00570739|4101714|P1|Overall Study|Adverse Event|8
1250729|NCT00570713|4101866|P2|Overall Study|Discontinuation of Study by the Sponsor|7
1250730|NCT00570713|4101867|P1|Overall Study|Discontinuation of Study by the Sponsor|10
1250731|NCT00570713|4101866|P2|Overall Study|Withdrawal by Subject|3
1250732|NCT00570713|4101867|P1|Overall Study|Withdrawal by Subject|3
1250733|NCT00570713|4101866|P2|Overall Study|Physician Decision|2
1250734|NCT00570713|4101867|P1|Overall Study|Physician Decision|2
1250735|NCT00570713|4101866|P2|Overall Study|Lack of Efficacy|49
1250736|NCT00570713|4101867|P1|Overall Study|Lack of Efficacy|40
1250737|NCT00570713|4101866|P2|Overall Study|Death|7
1250738|NCT00570713|4101867|P1|Overall Study|Death|7
1250739|NCT00570713|4101866|P2|Overall Study|Adverse Event|9
1250740|NCT00570713|4101867|P1|Overall Study|Adverse Event|16
1250741|NCT00570687|4101885|P10|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1250742|NCT00570687|4101886|P9|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1250743|NCT00570687|4101887|P8|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1250744|NCT00570687|4101888|P7|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1
1250745|NCT00570687|4101889|P6|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1250746|NCT00570687|4101890|P5|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1250747|NCT00570687|4101891|P4|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1250748|NCT00570687|4101892|P3|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1250749|NCT00570687|4101893|P2|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1250750|NCT00570687|4101894|P1|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1250751|NCT00570687|4101885|P10|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1250752|NCT00570687|4101886|P9|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1
1250753|NCT00570687|4101887|P8|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1250754|NCT00570687|4101888|P7|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1250755|NCT00570687|4101889|P6|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1250756|NCT00570687|4101890|P5|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1250757|NCT00570687|4101891|P4|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1250758|NCT00570687|4101892|P3|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1250759|NCT00570687|4101893|P2|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1250760|NCT00570687|4101894|P1|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1250761|NCT00570687|4101885|P10|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
1250762|NCT00570687|4101886|P9|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
1250763|NCT00570687|4101887|P8|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
1250764|NCT00570687|4101888|P7|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
1250765|NCT00570687|4101889|P6|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
1250766|NCT00570687|4101890|P5|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
1250767|NCT00570687|4101891|P4|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1250768|NCT00570687|4101892|P3|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1250769|NCT00570687|4101893|P2|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1250770|NCT00570687|4101894|P1|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1250771|NCT00570674|4101920|P7|Overall Study|Withdrawal by Subject|0
1250772|NCT00570674|4101921|P6|Overall Study|Withdrawal by Subject|0
1250773|NCT00570674|4101922|P5|Overall Study|Withdrawal by Subject|0
1250774|NCT00570674|4101923|P4|Overall Study|Withdrawal by Subject|0
1250775|NCT00570674|4101924|P3|Overall Study|Withdrawal by Subject|1
1250776|NCT00570674|4101925|P2|Overall Study|Withdrawal by Subject|0
1250777|NCT00570674|4101926|P1|Overall Study|Withdrawal by Subject|0
1250778|NCT00570505|4101949|P1|Overall Study|Other loss to follow-up|4
1250779|NCT00570505|4101949|P1|Overall Study|Lost to Follow-up|23
1250780|NCT00570505|4101949|P1|Overall Study|Withdrawal by Subject|7
1250781|NCT00570505|4101949|P1|Overall Study|Adverse Event|7
1250782|NCT00570492|4101962|P3|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
1250783|NCT00570492|4101963|P2|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3
1250784|NCT00570492|4101964|P1|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
1250785|NCT00570492|4101962|P3|52-week Double-blind Treatment Period|Lack of Efficacy|0
1250786|NCT00570492|4101963|P2|52-week Double-blind Treatment Period|Lack of Efficacy|3
1250787|NCT00570492|4101964|P1|52-week Double-blind Treatment Period|Lack of Efficacy|0
1250788|NCT00570492|4101962|P3|52-week Double-blind Treatment Period|Physician Decision|4
1250789|NCT00570492|4101963|P2|52-week Double-blind Treatment Period|Physician Decision|2
1250790|NCT00570492|4101964|P1|52-week Double-blind Treatment Period|Physician Decision|0
1250791|NCT00570492|4101962|P3|52-week Double-blind Treatment Period|Adverse Event|5
1250792|NCT00570492|4101963|P2|52-week Double-blind Treatment Period|Adverse Event|5
1250793|NCT00570492|4101964|P1|52-week Double-blind Treatment Period|Adverse Event|0
1250794|NCT00570492|4101962|P3|52-week Double-blind Treatment Period|Lost to Follow-up|7
1250795|NCT00570492|4101963|P2|52-week Double-blind Treatment Period|Lost to Follow-up|5
1250796|NCT00570492|4101964|P1|52-week Double-blind Treatment Period|Lost to Follow-up|0
1250797|NCT00570492|4101962|P3|52-week Double-blind Treatment Period|Protocol Violation|15
1250798|NCT00570492|4101963|P2|52-week Double-blind Treatment Period|Protocol Violation|12
1250799|NCT00570492|4101964|P1|52-week Double-blind Treatment Period|Protocol Violation|0
1250800|NCT00570492|4101962|P3|52-week Double-blind Treatment Period|Withdrawal by Subject|20
1250801|NCT00570492|4101963|P2|52-week Double-blind Treatment Period|Withdrawal by Subject|20
1250802|NCT00570492|4101964|P1|52-week Double-blind Treatment Period|Withdrawal by Subject|0
1250803|NCT00570492|4101962|P3|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
1250804|NCT00570492|4101963|P2|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
1250805|NCT00570492|4101964|P1|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1
1250806|NCT00570492|4101962|P3|16-week Single-blind Baseline Period|Adverse Event|0
1250807|NCT00570492|4101963|P2|16-week Single-blind Baseline Period|Adverse Event|0
1250808|NCT00570492|4101964|P1|16-week Single-blind Baseline Period|Adverse Event|1
1250809|NCT00570492|4101962|P3|16-week Single-blind Baseline Period|Lost to Follow-up|0
1250810|NCT00570492|4101963|P2|16-week Single-blind Baseline Period|Lost to Follow-up|0
1250811|NCT00570492|4101964|P1|16-week Single-blind Baseline Period|Lost to Follow-up|2
1250812|NCT00570492|4101962|P3|16-week Single-blind Baseline Period|Protocol Violation|0
1250813|NCT00570492|4101963|P2|16-week Single-blind Baseline Period|Protocol Violation|0
1250814|NCT00570492|4101964|P1|16-week Single-blind Baseline Period|Protocol Violation|15
1250815|NCT00570492|4101962|P3|16-week Single-blind Baseline Period|Withdrawal by Subject|0
1250816|NCT00570492|4101963|P2|16-week Single-blind Baseline Period|Withdrawal by Subject|0
1250817|NCT00570492|4101964|P1|16-week Single-blind Baseline Period|Withdrawal by Subject|56
1250818|NCT00570492|4101962|P3|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
1250819|NCT00570492|4101963|P2|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
1250820|NCT00570492|4101964|P1|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263
1250821|NCT00570492|4101962|P3|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
1250822|NCT00570492|4101963|P2|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
1250823|NCT00570492|4101964|P1|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98
1250824|NCT00570401|4102002|P1|Overall Study|Adverse Event|2
1250825|NCT00570310|4102036|P2|Overall Study|Lack of Efficacy|4
1250826|NCT00570310|4102037|P1|Overall Study|Lack of Efficacy|1
1250827|NCT00570310|4102036|P2|Overall Study|Adverse Event|2
1250828|NCT00570310|4102037|P1|Overall Study|Adverse Event|1
1250829|NCT00570232|4102045|P1|Overall Study|discontinued due to noncompliance|2
1250830|NCT00570232|4102045|P1|Overall Study|discontinued due to recurrence|8
1250831|NCT00570232|4102045|P1|Overall Study|discontinued due to medical condition|3
1250832|NCT00570232|4102045|P1|Overall Study|Adverse Event|10
1250833|NCT00570141|4102051|P1|Overall Study|Lost to Follow-up|1
1250834|NCT00570141|4102051|P1|Overall Study|Missed visits|1
1250835|NCT00570141|4102051|P1|Overall Study|Adverse Event|1
1250836|NCT00570063|4102067|P2|Overall Study|Sponsor's Decision|3
1250837|NCT00570063|4102068|P1|Overall Study|Sponsor's Decision|7
1250838|NCT00570063|4102067|P2|Overall Study|Withdrawal by Subject|3
1250839|NCT00570063|4102068|P1|Overall Study|Withdrawal by Subject|4
1250840|NCT00570063|4102067|P2|Overall Study|Lack of Efficacy|1
1250841|NCT00570063|4102068|P1|Overall Study|Lack of Efficacy|0
1250842|NCT00570063|4102067|P2|Overall Study|Adverse Event|1
1250843|NCT00570063|4102068|P1|Overall Study|Adverse Event|4
1250844|NCT00570037|4102134|P2|Overall Study|Could not reach for 6-8 week contact|69
1250845|NCT00570037|4102135|P1|Overall Study|Could not reach for 6-8 week contact|44
1250846|NCT00569946|4102145|P1|Overall Study|Global Deterioration of Health Status|1
1250847|NCT00569946|4102145|P1|Overall Study|Objective Progression or Relapse|42
1250848|NCT00569946|4102145|P1|Overall Study|Adverse Event|16
1250849|NCT00569803|4102177|P8|Overall Study|Withdrawal by Subject|1
1250850|NCT00569803|4102178|P7|Overall Study|Withdrawal by Subject|0
1250851|NCT00569803|4102179|P6|Overall Study|Withdrawal by Subject|0
1250852|NCT00569803|4102180|P5|Overall Study|Withdrawal by Subject|0
1250853|NCT00569803|4102181|P4|Overall Study|Withdrawal by Subject|0
1250854|NCT00569803|4102182|P3|Overall Study|Withdrawal by Subject|0
1250855|NCT00569803|4102183|P2|Overall Study|Withdrawal by Subject|0
1250856|NCT00569803|4102184|P1|Overall Study|Withdrawal by Subject|0
1250857|NCT00569803|4102177|P8|Overall Study|injection syringe leaked during dosing|0
1250858|NCT00569803|4102178|P7|Overall Study|injection syringe leaked during dosing|0
1250859|NCT00569803|4102179|P6|Overall Study|injection syringe leaked during dosing|0
1250860|NCT00569803|4102180|P5|Overall Study|injection syringe leaked during dosing|0
1250861|NCT00569803|4102181|P4|Overall Study|injection syringe leaked during dosing|1
1250862|NCT00569803|4102182|P3|Overall Study|injection syringe leaked during dosing|0
1250863|NCT00569803|4102183|P2|Overall Study|injection syringe leaked during dosing|0
1250864|NCT00569803|4102184|P1|Overall Study|injection syringe leaked during dosing|0
1250865|NCT00569803|4102177|P8|Overall Study|Lost to Follow-up|0
1250866|NCT00569803|4102178|P7|Overall Study|Lost to Follow-up|0
1250867|NCT00569803|4102179|P6|Overall Study|Lost to Follow-up|0
1250868|NCT00569803|4102180|P5|Overall Study|Lost to Follow-up|0
1250869|NCT00569803|4102181|P4|Overall Study|Lost to Follow-up|0
1250870|NCT00569803|4102182|P3|Overall Study|Lost to Follow-up|0
1250871|NCT00569803|4102183|P2|Overall Study|Lost to Follow-up|0
1250872|NCT00569803|4102184|P1|Overall Study|Lost to Follow-up|1
1250873|NCT00569777|4102311|P2|Overall Study|pregnant|0
1250874|NCT00569777|4102312|P1|Overall Study|pregnant|1
1250875|NCT00569777|4102311|P2|Overall Study|did not meet exclusion criteria|2
1250876|NCT00569777|4102312|P1|Overall Study|did not meet exclusion criteria|1
1250877|NCT00569777|4102311|P2|Overall Study|scheduled eye surgery|1
1250878|NCT00569777|4102312|P1|Overall Study|scheduled eye surgery|0
1250879|NCT00569777|4102311|P2|Overall Study|Lost to Follow-up|0
1250880|NCT00569777|4102312|P1|Overall Study|Lost to Follow-up|1
1250881|NCT00569777|4102311|P2|Overall Study|Adverse Event|0
1250882|NCT00569777|4102312|P1|Overall Study|Adverse Event|3
1250883|NCT00569777|4102311|P2|Overall Study|Withdrawal by Subject|0
1250884|NCT00569777|4102312|P1|Overall Study|Withdrawal by Subject|4
1250885|NCT00569582|4102363|P1|Overall Study|Subject was non-compliant.|1
1250886|NCT00569582|4102363|P1|Overall Study|Subject was too ill to travel.|1
1250887|NCT00569582|4102363|P1|Overall Study|Adverse Event|7
1250888|NCT00569582|4102363|P1|Overall Study|Death|2
1250889|NCT00569582|4102363|P1|Overall Study|Withdrawal by Subject|5
1250890|NCT00569374|4102379|P1|Overall Study|Withdrawal by Subject|4
1250891|NCT00569270|4102398|P2|Period: First Intervention|Protocol Violation|1
1250892|NCT00569270|4102399|P1|Period: First Intervention|Protocol Violation|0
1250893|NCT00569231|4102434|P1|Overall Study|Non-compliance|2
1250894|NCT00569231|4102434|P1|Overall Study|Car accident injury|1
1250895|NCT00569231|4102434|P1|Overall Study|Withdrawal by Subject|1
1250896|NCT00569231|4102434|P1|Overall Study|Airfare expense|2
1250897|NCT00569231|4102434|P1|Overall Study|Study unrelated surgery|1
1250898|NCT00569166|4102472|P3|Overall Study|Lost to Follow-up|1
1250899|NCT00569166|4102473|P2|Overall Study|Lost to Follow-up|1
1250900|NCT00569166|4102474|P1|Overall Study|Lost to Follow-up|2
1250901|NCT00569166|4102472|P3|Overall Study|Withdrawal by Subject|3
1250902|NCT00569166|4102473|P2|Overall Study|Withdrawal by Subject|5
1250903|NCT00569166|4102474|P1|Overall Study|Withdrawal by Subject|7
1250904|NCT00569127|4102508|P2|Overall Study|Still on Treatment|3
1250905|NCT00569127|4102509|P1|Overall Study|Still on Treatment|7
1250906|NCT00569127|4102508|P2|Overall Study|Not Eligible|11
1250907|NCT00569127|4102509|P1|Overall Study|Not Eligible|14
1250908|NCT00569127|4102508|P2|Overall Study|Lost to Follow-up|3
1250909|NCT00569127|4102509|P1|Overall Study|Lost to Follow-up|0
1250910|NCT00569127|4102508|P2|Overall Study|Not Specified|19
1250911|NCT00569127|4102509|P1|Overall Study|Not Specified|20
1250912|NCT00569127|4102508|P2|Overall Study|Death|3
1250913|NCT00569127|4102509|P1|Overall Study|Death|4
1250914|NCT00569127|4102508|P2|Overall Study|Progression|100
1250915|NCT00569127|4102509|P1|Overall Study|Progression|99
1250916|NCT00569127|4102508|P2|Overall Study|Withdrawal by Subject|27
1250917|NCT00569127|4102509|P1|Overall Study|Withdrawal by Subject|13
1250918|NCT00569127|4102508|P2|Overall Study|Adverse Event|47
1250919|NCT00569127|4102509|P1|Overall Study|Adverse Event|57
1250920|NCT00568958|4102544|P2|Follow-Up|Adverse Event|0
1250921|NCT00568958|4102545|P1|Follow-Up|Adverse Event|1
1250922|NCT00568958|4102544|P2|Follow-Up|Family Emergency|0
1250923|NCT00568958|4102545|P1|Follow-Up|Family Emergency|1
1250924|NCT00568958|4102544|P2|Follow-Up|Physician Decision|1
1250925|NCT00568958|4102545|P1|Follow-Up|Physician Decision|1
1250926|NCT00568958|4102544|P2|Follow-Up|Withdrawal by Subject|6
1250927|NCT00568958|4102545|P1|Follow-Up|Withdrawal by Subject|6
1250928|NCT00568958|4102544|P2|Allocation|Physician Decision|0
1250929|NCT00568958|4102545|P1|Allocation|Physician Decision|2
1250930|NCT00568958|4102544|P2|Allocation|Withdrawal by Subject|3
1250931|NCT00568958|4102545|P1|Allocation|Withdrawal by Subject|7
1250932|NCT00568776|4102578|P4|Overall Study|Miscellaeneous|4
1250933|NCT00568776|4102579|P3|Overall Study|Miscellaeneous|1
1250934|NCT00568776|4102580|P2|Overall Study|Miscellaeneous|3
1250935|NCT00568776|4102581|P1|Overall Study|Miscellaeneous|3
1250936|NCT00568776|4102578|P4|Overall Study|Sponsor Decision|42
1250937|NCT00568776|4102579|P3|Overall Study|Sponsor Decision|41
1250938|NCT00568776|4102580|P2|Overall Study|Sponsor Decision|2
1250939|NCT00568776|4102581|P1|Overall Study|Sponsor Decision|2
1250940|NCT00568776|4102578|P4|Overall Study|Loss of Caregiver|2
1250941|NCT00568776|4102579|P3|Overall Study|Loss of Caregiver|1
1250942|NCT00568776|4102580|P2|Overall Study|Loss of Caregiver|2
1250943|NCT00568776|4102581|P1|Overall Study|Loss of Caregiver|0
1250944|NCT00568776|4102578|P4|Overall Study|Withdrawal by Subject|7
1250945|NCT00568776|4102579|P3|Overall Study|Withdrawal by Subject|13
1250946|NCT00568776|4102580|P2|Overall Study|Withdrawal by Subject|15
1250947|NCT00568776|4102581|P1|Overall Study|Withdrawal by Subject|13
1250948|NCT00568776|4102578|P4|Overall Study|Protocol Violation|1
1250949|NCT00568776|4102579|P3|Overall Study|Protocol Violation|1
1250950|NCT00568776|4102580|P2|Overall Study|Protocol Violation|0
1250951|NCT00568776|4102581|P1|Overall Study|Protocol Violation|1
1250952|NCT00568776|4102578|P4|Overall Study|Lost to Follow-up|1
1250953|NCT00568776|4102579|P3|Overall Study|Lost to Follow-up|1
1250954|NCT00568776|4102580|P2|Overall Study|Lost to Follow-up|1
1250955|NCT00568776|4102581|P1|Overall Study|Lost to Follow-up|1
1250956|NCT00568776|4102578|P4|Overall Study|Lack of Efficacy|4
1250957|NCT00568776|4102579|P3|Overall Study|Lack of Efficacy|2
1250958|NCT00568776|4102580|P2|Overall Study|Lack of Efficacy|2
1250959|NCT00568776|4102581|P1|Overall Study|Lack of Efficacy|2
1250960|NCT00568776|4102578|P4|Overall Study|Physician Decision|0
1250961|NCT00568776|4102579|P3|Overall Study|Physician Decision|0
1250962|NCT00568776|4102580|P2|Overall Study|Physician Decision|2
1250963|NCT00568776|4102581|P1|Overall Study|Physician Decision|0
1250964|NCT00568776|4102578|P4|Overall Study|Death|3
1250965|NCT00568776|4102579|P3|Overall Study|Death|4
1250966|NCT00568776|4102580|P2|Overall Study|Death|1
1250967|NCT00568776|4102581|P1|Overall Study|Death|0
1250968|NCT00568776|4102578|P4|Overall Study|Adverse Event|8
1250969|NCT00568776|4102579|P3|Overall Study|Adverse Event|10
1250970|NCT00568776|4102580|P2|Overall Study|Adverse Event|8
1250971|NCT00568776|4102581|P1|Overall Study|Adverse Event|8
1250972|NCT00568685|4102618|P3|Overall Study|Protocol Violation|0
1250973|NCT00568685|4102619|P2|Overall Study|Protocol Violation|0
1250974|NCT00568685|4102620|P1|Overall Study|Protocol Violation|1
1250975|NCT00568685|4102618|P3|Overall Study|Withdrawal by Subject|2
1250976|NCT00568685|4102619|P2|Overall Study|Withdrawal by Subject|2
1250977|NCT00568685|4102620|P1|Overall Study|Withdrawal by Subject|7
1250978|NCT00568685|4102618|P3|Overall Study|Adverse Event|3
1250979|NCT00568685|4102619|P2|Overall Study|Adverse Event|3
1250980|NCT00568685|4102620|P1|Overall Study|Adverse Event|2
1250981|NCT00568555|4102654|P2|Overall Study|Withdrawal by Subject|1
1250982|NCT00568555|4102655|P1|Overall Study|Withdrawal by Subject|1
1250983|NCT00568451|4102673|P4|Overall Study|Disease Progression|7
1250984|NCT00568451|4102674|P3|Overall Study|Disease Progression|2
1250985|NCT00568451|4102675|P2|Overall Study|Disease Progression|0
1250986|NCT00568451|4102676|P1|Overall Study|Disease Progression|0
1250987|NCT00568399|4102692|P1|Overall Study|Withdrawal by Subject|8
1250988|NCT00568399|4102692|P1|Overall Study|Adverse Event|5
1250989|NCT00568399|4102692|P1|Overall Study|Death|2
1250990|NCT00568334|4102707|P2|Overall Study|Lost to Follow-up|0
1250991|NCT00568334|4102708|P1|Overall Study|Lost to Follow-up|1
1250992|NCT00568334|4102707|P2|Overall Study|Withdrawal by Subject|1
1250993|NCT00568334|4102708|P1|Overall Study|Withdrawal by Subject|0
1250994|NCT00568178|4102734|P6|Open Label Extension|Withdrawal by Subject|4
1250995|NCT00568178|4102735|P5|Open Label Extension|Withdrawal by Subject|4
1250996|NCT00568178|4102736|P4|Open Label Extension|Withdrawal by Subject|0
1250997|NCT00568178|4102737|P3|Open Label Extension|Withdrawal by Subject|0
1250998|NCT00568178|4102738|P2|Open Label Extension|Withdrawal by Subject|0
1250999|NCT00568178|4102739|P1|Open Label Extension|Withdrawal by Subject|0
1251000|NCT00568178|4102734|P6|Open Label Extension|Termination of Trial|47
1251001|NCT00568178|4102735|P5|Open Label Extension|Termination of Trial|45
1251002|NCT00568178|4102736|P4|Open Label Extension|Termination of Trial|0
1251003|NCT00568178|4102737|P3|Open Label Extension|Termination of Trial|0
1251004|NCT00568178|4102738|P2|Open Label Extension|Termination of Trial|0
1251005|NCT00568178|4102739|P1|Open Label Extension|Termination of Trial|0
1251006|NCT00568178|4102734|P6|Open Label Extension|Progressive Disease|1
1251007|NCT00568178|4102735|P5|Open Label Extension|Progressive Disease|3
1251008|NCT00568178|4102736|P4|Open Label Extension|Progressive Disease|0
1251009|NCT00568178|4102737|P3|Open Label Extension|Progressive Disease|0
1251010|NCT00568178|4102738|P2|Open Label Extension|Progressive Disease|0
1251011|NCT00568178|4102739|P1|Open Label Extension|Progressive Disease|0
1251012|NCT00568178|4102734|P6|Open Label Extension|Pregnancy|1
1251013|NCT00568178|4102735|P5|Open Label Extension|Pregnancy|0
1251014|NCT00568178|4102736|P4|Open Label Extension|Pregnancy|0
1251015|NCT00568178|4102737|P3|Open Label Extension|Pregnancy|0
1251016|NCT00568178|4102738|P2|Open Label Extension|Pregnancy|0
1251017|NCT00568178|4102739|P1|Open Label Extension|Pregnancy|0
1251018|NCT00568178|4102734|P6|Open Label Extension|Physician Decision|8
1251019|NCT00568178|4102735|P5|Open Label Extension|Physician Decision|9
1251020|NCT00568178|4102736|P4|Open Label Extension|Physician Decision|0
1251021|NCT00568178|4102737|P3|Open Label Extension|Physician Decision|0
1251022|NCT00568178|4102738|P2|Open Label Extension|Physician Decision|0
1251023|NCT00568178|4102739|P1|Open Label Extension|Physician Decision|0
1251024|NCT00568178|4102734|P6|Open Label Extension|Lost to Follow-up|11
1251025|NCT00568178|4102735|P5|Open Label Extension|Lost to Follow-up|6
1251026|NCT00568178|4102736|P4|Open Label Extension|Lost to Follow-up|0
1251027|NCT00568178|4102737|P3|Open Label Extension|Lost to Follow-up|0
1251028|NCT00568178|4102738|P2|Open Label Extension|Lost to Follow-up|0
1251029|NCT00568178|4102739|P1|Open Label Extension|Lost to Follow-up|0
1251030|NCT00568178|4102734|P6|Open Label Extension|Protocol Violation|0
1251031|NCT00568178|4102735|P5|Open Label Extension|Protocol Violation|1
1251032|NCT00568178|4102736|P4|Open Label Extension|Protocol Violation|0
1251033|NCT00568178|4102737|P3|Open Label Extension|Protocol Violation|0
1251034|NCT00568178|4102738|P2|Open Label Extension|Protocol Violation|0
1251035|NCT00568178|4102739|P1|Open Label Extension|Protocol Violation|0
1251036|NCT00568178|4102734|P6|Open Label Extension|Adverse Event|8
1251037|NCT00568178|4102735|P5|Open Label Extension|Adverse Event|11
1251038|NCT00568178|4102736|P4|Open Label Extension|Adverse Event|0
1251039|NCT00568178|4102737|P3|Open Label Extension|Adverse Event|0
1251040|NCT00568178|4102738|P2|Open Label Extension|Adverse Event|0
1251041|NCT00568178|4102739|P1|Open Label Extension|Adverse Event|0
1251042|NCT00568178|4102734|P6|Double Blind Base Study|Progressive Disease|0
1251043|NCT00568178|4102735|P5|Double Blind Base Study|Progressive Disease|0
1251044|NCT00568178|4102736|P4|Double Blind Base Study|Progressive Disease|1
1251045|NCT00568178|4102737|P3|Double Blind Base Study|Progressive Disease|0
1251046|NCT00568178|4102738|P2|Double Blind Base Study|Progressive Disease|0
1251047|NCT00568178|4102739|P1|Double Blind Base Study|Progressive Disease|0
1251048|NCT00568178|4102734|P6|Double Blind Base Study|Withdrawal by Subject|0
1251049|NCT00568178|4102735|P5|Double Blind Base Study|Withdrawal by Subject|0
1251050|NCT00568178|4102736|P4|Double Blind Base Study|Withdrawal by Subject|0
1251051|NCT00568178|4102737|P3|Double Blind Base Study|Withdrawal by Subject|0
1251052|NCT00568178|4102738|P2|Double Blind Base Study|Withdrawal by Subject|1
1251053|NCT00568178|4102739|P1|Double Blind Base Study|Withdrawal by Subject|1
1251054|NCT00568178|4102734|P6|Double Blind Base Study|Protocol Violation|0
1251055|NCT00568178|4102735|P5|Double Blind Base Study|Protocol Violation|0
1251056|NCT00568178|4102736|P4|Double Blind Base Study|Protocol Violation|0
1251057|NCT00568178|4102737|P3|Double Blind Base Study|Protocol Violation|0
1251058|NCT00568178|4102738|P2|Double Blind Base Study|Protocol Violation|2
1251059|NCT00568178|4102739|P1|Double Blind Base Study|Protocol Violation|3
1251060|NCT00568178|4102734|P6|Double Blind Base Study|Physician Decision|0
1251061|NCT00568178|4102735|P5|Double Blind Base Study|Physician Decision|0
1251062|NCT00568178|4102736|P4|Double Blind Base Study|Physician Decision|1
1251063|NCT00568178|4102737|P3|Double Blind Base Study|Physician Decision|0
1251064|NCT00568178|4102738|P2|Double Blind Base Study|Physician Decision|1
1251065|NCT00568178|4102739|P1|Double Blind Base Study|Physician Decision|1
1251066|NCT00568178|4102734|P6|Double Blind Base Study|Lost to Follow-up|0
1251067|NCT00568178|4102735|P5|Double Blind Base Study|Lost to Follow-up|0
1251068|NCT00568178|4102736|P4|Double Blind Base Study|Lost to Follow-up|1
1251069|NCT00568178|4102737|P3|Double Blind Base Study|Lost to Follow-up|0
1251070|NCT00568178|4102738|P2|Double Blind Base Study|Lost to Follow-up|0
1251071|NCT00568178|4102739|P1|Double Blind Base Study|Lost to Follow-up|1
1251072|NCT00568178|4102734|P6|Double Blind Base Study|Adverse Event|0
1251073|NCT00568178|4102735|P5|Double Blind Base Study|Adverse Event|0
1251074|NCT00568178|4102736|P4|Double Blind Base Study|Adverse Event|2
1251075|NCT00568178|4102737|P3|Double Blind Base Study|Adverse Event|1
1251076|NCT00568178|4102738|P2|Double Blind Base Study|Adverse Event|2
1251077|NCT00568178|4102739|P1|Double Blind Base Study|Adverse Event|0
1251078|NCT00568061|4102770|P2|Overall Study|Adverse Event|1
1251079|NCT00568061|4102771|P1|Overall Study|Adverse Event|0
1251080|NCT00568061|4102770|P2|Overall Study|Inclusion / exclusion criteria|1
1251081|NCT00568061|4102771|P1|Overall Study|Inclusion / exclusion criteria|5
1251082|NCT00567996|4102815|P3|Overall Study|Patient's inability to use the device|0
1251083|NCT00567996|4102816|P2|Overall Study|Patient's inability to use the device|1
1251084|NCT00567996|4102817|P1|Overall Study|Patient's inability to use the device|0
1251085|NCT00567996|4102815|P3|Overall Study|Death|2
1251086|NCT00567996|4102816|P2|Overall Study|Death|0
1251087|NCT00567996|4102817|P1|Overall Study|Death|1
1251088|NCT00567996|4102815|P3|Overall Study|Administrative problems|0
1251089|NCT00567996|4102816|P2|Overall Study|Administrative problems|1
1251090|NCT00567996|4102817|P1|Overall Study|Administrative problems|1
1251091|NCT00567996|4102815|P3|Overall Study|Unsatisfactory therapeutic effect|15
1251092|NCT00567996|4102816|P2|Overall Study|Unsatisfactory therapeutic effect|2
1251093|NCT00567996|4102817|P1|Overall Study|Unsatisfactory therapeutic effect|1
1251094|NCT00567996|4102815|P3|Overall Study|Lost to Follow-up|2
1251095|NCT00567996|4102816|P2|Overall Study|Lost to Follow-up|5
1251096|NCT00567996|4102817|P1|Overall Study|Lost to Follow-up|2
1251097|NCT00567996|4102815|P3|Overall Study|Abnormal test procedure result(s)|1
1251098|NCT00567996|4102816|P2|Overall Study|Abnormal test procedure result(s)|1
1251099|NCT00567996|4102817|P1|Overall Study|Abnormal test procedure result(s)|2
1251100|NCT00567996|4102815|P3|Overall Study|Abnormal Lab value(s)|2
1251101|NCT00567996|4102816|P2|Overall Study|Abnormal Lab value(s)|1
1251102|NCT00567996|4102817|P1|Overall Study|Abnormal Lab value(s)|2
1251103|NCT00567996|4102815|P3|Overall Study|Withdrawal by Subject|22
1251104|NCT00567996|4102816|P2|Overall Study|Withdrawal by Subject|12
1251105|NCT00567996|4102817|P1|Overall Study|Withdrawal by Subject|8
1251106|NCT00567996|4102815|P3|Overall Study|Protocol Deviation|13
1251107|NCT00567996|4102816|P2|Overall Study|Protocol Deviation|11
1251108|NCT00567996|4102817|P1|Overall Study|Protocol Deviation|9
1251109|NCT00567996|4102815|P3|Overall Study|Adverse Event|13
1251110|NCT00567996|4102816|P2|Overall Study|Adverse Event|16
1251111|NCT00567996|4102817|P1|Overall Study|Adverse Event|18
1251112|NCT00567892|4102833|P4|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
1251113|NCT00567892|4102834|P3|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
1251114|NCT00567892|4102835|P2|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
1251115|NCT00567892|4102836|P1|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
1251116|NCT00567892|4102833|P4|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4
1251117|NCT00567892|4102834|P3|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
1251118|NCT00567892|4102835|P2|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
1251119|NCT00567892|4102836|P1|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
1251120|NCT00567879|4102854|P6|Overall Study|Disease progression|3
1251121|NCT00567879|4102855|P5|Overall Study|Disease progression|11
1251122|NCT00567879|4102856|P4|Overall Study|Disease progression|5
1251123|NCT00567879|4102857|P3|Overall Study|Disease progression|15
1251124|NCT00567879|4102858|P2|Overall Study|Disease progression|7
1251125|NCT00567879|4102859|P1|Overall Study|Disease progression|5
1251126|NCT00567879|4102854|P6|Overall Study|New cancer therapy|0
1251127|NCT00567879|4102855|P5|Overall Study|New cancer therapy|0
1251128|NCT00567879|4102856|P4|Overall Study|New cancer therapy|0
1251129|NCT00567879|4102857|P3|Overall Study|New cancer therapy|1
1251130|NCT00567879|4102858|P2|Overall Study|New cancer therapy|0
1251131|NCT00567879|4102859|P1|Overall Study|New cancer therapy|0
1251132|NCT00567879|4102854|P6|Overall Study|Withdrawal by Subject|0
1251133|NCT00567879|4102855|P5|Overall Study|Withdrawal by Subject|0
1251134|NCT00567879|4102856|P4|Overall Study|Withdrawal by Subject|1
1251135|NCT00567879|4102857|P3|Overall Study|Withdrawal by Subject|3
1251136|NCT00567879|4102858|P2|Overall Study|Withdrawal by Subject|0
1251137|NCT00567879|4102859|P1|Overall Study|Withdrawal by Subject|0
1251138|NCT00567879|4102854|P6|Overall Study|Abnormal test procedure(s)|0
1251139|NCT00567879|4102855|P5|Overall Study|Abnormal test procedure(s)|0
1251140|NCT00567879|4102856|P4|Overall Study|Abnormal test procedure(s)|0
1251141|NCT00567879|4102857|P3|Overall Study|Abnormal test procedure(s)|1
1251142|NCT00567879|4102858|P2|Overall Study|Abnormal test procedure(s)|0
1251143|NCT00567879|4102859|P1|Overall Study|Abnormal test procedure(s)|0
1251144|NCT00567879|4102854|P6|Overall Study|Adverse Event|0
1251145|NCT00567879|4102855|P5|Overall Study|Adverse Event|1
1251146|NCT00567879|4102856|P4|Overall Study|Adverse Event|0
1251147|NCT00567879|4102857|P3|Overall Study|Adverse Event|1
1251148|NCT00567879|4102858|P2|Overall Study|Adverse Event|0
1251149|NCT00567879|4102859|P1|Overall Study|Adverse Event|2
1251150|NCT00567593|4102926|P1|Overall Study|Physician Decision|1
1251151|NCT00567593|4102926|P1|Overall Study|Adverse Event|1
1251152|NCT00567567|4102933|P3|Overall Study|Unable adequate stem cell for transplant|2
1251153|NCT00567567|4102934|P2|Overall Study|Unable adequate stem cell for transplant|0
1251154|NCT00567567|4102935|P1|Overall Study|Unable adequate stem cell for transplant|0
1251155|NCT00567567|4102933|P3|Overall Study|Enrolled another COG therapeutic study|0
1251156|NCT00567567|4102934|P2|Overall Study|Enrolled another COG therapeutic study|80
1251157|NCT00567567|4102935|P1|Overall Study|Enrolled another COG therapeutic study|99
1251158|NCT00567567|4102933|P3|Overall Study|Refusal by patient/parent/guardian|122
1251159|NCT00567567|4102934|P2|Overall Study|Refusal by patient/parent/guardian|16
1251160|NCT00567567|4102935|P1|Overall Study|Refusal by patient/parent/guardian|9
1251161|NCT00567567|4102933|P3|Overall Study|Ineligible|9
1251162|NCT00567567|4102934|P2|Overall Study|Ineligible|0
1251163|NCT00567567|4102935|P1|Overall Study|Ineligible|4
1251164|NCT00567567|4102933|P3|Overall Study|Withdrawal by Subject|2
1251165|NCT00567567|4102934|P2|Overall Study|Withdrawal by Subject|0
1251166|NCT00567567|4102935|P1|Overall Study|Withdrawal by Subject|0
1251167|NCT00567567|4102933|P3|Overall Study|Physician Decision|84
1251168|NCT00567567|4102934|P2|Overall Study|Physician Decision|18
1251169|NCT00567567|4102935|P1|Overall Study|Physician Decision|16
1251170|NCT00567567|4102933|P3|Overall Study|Lost to Follow-up|1
1251171|NCT00567567|4102934|P2|Overall Study|Lost to Follow-up|0
1251172|NCT00567567|4102935|P1|Overall Study|Lost to Follow-up|0
1251173|NCT00567567|4102933|P3|Overall Study|Lack of Efficacy|48
1251174|NCT00567567|4102934|P2|Overall Study|Lack of Efficacy|17
1251175|NCT00567567|4102935|P1|Overall Study|Lack of Efficacy|16
1251176|NCT00567567|4102933|P3|Overall Study|Death|5
1251177|NCT00567567|4102934|P2|Overall Study|Death|1
1251178|NCT00567567|4102935|P1|Overall Study|Death|8
1251179|NCT00567567|4102933|P3|Overall Study|Adverse Event|5
1251180|NCT00567567|4102934|P2|Overall Study|Adverse Event|2
1251181|NCT00567567|4102935|P1|Overall Study|Adverse Event|0
1251182|NCT00567541|4102961|P2|Overall Study|Adverse Event|1
1251183|NCT00567541|4102962|P1|Overall Study|Adverse Event|0
1251184|NCT00567502|4102972|P4|Overall Study|Never Initiated Treatment|72
1251185|NCT00567502|4102973|P3|Overall Study|Never Initiated Treatment|0
1251186|NCT00567502|4102974|P2|Overall Study|Never Initiated Treatment|0
1251187|NCT00567502|4102975|P1|Overall Study|Never Initiated Treatment|0
1251188|NCT00567502|4102972|P4|Overall Study|Sponsor request|1
1251189|NCT00567502|4102973|P3|Overall Study|Sponsor request|30
1251190|NCT00567502|4102974|P2|Overall Study|Sponsor request|0
1251191|NCT00567502|4102975|P1|Overall Study|Sponsor request|9
1251192|NCT00567502|4102972|P4|Overall Study|Participant request|1
1251193|NCT00567502|4102973|P3|Overall Study|Participant request|33
1251194|NCT00567502|4102974|P2|Overall Study|Participant request|1
1251195|NCT00567502|4102975|P1|Overall Study|Participant request|12
1251196|NCT00567502|4102972|P4|Overall Study|Other|6
1251197|NCT00567502|4102973|P3|Overall Study|Other|134
1251198|NCT00567502|4102974|P2|Overall Study|Other|2
1251199|NCT00567502|4102975|P1|Overall Study|Other|64
1251200|NCT00567502|4102972|P4|Overall Study|Death|5
1251201|NCT00567502|4102973|P3|Overall Study|Death|360
1251202|NCT00567502|4102974|P2|Overall Study|Death|16
1251203|NCT00567502|4102975|P1|Overall Study|Death|65
1251204|NCT00567502|4102972|P4|Overall Study|Lost to Follow-up|2
1251205|NCT00567502|4102973|P3|Overall Study|Lost to Follow-up|351
1251206|NCT00567502|4102974|P2|Overall Study|Lost to Follow-up|14
1251207|NCT00567502|4102975|P1|Overall Study|Lost to Follow-up|91
1251208|NCT00567476|4103012|P2|Overall Study|Non-adherence to protocol|1
1251209|NCT00567476|4103013|P1|Overall Study|Non-adherence to protocol|0
1251210|NCT00567476|4103012|P2|Overall Study|Medical Decision|1
1251211|NCT00567476|4103013|P1|Overall Study|Medical Decision|0
1251212|NCT00567476|4103012|P2|Overall Study|Administrative issues|0
1251213|NCT00567476|4103013|P1|Overall Study|Administrative issues|1
1251214|NCT00567476|4103012|P2|Overall Study|Lost to Follow-up|1
1251215|NCT00567476|4103013|P1|Overall Study|Lost to Follow-up|0
1251216|NCT00567476|4103012|P2|Overall Study|Protocol Violation|1
1251217|NCT00567476|4103013|P1|Overall Study|Protocol Violation|4
1251218|NCT00567476|4103012|P2|Overall Study|Pregnancy|0
1251219|NCT00567476|4103013|P1|Overall Study|Pregnancy|1
1251220|NCT00567476|4103012|P2|Overall Study|Adverse Event|0
1251221|NCT00567476|4103013|P1|Overall Study|Adverse Event|2
1251222|NCT00567359|4103037|P1|Overall Study|Withdrawal by Subject|1
1251223|NCT00567268|4103062|P1|Overall Study|"Safety Evaluation Not Assessable"|1
1251224|NCT00567268|4103062|P1|Overall Study|No Drug Administration|4
1251225|NCT00567268|4103062|P1|Overall Study|No Visit After First Day of Treatment|2
1251226|NCT00567268|4103062|P1|Overall Study|Lost to Follow-up|36
1251227|NCT00567268|4103062|P1|Overall Study|Protocol Violation|7
1251228|NCT00567255|4103113|P2|Overall Study|Drug noncompliance,moved,other|15
1251229|NCT00567255|4103114|P1|Overall Study|Drug noncompliance,moved,other|25
1251230|NCT00567255|4103113|P2|Overall Study|Pregnancy|0
1251231|NCT00567255|4103114|P1|Overall Study|Pregnancy|6
1251232|NCT00567255|4103113|P2|Overall Study|Protocol Violation|8
1251233|NCT00567255|4103114|P1|Overall Study|Protocol Violation|20
1251234|NCT00567255|4103113|P2|Overall Study|Lack of Efficacy|33
1251235|NCT00567255|4103114|P1|Overall Study|Lack of Efficacy|19
1251236|NCT00567255|4103113|P2|Overall Study|Withdrawal by Subject|56
1251237|NCT00567255|4103114|P1|Overall Study|Withdrawal by Subject|75
1251238|NCT00567255|4103113|P2|Overall Study|Lost to Follow-up|48
1251239|NCT00567255|4103114|P1|Overall Study|Lost to Follow-up|77
1251240|NCT00567255|4103113|P2|Overall Study|Adverse Event|68
1251241|NCT00567255|4103114|P1|Overall Study|Adverse Event|241
1251242|NCT00567190|4103177|P2|Overall Study|Withdrew Consent or Lost to Follow-up|43
1251243|NCT00567190|4103178|P1|Overall Study|Withdrew Consent or Lost to Follow-up|42
1251244|NCT00567190|4103177|P2|Overall Study|Death|221
1251245|NCT00567190|4103178|P1|Overall Study|Death|168
1251246|NCT00567164|4103198|P3|Overall Study|Missing|0
1251247|NCT00567164|4103199|P2|Overall Study|Missing|0
1251248|NCT00567164|4103200|P1|Overall Study|Missing|1
1251249|NCT00567164|4103198|P3|Overall Study|Primary Reason coded as 'Other'|16
1251250|NCT00567164|4103199|P2|Overall Study|Primary Reason coded as 'Other'|8
1251251|NCT00567164|4103200|P1|Overall Study|Primary Reason coded as 'Other'|37
1251252|NCT00567164|4103198|P3|Overall Study|Pregnancy|6
1251253|NCT00567164|4103199|P2|Overall Study|Pregnancy|4
1251254|NCT00567164|4103200|P1|Overall Study|Pregnancy|20
1251255|NCT00567164|4103198|P3|Overall Study|Lost to Follow-up|21
1251256|NCT00567164|4103199|P2|Overall Study|Lost to Follow-up|23
1251257|NCT00567164|4103200|P1|Overall Study|Lost to Follow-up|202
1251258|NCT00567164|4103198|P3|Overall Study|Death|1
1251259|NCT00567164|4103199|P2|Overall Study|Death|0
1251260|NCT00567164|4103200|P1|Overall Study|Death|0
1251261|NCT00567164|4103198|P3|Overall Study|Adverse Event|9
1251262|NCT00567164|4103199|P2|Overall Study|Adverse Event|13
1251263|NCT00567164|4103200|P1|Overall Study|Adverse Event|92
1251264|NCT00567164|4103198|P3|Overall Study|Protocol Violation|2
1251265|NCT00567164|4103199|P2|Overall Study|Protocol Violation|4
1251266|NCT00567164|4103200|P1|Overall Study|Protocol Violation|23
1251267|NCT00567164|4103198|P3|Overall Study|Withdrawal by Subject|17
1251268|NCT00567164|4103199|P2|Overall Study|Withdrawal by Subject|21
1251269|NCT00567164|4103200|P1|Overall Study|Withdrawal by Subject|171
1251270|NCT00567112|4103272|P3|Washout Period 3 (3 Days)|Protocol Violation|0
1251271|NCT00567112|4103273|P2|Washout Period 3 (3 Days)|Protocol Violation|0
1251272|NCT00567112|4103274|P1|Washout Period 3 (3 Days)|Protocol Violation|1
1251273|NCT00567112|4103272|P3|Washout Period 3 (3 Days)|Lost to Follow-up|0
1251274|NCT00567112|4103273|P2|Washout Period 3 (3 Days)|Lost to Follow-up|0
1251275|NCT00567112|4103274|P1|Washout Period 3 (3 Days)|Lost to Follow-up|2
1251276|NCT00567112|4103272|P3|Treatment Period 2 (3 Days)|Protocol Violation|0
1251277|NCT00567112|4103273|P2|Treatment Period 2 (3 Days)|Protocol Violation|1
1251278|NCT00567112|4103274|P1|Treatment Period 2 (3 Days)|Protocol Violation|0
1251279|NCT00566995|4103305|P1|Overall Study|Withdrew consent|3
1251280|NCT00566995|4103305|P1|Overall Study|Toxicity|4
1251281|NCT00566982|4103320|P2|Overall Study|Other-family problems & doctor's request|2
1251282|NCT00566982|4103321|P1|Overall Study|Other-family problems & doctor's request|0
1251283|NCT00566982|4103320|P2|Overall Study|Lost to Follow-up|1
1251284|NCT00566982|4103321|P1|Overall Study|Lost to Follow-up|0
1251285|NCT00566982|4103320|P2|Overall Study|Protocol Violation|4
1251286|NCT00566982|4103321|P1|Overall Study|Protocol Violation|1
1251287|NCT00566982|4103320|P2|Overall Study|Withdrawal by Subject|14
1251288|NCT00566982|4103321|P1|Overall Study|Withdrawal by Subject|1
1251289|NCT00566982|4103320|P2|Overall Study|Adverse Event|48
1251290|NCT00566982|4103321|P1|Overall Study|Adverse Event|6
1251291|NCT00566852|4103386|P2|Overall Study|Missing reason not reported|20
1251292|NCT00566852|4103387|P1|Overall Study|Missing reason not reported|16
1251293|NCT00566852|4103386|P2|Overall Study|Missing reason not specified|2
1251294|NCT00566852|4103387|P1|Overall Study|Missing reason not specified|1
1251295|NCT00566852|4103386|P2|Overall Study|Not tested due to disability|12
1251296|NCT00566852|4103387|P1|Overall Study|Not tested due to disability|6
1251297|NCT00566852|4103386|P2|Overall Study|Patient refusal|37
1251298|NCT00566852|4103387|P1|Overall Study|Patient refusal|37
1251299|NCT00566852|4103386|P2|Overall Study|Withdrawal by Subject|25
1251300|NCT00566852|4103387|P1|Overall Study|Withdrawal by Subject|30
1251301|NCT00566852|4103386|P2|Overall Study|Death|78
1251302|NCT00566852|4103387|P1|Overall Study|Death|95
1251303|NCT00566852|4103386|P2|Overall Study|Protocol Violation|24
1251304|NCT00566852|4103387|P1|Overall Study|Protocol Violation|22
1251305|NCT00566735|4103418|P2|Overall Study|Switched into a manic episode|1
1251306|NCT00566735|4103419|P1|Overall Study|Switched into a manic episode|0
1251307|NCT00566735|4103418|P2|Overall Study|Refused neuropsychological testing|5
1251308|NCT00566735|4103419|P1|Overall Study|Refused neuropsychological testing|2
1251309|NCT00566735|4103418|P2|Overall Study|Withdrawal by Subject|1
1251310|NCT00566735|4103419|P1|Overall Study|Withdrawal by Subject|0
1251311|NCT00566722|4103432|P3|Overall Study|Noncompliant with drug administration|1
1251312|NCT00566722|4103433|P2|Overall Study|Noncompliant with drug administration|0
1251313|NCT00566722|4103434|P1|Overall Study|Noncompliant with drug administration|0
1251314|NCT00566722|4103432|P3|Overall Study|Serious adverse event|0
1251315|NCT00566722|4103433|P2|Overall Study|Serious adverse event|1
1251316|NCT00566722|4103434|P1|Overall Study|Serious adverse event|0
1251317|NCT00566722|4103432|P3|Overall Study|Did not meet exclusion criteria|2
1251318|NCT00566722|4103433|P2|Overall Study|Did not meet exclusion criteria|0
1251319|NCT00566722|4103434|P1|Overall Study|Did not meet exclusion criteria|0
1251320|NCT00566722|4103432|P3|Overall Study|Lack of Efficacy|4
1251321|NCT00566722|4103433|P2|Overall Study|Lack of Efficacy|2
1251322|NCT00566722|4103434|P1|Overall Study|Lack of Efficacy|1
1251323|NCT00566722|4103432|P3|Overall Study|Lost to Follow-up|1
1251324|NCT00566722|4103433|P2|Overall Study|Lost to Follow-up|1
1251325|NCT00566722|4103434|P1|Overall Study|Lost to Follow-up|1
1251326|NCT00566722|4103432|P3|Overall Study|Withdrawal by Subject|1
1251327|NCT00566722|4103433|P2|Overall Study|Withdrawal by Subject|0
1251328|NCT00566722|4103434|P1|Overall Study|Withdrawal by Subject|0
1251329|NCT00566722|4103432|P3|Overall Study|Adverse Event|0
1251330|NCT00566722|4103433|P2|Overall Study|Adverse Event|1
1251331|NCT00566722|4103434|P1|Overall Study|Adverse Event|0
1251332|NCT00566709|4103480|P2|Overall Study|Protocol Violation|0
1251333|NCT00566709|4103481|P1|Overall Study|Protocol Violation|5
1251334|NCT00566696|4103497|P1|Overall Study|Non-Patient Donors|37
1251335|NCT00566696|4103497|P1|Overall Study|Physician Decision|1
1251336|NCT00566696|4103497|P1|Overall Study|Health Status Change|1
1251337|NCT00566696|4103497|P1|Overall Study|Muromonab not available|1
1251338|NCT00566696|4103497|P1|Overall Study|Met Exclusion Criteria|2
1251339|NCT00566631|4103505|P1|Part 2: Extension Phase|Other|5
1251340|NCT00566631|4103505|P1|Part 2: Extension Phase|Death|1
1251341|NCT00566631|4103505|P1|Part 2: Extension Phase|Lost to Follow-up|6
1251342|NCT00566631|4103505|P1|Part 2: Extension Phase|Adverse Event|11
1251343|NCT00566631|4103505|P1|Part 2: Extension Phase|Withdrawal by Subject|34
1251344|NCT00566631|4103505|P1|Part 2: Extension Phase|Lack of Efficacy|25
1251345|NCT00566631|4103505|P1|Between Treatment and Extension Phase|Participants not willing to participate|95
1251346|NCT00566631|4103505|P1|Part 1: Core Treatment Phase|Met exclusion criteria|1
1251347|NCT00566631|4103505|P1|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1
1251348|NCT00566631|4103505|P1|Part 1: Core Treatment Phase|Withdrawal by Subject|26
1251349|NCT00566631|4103505|P1|Part 1: Core Treatment Phase|Lost to Follow-up|4
1251350|NCT00566631|4103505|P1|Part 1: Core Treatment Phase|Adverse Event|9
1251351|NCT00566631|4103505|P1|Part 1: Core Treatment Phase|Physician Decision|1
1251352|NCT00566631|4103505|P1|Part 1: Core Treatment Phase|Lack of Efficacy|18
1251353|NCT00566527|4103532|P3|Overall Study|Withdrawal by Subject|43
1251354|NCT00566527|4103533|P2|Overall Study|Withdrawal by Subject|43
1251355|NCT00566527|4103534|P1|Overall Study|Withdrawal by Subject|6
1251356|NCT00566527|4103532|P3|Overall Study|Lost to Follow-up|4
1251357|NCT00566527|4103533|P2|Overall Study|Lost to Follow-up|4
1251358|NCT00566527|4103534|P1|Overall Study|Lost to Follow-up|3
1251359|NCT00566527|4103532|P3|Overall Study|Physician Decision|20
1251360|NCT00566527|4103533|P2|Overall Study|Physician Decision|8
1251361|NCT00566527|4103534|P1|Overall Study|Physician Decision|3
1251362|NCT00566527|4103532|P3|Overall Study|Adverse Event|1
1251363|NCT00566527|4103533|P2|Overall Study|Adverse Event|0
1251364|NCT00566527|4103534|P1|Overall Study|Adverse Event|2
1251365|NCT00566527|4103532|P3|Overall Study|Reason not provided|10
1251366|NCT00566527|4103533|P2|Overall Study|Reason not provided|11
1251367|NCT00566527|4103534|P1|Overall Study|Reason not provided|3
1251368|NCT00566254|4103595|P2|Overall Study|Not Specified|2
1251369|NCT00566254|4103596|P1|Overall Study|Not Specified|0
1251370|NCT00566254|4103595|P2|Overall Study|Lack of Efficacy|6
1251371|NCT00566254|4103596|P1|Overall Study|Lack of Efficacy|5
1251372|NCT00566254|4103595|P2|Overall Study|Withdrawal by Subject|2
1251373|NCT00566254|4103596|P1|Overall Study|Withdrawal by Subject|1
1251374|NCT00566254|4103595|P2|Overall Study|Protocol Violation|3
1251375|NCT00566254|4103596|P1|Overall Study|Protocol Violation|1
1251376|NCT00566254|4103595|P2|Overall Study|Adverse Event|1
1251377|NCT00566254|4103596|P1|Overall Study|Adverse Event|3
1251378|NCT00566228|4103610|P2|Overall Study|progressed before infusion could occur|1
1251379|NCT00566228|4103611|P1|Overall Study|progressed before infusion could occur|0
1251380|NCT00566228|4103610|P2|Overall Study|Unable to collect sufficient CD34 cells|2
1251381|NCT00566228|4103611|P1|Overall Study|Unable to collect sufficient CD34 cells|3
1251382|NCT00566228|4103610|P2|Overall Study|Attempt to mobilize stem cells failed|2
1251383|NCT00566228|4103611|P1|Overall Study|Attempt to mobilize stem cells failed|2
1251384|NCT00566228|4103610|P2|Overall Study|Withdrawal by Subject|0
1251385|NCT00566228|4103611|P1|Overall Study|Withdrawal by Subject|1
1251386|NCT00566111|4103644|P2|Overall Study|Adverse Event|2
1251387|NCT00566111|4103645|P1|Overall Study|Adverse Event|0
1251388|NCT00566098|4103659|P1|Administration of ASCT+MILs|Lack of Efficacy|8
1251389|NCT00566098|4103659|P1|Administration of ASCT+MILs|Death|10
1251390|NCT00566098|4103659|P1|Generation of MILs Product|Relapsed|1
1251391|NCT00566098|4103659|P1|Collection of MILs|Relapsed|1
1251392|NCT00566098|4103659|P1|Collection of MILs|Withdrawal by Subject|1
1251393|NCT00566020|4103669|P2|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1
1251394|NCT00566020|4103670|P1|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0
1251395|NCT00566020|4103669|P2|46-week Long-term Administration Phase|Lost to Follow-up|2
1251396|NCT00566020|4103670|P1|46-week Long-term Administration Phase|Lost to Follow-up|0
1251397|NCT00566020|4103669|P2|46-week Long-term Administration Phase|Physician Decision|7
1251398|NCT00566020|4103670|P1|46-week Long-term Administration Phase|Physician Decision|0
1251399|NCT00566020|4103669|P2|46-week Long-term Administration Phase|Adverse Event|7
1251400|NCT00566020|4103670|P1|46-week Long-term Administration Phase|Adverse Event|0
1251401|NCT00566020|4103669|P2|6-week Dosage Adjustment Phase|Lack of Efficacy|0
1251402|NCT00566020|4103670|P1|6-week Dosage Adjustment Phase|Lack of Efficacy|2
1251403|NCT00566020|4103669|P2|6-week Dosage Adjustment Phase|Adverse Event|0
1251404|NCT00566020|4103670|P1|6-week Dosage Adjustment Phase|Adverse Event|5
1251405|NCT00565812|4103759|P3|Overall Study|Physician Decision|0
1251406|NCT00565812|4103760|P2|Overall Study|Physician Decision|0
1251407|NCT00565812|4103761|P1|Overall Study|Physician Decision|2
1251408|NCT00565812|4103759|P3|Overall Study|Follow-up Visit Not Completed|1
1251409|NCT00565812|4103760|P2|Overall Study|Follow-up Visit Not Completed|0
1251410|NCT00565812|4103761|P1|Overall Study|Follow-up Visit Not Completed|2
1251411|NCT00565812|4103759|P3|Overall Study|Low Compliance|1
1251412|NCT00565812|4103760|P2|Overall Study|Low Compliance|0
1251413|NCT00565812|4103761|P1|Overall Study|Low Compliance|1
1251414|NCT00565812|4103759|P3|Overall Study|Surgical Intervention|2
1251415|NCT00565812|4103760|P2|Overall Study|Surgical Intervention|1
1251416|NCT00565812|4103761|P1|Overall Study|Surgical Intervention|0
1251417|NCT00565812|4103759|P3|Overall Study|Research Site Closure|8
1251418|NCT00565812|4103760|P2|Overall Study|Research Site Closure|1
1251419|NCT00565812|4103761|P1|Overall Study|Research Site Closure|6
1251420|NCT00565812|4103759|P3|Overall Study|Domestic Reasons|3
1251421|NCT00565812|4103760|P2|Overall Study|Domestic Reasons|1
1251422|NCT00565812|4103761|P1|Overall Study|Domestic Reasons|7
1251423|NCT00565812|4103759|P3|Overall Study|Sponsor Decision|1
1251424|NCT00565812|4103760|P2|Overall Study|Sponsor Decision|5
1251425|NCT00565812|4103761|P1|Overall Study|Sponsor Decision|1
1251426|NCT00565812|4103759|P3|Overall Study|Relocated Out of Area|9
1251427|NCT00565812|4103760|P2|Overall Study|Relocated Out of Area|8
1251428|NCT00565812|4103761|P1|Overall Study|Relocated Out of Area|5
1251429|NCT00565812|4103759|P3|Overall Study|Jury Duty|0
1251430|NCT00565812|4103760|P2|Overall Study|Jury Duty|0
1251431|NCT00565812|4103761|P1|Overall Study|Jury Duty|1
1251432|NCT00565812|4103759|P3|Overall Study|Adverse Event|40
1251433|NCT00565812|4103760|P2|Overall Study|Adverse Event|54
1251434|NCT00565812|4103761|P1|Overall Study|Adverse Event|41
1251435|NCT00565812|4103759|P3|Overall Study|Protocol Violation|4
1251436|NCT00565812|4103760|P2|Overall Study|Protocol Violation|6
1251437|NCT00565812|4103761|P1|Overall Study|Protocol Violation|2
1251438|NCT00565812|4103759|P3|Overall Study|Work Schedule|1
1251439|NCT00565812|4103760|P2|Overall Study|Work Schedule|3
1251440|NCT00565812|4103761|P1|Overall Study|Work Schedule|5
1251441|NCT00565812|4103759|P3|Overall Study|Withdrawal by Subject|48
1251442|NCT00565812|4103760|P2|Overall Study|Withdrawal by Subject|47
1251443|NCT00565812|4103761|P1|Overall Study|Withdrawal by Subject|58
1251444|NCT00565812|4103759|P3|Overall Study|Lost to Follow-up|8
1251445|NCT00565812|4103760|P2|Overall Study|Lost to Follow-up|8
1251446|NCT00565812|4103761|P1|Overall Study|Lost to Follow-up|10
1251447|NCT00565812|4103759|P3|Overall Study|Did not Meet Entrance Criteria|1
1251448|NCT00565812|4103760|P2|Overall Study|Did not Meet Entrance Criteria|0
1251449|NCT00565812|4103761|P1|Overall Study|Did not Meet Entrance Criteria|1
1251450|NCT00565812|4103759|P3|Overall Study|Death|3
1251451|NCT00565812|4103760|P2|Overall Study|Death|1
1251452|NCT00565812|4103761|P1|Overall Study|Death|2
1251453|NCT00565747|4103900|P2|Overall Study|No embryo transfer|73
1251454|NCT00565747|4103901|P1|Overall Study|No embryo transfer|67
1251455|NCT00565721|4103911|P1|Overall Study|Other reasons|6
1251456|NCT00565721|4103911|P1|Overall Study|Physician Decision|2
1251457|NCT00565721|4103911|P1|Overall Study|Technical Problems|1
1251458|NCT00565721|4103911|P1|Overall Study|Lost to Follow-up|6
1251459|NCT00565721|4103911|P1|Overall Study|Screen Failure|2
1251460|NCT00565617|4103960|P1|Overall Study|Withdrawal by Subject|1
1251461|NCT00565604|4103964|P1|Overall Study|Lost to Follow-up|2
1251462|NCT00565604|4103964|P1|Overall Study|Failure to treat|2
1251463|NCT00565448|4103992|P2|Overall Study|Withdrawal by Subject|0
1251464|NCT00565448|4103993|P1|Overall Study|Withdrawal by Subject|1
1251465|NCT00565448|4103992|P2|Overall Study|Disease progression|0
1251466|NCT00565448|4103993|P1|Overall Study|Disease progression|1
1251467|NCT00565448|4103992|P2|Overall Study|Adverse Event|2
1251468|NCT00565448|4103993|P1|Overall Study|Adverse Event|1
1251469|NCT00565409|4104004|P4|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43
1251470|NCT00565409|4104005|P3|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11
1251471|NCT00565409|4104006|P2|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4
1251472|NCT00565409|4104007|P1|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0
1251473|NCT00565409|4104004|P4|Period 2 Double-Blind|Other|9
1251474|NCT00565409|4104005|P3|Period 2 Double-Blind|Other|5
1251475|NCT00565409|4104006|P2|Period 2 Double-Blind|Other|4
1251476|NCT00565409|4104007|P1|Period 2 Double-Blind|Other|0
1251477|NCT00565409|4104004|P4|Period 2 Double-Blind|Lost to Follow-up|0
1251478|NCT00565409|4104005|P3|Period 2 Double-Blind|Lost to Follow-up|1
1251479|NCT00565409|4104006|P2|Period 2 Double-Blind|Lost to Follow-up|0
1251480|NCT00565409|4104007|P1|Period 2 Double-Blind|Lost to Follow-up|0
1251481|NCT00565409|4104004|P4|Period 2 Double-Blind|Protocol Violation|2
1251482|NCT00565409|4104005|P3|Period 2 Double-Blind|Protocol Violation|6
1251483|NCT00565409|4104006|P2|Period 2 Double-Blind|Protocol Violation|4
1251484|NCT00565409|4104007|P1|Period 2 Double-Blind|Protocol Violation|0
1251485|NCT00565409|4104004|P4|Period 2 Double-Blind|Death|0
1251486|NCT00565409|4104005|P3|Period 2 Double-Blind|Death|0
1251487|NCT00565409|4104006|P2|Period 2 Double-Blind|Death|2
1251488|NCT00565409|4104007|P1|Period 2 Double-Blind|Death|0
1251489|NCT00565409|4104004|P4|Period 2 Double-Blind|Adverse Event|5
1251490|NCT00565409|4104005|P3|Period 2 Double-Blind|Adverse Event|4
1251491|NCT00565409|4104006|P2|Period 2 Double-Blind|Adverse Event|7
1251492|NCT00565409|4104007|P1|Period 2 Double-Blind|Adverse Event|0
1251493|NCT00565409|4104004|P4|After Period 1, Prior to Period 2|did not meet criteria|0
1251494|NCT00565409|4104005|P3|After Period 1, Prior to Period 2|did not meet criteria|0
1251495|NCT00565409|4104006|P2|After Period 1, Prior to Period 2|did not meet criteria|0
1251496|NCT00565409|4104007|P1|After Period 1, Prior to Period 2|did not meet criteria|152
1251497|NCT00565409|4104004|P4|Period 1 Open Label|no conclusion of participation record|0
1251498|NCT00565409|4104005|P3|Period 1 Open Label|no conclusion of participation record|0
1251499|NCT00565409|4104006|P2|Period 1 Open Label|no conclusion of participation record|0
1251500|NCT00565409|4104007|P1|Period 1 Open Label|no conclusion of participation record|1
1251501|NCT00565409|4104004|P4|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
1251502|NCT00565409|4104005|P3|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
1251503|NCT00565409|4104006|P2|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
1251504|NCT00565409|4104007|P1|Period 1 Open Label|Unsatisfactory Response-Efficacy|22
1251505|NCT00565409|4104004|P4|Period 1 Open Label|Protocol Violation|0
1251506|NCT00565409|4104005|P3|Period 1 Open Label|Protocol Violation|0
1251507|NCT00565409|4104006|P2|Period 1 Open Label|Protocol Violation|0
1251508|NCT00565409|4104007|P1|Period 1 Open Label|Protocol Violation|14
1251509|NCT00565409|4104004|P4|Period 1 Open Label|Other|0
1251510|NCT00565409|4104005|P3|Period 1 Open Label|Other|0
1251511|NCT00565409|4104006|P2|Period 1 Open Label|Other|0
1251512|NCT00565409|4104007|P1|Period 1 Open Label|Other|21
1251513|NCT00565409|4104004|P4|Period 1 Open Label|Lost to Follow-up|0
1251514|NCT00565409|4104005|P3|Period 1 Open Label|Lost to Follow-up|0
1251515|NCT00565409|4104006|P2|Period 1 Open Label|Lost to Follow-up|0
1251516|NCT00565409|4104007|P1|Period 1 Open Label|Lost to Follow-up|1
1251517|NCT00565409|4104004|P4|Period 1 Open Label|Death|0
1251518|NCT00565409|4104005|P3|Period 1 Open Label|Death|0
1251519|NCT00565409|4104006|P2|Period 1 Open Label|Death|0
1251520|NCT00565409|4104007|P1|Period 1 Open Label|Death|2
1251521|NCT00565409|4104004|P4|Period 1 Open Label|Adverse Event|0
1251522|NCT00565409|4104005|P3|Period 1 Open Label|Adverse Event|0
1251523|NCT00565409|4104006|P2|Period 1 Open Label|Adverse Event|0
1251524|NCT00565409|4104007|P1|Period 1 Open Label|Adverse Event|17
1251525|NCT00565136|4104143|P1|Overall Study|Protocol Violation|1
1251526|NCT00565136|4104143|P1|Overall Study|Withdrawal by Subject|1
1251527|NCT00565136|4104143|P1|Overall Study|Lost to Follow-up|1
1251528|NCT00565058|4104184|P2|Overall Study|Adverse Event|0
1251529|NCT00565058|4104185|P1|Overall Study|Adverse Event|1
1251530|NCT00564902|4104232|P3|Overall Study|Death|0
1251531|NCT00564902|4104233|P2|Overall Study|Death|1
1251532|NCT00564902|4104234|P1|Overall Study|Death|1
1251533|NCT00564902|4104232|P3|Overall Study|Withdrawal by Subject|4
1251534|NCT00564902|4104233|P2|Overall Study|Withdrawal by Subject|3
1251535|NCT00564902|4104234|P1|Overall Study|Withdrawal by Subject|0
1251536|NCT00564889|4104266|P1|Overall Study|Other, not specified|4
1251537|NCT00564889|4104266|P1|Overall Study|Disease progression|3
1251538|NCT00564889|4104266|P1|Overall Study|Alternative treatment|3
1251539|NCT00564889|4104266|P1|Overall Study|Adverse Event|12
1251540|NCT00564889|4104266|P1|Overall Study|Death|7
1251541|NCT00564850|4104281|P1|Overall Study|Protocol Violation|2
1251542|NCT00564733|4104299|P1|Overall Study|Ineligible|5
1251543|NCT00564733|4104299|P1|Overall Study|Withdrawal by Subject|4
1251544|NCT00564629|4104333|P2|Overall Study|Vomited within 2 hours of receiving drug|9
1251545|NCT00564629|4104334|P1|Overall Study|Vomited within 2 hours of receiving drug|15
1251546|NCT00564486|4104359|P4|Overall Study|Lost to Follow-up|2
1251547|NCT00564486|4104360|P3|Overall Study|Lost to Follow-up|2
1251548|NCT00564486|4104361|P2|Overall Study|Lost to Follow-up|0
1251549|NCT00564486|4104362|P1|Overall Study|Lost to Follow-up|3
1251550|NCT00564486|4104359|P4|Overall Study|Subject refused to have blood drawn|0
1251551|NCT00564486|4104360|P3|Overall Study|Subject refused to have blood drawn|1
1251552|NCT00564486|4104361|P2|Overall Study|Subject refused to have blood drawn|0
1251553|NCT00564486|4104362|P1|Overall Study|Subject refused to have blood drawn|0
1251554|NCT00564486|4104359|P4|Overall Study|Withdrawal by Subject|5
1251555|NCT00564486|4104360|P3|Overall Study|Withdrawal by Subject|0
1251556|NCT00564486|4104361|P2|Overall Study|Withdrawal by Subject|0
1251557|NCT00564486|4104362|P1|Overall Study|Withdrawal by Subject|4
1251558|NCT00564486|4104359|P4|Overall Study|Adverse Event|0
1251559|NCT00564486|4104360|P3|Overall Study|Adverse Event|0
1251560|NCT00564486|4104361|P2|Overall Study|Adverse Event|1
1251561|NCT00564486|4104362|P1|Overall Study|Adverse Event|0
1251562|NCT00564395|4104411|P2|First Intervention (10 Days)|Trouble with the CGM tracing|2
1251563|NCT00564395|4104412|P1|First Intervention (10 Days)|Trouble with the CGM tracing|1
1251564|NCT00564395|4104411|P2|First Intervention (10 Days)|Withdrawal by Subject|0
1251565|NCT00564395|4104412|P1|First Intervention (10 Days)|Withdrawal by Subject|1
1251566|NCT00564278|4104420|P2|Overall Study|Withdrawal by Subject|7
1251567|NCT00564278|4104421|P1|Overall Study|Withdrawal by Subject|11
1251568|NCT00564278|4104420|P2|Overall Study|Physician Decision|2
1251569|NCT00564278|4104421|P1|Overall Study|Physician Decision|1
1251570|NCT00564278|4104420|P2|Overall Study|Lost to Follow-up|33
1251571|NCT00564278|4104421|P1|Overall Study|Lost to Follow-up|35
1251572|NCT00564070|4104443|P2|Overall Study|Worsening depression, referred to care|0
1251573|NCT00564070|4104444|P1|Overall Study|Worsening depression, referred to care|3
1251574|NCT00564070|4104443|P2|Overall Study|Lost to Follow-up|7
1251575|NCT00564070|4104444|P1|Overall Study|Lost to Follow-up|9
1251576|NCT00563797|4104470|P2|Overall Study|Lost to Follow-up|2
1251577|NCT00563797|4104471|P1|Overall Study|Lost to Follow-up|7
1251578|NCT00563706|4104492|P9|DB Treatment Period (Day 1 up to Day 28)|Other|2
1251579|NCT00563706|4104493|P8|DB Treatment Period (Day 1 up to Day 28)|Other|1
1251580|NCT00563706|4104494|P7|DB Treatment Period (Day 1 up to Day 28)|Other|0
1251581|NCT00563706|4104495|P6|DB Treatment Period (Day 1 up to Day 28)|Other|0
1251582|NCT00563706|4104496|P5|DB Treatment Period (Day 1 up to Day 28)|Other|0
1251583|NCT00563706|4104497|P4|DB Treatment Period (Day 1 up to Day 28)|Other|0
1251584|NCT00563706|4104498|P3|DB Treatment Period (Day 1 up to Day 28)|Other|0
1251585|NCT00563706|4104499|P2|DB Treatment Period (Day 1 up to Day 28)|Other|0
1251586|NCT00563706|4104500|P1|DB Treatment Period (Day 1 up to Day 28)|Other|0
1251587|NCT00563706|4104492|P9|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
1251588|NCT00563706|4104493|P8|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1
1251589|NCT00563706|4104494|P7|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
1251590|NCT00563706|4104495|P6|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
1251591|NCT00563706|4104496|P5|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
1251592|NCT00563706|4104497|P4|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
1251593|NCT00563706|4104498|P3|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
1251594|NCT00563706|4104499|P2|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
1251595|NCT00563706|4104500|P1|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2
1251596|NCT00563706|4104492|P9|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
1251597|NCT00563706|4104493|P8|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6
1251598|NCT00563706|4104494|P7|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1
1251599|NCT00563706|4104495|P6|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
1251600|NCT00563706|4104496|P5|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4
1251601|NCT00563706|4104497|P4|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5
1251602|NCT00563706|4104498|P3|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2
1251603|NCT00563706|4104499|P2|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
1251604|NCT00563706|4104500|P1|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9
1251605|NCT00563706|4104492|P9|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
1251606|NCT00563706|4104493|P8|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5
1251607|NCT00563706|4104494|P7|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
1251608|NCT00563706|4104495|P6|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
1251609|NCT00563706|4104496|P5|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
1251610|NCT00563706|4104497|P4|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4
1251611|NCT00563706|4104498|P3|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
1251612|NCT00563706|4104499|P2|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
1251613|NCT00563706|4104500|P1|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
1251614|NCT00563706|4104492|P9|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5
1251615|NCT00563706|4104493|P8|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
1251616|NCT00563706|4104494|P7|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
1251617|NCT00563706|4104495|P6|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
1251618|NCT00563706|4104496|P5|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
1251619|NCT00563706|4104497|P4|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
1251620|NCT00563706|4104498|P3|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
1251621|NCT00563706|4104499|P2|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
1251622|NCT00563706|4104500|P1|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4
1251623|NCT00563381|4104616|P2|Overall Study|Individual different reasons|34
1251624|NCT00563381|4104617|P1|Overall Study|Individual different reasons|24
1251625|NCT00563381|4104616|P2|Overall Study|Lack of Efficacy|24
1251626|NCT00563381|4104617|P1|Overall Study|Lack of Efficacy|32
1251627|NCT00563381|4104616|P2|Overall Study|Withdrawal by Subject|209
1251628|NCT00563381|4104617|P1|Overall Study|Withdrawal by Subject|192
1251629|NCT00563381|4104616|P2|Overall Study|Lost to Follow-up|15
1251630|NCT00563381|4104617|P1|Overall Study|Lost to Follow-up|7
1251631|NCT00563381|4104616|P2|Overall Study|Protocol Violation|74
1251632|NCT00563381|4104617|P1|Overall Study|Protocol Violation|66
1251633|NCT00563381|4104616|P2|Overall Study|Adverse Event|292
1251634|NCT00563381|4104617|P1|Overall Study|Adverse Event|264
1251635|NCT00563368|4104690|P7|Overall Study|not specified|0
1251636|NCT00563368|4104691|P6|Overall Study|not specified|4
1251637|NCT00563368|4104692|P5|Overall Study|not specified|4
1251638|NCT00563368|4104693|P4|Overall Study|not specified|4
1251639|NCT00563368|4104694|P3|Overall Study|not specified|3
1251640|NCT00563368|4104695|P2|Overall Study|not specified|5
1251641|NCT00563368|4104696|P1|Overall Study|not specified|5
1251642|NCT00563368|4104690|P7|Overall Study|requirement for restricted medication|0
1251643|NCT00563368|4104691|P6|Overall Study|requirement for restricted medication|0
1251644|NCT00563368|4104692|P5|Overall Study|requirement for restricted medication|0
1251645|NCT00563368|4104693|P4|Overall Study|requirement for restricted medication|0
1251646|NCT00563368|4104694|P3|Overall Study|requirement for restricted medication|2
1251647|NCT00563368|4104695|P2|Overall Study|requirement for restricted medication|0
1251648|NCT00563368|4104696|P1|Overall Study|requirement for restricted medication|0
1251649|NCT00563368|4104690|P7|Overall Study|Pregnancy|0
1251650|NCT00563368|4104691|P6|Overall Study|Pregnancy|2
1251651|NCT00563368|4104692|P5|Overall Study|Pregnancy|1
1251652|NCT00563368|4104693|P4|Overall Study|Pregnancy|2
1251653|NCT00563368|4104694|P3|Overall Study|Pregnancy|1
1251654|NCT00563368|4104695|P2|Overall Study|Pregnancy|0
1251655|NCT00563368|4104696|P1|Overall Study|Pregnancy|1
1251656|NCT00563368|4104690|P7|Overall Study|protocol non-compliance|3
1251657|NCT00563368|4104691|P6|Overall Study|protocol non-compliance|1
1251658|NCT00563368|4104692|P5|Overall Study|protocol non-compliance|0
1251659|NCT00563368|4104693|P4|Overall Study|protocol non-compliance|1
1251660|NCT00563368|4104694|P3|Overall Study|protocol non-compliance|2
1251661|NCT00563368|4104695|P2|Overall Study|protocol non-compliance|1
1251662|NCT00563368|4104696|P1|Overall Study|protocol non-compliance|1
1251663|NCT00563368|4104690|P7|Overall Study|Withdrawal by Subject|4
1251664|NCT00563368|4104691|P6|Overall Study|Withdrawal by Subject|5
1251665|NCT00563368|4104692|P5|Overall Study|Withdrawal by Subject|8
1251666|NCT00563368|4104693|P4|Overall Study|Withdrawal by Subject|7
1251667|NCT00563368|4104694|P3|Overall Study|Withdrawal by Subject|5
1251668|NCT00563368|4104695|P2|Overall Study|Withdrawal by Subject|6
1251669|NCT00563368|4104696|P1|Overall Study|Withdrawal by Subject|11
1251670|NCT00563368|4104690|P7|Overall Study|Adverse Event|17
1251671|NCT00563368|4104691|P6|Overall Study|Adverse Event|10
1251672|NCT00563368|4104692|P5|Overall Study|Adverse Event|6
1251673|NCT00563368|4104693|P4|Overall Study|Adverse Event|9
1251674|NCT00563368|4104694|P3|Overall Study|Adverse Event|5
1251675|NCT00563368|4104695|P2|Overall Study|Adverse Event|4
1251676|NCT00563368|4104696|P1|Overall Study|Adverse Event|3
1251677|NCT00563368|4104690|P7|Overall Study|Lost to Follow-up|9
1251678|NCT00563368|4104691|P6|Overall Study|Lost to Follow-up|8
1251679|NCT00563368|4104692|P5|Overall Study|Lost to Follow-up|9
1251680|NCT00563368|4104693|P4|Overall Study|Lost to Follow-up|6
1251681|NCT00563368|4104694|P3|Overall Study|Lost to Follow-up|12
1251682|NCT00563368|4104695|P2|Overall Study|Lost to Follow-up|14
1251683|NCT00563368|4104696|P1|Overall Study|Lost to Follow-up|14
1251684|NCT00563316|4104719|P1|Overall Study|Other|1
1251685|NCT00563316|4104719|P1|Overall Study|On-going in study as of 16 July 2009.|5
1251686|NCT00563316|4104719|P1|Overall Study|Death|1
1251687|NCT00563316|4104719|P1|Overall Study|Lost to Follow-up|2
1251688|NCT00563316|4104719|P1|Overall Study|Physician Decision|1
1251689|NCT00563316|4104719|P1|Overall Study|Adverse Event|2
1251690|NCT00563186|4104744|P2|Overall Study|Incomplete data|1
1251691|NCT00563186|4104745|P1|Overall Study|Incomplete data|1
1251692|NCT00563186|4104744|P2|Overall Study|LOS<48 hours|74
1251693|NCT00563186|4104745|P1|Overall Study|LOS<48 hours|97
1251694|NCT00562965|4104756|P2|Overall Study|Other|1
1251695|NCT00562965|4104757|P1|Overall Study|Other|0
1251696|NCT00562965|4104756|P2|Overall Study|Lost to Follow-up|0
1251697|NCT00562965|4104757|P1|Overall Study|Lost to Follow-up|1
1251698|NCT00562965|4104756|P2|Overall Study|Death|4
1251699|NCT00562965|4104757|P1|Overall Study|Death|2
1251700|NCT00562965|4104756|P2|Overall Study|Withdrawal by Subject|1
1251701|NCT00562965|4104757|P1|Overall Study|Withdrawal by Subject|0
1251702|NCT00562861|4104778|P2|Overall Study|Lost to Follow-up|3
1251703|NCT00562861|4104779|P1|Overall Study|Lost to Follow-up|7
1251704|NCT00562861|4104778|P2|Overall Study|noncompliance, moved|2
1251705|NCT00562861|4104779|P1|Overall Study|noncompliance, moved|7
1251706|NCT00562861|4104778|P2|Overall Study|Lack of Efficacy|5
1251707|NCT00562861|4104779|P1|Overall Study|Lack of Efficacy|5
1251708|NCT00562861|4104778|P2|Overall Study|Adverse Event|1
1251709|NCT00562861|4104779|P1|Overall Study|Adverse Event|1
1251710|NCT00562627|4104788|P3|Overall Study|Protocol Violation|1
1251711|NCT00562627|4104789|P2|Overall Study|Protocol Violation|1
1251712|NCT00562627|4104790|P1|Overall Study|Protocol Violation|1
1251713|NCT00562588|4104806|P2|Overall Study|Other|2
1251714|NCT00562588|4104807|P1|Overall Study|Other|0
1251715|NCT00562588|4104806|P2|Overall Study|Withdrawal by Subject|9
1251716|NCT00562588|4104807|P1|Overall Study|Withdrawal by Subject|10
1251717|NCT00562588|4104806|P2|Overall Study|Lost to Follow-up|4
1251718|NCT00562588|4104807|P1|Overall Study|Lost to Follow-up|12
1251719|NCT00562588|4104806|P2|Overall Study|Protocol Violation|26
1251720|NCT00562588|4104807|P1|Overall Study|Protocol Violation|30
1251721|NCT00562588|4104806|P2|Overall Study|Adverse Event|58
1251722|NCT00562588|4104807|P1|Overall Study|Adverse Event|40
1251723|NCT00562484|4104837|P2|Overall Study|Reason not provided or not specified|12
1251724|NCT00562484|4104838|P1|Overall Study|Reason not provided or not specified|25
1251725|NCT00562484|4104837|P2|Overall Study|Lost to Follow-up|71
1251726|NCT00562484|4104838|P1|Overall Study|Lost to Follow-up|132
1251727|NCT00562484|4104837|P2|Overall Study|Moved away from the study area|9
1251728|NCT00562484|4104838|P1|Overall Study|Moved away from the study area|20
1251729|NCT00562484|4104837|P2|Overall Study|Withdrawal by Subject|9
1251730|NCT00562484|4104838|P1|Overall Study|Withdrawal by Subject|12
1251731|NCT00562484|4104837|P2|Overall Study|Protocol Violation|2
1251732|NCT00562484|4104838|P1|Overall Study|Protocol Violation|11
1251733|NCT00562484|4104837|P2|Overall Study|Adverse Event|1
1251734|NCT00562484|4104838|P1|Overall Study|Adverse Event|6
1251735|NCT00562354|4104870|P2|Overall Study|Lost to Follow-up|1
1251736|NCT00562354|4104871|P1|Overall Study|Lost to Follow-up|0
1251737|NCT00562354|4104870|P2|Overall Study|Physician Decision|1
1251738|NCT00562354|4104871|P1|Overall Study|Physician Decision|0
1251739|NCT00562302|4104933|P2|Overall Study|Not stated|4
1251740|NCT00562302|4104934|P1|Overall Study|Not stated|1
1251741|NCT00562302|4104933|P2|Overall Study|Lung resection prior to study completion|7
1251742|NCT00562302|4104934|P1|Overall Study|Lung resection prior to study completion|7
1251743|NCT00562302|4104933|P2|Overall Study|Death|2
1251744|NCT00562302|4104934|P1|Overall Study|Death|1
1251745|NCT00562302|4104933|P2|Overall Study|Withdrawal by Subject|8
1251746|NCT00562302|4104934|P1|Overall Study|Withdrawal by Subject|7
1251747|NCT00562302|4104933|P2|Overall Study|Non-compliance|2
1251748|NCT00562302|4104934|P1|Overall Study|Non-compliance|1
1251749|NCT00562302|4104933|P2|Overall Study|Adverse Event|6
1251750|NCT00562302|4104934|P1|Overall Study|Adverse Event|0
1251751|NCT00562302|4104933|P2|Overall Study|Lost to Follow-up|3
1251752|NCT00562302|4104934|P1|Overall Study|Lost to Follow-up|3
1251753|NCT00562159|4104956|P2|Overall Study|Did not meet protocol eligibility|1
1251754|NCT00562159|4104957|P1|Overall Study|Did not meet protocol eligibility|1
1251755|NCT00562159|4104956|P2|Overall Study|Protocol Violation|12
1251756|NCT00562159|4104957|P1|Overall Study|Protocol Violation|12
1251757|NCT00562159|4104956|P2|Overall Study|Withdrawal by Subject|8
1251758|NCT00562159|4104957|P1|Overall Study|Withdrawal by Subject|9
1251759|NCT00562159|4104956|P2|Overall Study|Lost to Follow-up|4
1251760|NCT00562159|4104957|P1|Overall Study|Lost to Follow-up|5
1251761|NCT00562159|4104956|P2|Overall Study|Adverse Event|8
1251762|NCT00562159|4104957|P1|Overall Study|Adverse Event|11
1251763|NCT00562120|4104969|P4|First Intervention Period|Randomized but not Treated|0
1251764|NCT00562120|4104970|P3|First Intervention Period|Randomized but not Treated|0
1251765|NCT00562120|4104971|P2|First Intervention Period|Randomized but not Treated|0
1251766|NCT00562120|4104972|P1|First Intervention Period|Randomized but not Treated|1
1251767|NCT00562120|4104969|P4|First Intervention Period|Adverse Event|0
1251768|NCT00562120|4104970|P3|First Intervention Period|Adverse Event|0
1251769|NCT00562120|4104971|P2|First Intervention Period|Adverse Event|0
1251770|NCT00562120|4104972|P1|First Intervention Period|Adverse Event|1
1251771|NCT00562094|4105004|P1|Overall Study|Lost to Follow-up|62
1251772|NCT00561977|4105019|P3|Overall Study|Pregnancy|1
1251773|NCT00561977|4105020|P2|Overall Study|Pregnancy|1
1251774|NCT00561977|4105021|P1|Overall Study|Pregnancy|0
1251775|NCT00561977|4105019|P3|Overall Study|Withdrawal by Subject|1
1251776|NCT00561977|4105020|P2|Overall Study|Withdrawal by Subject|2
1251777|NCT00561977|4105021|P1|Overall Study|Withdrawal by Subject|0
1251778|NCT00561951|4105047|P3|Overall Study|Adverse Event Occured Before Treatment|1
1251779|NCT00561951|4105048|P2|Overall Study|Adverse Event Occured Before Treatment|2
1251780|NCT00561951|4105049|P1|Overall Study|Adverse Event Occured Before Treatment|1
1251781|NCT00561951|4105047|P3|Overall Study|Meet Withdrawal Criterion|1
1251782|NCT00561951|4105048|P2|Overall Study|Meet Withdrawal Criterion|1
1251783|NCT00561951|4105049|P1|Overall Study|Meet Withdrawal Criterion|0
1251784|NCT00561951|4105047|P3|Overall Study|Pregnancy|0
1251785|NCT00561951|4105048|P2|Overall Study|Pregnancy|1
1251786|NCT00561951|4105049|P1|Overall Study|Pregnancy|0
1251787|NCT00561951|4105047|P3|Overall Study|Physician Decision|0
1251788|NCT00561951|4105048|P2|Overall Study|Physician Decision|0
1251789|NCT00561951|4105049|P1|Overall Study|Physician Decision|1
1251790|NCT00561951|4105047|P3|Overall Study|Protocol Violation|4
1251791|NCT00561951|4105048|P2|Overall Study|Protocol Violation|3
1251792|NCT00561951|4105049|P1|Overall Study|Protocol Violation|4
1251793|NCT00561951|4105047|P3|Overall Study|Withdrawal by Subject|10
1251794|NCT00561951|4105048|P2|Overall Study|Withdrawal by Subject|9
1251795|NCT00561951|4105049|P1|Overall Study|Withdrawal by Subject|10
1251796|NCT00561951|4105047|P3|Overall Study|Lost to Follow-up|0
1251797|NCT00561951|4105048|P2|Overall Study|Lost to Follow-up|1
1251798|NCT00561951|4105049|P1|Overall Study|Lost to Follow-up|1
1251799|NCT00561951|4105047|P3|Overall Study|Lack of Efficacy|2
1251800|NCT00561951|4105048|P2|Overall Study|Lack of Efficacy|3
1251801|NCT00561951|4105049|P1|Overall Study|Lack of Efficacy|5
1251802|NCT00561951|4105047|P3|Overall Study|Adverse Event|14
1251803|NCT00561951|4105048|P2|Overall Study|Adverse Event|14
1251804|NCT00561951|4105049|P1|Overall Study|Adverse Event|11
1251805|NCT00561925|4105105|P5|Open-Label Extension Period|Declined entry into extension period|50
1251806|NCT00561925|4105106|P4|Open-Label Extension Period|Declined entry into extension period|43
1251807|NCT00561925|4105107|P3|Open-Label Extension Period|Declined entry into extension period|0
1251808|NCT00561925|4105108|P2|Open-Label Extension Period|Declined entry into extension period|0
1251809|NCT00561925|4105109|P1|Open-Label Extension Period|Declined entry into extension period|0
1251810|NCT00561925|4105105|P5|144-week Double-blind, Double-dummy|Other|0
1251811|NCT00561925|4105106|P4|144-week Double-blind, Double-dummy|Other|0
1251812|NCT00561925|4105107|P3|144-week Double-blind, Double-dummy|Other|11
1251813|NCT00561925|4105108|P2|144-week Double-blind, Double-dummy|Other|8
1251814|NCT00561925|4105109|P1|144-week Double-blind, Double-dummy|Other|0
1251815|NCT00561925|4105105|P5|144-week Double-blind, Double-dummy|Not treated with study drug|0
1251816|NCT00561925|4105106|P4|144-week Double-blind, Double-dummy|Not treated with study drug|0
1251817|NCT00561925|4105107|P3|144-week Double-blind, Double-dummy|Not treated with study drug|0
1251818|NCT00561925|4105108|P2|144-week Double-blind, Double-dummy|Not treated with study drug|2
1251819|NCT00561925|4105109|P1|144-week Double-blind, Double-dummy|Not treated with study drug|0
1251820|NCT00561925|4105105|P5|144-week Double-blind, Double-dummy|Death|0
1251821|NCT00561925|4105106|P4|144-week Double-blind, Double-dummy|Death|0
1251822|NCT00561925|4105107|P3|144-week Double-blind, Double-dummy|Death|3
1251823|NCT00561925|4105108|P2|144-week Double-blind, Double-dummy|Death|6
1251824|NCT00561925|4105109|P1|144-week Double-blind, Double-dummy|Death|0
1251825|NCT00561925|4105105|P5|144-week Double-blind, Double-dummy|Pregnancy|0
1251826|NCT00561925|4105106|P4|144-week Double-blind, Double-dummy|Pregnancy|0
1251827|NCT00561925|4105107|P3|144-week Double-blind, Double-dummy|Pregnancy|9
1251828|NCT00561925|4105108|P2|144-week Double-blind, Double-dummy|Pregnancy|1
1251829|NCT00561925|4105109|P1|144-week Double-blind, Double-dummy|Pregnancy|0
1251830|NCT00561925|4105105|P5|144-week Double-blind, Double-dummy|Lack of Efficacy|0
1251831|NCT00561925|4105106|P4|144-week Double-blind, Double-dummy|Lack of Efficacy|0
1251832|NCT00561925|4105107|P3|144-week Double-blind, Double-dummy|Lack of Efficacy|33
1251833|NCT00561925|4105108|P2|144-week Double-blind, Double-dummy|Lack of Efficacy|36
1251834|NCT00561925|4105109|P1|144-week Double-blind, Double-dummy|Lack of Efficacy|0
1251835|NCT00561925|4105105|P5|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
1251836|NCT00561925|4105106|P4|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
1251837|NCT00561925|4105107|P3|144-week Double-blind, Double-dummy|Withdrawal by Subject|7
1251838|NCT00561925|4105108|P2|144-week Double-blind, Double-dummy|Withdrawal by Subject|19
1251839|NCT00561925|4105109|P1|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
1251840|NCT00561925|4105105|P5|144-week Double-blind, Double-dummy|Lost to Follow-up|0
1251841|NCT00561925|4105106|P4|144-week Double-blind, Double-dummy|Lost to Follow-up|0
1251842|NCT00561925|4105107|P3|144-week Double-blind, Double-dummy|Lost to Follow-up|12
1251843|NCT00561925|4105108|P2|144-week Double-blind, Double-dummy|Lost to Follow-up|15
1251844|NCT00561925|4105109|P1|144-week Double-blind, Double-dummy|Lost to Follow-up|0
1251845|NCT00561925|4105105|P5|144-week Double-blind, Double-dummy|Protocol Violation|0
1251846|NCT00561925|4105106|P4|144-week Double-blind, Double-dummy|Protocol Violation|0
1251847|NCT00561925|4105107|P3|144-week Double-blind, Double-dummy|Protocol Violation|9
1251848|NCT00561925|4105108|P2|144-week Double-blind, Double-dummy|Protocol Violation|15
1251849|NCT00561925|4105109|P1|144-week Double-blind, Double-dummy|Protocol Violation|0
1251850|NCT00561925|4105105|P5|144-week Double-blind, Double-dummy|Adverse Event|0
1251851|NCT00561925|4105106|P4|144-week Double-blind, Double-dummy|Adverse Event|0
1251852|NCT00561925|4105107|P3|144-week Double-blind, Double-dummy|Adverse Event|43
1251853|NCT00561925|4105108|P2|144-week Double-blind, Double-dummy|Adverse Event|48
1251854|NCT00561925|4105109|P1|144-week Double-blind, Double-dummy|Adverse Event|0
1251855|NCT00561925|4105105|P5|14 Day Lead-In Period|Other|0
1251856|NCT00561925|4105106|P4|14 Day Lead-In Period|Other|0
1251857|NCT00561925|4105107|P3|14 Day Lead-In Period|Other|0
1251858|NCT00561925|4105108|P2|14 Day Lead-In Period|Other|0
1251859|NCT00561925|4105109|P1|14 Day Lead-In Period|Other|5
1251860|NCT00561925|4105105|P5|14 Day Lead-In Period|Withdrawal by Subject|0
1251861|NCT00561925|4105106|P4|14 Day Lead-In Period|Withdrawal by Subject|0
1251862|NCT00561925|4105107|P3|14 Day Lead-In Period|Withdrawal by Subject|0
1251863|NCT00561925|4105108|P2|14 Day Lead-In Period|Withdrawal by Subject|0
1251864|NCT00561925|4105109|P1|14 Day Lead-In Period|Withdrawal by Subject|4
1251865|NCT00561925|4105105|P5|14 Day Lead-In Period|Lost to Follow-up|0
1251866|NCT00561925|4105106|P4|14 Day Lead-In Period|Lost to Follow-up|0
1251867|NCT00561925|4105107|P3|14 Day Lead-In Period|Lost to Follow-up|0
1251868|NCT00561925|4105108|P2|14 Day Lead-In Period|Lost to Follow-up|0
1251869|NCT00561925|4105109|P1|14 Day Lead-In Period|Lost to Follow-up|4
1251870|NCT00561925|4105105|P5|14 Day Lead-In Period|In/Exclusion criteria|0
1251871|NCT00561925|4105106|P4|14 Day Lead-In Period|In/Exclusion criteria|0
1251872|NCT00561925|4105107|P3|14 Day Lead-In Period|In/Exclusion criteria|0
1251873|NCT00561925|4105108|P2|14 Day Lead-In Period|In/Exclusion criteria|0
1251874|NCT00561925|4105109|P1|14 Day Lead-In Period|In/Exclusion criteria|4
1251875|NCT00561925|4105105|P5|14 Day Lead-In Period|Adverse Event|0
1251876|NCT00561925|4105106|P4|14 Day Lead-In Period|Adverse Event|0
1251877|NCT00561925|4105107|P3|14 Day Lead-In Period|Adverse Event|0
1251878|NCT00561925|4105108|P2|14 Day Lead-In Period|Adverse Event|0
1251879|NCT00561925|4105109|P1|14 Day Lead-In Period|Adverse Event|38
1251880|NCT00561912|4105158|P1|Overall Study|ineligible|1
1251881|NCT00561821|4105170|P4|Overall Study|Adverse Event|1
1251882|NCT00561821|4105171|P3|Overall Study|Adverse Event|1
1251883|NCT00561821|4105172|P2|Overall Study|Adverse Event|3
1251884|NCT00561821|4105173|P1|Overall Study|Adverse Event|2
1251885|NCT00561821|4105170|P4|Overall Study|Other (reason not specified)|0
1251886|NCT00561821|4105171|P3|Overall Study|Other (reason not specified)|0
1251887|NCT00561821|4105172|P2|Overall Study|Other (reason not specified)|1
1251888|NCT00561821|4105173|P1|Overall Study|Other (reason not specified)|1
1251889|NCT00561821|4105170|P4|Overall Study|Reasons not related to trial|0
1251890|NCT00561821|4105171|P3|Overall Study|Reasons not related to trial|0
1251891|NCT00561821|4105172|P2|Overall Study|Reasons not related to trial|1
1251892|NCT00561821|4105173|P1|Overall Study|Reasons not related to trial|2
1251893|NCT00561821|4105170|P4|Overall Study|Withdrawal by Subject|2
1251894|NCT00561821|4105171|P3|Overall Study|Withdrawal by Subject|0
1251895|NCT00561821|4105172|P2|Overall Study|Withdrawal by Subject|1
1251896|NCT00561821|4105173|P1|Overall Study|Withdrawal by Subject|0
1251897|NCT00561821|4105170|P4|Overall Study|Not treated|0
1251898|NCT00561821|4105171|P3|Overall Study|Not treated|1
1251899|NCT00561821|4105172|P2|Overall Study|Not treated|0
1251900|NCT00561821|4105173|P1|Overall Study|Not treated|0
1251901|NCT00561795|4105249|P4|Overall Study|Physician Decision|0
1251902|NCT00561795|4105250|P3|Overall Study|Physician Decision|0
1251903|NCT00561795|4105251|P2|Overall Study|Physician Decision|0
1251904|NCT00561795|4105252|P1|Overall Study|Physician Decision|1
1251905|NCT00561795|4105249|P4|Overall Study|Study Closed/Terminated|0
1251906|NCT00561795|4105250|P3|Overall Study|Study Closed/Terminated|0
1251907|NCT00561795|4105251|P2|Overall Study|Study Closed/Terminated|3
1251908|NCT00561795|4105252|P1|Overall Study|Study Closed/Terminated|0
1251909|NCT00561795|4105249|P4|Overall Study|Adverse Event|0
1251910|NCT00561795|4105250|P3|Overall Study|Adverse Event|0
1251911|NCT00561795|4105251|P2|Overall Study|Adverse Event|3
1251912|NCT00561795|4105252|P1|Overall Study|Adverse Event|3
1251913|NCT00561730|4105272|P1|Overall Study|Not specified reasons|1
1251914|NCT00561730|4105272|P1|Overall Study|Lost to Follow-up|5
1251915|NCT00561730|4105272|P1|Overall Study|Handling of the drug|1
1251916|NCT00561730|4105272|P1|Overall Study|Adverse Event|2
1251917|NCT00561678|4105288|P2|Overall Study|anesthesia provider refusal|0
1251918|NCT00561678|4105289|P1|Overall Study|anesthesia provider refusal|1
1251919|NCT00561678|4105288|P2|Overall Study|surgery rescheduled to different site|2
1251920|NCT00561678|4105289|P1|Overall Study|surgery rescheduled to different site|2
1251921|NCT00561678|4105288|P2|Overall Study|surgery cancelled|1
1251922|NCT00561678|4105289|P1|Overall Study|surgery cancelled|1
1251923|NCT00561678|4105288|P2|Overall Study|Withdrawal by Subject|3
1251924|NCT00561678|4105289|P1|Overall Study|Withdrawal by Subject|4
1251925|NCT00561652|4105307|P2|Overall Study|Withdrawal by Subject|1
1251926|NCT00561652|4105308|P1|Overall Study|Withdrawal by Subject|0
1251927|NCT00561574|4105391|P2|Overall Study|Other|7
1251928|NCT00561574|4105392|P1|Overall Study|Other|5
1251929|NCT00561574|4105391|P2|Overall Study|Lost to Follow-up|0
1251930|NCT00561574|4105392|P1|Overall Study|Lost to Follow-up|1
1251931|NCT00561574|4105391|P2|Overall Study|Reason Unrelated to Trial|2
1251932|NCT00561574|4105392|P1|Overall Study|Reason Unrelated to Trial|6
1251933|NCT00561574|4105391|P2|Overall Study|Withdrawal by Subject|4
1251934|NCT00561574|4105392|P1|Overall Study|Withdrawal by Subject|4
1251935|NCT00561574|4105391|P2|Overall Study|Lack of Efficacy|21
1251936|NCT00561574|4105392|P1|Overall Study|Lack of Efficacy|11
1251937|NCT00561574|4105391|P2|Overall Study|Adverse Event|24
1251938|NCT00561574|4105392|P1|Overall Study|Adverse Event|21
1251939|NCT00561470|4105418|P2|Overall Study|Ongoing Treatment|14
1251940|NCT00561470|4105419|P1|Overall Study|Ongoing Treatment|11
1251941|NCT00561470|4105418|P2|Overall Study|Planning surgery|1
1251942|NCT00561470|4105419|P1|Overall Study|Planning surgery|1
1251943|NCT00561470|4105418|P2|Overall Study|Missed visit window|4
1251944|NCT00561470|4105419|P1|Overall Study|Missed visit window|1
1251945|NCT00561470|4105418|P2|Overall Study|Randomized but not treated|5
1251946|NCT00561470|4105419|P1|Overall Study|Randomized but not treated|5
1251947|NCT00561470|4105418|P2|Overall Study|Unauthorized procedure|1
1251948|NCT00561470|4105419|P1|Overall Study|Unauthorized procedure|3
1251949|NCT00561470|4105418|P2|Overall Study|Metastatic surgery|12
1251950|NCT00561470|4105419|P1|Overall Study|Metastatic surgery|10
1251951|NCT00561470|4105418|P2|Overall Study|Subject request|77
1251952|NCT00561470|4105419|P1|Overall Study|Subject request|43
1251953|NCT00561470|4105418|P2|Overall Study|Consent Withdrawn|6
1251954|NCT00561470|4105419|P1|Overall Study|Consent Withdrawn|2
1251955|NCT00561470|4105418|P2|Overall Study|Physician Decision|20
1251956|NCT00561470|4105419|P1|Overall Study|Physician Decision|21
1251957|NCT00561470|4105418|P2|Overall Study|Lost to Follow-up|0
1251958|NCT00561470|4105419|P1|Overall Study|Lost to Follow-up|2
1251959|NCT00561470|4105418|P2|Overall Study|poor compliance to protocol|4
1251960|NCT00561470|4105419|P1|Overall Study|poor compliance to protocol|4
1251961|NCT00561470|4105418|P2|Overall Study|Disease progression|305
1251962|NCT00561470|4105419|P1|Overall Study|Disease progression|437
1251963|NCT00561470|4105418|P2|Overall Study|Adverse Event|163
1251964|NCT00561470|4105419|P1|Overall Study|Adverse Event|74
1251965|NCT00561392|4105455|P1|Overall Study|Administrative problems|4
1251966|NCT00561392|4105455|P1|Overall Study|Withdrawal by Subject|8
1251967|NCT00561392|4105455|P1|Overall Study|Protocol Violation|1
1251968|NCT00561392|4105455|P1|Overall Study|Lack of Efficacy|2
1251969|NCT00561392|4105455|P1|Overall Study|Adverse Event|38
1251970|NCT00561353|4105477|P10|Overall Study|Withdrawal by Subject|0
1251971|NCT00561353|4105478|P9|Overall Study|Withdrawal by Subject|0
1251972|NCT00561353|4105479|P8|Overall Study|Withdrawal by Subject|0
1251973|NCT00561353|4105480|P7|Overall Study|Withdrawal by Subject|0
1251974|NCT00561353|4105481|P6|Overall Study|Withdrawal by Subject|0
1251975|NCT00561353|4105482|P5|Overall Study|Withdrawal by Subject|0
1251976|NCT00561353|4105483|P4|Overall Study|Withdrawal by Subject|0
1251977|NCT00561353|4105484|P3|Overall Study|Withdrawal by Subject|0
1251978|NCT00561353|4105485|P2|Overall Study|Withdrawal by Subject|2
1251979|NCT00561353|4105486|P1|Overall Study|Withdrawal by Subject|0
1251980|NCT00561353|4105477|P10|Overall Study|Lost to Follow-up|0
1251981|NCT00561353|4105478|P9|Overall Study|Lost to Follow-up|0
1251982|NCT00561353|4105479|P8|Overall Study|Lost to Follow-up|0
1251983|NCT00561353|4105480|P7|Overall Study|Lost to Follow-up|0
1251984|NCT00561353|4105481|P6|Overall Study|Lost to Follow-up|0
1251985|NCT00561353|4105482|P5|Overall Study|Lost to Follow-up|0
1251986|NCT00561353|4105483|P4|Overall Study|Lost to Follow-up|0
1251987|NCT00561353|4105484|P3|Overall Study|Lost to Follow-up|1
1251988|NCT00561353|4105485|P2|Overall Study|Lost to Follow-up|0
1251989|NCT00561353|4105486|P1|Overall Study|Lost to Follow-up|2
1251990|NCT00561353|4105477|P10|Overall Study|Adverse Event|1
1251991|NCT00561353|4105478|P9|Overall Study|Adverse Event|0
1251992|NCT00561353|4105479|P8|Overall Study|Adverse Event|0
1251993|NCT00561353|4105480|P7|Overall Study|Adverse Event|1
1251994|NCT00561353|4105481|P6|Overall Study|Adverse Event|0
1251995|NCT00561353|4105482|P5|Overall Study|Adverse Event|0
1251996|NCT00561353|4105483|P4|Overall Study|Adverse Event|2
1251997|NCT00561353|4105484|P3|Overall Study|Adverse Event|0
1251998|NCT00561353|4105485|P2|Overall Study|Adverse Event|0
1251999|NCT00561353|4105486|P1|Overall Study|Adverse Event|0
1252000|NCT00561353|4105477|P10|Overall Study|Not specified|0
1252001|NCT00561353|4105478|P9|Overall Study|Not specified|0
1252002|NCT00561353|4105479|P8|Overall Study|Not specified|0
1252003|NCT00561353|4105480|P7|Overall Study|Not specified|0
1252004|NCT00561353|4105481|P6|Overall Study|Not specified|2
1252005|NCT00561353|4105482|P5|Overall Study|Not specified|0
1252006|NCT00561353|4105483|P4|Overall Study|Not specified|0
1252007|NCT00561353|4105484|P3|Overall Study|Not specified|1
1252008|NCT00561353|4105485|P2|Overall Study|Not specified|0
1252009|NCT00561353|4105486|P1|Overall Study|Not specified|1
1252010|NCT00561353|4105477|P10|Overall Study|Subject ineligible to continue the trial|1
1252011|NCT00561353|4105478|P9|Overall Study|Subject ineligible to continue the trial|2
1252012|NCT00561353|4105479|P8|Overall Study|Subject ineligible to continue the trial|0
1252013|NCT00561353|4105480|P7|Overall Study|Subject ineligible to continue the trial|1
1252014|NCT00561353|4105481|P6|Overall Study|Subject ineligible to continue the trial|1
1252015|NCT00561353|4105482|P5|Overall Study|Subject ineligible to continue the trial|0
1252016|NCT00561353|4105483|P4|Overall Study|Subject ineligible to continue the trial|0
1252017|NCT00561353|4105484|P3|Overall Study|Subject ineligible to continue the trial|0
1252018|NCT00561353|4105485|P2|Overall Study|Subject ineligible to continue the trial|0
1252019|NCT00561353|4105486|P1|Overall Study|Subject ineligible to continue the trial|0
1252020|NCT00561353|4105477|P10|Overall Study|Subject reached a virologic endpoint|0
1252021|NCT00561353|4105478|P9|Overall Study|Subject reached a virologic endpoint|5
1252022|NCT00561353|4105479|P8|Overall Study|Subject reached a virologic endpoint|4
1252023|NCT00561353|4105480|P7|Overall Study|Subject reached a virologic endpoint|4
1252024|NCT00561353|4105481|P6|Overall Study|Subject reached a virologic endpoint|3
1252025|NCT00561353|4105482|P5|Overall Study|Subject reached a virologic endpoint|1
1252026|NCT00561353|4105483|P4|Overall Study|Subject reached a virologic endpoint|4
1252027|NCT00561353|4105484|P3|Overall Study|Subject reached a virologic endpoint|1
1252028|NCT00561353|4105485|P2|Overall Study|Subject reached a virologic endpoint|1
1252029|NCT00561353|4105486|P1|Overall Study|Subject reached a virologic endpoint|2
1252030|NCT00561340|4105641|P2|Overall Study|refused to drink pediasure|0
1252031|NCT00561340|4105642|P1|Overall Study|refused to drink pediasure|6
1252032|NCT00561080|4105662|P3|12-month Post Last Dose Follow-up|Lost to Follow-up|0
1252033|NCT00561080|4105663|P2|12-month Post Last Dose Follow-up|Lost to Follow-up|0
1252034|NCT00561080|4105664|P1|12-month Post Last Dose Follow-up|Lost to Follow-up|2
1252035|NCT00561080|4105662|P3|12-month Post Last Dose Follow-up|Withdrawal by Subject|5
1252036|NCT00561080|4105663|P2|12-month Post Last Dose Follow-up|Withdrawal by Subject|6
1252037|NCT00561080|4105664|P1|12-month Post Last Dose Follow-up|Withdrawal by Subject|2
1252038|NCT00561080|4105662|P3|12-month Post Last Dose Follow-up|Protocol Violation|4
1252039|NCT00561080|4105663|P2|12-month Post Last Dose Follow-up|Protocol Violation|0
1252040|NCT00561080|4105664|P1|12-month Post Last Dose Follow-up|Protocol Violation|0
1252041|NCT00561080|4105662|P3|12-month Post Last Dose Follow-up|Adverse Event|1
1252042|NCT00561080|4105663|P2|12-month Post Last Dose Follow-up|Adverse Event|3
1252043|NCT00561080|4105664|P1|12-month Post Last Dose Follow-up|Adverse Event|3
1252044|NCT00561080|4105662|P3|Vaccination Period (up to Month 4)|Other|1
1252045|NCT00561080|4105663|P2|Vaccination Period (up to Month 4)|Other|2
1252046|NCT00561080|4105664|P1|Vaccination Period (up to Month 4)|Other|0
1252047|NCT00561080|4105662|P3|Vaccination Period (up to Month 4)|Lost to Follow-up|0
1252048|NCT00561080|4105663|P2|Vaccination Period (up to Month 4)|Lost to Follow-up|1
1252049|NCT00561080|4105664|P1|Vaccination Period (up to Month 4)|Lost to Follow-up|0
1252050|NCT00561080|4105662|P3|Vaccination Period (up to Month 4)|Withdrawal by Subject|13
1252051|NCT00561080|4105663|P2|Vaccination Period (up to Month 4)|Withdrawal by Subject|16
1252052|NCT00561080|4105664|P1|Vaccination Period (up to Month 4)|Withdrawal by Subject|3
1252053|NCT00561080|4105662|P3|Vaccination Period (up to Month 4)|Protocol Violation|3
1252054|NCT00561080|4105663|P2|Vaccination Period (up to Month 4)|Protocol Violation|1
1252055|NCT00561080|4105664|P1|Vaccination Period (up to Month 4)|Protocol Violation|0
1252056|NCT00561080|4105662|P3|Vaccination Period (up to Month 4)|Definitive Contra-indication|3
1252057|NCT00561080|4105663|P2|Vaccination Period (up to Month 4)|Definitive Contra-indication|2
1252058|NCT00561080|4105664|P1|Vaccination Period (up to Month 4)|Definitive Contra-indication|0
1252059|NCT00561080|4105662|P3|Vaccination Period (up to Month 4)|Adverse Event|6
1252060|NCT00561080|4105663|P2|Vaccination Period (up to Month 4)|Adverse Event|4
1252061|NCT00561080|4105664|P1|Vaccination Period (up to Month 4)|Adverse Event|0
1252062|NCT00561015|4105741|P6|Overall Study|Participant non-compliance|0
1252063|NCT00561015|4105742|P5|Overall Study|Participant non-compliance|0
1252064|NCT00561015|4105743|P4|Overall Study|Participant non-compliance|0
1252065|NCT00561015|4105744|P3|Overall Study|Participant non-compliance|0
1252066|NCT00561015|4105745|P2|Overall Study|Participant non-compliance|0
1252067|NCT00561015|4105746|P1|Overall Study|Participant non-compliance|2
1252068|NCT00561015|4105741|P6|Overall Study|Lost to Follow-up|3
1252069|NCT00561015|4105742|P5|Overall Study|Lost to Follow-up|0
1252070|NCT00561015|4105743|P4|Overall Study|Lost to Follow-up|1
1252071|NCT00561015|4105744|P3|Overall Study|Lost to Follow-up|0
1252072|NCT00561015|4105745|P2|Overall Study|Lost to Follow-up|0
1252073|NCT00561015|4105746|P1|Overall Study|Lost to Follow-up|2
1252074|NCT00561015|4105741|P6|Overall Study|Adverse Event|0
1252075|NCT00561015|4105742|P5|Overall Study|Adverse Event|1
1252076|NCT00561015|4105743|P4|Overall Study|Adverse Event|0
1252077|NCT00561015|4105744|P3|Overall Study|Adverse Event|0
1252078|NCT00561015|4105745|P2|Overall Study|Adverse Event|0
1252079|NCT00561015|4105746|P1|Overall Study|Adverse Event|0
1252080|NCT00560950|4105837|P2|Overall Study|Lost to Follow-up|0
1252081|NCT00560950|4105838|P1|Overall Study|Lost to Follow-up|1
1252082|NCT00560937|4105876|P2|Overall Study|Physician Decision|1
1252083|NCT00560937|4105877|P1|Overall Study|Physician Decision|1
1252084|NCT00560937|4105876|P2|Overall Study|Withdrawal by Subject|1
1252085|NCT00560937|4105877|P1|Overall Study|Withdrawal by Subject|0
1252086|NCT00560885|4105893|P1|Overall Study|Withdrawal by Subject|1
1252087|NCT00560885|4105893|P1|Overall Study|Death|7
1252088|NCT00560833|4105918|P5|Overall Study|Never received drug|1
1252089|NCT00560833|4105919|P4|Overall Study|Never received drug|0
1252090|NCT00560833|4105920|P3|Overall Study|Never received drug|0
1252091|NCT00560833|4105921|P2|Overall Study|Never received drug|1
1252092|NCT00560833|4105922|P1|Overall Study|Never received drug|0
1252093|NCT00560833|4105918|P5|Overall Study|Other|0
1252094|NCT00560833|4105919|P4|Overall Study|Other|0
1252095|NCT00560833|4105920|P3|Overall Study|Other|3
1252096|NCT00560833|4105921|P2|Overall Study|Other|1
1252097|NCT00560833|4105922|P1|Overall Study|Other|1
1252098|NCT00560833|4105918|P5|Overall Study|Participant uncooperative|2
1252099|NCT00560833|4105919|P4|Overall Study|Participant uncooperative|4
1252100|NCT00560833|4105920|P3|Overall Study|Participant uncooperative|4
1252101|NCT00560833|4105921|P2|Overall Study|Participant uncooperative|5
1252102|NCT00560833|4105922|P1|Overall Study|Participant uncooperative|5
1252103|NCT00560833|4105918|P5|Overall Study|Lack of Efficacy|4
1252104|NCT00560833|4105919|P4|Overall Study|Lack of Efficacy|4
1252105|NCT00560833|4105920|P3|Overall Study|Lack of Efficacy|6
1252106|NCT00560833|4105921|P2|Overall Study|Lack of Efficacy|9
1252107|NCT00560833|4105922|P1|Overall Study|Lack of Efficacy|22
1252108|NCT00560833|4105918|P5|Overall Study|Lost to Follow-up|0
1252109|NCT00560833|4105919|P4|Overall Study|Lost to Follow-up|0
1252110|NCT00560833|4105920|P3|Overall Study|Lost to Follow-up|1
1252111|NCT00560833|4105921|P2|Overall Study|Lost to Follow-up|0
1252112|NCT00560833|4105922|P1|Overall Study|Lost to Follow-up|0
1252113|NCT00560833|4105918|P5|Overall Study|Adverse Event|35
1252114|NCT00560833|4105919|P4|Overall Study|Adverse Event|23
1252115|NCT00560833|4105920|P3|Overall Study|Adverse Event|25
1252116|NCT00560833|4105921|P2|Overall Study|Adverse Event|10
1252117|NCT00560833|4105922|P1|Overall Study|Adverse Event|16
1252118|NCT00560794|4105954|P1|Overall Study|Received Bone Marrow Transplant|6
1252119|NCT00560794|4105954|P1|Overall Study|Hematological Relapse|1
1252120|NCT00560794|4105954|P1|Overall Study|Minimal Residual Disease Relapse|1
1252121|NCT00560794|4105954|P1|Overall Study|Patient was not Compliant|1
1252122|NCT00560794|4105954|P1|Overall Study|Adverse Event|2
1252123|NCT00560755|4105971|P1|Overall Study|Physician Decision|2
1252124|NCT00560755|4105971|P1|Overall Study|Adverse Event|8
1252125|NCT00560755|4105971|P1|Overall Study|Lost to Follow-up|9
1252126|NCT00560755|4105971|P1|Overall Study|Withdrawal by Subject|26
1252127|NCT00560755|4105971|P1|Overall Study|Protocol Violation|15
1252128|NCT00560703|4105992|P2|Overall Study|non-compliance|1
1252129|NCT00560703|4105993|P1|Overall Study|non-compliance|0
1252130|NCT00560703|4105992|P2|Overall Study|Withdrawal by Subject|1
1252131|NCT00560703|4105993|P1|Overall Study|Withdrawal by Subject|0
1252132|NCT00560703|4105992|P2|Overall Study|Protocol Violation|2
1252133|NCT00560703|4105993|P1|Overall Study|Protocol Violation|0
1252134|NCT00560703|4105992|P2|Overall Study|Adverse Event|2
1252135|NCT00560703|4105993|P1|Overall Study|Adverse Event|0
1252136|NCT00560573|4106010|P6|Overall Study|Enrolled, not treated|0
1252137|NCT00560573|4106011|P5|Overall Study|Enrolled, not treated|1
1252138|NCT00560573|4106012|P4|Overall Study|Enrolled, not treated|0
1252139|NCT00560573|4106013|P3|Overall Study|Enrolled, not treated|0
1252140|NCT00560573|4106014|P2|Overall Study|Enrolled, not treated|0
1252141|NCT00560573|4106015|P1|Overall Study|Enrolled, not treated|0
1252142|NCT00560573|4106010|P6|Overall Study|Other|3
1252143|NCT00560573|4106011|P5|Overall Study|Other|3
1252144|NCT00560573|4106012|P4|Overall Study|Other|3
1252145|NCT00560573|4106013|P3|Overall Study|Other|2
1252146|NCT00560573|4106014|P2|Overall Study|Other|2
1252147|NCT00560573|4106015|P1|Overall Study|Other|2
1252148|NCT00560573|4106010|P6|Overall Study|Withdrawal by Subject|0
1252149|NCT00560573|4106011|P5|Overall Study|Withdrawal by Subject|1
1252150|NCT00560573|4106012|P4|Overall Study|Withdrawal by Subject|1
1252151|NCT00560573|4106013|P3|Overall Study|Withdrawal by Subject|0
1252152|NCT00560573|4106014|P2|Overall Study|Withdrawal by Subject|0
1252153|NCT00560573|4106015|P1|Overall Study|Withdrawal by Subject|0
1252154|NCT00560573|4106010|P6|Overall Study|Lost to Follow-up|0
1252155|NCT00560573|4106011|P5|Overall Study|Lost to Follow-up|1
1252156|NCT00560573|4106012|P4|Overall Study|Lost to Follow-up|1
1252157|NCT00560573|4106013|P3|Overall Study|Lost to Follow-up|0
1252158|NCT00560573|4106014|P2|Overall Study|Lost to Follow-up|0
1252159|NCT00560573|4106015|P1|Overall Study|Lost to Follow-up|0
1252160|NCT00560573|4106010|P6|Overall Study|Death|10
1252161|NCT00560573|4106011|P5|Overall Study|Death|1
1252162|NCT00560573|4106012|P4|Overall Study|Death|5
1252163|NCT00560573|4106013|P3|Overall Study|Death|4
1252164|NCT00560573|4106014|P2|Overall Study|Death|1
1252165|NCT00560573|4106015|P1|Overall Study|Death|4
1252166|NCT00560508|4106092|P2|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
1252167|NCT00560508|4106093|P1|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
1252168|NCT00560508|4106092|P2|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3
1252169|NCT00560508|4106093|P1|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0
1252170|NCT00560508|4106092|P2|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
1252171|NCT00560508|4106093|P1|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
1252172|NCT00560508|4106092|P2|52-week Open-label Period Pramipexole ER|Adverse Event|6
1252173|NCT00560508|4106093|P1|52-week Open-label Period Pramipexole ER|Adverse Event|6
1252174|NCT00560508|4106092|P2|12 Week Double-blind Period|Withdrawal by Subject|1
1252175|NCT00560508|4106093|P1|12 Week Double-blind Period|Withdrawal by Subject|1
1252176|NCT00560508|4106092|P2|12 Week Double-blind Period|Protocol Violation|0
1252177|NCT00560508|4106093|P1|12 Week Double-blind Period|Protocol Violation|1
1252178|NCT00560508|4106092|P2|12 Week Double-blind Period|Adverse Event|2
1252179|NCT00560508|4106093|P1|12 Week Double-blind Period|Adverse Event|3
1252180|NCT00560417|4106152|P2|Overall Study|Withdrawal by Subject|3
1252181|NCT00560417|4106153|P1|Overall Study|Withdrawal by Subject|3
1252182|NCT00560417|4106152|P2|Overall Study|Sponsor Decision|0
1252183|NCT00560417|4106153|P1|Overall Study|Sponsor Decision|2
1252184|NCT00560417|4106152|P2|Overall Study|Protocol Violation|5
1252185|NCT00560417|4106153|P1|Overall Study|Protocol Violation|6
1252186|NCT00560417|4106152|P2|Overall Study|Physician Decision|6
1252187|NCT00560417|4106153|P1|Overall Study|Physician Decision|2
1252188|NCT00560417|4106152|P2|Overall Study|Lost to Follow-up|1
1252189|NCT00560417|4106153|P1|Overall Study|Lost to Follow-up|0
1252190|NCT00560417|4106152|P2|Overall Study|Entry Criteria Not Met|0
1252191|NCT00560417|4106153|P1|Overall Study|Entry Criteria Not Met|1
1252192|NCT00560417|4106152|P2|Overall Study|Adverse Event|2
1252193|NCT00560417|4106153|P1|Overall Study|Adverse Event|3
1252194|NCT00560404|4106181|P2|Overall Study|Other withdrawal reason|5
1252195|NCT00560404|4106182|P1|Overall Study|Other withdrawal reason|13
1252196|NCT00560404|4106181|P2|Overall Study|Failure to return|2
1252197|NCT00560404|4106182|P1|Overall Study|Failure to return|1
1252198|NCT00560404|4106181|P2|Overall Study|Withdrew Consent|0
1252199|NCT00560404|4106182|P1|Overall Study|Withdrew Consent|4
1252200|NCT00560404|4106181|P2|Overall Study|Administrative Reasons|1
1252201|NCT00560404|4106182|P1|Overall Study|Administrative Reasons|1
1252202|NCT00560404|4106181|P2|Overall Study|Protocol Violation|7
1252203|NCT00560404|4106182|P1|Overall Study|Protocol Violation|12
1252204|NCT00560404|4106181|P2|Overall Study|Death|3
1252205|NCT00560404|4106182|P1|Overall Study|Death|3
1252206|NCT00560404|4106181|P2|Overall Study|Adverse Event|3
1252207|NCT00560404|4106182|P1|Overall Study|Adverse Event|2
1252208|NCT00560391|4106229|P5|Overall Study|Still on treatment|2
1252209|NCT00560391|4106230|P4|Overall Study|Still on treatment|1
1252210|NCT00560391|4106231|P3|Overall Study|Still on treatment|0
1252211|NCT00560391|4106232|P2|Overall Study|Still on treatment|0
1252212|NCT00560391|4106233|P1|Overall Study|Still on treatment|0
1252213|NCT00560352|4106289|P3|Overall Study|Maximum clinical benefit|0
1252214|NCT00560352|4106290|P2|Overall Study|Maximum clinical benefit|0
1252215|NCT00560352|4106291|P1|Overall Study|Maximum clinical benefit|1
1252216|NCT00560352|4106289|P3|Overall Study|Withdrawal by Subject|1
1252217|NCT00560352|4106290|P2|Overall Study|Withdrawal by Subject|1
1252218|NCT00560352|4106291|P1|Overall Study|Withdrawal by Subject|1
1252219|NCT00560352|4106289|P3|Overall Study|Disease progression|1
1252220|NCT00560352|4106290|P2|Overall Study|Disease progression|1
1252221|NCT00560352|4106291|P1|Overall Study|Disease progression|0
1252222|NCT00560352|4106289|P3|Overall Study|Study drug toxicity|1
1252223|NCT00560352|4106290|P2|Overall Study|Study drug toxicity|0
1252224|NCT00560352|4106291|P1|Overall Study|Study drug toxicity|3
1252225|NCT00560352|4106289|P3|Overall Study|Adverse event unrelated to study drug|1
1252226|NCT00560352|4106290|P2|Overall Study|Adverse event unrelated to study drug|1
1252227|NCT00560352|4106291|P1|Overall Study|Adverse event unrelated to study drug|2
1252228|NCT00560313|4106308|P1|Overall Study|Protocol Violation|1
1252229|NCT00560313|4106308|P1|Overall Study|Lost to Follow-up|1
1252230|NCT00560313|4106308|P1|Overall Study|Withdrawal by Subject|2
1252231|NCT00560313|4106308|P1|Overall Study|Adverse Events or Death|2
1252232|NCT00560235|4106335|P3|Phase 2|Ongoing at Date of Cut-Off|1
1252233|NCT00560235|4106336|P2|Phase 2|Ongoing at Date of Cut-Off|0
1252234|NCT00560235|4106337|P1|Phase 2|Ongoing at Date of Cut-Off|0
1252235|NCT00560235|4106335|P3|Phase 2|Discontinued|96
1252236|NCT00560235|4106336|P2|Phase 2|Discontinued|0
1252237|NCT00560235|4106337|P1|Phase 2|Discontinued|0
1252238|NCT00560235|4106335|P3|Phase 1B|Discontinued|0
1252239|NCT00560235|4106336|P2|Phase 1B|Discontinued|19
1252240|NCT00560235|4106337|P1|Phase 1B|Discontinued|0
1252241|NCT00560235|4106335|P3|Phase 1|Discontinued|0
1252242|NCT00560235|4106336|P2|Phase 1|Discontinued|0
1252243|NCT00560235|4106337|P1|Phase 1|Discontinued|8
1252244|NCT00560105|4106368|P2|Overall Study|musculoskeletal chest discomfort with us|2
1252245|NCT00560105|4106369|P1|Overall Study|musculoskeletal chest discomfort with us|1
1252246|NCT00560066|4106383|P2|Overall Study|Missing primary reason|2
1252247|NCT00560066|4106384|P1|Overall Study|Missing primary reason|0
1252248|NCT00560066|4106383|P2|Overall Study|Administrative reason|5
1252249|NCT00560066|4106384|P1|Overall Study|Administrative reason|0
1252250|NCT00560066|4106383|P2|Overall Study|Protocol Violation|1
1252251|NCT00560066|4106384|P1|Overall Study|Protocol Violation|0
1252252|NCT00560066|4106383|P2|Overall Study|Lost to Follow-up|10
1252253|NCT00560066|4106384|P1|Overall Study|Lost to Follow-up|4
1252254|NCT00560066|4106383|P2|Overall Study|Withdrawal by Subject|3
1252255|NCT00560066|4106384|P1|Overall Study|Withdrawal by Subject|0
1252256|NCT00560066|4106383|P2|Overall Study|Death|1
1252257|NCT00560066|4106384|P1|Overall Study|Death|2
1252258|NCT00559988|4106416|P2|Overall Study|ICD device explanted|17
1252259|NCT00559988|4106417|P1|Overall Study|ICD device explanted|10
1252260|NCT00559988|4106416|P2|Overall Study|Lost to Follow-up|56
1252261|NCT00559988|4106417|P1|Overall Study|Lost to Follow-up|42
1252262|NCT00559988|4106416|P2|Overall Study|Withdrawal by Subject|139
1252263|NCT00559988|4106417|P1|Overall Study|Withdrawal by Subject|152
1252264|NCT00559988|4106416|P2|Overall Study|Death|140
1252265|NCT00559988|4106417|P1|Overall Study|Death|147
1252266|NCT00559962|4106447|P8|Overall Study|Inclusion/exclusion criteria not met|0
1252267|NCT00559962|4106448|P7|Overall Study|Inclusion/exclusion criteria not met|1
1252268|NCT00559962|4106449|P6|Overall Study|Inclusion/exclusion criteria not met|0
1252269|NCT00559962|4106450|P5|Overall Study|Inclusion/exclusion criteria not met|0
1252270|NCT00559962|4106451|P4|Overall Study|Inclusion/exclusion criteria not met|0
1252271|NCT00559962|4106452|P3|Overall Study|Inclusion/exclusion criteria not met|0
1252272|NCT00559962|4106453|P2|Overall Study|Inclusion/exclusion criteria not met|0
1252273|NCT00559962|4106454|P1|Overall Study|Inclusion/exclusion criteria not met|0
1252274|NCT00559962|4106447|P8|Overall Study|Withdrawal by Subject|2
1252275|NCT00559962|4106448|P7|Overall Study|Withdrawal by Subject|0
1252276|NCT00559962|4106449|P6|Overall Study|Withdrawal by Subject|1
1252277|NCT00559962|4106450|P5|Overall Study|Withdrawal by Subject|3
1252278|NCT00559962|4106451|P4|Overall Study|Withdrawal by Subject|0
1252279|NCT00559962|4106452|P3|Overall Study|Withdrawal by Subject|2
1252280|NCT00559962|4106453|P2|Overall Study|Withdrawal by Subject|1
1252281|NCT00559962|4106454|P1|Overall Study|Withdrawal by Subject|1
1252282|NCT00559962|4106447|P8|Overall Study|Lost to Follow-up|0
1252283|NCT00559962|4106448|P7|Overall Study|Lost to Follow-up|0
1252284|NCT00559962|4106449|P6|Overall Study|Lost to Follow-up|0
1252285|NCT00559962|4106450|P5|Overall Study|Lost to Follow-up|0
1252286|NCT00559962|4106451|P4|Overall Study|Lost to Follow-up|0
1252287|NCT00559962|4106452|P3|Overall Study|Lost to Follow-up|0
1252288|NCT00559962|4106453|P2|Overall Study|Lost to Follow-up|1
1252289|NCT00559962|4106454|P1|Overall Study|Lost to Follow-up|0
1252290|NCT00559962|4106447|P8|Overall Study|Adverse Event|2
1252291|NCT00559962|4106448|P7|Overall Study|Adverse Event|4
1252292|NCT00559962|4106449|P6|Overall Study|Adverse Event|4
1252293|NCT00559962|4106450|P5|Overall Study|Adverse Event|11
1252294|NCT00559962|4106451|P4|Overall Study|Adverse Event|5
1252295|NCT00559962|4106452|P3|Overall Study|Adverse Event|8
1252296|NCT00559962|4106453|P2|Overall Study|Adverse Event|7
1252297|NCT00559962|4106454|P1|Overall Study|Adverse Event|1
1252298|NCT00559949|4106474|P1|Overall Study|No disease evaluation per protocol|1
1252299|NCT00559949|4106474|P1|Overall Study|Withdrawal by Subject|4
1252300|NCT00559949|4106474|P1|Overall Study|Adverse Event|1
1252301|NCT00559949|4106474|P1|Overall Study|Progressive Disease during cycle 1|1
1252302|NCT00559845|4106490|P1|Overall Study|Premature Surgery-Investigator Decision|1
1252303|NCT00559845|4106490|P1|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1
1252304|NCT00559845|4106490|P1|Overall Study|Adverse Event|3
1252305|NCT00559845|4106490|P1|Overall Study|Disease Progression|1
1252306|NCT00559845|4106490|P1|Overall Study|Withdrew Consent|1
1252307|NCT00559754|4106499|P1|Overall Study|Withdrawal by Subject|2
1252308|NCT00559754|4106499|P1|Overall Study|Investigator criteria|2
1252309|NCT00559754|4106499|P1|Overall Study|Protocol Violation|1
1252310|NCT00559754|4106499|P1|Overall Study|Adverse Event|5
1252311|NCT00559754|4106499|P1|Overall Study|Disease progression|1
1252312|NCT00559637|4106523|P1|Overall Study|Inclusion or exclusion criteria violated|2
1252313|NCT00559637|4106523|P1|Overall Study|Change of home|1
1252314|NCT00559637|4106523|P1|Overall Study|Change of center|1
1252315|NCT00559637|4106523|P1|Overall Study|Delayed administration of C.E.R.A|1
1252316|NCT00559637|4106523|P1|Overall Study|Participation in another study|1
1252317|NCT00559637|4106523|P1|Overall Study|Suspected lung cancer|1
1252318|NCT00559637|4106523|P1|Overall Study|Started requiring dialysis after month 7|2
1252319|NCT00559637|4106523|P1|Overall Study|Insufficient response|3
1252320|NCT00559637|4106523|P1|Overall Study|Failure to return|6
1252321|NCT00559637|4106523|P1|Overall Study|Withdrawal criteria fulfilled|4
1252322|NCT00559637|4106523|P1|Overall Study|Protocol Violation|6
1252323|NCT00559637|4106523|P1|Overall Study|Withdrawal by Subject|4
1252324|NCT00559637|4106523|P1|Overall Study|Adverse Event|22
1252325|NCT00559585|4106536|P2|Open Label LT Period Main + Sub-Study|no end of study status page|0
1252326|NCT00559585|4106537|P1|Open Label LT Period Main + Sub-Study|no end of study status page|1
1252327|NCT00559585|4106536|P2|Open Label LT Period Main + Sub-Study|non-specified|0
1252328|NCT00559585|4106537|P1|Open Label LT Period Main + Sub-Study|non-specified|71
1252329|NCT00559585|4106536|P2|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0
1252330|NCT00559585|4106537|P1|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8
1252331|NCT00559585|4106536|P2|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0
1252332|NCT00559585|4106537|P1|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89
1252333|NCT00559585|4106536|P2|Open Label LT Period Main + Sub-Study|No longer met criteria|0
1252334|NCT00559585|4106537|P1|Open Label LT Period Main + Sub-Study|No longer met criteria|1
1252335|NCT00559585|4106536|P2|Open Label LT Period Main + Sub-Study|Death|0
1252336|NCT00559585|4106537|P1|Open Label LT Period Main + Sub-Study|Death|20
1252337|NCT00559585|4106536|P2|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0
1252338|NCT00559585|4106537|P1|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9
1252339|NCT00559585|4106536|P2|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0
1252340|NCT00559585|4106537|P1|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32
1252341|NCT00559585|4106536|P2|Open Label LT Period Main + Sub-Study|Pregnancy|0
1252342|NCT00559585|4106537|P1|Open Label LT Period Main + Sub-Study|Pregnancy|16
1252343|NCT00559585|4106536|P2|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0
1252344|NCT00559585|4106537|P1|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81
1252345|NCT00559585|4106536|P2|Open Label LT Period Main + Sub-Study|Adverse Event|0
1252346|NCT00559585|4106537|P1|Open Label LT Period Main + Sub-Study|Adverse Event|100
1252347|NCT00559585|4106536|P2|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
1252348|NCT00559585|4106537|P1|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
1252349|NCT00559585|4106536|P2|Double Blind ST Period Main Study|Ongoing Infection Risk|0
1252350|NCT00559585|4106537|P1|Double Blind ST Period Main Study|Ongoing Infection Risk|1
1252351|NCT00559585|4106536|P2|Double Blind ST Period Main Study|Investigator Decision|1
1252352|NCT00559585|4106537|P1|Double Blind ST Period Main Study|Investigator Decision|0
1252353|NCT00559585|4106536|P2|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1
1252354|NCT00559585|4106537|P1|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0
1252355|NCT00559585|4106536|P2|Double Blind ST Period Main Study|Participant Weight Gain|0
1252356|NCT00559585|4106537|P1|Double Blind ST Period Main Study|Participant Weight Gain|1
1252357|NCT00559585|4106536|P2|Double Blind ST Period Main Study|Early Discontinuation|1
1252358|NCT00559585|4106537|P1|Double Blind ST Period Main Study|Early Discontinuation|0
1252359|NCT00559585|4106536|P2|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1
1252360|NCT00559585|4106537|P1|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0
1252361|NCT00559585|4106536|P2|Double Blind ST Period Main Study|Incomplete Breast Exam|1
1252362|NCT00559585|4106537|P1|Double Blind ST Period Main Study|Incomplete Breast Exam|0
1252363|NCT00559585|4106536|P2|Double Blind ST Period Main Study|Missed Doses|1
1252364|NCT00559585|4106537|P1|Double Blind ST Period Main Study|Missed Doses|0
1252365|NCT00559585|4106536|P2|Double Blind ST Period Main Study|Poor/Non-Compliance|0
1252366|NCT00559585|4106537|P1|Double Blind ST Period Main Study|Poor/Non-Compliance|3
1252367|NCT00559585|4106536|P2|Double Blind ST Period Main Study|Lack of Efficacy|1
1252368|NCT00559585|4106537|P1|Double Blind ST Period Main Study|Lack of Efficacy|6
1252369|NCT00559585|4106536|P2|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1
1252370|NCT00559585|4106537|P1|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2
1252371|NCT00559585|4106536|P2|Double Blind ST Period Main Study|Death|1
1252372|NCT00559585|4106537|P1|Double Blind ST Period Main Study|Death|1
1252373|NCT00559585|4106536|P2|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0
1252374|NCT00559585|4106537|P1|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1
1252375|NCT00559585|4106536|P2|Double Blind ST Period Main Study|Lost to Follow-up|6
1252376|NCT00559585|4106537|P1|Double Blind ST Period Main Study|Lost to Follow-up|0
1252377|NCT00559585|4106536|P2|Double Blind ST Period Main Study|Withdrawal by Subject|5
1252378|NCT00559585|4106537|P1|Double Blind ST Period Main Study|Withdrawal by Subject|11
1252379|NCT00559585|4106536|P2|Double Blind ST Period Main Study|Adverse Event|25
1252380|NCT00559585|4106537|P1|Double Blind ST Period Main Study|Adverse Event|17
1252381|NCT00559507|4106597|P1|Overall Study|Not treated, patient ineligible|3
1252382|NCT00559377|4106603|P1|Overall Study|Withdrawal by Subject|9
1252383|NCT00559364|4106613|P2|Overall Study|Inclusion/exclusion criteria failure|0
1252384|NCT00559364|4106614|P1|Overall Study|Inclusion/exclusion criteria failure|1
1252385|NCT00559273|4106626|P2|Evaluation Period (8 Weeks)|Physician Decision|1
1252386|NCT00559273|4106627|P1|Evaluation Period (8 Weeks)|Physician Decision|0
1252387|NCT00559273|4106626|P2|Evaluation Period (8 Weeks)|Withdrawal by Subject|0
1252388|NCT00559273|4106627|P1|Evaluation Period (8 Weeks)|Withdrawal by Subject|2
1252389|NCT00559273|4106626|P2|Evaluation Period (8 Weeks)|Adverse Event|1
1252390|NCT00559273|4106627|P1|Evaluation Period (8 Weeks)|Adverse Event|0
1252391|NCT00559273|4106626|P2|Evaluation Period (8 Weeks)|Death|3
1252392|NCT00559273|4106627|P1|Evaluation Period (8 Weeks)|Death|1
1252393|NCT00559273|4106626|P2|Correction Period (20 Weeks)|Did not received study treatment|0
1252394|NCT00559273|4106627|P1|Correction Period (20 Weeks)|Did not received study treatment|2
1252395|NCT00559273|4106626|P2|Correction Period (20 Weeks)|Participant treated by another center|1
1252396|NCT00559273|4106627|P1|Correction Period (20 Weeks)|Participant treated by another center|0
1252397|NCT00559273|4106626|P2|Correction Period (20 Weeks)|Withdrawal by Subject|6
1252398|NCT00559273|4106627|P1|Correction Period (20 Weeks)|Withdrawal by Subject|2
1252399|NCT00559273|4106626|P2|Correction Period (20 Weeks)|Adverse Event|1
1252400|NCT00559273|4106627|P1|Correction Period (20 Weeks)|Adverse Event|2
1252401|NCT00559273|4106626|P2|Correction Period (20 Weeks)|Death|4
1252402|NCT00559273|4106627|P1|Correction Period (20 Weeks)|Death|3
1252403|NCT00559104|4106649|P2|Overall Study|Lack of Efficacy|0
1252404|NCT00559104|4106650|P1|Overall Study|Lack of Efficacy|9
1252405|NCT00558896|4106671|P7|Overall Study|Continues on treatment|6
1252406|NCT00558896|4106672|P6|Overall Study|Continues on treatment|25
1252407|NCT00558896|4106673|P5|Overall Study|Continues on treatment|9
1252408|NCT00558896|4106674|P4|Overall Study|Continues on treatment|1
1252409|NCT00558896|4106675|P3|Overall Study|Continues on treatment|0
1252410|NCT00558896|4106676|P2|Overall Study|Continues on treatment|1
1252411|NCT00558896|4106677|P1|Overall Study|Continues on treatment|10
1252412|NCT00558896|4106671|P7|Overall Study|Physician discretion|3
1252413|NCT00558896|4106672|P6|Overall Study|Physician discretion|3
1252414|NCT00558896|4106673|P5|Overall Study|Physician discretion|1
1252415|NCT00558896|4106674|P4|Overall Study|Physician discretion|2
1252416|NCT00558896|4106675|P3|Overall Study|Physician discretion|1
1252417|NCT00558896|4106676|P2|Overall Study|Physician discretion|2
1252418|NCT00558896|4106677|P1|Overall Study|Physician discretion|3
1252419|NCT00558896|4106671|P7|Overall Study|Alternative Treatment|1
1252420|NCT00558896|4106672|P6|Overall Study|Alternative Treatment|7
1252421|NCT00558896|4106673|P5|Overall Study|Alternative Treatment|6
1252422|NCT00558896|4106674|P4|Overall Study|Alternative Treatment|2
1252423|NCT00558896|4106675|P3|Overall Study|Alternative Treatment|0
1252424|NCT00558896|4106676|P2|Overall Study|Alternative Treatment|2
1252425|NCT00558896|4106677|P1|Overall Study|Alternative Treatment|2
1252426|NCT00558896|4106671|P7|Overall Study|Withdrawal by Subject|5
1252427|NCT00558896|4106672|P6|Overall Study|Withdrawal by Subject|5
1252428|NCT00558896|4106673|P5|Overall Study|Withdrawal by Subject|1
1252429|NCT00558896|4106674|P4|Overall Study|Withdrawal by Subject|1
1252430|NCT00558896|4106675|P3|Overall Study|Withdrawal by Subject|1
1252431|NCT00558896|4106676|P2|Overall Study|Withdrawal by Subject|1
1252432|NCT00558896|4106677|P1|Overall Study|Withdrawal by Subject|2
1252433|NCT00558896|4106671|P7|Overall Study|Death|6
1252434|NCT00558896|4106672|P6|Overall Study|Death|2
1252435|NCT00558896|4106673|P5|Overall Study|Death|2
1252436|NCT00558896|4106674|P4|Overall Study|Death|3
1252437|NCT00558896|4106675|P3|Overall Study|Death|2
1252438|NCT00558896|4106676|P2|Overall Study|Death|0
1252439|NCT00558896|4106677|P1|Overall Study|Death|3
1252440|NCT00558896|4106671|P7|Overall Study|Adverse Event|3
1252441|NCT00558896|4106672|P6|Overall Study|Adverse Event|10
1252442|NCT00558896|4106673|P5|Overall Study|Adverse Event|4
1252443|NCT00558896|4106674|P4|Overall Study|Adverse Event|3
1252444|NCT00558896|4106675|P3|Overall Study|Adverse Event|1
1252445|NCT00558896|4106676|P2|Overall Study|Adverse Event|1
1252446|NCT00558896|4106677|P1|Overall Study|Adverse Event|1
1252447|NCT00558831|4106718|P1|Overall Study|Lost to Follow-up|1
1252448|NCT00558753|4106775|P2|Overall Study|Lost to Follow-up|7
1252449|NCT00558753|4106776|P1|Overall Study|Lost to Follow-up|5
1252450|NCT00558701|4106788|P2|Overall Study|Protocol Deviations|4
1252451|NCT00558701|4106789|P1|Overall Study|Protocol Deviations|1
1252452|NCT00558636|4106797|P2|Follow-up|Premature termination of the study|7
1252453|NCT00558636|4106798|P1|Follow-up|Premature termination of the study|12
1252454|NCT00558636|4106797|P2|Treatment|Disease progression|5
1252455|NCT00558636|4106798|P1|Treatment|Disease progression|1
1252456|NCT00558636|4106797|P2|Treatment|Premature termination of the study|37
1252457|NCT00558636|4106798|P1|Treatment|Premature termination of the study|35
1252458|NCT00558636|4106797|P2|Treatment|Withdrawal by Subject|0
1252459|NCT00558636|4106798|P1|Treatment|Withdrawal by Subject|2
1252460|NCT00558636|4106797|P2|Treatment|Adverse Event|2
1252461|NCT00558636|4106798|P1|Treatment|Adverse Event|9
1252462|NCT00558558|4106898|P1|Overall Study|Lack of Efficacy|4
1252463|NCT00558558|4106898|P1|Overall Study|Withdrawal by Subject|1
1252464|NCT00558558|4106898|P1|Overall Study|Unable to swallow|1
1252465|NCT00558467|4106904|P2|Overall Study|Patient moving out of state|1
1252466|NCT00558467|4106905|P1|Overall Study|Patient moving out of state|0
1252467|NCT00558467|4106904|P2|Overall Study|Lack of Efficacy|1
1252468|NCT00558467|4106905|P1|Overall Study|Lack of Efficacy|0
1252469|NCT00558467|4106904|P2|Overall Study|Adverse Event|2
1252470|NCT00558467|4106905|P1|Overall Study|Adverse Event|1
1252471|NCT00558428|4106965|P4|Overall Study|Other|1
1252472|NCT00558428|4106966|P3|Overall Study|Other|0
1252473|NCT00558428|4106967|P2|Overall Study|Other|0
1252474|NCT00558428|4106968|P1|Overall Study|Other|3
1252475|NCT00558428|4106965|P4|Overall Study|Consent withdrawn|1
1252476|NCT00558428|4106966|P3|Overall Study|Consent withdrawn|0
1252477|NCT00558428|4106967|P2|Overall Study|Consent withdrawn|1
1252478|NCT00558428|4106968|P1|Overall Study|Consent withdrawn|2
1252479|NCT00558428|4106965|P4|Overall Study|Non compliant with protocol|3
1252480|NCT00558428|4106966|P3|Overall Study|Non compliant with protocol|0
1252481|NCT00558428|4106967|P2|Overall Study|Non compliant with protocol|0
1252482|NCT00558428|4106968|P1|Overall Study|Non compliant with protocol|1
1252483|NCT00558428|4106965|P4|Overall Study|Lack of Efficacy|2
1252484|NCT00558428|4106966|P3|Overall Study|Lack of Efficacy|1
1252485|NCT00558428|4106967|P2|Overall Study|Lack of Efficacy|0
1252486|NCT00558428|4106968|P1|Overall Study|Lack of Efficacy|0
1252487|NCT00558428|4106965|P4|Overall Study|Lost to Follow-up|0
1252488|NCT00558428|4106966|P3|Overall Study|Lost to Follow-up|0
1252489|NCT00558428|4106967|P2|Overall Study|Lost to Follow-up|1
1252490|NCT00558428|4106968|P1|Overall Study|Lost to Follow-up|0
1252491|NCT00558428|4106965|P4|Overall Study|Adverse Event|4
1252492|NCT00558428|4106966|P3|Overall Study|Adverse Event|3
1252493|NCT00558428|4106967|P2|Overall Study|Adverse Event|22
1252494|NCT00558428|4106968|P1|Overall Study|Adverse Event|6
1252495|NCT00558363|4107008|P2|Overall Study|Hospitalized; Unable to Continue|1
1252496|NCT00558363|4107009|P1|Overall Study|Hospitalized; Unable to Continue|0
1252497|NCT00558363|4107008|P2|Overall Study|Randomized in Error|2
1252498|NCT00558363|4107009|P1|Overall Study|Randomized in Error|1
1252499|NCT00558363|4107008|P2|Overall Study|Met Protocol-defined Stopping Criteria|16
1252500|NCT00558363|4107009|P1|Overall Study|Met Protocol-defined Stopping Criteria|32
1252501|NCT00558363|4107008|P2|Overall Study|Lost to Follow-up|1
1252502|NCT00558363|4107009|P1|Overall Study|Lost to Follow-up|0
1252503|NCT00558363|4107008|P2|Overall Study|Protocol Violation|1
1252504|NCT00558363|4107009|P1|Overall Study|Protocol Violation|2
1252505|NCT00558363|4107008|P2|Overall Study|Lack of Efficacy|2
1252506|NCT00558363|4107009|P1|Overall Study|Lack of Efficacy|2
1252507|NCT00558363|4107008|P2|Overall Study|Adverse Event|5
1252508|NCT00558363|4107009|P1|Overall Study|Adverse Event|5
1252509|NCT00558363|4107008|P2|Overall Study|Withdrawal by Subject|4
1252510|NCT00558363|4107009|P1|Overall Study|Withdrawal by Subject|11
1252511|NCT00558363|4107008|P2|Overall Study|Physician Decision|4
1252512|NCT00558363|4107009|P1|Overall Study|Physician Decision|18
1252513|NCT00558285|4107064|P5|Overall Study|Protocol deviation|0
1252514|NCT00558285|4107065|P4|Overall Study|Protocol deviation|1
1252515|NCT00558285|4107066|P3|Overall Study|Protocol deviation|0
1252516|NCT00558285|4107067|P2|Overall Study|Protocol deviation|1
1252517|NCT00558285|4107068|P1|Overall Study|Protocol deviation|1
1252518|NCT00558285|4107064|P5|Overall Study|Administrative problems|1
1252519|NCT00558285|4107065|P4|Overall Study|Administrative problems|1
1252520|NCT00558285|4107066|P3|Overall Study|Administrative problems|0
1252521|NCT00558285|4107067|P2|Overall Study|Administrative problems|0
1252522|NCT00558285|4107068|P1|Overall Study|Administrative problems|0
1252523|NCT00558285|4107064|P5|Overall Study|Lost to Follow-up|0
1252524|NCT00558285|4107065|P4|Overall Study|Lost to Follow-up|0
1252525|NCT00558285|4107066|P3|Overall Study|Lost to Follow-up|0
1252526|NCT00558285|4107067|P2|Overall Study|Lost to Follow-up|1
1252527|NCT00558285|4107068|P1|Overall Study|Lost to Follow-up|1
1252528|NCT00558285|4107064|P5|Overall Study|Subject withdrew consent|1
1252529|NCT00558285|4107065|P4|Overall Study|Subject withdrew consent|1
1252530|NCT00558285|4107066|P3|Overall Study|Subject withdrew consent|1
1252531|NCT00558285|4107067|P2|Overall Study|Subject withdrew consent|0
1252532|NCT00558285|4107068|P1|Overall Study|Subject withdrew consent|2
1252533|NCT00558285|4107064|P5|Overall Study|Abnormal test procedure result(s)|0
1252534|NCT00558285|4107065|P4|Overall Study|Abnormal test procedure result(s)|0
1252535|NCT00558285|4107066|P3|Overall Study|Abnormal test procedure result(s)|0
1252536|NCT00558285|4107067|P2|Overall Study|Abnormal test procedure result(s)|0
1252537|NCT00558285|4107068|P1|Overall Study|Abnormal test procedure result(s)|1
1252538|NCT00558285|4107064|P5|Overall Study|Adverse Event|2
1252539|NCT00558285|4107065|P4|Overall Study|Adverse Event|1
1252540|NCT00558285|4107066|P3|Overall Study|Adverse Event|4
1252541|NCT00558285|4107067|P2|Overall Study|Adverse Event|1
1252542|NCT00558285|4107068|P1|Overall Study|Adverse Event|1
1252543|NCT00558272|4107112|P2|Overall Study|Withdrawal by Subject|1
1252544|NCT00558272|4107113|P1|Overall Study|Withdrawal by Subject|0
1252545|NCT00558272|4107112|P2|Overall Study|Incorrectly enrolled|0
1252546|NCT00558272|4107113|P1|Overall Study|Incorrectly enrolled|1
1252547|NCT00558272|4107112|P2|Overall Study|AZ study team decision|1
1252548|NCT00558272|4107113|P1|Overall Study|AZ study team decision|0
1252549|NCT00558272|4107112|P2|Overall Study|Dev. of study specific discon. criteria|0
1252550|NCT00558272|4107113|P1|Overall Study|Dev. of study specific discon. criteria|1
1252551|NCT00558272|4107112|P2|Overall Study|Death|0
1252552|NCT00558272|4107113|P1|Overall Study|Death|1
1252553|NCT00558272|4107112|P2|Overall Study|Adverse Event|0
1252554|NCT00558272|4107113|P1|Overall Study|Adverse Event|10
1252555|NCT00558259|4107153|P2|Overall Study|Withdrawal by Subject|13
1252556|NCT00558259|4107154|P1|Overall Study|Withdrawal by Subject|12
1252557|NCT00558259|4107153|P2|Overall Study|Protocol Violation|5
1252558|NCT00558259|4107154|P1|Overall Study|Protocol Violation|9
1252559|NCT00558259|4107153|P2|Overall Study|Adverse Event|81
1252560|NCT00558259|4107154|P1|Overall Study|Adverse Event|50
1252561|NCT00558103|4107194|P6|Monotherapy Extension Phase|Disease Progression|8
1252562|NCT00558103|4107195|P5|Monotherapy Extension Phase|Disease Progression|0
1252563|NCT00558103|4107196|P4|Monotherapy Extension Phase|Disease Progression|0
1252564|NCT00558103|4107197|P3|Monotherapy Extension Phase|Disease Progression|0
1252565|NCT00558103|4107198|P2|Monotherapy Extension Phase|Disease Progression|0
1252566|NCT00558103|4107199|P1|Monotherapy Extension Phase|Disease Progression|0
1252567|NCT00558103|4107194|P6|Monotherapy Extension Phase|Protocol Violation|1
1252568|NCT00558103|4107195|P5|Monotherapy Extension Phase|Protocol Violation|0
1252569|NCT00558103|4107196|P4|Monotherapy Extension Phase|Protocol Violation|0
1252570|NCT00558103|4107197|P3|Monotherapy Extension Phase|Protocol Violation|0
1252571|NCT00558103|4107198|P2|Monotherapy Extension Phase|Protocol Violation|0
1252572|NCT00558103|4107199|P1|Monotherapy Extension Phase|Protocol Violation|0
1252573|NCT00558103|4107194|P6|Randomized Treatment Phase|Adverse Event|0
1252574|NCT00558103|4107195|P5|Randomized Treatment Phase|Adverse Event|1
1252575|NCT00558103|4107196|P4|Randomized Treatment Phase|Adverse Event|1
1252576|NCT00558103|4107197|P3|Randomized Treatment Phase|Adverse Event|0
1252577|NCT00558103|4107198|P2|Randomized Treatment Phase|Adverse Event|0
1252578|NCT00558103|4107199|P1|Randomized Treatment Phase|Adverse Event|0
1252579|NCT00558103|4107194|P6|Randomized Treatment Phase|Disease Progression|0
1252580|NCT00558103|4107195|P5|Randomized Treatment Phase|Disease Progression|0
1252581|NCT00558103|4107196|P4|Randomized Treatment Phase|Disease Progression|0
1252582|NCT00558103|4107197|P3|Randomized Treatment Phase|Disease Progression|1
1252583|NCT00558103|4107198|P2|Randomized Treatment Phase|Disease Progression|0
1252584|NCT00558103|4107199|P1|Randomized Treatment Phase|Disease Progression|1
1252585|NCT00558103|4107194|P6|Randomized Treatment Phase|Withdrawal by Subject|0
1252586|NCT00558103|4107195|P5|Randomized Treatment Phase|Withdrawal by Subject|1
1252587|NCT00558103|4107196|P4|Randomized Treatment Phase|Withdrawal by Subject|0
1252588|NCT00558103|4107197|P3|Randomized Treatment Phase|Withdrawal by Subject|0
1252589|NCT00558103|4107198|P2|Randomized Treatment Phase|Withdrawal by Subject|2
1252590|NCT00558103|4107199|P1|Randomized Treatment Phase|Withdrawal by Subject|2
1252591|NCT00558103|4107194|P6|Randomized Treatment Phase|Lost to Follow-up|0
1252592|NCT00558103|4107195|P5|Randomized Treatment Phase|Lost to Follow-up|3
1252593|NCT00558103|4107196|P4|Randomized Treatment Phase|Lost to Follow-up|1
1252594|NCT00558103|4107197|P3|Randomized Treatment Phase|Lost to Follow-up|2
1252595|NCT00558103|4107198|P2|Randomized Treatment Phase|Lost to Follow-up|2
1252596|NCT00558103|4107199|P1|Randomized Treatment Phase|Lost to Follow-up|2
1252597|NCT00558064|4107229|P2|Overall Study|No visit within allowance period|0
1252598|NCT00558064|4107230|P1|Overall Study|No visit within allowance period|1
1252599|NCT00558064|4107229|P2|Overall Study|Withdrawal by Subject|1
1252600|NCT00558064|4107230|P1|Overall Study|Withdrawal by Subject|0
1252601|NCT00558064|4107229|P2|Overall Study|Lost to Follow-up|1
1252602|NCT00558064|4107230|P1|Overall Study|Lost to Follow-up|0
1252603|NCT00558064|4107229|P2|Overall Study|Protocol Violation|0
1252604|NCT00558064|4107230|P1|Overall Study|Protocol Violation|1
1252605|NCT00558064|4107229|P2|Overall Study|Lack of Efficacy|1
1252606|NCT00558064|4107230|P1|Overall Study|Lack of Efficacy|0
1252607|NCT00558064|4107229|P2|Overall Study|Adverse Event|2
1252608|NCT00558064|4107230|P1|Overall Study|Adverse Event|3
1252609|NCT00558025|4107252|P2|Overall Study|Protocol Violation|0
1252610|NCT00558025|4107253|P1|Overall Study|Protocol Violation|1
1252611|NCT00558025|4107252|P2|Overall Study|Withdrawal by Subject|2
1252612|NCT00558025|4107253|P1|Overall Study|Withdrawal by Subject|2
1252613|NCT00558025|4107252|P2|Overall Study|Adverse Event|1
1252614|NCT00558025|4107253|P1|Overall Study|Adverse Event|1
1252615|NCT00557856|4107300|P9|Part 2: Exploratory Phase|global deterioration of health status|1
1252616|NCT00557856|4107301|P8|Part 2: Exploratory Phase|global deterioration of health status|0
1252617|NCT00557856|4107302|P7|Part 2: Exploratory Phase|global deterioration of health status|0
1252618|NCT00557856|4107303|P6|Part 2: Exploratory Phase|global deterioration of health status|0
1252619|NCT00557856|4107304|P5|Part 2: Exploratory Phase|global deterioration of health status|0
1252620|NCT00557856|4107305|P4|Part 2: Exploratory Phase|global deterioration of health status|0
1252621|NCT00557856|4107306|P3|Part 2: Exploratory Phase|global deterioration of health status|0
1252622|NCT00557856|4107307|P2|Part 2: Exploratory Phase|global deterioration of health status|0
1252623|NCT00557856|4107308|P1|Part 2: Exploratory Phase|global deterioration of health status|0
1252624|NCT00557856|4107300|P9|Part 2: Exploratory Phase|Death|2
1252625|NCT00557856|4107301|P8|Part 2: Exploratory Phase|Death|0
1252626|NCT00557856|4107302|P7|Part 2: Exploratory Phase|Death|0
1252627|NCT00557856|4107303|P6|Part 2: Exploratory Phase|Death|0
1252628|NCT00557856|4107304|P5|Part 2: Exploratory Phase|Death|0
1252629|NCT00557856|4107305|P4|Part 2: Exploratory Phase|Death|0
1252630|NCT00557856|4107306|P3|Part 2: Exploratory Phase|Death|0
1252631|NCT00557856|4107307|P2|Part 2: Exploratory Phase|Death|0
1252632|NCT00557856|4107308|P1|Part 2: Exploratory Phase|Death|0
1252633|NCT00557856|4107300|P9|Part 2: Exploratory Phase|Other|1
1252634|NCT00557856|4107301|P8|Part 2: Exploratory Phase|Other|0
1252635|NCT00557856|4107302|P7|Part 2: Exploratory Phase|Other|0
1252636|NCT00557856|4107303|P6|Part 2: Exploratory Phase|Other|0
1252637|NCT00557856|4107304|P5|Part 2: Exploratory Phase|Other|0
1252638|NCT00557856|4107305|P4|Part 2: Exploratory Phase|Other|0
1252639|NCT00557856|4107306|P3|Part 2: Exploratory Phase|Other|0
1252640|NCT00557856|4107307|P2|Part 2: Exploratory Phase|Other|0
1252641|NCT00557856|4107308|P1|Part 2: Exploratory Phase|Other|0
1252642|NCT00557856|4107300|P9|Part 2: Exploratory Phase|Adverse Event|4
1252643|NCT00557856|4107301|P8|Part 2: Exploratory Phase|Adverse Event|0
1252644|NCT00557856|4107302|P7|Part 2: Exploratory Phase|Adverse Event|0
1252645|NCT00557856|4107303|P6|Part 2: Exploratory Phase|Adverse Event|0
1252646|NCT00557856|4107304|P5|Part 2: Exploratory Phase|Adverse Event|0
1252647|NCT00557856|4107305|P4|Part 2: Exploratory Phase|Adverse Event|0
1252648|NCT00557856|4107306|P3|Part 2: Exploratory Phase|Adverse Event|0
1252649|NCT00557856|4107307|P2|Part 2: Exploratory Phase|Adverse Event|0
1252650|NCT00557856|4107308|P1|Part 2: Exploratory Phase|Adverse Event|0
1252651|NCT00557856|4107300|P9|Part 2: Exploratory Phase|Withdrawal by Subject|1
1252652|NCT00557856|4107301|P8|Part 2: Exploratory Phase|Withdrawal by Subject|0
1252653|NCT00557856|4107302|P7|Part 2: Exploratory Phase|Withdrawal by Subject|0
1252654|NCT00557856|4107303|P6|Part 2: Exploratory Phase|Withdrawal by Subject|0
1252655|NCT00557856|4107304|P5|Part 2: Exploratory Phase|Withdrawal by Subject|0
1252656|NCT00557856|4107305|P4|Part 2: Exploratory Phase|Withdrawal by Subject|0
1252657|NCT00557856|4107306|P3|Part 2: Exploratory Phase|Withdrawal by Subject|0
1252658|NCT00557856|4107307|P2|Part 2: Exploratory Phase|Withdrawal by Subject|0
1252659|NCT00557856|4107308|P1|Part 2: Exploratory Phase|Withdrawal by Subject|0
1252660|NCT00557856|4107300|P9|Part 2: Exploratory Phase|objective progression or relapse|15
1252661|NCT00557856|4107301|P8|Part 2: Exploratory Phase|objective progression or relapse|0
1252662|NCT00557856|4107302|P7|Part 2: Exploratory Phase|objective progression or relapse|0
1252663|NCT00557856|4107303|P6|Part 2: Exploratory Phase|objective progression or relapse|0
1252664|NCT00557856|4107304|P5|Part 2: Exploratory Phase|objective progression or relapse|0
1252665|NCT00557856|4107305|P4|Part 2: Exploratory Phase|objective progression or relapse|0
1252666|NCT00557856|4107306|P3|Part 2: Exploratory Phase|objective progression or relapse|0
1252667|NCT00557856|4107307|P2|Part 2: Exploratory Phase|objective progression or relapse|0
1252668|NCT00557856|4107308|P1|Part 2: Exploratory Phase|objective progression or relapse|0
1252669|NCT00557856|4107300|P9|Part 1: Dose Escalation Phase|randomized but not treated|0
1252670|NCT00557856|4107301|P8|Part 1: Dose Escalation Phase|randomized but not treated|0
1252671|NCT00557856|4107302|P7|Part 1: Dose Escalation Phase|randomized but not treated|0
1252672|NCT00557856|4107303|P6|Part 1: Dose Escalation Phase|randomized but not treated|0
1252673|NCT00557856|4107304|P5|Part 1: Dose Escalation Phase|randomized but not treated|0
1252674|NCT00557856|4107305|P4|Part 1: Dose Escalation Phase|randomized but not treated|0
1252675|NCT00557856|4107306|P3|Part 1: Dose Escalation Phase|randomized but not treated|0
1252676|NCT00557856|4107307|P2|Part 1: Dose Escalation Phase|randomized but not treated|0
1252677|NCT00557856|4107308|P1|Part 1: Dose Escalation Phase|randomized but not treated|2
1252678|NCT00557856|4107300|P9|Part 1: Dose Escalation Phase|global deterioration of health status|0
1252679|NCT00557856|4107301|P8|Part 1: Dose Escalation Phase|global deterioration of health status|0
1252680|NCT00557856|4107302|P7|Part 1: Dose Escalation Phase|global deterioration of health status|1
1252681|NCT00557856|4107303|P6|Part 1: Dose Escalation Phase|global deterioration of health status|2
1252682|NCT00557856|4107304|P5|Part 1: Dose Escalation Phase|global deterioration of health status|0
1252683|NCT00557856|4107305|P4|Part 1: Dose Escalation Phase|global deterioration of health status|0
1252684|NCT00557856|4107306|P3|Part 1: Dose Escalation Phase|global deterioration of health status|0
1252685|NCT00557856|4107307|P2|Part 1: Dose Escalation Phase|global deterioration of health status|0
1252686|NCT00557856|4107308|P1|Part 1: Dose Escalation Phase|global deterioration of health status|0
1252687|NCT00557856|4107300|P9|Part 1: Dose Escalation Phase|Death|0
1252688|NCT00557856|4107301|P8|Part 1: Dose Escalation Phase|Death|0
1252689|NCT00557856|4107302|P7|Part 1: Dose Escalation Phase|Death|0
1252690|NCT00557856|4107303|P6|Part 1: Dose Escalation Phase|Death|1
1252691|NCT00557856|4107304|P5|Part 1: Dose Escalation Phase|Death|0
1252692|NCT00557856|4107305|P4|Part 1: Dose Escalation Phase|Death|0
1252693|NCT00557856|4107306|P3|Part 1: Dose Escalation Phase|Death|0
1252694|NCT00557856|4107307|P2|Part 1: Dose Escalation Phase|Death|0
1252695|NCT00557856|4107308|P1|Part 1: Dose Escalation Phase|Death|0
1252696|NCT00557856|4107300|P9|Part 1: Dose Escalation Phase|Other|0
1252697|NCT00557856|4107301|P8|Part 1: Dose Escalation Phase|Other|1
1252698|NCT00557856|4107302|P7|Part 1: Dose Escalation Phase|Other|0
1252699|NCT00557856|4107303|P6|Part 1: Dose Escalation Phase|Other|0
1252700|NCT00557856|4107304|P5|Part 1: Dose Escalation Phase|Other|0
1252701|NCT00557856|4107305|P4|Part 1: Dose Escalation Phase|Other|1
1252702|NCT00557856|4107306|P3|Part 1: Dose Escalation Phase|Other|1
1252703|NCT00557856|4107307|P2|Part 1: Dose Escalation Phase|Other|0
1252704|NCT00557856|4107308|P1|Part 1: Dose Escalation Phase|Other|0
1252705|NCT00557856|4107300|P9|Part 1: Dose Escalation Phase|Adverse Event|0
1252706|NCT00557856|4107301|P8|Part 1: Dose Escalation Phase|Adverse Event|2
1252707|NCT00557856|4107302|P7|Part 1: Dose Escalation Phase|Adverse Event|1
1252708|NCT00557856|4107303|P6|Part 1: Dose Escalation Phase|Adverse Event|3
1252709|NCT00557856|4107304|P5|Part 1: Dose Escalation Phase|Adverse Event|1
1252710|NCT00557856|4107305|P4|Part 1: Dose Escalation Phase|Adverse Event|1
1252711|NCT00557856|4107306|P3|Part 1: Dose Escalation Phase|Adverse Event|1
1252712|NCT00557856|4107307|P2|Part 1: Dose Escalation Phase|Adverse Event|0
1252713|NCT00557856|4107308|P1|Part 1: Dose Escalation Phase|Adverse Event|1
1252714|NCT00557856|4107300|P9|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
1252715|NCT00557856|4107301|P8|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
1252716|NCT00557856|4107302|P7|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
1252717|NCT00557856|4107303|P6|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
1252718|NCT00557856|4107304|P5|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
1252719|NCT00557856|4107305|P4|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
1252720|NCT00557856|4107306|P3|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
1252721|NCT00557856|4107307|P2|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
1252722|NCT00557856|4107308|P1|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
1252723|NCT00557856|4107300|P9|Part 1: Dose Escalation Phase|objective progression or relapse|0
1252724|NCT00557856|4107301|P8|Part 1: Dose Escalation Phase|objective progression or relapse|3
1252725|NCT00557856|4107302|P7|Part 1: Dose Escalation Phase|objective progression or relapse|5
1252726|NCT00557856|4107303|P6|Part 1: Dose Escalation Phase|objective progression or relapse|2
1252727|NCT00557856|4107304|P5|Part 1: Dose Escalation Phase|objective progression or relapse|3
1252728|NCT00557856|4107305|P4|Part 1: Dose Escalation Phase|objective progression or relapse|1
1252729|NCT00557856|4107306|P3|Part 1: Dose Escalation Phase|objective progression or relapse|3
1252730|NCT00557856|4107307|P2|Part 1: Dose Escalation Phase|objective progression or relapse|5
1252731|NCT00557856|4107308|P1|Part 1: Dose Escalation Phase|objective progression or relapse|3
1252732|NCT00557830|4107507|P3|Screening Treatment Phase|Unable to tolerate standard dose|0
1252733|NCT00557830|4107508|P2|Screening Treatment Phase|Unable to tolerate standard dose|0
1252734|NCT00557830|4107509|P1|Screening Treatment Phase|Unable to tolerate standard dose|3
1252735|NCT00557830|4107507|P3|Screening Treatment Phase|Adverse Event|0
1252736|NCT00557830|4107508|P2|Screening Treatment Phase|Adverse Event|0
1252737|NCT00557830|4107509|P1|Screening Treatment Phase|Adverse Event|2
1252738|NCT00557830|4107507|P3|Screening Treatment Phase|Withdrawal by Subject|0
1252739|NCT00557830|4107508|P2|Screening Treatment Phase|Withdrawal by Subject|0
1252740|NCT00557830|4107509|P1|Screening Treatment Phase|Withdrawal by Subject|1
1252741|NCT00557622|4107531|P2|12-Week Treatment Phase|Lost to Follow-up|1
1252742|NCT00557622|4107532|P1|12-Week Treatment Phase|Lost to Follow-up|0
1252743|NCT00557622|4107531|P2|4-Week Run-in Phase|Protocol-defined stopping criteria|0
1252744|NCT00557622|4107532|P1|4-Week Run-in Phase|Protocol-defined stopping criteria|1
1252745|NCT00557622|4107531|P2|4-Week Run-in Phase|Withdrawal by Subject|0
1252746|NCT00557622|4107532|P1|4-Week Run-in Phase|Withdrawal by Subject|1
1252747|NCT00557505|4107561|P9|Overall Study|Withdrawal by Subject|1
1252748|NCT00557505|4107562|P8|Overall Study|Withdrawal by Subject|0
1252749|NCT00557505|4107563|P7|Overall Study|Withdrawal by Subject|0
1252750|NCT00557505|4107564|P6|Overall Study|Withdrawal by Subject|0
1252751|NCT00557505|4107565|P5|Overall Study|Withdrawal by Subject|0
1252752|NCT00557505|4107566|P4|Overall Study|Withdrawal by Subject|1
1252753|NCT00557505|4107567|P3|Overall Study|Withdrawal by Subject|0
1252754|NCT00557505|4107568|P2|Overall Study|Withdrawal by Subject|0
1252755|NCT00557505|4107569|P1|Overall Study|Withdrawal by Subject|0
1252756|NCT00557505|4107561|P9|Overall Study|Objective progression or relapse|15
1252757|NCT00557505|4107562|P8|Overall Study|Objective progression or relapse|5
1252758|NCT00557505|4107563|P7|Overall Study|Objective progression or relapse|2
1252759|NCT00557505|4107564|P6|Overall Study|Objective progression or relapse|3
1252760|NCT00557505|4107565|P5|Overall Study|Objective progression or relapse|2
1252761|NCT00557505|4107566|P4|Overall Study|Objective progression or relapse|2
1252762|NCT00557505|4107567|P3|Overall Study|Objective progression or relapse|3
1252763|NCT00557505|4107568|P2|Overall Study|Objective progression or relapse|3
1252764|NCT00557505|4107569|P1|Overall Study|Objective progression or relapse|2
1252765|NCT00557505|4107561|P9|Overall Study|Global deterioration of health|0
1252766|NCT00557505|4107562|P8|Overall Study|Global deterioration of health|0
1252767|NCT00557505|4107563|P7|Overall Study|Global deterioration of health|0
1252768|NCT00557505|4107564|P6|Overall Study|Global deterioration of health|0
1252769|NCT00557505|4107565|P5|Overall Study|Global deterioration of health|0
1252770|NCT00557505|4107566|P4|Overall Study|Global deterioration of health|0
1252771|NCT00557505|4107567|P3|Overall Study|Global deterioration of health|0
1252772|NCT00557505|4107568|P2|Overall Study|Global deterioration of health|0
1252773|NCT00557505|4107569|P1|Overall Study|Global deterioration of health|1
1252774|NCT00557505|4107561|P9|Overall Study|Adverse Event|0
1252775|NCT00557505|4107562|P8|Overall Study|Adverse Event|0
1252776|NCT00557505|4107563|P7|Overall Study|Adverse Event|1
1252777|NCT00557505|4107564|P6|Overall Study|Adverse Event|0
1252778|NCT00557505|4107565|P5|Overall Study|Adverse Event|0
1252779|NCT00557505|4107566|P4|Overall Study|Adverse Event|0
1252780|NCT00557505|4107567|P3|Overall Study|Adverse Event|1
1252781|NCT00557505|4107568|P2|Overall Study|Adverse Event|0
1252782|NCT00557505|4107569|P1|Overall Study|Adverse Event|0
1252783|NCT00557505|4107561|P9|Overall Study|Death|1
1252784|NCT00557505|4107562|P8|Overall Study|Death|0
1252785|NCT00557505|4107563|P7|Overall Study|Death|0
1252786|NCT00557505|4107564|P6|Overall Study|Death|0
1252787|NCT00557505|4107565|P5|Overall Study|Death|0
1252788|NCT00557505|4107566|P4|Overall Study|Death|0
1252789|NCT00557505|4107567|P3|Overall Study|Death|0
1252790|NCT00557505|4107568|P2|Overall Study|Death|0
1252791|NCT00557505|4107569|P1|Overall Study|Death|0
1252792|NCT00557492|4107733|P1|Overall Study|Change in health insurance|1
1252793|NCT00557466|4107751|P6|Overall Study|Lost to Follow-up|0
1252794|NCT00557466|4107752|P5|Overall Study|Lost to Follow-up|0
1252795|NCT00557466|4107753|P4|Overall Study|Lost to Follow-up|1
1252796|NCT00557466|4107754|P3|Overall Study|Lost to Follow-up|0
1252797|NCT00557466|4107755|P2|Overall Study|Lost to Follow-up|0
1252798|NCT00557466|4107756|P1|Overall Study|Lost to Follow-up|0
1252799|NCT00557466|4107751|P6|Overall Study|Abnormal test procedure results|0
1252800|NCT00557466|4107752|P5|Overall Study|Abnormal test procedure results|0
1252801|NCT00557466|4107753|P4|Overall Study|Abnormal test procedure results|0
1252802|NCT00557466|4107754|P3|Overall Study|Abnormal test procedure results|1
1252803|NCT00557466|4107755|P2|Overall Study|Abnormal test procedure results|0
1252804|NCT00557466|4107756|P1|Overall Study|Abnormal test procedure results|0
1252805|NCT00557466|4107751|P6|Overall Study|Administrative problems|0
1252806|NCT00557466|4107752|P5|Overall Study|Administrative problems|0
1252807|NCT00557466|4107753|P4|Overall Study|Administrative problems|0
1252808|NCT00557466|4107754|P3|Overall Study|Administrative problems|1
1252809|NCT00557466|4107755|P2|Overall Study|Administrative problems|1
1252810|NCT00557466|4107756|P1|Overall Study|Administrative problems|0
1252811|NCT00557466|4107751|P6|Overall Study|Subject withdrew consent|2
1252812|NCT00557466|4107752|P5|Overall Study|Subject withdrew consent|1
1252813|NCT00557466|4107753|P4|Overall Study|Subject withdrew consent|0
1252814|NCT00557466|4107754|P3|Overall Study|Subject withdrew consent|0
1252815|NCT00557466|4107755|P2|Overall Study|Subject withdrew consent|0
1252816|NCT00557466|4107756|P1|Overall Study|Subject withdrew consent|0
1252817|NCT00557466|4107751|P6|Overall Study|Protocol deviation|0
1252818|NCT00557466|4107752|P5|Overall Study|Protocol deviation|0
1252819|NCT00557466|4107753|P4|Overall Study|Protocol deviation|2
1252820|NCT00557466|4107754|P3|Overall Study|Protocol deviation|0
1252821|NCT00557466|4107755|P2|Overall Study|Protocol deviation|1
1252822|NCT00557466|4107756|P1|Overall Study|Protocol deviation|0
1252823|NCT00557466|4107751|P6|Overall Study|Abnormal laboratory value(s)|0
1252824|NCT00557466|4107752|P5|Overall Study|Abnormal laboratory value(s)|0
1252825|NCT00557466|4107753|P4|Overall Study|Abnormal laboratory value(s)|0
1252826|NCT00557466|4107754|P3|Overall Study|Abnormal laboratory value(s)|0
1252827|NCT00557466|4107755|P2|Overall Study|Abnormal laboratory value(s)|2
1252828|NCT00557466|4107756|P1|Overall Study|Abnormal laboratory value(s)|1
1252829|NCT00557466|4107751|P6|Overall Study|Adverse Event|4
1252830|NCT00557466|4107752|P5|Overall Study|Adverse Event|2
1252831|NCT00557466|4107753|P4|Overall Study|Adverse Event|1
1252832|NCT00557466|4107754|P3|Overall Study|Adverse Event|4
1252833|NCT00557466|4107755|P2|Overall Study|Adverse Event|1
1252834|NCT00557466|4107756|P1|Overall Study|Adverse Event|3
1252835|NCT00557440|4107809|P3|Treatment Period 1|Adverse Event|1
1252836|NCT00557440|4107810|P2|Treatment Period 1|Adverse Event|0
1252837|NCT00557440|4107811|P1|Treatment Period 1|Adverse Event|0
1252838|NCT00557323|4107865|P1|Overall Study|Administrative change|2
1252839|NCT00557323|4107865|P1|Overall Study|Withdrawal by Subject|2
1252840|NCT00557323|4107865|P1|Overall Study|Death|3
1252841|NCT00557310|4107870|P1|Extension Phase (18 - 24 Months)|Protocol Violation|1
1252842|NCT00557310|4107870|P1|Extension Phase (18 - 24 Months)|Physician Decision|2
1252843|NCT00557310|4107870|P1|Extension Phase (18 - 24 Months)|Lost to Follow-up|1
1252844|NCT00557310|4107870|P1|Extension Phase (18 - 24 Months)|Adverse Event|1
1252845|NCT00557310|4107870|P1|Main Study (0 - 18 Months)|Withdrawal by Subject|1
1252846|NCT00557310|4107870|P1|Main Study (0 - 18 Months)|Adverse Event|4
1252847|NCT00557245|4107916|P3|Overall Study|Ineligible|2
1252848|NCT00557245|4107917|P2|Overall Study|Ineligible|4
1252849|NCT00557245|4107918|P1|Overall Study|Ineligible|5
1252850|NCT00557245|4107916|P3|Overall Study|Lost to Follow-up|10
1252851|NCT00557245|4107917|P2|Overall Study|Lost to Follow-up|8
1252852|NCT00557245|4107918|P1|Overall Study|Lost to Follow-up|7
1252853|NCT00557193|4107956|P6|Post Induction Therapy by Tx Assignment|Induction Failure|5
1252854|NCT00557193|4107957|P5|Post Induction Therapy by Tx Assignment|Induction Failure|0
1252855|NCT00557193|4107958|P4|Post Induction Therapy by Tx Assignment|Induction Failure|0
1252856|NCT00557193|4107959|P3|Post Induction Therapy by Tx Assignment|Induction Failure|4
1252857|NCT00557193|4107960|P2|Post Induction Therapy by Tx Assignment|Induction Failure|0
1252858|NCT00557193|4107961|P1|Post Induction Therapy by Tx Assignment|Induction Failure|0
1252859|NCT00557193|4107956|P6|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
1252860|NCT00557193|4107957|P5|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
1252861|NCT00557193|4107958|P4|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
1252862|NCT00557193|4107959|P3|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2
1252863|NCT00557193|4107960|P2|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
1252864|NCT00557193|4107961|P1|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
1252865|NCT00557193|4107956|P6|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
1252866|NCT00557193|4107957|P5|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
1252867|NCT00557193|4107958|P4|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
1252868|NCT00557193|4107959|P3|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1
1252869|NCT00557193|4107960|P2|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
1252870|NCT00557193|4107961|P1|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
1252871|NCT00557193|4107956|P6|Post Induction Therapy by Tx Assignment|Relapse|20
1252872|NCT00557193|4107957|P5|Post Induction Therapy by Tx Assignment|Relapse|1
1252873|NCT00557193|4107958|P4|Post Induction Therapy by Tx Assignment|Relapse|3
1252874|NCT00557193|4107959|P3|Post Induction Therapy by Tx Assignment|Relapse|16
1252875|NCT00557193|4107960|P2|Post Induction Therapy by Tx Assignment|Relapse|5
1252876|NCT00557193|4107961|P1|Post Induction Therapy by Tx Assignment|Relapse|0
1252877|NCT00557193|4107956|P6|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5
1252878|NCT00557193|4107957|P5|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2
1252879|NCT00557193|4107958|P4|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2
1252880|NCT00557193|4107959|P3|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0
1252881|NCT00557193|4107960|P2|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1
1252882|NCT00557193|4107961|P1|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0
1252883|NCT00557193|4107956|P6|Post Induction Therapy by Tx Assignment|Physician Decision|2
1252884|NCT00557193|4107957|P5|Post Induction Therapy by Tx Assignment|Physician Decision|2
1252885|NCT00557193|4107958|P4|Post Induction Therapy by Tx Assignment|Physician Decision|1
1252886|NCT00557193|4107959|P3|Post Induction Therapy by Tx Assignment|Physician Decision|5
1252887|NCT00557193|4107960|P2|Post Induction Therapy by Tx Assignment|Physician Decision|3
1252888|NCT00557193|4107961|P1|Post Induction Therapy by Tx Assignment|Physician Decision|0
1252889|NCT00557193|4107956|P6|Post Induction Therapy by Tx Assignment|Death|2
1252890|NCT00557193|4107957|P5|Post Induction Therapy by Tx Assignment|Death|2
1252891|NCT00557193|4107958|P4|Post Induction Therapy by Tx Assignment|Death|0
1252892|NCT00557193|4107959|P3|Post Induction Therapy by Tx Assignment|Death|2
1252893|NCT00557193|4107960|P2|Post Induction Therapy by Tx Assignment|Death|0
1252894|NCT00557193|4107961|P1|Post Induction Therapy by Tx Assignment|Death|0
1252895|NCT00557193|4107956|P6|Post Induction Therapy by Tx Assignment|Adverse Event|3
1252896|NCT00557193|4107957|P5|Post Induction Therapy by Tx Assignment|Adverse Event|0
1252897|NCT00557193|4107958|P4|Post Induction Therapy by Tx Assignment|Adverse Event|1
1252898|NCT00557193|4107959|P3|Post Induction Therapy by Tx Assignment|Adverse Event|2
1252899|NCT00557193|4107960|P2|Post Induction Therapy by Tx Assignment|Adverse Event|1
1252900|NCT00557193|4107961|P1|Post Induction Therapy by Tx Assignment|Adverse Event|0
1252901|NCT00557193|4107956|P6|Induction|Unable to receive Lestaurtinib-Not in US|0
1252902|NCT00557193|4107957|P5|Induction|Unable to receive Lestaurtinib-Not in US|0
1252903|NCT00557193|4107958|P4|Induction|Unable to receive Lestaurtinib-Not in US|0
1252904|NCT00557193|4107959|P3|Induction|Unable to receive Lestaurtinib-Not in US|0
1252905|NCT00557193|4107960|P2|Induction|Unable to receive Lestaurtinib-Not in US|0
1252906|NCT00557193|4107961|P1|Induction|Unable to receive Lestaurtinib-Not in US|2
1252907|NCT00557193|4107956|P6|Induction|Inevaluable for post Induction|0
1252908|NCT00557193|4107957|P5|Induction|Inevaluable for post Induction|0
1252909|NCT00557193|4107958|P4|Induction|Inevaluable for post Induction|0
1252910|NCT00557193|4107959|P3|Induction|Inevaluable for post Induction|0
1252911|NCT00557193|4107960|P2|Induction|Inevaluable for post Induction|0
1252912|NCT00557193|4107961|P1|Induction|Inevaluable for post Induction|2
1252913|NCT00557193|4107956|P6|Induction|Ineligible|0
1252914|NCT00557193|4107957|P5|Induction|Ineligible|0
1252915|NCT00557193|4107958|P4|Induction|Ineligible|0
1252916|NCT00557193|4107959|P3|Induction|Ineligible|0
1252917|NCT00557193|4107960|P2|Induction|Ineligible|0
1252918|NCT00557193|4107961|P1|Induction|Ineligible|8
1252919|NCT00557193|4107956|P6|Induction|Refusal of Further Protocol Therapy|0
1252920|NCT00557193|4107957|P5|Induction|Refusal of Further Protocol Therapy|0
1252921|NCT00557193|4107958|P4|Induction|Refusal of Further Protocol Therapy|0
1252922|NCT00557193|4107959|P3|Induction|Refusal of Further Protocol Therapy|0
1252923|NCT00557193|4107960|P2|Induction|Refusal of Further Protocol Therapy|0
1252924|NCT00557193|4107961|P1|Induction|Refusal of Further Protocol Therapy|2
1252925|NCT00557193|4107956|P6|Induction|Withdrawal by Subject|0
1252926|NCT00557193|4107957|P5|Induction|Withdrawal by Subject|0
1252927|NCT00557193|4107958|P4|Induction|Withdrawal by Subject|0
1252928|NCT00557193|4107959|P3|Induction|Withdrawal by Subject|0
1252929|NCT00557193|4107960|P2|Induction|Withdrawal by Subject|0
1252930|NCT00557193|4107961|P1|Induction|Withdrawal by Subject|1
1252931|NCT00557193|4107956|P6|Induction|Physician Decision|0
1252932|NCT00557193|4107957|P5|Induction|Physician Decision|0
1252933|NCT00557193|4107958|P4|Induction|Physician Decision|0
1252934|NCT00557193|4107959|P3|Induction|Physician Decision|0
1252935|NCT00557193|4107960|P2|Induction|Physician Decision|0
1252936|NCT00557193|4107961|P1|Induction|Physician Decision|3
1252937|NCT00557193|4107956|P6|Induction|Death|0
1252938|NCT00557193|4107957|P5|Induction|Death|0
1252939|NCT00557193|4107958|P4|Induction|Death|0
1252940|NCT00557193|4107959|P3|Induction|Death|0
1252941|NCT00557193|4107960|P2|Induction|Death|0
1252942|NCT00557193|4107961|P1|Induction|Death|6
1252943|NCT00557193|4107956|P6|Induction|Adverse Event|0
1252944|NCT00557193|4107957|P5|Induction|Adverse Event|0
1252945|NCT00557193|4107958|P4|Induction|Adverse Event|0
1252946|NCT00557193|4107959|P3|Induction|Adverse Event|0
1252947|NCT00557193|4107960|P2|Induction|Adverse Event|0
1252948|NCT00557193|4107961|P1|Induction|Adverse Event|2
1252949|NCT00557076|4107986|P2|Overall Study|Unblinding|1
1252950|NCT00557076|4107987|P1|Overall Study|Unblinding|0
1252951|NCT00556998|4107995|P1|Voriconazole Oral|Intolerant of oral treatment|1
1252952|NCT00556998|4107995|P1|Voriconazole Oral|Adverse Event|1
1252953|NCT00556998|4107995|P1|Voriconazole Intravenous (IV)|Other|4
1252954|NCT00556998|4107995|P1|Voriconazole Intravenous (IV)|Adverse Event|1
1252955|NCT00556933|4108030|P4|CNI Withdrawal vs. Minimization|Death|1
1252956|NCT00556933|4108031|P3|CNI Withdrawal vs. Minimization|Death|0
1252957|NCT00556933|4108032|P2|CNI Withdrawal vs. Minimization|Death|0
1252958|NCT00556933|4108033|P1|CNI Withdrawal vs. Minimization|Death|0
1252959|NCT00556933|4108030|P4|CNI Withdrawal vs. Minimization|Graft loss|0
1252960|NCT00556933|4108031|P3|CNI Withdrawal vs. Minimization|Graft loss|2
1252961|NCT00556933|4108032|P2|CNI Withdrawal vs. Minimization|Graft loss|1
1252962|NCT00556933|4108033|P1|CNI Withdrawal vs. Minimization|Graft loss|0
1252963|NCT00556933|4108030|P4|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
1252964|NCT00556933|4108031|P3|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
1252965|NCT00556933|4108032|P2|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
1252966|NCT00556933|4108033|P1|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
1252967|NCT00556933|4108030|P4|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
1252968|NCT00556933|4108031|P3|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
1252969|NCT00556933|4108032|P2|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
1252970|NCT00556933|4108033|P1|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
1252971|NCT00556933|4108030|P4|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
1252972|NCT00556933|4108031|P3|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
1252973|NCT00556933|4108032|P2|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
1252974|NCT00556933|4108033|P1|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
1252975|NCT00556933|4108030|P4|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
1252976|NCT00556933|4108031|P3|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
1252977|NCT00556933|4108032|P2|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1
1252978|NCT00556933|4108033|P1|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
1252979|NCT00556933|4108030|P4|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
1252980|NCT00556933|4108031|P3|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
1252981|NCT00556933|4108032|P2|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1
1252982|NCT00556933|4108033|P1|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
1252983|NCT00556933|4108030|P4|Single vs. Divided-dose rATG Induction|Death|0
1252984|NCT00556933|4108031|P3|Single vs. Divided-dose rATG Induction|Death|0
1252985|NCT00556933|4108032|P2|Single vs. Divided-dose rATG Induction|Death|1
1252986|NCT00556933|4108033|P1|Single vs. Divided-dose rATG Induction|Death|0
1252987|NCT00556933|4108030|P4|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
1252988|NCT00556933|4108031|P3|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
1252989|NCT00556933|4108032|P2|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
1252990|NCT00556933|4108033|P1|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0
1252991|NCT00556933|4108030|P4|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
1252992|NCT00556933|4108031|P3|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1
1252993|NCT00556933|4108032|P2|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
1252994|NCT00556933|4108033|P1|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
1252995|NCT00556933|4108030|P4|Single vs. Divided-dose rATG Induction|Protocol Violation|0
1252996|NCT00556933|4108031|P3|Single vs. Divided-dose rATG Induction|Protocol Violation|3
1252997|NCT00556933|4108032|P2|Single vs. Divided-dose rATG Induction|Protocol Violation|3
1252998|NCT00556933|4108033|P1|Single vs. Divided-dose rATG Induction|Protocol Violation|2
1252999|NCT00556894|4108090|P3|Overall Study|Withdrawal by Subject|1
1253000|NCT00556894|4108091|P2|Overall Study|Withdrawal by Subject|1
1253001|NCT00556894|4108092|P1|Overall Study|Withdrawal by Subject|1
1253002|NCT00556894|4108090|P3|Overall Study|Change in therapy|2
1253003|NCT00556894|4108091|P2|Overall Study|Change in therapy|1
1253004|NCT00556894|4108092|P1|Overall Study|Change in therapy|2
1253005|NCT00556894|4108090|P3|Overall Study|regulatory decision in Bulgaria|13
1253006|NCT00556894|4108091|P2|Overall Study|regulatory decision in Bulgaria|14
1253007|NCT00556894|4108092|P1|Overall Study|regulatory decision in Bulgaria|10
1253008|NCT00556894|4108090|P3|Overall Study|Death|0
1253009|NCT00556894|4108091|P2|Overall Study|Death|0
1253010|NCT00556894|4108092|P1|Overall Study|Death|1
1253011|NCT00556894|4108090|P3|Overall Study|Adverse Event|3
1253012|NCT00556894|4108091|P2|Overall Study|Adverse Event|3
1253013|NCT00556894|4108092|P1|Overall Study|Adverse Event|2
1253014|NCT00556712|4108102|P2|Overall Study|Ongoing at Data Cutoff|66
1253015|NCT00556712|4108103|P1|Overall Study|Ongoing at Data Cutoff|32
1253016|NCT00556712|4108102|P2|Overall Study|Not Specified|2
1253017|NCT00556712|4108103|P1|Overall Study|Not Specified|2
1253018|NCT00556712|4108102|P2|Overall Study|Failure to Return|3
1253019|NCT00556712|4108103|P1|Overall Study|Failure to Return|2
1253020|NCT00556712|4108102|P2|Overall Study|Refused Treatment|16
1253021|NCT00556712|4108103|P1|Overall Study|Refused Treatment|17
1253022|NCT00556712|4108102|P2|Overall Study|Protocol Violation|2
1253023|NCT00556712|4108103|P1|Overall Study|Protocol Violation|3
1253024|NCT00556712|4108102|P2|Overall Study|Progressive Disease|320
1253025|NCT00556712|4108103|P1|Overall Study|Progressive Disease|383
1253026|NCT00556712|4108102|P2|Overall Study|Death|10
1253027|NCT00556712|4108103|P1|Overall Study|Death|5
1253028|NCT00556712|4108102|P2|Overall Study|Adverse Event|19
1253029|NCT00556712|4108103|P1|Overall Study|Adverse Event|7
1253030|NCT00556673|4108181|P2|Overall Study|Protocol deviation|2
1253031|NCT00556673|4108182|P1|Overall Study|Protocol deviation|3
1253032|NCT00556439|4108318|P4|After Week 12 (Randomized Study Period)|Severe infection|0
1253033|NCT00556439|4108319|P3|After Week 12 (Randomized Study Period)|Severe infection|0
1253034|NCT00556439|4108320|P2|After Week 12 (Randomized Study Period)|Severe infection|0
1253035|NCT00556439|4108321|P1|After Week 12 (Randomized Study Period)|Severe infection|1
1253036|NCT00556439|4108318|P4|After Week 12 (Randomized Study Period)|Malignancy|1
1253037|NCT00556439|4108319|P3|After Week 12 (Randomized Study Period)|Malignancy|0
1253038|NCT00556439|4108320|P2|After Week 12 (Randomized Study Period)|Malignancy|1
1253039|NCT00556439|4108321|P1|After Week 12 (Randomized Study Period)|Malignancy|0
1253040|NCT00556439|4108318|P4|After Week 12 (Randomized Study Period)|Physician Decision|0
1253041|NCT00556439|4108319|P3|After Week 12 (Randomized Study Period)|Physician Decision|0
1253042|NCT00556439|4108320|P2|After Week 12 (Randomized Study Period)|Physician Decision|0
1253043|NCT00556439|4108321|P1|After Week 12 (Randomized Study Period)|Physician Decision|1
1253044|NCT00556439|4108318|P4|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
1253045|NCT00556439|4108319|P3|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
1253046|NCT00556439|4108320|P2|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3
1253047|NCT00556439|4108321|P1|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1
1253048|NCT00556439|4108318|P4|Study Entry to Week 12|Malignancy|0
1253049|NCT00556439|4108319|P3|Study Entry to Week 12|Malignancy|1
1253050|NCT00556439|4108320|P2|Study Entry to Week 12|Malignancy|0
1253051|NCT00556439|4108321|P1|Study Entry to Week 12|Malignancy|0
1253052|NCT00556439|4108318|P4|Study Entry to Week 12|Recurrent infection|0
1253053|NCT00556439|4108319|P3|Study Entry to Week 12|Recurrent infection|0
1253054|NCT00556439|4108320|P2|Study Entry to Week 12|Recurrent infection|0
1253055|NCT00556439|4108321|P1|Study Entry to Week 12|Recurrent infection|1
1253056|NCT00556439|4108318|P4|Study Entry to Week 12|Withdrawal by Subject|0
1253057|NCT00556439|4108319|P3|Study Entry to Week 12|Withdrawal by Subject|1
1253058|NCT00556439|4108320|P2|Study Entry to Week 12|Withdrawal by Subject|0
1253059|NCT00556439|4108321|P1|Study Entry to Week 12|Withdrawal by Subject|1
1253060|NCT00556439|4108318|P4|Study Entry to Week 12|Physician Decision|0
1253061|NCT00556439|4108319|P3|Study Entry to Week 12|Physician Decision|0
1253062|NCT00556439|4108320|P2|Study Entry to Week 12|Physician Decision|0
1253063|NCT00556439|4108321|P1|Study Entry to Week 12|Physician Decision|1
1253064|NCT00556439|4108318|P4|Study Entry to Week 12|Lack of Efficacy|0
1253065|NCT00556439|4108319|P3|Study Entry to Week 12|Lack of Efficacy|6
1253066|NCT00556439|4108320|P2|Study Entry to Week 12|Lack of Efficacy|0
1253067|NCT00556439|4108321|P1|Study Entry to Week 12|Lack of Efficacy|5
1253068|NCT00556426|4108331|P1|Overall Study|Death|6
1253069|NCT00556426|4108331|P1|Overall Study|Withdrawal by Subject|3
1253070|NCT00556374|4108353|P2|Overall Study|Lost to Follow-up|5
1253071|NCT00556374|4108354|P1|Overall Study|Lost to Follow-up|7
1253072|NCT00556374|4108353|P2|Overall Study|Death|43
1253073|NCT00556374|4108354|P1|Overall Study|Death|50
1253074|NCT00556374|4108353|P2|Overall Study|Withdrawal by Subject|172
1253075|NCT00556374|4108354|P1|Overall Study|Withdrawal by Subject|190
1253076|NCT00556322|4108372|P2|Overall Study|Death|14
1253077|NCT00556322|4108373|P1|Overall Study|Death|20
1253078|NCT00556322|4108372|P2|Overall Study|Ongoing at data cutoff|5
1253079|NCT00556322|4108373|P1|Overall Study|Ongoing at data cutoff|3
1253080|NCT00556322|4108372|P2|Overall Study|Protocol Violation|1
1253081|NCT00556322|4108373|P1|Overall Study|Protocol Violation|5
1253082|NCT00556322|4108372|P2|Overall Study|Withdrawal by Subject|7
1253083|NCT00556322|4108373|P1|Overall Study|Withdrawal by Subject|19
1253084|NCT00556322|4108372|P2|Overall Study|Lost to Follow-up|3
1253085|NCT00556322|4108373|P1|Overall Study|Lost to Follow-up|5
1253086|NCT00556322|4108372|P2|Overall Study|Other|1
1253087|NCT00556322|4108373|P1|Overall Study|Other|4
1253088|NCT00556322|4108372|P2|Overall Study|Adverse Event|4
1253089|NCT00556322|4108373|P1|Overall Study|Adverse Event|7
1253090|NCT00556322|4108372|P2|Overall Study|Insufficient therapeutic response|168
1253091|NCT00556322|4108373|P1|Overall Study|Insufficient therapeutic response|158
1253092|NCT00556166|4108421|P1|Overall Study|Withdrawal by Subject|1
1253093|NCT00556075|4108434|P3|Overall Study|Endometrial stripe not viewed on 2 tvu|0
1253094|NCT00556075|4108435|P2|Overall Study|Endometrial stripe not viewed on 2 tvu|1
1253095|NCT00556075|4108436|P1|Overall Study|Endometrial stripe not viewed on 2 tvu|0
1253096|NCT00556075|4108434|P3|Overall Study|Personal issues|0
1253097|NCT00556075|4108435|P2|Overall Study|Personal issues|1
1253098|NCT00556075|4108436|P1|Overall Study|Personal issues|4
1253099|NCT00556075|4108434|P3|Overall Study|Adverse Event|0
1253100|NCT00556075|4108435|P2|Overall Study|Adverse Event|2
1253101|NCT00556075|4108436|P1|Overall Study|Adverse Event|1
1253102|NCT00556075|4108434|P3|Overall Study|Not eligible|2
1253103|NCT00556075|4108435|P2|Overall Study|Not eligible|1
1253104|NCT00556075|4108436|P1|Overall Study|Not eligible|1
1253105|NCT00556075|4108434|P3|Overall Study|Protocol Violation|3
1253106|NCT00556075|4108435|P2|Overall Study|Protocol Violation|1
1253107|NCT00556075|4108436|P1|Overall Study|Protocol Violation|1
1253108|NCT00556075|4108434|P3|Overall Study|Withdrawal by Subject|0
1253109|NCT00556075|4108435|P2|Overall Study|Withdrawal by Subject|3
1253110|NCT00556075|4108436|P1|Overall Study|Withdrawal by Subject|3
1253111|NCT00556075|4108434|P3|Overall Study|Lost to Follow-up|3
1253112|NCT00556075|4108435|P2|Overall Study|Lost to Follow-up|0
1253113|NCT00556075|4108436|P1|Overall Study|Lost to Follow-up|3
1253114|NCT00555906|4108488|P5|Phase 2|Randomized but not Treated|2
1253115|NCT00555906|4108489|P4|Phase 2|Randomized but not Treated|0
1253116|NCT00555906|4108490|P3|Phase 2|Randomized but not Treated|0
1253117|NCT00555906|4108491|P2|Phase 2|Randomized but not Treated|0
1253118|NCT00555906|4108492|P1|Phase 2|Randomized but not Treated|0
1253119|NCT00555906|4108488|P5|Phase 2|Other|6
1253120|NCT00555906|4108489|P4|Phase 2|Other|0
1253121|NCT00555906|4108490|P3|Phase 2|Other|0
1253122|NCT00555906|4108491|P2|Phase 2|Other|0
1253123|NCT00555906|4108492|P1|Phase 2|Other|0
1253124|NCT00555906|4108488|P5|Phase 2|Withdrawal by Subject|2
1253125|NCT00555906|4108489|P4|Phase 2|Withdrawal by Subject|0
1253126|NCT00555906|4108490|P3|Phase 2|Withdrawal by Subject|0
1253127|NCT00555906|4108491|P2|Phase 2|Withdrawal by Subject|0
1253128|NCT00555906|4108492|P1|Phase 2|Withdrawal by Subject|0
1253129|NCT00555906|4108488|P5|Phase 2|Objective Progression or Relapse|16
1253130|NCT00555906|4108489|P4|Phase 2|Objective Progression or Relapse|0
1253131|NCT00555906|4108490|P3|Phase 2|Objective Progression or Relapse|0
1253132|NCT00555906|4108491|P2|Phase 2|Objective Progression or Relapse|0
1253133|NCT00555906|4108492|P1|Phase 2|Objective Progression or Relapse|0
1253134|NCT00555906|4108488|P5|Phase 2|Global Deterioration of Health Status|2
1253135|NCT00555906|4108489|P4|Phase 2|Global Deterioration of Health Status|0
1253136|NCT00555906|4108490|P3|Phase 2|Global Deterioration of Health Status|0
1253137|NCT00555906|4108491|P2|Phase 2|Global Deterioration of Health Status|0
1253138|NCT00555906|4108492|P1|Phase 2|Global Deterioration of Health Status|0
1253139|NCT00555906|4108488|P5|Phase 2|Adverse Event|4
1253140|NCT00555906|4108489|P4|Phase 2|Adverse Event|0
1253141|NCT00555906|4108490|P3|Phase 2|Adverse Event|0
1253142|NCT00555906|4108491|P2|Phase 2|Adverse Event|0
1253143|NCT00555906|4108492|P1|Phase 2|Adverse Event|0
1253144|NCT00555906|4108488|P5|Phase 1|Withdrawal by Subject|0
1253145|NCT00555906|4108489|P4|Phase 1|Withdrawal by Subject|1
1253146|NCT00555906|4108490|P3|Phase 1|Withdrawal by Subject|0
1253147|NCT00555906|4108491|P2|Phase 1|Withdrawal by Subject|0
1253148|NCT00555906|4108492|P1|Phase 1|Withdrawal by Subject|0
1253149|NCT00555906|4108488|P5|Phase 1|Adverse Event|0
1253150|NCT00555906|4108489|P4|Phase 1|Adverse Event|2
1253151|NCT00555906|4108490|P3|Phase 1|Adverse Event|3
1253152|NCT00555906|4108491|P2|Phase 1|Adverse Event|0
1253153|NCT00555906|4108492|P1|Phase 1|Adverse Event|0
1253154|NCT00555906|4108488|P5|Phase 1|Global Deterioration of Health Status|0
1253155|NCT00555906|4108489|P4|Phase 1|Global Deterioration of Health Status|1
1253156|NCT00555906|4108490|P3|Phase 1|Global Deterioration of Health Status|1
1253157|NCT00555906|4108491|P2|Phase 1|Global Deterioration of Health Status|1
1253158|NCT00555906|4108492|P1|Phase 1|Global Deterioration of Health Status|0
1253159|NCT00555906|4108488|P5|Phase 1|Objective Progression or Relapse|0
1253160|NCT00555906|4108489|P4|Phase 1|Objective Progression or Relapse|1
1253161|NCT00555906|4108490|P3|Phase 1|Objective Progression or Relapse|3
1253162|NCT00555906|4108491|P2|Phase 1|Objective Progression or Relapse|5
1253163|NCT00555906|4108492|P1|Phase 1|Objective Progression or Relapse|3
1253164|NCT00555672|4108614|P2|Overall Study|Participant refused|0
1253165|NCT00555672|4108615|P1|Overall Study|Participant refused|2
1253166|NCT00555672|4108614|P2|Overall Study|Other|1
1253167|NCT00555672|4108615|P1|Overall Study|Other|3
1253168|NCT00555672|4108614|P2|Overall Study|Objective progression or relapse|5
1253169|NCT00555672|4108615|P1|Overall Study|Objective progression or relapse|11
1253170|NCT00555672|4108614|P2|Overall Study|Adverse Event|2
1253171|NCT00555672|4108615|P1|Overall Study|Adverse Event|8
1253172|NCT00555672|4108614|P2|Overall Study|Death|2
1253173|NCT00555672|4108615|P1|Overall Study|Death|0
1253174|NCT00555620|4108640|P6|Overall Study|Not specified|3
1253175|NCT00555620|4108641|P5|Overall Study|Not specified|0
1253176|NCT00555620|4108642|P4|Overall Study|Not specified|1
1253177|NCT00555620|4108643|P3|Overall Study|Not specified|0
1253178|NCT00555620|4108644|P2|Overall Study|Not specified|0
1253179|NCT00555620|4108645|P1|Overall Study|Not specified|0
1253180|NCT00555620|4108640|P6|Overall Study|Participant refused treatment|1
1253181|NCT00555620|4108641|P5|Overall Study|Participant refused treatment|0
1253182|NCT00555620|4108642|P4|Overall Study|Participant refused treatment|0
1253183|NCT00555620|4108643|P3|Overall Study|Participant refused treatment|1
1253184|NCT00555620|4108644|P2|Overall Study|Participant refused treatment|1
1253185|NCT00555620|4108645|P1|Overall Study|Participant refused treatment|0
1253186|NCT00555620|4108640|P6|Overall Study|Objective progression or relapse|16
1253187|NCT00555620|4108641|P5|Overall Study|Objective progression or relapse|3
1253188|NCT00555620|4108642|P4|Overall Study|Objective progression or relapse|17
1253189|NCT00555620|4108643|P3|Overall Study|Objective progression or relapse|12
1253190|NCT00555620|4108644|P2|Overall Study|Objective progression or relapse|5
1253191|NCT00555620|4108645|P1|Overall Study|Objective progression or relapse|6
1253192|NCT00555620|4108640|P6|Overall Study|Adverse Event|1
1253193|NCT00555620|4108641|P5|Overall Study|Adverse Event|0
1253194|NCT00555620|4108642|P4|Overall Study|Adverse Event|5
1253195|NCT00555620|4108643|P3|Overall Study|Adverse Event|1
1253196|NCT00555620|4108644|P2|Overall Study|Adverse Event|0
1253197|NCT00555620|4108645|P1|Overall Study|Adverse Event|0
1253198|NCT00555620|4108640|P6|Overall Study|Study terminated by sponsor|0
1253199|NCT00555620|4108641|P5|Overall Study|Study terminated by sponsor|0
1253200|NCT00555620|4108642|P4|Overall Study|Study terminated by sponsor|0
1253201|NCT00555620|4108643|P3|Overall Study|Study terminated by sponsor|1
1253202|NCT00555620|4108644|P2|Overall Study|Study terminated by sponsor|0
1253203|NCT00555620|4108645|P1|Overall Study|Study terminated by sponsor|0
1253204|NCT00555620|4108640|P6|Overall Study|Death|1
1253205|NCT00555620|4108641|P5|Overall Study|Death|0
1253206|NCT00555620|4108642|P4|Overall Study|Death|0
1253207|NCT00555620|4108643|P3|Overall Study|Death|0
1253208|NCT00555620|4108644|P2|Overall Study|Death|1
1253209|NCT00555620|4108645|P1|Overall Study|Death|0
1253210|NCT00555568|4108769|P3|Overall Study|Lost to Follow-up|16
1253211|NCT00555568|4108770|P2|Overall Study|Lost to Follow-up|16
1253212|NCT00555568|4108771|P1|Overall Study|Lost to Follow-up|26
1253213|NCT00555477|4108793|P2|Overall Study|Physician Decision|2
1253214|NCT00555477|4108794|P1|Overall Study|Physician Decision|1
1253215|NCT00555477|4108793|P2|Overall Study|Withdrawal by Subject|2
1253216|NCT00555477|4108794|P1|Overall Study|Withdrawal by Subject|1
1253217|NCT00555477|4108793|P2|Overall Study|Adverse Event|9
1253218|NCT00555477|4108794|P1|Overall Study|Adverse Event|0
1253219|NCT00555438|4108810|P1|Between 10 Days and 30 Days Postoperativ|Death|5
1253220|NCT00555438|4108810|P1|10 Days Post-operative|Death|4
1253221|NCT00555425|4108820|P2|Overall Study|Became pregnant and transferred care|1
1253222|NCT00555425|4108821|P1|Overall Study|Became pregnant and transferred care|0
1253223|NCT00555425|4108820|P2|Overall Study|Met criteria for protective transfer|3
1253224|NCT00555425|4108821|P1|Overall Study|Met criteria for protective transfer|16
1253225|NCT00555425|4108820|P2|Overall Study|Missed 3 physician management visits|0
1253226|NCT00555425|4108821|P1|Overall Study|Missed 3 physician management visits|1
1253227|NCT00555425|4108820|P2|Overall Study|Missed Medication > 1 wk|15
1253228|NCT00555425|4108821|P1|Overall Study|Missed Medication > 1 wk|34
1253229|NCT00555321|4108857|P5|Long-term Extension Phase|Other Reason|0
1253230|NCT00555321|4108858|P4|Long-term Extension Phase|Other Reason|0
1253231|NCT00555321|4108859|P3|Long-term Extension Phase|Other Reason|2
1253232|NCT00555321|4108860|P2|Long-term Extension Phase|Other Reason|0
1253233|NCT00555321|4108861|P1|Long-term Extension Phase|Other Reason|1
1253234|NCT00555321|4108857|P5|Long-term Extension Phase|Participant did not meet study criteria|1
1253235|NCT00555321|4108858|P4|Long-term Extension Phase|Participant did not meet study criteria|0
1253236|NCT00555321|4108859|P3|Long-term Extension Phase|Participant did not meet study criteria|0
1253237|NCT00555321|4108860|P2|Long-term Extension Phase|Participant did not meet study criteria|0
1253238|NCT00555321|4108861|P1|Long-term Extension Phase|Participant did not meet study criteria|0
1253239|NCT00555321|4108857|P5|Long-term Extension Phase|Death|0
1253240|NCT00555321|4108858|P4|Long-term Extension Phase|Death|3
1253241|NCT00555321|4108859|P3|Long-term Extension Phase|Death|0
1253242|NCT00555321|4108860|P2|Long-term Extension Phase|Death|0
1253243|NCT00555321|4108861|P1|Long-term Extension Phase|Death|2
1253244|NCT00555321|4108857|P5|Long-term Extension Phase|Administrative reason by sponsor|23
1253245|NCT00555321|4108858|P4|Long-term Extension Phase|Administrative reason by sponsor|31
1253246|NCT00555321|4108859|P3|Long-term Extension Phase|Administrative reason by sponsor|18
1253247|NCT00555321|4108860|P2|Long-term Extension Phase|Administrative reason by sponsor|21
1253248|NCT00555321|4108861|P1|Long-term Extension Phase|Administrative reason by sponsor|23
1253249|NCT00555321|4108857|P5|Long-term Extension Phase|Withdrawal by Subject|2
1253250|NCT00555321|4108858|P4|Long-term Extension Phase|Withdrawal by Subject|3
1253251|NCT00555321|4108859|P3|Long-term Extension Phase|Withdrawal by Subject|2
1253252|NCT00555321|4108860|P2|Long-term Extension Phase|Withdrawal by Subject|1
1253253|NCT00555321|4108861|P1|Long-term Extension Phase|Withdrawal by Subject|2
1253254|NCT00555321|4108857|P5|Long-term Extension Phase|Adverse Event|0
1253255|NCT00555321|4108858|P4|Long-term Extension Phase|Adverse Event|1
1253256|NCT00555321|4108859|P3|Long-term Extension Phase|Adverse Event|2
1253257|NCT00555321|4108860|P2|Long-term Extension Phase|Adverse Event|5
1253258|NCT00555321|4108861|P1|Long-term Extension Phase|Adverse Event|2
1253259|NCT00555321|4108857|P5|Treatment Phase up to 12-months|Never treated|4
1253260|NCT00555321|4108858|P4|Treatment Phase up to 12-months|Never treated|0
1253261|NCT00555321|4108859|P3|Treatment Phase up to 12-months|Never treated|1
1253262|NCT00555321|4108860|P2|Treatment Phase up to 12-months|Never treated|3
1253263|NCT00555321|4108861|P1|Treatment Phase up to 12-months|Never treated|2
1253264|NCT00555321|4108857|P5|Treatment Phase up to 12-months|Other Reason|0
1253265|NCT00555321|4108858|P4|Treatment Phase up to 12-months|Other Reason|0
1253266|NCT00555321|4108859|P3|Treatment Phase up to 12-months|Other Reason|2
1253267|NCT00555321|4108860|P2|Treatment Phase up to 12-months|Other Reason|3
1253268|NCT00555321|4108861|P1|Treatment Phase up to 12-months|Other Reason|1
1253269|NCT00555321|4108857|P5|Treatment Phase up to 12-months|Lack of Efficacy|0
1253270|NCT00555321|4108858|P4|Treatment Phase up to 12-months|Lack of Efficacy|0
1253271|NCT00555321|4108859|P3|Treatment Phase up to 12-months|Lack of Efficacy|5
1253272|NCT00555321|4108860|P2|Treatment Phase up to 12-months|Lack of Efficacy|8
1253273|NCT00555321|4108861|P1|Treatment Phase up to 12-months|Lack of Efficacy|9
1253274|NCT00555321|4108857|P5|Treatment Phase up to 12-months|Death|0
1253275|NCT00555321|4108858|P4|Treatment Phase up to 12-months|Death|0
1253276|NCT00555321|4108859|P3|Treatment Phase up to 12-months|Death|4
1253277|NCT00555321|4108860|P2|Treatment Phase up to 12-months|Death|1
1253278|NCT00555321|4108861|P1|Treatment Phase up to 12-months|Death|2
1253279|NCT00555321|4108857|P5|Treatment Phase up to 12-months|Withdrawal by Subject|0
1253280|NCT00555321|4108858|P4|Treatment Phase up to 12-months|Withdrawal by Subject|0
1253281|NCT00555321|4108859|P3|Treatment Phase up to 12-months|Withdrawal by Subject|1
1253282|NCT00555321|4108860|P2|Treatment Phase up to 12-months|Withdrawal by Subject|0
1253283|NCT00555321|4108861|P1|Treatment Phase up to 12-months|Withdrawal by Subject|1
1253284|NCT00555321|4108857|P5|Treatment Phase up to 12-months|Adverse Event|18
1253285|NCT00555321|4108858|P4|Treatment Phase up to 12-months|Adverse Event|7
1253286|NCT00555321|4108859|P3|Treatment Phase up to 12-months|Adverse Event|11
1253287|NCT00555321|4108860|P2|Treatment Phase up to 12-months|Adverse Event|7
1253288|NCT00555321|4108861|P1|Treatment Phase up to 12-months|Adverse Event|6
1253289|NCT00555217|4109165|P2|Overall Study|close out sites|17
1253290|NCT00555217|4109166|P1|Overall Study|close out sites|21
1253291|NCT00555217|4109165|P2|Overall Study|Lost to Follow-up|20
1253292|NCT00555217|4109166|P1|Overall Study|Lost to Follow-up|19
1253293|NCT00555217|4109165|P2|Overall Study|Withdrawal by Subject|31
1253294|NCT00555217|4109166|P1|Overall Study|Withdrawal by Subject|35
1253295|NCT00555061|4109203|P1|Overall Study|Participant enrolled, but never treated|1
1253296|NCT00555061|4109203|P1|Overall Study|Withdrawal by Subject|2
1253297|NCT00555061|4109203|P1|Overall Study|Lost to Follow-up|2
1253298|NCT00555061|4109203|P1|Overall Study|Protocol Violation|1
1253299|NCT00555061|4109203|P1|Overall Study|Adverse Event|3
1253300|NCT00555009|4109222|P2|Overall Study|Terminated by Sponsor|5
1253301|NCT00555009|4109223|P1|Overall Study|Terminated by Sponsor|2
1253302|NCT00555009|4109222|P2|Overall Study|Withdrawal by Subject|1
1253303|NCT00555009|4109223|P1|Overall Study|Withdrawal by Subject|0
1253304|NCT00554840|4109303|P2|Overall Study|Physician Decision|1
1253305|NCT00554840|4109304|P1|Overall Study|Physician Decision|0
1253306|NCT00554801|4109322|P2|Overall Study|Withdrawal by Subject|0
1253307|NCT00554801|4109323|P1|Overall Study|Withdrawal by Subject|14
1253308|NCT00554801|4109322|P2|Overall Study|left area before completion|0
1253309|NCT00554801|4109323|P1|Overall Study|left area before completion|5
1253310|NCT00554619|4109351|P1|Overall Study|Liver Function Test Abnormality|1
1253311|NCT00554619|4109351|P1|Overall Study|Physician Decision|1
1253312|NCT00554619|4109351|P1|Overall Study|Adverse Event|1
1253313|NCT00554515|4109363|P1|Overall Study|Misc|15
1253314|NCT00554515|4109363|P1|Overall Study|Other|1
1253315|NCT00554515|4109363|P1|Overall Study|Achieved Stable Disease|7
1253316|NCT00554515|4109363|P1|Overall Study|Death|2
1253317|NCT00554515|4109363|P1|Overall Study|Adverse Event|9
1253318|NCT00554515|4109363|P1|Overall Study|Withdrawal by Subject|11
1253319|NCT00554515|4109363|P1|Overall Study|Physician Decision|18
1253320|NCT00554515|4109363|P1|Overall Study|Disease progression|52
1253321|NCT00554515|4109363|P1|Overall Study|Withdrawal by Subject|3
1253322|NCT00554229|4109420|P2|Overall Study|Randomised but no treatment received|0
1253323|NCT00554229|4109421|P1|Overall Study|Randomised but no treatment received|1
1253324|NCT00554229|4109420|P2|Overall Study|Reason not otherwise captured, eg; death|140
1253325|NCT00554229|4109421|P1|Overall Study|Reason not otherwise captured, eg; death|119
1253326|NCT00554229|4109420|P2|Overall Study|Protocol Violation|3
1253327|NCT00554229|4109421|P1|Overall Study|Protocol Violation|3
1253328|NCT00554229|4109420|P2|Overall Study|Adverse Event|39
1253329|NCT00554229|4109421|P1|Overall Study|Adverse Event|71
1253330|NCT00554229|4109420|P2|Overall Study|Withdrawal by Subject|37
1253331|NCT00554229|4109421|P1|Overall Study|Withdrawal by Subject|29
1253332|NCT00554229|4109420|P2|Overall Study|Lost to Follow-up|6
1253333|NCT00554229|4109421|P1|Overall Study|Lost to Follow-up|3
1253334|NCT00554216|4109446|P3|Overall Study|Lack of Efficacy|0
1253335|NCT00554216|4109447|P2|Overall Study|Lack of Efficacy|3
1253336|NCT00554216|4109448|P1|Overall Study|Lack of Efficacy|15
1253337|NCT00554216|4109446|P3|Overall Study|not specified|10
1253338|NCT00554216|4109447|P2|Overall Study|not specified|7
1253339|NCT00554216|4109448|P1|Overall Study|not specified|12
1253340|NCT00554216|4109446|P3|Overall Study|Restricted med|1
1253341|NCT00554216|4109447|P2|Overall Study|Restricted med|1
1253342|NCT00554216|4109448|P1|Overall Study|Restricted med|3
1253343|NCT00554216|4109446|P3|Overall Study|Pregnancy|14
1253344|NCT00554216|4109447|P2|Overall Study|Pregnancy|1
1253345|NCT00554216|4109448|P1|Overall Study|Pregnancy|2
1253346|NCT00554216|4109446|P3|Overall Study|Non compliance|5
1253347|NCT00554216|4109447|P2|Overall Study|Non compliance|4
1253348|NCT00554216|4109448|P1|Overall Study|Non compliance|10
1253349|NCT00554216|4109446|P3|Overall Study|Withdrawal by Subject|43
1253350|NCT00554216|4109447|P2|Overall Study|Withdrawal by Subject|31
1253351|NCT00554216|4109448|P1|Overall Study|Withdrawal by Subject|92
1253352|NCT00554216|4109446|P3|Overall Study|Adverse Event|36
1253353|NCT00554216|4109447|P2|Overall Study|Adverse Event|16
1253354|NCT00554216|4109448|P1|Overall Study|Adverse Event|16
1253355|NCT00554216|4109446|P3|Overall Study|Lost to Follow-up|63
1253356|NCT00554216|4109447|P2|Overall Study|Lost to Follow-up|31
1253357|NCT00554216|4109448|P1|Overall Study|Lost to Follow-up|92
1253358|NCT00554190|4109459|P1|Overall Study|Termination forms not completed|10
1253359|NCT00554099|4109468|P3|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
1253360|NCT00554099|4109469|P2|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
1253361|NCT00554099|4109470|P1|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4
1253362|NCT00554099|4109468|P3|Non-Treatment Phase (9 Months)|Relapse|1
1253363|NCT00554099|4109469|P2|Non-Treatment Phase (9 Months)|Relapse|1
1253364|NCT00554099|4109470|P1|Non-Treatment Phase (9 Months)|Relapse|2
1253365|NCT00554099|4109468|P3|Non-Treatment Phase (9 Months)|Lost to Follow-up|0
1253366|NCT00554099|4109469|P2|Non-Treatment Phase (9 Months)|Lost to Follow-up|2
1253367|NCT00554099|4109470|P1|Non-Treatment Phase (9 Months)|Lost to Follow-up|1
1253368|NCT00554099|4109468|P3|Treatment Period (12 Weeks)|Withdrawal by Subject|4
1253369|NCT00554099|4109469|P2|Treatment Period (12 Weeks)|Withdrawal by Subject|1
1253370|NCT00554099|4109470|P1|Treatment Period (12 Weeks)|Withdrawal by Subject|4
1253371|NCT00554099|4109468|P3|Treatment Period (12 Weeks)|Protocol Violation|2
1253372|NCT00554099|4109469|P2|Treatment Period (12 Weeks)|Protocol Violation|0
1253373|NCT00554099|4109470|P1|Treatment Period (12 Weeks)|Protocol Violation|0
1253374|NCT00554099|4109468|P3|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0
1253375|NCT00554099|4109469|P2|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2
1253376|NCT00554099|4109470|P1|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1
1253377|NCT00554099|4109468|P3|Treatment Period (12 Weeks)|Lost to Follow-up|2
1253378|NCT00554099|4109469|P2|Treatment Period (12 Weeks)|Lost to Follow-up|0
1253379|NCT00554099|4109470|P1|Treatment Period (12 Weeks)|Lost to Follow-up|1
1253380|NCT00554099|4109468|P3|Treatment Period (12 Weeks)|Physician Decision|0
1253381|NCT00554099|4109469|P2|Treatment Period (12 Weeks)|Physician Decision|0
1253382|NCT00554099|4109470|P1|Treatment Period (12 Weeks)|Physician Decision|3
1253383|NCT00554099|4109468|P3|Treatment Period (12 Weeks)|Adverse Event|1
1253384|NCT00554099|4109469|P2|Treatment Period (12 Weeks)|Adverse Event|5
1253385|NCT00554099|4109470|P1|Treatment Period (12 Weeks)|Adverse Event|3
1253386|NCT00553787|4109525|P3|Overall Study|not specified|13
1253387|NCT00553787|4109526|P2|Overall Study|not specified|10
1253388|NCT00553787|4109527|P1|Overall Study|not specified|18
1253389|NCT00553787|4109525|P3|Overall Study|Requirement for restricted medication|5
1253390|NCT00553787|4109526|P2|Overall Study|Requirement for restricted medication|7
1253391|NCT00553787|4109527|P1|Overall Study|Requirement for restricted medication|8
1253392|NCT00553787|4109525|P3|Overall Study|non compliance|11
1253393|NCT00553787|4109526|P2|Overall Study|non compliance|0
1253394|NCT00553787|4109527|P1|Overall Study|non compliance|4
1253395|NCT00553787|4109525|P3|Overall Study|Pregnancy|2
1253396|NCT00553787|4109526|P2|Overall Study|Pregnancy|1
1253397|NCT00553787|4109527|P1|Overall Study|Pregnancy|0
1253398|NCT00553787|4109525|P3|Overall Study|Lack of Efficacy|3
1253399|NCT00553787|4109526|P2|Overall Study|Lack of Efficacy|1
1253400|NCT00553787|4109527|P1|Overall Study|Lack of Efficacy|31
1253401|NCT00553787|4109525|P3|Overall Study|Withdrawal by Subject|83
1253402|NCT00553787|4109526|P2|Overall Study|Withdrawal by Subject|40
1253403|NCT00553787|4109527|P1|Overall Study|Withdrawal by Subject|151
1253404|NCT00553787|4109525|P3|Overall Study|Lost to Follow-up|78
1253405|NCT00553787|4109526|P2|Overall Study|Lost to Follow-up|44
1253406|NCT00553787|4109527|P1|Overall Study|Lost to Follow-up|132
1253407|NCT00553787|4109525|P3|Overall Study|Adverse Event|67
1253408|NCT00553787|4109526|P2|Overall Study|Adverse Event|21
1253409|NCT00553787|4109527|P1|Overall Study|Adverse Event|34
1253410|NCT00553696|4109559|P4|Overall Study|Withdrawal by Subject|0
1253411|NCT00553696|4109560|P3|Overall Study|Withdrawal by Subject|0
1253412|NCT00553696|4109561|P2|Overall Study|Withdrawal by Subject|1
1253413|NCT00553696|4109562|P1|Overall Study|Withdrawal by Subject|0
1253414|NCT00553696|4109559|P4|Overall Study|Objective progression or relapse|0
1253415|NCT00553696|4109560|P3|Overall Study|Objective progression or relapse|6
1253416|NCT00553696|4109561|P2|Overall Study|Objective progression or relapse|9
1253417|NCT00553696|4109562|P1|Overall Study|Objective progression or relapse|2
1253418|NCT00553696|4109559|P4|Overall Study|Global deterioration of health status|0
1253419|NCT00553696|4109560|P3|Overall Study|Global deterioration of health status|0
1253420|NCT00553696|4109561|P2|Overall Study|Global deterioration of health status|2
1253421|NCT00553696|4109562|P1|Overall Study|Global deterioration of health status|0
1253422|NCT00553696|4109559|P4|Overall Study|Adverse Event|1
1253423|NCT00553696|4109560|P3|Overall Study|Adverse Event|0
1253424|NCT00553696|4109561|P2|Overall Study|Adverse Event|4
1253425|NCT00553696|4109562|P1|Overall Study|Adverse Event|2
1253426|NCT00553644|4109600|P1|Overall Study|Alternative therapy|6
1253427|NCT00553644|4109600|P1|Overall Study|Physician Decision|1
1253428|NCT00553644|4109600|P1|Overall Study|Withdrawal by Subject|4
1253429|NCT00553644|4109600|P1|Overall Study|Adverse Event|17
1253430|NCT00553631|4109609|P2|Overall Study|Lost to Follow-up|0
1253431|NCT00553631|4109610|P1|Overall Study|Lost to Follow-up|1
1253432|NCT00553631|4109609|P2|Overall Study|Withdrawal by Subject|1
1253433|NCT00553631|4109610|P1|Overall Study|Withdrawal by Subject|0
1253434|NCT00553605|4109632|P2|Overall Study|Randomized but not treated|0
1253435|NCT00553605|4109633|P1|Overall Study|Randomized but not treated|2
1253436|NCT00553605|4109632|P2|Overall Study|Did not receive full dose|0
1253437|NCT00553605|4109633|P1|Overall Study|Did not receive full dose|1
1253438|NCT00553605|4109632|P2|Overall Study|Did not meet entrance criteria|3
1253439|NCT00553605|4109633|P1|Overall Study|Did not meet entrance criteria|1
1253440|NCT00553514|4109662|P5|Overall Study|Other|1
1253441|NCT00553514|4109663|P4|Overall Study|Other|0
1253442|NCT00553514|4109664|P3|Overall Study|Other|0
1253443|NCT00553514|4109665|P2|Overall Study|Other|1
1253444|NCT00553514|4109666|P1|Overall Study|Other|1
1253445|NCT00553514|4109662|P5|Overall Study|Risk of multiple pregnancy|0
1253446|NCT00553514|4109663|P4|Overall Study|Risk of multiple pregnancy|1
1253447|NCT00553514|4109664|P3|Overall Study|Risk of multiple pregnancy|0
1253448|NCT00553514|4109665|P2|Overall Study|Risk of multiple pregnancy|2
1253449|NCT00553514|4109666|P1|Overall Study|Risk of multiple pregnancy|0
1253450|NCT00553514|4109662|P5|Overall Study|Ovarian hyperstimulation syndrome risk|0
1253451|NCT00553514|4109663|P4|Overall Study|Ovarian hyperstimulation syndrome risk|0
1253452|NCT00553514|4109664|P3|Overall Study|Ovarian hyperstimulation syndrome risk|1
1253453|NCT00553514|4109665|P2|Overall Study|Ovarian hyperstimulation syndrome risk|0
1253454|NCT00553514|4109666|P1|Overall Study|Ovarian hyperstimulation syndrome risk|3
1253455|NCT00553514|4109662|P5|Overall Study|Lack of ovarian response|6
1253456|NCT00553514|4109663|P4|Overall Study|Lack of ovarian response|5
1253457|NCT00553514|4109664|P3|Overall Study|Lack of ovarian response|5
1253458|NCT00553514|4109665|P2|Overall Study|Lack of ovarian response|5
1253459|NCT00553514|4109666|P1|Overall Study|Lack of ovarian response|4
1253460|NCT00553514|4109662|P5|Overall Study|Protocol deviation|0
1253461|NCT00553514|4109663|P4|Overall Study|Protocol deviation|1
1253462|NCT00553514|4109664|P3|Overall Study|Protocol deviation|0
1253463|NCT00553514|4109665|P2|Overall Study|Protocol deviation|0
1253464|NCT00553514|4109666|P1|Overall Study|Protocol deviation|0
1253465|NCT00553501|4109703|P1|Overall Study|Progression|1
1253466|NCT00553501|4109703|P1|Overall Study|Death|1
1253467|NCT00553501|4109703|P1|Overall Study|Adverse Event|2
1253468|NCT00553475|4109712|P3|Overall Study|Due to moving|0
1253469|NCT00553475|4109713|P2|Overall Study|Due to moving|1
1253470|NCT00553475|4109714|P1|Overall Study|Due to moving|0
1253471|NCT00553475|4109712|P3|Overall Study|Physician Decision|0
1253472|NCT00553475|4109713|P2|Overall Study|Physician Decision|0
1253473|NCT00553475|4109714|P1|Overall Study|Physician Decision|1
1253474|NCT00553475|4109712|P3|Overall Study|Withdrawal by Subject|0
1253475|NCT00553475|4109713|P2|Overall Study|Withdrawal by Subject|1
1253476|NCT00553475|4109714|P1|Overall Study|Withdrawal by Subject|1
1253477|NCT00553475|4109712|P3|Overall Study|Lack of Efficacy|0
1253478|NCT00553475|4109713|P2|Overall Study|Lack of Efficacy|1
1253479|NCT00553475|4109714|P1|Overall Study|Lack of Efficacy|7
1253480|NCT00553475|4109712|P3|Overall Study|Adverse Event|13
1253481|NCT00553475|4109713|P2|Overall Study|Adverse Event|17
1253482|NCT00553475|4109714|P1|Overall Study|Adverse Event|7
1253483|NCT00553462|4109836|P1|Overall Study|Physician Decision|1
1253484|NCT00553462|4109836|P1|Overall Study|Withdrawal by Subject|5
1253485|NCT00553462|4109836|P1|Overall Study|Progression|4
1253486|NCT00553462|4109836|P1|Overall Study|Adverse Event|4
1253487|NCT00553436|4109842|P1|Overall Study|Conversion to another procedure|1
1253488|NCT00553358|4109851|P3|Overall Study|Other: Reason Not Specified|20
1253489|NCT00553358|4109852|P2|Overall Study|Other: Reason Not Specified|4
1253490|NCT00553358|4109853|P1|Overall Study|Other: Reason Not Specified|15
1253491|NCT00553358|4109851|P3|Overall Study|Missing|1
1253492|NCT00553358|4109852|P2|Overall Study|Missing|1
1253493|NCT00553358|4109853|P1|Overall Study|Missing|1
1253494|NCT00553358|4109851|P3|Overall Study|Participant Withdrawal from Drug|3
1253495|NCT00553358|4109852|P2|Overall Study|Participant Withdrawal from Drug|0
1253496|NCT00553358|4109853|P1|Overall Study|Participant Withdrawal from Drug|0
1253497|NCT00553358|4109851|P3|Overall Study|Recurrence of Disease|1
1253498|NCT00553358|4109852|P2|Overall Study|Recurrence of Disease|4
1253499|NCT00553358|4109853|P1|Overall Study|Recurrence of Disease|3
1253500|NCT00553358|4109851|P3|Overall Study|Withdrawal by Subject|1
1253501|NCT00553358|4109852|P2|Overall Study|Withdrawal by Subject|0
1253502|NCT00553358|4109853|P1|Overall Study|Withdrawal by Subject|5
1253503|NCT00553358|4109851|P3|Overall Study|Protocol Violation|1
1253504|NCT00553358|4109852|P2|Overall Study|Protocol Violation|1
1253505|NCT00553358|4109853|P1|Overall Study|Protocol Violation|0
1253506|NCT00553358|4109851|P3|Overall Study|Lost to Follow-up|1
1253507|NCT00553358|4109852|P2|Overall Study|Lost to Follow-up|0
1253508|NCT00553358|4109853|P1|Overall Study|Lost to Follow-up|0
1253509|NCT00553358|4109851|P3|Overall Study|Adverse Event|32
1253510|NCT00553358|4109852|P2|Overall Study|Adverse Event|2
1253511|NCT00553358|4109853|P1|Overall Study|Adverse Event|29
1253512|NCT00553332|4109879|P1|Overall Study|ineligible, incorrect diagnosis|1
1253513|NCT00553319|4109891|P3|Overall Study|moved|1
1253514|NCT00553319|4109892|P2|Overall Study|moved|0
1253515|NCT00553319|4109893|P1|Overall Study|moved|1
1253516|NCT00553319|4109891|P3|Overall Study|incarceration|0
1253517|NCT00553319|4109892|P2|Overall Study|incarceration|0
1253518|NCT00553319|4109893|P1|Overall Study|incarceration|1
1253519|NCT00553319|4109891|P3|Overall Study|non-compliance|2
1253520|NCT00553319|4109892|P2|Overall Study|non-compliance|0
1253521|NCT00553319|4109893|P1|Overall Study|non-compliance|0
1253522|NCT00553319|4109891|P3|Overall Study|wanted treatment elsewhere|1
1253523|NCT00553319|4109892|P2|Overall Study|wanted treatment elsewhere|1
1253524|NCT00553319|4109893|P1|Overall Study|wanted treatment elsewhere|2
1253525|NCT00553319|4109891|P3|Overall Study|Lost to Follow-up|5
1253526|NCT00553319|4109892|P2|Overall Study|Lost to Follow-up|9
1253527|NCT00553319|4109893|P1|Overall Study|Lost to Follow-up|10
1253528|NCT00553280|4109904|P1|Overall Study|Physician Decision|1
1253529|NCT00553280|4109904|P1|Overall Study|Withdrawal by Subject|3
1253530|NCT00553280|4109904|P1|Overall Study|Lack of Efficacy|3
1253531|NCT00553280|4109904|P1|Overall Study|Adverse Event|19
1253532|NCT00553267|4109916|P3|Overall Study|Specified category|1
1253533|NCT00553267|4109917|P2|Overall Study|Specified category|2
1253534|NCT00553267|4109918|P1|Overall Study|Specified category|1
1253535|NCT00553267|4109916|P3|Overall Study|Consent withdrawn|1
1253536|NCT00553267|4109917|P2|Overall Study|Consent withdrawn|3
1253537|NCT00553267|4109918|P1|Overall Study|Consent withdrawn|2
1253538|NCT00553267|4109916|P3|Overall Study|Lost to Follow-up|1
1253539|NCT00553267|4109917|P2|Overall Study|Lost to Follow-up|0
1253540|NCT00553267|4109918|P1|Overall Study|Lost to Follow-up|0
1253541|NCT00553267|4109916|P3|Overall Study|Non compliant with protocol|2
1253542|NCT00553267|4109917|P2|Overall Study|Non compliant with protocol|3
1253543|NCT00553267|4109918|P1|Overall Study|Non compliant with protocol|3
1253544|NCT00553267|4109916|P3|Overall Study|Adverse Event|5
1253545|NCT00553267|4109917|P2|Overall Study|Adverse Event|10
1253546|NCT00553267|4109918|P1|Overall Study|Adverse Event|8
1253547|NCT00553202|4109953|P1|Overall Study|Fails to meet organ function|6
1253548|NCT00553202|4109953|P1|Overall Study|No donor identified|16
1253549|NCT00553202|4109953|P1|Overall Study|Withdrawal by Subject|1
1253550|NCT00553202|4109953|P1|Overall Study|Physician Decision|28
1253551|NCT00553202|4109953|P1|Overall Study|Lost to Follow-up|1
1253552|NCT00553202|4109953|P1|Overall Study|Death|16
1253553|NCT00553150|4109963|P4|Overall Study|Ineligible|1
1253554|NCT00553150|4109964|P3|Overall Study|Ineligible|0
1253555|NCT00553150|4109965|P2|Overall Study|Ineligible|0
1253556|NCT00553150|4109966|P1|Overall Study|Ineligible|0
1253557|NCT00553150|4109963|P4|Overall Study|Protocol Violation|1
1253558|NCT00553150|4109964|P3|Overall Study|Protocol Violation|0
1253559|NCT00553150|4109965|P2|Overall Study|Protocol Violation|0
1253560|NCT00553150|4109966|P1|Overall Study|Protocol Violation|0
1253561|NCT00553150|4109963|P4|Overall Study|Withdrawal by Subject|2
1253562|NCT00553150|4109964|P3|Overall Study|Withdrawal by Subject|0
1253563|NCT00553150|4109965|P2|Overall Study|Withdrawal by Subject|0
1253564|NCT00553150|4109966|P1|Overall Study|Withdrawal by Subject|0
1253565|NCT00552760|4110011|P2|Overall Study|Medication Change|0
1253566|NCT00552760|4110012|P1|Overall Study|Medication Change|1
1253567|NCT00552760|4110011|P2|Overall Study|Withdrawal by Subject|0
1253568|NCT00552760|4110012|P1|Overall Study|Withdrawal by Subject|3
1253569|NCT00552760|4110011|P2|Overall Study|Medical Condition|1
1253570|NCT00552760|4110012|P1|Overall Study|Medical Condition|1
1253571|NCT00552760|4110011|P2|Overall Study|Non-compliance|1
1253572|NCT00552760|4110012|P1|Overall Study|Non-compliance|1
1253573|NCT00552760|4110011|P2|Overall Study|Lost to Follow-up|1
1253574|NCT00552760|4110012|P1|Overall Study|Lost to Follow-up|1
1253575|NCT00552760|4110011|P2|Overall Study|Protocol Violation|1
1253576|NCT00552760|4110012|P1|Overall Study|Protocol Violation|0
1253577|NCT00552760|4110011|P2|Overall Study|Relapsed- Mixed Event|5
1253578|NCT00552760|4110012|P1|Overall Study|Relapsed- Mixed Event|3
1253579|NCT00552760|4110011|P2|Overall Study|Relapse- Manic Event|3
1253580|NCT00552760|4110012|P1|Overall Study|Relapse- Manic Event|3
1253581|NCT00552760|4110011|P2|Overall Study|Relapsed- Depressed Event|16
1253582|NCT00552760|4110012|P1|Overall Study|Relapsed- Depressed Event|10
1253583|NCT00552760|4110011|P2|Overall Study|Adverse Event|5
1253584|NCT00552760|4110012|P1|Overall Study|Adverse Event|3
1253585|NCT00552669|4110039|P2|Overall Study|Death|7
1253586|NCT00552669|4110040|P1|Overall Study|Death|3
1253587|NCT00552578|4110052|P2|Overall Study|Lost to Follow-up|1
1253588|NCT00552578|4110053|P1|Overall Study|Lost to Follow-up|1
1253589|NCT00552513|4110065|P2|Overall Study|Lost to Follow-up|1
1253590|NCT00552513|4110066|P1|Overall Study|Lost to Follow-up|5
1253591|NCT00552396|4110111|P7|Overall Study|protocol withdrawal criteria|9
1253592|NCT00552396|4110112|P6|Overall Study|protocol withdrawal criteria|3
1253593|NCT00552396|4110113|P5|Overall Study|protocol withdrawal criteria|3
1253594|NCT00552396|4110114|P4|Overall Study|protocol withdrawal criteria|6
1253595|NCT00552396|4110115|P3|Overall Study|protocol withdrawal criteria|3
1253596|NCT00552396|4110116|P2|Overall Study|protocol withdrawal criteria|3
1253597|NCT00552396|4110117|P1|Overall Study|protocol withdrawal criteria|3
1253598|NCT00552344|4110154|P1|Overall Study|Other Reason|22
1253599|NCT00552344|4110154|P1|Overall Study|SAE, fatal + AE, non-serious non-fatal|1
1253600|NCT00552344|4110154|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62
1253601|NCT00552344|4110154|P1|Overall Study|AE, non-serious non-fatal|38
1253602|NCT00552344|4110154|P1|Overall Study|SAE, non-fatal|6
1253603|NCT00552344|4110154|P1|Overall Study|Withdrawal by Subject|48
1253604|NCT00552344|4110154|P1|Overall Study|Lost to Follow-up|8
1253605|NCT00552344|4110154|P1|Overall Study|Loss of efficacy|75
1253606|NCT00552344|4110154|P1|Overall Study|Lack of Efficacy|55
1253607|NCT00552305|4110163|P1|Overall Study|Other: Subject went to rehab|1
1253608|NCT00552305|4110163|P1|Overall Study|Other: Subject incarcerated|1
1253609|NCT00552305|4110163|P1|Overall Study|Other: Subject moved from area|2
1253610|NCT00552305|4110163|P1|Overall Study|Other: Health problems, not drug related|1
1253611|NCT00552305|4110163|P1|Overall Study|Other: Subject became pregnant|1
1253612|NCT00552305|4110163|P1|Overall Study|Other: Subject underwent surgery|4
1253613|NCT00552305|4110163|P1|Overall Study|Other: Unable to attend visits|1
1253614|NCT00552305|4110163|P1|Overall Study|Other: Personal problems|1
1253615|NCT00552305|4110163|P1|Overall Study|Other: Site closed|4
1253616|NCT00552305|4110163|P1|Overall Study|LoE/WD consent/Other: cannot make visits|1
1253617|NCT00552305|4110163|P1|Overall Study|AE/Other: prohibited drug required|1
1253618|NCT00552305|4110163|P1|Overall Study|Poor compliance/lost to follow-up|1
1253619|NCT00552305|4110163|P1|Overall Study|Unsatisfactory compliance|11
1253620|NCT00552305|4110163|P1|Overall Study|Adverse event (AE)/withdrew (WD) consent|2
1253621|NCT00552305|4110163|P1|Overall Study|Lack of efficacy (LoE)/adverse event|3
1253622|NCT00552305|4110163|P1|Overall Study|Lack of efficacy/withdrew consent|1
1253623|NCT00552305|4110163|P1|Overall Study|Withdrawal by Subject|44
1253624|NCT00552305|4110163|P1|Overall Study|Protocol Violation|3
1253625|NCT00552305|4110163|P1|Overall Study|Lost to Follow-up|4
1253626|NCT00552305|4110163|P1|Overall Study|Lack of Efficacy|120
1253627|NCT00552305|4110163|P1|Overall Study|Adverse Event|43
1253628|NCT00552279|4110173|P2|Overall Study|Other|1
1253629|NCT00552279|4110174|P1|Overall Study|Other|1
1253630|NCT00552279|4110173|P2|Overall Study|Lost to Follow-up|0
1253631|NCT00552279|4110174|P1|Overall Study|Lost to Follow-up|1
1253632|NCT00552279|4110173|P2|Overall Study|Withdrawal by Subject|1
1253633|NCT00552279|4110174|P1|Overall Study|Withdrawal by Subject|12
1253634|NCT00552279|4110173|P2|Overall Study|Adverse Event|1
1253635|NCT00552279|4110174|P1|Overall Study|Adverse Event|0
1253636|NCT00552240|4110200|P2|Overall Study|not specified|0
1253637|NCT00552240|4110201|P1|Overall Study|not specified|1
1253638|NCT00552240|4110200|P2|Overall Study|Lack of Efficacy|0
1253639|NCT00552240|4110201|P1|Overall Study|Lack of Efficacy|6
1253640|NCT00552240|4110200|P2|Overall Study|Withdrawal by Subject|2
1253641|NCT00552240|4110201|P1|Overall Study|Withdrawal by Subject|2
1253642|NCT00552240|4110200|P2|Overall Study|Lost to Follow-up|6
1253643|NCT00552240|4110201|P1|Overall Study|Lost to Follow-up|5
1253644|NCT00552240|4110200|P2|Overall Study|Protocol Violation|1
1253645|NCT00552240|4110201|P1|Overall Study|Protocol Violation|1
1253646|NCT00552240|4110200|P2|Overall Study|Adverse Event|9
1253647|NCT00552240|4110201|P1|Overall Study|Adverse Event|9
1253648|NCT00552188|4110303|P2|Overall Study|Subject returned to home country|1
1253649|NCT00552188|4110304|P1|Overall Study|Subject returned to home country|0
1253650|NCT00552188|4110303|P2|Overall Study|Withdrawal of consent|1
1253651|NCT00552188|4110304|P1|Overall Study|Withdrawal of consent|0
1253652|NCT00552188|4110303|P2|Overall Study|Lost to Follow-up|1
1253653|NCT00552188|4110304|P1|Overall Study|Lost to Follow-up|2
1253654|NCT00552188|4110303|P2|Overall Study|Adverse Event|2
1253655|NCT00552188|4110304|P1|Overall Study|Adverse Event|0
1253656|NCT00552175|4110315|P3|Overall Study|Reason Not Specified|1
1253657|NCT00552175|4110316|P2|Overall Study|Reason Not Specified|1
1253658|NCT00552175|4110317|P1|Overall Study|Reason Not Specified|3
1253659|NCT00552175|4110315|P3|Overall Study|Entry Criteria Not Met|0
1253660|NCT00552175|4110316|P2|Overall Study|Entry Criteria Not Met|1
1253661|NCT00552175|4110317|P1|Overall Study|Entry Criteria Not Met|1
1253662|NCT00552175|4110315|P3|Overall Study|Lost to Follow-up|1
1253663|NCT00552175|4110316|P2|Overall Study|Lost to Follow-up|0
1253664|NCT00552175|4110317|P1|Overall Study|Lost to Follow-up|0
1253665|NCT00552175|4110315|P3|Overall Study|Withdrawal by Subject|1
1253666|NCT00552175|4110316|P2|Overall Study|Withdrawal by Subject|2
1253667|NCT00552175|4110317|P1|Overall Study|Withdrawal by Subject|2
1253668|NCT00552175|4110315|P3|Overall Study|Adverse Event|10
1253669|NCT00552175|4110316|P2|Overall Study|Adverse Event|9
1253670|NCT00552175|4110317|P1|Overall Study|Adverse Event|9
1253671|NCT00552175|4110315|P3|Overall Study|Lack of Efficacy|1
1253672|NCT00552175|4110316|P2|Overall Study|Lack of Efficacy|0
1253673|NCT00552175|4110317|P1|Overall Study|Lack of Efficacy|2
1253674|NCT00552110|4110357|P5|Overall Study|Nonserious Adverse Event (AE)|0
1253675|NCT00552110|4110358|P4|Overall Study|Nonserious Adverse Event (AE)|1
1253676|NCT00552110|4110359|P3|Overall Study|Nonserious Adverse Event (AE)|0
1253677|NCT00552110|4110360|P2|Overall Study|Nonserious Adverse Event (AE)|0
1253678|NCT00552110|4110361|P1|Overall Study|Nonserious Adverse Event (AE)|1
1253679|NCT00552110|4110357|P5|Overall Study|Increased Blood Pressure at Visit 2|0
1253680|NCT00552110|4110358|P4|Overall Study|Increased Blood Pressure at Visit 2|1
1253681|NCT00552110|4110359|P3|Overall Study|Increased Blood Pressure at Visit 2|0
1253682|NCT00552110|4110360|P2|Overall Study|Increased Blood Pressure at Visit 2|0
1253683|NCT00552110|4110361|P1|Overall Study|Increased Blood Pressure at Visit 2|0
1253684|NCT00552110|4110357|P5|Overall Study|Delay of Study due to Relabeling|0
1253685|NCT00552110|4110358|P4|Overall Study|Delay of Study due to Relabeling|1
1253686|NCT00552110|4110359|P3|Overall Study|Delay of Study due to Relabeling|0
1253687|NCT00552110|4110360|P2|Overall Study|Delay of Study due to Relabeling|0
1253688|NCT00552110|4110361|P1|Overall Study|Delay of Study due to Relabeling|0
1253689|NCT00552110|4110357|P5|Overall Study|Use of Prohibited Medication|0
1253690|NCT00552110|4110358|P4|Overall Study|Use of Prohibited Medication|0
1253691|NCT00552110|4110359|P3|Overall Study|Use of Prohibited Medication|0
1253692|NCT00552110|4110360|P2|Overall Study|Use of Prohibited Medication|1
1253693|NCT00552110|4110361|P1|Overall Study|Use of Prohibited Medication|1
1253694|NCT00552110|4110357|P5|Overall Study|Withdrawn per Sponsor|1
1253695|NCT00552110|4110358|P4|Overall Study|Withdrawn per Sponsor|0
1253696|NCT00552110|4110359|P3|Overall Study|Withdrawn per Sponsor|0
1253697|NCT00552110|4110360|P2|Overall Study|Withdrawn per Sponsor|1
1253698|NCT00552110|4110361|P1|Overall Study|Withdrawn per Sponsor|0
1253699|NCT00552110|4110357|P5|Overall Study|Failed to Comply With Study Requirements|1
1253700|NCT00552110|4110358|P4|Overall Study|Failed to Comply With Study Requirements|0
1253701|NCT00552110|4110359|P3|Overall Study|Failed to Comply With Study Requirements|1
1253702|NCT00552110|4110360|P2|Overall Study|Failed to Comply With Study Requirements|1
1253703|NCT00552110|4110361|P1|Overall Study|Failed to Comply With Study Requirements|1
1253704|NCT00552110|4110357|P5|Overall Study|Lost to Follow-up|1
1253705|NCT00552110|4110358|P4|Overall Study|Lost to Follow-up|1
1253706|NCT00552110|4110359|P3|Overall Study|Lost to Follow-up|0
1253707|NCT00552110|4110360|P2|Overall Study|Lost to Follow-up|0
1253708|NCT00552110|4110361|P1|Overall Study|Lost to Follow-up|0
1253709|NCT00552110|4110357|P5|Overall Study|Withdrawal by Subject|2
1253710|NCT00552110|4110358|P4|Overall Study|Withdrawal by Subject|3
1253711|NCT00552110|4110359|P3|Overall Study|Withdrawal by Subject|0
1253712|NCT00552110|4110360|P2|Overall Study|Withdrawal by Subject|2
1253713|NCT00552110|4110361|P1|Overall Study|Withdrawal by Subject|0
1253714|NCT00552110|4110357|P5|Overall Study|Lack of Efficacy|4
1253715|NCT00552110|4110358|P4|Overall Study|Lack of Efficacy|1
1253716|NCT00552110|4110359|P3|Overall Study|Lack of Efficacy|0
1253717|NCT00552110|4110360|P2|Overall Study|Lack of Efficacy|0
1253718|NCT00552110|4110361|P1|Overall Study|Lack of Efficacy|1
1253719|NCT00552110|4110357|P5|Overall Study|Serious or Life-Threatening AE|0
1253720|NCT00552110|4110358|P4|Overall Study|Serious or Life-Threatening AE|0
1253721|NCT00552110|4110359|P3|Overall Study|Serious or Life-Threatening AE|1
1253722|NCT00552110|4110360|P2|Overall Study|Serious or Life-Threatening AE|0
1253723|NCT00552110|4110361|P1|Overall Study|Serious or Life-Threatening AE|0
1253724|NCT00552084|4110380|P2|Overall Study|change in anti-arrythmic drug|1
1253725|NCT00552084|4110381|P1|Overall Study|change in anti-arrythmic drug|1
1253726|NCT00552084|4110380|P2|Overall Study|Protocol Violation|0
1253727|NCT00552084|4110381|P1|Overall Study|Protocol Violation|1
1253728|NCT00552084|4110380|P2|Overall Study|Withdrawal by Subject|5
1253729|NCT00552084|4110381|P1|Overall Study|Withdrawal by Subject|4
1253730|NCT00552084|4110380|P2|Overall Study|Adverse Event|3
1253731|NCT00552084|4110381|P1|Overall Study|Adverse Event|2
1253732|NCT00552071|4110389|P2|Overall Study|Withdrawal by Subject|1
1253733|NCT00552071|4110390|P1|Overall Study|Withdrawal by Subject|0
1253734|NCT00552071|4110389|P2|Overall Study|Death|1
1253735|NCT00552071|4110390|P1|Overall Study|Death|0
1253736|NCT00552071|4110389|P2|Overall Study|Pregnancy|0
1253737|NCT00552071|4110390|P1|Overall Study|Pregnancy|1
1253738|NCT00552071|4110389|P2|Overall Study|Physician Decision|0
1253739|NCT00552071|4110390|P1|Overall Study|Physician Decision|1
1253740|NCT00552071|4110389|P2|Overall Study|Lack of Efficacy|0
1253741|NCT00552071|4110390|P1|Overall Study|Lack of Efficacy|1
1253742|NCT00552071|4110389|P2|Overall Study|Adverse Event|0
1253743|NCT00552071|4110390|P1|Overall Study|Adverse Event|1
1253744|NCT00552058|4110400|P2|Overall Study|Other: Early Roll Over|0
1253745|NCT00552058|4110401|P1|Overall Study|Other: Early Roll Over|1
1253746|NCT00552058|4110400|P2|Overall Study|Other: Sponsors Decision|1
1253747|NCT00552058|4110401|P1|Overall Study|Other: Sponsors Decision|0
1253748|NCT00552058|4110400|P2|Overall Study|Other: Randomized in error|1
1253749|NCT00552058|4110401|P1|Overall Study|Other: Randomized in error|0
1253750|NCT00552058|4110400|P2|Overall Study|Other: Positive Stool Result|1
1253751|NCT00552058|4110401|P1|Overall Study|Other: Positive Stool Result|0
1253752|NCT00552058|4110400|P2|Overall Study|Other: Low CDAI score, entry violation|1
1253753|NCT00552058|4110401|P1|Overall Study|Other: Low CDAI score, entry violation|0
1253754|NCT00552058|4110400|P2|Overall Study|Other: Crossed Over to a Follow-up Study|1
1253755|NCT00552058|4110401|P1|Overall Study|Other: Crossed Over to a Follow-up Study|0
1253756|NCT00552058|4110400|P2|Overall Study|Other: Non Compliance|2
1253757|NCT00552058|4110401|P1|Overall Study|Other: Non Compliance|1
1253758|NCT00552058|4110400|P2|Overall Study|Other: Protocol Violation|1
1253759|NCT00552058|4110401|P1|Overall Study|Other: Protocol Violation|0
1253760|NCT00552058|4110400|P2|Overall Study|Withdrawal by Subject|4
1253761|NCT00552058|4110401|P1|Overall Study|Withdrawal by Subject|4
1253762|NCT00552058|4110400|P2|Overall Study|Lost to Follow-up|0
1253763|NCT00552058|4110401|P1|Overall Study|Lost to Follow-up|1
1253764|NCT00552058|4110400|P2|Overall Study|Lack of Efficacy|5
1253765|NCT00552058|4110401|P1|Overall Study|Lack of Efficacy|1
1253766|NCT00552058|4110400|P2|Overall Study|Adverse Event|7
1253767|NCT00552058|4110401|P1|Overall Study|Adverse Event|8
1253768|NCT00552032|4110441|P2|Overall Study|Lost to Follow-up|5
1253769|NCT00552032|4110442|P1|Overall Study|Lost to Follow-up|8
1253770|NCT00552032|4110441|P2|Overall Study|Protocol Violation|12
1253771|NCT00552032|4110442|P1|Overall Study|Protocol Violation|7
1253772|NCT00552032|4110441|P2|Overall Study|Withdrawal by Subject|2
1253773|NCT00552032|4110442|P1|Overall Study|Withdrawal by Subject|2
1253774|NCT00551759|4110486|P1|Overall Study|Ineligible|1
1253775|NCT00551759|4110486|P1|Overall Study|Death|5
1253776|NCT00551759|4110486|P1|Overall Study|Adverse Event|7
1253777|NCT00551642|4110527|P2|Overall Study|Inclusion/Exclusion criteria|4
1253778|NCT00551642|4110528|P1|Overall Study|Inclusion/Exclusion criteria|4
1253779|NCT00551642|4110527|P2|Overall Study|Delivery device failure|3
1253780|NCT00551642|4110528|P1|Overall Study|Delivery device failure|1
1253781|NCT00551642|4110527|P2|Overall Study|Physician Decision|1
1253782|NCT00551642|4110528|P1|Overall Study|Physician Decision|0
1253783|NCT00551642|4110527|P2|Overall Study|Protocol Violation|11
1253784|NCT00551642|4110528|P1|Overall Study|Protocol Violation|6
1253785|NCT00551642|4110527|P2|Overall Study|Death|31
1253786|NCT00551642|4110528|P1|Overall Study|Death|33
1253787|NCT00551642|4110527|P2|Overall Study|Adverse Event|12
1253788|NCT00551642|4110528|P1|Overall Study|Adverse Event|15
1253789|NCT00551642|4110527|P2|Overall Study|Withdrawal by Subject|1
1253790|NCT00551642|4110528|P1|Overall Study|Withdrawal by Subject|2
1253791|NCT00551525|4110534|P1|Overall Study|Protocol Violation|5
1253792|NCT00551460|4110543|P1|Overall Study|Not analyzable (did not start treatment)|4
1253793|NCT00551460|4110543|P1|Overall Study|Ineligible|4
1253794|NCT00551460|4110543|P1|Overall Study|Death|7
1253795|NCT00551460|4110543|P1|Overall Study|Physician Decision|1
1253796|NCT00551460|4110543|P1|Overall Study|Withdrawal by Subject|1
1253797|NCT00551460|4110543|P1|Overall Study|Adverse Event|1
1253798|NCT00551421|4110549|P1|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1
1253799|NCT00551369|4110556|P1|Overall Study|Not treated per protocol and re|1
1253800|NCT00551369|4110556|P1|Overall Study|Withdrawal by Subject|1
1253801|NCT00551369|4110556|P1|Overall Study|Protocol Violation|5
1253802|NCT00551291|4110564|P1|Overall Study|Physician Decision|1
1253803|NCT00551213|4110572|P2|Overall Study|Not Treated|2
1253804|NCT00551213|4110573|P1|Overall Study|Not Treated|1
1253805|NCT00551213|4110572|P2|Overall Study|Withdrawal by Subject|0
1253806|NCT00551213|4110573|P1|Overall Study|Withdrawal by Subject|2
1253807|NCT00551213|4110572|P2|Overall Study|Progressive Disease|12
1253808|NCT00551213|4110573|P1|Overall Study|Progressive Disease|41
1253809|NCT00551213|4110572|P2|Overall Study|Adverse Event|3
1253810|NCT00551213|4110573|P1|Overall Study|Adverse Event|6
1253811|NCT00551161|4110617|P1|Overall Study|Withdrawal by Subject|1
1253812|NCT00551135|4110625|P4|Overall Study|Withdrawal by Subject|1
1253813|NCT00551135|4110626|P3|Overall Study|Withdrawal by Subject|3
1253814|NCT00551135|4110627|P2|Overall Study|Withdrawal by Subject|0
1253815|NCT00551135|4110628|P1|Overall Study|Withdrawal by Subject|1
1253816|NCT00551135|4110625|P4|Overall Study|Other|2
1253817|NCT00551135|4110626|P3|Overall Study|Other|1
1253818|NCT00551135|4110627|P2|Overall Study|Other|2
1253819|NCT00551135|4110628|P1|Overall Study|Other|3
1253820|NCT00551135|4110625|P4|Overall Study|Lost to Follow-up|1
1253821|NCT00551135|4110626|P3|Overall Study|Lost to Follow-up|0
1253822|NCT00551135|4110627|P2|Overall Study|Lost to Follow-up|0
1253823|NCT00551135|4110628|P1|Overall Study|Lost to Follow-up|0
1253824|NCT00551135|4110625|P4|Overall Study|Adverse Event|1
1253825|NCT00551135|4110626|P3|Overall Study|Adverse Event|1
1253826|NCT00551135|4110627|P2|Overall Study|Adverse Event|0
1253827|NCT00551135|4110628|P1|Overall Study|Adverse Event|1
1253828|NCT00551031|4110757|P5|Overall Study|Did not receive vaccine|0
1253829|NCT00551031|4110758|P4|Overall Study|Did not receive vaccine|0
1253830|NCT00551031|4110759|P3|Overall Study|Did not receive vaccine|0
1253831|NCT00551031|4110760|P2|Overall Study|Did not receive vaccine|2
1253832|NCT00551031|4110761|P1|Overall Study|Did not receive vaccine|1
1253833|NCT00551031|4110757|P5|Overall Study|Serious Adverse Event|0
1253834|NCT00551031|4110758|P4|Overall Study|Serious Adverse Event|0
1253835|NCT00551031|4110759|P3|Overall Study|Serious Adverse Event|1
1253836|NCT00551031|4110760|P2|Overall Study|Serious Adverse Event|2
1253837|NCT00551031|4110761|P1|Overall Study|Serious Adverse Event|0
1253838|NCT00551031|4110757|P5|Overall Study|Withdrawal by Subject|0
1253839|NCT00551031|4110758|P4|Overall Study|Withdrawal by Subject|2
1253840|NCT00551031|4110759|P3|Overall Study|Withdrawal by Subject|1
1253841|NCT00551031|4110760|P2|Overall Study|Withdrawal by Subject|4
1253842|NCT00551031|4110761|P1|Overall Study|Withdrawal by Subject|0
1253843|NCT00551031|4110757|P5|Overall Study|Lost to Follow-up|1
1253844|NCT00551031|4110758|P4|Overall Study|Lost to Follow-up|1
1253845|NCT00551031|4110759|P3|Overall Study|Lost to Follow-up|0
1253846|NCT00551031|4110760|P2|Overall Study|Lost to Follow-up|1
1253847|NCT00551031|4110761|P1|Overall Study|Lost to Follow-up|0
1253848|NCT00551031|4110757|P5|Overall Study|Protocol Violation|0
1253849|NCT00551031|4110758|P4|Overall Study|Protocol Violation|0
1253850|NCT00551031|4110759|P3|Overall Study|Protocol Violation|0
1253851|NCT00551031|4110760|P2|Overall Study|Protocol Violation|1
1253852|NCT00551031|4110761|P1|Overall Study|Protocol Violation|1
1253853|NCT00551031|4110757|P5|Overall Study|Adverse Event|0
1253854|NCT00551031|4110758|P4|Overall Study|Adverse Event|0
1253855|NCT00551031|4110759|P3|Overall Study|Adverse Event|0
1253856|NCT00551031|4110760|P2|Overall Study|Adverse Event|1
1253857|NCT00551031|4110761|P1|Overall Study|Adverse Event|0
1253858|NCT00550953|4110790|P2|Overall Study|Not able to visit the site|3
1253859|NCT00550953|4110791|P1|Overall Study|Not able to visit the site|2
1253860|NCT00550953|4110790|P2|Overall Study|Adverse Event|3
1253861|NCT00550953|4110791|P1|Overall Study|Adverse Event|4
1253862|NCT00550836|4110838|P2|Overall Study|Withdrawal by Subject|9
1253863|NCT00550836|4110839|P1|Overall Study|Withdrawal by Subject|3
1253864|NCT00550771|4110855|P2|Overall Study|Protocol Violation|5
1253865|NCT00550771|4110856|P1|Overall Study|Protocol Violation|4
1253866|NCT00550771|4110855|P2|Overall Study|Withdrawal by Subject|1
1253867|NCT00550771|4110856|P1|Overall Study|Withdrawal by Subject|0
1253868|NCT00550771|4110855|P2|Overall Study|Physician Decision|0
1253869|NCT00550771|4110856|P1|Overall Study|Physician Decision|2
1253870|NCT00550771|4110855|P2|Overall Study|Discontinued for study-related reasons|1
1253871|NCT00550771|4110856|P1|Overall Study|Discontinued for study-related reasons|0
1253872|NCT00550771|4110855|P2|Overall Study|Adverse Event|3
1253873|NCT00550771|4110856|P1|Overall Study|Adverse Event|11
1253874|NCT00550745|4110870|P2|Overall Study|Screen failure|0
1253875|NCT00550745|4110871|P1|Overall Study|Screen failure|1
1253876|NCT00550745|4110870|P2|Overall Study|Withdrawal by Subject|10
1253877|NCT00550745|4110871|P1|Overall Study|Withdrawal by Subject|17
1253878|NCT00550745|4110870|P2|Overall Study|Protocol Violation|2
1253879|NCT00550745|4110871|P1|Overall Study|Protocol Violation|4
1253880|NCT00550745|4110870|P2|Overall Study|Physician Decision|2
1253881|NCT00550745|4110871|P1|Overall Study|Physician Decision|0
1253882|NCT00550745|4110870|P2|Overall Study|Lost to Follow-up|30
1253883|NCT00550745|4110871|P1|Overall Study|Lost to Follow-up|45
1253884|NCT00550745|4110870|P2|Overall Study|Death|16
1253885|NCT00550745|4110871|P1|Overall Study|Death|20
1253886|NCT00550732|4110879|P1|Overall Study|Adverse Event|1
1253887|NCT00550732|4110879|P1|Overall Study|Palliative care|1
1253888|NCT00550732|4110879|P1|Overall Study|Lost to Follow-up|1
1253889|NCT00550732|4110879|P1|Overall Study|Physician Decision|2
1253890|NCT00550732|4110879|P1|Overall Study|Withdrawal by Subject|2
1253891|NCT00550732|4110879|P1|Overall Study|Death|4
1253892|NCT00550680|4110890|P1|Overall Study|Screen Failure|6
1253893|NCT00550680|4110890|P1|Overall Study|Refused Treatment|19
1253894|NCT00550680|4110890|P1|Overall Study|Protocol Violation|7
1253895|NCT00550680|4110890|P1|Overall Study|Not Specified|10
1253896|NCT00550680|4110890|P1|Overall Study|Lack of Efficacy|1
1253897|NCT00550680|4110890|P1|Overall Study|Lost to Follow-up|3
1253898|NCT00550680|4110890|P1|Overall Study|Early Improvement|1
1253899|NCT00550680|4110890|P1|Overall Study|Death|3
1253900|NCT00550680|4110890|P1|Overall Study|Adverse Event|5
1253901|NCT00550680|4110890|P1|Overall Study|Administrative Reasons|1
1253902|NCT00550550|4110922|P2|Overall Study|Randomized But Not Treated|0
1253903|NCT00550550|4110923|P1|Overall Study|Randomized But Not Treated|1
1253904|NCT00550550|4110922|P2|Overall Study|Did Not Meet Protocol Eligibility|1
1253905|NCT00550550|4110923|P1|Overall Study|Did Not Meet Protocol Eligibility|1
1253906|NCT00550550|4110922|P2|Overall Study|Protocol Violation|14
1253907|NCT00550550|4110923|P1|Overall Study|Protocol Violation|5
1253908|NCT00550550|4110922|P2|Overall Study|Withdrawal by Subject|8
1253909|NCT00550550|4110923|P1|Overall Study|Withdrawal by Subject|10
1253910|NCT00550550|4110922|P2|Overall Study|Lost to Follow-up|0
1253911|NCT00550550|4110923|P1|Overall Study|Lost to Follow-up|4
1253912|NCT00550550|4110922|P2|Overall Study|Treatment Failure|1
1253913|NCT00550550|4110923|P1|Overall Study|Treatment Failure|0
1253914|NCT00550550|4110922|P2|Overall Study|Adverse Event|5
1253915|NCT00550550|4110923|P1|Overall Study|Adverse Event|13
1253916|NCT00550537|4110935|P1|Overall Study|Treated closer to home|4
1253917|NCT00550537|4110935|P1|Overall Study|Declining performance status|2
1253918|NCT00550537|4110935|P1|Overall Study|Other complicating ilness|3
1253919|NCT00550537|4110935|P1|Overall Study|Change in treatment plan|4
1253920|NCT00550537|4110935|P1|Overall Study|Withdrawal by Subject|7
1253921|NCT00550537|4110935|P1|Overall Study|Disease progression before|46
1253922|NCT00550537|4110935|P1|Overall Study|Adverse Event|20
1253923|NCT00550537|4110935|P1|Overall Study|Death|18
1253924|NCT00550459|4110952|P2|Overall Study|Withdrawal by Subject|1
1253925|NCT00550459|4110953|P1|Overall Study|Withdrawal by Subject|1
1253926|NCT00550459|4110952|P2|Overall Study|Adverse Event|2
1253927|NCT00550459|4110953|P1|Overall Study|Adverse Event|0
1253928|NCT00550446|4111022|P11|Post Week 12|Other|0
1253929|NCT00550446|4111023|P10|Post Week 12|Other|1
1253930|NCT00550446|4111024|P9|Post Week 12|Other|1
1253931|NCT00550446|4111025|P8|Post Week 12|Other|0
1253932|NCT00550446|4111026|P7|Post Week 12|Other|1
1253933|NCT00550446|4111027|P6|Post Week 12|Other|0
1253934|NCT00550446|4111028|P5|Post Week 12|Other|0
1253935|NCT00550446|4111029|P4|Post Week 12|Other|1
1253936|NCT00550446|4111030|P3|Post Week 12|Other|0
1253937|NCT00550446|4111031|P2|Post Week 12|Other|1
1253938|NCT00550446|4111032|P1|Post Week 12|Other|1
1253939|NCT00550446|4111022|P11|Post Week 12|Withdrawal by Subject|0
1253940|NCT00550446|4111023|P10|Post Week 12|Withdrawal by Subject|0
1253941|NCT00550446|4111024|P9|Post Week 12|Withdrawal by Subject|0
1253942|NCT00550446|4111025|P8|Post Week 12|Withdrawal by Subject|0
1253943|NCT00550446|4111026|P7|Post Week 12|Withdrawal by Subject|0
1253944|NCT00550446|4111027|P6|Post Week 12|Withdrawal by Subject|0
1253945|NCT00550446|4111028|P5|Post Week 12|Withdrawal by Subject|1
1253946|NCT00550446|4111029|P4|Post Week 12|Withdrawal by Subject|0
1253947|NCT00550446|4111030|P3|Post Week 12|Withdrawal by Subject|0
1253948|NCT00550446|4111031|P2|Post Week 12|Withdrawal by Subject|0
1253949|NCT00550446|4111032|P1|Post Week 12|Withdrawal by Subject|0
1253950|NCT00550446|4111022|P11|Post Week 12|Lost to Follow-up|0
1253951|NCT00550446|4111023|P10|Post Week 12|Lost to Follow-up|0
1253952|NCT00550446|4111024|P9|Post Week 12|Lost to Follow-up|0
1253953|NCT00550446|4111025|P8|Post Week 12|Lost to Follow-up|0
1253954|NCT00550446|4111026|P7|Post Week 12|Lost to Follow-up|1
1253955|NCT00550446|4111027|P6|Post Week 12|Lost to Follow-up|0
1253956|NCT00550446|4111028|P5|Post Week 12|Lost to Follow-up|0
1253957|NCT00550446|4111029|P4|Post Week 12|Lost to Follow-up|1
1253958|NCT00550446|4111030|P3|Post Week 12|Lost to Follow-up|1
1253959|NCT00550446|4111031|P2|Post Week 12|Lost to Follow-up|0
1253960|NCT00550446|4111032|P1|Post Week 12|Lost to Follow-up|0
1253961|NCT00550446|4111022|P11|Post Week 12|Lack of Efficacy|1
1253962|NCT00550446|4111023|P10|Post Week 12|Lack of Efficacy|2
1253963|NCT00550446|4111024|P9|Post Week 12|Lack of Efficacy|1
1253964|NCT00550446|4111025|P8|Post Week 12|Lack of Efficacy|1
1253965|NCT00550446|4111026|P7|Post Week 12|Lack of Efficacy|0
1253966|NCT00550446|4111027|P6|Post Week 12|Lack of Efficacy|0
1253967|NCT00550446|4111028|P5|Post Week 12|Lack of Efficacy|0
1253968|NCT00550446|4111029|P4|Post Week 12|Lack of Efficacy|0
1253969|NCT00550446|4111030|P3|Post Week 12|Lack of Efficacy|1
1253970|NCT00550446|4111031|P2|Post Week 12|Lack of Efficacy|0
1253971|NCT00550446|4111032|P1|Post Week 12|Lack of Efficacy|0
1253972|NCT00550446|4111022|P11|Post Week 12|Adverse Event|0
1253973|NCT00550446|4111023|P10|Post Week 12|Adverse Event|4
1253974|NCT00550446|4111024|P9|Post Week 12|Adverse Event|0
1253975|NCT00550446|4111025|P8|Post Week 12|Adverse Event|0
1253976|NCT00550446|4111026|P7|Post Week 12|Adverse Event|0
1253977|NCT00550446|4111027|P6|Post Week 12|Adverse Event|1
1253978|NCT00550446|4111028|P5|Post Week 12|Adverse Event|1
1253979|NCT00550446|4111029|P4|Post Week 12|Adverse Event|1
1253980|NCT00550446|4111030|P3|Post Week 12|Adverse Event|1
1253981|NCT00550446|4111031|P2|Post Week 12|Adverse Event|1
1253982|NCT00550446|4111032|P1|Post Week 12|Adverse Event|2
1253983|NCT00550446|4111022|P11|Up To Week 12|Randomized not treated|0
1253984|NCT00550446|4111023|P10|Up To Week 12|Randomized not treated|0
1253985|NCT00550446|4111024|P9|Up To Week 12|Randomized not treated|0
1253986|NCT00550446|4111025|P8|Up To Week 12|Randomized not treated|0
1253987|NCT00550446|4111026|P7|Up To Week 12|Randomized not treated|0
1253988|NCT00550446|4111027|P6|Up To Week 12|Randomized not treated|0
1253989|NCT00550446|4111028|P5|Up To Week 12|Randomized not treated|0
1253990|NCT00550446|4111029|P4|Up To Week 12|Randomized not treated|0
1253991|NCT00550446|4111030|P3|Up To Week 12|Randomized not treated|1
1253992|NCT00550446|4111031|P2|Up To Week 12|Randomized not treated|1
1253993|NCT00550446|4111032|P1|Up To Week 12|Randomized not treated|0
1253994|NCT00550446|4111022|P11|Up To Week 12|Other|0
1253995|NCT00550446|4111023|P10|Up To Week 12|Other|0
1253996|NCT00550446|4111024|P9|Up To Week 12|Other|0
1253997|NCT00550446|4111025|P8|Up To Week 12|Other|0
1253998|NCT00550446|4111026|P7|Up To Week 12|Other|4
1253999|NCT00550446|4111027|P6|Up To Week 12|Other|1
1254000|NCT00550446|4111028|P5|Up To Week 12|Other|0
1254001|NCT00550446|4111029|P4|Up To Week 12|Other|0
1254002|NCT00550446|4111030|P3|Up To Week 12|Other|0
1254003|NCT00550446|4111031|P2|Up To Week 12|Other|0
1254004|NCT00550446|4111032|P1|Up To Week 12|Other|3
1254005|NCT00550446|4111022|P11|Up To Week 12|Withdrawal by Subject|0
1254006|NCT00550446|4111023|P10|Up To Week 12|Withdrawal by Subject|0
1254007|NCT00550446|4111024|P9|Up To Week 12|Withdrawal by Subject|0
1254008|NCT00550446|4111025|P8|Up To Week 12|Withdrawal by Subject|0
1254009|NCT00550446|4111026|P7|Up To Week 12|Withdrawal by Subject|3
1254010|NCT00550446|4111027|P6|Up To Week 12|Withdrawal by Subject|1
1254011|NCT00550446|4111028|P5|Up To Week 12|Withdrawal by Subject|0
1254012|NCT00550446|4111029|P4|Up To Week 12|Withdrawal by Subject|2
1254013|NCT00550446|4111030|P3|Up To Week 12|Withdrawal by Subject|3
1254014|NCT00550446|4111031|P2|Up To Week 12|Withdrawal by Subject|0
1254015|NCT00550446|4111032|P1|Up To Week 12|Withdrawal by Subject|2
1254016|NCT00550446|4111022|P11|Up To Week 12|Lost to Follow-up|0
1254017|NCT00550446|4111023|P10|Up To Week 12|Lost to Follow-up|0
1254018|NCT00550446|4111024|P9|Up To Week 12|Lost to Follow-up|0
1254019|NCT00550446|4111025|P8|Up To Week 12|Lost to Follow-up|0
1254020|NCT00550446|4111026|P7|Up To Week 12|Lost to Follow-up|2
1254021|NCT00550446|4111027|P6|Up To Week 12|Lost to Follow-up|1
1254022|NCT00550446|4111028|P5|Up To Week 12|Lost to Follow-up|1
1254023|NCT00550446|4111029|P4|Up To Week 12|Lost to Follow-up|0
1254024|NCT00550446|4111030|P3|Up To Week 12|Lost to Follow-up|0
1254025|NCT00550446|4111031|P2|Up To Week 12|Lost to Follow-up|1
1254026|NCT00550446|4111032|P1|Up To Week 12|Lost to Follow-up|0
1254027|NCT00550446|4111022|P11|Up To Week 12|Lack of Efficacy|0
1254028|NCT00550446|4111023|P10|Up To Week 12|Lack of Efficacy|0
1254029|NCT00550446|4111024|P9|Up To Week 12|Lack of Efficacy|0
1254030|NCT00550446|4111025|P8|Up To Week 12|Lack of Efficacy|0
1254031|NCT00550446|4111026|P7|Up To Week 12|Lack of Efficacy|3
1254032|NCT00550446|4111027|P6|Up To Week 12|Lack of Efficacy|3
1254033|NCT00550446|4111028|P5|Up To Week 12|Lack of Efficacy|0
1254034|NCT00550446|4111029|P4|Up To Week 12|Lack of Efficacy|1
1254035|NCT00550446|4111030|P3|Up To Week 12|Lack of Efficacy|0
1254036|NCT00550446|4111031|P2|Up To Week 12|Lack of Efficacy|1
1254037|NCT00550446|4111032|P1|Up To Week 12|Lack of Efficacy|3
1254038|NCT00550446|4111022|P11|Up To Week 12|Adverse Event|0
1254039|NCT00550446|4111023|P10|Up To Week 12|Adverse Event|0
1254040|NCT00550446|4111024|P9|Up To Week 12|Adverse Event|0
1254041|NCT00550446|4111025|P8|Up To Week 12|Adverse Event|0
1254042|NCT00550446|4111026|P7|Up To Week 12|Adverse Event|1
1254043|NCT00550446|4111027|P6|Up To Week 12|Adverse Event|2
1254044|NCT00550446|4111028|P5|Up To Week 12|Adverse Event|2
1254045|NCT00550446|4111029|P4|Up To Week 12|Adverse Event|0
1254046|NCT00550446|4111030|P3|Up To Week 12|Adverse Event|0
1254047|NCT00550446|4111031|P2|Up To Week 12|Adverse Event|2
1254048|NCT00550446|4111032|P1|Up To Week 12|Adverse Event|2
1254049|NCT00550420|4111464|P1|Overall Study|Prohibited medicine|1
1254050|NCT00550420|4111464|P1|Overall Study|Exclusion criteria|1
1254051|NCT00550420|4111464|P1|Overall Study|Out of Electrocardiogram criteria|1
1254052|NCT00550420|4111464|P1|Overall Study|Caregiver's decision to withdraw|1
1254053|NCT00550420|4111464|P1|Overall Study|Unethical stop of enrollment|2
1254054|NCT00550420|4111464|P1|Overall Study|Lack of curative effect|1
1254055|NCT00550420|4111464|P1|Overall Study|Investigators opinion|1
1254056|NCT00550420|4111464|P1|Overall Study|Prolonged QT Interval Electrocardiogram|12
1254057|NCT00550420|4111464|P1|Overall Study|Missing|2
1254058|NCT00550420|4111464|P1|Overall Study|Still in study at termination|206
1254059|NCT00550420|4111464|P1|Overall Study|Withdrawal by Subject|30
1254060|NCT00550420|4111464|P1|Overall Study|Protocol Violation|11
1254061|NCT00550420|4111464|P1|Overall Study|Lost to Follow-up|8
1254062|NCT00550420|4111464|P1|Overall Study|Adverse Event|28
1254063|NCT00550407|4111487|P3|26-Week Randomized Phase|Withdrawal by Subject|3
1254064|NCT00550407|4111488|P2|26-Week Randomized Phase|Withdrawal by Subject|1
1254065|NCT00550407|4111489|P1|26-Week Randomized Phase|Withdrawal by Subject|0
1254066|NCT00550407|4111487|P3|26-Week Randomized Phase|Investigator Discretion|0
1254067|NCT00550407|4111488|P2|26-Week Randomized Phase|Investigator Discretion|1
1254068|NCT00550407|4111489|P1|26-Week Randomized Phase|Investigator Discretion|0
1254069|NCT00550407|4111487|P3|26-Week Randomized Phase|Lack of Efficacy|19
1254070|NCT00550407|4111488|P2|26-Week Randomized Phase|Lack of Efficacy|36
1254071|NCT00550407|4111489|P1|26-Week Randomized Phase|Lack of Efficacy|0
1254072|NCT00550407|4111487|P3|26-Week Randomized Phase|Adverse Event|2
1254073|NCT00550407|4111488|P2|26-Week Randomized Phase|Adverse Event|5
1254074|NCT00550407|4111489|P1|26-Week Randomized Phase|Adverse Event|0
1254075|NCT00550407|4111487|P3|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
1254076|NCT00550407|4111488|P2|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
1254077|NCT00550407|4111489|P1|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1
1254078|NCT00550407|4111487|P3|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
1254079|NCT00550407|4111488|P2|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
1254080|NCT00550407|4111489|P1|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6
1254081|NCT00550407|4111487|P3|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
1254082|NCT00550407|4111488|P2|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
1254083|NCT00550407|4111489|P1|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8
1254084|NCT00550407|4111487|P3|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
1254085|NCT00550407|4111488|P2|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
1254086|NCT00550407|4111489|P1|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1
1254087|NCT00550407|4111487|P3|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
1254088|NCT00550407|4111488|P2|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
1254089|NCT00550407|4111489|P1|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1
1254090|NCT00550407|4111487|P3|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
1254091|NCT00550407|4111488|P2|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
1254092|NCT00550407|4111489|P1|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1
1254093|NCT00550407|4111487|P3|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
1254094|NCT00550407|4111488|P2|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
1254095|NCT00550407|4111489|P1|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39
1254096|NCT00550407|4111487|P3|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
1254097|NCT00550407|4111488|P2|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
1254098|NCT00550407|4111489|P1|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55
1254099|NCT00550173|4111564|P3|Overall Study|Lost to Follow-up|3
1254100|NCT00550173|4111565|P2|Overall Study|Lost to Follow-up|4
1254101|NCT00550173|4111566|P1|Overall Study|Lost to Follow-up|4
1254102|NCT00550173|4111564|P3|Overall Study|Sponsor Decision|1
1254103|NCT00550173|4111565|P2|Overall Study|Sponsor Decision|7
1254104|NCT00550173|4111566|P1|Overall Study|Sponsor Decision|13
1254105|NCT00550173|4111564|P3|Overall Study|Withdrawal by Subject|17
1254106|NCT00550173|4111565|P2|Overall Study|Withdrawal by Subject|12
1254107|NCT00550173|4111566|P1|Overall Study|Withdrawal by Subject|9
1254108|NCT00550173|4111564|P3|Overall Study|Physician Decision|2
1254109|NCT00550173|4111565|P2|Overall Study|Physician Decision|2
1254110|NCT00550173|4111566|P1|Overall Study|Physician Decision|1
1254111|NCT00550173|4111564|P3|Overall Study|Death|50
1254112|NCT00550173|4111565|P2|Overall Study|Death|38
1254113|NCT00550173|4111566|P1|Overall Study|Death|45
1254114|NCT00550147|4111595|P1|Quetiapine Addition Treatment Period|Moved out of state|1
1254115|NCT00550147|4111595|P1|Quetiapine Addition Treatment Period|Noncompliance|2
1254116|NCT00550147|4111595|P1|Quetiapine Addition Treatment Period|Adverse Event|3
1254117|NCT00550147|4111595|P1|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2
1254118|NCT00550147|4111595|P1|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4
1254119|NCT00550043|4111618|P5|Overall Study|Other Reasons- Unspecified|0
1254120|NCT00550043|4111619|P4|Overall Study|Other Reasons- Unspecified|1
1254121|NCT00550043|4111620|P3|Overall Study|Other Reasons- Unspecified|0
1254122|NCT00550043|4111621|P2|Overall Study|Other Reasons- Unspecified|1
1254123|NCT00550043|4111622|P1|Overall Study|Other Reasons- Unspecified|0
1254124|NCT00550043|4111618|P5|Overall Study|Subject Withdrew Consent|0
1254125|NCT00550043|4111619|P4|Overall Study|Subject Withdrew Consent|0
1254126|NCT00550043|4111620|P3|Overall Study|Subject Withdrew Consent|1
1254127|NCT00550043|4111621|P2|Overall Study|Subject Withdrew Consent|2
1254128|NCT00550043|4111622|P1|Overall Study|Subject Withdrew Consent|0
1254129|NCT00550043|4111618|P5|Overall Study|Adverse Event|1
1254130|NCT00550043|4111619|P4|Overall Study|Adverse Event|1
1254131|NCT00550043|4111620|P3|Overall Study|Adverse Event|0
1254132|NCT00550043|4111621|P2|Overall Study|Adverse Event|0
1254133|NCT00550043|4111622|P1|Overall Study|Adverse Event|0
1254134|NCT00549939|4111677|P3|40-week Open Label Treatment Period|Other|4
1254135|NCT00549939|4111678|P2|40-week Open Label Treatment Period|Other|1
1254136|NCT00549939|4111679|P1|40-week Open Label Treatment Period|Other|0
1254137|NCT00549939|4111677|P3|40-week Open Label Treatment Period|Protocol Violation|0
1254138|NCT00549939|4111678|P2|40-week Open Label Treatment Period|Protocol Violation|1
1254139|NCT00549939|4111679|P1|40-week Open Label Treatment Period|Protocol Violation|0
1254140|NCT00549939|4111677|P3|40-week Open Label Treatment Period|Lack of Efficacy|0
1254141|NCT00549939|4111678|P2|40-week Open Label Treatment Period|Lack of Efficacy|1
1254142|NCT00549939|4111679|P1|40-week Open Label Treatment Period|Lack of Efficacy|0
1254143|NCT00549939|4111677|P3|40-week Open Label Treatment Period|Adverse Event|1
1254144|NCT00549939|4111678|P2|40-week Open Label Treatment Period|Adverse Event|2
1254145|NCT00549939|4111679|P1|40-week Open Label Treatment Period|Adverse Event|0
1254146|NCT00549939|4111677|P3|12-week Double Blind Treatment Period|Too many blood draws|0
1254147|NCT00549939|4111678|P2|12-week Double Blind Treatment Period|Too many blood draws|1
1254148|NCT00549939|4111679|P1|12-week Double Blind Treatment Period|Too many blood draws|0
1254149|NCT00549939|4111677|P3|12-week Double Blind Treatment Period|Adverse Event|2
1254150|NCT00549939|4111678|P2|12-week Double Blind Treatment Period|Adverse Event|1
1254151|NCT00549939|4111679|P1|12-week Double Blind Treatment Period|Adverse Event|1
1254152|NCT00549900|4111706|P1|Overall Study|Adverse Event|1
1254153|NCT00549770|4111762|P8|Overall Study|Adverse Event|4
1254154|NCT00549770|4111763|P7|Overall Study|Adverse Event|5
1254155|NCT00549770|4111764|P6|Overall Study|Adverse Event|0
1254156|NCT00549770|4111765|P5|Overall Study|Adverse Event|1
1254157|NCT00549770|4111766|P4|Overall Study|Adverse Event|2
1254158|NCT00549770|4111767|P3|Overall Study|Adverse Event|1
1254159|NCT00549770|4111768|P2|Overall Study|Adverse Event|3
1254160|NCT00549770|4111769|P1|Overall Study|Adverse Event|1
1254161|NCT00549770|4111762|P8|Overall Study|Abnormal laboratory values|0
1254162|NCT00549770|4111763|P7|Overall Study|Abnormal laboratory values|0
1254163|NCT00549770|4111764|P6|Overall Study|Abnormal laboratory values|1
1254164|NCT00549770|4111765|P5|Overall Study|Abnormal laboratory values|0
1254165|NCT00549770|4111766|P4|Overall Study|Abnormal laboratory values|0
1254166|NCT00549770|4111767|P3|Overall Study|Abnormal laboratory values|0
1254167|NCT00549770|4111768|P2|Overall Study|Abnormal laboratory values|0
1254168|NCT00549770|4111769|P1|Overall Study|Abnormal laboratory values|0
1254169|NCT00549770|4111762|P8|Overall Study|Abnormal test procedure results|1
1254170|NCT00549770|4111763|P7|Overall Study|Abnormal test procedure results|1
1254171|NCT00549770|4111764|P6|Overall Study|Abnormal test procedure results|1
1254172|NCT00549770|4111765|P5|Overall Study|Abnormal test procedure results|0
1254173|NCT00549770|4111766|P4|Overall Study|Abnormal test procedure results|2
1254174|NCT00549770|4111767|P3|Overall Study|Abnormal test procedure results|0
1254175|NCT00549770|4111768|P2|Overall Study|Abnormal test procedure results|0
1254176|NCT00549770|4111769|P1|Overall Study|Abnormal test procedure results|0
1254177|NCT00549770|4111762|P8|Overall Study|Lack of Efficacy|8
1254178|NCT00549770|4111763|P7|Overall Study|Lack of Efficacy|3
1254179|NCT00549770|4111764|P6|Overall Study|Lack of Efficacy|1
1254180|NCT00549770|4111765|P5|Overall Study|Lack of Efficacy|5
1254181|NCT00549770|4111766|P4|Overall Study|Lack of Efficacy|3
1254182|NCT00549770|4111767|P3|Overall Study|Lack of Efficacy|2
1254183|NCT00549770|4111768|P2|Overall Study|Lack of Efficacy|0
1254184|NCT00549770|4111769|P1|Overall Study|Lack of Efficacy|1
1254185|NCT00549770|4111762|P8|Overall Study|Withdrawal by Subject|9
1254186|NCT00549770|4111763|P7|Overall Study|Withdrawal by Subject|4
1254187|NCT00549770|4111764|P6|Overall Study|Withdrawal by Subject|6
1254188|NCT00549770|4111765|P5|Overall Study|Withdrawal by Subject|6
1254189|NCT00549770|4111766|P4|Overall Study|Withdrawal by Subject|5
1254190|NCT00549770|4111767|P3|Overall Study|Withdrawal by Subject|4
1254191|NCT00549770|4111768|P2|Overall Study|Withdrawal by Subject|6
1254192|NCT00549770|4111769|P1|Overall Study|Withdrawal by Subject|4
1254193|NCT00549770|4111762|P8|Overall Study|Lost to Follow-up|0
1254194|NCT00549770|4111763|P7|Overall Study|Lost to Follow-up|0
1254195|NCT00549770|4111764|P6|Overall Study|Lost to Follow-up|2
1254196|NCT00549770|4111765|P5|Overall Study|Lost to Follow-up|3
1254197|NCT00549770|4111766|P4|Overall Study|Lost to Follow-up|2
1254198|NCT00549770|4111767|P3|Overall Study|Lost to Follow-up|2
1254199|NCT00549770|4111768|P2|Overall Study|Lost to Follow-up|0
1254200|NCT00549770|4111769|P1|Overall Study|Lost to Follow-up|0
1254201|NCT00549770|4111762|P8|Overall Study|Administrative problems|1
1254202|NCT00549770|4111763|P7|Overall Study|Administrative problems|0
1254203|NCT00549770|4111764|P6|Overall Study|Administrative problems|0
1254204|NCT00549770|4111765|P5|Overall Study|Administrative problems|0
1254205|NCT00549770|4111766|P4|Overall Study|Administrative problems|0
1254206|NCT00549770|4111767|P3|Overall Study|Administrative problems|0
1254207|NCT00549770|4111768|P2|Overall Study|Administrative problems|1
1254208|NCT00549770|4111769|P1|Overall Study|Administrative problems|0
1254209|NCT00549770|4111762|P8|Overall Study|Protocol deviation|2
1254210|NCT00549770|4111763|P7|Overall Study|Protocol deviation|1
1254211|NCT00549770|4111764|P6|Overall Study|Protocol deviation|2
1254212|NCT00549770|4111765|P5|Overall Study|Protocol deviation|2
1254213|NCT00549770|4111766|P4|Overall Study|Protocol deviation|2
1254214|NCT00549770|4111767|P3|Overall Study|Protocol deviation|1
1254215|NCT00549770|4111768|P2|Overall Study|Protocol deviation|1
1254216|NCT00549770|4111769|P1|Overall Study|Protocol deviation|1
1254217|NCT00549757|4111853|P2|Extension Period (in Average 9 Months)|Patient's request|436
1254218|NCT00549757|4111854|P1|Extension Period (in Average 9 Months)|Patient's request|421
1254219|NCT00549757|4111853|P2|Extension Period (in Average 9 Months)|Withdrawal by Subject|16
1254220|NCT00549757|4111854|P1|Extension Period (in Average 9 Months)|Withdrawal by Subject|9
1254221|NCT00549757|4111853|P2|Extension Period (in Average 9 Months)|Lost to Follow-up|47
1254222|NCT00549757|4111854|P1|Extension Period (in Average 9 Months)|Lost to Follow-up|52
1254223|NCT00549757|4111853|P2|Extension Period (in Average 9 Months)|Death|136
1254224|NCT00549757|4111854|P1|Extension Period (in Average 9 Months)|Death|143
1254225|NCT00549757|4111853|P2|Active Treatment Phase: Max. 50 Months|Missing data|9
1254226|NCT00549757|4111854|P1|Active Treatment Phase: Max. 50 Months|Missing data|8
1254227|NCT00549757|4111853|P2|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55
1254228|NCT00549757|4111854|P1|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69
1254229|NCT00549757|4111853|P2|Active Treatment Phase: Max. 50 Months|Patient's request|380
1254230|NCT00549757|4111854|P1|Active Treatment Phase: Max. 50 Months|Patient's request|353
1254231|NCT00549757|4111853|P2|Active Treatment Phase: Max. 50 Months|Death|200
1254232|NCT00549757|4111854|P1|Active Treatment Phase: Max. 50 Months|Death|188
1254233|NCT00549757|4111853|P2|Active Treatment Phase: Max. 50 Months|Administrative problems|3019
1254234|NCT00549757|4111854|P1|Active Treatment Phase: Max. 50 Months|Administrative problems|2857
1254235|NCT00549757|4111853|P2|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29
1254236|NCT00549757|4111854|P1|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41
1254237|NCT00549757|4111853|P2|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
1254238|NCT00549757|4111854|P1|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
1254239|NCT00549757|4111853|P2|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53
1254240|NCT00549757|4111854|P1|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47
1254241|NCT00549757|4111853|P2|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
1254242|NCT00549757|4111854|P1|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
1254243|NCT00549757|4111853|P2|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58
1254244|NCT00549757|4111854|P1|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98
1254245|NCT00549757|4111853|P2|Active Treatment Phase: Max. 50 Months|Adverse Event|462
1254246|NCT00549757|4111854|P1|Active Treatment Phase: Max. 50 Months|Adverse Event|590
1254247|NCT00549718|4111916|P4|Overall Study|Administrative|1
1254248|NCT00549718|4111917|P3|Overall Study|Administrative|2
1254249|NCT00549718|4111918|P2|Overall Study|Administrative|2
1254250|NCT00549718|4111919|P1|Overall Study|Administrative|2
1254251|NCT00549718|4111916|P4|Overall Study|Withdrawal by Subject|13
1254252|NCT00549718|4111917|P3|Overall Study|Withdrawal by Subject|12
1254253|NCT00549718|4111918|P2|Overall Study|Withdrawal by Subject|18
1254254|NCT00549718|4111919|P1|Overall Study|Withdrawal by Subject|9
1254255|NCT00549718|4111916|P4|Overall Study|Lost to Follow-up|6
1254256|NCT00549718|4111917|P3|Overall Study|Lost to Follow-up|0
1254257|NCT00549718|4111918|P2|Overall Study|Lost to Follow-up|2
1254258|NCT00549718|4111919|P1|Overall Study|Lost to Follow-up|4
1254259|NCT00549718|4111916|P4|Overall Study|Adverse Event|3
1254260|NCT00549718|4111917|P3|Overall Study|Adverse Event|7
1254261|NCT00549718|4111918|P2|Overall Study|Adverse Event|8
1254262|NCT00549718|4111919|P1|Overall Study|Adverse Event|6
1254263|NCT00549718|4111916|P4|Overall Study|Insufficient clinical response|32
1254264|NCT00549718|4111917|P3|Overall Study|Insufficient clinical response|18
1254265|NCT00549718|4111918|P2|Overall Study|Insufficient clinical response|7
1254266|NCT00549718|4111919|P1|Overall Study|Insufficient clinical response|20
1254267|NCT00549640|4111935|P2|Overall Study|Lost to Follow-up|4
1254268|NCT00549640|4111936|P1|Overall Study|Lost to Follow-up|7
1254269|NCT00549640|4111935|P2|Overall Study|Adverse Event|0
1254270|NCT00549640|4111936|P1|Overall Study|Adverse Event|5
1254271|NCT00549640|4111935|P2|Overall Study|Withdrawal by Subject|12
1254272|NCT00549640|4111936|P1|Overall Study|Withdrawal by Subject|6
1254273|NCT00549601|4111949|P3|Received Study Drug|Withdrawal by Subject|1
1254274|NCT00549601|4111950|P2|Received Study Drug|Withdrawal by Subject|0
1254275|NCT00549601|4111951|P1|Received Study Drug|Withdrawal by Subject|2
1254276|NCT00549601|4111949|P3|Received Study Drug|Protocol Violation|1
1254277|NCT00549601|4111950|P2|Received Study Drug|Protocol Violation|4
1254278|NCT00549601|4111951|P1|Received Study Drug|Protocol Violation|3
1254279|NCT00549601|4111949|P3|Received Study Drug|Lost to Follow-up|1
1254280|NCT00549601|4111950|P2|Received Study Drug|Lost to Follow-up|1
1254281|NCT00549601|4111951|P1|Received Study Drug|Lost to Follow-up|0
1254282|NCT00549601|4111949|P3|Received Study Drug|Death|0
1254283|NCT00549601|4111950|P2|Received Study Drug|Death|1
1254284|NCT00549601|4111951|P1|Received Study Drug|Death|0
1254285|NCT00549601|4111949|P3|Received Study Drug|Adverse Event|1
1254286|NCT00549601|4111950|P2|Received Study Drug|Adverse Event|5
1254287|NCT00549601|4111951|P1|Received Study Drug|Adverse Event|2
1254288|NCT00549601|4111949|P3|Randomized|Withdrawal by Subject|1
1254289|NCT00549601|4111950|P2|Randomized|Withdrawal by Subject|1
1254290|NCT00549601|4111951|P1|Randomized|Withdrawal by Subject|0
1254291|NCT00549601|4111949|P3|Randomized|Protocol Violation|1
1254292|NCT00549601|4111950|P2|Randomized|Protocol Violation|0
1254293|NCT00549601|4111951|P1|Randomized|Protocol Violation|0
1254294|NCT00549562|4111973|P1|Overall Study|Lack of Efficacy|1
1254295|NCT00549562|4111973|P1|Overall Study|Adverse Event|1
1254296|NCT00549549|4111985|P4|Overall Study|Randomized but not treated|1
1254297|NCT00549549|4111986|P3|Overall Study|Randomized but not treated|1
1254298|NCT00549549|4111987|P2|Overall Study|Randomized but not treated|0
1254299|NCT00549549|4111988|P1|Overall Study|Randomized but not treated|0
1254300|NCT00549549|4111985|P4|Overall Study|Other|11
1254301|NCT00549549|4111986|P3|Overall Study|Other|9
1254302|NCT00549549|4111987|P2|Overall Study|Other|9
1254303|NCT00549549|4111988|P1|Overall Study|Other|9
1254304|NCT00549549|4111985|P4|Overall Study|Withdrawal by Subject|0
1254305|NCT00549549|4111986|P3|Overall Study|Withdrawal by Subject|1
1254306|NCT00549549|4111987|P2|Overall Study|Withdrawal by Subject|4
1254307|NCT00549549|4111988|P1|Overall Study|Withdrawal by Subject|0
1254308|NCT00549549|4111985|P4|Overall Study|Lost to Follow-up|2
1254309|NCT00549549|4111986|P3|Overall Study|Lost to Follow-up|1
1254310|NCT00549549|4111987|P2|Overall Study|Lost to Follow-up|0
1254311|NCT00549549|4111988|P1|Overall Study|Lost to Follow-up|1
1254312|NCT00549549|4111985|P4|Overall Study|Lack of Efficacy|2
1254313|NCT00549549|4111986|P3|Overall Study|Lack of Efficacy|4
1254314|NCT00549549|4111987|P2|Overall Study|Lack of Efficacy|6
1254315|NCT00549549|4111988|P1|Overall Study|Lack of Efficacy|9
1254316|NCT00549549|4111985|P4|Overall Study|Adverse Event|9
1254317|NCT00549549|4111986|P3|Overall Study|Adverse Event|1
1254318|NCT00549549|4111987|P2|Overall Study|Adverse Event|3
1254319|NCT00549549|4111988|P1|Overall Study|Adverse Event|5
1254320|NCT00549445|4112056|P2|Overall Study|Sputum & Blood Samples Not Available|17
1254321|NCT00549445|4112057|P1|Overall Study|Sputum & Blood Samples Not Available|15
1254322|NCT00549328|4112076|P1|Overall Study|Use of Prohibited Medication|1
1254323|NCT00549328|4112076|P1|Overall Study|Death|1
1254324|NCT00549328|4112076|P1|Overall Study|Disease Progression|10
1254325|NCT00549328|4112076|P1|Overall Study|Adverse Event|2
1254326|NCT00549302|4112087|P3|Open-Label|Withdrawal by Subject|6
1254327|NCT00549302|4112088|P2|Open-Label|Withdrawal by Subject|0
1254328|NCT00549302|4112089|P1|Open-Label|Withdrawal by Subject|0
1254329|NCT00549302|4112087|P3|Open-Label|New drug pulmonary atrial hypertension|2
1254330|NCT00549302|4112088|P2|Open-Label|New drug pulmonary atrial hypertension|0
1254331|NCT00549302|4112089|P1|Open-Label|New drug pulmonary atrial hypertension|0
1254332|NCT00549302|4112087|P3|Open-Label|Other|3
1254333|NCT00549302|4112088|P2|Open-Label|Other|0
1254334|NCT00549302|4112089|P1|Open-Label|Other|0
1254335|NCT00549302|4112087|P3|Open-Label|Lost to Follow-up|2
1254336|NCT00549302|4112088|P2|Open-Label|Lost to Follow-up|0
1254337|NCT00549302|4112089|P1|Open-Label|Lost to Follow-up|0
1254338|NCT00549302|4112087|P3|Open-Label|Investigator Decision|5
1254339|NCT00549302|4112088|P2|Open-Label|Investigator Decision|0
1254340|NCT00549302|4112089|P1|Open-Label|Investigator Decision|0
1254341|NCT00549302|4112087|P3|Open-Label|Death|40
1254342|NCT00549302|4112088|P2|Open-Label|Death|0
1254343|NCT00549302|4112089|P1|Open-Label|Death|0
1254344|NCT00549302|4112087|P3|Open-Label|Adverse Event|11
1254345|NCT00549302|4112088|P2|Open-Label|Adverse Event|0
1254346|NCT00549302|4112089|P1|Open-Label|Adverse Event|0
1254347|NCT00549302|4112087|P3|Double-Blind|New condition or starts new therapy|0
1254348|NCT00549302|4112088|P2|Double-Blind|New condition or starts new therapy|2
1254349|NCT00549302|4112089|P1|Double-Blind|New condition or starts new therapy|0
1254350|NCT00549302|4112087|P3|Double-Blind|New Drug Pulmonary Atrial Hypertension|0
1254351|NCT00549302|4112088|P2|Double-Blind|New Drug Pulmonary Atrial Hypertension|10
1254352|NCT00549302|4112089|P1|Double-Blind|New Drug Pulmonary Atrial Hypertension|1
1254353|NCT00549302|4112087|P3|Double-Blind|Lost to Follow-up|0
1254354|NCT00549302|4112088|P2|Double-Blind|Lost to Follow-up|2
1254355|NCT00549302|4112089|P1|Double-Blind|Lost to Follow-up|1
1254356|NCT00549302|4112087|P3|Double-Blind|Sponsor Decision|0
1254357|NCT00549302|4112088|P2|Double-Blind|Sponsor Decision|1
1254358|NCT00549302|4112089|P1|Double-Blind|Sponsor Decision|0
1254359|NCT00549302|4112087|P3|Double-Blind|Investigator Decision|0
1254360|NCT00549302|4112088|P2|Double-Blind|Investigator Decision|5
1254361|NCT00549302|4112089|P1|Double-Blind|Investigator Decision|1
1254362|NCT00549302|4112087|P3|Double-Blind|Withdrawal by Subject|0
1254363|NCT00549302|4112088|P2|Double-Blind|Withdrawal by Subject|8
1254364|NCT00549302|4112089|P1|Double-Blind|Withdrawal by Subject|3
1254365|NCT00549302|4112087|P3|Double-Blind|Adverse Event|0
1254366|NCT00549302|4112088|P2|Double-Blind|Adverse Event|16
1254367|NCT00549302|4112089|P1|Double-Blind|Adverse Event|3
1254368|NCT00549302|4112087|P3|Double-Blind|Death|0
1254369|NCT00549302|4112088|P2|Double-Blind|Death|9
1254370|NCT00549302|4112089|P1|Double-Blind|Death|2
1254371|NCT00549198|4112101|P2|Overall Study|Not Exposed to Study Drug|4
1254372|NCT00549198|4112102|P1|Overall Study|Not Exposed to Study Drug|3
1254373|NCT00549198|4112101|P2|Overall Study|Pregnancy|3
1254374|NCT00549198|4112102|P1|Overall Study|Pregnancy|0
1254375|NCT00549198|4112101|P2|Overall Study|No scan facilities|2
1254376|NCT00549198|4112102|P1|Overall Study|No scan facilities|0
1254377|NCT00549198|4112101|P2|Overall Study|Participant overweight, no scan possible|0
1254378|NCT00549198|4112102|P1|Overall Study|Participant overweight, no scan possible|1
1254379|NCT00549198|4112101|P2|Overall Study|Participant planning pregnancy|0
1254380|NCT00549198|4112102|P1|Overall Study|Participant planning pregnancy|1
1254381|NCT00549198|4112101|P2|Overall Study|Prohibited Medication|2
1254382|NCT00549198|4112102|P1|Overall Study|Prohibited Medication|1
1254383|NCT00549198|4112101|P2|Overall Study|Participant moved.Week 96 visit, no scan|0
1254384|NCT00549198|4112102|P1|Overall Study|Participant moved.Week 96 visit, no scan|1
1254385|NCT00549198|4112101|P2|Overall Study|Participant not able to perform Week 96|0
1254386|NCT00549198|4112102|P1|Overall Study|Participant not able to perform Week 96|1
1254387|NCT00549198|4112101|P2|Overall Study|Participant Moved|0
1254388|NCT00549198|4112102|P1|Overall Study|Participant Moved|2
1254389|NCT00549198|4112101|P2|Overall Study|Disease Progression|0
1254390|NCT00549198|4112102|P1|Overall Study|Disease Progression|1
1254391|NCT00549198|4112101|P2|Overall Study|Withdrawal by Subject|7
1254392|NCT00549198|4112102|P1|Overall Study|Withdrawal by Subject|7
1254393|NCT00549198|4112101|P2|Overall Study|Investigator Decision|3
1254394|NCT00549198|4112102|P1|Overall Study|Investigator Decision|4
1254395|NCT00549198|4112101|P2|Overall Study|Protocol Violation|2
1254396|NCT00549198|4112102|P1|Overall Study|Protocol Violation|7
1254397|NCT00549198|4112101|P2|Overall Study|Treatment Eligibility Criteria Not Met|0
1254398|NCT00549198|4112102|P1|Overall Study|Treatment Eligibility Criteria Not Met|3
1254399|NCT00549198|4112101|P2|Overall Study|Lost to Follow-up|8
1254400|NCT00549198|4112102|P1|Overall Study|Lost to Follow-up|7
1254401|NCT00549198|4112101|P2|Overall Study|Non-compliance|4
1254402|NCT00549198|4112102|P1|Overall Study|Non-compliance|2
1254403|NCT00549198|4112101|P2|Overall Study|Protocol-defined Virological Failure|0
1254404|NCT00549198|4112102|P1|Overall Study|Protocol-defined Virological Failure|7
1254405|NCT00549198|4112101|P2|Overall Study|Insufficient Viral Load Response|2
1254406|NCT00549198|4112102|P1|Overall Study|Insufficient Viral Load Response|4
1254407|NCT00549198|4112101|P2|Overall Study|Adverse Event|26
1254408|NCT00549198|4112102|P1|Overall Study|Adverse Event|28
1254409|NCT00549055|4112239|P1|Overall Study|Very low visual acuity (VA)|1
1254410|NCT00549055|4112239|P1|Overall Study|Choroidal neovascularization|1
1254411|NCT00549055|4112239|P1|Overall Study|Growth choroidal neovascularisation|1
1254412|NCT00549055|4112239|P1|Overall Study|Vitreous hemorrhage|1
1254413|NCT00549055|4112239|P1|Overall Study|Active choroidal neovascula increased|1
1254414|NCT00549055|4112239|P1|Overall Study|Decrease of size|1
1254415|NCT00549055|4112239|P1|Overall Study|Progression to fibrosis|2
1254416|NCT00549055|4112239|P1|Overall Study|Stabilization|5
1254417|NCT00549055|4112239|P1|Overall Study|Lack of Efficacy|18
1254418|NCT00549055|4112239|P1|Overall Study|Adverse Event|4
1254419|NCT00548847|4112263|P1|Overall Study|Disease progression|7
1254420|NCT00548808|4112270|P2|Overall Study|Sponsor Decision|1
1254421|NCT00548808|4112271|P1|Overall Study|Sponsor Decision|1
1254422|NCT00548808|4112270|P2|Overall Study|Lack of Efficacy|0
1254423|NCT00548808|4112271|P1|Overall Study|Lack of Efficacy|2
1254424|NCT00548808|4112270|P2|Overall Study|Entry Criteria Not Met|2
1254425|NCT00548808|4112271|P1|Overall Study|Entry Criteria Not Met|2
1254426|NCT00548808|4112270|P2|Overall Study|Death|0
1254427|NCT00548808|4112271|P1|Overall Study|Death|2
1254428|NCT00548808|4112270|P2|Overall Study|Adverse Event|5
1254429|NCT00548808|4112271|P1|Overall Study|Adverse Event|4
1254430|NCT00548808|4112270|P2|Overall Study|Physician Decision|3
1254431|NCT00548808|4112271|P1|Overall Study|Physician Decision|6
1254432|NCT00548808|4112270|P2|Overall Study|Withdrawal by Subject|4
1254433|NCT00548808|4112271|P1|Overall Study|Withdrawal by Subject|8
1254434|NCT00548808|4112270|P2|Overall Study|Protocol Violation|8
1254435|NCT00548808|4112271|P1|Overall Study|Protocol Violation|8
1254436|NCT00548808|4112270|P2|Overall Study|Lost to Follow-up|3
1254437|NCT00548808|4112271|P1|Overall Study|Lost to Follow-up|9
1254438|NCT00548717|4112295|P2|Overall Study|Alternative treatment for GVHD|0
1254439|NCT00548717|4112296|P1|Overall Study|Alternative treatment for GVHD|1
1254440|NCT00548717|4112295|P2|Overall Study|Relapse|0
1254441|NCT00548717|4112296|P1|Overall Study|Relapse|3
1254442|NCT00548717|4112295|P2|Overall Study|Death|2
1254443|NCT00548717|4112296|P1|Overall Study|Death|5
1254444|NCT00548548|4112324|P2|Overall Study|Lost to Follow-up|18
1254445|NCT00548548|4112325|P1|Overall Study|Lost to Follow-up|17
1254446|NCT00548548|4112324|P2|Overall Study|Death|348
1254447|NCT00548548|4112325|P1|Overall Study|Death|345
1254448|NCT00548405|4112368|P3|Overall Study|Randomized but not treated|0
1254449|NCT00548405|4112369|P2|Overall Study|Randomized but not treated|0
1254450|NCT00548405|4112370|P1|Overall Study|Randomized but not treated|1
1254451|NCT00548405|4112368|P3|Overall Study|Sponsor decision|0
1254452|NCT00548405|4112369|P2|Overall Study|Sponsor decision|0
1254453|NCT00548405|4112370|P1|Overall Study|Sponsor decision|1
1254454|NCT00548405|4112368|P3|Overall Study|Death|1
1254455|NCT00548405|4112369|P2|Overall Study|Death|1
1254456|NCT00548405|4112370|P1|Overall Study|Death|0
1254457|NCT00548405|4112368|P3|Overall Study|Lost to Follow-up|2
1254458|NCT00548405|4112369|P2|Overall Study|Lost to Follow-up|1
1254459|NCT00548405|4112370|P1|Overall Study|Lost to Follow-up|1
1254460|NCT00548405|4112368|P3|Overall Study|Withdrawal by Subject|5
1254461|NCT00548405|4112369|P2|Overall Study|Withdrawal by Subject|12
1254462|NCT00548405|4112370|P1|Overall Study|Withdrawal by Subject|36
1254463|NCT00548405|4112368|P3|Overall Study|Protocol Violation|0
1254464|NCT00548405|4112369|P2|Overall Study|Protocol Violation|0
1254465|NCT00548405|4112370|P1|Overall Study|Protocol Violation|1
1254466|NCT00548405|4112368|P3|Overall Study|Pregnancy|0
1254467|NCT00548405|4112369|P2|Overall Study|Pregnancy|0
1254468|NCT00548405|4112370|P1|Overall Study|Pregnancy|1
1254469|NCT00548405|4112368|P3|Overall Study|Physician Decision|1
1254470|NCT00548405|4112369|P2|Overall Study|Physician Decision|4
1254471|NCT00548405|4112370|P1|Overall Study|Physician Decision|3
1254472|NCT00548405|4112368|P3|Overall Study|Lack of Efficacy|0
1254473|NCT00548405|4112369|P2|Overall Study|Lack of Efficacy|0
1254474|NCT00548405|4112370|P1|Overall Study|Lack of Efficacy|6
1254475|NCT00548405|4112368|P3|Overall Study|Adverse Event|0
1254476|NCT00548405|4112369|P2|Overall Study|Adverse Event|2
1254477|NCT00548405|4112370|P1|Overall Study|Adverse Event|6
1254478|NCT00548340|4112391|P3|Overall Study|Other|1
1254479|NCT00548340|4112392|P2|Overall Study|Other|1
1254480|NCT00548340|4112393|P1|Overall Study|Other|1
1254481|NCT00548340|4112391|P3|Overall Study|Withdrawal by Subject|3
1254482|NCT00548340|4112392|P2|Overall Study|Withdrawal by Subject|4
1254483|NCT00548340|4112393|P1|Overall Study|Withdrawal by Subject|2
1254484|NCT00548340|4112391|P3|Overall Study|Lost to Follow-up|0
1254485|NCT00548340|4112392|P2|Overall Study|Lost to Follow-up|1
1254486|NCT00548340|4112393|P1|Overall Study|Lost to Follow-up|1
1254487|NCT00548340|4112391|P3|Overall Study|Adverse Event|2
1254488|NCT00548340|4112392|P2|Overall Study|Adverse Event|2
1254489|NCT00548340|4112393|P1|Overall Study|Adverse Event|2
1254490|NCT00548340|4112391|P3|Overall Study|Protocol Violation|3
1254491|NCT00548340|4112392|P2|Overall Study|Protocol Violation|3
1254492|NCT00548340|4112393|P1|Overall Study|Protocol Violation|2
1254493|NCT00548327|4112412|P2|Overall Study|Adverse Event|1
1254494|NCT00548327|4112413|P1|Overall Study|Adverse Event|0
1254495|NCT00548262|4112431|P1|Overall Study|Withdrawal by Subject|1
1254496|NCT00548262|4112431|P1|Overall Study|Other|3
1254497|NCT00548262|4112431|P1|Overall Study|Lost to Follow-up|1
1254498|NCT00548262|4112431|P1|Overall Study|Lack of Efficacy|4
1254499|NCT00548262|4112431|P1|Overall Study|Adverse Event|2
1254500|NCT00548262|4112431|P1|Overall Study|Death|21
1254501|NCT00548249|4112461|P5|Overall Study|Sponsor's request|0
1254502|NCT00548249|4112462|P4|Overall Study|Sponsor's request|1
1254503|NCT00548249|4112463|P3|Overall Study|Sponsor's request|0
1254504|NCT00548249|4112464|P2|Overall Study|Sponsor's request|0
1254505|NCT00548249|4112465|P1|Overall Study|Sponsor's request|0
1254506|NCT00548249|4112461|P5|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
1254507|NCT00548249|4112462|P4|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
1254508|NCT00548249|4112463|P3|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
1254509|NCT00548249|4112464|P2|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
1254510|NCT00548249|4112465|P1|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
1254511|NCT00548249|4112461|P5|Overall Study|Withdrawal by Subject|0
1254512|NCT00548249|4112462|P4|Overall Study|Withdrawal by Subject|0
1254513|NCT00548249|4112463|P3|Overall Study|Withdrawal by Subject|0
1254514|NCT00548249|4112464|P2|Overall Study|Withdrawal by Subject|0
1254515|NCT00548249|4112465|P1|Overall Study|Withdrawal by Subject|2
1254516|NCT00548249|4112461|P5|Overall Study|Prolonged hospitalization|0
1254517|NCT00548249|4112462|P4|Overall Study|Prolonged hospitalization|1
1254518|NCT00548249|4112463|P3|Overall Study|Prolonged hospitalization|2
1254519|NCT00548249|4112464|P2|Overall Study|Prolonged hospitalization|0
1254520|NCT00548249|4112465|P1|Overall Study|Prolonged hospitalization|0
1254521|NCT00548249|4112461|P5|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0
1254522|NCT00548249|4112462|P4|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
1254523|NCT00548249|4112463|P3|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
1254524|NCT00548249|4112464|P2|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
1254525|NCT00548249|4112465|P1|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
1254526|NCT00548249|4112461|P5|Overall Study|Erythropoietin (ESA)Dose Change Required|2
1254527|NCT00548249|4112462|P4|Overall Study|Erythropoietin (ESA)Dose Change Required|2
1254528|NCT00548249|4112463|P3|Overall Study|Erythropoietin (ESA)Dose Change Required|1
1254529|NCT00548249|4112464|P2|Overall Study|Erythropoietin (ESA)Dose Change Required|0
1254530|NCT00548249|4112465|P1|Overall Study|Erythropoietin (ESA)Dose Change Required|0
1254531|NCT00548249|4112461|P5|Overall Study|Post-dialysis high TSAT or low UIBC|2
1254532|NCT00548249|4112462|P4|Overall Study|Post-dialysis high TSAT or low UIBC|3
1254533|NCT00548249|4112463|P3|Overall Study|Post-dialysis high TSAT or low UIBC|1
1254534|NCT00548249|4112464|P2|Overall Study|Post-dialysis high TSAT or low UIBC|0
1254535|NCT00548249|4112465|P1|Overall Study|Post-dialysis high TSAT or low UIBC|0
1254536|NCT00548249|4112461|P5|Overall Study|Adverse Event|1
1254537|NCT00548249|4112462|P4|Overall Study|Adverse Event|1
1254538|NCT00548249|4112463|P3|Overall Study|Adverse Event|0
1254539|NCT00548249|4112464|P2|Overall Study|Adverse Event|2
1254540|NCT00548249|4112465|P1|Overall Study|Adverse Event|2
1254541|NCT00548249|4112461|P5|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4
1254542|NCT00548249|4112462|P4|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1
1254543|NCT00548249|4112463|P3|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2
1254544|NCT00548249|4112464|P2|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
1254545|NCT00548249|4112465|P1|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
1254546|NCT00548249|4112461|P5|Overall Study|Miscellaneous|2
1254547|NCT00548249|4112462|P4|Overall Study|Miscellaneous|0
1254548|NCT00548249|4112463|P3|Overall Study|Miscellaneous|2
1254549|NCT00548249|4112464|P2|Overall Study|Miscellaneous|3
1254550|NCT00548249|4112465|P1|Overall Study|Miscellaneous|2
1254551|NCT00548249|4112461|P5|Overall Study|Protocol Violation|3
1254552|NCT00548249|4112462|P4|Overall Study|Protocol Violation|0
1254553|NCT00548249|4112463|P3|Overall Study|Protocol Violation|4
1254554|NCT00548249|4112464|P2|Overall Study|Protocol Violation|1
1254555|NCT00548249|4112465|P1|Overall Study|Protocol Violation|1
1254556|NCT00548249|4112461|P5|Overall Study|Transferrin Saturation (TSAT) <20%|2
1254557|NCT00548249|4112462|P4|Overall Study|Transferrin Saturation (TSAT) <20%|1
1254558|NCT00548249|4112463|P3|Overall Study|Transferrin Saturation (TSAT) <20%|3
1254559|NCT00548249|4112464|P2|Overall Study|Transferrin Saturation (TSAT) <20%|1
1254560|NCT00548249|4112465|P1|Overall Study|Transferrin Saturation (TSAT) <20%|5
1254561|NCT00548249|4112461|P5|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
1254562|NCT00548249|4112462|P4|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2
1254563|NCT00548249|4112463|P3|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
1254564|NCT00548249|4112464|P2|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
1254565|NCT00548249|4112465|P1|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3
1254566|NCT00548184|4112513|P1|Overall Study|Found Her2 negative|1
1254567|NCT00548184|4112513|P1|Overall Study|took other drug|1
1254568|NCT00548184|4112513|P1|Overall Study|Adverse Event|3
1254569|NCT00548145|4112519|P2|Overall Study|Physician Decision|1
1254570|NCT00548145|4112520|P1|Overall Study|Physician Decision|1
1254571|NCT00548145|4112519|P2|Overall Study|Withdrawal by Subject|2
1254572|NCT00548145|4112520|P1|Overall Study|Withdrawal by Subject|0
1254573|NCT00548145|4112519|P2|Overall Study|Death|1
1254574|NCT00548145|4112520|P1|Overall Study|Death|0
1254575|NCT00547911|4112545|P6|Overall Study|Adverse Event|0
1254576|NCT00547911|4112546|P5|Overall Study|Adverse Event|0
1254577|NCT00547911|4112547|P4|Overall Study|Adverse Event|1
1254578|NCT00547911|4112548|P3|Overall Study|Adverse Event|0
1254579|NCT00547911|4112549|P2|Overall Study|Adverse Event|0
1254580|NCT00547911|4112550|P1|Overall Study|Adverse Event|0
1254581|NCT00547703|4112581|P2|Overall Study|Lost to Follow-up|0
1254582|NCT00547703|4112582|P1|Overall Study|Lost to Follow-up|1
1254583|NCT00547534|4112607|P1|Overall Study|Disease Progression|4
1254584|NCT00547534|4112607|P1|Overall Study|Adverse Event|7
1254585|NCT00547521|4112615|P2|Long Term Extension (LTE) Study|Poor/Non-Compliance|1
1254586|NCT00547521|4112616|P1|Long Term Extension (LTE) Study|Poor/Non-Compliance|0
1254587|NCT00547521|4112615|P2|Long Term Extension (LTE) Study|Not Specified|2
1254588|NCT00547521|4112616|P1|Long Term Extension (LTE) Study|Not Specified|0
1254589|NCT00547521|4112615|P2|Long Term Extension (LTE) Study|Withdrawal by Subject|2
1254590|NCT00547521|4112616|P1|Long Term Extension (LTE) Study|Withdrawal by Subject|0
1254591|NCT00547521|4112615|P2|Long Term Extension (LTE) Study|Lost to Follow-up|3
1254592|NCT00547521|4112616|P1|Long Term Extension (LTE) Study|Lost to Follow-up|0
1254593|NCT00547521|4112615|P2|Long Term Extension (LTE) Study|Adverse Event|9
1254594|NCT00547521|4112616|P1|Long Term Extension (LTE) Study|Adverse Event|0
1254595|NCT00547521|4112615|P2|Long Term Extension (LTE) Study|Lack of Efficacy|14
1254596|NCT00547521|4112616|P1|Long Term Extension (LTE) Study|Lack of Efficacy|0
1254597|NCT00547521|4112615|P2|Short Term Study (4 Months)|primary endpoint evaluation not complete|1
1254598|NCT00547521|4112616|P1|Short Term Study (4 Months)|primary endpoint evaluation not complete|0
1254599|NCT00547521|4112615|P2|Short Term Study (4 Months)|Withdrawal of consent|1
1254600|NCT00547521|4112616|P1|Short Term Study (4 Months)|Withdrawal of consent|0
1254601|NCT00547521|4112615|P2|Short Term Study (4 Months)|Lack of Efficacy|2
1254602|NCT00547521|4112616|P1|Short Term Study (4 Months)|Lack of Efficacy|0
1254603|NCT00547521|4112615|P2|Short Term Study (4 Months)|Adverse Event|0
1254604|NCT00547521|4112616|P1|Short Term Study (4 Months)|Adverse Event|1
1254605|NCT00547378|4112693|P3|All Implanted Cohort|Other reasons|1
1254606|NCT00547378|4112694|P2|All Implanted Cohort|Other reasons|0
1254607|NCT00547378|4112695|P1|All Implanted Cohort|Other reasons|1
1254608|NCT00547378|4112693|P3|All Implanted Cohort|Site closure|1
1254609|NCT00547378|4112694|P2|All Implanted Cohort|Site closure|0
1254610|NCT00547378|4112695|P1|All Implanted Cohort|Site closure|2
1254611|NCT00547378|4112693|P3|All Implanted Cohort|Physician Decision|6
1254612|NCT00547378|4112694|P2|All Implanted Cohort|Physician Decision|2
1254613|NCT00547378|4112695|P1|All Implanted Cohort|Physician Decision|0
1254614|NCT00547378|4112693|P3|All Implanted Cohort|Death|4
1254615|NCT00547378|4112694|P2|All Implanted Cohort|Death|1
1254616|NCT00547378|4112695|P1|All Implanted Cohort|Death|3
1254617|NCT00547378|4112693|P3|All Implanted Cohort|Lost to Follow-up|14
1254618|NCT00547378|4112694|P2|All Implanted Cohort|Lost to Follow-up|1
1254619|NCT00547378|4112695|P1|All Implanted Cohort|Lost to Follow-up|0
1254620|NCT00547378|4112693|P3|All Implanted Cohort|Adverse Event|17
1254621|NCT00547378|4112694|P2|All Implanted Cohort|Adverse Event|10
1254622|NCT00547378|4112695|P1|All Implanted Cohort|Adverse Event|4
1254623|NCT00547378|4112693|P3|All Implanted Cohort|Withdrawal by Subject|27
1254624|NCT00547378|4112694|P2|All Implanted Cohort|Withdrawal by Subject|4
1254625|NCT00547378|4112695|P1|All Implanted Cohort|Withdrawal by Subject|5
1254626|NCT00547378|4112693|P3|Randomized Cohort|Other reasons|0
1254627|NCT00547378|4112694|P2|Randomized Cohort|Other reasons|0
1254628|NCT00547378|4112695|P1|Randomized Cohort|Other reasons|2
1254629|NCT00547378|4112693|P3|Randomized Cohort|Adverse Event|0
1254630|NCT00547378|4112694|P2|Randomized Cohort|Adverse Event|0
1254631|NCT00547378|4112695|P1|Randomized Cohort|Adverse Event|1
1254632|NCT00547378|4112693|P3|Randomized Cohort|Lost to Follow-up|0
1254633|NCT00547378|4112694|P2|Randomized Cohort|Lost to Follow-up|0
1254634|NCT00547378|4112695|P1|Randomized Cohort|Lost to Follow-up|1
1254635|NCT00547378|4112693|P3|Randomized Cohort|Death|0
1254636|NCT00547378|4112694|P2|Randomized Cohort|Death|1
1254637|NCT00547378|4112695|P1|Randomized Cohort|Death|0
1254638|NCT00547378|4112693|P3|Randomized Cohort|Withdrawal by Subject|0
1254639|NCT00547378|4112694|P2|Randomized Cohort|Withdrawal by Subject|5
1254640|NCT00547378|4112695|P1|Randomized Cohort|Withdrawal by Subject|7
1254641|NCT00547365|4112705|P1|Overall Study|death (not related to study)|4
1254642|NCT00547365|4112705|P1|Overall Study|Protocol Violation|2
1254643|NCT00547365|4112705|P1|Overall Study|Lost to Follow-up|1
1254644|NCT00547365|4112705|P1|Overall Study|Physician Decision|1
1254645|NCT00547157|4112712|P2|Overall Study|Lost to Follow-up|2
1254646|NCT00547157|4112713|P1|Overall Study|Lost to Follow-up|4
1254647|NCT00547157|4112712|P2|Overall Study|Administrative decision|2
1254648|NCT00547157|4112713|P1|Overall Study|Administrative decision|3
1254649|NCT00547157|4112712|P2|Overall Study|Withdrawal by Subject|1
1254650|NCT00547157|4112713|P1|Overall Study|Withdrawal by Subject|3
1254651|NCT00547157|4112712|P2|Overall Study|Death|18
1254652|NCT00547157|4112713|P1|Overall Study|Death|38
1254653|NCT00547157|4112712|P2|Overall Study|Other|0
1254654|NCT00547157|4112713|P1|Overall Study|Other|1
1254655|NCT00547118|4112731|P2|Overall Study|Study suspended|8
1254656|NCT00547118|4112732|P1|Overall Study|Study suspended|7
1254657|NCT00547118|4112731|P2|Overall Study|Did not qualify prior to starting drug|1
1254658|NCT00547118|4112732|P1|Overall Study|Did not qualify prior to starting drug|1
1254659|NCT00546910|4112776|P2|Overall Study|Withdrawal by Subject|0
1254660|NCT00546910|4112777|P1|Overall Study|Withdrawal by Subject|2
1254661|NCT00546910|4112776|P2|Overall Study|Physician Decision|1
1254662|NCT00546910|4112777|P1|Overall Study|Physician Decision|0
1254663|NCT00546910|4112776|P2|Overall Study|Lack of Efficacy|7
1254664|NCT00546910|4112777|P1|Overall Study|Lack of Efficacy|5
1254665|NCT00546910|4112776|P2|Overall Study|Adverse Event|3
1254666|NCT00546910|4112777|P1|Overall Study|Adverse Event|2
1254667|NCT00546871|4112843|P2|Study Extension Period|Withdrawal by Subject|1
1254668|NCT00546871|4112844|P1|Study Extension Period|Withdrawal by Subject|0
1254669|NCT00546871|4112843|P2|Study Extension Period|Protocol Violation|0
1254670|NCT00546871|4112844|P1|Study Extension Period|Protocol Violation|1
1254671|NCT00546871|4112843|P2|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1
1254672|NCT00546871|4112844|P1|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0
1254673|NCT00546871|4112843|P2|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2
1254674|NCT00546871|4112844|P1|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1
1254675|NCT00546871|4112843|P2|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0
1254676|NCT00546871|4112844|P1|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1
1254677|NCT00546819|4112949|P2|Overall Study|Withdrawal by Subject|2
1254678|NCT00546819|4112950|P1|Overall Study|Withdrawal by Subject|4
1254679|NCT00546819|4112949|P2|Overall Study|Lost to Follow-up|1
1254680|NCT00546819|4112950|P1|Overall Study|Lost to Follow-up|2
1254681|NCT00546819|4112949|P2|Overall Study|Adverse Event|3
1254682|NCT00546819|4112950|P1|Overall Study|Adverse Event|2
1254683|NCT00546754|4112962|P2|Overall Study|Missing|7
1254684|NCT00546754|4112963|P1|Overall Study|Missing|14
1254685|NCT00546754|4112962|P2|Overall Study|Patient's Decision|1
1254686|NCT00546754|4112963|P1|Overall Study|Patient's Decision|0
1254687|NCT00546754|4112962|P2|Overall Study|Elevated Creatinine and Potassium levels|1
1254688|NCT00546754|4112963|P1|Overall Study|Elevated Creatinine and Potassium levels|0
1254689|NCT00546754|4112962|P2|Overall Study|Missing Cooperation|0
1254690|NCT00546754|4112963|P1|Overall Study|Missing Cooperation|1
1254691|NCT00546754|4112962|P2|Overall Study|Suicide|0
1254692|NCT00546754|4112963|P1|Overall Study|Suicide|1
1254693|NCT00546754|4112962|P2|Overall Study|Hip Replacement|0
1254694|NCT00546754|4112963|P1|Overall Study|Hip Replacement|1
1254695|NCT00546754|4112962|P2|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0
1254696|NCT00546754|4112963|P1|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1
1254697|NCT00546754|4112962|P2|Overall Study|Dyspnea|0
1254698|NCT00546754|4112963|P1|Overall Study|Dyspnea|1
1254699|NCT00546754|4112962|P2|Overall Study|Withdrawal by Subject|7
1254700|NCT00546754|4112963|P1|Overall Study|Withdrawal by Subject|6
1254701|NCT00546754|4112962|P2|Overall Study|Protocol Violation|0
1254702|NCT00546754|4112963|P1|Overall Study|Protocol Violation|3
1254703|NCT00546754|4112962|P2|Overall Study|Lost to Follow-up|15
1254704|NCT00546754|4112963|P1|Overall Study|Lost to Follow-up|9
1254705|NCT00546754|4112962|P2|Overall Study|Lack of Efficacy|1
1254706|NCT00546754|4112963|P1|Overall Study|Lack of Efficacy|1
1254707|NCT00546754|4112962|P2|Overall Study|Adverse Event|16
1254708|NCT00546754|4112963|P1|Overall Study|Adverse Event|11
1254709|NCT00546754|4112962|P2|Overall Study|Serious Adverse Event|1
1254710|NCT00546754|4112963|P1|Overall Study|Serious Adverse Event|1
1254711|NCT00546715|4113006|P4|Overall Study|Withdrawal by Subject|0
1254712|NCT00546715|4113007|P3|Overall Study|Withdrawal by Subject|0
1254713|NCT00546715|4113008|P2|Overall Study|Withdrawal by Subject|1
1254714|NCT00546715|4113009|P1|Overall Study|Withdrawal by Subject|0
1254715|NCT00546637|4113064|P2|Overall Study|Randomized, but not treated|1
1254716|NCT00546637|4113065|P1|Overall Study|Randomized, but not treated|3
1254717|NCT00546637|4113064|P2|Overall Study|Withdrawal by Subject|9
1254718|NCT00546637|4113065|P1|Overall Study|Withdrawal by Subject|7
1254719|NCT00546637|4113064|P2|Overall Study|Other|12
1254720|NCT00546637|4113065|P1|Overall Study|Other|10
1254721|NCT00546637|4113064|P2|Overall Study|Lost to Follow-up|2
1254722|NCT00546637|4113065|P1|Overall Study|Lost to Follow-up|2
1254723|NCT00546637|4113064|P2|Overall Study|Lack of Efficacy|5
1254724|NCT00546637|4113065|P1|Overall Study|Lack of Efficacy|5
1254725|NCT00546637|4113064|P2|Overall Study|Adverse Event|20
1254726|NCT00546637|4113065|P1|Overall Study|Adverse Event|46
1254727|NCT00546572|4113139|P2|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1
1254728|NCT00546572|4113140|P1|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2
1254729|NCT00546572|4113139|P2|Vax 2 / Year 1|Adverse Event|0
1254730|NCT00546572|4113140|P1|Vax 2 / Year 1|Adverse Event|1
1254731|NCT00546572|4113139|P2|Vax 2 / Year 1|Other|1
1254732|NCT00546572|4113140|P1|Vax 2 / Year 1|Other|1
1254733|NCT00546572|4113139|P2|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59
1254734|NCT00546572|4113140|P1|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64
1254735|NCT00546572|4113139|P2|Vax 1 / Year 0|Lost to Follow-up|1
1254736|NCT00546572|4113140|P1|Vax 1 / Year 0|Lost to Follow-up|0
1254737|NCT00546572|4113139|P2|Vax 1 / Year 0|Adverse Event|1
1254738|NCT00546572|4113140|P1|Vax 1 / Year 0|Adverse Event|0
1254739|NCT00546572|4113139|P2|Vax 1 / Year 0|Death|2
1254740|NCT00546572|4113140|P1|Vax 1 / Year 0|Death|2
1254741|NCT00546572|4113139|P2|Vax 1 / Year 0|Protocol Violation|4
1254742|NCT00546572|4113140|P1|Vax 1 / Year 0|Protocol Violation|3
1254743|NCT00546572|4113139|P2|Vax 1 / Year 0|Withdrawal by Subject|2
1254744|NCT00546572|4113140|P1|Vax 1 / Year 0|Withdrawal by Subject|3
1254745|NCT00546572|4113139|P2|Vax 1 / Year 0|Randomized, not treated|1
1254746|NCT00546572|4113140|P1|Vax 1 / Year 0|Randomized, not treated|1
1254747|NCT00546481|4113184|P3|Maintenance Phase (CERA)|Other Reason|1
1254748|NCT00546481|4113185|P2|Maintenance Phase (CERA)|Other Reason|0
1254749|NCT00546481|4113186|P1|Maintenance Phase (CERA)|Other Reason|0
1254750|NCT00546481|4113184|P3|Maintenance Phase (CERA)|Kidney transplantation|1
1254751|NCT00546481|4113185|P2|Maintenance Phase (CERA)|Kidney transplantation|0
1254752|NCT00546481|4113186|P1|Maintenance Phase (CERA)|Kidney transplantation|0
1254753|NCT00546481|4113184|P3|Maintenance Phase (CERA)|Withdrawal by Subject|2
1254754|NCT00546481|4113185|P2|Maintenance Phase (CERA)|Withdrawal by Subject|0
1254755|NCT00546481|4113186|P1|Maintenance Phase (CERA)|Withdrawal by Subject|0
1254756|NCT00546481|4113184|P3|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
1254757|NCT00546481|4113185|P2|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1
1254758|NCT00546481|4113186|P1|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
1254759|NCT00546481|4113184|P3|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0
1254760|NCT00546481|4113185|P2|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
1254761|NCT00546481|4113186|P1|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
1254762|NCT00546481|4113184|P3|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
1254763|NCT00546481|4113185|P2|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
1254764|NCT00546481|4113186|P1|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2
1254765|NCT00546481|4113184|P3|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
1254766|NCT00546481|4113185|P2|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
1254767|NCT00546481|4113186|P1|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1
1254768|NCT00546481|4113184|P3|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0
1254769|NCT00546481|4113185|P2|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3
1254770|NCT00546481|4113186|P1|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1
1254771|NCT00546481|4113184|P3|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
1254772|NCT00546481|4113185|P2|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
1254773|NCT00546481|4113186|P1|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1
1254774|NCT00546377|4113213|P1|Overall Study|Adverse Event|6
1254775|NCT00546377|4113213|P1|Overall Study|Deemed ineligible|1
1254776|NCT00546364|4113221|P3|Overall Study|Sponsor decision|1
1254777|NCT00546364|4113222|P2|Overall Study|Sponsor decision|0
1254778|NCT00546364|4113223|P1|Overall Study|Sponsor decision|0
1254779|NCT00546364|4113221|P3|Overall Study|Physician Decision|1
1254780|NCT00546364|4113222|P2|Overall Study|Physician Decision|0
1254781|NCT00546364|4113223|P1|Overall Study|Physician Decision|0
1254782|NCT00546364|4113221|P3|Overall Study|Target lesions resected|0
1254783|NCT00546364|4113222|P2|Overall Study|Target lesions resected|0
1254784|NCT00546364|4113223|P1|Overall Study|Target lesions resected|1
1254785|NCT00546364|4113221|P3|Overall Study|Palliative treatment|1
1254786|NCT00546364|4113222|P2|Overall Study|Palliative treatment|0
1254787|NCT00546364|4113223|P1|Overall Study|Palliative treatment|1
1254788|NCT00546364|4113221|P3|Overall Study|Mixed response|0
1254789|NCT00546364|4113222|P2|Overall Study|Mixed response|0
1254790|NCT00546364|4113223|P1|Overall Study|Mixed response|1
1254791|NCT00546364|4113221|P3|Overall Study|Prior taxotere|0
1254792|NCT00546364|4113222|P2|Overall Study|Prior taxotere|0
1254793|NCT00546364|4113223|P1|Overall Study|Prior taxotere|1
1254794|NCT00546364|4113221|P3|Overall Study|Withdrawal by Subject|3
1254795|NCT00546364|4113222|P2|Overall Study|Withdrawal by Subject|6
1254796|NCT00546364|4113223|P1|Overall Study|Withdrawal by Subject|5
1254797|NCT00546364|4113221|P3|Overall Study|No longer meets study criteria|0
1254798|NCT00546364|4113222|P2|Overall Study|No longer meets study criteria|1
1254799|NCT00546364|4113223|P1|Overall Study|No longer meets study criteria|1
1254800|NCT00546364|4113221|P3|Overall Study|Poor compliance/noncompliance|1
1254801|NCT00546364|4113222|P2|Overall Study|Poor compliance/noncompliance|0
1254802|NCT00546364|4113223|P1|Overall Study|Poor compliance/noncompliance|0
1254803|NCT00546364|4113221|P3|Overall Study|Administrative reason by sponsor|0
1254804|NCT00546364|4113222|P2|Overall Study|Administrative reason by sponsor|0
1254805|NCT00546364|4113223|P1|Overall Study|Administrative reason by sponsor|1
1254806|NCT00546364|4113221|P3|Overall Study|Completed and off treatment|2
1254807|NCT00546364|4113222|P2|Overall Study|Completed and off treatment|0
1254808|NCT00546364|4113223|P1|Overall Study|Completed and off treatment|1
1254809|NCT00546364|4113221|P3|Overall Study|Disease progression|8
1254810|NCT00546364|4113222|P2|Overall Study|Disease progression|11
1254811|NCT00546364|4113223|P1|Overall Study|Disease progression|5
1254812|NCT00546351|4113258|P1|Overall Study|Other reasons for premature termination|17
1254813|NCT00546351|4113258|P1|Overall Study|Unsatisfactory compliance|9
1254814|NCT00546351|4113258|P1|Overall Study|Protocol Deviation|1
1254815|NCT00546351|4113258|P1|Overall Study|Lost to Follow-up|9
1254816|NCT00546351|4113258|P1|Overall Study|Withdrawal by Subject|109
1254817|NCT00546351|4113258|P1|Overall Study|Lack of Efficacy|15
1254818|NCT00546351|4113258|P1|Overall Study|Adverse Event|76
1254819|NCT00546260|4113304|P2|Overall Study|Drug not given pre diagnostic angiogr|2
1254820|NCT00546260|4113305|P1|Overall Study|Drug not given pre diagnostic angiogr|8
1254821|NCT00546117|4113327|P2|Overall Study|Inability to schedule follow-up visit|0
1254822|NCT00546117|4113328|P1|Overall Study|Inability to schedule follow-up visit|1
1254823|NCT00546117|4113327|P2|Overall Study|Withdrawal by Subject|0
1254824|NCT00546117|4113328|P1|Overall Study|Withdrawal by Subject|3
1254825|NCT00546078|4113353|P2|Overall Study|Other reason|1
1254826|NCT00546078|4113354|P1|Overall Study|Other reason|1
1254827|NCT00546078|4113353|P2|Overall Study|Withdrawal by Subject|3
1254828|NCT00546078|4113354|P1|Overall Study|Withdrawal by Subject|2
1254829|NCT00546078|4113353|P2|Overall Study|Lost to Follow-up|3
1254830|NCT00546078|4113354|P1|Overall Study|Lost to Follow-up|1
1254831|NCT00546052|4113392|P1|Overall Study|Non Compliance|7
1254832|NCT00546052|4113392|P1|Overall Study|Withdrawal by Subject|20
1254833|NCT00546052|4113392|P1|Overall Study|Protocol Violation|9
1254834|NCT00546052|4113392|P1|Overall Study|Lost to Follow-up|144
1254835|NCT00546052|4113392|P1|Overall Study|Adverse Event|47
1254836|NCT00546000|4113410|P1|Overall Study|Baseline HPA Axis Supression|2
1254837|NCT00546000|4113410|P1|Overall Study|Lost to Follow-up|1
1254838|NCT00546000|4113410|P1|Overall Study|Adverse Event|1
1254839|NCT00545948|4113429|P3|Overall Study|Not Treated|7
1254840|NCT00545948|4113430|P2|Overall Study|Not Treated|1
1254841|NCT00545948|4113431|P1|Overall Study|Not Treated|1
1254842|NCT00545844|4113441|P1|Overall Study|Withdrawal by Subject|2
1254843|NCT00545844|4113441|P1|Overall Study|Protocol Violation|1
1254844|NCT00545844|4113441|P1|Overall Study|Lost to Follow-up|9
1254845|NCT00545792|4113455|P1|Overall Study|Withdrawal by Subject|1
1254846|NCT00545779|4113460|P1|Overall Study|Failure to return|3
1254847|NCT00545779|4113460|P1|Overall Study|Adverse Event/intercurrent illness|5
1254848|NCT00545779|4113460|P1|Overall Study|Withdrawal by Subject|20
1254849|NCT00545779|4113460|P1|Overall Study|Did not cooperate|7
1254850|NCT00545779|4113460|P1|Overall Study|Other protocol violation|1
1254851|NCT00545779|4113460|P1|Overall Study|Violation of selection criteria at entry|8
1254852|NCT00545753|4113480|P3|Overall Study|Protocol Violation|4
1254853|NCT00545753|4113481|P2|Overall Study|Protocol Violation|1
1254854|NCT00545753|4113482|P1|Overall Study|Protocol Violation|3
1254855|NCT00545753|4113480|P3|Overall Study|Lost to Follow-up|12
1254856|NCT00545753|4113481|P2|Overall Study|Lost to Follow-up|3
1254857|NCT00545753|4113482|P1|Overall Study|Lost to Follow-up|13
1254858|NCT00545753|4113480|P3|Overall Study|Withdrawal by Subject|10
1254859|NCT00545753|4113481|P2|Overall Study|Withdrawal by Subject|1
1254860|NCT00545753|4113482|P1|Overall Study|Withdrawal by Subject|0
1254861|NCT00545740|4113495|P4|Overall Study|Husband against study|0
1254862|NCT00545740|4113496|P3|Overall Study|Husband against study|1
1254863|NCT00545740|4113497|P2|Overall Study|Husband against study|0
1254864|NCT00545740|4113498|P1|Overall Study|Husband against study|0
1254865|NCT00545740|4113495|P4|Overall Study|Patient difficulties|0
1254866|NCT00545740|4113496|P3|Overall Study|Patient difficulties|0
1254867|NCT00545740|4113497|P2|Overall Study|Patient difficulties|1
1254868|NCT00545740|4113498|P1|Overall Study|Patient difficulties|0
1254869|NCT00545740|4113495|P4|Overall Study|Non-adherence to visits|0
1254870|NCT00545740|4113496|P3|Overall Study|Non-adherence to visits|0
1254871|NCT00545740|4113497|P2|Overall Study|Non-adherence to visits|1
1254872|NCT00545740|4113498|P1|Overall Study|Non-adherence to visits|0
1254873|NCT00545740|4113495|P4|Overall Study|Lack of time|0
1254874|NCT00545740|4113496|P3|Overall Study|Lack of time|0
1254875|NCT00545740|4113497|P2|Overall Study|Lack of time|1
1254876|NCT00545740|4113498|P1|Overall Study|Lack of time|0
1254877|NCT00545740|4113495|P4|Overall Study|Sponsor decision|0
1254878|NCT00545740|4113496|P3|Overall Study|Sponsor decision|0
1254879|NCT00545740|4113497|P2|Overall Study|Sponsor decision|1
1254880|NCT00545740|4113498|P1|Overall Study|Sponsor decision|0
1254881|NCT00545740|4113495|P4|Overall Study|Accepted only monthly telephone calls|0
1254882|NCT00545740|4113496|P3|Overall Study|Accepted only monthly telephone calls|0
1254883|NCT00545740|4113497|P2|Overall Study|Accepted only monthly telephone calls|0
1254884|NCT00545740|4113498|P1|Overall Study|Accepted only monthly telephone calls|1
1254885|NCT00545740|4113495|P4|Overall Study|Physician Decision|0
1254886|NCT00545740|4113496|P3|Overall Study|Physician Decision|3
1254887|NCT00545740|4113497|P2|Overall Study|Physician Decision|0
1254888|NCT00545740|4113498|P1|Overall Study|Physician Decision|0
1254889|NCT00545740|4113495|P4|Overall Study|Missed visit|0
1254890|NCT00545740|4113496|P3|Overall Study|Missed visit|0
1254891|NCT00545740|4113497|P2|Overall Study|Missed visit|0
1254892|NCT00545740|4113498|P1|Overall Study|Missed visit|1
1254893|NCT00545740|4113495|P4|Overall Study|Site closure|0
1254894|NCT00545740|4113496|P3|Overall Study|Site closure|0
1254895|NCT00545740|4113497|P2|Overall Study|Site closure|0
1254896|NCT00545740|4113498|P1|Overall Study|Site closure|1
1254897|NCT00545740|4113495|P4|Overall Study|Suspected Diverticulitis Recurrence|1
1254898|NCT00545740|4113496|P3|Overall Study|Suspected Diverticulitis Recurrence|1
1254899|NCT00545740|4113497|P2|Overall Study|Suspected Diverticulitis Recurrence|1
1254900|NCT00545740|4113498|P1|Overall Study|Suspected Diverticulitis Recurrence|1
1254901|NCT00545740|4113495|P4|Overall Study|Diverticulitis attack|1
1254902|NCT00545740|4113496|P3|Overall Study|Diverticulitis attack|1
1254903|NCT00545740|4113497|P2|Overall Study|Diverticulitis attack|0
1254904|NCT00545740|4113498|P1|Overall Study|Diverticulitis attack|0
1254905|NCT00545740|4113495|P4|Overall Study|Moved|0
1254906|NCT00545740|4113496|P3|Overall Study|Moved|1
1254907|NCT00545740|4113497|P2|Overall Study|Moved|0
1254908|NCT00545740|4113498|P1|Overall Study|Moved|2
1254909|NCT00545740|4113495|P4|Overall Study|Non-compliance|0
1254910|NCT00545740|4113496|P3|Overall Study|Non-compliance|1
1254911|NCT00545740|4113497|P2|Overall Study|Non-compliance|2
1254912|NCT00545740|4113498|P1|Overall Study|Non-compliance|0
1254913|NCT00545740|4113495|P4|Overall Study|Protocol Violation|0
1254914|NCT00545740|4113496|P3|Overall Study|Protocol Violation|1
1254915|NCT00545740|4113497|P2|Overall Study|Protocol Violation|3
1254916|NCT00545740|4113498|P1|Overall Study|Protocol Violation|1
1254917|NCT00545740|4113495|P4|Overall Study|Lost to Follow-up|6
1254918|NCT00545740|4113496|P3|Overall Study|Lost to Follow-up|5
1254919|NCT00545740|4113497|P2|Overall Study|Lost to Follow-up|5
1254920|NCT00545740|4113498|P1|Overall Study|Lost to Follow-up|7
1254921|NCT00545740|4113495|P4|Overall Study|Adverse Event|9
1254922|NCT00545740|4113496|P3|Overall Study|Adverse Event|19
1254923|NCT00545740|4113497|P2|Overall Study|Adverse Event|18
1254924|NCT00545740|4113498|P1|Overall Study|Adverse Event|10
1254925|NCT00545740|4113495|P4|Overall Study|Withdrawal by Subject|18
1254926|NCT00545740|4113496|P3|Overall Study|Withdrawal by Subject|16
1254927|NCT00545740|4113497|P2|Overall Study|Withdrawal by Subject|15
1254928|NCT00545740|4113498|P1|Overall Study|Withdrawal by Subject|17
1254929|NCT00545740|4113495|P4|Overall Study|Lack of Efficacy|36
1254930|NCT00545740|4113496|P3|Overall Study|Lack of Efficacy|47
1254931|NCT00545740|4113497|P2|Overall Study|Lack of Efficacy|35
1254932|NCT00545740|4113498|P1|Overall Study|Lack of Efficacy|34
1254933|NCT00545688|4113536|P4|Follow-Up Period|Violation of Selection Criteria at Entry|1
1254934|NCT00545688|4113537|P3|Follow-Up Period|Violation of Selection Criteria at Entry|0
1254935|NCT00545688|4113538|P2|Follow-Up Period|Violation of Selection Criteria at Entry|2
1254936|NCT00545688|4113539|P1|Follow-Up Period|Violation of Selection Criteria at Entry|0
1254937|NCT00545688|4113536|P4|Follow-Up Period|Unspecified Reason|8
1254938|NCT00545688|4113537|P3|Follow-Up Period|Unspecified Reason|6
1254939|NCT00545688|4113538|P2|Follow-Up Period|Unspecified Reason|5
1254940|NCT00545688|4113539|P1|Follow-Up Period|Unspecified Reason|2
1254941|NCT00545688|4113536|P4|Follow-Up Period|Lost to Follow-up|1
1254942|NCT00545688|4113537|P3|Follow-Up Period|Lost to Follow-up|3
1254943|NCT00545688|4113538|P2|Follow-Up Period|Lost to Follow-up|3
1254944|NCT00545688|4113539|P1|Follow-Up Period|Lost to Follow-up|3
1254945|NCT00545688|4113536|P4|Follow-Up Period|Refused Treatment|2
1254946|NCT00545688|4113537|P3|Follow-Up Period|Refused Treatment|0
1254947|NCT00545688|4113538|P2|Follow-Up Period|Refused Treatment|2
1254948|NCT00545688|4113539|P1|Follow-Up Period|Refused Treatment|6
1254949|NCT00545688|4113536|P4|Follow-Up Period|Disease Progression|9
1254950|NCT00545688|4113537|P3|Follow-Up Period|Disease Progression|9
1254951|NCT00545688|4113538|P2|Follow-Up Period|Disease Progression|5
1254952|NCT00545688|4113539|P1|Follow-Up Period|Disease Progression|6
1254953|NCT00545688|4113536|P4|Follow-Up Period|Death|6
1254954|NCT00545688|4113537|P3|Follow-Up Period|Death|2
1254955|NCT00545688|4113538|P2|Follow-Up Period|Death|2
1254956|NCT00545688|4113539|P1|Follow-Up Period|Death|4
1254957|NCT00545688|4113536|P4|Adjuvant Treatment Period|Unknown Reason|0
1254958|NCT00545688|4113537|P3|Adjuvant Treatment Period|Unknown Reason|0
1254959|NCT00545688|4113538|P2|Adjuvant Treatment Period|Unknown Reason|1
1254960|NCT00545688|4113539|P1|Adjuvant Treatment Period|Unknown Reason|0
1254961|NCT00545688|4113536|P4|Adjuvant Treatment Period|Adverse Event|2
1254962|NCT00545688|4113537|P3|Adjuvant Treatment Period|Adverse Event|2
1254963|NCT00545688|4113538|P2|Adjuvant Treatment Period|Adverse Event|3
1254964|NCT00545688|4113539|P1|Adjuvant Treatment Period|Adverse Event|0
1254965|NCT00545688|4113536|P4|Adjuvant Treatment Period|Lost to Follow-up|0
1254966|NCT00545688|4113537|P3|Adjuvant Treatment Period|Lost to Follow-up|1
1254967|NCT00545688|4113538|P2|Adjuvant Treatment Period|Lost to Follow-up|0
1254968|NCT00545688|4113539|P1|Adjuvant Treatment Period|Lost to Follow-up|1
1254969|NCT00545688|4113536|P4|Adjuvant Treatment Period|Refused Treatment|5
1254970|NCT00545688|4113537|P3|Adjuvant Treatment Period|Refused Treatment|1
1254971|NCT00545688|4113538|P2|Adjuvant Treatment Period|Refused Treatment|1
1254972|NCT00545688|4113539|P1|Adjuvant Treatment Period|Refused Treatment|1
1254973|NCT00545688|4113536|P4|Adjuvant Treatment Period|Disease Progression|7
1254974|NCT00545688|4113537|P3|Adjuvant Treatment Period|Disease Progression|0
1254975|NCT00545688|4113538|P2|Adjuvant Treatment Period|Disease Progression|3
1254976|NCT00545688|4113539|P1|Adjuvant Treatment Period|Disease Progression|3
1254977|NCT00545688|4113536|P4|Neo-Adjuvant Treatment Period|Adverse Event|2
1254978|NCT00545688|4113537|P3|Neo-Adjuvant Treatment Period|Adverse Event|2
1254979|NCT00545688|4113538|P2|Neo-Adjuvant Treatment Period|Adverse Event|0
1254980|NCT00545688|4113539|P1|Neo-Adjuvant Treatment Period|Adverse Event|0
1254981|NCT00545688|4113536|P4|Neo-Adjuvant Treatment Period|Unknown Reason|0
1254982|NCT00545688|4113537|P3|Neo-Adjuvant Treatment Period|Unknown Reason|0
1254983|NCT00545688|4113538|P2|Neo-Adjuvant Treatment Period|Unknown Reason|0
1254984|NCT00545688|4113539|P1|Neo-Adjuvant Treatment Period|Unknown Reason|1
1254985|NCT00545688|4113536|P4|Neo-Adjuvant Treatment Period|Disease Progression|2
1254986|NCT00545688|4113537|P3|Neo-Adjuvant Treatment Period|Disease Progression|7
1254987|NCT00545688|4113538|P2|Neo-Adjuvant Treatment Period|Disease Progression|1
1254988|NCT00545688|4113539|P1|Neo-Adjuvant Treatment Period|Disease Progression|0
1254989|NCT00545688|4113536|P4|Neo-Adjuvant Treatment Period|Death|0
1254990|NCT00545688|4113537|P3|Neo-Adjuvant Treatment Period|Death|0
1254991|NCT00545688|4113538|P2|Neo-Adjuvant Treatment Period|Death|1
1254992|NCT00545688|4113539|P1|Neo-Adjuvant Treatment Period|Death|0
1254993|NCT00545688|4113536|P4|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
1254994|NCT00545688|4113537|P3|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
1254995|NCT00545688|4113538|P2|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
1254996|NCT00545688|4113539|P1|Neo-Adjuvant Treatment Period|Lost to Follow-up|1
1254997|NCT00545688|4113536|P4|Neo-Adjuvant Treatment Period|Refused Treatment|1
1254998|NCT00545688|4113537|P3|Neo-Adjuvant Treatment Period|Refused Treatment|4
1254999|NCT00545688|4113538|P2|Neo-Adjuvant Treatment Period|Refused Treatment|1
1255000|NCT00545688|4113539|P1|Neo-Adjuvant Treatment Period|Refused Treatment|1
1255001|NCT00545688|4113536|P4|Neo-Adjuvant Treatment Period|Protocol Violation|1
1255002|NCT00545688|4113537|P3|Neo-Adjuvant Treatment Period|Protocol Violation|1
1255003|NCT00545688|4113538|P2|Neo-Adjuvant Treatment Period|Protocol Violation|2
1255004|NCT00545688|4113539|P1|Neo-Adjuvant Treatment Period|Protocol Violation|1
1255005|NCT00545584|4113638|P3|Overall Study|Two or more reasons for discontinuation|8
1255006|NCT00545584|4113639|P2|Overall Study|Two or more reasons for discontinuation|19
1255007|NCT00545584|4113640|P1|Overall Study|Two or more reasons for discontinuation|17
1255008|NCT00545584|4113638|P3|Overall Study|Only one reason for discontinuation|48
1255009|NCT00545584|4113639|P2|Overall Study|Only one reason for discontinuation|61
1255010|NCT00545584|4113640|P1|Overall Study|Only one reason for discontinuation|62
1255011|NCT00545571|4113651|P1|Overall Study|Kidney Transplantation|3
1255012|NCT00545571|4113651|P1|Overall Study|Early Termination of Study|24
1255013|NCT00545571|4113651|P1|Overall Study|Transfusion|12
1255014|NCT00545571|4113651|P1|Overall Study|Screen Failure|16
1255015|NCT00545571|4113651|P1|Overall Study|Refused Treatment|1
1255016|NCT00545571|4113651|P1|Overall Study|Protocol Violation|2
1255017|NCT00545571|4113651|P1|Overall Study|Lack of Efficacy|1
1255018|NCT00545571|4113651|P1|Overall Study|Death|5
1255019|NCT00545571|4113651|P1|Overall Study|Adverse Event|2
1255020|NCT00545571|4113651|P1|Overall Study|Administrative Reasons|1
1255021|NCT00545532|4113666|P2|Overall Study|Death|1
1255022|NCT00545532|4113667|P1|Overall Study|Death|0
1255023|NCT00545532|4113666|P2|Overall Study|Lost to Follow-up|6
1255024|NCT00545532|4113667|P1|Overall Study|Lost to Follow-up|5
1255025|NCT00545532|4113666|P2|Overall Study|Withdrawal by Subject|3
1255026|NCT00545532|4113667|P1|Overall Study|Withdrawal by Subject|1
1255027|NCT00545441|4113758|P2|Overall Study|Patients were not treated|3
1255028|NCT00545441|4113759|P1|Overall Study|Patients were not treated|1
1255029|NCT00545441|4113758|P2|Overall Study|Persistence or recurrence of fistula|2
1255030|NCT00545441|4113759|P1|Overall Study|Persistence or recurrence of fistula|5
1255031|NCT00545441|4113758|P2|Overall Study|Withdrawal by Subject|1
1255032|NCT00545441|4113759|P1|Overall Study|Withdrawal by Subject|1
1255033|NCT00545441|4113758|P2|Overall Study|Technical failure|1
1255034|NCT00545441|4113759|P1|Overall Study|Technical failure|0
1255035|NCT00545441|4113758|P2|Overall Study|Lost to Follow-up|5
1255036|NCT00545441|4113759|P1|Overall Study|Lost to Follow-up|9
1255037|NCT00545441|4113758|P2|Overall Study|Fistula draining at 6 months|4
1255038|NCT00545441|4113759|P1|Overall Study|Fistula draining at 6 months|2
1255039|NCT00545402|4113767|P2|Overall Study|Reason not specified|1
1255040|NCT00545402|4113768|P1|Overall Study|Reason not specified|1
1255041|NCT00545402|4113767|P2|Overall Study|Protocol Violation|0
1255042|NCT00545402|4113768|P1|Overall Study|Protocol Violation|1
1255043|NCT00545402|4113767|P2|Overall Study|Withdrawal by Subject|1
1255044|NCT00545402|4113768|P1|Overall Study|Withdrawal by Subject|0
1255045|NCT00545402|4113767|P2|Overall Study|Graft loss|4
1255046|NCT00545402|4113768|P1|Overall Study|Graft loss|2
1255047|NCT00545402|4113767|P2|Overall Study|Death|7
1255048|NCT00545402|4113768|P1|Overall Study|Death|5
1255049|NCT00545402|4113767|P2|Overall Study|Use of unauthorized immunosuppressant|7
1255050|NCT00545402|4113768|P1|Overall Study|Use of unauthorized immunosuppressant|8
1255051|NCT00545402|4113767|P2|Overall Study|Discontinuation of treatment|9
1255052|NCT00545402|4113768|P1|Overall Study|Discontinuation of treatment|17
1255053|NCT00545363|4113786|P2|Overall Study|Other|1
1255054|NCT00545363|4113787|P1|Overall Study|Other|1
1255055|NCT00545363|4113786|P2|Overall Study|Lost to Follow-up|0
1255056|NCT00545363|4113787|P1|Overall Study|Lost to Follow-up|2
1255057|NCT00545363|4113786|P2|Overall Study|Did not meet entry criteria|1
1255058|NCT00545363|4113787|P1|Overall Study|Did not meet entry criteria|1
1255059|NCT00545363|4113786|P2|Overall Study|Non-compliance|1
1255060|NCT00545363|4113787|P1|Overall Study|Non-compliance|3
1255061|NCT00545363|4113786|P2|Overall Study|Withdrawal by Subject|5
1255062|NCT00545363|4113787|P1|Overall Study|Withdrawal by Subject|6
1255063|NCT00545363|4113786|P2|Overall Study|Adverse Event|7
1255064|NCT00545363|4113787|P1|Overall Study|Adverse Event|6
1255065|NCT00545298|4113802|P3|Overall Study|Issues with Standard of Care|1
1255066|NCT00545298|4113803|P2|Overall Study|Issues with Standard of Care|0
1255067|NCT00545298|4113804|P1|Overall Study|Issues with Standard of Care|2
1255068|NCT00545272|4113821|P6|Overall Study|Lost to Follow-up|0
1255069|NCT00545272|4113822|P5|Overall Study|Lost to Follow-up|1
1255070|NCT00545272|4113823|P4|Overall Study|Lost to Follow-up|0
1255071|NCT00545272|4113824|P3|Overall Study|Lost to Follow-up|0
1255072|NCT00545272|4113825|P2|Overall Study|Lost to Follow-up|0
1255073|NCT00545272|4113826|P1|Overall Study|Lost to Follow-up|0
1255074|NCT00545272|4113821|P6|Overall Study|Abnormal test procedure result(s)|0
1255075|NCT00545272|4113822|P5|Overall Study|Abnormal test procedure result(s)|1
1255076|NCT00545272|4113823|P4|Overall Study|Abnormal test procedure result(s)|0
1255077|NCT00545272|4113824|P3|Overall Study|Abnormal test procedure result(s)|0
1255078|NCT00545272|4113825|P2|Overall Study|Abnormal test procedure result(s)|0
1255079|NCT00545272|4113826|P1|Overall Study|Abnormal test procedure result(s)|0
1255080|NCT00545272|4113821|P6|Overall Study|Abnormal laboratory value(s)|1
1255081|NCT00545272|4113822|P5|Overall Study|Abnormal laboratory value(s)|0
1255082|NCT00545272|4113823|P4|Overall Study|Abnormal laboratory value(s)|0
1255083|NCT00545272|4113824|P3|Overall Study|Abnormal laboratory value(s)|0
1255084|NCT00545272|4113825|P2|Overall Study|Abnormal laboratory value(s)|0
1255085|NCT00545272|4113826|P1|Overall Study|Abnormal laboratory value(s)|0
1255086|NCT00545272|4113821|P6|Overall Study|Adverse Event|1
1255087|NCT00545272|4113822|P5|Overall Study|Adverse Event|0
1255088|NCT00545272|4113823|P4|Overall Study|Adverse Event|0
1255089|NCT00545272|4113824|P3|Overall Study|Adverse Event|1
1255090|NCT00545272|4113825|P2|Overall Study|Adverse Event|0
1255091|NCT00545272|4113826|P1|Overall Study|Adverse Event|0
1255092|NCT00545272|4113821|P6|Overall Study|Protocol deviation|1
1255093|NCT00545272|4113822|P5|Overall Study|Protocol deviation|0
1255094|NCT00545272|4113823|P4|Overall Study|Protocol deviation|1
1255095|NCT00545272|4113824|P3|Overall Study|Protocol deviation|0
1255096|NCT00545272|4113825|P2|Overall Study|Protocol deviation|1
1255097|NCT00545272|4113826|P1|Overall Study|Protocol deviation|0
1255098|NCT00545233|4113878|P2|Overall Study|Physician Decision|1
1255099|NCT00545233|4113879|P1|Overall Study|Physician Decision|2
1255100|NCT00545233|4113878|P2|Overall Study|Insufficient response|15
1255101|NCT00545233|4113879|P1|Overall Study|Insufficient response|14
1255102|NCT00545233|4113878|P2|Overall Study|Failure to Return|6
1255103|NCT00545233|4113879|P1|Overall Study|Failure to Return|4
1255104|NCT00545233|4113878|P2|Overall Study|Refused Treatment|7
1255105|NCT00545233|4113879|P1|Overall Study|Refused Treatment|9
1255106|NCT00545233|4113878|P2|Overall Study|Protocol Violation|0
1255107|NCT00545233|4113879|P1|Overall Study|Protocol Violation|2
1255108|NCT00545233|4113878|P2|Overall Study|Violation of Selection Criteria at Entry|1
1255109|NCT00545233|4113879|P1|Overall Study|Violation of Selection Criteria at Entry|5
1255110|NCT00545233|4113878|P2|Overall Study|Adverse Event|5
1255111|NCT00545233|4113879|P1|Overall Study|Adverse Event|10
1255112|NCT00545168|4113938|P3|Overall Study|Visit for Day 21 was not done in error|2
1255113|NCT00545168|4113939|P2|Overall Study|Visit for Day 21 was not done in error|0
1255114|NCT00545168|4113940|P1|Overall Study|Visit for Day 21 was not done in error|1
1255115|NCT00545168|4113938|P3|Overall Study|Protocol Violation|1
1255116|NCT00545168|4113939|P2|Overall Study|Protocol Violation|0
1255117|NCT00545168|4113940|P1|Overall Study|Protocol Violation|1
1255118|NCT00545168|4113938|P3|Overall Study|Withdrawal by Subject|13
1255119|NCT00545168|4113939|P2|Overall Study|Withdrawal by Subject|0
1255120|NCT00545168|4113940|P1|Overall Study|Withdrawal by Subject|9
1255121|NCT00545168|4113938|P3|Overall Study|Lost to Follow-up|5
1255122|NCT00545168|4113939|P2|Overall Study|Lost to Follow-up|5
1255123|NCT00545168|4113940|P1|Overall Study|Lost to Follow-up|5
1255124|NCT00545103|4113966|P4|Overall Study|Death|0
1255125|NCT00545103|4113967|P3|Overall Study|Death|0
1255126|NCT00545103|4113968|P2|Overall Study|Death|1
1255127|NCT00545103|4113969|P1|Overall Study|Death|0
1255128|NCT00545103|4113966|P4|Overall Study|Subject met endpoint under protocol v. 1|0
1255129|NCT00545103|4113967|P3|Overall Study|Subject met endpoint under protocol v. 1|1
1255130|NCT00545103|4113968|P2|Overall Study|Subject met endpoint under protocol v. 1|0
1255131|NCT00545103|4113969|P1|Overall Study|Subject met endpoint under protocol v. 1|0
1255132|NCT00545103|4113966|P4|Overall Study|Does not want to take study drug anymore|0
1255133|NCT00545103|4113967|P3|Overall Study|Does not want to take study drug anymore|1
1255134|NCT00545103|4113968|P2|Overall Study|Does not want to take study drug anymore|0
1255135|NCT00545103|4113969|P1|Overall Study|Does not want to take study drug anymore|1
1255136|NCT00545103|4113966|P4|Overall Study|Use of prohibited medication|0
1255137|NCT00545103|4113967|P3|Overall Study|Use of prohibited medication|1
1255138|NCT00545103|4113968|P2|Overall Study|Use of prohibited medication|0
1255139|NCT00545103|4113969|P1|Overall Study|Use of prohibited medication|0
1255140|NCT00545103|4113966|P4|Overall Study|Subject moved|0
1255141|NCT00545103|4113967|P3|Overall Study|Subject moved|0
1255142|NCT00545103|4113968|P2|Overall Study|Subject moved|1
1255143|NCT00545103|4113969|P1|Overall Study|Subject moved|0
1255144|NCT00545103|4113966|P4|Overall Study|Investigator decision|0
1255145|NCT00545103|4113967|P3|Overall Study|Investigator decision|1
1255146|NCT00545103|4113968|P2|Overall Study|Investigator decision|0
1255147|NCT00545103|4113969|P1|Overall Study|Investigator decision|0
1255148|NCT00545103|4113966|P4|Overall Study|Noncompliance|0
1255149|NCT00545103|4113967|P3|Overall Study|Noncompliance|0
1255150|NCT00545103|4113968|P2|Overall Study|Noncompliance|1
1255151|NCT00545103|4113969|P1|Overall Study|Noncompliance|0
1255152|NCT00545103|4113966|P4|Overall Study|Subject's decision|0
1255153|NCT00545103|4113967|P3|Overall Study|Subject's decision|0
1255154|NCT00545103|4113968|P2|Overall Study|Subject's decision|0
1255155|NCT00545103|4113969|P1|Overall Study|Subject's decision|1
1255156|NCT00545103|4113966|P4|Overall Study|Personal reasons|0
1255157|NCT00545103|4113967|P3|Overall Study|Personal reasons|0
1255158|NCT00545103|4113968|P2|Overall Study|Personal reasons|0
1255159|NCT00545103|4113969|P1|Overall Study|Personal reasons|1
1255160|NCT00545103|4113966|P4|Overall Study|Diverticulitis crisis|1
1255161|NCT00545103|4113967|P3|Overall Study|Diverticulitis crisis|0
1255162|NCT00545103|4113968|P2|Overall Study|Diverticulitis crisis|0
1255163|NCT00545103|4113969|P1|Overall Study|Diverticulitis crisis|0
1255164|NCT00545103|4113966|P4|Overall Study|Wish to start a family|1
1255165|NCT00545103|4113967|P3|Overall Study|Wish to start a family|0
1255166|NCT00545103|4113968|P2|Overall Study|Wish to start a family|0
1255167|NCT00545103|4113969|P1|Overall Study|Wish to start a family|0
1255168|NCT00545103|4113966|P4|Overall Study|Investigational product not taken|1
1255169|NCT00545103|4113967|P3|Overall Study|Investigational product not taken|0
1255170|NCT00545103|4113968|P2|Overall Study|Investigational product not taken|0
1255171|NCT00545103|4113969|P1|Overall Study|Investigational product not taken|1
1255172|NCT00545103|4113966|P4|Overall Study|Difficult to open package|1
1255173|NCT00545103|4113967|P3|Overall Study|Difficult to open package|0
1255174|NCT00545103|4113968|P2|Overall Study|Difficult to open package|0
1255175|NCT00545103|4113969|P1|Overall Study|Difficult to open package|0
1255176|NCT00545103|4113966|P4|Overall Study|Suspected recurrence of diverticulitis|3
1255177|NCT00545103|4113967|P3|Overall Study|Suspected recurrence of diverticulitis|0
1255178|NCT00545103|4113968|P2|Overall Study|Suspected recurrence of diverticulitis|0
1255179|NCT00545103|4113969|P1|Overall Study|Suspected recurrence of diverticulitis|1
1255180|NCT00545103|4113966|P4|Overall Study|Protocol Violation|0
1255181|NCT00545103|4113967|P3|Overall Study|Protocol Violation|3
1255182|NCT00545103|4113968|P2|Overall Study|Protocol Violation|2
1255183|NCT00545103|4113969|P1|Overall Study|Protocol Violation|1
1255184|NCT00545103|4113966|P4|Overall Study|Lost to Follow-up|4
1255185|NCT00545103|4113967|P3|Overall Study|Lost to Follow-up|3
1255186|NCT00545103|4113968|P2|Overall Study|Lost to Follow-up|6
1255187|NCT00545103|4113969|P1|Overall Study|Lost to Follow-up|4
1255188|NCT00545103|4113966|P4|Overall Study|Adverse Event|10
1255189|NCT00545103|4113967|P3|Overall Study|Adverse Event|17
1255190|NCT00545103|4113968|P2|Overall Study|Adverse Event|12
1255191|NCT00545103|4113969|P1|Overall Study|Adverse Event|11
1255192|NCT00545103|4113966|P4|Overall Study|Withdrawal by Subject|22
1255193|NCT00545103|4113967|P3|Overall Study|Withdrawal by Subject|18
1255194|NCT00545103|4113968|P2|Overall Study|Withdrawal by Subject|10
1255195|NCT00545103|4113969|P1|Overall Study|Withdrawal by Subject|6
1255196|NCT00545103|4113966|P4|Overall Study|Lack of Efficacy|27
1255197|NCT00545103|4113967|P3|Overall Study|Lack of Efficacy|31
1255198|NCT00545103|4113968|P2|Overall Study|Lack of Efficacy|45
1255199|NCT00545103|4113969|P1|Overall Study|Lack of Efficacy|48
1255200|NCT00545064|4114003|P1|Overall Study|inclement weather|1
1255201|NCT00545064|4114003|P1|Overall Study|cancel all appointments, no rebooking|1
1255202|NCT00545064|4114003|P1|Overall Study|did not complete course of treatment|1
1255203|NCT00545064|4114003|P1|Overall Study|Withdrawal by Subject|2
1255204|NCT00545064|4114003|P1|Overall Study|Lost to Follow-up|3
1255205|NCT00545051|4114014|P2|Overall Study|Administrative reasons|1
1255206|NCT00545051|4114015|P1|Overall Study|Administrative reasons|0
1255207|NCT00545051|4114014|P2|Overall Study|Withdrawal by Subject|1
1255208|NCT00545051|4114015|P1|Overall Study|Withdrawal by Subject|0
1255209|NCT00545051|4114014|P2|Overall Study|Protocol Violation|0
1255210|NCT00545051|4114015|P1|Overall Study|Protocol Violation|1
1255211|NCT00545051|4114014|P2|Overall Study|Violation of inclusion/exclusion|2
1255212|NCT00545051|4114015|P1|Overall Study|Violation of inclusion/exclusion|0
1255213|NCT00545051|4114014|P2|Overall Study|Death|0
1255214|NCT00545051|4114015|P1|Overall Study|Death|1
1255215|NCT00545051|4114014|P2|Overall Study|Adverse Event|3
1255216|NCT00545051|4114015|P1|Overall Study|Adverse Event|7
1255217|NCT00544882|4114059|P3|Cycle 3: Follow-up|Pregnancy|0
1255218|NCT00544882|4114060|P2|Cycle 3: Follow-up|Pregnancy|1
1255219|NCT00544882|4114061|P1|Cycle 3: Follow-up|Pregnancy|0
1255220|NCT00544882|4114059|P3|Cycle 3: Follow-up|Noncompliance|0
1255221|NCT00544882|4114060|P2|Cycle 3: Follow-up|Noncompliance|1
1255222|NCT00544882|4114061|P1|Cycle 3: Follow-up|Noncompliance|0
1255223|NCT00544882|4114059|P3|Cycle 2: Randomized Treatment Cycle|Noncompliance|1
1255224|NCT00544882|4114060|P2|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
1255225|NCT00544882|4114061|P1|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
1255226|NCT00544882|4114059|P3|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
1255227|NCT00544882|4114060|P2|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1
1255228|NCT00544882|4114061|P1|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
1255229|NCT00544882|4114059|P3|Cycle 1: Run-in Cycle|Adverse Event|0
1255230|NCT00544882|4114060|P2|Cycle 1: Run-in Cycle|Adverse Event|0
1255231|NCT00544882|4114061|P1|Cycle 1: Run-in Cycle|Adverse Event|1
1255232|NCT00544882|4114059|P3|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
1255233|NCT00544882|4114060|P2|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
1255234|NCT00544882|4114061|P1|Cycle 1: Run-in Cycle|Withdrawal by Subject|2
1255235|NCT00544869|4114086|P3|Overall Study|Physician Decision|0
1255236|NCT00544869|4114087|P2|Overall Study|Physician Decision|0
1255237|NCT00544869|4114088|P1|Overall Study|Physician Decision|2
1255238|NCT00544869|4114086|P3|Overall Study|Lack of Efficacy|0
1255239|NCT00544869|4114087|P2|Overall Study|Lack of Efficacy|1
1255240|NCT00544869|4114088|P1|Overall Study|Lack of Efficacy|1
1255241|NCT00544869|4114086|P3|Overall Study|Adverse Event|0
1255242|NCT00544869|4114087|P2|Overall Study|Adverse Event|1
1255243|NCT00544869|4114088|P1|Overall Study|Adverse Event|6
1255244|NCT00544869|4114086|P3|Overall Study|Rsolution of congenitive symptoms|0
1255245|NCT00544869|4114087|P2|Overall Study|Rsolution of congenitive symptoms|0
1255246|NCT00544869|4114088|P1|Overall Study|Rsolution of congenitive symptoms|3
1255247|NCT00544817|4114096|P1|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1
1255248|NCT00544817|4114096|P1|Follow-up Systemic Therapy|Physician Decision|3
1255249|NCT00544817|4114096|P1|Follow-up Systemic Therapy|Lack of Efficacy|15
1255250|NCT00544817|4114096|P1|No Treatment Interval|Adverse Event|1
1255251|NCT00544817|4114096|P1|No Treatment Interval|Physician Decision|3
1255252|NCT00544817|4114096|P1|No Treatment Interval|Lack of Efficacy|8
1255253|NCT00544817|4114096|P1|Combined Modality|Intercurrent Illness - Pneumonia|1
1255254|NCT00544817|4114096|P1|Combined Modality|Adverse Event|2
1255255|NCT00544817|4114096|P1|Combined Modality|Worsening Neurologic Symptoms|2
1255256|NCT00544817|4114096|P1|Combined Modality|Lack of Efficacy|2
1255257|NCT00544648|4114145|P2|Overall Study|progression of disease|0
1255258|NCT00544648|4114146|P1|Overall Study|progression of disease|1
1255259|NCT00544648|4114145|P2|Overall Study|Adverse Event|1
1255260|NCT00544648|4114146|P1|Overall Study|Adverse Event|1
1255261|NCT00544648|4114145|P2|Overall Study|Withdrawal by Subject|0
1255262|NCT00544648|4114146|P1|Overall Study|Withdrawal by Subject|1
1255263|NCT00544557|4114160|P1|Overall Study|Other|98
1255264|NCT00544557|4114160|P1|Overall Study|Lack of Efficacy|196
1255265|NCT00544557|4114160|P1|Overall Study|Adverse Event|140
1255266|NCT00544544|4114191|P1|Overall Study|Lost to Follow-up|1
1255267|NCT00544544|4114191|P1|Overall Study|Adverse Event|1
1255268|NCT00544544|4114191|P1|Overall Study|Withdrawal by Subject|1
1255269|NCT00544440|4114198|P1|Overall Study|Other|5
1255270|NCT00544440|4114198|P1|Overall Study|Progressive Disease|47
1255271|NCT00544440|4114198|P1|Overall Study|Subject Non-compliance|1
1255272|NCT00544440|4114198|P1|Overall Study|Withdrawal by Subject|2
1255273|NCT00544440|4114198|P1|Overall Study|Adverse Event|1
1255274|NCT00544440|4114198|P1|Overall Study|Other|1
1255275|NCT00544167|4114205|P1|Overall Study|Physician Decision|8
1255276|NCT00544167|4114205|P1|Overall Study|Adverse Event|21
1255277|NCT00543985|4114209|P1|Overall Study|Withdrawal by Subject|4
1255278|NCT00543855|4114220|P4|Overall Study|Protocol Violation|0
1255279|NCT00543855|4114221|P3|Overall Study|Protocol Violation|0
1255280|NCT00543855|4114222|P2|Overall Study|Protocol Violation|0
1255281|NCT00543855|4114223|P1|Overall Study|Protocol Violation|1
1255282|NCT00543855|4114220|P4|Overall Study|Withdrawal by Subject|0
1255283|NCT00543855|4114221|P3|Overall Study|Withdrawal by Subject|2
1255284|NCT00543855|4114222|P2|Overall Study|Withdrawal by Subject|1
1255285|NCT00543855|4114223|P1|Overall Study|Withdrawal by Subject|0
1255286|NCT00543855|4114220|P4|Overall Study|Lost to Follow-up|0
1255287|NCT00543855|4114221|P3|Overall Study|Lost to Follow-up|1
1255288|NCT00543855|4114222|P2|Overall Study|Lost to Follow-up|0
1255289|NCT00543855|4114223|P1|Overall Study|Lost to Follow-up|0
1255290|NCT00543855|4114220|P4|Overall Study|Adverse Event|4
1255291|NCT00543855|4114221|P3|Overall Study|Adverse Event|3
1255292|NCT00543855|4114222|P2|Overall Study|Adverse Event|1
1255293|NCT00543855|4114223|P1|Overall Study|Adverse Event|3
1255294|NCT00543803|4114245|P1|Overall Study|not specified|86
1255295|NCT00543803|4114245|P1|Overall Study|Lost to Follow-up|20
1255296|NCT00543803|4114245|P1|Overall Study|Lack of Efficacy|22
1255297|NCT00543803|4114245|P1|Overall Study|Adverse Event|14
1255298|NCT00543725|4114273|P2|Overall Study|Not specified|3
1255299|NCT00543725|4114274|P1|Overall Study|Not specified|3
1255300|NCT00543725|4114273|P2|Overall Study|Lost to Follow-up|11
1255301|NCT00543725|4114274|P1|Overall Study|Lost to Follow-up|15
1255302|NCT00543725|4114273|P2|Overall Study|Withdrawal by Subject|13
1255303|NCT00543725|4114274|P1|Overall Study|Withdrawal by Subject|4
1255304|NCT00543725|4114273|P2|Overall Study|Protocol Violation|1
1255305|NCT00543725|4114274|P1|Overall Study|Protocol Violation|0
1255306|NCT00543725|4114273|P2|Overall Study|Subject Reached A Virologic Endpoint|14
1255307|NCT00543725|4114274|P1|Overall Study|Subject Reached A Virologic Endpoint|22
1255308|NCT00543725|4114273|P2|Overall Study|Subject Ineligible To Continue The Trial|0
1255309|NCT00543725|4114274|P1|Overall Study|Subject Ineligible To Continue The Trial|2
1255310|NCT00543725|4114273|P2|Overall Study|Subject Non-Compliant|4
1255311|NCT00543725|4114274|P1|Overall Study|Subject Non-Compliant|4
1255312|NCT00543725|4114273|P2|Overall Study|Sponsor's Decision|1
1255313|NCT00543725|4114274|P1|Overall Study|Sponsor's Decision|0
1255314|NCT00543725|4114273|P2|Overall Study|Adverse Event|27
1255315|NCT00543725|4114274|P1|Overall Study|Adverse Event|18
1255316|NCT00543569|4114300|P4|Overall Study|Randomized but never received study drug|3
1255317|NCT00543569|4114301|P3|Overall Study|Randomized but never received study drug|5
1255318|NCT00543569|4114302|P2|Overall Study|Randomized but never received study drug|3
1255319|NCT00543569|4114303|P1|Overall Study|Randomized but never received study drug|3
1255320|NCT00543569|4114300|P4|Overall Study|Miscellaneous Reasons|4
1255321|NCT00543569|4114301|P3|Overall Study|Miscellaneous Reasons|11
1255322|NCT00543569|4114302|P2|Overall Study|Miscellaneous Reasons|3
1255323|NCT00543569|4114303|P1|Overall Study|Miscellaneous Reasons|7
1255324|NCT00543569|4114300|P4|Overall Study|Lost to Follow-up|1
1255325|NCT00543569|4114301|P3|Overall Study|Lost to Follow-up|1
1255326|NCT00543569|4114302|P2|Overall Study|Lost to Follow-up|0
1255327|NCT00543569|4114303|P1|Overall Study|Lost to Follow-up|0
1255328|NCT00543569|4114300|P4|Overall Study|Death|1
1255329|NCT00543569|4114301|P3|Overall Study|Death|3
1255330|NCT00543569|4114302|P2|Overall Study|Death|2
1255331|NCT00543569|4114303|P1|Overall Study|Death|2
1255332|NCT00543543|4114409|P4|Extension Study|Withdrawal by Subject|120
1255333|NCT00543543|4114410|P3|Extension Study|Withdrawal by Subject|0
1255334|NCT00543543|4114411|P2|Extension Study|Withdrawal by Subject|0
1255335|NCT00543543|4114412|P1|Extension Study|Withdrawal by Subject|0
1255336|NCT00543543|4114409|P4|Extension Study|Protocol Violation|11
1255337|NCT00543543|4114410|P3|Extension Study|Protocol Violation|0
1255338|NCT00543543|4114411|P2|Extension Study|Protocol Violation|0
1255339|NCT00543543|4114412|P1|Extension Study|Protocol Violation|0
1255340|NCT00543543|4114409|P4|Extension Study|Pregnancy|6
1255341|NCT00543543|4114410|P3|Extension Study|Pregnancy|0
1255342|NCT00543543|4114411|P2|Extension Study|Pregnancy|0
1255343|NCT00543543|4114412|P1|Extension Study|Pregnancy|0
1255344|NCT00543543|4114409|P4|Extension Study|Physician Decision|7
1255345|NCT00543543|4114410|P3|Extension Study|Physician Decision|0
1255346|NCT00543543|4114411|P2|Extension Study|Physician Decision|0
1255347|NCT00543543|4114412|P1|Extension Study|Physician Decision|0
1255348|NCT00543543|4114409|P4|Extension Study|Lost to Follow-up|77
1255349|NCT00543543|4114410|P3|Extension Study|Lost to Follow-up|0
1255350|NCT00543543|4114411|P2|Extension Study|Lost to Follow-up|0
1255351|NCT00543543|4114412|P1|Extension Study|Lost to Follow-up|0
1255352|NCT00543543|4114409|P4|Extension Study|Adverse Event|5
1255353|NCT00543543|4114410|P3|Extension Study|Adverse Event|0
1255354|NCT00543543|4114411|P2|Extension Study|Adverse Event|0
1255355|NCT00543543|4114412|P1|Extension Study|Adverse Event|0
1255356|NCT00543543|4114409|P4|Base Study|Withdrawal by Subject|503
1255357|NCT00543543|4114410|P3|Base Study|Withdrawal by Subject|5
1255358|NCT00543543|4114411|P2|Base Study|Withdrawal by Subject|482
1255359|NCT00543543|4114412|P1|Base Study|Withdrawal by Subject|7
1255360|NCT00543543|4114409|P4|Base Study|Protocol Violation|6
1255361|NCT00543543|4114410|P3|Base Study|Protocol Violation|0
1255362|NCT00543543|4114411|P2|Base Study|Protocol Violation|6
1255363|NCT00543543|4114412|P1|Base Study|Protocol Violation|0
1255364|NCT00543543|4114409|P4|Base Study|Physician Decision|7
1255365|NCT00543543|4114410|P3|Base Study|Physician Decision|0
1255366|NCT00543543|4114411|P2|Base Study|Physician Decision|4
1255367|NCT00543543|4114412|P1|Base Study|Physician Decision|0
1255368|NCT00543543|4114409|P4|Base Study|Lost to Follow-up|701
1255369|NCT00543543|4114410|P3|Base Study|Lost to Follow-up|9
1255370|NCT00543543|4114411|P2|Base Study|Lost to Follow-up|749
1255371|NCT00543543|4114412|P1|Base Study|Lost to Follow-up|12
1255372|NCT00543543|4114409|P4|Base Study|Adverse Event|5
1255373|NCT00543543|4114410|P3|Base Study|Adverse Event|0
1255374|NCT00543543|4114411|P2|Base Study|Adverse Event|11
1255375|NCT00543543|4114412|P1|Base Study|Adverse Event|1
1255376|NCT00543387|4114479|P11|Crossover Participants|Study Terminated by Sponsor|1
1255377|NCT00543387|4114480|P10|Crossover Participants|Study Terminated by Sponsor|0
1255378|NCT00543387|4114481|P9|Crossover Participants|Study Terminated by Sponsor|0
1255379|NCT00543387|4114482|P8|Crossover Participants|Study Terminated by Sponsor|0
1255380|NCT00543387|4114483|P7|Crossover Participants|Study Terminated by Sponsor|0
1255381|NCT00543387|4114484|P6|Crossover Participants|Study Terminated by Sponsor|0
1255382|NCT00543387|4114485|P5|Crossover Participants|Study Terminated by Sponsor|0
1255383|NCT00543387|4114486|P4|Crossover Participants|Study Terminated by Sponsor|0
1255384|NCT00543387|4114487|P3|Crossover Participants|Study Terminated by Sponsor|0
1255385|NCT00543387|4114488|P2|Crossover Participants|Study Terminated by Sponsor|0
1255386|NCT00543387|4114489|P1|Crossover Participants|Study Terminated by Sponsor|0
1255387|NCT00543387|4114479|P11|Crossover Participants|Progressive Disease|2
1255388|NCT00543387|4114480|P10|Crossover Participants|Progressive Disease|1
1255389|NCT00543387|4114481|P9|Crossover Participants|Progressive Disease|0
1255390|NCT00543387|4114482|P8|Crossover Participants|Progressive Disease|0
1255391|NCT00543387|4114483|P7|Crossover Participants|Progressive Disease|0
1255392|NCT00543387|4114484|P6|Crossover Participants|Progressive Disease|0
1255393|NCT00543387|4114485|P5|Crossover Participants|Progressive Disease|0
1255394|NCT00543387|4114486|P4|Crossover Participants|Progressive Disease|0
1255395|NCT00543387|4114487|P3|Crossover Participants|Progressive Disease|0
1255396|NCT00543387|4114488|P2|Crossover Participants|Progressive Disease|0
1255397|NCT00543387|4114489|P1|Crossover Participants|Progressive Disease|0
1255398|NCT00543387|4114479|P11|Panel 1 + Panel 2|Withdrawal by Subject|0
1255399|NCT00543387|4114480|P10|Panel 1 + Panel 2|Withdrawal by Subject|0
1255400|NCT00543387|4114481|P9|Panel 1 + Panel 2|Withdrawal by Subject|0
1255401|NCT00543387|4114482|P8|Panel 1 + Panel 2|Withdrawal by Subject|0
1255402|NCT00543387|4114483|P7|Panel 1 + Panel 2|Withdrawal by Subject|1
1255403|NCT00543387|4114484|P6|Panel 1 + Panel 2|Withdrawal by Subject|0
1255404|NCT00543387|4114485|P5|Panel 1 + Panel 2|Withdrawal by Subject|0
1255405|NCT00543387|4114486|P4|Panel 1 + Panel 2|Withdrawal by Subject|0
1255406|NCT00543387|4114487|P3|Panel 1 + Panel 2|Withdrawal by Subject|0
1255407|NCT00543387|4114488|P2|Panel 1 + Panel 2|Withdrawal by Subject|0
1255408|NCT00543387|4114489|P1|Panel 1 + Panel 2|Withdrawal by Subject|0
1255409|NCT00543387|4114479|P11|Panel 1 + Panel 2|Progressive Disease (PD)|0
1255410|NCT00543387|4114480|P10|Panel 1 + Panel 2|Progressive Disease (PD)|0
1255411|NCT00543387|4114481|P9|Panel 1 + Panel 2|Progressive Disease (PD)|4
1255412|NCT00543387|4114482|P8|Panel 1 + Panel 2|Progressive Disease (PD)|4
1255413|NCT00543387|4114483|P7|Panel 1 + Panel 2|Progressive Disease (PD)|5
1255414|NCT00543387|4114484|P6|Panel 1 + Panel 2|Progressive Disease (PD)|3
1255415|NCT00543387|4114485|P5|Panel 1 + Panel 2|Progressive Disease (PD)|3
1255416|NCT00543387|4114486|P4|Panel 1 + Panel 2|Progressive Disease (PD)|3
1255417|NCT00543387|4114487|P3|Panel 1 + Panel 2|Progressive Disease (PD)|2
1255418|NCT00543387|4114488|P2|Panel 1 + Panel 2|Progressive Disease (PD)|2
1255419|NCT00543387|4114489|P1|Panel 1 + Panel 2|Progressive Disease (PD)|3
1255420|NCT00543387|4114479|P11|Panel 1 + Panel 2|Physician Decision|0
1255421|NCT00543387|4114480|P10|Panel 1 + Panel 2|Physician Decision|0
1255422|NCT00543387|4114481|P9|Panel 1 + Panel 2|Physician Decision|0
1255423|NCT00543387|4114482|P8|Panel 1 + Panel 2|Physician Decision|1
1255424|NCT00543387|4114483|P7|Panel 1 + Panel 2|Physician Decision|0
1255425|NCT00543387|4114484|P6|Panel 1 + Panel 2|Physician Decision|0
1255426|NCT00543387|4114485|P5|Panel 1 + Panel 2|Physician Decision|0
1255427|NCT00543387|4114486|P4|Panel 1 + Panel 2|Physician Decision|0
1255428|NCT00543387|4114487|P3|Panel 1 + Panel 2|Physician Decision|1
1255429|NCT00543387|4114488|P2|Panel 1 + Panel 2|Physician Decision|0
1255430|NCT00543387|4114489|P1|Panel 1 + Panel 2|Physician Decision|0
1255431|NCT00543387|4114479|P11|Panel 1 + Panel 2|Adverse Event|0
1255432|NCT00543387|4114480|P10|Panel 1 + Panel 2|Adverse Event|0
1255433|NCT00543387|4114481|P9|Panel 1 + Panel 2|Adverse Event|1
1255434|NCT00543387|4114482|P8|Panel 1 + Panel 2|Adverse Event|1
1255435|NCT00543387|4114483|P7|Panel 1 + Panel 2|Adverse Event|0
1255436|NCT00543387|4114484|P6|Panel 1 + Panel 2|Adverse Event|0
1255437|NCT00543387|4114485|P5|Panel 1 + Panel 2|Adverse Event|0
1255438|NCT00543387|4114486|P4|Panel 1 + Panel 2|Adverse Event|0
1255439|NCT00543387|4114487|P3|Panel 1 + Panel 2|Adverse Event|0
1255440|NCT00543387|4114488|P2|Panel 1 + Panel 2|Adverse Event|1
1255441|NCT00543387|4114489|P1|Panel 1 + Panel 2|Adverse Event|0
1255442|NCT00543309|4114527|P3|Overall Study|Physician Decision|0
1255443|NCT00543309|4114528|P2|Overall Study|Physician Decision|1
1255444|NCT00543309|4114529|P1|Overall Study|Physician Decision|0
1255445|NCT00543296|4114579|P1|Overall Study|Physician Decision|7
1255446|NCT00543140|4114586|P1|Overall Study|Conversion to different procedure|1
1255447|NCT00543140|4114586|P1|Overall Study|Subject moved|1
1255448|NCT00543140|4114586|P1|Overall Study|Death|1
1255449|NCT00543140|4114586|P1|Overall Study|SAE leading to explant of SAGB|3
1255450|NCT00543140|4114586|P1|Overall Study|Insufficient weight loss|10
1255451|NCT00543140|4114586|P1|Overall Study|Protocol Violation|10
1255452|NCT00543140|4114586|P1|Overall Study|Withdrawal by Subject|13
1255453|NCT00543140|4114586|P1|Overall Study|Lost to Follow-up|33
1255454|NCT00542997|4114609|P1|Efficacy Period|Adverse Event|3
1255455|NCT00542997|4114609|P1|Wash in / Wash Out Period|Adverse Event|3
1255456|NCT00542997|4114609|P1|Wash in / Wash Out Period|Withdrawal by Subject|2
1255457|NCT00542880|4114631|P2|Period 3|Adverse Event|2
1255458|NCT00542880|4114632|P1|Period 3|Adverse Event|0
1255459|NCT00542880|4114631|P2|Period 2|Not specified|1
1255460|NCT00542880|4114632|P1|Period 2|Not specified|0
1255461|NCT00542880|4114631|P2|Period 2|Severe non-compliance|1
1255462|NCT00542880|4114632|P1|Period 2|Severe non-compliance|0
1255463|NCT00542880|4114631|P2|Period 2|Discontinuation criteria|0
1255464|NCT00542880|4114632|P1|Period 2|Discontinuation criteria|2
1255465|NCT00542880|4114631|P2|Period 2|Eligibility not fulfilled|1
1255466|NCT00542880|4114632|P1|Period 2|Eligibility not fulfilled|0
1255467|NCT00542880|4114631|P2|Period 2|Adverse Event|7
1255468|NCT00542880|4114632|P1|Period 2|Adverse Event|5
1255469|NCT00542880|4114631|P2|Period 1|Protocol Violation|1
1255470|NCT00542880|4114632|P1|Period 1|Protocol Violation|0
1255471|NCT00542880|4114631|P2|Period 1|Withdrawal by Subject|1
1255472|NCT00542880|4114632|P1|Period 1|Withdrawal by Subject|1
1255473|NCT00542880|4114631|P2|Period 1|Development of study-specific criteria|2
1255474|NCT00542880|4114632|P1|Period 1|Development of study-specific criteria|1
1255475|NCT00542880|4114631|P2|Period 1|Adverse Event|2
1255476|NCT00542880|4114632|P1|Period 1|Adverse Event|2
1255477|NCT00542880|4114631|P2|Period 1|Eligibility criteria not fulfilled|6
1255478|NCT00542880|4114632|P1|Period 1|Eligibility criteria not fulfilled|2
1255479|NCT00542828|4114668|P1|Overall Study|Did Not Receive Thymoglobulin Treatment|2
1255480|NCT00542828|4114668|P1|Overall Study|Study Prematurely Discontinued|7
1255481|NCT00542828|4114668|P1|Overall Study|Need for Prohibited Treatment|3
1255482|NCT00542828|4114668|P1|Overall Study|Physician Decision|1
1255483|NCT00542815|4114686|P3|Overall Study|Other reasons|10
1255484|NCT00542815|4114687|P2|Overall Study|Other reasons|10
1255485|NCT00542815|4114688|P1|Overall Study|Other reasons|24
1255486|NCT00542815|4114686|P3|Overall Study|Withdrawal by Subject|8
1255487|NCT00542815|4114687|P2|Overall Study|Withdrawal by Subject|5
1255488|NCT00542815|4114688|P1|Overall Study|Withdrawal by Subject|41
1255489|NCT00542815|4114686|P3|Overall Study|Protocol Violation|2
1255490|NCT00542815|4114687|P2|Overall Study|Protocol Violation|1
1255491|NCT00542815|4114688|P1|Overall Study|Protocol Violation|1
1255492|NCT00542815|4114686|P3|Overall Study|Physician Decision|0
1255493|NCT00542815|4114687|P2|Overall Study|Physician Decision|1
1255494|NCT00542815|4114688|P1|Overall Study|Physician Decision|2
1255495|NCT00542815|4114686|P3|Overall Study|Lack of Efficacy|0
1255496|NCT00542815|4114687|P2|Overall Study|Lack of Efficacy|2
1255497|NCT00542815|4114688|P1|Overall Study|Lack of Efficacy|9
1255498|NCT00542815|4114686|P3|Overall Study|Death|3
1255499|NCT00542815|4114687|P2|Overall Study|Death|7
1255500|NCT00542815|4114688|P1|Overall Study|Death|10
1255501|NCT00542815|4114686|P3|Overall Study|Adverse Event|9
1255502|NCT00542815|4114687|P2|Overall Study|Adverse Event|6
1255503|NCT00542815|4114688|P1|Overall Study|Adverse Event|19
1255504|NCT00542789|4114701|P2|Overall Study|Recurrence of Gastric Ulcer|57
1255505|NCT00542789|4114702|P1|Overall Study|Recurrence of Gastric Ulcer|8
1255506|NCT00542789|4114701|P2|Overall Study|Protocol Violation|1
1255507|NCT00542789|4114702|P1|Overall Study|Protocol Violation|8
1255508|NCT00542789|4114701|P2|Overall Study|Withdrawal by Subject|3
1255509|NCT00542789|4114702|P1|Overall Study|Withdrawal by Subject|7
1255510|NCT00542789|4114701|P2|Overall Study|Adverse Event|17
1255511|NCT00542789|4114702|P1|Overall Study|Adverse Event|18
1255512|NCT00542425|4114802|P5|Extended 24 Weeks of Treatment|Other|1
1255513|NCT00542425|4114803|P4|Extended 24 Weeks of Treatment|Other|0
1255514|NCT00542425|4114804|P3|Extended 24 Weeks of Treatment|Other|0
1255515|NCT00542425|4114805|P2|Extended 24 Weeks of Treatment|Other|1
1255516|NCT00542425|4114806|P1|Extended 24 Weeks of Treatment|Other|1
1255517|NCT00542425|4114802|P5|Extended 24 Weeks of Treatment|Refusal of treatment|0
1255518|NCT00542425|4114803|P4|Extended 24 Weeks of Treatment|Refusal of treatment|0
1255519|NCT00542425|4114804|P3|Extended 24 Weeks of Treatment|Refusal of treatment|0
1255520|NCT00542425|4114805|P2|Extended 24 Weeks of Treatment|Refusal of treatment|1
1255521|NCT00542425|4114806|P1|Extended 24 Weeks of Treatment|Refusal of treatment|0
1255522|NCT00542425|4114802|P5|Extended 24 Weeks of Treatment|Protocol Violation|0
1255523|NCT00542425|4114803|P4|Extended 24 Weeks of Treatment|Protocol Violation|0
1255524|NCT00542425|4114804|P3|Extended 24 Weeks of Treatment|Protocol Violation|1
1255525|NCT00542425|4114805|P2|Extended 24 Weeks of Treatment|Protocol Violation|0
1255526|NCT00542425|4114806|P1|Extended 24 Weeks of Treatment|Protocol Violation|0
1255527|NCT00542425|4114802|P5|Extended 24 Weeks of Treatment|Adverse Event|0
1255528|NCT00542425|4114803|P4|Extended 24 Weeks of Treatment|Adverse Event|1
1255529|NCT00542425|4114804|P3|Extended 24 Weeks of Treatment|Adverse Event|1
1255530|NCT00542425|4114805|P2|Extended 24 Weeks of Treatment|Adverse Event|0
1255531|NCT00542425|4114806|P1|Extended 24 Weeks of Treatment|Adverse Event|0
1255532|NCT00542425|4114802|P5|Initial 24 Weeks|Other|0
1255533|NCT00542425|4114803|P4|Initial 24 Weeks|Other|0
1255534|NCT00542425|4114804|P3|Initial 24 Weeks|Other|1
1255535|NCT00542425|4114805|P2|Initial 24 Weeks|Other|2
1255536|NCT00542425|4114806|P1|Initial 24 Weeks|Other|0
1255537|NCT00542425|4114802|P5|Initial 24 Weeks|Refusal of treatment|1
1255538|NCT00542425|4114803|P4|Initial 24 Weeks|Refusal of treatment|4
1255539|NCT00542425|4114804|P3|Initial 24 Weeks|Refusal of treatment|1
1255540|NCT00542425|4114805|P2|Initial 24 Weeks|Refusal of treatment|2
1255541|NCT00542425|4114806|P1|Initial 24 Weeks|Refusal of treatment|2
1255542|NCT00542425|4114802|P5|Initial 24 Weeks|Protocol Violation|0
1255543|NCT00542425|4114803|P4|Initial 24 Weeks|Protocol Violation|1
1255544|NCT00542425|4114804|P3|Initial 24 Weeks|Protocol Violation|0
1255545|NCT00542425|4114805|P2|Initial 24 Weeks|Protocol Violation|0
1255546|NCT00542425|4114806|P1|Initial 24 Weeks|Protocol Violation|0
1255547|NCT00542425|4114802|P5|Initial 24 Weeks|Non-compliance|1
1255548|NCT00542425|4114803|P4|Initial 24 Weeks|Non-compliance|1
1255549|NCT00542425|4114804|P3|Initial 24 Weeks|Non-compliance|0
1255550|NCT00542425|4114805|P2|Initial 24 Weeks|Non-compliance|0
1255551|NCT00542425|4114806|P1|Initial 24 Weeks|Non-compliance|0
1255552|NCT00542425|4114802|P5|Initial 24 Weeks|Lost to Follow-up|0
1255553|NCT00542425|4114803|P4|Initial 24 Weeks|Lost to Follow-up|0
1255554|NCT00542425|4114804|P3|Initial 24 Weeks|Lost to Follow-up|1
1255555|NCT00542425|4114805|P2|Initial 24 Weeks|Lost to Follow-up|2
1255556|NCT00542425|4114806|P1|Initial 24 Weeks|Lost to Follow-up|2
1255557|NCT00542425|4114802|P5|Initial 24 Weeks|Inability to complete procedures|2
1255558|NCT00542425|4114803|P4|Initial 24 Weeks|Inability to complete procedures|1
1255559|NCT00542425|4114804|P3|Initial 24 Weeks|Inability to complete procedures|2
1255560|NCT00542425|4114805|P2|Initial 24 Weeks|Inability to complete procedures|3
1255561|NCT00542425|4114806|P1|Initial 24 Weeks|Inability to complete procedures|0
1255562|NCT00542425|4114802|P5|Initial 24 Weeks|Adverse Event|2
1255563|NCT00542425|4114803|P4|Initial 24 Weeks|Adverse Event|3
1255564|NCT00542425|4114804|P3|Initial 24 Weeks|Adverse Event|1
1255565|NCT00542425|4114805|P2|Initial 24 Weeks|Adverse Event|1
1255566|NCT00542425|4114806|P1|Initial 24 Weeks|Adverse Event|0
1255567|NCT00542425|4114802|P5|Initial 24 Weeks|Administrative reasons|0
1255568|NCT00542425|4114803|P4|Initial 24 Weeks|Administrative reasons|1
1255569|NCT00542425|4114804|P3|Initial 24 Weeks|Administrative reasons|1
1255570|NCT00542425|4114805|P2|Initial 24 Weeks|Administrative reasons|0
1255571|NCT00542425|4114806|P1|Initial 24 Weeks|Administrative reasons|0
1255572|NCT00542386|4114844|P6|Overall Study|Other Reasons|2
1255573|NCT00542386|4114845|P5|Overall Study|Other Reasons|4
1255574|NCT00542386|4114846|P4|Overall Study|Other Reasons|3
1255575|NCT00542386|4114847|P3|Overall Study|Other Reasons|4
1255576|NCT00542386|4114848|P2|Overall Study|Other Reasons|1
1255577|NCT00542386|4114849|P1|Overall Study|Other Reasons|4
1255578|NCT00542386|4114844|P6|Overall Study|Withdrawal by Subject|7
1255579|NCT00542386|4114845|P5|Overall Study|Withdrawal by Subject|15
1255580|NCT00542386|4114846|P4|Overall Study|Withdrawal by Subject|11
1255581|NCT00542386|4114847|P3|Overall Study|Withdrawal by Subject|10
1255582|NCT00542386|4114848|P2|Overall Study|Withdrawal by Subject|8
1255583|NCT00542386|4114849|P1|Overall Study|Withdrawal by Subject|5
1255584|NCT00542386|4114844|P6|Overall Study|Protocol Violation|4
1255585|NCT00542386|4114845|P5|Overall Study|Protocol Violation|0
1255586|NCT00542386|4114846|P4|Overall Study|Protocol Violation|0
1255587|NCT00542386|4114847|P3|Overall Study|Protocol Violation|1
1255588|NCT00542386|4114848|P2|Overall Study|Protocol Violation|0
1255589|NCT00542386|4114849|P1|Overall Study|Protocol Violation|0
1255590|NCT00542386|4114844|P6|Overall Study|Physician Decision|0
1255591|NCT00542386|4114845|P5|Overall Study|Physician Decision|0
1255592|NCT00542386|4114846|P4|Overall Study|Physician Decision|1
1255593|NCT00542386|4114847|P3|Overall Study|Physician Decision|0
1255594|NCT00542386|4114848|P2|Overall Study|Physician Decision|0
1255595|NCT00542386|4114849|P1|Overall Study|Physician Decision|1
1255596|NCT00542386|4114844|P6|Overall Study|Lack of Efficacy|31
1255597|NCT00542386|4114845|P5|Overall Study|Lack of Efficacy|7
1255598|NCT00542386|4114846|P4|Overall Study|Lack of Efficacy|13
1255599|NCT00542386|4114847|P3|Overall Study|Lack of Efficacy|10
1255600|NCT00542386|4114848|P2|Overall Study|Lack of Efficacy|12
1255601|NCT00542386|4114849|P1|Overall Study|Lack of Efficacy|32
1255602|NCT00542386|4114844|P6|Overall Study|Death|2
1255603|NCT00542386|4114845|P5|Overall Study|Death|1
1255604|NCT00542386|4114846|P4|Overall Study|Death|2
1255605|NCT00542386|4114847|P3|Overall Study|Death|1
1255606|NCT00542386|4114848|P2|Overall Study|Death|0
1255607|NCT00542386|4114849|P1|Overall Study|Death|0
1255608|NCT00542386|4114844|P6|Overall Study|Adverse Event|4
1255609|NCT00542386|4114845|P5|Overall Study|Adverse Event|13
1255610|NCT00542386|4114846|P4|Overall Study|Adverse Event|8
1255611|NCT00542386|4114847|P3|Overall Study|Adverse Event|7
1255612|NCT00542386|4114848|P2|Overall Study|Adverse Event|7
1255613|NCT00542386|4114849|P1|Overall Study|Adverse Event|1
1255614|NCT00542321|4114871|P2|Overall Study|Death|1
1255615|NCT00542321|4114872|P1|Overall Study|Death|0
1255616|NCT00542269|4114894|P3|Overall Study|Administrative problems|1
1255617|NCT00542269|4114895|P2|Overall Study|Administrative problems|1
1255618|NCT00542269|4114896|P1|Overall Study|Administrative problems|1
1255619|NCT00542269|4114894|P3|Overall Study|Withdrawal by Subject|0
1255620|NCT00542269|4114895|P2|Overall Study|Withdrawal by Subject|0
1255621|NCT00542269|4114896|P1|Overall Study|Withdrawal by Subject|1
1255622|NCT00542269|4114894|P3|Overall Study|Protocol Violation|0
1255623|NCT00542269|4114895|P2|Overall Study|Protocol Violation|1
1255624|NCT00542269|4114896|P1|Overall Study|Protocol Violation|1
1255625|NCT00542269|4114894|P3|Overall Study|Adverse Event|5
1255626|NCT00542269|4114895|P2|Overall Study|Adverse Event|4
1255627|NCT00542269|4114896|P1|Overall Study|Adverse Event|10
1255628|NCT00542178|4114931|P8|Overall Study|did not complete year 4 follow-up|85
1255629|NCT00542178|4114932|P7|Overall Study|did not complete year 4 follow-up|87
1255630|NCT00542178|4114933|P6|Overall Study|did not complete year 4 follow-up|89
1255631|NCT00542178|4114934|P5|Overall Study|did not complete year 4 follow-up|64
1255632|NCT00542178|4114935|P4|Overall Study|did not complete year 4 follow-up|62
1255633|NCT00542178|4114936|P3|Overall Study|did not complete year 4 follow-up|74
1255634|NCT00542178|4114937|P2|Overall Study|did not complete year 4 follow-up|80
1255635|NCT00542178|4114938|P1|Overall Study|did not complete year 4 follow-up|75
1255636|NCT00541970|4114974|P4|Month 60|Protocol Violation|72
1255637|NCT00541970|4114975|P3|Month 60|Protocol Violation|82
1255638|NCT00541970|4114976|P2|Month 60|Protocol Violation|77
1255639|NCT00541970|4114977|P1|Month 60|Protocol Violation|78
1255640|NCT00541970|4114974|P4|Month 48|Lost to Follow-up|73
1255641|NCT00541970|4114975|P3|Month 48|Lost to Follow-up|68
1255642|NCT00541970|4114976|P2|Month 48|Lost to Follow-up|68
1255643|NCT00541970|4114977|P1|Month 48|Lost to Follow-up|66
1255644|NCT00541970|4114974|P4|Month 48|Other|0
1255645|NCT00541970|4114975|P3|Month 48|Other|1
1255646|NCT00541970|4114976|P2|Month 48|Other|1
1255647|NCT00541970|4114977|P1|Month 48|Other|3
1255648|NCT00541970|4114974|P4|Month 48|Withdrawal by Subject|2
1255649|NCT00541970|4114975|P3|Month 48|Withdrawal by Subject|4
1255650|NCT00541970|4114976|P2|Month 48|Withdrawal by Subject|4
1255651|NCT00541970|4114977|P1|Month 48|Withdrawal by Subject|2
1255652|NCT00541970|4114974|P4|Month 36|Protocol Violation|60
1255653|NCT00541970|4114975|P3|Month 36|Protocol Violation|66
1255654|NCT00541970|4114976|P2|Month 36|Protocol Violation|66
1255655|NCT00541970|4114977|P1|Month 36|Protocol Violation|61
1255656|NCT00541970|4114974|P4|Month 24|Protocol Violation|21
1255657|NCT00541970|4114975|P3|Month 24|Protocol Violation|31
1255658|NCT00541970|4114976|P2|Month 24|Protocol Violation|31
1255659|NCT00541970|4114977|P1|Month 24|Protocol Violation|29
1255660|NCT00541970|4114974|P4|Month 24|Adverse Event|1
1255661|NCT00541970|4114975|P3|Month 24|Adverse Event|1
1255662|NCT00541970|4114976|P2|Month 24|Adverse Event|1
1255663|NCT00541970|4114977|P1|Month 24|Adverse Event|0
1255664|NCT00541970|4114974|P4|Month 18|Protocol Violation|16
1255665|NCT00541970|4114975|P3|Month 18|Protocol Violation|24
1255666|NCT00541970|4114976|P2|Month 18|Protocol Violation|23
1255667|NCT00541970|4114977|P1|Month 18|Protocol Violation|14
1255668|NCT00541970|4114974|P4|Month 18|Adverse Event|1
1255669|NCT00541970|4114975|P3|Month 18|Adverse Event|1
1255670|NCT00541970|4114976|P2|Month 18|Adverse Event|1
1255671|NCT00541970|4114977|P1|Month 18|Adverse Event|0
1255672|NCT00541970|4114974|P4|Month 12|Protocol Violation|15
1255673|NCT00541970|4114975|P3|Month 12|Protocol Violation|20
1255674|NCT00541970|4114976|P2|Month 12|Protocol Violation|21
1255675|NCT00541970|4114977|P1|Month 12|Protocol Violation|12
1255676|NCT00541970|4114974|P4|Month 12|Adverse Event|1
1255677|NCT00541970|4114975|P3|Month 12|Adverse Event|1
1255678|NCT00541970|4114976|P2|Month 12|Adverse Event|1
1255679|NCT00541970|4114977|P1|Month 12|Adverse Event|0
1255680|NCT00541970|4114974|P4|Month 7|Protocol Violation|5
1255681|NCT00541970|4114975|P3|Month 7|Protocol Violation|11
1255682|NCT00541970|4114976|P2|Month 7|Protocol Violation|13
1255683|NCT00541970|4114977|P1|Month 7|Protocol Violation|9
1255684|NCT00541931|4115128|P2|Overall Study|Transportation Issue|1
1255685|NCT00541931|4115129|P1|Overall Study|Transportation Issue|0
1255686|NCT00541931|4115128|P2|Overall Study|Withdrawal by Subject|0
1255687|NCT00541931|4115129|P1|Overall Study|Withdrawal by Subject|1
1255688|NCT00541931|4115128|P2|Overall Study|Lost to Follow-up|3
1255689|NCT00541931|4115129|P1|Overall Study|Lost to Follow-up|3
1255690|NCT00541931|4115128|P2|Overall Study|Adverse Event|0
1255691|NCT00541931|4115129|P1|Overall Study|Adverse Event|1
1255692|NCT00541866|4115142|P5|Overall Study|Physician Decision|0
1255693|NCT00541866|4115143|P4|Overall Study|Physician Decision|1
1255694|NCT00541866|4115144|P3|Overall Study|Physician Decision|2
1255695|NCT00541866|4115145|P2|Overall Study|Physician Decision|0
1255696|NCT00541866|4115146|P1|Overall Study|Physician Decision|0
1255697|NCT00541866|4115142|P5|Overall Study|Not Reported or Other|1
1255698|NCT00541866|4115143|P4|Overall Study|Not Reported or Other|3
1255699|NCT00541866|4115144|P3|Overall Study|Not Reported or Other|3
1255700|NCT00541866|4115145|P2|Overall Study|Not Reported or Other|3
1255701|NCT00541866|4115146|P1|Overall Study|Not Reported or Other|11
1255702|NCT00541866|4115142|P5|Overall Study|Lack of Efficacy|14
1255703|NCT00541866|4115143|P4|Overall Study|Lack of Efficacy|12
1255704|NCT00541866|4115144|P3|Overall Study|Lack of Efficacy|10
1255705|NCT00541866|4115145|P2|Overall Study|Lack of Efficacy|15
1255706|NCT00541866|4115146|P1|Overall Study|Lack of Efficacy|19
1255707|NCT00541866|4115142|P5|Overall Study|Death|0
1255708|NCT00541866|4115143|P4|Overall Study|Death|0
1255709|NCT00541866|4115144|P3|Overall Study|Death|0
1255710|NCT00541866|4115145|P2|Overall Study|Death|0
1255711|NCT00541866|4115146|P1|Overall Study|Death|1
1255712|NCT00541866|4115142|P5|Overall Study|Adverse Event|0
1255713|NCT00541866|4115143|P4|Overall Study|Adverse Event|0
1255714|NCT00541866|4115144|P3|Overall Study|Adverse Event|0
1255715|NCT00541866|4115145|P2|Overall Study|Adverse Event|0
1255716|NCT00541866|4115146|P1|Overall Study|Adverse Event|3
1255717|NCT00541775|4115187|P3|Overall Study|Withdrawal by Subject and Other|2
1255718|NCT00541775|4115188|P2|Overall Study|Withdrawal by Subject and Other|0
1255719|NCT00541775|4115189|P1|Overall Study|Withdrawal by Subject and Other|5
1255720|NCT00541775|4115187|P3|Overall Study|Protocol Violation|0
1255721|NCT00541775|4115188|P2|Overall Study|Protocol Violation|0
1255722|NCT00541775|4115189|P1|Overall Study|Protocol Violation|1
1255723|NCT00541775|4115187|P3|Overall Study|Lost to Follow-up|2
1255724|NCT00541775|4115188|P2|Overall Study|Lost to Follow-up|0
1255725|NCT00541775|4115189|P1|Overall Study|Lost to Follow-up|0
1255726|NCT00541775|4115187|P3|Overall Study|Lack of Efficacy|3
1255727|NCT00541775|4115188|P2|Overall Study|Lack of Efficacy|0
1255728|NCT00541775|4115189|P1|Overall Study|Lack of Efficacy|0
1255729|NCT00541775|4115187|P3|Overall Study|Adverse Event|1
1255730|NCT00541775|4115188|P2|Overall Study|Adverse Event|2
1255731|NCT00541775|4115189|P1|Overall Study|Adverse Event|3
1255732|NCT00541658|4115215|P3|Overall Study|Took No Study Drug|0
1255733|NCT00541658|4115216|P2|Overall Study|Took No Study Drug|0
1255734|NCT00541658|4115217|P1|Overall Study|Took No Study Drug|1
1255735|NCT00541658|4115215|P3|Overall Study|Withdrawal by Subject|32
1255736|NCT00541658|4115216|P2|Overall Study|Withdrawal by Subject|32
1255737|NCT00541658|4115217|P1|Overall Study|Withdrawal by Subject|28
1255738|NCT00541658|4115215|P3|Overall Study|Protocol Violation|1
1255739|NCT00541658|4115216|P2|Overall Study|Protocol Violation|1
1255740|NCT00541658|4115217|P1|Overall Study|Protocol Violation|0
1255741|NCT00541658|4115215|P3|Overall Study|Lost to Follow-up|6
1255742|NCT00541658|4115216|P2|Overall Study|Lost to Follow-up|3
1255743|NCT00541658|4115217|P1|Overall Study|Lost to Follow-up|3
1255744|NCT00541658|4115215|P3|Overall Study|Physician Decision|4
1255745|NCT00541658|4115216|P2|Overall Study|Physician Decision|0
1255746|NCT00541658|4115217|P1|Overall Study|Physician Decision|0
1255747|NCT00541658|4115215|P3|Overall Study|Adverse Event|25
1255748|NCT00541658|4115216|P2|Overall Study|Adverse Event|37
1255749|NCT00541658|4115217|P1|Overall Study|Adverse Event|28
1255750|NCT00541450|4115380|P2|Phase B|Withdrawal by Subject|6
1255751|NCT00541450|4115381|P1|Phase B|Withdrawal by Subject|8
1255752|NCT00541450|4115380|P2|Phase B|Protocol Violation|3
1255753|NCT00541450|4115381|P1|Phase B|Protocol Violation|3
1255754|NCT00541450|4115380|P2|Phase B|Pregnancy|1
1255755|NCT00541450|4115381|P1|Phase B|Pregnancy|0
1255756|NCT00541450|4115380|P2|Phase B|Physician Decision|2
1255757|NCT00541450|4115381|P1|Phase B|Physician Decision|4
1255758|NCT00541450|4115380|P2|Phase B|Lost to Follow-up|4
1255759|NCT00541450|4115381|P1|Phase B|Lost to Follow-up|6
1255760|NCT00541450|4115380|P2|Phase B|Hyperglycemia|9
1255761|NCT00541450|4115381|P1|Phase B|Hyperglycemia|10
1255762|NCT00541450|4115380|P2|Phase B|Adverse Event|6
1255763|NCT00541450|4115381|P1|Phase B|Adverse Event|6
1255764|NCT00541450|4115380|P2|Phase A|Withdrawal by Subject|7
1255765|NCT00541450|4115381|P1|Phase A|Withdrawal by Subject|7
1255766|NCT00541450|4115380|P2|Phase A|Protocol Violation|3
1255767|NCT00541450|4115381|P1|Phase A|Protocol Violation|2
1255768|NCT00541450|4115380|P2|Phase A|Physician Decision|0
1255769|NCT00541450|4115381|P1|Phase A|Physician Decision|2
1255770|NCT00541450|4115380|P2|Phase A|Lost to Follow-up|4
1255771|NCT00541450|4115381|P1|Phase A|Lost to Follow-up|6
1255772|NCT00541450|4115380|P2|Phase A|Hyperglycemia|1
1255773|NCT00541450|4115381|P1|Phase A|Hyperglycemia|0
1255774|NCT00541450|4115380|P2|Phase A|Creatinine/CrCl -Increase in creatinine|2
1255775|NCT00541450|4115381|P1|Phase A|Creatinine/CrCl -Increase in creatinine|0
1255776|NCT00541450|4115380|P2|Phase A|Adverse Event|0
1255777|NCT00541450|4115381|P1|Phase A|Adverse Event|3
1255778|NCT00541346|4115399|P1|Follow-up|Adverse Event|1
1255779|NCT00541307|4115413|P1|Overall Study|Surgical Bypass|5
1255780|NCT00541307|4115413|P1|Overall Study|Subject returned early (outside window)|1
1255781|NCT00541307|4115413|P1|Overall Study|Lost to Follow-up|4
1255782|NCT00541307|4115413|P1|Overall Study|Withdrawal by Subject|6
1255783|NCT00541307|4115413|P1|Overall Study|Physician Decision|3
1255784|NCT00541307|4115413|P1|Overall Study|Death|5
1255785|NCT00541229|4115438|P6|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
1255786|NCT00541229|4115439|P5|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
1255787|NCT00541229|4115440|P4|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
1255788|NCT00541229|4115441|P3|Treatment Period III (Week 11)|Study Terminated by Sponsor|1
1255789|NCT00541229|4115442|P2|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
1255790|NCT00541229|4115443|P1|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
1255791|NCT00541229|4115438|P6|Treatment Period III (Week 11)|Protocol Specified Criteria|1
1255792|NCT00541229|4115439|P5|Treatment Period III (Week 11)|Protocol Specified Criteria|0
1255793|NCT00541229|4115440|P4|Treatment Period III (Week 11)|Protocol Specified Criteria|0
1255794|NCT00541229|4115441|P3|Treatment Period III (Week 11)|Protocol Specified Criteria|0
1255795|NCT00541229|4115442|P2|Treatment Period III (Week 11)|Protocol Specified Criteria|0
1255796|NCT00541229|4115443|P1|Treatment Period III (Week 11)|Protocol Specified Criteria|0
1255797|NCT00541229|4115438|P6|Treatment Period III (Week 11)|Adverse Event|0
1255798|NCT00541229|4115439|P5|Treatment Period III (Week 11)|Adverse Event|1
1255799|NCT00541229|4115440|P4|Treatment Period III (Week 11)|Adverse Event|0
1255800|NCT00541229|4115441|P3|Treatment Period III (Week 11)|Adverse Event|0
1255801|NCT00541229|4115442|P2|Treatment Period III (Week 11)|Adverse Event|0
1255802|NCT00541229|4115443|P1|Treatment Period III (Week 11)|Adverse Event|0
1255803|NCT00541229|4115438|P6|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
1255804|NCT00541229|4115439|P5|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
1255805|NCT00541229|4115440|P4|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
1255806|NCT00541229|4115441|P3|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2
1255807|NCT00541229|4115442|P2|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
1255808|NCT00541229|4115443|P1|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
1255809|NCT00541229|4115438|P6|Washout Period II (Week 7-10)|Withdrawal by Subject|0
1255810|NCT00541229|4115439|P5|Washout Period II (Week 7-10)|Withdrawal by Subject|1
1255811|NCT00541229|4115440|P4|Washout Period II (Week 7-10)|Withdrawal by Subject|0
1255812|NCT00541229|4115441|P3|Washout Period II (Week 7-10)|Withdrawal by Subject|0
1255813|NCT00541229|4115442|P2|Washout Period II (Week 7-10)|Withdrawal by Subject|0
1255814|NCT00541229|4115443|P1|Washout Period II (Week 7-10)|Withdrawal by Subject|0
1255815|NCT00541229|4115438|P6|Washout Period II (Week 7-10)|Protocol Violation|0
1255816|NCT00541229|4115439|P5|Washout Period II (Week 7-10)|Protocol Violation|0
1255817|NCT00541229|4115440|P4|Washout Period II (Week 7-10)|Protocol Violation|0
1255818|NCT00541229|4115441|P3|Washout Period II (Week 7-10)|Protocol Violation|0
1255819|NCT00541229|4115442|P2|Washout Period II (Week 7-10)|Protocol Violation|0
1255820|NCT00541229|4115443|P1|Washout Period II (Week 7-10)|Protocol Violation|1
1255821|NCT00541229|4115438|P6|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
1255822|NCT00541229|4115439|P5|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
1255823|NCT00541229|4115440|P4|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
1255824|NCT00541229|4115441|P3|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
1255825|NCT00541229|4115442|P2|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
1255826|NCT00541229|4115443|P1|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
1255827|NCT00541229|4115438|P6|Treatment Period II (Week 6)|Protocol Violation|1
1255828|NCT00541229|4115439|P5|Treatment Period II (Week 6)|Protocol Violation|1
1255829|NCT00541229|4115440|P4|Treatment Period II (Week 6)|Protocol Violation|0
1255830|NCT00541229|4115441|P3|Treatment Period II (Week 6)|Protocol Violation|0
1255831|NCT00541229|4115442|P2|Treatment Period II (Week 6)|Protocol Violation|0
1255832|NCT00541229|4115443|P1|Treatment Period II (Week 6)|Protocol Violation|0
1255833|NCT00541229|4115438|P6|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4
1255834|NCT00541229|4115439|P5|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1
1255835|NCT00541229|4115440|P4|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
1255836|NCT00541229|4115441|P3|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
1255837|NCT00541229|4115442|P2|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2
1255838|NCT00541229|4115443|P1|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
1255839|NCT00541229|4115438|P6|Washout Period I (Week 2-5)|Protocol Violation|1
1255840|NCT00541229|4115439|P5|Washout Period I (Week 2-5)|Protocol Violation|0
1255841|NCT00541229|4115440|P4|Washout Period I (Week 2-5)|Protocol Violation|0
1255842|NCT00541229|4115441|P3|Washout Period I (Week 2-5)|Protocol Violation|0
1255843|NCT00541229|4115442|P2|Washout Period I (Week 2-5)|Protocol Violation|0
1255844|NCT00541229|4115443|P1|Washout Period I (Week 2-5)|Protocol Violation|0
1255845|NCT00541229|4115438|P6|Washout Period I (Week 2-5)|Physician Decision|0
1255846|NCT00541229|4115439|P5|Washout Period I (Week 2-5)|Physician Decision|0
1255847|NCT00541229|4115440|P4|Washout Period I (Week 2-5)|Physician Decision|1
1255848|NCT00541229|4115441|P3|Washout Period I (Week 2-5)|Physician Decision|0
1255849|NCT00541229|4115442|P2|Washout Period I (Week 2-5)|Physician Decision|0
1255850|NCT00541229|4115443|P1|Washout Period I (Week 2-5)|Physician Decision|0
1255851|NCT00541229|4115438|P6|Washout Period I (Week 2-5)|Adverse Event|0
1255852|NCT00541229|4115439|P5|Washout Period I (Week 2-5)|Adverse Event|0
1255853|NCT00541229|4115440|P4|Washout Period I (Week 2-5)|Adverse Event|0
1255854|NCT00541229|4115441|P3|Washout Period I (Week 2-5)|Adverse Event|1
1255855|NCT00541229|4115442|P2|Washout Period I (Week 2-5)|Adverse Event|0
1255856|NCT00541229|4115443|P1|Washout Period I (Week 2-5)|Adverse Event|1
1255857|NCT00541229|4115438|P6|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
1255858|NCT00541229|4115439|P5|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
1255859|NCT00541229|4115440|P4|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
1255860|NCT00541229|4115441|P3|Treatment Period I (Week 1)|Study Terminated by Sponsor|2
1255861|NCT00541229|4115442|P2|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
1255862|NCT00541229|4115443|P1|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
1255863|NCT00541229|4115438|P6|Treatment Period I (Week 1)|Protocol Specified Criteria|1
1255864|NCT00541229|4115439|P5|Treatment Period I (Week 1)|Protocol Specified Criteria|0
1255865|NCT00541229|4115440|P4|Treatment Period I (Week 1)|Protocol Specified Criteria|0
1255866|NCT00541229|4115441|P3|Treatment Period I (Week 1)|Protocol Specified Criteria|0
1255867|NCT00541229|4115442|P2|Treatment Period I (Week 1)|Protocol Specified Criteria|0
1255868|NCT00541229|4115443|P1|Treatment Period I (Week 1)|Protocol Specified Criteria|0
1255869|NCT00541229|4115438|P6|Treatment Period I (Week 1)|Withdrawal by Subject|1
1255870|NCT00541229|4115439|P5|Treatment Period I (Week 1)|Withdrawal by Subject|0
1255871|NCT00541229|4115440|P4|Treatment Period I (Week 1)|Withdrawal by Subject|0
1255872|NCT00541229|4115441|P3|Treatment Period I (Week 1)|Withdrawal by Subject|0
1255873|NCT00541229|4115442|P2|Treatment Period I (Week 1)|Withdrawal by Subject|0
1255874|NCT00541229|4115443|P1|Treatment Period I (Week 1)|Withdrawal by Subject|0
1255875|NCT00541229|4115438|P6|Treatment Period I (Week 1)|Physician Decision|0
1255876|NCT00541229|4115439|P5|Treatment Period I (Week 1)|Physician Decision|0
1255877|NCT00541229|4115440|P4|Treatment Period I (Week 1)|Physician Decision|0
1255878|NCT00541229|4115441|P3|Treatment Period I (Week 1)|Physician Decision|1
1255879|NCT00541229|4115442|P2|Treatment Period I (Week 1)|Physician Decision|0
1255880|NCT00541229|4115443|P1|Treatment Period I (Week 1)|Physician Decision|0
1255881|NCT00541099|4115462|P1|Overall Study|Ineligible|3
1255882|NCT00541034|4115468|P1|Overall Study|Non-Compliance|3
1255883|NCT00540644|4115495|P2|Overall Study|Noncomplilance|0
1255884|NCT00540644|4115496|P1|Overall Study|Noncomplilance|1
1255885|NCT00540644|4115495|P2|Overall Study|Withdrawal by Subject|2
1255886|NCT00540644|4115496|P1|Overall Study|Withdrawal by Subject|2
1255887|NCT00540644|4115495|P2|Overall Study|Physician Decision|5
1255888|NCT00540644|4115496|P1|Overall Study|Physician Decision|0
1255889|NCT00540644|4115495|P2|Overall Study|Disease Progression|1
1255890|NCT00540644|4115496|P1|Overall Study|Disease Progression|3
1255891|NCT00540644|4115495|P2|Overall Study|Adverse Event|1
1255892|NCT00540644|4115496|P1|Overall Study|Adverse Event|3
1255893|NCT00540592|4115516|P10|Overall Study|Withdrawal by Subject|0
1255894|NCT00540592|4115517|P9|Overall Study|Withdrawal by Subject|0
1255895|NCT00540592|4115518|P8|Overall Study|Withdrawal by Subject|0
1255896|NCT00540592|4115519|P7|Overall Study|Withdrawal by Subject|0
1255897|NCT00540592|4115520|P6|Overall Study|Withdrawal by Subject|0
1255898|NCT00540592|4115521|P5|Overall Study|Withdrawal by Subject|0
1255899|NCT00540592|4115522|P4|Overall Study|Withdrawal by Subject|1
1255900|NCT00540592|4115523|P3|Overall Study|Withdrawal by Subject|1
1255901|NCT00540592|4115524|P2|Overall Study|Withdrawal by Subject|0
1255902|NCT00540592|4115525|P1|Overall Study|Withdrawal by Subject|0
1255903|NCT00540592|4115516|P10|Overall Study|Lost to Follow-up|0
1255904|NCT00540592|4115517|P9|Overall Study|Lost to Follow-up|0
1255905|NCT00540592|4115518|P8|Overall Study|Lost to Follow-up|0
1255906|NCT00540592|4115519|P7|Overall Study|Lost to Follow-up|0
1255907|NCT00540592|4115520|P6|Overall Study|Lost to Follow-up|0
1255908|NCT00540592|4115521|P5|Overall Study|Lost to Follow-up|0
1255909|NCT00540592|4115522|P4|Overall Study|Lost to Follow-up|0
1255910|NCT00540592|4115523|P3|Overall Study|Lost to Follow-up|0
1255911|NCT00540592|4115524|P2|Overall Study|Lost to Follow-up|0
1255912|NCT00540592|4115525|P1|Overall Study|Lost to Follow-up|2
1255913|NCT00540592|4115516|P10|Overall Study|Adverse Event|2
1255914|NCT00540592|4115517|P9|Overall Study|Adverse Event|1
1255915|NCT00540592|4115518|P8|Overall Study|Adverse Event|1
1255916|NCT00540592|4115519|P7|Overall Study|Adverse Event|0
1255917|NCT00540592|4115520|P6|Overall Study|Adverse Event|0
1255918|NCT00540592|4115521|P5|Overall Study|Adverse Event|1
1255919|NCT00540592|4115522|P4|Overall Study|Adverse Event|0
1255920|NCT00540592|4115523|P3|Overall Study|Adverse Event|0
1255921|NCT00540592|4115524|P2|Overall Study|Adverse Event|1
1255922|NCT00540592|4115525|P1|Overall Study|Adverse Event|0
1255923|NCT00540514|4115764|P2|Overall Study|Paclitaxel not available|2
1255924|NCT00540514|4115765|P1|Overall Study|Paclitaxel not available|0
1255925|NCT00540514|4115764|P2|Overall Study|Excluded prior to treatment|7
1255926|NCT00540514|4115765|P1|Overall Study|Excluded prior to treatment|7
1255927|NCT00540514|4115764|P2|Overall Study|Withdrawal by Subject|67
1255928|NCT00540514|4115765|P1|Overall Study|Withdrawal by Subject|65
1255929|NCT00540514|4115764|P2|Overall Study|Lost to Follow-up|1
1255930|NCT00540514|4115765|P1|Overall Study|Lost to Follow-up|1
1255931|NCT00540514|4115764|P2|Overall Study|Protocol Deviation|4
1255932|NCT00540514|4115765|P1|Overall Study|Protocol Deviation|3
1255933|NCT00540514|4115764|P2|Overall Study|Physician Decision|99
1255934|NCT00540514|4115765|P1|Overall Study|Physician Decision|86
1255935|NCT00540514|4115764|P2|Overall Study|Adverse Event|24
1255936|NCT00540514|4115765|P1|Overall Study|Adverse Event|20
1255937|NCT00540514|4115764|P2|Overall Study|Unacceptable Toxicity|62
1255938|NCT00540514|4115765|P1|Overall Study|Unacceptable Toxicity|61
1255939|NCT00540514|4115764|P2|Overall Study|Still on treatment|0
1255940|NCT00540514|4115765|P1|Overall Study|Still on treatment|3
1255941|NCT00540449|4115797|P2|Overall Study|Not specified|4
1255942|NCT00540449|4115798|P1|Overall Study|Not specified|1
1255943|NCT00540449|4115797|P2|Overall Study|Withdrawal by Subject|10
1255944|NCT00540449|4115798|P1|Overall Study|Withdrawal by Subject|10
1255945|NCT00540449|4115797|P2|Overall Study|Subject Reached A Virologic Endpoint|8
1255946|NCT00540449|4115798|P1|Overall Study|Subject Reached A Virologic Endpoint|32
1255947|NCT00540449|4115797|P2|Overall Study|Subject Non-Compliant|5
1255948|NCT00540449|4115798|P1|Overall Study|Subject Non-Compliant|7
1255949|NCT00540449|4115797|P2|Overall Study|Lost to Follow-up|17
1255950|NCT00540449|4115798|P1|Overall Study|Lost to Follow-up|19
1255951|NCT00540449|4115797|P2|Overall Study|Subject Ineligible To Continue The Trial|1
1255952|NCT00540449|4115798|P1|Overall Study|Subject Ineligible To Continue The Trial|2
1255953|NCT00540449|4115797|P2|Overall Study|Sponsor's Decision|1
1255954|NCT00540449|4115798|P1|Overall Study|Sponsor's Decision|1
1255955|NCT00540449|4115797|P2|Overall Study|Adverse Event|32
1255956|NCT00540449|4115798|P1|Overall Study|Adverse Event|12
1255957|NCT00540436|4115820|P1|Second 12-Week Treatment Period|Adverse Event|1
1255958|NCT00540436|4115820|P1|First 12-Week Treatment Period|Initiation of prohibited medication|1
1255959|NCT00540436|4115820|P1|First 12-Week Treatment Period|Withdrawal by Subject|1
1255960|NCT00540436|4115820|P1|First 12-Week Treatment Period|Adverse Event|1
1255961|NCT00540423|4115835|P3|Open-Label Treatment Period|Lack of Efficacy|2
1255962|NCT00540423|4115836|P2|Open-Label Treatment Period|Lack of Efficacy|0
1255963|NCT00540423|4115837|P1|Open-Label Treatment Period|Lack of Efficacy|0
1255964|NCT00540423|4115835|P3|Double-Blind Treatment Period|Adverse Event|0
1255965|NCT00540423|4115836|P2|Double-Blind Treatment Period|Adverse Event|1
1255966|NCT00540423|4115837|P1|Double-Blind Treatment Period|Adverse Event|0
1255967|NCT00540293|4115887|P1|Overall Study|Protocol violation, & subject schedule|12
1255968|NCT00540293|4115887|P1|Overall Study|Withdrawal by Subject|6
1255969|NCT00540293|4115887|P1|Overall Study|Adverse event not related to study drug|7
1255970|NCT00540293|4115887|P1|Overall Study|Adverse event related to study drug|10
1255971|NCT00540228|4115935|P5|Overall Study|Lost to Follow-up|0
1255972|NCT00540228|4115936|P4|Overall Study|Lost to Follow-up|0
1255973|NCT00540228|4115937|P3|Overall Study|Lost to Follow-up|0
1255974|NCT00540228|4115938|P2|Overall Study|Lost to Follow-up|1
1255975|NCT00540228|4115939|P1|Overall Study|Lost to Follow-up|1
1255976|NCT00540228|4115935|P5|Overall Study|Adverse Event|0
1255977|NCT00540228|4115936|P4|Overall Study|Adverse Event|0
1255978|NCT00540228|4115937|P3|Overall Study|Adverse Event|0
1255979|NCT00540228|4115938|P2|Overall Study|Adverse Event|0
1255980|NCT00540228|4115939|P1|Overall Study|Adverse Event|2
1255981|NCT00540124|4116009|P3|Overall Study|Withdrawal by Subject|0
1255982|NCT00540124|4116010|P2|Overall Study|Withdrawal by Subject|1
1255983|NCT00540124|4116011|P1|Overall Study|Withdrawal by Subject|1
1255984|NCT00540124|4116009|P3|Overall Study|Lack of Efficacy|0
1255985|NCT00540124|4116010|P2|Overall Study|Lack of Efficacy|0
1255986|NCT00540124|4116011|P1|Overall Study|Lack of Efficacy|1
1255987|NCT00540124|4116009|P3|Overall Study|Entry Criteria Not Met|0
1255988|NCT00540124|4116010|P2|Overall Study|Entry Criteria Not Met|0
1255989|NCT00540124|4116011|P1|Overall Study|Entry Criteria Not Met|2
1255990|NCT00540124|4116009|P3|Overall Study|Adverse Event|1
1255991|NCT00540124|4116010|P2|Overall Study|Adverse Event|2
1255992|NCT00540124|4116011|P1|Overall Study|Adverse Event|0
1255993|NCT00540046|4116057|P2|Overall Study|Lost to Follow-up|23
1255994|NCT00540046|4116058|P1|Overall Study|Lost to Follow-up|33
1255995|NCT00539994|4116094|P3|Overall Study|Physician Decision|1
1255996|NCT00539994|4116095|P2|Overall Study|Physician Decision|0
1255997|NCT00539994|4116096|P1|Overall Study|Physician Decision|0
1255998|NCT00539994|4116094|P3|Overall Study|Withdrawal by Subject|1
1255999|NCT00539994|4116095|P2|Overall Study|Withdrawal by Subject|0
1256000|NCT00539994|4116096|P1|Overall Study|Withdrawal by Subject|1
1256001|NCT00539994|4116094|P3|Overall Study|Lost to Follow-up|0
1256002|NCT00539994|4116095|P2|Overall Study|Lost to Follow-up|1
1256003|NCT00539994|4116096|P1|Overall Study|Lost to Follow-up|2
1256004|NCT00539864|4116146|P2|Overall Study|Withdrawal by Subject|1
1256005|NCT00539864|4116147|P1|Overall Study|Withdrawal by Subject|1
1256006|NCT00539864|4116146|P2|Overall Study|Lost to Follow-up|1
1256007|NCT00539864|4116147|P1|Overall Study|Lost to Follow-up|0
1256008|NCT00539734|4116159|P1|Overall Study|Protocol Violation|1
1256009|NCT00539591|4116178|P3|Overall Study|Disease progression|3
1256010|NCT00539591|4116179|P2|Overall Study|Disease progression|2
1256011|NCT00539591|4116180|P1|Overall Study|Disease progression|2
1256012|NCT00539591|4116178|P3|Overall Study|Toxicity|0
1256013|NCT00539591|4116179|P2|Overall Study|Toxicity|0
1256014|NCT00539591|4116180|P1|Overall Study|Toxicity|3
1256015|NCT00539513|4116332|P2|Overall Study|Lost to Follow-up|1
1256016|NCT00539513|4116333|P1|Overall Study|Lost to Follow-up|0
1256017|NCT00539513|4116332|P2|Overall Study|Withdrawal by Subject|1
1256018|NCT00539513|4116333|P1|Overall Study|Withdrawal by Subject|2
1256019|NCT00539305|4116347|P2|Overall Study|Withdrawal by Subject|1
1256020|NCT00539305|4116348|P1|Overall Study|Withdrawal by Subject|0
1256021|NCT00539305|4116347|P2|Overall Study|Substance Use|1
1256022|NCT00539305|4116348|P1|Overall Study|Substance Use|0
1256023|NCT00539305|4116347|P2|Overall Study|Adverse Event|0
1256024|NCT00539305|4116348|P1|Overall Study|Adverse Event|1
1256025|NCT00539279|4116362|P2|6-Month Follow-Up Assessment|Lost to Follow-up|7
1256026|NCT00539279|4116363|P1|6-Month Follow-Up Assessment|Lost to Follow-up|1
1256027|NCT00539279|4116362|P2|Post-Treatment Assessment|Lost to Follow-up|9
1256028|NCT00539279|4116363|P1|Post-Treatment Assessment|Lost to Follow-up|12
1256029|NCT00539279|4116362|P2|Treatment|Death|0
1256030|NCT00539279|4116363|P1|Treatment|Death|1
1256031|NCT00539279|4116362|P2|Treatment|Withdrawal by Subject|8
1256032|NCT00539279|4116363|P1|Treatment|Withdrawal by Subject|10
1256033|NCT00539240|4116389|P3|Overall Study|Adverse Event|10
1256034|NCT00539240|4116390|P2|Overall Study|Adverse Event|1
1256035|NCT00539240|4116391|P1|Overall Study|Adverse Event|3
1256036|NCT00539240|4116389|P3|Overall Study|Lost to Follow-up|1
1256037|NCT00539240|4116390|P2|Overall Study|Lost to Follow-up|3
1256038|NCT00539240|4116391|P1|Overall Study|Lost to Follow-up|2
1256039|NCT00539240|4116389|P3|Overall Study|Protocol Violation|4
1256040|NCT00539240|4116390|P2|Overall Study|Protocol Violation|1
1256041|NCT00539240|4116391|P1|Overall Study|Protocol Violation|1
1256042|NCT00539240|4116389|P3|Overall Study|Withdrawal by Subject|0
1256043|NCT00539240|4116390|P2|Overall Study|Withdrawal by Subject|2
1256044|NCT00539240|4116391|P1|Overall Study|Withdrawal by Subject|0
1256045|NCT00539188|4116410|P2|Overall Study|Lost to Follow-up|1
1256046|NCT00539188|4116411|P1|Overall Study|Lost to Follow-up|2
1256047|NCT00539188|4116410|P2|Overall Study|Withdrawal by Subject|0
1256048|NCT00539188|4116411|P1|Overall Study|Withdrawal by Subject|1
1256049|NCT00539032|4116434|P2|Overall Study|Withdrawal by Subject|1
1256050|NCT00539032|4116435|P1|Overall Study|Withdrawal by Subject|2
1256051|NCT00539006|4116449|P4|Treatment Period 2|Other|0
1256052|NCT00539006|4116450|P3|Treatment Period 2|Other|0
1256053|NCT00539006|4116451|P2|Treatment Period 2|Other|1
1256054|NCT00539006|4116452|P1|Treatment Period 2|Other|0
1256055|NCT00539006|4116449|P4|Treatment Period 2|Protocol Violation|0
1256056|NCT00539006|4116450|P3|Treatment Period 2|Protocol Violation|0
1256057|NCT00539006|4116451|P2|Treatment Period 2|Protocol Violation|0
1256058|NCT00539006|4116452|P1|Treatment Period 2|Protocol Violation|1
1256059|NCT00539006|4116449|P4|Washout|Other|3
1256060|NCT00539006|4116450|P3|Washout|Other|2
1256061|NCT00539006|4116451|P2|Washout|Other|1
1256062|NCT00539006|4116452|P1|Washout|Other|1
1256063|NCT00539006|4116449|P4|Washout|Failed to meet continuation criteria|6
1256064|NCT00539006|4116450|P3|Washout|Failed to meet continuation criteria|14
1256065|NCT00539006|4116451|P2|Washout|Failed to meet continuation criteria|5
1256066|NCT00539006|4116452|P1|Washout|Failed to meet continuation criteria|16
1256067|NCT00539006|4116449|P4|Washout|Withdrawal by Subject|0
1256068|NCT00539006|4116450|P3|Washout|Withdrawal by Subject|0
1256069|NCT00539006|4116451|P2|Washout|Withdrawal by Subject|2
1256070|NCT00539006|4116452|P1|Washout|Withdrawal by Subject|0
1256071|NCT00539006|4116449|P4|Washout|Protocol Violation|0
1256072|NCT00539006|4116450|P3|Washout|Protocol Violation|0
1256073|NCT00539006|4116451|P2|Washout|Protocol Violation|1
1256074|NCT00539006|4116452|P1|Washout|Protocol Violation|1
1256075|NCT00539006|4116449|P4|Washout|Adverse Event|0
1256076|NCT00539006|4116450|P3|Washout|Adverse Event|0
1256077|NCT00539006|4116451|P2|Washout|Adverse Event|1
1256078|NCT00539006|4116452|P1|Washout|Adverse Event|2
1256079|NCT00539006|4116449|P4|Treatment Period 1|Lack of Efficacy|1
1256080|NCT00539006|4116450|P3|Treatment Period 1|Lack of Efficacy|0
1256081|NCT00539006|4116451|P2|Treatment Period 1|Lack of Efficacy|0
1256082|NCT00539006|4116452|P1|Treatment Period 1|Lack of Efficacy|0
1256083|NCT00539006|4116449|P4|Treatment Period 1|Protocol Violation|0
1256084|NCT00539006|4116450|P3|Treatment Period 1|Protocol Violation|1
1256085|NCT00539006|4116451|P2|Treatment Period 1|Protocol Violation|0
1256086|NCT00539006|4116452|P1|Treatment Period 1|Protocol Violation|0
1256087|NCT00539006|4116449|P4|Treatment Period 1|Lost to Follow-up|0
1256088|NCT00539006|4116450|P3|Treatment Period 1|Lost to Follow-up|1
1256089|NCT00539006|4116451|P2|Treatment Period 1|Lost to Follow-up|0
1256090|NCT00539006|4116452|P1|Treatment Period 1|Lost to Follow-up|0
1256091|NCT00539006|4116449|P4|Pre-treatment|Other|0
1256092|NCT00539006|4116450|P3|Pre-treatment|Other|0
1256093|NCT00539006|4116451|P2|Pre-treatment|Other|1
1256094|NCT00539006|4116452|P1|Pre-treatment|Other|0
1256095|NCT00538902|4116497|P3|OL Wk 24 to End (Primary D/C Reasons)|Various|22
1256096|NCT00538902|4116498|P2|OL Wk 24 to End (Primary D/C Reasons)|Various|25
1256097|NCT00538902|4116499|P1|OL Wk 24 to End (Primary D/C Reasons)|Various|18
1256098|NCT00538902|4116497|P3|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6
1256099|NCT00538902|4116498|P2|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10
1256100|NCT00538902|4116499|P1|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1
1256101|NCT00538902|4116497|P3|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25
1256102|NCT00538902|4116498|P2|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19
1256103|NCT00538902|4116499|P1|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15
1256104|NCT00538902|4116497|P3|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11
1256105|NCT00538902|4116498|P2|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10
1256106|NCT00538902|4116499|P1|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2
1256107|NCT00538902|4116497|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
1256108|NCT00538902|4116498|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
1256109|NCT00538902|4116499|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
1256110|NCT00538902|4116497|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1
1256111|NCT00538902|4116498|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
1256112|NCT00538902|4116499|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
1256113|NCT00538902|4116497|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1
1256114|NCT00538902|4116498|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
1256115|NCT00538902|4116499|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
1256116|NCT00538902|4116497|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3
1256117|NCT00538902|4116498|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2
1256118|NCT00538902|4116499|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1
1256119|NCT00538785|4116560|P2|Overall Study|Lost to Follow-up|0
1256120|NCT00538785|4116561|P1|Overall Study|Lost to Follow-up|1
1256121|NCT00538785|4116560|P2|Overall Study|Withdrawal of consent|7
1256122|NCT00538785|4116561|P1|Overall Study|Withdrawal of consent|9
1256123|NCT00538785|4116560|P2|Overall Study|Death|10
1256124|NCT00538785|4116561|P1|Overall Study|Death|9
1256125|NCT00538733|4116582|P1|Overall Study|still on therapy|1
1256126|NCT00538733|4116582|P1|Overall Study|declined to participate|2
1256127|NCT00538733|4116582|P1|Overall Study|Death|1
1256128|NCT00538733|4116582|P1|Overall Study|Adverse Event|8
1256129|NCT00538629|4116632|P1|Overall Study|Subject's untimely distrust of medicine|1
1256130|NCT00538629|4116632|P1|Overall Study|Lost to Follow-up|6
1256131|NCT00538629|4116632|P1|Overall Study|Lack of Efficacy|12
1256132|NCT00538629|4116632|P1|Overall Study|Adverse Event|2
1256133|NCT00538629|4116632|P1|Overall Study|At subject's request|1
1256134|NCT00538590|4116688|P2|Overall Study|Death|0
1256135|NCT00538590|4116689|P1|Overall Study|Death|1
1256136|NCT00538473|4116727|P2|Overall Study|Adverse Event|0
1256137|NCT00538473|4116728|P1|Overall Study|Adverse Event|1
1256138|NCT00538291|4116808|P1|Overall Study|Withdrawal by Subject|1
1256139|NCT00538291|4116808|P1|Overall Study|Adverse Event|2
1256140|NCT00537979|4116866|P2|Overall Study|Heart failure|1
1256141|NCT00537979|4116867|P1|Overall Study|Heart failure|0
1256142|NCT00537979|4116866|P2|Overall Study|Kidney transplant|3
1256143|NCT00537979|4116867|P1|Overall Study|Kidney transplant|0
1256144|NCT00537979|4116866|P2|Overall Study|Death|3
1256145|NCT00537979|4116867|P1|Overall Study|Death|0
1256146|NCT00537979|4116866|P2|Overall Study|Non-compliance with treatment/procedure|2
1256147|NCT00537979|4116867|P1|Overall Study|Non-compliance with treatment/procedure|2
1256148|NCT00537979|4116866|P2|Overall Study|Lack of Efficacy|1
1256149|NCT00537979|4116867|P1|Overall Study|Lack of Efficacy|0
1256150|NCT00537979|4116866|P2|Overall Study|Lost to Follow-up|4
1256151|NCT00537979|4116867|P1|Overall Study|Lost to Follow-up|1
1256152|NCT00537979|4116866|P2|Overall Study|Withdrawal by Subject|4
1256153|NCT00537979|4116867|P1|Overall Study|Withdrawal by Subject|1
1256154|NCT00537979|4116866|P2|Overall Study|Adverse Event|2
1256155|NCT00537979|4116867|P1|Overall Study|Adverse Event|2
1256156|NCT00537940|4116883|P2|Overall Study|Other|12
1256157|NCT00537940|4116884|P1|Overall Study|Other|10
1256158|NCT00537940|4116883|P2|Overall Study|Study terminated by sponsor|3
1256159|NCT00537940|4116884|P1|Overall Study|Study terminated by sponsor|2
1256160|NCT00537940|4116883|P2|Overall Study|Pregnancy|1
1256161|NCT00537940|4116884|P1|Overall Study|Pregnancy|1
1256162|NCT00537940|4116883|P2|Overall Study|Protocol Violation|4
1256163|NCT00537940|4116884|P1|Overall Study|Protocol Violation|6
1256164|NCT00537940|4116883|P2|Overall Study|Withdrawal by Subject|95
1256165|NCT00537940|4116884|P1|Overall Study|Withdrawal by Subject|113
1256166|NCT00537940|4116883|P2|Overall Study|Lost to Follow-up|29
1256167|NCT00537940|4116884|P1|Overall Study|Lost to Follow-up|23
1256168|NCT00537940|4116883|P2|Overall Study|Lack of Efficacy|16
1256169|NCT00537940|4116884|P1|Overall Study|Lack of Efficacy|8
1256170|NCT00537940|4116883|P2|Overall Study|Adverse Event|19
1256171|NCT00537940|4116884|P1|Overall Study|Adverse Event|20
1256172|NCT00537823|4116908|P2|Overall Study|Adverse Event|0
1256173|NCT00537823|4116909|P1|Overall Study|Adverse Event|2
1256174|NCT00537810|4116935|P4|Overall Study|Medically withdrawn|1
1256175|NCT00537810|4116936|P3|Overall Study|Medically withdrawn|0
1256176|NCT00537810|4116937|P2|Overall Study|Medically withdrawn|2
1256177|NCT00537810|4116938|P1|Overall Study|Medically withdrawn|2
1256178|NCT00537810|4116935|P4|Overall Study|Withdrawal by Subject|3
1256179|NCT00537810|4116936|P3|Overall Study|Withdrawal by Subject|4
1256180|NCT00537810|4116937|P2|Overall Study|Withdrawal by Subject|11
1256181|NCT00537810|4116938|P1|Overall Study|Withdrawal by Subject|4
1256182|NCT00537771|4116954|P2|Overall Study|Severe Non-Compliance to Protocol|2
1256183|NCT00537771|4116955|P1|Overall Study|Severe Non-Compliance to Protocol|4
1256184|NCT00537771|4116954|P2|Overall Study|Protocol Violation|6
1256185|NCT00537771|4116955|P1|Overall Study|Protocol Violation|2
1256186|NCT00537771|4116954|P2|Overall Study|Lost to Follow-up|15
1256187|NCT00537771|4116955|P1|Overall Study|Lost to Follow-up|9
1256188|NCT00537771|4116954|P2|Overall Study|Adverse Event|15
1256189|NCT00537771|4116955|P1|Overall Study|Adverse Event|8
1256190|NCT00537771|4116954|P2|Overall Study|Withdrawal by Subject|23
1256191|NCT00537771|4116955|P1|Overall Study|Withdrawal by Subject|6
1256192|NCT00537745|4116965|P1|Overall Study|Subject unable to provide Interlock info|1
1256193|NCT00537745|4116965|P1|Overall Study|Withdrawal by Subject|2
1256194|NCT00537745|4116965|P1|Overall Study|Did not meet eligibility criteria|2
1256195|NCT00537485|4117010|P2|Overall Study|Physician Decision|0
1256196|NCT00537485|4117011|P1|Overall Study|Physician Decision|1
1256197|NCT00537485|4117010|P2|Overall Study|Withdrawal by Subject|3
1256198|NCT00537485|4117011|P1|Overall Study|Withdrawal by Subject|1
1256199|NCT00537485|4117010|P2|Overall Study|Withdrawal by Subject|2
1256200|NCT00537485|4117011|P1|Overall Study|Withdrawal by Subject|3
1256201|NCT00537485|4117010|P2|Overall Study|Adverse Event|5
1256202|NCT00537485|4117011|P1|Overall Study|Adverse Event|10
1256203|NCT00537394|4117084|P3|2nd Year of Follow-up|Clinic site closure|0
1256204|NCT00537394|4117085|P2|2nd Year of Follow-up|Clinic site closure|0
1256205|NCT00537394|4117086|P1|2nd Year of Follow-up|Clinic site closure|1
1256206|NCT00537394|4117084|P3|2nd Year of Follow-up|Lost to Follow-up|2
1256207|NCT00537394|4117085|P2|2nd Year of Follow-up|Lost to Follow-up|7
1256208|NCT00537394|4117086|P1|2nd Year of Follow-up|Lost to Follow-up|6
1256209|NCT00537394|4117084|P3|2nd Year of Follow-up|Withdrawal by Subject|2
1256210|NCT00537394|4117085|P2|2nd Year of Follow-up|Withdrawal by Subject|1
1256211|NCT00537394|4117086|P1|2nd Year of Follow-up|Withdrawal by Subject|0
1256212|NCT00537394|4117084|P3|2nd Year of Follow-up|Death|2
1256213|NCT00537394|4117085|P2|2nd Year of Follow-up|Death|1
1256214|NCT00537394|4117086|P1|2nd Year of Follow-up|Death|4
1256215|NCT00537394|4117084|P3|First Year of Follow-up|Lost to Follow-up|1
1256216|NCT00537394|4117085|P2|First Year of Follow-up|Lost to Follow-up|5
1256217|NCT00537394|4117086|P1|First Year of Follow-up|Lost to Follow-up|1
1256218|NCT00537394|4117084|P3|First Year of Follow-up|Withdrawal by Subject|1
1256219|NCT00537394|4117085|P2|First Year of Follow-up|Withdrawal by Subject|6
1256220|NCT00537394|4117086|P1|First Year of Follow-up|Withdrawal by Subject|3
1256221|NCT00537394|4117084|P3|First Year of Follow-up|Severe debilitation|1
1256222|NCT00537394|4117085|P2|First Year of Follow-up|Severe debilitation|0
1256223|NCT00537394|4117086|P1|First Year of Follow-up|Severe debilitation|1
1256224|NCT00537394|4117084|P3|First Year of Follow-up|Death|0
1256225|NCT00537394|4117085|P2|First Year of Follow-up|Death|0
1256226|NCT00537394|4117086|P1|First Year of Follow-up|Death|7
1256227|NCT00537381|4117122|P2|Overall Study|Other|3
1256228|NCT00537381|4117123|P1|Overall Study|Other|5
1256229|NCT00537381|4117122|P2|Overall Study|Sponsor decision|9
1256230|NCT00537381|4117123|P1|Overall Study|Sponsor decision|14
1256231|NCT00537381|4117122|P2|Overall Study|Disease Progression|18
1256232|NCT00537381|4117123|P1|Overall Study|Disease Progression|9
1256233|NCT00537381|4117122|P2|Overall Study|Physician Decision|6
1256234|NCT00537381|4117123|P1|Overall Study|Physician Decision|7
1256235|NCT00537381|4117122|P2|Overall Study|Withdrawal by Subject|14
1256236|NCT00537381|4117123|P1|Overall Study|Withdrawal by Subject|5
1256237|NCT00537381|4117122|P2|Overall Study|Death|3
1256238|NCT00537381|4117123|P1|Overall Study|Death|3
1256239|NCT00537381|4117122|P2|Overall Study|Adverse Event|9
1256240|NCT00537381|4117123|P1|Overall Study|Adverse Event|13
1256241|NCT00537329|4117143|P1|Overall Study|Other|1
1256242|NCT00537329|4117143|P1|Overall Study|Withdrawal by Subject|4
1256243|NCT00537329|4117143|P1|Overall Study|Lost to Follow-up|6
1256244|NCT00537329|4117143|P1|Overall Study|Lack of Efficacy|2
1256245|NCT00537329|4117143|P1|Overall Study|Adverse Event|3
1256246|NCT00537329|4117143|P1|Overall Study|Death|10
1256247|NCT00537316|4117163|P7|Part 2|Administrative|1
1256248|NCT00537316|4117164|P6|Part 2|Administrative|4
1256249|NCT00537316|4117165|P5|Part 2|Administrative|1
1256250|NCT00537316|4117166|P4|Part 2|Administrative|3
1256251|NCT00537316|4117167|P3|Part 2|Administrative|24
1256252|NCT00537316|4117168|P2|Part 2|Administrative|8
1256253|NCT00537316|4117169|P1|Part 2|Administrative|16
1256254|NCT00537316|4117163|P7|Part 2|Withdrawal by Subject|0
1256255|NCT00537316|4117164|P6|Part 2|Withdrawal by Subject|0
1256256|NCT00537316|4117165|P5|Part 2|Withdrawal by Subject|0
1256257|NCT00537316|4117166|P4|Part 2|Withdrawal by Subject|0
1256258|NCT00537316|4117167|P3|Part 2|Withdrawal by Subject|4
1256259|NCT00537316|4117168|P2|Part 2|Withdrawal by Subject|1
1256260|NCT00537316|4117169|P1|Part 2|Withdrawal by Subject|5
1256261|NCT00537316|4117163|P7|Part 2|Lost to Follow-up|0
1256262|NCT00537316|4117164|P6|Part 2|Lost to Follow-up|0
1256263|NCT00537316|4117165|P5|Part 2|Lost to Follow-up|0
1256264|NCT00537316|4117166|P4|Part 2|Lost to Follow-up|0
1256265|NCT00537316|4117167|P3|Part 2|Lost to Follow-up|2
1256266|NCT00537316|4117168|P2|Part 2|Lost to Follow-up|0
1256267|NCT00537316|4117169|P1|Part 2|Lost to Follow-up|1
1256268|NCT00537316|4117163|P7|Part 2|Adverse Event|0
1256269|NCT00537316|4117164|P6|Part 2|Adverse Event|0
1256270|NCT00537316|4117165|P5|Part 2|Adverse Event|0
1256271|NCT00537316|4117166|P4|Part 2|Adverse Event|0
1256272|NCT00537316|4117167|P3|Part 2|Adverse Event|2
1256273|NCT00537316|4117168|P2|Part 2|Adverse Event|0
1256274|NCT00537316|4117169|P1|Part 2|Adverse Event|4
1256275|NCT00537316|4117163|P7|Part 2|Never entered follow-up|1
1256276|NCT00537316|4117164|P6|Part 2|Never entered follow-up|0
1256277|NCT00537316|4117165|P5|Part 2|Never entered follow-up|0
1256278|NCT00537316|4117166|P4|Part 2|Never entered follow-up|0
1256279|NCT00537316|4117167|P3|Part 2|Never entered follow-up|0
1256280|NCT00537316|4117168|P2|Part 2|Never entered follow-up|0
1256281|NCT00537316|4117169|P1|Part 2|Never entered follow-up|0
1256282|NCT00537316|4117163|P7|Part 1|Administrative|0
1256283|NCT00537316|4117164|P6|Part 1|Administrative|0
1256284|NCT00537316|4117165|P5|Part 1|Administrative|0
1256285|NCT00537316|4117166|P4|Part 1|Administrative|0
1256286|NCT00537316|4117167|P3|Part 1|Administrative|2
1256287|NCT00537316|4117168|P2|Part 1|Administrative|0
1256288|NCT00537316|4117169|P1|Part 1|Administrative|0
1256289|NCT00537316|4117163|P7|Part 1|Did not meet protocol eligibility|0
1256290|NCT00537316|4117164|P6|Part 1|Did not meet protocol eligibility|0
1256291|NCT00537316|4117165|P5|Part 1|Did not meet protocol eligibility|0
1256292|NCT00537316|4117166|P4|Part 1|Did not meet protocol eligibility|0
1256293|NCT00537316|4117167|P3|Part 1|Did not meet protocol eligibility|2
1256294|NCT00537316|4117168|P2|Part 1|Did not meet protocol eligibility|3
1256295|NCT00537316|4117169|P1|Part 1|Did not meet protocol eligibility|1
1256296|NCT00537316|4117163|P7|Part 1|Protocol Violation|0
1256297|NCT00537316|4117164|P6|Part 1|Protocol Violation|0
1256298|NCT00537316|4117165|P5|Part 1|Protocol Violation|0
1256299|NCT00537316|4117166|P4|Part 1|Protocol Violation|0
1256300|NCT00537316|4117167|P3|Part 1|Protocol Violation|1
1256301|NCT00537316|4117168|P2|Part 1|Protocol Violation|5
1256302|NCT00537316|4117169|P1|Part 1|Protocol Violation|1
1256303|NCT00537316|4117163|P7|Part 1|Withdrawal by Subject|0
1256304|NCT00537316|4117164|P6|Part 1|Withdrawal by Subject|0
1256305|NCT00537316|4117165|P5|Part 1|Withdrawal by Subject|0
1256306|NCT00537316|4117166|P4|Part 1|Withdrawal by Subject|0
1256307|NCT00537316|4117167|P3|Part 1|Withdrawal by Subject|4
1256308|NCT00537316|4117168|P2|Part 1|Withdrawal by Subject|8
1256309|NCT00537316|4117169|P1|Part 1|Withdrawal by Subject|3
1256310|NCT00537316|4117163|P7|Part 1|Lost to Follow-up|0
1256311|NCT00537316|4117164|P6|Part 1|Lost to Follow-up|0
1256312|NCT00537316|4117165|P5|Part 1|Lost to Follow-up|0
1256313|NCT00537316|4117166|P4|Part 1|Lost to Follow-up|0
1256314|NCT00537316|4117167|P3|Part 1|Lost to Follow-up|0
1256315|NCT00537316|4117168|P2|Part 1|Lost to Follow-up|0
1256316|NCT00537316|4117169|P1|Part 1|Lost to Follow-up|1
1256317|NCT00537316|4117163|P7|Part 1|Protocol defined clinical event|0
1256318|NCT00537316|4117164|P6|Part 1|Protocol defined clinical event|0
1256319|NCT00537316|4117165|P5|Part 1|Protocol defined clinical event|0
1256320|NCT00537316|4117166|P4|Part 1|Protocol defined clinical event|0
1256321|NCT00537316|4117167|P3|Part 1|Protocol defined clinical event|0
1256322|NCT00537316|4117168|P2|Part 1|Protocol defined clinical event|0
1256323|NCT00537316|4117169|P1|Part 1|Protocol defined clinical event|1
1256324|NCT00537316|4117163|P7|Part 1|Adverse Event|0
1256325|NCT00537316|4117164|P6|Part 1|Adverse Event|0
1256326|NCT00537316|4117165|P5|Part 1|Adverse Event|0
1256327|NCT00537316|4117166|P4|Part 1|Adverse Event|0
1256328|NCT00537316|4117167|P3|Part 1|Adverse Event|8
1256329|NCT00537316|4117168|P2|Part 1|Adverse Event|11
1256330|NCT00537316|4117169|P1|Part 1|Adverse Event|7
1256331|NCT00537303|4117196|P2|Overall Study|Unclassified|7
1256332|NCT00537303|4117197|P1|Overall Study|Unclassified|8
1256333|NCT00537303|4117196|P2|Overall Study|Withdrawal criteria|3
1256334|NCT00537303|4117197|P1|Overall Study|Withdrawal criteria|3
1256335|NCT00537303|4117196|P2|Overall Study|Protocol Violation|4
1256336|NCT00537303|4117197|P1|Overall Study|Protocol Violation|8
1256337|NCT00537303|4117196|P2|Overall Study|Lack of Efficacy|7
1256338|NCT00537303|4117197|P1|Overall Study|Lack of Efficacy|6
1256339|NCT00537303|4117196|P2|Overall Study|Adverse Event|4
1256340|NCT00537303|4117197|P1|Overall Study|Adverse Event|1
1256341|NCT00537277|4117218|P1|Overall Study|Non-compliance with trial procedures|15
1256342|NCT00537277|4117218|P1|Overall Study|Inability to tolerate trial medication|4
1256343|NCT00537277|4117218|P1|Overall Study|Unclassified|4
1256344|NCT00537277|4117218|P1|Overall Study|Protocol Violation|11
1256345|NCT00537277|4117218|P1|Overall Study|Lost to Follow-up|12
1256346|NCT00537277|4117218|P1|Overall Study|Lack of Efficacy|2
1256347|NCT00537277|4117218|P1|Overall Study|Adverse Event|1
1256348|NCT00537238|4117229|P2|Overall Study|Other|52
1256349|NCT00537238|4117230|P1|Overall Study|Other|44
1256350|NCT00537238|4117229|P2|Overall Study|Does not meet entrance criteria|2
1256351|NCT00537238|4117230|P1|Overall Study|Does not meet entrance criteria|0
1256352|NCT00537238|4117229|P2|Overall Study|Protocol Violation|19
1256353|NCT00537238|4117230|P1|Overall Study|Protocol Violation|15
1256354|NCT00537238|4117229|P2|Overall Study|Withdrawal by Subject|47
1256355|NCT00537238|4117230|P1|Overall Study|Withdrawal by Subject|51
1256356|NCT00537238|4117229|P2|Overall Study|Lost to Follow-up|8
1256357|NCT00537238|4117230|P1|Overall Study|Lost to Follow-up|12
1256358|NCT00537238|4117229|P2|Overall Study|Lack of Efficacy|21
1256359|NCT00537238|4117230|P1|Overall Study|Lack of Efficacy|20
1256360|NCT00537238|4117229|P2|Overall Study|Adverse Event|22
1256361|NCT00537238|4117230|P1|Overall Study|Adverse Event|31
1256362|NCT00537238|4117229|P2|Overall Study|Death|2
1256363|NCT00537238|4117230|P1|Overall Study|Death|1
1256364|NCT00537199|4117250|P1|Overall Study|Study Terminated|1
1256365|NCT00537095|4117256|P2|Overall Study|Incorrect enrolment|1
1256366|NCT00537095|4117257|P1|Overall Study|Incorrect enrolment|0
1256367|NCT00537095|4117256|P2|Overall Study|subjective disease progression|1
1256368|NCT00537095|4117257|P1|Overall Study|subjective disease progression|0
1256369|NCT00537095|4117256|P2|Overall Study|Withdrawal by Subject|2
1256370|NCT00537095|4117257|P1|Overall Study|Withdrawal by Subject|2
1256371|NCT00537095|4117256|P2|Overall Study|Death|1
1256372|NCT00537095|4117257|P1|Overall Study|Death|3
1256373|NCT00537095|4117256|P2|Overall Study|disease progression|48
1256374|NCT00537095|4117257|P1|Overall Study|disease progression|21
1256375|NCT00537095|4117256|P2|Overall Study|Adverse Event|4
1256376|NCT00537095|4117257|P1|Overall Study|Adverse Event|24
1256377|NCT00537095|4117256|P2|Overall Study|surgery|0
1256378|NCT00537095|4117257|P1|Overall Study|surgery|1
1256379|NCT00537082|4117272|P3|Overall Study|Discontinued before initiating treatment|0
1256380|NCT00537082|4117273|P2|Overall Study|Discontinued before initiating treatment|0
1256381|NCT00537082|4117274|P1|Overall Study|Discontinued before initiating treatment|3
1256382|NCT00537082|4117272|P3|Overall Study|Withdrawal by Subject|0
1256383|NCT00537082|4117273|P2|Overall Study|Withdrawal by Subject|1
1256384|NCT00537082|4117274|P1|Overall Study|Withdrawal by Subject|0
1256385|NCT00537082|4117272|P3|Overall Study|Lack of Efficacy|2
1256386|NCT00537082|4117273|P2|Overall Study|Lack of Efficacy|0
1256387|NCT00537082|4117274|P1|Overall Study|Lack of Efficacy|0
1256388|NCT00537082|4117272|P3|Overall Study|Protocol Violation|1
1256389|NCT00537082|4117273|P2|Overall Study|Protocol Violation|2
1256390|NCT00537082|4117274|P1|Overall Study|Protocol Violation|0
1256391|NCT00537082|4117272|P3|Overall Study|Adverse Event|3
1256392|NCT00537082|4117273|P2|Overall Study|Adverse Event|6
1256393|NCT00537082|4117274|P1|Overall Study|Adverse Event|6
1256394|NCT00537056|4117291|P1|Interim PET/CT|scheduling conflicts and/or exposure|5
1256395|NCT00537030|4117303|P1|Overall Study|Inevaluable|3
1256396|NCT00537030|4117303|P1|Overall Study|Confirm patient ineligibility|1
1256397|NCT00537030|4117303|P1|Overall Study|Disease progression or relapse during ac|1
1256398|NCT00537030|4117303|P1|Overall Study|Greater then or equal to a Grade 2 aller|7
1256399|NCT00537030|4117303|P1|Overall Study|Withdrawal by Subject|2
1256400|NCT00537030|4117303|P1|Overall Study|Physician Decision|2
1256401|NCT00537017|4117307|P1|Follow-up Phase|Withdrawal by Subject|9
1256402|NCT00537017|4117307|P1|Treatment Phase|Protocol Violation|2
1256403|NCT00537017|4117307|P1|Treatment Phase|Withdrawal by Subject|13
1256404|NCT00537017|4117307|P1|Treatment Phase|Adverse Event|19
1256405|NCT00536991|4117318|P1|Overall Study|patient ineligible|2
1256406|NCT00536991|4117318|P1|Overall Study|Physician Decision|1
1256407|NCT00536991|4117318|P1|Overall Study|Withdrawal by Subject|10
1256408|NCT00536978|4117325|P1|Overall Study|Not eligible for Adback Infusion|22
1256409|NCT00536874|4117354|P1|Overall Study|Withdrawal by Subject|1
1256410|NCT00536874|4117354|P1|Overall Study|Death|2
1256411|NCT00536874|4117354|P1|Overall Study|Adverse Event|1
1256412|NCT00536809|4117364|P1|Phase II|Referred for surgical resection|1
1256413|NCT00536809|4117364|P1|Phase II|Adverse Event|1
1256414|NCT00536744|4117387|P2|Overall Study|PI tried alternative treatment|3
1256415|NCT00536744|4117388|P1|Overall Study|PI tried alternative treatment|1
1256416|NCT00536744|4117387|P2|Overall Study|Withdrawal by Subject|8
1256417|NCT00536744|4117388|P1|Overall Study|Withdrawal by Subject|7
1256418|NCT00536744|4117387|P2|Overall Study|Lost to Follow-up|5
1256419|NCT00536744|4117388|P1|Overall Study|Lost to Follow-up|3
1256420|NCT00536744|4117387|P2|Overall Study|Physician Decision|1
1256421|NCT00536744|4117388|P1|Overall Study|Physician Decision|3
1256422|NCT00536744|4117387|P2|Overall Study|Death|1
1256423|NCT00536744|4117388|P1|Overall Study|Death|2
1256424|NCT00536744|4117387|P2|Overall Study|Adverse Event|10
1256425|NCT00536744|4117388|P1|Overall Study|Adverse Event|13
1256426|NCT00536731|4117397|P3|Overall Study|Other|0
1256427|NCT00536731|4117398|P2|Overall Study|Other|1
1256428|NCT00536731|4117399|P1|Overall Study|Other|1
1256429|NCT00536731|4117397|P3|Overall Study|Safety reasons|1
1256430|NCT00536731|4117398|P2|Overall Study|Safety reasons|0
1256431|NCT00536731|4117399|P1|Overall Study|Safety reasons|0
1256432|NCT00536731|4117397|P3|Overall Study|Intake of prohibited conc. medication|1
1256433|NCT00536731|4117398|P2|Overall Study|Intake of prohibited conc. medication|0
1256434|NCT00536731|4117399|P1|Overall Study|Intake of prohibited conc. medication|0
1256435|NCT00536731|4117397|P3|Overall Study|Withdrawal by Subject|0
1256436|NCT00536731|4117398|P2|Overall Study|Withdrawal by Subject|2
1256437|NCT00536731|4117399|P1|Overall Study|Withdrawal by Subject|0
1256438|NCT00536731|4117397|P3|Overall Study|Adverse Event|3
1256439|NCT00536731|4117398|P2|Overall Study|Adverse Event|2
1256440|NCT00536731|4117399|P1|Overall Study|Adverse Event|3
1256441|NCT00536575|4117443|P1|Overall Study|Death|1
1256442|NCT00536575|4117443|P1|Overall Study|Withdrawal by Subject|1
1256443|NCT00536510|4117449|P2|Overall Study|Patient Discontinued for Other Reasons|2
1256444|NCT00536510|4117450|P1|Overall Study|Patient Discontinued for Other Reasons|2
1256445|NCT00536510|4117449|P2|Overall Study|Laboratory Adverse Event|1
1256446|NCT00536510|4117450|P1|Overall Study|Laboratory Adverse Event|2
1256447|NCT00536510|4117449|P2|Overall Study|Flushing with Product|0
1256448|NCT00536510|4117450|P1|Overall Study|Flushing with Product|20
1256449|NCT00536510|4117449|P2|Overall Study|Withdrawal by Subject|9
1256450|NCT00536510|4117450|P1|Overall Study|Withdrawal by Subject|16
1256451|NCT00536510|4117449|P2|Overall Study|Protocol Violation|5
1256452|NCT00536510|4117450|P1|Overall Study|Protocol Violation|4
1256453|NCT00536510|4117449|P2|Overall Study|Lost to Follow-up|8
1256454|NCT00536510|4117450|P1|Overall Study|Lost to Follow-up|11
1256455|NCT00536510|4117449|P2|Overall Study|Adverse Event|4
1256456|NCT00536510|4117450|P1|Overall Study|Adverse Event|27
1256457|NCT00536484|4117460|P2|Overall Study|Other|0
1256458|NCT00536484|4117461|P1|Overall Study|Other|4
1256459|NCT00536484|4117460|P2|Overall Study|Lack of Efficacy|5
1256460|NCT00536484|4117461|P1|Overall Study|Lack of Efficacy|16
1256461|NCT00536484|4117460|P2|Overall Study|Lost to Follow-up|6
1256462|NCT00536484|4117461|P1|Overall Study|Lost to Follow-up|8
1256463|NCT00536484|4117460|P2|Overall Study|Withdrawal by Subject|11
1256464|NCT00536484|4117461|P1|Overall Study|Withdrawal by Subject|11
1256465|NCT00536484|4117460|P2|Overall Study|Adverse Event|34
1256466|NCT00536484|4117461|P1|Overall Study|Adverse Event|21
1256467|NCT00536471|4117495|P4|Overall Study|Sponsor Decision|2
1256468|NCT00536471|4117496|P3|Overall Study|Sponsor Decision|3
1256469|NCT00536471|4117497|P2|Overall Study|Sponsor Decision|1
1256470|NCT00536471|4117498|P1|Overall Study|Sponsor Decision|0
1256471|NCT00536471|4117495|P4|Overall Study|Death|2
1256472|NCT00536471|4117496|P3|Overall Study|Death|1
1256473|NCT00536471|4117497|P2|Overall Study|Death|0
1256474|NCT00536471|4117498|P1|Overall Study|Death|0
1256475|NCT00536471|4117495|P4|Overall Study|Physician Decision|2
1256476|NCT00536471|4117496|P3|Overall Study|Physician Decision|3
1256477|NCT00536471|4117497|P2|Overall Study|Physician Decision|1
1256478|NCT00536471|4117498|P1|Overall Study|Physician Decision|11
1256479|NCT00536471|4117495|P4|Overall Study|Protocol Violation|3
1256480|NCT00536471|4117496|P3|Overall Study|Protocol Violation|2
1256481|NCT00536471|4117497|P2|Overall Study|Protocol Violation|1
1256482|NCT00536471|4117498|P1|Overall Study|Protocol Violation|8
1256483|NCT00536471|4117495|P4|Overall Study|Lack of Efficacy|9
1256484|NCT00536471|4117496|P3|Overall Study|Lack of Efficacy|11
1256485|NCT00536471|4117497|P2|Overall Study|Lack of Efficacy|18
1256486|NCT00536471|4117498|P1|Overall Study|Lack of Efficacy|17
1256487|NCT00536471|4117495|P4|Overall Study|Withdrawal by Subject|21
1256488|NCT00536471|4117496|P3|Overall Study|Withdrawal by Subject|43
1256489|NCT00536471|4117497|P2|Overall Study|Withdrawal by Subject|24
1256490|NCT00536471|4117498|P1|Overall Study|Withdrawal by Subject|40
1256491|NCT00536471|4117495|P4|Overall Study|Adverse Event|13
1256492|NCT00536471|4117496|P3|Overall Study|Adverse Event|28
1256493|NCT00536471|4117497|P2|Overall Study|Adverse Event|16
1256494|NCT00536471|4117498|P1|Overall Study|Adverse Event|32
1256495|NCT00536471|4117495|P4|Overall Study|Lost to Follow-up|22
1256496|NCT00536471|4117496|P3|Overall Study|Lost to Follow-up|48
1256497|NCT00536471|4117497|P2|Overall Study|Lost to Follow-up|23
1256498|NCT00536471|4117498|P1|Overall Study|Lost to Follow-up|48
1256499|NCT00536380|4117743|P3|Overall Study|Administrative|1
1256500|NCT00536380|4117744|P2|Overall Study|Administrative|0
1256501|NCT00536380|4117745|P1|Overall Study|Administrative|0
1256502|NCT00536380|4117743|P3|Overall Study|Did not meet protocol eligibility|1
1256503|NCT00536380|4117744|P2|Overall Study|Did not meet protocol eligibility|0
1256504|NCT00536380|4117745|P1|Overall Study|Did not meet protocol eligibility|0
1256505|NCT00536380|4117743|P3|Overall Study|Noncompliance with protocol|2
1256506|NCT00536380|4117744|P2|Overall Study|Noncompliance with protocol|2
1256507|NCT00536380|4117745|P1|Overall Study|Noncompliance with protocol|3
1256508|NCT00536380|4117743|P3|Overall Study|Withdrawal related to study drug|2
1256509|NCT00536380|4117744|P2|Overall Study|Withdrawal related to study drug|5
1256510|NCT00536380|4117745|P1|Overall Study|Withdrawal related to study drug|7
1256511|NCT00536380|4117743|P3|Overall Study|Withdrawal unrelated to study drug|1
1256512|NCT00536380|4117744|P2|Overall Study|Withdrawal unrelated to study drug|0
1256513|NCT00536380|4117745|P1|Overall Study|Withdrawal unrelated to study drug|2
1256514|NCT00536380|4117743|P3|Overall Study|Lost to Follow-up|1
1256515|NCT00536380|4117744|P2|Overall Study|Lost to Follow-up|0
1256516|NCT00536380|4117745|P1|Overall Study|Lost to Follow-up|0
1256517|NCT00536380|4117743|P3|Overall Study|Adverse Event|2
1256518|NCT00536380|4117744|P2|Overall Study|Adverse Event|2
1256519|NCT00536380|4117745|P1|Overall Study|Adverse Event|0
1256520|NCT00536263|4117769|P3|Overall Study|Did not meet protocol eligibility|2
1256521|NCT00536263|4117770|P2|Overall Study|Did not meet protocol eligibility|2
1256522|NCT00536263|4117771|P1|Overall Study|Did not meet protocol eligibility|1
1256523|NCT00536263|4117769|P3|Overall Study|Noncompliance with protocol|1
1256524|NCT00536263|4117770|P2|Overall Study|Noncompliance with protocol|0
1256525|NCT00536263|4117771|P1|Overall Study|Noncompliance with protocol|0
1256526|NCT00536263|4117769|P3|Overall Study|Subject withdrew - treatment related|2
1256527|NCT00536263|4117770|P2|Overall Study|Subject withdrew - treatment related|3
1256528|NCT00536263|4117771|P1|Overall Study|Subject withdrew - treatment related|0
1256529|NCT00536263|4117769|P3|Overall Study|Subject withdrew - not treatment related|5
1256530|NCT00536263|4117770|P2|Overall Study|Subject withdrew - not treatment related|0
1256531|NCT00536263|4117771|P1|Overall Study|Subject withdrew - not treatment related|2
1256532|NCT00536263|4117769|P3|Overall Study|Lost to Follow-up|4
1256533|NCT00536263|4117770|P2|Overall Study|Lost to Follow-up|4
1256534|NCT00536263|4117771|P1|Overall Study|Lost to Follow-up|3
1256535|NCT00536263|4117769|P3|Overall Study|Adverse Event|7
1256536|NCT00536263|4117770|P2|Overall Study|Adverse Event|5
1256537|NCT00536263|4117771|P1|Overall Study|Adverse Event|5
1256538|NCT00536198|4117811|P2|Overall Study|Protocol Violation|1
1256539|NCT00536198|4117812|P1|Overall Study|Protocol Violation|0
1256540|NCT00536198|4117811|P2|Overall Study|Pregnancy|1
1256541|NCT00536198|4117812|P1|Overall Study|Pregnancy|1
1256542|NCT00536198|4117811|P2|Overall Study|Rescue|9
1256543|NCT00536198|4117812|P1|Overall Study|Rescue|3
1256544|NCT00536198|4117811|P2|Overall Study|Adverse Event|2
1256545|NCT00536198|4117812|P1|Overall Study|Adverse Event|2
1256546|NCT00536198|4117811|P2|Overall Study|Withdrawal by Subject|12
1256547|NCT00536198|4117812|P1|Overall Study|Withdrawal by Subject|16
1256548|NCT00536198|4117811|P2|Overall Study|Lost to Follow-up|14
1256549|NCT00536198|4117812|P1|Overall Study|Lost to Follow-up|15
1256550|NCT00536120|4117851|P2|Overall Study|Missed Study Visit|1
1256551|NCT00536120|4117852|P1|Overall Study|Missed Study Visit|0
1256552|NCT00536120|4117851|P2|Overall Study|Steroid Use|2
1256553|NCT00536120|4117852|P1|Overall Study|Steroid Use|0
1256554|NCT00536120|4117851|P2|Overall Study|Sponsor Decision Due to Lab Values|0
1256555|NCT00536120|4117852|P1|Overall Study|Sponsor Decision Due to Lab Values|1
1256556|NCT00536120|4117851|P2|Overall Study|Non-compliance|0
1256557|NCT00536120|4117852|P1|Overall Study|Non-compliance|1
1256558|NCT00536120|4117851|P2|Overall Study|Positive for Anti-natalizumab Antibodies|0
1256559|NCT00536120|4117852|P1|Overall Study|Positive for Anti-natalizumab Antibodies|3
1256560|NCT00536120|4117851|P2|Overall Study|Lost to Follow-up|0
1256561|NCT00536120|4117852|P1|Overall Study|Lost to Follow-up|1
1256562|NCT00536107|4117866|P2|Overall Study|Study Termination|4
1256563|NCT00536107|4117867|P1|Overall Study|Study Termination|2
1256564|NCT00536107|4117866|P2|Overall Study|Withdrawal by Subject|1
1256565|NCT00536107|4117867|P1|Overall Study|Withdrawal by Subject|0
1256566|NCT00536107|4117866|P2|Overall Study|Incorrect enrolment|0
1256567|NCT00536107|4117867|P1|Overall Study|Incorrect enrolment|1
1256568|NCT00536107|4117866|P2|Overall Study|Death|1
1256569|NCT00536107|4117867|P1|Overall Study|Death|5
1256570|NCT00535847|4117921|P3|Overall Study|Protocol-defined Virologic Stopping Rule|0
1256571|NCT00535847|4117922|P2|Overall Study|Protocol-defined Virologic Stopping Rule|10
1256572|NCT00535847|4117923|P1|Overall Study|Protocol-defined Virologic Stopping Rule|16
1256573|NCT00535847|4117921|P3|Overall Study|Non compliance|0
1256574|NCT00535847|4117922|P2|Overall Study|Non compliance|1
1256575|NCT00535847|4117923|P1|Overall Study|Non compliance|1
1256576|NCT00535847|4117921|P3|Overall Study|Adverse Event|2
1256577|NCT00535847|4117922|P2|Overall Study|Adverse Event|3
1256578|NCT00535847|4117923|P1|Overall Study|Adverse Event|5
1256579|NCT00535730|4117989|P2|Overall Study|Withdrawal by Subject|4
1256580|NCT00535730|4117990|P1|Overall Study|Withdrawal by Subject|0
1256581|NCT00535730|4117989|P2|Overall Study|Protocol Violation|0
1256582|NCT00535730|4117990|P1|Overall Study|Protocol Violation|1
1256583|NCT00535730|4117989|P2|Overall Study|Physician Decision|1
1256584|NCT00535730|4117990|P1|Overall Study|Physician Decision|0
1256585|NCT00535730|4117989|P2|Overall Study|Lost to Follow-up|1
1256586|NCT00535730|4117990|P1|Overall Study|Lost to Follow-up|0
1256587|NCT00535730|4117989|P2|Overall Study|Adverse Event|1
1256588|NCT00535730|4117990|P1|Overall Study|Adverse Event|1
1256589|NCT00535626|4118011|P1|Overall Study|Unable to return|2
1256590|NCT00535626|4118011|P1|Overall Study|Subject terminated|31
1256591|NCT00535626|4118011|P1|Overall Study|Removal/revision of study component|8
1256592|NCT00535626|4118011|P1|Overall Study|Withdrawal by Subject|20
1256593|NCT00535626|4118011|P1|Overall Study|Lost to Follow-up|29
1256594|NCT00535626|4118011|P1|Overall Study|Death|15
1256595|NCT00535496|4118038|P4|Overall Study|Not treated with sugammadex|0
1256596|NCT00535496|4118039|P3|Overall Study|Not treated with sugammadex|0
1256597|NCT00535496|4118040|P2|Overall Study|Not treated with sugammadex|1
1256598|NCT00535496|4118041|P1|Overall Study|Not treated with sugammadex|0
1256599|NCT00535496|4118038|P4|Overall Study|Lost to Follow-up|0
1256600|NCT00535496|4118039|P3|Overall Study|Lost to Follow-up|0
1256601|NCT00535496|4118040|P2|Overall Study|Lost to Follow-up|1
1256602|NCT00535496|4118041|P1|Overall Study|Lost to Follow-up|0
1256603|NCT00535405|4118061|P5|Overall Study|Withdrawal by Subject|8
1256604|NCT00535405|4118062|P4|Overall Study|Withdrawal by Subject|10
1256605|NCT00535405|4118063|P3|Overall Study|Withdrawal by Subject|10
1256606|NCT00535405|4118064|P2|Overall Study|Withdrawal by Subject|11
1256607|NCT00535405|4118065|P1|Overall Study|Withdrawal by Subject|5
1256608|NCT00535405|4118061|P5|Overall Study|Protocol Violation|0
1256609|NCT00535405|4118062|P4|Overall Study|Protocol Violation|1
1256610|NCT00535405|4118063|P3|Overall Study|Protocol Violation|2
1256611|NCT00535405|4118064|P2|Overall Study|Protocol Violation|2
1256612|NCT00535405|4118065|P1|Overall Study|Protocol Violation|2
1256613|NCT00535405|4118061|P5|Overall Study|Physician Decision|1
1256614|NCT00535405|4118062|P4|Overall Study|Physician Decision|1
1256615|NCT00535405|4118063|P3|Overall Study|Physician Decision|0
1256616|NCT00535405|4118064|P2|Overall Study|Physician Decision|2
1256617|NCT00535405|4118065|P1|Overall Study|Physician Decision|3
1256618|NCT00535405|4118061|P5|Overall Study|Lost to Follow-up|1
1256619|NCT00535405|4118062|P4|Overall Study|Lost to Follow-up|2
1256620|NCT00535405|4118063|P3|Overall Study|Lost to Follow-up|3
1256621|NCT00535405|4118064|P2|Overall Study|Lost to Follow-up|3
1256622|NCT00535405|4118065|P1|Overall Study|Lost to Follow-up|1
1256623|NCT00535405|4118061|P5|Overall Study|Adverse Event|6
1256624|NCT00535405|4118062|P4|Overall Study|Adverse Event|8
1256625|NCT00535405|4118063|P3|Overall Study|Adverse Event|3
1256626|NCT00535405|4118064|P2|Overall Study|Adverse Event|8
1256627|NCT00535405|4118065|P1|Overall Study|Adverse Event|6
1256628|NCT00535288|4118126|P5|Overall Study|Not specified|1
1256629|NCT00535288|4118127|P4|Overall Study|Not specified|2
1256630|NCT00535288|4118128|P3|Overall Study|Not specified|1
1256631|NCT00535288|4118129|P2|Overall Study|Not specified|1
1256632|NCT00535288|4118130|P1|Overall Study|Not specified|2
1256633|NCT00535288|4118126|P5|Overall Study|Unwilling to cooperate|4
1256634|NCT00535288|4118127|P4|Overall Study|Unwilling to cooperate|3
1256635|NCT00535288|4118128|P3|Overall Study|Unwilling to cooperate|3
1256636|NCT00535288|4118129|P2|Overall Study|Unwilling to cooperate|6
1256637|NCT00535288|4118130|P1|Overall Study|Unwilling to cooperate|6
1256638|NCT00535288|4118126|P5|Overall Study|Lack of Efficacy|7
1256639|NCT00535288|4118127|P4|Overall Study|Lack of Efficacy|4
1256640|NCT00535288|4118128|P3|Overall Study|Lack of Efficacy|4
1256641|NCT00535288|4118129|P2|Overall Study|Lack of Efficacy|3
1256642|NCT00535288|4118130|P1|Overall Study|Lack of Efficacy|26
1256643|NCT00535288|4118126|P5|Overall Study|Lost to Follow-up|0
1256644|NCT00535288|4118127|P4|Overall Study|Lost to Follow-up|0
1256645|NCT00535288|4118128|P3|Overall Study|Lost to Follow-up|0
1256646|NCT00535288|4118129|P2|Overall Study|Lost to Follow-up|3
1256647|NCT00535288|4118130|P1|Overall Study|Lost to Follow-up|0
1256648|NCT00535288|4118126|P5|Overall Study|Adverse Event|30
1256649|NCT00535288|4118127|P4|Overall Study|Adverse Event|20
1256650|NCT00535288|4118128|P3|Overall Study|Adverse Event|25
1256651|NCT00535288|4118129|P2|Overall Study|Adverse Event|19
1256652|NCT00535288|4118130|P1|Overall Study|Adverse Event|20
1256653|NCT00535262|4118207|P1|Overall Study|No funding|3
1256654|NCT00535223|4118213|P2|Overall Study|Withdrawal by Subject|1
1256655|NCT00535223|4118214|P1|Overall Study|Withdrawal by Subject|4
1256656|NCT00535145|4118222|P1|Phase II|Subject non-compliance|2
1256657|NCT00535145|4118222|P1|Phase II|Withdrawal by Subject|5
1256658|NCT00535145|4118222|P1|Phase II|Lost to Follow-up|5
1256659|NCT00535145|4118222|P1|Phase II|Lack of Efficacy|1
1256660|NCT00535145|4118222|P1|Phase II|Adverse Event|2
1256661|NCT00535145|4118222|P1|Phase I|(diagnosis)|3
1256662|NCT00535145|4118222|P1|Phase I|(PI decision)|1
1256663|NCT00535145|4118222|P1|Phase I|(protocol violation)|1
1256664|NCT00535145|4118222|P1|Phase I|(eligibility)|8
1256665|NCT00535145|4118222|P1|Phase I|Withdrawal by Subject|6
1256666|NCT00535145|4118222|P1|Phase I|Lost to Follow-up|7
1256667|NCT00535145|4118222|P1|Phase I|Adverse Event|3
1256668|NCT00535132|4118234|P2|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
1256669|NCT00535132|4118235|P1|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
1256670|NCT00535132|4118234|P2|Safety Analysis Set|Did Not Receive Study Medication|2
1256671|NCT00535132|4118235|P1|Safety Analysis Set|Did Not Receive Study Medication|2
1256672|NCT00534976|4118316|P2|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0
1256673|NCT00534976|4118317|P1|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1
1256674|NCT00534976|4118316|P2|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0
1256675|NCT00534976|4118317|P1|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1
1256676|NCT00534976|4118316|P2|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1
1256677|NCT00534976|4118317|P1|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0
1256678|NCT00534638|4118378|P2|Overall Study|Refused participation to study|883
1256679|NCT00534638|4118379|P1|Overall Study|Refused participation to study|1665
1256680|NCT00534638|4118378|P2|Overall Study|Rejected origin of signature|2
1256681|NCT00534638|4118379|P1|Overall Study|Rejected origin of signature|0
1256682|NCT00534638|4118378|P2|Overall Study|Received without ICF|1
1256683|NCT00534638|4118379|P1|Overall Study|Received without ICF|0
1256684|NCT00534638|4118378|P2|Overall Study|Subject unable to read|1
1256685|NCT00534638|4118379|P1|Overall Study|Subject unable to read|0
1256686|NCT00534638|4118378|P2|Overall Study|ICF not returned|1
1256687|NCT00534638|4118379|P1|Overall Study|ICF not returned|0
1256688|NCT00534638|4118378|P2|Overall Study|Mentally disabled|0
1256689|NCT00534638|4118379|P1|Overall Study|Mentally disabled|1
1256690|NCT00534638|4118378|P2|Overall Study|Death|5
1256691|NCT00534638|4118379|P1|Overall Study|Death|5
1256692|NCT00534638|4118378|P2|Overall Study|Pregnancy|4
1256693|NCT00534638|4118379|P1|Overall Study|Pregnancy|6
1256694|NCT00534638|4118378|P2|Overall Study|Blinded treatment broken|0
1256695|NCT00534638|4118379|P1|Overall Study|Blinded treatment broken|2
1256696|NCT00534638|4118378|P2|Overall Study|Urticaria|0
1256697|NCT00534638|4118379|P1|Overall Study|Urticaria|1
1256698|NCT00534638|4118378|P2|Overall Study|Already received HPV vaccine|1
1256699|NCT00534638|4118379|P1|Overall Study|Already received HPV vaccine|0
1256700|NCT00534638|4118378|P2|Overall Study|Lost to Follow-up|10875
1256701|NCT00534638|4118379|P1|Overall Study|Lost to Follow-up|4793
1256702|NCT00534638|4118378|P2|Overall Study|Migrated/moved from study area|13
1256703|NCT00534638|4118379|P1|Overall Study|Migrated/moved from study area|14
1256704|NCT00534638|4118378|P2|Overall Study|Withdrawal by Subject|5
1256705|NCT00534638|4118379|P1|Overall Study|Withdrawal by Subject|4
1256706|NCT00534599|4118414|P2|Overall Study|Other|0
1256707|NCT00534599|4118415|P1|Overall Study|Other|7
1256708|NCT00534599|4118414|P2|Overall Study|Withdrawal by Subject|6
1256709|NCT00534599|4118415|P1|Overall Study|Withdrawal by Subject|4
1256710|NCT00534599|4118414|P2|Overall Study|Lost to Follow-up|14
1256711|NCT00534599|4118415|P1|Overall Study|Lost to Follow-up|11
1256712|NCT00534599|4118414|P2|Overall Study|Protocol Violation|3
1256713|NCT00534599|4118415|P1|Overall Study|Protocol Violation|1
1256714|NCT00534599|4118414|P2|Overall Study|Generalized anxiety disorder worsened|1
1256715|NCT00534599|4118415|P1|Overall Study|Generalized anxiety disorder worsened|0
1256716|NCT00534599|4118414|P2|Overall Study|Lack of Efficacy|1
1256717|NCT00534599|4118415|P1|Overall Study|Lack of Efficacy|0
1256718|NCT00534599|4118414|P2|Overall Study|Developed study-specific d/c criteria|0
1256719|NCT00534599|4118415|P1|Overall Study|Developed study-specific d/c criteria|5
1256720|NCT00534599|4118414|P2|Overall Study|Mis-randomization|2
1256721|NCT00534599|4118415|P1|Overall Study|Mis-randomization|2
1256722|NCT00534599|4118414|P2|Overall Study|Incorrect enrollment|1
1256723|NCT00534599|4118415|P1|Overall Study|Incorrect enrollment|2
1256724|NCT00534599|4118414|P2|Overall Study|Adverse Event|4
1256725|NCT00534599|4118415|P1|Overall Study|Adverse Event|25
1256726|NCT00534495|4118451|P3|Long Term Ext. Phase Week 24-month 21|non compliance|2
1256727|NCT00534495|4118452|P2|Long Term Ext. Phase Week 24-month 21|non compliance|0
1256728|NCT00534495|4118453|P1|Long Term Ext. Phase Week 24-month 21|non compliance|0
1256729|NCT00534495|4118451|P3|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3
1256730|NCT00534495|4118452|P2|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
1256731|NCT00534495|4118453|P1|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
1256732|NCT00534495|4118451|P3|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5
1256733|NCT00534495|4118452|P2|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
1256734|NCT00534495|4118453|P1|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
1256735|NCT00534495|4118451|P3|Long Term Ext. Phase Week 24-month 21|Adverse Event|1
1256736|NCT00534495|4118452|P2|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
1256737|NCT00534495|4118453|P1|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
1256738|NCT00534495|4118451|P3|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0
1256739|NCT00534495|4118452|P2|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
1256740|NCT00534495|4118453|P1|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
1256741|NCT00534495|4118451|P3|All Active Treatment Phase Week 4-24|Lost to Follow-up|0
1256742|NCT00534495|4118452|P2|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
1256743|NCT00534495|4118453|P1|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
1256744|NCT00534495|4118451|P3|All Active Treatment Phase Week 4-24|Lack of Efficacy|0
1256745|NCT00534495|4118452|P2|All Active Treatment Phase Week 4-24|Lack of Efficacy|7
1256746|NCT00534495|4118453|P1|All Active Treatment Phase Week 4-24|Lack of Efficacy|1
1256747|NCT00534495|4118451|P3|All Active Treatment Phase Week 4-24|Adverse Event|0
1256748|NCT00534495|4118452|P2|All Active Treatment Phase Week 4-24|Adverse Event|0
1256749|NCT00534495|4118453|P1|All Active Treatment Phase Week 4-24|Adverse Event|1
1256750|NCT00534495|4118451|P3|Double Blind Placebo Phase Week 0-4|randomized in error|0
1256751|NCT00534495|4118452|P2|Double Blind Placebo Phase Week 0-4|randomized in error|1
1256752|NCT00534495|4118453|P1|Double Blind Placebo Phase Week 0-4|randomized in error|0
1256753|NCT00534404|4118491|P3|Overall Study|Lost to Follow-up|201
1256754|NCT00534404|4118492|P2|Overall Study|Lost to Follow-up|138
1256755|NCT00534404|4118493|P1|Overall Study|Lost to Follow-up|170
1256756|NCT00534404|4118491|P3|Overall Study|Removed by study staff|1
1256757|NCT00534404|4118492|P2|Overall Study|Removed by study staff|3
1256758|NCT00534404|4118493|P1|Overall Study|Removed by study staff|2
1256759|NCT00534404|4118491|P3|Overall Study|Withdrawal by Subject|38
1256760|NCT00534404|4118492|P2|Overall Study|Withdrawal by Subject|2
1256761|NCT00534404|4118493|P1|Overall Study|Withdrawal by Subject|8
1256762|NCT00534404|4118491|P3|Overall Study|Death|2
1256763|NCT00534404|4118492|P2|Overall Study|Death|0
1256764|NCT00534404|4118493|P1|Overall Study|Death|0
1256765|NCT00534352|4118524|P1|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1
1256766|NCT00534352|4118524|P1|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2
1256767|NCT00534352|4118524|P1|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1
1256768|NCT00534352|4118524|P1|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1
1256769|NCT00534352|4118524|P1|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1
1256770|NCT00534352|4118524|P1|Treatment A: TMC125 + TDF/FTC|Physician Decision|1
1256771|NCT00534313|4118568|P4|Long-term Period|Not specified|2
1256772|NCT00534313|4118569|P3|Long-term Period|Not specified|2
1256773|NCT00534313|4118570|P2|Long-term Period|Not specified|2
1256774|NCT00534313|4118571|P1|Long-term Period|Not specified|1
1256775|NCT00534313|4118568|P4|Long-term Period|Administrative reason by sponsor|18
1256776|NCT00534313|4118569|P3|Long-term Period|Administrative reason by sponsor|26
1256777|NCT00534313|4118570|P2|Long-term Period|Administrative reason by sponsor|15
1256778|NCT00534313|4118571|P1|Long-term Period|Administrative reason by sponsor|17
1256779|NCT00534313|4118568|P4|Long-term Period|Poor compliance/noncompliance|0
1256780|NCT00534313|4118569|P3|Long-term Period|Poor compliance/noncompliance|1
1256781|NCT00534313|4118570|P2|Long-term Period|Poor compliance/noncompliance|1
1256782|NCT00534313|4118571|P1|Long-term Period|Poor compliance/noncompliance|0
1256783|NCT00534313|4118568|P4|Long-term Period|No longer meets study criteria|0
1256784|NCT00534313|4118569|P3|Long-term Period|No longer meets study criteria|0
1256785|NCT00534313|4118570|P2|Long-term Period|No longer meets study criteria|1
1256786|NCT00534313|4118571|P1|Long-term Period|No longer meets study criteria|0
1256787|NCT00534313|4118568|P4|Long-term Period|Withdrawal by Subject|0
1256788|NCT00534313|4118569|P3|Long-term Period|Withdrawal by Subject|0
1256789|NCT00534313|4118570|P2|Long-term Period|Withdrawal by Subject|2
1256790|NCT00534313|4118571|P1|Long-term Period|Withdrawal by Subject|2
1256791|NCT00534313|4118568|P4|Long-term Period|Lost to Follow-up|0
1256792|NCT00534313|4118569|P3|Long-term Period|Lost to Follow-up|0
1256793|NCT00534313|4118570|P2|Long-term Period|Lost to Follow-up|2
1256794|NCT00534313|4118571|P1|Long-term Period|Lost to Follow-up|1
1256795|NCT00534313|4118568|P4|Long-term Period|Lack of Efficacy|12
1256796|NCT00534313|4118569|P3|Long-term Period|Lack of Efficacy|14
1256797|NCT00534313|4118570|P2|Long-term Period|Lack of Efficacy|10
1256798|NCT00534313|4118571|P1|Long-term Period|Lack of Efficacy|14
1256799|NCT00534313|4118568|P4|Long-term Period|Adverse Event|1
1256800|NCT00534313|4118569|P3|Long-term Period|Adverse Event|0
1256801|NCT00534313|4118570|P2|Long-term Period|Adverse Event|1
1256802|NCT00534313|4118571|P1|Long-term Period|Adverse Event|2
1256803|NCT00534313|4118568|P4|Short-term Period|Pregnancy|0
1256804|NCT00534313|4118569|P3|Short-term Period|Pregnancy|1
1256805|NCT00534313|4118570|P2|Short-term Period|Pregnancy|0
1256806|NCT00534313|4118571|P1|Short-term Period|Pregnancy|0
1256807|NCT00534313|4118568|P4|Short-term Period|Participant withdrew consent|2
1256808|NCT00534313|4118569|P3|Short-term Period|Participant withdrew consent|0
1256809|NCT00534313|4118570|P2|Short-term Period|Participant withdrew consent|0
1256810|NCT00534313|4118571|P1|Short-term Period|Participant withdrew consent|2
1256811|NCT00534313|4118568|P4|Short-term Period|Participant not meeting study criteria|1
1256812|NCT00534313|4118569|P3|Short-term Period|Participant not meeting study criteria|0
1256813|NCT00534313|4118570|P2|Short-term Period|Participant not meeting study criteria|0
1256814|NCT00534313|4118571|P1|Short-term Period|Participant not meeting study criteria|0
1256815|NCT00534313|4118568|P4|Short-term Period|Lack of Efficacy|3
1256816|NCT00534313|4118569|P3|Short-term Period|Lack of Efficacy|0
1256817|NCT00534313|4118570|P2|Short-term Period|Lack of Efficacy|4
1256818|NCT00534313|4118571|P1|Short-term Period|Lack of Efficacy|3
1256819|NCT00534313|4118568|P4|Short-term Period|Adverse Event|3
1256820|NCT00534313|4118569|P3|Short-term Period|Adverse Event|1
1256821|NCT00534313|4118570|P2|Short-term Period|Adverse Event|2
1256822|NCT00534313|4118571|P1|Short-term Period|Adverse Event|1
1256823|NCT00534248|4118666|P2|Overall Study|Withdrawal by Subject|255
1256824|NCT00534248|4118667|P1|Overall Study|Withdrawal by Subject|263
1256825|NCT00534248|4118666|P2|Overall Study|Protocol Violation|4
1256826|NCT00534248|4118667|P1|Overall Study|Protocol Violation|3
1256827|NCT00534248|4118666|P2|Overall Study|Physician Decision|7
1256828|NCT00534248|4118667|P1|Overall Study|Physician Decision|10
1256829|NCT00534248|4118666|P2|Overall Study|Other protocol specified criteria|3
1256830|NCT00534248|4118667|P1|Overall Study|Other protocol specified criteria|13
1256831|NCT00534248|4118666|P2|Overall Study|Lost to Follow-up|375
1256832|NCT00534248|4118667|P1|Overall Study|Lost to Follow-up|353
1256833|NCT00534248|4118666|P2|Overall Study|Adverse Event|29
1256834|NCT00534248|4118667|P1|Overall Study|Adverse Event|19
1256835|NCT00534105|4118697|P2|Overall Study|Lost to Follow-up|39
1256836|NCT00534105|4118698|P1|Overall Study|Lost to Follow-up|23
1256837|NCT00534092|4118712|P2|Overall Study|personal reasons/family concerns|0
1256838|NCT00534092|4118713|P1|Overall Study|personal reasons/family concerns|1
1256839|NCT00534092|4118712|P2|Overall Study|Lost to Follow-up|0
1256840|NCT00534092|4118713|P1|Overall Study|Lost to Follow-up|1
1256841|NCT00533949|4118751|P4|Overall Study|Withdrawal by Subject|1
1256842|NCT00533949|4118752|P3|Overall Study|Withdrawal by Subject|1
1256843|NCT00533949|4118753|P2|Overall Study|Withdrawal by Subject|2
1256844|NCT00533949|4118754|P1|Overall Study|Withdrawal by Subject|3
1256845|NCT00533949|4118751|P4|Overall Study|Protocol Violation|9
1256846|NCT00533949|4118752|P3|Overall Study|Protocol Violation|9
1256847|NCT00533949|4118753|P2|Overall Study|Protocol Violation|12
1256848|NCT00533949|4118754|P1|Overall Study|Protocol Violation|12
1256849|NCT00533897|4118785|P8|Long Term Extension (LTE)|not specified|6
1256850|NCT00533897|4118786|P7|Long Term Extension (LTE)|not specified|1
1256851|NCT00533897|4118787|P6|Long Term Extension (LTE)|not specified|0
1256852|NCT00533897|4118788|P5|Long Term Extension (LTE)|not specified|0
1256853|NCT00533897|4118789|P4|Long Term Extension (LTE)|not specified|0
1256854|NCT00533897|4118790|P3|Long Term Extension (LTE)|not specified|0
1256855|NCT00533897|4118791|P2|Long Term Extension (LTE)|not specified|0
1256856|NCT00533897|4118792|P1|Long Term Extension (LTE)|not specified|0
1256857|NCT00533897|4118785|P8|Long Term Extension (LTE)|Lost to Follow-up|1
1256858|NCT00533897|4118786|P7|Long Term Extension (LTE)|Lost to Follow-up|1
1256859|NCT00533897|4118787|P6|Long Term Extension (LTE)|Lost to Follow-up|0
1256860|NCT00533897|4118788|P5|Long Term Extension (LTE)|Lost to Follow-up|0
1256861|NCT00533897|4118789|P4|Long Term Extension (LTE)|Lost to Follow-up|0
1256862|NCT00533897|4118790|P3|Long Term Extension (LTE)|Lost to Follow-up|0
1256863|NCT00533897|4118791|P2|Long Term Extension (LTE)|Lost to Follow-up|0
1256864|NCT00533897|4118792|P1|Long Term Extension (LTE)|Lost to Follow-up|0
1256865|NCT00533897|4118785|P8|Long Term Extension (LTE)|Pregnancy|2
1256866|NCT00533897|4118786|P7|Long Term Extension (LTE)|Pregnancy|0
1256867|NCT00533897|4118787|P6|Long Term Extension (LTE)|Pregnancy|0
1256868|NCT00533897|4118788|P5|Long Term Extension (LTE)|Pregnancy|0
1256869|NCT00533897|4118789|P4|Long Term Extension (LTE)|Pregnancy|0
1256870|NCT00533897|4118790|P3|Long Term Extension (LTE)|Pregnancy|0
1256871|NCT00533897|4118791|P2|Long Term Extension (LTE)|Pregnancy|0
1256872|NCT00533897|4118792|P1|Long Term Extension (LTE)|Pregnancy|0
1256873|NCT00533897|4118785|P8|Long Term Extension (LTE)|Adverse Event|5
1256874|NCT00533897|4118786|P7|Long Term Extension (LTE)|Adverse Event|2
1256875|NCT00533897|4118787|P6|Long Term Extension (LTE)|Adverse Event|0
1256876|NCT00533897|4118788|P5|Long Term Extension (LTE)|Adverse Event|0
1256877|NCT00533897|4118789|P4|Long Term Extension (LTE)|Adverse Event|0
1256878|NCT00533897|4118790|P3|Long Term Extension (LTE)|Adverse Event|0
1256879|NCT00533897|4118791|P2|Long Term Extension (LTE)|Adverse Event|0
1256880|NCT00533897|4118792|P1|Long Term Extension (LTE)|Adverse Event|0
1256881|NCT00533897|4118785|P8|Long Term Extension (LTE)|Poor/Non-compliance|0
1256882|NCT00533897|4118786|P7|Long Term Extension (LTE)|Poor/Non-compliance|1
1256883|NCT00533897|4118787|P6|Long Term Extension (LTE)|Poor/Non-compliance|0
1256884|NCT00533897|4118788|P5|Long Term Extension (LTE)|Poor/Non-compliance|0
1256885|NCT00533897|4118789|P4|Long Term Extension (LTE)|Poor/Non-compliance|0
1256886|NCT00533897|4118790|P3|Long Term Extension (LTE)|Poor/Non-compliance|0
1256887|NCT00533897|4118791|P2|Long Term Extension (LTE)|Poor/Non-compliance|0
1256888|NCT00533897|4118792|P1|Long Term Extension (LTE)|Poor/Non-compliance|0
1256889|NCT00533897|4118785|P8|Long Term Extension (LTE)|Lack of Efficacy|3
1256890|NCT00533897|4118786|P7|Long Term Extension (LTE)|Lack of Efficacy|5
1256891|NCT00533897|4118787|P6|Long Term Extension (LTE)|Lack of Efficacy|0
1256892|NCT00533897|4118788|P5|Long Term Extension (LTE)|Lack of Efficacy|0
1256893|NCT00533897|4118789|P4|Long Term Extension (LTE)|Lack of Efficacy|0
1256894|NCT00533897|4118790|P3|Long Term Extension (LTE)|Lack of Efficacy|0
1256895|NCT00533897|4118791|P2|Long Term Extension (LTE)|Lack of Efficacy|0
1256896|NCT00533897|4118792|P1|Long Term Extension (LTE)|Lack of Efficacy|0
1256897|NCT00533897|4118785|P8|Long Term Extension (LTE)|Death|3
1256898|NCT00533897|4118786|P7|Long Term Extension (LTE)|Death|1
1256899|NCT00533897|4118787|P6|Long Term Extension (LTE)|Death|0
1256900|NCT00533897|4118788|P5|Long Term Extension (LTE)|Death|0
1256901|NCT00533897|4118789|P4|Long Term Extension (LTE)|Death|0
1256902|NCT00533897|4118790|P3|Long Term Extension (LTE)|Death|0
1256903|NCT00533897|4118791|P2|Long Term Extension (LTE)|Death|0
1256904|NCT00533897|4118792|P1|Long Term Extension (LTE)|Death|0
1256905|NCT00533897|4118785|P8|Long Term Extension (LTE)|Participant Withdrew Consent|5
1256906|NCT00533897|4118786|P7|Long Term Extension (LTE)|Participant Withdrew Consent|2
1256907|NCT00533897|4118787|P6|Long Term Extension (LTE)|Participant Withdrew Consent|0
1256908|NCT00533897|4118788|P5|Long Term Extension (LTE)|Participant Withdrew Consent|0
1256909|NCT00533897|4118789|P4|Long Term Extension (LTE)|Participant Withdrew Consent|0
1256910|NCT00533897|4118790|P3|Long Term Extension (LTE)|Participant Withdrew Consent|0
1256911|NCT00533897|4118791|P2|Long Term Extension (LTE)|Participant Withdrew Consent|0
1256912|NCT00533897|4118792|P1|Long Term Extension (LTE)|Participant Withdrew Consent|0
1256913|NCT00533897|4118785|P8|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
1256914|NCT00533897|4118786|P7|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
1256915|NCT00533897|4118787|P6|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1
1256916|NCT00533897|4118788|P5|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
1256917|NCT00533897|4118789|P4|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
1256918|NCT00533897|4118790|P3|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
1256919|NCT00533897|4118791|P2|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
1256920|NCT00533897|4118792|P1|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
1256921|NCT00533897|4118785|P8|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
1256922|NCT00533897|4118786|P7|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
1256923|NCT00533897|4118787|P6|Re-introduction (RI) Period 3|Participant Withdrew Consent|1
1256924|NCT00533897|4118788|P5|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
1256925|NCT00533897|4118789|P4|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
1256926|NCT00533897|4118790|P3|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
1256927|NCT00533897|4118791|P2|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
1256928|NCT00533897|4118792|P1|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
1256929|NCT00533897|4118785|P8|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
1256930|NCT00533897|4118786|P7|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
1256931|NCT00533897|4118787|P6|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
1256932|NCT00533897|4118788|P5|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
1256933|NCT00533897|4118789|P4|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
1256934|NCT00533897|4118790|P3|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1
1256935|NCT00533897|4118791|P2|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
1256936|NCT00533897|4118792|P1|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
1256937|NCT00533897|4118785|P8|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
1256938|NCT00533897|4118786|P7|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
1256939|NCT00533897|4118787|P6|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
1256940|NCT00533897|4118788|P5|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
1256941|NCT00533897|4118789|P4|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
1256942|NCT00533897|4118790|P3|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2
1256943|NCT00533897|4118791|P2|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1
1256944|NCT00533897|4118792|P1|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
1256945|NCT00533897|4118785|P8|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
1256946|NCT00533897|4118786|P7|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
1256947|NCT00533897|4118787|P6|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
1256948|NCT00533897|4118788|P5|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
1256949|NCT00533897|4118789|P4|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
1256950|NCT00533897|4118790|P3|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
1256951|NCT00533897|4118791|P2|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
1256952|NCT00533897|4118792|P1|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1
1256953|NCT00533897|4118785|P8|Lead-in (LI) Period 1|Lack of Efficacy|0
1256954|NCT00533897|4118786|P7|Lead-in (LI) Period 1|Lack of Efficacy|0
1256955|NCT00533897|4118787|P6|Lead-in (LI) Period 1|Lack of Efficacy|0
1256956|NCT00533897|4118788|P5|Lead-in (LI) Period 1|Lack of Efficacy|0
1256957|NCT00533897|4118789|P4|Lead-in (LI) Period 1|Lack of Efficacy|0
1256958|NCT00533897|4118790|P3|Lead-in (LI) Period 1|Lack of Efficacy|0
1256959|NCT00533897|4118791|P2|Lead-in (LI) Period 1|Lack of Efficacy|0
1256960|NCT00533897|4118792|P1|Lead-in (LI) Period 1|Lack of Efficacy|3
1256961|NCT00533897|4118785|P8|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
1256962|NCT00533897|4118786|P7|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
1256963|NCT00533897|4118787|P6|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
1256964|NCT00533897|4118788|P5|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
1256965|NCT00533897|4118789|P4|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
1256966|NCT00533897|4118790|P3|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
1256967|NCT00533897|4118791|P2|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
1256968|NCT00533897|4118792|P1|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2
1256969|NCT00533897|4118785|P8|Lead-in (LI) Period 1|Lost to Follow-up|0
1256970|NCT00533897|4118786|P7|Lead-in (LI) Period 1|Lost to Follow-up|0
1256971|NCT00533897|4118787|P6|Lead-in (LI) Period 1|Lost to Follow-up|0
1256972|NCT00533897|4118788|P5|Lead-in (LI) Period 1|Lost to Follow-up|0
1256973|NCT00533897|4118789|P4|Lead-in (LI) Period 1|Lost to Follow-up|0
1256974|NCT00533897|4118790|P3|Lead-in (LI) Period 1|Lost to Follow-up|0
1256975|NCT00533897|4118791|P2|Lead-in (LI) Period 1|Lost to Follow-up|0
1256976|NCT00533897|4118792|P1|Lead-in (LI) Period 1|Lost to Follow-up|1
1256977|NCT00533897|4118785|P8|Lead-in (LI) Period 1|Participant Withdrew Consent|0
1256978|NCT00533897|4118786|P7|Lead-in (LI) Period 1|Participant Withdrew Consent|0
1256979|NCT00533897|4118787|P6|Lead-in (LI) Period 1|Participant Withdrew Consent|0
1256980|NCT00533897|4118788|P5|Lead-in (LI) Period 1|Participant Withdrew Consent|0
1256981|NCT00533897|4118789|P4|Lead-in (LI) Period 1|Participant Withdrew Consent|0
1256982|NCT00533897|4118790|P3|Lead-in (LI) Period 1|Participant Withdrew Consent|0
1256983|NCT00533897|4118791|P2|Lead-in (LI) Period 1|Participant Withdrew Consent|0
1256984|NCT00533897|4118792|P1|Lead-in (LI) Period 1|Participant Withdrew Consent|2
1256985|NCT00533897|4118785|P8|Lead-in (LI) Period 1|Adverse Event|0
1256986|NCT00533897|4118786|P7|Lead-in (LI) Period 1|Adverse Event|0
1256987|NCT00533897|4118787|P6|Lead-in (LI) Period 1|Adverse Event|0
1256988|NCT00533897|4118788|P5|Lead-in (LI) Period 1|Adverse Event|0
1256989|NCT00533897|4118789|P4|Lead-in (LI) Period 1|Adverse Event|0
1256990|NCT00533897|4118790|P3|Lead-in (LI) Period 1|Adverse Event|0
1256991|NCT00533897|4118791|P2|Lead-in (LI) Period 1|Adverse Event|0
1256992|NCT00533897|4118792|P1|Lead-in (LI) Period 1|Adverse Event|1
1256993|NCT00533702|4118932|P2|Overall Study|Found ineligible after randomization|1
1256994|NCT00533702|4118933|P1|Overall Study|Found ineligible after randomization|2
1256995|NCT00533702|4118932|P2|Overall Study|Withdrawal by Subject|1
1256996|NCT00533702|4118933|P1|Overall Study|Withdrawal by Subject|3
1256997|NCT00533507|4118964|P1|Overall Study|Withdrawal by Subject|1
1256998|NCT00533273|4119009|P2|Open-label|Withdrawal by Subject|0
1256999|NCT00533273|4119010|P1|Open-label|Withdrawal by Subject|6
1257000|NCT00533273|4119009|P2|Double-blind|Withdrew consent|2
1257001|NCT00533273|4119010|P1|Double-blind|Withdrew consent|0
1257002|NCT00532948|4119059|P3|Overall Study|Failure to return|0
1257003|NCT00532948|4119060|P2|Overall Study|Failure to return|1
1257004|NCT00532948|4119061|P1|Overall Study|Failure to return|0
1257005|NCT00532948|4119059|P3|Overall Study|Violation of selection criteria at entry|0
1257006|NCT00532948|4119060|P2|Overall Study|Violation of selection criteria at entry|1
1257007|NCT00532948|4119061|P1|Overall Study|Violation of selection criteria at entry|0
1257008|NCT00532948|4119059|P3|Overall Study|Death|4
1257009|NCT00532948|4119060|P2|Overall Study|Death|3
1257010|NCT00532948|4119061|P1|Overall Study|Death|3
1257011|NCT00532948|4119059|P3|Overall Study|Protocol Violation|0
1257012|NCT00532948|4119060|P2|Overall Study|Protocol Violation|0
1257013|NCT00532948|4119061|P1|Overall Study|Protocol Violation|1
1257014|NCT00532935|4119093|P2|Overall Study|Protocol Specific Criteria|15
1257015|NCT00532935|4119094|P1|Overall Study|Protocol Specific Criteria|11
1257016|NCT00532935|4119093|P2|Overall Study|Withdrawal by Subject|9
1257017|NCT00532935|4119094|P1|Overall Study|Withdrawal by Subject|10
1257018|NCT00532935|4119093|P2|Overall Study|Protocol Violation|2
1257019|NCT00532935|4119094|P1|Overall Study|Protocol Violation|4
1257020|NCT00532935|4119093|P2|Overall Study|Pregnancy|0
1257021|NCT00532935|4119094|P1|Overall Study|Pregnancy|1
1257022|NCT00532935|4119093|P2|Overall Study|Physician Decision|5
1257023|NCT00532935|4119094|P1|Overall Study|Physician Decision|4
1257024|NCT00532935|4119093|P2|Overall Study|Lost to Follow-up|6
1257025|NCT00532935|4119094|P1|Overall Study|Lost to Follow-up|10
1257026|NCT00532935|4119093|P2|Overall Study|Lack of Efficacy|3
1257027|NCT00532935|4119094|P1|Overall Study|Lack of Efficacy|0
1257028|NCT00532935|4119093|P2|Overall Study|Adverse Event|12
1257029|NCT00532935|4119094|P1|Overall Study|Adverse Event|11
1257030|NCT00532883|4119112|P4|Overall Study|Early Study Termination|4
1257031|NCT00532883|4119113|P3|Overall Study|Early Study Termination|1
1257032|NCT00532883|4119114|P2|Overall Study|Early Study Termination|4
1257033|NCT00532883|4119115|P1|Overall Study|Early Study Termination|4
1257034|NCT00532883|4119112|P4|Overall Study|Subject was Nonadherent|0
1257035|NCT00532883|4119113|P3|Overall Study|Subject was Nonadherent|1
1257036|NCT00532883|4119114|P2|Overall Study|Subject was Nonadherent|1
1257037|NCT00532883|4119115|P1|Overall Study|Subject was Nonadherent|0
1257038|NCT00532883|4119112|P4|Overall Study|Withdrawal by Subject|0
1257039|NCT00532883|4119113|P3|Overall Study|Withdrawal by Subject|1
1257040|NCT00532883|4119114|P2|Overall Study|Withdrawal by Subject|1
1257041|NCT00532883|4119115|P1|Overall Study|Withdrawal by Subject|0
1257042|NCT00532883|4119112|P4|Overall Study|Lost to Follow-up|0
1257043|NCT00532883|4119113|P3|Overall Study|Lost to Follow-up|1
1257044|NCT00532883|4119114|P2|Overall Study|Lost to Follow-up|1
1257045|NCT00532883|4119115|P1|Overall Study|Lost to Follow-up|1
1257046|NCT00532883|4119112|P4|Overall Study|Adverse Event|1
1257047|NCT00532883|4119113|P3|Overall Study|Adverse Event|0
1257048|NCT00532883|4119114|P2|Overall Study|Adverse Event|0
1257049|NCT00532883|4119115|P1|Overall Study|Adverse Event|1
1257050|NCT00532779|4119128|P3|Overall Study|Drug noncompliance, moved, other|29
1257051|NCT00532779|4119129|P2|Overall Study|Drug noncompliance, moved, other|23
1257052|NCT00532779|4119130|P1|Overall Study|Drug noncompliance, moved, other|14
1257053|NCT00532779|4119128|P3|Overall Study|Death|0
1257054|NCT00532779|4119129|P2|Overall Study|Death|1
1257055|NCT00532779|4119130|P1|Overall Study|Death|0
1257056|NCT00532779|4119128|P3|Overall Study|Pregnancy|3
1257057|NCT00532779|4119129|P2|Overall Study|Pregnancy|5
1257058|NCT00532779|4119130|P1|Overall Study|Pregnancy|2
1257059|NCT00532779|4119128|P3|Overall Study|Protocol Violation|7
1257060|NCT00532779|4119129|P2|Overall Study|Protocol Violation|9
1257061|NCT00532779|4119130|P1|Overall Study|Protocol Violation|5
1257062|NCT00532779|4119128|P3|Overall Study|Lack of Efficacy|40
1257063|NCT00532779|4119129|P2|Overall Study|Lack of Efficacy|12
1257064|NCT00532779|4119130|P1|Overall Study|Lack of Efficacy|12
1257065|NCT00532779|4119128|P3|Overall Study|Withdrawal by Subject|90
1257066|NCT00532779|4119129|P2|Overall Study|Withdrawal by Subject|60
1257067|NCT00532779|4119130|P1|Overall Study|Withdrawal by Subject|63
1257068|NCT00532779|4119128|P3|Overall Study|Lost to Follow-up|66
1257069|NCT00532779|4119129|P2|Overall Study|Lost to Follow-up|65
1257070|NCT00532779|4119130|P1|Overall Study|Lost to Follow-up|76
1257071|NCT00532779|4119128|P3|Overall Study|Adverse Event|56
1257072|NCT00532779|4119129|P2|Overall Study|Adverse Event|112
1257073|NCT00532779|4119130|P1|Overall Study|Adverse Event|122
1257074|NCT00532493|4119191|P2|Overall Study|Contraindicative Medication|0
1257075|NCT00532493|4119192|P1|Overall Study|Contraindicative Medication|1
1257076|NCT00532493|4119191|P2|Overall Study|Subject Moved Away|1
1257077|NCT00532493|4119192|P1|Overall Study|Subject Moved Away|3
1257078|NCT00532493|4119191|P2|Overall Study|Protocol Deviation|0
1257079|NCT00532493|4119192|P1|Overall Study|Protocol Deviation|1
1257080|NCT00532493|4119191|P2|Overall Study|Adverse Event|5
1257081|NCT00532493|4119192|P1|Overall Study|Adverse Event|6
1257082|NCT00532493|4119191|P2|Overall Study|Physician Decision|6
1257083|NCT00532493|4119192|P1|Overall Study|Physician Decision|1
1257084|NCT00532493|4119191|P2|Overall Study|Withdrawal by Subject|9
1257085|NCT00532493|4119192|P1|Overall Study|Withdrawal by Subject|7
1257086|NCT00532493|4119191|P2|Overall Study|Lost to Follow-up|7
1257087|NCT00532493|4119192|P1|Overall Study|Lost to Follow-up|10
1257088|NCT00532493|4119191|P2|Overall Study|Death|1
1257089|NCT00532493|4119192|P1|Overall Study|Death|1
1257090|NCT00532441|4119226|P2|Overall Study|Death|0
1257091|NCT00532441|4119227|P1|Overall Study|Death|1
1257092|NCT00532298|4119242|P6|Overall Study|Lost to Follow-up|1
1257093|NCT00532298|4119243|P5|Overall Study|Lost to Follow-up|0
1257094|NCT00532298|4119244|P4|Overall Study|Lost to Follow-up|0
1257095|NCT00532298|4119245|P3|Overall Study|Lost to Follow-up|1
1257096|NCT00532298|4119246|P2|Overall Study|Lost to Follow-up|1
1257097|NCT00532298|4119247|P1|Overall Study|Lost to Follow-up|1
1257098|NCT00532298|4119242|P6|Overall Study|Adverse Event|1
1257099|NCT00532298|4119243|P5|Overall Study|Adverse Event|1
1257100|NCT00532298|4119244|P4|Overall Study|Adverse Event|0
1257101|NCT00532298|4119245|P3|Overall Study|Adverse Event|0
1257102|NCT00532298|4119246|P2|Overall Study|Adverse Event|0
1257103|NCT00532298|4119247|P1|Overall Study|Adverse Event|1
1257104|NCT00532259|4119327|P1|Overall Study|Protocol Violation|1
1257105|NCT00532259|4119327|P1|Overall Study|Physician Decision|3
1257106|NCT00532259|4119327|P1|Overall Study|Lost to Follow-up|3
1257107|NCT00532259|4119327|P1|Overall Study|Lack of Efficacy|21
1257108|NCT00532259|4119327|P1|Overall Study|Death|1
1257109|NCT00532259|4119327|P1|Overall Study|Adverse Event|1
1257110|NCT00532259|4119327|P1|Overall Study|Withdrawal by Subject|2
1257111|NCT00532155|4119334|P2|Overall Study|Did not receive study medication|6
1257112|NCT00532155|4119335|P1|Overall Study|Did not receive study medication|2
1257113|NCT00532155|4119334|P2|Overall Study|Study termination stop further treatment|0
1257114|NCT00532155|4119335|P1|Overall Study|Study termination stop further treatment|4
1257115|NCT00532155|4119334|P2|Overall Study|Study terminated by sponsor|0
1257116|NCT00532155|4119335|P1|Overall Study|Study terminated by sponsor|1
1257117|NCT00532155|4119334|P2|Overall Study|Study stopped|0
1257118|NCT00532155|4119335|P1|Overall Study|Study stopped|1
1257119|NCT00532155|4119334|P2|Overall Study|Had brain metastasis, was mis-randomized|0
1257120|NCT00532155|4119335|P1|Overall Study|Had brain metastasis, was mis-randomized|1
1257121|NCT00532155|4119334|P2|Overall Study|Progressive disease (by incorrect scan)|1
1257122|NCT00532155|4119335|P1|Overall Study|Progressive disease (by incorrect scan)|0
1257123|NCT00532155|4119334|P2|Overall Study|Promotor ended study|0
1257124|NCT00532155|4119335|P1|Overall Study|Promotor ended study|1
1257125|NCT00532155|4119334|P2|Overall Study|Occurence of a secondary cancer|1
1257126|NCT00532155|4119335|P1|Overall Study|Occurence of a secondary cancer|0
1257127|NCT00532155|4119334|P2|Overall Study|Occurence of a second cancer|1
1257128|NCT00532155|4119335|P1|Overall Study|Occurence of a second cancer|0
1257129|NCT00532155|4119334|P2|Overall Study|Pre-existing brain metastasis (by MRI)|0
1257130|NCT00532155|4119335|P1|Overall Study|Pre-existing brain metastasis (by MRI)|1
1257131|NCT00532155|4119334|P2|Overall Study|Moved|0
1257132|NCT00532155|4119335|P1|Overall Study|Moved|1
1257133|NCT00532155|4119334|P2|Overall Study|Consent withdrawn|7
1257134|NCT00532155|4119335|P1|Overall Study|Consent withdrawn|5
1257135|NCT00532155|4119334|P2|Overall Study|Withdrawal by Subject|44
1257136|NCT00532155|4119335|P1|Overall Study|Withdrawal by Subject|23
1257137|NCT00532155|4119334|P2|Overall Study|Physician Decision|15
1257138|NCT00532155|4119335|P1|Overall Study|Physician Decision|16
1257139|NCT00532155|4119334|P2|Overall Study|Lost to Follow-up|0
1257140|NCT00532155|4119335|P1|Overall Study|Lost to Follow-up|2
1257141|NCT00532155|4119334|P2|Overall Study|Protocol Violation|3
1257142|NCT00532155|4119335|P1|Overall Study|Protocol Violation|1
1257143|NCT00532155|4119334|P2|Overall Study|Lack of Efficacy|255
1257144|NCT00532155|4119335|P1|Overall Study|Lack of Efficacy|332
1257145|NCT00532155|4119334|P2|Overall Study|Adverse Event|123
1257146|NCT00532155|4119335|P1|Overall Study|Adverse Event|66
1257147|NCT00532129|4119349|P1|Follow-up Period|Other|6
1257148|NCT00532129|4119349|P1|Follow-up Period|Lost to Follow-up|1
1257149|NCT00532129|4119349|P1|Follow-up Period|Disease progression|57
1257150|NCT00532129|4119349|P1|Follow-up Period|Adverse event/Serious adverse event|1
1257151|NCT00532129|4119349|P1|Treatment Period|Other|5
1257152|NCT00532129|4119349|P1|Treatment Period|Protocol Violation|1
1257153|NCT00532129|4119349|P1|Treatment Period|Disease progression|3
1257154|NCT00532129|4119349|P1|Treatment Period|Physician Decision|15
1257155|NCT00532129|4119349|P1|Treatment Period|Adverse event/Serious adverse event|25
1257156|NCT00531960|4119369|P2|Overall Study|Not Specified|10
1257157|NCT00531960|4119370|P1|Overall Study|Not Specified|4
1257158|NCT00531960|4119369|P2|Overall Study|Refused Treatment|6
1257159|NCT00531960|4119370|P1|Overall Study|Refused Treatment|5
1257160|NCT00531960|4119369|P2|Overall Study|Violation of Selection Criteria|0
1257161|NCT00531960|4119370|P1|Overall Study|Violation of Selection Criteria|2
1257162|NCT00531960|4119369|P2|Overall Study|Lack of Efficacy|41
1257163|NCT00531960|4119370|P1|Overall Study|Lack of Efficacy|42
1257164|NCT00531960|4119369|P2|Overall Study|Death|2
1257165|NCT00531960|4119370|P1|Overall Study|Death|3
1257166|NCT00531960|4119369|P2|Overall Study|Adverse Event|4
1257167|NCT00531960|4119370|P1|Overall Study|Adverse Event|5
1257168|NCT00531947|4119388|P2|Overall Study|Other (e.g., Lack of Efficacy)|5
1257169|NCT00531947|4119389|P1|Overall Study|Other (e.g., Lack of Efficacy)|5
1257170|NCT00531947|4119388|P2|Overall Study|Non-Compliance|7
1257171|NCT00531947|4119389|P1|Overall Study|Non-Compliance|4
1257172|NCT00531947|4119388|P2|Overall Study|Protocol Violation|1
1257173|NCT00531947|4119389|P1|Overall Study|Protocol Violation|2
1257174|NCT00531947|4119388|P2|Overall Study|Withdrawal by Subject|19
1257175|NCT00531947|4119389|P1|Overall Study|Withdrawal by Subject|14
1257176|NCT00531947|4119388|P2|Overall Study|Lost to Follow-up|9
1257177|NCT00531947|4119389|P1|Overall Study|Lost to Follow-up|12
1257178|NCT00531947|4119388|P2|Overall Study|Adverse Event|10
1257179|NCT00531947|4119389|P1|Overall Study|Adverse Event|5
1257180|NCT00531934|4119433|P2|Overall Study|Not specified|2
1257181|NCT00531934|4119434|P1|Overall Study|Not specified|2
1257182|NCT00531934|4119433|P2|Overall Study|Withdrawal by Subject|1
1257183|NCT00531934|4119434|P1|Overall Study|Withdrawal by Subject|1
1257184|NCT00531934|4119433|P2|Overall Study|Death|10
1257185|NCT00531934|4119434|P1|Overall Study|Death|7
1257186|NCT00531934|4119433|P2|Overall Study|Progression|42
1257187|NCT00531934|4119434|P1|Overall Study|Progression|52
1257188|NCT00531934|4119433|P2|Overall Study|Adverse Event|8
1257189|NCT00531934|4119434|P1|Overall Study|Adverse Event|4
1257190|NCT00531752|4119562|P4|Second Double-blind Intervention Period|Lost to Follow-up|1
1257191|NCT00531752|4119563|P3|Second Double-blind Intervention Period|Lost to Follow-up|0
1257192|NCT00531752|4119564|P2|Second Double-blind Intervention Period|Lost to Follow-up|0
1257193|NCT00531752|4119565|P1|Second Double-blind Intervention Period|Lost to Follow-up|0
1257194|NCT00531752|4119562|P4|Second Double-blind Intervention Period|Withdrawal by Subject|1
1257195|NCT00531752|4119563|P3|Second Double-blind Intervention Period|Withdrawal by Subject|0
1257196|NCT00531752|4119564|P2|Second Double-blind Intervention Period|Withdrawal by Subject|0
1257197|NCT00531752|4119565|P1|Second Double-blind Intervention Period|Withdrawal by Subject|0
1257198|NCT00531752|4119562|P4|Second Double-blind Intervention Period|Other|0
1257199|NCT00531752|4119563|P3|Second Double-blind Intervention Period|Other|0
1257200|NCT00531752|4119564|P2|Second Double-blind Intervention Period|Other|1
1257201|NCT00531752|4119565|P1|Second Double-blind Intervention Period|Other|1
1257202|NCT00531752|4119562|P4|Second Double-blind Intervention Period|Adverse Event|0
1257203|NCT00531752|4119563|P3|Second Double-blind Intervention Period|Adverse Event|0
1257204|NCT00531752|4119564|P2|Second Double-blind Intervention Period|Adverse Event|1
1257205|NCT00531752|4119565|P1|Second Double-blind Intervention Period|Adverse Event|1
1257206|NCT00531752|4119562|P4|First Double-blind Intervention Period|Randomized but not treated|0
1257207|NCT00531752|4119563|P3|First Double-blind Intervention Period|Randomized but not treated|0
1257208|NCT00531752|4119564|P2|First Double-blind Intervention Period|Randomized but not treated|0
1257209|NCT00531752|4119565|P1|First Double-blind Intervention Period|Randomized but not treated|1
1257210|NCT00531752|4119562|P4|First Double-blind Intervention Period|Lost to Follow-up|1
1257211|NCT00531752|4119563|P3|First Double-blind Intervention Period|Lost to Follow-up|1
1257212|NCT00531752|4119564|P2|First Double-blind Intervention Period|Lost to Follow-up|0
1257213|NCT00531752|4119565|P1|First Double-blind Intervention Period|Lost to Follow-up|0
1257214|NCT00531752|4119562|P4|First Double-blind Intervention Period|Withdrawal by Subject|1
1257215|NCT00531752|4119563|P3|First Double-blind Intervention Period|Withdrawal by Subject|1
1257216|NCT00531752|4119564|P2|First Double-blind Intervention Period|Withdrawal by Subject|0
1257217|NCT00531752|4119565|P1|First Double-blind Intervention Period|Withdrawal by Subject|2
1257218|NCT00531752|4119562|P4|First Double-blind Intervention Period|Other|0
1257219|NCT00531752|4119563|P3|First Double-blind Intervention Period|Other|4
1257220|NCT00531752|4119564|P2|First Double-blind Intervention Period|Other|4
1257221|NCT00531752|4119565|P1|First Double-blind Intervention Period|Other|1
1257222|NCT00531752|4119562|P4|First Double-blind Intervention Period|Adverse Event|1
1257223|NCT00531752|4119563|P3|First Double-blind Intervention Period|Adverse Event|1
1257224|NCT00531752|4119564|P2|First Double-blind Intervention Period|Adverse Event|0
1257225|NCT00531752|4119565|P1|First Double-blind Intervention Period|Adverse Event|2
1257226|NCT00531479|4119676|P2|Overall Study|Did not receive treatment|3
1257227|NCT00531479|4119677|P1|Overall Study|Did not receive treatment|2
1257228|NCT00531479|4119676|P2|Overall Study|Withdrawal by Subject|6
1257229|NCT00531479|4119677|P1|Overall Study|Withdrawal by Subject|6
1257230|NCT00531479|4119676|P2|Overall Study|Other|1
1257231|NCT00531479|4119677|P1|Overall Study|Other|0
1257232|NCT00531479|4119676|P2|Overall Study|Lost to Follow-up|2
1257233|NCT00531479|4119677|P1|Overall Study|Lost to Follow-up|0
1257234|NCT00531479|4119676|P2|Overall Study|Death|71
1257235|NCT00531479|4119677|P1|Overall Study|Death|68
1257236|NCT00531427|4119708|P2|Overall Study|Administrative|9
1257237|NCT00531427|4119709|P1|Overall Study|Administrative|4
1257238|NCT00531427|4119708|P2|Overall Study|Lack of Efficacy|39
1257239|NCT00531427|4119709|P1|Overall Study|Lack of Efficacy|14
1257240|NCT00531427|4119708|P2|Overall Study|Lost to Follow-up|3
1257241|NCT00531427|4119709|P1|Overall Study|Lost to Follow-up|4
1257242|NCT00531427|4119708|P2|Overall Study|Adverse Event|30
1257243|NCT00531427|4119709|P1|Overall Study|Adverse Event|44
1257244|NCT00531427|4119708|P2|Overall Study|Withdrawal by Subject|13
1257245|NCT00531427|4119709|P1|Overall Study|Withdrawal by Subject|7
1257246|NCT00531284|4119737|P17|Overall Study|Other|0
1257247|NCT00531284|4119738|P16|Overall Study|Other|0
1257248|NCT00531284|4119739|P15|Overall Study|Other|1
1257249|NCT00531284|4119740|P14|Overall Study|Other|0
1257250|NCT00531284|4119741|P13|Overall Study|Other|0
1257251|NCT00531284|4119742|P12|Overall Study|Other|2
1257252|NCT00531284|4119743|P11|Overall Study|Other|0
1257253|NCT00531284|4119744|P10|Overall Study|Other|1
1257254|NCT00531284|4119745|P9|Overall Study|Other|2
1257255|NCT00531284|4119746|P8|Overall Study|Other|0
1257256|NCT00531284|4119747|P7|Overall Study|Other|0
1257257|NCT00531284|4119748|P6|Overall Study|Other|1
1257258|NCT00531284|4119749|P5|Overall Study|Other|2
1257259|NCT00531284|4119750|P4|Overall Study|Other|10
1257260|NCT00531284|4119751|P3|Overall Study|Other|0
1257261|NCT00531284|4119752|P2|Overall Study|Other|0
1257262|NCT00531284|4119753|P1|Overall Study|Other|1
1257263|NCT00531284|4119737|P17|Overall Study|Withdrawal by Subject|1
1257264|NCT00531284|4119738|P16|Overall Study|Withdrawal by Subject|1
1257265|NCT00531284|4119739|P15|Overall Study|Withdrawal by Subject|0
1257266|NCT00531284|4119740|P14|Overall Study|Withdrawal by Subject|1
1257267|NCT00531284|4119741|P13|Overall Study|Withdrawal by Subject|0
1257268|NCT00531284|4119742|P12|Overall Study|Withdrawal by Subject|3
1257269|NCT00531284|4119743|P11|Overall Study|Withdrawal by Subject|0
1257270|NCT00531284|4119744|P10|Overall Study|Withdrawal by Subject|0
1257271|NCT00531284|4119745|P9|Overall Study|Withdrawal by Subject|0
1257272|NCT00531284|4119746|P8|Overall Study|Withdrawal by Subject|0
1257273|NCT00531284|4119747|P7|Overall Study|Withdrawal by Subject|0
1257274|NCT00531284|4119748|P6|Overall Study|Withdrawal by Subject|0
1257275|NCT00531284|4119749|P5|Overall Study|Withdrawal by Subject|0
1257276|NCT00531284|4119750|P4|Overall Study|Withdrawal by Subject|4
1257277|NCT00531284|4119751|P3|Overall Study|Withdrawal by Subject|0
1257278|NCT00531284|4119752|P2|Overall Study|Withdrawal by Subject|0
1257279|NCT00531284|4119753|P1|Overall Study|Withdrawal by Subject|1
1257280|NCT00531284|4119737|P17|Overall Study|Adverse Event|2
1257281|NCT00531284|4119738|P16|Overall Study|Adverse Event|0
1257282|NCT00531284|4119739|P15|Overall Study|Adverse Event|1
1257283|NCT00531284|4119740|P14|Overall Study|Adverse Event|1
1257284|NCT00531284|4119741|P13|Overall Study|Adverse Event|0
1257285|NCT00531284|4119742|P12|Overall Study|Adverse Event|5
1257286|NCT00531284|4119743|P11|Overall Study|Adverse Event|0
1257287|NCT00531284|4119744|P10|Overall Study|Adverse Event|0
1257288|NCT00531284|4119745|P9|Overall Study|Adverse Event|3
1257289|NCT00531284|4119746|P8|Overall Study|Adverse Event|2
1257290|NCT00531284|4119747|P7|Overall Study|Adverse Event|3
1257291|NCT00531284|4119748|P6|Overall Study|Adverse Event|2
1257292|NCT00531284|4119749|P5|Overall Study|Adverse Event|0
1257293|NCT00531284|4119750|P4|Overall Study|Adverse Event|7
1257294|NCT00531284|4119751|P3|Overall Study|Adverse Event|1
1257295|NCT00531284|4119752|P2|Overall Study|Adverse Event|1
1257296|NCT00531284|4119753|P1|Overall Study|Adverse Event|0
1257297|NCT00531284|4119737|P17|Overall Study|Progressive Disease|5
1257298|NCT00531284|4119738|P16|Overall Study|Progressive Disease|11
1257299|NCT00531284|4119739|P15|Overall Study|Progressive Disease|2
1257300|NCT00531284|4119740|P14|Overall Study|Progressive Disease|1
1257301|NCT00531284|4119741|P13|Overall Study|Progressive Disease|2
1257302|NCT00531284|4119742|P12|Overall Study|Progressive Disease|14
1257303|NCT00531284|4119743|P11|Overall Study|Progressive Disease|3
1257304|NCT00531284|4119744|P10|Overall Study|Progressive Disease|3
1257305|NCT00531284|4119745|P9|Overall Study|Progressive Disease|6
1257306|NCT00531284|4119746|P8|Overall Study|Progressive Disease|8
1257307|NCT00531284|4119747|P7|Overall Study|Progressive Disease|3
1257308|NCT00531284|4119748|P6|Overall Study|Progressive Disease|4
1257309|NCT00531284|4119749|P5|Overall Study|Progressive Disease|4
1257310|NCT00531284|4119750|P4|Overall Study|Progressive Disease|42
1257311|NCT00531284|4119751|P3|Overall Study|Progressive Disease|5
1257312|NCT00531284|4119752|P2|Overall Study|Progressive Disease|3
1257313|NCT00531284|4119753|P1|Overall Study|Progressive Disease|1
1257314|NCT00531206|4119903|P1|Overall Study|including non-related adverse events|8
1257315|NCT00531206|4119903|P1|Overall Study|Lost to Follow-up|5
1257316|NCT00531206|4119903|P1|Overall Study|Lack of Efficacy|2
1257317|NCT00531206|4119903|P1|Overall Study|Adverse Event related|5
1257318|NCT00531050|4119933|P6|Part 2: Period 3|Abnormal test procedure|1
1257319|NCT00531050|4119934|P5|Part 2: Period 3|Abnormal test procedure|0
1257320|NCT00531050|4119935|P4|Part 2: Period 3|Abnormal test procedure|0
1257321|NCT00531050|4119936|P3|Part 2: Period 3|Abnormal test procedure|0
1257322|NCT00531050|4119937|P2|Part 2: Period 3|Abnormal test procedure|0
1257323|NCT00531050|4119938|P1|Part 2: Period 3|Abnormal test procedure|1
1257324|NCT00531050|4119933|P6|Part 2: Period 1|Adverse Event|1
1257325|NCT00531050|4119934|P5|Part 2: Period 1|Adverse Event|0
1257326|NCT00531050|4119935|P4|Part 2: Period 1|Adverse Event|0
1257327|NCT00531050|4119936|P3|Part 2: Period 1|Adverse Event|0
1257328|NCT00531050|4119937|P2|Part 2: Period 1|Adverse Event|0
1257329|NCT00531050|4119938|P1|Part 2: Period 1|Adverse Event|0
1257330|NCT00531050|4119933|P6|Part 1: Period 3|Adverse Event|0
1257331|NCT00531050|4119934|P5|Part 1: Period 3|Adverse Event|0
1257332|NCT00531050|4119935|P4|Part 1: Period 3|Adverse Event|0
1257333|NCT00531050|4119936|P3|Part 1: Period 3|Adverse Event|0
1257334|NCT00531050|4119937|P2|Part 1: Period 3|Adverse Event|0
1257335|NCT00531050|4119938|P1|Part 1: Period 3|Adverse Event|1
1257336|NCT00531050|4119933|P6|Part 1: Period 1|Protocol Deviation|0
1257337|NCT00531050|4119934|P5|Part 1: Period 1|Protocol Deviation|0
1257338|NCT00531050|4119935|P4|Part 1: Period 1|Protocol Deviation|1
1257339|NCT00531050|4119936|P3|Part 1: Period 1|Protocol Deviation|0
1257340|NCT00531050|4119937|P2|Part 1: Period 1|Protocol Deviation|0
1257341|NCT00531050|4119938|P1|Part 1: Period 1|Protocol Deviation|0
1257342|NCT00531050|4119933|P6|Part 1: Period 1|Adverse Event|0
1257343|NCT00531050|4119934|P5|Part 1: Period 1|Adverse Event|0
1257344|NCT00531050|4119935|P4|Part 1: Period 1|Adverse Event|0
1257345|NCT00531050|4119936|P3|Part 1: Period 1|Adverse Event|0
1257346|NCT00531050|4119937|P2|Part 1: Period 1|Adverse Event|1
1257347|NCT00531050|4119938|P1|Part 1: Period 1|Adverse Event|0
1257348|NCT00531011|4119967|P2|Overall Study|Physician Decision|3
1257349|NCT00531011|4119968|P1|Overall Study|Physician Decision|0
1257350|NCT00531011|4119967|P2|Overall Study|Lost to Follow-up|0
1257351|NCT00531011|4119968|P1|Overall Study|Lost to Follow-up|1
1257352|NCT00531011|4119967|P2|Overall Study|Death|0
1257353|NCT00531011|4119968|P1|Overall Study|Death|1
1257354|NCT00531011|4119967|P2|Overall Study|Withdrawal by Subject|4
1257355|NCT00531011|4119968|P1|Overall Study|Withdrawal by Subject|2
1257356|NCT00530946|4120014|P4|Overall Study|Noncompliance|0
1257357|NCT00530946|4120015|P3|Overall Study|Noncompliance|0
1257358|NCT00530946|4120016|P2|Overall Study|Noncompliance|0
1257359|NCT00530946|4120017|P1|Overall Study|Noncompliance|1
1257360|NCT00530946|4120014|P4|Overall Study|Protocol Violation|1
1257361|NCT00530946|4120015|P3|Overall Study|Protocol Violation|0
1257362|NCT00530946|4120016|P2|Overall Study|Protocol Violation|0
1257363|NCT00530946|4120017|P1|Overall Study|Protocol Violation|0
1257364|NCT00530946|4120014|P4|Overall Study|Adverse Event|1
1257365|NCT00530946|4120015|P3|Overall Study|Adverse Event|1
1257366|NCT00530946|4120016|P2|Overall Study|Adverse Event|2
1257367|NCT00530946|4120017|P1|Overall Study|Adverse Event|1
1257368|NCT00530920|4120070|P3|Overall Study|Withdrawal by Subject|1
1257369|NCT00530920|4120071|P2|Overall Study|Withdrawal by Subject|0
1257370|NCT00530920|4120072|P1|Overall Study|Withdrawal by Subject|0
1257371|NCT00530920|4120070|P3|Overall Study|Adverse Event|3
1257372|NCT00530920|4120071|P2|Overall Study|Adverse Event|0
1257373|NCT00530920|4120072|P1|Overall Study|Adverse Event|0
1257374|NCT00530920|4120070|P3|Overall Study|Randomized but not treated|0
1257375|NCT00530920|4120071|P2|Overall Study|Randomized but not treated|2
1257376|NCT00530920|4120072|P1|Overall Study|Randomized but not treated|0
1257377|NCT00530894|4120132|P4|Overall Study|Alive and censored prior to 1 year|0
1257378|NCT00530894|4120133|P3|Overall Study|Alive and censored prior to 1 year|0
1257379|NCT00530894|4120134|P2|Overall Study|Alive and censored prior to 1 year|0
1257380|NCT00530894|4120135|P1|Overall Study|Alive and censored prior to 1 year|2
1257381|NCT00530894|4120132|P4|Overall Study|Withdrawal by Subject|5
1257382|NCT00530894|4120133|P3|Overall Study|Withdrawal by Subject|0
1257383|NCT00530894|4120134|P2|Overall Study|Withdrawal by Subject|23
1257384|NCT00530894|4120135|P1|Overall Study|Withdrawal by Subject|1
1257385|NCT00530894|4120132|P4|Overall Study|Lost to Follow-up|0
1257386|NCT00530894|4120133|P3|Overall Study|Lost to Follow-up|0
1257387|NCT00530894|4120134|P2|Overall Study|Lost to Follow-up|3
1257388|NCT00530894|4120135|P1|Overall Study|Lost to Follow-up|1
1257389|NCT00530894|4120132|P4|Overall Study|Death|89
1257390|NCT00530894|4120133|P3|Overall Study|Death|55
1257391|NCT00530894|4120134|P2|Overall Study|Death|89
1257392|NCT00530894|4120135|P1|Overall Study|Death|84
1257393|NCT00530855|4120163|P1|Overall Study|Other reason for premature termination|17
1257394|NCT00530855|4120163|P1|Overall Study|Lost to Follow-up|9
1257395|NCT00530855|4120163|P1|Overall Study|Unsatisfactory compliance of subject|11
1257396|NCT00530855|4120163|P1|Overall Study|Protocol Violation|3
1257397|NCT00530855|4120163|P1|Overall Study|Non Fatal Non Serious AE|12
1257398|NCT00530855|4120163|P1|Overall Study|Non Fatal Serious AE|7
1257399|NCT00530855|4120163|P1|Overall Study|Fatal Serious AE|3
1257400|NCT00530855|4120163|P1|Overall Study|Withdrawal by Subject|30
1257401|NCT00530855|4120163|P1|Overall Study|Lack of Efficacy|20
1257402|NCT00530842|4120172|P2|Period 2|Individual different reasons|0
1257403|NCT00530842|4120173|P1|Period 2|Individual different reasons|2
1257404|NCT00530842|4120172|P2|Period 2|Withdrawal by Subject|2
1257405|NCT00530842|4120173|P1|Period 2|Withdrawal by Subject|1
1257406|NCT00530842|4120172|P2|Period 2|Protocol Violation|0
1257407|NCT00530842|4120173|P1|Period 2|Protocol Violation|1
1257408|NCT00530842|4120172|P2|Period 2|Lost to Follow-up|4
1257409|NCT00530842|4120173|P1|Period 2|Lost to Follow-up|0
1257410|NCT00530842|4120172|P2|Period 2|Lack of Efficacy|0
1257411|NCT00530842|4120173|P1|Period 2|Lack of Efficacy|1
1257412|NCT00530842|4120172|P2|Period 2|Adverse Event|3
1257413|NCT00530842|4120173|P1|Period 2|Adverse Event|3
1257414|NCT00530842|4120172|P2|Period 1|Individual different reasons|3
1257415|NCT00530842|4120173|P1|Period 1|Individual different reasons|2
1257416|NCT00530842|4120172|P2|Period 1|Withdrawal by Subject|3
1257417|NCT00530842|4120173|P1|Period 1|Withdrawal by Subject|2
1257418|NCT00530842|4120172|P2|Period 1|Protocol Violation|1
1257419|NCT00530842|4120173|P1|Period 1|Protocol Violation|2
1257420|NCT00530842|4120172|P2|Period 1|Lack of Efficacy|1
1257421|NCT00530842|4120173|P1|Period 1|Lack of Efficacy|1
1257422|NCT00530842|4120172|P2|Period 1|Adverse Event|3
1257423|NCT00530842|4120173|P1|Period 1|Adverse Event|7
1257424|NCT00530842|4120172|P2|Overall Study|Individual different reasons|3
1257425|NCT00530842|4120173|P1|Overall Study|Individual different reasons|4
1257426|NCT00530842|4120172|P2|Overall Study|Withdrawal by Subject|5
1257427|NCT00530842|4120173|P1|Overall Study|Withdrawal by Subject|4
1257428|NCT00530842|4120172|P2|Overall Study|Protocol Violation|2
1257429|NCT00530842|4120173|P1|Overall Study|Protocol Violation|3
1257430|NCT00530842|4120172|P2|Overall Study|Lost to Follow-up|4
1257431|NCT00530842|4120173|P1|Overall Study|Lost to Follow-up|0
1257432|NCT00530842|4120172|P2|Overall Study|Lack of Efficacy|1
1257433|NCT00530842|4120173|P1|Overall Study|Lack of Efficacy|2
1257434|NCT00530842|4120172|P2|Overall Study|Adverse Event|6
1257435|NCT00530842|4120173|P1|Overall Study|Adverse Event|10
1257436|NCT00530816|4120300|P3|Overall Study|Withdrawal by Subject|6
1257437|NCT00530816|4120301|P2|Overall Study|Withdrawal by Subject|2
1257438|NCT00530816|4120302|P1|Overall Study|Withdrawal by Subject|1
1257439|NCT00530816|4120300|P3|Overall Study|Other|4
1257440|NCT00530816|4120301|P2|Overall Study|Other|3
1257441|NCT00530816|4120302|P1|Overall Study|Other|3
1257442|NCT00530816|4120300|P3|Overall Study|Adverse Event|7
1257443|NCT00530816|4120301|P2|Overall Study|Adverse Event|13
1257444|NCT00530816|4120302|P1|Overall Study|Adverse Event|6
1257445|NCT00530816|4120300|P3|Overall Study|Progressive Disease|24
1257446|NCT00530816|4120301|P2|Overall Study|Progressive Disease|24
1257447|NCT00530816|4120302|P1|Overall Study|Progressive Disease|16
1257448|NCT00530790|4120345|P1|Overall Study|Physician Decision|1
1257449|NCT00530790|4120345|P1|Overall Study|Withdrawal by Subject|2
1257450|NCT00530790|4120345|P1|Overall Study|Adverse Event|2
1257451|NCT00530777|4120367|P2|Overall Study|Unable to adhere to visit schedule|1
1257452|NCT00530777|4120368|P1|Overall Study|Unable to adhere to visit schedule|5
1257453|NCT00530777|4120367|P2|Overall Study|Withdrawal by Subject|1
1257454|NCT00530777|4120368|P1|Overall Study|Withdrawal by Subject|0
1257455|NCT00530777|4120367|P2|Overall Study|Physician Decision|0
1257456|NCT00530777|4120368|P1|Overall Study|Physician Decision|1
1257457|NCT00530777|4120367|P2|Overall Study|Death|2
1257458|NCT00530777|4120368|P1|Overall Study|Death|1
1257459|NCT00530777|4120367|P2|Overall Study|Lost to Follow-up|1
1257460|NCT00530777|4120368|P1|Overall Study|Lost to Follow-up|0
1257461|NCT00530712|4120425|P1|12 Month Follow-up Visit|Death|9
1257462|NCT00530712|4120425|P1|12 Month Follow-up Visit|Lost to Follow-up|7
1257463|NCT00530712|4120425|P1|12 Month Follow-up Visit|Missed Visit|3
1257464|NCT00530712|4120425|P1|12 Month Follow-up Visit|Withdrawal by Subject|5
1257465|NCT00530712|4120425|P1|6 Month Follow-up Visit|Death|2
1257466|NCT00530712|4120425|P1|6 Month Follow-up Visit|Lost to Follow-up|3
1257467|NCT00530712|4120425|P1|6 Month Follow-up Visit|Missed Visit|3
1257468|NCT00530712|4120425|P1|6 Month Follow-up Visit|Withdrawal by Subject|4
1257469|NCT00530712|4120425|P1|30 Day Follow-up Visit|Missed Visit|5
1257470|NCT00530712|4120425|P1|30 Day Follow-up Visit|Withdrawal by Subject|2
1257471|NCT00530504|4120444|P1|Overall Study|Exited study due to other reasons|33
1257472|NCT00530504|4120444|P1|Overall Study|Withdrawal by Subject|39
1257473|NCT00530504|4120444|P1|Overall Study|Lost to Follow-up|26
1257474|NCT00530504|4120444|P1|Overall Study|Death|54
1257475|NCT00530439|4120450|P2|Overall Study|Severe malformation/abortion|3
1257476|NCT00530439|4120451|P1|Overall Study|Severe malformation/abortion|0
1257477|NCT00530439|4120450|P2|Overall Study|Twin pregnancy|2
1257478|NCT00530439|4120451|P1|Overall Study|Twin pregnancy|0
1257479|NCT00530439|4120450|P2|Overall Study|Misclassification|0
1257480|NCT00530439|4120451|P1|Overall Study|Misclassification|2
1257481|NCT00530439|4120450|P2|Overall Study|Missed abortion|4
1257482|NCT00530439|4120451|P1|Overall Study|Missed abortion|1
1257483|NCT00530439|4120450|P2|Overall Study|Withdraw|14
1257484|NCT00530439|4120451|P1|Overall Study|Withdraw|18
1257485|NCT00530439|4120450|P2|Overall Study|GDM|3
1257486|NCT00530439|4120451|P1|Overall Study|GDM|9
1257487|NCT00530348|4120459|P2|Overall Study|Noncompliance with inclusion criterion 3|1
1257488|NCT00530348|4120460|P1|Overall Study|Noncompliance with inclusion criterion 3|0
1257489|NCT00530348|4120459|P2|Overall Study|Randomised in error|0
1257490|NCT00530348|4120460|P1|Overall Study|Randomised in error|1
1257491|NCT00530348|4120459|P2|Overall Study|Withdrawal by Subject|12
1257492|NCT00530348|4120460|P1|Overall Study|Withdrawal by Subject|12
1257493|NCT00530348|4120459|P2|Overall Study|Pregnancy|0
1257494|NCT00530348|4120460|P1|Overall Study|Pregnancy|1
1257495|NCT00530348|4120459|P2|Overall Study|Physician Decision|2
1257496|NCT00530348|4120460|P1|Overall Study|Physician Decision|1
1257497|NCT00530348|4120459|P2|Overall Study|Lost to Follow-up|2
1257498|NCT00530348|4120460|P1|Overall Study|Lost to Follow-up|0
1257499|NCT00530348|4120459|P2|Overall Study|Lack of Efficacy|0
1257500|NCT00530348|4120460|P1|Overall Study|Lack of Efficacy|2
1257501|NCT00530348|4120459|P2|Overall Study|Death|1
1257502|NCT00530348|4120460|P1|Overall Study|Death|0
1257503|NCT00530348|4120459|P2|Overall Study|Adverse Event|1
1257504|NCT00530348|4120460|P1|Overall Study|Adverse Event|5
1257505|NCT00530335|4120476|P1|Overall Study|Physician Decision|1
1257506|NCT00530335|4120476|P1|Overall Study|Withdrawal by Subject|1
1257507|NCT00530335|4120476|P1|Overall Study|Protocol Violation|1
1257508|NCT00530335|4120476|P1|Overall Study|Adverse Event|3
1257509|NCT00530270|4120493|P2|Overall Study|Protocol Violation|0
1257510|NCT00530270|4120494|P1|Overall Study|Protocol Violation|1
1257511|NCT00530257|4120508|P1|Overall Study|Lost to Follow-up|1
1257512|NCT00530218|4120536|P1|Overall Study|Death|12
1257513|NCT00530218|4120536|P1|Overall Study|CMV Not Detected|13
1257514|NCT00530088|4120543|P1|Overall Study|Other Not Specified|2
1257515|NCT00530088|4120543|P1|Overall Study|Physician Decision|4
1257516|NCT00530088|4120543|P1|Overall Study|Disease Progression|4
1257517|NCT00530075|4120548|P1|Overall Study|Withdrawal by Subject|1
1257518|NCT00530075|4120548|P1|Overall Study|Protocol Violation|1
1257519|NCT00530075|4120548|P1|Overall Study|Lack of Efficacy|3
1257520|NCT00530075|4120548|P1|Overall Study|Death|1
1257521|NCT00530075|4120548|P1|Overall Study|Adverse Event|1
1257522|NCT00530023|4120561|P2|Overall Study|Withdrawal by Subject|1
1257523|NCT00530023|4120562|P1|Overall Study|Withdrawal by Subject|0
1257524|NCT00529802|4120576|P1|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2
1257525|NCT00529802|4120576|P1|Evaluable for Primary Endpoint|Lost to Follow-up|1
1257526|NCT00529802|4120576|P1|Evaluable for Primary Endpoint|Lack of Efficacy|1
1257527|NCT00529802|4120576|P1|Evaluable for Primary Endpoint|Death|1
1257528|NCT00529802|4120576|P1|Evaluable for Primary Endpoint|Adverse Event|2
1257529|NCT00529802|4120576|P1|Evaluable for Primary Endpoint|Worsening performance status|2
1257530|NCT00529802|4120576|P1|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3
1257531|NCT00529789|4120582|P1|Study Period IV|Lost to Follow-up|3
1257532|NCT00529789|4120582|P1|Study Period IV|Lack of Efficacy|1
1257533|NCT00529789|4120582|P1|Study Period IV|Adverse Event|1
1257534|NCT00529789|4120582|P1|Study Period IV|Parent/Caregiver Decision|1
1257535|NCT00529789|4120582|P1|Study Period II/III|Lost to Follow-up|3
1257536|NCT00529789|4120582|P1|Study Period II/III|Physician Decision|3
1257537|NCT00529789|4120582|P1|Study Period II/III|Protocol Violation|3
1257538|NCT00529789|4120582|P1|Study Period II/III|Withdrawal by Subject|1
1257539|NCT00529789|4120582|P1|Study Period II/III|Lack of Efficacy|2
1257540|NCT00529789|4120582|P1|Study Period II/III|Adverse Event|3
1257541|NCT00529789|4120582|P1|Study Period II/III|Parent/Caregiver Decision|9
1257542|NCT00529763|4120607|P3|Overall Study|Patient Withdrew Consent|2
1257543|NCT00529763|4120608|P2|Overall Study|Patient Withdrew Consent|3
1257544|NCT00529763|4120609|P1|Overall Study|Patient Withdrew Consent|2
1257545|NCT00529763|4120607|P3|Overall Study|Study Drug Toxicity|1
1257546|NCT00529763|4120608|P2|Overall Study|Study Drug Toxicity|6
1257547|NCT00529763|4120609|P1|Overall Study|Study Drug Toxicity|1
1257548|NCT00529763|4120607|P3|Overall Study|Stem Cell Transplant|0
1257549|NCT00529763|4120608|P2|Overall Study|Stem Cell Transplant|3
1257550|NCT00529763|4120609|P1|Overall Study|Stem Cell Transplant|0
1257551|NCT00529763|4120607|P3|Overall Study|Lost to Follow-up|1
1257552|NCT00529763|4120608|P2|Overall Study|Lost to Follow-up|1
1257553|NCT00529763|4120609|P1|Overall Study|Lost to Follow-up|0
1257554|NCT00529763|4120607|P3|Overall Study|Disease Progression|1
1257555|NCT00529763|4120608|P2|Overall Study|Disease Progression|16
1257556|NCT00529763|4120609|P1|Overall Study|Disease Progression|6
1257557|NCT00529763|4120607|P3|Overall Study|Death|1
1257558|NCT00529763|4120608|P2|Overall Study|Death|1
1257559|NCT00529763|4120609|P1|Overall Study|Death|0
1257560|NCT00529763|4120607|P3|Overall Study|Adverse Event Unrelated to Study Drug|1
1257561|NCT00529763|4120608|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
1257562|NCT00529763|4120609|P1|Overall Study|Adverse Event Unrelated to Study Drug|1
1257563|NCT00529659|4120647|P2|Overall Study|Withdrawal by Subject|6
1257564|NCT00529659|4120648|P1|Overall Study|Withdrawal by Subject|1
1257565|NCT00529659|4120647|P2|Overall Study|Protocol Violation|6
1257566|NCT00529659|4120648|P1|Overall Study|Protocol Violation|2
1257567|NCT00529659|4120647|P2|Overall Study|Physician Decision|2
1257568|NCT00529659|4120648|P1|Overall Study|Physician Decision|0
1257569|NCT00529659|4120647|P2|Overall Study|Lost to Follow-up|2
1257570|NCT00529659|4120648|P1|Overall Study|Lost to Follow-up|0
1257571|NCT00529659|4120647|P2|Overall Study|Adverse Event|7
1257572|NCT00529659|4120648|P1|Overall Study|Adverse Event|8
1257573|NCT00529633|4120666|P2|Overall Study|Withdrawal by Subject|1
1257574|NCT00529633|4120667|P1|Overall Study|Withdrawal by Subject|1
1257575|NCT00529568|4120679|P3|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19
1257576|NCT00529568|4120680|P2|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17
1257577|NCT00529568|4120681|P1|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0
1257578|NCT00529568|4120679|P3|Double-bilnd Antiviral Treatment Phase|Physician Decision|8
1257579|NCT00529568|4120680|P2|Double-bilnd Antiviral Treatment Phase|Physician Decision|5
1257580|NCT00529568|4120681|P1|Double-bilnd Antiviral Treatment Phase|Physician Decision|0
1257581|NCT00529568|4120679|P3|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48
1257582|NCT00529568|4120680|P2|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15
1257583|NCT00529568|4120681|P1|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0
1257584|NCT00529568|4120679|P3|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
1257585|NCT00529568|4120680|P2|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1
1257586|NCT00529568|4120681|P1|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
1257587|NCT00529568|4120679|P3|Double-bilnd Antiviral Treatment Phase|Adverse Event|27
1257588|NCT00529568|4120680|P2|Double-bilnd Antiviral Treatment Phase|Adverse Event|10
1257589|NCT00529568|4120681|P1|Double-bilnd Antiviral Treatment Phase|Adverse Event|0
1257590|NCT00529568|4120679|P3|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
1257591|NCT00529568|4120680|P2|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
1257592|NCT00529568|4120681|P1|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3
1257593|NCT00529568|4120679|P3|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
1257594|NCT00529568|4120680|P2|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
1257595|NCT00529568|4120681|P1|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13
1257596|NCT00529568|4120679|P3|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
1257597|NCT00529568|4120680|P2|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
1257598|NCT00529568|4120681|P1|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8
1257599|NCT00529568|4120679|P3|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
1257600|NCT00529568|4120680|P2|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
1257601|NCT00529568|4120681|P1|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5
1257602|NCT00529568|4120679|P3|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
1257603|NCT00529568|4120680|P2|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
1257604|NCT00529568|4120681|P1|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12
1257605|NCT00529568|4120679|P3|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
1257606|NCT00529568|4120680|P2|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
1257607|NCT00529568|4120681|P1|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5
1257608|NCT00529542|4120744|P2|Overall Study|Lost to Follow-up|1
1257609|NCT00529542|4120745|P1|Overall Study|Lost to Follow-up|0
1257610|NCT00529542|4120744|P2|Overall Study|Withdrawal by Subject|0
1257611|NCT00529542|4120745|P1|Overall Study|Withdrawal by Subject|1
1257612|NCT00529529|4120788|P3|Overall Study|Administrative problems|3
1257613|NCT00529529|4120789|P2|Overall Study|Administrative problems|0
1257614|NCT00529529|4120790|P1|Overall Study|Administrative problems|1
1257615|NCT00529529|4120788|P3|Overall Study|Abnormal test procedure result(s)|0
1257616|NCT00529529|4120789|P2|Overall Study|Abnormal test procedure result(s)|0
1257617|NCT00529529|4120790|P1|Overall Study|Abnormal test procedure result(s)|1
1257618|NCT00529529|4120788|P3|Overall Study|Death|0
1257619|NCT00529529|4120789|P2|Overall Study|Death|0
1257620|NCT00529529|4120790|P1|Overall Study|Death|2
1257621|NCT00529529|4120788|P3|Overall Study|Unsatisfactory therapeutic effect|2
1257622|NCT00529529|4120789|P2|Overall Study|Unsatisfactory therapeutic effect|2
1257623|NCT00529529|4120790|P1|Overall Study|Unsatisfactory therapeutic effect|2
1257624|NCT00529529|4120788|P3|Overall Study|Lost to Follow-up|1
1257625|NCT00529529|4120789|P2|Overall Study|Lost to Follow-up|3
1257626|NCT00529529|4120790|P1|Overall Study|Lost to Follow-up|5
1257627|NCT00529529|4120788|P3|Overall Study|Protocol deviation|5
1257628|NCT00529529|4120789|P2|Overall Study|Protocol deviation|12
1257629|NCT00529529|4120790|P1|Overall Study|Protocol deviation|8
1257630|NCT00529529|4120788|P3|Overall Study|Subject withdrew consent|12
1257631|NCT00529529|4120789|P2|Overall Study|Subject withdrew consent|9
1257632|NCT00529529|4120790|P1|Overall Study|Subject withdrew consent|12
1257633|NCT00529529|4120788|P3|Overall Study|Adverse Event|8
1257634|NCT00529529|4120789|P2|Overall Study|Adverse Event|17
1257635|NCT00529529|4120790|P1|Overall Study|Adverse Event|12
1257636|NCT00529516|4120849|P3|Overall Study|Lost to Follow-up|1
1257637|NCT00529516|4120850|P2|Overall Study|Lost to Follow-up|0
1257638|NCT00529516|4120851|P1|Overall Study|Lost to Follow-up|0
1257639|NCT00529516|4120849|P3|Overall Study|Withdrawal by Subject|0
1257640|NCT00529516|4120850|P2|Overall Study|Withdrawal by Subject|1
1257641|NCT00529516|4120851|P1|Overall Study|Withdrawal by Subject|1
1257642|NCT00529516|4120849|P3|Overall Study|Adverse Event|0
1257643|NCT00529516|4120850|P2|Overall Study|Adverse Event|1
1257644|NCT00529516|4120851|P1|Overall Study|Adverse Event|2
1257645|NCT00529451|4120936|P4|Overall Study|Administrative problems|2
1257646|NCT00529451|4120937|P3|Overall Study|Administrative problems|0
1257647|NCT00529451|4120938|P2|Overall Study|Administrative problems|1
1257648|NCT00529451|4120939|P1|Overall Study|Administrative problems|1
1257649|NCT00529451|4120936|P4|Overall Study|Protocol deviation|1
1257650|NCT00529451|4120937|P3|Overall Study|Protocol deviation|4
1257651|NCT00529451|4120938|P2|Overall Study|Protocol deviation|1
1257652|NCT00529451|4120939|P1|Overall Study|Protocol deviation|1
1257653|NCT00529451|4120936|P4|Overall Study|Lost to Follow-up|4
1257654|NCT00529451|4120937|P3|Overall Study|Lost to Follow-up|4
1257655|NCT00529451|4120938|P2|Overall Study|Lost to Follow-up|7
1257656|NCT00529451|4120939|P1|Overall Study|Lost to Follow-up|4
1257657|NCT00529451|4120936|P4|Overall Study|Unsatisfactory therapeutic response|4
1257658|NCT00529451|4120937|P3|Overall Study|Unsatisfactory therapeutic response|5
1257659|NCT00529451|4120938|P2|Overall Study|Unsatisfactory therapeutic response|2
1257660|NCT00529451|4120939|P1|Overall Study|Unsatisfactory therapeutic response|6
1257661|NCT00529451|4120936|P4|Overall Study|Adverse Event|8
1257662|NCT00529451|4120937|P3|Overall Study|Adverse Event|14
1257663|NCT00529451|4120938|P2|Overall Study|Adverse Event|16
1257664|NCT00529451|4120939|P1|Overall Study|Adverse Event|9
1257665|NCT00529451|4120936|P4|Overall Study|Subject withdrew consent|12
1257666|NCT00529451|4120937|P3|Overall Study|Subject withdrew consent|13
1257667|NCT00529451|4120938|P2|Overall Study|Subject withdrew consent|21
1257668|NCT00529451|4120939|P1|Overall Study|Subject withdrew consent|16
1257669|NCT00529399|4120966|P3|Overall Study|Non-compliant|0
1257670|NCT00529399|4120967|P2|Overall Study|Non-compliant|1
1257671|NCT00529399|4120968|P1|Overall Study|Non-compliant|0
1257672|NCT00529399|4120966|P3|Overall Study|Withdrawal by Subject|1
1257673|NCT00529399|4120967|P2|Overall Study|Withdrawal by Subject|0
1257674|NCT00529399|4120968|P1|Overall Study|Withdrawal by Subject|1
1257675|NCT00529399|4120966|P3|Overall Study|Lost to Follow-up|1
1257676|NCT00529399|4120967|P2|Overall Study|Lost to Follow-up|0
1257677|NCT00529399|4120968|P1|Overall Study|Lost to Follow-up|1
1257678|NCT00529308|4120978|P2|Overall Study|Withdrawal by Subject|1
1257679|NCT00529308|4120979|P1|Overall Study|Withdrawal by Subject|1
1257680|NCT00529243|4121008|P1|Overall Study|Relocated|1
1257681|NCT00529243|4121008|P1|Overall Study|Death|1
1257682|NCT00529243|4121008|P1|Overall Study|Adverse Event|1
1257683|NCT00529217|4121013|P1|Overall Study|Unable to adhere to study schedule|2
1257684|NCT00529217|4121013|P1|Overall Study|Lack of Efficacy|2
1257685|NCT00529152|4121049|P1|Overall Study|Lost to Follow-up|1
1257686|NCT00529152|4121049|P1|Overall Study|Withdrawal by Subject|2
1257687|NCT00529152|4121049|P1|Overall Study|Adverse Event|2
1257688|NCT00529100|4121073|P2|Overall Study|Participant Ineligibility|1
1257689|NCT00529100|4121074|P1|Overall Study|Participant Ineligibility|0
1257690|NCT00529100|4121073|P2|Overall Study|Withdrawal by Subject|1
1257691|NCT00529100|4121074|P1|Overall Study|Withdrawal by Subject|0
1257692|NCT00529100|4121073|P2|Overall Study|Progressive Disease|1
1257693|NCT00529100|4121074|P1|Overall Study|Progressive Disease|0
1257694|NCT00529100|4121073|P2|Overall Study|Protocol Violation|1
1257695|NCT00529100|4121074|P1|Overall Study|Protocol Violation|0
1257696|NCT00529100|4121073|P2|Overall Study|Adverse Event|5
1257697|NCT00529100|4121074|P1|Overall Study|Adverse Event|0
1257698|NCT00529087|4121091|P3|Overall Study|Protocol deviation|2
1257699|NCT00529087|4121092|P2|Overall Study|Protocol deviation|1
1257700|NCT00529087|4121093|P1|Overall Study|Protocol deviation|1
1257701|NCT00529087|4121091|P3|Overall Study|Withdrawal by Subject|3
1257702|NCT00529087|4121092|P2|Overall Study|Withdrawal by Subject|3
1257703|NCT00529087|4121093|P1|Overall Study|Withdrawal by Subject|3
1257704|NCT00529087|4121091|P3|Overall Study|Protocol Violation|6
1257705|NCT00529087|4121092|P2|Overall Study|Protocol Violation|7
1257706|NCT00529087|4121093|P1|Overall Study|Protocol Violation|8
1257707|NCT00529087|4121091|P3|Overall Study|Lost to Follow-up|1
1257708|NCT00529087|4121092|P2|Overall Study|Lost to Follow-up|4
1257709|NCT00529087|4121093|P1|Overall Study|Lost to Follow-up|6
1257710|NCT00529087|4121091|P3|Overall Study|Adverse Event|4
1257711|NCT00529087|4121092|P2|Overall Study|Adverse Event|13
1257712|NCT00529087|4121093|P1|Overall Study|Adverse Event|10
1257713|NCT00529035|4121157|P1|Overall Study|Withdrawal by Subject|1
1257714|NCT00528957|4121170|P2|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
1257715|NCT00528957|4121171|P1|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
1257716|NCT00528957|4121170|P2|Long-Term Extension (Week 336 and On)|Withdrew Consent|1
1257717|NCT00528957|4121171|P1|Long-Term Extension (Week 336 and On)|Withdrew Consent|2
1257718|NCT00528957|4121170|P2|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5
1257719|NCT00528957|4121171|P1|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3
1257720|NCT00528957|4121170|P2|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10
1257721|NCT00528957|4121171|P1|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4
1257722|NCT00528957|4121170|P2|Third Extension (Week 240 to Week 336)|Withdrew Consent|1
1257723|NCT00528957|4121171|P1|Third Extension (Week 240 to Week 336)|Withdrew Consent|0
1257724|NCT00528957|4121170|P2|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1
1257725|NCT00528957|4121171|P1|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0
1257726|NCT00528957|4121170|P2|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
1257727|NCT00528957|4121171|P1|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
1257728|NCT00528957|4121170|P2|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3
1257729|NCT00528957|4121171|P1|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0
1257730|NCT00528957|4121170|P2|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4
1257731|NCT00528957|4121171|P1|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5
1257732|NCT00528957|4121170|P2|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0
1257733|NCT00528957|4121171|P1|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3
1257734|NCT00528957|4121170|P2|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3
1257735|NCT00528957|4121171|P1|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4
1257736|NCT00528957|4121170|P2|First Extension (Week 48 to Week 144)|Withdrew Consent|1
1257737|NCT00528957|4121171|P1|First Extension (Week 48 to Week 144)|Withdrew Consent|0
1257738|NCT00528957|4121170|P2|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0
1257739|NCT00528957|4121171|P1|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1
1257740|NCT00528957|4121170|P2|First Extension (Week 48 to Week 144)|Investigator's Discretion|0
1257741|NCT00528957|4121171|P1|First Extension (Week 48 to Week 144)|Investigator's Discretion|2
1257742|NCT00528957|4121170|P2|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0
1257743|NCT00528957|4121171|P1|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2
1257744|NCT00528957|4121170|P2|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1
1257745|NCT00528957|4121171|P1|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2
1257746|NCT00528931|4121312|P1|Overall Study|Lost to Follow-up|1
1257747|NCT00528879|4121324|P4|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0
1257748|NCT00528879|4121325|P3|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
1257749|NCT00528879|4121326|P2|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
1257750|NCT00528879|4121327|P1|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
1257751|NCT00528879|4121324|P4|Long-term Period (Weeks 24 to 102)|Pregnancy|0
1257752|NCT00528879|4121325|P3|Long-term Period (Weeks 24 to 102)|Pregnancy|0
1257753|NCT00528879|4121326|P2|Long-term Period (Weeks 24 to 102)|Pregnancy|0
1257754|NCT00528879|4121327|P1|Long-term Period (Weeks 24 to 102)|Pregnancy|1
1257755|NCT00528879|4121324|P4|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2
1257756|NCT00528879|4121325|P3|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1
1257757|NCT00528879|4121326|P2|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5
1257758|NCT00528879|4121327|P1|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0
1257759|NCT00528879|4121324|P4|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7
1257760|NCT00528879|4121325|P3|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3
1257761|NCT00528879|4121326|P2|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5
1257762|NCT00528879|4121327|P1|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4
1257763|NCT00528879|4121324|P4|Long-term Period (Weeks 24 to 102)|Death|0
1257764|NCT00528879|4121325|P3|Long-term Period (Weeks 24 to 102)|Death|0
1257765|NCT00528879|4121326|P2|Long-term Period (Weeks 24 to 102)|Death|1
1257766|NCT00528879|4121327|P1|Long-term Period (Weeks 24 to 102)|Death|0
1257767|NCT00528879|4121324|P4|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
1257768|NCT00528879|4121325|P3|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8
1257769|NCT00528879|4121326|P2|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6
1257770|NCT00528879|4121327|P1|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
1257771|NCT00528879|4121324|P4|Long-term Period (Weeks 24 to 102)|Adverse Event|2
1257772|NCT00528879|4121325|P3|Long-term Period (Weeks 24 to 102)|Adverse Event|3
1257773|NCT00528879|4121326|P2|Long-term Period (Weeks 24 to 102)|Adverse Event|4
1257774|NCT00528879|4121327|P1|Long-term Period (Weeks 24 to 102)|Adverse Event|5
1257775|NCT00528879|4121324|P4|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9
1257776|NCT00528879|4121325|P3|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17
1257777|NCT00528879|4121326|P2|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16
1257778|NCT00528879|4121327|P1|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27
1257779|NCT00528879|4121324|P4|Short-term Period (Day 1 to Week 24)|Not specified|1
1257780|NCT00528879|4121325|P3|Short-term Period (Day 1 to Week 24)|Not specified|1
1257781|NCT00528879|4121326|P2|Short-term Period (Day 1 to Week 24)|Not specified|0
1257782|NCT00528879|4121327|P1|Short-term Period (Day 1 to Week 24)|Not specified|0
1257783|NCT00528879|4121324|P4|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
1257784|NCT00528879|4121325|P3|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0
1257785|NCT00528879|4121326|P2|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
1257786|NCT00528879|4121327|P1|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
1257787|NCT00528879|4121324|P4|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
1257788|NCT00528879|4121325|P3|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
1257789|NCT00528879|4121326|P2|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3
1257790|NCT00528879|4121327|P1|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
1257791|NCT00528879|4121324|P4|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
1257792|NCT00528879|4121325|P3|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2
1257793|NCT00528879|4121326|P2|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
1257794|NCT00528879|4121327|P1|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
1257795|NCT00528879|4121324|P4|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
1257796|NCT00528879|4121325|P3|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
1257797|NCT00528879|4121326|P2|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
1257798|NCT00528879|4121327|P1|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
1257799|NCT00528879|4121324|P4|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3
1257800|NCT00528879|4121325|P3|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
1257801|NCT00528879|4121326|P2|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
1257802|NCT00528879|4121327|P1|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7
1257803|NCT00528879|4121324|P4|Short-term Period (Day 1 to Week 24)|Adverse Event|4
1257804|NCT00528879|4121325|P3|Short-term Period (Day 1 to Week 24)|Adverse Event|2
1257805|NCT00528879|4121326|P2|Short-term Period (Day 1 to Week 24)|Adverse Event|4
1257806|NCT00528879|4121327|P1|Short-term Period (Day 1 to Week 24)|Adverse Event|4
1257807|NCT00528879|4121324|P4|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
1257808|NCT00528879|4121325|P3|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1
1257809|NCT00528879|4121326|P2|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
1257810|NCT00528879|4121327|P1|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3
1257811|NCT00528866|4121393|P1|Overall Study|Protocol Violation|6
1257812|NCT00528840|4121405|P1|Overall Study|Not Specified|2
1257813|NCT00528840|4121405|P1|Overall Study|Administrative Reasons|1
1257814|NCT00528840|4121405|P1|Overall Study|Death|2
1257815|NCT00528840|4121405|P1|Overall Study|Withdrawal by Subject|17
1257816|NCT00528840|4121405|P1|Overall Study|Adverse Event|1
1257817|NCT00528840|4121405|P1|Overall Study|Lost to Follow-up|10
1257818|NCT00528801|4121419|P2|Overall Study|Administrative Reasons|1
1257819|NCT00528801|4121420|P1|Overall Study|Administrative Reasons|0
1257820|NCT00528801|4121419|P2|Overall Study|Lost to Follow-up|4
1257821|NCT00528801|4121420|P1|Overall Study|Lost to Follow-up|15
1257822|NCT00528801|4121419|P2|Overall Study|Protocol Violation|5
1257823|NCT00528801|4121420|P1|Overall Study|Protocol Violation|11
1257824|NCT00528801|4121419|P2|Overall Study|Withdrawal by Subject|1
1257825|NCT00528801|4121420|P1|Overall Study|Withdrawal by Subject|1
1257826|NCT00528775|4121434|P1|Overall Study|Other not specified|1
1257827|NCT00528645|4121442|P1|Overall Study|Adverse Event|3
1257828|NCT00528606|4121451|P2|Overall Study|Not specified|0
1257829|NCT00528606|4121452|P1|Overall Study|Not specified|2
1257830|NCT00528606|4121451|P2|Overall Study|Adverse Event|0
1257831|NCT00528606|4121452|P1|Overall Study|Adverse Event|3
1257832|NCT00528606|4121451|P2|Overall Study|Lost to Follow-up|1
1257833|NCT00528606|4121452|P1|Overall Study|Lost to Follow-up|4
1257834|NCT00528606|4121451|P2|Overall Study|Withdrew consent|3
1257835|NCT00528606|4121452|P1|Overall Study|Withdrew consent|4
1257836|NCT00528567|4121485|P2|Overall Study|Administrative/Other|75
1257837|NCT00528567|4121486|P1|Overall Study|Administrative/Other|22
1257838|NCT00528567|4121485|P2|Overall Study|Other Protocol Violation|21
1257839|NCT00528567|4121486|P1|Overall Study|Other Protocol Violation|5
1257840|NCT00528567|4121485|P2|Overall Study|Failure to Return|4
1257841|NCT00528567|4121486|P1|Overall Study|Failure to Return|1
1257842|NCT00528567|4121485|P2|Overall Study|Refused Treatment/Did Not Cooperate|42
1257843|NCT00528567|4121486|P1|Overall Study|Refused Treatment/Did Not Cooperate|52
1257844|NCT00528567|4121485|P2|Overall Study|Withdrew Consent|55
1257845|NCT00528567|4121486|P1|Overall Study|Withdrew Consent|59
1257846|NCT00528567|4121485|P2|Overall Study|Violation Criteria at Entry|17
1257847|NCT00528567|4121486|P1|Overall Study|Violation Criteria at Entry|3
1257848|NCT00528567|4121485|P2|Overall Study|Adverse Event/Intermittent Illness|29
1257849|NCT00528567|4121486|P1|Overall Study|Adverse Event/Intermittent Illness|255
1257850|NCT00528567|4121485|P2|Overall Study|Breast Cancer Recurrence/2nd Primary|60
1257851|NCT00528567|4121486|P1|Overall Study|Breast Cancer Recurrence/2nd Primary|30
1257852|NCT00528567|4121485|P2|Overall Study|Death|5
1257853|NCT00528567|4121486|P1|Overall Study|Death|4
1257854|NCT00528528|4121553|P4|Overall Study|Ongoing participant|0
1257855|NCT00528528|4121554|P3|Overall Study|Ongoing participant|1
1257856|NCT00528528|4121555|P2|Overall Study|Ongoing participant|0
1257857|NCT00528528|4121556|P1|Overall Study|Ongoing participant|0
1257858|NCT00528528|4121553|P4|Overall Study|Withdrawal by Subject|1
1257859|NCT00528528|4121554|P3|Overall Study|Withdrawal by Subject|1
1257860|NCT00528528|4121555|P2|Overall Study|Withdrawal by Subject|2
1257861|NCT00528528|4121556|P1|Overall Study|Withdrawal by Subject|3
1257862|NCT00528528|4121553|P4|Overall Study|Other|0
1257863|NCT00528528|4121554|P3|Overall Study|Other|0
1257864|NCT00528528|4121555|P2|Overall Study|Other|1
1257865|NCT00528528|4121556|P1|Overall Study|Other|0
1257866|NCT00528528|4121553|P4|Overall Study|Ineligible to continue the trial|1
1257867|NCT00528528|4121554|P3|Overall Study|Ineligible to continue the trial|0
1257868|NCT00528528|4121555|P2|Overall Study|Ineligible to continue the trial|0
1257869|NCT00528528|4121556|P1|Overall Study|Ineligible to continue the trial|0
1257870|NCT00528528|4121553|P4|Overall Study|Lost to Follow-up|1
1257871|NCT00528528|4121554|P3|Overall Study|Lost to Follow-up|1
1257872|NCT00528528|4121555|P2|Overall Study|Lost to Follow-up|0
1257873|NCT00528528|4121556|P1|Overall Study|Lost to Follow-up|0
1257874|NCT00528424|4121594|P1|Overall Study|Not specified|12
1257875|NCT00528424|4121594|P1|Overall Study|Administrative reason|2
1257876|NCT00528424|4121594|P1|Overall Study|Withdrew consent|2
1257877|NCT00528424|4121594|P1|Overall Study|Lost to Follow-up|13
1257878|NCT00528411|4121609|P3|Overall Study|Prior commitment medication|0
1257879|NCT00528411|4121610|P2|Overall Study|Prior commitment medication|1
1257880|NCT00528411|4121611|P1|Overall Study|Prior commitment medication|0
1257881|NCT00528411|4121609|P3|Overall Study|Severe non-compliance to protocol|0
1257882|NCT00528411|4121610|P2|Overall Study|Severe non-compliance to protocol|1
1257883|NCT00528411|4121611|P1|Overall Study|Severe non-compliance to protocol|0
1257884|NCT00528411|4121609|P3|Overall Study|Incorrect Enrolment|0
1257885|NCT00528411|4121610|P2|Overall Study|Incorrect Enrolment|1
1257886|NCT00528411|4121611|P1|Overall Study|Incorrect Enrolment|1
1257887|NCT00528411|4121609|P3|Overall Study|Adverse Event|1
1257888|NCT00528411|4121610|P2|Overall Study|Adverse Event|0
1257889|NCT00528411|4121611|P1|Overall Study|Adverse Event|4
1257890|NCT00528372|4121748|P9|Long-term (LT) Period (Weeks 24-102)|Not specified|0
1257891|NCT00528372|4121749|P8|Long-term (LT) Period (Weeks 24-102)|Not specified|1
1257892|NCT00528372|4121750|P7|Long-term (LT) Period (Weeks 24-102)|Not specified|3
1257893|NCT00528372|4121751|P6|Long-term (LT) Period (Weeks 24-102)|Not specified|0
1257894|NCT00528372|4121752|P5|Long-term (LT) Period (Weeks 24-102)|Not specified|3
1257895|NCT00528372|4121753|P4|Long-term (LT) Period (Weeks 24-102)|Not specified|2
1257896|NCT00528372|4121754|P3|Long-term (LT) Period (Weeks 24-102)|Not specified|1
1257897|NCT00528372|4121755|P2|Long-term (LT) Period (Weeks 24-102)|Not specified|2
1257898|NCT00528372|4121756|P1|Long-term (LT) Period (Weeks 24-102)|Not specified|2
1257899|NCT00528372|4121748|P9|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
1257900|NCT00528372|4121749|P8|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
1257901|NCT00528372|4121750|P7|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
1257902|NCT00528372|4121751|P6|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
1257903|NCT00528372|4121752|P5|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
1257904|NCT00528372|4121753|P4|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
1257905|NCT00528372|4121754|P3|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
1257906|NCT00528372|4121755|P2|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
1257907|NCT00528372|4121756|P1|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
1258051|NCT00528112|4121888|P2|Treatment up to 3 Years|Adverse Event|278
1257908|NCT00528372|4121748|P9|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
1257909|NCT00528372|4121749|P8|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
1257910|NCT00528372|4121750|P7|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
1257911|NCT00528372|4121751|P6|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1
1257912|NCT00528372|4121752|P5|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2
1257913|NCT00528372|4121753|P4|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
1257914|NCT00528372|4121754|P3|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
1257915|NCT00528372|4121755|P2|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
1257916|NCT00528372|4121756|P1|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
1257917|NCT00528372|4121748|P9|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
1257918|NCT00528372|4121749|P8|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
1257919|NCT00528372|4121750|P7|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
1257920|NCT00528372|4121751|P6|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
1257921|NCT00528372|4121752|P5|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
1257922|NCT00528372|4121753|P4|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
1257923|NCT00528372|4121754|P3|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
1257924|NCT00528372|4121755|P2|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
1257925|NCT00528372|4121756|P1|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
1257926|NCT00528372|4121748|P9|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
1257927|NCT00528372|4121749|P8|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
1257928|NCT00528372|4121750|P7|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
1257929|NCT00528372|4121751|P6|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4
1257930|NCT00528372|4121752|P5|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0
1257931|NCT00528372|4121753|P4|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
1257932|NCT00528372|4121754|P3|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
1257933|NCT00528372|4121755|P2|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
1257934|NCT00528372|4121756|P1|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
1257935|NCT00528372|4121748|P9|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
1257936|NCT00528372|4121749|P8|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2
1257937|NCT00528372|4121750|P7|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
1257938|NCT00528372|4121751|P6|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0
1257939|NCT00528372|4121752|P5|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7
1257940|NCT00528372|4121753|P4|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
1257941|NCT00528372|4121754|P3|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
1257942|NCT00528372|4121755|P2|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
1257943|NCT00528372|4121756|P1|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
1257944|NCT00528372|4121748|P9|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
1257945|NCT00528372|4121749|P8|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
1257946|NCT00528372|4121750|P7|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4
1257947|NCT00528372|4121751|P6|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
1257948|NCT00528372|4121752|P5|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2
1257949|NCT00528372|4121753|P4|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
1257950|NCT00528372|4121754|P3|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
1257951|NCT00528372|4121755|P2|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
1257952|NCT00528372|4121756|P1|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
1257953|NCT00528372|4121748|P9|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
1257954|NCT00528372|4121749|P8|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
1257955|NCT00528372|4121750|P7|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2
1257956|NCT00528372|4121751|P6|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
1257957|NCT00528372|4121752|P5|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
1257958|NCT00528372|4121753|P4|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
1257959|NCT00528372|4121754|P3|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1
1257960|NCT00528372|4121755|P2|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
1257961|NCT00528372|4121756|P1|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
1257962|NCT00528372|4121748|P9|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
1257963|NCT00528372|4121749|P8|Short-term (ST) Period (Day 1-Week 24)|Not specified|1
1257964|NCT00528372|4121750|P7|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
1257965|NCT00528372|4121751|P6|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
1257966|NCT00528372|4121752|P5|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
1257967|NCT00528372|4121753|P4|Short-term (ST) Period (Day 1-Week 24)|Not specified|1
1257968|NCT00528372|4121754|P3|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
1257969|NCT00528372|4121755|P2|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
1257970|NCT00528372|4121756|P1|Short-term (ST) Period (Day 1-Week 24)|Not specified|3
1257971|NCT00528372|4121748|P9|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
1257972|NCT00528372|4121749|P8|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
1257973|NCT00528372|4121750|P7|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
1257974|NCT00528372|4121751|P6|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
1257975|NCT00528372|4121752|P5|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
1258052|NCT00528112|4121889|P1|Treatment up to 3 Years|Adverse Event|313
1257976|NCT00528372|4121753|P4|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
1257977|NCT00528372|4121754|P3|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
1257978|NCT00528372|4121755|P2|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
1257979|NCT00528372|4121756|P1|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
1257980|NCT00528372|4121748|P9|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
1257981|NCT00528372|4121749|P8|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
1257982|NCT00528372|4121750|P7|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
1257983|NCT00528372|4121751|P6|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1
1257984|NCT00528372|4121752|P5|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
1257985|NCT00528372|4121753|P4|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2
1257986|NCT00528372|4121754|P3|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
1257987|NCT00528372|4121755|P2|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
1257988|NCT00528372|4121756|P1|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
1257989|NCT00528372|4121748|P9|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
1257990|NCT00528372|4121749|P8|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
1257991|NCT00528372|4121750|P7|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
1257992|NCT00528372|4121751|P6|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
1257993|NCT00528372|4121752|P5|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
1257994|NCT00528372|4121753|P4|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
1257995|NCT00528372|4121754|P3|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
1257996|NCT00528372|4121755|P2|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
1257997|NCT00528372|4121756|P1|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5
1257998|NCT00528372|4121748|P9|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
1257999|NCT00528372|4121749|P8|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
1258000|NCT00528372|4121750|P7|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
1258001|NCT00528372|4121751|P6|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
1258002|NCT00528372|4121752|P5|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
1258003|NCT00528372|4121753|P4|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
1258004|NCT00528372|4121754|P3|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7
1258005|NCT00528372|4121755|P2|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
1258006|NCT00528372|4121756|P1|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
1258007|NCT00528372|4121748|P9|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
1258008|NCT00528372|4121749|P8|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
1258009|NCT00528372|4121750|P7|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
1258010|NCT00528372|4121751|P6|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
1258011|NCT00528372|4121752|P5|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
1258012|NCT00528372|4121753|P4|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6
1258013|NCT00528372|4121754|P3|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
1258014|NCT00528372|4121755|P2|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
1258015|NCT00528372|4121756|P1|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
1258016|NCT00528372|4121748|P9|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
1258017|NCT00528372|4121749|P8|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
1258018|NCT00528372|4121750|P7|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
1258019|NCT00528372|4121751|P6|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
1258020|NCT00528372|4121752|P5|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
1258021|NCT00528372|4121753|P4|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
1258022|NCT00528372|4121754|P3|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
1258023|NCT00528372|4121755|P2|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
1258024|NCT00528372|4121756|P1|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2
1258025|NCT00528112|4121888|P2|Extension Phase|Protocol Violation|2
1258026|NCT00528112|4121889|P1|Extension Phase|Protocol Violation|0
1258027|NCT00528112|4121888|P2|Extension Phase|Adverse Event|36
1258028|NCT00528112|4121889|P1|Extension Phase|Adverse Event|0
1258029|NCT00528112|4121888|P2|Extension Phase|Death|1
1258030|NCT00528112|4121889|P1|Extension Phase|Death|0
1258031|NCT00528112|4121888|P2|Extension Phase|Lost to Follow-up|12
1258032|NCT00528112|4121889|P1|Extension Phase|Lost to Follow-up|0
1258033|NCT00528112|4121888|P2|Extension Phase|Pregnancy|3
1258034|NCT00528112|4121889|P1|Extension Phase|Pregnancy|0
1258035|NCT00528112|4121888|P2|Extension Phase|Other reasons|100
1258036|NCT00528112|4121889|P1|Extension Phase|Other reasons|0
1258037|NCT00528112|4121888|P2|Extension Phase|Withdrawal by Subject|3
1258038|NCT00528112|4121889|P1|Extension Phase|Withdrawal by Subject|0
1258039|NCT00528112|4121888|P2|Treatment up to 3 Years|Other reasons|186
1258040|NCT00528112|4121889|P1|Treatment up to 3 Years|Other reasons|186
1258041|NCT00528112|4121888|P2|Treatment up to 3 Years|Pregnancy|10
1258042|NCT00528112|4121889|P1|Treatment up to 3 Years|Pregnancy|9
1258043|NCT00528112|4121888|P2|Treatment up to 3 Years|Lost to Follow-up|61
1258044|NCT00528112|4121889|P1|Treatment up to 3 Years|Lost to Follow-up|63
1258045|NCT00528112|4121888|P2|Treatment up to 3 Years|Death|1
1258046|NCT00528112|4121889|P1|Treatment up to 3 Years|Death|0
1258047|NCT00528112|4121888|P2|Treatment up to 3 Years|Protocol Violation|16
1258048|NCT00528112|4121889|P1|Treatment up to 3 Years|Protocol Violation|16
1258049|NCT00528112|4121888|P2|Treatment up to 3 Years|Withdrawal by Subject|31
1258050|NCT00528112|4121889|P1|Treatment up to 3 Years|Withdrawal by Subject|26
1258053|NCT00528021|4121947|P4|Overall Study|Lack of Efficacy|9
1258054|NCT00528021|4121948|P3|Overall Study|Lack of Efficacy|7
1258055|NCT00528021|4121949|P2|Overall Study|Lack of Efficacy|13
1258056|NCT00528021|4121950|P1|Overall Study|Lack of Efficacy|17
1258057|NCT00527982|4121962|P2|Overall Study|Physician Decision|0
1258058|NCT00527982|4121963|P1|Overall Study|Physician Decision|1
1258059|NCT00527904|4122004|P1|Overall Study|misc|22
1258060|NCT00527904|4122004|P1|Overall Study|Lost to Follow-up|8
1258061|NCT00527904|4122004|P1|Overall Study|Withdrawal by Subject|21
1258062|NCT00527904|4122004|P1|Overall Study|Adverse Event|45
1258063|NCT00527826|4122023|P2|Overall Study|Participant moved away|1
1258064|NCT00527826|4122024|P1|Overall Study|Participant moved away|0
1258065|NCT00527826|4122023|P2|Overall Study|Additional Intake of Viani forte|1
1258066|NCT00527826|4122024|P1|Overall Study|Additional Intake of Viani forte|0
1258067|NCT00527826|4122023|P2|Overall Study|Alpha-1 Antitrypsin Deficiency|1
1258068|NCT00527826|4122024|P1|Overall Study|Alpha-1 Antitrypsin Deficiency|0
1258069|NCT00527826|4122023|P2|Overall Study|Inclusion Criteria Not Met|3
1258070|NCT00527826|4122024|P1|Overall Study|Inclusion Criteria Not Met|3
1258071|NCT00527826|4122023|P2|Overall Study|Withdrawal by Subject|8
1258072|NCT00527826|4122024|P1|Overall Study|Withdrawal by Subject|5
1258073|NCT00527826|4122023|P2|Overall Study|Lost to Follow-up|2
1258074|NCT00527826|4122024|P1|Overall Study|Lost to Follow-up|3
1258075|NCT00527826|4122023|P2|Overall Study|Adverse Event|10
1258076|NCT00527826|4122024|P1|Overall Study|Adverse Event|10
1258077|NCT00527787|4122073|P2|Overall Study|misc|2
1258078|NCT00527787|4122074|P1|Overall Study|misc|5
1258079|NCT00527787|4122073|P2|Overall Study|Duodenal Ulcer|10
1258080|NCT00527787|4122074|P1|Overall Study|Duodenal Ulcer|1
1258081|NCT00527787|4122073|P2|Overall Study|Lost to Follow-up|2
1258082|NCT00527787|4122074|P1|Overall Study|Lost to Follow-up|5
1258083|NCT00527787|4122073|P2|Overall Study|Withdrawal by Subject|25
1258084|NCT00527787|4122074|P1|Overall Study|Withdrawal by Subject|13
1258085|NCT00527787|4122073|P2|Overall Study|Adverse Event|24
1258086|NCT00527787|4122074|P1|Overall Study|Adverse Event|14
1258087|NCT00527748|4122096|P1|Overall Study|Other|3
1258088|NCT00527735|4122103|P3|Overall Study|Completed treatment during maintenance|1
1258089|NCT00527735|4122104|P2|Overall Study|Completed treatment during maintenance|2
1258090|NCT00527735|4122105|P1|Overall Study|Completed treatment during maintenance|2
1258091|NCT00527735|4122103|P3|Overall Study|Poor compliance or noncompliance|1
1258092|NCT00527735|4122104|P2|Overall Study|Poor compliance or noncompliance|1
1258093|NCT00527735|4122105|P1|Overall Study|Poor compliance or noncompliance|0
1258094|NCT00527735|4122103|P3|Overall Study|Lost to Follow-up|3
1258095|NCT00527735|4122104|P2|Overall Study|Lost to Follow-up|0
1258096|NCT00527735|4122105|P1|Overall Study|Lost to Follow-up|0
1258097|NCT00527735|4122103|P3|Overall Study|No longer met study criteria|1
1258098|NCT00527735|4122104|P2|Overall Study|No longer met study criteria|2
1258099|NCT00527735|4122105|P1|Overall Study|No longer met study criteria|2
1258100|NCT00527735|4122103|P3|Overall Study|Withdrawal by Subject|3
1258101|NCT00527735|4122104|P2|Overall Study|Withdrawal by Subject|4
1258102|NCT00527735|4122105|P1|Overall Study|Withdrawal by Subject|5
1258103|NCT00527735|4122103|P3|Overall Study|Not identified|5
1258104|NCT00527735|4122104|P2|Overall Study|Not identified|5
1258105|NCT00527735|4122105|P1|Overall Study|Not identified|5
1258106|NCT00527735|4122103|P3|Overall Study|Adverse Event|7
1258107|NCT00527735|4122104|P2|Overall Study|Adverse Event|6
1258108|NCT00527735|4122105|P1|Overall Study|Adverse Event|10
1258109|NCT00527735|4122103|P3|Overall Study|Completed treatment in treatment phase|18
1258110|NCT00527735|4122104|P2|Overall Study|Completed treatment in treatment phase|13
1258111|NCT00527735|4122105|P1|Overall Study|Completed treatment in treatment phase|14
1258112|NCT00527735|4122103|P3|Overall Study|Death|15
1258113|NCT00527735|4122104|P2|Overall Study|Death|13
1258114|NCT00527735|4122105|P1|Overall Study|Death|23
1258115|NCT00527735|4122103|P3|Overall Study|Disease progression|53
1258116|NCT00527735|4122104|P2|Overall Study|Disease progression|61
1258117|NCT00527735|4122105|P1|Overall Study|Disease progression|47
1258118|NCT00527618|4122191|P2|Week 15-18 (Second Intervention)|Withdrawal by Subject|1
1258119|NCT00527618|4122192|P1|Week 15-18 (Second Intervention)|Withdrawal by Subject|0
1258120|NCT00527618|4122191|P2|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1
1258121|NCT00527618|4122192|P1|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0
1258122|NCT00527618|4122191|P2|Week 15-18 (Second Intervention)|Lost to Follow-up|1
1258123|NCT00527618|4122192|P1|Week 15-18 (Second Intervention)|Lost to Follow-up|0
1258124|NCT00527618|4122191|P2|Week 13-14 (Washout)|Lost to Follow-up|0
1258125|NCT00527618|4122192|P1|Week 13-14 (Washout)|Lost to Follow-up|1
1258126|NCT00527618|4122191|P2|Week 1-12 (First Intervention)|Adverse Event|1
1258127|NCT00527618|4122192|P1|Week 1-12 (First Intervention)|Adverse Event|0
1258128|NCT00527618|4122191|P2|Week 1-12 (First Intervention)|Lost to Follow-up|1
1258129|NCT00527618|4122192|P1|Week 1-12 (First Intervention)|Lost to Follow-up|3
1258130|NCT00527605|4122207|P2|Overall Study|Protocol Violation|2
1258131|NCT00527605|4122208|P1|Overall Study|Protocol Violation|1
1258132|NCT00527605|4122207|P2|Overall Study|Lost to Follow-up|2
1258133|NCT00527605|4122208|P1|Overall Study|Lost to Follow-up|6
1258134|NCT00527605|4122207|P2|Overall Study|Withdrawal by Subject|7
1258135|NCT00527605|4122208|P1|Overall Study|Withdrawal by Subject|3
1258136|NCT00527605|4122207|P2|Overall Study|Adverse Event|0
1258137|NCT00527605|4122208|P1|Overall Study|Adverse Event|3
1258138|NCT00527514|4122259|P1|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1
1258139|NCT00527514|4122259|P1|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1
1258140|NCT00527514|4122259|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1
1258141|NCT00527514|4122259|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1
1258142|NCT00527514|4122259|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1
1258143|NCT00527514|4122259|P1|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2
1258144|NCT00527514|4122259|P1|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1
1258145|NCT00527488|4122275|P4|Overall Study|Withdrawn prior to dosing|0
1258146|NCT00527488|4122276|P3|Overall Study|Withdrawn prior to dosing|1
1258147|NCT00527488|4122277|P2|Overall Study|Withdrawn prior to dosing|1
1258148|NCT00527488|4122278|P1|Overall Study|Withdrawn prior to dosing|0
1258149|NCT00527423|4122361|P1|Overall Study|Death|9
1258150|NCT00527423|4122361|P1|Overall Study|OTHER|4
1258151|NCT00527423|4122361|P1|Overall Study|Lost to Follow-up|4
1258152|NCT00527423|4122361|P1|Overall Study|Withdrawal by Subject|10
1258153|NCT00527423|4122361|P1|Overall Study|Physician Decision|4
1258154|NCT00527423|4122361|P1|Overall Study|Adverse Event|5
1258155|NCT00527423|4122361|P1|Overall Study|Protocol Violation|1
1258156|NCT00527397|4122367|P1|Overall Study|Study terminated by sponsor|13
1258157|NCT00527397|4122367|P1|Overall Study|Withdrawal by Subject|6
1258158|NCT00527397|4122367|P1|Overall Study|Protocol Violation|1
1258159|NCT00527397|4122367|P1|Overall Study|Lack of Efficacy|1
1258160|NCT00527397|4122367|P1|Overall Study|Adverse Event|3
1258161|NCT00527332|4122393|P2|Overall Study|Withdrew consent|1
1258162|NCT00527332|4122394|P1|Overall Study|Withdrew consent|5
1258163|NCT00527332|4122393|P2|Overall Study|Protocol Violation|8
1258164|NCT00527332|4122394|P1|Overall Study|Protocol Violation|4
1258165|NCT00527319|4122403|P3|Overall Study|Adverse Event|1
1258166|NCT00527319|4122404|P2|Overall Study|Adverse Event|0
1258167|NCT00527319|4122405|P1|Overall Study|Adverse Event|0
1258168|NCT00527319|4122403|P3|Overall Study|Intercurrent Medical Illness|3
1258169|NCT00527319|4122404|P2|Overall Study|Intercurrent Medical Illness|1
1258170|NCT00527319|4122405|P1|Overall Study|Intercurrent Medical Illness|0
1258171|NCT00527319|4122403|P3|Overall Study|Death|1
1258172|NCT00527319|4122404|P2|Overall Study|Death|3
1258173|NCT00527319|4122405|P1|Overall Study|Death|0
1258174|NCT00527319|4122403|P3|Overall Study|Lost to Follow-up|0
1258175|NCT00527319|4122404|P2|Overall Study|Lost to Follow-up|0
1258176|NCT00527319|4122405|P1|Overall Study|Lost to Follow-up|1
1258177|NCT00527319|4122403|P3|Overall Study|Withdrawal by Subject|1
1258178|NCT00527319|4122404|P2|Overall Study|Withdrawal by Subject|0
1258179|NCT00527319|4122405|P1|Overall Study|Withdrawal by Subject|5
1258180|NCT00527111|4122435|P2|Overall Study|Other|2
1258181|NCT00527111|4122436|P1|Overall Study|Other|2
1258182|NCT00527111|4122435|P2|Overall Study|Patient Request|5
1258183|NCT00527111|4122436|P1|Overall Study|Patient Request|2
1258184|NCT00527111|4122435|P2|Overall Study|Investigator Request|1
1258185|NCT00527111|4122436|P1|Overall Study|Investigator Request|2
1258186|NCT00527111|4122435|P2|Overall Study|Death|1
1258187|NCT00527111|4122436|P1|Overall Study|Death|0
1258188|NCT00527111|4122435|P2|Overall Study|Adverse Event|13
1258189|NCT00527111|4122436|P1|Overall Study|Adverse Event|14
1258190|NCT00527072|4122458|P1|Overall Study|Withdrawal by Subject|7
1258191|NCT00527072|4122458|P1|Overall Study|Protocol Violation|2
1258192|NCT00527072|4122458|P1|Overall Study|Lost to Follow-up|3
1258193|NCT00527072|4122458|P1|Overall Study|Lack of Efficacy|11
1258194|NCT00527072|4122458|P1|Overall Study|Adverse Event|13
1258195|NCT00526994|4122467|P3|Overall Study|incarcerated, impaired, incomplete|3
1258196|NCT00526994|4122468|P2|Overall Study|incarcerated, impaired, incomplete|3
1258197|NCT00526994|4122469|P1|Overall Study|incarcerated, impaired, incomplete|4
1258198|NCT00526994|4122467|P3|Overall Study|Withdrawal by Subject|5
1258199|NCT00526994|4122468|P2|Overall Study|Withdrawal by Subject|7
1258200|NCT00526994|4122469|P1|Overall Study|Withdrawal by Subject|2
1258201|NCT00526994|4122467|P3|Overall Study|Death|3
1258202|NCT00526994|4122468|P2|Overall Study|Death|3
1258203|NCT00526994|4122469|P1|Overall Study|Death|4
1258204|NCT00526994|4122467|P3|Overall Study|Lost to Follow-up|96
1258205|NCT00526994|4122468|P2|Overall Study|Lost to Follow-up|108
1258206|NCT00526994|4122469|P1|Overall Study|Lost to Follow-up|98
1258207|NCT00526890|4122486|P1|Overall Study|Adverse Event|2
1258208|NCT00526799|4122498|P2|Overall Study|Intercurrent Complicating Disease|1
1258209|NCT00526799|4122499|P1|Overall Study|Intercurrent Complicating Disease|0
1258210|NCT00526799|4122498|P2|Overall Study|Withdrawal by Subject|0
1258211|NCT00526799|4122499|P1|Overall Study|Withdrawal by Subject|1
1258212|NCT00526669|4122507|P2|Combined Treatment Phase|Death|2
1258213|NCT00526669|4122508|P1|Combined Treatment Phase|Death|0
1258214|NCT00526669|4122507|P2|Combined Treatment Phase|Sponsor Terminated Study|2
1258215|NCT00526669|4122508|P1|Combined Treatment Phase|Sponsor Terminated Study|0
1258216|NCT00526669|4122507|P2|Combined Treatment Phase|Withdrawal by Subject|2
1258217|NCT00526669|4122508|P1|Combined Treatment Phase|Withdrawal by Subject|0
1258218|NCT00526669|4122507|P2|Combined Treatment Phase|Lost to Follow-up|2
1258219|NCT00526669|4122508|P1|Combined Treatment Phase|Lost to Follow-up|0
1258220|NCT00526630|4122537|P2|Second Intervention Period - 12 Weeks|Withdrawn|1
1258221|NCT00526630|4122538|P1|Second Intervention Period - 12 Weeks|Withdrawn|2
1258222|NCT00526630|4122537|P2|First Intervention Period - 12 Weeks|Withdrawn|3
1258223|NCT00526630|4122538|P1|First Intervention Period - 12 Weeks|Withdrawn|0
1258224|NCT00526331|4122650|P1|Overall Study|Sponsor Termination|55
1258225|NCT00526227|4122658|P1|Overall Study|Death|1
1258226|NCT00526227|4122658|P1|Overall Study|Device not implanted|1
1258227|NCT00526162|4122669|P1|Overall Study|Device not implanted|3
1258228|NCT00526110|4122699|P2|Overall Study|Poor Tolerance|5
1258229|NCT00526110|4122700|P1|Overall Study|Poor Tolerance|0
1258230|NCT00526110|4122699|P2|Overall Study|Withdrawal by Subject|2
1258231|NCT00526110|4122700|P1|Overall Study|Withdrawal by Subject|0
1258232|NCT00526110|4122699|P2|Overall Study|Maximal Response|6
1258233|NCT00526110|4122700|P1|Overall Study|Maximal Response|0
1258234|NCT00526110|4122699|P2|Overall Study|Disease Progression|19
1258235|NCT00526110|4122700|P1|Overall Study|Disease Progression|0
1258236|NCT00526110|4122699|P2|Overall Study|Adverse Event|9
1258237|NCT00526110|4122700|P1|Overall Study|Adverse Event|2
1258238|NCT00526097|4122709|P2|Overall Study|Other|1
1258239|NCT00526097|4122710|P1|Overall Study|Other|2
1258240|NCT00526097|4122709|P2|Overall Study|Withdrawal by Subject|1
1258241|NCT00526097|4122710|P1|Overall Study|Withdrawal by Subject|3
1258242|NCT00526097|4122709|P2|Overall Study|Protocol Violation|10
1258243|NCT00526097|4122710|P1|Overall Study|Protocol Violation|4
1258244|NCT00526097|4122709|P2|Overall Study|Adverse Event|44
1258245|NCT00526097|4122710|P1|Overall Study|Adverse Event|6
1258246|NCT00526071|4122886|P1|Overall Study|Lack of Response to Study Drug|4
1258247|NCT00526071|4122886|P1|Overall Study|Withdrawal by Subject|1
1258248|NCT00526071|4122886|P1|Overall Study|Adverse Event|1
1258249|NCT00525915|4122912|P2|Overall Study|Unrelated illness|0
1258250|NCT00525915|4122913|P1|Overall Study|Unrelated illness|1
1258251|NCT00525915|4122912|P2|Overall Study|Refused Surgery|2
1258252|NCT00525915|4122913|P1|Overall Study|Refused Surgery|1
1258253|NCT00525915|4122912|P2|Overall Study|Withdrawal by Subject|0
1258254|NCT00525915|4122913|P1|Overall Study|Withdrawal by Subject|1
1258255|NCT00525915|4122912|P2|Overall Study|Disease Progression|6
1258256|NCT00525915|4122913|P1|Overall Study|Disease Progression|5
1258257|NCT00525915|4122912|P2|Overall Study|Non-Compliance|1
1258258|NCT00525915|4122913|P1|Overall Study|Non-Compliance|0
1258259|NCT00525902|4122919|P1|Overall Study|Lack of Efficacy|1
1258260|NCT00525824|4122943|P4|Overall Study|Other|1
1258261|NCT00525824|4122944|P3|Overall Study|Other|3
1258262|NCT00525824|4122945|P2|Overall Study|Other|3
1258263|NCT00525824|4122946|P1|Overall Study|Other|1
1258264|NCT00525824|4122943|P4|Overall Study|Safety reasons|0
1258265|NCT00525824|4122944|P3|Overall Study|Safety reasons|1
1258266|NCT00525824|4122945|P2|Overall Study|Safety reasons|0
1258267|NCT00525824|4122946|P1|Overall Study|Safety reasons|1
1258268|NCT00525824|4122943|P4|Overall Study|Severe non-compliance|1
1258269|NCT00525824|4122944|P3|Overall Study|Severe non-compliance|1
1258270|NCT00525824|4122945|P2|Overall Study|Severe non-compliance|1
1258271|NCT00525824|4122946|P1|Overall Study|Severe non-compliance|0
1258272|NCT00525824|4122943|P4|Overall Study|Incorrect enrolment/mis-randomisation|2
1258273|NCT00525824|4122944|P3|Overall Study|Incorrect enrolment/mis-randomisation|1
1258274|NCT00525824|4122945|P2|Overall Study|Incorrect enrolment/mis-randomisation|2
1258275|NCT00525824|4122946|P1|Overall Study|Incorrect enrolment/mis-randomisation|1
1258276|NCT00525824|4122943|P4|Overall Study|Lost to Follow-up|0
1258277|NCT00525824|4122944|P3|Overall Study|Lost to Follow-up|4
1258278|NCT00525824|4122945|P2|Overall Study|Lost to Follow-up|2
1258279|NCT00525824|4122946|P1|Overall Study|Lost to Follow-up|4
1258280|NCT00525824|4122943|P4|Overall Study|Withdrawal by Subject|4
1258281|NCT00525824|4122944|P3|Overall Study|Withdrawal by Subject|3
1258282|NCT00525824|4122945|P2|Overall Study|Withdrawal by Subject|9
1258283|NCT00525824|4122946|P1|Overall Study|Withdrawal by Subject|5
1258284|NCT00525824|4122943|P4|Overall Study|Adverse Event|7
1258285|NCT00525824|4122944|P3|Overall Study|Adverse Event|6
1258286|NCT00525824|4122945|P2|Overall Study|Adverse Event|11
1258287|NCT00525824|4122946|P1|Overall Study|Adverse Event|7
1258288|NCT00525512|4123051|P4|Open-Label Phase|Other reason (not specified)|5
1258289|NCT00525512|4123052|P3|Open-Label Phase|Other reason (not specified)|4
1258290|NCT00525512|4123053|P2|Open-Label Phase|Other reason (not specified)|0
1258291|NCT00525512|4123054|P1|Open-Label Phase|Other reason (not specified)|0
1258292|NCT00525512|4123051|P4|Open-Label Phase|Lost to Follow-up|0
1258293|NCT00525512|4123052|P3|Open-Label Phase|Lost to Follow-up|1
1258294|NCT00525512|4123053|P2|Open-Label Phase|Lost to Follow-up|0
1258295|NCT00525512|4123054|P1|Open-Label Phase|Lost to Follow-up|0
1258296|NCT00525512|4123051|P4|Open-Label Phase|Adverse Event|0
1258297|NCT00525512|4123052|P3|Open-Label Phase|Adverse Event|1
1258298|NCT00525512|4123053|P2|Open-Label Phase|Adverse Event|0
1258299|NCT00525512|4123054|P1|Open-Label Phase|Adverse Event|0
1258300|NCT00525512|4123051|P4|Double-Blind Phase|Other reason (not specified)|0
1258301|NCT00525512|4123052|P3|Double-Blind Phase|Other reason (not specified)|0
1258302|NCT00525512|4123053|P2|Double-Blind Phase|Other reason (not specified)|13
1258303|NCT00525512|4123054|P1|Double-Blind Phase|Other reason (not specified)|12
1258304|NCT00525512|4123051|P4|Double-Blind Phase|Lack of Efficacy|0
1258305|NCT00525512|4123052|P3|Double-Blind Phase|Lack of Efficacy|0
1258306|NCT00525512|4123053|P2|Double-Blind Phase|Lack of Efficacy|5
1258307|NCT00525512|4123054|P1|Double-Blind Phase|Lack of Efficacy|13
1258308|NCT00525512|4123051|P4|Double-Blind Phase|Withdrawal by Subject|0
1258309|NCT00525512|4123052|P3|Double-Blind Phase|Withdrawal by Subject|0
1258310|NCT00525512|4123053|P2|Double-Blind Phase|Withdrawal by Subject|12
1258311|NCT00525512|4123054|P1|Double-Blind Phase|Withdrawal by Subject|17
1258312|NCT00525512|4123051|P4|Double-Blind Phase|Lost to Follow-up|0
1258313|NCT00525512|4123052|P3|Double-Blind Phase|Lost to Follow-up|0
1258314|NCT00525512|4123053|P2|Double-Blind Phase|Lost to Follow-up|7
1258315|NCT00525512|4123054|P1|Double-Blind Phase|Lost to Follow-up|3
1258316|NCT00525512|4123051|P4|Double-Blind Phase|Protocol Violation|0
1258317|NCT00525512|4123052|P3|Double-Blind Phase|Protocol Violation|0
1258318|NCT00525512|4123053|P2|Double-Blind Phase|Protocol Violation|1
1258319|NCT00525512|4123054|P1|Double-Blind Phase|Protocol Violation|3
1258320|NCT00525512|4123051|P4|Double-Blind Phase|Adverse Event|0
1258321|NCT00525512|4123052|P3|Double-Blind Phase|Adverse Event|0
1258322|NCT00525512|4123053|P2|Double-Blind Phase|Adverse Event|28
1258323|NCT00525512|4123054|P1|Double-Blind Phase|Adverse Event|48
1258324|NCT00525499|4123196|P4|Overall Study|Protocol Violation|0
1258325|NCT00525499|4123197|P3|Overall Study|Protocol Violation|1
1258326|NCT00525499|4123198|P2|Overall Study|Protocol Violation|1
1258327|NCT00525499|4123199|P1|Overall Study|Protocol Violation|0
1258328|NCT00525499|4123196|P4|Overall Study|Withdrawal by Subject|2
1258329|NCT00525499|4123197|P3|Overall Study|Withdrawal by Subject|5
1258330|NCT00525499|4123198|P2|Overall Study|Withdrawal by Subject|1
1258331|NCT00525499|4123199|P1|Overall Study|Withdrawal by Subject|5
1258332|NCT00525499|4123196|P4|Overall Study|Adverse Event|1
1258333|NCT00525499|4123197|P3|Overall Study|Adverse Event|0
1258334|NCT00525499|4123198|P2|Overall Study|Adverse Event|1
1258335|NCT00525499|4123199|P1|Overall Study|Adverse Event|0
1258336|NCT00525499|4123196|P4|Overall Study|Lost to Follow-up|4
1258337|NCT00525499|4123197|P3|Overall Study|Lost to Follow-up|1
1258338|NCT00525499|4123198|P2|Overall Study|Lost to Follow-up|4
1258339|NCT00525499|4123199|P1|Overall Study|Lost to Follow-up|2
1258340|NCT00525265|4123226|P2|Overall Study|Protocol Violation|0
1258341|NCT00525265|4123227|P1|Overall Study|Protocol Violation|1
1258342|NCT00525161|4123284|P1|Overall Study|Adverse Event|1
1258343|NCT00525148|4123294|P4|Overall Study|Other than stated|3
1258344|NCT00525148|4123295|P3|Overall Study|Other than stated|0
1258345|NCT00525148|4123296|P2|Overall Study|Other than stated|1
1258346|NCT00525148|4123297|P1|Overall Study|Other than stated|2
1258347|NCT00525148|4123294|P4|Overall Study|Refused continuation of study medication|1
1258348|NCT00525148|4123295|P3|Overall Study|Refused continuation of study medication|0
1258349|NCT00525148|4123296|P2|Overall Study|Refused continuation of study medication|2
1258350|NCT00525148|4123297|P1|Overall Study|Refused continuation of study medication|0
1258351|NCT00525148|4123294|P4|Overall Study|Progressive disease|49
1258352|NCT00525148|4123295|P3|Overall Study|Progressive disease|6
1258353|NCT00525148|4123296|P2|Overall Study|Progressive disease|30
1258354|NCT00525148|4123297|P1|Overall Study|Progressive disease|18
1258355|NCT00525148|4123294|P4|Overall Study|Other Adverse Event|8
1258356|NCT00525148|4123295|P3|Overall Study|Other Adverse Event|1
1258357|NCT00525148|4123296|P2|Overall Study|Other Adverse Event|5
1258358|NCT00525148|4123297|P1|Overall Study|Other Adverse Event|3
1258359|NCT00525031|4123325|P2|Overall Study|Disease Progression|1
1258360|NCT00525031|4123326|P1|Overall Study|Disease Progression|1
1258361|NCT00524771|4123340|P2|Overall Study|Protocol Violation|585
1258362|NCT00524771|4123341|P1|Overall Study|Protocol Violation|220
1258363|NCT00524745|4123355|P4|Overall Study|subject withdrawal or lost to follow up|22
1258364|NCT00524745|4123356|P3|Overall Study|subject withdrawal or lost to follow up|29
1258365|NCT00524745|4123357|P2|Overall Study|subject withdrawal or lost to follow up|13
1258366|NCT00524745|4123358|P1|Overall Study|subject withdrawal or lost to follow up|34
1258367|NCT00524680|4123384|P4|Overall Study|Withdrawal by Subject|1
1258368|NCT00524680|4123385|P3|Overall Study|Withdrawal by Subject|1
1258369|NCT00524680|4123386|P2|Overall Study|Withdrawal by Subject|0
1258370|NCT00524680|4123387|P1|Overall Study|Withdrawal by Subject|1
1258371|NCT00524680|4123384|P4|Overall Study|not specified|3
1258372|NCT00524680|4123385|P3|Overall Study|not specified|2
1258373|NCT00524680|4123386|P2|Overall Study|not specified|1
1258374|NCT00524680|4123387|P1|Overall Study|not specified|0
1258375|NCT00524680|4123384|P4|Overall Study|Adverse Event|1
1258376|NCT00524680|4123385|P3|Overall Study|Adverse Event|0
1258377|NCT00524680|4123386|P2|Overall Study|Adverse Event|0
1258378|NCT00524680|4123387|P1|Overall Study|Adverse Event|2
1258379|NCT00524680|4123384|P4|Overall Study|progression|1
1258380|NCT00524680|4123385|P3|Overall Study|progression|0
1258381|NCT00524680|4123386|P2|Overall Study|progression|0
1258382|NCT00524680|4123387|P1|Overall Study|progression|0
1258383|NCT00524589|4123409|P1|Overall Study|Disease Progression|16
1258384|NCT00524589|4123409|P1|Overall Study|Withdrawal by Subject|2
1258385|NCT00524485|4123460|P1|Overall Study|Withdrawal by Subject|5
1258386|NCT00524459|4123489|P1|Overall Study|Other|1
1258387|NCT00524459|4123489|P1|Overall Study|Withdrawal by Subject|1
1258388|NCT00524420|4123499|P2|Overall Study|Lack of Efficacy|0
1258389|NCT00524420|4123500|P1|Overall Study|Lack of Efficacy|1
1258390|NCT00524368|4123518|P2|Overall Study|Other|2
1258391|NCT00524368|4123519|P1|Overall Study|Other|3
1258392|NCT00524368|4123518|P2|Overall Study|Ineligible to Continue the study|5
1258393|NCT00524368|4123519|P1|Overall Study|Ineligible to Continue the study|2
1258394|NCT00524368|4123518|P2|Overall Study|Sponsor's Decision|0
1258395|NCT00524368|4123519|P1|Overall Study|Sponsor's Decision|2
1258396|NCT00524368|4123518|P2|Overall Study|Reached a Virologic Endpoint|2
1258397|NCT00524368|4123519|P1|Overall Study|Reached a Virologic Endpoint|3
1258398|NCT00524368|4123518|P2|Overall Study|Non-compliant|9
1258399|NCT00524368|4123519|P1|Overall Study|Non-compliant|8
1258400|NCT00524368|4123518|P2|Overall Study|Withdrawal by Subject|5
1258401|NCT00524368|4123519|P1|Overall Study|Withdrawal by Subject|4
1258402|NCT00524368|4123518|P2|Overall Study|Lost to Follow-up|13
1258403|NCT00524368|4123519|P1|Overall Study|Lost to Follow-up|9
1258404|NCT00524368|4123518|P2|Overall Study|Adverse Event|12
1258405|NCT00524368|4123519|P1|Overall Study|Adverse Event|10
1258406|NCT00524316|4123553|P1|Overall Study|Disease Progression|7
1258407|NCT00524316|4123553|P1|Overall Study|Adverse Event|7
1258408|NCT00524316|4123553|P1|Overall Study|Withdrawal by Subject|2
1258409|NCT00524303|4123565|P3|Overall Study|Completed 5 years|1
1258410|NCT00524303|4123566|P2|Overall Study|Completed 5 years|0
1258411|NCT00524303|4123567|P1|Overall Study|Completed 5 years|0
1258412|NCT00524303|4123565|P3|Overall Study|Physician Decision|1
1258413|NCT00524303|4123566|P2|Overall Study|Physician Decision|0
1258414|NCT00524303|4123567|P1|Overall Study|Physician Decision|0
1258415|NCT00524303|4123565|P3|Overall Study|Sponsor Request|1
1258416|NCT00524303|4123566|P2|Overall Study|Sponsor Request|0
1258417|NCT00524303|4123567|P1|Overall Study|Sponsor Request|0
1258418|NCT00524303|4123565|P3|Overall Study|Disease Recurrence|0
1258419|NCT00524303|4123566|P2|Overall Study|Disease Recurrence|1
1258420|NCT00524303|4123567|P1|Overall Study|Disease Recurrence|0
1258421|NCT00524303|4123565|P3|Overall Study|Disease Progression|1
1258422|NCT00524303|4123566|P2|Overall Study|Disease Progression|4
1258423|NCT00524303|4123567|P1|Overall Study|Disease Progression|0
1258424|NCT00524303|4123565|P3|Overall Study|Worsening Peripheral Neuropathy|0
1258425|NCT00524303|4123566|P2|Overall Study|Worsening Peripheral Neuropathy|0
1258426|NCT00524303|4123567|P1|Overall Study|Worsening Peripheral Neuropathy|1
1258427|NCT00524303|4123565|P3|Overall Study|Did not Complete Study Dosing|0
1258428|NCT00524303|4123566|P2|Overall Study|Did not Complete Study Dosing|0
1258429|NCT00524303|4123567|P1|Overall Study|Did not Complete Study Dosing|1
1258430|NCT00524303|4123565|P3|Overall Study|Adverse Event|3
1258431|NCT00524303|4123566|P2|Overall Study|Adverse Event|2
1258432|NCT00524303|4123567|P1|Overall Study|Adverse Event|1
1258433|NCT00524303|4123565|P3|Overall Study|Death|3
1258434|NCT00524303|4123566|P2|Overall Study|Death|2
1258435|NCT00524303|4123567|P1|Overall Study|Death|0
1258436|NCT00524303|4123565|P3|Overall Study|Withdrawal by Subject|4
1258437|NCT00524303|4123566|P2|Overall Study|Withdrawal by Subject|0
1258438|NCT00524303|4123567|P1|Overall Study|Withdrawal by Subject|3
1258439|NCT00524303|4123565|P3|Overall Study|Protocol Violation|1
1258440|NCT00524303|4123566|P2|Overall Study|Protocol Violation|1
1258441|NCT00524303|4123567|P1|Overall Study|Protocol Violation|0
1258442|NCT00524303|4123565|P3|Overall Study|Lost to Follow-up|3
1258443|NCT00524303|4123566|P2|Overall Study|Lost to Follow-up|0
1258444|NCT00524303|4123567|P1|Overall Study|Lost to Follow-up|6
1258445|NCT00524173|4123619|P2|Overall Study|Had not reached endpoint at study close|1
1258446|NCT00524173|4123620|P1|Overall Study|Had not reached endpoint at study close|4
1258447|NCT00524173|4123619|P2|Overall Study|Death|0
1258448|NCT00524173|4123620|P1|Overall Study|Death|1
1258449|NCT00524173|4123619|P2|Overall Study|Lost to Follow-up|1
1258450|NCT00524173|4123620|P1|Overall Study|Lost to Follow-up|0
1258451|NCT00524134|4123632|P1|Overall Study|Physician Decision|1
1258452|NCT00524134|4123632|P1|Overall Study|Withdrawal by Subject|1
1258453|NCT00524121|4123639|P1|Overall Study|Not treated (changed mind)|1
1258454|NCT00524121|4123639|P1|Overall Study|Not treated (became ineligible)|4
1258455|NCT00524121|4123639|P1|Overall Study|Death|1
1258456|NCT00524121|4123639|P1|Overall Study|Other|1
1258457|NCT00524121|4123639|P1|Overall Study|Patient refused|2
1258458|NCT00524121|4123639|P1|Overall Study|Adverse Event|4
1258459|NCT00524121|4123639|P1|Overall Study|Disease progression|6
1258460|NCT00524043|4123659|P3|Overall Study|Various (eg, incarceration)|0
1258461|NCT00524043|4123660|P2|Overall Study|Various (eg, incarceration)|1
1258462|NCT00524043|4123661|P1|Overall Study|Various (eg, incarceration)|2
1258463|NCT00524043|4123659|P3|Overall Study|Lost to Follow-up|3
1258464|NCT00524043|4123660|P2|Overall Study|Lost to Follow-up|5
1258465|NCT00524043|4123661|P1|Overall Study|Lost to Follow-up|3
1258466|NCT00524043|4123659|P3|Overall Study|Adverse Event|7
1258467|NCT00524043|4123660|P2|Overall Study|Adverse Event|2
1258468|NCT00524043|4123661|P1|Overall Study|Adverse Event|5
1258469|NCT00524043|4123659|P3|Overall Study|Withdrawal by Subject|7
1258470|NCT00524043|4123660|P2|Overall Study|Withdrawal by Subject|7
1258471|NCT00524043|4123661|P1|Overall Study|Withdrawal by Subject|5
1258472|NCT00524043|4123659|P3|Overall Study|Lack of Efficacy|14
1258473|NCT00524043|4123660|P2|Overall Study|Lack of Efficacy|13
1258474|NCT00524043|4123661|P1|Overall Study|Lack of Efficacy|15
1258475|NCT00524030|4123683|P2|Overall Study|Death|1
1258476|NCT00524030|4123684|P1|Overall Study|Death|0
1258477|NCT00524030|4123683|P2|Overall Study|Adverse Event|21
1258478|NCT00524030|4123684|P1|Overall Study|Adverse Event|3
1258479|NCT00524030|4123683|P2|Overall Study|Pregnancy|0
1258480|NCT00524030|4123684|P1|Overall Study|Pregnancy|1
1258481|NCT00524030|4123683|P2|Overall Study|Protocol Violation|1
1258482|NCT00524030|4123684|P1|Overall Study|Protocol Violation|0
1258483|NCT00524030|4123683|P2|Overall Study|Noncompliance/Investigator discretion|2
1258484|NCT00524030|4123684|P1|Overall Study|Noncompliance/Investigator discretion|0
1258485|NCT00524030|4123683|P2|Overall Study|Withdrawal by Subject|8
1258486|NCT00524030|4123684|P1|Overall Study|Withdrawal by Subject|3
1258487|NCT00524030|4123683|P2|Overall Study|Lost to Follow-up|2
1258488|NCT00524030|4123684|P1|Overall Study|Lost to Follow-up|0
1258489|NCT00524030|4123683|P2|Overall Study|Lack of Efficacy|24
1258490|NCT00524030|4123684|P1|Overall Study|Lack of Efficacy|10
1258491|NCT00523991|4123702|P2|Overall Study|Other reason (not specified)|0
1258492|NCT00523991|4123703|P1|Overall Study|Other reason (not specified)|3
1258493|NCT00523991|4123702|P2|Overall Study|Withdrawal by Subject|17
1258494|NCT00523991|4123703|P1|Overall Study|Withdrawal by Subject|7
1258495|NCT00523991|4123702|P2|Overall Study|Lost to Follow-up|1
1258496|NCT00523991|4123703|P1|Overall Study|Lost to Follow-up|4
1258497|NCT00523991|4123702|P2|Overall Study|Protocol Violation|4
1258498|NCT00523991|4123703|P1|Overall Study|Protocol Violation|1
1258499|NCT00523991|4123702|P2|Overall Study|Adverse Event|5
1258500|NCT00523991|4123703|P1|Overall Study|Adverse Event|6
1258501|NCT00523978|4123983|P2|Overall Study|Death|0
1258502|NCT00523978|4123984|P1|Overall Study|Death|1
1258503|NCT00523978|4123983|P2|Overall Study|Screen Failures|1
1258504|NCT00523978|4123984|P1|Overall Study|Screen Failures|5
1258505|NCT00523978|4123983|P2|Overall Study|Withdrawal by Subject|7
1258506|NCT00523978|4123984|P1|Overall Study|Withdrawal by Subject|3
1258507|NCT00523848|4124006|P1|Overall Study|Other, unspecified|4
1258508|NCT00523848|4124006|P1|Overall Study|Disease Progression|5
1258509|NCT00523848|4124006|P1|Overall Study|NOT TREATED (Became ineligible)|2
1258510|NCT00523848|4124006|P1|Overall Study|Withdrawal by Subject|2
1258511|NCT00523848|4124006|P1|Overall Study|Adverse Event|11
1258512|NCT00523744|4124016|P1|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1
1258513|NCT00523744|4124016|P1|Phase 2 - Amlodipine+Valsartan|Adverse Event|2
1258514|NCT00523744|4124016|P1|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1
1258515|NCT00523744|4124016|P1|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2
1258516|NCT00523744|4124016|P1|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1
1258517|NCT00523744|4124016|P1|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2
1258518|NCT00523718|4124035|P2|Overall Study|Protocol Violation|0
1258519|NCT00523718|4124036|P1|Overall Study|Protocol Violation|2
1258520|NCT00523718|4124035|P2|Overall Study|Withdrawal by Subject|0
1258521|NCT00523718|4124036|P1|Overall Study|Withdrawal by Subject|1
1258522|NCT00523705|4124050|P2|Overall Study|No time for study.|1
1258523|NCT00523705|4124051|P1|Overall Study|No time for study.|0
1258524|NCT00523640|4124063|P1|Overall Study|Death|1
1258525|NCT00523549|4124080|P2|Overall Study|Lost to Follow-up|5
1258526|NCT00523549|4124081|P1|Overall Study|Lost to Follow-up|3
1258527|NCT00523549|4124080|P2|Overall Study|Patient withdrew consent|6
1258528|NCT00523549|4124081|P1|Overall Study|Patient withdrew consent|7
1258529|NCT00523549|4124080|P2|Overall Study|Protocol Deviation|1
1258530|NCT00523549|4124081|P1|Overall Study|Protocol Deviation|3
1258531|NCT00523549|4124080|P2|Overall Study|Unsatisfactory therapeutic effect|1
1258532|NCT00523549|4124081|P1|Overall Study|Unsatisfactory therapeutic effect|0
1258533|NCT00523549|4124080|P2|Overall Study|Adverse Event|3
1258534|NCT00523549|4124081|P1|Overall Study|Adverse Event|6
1258535|NCT00523419|4124099|P1|Overall Study|Death due to Adverse Event|2
1258536|NCT00523419|4124099|P1|Overall Study|Death due to Study Disease|4
1258537|NCT00523419|4124099|P1|Overall Study|Progressive Disease|22
1258538|NCT00523419|4124099|P1|Overall Study|Physician Decision|2
1258539|NCT00523419|4124099|P1|Overall Study|Withdrawal by Subject|1
1258540|NCT00523419|4124099|P1|Overall Study|Adverse Event|1
1258541|NCT00523367|4124109|P1|Overall Study|4 Withdrawn by PI|4
1258542|NCT00523367|4124109|P1|Overall Study|19 screen failures|19
1258543|NCT00523341|4124115|P2|Overall Study|Disease Progression|0
1258544|NCT00523341|4124116|P1|Overall Study|Disease Progression|1
1258545|NCT00523341|4124115|P2|Overall Study|Ineligibility Determined|4
1258546|NCT00523341|4124116|P1|Overall Study|Ineligibility Determined|3
1258547|NCT00523341|4124115|P2|Overall Study|Protocol Deviation|5
1258548|NCT00523341|4124116|P1|Overall Study|Protocol Deviation|6
1258549|NCT00523341|4124115|P2|Overall Study|Requirement for Alternative Therapy|14
1258550|NCT00523341|4124116|P1|Overall Study|Requirement for Alternative Therapy|4
1258551|NCT00523341|4124115|P2|Overall Study|Physician Decision|13
1258552|NCT00523341|4124116|P1|Overall Study|Physician Decision|14
1258553|NCT00523341|4124115|P2|Overall Study|Non-compliance|13
1258554|NCT00523341|4124116|P1|Overall Study|Non-compliance|20
1258555|NCT00523341|4124115|P2|Overall Study|Lost to Follow-up|61
1258556|NCT00523341|4124116|P1|Overall Study|Lost to Follow-up|73
1258557|NCT00523341|4124115|P2|Overall Study|Death|110
1258558|NCT00523341|4124116|P1|Overall Study|Death|101
1258559|NCT00523341|4124115|P2|Overall Study|Adverse Event|155
1258560|NCT00523341|4124116|P1|Overall Study|Adverse Event|122
1258561|NCT00523341|4124115|P2|Overall Study|Other|198
1258562|NCT00523341|4124116|P1|Overall Study|Other|181
1258563|NCT00523341|4124115|P2|Overall Study|Withdrawal by Subject|427
1258564|NCT00523341|4124116|P1|Overall Study|Withdrawal by Subject|399
1258565|NCT00522951|4124233|P2|Period 2|residual contrast medium|1
1258566|NCT00522951|4124234|P1|Period 2|residual contrast medium|1
1258567|NCT00522951|4124233|P2|Period 2|Withdrawal by Subject|0
1258568|NCT00522951|4124234|P1|Period 2|Withdrawal by Subject|1
1258569|NCT00522951|4124233|P2|Washout Period|Death|1
1258570|NCT00522951|4124234|P1|Washout Period|Death|0
1258571|NCT00522951|4124233|P2|Washout Period|Adverse Event|1
1258572|NCT00522951|4124234|P1|Washout Period|Adverse Event|0
1258573|NCT00522951|4124233|P2|Period 1|body motion|1
1258574|NCT00522951|4124234|P1|Period 1|body motion|0
1258575|NCT00522873|4124289|P2|Overall Study|Never Received Medication|0
1258576|NCT00522873|4124290|P1|Overall Study|Never Received Medication|1
1258577|NCT00522873|4124289|P2|Overall Study|Medication Errors|1
1258578|NCT00522873|4124290|P1|Overall Study|Medication Errors|1
1258579|NCT00522873|4124289|P2|Overall Study|Personal Reasons|1
1258580|NCT00522873|4124290|P1|Overall Study|Personal Reasons|8
1258581|NCT00522873|4124289|P2|Overall Study|Lost to Follow-up|3
1258582|NCT00522873|4124290|P1|Overall Study|Lost to Follow-up|11
1258583|NCT00522873|4124289|P2|Overall Study|Protocol Violation|4
1258584|NCT00522873|4124290|P1|Overall Study|Protocol Violation|14
1258585|NCT00522873|4124289|P2|Overall Study|Withdrawal by Subject|9
1258586|NCT00522873|4124290|P1|Overall Study|Withdrawal by Subject|20
1258587|NCT00522873|4124289|P2|Overall Study|Adverse Event|26
1258588|NCT00522873|4124290|P1|Overall Study|Adverse Event|41
1258589|NCT00522626|4124303|P1|Overall Study|Lost to Follow-up|7
1258590|NCT00522548|4124309|P2|Overall Study|Withdrawal by Subject|2
1258591|NCT00522548|4124310|P1|Overall Study|Withdrawal by Subject|0
1258592|NCT00522548|4124309|P2|Overall Study|Adverse Event|2
1258593|NCT00522548|4124310|P1|Overall Study|Adverse Event|2
1258594|NCT00522457|4124338|P1|Overall Study|Adverse Event|2
1258595|NCT00522457|4124338|P1|Overall Study|Due to disease progression|16
1258596|NCT00522431|4124344|P1|Overall Study|Other/unknown|1
1258597|NCT00522431|4124344|P1|Overall Study|Subject non-compliance|1
1258598|NCT00522431|4124344|P1|Overall Study|Withdrawal by Subject|2
1258599|NCT00522431|4124344|P1|Overall Study|Protocol Violation|2
1258600|NCT00522431|4124344|P1|Overall Study|Adverse Event|5
1258601|NCT00522418|4124351|P2|Overall Study|Lack of Efficacy|1
1258602|NCT00522418|4124352|P1|Overall Study|Lack of Efficacy|0
1258603|NCT00522418|4124351|P2|Overall Study|Consent Withdraw|2
1258604|NCT00522418|4124352|P1|Overall Study|Consent Withdraw|1
1258605|NCT00522418|4124351|P2|Overall Study|Reason Not Specified|1
1258606|NCT00522418|4124352|P1|Overall Study|Reason Not Specified|3
1258607|NCT00522418|4124351|P2|Overall Study|Noncompliance|2
1258608|NCT00522418|4124352|P1|Overall Study|Noncompliance|2
1258609|NCT00522418|4124351|P2|Overall Study|Early Study Termination|47
1258610|NCT00522418|4124352|P1|Overall Study|Early Study Termination|46
1258611|NCT00522418|4124351|P2|Overall Study|Local IRB Consent Violation|5
1258612|NCT00522418|4124352|P1|Overall Study|Local IRB Consent Violation|5
1258613|NCT00522392|4124400|P2|Overall Study|Non-compliance|1
1258614|NCT00522392|4124401|P1|Overall Study|Non-compliance|0
1258615|NCT00522392|4124400|P2|Overall Study|Physician Decision|1
1258616|NCT00522392|4124401|P1|Overall Study|Physician Decision|0
1258617|NCT00522392|4124400|P2|Overall Study|Withdrawal by Subject|1
1258618|NCT00522392|4124401|P1|Overall Study|Withdrawal by Subject|1
1258619|NCT00522392|4124400|P2|Overall Study|Adverse Event|7
1258620|NCT00522392|4124401|P1|Overall Study|Adverse Event|7
1258621|NCT00522392|4124400|P2|Overall Study|Disease progression|3
1258622|NCT00522392|4124401|P1|Overall Study|Disease progression|0
1258623|NCT00522379|4124418|P5|Overall Study|Subject Withdrawal|0
1258624|NCT00522379|4124419|P4|Overall Study|Subject Withdrawal|1
1258625|NCT00522379|4124420|P3|Overall Study|Subject Withdrawal|0
1258626|NCT00522379|4124421|P2|Overall Study|Subject Withdrawal|0
1258627|NCT00522379|4124422|P1|Overall Study|Subject Withdrawal|0
1258628|NCT00522379|4124418|P5|Overall Study|Site Closed|0
1258629|NCT00522379|4124419|P4|Overall Study|Site Closed|1
1258630|NCT00522379|4124420|P3|Overall Study|Site Closed|0
1258631|NCT00522379|4124421|P2|Overall Study|Site Closed|0
1258632|NCT00522379|4124422|P1|Overall Study|Site Closed|0
1258633|NCT00522379|4124418|P5|Overall Study|Family Problem|0
1258634|NCT00522379|4124419|P4|Overall Study|Family Problem|0
1258635|NCT00522379|4124420|P3|Overall Study|Family Problem|1
1258636|NCT00522379|4124421|P2|Overall Study|Family Problem|0
1258637|NCT00522379|4124422|P1|Overall Study|Family Problem|0
1258638|NCT00522379|4124418|P5|Overall Study|Sponsor Request|0
1258639|NCT00522379|4124419|P4|Overall Study|Sponsor Request|0
1258640|NCT00522379|4124420|P3|Overall Study|Sponsor Request|0
1258641|NCT00522379|4124421|P2|Overall Study|Sponsor Request|1
1258642|NCT00522379|4124422|P1|Overall Study|Sponsor Request|0
1258643|NCT00522379|4124418|P5|Overall Study|Subject Moved|0
1258644|NCT00522379|4124419|P4|Overall Study|Subject Moved|0
1258645|NCT00522379|4124420|P3|Overall Study|Subject Moved|0
1258646|NCT00522379|4124421|P2|Overall Study|Subject Moved|1
1258647|NCT00522379|4124422|P1|Overall Study|Subject Moved|1
1258648|NCT00522379|4124418|P5|Overall Study|Dispensing error|0
1258649|NCT00522379|4124419|P4|Overall Study|Dispensing error|1
1258650|NCT00522379|4124420|P3|Overall Study|Dispensing error|0
1258651|NCT00522379|4124421|P2|Overall Study|Dispensing error|0
1258652|NCT00522379|4124422|P1|Overall Study|Dispensing error|1
1258653|NCT00522379|4124418|P5|Overall Study|Randomization error|1
1258654|NCT00522379|4124419|P4|Overall Study|Randomization error|0
1258655|NCT00522379|4124420|P3|Overall Study|Randomization error|0
1258656|NCT00522379|4124421|P2|Overall Study|Randomization error|0
1258657|NCT00522379|4124422|P1|Overall Study|Randomization error|0
1258658|NCT00522379|4124418|P5|Overall Study|Lost to Follow-up|2
1258659|NCT00522379|4124419|P4|Overall Study|Lost to Follow-up|2
1258660|NCT00522379|4124420|P3|Overall Study|Lost to Follow-up|4
1258661|NCT00522379|4124421|P2|Overall Study|Lost to Follow-up|0
1258662|NCT00522379|4124422|P1|Overall Study|Lost to Follow-up|1
1258663|NCT00522379|4124418|P5|Overall Study|Unsatisfactory Subject Compliance|0
1258664|NCT00522379|4124419|P4|Overall Study|Unsatisfactory Subject Compliance|0
1258665|NCT00522379|4124420|P3|Overall Study|Unsatisfactory Subject Compliance|0
1258666|NCT00522379|4124421|P2|Overall Study|Unsatisfactory Subject Compliance|2
1258667|NCT00522379|4124422|P1|Overall Study|Unsatisfactory Subject Compliance|1
1258668|NCT00522379|4124418|P5|Overall Study|Protocol Violation|0
1258669|NCT00522379|4124419|P4|Overall Study|Protocol Violation|0
1258670|NCT00522379|4124420|P3|Overall Study|Protocol Violation|2
1258671|NCT00522379|4124421|P2|Overall Study|Protocol Violation|1
1258672|NCT00522379|4124422|P1|Overall Study|Protocol Violation|1
1258673|NCT00522379|4124418|P5|Overall Study|Withdrawal by Subject|0
1258674|NCT00522379|4124419|P4|Overall Study|Withdrawal by Subject|2
1258675|NCT00522379|4124420|P3|Overall Study|Withdrawal by Subject|1
1258676|NCT00522379|4124421|P2|Overall Study|Withdrawal by Subject|3
1258677|NCT00522379|4124422|P1|Overall Study|Withdrawal by Subject|2
1258678|NCT00522379|4124418|P5|Overall Study|Lack of Efficacy|7
1258679|NCT00522379|4124419|P4|Overall Study|Lack of Efficacy|2
1258680|NCT00522379|4124420|P3|Overall Study|Lack of Efficacy|2
1258681|NCT00522379|4124421|P2|Overall Study|Lack of Efficacy|0
1258682|NCT00522379|4124422|P1|Overall Study|Lack of Efficacy|3
1258683|NCT00522379|4124418|P5|Overall Study|Adverse Event|17
1258684|NCT00522379|4124419|P4|Overall Study|Adverse Event|5
1258685|NCT00522379|4124420|P3|Overall Study|Adverse Event|12
1258686|NCT00522379|4124421|P2|Overall Study|Adverse Event|15
1258687|NCT00522379|4124422|P1|Overall Study|Adverse Event|12
1258688|NCT00522301|4124524|P1|Overall Study|Adverse Event|5
1258689|NCT00522301|4124524|P1|Overall Study|Withdrawal by Subject|1
1258690|NCT00522275|4124528|P1|Overall Study|Other: Subject had surgery for epilepsy|2
1258691|NCT00522275|4124528|P1|Overall Study|Other: Subject ran out of medication|1
1258692|NCT00522275|4124528|P1|Overall Study|Other: Sponsor request|2
1258693|NCT00522275|4124528|P1|Overall Study|Other: Travel to / from site difficulty|3
1258694|NCT00522275|4124528|P1|Overall Study|Other: Site / clinic closed|4
1258695|NCT00522275|4124528|P1|Overall Study|Other: Subject arrested|1
1258696|NCT00522275|4124528|P1|Overall Study|Other: Subject relocated|2
1258697|NCT00522275|4124528|P1|Overall Study|Other: Subject is pregnant|2
1258698|NCT00522275|4124528|P1|Overall Study|Other: Subject wants to become pregnant|2
1258699|NCT00522275|4124528|P1|Overall Study|Lost to Follow-up|8
1258700|NCT00522275|4124528|P1|Overall Study|Unsatisfactory compliance|11
1258701|NCT00522275|4124528|P1|Overall Study|Protocol deviation|1
1258702|NCT00522275|4124528|P1|Overall Study|Subject withdrew consent|16
1258703|NCT00522275|4124528|P1|Overall Study|Lack of Efficacy|80
1258704|NCT00522275|4124528|P1|Overall Study|Adverse Event|35
1258705|NCT00522041|4124549|P2|Overall Study|Did not receive treatment|1
1258706|NCT00522041|4124550|P1|Overall Study|Did not receive treatment|0
1258707|NCT00522041|4124549|P2|Overall Study|Voluntary withdrawal|4
1258708|NCT00522041|4124550|P1|Overall Study|Voluntary withdrawal|5
1258709|NCT00522041|4124549|P2|Overall Study|Lost to Follow-up|4
1258710|NCT00522041|4124550|P1|Overall Study|Lost to Follow-up|1
1258711|NCT00522041|4124549|P2|Overall Study|Protocol Violation|0
1258712|NCT00522041|4124550|P1|Overall Study|Protocol Violation|2
1258713|NCT00522041|4124549|P2|Overall Study|Adverse Event|3
1258714|NCT00522041|4124550|P1|Overall Study|Adverse Event|9
1258715|NCT00521599|4124609|P3|Overall Study|Did not meet protocol eligibility|1
1258716|NCT00521599|4124610|P2|Overall Study|Did not meet protocol eligibility|2
1258717|NCT00521599|4124611|P1|Overall Study|Did not meet protocol eligibility|2
1258718|NCT00521599|4124609|P3|Overall Study|Protocol Violation|2
1258719|NCT00521599|4124610|P2|Overall Study|Protocol Violation|4
1258720|NCT00521599|4124611|P1|Overall Study|Protocol Violation|2
1258721|NCT00521599|4124609|P3|Overall Study|Withdrawal by subject treatment related|2
1258722|NCT00521599|4124610|P2|Overall Study|Withdrawal by subject treatment related|1
1258723|NCT00521599|4124611|P1|Overall Study|Withdrawal by subject treatment related|3
1258724|NCT00521599|4124609|P3|Overall Study|Withdrawal by Subject|1
1258725|NCT00521599|4124610|P2|Overall Study|Withdrawal by Subject|5
1258726|NCT00521599|4124611|P1|Overall Study|Withdrawal by Subject|3
1258727|NCT00521599|4124609|P3|Overall Study|Lost to Follow-up|2
1258728|NCT00521599|4124610|P2|Overall Study|Lost to Follow-up|1
1258729|NCT00521599|4124611|P1|Overall Study|Lost to Follow-up|2
1258730|NCT00521599|4124609|P3|Overall Study|Treatment Failure|22
1258731|NCT00521599|4124610|P2|Overall Study|Treatment Failure|9
1258732|NCT00521599|4124611|P1|Overall Study|Treatment Failure|8
1258733|NCT00521599|4124609|P3|Overall Study|Adverse Event|6
1258734|NCT00521599|4124610|P2|Overall Study|Adverse Event|7
1258735|NCT00521599|4124611|P1|Overall Study|Adverse Event|5
1258736|NCT00521586|4124622|P2|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7
1258737|NCT00521586|4124623|P1|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2
1258738|NCT00521586|4124622|P2|Revaccination With 13vPnC (Year 5)|Failed to return|4
1258739|NCT00521586|4124623|P1|Revaccination With 13vPnC (Year 5)|Failed to return|1
1258740|NCT00521586|4124622|P2|Revaccination With 13vPnC (Year 5)|Subject request|1
1258741|NCT00521586|4124623|P1|Revaccination With 13vPnC (Year 5)|Subject request|0
1258742|NCT00521586|4124622|P2|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57
1258743|NCT00521586|4124623|P1|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54
1258744|NCT00521586|4124622|P2|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22
1258745|NCT00521586|4124623|P1|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18
1258746|NCT00521586|4124622|P2|Follow-up (From 6-month[Year 0]-Year 5)|Other|26
1258747|NCT00521586|4124623|P1|Follow-up (From 6-month[Year 0]-Year 5)|Other|22
1258748|NCT00521586|4124622|P2|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56
1258749|NCT00521586|4124623|P1|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55
1258750|NCT00521586|4124622|P2|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
1258751|NCT00521586|4124623|P1|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
1258752|NCT00521586|4124622|P2|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3
1258753|NCT00521586|4124623|P1|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7
1258754|NCT00521586|4124622|P2|Follow-up (From 6-month[Year 0]-Year 5)|Death|2
1258755|NCT00521586|4124623|P1|Follow-up (From 6-month[Year 0]-Year 5)|Death|5
1258756|NCT00521586|4124622|P2|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1
1258757|NCT00521586|4124623|P1|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5
1258758|NCT00521586|4124622|P2|Initial Vaccination (Year 0)|Failed to return|1
1258759|NCT00521586|4124623|P1|Initial Vaccination (Year 0)|Failed to return|0
1258760|NCT00521586|4124622|P2|Initial Vaccination (Year 0)|Death|0
1258761|NCT00521586|4124623|P1|Initial Vaccination (Year 0)|Death|1
1258762|NCT00521586|4124622|P2|Initial Vaccination (Year 0)|Adverse Event|1
1258763|NCT00521586|4124623|P1|Initial Vaccination (Year 0)|Adverse Event|0
1258764|NCT00521586|4124622|P2|Initial Vaccination (Year 0)|Investigator request|0
1258765|NCT00521586|4124623|P1|Initial Vaccination (Year 0)|Investigator request|2
1258766|NCT00521586|4124622|P2|Initial Vaccination (Year 0)|Other, unspecified|1
1258767|NCT00521586|4124623|P1|Initial Vaccination (Year 0)|Other, unspecified|3
1258768|NCT00521586|4124622|P2|Initial Vaccination (Year 0)|Protocol Violation|5
1258769|NCT00521586|4124623|P1|Initial Vaccination (Year 0)|Protocol Violation|2
1258770|NCT00521586|4124622|P2|Initial Vaccination (Year 0)|Lost to Follow-up|10
1258771|NCT00521586|4124623|P1|Initial Vaccination (Year 0)|Lost to Follow-up|5
1258772|NCT00521586|4124622|P2|Initial Vaccination (Year 0)|Subject request|11
1258773|NCT00521586|4124623|P1|Initial Vaccination (Year 0)|Subject request|8
1258774|NCT00521365|4124696|P1|Overall Study|Usage of not allowed drugs|6
1258775|NCT00521365|4124696|P1|Overall Study|Drug compliance|3
1258776|NCT00521365|4124696|P1|Overall Study|Protocol deviation|2
1258777|NCT00521365|4124696|P1|Overall Study|Lost to Follow-up|6
1258778|NCT00521365|4124696|P1|Overall Study|Adverse Event|3
1258779|NCT00521339|4124726|P3|Treatment Extension Phase|Death|1
1258780|NCT00521339|4124727|P2|Treatment Extension Phase|Death|0
1258781|NCT00521339|4124728|P1|Treatment Extension Phase|Death|0
1258782|NCT00521339|4124726|P3|Treatment Extension Phase|Withdrawal by Subject|2
1258783|NCT00521339|4124727|P2|Treatment Extension Phase|Withdrawal by Subject|0
1258784|NCT00521339|4124728|P1|Treatment Extension Phase|Withdrawal by Subject|0
1258785|NCT00521339|4124726|P3|Treatment Phase|Protocol Violation|0
1258786|NCT00521339|4124727|P2|Treatment Phase|Protocol Violation|0
1258787|NCT00521339|4124728|P1|Treatment Phase|Protocol Violation|1
1258788|NCT00521339|4124726|P3|Treatment Phase|Lost to Follow-up|0
1258789|NCT00521339|4124727|P2|Treatment Phase|Lost to Follow-up|0
1258790|NCT00521339|4124728|P1|Treatment Phase|Lost to Follow-up|1
1258791|NCT00521339|4124726|P3|Treatment Phase|Withdrawal by Subject|0
1258792|NCT00521339|4124727|P2|Treatment Phase|Withdrawal by Subject|0
1258793|NCT00521339|4124728|P1|Treatment Phase|Withdrawal by Subject|3
1258794|NCT00521339|4124726|P3|Treatment Phase|Lack of Efficacy|0
1258795|NCT00521339|4124727|P2|Treatment Phase|Lack of Efficacy|0
1258796|NCT00521339|4124728|P1|Treatment Phase|Lack of Efficacy|3
1258797|NCT00521339|4124726|P3|Treatment Phase|Intolerability to study drug|0
1258798|NCT00521339|4124727|P2|Treatment Phase|Intolerability to study drug|0
1258799|NCT00521339|4124728|P1|Treatment Phase|Intolerability to study drug|2
1258800|NCT00521339|4124726|P3|Treatment Phase|Adverse Event|0
1258801|NCT00521339|4124727|P2|Treatment Phase|Adverse Event|0
1258802|NCT00521339|4124728|P1|Treatment Phase|Adverse Event|2
1258803|NCT00521144|4124796|P5|Overall Study|Progressive Disease|6
1258804|NCT00521144|4124797|P4|Overall Study|Progressive Disease|0
1258805|NCT00521144|4124798|P3|Overall Study|Progressive Disease|2
1258806|NCT00521144|4124799|P2|Overall Study|Progressive Disease|2
1258807|NCT00521144|4124800|P1|Overall Study|Progressive Disease|4
1258808|NCT00521144|4124796|P5|Overall Study|Adverse Event|1
1258809|NCT00521144|4124797|P4|Overall Study|Adverse Event|0
1258810|NCT00521144|4124798|P3|Overall Study|Adverse Event|0
1258811|NCT00521144|4124799|P2|Overall Study|Adverse Event|1
1258812|NCT00521144|4124800|P1|Overall Study|Adverse Event|0
1258813|NCT00521144|4124796|P5|Overall Study|Not Treated|0
1258814|NCT00521144|4124797|P4|Overall Study|Not Treated|1
1258815|NCT00521144|4124798|P3|Overall Study|Not Treated|0
1258816|NCT00521144|4124799|P2|Overall Study|Not Treated|0
1258817|NCT00521144|4124800|P1|Overall Study|Not Treated|0
1258818|NCT00521079|4124814|P2|Overall Study|Withdrawal by Subject|3
1258819|NCT00521079|4124815|P1|Overall Study|Withdrawal by Subject|5
1258820|NCT00521079|4124814|P2|Overall Study|Lost to Follow-up|1
1258821|NCT00521079|4124815|P1|Overall Study|Lost to Follow-up|2
1258822|NCT00521079|4124814|P2|Overall Study|Adverse Event|1
1258823|NCT00521079|4124815|P1|Overall Study|Adverse Event|7
1258824|NCT00521053|4124825|P1|Observation Phase|Physician Decision|1
1258825|NCT00521053|4124825|P1|Observation Phase|Other non-study melanoma treatment|1
1258826|NCT00521053|4124825|P1|Observation Phase|Adverse Event|1
1258827|NCT00521053|4124825|P1|Observation Phase|Death|2
1258828|NCT00521053|4124825|P1|Observation Phase|Additional PV-10 via alternate protocol|8
1258829|NCT00521053|4124825|P1|Observation Phase|Disease Progression|55
1258830|NCT00521014|4124835|P1|Overall Study|Inevaluable, not treated|1
1258831|NCT00521001|4124839|P1|Overall Study|Ineligible|1
1258832|NCT00520975|4124848|P2|Overall Study|Not start protocol therapy|2
1258833|NCT00520975|4124849|P1|Overall Study|Not start protocol therapy|1
1258834|NCT00520975|4124848|P2|Overall Study|Other reasons|2
1258835|NCT00520975|4124849|P1|Overall Study|Other reasons|4
1258836|NCT00520975|4124848|P2|Overall Study|Other therapy|4
1258837|NCT00520975|4124849|P1|Overall Study|Other therapy|2
1258838|NCT00520975|4124848|P2|Overall Study|Withdrawal by Subject|5
1258839|NCT00520975|4124849|P1|Overall Study|Withdrawal by Subject|3
1258840|NCT00520975|4124848|P2|Overall Study|Death|2
1258841|NCT00520975|4124849|P1|Overall Study|Death|0
1258842|NCT00520975|4124848|P2|Overall Study|Adverse Event|10
1258843|NCT00520975|4124849|P1|Overall Study|Adverse Event|7
1258844|NCT00520975|4124848|P2|Overall Study|Disease progression|23
1258845|NCT00520975|4124849|P1|Overall Study|Disease progression|31
1258846|NCT00520936|4124881|P8|Overall Study|Protocol Violation|0
1258847|NCT00520936|4124882|P7|Overall Study|Protocol Violation|1
1258848|NCT00520936|4124883|P6|Overall Study|Protocol Violation|0
1258849|NCT00520936|4124884|P5|Overall Study|Protocol Violation|1
1258850|NCT00520936|4124885|P4|Overall Study|Protocol Violation|0
1258851|NCT00520936|4124886|P3|Overall Study|Protocol Violation|1
1258852|NCT00520936|4124887|P2|Overall Study|Protocol Violation|1
1258853|NCT00520936|4124888|P1|Overall Study|Protocol Violation|0
1258854|NCT00520936|4124881|P8|Overall Study|Death|0
1258855|NCT00520936|4124882|P7|Overall Study|Death|1
1258856|NCT00520936|4124883|P6|Overall Study|Death|0
1258857|NCT00520936|4124884|P5|Overall Study|Death|0
1258858|NCT00520936|4124885|P4|Overall Study|Death|0
1258859|NCT00520936|4124886|P3|Overall Study|Death|0
1258860|NCT00520936|4124887|P2|Overall Study|Death|0
1258861|NCT00520936|4124888|P1|Overall Study|Death|0
1258862|NCT00520936|4124881|P8|Overall Study|Toxicity Requiring Removal from Study|0
1258863|NCT00520936|4124882|P7|Overall Study|Toxicity Requiring Removal from Study|2
1258864|NCT00520936|4124883|P6|Overall Study|Toxicity Requiring Removal from Study|0
1258865|NCT00520936|4124884|P5|Overall Study|Toxicity Requiring Removal from Study|0
1258866|NCT00520936|4124885|P4|Overall Study|Toxicity Requiring Removal from Study|0
1258867|NCT00520936|4124886|P3|Overall Study|Toxicity Requiring Removal from Study|0
1258868|NCT00520936|4124887|P2|Overall Study|Toxicity Requiring Removal from Study|1
1258869|NCT00520936|4124888|P1|Overall Study|Toxicity Requiring Removal from Study|0
1258870|NCT00520936|4124881|P8|Overall Study|Withdrawal by Subject|1
1258871|NCT00520936|4124882|P7|Overall Study|Withdrawal by Subject|0
1258872|NCT00520936|4124883|P6|Overall Study|Withdrawal by Subject|0
1258873|NCT00520936|4124884|P5|Overall Study|Withdrawal by Subject|0
1258874|NCT00520936|4124885|P4|Overall Study|Withdrawal by Subject|0
1258875|NCT00520936|4124886|P3|Overall Study|Withdrawal by Subject|0
1258876|NCT00520936|4124887|P2|Overall Study|Withdrawal by Subject|0
1258877|NCT00520936|4124888|P1|Overall Study|Withdrawal by Subject|0
1258878|NCT00520936|4124881|P8|Overall Study|Physician Decision|0
1258879|NCT00520936|4124882|P7|Overall Study|Physician Decision|0
1258880|NCT00520936|4124883|P6|Overall Study|Physician Decision|0
1258881|NCT00520936|4124884|P5|Overall Study|Physician Decision|0
1258882|NCT00520936|4124885|P4|Overall Study|Physician Decision|0
1258883|NCT00520936|4124886|P3|Overall Study|Physician Decision|1
1258884|NCT00520936|4124887|P2|Overall Study|Physician Decision|2
1258885|NCT00520936|4124888|P1|Overall Study|Physician Decision|0
1258886|NCT00520845|4124915|P1|Overall Study|Alternative Therapy|1
1258887|NCT00520845|4124915|P1|Overall Study|Withdrawal by Subject|1
1258888|NCT00520845|4124915|P1|Overall Study|Disease Progression, relapse|13
1258889|NCT00520845|4124915|P1|Overall Study|Adverse Event|4
1258890|NCT00520845|4124915|P1|Overall Study|Death|3
1258891|NCT00520767|4124923|P1|Overall Study|Death|2
1258892|NCT00520741|4124929|P2|Overall Study|Other reasons for premature termination|6
1258893|NCT00520741|4124930|P1|Overall Study|Other reasons for premature termination|0
1258894|NCT00520741|4124929|P2|Overall Study|Lost to Follow-up|4
1258895|NCT00520741|4124930|P1|Overall Study|Lost to Follow-up|4
1258896|NCT00520741|4124929|P2|Overall Study|Unsatisfactory compliance of subject|3
1258897|NCT00520741|4124930|P1|Overall Study|Unsatisfactory compliance of subject|4
1258898|NCT00520741|4124929|P2|Overall Study|Protocol Violation|15
1258899|NCT00520741|4124930|P1|Overall Study|Protocol Violation|2
1258900|NCT00520741|4124929|P2|Overall Study|Withdrawal by Subject|11
1258901|NCT00520741|4124930|P1|Overall Study|Withdrawal by Subject|0
1258902|NCT00520741|4124929|P2|Overall Study|Lack of Efficacy|30
1258903|NCT00520741|4124930|P1|Overall Study|Lack of Efficacy|11
1258904|NCT00520741|4124929|P2|Overall Study|Adverse Event|56
1258905|NCT00520741|4124930|P1|Overall Study|Adverse Event|16
1258906|NCT00520676|4124948|P2|Overall Study|Withdrawal by Subject|11
1258907|NCT00520676|4124949|P1|Overall Study|Withdrawal by Subject|7
1258908|NCT00520676|4124948|P2|Overall Study|Physician Decision|1
1258909|NCT00520676|4124949|P1|Overall Study|Physician Decision|4
1258910|NCT00520676|4124948|P2|Overall Study|Lost to Follow-up|10
1258911|NCT00520676|4124949|P1|Overall Study|Lost to Follow-up|6
1258912|NCT00520676|4124948|P2|Overall Study|Death|81
1258913|NCT00520676|4124949|P1|Overall Study|Death|84
1258914|NCT00520572|4124975|P6|Overall Study|Did not receive Treatment|0
1258915|NCT00520572|4124976|P5|Overall Study|Did not receive Treatment|0
1258916|NCT00520572|4124977|P4|Overall Study|Did not receive Treatment|0
1258917|NCT00520572|4124978|P3|Overall Study|Did not receive Treatment|1
1258918|NCT00520572|4124979|P2|Overall Study|Did not receive Treatment|0
1258919|NCT00520572|4124980|P1|Overall Study|Did not receive Treatment|1
1258920|NCT00520572|4124975|P6|Overall Study|Long break in taking Medication|0
1258921|NCT00520572|4124976|P5|Overall Study|Long break in taking Medication|0
1258922|NCT00520572|4124977|P4|Overall Study|Long break in taking Medication|1
1258923|NCT00520572|4124978|P3|Overall Study|Long break in taking Medication|0
1258924|NCT00520572|4124979|P2|Overall Study|Long break in taking Medication|0
1258925|NCT00520572|4124980|P1|Overall Study|Long break in taking Medication|0
1258926|NCT00520572|4124975|P6|Overall Study|Oral corticotherapy for acute urticaria|0
1258927|NCT00520572|4124976|P5|Overall Study|Oral corticotherapy for acute urticaria|0
1258928|NCT00520572|4124977|P4|Overall Study|Oral corticotherapy for acute urticaria|0
1258929|NCT00520572|4124978|P3|Overall Study|Oral corticotherapy for acute urticaria|0
1258930|NCT00520572|4124979|P2|Overall Study|Oral corticotherapy for acute urticaria|1
1258931|NCT00520572|4124980|P1|Overall Study|Oral corticotherapy for acute urticaria|0
1258932|NCT00520572|4124975|P6|Overall Study|Incorrect enrollment|0
1258933|NCT00520572|4124976|P5|Overall Study|Incorrect enrollment|1
1258934|NCT00520572|4124977|P4|Overall Study|Incorrect enrollment|0
1258935|NCT00520572|4124978|P3|Overall Study|Incorrect enrollment|1
1258936|NCT00520572|4124979|P2|Overall Study|Incorrect enrollment|0
1258937|NCT00520572|4124980|P1|Overall Study|Incorrect enrollment|1
1258938|NCT00520572|4124975|P6|Overall Study|Lost to Follow-up|0
1258939|NCT00520572|4124976|P5|Overall Study|Lost to Follow-up|1
1258940|NCT00520572|4124977|P4|Overall Study|Lost to Follow-up|0
1258941|NCT00520572|4124978|P3|Overall Study|Lost to Follow-up|0
1258942|NCT00520572|4124979|P2|Overall Study|Lost to Follow-up|0
1258943|NCT00520572|4124980|P1|Overall Study|Lost to Follow-up|0
1258944|NCT00520572|4124975|P6|Overall Study|Lack of Efficacy|0
1258945|NCT00520572|4124976|P5|Overall Study|Lack of Efficacy|1
1258946|NCT00520572|4124977|P4|Overall Study|Lack of Efficacy|2
1258947|NCT00520572|4124978|P3|Overall Study|Lack of Efficacy|1
1258948|NCT00520572|4124979|P2|Overall Study|Lack of Efficacy|1
1258949|NCT00520572|4124980|P1|Overall Study|Lack of Efficacy|1
1258950|NCT00520572|4124975|P6|Overall Study|Protocol Violation|0
1258951|NCT00520572|4124976|P5|Overall Study|Protocol Violation|0
1258952|NCT00520572|4124977|P4|Overall Study|Protocol Violation|0
1258953|NCT00520572|4124978|P3|Overall Study|Protocol Violation|1
1258954|NCT00520572|4124979|P2|Overall Study|Protocol Violation|0
1258955|NCT00520572|4124980|P1|Overall Study|Protocol Violation|0
1258956|NCT00520572|4124975|P6|Overall Study|Withdrawal by Subject|0
1258957|NCT00520572|4124976|P5|Overall Study|Withdrawal by Subject|2
1258958|NCT00520572|4124977|P4|Overall Study|Withdrawal by Subject|2
1258959|NCT00520572|4124978|P3|Overall Study|Withdrawal by Subject|5
1258960|NCT00520572|4124979|P2|Overall Study|Withdrawal by Subject|9
1258961|NCT00520572|4124980|P1|Overall Study|Withdrawal by Subject|0
1258962|NCT00520572|4124975|P6|Overall Study|Adverse Event|2
1258963|NCT00520572|4124976|P5|Overall Study|Adverse Event|7
1258964|NCT00520572|4124977|P4|Overall Study|Adverse Event|9
1258965|NCT00520572|4124978|P3|Overall Study|Adverse Event|6
1258966|NCT00520572|4124979|P2|Overall Study|Adverse Event|3
1258967|NCT00520572|4124980|P1|Overall Study|Adverse Event|9
1258968|NCT00520546|4125018|P1|Overall Study|failed radiopharmaceut. synthesis of FEC|5
1258969|NCT00520546|4125018|P1|Overall Study|Withdrawal by Subject|1
1258970|NCT00520494|4125033|P1|Overall Study|Withdrawal by Subject|1
1258971|NCT00520481|4125058|P2|Overall Study|Withdrawal by Subject|0
1258972|NCT00520481|4125059|P1|Overall Study|Withdrawal by Subject|3
1258973|NCT00520481|4125058|P2|Overall Study|Adverse Event|1
1258974|NCT00520481|4125059|P1|Overall Study|Adverse Event|4
1258975|NCT00520403|4125083|P1|Bevacizumab Monotherapy|Symptomatic progression of cancer|1
1258976|NCT00520403|4125083|P1|Bevacizumab Monotherapy|Radiological progression of cancer|1
1258977|NCT00520403|4125083|P1|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1
1258978|NCT00520403|4125083|P1|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1
1258979|NCT00520403|4125083|P1|Bevacizumab + IFN/Vinblastine|Death|2
1258980|NCT00520403|4125083|P1|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4
1258981|NCT00520403|4125083|P1|Bevacizumab + IFN/Vinblastine|Adverse Event|4
1258982|NCT00520403|4125083|P1|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6
1258983|NCT00520351|4125092|P2|First Intervention|Withdrawal by Subject|1
1258984|NCT00520351|4125093|P1|First Intervention|Withdrawal by Subject|1
1258985|NCT00520299|4125108|P3|Overall Study|Progressive disease|4
1258986|NCT00520299|4125109|P2|Overall Study|Progressive disease|3
1258987|NCT00520299|4125110|P1|Overall Study|Progressive disease|0
1258988|NCT00520299|4125108|P3|Overall Study|Withdrawal by Subject|2
1258989|NCT00520299|4125109|P2|Overall Study|Withdrawal by Subject|0
1258990|NCT00520299|4125110|P1|Overall Study|Withdrawal by Subject|0
1258991|NCT00520130|4125165|P2|Overall Study|Physician Decision|1
1258992|NCT00520130|4125166|P1|Overall Study|Physician Decision|1
1258993|NCT00520130|4125165|P2|Overall Study|Disease progression on study|0
1258994|NCT00520130|4125166|P1|Overall Study|Disease progression on study|4
1258995|NCT00520039|4125208|P2|Overall Study|Exclusion criteria met at first visit|5
1258996|NCT00520039|4125209|P1|Overall Study|Exclusion criteria met at first visit|7
1258997|NCT00520013|4125222|P3|Overall Study|Physician Decision|3
1258998|NCT00520013|4125223|P2|Overall Study|Physician Decision|0
1258999|NCT00520013|4125224|P1|Overall Study|Physician Decision|0
1259000|NCT00520013|4125222|P3|Overall Study|Death|0
1259001|NCT00520013|4125223|P2|Overall Study|Death|1
1259002|NCT00520013|4125224|P1|Overall Study|Death|0
1259003|NCT00520013|4125222|P3|Overall Study|Clinical Progression|0
1259004|NCT00520013|4125223|P2|Overall Study|Clinical Progression|1
1259005|NCT00520013|4125224|P1|Overall Study|Clinical Progression|3
1259006|NCT00520013|4125222|P3|Overall Study|Progressive Disease|0
1259007|NCT00520013|4125223|P2|Overall Study|Progressive Disease|3
1259008|NCT00520013|4125224|P1|Overall Study|Progressive Disease|7
1259009|NCT00520013|4125222|P3|Overall Study|Adverse Event|7
1259010|NCT00520013|4125223|P2|Overall Study|Adverse Event|10
1259011|NCT00520013|4125224|P1|Overall Study|Adverse Event|2
1259012|NCT00520013|4125222|P3|Overall Study|Withdrawal by Subject|1
1259013|NCT00520013|4125223|P2|Overall Study|Withdrawal by Subject|0
1259014|NCT00520013|4125224|P1|Overall Study|Withdrawal by Subject|0
1259015|NCT00519896|4125234|P1|Overall Study|Adverse Event|1
1259016|NCT00519896|4125234|P1|Overall Study|Protocol Violation|1
1259017|NCT00519831|4125240|P1|Overall Study|Adverse Event|3
1259018|NCT00519779|4125257|P2|Overall Study|Withdrawal by Subject|1
1259019|NCT00519779|4125258|P1|Overall Study|Withdrawal by Subject|0
1259020|NCT00519649|4125274|P1|Overall Study|Withdrawal by Subject|1
1259021|NCT00519636|4125287|P4|Post Study Period|Subject randomized in error|1
1259022|NCT00519636|4125288|P3|Post Study Period|Subject randomized in error|0
1259023|NCT00519636|4125289|P2|Post Study Period|Subject randomized in error|0
1259024|NCT00519636|4125290|P1|Post Study Period|Subject randomized in error|0
1259025|NCT00519636|4125287|P4|Treatment Period 2|Subject misrandomized|1
1259026|NCT00519636|4125288|P3|Treatment Period 2|Subject misrandomized|0
1259027|NCT00519636|4125289|P2|Treatment Period 2|Subject misrandomized|0
1259028|NCT00519636|4125290|P1|Treatment Period 2|Subject misrandomized|0
1259029|NCT00519636|4125287|P4|Treatment Period 2|Per doctors request|0
1259030|NCT00519636|4125288|P3|Treatment Period 2|Per doctors request|1
1259031|NCT00519636|4125289|P2|Treatment Period 2|Per doctors request|0
1259032|NCT00519636|4125290|P1|Treatment Period 2|Per doctors request|0
1259033|NCT00519636|4125287|P4|Treatment Period 2|Subject randomized in error|0
1259034|NCT00519636|4125288|P3|Treatment Period 2|Subject randomized in error|0
1259035|NCT00519636|4125289|P2|Treatment Period 2|Subject randomized in error|1
1259036|NCT00519636|4125290|P1|Treatment Period 2|Subject randomized in error|0
1259037|NCT00519636|4125287|P4|Treatment Period 2|Failed To Meet Continuation Criteria|1
1259038|NCT00519636|4125288|P3|Treatment Period 2|Failed To Meet Continuation Criteria|0
1259039|NCT00519636|4125289|P2|Treatment Period 2|Failed To Meet Continuation Criteria|0
1259040|NCT00519636|4125290|P1|Treatment Period 2|Failed To Meet Continuation Criteria|0
1259041|NCT00519636|4125287|P4|Washout Period|Prohibited medications|0
1259042|NCT00519636|4125288|P3|Washout Period|Prohibited medications|1
1259043|NCT00519636|4125289|P2|Washout Period|Prohibited medications|0
1259044|NCT00519636|4125290|P1|Washout Period|Prohibited medications|0
1259045|NCT00519636|4125287|P4|Washout Period|Subject randomized in error|0
1259046|NCT00519636|4125288|P3|Washout Period|Subject randomized in error|1
1259047|NCT00519636|4125289|P2|Washout Period|Subject randomized in error|0
1259048|NCT00519636|4125290|P1|Washout Period|Subject randomized in error|0
1259049|NCT00519636|4125287|P4|Washout Period|Per doctors request|0
1259050|NCT00519636|4125288|P3|Washout Period|Per doctors request|0
1259051|NCT00519636|4125289|P2|Washout Period|Per doctors request|1
1259052|NCT00519636|4125290|P1|Washout Period|Per doctors request|0
1259053|NCT00519636|4125287|P4|Washout Period|Non-compliant|0
1259054|NCT00519636|4125288|P3|Washout Period|Non-compliant|0
1259055|NCT00519636|4125289|P2|Washout Period|Non-compliant|1
1259056|NCT00519636|4125290|P1|Washout Period|Non-compliant|0
1259057|NCT00519636|4125287|P4|Washout Period|Participating in study at another site|0
1259058|NCT00519636|4125288|P3|Washout Period|Participating in study at another site|0
1259059|NCT00519636|4125289|P2|Washout Period|Participating in study at another site|0
1259060|NCT00519636|4125290|P1|Washout Period|Participating in study at another site|1
1259061|NCT00519636|4125287|P4|Washout Period|Out of pollen area > 48 hours|0
1259062|NCT00519636|4125288|P3|Washout Period|Out of pollen area > 48 hours|0
1259063|NCT00519636|4125289|P2|Washout Period|Out of pollen area > 48 hours|0
1259064|NCT00519636|4125290|P1|Washout Period|Out of pollen area > 48 hours|1
1259065|NCT00519636|4125287|P4|Washout Period|Failed to meet continuation criteria|3
1259066|NCT00519636|4125288|P3|Washout Period|Failed to meet continuation criteria|9
1259067|NCT00519636|4125289|P2|Washout Period|Failed to meet continuation criteria|11
1259068|NCT00519636|4125290|P1|Washout Period|Failed to meet continuation criteria|14
1259069|NCT00519636|4125287|P4|Washout Period|Withdrawal by Subject|0
1259070|NCT00519636|4125288|P3|Washout Period|Withdrawal by Subject|1
1259071|NCT00519636|4125289|P2|Washout Period|Withdrawal by Subject|0
1259072|NCT00519636|4125290|P1|Washout Period|Withdrawal by Subject|1
1259073|NCT00519636|4125287|P4|Washout Period|Protocol Violation|2
1259074|NCT00519636|4125288|P3|Washout Period|Protocol Violation|1
1259075|NCT00519636|4125289|P2|Washout Period|Protocol Violation|0
1259076|NCT00519636|4125290|P1|Washout Period|Protocol Violation|0
1259077|NCT00519636|4125287|P4|Washout Period|Lost to Follow-up|0
1259078|NCT00519636|4125288|P3|Washout Period|Lost to Follow-up|0
1259079|NCT00519636|4125289|P2|Washout Period|Lost to Follow-up|0
1259080|NCT00519636|4125290|P1|Washout Period|Lost to Follow-up|1
1259081|NCT00519636|4125287|P4|Washout Period|Adverse Event|0
1259082|NCT00519636|4125288|P3|Washout Period|Adverse Event|1
1259083|NCT00519636|4125289|P2|Washout Period|Adverse Event|1
1259084|NCT00519636|4125290|P1|Washout Period|Adverse Event|2
1259085|NCT00519636|4125287|P4|Treatment Period 1|Sponsor request due to missed visit|0
1259086|NCT00519636|4125288|P3|Treatment Period 1|Sponsor request due to missed visit|0
1259087|NCT00519636|4125289|P2|Treatment Period 1|Sponsor request due to missed visit|0
1259088|NCT00519636|4125290|P1|Treatment Period 1|Sponsor request due to missed visit|1
1259089|NCT00519636|4125287|P4|Treatment Period 1|Adverse Event|0
1259090|NCT00519636|4125288|P3|Treatment Period 1|Adverse Event|1
1259091|NCT00519636|4125289|P2|Treatment Period 1|Adverse Event|0
1259092|NCT00519636|4125290|P1|Treatment Period 1|Adverse Event|1
1259093|NCT00519623|4125320|P1|Overall Study|Adverse Event|1
1259094|NCT00519532|4125354|P1|Overall Study|Lost to Follow-up|2
1259095|NCT00519532|4125354|P1|Overall Study|Withdrawal by Subject|5
1259096|NCT00519532|4125354|P1|Overall Study|Adverse Event|11
1259097|NCT00519428|4125364|P3|Overall Study|unstated|2
1259098|NCT00519428|4125365|P2|Overall Study|unstated|3
1259099|NCT00519428|4125366|P1|Overall Study|unstated|1
1259100|NCT00519428|4125364|P3|Overall Study|Withdrawal by Subject|7
1259101|NCT00519428|4125365|P2|Overall Study|Withdrawal by Subject|3
1259102|NCT00519428|4125366|P1|Overall Study|Withdrawal by Subject|8
1259103|NCT00519428|4125364|P3|Overall Study|Lost to Follow-up|6
1259104|NCT00519428|4125365|P2|Overall Study|Lost to Follow-up|7
1259105|NCT00519428|4125366|P1|Overall Study|Lost to Follow-up|7
1259106|NCT00519428|4125364|P3|Overall Study|Adverse Event|10
1259107|NCT00519428|4125365|P2|Overall Study|Adverse Event|2
1259108|NCT00519428|4125366|P1|Overall Study|Adverse Event|5
1259109|NCT00519376|4125386|P16|Treatment Period 4|Lost to Follow-up|0
1259110|NCT00519376|4125387|P15|Treatment Period 4|Lost to Follow-up|0
1259111|NCT00519376|4125388|P14|Treatment Period 4|Lost to Follow-up|0
1259112|NCT00519376|4125389|P13|Treatment Period 4|Lost to Follow-up|0
1259113|NCT00519376|4125390|P12|Treatment Period 4|Lost to Follow-up|0
1259114|NCT00519376|4125391|P11|Treatment Period 4|Lost to Follow-up|0
1259115|NCT00519376|4125392|P10|Treatment Period 4|Lost to Follow-up|0
1259116|NCT00519376|4125393|P9|Treatment Period 4|Lost to Follow-up|0
1259117|NCT00519376|4125394|P8|Treatment Period 4|Lost to Follow-up|0
1259118|NCT00519376|4125395|P7|Treatment Period 4|Lost to Follow-up|0
1259119|NCT00519376|4125396|P6|Treatment Period 4|Lost to Follow-up|0
1259120|NCT00519376|4125397|P5|Treatment Period 4|Lost to Follow-up|0
1259121|NCT00519376|4125398|P4|Treatment Period 4|Lost to Follow-up|0
1259122|NCT00519376|4125399|P3|Treatment Period 4|Lost to Follow-up|1
1259123|NCT00519376|4125400|P2|Treatment Period 4|Lost to Follow-up|0
1259124|NCT00519376|4125401|P1|Treatment Period 4|Lost to Follow-up|0
1259125|NCT00519376|4125386|P16|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1259126|NCT00519376|4125387|P15|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1259127|NCT00519376|4125388|P14|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1259128|NCT00519376|4125389|P13|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1
1259129|NCT00519376|4125390|P12|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1259130|NCT00519376|4125391|P11|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1259131|NCT00519376|4125392|P10|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1259132|NCT00519376|4125393|P9|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1259133|NCT00519376|4125394|P8|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1259134|NCT00519376|4125395|P7|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1259135|NCT00519376|4125396|P6|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1259136|NCT00519376|4125397|P5|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1259137|NCT00519376|4125398|P4|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1259138|NCT00519376|4125399|P3|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1259139|NCT00519376|4125400|P2|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1259140|NCT00519376|4125401|P1|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1259141|NCT00519285|4125525|P2|Overall Study|Treatment ongoing|2
1259142|NCT00519285|4125526|P1|Overall Study|Treatment ongoing|1
1259143|NCT00519285|4125525|P2|Overall Study|Not treated|7
1259144|NCT00519285|4125526|P1|Overall Study|Not treated|8
1259145|NCT00519285|4125525|P2|Overall Study|Reason unspecified|8
1259146|NCT00519285|4125526|P1|Overall Study|Reason unspecified|5
1259147|NCT00519285|4125525|P2|Overall Study|Poor compliance to protocol|7
1259148|NCT00519285|4125526|P1|Overall Study|Poor compliance to protocol|5
1259149|NCT00519285|4125525|P2|Overall Study|Consent withdrawn|5
1259150|NCT00519285|4125526|P1|Overall Study|Consent withdrawn|4
1259151|NCT00519285|4125525|P2|Overall Study|Participant's request|84
1259152|NCT00519285|4125526|P1|Overall Study|Participant's request|53
1259153|NCT00519285|4125525|P2|Overall Study|Physician Decision|47
1259154|NCT00519285|4125526|P1|Overall Study|Physician Decision|75
1259155|NCT00519285|4125525|P2|Overall Study|Disease progression|186
1259156|NCT00519285|4125526|P1|Overall Study|Disease progression|334
1259157|NCT00519285|4125525|P2|Overall Study|Adverse Event|266
1259158|NCT00519285|4125526|P1|Overall Study|Adverse Event|127
1259159|NCT00519194|4125552|P1|Overall Study|Lost to Follow-up|3
1259160|NCT00519194|4125552|P1|Overall Study|Death|9
1259161|NCT00519194|4125552|P1|Overall Study|Withdrawal by Subject|9
1259162|NCT00519077|4125567|P1|Overall Study|Other|2
1259163|NCT00519077|4125567|P1|Overall Study|Death|6
1259164|NCT00518986|4125574|P2|Overall Study|Non-Specific|1
1259165|NCT00518986|4125575|P1|Overall Study|Non-Specific|2
1259166|NCT00518986|4125574|P2|Overall Study|Withdrawal by Subject|4
1259167|NCT00518986|4125575|P1|Overall Study|Withdrawal by Subject|4
1259168|NCT00518986|4125574|P2|Overall Study|Protocol Violation|7
1259169|NCT00518986|4125575|P1|Overall Study|Protocol Violation|5
1259170|NCT00518986|4125574|P2|Overall Study|Physician Decision|3
1259171|NCT00518986|4125575|P1|Overall Study|Physician Decision|0
1259172|NCT00518986|4125574|P2|Overall Study|Lost to Follow-up|2
1259173|NCT00518986|4125575|P1|Overall Study|Lost to Follow-up|3
1259174|NCT00518986|4125574|P2|Overall Study|Lack of Efficacy|2
1259175|NCT00518986|4125575|P1|Overall Study|Lack of Efficacy|0
1259176|NCT00518986|4125574|P2|Overall Study|Adverse Event|7
1259177|NCT00518986|4125575|P1|Overall Study|Adverse Event|12
1259178|NCT00518882|4125701|P2|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25
1259179|NCT00518882|4125702|P1|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18
1259180|NCT00518882|4125701|P2|Open-Label Extension, Week 26-78|Subject decision|0
1259181|NCT00518882|4125702|P1|Open-Label Extension, Week 26-78|Subject decision|2
1259182|NCT00518882|4125701|P2|Open-Label Extension, Week 26-78|Exclusion criteria|0
1259183|NCT00518882|4125702|P1|Open-Label Extension, Week 26-78|Exclusion criteria|2
1259184|NCT00518882|4125701|P2|Open-Label Extension, Week 26-78|Decreased kidney function|0
1259185|NCT00518882|4125702|P1|Open-Label Extension, Week 26-78|Decreased kidney function|1
1259186|NCT00518882|4125701|P2|Open-Label Extension, Week 26-78|Creatine increased|0
1259187|NCT00518882|4125702|P1|Open-Label Extension, Week 26-78|Creatine increased|1
1259188|NCT00518882|4125701|P2|Open-Label Extension, Week 26-78|Change in treatment|1
1259189|NCT00518882|4125702|P1|Open-Label Extension, Week 26-78|Change in treatment|1
1259190|NCT00518882|4125701|P2|Open-Label Extension, Week 26-78|Consent withdrawn|1
1259191|NCT00518882|4125702|P1|Open-Label Extension, Week 26-78|Consent withdrawn|2
1259192|NCT00518882|4125701|P2|Open-Label Extension, Week 26-78|Lost to follow up|1
1259193|NCT00518882|4125702|P1|Open-Label Extension, Week 26-78|Lost to follow up|1
1259194|NCT00518882|4125701|P2|Open-Label Extension, Week 26-78|Hypoglycaemia|1
1259195|NCT00518882|4125702|P1|Open-Label Extension, Week 26-78|Hypoglycaemia|0
1259196|NCT00518882|4125701|P2|Open-Label Extension, Week 26-78|Withdrawel criteria|2
1259197|NCT00518882|4125702|P1|Open-Label Extension, Week 26-78|Withdrawel criteria|1
1259198|NCT00518882|4125701|P2|Open-Label Extension, Week 26-78|Protocol Violation|4
1259199|NCT00518882|4125702|P1|Open-Label Extension, Week 26-78|Protocol Violation|3
1259200|NCT00518882|4125701|P2|Open-Label Extension, Week 26-78|Lack of Efficacy|5
1259201|NCT00518882|4125702|P1|Open-Label Extension, Week 26-78|Lack of Efficacy|6
1259202|NCT00518882|4125701|P2|Open-Label Extension, Week 26-78|Adverse Event|9
1259203|NCT00518882|4125702|P1|Open-Label Extension, Week 26-78|Adverse Event|3
1259204|NCT00518882|4125701|P2|Double-Blind, Week 0-26|Mutual consent|1
1259205|NCT00518882|4125702|P1|Double-Blind, Week 0-26|Mutual consent|0
1259206|NCT00518882|4125701|P2|Double-Blind, Week 0-26|Hypoglycaemia|2
1259207|NCT00518882|4125702|P1|Double-Blind, Week 0-26|Hypoglycaemia|0
1259208|NCT00518882|4125701|P2|Double-Blind, Week 0-26|Fear of hypoglycaemia|1
1259209|NCT00518882|4125702|P1|Double-Blind, Week 0-26|Fear of hypoglycaemia|0
1259210|NCT00518882|4125701|P2|Double-Blind, Week 0-26|Loss of trust|1
1259211|NCT00518882|4125702|P1|Double-Blind, Week 0-26|Loss of trust|0
1259212|NCT00518882|4125701|P2|Double-Blind, Week 0-26|Withdrawal of consent|3
1259213|NCT00518882|4125702|P1|Double-Blind, Week 0-26|Withdrawal of consent|1
1259214|NCT00518882|4125701|P2|Double-Blind, Week 0-26|Subject decision|1
1259215|NCT00518882|4125702|P1|Double-Blind, Week 0-26|Subject decision|1
1259216|NCT00518882|4125701|P2|Double-Blind, Week 0-26|Lost to follow up|1
1259217|NCT00518882|4125702|P1|Double-Blind, Week 0-26|Lost to follow up|2
1259218|NCT00518882|4125701|P2|Double-Blind, Week 0-26|Withdrawal criteria|1
1259219|NCT00518882|4125702|P1|Double-Blind, Week 0-26|Withdrawal criteria|1
1259220|NCT00518882|4125701|P2|Double-Blind, Week 0-26|Protocol Violation|3
1259221|NCT00518882|4125702|P1|Double-Blind, Week 0-26|Protocol Violation|4
1259222|NCT00518882|4125701|P2|Double-Blind, Week 0-26|Lack of Efficacy|0
1259223|NCT00518882|4125702|P1|Double-Blind, Week 0-26|Lack of Efficacy|1
1259224|NCT00518882|4125701|P2|Double-Blind, Week 0-26|Adverse Event|31
1259225|NCT00518882|4125702|P1|Double-Blind, Week 0-26|Adverse Event|23
1259226|NCT00518687|4125883|P2|Overall Study|Withdrawal by Subject|110
1259227|NCT00518687|4125884|P1|Overall Study|Withdrawal by Subject|110
1259228|NCT00518687|4125883|P2|Overall Study|Study terminated by sponsor|918
1259229|NCT00518687|4125884|P1|Overall Study|Study terminated by sponsor|930
1259230|NCT00518687|4125883|P2|Overall Study|Protocol Violation|10
1259231|NCT00518687|4125884|P1|Overall Study|Protocol Violation|8
1259232|NCT00518687|4125883|P2|Overall Study|Progressive disease|2
1259233|NCT00518687|4125884|P1|Overall Study|Progressive disease|2
1259234|NCT00518687|4125883|P2|Overall Study|Physician Decision|48
1259235|NCT00518687|4125884|P1|Overall Study|Physician Decision|42
1259236|NCT00518687|4125883|P2|Overall Study|Lost to Follow-up|155
1259237|NCT00518687|4125884|P1|Overall Study|Lost to Follow-up|144
1259238|NCT00518687|4125883|P2|Overall Study|Adverse Event|177
1259239|NCT00518687|4125884|P1|Overall Study|Adverse Event|201
1259240|NCT00518622|4125904|P8|Overall Study|Study medication taken incorrectly|0
1259241|NCT00518622|4125905|P7|Overall Study|Study medication taken incorrectly|0
1259242|NCT00518622|4125906|P6|Overall Study|Study medication taken incorrectly|0
1259243|NCT00518622|4125907|P5|Overall Study|Study medication taken incorrectly|0
1259244|NCT00518622|4125908|P4|Overall Study|Study medication taken incorrectly|0
1259245|NCT00518622|4125909|P3|Overall Study|Study medication taken incorrectly|0
1259246|NCT00518622|4125910|P2|Overall Study|Study medication taken incorrectly|1
1259247|NCT00518622|4125911|P1|Overall Study|Study medication taken incorrectly|0
1259248|NCT00518622|4125904|P8|Overall Study|Lost to Follow-up|0
1259249|NCT00518622|4125905|P7|Overall Study|Lost to Follow-up|0
1259250|NCT00518622|4125906|P6|Overall Study|Lost to Follow-up|0
1259251|NCT00518622|4125907|P5|Overall Study|Lost to Follow-up|0
1259252|NCT00518622|4125908|P4|Overall Study|Lost to Follow-up|0
1259253|NCT00518622|4125909|P3|Overall Study|Lost to Follow-up|1
1259254|NCT00518622|4125910|P2|Overall Study|Lost to Follow-up|0
1259255|NCT00518622|4125911|P1|Overall Study|Lost to Follow-up|0
1259256|NCT00518531|4125939|P2|Treatment Period 2|Non-compliance|2
1259257|NCT00518531|4125940|P1|Treatment Period 2|Non-compliance|1
1259258|NCT00518531|4125939|P2|Treatment Period 2|Protocol-specified criteria|1
1259259|NCT00518531|4125940|P1|Treatment Period 2|Protocol-specified criteria|0
1259260|NCT00518531|4125939|P2|Treatment Period 2|Adverse Event|7
1259261|NCT00518531|4125940|P1|Treatment Period 2|Adverse Event|1
1259262|NCT00518531|4125939|P2|Treatment Period 2|Complete out of scheduled visit window|2
1259263|NCT00518531|4125940|P1|Treatment Period 2|Complete out of scheduled visit window|1
1259264|NCT00518531|4125939|P2|Treatment Period 2|Withdrawal by Subject|8
1259265|NCT00518531|4125940|P1|Treatment Period 2|Withdrawal by Subject|0
1259266|NCT00518531|4125939|P2|Treatment Period 1|Early crossover|3
1259267|NCT00518531|4125940|P1|Treatment Period 1|Early crossover|1
1259268|NCT00518531|4125939|P2|Treatment Period 1|Withdrawal by Subject|6
1259269|NCT00518531|4125940|P1|Treatment Period 1|Withdrawal by Subject|4
1259270|NCT00518531|4125939|P2|Treatment Period 1|Protocol Violation|0
1259271|NCT00518531|4125940|P1|Treatment Period 1|Protocol Violation|2
1259272|NCT00518531|4125939|P2|Treatment Period 1|Physician Decision|0
1259273|NCT00518531|4125940|P1|Treatment Period 1|Physician Decision|1
1259274|NCT00518531|4125939|P2|Treatment Period 1|Lost to Follow-up|3
1259275|NCT00518531|4125940|P1|Treatment Period 1|Lost to Follow-up|5
1259276|NCT00518531|4125939|P2|Treatment Period 1|Adverse Event|0
1259277|NCT00518531|4125940|P1|Treatment Period 1|Adverse Event|5
1259278|NCT00518336|4125985|P2|Year 9|Personal reasons|0
1259279|NCT00518336|4125986|P1|Year 9|Personal reasons|1
1259280|NCT00518336|4125985|P2|Year 9|Lost to Follow-up|0
1259281|NCT00518336|4125986|P1|Year 9|Lost to Follow-up|3
1259282|NCT00518336|4125985|P2|Year 9|Migrated/moved from study area|1
1259283|NCT00518336|4125986|P1|Year 9|Migrated/moved from study area|1
1259284|NCT00518336|4125985|P2|Year 8|Could not attend in time|1
1259285|NCT00518336|4125986|P1|Year 8|Could not attend in time|0
1259286|NCT00518336|4125985|P2|Year 8|Lost to Follow-up|1
1259287|NCT00518336|4125986|P1|Year 8|Lost to Follow-up|1
1259288|NCT00518336|4125985|P2|Year 7|Could not attend in time|3
1259289|NCT00518336|4125986|P1|Year 7|Could not attend in time|0
1259290|NCT00518336|4125985|P2|Year 7|Lost to Follow-up|0
1259291|NCT00518336|4125986|P1|Year 7|Lost to Follow-up|2
1259292|NCT00518323|4126152|P4|Overall Study|Prohibited medication and others|0
1259293|NCT00518323|4126153|P3|Overall Study|Prohibited medication and others|1
1259294|NCT00518323|4126154|P2|Overall Study|Prohibited medication and others|1
1259295|NCT00518323|4126155|P1|Overall Study|Prohibited medication and others|3
1259296|NCT00518323|4126152|P4|Overall Study|Adverse Event|0
1259297|NCT00518323|4126153|P3|Overall Study|Adverse Event|1
1259298|NCT00518323|4126154|P2|Overall Study|Adverse Event|1
1259299|NCT00518323|4126155|P1|Overall Study|Adverse Event|1
1259300|NCT00518323|4126152|P4|Overall Study|Lost to Follow-up|3
1259301|NCT00518323|4126153|P3|Overall Study|Lost to Follow-up|1
1259302|NCT00518323|4126154|P2|Overall Study|Lost to Follow-up|2
1259303|NCT00518323|4126155|P1|Overall Study|Lost to Follow-up|0
1259304|NCT00518323|4126152|P4|Overall Study|Withdrawal by Subject|2
1259305|NCT00518323|4126153|P3|Overall Study|Withdrawal by Subject|4
1259306|NCT00518323|4126154|P2|Overall Study|Withdrawal by Subject|2
1259307|NCT00518323|4126155|P1|Overall Study|Withdrawal by Subject|1
1259308|NCT00518323|4126152|P4|Overall Study|Lack of Efficacy|20
1259309|NCT00518323|4126153|P3|Overall Study|Lack of Efficacy|4
1259310|NCT00518323|4126154|P2|Overall Study|Lack of Efficacy|2
1259311|NCT00518323|4126155|P1|Overall Study|Lack of Efficacy|14
1259312|NCT00518284|4126185|P4|Overall Study|Study Termination|2
1259313|NCT00518284|4126186|P3|Overall Study|Study Termination|1
1259314|NCT00518284|4126187|P2|Overall Study|Study Termination|2
1259315|NCT00518284|4126188|P1|Overall Study|Study Termination|0
1259316|NCT00518284|4126185|P4|Overall Study|Adverse Event|0
1259317|NCT00518284|4126186|P3|Overall Study|Adverse Event|0
1259318|NCT00518284|4126187|P2|Overall Study|Adverse Event|1
1259319|NCT00518284|4126188|P1|Overall Study|Adverse Event|0
1259320|NCT00518206|4126244|P2|Overall Study|Completion Status Unknown|0
1259321|NCT00518206|4126245|P1|Overall Study|Completion Status Unknown|1
1259322|NCT00518206|4126244|P2|Overall Study|Reason Unknown|0
1259323|NCT00518206|4126245|P1|Overall Study|Reason Unknown|1
1259324|NCT00518206|4126244|P2|Overall Study|Drug Supply Issue|0
1259325|NCT00518206|4126245|P1|Overall Study|Drug Supply Issue|1
1259326|NCT00518206|4126244|P2|Overall Study|Withdrawal by Subject|0
1259327|NCT00518206|4126245|P1|Overall Study|Withdrawal by Subject|2
1259328|NCT00518206|4126244|P2|Overall Study|Disease Progression Requiring Therapy|6
1259329|NCT00518206|4126245|P1|Overall Study|Disease Progression Requiring Therapy|6
1259330|NCT00518180|4126262|P3|Overall Study|Adverse Event|0
1259331|NCT00518180|4126263|P2|Overall Study|Adverse Event|0
1259332|NCT00518180|4126264|P1|Overall Study|Adverse Event|1
1259333|NCT00518180|4126262|P3|Overall Study|Unable to classify|0
1259334|NCT00518180|4126263|P2|Overall Study|Unable to classify|2
1259335|NCT00518180|4126264|P1|Overall Study|Unable to classify|0
1259336|NCT00518180|4126262|P3|Overall Study|Protocol Violation|4
1259337|NCT00518180|4126263|P2|Overall Study|Protocol Violation|7
1259338|NCT00518180|4126264|P1|Overall Study|Protocol Violation|5
1259339|NCT00518180|4126262|P3|Overall Study|Administrative reason|2
1259340|NCT00518180|4126263|P2|Overall Study|Administrative reason|2
1259341|NCT00518180|4126264|P1|Overall Study|Administrative reason|0
1259342|NCT00518180|4126262|P3|Overall Study|Lost to Follow-up|34
1259343|NCT00518180|4126263|P2|Overall Study|Lost to Follow-up|28
1259344|NCT00518180|4126264|P1|Overall Study|Lost to Follow-up|30
1259345|NCT00518180|4126262|P3|Overall Study|Withdrawal by Subject|42
1259346|NCT00518180|4126263|P2|Overall Study|Withdrawal by Subject|30
1259347|NCT00518180|4126264|P1|Overall Study|Withdrawal by Subject|29
1259348|NCT00518115|4126316|P10|Overall Study|Moved Out of State|1
1259349|NCT00518115|4126317|P9|Overall Study|Moved Out of State|0
1259350|NCT00518115|4126318|P8|Overall Study|Moved Out of State|0
1259351|NCT00518115|4126319|P7|Overall Study|Moved Out of State|0
1259352|NCT00518115|4126320|P6|Overall Study|Moved Out of State|0
1259353|NCT00518115|4126321|P5|Overall Study|Moved Out of State|0
1259354|NCT00518115|4126322|P4|Overall Study|Moved Out of State|0
1259355|NCT00518115|4126323|P3|Overall Study|Moved Out of State|0
1259356|NCT00518115|4126324|P2|Overall Study|Moved Out of State|0
1259357|NCT00518115|4126325|P1|Overall Study|Moved Out of State|0
1259358|NCT00518115|4126316|P10|Overall Study|Withdrew Consent|0
1259359|NCT00518115|4126317|P9|Overall Study|Withdrew Consent|0
1259360|NCT00518115|4126318|P8|Overall Study|Withdrew Consent|0
1259361|NCT00518115|4126319|P7|Overall Study|Withdrew Consent|0
1259362|NCT00518115|4126320|P6|Overall Study|Withdrew Consent|1
1259363|NCT00518115|4126321|P5|Overall Study|Withdrew Consent|0
1259364|NCT00518115|4126322|P4|Overall Study|Withdrew Consent|0
1259365|NCT00518115|4126323|P3|Overall Study|Withdrew Consent|0
1259366|NCT00518115|4126324|P2|Overall Study|Withdrew Consent|0
1259367|NCT00518115|4126325|P1|Overall Study|Withdrew Consent|0
1259368|NCT00518115|4126316|P10|Overall Study|Family Emergency; Had to Go to England|0
1259369|NCT00518115|4126317|P9|Overall Study|Family Emergency; Had to Go to England|0
1259370|NCT00518115|4126318|P8|Overall Study|Family Emergency; Had to Go to England|0
1259371|NCT00518115|4126319|P7|Overall Study|Family Emergency; Had to Go to England|0
1259372|NCT00518115|4126320|P6|Overall Study|Family Emergency; Had to Go to England|0
1259373|NCT00518115|4126321|P5|Overall Study|Family Emergency; Had to Go to England|1
1259374|NCT00518115|4126322|P4|Overall Study|Family Emergency; Had to Go to England|0
1259375|NCT00518115|4126323|P3|Overall Study|Family Emergency; Had to Go to England|0
1259376|NCT00518115|4126324|P2|Overall Study|Family Emergency; Had to Go to England|0
1259377|NCT00518115|4126325|P1|Overall Study|Family Emergency; Had to Go to England|0
1259378|NCT00518115|4126316|P10|Overall Study|Violation of Exclusion Criteria|0
1259379|NCT00518115|4126317|P9|Overall Study|Violation of Exclusion Criteria|0
1259380|NCT00518115|4126318|P8|Overall Study|Violation of Exclusion Criteria|0
1259381|NCT00518115|4126319|P7|Overall Study|Violation of Exclusion Criteria|1
1259382|NCT00518115|4126320|P6|Overall Study|Violation of Exclusion Criteria|0
1259383|NCT00518115|4126321|P5|Overall Study|Violation of Exclusion Criteria|0
1259384|NCT00518115|4126322|P4|Overall Study|Violation of Exclusion Criteria|1
1259385|NCT00518115|4126323|P3|Overall Study|Violation of Exclusion Criteria|0
1259386|NCT00518115|4126324|P2|Overall Study|Violation of Exclusion Criteria|0
1259387|NCT00518115|4126325|P1|Overall Study|Violation of Exclusion Criteria|0
1259388|NCT00518115|4126316|P10|Overall Study|Wrong Monotherapy Administered|0
1259389|NCT00518115|4126317|P9|Overall Study|Wrong Monotherapy Administered|0
1259390|NCT00518115|4126318|P8|Overall Study|Wrong Monotherapy Administered|0
1259391|NCT00518115|4126319|P7|Overall Study|Wrong Monotherapy Administered|1
1259392|NCT00518115|4126320|P6|Overall Study|Wrong Monotherapy Administered|0
1259393|NCT00518115|4126321|P5|Overall Study|Wrong Monotherapy Administered|0
1259394|NCT00518115|4126322|P4|Overall Study|Wrong Monotherapy Administered|0
1259395|NCT00518115|4126323|P3|Overall Study|Wrong Monotherapy Administered|1
1259396|NCT00518115|4126324|P2|Overall Study|Wrong Monotherapy Administered|0
1259397|NCT00518115|4126325|P1|Overall Study|Wrong Monotherapy Administered|0
1259398|NCT00518115|4126316|P10|Overall Study|Different Monotherapy Diabetic Drug|0
1259399|NCT00518115|4126317|P9|Overall Study|Different Monotherapy Diabetic Drug|1
1259400|NCT00518115|4126318|P8|Overall Study|Different Monotherapy Diabetic Drug|0
1259401|NCT00518115|4126319|P7|Overall Study|Different Monotherapy Diabetic Drug|0
1259402|NCT00518115|4126320|P6|Overall Study|Different Monotherapy Diabetic Drug|0
1259403|NCT00518115|4126321|P5|Overall Study|Different Monotherapy Diabetic Drug|0
1259404|NCT00518115|4126322|P4|Overall Study|Different Monotherapy Diabetic Drug|0
1259405|NCT00518115|4126323|P3|Overall Study|Different Monotherapy Diabetic Drug|1
1259406|NCT00518115|4126324|P2|Overall Study|Different Monotherapy Diabetic Drug|0
1259407|NCT00518115|4126325|P1|Overall Study|Different Monotherapy Diabetic Drug|0
1259408|NCT00518115|4126316|P10|Overall Study|Physician Prescribed Antidiabetic Drug|0
1259409|NCT00518115|4126317|P9|Overall Study|Physician Prescribed Antidiabetic Drug|0
1259410|NCT00518115|4126318|P8|Overall Study|Physician Prescribed Antidiabetic Drug|0
1259411|NCT00518115|4126319|P7|Overall Study|Physician Prescribed Antidiabetic Drug|0
1259412|NCT00518115|4126320|P6|Overall Study|Physician Prescribed Antidiabetic Drug|0
1259413|NCT00518115|4126321|P5|Overall Study|Physician Prescribed Antidiabetic Drug|0
1259414|NCT00518115|4126322|P4|Overall Study|Physician Prescribed Antidiabetic Drug|0
1259415|NCT00518115|4126323|P3|Overall Study|Physician Prescribed Antidiabetic Drug|0
1259416|NCT00518115|4126324|P2|Overall Study|Physician Prescribed Antidiabetic Drug|0
1259417|NCT00518115|4126325|P1|Overall Study|Physician Prescribed Antidiabetic Drug|1
1259418|NCT00518115|4126316|P10|Overall Study|Treatment Eligibility Criteria Not Met|0
1259419|NCT00518115|4126317|P9|Overall Study|Treatment Eligibility Criteria Not Met|0
1259420|NCT00518115|4126318|P8|Overall Study|Treatment Eligibility Criteria Not Met|0
1259511|NCT00517933|4126524|P1|Period 1|Lost to Follow-up|2
1259421|NCT00518115|4126319|P7|Overall Study|Treatment Eligibility Criteria Not Met|0
1259422|NCT00518115|4126320|P6|Overall Study|Treatment Eligibility Criteria Not Met|4
1259423|NCT00518115|4126321|P5|Overall Study|Treatment Eligibility Criteria Not Met|0
1259424|NCT00518115|4126322|P4|Overall Study|Treatment Eligibility Criteria Not Met|0
1259425|NCT00518115|4126323|P3|Overall Study|Treatment Eligibility Criteria Not Met|0
1259426|NCT00518115|4126324|P2|Overall Study|Treatment Eligibility Criteria Not Met|1
1259427|NCT00518115|4126325|P1|Overall Study|Treatment Eligibility Criteria Not Met|1
1259428|NCT00518115|4126316|P10|Overall Study|Non-Compliance|1
1259429|NCT00518115|4126317|P9|Overall Study|Non-Compliance|0
1259430|NCT00518115|4126318|P8|Overall Study|Non-Compliance|1
1259431|NCT00518115|4126319|P7|Overall Study|Non-Compliance|1
1259432|NCT00518115|4126320|P6|Overall Study|Non-Compliance|1
1259433|NCT00518115|4126321|P5|Overall Study|Non-Compliance|1
1259434|NCT00518115|4126322|P4|Overall Study|Non-Compliance|0
1259435|NCT00518115|4126323|P3|Overall Study|Non-Compliance|1
1259436|NCT00518115|4126324|P2|Overall Study|Non-Compliance|0
1259437|NCT00518115|4126325|P1|Overall Study|Non-Compliance|1
1259438|NCT00518115|4126316|P10|Overall Study|Lack of Efficacy|0
1259439|NCT00518115|4126317|P9|Overall Study|Lack of Efficacy|0
1259440|NCT00518115|4126318|P8|Overall Study|Lack of Efficacy|1
1259441|NCT00518115|4126319|P7|Overall Study|Lack of Efficacy|0
1259442|NCT00518115|4126320|P6|Overall Study|Lack of Efficacy|0
1259443|NCT00518115|4126321|P5|Overall Study|Lack of Efficacy|0
1259444|NCT00518115|4126322|P4|Overall Study|Lack of Efficacy|1
1259445|NCT00518115|4126323|P3|Overall Study|Lack of Efficacy|1
1259446|NCT00518115|4126324|P2|Overall Study|Lack of Efficacy|0
1259447|NCT00518115|4126325|P1|Overall Study|Lack of Efficacy|1
1259448|NCT00518115|4126316|P10|Overall Study|Withdrawal by Subject|3
1259449|NCT00518115|4126317|P9|Overall Study|Withdrawal by Subject|1
1259450|NCT00518115|4126318|P8|Overall Study|Withdrawal by Subject|2
1259451|NCT00518115|4126319|P7|Overall Study|Withdrawal by Subject|0
1259452|NCT00518115|4126320|P6|Overall Study|Withdrawal by Subject|1
1259453|NCT00518115|4126321|P5|Overall Study|Withdrawal by Subject|2
1259454|NCT00518115|4126322|P4|Overall Study|Withdrawal by Subject|0
1259455|NCT00518115|4126323|P3|Overall Study|Withdrawal by Subject|5
1259456|NCT00518115|4126324|P2|Overall Study|Withdrawal by Subject|1
1259457|NCT00518115|4126325|P1|Overall Study|Withdrawal by Subject|1
1259458|NCT00518115|4126316|P10|Overall Study|Protocol Violation|0
1259459|NCT00518115|4126317|P9|Overall Study|Protocol Violation|0
1259460|NCT00518115|4126318|P8|Overall Study|Protocol Violation|0
1259461|NCT00518115|4126319|P7|Overall Study|Protocol Violation|0
1259462|NCT00518115|4126320|P6|Overall Study|Protocol Violation|0
1259463|NCT00518115|4126321|P5|Overall Study|Protocol Violation|0
1259464|NCT00518115|4126322|P4|Overall Study|Protocol Violation|0
1259465|NCT00518115|4126323|P3|Overall Study|Protocol Violation|1
1259466|NCT00518115|4126324|P2|Overall Study|Protocol Violation|3
1259467|NCT00518115|4126325|P1|Overall Study|Protocol Violation|1
1259468|NCT00518115|4126316|P10|Overall Study|Lost to Follow-up|1
1259469|NCT00518115|4126317|P9|Overall Study|Lost to Follow-up|1
1259470|NCT00518115|4126318|P8|Overall Study|Lost to Follow-up|1
1259471|NCT00518115|4126319|P7|Overall Study|Lost to Follow-up|0
1259472|NCT00518115|4126320|P6|Overall Study|Lost to Follow-up|3
1259473|NCT00518115|4126321|P5|Overall Study|Lost to Follow-up|1
1259474|NCT00518115|4126322|P4|Overall Study|Lost to Follow-up|3
1259475|NCT00518115|4126323|P3|Overall Study|Lost to Follow-up|2
1259476|NCT00518115|4126324|P2|Overall Study|Lost to Follow-up|0
1259477|NCT00518115|4126325|P1|Overall Study|Lost to Follow-up|0
1259478|NCT00518115|4126316|P10|Overall Study|Adverse Event|9
1259479|NCT00518115|4126317|P9|Overall Study|Adverse Event|2
1259480|NCT00518115|4126318|P8|Overall Study|Adverse Event|10
1259481|NCT00518115|4126319|P7|Overall Study|Adverse Event|5
1259482|NCT00518115|4126320|P6|Overall Study|Adverse Event|5
1259483|NCT00518115|4126321|P5|Overall Study|Adverse Event|5
1259484|NCT00518115|4126322|P4|Overall Study|Adverse Event|6
1259485|NCT00518115|4126323|P3|Overall Study|Adverse Event|5
1259486|NCT00518115|4126324|P2|Overall Study|Adverse Event|1
1259487|NCT00518115|4126325|P1|Overall Study|Adverse Event|6
1259488|NCT00518011|4126500|P2|Overall Study|Withdrawal by Subject|0
1259489|NCT00518011|4126501|P1|Overall Study|Withdrawal by Subject|1
1259490|NCT00518011|4126500|P2|Overall Study|Other Reasons|2
1259491|NCT00518011|4126501|P1|Overall Study|Other Reasons|3
1259492|NCT00518011|4126500|P2|Overall Study|Disease Progression|2
1259493|NCT00518011|4126501|P1|Overall Study|Disease Progression|2
1259494|NCT00518011|4126500|P2|Overall Study|Adverse Event|3
1259495|NCT00518011|4126501|P1|Overall Study|Adverse Event|2
1259496|NCT00518011|4126500|P2|Overall Study|Death|1
1259497|NCT00518011|4126501|P1|Overall Study|Death|1
1259498|NCT00517933|4126523|P2|Period 2|Underwent lung transplant|2
1259499|NCT00517933|4126524|P1|Period 2|Underwent lung transplant|0
1259500|NCT00517933|4126523|P2|Period 2|Withdrawal by Subject|3
1259501|NCT00517933|4126524|P1|Period 2|Withdrawal by Subject|1
1259502|NCT00517933|4126523|P2|Period 2|Physician Decision|0
1259503|NCT00517933|4126524|P1|Period 2|Physician Decision|1
1259504|NCT00517933|4126523|P2|Period 2|Adverse Event|4
1259505|NCT00517933|4126524|P1|Period 2|Adverse Event|2
1259506|NCT00517933|4126523|P2|Period 2|Death|4
1259507|NCT00517933|4126524|P1|Period 2|Death|2
1259508|NCT00517933|4126523|P2|Period 1|Underwent lung transplant|1
1259509|NCT00517933|4126524|P1|Period 1|Underwent lung transplant|0
1259510|NCT00517933|4126523|P2|Period 1|Lost to Follow-up|0
1259512|NCT00517933|4126523|P2|Period 1|Adverse Event|4
1259513|NCT00517933|4126524|P1|Period 1|Adverse Event|4
1259514|NCT00517933|4126523|P2|Period 1|Death|1
1259515|NCT00517933|4126524|P1|Period 1|Death|2
1259516|NCT00517881|4126588|P1|Overall Study|Renal transplantation|2
1259517|NCT00517881|4126588|P1|Overall Study|Adverse Event|1
1259518|NCT00517881|4126588|P1|Overall Study|Protocol Violation|2
1259519|NCT00517829|4126600|P2|Overall Study|Other|1
1259520|NCT00517829|4126601|P1|Overall Study|Other|3
1259521|NCT00517829|4126600|P2|Overall Study|Investigator Request|3
1259522|NCT00517829|4126601|P1|Overall Study|Investigator Request|5
1259523|NCT00517829|4126600|P2|Overall Study|Patient Request|5
1259524|NCT00517829|4126601|P1|Overall Study|Patient Request|6
1259525|NCT00517829|4126600|P2|Overall Study|Disease Progression|32
1259526|NCT00517829|4126601|P1|Overall Study|Disease Progression|39
1259527|NCT00517829|4126600|P2|Overall Study|Adverse Event|34
1259528|NCT00517829|4126601|P1|Overall Study|Adverse Event|22
1259529|NCT00517751|4126615|P1|Overall Study|Missing|3
1259530|NCT00517751|4126615|P1|Overall Study|Patient not due for visit|76
1259531|NCT00517751|4126615|P1|Overall Study|patient not over due|6
1259532|NCT00517751|4126615|P1|Overall Study|Lost to Follow-up|4
1259533|NCT00517751|4126615|P1|Overall Study|Withdrawal by Subject|37
1259534|NCT00517751|4126615|P1|Overall Study|Death|3
1259535|NCT00517699|4126638|P1|Overall Study|Study terminated by Sponsor|2
1259536|NCT00517699|4126638|P1|Overall Study|Administrative error|1
1259537|NCT00517699|4126638|P1|Overall Study|Lack of Efficacy|1
1259538|NCT00517699|4126638|P1|Overall Study|Withdrawal by Subject|1
1259539|NCT00517634|4126646|P6|Second Treatment Period|Withdrawal by Subject|0
1259540|NCT00517634|4126647|P5|Second Treatment Period|Withdrawal by Subject|1
1259541|NCT00517634|4126648|P4|Second Treatment Period|Withdrawal by Subject|0
1259542|NCT00517634|4126649|P3|Second Treatment Period|Withdrawal by Subject|0
1259543|NCT00517634|4126650|P2|Second Treatment Period|Withdrawal by Subject|0
1259544|NCT00517634|4126651|P1|Second Treatment Period|Withdrawal by Subject|0
1259545|NCT00517413|4126753|P1|Overall Study|Other-Reasons|23
1259546|NCT00517413|4126753|P1|Overall Study|Failure to return|1
1259547|NCT00517413|4126753|P1|Overall Study|Withdrawal by Subject|2
1259548|NCT00517413|4126753|P1|Overall Study|Protocol Violation|15
1259549|NCT00517413|4126753|P1|Overall Study|Death|13
1259550|NCT00517413|4126753|P1|Overall Study|Adverse Event|7
1259551|NCT00517361|4126774|P1|Overall Study|The study was terminated|5
1259552|NCT00517361|4126774|P1|Overall Study|Death|6
1259553|NCT00517296|4126783|P2|Overall Study|Withdrawal by Subject|0
1259554|NCT00517296|4126784|P1|Overall Study|Withdrawal by Subject|1
1259555|NCT00517192|4126796|P2|Overall Study|Early termination of the trial|18
1259556|NCT00517192|4126797|P1|Overall Study|Early termination of the trial|16
1259557|NCT00517192|4126796|P2|Overall Study|Withdrawal by Subject|0
1259558|NCT00517192|4126797|P1|Overall Study|Withdrawal by Subject|1
1259559|NCT00517192|4126796|P2|Overall Study|Lost to Follow-up|1
1259560|NCT00517192|4126797|P1|Overall Study|Lost to Follow-up|1
1259561|NCT00517192|4126796|P2|Overall Study|Adverse Event|1
1259562|NCT00517192|4126797|P1|Overall Study|Adverse Event|1
1259563|NCT00516906|4126904|P2|Overall Study|Final Dressing Removal Data not captured|2
1259564|NCT00516906|4126905|P1|Overall Study|Final Dressing Removal Data not captured|6
1259565|NCT00516893|4126915|P1|Overall Study|Received Medication From Another Study|1
1259566|NCT00516893|4126915|P1|Overall Study|Pregnancy|1
1259567|NCT00516893|4126915|P1|Overall Study|Relocated|1
1259568|NCT00516893|4126915|P1|Overall Study|Persistent Antibodies per Protocol|6
1259569|NCT00516893|4126915|P1|Overall Study|Death|1
1259570|NCT00516893|4126915|P1|Overall Study|Noncompliance|2
1259571|NCT00516893|4126915|P1|Overall Study|Withdrawal by Subject|2
1259572|NCT00516893|4126915|P1|Overall Study|Adverse Event|3
1259573|NCT00516893|4126915|P1|Overall Study|Lost to Follow-up|4
1259574|NCT00516737|4126924|P2|Overall Study|Lack of Qualifying Event|6
1259575|NCT00516737|4126925|P1|Overall Study|Lack of Qualifying Event|9
1259576|NCT00516737|4126924|P2|Overall Study|Withdrawal by Subject|1
1259577|NCT00516737|4126925|P1|Overall Study|Withdrawal by Subject|0
1259578|NCT00516737|4126924|P2|Overall Study|Physician Decision|1
1259579|NCT00516737|4126925|P1|Overall Study|Physician Decision|0
1259580|NCT00516737|4126924|P2|Overall Study|Lost to Follow-up|0
1259581|NCT00516737|4126925|P1|Overall Study|Lost to Follow-up|2
1259582|NCT00516386|4126964|P1|Overall Study|Lost to Follow-up|2
1259583|NCT00516386|4126964|P1|Overall Study|not interested in the study|4
1259584|NCT00516321|4126971|P3|Double-blind (DB) Antiviral Treatment|Physician Decision|0
1259585|NCT00516321|4126972|P2|Double-blind (DB) Antiviral Treatment|Physician Decision|2
1259586|NCT00516321|4126973|P1|Double-blind (DB) Antiviral Treatment|Physician Decision|0
1259587|NCT00516321|4126971|P3|Double-blind (DB) Antiviral Treatment|Protocol Violation|1
1259588|NCT00516321|4126972|P2|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
1259589|NCT00516321|4126973|P1|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
1259590|NCT00516321|4126971|P3|Double-blind (DB) Antiviral Treatment|Adverse Event|13
1259591|NCT00516321|4126972|P2|Double-blind (DB) Antiviral Treatment|Adverse Event|8
1259592|NCT00516321|4126973|P1|Double-blind (DB) Antiviral Treatment|Adverse Event|0
1259593|NCT00516321|4126971|P3|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18
1259594|NCT00516321|4126972|P2|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13
1259595|NCT00516321|4126973|P1|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0
1259596|NCT00516321|4126971|P3|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22
1259597|NCT00516321|4126972|P2|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12
1259598|NCT00516321|4126973|P1|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0
1259599|NCT00516321|4126971|P3|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
1259600|NCT00516321|4126972|P2|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
1259601|NCT00516321|4126973|P1|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3
1259602|NCT00516321|4126971|P3|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
1259603|NCT00516321|4126972|P2|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
1259604|NCT00516321|4126973|P1|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7
1259605|NCT00516321|4126971|P3|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
1259606|NCT00516321|4126972|P2|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
1259607|NCT00516321|4126973|P1|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2
1259608|NCT00516321|4126971|P3|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
1259609|NCT00516321|4126972|P2|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
1259610|NCT00516321|4126973|P1|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1
1259611|NCT00516321|4126971|P3|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
1259612|NCT00516321|4126972|P2|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
1259613|NCT00516321|4126973|P1|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9
1259614|NCT00516321|4126971|P3|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
1259615|NCT00516321|4126972|P2|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
1259616|NCT00516321|4126973|P1|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11
1259617|NCT00516295|4127024|P3|Overall Study|Ineligible|0
1259618|NCT00516295|4127025|P2|Overall Study|Ineligible|0
1259619|NCT00516295|4127026|P1|Overall Study|Ineligible|1
1259620|NCT00516295|4127024|P3|Overall Study|Lack of Efficacy|0
1259621|NCT00516295|4127025|P2|Overall Study|Lack of Efficacy|0
1259622|NCT00516295|4127026|P1|Overall Study|Lack of Efficacy|2
1259623|NCT00516269|4127039|P2|Overall Study|Protocol Violation|1
1259624|NCT00516269|4127040|P1|Overall Study|Protocol Violation|0
1259625|NCT00516269|4127039|P2|Overall Study|Lost to Follow-up|1
1259626|NCT00516269|4127040|P1|Overall Study|Lost to Follow-up|0
1259627|NCT00516269|4127039|P2|Overall Study|Adverse Event|1
1259628|NCT00516269|4127040|P1|Overall Study|Adverse Event|2
1259629|NCT00516139|4127061|P1|Overall Study|Lack of Efficacy|1
1259630|NCT00516139|4127061|P1|Overall Study|Withdrawal by Subject|8
1259631|NCT00516139|4127061|P1|Overall Study|Protocol Violation|1
1259632|NCT00516139|4127061|P1|Overall Study|Lost to Follow-up|1
1259633|NCT00516139|4127061|P1|Overall Study|Adverse Event|27
1259634|NCT00516074|4127092|P2|Overall Study|Loss of Glucose Control|0
1259635|NCT00516074|4127093|P1|Overall Study|Loss of Glucose Control|2
1259636|NCT00516074|4127092|P2|Overall Study|Subject Decision|2
1259637|NCT00516074|4127093|P1|Overall Study|Subject Decision|4
1259638|NCT00516074|4127092|P2|Overall Study|Adverse Event|1
1259639|NCT00516074|4127093|P1|Overall Study|Adverse Event|0
1259640|NCT00516048|4127111|P3|Overall Study|Subject Decision|0
1259641|NCT00516048|4127112|P2|Overall Study|Subject Decision|2
1259642|NCT00516048|4127113|P1|Overall Study|Subject Decision|0
1259643|NCT00516048|4127111|P3|Overall Study|Death|1
1259644|NCT00516048|4127112|P2|Overall Study|Death|0
1259645|NCT00516048|4127113|P1|Overall Study|Death|0
1259646|NCT00515827|4127140|P2|Second Intervention (12 Weeks)|Consent withdraw|0
1259647|NCT00515827|4127141|P1|Second Intervention (12 Weeks)|Consent withdraw|1
1259648|NCT00515827|4127140|P2|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
1259649|NCT00515827|4127141|P1|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
1259650|NCT00515671|4127176|P2|Overall Study|incarcerated|2
1259651|NCT00515671|4127177|P1|Overall Study|incarcerated|1
1259652|NCT00515671|4127176|P2|Overall Study|Withdrawal by Subject|5
1259653|NCT00515671|4127177|P1|Overall Study|Withdrawal by Subject|3
1259654|NCT00515671|4127176|P2|Overall Study|Lost to Follow-up|10
1259655|NCT00515671|4127177|P1|Overall Study|Lost to Follow-up|13
1259656|NCT00515619|4127185|P1|Overall Study|Other: Subject interested in other AED|1
1259657|NCT00515619|4127185|P1|Overall Study|Other: Drug available on license|1
1259658|NCT00515619|4127185|P1|Overall Study|Other: Request from sponsor|1
1259659|NCT00515619|4127185|P1|Overall Study|Other: Subject became pregnant|1
1259660|NCT00515619|4127185|P1|Overall Study|Other: Investigator decision|1
1259661|NCT00515619|4127185|P1|Overall Study|Other: Subject moved to another country|1
1259662|NCT00515619|4127185|P1|Overall Study|Other: Subject required surgery|1
1259663|NCT00515619|4127185|P1|Overall Study|Other: Subject cannot attend visits|2
1259664|NCT00515619|4127185|P1|Overall Study|Other: Site discontinuing trials|2
1259665|NCT00515619|4127185|P1|Overall Study|Unsatisfactory compliance|6
1259666|NCT00515619|4127185|P1|Overall Study|Lost to Follow-up|4
1259667|NCT00515619|4127185|P1|Overall Study|Protocol Violation|3
1259668|NCT00515619|4127185|P1|Overall Study|Withdrawal by Subject|66
1259669|NCT00515619|4127185|P1|Overall Study|Lack of Efficacy|92
1259670|NCT00515619|4127185|P1|Overall Study|Adverse Event|34
1259671|NCT00515541|4127197|P4|Overall Study|Withdrawal by Subject|2
1259672|NCT00515541|4127198|P3|Overall Study|Withdrawal by Subject|0
1259673|NCT00515541|4127199|P2|Overall Study|Withdrawal by Subject|2
1259674|NCT00515541|4127200|P1|Overall Study|Withdrawal by Subject|0
1259675|NCT00515541|4127197|P4|Overall Study|No show for appointments|2
1259676|NCT00515541|4127198|P3|Overall Study|No show for appointments|0
1259677|NCT00515541|4127199|P2|Overall Study|No show for appointments|1
1259678|NCT00515541|4127200|P1|Overall Study|No show for appointments|0
1259679|NCT00515541|4127197|P4|Overall Study|Physician Decision|1
1259680|NCT00515541|4127198|P3|Overall Study|Physician Decision|0
1259681|NCT00515541|4127199|P2|Overall Study|Physician Decision|2
1259682|NCT00515541|4127200|P1|Overall Study|Physician Decision|0
1259683|NCT00515502|4127222|P12|Treatment Period 2|Adverse Event|0
1259684|NCT00515502|4127223|P11|Treatment Period 2|Adverse Event|0
1259685|NCT00515502|4127224|P10|Treatment Period 2|Adverse Event|0
1259686|NCT00515502|4127225|P9|Treatment Period 2|Adverse Event|0
1259687|NCT00515502|4127226|P8|Treatment Period 2|Adverse Event|0
1259688|NCT00515502|4127227|P7|Treatment Period 2|Adverse Event|0
1259689|NCT00515502|4127228|P6|Treatment Period 2|Adverse Event|0
1259690|NCT00515502|4127229|P5|Treatment Period 2|Adverse Event|0
1259691|NCT00515502|4127230|P4|Treatment Period 2|Adverse Event|0
1259692|NCT00515502|4127231|P3|Treatment Period 2|Adverse Event|0
1259693|NCT00515502|4127232|P2|Treatment Period 2|Adverse Event|1
1259694|NCT00515502|4127233|P1|Treatment Period 2|Adverse Event|0
1259695|NCT00515502|4127222|P12|Treatment Period 1|Adverse Event|1
1259696|NCT00515502|4127223|P11|Treatment Period 1|Adverse Event|0
1259697|NCT00515502|4127224|P10|Treatment Period 1|Adverse Event|0
1259698|NCT00515502|4127225|P9|Treatment Period 1|Adverse Event|1
1259699|NCT00515502|4127226|P8|Treatment Period 1|Adverse Event|0
1259700|NCT00515502|4127227|P7|Treatment Period 1|Adverse Event|1
1259701|NCT00515502|4127228|P6|Treatment Period 1|Adverse Event|0
1259702|NCT00515502|4127229|P5|Treatment Period 1|Adverse Event|0
1259703|NCT00515502|4127230|P4|Treatment Period 1|Adverse Event|0
1259704|NCT00515502|4127231|P3|Treatment Period 1|Adverse Event|0
1259705|NCT00515502|4127232|P2|Treatment Period 1|Adverse Event|0
1259706|NCT00515502|4127233|P1|Treatment Period 1|Adverse Event|0
1259707|NCT00515463|4127393|P2|Overall Study|Other|1
1259708|NCT00515463|4127394|P1|Overall Study|Other|0
1259709|NCT00515463|4127393|P2|Overall Study|Lost to Follow-up|5
1259710|NCT00515463|4127394|P1|Overall Study|Lost to Follow-up|6
1259711|NCT00515463|4127393|P2|Overall Study|Withdrawal by Subject|4
1259712|NCT00515463|4127394|P1|Overall Study|Withdrawal by Subject|3
1259713|NCT00515463|4127393|P2|Overall Study|Adverse Event|2
1259714|NCT00515463|4127394|P1|Overall Study|Adverse Event|1
1259715|NCT00515463|4127393|P2|Overall Study|Physician Decision|2
1259716|NCT00515463|4127394|P1|Overall Study|Physician Decision|4
1259717|NCT00515294|4127577|P4|Overall Study|Caffeine amount inaccurate|0
1259718|NCT00515294|4127578|P3|Overall Study|Caffeine amount inaccurate|7
1259719|NCT00515294|4127579|P2|Overall Study|Caffeine amount inaccurate|0
1259720|NCT00515294|4127580|P1|Overall Study|Caffeine amount inaccurate|5
1259721|NCT00515294|4127577|P4|Overall Study|Driver simulator problems|3
1259722|NCT00515294|4127578|P3|Overall Study|Driver simulator problems|1
1259723|NCT00515294|4127579|P2|Overall Study|Driver simulator problems|1
1259724|NCT00515294|4127580|P1|Overall Study|Driver simulator problems|1
1259725|NCT00515294|4127577|P4|Overall Study|Lost to Follow-up|1
1259726|NCT00515294|4127578|P3|Overall Study|Lost to Follow-up|3
1259727|NCT00515294|4127579|P2|Overall Study|Lost to Follow-up|2
1259728|NCT00515294|4127580|P1|Overall Study|Lost to Follow-up|3
1259729|NCT00515216|4127594|P1|Overall Study|Withdrawal by Subject|1
1259730|NCT00515112|4127656|P2|Overall Study|The study was terminated|2
1259731|NCT00515112|4127657|P1|Overall Study|The study was terminated|3
1259732|NCT00515112|4127656|P2|Overall Study|Death|1
1259733|NCT00515112|4127657|P1|Overall Study|Death|0
1259734|NCT00515099|4127667|P2|Overall Study|IRB Recommendation|0
1259735|NCT00515099|4127668|P1|Overall Study|IRB Recommendation|1
1259736|NCT00515099|4127667|P2|Overall Study|Withdrawal by Subject|0
1259737|NCT00515099|4127668|P1|Overall Study|Withdrawal by Subject|2
1259738|NCT00515099|4127667|P2|Overall Study|Lost to Follow-up|4
1259739|NCT00515099|4127668|P1|Overall Study|Lost to Follow-up|0
1259740|NCT00515086|4127690|P4|Overall Study|Death|0
1259741|NCT00515086|4127691|P3|Overall Study|Death|0
1259742|NCT00515086|4127692|P2|Overall Study|Death|0
1259743|NCT00515086|4127693|P1|Overall Study|Death|2
1259744|NCT00515086|4127690|P4|Overall Study|Study drug no longer required|0
1259745|NCT00515086|4127691|P3|Overall Study|Study drug no longer required|0
1259746|NCT00515086|4127692|P2|Overall Study|Study drug no longer required|1
1259747|NCT00515086|4127693|P1|Overall Study|Study drug no longer required|0
1259748|NCT00515086|4127690|P4|Overall Study|Lost to Follow-up|0
1259749|NCT00515086|4127691|P3|Overall Study|Lost to Follow-up|0
1259750|NCT00515086|4127692|P2|Overall Study|Lost to Follow-up|0
1259751|NCT00515086|4127693|P1|Overall Study|Lost to Follow-up|1
1259752|NCT00515086|4127690|P4|Overall Study|Unsatisfactory therapeutic effect|2
1259753|NCT00515086|4127691|P3|Overall Study|Unsatisfactory therapeutic effect|3
1259754|NCT00515086|4127692|P2|Overall Study|Unsatisfactory therapeutic effect|3
1259755|NCT00515086|4127693|P1|Overall Study|Unsatisfactory therapeutic effect|18
1259756|NCT00515086|4127690|P4|Overall Study|Withdrawal by Subject|1
1259757|NCT00515086|4127691|P3|Overall Study|Withdrawal by Subject|0
1259758|NCT00515086|4127692|P2|Overall Study|Withdrawal by Subject|0
1259759|NCT00515086|4127693|P1|Overall Study|Withdrawal by Subject|1
1259760|NCT00515086|4127690|P4|Overall Study|Administrative|0
1259761|NCT00515086|4127691|P3|Overall Study|Administrative|0
1259762|NCT00515086|4127692|P2|Overall Study|Administrative|1
1259763|NCT00515086|4127693|P1|Overall Study|Administrative|1
1259764|NCT00515086|4127690|P4|Overall Study|Adverse Event|3
1259765|NCT00515086|4127691|P3|Overall Study|Adverse Event|2
1259766|NCT00515086|4127692|P2|Overall Study|Adverse Event|1
1259767|NCT00515086|4127693|P1|Overall Study|Adverse Event|1
1259768|NCT00515073|4127720|P1|Overall Study|Physician Decision|1
1259769|NCT00515073|4127720|P1|Overall Study|Withdrawal by Subject|1
1259770|NCT00515034|4127728|P4|Overall Study|Other|1
1259771|NCT00515034|4127729|P3|Overall Study|Other|2
1259772|NCT00515034|4127730|P2|Overall Study|Other|0
1259773|NCT00515034|4127731|P1|Overall Study|Other|1
1259774|NCT00515034|4127728|P4|Overall Study|Physician Decision|1
1259775|NCT00515034|4127729|P3|Overall Study|Physician Decision|1
1259776|NCT00515034|4127730|P2|Overall Study|Physician Decision|0
1259777|NCT00515034|4127731|P1|Overall Study|Physician Decision|0
1259778|NCT00515034|4127728|P4|Overall Study|Withdrawal by Subject|0
1259779|NCT00515034|4127729|P3|Overall Study|Withdrawal by Subject|3
1259780|NCT00515034|4127730|P2|Overall Study|Withdrawal by Subject|0
1259781|NCT00515034|4127731|P1|Overall Study|Withdrawal by Subject|1
1259782|NCT00515034|4127728|P4|Overall Study|Death|3
1259783|NCT00515034|4127729|P3|Overall Study|Death|1
1259784|NCT00515034|4127730|P2|Overall Study|Death|2
1259785|NCT00515034|4127731|P1|Overall Study|Death|4
1259786|NCT00515034|4127728|P4|Overall Study|Adverse Event|0
1259787|NCT00515034|4127729|P3|Overall Study|Adverse Event|1
1259788|NCT00515034|4127730|P2|Overall Study|Adverse Event|0
1259789|NCT00515034|4127731|P1|Overall Study|Adverse Event|2
1259790|NCT00515008|4127751|P2|Overall Study|Scheduling conflict|0
1259791|NCT00515008|4127752|P1|Overall Study|Scheduling conflict|1
1259792|NCT00515008|4127751|P2|Overall Study|Left the Boston Area|1
1259793|NCT00515008|4127752|P1|Overall Study|Left the Boston Area|1
1259794|NCT00515008|4127751|P2|Overall Study|Declined|3
1259795|NCT00515008|4127752|P1|Overall Study|Declined|0
1259796|NCT00515008|4127751|P2|Overall Study|Lost to Follow-up|0
1259797|NCT00515008|4127752|P1|Overall Study|Lost to Follow-up|1
1259798|NCT00514943|4127776|P2|Stage 2|Other than stated above|2
1259799|NCT00514943|4127777|P1|Stage 2|Other than stated above|0
1259800|NCT00514943|4127776|P2|Stage 2|Patient refused to continue study meds|0
1259801|NCT00514943|4127777|P1|Stage 2|Patient refused to continue study meds|2
1259802|NCT00514943|4127776|P2|Stage 2|Other Adverse Event|10
1259803|NCT00514943|4127777|P1|Stage 2|Other Adverse Event|3
1259804|NCT00514943|4127776|P2|Stage 2|Progressive disease|24
1259805|NCT00514943|4127777|P1|Stage 2|Progressive disease|27
1259806|NCT00514943|4127776|P2|Stage 1|Other than stated above|7
1259807|NCT00514943|4127777|P1|Stage 1|Other than stated above|1
1259808|NCT00514943|4127776|P2|Stage 1|Patient refused to continue study meds|3
1259809|NCT00514943|4127777|P1|Stage 1|Patient refused to continue study meds|8
1259810|NCT00514943|4127776|P2|Stage 1|Not treated|2
1259811|NCT00514943|4127777|P1|Stage 1|Not treated|1
1259812|NCT00514943|4127776|P2|Stage 1|Other Adverse Event|6
1259813|NCT00514943|4127777|P1|Stage 1|Other Adverse Event|16
1259814|NCT00514943|4127776|P2|Stage 1|Progressive disease|8
1259815|NCT00514943|4127777|P1|Stage 1|Progressive disease|4
1259816|NCT00514917|4127835|P2|Overall Study|Undefined|5
1259817|NCT00514917|4127836|P1|Overall Study|Undefined|11
1259818|NCT00514917|4127835|P2|Overall Study|Discontinued due to study closure|81
1259819|NCT00514917|4127836|P1|Overall Study|Discontinued due to study closure|88
1259820|NCT00514917|4127835|P2|Overall Study|Withdrawal by Subject|16
1259821|NCT00514917|4127836|P1|Overall Study|Withdrawal by Subject|18
1259822|NCT00514917|4127835|P2|Overall Study|Lost to Follow-up|3
1259823|NCT00514917|4127836|P1|Overall Study|Lost to Follow-up|4
1259824|NCT00514917|4127835|P2|Overall Study|Protocol Violation|0
1259825|NCT00514917|4127836|P1|Overall Study|Protocol Violation|1
1259826|NCT00514917|4127835|P2|Overall Study|Death|10
1259827|NCT00514917|4127836|P1|Overall Study|Death|4
1259828|NCT00514904|4127864|P2|Overall Study|Lost to Follow-up|3
1259829|NCT00514904|4127865|P1|Overall Study|Lost to Follow-up|21
1259830|NCT00514904|4127864|P2|Overall Study|Withdrawal by Subject|2
1259831|NCT00514904|4127865|P1|Overall Study|Withdrawal by Subject|3
1259832|NCT00514813|4127930|P4|Overall Study|Death|2
1259833|NCT00514813|4127931|P3|Overall Study|Death|3
1259834|NCT00514813|4127932|P2|Overall Study|Death|2
1259835|NCT00514813|4127933|P1|Overall Study|Death|0
1259836|NCT00514813|4127930|P4|Overall Study|Kidney transplant|0
1259837|NCT00514813|4127931|P3|Overall Study|Kidney transplant|2
1259838|NCT00514813|4127932|P2|Overall Study|Kidney transplant|6
1259839|NCT00514813|4127933|P1|Overall Study|Kidney transplant|0
1259840|NCT00514813|4127930|P4|Overall Study|Lack of Efficacy|0
1259841|NCT00514813|4127931|P3|Overall Study|Lack of Efficacy|0
1259842|NCT00514813|4127932|P2|Overall Study|Lack of Efficacy|1
1259843|NCT00514813|4127933|P1|Overall Study|Lack of Efficacy|0
1259844|NCT00514813|4127930|P4|Overall Study|Withdrawal by Subject|0
1259845|NCT00514813|4127931|P3|Overall Study|Withdrawal by Subject|0
1259846|NCT00514813|4127932|P2|Overall Study|Withdrawal by Subject|1
1259847|NCT00514813|4127933|P1|Overall Study|Withdrawal by Subject|0
1259848|NCT00514813|4127930|P4|Overall Study|Protocol Violation|0
1259849|NCT00514813|4127931|P3|Overall Study|Protocol Violation|0
1259850|NCT00514813|4127932|P2|Overall Study|Protocol Violation|0
1259851|NCT00514813|4127933|P1|Overall Study|Protocol Violation|1
1259852|NCT00514813|4127930|P4|Overall Study|Adverse Event|0
1259853|NCT00514813|4127931|P3|Overall Study|Adverse Event|2
1259854|NCT00514813|4127932|P2|Overall Study|Adverse Event|2
1259855|NCT00514813|4127933|P1|Overall Study|Adverse Event|0
1259856|NCT00514813|4127930|P4|Overall Study|Study terminated|2
1259857|NCT00514813|4127931|P3|Overall Study|Study terminated|40
1259858|NCT00514813|4127932|P2|Overall Study|Study terminated|74
1259859|NCT00514813|4127933|P1|Overall Study|Study terminated|14
1259860|NCT00514735|4127953|P2|Overall Study|Lost to Follow-up|1
1259861|NCT00514735|4127954|P1|Overall Study|Lost to Follow-up|0
1259862|NCT00514735|4127953|P2|Overall Study|Death|0
1259863|NCT00514735|4127954|P1|Overall Study|Death|1
1259864|NCT00514735|4127953|P2|Overall Study|Withdrawal by Subject|5
1259865|NCT00514735|4127954|P1|Overall Study|Withdrawal by Subject|13
1259866|NCT00514683|4127990|P5|Overall Study|Reason other than listed above|1
1259867|NCT00514683|4127991|P4|Overall Study|Reason other than listed above|0
1259868|NCT00514683|4127992|P3|Overall Study|Reason other than listed above|2
1259869|NCT00514683|4127993|P2|Overall Study|Reason other than listed above|1
1259870|NCT00514683|4127994|P1|Overall Study|Reason other than listed above|0
1259871|NCT00514683|4127990|P5|Overall Study|Withdrawal by Subject|4
1259872|NCT00514683|4127991|P4|Overall Study|Withdrawal by Subject|0
1259873|NCT00514683|4127992|P3|Overall Study|Withdrawal by Subject|1
1259874|NCT00514683|4127993|P2|Overall Study|Withdrawal by Subject|2
1259875|NCT00514683|4127994|P1|Overall Study|Withdrawal by Subject|2
1259876|NCT00514683|4127990|P5|Overall Study|Protocol Violation|0
1259877|NCT00514683|4127991|P4|Overall Study|Protocol Violation|1
1259878|NCT00514683|4127992|P3|Overall Study|Protocol Violation|0
1259879|NCT00514683|4127993|P2|Overall Study|Protocol Violation|1
1259880|NCT00514683|4127994|P1|Overall Study|Protocol Violation|1
1259881|NCT00514683|4127990|P5|Overall Study|Adverse Event|27
1259882|NCT00514683|4127991|P4|Overall Study|Adverse Event|13
1259883|NCT00514683|4127992|P3|Overall Study|Adverse Event|15
1259884|NCT00514683|4127993|P2|Overall Study|Adverse Event|20
1259885|NCT00514683|4127994|P1|Overall Study|Adverse Event|21
1259886|NCT00514683|4127990|P5|Overall Study|Not treated|1
1259887|NCT00514683|4127991|P4|Overall Study|Not treated|0
1259888|NCT00514683|4127992|P3|Overall Study|Not treated|0
1259889|NCT00514683|4127993|P2|Overall Study|Not treated|1
1259890|NCT00514683|4127994|P1|Overall Study|Not treated|2
1259891|NCT00514514|4128193|P3|Extension - 4 Years|Adverse Event|3
1259892|NCT00514514|4128194|P2|Extension - 4 Years|Adverse Event|6
1259893|NCT00514514|4128195|P1|Extension - 4 Years|Adverse Event|9
1259894|NCT00514514|4128193|P3|Extension - 4 Years|Death|6
1259895|NCT00514514|4128194|P2|Extension - 4 Years|Death|3
1259896|NCT00514514|4128195|P1|Extension - 4 Years|Death|8
1259897|NCT00514514|4128193|P3|Extension - 4 Years|Administrative problems|1
1259898|NCT00514514|4128194|P2|Extension - 4 Years|Administrative problems|1
1259899|NCT00514514|4128195|P1|Extension - 4 Years|Administrative problems|3
1259900|NCT00514514|4128193|P3|Extension - 4 Years|Lost to Follow-up|9
1259901|NCT00514514|4128194|P2|Extension - 4 Years|Lost to Follow-up|10
1259902|NCT00514514|4128195|P1|Extension - 4 Years|Lost to Follow-up|12
1259903|NCT00514514|4128193|P3|Extension - 4 Years|Withdrawal by Subject|2
1259904|NCT00514514|4128194|P2|Extension - 4 Years|Withdrawal by Subject|2
1259905|NCT00514514|4128195|P1|Extension - 4 Years|Withdrawal by Subject|5
1259906|NCT00514514|4128193|P3|Randomized - 9 Month|Adverse Event|27
1259907|NCT00514514|4128194|P2|Randomized - 9 Month|Adverse Event|44
1259908|NCT00514514|4128195|P1|Randomized - 9 Month|Adverse Event|25
1259909|NCT00514514|4128193|P3|Randomized - 9 Month|Abnormal laboratory values|1
1259910|NCT00514514|4128194|P2|Randomized - 9 Month|Abnormal laboratory values|3
1259911|NCT00514514|4128195|P1|Randomized - 9 Month|Abnormal laboratory values|0
1259912|NCT00514514|4128193|P3|Randomized - 9 Month|Lack of Efficacy|1
1259913|NCT00514514|4128194|P2|Randomized - 9 Month|Lack of Efficacy|3
1259914|NCT00514514|4128195|P1|Randomized - 9 Month|Lack of Efficacy|2
1259915|NCT00514514|4128193|P3|Randomized - 9 Month|Protocol Violation|0
1259916|NCT00514514|4128194|P2|Randomized - 9 Month|Protocol Violation|1
1259917|NCT00514514|4128195|P1|Randomized - 9 Month|Protocol Violation|1
1259918|NCT00514514|4128193|P3|Randomized - 9 Month|Withdrawal by Subject|5
1259919|NCT00514514|4128194|P2|Randomized - 9 Month|Withdrawal by Subject|7
1259920|NCT00514514|4128195|P1|Randomized - 9 Month|Withdrawal by Subject|7
1259921|NCT00514514|4128193|P3|Randomized - 9 Month|Administrative problems|2
1259922|NCT00514514|4128194|P2|Randomized - 9 Month|Administrative problems|1
1259923|NCT00514514|4128195|P1|Randomized - 9 Month|Administrative problems|1
1259924|NCT00514514|4128193|P3|Randomized - 9 Month|Death|2
1259925|NCT00514514|4128194|P2|Randomized - 9 Month|Death|2
1259926|NCT00514514|4128195|P1|Randomized - 9 Month|Death|3
1259927|NCT00514514|4128193|P3|Pre-phase|Withdrawal by Subject|0
1259928|NCT00514514|4128194|P2|Pre-phase|Withdrawal by Subject|0
1259929|NCT00514514|4128195|P1|Pre-phase|Withdrawal by Subject|66
1259930|NCT00514514|4128193|P3|Pre-phase|Adverse Event|0
1259931|NCT00514514|4128194|P2|Pre-phase|Adverse Event|0
1259932|NCT00514514|4128195|P1|Pre-phase|Adverse Event|137
1259933|NCT00514514|4128193|P3|Pre-phase|Lack of Efficacy|0
1259934|NCT00514514|4128194|P2|Pre-phase|Lack of Efficacy|0
1259935|NCT00514514|4128195|P1|Pre-phase|Lack of Efficacy|35
1259936|NCT00514514|4128193|P3|Pre-phase|abnormal lab values|0
1259937|NCT00514514|4128194|P2|Pre-phase|abnormal lab values|0
1259938|NCT00514514|4128195|P1|Pre-phase|abnormal lab values|23
1259939|NCT00514514|4128193|P3|Pre-phase|Lost to Follow-up|0
1259940|NCT00514514|4128194|P2|Pre-phase|Lost to Follow-up|0
1259941|NCT00514514|4128195|P1|Pre-phase|Lost to Follow-up|2
1259942|NCT00514514|4128193|P3|Pre-phase|abnormal test procedure results|0
1259943|NCT00514514|4128194|P2|Pre-phase|abnormal test procedure results|0
1259944|NCT00514514|4128195|P1|Pre-phase|abnormal test procedure results|15
1259945|NCT00514514|4128193|P3|Pre-phase|condition no longer requires study drug|0
1259946|NCT00514514|4128194|P2|Pre-phase|condition no longer requires study drug|0
1259947|NCT00514514|4128195|P1|Pre-phase|condition no longer requires study drug|7
1259948|NCT00514514|4128193|P3|Pre-phase|Protocol Violation|0
1259949|NCT00514514|4128194|P2|Pre-phase|Protocol Violation|0
1259950|NCT00514514|4128195|P1|Pre-phase|Protocol Violation|6
1259951|NCT00514514|4128193|P3|Pre-phase|administrative problems|0
1259952|NCT00514514|4128194|P2|Pre-phase|administrative problems|0
1259953|NCT00514514|4128195|P1|Pre-phase|administrative problems|2
1259954|NCT00514514|4128193|P3|Pre-phase|Death|0
1259955|NCT00514514|4128194|P2|Pre-phase|Death|0
1259956|NCT00514514|4128195|P1|Pre-phase|Death|10
1259957|NCT00514449|4128247|P2|Overall Study|Lost to Follow-up|0
1259958|NCT00514449|4128248|P1|Overall Study|Lost to Follow-up|1
1259959|NCT00514449|4128247|P2|Overall Study|Protocol Violation|2
1259960|NCT00514449|4128248|P1|Overall Study|Protocol Violation|1
1259961|NCT00514449|4128247|P2|Overall Study|Withdrawal by Subject|2
1259962|NCT00514449|4128248|P1|Overall Study|Withdrawal by Subject|1
1259963|NCT00514020|4128269|P1|Overall Study|"patients moved to the no tx group"|6
1259964|NCT00514020|4128269|P1|Overall Study|patient went to radiation treatment|1
1259965|NCT00514020|4128269|P1|Overall Study|other complicating disease|2
1259966|NCT00514020|4128269|P1|Overall Study|disease progression|9
1259967|NCT00514020|4128269|P1|Overall Study|Physician Decision|1
1259968|NCT00514020|4128269|P1|Overall Study|Withdrawal by Subject|3
1259969|NCT00514020|4128269|P1|Overall Study|Adverse Event|6
1259970|NCT00513708|4128301|P3|Overall Study|Lost to Follow-up|4
1259971|NCT00513708|4128302|P2|Overall Study|Lost to Follow-up|4
1259972|NCT00513708|4128303|P1|Overall Study|Lost to Follow-up|4
1259973|NCT00513695|4128317|P1|Overall Study|Progression prior to surgery|3
1259974|NCT00513695|4128317|P1|Overall Study|Discontinued therapy|2
1259975|NCT00513682|4128326|P1|Washout Phase|Adverse Event|2
1259976|NCT00513604|4128356|P5|Overall Study|Death during treatment|0
1259977|NCT00513604|4128357|P4|Overall Study|Death during treatment|0
1259978|NCT00513604|4128358|P3|Overall Study|Death during treatment|2
1259979|NCT00513604|4128359|P2|Overall Study|Death during treatment|3
1259980|NCT00513604|4128360|P1|Overall Study|Death during treatment|0
1259981|NCT00513604|4128356|P5|Overall Study|Not treated|0
1259982|NCT00513604|4128357|P4|Overall Study|Not treated|0
1259983|NCT00513604|4128358|P3|Overall Study|Not treated|1
1259984|NCT00513604|4128359|P2|Overall Study|Not treated|0
1259985|NCT00513604|4128360|P1|Overall Study|Not treated|2
1259986|NCT00513500|4128394|P2|Overall Study|Hospitalized|14
1259987|NCT00513500|4128395|P1|Overall Study|Hospitalized|4
1259988|NCT00513500|4128394|P2|Overall Study|Death|1
1259989|NCT00513500|4128395|P1|Overall Study|Death|2
1259990|NCT00513500|4128394|P2|Overall Study|Lost to Follow-up|39
1259991|NCT00513500|4128395|P1|Overall Study|Lost to Follow-up|35
1259992|NCT00513474|4128407|P2|Overall Study|Participant Withdrew Consent|0
1259993|NCT00513474|4128408|P1|Overall Study|Participant Withdrew Consent|1
1259994|NCT00513474|4128407|P2|Overall Study|Death|9
1259995|NCT00513474|4128408|P1|Overall Study|Death|6
1259996|NCT00513409|4128464|P2|Overall Study|Visit 3 not done|2
1259997|NCT00513409|4128465|P1|Overall Study|Visit 3 not done|1
1259998|NCT00513409|4128464|P2|Overall Study|Physician Decision|0
1259999|NCT00513409|4128465|P1|Overall Study|Physician Decision|1
1260000|NCT00513409|4128464|P2|Overall Study|Lost to Follow-up|1
1260001|NCT00513409|4128465|P1|Overall Study|Lost to Follow-up|0
1260002|NCT00513409|4128464|P2|Overall Study|Withdrawal by Subject|2
1260003|NCT00513409|4128465|P1|Overall Study|Withdrawal by Subject|0
1260004|NCT00513409|4128464|P2|Overall Study|Adverse Event|1
1260005|NCT00513409|4128465|P1|Overall Study|Adverse Event|0
1260006|NCT00513357|4128521|P2|Overall Study|Disease Progression|1
1260007|NCT00513357|4128522|P1|Overall Study|Disease Progression|2
1260008|NCT00513357|4128521|P2|Overall Study|Withdrawal by Subject|4
1260009|NCT00513357|4128522|P1|Overall Study|Withdrawal by Subject|5
1260010|NCT00513357|4128521|P2|Overall Study|Death|0
1260011|NCT00513357|4128522|P1|Overall Study|Death|2
1260012|NCT00513357|4128521|P2|Overall Study|Adverse Event|2
1260013|NCT00513357|4128522|P1|Overall Study|Adverse Event|4
1260014|NCT00513357|4128521|P2|Overall Study|did not receive allocated placebo|3
1260015|NCT00513357|4128522|P1|Overall Study|did not receive allocated placebo|2
1260016|NCT00513305|4128541|P2|Overall Study|Sponsor Decision|2
1260017|NCT00513305|4128542|P1|Overall Study|Sponsor Decision|0
1260018|NCT00513305|4128541|P2|Overall Study|Persistent hypocellularity|1
1260019|NCT00513305|4128542|P1|Overall Study|Persistent hypocellularity|0
1260020|NCT00513305|4128541|P2|Overall Study|Physician Decision|0
1260021|NCT00513305|4128542|P1|Overall Study|Physician Decision|1
1260022|NCT00513305|4128541|P2|Overall Study|Hematologic counts did not recover|0
1260023|NCT00513305|4128542|P1|Overall Study|Hematologic counts did not recover|1
1260024|NCT00513305|4128541|P2|Overall Study|Eligible for stem cell transplant|0
1260025|NCT00513305|4128542|P1|Overall Study|Eligible for stem cell transplant|1
1260026|NCT00513305|4128541|P2|Overall Study|Disease progression|5
1260027|NCT00513305|4128542|P1|Overall Study|Disease progression|8
1260028|NCT00513305|4128541|P2|Overall Study|Withdrawal by Subject|2
1260029|NCT00513305|4128542|P1|Overall Study|Withdrawal by Subject|1
1260030|NCT00513305|4128541|P2|Overall Study|Lack of Efficacy|13
1260031|NCT00513305|4128542|P1|Overall Study|Lack of Efficacy|8
1260032|NCT00513305|4128541|P2|Overall Study|Death (through Consolidation Treatment)|2
1260033|NCT00513305|4128542|P1|Overall Study|Death (through Consolidation Treatment)|2
1260034|NCT00513305|4128541|P2|Overall Study|Adverse Event|2
1260035|NCT00513305|4128542|P1|Overall Study|Adverse Event|6
1260036|NCT00513240|4128579|P2|Overall Study|Withdrawal by Subject|4
1260037|NCT00513240|4128580|P1|Overall Study|Withdrawal by Subject|7
1260038|NCT00513240|4128579|P2|Overall Study|Death|3
1260039|NCT00513240|4128580|P1|Overall Study|Death|3
1260040|NCT00513240|4128579|P2|Overall Study|Did not have intended surgery|0
1260041|NCT00513240|4128580|P1|Overall Study|Did not have intended surgery|3
1260042|NCT00513071|4128587|P1|Overall Study|Physician Decision|3
1260043|NCT00513071|4128587|P1|Overall Study|Withdrawal by Subject|1
1260044|NCT00513071|4128587|P1|Overall Study|Adverse Event|1
1260045|NCT00513019|4128599|P2|Overall Study|Withdrawal by Subject|5
1260046|NCT00513019|4128600|P1|Overall Study|Withdrawal by Subject|4
1260047|NCT00513019|4128599|P2|Overall Study|Adverse Event|0
1260048|NCT00513019|4128600|P1|Overall Study|Adverse Event|1
1260049|NCT00512902|4128606|P1|Overall Study|Lost to Follow-up|1
1260050|NCT00512902|4128606|P1|Overall Study|Adverse Event|7
1260051|NCT00512798|4128621|P2|Overall Study|Withdrawal by Subject|0
1260052|NCT00512798|4128622|P1|Overall Study|Withdrawal by Subject|3
1260053|NCT00512798|4128621|P2|Overall Study|Progression of disease|20
1260054|NCT00512798|4128622|P1|Overall Study|Progression of disease|14
1260055|NCT00512798|4128621|P2|Overall Study|Adverse Event|4
1260056|NCT00512798|4128622|P1|Overall Study|Adverse Event|2
1260057|NCT00512798|4128621|P2|Overall Study|Death|3
1260058|NCT00512798|4128622|P1|Overall Study|Death|0
1260059|NCT00512707|4128633|P2|Overall Study|Unable to tolerate the smell of the gel|0
1260060|NCT00512707|4128634|P1|Overall Study|Unable to tolerate the smell of the gel|1
1260061|NCT00512707|4128633|P2|Overall Study|Developed a hematocrit exceeding 0.54|0
1260062|NCT00512707|4128634|P1|Overall Study|Developed a hematocrit exceeding 0.54|2
1260063|NCT00512707|4128633|P2|Overall Study|Developed skin irritation|1
1260064|NCT00512707|4128634|P1|Overall Study|Developed skin irritation|2
1260065|NCT00512707|4128633|P2|Overall Study|Lost to Follow-up|11
1260066|NCT00512707|4128634|P1|Overall Study|Lost to Follow-up|5
1260067|NCT00512252|4128684|P3|Overall Study|Death|1
1260068|NCT00512252|4128685|P2|Overall Study|Death|0
1260069|NCT00512252|4128686|P1|Overall Study|Death|0
1260070|NCT00512252|4128684|P3|Overall Study|Protocol Violation|1
1260071|NCT00512252|4128685|P2|Overall Study|Protocol Violation|0
1260072|NCT00512252|4128686|P1|Overall Study|Protocol Violation|0
1260073|NCT00512252|4128684|P3|Overall Study|Lost to Follow-up|1
1260074|NCT00512252|4128685|P2|Overall Study|Lost to Follow-up|0
1260075|NCT00512252|4128686|P1|Overall Study|Lost to Follow-up|0
1260076|NCT00512148|4128714|P1|Primay Study Period|Withdrawal by Subject|1
1260077|NCT00512096|4128720|P1|Overall Study|Lack of Efficacy|3
1260078|NCT00512096|4128720|P1|Overall Study|Withdrawal by Subject|2
1260079|NCT00512096|4128720|P1|Overall Study|Adverse Event|2
1260080|NCT00511901|4128748|P2|Overall Study|Withdrawal by Subject|3
1260081|NCT00511901|4128749|P1|Overall Study|Withdrawal by Subject|1
1260082|NCT00511875|4128771|P2|Overall Study|Missing variables|0
1260083|NCT00511875|4128772|P1|Overall Study|Missing variables|1
1260084|NCT00511875|4128771|P2|Overall Study|Lost to Follow-up|0
1260085|NCT00511875|4128772|P1|Overall Study|Lost to Follow-up|4
1260086|NCT00511836|4128812|P2|Double-blind Period|Lost to Follow-up|0
1260087|NCT00511836|4128813|P1|Double-blind Period|Lost to Follow-up|1
1260088|NCT00511810|4128830|P2|Overall Study|Refused second scn|1
1260089|NCT00511810|4128831|P1|Overall Study|Refused second scn|0
1260090|NCT00511810|4128830|P2|Overall Study|Lack of Efficacy|2
1260091|NCT00511810|4128831|P1|Overall Study|Lack of Efficacy|0
1260092|NCT00511810|4128830|P2|Overall Study|Lost to Follow-up|2
1260093|NCT00511810|4128831|P1|Overall Study|Lost to Follow-up|1
1260094|NCT00511797|4128841|P4|Overall Study|Other (moving etc)|2
1260095|NCT00511797|4128842|P3|Overall Study|Other (moving etc)|1
1260096|NCT00511797|4128843|P2|Overall Study|Other (moving etc)|0
1260097|NCT00511797|4128844|P1|Overall Study|Other (moving etc)|1
1260098|NCT00511797|4128841|P4|Overall Study|Partially missing diary|0
1260099|NCT00511797|4128842|P3|Overall Study|Partially missing diary|1
1260100|NCT00511797|4128843|P2|Overall Study|Partially missing diary|0
1260101|NCT00511797|4128844|P1|Overall Study|Partially missing diary|0
1260102|NCT00511797|4128841|P4|Overall Study|Study drug not taken|1
1260103|NCT00511797|4128842|P3|Overall Study|Study drug not taken|0
1260104|NCT00511797|4128843|P2|Overall Study|Study drug not taken|1
1260105|NCT00511797|4128844|P1|Overall Study|Study drug not taken|0
1260106|NCT00511797|4128841|P4|Overall Study|Never dispensed|3
1260107|NCT00511797|4128842|P3|Overall Study|Never dispensed|1
1260108|NCT00511797|4128843|P2|Overall Study|Never dispensed|0
1260109|NCT00511797|4128844|P1|Overall Study|Never dispensed|1
1260110|NCT00511797|4128841|P4|Overall Study|Withdrawal by Subject|2
1260111|NCT00511797|4128842|P3|Overall Study|Withdrawal by Subject|4
1260112|NCT00511797|4128843|P2|Overall Study|Withdrawal by Subject|3
1260113|NCT00511797|4128844|P1|Overall Study|Withdrawal by Subject|3
1260114|NCT00511797|4128841|P4|Overall Study|Protocol Violation|3
1260115|NCT00511797|4128842|P3|Overall Study|Protocol Violation|2
1260116|NCT00511797|4128843|P2|Overall Study|Protocol Violation|2
1260117|NCT00511797|4128844|P1|Overall Study|Protocol Violation|0
1260118|NCT00511797|4128841|P4|Overall Study|Pregnancy|1
1260119|NCT00511797|4128842|P3|Overall Study|Pregnancy|0
1260120|NCT00511797|4128843|P2|Overall Study|Pregnancy|0
1260121|NCT00511797|4128844|P1|Overall Study|Pregnancy|0
1260122|NCT00511797|4128841|P4|Overall Study|Lost to Follow-up|1
1260123|NCT00511797|4128842|P3|Overall Study|Lost to Follow-up|0
1260124|NCT00511797|4128843|P2|Overall Study|Lost to Follow-up|0
1260125|NCT00511797|4128844|P1|Overall Study|Lost to Follow-up|1
1260126|NCT00511797|4128841|P4|Overall Study|Adverse Event|2
1260127|NCT00511797|4128842|P3|Overall Study|Adverse Event|2
1260128|NCT00511797|4128843|P2|Overall Study|Adverse Event|2
1260129|NCT00511797|4128844|P1|Overall Study|Adverse Event|1
1260130|NCT00511667|4128963|P2|Overall Study|Other|1
1260131|NCT00511667|4128964|P1|Overall Study|Other|2
1260132|NCT00511667|4128963|P2|Overall Study|Site terminated|1
1260133|NCT00511667|4128964|P1|Overall Study|Site terminated|6
1260134|NCT00511667|4128963|P2|Overall Study|Withdrawal by Subject|0
1260135|NCT00511667|4128964|P1|Overall Study|Withdrawal by Subject|2
1260136|NCT00511667|4128963|P2|Overall Study|Protocol Violation|1
1260137|NCT00511667|4128964|P1|Overall Study|Protocol Violation|1
1260138|NCT00511667|4128963|P2|Overall Study|Adverse Event|0
1260139|NCT00511667|4128964|P1|Overall Study|Adverse Event|1
1260140|NCT00511472|4128999|P2|Overall Study|Not reported|2
1260141|NCT00511472|4129000|P1|Overall Study|Not reported|2
1260142|NCT00511472|4128999|P2|Overall Study|Laboratory Adverse Event|2
1260143|NCT00511472|4129000|P1|Overall Study|Laboratory Adverse Event|0
1260144|NCT00511472|4128999|P2|Overall Study|Clinical Adverse Event|2
1260145|NCT00511472|4129000|P1|Overall Study|Clinical Adverse Event|1
1260146|NCT00511433|4129019|P2|Overall Study|Other Reason|1
1260147|NCT00511433|4129020|P1|Overall Study|Other Reason|1
1260148|NCT00511433|4129019|P2|Overall Study|Adverse Event|0
1260149|NCT00511433|4129020|P1|Overall Study|Adverse Event|5
1260150|NCT00511355|4129060|P2|Overall Study|Other reason pre-treatment|1
1260151|NCT00511355|4129061|P1|Overall Study|Other reason pre-treatment|0
1260152|NCT00511355|4129060|P2|Overall Study|Withdrawal of informed consent|1
1260153|NCT00511355|4129061|P1|Overall Study|Withdrawal of informed consent|0
1260154|NCT00511355|4129060|P2|Overall Study|Pre-treatment (serious) adverse event|1
1260155|NCT00511355|4129061|P1|Overall Study|Pre-treatment (serious) adverse event|0
1260156|NCT00511355|4129060|P2|Overall Study|Other Reason|1
1260157|NCT00511355|4129061|P1|Overall Study|Other Reason|0
1260158|NCT00511355|4129060|P2|Overall Study|Lost to Follow-up|1
1260159|NCT00511355|4129061|P1|Overall Study|Lost to Follow-up|2
1260160|NCT00511355|4129060|P2|Overall Study|Pregnancy Wish|0
1260161|NCT00511355|4129061|P1|Overall Study|Pregnancy Wish|1
1260162|NCT00511355|4129060|P2|Overall Study|Adverse Event|4
1260163|NCT00511355|4129061|P1|Overall Study|Adverse Event|4
1260164|NCT00511342|4129161|P2|Overall Study|Other Reason|2
1260165|NCT00511342|4129162|P1|Overall Study|Other Reason|2
1260166|NCT00511342|4129161|P2|Overall Study|Lost to Follow-up|5
1260167|NCT00511342|4129162|P1|Overall Study|Lost to Follow-up|1
1260168|NCT00511342|4129161|P2|Overall Study|Pregnancy wish|1
1260169|NCT00511342|4129162|P1|Overall Study|Pregnancy wish|0
1260170|NCT00511342|4129161|P2|Overall Study|Pregnancy|1
1260171|NCT00511342|4129162|P1|Overall Study|Pregnancy|0
1260172|NCT00511342|4129161|P2|Overall Study|Other Adverse Event (AE)/ Serious AE|12
1260173|NCT00511342|4129162|P1|Overall Study|Other Adverse Event (AE)/ Serious AE|8
1260174|NCT00511342|4129161|P2|Overall Study|Unacceptable vaginal bleeding|1
1260175|NCT00511342|4129162|P1|Overall Study|Unacceptable vaginal bleeding|2
1260176|NCT00511238|4129193|P2|Overall Study|various reasons|14
1260177|NCT00511238|4129194|P1|Overall Study|various reasons|4
1260178|NCT00511238|4129193|P2|Overall Study|Progressive Disease|157
1260179|NCT00511238|4129194|P1|Overall Study|Progressive Disease|23
1260180|NCT00511238|4129193|P2|Overall Study|Withdrawal by Subject|22
1260181|NCT00511238|4129194|P1|Overall Study|Withdrawal by Subject|2
1260182|NCT00511238|4129193|P2|Overall Study|Adverse Event|33
1260183|NCT00511238|4129194|P1|Overall Study|Adverse Event|13
1260184|NCT00511199|4129213|P2|Overall Study|Other Reason|37
1260185|NCT00511199|4129214|P1|Overall Study|Other Reason|78
1260186|NCT00511199|4129213|P2|Overall Study|Lost to Follow-up|17
1260187|NCT00511199|4129214|P1|Overall Study|Lost to Follow-up|40
1260188|NCT00511199|4129213|P2|Overall Study|Pregnancy Wish|8
1260189|NCT00511199|4129214|P1|Overall Study|Pregnancy Wish|16
1260190|NCT00511199|4129213|P2|Overall Study|Pregnancy|3
1260191|NCT00511199|4129214|P1|Overall Study|Pregnancy|6
1260192|NCT00511199|4129213|P2|Overall Study|Withdrawal of Informed Consent|4
1260193|NCT00511199|4129214|P1|Overall Study|Withdrawal of Informed Consent|19
1260194|NCT00511199|4129213|P2|Overall Study|Other Adverse Event (AE)/ Serious AE|52
1260195|NCT00511199|4129214|P1|Overall Study|Other Adverse Event (AE)/ Serious AE|227
1260196|NCT00511199|4129213|P2|Overall Study|Unacceptable Vaginal Bleeding|4
1260197|NCT00511199|4129214|P1|Overall Study|Unacceptable Vaginal Bleeding|63
1260198|NCT00511147|4129243|P1|Overall Study|Required platelet transfusion|1
1260199|NCT00511147|4129243|P1|Overall Study|Disease progression|5
1260200|NCT00511147|4129243|P1|Overall Study|Withdrawal by Subject|1
1260201|NCT00511134|4129252|P2|Overall Study|Withdrawal by Subject|2
1260202|NCT00511134|4129253|P1|Overall Study|Withdrawal by Subject|0
1260203|NCT00511108|4129265|P4|Overall Study|Withdrawal by Subject|2
1260204|NCT00511108|4129266|P3|Overall Study|Withdrawal by Subject|3
1260205|NCT00511108|4129267|P2|Overall Study|Withdrawal by Subject|0
1260206|NCT00511108|4129268|P1|Overall Study|Withdrawal by Subject|4
1260207|NCT00511108|4129265|P4|Overall Study|Physician Decision|1
1260208|NCT00511108|4129266|P3|Overall Study|Physician Decision|0
1260209|NCT00511108|4129267|P2|Overall Study|Physician Decision|0
1260210|NCT00511108|4129268|P1|Overall Study|Physician Decision|0
1260211|NCT00511108|4129265|P4|Overall Study|Lost to Follow-up|0
1260212|NCT00511108|4129266|P3|Overall Study|Lost to Follow-up|1
1260213|NCT00511108|4129267|P2|Overall Study|Lost to Follow-up|2
1260214|NCT00511108|4129268|P1|Overall Study|Lost to Follow-up|0
1260215|NCT00511108|4129265|P4|Overall Study|Adverse Event|2
1260216|NCT00511108|4129266|P3|Overall Study|Adverse Event|1
1260217|NCT00511108|4129267|P2|Overall Study|Adverse Event|0
1260218|NCT00511108|4129268|P1|Overall Study|Adverse Event|2
1260219|NCT00511004|4129299|P3|Overall Study|Lost to Follow-up|4
1260220|NCT00511004|4129300|P2|Overall Study|Lost to Follow-up|0
1260221|NCT00511004|4129301|P1|Overall Study|Lost to Follow-up|0
1260222|NCT00510952|4129320|P2|Overall Study|Did Not Receive Study Drug|0
1260223|NCT00510952|4129321|P1|Overall Study|Did Not Receive Study Drug|2
1260224|NCT00510952|4129320|P2|Overall Study|Withdrawal by Subject|7
1260225|NCT00510952|4129321|P1|Overall Study|Withdrawal by Subject|6
1260226|NCT00510952|4129320|P2|Overall Study|Sponsor Decision|0
1260227|NCT00510952|4129321|P1|Overall Study|Sponsor Decision|1
1260228|NCT00510952|4129320|P2|Overall Study|Protocol Violation|4
1260229|NCT00510952|4129321|P1|Overall Study|Protocol Violation|7
1260230|NCT00510952|4129320|P2|Overall Study|Physician Decision|1
1260231|NCT00510952|4129321|P1|Overall Study|Physician Decision|1
1260232|NCT00510952|4129320|P2|Overall Study|Lost to Follow-up|3
1260233|NCT00510952|4129321|P1|Overall Study|Lost to Follow-up|5
1260234|NCT00510952|4129320|P2|Overall Study|Entry Criteria Not Met|1
1260235|NCT00510952|4129321|P1|Overall Study|Entry Criteria Not Met|3
1260236|NCT00510952|4129320|P2|Overall Study|Adverse Event|0
1260237|NCT00510952|4129321|P1|Overall Study|Adverse Event|1
1260238|NCT00510887|4129347|P1|Overall Study|Lost to Follow-up|1
1260239|NCT00510874|4129363|P7|Overall Study|Lost to Follow-up|1
1260240|NCT00510874|4129364|P6|Overall Study|Lost to Follow-up|0
1260241|NCT00510874|4129365|P5|Overall Study|Lost to Follow-up|4
1260242|NCT00510874|4129366|P4|Overall Study|Lost to Follow-up|3
1260243|NCT00510874|4129367|P3|Overall Study|Lost to Follow-up|1
1260244|NCT00510874|4129368|P2|Overall Study|Lost to Follow-up|3
1260245|NCT00510874|4129369|P1|Overall Study|Lost to Follow-up|2
1260246|NCT00510874|4129363|P7|Overall Study|Withdrawal by Subject|0
1260247|NCT00510874|4129364|P6|Overall Study|Withdrawal by Subject|0
1260248|NCT00510874|4129365|P5|Overall Study|Withdrawal by Subject|3
1260249|NCT00510874|4129366|P4|Overall Study|Withdrawal by Subject|0
1260250|NCT00510874|4129367|P3|Overall Study|Withdrawal by Subject|0
1260251|NCT00510874|4129368|P2|Overall Study|Withdrawal by Subject|1
1260252|NCT00510874|4129369|P1|Overall Study|Withdrawal by Subject|1
1260253|NCT00510835|4129472|P3|Overall Study|Withdrawal by Subject|2
1260254|NCT00510835|4129473|P2|Overall Study|Withdrawal by Subject|2
1260255|NCT00510835|4129474|P1|Overall Study|Withdrawal by Subject|6
1260256|NCT00510783|4129500|P2|Overall Study|Protocol Violation|1
1260257|NCT00510783|4129501|P1|Overall Study|Protocol Violation|0
1260258|NCT00510783|4129500|P2|Overall Study|Withdrawal by Subject|3
1260259|NCT00510783|4129501|P1|Overall Study|Withdrawal by Subject|2
1260260|NCT00510783|4129500|P2|Overall Study|Lost to Follow-up|25
1260261|NCT00510783|4129501|P1|Overall Study|Lost to Follow-up|29
1260262|NCT00510692|4129513|P2|Overall Study|Withdrawal by Subject|0
1260263|NCT00510692|4129514|P1|Overall Study|Withdrawal by Subject|1
1260264|NCT00510692|4129513|P2|Overall Study|Adverse Event|3
1260265|NCT00510692|4129514|P1|Overall Study|Adverse Event|1
1260266|NCT00510653|4129528|P1|Overall Study|Monetary|3
1260267|NCT00510653|4129528|P1|Overall Study|Withdrawal by Subject|8
1260268|NCT00510510|4129535|P3|Overall Study|Protocol Violation|4
1260269|NCT00510510|4129536|P2|Overall Study|Protocol Violation|3
1260270|NCT00510510|4129537|P1|Overall Study|Protocol Violation|0
1260271|NCT00510510|4129535|P3|Overall Study|Lost to Follow-up|1
1260272|NCT00510510|4129536|P2|Overall Study|Lost to Follow-up|0
1260273|NCT00510510|4129537|P1|Overall Study|Lost to Follow-up|0
1260274|NCT00510510|4129535|P3|Overall Study|Withdrawal by Subject|3
1260275|NCT00510510|4129536|P2|Overall Study|Withdrawal by Subject|2
1260276|NCT00510510|4129537|P1|Overall Study|Withdrawal by Subject|1
1260277|NCT00510510|4129535|P3|Overall Study|Subjects no longer requires study drug|2
1260278|NCT00510510|4129536|P2|Overall Study|Subjects no longer requires study drug|0
1260279|NCT00510510|4129537|P1|Overall Study|Subjects no longer requires study drug|0
1260280|NCT00510510|4129535|P3|Overall Study|Lack of Efficacy|1
1260281|NCT00510510|4129536|P2|Overall Study|Lack of Efficacy|1
1260282|NCT00510510|4129537|P1|Overall Study|Lack of Efficacy|0
1260283|NCT00510510|4129535|P3|Overall Study|Adverse Event|6
1260284|NCT00510510|4129536|P2|Overall Study|Adverse Event|3
1260285|NCT00510510|4129537|P1|Overall Study|Adverse Event|4
1260286|NCT00510484|4129555|P2|Wash-out Period|Adverse Event|1
1260287|NCT00510484|4129556|P1|Wash-out Period|Adverse Event|0
1260288|NCT00510458|4129576|P1|Overall Study|Revision|2
1260289|NCT00510458|4129576|P1|Overall Study|Withdrawal by Subject|3
1260290|NCT00510458|4129576|P1|Overall Study|Lost to Follow-up|6
1260291|NCT00510458|4129576|P1|Overall Study|Terminated|14
1260292|NCT00510458|4129576|P1|Overall Study|Death|1
1260293|NCT00510458|4129576|P1|Overall Study|5 year not evaluable/missed|21
1260294|NCT00510289|4129589|P1|Overall Study|Progressed prior to starting drug|2
1260295|NCT00510289|4129589|P1|Overall Study|Lost to Follow-up|1
1260296|NCT00510289|4129589|P1|Overall Study|Refused bone marrow biopsy|2
1260297|NCT00510289|4129589|P1|Overall Study|Withdrawal by Subject|7
1260298|NCT00510276|4129599|P2|Extension Open-Label Phase|Subject Decision|9
1260299|NCT00510276|4129600|P1|Extension Open-Label Phase|Subject Decision|7
1260300|NCT00510276|4129599|P2|Extension Open-Label Phase|Sponsor Decision|0
1260301|NCT00510276|4129600|P1|Extension Open-Label Phase|Sponsor Decision|1
1260302|NCT00510276|4129599|P2|Extension Open-Label Phase|Protocol Violation|1
1260303|NCT00510276|4129600|P1|Extension Open-Label Phase|Protocol Violation|0
1260304|NCT00510276|4129599|P2|Extension Open-Label Phase|Physician Decision|3
1260305|NCT00510276|4129600|P1|Extension Open-Label Phase|Physician Decision|2
1260306|NCT00510276|4129599|P2|Extension Open-Label Phase|Lost to Follow-up|10
1260307|NCT00510276|4129600|P1|Extension Open-Label Phase|Lost to Follow-up|12
1260308|NCT00510276|4129599|P2|Extension Open-Label Phase|Lack of Efficacy|7
1260309|NCT00510276|4129600|P1|Extension Open-Label Phase|Lack of Efficacy|2
1260310|NCT00510276|4129599|P2|Extension Open-Label Phase|Adverse Event|18
1260311|NCT00510276|4129600|P1|Extension Open-Label Phase|Adverse Event|9
1260312|NCT00510276|4129599|P2|Acute Double-Blind Phase|Subject Decision|28
1260313|NCT00510276|4129600|P1|Acute Double-Blind Phase|Subject Decision|26
1260314|NCT00510276|4129599|P2|Acute Double-Blind Phase|Sponsor Decision|1
1260315|NCT00510276|4129600|P1|Acute Double-Blind Phase|Sponsor Decision|2
1260316|NCT00510276|4129599|P2|Acute Double-Blind Phase|Protocol Violation|3
1260317|NCT00510276|4129600|P1|Acute Double-Blind Phase|Protocol Violation|4
1260318|NCT00510276|4129599|P2|Acute Double-Blind Phase|Physician Decision|3
1260319|NCT00510276|4129600|P1|Acute Double-Blind Phase|Physician Decision|0
1260320|NCT00510276|4129599|P2|Acute Double-Blind Phase|Lost to Follow-up|49
1260321|NCT00510276|4129600|P1|Acute Double-Blind Phase|Lost to Follow-up|48
1260322|NCT00510276|4129599|P2|Acute Double-Blind Phase|Lack of Efficacy|4
1260323|NCT00510276|4129600|P1|Acute Double-Blind Phase|Lack of Efficacy|3
1260324|NCT00510276|4129599|P2|Acute Double-Blind Phase|Entry Criteria Not Met|1
1260325|NCT00510276|4129600|P1|Acute Double-Blind Phase|Entry Criteria Not Met|1
1260326|NCT00510276|4129599|P2|Acute Double-Blind Phase|Adverse Event|6
1260327|NCT00510276|4129600|P1|Acute Double-Blind Phase|Adverse Event|21
1260328|NCT00510146|4129694|P2|Open-Label Treatment|Sponsor Decision|0
1260329|NCT00510146|4129695|P1|Open-Label Treatment|Sponsor Decision|2
1260330|NCT00510146|4129694|P2|Open-Label Treatment|Clinical Relapse|1
1260331|NCT00510146|4129695|P1|Open-Label Treatment|Clinical Relapse|1
1260332|NCT00510146|4129694|P2|Open-Label Treatment|Withdrawal by Subject|12
1260333|NCT00510146|4129695|P1|Open-Label Treatment|Withdrawal by Subject|24
1260334|NCT00510146|4129694|P2|Open-Label Treatment|Protocol Violation|2
1260335|NCT00510146|4129695|P1|Open-Label Treatment|Protocol Violation|4
1260336|NCT00510146|4129694|P2|Open-Label Treatment|Physician Decision|1
1260337|NCT00510146|4129695|P1|Open-Label Treatment|Physician Decision|3
1260338|NCT00510146|4129694|P2|Open-Label Treatment|Lost to Follow-up|1
1260339|NCT00510146|4129695|P1|Open-Label Treatment|Lost to Follow-up|10
1260340|NCT00510146|4129694|P2|Open-Label Treatment|Lack of Efficacy|0
1260341|NCT00510146|4129695|P1|Open-Label Treatment|Lack of Efficacy|4
1260342|NCT00510146|4129694|P2|Open-Label Treatment|Death|1
1260343|NCT00510146|4129695|P1|Open-Label Treatment|Death|1
1260344|NCT00510146|4129694|P2|Open-Label Treatment|Adverse Event|8
1260345|NCT00510146|4129695|P1|Open-Label Treatment|Adverse Event|22
1260346|NCT00510146|4129694|P2|Double-Blind Treatment|Entry Criteria Not Met|0
1260347|NCT00510146|4129695|P1|Double-Blind Treatment|Entry Criteria Not Met|3
1260348|NCT00510146|4129694|P2|Double-Blind Treatment|Clinical Relapse|1
1260349|NCT00510146|4129695|P1|Double-Blind Treatment|Clinical Relapse|0
1260350|NCT00510146|4129694|P2|Double-Blind Treatment|Withdrawal by Subject|13
1260351|NCT00510146|4129695|P1|Double-Blind Treatment|Withdrawal by Subject|27
1260352|NCT00510146|4129694|P2|Double-Blind Treatment|Protocol Violation|2
1260353|NCT00510146|4129695|P1|Double-Blind Treatment|Protocol Violation|1
1260354|NCT00510146|4129694|P2|Double-Blind Treatment|Physician Decision|0
1260355|NCT00510146|4129695|P1|Double-Blind Treatment|Physician Decision|6
1260356|NCT00510146|4129694|P2|Double-Blind Treatment|Lost to Follow-up|7
1260357|NCT00510146|4129695|P1|Double-Blind Treatment|Lost to Follow-up|3
1260358|NCT00510146|4129694|P2|Double-Blind Treatment|Lack of Efficacy|13
1260359|NCT00510146|4129695|P1|Double-Blind Treatment|Lack of Efficacy|6
1260360|NCT00510146|4129694|P2|Double-Blind Treatment|Adverse Event|13
1260361|NCT00510146|4129695|P1|Double-Blind Treatment|Adverse Event|30
1260362|NCT00510068|4129784|P2|Open-label Period|Abnormal laboratory value (s)|0
1260363|NCT00510068|4129785|P1|Open-label Period|Abnormal laboratory value (s)|1
1260364|NCT00510068|4129784|P2|Open-label Period|Protocol Violation|0
1260365|NCT00510068|4129785|P1|Open-label Period|Protocol Violation|2
1260366|NCT00510068|4129784|P2|Open-label Period|New cancer therapy|0
1260367|NCT00510068|4129785|P1|Open-label Period|New cancer therapy|7
1260368|NCT00510068|4129784|P2|Open-label Period|Death|0
1260369|NCT00510068|4129785|P1|Open-label Period|Death|7
1260370|NCT00510068|4129784|P2|Open-label Period|Administrative problems|0
1260371|NCT00510068|4129785|P1|Open-label Period|Administrative problems|17
1260372|NCT00510068|4129784|P2|Open-label Period|Withdrawal by Subject|0
1260373|NCT00510068|4129785|P1|Open-label Period|Withdrawal by Subject|21
1260374|NCT00510068|4129784|P2|Open-label Period|Adverse Event|0
1260375|NCT00510068|4129785|P1|Open-label Period|Adverse Event|46
1260376|NCT00510068|4129784|P2|Open-label Period|Disease Progression|0
1260377|NCT00510068|4129785|P1|Open-label Period|Disease Progression|124
1260378|NCT00510068|4129784|P2|Double-blind Period|Protocol Violation|0
1260379|NCT00510068|4129785|P1|Double-blind Period|Protocol Violation|6
1260380|NCT00510068|4129784|P2|Double-blind Period|Lost to Follow-up|0
1260381|NCT00510068|4129785|P1|Double-blind Period|Lost to Follow-up|1
1260382|NCT00510068|4129784|P2|Double-blind Period|Abnormal test result (s)|0
1260383|NCT00510068|4129785|P1|Double-blind Period|Abnormal test result (s)|1
1260384|NCT00510068|4129784|P2|Double-blind Period|Death|3
1260385|NCT00510068|4129785|P1|Double-blind Period|Death|4
1260386|NCT00510068|4129784|P2|Double-blind Period|Withdrawal by Subject|6
1260387|NCT00510068|4129785|P1|Double-blind Period|Withdrawal by Subject|8
1260388|NCT00510068|4129784|P2|Double-blind Period|Adverse Event|7
1260389|NCT00510068|4129785|P1|Double-blind Period|Adverse Event|37
1260390|NCT00510068|4129784|P2|Double-blind Period|Final primary analysis|18
1260391|NCT00510068|4129785|P1|Double-blind Period|Final primary analysis|52
1260392|NCT00510068|4129784|P2|Double-blind Period|Disease progression|169
1260393|NCT00510068|4129785|P1|Double-blind Period|Disease progression|98
1260394|NCT00509925|4129826|P2|Overall Study|Personal reasons|1
1260395|NCT00509925|4129827|P1|Overall Study|Personal reasons|0
1260396|NCT00509899|4129875|P8|Overall Study|Lack of Efficacy|0
1260397|NCT00509899|4129876|P7|Overall Study|Lack of Efficacy|0
1260398|NCT00509899|4129877|P6|Overall Study|Lack of Efficacy|1
1260399|NCT00509899|4129878|P5|Overall Study|Lack of Efficacy|0
1260400|NCT00509899|4129879|P4|Overall Study|Lack of Efficacy|0
1260401|NCT00509899|4129880|P3|Overall Study|Lack of Efficacy|2
1260402|NCT00509899|4129881|P2|Overall Study|Lack of Efficacy|0
1260403|NCT00509899|4129882|P1|Overall Study|Lack of Efficacy|1
1260404|NCT00509899|4129875|P8|Overall Study|Death|1
1260405|NCT00509899|4129876|P7|Overall Study|Death|1
1260406|NCT00509899|4129877|P6|Overall Study|Death|1
1260407|NCT00509899|4129878|P5|Overall Study|Death|1
1260408|NCT00509899|4129879|P4|Overall Study|Death|0
1260409|NCT00509899|4129880|P3|Overall Study|Death|3
1260410|NCT00509899|4129881|P2|Overall Study|Death|2
1260411|NCT00509899|4129882|P1|Overall Study|Death|2
1260412|NCT00509899|4129875|P8|Overall Study|Intercurrent Illness|0
1260413|NCT00509899|4129876|P7|Overall Study|Intercurrent Illness|0
1260414|NCT00509899|4129877|P6|Overall Study|Intercurrent Illness|1
1260415|NCT00509899|4129878|P5|Overall Study|Intercurrent Illness|0
1260416|NCT00509899|4129879|P4|Overall Study|Intercurrent Illness|1
1260417|NCT00509899|4129880|P3|Overall Study|Intercurrent Illness|0
1260418|NCT00509899|4129881|P2|Overall Study|Intercurrent Illness|0
1260419|NCT00509899|4129882|P1|Overall Study|Intercurrent Illness|1
1260420|NCT00509899|4129875|P8|Overall Study|Physician Decision|0
1260421|NCT00509899|4129876|P7|Overall Study|Physician Decision|0
1260422|NCT00509899|4129877|P6|Overall Study|Physician Decision|4
1260423|NCT00509899|4129878|P5|Overall Study|Physician Decision|1
1260424|NCT00509899|4129879|P4|Overall Study|Physician Decision|0
1260425|NCT00509899|4129880|P3|Overall Study|Physician Decision|7
1260426|NCT00509899|4129881|P2|Overall Study|Physician Decision|2
1260427|NCT00509899|4129882|P1|Overall Study|Physician Decision|4
1260428|NCT00509899|4129875|P8|Overall Study|Withdrawal by Subject|0
1260429|NCT00509899|4129876|P7|Overall Study|Withdrawal by Subject|0
1260430|NCT00509899|4129877|P6|Overall Study|Withdrawal by Subject|2
1260431|NCT00509899|4129878|P5|Overall Study|Withdrawal by Subject|3
1260432|NCT00509899|4129879|P4|Overall Study|Withdrawal by Subject|0
1260433|NCT00509899|4129880|P3|Overall Study|Withdrawal by Subject|3
1260434|NCT00509899|4129881|P2|Overall Study|Withdrawal by Subject|2
1260435|NCT00509899|4129882|P1|Overall Study|Withdrawal by Subject|6
1260436|NCT00509899|4129875|P8|Overall Study|Unacceptable Toxicity|0
1260437|NCT00509899|4129876|P7|Overall Study|Unacceptable Toxicity|0
1260438|NCT00509899|4129877|P6|Overall Study|Unacceptable Toxicity|0
1260439|NCT00509899|4129878|P5|Overall Study|Unacceptable Toxicity|0
1260440|NCT00509899|4129879|P4|Overall Study|Unacceptable Toxicity|2
1260441|NCT00509899|4129880|P3|Overall Study|Unacceptable Toxicity|0
1260442|NCT00509899|4129881|P2|Overall Study|Unacceptable Toxicity|0
1260443|NCT00509899|4129882|P1|Overall Study|Unacceptable Toxicity|1
1260444|NCT00509899|4129875|P8|Overall Study|Progressive disease|0
1260445|NCT00509899|4129876|P7|Overall Study|Progressive disease|0
1260446|NCT00509899|4129877|P6|Overall Study|Progressive disease|1
1260447|NCT00509899|4129878|P5|Overall Study|Progressive disease|0
1260448|NCT00509899|4129879|P4|Overall Study|Progressive disease|1
1260449|NCT00509899|4129880|P3|Overall Study|Progressive disease|5
1260450|NCT00509899|4129881|P2|Overall Study|Progressive disease|3
1260451|NCT00509899|4129882|P1|Overall Study|Progressive disease|1
1260452|NCT00509795|4129941|P4|Overall Study|Withdrawal by Subject|8
1260453|NCT00509795|4129942|P3|Overall Study|Withdrawal by Subject|7
1260454|NCT00509795|4129943|P2|Overall Study|Withdrawal by Subject|5
1260455|NCT00509795|4129944|P1|Overall Study|Withdrawal by Subject|10
1260456|NCT00509795|4129941|P4|Overall Study|Protocol Violation|1
1260457|NCT00509795|4129942|P3|Overall Study|Protocol Violation|3
1260458|NCT00509795|4129943|P2|Overall Study|Protocol Violation|0
1260459|NCT00509795|4129944|P1|Overall Study|Protocol Violation|3
1260460|NCT00509795|4129941|P4|Overall Study|OTHER|1
1260461|NCT00509795|4129942|P3|Overall Study|OTHER|4
1260462|NCT00509795|4129943|P2|Overall Study|OTHER|0
1260463|NCT00509795|4129944|P1|Overall Study|OTHER|1
1260464|NCT00509795|4129941|P4|Overall Study|Lost to Follow-up|4
1260465|NCT00509795|4129942|P3|Overall Study|Lost to Follow-up|4
1260466|NCT00509795|4129943|P2|Overall Study|Lost to Follow-up|2
1260467|NCT00509795|4129944|P1|Overall Study|Lost to Follow-up|1
1260468|NCT00509795|4129941|P4|Overall Study|Lack of Efficacy|2
1260469|NCT00509795|4129942|P3|Overall Study|Lack of Efficacy|2
1260470|NCT00509795|4129943|P2|Overall Study|Lack of Efficacy|0
1260471|NCT00509795|4129944|P1|Overall Study|Lack of Efficacy|0
1260472|NCT00509795|4129941|P4|Overall Study|Death|7
1260473|NCT00509795|4129942|P3|Overall Study|Death|2
1260474|NCT00509795|4129943|P2|Overall Study|Death|1
1260475|NCT00509795|4129944|P1|Overall Study|Death|3
1260476|NCT00509795|4129941|P4|Overall Study|Adverse Event|4
1260477|NCT00509795|4129942|P3|Overall Study|Adverse Event|5
1260478|NCT00509795|4129943|P2|Overall Study|Adverse Event|3
1260479|NCT00509795|4129944|P1|Overall Study|Adverse Event|4
1260480|NCT00509769|4129975|P1|Overall Study|Use of prohibited therapies during study|1
1260481|NCT00509769|4129975|P1|Overall Study|Physician Decision|8
1260482|NCT00509769|4129975|P1|Overall Study|Patient’s decision|1
1260483|NCT00509769|4129975|P1|Overall Study|Adverse Event|4
1260484|NCT00509769|4129975|P1|Overall Study|Progressive disease|77
1260485|NCT00509600|4129994|P1|Overall Study|Adverse Event|1
1260486|NCT00509366|4130073|P5|Overall Study|Not Treated (Screen Failure)|0
1260487|NCT00509366|4130074|P4|Overall Study|Not Treated (Screen Failure)|0
1260488|NCT00509366|4130075|P3|Overall Study|Not Treated (Screen Failure)|1
1260489|NCT00509366|4130076|P2|Overall Study|Not Treated (Screen Failure)|1
1260490|NCT00509366|4130077|P1|Overall Study|Not Treated (Screen Failure)|1
1260491|NCT00509262|4130101|P2|Overall Study|Withdrawal by Subject|11
1260492|NCT00509262|4130102|P1|Overall Study|Withdrawal by Subject|24
1260493|NCT00509262|4130101|P2|Overall Study|Protocol Violation|2
1260494|NCT00509262|4130102|P1|Overall Study|Protocol Violation|2
1260495|NCT00509262|4130101|P2|Overall Study|Physician Decision|3
1260496|NCT00509262|4130102|P1|Overall Study|Physician Decision|1
1260497|NCT00509262|4130101|P2|Overall Study|Lost to Follow-up|6
1260498|NCT00509262|4130102|P1|Overall Study|Lost to Follow-up|1
1260499|NCT00509262|4130101|P2|Overall Study|Lack of Efficacy|0
1260500|NCT00509262|4130102|P1|Overall Study|Lack of Efficacy|1
1260501|NCT00509262|4130101|P2|Overall Study|Not specified|2
1260502|NCT00509262|4130102|P1|Overall Study|Not specified|2
1260503|NCT00509262|4130101|P2|Overall Study|Adverse Event|18
1260504|NCT00509262|4130102|P1|Overall Study|Adverse Event|16
1260505|NCT00509236|4130120|P2|Overall Study|Scheduled Kidney Transplant|0
1260506|NCT00509236|4130121|P1|Overall Study|Scheduled Kidney Transplant|1
1260507|NCT00509236|4130120|P2|Overall Study|Excluded Medication|1
1260508|NCT00509236|4130121|P1|Overall Study|Excluded Medication|1
1260509|NCT00509236|4130120|P2|Overall Study|Protocol Violation|0
1260510|NCT00509236|4130121|P1|Overall Study|Protocol Violation|3
1260511|NCT00509236|4130120|P2|Overall Study|Withdrawal by Subject|10
1260512|NCT00509236|4130121|P1|Overall Study|Withdrawal by Subject|5
1260513|NCT00509236|4130120|P2|Overall Study|Adverse Event|9
1260514|NCT00509236|4130121|P1|Overall Study|Adverse Event|7
1260515|NCT00509223|4130136|P2|Overall Study|Did not meet revised inclusion criteria|62
1260516|NCT00509223|4130137|P1|Overall Study|Did not meet revised inclusion criteria|56
1260517|NCT00509223|4130136|P2|Overall Study|Including: subject change of address|2
1260518|NCT00509223|4130137|P1|Overall Study|Including: subject change of address|5
1260519|NCT00509223|4130136|P2|Overall Study|Withdrawal by Subject|6
1260520|NCT00509223|4130137|P1|Overall Study|Withdrawal by Subject|25
1260521|NCT00509223|4130136|P2|Overall Study|Adverse Event|1
1260522|NCT00509223|4130137|P1|Overall Study|Adverse Event|1
1260523|NCT00509223|4130136|P2|Overall Study|Lost to Follow-up|1
1260524|NCT00509223|4130137|P1|Overall Study|Lost to Follow-up|1
1260525|NCT00509106|4130160|P2|Overall Study|Death|6
1260526|NCT00509106|4130161|P1|Overall Study|Death|6
1260527|NCT00509106|4130160|P2|Overall Study|Other|0
1260528|NCT00509106|4130161|P1|Overall Study|Other|1
1260529|NCT00509106|4130160|P2|Overall Study|Lost to Follow-up|10
1260530|NCT00509106|4130161|P1|Overall Study|Lost to Follow-up|16
1260531|NCT00509106|4130160|P2|Overall Study|Withdrew consent|8
1260532|NCT00509106|4130161|P1|Overall Study|Withdrew consent|4
1260533|NCT00509106|4130160|P2|Overall Study|At the request of sponsor/investigator|2
1260534|NCT00509106|4130161|P1|Overall Study|At the request of sponsor/investigator|1
1260535|NCT00509106|4130160|P2|Overall Study|Noncompliance|1
1260536|NCT00509106|4130161|P1|Overall Study|Noncompliance|0
1260537|NCT00509106|4130160|P2|Overall Study|Adverse Event|2
1260538|NCT00509106|4130161|P1|Overall Study|Adverse Event|3
1260539|NCT00509067|4130169|P2|Overall Study|Protocol Violation|3
1260540|NCT00509067|4130170|P1|Overall Study|Protocol Violation|0
1260541|NCT00509067|4130169|P2|Overall Study|Adverse Event|1
1260542|NCT00509067|4130170|P1|Overall Study|Adverse Event|3
1260543|NCT00509067|4130169|P2|Overall Study|Lost to Follow-up|1
1260544|NCT00509067|4130170|P1|Overall Study|Lost to Follow-up|1
1260545|NCT00509028|4130189|P2|Overall Study|Non-compliance|1
1260546|NCT00509028|4130190|P1|Overall Study|Non-compliance|2
1260547|NCT00509028|4130189|P2|Overall Study|Protocol Violation|2
1260548|NCT00509028|4130190|P1|Overall Study|Protocol Violation|4
1260549|NCT00509028|4130189|P2|Overall Study|Lost to Follow-up|1
1260550|NCT00509028|4130190|P1|Overall Study|Lost to Follow-up|0
1260551|NCT00509028|4130189|P2|Overall Study|Withdrawal by Subject|3
1260552|NCT00509028|4130190|P1|Overall Study|Withdrawal by Subject|4
1260553|NCT00509028|4130189|P2|Overall Study|Adverse Event|0
1260554|NCT00509028|4130190|P1|Overall Study|Adverse Event|2
1260555|NCT00508924|4130230|P4|Overall Study|Protocol Violation|1
1260556|NCT00508924|4130231|P3|Overall Study|Protocol Violation|1
1260557|NCT00508924|4130232|P2|Overall Study|Protocol Violation|0
1260558|NCT00508924|4130233|P1|Overall Study|Protocol Violation|0
1260559|NCT00508872|4130247|P1|Overall Study|Physician Decision|1
1260560|NCT00508872|4130247|P1|Overall Study|Lost to Follow-up|1
1260561|NCT00508820|4130253|P2|Overall Study|Protocol-specified Criteria|12
1260562|NCT00508820|4130254|P1|Overall Study|Protocol-specified Criteria|3
1260563|NCT00508820|4130253|P2|Overall Study|Requirement for alternative therapy|15
1260564|NCT00508820|4130254|P1|Overall Study|Requirement for alternative therapy|7
1260565|NCT00508820|4130253|P2|Overall Study|Noncompliance|0
1260566|NCT00508820|4130254|P1|Overall Study|Noncompliance|1
1260567|NCT00508820|4130253|P2|Overall Study|Other|2
1260568|NCT00508820|4130254|P1|Overall Study|Other|11
1260569|NCT00508820|4130253|P2|Overall Study|Withdrawal by Subject|12
1260570|NCT00508820|4130254|P1|Overall Study|Withdrawal by Subject|10
1260571|NCT00508820|4130253|P2|Overall Study|Protocol Violation|0
1260572|NCT00508820|4130254|P1|Overall Study|Protocol Violation|2
1260573|NCT00508820|4130253|P2|Overall Study|Pregnancy|2
1260574|NCT00508820|4130254|P1|Overall Study|Pregnancy|0
1260575|NCT00508820|4130253|P2|Overall Study|Physician Decision|2
1260576|NCT00508820|4130254|P1|Overall Study|Physician Decision|8
1260577|NCT00508820|4130253|P2|Overall Study|Lost to Follow-up|1
1260578|NCT00508820|4130254|P1|Overall Study|Lost to Follow-up|1
1260579|NCT00508820|4130253|P2|Overall Study|Death|8
1260580|NCT00508820|4130254|P1|Overall Study|Death|6
1260581|NCT00508820|4130253|P2|Overall Study|Adverse Event|10
1260582|NCT00508820|4130254|P1|Overall Study|Adverse Event|6
1260583|NCT00508755|4130264|P1|Overall Study|Withdrawal by Subject|1
1260584|NCT00508742|4130272|P2|Period 3: Toddler Dose|Other|4
1260585|NCT00508742|4130273|P1|Period 3: Toddler Dose|Other|5
1260586|NCT00508742|4130272|P2|Period 3: Toddler Dose|Parent/Legal Guardian Request|8
1260587|NCT00508742|4130273|P1|Period 3: Toddler Dose|Parent/Legal Guardian Request|17
1260588|NCT00508742|4130272|P2|Period 3: Toddler Dose|Lost to Follow-up|3
1260589|NCT00508742|4130273|P1|Period 3: Toddler Dose|Lost to Follow-up|2
1260590|NCT00508742|4130272|P2|Period 3: Toddler Dose|Adverse Event|0
1260591|NCT00508742|4130273|P1|Period 3: Toddler Dose|Adverse Event|1
1260592|NCT00508742|4130272|P2|Period 2: After Infant Series|Other|1
1260593|NCT00508742|4130273|P1|Period 2: After Infant Series|Other|2
1260594|NCT00508742|4130272|P2|Period 2: After Infant Series|Failed to Return|0
1260595|NCT00508742|4130273|P1|Period 2: After Infant Series|Failed to Return|1
1260596|NCT00508742|4130272|P2|Period 2: After Infant Series|Parent/Legal Guardian Request|3
1260597|NCT00508742|4130273|P1|Period 2: After Infant Series|Parent/Legal Guardian Request|0
1260598|NCT00508742|4130272|P2|Period 2: After Infant Series|Protocol Violation|0
1260599|NCT00508742|4130273|P1|Period 2: After Infant Series|Protocol Violation|1
1260600|NCT00508742|4130272|P2|Period 2: After Infant Series|Lost to Follow-up|1
1260601|NCT00508742|4130273|P1|Period 2: After Infant Series|Lost to Follow-up|1
1260602|NCT00508742|4130272|P2|Period 2: After Infant Series|Adverse Event|6
1260603|NCT00508742|4130273|P1|Period 2: After Infant Series|Adverse Event|2
1260604|NCT00508742|4130272|P2|Period 1: Infant Series|Other|1
1260605|NCT00508742|4130273|P1|Period 1: Infant Series|Other|4
1260606|NCT00508742|4130272|P2|Period 1: Infant Series|Physician Decision|0
1260607|NCT00508742|4130273|P1|Period 1: Infant Series|Physician Decision|1
1260608|NCT00508742|4130272|P2|Period 1: Infant Series|Parent/Legal Guardian Request|40
1260609|NCT00508742|4130273|P1|Period 1: Infant Series|Parent/Legal Guardian Request|31
1260610|NCT00508742|4130272|P2|Period 1: Infant Series|Protocol Violation|0
1260611|NCT00508742|4130273|P1|Period 1: Infant Series|Protocol Violation|1
1260612|NCT00508742|4130272|P2|Period 1: Infant Series|Adverse Event|4
1260613|NCT00508742|4130273|P1|Period 1: Infant Series|Adverse Event|5
1260614|NCT00508651|4130298|P2|Overall Study|Withdrawal by Subject|1
1260615|NCT00508651|4130299|P1|Overall Study|Withdrawal by Subject|1
1260616|NCT00508651|4130298|P2|Overall Study|Lost to Follow-up|1
1260617|NCT00508651|4130299|P1|Overall Study|Lost to Follow-up|3
1260618|NCT00508482|4130380|P3|at the 4th Week of Follow-up|Lost to Follow-up|1
1260619|NCT00508482|4130381|P2|at the 4th Week of Follow-up|Lost to Follow-up|6
1260620|NCT00508482|4130382|P1|at the 4th Week of Follow-up|Lost to Follow-up|20
1260621|NCT00508482|4130380|P3|Over 4 Weeks of Treatment|Lost to Follow-up|16
1260622|NCT00508482|4130381|P2|Over 4 Weeks of Treatment|Lost to Follow-up|10
1260623|NCT00508482|4130382|P1|Over 4 Weeks of Treatment|Lost to Follow-up|12
1260624|NCT00508482|4130380|P3|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|4
1260625|NCT00508482|4130381|P2|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|7
1260626|NCT00508482|4130382|P1|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|9
1260627|NCT00508404|4130426|P1|Overall Study|Other - Not Specified|3
1260628|NCT00508404|4130426|P1|Overall Study|Lost to Follow-up|2
1260629|NCT00508404|4130426|P1|Overall Study|Protocol-specified Criteria|2
1260630|NCT00508404|4130426|P1|Overall Study|Withdrawal by Subject|3
1260631|NCT00508404|4130426|P1|Overall Study|Physician Decision|2
1260632|NCT00508404|4130426|P1|Overall Study|Death|16
1260633|NCT00508404|4130426|P1|Overall Study|Adverse Event|2
1260634|NCT00508404|4130426|P1|Overall Study|Ongoing at Data Cut-off|12
1260635|NCT00508391|4130453|P2|Second Treatment|Withdrawal by Subject|0
1260636|NCT00508391|4130454|P1|Second Treatment|Withdrawal by Subject|2
1260637|NCT00508391|4130453|P2|First Treatment|Withdrawal by Subject|3
1260638|NCT00508391|4130454|P1|First Treatment|Withdrawal by Subject|6
1260639|NCT00508274|4130465|P1|Overall Study|Withdrawal by Subject|1
1260640|NCT00508274|4130465|P1|Overall Study|Adverse Event|1
1260641|NCT00508157|4130493|P2|Overall Study|Other known cause|1
1260642|NCT00508157|4130494|P1|Overall Study|Other known cause|0
1260643|NCT00508157|4130493|P2|Overall Study|Subject no longer met study criteria|1
1260644|NCT00508157|4130494|P1|Overall Study|Subject no longer met study criteria|0
1260645|NCT00508157|4130493|P2|Overall Study|Lost to Follow-up|0
1260646|NCT00508157|4130494|P1|Overall Study|Lost to Follow-up|1
1260647|NCT00508157|4130493|P2|Overall Study|Subject Withdrew Consent|0
1260648|NCT00508157|4130494|P1|Overall Study|Subject Withdrew Consent|1
1260649|NCT00508157|4130493|P2|Overall Study|Adverse Event|1
1260650|NCT00508157|4130494|P1|Overall Study|Adverse Event|0
1260651|NCT00508144|4130516|P1|Overall Study|Death|5
1260652|NCT00508144|4130516|P1|Overall Study|Not eligible|6
1260653|NCT00508027|4130542|P1|Dose Level 2|Withdrawal by Subject|2
1260654|NCT00508027|4130542|P1|Dose Level 2|Lost to Follow-up|2
1260655|NCT00508027|4130542|P1|Dose Level 1|Physician Decision|2
1260656|NCT00508027|4130542|P1|Dose Level 1|Withdrawal by Subject|2
1260657|NCT00508027|4130542|P1|Dose Level 1|Lost to Follow-up|4
1260658|NCT00508001|4130583|P3|Overall Study|Withdrawal by Subject|1
1260659|NCT00508001|4130584|P2|Overall Study|Withdrawal by Subject|4
1260660|NCT00508001|4130585|P1|Overall Study|Withdrawal by Subject|4
1260661|NCT00508001|4130583|P3|Overall Study|Death|1
1260662|NCT00508001|4130584|P2|Overall Study|Death|1
1260663|NCT00508001|4130585|P1|Overall Study|Death|0
1260664|NCT00508001|4130583|P3|Overall Study|condition under investigation worsened|1
1260665|NCT00508001|4130584|P2|Overall Study|condition under investigation worsened|7
1260666|NCT00508001|4130585|P1|Overall Study|condition under investigation worsened|13
1260667|NCT00508001|4130583|P3|Overall Study|Adverse Event|4
1260668|NCT00508001|4130584|P2|Overall Study|Adverse Event|0
1260669|NCT00508001|4130585|P1|Overall Study|Adverse Event|2
1260670|NCT00507819|4130602|P2|Washout (6 Weeks)|Withdrawal by Subject|0
1260671|NCT00507819|4130603|P1|Washout (6 Weeks)|Withdrawal by Subject|1
1260672|NCT00507689|4130622|P2|Randomized Period|Withdrawal by Subject|1
1260673|NCT00507689|4130623|P1|Randomized Period|Withdrawal by Subject|0
1260674|NCT00507689|4130622|P2|Randomized Period|Adverse Event|1
1260675|NCT00507689|4130623|P1|Randomized Period|Adverse Event|1
1260676|NCT00507689|4130622|P2|Pre-Randomization Period|Withdrawal by Subject|0
1260677|NCT00507689|4130623|P1|Pre-Randomization Period|Withdrawal by Subject|1
1260678|NCT00507689|4130622|P2|Pre-Randomization Period|Physician Decision|0
1260679|NCT00507689|4130623|P1|Pre-Randomization Period|Physician Decision|1
1260680|NCT00507689|4130622|P2|Pre-Randomization Period|Adverse Event|0
1260681|NCT00507689|4130623|P1|Pre-Randomization Period|Adverse Event|1
1260682|NCT00507546|4130655|P2|Overall Study|Physician Decision|1
1260683|NCT00507546|4130656|P1|Overall Study|Physician Decision|0
1260684|NCT00507546|4130655|P2|Overall Study|Protocol Violation|0
1260685|NCT00507546|4130656|P1|Overall Study|Protocol Violation|1
1260686|NCT00507546|4130655|P2|Overall Study|Withdrawal by Subject|0
1260687|NCT00507546|4130656|P1|Overall Study|Withdrawal by Subject|1
1260688|NCT00507507|4130666|P2|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16
1260689|NCT00507507|4130667|P1|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9
1260690|NCT00507507|4130666|P2|24-week Treatment-free Follow-up Period|Adverse Event|1
1260691|NCT00507507|4130667|P1|24-week Treatment-free Follow-up Period|Adverse Event|0
1260692|NCT00507507|4130666|P2|24-week Treatment-free Follow-up Period|Physician Decision|0
1260693|NCT00507507|4130667|P1|24-week Treatment-free Follow-up Period|Physician Decision|1
1260694|NCT00507507|4130666|P2|Treatment Period|Withdrawal by Subject|47
1260695|NCT00507507|4130667|P1|Treatment Period|Withdrawal by Subject|46
1260696|NCT00507507|4130666|P2|Treatment Period|Adverse Event|1
1260697|NCT00507507|4130667|P1|Treatment Period|Adverse Event|1
1260698|NCT00507507|4130666|P2|Treatment Period|Protocol Violation|2
1260699|NCT00507507|4130667|P1|Treatment Period|Protocol Violation|1
1260700|NCT00507507|4130666|P2|Treatment Period|Physician Decision|1
1260701|NCT00507507|4130667|P1|Treatment Period|Physician Decision|4
1260702|NCT00507507|4130666|P2|Treatment Period|Lost to Follow-up|2
1260703|NCT00507507|4130667|P1|Treatment Period|Lost to Follow-up|0
1260704|NCT00507455|4130702|P3|Overall Study|Other - miscellaneous reason|1
1260705|NCT00507455|4130703|P2|Overall Study|Other - miscellaneous reason|0
1260706|NCT00507455|4130704|P1|Overall Study|Other - miscellaneous reason|1
1260707|NCT00507455|4130702|P3|Overall Study|Lack of Efficacy|0
1260708|NCT00507455|4130703|P2|Overall Study|Lack of Efficacy|1
1260709|NCT00507455|4130704|P1|Overall Study|Lack of Efficacy|0
1260710|NCT00507455|4130702|P3|Overall Study|Lost to Follow-up|2
1260711|NCT00507455|4130703|P2|Overall Study|Lost to Follow-up|0
1260712|NCT00507455|4130704|P1|Overall Study|Lost to Follow-up|2
1260713|NCT00507455|4130702|P3|Overall Study|Protocol Violation|1
1260714|NCT00507455|4130703|P2|Overall Study|Protocol Violation|1
1260715|NCT00507455|4130704|P1|Overall Study|Protocol Violation|4
1260716|NCT00507455|4130702|P3|Overall Study|Withdrawal by Subject|2
1260717|NCT00507455|4130703|P2|Overall Study|Withdrawal by Subject|1
1260718|NCT00507455|4130704|P1|Overall Study|Withdrawal by Subject|2
1260719|NCT00507455|4130702|P3|Overall Study|Adverse Event|6
1260720|NCT00507455|4130703|P2|Overall Study|Adverse Event|3
1260721|NCT00507455|4130704|P1|Overall Study|Adverse Event|3
1260722|NCT00507442|4130767|P4|Overall Study|Not Specified|2
1260723|NCT00507442|4130768|P3|Overall Study|Not Specified|2
1260724|NCT00507442|4130769|P2|Overall Study|Not Specified|5
1260725|NCT00507442|4130770|P1|Overall Study|Not Specified|2
1260726|NCT00507442|4130767|P4|Overall Study|Withdrawal by Subject|1
1260727|NCT00507442|4130768|P3|Overall Study|Withdrawal by Subject|2
1260728|NCT00507442|4130769|P2|Overall Study|Withdrawal by Subject|4
1260729|NCT00507442|4130770|P1|Overall Study|Withdrawal by Subject|4
1260730|NCT00507442|4130767|P4|Overall Study|Progressive Disease|0
1260731|NCT00507442|4130768|P3|Overall Study|Progressive Disease|2
1260732|NCT00507442|4130769|P2|Overall Study|Progressive Disease|4
1260733|NCT00507442|4130770|P1|Overall Study|Progressive Disease|2
1260734|NCT00507442|4130767|P4|Overall Study|Physician Decision|1
1260735|NCT00507442|4130768|P3|Overall Study|Physician Decision|4
1260736|NCT00507442|4130769|P2|Overall Study|Physician Decision|2
1260737|NCT00507442|4130770|P1|Overall Study|Physician Decision|0
1260738|NCT00507442|4130767|P4|Overall Study|Lost to Follow-up|0
1260739|NCT00507442|4130768|P3|Overall Study|Lost to Follow-up|1
1260740|NCT00507442|4130769|P2|Overall Study|Lost to Follow-up|0
1260741|NCT00507442|4130770|P1|Overall Study|Lost to Follow-up|0
1260742|NCT00507442|4130767|P4|Overall Study|Protocol Violation|0
1260743|NCT00507442|4130768|P3|Overall Study|Protocol Violation|0
1260744|NCT00507442|4130769|P2|Overall Study|Protocol Violation|1
1260745|NCT00507442|4130770|P1|Overall Study|Protocol Violation|0
1260746|NCT00507442|4130767|P4|Overall Study|Adverse Event|1
1260747|NCT00507442|4130768|P3|Overall Study|Adverse Event|4
1260748|NCT00507442|4130769|P2|Overall Study|Adverse Event|11
1260749|NCT00507442|4130770|P1|Overall Study|Adverse Event|8
1260750|NCT00507429|4130822|P2|Maintenance Phase|Progressive Disease|0
1260751|NCT00507429|4130823|P1|Maintenance Phase|Progressive Disease|14
1260752|NCT00507429|4130822|P2|Treatment Phase|Other|3
1260753|NCT00507429|4130823|P1|Treatment Phase|Other|6
1260754|NCT00507429|4130822|P2|Treatment Phase|Physician Decision|2
1260755|NCT00507429|4130823|P1|Treatment Phase|Physician Decision|4
1260756|NCT00507429|4130822|P2|Treatment Phase|Withdrawal by Subject|3
1260757|NCT00507429|4130823|P1|Treatment Phase|Withdrawal by Subject|3
1260758|NCT00507429|4130822|P2|Treatment Phase|Adverse Event|5
1260759|NCT00507429|4130823|P1|Treatment Phase|Adverse Event|12
1260760|NCT00507429|4130822|P2|Treatment Phase|Disease Progression|5
1260761|NCT00507429|4130823|P1|Treatment Phase|Disease Progression|12
1260762|NCT00507416|4130834|P3|Overall Study|Did not Receive Study Treatment|4
1260763|NCT00507416|4130835|P2|Overall Study|Did not Receive Study Treatment|9
1260764|NCT00507416|4130836|P1|Overall Study|Did not Receive Study Treatment|3
1260765|NCT00507416|4130834|P3|Overall Study|Other|13
1260766|NCT00507416|4130835|P2|Overall Study|Other|16
1260767|NCT00507416|4130836|P1|Overall Study|Other|11
1260768|NCT00507416|4130834|P3|Overall Study|Patient declined further treatment|11
1260769|NCT00507416|4130835|P2|Overall Study|Patient declined further treatment|14
1260770|NCT00507416|4130836|P1|Overall Study|Patient declined further treatment|18
1260771|NCT00507416|4130834|P3|Overall Study|Progressive Disease|13
1260772|NCT00507416|4130835|P2|Overall Study|Progressive Disease|10
1260773|NCT00507416|4130836|P1|Overall Study|Progressive Disease|20
1260774|NCT00507416|4130834|P3|Overall Study|Lack ofEfficacy / Physician Decision|8
1260775|NCT00507416|4130835|P2|Overall Study|Lack ofEfficacy / Physician Decision|7
1260776|NCT00507416|4130836|P1|Overall Study|Lack ofEfficacy / Physician Decision|7
1260777|NCT00507416|4130834|P3|Overall Study|Protocol Violation|0
1260778|NCT00507416|4130835|P2|Overall Study|Protocol Violation|2
1260779|NCT00507416|4130836|P1|Overall Study|Protocol Violation|1
1260780|NCT00507416|4130834|P3|Overall Study|Adverse Event|65
1260781|NCT00507416|4130835|P2|Overall Study|Adverse Event|67
1260782|NCT00507416|4130836|P1|Overall Study|Adverse Event|58
1260783|NCT00507130|4130878|P4|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
1260784|NCT00507130|4130879|P3|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
1260785|NCT00507130|4130880|P2|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
1260786|NCT00507130|4130881|P1|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1
1260787|NCT00507130|4130878|P4|Overall Study|Lost to Follow-up|1
1260788|NCT00507130|4130879|P3|Overall Study|Lost to Follow-up|1
1260789|NCT00507130|4130880|P2|Overall Study|Lost to Follow-up|0
1260790|NCT00507130|4130881|P1|Overall Study|Lost to Follow-up|0
1260791|NCT00506948|4130923|P1|Overall Study|Physician Decision|1
1260792|NCT00506948|4130923|P1|Overall Study|Adverse Event|5
1260793|NCT00506948|4130923|P1|Overall Study|Death|4
1260794|NCT00506922|4130932|P5|Overall Study|Withdrawal by Subject|1
1260795|NCT00506922|4130933|P4|Overall Study|Withdrawal by Subject|0
1260796|NCT00506922|4130934|P3|Overall Study|Withdrawal by Subject|0
1260797|NCT00506922|4130935|P2|Overall Study|Withdrawal by Subject|0
1260798|NCT00506922|4130936|P1|Overall Study|Withdrawal by Subject|0
1260799|NCT00506922|4130932|P5|Overall Study|Physician Decision|0
1260800|NCT00506922|4130933|P4|Overall Study|Physician Decision|2
1260801|NCT00506922|4130934|P3|Overall Study|Physician Decision|0
1260802|NCT00506922|4130935|P2|Overall Study|Physician Decision|0
1260803|NCT00506922|4130936|P1|Overall Study|Physician Decision|0
1260804|NCT00506883|4130947|P3|Overall Study|Other|1
1260805|NCT00506883|4130948|P2|Overall Study|Other|1
1260806|NCT00506883|4130949|P1|Overall Study|Other|5
1260807|NCT00506883|4130947|P3|Overall Study|Lack of Efficacy|1
1260808|NCT00506883|4130948|P2|Overall Study|Lack of Efficacy|1
1260809|NCT00506883|4130949|P1|Overall Study|Lack of Efficacy|0
1260810|NCT00506883|4130947|P3|Overall Study|Withdrawal by Subject|1
1260811|NCT00506883|4130948|P2|Overall Study|Withdrawal by Subject|0
1260812|NCT00506883|4130949|P1|Overall Study|Withdrawal by Subject|1
1260813|NCT00506883|4130947|P3|Overall Study|Lost to Follow-up|1
1260814|NCT00506883|4130948|P2|Overall Study|Lost to Follow-up|1
1260815|NCT00506883|4130949|P1|Overall Study|Lost to Follow-up|1
1260816|NCT00506831|4130962|P1|Overall Study|Withdrawal by Subject|1
1260817|NCT00506831|4130962|P1|Overall Study|Death|1
1260818|NCT00506662|4131001|P2|Overall Study|Not recorded|6
1260819|NCT00506662|4131002|P1|Overall Study|Not recorded|4
1260820|NCT00506662|4131001|P2|Overall Study|Trial terminated|16
1260821|NCT00506662|4131002|P1|Overall Study|Trial terminated|10
1260822|NCT00506662|4131001|P2|Overall Study|Protocol Violation|4
1260823|NCT00506662|4131002|P1|Overall Study|Protocol Violation|2
1260824|NCT00506662|4131001|P2|Overall Study|Lack of Efficacy|0
1260825|NCT00506662|4131002|P1|Overall Study|Lack of Efficacy|1
1260826|NCT00506662|4131001|P2|Overall Study|Adverse Event|2
1260827|NCT00506662|4131002|P1|Overall Study|Adverse Event|0
1260828|NCT00506493|4131036|P1|Overall Study|Withdrawal by Subject|5
1260829|NCT00506493|4131036|P1|Overall Study|Death|6
1260830|NCT00506454|4131045|P2|Overall Study|Withdrawal by Subject|1
1260831|NCT00506454|4131046|P1|Overall Study|Withdrawal by Subject|1
1260832|NCT00506441|4131052|P2|Period 2; Double-blind Period|Other Reason|1
1260833|NCT00506441|4131053|P1|Period 2; Double-blind Period|Other Reason|1
1260834|NCT00506441|4131052|P2|Period 2; Double-blind Period|Withdrawal by Subject|0
1260835|NCT00506441|4131053|P1|Period 2; Double-blind Period|Withdrawal by Subject|1
1260836|NCT00506441|4131052|P2|Period 2; Double-blind Period|Physician Decision|1
1260837|NCT00506441|4131053|P1|Period 2; Double-blind Period|Physician Decision|1
1260838|NCT00506441|4131052|P2|Period 2; Double-blind Period|Lack of Efficacy|2
1260839|NCT00506441|4131053|P1|Period 2; Double-blind Period|Lack of Efficacy|0
1260840|NCT00506441|4131052|P2|Period 2; Double-blind Period|Adverse Event|1
1260841|NCT00506441|4131053|P1|Period 2; Double-blind Period|Adverse Event|0
1260842|NCT00506441|4131052|P2|Period 1; Open-label Period|Other Reasons|0
1260843|NCT00506441|4131053|P1|Period 1; Open-label Period|Other Reasons|13
1260844|NCT00506441|4131052|P2|Period 1; Open-label Period|Withdrawal by Subject|0
1260845|NCT00506441|4131053|P1|Period 1; Open-label Period|Withdrawal by Subject|13
1260846|NCT00506441|4131052|P2|Period 1; Open-label Period|Protocol Violation|0
1260847|NCT00506441|4131053|P1|Period 1; Open-label Period|Protocol Violation|9
1260848|NCT00506441|4131052|P2|Period 1; Open-label Period|Physician Decision|0
1260849|NCT00506441|4131053|P1|Period 1; Open-label Period|Physician Decision|5
1260850|NCT00506441|4131052|P2|Period 1; Open-label Period|Lost to Follow-up|0
1260851|NCT00506441|4131053|P1|Period 1; Open-label Period|Lost to Follow-up|2
1260852|NCT00506441|4131052|P2|Period 1; Open-label Period|Lack of Efficacy|0
1260853|NCT00506441|4131053|P1|Period 1; Open-label Period|Lack of Efficacy|13
1260854|NCT00506441|4131052|P2|Period 1; Open-label Period|Adverse Event|0
1260855|NCT00506441|4131053|P1|Period 1; Open-label Period|Adverse Event|21
1260856|NCT00506415|4131061|P4|Extended Open Label (Maximum 48 Weeks)|Death|7
1260857|NCT00506415|4131062|P3|Extended Open Label (Maximum 48 Weeks)|Death|0
1260858|NCT00506415|4131063|P2|Extended Open Label (Maximum 48 Weeks)|Death|0
1260859|NCT00506415|4131064|P1|Extended Open Label (Maximum 48 Weeks)|Death|0
1260860|NCT00506415|4131061|P4|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6
1260861|NCT00506415|4131062|P3|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
1260862|NCT00506415|4131063|P2|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
1260863|NCT00506415|4131064|P1|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
1260864|NCT00506415|4131061|P4|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5
1260865|NCT00506415|4131062|P3|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
1260866|NCT00506415|4131063|P2|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
1260867|NCT00506415|4131064|P1|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
1260868|NCT00506415|4131061|P4|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14
1260869|NCT00506415|4131062|P3|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
1260870|NCT00506415|4131063|P2|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
1260871|NCT00506415|4131064|P1|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
1260872|NCT00506415|4131061|P4|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8
1260873|NCT00506415|4131062|P3|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
1260874|NCT00506415|4131063|P2|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
1260875|NCT00506415|4131064|P1|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
1260876|NCT00506415|4131061|P4|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18
1260877|NCT00506415|4131062|P3|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
1260878|NCT00506415|4131063|P2|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
1260879|NCT00506415|4131064|P1|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
1260880|NCT00506415|4131061|P4|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4
1260881|NCT00506415|4131062|P3|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
1260882|NCT00506415|4131063|P2|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
1260883|NCT00506415|4131064|P1|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
1260884|NCT00506415|4131061|P4|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
1260885|NCT00506415|4131062|P3|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1
1260886|NCT00506415|4131063|P2|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
1260887|NCT00506415|4131064|P1|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
1260888|NCT00506415|4131061|P4|Double Blind (Maximum 48 Weeks )|Administrative problems|0
1260889|NCT00506415|4131062|P3|Double Blind (Maximum 48 Weeks )|Administrative problems|2
1260890|NCT00506415|4131063|P2|Double Blind (Maximum 48 Weeks )|Administrative problems|3
1260891|NCT00506415|4131064|P1|Double Blind (Maximum 48 Weeks )|Administrative problems|0
1260892|NCT00506415|4131061|P4|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
1260893|NCT00506415|4131062|P3|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17
1260967|NCT00506389|4131089|P3|In-treatment Period|Lack of compliance|0
1260894|NCT00506415|4131063|P2|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20
1260895|NCT00506415|4131064|P1|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
1260896|NCT00506415|4131061|P4|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
1260897|NCT00506415|4131062|P3|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6
1260898|NCT00506415|4131063|P2|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4
1260899|NCT00506415|4131064|P1|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
1260900|NCT00506415|4131061|P4|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
1260901|NCT00506415|4131062|P3|Double Blind (Maximum 48 Weeks )|Protocol Violation|3
1260902|NCT00506415|4131063|P2|Double Blind (Maximum 48 Weeks )|Protocol Violation|5
1260903|NCT00506415|4131064|P1|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
1260904|NCT00506415|4131061|P4|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
1260905|NCT00506415|4131062|P3|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
1260906|NCT00506415|4131063|P2|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
1260907|NCT00506415|4131064|P1|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
1260908|NCT00506415|4131061|P4|Double Blind (Maximum 48 Weeks )|Death|0
1260909|NCT00506415|4131062|P3|Double Blind (Maximum 48 Weeks )|Death|3
1260910|NCT00506415|4131063|P2|Double Blind (Maximum 48 Weeks )|Death|5
1260911|NCT00506415|4131064|P1|Double Blind (Maximum 48 Weeks )|Death|0
1260912|NCT00506415|4131061|P4|Double Blind (Maximum 48 Weeks )|Adverse Event|0
1260913|NCT00506415|4131062|P3|Double Blind (Maximum 48 Weeks )|Adverse Event|28
1260914|NCT00506415|4131063|P2|Double Blind (Maximum 48 Weeks )|Adverse Event|33
1260915|NCT00506415|4131064|P1|Double Blind (Maximum 48 Weeks )|Adverse Event|0
1260916|NCT00506415|4131061|P4|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
1260917|NCT00506415|4131062|P3|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
1260918|NCT00506415|4131063|P2|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
1260919|NCT00506415|4131064|P1|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28
1260920|NCT00506415|4131061|P4|Initial Open Label (Maximum 48 Weeks)|Death|0
1260921|NCT00506415|4131062|P3|Initial Open Label (Maximum 48 Weeks)|Death|0
1260922|NCT00506415|4131063|P2|Initial Open Label (Maximum 48 Weeks)|Death|0
1260923|NCT00506415|4131064|P1|Initial Open Label (Maximum 48 Weeks)|Death|22
1260924|NCT00506415|4131061|P4|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
1260925|NCT00506415|4131062|P3|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
1260926|NCT00506415|4131063|P2|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
1260927|NCT00506415|4131064|P1|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7
1260928|NCT00506415|4131061|P4|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
1260929|NCT00506415|4131062|P3|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
1260930|NCT00506415|4131063|P2|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
1260931|NCT00506415|4131064|P1|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22
1260932|NCT00506415|4131061|P4|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
1260933|NCT00506415|4131062|P3|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
1260934|NCT00506415|4131063|P2|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
1260935|NCT00506415|4131064|P1|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88
1260936|NCT00506415|4131061|P4|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
1260937|NCT00506415|4131062|P3|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
1260938|NCT00506415|4131063|P2|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
1260939|NCT00506415|4131064|P1|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58
1260940|NCT00506415|4131061|P4|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
1260941|NCT00506415|4131062|P3|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
1260942|NCT00506415|4131063|P2|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
1260943|NCT00506415|4131064|P1|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1
1260944|NCT00506415|4131061|P4|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
1260945|NCT00506415|4131062|P3|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
1260946|NCT00506415|4131063|P2|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
1260947|NCT00506415|4131064|P1|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1
1260948|NCT00506415|4131061|P4|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
1260949|NCT00506415|4131062|P3|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
1260950|NCT00506415|4131063|P2|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
1260951|NCT00506415|4131064|P1|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272
1260952|NCT00506389|4131089|P3|In-treatment Period|Randomized but not treated|1
1260953|NCT00506389|4131090|P2|In-treatment Period|Randomized but not treated|1
1260954|NCT00506389|4131091|P1|In-treatment Period|Randomized but not treated|4
1260955|NCT00506389|4131089|P3|In-treatment Period|Adverse Event|2
1260956|NCT00506389|4131090|P2|In-treatment Period|Adverse Event|5
1260957|NCT00506389|4131091|P1|In-treatment Period|Adverse Event|11
1260958|NCT00506389|4131089|P3|In-treatment Period|Lack of Efficacy|0
1260959|NCT00506389|4131090|P2|In-treatment Period|Lack of Efficacy|2
1260960|NCT00506389|4131091|P1|In-treatment Period|Lack of Efficacy|0
1260961|NCT00506389|4131089|P3|In-treatment Period|Withdrawal by Subject|4
1260962|NCT00506389|4131090|P2|In-treatment Period|Withdrawal by Subject|3
1260963|NCT00506389|4131091|P1|In-treatment Period|Withdrawal by Subject|3
1260964|NCT00506389|4131089|P3|In-treatment Period|Reasons not related to trial|0
1260965|NCT00506389|4131090|P2|In-treatment Period|Reasons not related to trial|1
1260966|NCT00506389|4131091|P1|In-treatment Period|Reasons not related to trial|4
1260968|NCT00506389|4131090|P2|In-treatment Period|Lack of compliance|0
1260969|NCT00506389|4131091|P1|In-treatment Period|Lack of compliance|1
1260970|NCT00506389|4131089|P3|In-treatment Period|Lost to Follow-up|1
1260971|NCT00506389|4131090|P2|In-treatment Period|Lost to Follow-up|0
1260972|NCT00506389|4131091|P1|In-treatment Period|Lost to Follow-up|0
1260973|NCT00506389|4131089|P3|In-treatment Period|Not specified|4
1260974|NCT00506389|4131090|P2|In-treatment Period|Not specified|3
1260975|NCT00506389|4131091|P1|In-treatment Period|Not specified|3
1260976|NCT00506350|4131117|P9|Overall Study|Not specified|2
1260977|NCT00506350|4131118|P8|Overall Study|Not specified|2
1260978|NCT00506350|4131119|P7|Overall Study|Not specified|0
1260979|NCT00506350|4131120|P6|Overall Study|Not specified|0
1260980|NCT00506350|4131121|P5|Overall Study|Not specified|3
1260981|NCT00506350|4131122|P4|Overall Study|Not specified|0
1260982|NCT00506350|4131123|P3|Overall Study|Not specified|3
1260983|NCT00506350|4131124|P2|Overall Study|Not specified|1
1260984|NCT00506350|4131125|P1|Overall Study|Not specified|1
1260985|NCT00506350|4131117|P9|Overall Study|Medical Reason|0
1260986|NCT00506350|4131118|P8|Overall Study|Medical Reason|0
1260987|NCT00506350|4131119|P7|Overall Study|Medical Reason|0
1260988|NCT00506350|4131120|P6|Overall Study|Medical Reason|0
1260989|NCT00506350|4131121|P5|Overall Study|Medical Reason|1
1260990|NCT00506350|4131122|P4|Overall Study|Medical Reason|0
1260991|NCT00506350|4131123|P3|Overall Study|Medical Reason|0
1260992|NCT00506350|4131124|P2|Overall Study|Medical Reason|0
1260993|NCT00506350|4131125|P1|Overall Study|Medical Reason|0
1260994|NCT00506350|4131117|P9|Overall Study|Lost to Follow-up|2
1260995|NCT00506350|4131118|P8|Overall Study|Lost to Follow-up|0
1260996|NCT00506350|4131119|P7|Overall Study|Lost to Follow-up|0
1260997|NCT00506350|4131120|P6|Overall Study|Lost to Follow-up|1
1260998|NCT00506350|4131121|P5|Overall Study|Lost to Follow-up|2
1260999|NCT00506350|4131122|P4|Overall Study|Lost to Follow-up|1
1261000|NCT00506350|4131123|P3|Overall Study|Lost to Follow-up|1
1261001|NCT00506350|4131124|P2|Overall Study|Lost to Follow-up|1
1261002|NCT00506350|4131125|P1|Overall Study|Lost to Follow-up|1
1261003|NCT00506350|4131117|P9|Overall Study|Withdrawal by Subject|0
1261004|NCT00506350|4131118|P8|Overall Study|Withdrawal by Subject|2
1261005|NCT00506350|4131119|P7|Overall Study|Withdrawal by Subject|1
1261006|NCT00506350|4131120|P6|Overall Study|Withdrawal by Subject|1
1261007|NCT00506350|4131121|P5|Overall Study|Withdrawal by Subject|4
1261008|NCT00506350|4131122|P4|Overall Study|Withdrawal by Subject|1
1261009|NCT00506350|4131123|P3|Overall Study|Withdrawal by Subject|1
1261010|NCT00506350|4131124|P2|Overall Study|Withdrawal by Subject|1
1261011|NCT00506350|4131125|P1|Overall Study|Withdrawal by Subject|0
1261012|NCT00506350|4131117|P9|Overall Study|Protocol Violation|0
1261013|NCT00506350|4131118|P8|Overall Study|Protocol Violation|0
1261014|NCT00506350|4131119|P7|Overall Study|Protocol Violation|1
1261015|NCT00506350|4131120|P6|Overall Study|Protocol Violation|0
1261016|NCT00506350|4131121|P5|Overall Study|Protocol Violation|0
1261017|NCT00506350|4131122|P4|Overall Study|Protocol Violation|0
1261018|NCT00506350|4131123|P3|Overall Study|Protocol Violation|1
1261019|NCT00506350|4131124|P2|Overall Study|Protocol Violation|0
1261020|NCT00506350|4131125|P1|Overall Study|Protocol Violation|0
1261021|NCT00506350|4131117|P9|Overall Study|Adverse Event|1
1261022|NCT00506350|4131118|P8|Overall Study|Adverse Event|1
1261023|NCT00506350|4131119|P7|Overall Study|Adverse Event|0
1261024|NCT00506350|4131120|P6|Overall Study|Adverse Event|0
1261025|NCT00506350|4131121|P5|Overall Study|Adverse Event|0
1261026|NCT00506350|4131122|P4|Overall Study|Adverse Event|0
1261027|NCT00506350|4131123|P3|Overall Study|Adverse Event|0
1261028|NCT00506350|4131124|P2|Overall Study|Adverse Event|0
1261029|NCT00506350|4131125|P1|Overall Study|Adverse Event|0
1261030|NCT00506350|4131117|P9|Overall Study|Serious Adverse Event|0
1261031|NCT00506350|4131118|P8|Overall Study|Serious Adverse Event|0
1261032|NCT00506350|4131119|P7|Overall Study|Serious Adverse Event|0
1261033|NCT00506350|4131120|P6|Overall Study|Serious Adverse Event|0
1261034|NCT00506350|4131121|P5|Overall Study|Serious Adverse Event|0
1261035|NCT00506350|4131122|P4|Overall Study|Serious Adverse Event|0
1261036|NCT00506350|4131123|P3|Overall Study|Serious Adverse Event|0
1261037|NCT00506350|4131124|P2|Overall Study|Serious Adverse Event|0
1261038|NCT00506350|4131125|P1|Overall Study|Serious Adverse Event|1
1261039|NCT00506285|4131272|P2|6-month Open Label Phase|Withdrawal by Subject|5
1261040|NCT00506285|4131273|P1|6-month Open Label Phase|Withdrawal by Subject|9
1261041|NCT00506285|4131272|P2|6-month Open Label Phase|Lost to Follow-up|7
1261042|NCT00506285|4131273|P1|6-month Open Label Phase|Lost to Follow-up|1
1261043|NCT00506285|4131272|P2|Double Blind Cross-Over Phase|Lost to Follow-up|2
1261044|NCT00506285|4131273|P1|Double Blind Cross-Over Phase|Lost to Follow-up|5
1261045|NCT00506285|4131272|P2|Double Blind Cross-Over Phase|Withdrawal by Subject|3
1261046|NCT00506285|4131273|P1|Double Blind Cross-Over Phase|Withdrawal by Subject|4
1261047|NCT00506285|4131272|P2|3 Week Screening Phase|Withdrawal by Subject|10
1261048|NCT00506285|4131273|P1|3 Week Screening Phase|Withdrawal by Subject|17
1261049|NCT00506077|4131288|P2|Treatment Period 2|Withdrawal by Subject|0
1261050|NCT00506077|4131289|P1|Treatment Period 2|Withdrawal by Subject|1
1261051|NCT00506077|4131288|P2|Treatment Period 2|Adverse Event|1
1261052|NCT00506077|4131289|P1|Treatment Period 2|Adverse Event|0
1261053|NCT00506077|4131288|P2|Treatment Period 1|Withdrawal by Subject|0
1261054|NCT00506077|4131289|P1|Treatment Period 1|Withdrawal by Subject|2
1261055|NCT00506077|4131288|P2|Treatment Period 1|Lost to Follow-up|2
1261056|NCT00506077|4131289|P1|Treatment Period 1|Lost to Follow-up|0
1261057|NCT00506077|4131288|P2|Treatment Period 1|Adverse Event|1
1261058|NCT00506077|4131289|P1|Treatment Period 1|Adverse Event|2
1261059|NCT00505934|4131331|P1|Overall Study|Other: IV dose needed to be changed|1
1261060|NCT00505934|4131331|P1|Overall Study|Other: Unable to obtain IV & PK samples|1
1261061|NCT00505934|4131331|P1|Overall Study|Adverse Event|1
1261062|NCT00505921|4131337|P1|Overall Study|Failed to Mobilize|8
1261063|NCT00505921|4131337|P1|Overall Study|Ineligible|1
1261064|NCT00505778|4131354|P2|Overall Study|Took No Study Drug|2
1261065|NCT00505778|4131355|P1|Overall Study|Took No Study Drug|2
1261066|NCT00505778|4131354|P2|Overall Study|Relapse|65
1261067|NCT00505778|4131355|P1|Overall Study|Relapse|65
1261068|NCT00505778|4131354|P2|Overall Study|Withdrawal by Subject|14
1261069|NCT00505778|4131355|P1|Overall Study|Withdrawal by Subject|29
1261070|NCT00505778|4131354|P2|Overall Study|Protocol Violation|9
1261071|NCT00505778|4131355|P1|Overall Study|Protocol Violation|7
1261072|NCT00505778|4131354|P2|Overall Study|Unable to Meet Protocol Criteria|1
1261073|NCT00505778|4131355|P1|Overall Study|Unable to Meet Protocol Criteria|4
1261074|NCT00505778|4131354|P2|Overall Study|Lost to Follow-up|23
1261075|NCT00505778|4131355|P1|Overall Study|Lost to Follow-up|17
1261076|NCT00505778|4131354|P2|Overall Study|Physician Decision|14
1261077|NCT00505778|4131355|P1|Overall Study|Physician Decision|8
1261078|NCT00505778|4131354|P2|Overall Study|Adverse Event|7
1261079|NCT00505778|4131355|P1|Overall Study|Adverse Event|2
1261080|NCT00505765|4131374|P3|Overall Study|Noncompliance|3
1261081|NCT00505765|4131375|P2|Overall Study|Noncompliance|1
1261082|NCT00505765|4131376|P1|Overall Study|Noncompliance|0
1261083|NCT00505765|4131374|P3|Overall Study|Adverse Event|0
1261084|NCT00505765|4131375|P2|Overall Study|Adverse Event|2
1261085|NCT00505765|4131376|P1|Overall Study|Adverse Event|1
1261086|NCT00505765|4131374|P3|Overall Study|Withdrawal by Subject|0
1261087|NCT00505765|4131375|P2|Overall Study|Withdrawal by Subject|0
1261088|NCT00505765|4131376|P1|Overall Study|Withdrawal by Subject|1
1261089|NCT00505752|4131403|P4|Overall Study|Other|2
1261090|NCT00505752|4131404|P3|Overall Study|Other|1
1261091|NCT00505752|4131405|P2|Overall Study|Other|2
1261092|NCT00505752|4131406|P1|Overall Study|Other|1
1261093|NCT00505752|4131403|P4|Overall Study|All embryos/blastocysts discarded|1
1261094|NCT00505752|4131404|P3|Overall Study|All embryos/blastocysts discarded|1
1261095|NCT00505752|4131405|P2|Overall Study|All embryos/blastocysts discarded|0
1261096|NCT00505752|4131406|P1|Overall Study|All embryos/blastocysts discarded|0
1261097|NCT00505752|4131403|P4|Overall Study|No Fertilization|1
1261098|NCT00505752|4131404|P3|Overall Study|No Fertilization|2
1261099|NCT00505752|4131405|P2|Overall Study|No Fertilization|1
1261100|NCT00505752|4131406|P1|Overall Study|No Fertilization|1
1261101|NCT00505752|4131403|P4|Overall Study|No oocytes retrieved|1
1261102|NCT00505752|4131404|P3|Overall Study|No oocytes retrieved|0
1261103|NCT00505752|4131405|P2|Overall Study|No oocytes retrieved|2
1261104|NCT00505752|4131406|P1|Overall Study|No oocytes retrieved|0
1261105|NCT00505752|4131403|P4|Overall Study|Ovarian hyperstimulation syndrome risk|1
1261106|NCT00505752|4131404|P3|Overall Study|Ovarian hyperstimulation syndrome risk|3
1261107|NCT00505752|4131405|P2|Overall Study|Ovarian hyperstimulation syndrome risk|1
1261108|NCT00505752|4131406|P1|Overall Study|Ovarian hyperstimulation syndrome risk|1
1261109|NCT00505752|4131403|P4|Overall Study|Lack of ovarian response|0
1261110|NCT00505752|4131404|P3|Overall Study|Lack of ovarian response|0
1261111|NCT00505752|4131405|P2|Overall Study|Lack of ovarian response|3
1261112|NCT00505752|4131406|P1|Overall Study|Lack of ovarian response|1
1261113|NCT00505752|4131403|P4|Overall Study|Lost to Follow-up|0
1261114|NCT00505752|4131404|P3|Overall Study|Lost to Follow-up|0
1261115|NCT00505752|4131405|P2|Overall Study|Lost to Follow-up|0
1261116|NCT00505752|4131406|P1|Overall Study|Lost to Follow-up|1
1261117|NCT00505752|4131403|P4|Overall Study|Adverse Event|0
1261118|NCT00505752|4131404|P3|Overall Study|Adverse Event|1
1261119|NCT00505752|4131405|P2|Overall Study|Adverse Event|0
1261120|NCT00505752|4131406|P1|Overall Study|Adverse Event|1
1261121|NCT00505687|4131420|P1|Overall Study|Other: As Per Sponsor|8
1261122|NCT00505687|4131420|P1|Overall Study|Other: Disease Progression|1
1261123|NCT00505687|4131420|P1|Overall Study|Other: Neupro Given In Hospital|1
1261124|NCT00505687|4131420|P1|Overall Study|Other: Patches Would Not Stick D/T Sweat|1
1261125|NCT00505687|4131420|P1|Overall Study|Other: Prolonged Hospitalization|1
1261126|NCT00505687|4131420|P1|Overall Study|Other: Scheduled DBS Surgery|1
1261127|NCT00505687|4131420|P1|Overall Study|Other: Underwent Implantation Of DBS|1
1261128|NCT00505687|4131420|P1|Overall Study|Lost to Follow-up|1
1261129|NCT00505687|4131420|P1|Overall Study|Subject withdrew consent|15
1261130|NCT00505687|4131420|P1|Overall Study|Adverse Event|48
1261131|NCT00505687|4131420|P1|Overall Study|Lack of Efficacy|15
1261132|NCT00505687|4131420|P1|Overall Study|Important protocol violation|2
1261133|NCT00505661|4131426|P1|Overall Study|Not Eligible|4
1261134|NCT00505622|4131437|P3|Overall Study|Study termination by sponsor|90
1261135|NCT00505622|4131438|P2|Overall Study|Study termination by sponsor|98
1261136|NCT00505622|4131439|P1|Overall Study|Study termination by sponsor|115
1261137|NCT00505622|4131437|P3|Overall Study|Withdrawal by Subject|2
1261138|NCT00505622|4131438|P2|Overall Study|Withdrawal by Subject|3
1261139|NCT00505622|4131439|P1|Overall Study|Withdrawal by Subject|0
1261140|NCT00505622|4131437|P3|Overall Study|Protocol Violation|0
1261141|NCT00505622|4131438|P2|Overall Study|Protocol Violation|1
1261142|NCT00505622|4131439|P1|Overall Study|Protocol Violation|1
1261143|NCT00505622|4131437|P3|Overall Study|Adverse Event|4
1261144|NCT00505622|4131438|P2|Overall Study|Adverse Event|6
1261145|NCT00505622|4131439|P1|Overall Study|Adverse Event|5
1261146|NCT00505414|4131464|P5|Maintenance Phase|underlying disease and therapy required|0
1261147|NCT00505414|4131465|P4|Maintenance Phase|underlying disease and therapy required|0
1261148|NCT00505414|4131466|P3|Maintenance Phase|underlying disease and therapy required|2
1261149|NCT00505414|4131467|P2|Maintenance Phase|underlying disease and therapy required|2
1261150|NCT00505414|4131468|P1|Maintenance Phase|underlying disease and therapy required|0
1261151|NCT00505414|4131464|P5|Maintenance Phase|Withdrawal by Subject|0
1261152|NCT00505414|4131465|P4|Maintenance Phase|Withdrawal by Subject|0
1261153|NCT00505414|4131466|P3|Maintenance Phase|Withdrawal by Subject|1
1261154|NCT00505414|4131467|P2|Maintenance Phase|Withdrawal by Subject|0
1261155|NCT00505414|4131468|P1|Maintenance Phase|Withdrawal by Subject|0
1261156|NCT00505414|4131464|P5|Maintenance Phase|Lack of Efficacy|0
1261157|NCT00505414|4131465|P4|Maintenance Phase|Lack of Efficacy|0
1261158|NCT00505414|4131466|P3|Maintenance Phase|Lack of Efficacy|1
1261159|NCT00505414|4131467|P2|Maintenance Phase|Lack of Efficacy|1
1261160|NCT00505414|4131468|P1|Maintenance Phase|Lack of Efficacy|2
1261161|NCT00505414|4131464|P5|Maintenance Phase|Death|0
1261162|NCT00505414|4131465|P4|Maintenance Phase|Death|0
1261163|NCT00505414|4131466|P3|Maintenance Phase|Death|1
1261164|NCT00505414|4131467|P2|Maintenance Phase|Death|0
1261165|NCT00505414|4131468|P1|Maintenance Phase|Death|2
1261166|NCT00505414|4131464|P5|Maintenance Phase|Adverse Event|0
1261167|NCT00505414|4131465|P4|Maintenance Phase|Adverse Event|0
1261168|NCT00505414|4131466|P3|Maintenance Phase|Adverse Event|3
1261169|NCT00505414|4131467|P2|Maintenance Phase|Adverse Event|2
1261170|NCT00505414|4131468|P1|Maintenance Phase|Adverse Event|2
1261171|NCT00505414|4131464|P5|Titration Phase|Underlying disease and therapy required|3
1261172|NCT00505414|4131465|P4|Titration Phase|Underlying disease and therapy required|7
1261173|NCT00505414|4131466|P3|Titration Phase|Underlying disease and therapy required|0
1261174|NCT00505414|4131467|P2|Titration Phase|Underlying disease and therapy required|0
1261175|NCT00505414|4131468|P1|Titration Phase|Underlying disease and therapy required|0
1261176|NCT00505414|4131464|P5|Titration Phase|Withdrawal by Subject|4
1261177|NCT00505414|4131465|P4|Titration Phase|Withdrawal by Subject|3
1261178|NCT00505414|4131466|P3|Titration Phase|Withdrawal by Subject|0
1261179|NCT00505414|4131467|P2|Titration Phase|Withdrawal by Subject|0
1261180|NCT00505414|4131468|P1|Titration Phase|Withdrawal by Subject|0
1261181|NCT00505414|4131464|P5|Titration Phase|Protocol Violation|1
1261182|NCT00505414|4131465|P4|Titration Phase|Protocol Violation|0
1261183|NCT00505414|4131466|P3|Titration Phase|Protocol Violation|0
1261184|NCT00505414|4131467|P2|Titration Phase|Protocol Violation|0
1261185|NCT00505414|4131468|P1|Titration Phase|Protocol Violation|0
1261186|NCT00505414|4131464|P5|Titration Phase|Lack of Efficacy|1
1261187|NCT00505414|4131465|P4|Titration Phase|Lack of Efficacy|10
1261188|NCT00505414|4131466|P3|Titration Phase|Lack of Efficacy|0
1261189|NCT00505414|4131467|P2|Titration Phase|Lack of Efficacy|0
1261190|NCT00505414|4131468|P1|Titration Phase|Lack of Efficacy|0
1261191|NCT00505414|4131464|P5|Titration Phase|Death|0
1261192|NCT00505414|4131465|P4|Titration Phase|Death|2
1261193|NCT00505414|4131466|P3|Titration Phase|Death|0
1261194|NCT00505414|4131467|P2|Titration Phase|Death|0
1261195|NCT00505414|4131468|P1|Titration Phase|Death|0
1261196|NCT00505414|4131464|P5|Titration Phase|Adverse Event|3
1261197|NCT00505414|4131465|P4|Titration Phase|Adverse Event|8
1261198|NCT00505414|4131466|P3|Titration Phase|Adverse Event|0
1261199|NCT00505414|4131467|P2|Titration Phase|Adverse Event|0
1261200|NCT00505414|4131468|P1|Titration Phase|Adverse Event|0
1261201|NCT00505375|4131485|P2|Overall Study|Travel issues|1
1261202|NCT00505375|4131486|P1|Overall Study|Travel issues|0
1261203|NCT00505375|4131485|P2|Overall Study|Pregnancy|0
1261204|NCT00505375|4131486|P1|Overall Study|Pregnancy|1
1261205|NCT00505375|4131485|P2|Overall Study|Lost to Follow-up|2
1261206|NCT00505375|4131486|P1|Overall Study|Lost to Follow-up|0
1261207|NCT00505375|4131485|P2|Overall Study|Withdrawal by Subject|2
1261208|NCT00505375|4131486|P1|Overall Study|Withdrawal by Subject|2
1261209|NCT00505375|4131485|P2|Overall Study|Death|0
1261210|NCT00505375|4131486|P1|Overall Study|Death|1
1261211|NCT00505284|4131508|P5|Overall Study|Not specified|4
1261212|NCT00505284|4131509|P4|Overall Study|Not specified|4
1261213|NCT00505284|4131510|P3|Overall Study|Not specified|0
1261214|NCT00505284|4131511|P2|Overall Study|Not specified|0
1261215|NCT00505284|4131512|P1|Overall Study|Not specified|5
1261216|NCT00505284|4131508|P5|Overall Study|Physician Decision|0
1261217|NCT00505284|4131509|P4|Overall Study|Physician Decision|0
1261218|NCT00505284|4131510|P3|Overall Study|Physician Decision|0
1261219|NCT00505284|4131511|P2|Overall Study|Physician Decision|1
1261220|NCT00505284|4131512|P1|Overall Study|Physician Decision|0
1261221|NCT00505284|4131508|P5|Overall Study|Lack of Efficacy|1
1261222|NCT00505284|4131509|P4|Overall Study|Lack of Efficacy|1
1261223|NCT00505284|4131510|P3|Overall Study|Lack of Efficacy|1
1261224|NCT00505284|4131511|P2|Overall Study|Lack of Efficacy|1
1261225|NCT00505284|4131512|P1|Overall Study|Lack of Efficacy|0
1261226|NCT00505284|4131508|P5|Overall Study|Withdrawal by Subject|6
1261227|NCT00505284|4131509|P4|Overall Study|Withdrawal by Subject|0
1261228|NCT00505284|4131510|P3|Overall Study|Withdrawal by Subject|1
1261229|NCT00505284|4131511|P2|Overall Study|Withdrawal by Subject|6
1261230|NCT00505284|4131512|P1|Overall Study|Withdrawal by Subject|2
1261231|NCT00505284|4131508|P5|Overall Study|Protocol Violation|0
1261232|NCT00505284|4131509|P4|Overall Study|Protocol Violation|0
1261233|NCT00505284|4131510|P3|Overall Study|Protocol Violation|1
1261234|NCT00505284|4131511|P2|Overall Study|Protocol Violation|1
1261235|NCT00505284|4131512|P1|Overall Study|Protocol Violation|0
1261236|NCT00505284|4131508|P5|Overall Study|Adverse Event|22
1261237|NCT00505284|4131509|P4|Overall Study|Adverse Event|14
1261238|NCT00505284|4131510|P3|Overall Study|Adverse Event|9
1261239|NCT00505284|4131511|P2|Overall Study|Adverse Event|7
1261240|NCT00505284|4131512|P1|Overall Study|Adverse Event|3
1261241|NCT00505076|4131582|P3|Overall Study|Withdrawal by Subject|2
1261242|NCT00505076|4131583|P2|Overall Study|Withdrawal by Subject|1
1261243|NCT00505076|4131584|P1|Overall Study|Withdrawal by Subject|0
1261244|NCT00505076|4131582|P3|Overall Study|Protocol Violation|2
1261245|NCT00505076|4131583|P2|Overall Study|Protocol Violation|1
1261246|NCT00505076|4131584|P1|Overall Study|Protocol Violation|2
1261247|NCT00505076|4131582|P3|Overall Study|Adverse Event|1
1261248|NCT00505076|4131583|P2|Overall Study|Adverse Event|0
1261249|NCT00505076|4131584|P1|Overall Study|Adverse Event|1
1261250|NCT00504881|4131613|P2|Overall Study|AE of unknown type|0
1261251|NCT00504881|4131614|P1|Overall Study|AE of unknown type|1
1261252|NCT00504881|4131613|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2
1261253|NCT00504881|4131614|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
1261254|NCT00504881|4131613|P2|Overall Study|AE, non-serious non-fatal|14
1261255|NCT00504881|4131614|P1|Overall Study|AE, non-serious non-fatal|4
1261256|NCT00504881|4131613|P2|Overall Study|SAE, non-fatal|6
1261257|NCT00504881|4131614|P1|Overall Study|SAE, non-fatal|2
1261258|NCT00504881|4131613|P2|Overall Study|AE, serious fatal|1
1261259|NCT00504881|4131614|P1|Overall Study|AE, serious fatal|0
1261260|NCT00504881|4131613|P2|Overall Study|Safety Visit not performed|1
1261261|NCT00504881|4131614|P1|Overall Study|Safety Visit not performed|0
1261262|NCT00504881|4131613|P2|Overall Study|No Birth Control|1
1261263|NCT00504881|4131614|P1|Overall Study|No Birth Control|0
1261264|NCT00504881|4131613|P2|Overall Study|Non-Compliance|0
1261265|NCT00504881|4131614|P1|Overall Study|Non-Compliance|1
1261266|NCT00504881|4131613|P2|Overall Study|Withdrawal by Subject|4
1261267|NCT00504881|4131614|P1|Overall Study|Withdrawal by Subject|1
1261268|NCT00504881|4131613|P2|Overall Study|Lost to Follow-up|2
1261269|NCT00504881|4131614|P1|Overall Study|Lost to Follow-up|0
1261270|NCT00504881|4131613|P2|Overall Study|Lack of Efficacy|5
1261271|NCT00504881|4131614|P1|Overall Study|Lack of Efficacy|1
1261272|NCT00504777|4131664|P1|Overall Study|Adverse Event|1
1261273|NCT00504725|4131677|P2|Overall Study|Protocol Violation|0
1261274|NCT00504725|4131678|P1|Overall Study|Protocol Violation|1
1261275|NCT00504595|4131701|P4|Overall Study|Not specified|0
1261276|NCT00504595|4131702|P3|Overall Study|Not specified|2
1261277|NCT00504595|4131703|P2|Overall Study|Not specified|0
1261278|NCT00504595|4131704|P1|Overall Study|Not specified|0
1261279|NCT00504595|4131701|P4|Overall Study|Lack of Efficacy|0
1261280|NCT00504595|4131702|P3|Overall Study|Lack of Efficacy|0
1261281|NCT00504595|4131703|P2|Overall Study|Lack of Efficacy|0
1261282|NCT00504595|4131704|P1|Overall Study|Lack of Efficacy|1
1261283|NCT00504556|4131721|P5|Overall Study|not in safety analysis set|1
1261284|NCT00504556|4131722|P4|Overall Study|not in safety analysis set|0
1261285|NCT00504556|4131723|P3|Overall Study|not in safety analysis set|1
1261286|NCT00504556|4131724|P2|Overall Study|not in safety analysis set|1
1261287|NCT00504556|4131725|P1|Overall Study|not in safety analysis set|0
1261288|NCT00504556|4131721|P5|Overall Study|not specified|0
1261289|NCT00504556|4131722|P4|Overall Study|not specified|3
1261290|NCT00504556|4131723|P3|Overall Study|not specified|2
1261291|NCT00504556|4131724|P2|Overall Study|not specified|2
1261292|NCT00504556|4131725|P1|Overall Study|not specified|2
1261293|NCT00504556|4131721|P5|Overall Study|data monitor committee decision|0
1261294|NCT00504556|4131722|P4|Overall Study|data monitor committee decision|100
1261295|NCT00504556|4131723|P3|Overall Study|data monitor committee decision|0
1261296|NCT00504556|4131724|P2|Overall Study|data monitor committee decision|0
1261297|NCT00504556|4131725|P1|Overall Study|data monitor committee decision|0
1261298|NCT00504556|4131721|P5|Overall Study|did not meet entry criteria|0
1261299|NCT00504556|4131722|P4|Overall Study|did not meet entry criteria|1
1261300|NCT00504556|4131723|P3|Overall Study|did not meet entry criteria|1
1261301|NCT00504556|4131724|P2|Overall Study|did not meet entry criteria|0
1261302|NCT00504556|4131725|P1|Overall Study|did not meet entry criteria|2
1261303|NCT00504556|4131721|P5|Overall Study|administrative reasons|2
1261304|NCT00504556|4131722|P4|Overall Study|administrative reasons|1
1261305|NCT00504556|4131723|P3|Overall Study|administrative reasons|2
1261306|NCT00504556|4131724|P2|Overall Study|administrative reasons|2
1261307|NCT00504556|4131725|P1|Overall Study|administrative reasons|0
1261308|NCT00504556|4131721|P5|Overall Study|Withdrawal by Subject|12
1261309|NCT00504556|4131722|P4|Overall Study|Withdrawal by Subject|8
1261310|NCT00504556|4131723|P3|Overall Study|Withdrawal by Subject|7
1261311|NCT00504556|4131724|P2|Overall Study|Withdrawal by Subject|16
1261312|NCT00504556|4131725|P1|Overall Study|Withdrawal by Subject|16
1261313|NCT00504556|4131721|P5|Overall Study|Lost to Follow-up|1
1261314|NCT00504556|4131722|P4|Overall Study|Lost to Follow-up|1
1261315|NCT00504556|4131723|P3|Overall Study|Lost to Follow-up|1
1261316|NCT00504556|4131724|P2|Overall Study|Lost to Follow-up|0
1261317|NCT00504556|4131725|P1|Overall Study|Lost to Follow-up|0
1261318|NCT00504556|4131721|P5|Overall Study|Protocol Violation|2
1261319|NCT00504556|4131722|P4|Overall Study|Protocol Violation|1
1261320|NCT00504556|4131723|P3|Overall Study|Protocol Violation|2
1261321|NCT00504556|4131724|P2|Overall Study|Protocol Violation|3
1261322|NCT00504556|4131725|P1|Overall Study|Protocol Violation|1
1261323|NCT00504556|4131721|P5|Overall Study|Death|2
1261324|NCT00504556|4131722|P4|Overall Study|Death|0
1261325|NCT00504556|4131723|P3|Overall Study|Death|1
1261326|NCT00504556|4131724|P2|Overall Study|Death|3
1261327|NCT00504556|4131725|P1|Overall Study|Death|3
1261328|NCT00504556|4131721|P5|Overall Study|Adverse Event|5
1261329|NCT00504556|4131722|P4|Overall Study|Adverse Event|13
1261330|NCT00504556|4131723|P3|Overall Study|Adverse Event|14
1261331|NCT00504556|4131724|P2|Overall Study|Adverse Event|11
1261332|NCT00504556|4131725|P1|Overall Study|Adverse Event|11
1261333|NCT00504426|4131793|P4|Overall Study|Withdrawal by Subject|0
1261334|NCT00504426|4131794|P3|Overall Study|Withdrawal by Subject|0
1261335|NCT00504426|4131795|P2|Overall Study|Withdrawal by Subject|0
1261336|NCT00504426|4131796|P1|Overall Study|Withdrawal by Subject|2
1261337|NCT00504426|4131793|P4|Overall Study|Protocol Violation|0
1261338|NCT00504426|4131794|P3|Overall Study|Protocol Violation|2
1261339|NCT00504426|4131795|P2|Overall Study|Protocol Violation|1
1261340|NCT00504426|4131796|P1|Overall Study|Protocol Violation|1
1261341|NCT00504426|4131793|P4|Overall Study|Adverse Event|0
1261342|NCT00504426|4131794|P3|Overall Study|Adverse Event|2
1261343|NCT00504426|4131795|P2|Overall Study|Adverse Event|0
1261344|NCT00504426|4131796|P1|Overall Study|Adverse Event|0
1261345|NCT00504309|4131816|P6|Overall Study|Withdrawal by Subject|0
1261346|NCT00504309|4131817|P5|Overall Study|Withdrawal by Subject|0
1261347|NCT00504309|4131818|P4|Overall Study|Withdrawal by Subject|0
1261348|NCT00504309|4131819|P3|Overall Study|Withdrawal by Subject|1
1261349|NCT00504309|4131820|P2|Overall Study|Withdrawal by Subject|0
1261350|NCT00504309|4131821|P1|Overall Study|Withdrawal by Subject|0
1261351|NCT00504309|4131816|P6|Overall Study|Death|0
1261352|NCT00504309|4131817|P5|Overall Study|Death|1
1261353|NCT00504309|4131818|P4|Overall Study|Death|0
1261354|NCT00504309|4131819|P3|Overall Study|Death|0
1261355|NCT00504309|4131820|P2|Overall Study|Death|0
1261356|NCT00504309|4131821|P1|Overall Study|Death|0
1261357|NCT00504257|4131859|P1|Overall Study|ineligible histology|2
1261358|NCT00504257|4131859|P1|Overall Study|Withdrawal by Subject|2
1261359|NCT00504231|4131871|P4|Overall Study|Discrepant chart documentation re route|0
1261360|NCT00504231|4131872|P3|Overall Study|Discrepant chart documentation re route|1
1261361|NCT00504231|4131873|P2|Overall Study|Discrepant chart documentation re route|0
1261362|NCT00504231|4131874|P1|Overall Study|Discrepant chart documentation re route|0
1261363|NCT00504166|4131894|P2|Overall Study|Lost to Follow-up|3
1261364|NCT00504166|4131895|P1|Overall Study|Lost to Follow-up|1
1261365|NCT00504166|4131894|P2|Overall Study|Physician Decision|1
1261366|NCT00504166|4131895|P1|Overall Study|Physician Decision|1
1261367|NCT00504166|4131894|P2|Overall Study|Withdrawal by Subject|6
1261368|NCT00504166|4131895|P1|Overall Study|Withdrawal by Subject|3
1261369|NCT00504166|4131894|P2|Overall Study|Adverse Event|4
1261370|NCT00504166|4131895|P1|Overall Study|Adverse Event|1
1261371|NCT00504153|4131901|P1|Overall Study|Death|1
1261372|NCT00504153|4131901|P1|Overall Study|Adverse Event|4
1261373|NCT00504153|4131901|P1|Overall Study|Withdrawal by Subject|1
1261374|NCT00504075|4131909|P1|Overall Study|Required other therapeutic intervention|1
1261375|NCT00504075|4131909|P1|Overall Study|Withdrawal by Subject|1
1261376|NCT00504075|4131909|P1|Overall Study|Lost to Follow-up|5
1261377|NCT00504075|4131909|P1|Overall Study|Adverse Event|1
1261378|NCT00503997|4131919|P1|Overall Study|Withdrawal by Subject|1
1261379|NCT00503997|4131919|P1|Overall Study|Death|1
1261380|NCT00503997|4131919|P1|Overall Study|Adverse Event|5
1261381|NCT00503997|4131919|P1|Overall Study|disease progression|1
1261382|NCT00503984|4131925|P6|Overall Study|Death|0
1261383|NCT00503984|4131926|P5|Overall Study|Death|1
1261384|NCT00503984|4131927|P4|Overall Study|Death|0
1261385|NCT00503984|4131928|P3|Overall Study|Death|0
1261386|NCT00503984|4131929|P2|Overall Study|Death|0
1261387|NCT00503984|4131930|P1|Overall Study|Death|0
1261388|NCT00503984|4131925|P6|Overall Study|Adverse Event|0
1261389|NCT00503984|4131926|P5|Overall Study|Adverse Event|0
1261390|NCT00503984|4131927|P4|Overall Study|Adverse Event|0
1261391|NCT00503984|4131928|P3|Overall Study|Adverse Event|0
1261392|NCT00503984|4131929|P2|Overall Study|Adverse Event|1
1261393|NCT00503984|4131930|P1|Overall Study|Adverse Event|0
1261394|NCT00503984|4131925|P6|Overall Study|Protocol Violation|0
1261395|NCT00503984|4131926|P5|Overall Study|Protocol Violation|0
1261396|NCT00503984|4131927|P4|Overall Study|Protocol Violation|0
1261397|NCT00503984|4131928|P3|Overall Study|Protocol Violation|0
1261398|NCT00503984|4131929|P2|Overall Study|Protocol Violation|1
1261399|NCT00503984|4131930|P1|Overall Study|Protocol Violation|0
1261400|NCT00503906|4131956|P1|Overall Study|Withdrawal by Subject|1
1261401|NCT00503841|4131978|P1|Overall Study|All screen failures|44
1261402|NCT00503776|4131986|P4|Overall Study|Physician Decision|1
1261403|NCT00503776|4131987|P3|Overall Study|Physician Decision|1
1261404|NCT00503776|4131988|P2|Overall Study|Physician Decision|0
1261405|NCT00503776|4131989|P1|Overall Study|Physician Decision|0
1261406|NCT00503776|4131986|P4|Overall Study|Withdrawal by Subject|1
1261407|NCT00503776|4131987|P3|Overall Study|Withdrawal by Subject|1
1261408|NCT00503776|4131988|P2|Overall Study|Withdrawal by Subject|0
1261409|NCT00503776|4131989|P1|Overall Study|Withdrawal by Subject|1
1261410|NCT00503698|4132022|P2|Overall Study|Not exposed to trial drug|6
1261411|NCT00503698|4132023|P1|Overall Study|Not exposed to trial drug|11
1261412|NCT00503698|4132022|P2|Overall Study|Unclassified|32
1261413|NCT00503698|4132023|P1|Overall Study|Unclassified|48
1261414|NCT00503698|4132022|P2|Overall Study|Critically ill|0
1261415|NCT00503698|4132023|P1|Overall Study|Critically ill|2
1261416|NCT00503698|4132022|P2|Overall Study|Move to nonparticipating dialysis center|1
1261417|NCT00503698|4132023|P1|Overall Study|Move to nonparticipating dialysis center|2
1261418|NCT00503698|4132022|P2|Overall Study|Switch to peritoneal or home dialysis|2
1261419|NCT00503698|4132023|P1|Overall Study|Switch to peritoneal or home dialysis|2
1261420|NCT00503698|4132022|P2|Overall Study|Any condition in exclusion criteria|6
1261421|NCT00503698|4132023|P1|Overall Study|Any condition in exclusion criteria|4
1261422|NCT00503698|4132022|P2|Overall Study|Pregnancy/intention to become pregnant|0
1261423|NCT00503698|4132023|P1|Overall Study|Pregnancy/intention to become pregnant|1
1261424|NCT00503698|4132022|P2|Overall Study|End hemodialysis due to renal transplant|4
1261425|NCT00503698|4132023|P1|Overall Study|End hemodialysis due to renal transplant|10
1261426|NCT00503698|4132022|P2|Overall Study|Trial terminated|253
1261427|NCT00503698|4132023|P1|Overall Study|Trial terminated|216
1261428|NCT00503698|4132022|P2|Overall Study|Lack of Efficacy|4
1261429|NCT00503698|4132023|P1|Overall Study|Lack of Efficacy|3
1261430|NCT00503698|4132022|P2|Overall Study|Death|0
1261431|NCT00503698|4132023|P1|Overall Study|Death|1
1261432|NCT00503698|4132022|P2|Overall Study|Adverse Event|41
1261433|NCT00503698|4132023|P1|Overall Study|Adverse Event|52
1261434|NCT00503698|4132022|P2|Overall Study|Protocol Violation|6
1261435|NCT00503698|4132023|P1|Overall Study|Protocol Violation|5
1261436|NCT00503685|4132040|P3|Overall Study|Eligibility Criteria Not Met|0
1261437|NCT00503685|4132041|P2|Overall Study|Eligibility Criteria Not Met|1
1261438|NCT00503685|4132042|P1|Overall Study|Eligibility Criteria Not Met|0
1261439|NCT00503685|4132040|P3|Overall Study|Protocol Violation|0
1261440|NCT00503685|4132041|P2|Overall Study|Protocol Violation|1
1261441|NCT00503685|4132042|P1|Overall Study|Protocol Violation|0
1261442|NCT00503685|4132040|P3|Overall Study|Withdrawal by Subject|0
1261443|NCT00503685|4132041|P2|Overall Study|Withdrawal by Subject|1
1261444|NCT00503685|4132042|P1|Overall Study|Withdrawal by Subject|0
1261445|NCT00503685|4132040|P3|Overall Study|Adverse Event|2
1261446|NCT00503685|4132041|P2|Overall Study|Adverse Event|0
1261447|NCT00503685|4132042|P1|Overall Study|Adverse Event|0
1261448|NCT00503425|4132084|P1|Overall Study|Missing Data/Unknown|4
1261449|NCT00503425|4132084|P1|Overall Study|Death|3
1261450|NCT00503425|4132084|P1|Overall Study|Lost to Follow-up|3
1261451|NCT00503425|4132084|P1|Overall Study|Withdrawal by Subject|8
1261452|NCT00503425|4132084|P1|Overall Study|Lack of Efficacy|25
1261453|NCT00503425|4132084|P1|Overall Study|Adverse Event|5
1261454|NCT00503425|4132084|P1|Overall Study|Participant files lost|6
1261455|NCT00503399|4132094|P2|Overall Study|Lost to Follow-up|2
1261456|NCT00503399|4132095|P1|Overall Study|Lost to Follow-up|0
1261457|NCT00503399|4132094|P2|Overall Study|Adverse Event|3
1261458|NCT00503399|4132095|P1|Overall Study|Adverse Event|0
1261459|NCT00503399|4132094|P2|Overall Study|Withdrawal by Subject|2
1261460|NCT00503399|4132095|P1|Overall Study|Withdrawal by Subject|4
1261461|NCT00503399|4132094|P2|Overall Study|Protocol Violation|0
1261462|NCT00503399|4132095|P1|Overall Study|Protocol Violation|1
1261463|NCT00503399|4132094|P2|Overall Study|Death|1
1261464|NCT00503399|4132095|P1|Overall Study|Death|2
1261465|NCT00503308|4132119|P2|Overall Study|Protocol Violation|1
1261466|NCT00503308|4132120|P1|Overall Study|Protocol Violation|2
1261467|NCT00503139|4132126|P1|Overall Study|Protocol Violation|4
1261468|NCT00503139|4132126|P1|Overall Study|Case Report Forms were not collected|4
1261469|NCT00503009|4132174|P3|Overall Study|Physician Decision|1
1261470|NCT00503009|4132175|P2|Overall Study|Physician Decision|1
1261471|NCT00503009|4132176|P1|Overall Study|Physician Decision|0
1261472|NCT00503009|4132174|P3|Overall Study|Withdrawal by Subject|1
1261473|NCT00503009|4132175|P2|Overall Study|Withdrawal by Subject|1
1261474|NCT00503009|4132176|P1|Overall Study|Withdrawal by Subject|0
1261475|NCT00503009|4132174|P3|Overall Study|Protocol Violation|1
1261476|NCT00503009|4132175|P2|Overall Study|Protocol Violation|0
1261477|NCT00503009|4132176|P1|Overall Study|Protocol Violation|1
1261478|NCT00502996|4132193|P1|Overall Study|Adverse Event|2
1261479|NCT00502996|4132193|P1|Overall Study|Withdrawal Informed Consent|6
1261480|NCT00502996|4132193|P1|Overall Study|Treatment failure|25
1261481|NCT00502996|4132193|P1|Overall Study|Protocol Violation|2
1261482|NCT00502996|4132193|P1|Overall Study|Lost to Follow-up|9
1261483|NCT00502840|4132261|P1|Overall Study|Not specified|20
1261484|NCT00502840|4132261|P1|Overall Study|Administrative problems|1
1261485|NCT00502840|4132261|P1|Overall Study|Lost to Follow-up|6
1261486|NCT00502840|4132261|P1|Overall Study|Withdrawal by Subject|5
1261487|NCT00502840|4132261|P1|Overall Study|Protocol Violation|4
1261488|NCT00502840|4132261|P1|Overall Study|Lack of Efficacy|11
1261489|NCT00502840|4132261|P1|Overall Study|Additional or changed therapy|48
1261490|NCT00502840|4132261|P1|Overall Study|Adverse Event|5
1261491|NCT00502801|4132289|P1|End of Therapy to Test of Cure|OTHER|2
1261492|NCT00502801|4132289|P1|End of Therapy to Test of Cure|Death|3
1261493|NCT00502801|4132289|P1|End of Therapy to Test of Cure|Lost to Follow-up|2
1261494|NCT00502801|4132289|P1|End of Therapy to Test of Cure|Withdrawal by Subject|1
1261495|NCT00502801|4132289|P1|Treatment Period|OTHER|30
1261496|NCT00502801|4132289|P1|Treatment Period|Death|14
1261497|NCT00502801|4132289|P1|Treatment Period|Adverse Event|7
1261498|NCT00502801|4132289|P1|Treatment Period|Withdrawal by Subject|3
1261499|NCT00502775|4132297|P3|Overall Study|Subject took disallowed drug|1
1261500|NCT00502775|4132298|P2|Overall Study|Subject took disallowed drug|0
1261501|NCT00502775|4132299|P1|Overall Study|Subject took disallowed drug|0
1261502|NCT00502775|4132297|P3|Overall Study|Subject in jail|0
1261503|NCT00502775|4132298|P2|Overall Study|Subject in jail|1
1261504|NCT00502775|4132299|P1|Overall Study|Subject in jail|0
1261505|NCT00502775|4132297|P3|Overall Study|Declining pollen counts|1
1261506|NCT00502775|4132298|P2|Overall Study|Declining pollen counts|1
1261507|NCT00502775|4132299|P1|Overall Study|Declining pollen counts|0
1261508|NCT00502775|4132297|P3|Overall Study|Outside pollen area more than 48 hours|0
1261509|NCT00502775|4132298|P2|Overall Study|Outside pollen area more than 48 hours|1
1261510|NCT00502775|4132299|P1|Overall Study|Outside pollen area more than 48 hours|0
1261511|NCT00502775|4132297|P3|Overall Study|Non-compliance|2
1261512|NCT00502775|4132298|P2|Overall Study|Non-compliance|2
1261513|NCT00502775|4132299|P1|Overall Study|Non-compliance|0
1261514|NCT00502775|4132297|P3|Overall Study|Randomized in error|1
1261515|NCT00502775|4132298|P2|Overall Study|Randomized in error|1
1261516|NCT00502775|4132299|P1|Overall Study|Randomized in error|0
1261517|NCT00502775|4132297|P3|Overall Study|Logpad compliance <80%|0
1261518|NCT00502775|4132298|P2|Overall Study|Logpad compliance <80%|0
1261519|NCT00502775|4132299|P1|Overall Study|Logpad compliance <80%|1
1261520|NCT00502775|4132297|P3|Overall Study|Subject unable to swallow capsule|1
1261521|NCT00502775|4132298|P2|Overall Study|Subject unable to swallow capsule|0
1261522|NCT00502775|4132299|P1|Overall Study|Subject unable to swallow capsule|1
1261523|NCT00502775|4132297|P3|Overall Study|Non-compliance with eDiary|1
1261524|NCT00502775|4132298|P2|Overall Study|Non-compliance with eDiary|1
1261525|NCT00502775|4132299|P1|Overall Study|Non-compliance with eDiary|4
1261526|NCT00502775|4132297|P3|Overall Study|Sponsor Terminated Study|1
1261527|NCT00502775|4132298|P2|Overall Study|Sponsor Terminated Study|0
1261528|NCT00502775|4132299|P1|Overall Study|Sponsor Terminated Study|1
1261529|NCT00502775|4132297|P3|Overall Study|Withdrawal by Subject|2
1261530|NCT00502775|4132298|P2|Overall Study|Withdrawal by Subject|1
1261531|NCT00502775|4132299|P1|Overall Study|Withdrawal by Subject|1
1261532|NCT00502775|4132297|P3|Overall Study|Protocol Violation|2
1261533|NCT00502775|4132298|P2|Overall Study|Protocol Violation|5
1261534|NCT00502775|4132299|P1|Overall Study|Protocol Violation|1
1261535|NCT00502775|4132297|P3|Overall Study|Adverse Event|1
1261536|NCT00502775|4132298|P2|Overall Study|Adverse Event|2
1261537|NCT00502775|4132299|P1|Overall Study|Adverse Event|1
1261538|NCT00502697|4132342|P2|Overall Study|did not meet assignment criteria|2
1261539|NCT00502697|4132343|P1|Overall Study|did not meet assignment criteria|4
1261540|NCT00502697|4132342|P2|Overall Study|found not to meet eligibility criteria|4
1261541|NCT00502697|4132343|P1|Overall Study|found not to meet eligibility criteria|3
1261542|NCT00502697|4132342|P2|Overall Study|disenrolled due to pregnancy loss|5
1261543|NCT00502697|4132343|P1|Overall Study|disenrolled due to pregnancy loss|3
1261544|NCT00502697|4132342|P2|Overall Study|Withdrawal by Subject|1
1261545|NCT00502697|4132343|P1|Overall Study|Withdrawal by Subject|3
1261546|NCT00502671|4132351|P1|Overall Study|Adverse Event|19
1261547|NCT00502671|4132351|P1|Overall Study|Protocol Violation|16
1261548|NCT00502671|4132351|P1|Overall Study|Lost to Follow-up|7
1261549|NCT00502671|4132351|P1|Overall Study|Personal Reasons|22
1261550|NCT00502671|4132351|P1|Overall Study|Disease Progression|13
1261551|NCT00502593|4132368|P12|Overall Study|Lost to Follow-up|0
1261552|NCT00502593|4132369|P11|Overall Study|Lost to Follow-up|1
1261553|NCT00502593|4132370|P10|Overall Study|Lost to Follow-up|0
1261554|NCT00502593|4132371|P9|Overall Study|Lost to Follow-up|3
1261555|NCT00502593|4132372|P8|Overall Study|Lost to Follow-up|0
1261556|NCT00502593|4132373|P7|Overall Study|Lost to Follow-up|0
1261557|NCT00502593|4132374|P6|Overall Study|Lost to Follow-up|0
1261558|NCT00502593|4132375|P5|Overall Study|Lost to Follow-up|0
1261559|NCT00502593|4132376|P4|Overall Study|Lost to Follow-up|1
1261560|NCT00502593|4132377|P3|Overall Study|Lost to Follow-up|1
1261561|NCT00502593|4132378|P2|Overall Study|Lost to Follow-up|1
1261562|NCT00502593|4132379|P1|Overall Study|Lost to Follow-up|2
1261563|NCT00502593|4132368|P12|Overall Study|Withdrawal by Subject|0
1261564|NCT00502593|4132369|P11|Overall Study|Withdrawal by Subject|1
1261565|NCT00502593|4132370|P10|Overall Study|Withdrawal by Subject|0
1261566|NCT00502593|4132371|P9|Overall Study|Withdrawal by Subject|3
1261567|NCT00502593|4132372|P8|Overall Study|Withdrawal by Subject|0
1261568|NCT00502593|4132373|P7|Overall Study|Withdrawal by Subject|3
1261569|NCT00502593|4132374|P6|Overall Study|Withdrawal by Subject|0
1261570|NCT00502593|4132375|P5|Overall Study|Withdrawal by Subject|2
1261571|NCT00502593|4132376|P4|Overall Study|Withdrawal by Subject|2
1261572|NCT00502593|4132377|P3|Overall Study|Withdrawal by Subject|6
1261573|NCT00502593|4132378|P2|Overall Study|Withdrawal by Subject|0
1261574|NCT00502593|4132379|P1|Overall Study|Withdrawal by Subject|0
1261575|NCT00502593|4132368|P12|Overall Study|Withdrawn unspecified reason|0
1261576|NCT00502593|4132369|P11|Overall Study|Withdrawn unspecified reason|0
1261577|NCT00502593|4132370|P10|Overall Study|Withdrawn unspecified reason|0
1261578|NCT00502593|4132371|P9|Overall Study|Withdrawn unspecified reason|0
1261579|NCT00502593|4132372|P8|Overall Study|Withdrawn unspecified reason|0
1261580|NCT00502593|4132373|P7|Overall Study|Withdrawn unspecified reason|2
1261581|NCT00502593|4132374|P6|Overall Study|Withdrawn unspecified reason|0
1261582|NCT00502593|4132375|P5|Overall Study|Withdrawn unspecified reason|2
1261583|NCT00502593|4132376|P4|Overall Study|Withdrawn unspecified reason|1
1261584|NCT00502593|4132377|P3|Overall Study|Withdrawn unspecified reason|3
1261585|NCT00502593|4132378|P2|Overall Study|Withdrawn unspecified reason|1
1261586|NCT00502593|4132379|P1|Overall Study|Withdrawn unspecified reason|1
1261587|NCT00502320|4132895|P2|Overall Study|Adverse Event|5
1261588|NCT00502320|4132896|P1|Overall Study|Adverse Event|3
1261589|NCT00502320|4132895|P2|Overall Study|Screen Failure|1
1261590|NCT00502320|4132896|P1|Overall Study|Screen Failure|0
1261591|NCT00502320|4132895|P2|Overall Study|No longer met criteria|0
1261592|NCT00502320|4132896|P1|Overall Study|No longer met criteria|1
1261593|NCT00502320|4132895|P2|Overall Study|Withdrew Consent|0
1261594|NCT00502320|4132896|P1|Overall Study|Withdrew Consent|1
1261595|NCT00502320|4132895|P2|Overall Study|Lost to Follow-up|1
1261596|NCT00502320|4132896|P1|Overall Study|Lost to Follow-up|1
1261597|NCT00502242|4132908|P2|Overall Study|Withdrawal by Subject|7
1261598|NCT00502242|4132909|P1|Overall Study|Withdrawal by Subject|6
1261599|NCT00502242|4132908|P2|Overall Study|Protocol Violation|1
1261600|NCT00502242|4132909|P1|Overall Study|Protocol Violation|3
1261601|NCT00502242|4132908|P2|Overall Study|Other - Unspecified|14
1261602|NCT00502242|4132909|P1|Overall Study|Other - Unspecified|8
1261603|NCT00502242|4132908|P2|Overall Study|Physician Decision|3
1261604|NCT00502242|4132909|P1|Overall Study|Physician Decision|2
1261605|NCT00502242|4132908|P2|Overall Study|Adverse Event|20
1261606|NCT00502242|4132909|P1|Overall Study|Adverse Event|31
1261607|NCT00502242|4132908|P2|Overall Study|Lack of Efficacy|11
1261608|NCT00502242|4132909|P1|Overall Study|Lack of Efficacy|1
1261609|NCT00502203|4132973|P1|Overall Study|Inevaluable|1
1261610|NCT00501969|4132982|P1|Overall Study|Other: Sponsor Termination/Commercial RX|1
1261611|NCT00501969|4132982|P1|Overall Study|Other: Admin Request from the Sponsor|3
1261612|NCT00501969|4132982|P1|Overall Study|Other: As Required by Local EC|2
1261613|NCT00501969|4132982|P1|Overall Study|Other: DX Changed - Parkinsons to PSNP|1
1261614|NCT00501969|4132982|P1|Overall Study|Other: Pat Pending Surgery for PD|1
1261615|NCT00501969|4132982|P1|Overall Study|Other: Patient is Going to Have DBS|1
1261616|NCT00501969|4132982|P1|Overall Study|Other: Patients + Investigator Agreement|1
1261617|NCT00501969|4132982|P1|Overall Study|Other: Severe Dementia Unable Sign PIC|1
1261618|NCT00501969|4132982|P1|Overall Study|Other: Sponsor Stopped Study|12
1261619|NCT00501969|4132982|P1|Overall Study|Other: Sponsor Termination at Site|1
1261620|NCT00501969|4132982|P1|Overall Study|Other: Sponsors Request|10
1261621|NCT00501969|4132982|P1|Overall Study|Other: Tired Of Clinical Trial Process|1
1261622|NCT00501969|4132982|P1|Overall Study|Lost to Follow-up|4
1261623|NCT00501969|4132982|P1|Overall Study|Subject withdrew consent|51
1261624|NCT00501969|4132982|P1|Overall Study|Unsatisfactory compliance of subject|7
1261625|NCT00501969|4132982|P1|Overall Study|Adverse Event|76
1261626|NCT00501969|4132982|P1|Overall Study|Lack of Efficacy|29
1261627|NCT00501969|4132982|P1|Overall Study|Major Protocol Violation|4
1261628|NCT00501852|4133014|P1|Overall Study|Withdrawal by Subject|2
1261629|NCT00501852|4133014|P1|Overall Study|Adverse Event|3
1261630|NCT00501644|4133034|P1|Overall Study|Withdrawal by Subject|1
1261631|NCT00501644|4133034|P1|Overall Study|Adverse Event|4
1261632|NCT00501540|4133063|P1|Overall Study|Death|5
1261633|NCT00501293|4133075|P2|Maintenance Period|Application site reaction|0
1261634|NCT00501293|4133076|P1|Maintenance Period|Application site reaction|1
1261635|NCT00501293|4133075|P2|Maintenance Period|Would not wear patch|0
1261636|NCT00501293|4133076|P1|Maintenance Period|Would not wear patch|1
1261637|NCT00501293|4133075|P2|Maintenance Period|Went into rehabilitation|0
1261638|NCT00501293|4133076|P1|Maintenance Period|Went into rehabilitation|1
1261639|NCT00501293|4133075|P2|Maintenance Period|Noncompliant with study medication|0
1261640|NCT00501293|4133076|P1|Maintenance Period|Noncompliant with study medication|5
1261641|NCT00501293|4133075|P2|Maintenance Period|Lack of Efficacy|1
1261642|NCT00501293|4133076|P1|Maintenance Period|Lack of Efficacy|4
1261643|NCT00501293|4133075|P2|Maintenance Period|Protocol Violation|1
1261644|NCT00501293|4133076|P1|Maintenance Period|Protocol Violation|2
1261645|NCT00501293|4133075|P2|Maintenance Period|Adverse Event|6
1261646|NCT00501293|4133076|P1|Maintenance Period|Adverse Event|6
1261647|NCT00501293|4133075|P2|Maintenance Period|Lost to Follow-up|7
1261648|NCT00501293|4133076|P1|Maintenance Period|Lost to Follow-up|12
1261649|NCT00501293|4133075|P2|Maintenance Period|Withdrawal by Subject|13
1261650|NCT00501293|4133076|P1|Maintenance Period|Withdrawal by Subject|14
1261651|NCT00501293|4133075|P2|Optimization Period|Enrolled in error|0
1261652|NCT00501293|4133076|P1|Optimization Period|Enrolled in error|1
1261653|NCT00501228|4133103|P1|Overall Study|Withdrawal by Subject|1
1261654|NCT00501085|4133107|P1|Overall Study|Other loss to follow-up|32
1261655|NCT00501085|4133107|P1|Overall Study|Study closed by sponsor|109
1261656|NCT00501085|4133107|P1|Overall Study|Non-Compliance|24
1261657|NCT00501085|4133107|P1|Overall Study|Adverse Event|4
1261658|NCT00501085|4133107|P1|Overall Study|Explantation Surgery|26
1261659|NCT00501085|4133107|P1|Overall Study|Revision Surgery|7
1261660|NCT00501085|4133107|P1|Overall Study|Subject Decision|1
1261661|NCT00501085|4133107|P1|Overall Study|Withdrawal by Subject|34
1261662|NCT00501085|4133107|P1|Overall Study|Lost to Follow-up|195
1261663|NCT00501059|4133117|P2|Overall Study|Not treated|17
1261664|NCT00501059|4133118|P1|Overall Study|Not treated|25
1261665|NCT00501059|4133117|P2|Overall Study|Lost to Follow-up|198
1261666|NCT00501059|4133118|P1|Overall Study|Lost to Follow-up|210
1261667|NCT00501059|4133117|P2|Overall Study|Adverse Event|122
1261668|NCT00501059|4133118|P1|Overall Study|Adverse Event|129
1261669|NCT00501059|4133117|P2|Overall Study|Reason not given|1
1261670|NCT00501059|4133118|P1|Overall Study|Reason not given|3
1261671|NCT00501059|4133117|P2|Overall Study|Non-compliant with study treatment|16
1261672|NCT00501059|4133118|P1|Overall Study|Non-compliant with study treatment|23
1261673|NCT00501059|4133117|P2|Overall Study|Consent withdrawn by subject|873
1261674|NCT00501059|4133118|P1|Overall Study|Consent withdrawn by subject|817
1261675|NCT00501059|4133117|P2|Overall Study|Insufficient therapeutic effect|5
1261676|NCT00501059|4133118|P1|Overall Study|Insufficient therapeutic effect|4
1261677|NCT00501059|4133117|P2|Overall Study|Clinical endpoint reached|123
1261678|NCT00501059|4133118|P1|Overall Study|Clinical endpoint reached|110
1261679|NCT00501059|4133117|P2|Overall Study|Missing end-of-study page|92
1261680|NCT00501059|4133118|P1|Overall Study|Missing end-of-study page|91
1261681|NCT00501059|4133117|P2|Overall Study|Other|239
1261682|NCT00501059|4133118|P1|Overall Study|Other|236
1261683|NCT00501059|4133117|P2|Overall Study|Death|137
1261684|NCT00501059|4133118|P1|Overall Study|Death|140
1261685|NCT00501059|4133117|P2|Overall Study|Protocol Violation|69
1261686|NCT00501059|4133118|P1|Overall Study|Protocol Violation|80
1261687|NCT00501046|4133142|P2|Overall Study|Reaching endpoints,Noncompliance,etc|137
1261688|NCT00501046|4133143|P1|Overall Study|Reaching endpoints,Noncompliance,etc|119
1261689|NCT00501046|4133142|P2|Overall Study|Withdrawal by Subject|83
1261690|NCT00501046|4133143|P1|Overall Study|Withdrawal by Subject|84
1261691|NCT00501046|4133142|P2|Overall Study|Protocol Violation|1
1261692|NCT00501046|4133143|P1|Overall Study|Protocol Violation|2
1261693|NCT00501046|4133142|P2|Overall Study|Pregnancy|3
1261694|NCT00501046|4133143|P1|Overall Study|Pregnancy|0
1261695|NCT00501046|4133142|P2|Overall Study|Physician Decision|2
1261696|NCT00501046|4133143|P1|Overall Study|Physician Decision|7
1261697|NCT00501046|4133142|P2|Overall Study|Lost to Follow-up|13
1261698|NCT00501046|4133143|P1|Overall Study|Lost to Follow-up|14
1261699|NCT00501046|4133142|P2|Overall Study|Death|30
1261700|NCT00501046|4133143|P1|Overall Study|Death|23
1261701|NCT00501046|4133142|P2|Overall Study|Adverse Event|25
1261702|NCT00501046|4133143|P1|Overall Study|Adverse Event|21
1261703|NCT00501007|4133149|P2|Overall Study|Inclusion criteria not met.|25
1261704|NCT00501007|4133150|P1|Overall Study|Inclusion criteria not met.|29
1261705|NCT00500760|4133158|P2|Overall Study|Other|2
1261706|NCT00500760|4133159|P1|Overall Study|Other|1
1261707|NCT00500760|4133158|P2|Overall Study|Lost to Follow-up|0
1261708|NCT00500760|4133159|P1|Overall Study|Lost to Follow-up|3
1261709|NCT00500760|4133158|P2|Overall Study|Administrative decision|0
1261710|NCT00500760|4133159|P1|Overall Study|Administrative decision|2
1261711|NCT00500760|4133158|P2|Overall Study|Withdrawal by Subject|7
1261712|NCT00500760|4133159|P1|Overall Study|Withdrawal by Subject|5
1261713|NCT00500760|4133158|P2|Overall Study|Death|15
1261714|NCT00500760|4133159|P1|Overall Study|Death|32
1261715|NCT00500682|4133179|P2|Overall Study|Reaching endpoints, Noncompliance, etc|144
1261716|NCT00500682|4133180|P1|Overall Study|Reaching endpoints, Noncompliance, etc|144
1261717|NCT00500682|4133179|P2|Overall Study|Withdrawal by Subject|74
1261718|NCT00500682|4133180|P1|Overall Study|Withdrawal by Subject|80
1261719|NCT00500682|4133179|P2|Overall Study|Protocol Violation|3
1261720|NCT00500682|4133180|P1|Overall Study|Protocol Violation|1
1261721|NCT00500682|4133179|P2|Overall Study|Pregnancy|0
1261722|NCT00500682|4133180|P1|Overall Study|Pregnancy|2
1261723|NCT00500682|4133179|P2|Overall Study|Physician Decision|10
1261724|NCT00500682|4133180|P1|Overall Study|Physician Decision|6
1261725|NCT00500682|4133179|P2|Overall Study|Lost to Follow-up|11
1261726|NCT00500682|4133180|P1|Overall Study|Lost to Follow-up|11
1261727|NCT00500682|4133179|P2|Overall Study|Death|16
1261728|NCT00500682|4133180|P1|Overall Study|Death|25
1261729|NCT00500682|4133179|P2|Overall Study|Adverse Event|29
1261730|NCT00500682|4133180|P1|Overall Study|Adverse Event|37
1261731|NCT00500539|4133214|P1|Follow-up Period (16 Weeks)|Missing|3
1261732|NCT00500539|4133214|P1|Follow-up Period (16 Weeks)|Protocol Deviation|1
1261733|NCT00500539|4133214|P1|Follow-up Period (16 Weeks)|Death|1
1261734|NCT00500539|4133214|P1|Follow-up Period (16 Weeks)|Administrative problems|1
1261735|NCT00500539|4133214|P1|Follow-up Period (16 Weeks)|Lost to Follow-up|3
1261736|NCT00500539|4133214|P1|Follow-up Period (16 Weeks)|Subject withdrew consent|2
1261737|NCT00500539|4133214|P1|Follow-up Period (16 Weeks)|Adverse Event|1
1261738|NCT00500539|4133214|P1|Treatment Period (24 Weeks)|Protocol Deviation|5
1261739|NCT00500539|4133214|P1|Treatment Period (24 Weeks)|Administrative problems|2
1261740|NCT00500539|4133214|P1|Treatment Period (24 Weeks)|Lost to Follow-up|2
1261741|NCT00500539|4133214|P1|Treatment Period (24 Weeks)|Subject withdrew consent|1
1261742|NCT00500539|4133214|P1|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1
1261743|NCT00500539|4133214|P1|Treatment Period (24 Weeks)|Adverse Event|4
1261744|NCT00500370|4133240|P2|Overall Study|Subject Decision|17
1261745|NCT00500370|4133241|P1|Overall Study|Subject Decision|10
1261746|NCT00500370|4133240|P2|Overall Study|Sponsor Decision|0
1261747|NCT00500370|4133241|P1|Overall Study|Sponsor Decision|2
1261748|NCT00500370|4133240|P2|Overall Study|Protocol Violation|4
1261749|NCT00500370|4133241|P1|Overall Study|Protocol Violation|2
1261750|NCT00500370|4133240|P2|Overall Study|Lost to Follow-up|10
1261751|NCT00500370|4133241|P1|Overall Study|Lost to Follow-up|10
1261752|NCT00500370|4133240|P2|Overall Study|Adverse Event|3
1261753|NCT00500370|4133241|P1|Overall Study|Adverse Event|9
1261754|NCT00500357|4133277|P1|Overall Study|Death|1
1261755|NCT00500331|4133303|P7|Overall Study|Protocol violated|0
1261756|NCT00500331|4133304|P6|Overall Study|Protocol violated|0
1261757|NCT00500331|4133305|P5|Overall Study|Protocol violated|0
1261758|NCT00500331|4133306|P4|Overall Study|Protocol violated|1
1261759|NCT00500331|4133307|P3|Overall Study|Protocol violated|0
1261760|NCT00500331|4133308|P2|Overall Study|Protocol violated|0
1261761|NCT00500331|4133309|P1|Overall Study|Protocol violated|0
1261762|NCT00500331|4133303|P7|Overall Study|State ban of biological samples export|0
1261763|NCT00500331|4133304|P6|Overall Study|State ban of biological samples export|0
1261764|NCT00500331|4133305|P5|Overall Study|State ban of biological samples export|0
1261765|NCT00500331|4133306|P4|Overall Study|State ban of biological samples export|1
1261766|NCT00500331|4133307|P3|Overall Study|State ban of biological samples export|0
1261767|NCT00500331|4133308|P2|Overall Study|State ban of biological samples export|0
1261768|NCT00500331|4133309|P1|Overall Study|State ban of biological samples export|0
1261769|NCT00500331|4133303|P7|Overall Study|Diabetologist nurse in the study|0
1261770|NCT00500331|4133304|P6|Overall Study|Diabetologist nurse in the study|0
1261771|NCT00500331|4133305|P5|Overall Study|Diabetologist nurse in the study|0
1261772|NCT00500331|4133306|P4|Overall Study|Diabetologist nurse in the study|0
1261773|NCT00500331|4133307|P3|Overall Study|Diabetologist nurse in the study|1
1261774|NCT00500331|4133308|P2|Overall Study|Diabetologist nurse in the study|0
1261775|NCT00500331|4133309|P1|Overall Study|Diabetologist nurse in the study|0
1261776|NCT00500331|4133303|P7|Overall Study|Participant was randomized by mistake|0
1261777|NCT00500331|4133304|P6|Overall Study|Participant was randomized by mistake|0
1261778|NCT00500331|4133305|P5|Overall Study|Participant was randomized by mistake|0
1261779|NCT00500331|4133306|P4|Overall Study|Participant was randomized by mistake|0
1261780|NCT00500331|4133307|P3|Overall Study|Participant was randomized by mistake|0
1261781|NCT00500331|4133308|P2|Overall Study|Participant was randomized by mistake|0
1261782|NCT00500331|4133309|P1|Overall Study|Participant was randomized by mistake|1
1261783|NCT00500331|4133303|P7|Overall Study|Sponsor decided to withdraw participant|0
1261784|NCT00500331|4133304|P6|Overall Study|Sponsor decided to withdraw participant|0
1261785|NCT00500331|4133305|P5|Overall Study|Sponsor decided to withdraw participant|0
1261786|NCT00500331|4133306|P4|Overall Study|Sponsor decided to withdraw participant|0
1261787|NCT00500331|4133307|P3|Overall Study|Sponsor decided to withdraw participant|0
1261788|NCT00500331|4133308|P2|Overall Study|Sponsor decided to withdraw participant|0
1261789|NCT00500331|4133309|P1|Overall Study|Sponsor decided to withdraw participant|1
1261790|NCT00500331|4133303|P7|Overall Study|Exclusion citeria not met on Visit 4|0
1261791|NCT00500331|4133304|P6|Overall Study|Exclusion citeria not met on Visit 4|0
1261792|NCT00500331|4133305|P5|Overall Study|Exclusion citeria not met on Visit 4|0
1261793|NCT00500331|4133306|P4|Overall Study|Exclusion citeria not met on Visit 4|0
1261794|NCT00500331|4133307|P3|Overall Study|Exclusion citeria not met on Visit 4|0
1261795|NCT00500331|4133308|P2|Overall Study|Exclusion citeria not met on Visit 4|0
1261796|NCT00500331|4133309|P1|Overall Study|Exclusion citeria not met on Visit 4|1
1261797|NCT00500331|4133303|P7|Overall Study|Didn't return for continuation of study|0
1261798|NCT00500331|4133304|P6|Overall Study|Didn't return for continuation of study|0
1261799|NCT00500331|4133305|P5|Overall Study|Didn't return for continuation of study|0
1261800|NCT00500331|4133306|P4|Overall Study|Didn't return for continuation of study|0
1261801|NCT00500331|4133307|P3|Overall Study|Didn't return for continuation of study|0
1261802|NCT00500331|4133308|P2|Overall Study|Didn't return for continuation of study|0
1261803|NCT00500331|4133309|P1|Overall Study|Didn't return for continuation of study|1
1261804|NCT00500331|4133303|P7|Overall Study|Increased serum creatinine from Baseline|0
1261805|NCT00500331|4133304|P6|Overall Study|Increased serum creatinine from Baseline|1
1261806|NCT00500331|4133305|P5|Overall Study|Increased serum creatinine from Baseline|0
1261807|NCT00500331|4133306|P4|Overall Study|Increased serum creatinine from Baseline|0
1261808|NCT00500331|4133307|P3|Overall Study|Increased serum creatinine from Baseline|0
1261809|NCT00500331|4133308|P2|Overall Study|Increased serum creatinine from Baseline|0
1261810|NCT00500331|4133309|P1|Overall Study|Increased serum creatinine from Baseline|0
1261811|NCT00500331|4133303|P7|Overall Study|Liver function test abnormality|0
1261812|NCT00500331|4133304|P6|Overall Study|Liver function test abnormality|0
1261813|NCT00500331|4133305|P5|Overall Study|Liver function test abnormality|0
1261814|NCT00500331|4133306|P4|Overall Study|Liver function test abnormality|0
1261815|NCT00500331|4133307|P3|Overall Study|Liver function test abnormality|1
1261816|NCT00500331|4133308|P2|Overall Study|Liver function test abnormality|0
1261817|NCT00500331|4133309|P1|Overall Study|Liver function test abnormality|0
1261818|NCT00500331|4133303|P7|Overall Study|Lack of Efficacy|0
1261819|NCT00500331|4133304|P6|Overall Study|Lack of Efficacy|0
1261820|NCT00500331|4133305|P5|Overall Study|Lack of Efficacy|0
1261821|NCT00500331|4133306|P4|Overall Study|Lack of Efficacy|0
1261822|NCT00500331|4133307|P3|Overall Study|Lack of Efficacy|0
1261823|NCT00500331|4133308|P2|Overall Study|Lack of Efficacy|1
1261824|NCT00500331|4133309|P1|Overall Study|Lack of Efficacy|3
1261825|NCT00500331|4133303|P7|Overall Study|Withdrawal by Subject|1
1261826|NCT00500331|4133304|P6|Overall Study|Withdrawal by Subject|1
1261827|NCT00500331|4133305|P5|Overall Study|Withdrawal by Subject|0
1261828|NCT00500331|4133306|P4|Overall Study|Withdrawal by Subject|5
1261829|NCT00500331|4133307|P3|Overall Study|Withdrawal by Subject|1
1261830|NCT00500331|4133308|P2|Overall Study|Withdrawal by Subject|0
1261831|NCT00500331|4133309|P1|Overall Study|Withdrawal by Subject|4
1261832|NCT00500331|4133303|P7|Overall Study|Protocol Violation|1
1261833|NCT00500331|4133304|P6|Overall Study|Protocol Violation|1
1261834|NCT00500331|4133305|P5|Overall Study|Protocol Violation|1
1261835|NCT00500331|4133306|P4|Overall Study|Protocol Violation|0
1261836|NCT00500331|4133307|P3|Overall Study|Protocol Violation|1
1261837|NCT00500331|4133308|P2|Overall Study|Protocol Violation|1
1261838|NCT00500331|4133309|P1|Overall Study|Protocol Violation|3
1261839|NCT00500331|4133303|P7|Overall Study|Lost to Follow-up|0
1261840|NCT00500331|4133304|P6|Overall Study|Lost to Follow-up|0
1261841|NCT00500331|4133305|P5|Overall Study|Lost to Follow-up|1
1261842|NCT00500331|4133306|P4|Overall Study|Lost to Follow-up|2
1261843|NCT00500331|4133307|P3|Overall Study|Lost to Follow-up|1
1261844|NCT00500331|4133308|P2|Overall Study|Lost to Follow-up|1
1261845|NCT00500331|4133309|P1|Overall Study|Lost to Follow-up|1
1261846|NCT00500331|4133303|P7|Overall Study|Adverse Event|0
1261847|NCT00500331|4133304|P6|Overall Study|Adverse Event|2
1261848|NCT00500331|4133305|P5|Overall Study|Adverse Event|2
1261849|NCT00500331|4133306|P4|Overall Study|Adverse Event|1
1261850|NCT00500331|4133307|P3|Overall Study|Adverse Event|0
1261851|NCT00500331|4133308|P2|Overall Study|Adverse Event|2
1261852|NCT00500331|4133309|P1|Overall Study|Adverse Event|0
1261853|NCT00500318|4133446|P2|Overall Study|Other Reason|1
1261854|NCT00500318|4133447|P1|Overall Study|Other Reason|0
1261855|NCT00500318|4133446|P2|Overall Study|Lack of Efficacy|3
1261856|NCT00500318|4133447|P1|Overall Study|Lack of Efficacy|0
1261857|NCT00500318|4133446|P2|Overall Study|Withdrawal by Subject|2
1261858|NCT00500318|4133447|P1|Overall Study|Withdrawal by Subject|1
1261859|NCT00500318|4133446|P2|Overall Study|Protocol Violation|3
1261860|NCT00500318|4133447|P1|Overall Study|Protocol Violation|1
1261861|NCT00500318|4133446|P2|Overall Study|Adverse Event|8
1261862|NCT00500318|4133447|P1|Overall Study|Adverse Event|3
1261863|NCT00500292|4133464|P3|Overall Study|Other|4
1261864|NCT00500292|4133465|P2|Overall Study|Other|1
1261865|NCT00500292|4133466|P1|Overall Study|Other|1
1261866|NCT00500292|4133464|P3|Overall Study|Withdrawal by Subject|0
1261867|NCT00500292|4133465|P2|Overall Study|Withdrawal by Subject|1
1261868|NCT00500292|4133466|P1|Overall Study|Withdrawal by Subject|0
1261869|NCT00500292|4133464|P3|Overall Study|Condition under investigation worsened|19
1261870|NCT00500292|4133465|P2|Overall Study|Condition under investigation worsened|23
1261871|NCT00500292|4133466|P1|Overall Study|Condition under investigation worsened|21
1261872|NCT00500292|4133464|P3|Overall Study|Adverse Event|4
1261873|NCT00500292|4133465|P2|Overall Study|Adverse Event|6
1261874|NCT00500292|4133466|P1|Overall Study|Adverse Event|3
1261875|NCT00500149|4133487|P2|Second Intervention (Cross-over Phase)|Lost to Follow-up|0
1261876|NCT00500149|4133488|P1|Second Intervention (Cross-over Phase)|Lost to Follow-up|2
1261877|NCT00500149|4133487|P2|First Intervention (Cross-over Phase)|Protocol Violation|0
1261878|NCT00500149|4133488|P1|First Intervention (Cross-over Phase)|Protocol Violation|1
1261879|NCT00500149|4133487|P2|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
1261880|NCT00500149|4133488|P1|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
1261881|NCT00500149|4133487|P2|First Intervention (Cross-over Phase)|Adverse Event|1
1261882|NCT00500149|4133488|P1|First Intervention (Cross-over Phase)|Adverse Event|0
1261883|NCT00500149|4133487|P2|Enrolled (Dose-optimization Phase)|Protocol Violation|0
1261884|NCT00500149|4133488|P1|Enrolled (Dose-optimization Phase)|Protocol Violation|1
1261885|NCT00500149|4133487|P2|Enrolled (Dose-optimization Phase)|Adverse Event|0
1261886|NCT00500149|4133488|P1|Enrolled (Dose-optimization Phase)|Adverse Event|8
1261887|NCT00500149|4133487|P2|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0
1261888|NCT00500149|4133488|P1|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3
1261889|NCT00500110|4133496|P1|Overall Study|Withdrawal by Subject|3
1261890|NCT00500071|4133500|P1|30-day Safety Follow-up|Lost to Follow-up|17
1261891|NCT00500071|4133500|P1|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4
1261892|NCT00500071|4133500|P1|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1
1261893|NCT00500071|4133500|P1|Dose-optimization and Maintenance Phase|Lack of Efficacy|2
1261894|NCT00500071|4133500|P1|Dose-optimization and Maintenance Phase|Protocol Violation|2
1261895|NCT00500071|4133500|P1|Dose-optimization and Maintenance Phase|Adverse Event|13
1261896|NCT00500071|4133500|P1|Screening and Washout Phase|Protocol Violation|1
1261897|NCT00499889|4133518|P1|Overall Study|Infection prior to treatment|1
1261898|NCT00499863|4133526|P2|Overall Study|Lost to Follow-up|1
1261899|NCT00499863|4133527|P1|Overall Study|Lost to Follow-up|1
1261900|NCT00499863|4133526|P2|Overall Study|Sponsor decision|2
1261901|NCT00499863|4133527|P1|Overall Study|Sponsor decision|2
1261902|NCT00499863|4133526|P2|Overall Study|Adverse Event|2
1261903|NCT00499863|4133527|P1|Overall Study|Adverse Event|8
1261904|NCT00499863|4133526|P2|Overall Study|Withdrawal by Subject|4
1261905|NCT00499863|4133527|P1|Overall Study|Withdrawal by Subject|6
1261906|NCT00499863|4133526|P2|Overall Study|Protocol Violation|7
1261907|NCT00499863|4133527|P1|Overall Study|Protocol Violation|12
1261908|NCT00499863|4133526|P2|Overall Study|Lack of Efficacy|27
1261909|NCT00499863|4133527|P1|Overall Study|Lack of Efficacy|21
1261910|NCT00500266|4133555|P1|Overall Study|Assigned, not treated|4
1261911|NCT00500266|4133555|P1|Overall Study|Withdrawal by Subject|3
1261912|NCT00500266|4133555|P1|Overall Study|Lost to Follow-up|3
1261913|NCT00500266|4133555|P1|Overall Study|Death|3
1261914|NCT00499746|4133562|P1|Phase 1(6-9 One Day Sessions)|Unable to determine|1
1261915|NCT00499746|4133562|P1|Phase 1(6-9 One Day Sessions)|Investigator decision|1
1261916|NCT00499746|4133562|P1|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3
1261917|NCT00499746|4133562|P1|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7
1261918|NCT00499694|4133631|P1|Overall Study|Patient never received treatment.|1
1261919|NCT00499681|4133640|P2|Overall Study|disease progression|1
1261920|NCT00499681|4133641|P1|Overall Study|disease progression|0
1261921|NCT00499681|4133640|P2|Overall Study|toxicity|1
1261922|NCT00499681|4133641|P1|Overall Study|toxicity|0
1261923|NCT00499616|4133668|P4|Overall Study|Patient/Parent Refusal|0
1261924|NCT00499616|4133669|P3|Overall Study|Patient/Parent Refusal|3
1261925|NCT00499616|4133670|P2|Overall Study|Patient/Parent Refusal|5
1261926|NCT00499616|4133671|P1|Overall Study|Patient/Parent Refusal|1
1261927|NCT00499616|4133668|P4|Overall Study|Not evaluable|41
1261928|NCT00499616|4133669|P3|Overall Study|Not evaluable|0
1261929|NCT00499616|4133670|P2|Overall Study|Not evaluable|0
1261930|NCT00499616|4133671|P1|Overall Study|Not evaluable|0
1261931|NCT00499616|4133668|P4|Overall Study|Ineligible|15
1261932|NCT00499616|4133669|P3|Overall Study|Ineligible|0
1261933|NCT00499616|4133670|P2|Overall Study|Ineligible|2
1261934|NCT00499616|4133671|P1|Overall Study|Ineligible|1
1261935|NCT00499616|4133668|P4|Overall Study|Withdrawal by Subject|0
1261936|NCT00499616|4133669|P3|Overall Study|Withdrawal by Subject|1
1261937|NCT00499616|4133670|P2|Overall Study|Withdrawal by Subject|0
1261938|NCT00499616|4133671|P1|Overall Study|Withdrawal by Subject|1
1261939|NCT00499616|4133668|P4|Overall Study|Physician Decision|0
1261940|NCT00499616|4133669|P3|Overall Study|Physician Decision|9
1261941|NCT00499616|4133670|P2|Overall Study|Physician Decision|16
1261942|NCT00499616|4133671|P1|Overall Study|Physician Decision|6
1261943|NCT00499616|4133668|P4|Overall Study|Lost to Follow-up|0
1261944|NCT00499616|4133669|P3|Overall Study|Lost to Follow-up|1
1261945|NCT00499616|4133670|P2|Overall Study|Lost to Follow-up|0
1261946|NCT00499616|4133671|P1|Overall Study|Lost to Follow-up|0
1261947|NCT00499616|4133668|P4|Overall Study|Lack of Efficacy|0
1261948|NCT00499616|4133669|P3|Overall Study|Lack of Efficacy|19
1261949|NCT00499616|4133670|P2|Overall Study|Lack of Efficacy|0
1261950|NCT00499616|4133671|P1|Overall Study|Lack of Efficacy|5
1261951|NCT00499616|4133668|P4|Overall Study|Death|1
1261952|NCT00499616|4133669|P3|Overall Study|Death|3
1261953|NCT00499616|4133670|P2|Overall Study|Death|5
1261954|NCT00499616|4133671|P1|Overall Study|Death|1
1261955|NCT00499603|4133708|P2|Overall Study|Adverse Event|1
1261956|NCT00499603|4133709|P1|Overall Study|Adverse Event|0
1261957|NCT00499590|4133722|P3|Overall Study|Not treated|1
1261958|NCT00499590|4133723|P2|Overall Study|Not treated|0
1261959|NCT00499590|4133724|P1|Overall Study|Not treated|1
1261960|NCT00499590|4133722|P3|Overall Study|Study Terminated|112
1261961|NCT00499590|4133723|P2|Overall Study|Study Terminated|112
1261962|NCT00499590|4133724|P1|Overall Study|Study Terminated|112
1261963|NCT00499486|4133735|P1|Overall Study|Withdrawal by Subject|16
1261964|NCT00499460|4133762|P2|Intervention 2 (30 Days)|Withdrawal by Subject|1
1261965|NCT00499460|4133763|P1|Intervention 2 (30 Days)|Withdrawal by Subject|0
1261966|NCT00499460|4133762|P2|Intervention 1 (30 Days)|Fainting upon Blood Draw|0
1261967|NCT00499460|4133763|P1|Intervention 1 (30 Days)|Fainting upon Blood Draw|1
1261968|NCT00499460|4133762|P2|Intervention 1 (30 Days)|Withdrawal by Subject|0
1261969|NCT00499460|4133763|P1|Intervention 1 (30 Days)|Withdrawal by Subject|1
1261970|NCT00499369|4133796|P5|Overall Study|Ineligible|0
1261971|NCT00499369|4133797|P4|Overall Study|Ineligible|1
1261972|NCT00499369|4133798|P3|Overall Study|Ineligible|1
1261973|NCT00499369|4133799|P2|Overall Study|Ineligible|2
1261974|NCT00499369|4133800|P1|Overall Study|Ineligible|2
1261975|NCT00499369|4133796|P5|Overall Study|Not protocol specified|0
1261976|NCT00499369|4133797|P4|Overall Study|Not protocol specified|1
1261977|NCT00499369|4133798|P3|Overall Study|Not protocol specified|3
1261978|NCT00499369|4133799|P2|Overall Study|Not protocol specified|0
1261979|NCT00499369|4133800|P1|Overall Study|Not protocol specified|2
1261980|NCT00499369|4133796|P5|Overall Study|Death|0
1261981|NCT00499369|4133797|P4|Overall Study|Death|0
1261982|NCT00499369|4133798|P3|Overall Study|Death|0
1261983|NCT00499369|4133799|P2|Overall Study|Death|1
1261984|NCT00499369|4133800|P1|Overall Study|Death|0
1261985|NCT00499369|4133796|P5|Overall Study|Progression|10
1261986|NCT00499369|4133797|P4|Overall Study|Progression|6
1261987|NCT00499369|4133798|P3|Overall Study|Progression|9
1261988|NCT00499369|4133799|P2|Overall Study|Progression|12
1261989|NCT00499369|4133800|P1|Overall Study|Progression|10
1261990|NCT00499369|4133796|P5|Overall Study|Withdrawal by Subject|0
1261991|NCT00499369|4133797|P4|Overall Study|Withdrawal by Subject|0
1261992|NCT00499369|4133798|P3|Overall Study|Withdrawal by Subject|1
1261993|NCT00499369|4133799|P2|Overall Study|Withdrawal by Subject|1
1261994|NCT00499369|4133800|P1|Overall Study|Withdrawal by Subject|0
1261995|NCT00499369|4133796|P5|Overall Study|Adverse Event|2
1261996|NCT00499369|4133797|P4|Overall Study|Adverse Event|1
1261997|NCT00499369|4133798|P3|Overall Study|Adverse Event|3
1261998|NCT00499369|4133799|P2|Overall Study|Adverse Event|2
1261999|NCT00499369|4133800|P1|Overall Study|Adverse Event|2
1262000|NCT00499252|4133836|P1|Overall Study|<no further label>|3
1262001|NCT00499252|4133836|P1|Overall Study|Ineligible|4
1262002|NCT00499252|4133836|P1|Overall Study|Refused further treatment|2
1262003|NCT00499252|4133836|P1|Overall Study|Adverse Event|3
1262004|NCT00499122|4133846|P1|Overall Study|Withdrawal by Subject|2
1262005|NCT00499083|4133889|P1|Overall Study|Not evaluable|3
1262006|NCT00499031|4133896|P1|Overall Study|Never treated|1
1262007|NCT00499031|4133896|P1|Overall Study|Required test not done|1
1262008|NCT00499031|4133896|P1|Overall Study|Improper pre-protocol treatment|1
1262009|NCT00498797|4133919|P2|Overall Study|Other|1
1262010|NCT00498797|4133920|P1|Overall Study|Other|3
1262011|NCT00498797|4133919|P2|Overall Study|Condition under investigation worsened|21
1262012|NCT00498797|4133920|P1|Overall Study|Condition under investigation worsened|19
1262013|NCT00498797|4133919|P2|Overall Study|Adverse Event|5
1262014|NCT00498797|4133920|P1|Overall Study|Adverse Event|12
1262015|NCT00498797|4133919|P2|Overall Study|Withdrawal by Subject|2
1262016|NCT00498797|4133920|P1|Overall Study|Withdrawal by Subject|4
1262017|NCT00498602|4133978|P7|Overall Study|Not specified|0
1262018|NCT00498602|4133979|P6|Overall Study|Not specified|3
1262019|NCT00498602|4133980|P5|Overall Study|Not specified|0
1262020|NCT00498602|4133981|P4|Overall Study|Not specified|0
1262021|NCT00498602|4133982|P3|Overall Study|Not specified|1
1262022|NCT00498602|4133983|P2|Overall Study|Not specified|3
1262023|NCT00498602|4133984|P1|Overall Study|Not specified|2
1262024|NCT00498602|4133978|P7|Overall Study|Subject Request|1
1262025|NCT00498602|4133979|P6|Overall Study|Subject Request|4
1262026|NCT00498602|4133980|P5|Overall Study|Subject Request|1
1262027|NCT00498602|4133981|P4|Overall Study|Subject Request|1
1262028|NCT00498602|4133982|P3|Overall Study|Subject Request|1
1262029|NCT00498602|4133983|P2|Overall Study|Subject Request|0
1262030|NCT00498602|4133984|P1|Overall Study|Subject Request|3
1262031|NCT00498602|4133978|P7|Overall Study|Investigator Request|0
1262032|NCT00498602|4133979|P6|Overall Study|Investigator Request|0
1262033|NCT00498602|4133980|P5|Overall Study|Investigator Request|0
1262034|NCT00498602|4133981|P4|Overall Study|Investigator Request|0
1262035|NCT00498602|4133982|P3|Overall Study|Investigator Request|1
1262036|NCT00498602|4133983|P2|Overall Study|Investigator Request|0
1262037|NCT00498602|4133984|P1|Overall Study|Investigator Request|0
1262038|NCT00498602|4133978|P7|Overall Study|Caregiver Request|0
1262039|NCT00498602|4133979|P6|Overall Study|Caregiver Request|2
1262040|NCT00498602|4133980|P5|Overall Study|Caregiver Request|1
1262041|NCT00498602|4133981|P4|Overall Study|Caregiver Request|0
1262042|NCT00498602|4133982|P3|Overall Study|Caregiver Request|2
1262043|NCT00498602|4133983|P2|Overall Study|Caregiver Request|2
1262044|NCT00498602|4133984|P1|Overall Study|Caregiver Request|2
1262045|NCT00498602|4133978|P7|Overall Study|AE not related to Study Drug|1
1262046|NCT00498602|4133979|P6|Overall Study|AE not related to Study Drug|2
1262047|NCT00498602|4133980|P5|Overall Study|AE not related to Study Drug|2
1262048|NCT00498602|4133981|P4|Overall Study|AE not related to Study Drug|0
1262049|NCT00498602|4133982|P3|Overall Study|AE not related to Study Drug|0
1262050|NCT00498602|4133983|P2|Overall Study|AE not related to Study Drug|3
1262051|NCT00498602|4133984|P1|Overall Study|AE not related to Study Drug|1
1262052|NCT00498602|4133978|P7|Overall Study|Adverse Event (AE) related to Study Drug|0
1262053|NCT00498602|4133979|P6|Overall Study|Adverse Event (AE) related to Study Drug|1
1262054|NCT00498602|4133980|P5|Overall Study|Adverse Event (AE) related to Study Drug|0
1262055|NCT00498602|4133981|P4|Overall Study|Adverse Event (AE) related to Study Drug|2
1262056|NCT00498602|4133982|P3|Overall Study|Adverse Event (AE) related to Study Drug|3
1262057|NCT00498602|4133983|P2|Overall Study|Adverse Event (AE) related to Study Drug|0
1262058|NCT00498602|4133984|P1|Overall Study|Adverse Event (AE) related to Study Drug|1
1262059|NCT00498602|4133978|P7|Overall Study|Lost to Follow-up|0
1262060|NCT00498602|4133979|P6|Overall Study|Lost to Follow-up|0
1262061|NCT00498602|4133980|P5|Overall Study|Lost to Follow-up|0
1262062|NCT00498602|4133981|P4|Overall Study|Lost to Follow-up|2
1262063|NCT00498602|4133982|P3|Overall Study|Lost to Follow-up|0
1262064|NCT00498602|4133983|P2|Overall Study|Lost to Follow-up|2
1262065|NCT00498602|4133984|P1|Overall Study|Lost to Follow-up|0
1262066|NCT00498602|4133978|P7|Overall Study|Lack of Efficacy|0
1262067|NCT00498602|4133979|P6|Overall Study|Lack of Efficacy|0
1262068|NCT00498602|4133980|P5|Overall Study|Lack of Efficacy|0
1262069|NCT00498602|4133981|P4|Overall Study|Lack of Efficacy|0
1262070|NCT00498602|4133982|P3|Overall Study|Lack of Efficacy|0
1262071|NCT00498602|4133983|P2|Overall Study|Lack of Efficacy|0
1262072|NCT00498602|4133984|P1|Overall Study|Lack of Efficacy|1
1262073|NCT00498602|4133978|P7|Overall Study|Death|0
1262074|NCT00498602|4133979|P6|Overall Study|Death|1
1262075|NCT00498602|4133980|P5|Overall Study|Death|0
1262076|NCT00498602|4133981|P4|Overall Study|Death|0
1262077|NCT00498602|4133982|P3|Overall Study|Death|0
1262078|NCT00498602|4133983|P2|Overall Study|Death|0
1262079|NCT00498602|4133984|P1|Overall Study|Death|0
1262080|NCT00498485|4134032|P2|Overall Study|Adverse Event|5
1262081|NCT00498485|4134033|P1|Overall Study|Adverse Event|1
1262082|NCT00498433|4134044|P3|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
1262083|NCT00498433|4134045|P2|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
1262084|NCT00498433|4134046|P1|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1
1262085|NCT00498433|4134044|P3|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
1262086|NCT00498433|4134045|P2|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
1262087|NCT00498433|4134046|P1|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15
1262088|NCT00498433|4134044|P3|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
1262089|NCT00498433|4134045|P2|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
1262090|NCT00498433|4134046|P1|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2
1262429|NCT00494299|4135312|P1|Overall Study|Physician Decision|0
1262091|NCT00498433|4134044|P3|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
1262092|NCT00498433|4134045|P2|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
1262093|NCT00498433|4134046|P1|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2
1262094|NCT00498368|4134091|P2|Overall Study|Withdrawal by Subject|2
1262095|NCT00498368|4134092|P1|Overall Study|Withdrawal by Subject|3
1262096|NCT00498355|4134104|P1|Overall Study|Lost to Follow-up|1
1262097|NCT00498186|4134112|P1|Overall Study|Other|10
1262098|NCT00498186|4134112|P1|Overall Study|Lost to Follow-up|3
1262099|NCT00498186|4134112|P1|Overall Study|Withdrawal by Subject|18
1262100|NCT00498186|4134112|P1|Overall Study|Unsatisfactory compliance of subject|12
1262101|NCT00498186|4134112|P1|Overall Study|Adverse Event|89
1262102|NCT00498186|4134112|P1|Overall Study|Lack of Efficacy|31
1262103|NCT00498186|4134112|P1|Overall Study|Protocol Violation|10
1262104|NCT00498173|4134119|P3|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0
1262105|NCT00498173|4134120|P2|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1
1262106|NCT00498173|4134121|P1|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2
1262107|NCT00497874|4134151|P2|Overall Study|Unable to schedule|24
1262108|NCT00497874|4134152|P1|Overall Study|Unable to schedule|37
1262109|NCT00497874|4134151|P2|Overall Study|Unable to contact|67
1262110|NCT00497874|4134152|P1|Overall Study|Unable to contact|52
1262111|NCT00497874|4134151|P2|Overall Study|Death|4
1262112|NCT00497874|4134152|P1|Overall Study|Death|2
1262113|NCT00497874|4134151|P2|Overall Study|Illness|4
1262114|NCT00497874|4134152|P1|Overall Study|Illness|8
1262115|NCT00497874|4134151|P2|Overall Study|Withdrawal by Subject|17
1262116|NCT00497874|4134152|P1|Overall Study|Withdrawal by Subject|48
1262117|NCT00497796|4134170|P2|Overall Study|Not applicable (randomized not treated)|4
1262118|NCT00497796|4134171|P1|Overall Study|Not applicable (randomized not treated)|0
1262119|NCT00497796|4134170|P2|Overall Study|Lost to Follow-up|1
1262120|NCT00497796|4134171|P1|Overall Study|Lost to Follow-up|0
1262121|NCT00497796|4134170|P2|Overall Study|Investigator/sponsor discretion|34
1262122|NCT00497796|4134171|P1|Overall Study|Investigator/sponsor discretion|31
1262123|NCT00497796|4134170|P2|Overall Study|Consent withdrawn|3
1262124|NCT00497796|4134171|P1|Overall Study|Consent withdrawn|10
1262125|NCT00497796|4134170|P2|Overall Study|CMV infection or disease treatment|4
1262126|NCT00497796|4134171|P1|Overall Study|CMV infection or disease treatment|30
1262127|NCT00497796|4134170|P2|Overall Study|Adverse event (related)|4
1262128|NCT00497796|4134171|P1|Overall Study|Adverse event (related)|5
1262129|NCT00497796|4134170|P2|Overall Study|Adverse event (not related)|9
1262130|NCT00497796|4134171|P1|Overall Study|Adverse event (not related)|9
1262131|NCT00497198|4134258|P2|Overall Study|Withdrawal by Subject|1
1262132|NCT00497198|4134259|P1|Overall Study|Withdrawal by Subject|0
1262133|NCT00497198|4134258|P2|Overall Study|Physician Decision|2
1262134|NCT00497198|4134259|P1|Overall Study|Physician Decision|1
1262135|NCT00497198|4134258|P2|Overall Study|Adverse Event|2
1262136|NCT00497198|4134259|P1|Overall Study|Adverse Event|4
1262137|NCT00497146|4134275|P2|Long-term Follow-up Period|Other|1
1262138|NCT00497146|4134276|P1|Long-term Follow-up Period|Other|0
1262139|NCT00497146|4134275|P2|Long-term Follow-up Period|Lost to Follow-up|1
1262140|NCT00497146|4134276|P1|Long-term Follow-up Period|Lost to Follow-up|5
1262141|NCT00497146|4134275|P2|Long-term Follow-up Period|Withdrawal by Subject|2
1262142|NCT00497146|4134276|P1|Long-term Follow-up Period|Withdrawal by Subject|8
1262143|NCT00497146|4134275|P2|Long-term Follow-up Period|Adverse Event|2
1262144|NCT00497146|4134276|P1|Long-term Follow-up Period|Adverse Event|2
1262145|NCT00497146|4134275|P2|Treatment Period|Other Reason|3
1262146|NCT00497146|4134276|P1|Treatment Period|Other Reason|2
1262147|NCT00497146|4134275|P2|Treatment Period|Unable to dose reduce per protocol|1
1262148|NCT00497146|4134276|P1|Treatment Period|Unable to dose reduce per protocol|4
1262149|NCT00497146|4134275|P2|Treatment Period|Change in RAAS inhibitor therapy|2
1262150|NCT00497146|4134276|P1|Treatment Period|Change in RAAS inhibitor therapy|5
1262151|NCT00497146|4134275|P2|Treatment Period|Required dialysis|1
1262152|NCT00497146|4134276|P1|Treatment Period|Required dialysis|4
1262153|NCT00497146|4134275|P2|Treatment Period|Lost to Follow-up|3
1262154|NCT00497146|4134276|P1|Treatment Period|Lost to Follow-up|1
1262155|NCT00497146|4134275|P2|Treatment Period|Withdrawal by Subject|9
1262156|NCT00497146|4134276|P1|Treatment Period|Withdrawal by Subject|5
1262157|NCT00497146|4134275|P2|Treatment Period|Adverse Event|2
1262158|NCT00497146|4134276|P1|Treatment Period|Adverse Event|6
1262159|NCT00496964|4134344|P2|Overall Study|Withdrawal by Subject|1
1262160|NCT00496964|4134345|P1|Overall Study|Withdrawal by Subject|0
1262161|NCT00496873|4134363|P1|Overall Study|Withdrawal by Subject|3
1262162|NCT00496873|4134363|P1|Overall Study|Death|2
1262163|NCT00496873|4134363|P1|Overall Study|Ineligible|2
1262164|NCT00496834|4134396|P2|Overall Study|Blood Pressure control failure|1
1262165|NCT00496834|4134397|P1|Overall Study|Blood Pressure control failure|2
1262166|NCT00496834|4134396|P2|Overall Study|Lost to Follow-up|0
1262167|NCT00496834|4134397|P1|Overall Study|Lost to Follow-up|2
1262168|NCT00496834|4134396|P2|Overall Study|IP administration violation|0
1262169|NCT00496834|4134397|P1|Overall Study|IP administration violation|2
1262170|NCT00496834|4134396|P2|Overall Study|Adverse Event|3
1262171|NCT00496834|4134397|P1|Overall Study|Adverse Event|5
1262172|NCT00496834|4134396|P2|Overall Study|Inclusion/exclusion criteria not met|2
1262173|NCT00496834|4134397|P1|Overall Study|Inclusion/exclusion criteria not met|3
1262174|NCT00496834|4134396|P2|Overall Study|Contraindicated medication administered|1
1262175|NCT00496834|4134397|P1|Overall Study|Contraindicated medication administered|0
1262176|NCT00496834|4134396|P2|Overall Study|Withdrawal by Subject|6
1262177|NCT00496834|4134397|P1|Overall Study|Withdrawal by Subject|4
1262178|NCT00496782|4134416|P2|Overall Study|Protocol Violation|2
1262179|NCT00496782|4134417|P1|Overall Study|Protocol Violation|1
1262180|NCT00496769|4134451|P3|Open Label|>=1 reason assigned per patient|1011
1262181|NCT00496769|4134452|P2|Open Label|>=1 reason assigned per patient|0
1262182|NCT00496769|4134453|P1|Open Label|>=1 reason assigned per patient|0
1262183|NCT00496769|4134451|P3|Double Blind|>=1 reason assigned per patient|0
1262184|NCT00496769|4134452|P2|Double Blind|>=1 reason assigned per patient|649
1262185|NCT00496769|4134453|P1|Double Blind|>=1 reason assigned per patient|558
1262186|NCT00496730|4134478|P2|Overall Study|Withdrawal by Subject|2
1262187|NCT00496730|4134479|P1|Overall Study|Withdrawal by Subject|2
1262188|NCT00496730|4134478|P2|Overall Study|Lost to Follow-up|3
1262189|NCT00496730|4134479|P1|Overall Study|Lost to Follow-up|4
1262190|NCT00496626|4134491|P2|Overall Study|Relocated|1
1262191|NCT00496626|4134492|P1|Overall Study|Relocated|0
1262192|NCT00496626|4134491|P2|Overall Study|Withdrawal by Subject|4
1262193|NCT00496626|4134492|P1|Overall Study|Withdrawal by Subject|5
1262194|NCT00496626|4134491|P2|Overall Study|Protocol Violation|0
1262195|NCT00496626|4134492|P1|Overall Study|Protocol Violation|1
1262196|NCT00496626|4134491|P2|Overall Study|Lost to Follow-up|1
1262197|NCT00496626|4134492|P1|Overall Study|Lost to Follow-up|0
1262198|NCT00496587|4134504|P1|Overall Study|Complications unrelated|2
1262199|NCT00496587|4134504|P1|Overall Study|Death|1
1262200|NCT00496587|4134504|P1|Overall Study|Withdrawal by Subject|2
1262201|NCT00496587|4134504|P1|Overall Study|Progressive Disease|24
1262202|NCT00496587|4134504|P1|Overall Study|Adverse Event|2
1262203|NCT00496483|4134510|P1|Overall Study|Lack of Efficacy|1
1262204|NCT00496483|4134510|P1|Overall Study|Adverse Event|2
1262205|NCT00496483|4134510|P1|Overall Study|Not dosed|9
1262206|NCT00496470|4134527|P2|Overall Study|Other reason|2
1262207|NCT00496470|4134528|P1|Overall Study|Other reason|0
1262208|NCT00496470|4134527|P2|Overall Study|Incorrectly enrolled|5
1262209|NCT00496470|4134528|P1|Overall Study|Incorrectly enrolled|13
1262210|NCT00496470|4134527|P2|Overall Study|Withdrawal by Subject|12
1262211|NCT00496470|4134528|P1|Overall Study|Withdrawal by Subject|5
1262212|NCT00496470|4134527|P2|Overall Study|Adverse Event|10
1262213|NCT00496470|4134528|P1|Overall Study|Adverse Event|8
1262214|NCT00496366|4134614|P1|Overall Study|Death|1
1262215|NCT00496197|4134645|P1|Overall Study|Protocol Violation|8
1262216|NCT00496197|4134645|P1|Overall Study|Other|14
1262217|NCT00496197|4134645|P1|Overall Study|Pathogen not isolated baseline specimen|4
1262218|NCT00496197|4134645|P1|Overall Study|Withdrawal by Subject|11
1262219|NCT00496197|4134645|P1|Overall Study|Lost to Follow-up|11
1262220|NCT00496197|4134645|P1|Overall Study|Insufficient bacteriological response|10
1262221|NCT00496197|4134645|P1|Overall Study|Insufficient clinical response|3
1262222|NCT00496197|4134645|P1|Overall Study|Does not meet entrance criteria|5
1262223|NCT00496197|4134645|P1|Overall Study|Adverse Event|13
1262224|NCT00496197|4134645|P1|Overall Study|Discontinued study due to death|43
1262225|NCT00496080|4134672|P1|Overall Study|Physician Decision|6
1262226|NCT00496080|4134672|P1|Overall Study|Withdrawal by Subject|5
1262227|NCT00496080|4134672|P1|Overall Study|Surgical re-intervention|7
1262228|NCT00496080|4134672|P1|Overall Study|Lost to Follow-up|9
1262229|NCT00496054|4134682|P1|Overall Study|Lost to Follow-up|7
1262230|NCT00496054|4134682|P1|Overall Study|Adverse Event|1
1262231|NCT00495820|4134711|P2|Overall Study|Adverse Event|1
1262232|NCT00495820|4134712|P1|Overall Study|Adverse Event|1
1262233|NCT00495794|4134724|P2|Overall Study|Pharmacist did not activate patient|0
1262234|NCT00495794|4134725|P1|Overall Study|Pharmacist did not activate patient|522
1262235|NCT00495755|4134735|P1|Overall Study|Adverse Event|3
1262236|NCT00495677|4134747|P7|Stage 1 (25 Days)|Adverse Event|0
1262237|NCT00495677|4134748|P6|Stage 1 (25 Days)|Adverse Event|0
1262238|NCT00495677|4134749|P5|Stage 1 (25 Days)|Adverse Event|0
1262239|NCT00495677|4134750|P4|Stage 1 (25 Days)|Adverse Event|0
1262240|NCT00495677|4134751|P3|Stage 1 (25 Days)|Adverse Event|1
1262241|NCT00495677|4134752|P2|Stage 1 (25 Days)|Adverse Event|0
1262242|NCT00495677|4134753|P1|Stage 1 (25 Days)|Adverse Event|0
1262243|NCT00495625|4134808|P1|Overall Study|Did not complete at least 1 42 day cycle|10
1262244|NCT00495612|4134819|P2|Overall Study|Subject's Decision to Withdraw|0
1262245|NCT00495612|4134820|P1|Overall Study|Subject's Decision to Withdraw|3
1262246|NCT00495612|4134819|P2|Overall Study|Lost to Follow-up|0
1262247|NCT00495612|4134820|P1|Overall Study|Lost to Follow-up|1
1262248|NCT00495586|4134838|P2|Overall Study|Withdrawal by Subject|4
1262249|NCT00495586|4134839|P1|Overall Study|Withdrawal by Subject|4
1262250|NCT00495521|4134849|P2|Overall Study|Physician Decision|1
1262251|NCT00495521|4134850|P1|Overall Study|Physician Decision|0
1262252|NCT00495495|4134880|P1|Overall Study|Protocol Violation|99
1262253|NCT00495469|4134900|P7|Overall Study|ST depression at randomisation in ECG|0
1262254|NCT00495469|4134901|P6|Overall Study|ST depression at randomisation in ECG|0
1262255|NCT00495469|4134902|P5|Overall Study|ST depression at randomisation in ECG|0
1262256|NCT00495469|4134903|P4|Overall Study|ST depression at randomisation in ECG|0
1262257|NCT00495469|4134904|P3|Overall Study|ST depression at randomisation in ECG|0
1262258|NCT00495469|4134905|P2|Overall Study|ST depression at randomisation in ECG|1
1262259|NCT00495469|4134906|P1|Overall Study|ST depression at randomisation in ECG|0
1262260|NCT00495469|4134900|P7|Overall Study|Liver function test abnormality|0
1262261|NCT00495469|4134901|P6|Overall Study|Liver function test abnormality|0
1262262|NCT00495469|4134902|P5|Overall Study|Liver function test abnormality|0
1262263|NCT00495469|4134903|P4|Overall Study|Liver function test abnormality|0
1262264|NCT00495469|4134904|P3|Overall Study|Liver function test abnormality|0
1262265|NCT00495469|4134905|P2|Overall Study|Liver function test abnormality|1
1262266|NCT00495469|4134906|P1|Overall Study|Liver function test abnormality|0
1262267|NCT00495469|4134900|P7|Overall Study|Lack of Efficacy|1
1262268|NCT00495469|4134901|P6|Overall Study|Lack of Efficacy|0
1262269|NCT00495469|4134902|P5|Overall Study|Lack of Efficacy|0
1262270|NCT00495469|4134903|P4|Overall Study|Lack of Efficacy|0
1262271|NCT00495469|4134904|P3|Overall Study|Lack of Efficacy|0
1262272|NCT00495469|4134905|P2|Overall Study|Lack of Efficacy|0
1262273|NCT00495469|4134906|P1|Overall Study|Lack of Efficacy|0
1262274|NCT00495469|4134900|P7|Overall Study|Withdrawal by Subject|3
1262275|NCT00495469|4134901|P6|Overall Study|Withdrawal by Subject|2
1262276|NCT00495469|4134902|P5|Overall Study|Withdrawal by Subject|3
1262277|NCT00495469|4134903|P4|Overall Study|Withdrawal by Subject|3
1262278|NCT00495469|4134904|P3|Overall Study|Withdrawal by Subject|1
1262279|NCT00495469|4134905|P2|Overall Study|Withdrawal by Subject|3
1262280|NCT00495469|4134906|P1|Overall Study|Withdrawal by Subject|5
1262281|NCT00495469|4134900|P7|Overall Study|Protocol Violation|0
1262282|NCT00495469|4134901|P6|Overall Study|Protocol Violation|2
1262283|NCT00495469|4134902|P5|Overall Study|Protocol Violation|1
1262284|NCT00495469|4134903|P4|Overall Study|Protocol Violation|0
1262285|NCT00495469|4134904|P3|Overall Study|Protocol Violation|0
1262286|NCT00495469|4134905|P2|Overall Study|Protocol Violation|0
1262287|NCT00495469|4134906|P1|Overall Study|Protocol Violation|0
1262288|NCT00495469|4134900|P7|Overall Study|Lost to Follow-up|0
1262289|NCT00495469|4134901|P6|Overall Study|Lost to Follow-up|0
1262290|NCT00495469|4134902|P5|Overall Study|Lost to Follow-up|0
1262291|NCT00495469|4134903|P4|Overall Study|Lost to Follow-up|1
1262292|NCT00495469|4134904|P3|Overall Study|Lost to Follow-up|3
1262293|NCT00495469|4134905|P2|Overall Study|Lost to Follow-up|1
1262294|NCT00495469|4134906|P1|Overall Study|Lost to Follow-up|1
1262295|NCT00495469|4134900|P7|Overall Study|Adverse Event|1
1262296|NCT00495469|4134901|P6|Overall Study|Adverse Event|1
1262297|NCT00495469|4134902|P5|Overall Study|Adverse Event|1
1262298|NCT00495469|4134903|P4|Overall Study|Adverse Event|0
1262299|NCT00495469|4134904|P3|Overall Study|Adverse Event|3
1262300|NCT00495469|4134905|P2|Overall Study|Adverse Event|1
1262301|NCT00495469|4134906|P1|Overall Study|Adverse Event|0
1262302|NCT00495391|4135050|P2|Overall Study|Withdrawal by Subject|3
1262303|NCT00495391|4135051|P1|Overall Study|Withdrawal by Subject|2
1262304|NCT00495391|4135050|P2|Overall Study|Lack of Efficacy|18
1262305|NCT00495391|4135051|P1|Overall Study|Lack of Efficacy|34
1262306|NCT00495131|4135089|P2|Overall Study|Withdrawal by Subject|0
1262307|NCT00495131|4135090|P1|Overall Study|Withdrawal by Subject|1
1262308|NCT00495131|4135089|P2|Overall Study|Lost to Follow-up|2
1262309|NCT00495131|4135090|P1|Overall Study|Lost to Follow-up|0
1262310|NCT00495131|4135089|P2|Overall Study|Lack of Efficacy|2
1262311|NCT00495131|4135090|P1|Overall Study|Lack of Efficacy|0
1262312|NCT00495131|4135089|P2|Overall Study|Adverse Event|2
1262313|NCT00495131|4135090|P1|Overall Study|Adverse Event|6
1262314|NCT00494871|4135118|P2|Follow-up (FU) Period|Clinical Endpoint Reached|2
1262315|NCT00494871|4135119|P1|Follow-up (FU) Period|Clinical Endpoint Reached|3
1262316|NCT00494871|4135118|P2|Follow-up (FU) Period|Withdrawal by Subject|5
1262317|NCT00494871|4135119|P1|Follow-up (FU) Period|Withdrawal by Subject|5
1262318|NCT00494871|4135118|P2|Follow-up (FU) Period|Protocol Violation|0
1262319|NCT00494871|4135119|P1|Follow-up (FU) Period|Protocol Violation|1
1262320|NCT00494871|4135118|P2|Follow-up (FU) Period|Physician Decision|1
1262321|NCT00494871|4135119|P1|Follow-up (FU) Period|Physician Decision|0
1262322|NCT00494871|4135118|P2|Follow-up (FU) Period|Lost to Follow-up|2
1262323|NCT00494871|4135119|P1|Follow-up (FU) Period|Lost to Follow-up|6
1262324|NCT00494871|4135118|P2|Follow-up (FU) Period|Death|12
1262325|NCT00494871|4135119|P1|Follow-up (FU) Period|Death|13
1262326|NCT00494871|4135118|P2|Follow-up (FU) Period|Adverse Event|1
1262327|NCT00494871|4135119|P1|Follow-up (FU) Period|Adverse Event|1
1262328|NCT00494871|4135118|P2|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
1262329|NCT00494871|4135119|P1|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
1262330|NCT00494871|4135118|P2|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
1262331|NCT00494871|4135119|P1|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
1262332|NCT00494871|4135118|P2|Double-blind (DB) Treatment Period|Site Closed by Investigator|2
1262333|NCT00494871|4135119|P1|Double-blind (DB) Treatment Period|Site Closed by Investigator|1
1262334|NCT00494871|4135118|P2|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8
1262335|NCT00494871|4135119|P1|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12
1262336|NCT00494871|4135118|P2|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1
1262337|NCT00494871|4135119|P1|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3
1262338|NCT00494871|4135118|P2|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28
1262339|NCT00494871|4135119|P1|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18
1262340|NCT00494871|4135118|P2|Double-blind (DB) Treatment Period|Protocol Violation|9
1262341|NCT00494871|4135119|P1|Double-blind (DB) Treatment Period|Protocol Violation|9
1262342|NCT00494871|4135118|P2|Double-blind (DB) Treatment Period|Lost to Follow-up|1
1262343|NCT00494871|4135119|P1|Double-blind (DB) Treatment Period|Lost to Follow-up|4
1262344|NCT00494871|4135118|P2|Double-blind (DB) Treatment Period|Physician Decision|13
1262345|NCT00494871|4135119|P1|Double-blind (DB) Treatment Period|Physician Decision|4
1262346|NCT00494871|4135118|P2|Double-blind (DB) Treatment Period|Death|3
1262347|NCT00494871|4135119|P1|Double-blind (DB) Treatment Period|Death|8
1262348|NCT00494871|4135118|P2|Double-blind (DB) Treatment Period|Withdrawal by Subject|35
1262349|NCT00494871|4135119|P1|Double-blind (DB) Treatment Period|Withdrawal by Subject|26
1262350|NCT00494871|4135118|P2|Double-blind (DB) Treatment Period|Adverse Event|70
1262351|NCT00494871|4135119|P1|Double-blind (DB) Treatment Period|Adverse Event|73
1262352|NCT00494780|4135160|P2|Overall Study|Insurance Issues|1
1262353|NCT00494780|4135161|P1|Overall Study|Insurance Issues|0
1262354|NCT00494780|4135160|P2|Overall Study|Residual Tumour Mass|1
1262355|NCT00494780|4135161|P1|Overall Study|Residual Tumour Mass|0
1262356|NCT00494780|4135160|P2|Overall Study|Non-compliance|0
1262357|NCT00494780|4135161|P1|Overall Study|Non-compliance|1
1262358|NCT00494780|4135160|P2|Overall Study|New Treatment|2
1262359|NCT00494780|4135161|P1|Overall Study|New Treatment|2
1262360|NCT00494780|4135160|P2|Overall Study|Progression of Study Disease|8
1262361|NCT00494780|4135161|P1|Overall Study|Progression of Study Disease|7
1262362|NCT00494780|4135160|P2|Overall Study|Withdrew before Dosed|1
1262363|NCT00494780|4135161|P1|Overall Study|Withdrew before Dosed|0
1262364|NCT00494780|4135160|P2|Overall Study|Adverse Event|0
1262365|NCT00494780|4135161|P1|Overall Study|Adverse Event|1
1262366|NCT00494676|4135199|P2|Second Intervention|Withdrawal by Subject|1
1262367|NCT00494676|4135200|P1|Second Intervention|Withdrawal by Subject|1
1262368|NCT00494676|4135199|P2|First Intervention|Withdrawal by Subject|3
1262369|NCT00494676|4135200|P1|First Intervention|Withdrawal by Subject|1
1262370|NCT00494676|4135199|P2|Allocation|Withdrawal by Subject|4
1262371|NCT00494676|4135200|P1|Allocation|Withdrawal by Subject|2
1262372|NCT00494507|4135215|P4|Open-Label Phase|Worsening Disease|2
1262373|NCT00494507|4135216|P3|Open-Label Phase|Worsening Disease|0
1262374|NCT00494507|4135217|P2|Open-Label Phase|Worsening Disease|0
1262375|NCT00494507|4135218|P1|Open-Label Phase|Worsening Disease|0
1262376|NCT00494507|4135215|P4|Open-Label Phase|Adverse Event|3
1262377|NCT00494507|4135216|P3|Open-Label Phase|Adverse Event|5
1262378|NCT00494507|4135217|P2|Open-Label Phase|Adverse Event|1
1262379|NCT00494507|4135218|P1|Open-Label Phase|Adverse Event|0
1262380|NCT00494507|4135215|P4|Double-Blind Phase|Negative DNA test|1
1262381|NCT00494507|4135216|P3|Double-Blind Phase|Negative DNA test|0
1262382|NCT00494507|4135217|P2|Double-Blind Phase|Negative DNA test|0
1262383|NCT00494507|4135218|P1|Double-Blind Phase|Negative DNA test|0
1262384|NCT00494507|4135215|P4|Double-Blind Phase|Subject Non-compliance|0
1262385|NCT00494507|4135216|P3|Double-Blind Phase|Subject Non-compliance|1
1262386|NCT00494507|4135217|P2|Double-Blind Phase|Subject Non-compliance|0
1262387|NCT00494507|4135218|P1|Double-Blind Phase|Subject Non-compliance|0
1262388|NCT00494507|4135215|P4|Double-Blind Phase|Withdrawal by Subject|0
1262389|NCT00494507|4135216|P3|Double-Blind Phase|Withdrawal by Subject|0
1262390|NCT00494507|4135217|P2|Double-Blind Phase|Withdrawal by Subject|0
1262391|NCT00494507|4135218|P1|Double-Blind Phase|Withdrawal by Subject|1
1262392|NCT00494507|4135215|P4|Double-Blind Phase|Adverse Event|0
1262393|NCT00494507|4135216|P3|Double-Blind Phase|Adverse Event|1
1262394|NCT00494507|4135217|P2|Double-Blind Phase|Adverse Event|0
1262395|NCT00494507|4135218|P1|Double-Blind Phase|Adverse Event|2
1262396|NCT00494481|4135285|P2|Overall Study|Never received IP|0
1262397|NCT00494481|4135286|P1|Overall Study|Never received IP|2
1262398|NCT00494481|4135285|P2|Overall Study|Other|0
1262399|NCT00494481|4135286|P1|Overall Study|Other|1
1262400|NCT00494481|4135285|P2|Overall Study|Adverse Event|11
1262401|NCT00494481|4135286|P1|Overall Study|Adverse Event|15
1262402|NCT00494481|4135285|P2|Overall Study|Condition under investigation worsened|13
1262403|NCT00494481|4135286|P1|Overall Study|Condition under investigation worsened|11
1262404|NCT00494442|4135294|P2|Overall Study|Intercurrent illness|1
1262405|NCT00494442|4135295|P1|Overall Study|Intercurrent illness|0
1262406|NCT00494442|4135294|P2|Overall Study|Non-compliance|1
1262407|NCT00494442|4135295|P1|Overall Study|Non-compliance|0
1262408|NCT00494442|4135294|P2|Overall Study|Physician Decision|1
1262409|NCT00494442|4135295|P1|Overall Study|Physician Decision|0
1262410|NCT00494442|4135294|P2|Overall Study|Adverse Event|2
1262411|NCT00494442|4135295|P1|Overall Study|Adverse Event|0
1262412|NCT00494442|4135294|P2|Overall Study|Lack of Efficacy|10
1262413|NCT00494442|4135295|P1|Overall Study|Lack of Efficacy|16
1262414|NCT00494442|4135294|P2|Overall Study|Death|1
1262415|NCT00494442|4135295|P1|Overall Study|Death|1
1262416|NCT00494299|4135311|P2|Overall Study|Protocol Driven Decision Point|22
1262417|NCT00494299|4135312|P1|Overall Study|Protocol Driven Decision Point|11
1262418|NCT00494299|4135311|P2|Overall Study|Site Closed by Sponsor|0
1262419|NCT00494299|4135312|P1|Overall Study|Site Closed by Sponsor|6
1262420|NCT00494299|4135311|P2|Overall Study|Participant Did Not Take Study Drug|2
1262421|NCT00494299|4135312|P1|Overall Study|Participant Did Not Take Study Drug|0
1262422|NCT00494299|4135311|P2|Overall Study|Disease Progression, Recurrence/Relapse|185
1262423|NCT00494299|4135312|P1|Overall Study|Disease Progression, Recurrence/Relapse|109
1262424|NCT00494299|4135311|P2|Overall Study|Withdrawal by Subject|3
1262425|NCT00494299|4135312|P1|Overall Study|Withdrawal by Subject|8
1262426|NCT00494299|4135311|P2|Overall Study|Protocol Violation|2
1262427|NCT00494299|4135312|P1|Overall Study|Protocol Violation|1
1262428|NCT00494299|4135311|P2|Overall Study|Physician Decision|2
1262430|NCT00494299|4135311|P2|Overall Study|Lost to Follow-up|0
1262431|NCT00494299|4135312|P1|Overall Study|Lost to Follow-up|1
1262432|NCT00494299|4135311|P2|Overall Study|Adverse Event|13
1262433|NCT00494299|4135312|P1|Overall Study|Adverse Event|93
1262434|NCT00494234|4135324|P2|Overall Study|Death|1
1262435|NCT00494234|4135325|P1|Overall Study|Death|2
1262436|NCT00494234|4135324|P2|Overall Study|Withdrawal by Subject|0
1262437|NCT00494234|4135325|P1|Overall Study|Withdrawal by Subject|1
1262438|NCT00494234|4135324|P2|Overall Study|Lack of Efficacy|9
1262439|NCT00494234|4135325|P1|Overall Study|Lack of Efficacy|12
1262440|NCT00494221|4135344|P3|Overall Study|Withdrawal by Subject|0
1262441|NCT00494221|4135345|P2|Overall Study|Withdrawal by Subject|2
1262442|NCT00494221|4135346|P1|Overall Study|Withdrawal by Subject|1
1262443|NCT00494221|4135344|P3|Overall Study|Death|14
1262444|NCT00494221|4135345|P2|Overall Study|Death|9
1262445|NCT00494221|4135346|P1|Overall Study|Death|15
1262446|NCT00494091|4135387|P2|Overall Study|Withdrawal by Subject|7
1262447|NCT00494091|4135388|P1|Overall Study|Withdrawal by Subject|0
1262448|NCT00494091|4135387|P2|Overall Study|Not Specified|11
1262449|NCT00494091|4135388|P1|Overall Study|Not Specified|1
1262450|NCT00494091|4135387|P2|Overall Study|Lost to Follow-up|4
1262451|NCT00494091|4135388|P1|Overall Study|Lost to Follow-up|0
1262452|NCT00494091|4135387|P2|Overall Study|Death|54
1262453|NCT00494091|4135388|P1|Overall Study|Death|5
1262454|NCT00494026|4135410|P1|Overall Study|Sponsor Decision|4
1262455|NCT00494013|4135420|P2|Overall Study|Sponsor Decision|1
1262456|NCT00494013|4135421|P1|Overall Study|Sponsor Decision|0
1262457|NCT00494013|4135420|P2|Overall Study|Withdrawal by Subject|14
1262458|NCT00494013|4135421|P1|Overall Study|Withdrawal by Subject|13
1262459|NCT00494013|4135420|P2|Overall Study|Protocol Violation|5
1262460|NCT00494013|4135421|P1|Overall Study|Protocol Violation|8
1262461|NCT00494013|4135420|P2|Overall Study|Physician Decision|5
1262462|NCT00494013|4135421|P1|Overall Study|Physician Decision|3
1262463|NCT00494013|4135420|P2|Overall Study|Lost to Follow-up|6
1262464|NCT00494013|4135421|P1|Overall Study|Lost to Follow-up|5
1262465|NCT00494013|4135420|P2|Overall Study|Entry Criteria Not Met|4
1262466|NCT00494013|4135421|P1|Overall Study|Entry Criteria Not Met|1
1262467|NCT00494013|4135420|P2|Overall Study|Adverse Event|1
1262468|NCT00494013|4135421|P1|Overall Study|Adverse Event|0
1262469|NCT00493974|4135451|P2|Overall Study|Lost to Follow-up|6
1262470|NCT00493974|4135452|P1|Overall Study|Lost to Follow-up|4
1262471|NCT00493974|4135451|P2|Overall Study|Withdrawal by Subject|6
1262472|NCT00493974|4135452|P1|Overall Study|Withdrawal by Subject|8
1262473|NCT00493974|4135451|P2|Overall Study|Death|2
1262474|NCT00493974|4135452|P1|Overall Study|Death|1
1262475|NCT00493779|4135479|P1|Overall Study|Logistical issue at site|1
1262476|NCT00493649|4135486|P1|Overall Study|Other|13
1262477|NCT00493649|4135486|P1|Overall Study|Lost to Follow-up|1
1262478|NCT00493649|4135486|P1|Overall Study|Disease Progression|1
1262479|NCT00493649|4135486|P1|Overall Study|Investigator Request|2
1262480|NCT00493649|4135486|P1|Overall Study|Patient Request|21
1262481|NCT00493649|4135486|P1|Overall Study|Adverse Event|44
1262482|NCT00493636|4135499|P2|Overall Study|Mis-randomization|1
1262483|NCT00493636|4135500|P1|Overall Study|Mis-randomization|1
1262484|NCT00493636|4135499|P2|Overall Study|Disease progression/recurrence/relapse|1
1262485|NCT00493636|4135500|P1|Overall Study|Disease progression/recurrence/relapse|0
1262486|NCT00493636|4135499|P2|Overall Study|Withdrawal by Subject|0
1262487|NCT00493636|4135500|P1|Overall Study|Withdrawal by Subject|1
1262488|NCT00493454|4135514|P1|Overall Study|Withdrawal by Subject|1
1262489|NCT00493311|4135520|P2|Overall Study|Need for rescue medication|2
1262490|NCT00493311|4135521|P1|Overall Study|Need for rescue medication|2
1262491|NCT00493285|4135541|P6|Overall Study|Lost to Follow-up|0
1262492|NCT00493285|4135542|P5|Overall Study|Lost to Follow-up|1
1262493|NCT00493285|4135543|P4|Overall Study|Lost to Follow-up|0
1262494|NCT00493285|4135544|P3|Overall Study|Lost to Follow-up|0
1262495|NCT00493285|4135545|P2|Overall Study|Lost to Follow-up|0
1262496|NCT00493285|4135546|P1|Overall Study|Lost to Follow-up|0
1262497|NCT00493246|4135778|P8|Overall Study|Lost to Follow-up|0
1262498|NCT00493246|4135779|P7|Overall Study|Lost to Follow-up|1
1262499|NCT00493246|4135780|P6|Overall Study|Lost to Follow-up|0
1262500|NCT00493246|4135781|P5|Overall Study|Lost to Follow-up|0
1262501|NCT00493246|4135782|P4|Overall Study|Lost to Follow-up|0
1262502|NCT00493246|4135783|P3|Overall Study|Lost to Follow-up|0
1262503|NCT00493246|4135784|P2|Overall Study|Lost to Follow-up|0
1262504|NCT00493246|4135785|P1|Overall Study|Lost to Follow-up|0
1262505|NCT00493246|4135778|P8|Overall Study|No access to draw blood|0
1262506|NCT00493246|4135779|P7|Overall Study|No access to draw blood|0
1262507|NCT00493246|4135780|P6|Overall Study|No access to draw blood|1
1262508|NCT00493246|4135781|P5|Overall Study|No access to draw blood|0
1262509|NCT00493246|4135782|P4|Overall Study|No access to draw blood|0
1262510|NCT00493246|4135783|P3|Overall Study|No access to draw blood|0
1262511|NCT00493246|4135784|P2|Overall Study|No access to draw blood|0
1262512|NCT00493246|4135785|P1|Overall Study|No access to draw blood|0
1262513|NCT00493246|4135778|P8|Overall Study|Withdrawal by Subject|0
1262514|NCT00493246|4135779|P7|Overall Study|Withdrawal by Subject|0
1262515|NCT00493246|4135780|P6|Overall Study|Withdrawal by Subject|0
1262516|NCT00493246|4135781|P5|Overall Study|Withdrawal by Subject|1
1262517|NCT00493246|4135782|P4|Overall Study|Withdrawal by Subject|0
1262518|NCT00493246|4135783|P3|Overall Study|Withdrawal by Subject|0
1262519|NCT00493246|4135784|P2|Overall Study|Withdrawal by Subject|0
1262520|NCT00493246|4135785|P1|Overall Study|Withdrawal by Subject|0
1262521|NCT00493220|4135849|P6|Third Intervention|Withdrawal by Subject|0
1262522|NCT00493220|4135850|P5|Third Intervention|Withdrawal by Subject|0
1262523|NCT00493220|4135851|P4|Third Intervention|Withdrawal by Subject|0
1262524|NCT00493220|4135852|P3|Third Intervention|Withdrawal by Subject|0
1262525|NCT00493220|4135853|P2|Third Intervention|Withdrawal by Subject|0
1262526|NCT00493220|4135854|P1|Third Intervention|Withdrawal by Subject|1
1262527|NCT00493038|4135882|P2|Follow-up|Lost to Follow-up|0
1262528|NCT00493038|4135883|P1|Follow-up|Lost to Follow-up|1
1262529|NCT00493038|4135882|P2|Treatment|Other|1
1262530|NCT00493038|4135883|P1|Treatment|Other|0
1262531|NCT00493038|4135882|P2|Treatment|Withdrawal by Subject|12
1262532|NCT00493038|4135883|P1|Treatment|Withdrawal by Subject|11
1262533|NCT00493038|4135882|P2|Treatment|Lost to Follow-up|3
1262534|NCT00493038|4135883|P1|Treatment|Lost to Follow-up|5
1262535|NCT00493038|4135882|P2|Treatment|Adverse Event|4
1262536|NCT00493038|4135883|P1|Treatment|Adverse Event|8
1262537|NCT00493025|4135897|P1|Overall Study|Physician Decision|19
1262538|NCT00493012|4135908|P2|Overall Study|Lost to Follow-up|17
1262539|NCT00493012|4135909|P1|Overall Study|Lost to Follow-up|18
1262540|NCT00492921|4135952|P3|Overall Study|Death|1
1262541|NCT00492921|4135953|P2|Overall Study|Death|0
1262542|NCT00492921|4135954|P1|Overall Study|Death|1
1262543|NCT00492856|4135965|P4|Post-consolidation|Observation Arm|0
1262544|NCT00492856|4135966|P3|Post-consolidation|Observation Arm|27
1262545|NCT00492856|4135967|P2|Post-consolidation|Observation Arm|0
1262546|NCT00492856|4135968|P1|Post-consolidation|Observation Arm|0
1262547|NCT00492856|4135965|P4|Post-consolidation|Lost to Follow-up|0
1262548|NCT00492856|4135966|P3|Post-consolidation|Lost to Follow-up|0
1262549|NCT00492856|4135967|P2|Post-consolidation|Lost to Follow-up|2
1262550|NCT00492856|4135968|P1|Post-consolidation|Lost to Follow-up|0
1262551|NCT00492856|4135965|P4|Post-consolidation|Not protocol specified|0
1262552|NCT00492856|4135966|P3|Post-consolidation|Not protocol specified|0
1262553|NCT00492856|4135967|P2|Post-consolidation|Not protocol specified|1
1262554|NCT00492856|4135968|P1|Post-consolidation|Not protocol specified|0
1262555|NCT00492856|4135965|P4|Post-consolidation|Death|0
1262556|NCT00492856|4135966|P3|Post-consolidation|Death|0
1262557|NCT00492856|4135967|P2|Post-consolidation|Death|1
1262558|NCT00492856|4135968|P1|Post-consolidation|Death|0
1262559|NCT00492856|4135965|P4|Post-consolidation|Withdrawal by Subject|0
1262560|NCT00492856|4135966|P3|Post-consolidation|Withdrawal by Subject|0
1262561|NCT00492856|4135967|P2|Post-consolidation|Withdrawal by Subject|4
1262562|NCT00492856|4135968|P1|Post-consolidation|Withdrawal by Subject|0
1262563|NCT00492856|4135965|P4|Post-consolidation|Adverse Event|1
1262564|NCT00492856|4135966|P3|Post-consolidation|Adverse Event|0
1262565|NCT00492856|4135967|P2|Post-consolidation|Adverse Event|4
1262566|NCT00492856|4135968|P1|Post-consolidation|Adverse Event|0
1262567|NCT00492856|4135965|P4|Consolidation|Lost to Follow-up|0
1262568|NCT00492856|4135966|P3|Consolidation|Lost to Follow-up|0
1262569|NCT00492856|4135967|P2|Consolidation|Lost to Follow-up|0
1262570|NCT00492856|4135968|P1|Consolidation|Lost to Follow-up|1
1262571|NCT00492856|4135965|P4|Consolidation|Not protocol specified|0
1262572|NCT00492856|4135966|P3|Consolidation|Not protocol specified|0
1262573|NCT00492856|4135967|P2|Consolidation|Not protocol specified|0
1262574|NCT00492856|4135968|P1|Consolidation|Not protocol specified|2
1262575|NCT00492856|4135965|P4|Consolidation|Adverse Event|0
1262576|NCT00492856|4135966|P3|Consolidation|Adverse Event|0
1262577|NCT00492856|4135967|P2|Consolidation|Adverse Event|0
1262578|NCT00492856|4135968|P1|Consolidation|Adverse Event|6
1262579|NCT00492856|4135965|P4|Induction|Death|0
1262580|NCT00492856|4135966|P3|Induction|Death|0
1262581|NCT00492856|4135967|P2|Induction|Death|0
1262582|NCT00492856|4135968|P1|Induction|Death|3
1262583|NCT00492856|4135965|P4|Induction|Withdrawal by Subject|0
1262584|NCT00492856|4135966|P3|Induction|Withdrawal by Subject|0
1262585|NCT00492856|4135967|P2|Induction|Withdrawal by Subject|0
1262586|NCT00492856|4135968|P1|Induction|Withdrawal by Subject|1
1262587|NCT00492856|4135965|P4|Induction|Adverse Event|0
1262588|NCT00492856|4135966|P3|Induction|Adverse Event|0
1262589|NCT00492856|4135967|P2|Induction|Adverse Event|0
1262590|NCT00492856|4135968|P1|Induction|Adverse Event|2
1262591|NCT00492752|4135982|P4|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
1262592|NCT00492752|4135983|P3|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
1262593|NCT00492752|4135984|P2|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
1262594|NCT00492752|4135985|P1|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1
1262595|NCT00492752|4135982|P4|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
1262596|NCT00492752|4135983|P3|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
1262597|NCT00492752|4135984|P2|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6
1262598|NCT00492752|4135985|P1|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
1262599|NCT00492752|4135982|P4|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1
1262600|NCT00492752|4135983|P3|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
1262601|NCT00492752|4135984|P2|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
1262602|NCT00492752|4135985|P1|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
1262603|NCT00492752|4135982|P4|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2
1262604|NCT00492752|4135983|P3|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
1262605|NCT00492752|4135984|P2|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1
1262606|NCT00492752|4135985|P1|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
1262607|NCT00492752|4135982|P4|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
1262608|NCT00492752|4135983|P3|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
1262609|NCT00492752|4135984|P2|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1
1262610|NCT00492752|4135985|P1|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2
1262611|NCT00492752|4135982|P4|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0
1262612|NCT00492752|4135983|P3|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2
1262613|NCT00492752|4135984|P2|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1
1262614|NCT00492752|4135985|P1|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8
1262615|NCT00492752|4135982|P4|Follow-up and/or Open Label Sorafenib|Death|1
1262616|NCT00492752|4135983|P3|Follow-up and/or Open Label Sorafenib|Death|45
1262617|NCT00492752|4135984|P2|Follow-up and/or Open Label Sorafenib|Death|5
1262618|NCT00492752|4135985|P1|Follow-up and/or Open Label Sorafenib|Death|75
1262619|NCT00492752|4135982|P4|Follow-up and/or Open Label Sorafenib|Adverse Event|2
1262620|NCT00492752|4135983|P3|Follow-up and/or Open Label Sorafenib|Adverse Event|0
1262621|NCT00492752|4135984|P2|Follow-up and/or Open Label Sorafenib|Adverse Event|2
1262622|NCT00492752|4135985|P1|Follow-up and/or Open Label Sorafenib|Adverse Event|0
1262623|NCT00492752|4135982|P4|Double Blind Treatment|Protocol Violation|0
1262624|NCT00492752|4135983|P3|Double Blind Treatment|Protocol Violation|1
1262625|NCT00492752|4135984|P2|Double Blind Treatment|Protocol Violation|0
1262626|NCT00492752|4135985|P1|Double Blind Treatment|Protocol Violation|0
1262627|NCT00492752|4135982|P4|Double Blind Treatment|Adverse Event|0
1262628|NCT00492752|4135983|P3|Double Blind Treatment|Adverse Event|0
1262629|NCT00492752|4135984|P2|Double Blind Treatment|Adverse Event|0
1262630|NCT00492752|4135985|P1|Double Blind Treatment|Adverse Event|1
1262631|NCT00492752|4135982|P4|Double Blind Treatment|Death|0
1262632|NCT00492752|4135983|P3|Double Blind Treatment|Death|2
1262633|NCT00492752|4135984|P2|Double Blind Treatment|Death|0
1262634|NCT00492752|4135985|P1|Double Blind Treatment|Death|13
1262635|NCT00492726|4136020|P2|Overall Study|Non compliant with study medication|3
1262636|NCT00492726|4136021|P1|Overall Study|Non compliant with study medication|0
1262637|NCT00492726|4136020|P2|Overall Study|Withdrawal by Subject|3
1262638|NCT00492726|4136021|P1|Overall Study|Withdrawal by Subject|6
1262639|NCT00492726|4136020|P2|Overall Study|Physician Decision|1
1262640|NCT00492726|4136021|P1|Overall Study|Physician Decision|0
1262641|NCT00492726|4136020|P2|Overall Study|Lost to Follow-up|19
1262642|NCT00492726|4136021|P1|Overall Study|Lost to Follow-up|27
1262643|NCT00492726|4136020|P2|Overall Study|Lack of Efficacy|2
1262644|NCT00492726|4136021|P1|Overall Study|Lack of Efficacy|0
1262645|NCT00492726|4136020|P2|Overall Study|Death|2
1262646|NCT00492726|4136021|P1|Overall Study|Death|7
1262647|NCT00492726|4136020|P2|Overall Study|Adverse Event|6
1262648|NCT00492726|4136021|P1|Overall Study|Adverse Event|10
1262649|NCT00492648|4136047|P2|Month 30 (109671 Study)|Protocol Violation|1
1262650|NCT00492648|4136048|P1|Month 30 (109671 Study)|Protocol Violation|0
1262651|NCT00492557|4136095|P2|Overall Study|Lost to Follow-up|1
1262652|NCT00492557|4136096|P1|Overall Study|Lost to Follow-up|0
1262653|NCT00492557|4136095|P2|Overall Study|Failed to return|0
1262654|NCT00492557|4136096|P1|Overall Study|Failed to return|1
1262655|NCT00492557|4136095|P2|Overall Study|Adverse Event|0
1262656|NCT00492557|4136096|P1|Overall Study|Adverse Event|1
1262657|NCT00492557|4136095|P2|Overall Study|Death|1
1262658|NCT00492557|4136096|P1|Overall Study|Death|1
1262659|NCT00492557|4136095|P2|Overall Study|Other|2
1262660|NCT00492557|4136096|P1|Overall Study|Other|2
1262661|NCT00492557|4136095|P2|Overall Study|Protocol Violation|8
1262662|NCT00492557|4136096|P1|Overall Study|Protocol Violation|7
1262663|NCT00492557|4136095|P2|Overall Study|Subject request|11
1262664|NCT00492557|4136096|P1|Overall Study|Subject request|12
1262665|NCT00492531|4136126|P2|Overall Study|Withdrawn(More than one reason selected)|23
1262666|NCT00492531|4136127|P1|Overall Study|Withdrawn(More than one reason selected)|22
1262667|NCT00492297|4136200|P1|Survival Only Follow-up|Study terminated by sponsor|12
1262668|NCT00492297|4136200|P1|Survival Only Follow-up|Lack of Efficacy|1
1262669|NCT00492297|4136200|P1|Survival Only Follow-up|Death|46
1262670|NCT00492297|4136200|P1|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2
1262671|NCT00492297|4136200|P1|Active Follow-up 30(+4) Days Duration|Death|17
1262672|NCT00492297|4136200|P1|Treatment|Study terminated by sponsor|3
1262673|NCT00492297|4136200|P1|Treatment|Death|2
1262674|NCT00492284|4136218|P4|Overall Study|Withdrawal by Subject|2
1262675|NCT00492284|4136219|P3|Overall Study|Withdrawal by Subject|0
1262676|NCT00492284|4136220|P2|Overall Study|Withdrawal by Subject|0
1262677|NCT00492284|4136221|P1|Overall Study|Withdrawal by Subject|1
1262678|NCT00492284|4136218|P4|Overall Study|Death|5
1262679|NCT00492284|4136219|P3|Overall Study|Death|2
1262680|NCT00492284|4136220|P2|Overall Study|Death|3
1262681|NCT00492284|4136221|P1|Overall Study|Death|0
1262682|NCT00492284|4136218|P4|Overall Study|Lost to Follow-up|1
1262683|NCT00492284|4136219|P3|Overall Study|Lost to Follow-up|3
1262684|NCT00492284|4136220|P2|Overall Study|Lost to Follow-up|0
1262685|NCT00492284|4136221|P1|Overall Study|Lost to Follow-up|0
1262686|NCT00492284|4136218|P4|Overall Study|Adverse Event|2
1262687|NCT00492284|4136219|P3|Overall Study|Adverse Event|1
1262688|NCT00492284|4136220|P2|Overall Study|Adverse Event|1
1262689|NCT00492284|4136221|P1|Overall Study|Adverse Event|0
1262690|NCT00492232|4136265|P2|Open-Label Treatment|Withdrawal by Subject|0
1262691|NCT00492232|4136266|P1|Open-Label Treatment|Withdrawal by Subject|1
1262692|NCT00492232|4136265|P2|Double-Blind Treatment|Randomized not treated|0
1262693|NCT00492232|4136266|P1|Double-Blind Treatment|Randomized not treated|1
1262694|NCT00492232|4136265|P2|Double-Blind Treatment|Other|5
1262695|NCT00492232|4136266|P1|Double-Blind Treatment|Other|6
1262696|NCT00492232|4136265|P2|Double-Blind Treatment|Lack of Efficacy|0
1262697|NCT00492232|4136266|P1|Double-Blind Treatment|Lack of Efficacy|1
1262698|NCT00492232|4136265|P2|Double-Blind Treatment|Withdrawal by Subject|8
1262699|NCT00492232|4136266|P1|Double-Blind Treatment|Withdrawal by Subject|4
1262700|NCT00492232|4136265|P2|Double-Blind Treatment|Lost to Follow-up|3
1262701|NCT00492232|4136266|P1|Double-Blind Treatment|Lost to Follow-up|2
1262702|NCT00492232|4136265|P2|Double-Blind Treatment|Protocol Violation|7
1262703|NCT00492232|4136266|P1|Double-Blind Treatment|Protocol Violation|3
1262704|NCT00492232|4136265|P2|Double-Blind Treatment|Adverse Event|2
1262705|NCT00492232|4136266|P1|Double-Blind Treatment|Adverse Event|1
1262706|NCT00492232|4136265|P2|Placebo Run-in|Missing|2
1262707|NCT00492232|4136266|P1|Placebo Run-in|Missing|0
1262708|NCT00492232|4136265|P2|Placebo Run-in|Other|6
1262709|NCT00492232|4136266|P1|Placebo Run-in|Other|0
1262710|NCT00492232|4136265|P2|Placebo Run-in|Entrance criteria not met|45
1262711|NCT00492232|4136266|P1|Placebo Run-in|Entrance criteria not met|0
1262712|NCT00492232|4136265|P2|Placebo Run-in|Pregnancy|1
1262713|NCT00492232|4136266|P1|Placebo Run-in|Pregnancy|0
1262714|NCT00492232|4136265|P2|Placebo Run-in|Withdrawal by Subject|8
1262715|NCT00492232|4136266|P1|Placebo Run-in|Withdrawal by Subject|0
1262716|NCT00492232|4136265|P2|Placebo Run-in|Lost to Follow-up|3
1262717|NCT00492232|4136266|P1|Placebo Run-in|Lost to Follow-up|0
1262718|NCT00492232|4136265|P2|Placebo Run-in|Protocol Violation|3
1262719|NCT00492232|4136266|P1|Placebo Run-in|Protocol Violation|0
1262720|NCT00492232|4136265|P2|Placebo Run-in|Adverse Event|2
1262721|NCT00492232|4136266|P1|Placebo Run-in|Adverse Event|0
1262722|NCT00492115|4136307|P2|Overall Study|Withdrawal by Subject|4
1262723|NCT00492115|4136308|P1|Overall Study|Withdrawal by Subject|3
1262724|NCT00492063|4136329|P4|Overall Study|Protocol Violation|1
1262725|NCT00492063|4136330|P3|Overall Study|Protocol Violation|0
1262726|NCT00492063|4136331|P2|Overall Study|Protocol Violation|0
1262727|NCT00492063|4136332|P1|Overall Study|Protocol Violation|0
1262728|NCT00492063|4136329|P4|Overall Study|Lost to Follow-up|3
1262729|NCT00492063|4136330|P3|Overall Study|Lost to Follow-up|5
1262730|NCT00492063|4136331|P2|Overall Study|Lost to Follow-up|11
1262731|NCT00492063|4136332|P1|Overall Study|Lost to Follow-up|6
1262732|NCT00492063|4136329|P4|Overall Study|Withdrawal by Subject|4
1262733|NCT00492063|4136330|P3|Overall Study|Withdrawal by Subject|5
1262734|NCT00492063|4136331|P2|Overall Study|Withdrawal by Subject|3
1262735|NCT00492063|4136332|P1|Overall Study|Withdrawal by Subject|4
1262736|NCT00492063|4136329|P4|Overall Study|Death|2
1262737|NCT00492063|4136330|P3|Overall Study|Death|1
1262738|NCT00492063|4136331|P2|Overall Study|Death|0
1262739|NCT00492063|4136332|P1|Overall Study|Death|0
1262740|NCT00492024|4136356|P2|Follow up|Lost to Follow-up|1
1262741|NCT00492024|4136357|P1|Follow up|Lost to Follow-up|1
1262742|NCT00492024|4136356|P2|Follow up|Lack of Efficacy|1
1262743|NCT00492024|4136357|P1|Follow up|Lack of Efficacy|0
1262744|NCT00492024|4136356|P2|Treatment|Withdrawal by Subject|0
1262745|NCT00492024|4136357|P1|Treatment|Withdrawal by Subject|2
1262746|NCT00492024|4136356|P2|Treatment|Lost to Follow-up|1
1262747|NCT00492024|4136357|P1|Treatment|Lost to Follow-up|3
1262748|NCT00492024|4136356|P2|Treatment|Lack of Efficacy|20
1262749|NCT00492024|4136357|P1|Treatment|Lack of Efficacy|21
1262750|NCT00492024|4136356|P2|Treatment|Adverse Event|1
1262751|NCT00492024|4136357|P1|Treatment|Adverse Event|3
1262752|NCT00491894|4136373|P1|Overall Study|Other-Intake of prohibited medication|1
1262753|NCT00491894|4136373|P1|Overall Study|Protocol Violation|2
1262754|NCT00491894|4136373|P1|Overall Study|Physician Decision|2
1262755|NCT00491894|4136373|P1|Overall Study|Other-Failed to meet any criteria|2
1262756|NCT00491894|4136373|P1|Overall Study|Lack of Efficacy|2
1262757|NCT00491894|4136373|P1|Overall Study|Lost to Follow-up|3
1262758|NCT00491894|4136373|P1|Overall Study|Death|3
1262759|NCT00491894|4136373|P1|Overall Study|Withdrawal by Subject|5
1262760|NCT00491894|4136373|P1|Overall Study|Adverse Event|14
1262761|NCT00491764|4136400|P6|Overall Study|Administrative|0
1262762|NCT00491764|4136401|P5|Overall Study|Administrative|0
1262763|NCT00491764|4136402|P4|Overall Study|Administrative|1
1262764|NCT00491764|4136403|P3|Overall Study|Administrative|2
1262765|NCT00491764|4136404|P2|Overall Study|Administrative|0
1262766|NCT00491764|4136405|P1|Overall Study|Administrative|1
1262767|NCT00491764|4136400|P6|Overall Study|Did not Meet Protocol Eligibility|1
1262768|NCT00491764|4136401|P5|Overall Study|Did not Meet Protocol Eligibility|1
1262769|NCT00491764|4136402|P4|Overall Study|Did not Meet Protocol Eligibility|0
1262770|NCT00491764|4136403|P3|Overall Study|Did not Meet Protocol Eligibility|1
1262771|NCT00491764|4136404|P2|Overall Study|Did not Meet Protocol Eligibility|1
1262772|NCT00491764|4136405|P1|Overall Study|Did not Meet Protocol Eligibility|0
1262773|NCT00491764|4136400|P6|Overall Study|Non Compliance with the Protocol|0
1262774|NCT00491764|4136401|P5|Overall Study|Non Compliance with the Protocol|0
1262775|NCT00491764|4136402|P4|Overall Study|Non Compliance with the Protocol|0
1262776|NCT00491764|4136403|P3|Overall Study|Non Compliance with the Protocol|0
1262777|NCT00491764|4136404|P2|Overall Study|Non Compliance with the Protocol|0
1262778|NCT00491764|4136405|P1|Overall Study|Non Compliance with the Protocol|1
1262779|NCT00491764|4136400|P6|Overall Study|Withdrawal by Subject|4
1262780|NCT00491764|4136401|P5|Overall Study|Withdrawal by Subject|2
1262781|NCT00491764|4136402|P4|Overall Study|Withdrawal by Subject|2
1262782|NCT00491764|4136403|P3|Overall Study|Withdrawal by Subject|1
1262783|NCT00491764|4136404|P2|Overall Study|Withdrawal by Subject|3
1262784|NCT00491764|4136405|P1|Overall Study|Withdrawal by Subject|2
1262785|NCT00491764|4136400|P6|Overall Study|Lost to Follow-up|3
1262786|NCT00491764|4136401|P5|Overall Study|Lost to Follow-up|0
1262787|NCT00491764|4136402|P4|Overall Study|Lost to Follow-up|1
1262788|NCT00491764|4136403|P3|Overall Study|Lost to Follow-up|0
1262789|NCT00491764|4136404|P2|Overall Study|Lost to Follow-up|1
1262790|NCT00491764|4136405|P1|Overall Study|Lost to Follow-up|0
1262791|NCT00491764|4136400|P6|Overall Study|Adverse Event|1
1262792|NCT00491764|4136401|P5|Overall Study|Adverse Event|0
1262793|NCT00491764|4136402|P4|Overall Study|Adverse Event|4
1262794|NCT00491764|4136403|P3|Overall Study|Adverse Event|4
1262795|NCT00491764|4136404|P2|Overall Study|Adverse Event|2
1262796|NCT00491764|4136405|P1|Overall Study|Adverse Event|1
1262797|NCT00491608|4136453|P1|Overall Study|Withdrawal by Subject|1
1262798|NCT00491608|4136453|P1|Overall Study|Death|2
1262799|NCT00491556|4136464|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1
1262800|NCT00491556|4136465|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0
1262801|NCT00491556|4136464|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1
1262802|NCT00491556|4136465|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0
1262803|NCT00491556|4136464|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Not Specified|0
1262804|NCT00491556|4136465|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Not Specified|2
1262805|NCT00491556|4136464|P2|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0
1262806|NCT00491556|4136465|P1|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2
1262807|NCT00491556|4136464|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0
1262808|NCT00491556|4136465|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2
1262809|NCT00491556|4136464|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0
1262810|NCT00491556|4136465|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5
1262811|NCT00491556|4136464|P2|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0
1262812|NCT00491556|4136465|P1|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2
1262813|NCT00491556|4136464|P2|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0
1262814|NCT00491556|4136465|P1|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5
1262815|NCT00491556|4136464|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1
1262816|NCT00491556|4136465|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2
1262817|NCT00491556|4136464|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0
1262818|NCT00491556|4136465|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2
1262819|NCT00491556|4136464|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
1262820|NCT00491556|4136465|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
1262821|NCT00491556|4136464|P2|Entry-Week (WK) 48: EXP/Standard Care|Not Specified|0
1262822|NCT00491556|4136465|P1|Entry-Week (WK) 48: EXP/Standard Care|Not Specified|3
1262823|NCT00491556|4136464|P2|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0
1262824|NCT00491556|4136465|P1|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3
1262825|NCT00491556|4136464|P2|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0
1262826|NCT00491556|4136465|P1|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2
1262827|NCT00491556|4136464|P2|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0
1262828|NCT00491556|4136465|P1|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2
1262829|NCT00491556|4136464|P2|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0
1262830|NCT00491556|4136465|P1|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11
1262831|NCT00491556|4136464|P2|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0
1262832|NCT00491556|4136465|P1|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2
1262833|NCT00491556|4136464|P2|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0
1262834|NCT00491556|4136465|P1|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1
1262835|NCT00491556|4136464|P2|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0
1262836|NCT00491556|4136465|P1|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1
1262837|NCT00491556|4136464|P2|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0
1262838|NCT00491556|4136465|P1|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1
1262839|NCT00491530|4136524|P3|Overall Study|Use of Prohibited Medication|1
1262840|NCT00491530|4136525|P2|Overall Study|Use of Prohibited Medication|0
1262841|NCT00491530|4136526|P1|Overall Study|Use of Prohibited Medication|0
1262842|NCT00491530|4136524|P3|Overall Study|Patient Request|0
1262843|NCT00491530|4136525|P2|Overall Study|Patient Request|1
1262844|NCT00491530|4136526|P1|Overall Study|Patient Request|0
1262845|NCT00491530|4136524|P3|Overall Study|Investigator Discretion|0
1262846|NCT00491530|4136525|P2|Overall Study|Investigator Discretion|1
1262847|NCT00491530|4136526|P1|Overall Study|Investigator Discretion|0
1262848|NCT00491530|4136524|P3|Overall Study|Lack of Efficacy|0
1262849|NCT00491530|4136525|P2|Overall Study|Lack of Efficacy|1
1262850|NCT00491530|4136526|P1|Overall Study|Lack of Efficacy|0
1262851|NCT00491530|4136524|P3|Overall Study|Lost to Follow-up|2
1262852|NCT00491530|4136525|P2|Overall Study|Lost to Follow-up|2
1262853|NCT00491530|4136526|P1|Overall Study|Lost to Follow-up|3
1262854|NCT00491530|4136524|P3|Overall Study|Withdrawal by Subject|0
1262855|NCT00491530|4136525|P2|Overall Study|Withdrawal by Subject|0
1262856|NCT00491530|4136526|P1|Overall Study|Withdrawal by Subject|3
1262857|NCT00491530|4136524|P3|Overall Study|Adverse Event|2
1262858|NCT00491530|4136525|P2|Overall Study|Adverse Event|1
1262859|NCT00491530|4136526|P1|Overall Study|Adverse Event|6
1262860|NCT00491504|4136556|P4|Overall Study|Protocol Violation|2
1262861|NCT00491504|4136557|P3|Overall Study|Protocol Violation|3
1262862|NCT00491504|4136558|P2|Overall Study|Protocol Violation|0
1262863|NCT00491504|4136559|P1|Overall Study|Protocol Violation|0
1262864|NCT00491504|4136556|P4|Overall Study|Withdrawal by Subject|2
1262865|NCT00491504|4136557|P3|Overall Study|Withdrawal by Subject|1
1262866|NCT00491504|4136558|P2|Overall Study|Withdrawal by Subject|0
1262867|NCT00491504|4136559|P1|Overall Study|Withdrawal by Subject|0
1262868|NCT00491504|4136556|P4|Overall Study|Adverse Event|0
1262869|NCT00491504|4136557|P3|Overall Study|Adverse Event|0
1262870|NCT00491504|4136558|P2|Overall Study|Adverse Event|1
1262871|NCT00491504|4136559|P1|Overall Study|Adverse Event|0
1262872|NCT00491400|4136569|P2|Overall Study|Withdrawal by Subject|4
1262873|NCT00491400|4136570|P1|Overall Study|Withdrawal by Subject|5
1262874|NCT00491387|4136578|P1|Overall Study|study terminated|20
1262875|NCT00491322|4136593|P2|Overall Study|Pregnancy|1
1262876|NCT00491322|4136594|P1|Overall Study|Pregnancy|0
1262877|NCT00491322|4136593|P2|Overall Study|Protocol Violation|0
1262878|NCT00491322|4136594|P1|Overall Study|Protocol Violation|1
1262879|NCT00491179|4136613|P2|Overall Study|Withdrawal by Subject|1
1262880|NCT00491179|4136614|P1|Overall Study|Withdrawal by Subject|2
1262881|NCT00491179|4136613|P2|Overall Study|Adverse Event|1
1262882|NCT00491179|4136614|P1|Overall Study|Adverse Event|5
1262883|NCT00491075|4136622|P1|Overall Study|Physician Decision|1
1262884|NCT00491075|4136622|P1|Overall Study|Withdrawal by Subject|1
1262885|NCT00490971|4136628|P5|Maintenance|Not specified|3
1262886|NCT00490971|4136629|P4|Maintenance|Not specified|9
1262887|NCT00490971|4136630|P3|Maintenance|Not specified|11
1262888|NCT00490971|4136631|P2|Maintenance|Not specified|0
1262889|NCT00490971|4136632|P1|Maintenance|Not specified|0
1262890|NCT00490971|4136628|P5|Maintenance|Withdrawal by Subject|18
1262891|NCT00490971|4136629|P4|Maintenance|Withdrawal by Subject|28
1262892|NCT00490971|4136630|P3|Maintenance|Withdrawal by Subject|26
1262893|NCT00490971|4136631|P2|Maintenance|Withdrawal by Subject|0
1262894|NCT00490971|4136632|P1|Maintenance|Withdrawal by Subject|0
1262895|NCT00490971|4136628|P5|Maintenance|Protocol Violation|1
1262896|NCT00490971|4136629|P4|Maintenance|Protocol Violation|1
1262897|NCT00490971|4136630|P3|Maintenance|Protocol Violation|4
1262898|NCT00490971|4136631|P2|Maintenance|Protocol Violation|0
1262899|NCT00490971|4136632|P1|Maintenance|Protocol Violation|0
1262900|NCT00490971|4136628|P5|Maintenance|Pregnancy|0
1262901|NCT00490971|4136629|P4|Maintenance|Pregnancy|0
1262902|NCT00490971|4136630|P3|Maintenance|Pregnancy|1
1262903|NCT00490971|4136631|P2|Maintenance|Pregnancy|0
1262904|NCT00490971|4136632|P1|Maintenance|Pregnancy|0
1262905|NCT00490971|4136628|P5|Maintenance|Lost to Follow-up|10
1262906|NCT00490971|4136629|P4|Maintenance|Lost to Follow-up|8
1262907|NCT00490971|4136630|P3|Maintenance|Lost to Follow-up|5
1262908|NCT00490971|4136631|P2|Maintenance|Lost to Follow-up|0
1262909|NCT00490971|4136632|P1|Maintenance|Lost to Follow-up|0
1262910|NCT00490971|4136628|P5|Maintenance|Death|0
1262911|NCT00490971|4136629|P4|Maintenance|Death|2
1262912|NCT00490971|4136630|P3|Maintenance|Death|0
1262913|NCT00490971|4136631|P2|Maintenance|Death|0
1262914|NCT00490971|4136632|P1|Maintenance|Death|0
1262915|NCT00490971|4136628|P5|Maintenance|Adverse Event|7
1262916|NCT00490971|4136629|P4|Maintenance|Adverse Event|5
1262917|NCT00490971|4136630|P3|Maintenance|Adverse Event|4
1262918|NCT00490971|4136631|P2|Maintenance|Adverse Event|0
1262919|NCT00490971|4136632|P1|Maintenance|Adverse Event|0
1262920|NCT00490971|4136628|P5|Acute/Continuation|Not specified|0
1262921|NCT00490971|4136629|P4|Acute/Continuation|Not specified|0
1262922|NCT00490971|4136630|P3|Acute/Continuation|Not specified|0
1262923|NCT00490971|4136631|P2|Acute/Continuation|Not specified|4
1262924|NCT00490971|4136632|P1|Acute/Continuation|Not specified|11
1262925|NCT00490971|4136628|P5|Acute/Continuation|Withdrawal by Subject|0
1262926|NCT00490971|4136629|P4|Acute/Continuation|Withdrawal by Subject|0
1262927|NCT00490971|4136630|P3|Acute/Continuation|Withdrawal by Subject|0
1262928|NCT00490971|4136631|P2|Acute/Continuation|Withdrawal by Subject|24
1262929|NCT00490971|4136632|P1|Acute/Continuation|Withdrawal by Subject|92
1262930|NCT00490971|4136628|P5|Acute/Continuation|Protocol Violation|0
1262931|NCT00490971|4136629|P4|Acute/Continuation|Protocol Violation|0
1262932|NCT00490971|4136630|P3|Acute/Continuation|Protocol Violation|0
1262933|NCT00490971|4136631|P2|Acute/Continuation|Protocol Violation|2
1262934|NCT00490971|4136632|P1|Acute/Continuation|Protocol Violation|10
1262935|NCT00490971|4136628|P5|Acute/Continuation|Lost to Follow-up|0
1262936|NCT00490971|4136629|P4|Acute/Continuation|Lost to Follow-up|0
1262937|NCT00490971|4136630|P3|Acute/Continuation|Lost to Follow-up|0
1262938|NCT00490971|4136631|P2|Acute/Continuation|Lost to Follow-up|7
1262939|NCT00490971|4136632|P1|Acute/Continuation|Lost to Follow-up|23
1262940|NCT00490971|4136628|P5|Acute/Continuation|Lack of Efficacy|0
1262941|NCT00490971|4136629|P4|Acute/Continuation|Lack of Efficacy|0
1262942|NCT00490971|4136630|P3|Acute/Continuation|Lack of Efficacy|0
1262943|NCT00490971|4136631|P2|Acute/Continuation|Lack of Efficacy|12
1262944|NCT00490971|4136632|P1|Acute/Continuation|Lack of Efficacy|106
1262945|NCT00490971|4136628|P5|Acute/Continuation|Death|0
1262946|NCT00490971|4136629|P4|Acute/Continuation|Death|0
1262947|NCT00490971|4136630|P3|Acute/Continuation|Death|0
1262948|NCT00490971|4136631|P2|Acute/Continuation|Death|0
1262949|NCT00490971|4136632|P1|Acute/Continuation|Death|2
1262950|NCT00490971|4136628|P5|Acute/Continuation|Adverse Event|0
1262951|NCT00490971|4136629|P4|Acute/Continuation|Adverse Event|0
1262952|NCT00490971|4136630|P3|Acute/Continuation|Adverse Event|0
1262953|NCT00490971|4136631|P2|Acute/Continuation|Adverse Event|13
1262954|NCT00490971|4136632|P1|Acute/Continuation|Adverse Event|62
1262955|NCT00490945|4136679|P5|Overall Study|Adverse Event|0
1262956|NCT00490945|4136680|P4|Overall Study|Adverse Event|0
1262957|NCT00490945|4136681|P3|Overall Study|Adverse Event|0
1262958|NCT00490945|4136682|P2|Overall Study|Adverse Event|1
1262959|NCT00490945|4136683|P1|Overall Study|Adverse Event|0
1262960|NCT00490919|4136719|P3|Double-blind Phase|Administrative|6
1262961|NCT00490919|4136720|P2|Double-blind Phase|Administrative|6
1262962|NCT00490919|4136721|P1|Double-blind Phase|Administrative|0
1262963|NCT00490919|4136719|P3|Double-blind Phase|Lack of Efficacy|36
1262964|NCT00490919|4136720|P2|Double-blind Phase|Lack of Efficacy|22
1262965|NCT00490919|4136721|P1|Double-blind Phase|Lack of Efficacy|0
1262966|NCT00490919|4136719|P3|Double-blind Phase|Lost to Follow-up|11
1262967|NCT00490919|4136720|P2|Double-blind Phase|Lost to Follow-up|8
1262968|NCT00490919|4136721|P1|Double-blind Phase|Lost to Follow-up|0
1262969|NCT00490919|4136719|P3|Double-blind Phase|Withdrawal by Subject|11
1262970|NCT00490919|4136720|P2|Double-blind Phase|Withdrawal by Subject|10
1262971|NCT00490919|4136721|P1|Double-blind Phase|Withdrawal by Subject|0
1262972|NCT00490919|4136719|P3|Double-blind Phase|Adverse Event|20
1262973|NCT00490919|4136720|P2|Double-blind Phase|Adverse Event|40
1262974|NCT00490919|4136721|P1|Double-blind Phase|Adverse Event|0
1262975|NCT00490919|4136719|P3|Open-label Run-in Period|Confirmed or suspected diversion|0
1262976|NCT00490919|4136720|P2|Open-label Run-in Period|Confirmed or suspected diversion|0
1262977|NCT00490919|4136721|P1|Open-label Run-in Period|Confirmed or suspected diversion|3
1262978|NCT00490919|4136719|P3|Open-label Run-in Period|Administrative|0
1262979|NCT00490919|4136720|P2|Open-label Run-in Period|Administrative|0
1262980|NCT00490919|4136721|P1|Open-label Run-in Period|Administrative|40
1262981|NCT00490919|4136719|P3|Open-label Run-in Period|Lack of Efficacy|0
1262982|NCT00490919|4136720|P2|Open-label Run-in Period|Lack of Efficacy|0
1262983|NCT00490919|4136721|P1|Open-label Run-in Period|Lack of Efficacy|143
1262984|NCT00490919|4136719|P3|Open-label Run-in Period|Lost to Follow-up|0
1262985|NCT00490919|4136720|P2|Open-label Run-in Period|Lost to Follow-up|0
1262986|NCT00490919|4136721|P1|Open-label Run-in Period|Lost to Follow-up|21
1262987|NCT00490919|4136719|P3|Open-label Run-in Period|Withdrawal by Subject|0
1262988|NCT00490919|4136720|P2|Open-label Run-in Period|Withdrawal by Subject|0
1262989|NCT00490919|4136721|P1|Open-label Run-in Period|Withdrawal by Subject|37
1262990|NCT00490919|4136719|P3|Open-label Run-in Period|Adverse Event|0
1262991|NCT00490919|4136720|P2|Open-label Run-in Period|Adverse Event|0
1262992|NCT00490919|4136721|P1|Open-label Run-in Period|Adverse Event|239
1262993|NCT00490841|4136732|P1|Overall Study|30 day f/u, only non-study stent used|3
1262994|NCT00490841|4136732|P1|Overall Study|Lost to Follow-up|1
1262995|NCT00490841|4136732|P1|Overall Study|Withdrawal by Subject|4
1262996|NCT00490841|4136732|P1|Overall Study|Death|5
1262997|NCT00490815|4136754|P2|Overall Study|Death|3
1262998|NCT00490815|4136755|P1|Overall Study|Death|1
1262999|NCT00490815|4136754|P2|Overall Study|Lost to Follow-up|3
1263000|NCT00490815|4136755|P1|Overall Study|Lost to Follow-up|1
1263001|NCT00490815|4136754|P2|Overall Study|Withdrawal by Subject|0
1263002|NCT00490815|4136755|P1|Overall Study|Withdrawal by Subject|4
1263003|NCT00490815|4136754|P2|Overall Study|Adverse Event|3
1263004|NCT00490815|4136755|P1|Overall Study|Adverse Event|2
1263005|NCT00490724|4136783|P3|Period II|Treatment Discontinuation|3
1263006|NCT00490724|4136784|P2|Period II|Treatment Discontinuation|1
1263007|NCT00490724|4136785|P1|Period II|Treatment Discontinuation|3
1263008|NCT00490724|4136783|P3|Period I|Physician Decision|1
1263009|NCT00490724|4136784|P2|Period I|Physician Decision|0
1263010|NCT00490724|4136785|P1|Period I|Physician Decision|0
1263011|NCT00490698|4136850|P1|Overall Study|Physician Decision|2
1263012|NCT00490698|4136850|P1|Overall Study|Disease Progression|7
1263013|NCT00490698|4136850|P1|Overall Study|Withdrawal by Subject|1
1263014|NCT00490646|4136856|P2|Overall Study|Never Treated (withdrew consent)|1
1263015|NCT00490646|4136857|P1|Overall Study|Never Treated (withdrew consent)|0
1263016|NCT00490646|4136856|P2|Overall Study|Never Treated (had an adverse event)|0
1263017|NCT00490646|4136857|P1|Overall Study|Never Treated (had an adverse event)|1
1263018|NCT00490646|4136856|P2|Overall Study|Still on trastuzumab monotherapy|1
1263019|NCT00490646|4136857|P1|Overall Study|Still on trastuzumab monotherapy|1
1263020|NCT00490568|4136877|P1|Overall Study|Participant withdrawal due to surgery|1
1263021|NCT00490568|4136877|P1|Overall Study|Participant died|1
1263022|NCT00490568|4136877|P1|Overall Study|Efficacy related|3
1263023|NCT00490568|4136877|P1|Overall Study|Non-Compliance|7
1263024|NCT00490568|4136877|P1|Overall Study|Investigator decision|3
1263025|NCT00490568|4136877|P1|Overall Study|Unmet inclusion-exclusion criteria|5
1263026|NCT00490568|4136877|P1|Overall Study|Disease progression|4
1263027|NCT00490568|4136877|P1|Overall Study|Legal representative withdrew consent|1
1263028|NCT00490568|4136877|P1|Overall Study|Participant refused follow-up|9
1263029|NCT00490568|4136877|P1|Overall Study|Abnormal ECG|25
1263030|NCT00490568|4136877|P1|Overall Study|Caregiver related|20
1263031|NCT00490568|4136877|P1|Overall Study|Exclusion criteria met|1
1263032|NCT00490568|4136877|P1|Overall Study|Other|1
1263033|NCT00490568|4136877|P1|Overall Study|Still in the study at termination|974
1263034|NCT00490568|4136877|P1|Overall Study|Withdrawal by Subject|135
1263035|NCT00490568|4136877|P1|Overall Study|Protocol Violation|45
1263036|NCT00490568|4136877|P1|Overall Study|Lost to Follow-up|13
1263037|NCT00490568|4136877|P1|Overall Study|Adverse Event|116
1263038|NCT00490555|4136901|P4|Overall Study|noncompliant with drug administration|0
1263039|NCT00490555|4136902|P3|Overall Study|noncompliant with drug administration|2
1263040|NCT00490555|4136903|P2|Overall Study|noncompliant with drug administration|0
1263041|NCT00490555|4136904|P1|Overall Study|noncompliant with drug administration|0
1263042|NCT00490542|4136932|P2|Overall Study|Lack of Efficacy|1
1263043|NCT00490542|4136933|P1|Overall Study|Lack of Efficacy|1
1263044|NCT00490542|4136932|P2|Overall Study|Adverse Event|3
1263045|NCT00490542|4136933|P1|Overall Study|Adverse Event|3
1263046|NCT00490542|4136932|P2|Overall Study|Lost to Follow-up|0
1263047|NCT00490542|4136933|P1|Overall Study|Lost to Follow-up|3
1263048|NCT00490490|4136939|P1|Completed Assessment for TTP|Lost to Follow-up|2
1263049|NCT00490490|4136939|P1|Completed Assessment for TTP|Withdrawal by Subject|1
1263050|NCT00490451|4136956|P2|Overall Study|Progressive Disease|34
1263051|NCT00490451|4136957|P1|Overall Study|Progressive Disease|53
1263052|NCT00490451|4136956|P2|Overall Study|Protocol Violation|0
1263053|NCT00490451|4136957|P1|Overall Study|Protocol Violation|1
1263054|NCT00490451|4136956|P2|Overall Study|Investigator Decision|0
1263055|NCT00490451|4136957|P1|Overall Study|Investigator Decision|1
1263056|NCT00490451|4136956|P2|Overall Study|Withdrawal by Subject|0
1263057|NCT00490451|4136957|P1|Overall Study|Withdrawal by Subject|2
1263058|NCT00490451|4136956|P2|Overall Study|Death|1
1263059|NCT00490451|4136957|P1|Overall Study|Death|3
1263060|NCT00490451|4136956|P2|Overall Study|Adverse Event|3
1263061|NCT00490451|4136957|P1|Overall Study|Adverse Event|3
1263062|NCT00490139|4136999|P4|Overall Study|Participant Withdrew Consent|116
1263063|NCT00490139|4137000|P3|Overall Study|Participant Withdrew Consent|208
1263064|NCT00490139|4137001|P2|Overall Study|Participant Withdrew Consent|110
1263065|NCT00490139|4137002|P1|Overall Study|Participant Withdrew Consent|146
1263066|NCT00490139|4136999|P4|Overall Study|Lost to Follow-up|56
1263067|NCT00490139|4137000|P3|Overall Study|Lost to Follow-up|58
1263068|NCT00490139|4137001|P2|Overall Study|Lost to Follow-up|46
1263069|NCT00490139|4137002|P1|Overall Study|Lost to Follow-up|56
1263070|NCT00490139|4136999|P4|Overall Study|Death|135
1263071|NCT00490139|4137000|P3|Overall Study|Death|168
1263072|NCT00490139|4137001|P2|Overall Study|Death|119
1263073|NCT00490139|4137002|P1|Overall Study|Death|106
1263074|NCT00490061|4137037|P1|Overall Study|Physician Decision|1
1263075|NCT00490035|4137046|P4|Overall Study|AE of unknown type|0
1263076|NCT00490035|4137047|P3|Overall Study|AE of unknown type|2
1263077|NCT00490035|4137048|P2|Overall Study|AE of unknown type|0
1263078|NCT00490035|4137049|P1|Overall Study|AE of unknown type|0
1263079|NCT00490035|4137046|P4|Overall Study|Serious adverse event (SAE), non-fatal|0
1263080|NCT00490035|4137047|P3|Overall Study|Serious adverse event (SAE), non-fatal|1
1263081|NCT00490035|4137048|P2|Overall Study|Serious adverse event (SAE), non-fatal|0
1263082|NCT00490035|4137049|P1|Overall Study|Serious adverse event (SAE), non-fatal|0
1263083|NCT00490035|4137046|P4|Overall Study|AE, serious fatal|0
1263084|NCT00490035|4137047|P3|Overall Study|AE, serious fatal|0
1263085|NCT00490035|4137048|P2|Overall Study|AE, serious fatal|0
1263086|NCT00490035|4137049|P1|Overall Study|AE, serious fatal|1
1263087|NCT00490035|4137046|P4|Overall Study|Other reason|1
1263088|NCT00490035|4137047|P3|Overall Study|Other reason|3
1263089|NCT00490035|4137048|P2|Overall Study|Other reason|1
1263090|NCT00490035|4137049|P1|Overall Study|Other reason|0
1263091|NCT00490035|4137046|P4|Overall Study|Withdrawal by Subject|0
1263092|NCT00490035|4137047|P3|Overall Study|Withdrawal by Subject|1
1263093|NCT00490035|4137048|P2|Overall Study|Withdrawal by Subject|1
1263094|NCT00490035|4137049|P1|Overall Study|Withdrawal by Subject|2
1263095|NCT00490035|4137046|P4|Overall Study|Lost to Follow-up|0
1263096|NCT00490035|4137047|P3|Overall Study|Lost to Follow-up|1
1263097|NCT00490035|4137048|P2|Overall Study|Lost to Follow-up|0
1263098|NCT00490035|4137049|P1|Overall Study|Lost to Follow-up|2
1263099|NCT00490035|4137046|P4|Overall Study|AE, non-serious non-fatal|5
1263100|NCT00490035|4137047|P3|Overall Study|AE, non-serious non-fatal|4
1263101|NCT00490035|4137048|P2|Overall Study|AE, non-serious non-fatal|4
1263102|NCT00490035|4137049|P1|Overall Study|AE, non-serious non-fatal|3
1263103|NCT00490022|4137149|P2|Overall Study|Subject failed to disclose concommitant|1
1263104|NCT00490022|4137150|P1|Overall Study|Subject failed to disclose concommitant|0
1263105|NCT00490022|4137149|P2|Overall Study|Withdrawal by Subject|0
1263106|NCT00490022|4137150|P1|Overall Study|Withdrawal by Subject|1
1263107|NCT00490022|4137149|P2|Overall Study|Adverse Event|2
1263108|NCT00490022|4137150|P1|Overall Study|Adverse Event|0
1263109|NCT00489918|4137196|P5|Overall Study|Physician Decision|0
1263110|NCT00489918|4137197|P4|Overall Study|Physician Decision|0
1263111|NCT00489918|4137198|P3|Overall Study|Physician Decision|1
1263112|NCT00489918|4137199|P2|Overall Study|Physician Decision|0
1263113|NCT00489918|4137200|P1|Overall Study|Physician Decision|0
1263114|NCT00489918|4137196|P5|Overall Study|Lost to Follow-up|0
1263115|NCT00489918|4137197|P4|Overall Study|Lost to Follow-up|1
1263116|NCT00489918|4137198|P3|Overall Study|Lost to Follow-up|1
1263117|NCT00489918|4137199|P2|Overall Study|Lost to Follow-up|0
1263118|NCT00489918|4137200|P1|Overall Study|Lost to Follow-up|0
1263119|NCT00489918|4137196|P5|Overall Study|Adverse Event|0
1263120|NCT00489918|4137197|P4|Overall Study|Adverse Event|0
1263121|NCT00489918|4137198|P3|Overall Study|Adverse Event|1
1263122|NCT00489918|4137199|P2|Overall Study|Adverse Event|1
1263123|NCT00489918|4137200|P1|Overall Study|Adverse Event|0
1263124|NCT00489918|4137196|P5|Overall Study|Withdrawal by Subject|1
1263125|NCT00489918|4137197|P4|Overall Study|Withdrawal by Subject|0
1263126|NCT00489918|4137198|P3|Overall Study|Withdrawal by Subject|1
1263127|NCT00489918|4137199|P2|Overall Study|Withdrawal by Subject|1
1263128|NCT00489918|4137200|P1|Overall Study|Withdrawal by Subject|2
1263129|NCT00489853|4137249|P3|Treatment Period 3|Study specific discontinuation criteria|0
1263130|NCT00489853|4137250|P2|Treatment Period 3|Study specific discontinuation criteria|1
1263131|NCT00489853|4137251|P1|Treatment Period 3|Study specific discontinuation criteria|0
1263132|NCT00489853|4137249|P3|Wash-out Period 2|Study specific discontinuation criteria|2
1263133|NCT00489853|4137250|P2|Wash-out Period 2|Study specific discontinuation criteria|2
1263134|NCT00489853|4137251|P1|Wash-out Period 2|Study specific discontinuation criteria|3
1263135|NCT00489853|4137249|P3|Wash-out Period 2|Adverse Event|0
1263136|NCT00489853|4137250|P2|Wash-out Period 2|Adverse Event|1
1263137|NCT00489853|4137251|P1|Wash-out Period 2|Adverse Event|1
1263138|NCT00489853|4137249|P3|Wash-out Period 1|Study-specific discontinuation criteria|4
1263139|NCT00489853|4137250|P2|Wash-out Period 1|Study-specific discontinuation criteria|1
1263140|NCT00489853|4137251|P1|Wash-out Period 1|Study-specific discontinuation criteria|0
1263141|NCT00489853|4137249|P3|Wash-out Period 1|Protocol Violation|1
1263142|NCT00489853|4137250|P2|Wash-out Period 1|Protocol Violation|1
1263143|NCT00489853|4137251|P1|Wash-out Period 1|Protocol Violation|0
1263144|NCT00489853|4137249|P3|Wash-out Period 1|Adverse Event|1
1263145|NCT00489853|4137250|P2|Wash-out Period 1|Adverse Event|1
1263146|NCT00489853|4137251|P1|Wash-out Period 1|Adverse Event|0
1263147|NCT00489853|4137249|P3|Wash-out Period 1|Withdrawal by Subject|0
1263148|NCT00489853|4137250|P2|Wash-out Period 1|Withdrawal by Subject|0
1263149|NCT00489853|4137251|P1|Wash-out Period 1|Withdrawal by Subject|1
1263150|NCT00489736|4137348|P2|Overall Study|Not coded/ Not pre-specified|8
1263151|NCT00489736|4137349|P1|Overall Study|Not coded/ Not pre-specified|5
1263152|NCT00489736|4137348|P2|Overall Study|Poor compliance|2
1263153|NCT00489736|4137349|P1|Overall Study|Poor compliance|6
1263154|NCT00489736|4137348|P2|Overall Study|Adverse Event|45
1263155|NCT00489736|4137349|P1|Overall Study|Adverse Event|32
1263156|NCT00489736|4137348|P2|Overall Study|Lack of Efficacy|14
1263157|NCT00489736|4137349|P1|Overall Study|Lack of Efficacy|53
1263158|NCT00489554|4137359|P1|Overall Study|Lost to Follow-up|1
1263159|NCT00489554|4137359|P1|Overall Study|Withdrawal by Subject|1
1263160|NCT00489554|4137359|P1|Overall Study|Adverse Event|2
1263161|NCT00489541|4137379|P2|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5
1263162|NCT00489541|4137380|P1|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4
1263163|NCT00489541|4137379|P2|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12
1263164|NCT00489541|4137380|P1|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23
1263165|NCT00489541|4137379|P2|12-Month Clinical Follow-up|Death|2
1263166|NCT00489541|4137380|P1|12-Month Clinical Follow-up|Death|3
1263167|NCT00489541|4137379|P2|12-Month Clinical Follow-up|Missed 12-Month Visit|0
1263168|NCT00489541|4137380|P1|12-Month Clinical Follow-up|Missed 12-Month Visit|2
1263169|NCT00489541|4137379|P2|12-Month Clinical Follow-up|Lost to Follow-up|0
1263170|NCT00489541|4137380|P1|12-Month Clinical Follow-up|Lost to Follow-up|2
1263171|NCT00489541|4137379|P2|12-Month Clinical Follow-up|Withdrawal by Subject|3
1263172|NCT00489541|4137380|P1|12-Month Clinical Follow-up|Withdrawal by Subject|2
1263173|NCT00489489|4137391|P3|Overall Study|Other than above|0
1263174|NCT00489489|4137392|P2|Overall Study|Other than above|1
1263175|NCT00489489|4137393|P1|Overall Study|Other than above|0
1263176|NCT00489489|4137391|P3|Overall Study|Participant did not wish to continue|0
1263177|NCT00489489|4137392|P2|Overall Study|Participant did not wish to continue|1
1263178|NCT00489489|4137393|P1|Overall Study|Participant did not wish to continue|1
1263179|NCT00489489|4137391|P3|Overall Study|Progressive disease|0
1263180|NCT00489489|4137392|P2|Overall Study|Progressive disease|1
1263181|NCT00489489|4137393|P1|Overall Study|Progressive disease|0
1263182|NCT00489489|4137391|P3|Overall Study|Protocol Violation|1
1263183|NCT00489489|4137392|P2|Overall Study|Protocol Violation|0
1263184|NCT00489489|4137393|P1|Overall Study|Protocol Violation|1
1263185|NCT00489489|4137391|P3|Overall Study|Adverse Event|1
1263186|NCT00489489|4137392|P2|Overall Study|Adverse Event|1
1263187|NCT00489489|4137393|P1|Overall Study|Adverse Event|1
1263188|NCT00489489|4137391|P3|Overall Study|Not treated due to protocol violation|1
1263189|NCT00489489|4137392|P2|Overall Study|Not treated due to protocol violation|1
1263190|NCT00489489|4137393|P1|Overall Study|Not treated due to protocol violation|0
1263191|NCT00489476|4137425|P4|Overall Study|Lost to Follow-up|0
1263192|NCT00489476|4137426|P3|Overall Study|Lost to Follow-up|0
1263193|NCT00489476|4137427|P2|Overall Study|Lost to Follow-up|1
1263194|NCT00489476|4137428|P1|Overall Study|Lost to Follow-up|0
1263195|NCT00489424|4137449|P3|Overall Study|Administrative problems|1
1263196|NCT00489424|4137450|P2|Overall Study|Administrative problems|2
1263197|NCT00489424|4137451|P1|Overall Study|Administrative problems|0
1263198|NCT00489424|4137449|P3|Overall Study|Lack of Efficacy|0
1263199|NCT00489424|4137450|P2|Overall Study|Lack of Efficacy|0
1263200|NCT00489424|4137451|P1|Overall Study|Lack of Efficacy|1
1263201|NCT00489424|4137449|P3|Overall Study|Adverse Event|4
1263202|NCT00489424|4137450|P2|Overall Study|Adverse Event|3
1263203|NCT00489424|4137451|P1|Overall Study|Adverse Event|3
1263204|NCT00489411|4137482|P2|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
1263205|NCT00489411|4137483|P1|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
1263206|NCT00489411|4137482|P2|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12
1263207|NCT00489411|4137483|P1|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11
1263208|NCT00489411|4137482|P2|Initial Treatment Period (Weeks 1-5)|Incomplete data|5
1263209|NCT00489411|4137483|P1|Initial Treatment Period (Weeks 1-5)|Incomplete data|1
1263210|NCT00489411|4137482|P2|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12
1263211|NCT00489411|4137483|P1|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21
1263212|NCT00489411|4137482|P2|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5
1263213|NCT00489411|4137483|P1|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6
1263214|NCT00489359|4137497|P2|Overall Study|Adverse Event|16
1263215|NCT00489359|4137498|P1|Overall Study|Adverse Event|0
1263216|NCT00489359|4137497|P2|Overall Study|Withdrawal by Subject|5
1263217|NCT00489359|4137498|P1|Overall Study|Withdrawal by Subject|1
1263218|NCT00489359|4137497|P2|Overall Study|Lost to Follow-up|0
1263219|NCT00489359|4137498|P1|Overall Study|Lost to Follow-up|1
1263220|NCT00489359|4137497|P2|Overall Study|Progressive Disease|6
1263221|NCT00489359|4137498|P1|Overall Study|Progressive Disease|5
1263222|NCT00489359|4137497|P2|Overall Study|Death|2
1263223|NCT00489359|4137498|P1|Overall Study|Death|0
1263224|NCT00489255|4137559|P2|Period 3: Days 57 to 84|Lost to Follow-up|1
1263225|NCT00489255|4137560|P1|Period 3: Days 57 to 84|Lost to Follow-up|0
1263226|NCT00489255|4137559|P2|Period 3: Days 57 to 84|Withdrawal by Subject|0
1263227|NCT00489255|4137560|P1|Period 3: Days 57 to 84|Withdrawal by Subject|1
1263228|NCT00489255|4137559|P2|Period 3: Days 57 to 84|Adverse Event|3
1263229|NCT00489255|4137560|P1|Period 3: Days 57 to 84|Adverse Event|3
1263230|NCT00489255|4137559|P2|Period 2: Days 29 to 56|Withdrawal by Subject|3
1263231|NCT00489255|4137560|P1|Period 2: Days 29 to 56|Withdrawal by Subject|0
1263232|NCT00489255|4137559|P2|Period 2: Days 29 to 56|Adverse Event|1
1263233|NCT00489255|4137560|P1|Period 2: Days 29 to 56|Adverse Event|3
1263234|NCT00489255|4137559|P2|Period 1: Days 1 to 28|Noncompliance|0
1263235|NCT00489255|4137560|P1|Period 1: Days 1 to 28|Noncompliance|2
1263236|NCT00489255|4137559|P2|Period 1: Days 1 to 28|Physician Decision|4
1263237|NCT00489255|4137560|P1|Period 1: Days 1 to 28|Physician Decision|1
1263238|NCT00489255|4137559|P2|Period 1: Days 1 to 28|Withdrawal by Subject|0
1263239|NCT00489255|4137560|P1|Period 1: Days 1 to 28|Withdrawal by Subject|5
1263240|NCT00489255|4137559|P2|Period 1: Days 1 to 28|Adverse Event|8
1263241|NCT00489255|4137560|P1|Period 1: Days 1 to 28|Adverse Event|21
1263242|NCT00489255|4137559|P2|Screening and Initial Randomization|Discontinued prior to taking study drug|3
1263243|NCT00489255|4137560|P1|Screening and Initial Randomization|Discontinued prior to taking study drug|9
1263244|NCT00489216|4137608|P1|Overall Study|Adverse Event|1
1263245|NCT00488826|4137630|P3|Overall Study|Protocol Deviations|1
1263246|NCT00488826|4137631|P2|Overall Study|Protocol Deviations|1
1263247|NCT00488826|4137632|P1|Overall Study|Protocol Deviations|2
1263248|NCT00488826|4137630|P3|Overall Study|Lost to Follow-up|0
1263249|NCT00488826|4137631|P2|Overall Study|Lost to Follow-up|1
1263250|NCT00488826|4137632|P1|Overall Study|Lost to Follow-up|5
1263251|NCT00488826|4137630|P3|Overall Study|Adverse Event|4
1263252|NCT00488826|4137631|P2|Overall Study|Adverse Event|15
1263253|NCT00488826|4137632|P1|Overall Study|Adverse Event|9
1263254|NCT00488826|4137630|P3|Overall Study|Protocol Violation|2
1263255|NCT00488826|4137631|P2|Overall Study|Protocol Violation|0
1263256|NCT00488826|4137632|P1|Overall Study|Protocol Violation|0
1263257|NCT00488826|4137630|P3|Overall Study|Withdrawal by Subject|19
1263258|NCT00488826|4137631|P2|Overall Study|Withdrawal by Subject|35
1263259|NCT00488826|4137632|P1|Overall Study|Withdrawal by Subject|40
1263260|NCT00488774|4137647|P4|Overall Study|Lost to Follow-up|1
1263261|NCT00488774|4137648|P3|Overall Study|Lost to Follow-up|1
1263262|NCT00488774|4137649|P2|Overall Study|Lost to Follow-up|0
1263263|NCT00488774|4137650|P1|Overall Study|Lost to Follow-up|0
1263264|NCT00488774|4137647|P4|Overall Study|Other|2
1263265|NCT00488774|4137648|P3|Overall Study|Other|2
1263266|NCT00488774|4137649|P2|Overall Study|Other|3
1263267|NCT00488774|4137650|P1|Overall Study|Other|6
1263268|NCT00488774|4137647|P4|Overall Study|Withdrawal of consent|0
1263269|NCT00488774|4137648|P3|Overall Study|Withdrawal of consent|2
1263270|NCT00488774|4137649|P2|Overall Study|Withdrawal of consent|2
1263271|NCT00488774|4137650|P1|Overall Study|Withdrawal of consent|2
1263272|NCT00488683|4137667|P3|Overall Study|Unable to Classify|0
1263273|NCT00488683|4137668|P2|Overall Study|Unable to Classify|0
1263274|NCT00488683|4137669|P1|Overall Study|Unable to Classify|1
1263275|NCT00488683|4137667|P3|Overall Study|Protocol Violation|0
1263276|NCT00488683|4137668|P2|Overall Study|Protocol Violation|1
1263277|NCT00488683|4137669|P1|Overall Study|Protocol Violation|5
1263278|NCT00488683|4137667|P3|Overall Study|Lost to Follow-up|0
1263279|NCT00488683|4137668|P2|Overall Study|Lost to Follow-up|3
1263280|NCT00488683|4137669|P1|Overall Study|Lost to Follow-up|5
1263281|NCT00488683|4137667|P3|Overall Study|Withdrawal by Subject|2
1263282|NCT00488683|4137668|P2|Overall Study|Withdrawal by Subject|2
1263283|NCT00488683|4137669|P1|Overall Study|Withdrawal by Subject|1
1263284|NCT00488644|4137728|P1|Overall Study|Not Evaluable|1
1263285|NCT00488644|4137728|P1|Overall Study|Not Eligible|1
1263286|NCT00488631|4137738|P10|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
1263287|NCT00488631|4137739|P9|Open Label Study Extension (Week 54-228)|Unspecified reasons|87
1263288|NCT00488631|4137740|P8|Open Label Study Extension (Week 54-228)|Unspecified reasons|14
1263289|NCT00488631|4137741|P7|Open Label Study Extension (Week 54-228)|Unspecified reasons|63
1263290|NCT00488631|4137742|P6|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
1263291|NCT00488631|4137743|P5|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
1263292|NCT00488631|4137744|P4|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
1263293|NCT00488631|4137745|P3|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
1263294|NCT00488631|4137746|P2|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
1263295|NCT00488631|4137747|P1|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
1263296|NCT00488631|4137738|P10|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
1263297|NCT00488631|4137739|P9|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6
1263298|NCT00488631|4137740|P8|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
1263299|NCT00488631|4137741|P7|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2
1263300|NCT00488631|4137742|P6|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
1263301|NCT00488631|4137743|P5|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
1263302|NCT00488631|4137744|P4|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
1263303|NCT00488631|4137745|P3|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
1263304|NCT00488631|4137746|P2|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
1263305|NCT00488631|4137747|P1|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
1263306|NCT00488631|4137738|P10|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3
1263307|NCT00488631|4137739|P9|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34
1263308|NCT00488631|4137740|P8|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
1263309|NCT00488631|4137741|P7|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
1263310|NCT00488631|4137742|P6|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
1263311|NCT00488631|4137743|P5|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
1263312|NCT00488631|4137744|P4|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
1263313|NCT00488631|4137745|P3|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
1263314|NCT00488631|4137746|P2|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
1263315|NCT00488631|4137747|P1|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
1263316|NCT00488631|4137738|P10|Open Label Study Extension (Week 54-228)|Death|0
1263317|NCT00488631|4137739|P9|Open Label Study Extension (Week 54-228)|Death|1
1263318|NCT00488631|4137740|P8|Open Label Study Extension (Week 54-228)|Death|0
1263319|NCT00488631|4137741|P7|Open Label Study Extension (Week 54-228)|Death|0
1263320|NCT00488631|4137742|P6|Open Label Study Extension (Week 54-228)|Death|0
1263321|NCT00488631|4137743|P5|Open Label Study Extension (Week 54-228)|Death|0
1263322|NCT00488631|4137744|P4|Open Label Study Extension (Week 54-228)|Death|0
1263323|NCT00488631|4137745|P3|Open Label Study Extension (Week 54-228)|Death|0
1263324|NCT00488631|4137746|P2|Open Label Study Extension (Week 54-228)|Death|0
1263325|NCT00488631|4137747|P1|Open Label Study Extension (Week 54-228)|Death|0
1263326|NCT00488631|4137738|P10|Open Label Study Extension (Week 54-228)|Adverse Event|0
1263327|NCT00488631|4137739|P9|Open Label Study Extension (Week 54-228)|Adverse Event|54
1263328|NCT00488631|4137740|P8|Open Label Study Extension (Week 54-228)|Adverse Event|8
1263329|NCT00488631|4137741|P7|Open Label Study Extension (Week 54-228)|Adverse Event|10
1263330|NCT00488631|4137742|P6|Open Label Study Extension (Week 54-228)|Adverse Event|0
1263331|NCT00488631|4137743|P5|Open Label Study Extension (Week 54-228)|Adverse Event|0
1263332|NCT00488631|4137744|P4|Open Label Study Extension (Week 54-228)|Adverse Event|0
1263333|NCT00488631|4137745|P3|Open Label Study Extension (Week 54-228)|Adverse Event|0
1263334|NCT00488631|4137746|P2|Open Label Study Extension (Week 54-228)|Adverse Event|0
1263335|NCT00488631|4137747|P1|Open Label Study Extension (Week 54-228)|Adverse Event|0
1263336|NCT00488631|4137738|P10|Double Blind Period (Week 0-54)|Other|0
1263337|NCT00488631|4137739|P9|Double Blind Period (Week 0-54)|Other|0
1263338|NCT00488631|4137740|P8|Double Blind Period (Week 0-54)|Other|0
1263339|NCT00488631|4137741|P7|Double Blind Period (Week 0-54)|Other|0
1263340|NCT00488631|4137742|P6|Double Blind Period (Week 0-54)|Other|34
1263341|NCT00488631|4137743|P5|Double Blind Period (Week 0-54)|Other|14
1263342|NCT00488631|4137744|P4|Double Blind Period (Week 0-54)|Other|11
1263343|NCT00488631|4137745|P3|Double Blind Period (Week 0-54)|Other|10
1263344|NCT00488631|4137746|P2|Double Blind Period (Week 0-54)|Other|12
1263345|NCT00488631|4137747|P1|Double Blind Period (Week 0-54)|Other|6
1263346|NCT00488631|4137738|P10|Double Blind Period (Week 0-54)|Lost to Follow-up|0
1263347|NCT00488631|4137739|P9|Double Blind Period (Week 0-54)|Lost to Follow-up|0
1263348|NCT00488631|4137740|P8|Double Blind Period (Week 0-54)|Lost to Follow-up|0
1263349|NCT00488631|4137741|P7|Double Blind Period (Week 0-54)|Lost to Follow-up|0
1263350|NCT00488631|4137742|P6|Double Blind Period (Week 0-54)|Lost to Follow-up|7
1263351|NCT00488631|4137743|P5|Double Blind Period (Week 0-54)|Lost to Follow-up|3
1263352|NCT00488631|4137744|P4|Double Blind Period (Week 0-54)|Lost to Follow-up|0
1263353|NCT00488631|4137745|P3|Double Blind Period (Week 0-54)|Lost to Follow-up|1
1263354|NCT00488631|4137746|P2|Double Blind Period (Week 0-54)|Lost to Follow-up|2
1263355|NCT00488631|4137747|P1|Double Blind Period (Week 0-54)|Lost to Follow-up|1
1263356|NCT00488631|4137738|P10|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
1263357|NCT00488631|4137739|P9|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
1263358|NCT00488631|4137740|P8|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
1263359|NCT00488631|4137741|P7|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
1263360|NCT00488631|4137742|P6|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124
1263361|NCT00488631|4137743|P5|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56
1263362|NCT00488631|4137744|P4|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18
1263363|NCT00488631|4137745|P3|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22
1263364|NCT00488631|4137746|P2|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17
1263365|NCT00488631|4137747|P1|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19
1263366|NCT00488631|4137738|P10|Double Blind Period (Week 0-54)|Death|0
1263367|NCT00488631|4137739|P9|Double Blind Period (Week 0-54)|Death|0
1263368|NCT00488631|4137740|P8|Double Blind Period (Week 0-54)|Death|0
1263369|NCT00488631|4137741|P7|Double Blind Period (Week 0-54)|Death|0
1263370|NCT00488631|4137742|P6|Double Blind Period (Week 0-54)|Death|1
1263371|NCT00488631|4137743|P5|Double Blind Period (Week 0-54)|Death|0
1263372|NCT00488631|4137744|P4|Double Blind Period (Week 0-54)|Death|0
1263373|NCT00488631|4137745|P3|Double Blind Period (Week 0-54)|Death|0
1263374|NCT00488631|4137746|P2|Double Blind Period (Week 0-54)|Death|0
1263375|NCT00488631|4137747|P1|Double Blind Period (Week 0-54)|Death|0
1263376|NCT00488631|4137738|P10|Double Blind Period (Week 0-54)|Adverse Event|0
1263377|NCT00488631|4137739|P9|Double Blind Period (Week 0-54)|Adverse Event|0
1263378|NCT00488631|4137740|P8|Double Blind Period (Week 0-54)|Adverse Event|0
1263379|NCT00488631|4137741|P7|Double Blind Period (Week 0-54)|Adverse Event|0
1263380|NCT00488631|4137742|P6|Double Blind Period (Week 0-54)|Adverse Event|50
1263381|NCT00488631|4137743|P5|Double Blind Period (Week 0-54)|Adverse Event|30
1263382|NCT00488631|4137744|P4|Double Blind Period (Week 0-54)|Adverse Event|12
1263383|NCT00488631|4137745|P3|Double Blind Period (Week 0-54)|Adverse Event|12
1263384|NCT00488631|4137746|P2|Double Blind Period (Week 0-54)|Adverse Event|12
1263385|NCT00488631|4137747|P1|Double Blind Period (Week 0-54)|Adverse Event|17
1263386|NCT00488618|4137784|P2|Overall Study|Lost to Follow-up|0
1263387|NCT00488618|4137785|P1|Overall Study|Lost to Follow-up|1
1263388|NCT00488618|4137784|P2|Overall Study|Withdrawal of Consent|13
1263389|NCT00488618|4137785|P1|Overall Study|Withdrawal of Consent|15
1263390|NCT00488618|4137784|P2|Overall Study|Protocol Violation|2
1263391|NCT00488618|4137785|P1|Overall Study|Protocol Violation|0
1263392|NCT00488618|4137784|P2|Overall Study|Insufficient Therapeutic Response|11
1263393|NCT00488618|4137785|P1|Overall Study|Insufficient Therapeutic Response|18
1263394|NCT00488618|4137784|P2|Overall Study|Adverse Event|17
1263395|NCT00488618|4137785|P1|Overall Study|Adverse Event|13
1263396|NCT00488592|4137793|P1|Overall Study|Enrolled but not treated|1
1263397|NCT00488592|4137793|P1|Overall Study|Disease progression|1
1263398|NCT00488592|4137793|P1|Overall Study|Withdrawal by Subject|1
1263399|NCT00488514|4137797|P1|Overall Study|Increased use of concomitant medication|1
1263400|NCT00488514|4137797|P1|Overall Study|Increase in number of migraines|2
1263401|NCT00488514|4137797|P1|Overall Study|Participant had too few migraines|5
1263402|NCT00488514|4137797|P1|Overall Study|Investigator decision|1
1263403|NCT00488514|4137797|P1|Overall Study|Withdrawn per medical monitor decision|2
1263404|NCT00488514|4137797|P1|Overall Study|Postive drug screen|1
1263405|NCT00488514|4137797|P1|Overall Study|Did not meet criteria for treatment|30
1263406|NCT00488514|4137797|P1|Overall Study|Lack of Efficacy|28
1263407|NCT00488514|4137797|P1|Overall Study|Withdrawal by Subject|106
1263408|NCT00488514|4137797|P1|Overall Study|Protocol Violation|32
1263409|NCT00488514|4137797|P1|Overall Study|Lost to Follow-up|44
1263410|NCT00488514|4137797|P1|Overall Study|Adverse Event|41
1263411|NCT00488475|4137885|P1|Overall Study|Other|1754
1263412|NCT00488345|4137914|P3|Overall Study|Parent/legal guardian request|1
1263413|NCT00488345|4137915|P2|Overall Study|Parent/legal guardian request|1
1263414|NCT00488345|4137916|P1|Overall Study|Parent/legal guardian request|0
1263415|NCT00488345|4137914|P3|Overall Study|Surgical team recommendation|0
1263416|NCT00488345|4137915|P2|Overall Study|Surgical team recommendation|1
1263417|NCT00488345|4137916|P1|Overall Study|Surgical team recommendation|0
1263418|NCT00488345|4137914|P3|Overall Study|Institutional Review Board review|1
1263419|NCT00488345|4137915|P2|Overall Study|Institutional Review Board review|0
1263420|NCT00488345|4137916|P1|Overall Study|Institutional Review Board review|0
1263421|NCT00488345|4137914|P3|Overall Study|Unable to administer antibiotics at home|0
1263422|NCT00488345|4137915|P2|Overall Study|Unable to administer antibiotics at home|1
1263423|NCT00488345|4137916|P1|Overall Study|Unable to administer antibiotics at home|0
1263424|NCT00488345|4137914|P3|Overall Study|Adverse Event|1
1263425|NCT00488345|4137915|P2|Overall Study|Adverse Event|1
1263426|NCT00488345|4137916|P1|Overall Study|Adverse Event|0
1263427|NCT00488319|4137942|P3|Overall Study|Other reasons for withdrawal|12
1263428|NCT00488319|4137943|P2|Overall Study|Other reasons for withdrawal|4
1263429|NCT00488319|4137944|P1|Overall Study|Other reasons for withdrawal|0
1263430|NCT00488319|4137942|P3|Overall Study|Withdrawal by Subject|44
1263431|NCT00488319|4137943|P2|Overall Study|Withdrawal by Subject|20
1263432|NCT00488319|4137944|P1|Overall Study|Withdrawal by Subject|5
1263433|NCT00488319|4137942|P3|Overall Study|Lost to Follow-up|16
1263434|NCT00488319|4137943|P2|Overall Study|Lost to Follow-up|5
1263435|NCT00488319|4137944|P1|Overall Study|Lost to Follow-up|3
1263436|NCT00488319|4137942|P3|Overall Study|Lack of Efficacy|27
1263437|NCT00488319|4137943|P2|Overall Study|Lack of Efficacy|12
1263438|NCT00488319|4137944|P1|Overall Study|Lack of Efficacy|6
1263439|NCT00488319|4137942|P3|Overall Study|Adverse Event|23
1263440|NCT00488319|4137943|P2|Overall Study|Adverse Event|2
1263441|NCT00488319|4137944|P1|Overall Study|Adverse Event|1
1263442|NCT00488293|4138031|P2|Overall Study|Misrandomization/Other Unspecified|1
1263443|NCT00488293|4138032|P1|Overall Study|Misrandomization/Other Unspecified|1
1263444|NCT00488293|4138031|P2|Overall Study|Death|1
1263445|NCT00488293|4138032|P1|Overall Study|Death|2
1263446|NCT00488293|4138031|P2|Overall Study|Withdrawal by Subject|3
1263447|NCT00488293|4138032|P1|Overall Study|Withdrawal by Subject|5
1263448|NCT00488293|4138031|P2|Overall Study|Lost to Follow-up|25
1263449|NCT00488293|4138032|P1|Overall Study|Lost to Follow-up|28
1263450|NCT00488033|4138077|P2|Overall Study|Withdrawal by Subject|0
1263451|NCT00488033|4138078|P1|Overall Study|Withdrawal by Subject|1
1263452|NCT00487981|4138094|P1|Overall Study|Hypothyroidism diagnosis|1
1263453|NCT00487942|4138102|P4|Overall Study|Withdrawal by Subject|0
1263454|NCT00487942|4138103|P3|Overall Study|Withdrawal by Subject|2
1263455|NCT00487942|4138104|P2|Overall Study|Withdrawal by Subject|1
1263456|NCT00487942|4138105|P1|Overall Study|Withdrawal by Subject|0
1263457|NCT00487942|4138102|P4|Overall Study|Protocol Violation|0
1263458|NCT00487942|4138103|P3|Overall Study|Protocol Violation|0
1263459|NCT00487942|4138104|P2|Overall Study|Protocol Violation|1
1263460|NCT00487942|4138105|P1|Overall Study|Protocol Violation|1
1263461|NCT00487942|4138102|P4|Overall Study|Lost to Follow-up|1
1263462|NCT00487942|4138103|P3|Overall Study|Lost to Follow-up|0
1263463|NCT00487942|4138104|P2|Overall Study|Lost to Follow-up|0
1263464|NCT00487942|4138105|P1|Overall Study|Lost to Follow-up|1
1263465|NCT00487942|4138102|P4|Overall Study|Adverse Event|1
1263466|NCT00487942|4138103|P3|Overall Study|Adverse Event|1
1263467|NCT00487942|4138104|P2|Overall Study|Adverse Event|1
1263468|NCT00487942|4138105|P1|Overall Study|Adverse Event|1
1263469|NCT00487825|4138489|P2|Overall Study|not specified|2
1263470|NCT00487825|4138490|P1|Overall Study|not specified|3
1263471|NCT00487825|4138489|P2|Overall Study|Lack of Efficacy|1
1263472|NCT00487825|4138490|P1|Overall Study|Lack of Efficacy|1
1263473|NCT00487825|4138489|P2|Overall Study|Adverse Event|2
1263474|NCT00487825|4138490|P1|Overall Study|Adverse Event|2
1263475|NCT00487747|4138502|P1|Overall Study|Lack of Efficacy|1
1263476|NCT00487747|4138502|P1|Overall Study|Lost to Follow-up|9
1263477|NCT00487747|4138502|P1|Overall Study|Adverse Event|1
1263478|NCT00487695|4138519|P2|Second Procedure|Withdrawal by Subject|2
1263479|NCT00487695|4138520|P1|Second Procedure|Withdrawal by Subject|1
1263480|NCT00487695|4138519|P2|Second Procedure|active wheezing|1
1263481|NCT00487695|4138520|P1|Second Procedure|active wheezing|0
1263482|NCT00487695|4138519|P2|First Procedure|esophageal stricture found (excl crit)|0
1263483|NCT00487695|4138520|P1|First Procedure|esophageal stricture found (excl crit)|1
1263484|NCT00487695|4138519|P2|First Procedure|active wheezing (did not have procedure)|0
1263485|NCT00487695|4138520|P1|First Procedure|active wheezing (did not have procedure)|1
1263486|NCT00487695|4138519|P2|First Procedure|invasive cancer on EGD (excl criteria)|0
1263487|NCT00487695|4138520|P1|First Procedure|invasive cancer on EGD (excl criteria)|1
1263488|NCT00487578|4138548|P2|Overall Study|Lost to Follow-up|1
1263489|NCT00487578|4138549|P1|Overall Study|Lost to Follow-up|0
1263490|NCT00487578|4138548|P2|Overall Study|Lack of Efficacy|1
1263491|NCT00487578|4138549|P1|Overall Study|Lack of Efficacy|0
1263492|NCT00487578|4138548|P2|Overall Study|Adverse Event|2
1263493|NCT00487578|4138549|P1|Overall Study|Adverse Event|1
1263494|NCT00487552|4138569|P1|Overall Study|Stent not placed|1
1263495|NCT00487552|4138569|P1|Overall Study|Death due to progressive malignancy|2
1263496|NCT00487552|4138569|P1|Overall Study|Unsuccessful magnet placements|3
1263497|NCT00487539|4138578|P4|Overall Study|Other|2
1263498|NCT00487539|4138579|P3|Overall Study|Other|2
1263499|NCT00487539|4138580|P2|Overall Study|Other|1
1263500|NCT00487539|4138581|P1|Overall Study|Other|3
1263501|NCT00487539|4138578|P4|Overall Study|Unsatisfactory therapeutic effect|1
1263502|NCT00487539|4138579|P3|Overall Study|Unsatisfactory therapeutic effect|0
1263503|NCT00487539|4138580|P2|Overall Study|Unsatisfactory therapeutic effect|0
1263504|NCT00487539|4138581|P1|Overall Study|Unsatisfactory therapeutic effect|1
1263505|NCT00487539|4138578|P4|Overall Study|Adverse Event|1
1263506|NCT00487539|4138579|P3|Overall Study|Adverse Event|1
1263507|NCT00487539|4138580|P2|Overall Study|Adverse Event|2
1263508|NCT00487539|4138581|P1|Overall Study|Adverse Event|3
1263509|NCT00487435|4138615|P1|Overall Study|Other|83
1263510|NCT00487435|4138615|P1|Overall Study|Study Medication Non-Compliant|32
1263511|NCT00487435|4138615|P1|Overall Study|Resolution Of Pain|1
1263512|NCT00487435|4138615|P1|Overall Study|Withdrawal by Subject|132
1263513|NCT00487435|4138615|P1|Overall Study|Pregnancy|2
1263514|NCT00487435|4138615|P1|Overall Study|Lost to Follow-up|54
1263515|NCT00487435|4138615|P1|Overall Study|Lack of Efficacy|33
1263516|NCT00487435|4138615|P1|Overall Study|Death|2
1263517|NCT00487435|4138615|P1|Overall Study|Adverse Event|146
1263518|NCT00487279|4138628|P2|Overall Study|Withdrawal by Subject|2
1263519|NCT00487279|4138629|P1|Overall Study|Withdrawal by Subject|0
1263520|NCT00487279|4138628|P2|Overall Study|Death|0
1263521|NCT00487279|4138629|P1|Overall Study|Death|1
1263522|NCT00487240|4138639|P2|Overall Study|Physician Decision|0
1263523|NCT00487240|4138640|P1|Overall Study|Physician Decision|2
1263524|NCT00487240|4138639|P2|Overall Study|Sponsor Decision|1
1263525|NCT00487240|4138640|P1|Overall Study|Sponsor Decision|2
1263526|NCT00487240|4138639|P2|Overall Study|Entry Criteria Not Met|4
1263527|NCT00487240|4138640|P1|Overall Study|Entry Criteria Not Met|3
1263528|NCT00487240|4138639|P2|Overall Study|Protocol Violation|5
1263529|NCT00487240|4138640|P1|Overall Study|Protocol Violation|5
1263530|NCT00487240|4138639|P2|Overall Study|Adverse Event|4
1263531|NCT00487240|4138640|P1|Overall Study|Adverse Event|0
1263532|NCT00487240|4138639|P2|Overall Study|Lost to Follow-up|6
1263533|NCT00487240|4138640|P1|Overall Study|Lost to Follow-up|7
1263534|NCT00487240|4138639|P2|Overall Study|Withdrawal by Subject|6
1263535|NCT00487240|4138640|P1|Overall Study|Withdrawal by Subject|12
1263536|NCT00487188|4138668|P3|Maintenance Phase|Administrative|1
1263537|NCT00487188|4138669|P2|Maintenance Phase|Administrative|0
1263538|NCT00487188|4138670|P1|Maintenance Phase|Administrative|0
1263539|NCT00487188|4138668|P3|Maintenance Phase|Lost to Follow-up|0
1263540|NCT00487188|4138669|P2|Maintenance Phase|Lost to Follow-up|0
1263541|NCT00487188|4138670|P1|Maintenance Phase|Lost to Follow-up|1
1263542|NCT00487188|4138668|P3|Maintenance Phase|Death|0
1263543|NCT00487188|4138669|P2|Maintenance Phase|Death|0
1263544|NCT00487188|4138670|P1|Maintenance Phase|Death|1
1263545|NCT00487188|4138668|P3|Maintenance Phase|Adverse Event|0
1263546|NCT00487188|4138669|P2|Maintenance Phase|Adverse Event|0
1263547|NCT00487188|4138670|P1|Maintenance Phase|Adverse Event|1
1263548|NCT00487188|4138668|P3|Induction Phase|Administrative|0
1263549|NCT00487188|4138669|P2|Induction Phase|Administrative|1
1263550|NCT00487188|4138670|P1|Induction Phase|Administrative|0
1263551|NCT00487188|4138668|P3|Induction Phase|Lost to Follow-up|0
1263552|NCT00487188|4138669|P2|Induction Phase|Lost to Follow-up|2
1263553|NCT00487188|4138670|P1|Induction Phase|Lost to Follow-up|2
1263554|NCT00487188|4138668|P3|Induction Phase|Refused Treatment|0
1263555|NCT00487188|4138669|P2|Induction Phase|Refused Treatment|2
1263556|NCT00487188|4138670|P1|Induction Phase|Refused Treatment|1
1263557|NCT00487188|4138668|P3|Induction Phase|Protocol Violation|0
1263558|NCT00487188|4138669|P2|Induction Phase|Protocol Violation|0
1263559|NCT00487188|4138670|P1|Induction Phase|Protocol Violation|1
1263560|NCT00487188|4138668|P3|Induction Phase|Lack of Efficacy|0
1263561|NCT00487188|4138669|P2|Induction Phase|Lack of Efficacy|1
1263562|NCT00487188|4138670|P1|Induction Phase|Lack of Efficacy|0
1263563|NCT00487188|4138668|P3|Induction Phase|Adverse Event|0
1263564|NCT00487188|4138669|P2|Induction Phase|Adverse Event|0
1263565|NCT00487188|4138670|P1|Induction Phase|Adverse Event|5
1263566|NCT00487188|4138668|P3|Induction Phase|Abnormality of Laboratory Test|0
1263567|NCT00487188|4138669|P2|Induction Phase|Abnormality of Laboratory Test|1
1263568|NCT00487188|4138670|P1|Induction Phase|Abnormality of Laboratory Test|0
1263569|NCT00487162|4138709|P2|Overall Study|Withdrawal by Subject|3
1263570|NCT00487162|4138710|P1|Overall Study|Withdrawal by Subject|2
1263571|NCT00487162|4138709|P2|Overall Study|Physician Decision|1
1263572|NCT00487162|4138710|P1|Overall Study|Physician Decision|0
1263573|NCT00487162|4138709|P2|Overall Study|Adverse Event|1
1263574|NCT00487162|4138710|P1|Overall Study|Adverse Event|0
1263575|NCT00487084|4138721|P3|Overall Study|Did not receive intervention|5
1263576|NCT00487084|4138722|P2|Overall Study|Did not receive intervention|3
1263577|NCT00487084|4138723|P1|Overall Study|Did not receive intervention|4
1263578|NCT00486954|4138744|P5|Randomized Part|Sponsor Terminated Study|13
1263579|NCT00486954|4138745|P4|Randomized Part|Sponsor Terminated Study|19
1263580|NCT00486954|4138746|P3|Randomized Part|Sponsor Terminated Study|0
1263581|NCT00486954|4138747|P2|Randomized Part|Sponsor Terminated Study|0
1263582|NCT00486954|4138748|P1|Randomized Part|Sponsor Terminated Study|0
1263583|NCT00486954|4138744|P5|Randomized Part|Withdrawal by Subject|0
1263584|NCT00486954|4138745|P4|Randomized Part|Withdrawal by Subject|1
1263585|NCT00486954|4138746|P3|Randomized Part|Withdrawal by Subject|0
1263586|NCT00486954|4138747|P2|Randomized Part|Withdrawal by Subject|0
1263587|NCT00486954|4138748|P1|Randomized Part|Withdrawal by Subject|0
1263588|NCT00486954|4138744|P5|Randomized Part|Lost to Follow-up|1
1263589|NCT00486954|4138745|P4|Randomized Part|Lost to Follow-up|0
1263590|NCT00486954|4138746|P3|Randomized Part|Lost to Follow-up|0
1263591|NCT00486954|4138747|P2|Randomized Part|Lost to Follow-up|0
1263592|NCT00486954|4138748|P1|Randomized Part|Lost to Follow-up|0
1263593|NCT00486954|4138744|P5|Pilot Part|Disease Progression|0
1263594|NCT00486954|4138745|P4|Pilot Part|Disease Progression|0
1263595|NCT00486954|4138746|P3|Pilot Part|Disease Progression|1
1263596|NCT00486954|4138747|P2|Pilot Part|Disease Progression|0
1263597|NCT00486954|4138748|P1|Pilot Part|Disease Progression|2
1263598|NCT00486954|4138744|P5|Pilot Part|Adverse Event|0
1263599|NCT00486954|4138745|P4|Pilot Part|Adverse Event|0
1263600|NCT00486954|4138746|P3|Pilot Part|Adverse Event|5
1263601|NCT00486954|4138747|P2|Pilot Part|Adverse Event|0
1263602|NCT00486954|4138748|P1|Pilot Part|Adverse Event|4
1263603|NCT00486902|4138846|P2|Overall Study|No toradol due to hemmorhage or allergy|1
1263604|NCT00486902|4138847|P1|Overall Study|No toradol due to hemmorhage or allergy|3
1263605|NCT00486902|4138846|P2|Overall Study|Did not meet inclusion criteria|0
1263606|NCT00486902|4138847|P1|Overall Study|Did not meet inclusion criteria|1
1263607|NCT00486902|4138846|P2|Overall Study|spinal anesthetic protocal violation|1
1263608|NCT00486902|4138847|P1|Overall Study|spinal anesthetic protocal violation|1
1263609|NCT00486902|4138846|P2|Overall Study|decision for postpartum tubal ligation|1
1263610|NCT00486902|4138847|P1|Overall Study|decision for postpartum tubal ligation|3
1263611|NCT00486902|4138846|P2|Overall Study|Withdrawal by Subject|2
1263612|NCT00486902|4138847|P1|Overall Study|Withdrawal by Subject|1
1263613|NCT00486837|4138914|P2|Overall Study|No sputum, devise issues, exacerbation|4
1263614|NCT00486837|4138915|P1|Overall Study|No sputum, devise issues, exacerbation|3
1263615|NCT00486837|4138914|P2|Overall Study|Protocol Violation|2
1263616|NCT00486837|4138915|P1|Overall Study|Protocol Violation|4
1263617|NCT00486837|4138914|P2|Overall Study|Adverse Event|1
1263618|NCT00486837|4138915|P1|Overall Study|Adverse Event|1
1263619|NCT00486837|4138914|P2|Overall Study|Withdrawal by Subject|0
1263620|NCT00486837|4138915|P1|Overall Study|Withdrawal by Subject|1
1263621|NCT00486811|4138955|P3|Overall Study|All other|7
1263622|NCT00486811|4138956|P2|Overall Study|All other|11
1263623|NCT00486811|4138957|P1|Overall Study|All other|18
1263624|NCT00486811|4138955|P3|Overall Study|Study drug non-compliant|3
1263625|NCT00486811|4138956|P2|Overall Study|Study drug non-compliant|6
1263626|NCT00486811|4138957|P1|Overall Study|Study drug non-compliant|5
1263627|NCT00486811|4138955|P3|Overall Study|Withdrawal by Subject|58
1263628|NCT00486811|4138956|P2|Overall Study|Withdrawal by Subject|44
1263629|NCT00486811|4138957|P1|Overall Study|Withdrawal by Subject|33
1263630|NCT00486811|4138955|P3|Overall Study|Lost to Follow-up|4
1263631|NCT00486811|4138956|P2|Overall Study|Lost to Follow-up|6
1263632|NCT00486811|4138957|P1|Overall Study|Lost to Follow-up|4
1263633|NCT00486811|4138955|P3|Overall Study|Lack of Efficacy|7
1263634|NCT00486811|4138956|P2|Overall Study|Lack of Efficacy|14
1263635|NCT00486811|4138957|P1|Overall Study|Lack of Efficacy|34
1263636|NCT00486811|4138955|P3|Overall Study|Adverse Event|135
1263637|NCT00486811|4138956|P2|Overall Study|Adverse Event|60
1263638|NCT00486811|4138957|P1|Overall Study|Adverse Event|28
1263639|NCT00486759|4139000|P2|Safety Follow-up|Adverse event/intercurrent illness|0
1263640|NCT00486759|4139001|P1|Safety Follow-up|Adverse event/intercurrent illness|4
1263641|NCT00486759|4139000|P2|Safety Follow-up|Refused treatment/did not cooperate|4
1263642|NCT00486759|4139001|P1|Safety Follow-up|Refused treatment/did not cooperate|6
1263643|NCT00486759|4139000|P2|Safety Follow-up|Administrative/not specified|6
1263644|NCT00486759|4139001|P1|Safety Follow-up|Administrative/not specified|8
1263645|NCT00486759|4139000|P2|Safety Follow-up|Failure to return|6
1263646|NCT00486759|4139001|P1|Safety Follow-up|Failure to return|9
1263647|NCT00486759|4139000|P2|Safety Follow-up|Withdrew consent|23
1263648|NCT00486759|4139001|P1|Safety Follow-up|Withdrew consent|32
1263649|NCT00486759|4139000|P2|Safety Follow-up|Death|29
1263650|NCT00486759|4139001|P1|Safety Follow-up|Death|40
1263651|NCT00486759|4139000|P2|Safety Follow-up|Insufficient therapeutic response|50
1263652|NCT00486759|4139001|P1|Safety Follow-up|Insufficient therapeutic response|40
1263653|NCT00486759|4139000|P2|Treatment|Failure to return|1
1263654|NCT00486759|4139001|P1|Treatment|Failure to return|1
1263655|NCT00486759|4139000|P2|Treatment|Other protocol violation|5
1263656|NCT00486759|4139001|P1|Treatment|Other protocol violation|1
1263657|NCT00486759|4139000|P2|Treatment|Violation of selection criteria at entry|3
1263658|NCT00486759|4139001|P1|Treatment|Violation of selection criteria at entry|3
1263659|NCT00486759|4139000|P2|Treatment|Refused treatment|7
1263660|NCT00486759|4139001|P1|Treatment|Refused treatment|10
1263661|NCT00486759|4139000|P2|Treatment|Administrative/reason not specified|21
1263662|NCT00486759|4139001|P1|Treatment|Administrative/reason not specified|17
1263663|NCT00486759|4139000|P2|Treatment|Withdrew consent|12
1263664|NCT00486759|4139001|P1|Treatment|Withdrew consent|15
1263665|NCT00486759|4139000|P2|Treatment|Death|10
1263666|NCT00486759|4139001|P1|Treatment|Death|17
1263667|NCT00486759|4139000|P2|Treatment|Insufficient therapeutic response|39
1263668|NCT00486759|4139001|P1|Treatment|Insufficient therapeutic response|37
1263669|NCT00486759|4139000|P2|Treatment|Adverse event/intercurrent illness|39
1263670|NCT00486759|4139001|P1|Treatment|Adverse event/intercurrent illness|86
1263671|NCT00486720|4139013|P2|Overall Study|Progressive Disease|1
1263672|NCT00486720|4139014|P1|Overall Study|Progressive Disease|0
1263673|NCT00486720|4139013|P2|Overall Study|Withdrawal by Subject|1
1263674|NCT00486720|4139014|P1|Overall Study|Withdrawal by Subject|3
1263675|NCT00486720|4139013|P2|Overall Study|Protocol Violation|0
1263676|NCT00486720|4139014|P1|Overall Study|Protocol Violation|1
1263677|NCT00486720|4139013|P2|Overall Study|Physician Decision|2
1263678|NCT00486720|4139014|P1|Overall Study|Physician Decision|1
1263679|NCT00486720|4139013|P2|Overall Study|Lack of Efficacy|6
1263680|NCT00486720|4139014|P1|Overall Study|Lack of Efficacy|4
1263681|NCT00486720|4139013|P2|Overall Study|Adverse Event|2
1263682|NCT00486720|4139014|P1|Overall Study|Adverse Event|1
1263683|NCT00486434|4139073|P2|Overall Study|Personal reasons|6
1263684|NCT00486434|4139074|P1|Overall Study|Personal reasons|5
1263685|NCT00486434|4139073|P2|Overall Study|Death|2
1263686|NCT00486434|4139074|P1|Overall Study|Death|1
1263687|NCT00486434|4139073|P2|Overall Study|Lost to Follow-up|3
1263688|NCT00486434|4139074|P1|Overall Study|Lost to Follow-up|2
1263689|NCT00486434|4139073|P2|Overall Study|Lack of Efficacy|19
1263690|NCT00486434|4139074|P1|Overall Study|Lack of Efficacy|12
1263691|NCT00486434|4139073|P2|Overall Study|Protocol Violation|21
1263692|NCT00486434|4139074|P1|Overall Study|Protocol Violation|22
1263693|NCT00486434|4139073|P2|Overall Study|Adverse Event|44
1263694|NCT00486434|4139074|P1|Overall Study|Adverse Event|118
1263695|NCT00486434|4139073|P2|Overall Study|Withdrawal by Subject|39
1263696|NCT00486434|4139074|P1|Overall Study|Withdrawal by Subject|34
1263697|NCT00486330|4139084|P1|Overall Study|Adverse Event|2
1263698|NCT00486291|4139090|P2|Overall Study|requirement for restricted medication|3
1263877|NCT00485134|4139609|P5|Overall Study|Positive drug test|2
1263699|NCT00486291|4139091|P1|Overall Study|requirement for restricted medication|0
1263700|NCT00486291|4139090|P2|Overall Study|protocol non-compliance|15
1263701|NCT00486291|4139091|P1|Overall Study|protocol non-compliance|10
1263702|NCT00486291|4139090|P2|Overall Study|Lost to Follow-up|7
1263703|NCT00486291|4139091|P1|Overall Study|Lost to Follow-up|3
1263704|NCT00486291|4139090|P2|Overall Study|Adverse Event|4
1263705|NCT00486291|4139091|P1|Overall Study|Adverse Event|3
1263706|NCT00486278|4139099|P1|Overall Study|Physician Decision|2
1263707|NCT00486278|4139099|P1|Overall Study|Withdrawal by Subject|2
1263708|NCT00486278|4139099|P1|Overall Study|Adverse Event|5
1263709|NCT00486265|4139233|P1|Overall Study|Lack of Efficacy|8
1263710|NCT00486265|4139233|P1|Overall Study|Adverse Event|1
1263711|NCT00486252|4139237|P1|Overall Study|Other|18
1263712|NCT00486252|4139237|P1|Overall Study|Lost to Follow-up|24
1263713|NCT00486252|4139237|P1|Overall Study|Lack of Efficacy|9
1263714|NCT00486252|4139237|P1|Overall Study|Adverse Event|7
1263715|NCT00486226|4139252|P1|Overall Study|Lost to Follow-up|8
1263716|NCT00486226|4139252|P1|Overall Study|Withdrawal by Subject|1
1263717|NCT00486226|4139252|P1|Overall Study|Adverse Event|1
1263718|NCT00486226|4139252|P1|Overall Study|Death|3
1263719|NCT00486044|4139262|P2|Overall Study|Lost to Follow-up|1
1263720|NCT00486044|4139263|P1|Overall Study|Lost to Follow-up|0
1263721|NCT00486044|4139262|P2|Overall Study|Adverse Event|1
1263722|NCT00486044|4139263|P1|Overall Study|Adverse Event|0
1263723|NCT00486044|4139262|P2|Overall Study|Withdrawal by Subject|1
1263724|NCT00486044|4139263|P1|Overall Study|Withdrawal by Subject|2
1263725|NCT00485758|4139356|P2|Overall Study|Study Terminated by Sponsor|0
1263726|NCT00485758|4139357|P1|Overall Study|Study Terminated by Sponsor|3
1263727|NCT00485758|4139356|P2|Overall Study|Withdrawal by Subject|27
1263728|NCT00485758|4139357|P1|Overall Study|Withdrawal by Subject|32
1263729|NCT00485758|4139356|P2|Overall Study|Protocol Violation|2
1263730|NCT00485758|4139357|P1|Overall Study|Protocol Violation|11
1263731|NCT00485758|4139356|P2|Overall Study|Physician Decision|3
1263732|NCT00485758|4139357|P1|Overall Study|Physician Decision|3
1263733|NCT00485758|4139356|P2|Overall Study|Lost to Follow-up|1
1263734|NCT00485758|4139357|P1|Overall Study|Lost to Follow-up|5
1263735|NCT00485758|4139356|P2|Overall Study|Death|1
1263736|NCT00485758|4139357|P1|Overall Study|Death|0
1263737|NCT00485758|4139356|P2|Overall Study|Adverse Event|31
1263738|NCT00485758|4139357|P1|Overall Study|Adverse Event|102
1263739|NCT00485732|4139369|P2|Overall Study|Lost to Follow-up|2
1263740|NCT00485732|4139370|P1|Overall Study|Lost to Follow-up|2
1263741|NCT00485732|4139369|P2|Overall Study|Withdrawal by Subject|4
1263742|NCT00485732|4139370|P1|Overall Study|Withdrawal by Subject|5
1263743|NCT00485732|4139369|P2|Overall Study|Protocol Violation|3
1263744|NCT00485732|4139370|P1|Overall Study|Protocol Violation|1
1263745|NCT00485472|4139408|P2|Overall Study|Lost to Follow-up|1
1263746|NCT00485472|4139409|P1|Overall Study|Lost to Follow-up|0
1263747|NCT00485472|4139408|P2|Overall Study|Other|1
1263748|NCT00485472|4139409|P1|Overall Study|Other|2
1263749|NCT00485472|4139408|P2|Overall Study|Protocol Violation|1
1263750|NCT00485472|4139409|P1|Overall Study|Protocol Violation|0
1263751|NCT00485472|4139408|P2|Overall Study|Withdrawal by Subject|0
1263752|NCT00485472|4139409|P1|Overall Study|Withdrawal by Subject|1
1263753|NCT00485472|4139408|P2|Overall Study|Lack of Efficacy|4
1263754|NCT00485472|4139409|P1|Overall Study|Lack of Efficacy|5
1263755|NCT00485472|4139408|P2|Overall Study|Adverse Event|5
1263756|NCT00485472|4139409|P1|Overall Study|Adverse Event|8
1263757|NCT00485303|4139446|P1|Overall Study|Treatment ongoing at cutoff date|2
1263758|NCT00485303|4139446|P1|Overall Study|Initiation of new anti-cancer treatment|2
1263759|NCT00485303|4139446|P1|Overall Study|Other|3
1263760|NCT00485303|4139446|P1|Overall Study|Progressive Disease|44
1263761|NCT00485303|4139446|P1|Overall Study|Adverse Event|5
1263762|NCT00485264|4139464|P6|Overall Study|Other Reason|0
1263763|NCT00485264|4139465|P5|Overall Study|Other Reason|0
1263764|NCT00485264|4139466|P4|Overall Study|Other Reason|0
1263765|NCT00485264|4139467|P3|Overall Study|Other Reason|0
1263766|NCT00485264|4139468|P2|Overall Study|Other Reason|0
1263767|NCT00485264|4139469|P1|Overall Study|Other Reason|3
1263768|NCT00485264|4139464|P6|Overall Study|Lost to Follow-up|1
1263769|NCT00485264|4139465|P5|Overall Study|Lost to Follow-up|0
1263770|NCT00485264|4139466|P4|Overall Study|Lost to Follow-up|0
1263771|NCT00485264|4139467|P3|Overall Study|Lost to Follow-up|1
1263772|NCT00485264|4139468|P2|Overall Study|Lost to Follow-up|1
1263773|NCT00485264|4139469|P1|Overall Study|Lost to Follow-up|2
1263774|NCT00485264|4139464|P6|Overall Study|Non-Compliant|0
1263775|NCT00485264|4139465|P5|Overall Study|Non-Compliant|1
1263776|NCT00485264|4139466|P4|Overall Study|Non-Compliant|0
1263777|NCT00485264|4139467|P3|Overall Study|Non-Compliant|1
1263778|NCT00485264|4139468|P2|Overall Study|Non-Compliant|2
1263779|NCT00485264|4139469|P1|Overall Study|Non-Compliant|17
1263780|NCT00485264|4139464|P6|Overall Study|Not Able to Attend Clinic|2
1263781|NCT00485264|4139465|P5|Overall Study|Not Able to Attend Clinic|1
1263782|NCT00485264|4139466|P4|Overall Study|Not Able to Attend Clinic|1
1263783|NCT00485264|4139467|P3|Overall Study|Not Able to Attend Clinic|0
1263784|NCT00485264|4139468|P2|Overall Study|Not Able to Attend Clinic|0
1263785|NCT00485264|4139469|P1|Overall Study|Not Able to Attend Clinic|5
1263786|NCT00485264|4139464|P6|Overall Study|Intolerance/Unable to Tolerate Dose|0
1263787|NCT00485264|4139465|P5|Overall Study|Intolerance/Unable to Tolerate Dose|0
1263788|NCT00485264|4139466|P4|Overall Study|Intolerance/Unable to Tolerate Dose|0
1263789|NCT00485264|4139467|P3|Overall Study|Intolerance/Unable to Tolerate Dose|1
1263790|NCT00485264|4139468|P2|Overall Study|Intolerance/Unable to Tolerate Dose|0
1263791|NCT00485264|4139469|P1|Overall Study|Intolerance/Unable to Tolerate Dose|0
1263792|NCT00485264|4139464|P6|Overall Study|Physician Decision|0
1263793|NCT00485264|4139465|P5|Overall Study|Physician Decision|0
1263794|NCT00485264|4139466|P4|Overall Study|Physician Decision|0
1263795|NCT00485264|4139467|P3|Overall Study|Physician Decision|0
1263796|NCT00485264|4139468|P2|Overall Study|Physician Decision|2
1263797|NCT00485264|4139469|P1|Overall Study|Physician Decision|0
1263798|NCT00485264|4139464|P6|Overall Study|Guardian Consent Withdrawn|0
1263799|NCT00485264|4139465|P5|Overall Study|Guardian Consent Withdrawn|1
1263800|NCT00485264|4139466|P4|Overall Study|Guardian Consent Withdrawn|0
1263801|NCT00485264|4139467|P3|Overall Study|Guardian Consent Withdrawn|0
1263802|NCT00485264|4139468|P2|Overall Study|Guardian Consent Withdrawn|0
1263803|NCT00485264|4139469|P1|Overall Study|Guardian Consent Withdrawn|1
1263804|NCT00485264|4139464|P6|Overall Study|Lack of Efficacy|0
1263805|NCT00485264|4139465|P5|Overall Study|Lack of Efficacy|0
1263806|NCT00485264|4139466|P4|Overall Study|Lack of Efficacy|0
1263807|NCT00485264|4139467|P3|Overall Study|Lack of Efficacy|0
1263808|NCT00485264|4139468|P2|Overall Study|Lack of Efficacy|1
1263809|NCT00485264|4139469|P1|Overall Study|Lack of Efficacy|0
1263810|NCT00485264|4139464|P6|Overall Study|Number/Volume/Timing of Study Meds|0
1263811|NCT00485264|4139465|P5|Overall Study|Number/Volume/Timing of Study Meds|0
1263812|NCT00485264|4139466|P4|Overall Study|Number/Volume/Timing of Study Meds|0
1263813|NCT00485264|4139467|P3|Overall Study|Number/Volume/Timing of Study Meds|1
1263814|NCT00485264|4139468|P2|Overall Study|Number/Volume/Timing of Study Meds|1
1263815|NCT00485264|4139469|P1|Overall Study|Number/Volume/Timing of Study Meds|2
1263816|NCT00485264|4139464|P6|Overall Study|Disallowed Medication|1
1263817|NCT00485264|4139465|P5|Overall Study|Disallowed Medication|0
1263818|NCT00485264|4139466|P4|Overall Study|Disallowed Medication|0
1263819|NCT00485264|4139467|P3|Overall Study|Disallowed Medication|0
1263820|NCT00485264|4139468|P2|Overall Study|Disallowed Medication|0
1263821|NCT00485264|4139469|P1|Overall Study|Disallowed Medication|0
1263822|NCT00485264|4139464|P6|Overall Study|Pregnancy|0
1263823|NCT00485264|4139465|P5|Overall Study|Pregnancy|0
1263824|NCT00485264|4139466|P4|Overall Study|Pregnancy|0
1263825|NCT00485264|4139467|P3|Overall Study|Pregnancy|0
1263826|NCT00485264|4139468|P2|Overall Study|Pregnancy|0
1263827|NCT00485264|4139469|P1|Overall Study|Pregnancy|4
1263828|NCT00485264|4139464|P6|Overall Study|Adverse Event|3
1263829|NCT00485264|4139465|P5|Overall Study|Adverse Event|1
1263830|NCT00485264|4139466|P4|Overall Study|Adverse Event|3
1263831|NCT00485264|4139467|P3|Overall Study|Adverse Event|2
1263832|NCT00485264|4139468|P2|Overall Study|Adverse Event|0
1263833|NCT00485264|4139469|P1|Overall Study|Adverse Event|1
1263834|NCT00485264|4139464|P6|Overall Study|Death|0
1263835|NCT00485264|4139465|P5|Overall Study|Death|1
1263836|NCT00485264|4139466|P4|Overall Study|Death|0
1263837|NCT00485264|4139467|P3|Overall Study|Death|0
1263838|NCT00485264|4139468|P2|Overall Study|Death|0
1263839|NCT00485264|4139469|P1|Overall Study|Death|1
1263840|NCT00485264|4139464|P6|Overall Study|Enrolled But Not Given Treatment|0
1263841|NCT00485264|4139465|P5|Overall Study|Enrolled But Not Given Treatment|1
1263842|NCT00485264|4139466|P4|Overall Study|Enrolled But Not Given Treatment|0
1263843|NCT00485264|4139467|P3|Overall Study|Enrolled But Not Given Treatment|0
1263844|NCT00485264|4139468|P2|Overall Study|Enrolled But Not Given Treatment|0
1263845|NCT00485264|4139469|P1|Overall Study|Enrolled But Not Given Treatment|0
1263846|NCT00485173|4139557|P2|Overall Study|Lost to Follow-up|61
1263847|NCT00485173|4139558|P1|Overall Study|Lost to Follow-up|32
1263848|NCT00485173|4139557|P2|Overall Study|Death|3
1263849|NCT00485173|4139558|P1|Overall Study|Death|4
1263850|NCT00485134|4139606|P8|Overall Study|Pregnancy|0
1263851|NCT00485134|4139607|P7|Overall Study|Pregnancy|1
1263852|NCT00485134|4139608|P6|Overall Study|Pregnancy|0
1263853|NCT00485134|4139609|P5|Overall Study|Pregnancy|0
1263854|NCT00485134|4139610|P4|Overall Study|Pregnancy|0
1263855|NCT00485134|4139611|P3|Overall Study|Pregnancy|0
1263856|NCT00485134|4139612|P2|Overall Study|Pregnancy|0
1263857|NCT00485134|4139613|P1|Overall Study|Pregnancy|0
1263858|NCT00485134|4139606|P8|Overall Study|Unable to comply with study schedule|1
1263859|NCT00485134|4139607|P7|Overall Study|Unable to comply with study schedule|0
1263860|NCT00485134|4139608|P6|Overall Study|Unable to comply with study schedule|0
1263861|NCT00485134|4139609|P5|Overall Study|Unable to comply with study schedule|0
1263862|NCT00485134|4139610|P4|Overall Study|Unable to comply with study schedule|0
1263863|NCT00485134|4139611|P3|Overall Study|Unable to comply with study schedule|0
1263864|NCT00485134|4139612|P2|Overall Study|Unable to comply with study schedule|0
1263865|NCT00485134|4139613|P1|Overall Study|Unable to comply with study schedule|0
1263866|NCT00485134|4139606|P8|Overall Study|Non-compliance|0
1263867|NCT00485134|4139607|P7|Overall Study|Non-compliance|2
1263868|NCT00485134|4139608|P6|Overall Study|Non-compliance|2
1263869|NCT00485134|4139609|P5|Overall Study|Non-compliance|1
1263870|NCT00485134|4139610|P4|Overall Study|Non-compliance|0
1263871|NCT00485134|4139611|P3|Overall Study|Non-compliance|0
1263872|NCT00485134|4139612|P2|Overall Study|Non-compliance|0
1263873|NCT00485134|4139613|P1|Overall Study|Non-compliance|0
1263874|NCT00485134|4139606|P8|Overall Study|Positive drug test|0
1263875|NCT00485134|4139607|P7|Overall Study|Positive drug test|0
1263876|NCT00485134|4139608|P6|Overall Study|Positive drug test|1
1263878|NCT00485134|4139610|P4|Overall Study|Positive drug test|0
1263879|NCT00485134|4139611|P3|Overall Study|Positive drug test|0
1263880|NCT00485134|4139612|P2|Overall Study|Positive drug test|0
1263881|NCT00485134|4139613|P1|Overall Study|Positive drug test|0
1263882|NCT00485134|4139606|P8|Overall Study|Withdrew for adverse event|0
1263883|NCT00485134|4139607|P7|Overall Study|Withdrew for adverse event|0
1263884|NCT00485134|4139608|P6|Overall Study|Withdrew for adverse event|0
1263885|NCT00485134|4139609|P5|Overall Study|Withdrew for adverse event|0
1263886|NCT00485134|4139610|P4|Overall Study|Withdrew for adverse event|0
1263887|NCT00485134|4139611|P3|Overall Study|Withdrew for adverse event|1
1263888|NCT00485134|4139612|P2|Overall Study|Withdrew for adverse event|0
1263889|NCT00485134|4139613|P1|Overall Study|Withdrew for adverse event|0
1263890|NCT00485134|4139606|P8|Overall Study|Change in health status|0
1263891|NCT00485134|4139607|P7|Overall Study|Change in health status|0
1263892|NCT00485134|4139608|P6|Overall Study|Change in health status|1
1263893|NCT00485134|4139609|P5|Overall Study|Change in health status|0
1263894|NCT00485134|4139610|P4|Overall Study|Change in health status|1
1263895|NCT00485134|4139611|P3|Overall Study|Change in health status|2
1263896|NCT00485134|4139612|P2|Overall Study|Change in health status|1
1263897|NCT00485134|4139613|P1|Overall Study|Change in health status|0
1263898|NCT00485134|4139606|P8|Overall Study|Withdrawal by Subject|0
1263899|NCT00485134|4139607|P7|Overall Study|Withdrawal by Subject|0
1263900|NCT00485134|4139608|P6|Overall Study|Withdrawal by Subject|0
1263901|NCT00485134|4139609|P5|Overall Study|Withdrawal by Subject|0
1263902|NCT00485134|4139610|P4|Overall Study|Withdrawal by Subject|0
1263903|NCT00485134|4139611|P3|Overall Study|Withdrawal by Subject|0
1263904|NCT00485134|4139612|P2|Overall Study|Withdrawal by Subject|1
1263905|NCT00485134|4139613|P1|Overall Study|Withdrawal by Subject|0
1263906|NCT00485134|4139606|P8|Overall Study|Lost to Follow-up|0
1263907|NCT00485134|4139607|P7|Overall Study|Lost to Follow-up|0
1263908|NCT00485134|4139608|P6|Overall Study|Lost to Follow-up|0
1263909|NCT00485134|4139609|P5|Overall Study|Lost to Follow-up|0
1263910|NCT00485134|4139610|P4|Overall Study|Lost to Follow-up|0
1263911|NCT00485134|4139611|P3|Overall Study|Lost to Follow-up|0
1263912|NCT00485134|4139612|P2|Overall Study|Lost to Follow-up|0
1263913|NCT00485134|4139613|P1|Overall Study|Lost to Follow-up|1
1263914|NCT00485069|4139635|P2|Overall Study|Withdrawal by Subject|6
1263915|NCT00485069|4139636|P1|Overall Study|Withdrawal by Subject|6
1263916|NCT00485069|4139635|P2|Overall Study|Protocol Violation|1
1263917|NCT00485069|4139636|P1|Overall Study|Protocol Violation|0
1263918|NCT00485069|4139635|P2|Overall Study|Lack of Efficacy|1
1263919|NCT00485069|4139636|P1|Overall Study|Lack of Efficacy|2
1263920|NCT00485069|4139635|P2|Overall Study|Adverse Event|4
1263921|NCT00485069|4139636|P1|Overall Study|Adverse Event|10
1263922|NCT00484939|4139681|P2|Overall Study|Reason Not Specified|6
1263923|NCT00484939|4139682|P1|Overall Study|Reason Not Specified|11
1263924|NCT00484939|4139681|P2|Overall Study|Screen Failure|2
1263925|NCT00484939|4139682|P1|Overall Study|Screen Failure|2
1263926|NCT00484939|4139681|P2|Overall Study|Disease progression|88
1263927|NCT00484939|4139682|P1|Overall Study|Disease progression|67
1263928|NCT00484939|4139681|P2|Overall Study|Discretion of Investigator or Sponsor|3
1263929|NCT00484939|4139682|P1|Overall Study|Discretion of Investigator or Sponsor|7
1263930|NCT00484939|4139681|P2|Overall Study|Lost to Follow-up|3
1263931|NCT00484939|4139682|P1|Overall Study|Lost to Follow-up|0
1263932|NCT00484939|4139681|P2|Overall Study|Protocol Violation|3
1263933|NCT00484939|4139682|P1|Overall Study|Protocol Violation|3
1263934|NCT00484939|4139681|P2|Overall Study|Patient Withdrew Consent|10
1263935|NCT00484939|4139682|P1|Overall Study|Patient Withdrew Consent|19
1263936|NCT00484939|4139681|P2|Overall Study|Adverse Event|12
1263937|NCT00484939|4139682|P1|Overall Study|Adverse Event|22
1263938|NCT00484939|4139681|P2|Overall Study|Death|13
1263939|NCT00484939|4139682|P1|Overall Study|Death|9
1263940|NCT00484679|4139709|P1|Overall Study|Withdrawal by Subject|3
1263941|NCT00484419|4139716|P3|Overall Study|sponsor decision, randomized in error|2
1263942|NCT00484419|4139717|P2|Overall Study|sponsor decision, randomized in error|0
1263943|NCT00484419|4139718|P1|Overall Study|sponsor decision, randomized in error|0
1263944|NCT00484419|4139716|P3|Overall Study|subject relocated|0
1263945|NCT00484419|4139717|P2|Overall Study|subject relocated|1
1263946|NCT00484419|4139718|P1|Overall Study|subject relocated|0
1263947|NCT00484419|4139716|P3|Overall Study|subject unable to receive medication|0
1263948|NCT00484419|4139717|P2|Overall Study|subject unable to receive medication|0
1263949|NCT00484419|4139718|P1|Overall Study|subject unable to receive medication|1
1263950|NCT00484419|4139716|P3|Overall Study|Physician Decision|1
1263951|NCT00484419|4139717|P2|Overall Study|Physician Decision|1
1263952|NCT00484419|4139718|P1|Overall Study|Physician Decision|1
1263953|NCT00484419|4139716|P3|Overall Study|required restricted medication|1
1263954|NCT00484419|4139717|P2|Overall Study|required restricted medication|0
1263955|NCT00484419|4139718|P1|Overall Study|required restricted medication|1
1263956|NCT00484419|4139716|P3|Overall Study|subject met discontinuation criteria|4
1263957|NCT00484419|4139717|P2|Overall Study|subject met discontinuation criteria|2
1263958|NCT00484419|4139718|P1|Overall Study|subject met discontinuation criteria|2
1263959|NCT00484419|4139716|P3|Overall Study|Withdrawal by Subject|1
1263960|NCT00484419|4139717|P2|Overall Study|Withdrawal by Subject|1
1263961|NCT00484419|4139718|P1|Overall Study|Withdrawal by Subject|3
1263962|NCT00484419|4139716|P3|Overall Study|Lost to Follow-up|2
1263963|NCT00484419|4139717|P2|Overall Study|Lost to Follow-up|0
1263964|NCT00484419|4139718|P1|Overall Study|Lost to Follow-up|1
1263965|NCT00484419|4139716|P3|Overall Study|Adverse Event|0
1263966|NCT00484419|4139717|P2|Overall Study|Adverse Event|0
1263967|NCT00484419|4139718|P1|Overall Study|Adverse Event|3
1263968|NCT00484315|4139802|P2|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2
1263969|NCT00484315|4139803|P1|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3
1263970|NCT00484315|4139802|P2|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11
1263971|NCT00484315|4139803|P1|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25
1263972|NCT00484315|4139802|P2|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2
1263973|NCT00484315|4139803|P1|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3
1263974|NCT00484315|4139802|P2|12-Month Clinical Follow-up|Missed 12-Month Visit|4
1263975|NCT00484315|4139803|P1|12-Month Clinical Follow-up|Missed 12-Month Visit|13
1263976|NCT00484315|4139802|P2|12-Month Clinical Follow-up|Lost to Follow-up|1
1263977|NCT00484315|4139803|P1|12-Month Clinical Follow-up|Lost to Follow-up|2
1263978|NCT00484315|4139802|P2|12-Month Clinical Follow-up|Withdrawal by Subject|0
1263979|NCT00484315|4139803|P1|12-Month Clinical Follow-up|Withdrawal by Subject|4
1263980|NCT00484315|4139802|P2|12-Month Clinical Follow-up|Death|2
1263981|NCT00484315|4139803|P1|12-Month Clinical Follow-up|Death|6
1263982|NCT00484289|4139814|P3|Post Marketing Phase|Adverse Event|0
1263983|NCT00484289|4139815|P2|Post Marketing Phase|Adverse Event|1
1263984|NCT00484289|4139816|P1|Post Marketing Phase|Adverse Event|0
1263985|NCT00484289|4139814|P3|Long Term Phase|Other Reason|1
1263986|NCT00484289|4139815|P2|Long Term Phase|Other Reason|5
1263987|NCT00484289|4139816|P1|Long Term Phase|Other Reason|0
1263988|NCT00484289|4139814|P3|Long Term Phase|Inadequate response|4
1263989|NCT00484289|4139815|P2|Long Term Phase|Inadequate response|7
1263990|NCT00484289|4139816|P1|Long Term Phase|Inadequate response|2
1263991|NCT00484289|4139814|P3|Long Term Phase|Withdrawal by Subject|6
1263992|NCT00484289|4139815|P2|Long Term Phase|Withdrawal by Subject|7
1263993|NCT00484289|4139816|P1|Long Term Phase|Withdrawal by Subject|0
1263994|NCT00484289|4139814|P3|Long Term Phase|Adverse Event|5
1263995|NCT00484289|4139815|P2|Long Term Phase|Adverse Event|17
1263996|NCT00484289|4139816|P1|Long Term Phase|Adverse Event|1
1263997|NCT00484185|4139888|P1|Overall Study|Death|2
1263998|NCT00484185|4139888|P1|Overall Study|Randomized but not treated|5
1263999|NCT00484185|4139888|P1|Overall Study|Other|20
1264000|NCT00484185|4139888|P1|Overall Study|Lost to Follow-up|44
1264001|NCT00484159|4139910|P3|Overall Study|Lost to Follow-up|0
1264002|NCT00484159|4139911|P2|Overall Study|Lost to Follow-up|1
1264003|NCT00484159|4139912|P1|Overall Study|Lost to Follow-up|1
1264004|NCT00484094|4139923|P1|Overall Study|Other|3
1264005|NCT00484094|4139923|P1|Overall Study|Discontinued|39
1264006|NCT00483938|4139939|P7|Overall Study|Other|32
1264007|NCT00483938|4139940|P6|Overall Study|Other|4
1264008|NCT00483938|4139941|P5|Overall Study|Other|0
1264009|NCT00483938|4139942|P4|Overall Study|Other|4
1264010|NCT00483938|4139943|P3|Overall Study|Other|0
1264011|NCT00483938|4139944|P2|Overall Study|Other|9
1264012|NCT00483938|4139945|P1|Overall Study|Other|3
1264013|NCT00483938|4139939|P7|Overall Study|Death|0
1264014|NCT00483938|4139940|P6|Overall Study|Death|0
1264015|NCT00483938|4139941|P5|Overall Study|Death|0
1264016|NCT00483938|4139942|P4|Overall Study|Death|0
1264017|NCT00483938|4139943|P3|Overall Study|Death|0
1264018|NCT00483938|4139944|P2|Overall Study|Death|2
1264019|NCT00483938|4139945|P1|Overall Study|Death|0
1264020|NCT00483938|4139939|P7|Overall Study|Lost to Follow-up|3
1264021|NCT00483938|4139940|P6|Overall Study|Lost to Follow-up|1
1264022|NCT00483938|4139941|P5|Overall Study|Lost to Follow-up|1
1264023|NCT00483938|4139942|P4|Overall Study|Lost to Follow-up|2
1264024|NCT00483938|4139943|P3|Overall Study|Lost to Follow-up|0
1264025|NCT00483938|4139944|P2|Overall Study|Lost to Follow-up|2
1264026|NCT00483938|4139945|P1|Overall Study|Lost to Follow-up|1
1264027|NCT00483938|4139939|P7|Overall Study|Withdrawal by Subject|2
1264028|NCT00483938|4139940|P6|Overall Study|Withdrawal by Subject|3
1264029|NCT00483938|4139941|P5|Overall Study|Withdrawal by Subject|1
1264030|NCT00483938|4139942|P4|Overall Study|Withdrawal by Subject|0
1264031|NCT00483938|4139943|P3|Overall Study|Withdrawal by Subject|0
1264032|NCT00483938|4139944|P2|Overall Study|Withdrawal by Subject|6
1264033|NCT00483938|4139945|P1|Overall Study|Withdrawal by Subject|1
1264034|NCT00483938|4139939|P7|Overall Study|Protocol Violation|3
1264035|NCT00483938|4139940|P6|Overall Study|Protocol Violation|0
1264036|NCT00483938|4139941|P5|Overall Study|Protocol Violation|0
1264037|NCT00483938|4139942|P4|Overall Study|Protocol Violation|0
1264038|NCT00483938|4139943|P3|Overall Study|Protocol Violation|0
1264039|NCT00483938|4139944|P2|Overall Study|Protocol Violation|0
1264040|NCT00483938|4139945|P1|Overall Study|Protocol Violation|0
1264041|NCT00483756|4139969|P3|Overall Study|Randomized, Not Treated|4
1264042|NCT00483756|4139970|P2|Overall Study|Randomized, Not Treated|4
1264043|NCT00483756|4139971|P1|Overall Study|Randomized, Not Treated|1
1264044|NCT00483756|4139969|P3|Overall Study|Other|3
1264045|NCT00483756|4139970|P2|Overall Study|Other|4
1264046|NCT00483756|4139971|P1|Overall Study|Other|2
1264047|NCT00483756|4139969|P3|Overall Study|Withdrawal by Subject|4
1264048|NCT00483756|4139970|P2|Overall Study|Withdrawal by Subject|3
1264049|NCT00483756|4139971|P1|Overall Study|Withdrawal by Subject|5
1264050|NCT00483756|4139969|P3|Overall Study|Lost to Follow-up|0
1264051|NCT00483756|4139970|P2|Overall Study|Lost to Follow-up|1
1264052|NCT00483756|4139971|P1|Overall Study|Lost to Follow-up|3
1264053|NCT00483756|4139969|P3|Overall Study|Lack of Efficacy|0
1264054|NCT00483756|4139970|P2|Overall Study|Lack of Efficacy|0
1264055|NCT00483756|4139971|P1|Overall Study|Lack of Efficacy|1
1264056|NCT00483756|4139969|P3|Overall Study|Adverse Event|40
1264057|NCT00483756|4139970|P2|Overall Study|Adverse Event|38
1264058|NCT00483756|4139971|P1|Overall Study|Adverse Event|19
1264059|NCT00483756|4139969|P3|Overall Study|Death|1
1264060|NCT00483756|4139970|P2|Overall Study|Death|0
1264061|NCT00483756|4139971|P1|Overall Study|Death|2
1264062|NCT00483717|4140035|P2|Overall Study|Withdrawal by Subject|0
1264063|NCT00483717|4140036|P1|Overall Study|Withdrawal by Subject|1
1264064|NCT00483717|4140035|P2|Overall Study|Lost to Follow-up|0
1264065|NCT00483717|4140036|P1|Overall Study|Lost to Follow-up|1
1264066|NCT00483717|4140035|P2|Overall Study|No treatment for migraine|13
1264067|NCT00483717|4140036|P1|Overall Study|No treatment for migraine|16
1264068|NCT00483717|4140035|P2|Overall Study|Time of dosing missing|1
1264069|NCT00483717|4140036|P1|Overall Study|Time of dosing missing|1
1264070|NCT00483717|4140035|P2|Overall Study|Protocol Violation|7
1264071|NCT00483717|4140036|P1|Overall Study|Protocol Violation|5
1264072|NCT00483704|4140059|P3|Treatment|Physician Decision|4
1264073|NCT00483704|4140060|P2|Treatment|Physician Decision|1
1264074|NCT00483704|4140061|P1|Treatment|Physician Decision|0
1264075|NCT00483704|4140059|P3|Treatment|Pregnancy|0
1264076|NCT00483704|4140060|P2|Treatment|Pregnancy|1
1264077|NCT00483704|4140061|P1|Treatment|Pregnancy|0
1264078|NCT00483704|4140059|P3|Treatment|Lack of Efficacy|1
1264079|NCT00483704|4140060|P2|Treatment|Lack of Efficacy|1
1264080|NCT00483704|4140061|P1|Treatment|Lack of Efficacy|1
1264081|NCT00483704|4140059|P3|Treatment|Lost to Follow-up|5
1264082|NCT00483704|4140060|P2|Treatment|Lost to Follow-up|7
1264083|NCT00483704|4140061|P1|Treatment|Lost to Follow-up|2
1264084|NCT00483704|4140059|P3|Treatment|Protocol Violation|5
1264085|NCT00483704|4140060|P2|Treatment|Protocol Violation|3
1264086|NCT00483704|4140061|P1|Treatment|Protocol Violation|6
1264087|NCT00483704|4140059|P3|Treatment|Withdrawal by Subject|21
1264088|NCT00483704|4140060|P2|Treatment|Withdrawal by Subject|12
1264089|NCT00483704|4140061|P1|Treatment|Withdrawal by Subject|16
1264090|NCT00483704|4140059|P3|Treatment|Adverse Event|4
1264091|NCT00483704|4140060|P2|Treatment|Adverse Event|5
1264092|NCT00483704|4140061|P1|Treatment|Adverse Event|3
1264093|NCT00483704|4140059|P3|Treatment|Lack of qualifying migraines|116
1264094|NCT00483704|4140060|P2|Treatment|Lack of qualifying migraines|99
1264095|NCT00483704|4140061|P1|Treatment|Lack of qualifying migraines|101
1264096|NCT00483704|4140059|P3|Randomization|Lack of qualifying migraines|31
1264097|NCT00483704|4140060|P2|Randomization|Lack of qualifying migraines|25
1264098|NCT00483704|4140061|P1|Randomization|Lack of qualifying migraines|21
1264099|NCT00483704|4140059|P3|Randomization|Progressive disease|1
1264100|NCT00483704|4140060|P2|Randomization|Progressive disease|0
1264101|NCT00483704|4140061|P1|Randomization|Progressive disease|0
1264102|NCT00483704|4140059|P3|Randomization|Physician Decision|0
1264103|NCT00483704|4140060|P2|Randomization|Physician Decision|4
1264104|NCT00483704|4140061|P1|Randomization|Physician Decision|2
1264105|NCT00483704|4140059|P3|Randomization|Pregnancy|0
1264106|NCT00483704|4140060|P2|Randomization|Pregnancy|0
1264107|NCT00483704|4140061|P1|Randomization|Pregnancy|1
1264108|NCT00483704|4140059|P3|Randomization|Lost to Follow-up|19
1264109|NCT00483704|4140060|P2|Randomization|Lost to Follow-up|14
1264110|NCT00483704|4140061|P1|Randomization|Lost to Follow-up|14
1264111|NCT00483704|4140059|P3|Randomization|Protocol Violation|22
1264112|NCT00483704|4140060|P2|Randomization|Protocol Violation|25
1264113|NCT00483704|4140061|P1|Randomization|Protocol Violation|14
1264114|NCT00483704|4140059|P3|Randomization|Withdrawal by Subject|18
1264115|NCT00483704|4140060|P2|Randomization|Withdrawal by Subject|28
1264116|NCT00483704|4140061|P1|Randomization|Withdrawal by Subject|19
1264117|NCT00483652|4140107|P2|Double-blind Treatment Period|Withdrawal due to AE before study began|0
1264118|NCT00483652|4140108|P1|Double-blind Treatment Period|Withdrawal due to AE before study began|1
1264119|NCT00483652|4140107|P2|Double-blind Treatment Period|Protocol inclusion deviation|0
1264120|NCT00483652|4140108|P1|Double-blind Treatment Period|Protocol inclusion deviation|1
1264121|NCT00483652|4140107|P2|Double-blind Treatment Period|Adverse Event|4
1264122|NCT00483652|4140108|P1|Double-blind Treatment Period|Adverse Event|3
1264123|NCT00483652|4140107|P2|Double-blind Treatment Period|Protocol Violation|1
1264124|NCT00483652|4140108|P1|Double-blind Treatment Period|Protocol Violation|2
1264125|NCT00483574|4140118|P2|Overall Study|Withdrawal by Subject|0
1264126|NCT00483574|4140119|P1|Overall Study|Withdrawal by Subject|52
1264127|NCT00483574|4140118|P2|Overall Study|Lost to Follow-up|4
1264128|NCT00483574|4140119|P1|Overall Study|Lost to Follow-up|16
1264129|NCT00483574|4140118|P2|Overall Study|Protocol Violation|9
1264130|NCT00483574|4140119|P1|Overall Study|Protocol Violation|28
1264131|NCT00483574|4140118|P2|Overall Study|Adverse Event|0
1264132|NCT00483574|4140119|P1|Overall Study|Adverse Event|6
1264133|NCT00483548|4140134|P2|Overall Study|Withdrawal by Subject|2
1264134|NCT00483548|4140135|P1|Overall Study|Withdrawal by Subject|5
1264135|NCT00483548|4140134|P2|Overall Study|Lost to Follow-up|4
1264136|NCT00483548|4140135|P1|Overall Study|Lost to Follow-up|3
1264137|NCT00483548|4140134|P2|Overall Study|Non-compliance with medication|0
1264138|NCT00483548|4140135|P1|Overall Study|Non-compliance with medication|2
1264139|NCT00483548|4140134|P2|Overall Study|Unable to comply with protocol schedule|0
1264140|NCT00483548|4140135|P1|Overall Study|Unable to comply with protocol schedule|1
1264141|NCT00483548|4140134|P2|Overall Study|Protocol required discontinuation|6
1264142|NCT00483548|4140135|P1|Overall Study|Protocol required discontinuation|6
1264143|NCT00483548|4140134|P2|Overall Study|Pregnancy|0
1264144|NCT00483548|4140135|P1|Overall Study|Pregnancy|1
1264145|NCT00483548|4140134|P2|Overall Study|Protocol Violation|7
1264146|NCT00483548|4140135|P1|Overall Study|Protocol Violation|11
1264147|NCT00483548|4140134|P2|Overall Study|Lack of Efficacy|8
1264148|NCT00483548|4140135|P1|Overall Study|Lack of Efficacy|4
1264149|NCT00483548|4140134|P2|Overall Study|Laboratory abnormality|2
1264150|NCT00483548|4140135|P1|Overall Study|Laboratory abnormality|1
1264151|NCT00483548|4140134|P2|Overall Study|Adverse Event|14
1264152|NCT00483548|4140135|P1|Overall Study|Adverse Event|25
1264153|NCT00483548|4140134|P2|Overall Study|Randomized; not treated with study drug|3
1264154|NCT00483548|4140135|P1|Overall Study|Randomized; not treated with study drug|1
1264155|NCT00483405|4140185|P1|Overall Study|Other complicating disease|1
1264156|NCT00483405|4140185|P1|Overall Study|Withdrawal by Subject|2
1264157|NCT00483405|4140185|P1|Overall Study|Death|3
1264158|NCT00483405|4140185|P1|Overall Study|Lack of Efficacy|14
1264159|NCT00483405|4140185|P1|Overall Study|Adverse Event|8
1264160|NCT00483379|4140194|P2|Treatment Period|Withdrawal by Subject|0
1264161|NCT00483379|4140195|P1|Treatment Period|Withdrawal by Subject|1
1264162|NCT00483379|4140194|P2|Treatment Period|Adverse Event|0
1264163|NCT00483379|4140195|P1|Treatment Period|Adverse Event|1
1264164|NCT00483327|4140231|P1|Overall Study|Patient Non Compliance|2
1264165|NCT00483327|4140231|P1|Overall Study|Lost to Follow-up|4
1264166|NCT00483327|4140231|P1|Overall Study|Withdrawal by Subject|3
1264167|NCT00483327|4140231|P1|Overall Study|Adverse Event|1
1264168|NCT00483184|4140263|P3|Overall Study|Protocol Violation|1
1264169|NCT00483184|4140264|P2|Overall Study|Protocol Violation|0
1264170|NCT00483184|4140265|P1|Overall Study|Protocol Violation|1
1264171|NCT00483184|4140263|P3|Overall Study|Adverse Event|2
1264172|NCT00483184|4140264|P2|Overall Study|Adverse Event|2
1264173|NCT00483184|4140265|P1|Overall Study|Adverse Event|1
1264174|NCT00483184|4140263|P3|Overall Study|Lost to Follow-up|0
1264175|NCT00483184|4140264|P2|Overall Study|Lost to Follow-up|0
1264176|NCT00483184|4140265|P1|Overall Study|Lost to Follow-up|1
1264177|NCT00483184|4140263|P3|Overall Study|Withdrawal by Subject|0
1264178|NCT00483184|4140264|P2|Overall Study|Withdrawal by Subject|2
1264179|NCT00483184|4140265|P1|Overall Study|Withdrawal by Subject|2
1264180|NCT00483119|4140275|P2|Overall Study|Physician Decision|0
1264181|NCT00483119|4140276|P1|Overall Study|Physician Decision|1
1264182|NCT00483119|4140275|P2|Overall Study|Adverse Event|1
1264183|NCT00483119|4140276|P1|Overall Study|Adverse Event|0
1264184|NCT00483041|4140290|P2|Overall Study|ABNORMAL LAB DATA AT SCREENING|1
1264185|NCT00483041|4140291|P1|Overall Study|ABNORMAL LAB DATA AT SCREENING|0
1264186|NCT00483002|4140321|P1|Overall Study|Other|967
1264187|NCT00483002|4140321|P1|Overall Study|Other|2
1264188|NCT00483002|4140321|P1|Overall Study|Lost to Follow-up|962
1264189|NCT00483002|4140321|P1|Overall Study|Lack of Efficacy|555
1264190|NCT00483002|4140321|P1|Overall Study|Adverse Event|68
1264191|NCT00482729|4140346|P2|Overall Study|Withdrawal by Subject|69
1264192|NCT00482729|4140347|P1|Overall Study|Withdrawal by Subject|67
1264193|NCT00482729|4140346|P2|Overall Study|Protocol Violation|18
1264194|NCT00482729|4140347|P1|Overall Study|Protocol Violation|10
1264195|NCT00482729|4140346|P2|Overall Study|Pregnancy|2
1264196|NCT00482729|4140347|P1|Overall Study|Pregnancy|4
1264197|NCT00482729|4140346|P2|Overall Study|Physician Decision|7
1264198|NCT00482729|4140347|P1|Overall Study|Physician Decision|10
1264199|NCT00482729|4140346|P2|Overall Study|Lost to Follow-up|66
1264200|NCT00482729|4140347|P1|Overall Study|Lost to Follow-up|86
1264201|NCT00482729|4140346|P2|Overall Study|Lack of Efficacy|16
1264202|NCT00482729|4140347|P1|Overall Study|Lack of Efficacy|4
1264203|NCT00482729|4140346|P2|Overall Study|Hyperglycemia Criteria|5
1264204|NCT00482729|4140347|P1|Overall Study|Hyperglycemia Criteria|7
1264205|NCT00482729|4140346|P2|Overall Study|Creatinine/Creatinine Clearance Criteria|2
1264206|NCT00482729|4140347|P1|Overall Study|Creatinine/Creatinine Clearance Criteria|0
1264207|NCT00482729|4140346|P2|Overall Study|Adverse Event|33
1264208|NCT00482729|4140347|P1|Overall Study|Adverse Event|29
1264209|NCT00482703|4140363|P2|Overall Study|Poor compliance|0
1264210|NCT00482703|4140364|P1|Overall Study|Poor compliance|1
1264211|NCT00482612|4140435|P4|Follow-up Period|Reasons not related to trial|3
1264212|NCT00482612|4140436|P3|Follow-up Period|Reasons not related to trial|1
1264213|NCT00482612|4140437|P2|Follow-up Period|Reasons not related to trial|0
1264214|NCT00482612|4140438|P1|Follow-up Period|Reasons not related to trial|1
1264215|NCT00482612|4140435|P4|Follow-up Period|Withdrawal by Subject|2
1264216|NCT00482612|4140436|P3|Follow-up Period|Withdrawal by Subject|7
1264217|NCT00482612|4140437|P2|Follow-up Period|Withdrawal by Subject|5
1264218|NCT00482612|4140438|P1|Follow-up Period|Withdrawal by Subject|3
1264219|NCT00482612|4140435|P4|Follow-up Period|Lack of Efficacy|0
1264220|NCT00482612|4140436|P3|Follow-up Period|Lack of Efficacy|1
1264221|NCT00482612|4140437|P2|Follow-up Period|Lack of Efficacy|0
1264222|NCT00482612|4140438|P1|Follow-up Period|Lack of Efficacy|2
1264223|NCT00482612|4140435|P4|Follow-up Period|Adverse Event|0
1264224|NCT00482612|4140436|P3|Follow-up Period|Adverse Event|9
1264225|NCT00482612|4140437|P2|Follow-up Period|Adverse Event|7
1264226|NCT00482612|4140438|P1|Follow-up Period|Adverse Event|4
1264227|NCT00482612|4140435|P4|Follow-up Period|Lost to Follow-up|1
1264228|NCT00482612|4140436|P3|Follow-up Period|Lost to Follow-up|2
1264229|NCT00482612|4140437|P2|Follow-up Period|Lost to Follow-up|4
1264230|NCT00482612|4140438|P1|Follow-up Period|Lost to Follow-up|0
1264231|NCT00482612|4140435|P4|Follow-up Period|Lack of compliance|0
1264232|NCT00482612|4140436|P3|Follow-up Period|Lack of compliance|1
1264233|NCT00482612|4140437|P2|Follow-up Period|Lack of compliance|0
1264234|NCT00482612|4140438|P1|Follow-up Period|Lack of compliance|0
1264235|NCT00482612|4140435|P4|Follow-up Period|Other|2
1264236|NCT00482612|4140436|P3|Follow-up Period|Other|1
1264237|NCT00482612|4140437|P2|Follow-up Period|Other|2
1264238|NCT00482612|4140438|P1|Follow-up Period|Other|4
1264239|NCT00482612|4140435|P4|In-treatment Period|No study medication administered|0
1264240|NCT00482612|4140436|P3|In-treatment Period|No study medication administered|1
1264241|NCT00482612|4140437|P2|In-treatment Period|No study medication administered|0
1264242|NCT00482612|4140438|P1|In-treatment Period|No study medication administered|0
1264243|NCT00482391|4140487|P1|Overall Study|Death|1
1264244|NCT00482391|4140487|P1|Overall Study|Adverse Event|1
1264245|NCT00482391|4140487|P1|Overall Study|Withdrawal by Subject|1
1264246|NCT00482274|4140492|P1|Overall Study|Adverse Event|1
1264247|NCT00482170|4140502|P2|Overall Study|Unspecified reason|2
1264248|NCT00482170|4140503|P1|Overall Study|Unspecified reason|0
1264249|NCT00482170|4140502|P2|Overall Study|Lost to Follow-up|0
1264250|NCT00482170|4140503|P1|Overall Study|Lost to Follow-up|2
1264251|NCT00482170|4140502|P2|Overall Study|Protocol Violation|3
1264252|NCT00482170|4140503|P1|Overall Study|Protocol Violation|2
1264253|NCT00482170|4140502|P2|Overall Study|Withdrawal by Subject|1
1264254|NCT00482170|4140503|P1|Overall Study|Withdrawal by Subject|6
1264255|NCT00482170|4140502|P2|Overall Study|Adverse Event|14
1264256|NCT00482170|4140503|P1|Overall Study|Adverse Event|5
1264257|NCT00482053|4140621|P1|Inter-treatment Period|Disease progression|1
1264258|NCT00482014|4140635|P4|Overall Study|Sponsor Decision|1
1264259|NCT00482014|4140636|P3|Overall Study|Sponsor Decision|1
1264260|NCT00482014|4140637|P2|Overall Study|Sponsor Decision|2
1264261|NCT00482014|4140638|P1|Overall Study|Sponsor Decision|1
1264262|NCT00482014|4140635|P4|Overall Study|Lack of Efficacy|6
1264263|NCT00482014|4140636|P3|Overall Study|Lack of Efficacy|4
1264264|NCT00482014|4140637|P2|Overall Study|Lack of Efficacy|0
1264265|NCT00482014|4140638|P1|Overall Study|Lack of Efficacy|1
1264266|NCT00482014|4140635|P4|Overall Study|Death|4
1264267|NCT00482014|4140636|P3|Overall Study|Death|1
1264268|NCT00482014|4140637|P2|Overall Study|Death|2
1264269|NCT00482014|4140638|P1|Overall Study|Death|1
1264270|NCT00482014|4140635|P4|Overall Study|Adverse Event|8
1264271|NCT00482014|4140636|P3|Overall Study|Adverse Event|2
1264272|NCT00482014|4140637|P2|Overall Study|Adverse Event|0
1264273|NCT00482014|4140638|P1|Overall Study|Adverse Event|3
1264274|NCT00482014|4140635|P4|Overall Study|Withdrawal by Subject|4
1264275|NCT00482014|4140636|P3|Overall Study|Withdrawal by Subject|3
1264276|NCT00482014|4140637|P2|Overall Study|Withdrawal by Subject|2
1264277|NCT00482014|4140638|P1|Overall Study|Withdrawal by Subject|1
1264278|NCT00481988|4140662|P2|Overall Study|Withdrawal by Subject|1
1264279|NCT00481988|4140663|P1|Overall Study|Withdrawal by Subject|1
1264280|NCT00481871|4140676|P5|Overall Study|Progressive Disease - pt withdrew|0
1264281|NCT00481871|4140677|P4|Overall Study|Progressive Disease - pt withdrew|0
1264282|NCT00481871|4140678|P3|Overall Study|Progressive Disease - pt withdrew|1
1264283|NCT00481871|4140679|P2|Overall Study|Progressive Disease - pt withdrew|0
1264284|NCT00481871|4140680|P1|Overall Study|Progressive Disease - pt withdrew|0
1264285|NCT00481832|4140705|P1|Inter-transplant Period|Lack of allogeneic donor|5
1264286|NCT00481832|4140705|P1|Inter-transplant Period|Disease relapse|11
1264287|NCT00481832|4140705|P1|Inter-transplant Period|Physician Decision|4
1264288|NCT00481832|4140705|P1|Inter-transplant Period|Death|3
1264289|NCT00481832|4140705|P1|Inter-transplant Period|Adverse Event|4
1264290|NCT00481832|4140705|P1|Enrollment|Unable to collect enough stem cells|2
1264291|NCT00481832|4140705|P1|Enrollment|Physician Decision|8
1264292|NCT00481767|4140720|P2|Overall Study|Lost to Follow-up|10
1264293|NCT00481767|4140721|P1|Overall Study|Lost to Follow-up|16
1264294|NCT00481767|4140720|P2|Overall Study|Withdrawal by Subject|11
1264295|NCT00481767|4140721|P1|Overall Study|Withdrawal by Subject|16
1264296|NCT00481676|4140755|P2|Overall Study|Administrative problem|0
1264297|NCT00481676|4140756|P1|Overall Study|Administrative problem|1
1264298|NCT00481676|4140755|P2|Overall Study|Unsatisfactory therapeutic effect|4
1264299|NCT00481676|4140756|P1|Overall Study|Unsatisfactory therapeutic effect|1
1264300|NCT00481676|4140755|P2|Overall Study|Adverse Event|1
1264301|NCT00481676|4140756|P1|Overall Study|Adverse Event|0
1264302|NCT00481247|4140806|P2|Overall Study|Did not receive treatment|2
1264303|NCT00481247|4140807|P1|Overall Study|Did not receive treatment|1
1264304|NCT00481247|4140806|P2|Overall Study|Varied|15
1264305|NCT00481247|4140807|P1|Overall Study|Varied|6
1264306|NCT00481247|4140806|P2|Overall Study|Administrative reason by sponsor|162
1264307|NCT00481247|4140807|P1|Overall Study|Administrative reason by sponsor|157
1264308|NCT00481247|4140806|P2|Overall Study|Poor compliance/noncompliance|7
1264309|NCT00481247|4140807|P1|Overall Study|Poor compliance/noncompliance|1
1264310|NCT00481247|4140806|P2|Overall Study|Lost to Follow-up|2
1264311|NCT00481247|4140807|P1|Overall Study|Lost to Follow-up|1
1264312|NCT00481247|4140806|P2|Overall Study|Pregnancy|1
1264313|NCT00481247|4140807|P1|Overall Study|Pregnancy|2
1264314|NCT00481247|4140806|P2|Overall Study|Withdrawal by Subject|13
1264315|NCT00481247|4140807|P1|Overall Study|Withdrawal by Subject|8
1264316|NCT00481247|4140806|P2|Overall Study|AE unrelated to study drug|4
1264317|NCT00481247|4140807|P1|Overall Study|AE unrelated to study drug|13
1264318|NCT00481247|4140806|P2|Overall Study|Treatment failure|14
1264319|NCT00481247|4140807|P1|Overall Study|Treatment failure|10
1264320|NCT00481247|4140806|P2|Overall Study|Intolerance|17
1264321|NCT00481247|4140807|P1|Overall Study|Intolerance|42
1264322|NCT00481247|4140806|P2|Overall Study|Disease progression|22
1264323|NCT00481247|4140807|P1|Overall Study|Disease progression|18
1264324|NCT00481247|4140806|P2|Overall Study|Death|1
1264325|NCT00481247|4140807|P1|Overall Study|Death|0
1264326|NCT00481195|4140831|P2|Overall Study|Miscellaneous|2
1264327|NCT00481195|4140832|P1|Overall Study|Miscellaneous|2
1264328|NCT00481195|4140831|P2|Overall Study|Withdrawal by Subject|9
1264329|NCT00481195|4140832|P1|Overall Study|Withdrawal by Subject|3
1264330|NCT00481195|4140831|P2|Overall Study|Protocol Violation|7
1264331|NCT00481195|4140832|P1|Overall Study|Protocol Violation|10
1264332|NCT00481195|4140831|P2|Overall Study|Physician Decision|1
1264333|NCT00481195|4140832|P1|Overall Study|Physician Decision|3
1264334|NCT00481195|4140831|P2|Overall Study|Lost to Follow-up|6
1264335|NCT00481195|4140832|P1|Overall Study|Lost to Follow-up|4
1264336|NCT00481195|4140831|P2|Overall Study|Lack of Efficacy|3
1264337|NCT00481195|4140832|P1|Overall Study|Lack of Efficacy|1
1264338|NCT00481195|4140831|P2|Overall Study|Adverse Event|11
1264339|NCT00481195|4140832|P1|Overall Study|Adverse Event|16
1264340|NCT00481078|4140918|P2|Overall Study|Brain metastasis|1
1264341|NCT00481078|4140919|P1|Overall Study|Brain metastasis|0
1264342|NCT00481078|4140918|P2|Overall Study|Received other treatment|1
1264343|NCT00481078|4140919|P1|Overall Study|Received other treatment|2
1264344|NCT00481078|4140918|P2|Overall Study|Information not available|0
1264345|NCT00481078|4140919|P1|Overall Study|Information not available|1
1264346|NCT00481078|4140918|P2|Overall Study|Withdrawal by Subject|1
1264347|NCT00481078|4140919|P1|Overall Study|Withdrawal by Subject|7
1264348|NCT00481078|4140918|P2|Overall Study|Intercurrent illness|0
1264349|NCT00481078|4140919|P1|Overall Study|Intercurrent illness|1
1264350|NCT00481078|4140918|P2|Overall Study|Death|3
1264351|NCT00481078|4140919|P1|Overall Study|Death|5
1264352|NCT00481078|4140918|P2|Overall Study|Adverse Event|3
1264353|NCT00481078|4140919|P1|Overall Study|Adverse Event|15
1264354|NCT00481078|4140918|P2|Overall Study|Progression of disease|11
1264355|NCT00481078|4140919|P1|Overall Study|Progression of disease|11
1264356|NCT00481065|4140937|P8|Overall Study|Unable to classify|0
1264357|NCT00481065|4140938|P7|Overall Study|Unable to classify|0
1264358|NCT00481065|4140939|P6|Overall Study|Unable to classify|0
1264359|NCT00481065|4140940|P5|Overall Study|Unable to classify|1
1264360|NCT00481065|4140941|P4|Overall Study|Unable to classify|0
1264361|NCT00481065|4140942|P3|Overall Study|Unable to classify|2
1264362|NCT00481065|4140943|P2|Overall Study|Unable to classify|1
1264363|NCT00481065|4140944|P1|Overall Study|Unable to classify|0
1264364|NCT00481065|4140937|P8|Overall Study|Protocol Violation|2
1264365|NCT00481065|4140938|P7|Overall Study|Protocol Violation|3
1264366|NCT00481065|4140939|P6|Overall Study|Protocol Violation|6
1264367|NCT00481065|4140940|P5|Overall Study|Protocol Violation|2
1264368|NCT00481065|4140941|P4|Overall Study|Protocol Violation|1
1264369|NCT00481065|4140942|P3|Overall Study|Protocol Violation|1
1264370|NCT00481065|4140943|P2|Overall Study|Protocol Violation|1
1264371|NCT00481065|4140944|P1|Overall Study|Protocol Violation|2
1264372|NCT00481065|4140937|P8|Overall Study|Administrative reason|0
1264373|NCT00481065|4140938|P7|Overall Study|Administrative reason|1
1264374|NCT00481065|4140939|P6|Overall Study|Administrative reason|2
1264375|NCT00481065|4140940|P5|Overall Study|Administrative reason|0
1264376|NCT00481065|4140941|P4|Overall Study|Administrative reason|0
1264377|NCT00481065|4140942|P3|Overall Study|Administrative reason|0
1264378|NCT00481065|4140943|P2|Overall Study|Administrative reason|0
1264379|NCT00481065|4140944|P1|Overall Study|Administrative reason|0
1264380|NCT00481065|4140937|P8|Overall Study|Inappropriate enrollment|1
1264381|NCT00481065|4140938|P7|Overall Study|Inappropriate enrollment|0
1264382|NCT00481065|4140939|P6|Overall Study|Inappropriate enrollment|1
1264383|NCT00481065|4140940|P5|Overall Study|Inappropriate enrollment|2
1264384|NCT00481065|4140941|P4|Overall Study|Inappropriate enrollment|0
1264385|NCT00481065|4140942|P3|Overall Study|Inappropriate enrollment|2
1264386|NCT00481065|4140943|P2|Overall Study|Inappropriate enrollment|0
1264387|NCT00481065|4140944|P1|Overall Study|Inappropriate enrollment|4
1264388|NCT00481065|4140937|P8|Overall Study|Lost to Follow-up|5
1264389|NCT00481065|4140938|P7|Overall Study|Lost to Follow-up|2
1264390|NCT00481065|4140939|P6|Overall Study|Lost to Follow-up|3
1264391|NCT00481065|4140940|P5|Overall Study|Lost to Follow-up|3
1264392|NCT00481065|4140941|P4|Overall Study|Lost to Follow-up|3
1264393|NCT00481065|4140942|P3|Overall Study|Lost to Follow-up|4
1264394|NCT00481065|4140943|P2|Overall Study|Lost to Follow-up|2
1264395|NCT00481065|4140944|P1|Overall Study|Lost to Follow-up|4
1264396|NCT00481065|4140937|P8|Overall Study|Withdrawal by Subject|10
1264397|NCT00481065|4140938|P7|Overall Study|Withdrawal by Subject|9
1264398|NCT00481065|4140939|P6|Overall Study|Withdrawal by Subject|12
1264399|NCT00481065|4140940|P5|Overall Study|Withdrawal by Subject|13
1264400|NCT00481065|4140941|P4|Overall Study|Withdrawal by Subject|11
1264401|NCT00481065|4140942|P3|Overall Study|Withdrawal by Subject|7
1264402|NCT00481065|4140943|P2|Overall Study|Withdrawal by Subject|12
1264403|NCT00481065|4140944|P1|Overall Study|Withdrawal by Subject|11
1264404|NCT00481065|4140937|P8|Overall Study|Adverse event or death|1
1264405|NCT00481065|4140938|P7|Overall Study|Adverse event or death|1
1264406|NCT00481065|4140939|P6|Overall Study|Adverse event or death|0
1264407|NCT00481065|4140940|P5|Overall Study|Adverse event or death|2
1264408|NCT00481065|4140941|P4|Overall Study|Adverse event or death|0
1264409|NCT00481065|4140942|P3|Overall Study|Adverse event or death|3
1264410|NCT00481065|4140943|P2|Overall Study|Adverse event or death|1
1264411|NCT00481065|4140944|P1|Overall Study|Adverse event or death|1
1264412|NCT00480857|4141034|P1|Overall Study|Lack of Efficacy|2
1264413|NCT00480779|4141044|P2|Overall Study|Job and Health-related|3
1264414|NCT00480779|4141045|P1|Overall Study|Job and Health-related|0
1264415|NCT00480779|4141044|P2|Overall Study|Other|0
1264416|NCT00480779|4141045|P1|Overall Study|Other|2
1264417|NCT00480636|4141082|P1|Overall Study|Lost to follow-up; subsequently died|1
1264418|NCT00480636|4141082|P1|Overall Study|Other|2
1264419|NCT00480636|4141082|P1|Overall Study|Lost to Follow-up|4
1264420|NCT00480636|4141082|P1|Overall Study|Death|12
1264421|NCT00480532|4141094|P4|Overall Study|Protocol Violation|0
1264422|NCT00480532|4141095|P3|Overall Study|Protocol Violation|1
1264423|NCT00480532|4141096|P2|Overall Study|Protocol Violation|0
1264424|NCT00480532|4141097|P1|Overall Study|Protocol Violation|0
1264425|NCT00480532|4141094|P4|Overall Study|Withdrawal by Subject|1
1264426|NCT00480532|4141095|P3|Overall Study|Withdrawal by Subject|3
1264427|NCT00480532|4141096|P2|Overall Study|Withdrawal by Subject|4
1264428|NCT00480532|4141097|P1|Overall Study|Withdrawal by Subject|2
1264429|NCT00480493|4141117|P2|Overall Study|moved|7
1264430|NCT00480493|4141118|P1|Overall Study|moved|2
1264431|NCT00480324|4141130|P2|Overall Study|Subject’s mother pregnant|1
1264432|NCT00480324|4141131|P1|Overall Study|Subject’s mother pregnant|0
1264433|NCT00480324|4141130|P2|Overall Study|Lost to Follow-up|8
1264434|NCT00480324|4141131|P1|Overall Study|Lost to Follow-up|17
1264435|NCT00480324|4141130|P2|Overall Study|Withdrawal by Subject|5
1264436|NCT00480324|4141131|P1|Overall Study|Withdrawal by Subject|14
1264437|NCT00480324|4141130|P2|Overall Study|Protocol Violation|1
1264438|NCT00480324|4141131|P1|Overall Study|Protocol Violation|0
1264439|NCT00480324|4141130|P2|Overall Study|Adverse Event|1
1264440|NCT00480324|4141131|P1|Overall Study|Adverse Event|1
1264441|NCT00479882|4141161|P4|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
1264442|NCT00479882|4141162|P3|Crossover: Period III (Weeks 13-20)|Protocol Violation|1
1264443|NCT00479882|4141163|P2|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
1264444|NCT00479882|4141164|P1|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
1264445|NCT00479882|4141161|P4|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
1264446|NCT00479882|4141162|P3|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1
1264447|NCT00479882|4141163|P2|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
1264448|NCT00479882|4141164|P1|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
1264449|NCT00479882|4141161|P4|Crossover: Period III (Weeks 13-20)|Participant moved|0
1264450|NCT00479882|4141162|P3|Crossover: Period III (Weeks 13-20)|Participant moved|1
1264451|NCT00479882|4141163|P2|Crossover: Period III (Weeks 13-20)|Participant moved|2
1264452|NCT00479882|4141164|P1|Crossover: Period III (Weeks 13-20)|Participant moved|1
1264453|NCT00479882|4141161|P4|Crossover: Period III (Weeks 13-20)|Other|2
1264454|NCT00479882|4141162|P3|Crossover: Period III (Weeks 13-20)|Other|2
1264455|NCT00479882|4141163|P2|Crossover: Period III (Weeks 13-20)|Other|0
1264456|NCT00479882|4141164|P1|Crossover: Period III (Weeks 13-20)|Other|5
1264457|NCT00479882|4141161|P4|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
1264458|NCT00479882|4141162|P3|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
1264459|NCT00479882|4141163|P2|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2
1264460|NCT00479882|4141164|P1|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
1264461|NCT00479882|4141161|P4|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
1264462|NCT00479882|4141162|P3|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
1264463|NCT00479882|4141163|P2|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1
1264464|NCT00479882|4141164|P1|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3
1264465|NCT00479882|4141161|P4|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10
1264466|NCT00479882|4141162|P3|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
1264467|NCT00479882|4141163|P2|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13
1264468|NCT00479882|4141164|P1|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
1264469|NCT00479882|4141161|P4|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
1264470|NCT00479882|4141162|P3|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5
1264471|NCT00479882|4141163|P2|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
1264472|NCT00479882|4141164|P1|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2
1264473|NCT00479882|4141161|P4|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25
1264474|NCT00479882|4141162|P3|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30
1264475|NCT00479882|4141163|P2|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33
1264476|NCT00479882|4141164|P1|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24
1264477|NCT00479882|4141161|P4|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1
1264478|NCT00479882|4141162|P3|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2
1264479|NCT00479882|4141163|P2|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4
1264480|NCT00479882|4141164|P1|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0
1264481|NCT00479882|4141161|P4|Precrossover: Periods I/II (Weeks 1-12)|Other|5
1264482|NCT00479882|4141162|P3|Precrossover: Periods I/II (Weeks 1-12)|Other|9
1264483|NCT00479882|4141163|P2|Precrossover: Periods I/II (Weeks 1-12)|Other|6
1264484|NCT00479882|4141164|P1|Precrossover: Periods I/II (Weeks 1-12)|Other|4
1264485|NCT00479882|4141161|P4|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11
1264486|NCT00479882|4141162|P3|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
1264487|NCT00479882|4141163|P2|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
1264488|NCT00479882|4141164|P1|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12
1264489|NCT00479882|4141161|P4|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
1264490|NCT00479882|4141162|P3|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
1264491|NCT00479882|4141163|P2|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
1264492|NCT00479882|4141164|P1|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0
1264493|NCT00479882|4141161|P4|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87
1264494|NCT00479882|4141162|P3|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98
1264495|NCT00479882|4141163|P2|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99
1264496|NCT00479882|4141164|P1|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96
1264497|NCT00479856|4141294|P1|Overall Study|Physician Decision|1
1264498|NCT00479856|4141294|P1|Overall Study|Withdrawal by Subject|1
1264499|NCT00479856|4141294|P1|Overall Study|Adverse Event|1
1264500|NCT00479765|4141303|P1|Overall Study|study terminated|4
1264501|NCT00479713|4141309|P2|Overall Study|Withdrawal by Subject|1
1264502|NCT00479713|4141310|P1|Overall Study|Withdrawal by Subject|4
1264503|NCT00479713|4141309|P2|Overall Study|Protocol Violation|1
1264504|NCT00479713|4141310|P1|Overall Study|Protocol Violation|0
1264505|NCT00479713|4141309|P2|Overall Study|Lost to Follow-up|1
1264506|NCT00479713|4141310|P1|Overall Study|Lost to Follow-up|0
1264507|NCT00479713|4141309|P2|Overall Study|Death|0
1264508|NCT00479713|4141310|P1|Overall Study|Death|1
1264509|NCT00479713|4141309|P2|Overall Study|Adverse Event|6
1264510|NCT00479713|4141310|P1|Overall Study|Adverse Event|8
1264511|NCT00479674|4141334|P1|Overall Study|none provided|3
1264512|NCT00479674|4141334|P1|Overall Study|Physician Decision|14
1264513|NCT00479674|4141334|P1|Overall Study|Withdrawal by Subject|6
1264514|NCT00479674|4141334|P1|Overall Study|Adverse Event|18
1264515|NCT00479557|4141349|P7|Overall Study|Not specified|0
1264516|NCT00479557|4141350|P6|Overall Study|Not specified|3
1264517|NCT00479557|4141351|P5|Overall Study|Not specified|0
1264518|NCT00479557|4141352|P4|Overall Study|Not specified|0
1264519|NCT00479557|4141353|P3|Overall Study|Not specified|1
1264520|NCT00479557|4141354|P2|Overall Study|Not specified|3
1264521|NCT00479557|4141355|P1|Overall Study|Not specified|2
1264522|NCT00479557|4141349|P7|Overall Study|Subject Request|1
1264523|NCT00479557|4141350|P6|Overall Study|Subject Request|4
1264524|NCT00479557|4141351|P5|Overall Study|Subject Request|1
1264525|NCT00479557|4141352|P4|Overall Study|Subject Request|1
1264526|NCT00479557|4141353|P3|Overall Study|Subject Request|1
1264527|NCT00479557|4141354|P2|Overall Study|Subject Request|0
1264528|NCT00479557|4141355|P1|Overall Study|Subject Request|3
1264529|NCT00479557|4141349|P7|Overall Study|Investigator Request|0
1264530|NCT00479557|4141350|P6|Overall Study|Investigator Request|0
1264531|NCT00479557|4141351|P5|Overall Study|Investigator Request|0
1264532|NCT00479557|4141352|P4|Overall Study|Investigator Request|0
1264533|NCT00479557|4141353|P3|Overall Study|Investigator Request|1
1264534|NCT00479557|4141354|P2|Overall Study|Investigator Request|0
1264535|NCT00479557|4141355|P1|Overall Study|Investigator Request|0
1264536|NCT00479557|4141349|P7|Overall Study|Caregiver Request|0
1264537|NCT00479557|4141350|P6|Overall Study|Caregiver Request|2
1264538|NCT00479557|4141351|P5|Overall Study|Caregiver Request|1
1264539|NCT00479557|4141352|P4|Overall Study|Caregiver Request|0
1264540|NCT00479557|4141353|P3|Overall Study|Caregiver Request|2
1264541|NCT00479557|4141354|P2|Overall Study|Caregiver Request|2
1264542|NCT00479557|4141355|P1|Overall Study|Caregiver Request|2
1264543|NCT00479557|4141349|P7|Overall Study|AE not related to Study Drug|1
1264544|NCT00479557|4141350|P6|Overall Study|AE not related to Study Drug|2
1264545|NCT00479557|4141351|P5|Overall Study|AE not related to Study Drug|2
1264546|NCT00479557|4141352|P4|Overall Study|AE not related to Study Drug|0
1264547|NCT00479557|4141353|P3|Overall Study|AE not related to Study Drug|0
1264548|NCT00479557|4141354|P2|Overall Study|AE not related to Study Drug|3
1264549|NCT00479557|4141355|P1|Overall Study|AE not related to Study Drug|1
1264550|NCT00479557|4141349|P7|Overall Study|Adverse Event (AE) related to Study Drug|0
1264551|NCT00479557|4141350|P6|Overall Study|Adverse Event (AE) related to Study Drug|1
1264552|NCT00479557|4141351|P5|Overall Study|Adverse Event (AE) related to Study Drug|0
1264553|NCT00479557|4141352|P4|Overall Study|Adverse Event (AE) related to Study Drug|2
1264554|NCT00479557|4141353|P3|Overall Study|Adverse Event (AE) related to Study Drug|3
1264555|NCT00479557|4141354|P2|Overall Study|Adverse Event (AE) related to Study Drug|0
1264556|NCT00479557|4141355|P1|Overall Study|Adverse Event (AE) related to Study Drug|1
1264557|NCT00479557|4141349|P7|Overall Study|Lost to Follow-up|0
1264558|NCT00479557|4141350|P6|Overall Study|Lost to Follow-up|0
1264559|NCT00479557|4141351|P5|Overall Study|Lost to Follow-up|0
1264560|NCT00479557|4141352|P4|Overall Study|Lost to Follow-up|2
1264561|NCT00479557|4141353|P3|Overall Study|Lost to Follow-up|0
1264562|NCT00479557|4141354|P2|Overall Study|Lost to Follow-up|2
1264563|NCT00479557|4141355|P1|Overall Study|Lost to Follow-up|0
1264564|NCT00479557|4141349|P7|Overall Study|Lack of Efficacy|0
1264565|NCT00479557|4141350|P6|Overall Study|Lack of Efficacy|0
1264566|NCT00479557|4141351|P5|Overall Study|Lack of Efficacy|0
1264567|NCT00479557|4141352|P4|Overall Study|Lack of Efficacy|0
1264568|NCT00479557|4141353|P3|Overall Study|Lack of Efficacy|0
1264569|NCT00479557|4141354|P2|Overall Study|Lack of Efficacy|0
1264570|NCT00479557|4141355|P1|Overall Study|Lack of Efficacy|1
1264571|NCT00479557|4141349|P7|Overall Study|Death|0
1264572|NCT00479557|4141350|P6|Overall Study|Death|1
1264573|NCT00479557|4141351|P5|Overall Study|Death|0
1264574|NCT00479557|4141352|P4|Overall Study|Death|0
1264575|NCT00479557|4141353|P3|Overall Study|Death|0
1264576|NCT00479557|4141354|P2|Overall Study|Death|0
1264577|NCT00479557|4141355|P1|Overall Study|Death|0
1264578|NCT00479466|4141398|P6|Overall Study|Withdrawal by Subject|1
1264579|NCT00479466|4141399|P5|Overall Study|Withdrawal by Subject|3
1264580|NCT00479466|4141400|P4|Overall Study|Withdrawal by Subject|2
1264581|NCT00479466|4141401|P3|Overall Study|Withdrawal by Subject|0
1264582|NCT00479466|4141402|P2|Overall Study|Withdrawal by Subject|5
1264583|NCT00479466|4141403|P1|Overall Study|Withdrawal by Subject|3
1264584|NCT00479466|4141398|P6|Overall Study|Protocol Violation|0
1264585|NCT00479466|4141399|P5|Overall Study|Protocol Violation|0
1264586|NCT00479466|4141400|P4|Overall Study|Protocol Violation|0
1264587|NCT00479466|4141401|P3|Overall Study|Protocol Violation|0
1264588|NCT00479466|4141402|P2|Overall Study|Protocol Violation|0
1264589|NCT00479466|4141403|P1|Overall Study|Protocol Violation|1
1264590|NCT00479466|4141398|P6|Overall Study|Pregnancy|0
1264591|NCT00479466|4141399|P5|Overall Study|Pregnancy|1
1264592|NCT00479466|4141400|P4|Overall Study|Pregnancy|0
1264593|NCT00479466|4141401|P3|Overall Study|Pregnancy|0
1264594|NCT00479466|4141402|P2|Overall Study|Pregnancy|0
1264595|NCT00479466|4141403|P1|Overall Study|Pregnancy|0
1264596|NCT00479466|4141398|P6|Overall Study|Physician Decision|0
1264597|NCT00479466|4141399|P5|Overall Study|Physician Decision|0
1264598|NCT00479466|4141400|P4|Overall Study|Physician Decision|0
1264599|NCT00479466|4141401|P3|Overall Study|Physician Decision|1
1264600|NCT00479466|4141402|P2|Overall Study|Physician Decision|1
1264601|NCT00479466|4141403|P1|Overall Study|Physician Decision|2
1264602|NCT00479466|4141398|P6|Overall Study|Lost to Follow-up|2
1264603|NCT00479466|4141399|P5|Overall Study|Lost to Follow-up|2
1264604|NCT00479466|4141400|P4|Overall Study|Lost to Follow-up|0
1264605|NCT00479466|4141401|P3|Overall Study|Lost to Follow-up|1
1264606|NCT00479466|4141402|P2|Overall Study|Lost to Follow-up|1
1264607|NCT00479466|4141403|P1|Overall Study|Lost to Follow-up|0
1264608|NCT00479466|4141398|P6|Overall Study|Lack of Efficacy|0
1264609|NCT00479466|4141399|P5|Overall Study|Lack of Efficacy|0
1264610|NCT00479466|4141400|P4|Overall Study|Lack of Efficacy|0
1264611|NCT00479466|4141401|P3|Overall Study|Lack of Efficacy|1
1264612|NCT00479466|4141402|P2|Overall Study|Lack of Efficacy|0
1264613|NCT00479466|4141403|P1|Overall Study|Lack of Efficacy|2
1264614|NCT00479466|4141398|P6|Overall Study|Hyperglycemia|1
1264615|NCT00479466|4141399|P5|Overall Study|Hyperglycemia|0
1264616|NCT00479466|4141400|P4|Overall Study|Hyperglycemia|0
1264617|NCT00479466|4141401|P3|Overall Study|Hyperglycemia|0
1264618|NCT00479466|4141402|P2|Overall Study|Hyperglycemia|0
1264619|NCT00479466|4141403|P1|Overall Study|Hyperglycemia|0
1264620|NCT00479466|4141398|P6|Overall Study|Adverse Event|0
1264621|NCT00479466|4141399|P5|Overall Study|Adverse Event|2
1264622|NCT00479466|4141400|P4|Overall Study|Adverse Event|1
1264623|NCT00479466|4141401|P3|Overall Study|Adverse Event|0
1264624|NCT00479466|4141402|P2|Overall Study|Adverse Event|1
1264625|NCT00479466|4141403|P1|Overall Study|Adverse Event|5
1264626|NCT00479401|4141432|P3|Overall Study|Exclusion criteria, relocation|0
1264627|NCT00479401|4141433|P2|Overall Study|Exclusion criteria, relocation|3
1264628|NCT00479401|4141434|P1|Overall Study|Exclusion criteria, relocation|4
1264629|NCT00479401|4141432|P3|Overall Study|Withdrawal by Subject|2
1264630|NCT00479401|4141433|P2|Overall Study|Withdrawal by Subject|10
1264631|NCT00479401|4141434|P1|Overall Study|Withdrawal by Subject|16
1264632|NCT00479401|4141432|P3|Overall Study|Lost to Follow-up|1
1264633|NCT00479401|4141433|P2|Overall Study|Lost to Follow-up|1
1264634|NCT00479401|4141434|P1|Overall Study|Lost to Follow-up|1
1264635|NCT00479401|4141432|P3|Overall Study|Protocol Violation|1
1264636|NCT00479401|4141433|P2|Overall Study|Protocol Violation|1
1264637|NCT00479401|4141434|P1|Overall Study|Protocol Violation|2
1264638|NCT00479401|4141432|P3|Overall Study|Lack of Efficacy|4
1264639|NCT00479401|4141433|P2|Overall Study|Lack of Efficacy|2
1264640|NCT00479401|4141434|P1|Overall Study|Lack of Efficacy|2
1264641|NCT00479401|4141432|P3|Overall Study|Adverse Event|4
1264642|NCT00479401|4141433|P2|Overall Study|Adverse Event|20
1264643|NCT00479401|4141434|P1|Overall Study|Adverse Event|24
1264644|NCT00479388|4141489|P2|Overall Study|Withdrawal by Subject|17
1264645|NCT00479388|4141490|P1|Overall Study|Withdrawal by Subject|32
1264646|NCT00479388|4141489|P2|Overall Study|Protocol Violation|9
1264647|NCT00479388|4141490|P1|Overall Study|Protocol Violation|10
1264648|NCT00479388|4141489|P2|Overall Study|Lost to Follow-up|2
1264649|NCT00479388|4141490|P1|Overall Study|Lost to Follow-up|0
1264650|NCT00479388|4141489|P2|Overall Study|Adverse Event|45
1264651|NCT00479388|4141490|P1|Overall Study|Adverse Event|90
1264652|NCT00479336|4141504|P4|Overall Study|Resolution of all hepatic edema findings|0
1264653|NCT00479336|4141505|P3|Overall Study|Resolution of all hepatic edema findings|0
1264742|NCT00478673|4141646|P1|12-Months Post-Procedure|Lost to Follow-up|4
1264654|NCT00479336|4141506|P2|Overall Study|Resolution of all hepatic edema findings|1
1264655|NCT00479336|4141507|P1|Overall Study|Resolution of all hepatic edema findings|1
1264656|NCT00479336|4141504|P4|Overall Study|Physician Decision|2
1264657|NCT00479336|4141505|P3|Overall Study|Physician Decision|0
1264658|NCT00479336|4141506|P2|Overall Study|Physician Decision|1
1264659|NCT00479336|4141507|P1|Overall Study|Physician Decision|0
1264660|NCT00479336|4141504|P4|Overall Study|Withdrawal by Subject|0
1264661|NCT00479336|4141505|P3|Overall Study|Withdrawal by Subject|0
1264662|NCT00479336|4141506|P2|Overall Study|Withdrawal by Subject|2
1264663|NCT00479336|4141507|P1|Overall Study|Withdrawal by Subject|1
1264664|NCT00479336|4141504|P4|Overall Study|Protocol Violation|0
1264665|NCT00479336|4141505|P3|Overall Study|Protocol Violation|0
1264666|NCT00479336|4141506|P2|Overall Study|Protocol Violation|1
1264667|NCT00479336|4141507|P1|Overall Study|Protocol Violation|0
1264668|NCT00479336|4141504|P4|Overall Study|Lack of Efficacy|0
1264669|NCT00479336|4141505|P3|Overall Study|Lack of Efficacy|0
1264670|NCT00479336|4141506|P2|Overall Study|Lack of Efficacy|0
1264671|NCT00479336|4141507|P1|Overall Study|Lack of Efficacy|1
1264672|NCT00479336|4141504|P4|Overall Study|Adverse Event|3
1264673|NCT00479336|4141505|P3|Overall Study|Adverse Event|1
1264674|NCT00479336|4141506|P2|Overall Study|Adverse Event|1
1264675|NCT00479336|4141507|P1|Overall Study|Adverse Event|1
1264676|NCT00479232|4141530|P6|Overall Study|Withdrew Consent|3
1264677|NCT00479232|4141531|P5|Overall Study|Withdrew Consent|1
1264678|NCT00479232|4141532|P4|Overall Study|Withdrew Consent|0
1264679|NCT00479232|4141533|P3|Overall Study|Withdrew Consent|6
1264680|NCT00479232|4141534|P2|Overall Study|Withdrew Consent|2
1264681|NCT00479232|4141535|P1|Overall Study|Withdrew Consent|0
1264682|NCT00479232|4141530|P6|Overall Study|Progressive Disease|12
1264683|NCT00479232|4141531|P5|Overall Study|Progressive Disease|3
1264684|NCT00479232|4141532|P4|Overall Study|Progressive Disease|3
1264685|NCT00479232|4141533|P3|Overall Study|Progressive Disease|12
1264686|NCT00479232|4141534|P2|Overall Study|Progressive Disease|1
1264687|NCT00479232|4141535|P1|Overall Study|Progressive Disease|3
1264688|NCT00479232|4141530|P6|Overall Study|Physician Decision|1
1264689|NCT00479232|4141531|P5|Overall Study|Physician Decision|0
1264690|NCT00479232|4141532|P4|Overall Study|Physician Decision|0
1264691|NCT00479232|4141533|P3|Overall Study|Physician Decision|2
1264692|NCT00479232|4141534|P2|Overall Study|Physician Decision|0
1264693|NCT00479232|4141535|P1|Overall Study|Physician Decision|0
1264694|NCT00479232|4141530|P6|Overall Study|Lack of Efficacy|4
1264695|NCT00479232|4141531|P5|Overall Study|Lack of Efficacy|0
1264696|NCT00479232|4141532|P4|Overall Study|Lack of Efficacy|0
1264697|NCT00479232|4141533|P3|Overall Study|Lack of Efficacy|2
1264698|NCT00479232|4141534|P2|Overall Study|Lack of Efficacy|0
1264699|NCT00479232|4141535|P1|Overall Study|Lack of Efficacy|0
1264700|NCT00479232|4141530|P6|Overall Study|Deviation from Protocol|0
1264701|NCT00479232|4141531|P5|Overall Study|Deviation from Protocol|0
1264702|NCT00479232|4141532|P4|Overall Study|Deviation from Protocol|0
1264703|NCT00479232|4141533|P3|Overall Study|Deviation from Protocol|1
1264704|NCT00479232|4141534|P2|Overall Study|Deviation from Protocol|0
1264705|NCT00479232|4141535|P1|Overall Study|Deviation from Protocol|0
1264706|NCT00479232|4141530|P6|Overall Study|Adverse Event|10
1264707|NCT00479232|4141531|P5|Overall Study|Adverse Event|0
1264708|NCT00479232|4141532|P4|Overall Study|Adverse Event|0
1264709|NCT00479232|4141533|P3|Overall Study|Adverse Event|5
1264710|NCT00479232|4141534|P2|Overall Study|Adverse Event|0
1264711|NCT00479232|4141535|P1|Overall Study|Adverse Event|0
1264712|NCT00478933|4141588|P1|Overall Study|Inadequate data available|53
1264713|NCT00478933|4141588|P1|Overall Study|Informed consent not verified|3
1264714|NCT00478933|4141588|P1|Overall Study|Protocol Violation|22
1264715|NCT00478881|4141614|P2|Overall Study|Non-Compliance with Study Medication|2
1264716|NCT00478881|4141615|P1|Overall Study|Non-Compliance with Study Medication|0
1264717|NCT00478881|4141614|P2|Overall Study|Withdrawal by Subject|2
1264718|NCT00478881|4141615|P1|Overall Study|Withdrawal by Subject|6
1264719|NCT00478881|4141614|P2|Overall Study|Protocol Violation|2
1264720|NCT00478881|4141615|P1|Overall Study|Protocol Violation|2
1264721|NCT00478881|4141614|P2|Overall Study|Lost to Follow-up|1
1264722|NCT00478881|4141615|P1|Overall Study|Lost to Follow-up|0
1264723|NCT00478881|4141614|P2|Overall Study|Lack of Efficacy|3
1264724|NCT00478881|4141615|P1|Overall Study|Lack of Efficacy|0
1264725|NCT00478881|4141614|P2|Overall Study|Adverse Event|12
1264726|NCT00478881|4141615|P1|Overall Study|Adverse Event|31
1264727|NCT00478777|4141639|P1|Overall Study|Not treated with lenalidomide|6
1264728|NCT00478777|4141639|P1|Overall Study|End of therapy|2
1264729|NCT00478777|4141639|P1|Overall Study|Lymphocytes infusion|1
1264730|NCT00478777|4141639|P1|Overall Study|Lack of compliance|1
1264731|NCT00478777|4141639|P1|Overall Study|Intolerance of therapy|1
1264732|NCT00478777|4141639|P1|Overall Study|Physician Decision|1
1264733|NCT00478777|4141639|P1|Overall Study|Lost to Follow-up|3
1264734|NCT00478777|4141639|P1|Overall Study|Protocol Violation|3
1264735|NCT00478777|4141639|P1|Overall Study|Death|3
1264736|NCT00478777|4141639|P1|Overall Study|Withdrawal by Subject|4
1264737|NCT00478777|4141639|P1|Overall Study|Lack of Efficacy|23
1264738|NCT00478777|4141639|P1|Overall Study|Adverse Event|29
1264739|NCT00478673|4141646|P1|12-Months Post-Procedure|Visit Not Required by Protocol|6
1264740|NCT00478673|4141646|P1|12-Months Post-Procedure|Missed Visit|25
1264741|NCT00478673|4141646|P1|12-Months Post-Procedure|Withdrawal by Subject|6
1264743|NCT00478673|4141646|P1|12-Months Post-Procedure|Death|23
1264744|NCT00478673|4141646|P1|30-Days Post-Procedure|Missed Visit|7
1264745|NCT00478673|4141646|P1|30-Days Post-Procedure|Withdrawal by Subject|1
1264746|NCT00478673|4141646|P1|30-Days Post-Procedure|Death|2
1264747|NCT00478647|4141651|P1|Overall Study|Withdrawal by Subject|1
1264748|NCT00478647|4141651|P1|Overall Study|Adverse Event|1
1264749|NCT00478608|4141659|P1|Overall Study|Protocol Violation|3
1264750|NCT00478608|4141659|P1|Overall Study|Withdrawal by Subject|2
1264751|NCT00478608|4141659|P1|Overall Study|Serious Adverse Event|14
1264752|NCT00478608|4141659|P1|Overall Study|Adverse Event|1
1264753|NCT00478257|4141703|P2|Overall Study|Withdrawal by Subject|3
1264754|NCT00478257|4141704|P1|Overall Study|Withdrawal by Subject|8
1264755|NCT00478244|4141710|P1|Overall Study|Did not receive transplant|1
1264756|NCT00478231|4141723|P1|Overall Study|Randomized, not treated|3
1264757|NCT00478231|4141723|P1|Overall Study|Adverse Event|5
1264758|NCT00478231|4141723|P1|Overall Study|Other|9
1264759|NCT00478231|4141723|P1|Overall Study|Withdrawal by Subject|6
1264760|NCT00478231|4141723|P1|Overall Study|Lost to Follow-up|7
1264761|NCT00478231|4141723|P1|Overall Study|Lack of Efficacy|47
1264762|NCT00478231|4141723|P1|Overall Study|Death|7
1264763|NCT00478205|4141759|P2|Overall Study|Not specified|12
1264764|NCT00478205|4141760|P1|Overall Study|Not specified|24
1264765|NCT00478205|4141759|P2|Overall Study|Lack of Efficacy|0
1264766|NCT00478205|4141760|P1|Overall Study|Lack of Efficacy|1
1264767|NCT00478205|4141759|P2|Overall Study|Withdrawal by Subject|22
1264768|NCT00478205|4141760|P1|Overall Study|Withdrawal by Subject|61
1264769|NCT00478205|4141759|P2|Overall Study|Request of Investigator or Sponsor|5
1264770|NCT00478205|4141760|P1|Overall Study|Request of Investigator or Sponsor|4
1264771|NCT00478205|4141759|P2|Overall Study|Protocol Violation|5
1264772|NCT00478205|4141760|P1|Overall Study|Protocol Violation|15
1264773|NCT00478205|4141759|P2|Overall Study|Medication Non-compliance|4
1264774|NCT00478205|4141760|P1|Overall Study|Medication Non-compliance|9
1264775|NCT00478205|4141759|P2|Overall Study|Adverse Event|39
1264776|NCT00478205|4141760|P1|Overall Study|Adverse Event|182
1264777|NCT00478140|4141804|P1|Overall Study|Disease Progression|3
1264778|NCT00478023|4141833|P5|Overall Study|Lack of pain, Technical difficulties|3
1264779|NCT00478023|4141834|P4|Overall Study|Lack of pain, Technical difficulties|6
1264780|NCT00478023|4141835|P3|Overall Study|Lack of pain, Technical difficulties|5
1264781|NCT00478023|4141836|P2|Overall Study|Lack of pain, Technical difficulties|3
1264782|NCT00478023|4141837|P1|Overall Study|Lack of pain, Technical difficulties|7
1264783|NCT00478023|4141833|P5|Overall Study|Withdrawal by Subject|5
1264784|NCT00478023|4141834|P4|Overall Study|Withdrawal by Subject|4
1264785|NCT00478023|4141835|P3|Overall Study|Withdrawal by Subject|2
1264786|NCT00478023|4141836|P2|Overall Study|Withdrawal by Subject|3
1264787|NCT00478023|4141837|P1|Overall Study|Withdrawal by Subject|2
1264788|NCT00478023|4141833|P5|Overall Study|Lost to Follow-up|0
1264789|NCT00478023|4141834|P4|Overall Study|Lost to Follow-up|1
1264790|NCT00478023|4141835|P3|Overall Study|Lost to Follow-up|1
1264791|NCT00478023|4141836|P2|Overall Study|Lost to Follow-up|1
1264792|NCT00478023|4141837|P1|Overall Study|Lost to Follow-up|3
1264793|NCT00478023|4141833|P5|Overall Study|Lack of Efficacy|41
1264794|NCT00478023|4141834|P4|Overall Study|Lack of Efficacy|5
1264795|NCT00478023|4141835|P3|Overall Study|Lack of Efficacy|4
1264796|NCT00478023|4141836|P2|Overall Study|Lack of Efficacy|10
1264797|NCT00478023|4141837|P1|Overall Study|Lack of Efficacy|11
1264798|NCT00478023|4141833|P5|Overall Study|Death|0
1264799|NCT00478023|4141834|P4|Overall Study|Death|0
1264800|NCT00478023|4141835|P3|Overall Study|Death|0
1264801|NCT00478023|4141836|P2|Overall Study|Death|0
1264802|NCT00478023|4141837|P1|Overall Study|Death|1
1264803|NCT00478023|4141833|P5|Overall Study|Adverse Event|6
1264804|NCT00478023|4141834|P4|Overall Study|Adverse Event|14
1264805|NCT00478023|4141835|P3|Overall Study|Adverse Event|8
1264806|NCT00478023|4141836|P2|Overall Study|Adverse Event|7
1264807|NCT00478023|4141837|P1|Overall Study|Adverse Event|11
1264808|NCT00477971|4141856|P2|Overall Study|Alternative treatment|1
1264809|NCT00477971|4141857|P1|Overall Study|Alternative treatment|3
1264810|NCT00477971|4141856|P2|Overall Study|Death|4
1264811|NCT00477971|4141857|P1|Overall Study|Death|2
1264812|NCT00477971|4141856|P2|Overall Study|Adverse Event|0
1264813|NCT00477971|4141857|P1|Overall Study|Adverse Event|3
1264814|NCT00477971|4141856|P2|Overall Study|Withdrawal by Subject|1
1264815|NCT00477971|4141857|P1|Overall Study|Withdrawal by Subject|3
1264816|NCT00477971|4141856|P2|Overall Study|Disease progression|0
1264817|NCT00477971|4141857|P1|Overall Study|Disease progression|6
1264818|NCT00477750|4141869|P1|Overall Study|Currently Receiving Treatment|11
1264819|NCT00477672|4141881|P3|Overall Study|Discretion of Sponsor|0
1264820|NCT00477672|4141882|P2|Overall Study|Discretion of Sponsor|2
1264821|NCT00477672|4141883|P1|Overall Study|Discretion of Sponsor|1
1264822|NCT00477672|4141881|P3|Overall Study|Consent withdrawn|10
1264823|NCT00477672|4141882|P2|Overall Study|Consent withdrawn|5
1264824|NCT00477672|4141883|P1|Overall Study|Consent withdrawn|2
1264825|NCT00477672|4141881|P3|Overall Study|Protocol noncompliance|0
1264826|NCT00477672|4141882|P2|Overall Study|Protocol noncompliance|2
1264827|NCT00477672|4141883|P1|Overall Study|Protocol noncompliance|0
1264828|NCT00477672|4141881|P3|Overall Study|Physician Decision|0
1264829|NCT00477672|4141882|P2|Overall Study|Physician Decision|0
1264830|NCT00477672|4141883|P1|Overall Study|Physician Decision|1
1264831|NCT00477672|4141881|P3|Overall Study|Disease progression|0
1264832|NCT00477672|4141882|P2|Overall Study|Disease progression|1
1264833|NCT00477672|4141883|P1|Overall Study|Disease progression|0
1264834|NCT00477672|4141881|P3|Overall Study|Death|0
1264835|NCT00477672|4141882|P2|Overall Study|Death|1
1264836|NCT00477672|4141883|P1|Overall Study|Death|0
1264837|NCT00477672|4141881|P3|Overall Study|Adverse Event|6
1264838|NCT00477672|4141882|P2|Overall Study|Adverse Event|5
1264839|NCT00477672|4141883|P1|Overall Study|Adverse Event|3
1264840|NCT00477633|4141894|P1|Overall Study|Various (Moving, Enrollment closed)|75
1264841|NCT00477633|4141894|P1|Overall Study|Protocol Violation|25
1264842|NCT00477633|4141894|P1|Overall Study|Withdrawal by Subject|149
1264843|NCT00477633|4141894|P1|Overall Study|Lost to Follow-up|271
1264844|NCT00477633|4141894|P1|Overall Study|Pregnancy|23
1264845|NCT00477633|4141894|P1|Overall Study|Adverse Event|143
1264846|NCT00477633|4141894|P1|Overall Study|Did not receive treatment|23
1264847|NCT00477607|4141902|P2|Overall Study|Lost to Follow-up|7
1264848|NCT00477607|4141903|P1|Overall Study|Lost to Follow-up|7
1264849|NCT00477594|4141915|P2|Follow-up Period|Other|0
1264850|NCT00477594|4141916|P1|Follow-up Period|Other|1
1264851|NCT00477594|4141915|P2|Follow-up Period|Withdrawal by Subject|1
1264852|NCT00477594|4141916|P1|Follow-up Period|Withdrawal by Subject|2
1264853|NCT00477594|4141915|P2|Year 3|Withdrawal by Subject|0
1264854|NCT00477594|4141916|P1|Year 3|Withdrawal by Subject|1
1264855|NCT00477594|4141915|P2|Year 3|Adverse Event|0
1264856|NCT00477594|4141916|P1|Year 3|Adverse Event|1
1264857|NCT00477594|4141915|P2|Year 1 and Year 2|Other|0
1264858|NCT00477594|4141916|P1|Year 1 and Year 2|Other|1
1264859|NCT00477594|4141915|P2|Year 1 and Year 2|Withdrawal by Subject|1
1264860|NCT00477594|4141916|P1|Year 1 and Year 2|Withdrawal by Subject|2
1264861|NCT00477594|4141915|P2|Year 1 and Year 2|Physician Decision|1
1264862|NCT00477594|4141916|P1|Year 1 and Year 2|Physician Decision|2
1264863|NCT00477594|4141915|P2|Year 1 and Year 2|Adverse Event|2
1264864|NCT00477594|4141916|P1|Year 1 and Year 2|Adverse Event|4
1264865|NCT00477490|4141977|P9|Part II: Extension Week 5 up to Day 169|Not reported|0
1264866|NCT00477490|4141978|P8|Part II: Extension Week 5 up to Day 169|Not reported|0
1264867|NCT00477490|4141979|P7|Part II: Extension Week 5 up to Day 169|Not reported|0
1264868|NCT00477490|4141980|P6|Part II: Extension Week 5 up to Day 169|Not reported|0
1264869|NCT00477490|4141981|P5|Part II: Extension Week 5 up to Day 169|Not reported|1
1264870|NCT00477490|4141982|P4|Part II: Extension Week 5 up to Day 169|Not reported|0
1264871|NCT00477490|4141983|P3|Part II: Extension Week 5 up to Day 169|Not reported|1
1264872|NCT00477490|4141984|P2|Part II: Extension Week 5 up to Day 169|Not reported|3
1264873|NCT00477490|4141985|P1|Part II: Extension Week 5 up to Day 169|Not reported|0
1264874|NCT00477490|4141977|P9|Part II: Extension Week 5 up to Day 169|Other, not specified|1
1264875|NCT00477490|4141978|P8|Part II: Extension Week 5 up to Day 169|Other, not specified|0
1264876|NCT00477490|4141979|P7|Part II: Extension Week 5 up to Day 169|Other, not specified|1
1264877|NCT00477490|4141980|P6|Part II: Extension Week 5 up to Day 169|Other, not specified|1
1264878|NCT00477490|4141981|P5|Part II: Extension Week 5 up to Day 169|Other, not specified|2
1264879|NCT00477490|4141982|P4|Part II: Extension Week 5 up to Day 169|Other, not specified|4
1264880|NCT00477490|4141983|P3|Part II: Extension Week 5 up to Day 169|Other, not specified|2
1264881|NCT00477490|4141984|P2|Part II: Extension Week 5 up to Day 169|Other, not specified|4
1264882|NCT00477490|4141985|P1|Part II: Extension Week 5 up to Day 169|Other, not specified|0
1264883|NCT00477490|4141977|P9|Part II: Extension Week 5 up to Day 169|Excluded medication|0
1264884|NCT00477490|4141978|P8|Part II: Extension Week 5 up to Day 169|Excluded medication|0
1264885|NCT00477490|4141979|P7|Part II: Extension Week 5 up to Day 169|Excluded medication|0
1264886|NCT00477490|4141980|P6|Part II: Extension Week 5 up to Day 169|Excluded medication|0
1264887|NCT00477490|4141981|P5|Part II: Extension Week 5 up to Day 169|Excluded medication|0
1264888|NCT00477490|4141982|P4|Part II: Extension Week 5 up to Day 169|Excluded medication|0
1264889|NCT00477490|4141983|P3|Part II: Extension Week 5 up to Day 169|Excluded medication|0
1264890|NCT00477490|4141984|P2|Part II: Extension Week 5 up to Day 169|Excluded medication|1
1264891|NCT00477490|4141985|P1|Part II: Extension Week 5 up to Day 169|Excluded medication|0
1264892|NCT00477490|4141977|P9|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
1264893|NCT00477490|4141978|P8|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
1264894|NCT00477490|4141979|P7|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
1264895|NCT00477490|4141980|P6|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
1264896|NCT00477490|4141981|P5|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
1264897|NCT00477490|4141982|P4|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
1264898|NCT00477490|4141983|P3|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
1264899|NCT00477490|4141984|P2|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
1264900|NCT00477490|4141985|P1|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
1264901|NCT00477490|4141977|P9|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
1264902|NCT00477490|4141978|P8|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
1264903|NCT00477490|4141979|P7|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1
1264904|NCT00477490|4141980|P6|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
1264905|NCT00477490|4141981|P5|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5
1264906|NCT00477490|4141982|P4|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
1264907|NCT00477490|4141983|P3|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2
1264908|NCT00477490|4141984|P2|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3
1264909|NCT00477490|4141985|P1|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
1264910|NCT00477490|4141977|P9|Part II: Extension Week 5 up to Day 169|Adverse Event|4
1264911|NCT00477490|4141978|P8|Part II: Extension Week 5 up to Day 169|Adverse Event|1
1264912|NCT00477490|4141979|P7|Part II: Extension Week 5 up to Day 169|Adverse Event|1
1264913|NCT00477490|4141980|P6|Part II: Extension Week 5 up to Day 169|Adverse Event|1
1264914|NCT00477490|4141981|P5|Part II: Extension Week 5 up to Day 169|Adverse Event|1
1264915|NCT00477490|4141982|P4|Part II: Extension Week 5 up to Day 169|Adverse Event|1
1264916|NCT00477490|4141983|P3|Part II: Extension Week 5 up to Day 169|Adverse Event|3
1264917|NCT00477490|4141984|P2|Part II: Extension Week 5 up to Day 169|Adverse Event|2
1264918|NCT00477490|4141985|P1|Part II: Extension Week 5 up to Day 169|Adverse Event|0
1264919|NCT00477490|4141977|P9|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
1264920|NCT00477490|4141978|P8|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3
1264921|NCT00477490|4141979|P7|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
1264922|NCT00477490|4141980|P6|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4
1264923|NCT00477490|4141981|P5|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10
1264924|NCT00477490|4141982|P4|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
1264925|NCT00477490|4141983|P3|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
1264926|NCT00477490|4141984|P2|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15
1264927|NCT00477490|4141985|P1|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0
1264928|NCT00477490|4141977|P9|Part I: 4 Week Efficacy|Not Reported|0
1264929|NCT00477490|4141978|P8|Part I: 4 Week Efficacy|Not Reported|0
1264930|NCT00477490|4141979|P7|Part I: 4 Week Efficacy|Not Reported|0
1264931|NCT00477490|4141980|P6|Part I: 4 Week Efficacy|Not Reported|0
1264932|NCT00477490|4141981|P5|Part I: 4 Week Efficacy|Not Reported|1
1264933|NCT00477490|4141982|P4|Part I: 4 Week Efficacy|Not Reported|0
1264934|NCT00477490|4141983|P3|Part I: 4 Week Efficacy|Not Reported|3
1264935|NCT00477490|4141984|P2|Part I: 4 Week Efficacy|Not Reported|2
1264936|NCT00477490|4141985|P1|Part I: 4 Week Efficacy|Not Reported|1
1264937|NCT00477490|4141977|P9|Part I: 4 Week Efficacy|Other, not specified|0
1264938|NCT00477490|4141978|P8|Part I: 4 Week Efficacy|Other, not specified|0
1264939|NCT00477490|4141979|P7|Part I: 4 Week Efficacy|Other, not specified|0
1264940|NCT00477490|4141980|P6|Part I: 4 Week Efficacy|Other, not specified|0
1264941|NCT00477490|4141981|P5|Part I: 4 Week Efficacy|Other, not specified|1
1264942|NCT00477490|4141982|P4|Part I: 4 Week Efficacy|Other, not specified|1
1264943|NCT00477490|4141983|P3|Part I: 4 Week Efficacy|Other, not specified|0
1264944|NCT00477490|4141984|P2|Part I: 4 Week Efficacy|Other, not specified|4
1264945|NCT00477490|4141985|P1|Part I: 4 Week Efficacy|Other, not specified|2
1264946|NCT00477490|4141977|P9|Part I: 4 Week Efficacy|Lost to Follow-up|0
1264947|NCT00477490|4141978|P8|Part I: 4 Week Efficacy|Lost to Follow-up|0
1264948|NCT00477490|4141979|P7|Part I: 4 Week Efficacy|Lost to Follow-up|0
1264949|NCT00477490|4141980|P6|Part I: 4 Week Efficacy|Lost to Follow-up|0
1264950|NCT00477490|4141981|P5|Part I: 4 Week Efficacy|Lost to Follow-up|3
1264951|NCT00477490|4141982|P4|Part I: 4 Week Efficacy|Lost to Follow-up|5
1264952|NCT00477490|4141983|P3|Part I: 4 Week Efficacy|Lost to Follow-up|1
1264953|NCT00477490|4141984|P2|Part I: 4 Week Efficacy|Lost to Follow-up|4
1264954|NCT00477490|4141985|P1|Part I: 4 Week Efficacy|Lost to Follow-up|2
1264955|NCT00477490|4141977|P9|Part I: 4 Week Efficacy|Withdrawal by Subject|0
1264956|NCT00477490|4141978|P8|Part I: 4 Week Efficacy|Withdrawal by Subject|0
1264957|NCT00477490|4141979|P7|Part I: 4 Week Efficacy|Withdrawal by Subject|0
1264958|NCT00477490|4141980|P6|Part I: 4 Week Efficacy|Withdrawal by Subject|0
1264959|NCT00477490|4141981|P5|Part I: 4 Week Efficacy|Withdrawal by Subject|9
1264960|NCT00477490|4141982|P4|Part I: 4 Week Efficacy|Withdrawal by Subject|4
1264961|NCT00477490|4141983|P3|Part I: 4 Week Efficacy|Withdrawal by Subject|6
1264962|NCT00477490|4141984|P2|Part I: 4 Week Efficacy|Withdrawal by Subject|5
1264963|NCT00477490|4141985|P1|Part I: 4 Week Efficacy|Withdrawal by Subject|6
1264964|NCT00477490|4141977|P9|Part I: 4 Week Efficacy|Protocol Violation|0
1264965|NCT00477490|4141978|P8|Part I: 4 Week Efficacy|Protocol Violation|0
1264966|NCT00477490|4141979|P7|Part I: 4 Week Efficacy|Protocol Violation|0
1264967|NCT00477490|4141980|P6|Part I: 4 Week Efficacy|Protocol Violation|0
1264968|NCT00477490|4141981|P5|Part I: 4 Week Efficacy|Protocol Violation|1
1264969|NCT00477490|4141982|P4|Part I: 4 Week Efficacy|Protocol Violation|0
1264970|NCT00477490|4141983|P3|Part I: 4 Week Efficacy|Protocol Violation|0
1264971|NCT00477490|4141984|P2|Part I: 4 Week Efficacy|Protocol Violation|0
1264972|NCT00477490|4141985|P1|Part I: 4 Week Efficacy|Protocol Violation|2
1264973|NCT00477490|4141977|P9|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
1264974|NCT00477490|4141978|P8|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
1264975|NCT00477490|4141979|P7|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
1264976|NCT00477490|4141980|P6|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
1264977|NCT00477490|4141981|P5|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4
1264978|NCT00477490|4141982|P4|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5
1264979|NCT00477490|4141983|P3|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
1264980|NCT00477490|4141984|P2|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
1264981|NCT00477490|4141985|P1|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1
1264982|NCT00477490|4141977|P9|Part I: 4 Week Efficacy|Adverse Event|0
1264983|NCT00477490|4141978|P8|Part I: 4 Week Efficacy|Adverse Event|0
1264984|NCT00477490|4141979|P7|Part I: 4 Week Efficacy|Adverse Event|0
1264985|NCT00477490|4141980|P6|Part I: 4 Week Efficacy|Adverse Event|0
1264986|NCT00477490|4141981|P5|Part I: 4 Week Efficacy|Adverse Event|6
1264987|NCT00477490|4141982|P4|Part I: 4 Week Efficacy|Adverse Event|5
1264988|NCT00477490|4141983|P3|Part I: 4 Week Efficacy|Adverse Event|0
1264989|NCT00477490|4141984|P2|Part I: 4 Week Efficacy|Adverse Event|4
1264990|NCT00477490|4141985|P1|Part I: 4 Week Efficacy|Adverse Event|1
1264991|NCT00477464|4142069|P1|Overall Study|Completion of protocol-defined follow-up|14
1264992|NCT00477464|4142069|P1|Overall Study|Death|36
1264993|NCT00477464|4142069|P1|Overall Study|Lost to Follow-up|1
1264994|NCT00477386|4142113|P2|Overall Study|Withdrawal by Subject|0
1264995|NCT00477386|4142114|P1|Overall Study|Withdrawal by Subject|1
1264996|NCT00477386|4142113|P2|Overall Study|Physician Decision|0
1264997|NCT00477386|4142114|P1|Overall Study|Physician Decision|1
1264998|NCT00477386|4142113|P2|Overall Study|Other|2
1264999|NCT00477386|4142114|P1|Overall Study|Other|1
1265000|NCT00477386|4142113|P2|Overall Study|Disease progression, refractory|3
1265001|NCT00477386|4142114|P1|Overall Study|Disease progression, refractory|1
1265002|NCT00477386|4142113|P2|Overall Study|Disease progression, relapse|4
1265003|NCT00477386|4142114|P1|Overall Study|Disease progression, relapse|3
1265004|NCT00477386|4142113|P2|Overall Study|Adverse Event|8
1265005|NCT00477386|4142114|P1|Overall Study|Adverse Event|4
1265006|NCT00477334|4142124|P2|Overall Study|Protocol Violation|1
1265007|NCT00477334|4142125|P1|Overall Study|Protocol Violation|7
1265008|NCT00477334|4142124|P2|Overall Study|Administrative Problems|15
1265009|NCT00477334|4142125|P1|Overall Study|Administrative Problems|39
1265010|NCT00477334|4142124|P2|Overall Study|Lost to Follow-up|4
1265011|NCT00477334|4142125|P1|Overall Study|Lost to Follow-up|15
1265012|NCT00477334|4142124|P2|Overall Study|Withdrawal by Subject|1
1265013|NCT00477334|4142125|P1|Overall Study|Withdrawal by Subject|2
1265014|NCT00477334|4142124|P2|Overall Study|Adverse Event|2
1265015|NCT00477334|4142125|P1|Overall Study|Adverse Event|1
1265016|NCT00477334|4142124|P2|Overall Study|Discontinued prior to taking study drug|53
1265017|NCT00477334|4142125|P1|Overall Study|Discontinued prior to taking study drug|106
1265018|NCT00477295|4142151|P2|Overall Study|Not specified|3
1265019|NCT00477295|4142152|P1|Overall Study|Not specified|4
1265020|NCT00477295|4142151|P2|Overall Study|Lost to Follow-up|11
1265021|NCT00477295|4142152|P1|Overall Study|Lost to Follow-up|21
1265022|NCT00477295|4142151|P2|Overall Study|Physician Decision|5
1265023|NCT00477295|4142152|P1|Overall Study|Physician Decision|4
1265024|NCT00477295|4142151|P2|Overall Study|Protocol Violation|8
1265025|NCT00477295|4142152|P1|Overall Study|Protocol Violation|3
1265026|NCT00477295|4142151|P2|Overall Study|Lack of Efficacy|23
1265027|NCT00477295|4142152|P1|Overall Study|Lack of Efficacy|23
1265028|NCT00477295|4142151|P2|Overall Study|Withdrawal by Subject|24
1265029|NCT00477295|4142152|P1|Overall Study|Withdrawal by Subject|35
1265030|NCT00477295|4142151|P2|Overall Study|Adverse Event|35
1265031|NCT00477295|4142152|P1|Overall Study|Adverse Event|31
1265032|NCT00477269|4142180|P3|Open Label Extension|Death|4
1265033|NCT00477269|4142181|P2|Open Label Extension|Death|0
1265034|NCT00477269|4142182|P1|Open Label Extension|Death|0
1265035|NCT00477269|4142180|P3|Open Label Extension|Adminiatrative problems|2
1265036|NCT00477269|4142181|P2|Open Label Extension|Adminiatrative problems|0
1265037|NCT00477269|4142182|P1|Open Label Extension|Adminiatrative problems|0
1265038|NCT00477269|4142180|P3|Open Label Extension|unsatisfactory therapeutic effects|2
1265039|NCT00477269|4142181|P2|Open Label Extension|unsatisfactory therapeutic effects|0
1265040|NCT00477269|4142182|P1|Open Label Extension|unsatisfactory therapeutic effects|0
1265041|NCT00477269|4142180|P3|Open Label Extension|Abnormal laboratory values|1
1265042|NCT00477269|4142181|P2|Open Label Extension|Abnormal laboratory values|0
1265043|NCT00477269|4142182|P1|Open Label Extension|Abnormal laboratory values|0
1265044|NCT00477269|4142180|P3|Open Label Extension|Adverse Event|4
1265045|NCT00477269|4142181|P2|Open Label Extension|Adverse Event|0
1265046|NCT00477269|4142182|P1|Open Label Extension|Adverse Event|0
1265047|NCT00477269|4142180|P3|Core Study|Withdrawn Consent|0
1265048|NCT00477269|4142181|P2|Core Study|Withdrawn Consent|1
1265049|NCT00477269|4142182|P1|Core Study|Withdrawn Consent|0
1265050|NCT00477269|4142180|P3|Core Study|Death|0
1265051|NCT00477269|4142181|P2|Core Study|Death|3
1265052|NCT00477269|4142182|P1|Core Study|Death|3
1265053|NCT00477269|4142180|P3|Core Study|Adverse Event|0
1265054|NCT00477269|4142181|P2|Core Study|Adverse Event|4
1265055|NCT00477269|4142182|P1|Core Study|Adverse Event|6
1265056|NCT00477165|4142261|P2|Overall Study|Adverse Event|2
1265057|NCT00477165|4142262|P1|Overall Study|Adverse Event|7
1265058|NCT00477152|4142274|P1|Overall Study|Adverse Event|1
1265059|NCT00477152|4142274|P1|Overall Study|Parent withdrew consent|2
1265060|NCT00476957|4142289|P2|Overall Study|Lost to Follow-up|193
1265061|NCT00476957|4142290|P1|Overall Study|Lost to Follow-up|176
1265062|NCT00476593|4142354|P4|Overall Study|Lost to Follow-up|22
1265063|NCT00476593|4142355|P3|Overall Study|Lost to Follow-up|8
1265064|NCT00476593|4142356|P2|Overall Study|Lost to Follow-up|2
1265065|NCT00476593|4142357|P1|Overall Study|Lost to Follow-up|10
1265066|NCT00476476|4142369|P2|Overall Study|Progressive Disease|17
1265067|NCT00476476|4142370|P1|Overall Study|Progressive Disease|0
1265068|NCT00476476|4142369|P2|Overall Study|Adverse Event|7
1265069|NCT00476476|4142370|P1|Overall Study|Adverse Event|2
1265070|NCT00476229|4142388|P1|Overall Study|Progressive shortness of breath|1
1265071|NCT00476151|4142394|P2|Overall Study|Physician Decision|2
1265072|NCT00476151|4142395|P1|Overall Study|Physician Decision|0
1265073|NCT00476151|4142394|P2|Overall Study|Withdrawal by Subject|0
1265074|NCT00476151|4142395|P1|Overall Study|Withdrawal by Subject|2
1265075|NCT00476151|4142394|P2|Overall Study|Protocol Violation|3
1265076|NCT00476151|4142395|P1|Overall Study|Protocol Violation|1
1265077|NCT00476151|4142394|P2|Overall Study|Adverse Event|2
1265078|NCT00476151|4142395|P1|Overall Study|Adverse Event|0
1265079|NCT00476086|4142401|P1|Overall Study|Progressive Disease|4
1265080|NCT00476086|4142401|P1|Overall Study|Alternative therapy|1
1265081|NCT00476047|4142407|P1|Overall Study|Lost to Follow-up|1
1265082|NCT00476008|4142433|P2|Overall Study|Death|0
1265083|NCT00476008|4142434|P1|Overall Study|Death|1
1265084|NCT00476008|4142433|P2|Overall Study|Withdrawal by Subject|1
1265085|NCT00476008|4142434|P1|Overall Study|Withdrawal by Subject|0
1265086|NCT00476008|4142433|P2|Overall Study|Physician Decision: Medication Noncompli|1
1265087|NCT00476008|4142434|P1|Overall Study|Physician Decision: Medication Noncompli|2
1265088|NCT00476008|4142433|P2|Overall Study|Placebo concerns|2
1265089|NCT00476008|4142434|P1|Overall Study|Placebo concerns|2
1265090|NCT00476008|4142433|P2|Overall Study|Adverse Event|4
1265091|NCT00476008|4142434|P1|Overall Study|Adverse Event|4
1265092|NCT00475865|4142488|P3|Overall Study|Other than above|0
1265093|NCT00475865|4142489|P2|Overall Study|Other than above|1
1265094|NCT00475865|4142490|P1|Overall Study|Other than above|0
1265095|NCT00475865|4142488|P3|Overall Study|Participant did not wish to continue|0
1265096|NCT00475865|4142489|P2|Overall Study|Participant did not wish to continue|0
1265097|NCT00475865|4142490|P1|Overall Study|Participant did not wish to continue|1
1265098|NCT00475865|4142488|P3|Overall Study|Progressive disease|2
1265099|NCT00475865|4142489|P2|Overall Study|Progressive disease|1
1265100|NCT00475865|4142490|P1|Overall Study|Progressive disease|0
1265101|NCT00475865|4142488|P3|Overall Study|Lack of Efficacy|0
1265102|NCT00475865|4142489|P2|Overall Study|Lack of Efficacy|0
1265103|NCT00475865|4142490|P1|Overall Study|Lack of Efficacy|1
1265104|NCT00475865|4142488|P3|Overall Study|Adverse Event|4
1265105|NCT00475865|4142489|P2|Overall Study|Adverse Event|3
1265106|NCT00475865|4142490|P1|Overall Study|Adverse Event|0
1265107|NCT00475852|4142520|P2|Overall Study|Lost to Follow-up|68
1265108|NCT00475852|4142521|P1|Overall Study|Lost to Follow-up|54
1265109|NCT00475852|4142520|P2|Overall Study|Withdrawal by Subject|24
1265110|NCT00475852|4142521|P1|Overall Study|Withdrawal by Subject|19
1265111|NCT00475852|4142520|P2|Overall Study|Death|456
1265112|NCT00475852|4142521|P1|Overall Study|Death|444
1265113|NCT00475735|4142572|P6|Treatment Period 2|Withdrawal by Subject|0
1265114|NCT00475735|4142573|P5|Treatment Period 2|Withdrawal by Subject|1
1265115|NCT00475735|4142574|P4|Treatment Period 2|Withdrawal by Subject|0
1265116|NCT00475735|4142575|P3|Treatment Period 2|Withdrawal by Subject|0
1265117|NCT00475735|4142576|P2|Treatment Period 2|Withdrawal by Subject|0
1265118|NCT00475735|4142577|P1|Treatment Period 2|Withdrawal by Subject|0
1265119|NCT00475735|4142572|P6|Treatment Period 2|Lack of Efficacy|1
1265120|NCT00475735|4142573|P5|Treatment Period 2|Lack of Efficacy|0
1265121|NCT00475735|4142574|P4|Treatment Period 2|Lack of Efficacy|0
1265122|NCT00475735|4142575|P3|Treatment Period 2|Lack of Efficacy|0
1265123|NCT00475735|4142576|P2|Treatment Period 2|Lack of Efficacy|0
1265124|NCT00475735|4142577|P1|Treatment Period 2|Lack of Efficacy|0
1265125|NCT00475735|4142572|P6|Treatment Period 2|Adverse Event|0
1265126|NCT00475735|4142573|P5|Treatment Period 2|Adverse Event|0
1265127|NCT00475735|4142574|P4|Treatment Period 2|Adverse Event|2
1265128|NCT00475735|4142575|P3|Treatment Period 2|Adverse Event|0
1265129|NCT00475735|4142576|P2|Treatment Period 2|Adverse Event|1
1265130|NCT00475735|4142577|P1|Treatment Period 2|Adverse Event|0
1265131|NCT00475735|4142572|P6|Treatment Washout|Protocol Violation|0
1265132|NCT00475735|4142573|P5|Treatment Washout|Protocol Violation|0
1265133|NCT00475735|4142574|P4|Treatment Washout|Protocol Violation|0
1265134|NCT00475735|4142575|P3|Treatment Washout|Protocol Violation|0
1265135|NCT00475735|4142576|P2|Treatment Washout|Protocol Violation|1
1265136|NCT00475735|4142577|P1|Treatment Washout|Protocol Violation|0
1265137|NCT00475735|4142572|P6|Treatment Washout|Lost to Follow-up|0
1265138|NCT00475735|4142573|P5|Treatment Washout|Lost to Follow-up|0
1265139|NCT00475735|4142574|P4|Treatment Washout|Lost to Follow-up|0
1265140|NCT00475735|4142575|P3|Treatment Washout|Lost to Follow-up|0
1265141|NCT00475735|4142576|P2|Treatment Washout|Lost to Follow-up|1
1265142|NCT00475735|4142577|P1|Treatment Washout|Lost to Follow-up|0
1265143|NCT00475735|4142572|P6|Treatment Period 1|DC due to no efficacy but Continuing|0
1265144|NCT00475735|4142573|P5|Treatment Period 1|DC due to no efficacy but Continuing|0
1265145|NCT00475735|4142574|P4|Treatment Period 1|DC due to no efficacy but Continuing|0
1265146|NCT00475735|4142575|P3|Treatment Period 1|DC due to no efficacy but Continuing|0
1265147|NCT00475735|4142576|P2|Treatment Period 1|DC due to no efficacy but Continuing|1
1265148|NCT00475735|4142577|P1|Treatment Period 1|DC due to no efficacy but Continuing|0
1265149|NCT00475735|4142572|P6|Treatment Period 1|DC due to AE but continuing|2
1265150|NCT00475735|4142573|P5|Treatment Period 1|DC due to AE but continuing|2
1265151|NCT00475735|4142574|P4|Treatment Period 1|DC due to AE but continuing|1
1265152|NCT00475735|4142575|P3|Treatment Period 1|DC due to AE but continuing|0
1265153|NCT00475735|4142576|P2|Treatment Period 1|DC due to AE but continuing|0
1265154|NCT00475735|4142577|P1|Treatment Period 1|DC due to AE but continuing|0
1265155|NCT00475735|4142572|P6|Treatment Period 1|Withdrawal by Subject|0
1265156|NCT00475735|4142573|P5|Treatment Period 1|Withdrawal by Subject|0
1265157|NCT00475735|4142574|P4|Treatment Period 1|Withdrawal by Subject|0
1265158|NCT00475735|4142575|P3|Treatment Period 1|Withdrawal by Subject|0
1265159|NCT00475735|4142576|P2|Treatment Period 1|Withdrawal by Subject|1
1265160|NCT00475735|4142577|P1|Treatment Period 1|Withdrawal by Subject|1
1265161|NCT00475735|4142572|P6|Treatment Period 1|Protocol Violation|0
1265162|NCT00475735|4142573|P5|Treatment Period 1|Protocol Violation|0
1265163|NCT00475735|4142574|P4|Treatment Period 1|Protocol Violation|1
1265164|NCT00475735|4142575|P3|Treatment Period 1|Protocol Violation|0
1265165|NCT00475735|4142576|P2|Treatment Period 1|Protocol Violation|0
1265166|NCT00475735|4142577|P1|Treatment Period 1|Protocol Violation|0
1265167|NCT00475735|4142572|P6|Treatment Period 1|Lost to Follow-up|1
1265168|NCT00475735|4142573|P5|Treatment Period 1|Lost to Follow-up|0
1265169|NCT00475735|4142574|P4|Treatment Period 1|Lost to Follow-up|0
1265170|NCT00475735|4142575|P3|Treatment Period 1|Lost to Follow-up|0
1265171|NCT00475735|4142576|P2|Treatment Period 1|Lost to Follow-up|0
1265172|NCT00475735|4142577|P1|Treatment Period 1|Lost to Follow-up|0
1265173|NCT00475735|4142572|P6|Treatment Period 1|Lack of Efficacy|0
1265174|NCT00475735|4142573|P5|Treatment Period 1|Lack of Efficacy|0
1265175|NCT00475735|4142574|P4|Treatment Period 1|Lack of Efficacy|0
1265176|NCT00475735|4142575|P3|Treatment Period 1|Lack of Efficacy|0
1265177|NCT00475735|4142576|P2|Treatment Period 1|Lack of Efficacy|0
1265178|NCT00475735|4142577|P1|Treatment Period 1|Lack of Efficacy|1
1265179|NCT00475735|4142572|P6|Treatment Period 1|Adverse Event|0
1265180|NCT00475735|4142573|P5|Treatment Period 1|Adverse Event|0
1265181|NCT00475735|4142574|P4|Treatment Period 1|Adverse Event|0
1265182|NCT00475735|4142575|P3|Treatment Period 1|Adverse Event|0
1265183|NCT00475735|4142576|P2|Treatment Period 1|Adverse Event|0
1265184|NCT00475735|4142577|P1|Treatment Period 1|Adverse Event|2
1265185|NCT00475722|4142590|P2|Overall Study|Protocol Violation|0
1265186|NCT00475722|4142591|P1|Overall Study|Protocol Violation|3
1265187|NCT00475722|4142590|P2|Overall Study|Withdrawal by Subject|12
1265188|NCT00475722|4142591|P1|Overall Study|Withdrawal by Subject|12
1265189|NCT00475709|4142597|P1|Overall Study|Lost to Follow-up|21
1265190|NCT00475709|4142597|P1|Overall Study|Device Explant|6
1265191|NCT00475709|4142597|P1|Overall Study|Death|41
1265192|NCT00475709|4142597|P1|Overall Study|Did not meet eligibility criteria|8
1265193|NCT00475670|4142605|P2|Overall Study|Not Specified|3
1265194|NCT00475670|4142606|P1|Overall Study|Not Specified|0
1265195|NCT00475670|4142605|P2|Overall Study|Failure to Return|1
1265196|NCT00475670|4142606|P1|Overall Study|Failure to Return|0
1265197|NCT00475670|4142605|P2|Overall Study|Refused treatment|2
1265198|NCT00475670|4142606|P1|Overall Study|Refused treatment|0
1265199|NCT00475670|4142605|P2|Overall Study|Lack of Efficacy|34
1265200|NCT00475670|4142606|P1|Overall Study|Lack of Efficacy|3
1265201|NCT00475670|4142605|P2|Overall Study|Death|1
1265202|NCT00475670|4142606|P1|Overall Study|Death|0
1265203|NCT00475657|4142630|P1|Overall Study|Sponsor's Decision|3
1265204|NCT00475657|4142630|P1|Overall Study|Death|1
1265205|NCT00475644|4142638|P1|Overall Study|Protocol Violation|13
1265206|NCT00475423|4142703|P1|Overall Study|Lost to Follow-up|7
1265207|NCT00475423|4142703|P1|Overall Study|Reason not specified|1
1265208|NCT00475423|4142703|P1|Overall Study|Death|1
1265209|NCT00475423|4142703|P1|Overall Study|Lack of Efficacy|8
1265210|NCT00475423|4142703|P1|Overall Study|Withdrawal by Subject|6
1265211|NCT00475423|4142703|P1|Overall Study|Adverse Event|4
1265212|NCT00475423|4142703|P1|Overall Study|Protocol Violation|5
1265213|NCT00475306|4142749|P4|Overall Study|Protocol Violation|1
1265214|NCT00475306|4142750|P3|Overall Study|Protocol Violation|0
1265215|NCT00475306|4142751|P2|Overall Study|Protocol Violation|1
1265216|NCT00475306|4142752|P1|Overall Study|Protocol Violation|1
1265217|NCT00475228|4142777|P2|Overall Study|Lost to Follow-up|17
1265218|NCT00475228|4142778|P1|Overall Study|Lost to Follow-up|17
1265219|NCT00475176|4142788|P1|Overall Study|Protocol Violation|1
1265220|NCT00475176|4142788|P1|Overall Study|Withdrawal by Subject|1
1265221|NCT00475176|4142788|P1|Overall Study|Adverse Event|2
1265222|NCT00475033|4142828|P2|Toddler Dose|Lost to Follow-up|0
1265223|NCT00475033|4142829|P1|Toddler Dose|Lost to Follow-up|1
1265224|NCT00475033|4142828|P2|Toddler Dose|Failed to return|0
1265225|NCT00475033|4142829|P1|Toddler Dose|Failed to return|1
1265226|NCT00475033|4142828|P2|Toddler Dose|Parent or legal guardian request|0
1265227|NCT00475033|4142829|P1|Toddler Dose|Parent or legal guardian request|2
1265228|NCT00475033|4142828|P2|After the Infant Series|Other|1
1265229|NCT00475033|4142829|P1|After the Infant Series|Other|0
1265230|NCT00475033|4142828|P2|After the Infant Series|Lost to Follow-up|0
1265231|NCT00475033|4142829|P1|After the Infant Series|Lost to Follow-up|1
1265232|NCT00475033|4142828|P2|After the Infant Series|Protocol Violation|0
1265233|NCT00475033|4142829|P1|After the Infant Series|Protocol Violation|1
1265234|NCT00475033|4142828|P2|After the Infant Series|Failed to return|1
1265235|NCT00475033|4142829|P1|After the Infant Series|Failed to return|2
1265236|NCT00475033|4142828|P2|After the Infant Series|Parent or legal guardian request|2
1265237|NCT00475033|4142829|P1|After the Infant Series|Parent or legal guardian request|2
1265238|NCT00475033|4142828|P2|After the Infant Series|Adverse Event|4
1265239|NCT00475033|4142829|P1|After the Infant Series|Adverse Event|0
1265240|NCT00475033|4142828|P2|Infant Series|Adverse Event|2
1265241|NCT00475033|4142829|P1|Infant Series|Adverse Event|0
1265242|NCT00475033|4142828|P2|Infant Series|Lost to Follow-up|0
1265243|NCT00475033|4142829|P1|Infant Series|Lost to Follow-up|2
1265244|NCT00475033|4142828|P2|Infant Series|Protocol Violation|2
1265245|NCT00475033|4142829|P1|Infant Series|Protocol Violation|1
1265246|NCT00475033|4142828|P2|Infant Series|Parent or legal guardian request|5
1265247|NCT00475033|4142829|P1|Infant Series|Parent or legal guardian request|1
1265248|NCT00475033|4142828|P2|Infant Series|Failed to return|4
1265249|NCT00475033|4142829|P1|Infant Series|Failed to return|3
1265250|NCT00475020|4142877|P1|Overall Study|Donor not able to donate the last minute|1
1265251|NCT00475020|4142877|P1|Overall Study|Insurance Denial|1
1265252|NCT00475020|4142877|P1|Overall Study|Physician Decision|3
1265253|NCT00474994|4142882|P1|Overall Study|Patient found to be ineligible|1
1265254|NCT00474994|4142882|P1|Overall Study|Patient evaluable for toxicity only|3
1265255|NCT00474994|4142882|P1|Overall Study|Patient Not treated|1
1265256|NCT00474968|4142888|P2|Overall Study|Sample not collected|1
1265257|NCT00474968|4142889|P1|Overall Study|Sample not collected|1
1265258|NCT00474968|4142888|P2|Overall Study|Protocol Violation|8
1265259|NCT00474968|4142889|P1|Overall Study|Protocol Violation|9
1265260|NCT00474968|4142888|P2|Overall Study|Withdrawal by Subject|7
1265261|NCT00474968|4142889|P1|Overall Study|Withdrawal by Subject|8
1265262|NCT00474955|4142899|P1|Overall Study|Personal reasons|5
1265263|NCT00474955|4142899|P1|Overall Study|Drug unavailability|1
1265264|NCT00474955|4142899|P1|Overall Study|Adverse Event|2
1265265|NCT00474929|4142915|P5|Overall Study|Physician Decision|0
1265266|NCT00474929|4142916|P4|Overall Study|Physician Decision|2
1265267|NCT00474929|4142917|P3|Overall Study|Physician Decision|1
1265268|NCT00474929|4142918|P2|Overall Study|Physician Decision|0
1265269|NCT00474929|4142919|P1|Overall Study|Physician Decision|0
1265270|NCT00474929|4142915|P5|Overall Study|Unrelated medical condition|0
1265271|NCT00474929|4142916|P4|Overall Study|Unrelated medical condition|0
1265272|NCT00474929|4142917|P3|Overall Study|Unrelated medical condition|1
1265273|NCT00474929|4142918|P2|Overall Study|Unrelated medical condition|0
1265274|NCT00474929|4142919|P1|Overall Study|Unrelated medical condition|0
1265275|NCT00474929|4142915|P5|Overall Study|Withdrawal by Subject|0
1265276|NCT00474929|4142916|P4|Overall Study|Withdrawal by Subject|0
1265277|NCT00474929|4142917|P3|Overall Study|Withdrawal by Subject|0
1265278|NCT00474929|4142918|P2|Overall Study|Withdrawal by Subject|1
1265279|NCT00474929|4142919|P1|Overall Study|Withdrawal by Subject|0
1265280|NCT00474903|4142936|P3|Overall Study|Protocol Violation|2
1265281|NCT00474903|4142937|P2|Overall Study|Protocol Violation|5
1265282|NCT00474903|4142938|P1|Overall Study|Protocol Violation|1
1265283|NCT00474812|4142960|P1|Overall Study|No Initiation of treatment|2
1265284|NCT00474812|4142960|P1|Overall Study|Withdrawal by Subject|5
1265285|NCT00474786|4142970|P2|Overall Study|Not specified|0
1265286|NCT00474786|4142971|P1|Overall Study|Not specified|5
1265287|NCT00474786|4142970|P2|Overall Study|Withdrawal by Subject|15
1265288|NCT00474786|4142971|P1|Overall Study|Withdrawal by Subject|15
1265289|NCT00474786|4142970|P2|Overall Study|Protocol Violation|0
1265290|NCT00474786|4142971|P1|Overall Study|Protocol Violation|2
1265291|NCT00474786|4142970|P2|Overall Study|Lost to Follow-up|7
1265292|NCT00474786|4142971|P1|Overall Study|Lost to Follow-up|4
1265293|NCT00474786|4142970|P2|Overall Study|Discontinuation of Study by Sponsor|59
1265294|NCT00474786|4142971|P1|Overall Study|Discontinuation of Study by Sponsor|42
1265295|NCT00474786|4142970|P2|Overall Study|Death|170
1265296|NCT00474786|4142971|P1|Overall Study|Death|189
1265297|NCT00474786|4142970|P2|Overall Study|Investigator Request|1
1265298|NCT00474786|4142971|P1|Overall Study|Investigator Request|2
1265299|NCT00474786|4142970|P2|Overall Study|Not Meeting Study Criteria|1
1265300|NCT00474786|4142971|P1|Overall Study|Not Meeting Study Criteria|0
1265301|NCT00474760|4142996|P7|Overall Study|Terminated by sponsor|2
1265302|NCT00474760|4142997|P6|Overall Study|Terminated by sponsor|0
1265303|NCT00474760|4142998|P5|Overall Study|Terminated by sponsor|0
1265304|NCT00474760|4142999|P4|Overall Study|Terminated by sponsor|0
1265305|NCT00474760|4143000|P3|Overall Study|Terminated by sponsor|0
1265306|NCT00474760|4143001|P2|Overall Study|Terminated by sponsor|0
1265307|NCT00474760|4143002|P1|Overall Study|Terminated by sponsor|0
1265308|NCT00474760|4142996|P7|Overall Study|Progressive disease|7
1265309|NCT00474760|4142997|P6|Overall Study|Progressive disease|20
1265310|NCT00474760|4142998|P5|Overall Study|Progressive disease|8
1265311|NCT00474760|4142999|P4|Overall Study|Progressive disease|2
1265312|NCT00474760|4143000|P3|Overall Study|Progressive disease|3
1265313|NCT00474760|4143001|P2|Overall Study|Progressive disease|2
1265314|NCT00474760|4143002|P1|Overall Study|Progressive disease|3
1265315|NCT00474760|4142996|P7|Overall Study|Other|0
1265316|NCT00474760|4142997|P6|Overall Study|Other|0
1265317|NCT00474760|4142998|P5|Overall Study|Other|1
1265318|NCT00474760|4142999|P4|Overall Study|Other|0
1265319|NCT00474760|4143000|P3|Overall Study|Other|0
1265320|NCT00474760|4143001|P2|Overall Study|Other|1
1265321|NCT00474760|4143002|P1|Overall Study|Other|0
1265322|NCT00474760|4142996|P7|Overall Study|Withdrawal by Subject|1
1265323|NCT00474760|4142997|P6|Overall Study|Withdrawal by Subject|1
1265324|NCT00474760|4142998|P5|Overall Study|Withdrawal by Subject|0
1265325|NCT00474760|4142999|P4|Overall Study|Withdrawal by Subject|1
1265326|NCT00474760|4143000|P3|Overall Study|Withdrawal by Subject|0
1265327|NCT00474760|4143001|P2|Overall Study|Withdrawal by Subject|0
1265328|NCT00474760|4143002|P1|Overall Study|Withdrawal by Subject|0
1265329|NCT00474760|4142996|P7|Overall Study|Laboratory abnormality|0
1265330|NCT00474760|4142997|P6|Overall Study|Laboratory abnormality|1
1265331|NCT00474760|4142998|P5|Overall Study|Laboratory abnormality|0
1265332|NCT00474760|4142999|P4|Overall Study|Laboratory abnormality|0
1265333|NCT00474760|4143000|P3|Overall Study|Laboratory abnormality|0
1265334|NCT00474760|4143001|P2|Overall Study|Laboratory abnormality|0
1265335|NCT00474760|4143002|P1|Overall Study|Laboratory abnormality|0
1265336|NCT00474760|4142996|P7|Overall Study|Adverse Event|0
1265337|NCT00474760|4142997|P6|Overall Study|Adverse Event|7
1265338|NCT00474760|4142998|P5|Overall Study|Adverse Event|1
1265339|NCT00474760|4142999|P4|Overall Study|Adverse Event|0
1265340|NCT00474760|4143000|P3|Overall Study|Adverse Event|0
1265341|NCT00474760|4143001|P2|Overall Study|Adverse Event|0
1265342|NCT00474760|4143002|P1|Overall Study|Adverse Event|0
1265343|NCT00474760|4142996|P7|Overall Study|Death|0
1265344|NCT00474760|4142997|P6|Overall Study|Death|0
1265345|NCT00474760|4142998|P5|Overall Study|Death|2
1265346|NCT00474760|4142999|P4|Overall Study|Death|0
1265347|NCT00474760|4143000|P3|Overall Study|Death|0
1265348|NCT00474760|4143001|P2|Overall Study|Death|0
1265349|NCT00474760|4143002|P1|Overall Study|Death|0
1265350|NCT00474708|4143109|P2|Overall Study|Physician Decision|6
1265351|NCT00474708|4143110|P1|Overall Study|Physician Decision|9
1265352|NCT00474708|4143109|P2|Overall Study|Lost to Follow-up|9
1265353|NCT00474708|4143110|P1|Overall Study|Lost to Follow-up|18
1265354|NCT00474708|4143109|P2|Overall Study|Lack of compliance|4
1265355|NCT00474708|4143110|P1|Overall Study|Lack of compliance|12
1265356|NCT00474708|4143109|P2|Overall Study|Withdrawal by Subject|0
1265357|NCT00474708|4143110|P1|Overall Study|Withdrawal by Subject|7
1265358|NCT00474708|4143109|P2|Overall Study|Suicide ideation/behavior|1
1265359|NCT00474708|4143110|P1|Overall Study|Suicide ideation/behavior|0
1265360|NCT00474708|4143109|P2|Overall Study|Lack of Efficacy|5
1265361|NCT00474708|4143110|P1|Overall Study|Lack of Efficacy|11
1265362|NCT00474630|4143120|P2|Overall Study|Drug noncompliance, other|4
1265363|NCT00474630|4143121|P1|Overall Study|Drug noncompliance, other|11
1265364|NCT00474630|4143120|P2|Overall Study|Lack of Efficacy|6
1265365|NCT00474630|4143121|P1|Overall Study|Lack of Efficacy|5
1265366|NCT00474630|4143120|P2|Overall Study|Protocol Violation|4
1265367|NCT00474630|4143121|P1|Overall Study|Protocol Violation|3
1265368|NCT00474630|4143120|P2|Overall Study|Withdrawal by Subject|15
1265369|NCT00474630|4143121|P1|Overall Study|Withdrawal by Subject|21
1265370|NCT00474630|4143120|P2|Overall Study|Lost to Follow-up|15
1265371|NCT00474630|4143121|P1|Overall Study|Lost to Follow-up|22
1265372|NCT00474630|4143120|P2|Overall Study|Adverse Event|26
1265373|NCT00474630|4143121|P1|Overall Study|Adverse Event|98
1265374|NCT00474539|4143177|P2|Toddler Dose|Protocol Violation|0
1265375|NCT00474539|4143178|P1|Toddler Dose|Protocol Violation|1
1265376|NCT00474539|4143177|P2|After Infant Series|Withdrawal by Subject|0
1265377|NCT00474539|4143178|P1|After Infant Series|Withdrawal by Subject|1
1265378|NCT00474539|4143177|P2|After Infant Series|Lost to Follow-up|0
1265379|NCT00474539|4143178|P1|After Infant Series|Lost to Follow-up|3
1265380|NCT00474539|4143177|P2|Infant Series|Protocol Violation|1
1265381|NCT00474539|4143178|P1|Infant Series|Protocol Violation|0
1265382|NCT00474539|4143177|P2|Infant Series|Lost to Follow-up|1
1265383|NCT00474539|4143178|P1|Infant Series|Lost to Follow-up|2
1265384|NCT00474539|4143177|P2|Infant Series|Randomization error|0
1265385|NCT00474539|4143178|P1|Infant Series|Randomization error|5
1265386|NCT00474539|4143177|P2|Infant Series|Withdrawal by Subject|4
1265387|NCT00474539|4143178|P1|Infant Series|Withdrawal by Subject|3
1265388|NCT00474526|4143243|P17|Overall Study|Withdrawal by Subject|1
1265389|NCT00474526|4143244|P16|Overall Study|Withdrawal by Subject|1
1265390|NCT00474526|4143245|P15|Overall Study|Withdrawal by Subject|22
1265391|NCT00474526|4143246|P14|Overall Study|Withdrawal by Subject|37
1265392|NCT00474526|4143247|P13|Overall Study|Withdrawal by Subject|4
1265393|NCT00474526|4143248|P12|Overall Study|Withdrawal by Subject|4
1265394|NCT00474526|4143249|P11|Overall Study|Withdrawal by Subject|5
1265395|NCT00474526|4143250|P10|Overall Study|Withdrawal by Subject|13
1265396|NCT00474526|4143251|P9|Overall Study|Withdrawal by Subject|4
1265397|NCT00474526|4143252|P8|Overall Study|Withdrawal by Subject|4
1265398|NCT00474526|4143253|P7|Overall Study|Withdrawal by Subject|12
1265399|NCT00474526|4143254|P6|Overall Study|Withdrawal by Subject|6
1265400|NCT00474526|4143255|P5|Overall Study|Withdrawal by Subject|38
1265401|NCT00474526|4143256|P4|Overall Study|Withdrawal by Subject|52
1265402|NCT00474526|4143257|P3|Overall Study|Withdrawal by Subject|21
1265403|NCT00474526|4143258|P2|Overall Study|Withdrawal by Subject|24
1265404|NCT00474526|4143259|P1|Overall Study|Withdrawal by Subject|9
1265405|NCT00474526|4143243|P17|Overall Study|UNABLE TO CLASSIFY|1
1265406|NCT00474526|4143244|P16|Overall Study|UNABLE TO CLASSIFY|6
1265407|NCT00474526|4143245|P15|Overall Study|UNABLE TO CLASSIFY|12
1265408|NCT00474526|4143246|P14|Overall Study|UNABLE TO CLASSIFY|20
1265409|NCT00474526|4143247|P13|Overall Study|UNABLE TO CLASSIFY|0
1265410|NCT00474526|4143248|P12|Overall Study|UNABLE TO CLASSIFY|0
1265411|NCT00474526|4143249|P11|Overall Study|UNABLE TO CLASSIFY|0
1265412|NCT00474526|4143250|P10|Overall Study|UNABLE TO CLASSIFY|3
1265413|NCT00474526|4143251|P9|Overall Study|UNABLE TO CLASSIFY|0
1265414|NCT00474526|4143252|P8|Overall Study|UNABLE TO CLASSIFY|1
1265415|NCT00474526|4143253|P7|Overall Study|UNABLE TO CLASSIFY|0
1265416|NCT00474526|4143254|P6|Overall Study|UNABLE TO CLASSIFY|2
1265417|NCT00474526|4143255|P5|Overall Study|UNABLE TO CLASSIFY|3
1265418|NCT00474526|4143256|P4|Overall Study|UNABLE TO CLASSIFY|1
1265419|NCT00474526|4143257|P3|Overall Study|UNABLE TO CLASSIFY|0
1265420|NCT00474526|4143258|P2|Overall Study|UNABLE TO CLASSIFY|0
1265421|NCT00474526|4143259|P1|Overall Study|UNABLE TO CLASSIFY|1
1265422|NCT00474526|4143243|P17|Overall Study|Protocol Violation|2
1265423|NCT00474526|4143244|P16|Overall Study|Protocol Violation|6
1265424|NCT00474526|4143245|P15|Overall Study|Protocol Violation|9
1265425|NCT00474526|4143246|P14|Overall Study|Protocol Violation|19
1265426|NCT00474526|4143247|P13|Overall Study|Protocol Violation|4
1265427|NCT00474526|4143248|P12|Overall Study|Protocol Violation|2
1265428|NCT00474526|4143249|P11|Overall Study|Protocol Violation|2
1265429|NCT00474526|4143250|P10|Overall Study|Protocol Violation|4
1265430|NCT00474526|4143251|P9|Overall Study|Protocol Violation|0
1265431|NCT00474526|4143252|P8|Overall Study|Protocol Violation|0
1265432|NCT00474526|4143253|P7|Overall Study|Protocol Violation|3
1265433|NCT00474526|4143254|P6|Overall Study|Protocol Violation|1
1265434|NCT00474526|4143255|P5|Overall Study|Protocol Violation|3
1265435|NCT00474526|4143256|P4|Overall Study|Protocol Violation|12
1265436|NCT00474526|4143257|P3|Overall Study|Protocol Violation|4
1265437|NCT00474526|4143258|P2|Overall Study|Protocol Violation|6
1265438|NCT00474526|4143259|P1|Overall Study|Protocol Violation|2
1265439|NCT00474526|4143243|P17|Overall Study|Lost to Follow-up|5
1265440|NCT00474526|4143244|P16|Overall Study|Lost to Follow-up|4
1265441|NCT00474526|4143245|P15|Overall Study|Lost to Follow-up|29
1265442|NCT00474526|4143246|P14|Overall Study|Lost to Follow-up|74
1265443|NCT00474526|4143247|P13|Overall Study|Lost to Follow-up|6
1265444|NCT00474526|4143248|P12|Overall Study|Lost to Follow-up|4
1265445|NCT00474526|4143249|P11|Overall Study|Lost to Follow-up|2
1265446|NCT00474526|4143250|P10|Overall Study|Lost to Follow-up|6
1265447|NCT00474526|4143251|P9|Overall Study|Lost to Follow-up|0
1265448|NCT00474526|4143252|P8|Overall Study|Lost to Follow-up|1
1265449|NCT00474526|4143253|P7|Overall Study|Lost to Follow-up|8
1265450|NCT00474526|4143254|P6|Overall Study|Lost to Follow-up|5
1265451|NCT00474526|4143255|P5|Overall Study|Lost to Follow-up|11
1265452|NCT00474526|4143256|P4|Overall Study|Lost to Follow-up|29
1265453|NCT00474526|4143257|P3|Overall Study|Lost to Follow-up|13
1265454|NCT00474526|4143258|P2|Overall Study|Lost to Follow-up|6
1265455|NCT00474526|4143259|P1|Overall Study|Lost to Follow-up|8
1265456|NCT00474526|4143243|P17|Overall Study|INAPPROPRIATE ENROLLMENT|0
1265457|NCT00474526|4143244|P16|Overall Study|INAPPROPRIATE ENROLLMENT|0
1265458|NCT00474526|4143245|P15|Overall Study|INAPPROPRIATE ENROLLMENT|2
1265459|NCT00474526|4143246|P14|Overall Study|INAPPROPRIATE ENROLLMENT|2
1265460|NCT00474526|4143247|P13|Overall Study|INAPPROPRIATE ENROLLMENT|0
1265461|NCT00474526|4143248|P12|Overall Study|INAPPROPRIATE ENROLLMENT|0
1265462|NCT00474526|4143249|P11|Overall Study|INAPPROPRIATE ENROLLMENT|0
1265463|NCT00474526|4143250|P10|Overall Study|INAPPROPRIATE ENROLLMENT|0
1265464|NCT00474526|4143251|P9|Overall Study|INAPPROPRIATE ENROLLMENT|0
1265465|NCT00474526|4143252|P8|Overall Study|INAPPROPRIATE ENROLLMENT|0
1265466|NCT00474526|4143253|P7|Overall Study|INAPPROPRIATE ENROLLMENT|0
1265467|NCT00474526|4143254|P6|Overall Study|INAPPROPRIATE ENROLLMENT|0
1265468|NCT00474526|4143255|P5|Overall Study|INAPPROPRIATE ENROLLMENT|2
1265469|NCT00474526|4143256|P4|Overall Study|INAPPROPRIATE ENROLLMENT|1
1265470|NCT00474526|4143257|P3|Overall Study|INAPPROPRIATE ENROLLMENT|0
1265471|NCT00474526|4143258|P2|Overall Study|INAPPROPRIATE ENROLLMENT|1
1265472|NCT00474526|4143259|P1|Overall Study|INAPPROPRIATE ENROLLMENT|0
1265473|NCT00474526|4143243|P17|Overall Study|Death|0
1265474|NCT00474526|4143244|P16|Overall Study|Death|0
1265475|NCT00474526|4143245|P15|Overall Study|Death|0
1265476|NCT00474526|4143246|P14|Overall Study|Death|3
1265477|NCT00474526|4143247|P13|Overall Study|Death|0
1265478|NCT00474526|4143248|P12|Overall Study|Death|0
1265479|NCT00474526|4143249|P11|Overall Study|Death|0
1265480|NCT00474526|4143250|P10|Overall Study|Death|0
1265481|NCT00474526|4143251|P9|Overall Study|Death|0
1265482|NCT00474526|4143252|P8|Overall Study|Death|0
1265483|NCT00474526|4143253|P7|Overall Study|Death|0
1265484|NCT00474526|4143254|P6|Overall Study|Death|0
1265485|NCT00474526|4143255|P5|Overall Study|Death|0
1265486|NCT00474526|4143256|P4|Overall Study|Death|0
1265487|NCT00474526|4143257|P3|Overall Study|Death|0
1265488|NCT00474526|4143258|P2|Overall Study|Death|0
1265489|NCT00474526|4143259|P1|Overall Study|Death|0
1265490|NCT00474526|4143243|P17|Overall Study|Adverse Event|0
1265491|NCT00474526|4143244|P16|Overall Study|Adverse Event|1
1265492|NCT00474526|4143245|P15|Overall Study|Adverse Event|1
1265493|NCT00474526|4143246|P14|Overall Study|Adverse Event|0
1265494|NCT00474526|4143247|P13|Overall Study|Adverse Event|0
1265495|NCT00474526|4143248|P12|Overall Study|Adverse Event|0
1265496|NCT00474526|4143249|P11|Overall Study|Adverse Event|0
1265497|NCT00474526|4143250|P10|Overall Study|Adverse Event|0
1265498|NCT00474526|4143251|P9|Overall Study|Adverse Event|0
1265499|NCT00474526|4143252|P8|Overall Study|Adverse Event|0
1265500|NCT00474526|4143253|P7|Overall Study|Adverse Event|1
1265501|NCT00474526|4143254|P6|Overall Study|Adverse Event|1
1265502|NCT00474526|4143255|P5|Overall Study|Adverse Event|2
1265503|NCT00474526|4143256|P4|Overall Study|Adverse Event|4
1265504|NCT00474526|4143257|P3|Overall Study|Adverse Event|2
1265505|NCT00474526|4143258|P2|Overall Study|Adverse Event|0
1265506|NCT00474526|4143259|P1|Overall Study|Adverse Event|2
1265507|NCT00474526|4143243|P17|Overall Study|ADMINISTRATIVE REASON|0
1265508|NCT00474526|4143244|P16|Overall Study|ADMINISTRATIVE REASON|0
1265509|NCT00474526|4143245|P15|Overall Study|ADMINISTRATIVE REASON|2
1265510|NCT00474526|4143246|P14|Overall Study|ADMINISTRATIVE REASON|1
1265511|NCT00474526|4143247|P13|Overall Study|ADMINISTRATIVE REASON|1
1265512|NCT00474526|4143248|P12|Overall Study|ADMINISTRATIVE REASON|1
1265513|NCT00474526|4143249|P11|Overall Study|ADMINISTRATIVE REASON|1
1265514|NCT00474526|4143250|P10|Overall Study|ADMINISTRATIVE REASON|1
1265515|NCT00474526|4143251|P9|Overall Study|ADMINISTRATIVE REASON|2
1265516|NCT00474526|4143252|P8|Overall Study|ADMINISTRATIVE REASON|0
1265517|NCT00474526|4143253|P7|Overall Study|ADMINISTRATIVE REASON|1
1265518|NCT00474526|4143254|P6|Overall Study|ADMINISTRATIVE REASON|1
1265519|NCT00474526|4143255|P5|Overall Study|ADMINISTRATIVE REASON|9
1265520|NCT00474526|4143256|P4|Overall Study|ADMINISTRATIVE REASON|20
1265521|NCT00474526|4143257|P3|Overall Study|ADMINISTRATIVE REASON|9
1265522|NCT00474526|4143258|P2|Overall Study|ADMINISTRATIVE REASON|9
1265523|NCT00474526|4143259|P1|Overall Study|ADMINISTRATIVE REASON|11
1265524|NCT00474487|4143424|P4|Overall Study|Death|0
1265525|NCT00474487|4143425|P3|Overall Study|Death|0
1265526|NCT00474487|4143426|P2|Overall Study|Death|1
1265527|NCT00474487|4143427|P1|Overall Study|Death|0
1265528|NCT00474487|4143424|P4|Overall Study|Inappropriate enrollment|0
1265529|NCT00474487|4143425|P3|Overall Study|Inappropriate enrollment|7
1265530|NCT00474487|4143426|P2|Overall Study|Inappropriate enrollment|0
1265531|NCT00474487|4143427|P1|Overall Study|Inappropriate enrollment|4
1265532|NCT00474487|4143424|P4|Overall Study|Lost to Follow-up|0
1265533|NCT00474487|4143425|P3|Overall Study|Lost to Follow-up|7
1265534|NCT00474487|4143426|P2|Overall Study|Lost to Follow-up|1
1265535|NCT00474487|4143427|P1|Overall Study|Lost to Follow-up|20
1265536|NCT00474487|4143424|P4|Overall Study|Withdrawal by Subject|0
1265537|NCT00474487|4143425|P3|Overall Study|Withdrawal by Subject|0
1265538|NCT00474487|4143426|P2|Overall Study|Withdrawal by Subject|0
1265539|NCT00474487|4143427|P1|Overall Study|Withdrawal by Subject|6
1265540|NCT00474383|4143447|P2|Extension|Progressive Disease|5
1265541|NCT00474383|4143448|P1|Extension|Progressive Disease|0
1265542|NCT00474383|4143447|P2|Between Main Study and Extension|Did Not Enter Extension Phase|0
1265543|NCT00474383|4143448|P1|Between Main Study and Extension|Did Not Enter Extension Phase|6
1265544|NCT00474383|4143447|P2|Main Study|Other|0
1265545|NCT00474383|4143448|P1|Main Study|Other|1
1265546|NCT00474383|4143447|P2|Main Study|Progressive Disease|0
1265547|NCT00474383|4143448|P1|Main Study|Progressive Disease|23
1265548|NCT00474383|4143447|P2|Main Study|Symptomatic Deterioration|0
1265549|NCT00474383|4143448|P1|Main Study|Symptomatic Deterioration|1
1265550|NCT00474383|4143447|P2|Main Study|Adverse Event|0
1265551|NCT00474383|4143448|P1|Main Study|Adverse Event|11
1265552|NCT00474266|4143463|P4|Overall Study|Withdrawal by Subject|7
1265553|NCT00474266|4143464|P3|Overall Study|Withdrawal by Subject|4
1265554|NCT00474266|4143465|P2|Overall Study|Withdrawal by Subject|20
1265555|NCT00474266|4143466|P1|Overall Study|Withdrawal by Subject|7
1265556|NCT00474240|4143574|P6|Overall Study|Removed due to lab value|1
1265557|NCT00474240|4143575|P5|Overall Study|Removed due to lab value|0
1265558|NCT00474240|4143576|P4|Overall Study|Removed due to lab value|0
1265559|NCT00474240|4143577|P3|Overall Study|Removed due to lab value|0
1265560|NCT00474240|4143578|P2|Overall Study|Removed due to lab value|0
1265561|NCT00474240|4143579|P1|Overall Study|Removed due to lab value|0
1265562|NCT00474240|4143574|P6|Overall Study|Adverse Event|16
1265563|NCT00474240|4143575|P5|Overall Study|Adverse Event|5
1265564|NCT00474240|4143576|P4|Overall Study|Adverse Event|14
1265565|NCT00474240|4143577|P3|Overall Study|Adverse Event|9
1265566|NCT00474240|4143578|P2|Overall Study|Adverse Event|0
1265567|NCT00474240|4143579|P1|Overall Study|Adverse Event|0
1265568|NCT00474240|4143574|P6|Overall Study|Withdrawal by Subject|1
1265569|NCT00474240|4143575|P5|Overall Study|Withdrawal by Subject|3
1265570|NCT00474240|4143576|P4|Overall Study|Withdrawal by Subject|2
1265571|NCT00474240|4143577|P3|Overall Study|Withdrawal by Subject|0
1265572|NCT00474240|4143578|P2|Overall Study|Withdrawal by Subject|1
1265573|NCT00474240|4143579|P1|Overall Study|Withdrawal by Subject|1
1265574|NCT00474188|4143604|P1|Overall Study|Study discontinued by sponsor|5
1265575|NCT00474188|4143604|P1|Overall Study|Withdrawal by Subject|1
1265576|NCT00474175|4143614|P3|Overall Study|Administrative|0
1265577|NCT00474175|4143615|P2|Overall Study|Administrative|1
1265578|NCT00474175|4143616|P1|Overall Study|Administrative|0
1265579|NCT00474175|4143614|P3|Overall Study|Protocol Violation|1
1265580|NCT00474175|4143615|P2|Overall Study|Protocol Violation|2
1265581|NCT00474175|4143616|P1|Overall Study|Protocol Violation|0
1265582|NCT00474175|4143614|P3|Overall Study|Ineligible|1
1265583|NCT00474175|4143615|P2|Overall Study|Ineligible|3
1265584|NCT00474175|4143616|P1|Overall Study|Ineligible|1
1265585|NCT00474175|4143614|P3|Overall Study|Withdrawal by Subject|1
1265586|NCT00474175|4143615|P2|Overall Study|Withdrawal by Subject|1
1265587|NCT00474175|4143616|P1|Overall Study|Withdrawal by Subject|0
1265588|NCT00474175|4143614|P3|Overall Study|Lack of Efficacy|1
1265589|NCT00474175|4143615|P2|Overall Study|Lack of Efficacy|0
1265590|NCT00474175|4143616|P1|Overall Study|Lack of Efficacy|0
1265591|NCT00474058|4143680|P2|Overall Study|Other|0
1265592|NCT00474058|4143681|P1|Overall Study|Other|2
1265593|NCT00474058|4143680|P2|Overall Study|Withdrawal by Subject|7
1265594|NCT00474058|4143681|P1|Overall Study|Withdrawal by Subject|11
1265595|NCT00474058|4143680|P2|Overall Study|Lack of Efficacy|4
1265596|NCT00474058|4143681|P1|Overall Study|Lack of Efficacy|0
1265597|NCT00474058|4143680|P2|Overall Study|Adverse Event|6
1265598|NCT00474058|4143681|P1|Overall Study|Adverse Event|11
1265599|NCT00474045|4143695|P2|Overall Study|Withdrawal criteria|50
1265600|NCT00474045|4143696|P1|Overall Study|Withdrawal criteria|60
1265601|NCT00474045|4143695|P2|Overall Study|Withdrawal by Subject|18
1265602|NCT00474045|4143696|P1|Overall Study|Withdrawal by Subject|16
1265603|NCT00474045|4143695|P2|Overall Study|Protocol Violation|12
1265604|NCT00474045|4143696|P1|Overall Study|Protocol Violation|10
1265605|NCT00474045|4143695|P2|Overall Study|Lost to Follow-up|1
1265606|NCT00474045|4143696|P1|Overall Study|Lost to Follow-up|1
1265607|NCT00474045|4143695|P2|Overall Study|Lack of Efficacy|9
1265608|NCT00474045|4143696|P1|Overall Study|Lack of Efficacy|0
1265609|NCT00474045|4143695|P2|Overall Study|Unclassified|3
1265610|NCT00474045|4143696|P1|Overall Study|Unclassified|1
1265611|NCT00474045|4143695|P2|Overall Study|Adverse Event|8
1265612|NCT00474045|4143696|P1|Overall Study|Adverse Event|18
1265613|NCT00473889|4143796|P2|Overall Study|Withdrawal by Subject|0
1265614|NCT00473889|4143797|P1|Overall Study|Withdrawal by Subject|5
1265615|NCT00473889|4143796|P2|Overall Study|Trial Terminated|6
1265616|NCT00473889|4143797|P1|Overall Study|Trial Terminated|3
1265617|NCT00473889|4143796|P2|Overall Study|Physician Decision|5
1265618|NCT00473889|4143797|P1|Overall Study|Physician Decision|10
1265619|NCT00473889|4143796|P2|Overall Study|Lost to Follow-up|1
1265620|NCT00473889|4143797|P1|Overall Study|Lost to Follow-up|2
1265621|NCT00473889|4143796|P2|Overall Study|Lack of Efficacy|29
1265622|NCT00473889|4143797|P1|Overall Study|Lack of Efficacy|28
1265623|NCT00473889|4143796|P2|Overall Study|Protocol Violation|2
1265624|NCT00473889|4143797|P1|Overall Study|Protocol Violation|4
1265625|NCT00473889|4143796|P2|Overall Study|Adverse Event|17
1265626|NCT00473889|4143797|P1|Overall Study|Adverse Event|30
1265627|NCT00473889|4143796|P2|Overall Study|Did not receive study medication|4
1265628|NCT00473889|4143797|P1|Overall Study|Did not receive study medication|1
1265629|NCT00473876|4143809|P2|Overall Study|Lost to Follow-up|1
1265630|NCT00473876|4143810|P1|Overall Study|Lost to Follow-up|3
1265631|NCT00473824|4143829|P2|Overall Study|Withdrawal by physician|0
1265632|NCT00473824|4143830|P1|Overall Study|Withdrawal by physician|1
1265633|NCT00473824|4143829|P2|Overall Study|Lost to Follow-up|0
1265634|NCT00473824|4143830|P1|Overall Study|Lost to Follow-up|1
1265635|NCT00473824|4143829|P2|Overall Study|Death|0
1265636|NCT00473824|4143830|P1|Overall Study|Death|1
1265637|NCT00473824|4143829|P2|Overall Study|Adverse Event|0
1265638|NCT00473824|4143830|P1|Overall Study|Adverse Event|1
1265639|NCT00473824|4143829|P2|Overall Study|Virologic Breakthrough|0
1265640|NCT00473824|4143830|P1|Overall Study|Virologic Breakthrough|1
1265641|NCT00473746|4143841|P5|Period 2 (Phase 2)|Reason not specified|3
1265642|NCT00473746|4143842|P4|Period 2 (Phase 2)|Reason not specified|0
1265643|NCT00473746|4143843|P3|Period 2 (Phase 2)|Reason not specified|0
1265644|NCT00473746|4143844|P2|Period 2 (Phase 2)|Reason not specified|0
1265645|NCT00473746|4143845|P1|Period 2 (Phase 2)|Reason not specified|0
1265646|NCT00473746|4143841|P5|Period 2 (Phase 2)|Progressive Disease|20
1265647|NCT00473746|4143842|P4|Period 2 (Phase 2)|Progressive Disease|0
1265648|NCT00473746|4143843|P3|Period 2 (Phase 2)|Progressive Disease|0
1265649|NCT00473746|4143844|P2|Period 2 (Phase 2)|Progressive Disease|0
1265650|NCT00473746|4143845|P1|Period 2 (Phase 2)|Progressive Disease|0
1265651|NCT00473746|4143841|P5|Period 2 (Phase 2)|Death|1
1265652|NCT00473746|4143842|P4|Period 2 (Phase 2)|Death|0
1265653|NCT00473746|4143843|P3|Period 2 (Phase 2)|Death|0
1265654|NCT00473746|4143844|P2|Period 2 (Phase 2)|Death|0
1265655|NCT00473746|4143845|P1|Period 2 (Phase 2)|Death|0
1265656|NCT00473746|4143841|P5|Period 2 (Phase 2)|Adverse Event|3
1265657|NCT00473746|4143842|P4|Period 2 (Phase 2)|Adverse Event|0
1265658|NCT00473746|4143843|P3|Period 2 (Phase 2)|Adverse Event|0
1265659|NCT00473746|4143844|P2|Period 2 (Phase 2)|Adverse Event|0
1265660|NCT00473746|4143845|P1|Period 2 (Phase 2)|Adverse Event|0
1265661|NCT00473746|4143841|P5|Period 1 (Phase 1)|Reason not specified|0
1265662|NCT00473746|4143842|P4|Period 1 (Phase 1)|Reason not specified|0
1265663|NCT00473746|4143843|P3|Period 1 (Phase 1)|Reason not specified|0
1265664|NCT00473746|4143844|P2|Period 1 (Phase 1)|Reason not specified|1
1265665|NCT00473746|4143845|P1|Period 1 (Phase 1)|Reason not specified|0
1265666|NCT00473746|4143841|P5|Period 1 (Phase 1)|Symptomatic Deterioration|0
1265667|NCT00473746|4143842|P4|Period 1 (Phase 1)|Symptomatic Deterioration|0
1265668|NCT00473746|4143843|P3|Period 1 (Phase 1)|Symptomatic Deterioration|0
1265669|NCT00473746|4143844|P2|Period 1 (Phase 1)|Symptomatic Deterioration|1
1265670|NCT00473746|4143845|P1|Period 1 (Phase 1)|Symptomatic Deterioration|0
1265671|NCT00473746|4143841|P5|Period 1 (Phase 1)|Progressive Disease|0
1265672|NCT00473746|4143842|P4|Period 1 (Phase 1)|Progressive Disease|10
1265673|NCT00473746|4143843|P3|Period 1 (Phase 1)|Progressive Disease|6
1265674|NCT00473746|4143844|P2|Period 1 (Phase 1)|Progressive Disease|6
1265675|NCT00473746|4143845|P1|Period 1 (Phase 1)|Progressive Disease|5
1265676|NCT00473746|4143841|P5|Period 1 (Phase 1)|Withdrawal by Subject|0
1265677|NCT00473746|4143842|P4|Period 1 (Phase 1)|Withdrawal by Subject|0
1265678|NCT00473746|4143843|P3|Period 1 (Phase 1)|Withdrawal by Subject|0
1265679|NCT00473746|4143844|P2|Period 1 (Phase 1)|Withdrawal by Subject|1
1265680|NCT00473746|4143845|P1|Period 1 (Phase 1)|Withdrawal by Subject|0
1265681|NCT00473746|4143841|P5|Period 1 (Phase 1)|Adverse Event|0
1265682|NCT00473746|4143842|P4|Period 1 (Phase 1)|Adverse Event|0
1265683|NCT00473746|4143843|P3|Period 1 (Phase 1)|Adverse Event|0
1265684|NCT00473746|4143844|P2|Period 1 (Phase 1)|Adverse Event|0
1265685|NCT00473746|4143845|P1|Period 1 (Phase 1)|Adverse Event|1
1265686|NCT00473668|4143893|P3|Overall Study|Other|4
1265687|NCT00473668|4143894|P2|Overall Study|Other|3
1265688|NCT00473668|4143895|P1|Overall Study|Other|2
1265689|NCT00473668|4143893|P3|Overall Study|Lost to Follow-up|6
1265690|NCT00473668|4143894|P2|Overall Study|Lost to Follow-up|4
1265691|NCT00473668|4143895|P1|Overall Study|Lost to Follow-up|0
1265692|NCT00473668|4143893|P3|Overall Study|Migrated/moved from study area|0
1265693|NCT00473668|4143894|P2|Overall Study|Migrated/moved from study area|2
1265694|NCT00473668|4143895|P1|Overall Study|Migrated/moved from study area|3
1265695|NCT00473668|4143893|P3|Overall Study|Withdrawal by Subject|0
1265696|NCT00473668|4143894|P2|Overall Study|Withdrawal by Subject|2
1265697|NCT00473668|4143895|P1|Overall Study|Withdrawal by Subject|0
1265698|NCT00473655|4143948|P3|Overall Study|Lost to Follow-up|8
1265699|NCT00473655|4143949|P2|Overall Study|Lost to Follow-up|5
1265700|NCT00473655|4143950|P1|Overall Study|Lost to Follow-up|9
1265701|NCT00473590|4143997|P2|Overall Study|Other|1
1265702|NCT00473590|4143998|P1|Overall Study|Other|0
1265703|NCT00473590|4143997|P2|Overall Study|Withdrawal by Subject|3
1265704|NCT00473590|4143998|P1|Overall Study|Withdrawal by Subject|5
1265705|NCT00473590|4143997|P2|Overall Study|Physician Decision|4
1265706|NCT00473590|4143998|P1|Overall Study|Physician Decision|2
1265707|NCT00473590|4143997|P2|Overall Study|Non–protocol-specified therapy|5
1265708|NCT00473590|4143998|P1|Overall Study|Non–protocol-specified therapy|7
1265709|NCT00473590|4143997|P2|Overall Study|Progression not resulting in death|20
1265710|NCT00473590|4143998|P1|Overall Study|Progression not resulting in death|24
1265711|NCT00473590|4143997|P2|Overall Study|Death|2
1265712|NCT00473590|4143998|P1|Overall Study|Death|4
1265713|NCT00473590|4143997|P2|Overall Study|Adverse Event|3
1265714|NCT00473590|4143998|P1|Overall Study|Adverse Event|3
1265715|NCT00473564|4144014|P1|Overall Study|robot surgery aborted in OR|23
1265716|NCT00473512|4144024|P5|Period 2 (Phase 2)|Other|0
1265717|NCT00473512|4144025|P4|Period 2 (Phase 2)|Other|3
1265718|NCT00473512|4144026|P3|Period 2 (Phase 2)|Other|0
1265719|NCT00473512|4144027|P2|Period 2 (Phase 2)|Other|0
1265720|NCT00473512|4144028|P1|Period 2 (Phase 2)|Other|1
1265721|NCT00473512|4144024|P5|Period 2 (Phase 2)|Symptomatic Deterioration|0
1265722|NCT00473512|4144025|P4|Period 2 (Phase 2)|Symptomatic Deterioration|1
1265723|NCT00473512|4144026|P3|Period 2 (Phase 2)|Symptomatic Deterioration|0
1265724|NCT00473512|4144027|P2|Period 2 (Phase 2)|Symptomatic Deterioration|0
1265725|NCT00473512|4144028|P1|Period 2 (Phase 2)|Symptomatic Deterioration|0
1265726|NCT00473512|4144024|P5|Period 2 (Phase 2)|Disease Progression|1
1265727|NCT00473512|4144025|P4|Period 2 (Phase 2)|Disease Progression|17
1265728|NCT00473512|4144026|P3|Period 2 (Phase 2)|Disease Progression|2
1265729|NCT00473512|4144027|P2|Period 2 (Phase 2)|Disease Progression|2
1265730|NCT00473512|4144028|P1|Period 2 (Phase 2)|Disease Progression|0
1265731|NCT00473512|4144024|P5|Period 2 (Phase 2)|Death|1
1265732|NCT00473512|4144025|P4|Period 2 (Phase 2)|Death|1
1265733|NCT00473512|4144026|P3|Period 2 (Phase 2)|Death|0
1265734|NCT00473512|4144027|P2|Period 2 (Phase 2)|Death|0
1265735|NCT00473512|4144028|P1|Period 2 (Phase 2)|Death|0
1265736|NCT00473512|4144024|P5|Period 2 (Phase 2)|Adverse Event|0
1265737|NCT00473512|4144025|P4|Period 2 (Phase 2)|Adverse Event|1
1265738|NCT00473512|4144026|P3|Period 2 (Phase 2)|Adverse Event|0
1265739|NCT00473512|4144027|P2|Period 2 (Phase 2)|Adverse Event|0
1265740|NCT00473512|4144028|P1|Period 2 (Phase 2)|Adverse Event|0
1265741|NCT00473512|4144024|P5|Period 1 (Phase 1)|Other|0
1265742|NCT00473512|4144025|P4|Period 1 (Phase 1)|Other|1
1265743|NCT00473512|4144026|P3|Period 1 (Phase 1)|Other|0
1265744|NCT00473512|4144027|P2|Period 1 (Phase 1)|Other|0
1265745|NCT00473512|4144028|P1|Period 1 (Phase 1)|Other|0
1265746|NCT00473512|4144024|P5|Period 1 (Phase 1)|Disease Progression|1
1265747|NCT00473512|4144025|P4|Period 1 (Phase 1)|Disease Progression|10
1265748|NCT00473512|4144026|P3|Period 1 (Phase 1)|Disease Progression|0
1265749|NCT00473512|4144027|P2|Period 1 (Phase 1)|Disease Progression|1
1265750|NCT00473512|4144028|P1|Period 1 (Phase 1)|Disease Progression|1
1265751|NCT00473512|4144024|P5|Period 1 (Phase 1)|Death|0
1265752|NCT00473512|4144025|P4|Period 1 (Phase 1)|Death|1
1265753|NCT00473512|4144026|P3|Period 1 (Phase 1)|Death|0
1265754|NCT00473512|4144027|P2|Period 1 (Phase 1)|Death|0
1265755|NCT00473512|4144028|P1|Period 1 (Phase 1)|Death|0
1265756|NCT00473512|4144024|P5|Period 1 (Phase 1)|Adverse Event|0
1265757|NCT00473512|4144025|P4|Period 1 (Phase 1)|Adverse Event|5
1265758|NCT00473512|4144026|P3|Period 1 (Phase 1)|Adverse Event|0
1265759|NCT00473512|4144027|P2|Period 1 (Phase 1)|Adverse Event|0
1265760|NCT00473512|4144028|P1|Period 1 (Phase 1)|Adverse Event|0
1265761|NCT00473434|4144086|P1|Overall Study|No longer required|1
1265762|NCT00473434|4144086|P1|Overall Study|Switching to trial medication|1
1265763|NCT00473434|4144086|P1|Overall Study|Ceased in favor of Paliperidone|1
1265764|NCT00473434|4144086|P1|Overall Study|Reason not specified|6
1265765|NCT00473434|4144086|P1|Overall Study|Safety evaluation|1
1265766|NCT00473434|4144086|P1|Overall Study|Patient was selling medication to others|1
1265767|NCT00473434|4144086|P1|Overall Study|Adverse Event|3
1265768|NCT00473434|4144086|P1|Overall Study|Lack of Efficacy|3
1265769|NCT00473434|4144086|P1|Overall Study|Compliance|3
1265770|NCT00473434|4144086|P1|Overall Study|Withdrawal by Subject|9
1265771|NCT00473434|4144086|P1|Overall Study|Physician Decision|3
1265772|NCT00473382|4144151|P3|Open-label Extension Through Month 60|Subject Required Other Intervention|0
1265773|NCT00473382|4144152|P2|Open-label Extension Through Month 60|Subject Required Other Intervention|1
1265774|NCT00473382|4144153|P1|Open-label Extension Through Month 60|Subject Required Other Intervention|2
1265775|NCT00473382|4144151|P3|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|69
1265776|NCT00473382|4144152|P2|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|70
1266017|NCT00471497|4144650|P2|Overall Study|Protocol Violation|3
1265777|NCT00473382|4144153|P1|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|75
1265778|NCT00473382|4144151|P3|Open-label Extension Through Month 60|Subject's Decision|6
1265779|NCT00473382|4144152|P2|Open-label Extension Through Month 60|Subject's Decision|1
1265780|NCT00473382|4144153|P1|Open-label Extension Through Month 60|Subject's Decision|7
1265781|NCT00473382|4144151|P3|Open-label Extension Through Month 60|Lost to Follow-up|1
1265782|NCT00473382|4144152|P2|Open-label Extension Through Month 60|Lost to Follow-up|3
1265783|NCT00473382|4144153|P1|Open-label Extension Through Month 60|Lost to Follow-up|1
1265784|NCT00473382|4144151|P3|Open-label Extension Through Month 60|Death|4
1265785|NCT00473382|4144152|P2|Open-label Extension Through Month 60|Death|7
1265786|NCT00473382|4144153|P1|Open-label Extension Through Month 60|Death|1
1265787|NCT00473382|4144151|P3|Open-label Extension Through Month 60|Adverse Event|2
1265788|NCT00473382|4144152|P2|Open-label Extension Through Month 60|Adverse Event|0
1265789|NCT00473382|4144153|P1|Open-label Extension Through Month 60|Adverse Event|0
1265790|NCT00473382|4144151|P3|Open-label Extension Through Month 48|Subject Required Other Intervention|0
1265791|NCT00473382|4144152|P2|Open-label Extension Through Month 48|Subject Required Other Intervention|1
1265792|NCT00473382|4144153|P1|Open-label Extension Through Month 48|Subject Required Other Intervention|2
1265793|NCT00473382|4144151|P3|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|36
1265794|NCT00473382|4144152|P2|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|34
1265795|NCT00473382|4144153|P1|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|41
1265796|NCT00473382|4144151|P3|Open-label Extension Through Month 48|Subject's Decision|6
1265797|NCT00473382|4144152|P2|Open-label Extension Through Month 48|Subject's Decision|1
1265798|NCT00473382|4144153|P1|Open-label Extension Through Month 48|Subject's Decision|5
1265799|NCT00473382|4144151|P3|Open-label Extension Through Month 48|Lost to Follow-up|1
1265800|NCT00473382|4144152|P2|Open-label Extension Through Month 48|Lost to Follow-up|2
1265801|NCT00473382|4144153|P1|Open-label Extension Through Month 48|Lost to Follow-up|1
1265802|NCT00473382|4144151|P3|Open-label Extension Through Month 48|Death|3
1265803|NCT00473382|4144152|P2|Open-label Extension Through Month 48|Death|3
1265804|NCT00473382|4144153|P1|Open-label Extension Through Month 48|Death|1
1265805|NCT00473382|4144151|P3|Open-label Extension Through Month 48|Adverse Event|1
1265806|NCT00473382|4144152|P2|Open-label Extension Through Month 48|Adverse Event|0
1265807|NCT00473382|4144153|P1|Open-label Extension Through Month 48|Adverse Event|0
1265808|NCT00473382|4144151|P3|Core Study|Subject's decision|10
1265809|NCT00473382|4144152|P2|Core Study|Subject's decision|11
1265810|NCT00473382|4144153|P1|Core Study|Subject's decision|12
1265811|NCT00473382|4144151|P3|Core Study|Subject needed other treatment|2
1265812|NCT00473382|4144152|P2|Core Study|Subject needed other treatment|3
1265813|NCT00473382|4144153|P1|Core Study|Subject needed other treatment|1
1265814|NCT00473382|4144151|P3|Core Study|Subject non-compliance|1
1265815|NCT00473382|4144152|P2|Core Study|Subject non-compliance|2
1265816|NCT00473382|4144153|P1|Core Study|Subject non-compliance|5
1265817|NCT00473382|4144151|P3|Core Study|Physician Decision|2
1265818|NCT00473382|4144152|P2|Core Study|Physician Decision|2
1265819|NCT00473382|4144153|P1|Core Study|Physician Decision|1
1265820|NCT00473382|4144151|P3|Core Study|Lost to Follow-up|3
1265821|NCT00473382|4144152|P2|Core Study|Lost to Follow-up|3
1265822|NCT00473382|4144153|P1|Core Study|Lost to Follow-up|3
1265823|NCT00473382|4144151|P3|Core Study|Death|10
1265824|NCT00473382|4144152|P2|Core Study|Death|5
1265825|NCT00473382|4144153|P1|Core Study|Death|3
1265826|NCT00473382|4144151|P3|Core Study|Adverse Event|1
1265827|NCT00473382|4144152|P2|Core Study|Adverse Event|1
1265828|NCT00473382|4144153|P1|Core Study|Adverse Event|3
1265829|NCT00473330|4144211|P3|Open-label Extension Through Month 60|Subject Required Other Therapy|1
1265830|NCT00473330|4144212|P2|Open-label Extension Through Month 60|Subject Required Other Therapy|0
1265831|NCT00473330|4144213|P1|Open-label Extension Through Month 60|Subject Required Other Therapy|1
1265832|NCT00473330|4144211|P3|Open-label Extension Through Month 60|Subject Non-compliance|0
1265833|NCT00473330|4144212|P2|Open-label Extension Through Month 60|Subject Non-compliance|1
1265834|NCT00473330|4144213|P1|Open-label Extension Through Month 60|Subject Non-compliance|2
1265835|NCT00473330|4144211|P3|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|62
1265836|NCT00473330|4144212|P2|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|71
1265837|NCT00473330|4144213|P1|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|77
1265838|NCT00473330|4144211|P3|Open-label Extension Through Month 60|Subject's Decision|4
1265839|NCT00473330|4144212|P2|Open-label Extension Through Month 60|Subject's Decision|3
1265840|NCT00473330|4144213|P1|Open-label Extension Through Month 60|Subject's Decision|1
1265841|NCT00473330|4144211|P3|Open-label Extension Through Month 60|Physician's Decision|3
1265842|NCT00473330|4144212|P2|Open-label Extension Through Month 60|Physician's Decision|1
1265843|NCT00473330|4144213|P1|Open-label Extension Through Month 60|Physician's Decision|2
1265844|NCT00473330|4144211|P3|Open-label Extension Through Month 60|Lost to Follow-up|4
1265845|NCT00473330|4144212|P2|Open-label Extension Through Month 60|Lost to Follow-up|0
1265846|NCT00473330|4144213|P1|Open-label Extension Through Month 60|Lost to Follow-up|3
1265847|NCT00473330|4144211|P3|Open-label Extension Through Month 60|Death|1
1265848|NCT00473330|4144212|P2|Open-label Extension Through Month 60|Death|2
1265849|NCT00473330|4144213|P1|Open-label Extension Through Month 60|Death|2
1265850|NCT00473330|4144211|P3|Open-label Extension Through Month 60|Adverse Event|2
1265851|NCT00473330|4144212|P2|Open-label Extension Through Month 60|Adverse Event|0
1265852|NCT00473330|4144213|P1|Open-label Extension Through Month 60|Adverse Event|0
1265853|NCT00473330|4144211|P3|Open-label Extension Through Month 48|Subject Required Other Therapy|1
1265854|NCT00473330|4144212|P2|Open-label Extension Through Month 48|Subject Required Other Therapy|0
1265855|NCT00473330|4144213|P1|Open-label Extension Through Month 48|Subject Required Other Therapy|0
1265856|NCT00473330|4144211|P3|Open-label Extension Through Month 48|Subject Non-compliance|0
1265857|NCT00473330|4144212|P2|Open-label Extension Through Month 48|Subject Non-compliance|1
1265858|NCT00473330|4144213|P1|Open-label Extension Through Month 48|Subject Non-compliance|2
1265859|NCT00473330|4144211|P3|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|16
1265860|NCT00473330|4144212|P2|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|15
1265861|NCT00473330|4144213|P1|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|18
1265862|NCT00473330|4144211|P3|Open-label Extension Through Month 48|Subject's Decision|3
1265863|NCT00473330|4144212|P2|Open-label Extension Through Month 48|Subject's Decision|3
1265864|NCT00473330|4144213|P1|Open-label Extension Through Month 48|Subject's Decision|1
1265865|NCT00473330|4144211|P3|Open-label Extension Through Month 48|Physician's Decision|3
1265866|NCT00473330|4144212|P2|Open-label Extension Through Month 48|Physician's Decision|1
1265867|NCT00473330|4144213|P1|Open-label Extension Through Month 48|Physician's Decision|2
1265868|NCT00473330|4144211|P3|Open-label Extension Through Month 48|Lost to Follow-up|2
1265869|NCT00473330|4144212|P2|Open-label Extension Through Month 48|Lost to Follow-up|0
1265870|NCT00473330|4144213|P1|Open-label Extension Through Month 48|Lost to Follow-up|1
1265871|NCT00473330|4144211|P3|Open-label Extension Through Month 48|Death|0
1265872|NCT00473330|4144212|P2|Open-label Extension Through Month 48|Death|0
1265873|NCT00473330|4144213|P1|Open-label Extension Through Month 48|Death|2
1265874|NCT00473330|4144211|P3|Open-label Extension Through Month 48|Adverse Event|2
1265875|NCT00473330|4144212|P2|Open-label Extension Through Month 48|Adverse Event|0
1265876|NCT00473330|4144213|P1|Open-label Extension Through Month 48|Adverse Event|0
1265877|NCT00473330|4144211|P3|Core Study|Subject's Decision|19
1265878|NCT00473330|4144212|P2|Core Study|Subject's Decision|8
1265879|NCT00473330|4144213|P1|Core Study|Subject's Decision|9
1265880|NCT00473330|4144211|P3|Core Study|Subject Required Other Therapy|3
1265881|NCT00473330|4144212|P2|Core Study|Subject Required Other Therapy|1
1265882|NCT00473330|4144213|P1|Core Study|Subject Required Other Therapy|0
1265883|NCT00473330|4144211|P3|Core Study|Subject Non-compliance|1
1265884|NCT00473330|4144212|P2|Core Study|Subject Non-compliance|2
1265885|NCT00473330|4144213|P1|Core Study|Subject Non-compliance|1
1265886|NCT00473330|4144211|P3|Core Study|Physician Decision|3
1265887|NCT00473330|4144212|P2|Core Study|Physician Decision|1
1265888|NCT00473330|4144213|P1|Core Study|Physician Decision|2
1265889|NCT00473330|4144211|P3|Core Study|Lost to Follow-up|10
1265890|NCT00473330|4144212|P2|Core Study|Lost to Follow-up|5
1265891|NCT00473330|4144213|P1|Core Study|Lost to Follow-up|5
1265892|NCT00473330|4144211|P3|Core Study|Death|4
1265893|NCT00473330|4144212|P2|Core Study|Death|4
1265894|NCT00473330|4144213|P1|Core Study|Death|6
1265895|NCT00473330|4144211|P3|Core Study|Adverse Event|1
1265896|NCT00473330|4144212|P2|Core Study|Adverse Event|4
1265897|NCT00473330|4144213|P1|Core Study|Adverse Event|4
1265898|NCT00473265|4144268|P1|Overall Study|Off treatment early|15
1265899|NCT00473265|4144268|P1|Overall Study|Unrelated adverse event|5
1265900|NCT00473083|4144280|P3|Overall Study|Adverse Event|0
1265901|NCT00473083|4144281|P2|Overall Study|Adverse Event|0
1265902|NCT00473083|4144282|P1|Overall Study|Adverse Event|1
1265903|NCT00472641|4144357|P1|Overall Study|Lost to Follow-up|1
1265904|NCT00472641|4144357|P1|Overall Study|Adverse Event|3
1265905|NCT00472641|4144357|P1|Overall Study|Lack of Efficacy|3
1265906|NCT00472446|4144377|P4|Overall Study|Questionnaires not returned|4
1265907|NCT00472446|4144378|P3|Overall Study|Questionnaires not returned|6
1265908|NCT00472446|4144379|P2|Overall Study|Questionnaires not returned|6
1265909|NCT00472446|4144380|P1|Overall Study|Questionnaires not returned|5
1265910|NCT00472446|4144377|P4|Overall Study|Reintervention|1
1265911|NCT00472446|4144378|P3|Overall Study|Reintervention|1
1265912|NCT00472446|4144379|P2|Overall Study|Reintervention|0
1265913|NCT00472446|4144380|P1|Overall Study|Reintervention|0
1265914|NCT00472446|4144377|P4|Overall Study|Protocol Violation|1
1265915|NCT00472446|4144378|P3|Overall Study|Protocol Violation|0
1265916|NCT00472446|4144379|P2|Overall Study|Protocol Violation|0
1265917|NCT00472446|4144380|P1|Overall Study|Protocol Violation|0
1265918|NCT00472420|4144410|P1|Follow-up Period|Protocol Violation|1
1265919|NCT00472420|4144410|P1|Follow-up Period|Lost to Follow-up|2
1265920|NCT00472420|4144410|P1|Follow-up Period|Physician Decision|9
1265921|NCT00472420|4144410|P1|Follow-up Period|Death|5
1265922|NCT00472420|4144410|P1|Induction Treatment Period|Death|3
1265923|NCT00472420|4144410|P1|Induction Treatment Period|Non-compliance|1
1265924|NCT00472420|4144410|P1|Induction Treatment Period|Adverse Event|3
1265925|NCT00472420|4144410|P1|Induction Treatment Period|Physician Decision|9
1265926|NCT00472303|4144418|P3|Maintenance Phase|not specified|0
1265927|NCT00472303|4144419|P2|Maintenance Phase|not specified|1
1265928|NCT00472303|4144420|P1|Maintenance Phase|not specified|1
1265929|NCT00472303|4144418|P3|Maintenance Phase|Resolution of pain|1
1265930|NCT00472303|4144419|P2|Maintenance Phase|Resolution of pain|0
1265931|NCT00472303|4144420|P1|Maintenance Phase|Resolution of pain|0
1265932|NCT00472303|4144418|P3|Maintenance Phase|Trial medication non-compliant|1
1265933|NCT00472303|4144419|P2|Maintenance Phase|Trial medication non-compliant|0
1265934|NCT00472303|4144420|P1|Maintenance Phase|Trial medication non-compliant|0
1265935|NCT00472303|4144418|P3|Maintenance Phase|Withdrawal by Subject|3
1265936|NCT00472303|4144419|P2|Maintenance Phase|Withdrawal by Subject|7
1265937|NCT00472303|4144420|P1|Maintenance Phase|Withdrawal by Subject|6
1265938|NCT00472303|4144418|P3|Maintenance Phase|Lack of Efficacy|4
1265939|NCT00472303|4144419|P2|Maintenance Phase|Lack of Efficacy|2
1265940|NCT00472303|4144420|P1|Maintenance Phase|Lack of Efficacy|2
1265941|NCT00472303|4144418|P3|Maintenance Phase|Death|2
1265942|NCT00472303|4144419|P2|Maintenance Phase|Death|0
1265943|NCT00472303|4144420|P1|Maintenance Phase|Death|3
1265944|NCT00472303|4144418|P3|Maintenance Phase|Adverse Event|6
1265945|NCT00472303|4144419|P2|Maintenance Phase|Adverse Event|6
1265946|NCT00472303|4144420|P1|Maintenance Phase|Adverse Event|5
1265947|NCT00472303|4144418|P3|Discontinuations After Titration Phase|not specified|0
1265948|NCT00472303|4144419|P2|Discontinuations After Titration Phase|not specified|0
1265949|NCT00472303|4144420|P1|Discontinuations After Titration Phase|not specified|5
1265950|NCT00472303|4144418|P3|Discontinuations After Titration Phase|Trial Medication non-compliant|0
1265951|NCT00472303|4144419|P2|Discontinuations After Titration Phase|Trial Medication non-compliant|1
1265952|NCT00472303|4144420|P1|Discontinuations After Titration Phase|Trial Medication non-compliant|0
1265953|NCT00472303|4144418|P3|Discontinuations After Titration Phase|Withdrawal by Subject|0
1265954|NCT00472303|4144419|P2|Discontinuations After Titration Phase|Withdrawal by Subject|2
1265955|NCT00472303|4144420|P1|Discontinuations After Titration Phase|Withdrawal by Subject|2
1265956|NCT00472303|4144418|P3|Discontinuations After Titration Phase|Lack of Efficacy|0
1265957|NCT00472303|4144419|P2|Discontinuations After Titration Phase|Lack of Efficacy|17
1265958|NCT00472303|4144420|P1|Discontinuations After Titration Phase|Lack of Efficacy|48
1265959|NCT00472303|4144418|P3|Discontinuations After Titration Phase|Adverse Event|0
1265960|NCT00472303|4144419|P2|Discontinuations After Titration Phase|Adverse Event|0
1265961|NCT00472303|4144420|P1|Discontinuations After Titration Phase|Adverse Event|6
1265962|NCT00472303|4144418|P3|Titration Phase|not specified|0
1265963|NCT00472303|4144419|P2|Titration Phase|not specified|1
1265964|NCT00472303|4144420|P1|Titration Phase|not specified|3
1265965|NCT00472303|4144418|P3|Titration Phase|Trial Medication non-compliant|0
1265966|NCT00472303|4144419|P2|Titration Phase|Trial Medication non-compliant|1
1265967|NCT00472303|4144420|P1|Titration Phase|Trial Medication non-compliant|4
1265968|NCT00472303|4144418|P3|Titration Phase|Withdrawal by Subject|0
1265969|NCT00472303|4144419|P2|Titration Phase|Withdrawal by Subject|13
1265970|NCT00472303|4144420|P1|Titration Phase|Withdrawal by Subject|16
1265971|NCT00472303|4144418|P3|Titration Phase|Lack of Efficacy|0
1265972|NCT00472303|4144419|P2|Titration Phase|Lack of Efficacy|0
1265973|NCT00472303|4144420|P1|Titration Phase|Lack of Efficacy|10
1265974|NCT00472303|4144418|P3|Titration Phase|Death|0
1265975|NCT00472303|4144419|P2|Titration Phase|Death|2
1265976|NCT00472303|4144420|P1|Titration Phase|Death|4
1265977|NCT00472303|4144418|P3|Titration Phase|Adverse Event|0
1265978|NCT00472303|4144419|P2|Titration Phase|Adverse Event|12
1265979|NCT00472303|4144420|P1|Titration Phase|Adverse Event|22
1265980|NCT00472290|4144483|P1|Overall Study|Requirement for alternative therapy|7
1265981|NCT00472290|4144483|P1|Overall Study|Adverse Event|6
1265982|NCT00472290|4144483|P1|Overall Study|Withdrawal by Subject|5
1265983|NCT00472290|4144483|P1|Overall Study|Disease Progression|4
1265984|NCT00472290|4144483|P1|Overall Study|Lack of Efficacy|1
1265985|NCT00472290|4144483|P1|Overall Study|Lost to Follow-up|1
1265986|NCT00472290|4144483|P1|Overall Study|Death|3
1265987|NCT00472290|4144483|P1|Overall Study|Administrative Decision|37
1265988|NCT00472290|4144483|P1|Overall Study|Protocol Specified Criteria|7
1265989|NCT00472290|4144483|P1|Overall Study|Progression of Therapy-Related MDS|1
1265990|NCT00472199|4144495|P2|Overall Study|patient was asymptomatic|0
1265991|NCT00472199|4144496|P1|Overall Study|patient was asymptomatic|1
1265992|NCT00472199|4144495|P2|Overall Study|personal reason|1
1265993|NCT00472199|4144496|P1|Overall Study|personal reason|0
1265994|NCT00472199|4144495|P2|Overall Study|Withdrawal by Subject|5
1265995|NCT00472199|4144496|P1|Overall Study|Withdrawal by Subject|6
1265996|NCT00472199|4144495|P2|Overall Study|Protocol Violation|2
1265997|NCT00472199|4144496|P1|Overall Study|Protocol Violation|3
1265998|NCT00472199|4144495|P2|Overall Study|Lost to Follow-up|4
1265999|NCT00472199|4144496|P1|Overall Study|Lost to Follow-up|2
1266000|NCT00472199|4144495|P2|Overall Study|Lack of Efficacy|25
1266001|NCT00472199|4144496|P1|Overall Study|Lack of Efficacy|4
1266002|NCT00472199|4144495|P2|Overall Study|Adverse Event|23
1266003|NCT00472199|4144496|P1|Overall Study|Adverse Event|19
1266004|NCT00472082|4144562|P1|Overall Study|Study prematurely terminated|5
1266005|NCT00472030|4144584|P2|Overall Study|Physician Decision|0
1266006|NCT00472030|4144585|P1|Overall Study|Physician Decision|1
1266007|NCT00471822|4144601|P1|Overall Study|Protocol Violation|2
1266008|NCT00471718|4144609|P1|Overall Study|Withdrawal by Subject|1
1266009|NCT00471718|4144609|P1|Overall Study|disease progression|22
1266010|NCT00471718|4144609|P1|Overall Study|other complicating disease|1
1266011|NCT00471718|4144609|P1|Overall Study|Adverse Event|3
1266012|NCT00471536|4144637|P1|Overall Study|Withdrawal by Subject|1
1266013|NCT00471497|4144649|P3|Overall Study|Sub optimal response or treat. failure|0
1266014|NCT00471497|4144650|P2|Overall Study|Sub optimal response or treat. failure|3
1266015|NCT00471497|4144651|P1|Overall Study|Sub optimal response or treat. failure|8
1266016|NCT00471497|4144649|P3|Overall Study|Protocol Violation|5
1266018|NCT00471497|4144651|P1|Overall Study|Protocol Violation|3
1266019|NCT00471497|4144649|P3|Overall Study|Disease Progression|2
1266020|NCT00471497|4144650|P2|Overall Study|Disease Progression|2
1266021|NCT00471497|4144651|P1|Overall Study|Disease Progression|8
1266022|NCT00471497|4144649|P3|Overall Study|Death|0
1266023|NCT00471497|4144650|P2|Overall Study|Death|2
1266024|NCT00471497|4144651|P1|Overall Study|Death|0
1266025|NCT00471497|4144649|P3|Overall Study|Lost to Follow-up|1
1266026|NCT00471497|4144650|P2|Overall Study|Lost to Follow-up|2
1266027|NCT00471497|4144651|P1|Overall Study|Lost to Follow-up|1
1266028|NCT00471497|4144649|P3|Overall Study|Withdrawal by Subject|5
1266029|NCT00471497|4144650|P2|Overall Study|Withdrawal by Subject|5
1266030|NCT00471497|4144651|P1|Overall Study|Withdrawal by Subject|3
1266031|NCT00471497|4144649|P3|Overall Study|Condition no longer requires study drug|0
1266032|NCT00471497|4144650|P2|Overall Study|Condition no longer requires study drug|1
1266033|NCT00471497|4144651|P1|Overall Study|Condition no longer requires study drug|0
1266034|NCT00471497|4144649|P3|Overall Study|Abnormal Test Procedure|1
1266035|NCT00471497|4144650|P2|Overall Study|Abnormal Test Procedure|0
1266036|NCT00471497|4144651|P1|Overall Study|Abnormal Test Procedure|1
1266037|NCT00471497|4144649|P3|Overall Study|Abnormal Laboratory Value|4
1266038|NCT00471497|4144650|P2|Overall Study|Abnormal Laboratory Value|6
1266039|NCT00471497|4144651|P1|Overall Study|Abnormal Laboratory Value|3
1266040|NCT00471497|4144649|P3|Overall Study|Adverse Event|22
1266041|NCT00471497|4144650|P2|Overall Study|Adverse Event|11
1266042|NCT00471497|4144651|P1|Overall Study|Adverse Event|19
1266043|NCT00471445|4144661|P2|Overall Study|Protocol Violation|1
1266044|NCT00471445|4144662|P1|Overall Study|Protocol Violation|0
1266045|NCT00471445|4144661|P2|Overall Study|Ineligible|0
1266046|NCT00471445|4144662|P1|Overall Study|Ineligible|1
1266047|NCT00471445|4144661|P2|Overall Study|Withdrawal by Subject|1
1266048|NCT00471445|4144662|P1|Overall Study|Withdrawal by Subject|1
1266049|NCT00471354|4144675|P1|Overall Study|Patient/Caregiver Decision|12
1266050|NCT00471354|4144675|P1|Overall Study|Lack of Efficacy|5
1266051|NCT00471354|4144675|P1|Overall Study|Lost to Follow-up|3
1266052|NCT00471354|4144675|P1|Overall Study|Sponsor Decision|1
1266053|NCT00471354|4144675|P1|Overall Study|Physician Decision|4
1266054|NCT00471354|4144675|P1|Overall Study|Withdrawal by Subject|1
1266055|NCT00471354|4144675|P1|Overall Study|Protocol Violation|12
1266056|NCT00471354|4144675|P1|Overall Study|Adverse Event|13
1266057|NCT00471354|4144675|P1|Overall Study|Protocol Entry Criteria Not Met|1
1266058|NCT00471328|4144687|P2|Extension Phase|Administrative Problem|0
1266059|NCT00471328|4144688|P1|Extension Phase|Administrative Problem|1
1266060|NCT00471328|4144687|P2|Extension Phase|New cancer Therapy|0
1266061|NCT00471328|4144688|P1|Extension Phase|New cancer Therapy|1
1266062|NCT00471328|4144687|P2|Extension Phase|Disease Progression|44
1266063|NCT00471328|4144688|P1|Extension Phase|Disease Progression|32
1266064|NCT00471328|4144687|P2|Extension Phase|Treatment duration as per protocol|1
1266065|NCT00471328|4144688|P1|Extension Phase|Treatment duration as per protocol|0
1266066|NCT00471328|4144687|P2|Extension Phase|Protocol Deviation|1
1266067|NCT00471328|4144688|P1|Extension Phase|Protocol Deviation|3
1266068|NCT00471328|4144687|P2|Extension Phase|Death|7
1266069|NCT00471328|4144688|P1|Extension Phase|Death|1
1266070|NCT00471328|4144687|P2|Extension Phase|Withdrawal by Subject|2
1266071|NCT00471328|4144688|P1|Extension Phase|Withdrawal by Subject|0
1266072|NCT00471328|4144687|P2|Extension Phase|Adverse Event|12
1266073|NCT00471328|4144688|P1|Extension Phase|Adverse Event|3
1266074|NCT00471328|4144687|P2|Core Phase|Protocol Deviation|1
1266075|NCT00471328|4144688|P1|Core Phase|Protocol Deviation|0
1266076|NCT00471328|4144687|P2|Core Phase|Administrative Problem|1
1266077|NCT00471328|4144688|P1|Core Phase|Administrative Problem|0
1266078|NCT00471328|4144687|P2|Core Phase|Disease Progression|53
1266079|NCT00471328|4144688|P1|Core Phase|Disease Progression|78
1266080|NCT00471328|4144687|P2|Core Phase|Abnormal laboratory value|0
1266081|NCT00471328|4144688|P1|Core Phase|Abnormal laboratory value|1
1266082|NCT00471328|4144687|P2|Core Phase|Withdrawal by Subject|2
1266083|NCT00471328|4144688|P1|Core Phase|Withdrawal by Subject|2
1266084|NCT00471328|4144687|P2|Core Phase|Death|4
1266085|NCT00471328|4144688|P1|Core Phase|Death|8
1266086|NCT00471328|4144687|P2|Core Phase|Adverse Event|6
1266087|NCT00471328|4144688|P1|Core Phase|Adverse Event|18
1266088|NCT00471315|4144707|P1|Overall Study|Withdrawal by Subject|1
1266089|NCT00471315|4144707|P1|Overall Study|Adverse Event|7
1266090|NCT00471276|4144712|P1|Overall Study|Refused treatment|6
1266091|NCT00471276|4144712|P1|Overall Study|Other|3
1266092|NCT00471276|4144712|P1|Overall Study|Global deterioration of health status|1
1266093|NCT00471276|4144712|P1|Overall Study|Objective progression or relapse|54
1266094|NCT00471276|4144712|P1|Overall Study|Protocol Violation|1
1266095|NCT00471276|4144712|P1|Overall Study|Adverse Event|16
1266096|NCT00471276|4144712|P1|Overall Study|Death|2
1266097|NCT00471237|4144742|P7|Overall Study|Participant's decision|0
1266098|NCT00471237|4144743|P6|Overall Study|Participant's decision|1
1266099|NCT00471237|4144744|P5|Overall Study|Participant's decision|0
1266100|NCT00471237|4144745|P4|Overall Study|Participant's decision|0
1266101|NCT00471237|4144746|P3|Overall Study|Participant's decision|0
1266102|NCT00471237|4144747|P2|Overall Study|Participant's decision|0
1266103|NCT00471237|4144748|P1|Overall Study|Participant's decision|0
1266104|NCT00471237|4144742|P7|Overall Study|Participant shifted residence|0
1266105|NCT00471237|4144743|P6|Overall Study|Participant shifted residence|0
1266106|NCT00471237|4144744|P5|Overall Study|Participant shifted residence|1
1266107|NCT00471237|4144745|P4|Overall Study|Participant shifted residence|0
1266108|NCT00471237|4144746|P3|Overall Study|Participant shifted residence|0
1266109|NCT00471237|4144747|P2|Overall Study|Participant shifted residence|0
1266110|NCT00471237|4144748|P1|Overall Study|Participant shifted residence|0
1266111|NCT00471237|4144742|P7|Overall Study|Administration of prohibited medicine|0
1266112|NCT00471237|4144743|P6|Overall Study|Administration of prohibited medicine|0
1266113|NCT00471237|4144744|P5|Overall Study|Administration of prohibited medicine|1
1266114|NCT00471237|4144745|P4|Overall Study|Administration of prohibited medicine|0
1266115|NCT00471237|4144746|P3|Overall Study|Administration of prohibited medicine|0
1266116|NCT00471237|4144747|P2|Overall Study|Administration of prohibited medicine|0
1266117|NCT00471237|4144748|P1|Overall Study|Administration of prohibited medicine|0
1266118|NCT00471237|4144742|P7|Overall Study|Participant lost medication|0
1266119|NCT00471237|4144743|P6|Overall Study|Participant lost medication|0
1266120|NCT00471237|4144744|P5|Overall Study|Participant lost medication|1
1266121|NCT00471237|4144745|P4|Overall Study|Participant lost medication|0
1266122|NCT00471237|4144746|P3|Overall Study|Participant lost medication|0
1266123|NCT00471237|4144747|P2|Overall Study|Participant lost medication|0
1266124|NCT00471237|4144748|P1|Overall Study|Participant lost medication|0
1266125|NCT00471237|4144742|P7|Overall Study|High parathyroid hormone|0
1266126|NCT00471237|4144743|P6|Overall Study|High parathyroid hormone|0
1266127|NCT00471237|4144744|P5|Overall Study|High parathyroid hormone|0
1266128|NCT00471237|4144745|P4|Overall Study|High parathyroid hormone|0
1266129|NCT00471237|4144746|P3|Overall Study|High parathyroid hormone|1
1266130|NCT00471237|4144747|P2|Overall Study|High parathyroid hormone|0
1266131|NCT00471237|4144748|P1|Overall Study|High parathyroid hormone|0
1266132|NCT00471237|4144742|P7|Overall Study|Participant planned to travel to abraod|0
1266133|NCT00471237|4144743|P6|Overall Study|Participant planned to travel to abraod|1
1266134|NCT00471237|4144744|P5|Overall Study|Participant planned to travel to abraod|0
1266135|NCT00471237|4144745|P4|Overall Study|Participant planned to travel to abraod|0
1266136|NCT00471237|4144746|P3|Overall Study|Participant planned to travel to abraod|0
1266137|NCT00471237|4144747|P2|Overall Study|Participant planned to travel to abraod|0
1266138|NCT00471237|4144748|P1|Overall Study|Participant planned to travel to abraod|1
1266139|NCT00471237|4144742|P7|Overall Study|Early stopping due to non-efficacy|0
1266140|NCT00471237|4144743|P6|Overall Study|Early stopping due to non-efficacy|0
1266141|NCT00471237|4144744|P5|Overall Study|Early stopping due to non-efficacy|1
1266142|NCT00471237|4144745|P4|Overall Study|Early stopping due to non-efficacy|0
1266143|NCT00471237|4144746|P3|Overall Study|Early stopping due to non-efficacy|0
1266144|NCT00471237|4144747|P2|Overall Study|Early stopping due to non-efficacy|0
1266145|NCT00471237|4144748|P1|Overall Study|Early stopping due to non-efficacy|1
1266146|NCT00471237|4144742|P7|Overall Study|Met serum creatinine withdrawal criteria|0
1266147|NCT00471237|4144743|P6|Overall Study|Met serum creatinine withdrawal criteria|0
1266148|NCT00471237|4144744|P5|Overall Study|Met serum creatinine withdrawal criteria|0
1266149|NCT00471237|4144745|P4|Overall Study|Met serum creatinine withdrawal criteria|2
1266150|NCT00471237|4144746|P3|Overall Study|Met serum creatinine withdrawal criteria|2
1266151|NCT00471237|4144747|P2|Overall Study|Met serum creatinine withdrawal criteria|0
1266152|NCT00471237|4144748|P1|Overall Study|Met serum creatinine withdrawal criteria|1
1266153|NCT00471237|4144742|P7|Overall Study|Non-compliance|0
1266154|NCT00471237|4144743|P6|Overall Study|Non-compliance|0
1266155|NCT00471237|4144744|P5|Overall Study|Non-compliance|0
1266156|NCT00471237|4144745|P4|Overall Study|Non-compliance|1
1266157|NCT00471237|4144746|P3|Overall Study|Non-compliance|0
1266158|NCT00471237|4144747|P2|Overall Study|Non-compliance|1
1266159|NCT00471237|4144748|P1|Overall Study|Non-compliance|0
1266160|NCT00471237|4144742|P7|Overall Study|Sponsor terminated study|0
1266161|NCT00471237|4144743|P6|Overall Study|Sponsor terminated study|24
1266162|NCT00471237|4144744|P5|Overall Study|Sponsor terminated study|18
1266163|NCT00471237|4144745|P4|Overall Study|Sponsor terminated study|22
1266164|NCT00471237|4144746|P3|Overall Study|Sponsor terminated study|19
1266165|NCT00471237|4144747|P2|Overall Study|Sponsor terminated study|23
1266166|NCT00471237|4144748|P1|Overall Study|Sponsor terminated study|20
1266167|NCT00471237|4144742|P7|Overall Study|Withdrawal by Subject|2
1266168|NCT00471237|4144743|P6|Overall Study|Withdrawal by Subject|4
1266169|NCT00471237|4144744|P5|Overall Study|Withdrawal by Subject|7
1266170|NCT00471237|4144745|P4|Overall Study|Withdrawal by Subject|8
1266171|NCT00471237|4144746|P3|Overall Study|Withdrawal by Subject|5
1266172|NCT00471237|4144747|P2|Overall Study|Withdrawal by Subject|6
1266173|NCT00471237|4144748|P1|Overall Study|Withdrawal by Subject|8
1266174|NCT00471237|4144742|P7|Overall Study|Protocol Violation|1
1266175|NCT00471237|4144743|P6|Overall Study|Protocol Violation|4
1266176|NCT00471237|4144744|P5|Overall Study|Protocol Violation|2
1266177|NCT00471237|4144745|P4|Overall Study|Protocol Violation|2
1266178|NCT00471237|4144746|P3|Overall Study|Protocol Violation|3
1266179|NCT00471237|4144747|P2|Overall Study|Protocol Violation|6
1266180|NCT00471237|4144748|P1|Overall Study|Protocol Violation|3
1266181|NCT00471237|4144742|P7|Overall Study|Lost to Follow-up|0
1266182|NCT00471237|4144743|P6|Overall Study|Lost to Follow-up|0
1266183|NCT00471237|4144744|P5|Overall Study|Lost to Follow-up|3
1266184|NCT00471237|4144745|P4|Overall Study|Lost to Follow-up|2
1266185|NCT00471237|4144746|P3|Overall Study|Lost to Follow-up|0
1266186|NCT00471237|4144747|P2|Overall Study|Lost to Follow-up|1
1266187|NCT00471237|4144748|P1|Overall Study|Lost to Follow-up|1
1266188|NCT00471237|4144742|P7|Overall Study|Adverse Event|0
1266189|NCT00471237|4144743|P6|Overall Study|Adverse Event|5
1266190|NCT00471237|4144744|P5|Overall Study|Adverse Event|7
1266191|NCT00471237|4144745|P4|Overall Study|Adverse Event|8
1266192|NCT00471237|4144746|P3|Overall Study|Adverse Event|4
1266193|NCT00471237|4144747|P2|Overall Study|Adverse Event|5
1266194|NCT00471237|4144748|P1|Overall Study|Adverse Event|6
1266195|NCT00471146|4144898|P2|Overall Study|Other|5
1266196|NCT00471146|4144899|P1|Overall Study|Other|4
1266197|NCT00471146|4144898|P2|Overall Study|Randomized but not treated|8
1266198|NCT00471146|4144899|P1|Overall Study|Randomized but not treated|9
1266199|NCT00471146|4144898|P2|Overall Study|Global deterioration of health status|14
1266200|NCT00471146|4144899|P1|Overall Study|Global deterioration of health status|12
1266201|NCT00471146|4144898|P2|Overall Study|Objective progression or relapse|87
1266202|NCT00471146|4144899|P1|Overall Study|Objective progression or relapse|84
1266203|NCT00471146|4144898|P2|Overall Study|Protocol Violation|2
1266204|NCT00471146|4144899|P1|Overall Study|Protocol Violation|2
1266205|NCT00471146|4144898|P2|Overall Study|Lost to Follow-up|2
1266206|NCT00471146|4144899|P1|Overall Study|Lost to Follow-up|4
1266207|NCT00471146|4144898|P2|Overall Study|Death|12
1266208|NCT00471146|4144899|P1|Overall Study|Death|11
1266209|NCT00471146|4144898|P2|Overall Study|Withdrawal by Subject|11
1266210|NCT00471146|4144899|P1|Overall Study|Withdrawal by Subject|14
1266211|NCT00471146|4144898|P2|Overall Study|Adverse Event|33
1266212|NCT00471146|4144899|P1|Overall Study|Adverse Event|32
1266213|NCT00471107|4144924|P3|Overall Study|Technical problems/data loss|3
1266214|NCT00471107|4144925|P2|Overall Study|Technical problems/data loss|1
1266215|NCT00471107|4144926|P1|Overall Study|Technical problems/data loss|3
1266216|NCT00471081|4144936|P2|Extended Safety Follow-Up|Missing confirmed|1
1266217|NCT00471081|4144937|P1|Extended Safety Follow-Up|Missing confirmed|0
1266218|NCT00471081|4144936|P2|Extended Safety Follow-Up|Lost to Follow-up|8
1266219|NCT00471081|4144937|P1|Extended Safety Follow-Up|Lost to Follow-up|1
1266220|NCT00471081|4144936|P2|Extended Safety Follow-Up|Withdrawal by Subject|4
1266221|NCT00471081|4144937|P1|Extended Safety Follow-Up|Withdrawal by Subject|1
1266222|NCT00471081|4144936|P2|Active Phase|Lost health plan/insurance|8
1266223|NCT00471081|4144937|P1|Active Phase|Lost health plan/insurance|1
1266224|NCT00471081|4144936|P2|Active Phase|Lost to Follow-up|1
1266225|NCT00471081|4144937|P1|Active Phase|Lost to Follow-up|0
1266226|NCT00471081|4144936|P2|Active Phase|Withdrawal by Subject|3
1266227|NCT00471081|4144937|P1|Active Phase|Withdrawal by Subject|0
1266228|NCT00471081|4144936|P2|Active Phase|Protocol Violation|1
1266229|NCT00471081|4144937|P1|Active Phase|Protocol Violation|1
1266230|NCT00470847|4144983|P1|Overall Study|Pt still receiving treatment|1
1266231|NCT00470834|4144996|P2|Extension Period (24 Months)|Disease Progression|1
1266232|NCT00470834|4144997|P1|Extension Period (24 Months)|Disease Progression|0
1266233|NCT00470834|4144996|P2|Extension Period (24 Months)|Non-compliance|1
1266234|NCT00470834|4144997|P1|Extension Period (24 Months)|Non-compliance|0
1266235|NCT00470834|4144996|P2|Extension Period (24 Months)|Lost to Follow-up|1
1266236|NCT00470834|4144997|P1|Extension Period (24 Months)|Lost to Follow-up|0
1266237|NCT00470834|4144996|P2|Extension Period (24 Months)|Sponsor Terminated Study|1
1266238|NCT00470834|4144997|P1|Extension Period (24 Months)|Sponsor Terminated Study|0
1266239|NCT00470834|4144996|P2|Extension Period (24 Months)|Physician Decision|3
1266240|NCT00470834|4144997|P1|Extension Period (24 Months)|Physician Decision|4
1266241|NCT00470834|4144996|P2|Extension Period (24 Months)|Withdrawal by Subject|5
1266242|NCT00470834|4144997|P1|Extension Period (24 Months)|Withdrawal by Subject|2
1266243|NCT00470834|4144996|P2|Extension Period (24 Months)|Adverse Event|4
1266244|NCT00470834|4144997|P1|Extension Period (24 Months)|Adverse Event|3
1266245|NCT00470834|4144996|P2|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7
1266246|NCT00470834|4144997|P1|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6
1266247|NCT00470834|4144996|P2|Treatment Period (18 Months)|Lack of Efficacy|0
1266248|NCT00470834|4144997|P1|Treatment Period (18 Months)|Lack of Efficacy|1
1266249|NCT00470834|4144996|P2|Treatment Period (18 Months)|Non-compliance|0
1266250|NCT00470834|4144997|P1|Treatment Period (18 Months)|Non-compliance|1
1266251|NCT00470834|4144996|P2|Treatment Period (18 Months)|Lost to Follow-up|0
1266252|NCT00470834|4144997|P1|Treatment Period (18 Months)|Lost to Follow-up|1
1266253|NCT00470834|4144996|P2|Treatment Period (18 Months)|Sponsor Terminated Study|1
1266254|NCT00470834|4144997|P1|Treatment Period (18 Months)|Sponsor Terminated Study|1
1266255|NCT00470834|4144996|P2|Treatment Period (18 Months)|Protocol Violation|1
1266256|NCT00470834|4144997|P1|Treatment Period (18 Months)|Protocol Violation|3
1266257|NCT00470834|4144996|P2|Treatment Period (18 Months)|Physician Decision|4
1266258|NCT00470834|4144997|P1|Treatment Period (18 Months)|Physician Decision|4
1266259|NCT00470834|4144996|P2|Treatment Period (18 Months)|Withdrawal by Subject|5
1266260|NCT00470834|4144997|P1|Treatment Period (18 Months)|Withdrawal by Subject|4
1266261|NCT00470834|4144996|P2|Treatment Period (18 Months)|Adverse Event|6
1266262|NCT00470834|4144997|P1|Treatment Period (18 Months)|Adverse Event|7
1266263|NCT00470834|4144996|P2|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14
1266264|NCT00470834|4144997|P1|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16
1266265|NCT00470626|4145011|P1|Overall Study|Withdrawal by Subject|7
1266266|NCT00470626|4145011|P1|Overall Study|Lost to Follow-up|10
1266267|NCT00470535|4145053|P1|Overall Study|Other|2
1266268|NCT00470535|4145053|P1|Overall Study|Death|1
1266269|NCT00470535|4145053|P1|Overall Study|Adverse Event|1
1266270|NCT00470535|4145053|P1|Overall Study|Withdrawal by Subject|1
1266271|NCT00470535|4145053|P1|Overall Study|Disease Progression|13
1266272|NCT00470470|4145062|P1|Overall Study|Not treated|1
1266273|NCT00470470|4145062|P1|Overall Study|Death|2
1266274|NCT00470470|4145062|P1|Overall Study|Adverse Event|2
1266275|NCT00470418|4145069|P2|Overall Study|Withdrawal by Subject|0
1266276|NCT00470418|4145070|P1|Overall Study|Withdrawal by Subject|1
1266277|NCT00470366|4145091|P1|Overall Study|Poor compliance|1
1266278|NCT00470366|4145091|P1|Overall Study|Adverse Event|3
1266279|NCT00470275|4145102|P1|Overall Study|Withdrawal by Subject|2
1266280|NCT00470275|4145102|P1|Overall Study|Lack of Efficacy|7
1266281|NCT00470275|4145102|P1|Overall Study|Death|1
1266282|NCT00470262|4145108|P2|Overall Study|Withdrawal by Subject|0
1266283|NCT00470262|4145109|P1|Overall Study|Withdrawal by Subject|2
1266284|NCT00470184|4145117|P1|Overall Study|recurrence|1
1266285|NCT00470184|4145117|P1|Overall Study|other|5
1266286|NCT00470184|4145117|P1|Overall Study|Withdrawal by Subject|4
1266287|NCT00470184|4145117|P1|Overall Study|Adverse Event|3
1266288|NCT00470184|4145117|P1|Overall Study|disease Progression|4
1266289|NCT00470184|4145117|P1|Overall Study|Not treated (other)|1
1266290|NCT00470184|4145117|P1|Overall Study|Not Treated(became ineligible)|4
1266291|NCT00470158|4145129|P5|Overall Study|Protocol Violation|0
1266292|NCT00470158|4145130|P4|Overall Study|Protocol Violation|0
1266293|NCT00470158|4145131|P3|Overall Study|Protocol Violation|0
1266294|NCT00470158|4145132|P2|Overall Study|Protocol Violation|0
1266295|NCT00470158|4145133|P1|Overall Study|Protocol Violation|1
1266296|NCT00470158|4145129|P5|Overall Study|Lost to Follow-up|4
1266297|NCT00470158|4145130|P4|Overall Study|Lost to Follow-up|5
1266298|NCT00470158|4145131|P3|Overall Study|Lost to Follow-up|8
1266299|NCT00470158|4145132|P2|Overall Study|Lost to Follow-up|8
1266300|NCT00470158|4145133|P1|Overall Study|Lost to Follow-up|7
1266301|NCT00470158|4145129|P5|Overall Study|Death|2
1266302|NCT00470158|4145130|P4|Overall Study|Death|0
1266303|NCT00470158|4145131|P3|Overall Study|Death|0
1266304|NCT00470158|4145132|P2|Overall Study|Death|0
1266305|NCT00470158|4145133|P1|Overall Study|Death|0
1266306|NCT00470093|4145166|P1|Overall Study|Adverse Event|2
1266307|NCT00470067|4145173|P1|Overall Study|Disease Progression|6
1266308|NCT00470067|4145173|P1|Overall Study|Death|1
1266309|NCT00470054|4145177|P1|Overall Study|Ineligible|1
1266310|NCT00469898|4145193|P1|Overall Study|Decreased performance status|1
1266311|NCT00469898|4145193|P1|Overall Study|Disease progression|9
1266312|NCT00469898|4145193|P1|Overall Study|Death|4
1266313|NCT00469898|4145193|P1|Overall Study|Withdrawal by Subject|4
1266314|NCT00469898|4145193|P1|Overall Study|Adverse Event|7
1266315|NCT00469859|4145202|P2|Overall Study|Inevaluable|2
1266316|NCT00469859|4145203|P1|Overall Study|Inevaluable|0
1266317|NCT00469833|4145211|P1|Overall Study|No IV access|2
1266318|NCT00469612|4145223|P2|Overall Study|Study terminated before data collected|0
1266319|NCT00469612|4145224|P1|Overall Study|Study terminated before data collected|2
1266320|NCT00469456|4145251|P2|Overall Study|Withdrawal by Subject|1
1266321|NCT00469456|4145252|P1|Overall Study|Withdrawal by Subject|4
1266322|NCT00469456|4145251|P2|Overall Study|Protocol Violation|0
1266323|NCT00469456|4145252|P1|Overall Study|Protocol Violation|1
1266324|NCT00469456|4145251|P2|Overall Study|Adverse Event|3
1266325|NCT00469456|4145252|P1|Overall Study|Adverse Event|4
1266326|NCT00469209|4145281|P3|Overall Study|Adverse Event|1
1266327|NCT00469209|4145282|P2|Overall Study|Adverse Event|0
1266328|NCT00469209|4145283|P1|Overall Study|Adverse Event|1
1266329|NCT00469092|4145293|P2|Overall Study|Use of Corticosteroid|0
1266330|NCT00469092|4145294|P1|Overall Study|Use of Corticosteroid|1
1266331|NCT00469092|4145293|P2|Overall Study|Abnormal lab value|0
1266332|NCT00469092|4145294|P1|Overall Study|Abnormal lab value|1
1266333|NCT00469092|4145293|P2|Overall Study|Hypoglycaemic Episodes|1
1266334|NCT00469092|4145294|P1|Overall Study|Hypoglycaemic Episodes|1
1266335|NCT00469092|4145293|P2|Overall Study|Use of lipid lowering drug|0
1266336|NCT00469092|4145294|P1|Overall Study|Use of lipid lowering drug|1
1266337|NCT00469092|4145293|P2|Overall Study|Contraindication metformin/glimepiride|0
1266338|NCT00469092|4145294|P1|Overall Study|Contraindication metformin/glimepiride|1
1266339|NCT00469092|4145293|P2|Overall Study|Incorrectly Randomised|3
1266340|NCT00469092|4145294|P1|Overall Study|Incorrectly Randomised|4
1266341|NCT00469092|4145293|P2|Overall Study|Withdrawal Criteria|4
1266342|NCT00469092|4145294|P1|Overall Study|Withdrawal Criteria|3
1266343|NCT00469092|4145293|P2|Overall Study|Withdrawal by Subject|4
1266344|NCT00469092|4145294|P1|Overall Study|Withdrawal by Subject|4
1266345|NCT00469092|4145293|P2|Overall Study|Protocol Violation|3
1266346|NCT00469092|4145294|P1|Overall Study|Protocol Violation|3
1266347|NCT00469092|4145293|P2|Overall Study|Lost to Follow-up|2
1266348|NCT00469092|4145294|P1|Overall Study|Lost to Follow-up|1
1266349|NCT00469092|4145293|P2|Overall Study|Lack of Efficacy|0
1266350|NCT00469092|4145294|P1|Overall Study|Lack of Efficacy|1
1266351|NCT00469092|4145293|P2|Overall Study|Adverse Event|4
1266352|NCT00469092|4145294|P1|Overall Study|Adverse Event|5
1266353|NCT00469079|4145313|P3|Overall Study|Ineligible|0
1266354|NCT00469079|4145314|P2|Overall Study|Ineligible|1
1266355|NCT00469079|4145315|P1|Overall Study|Ineligible|0
1266356|NCT00469079|4145313|P3|Overall Study|Withdrawal by Subject|2
1266357|NCT00469079|4145314|P2|Overall Study|Withdrawal by Subject|2
1266358|NCT00469079|4145315|P1|Overall Study|Withdrawal by Subject|1
1266359|NCT00469079|4145313|P3|Overall Study|Lost to Follow-up|10
1266360|NCT00469079|4145314|P2|Overall Study|Lost to Follow-up|8
1266361|NCT00469079|4145315|P1|Overall Study|Lost to Follow-up|4
1266362|NCT00469079|4145313|P3|Overall Study|Adverse Event|2
1266363|NCT00469079|4145314|P2|Overall Study|Adverse Event|3
1266364|NCT00469079|4145315|P1|Overall Study|Adverse Event|1
1266365|NCT00469079|4145313|P3|Overall Study|Lack of Efficacy|5
1266366|NCT00469079|4145314|P2|Overall Study|Lack of Efficacy|8
1266367|NCT00469079|4145315|P1|Overall Study|Lack of Efficacy|3
1266368|NCT00468910|4145334|P2|Overall Study|Medical Contraindication|1
1266369|NCT00468910|4145335|P1|Overall Study|Medical Contraindication|0
1266370|NCT00468910|4145334|P2|Overall Study|Withdrawal by Subject|1
1266371|NCT00468910|4145335|P1|Overall Study|Withdrawal by Subject|2
1266372|NCT00468910|4145334|P2|Overall Study|Lost to Follow-up|1
1266373|NCT00468910|4145335|P1|Overall Study|Lost to Follow-up|2
1266374|NCT00468858|4145354|P3|Overall Study|Other|1
1266375|NCT00468858|4145355|P2|Overall Study|Other|0
1266376|NCT00468858|4145356|P1|Overall Study|Other|0
1266377|NCT00468858|4145354|P3|Overall Study|Lost to Follow-up|5
1266378|NCT00468858|4145355|P2|Overall Study|Lost to Follow-up|2
1266379|NCT00468858|4145356|P1|Overall Study|Lost to Follow-up|1
1266380|NCT00468858|4145354|P3|Overall Study|Relocation|3
1266381|NCT00468858|4145355|P2|Overall Study|Relocation|3
1266382|NCT00468858|4145356|P1|Overall Study|Relocation|1
1266383|NCT00468858|4145354|P3|Overall Study|Withdrawal by Subject|5
1266384|NCT00468858|4145355|P2|Overall Study|Withdrawal by Subject|4
1266385|NCT00468858|4145356|P1|Overall Study|Withdrawal by Subject|7
1266386|NCT00468858|4145354|P3|Overall Study|Adverse Event|0
1266387|NCT00468858|4145355|P2|Overall Study|Adverse Event|1
1266388|NCT00468858|4145356|P1|Overall Study|Adverse Event|0
1266389|NCT00468845|4145477|P3|Overall Study|Randomized, not treated|2
1266390|NCT00468845|4145478|P2|Overall Study|Randomized, not treated|4
1266391|NCT00468845|4145479|P1|Overall Study|Randomized, not treated|1
1266392|NCT00468845|4145477|P3|Overall Study|No longer willing to participate|10
1266393|NCT00468845|4145478|P2|Overall Study|No longer willing to participate|6
1266394|NCT00468845|4145479|P1|Overall Study|No longer willing to participate|5
1266395|NCT00468845|4145477|P3|Overall Study|Other|5
1266396|NCT00468845|4145478|P2|Overall Study|Other|9
1266397|NCT00468845|4145479|P1|Overall Study|Other|4
1266398|NCT00468845|4145477|P3|Overall Study|Lost to Follow-up|2
1266399|NCT00468845|4145478|P2|Overall Study|Lost to Follow-up|1
1266400|NCT00468845|4145479|P1|Overall Study|Lost to Follow-up|2
1266401|NCT00468845|4145477|P3|Overall Study|Adverse Event|11
1266402|NCT00468845|4145478|P2|Overall Study|Adverse Event|14
1266403|NCT00468845|4145479|P1|Overall Study|Adverse Event|9
1266404|NCT00468819|4145616|P3|Overall Study|Drop-outs (Treatment never received)|0
1266405|NCT00468819|4145617|P2|Overall Study|Drop-outs (Treatment never received)|0
1266406|NCT00468819|4145618|P1|Overall Study|Drop-outs (Treatment never received)|2
1266407|NCT00468819|4145616|P3|Overall Study|Lost to Follow-up|1
1266408|NCT00468819|4145617|P2|Overall Study|Lost to Follow-up|0
1266409|NCT00468819|4145618|P1|Overall Study|Lost to Follow-up|0
1266410|NCT00468819|4145616|P3|Overall Study|Withdrawal by Subject|1
1266411|NCT00468819|4145617|P2|Overall Study|Withdrawal by Subject|0
1266412|NCT00468819|4145618|P1|Overall Study|Withdrawal by Subject|4
1266413|NCT00468728|4145698|P2|Follow-up|mITT failure|31
1266414|NCT00468728|4145699|P1|Follow-up|mITT failure|34
1266415|NCT00468728|4145698|P2|Treatment|criteria for mITT population|11
1266416|NCT00468728|4145699|P1|Treatment|criteria for mITT population|4
1266417|NCT00468676|4145711|P2|Overall Study|Death|1
1266418|NCT00468676|4145712|P1|Overall Study|Death|2
1266419|NCT00468676|4145711|P2|Overall Study|Lost to Follow-up|11
1266420|NCT00468676|4145712|P1|Overall Study|Lost to Follow-up|14
1266421|NCT00468650|4145729|P1|Overall Study|Protocol Violation|1
1266422|NCT00468650|4145729|P1|Overall Study|Withdrawal by Subject|2
1266423|NCT00468650|4145729|P1|Overall Study|Lost to Follow-up|4
1266424|NCT00468585|4145777|P4|Overall Study|Withdrawal by Subject|1
1266425|NCT00468585|4145778|P3|Overall Study|Withdrawal by Subject|2
1266426|NCT00468585|4145779|P2|Overall Study|Withdrawal by Subject|0
1266427|NCT00468585|4145780|P1|Overall Study|Withdrawal by Subject|0
1266428|NCT00468585|4145777|P4|Overall Study|Adverse Event|0
1266429|NCT00468585|4145778|P3|Overall Study|Adverse Event|1
1266430|NCT00468585|4145779|P2|Overall Study|Adverse Event|0
1266431|NCT00468585|4145780|P1|Overall Study|Adverse Event|0
1266432|NCT00468585|4145777|P4|Overall Study|Patient found to be ineligible|0
1266433|NCT00468585|4145778|P3|Overall Study|Patient found to be ineligible|1
1266434|NCT00468585|4145779|P2|Overall Study|Patient found to be ineligible|0
1266435|NCT00468585|4145780|P1|Overall Study|Patient found to be ineligible|0
1266436|NCT00468585|4145777|P4|Overall Study|Patient not treated|0
1266437|NCT00468585|4145778|P3|Overall Study|Patient not treated|1
1266438|NCT00468585|4145779|P2|Overall Study|Patient not treated|0
1266439|NCT00468585|4145780|P1|Overall Study|Patient not treated|1
1266440|NCT00468559|4145792|P3|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
1266441|NCT00468559|4145793|P2|Double-blind, Treatment-withdrawal Phase|Adverse Event|2
1266442|NCT00468559|4145794|P1|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
1266443|NCT00468559|4145792|P3|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17
1266444|NCT00468559|4145793|P2|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8
1266445|NCT00468559|4145794|P1|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0
1266446|NCT00468559|4145792|P3|Open-label Treatment Phase|Withdrawal by Subject|0
1266447|NCT00468559|4145793|P2|Open-label Treatment Phase|Withdrawal by Subject|0
1266448|NCT00468559|4145794|P1|Open-label Treatment Phase|Withdrawal by Subject|4
1266449|NCT00468559|4145792|P3|Open-label Treatment Phase|Lack of Efficacy|0
1266450|NCT00468559|4145793|P2|Open-label Treatment Phase|Lack of Efficacy|0
1266451|NCT00468559|4145794|P1|Open-label Treatment Phase|Lack of Efficacy|9
1266452|NCT00468559|4145792|P3|Open-label Treatment Phase|Adverse Event|0
1266453|NCT00468559|4145793|P2|Open-label Treatment Phase|Adverse Event|0
1266454|NCT00468559|4145794|P1|Open-label Treatment Phase|Adverse Event|5
1266455|NCT00468546|4145822|P2|Week 24 to Week 104 Analysis|Other|14
1266456|NCT00468546|4145823|P1|Week 24 to Week 104 Analysis|Other|17
1266457|NCT00468546|4145822|P2|Week 24 to Week 104 Analysis|Movement into re-treatment study|183
1266458|NCT00468546|4145823|P1|Week 24 to Week 104 Analysis|Movement into re-treatment study|77
1266459|NCT00468546|4145822|P2|Week 24 to Week 104 Analysis|Failure to return|2
1266460|NCT00468546|4145823|P1|Week 24 to Week 104 Analysis|Failure to return|1
1266461|NCT00468546|4145822|P2|Week 24 to Week 104 Analysis|Refused treatment|7
1266462|NCT00468546|4145823|P1|Week 24 to Week 104 Analysis|Refused treatment|4
1266463|NCT00468546|4145822|P2|Week 24 to Week 104 Analysis|Protocol Violation|2
1266464|NCT00468546|4145823|P1|Week 24 to Week 104 Analysis|Protocol Violation|0
1266465|NCT00468546|4145822|P2|Week 24 to Week 104 Analysis|Lack of Efficacy|12
1266466|NCT00468546|4145823|P1|Week 24 to Week 104 Analysis|Lack of Efficacy|3
1266467|NCT00468546|4145822|P2|Week 24 to Week 104 Analysis|Death|0
1266468|NCT00468546|4145823|P1|Week 24 to Week 104 Analysis|Death|1
1266469|NCT00468546|4145822|P2|Week 24 to Week 104 Analysis|Adverse Event|5
1266470|NCT00468546|4145823|P1|Week 24 to Week 104 Analysis|Adverse Event|2
1266471|NCT00468546|4145822|P2|Week 24 Analysis|Participant unblinded (clinical hold)|0
1266472|NCT00468546|4145823|P1|Week 24 Analysis|Participant unblinded (clinical hold)|1
1266473|NCT00468546|4145822|P2|Week 24 Analysis|Went onto rescue therapy|0
1266474|NCT00468546|4145823|P1|Week 24 Analysis|Went onto rescue therapy|1
1266475|NCT00468546|4145822|P2|Week 24 Analysis|Due to clinical hold|0
1266476|NCT00468546|4145823|P1|Week 24 Analysis|Due to clinical hold|1
1266477|NCT00468546|4145822|P2|Week 24 Analysis|Incorrect diagnosis and treatment|1
1266478|NCT00468546|4145823|P1|Week 24 Analysis|Incorrect diagnosis and treatment|0
1266479|NCT00468546|4145822|P2|Week 24 Analysis|Rescue therapy|0
1266480|NCT00468546|4145823|P1|Week 24 Analysis|Rescue therapy|2
1266481|NCT00468546|4145822|P2|Week 24 Analysis|Failure to return|4
1266482|NCT00468546|4145823|P1|Week 24 Analysis|Failure to return|3
1266483|NCT00468546|4145822|P2|Week 24 Analysis|Adverse Event|8
1266484|NCT00468546|4145823|P1|Week 24 Analysis|Adverse Event|1
1266485|NCT00468546|4145822|P2|Week 24 Analysis|Refused treatment|5
1266486|NCT00468546|4145823|P1|Week 24 Analysis|Refused treatment|5
1266487|NCT00468546|4145822|P2|Week 24 Analysis|Lack of Efficacy|37
1266488|NCT00468546|4145823|P1|Week 24 Analysis|Lack of Efficacy|83
1266489|NCT00468481|4145853|P2|Overall Study|Other|0
1266490|NCT00468481|4145854|P1|Overall Study|Other|6
1266491|NCT00468481|4145853|P2|Overall Study|Non-Compliance|0
1266492|NCT00468481|4145854|P1|Overall Study|Non-Compliance|5
1266493|NCT00468481|4145853|P2|Overall Study|Moved out of area|1
1266494|NCT00468481|4145854|P1|Overall Study|Moved out of area|4
1266495|NCT00468481|4145853|P2|Overall Study|Egg Donor|0
1266496|NCT00468481|4145854|P1|Overall Study|Egg Donor|1
1266497|NCT00468481|4145853|P2|Overall Study|Prohibited Medication|1
1266498|NCT00468481|4145854|P1|Overall Study|Prohibited Medication|1
1266499|NCT00468481|4145853|P2|Overall Study|susp/diag malignant/premalignant disease|0
1266500|NCT00468481|4145854|P1|Overall Study|susp/diag malignant/premalignant disease|1
1266501|NCT00468481|4145853|P2|Overall Study|Withdrawal by Subject|3
1266502|NCT00468481|4145854|P1|Overall Study|Withdrawal by Subject|12
1266503|NCT00468481|4145853|P2|Overall Study|Protocol Violation|8
1266504|NCT00468481|4145854|P1|Overall Study|Protocol Violation|18
1266505|NCT00468481|4145853|P2|Overall Study|Pregnancy|0
1266506|NCT00468481|4145854|P1|Overall Study|Pregnancy|2
1266507|NCT00468481|4145853|P2|Overall Study|Lost to Follow-up|8
1266508|NCT00468481|4145854|P1|Overall Study|Lost to Follow-up|25
1266509|NCT00468481|4145853|P2|Overall Study|Adverse Event|3
1266510|NCT00468481|4145854|P1|Overall Study|Adverse Event|13
1266511|NCT00468312|4145954|P2|Overall Study|Did not meet protocol eligibility|1
1266512|NCT00468312|4145955|P1|Overall Study|Did not meet protocol eligibility|0
1266513|NCT00468312|4145954|P2|Overall Study|Protocol Violation|1
1266514|NCT00468312|4145955|P1|Overall Study|Protocol Violation|2
1266515|NCT00468312|4145954|P2|Overall Study|Withdrawal by Subject|1
1266516|NCT00468312|4145955|P1|Overall Study|Withdrawal by Subject|0
1266517|NCT00468312|4145954|P2|Overall Study|Lack of Efficacy|1
1266518|NCT00468312|4145955|P1|Overall Study|Lack of Efficacy|0
1266519|NCT00468312|4145954|P2|Overall Study|Adverse Event|1
1266520|NCT00468312|4145955|P1|Overall Study|Adverse Event|2
1266521|NCT00468299|4145971|P2|Overall Study|Withdrawal by Subject|1
1266522|NCT00468299|4145972|P1|Overall Study|Withdrawal by Subject|0
1266523|NCT00468286|4145982|P2|Overall Study|Physician Decision|1
1266524|NCT00468286|4145983|P1|Overall Study|Physician Decision|0
1266525|NCT00468286|4145982|P2|Overall Study|Withdrawal by Subject|3
1266526|NCT00468286|4145983|P1|Overall Study|Withdrawal by Subject|4
1266527|NCT00468286|4145982|P2|Overall Study|Protocol Violation|2
1266528|NCT00468286|4145983|P1|Overall Study|Protocol Violation|2
1266529|NCT00468286|4145982|P2|Overall Study|Adverse Event|6
1266530|NCT00468286|4145983|P1|Overall Study|Adverse Event|1
1266531|NCT00468143|4146013|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|3
1266532|NCT00468143|4146014|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|3
1266533|NCT00468143|4146013|P2|First Intervention (3 Weeks)|Withdrawal by Subject|4
1266534|NCT00468143|4146014|P1|First Intervention (3 Weeks)|Withdrawal by Subject|3
1266535|NCT00468104|4146028|P2|Second Intervention|discarded for malposition of chest tube|2
1266536|NCT00468104|4146029|P1|Second Intervention|discarded for malposition of chest tube|0
1266537|NCT00468104|4146028|P2|Second Intervention|Withdrawal by Subject|2
1266538|NCT00468104|4146029|P1|Second Intervention|Withdrawal by Subject|5
1266539|NCT00468104|4146028|P2|First Intervention|trapped lung|0
1266540|NCT00468104|4146029|P1|First Intervention|trapped lung|1
1266541|NCT00468104|4146028|P2|First Intervention|associated prolonged pneumothorax|0
1266542|NCT00468104|4146029|P1|First Intervention|associated prolonged pneumothorax|1
1266543|NCT00468104|4146028|P2|First Intervention|large lung mass with minimal effusion|0
1266544|NCT00468104|4146029|P1|First Intervention|large lung mass with minimal effusion|1
1266545|NCT00468104|4146028|P2|First Intervention|malposition/blocked chest tube tube|0
1266546|NCT00468104|4146029|P1|First Intervention|malposition/blocked chest tube tube|2
1266547|NCT00468104|4146028|P2|First Intervention|died within 3 weeks|0
1266548|NCT00468104|4146029|P1|First Intervention|died within 3 weeks|1
1266549|NCT00468104|4146028|P2|First Intervention|bleeding at chest tube site--first dose|0
1266550|NCT00468104|4146029|P1|First Intervention|bleeding at chest tube site--first dose|1
1266551|NCT00468104|4146028|P2|First Intervention|Protocol Violation|1
1266552|NCT00468104|4146029|P1|First Intervention|Protocol Violation|2
1266553|NCT00468052|4146046|P2|Overall Study|Protocol Violation|8
1266554|NCT00468052|4146047|P1|Overall Study|Protocol Violation|7
1266555|NCT00467961|4146065|P1|Overall Study|Disease Progression|2
1266556|NCT00467961|4146065|P1|Overall Study|Technical Failures|5
1266557|NCT00467896|4146069|P1|Overall Study|Patient had no improvement|1
1266558|NCT00467896|4146069|P1|Overall Study|Started inhaled Remodulin|1
1266559|NCT00467896|4146069|P1|Overall Study|Started intravenous prostacyclin|1
1266560|NCT00467896|4146069|P1|Overall Study|Mainly used Prodose not I-neb® device|1
1266561|NCT00467896|4146069|P1|Overall Study|Patient weaned off iloprost|1
1266562|NCT00467896|4146069|P1|Overall Study|Patient had atrial septostomy|1
1266563|NCT00467896|4146069|P1|Overall Study|Patient received transplant|2
1266564|NCT00467896|4146069|P1|Overall Study|Changed therapy|2
1266565|NCT00467896|4146069|P1|Overall Study|Non-compliance|3
1266566|NCT00467896|4146069|P1|Overall Study|Serious Adverse Event|13
1266567|NCT00467896|4146069|P1|Overall Study|Adverse Event|7
1266568|NCT00467896|4146069|P1|Overall Study|Consent Withdrawal|18
1266569|NCT00467870|4146095|P6|Overall Study|Other/Unknown|0
1266570|NCT00467870|4146096|P5|Overall Study|Other/Unknown|4
1266571|NCT00467870|4146097|P4|Overall Study|Other/Unknown|5
1266572|NCT00467870|4146098|P3|Overall Study|Other/Unknown|1
1266573|NCT00467870|4146099|P2|Overall Study|Other/Unknown|5
1266574|NCT00467870|4146100|P1|Overall Study|Other/Unknown|8
1266575|NCT00467870|4146095|P6|Overall Study|Subject Non-compliance|0
1266576|NCT00467870|4146096|P5|Overall Study|Subject Non-compliance|5
1266577|NCT00467870|4146097|P4|Overall Study|Subject Non-compliance|1
1266578|NCT00467870|4146098|P3|Overall Study|Subject Non-compliance|0
1266579|NCT00467870|4146099|P2|Overall Study|Subject Non-compliance|4
1266580|NCT00467870|4146100|P1|Overall Study|Subject Non-compliance|3
1266581|NCT00467870|4146095|P6|Overall Study|Lost to Follow-up|0
1266582|NCT00467870|4146096|P5|Overall Study|Lost to Follow-up|3
1266583|NCT00467870|4146097|P4|Overall Study|Lost to Follow-up|1
1266584|NCT00467870|4146098|P3|Overall Study|Lost to Follow-up|1
1266585|NCT00467870|4146099|P2|Overall Study|Lost to Follow-up|3
1266586|NCT00467870|4146100|P1|Overall Study|Lost to Follow-up|5
1266587|NCT00467870|4146095|P6|Overall Study|Withdrawal by Subject|1
1266588|NCT00467870|4146096|P5|Overall Study|Withdrawal by Subject|10
1266589|NCT00467870|4146097|P4|Overall Study|Withdrawal by Subject|9
1266590|NCT00467870|4146098|P3|Overall Study|Withdrawal by Subject|0
1266591|NCT00467870|4146099|P2|Overall Study|Withdrawal by Subject|21
1266592|NCT00467870|4146100|P1|Overall Study|Withdrawal by Subject|14
1266593|NCT00467870|4146095|P6|Overall Study|Protocol Violation|0
1266594|NCT00467870|4146096|P5|Overall Study|Protocol Violation|0
1266595|NCT00467870|4146097|P4|Overall Study|Protocol Violation|2
1266596|NCT00467870|4146098|P3|Overall Study|Protocol Violation|1
1266597|NCT00467870|4146099|P2|Overall Study|Protocol Violation|1
1266598|NCT00467870|4146100|P1|Overall Study|Protocol Violation|2
1266599|NCT00467870|4146095|P6|Overall Study|Adverse Event|1
1266600|NCT00467870|4146096|P5|Overall Study|Adverse Event|15
1266601|NCT00467870|4146097|P4|Overall Study|Adverse Event|15
1266602|NCT00467870|4146098|P3|Overall Study|Adverse Event|1
1266603|NCT00467870|4146099|P2|Overall Study|Adverse Event|9
1266604|NCT00467870|4146100|P1|Overall Study|Adverse Event|13
1266605|NCT00467857|4146143|P2|Overall Study|Discontinuation reason missing|3
1266606|NCT00467857|4146144|P1|Overall Study|Discontinuation reason missing|0
1266607|NCT00467857|4146143|P2|Overall Study|Did not meet inclusion/exclusion criteri|2
1266608|NCT00467857|4146144|P1|Overall Study|Did not meet inclusion/exclusion criteri|0
1266609|NCT00467857|4146143|P2|Overall Study|Emergency care required|1
1266610|NCT00467857|4146144|P1|Overall Study|Emergency care required|0
1266611|NCT00467857|4146143|P2|Overall Study|Discharged from court service|1
1266612|NCT00467857|4146144|P1|Overall Study|Discharged from court service|0
1266613|NCT00467857|4146143|P2|Overall Study|Death|1
1266614|NCT00467857|4146144|P1|Overall Study|Death|0
1266615|NCT00467857|4146143|P2|Overall Study|Withdrew consent|0
1266616|NCT00467857|4146144|P1|Overall Study|Withdrew consent|2
1266617|NCT00467857|4146143|P2|Overall Study|Adverse Event|0
1266618|NCT00467857|4146144|P1|Overall Study|Adverse Event|1
1266619|NCT00467831|4146192|P1|Overall Study|Withdrawal by Subject|1
1266620|NCT00467831|4146192|P1|Overall Study|Death|2
1266621|NCT00467779|4146211|P15|Stage 3|Unspecified Reason|5
1266622|NCT00467779|4146212|P14|Stage 3|Unspecified Reason|0
1266623|NCT00467779|4146213|P13|Stage 3|Unspecified Reason|0
1266624|NCT00467779|4146214|P12|Stage 3|Unspecified Reason|0
1266625|NCT00467779|4146215|P11|Stage 3|Unspecified Reason|0
1266626|NCT00467779|4146216|P10|Stage 3|Unspecified Reason|0
1266627|NCT00467779|4146217|P9|Stage 3|Unspecified Reason|0
1266628|NCT00467779|4146218|P8|Stage 3|Unspecified Reason|0
1266629|NCT00467779|4146219|P7|Stage 3|Unspecified Reason|0
1266630|NCT00467779|4146220|P6|Stage 3|Unspecified Reason|0
1266631|NCT00467779|4146221|P5|Stage 3|Unspecified Reason|0
1266632|NCT00467779|4146222|P4|Stage 3|Unspecified Reason|0
1266633|NCT00467779|4146223|P3|Stage 3|Unspecified Reason|0
1266634|NCT00467779|4146224|P2|Stage 3|Unspecified Reason|0
1266635|NCT00467779|4146225|P1|Stage 3|Unspecified Reason|0
1266636|NCT00467779|4146211|P15|Stage 3|Disease Progression|9
1266637|NCT00467779|4146212|P14|Stage 3|Disease Progression|0
1266638|NCT00467779|4146213|P13|Stage 3|Disease Progression|0
1266639|NCT00467779|4146214|P12|Stage 3|Disease Progression|0
1266640|NCT00467779|4146215|P11|Stage 3|Disease Progression|0
1266641|NCT00467779|4146216|P10|Stage 3|Disease Progression|0
1266642|NCT00467779|4146217|P9|Stage 3|Disease Progression|0
1266643|NCT00467779|4146218|P8|Stage 3|Disease Progression|0
1266644|NCT00467779|4146219|P7|Stage 3|Disease Progression|0
1266645|NCT00467779|4146220|P6|Stage 3|Disease Progression|0
1266646|NCT00467779|4146221|P5|Stage 3|Disease Progression|0
1266647|NCT00467779|4146222|P4|Stage 3|Disease Progression|0
1266648|NCT00467779|4146223|P3|Stage 3|Disease Progression|0
1266649|NCT00467779|4146224|P2|Stage 3|Disease Progression|0
1266650|NCT00467779|4146225|P1|Stage 3|Disease Progression|0
1266651|NCT00467779|4146211|P15|Stage 3|Death|1
1266652|NCT00467779|4146212|P14|Stage 3|Death|0
1266653|NCT00467779|4146213|P13|Stage 3|Death|0
1266654|NCT00467779|4146214|P12|Stage 3|Death|0
1266655|NCT00467779|4146215|P11|Stage 3|Death|0
1266656|NCT00467779|4146216|P10|Stage 3|Death|0
1266657|NCT00467779|4146217|P9|Stage 3|Death|0
1266658|NCT00467779|4146218|P8|Stage 3|Death|0
1266659|NCT00467779|4146219|P7|Stage 3|Death|0
1266660|NCT00467779|4146220|P6|Stage 3|Death|0
1266661|NCT00467779|4146221|P5|Stage 3|Death|0
1266662|NCT00467779|4146222|P4|Stage 3|Death|0
1266663|NCT00467779|4146223|P3|Stage 3|Death|0
1266664|NCT00467779|4146224|P2|Stage 3|Death|0
1266665|NCT00467779|4146225|P1|Stage 3|Death|0
1266666|NCT00467779|4146211|P15|Stage 3|Adverse Event|2
1266667|NCT00467779|4146212|P14|Stage 3|Adverse Event|0
1266668|NCT00467779|4146213|P13|Stage 3|Adverse Event|0
1266669|NCT00467779|4146214|P12|Stage 3|Adverse Event|0
1266670|NCT00467779|4146215|P11|Stage 3|Adverse Event|0
1266671|NCT00467779|4146216|P10|Stage 3|Adverse Event|0
1266672|NCT00467779|4146217|P9|Stage 3|Adverse Event|0
1266673|NCT00467779|4146218|P8|Stage 3|Adverse Event|0
1266674|NCT00467779|4146219|P7|Stage 3|Adverse Event|0
1266675|NCT00467779|4146220|P6|Stage 3|Adverse Event|0
1266676|NCT00467779|4146221|P5|Stage 3|Adverse Event|0
1266677|NCT00467779|4146222|P4|Stage 3|Adverse Event|0
1266678|NCT00467779|4146223|P3|Stage 3|Adverse Event|0
1266679|NCT00467779|4146224|P2|Stage 3|Adverse Event|0
1266680|NCT00467779|4146225|P1|Stage 3|Adverse Event|0
1266681|NCT00467779|4146211|P15|Stage 2A|Withdrawal by Subject|0
1266682|NCT00467779|4146212|P14|Stage 2A|Withdrawal by Subject|1
1266683|NCT00467779|4146213|P13|Stage 2A|Withdrawal by Subject|0
1266684|NCT00467779|4146214|P12|Stage 2A|Withdrawal by Subject|0
1266685|NCT00467779|4146215|P11|Stage 2A|Withdrawal by Subject|0
1266686|NCT00467779|4146216|P10|Stage 2A|Withdrawal by Subject|0
1266687|NCT00467779|4146217|P9|Stage 2A|Withdrawal by Subject|0
1266688|NCT00467779|4146218|P8|Stage 2A|Withdrawal by Subject|0
1266689|NCT00467779|4146219|P7|Stage 2A|Withdrawal by Subject|0
1266690|NCT00467779|4146220|P6|Stage 2A|Withdrawal by Subject|0
1266691|NCT00467779|4146221|P5|Stage 2A|Withdrawal by Subject|0
1266692|NCT00467779|4146222|P4|Stage 2A|Withdrawal by Subject|0
1266693|NCT00467779|4146223|P3|Stage 2A|Withdrawal by Subject|0
1266694|NCT00467779|4146224|P2|Stage 2A|Withdrawal by Subject|0
1266695|NCT00467779|4146225|P1|Stage 2A|Withdrawal by Subject|0
1266696|NCT00467779|4146211|P15|Stage 2A|Unspecified Reason|0
1266697|NCT00467779|4146212|P14|Stage 2A|Unspecified Reason|7
1266698|NCT00467779|4146213|P13|Stage 2A|Unspecified Reason|0
1266699|NCT00467779|4146214|P12|Stage 2A|Unspecified Reason|0
1266700|NCT00467779|4146215|P11|Stage 2A|Unspecified Reason|0
1266701|NCT00467779|4146216|P10|Stage 2A|Unspecified Reason|0
1266702|NCT00467779|4146217|P9|Stage 2A|Unspecified Reason|0
1266703|NCT00467779|4146218|P8|Stage 2A|Unspecified Reason|0
1266704|NCT00467779|4146219|P7|Stage 2A|Unspecified Reason|0
1266705|NCT00467779|4146220|P6|Stage 2A|Unspecified Reason|0
1266706|NCT00467779|4146221|P5|Stage 2A|Unspecified Reason|0
1266707|NCT00467779|4146222|P4|Stage 2A|Unspecified Reason|0
1266708|NCT00467779|4146223|P3|Stage 2A|Unspecified Reason|0
1266709|NCT00467779|4146224|P2|Stage 2A|Unspecified Reason|0
1266710|NCT00467779|4146225|P1|Stage 2A|Unspecified Reason|0
1266711|NCT00467779|4146211|P15|Stage 2A|Disease Progression|0
1266712|NCT00467779|4146212|P14|Stage 2A|Disease Progression|10
1266713|NCT00467779|4146213|P13|Stage 2A|Disease Progression|0
1266714|NCT00467779|4146214|P12|Stage 2A|Disease Progression|0
1266715|NCT00467779|4146215|P11|Stage 2A|Disease Progression|0
1266716|NCT00467779|4146216|P10|Stage 2A|Disease Progression|0
1266717|NCT00467779|4146217|P9|Stage 2A|Disease Progression|0
1266718|NCT00467779|4146218|P8|Stage 2A|Disease Progression|0
1266719|NCT00467779|4146219|P7|Stage 2A|Disease Progression|0
1266720|NCT00467779|4146220|P6|Stage 2A|Disease Progression|0
1266721|NCT00467779|4146221|P5|Stage 2A|Disease Progression|0
1266722|NCT00467779|4146222|P4|Stage 2A|Disease Progression|0
1266723|NCT00467779|4146223|P3|Stage 2A|Disease Progression|0
1266724|NCT00467779|4146224|P2|Stage 2A|Disease Progression|0
1266725|NCT00467779|4146225|P1|Stage 2A|Disease Progression|0
1266726|NCT00467779|4146211|P15|Stage 2A|Death|0
1266727|NCT00467779|4146212|P14|Stage 2A|Death|1
1266728|NCT00467779|4146213|P13|Stage 2A|Death|0
1266729|NCT00467779|4146214|P12|Stage 2A|Death|0
1266730|NCT00467779|4146215|P11|Stage 2A|Death|0
1266731|NCT00467779|4146216|P10|Stage 2A|Death|0
1266732|NCT00467779|4146217|P9|Stage 2A|Death|0
1266733|NCT00467779|4146218|P8|Stage 2A|Death|0
1266734|NCT00467779|4146219|P7|Stage 2A|Death|0
1266735|NCT00467779|4146220|P6|Stage 2A|Death|0
1266736|NCT00467779|4146221|P5|Stage 2A|Death|0
1266737|NCT00467779|4146222|P4|Stage 2A|Death|0
1266738|NCT00467779|4146223|P3|Stage 2A|Death|0
1266739|NCT00467779|4146224|P2|Stage 2A|Death|0
1266740|NCT00467779|4146225|P1|Stage 2A|Death|0
1266741|NCT00467779|4146211|P15|Stage 2A|Adverse Event|0
1266742|NCT00467779|4146212|P14|Stage 2A|Adverse Event|2
1266743|NCT00467779|4146213|P13|Stage 2A|Adverse Event|0
1266744|NCT00467779|4146214|P12|Stage 2A|Adverse Event|0
1266745|NCT00467779|4146215|P11|Stage 2A|Adverse Event|0
1266746|NCT00467779|4146216|P10|Stage 2A|Adverse Event|0
1266747|NCT00467779|4146217|P9|Stage 2A|Adverse Event|0
1266748|NCT00467779|4146218|P8|Stage 2A|Adverse Event|0
1266749|NCT00467779|4146219|P7|Stage 2A|Adverse Event|0
1266750|NCT00467779|4146220|P6|Stage 2A|Adverse Event|0
1266751|NCT00467779|4146221|P5|Stage 2A|Adverse Event|0
1266752|NCT00467779|4146222|P4|Stage 2A|Adverse Event|0
1266753|NCT00467779|4146223|P3|Stage 2A|Adverse Event|0
1266754|NCT00467779|4146224|P2|Stage 2A|Adverse Event|0
1266755|NCT00467779|4146225|P1|Stage 2A|Adverse Event|0
1266756|NCT00467779|4146211|P15|Stage 2|Unspecified Reason|0
1266757|NCT00467779|4146212|P14|Stage 2|Unspecified Reason|0
1266758|NCT00467779|4146213|P13|Stage 2|Unspecified Reason|0
1266759|NCT00467779|4146214|P12|Stage 2|Unspecified Reason|0
1266760|NCT00467779|4146215|P11|Stage 2|Unspecified Reason|0
1266761|NCT00467779|4146216|P10|Stage 2|Unspecified Reason|0
1266762|NCT00467779|4146217|P9|Stage 2|Unspecified Reason|3
1266763|NCT00467779|4146218|P8|Stage 2|Unspecified Reason|0
1266764|NCT00467779|4146219|P7|Stage 2|Unspecified Reason|0
1266765|NCT00467779|4146220|P6|Stage 2|Unspecified Reason|0
1266766|NCT00467779|4146221|P5|Stage 2|Unspecified Reason|0
1266767|NCT00467779|4146222|P4|Stage 2|Unspecified Reason|0
1266768|NCT00467779|4146223|P3|Stage 2|Unspecified Reason|0
1266769|NCT00467779|4146224|P2|Stage 2|Unspecified Reason|0
1266770|NCT00467779|4146225|P1|Stage 2|Unspecified Reason|0
1266771|NCT00467779|4146211|P15|Stage 2|Disease Progression|0
1266772|NCT00467779|4146212|P14|Stage 2|Disease Progression|0
1266773|NCT00467779|4146213|P13|Stage 2|Disease Progression|0
1266774|NCT00467779|4146214|P12|Stage 2|Disease Progression|0
1266775|NCT00467779|4146215|P11|Stage 2|Disease Progression|0
1266776|NCT00467779|4146216|P10|Stage 2|Disease Progression|0
1266777|NCT00467779|4146217|P9|Stage 2|Disease Progression|16
1266778|NCT00467779|4146218|P8|Stage 2|Disease Progression|0
1266779|NCT00467779|4146219|P7|Stage 2|Disease Progression|0
1266780|NCT00467779|4146220|P6|Stage 2|Disease Progression|0
1266781|NCT00467779|4146221|P5|Stage 2|Disease Progression|0
1266782|NCT00467779|4146222|P4|Stage 2|Disease Progression|0
1266783|NCT00467779|4146223|P3|Stage 2|Disease Progression|0
1266784|NCT00467779|4146224|P2|Stage 2|Disease Progression|0
1266785|NCT00467779|4146225|P1|Stage 2|Disease Progression|0
1266786|NCT00467779|4146211|P15|Stage 2|Death|0
1266787|NCT00467779|4146212|P14|Stage 2|Death|0
1266788|NCT00467779|4146213|P13|Stage 2|Death|0
1266789|NCT00467779|4146214|P12|Stage 2|Death|0
1266790|NCT00467779|4146215|P11|Stage 2|Death|0
1266791|NCT00467779|4146216|P10|Stage 2|Death|0
1266792|NCT00467779|4146217|P9|Stage 2|Death|1
1266793|NCT00467779|4146218|P8|Stage 2|Death|0
1266794|NCT00467779|4146219|P7|Stage 2|Death|0
1266795|NCT00467779|4146220|P6|Stage 2|Death|0
1266796|NCT00467779|4146221|P5|Stage 2|Death|0
1266797|NCT00467779|4146222|P4|Stage 2|Death|0
1266798|NCT00467779|4146223|P3|Stage 2|Death|0
1266799|NCT00467779|4146224|P2|Stage 2|Death|0
1266800|NCT00467779|4146225|P1|Stage 2|Death|0
1266801|NCT00467779|4146211|P15|Stage 2|Adverse Event|0
1266802|NCT00467779|4146212|P14|Stage 2|Adverse Event|0
1266803|NCT00467779|4146213|P13|Stage 2|Adverse Event|0
1266804|NCT00467779|4146214|P12|Stage 2|Adverse Event|0
1266805|NCT00467779|4146215|P11|Stage 2|Adverse Event|0
1266806|NCT00467779|4146216|P10|Stage 2|Adverse Event|0
1266807|NCT00467779|4146217|P9|Stage 2|Adverse Event|1
1266808|NCT00467779|4146218|P8|Stage 2|Adverse Event|0
1266809|NCT00467779|4146219|P7|Stage 2|Adverse Event|0
1266810|NCT00467779|4146220|P6|Stage 2|Adverse Event|0
1266811|NCT00467779|4146221|P5|Stage 2|Adverse Event|0
1266812|NCT00467779|4146222|P4|Stage 2|Adverse Event|0
1266813|NCT00467779|4146223|P3|Stage 2|Adverse Event|0
1266814|NCT00467779|4146224|P2|Stage 2|Adverse Event|0
1266815|NCT00467779|4146225|P1|Stage 2|Adverse Event|0
1266816|NCT00467779|4146211|P15|Stage 1A|Unspecified Reason|0
1266817|NCT00467779|4146212|P14|Stage 1A|Unspecified Reason|0
1266818|NCT00467779|4146213|P13|Stage 1A|Unspecified Reason|1
1266819|NCT00467779|4146214|P12|Stage 1A|Unspecified Reason|1
1266820|NCT00467779|4146215|P11|Stage 1A|Unspecified Reason|0
1266821|NCT00467779|4146216|P10|Stage 1A|Unspecified Reason|0
1266822|NCT00467779|4146217|P9|Stage 1A|Unspecified Reason|0
1266823|NCT00467779|4146218|P8|Stage 1A|Unspecified Reason|0
1266824|NCT00467779|4146219|P7|Stage 1A|Unspecified Reason|0
1266825|NCT00467779|4146220|P6|Stage 1A|Unspecified Reason|0
1266826|NCT00467779|4146221|P5|Stage 1A|Unspecified Reason|0
1266827|NCT00467779|4146222|P4|Stage 1A|Unspecified Reason|0
1266828|NCT00467779|4146223|P3|Stage 1A|Unspecified Reason|0
1266829|NCT00467779|4146224|P2|Stage 1A|Unspecified Reason|0
1266830|NCT00467779|4146225|P1|Stage 1A|Unspecified Reason|0
1266831|NCT00467779|4146211|P15|Stage 1A|Withdrawal by Subject|0
1266832|NCT00467779|4146212|P14|Stage 1A|Withdrawal by Subject|0
1266833|NCT00467779|4146213|P13|Stage 1A|Withdrawal by Subject|1
1266834|NCT00467779|4146214|P12|Stage 1A|Withdrawal by Subject|1
1266835|NCT00467779|4146215|P11|Stage 1A|Withdrawal by Subject|1
1266836|NCT00467779|4146216|P10|Stage 1A|Withdrawal by Subject|0
1266837|NCT00467779|4146217|P9|Stage 1A|Withdrawal by Subject|0
1266838|NCT00467779|4146218|P8|Stage 1A|Withdrawal by Subject|0
1266839|NCT00467779|4146219|P7|Stage 1A|Withdrawal by Subject|0
1266840|NCT00467779|4146220|P6|Stage 1A|Withdrawal by Subject|0
1266841|NCT00467779|4146221|P5|Stage 1A|Withdrawal by Subject|0
1266842|NCT00467779|4146222|P4|Stage 1A|Withdrawal by Subject|0
1266843|NCT00467779|4146223|P3|Stage 1A|Withdrawal by Subject|0
1266844|NCT00467779|4146224|P2|Stage 1A|Withdrawal by Subject|0
1266845|NCT00467779|4146225|P1|Stage 1A|Withdrawal by Subject|0
1266846|NCT00467779|4146211|P15|Stage 1A|Physician Decision|0
1266847|NCT00467779|4146212|P14|Stage 1A|Physician Decision|0
1266848|NCT00467779|4146213|P13|Stage 1A|Physician Decision|0
1266849|NCT00467779|4146214|P12|Stage 1A|Physician Decision|0
1266850|NCT00467779|4146215|P11|Stage 1A|Physician Decision|0
1266851|NCT00467779|4146216|P10|Stage 1A|Physician Decision|1
1266852|NCT00467779|4146217|P9|Stage 1A|Physician Decision|0
1266853|NCT00467779|4146218|P8|Stage 1A|Physician Decision|0
1266854|NCT00467779|4146219|P7|Stage 1A|Physician Decision|0
1266855|NCT00467779|4146220|P6|Stage 1A|Physician Decision|0
1266856|NCT00467779|4146221|P5|Stage 1A|Physician Decision|0
1266857|NCT00467779|4146222|P4|Stage 1A|Physician Decision|0
1266858|NCT00467779|4146223|P3|Stage 1A|Physician Decision|0
1266859|NCT00467779|4146224|P2|Stage 1A|Physician Decision|0
1266860|NCT00467779|4146225|P1|Stage 1A|Physician Decision|0
1266861|NCT00467779|4146211|P15|Stage 1A|Disease Progression|0
1266862|NCT00467779|4146212|P14|Stage 1A|Disease Progression|0
1266863|NCT00467779|4146213|P13|Stage 1A|Disease Progression|2
1266864|NCT00467779|4146214|P12|Stage 1A|Disease Progression|5
1266865|NCT00467779|4146215|P11|Stage 1A|Disease Progression|2
1266866|NCT00467779|4146216|P10|Stage 1A|Disease Progression|2
1266867|NCT00467779|4146217|P9|Stage 1A|Disease Progression|0
1266868|NCT00467779|4146218|P8|Stage 1A|Disease Progression|0
1266869|NCT00467779|4146219|P7|Stage 1A|Disease Progression|0
1266870|NCT00467779|4146220|P6|Stage 1A|Disease Progression|0
1266871|NCT00467779|4146221|P5|Stage 1A|Disease Progression|0
1266872|NCT00467779|4146222|P4|Stage 1A|Disease Progression|0
1266873|NCT00467779|4146223|P3|Stage 1A|Disease Progression|0
1266874|NCT00467779|4146224|P2|Stage 1A|Disease Progression|0
1266875|NCT00467779|4146225|P1|Stage 1A|Disease Progression|0
1266876|NCT00467779|4146211|P15|Stage 1A|Death|0
1266877|NCT00467779|4146212|P14|Stage 1A|Death|0
1266878|NCT00467779|4146213|P13|Stage 1A|Death|1
1266879|NCT00467779|4146214|P12|Stage 1A|Death|1
1266880|NCT00467779|4146215|P11|Stage 1A|Death|0
1266881|NCT00467779|4146216|P10|Stage 1A|Death|0
1266882|NCT00467779|4146217|P9|Stage 1A|Death|0
1266883|NCT00467779|4146218|P8|Stage 1A|Death|0
1266884|NCT00467779|4146219|P7|Stage 1A|Death|0
1266885|NCT00467779|4146220|P6|Stage 1A|Death|0
1266886|NCT00467779|4146221|P5|Stage 1A|Death|0
1266887|NCT00467779|4146222|P4|Stage 1A|Death|0
1266888|NCT00467779|4146223|P3|Stage 1A|Death|0
1266889|NCT00467779|4146224|P2|Stage 1A|Death|0
1266890|NCT00467779|4146225|P1|Stage 1A|Death|0
1266891|NCT00467779|4146211|P15|Stage 1A|Adverse Event|0
1266892|NCT00467779|4146212|P14|Stage 1A|Adverse Event|0
1266893|NCT00467779|4146213|P13|Stage 1A|Adverse Event|1
1266894|NCT00467779|4146214|P12|Stage 1A|Adverse Event|0
1266895|NCT00467779|4146215|P11|Stage 1A|Adverse Event|0
1266896|NCT00467779|4146216|P10|Stage 1A|Adverse Event|0
1266897|NCT00467779|4146217|P9|Stage 1A|Adverse Event|0
1266898|NCT00467779|4146218|P8|Stage 1A|Adverse Event|0
1266899|NCT00467779|4146219|P7|Stage 1A|Adverse Event|0
1266900|NCT00467779|4146220|P6|Stage 1A|Adverse Event|0
1266901|NCT00467779|4146221|P5|Stage 1A|Adverse Event|0
1266902|NCT00467779|4146222|P4|Stage 1A|Adverse Event|0
1266903|NCT00467779|4146223|P3|Stage 1A|Adverse Event|0
1266904|NCT00467779|4146224|P2|Stage 1A|Adverse Event|0
1266905|NCT00467779|4146225|P1|Stage 1A|Adverse Event|0
1266906|NCT00467779|4146211|P15|Stage 1|Withdrawal by Subject|0
1266907|NCT00467779|4146212|P14|Stage 1|Withdrawal by Subject|0
1266908|NCT00467779|4146213|P13|Stage 1|Withdrawal by Subject|0
1266909|NCT00467779|4146214|P12|Stage 1|Withdrawal by Subject|0
1266910|NCT00467779|4146215|P11|Stage 1|Withdrawal by Subject|0
1266911|NCT00467779|4146216|P10|Stage 1|Withdrawal by Subject|0
1266912|NCT00467779|4146217|P9|Stage 1|Withdrawal by Subject|0
1266913|NCT00467779|4146218|P8|Stage 1|Withdrawal by Subject|1
1266914|NCT00467779|4146219|P7|Stage 1|Withdrawal by Subject|1
1266915|NCT00467779|4146220|P6|Stage 1|Withdrawal by Subject|0
1266916|NCT00467779|4146221|P5|Stage 1|Withdrawal by Subject|0
1266917|NCT00467779|4146222|P4|Stage 1|Withdrawal by Subject|0
1266918|NCT00467779|4146223|P3|Stage 1|Withdrawal by Subject|0
1266919|NCT00467779|4146224|P2|Stage 1|Withdrawal by Subject|0
1266920|NCT00467779|4146225|P1|Stage 1|Withdrawal by Subject|0
1266921|NCT00467779|4146211|P15|Stage 1|Physician Decision|0
1266922|NCT00467779|4146212|P14|Stage 1|Physician Decision|0
1266923|NCT00467779|4146213|P13|Stage 1|Physician Decision|0
1266924|NCT00467779|4146214|P12|Stage 1|Physician Decision|0
1266925|NCT00467779|4146215|P11|Stage 1|Physician Decision|0
1266926|NCT00467779|4146216|P10|Stage 1|Physician Decision|0
1266927|NCT00467779|4146217|P9|Stage 1|Physician Decision|0
1266928|NCT00467779|4146218|P8|Stage 1|Physician Decision|0
1266929|NCT00467779|4146219|P7|Stage 1|Physician Decision|0
1266930|NCT00467779|4146220|P6|Stage 1|Physician Decision|0
1266931|NCT00467779|4146221|P5|Stage 1|Physician Decision|0
1266932|NCT00467779|4146222|P4|Stage 1|Physician Decision|0
1266933|NCT00467779|4146223|P3|Stage 1|Physician Decision|0
1266934|NCT00467779|4146224|P2|Stage 1|Physician Decision|1
1266935|NCT00467779|4146225|P1|Stage 1|Physician Decision|0
1266936|NCT00467779|4146211|P15|Stage 1|Unspecified Reason|0
1266937|NCT00467779|4146212|P14|Stage 1|Unspecified Reason|0
1266938|NCT00467779|4146213|P13|Stage 1|Unspecified Reason|0
1266939|NCT00467779|4146214|P12|Stage 1|Unspecified Reason|0
1266940|NCT00467779|4146215|P11|Stage 1|Unspecified Reason|0
1266941|NCT00467779|4146216|P10|Stage 1|Unspecified Reason|0
1266942|NCT00467779|4146217|P9|Stage 1|Unspecified Reason|0
1266943|NCT00467779|4146218|P8|Stage 1|Unspecified Reason|0
1266944|NCT00467779|4146219|P7|Stage 1|Unspecified Reason|0
1266945|NCT00467779|4146220|P6|Stage 1|Unspecified Reason|2
1266946|NCT00467779|4146221|P5|Stage 1|Unspecified Reason|1
1266947|NCT00467779|4146222|P4|Stage 1|Unspecified Reason|0
1266948|NCT00467779|4146223|P3|Stage 1|Unspecified Reason|1
1266949|NCT00467779|4146224|P2|Stage 1|Unspecified Reason|0
1266950|NCT00467779|4146225|P1|Stage 1|Unspecified Reason|1
1266951|NCT00467779|4146211|P15|Stage 1|Disease Progression|0
1266952|NCT00467779|4146212|P14|Stage 1|Disease Progression|0
1266953|NCT00467779|4146213|P13|Stage 1|Disease Progression|0
1266954|NCT00467779|4146214|P12|Stage 1|Disease Progression|0
1266955|NCT00467779|4146215|P11|Stage 1|Disease Progression|0
1266956|NCT00467779|4146216|P10|Stage 1|Disease Progression|0
1266957|NCT00467779|4146217|P9|Stage 1|Disease Progression|0
1266958|NCT00467779|4146218|P8|Stage 1|Disease Progression|5
1266959|NCT00467779|4146219|P7|Stage 1|Disease Progression|4
1266960|NCT00467779|4146220|P6|Stage 1|Disease Progression|2
1266961|NCT00467779|4146221|P5|Stage 1|Disease Progression|2
1266962|NCT00467779|4146222|P4|Stage 1|Disease Progression|3
1266963|NCT00467779|4146223|P3|Stage 1|Disease Progression|2
1266964|NCT00467779|4146224|P2|Stage 1|Disease Progression|2
1266965|NCT00467779|4146225|P1|Stage 1|Disease Progression|2
1266966|NCT00467779|4146211|P15|Stage 1|Adverse Event|0
1266967|NCT00467779|4146212|P14|Stage 1|Adverse Event|0
1266968|NCT00467779|4146213|P13|Stage 1|Adverse Event|0
1266969|NCT00467779|4146214|P12|Stage 1|Adverse Event|0
1266970|NCT00467779|4146215|P11|Stage 1|Adverse Event|0
1266971|NCT00467779|4146216|P10|Stage 1|Adverse Event|0
1266972|NCT00467779|4146217|P9|Stage 1|Adverse Event|0
1266973|NCT00467779|4146218|P8|Stage 1|Adverse Event|1
1266974|NCT00467779|4146219|P7|Stage 1|Adverse Event|2
1266975|NCT00467779|4146220|P6|Stage 1|Adverse Event|1
1266976|NCT00467779|4146221|P5|Stage 1|Adverse Event|0
1266977|NCT00467779|4146222|P4|Stage 1|Adverse Event|0
1266978|NCT00467779|4146223|P3|Stage 1|Adverse Event|0
1266979|NCT00467779|4146224|P2|Stage 1|Adverse Event|0
1266980|NCT00467779|4146225|P1|Stage 1|Adverse Event|1
1266981|NCT00467753|4146399|P2|Overall Study|Adverse Event|0
1266982|NCT00467753|4146400|P1|Overall Study|Adverse Event|2
1266983|NCT00467753|4146399|P2|Overall Study|Lost to Follow-up|2
1266984|NCT00467753|4146400|P1|Overall Study|Lost to Follow-up|1
1266985|NCT00467740|4146411|P5|Overall Study|Lack of Efficacy|0
1266986|NCT00467740|4146412|P4|Overall Study|Lack of Efficacy|0
1266987|NCT00467740|4146413|P3|Overall Study|Lack of Efficacy|0
1266988|NCT00467740|4146414|P2|Overall Study|Lack of Efficacy|1
1266989|NCT00467740|4146415|P1|Overall Study|Lack of Efficacy|0
1266990|NCT00467740|4146411|P5|Overall Study|Withdrawal by Subject|0
1266991|NCT00467740|4146412|P4|Overall Study|Withdrawal by Subject|1
1266992|NCT00467740|4146413|P3|Overall Study|Withdrawal by Subject|0
1266993|NCT00467740|4146414|P2|Overall Study|Withdrawal by Subject|1
1266994|NCT00467740|4146415|P1|Overall Study|Withdrawal by Subject|1
1266995|NCT00467740|4146411|P5|Overall Study|Lost to Follow-up|0
1266996|NCT00467740|4146412|P4|Overall Study|Lost to Follow-up|0
1266997|NCT00467740|4146413|P3|Overall Study|Lost to Follow-up|0
1266998|NCT00467740|4146414|P2|Overall Study|Lost to Follow-up|1
1266999|NCT00467740|4146415|P1|Overall Study|Lost to Follow-up|0
1267000|NCT00467740|4146411|P5|Overall Study|Protocol Violation|0
1267001|NCT00467740|4146412|P4|Overall Study|Protocol Violation|0
1267002|NCT00467740|4146413|P3|Overall Study|Protocol Violation|1
1267003|NCT00467740|4146414|P2|Overall Study|Protocol Violation|0
1267004|NCT00467740|4146415|P1|Overall Study|Protocol Violation|0
1267005|NCT00467740|4146411|P5|Overall Study|Adverse Event|0
1267006|NCT00467740|4146412|P4|Overall Study|Adverse Event|0
1267007|NCT00467740|4146413|P3|Overall Study|Adverse Event|1
1267008|NCT00467740|4146414|P2|Overall Study|Adverse Event|0
1267009|NCT00467740|4146415|P1|Overall Study|Adverse Event|0
1267010|NCT00467649|4146604|P6|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1
1267011|NCT00467649|4146605|P5|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
1267012|NCT00467649|4146606|P4|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
1267013|NCT00467649|4146607|P3|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
1267014|NCT00467649|4146608|P2|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
1267015|NCT00467649|4146609|P1|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
1267016|NCT00467649|4146604|P6|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
1267017|NCT00467649|4146605|P5|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
1267018|NCT00467649|4146606|P4|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1
1267019|NCT00467649|4146607|P3|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
1267020|NCT00467649|4146608|P2|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
1267021|NCT00467649|4146609|P1|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
1267022|NCT00467649|4146604|P6|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
1267023|NCT00467649|4146605|P5|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
1267024|NCT00467649|4146606|P4|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1
1267025|NCT00467649|4146607|P3|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
1267026|NCT00467649|4146608|P2|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
1267027|NCT00467649|4146609|P1|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
1267028|NCT00467649|4146604|P6|Phase 1 (Randomized Population)|Withdrawal of Consent|0
1267029|NCT00467649|4146605|P5|Phase 1 (Randomized Population)|Withdrawal of Consent|0
1267030|NCT00467649|4146606|P4|Phase 1 (Randomized Population)|Withdrawal of Consent|0
1267031|NCT00467649|4146607|P3|Phase 1 (Randomized Population)|Withdrawal of Consent|0
1267032|NCT00467649|4146608|P2|Phase 1 (Randomized Population)|Withdrawal of Consent|2
1267033|NCT00467649|4146609|P1|Phase 1 (Randomized Population)|Withdrawal of Consent|4
1267034|NCT00467649|4146604|P6|Phase 1 (Randomized Population)|Lost to Follow-up|0
1267035|NCT00467649|4146605|P5|Phase 1 (Randomized Population)|Lost to Follow-up|0
1267036|NCT00467649|4146606|P4|Phase 1 (Randomized Population)|Lost to Follow-up|0
1267037|NCT00467649|4146607|P3|Phase 1 (Randomized Population)|Lost to Follow-up|0
1267038|NCT00467649|4146608|P2|Phase 1 (Randomized Population)|Lost to Follow-up|4
1267039|NCT00467649|4146609|P1|Phase 1 (Randomized Population)|Lost to Follow-up|2
1267040|NCT00467649|4146604|P6|Phase 1 (Randomized Population)|Investigator Decision|0
1267041|NCT00467649|4146605|P5|Phase 1 (Randomized Population)|Investigator Decision|0
1267042|NCT00467649|4146606|P4|Phase 1 (Randomized Population)|Investigator Decision|0
1267043|NCT00467649|4146607|P3|Phase 1 (Randomized Population)|Investigator Decision|0
1267044|NCT00467649|4146608|P2|Phase 1 (Randomized Population)|Investigator Decision|0
1267045|NCT00467649|4146609|P1|Phase 1 (Randomized Population)|Investigator Decision|1
1267046|NCT00467649|4146604|P6|Phase 1 (Randomized Population)|Adverse Event|0
1267047|NCT00467649|4146605|P5|Phase 1 (Randomized Population)|Adverse Event|0
1267048|NCT00467649|4146606|P4|Phase 1 (Randomized Population)|Adverse Event|0
1267049|NCT00467649|4146607|P3|Phase 1 (Randomized Population)|Adverse Event|0
1267050|NCT00467649|4146608|P2|Phase 1 (Randomized Population)|Adverse Event|0
1267051|NCT00467649|4146609|P1|Phase 1 (Randomized Population)|Adverse Event|2
1267052|NCT00467610|4146649|P1|Overall Study|Withdrawal by Subject|1
1267053|NCT00467597|4146660|P2|Overall Study|Withdrawal by Subject|0
1267054|NCT00467597|4146661|P1|Overall Study|Withdrawal by Subject|2
1267055|NCT00467584|4146674|P3|Overall Study|Withdrawal by Subject|1
1267056|NCT00467584|4146675|P2|Overall Study|Withdrawal by Subject|5
1267057|NCT00467584|4146676|P1|Overall Study|Withdrawal by Subject|4
1267058|NCT00467558|4146686|P2|Overall Study|Lost to Follow-up|0
1267059|NCT00467558|4146687|P1|Overall Study|Lost to Follow-up|2
1267060|NCT00467519|4146697|P2|Overall Study|Withdrawal by Subject|10
1267061|NCT00467519|4146698|P1|Overall Study|Withdrawal by Subject|4
1267062|NCT00467519|4146697|P2|Overall Study|Lost to Follow-up|9
1267063|NCT00467519|4146698|P1|Overall Study|Lost to Follow-up|2
1267064|NCT00467519|4146697|P2|Overall Study|Protocol Violation|4
1267065|NCT00467519|4146698|P1|Overall Study|Protocol Violation|8
1267066|NCT00467363|4146727|P2|Overall Study|Lost to Follow-up|70
1267067|NCT00467363|4146728|P1|Overall Study|Lost to Follow-up|80
1267068|NCT00467285|4146775|P2|Overall Study|Lost to Follow-up|4
1267069|NCT00467285|4146776|P1|Overall Study|Lost to Follow-up|4
1267070|NCT00467259|4146796|P2|Overall Study|Site Closed|1
1267071|NCT00467259|4146797|P1|Overall Study|Site Closed|2
1267072|NCT00467259|4146796|P2|Overall Study|Lost to Follow-up|34
1267073|NCT00467259|4146797|P1|Overall Study|Lost to Follow-up|14
1267074|NCT00467259|4146796|P2|Overall Study|Physician Decision|2
1267075|NCT00467259|4146797|P1|Overall Study|Physician Decision|0
1267076|NCT00467259|4146796|P2|Overall Study|Withdrawal by Subject|108
1267077|NCT00467259|4146797|P1|Overall Study|Withdrawal by Subject|34
1267078|NCT00467259|4146796|P2|Overall Study|Protocol Violation|7
1267079|NCT00467259|4146797|P1|Overall Study|Protocol Violation|1
1267080|NCT00467259|4146796|P2|Overall Study|Adverse Event|90
1267081|NCT00467259|4146797|P1|Overall Study|Adverse Event|24
1267082|NCT00467051|4146814|P1|Overall Study|Adverse Event|2
1267083|NCT00466947|4146841|P2|Study End Analysis Period|Other – Unconformity in team’s treatment|1
1267084|NCT00466947|4146842|P1|Study End Analysis Period|Other – Unconformity in team’s treatment|0
1267085|NCT00466947|4146841|P2|Study End Analysis Period|Other – Subject without a legal guardian|0
1267086|NCT00466947|4146842|P1|Study End Analysis Period|Other – Subject without a legal guardian|1
1267087|NCT00466947|4146841|P2|Study End Analysis Period|Other – Forbidden vaccination|10
1267088|NCT00466947|4146842|P1|Study End Analysis Period|Other – Forbidden vaccination|21
1267089|NCT00466947|4146841|P2|Study End Analysis Period|Withdrawal by Subject|1267
1267090|NCT00466947|4146842|P1|Study End Analysis Period|Withdrawal by Subject|1264
1267091|NCT00466947|4146841|P2|Study End Analysis Period|Protocol Violation|17
1267092|NCT00466947|4146842|P1|Study End Analysis Period|Protocol Violation|9
1267093|NCT00466947|4146841|P2|Study End Analysis Period|Physician Decision|29
1267094|NCT00466947|4146842|P1|Study End Analysis Period|Physician Decision|29
1267095|NCT00466947|4146841|P2|Study End Analysis Period|Lost to Follow-up|1167
1267096|NCT00466947|4146842|P1|Study End Analysis Period|Lost to Follow-up|1137
1267097|NCT00466947|4146841|P2|Study End Analysis Period|Adverse Event|43
1267098|NCT00466947|4146842|P1|Study End Analysis Period|Adverse Event|35
1267099|NCT00466947|4146841|P2|Primary Outcome Analysis Period|Other: study still ongoing|11863
1267100|NCT00466947|4146842|P1|Primary Outcome Analysis Period|Other: study still ongoing|11875
1267101|NCT00466726|4147033|P1|Overall Study|Not evaluable for response|14
1267102|NCT00466687|4147039|P1|Overall Study|Disease progression|29
1267103|NCT00466687|4147039|P1|Overall Study|Withdrawal by Subject|1
1267104|NCT00466687|4147039|P1|Overall Study|Other complicating illness|3
1267105|NCT00466687|4147039|P1|Overall Study|Adverse Event|1
1267106|NCT00466505|4147071|P1|Overall Study|Adverse Event|4
1267107|NCT00466505|4147071|P1|Overall Study|disease progression|13
1267108|NCT00466193|4147121|P2|Overall Study|Patient refused Visit 4 procedures|0
1267109|NCT00466193|4147122|P1|Overall Study|Patient refused Visit 4 procedures|1
1267110|NCT00466193|4147121|P2|Overall Study|Withdrawal by Subject|2
1267111|NCT00466193|4147122|P1|Overall Study|Withdrawal by Subject|7
1267112|NCT00466193|4147121|P2|Overall Study|Protocol Violation|1
1267113|NCT00466193|4147122|P1|Overall Study|Protocol Violation|1
1267114|NCT00466193|4147121|P2|Overall Study|Physician Decision|0
1267115|NCT00466193|4147122|P1|Overall Study|Physician Decision|1
1267116|NCT00466193|4147121|P2|Overall Study|Lost to Follow-up|4
1267117|NCT00466193|4147122|P1|Overall Study|Lost to Follow-up|2
1267118|NCT00466193|4147121|P2|Overall Study|Adverse Event|1
1267119|NCT00466193|4147122|P1|Overall Study|Adverse Event|0
1267120|NCT00466167|4147149|P3|Overall Study|Not treated|0
1267121|NCT00466167|4147150|P2|Overall Study|Not treated|0
1267122|NCT00466167|4147151|P1|Overall Study|Not treated|1
1267123|NCT00466167|4147149|P3|Overall Study|patient did not meet inclusion criteria|1
1267124|NCT00466167|4147150|P2|Overall Study|patient did not meet inclusion criteria|0
1267125|NCT00466167|4147151|P1|Overall Study|patient did not meet inclusion criteria|1
1267126|NCT00466167|4147149|P3|Overall Study|Withdrawal by Subject|6
1267127|NCT00466167|4147150|P2|Overall Study|Withdrawal by Subject|1
1267128|NCT00466167|4147151|P1|Overall Study|Withdrawal by Subject|4
1267129|NCT00466167|4147149|P3|Overall Study|Lost to Follow-up|2
1267130|NCT00466167|4147150|P2|Overall Study|Lost to Follow-up|2
1267131|NCT00466167|4147151|P1|Overall Study|Lost to Follow-up|3
1267132|NCT00466167|4147149|P3|Overall Study|Protocol Violation|2
1267133|NCT00466167|4147150|P2|Overall Study|Protocol Violation|1
1267134|NCT00466167|4147151|P1|Overall Study|Protocol Violation|1
1267135|NCT00466167|4147149|P3|Overall Study|Lack of Efficacy|3
1267136|NCT00466167|4147150|P2|Overall Study|Lack of Efficacy|0
1267137|NCT00466167|4147151|P1|Overall Study|Lack of Efficacy|2
1267138|NCT00466167|4147149|P3|Overall Study|Adverse Event|7
1267139|NCT00466167|4147150|P2|Overall Study|Adverse Event|8
1267140|NCT00466167|4147151|P1|Overall Study|Adverse Event|8
1267141|NCT00465985|4147212|P2|Part III - Open-label Treatment Period|Adverse Event|0
1267142|NCT00465985|4147213|P1|Part III - Open-label Treatment Period|Adverse Event|1
1267143|NCT00465985|4147212|P2|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
1267144|NCT00465985|4147213|P1|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1
1267145|NCT00465985|4147212|P2|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12
1267146|NCT00465985|4147213|P1|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0
1267147|NCT00465985|4147212|P2|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
1267148|NCT00465985|4147213|P1|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4
1267149|NCT00465972|4147236|P2|Overall Study|Withdrawal by Subject|1
1267150|NCT00465972|4147237|P1|Overall Study|Withdrawal by Subject|2
1267151|NCT00465894|4147247|P2|Treatment For 12 Weeks|Withdrawal by Subject|1
1267152|NCT00465894|4147248|P1|Treatment For 12 Weeks|Withdrawal by Subject|0
1267153|NCT00465894|4147247|P2|Treatment For 12 Weeks|Family Issues|1
1267154|NCT00465894|4147248|P1|Treatment For 12 Weeks|Family Issues|1
1267155|NCT00465894|4147247|P2|Treatment For 12 Weeks|Lost to Follow-up|1
1267156|NCT00465894|4147248|P1|Treatment For 12 Weeks|Lost to Follow-up|4
1267157|NCT00465816|4147281|P3|Overall Study|Lost to Follow-up|2
1267158|NCT00465816|4147282|P2|Overall Study|Lost to Follow-up|0
1267159|NCT00465816|4147283|P1|Overall Study|Lost to Follow-up|0
1267160|NCT00465738|4147346|P2|Overall Study|Other|5
1267161|NCT00465738|4147347|P1|Overall Study|Other|2
1267162|NCT00465738|4147346|P2|Overall Study|Withdrawal by Subject|0
1267163|NCT00465738|4147347|P1|Overall Study|Withdrawal by Subject|2
1267164|NCT00465738|4147346|P2|Overall Study|Adverse Event|1
1267165|NCT00465738|4147347|P1|Overall Study|Adverse Event|0
1267166|NCT00465738|4147346|P2|Overall Study|Lost to Follow-up|0
1267167|NCT00465738|4147347|P1|Overall Study|Lost to Follow-up|2
1267168|NCT00465647|4147441|P4|Overall Study|"The other reasons included loss of IV"|2
1267169|NCT00465647|4147442|P3|Overall Study|"The other reasons included loss of IV"|3
1267170|NCT00465647|4147443|P2|Overall Study|"The other reasons included loss of IV"|4
1267171|NCT00465647|4147444|P1|Overall Study|"The other reasons included loss of IV"|8
1267172|NCT00465647|4147441|P4|Overall Study|Withdrawal by Subject|7
1267173|NCT00465647|4147442|P3|Overall Study|Withdrawal by Subject|2
1267174|NCT00465647|4147443|P2|Overall Study|Withdrawal by Subject|2
1267175|NCT00465647|4147444|P1|Overall Study|Withdrawal by Subject|1
1267176|NCT00465647|4147441|P4|Overall Study|Adverse Event|2
1267177|NCT00465647|4147442|P3|Overall Study|Adverse Event|3
1267178|NCT00465647|4147443|P2|Overall Study|Adverse Event|0
1267179|NCT00465647|4147444|P1|Overall Study|Adverse Event|2
1267180|NCT00465647|4147441|P4|Overall Study|Administrative|2
1267181|NCT00465647|4147442|P3|Overall Study|Administrative|3
1267182|NCT00465647|4147443|P2|Overall Study|Administrative|2
1267183|NCT00465647|4147444|P1|Overall Study|Administrative|2
1267184|NCT00465569|4147492|P2|Overall Study|persistent eczema during dose escalation|0
1267185|NCT00465569|4147493|P1|Overall Study|persistent eczema during dose escalation|1
1267186|NCT00465361|4147516|P1|Baseline Assessment|Personal Issues/Scheduling|4
1267187|NCT00465270|4147522|P2|Overall Study|Investigator request|4
1267188|NCT00465270|4147523|P1|Overall Study|Investigator request|3
1267189|NCT00465270|4147522|P2|Overall Study|Lost to Follow-up|67
1267190|NCT00465270|4147523|P1|Overall Study|Lost to Follow-up|60
1267191|NCT00465270|4147522|P2|Overall Study|Withdrawal by Subject|78
1267192|NCT00465270|4147523|P1|Overall Study|Withdrawal by Subject|34
1267193|NCT00465270|4147522|P2|Overall Study|Death|11
1267194|NCT00465270|4147523|P1|Overall Study|Death|7
1267195|NCT00465179|4147532|P1|Overall Study|Progression of Disease|47
1267196|NCT00465179|4147532|P1|Overall Study|Withdrawal by Subject|2
1267197|NCT00465179|4147532|P1|Overall Study|Adverse Event|4
1267198|NCT00465101|4147538|P1|Overall Study|Withdrew consent prior to procedure|3
1267199|NCT00465101|4147538|P1|Overall Study|Physician Decision|1
1267200|NCT00465101|4147538|P1|Overall Study|Withdrawal by Subject|25
1267201|NCT00465101|4147538|P1|Overall Study|Death|3
1267202|NCT00465101|4147538|P1|Overall Study|Unable to obtain IRB approval|1
1267203|NCT00465101|4147538|P1|Overall Study|Site closed due to IRB expiration|1
1267204|NCT00465101|4147538|P1|Overall Study|Patient postponed procedure|1
1267205|NCT00465101|4147538|P1|Overall Study|Pt. Insurance not accepted at center|2
1267206|NCT00465101|4147538|P1|Overall Study|Other|6
1267207|NCT00465101|4147538|P1|Overall Study|Lost to Follow-up|5
1267208|NCT00465101|4147538|P1|Overall Study|Did not meet study criteria|4
1267209|NCT00465101|4147538|P1|Overall Study|Change in health precluded follow up|4
1267210|NCT00465101|4147538|P1|Overall Study|Aborted Proc./Treatment Not Attempted|3
1267211|NCT00464945|4147608|P2|Toddler Dose|Lost to Follow-up|1
1267212|NCT00464945|4147609|P1|Toddler Dose|Lost to Follow-up|0
1267213|NCT00464945|4147608|P2|After Infant Series|Withdrawal by Subject|2
1267214|NCT00464945|4147609|P1|After Infant Series|Withdrawal by Subject|0
1267215|NCT00464945|4147608|P2|Infant Series|Lost to Follow-up|0
1267216|NCT00464945|4147609|P1|Infant Series|Lost to Follow-up|1
1267217|NCT00464945|4147608|P2|Infant Series|Protocol Violation|0
1267218|NCT00464945|4147609|P1|Infant Series|Protocol Violation|1
1267219|NCT00464945|4147608|P2|Infant Series|Withdrawal by parent/guardian request|1
1267220|NCT00464945|4147609|P1|Infant Series|Withdrawal by parent/guardian request|2
1267221|NCT00464815|4147639|P2|Overall Study|Withdrawal by Subject|3
1267222|NCT00464815|4147640|P1|Overall Study|Withdrawal by Subject|6
1267223|NCT00464737|4147673|P3|Overall Study|Other: Subject's disability per sponsor|1
1267224|NCT00464737|4147674|P2|Overall Study|Other: Subject's disability per sponsor|0
1267225|NCT00464737|4147675|P1|Overall Study|Other: Subject's disability per sponsor|0
1267226|NCT00464737|4147673|P3|Overall Study|Other: Personal family reasons|1
1267227|NCT00464737|4147674|P2|Overall Study|Other: Personal family reasons|0
1267228|NCT00464737|4147675|P1|Overall Study|Other: Personal family reasons|0
1267229|NCT00464737|4147673|P3|Overall Study|Other: Study demands too great|0
1267230|NCT00464737|4147674|P2|Overall Study|Other: Study demands too great|1
1267231|NCT00464737|4147675|P1|Overall Study|Other: Study demands too great|0
1267232|NCT00464737|4147673|P3|Overall Study|Other: Subject left town; family illness|0
1267233|NCT00464737|4147674|P2|Overall Study|Other: Subject left town; family illness|0
1267234|NCT00464737|4147675|P1|Overall Study|Other: Subject left town; family illness|1
1267235|NCT00464737|4147673|P3|Overall Study|Other: Subject's schedule doesn't permit|0
1267236|NCT00464737|4147674|P2|Overall Study|Other: Subject's schedule doesn't permit|0
1267237|NCT00464737|4147675|P1|Overall Study|Other: Subject's schedule doesn't permit|1
1267238|NCT00464737|4147673|P3|Overall Study|Lost to Follow-up|5
1267239|NCT00464737|4147674|P2|Overall Study|Lost to Follow-up|2
1267240|NCT00464737|4147675|P1|Overall Study|Lost to Follow-up|5
1267241|NCT00464737|4147673|P3|Overall Study|Non-compliance|1
1267242|NCT00464737|4147674|P2|Overall Study|Non-compliance|1
1267243|NCT00464737|4147675|P1|Overall Study|Non-compliance|0
1267244|NCT00464737|4147673|P3|Overall Study|Protocol Violation|5
1267245|NCT00464737|4147674|P2|Overall Study|Protocol Violation|1
1267246|NCT00464737|4147675|P1|Overall Study|Protocol Violation|1
1267247|NCT00464737|4147673|P3|Overall Study|Withdrawal by Subject|5
1267248|NCT00464737|4147674|P2|Overall Study|Withdrawal by Subject|3
1267249|NCT00464737|4147675|P1|Overall Study|Withdrawal by Subject|5
1267250|NCT00464737|4147673|P3|Overall Study|Lack of Efficacy|4
1267251|NCT00464737|4147674|P2|Overall Study|Lack of Efficacy|7
1267252|NCT00464737|4147675|P1|Overall Study|Lack of Efficacy|7
1267253|NCT00464737|4147673|P3|Overall Study|Adverse Event|33
1267254|NCT00464737|4147674|P2|Overall Study|Adverse Event|17
1267255|NCT00464737|4147675|P1|Overall Study|Adverse Event|12
1267256|NCT00464672|4147755|P6|Overall Study|Lost to Follow-up|0
1267257|NCT00464672|4147756|P5|Overall Study|Lost to Follow-up|1
1267258|NCT00464672|4147757|P4|Overall Study|Lost to Follow-up|0
1267259|NCT00464672|4147758|P3|Overall Study|Lost to Follow-up|0
1267260|NCT00464672|4147759|P2|Overall Study|Lost to Follow-up|10
1267261|NCT00464672|4147760|P1|Overall Study|Lost to Follow-up|25
1267262|NCT00464672|4147755|P6|Overall Study|withdrawal of consent|4
1267263|NCT00464672|4147756|P5|Overall Study|withdrawal of consent|9
1267264|NCT00464672|4147757|P4|Overall Study|withdrawal of consent|1
1267265|NCT00464672|4147758|P3|Overall Study|withdrawal of consent|0
1267266|NCT00464672|4147759|P2|Overall Study|withdrawal of consent|0
1267267|NCT00464672|4147760|P1|Overall Study|withdrawal of consent|0
1267268|NCT00464620|4147839|P3|Overall Study|Use of prohibited concomitant medication|2
1267269|NCT00464620|4147840|P2|Overall Study|Use of prohibited concomitant medication|0
1267270|NCT00464620|4147841|P1|Overall Study|Use of prohibited concomitant medication|0
1267271|NCT00464620|4147839|P3|Overall Study|Ineligible sarcoma subtype|2
1267272|NCT00464620|4147840|P2|Overall Study|Ineligible sarcoma subtype|2
1267273|NCT00464620|4147841|P1|Overall Study|Ineligible sarcoma subtype|0
1267274|NCT00464620|4147839|P3|Overall Study|Withdrawal by Subject|3
1267275|NCT00464620|4147840|P2|Overall Study|Withdrawal by Subject|0
1267276|NCT00464620|4147841|P1|Overall Study|Withdrawal by Subject|1
1267277|NCT00464620|4147839|P3|Overall Study|Physician Decision|0
1267278|NCT00464620|4147840|P2|Overall Study|Physician Decision|0
1267279|NCT00464620|4147841|P1|Overall Study|Physician Decision|1
1267280|NCT00464568|4147868|P1|Overall Study|Adverse Event|2
1267281|NCT00464542|4147941|P1|Pre-treatment|Withdrawal by Subject|2
1267282|NCT00464490|4147948|P2|Overall Study|Physician Decision|11
1267283|NCT00464490|4147949|P1|Overall Study|Physician Decision|11
1267284|NCT00464334|4147996|P11|Overall Study|Withdrawal by Subject|0
1267285|NCT00464334|4147997|P10|Overall Study|Withdrawal by Subject|0
1267286|NCT00464334|4147998|P9|Overall Study|Withdrawal by Subject|3
1267287|NCT00464334|4147999|P8|Overall Study|Withdrawal by Subject|1
1267288|NCT00464334|4148000|P7|Overall Study|Withdrawal by Subject|2
1267289|NCT00464334|4148001|P6|Overall Study|Withdrawal by Subject|2
1267290|NCT00464334|4148002|P5|Overall Study|Withdrawal by Subject|2
1267291|NCT00464334|4148003|P4|Overall Study|Withdrawal by Subject|2
1267292|NCT00464334|4148004|P3|Overall Study|Withdrawal by Subject|4
1267293|NCT00464334|4148005|P2|Overall Study|Withdrawal by Subject|7
1267294|NCT00464334|4148006|P1|Overall Study|Withdrawal by Subject|1
1267295|NCT00464334|4147996|P11|Overall Study|Study Terminated by Sponsor|0
1267296|NCT00464334|4147997|P10|Overall Study|Study Terminated by Sponsor|0
1267297|NCT00464334|4147998|P9|Overall Study|Study Terminated by Sponsor|0
1267298|NCT00464334|4147999|P8|Overall Study|Study Terminated by Sponsor|0
1267299|NCT00464334|4148000|P7|Overall Study|Study Terminated by Sponsor|0
1267300|NCT00464334|4148001|P6|Overall Study|Study Terminated by Sponsor|0
1267301|NCT00464334|4148002|P5|Overall Study|Study Terminated by Sponsor|0
1267302|NCT00464334|4148003|P4|Overall Study|Study Terminated by Sponsor|1
1267303|NCT00464334|4148004|P3|Overall Study|Study Terminated by Sponsor|0
1267304|NCT00464334|4148005|P2|Overall Study|Study Terminated by Sponsor|0
1267305|NCT00464334|4148006|P1|Overall Study|Study Terminated by Sponsor|0
1267306|NCT00464334|4147996|P11|Overall Study|Progressive Disease|0
1267307|NCT00464334|4147997|P10|Overall Study|Progressive Disease|0
1267308|NCT00464334|4147998|P9|Overall Study|Progressive Disease|1
1267309|NCT00464334|4147999|P8|Overall Study|Progressive Disease|0
1267310|NCT00464334|4148000|P7|Overall Study|Progressive Disease|0
1267311|NCT00464334|4148001|P6|Overall Study|Progressive Disease|1
1267312|NCT00464334|4148002|P5|Overall Study|Progressive Disease|0
1267313|NCT00464334|4148003|P4|Overall Study|Progressive Disease|0
1267314|NCT00464334|4148004|P3|Overall Study|Progressive Disease|0
1267315|NCT00464334|4148005|P2|Overall Study|Progressive Disease|0
1267316|NCT00464334|4148006|P1|Overall Study|Progressive Disease|0
1267317|NCT00464334|4147996|P11|Overall Study|Lost to Follow-up|2
1267318|NCT00464334|4147997|P10|Overall Study|Lost to Follow-up|0
1267319|NCT00464334|4147998|P9|Overall Study|Lost to Follow-up|0
1267320|NCT00464334|4147999|P8|Overall Study|Lost to Follow-up|0
1267321|NCT00464334|4148000|P7|Overall Study|Lost to Follow-up|1
1267322|NCT00464334|4148001|P6|Overall Study|Lost to Follow-up|0
1267323|NCT00464334|4148002|P5|Overall Study|Lost to Follow-up|1
1267324|NCT00464334|4148003|P4|Overall Study|Lost to Follow-up|0
1267325|NCT00464334|4148004|P3|Overall Study|Lost to Follow-up|1
1267326|NCT00464334|4148005|P2|Overall Study|Lost to Follow-up|0
1267327|NCT00464334|4148006|P1|Overall Study|Lost to Follow-up|0
1267328|NCT00464334|4147996|P11|Overall Study|Lack of Efficacy|0
1267329|NCT00464334|4147997|P10|Overall Study|Lack of Efficacy|0
1267330|NCT00464334|4147998|P9|Overall Study|Lack of Efficacy|0
1267331|NCT00464334|4147999|P8|Overall Study|Lack of Efficacy|0
1267332|NCT00464334|4148000|P7|Overall Study|Lack of Efficacy|0
1267333|NCT00464334|4148001|P6|Overall Study|Lack of Efficacy|0
1267334|NCT00464334|4148002|P5|Overall Study|Lack of Efficacy|0
1267335|NCT00464334|4148003|P4|Overall Study|Lack of Efficacy|0
1267336|NCT00464334|4148004|P3|Overall Study|Lack of Efficacy|0
1267337|NCT00464334|4148005|P2|Overall Study|Lack of Efficacy|1
1267338|NCT00464334|4148006|P1|Overall Study|Lack of Efficacy|0
1267339|NCT00464334|4147996|P11|Overall Study|Adverse Event|2
1267340|NCT00464334|4147997|P10|Overall Study|Adverse Event|1
1267341|NCT00464334|4147998|P9|Overall Study|Adverse Event|2
1267342|NCT00464334|4147999|P8|Overall Study|Adverse Event|0
1267343|NCT00464334|4148000|P7|Overall Study|Adverse Event|0
1267344|NCT00464334|4148001|P6|Overall Study|Adverse Event|1
1267345|NCT00464334|4148002|P5|Overall Study|Adverse Event|1
1267346|NCT00464334|4148003|P4|Overall Study|Adverse Event|1
1267347|NCT00464334|4148004|P3|Overall Study|Adverse Event|0
1267348|NCT00464334|4148005|P2|Overall Study|Adverse Event|0
1267349|NCT00464334|4148006|P1|Overall Study|Adverse Event|0
1267350|NCT00464308|4148066|P3|Overall Study|Physician Decision|0
1267351|NCT00464308|4148067|P2|Overall Study|Physician Decision|0
1267352|NCT00464308|4148068|P1|Overall Study|Physician Decision|1
1267353|NCT00464308|4148066|P3|Overall Study|Patient discontinued and other reasons|23
1267354|NCT00464308|4148067|P2|Overall Study|Patient discontinued and other reasons|17
1267355|NCT00464308|4148068|P1|Overall Study|Patient discontinued and other reasons|17
1267356|NCT00464308|4148066|P3|Overall Study|Lost to Follow-up|20
1267357|NCT00464308|4148067|P2|Overall Study|Lost to Follow-up|19
1267358|NCT00464308|4148068|P1|Overall Study|Lost to Follow-up|29
1267359|NCT00464308|4148066|P3|Overall Study|Adverse Event|16
1267360|NCT00464308|4148067|P2|Overall Study|Adverse Event|27
1267361|NCT00464308|4148068|P1|Overall Study|Adverse Event|22
1267362|NCT00464269|4148098|P4|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
1267363|NCT00464269|4148099|P3|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
1267364|NCT00464269|4148100|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
1267365|NCT00464269|4148101|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
1267366|NCT00464269|4148098|P4|Overall Study|AE, non-serious non-fatal|4
1267367|NCT00464269|4148099|P3|Overall Study|AE, non-serious non-fatal|3
1267368|NCT00464269|4148100|P2|Overall Study|AE, non-serious non-fatal|8
1267369|NCT00464269|4148101|P1|Overall Study|AE, non-serious non-fatal|2
1267370|NCT00464269|4148098|P4|Overall Study|SAE, non-fatal|1
1267371|NCT00464269|4148099|P3|Overall Study|SAE, non-fatal|0
1267372|NCT00464269|4148100|P2|Overall Study|SAE, non-fatal|0
1267373|NCT00464269|4148101|P1|Overall Study|SAE, non-fatal|0
1267374|NCT00464269|4148098|P4|Overall Study|AE, serious fatal|1
1267375|NCT00464269|4148099|P3|Overall Study|AE, serious fatal|1
1267376|NCT00464269|4148100|P2|Overall Study|AE, serious fatal|0
1267377|NCT00464269|4148101|P1|Overall Study|AE, serious fatal|0
1267378|NCT00464269|4148098|P4|Overall Study|Other reason|1
1267379|NCT00464269|4148099|P3|Overall Study|Other reason|1
1267380|NCT00464269|4148100|P2|Overall Study|Other reason|3
1267381|NCT00464269|4148101|P1|Overall Study|Other reason|3
1267382|NCT00464269|4148098|P4|Overall Study|Withdrawal by Subject|1
1267383|NCT00464269|4148099|P3|Overall Study|Withdrawal by Subject|1
1267384|NCT00464269|4148100|P2|Overall Study|Withdrawal by Subject|2
1267385|NCT00464269|4148101|P1|Overall Study|Withdrawal by Subject|0
1267386|NCT00464269|4148098|P4|Overall Study|Lost to Follow-up|1
1267387|NCT00464269|4148099|P3|Overall Study|Lost to Follow-up|0
1267388|NCT00464269|4148100|P2|Overall Study|Lost to Follow-up|4
1267389|NCT00464269|4148101|P1|Overall Study|Lost to Follow-up|0
1267390|NCT00464269|4148098|P4|Overall Study|Lack of Efficacy|0
1267391|NCT00464269|4148099|P3|Overall Study|Lack of Efficacy|0
1267392|NCT00464269|4148100|P2|Overall Study|Lack of Efficacy|0
1267393|NCT00464269|4148101|P1|Overall Study|Lack of Efficacy|1
1267394|NCT00464087|4148239|P3|Overall Study|No PCI per inclusion criteria|29
1267395|NCT00464087|4148240|P2|Overall Study|No PCI per inclusion criteria|0
1267396|NCT00464087|4148241|P1|Overall Study|No PCI per inclusion criteria|0
1267397|NCT00463866|4148259|P2|Overall Study|Other|22
1267398|NCT00463866|4148260|P1|Overall Study|Other|22
1267399|NCT00463866|4148259|P2|Overall Study|Mis-Randomization of subject|1
1267400|NCT00463866|4148260|P1|Overall Study|Mis-Randomization of subject|0
1267401|NCT00463866|4148259|P2|Overall Study|Safety Reason|3
1267402|NCT00463866|4148260|P1|Overall Study|Safety Reason|1
1267403|NCT00463866|4148259|P2|Overall Study|Severe Non-Compliance to Protocol|21
1267404|NCT00463866|4148260|P1|Overall Study|Severe Non-Compliance to Protocol|25
1267405|NCT00463866|4148259|P2|Overall Study|Incorrect Enrolment|66
1267406|NCT00463866|4148260|P1|Overall Study|Incorrect Enrolment|64
1267407|NCT00463866|4148259|P2|Overall Study|Lost to Follow-up|55
1267408|NCT00463866|4148260|P1|Overall Study|Lost to Follow-up|46
1267409|NCT00463866|4148259|P2|Overall Study|Withdrawal by Subject|79
1267410|NCT00463866|4148260|P1|Overall Study|Withdrawal by Subject|81
1267411|NCT00463866|4148259|P2|Overall Study|Adverse Event|93
1267412|NCT00463866|4148260|P1|Overall Study|Adverse Event|70
1267413|NCT00463840|4148280|P1|Overall Study|Adverse Event|3
1267414|NCT00463840|4148280|P1|Overall Study|Withdrawal by Subject|2
1267415|NCT00463840|4148280|P1|Overall Study|Disease progression|7
1267416|NCT00463801|4148285|P1|Overall Study|No longer require therapy|1
1267417|NCT00463801|4148285|P1|Overall Study|Lost to Follow-up|5
1267418|NCT00463801|4148285|P1|Overall Study|Adverse Event|4
1267419|NCT00463801|4148285|P1|Overall Study|Lack of Efficacy|2
1267420|NCT00463801|4148285|P1|Overall Study|Protocol Violation|1
1267421|NCT00463788|4148291|P2|Overall Study|Randomized but not treated|1
1267422|NCT00463788|4148292|P1|Overall Study|Randomized but not treated|1
1267423|NCT00463788|4148291|P2|Overall Study|Other|0
1267424|NCT00463788|4148292|P1|Overall Study|Other|3
1267425|NCT00463788|4148291|P2|Overall Study|Protocol Violation|1
1267426|NCT00463788|4148292|P1|Overall Study|Protocol Violation|0
1267427|NCT00463788|4148291|P2|Overall Study|Lost to Follow-up|0
1267428|NCT00463788|4148292|P1|Overall Study|Lost to Follow-up|1
1267429|NCT00463788|4148291|P2|Overall Study|Symptomatic Deterioration|3
1267430|NCT00463788|4148292|P1|Overall Study|Symptomatic Deterioration|2
1267431|NCT00463788|4148291|P2|Overall Study|Death|3
1267432|NCT00463788|4148292|P1|Overall Study|Death|4
1267433|NCT00463788|4148291|P2|Overall Study|Withdrawal by Subject|2
1267434|NCT00463788|4148292|P1|Overall Study|Withdrawal by Subject|6
1267435|NCT00463788|4148291|P2|Overall Study|Adverse Event|2
1267436|NCT00463788|4148292|P1|Overall Study|Adverse Event|6
1267437|NCT00463788|4148291|P2|Overall Study|Progressive Disease|42
1267438|NCT00463788|4148292|P1|Overall Study|Progressive Disease|86
1267439|NCT00463606|4148310|P3|Overall Study|Protocol Violation|1
1267440|NCT00463606|4148311|P2|Overall Study|Protocol Violation|0
1267441|NCT00463606|4148312|P1|Overall Study|Protocol Violation|0
1267442|NCT00463606|4148310|P3|Overall Study|Participation in another ABT-335 trial|0
1267443|NCT00463606|4148311|P2|Overall Study|Participation in another ABT-335 trial|0
1267444|NCT00463606|4148312|P1|Overall Study|Participation in another ABT-335 trial|1
1267445|NCT00463606|4148310|P3|Overall Study|Patient randomized in error|0
1267446|NCT00463606|4148311|P2|Overall Study|Patient randomized in error|0
1267447|NCT00463606|4148312|P1|Overall Study|Patient randomized in error|1
1267448|NCT00463606|4148310|P3|Overall Study|Coordinator error|0
1267449|NCT00463606|4148311|P2|Overall Study|Coordinator error|0
1267450|NCT00463606|4148312|P1|Overall Study|Coordinator error|1
1267451|NCT00463606|4148310|P3|Overall Study|Exclusion criteria violation|0
1267452|NCT00463606|4148311|P2|Overall Study|Exclusion criteria violation|0
1267453|NCT00463606|4148312|P1|Overall Study|Exclusion criteria violation|2
1267454|NCT00463606|4148310|P3|Overall Study|Sponsor request|0
1267455|NCT00463606|4148311|P2|Overall Study|Sponsor request|1
1267456|NCT00463606|4148312|P1|Overall Study|Sponsor request|0
1267457|NCT00463606|4148310|P3|Overall Study|Physician Decision|0
1267458|NCT00463606|4148311|P2|Overall Study|Physician Decision|1
1267459|NCT00463606|4148312|P1|Overall Study|Physician Decision|0
1267460|NCT00463606|4148310|P3|Overall Study|Subject moved out of town|0
1267461|NCT00463606|4148311|P2|Overall Study|Subject moved out of town|0
1267462|NCT00463606|4148312|P1|Overall Study|Subject moved out of town|1
1267463|NCT00463606|4148310|P3|Overall Study|Subject noncompliance|0
1267464|NCT00463606|4148311|P2|Overall Study|Subject noncompliance|1
1267465|NCT00463606|4148312|P1|Overall Study|Subject noncompliance|1
1267466|NCT00463606|4148310|P3|Overall Study|Lost to Follow-up|3
1267467|NCT00463606|4148311|P2|Overall Study|Lost to Follow-up|2
1267468|NCT00463606|4148312|P1|Overall Study|Lost to Follow-up|2
1267469|NCT00463606|4148310|P3|Overall Study|Withdrawal by Subject|5
1267470|NCT00463606|4148311|P2|Overall Study|Withdrawal by Subject|11
1267471|NCT00463606|4148312|P1|Overall Study|Withdrawal by Subject|11
1267472|NCT00463606|4148310|P3|Overall Study|Adverse Event|11
1267473|NCT00463606|4148311|P2|Overall Study|Adverse Event|18
1267474|NCT00463606|4148312|P1|Overall Study|Adverse Event|21
1267475|NCT00463580|4148337|P2|Overall Study|Medical/psychiatric complications|2
1267476|NCT00463580|4148338|P1|Overall Study|Medical/psychiatric complications|0
1267477|NCT00463580|4148337|P2|Overall Study|Schedule conflict|0
1267478|NCT00463580|4148338|P1|Overall Study|Schedule conflict|2
1267479|NCT00463580|4148337|P2|Overall Study|Lost to Follow-up|0
1267480|NCT00463580|4148338|P1|Overall Study|Lost to Follow-up|1
1267481|NCT00463567|4148371|P7|Overall Study|Death|0
1267482|NCT00463567|4148372|P6|Overall Study|Death|0
1267483|NCT00463567|4148373|P5|Overall Study|Death|0
1267484|NCT00463567|4148374|P4|Overall Study|Death|0
1267485|NCT00463567|4148375|P3|Overall Study|Death|2
1267486|NCT00463567|4148376|P2|Overall Study|Death|0
1267487|NCT00463567|4148377|P1|Overall Study|Death|1
1267488|NCT00463567|4148371|P7|Overall Study|Abnormal test procedure result(s)|0
1267489|NCT00463567|4148372|P6|Overall Study|Abnormal test procedure result(s)|2
1267490|NCT00463567|4148373|P5|Overall Study|Abnormal test procedure result(s)|0
1267491|NCT00463567|4148374|P4|Overall Study|Abnormal test procedure result(s)|2
1267492|NCT00463567|4148375|P3|Overall Study|Abnormal test procedure result(s)|6
1267493|NCT00463567|4148376|P2|Overall Study|Abnormal test procedure result(s)|1
1267494|NCT00463567|4148377|P1|Overall Study|Abnormal test procedure result(s)|1
1267495|NCT00463567|4148371|P7|Overall Study|Abnormal lab value(s)|0
1267496|NCT00463567|4148372|P6|Overall Study|Abnormal lab value(s)|0
1267497|NCT00463567|4148373|P5|Overall Study|Abnormal lab value(s)|1
1267498|NCT00463567|4148374|P4|Overall Study|Abnormal lab value(s)|1
1267499|NCT00463567|4148375|P3|Overall Study|Abnormal lab value(s)|2
1267500|NCT00463567|4148376|P2|Overall Study|Abnormal lab value(s)|1
1267501|NCT00463567|4148377|P1|Overall Study|Abnormal lab value(s)|1
1267502|NCT00463567|4148371|P7|Overall Study|Lack of Efficacy|1
1267503|NCT00463567|4148372|P6|Overall Study|Lack of Efficacy|0
1267504|NCT00463567|4148373|P5|Overall Study|Lack of Efficacy|1
1267505|NCT00463567|4148374|P4|Overall Study|Lack of Efficacy|17
1267506|NCT00463567|4148375|P3|Overall Study|Lack of Efficacy|9
1267507|NCT00463567|4148376|P2|Overall Study|Lack of Efficacy|9
1267508|NCT00463567|4148377|P1|Overall Study|Lack of Efficacy|4
1267509|NCT00463567|4148371|P7|Overall Study|Administrative problems|2
1267510|NCT00463567|4148372|P6|Overall Study|Administrative problems|2
1267511|NCT00463567|4148373|P5|Overall Study|Administrative problems|3
1267512|NCT00463567|4148374|P4|Overall Study|Administrative problems|9
1267513|NCT00463567|4148375|P3|Overall Study|Administrative problems|6
1267514|NCT00463567|4148376|P2|Overall Study|Administrative problems|3
1267515|NCT00463567|4148377|P1|Overall Study|Administrative problems|5
1267516|NCT00463567|4148371|P7|Overall Study|Lost to Follow-up|1
1267517|NCT00463567|4148372|P6|Overall Study|Lost to Follow-up|1
1267518|NCT00463567|4148373|P5|Overall Study|Lost to Follow-up|1
1267519|NCT00463567|4148374|P4|Overall Study|Lost to Follow-up|8
1267520|NCT00463567|4148375|P3|Overall Study|Lost to Follow-up|13
1267521|NCT00463567|4148376|P2|Overall Study|Lost to Follow-up|6
1267522|NCT00463567|4148377|P1|Overall Study|Lost to Follow-up|12
1267523|NCT00463567|4148371|P7|Overall Study|Protocol Deviation|2
1267524|NCT00463567|4148372|P6|Overall Study|Protocol Deviation|1
1267525|NCT00463567|4148373|P5|Overall Study|Protocol Deviation|1
1267526|NCT00463567|4148374|P4|Overall Study|Protocol Deviation|11
1267527|NCT00463567|4148375|P3|Overall Study|Protocol Deviation|14
1267528|NCT00463567|4148376|P2|Overall Study|Protocol Deviation|9
1267529|NCT00463567|4148377|P1|Overall Study|Protocol Deviation|13
1267530|NCT00463567|4148371|P7|Overall Study|Withdrawal by Subject|1
1267531|NCT00463567|4148372|P6|Overall Study|Withdrawal by Subject|5
1267532|NCT00463567|4148373|P5|Overall Study|Withdrawal by Subject|6
1267533|NCT00463567|4148374|P4|Overall Study|Withdrawal by Subject|37
1267534|NCT00463567|4148375|P3|Overall Study|Withdrawal by Subject|20
1267535|NCT00463567|4148376|P2|Overall Study|Withdrawal by Subject|22
1267536|NCT00463567|4148377|P1|Overall Study|Withdrawal by Subject|29
1267537|NCT00463567|4148371|P7|Overall Study|Adverse Event|4
1267538|NCT00463567|4148372|P6|Overall Study|Adverse Event|10
1267539|NCT00463567|4148373|P5|Overall Study|Adverse Event|10
1267540|NCT00463567|4148374|P4|Overall Study|Adverse Event|46
1267541|NCT00463567|4148375|P3|Overall Study|Adverse Event|17
1267542|NCT00463567|4148376|P2|Overall Study|Adverse Event|26
1267543|NCT00463567|4148377|P1|Overall Study|Adverse Event|29
1267544|NCT00463385|4148481|P4|Overall Study|1 participant received commercial drug|0
1267545|NCT00463385|4148482|P3|Overall Study|1 participant received commercial drug|0
1267546|NCT00463385|4148483|P2|Overall Study|1 participant received commercial drug|1
1267547|NCT00463385|4148484|P1|Overall Study|1 participant received commercial drug|0
1267548|NCT00463385|4148481|P4|Overall Study|Missing|2
1267549|NCT00463385|4148482|P3|Overall Study|Missing|0
1267550|NCT00463385|4148483|P2|Overall Study|Missing|0
1267551|NCT00463385|4148484|P1|Overall Study|Missing|2
1267552|NCT00463385|4148481|P4|Overall Study|Death|0
1267553|NCT00463385|4148482|P3|Overall Study|Death|2
1267554|NCT00463385|4148483|P2|Overall Study|Death|1
1267555|NCT00463385|4148484|P1|Overall Study|Death|2
1267556|NCT00463385|4148481|P4|Overall Study|Lost to Follow-up|1
1267557|NCT00463385|4148482|P3|Overall Study|Lost to Follow-up|0
1267558|NCT00463385|4148483|P2|Overall Study|Lost to Follow-up|0
1267559|NCT00463385|4148484|P1|Overall Study|Lost to Follow-up|0
1267560|NCT00463385|4148481|P4|Overall Study|Withdrawal by Subject|4
1267561|NCT00463385|4148482|P3|Overall Study|Withdrawal by Subject|3
1267562|NCT00463385|4148483|P2|Overall Study|Withdrawal by Subject|3
1267563|NCT00463385|4148484|P1|Overall Study|Withdrawal by Subject|3
1267564|NCT00463385|4148481|P4|Overall Study|Lack of Efficacy|9
1267565|NCT00463385|4148482|P3|Overall Study|Lack of Efficacy|7
1267566|NCT00463385|4148483|P2|Overall Study|Lack of Efficacy|6
1267567|NCT00463385|4148484|P1|Overall Study|Lack of Efficacy|6
1267568|NCT00463385|4148481|P4|Overall Study|Adverse Event|2
1267569|NCT00463385|4148482|P3|Overall Study|Adverse Event|4
1267570|NCT00463385|4148483|P2|Overall Study|Adverse Event|8
1267571|NCT00463385|4148484|P1|Overall Study|Adverse Event|5
1267572|NCT00463385|4148481|P4|Overall Study|Other|4
1267573|NCT00463385|4148482|P3|Overall Study|Other|6
1267574|NCT00463385|4148483|P2|Overall Study|Other|3
1267575|NCT00463385|4148484|P1|Overall Study|Other|4
1267576|NCT00463346|4148536|P2|Overall Study|Withdrawal by Subject|3
1267577|NCT00463346|4148537|P1|Overall Study|Withdrawal by Subject|3
1267578|NCT00463229|4148547|P2|Overall Study|Death|3
1267579|NCT00463229|4148548|P1|Overall Study|Death|4
1267580|NCT00463229|4148547|P2|Overall Study|Lost to Follow-up|7
1267581|NCT00463229|4148548|P1|Overall Study|Lost to Follow-up|5
1267582|NCT00463060|4148568|P1|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1
1267583|NCT00463060|4148568|P1|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5
1267584|NCT00463047|4148582|P2|Double-Blind Treatment Period 2|Non-compliance with procedures|0
1267585|NCT00463047|4148583|P1|Double-Blind Treatment Period 2|Non-compliance with procedures|1
1267586|NCT00463047|4148582|P2|Double-Blind Treatment Period 2|Withdrawal by Subject|1
1267587|NCT00463047|4148583|P1|Double-Blind Treatment Period 2|Withdrawal by Subject|0
1267588|NCT00463047|4148582|P2|Double-Blind Treatment Period 2|Adverse Event|1
1267589|NCT00463047|4148583|P1|Double-Blind Treatment Period 2|Adverse Event|0
1267590|NCT00463047|4148582|P2|Double-Blind Treatment Period 1|Not specified|0
1267591|NCT00463047|4148583|P1|Double-Blind Treatment Period 1|Not specified|1
1267592|NCT00463047|4148582|P2|Double-Blind Treatment Period 1|Non-compliance with procedures|0
1267593|NCT00463047|4148583|P1|Double-Blind Treatment Period 1|Non-compliance with procedures|1
1267594|NCT00463047|4148582|P2|Double-Blind Treatment Period 1|Protocol Violation|2
1267595|NCT00463047|4148583|P1|Double-Blind Treatment Period 1|Protocol Violation|1
1267596|NCT00463047|4148582|P2|Double-Blind Treatment Period 1|Adverse Event|2
1267597|NCT00463047|4148583|P1|Double-Blind Treatment Period 1|Adverse Event|0
1267598|NCT00463047|4148582|P2|Titration Period 2|Not specified|2
1267599|NCT00463047|4148583|P1|Titration Period 2|Not specified|3
1267600|NCT00463047|4148582|P2|Titration Period 2|Non-compliance procedures|1
1267601|NCT00463047|4148583|P1|Titration Period 2|Non-compliance procedures|4
1267602|NCT00463047|4148582|P2|Titration Period 2|Non-compliance study medication|2
1267603|NCT00463047|4148583|P1|Titration Period 2|Non-compliance study medication|4
1267604|NCT00463047|4148582|P2|Titration Period 2|Lost to Follow-up|2
1267605|NCT00463047|4148583|P1|Titration Period 2|Lost to Follow-up|1
1267606|NCT00463047|4148582|P2|Titration Period 2|Protocol Violation|3
1267607|NCT00463047|4148583|P1|Titration Period 2|Protocol Violation|2
1267608|NCT00463047|4148582|P2|Titration Period 2|Withdrawal by Subject|0
1267609|NCT00463047|4148583|P1|Titration Period 2|Withdrawal by Subject|1
1267610|NCT00463047|4148582|P2|Titration Period 2|Lack of Efficacy|4
1267611|NCT00463047|4148583|P1|Titration Period 2|Lack of Efficacy|6
1267612|NCT00463047|4148582|P2|Titration Period 2|Adverse Event|9
1267613|NCT00463047|4148583|P1|Titration Period 2|Adverse Event|9
1267614|NCT00463047|4148582|P2|Titration Period 1|Not specified|2
1267615|NCT00463047|4148583|P1|Titration Period 1|Not specified|0
1267616|NCT00463047|4148582|P2|Titration Period 1|Non-compliance procedures|10
1267617|NCT00463047|4148583|P1|Titration Period 1|Non-compliance procedures|4
1267618|NCT00463047|4148582|P2|Titration Period 1|Withdrawal by Subject|5
1267619|NCT00463047|4148583|P1|Titration Period 1|Withdrawal by Subject|3
1267620|NCT00463047|4148582|P2|Titration Period 1|Protocol Violation|5
1267621|NCT00463047|4148583|P1|Titration Period 1|Protocol Violation|5
1267622|NCT00463047|4148582|P2|Titration Period 1|Non-compliance with study medication|5
1267623|NCT00463047|4148583|P1|Titration Period 1|Non-compliance with study medication|3
1267624|NCT00463047|4148582|P2|Titration Period 1|Lost to Follow-up|0
1267625|NCT00463047|4148583|P1|Titration Period 1|Lost to Follow-up|2
1267626|NCT00463047|4148582|P2|Titration Period 1|Lack of Efficacy|4
1267627|NCT00463047|4148583|P1|Titration Period 1|Lack of Efficacy|10
1267628|NCT00463047|4148582|P2|Titration Period 1|Adverse Event|8
1267629|NCT00463047|4148583|P1|Titration Period 1|Adverse Event|10
1267630|NCT00462982|4148668|P1|Overall Study|Patient Not Treated|2
1267631|NCT00462982|4148668|P1|Overall Study|Adverse Event|1
1267632|NCT00462943|4148675|P3|Overall Study|Withdrawal by Subject|0
1267633|NCT00462943|4148676|P2|Overall Study|Withdrawal by Subject|1
1267634|NCT00462943|4148677|P1|Overall Study|Withdrawal by Subject|0
1267635|NCT00462943|4148675|P3|Overall Study|Physician Decision|0
1267636|NCT00462943|4148676|P2|Overall Study|Physician Decision|0
1267637|NCT00462943|4148677|P1|Overall Study|Physician Decision|1
1267638|NCT00462943|4148675|P3|Overall Study|Transplant - not specified|1
1267639|NCT00462943|4148676|P2|Overall Study|Transplant - not specified|0
1267640|NCT00462943|4148677|P1|Overall Study|Transplant - not specified|1
1267641|NCT00462943|4148675|P3|Overall Study|Required Lymphocyte Infusion|0
1267642|NCT00462943|4148676|P2|Overall Study|Required Lymphocyte Infusion|0
1267643|NCT00462943|4148677|P1|Overall Study|Required Lymphocyte Infusion|1
1267644|NCT00462943|4148675|P3|Overall Study|Bone Marrow Transplant|0
1267645|NCT00462943|4148676|P2|Overall Study|Bone Marrow Transplant|0
1267646|NCT00462943|4148677|P1|Overall Study|Bone Marrow Transplant|1
1267647|NCT00462943|4148675|P3|Overall Study|Stem Cell Transplant|0
1267648|NCT00462943|4148676|P2|Overall Study|Stem Cell Transplant|1
1267649|NCT00462943|4148677|P1|Overall Study|Stem Cell Transplant|1
1267650|NCT00462943|4148675|P3|Overall Study|Death|7
1267651|NCT00462943|4148676|P2|Overall Study|Death|2
1267652|NCT00462943|4148677|P1|Overall Study|Death|5
1267653|NCT00462943|4148675|P3|Overall Study|Disease Progression|9
1267654|NCT00462943|4148676|P2|Overall Study|Disease Progression|15
1267655|NCT00462943|4148677|P1|Overall Study|Disease Progression|15
1267656|NCT00462943|4148675|P3|Overall Study|Request of Patient, PI, Sponsor or RA|4
1267657|NCT00462943|4148676|P2|Overall Study|Request of Patient, PI, Sponsor or RA|2
1267658|NCT00462943|4148677|P1|Overall Study|Request of Patient, PI, Sponsor or RA|8
1267659|NCT00462943|4148675|P3|Overall Study|Protocol Violation|0
1267660|NCT00462943|4148676|P2|Overall Study|Protocol Violation|0
1267661|NCT00462943|4148677|P1|Overall Study|Protocol Violation|1
1267662|NCT00462943|4148675|P3|Overall Study|Adverse Event|1
1267663|NCT00462943|4148676|P2|Overall Study|Adverse Event|4
1267664|NCT00462943|4148677|P1|Overall Study|Adverse Event|6
1267665|NCT00462943|4148675|P3|Overall Study|Failure to achieve a response|1
1267666|NCT00462943|4148676|P2|Overall Study|Failure to achieve a response|5
1267667|NCT00462943|4148677|P1|Overall Study|Failure to achieve a response|5
1267668|NCT00462865|4148769|P1|Overall Study|Adverse Event|1
1267669|NCT00462826|4148788|P1|Overall Study|Never treated|1
1267670|NCT00462826|4148788|P1|Overall Study|Ineligible - wrong primary|2
1267671|NCT00462826|4148788|P1|Overall Study|Ineligible - wrong cell type|1
1267672|NCT00462826|4148788|P1|Overall Study|Ineligible - second primary|1
1267673|NCT00462748|4148804|P3|Overall Study|Discontinued after 41 days Rx|0
1267674|NCT00462748|4148805|P2|Overall Study|Discontinued after 41 days Rx|0
1267675|NCT00462748|4148806|P1|Overall Study|Discontinued after 41 days Rx|1
1267676|NCT00462748|4148804|P3|Overall Study|Lost to Follow-up|1
1267677|NCT00462748|4148805|P2|Overall Study|Lost to Follow-up|1
1267678|NCT00462748|4148806|P1|Overall Study|Lost to Follow-up|1
1267679|NCT00462748|4148804|P3|Overall Study|Withdrew consent|0
1267680|NCT00462748|4148805|P2|Overall Study|Withdrew consent|3
1267681|NCT00462748|4148806|P1|Overall Study|Withdrew consent|3
1267682|NCT00462748|4148804|P3|Overall Study|Protocol Violation|1
1267683|NCT00462748|4148805|P2|Overall Study|Protocol Violation|2
1267684|NCT00462748|4148806|P1|Overall Study|Protocol Violation|0
1267685|NCT00462748|4148804|P3|Overall Study|Adverse Event|9
1267686|NCT00462748|4148805|P2|Overall Study|Adverse Event|5
1267687|NCT00462748|4148806|P1|Overall Study|Adverse Event|7
1267688|NCT00462709|4148859|P1|Overall Study|Withdrew to start treatment with Cetor|1
1267689|NCT00462709|4148859|P1|Overall Study|Physician Decision|1
1267690|NCT00462709|4148859|P1|Overall Study|Logistical reasons|2
1267691|NCT00462709|4148859|P1|Overall Study|Death|2
1267692|NCT00462709|4148859|P1|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3
1267693|NCT00462709|4148859|P1|Overall Study|Withdrawal by Subject|8
1267694|NCT00462709|4148859|P1|Overall Study|Lost to Follow-up|10
1267695|NCT00462709|4148859|P1|Overall Study|Transitioned to commercial C1INH-nf|40
1267696|NCT00462670|4148868|P2|Overall Study|Resolution of signs and symptoms|2
1267697|NCT00462670|4148869|P1|Overall Study|Resolution of signs and symptoms|0
1267698|NCT00462670|4148868|P2|Overall Study|Protocol Violation|0
1267699|NCT00462670|4148869|P1|Overall Study|Protocol Violation|1
1267700|NCT00462670|4148868|P2|Overall Study|Lack of Efficacy|0
1267701|NCT00462670|4148869|P1|Overall Study|Lack of Efficacy|1
1267702|NCT00462670|4148868|P2|Overall Study|Adverse Event|5
1267703|NCT00462670|4148869|P1|Overall Study|Adverse Event|3
1267704|NCT00462501|4148906|P1|Overall Study|Adverse Event|2
1267705|NCT00462501|4148906|P1|Overall Study|Not treated|3
1267706|NCT00462462|4148912|P2|Overall Study|Physician Decision|1
1267707|NCT00462462|4148913|P1|Overall Study|Physician Decision|0
1267708|NCT00462384|4148941|P1|Overall Study|Other|4
1267709|NCT00462384|4148941|P1|Overall Study|Withdrawal by Subject|1
1267710|NCT00462384|4148941|P1|Overall Study|Death|2
1267711|NCT00462384|4148941|P1|Overall Study|Adverse Event|2
1267712|NCT00462345|4148949|P1|Overall Study|Did not complete second course|1
1267713|NCT00462345|4148949|P1|Overall Study|Withdrawal by Subject|2
1267714|NCT00462306|4148984|P2|Overall Study|insufficient data|13
1267715|NCT00462306|4148985|P1|Overall Study|insufficient data|0
1267716|NCT00461981|4149111|P2|Overall Study|Withdrawal by Subject|3
1267717|NCT00461981|4149112|P1|Overall Study|Withdrawal by Subject|2
1267718|NCT00461981|4149111|P2|Overall Study|Lost to Follow-up|6
1267719|NCT00461981|4149112|P1|Overall Study|Lost to Follow-up|9
1267720|NCT00461812|4149228|P1|Overall Study|study terminated|10
1267721|NCT00461786|4149233|P1|Overall Study|Inevaluable (Never Treated)|1
1267722|NCT00461786|4149233|P1|Overall Study|Entry Criteria Not Met|2
1267723|NCT00461708|4149278|P2|Overall Study|Death|1
1267724|NCT00461708|4149279|P1|Overall Study|Death|8
1267725|NCT00461708|4149278|P2|Overall Study|Not specified|4
1267726|NCT00461708|4149279|P1|Overall Study|Not specified|4
1267727|NCT00461708|4149278|P2|Overall Study|Withdrawal by Subject|2
1267728|NCT00461708|4149279|P1|Overall Study|Withdrawal by Subject|8
1267729|NCT00461708|4149278|P2|Overall Study|Physician Decision|4
1267730|NCT00461708|4149279|P1|Overall Study|Physician Decision|10
1267731|NCT00461708|4149278|P2|Overall Study|Lack of Efficacy|20
1267732|NCT00461708|4149279|P1|Overall Study|Lack of Efficacy|68
1267733|NCT00461708|4149278|P2|Overall Study|Adverse Event|7
1267734|NCT00461708|4149279|P1|Overall Study|Adverse Event|17
1267735|NCT00461682|4149305|P1|Overall Study|Protocol Violation|1
1267736|NCT00461630|4149333|P2|Overall Study|Lost to Follow-up|95
1267737|NCT00461630|4149334|P1|Overall Study|Lost to Follow-up|108
1267738|NCT00461630|4149333|P2|Overall Study|Death|732
1267739|NCT00461630|4149334|P1|Overall Study|Death|798
1267740|NCT00461500|4149386|P2|Overall Study|Lost to Follow-up|2
1267741|NCT00461500|4149387|P1|Overall Study|Lost to Follow-up|2
1267742|NCT00461500|4149386|P2|Overall Study|No Longer Willing to Take Part in Study|0
1267743|NCT00461500|4149387|P1|Overall Study|No Longer Willing to Take Part in Study|1
1267744|NCT00461500|4149386|P2|Overall Study|Drug Treatment Misuse|0
1267745|NCT00461500|4149387|P1|Overall Study|Drug Treatment Misuse|1
1267746|NCT00461500|4149386|P2|Overall Study|Study Stopped|2
1267747|NCT00461500|4149387|P1|Overall Study|Study Stopped|1
1267748|NCT00461500|4149386|P2|Overall Study|Expired Drug Treatment|1
1267749|NCT00461500|4149387|P1|Overall Study|Expired Drug Treatment|1
1267750|NCT00461500|4149386|P2|Overall Study|Lack of Efficacy|1
1267751|NCT00461500|4149387|P1|Overall Study|Lack of Efficacy|0
1267752|NCT00461500|4149386|P2|Overall Study|Adverse Event|0
1267753|NCT00461500|4149387|P1|Overall Study|Adverse Event|1
1267754|NCT00461305|4149430|P2|Continued Treatment|Other (missing drug etc)|0
1267755|NCT00461305|4149431|P1|Continued Treatment|Other (missing drug etc)|2
1267756|NCT00461305|4149430|P2|Continued Treatment|Partially missing diary|0
1267757|NCT00461305|4149431|P1|Continued Treatment|Partially missing diary|2
1267758|NCT00461305|4149430|P2|Continued Treatment|Withdrawal by Subject|0
1267759|NCT00461305|4149431|P1|Continued Treatment|Withdrawal by Subject|48
1267760|NCT00461305|4149430|P2|Continued Treatment|Protocol Violation|0
1267761|NCT00461305|4149431|P1|Continued Treatment|Protocol Violation|13
1267762|NCT00461305|4149430|P2|Continued Treatment|Lost to Follow-up|0
1267763|NCT00461305|4149431|P1|Continued Treatment|Lost to Follow-up|4
1267764|NCT00461305|4149430|P2|Continued Treatment|Adverse Event|0
1267765|NCT00461305|4149431|P1|Continued Treatment|Adverse Event|26
1267766|NCT00461305|4149430|P2|Treatment|Other (missing drug etc)|0
1267767|NCT00461305|4149431|P1|Treatment|Other (missing drug etc)|2
1267768|NCT00461305|4149430|P2|Treatment|Partially missing diary|0
1267769|NCT00461305|4149431|P1|Treatment|Partially missing diary|2
1267770|NCT00461305|4149430|P2|Treatment|Study drug not taken|0
1267771|NCT00461305|4149431|P1|Treatment|Study drug not taken|1
1267772|NCT00461305|4149430|P2|Treatment|Never dispensed|0
1267773|NCT00461305|4149431|P1|Treatment|Never dispensed|5
1267774|NCT00461305|4149430|P2|Treatment|Withdrawal by Subject|2
1267775|NCT00461305|4149431|P1|Treatment|Withdrawal by Subject|48
1267776|NCT00461305|4149430|P2|Treatment|Protocol Violation|2
1267777|NCT00461305|4149431|P1|Treatment|Protocol Violation|13
1267778|NCT00461305|4149430|P2|Treatment|Lost to Follow-up|2
1267779|NCT00461305|4149431|P1|Treatment|Lost to Follow-up|4
1267780|NCT00461305|4149430|P2|Treatment|Adverse Event|3
1267781|NCT00461305|4149431|P1|Treatment|Adverse Event|26
1267782|NCT00461253|4149515|P2|Overall Study|administrative|7773
1267783|NCT00461253|4149516|P1|Overall Study|administrative|773
1267784|NCT00461253|4149515|P2|Overall Study|no response|11789
1267785|NCT00461253|4149516|P1|Overall Study|no response|2609
1267786|NCT00461253|4149515|P2|Overall Study|Protocol Violation|236
1267787|NCT00461253|4149516|P1|Overall Study|Protocol Violation|613
1267788|NCT00461253|4149515|P2|Overall Study|Death|0
1267789|NCT00461253|4149516|P1|Overall Study|Death|985
1267790|NCT00461175|4149524|P2|Overall Study|Protocol Violation|365
1267791|NCT00461175|4149525|P1|Overall Study|Protocol Violation|522
1267792|NCT00461123|4149535|P2|Overall Study|Withdrawal by Subject|3
1267793|NCT00461123|4149536|P1|Overall Study|Withdrawal by Subject|1
1267794|NCT00461123|4149535|P2|Overall Study|Protocol Violation|2
1267795|NCT00461123|4149536|P1|Overall Study|Protocol Violation|3
1267796|NCT00461123|4149535|P2|Overall Study|Lost to Follow-up|1
1267797|NCT00461123|4149536|P1|Overall Study|Lost to Follow-up|1
1267798|NCT00461123|4149535|P2|Overall Study|Adverse Event|0
1267799|NCT00461123|4149536|P1|Overall Study|Adverse Event|1
1267800|NCT00461032|4149581|P2|Overall Study|Not Specified|5
1267801|NCT00461032|4149582|P1|Overall Study|Not Specified|7
1267802|NCT00461032|4149581|P2|Overall Study|Patient Moved or Relocated|1
1267803|NCT00461032|4149582|P1|Overall Study|Patient Moved or Relocated|2
1267804|NCT00461032|4149581|P2|Overall Study|Withdrawal by Subject|15
1267805|NCT00461032|4149582|P1|Overall Study|Withdrawal by Subject|7
1267806|NCT00461032|4149581|P2|Overall Study|Protocol Violation|4
1267807|NCT00461032|4149582|P1|Overall Study|Protocol Violation|4
1267808|NCT00461032|4149581|P2|Overall Study|Lost to Follow-up|12
1267809|NCT00461032|4149582|P1|Overall Study|Lost to Follow-up|7
1267810|NCT00461032|4149581|P2|Overall Study|Lack of Efficacy|1
1267811|NCT00461032|4149582|P1|Overall Study|Lack of Efficacy|5
1267812|NCT00461032|4149581|P2|Overall Study|Adverse Event|6
1267813|NCT00461032|4149582|P1|Overall Study|Adverse Event|5
1267814|NCT00460811|4149608|P5|Overall Study|Lost to Follow-up|6
1267815|NCT00460811|4149609|P4|Overall Study|Lost to Follow-up|3
1267816|NCT00460811|4149610|P3|Overall Study|Lost to Follow-up|5
1267817|NCT00460811|4149611|P2|Overall Study|Lost to Follow-up|2
1267818|NCT00460811|4149612|P1|Overall Study|Lost to Follow-up|3
1267819|NCT00460811|4149608|P5|Overall Study|Physician Decision|0
1267820|NCT00460811|4149609|P4|Overall Study|Physician Decision|0
1267821|NCT00460811|4149610|P3|Overall Study|Physician Decision|0
1267822|NCT00460811|4149611|P2|Overall Study|Physician Decision|0
1267823|NCT00460811|4149612|P1|Overall Study|Physician Decision|1
1267824|NCT00460811|4149608|P5|Overall Study|Withdrawal by Subject|11
1267825|NCT00460811|4149609|P4|Overall Study|Withdrawal by Subject|3
1267826|NCT00460811|4149610|P3|Overall Study|Withdrawal by Subject|6
1267827|NCT00460811|4149611|P2|Overall Study|Withdrawal by Subject|7
1267828|NCT00460811|4149612|P1|Overall Study|Withdrawal by Subject|7
1267829|NCT00460811|4149608|P5|Overall Study|Noncompliance|1
1267830|NCT00460811|4149609|P4|Overall Study|Noncompliance|2
1267831|NCT00460811|4149610|P3|Overall Study|Noncompliance|0
1267832|NCT00460811|4149611|P2|Overall Study|Noncompliance|0
1267833|NCT00460811|4149612|P1|Overall Study|Noncompliance|1
1267834|NCT00460811|4149608|P5|Overall Study|Adverse Event|2
1267835|NCT00460811|4149609|P4|Overall Study|Adverse Event|10
1267836|NCT00460811|4149610|P3|Overall Study|Adverse Event|3
1267837|NCT00460811|4149611|P2|Overall Study|Adverse Event|6
1267838|NCT00460811|4149612|P1|Overall Study|Adverse Event|4
1267839|NCT00460798|4149654|P1|Overall Study|Missing/Incomplete Dosing Information|27
1267840|NCT00460798|4149654|P1|Overall Study|Ongoing at Date of Cut-Off|82
1267841|NCT00460798|4149654|P1|Overall Study|Other|27
1267842|NCT00460798|4149654|P1|Overall Study|Progressive Disease|99
1267843|NCT00460798|4149654|P1|Overall Study|Lost to Follow-up|19
1267844|NCT00460798|4149654|P1|Overall Study|Adverse Event|27
1267845|NCT00460798|4149654|P1|Overall Study|Death|59
1267846|NCT00460746|4149662|P1|Overall Study|Lost to Follow-up|1
1267847|NCT00460746|4149662|P1|Overall Study|Adverse Event|1
1267848|NCT00460655|4149677|P4|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1
1267849|NCT00460655|4149678|P3|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
1267850|NCT00460655|4149679|P2|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
1267851|NCT00460655|4149680|P1|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
1267852|NCT00460655|4149677|P4|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2
1267853|NCT00460655|4149678|P3|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6
1267854|NCT00460655|4149679|P2|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
1267855|NCT00460655|4149680|P1|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
1267856|NCT00460655|4149677|P4|Open-Label Phase (36 Weeks)|Adverse Event|6
1267857|NCT00460655|4149678|P3|Open-Label Phase (36 Weeks)|Adverse Event|1
1267858|NCT00460655|4149679|P2|Open-Label Phase (36 Weeks)|Adverse Event|0
1267859|NCT00460655|4149680|P1|Open-Label Phase (36 Weeks)|Adverse Event|0
1267860|NCT00460655|4149677|P4|Double-Blind Phase (12 Weeks)|Protocol Violation|0
1267861|NCT00460655|4149678|P3|Double-Blind Phase (12 Weeks)|Protocol Violation|0
1267862|NCT00460655|4149679|P2|Double-Blind Phase (12 Weeks)|Protocol Violation|1
1267863|NCT00460655|4149680|P1|Double-Blind Phase (12 Weeks)|Protocol Violation|0
1267864|NCT00460655|4149677|P4|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
1267865|NCT00460655|4149678|P3|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
1267866|NCT00460655|4149679|P2|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
1267867|NCT00460655|4149680|P1|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3
1267868|NCT00460655|4149677|P4|Double-Blind Phase (12 Weeks)|Adverse Event|0
1267869|NCT00460655|4149678|P3|Double-Blind Phase (12 Weeks)|Adverse Event|0
1267870|NCT00460655|4149679|P2|Double-Blind Phase (12 Weeks)|Adverse Event|0
1267871|NCT00460655|4149680|P1|Double-Blind Phase (12 Weeks)|Adverse Event|3
1267872|NCT00460603|4149724|P12|Phase 2|Randomized, but not treated|0
1267873|NCT00460603|4149725|P11|Phase 2|Randomized, but not treated|0
1267874|NCT00460603|4149726|P10|Phase 2|Randomized, but not treated|3
1267875|NCT00460603|4149727|P9|Phase 2|Randomized, but not treated|0
1267876|NCT00460603|4149728|P8|Phase 2|Randomized, but not treated|0
1267877|NCT00460603|4149729|P7|Phase 2|Randomized, but not treated|0
1267878|NCT00460603|4149730|P6|Phase 2|Randomized, but not treated|0
1267879|NCT00460603|4149731|P5|Phase 2|Randomized, but not treated|0
1267880|NCT00460603|4149732|P4|Phase 2|Randomized, but not treated|0
1267881|NCT00460603|4149733|P3|Phase 2|Randomized, but not treated|0
1267882|NCT00460603|4149734|P2|Phase 2|Randomized, but not treated|0
1267883|NCT00460603|4149735|P1|Phase 2|Randomized, but not treated|0
1267884|NCT00460603|4149724|P12|Phase 2|Withdrawal by Subject|5
1267885|NCT00460603|4149725|P11|Phase 2|Withdrawal by Subject|4
1267886|NCT00460603|4149726|P10|Phase 2|Withdrawal by Subject|5
1267887|NCT00460603|4149727|P9|Phase 2|Withdrawal by Subject|0
1267888|NCT00460603|4149728|P8|Phase 2|Withdrawal by Subject|0
1267889|NCT00460603|4149729|P7|Phase 2|Withdrawal by Subject|0
1267890|NCT00460603|4149730|P6|Phase 2|Withdrawal by Subject|0
1267891|NCT00460603|4149731|P5|Phase 2|Withdrawal by Subject|0
1267892|NCT00460603|4149732|P4|Phase 2|Withdrawal by Subject|0
1267893|NCT00460603|4149733|P3|Phase 2|Withdrawal by Subject|0
1267894|NCT00460603|4149734|P2|Phase 2|Withdrawal by Subject|0
1267895|NCT00460603|4149735|P1|Phase 2|Withdrawal by Subject|0
1267896|NCT00460603|4149724|P12|Phase 2|Global Deterioration of Health Status|0
1267897|NCT00460603|4149725|P11|Phase 2|Global Deterioration of Health Status|1
1267898|NCT00460603|4149726|P10|Phase 2|Global Deterioration of Health Status|0
1267899|NCT00460603|4149727|P9|Phase 2|Global Deterioration of Health Status|0
1267900|NCT00460603|4149728|P8|Phase 2|Global Deterioration of Health Status|0
1267901|NCT00460603|4149729|P7|Phase 2|Global Deterioration of Health Status|0
1267902|NCT00460603|4149730|P6|Phase 2|Global Deterioration of Health Status|0
1267903|NCT00460603|4149731|P5|Phase 2|Global Deterioration of Health Status|0
1267904|NCT00460603|4149732|P4|Phase 2|Global Deterioration of Health Status|0
1267905|NCT00460603|4149733|P3|Phase 2|Global Deterioration of Health Status|0
1267906|NCT00460603|4149734|P2|Phase 2|Global Deterioration of Health Status|0
1267907|NCT00460603|4149735|P1|Phase 2|Global Deterioration of Health Status|0
1267908|NCT00460603|4149724|P12|Phase 2|Objective Progression or Relapse|17
1267909|NCT00460603|4149725|P11|Phase 2|Objective Progression or Relapse|10
1267910|NCT00460603|4149726|P10|Phase 2|Objective Progression or Relapse|9
1267911|NCT00460603|4149727|P9|Phase 2|Objective Progression or Relapse|0
1267912|NCT00460603|4149728|P8|Phase 2|Objective Progression or Relapse|0
1267913|NCT00460603|4149729|P7|Phase 2|Objective Progression or Relapse|0
1267914|NCT00460603|4149730|P6|Phase 2|Objective Progression or Relapse|0
1267915|NCT00460603|4149731|P5|Phase 2|Objective Progression or Relapse|0
1267916|NCT00460603|4149732|P4|Phase 2|Objective Progression or Relapse|0
1267917|NCT00460603|4149733|P3|Phase 2|Objective Progression or Relapse|0
1267918|NCT00460603|4149734|P2|Phase 2|Objective Progression or Relapse|0
1267919|NCT00460603|4149735|P1|Phase 2|Objective Progression or Relapse|0
1267920|NCT00460603|4149724|P12|Phase 2|Other|7
1267921|NCT00460603|4149725|P11|Phase 2|Other|16
1267922|NCT00460603|4149726|P10|Phase 2|Other|6
1267923|NCT00460603|4149727|P9|Phase 2|Other|0
1267924|NCT00460603|4149728|P8|Phase 2|Other|0
1267925|NCT00460603|4149729|P7|Phase 2|Other|0
1267926|NCT00460603|4149730|P6|Phase 2|Other|0
1267927|NCT00460603|4149731|P5|Phase 2|Other|0
1267928|NCT00460603|4149732|P4|Phase 2|Other|0
1267929|NCT00460603|4149733|P3|Phase 2|Other|0
1267930|NCT00460603|4149734|P2|Phase 2|Other|0
1267931|NCT00460603|4149735|P1|Phase 2|Other|0
1267932|NCT00460603|4149724|P12|Phase 2|Lost to Follow-up|0
1267933|NCT00460603|4149725|P11|Phase 2|Lost to Follow-up|0
1267934|NCT00460603|4149726|P10|Phase 2|Lost to Follow-up|1
1267935|NCT00460603|4149727|P9|Phase 2|Lost to Follow-up|0
1267936|NCT00460603|4149728|P8|Phase 2|Lost to Follow-up|0
1267937|NCT00460603|4149729|P7|Phase 2|Lost to Follow-up|0
1267938|NCT00460603|4149730|P6|Phase 2|Lost to Follow-up|0
1267939|NCT00460603|4149731|P5|Phase 2|Lost to Follow-up|0
1267940|NCT00460603|4149732|P4|Phase 2|Lost to Follow-up|0
1267941|NCT00460603|4149733|P3|Phase 2|Lost to Follow-up|0
1267942|NCT00460603|4149734|P2|Phase 2|Lost to Follow-up|0
1267943|NCT00460603|4149735|P1|Phase 2|Lost to Follow-up|0
1267944|NCT00460603|4149724|P12|Phase 2|Protocol Violation|0
1267945|NCT00460603|4149725|P11|Phase 2|Protocol Violation|1
1267946|NCT00460603|4149726|P10|Phase 2|Protocol Violation|1
1267947|NCT00460603|4149727|P9|Phase 2|Protocol Violation|0
1267948|NCT00460603|4149728|P8|Phase 2|Protocol Violation|0
1267949|NCT00460603|4149729|P7|Phase 2|Protocol Violation|0
1267950|NCT00460603|4149730|P6|Phase 2|Protocol Violation|0
1267951|NCT00460603|4149731|P5|Phase 2|Protocol Violation|0
1267952|NCT00460603|4149732|P4|Phase 2|Protocol Violation|0
1267953|NCT00460603|4149733|P3|Phase 2|Protocol Violation|0
1267954|NCT00460603|4149734|P2|Phase 2|Protocol Violation|0
1267955|NCT00460603|4149735|P1|Phase 2|Protocol Violation|0
1267956|NCT00460603|4149724|P12|Phase 2|Death|2
1267957|NCT00460603|4149725|P11|Phase 2|Death|2
1267958|NCT00460603|4149726|P10|Phase 2|Death|4
1267959|NCT00460603|4149727|P9|Phase 2|Death|0
1267960|NCT00460603|4149728|P8|Phase 2|Death|0
1267961|NCT00460603|4149729|P7|Phase 2|Death|0
1267962|NCT00460603|4149730|P6|Phase 2|Death|0
1267963|NCT00460603|4149731|P5|Phase 2|Death|0
1267964|NCT00460603|4149732|P4|Phase 2|Death|0
1267965|NCT00460603|4149733|P3|Phase 2|Death|0
1267966|NCT00460603|4149734|P2|Phase 2|Death|0
1267967|NCT00460603|4149735|P1|Phase 2|Death|0
1267968|NCT00460603|4149724|P12|Phase 2|Adverse Event|10
1267969|NCT00460603|4149725|P11|Phase 2|Adverse Event|9
1267970|NCT00460603|4149726|P10|Phase 2|Adverse Event|12
1267971|NCT00460603|4149727|P9|Phase 2|Adverse Event|0
1267972|NCT00460603|4149728|P8|Phase 2|Adverse Event|0
1267973|NCT00460603|4149729|P7|Phase 2|Adverse Event|0
1267974|NCT00460603|4149730|P6|Phase 2|Adverse Event|0
1267975|NCT00460603|4149731|P5|Phase 2|Adverse Event|0
1267976|NCT00460603|4149732|P4|Phase 2|Adverse Event|0
1267977|NCT00460603|4149733|P3|Phase 2|Adverse Event|0
1267978|NCT00460603|4149734|P2|Phase 2|Adverse Event|0
1267979|NCT00460603|4149735|P1|Phase 2|Adverse Event|0
1267980|NCT00460603|4149724|P12|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
1267981|NCT00460603|4149725|P11|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
1267982|NCT00460603|4149726|P10|Phase 2|Ongoing in study A4061008 (NCT00828919)|1
1267983|NCT00460603|4149727|P9|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
1267984|NCT00460603|4149728|P8|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
1267985|NCT00460603|4149729|P7|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
1267986|NCT00460603|4149730|P6|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
1267987|NCT00460603|4149731|P5|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
1267988|NCT00460603|4149732|P4|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
1267989|NCT00460603|4149733|P3|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
1267990|NCT00460603|4149734|P2|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
1267991|NCT00460603|4149735|P1|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
1267992|NCT00460603|4149724|P12|Phase 1|Other|0
1267993|NCT00460603|4149725|P11|Phase 1|Other|0
1267994|NCT00460603|4149726|P10|Phase 1|Other|0
1267995|NCT00460603|4149727|P9|Phase 1|Other|0
1267996|NCT00460603|4149728|P8|Phase 1|Other|1
1267997|NCT00460603|4149729|P7|Phase 1|Other|0
1267998|NCT00460603|4149730|P6|Phase 1|Other|2
1267999|NCT00460603|4149731|P5|Phase 1|Other|1
1268000|NCT00460603|4149732|P4|Phase 1|Other|1
1268001|NCT00460603|4149733|P3|Phase 1|Other|1
1268002|NCT00460603|4149734|P2|Phase 1|Other|3
1268003|NCT00460603|4149735|P1|Phase 1|Other|0
1268004|NCT00460603|4149724|P12|Phase 1|Withdrawal by Subject|0
1268005|NCT00460603|4149725|P11|Phase 1|Withdrawal by Subject|0
1268006|NCT00460603|4149726|P10|Phase 1|Withdrawal by Subject|0
1268007|NCT00460603|4149727|P9|Phase 1|Withdrawal by Subject|2
1268008|NCT00460603|4149728|P8|Phase 1|Withdrawal by Subject|0
1268009|NCT00460603|4149729|P7|Phase 1|Withdrawal by Subject|1
1268010|NCT00460603|4149730|P6|Phase 1|Withdrawal by Subject|0
1268011|NCT00460603|4149731|P5|Phase 1|Withdrawal by Subject|3
1268012|NCT00460603|4149732|P4|Phase 1|Withdrawal by Subject|1
1268013|NCT00460603|4149733|P3|Phase 1|Withdrawal by Subject|1
1268014|NCT00460603|4149734|P2|Phase 1|Withdrawal by Subject|2
1268015|NCT00460603|4149735|P1|Phase 1|Withdrawal by Subject|1
1268016|NCT00460603|4149724|P12|Phase 1|Lack of Efficacy|0
1268017|NCT00460603|4149725|P11|Phase 1|Lack of Efficacy|0
1268018|NCT00460603|4149726|P10|Phase 1|Lack of Efficacy|0
1268019|NCT00460603|4149727|P9|Phase 1|Lack of Efficacy|11
1268020|NCT00460603|4149728|P8|Phase 1|Lack of Efficacy|2
1268021|NCT00460603|4149729|P7|Phase 1|Lack of Efficacy|2
1268022|NCT00460603|4149730|P6|Phase 1|Lack of Efficacy|2
1268023|NCT00460603|4149731|P5|Phase 1|Lack of Efficacy|2
1268024|NCT00460603|4149732|P4|Phase 1|Lack of Efficacy|2
1268025|NCT00460603|4149733|P3|Phase 1|Lack of Efficacy|1
1268026|NCT00460603|4149734|P2|Phase 1|Lack of Efficacy|0
1268027|NCT00460603|4149735|P1|Phase 1|Lack of Efficacy|1
1268028|NCT00460603|4149724|P12|Phase 1|Adverse Event|0
1268029|NCT00460603|4149725|P11|Phase 1|Adverse Event|0
1268030|NCT00460603|4149726|P10|Phase 1|Adverse Event|0
1268031|NCT00460603|4149727|P9|Phase 1|Adverse Event|4
1268032|NCT00460603|4149728|P8|Phase 1|Adverse Event|0
1268033|NCT00460603|4149729|P7|Phase 1|Adverse Event|3
1268034|NCT00460603|4149730|P6|Phase 1|Adverse Event|0
1268035|NCT00460603|4149731|P5|Phase 1|Adverse Event|0
1268036|NCT00460603|4149732|P4|Phase 1|Adverse Event|2
1268037|NCT00460603|4149733|P3|Phase 1|Adverse Event|1
1268038|NCT00460603|4149734|P2|Phase 1|Adverse Event|1
1268039|NCT00460603|4149735|P1|Phase 1|Adverse Event|3
1268040|NCT00460603|4149724|P12|Phase 1|Death|0
1268041|NCT00460603|4149725|P11|Phase 1|Death|0
1268042|NCT00460603|4149726|P10|Phase 1|Death|0
1268043|NCT00460603|4149727|P9|Phase 1|Death|1
1268044|NCT00460603|4149728|P8|Phase 1|Death|0
1268045|NCT00460603|4149729|P7|Phase 1|Death|0
1268046|NCT00460603|4149730|P6|Phase 1|Death|0
1268047|NCT00460603|4149731|P5|Phase 1|Death|0
1268048|NCT00460603|4149732|P4|Phase 1|Death|2
1268049|NCT00460603|4149733|P3|Phase 1|Death|0
1268050|NCT00460603|4149734|P2|Phase 1|Death|0
1268051|NCT00460603|4149735|P1|Phase 1|Death|1
1268052|NCT00460577|4149829|P2|Overall Study|Protocol Violation|6
1268053|NCT00460577|4149830|P1|Overall Study|Protocol Violation|2
1268054|NCT00460564|4149848|P8|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
1268055|NCT00460564|4149849|P7|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
1268056|NCT00460564|4149850|P6|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
1268057|NCT00460564|4149851|P5|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1
1268058|NCT00460564|4149852|P4|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
1268059|NCT00460564|4149853|P3|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
1268060|NCT00460564|4149854|P2|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
1268061|NCT00460564|4149855|P1|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
1268062|NCT00460564|4149848|P8|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
1268063|NCT00460564|4149849|P7|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
1268064|NCT00460564|4149850|P6|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1
1268065|NCT00460564|4149851|P5|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5
1268066|NCT00460564|4149852|P4|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
1268067|NCT00460564|4149853|P3|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
1268068|NCT00460564|4149854|P2|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
1268069|NCT00460564|4149855|P1|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
1268070|NCT00460564|4149848|P8|Open-Label Phase (36 Weeks)|Adverse Event|0
1268071|NCT00460564|4149849|P7|Open-Label Phase (36 Weeks)|Adverse Event|2
1268072|NCT00460564|4149850|P6|Open-Label Phase (36 Weeks)|Adverse Event|5
1268073|NCT00460564|4149851|P5|Open-Label Phase (36 Weeks)|Adverse Event|3
1268074|NCT00460564|4149852|P4|Open-Label Phase (36 Weeks)|Adverse Event|0
1268075|NCT00460564|4149853|P3|Open-Label Phase (36 Weeks)|Adverse Event|0
1268076|NCT00460564|4149854|P2|Open-Label Phase (36 Weeks)|Adverse Event|0
1268077|NCT00460564|4149855|P1|Open-Label Phase (36 Weeks)|Adverse Event|0
1268078|NCT00460564|4149848|P8|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
1268079|NCT00460564|4149849|P7|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
1268080|NCT00460564|4149850|P6|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
1268081|NCT00460564|4149851|P5|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
1268082|NCT00460564|4149852|P4|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
1268083|NCT00460564|4149853|P3|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
1268084|NCT00460564|4149854|P2|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
1268085|NCT00460564|4149855|P1|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1
1268086|NCT00460564|4149848|P8|Double-Blind Phase (12 Weeks)|Adverse Event|0
1268087|NCT00460564|4149849|P7|Double-Blind Phase (12 Weeks)|Adverse Event|0
1268088|NCT00460564|4149850|P6|Double-Blind Phase (12 Weeks)|Adverse Event|0
1268089|NCT00460564|4149851|P5|Double-Blind Phase (12 Weeks)|Adverse Event|0
1268090|NCT00460564|4149852|P4|Double-Blind Phase (12 Weeks)|Adverse Event|0
1268091|NCT00460564|4149853|P3|Double-Blind Phase (12 Weeks)|Adverse Event|0
1268092|NCT00460564|4149854|P2|Double-Blind Phase (12 Weeks)|Adverse Event|1
1268093|NCT00460564|4149855|P1|Double-Blind Phase (12 Weeks)|Adverse Event|3
1268094|NCT00460434|4149999|P2|Overall Study|Lost to Follow-up|7
1268095|NCT00460434|4150000|P1|Overall Study|Lost to Follow-up|3
1268096|NCT00460408|4150079|P4|Overall Study|Other|0
1268097|NCT00460408|4150080|P3|Overall Study|Other|0
1268098|NCT00460408|4150081|P2|Overall Study|Other|2
1268099|NCT00460408|4150082|P1|Overall Study|Other|12
1268100|NCT00460408|4150079|P4|Overall Study|Insufficient clinical response|0
1268101|NCT00460408|4150080|P3|Overall Study|Insufficient clinical response|5
1268102|NCT00460408|4150081|P2|Overall Study|Insufficient clinical response|1
1268103|NCT00460408|4150082|P1|Overall Study|Insufficient clinical response|5
1268104|NCT00460408|4150079|P4|Overall Study|Withdrawal by Subject|0
1268105|NCT00460408|4150080|P3|Overall Study|Withdrawal by Subject|0
1268106|NCT00460408|4150081|P2|Overall Study|Withdrawal by Subject|0
1268107|NCT00460408|4150082|P1|Overall Study|Withdrawal by Subject|31
1268108|NCT00460408|4150079|P4|Overall Study|Lost to Follow-up|0
1268109|NCT00460408|4150080|P3|Overall Study|Lost to Follow-up|1
1268110|NCT00460408|4150081|P2|Overall Study|Lost to Follow-up|0
1268111|NCT00460408|4150082|P1|Overall Study|Lost to Follow-up|11
1268112|NCT00460408|4150079|P4|Overall Study|Death|0
1268113|NCT00460408|4150080|P3|Overall Study|Death|0
1268114|NCT00460408|4150081|P2|Overall Study|Death|0
1268115|NCT00460408|4150082|P1|Overall Study|Death|7
1268116|NCT00460408|4150079|P4|Overall Study|Adverse Event|0
1268117|NCT00460408|4150080|P3|Overall Study|Adverse Event|0
1268118|NCT00460408|4150081|P2|Overall Study|Adverse Event|0
1268119|NCT00460408|4150082|P1|Overall Study|Adverse Event|1
1268120|NCT00460265|4150119|P2|Overall Study|Ongoing|47
1268121|NCT00460265|4150120|P1|Overall Study|Ongoing|60
1268122|NCT00460265|4150119|P2|Overall Study|Withdrawal by Subject|25
1268123|NCT00460265|4150120|P1|Overall Study|Withdrawal by Subject|10
1268124|NCT00460265|4150119|P2|Overall Study|Physician Decision|2
1268125|NCT00460265|4150120|P1|Overall Study|Physician Decision|1
1268126|NCT00460265|4150119|P2|Overall Study|Lost to Follow-up|15
1268127|NCT00460265|4150120|P1|Overall Study|Lost to Follow-up|14
1268128|NCT00460239|4150136|P9|Overall Study|Withdrawal by Subject|0
1268129|NCT00460239|4150137|P8|Overall Study|Withdrawal by Subject|0
1268130|NCT00460239|4150138|P7|Overall Study|Withdrawal by Subject|0
1268131|NCT00460239|4150139|P6|Overall Study|Withdrawal by Subject|1
1268132|NCT00460239|4150140|P5|Overall Study|Withdrawal by Subject|0
1268133|NCT00460239|4150141|P4|Overall Study|Withdrawal by Subject|0
1268134|NCT00460239|4150142|P3|Overall Study|Withdrawal by Subject|0
1268135|NCT00460239|4150143|P2|Overall Study|Withdrawal by Subject|0
1268136|NCT00460239|4150144|P1|Overall Study|Withdrawal by Subject|0
1268137|NCT00460239|4150136|P9|Overall Study|Physician Decision|0
1268138|NCT00460239|4150137|P8|Overall Study|Physician Decision|0
1268139|NCT00460239|4150138|P7|Overall Study|Physician Decision|0
1268140|NCT00460239|4150139|P6|Overall Study|Physician Decision|2
1268141|NCT00460239|4150140|P5|Overall Study|Physician Decision|0
1268142|NCT00460239|4150141|P4|Overall Study|Physician Decision|0
1268143|NCT00460239|4150142|P3|Overall Study|Physician Decision|0
1268144|NCT00460239|4150143|P2|Overall Study|Physician Decision|1
1268145|NCT00460239|4150144|P1|Overall Study|Physician Decision|0
1268146|NCT00460109|4150213|P1|Overall Study|Death|1
1268147|NCT00460031|4150221|P1|Overall Study|Death|1
1268148|NCT00460031|4150221|P1|Overall Study|Withdrawal by Subject|5
1268149|NCT00460031|4150221|P1|Overall Study|Adverse Event|5
1268150|NCT00459979|4150229|P1|Overall Study|Protocol Violation|1
1268151|NCT00459979|4150229|P1|Overall Study|Withdrawal by Subject|1
1268152|NCT00459953|4150241|P2|Overall Study|not analyzed-household member in study|1
1268153|NCT00459953|4150242|P1|Overall Study|not analyzed-household member in study|1
1268154|NCT00459875|4150248|P1|Overall Study|Adverse Event|2
1268155|NCT00459875|4150248|P1|Overall Study|Ineligible participant|1
1268156|NCT00459706|4150284|P2|Overall Study|Other|1
1268157|NCT00459706|4150285|P1|Overall Study|Other|0
1268158|NCT00459706|4150284|P2|Overall Study|Failed to Return|0
1268159|NCT00459706|4150285|P1|Overall Study|Failed to Return|1
1268160|NCT00459706|4150284|P2|Overall Study|Protocol Violation|1
1268161|NCT00459706|4150285|P1|Overall Study|Protocol Violation|2
1268162|NCT00459706|4150284|P2|Overall Study|Discontinuation of Study by Sponsor|0
1268163|NCT00459706|4150285|P1|Overall Study|Discontinuation of Study by Sponsor|1
1268164|NCT00459706|4150284|P2|Overall Study|Physician Decision|0
1268165|NCT00459706|4150285|P1|Overall Study|Physician Decision|2
1268166|NCT00459706|4150284|P2|Overall Study|Withdrawal by Subject|6
1268167|NCT00459706|4150285|P1|Overall Study|Withdrawal by Subject|1
1268168|NCT00459706|4150284|P2|Overall Study|Adverse Event|13
1268169|NCT00459706|4150285|P1|Overall Study|Adverse Event|19
1268170|NCT00459667|4150428|P3|Overall Study|No treatment administered|1
1268171|NCT00459667|4150429|P2|Overall Study|No treatment administered|3
1268172|NCT00459667|4150430|P1|Overall Study|No treatment administered|6
1268173|NCT00459667|4150428|P3|Overall Study|Other reason (incl. 2 missing subjects)|1
1268174|NCT00459667|4150429|P2|Overall Study|Other reason (incl. 2 missing subjects)|15
1268175|NCT00459667|4150430|P1|Overall Study|Other reason (incl. 2 missing subjects)|12
1268176|NCT00459667|4150428|P3|Overall Study|Other disease modifying treatment|1
1268177|NCT00459667|4150429|P2|Overall Study|Other disease modifying treatment|2
1268178|NCT00459667|4150430|P1|Overall Study|Other disease modifying treatment|1
1268179|NCT00459667|4150428|P3|Overall Study|Withdrawal by Subject|5
1268180|NCT00459667|4150429|P2|Overall Study|Withdrawal by Subject|5
1268181|NCT00459667|4150430|P1|Overall Study|Withdrawal by Subject|3
1268182|NCT00459667|4150428|P3|Overall Study|Protocol Violation|0
1268183|NCT00459667|4150429|P2|Overall Study|Protocol Violation|0
1268184|NCT00459667|4150430|P1|Overall Study|Protocol Violation|1
1268185|NCT00459667|4150428|P3|Overall Study|Pregnancy|1
1268186|NCT00459667|4150429|P2|Overall Study|Pregnancy|1
1268187|NCT00459667|4150430|P1|Overall Study|Pregnancy|1
1268188|NCT00459667|4150428|P3|Overall Study|Lost to Follow-up|3
1268189|NCT00459667|4150429|P2|Overall Study|Lost to Follow-up|9
1268190|NCT00459667|4150430|P1|Overall Study|Lost to Follow-up|5
1268191|NCT00459667|4150428|P3|Overall Study|Adverse Event|8
1268192|NCT00459667|4150429|P2|Overall Study|Adverse Event|12
1268193|NCT00459667|4150430|P1|Overall Study|Adverse Event|9
1268194|NCT00459537|4150452|P2|Overall Study|Missing|0
1268195|NCT00459537|4150453|P1|Overall Study|Missing|1
1268196|NCT00459537|4150452|P2|Overall Study|Protocol Violation|3
1268197|NCT00459537|4150453|P1|Overall Study|Protocol Violation|4
1268198|NCT00459537|4150452|P2|Overall Study|Administrative problems|0
1268199|NCT00459537|4150453|P1|Overall Study|Administrative problems|3
1268200|NCT00459537|4150452|P2|Overall Study|Lost to Follow-up|30
1268201|NCT00459537|4150453|P1|Overall Study|Lost to Follow-up|27
1268202|NCT00459537|4150452|P2|Overall Study|Withdrawal by Subject|26
1268203|NCT00459537|4150453|P1|Overall Study|Withdrawal by Subject|20
1268204|NCT00459537|4150452|P2|Overall Study|Lack of Efficacy|11
1268205|NCT00459537|4150453|P1|Overall Study|Lack of Efficacy|10
1268206|NCT00459537|4150452|P2|Overall Study|Adverse Event|6
1268207|NCT00459537|4150453|P1|Overall Study|Adverse Event|1
1268208|NCT00459355|4150488|P2|Overall Study|Subject no longer met inc criteria|18
1268297|NCT00457821|4150821|P8|Part 2|Withdrawal by Subject|1
1268209|NCT00459355|4150489|P1|Overall Study|Subject no longer met inc criteria|20
1268210|NCT00459342|4150501|P1|Overall Study|Not eligible|1
1268211|NCT00459316|4150510|P3|Step 3|Withdrawal by Subject|1
1268212|NCT00459316|4150511|P2|Step 3|Withdrawal by Subject|0
1268213|NCT00459316|4150512|P1|Step 3|Withdrawal by Subject|3
1268214|NCT00459316|4150510|P3|Steps 1 & 2|Lost to Follow-up|2
1268215|NCT00459316|4150511|P2|Steps 1 & 2|Lost to Follow-up|0
1268216|NCT00459316|4150512|P1|Steps 1 & 2|Lost to Follow-up|5
1268217|NCT00459316|4150510|P3|Steps 1 & 2|Not willing to adhere to regulations|0
1268218|NCT00459316|4150511|P2|Steps 1 & 2|Not willing to adhere to regulations|0
1268219|NCT00459316|4150512|P1|Steps 1 & 2|Not willing to adhere to regulations|1
1268220|NCT00459316|4150510|P3|Steps 1 & 2|Withdrawal by Subject|0
1268221|NCT00459316|4150511|P2|Steps 1 & 2|Withdrawal by Subject|1
1268222|NCT00459316|4150512|P1|Steps 1 & 2|Withdrawal by Subject|6
1268223|NCT00459316|4150510|P3|Steps 1 & 2|Not able to get to clinic|0
1268224|NCT00459316|4150511|P2|Steps 1 & 2|Not able to get to clinic|4
1268225|NCT00459316|4150512|P1|Steps 1 & 2|Not able to get to clinic|7
1268226|NCT00459316|4150510|P3|Steps 1 & 2|Death|0
1268227|NCT00459316|4150511|P2|Steps 1 & 2|Death|1
1268228|NCT00459316|4150512|P1|Steps 1 & 2|Death|1
1268229|NCT00459316|4150510|P3|Steps 1 & 2|Other eligibility failure|0
1268230|NCT00459316|4150511|P2|Steps 1 & 2|Other eligibility failure|1
1268231|NCT00459316|4150512|P1|Steps 1 & 2|Other eligibility failure|1
1268232|NCT00459290|4150577|P1|Overall Study|Ineligible|2
1268233|NCT00459290|4150577|P1|Overall Study|Adverse Event|3
1268234|NCT00459186|4150592|P1|PET Imaging and Assessment|Adverse Event|3
1268235|NCT00459186|4150592|P1|Single Agent RAD001|Withdrawal by Subject|1
1268236|NCT00459134|4150599|P2|Overall Study|Multiple Reasons|3
1268237|NCT00459134|4150600|P1|Overall Study|Multiple Reasons|2
1268238|NCT00459134|4150599|P2|Overall Study|Progression|0
1268239|NCT00459134|4150600|P1|Overall Study|Progression|1
1268240|NCT00459134|4150599|P2|Overall Study|Toxicity|5
1268241|NCT00459134|4150600|P1|Overall Study|Toxicity|4
1268242|NCT00459134|4150599|P2|Overall Study|Surgery|2
1268243|NCT00459134|4150600|P1|Overall Study|Surgery|1
1268244|NCT00459134|4150599|P2|Overall Study|Lost to Follow-up|7
1268245|NCT00459134|4150600|P1|Overall Study|Lost to Follow-up|6
1268246|NCT00459134|4150599|P2|Overall Study|Withdrawal by Subject|7
1268247|NCT00459134|4150600|P1|Overall Study|Withdrawal by Subject|8
1268248|NCT00459134|4150599|P2|Overall Study|Physician Decision|1
1268249|NCT00459134|4150600|P1|Overall Study|Physician Decision|1
1268250|NCT00459108|4150612|P1|Overall Study|Progression|1
1268251|NCT00459108|4150612|P1|Overall Study|Death|2
1268252|NCT00459108|4150612|P1|Overall Study|Adverse Event|3
1268253|NCT00459108|4150612|P1|Overall Study|Withdrawal by Subject|5
1268254|NCT00459056|4150622|P2|First Intervention (First Three Months)|Lost to Follow-up|1
1268255|NCT00459056|4150623|P1|First Intervention (First Three Months)|Lost to Follow-up|1
1268256|NCT00459043|4150631|P2|Overall Study|Withdrawal by Subject|0
1268257|NCT00459043|4150632|P1|Overall Study|Withdrawal by Subject|1
1268258|NCT00458705|4150653|P1|Overall Study|Not Treated|1
1268259|NCT00458705|4150653|P1|Overall Study|Adverse Event|4
1268260|NCT00458536|4150657|P1|Overall Study|Progressive disease during treatment|2
1268261|NCT00458536|4150657|P1|Overall Study|Withdrawal by Subject|1
1268262|NCT00458536|4150657|P1|Overall Study|Ineligible due to toxicity|1
1268263|NCT00458536|4150657|P1|Overall Study|Patient did not have surgery|1
1268264|NCT00458536|4150657|P1|Overall Study|Did not have renal cell carcinoma|2
1268265|NCT00458536|4150657|P1|Overall Study|No measurable disease after surgery|2
1268266|NCT00458536|4150657|P1|Overall Study|Unable to make vaccine|3
1268267|NCT00458536|4150657|P1|Overall Study|Disease progression prior to treatment|7
1268268|NCT00458393|4150684|P2|Overall Study|Sites marked other on the form.|20
1268269|NCT00458393|4150685|P1|Overall Study|Sites marked other on the form.|19
1268270|NCT00458393|4150684|P2|Overall Study|Lost to Follow-up|92
1268271|NCT00458393|4150685|P1|Overall Study|Lost to Follow-up|115
1268272|NCT00458393|4150684|P2|Overall Study|Relocated|81
1268273|NCT00458393|4150685|P1|Overall Study|Relocated|77
1268274|NCT00458393|4150684|P2|Overall Study|Physician Decision|22
1268275|NCT00458393|4150685|P1|Overall Study|Physician Decision|31
1268276|NCT00458393|4150684|P2|Overall Study|Withdrawal by Subject|80
1268277|NCT00458393|4150685|P1|Overall Study|Withdrawal by Subject|67
1268278|NCT00458302|4150733|P2|Overall Study|Other|2
1268279|NCT00458302|4150734|P1|Overall Study|Other|4
1268280|NCT00458302|4150733|P2|Overall Study|Lost to Follow-up|0
1268281|NCT00458302|4150734|P1|Overall Study|Lost to Follow-up|2
1268282|NCT00458302|4150733|P2|Overall Study|Study Termination By Sponsor|0
1268283|NCT00458302|4150734|P1|Overall Study|Study Termination By Sponsor|1
1268284|NCT00458302|4150733|P2|Overall Study|Inc/Exc Criteria Not Met|1
1268285|NCT00458302|4150734|P1|Overall Study|Inc/Exc Criteria Not Met|1
1268286|NCT00458302|4150733|P2|Overall Study|Withdrawal by Subject|4
1268287|NCT00458302|4150734|P1|Overall Study|Withdrawal by Subject|6
1268288|NCT00458302|4150733|P2|Overall Study|Protocol Violation|2
1268289|NCT00458302|4150734|P1|Overall Study|Protocol Violation|0
1268290|NCT00458302|4150733|P2|Overall Study|Pregnancy|1
1268291|NCT00458302|4150734|P1|Overall Study|Pregnancy|2
1268292|NCT00458302|4150733|P2|Overall Study|Adverse Event|14
1268293|NCT00458302|4150734|P1|Overall Study|Adverse Event|4
1268294|NCT00458211|4150779|P1|Overall Study|Protocol Violation|2
1268295|NCT00458211|4150779|P1|Overall Study|Withdrawal by Subject|2
1268296|NCT00458211|4150779|P1|Overall Study|Lack of Efficacy|12
1268298|NCT00457821|4150822|P7|Part 2|Withdrawal by Subject|0
1268299|NCT00457821|4150823|P6|Part 2|Withdrawal by Subject|0
1268300|NCT00457821|4150824|P5|Part 2|Withdrawal by Subject|0
1268301|NCT00457821|4150825|P4|Part 2|Withdrawal by Subject|0
1268302|NCT00457821|4150826|P3|Part 2|Withdrawal by Subject|0
1268303|NCT00457821|4150827|P2|Part 2|Withdrawal by Subject|0
1268304|NCT00457821|4150828|P1|Part 2|Withdrawal by Subject|0
1268305|NCT00457743|4150867|P3|Overall Study|Lack of Efficacy|3
1268306|NCT00457743|4150868|P2|Overall Study|Lack of Efficacy|23
1268307|NCT00457743|4150869|P1|Overall Study|Lack of Efficacy|3
1268308|NCT00457743|4150867|P3|Overall Study|Adverse Event|0
1268309|NCT00457743|4150868|P2|Overall Study|Adverse Event|4
1268310|NCT00457743|4150869|P1|Overall Study|Adverse Event|0
1268311|NCT00457691|4150926|P2|Overall Study|Disease progression, study terminated|196
1268312|NCT00457691|4150927|P1|Overall Study|Disease progression, study terminated|180
1268313|NCT00457691|4150926|P2|Overall Study|Subject refused (reason other than AE)|19
1268314|NCT00457691|4150927|P1|Overall Study|Subject refused (reason other than AE)|14
1268315|NCT00457691|4150926|P2|Overall Study|Study terminated by Sponsor|1
1268316|NCT00457691|4150927|P1|Overall Study|Study terminated by Sponsor|1
1268317|NCT00457691|4150926|P2|Overall Study|Lost to Follow-up|14
1268318|NCT00457691|4150927|P1|Overall Study|Lost to Follow-up|23
1268319|NCT00457691|4150926|P2|Overall Study|Protocol Violation|3
1268320|NCT00457691|4150927|P1|Overall Study|Protocol Violation|1
1268321|NCT00457691|4150926|P2|Overall Study|Death|148
1268322|NCT00457691|4150927|P1|Overall Study|Death|163
1268323|NCT00457691|4150926|P2|Overall Study|Adverse Event|1
1268324|NCT00457691|4150927|P1|Overall Study|Adverse Event|4
1268325|NCT00457418|4150947|P1|Post PK Maintenance|Lost to Follow-up|1
1268326|NCT00457418|4150947|P1|Post PK Maintenance|Withdrawal by Subject|11
1268327|NCT00457418|4150947|P1|Post PK Maintenance|Progression of Disease|6
1268328|NCT00457418|4150947|P1|Post PK Maintenance|Adverse Event|10
1268329|NCT00457418|4150947|P1|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2
1268330|NCT00457418|4150947|P1|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1
1268331|NCT00457418|4150947|P1|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2
1268332|NCT00457392|4150959|P2|Overall Study|Randomized, Not Treated|3
1268333|NCT00457392|4150960|P1|Overall Study|Randomized, Not Treated|7
1268334|NCT00457392|4150959|P2|Overall Study|Study Terminated by Sponsor|4
1268335|NCT00457392|4150960|P1|Overall Study|Study Terminated by Sponsor|1
1268336|NCT00457392|4150959|P2|Overall Study|Other|4
1268337|NCT00457392|4150960|P1|Overall Study|Other|7
1268338|NCT00457392|4150959|P2|Overall Study|Protocol Violation|3
1268339|NCT00457392|4150960|P1|Overall Study|Protocol Violation|4
1268340|NCT00457392|4150959|P2|Overall Study|Lost to Follow-up|7
1268341|NCT00457392|4150960|P1|Overall Study|Lost to Follow-up|6
1268342|NCT00457392|4150959|P2|Overall Study|Withdrawal by Subject|8
1268343|NCT00457392|4150960|P1|Overall Study|Withdrawal by Subject|14
1268344|NCT00457392|4150959|P2|Overall Study|Global Deterioration of Health Status|8
1268345|NCT00457392|4150960|P1|Overall Study|Global Deterioration of Health Status|22
1268346|NCT00457392|4150959|P2|Overall Study|Adverse Event|41
1268347|NCT00457392|4150960|P1|Overall Study|Adverse Event|84
1268348|NCT00457392|4150959|P2|Overall Study|Death|106
1268349|NCT00457392|4150960|P1|Overall Study|Death|106
1268350|NCT00457392|4150959|P2|Overall Study|Objective Progression or Relapse|296
1268351|NCT00457392|4150960|P1|Overall Study|Objective Progression or Relapse|229
1268352|NCT00457301|4150978|P2|Overall Study|Death|7
1268353|NCT00457301|4150979|P1|Overall Study|Death|5
1268354|NCT00457301|4150978|P2|Overall Study|Censored out of the study|14
1268355|NCT00457301|4150979|P1|Overall Study|Censored out of the study|15
1268356|NCT00457301|4150978|P2|Overall Study|Withdrawal by Subject|3
1268357|NCT00457301|4150979|P1|Overall Study|Withdrawal by Subject|3
1268358|NCT00457249|4150993|P2|Overall Study|Serious Adverse Events|0
1268359|NCT00457249|4150994|P1|Overall Study|Serious Adverse Events|2
1268360|NCT00457249|4150993|P2|Overall Study|Withdrawal by Subject|1
1268361|NCT00457249|4150994|P1|Overall Study|Withdrawal by Subject|3
1268362|NCT00457249|4150993|P2|Overall Study|Protocol Violation|1
1268363|NCT00457249|4150994|P1|Overall Study|Protocol Violation|4
1268364|NCT00457249|4150993|P2|Overall Study|Lost to Follow-up|0
1268365|NCT00457249|4150994|P1|Overall Study|Lost to Follow-up|3
1268366|NCT00457015|4151033|P2|Overall Study|Left study site against medical advice|1
1268367|NCT00457015|4151034|P1|Overall Study|Left study site against medical advice|0
1268368|NCT00457002|4151050|P2|Overall Study|treated for 1 day; missing status/reason|0
1268369|NCT00457002|4151051|P1|Overall Study|treated for 1 day; missing status/reason|1
1268370|NCT00457002|4151050|P2|Overall Study|non-specified|38
1268371|NCT00457002|4151051|P1|Overall Study|non-specified|29
1268372|NCT00457002|4151050|P2|Overall Study|Administrative reason by Sponsor|0
1268373|NCT00457002|4151051|P1|Overall Study|Administrative reason by Sponsor|1
1268374|NCT00457002|4151050|P2|Overall Study|No longer met criteria|37
1268375|NCT00457002|4151051|P1|Overall Study|No longer met criteria|41
1268376|NCT00457002|4151050|P2|Overall Study|Poor/Non-compliance|33
1268377|NCT00457002|4151051|P1|Overall Study|Poor/Non-compliance|46
1268378|NCT00457002|4151050|P2|Overall Study|Lost to Follow-up|71
1268379|NCT00457002|4151051|P1|Overall Study|Lost to Follow-up|72
1268380|NCT00457002|4151050|P2|Overall Study|Withdrawal by Subject|271
1268381|NCT00457002|4151051|P1|Overall Study|Withdrawal by Subject|299
1268382|NCT00457002|4151050|P2|Overall Study|Adverse Event|260
1268383|NCT00457002|4151051|P1|Overall Study|Adverse Event|284
1268384|NCT00457002|4151050|P2|Overall Study|Death|47
1268385|NCT00457002|4151051|P1|Overall Study|Death|40
1268386|NCT00456846|4151155|P2|Overall Study|Other|2
1268387|NCT00456846|4151156|P1|Overall Study|Other|0
1268388|NCT00456846|4151155|P2|Overall Study|Participant Discretion|5
1268389|NCT00456846|4151156|P1|Overall Study|Participant Discretion|1
1268390|NCT00456846|4151155|P2|Overall Study|Protocol Deviation|0
1268391|NCT00456846|4151156|P1|Overall Study|Protocol Deviation|2
1268392|NCT00456846|4151155|P2|Overall Study|Physician Decision|6
1268393|NCT00456846|4151156|P1|Overall Study|Physician Decision|11
1268394|NCT00456846|4151155|P2|Overall Study|Adverse Event|15
1268395|NCT00456846|4151156|P1|Overall Study|Adverse Event|2
1268396|NCT00456755|4151197|P2|Overall Study|Lost to Follow-up|1
1268397|NCT00456755|4151198|P1|Overall Study|Lost to Follow-up|2
1268398|NCT00456612|4151212|P1|Overall Study|Withdrawal by Subject|3
1268399|NCT00456599|4151217|P1|Overall Study|Withdrawal by Subject|2
1268400|NCT00456599|4151217|P1|Overall Study|Non-compliance|1
1268401|NCT00456521|4151240|P2|Overall Study|Drug non-compliance, moved, other|11
1268402|NCT00456521|4151241|P1|Overall Study|Drug non-compliance, moved, other|26
1268403|NCT00456521|4151240|P2|Overall Study|Pregnancy|1
1268404|NCT00456521|4151241|P1|Overall Study|Pregnancy|1
1268405|NCT00456521|4151240|P2|Overall Study|Protocol Violation|0
1268406|NCT00456521|4151241|P1|Overall Study|Protocol Violation|4
1268407|NCT00456521|4151240|P2|Overall Study|Lack of Efficacy|6
1268408|NCT00456521|4151241|P1|Overall Study|Lack of Efficacy|3
1268409|NCT00456521|4151240|P2|Overall Study|Lost to Follow-up|17
1268410|NCT00456521|4151241|P1|Overall Study|Lost to Follow-up|22
1268411|NCT00456521|4151240|P2|Overall Study|Withdrawal by Subject|24
1268412|NCT00456521|4151241|P1|Overall Study|Withdrawal by Subject|43
1268413|NCT00456521|4151240|P2|Overall Study|Adverse Event|25
1268414|NCT00456521|4151241|P1|Overall Study|Adverse Event|150
1268415|NCT00456495|4151287|P1|Overall Study|Physician Decision|2
1268416|NCT00456365|4151294|P2|Overall Study|oncologic diagnosis|1
1268417|NCT00456365|4151295|P1|Overall Study|oncologic diagnosis|1
1268418|NCT00456365|4151294|P2|Overall Study|Pregnancy|1
1268419|NCT00456365|4151295|P1|Overall Study|Pregnancy|1
1268420|NCT00456365|4151294|P2|Overall Study|Withdrawal by Subject|7
1268421|NCT00456365|4151295|P1|Overall Study|Withdrawal by Subject|4
1268422|NCT00456365|4151294|P2|Overall Study|Lost to Follow-up|3
1268423|NCT00456365|4151295|P1|Overall Study|Lost to Follow-up|1
1268424|NCT00455923|4151352|P2|Overall Study|Other|1
1268425|NCT00455923|4151353|P1|Overall Study|Other|3
1268426|NCT00455923|4151352|P2|Overall Study|Pregnancy|2
1268427|NCT00455923|4151353|P1|Overall Study|Pregnancy|0
1268428|NCT00455858|4151369|P1|Overall Study|Withdrawal|1
1268429|NCT00455858|4151369|P1|Overall Study|Well controlled FPG without insulin|1
1268430|NCT00455858|4151369|P1|Overall Study|Lack of Efficacy|1
1268431|NCT00455858|4151369|P1|Overall Study|Protocol Violation|1
1268432|NCT00455858|4151369|P1|Overall Study|Lost to Follow-up|2
1268433|NCT00455741|4151379|P2|Overall Study|Physician Decision|1
1268434|NCT00455741|4151380|P1|Overall Study|Physician Decision|0
1268435|NCT00455533|4151476|P3|Period Two: Randomized Period|Subject Withdrew Consent|1
1268436|NCT00455533|4151477|P2|Period Two: Randomized Period|Subject Withdrew Consent|2
1268437|NCT00455533|4151478|P1|Period Two: Randomized Period|Subject Withdrew Consent|0
1268438|NCT00455533|4151476|P3|Period Two: Randomized Period|Study Drug Toxicity|0
1268439|NCT00455533|4151477|P2|Period Two: Randomized Period|Study Drug Toxicity|2
1268440|NCT00455533|4151478|P1|Period Two: Randomized Period|Study Drug Toxicity|0
1268441|NCT00455533|4151476|P3|Period Two: Randomized Period|Other - need reasons|0
1268442|NCT00455533|4151477|P2|Period Two: Randomized Period|Other - need reasons|1
1268443|NCT00455533|4151478|P1|Period Two: Randomized Period|Other - need reasons|0
1268444|NCT00455533|4151476|P3|Period Two: Randomized Period|Lost to Follow-up|1
1268445|NCT00455533|4151477|P2|Period Two: Randomized Period|Lost to Follow-up|0
1268446|NCT00455533|4151478|P1|Period Two: Randomized Period|Lost to Follow-up|0
1268447|NCT00455533|4151476|P3|Period Two: Randomized Period|Disease Progression|1
1268448|NCT00455533|4151477|P2|Period Two: Randomized Period|Disease Progression|1
1268449|NCT00455533|4151478|P1|Period Two: Randomized Period|Disease Progression|0
1268450|NCT00455533|4151476|P3|Period Two: Randomized Period|Death|3
1268451|NCT00455533|4151477|P2|Period Two: Randomized Period|Death|0
1268452|NCT00455533|4151478|P1|Period Two: Randomized Period|Death|0
1268453|NCT00455533|4151476|P3|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
1268454|NCT00455533|4151477|P2|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
1268455|NCT00455533|4151478|P1|Period One: Initial Chemotherapy|Subject Withdrew Consent|2
1268456|NCT00455533|4151476|P3|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
1268457|NCT00455533|4151477|P2|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
1268458|NCT00455533|4151478|P1|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2
1268459|NCT00455533|4151476|P3|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
1268460|NCT00455533|4151477|P2|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
1268461|NCT00455533|4151478|P1|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1
1268462|NCT00455533|4151476|P3|Period One: Initial Chemotherapy|Study Drug Toxicity|0
1268463|NCT00455533|4151477|P2|Period One: Initial Chemotherapy|Study Drug Toxicity|0
1268464|NCT00455533|4151478|P1|Period One: Initial Chemotherapy|Study Drug Toxicity|2
1268465|NCT00455533|4151476|P3|Period One: Initial Chemotherapy|Other--Need Reasons|0
1268466|NCT00455533|4151477|P2|Period One: Initial Chemotherapy|Other--Need Reasons|0
1268467|NCT00455533|4151478|P1|Period One: Initial Chemotherapy|Other--Need Reasons|2
1268468|NCT00455533|4151476|P3|Period One: Initial Chemotherapy|Not Reported|0
1268469|NCT00455533|4151477|P2|Period One: Initial Chemotherapy|Not Reported|0
1268470|NCT00455533|4151478|P1|Period One: Initial Chemotherapy|Not Reported|1
1268471|NCT00455533|4151476|P3|Period One: Initial Chemotherapy|Lost to Follow-up|0
1268472|NCT00455533|4151477|P2|Period One: Initial Chemotherapy|Lost to Follow-up|0
1268473|NCT00455533|4151478|P1|Period One: Initial Chemotherapy|Lost to Follow-up|2
1268474|NCT00455533|4151476|P3|Period One: Initial Chemotherapy|Disease Progression|0
1268475|NCT00455533|4151477|P2|Period One: Initial Chemotherapy|Disease Progression|0
1268476|NCT00455533|4151478|P1|Period One: Initial Chemotherapy|Disease Progression|5
1268477|NCT00455533|4151476|P3|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
1268478|NCT00455533|4151477|P2|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
1268479|NCT00455533|4151478|P1|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1
1268480|NCT00455520|4151527|P2|Double Blind Tapentadol ER vs Placebo|All other|6
1268481|NCT00455520|4151528|P1|Double Blind Tapentadol ER vs Placebo|All other|4
1268482|NCT00455520|4151527|P2|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2
1268483|NCT00455520|4151528|P1|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4
1268484|NCT00455520|4151527|P2|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
1268485|NCT00455520|4151528|P1|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
1268486|NCT00455520|4151527|P2|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7
1268487|NCT00455520|4151528|P1|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15
1268488|NCT00455520|4151527|P2|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29
1268489|NCT00455520|4151528|P1|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8
1268490|NCT00455520|4151527|P2|Double Blind Tapentadol ER vs Placebo|Adverse Event|15
1268491|NCT00455520|4151528|P1|Double Blind Tapentadol ER vs Placebo|Adverse Event|29
1268492|NCT00455520|4151527|P2|Open Label Tapentadol Extended Release|All other|0
1268493|NCT00455520|4151528|P1|Open Label Tapentadol Extended Release|All other|33
1268494|NCT00455520|4151527|P2|Open Label Tapentadol Extended Release|Study drug non-compliant|0
1268495|NCT00455520|4151528|P1|Open Label Tapentadol Extended Release|Study drug non-compliant|13
1268496|NCT00455520|4151527|P2|Open Label Tapentadol Extended Release|Lack of Efficacy|0
1268497|NCT00455520|4151528|P1|Open Label Tapentadol Extended Release|Lack of Efficacy|23
1268498|NCT00455520|4151527|P2|Open Label Tapentadol Extended Release|Adverse Event|0
1268499|NCT00455520|4151528|P1|Open Label Tapentadol Extended Release|Adverse Event|100
1268500|NCT00455520|4151527|P2|Open Label Tapentadol Extended Release|Lost to Follow-up|0
1268501|NCT00455520|4151528|P1|Open Label Tapentadol Extended Release|Lost to Follow-up|3
1268502|NCT00455520|4151527|P2|Open Label Tapentadol Extended Release|Withdrawal by Subject|0
1268503|NCT00455520|4151528|P1|Open Label Tapentadol Extended Release|Withdrawal by Subject|24
1268504|NCT00455455|4151544|P2|Washout|Withdrawal by Subject|0
1268505|NCT00455455|4151545|P1|Washout|Withdrawal by Subject|1
1268506|NCT00455455|4151544|P2|Washout|Withdrawal by Subject|1
1268507|NCT00455455|4151545|P1|Washout|Withdrawal by Subject|0
1268508|NCT00455429|4151565|P4|Overall Study|Other|1
1268509|NCT00455429|4151566|P3|Overall Study|Other|0
1268510|NCT00455429|4151567|P2|Overall Study|Other|2
1268511|NCT00455429|4151568|P1|Overall Study|Other|0
1268512|NCT00455429|4151565|P4|Overall Study|Non-compliance|1
1268513|NCT00455429|4151566|P3|Overall Study|Non-compliance|0
1268514|NCT00455429|4151567|P2|Overall Study|Non-compliance|0
1268515|NCT00455429|4151568|P1|Overall Study|Non-compliance|0
1268516|NCT00455429|4151565|P4|Overall Study|Personal Reason|0
1268517|NCT00455429|4151566|P3|Overall Study|Personal Reason|0
1268518|NCT00455429|4151567|P2|Overall Study|Personal Reason|0
1268519|NCT00455429|4151568|P1|Overall Study|Personal Reason|1
1268520|NCT00455429|4151565|P4|Overall Study|Randomly assigned but not treated|2
1268521|NCT00455429|4151566|P3|Overall Study|Randomly assigned but not treated|0
1268522|NCT00455429|4151567|P2|Overall Study|Randomly assigned but not treated|0
1268523|NCT00455429|4151568|P1|Overall Study|Randomly assigned but not treated|0
1268524|NCT00455429|4151565|P4|Overall Study|Adverse Event|3
1268525|NCT00455429|4151566|P3|Overall Study|Adverse Event|0
1268526|NCT00455429|4151567|P2|Overall Study|Adverse Event|1
1268527|NCT00455429|4151568|P1|Overall Study|Adverse Event|0
1268528|NCT00455429|4151565|P4|Overall Study|Lack of Efficacy|1
1268529|NCT00455429|4151566|P3|Overall Study|Lack of Efficacy|0
1268530|NCT00455429|4151567|P2|Overall Study|Lack of Efficacy|1
1268531|NCT00455429|4151568|P1|Overall Study|Lack of Efficacy|0
1268532|NCT00455429|4151565|P4|Overall Study|Withdrawal by Subject|0
1268533|NCT00455429|4151566|P3|Overall Study|Withdrawal by Subject|1
1268534|NCT00455429|4151567|P2|Overall Study|Withdrawal by Subject|1
1268535|NCT00455429|4151568|P1|Overall Study|Withdrawal by Subject|0
1268536|NCT00455429|4151565|P4|Overall Study|Lost to Follow-up|3
1268537|NCT00455429|4151566|P3|Overall Study|Lost to Follow-up|0
1268538|NCT00455429|4151567|P2|Overall Study|Lost to Follow-up|0
1268539|NCT00455429|4151568|P1|Overall Study|Lost to Follow-up|1
1268540|NCT00455429|4151565|P4|Overall Study|Study Terminated by Sponsor|3
1268541|NCT00455429|4151566|P3|Overall Study|Study Terminated by Sponsor|0
1268542|NCT00455429|4151567|P2|Overall Study|Study Terminated by Sponsor|0
1268543|NCT00455429|4151568|P1|Overall Study|Study Terminated by Sponsor|0
1268544|NCT00455312|4151627|P2|Overall Study|Death|1
1268545|NCT00455312|4151628|P1|Overall Study|Death|0
1268546|NCT00455195|4151654|P2|Double-blind Study AGLU02704|Unable to commit time to study|1
1268547|NCT00455195|4151655|P1|Double-blind Study AGLU02704|Unable to commit time to study|0
1268548|NCT00455195|4151654|P2|Double-blind Study AGLU02704|Withdrawal by Subject|2
1268549|NCT00455195|4151655|P1|Double-blind Study AGLU02704|Withdrawal by Subject|2
1268550|NCT00455195|4151654|P2|Double-blind Study AGLU02704|Death|0
1268551|NCT00455195|4151655|P1|Double-blind Study AGLU02704|Death|1
1268552|NCT00455195|4151654|P2|Double-blind Study AGLU02704|Adverse Event|1
1268553|NCT00455195|4151655|P1|Double-blind Study AGLU02704|Adverse Event|2
1268554|NCT00455013|4151672|P3|Long Term Extension (LTE)|non-specified|1
1268555|NCT00455013|4151673|P2|Long Term Extension (LTE)|non-specified|0
1268556|NCT00455013|4151674|P1|Long Term Extension (LTE)|non-specified|0
1268557|NCT00455013|4151672|P3|Long Term Extension (LTE)|Poor non-compliance|0
1268558|NCT00455013|4151673|P2|Long Term Extension (LTE)|Poor non-compliance|1
1268559|NCT00455013|4151674|P1|Long Term Extension (LTE)|Poor non-compliance|0
1268560|NCT00455013|4151672|P3|Long Term Extension (LTE)|Subject Request or refused|3
1268561|NCT00455013|4151673|P2|Long Term Extension (LTE)|Subject Request or refused|0
1268562|NCT00455013|4151674|P1|Long Term Extension (LTE)|Subject Request or refused|0
1268563|NCT00455013|4151672|P3|Long Term Extension (LTE)|No longer met criteria|1
1268564|NCT00455013|4151673|P2|Long Term Extension (LTE)|No longer met criteria|0
1268565|NCT00455013|4151674|P1|Long Term Extension (LTE)|No longer met criteria|0
1268566|NCT00455013|4151672|P3|Long Term Extension (LTE)|Death|0
1268567|NCT00455013|4151673|P2|Long Term Extension (LTE)|Death|1
1268568|NCT00455013|4151674|P1|Long Term Extension (LTE)|Death|1
1268569|NCT00455013|4151672|P3|Long Term Extension (LTE)|Withdrawal by Subject|1
1268570|NCT00455013|4151673|P2|Long Term Extension (LTE)|Withdrawal by Subject|0
1268571|NCT00455013|4151674|P1|Long Term Extension (LTE)|Withdrawal by Subject|1
1268572|NCT00455013|4151672|P3|Long Term Extension (LTE)|Adverse Event|1
1268573|NCT00455013|4151673|P2|Long Term Extension (LTE)|Adverse Event|1
1268574|NCT00455013|4151674|P1|Long Term Extension (LTE)|Adverse Event|0
1268575|NCT00455013|4151672|P3|Short Term Period|Other|1
1268576|NCT00455013|4151673|P2|Short Term Period|Other|0
1268577|NCT00455013|4151674|P1|Short Term Period|Other|0
1268578|NCT00455013|4151672|P3|Short Term Period|Lack of Efficacy|0
1268579|NCT00455013|4151673|P2|Short Term Period|Lack of Efficacy|0
1268580|NCT00455013|4151674|P1|Short Term Period|Lack of Efficacy|4
1268581|NCT00455013|4151672|P3|Short Term Period|Withdrawal by Subject|1
1268582|NCT00455013|4151673|P2|Short Term Period|Withdrawal by Subject|0
1268583|NCT00455013|4151674|P1|Short Term Period|Withdrawal by Subject|0
1268584|NCT00455013|4151672|P3|Short Term Period|Adverse Event|0
1268585|NCT00455013|4151673|P2|Short Term Period|Adverse Event|5
1268586|NCT00455013|4151674|P1|Short Term Period|Adverse Event|2
1268587|NCT00454987|4151742|P3|Booster Period|Lost to Follow-up|0
1268588|NCT00454987|4151743|P2|Booster Period|Lost to Follow-up|0
1268589|NCT00454987|4151744|P1|Booster Period|Lost to Follow-up|1
1268590|NCT00454987|4151742|P3|Booster Period|Withdrawal by Subject|0
1268591|NCT00454987|4151743|P2|Booster Period|Withdrawal by Subject|1
1268592|NCT00454987|4151744|P1|Booster Period|Withdrawal by Subject|0
1268593|NCT00454987|4151742|P3|Booster Period|Adverse Event|0
1268594|NCT00454987|4151743|P2|Booster Period|Adverse Event|0
1268595|NCT00454987|4151744|P1|Booster Period|Adverse Event|1
1268596|NCT00454909|4151818|P3|Overall Study|Others|0
1268597|NCT00454909|4151819|P2|Overall Study|Others|0
1268598|NCT00454909|4151820|P1|Overall Study|Others|1
1268599|NCT00454909|4151818|P3|Overall Study|Lost to follow-up (complete vaccination)|1
1268600|NCT00454909|4151819|P2|Overall Study|Lost to follow-up (complete vaccination)|3
1268601|NCT00454909|4151820|P1|Overall Study|Lost to follow-up (complete vaccination)|5
1268602|NCT00454909|4151818|P3|Overall Study|Migrated/moved from study area|1
1268603|NCT00454909|4151819|P2|Overall Study|Migrated/moved from study area|0
1268604|NCT00454909|4151820|P1|Overall Study|Migrated/moved from study area|0
1268605|NCT00454909|4151818|P3|Overall Study|Withdrawal by Subject|0
1268606|NCT00454909|4151819|P2|Overall Study|Withdrawal by Subject|0
1268607|NCT00454909|4151820|P1|Overall Study|Withdrawal by Subject|1
1268608|NCT00454857|4151858|P1|Overall Study|Reason unknown|1
1268609|NCT00454857|4151858|P1|Overall Study|Other|11
1268610|NCT00454857|4151858|P1|Overall Study|Death|5
1268611|NCT00454857|4151858|P1|Overall Study|Noncompliance|6
1268612|NCT00454857|4151858|P1|Overall Study|Lost to Follow-up|16
1268613|NCT00454857|4151858|P1|Overall Study|Withdrawal by Subject|15
1268614|NCT00454818|4151883|P5|Phase 2: Randomized Double-blind|Received left ventricular assist device|2
1268615|NCT00454818|4151884|P4|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
1268616|NCT00454818|4151885|P3|Phase 2: Randomized Double-blind|Received left ventricular assist device|1
1268617|NCT00454818|4151886|P2|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
1268618|NCT00454818|4151887|P1|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
1268619|NCT00454818|4151883|P5|Phase 2: Randomized Double-blind|Received a heart transplant|1
1268620|NCT00454818|4151884|P4|Phase 2: Randomized Double-blind|Received a heart transplant|0
1268621|NCT00454818|4151885|P3|Phase 2: Randomized Double-blind|Received a heart transplant|2
1268622|NCT00454818|4151886|P2|Phase 2: Randomized Double-blind|Received a heart transplant|0
1268623|NCT00454818|4151887|P1|Phase 2: Randomized Double-blind|Received a heart transplant|0
1268624|NCT00454818|4151883|P5|Phase 2: Randomized Double-blind|Death|1
1268625|NCT00454818|4151884|P4|Phase 2: Randomized Double-blind|Death|0
1268626|NCT00454818|4151885|P3|Phase 2: Randomized Double-blind|Death|0
1268627|NCT00454818|4151886|P2|Phase 2: Randomized Double-blind|Death|1
1268628|NCT00454818|4151887|P1|Phase 2: Randomized Double-blind|Death|0
1268629|NCT00454818|4151883|P5|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
1268630|NCT00454818|4151884|P4|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
1268631|NCT00454818|4151885|P3|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
1268632|NCT00454818|4151886|P2|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
1268633|NCT00454818|4151887|P1|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
1268634|NCT00454818|4151883|P5|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
1268635|NCT00454818|4151884|P4|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
1268636|NCT00454818|4151885|P3|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
1268637|NCT00454818|4151886|P2|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
1268638|NCT00454818|4151887|P1|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
1268639|NCT00454818|4151883|P5|Phase I: Open-label Dose-escalation|Death|0
1268640|NCT00454818|4151884|P4|Phase I: Open-label Dose-escalation|Death|0
1268641|NCT00454818|4151885|P3|Phase I: Open-label Dose-escalation|Death|0
1268642|NCT00454818|4151886|P2|Phase I: Open-label Dose-escalation|Death|1
1268643|NCT00454818|4151887|P1|Phase I: Open-label Dose-escalation|Death|0
1268644|NCT00454818|4151883|P5|Phase I: Open-label Dose-escalation|Received heart transplant|0
1268645|NCT00454818|4151884|P4|Phase I: Open-label Dose-escalation|Received heart transplant|0
1268646|NCT00454818|4151885|P3|Phase I: Open-label Dose-escalation|Received heart transplant|0
1268647|NCT00454818|4151886|P2|Phase I: Open-label Dose-escalation|Received heart transplant|0
1268648|NCT00454818|4151887|P1|Phase I: Open-label Dose-escalation|Received heart transplant|1
1268649|NCT00454805|4151966|P2|Overall Study|In order to begin radiotherapy|0
1268650|NCT00454805|4151967|P1|Overall Study|In order to begin radiotherapy|1
1268651|NCT00454805|4151966|P2|Overall Study|Disease progression|19
1268652|NCT00454805|4151967|P1|Overall Study|Disease progression|16
1268653|NCT00454805|4151966|P2|Overall Study|Death|2
1268654|NCT00454805|4151967|P1|Overall Study|Death|0
1268655|NCT00454805|4151966|P2|Overall Study|Withdrawal by Subject|2
1268656|NCT00454805|4151967|P1|Overall Study|Withdrawal by Subject|9
1268657|NCT00454779|4151983|P2|Second-line Treatment Phase|Ongoing|1
1268658|NCT00454779|4151984|P1|Second-line Treatment Phase|Ongoing|0
1268659|NCT00454779|4151983|P2|Second-line Treatment Phase|Ended follow-up prior to analysis|1
1268660|NCT00454779|4151984|P1|Second-line Treatment Phase|Ended follow-up prior to analysis|0
1268661|NCT00454779|4151983|P2|Second-line Treatment Phase|Withdrawal by Subject|1
1268662|NCT00454779|4151984|P1|Second-line Treatment Phase|Withdrawal by Subject|0
1268663|NCT00454779|4151983|P2|First-line Treatment Phase|Ongoing|0
1268664|NCT00454779|4151984|P1|First-line Treatment Phase|Ongoing|1
1268665|NCT00454779|4151983|P2|First-line Treatment Phase|Ended follow-up prior to analysis|1
1268666|NCT00454779|4151984|P1|First-line Treatment Phase|Ended follow-up prior to analysis|1
1268667|NCT00454779|4151983|P2|First-line Treatment Phase|Protocol Violation|1
1268668|NCT00454779|4151984|P1|First-line Treatment Phase|Protocol Violation|0
1268669|NCT00454779|4151983|P2|First-line Treatment Phase|Lost to Follow-up|0
1268670|NCT00454779|4151984|P1|First-line Treatment Phase|Lost to Follow-up|1
1268671|NCT00454779|4151983|P2|First-line Treatment Phase|Withdrawal by Subject|4
1268672|NCT00454779|4151984|P1|First-line Treatment Phase|Withdrawal by Subject|2
1268673|NCT00454779|4151983|P2|First-line Treatment Phase|Lack of Efficacy|2
1268674|NCT00454779|4151984|P1|First-line Treatment Phase|Lack of Efficacy|0
1268675|NCT00454649|4152022|P10|Overall Study|Withdrawal by Subject|0
1268676|NCT00454649|4152023|P9|Overall Study|Withdrawal by Subject|1
1268677|NCT00454649|4152024|P8|Overall Study|Withdrawal by Subject|2
1268678|NCT00454649|4152025|P7|Overall Study|Withdrawal by Subject|0
1268679|NCT00454649|4152026|P6|Overall Study|Withdrawal by Subject|1
1268680|NCT00454649|4152027|P5|Overall Study|Withdrawal by Subject|0
1268681|NCT00454649|4152028|P4|Overall Study|Withdrawal by Subject|0
1268682|NCT00454649|4152029|P3|Overall Study|Withdrawal by Subject|0
1268683|NCT00454649|4152030|P2|Overall Study|Withdrawal by Subject|0
1268684|NCT00454649|4152031|P1|Overall Study|Withdrawal by Subject|0
1268685|NCT00454649|4152022|P10|Overall Study|Other|1
1268686|NCT00454649|4152023|P9|Overall Study|Other|3
1268687|NCT00454649|4152024|P8|Overall Study|Other|0
1268688|NCT00454649|4152025|P7|Overall Study|Other|0
1268689|NCT00454649|4152026|P6|Overall Study|Other|0
1268690|NCT00454649|4152027|P5|Overall Study|Other|0
1268691|NCT00454649|4152028|P4|Overall Study|Other|3
1268692|NCT00454649|4152029|P3|Overall Study|Other|5
1268693|NCT00454649|4152030|P2|Overall Study|Other|1
1268694|NCT00454649|4152031|P1|Overall Study|Other|1
1268695|NCT00454649|4152022|P10|Overall Study|Lost to Follow-up|0
1268696|NCT00454649|4152023|P9|Overall Study|Lost to Follow-up|0
1268697|NCT00454649|4152024|P8|Overall Study|Lost to Follow-up|0
1268698|NCT00454649|4152025|P7|Overall Study|Lost to Follow-up|1
1268699|NCT00454649|4152026|P6|Overall Study|Lost to Follow-up|0
1268700|NCT00454649|4152027|P5|Overall Study|Lost to Follow-up|0
1268701|NCT00454649|4152028|P4|Overall Study|Lost to Follow-up|0
1268702|NCT00454649|4152029|P3|Overall Study|Lost to Follow-up|1
1268703|NCT00454649|4152030|P2|Overall Study|Lost to Follow-up|0
1268704|NCT00454649|4152031|P1|Overall Study|Lost to Follow-up|0
1268705|NCT00454649|4152022|P10|Overall Study|Adverse Event|2
1268706|NCT00454649|4152023|P9|Overall Study|Adverse Event|6
1268707|NCT00454649|4152024|P8|Overall Study|Adverse Event|4
1268708|NCT00454649|4152025|P7|Overall Study|Adverse Event|3
1268709|NCT00454649|4152026|P6|Overall Study|Adverse Event|2
1268710|NCT00454649|4152027|P5|Overall Study|Adverse Event|1
1268711|NCT00454649|4152028|P4|Overall Study|Adverse Event|0
1268712|NCT00454649|4152029|P3|Overall Study|Adverse Event|3
1268713|NCT00454649|4152030|P2|Overall Study|Adverse Event|1
1268714|NCT00454649|4152031|P1|Overall Study|Adverse Event|0
1268715|NCT00454649|4152022|P10|Overall Study|Lack of Efficacy|2
1268716|NCT00454649|4152023|P9|Overall Study|Lack of Efficacy|10
1268717|NCT00454649|4152024|P8|Overall Study|Lack of Efficacy|13
1268718|NCT00454649|4152025|P7|Overall Study|Lack of Efficacy|5
1268719|NCT00454649|4152026|P6|Overall Study|Lack of Efficacy|4
1268720|NCT00454649|4152027|P5|Overall Study|Lack of Efficacy|0
1268721|NCT00454649|4152028|P4|Overall Study|Lack of Efficacy|3
1268722|NCT00454649|4152029|P3|Overall Study|Lack of Efficacy|10
1268723|NCT00454649|4152030|P2|Overall Study|Lack of Efficacy|2
1268724|NCT00454649|4152031|P1|Overall Study|Lack of Efficacy|2
1268725|NCT00454636|4152160|P4|Overall Study|Lost to Follow-up|0
1268726|NCT00454636|4152161|P3|Overall Study|Lost to Follow-up|0
1268727|NCT00454636|4152162|P2|Overall Study|Lost to Follow-up|1
1268728|NCT00454636|4152163|P1|Overall Study|Lost to Follow-up|0
1268729|NCT00454636|4152160|P4|Overall Study|Patient refusal|2
1268730|NCT00454636|4152161|P3|Overall Study|Patient refusal|3
1268731|NCT00454636|4152162|P2|Overall Study|Patient refusal|1
1268732|NCT00454636|4152163|P1|Overall Study|Patient refusal|1
1268733|NCT00454636|4152160|P4|Overall Study|Death|1
1268734|NCT00454636|4152161|P3|Overall Study|Death|1
1268735|NCT00454636|4152162|P2|Overall Study|Death|1
1268736|NCT00454636|4152163|P1|Overall Study|Death|6
1268737|NCT00454636|4152160|P4|Overall Study|Protocol Violation|3
1268738|NCT00454636|4152161|P3|Overall Study|Protocol Violation|3
1268739|NCT00454636|4152162|P2|Overall Study|Protocol Violation|2
1268740|NCT00454636|4152163|P1|Overall Study|Protocol Violation|3
1268741|NCT00454636|4152160|P4|Overall Study|Disease Progression|11
1268742|NCT00454636|4152161|P3|Overall Study|Disease Progression|4
1268743|NCT00454636|4152162|P2|Overall Study|Disease Progression|12
1268744|NCT00454636|4152163|P1|Overall Study|Disease Progression|11
1268745|NCT00454636|4152160|P4|Overall Study|Adverse Event|15
1268746|NCT00454636|4152161|P3|Overall Study|Adverse Event|9
1268747|NCT00454636|4152162|P2|Overall Study|Adverse Event|6
1268748|NCT00454636|4152163|P1|Overall Study|Adverse Event|10
1268749|NCT00454584|4152196|P6|After Controlled Period|Other|17
1268750|NCT00454584|4152197|P5|After Controlled Period|Other|5
1268751|NCT00454584|4152198|P4|After Controlled Period|Other|13
1268752|NCT00454584|4152199|P3|After Controlled Period|Other|0
1268753|NCT00454584|4152200|P2|After Controlled Period|Other|0
1268754|NCT00454584|4152201|P1|After Controlled Period|Other|0
1268755|NCT00454584|4152196|P6|After Controlled Period|Other|0
1268756|NCT00454584|4152197|P5|After Controlled Period|Other|0
1268757|NCT00454584|4152198|P4|After Controlled Period|Other|1
1268758|NCT00454584|4152199|P3|After Controlled Period|Other|0
1268759|NCT00454584|4152200|P2|After Controlled Period|Other|0
1268760|NCT00454584|4152201|P1|After Controlled Period|Other|0
1268761|NCT00454584|4152196|P6|After Controlled Period|Lost to Follow-up|6
1268762|NCT00454584|4152197|P5|After Controlled Period|Lost to Follow-up|4
1268763|NCT00454584|4152198|P4|After Controlled Period|Lost to Follow-up|2
1268764|NCT00454584|4152199|P3|After Controlled Period|Lost to Follow-up|0
1268765|NCT00454584|4152200|P2|After Controlled Period|Lost to Follow-up|0
1268766|NCT00454584|4152201|P1|After Controlled Period|Lost to Follow-up|0
1268767|NCT00454584|4152196|P6|After Controlled Period|Lack of Efficacy|0
1268768|NCT00454584|4152197|P5|After Controlled Period|Lack of Efficacy|0
1268769|NCT00454584|4152198|P4|After Controlled Period|Lack of Efficacy|1
1268770|NCT00454584|4152199|P3|After Controlled Period|Lack of Efficacy|0
1268771|NCT00454584|4152200|P2|After Controlled Period|Lack of Efficacy|0
1268772|NCT00454584|4152201|P1|After Controlled Period|Lack of Efficacy|0
1268773|NCT00454584|4152196|P6|After Controlled Period|Adverse Event|9
1268774|NCT00454584|4152197|P5|After Controlled Period|Adverse Event|3
1268775|NCT00454584|4152198|P4|After Controlled Period|Adverse Event|9
1268776|NCT00454584|4152199|P3|After Controlled Period|Adverse Event|0
1268777|NCT00454584|4152200|P2|After Controlled Period|Adverse Event|0
1268778|NCT00454584|4152201|P1|After Controlled Period|Adverse Event|0
1268779|NCT00454584|4152196|P6|Controlled Period|Other|0
1268780|NCT00454584|4152197|P5|Controlled Period|Other|0
1268781|NCT00454584|4152198|P4|Controlled Period|Other|0
1268782|NCT00454584|4152199|P3|Controlled Period|Other|2
1268783|NCT00454584|4152200|P2|Controlled Period|Other|4
1268784|NCT00454584|4152201|P1|Controlled Period|Other|5
1268785|NCT00454584|4152196|P6|Controlled Period|Lost to Follow-up|0
1268786|NCT00454584|4152197|P5|Controlled Period|Lost to Follow-up|0
1268787|NCT00454584|4152198|P4|Controlled Period|Lost to Follow-up|0
1268788|NCT00454584|4152199|P3|Controlled Period|Lost to Follow-up|2
1268789|NCT00454584|4152200|P2|Controlled Period|Lost to Follow-up|2
1268790|NCT00454584|4152201|P1|Controlled Period|Lost to Follow-up|1
1268791|NCT00454584|4152196|P6|Controlled Period|Adverse Event|0
1268792|NCT00454584|4152197|P5|Controlled Period|Adverse Event|0
1268793|NCT00454584|4152198|P4|Controlled Period|Adverse Event|0
1268794|NCT00454584|4152199|P3|Controlled Period|Adverse Event|1
1268795|NCT00454584|4152200|P2|Controlled Period|Adverse Event|2
1268796|NCT00454584|4152201|P1|Controlled Period|Adverse Event|5
1268797|NCT00454571|4152223|P2|Overall Study|Withdrawal by Subject|5
1268798|NCT00454571|4152224|P1|Overall Study|Withdrawal by Subject|10
1268799|NCT00454571|4152223|P2|Overall Study|Protocol Violation|0
1268800|NCT00454571|4152224|P1|Overall Study|Protocol Violation|1
1268801|NCT00454571|4152223|P2|Overall Study|Physician Decision|1
1268802|NCT00454571|4152224|P1|Overall Study|Physician Decision|0
1268803|NCT00454571|4152223|P2|Overall Study|Adverse Event|0
1268804|NCT00454571|4152224|P1|Overall Study|Adverse Event|2
1268805|NCT00454363|4152259|P2|Overall Study|Withdrawal prior to 12 weeks treatment|0
1268806|NCT00454363|4152260|P1|Overall Study|Withdrawal prior to 12 weeks treatment|4
1268807|NCT00454363|4152259|P2|Overall Study|Adverse Event|2
1268808|NCT00454363|4152260|P1|Overall Study|Adverse Event|1
1268809|NCT00454246|4152285|P3|Overall Study|Early termination of study|9
1268810|NCT00454246|4152286|P2|Overall Study|Early termination of study|26
1268811|NCT00454246|4152287|P1|Overall Study|Early termination of study|62
1268812|NCT00454246|4152285|P3|Overall Study|Failure to return|0
1268813|NCT00454246|4152286|P2|Overall Study|Failure to return|0
1268814|NCT00454246|4152287|P1|Overall Study|Failure to return|1
1268815|NCT00454246|4152285|P3|Overall Study|Refused Treatment|0
1268816|NCT00454246|4152286|P2|Overall Study|Refused Treatment|1
1268817|NCT00454246|4152287|P1|Overall Study|Refused Treatment|1
1268818|NCT00454246|4152285|P3|Overall Study|Protocol Violation|0
1268819|NCT00454246|4152286|P2|Overall Study|Protocol Violation|0
1268820|NCT00454246|4152287|P1|Overall Study|Protocol Violation|1
1268821|NCT00454246|4152285|P3|Overall Study|Violation of selection criteria at entry|0
1268822|NCT00454246|4152286|P2|Overall Study|Violation of selection criteria at entry|0
1268823|NCT00454246|4152287|P1|Overall Study|Violation of selection criteria at entry|6
1268824|NCT00454246|4152285|P3|Overall Study|Adverse Event|0
1268825|NCT00454246|4152286|P2|Overall Study|Adverse Event|2
1268826|NCT00454246|4152287|P1|Overall Study|Adverse Event|2
1268827|NCT00454207|4152303|P2|Overall Study|Protocol Violation|1
1268828|NCT00454207|4152304|P1|Overall Study|Protocol Violation|0
1268829|NCT00454207|4152303|P2|Overall Study|Lack of Efficacy|0
1268830|NCT00454207|4152304|P1|Overall Study|Lack of Efficacy|1
1268831|NCT00454207|4152303|P2|Overall Study|Adverse Event|1
1268832|NCT00454207|4152304|P1|Overall Study|Adverse Event|3
1268833|NCT00454194|4152349|P2|Overall Study|Other Unspecified Reason|2
1268834|NCT00454194|4152350|P1|Overall Study|Other Unspecified Reason|2
1268835|NCT00454194|4152349|P2|Overall Study|Other Medical Problems|2
1268836|NCT00454194|4152350|P1|Overall Study|Other Medical Problems|1
1268837|NCT00454194|4152349|P2|Overall Study|Withdrawal by Subject|8
1268838|NCT00454194|4152350|P1|Overall Study|Withdrawal by Subject|12
1268839|NCT00454194|4152349|P2|Overall Study|Adverse Event|2
1268840|NCT00454194|4152350|P1|Overall Study|Adverse Event|7
1268841|NCT00454181|4152368|P2|Overall Study|Withdrawal by Subject|0
1268842|NCT00454181|4152369|P1|Overall Study|Withdrawal by Subject|2
1268843|NCT00454181|4152368|P2|Overall Study|Protocol Violation|1
1268844|NCT00454181|4152369|P1|Overall Study|Protocol Violation|1
1268845|NCT00454181|4152368|P2|Overall Study|Lost to Follow-up|1
1268846|NCT00454181|4152369|P1|Overall Study|Lost to Follow-up|11
1268847|NCT00454181|4152368|P2|Overall Study|Adverse Event|1
1268848|NCT00454181|4152369|P1|Overall Study|Adverse Event|1
1268849|NCT00454142|4152385|P1|Overall Study|Withdrawal by Subject|1
1268850|NCT00454116|4152403|P3|Overall Study|Other|0
1268851|NCT00454116|4152404|P2|Overall Study|Other|2
1268852|NCT00454116|4152405|P1|Overall Study|Other|2
1268853|NCT00454116|4152403|P3|Overall Study|Withdrawal by Subject|1
1268854|NCT00454116|4152404|P2|Overall Study|Withdrawal by Subject|3
1268855|NCT00454116|4152405|P1|Overall Study|Withdrawal by Subject|3
1268856|NCT00454116|4152403|P3|Overall Study|Condition under investigation worsened|18
1268857|NCT00454116|4152404|P2|Overall Study|Condition under investigation worsened|13
1268858|NCT00454116|4152405|P1|Overall Study|Condition under investigation worsened|17
1268859|NCT00454116|4152403|P3|Overall Study|Adverse Event|9
1268860|NCT00454116|4152404|P2|Overall Study|Adverse Event|11
1268861|NCT00454116|4152405|P1|Overall Study|Adverse Event|5
1268862|NCT00454051|4152415|P2|Overall Study|Protocol Violation|1
1268863|NCT00454051|4152416|P1|Overall Study|Protocol Violation|1
1268864|NCT00454051|4152415|P2|Overall Study|Withdrawal by Subject|0
1268865|NCT00454051|4152416|P1|Overall Study|Withdrawal by Subject|1
1268866|NCT00454051|4152415|P2|Overall Study|Adverse Event|2
1268867|NCT00454051|4152416|P1|Overall Study|Adverse Event|1
1268868|NCT00453999|4152449|P3|Overall Study|Subject Request|0
1268869|NCT00453999|4152450|P2|Overall Study|Subject Request|1
1268870|NCT00453999|4152451|P1|Overall Study|Subject Request|2
1268871|NCT00453999|4152449|P3|Overall Study|Withdrawal by Subject|1
1268872|NCT00453999|4152450|P2|Overall Study|Withdrawal by Subject|1
1268873|NCT00453999|4152451|P1|Overall Study|Withdrawal by Subject|2
1268874|NCT00453999|4152449|P3|Overall Study|Lost to Follow-up|1
1268875|NCT00453999|4152450|P2|Overall Study|Lost to Follow-up|1
1268876|NCT00453999|4152451|P1|Overall Study|Lost to Follow-up|0
1268877|NCT00453999|4152449|P3|Overall Study|Adverse Event|1
1268878|NCT00453999|4152450|P2|Overall Study|Adverse Event|2
1268879|NCT00453999|4152451|P1|Overall Study|Adverse Event|1
1268880|NCT00453986|4152479|P5|Overall Study|Lost to Follow-up|0
1268881|NCT00453986|4152480|P4|Overall Study|Lost to Follow-up|2
1268882|NCT00453986|4152481|P3|Overall Study|Lost to Follow-up|6
1268883|NCT00453986|4152482|P2|Overall Study|Lost to Follow-up|5
1268884|NCT00453986|4152483|P1|Overall Study|Lost to Follow-up|6
1268885|NCT00453973|4152576|P2|Overall Study|Sponsor Decision to Terminate Study|30
1268886|NCT00453973|4152577|P1|Overall Study|Sponsor Decision to Terminate Study|35
1268887|NCT00453973|4152576|P2|Overall Study|Site closed by sponsor|0
1268888|NCT00453973|4152577|P1|Overall Study|Site closed by sponsor|3
1268889|NCT00453973|4152576|P2|Overall Study|Renal transplant|1
1268890|NCT00453973|4152577|P1|Overall Study|Renal transplant|1
1268891|NCT00453973|4152576|P2|Overall Study|Relocation|0
1268892|NCT00453973|4152577|P1|Overall Study|Relocation|1
1268893|NCT00453973|4152576|P2|Overall Study|PI Decision|2
1268894|NCT00453973|4152577|P1|Overall Study|PI Decision|0
1268895|NCT00453973|4152576|P2|Overall Study|Withdrawal by Subject|6
1268896|NCT00453973|4152577|P1|Overall Study|Withdrawal by Subject|7
1268897|NCT00453973|4152576|P2|Overall Study|Adverse Event|9
1268898|NCT00453973|4152577|P1|Overall Study|Adverse Event|4
1268899|NCT00453921|4152587|P4|Overall Study|Lost to Follow-up|0
1268900|NCT00453921|4152588|P3|Overall Study|Lost to Follow-up|1
1268901|NCT00453921|4152589|P2|Overall Study|Lost to Follow-up|0
1268902|NCT00453921|4152590|P1|Overall Study|Lost to Follow-up|0
1268903|NCT00453921|4152587|P4|Overall Study|Withdrawal by Subject|1
1268904|NCT00453921|4152588|P3|Overall Study|Withdrawal by Subject|1
1268905|NCT00453921|4152589|P2|Overall Study|Withdrawal by Subject|1
1268906|NCT00453921|4152590|P1|Overall Study|Withdrawal by Subject|1
1268907|NCT00453362|4152729|P1|Overall Study|Screening Failure|14
1268908|NCT00453362|4152729|P1|Overall Study|Progression of disease|56
1268909|NCT00453362|4152729|P1|Overall Study|Withdrawal by Subject|3
1268910|NCT00453362|4152729|P1|Overall Study|Physician Decision|2
1268911|NCT00453362|4152729|P1|Overall Study|Death|7
1268912|NCT00453362|4152729|P1|Overall Study|Adverse Event|5
1268913|NCT00453349|4152755|P2|Completed Study|Lost to follow up after study treatment|11
1268914|NCT00453349|4152756|P1|Completed Study|Lost to follow up after study treatment|2
1268915|NCT00453349|4152755|P2|Completed Study|Withdrawal by Subject|5
1268916|NCT00453349|4152756|P1|Completed Study|Withdrawal by Subject|3
1268917|NCT00453349|4152755|P2|Completed Study|Protocol Violation|1
1268918|NCT00453349|4152756|P1|Completed Study|Protocol Violation|1
1268919|NCT00453349|4152755|P2|Completed Study|Lost to Follow-up|5
1268920|NCT00453349|4152756|P1|Completed Study|Lost to Follow-up|7
1268921|NCT00453349|4152755|P2|Completed Study|Lack of Efficacy|1
1268922|NCT00453349|4152756|P1|Completed Study|Lack of Efficacy|2
1268923|NCT00453349|4152755|P2|Completed Study|Adverse Event|11
1268924|NCT00453349|4152756|P1|Completed Study|Adverse Event|12
1268925|NCT00453349|4152755|P2|Reaching of Primary Endpoint (TOC)|Missing information|11
1268926|NCT00453349|4152756|P1|Reaching of Primary Endpoint (TOC)|Missing information|10
1268927|NCT00453349|4152755|P2|Randomized|Withdrawal by Subject|5
1268928|NCT00453349|4152756|P1|Randomized|Withdrawal by Subject|3
1268929|NCT00453349|4152755|P2|Randomized|Protocol Violation|1
1268930|NCT00453349|4152756|P1|Randomized|Protocol Violation|1
1268931|NCT00453349|4152755|P2|Randomized|Lost to Follow-up|5
1268932|NCT00453349|4152756|P1|Randomized|Lost to Follow-up|7
1268933|NCT00453349|4152755|P2|Randomized|Lack of Efficacy|1
1268934|NCT00453349|4152756|P1|Randomized|Lack of Efficacy|2
1268935|NCT00453349|4152755|P2|Randomized|Adverse Event|11
1268936|NCT00453349|4152756|P1|Randomized|Adverse Event|12
1268937|NCT00453310|4152787|P1|Overall Study|Progression of Disease|10
1268938|NCT00453206|4152791|P1|Overall Study|Death|1
1268939|NCT00453180|4152801|P2|Overall Study|Adverse Event|2
1268940|NCT00453180|4152802|P1|Overall Study|Adverse Event|1
1268941|NCT00453180|4152801|P2|Overall Study|Lost to Follow-up|1
1268942|NCT00453180|4152802|P1|Overall Study|Lost to Follow-up|2
1268943|NCT00453154|4152821|P4|Double BIind Maintenance|Randomized, did not receive therapy|5
1268944|NCT00453154|4152822|P3|Double BIind Maintenance|Randomized, did not receive therapy|5
1268945|NCT00453154|4152823|P2|Double BIind Maintenance|Randomized, did not receive therapy|0
1268946|NCT00453154|4152824|P1|Double BIind Maintenance|Randomized, did not receive therapy|0
1268947|NCT00453154|4152821|P4|Double BIind Maintenance|Medical Issues|1
1268948|NCT00453154|4152822|P3|Double BIind Maintenance|Medical Issues|3
1268949|NCT00453154|4152823|P2|Double BIind Maintenance|Medical Issues|0
1268950|NCT00453154|4152824|P1|Double BIind Maintenance|Medical Issues|0
1268951|NCT00453154|4152821|P4|Double BIind Maintenance|Progression|26
1268952|NCT00453154|4152822|P3|Double BIind Maintenance|Progression|29
1268953|NCT00453154|4152823|P2|Double BIind Maintenance|Progression|0
1268954|NCT00453154|4152824|P1|Double BIind Maintenance|Progression|0
1268955|NCT00453154|4152821|P4|Double BIind Maintenance|Withdrawal by Subject|4
1268956|NCT00453154|4152822|P3|Double BIind Maintenance|Withdrawal by Subject|4
1268957|NCT00453154|4152823|P2|Double BIind Maintenance|Withdrawal by Subject|0
1268958|NCT00453154|4152824|P1|Double BIind Maintenance|Withdrawal by Subject|0
1268959|NCT00453154|4152821|P4|Double BIind Maintenance|Death|1
1268960|NCT00453154|4152822|P3|Double BIind Maintenance|Death|2
1268961|NCT00453154|4152823|P2|Double BIind Maintenance|Death|0
1268962|NCT00453154|4152824|P1|Double BIind Maintenance|Death|0
1268963|NCT00453154|4152821|P4|Double BIind Maintenance|Adverse Event|12
1268964|NCT00453154|4152822|P3|Double BIind Maintenance|Adverse Event|3
1268965|NCT00453154|4152823|P2|Double BIind Maintenance|Adverse Event|0
1268966|NCT00453154|4152824|P1|Double BIind Maintenance|Adverse Event|0
1268967|NCT00453102|4152837|P1|Overall Study|Withdrawal by Subject|2
1268968|NCT00453063|4152848|P2|Overall Study|Protocol Violation|0
1268969|NCT00453063|4152849|P1|Overall Study|Protocol Violation|1
1268970|NCT00453063|4152848|P2|Overall Study|Withdrawal by Subject|1
1268971|NCT00453063|4152849|P1|Overall Study|Withdrawal by Subject|1
1268972|NCT00453063|4152848|P2|Overall Study|Adverse Event|2
1268973|NCT00453063|4152849|P1|Overall Study|Adverse Event|1
1268974|NCT00452790|4152869|P2|Toddler Dose|Parent/legal guardian request|1
1268975|NCT00452790|4152870|P1|Toddler Dose|Parent/legal guardian request|0
1268976|NCT00452790|4152869|P2|Toddler Dose|Failed to return|1
1268977|NCT00452790|4152870|P1|Toddler Dose|Failed to return|0
1268978|NCT00452790|4152869|P2|After Infant Series|Other reasons|0
1268979|NCT00452790|4152870|P1|After Infant Series|Other reasons|1
1268980|NCT00452790|4152869|P2|After Infant Series|Failed to return|0
1268981|NCT00452790|4152870|P1|After Infant Series|Failed to return|1
1268982|NCT00452790|4152869|P2|After Infant Series|Lost to Follow-up|0
1268983|NCT00452790|4152870|P1|After Infant Series|Lost to Follow-up|4
1268984|NCT00452790|4152869|P2|After Infant Series|Parent/legal guardian request|3
1268985|NCT00452790|4152870|P1|After Infant Series|Parent/legal guardian request|1
1268986|NCT00452790|4152869|P2|After Infant Series|Adverse Event|1
1268987|NCT00452790|4152870|P1|After Infant Series|Adverse Event|4
1268988|NCT00452790|4152869|P2|After Infant Series|Investigator request|10
1268989|NCT00452790|4152870|P1|After Infant Series|Investigator request|10
1268990|NCT00452790|4152869|P2|Infant Series|Death|1
1268991|NCT00452790|4152870|P1|Infant Series|Death|0
1268992|NCT00452790|4152869|P2|Infant Series|Investigator request|1
1268993|NCT00452790|4152870|P1|Infant Series|Investigator request|0
1268994|NCT00452790|4152869|P2|Infant Series|Other reasons|2
1268995|NCT00452790|4152870|P1|Infant Series|Other reasons|1
1268996|NCT00452790|4152869|P2|Infant Series|Adverse Event|2
1268997|NCT00452790|4152870|P1|Infant Series|Adverse Event|1
1268998|NCT00452790|4152869|P2|Infant Series|Lost to Follow-up|2
1268999|NCT00452790|4152870|P1|Infant Series|Lost to Follow-up|2
1269000|NCT00452790|4152869|P2|Infant Series|Protocol Violation|3
1269001|NCT00452790|4152870|P1|Infant Series|Protocol Violation|1
1269002|NCT00452790|4152869|P2|Infant Series|Failed to return|1
1269003|NCT00452790|4152870|P1|Infant Series|Failed to return|4
1269004|NCT00452790|4152869|P2|Infant Series|Parent/legal guardian request|6
1269005|NCT00452790|4152870|P1|Infant Series|Parent/legal guardian request|8
1269006|NCT00452790|4152869|P2|Infant Series|Clinical hold - consent withdrawn|123
1269007|NCT00452790|4152870|P1|Infant Series|Clinical hold - consent withdrawn|118
1269008|NCT00452699|4152906|P2|Overall Study|Other|7
1269009|NCT00452699|4152907|P1|Overall Study|Other|12
1269010|NCT00452699|4152906|P2|Overall Study|Withdrawal by Subject|25
1269011|NCT00452699|4152907|P1|Overall Study|Withdrawal by Subject|26
1269012|NCT00452699|4152906|P2|Overall Study|Protocol Violation|25
1269013|NCT00452699|4152907|P1|Overall Study|Protocol Violation|21
1269014|NCT00452699|4152906|P2|Overall Study|Lost to Follow-up|9
1269015|NCT00452699|4152907|P1|Overall Study|Lost to Follow-up|6
1269016|NCT00452699|4152906|P2|Overall Study|Lack of Efficacy|4
1269017|NCT00452699|4152907|P1|Overall Study|Lack of Efficacy|6
1269018|NCT00452699|4152906|P2|Overall Study|Adverse Event|3
1269019|NCT00452699|4152907|P1|Overall Study|Adverse Event|10
1269020|NCT00452673|4152923|P5|Dose Expansion Period|not specified|2
1269021|NCT00452673|4152924|P4|Dose Expansion Period|not specified|0
1269022|NCT00452673|4152925|P3|Dose Expansion Period|not specified|0
1269023|NCT00452673|4152926|P2|Dose Expansion Period|not specified|0
1269024|NCT00452673|4152927|P1|Dose Expansion Period|not specified|0
1269025|NCT00452673|4152923|P5|Dose Expansion Period|Disease Progression|19
1269026|NCT00452673|4152924|P4|Dose Expansion Period|Disease Progression|0
1269027|NCT00452673|4152925|P3|Dose Expansion Period|Disease Progression|0
1269028|NCT00452673|4152926|P2|Dose Expansion Period|Disease Progression|0
1269029|NCT00452673|4152927|P1|Dose Expansion Period|Disease Progression|0
1269030|NCT00452673|4152923|P5|Dose Escalation Period|Withdrawal by Subject|0
1269031|NCT00452673|4152924|P4|Dose Escalation Period|Withdrawal by Subject|1
1269032|NCT00452673|4152925|P3|Dose Escalation Period|Withdrawal by Subject|0
1269033|NCT00452673|4152926|P2|Dose Escalation Period|Withdrawal by Subject|0
1269034|NCT00452673|4152927|P1|Dose Escalation Period|Withdrawal by Subject|0
1269035|NCT00452673|4152923|P5|Dose Escalation Period|Adverse Event|0
1269036|NCT00452673|4152924|P4|Dose Escalation Period|Adverse Event|1
1269037|NCT00452673|4152925|P3|Dose Escalation Period|Adverse Event|0
1269038|NCT00452673|4152926|P2|Dose Escalation Period|Adverse Event|0
1269039|NCT00452673|4152927|P1|Dose Escalation Period|Adverse Event|0
1269040|NCT00452673|4152923|P5|Dose Escalation Period|not specified|0
1269041|NCT00452673|4152924|P4|Dose Escalation Period|not specified|0
1269042|NCT00452673|4152925|P3|Dose Escalation Period|not specified|1
1269043|NCT00452673|4152926|P2|Dose Escalation Period|not specified|0
1269044|NCT00452673|4152927|P1|Dose Escalation Period|not specified|0
1269045|NCT00452673|4152923|P5|Dose Escalation Period|study drug toxicity|0
1269046|NCT00452673|4152924|P4|Dose Escalation Period|study drug toxicity|1
1269047|NCT00452673|4152925|P3|Dose Escalation Period|study drug toxicity|3
1269048|NCT00452673|4152926|P2|Dose Escalation Period|study drug toxicity|3
1269049|NCT00452673|4152927|P1|Dose Escalation Period|study drug toxicity|1
1269050|NCT00452673|4152923|P5|Dose Escalation Period|Disease Progression|0
1269051|NCT00452673|4152924|P4|Dose Escalation Period|Disease Progression|6
1269052|NCT00452673|4152925|P3|Dose Escalation Period|Disease Progression|2
1269053|NCT00452673|4152926|P2|Dose Escalation Period|Disease Progression|6
1269054|NCT00452673|4152927|P1|Dose Escalation Period|Disease Progression|6
1269055|NCT00452530|4152974|P2|Overall Study|Not specified|11
1269056|NCT00452530|4152975|P1|Overall Study|Not specified|7
1269057|NCT00452530|4152974|P2|Overall Study|No longer met study criteria|22
1269058|NCT00452530|4152975|P1|Overall Study|No longer met study criteria|18
1269059|NCT00452530|4152974|P2|Overall Study|Poor compliance/noncompliance|2
1269060|NCT00452530|4152975|P1|Overall Study|Poor compliance/noncompliance|1
1269061|NCT00452530|4152974|P2|Overall Study|Lost to Follow-up|0
1269062|NCT00452530|4152975|P1|Overall Study|Lost to Follow-up|1
1269063|NCT00452530|4152974|P2|Overall Study|Withdrawal by Subject|57
1269064|NCT00452530|4152975|P1|Overall Study|Withdrawal by Subject|68
1269065|NCT00452530|4152974|P2|Overall Study|Adverse Event|44
1269066|NCT00452530|4152975|P1|Overall Study|Adverse Event|40
1269067|NCT00452530|4152974|P2|Overall Study|Death|0
1269068|NCT00452530|4152975|P1|Overall Study|Death|1
1269069|NCT00452452|4152996|P3|Overall Study|Lost to Follow-up|0
1269070|NCT00452452|4152997|P2|Overall Study|Lost to Follow-up|0
1269071|NCT00452452|4152998|P1|Overall Study|Lost to Follow-up|1
1269072|NCT00452452|4152996|P3|Overall Study|Withdrawal by Subject|0
1269073|NCT00452452|4152997|P2|Overall Study|Withdrawal by Subject|0
1269074|NCT00452452|4152998|P1|Overall Study|Withdrawal by Subject|1
1269075|NCT00452452|4152996|P3|Overall Study|Protocol Violation|1
1269076|NCT00452452|4152997|P2|Overall Study|Protocol Violation|0
1269077|NCT00452452|4152998|P1|Overall Study|Protocol Violation|0
1269078|NCT00452400|4153043|P5|Overall Study|Other reasons not listed above|1
1269079|NCT00452400|4153044|P4|Overall Study|Other reasons not listed above|1
1269080|NCT00452400|4153045|P3|Overall Study|Other reasons not listed above|0
1269081|NCT00452400|4153046|P2|Overall Study|Other reasons not listed above|0
1269082|NCT00452400|4153047|P1|Overall Study|Other reasons not listed above|0
1269083|NCT00452400|4153043|P5|Overall Study|Lack of Efficacy|0
1269084|NCT00452400|4153044|P4|Overall Study|Lack of Efficacy|0
1269085|NCT00452400|4153045|P3|Overall Study|Lack of Efficacy|0
1269086|NCT00452400|4153046|P2|Overall Study|Lack of Efficacy|0
1269087|NCT00452400|4153047|P1|Overall Study|Lack of Efficacy|2
1269088|NCT00452400|4153043|P5|Overall Study|Withdrawal by Subject|0
1269089|NCT00452400|4153044|P4|Overall Study|Withdrawal by Subject|0
1269090|NCT00452400|4153045|P3|Overall Study|Withdrawal by Subject|1
1269091|NCT00452400|4153046|P2|Overall Study|Withdrawal by Subject|0
1269092|NCT00452400|4153047|P1|Overall Study|Withdrawal by Subject|1
1269093|NCT00452400|4153043|P5|Overall Study|Lost to Follow-up|0
1269094|NCT00452400|4153044|P4|Overall Study|Lost to Follow-up|0
1269095|NCT00452400|4153045|P3|Overall Study|Lost to Follow-up|0
1269096|NCT00452400|4153046|P2|Overall Study|Lost to Follow-up|0
1269097|NCT00452400|4153047|P1|Overall Study|Lost to Follow-up|1
1269098|NCT00452400|4153043|P5|Overall Study|Protocol Violation|0
1269099|NCT00452400|4153044|P4|Overall Study|Protocol Violation|0
1269100|NCT00452400|4153045|P3|Overall Study|Protocol Violation|1
1269101|NCT00452400|4153046|P2|Overall Study|Protocol Violation|0
1269102|NCT00452400|4153047|P1|Overall Study|Protocol Violation|0
1269103|NCT00452400|4153043|P5|Overall Study|Adverse Event|2
1269104|NCT00452400|4153044|P4|Overall Study|Adverse Event|0
1269105|NCT00452400|4153045|P3|Overall Study|Adverse Event|5
1269106|NCT00452400|4153046|P2|Overall Study|Adverse Event|1
1269107|NCT00452400|4153047|P1|Overall Study|Adverse Event|1
1269108|NCT00452361|4153234|P2|Overall Study|Premature termination|9
1269109|NCT00452361|4153235|P1|Overall Study|Premature termination|13
1269110|NCT00452361|4153234|P2|Overall Study|Withdrawal by Subject|1
1269111|NCT00452361|4153235|P1|Overall Study|Withdrawal by Subject|0
1269112|NCT00452361|4153234|P2|Overall Study|Adverse Event|0
1269113|NCT00452361|4153235|P1|Overall Study|Adverse Event|8
1269114|NCT00452348|4153279|P2|Overall Study|Other|9
1269115|NCT00452348|4153280|P1|Overall Study|Other|9
1269116|NCT00452348|4153279|P2|Overall Study|Withdrawal by Subject|21
1269117|NCT00452348|4153280|P1|Overall Study|Withdrawal by Subject|18
1269118|NCT00452348|4153279|P2|Overall Study|Protocol Violation|28
1269119|NCT00452348|4153280|P1|Overall Study|Protocol Violation|22
1269120|NCT00452348|4153279|P2|Overall Study|Lost to Follow-up|8
1269121|NCT00452348|4153280|P1|Overall Study|Lost to Follow-up|14
1269122|NCT00452348|4153279|P2|Overall Study|Lack of Efficacy|9
1269123|NCT00452348|4153280|P1|Overall Study|Lack of Efficacy|10
1269124|NCT00452348|4153279|P2|Overall Study|Adverse Event|9
1269125|NCT00452348|4153280|P1|Overall Study|Adverse Event|6
1269126|NCT00452114|4153334|P2|Overall Study|Physician Decision|3
1269127|NCT00452114|4153335|P1|Overall Study|Physician Decision|3
1269128|NCT00451958|4153351|P5|CS21A (NCT00451958)|Miscellaneous reasons|0
1269129|NCT00451958|4153352|P4|CS21A (NCT00451958)|Miscellaneous reasons|14
1269130|NCT00451958|4153353|P3|CS21A (NCT00451958)|Miscellaneous reasons|17
1269131|NCT00451958|4153354|P2|CS21A (NCT00451958)|Miscellaneous reasons|27
1269132|NCT00451958|4153355|P1|CS21A (NCT00451958)|Miscellaneous reasons|28
1269133|NCT00451958|4153351|P5|CS21A (NCT00451958)|Withdrawal by Subject|0
1269134|NCT00451958|4153352|P4|CS21A (NCT00451958)|Withdrawal by Subject|3
1269135|NCT00451958|4153353|P3|CS21A (NCT00451958)|Withdrawal by Subject|4
1269136|NCT00451958|4153354|P2|CS21A (NCT00451958)|Withdrawal by Subject|4
1269137|NCT00451958|4153355|P1|CS21A (NCT00451958)|Withdrawal by Subject|7
1269138|NCT00451958|4153351|P5|CS21A (NCT00451958)|Physician Decision|0
1269139|NCT00451958|4153352|P4|CS21A (NCT00451958)|Physician Decision|4
1269140|NCT00451958|4153353|P3|CS21A (NCT00451958)|Physician Decision|4
1269141|NCT00451958|4153354|P2|CS21A (NCT00451958)|Physician Decision|4
1269142|NCT00451958|4153355|P1|CS21A (NCT00451958)|Physician Decision|2
1269143|NCT00451958|4153351|P5|CS21A (NCT00451958)|Protocol Violation|0
1269144|NCT00451958|4153352|P4|CS21A (NCT00451958)|Protocol Violation|0
1269145|NCT00451958|4153353|P3|CS21A (NCT00451958)|Protocol Violation|2
1269146|NCT00451958|4153354|P2|CS21A (NCT00451958)|Protocol Violation|3
1269147|NCT00451958|4153355|P1|CS21A (NCT00451958)|Protocol Violation|1
1269148|NCT00451958|4153351|P5|CS21A (NCT00451958)|Lost to Follow-up|0
1269149|NCT00451958|4153352|P4|CS21A (NCT00451958)|Lost to Follow-up|1
1269150|NCT00451958|4153353|P3|CS21A (NCT00451958)|Lost to Follow-up|1
1269151|NCT00451958|4153354|P2|CS21A (NCT00451958)|Lost to Follow-up|5
1269152|NCT00451958|4153355|P1|CS21A (NCT00451958)|Lost to Follow-up|6
1269153|NCT00451958|4153351|P5|CS21A (NCT00451958)|Adverse Event|0
1269154|NCT00451958|4153352|P4|CS21A (NCT00451958)|Adverse Event|17
1269155|NCT00451958|4153353|P3|CS21A (NCT00451958)|Adverse Event|14
1269156|NCT00451958|4153354|P2|CS21A (NCT00451958)|Adverse Event|34
1269157|NCT00451958|4153355|P1|CS21A (NCT00451958)|Adverse Event|21
1269158|NCT00451906|4153385|P1|Overall Study|Did not complete final visit|4
1269159|NCT00451906|4153385|P1|Overall Study|Other Reasons|121
1269160|NCT00451906|4153385|P1|Overall Study|Termination of the study|108
1269161|NCT00451906|4153385|P1|Overall Study|Progressive disease|1328
1269162|NCT00451906|4153385|P1|Overall Study|Protocol Violation|21
1269163|NCT00451906|4153385|P1|Overall Study|Withdrawal by Subject|111
1269164|NCT00451906|4153385|P1|Overall Study|Lost to Follow-up|31
1269165|NCT00451906|4153385|P1|Overall Study|Adverse Event|515
1269166|NCT00451451|4153414|P4|Overall Study|Other Reasons for Not Completing Study|14
1269167|NCT00451451|4153415|P3|Overall Study|Other Reasons for Not Completing Study|17
1269168|NCT00451451|4153416|P2|Overall Study|Other Reasons for Not Completing Study|30
1269169|NCT00451451|4153417|P1|Overall Study|Other Reasons for Not Completing Study|34
1269170|NCT00451451|4153414|P4|Overall Study|Death|1
1269171|NCT00451451|4153415|P3|Overall Study|Death|0
1269172|NCT00451451|4153416|P2|Overall Study|Death|0
1269173|NCT00451451|4153417|P1|Overall Study|Death|1
1269174|NCT00451451|4153414|P4|Overall Study|Subject Non-Compliance|3
1269175|NCT00451451|4153415|P3|Overall Study|Subject Non-Compliance|3
1269176|NCT00451451|4153416|P2|Overall Study|Subject Non-Compliance|4
1269177|NCT00451451|4153417|P1|Overall Study|Subject Non-Compliance|8
1269178|NCT00451451|4153414|P4|Overall Study|Investigator Decision|2
1269179|NCT00451451|4153415|P3|Overall Study|Investigator Decision|1
1269180|NCT00451451|4153416|P2|Overall Study|Investigator Decision|2
1269181|NCT00451451|4153417|P1|Overall Study|Investigator Decision|6
1269182|NCT00451451|4153414|P4|Overall Study|Consent Withdrawn|17
1269183|NCT00451451|4153415|P3|Overall Study|Consent Withdrawn|17
1269184|NCT00451451|4153416|P2|Overall Study|Consent Withdrawn|9
1269185|NCT00451451|4153417|P1|Overall Study|Consent Withdrawn|14
1269186|NCT00451451|4153414|P4|Overall Study|Lost to Follow-up|11
1269187|NCT00451451|4153415|P3|Overall Study|Lost to Follow-up|8
1269188|NCT00451451|4153416|P2|Overall Study|Lost to Follow-up|9
1269189|NCT00451451|4153417|P1|Overall Study|Lost to Follow-up|11
1269190|NCT00451451|4153414|P4|Overall Study|Adverse Event|10
1269191|NCT00451451|4153415|P3|Overall Study|Adverse Event|26
1269192|NCT00451451|4153416|P2|Overall Study|Adverse Event|21
1269193|NCT00451451|4153417|P1|Overall Study|Adverse Event|11
1269194|NCT00451321|4153452|P8|Overall Study|Sponsor decision to amend protocol|3
1269195|NCT00451321|4153453|P7|Overall Study|Sponsor decision to amend protocol|1
1269196|NCT00451321|4153454|P6|Overall Study|Sponsor decision to amend protocol|1
1269197|NCT00451321|4153455|P5|Overall Study|Sponsor decision to amend protocol|0
1269198|NCT00451321|4153456|P4|Overall Study|Sponsor decision to amend protocol|0
1269199|NCT00451321|4153457|P3|Overall Study|Sponsor decision to amend protocol|0
1269200|NCT00451321|4153458|P2|Overall Study|Sponsor decision to amend protocol|0
1269201|NCT00451321|4153459|P1|Overall Study|Sponsor decision to amend protocol|0
1269202|NCT00451321|4153452|P8|Overall Study|Study closed/terminated|3
1269203|NCT00451321|4153453|P7|Overall Study|Study closed/terminated|5
1269204|NCT00451321|4153454|P6|Overall Study|Study closed/terminated|7
1269205|NCT00451321|4153455|P5|Overall Study|Study closed/terminated|7
1269206|NCT00451321|4153456|P4|Overall Study|Study closed/terminated|5
1269207|NCT00451321|4153457|P3|Overall Study|Study closed/terminated|17
1269208|NCT00451321|4153458|P2|Overall Study|Study closed/terminated|1
1269209|NCT00451321|4153459|P1|Overall Study|Study closed/terminated|1
1269210|NCT00451321|4153452|P8|Overall Study|Withdrawal by Subject|0
1269211|NCT00451321|4153453|P7|Overall Study|Withdrawal by Subject|0
1269212|NCT00451321|4153454|P6|Overall Study|Withdrawal by Subject|0
1269213|NCT00451321|4153455|P5|Overall Study|Withdrawal by Subject|0
1269214|NCT00451321|4153456|P4|Overall Study|Withdrawal by Subject|4
1269215|NCT00451321|4153457|P3|Overall Study|Withdrawal by Subject|0
1269216|NCT00451321|4153458|P2|Overall Study|Withdrawal by Subject|1
1269217|NCT00451321|4153459|P1|Overall Study|Withdrawal by Subject|3
1269218|NCT00451321|4153452|P8|Overall Study|Lost to Follow-up|0
1269219|NCT00451321|4153453|P7|Overall Study|Lost to Follow-up|0
1269220|NCT00451321|4153454|P6|Overall Study|Lost to Follow-up|1
1269221|NCT00451321|4153455|P5|Overall Study|Lost to Follow-up|0
1269222|NCT00451321|4153456|P4|Overall Study|Lost to Follow-up|3
1269223|NCT00451321|4153457|P3|Overall Study|Lost to Follow-up|1
1269224|NCT00451321|4153458|P2|Overall Study|Lost to Follow-up|3
1269225|NCT00451321|4153459|P1|Overall Study|Lost to Follow-up|3
1269226|NCT00451282|4153631|P2|Overall Study|Lost to Follow-up|5
1269227|NCT00451282|4153632|P1|Overall Study|Lost to Follow-up|6
1269228|NCT00451204|4153646|P2|Overall Study|Other|2
1269229|NCT00451204|4153647|P1|Overall Study|Other|1
1269230|NCT00451204|4153646|P2|Overall Study|Patient refusal|4
1269231|NCT00451204|4153647|P1|Overall Study|Patient refusal|8
1269232|NCT00451204|4153646|P2|Overall Study|Protocol Violation|0
1269233|NCT00451204|4153647|P1|Overall Study|Protocol Violation|1
1269234|NCT00451204|4153646|P2|Overall Study|Lost to Follow-up|4
1269235|NCT00451204|4153647|P1|Overall Study|Lost to Follow-up|4
1269236|NCT00451204|4153646|P2|Overall Study|Lack of Efficacy|4
1269237|NCT00451204|4153647|P1|Overall Study|Lack of Efficacy|4
1269238|NCT00451204|4153646|P2|Overall Study|Adverse Event|6
1269239|NCT00451204|4153647|P1|Overall Study|Adverse Event|4
1269240|NCT00451191|4153665|P2|Overall Study|withdrawal or received alternate tx|11
1269241|NCT00451191|4153666|P1|Overall Study|withdrawal or received alternate tx|15
1269242|NCT00450866|4153693|P2|Overall Study|Physician Decision|0
1269243|NCT00450866|4153694|P1|Overall Study|Physician Decision|1
1269244|NCT00450866|4153693|P2|Overall Study|Death|0
1269245|NCT00450866|4153694|P1|Overall Study|Death|1
1269246|NCT00450866|4153693|P2|Overall Study|Withdrawal by Subject|2
1269247|NCT00450866|4153694|P1|Overall Study|Withdrawal by Subject|5
1269248|NCT00450866|4153693|P2|Overall Study|Adverse Event|1
1269249|NCT00450866|4153694|P1|Overall Study|Adverse Event|0
1269250|NCT00450801|4153704|P1|Overall Study|Death|1
1269251|NCT00450749|4153718|P3|Overall Study|Noncompliant|0
1269252|NCT00450749|4153719|P2|Overall Study|Noncompliant|1
1269253|NCT00450749|4153720|P1|Overall Study|Noncompliant|0
1269254|NCT00450749|4153718|P3|Overall Study|Withdrawal by Subject|2
1269255|NCT00450749|4153719|P2|Overall Study|Withdrawal by Subject|0
1269256|NCT00450749|4153720|P1|Overall Study|Withdrawal by Subject|0
1269257|NCT00450723|4153728|P1|Overall Study|Physician Decision|5
1269258|NCT00450658|4153736|P2|Overall Study|misc|10
1269259|NCT00450658|4153737|P1|Overall Study|misc|21
1269260|NCT00450658|4153736|P2|Overall Study|UGI ulcer|34
1269261|NCT00450658|4153737|P1|Overall Study|UGI ulcer|33
1269262|NCT00450658|4153736|P2|Overall Study|Lost to Follow-up|5
1269263|NCT00450658|4153737|P1|Overall Study|Lost to Follow-up|22
1269264|NCT00450658|4153736|P2|Overall Study|Withdrawal by Subject|26
1269265|NCT00450658|4153737|P1|Overall Study|Withdrawal by Subject|43
1269266|NCT00450658|4153736|P2|Overall Study|Adverse Event|15
1269267|NCT00450658|4153737|P1|Overall Study|Adverse Event|24
1269268|NCT00450619|4153751|P2|Overall Study|Adverse Event|0
1269269|NCT00450619|4153752|P1|Overall Study|Adverse Event|1
1269270|NCT00450619|4153751|P2|Overall Study|did not progress; refused further trmt|1
1269271|NCT00450619|4153752|P1|Overall Study|did not progress; refused further trmt|1
1269272|NCT00450619|4153751|P2|Overall Study|refused treatment after randomization|0
1269273|NCT00450619|4153752|P1|Overall Study|refused treatment after randomization|2
1269274|NCT00450580|4153778|P2|Overall Study|Withdrawal due to pregnancy|1
1269275|NCT00450580|4153779|P1|Overall Study|Withdrawal due to pregnancy|0
1269276|NCT00450580|4153778|P2|Overall Study|Patient could not swallow Norvir|0
1269277|NCT00450580|4153779|P1|Overall Study|Patient could not swallow Norvir|1
1269278|NCT00450580|4153778|P2|Overall Study|Patient went to Brazil|0
1269279|NCT00450580|4153779|P1|Overall Study|Patient went to Brazil|1
1269280|NCT00450580|4153778|P2|Overall Study|Could not comply with scheduled visits|0
1269281|NCT00450580|4153779|P1|Overall Study|Could not comply with scheduled visits|1
1269282|NCT00450580|4153778|P2|Overall Study|Protocol-defined virologic failure|0
1269283|NCT00450580|4153779|P1|Overall Study|Protocol-defined virologic failure|1
1269284|NCT00450580|4153778|P2|Overall Study|Protocol Violation|1
1269285|NCT00450580|4153779|P1|Overall Study|Protocol Violation|1
1269286|NCT00450580|4153778|P2|Overall Study|Withdrawal by Subject|2
1269287|NCT00450580|4153779|P1|Overall Study|Withdrawal by Subject|2
1269288|NCT00450580|4153778|P2|Overall Study|Lost to Follow-up|5
1269289|NCT00450580|4153779|P1|Overall Study|Lost to Follow-up|4
1269290|NCT00450580|4153778|P2|Overall Study|Adverse Event|7
1269291|NCT00450580|4153779|P1|Overall Study|Adverse Event|5
1269292|NCT00450450|4153816|P2|Overall Study|Missing Data|0
1269293|NCT00450450|4153817|P1|Overall Study|Missing Data|2
1269294|NCT00450450|4153816|P2|Overall Study|Relapse|0
1269295|NCT00450450|4153817|P1|Overall Study|Relapse|2
1269296|NCT00450450|4153816|P2|Overall Study|Death|3
1269297|NCT00450450|4153817|P1|Overall Study|Death|1
1269298|NCT00450437|4153841|P4|Overall Study|Unable to Classify|0
1269299|NCT00450437|4153842|P3|Overall Study|Unable to Classify|1
1269300|NCT00450437|4153843|P2|Overall Study|Unable to Classify|0
1269301|NCT00450437|4153844|P1|Overall Study|Unable to Classify|1
1269302|NCT00450437|4153841|P4|Overall Study|Administrative reason|0
1269303|NCT00450437|4153842|P3|Overall Study|Administrative reason|1
1269304|NCT00450437|4153843|P2|Overall Study|Administrative reason|0
1269305|NCT00450437|4153844|P1|Overall Study|Administrative reason|0
1269306|NCT00450437|4153841|P4|Overall Study|Inappropriate enrollment|0
1269307|NCT00450437|4153842|P3|Overall Study|Inappropriate enrollment|3
1269308|NCT00450437|4153843|P2|Overall Study|Inappropriate enrollment|1
1269309|NCT00450437|4153844|P1|Overall Study|Inappropriate enrollment|4
1269310|NCT00450437|4153841|P4|Overall Study|Protocol Violation|1
1269311|NCT00450437|4153842|P3|Overall Study|Protocol Violation|0
1269312|NCT00450437|4153843|P2|Overall Study|Protocol Violation|1
1269313|NCT00450437|4153844|P1|Overall Study|Protocol Violation|0
1269314|NCT00450437|4153841|P4|Overall Study|Lost to Follow-up|9
1269315|NCT00450437|4153842|P3|Overall Study|Lost to Follow-up|19
1269316|NCT00450437|4153843|P2|Overall Study|Lost to Follow-up|12
1269317|NCT00450437|4153844|P1|Overall Study|Lost to Follow-up|31
1269318|NCT00450437|4153841|P4|Overall Study|Withdrawal by Subject|1
1269319|NCT00450437|4153842|P3|Overall Study|Withdrawal by Subject|0
1269320|NCT00450437|4153843|P2|Overall Study|Withdrawal by Subject|2
1269321|NCT00450437|4153844|P1|Overall Study|Withdrawal by Subject|10
1269322|NCT00450411|4153875|P1|Overall Study|No protocol treatment|2
1269323|NCT00450411|4153875|P1|Overall Study|Protocol Violation|6
1269324|NCT00450385|4153880|P1|Overall Study|Other|3
1269325|NCT00450385|4153880|P1|Overall Study|Physician Decision|1
1269326|NCT00450385|4153880|P1|Overall Study|Adverse Event|1
1269327|NCT00450385|4153880|P1|Overall Study|Lack of Efficacy|2
1269328|NCT00450385|4153880|P1|Overall Study|Withdrawal by Subject|2
1269329|NCT00450385|4153880|P1|Overall Study|Protocol Violation|1
1269330|NCT00450385|4153880|P1|Overall Study|Death|3
1269331|NCT00450372|4153889|P1|Overall Study|Physician Decision|1
1269332|NCT00450333|4153902|P4|Overall Study|Death|2
1269333|NCT00450333|4153903|P3|Overall Study|Death|2
1269334|NCT00450333|4153904|P2|Overall Study|Death|2
1269335|NCT00450333|4153905|P1|Overall Study|Death|3
1269336|NCT00450333|4153902|P4|Overall Study|Kidney transplant|3
1269337|NCT00450333|4153903|P3|Overall Study|Kidney transplant|1
1269338|NCT00450333|4153904|P2|Overall Study|Kidney transplant|0
1269339|NCT00450333|4153905|P1|Overall Study|Kidney transplant|1
1269340|NCT00450333|4153902|P4|Overall Study|Withdrawal by Subject|0
1269341|NCT00450333|4153903|P3|Overall Study|Withdrawal by Subject|3
1269342|NCT00450333|4153904|P2|Overall Study|Withdrawal by Subject|0
1269343|NCT00450333|4153905|P1|Overall Study|Withdrawal by Subject|1
1269344|NCT00450333|4153902|P4|Overall Study|Protocol Violation|0
1269345|NCT00450333|4153903|P3|Overall Study|Protocol Violation|1
1269346|NCT00450333|4153904|P2|Overall Study|Protocol Violation|0
1269347|NCT00450333|4153905|P1|Overall Study|Protocol Violation|1
1269348|NCT00450333|4153902|P4|Overall Study|Adverse Event|2
1269349|NCT00450333|4153903|P3|Overall Study|Adverse Event|2
1269350|NCT00450333|4153904|P2|Overall Study|Adverse Event|7
1269351|NCT00450333|4153905|P1|Overall Study|Adverse Event|1
1269352|NCT00450333|4153902|P4|Overall Study|Study terminated|21
1269353|NCT00450333|4153903|P3|Overall Study|Study terminated|16
1269354|NCT00450333|4153904|P2|Overall Study|Study terminated|54
1269355|NCT00450333|4153905|P1|Overall Study|Study terminated|47
1269356|NCT00450255|4153928|P1|Overall Study|Prior RFA ablation of liver|1
1269357|NCT00450216|4153953|P2|Overall Study|misc|20
1269358|NCT00450216|4153954|P1|Overall Study|misc|21
1269359|NCT00450216|4153953|P2|Overall Study|upper gastrointestinal (UGI) ulcer|51
1269360|NCT00450216|4153954|P1|Overall Study|upper gastrointestinal (UGI) ulcer|51
1269361|NCT00450216|4153953|P2|Overall Study|Lost to Follow-up|9
1269362|NCT00450216|4153954|P1|Overall Study|Lost to Follow-up|16
1269363|NCT00450216|4153953|P2|Overall Study|Withdrawal by Subject|26
1269364|NCT00450216|4153954|P1|Overall Study|Withdrawal by Subject|48
1269365|NCT00450216|4153953|P2|Overall Study|Adverse Event|23
1269366|NCT00450216|4153954|P1|Overall Study|Adverse Event|38
1269367|NCT00450190|4153966|P1|Overall Study|Withdrawal by Subject|2
1269368|NCT00450112|4153976|P2|Overall Study|Others|3
1269369|NCT00450112|4153977|P1|Overall Study|Others|2
1269370|NCT00450112|4153976|P2|Overall Study|Lost to Follow-up|1
1269371|NCT00450112|4153977|P1|Overall Study|Lost to Follow-up|2
1269372|NCT00450112|4153976|P2|Overall Study|Withdrawal by Subject|1
1269373|NCT00450112|4153977|P1|Overall Study|Withdrawal by Subject|4
1269374|NCT00450112|4153976|P2|Overall Study|Other Treatment Required|1
1269375|NCT00450112|4153977|P1|Overall Study|Other Treatment Required|5
1269376|NCT00449956|4154015|P3|Overall Study|Physician Decision|1
1269377|NCT00449956|4154016|P2|Overall Study|Physician Decision|1
1269378|NCT00449956|4154017|P1|Overall Study|Physician Decision|2
1269379|NCT00449956|4154015|P3|Overall Study|Withdrawal by Subject|0
1269380|NCT00449956|4154016|P2|Overall Study|Withdrawal by Subject|1
1269381|NCT00449956|4154017|P1|Overall Study|Withdrawal by Subject|0
1269382|NCT00449956|4154015|P3|Overall Study|Protocol Violation|1
1269383|NCT00449956|4154016|P2|Overall Study|Protocol Violation|1
1269384|NCT00449956|4154017|P1|Overall Study|Protocol Violation|1
1269385|NCT00449956|4154015|P3|Overall Study|Lack of Efficacy|1
1269386|NCT00449956|4154016|P2|Overall Study|Lack of Efficacy|0
1269387|NCT00449956|4154017|P1|Overall Study|Lack of Efficacy|0
1269388|NCT00449956|4154015|P3|Overall Study|Adverse Event|6
1269389|NCT00449956|4154016|P2|Overall Study|Adverse Event|1
1269390|NCT00449956|4154017|P1|Overall Study|Adverse Event|7
1269391|NCT00449930|4154033|P2|Overall Study|Glycemic discontinuation criteria|1
1269392|NCT00449930|4154034|P1|Overall Study|Glycemic discontinuation criteria|1
1269393|NCT00449930|4154033|P2|Overall Study|Withdrawal by Subject|23
1269394|NCT00449930|4154034|P1|Overall Study|Withdrawal by Subject|16
1269395|NCT00449930|4154033|P2|Overall Study|Protocol Violation|15
1269396|NCT00449930|4154034|P1|Overall Study|Protocol Violation|14
1269397|NCT00449930|4154033|P2|Overall Study|Physician Decision|2
1269398|NCT00449930|4154034|P1|Overall Study|Physician Decision|1
1269399|NCT00449930|4154033|P2|Overall Study|Lost to Follow-up|14
1269400|NCT00449930|4154034|P1|Overall Study|Lost to Follow-up|9
1269401|NCT00449930|4154033|P2|Overall Study|Lack of Efficacy|1
1269402|NCT00449930|4154034|P1|Overall Study|Lack of Efficacy|10
1269403|NCT00449930|4154033|P2|Overall Study|Trial Terminated ( Site Closed)|0
1269404|NCT00449930|4154034|P1|Overall Study|Trial Terminated ( Site Closed)|1
1269405|NCT00449930|4154033|P2|Overall Study|Adverse Event|19
1269406|NCT00449930|4154034|P1|Overall Study|Adverse Event|9
1269407|NCT00449865|4154050|P2|Overall Study|Study was stopped|328
1269408|NCT00449865|4154051|P1|Overall Study|Study was stopped|324
1269409|NCT00449865|4154050|P2|Overall Study|Protocol Violation|7
1269410|NCT00449865|4154051|P1|Overall Study|Protocol Violation|8
1269411|NCT00449865|4154050|P2|Overall Study|Death|40
1269412|NCT00449865|4154051|P1|Overall Study|Death|31
1269413|NCT00449865|4154050|P2|Overall Study|Physician Decision|12
1269414|NCT00449865|4154051|P1|Overall Study|Physician Decision|13
1269415|NCT00449865|4154050|P2|Overall Study|Lost to Follow-up|37
1269416|NCT00449865|4154051|P1|Overall Study|Lost to Follow-up|36
1269417|NCT00449865|4154050|P2|Overall Study|Withdrawal by Subject|110
1269418|NCT00449865|4154051|P1|Overall Study|Withdrawal by Subject|110
1269419|NCT00449787|4154059|P2|Overall Study|Did not require medication|92
1269420|NCT00449787|4154060|P1|Overall Study|Did not require medication|95
1269421|NCT00449787|4154059|P2|Overall Study|Lost to Follow-up|8
1269422|NCT00449787|4154060|P1|Overall Study|Lost to Follow-up|10
1269423|NCT00449696|4154076|P2|Overall Study|Others|0
1269424|NCT00449696|4154077|P1|Overall Study|Others|7
1269425|NCT00449696|4154076|P2|Overall Study|Lost to Follow-up|3
1269426|NCT00449696|4154077|P1|Overall Study|Lost to Follow-up|2
1269427|NCT00449696|4154076|P2|Overall Study|Withdrawal by Subject|5
1269428|NCT00449696|4154077|P1|Overall Study|Withdrawal by Subject|5
1269429|NCT00449696|4154076|P2|Overall Study|Other Treatment Required|1
1269430|NCT00449696|4154077|P1|Overall Study|Other Treatment Required|6
1269431|NCT00449644|4154103|P4|Overall Study|Rolled-over to treatment with TMC207|1
1269432|NCT00449644|4154104|P3|Overall Study|Rolled-over to treatment with TMC207|0
1269433|NCT00449644|4154105|P2|Overall Study|Rolled-over to treatment with TMC207|0
1269434|NCT00449644|4154106|P1|Overall Study|Rolled-over to treatment with TMC207|0
1269435|NCT00449644|4154103|P4|Overall Study|Not specified|0
1269436|NCT00449644|4154104|P3|Overall Study|Not specified|1
1269437|NCT00449644|4154105|P2|Overall Study|Not specified|4
1269438|NCT00449644|4154106|P1|Overall Study|Not specified|1
1269439|NCT00449644|4154103|P4|Overall Study|Inclusion/exclusion criteria not met|6
1269440|NCT00449644|4154104|P3|Overall Study|Inclusion/exclusion criteria not met|2
1269441|NCT00449644|4154105|P2|Overall Study|Inclusion/exclusion criteria not met|0
1269442|NCT00449644|4154106|P1|Overall Study|Inclusion/exclusion criteria not met|0
1269443|NCT00449644|4154103|P4|Overall Study|Withdrawal by Subject|7
1269444|NCT00449644|4154104|P3|Overall Study|Withdrawal by Subject|6
1269445|NCT00449644|4154105|P2|Overall Study|Withdrawal by Subject|4
1269446|NCT00449644|4154106|P1|Overall Study|Withdrawal by Subject|3
1269447|NCT00449644|4154103|P4|Overall Study|Protocol Violation|7
1269448|NCT00449644|4154104|P3|Overall Study|Protocol Violation|3
1269449|NCT00449644|4154105|P2|Overall Study|Protocol Violation|4
1269450|NCT00449644|4154106|P1|Overall Study|Protocol Violation|4
1269451|NCT00449644|4154103|P4|Overall Study|Pregnancy|2
1269452|NCT00449644|4154104|P3|Overall Study|Pregnancy|3
1269453|NCT00449644|4154105|P2|Overall Study|Pregnancy|0
1269454|NCT00449644|4154106|P1|Overall Study|Pregnancy|0
1269455|NCT00449644|4154103|P4|Overall Study|Lost to Follow-up|3
1269456|NCT00449644|4154104|P3|Overall Study|Lost to Follow-up|5
1269457|NCT00449644|4154105|P2|Overall Study|Lost to Follow-up|1
1269458|NCT00449644|4154106|P1|Overall Study|Lost to Follow-up|1
1269459|NCT00449644|4154103|P4|Overall Study|Death|1
1269460|NCT00449644|4154104|P3|Overall Study|Death|6
1269461|NCT00449644|4154105|P2|Overall Study|Death|0
1269462|NCT00449644|4154106|P1|Overall Study|Death|1
1269463|NCT00449644|4154103|P4|Overall Study|Adverse Event|5
1269464|NCT00449644|4154104|P3|Overall Study|Adverse Event|3
1269465|NCT00449644|4154105|P2|Overall Study|Adverse Event|0
1269466|NCT00449644|4154106|P1|Overall Study|Adverse Event|0
1269467|NCT00449540|4154126|P3|Treatment Phase|did not experience or treat migraine|17
1269468|NCT00449540|4154127|P2|Treatment Phase|did not experience or treat migraine|20
1269469|NCT00449540|4154128|P1|Treatment Phase|did not experience or treat migraine|0
1269470|NCT00449540|4154126|P3|Pretreatment Phase|No migraine experienced|0
1269471|NCT00449540|4154127|P2|Pretreatment Phase|No migraine experienced|0
1269472|NCT00449540|4154128|P1|Pretreatment Phase|No migraine experienced|66
1269473|NCT00449176|4154145|P3|Overall Study|all other|20
1269474|NCT00449176|4154146|P2|Overall Study|all other|19
1269475|NCT00449176|4154147|P1|Overall Study|all other|22
1269476|NCT00449176|4154145|P3|Overall Study|Study drug non-compliant|11
1269477|NCT00449176|4154146|P2|Overall Study|Study drug non-compliant|11
1269478|NCT00449176|4154147|P1|Overall Study|Study drug non-compliant|14
1269479|NCT00449176|4154145|P3|Overall Study|Lack of Efficacy|50
1269480|NCT00449176|4154146|P2|Overall Study|Lack of Efficacy|7
1269481|NCT00449176|4154147|P1|Overall Study|Lack of Efficacy|13
1269482|NCT00449176|4154145|P3|Overall Study|Adverse Event|15
1269483|NCT00449176|4154146|P2|Overall Study|Adverse Event|107
1269484|NCT00449176|4154147|P1|Overall Study|Adverse Event|51
1269485|NCT00449176|4154145|P3|Overall Study|Lost to Follow-up|12
1269486|NCT00449176|4154146|P2|Overall Study|Lost to Follow-up|8
1269487|NCT00449176|4154147|P1|Overall Study|Lost to Follow-up|13
1269488|NCT00449176|4154145|P3|Overall Study|Withdrawal by Subject|59
1269489|NCT00449176|4154146|P2|Overall Study|Withdrawal by Subject|43
1269490|NCT00449176|4154147|P1|Overall Study|Withdrawal by Subject|39
1269491|NCT00449163|4154173|P1|Overall Study|Physician Decision|3
1269492|NCT00449150|4154183|P3|Overall Study|Protocol Violation|1
1269493|NCT00449150|4154184|P2|Overall Study|Protocol Violation|2
1269494|NCT00449150|4154185|P1|Overall Study|Protocol Violation|1
1269495|NCT00449150|4154183|P3|Overall Study|Withdrawal by Subject|21
1269496|NCT00449150|4154184|P2|Overall Study|Withdrawal by Subject|18
1269497|NCT00449150|4154185|P1|Overall Study|Withdrawal by Subject|17
1269498|NCT00449150|4154183|P3|Overall Study|Not specified|14
1269499|NCT00449150|4154184|P2|Overall Study|Not specified|13
1269500|NCT00449150|4154185|P1|Overall Study|Not specified|16
1269501|NCT00449150|4154183|P3|Overall Study|Lack of Efficacy|2
1269502|NCT00449150|4154184|P2|Overall Study|Lack of Efficacy|2
1269503|NCT00449150|4154185|P1|Overall Study|Lack of Efficacy|1
1269504|NCT00449150|4154183|P3|Overall Study|Adverse Event|9
1269505|NCT00449150|4154184|P2|Overall Study|Adverse Event|18
1269506|NCT00449150|4154185|P1|Overall Study|Adverse Event|11
1269507|NCT00449072|4154198|P2|Overall Study|Relocation|2
1269508|NCT00449072|4154199|P1|Overall Study|Relocation|3
1269509|NCT00449072|4154198|P2|Overall Study|Sponsor decision|3
1269510|NCT00449072|4154199|P1|Overall Study|Sponsor decision|1
1269511|NCT00449072|4154198|P2|Overall Study|Non-compliance|5
1269512|NCT00449072|4154199|P1|Overall Study|Non-compliance|2
1269513|NCT00449072|4154198|P2|Overall Study|Excluded medication|2
1269514|NCT00449072|4154199|P1|Overall Study|Excluded medication|0
1269515|NCT00449072|4154198|P2|Overall Study|Not treated|1
1269516|NCT00449072|4154199|P1|Overall Study|Not treated|0
1269517|NCT00449072|4154198|P2|Overall Study|Physician Decision|0
1269518|NCT00449072|4154199|P1|Overall Study|Physician Decision|1
1269519|NCT00449072|4154198|P2|Overall Study|Lack of Efficacy|1
1269520|NCT00449072|4154199|P1|Overall Study|Lack of Efficacy|1
1269521|NCT00449072|4154198|P2|Overall Study|Withdrawal by Subject|8
1269522|NCT00449072|4154199|P1|Overall Study|Withdrawal by Subject|11
1269523|NCT00449072|4154198|P2|Overall Study|Lost to Follow-up|7
1269524|NCT00449072|4154199|P1|Overall Study|Lost to Follow-up|5
1269525|NCT00449072|4154198|P2|Overall Study|Protocol Violation|12
1269526|NCT00449072|4154199|P1|Overall Study|Protocol Violation|14
1269527|NCT00449072|4154198|P2|Overall Study|Adverse Event|1
1269528|NCT00449072|4154199|P1|Overall Study|Adverse Event|3
1269529|NCT00449033|4154236|P2|Follow-up Period|Reason Missing|113
1269530|NCT00449033|4154237|P1|Follow-up Period|Reason Missing|120
1269531|NCT00449033|4154236|P2|Follow-up Period|Lost to Follow-up|10
1269532|NCT00449033|4154237|P1|Follow-up Period|Lost to Follow-up|6
1269533|NCT00449033|4154236|P2|Follow-up Period|Death|311
1269534|NCT00449033|4154237|P1|Follow-up Period|Death|299
1269535|NCT00449033|4154236|P2|Treatment Period|Treatment Ongoing|4
1269536|NCT00449033|4154237|P1|Treatment Period|Treatment Ongoing|6
1269537|NCT00449033|4154236|P2|Treatment Period|Reason Missing|4
1269538|NCT00449033|4154237|P1|Treatment Period|Reason Missing|0
1269539|NCT00449033|4154236|P2|Treatment Period|Second Malignancy|1
1269540|NCT00449033|4154237|P1|Treatment Period|Second Malignancy|0
1269541|NCT00449033|4154236|P2|Treatment Period|Non-compliance|8
1269542|NCT00449033|4154237|P1|Treatment Period|Non-compliance|7
1269543|NCT00449033|4154236|P2|Treatment Period|Amended Protocol Criteria|18
1269544|NCT00449033|4154237|P1|Treatment Period|Amended Protocol Criteria|22
1269545|NCT00449033|4154236|P2|Treatment Period|Consent Withdrawn|20
1269546|NCT00449033|4154237|P1|Treatment Period|Consent Withdrawn|36
1269547|NCT00449033|4154236|P2|Treatment Period|Disease Progression|288
1269548|NCT00449033|4154237|P1|Treatment Period|Disease Progression|231
1269549|NCT00449033|4154236|P2|Treatment Period|Protocol Violation|7
1269550|NCT00449033|4154237|P1|Treatment Period|Protocol Violation|8
1269551|NCT00449033|4154236|P2|Treatment Period|Physician Decision|5
1269552|NCT00449033|4154237|P1|Treatment Period|Physician Decision|4
1269553|NCT00449033|4154236|P2|Treatment Period|Lost to Follow-up|2
1269554|NCT00449033|4154237|P1|Treatment Period|Lost to Follow-up|0
1269555|NCT00449033|4154236|P2|Treatment Period|Death|12
1269556|NCT00449033|4154237|P1|Treatment Period|Death|21
1269557|NCT00449033|4154236|P2|Treatment Period|Adverse Event|83
1269558|NCT00449033|4154237|P1|Treatment Period|Adverse Event|117
1269559|NCT00448916|4154275|P4|Overall Study|Protocol Violation|1
1269560|NCT00448916|4154276|P3|Overall Study|Protocol Violation|0
1269561|NCT00448916|4154277|P2|Overall Study|Protocol Violation|0
1269562|NCT00448916|4154278|P1|Overall Study|Protocol Violation|0
1269563|NCT00448916|4154275|P4|Overall Study|Lost to Follow-up|1
1269564|NCT00448916|4154276|P3|Overall Study|Lost to Follow-up|0
1269565|NCT00448916|4154277|P2|Overall Study|Lost to Follow-up|1
1269566|NCT00448916|4154278|P1|Overall Study|Lost to Follow-up|0
1269567|NCT00448916|4154275|P4|Overall Study|Not specified|0
1269568|NCT00448916|4154276|P3|Overall Study|Not specified|0
1269569|NCT00448916|4154277|P2|Overall Study|Not specified|0
1269570|NCT00448916|4154278|P1|Overall Study|Not specified|1
1269571|NCT00448916|4154275|P4|Overall Study|Withdrawal by Subject|1
1269572|NCT00448916|4154276|P3|Overall Study|Withdrawal by Subject|1
1269573|NCT00448916|4154277|P2|Overall Study|Withdrawal by Subject|3
1269574|NCT00448916|4154278|P1|Overall Study|Withdrawal by Subject|3
1269575|NCT00448916|4154275|P4|Overall Study|Lack of Efficacy|1
1269576|NCT00448916|4154276|P3|Overall Study|Lack of Efficacy|2
1269577|NCT00448916|4154277|P2|Overall Study|Lack of Efficacy|0
1269578|NCT00448916|4154278|P1|Overall Study|Lack of Efficacy|1
1269579|NCT00448916|4154275|P4|Overall Study|Adverse Event|2
1269580|NCT00448916|4154276|P3|Overall Study|Adverse Event|3
1269581|NCT00448916|4154277|P2|Overall Study|Adverse Event|2
1269582|NCT00448916|4154278|P1|Overall Study|Adverse Event|2
1269583|NCT00448864|4154352|P3|Overall Study|Protocol Violation|0
1269584|NCT00448864|4154353|P2|Overall Study|Protocol Violation|2
1269585|NCT00448864|4154354|P1|Overall Study|Protocol Violation|0
1269586|NCT00448864|4154352|P3|Overall Study|Withdrawal by Subject|0
1269587|NCT00448864|4154353|P2|Overall Study|Withdrawal by Subject|2
1269588|NCT00448864|4154354|P1|Overall Study|Withdrawal by Subject|0
1269589|NCT00448864|4154352|P3|Overall Study|Physician Decision|1
1269590|NCT00448864|4154353|P2|Overall Study|Physician Decision|0
1269591|NCT00448864|4154354|P1|Overall Study|Physician Decision|1
1269592|NCT00448864|4154352|P3|Overall Study|Lost to Follow-up|0
1269593|NCT00448864|4154353|P2|Overall Study|Lost to Follow-up|1
1269594|NCT00448864|4154354|P1|Overall Study|Lost to Follow-up|3
1269595|NCT00448864|4154352|P3|Overall Study|Death|0
1269596|NCT00448864|4154353|P2|Overall Study|Death|0
1269597|NCT00448864|4154354|P1|Overall Study|Death|1
1269598|NCT00448760|4154370|P1|Overall Study|Death|3
1269599|NCT00448708|4154379|P2|Overall Study|not listed|2
1269600|NCT00448708|4154380|P1|Overall Study|not listed|0
1269601|NCT00448708|4154379|P2|Overall Study|Lost to Follow-up|8
1269602|NCT00448708|4154380|P1|Overall Study|Lost to Follow-up|6
1269603|NCT00448708|4154379|P2|Overall Study|Withdrawal by Subject|4
1269604|NCT00448708|4154380|P1|Overall Study|Withdrawal by Subject|8
1269605|NCT00448708|4154379|P2|Overall Study|Death|17
1269606|NCT00448708|4154380|P1|Overall Study|Death|21
1269607|NCT00448591|4154439|P1|Overall Study|Termination of Study|70
1269608|NCT00448591|4154439|P1|Overall Study|Not specified|154
1269609|NCT00448591|4154439|P1|Overall Study|Treatment Regimen Completed|70
1269610|NCT00448591|4154439|P1|Overall Study|Lost to Follow-up|19
1269611|NCT00448591|4154439|P1|Overall Study|Protocol Violation|41
1269612|NCT00448591|4154439|P1|Overall Study|Adverse Event|382
1269613|NCT00448591|4154439|P1|Overall Study|Progressive Disease|1382
1269614|NCT00448591|4154439|P1|Overall Study|Withdrawal by Subject|178
1269615|NCT00448539|4154450|P2|Overall Study|Lost to Follow-up|3
1269616|NCT00448539|4154451|P1|Overall Study|Lost to Follow-up|1
1269617|NCT00448539|4154450|P2|Overall Study|Change of meds|3
1269618|NCT00448539|4154451|P1|Overall Study|Change of meds|2
1269619|NCT00448539|4154450|P2|Overall Study|Miscellaneous|1
1269620|NCT00448539|4154451|P1|Overall Study|Miscellaneous|2
1269621|NCT00448539|4154450|P2|Overall Study|Lack of Efficacy|40
1269622|NCT00448539|4154451|P1|Overall Study|Lack of Efficacy|27
1269623|NCT00448539|4154450|P2|Overall Study|Adverse Event|26
1269624|NCT00448539|4154451|P1|Overall Study|Adverse Event|9
1269625|NCT00448539|4154450|P2|Overall Study|Diary non-compliance|0
1269626|NCT00448539|4154451|P1|Overall Study|Diary non-compliance|1
1269627|NCT00448539|4154450|P2|Overall Study|Withdrawal by Subject|24
1269628|NCT00448539|4154451|P1|Overall Study|Withdrawal by Subject|20
1269629|NCT00448539|4154450|P2|Overall Study|Request of the investigator or sponsor|54
1269630|NCT00448539|4154451|P1|Overall Study|Request of the investigator or sponsor|67
1269631|NCT00448539|4154450|P2|Overall Study|Protocol Violation|0
1269632|NCT00448539|4154451|P1|Overall Study|Protocol Violation|1
1269633|NCT00448539|4154450|P2|Overall Study|Medication non-compliance|1
1269634|NCT00448539|4154451|P1|Overall Study|Medication non-compliance|4
1269635|NCT00448448|4154459|P2|Overall Study|Signed consent lost|1
1269636|NCT00448448|4154460|P1|Overall Study|Signed consent lost|0
1269637|NCT00448448|4154459|P2|Overall Study|Wrong diagnosis (n=3) or other|1
1269638|NCT00448448|4154460|P1|Overall Study|Wrong diagnosis (n=3) or other|2
1269639|NCT00448448|4154459|P2|Overall Study|Lost to Follow-up|1
1269640|NCT00448448|4154460|P1|Overall Study|Lost to Follow-up|2
1269641|NCT00448448|4154459|P2|Overall Study|On protocol when study ended|36
1269642|NCT00448448|4154460|P1|Overall Study|On protocol when study ended|83
1269643|NCT00448448|4154459|P2|Overall Study|Withdrawal by Subject|2
1269644|NCT00448448|4154460|P1|Overall Study|Withdrawal by Subject|13
1269645|NCT00448435|4154466|P2|Washout Period - 2 Weeks|Withdrawal by Subject|0
1269646|NCT00448435|4154467|P1|Washout Period - 2 Weeks|Withdrawal by Subject|1
1269647|NCT00448344|4154518|P2|Overall Study|Physician Decision|2
1269648|NCT00448344|4154519|P1|Overall Study|Physician Decision|1
1269649|NCT00448344|4154518|P2|Overall Study|Death|4
1269650|NCT00448344|4154519|P1|Overall Study|Death|3
1269651|NCT00448344|4154518|P2|Overall Study|Withdrawal by Subject|8
1269652|NCT00448344|4154519|P1|Overall Study|Withdrawal by Subject|6
1269653|NCT00448344|4154518|P2|Overall Study|Lost to Follow-up|22
1269654|NCT00448344|4154519|P1|Overall Study|Lost to Follow-up|20
1269655|NCT00448279|4154529|P2|Overall Study|Protocol Violation|1
1269656|NCT00448279|4154530|P1|Overall Study|Protocol Violation|0
1269657|NCT00448279|4154529|P2|Overall Study|Not specified|4
1269658|NCT00448279|4154530|P1|Overall Study|Not specified|6
1269659|NCT00448279|4154529|P2|Overall Study|Withdrawal by Subject|3
1269660|NCT00448279|4154530|P1|Overall Study|Withdrawal by Subject|4
1269661|NCT00448279|4154529|P2|Overall Study|Disease progression|18
1269662|NCT00448279|4154530|P1|Overall Study|Disease progression|16
1269663|NCT00448279|4154529|P2|Overall Study|Adverse Event|1
1269664|NCT00448279|4154530|P1|Overall Study|Adverse Event|1
1269665|NCT00448279|4154529|P2|Overall Study|Lost to Follow-up|2
1269666|NCT00448279|4154530|P1|Overall Study|Lost to Follow-up|2
1269667|NCT00448136|4154593|P2|Overall Study|Investigator's decision (progression)|0
1269668|NCT00448136|4154594|P1|Overall Study|Investigator's decision (progression)|1
1269669|NCT00448136|4154593|P2|Overall Study|Death|8
1269670|NCT00448136|4154594|P1|Overall Study|Death|3
1269671|NCT00448123|4154632|P2|Overall Study|Physician Decision|6
1269672|NCT00448123|4154633|P1|Overall Study|Physician Decision|6
1269673|NCT00448123|4154632|P2|Overall Study|Lost to Follow-up|6
1269674|NCT00448123|4154633|P1|Overall Study|Lost to Follow-up|9
1269675|NCT00448019|4154643|P1|Overall Study|Insurance Issues|1
1269676|NCT00448019|4154643|P1|Overall Study|Death|2
1269677|NCT00448019|4154643|P1|Overall Study|Disease progression|1
1269678|NCT00448019|4154643|P1|Overall Study|Withdrawal by Subject|3
1269679|NCT00447902|4154651|P2|Overall Study|Lack of Efficacy|1
1269680|NCT00447902|4154652|P1|Overall Study|Lack of Efficacy|2
1269681|NCT00447902|4154651|P2|Overall Study|included patients who discontinued|1
1269682|NCT00447902|4154652|P1|Overall Study|included patients who discontinued|1
1269683|NCT00447902|4154651|P2|Overall Study|Withdrawal by Subject|1
1269684|NCT00447902|4154652|P1|Overall Study|Withdrawal by Subject|0
1269685|NCT00447902|4154651|P2|Overall Study|Protocol Violation|0
1269686|NCT00447902|4154652|P1|Overall Study|Protocol Violation|1
1269687|NCT00447902|4154651|P2|Overall Study|Adverse Event|3
1269688|NCT00447902|4154652|P1|Overall Study|Adverse Event|0
1269689|NCT00447876|4154694|P2|Overall Study|Deterioration of symptomology|0
1269690|NCT00447876|4154695|P1|Overall Study|Deterioration of symptomology|1
1269691|NCT00447876|4154694|P2|Overall Study|Lost to Follow-up|0
1269692|NCT00447876|4154695|P1|Overall Study|Lost to Follow-up|1
1269693|NCT00447876|4154694|P2|Overall Study|Withdrawal by Subject|4
1269694|NCT00447876|4154695|P1|Overall Study|Withdrawal by Subject|1
1269695|NCT00447772|4154725|P1|Overall Study|Premature re-injection required|1
1269696|NCT00447772|4154725|P1|Overall Study|Chemotherapy for lung cancer|1
1269697|NCT00447772|4154725|P1|Overall Study|Incomplete documentation at visit 1|1
1269698|NCT00447772|4154725|P1|Overall Study|Patient relocated|1
1269699|NCT00447772|4154725|P1|Overall Study|Adverse Event|1
1269700|NCT00447772|4154725|P1|Overall Study|Unable to attend all study visits|2
1269701|NCT00447772|4154725|P1|Overall Study|Withdrawal by Subject|1
1269702|NCT00447772|4154725|P1|Overall Study|Lost to Follow-up|9
1269703|NCT00447772|4154725|P1|Overall Study|Discontinuation of drug therapy|1
1269704|NCT00447772|4154725|P1|Overall Study|Insufficient compliance|6
1269705|NCT00447772|4154725|P1|Overall Study|Lack of Efficacy|3
1269706|NCT00447603|4154745|P3|Filter Period|Study terminated by Sponsor|10
1269707|NCT00447603|4154746|P2|Filter Period|Study terminated by Sponsor|1
1269708|NCT00447603|4154747|P1|Filter Period|Study terminated by Sponsor|0
1269709|NCT00447603|4154745|P3|Filter Period|Screen Failure|4
1269710|NCT00447603|4154746|P2|Filter Period|Screen Failure|3
1269711|NCT00447603|4154747|P1|Filter Period|Screen Failure|0
1269712|NCT00447603|4154745|P3|Filter Period|Adverse Event|1
1269713|NCT00447603|4154746|P2|Filter Period|Adverse Event|0
1269714|NCT00447603|4154747|P1|Filter Period|Adverse Event|0
1269715|NCT00447603|4154745|P3|Screening|Study Terminated by Sponsor|0
1269716|NCT00447603|4154746|P2|Screening|Study Terminated by Sponsor|0
1269717|NCT00447603|4154747|P1|Screening|Study Terminated by Sponsor|15
1269718|NCT00447603|4154745|P3|Screening|Screen Failure|0
1269719|NCT00447603|4154746|P2|Screening|Screen Failure|0
1269720|NCT00447603|4154747|P1|Screening|Screen Failure|4
1269721|NCT00447603|4154745|P3|Screening|Protocol Violation|0
1269722|NCT00447603|4154746|P2|Screening|Protocol Violation|0
1269723|NCT00447603|4154747|P1|Screening|Protocol Violation|1
1269724|NCT00447603|4154745|P3|Screening|Withdrawal by Subject|0
1269725|NCT00447603|4154746|P2|Screening|Withdrawal by Subject|0
1269726|NCT00447603|4154747|P1|Screening|Withdrawal by Subject|1
1269727|NCT00447590|4154767|P1|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10
1269728|NCT00447590|4154767|P1|Overall Study|Lost to Follow-up|24
1269729|NCT00447590|4154767|P1|Overall Study|Withdrawal by Subject|26
1269730|NCT00447499|4154776|P1|Overall Study|Physician Decision|1
1269731|NCT00447499|4154776|P1|Overall Study|Sponsor Decision|1
1269732|NCT00447499|4154776|P1|Overall Study|Patient Decision|4
1269733|NCT00447499|4154776|P1|Overall Study|Adverse Event|1
1269734|NCT00447421|4154786|P1|Overall Study|Sponsor Decision|2
1269735|NCT00447421|4154786|P1|Overall Study|Adverse Event|3
1269736|NCT00447421|4154786|P1|Overall Study|Lack of Efficacy|1
1269737|NCT00447382|4154798|P2|Overall Study|Unclassified|5
1269738|NCT00447382|4154799|P1|Overall Study|Unclassified|2
1269739|NCT00447382|4154798|P2|Overall Study|Protocol Violation|0
1269740|NCT00447382|4154799|P1|Overall Study|Protocol Violation|2
1269741|NCT00447382|4154798|P2|Overall Study|Lack of Efficacy|0
1269742|NCT00447382|4154799|P1|Overall Study|Lack of Efficacy|1
1269743|NCT00447382|4154798|P2|Overall Study|Adverse Event|1
1269744|NCT00447382|4154799|P1|Overall Study|Adverse Event|1
1269745|NCT00447278|4154860|P2|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8
1269746|NCT00447278|4154861|P1|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11
1269747|NCT00447278|4154860|P2|Period III (Optional 6 Month Extension)|Lack of Efficacy|0
1269748|NCT00447278|4154861|P1|Period III (Optional 6 Month Extension)|Lack of Efficacy|4
1269749|NCT00447278|4154860|P2|Period III (Optional 6 Month Extension)|Physician Decision|1
1269750|NCT00447278|4154861|P1|Period III (Optional 6 Month Extension)|Physician Decision|1
1269751|NCT00447278|4154860|P2|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1
1269752|NCT00447278|4154861|P1|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4
1269753|NCT00447278|4154860|P2|Period III (Optional 6 Month Extension)|Protocol Violation|1
1269754|NCT00447278|4154861|P1|Period III (Optional 6 Month Extension)|Protocol Violation|6
1269755|NCT00447278|4154860|P2|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
1269756|NCT00447278|4154861|P1|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
1269757|NCT00447278|4154860|P2|Period III (Optional 6 Month Extension)|Adverse Event|2
1269758|NCT00447278|4154861|P1|Period III (Optional 6 Month Extension)|Adverse Event|2
1269759|NCT00447278|4154860|P2|Period II (6 Month Open-Label)|Parent/Guardian Decision|10
1269760|NCT00447278|4154861|P1|Period II (6 Month Open-Label)|Parent/Guardian Decision|9
1269761|NCT00447278|4154860|P2|Period II (6 Month Open-Label)|Lack of Efficacy|1
1269762|NCT00447278|4154861|P1|Period II (6 Month Open-Label)|Lack of Efficacy|11
1269763|NCT00447278|4154860|P2|Period II (6 Month Open-Label)|Physician Decision|1
1269764|NCT00447278|4154861|P1|Period II (6 Month Open-Label)|Physician Decision|4
1269765|NCT00447278|4154860|P2|Period II (6 Month Open-Label)|Withdrawal by Subject|3
1269766|NCT00447278|4154861|P1|Period II (6 Month Open-Label)|Withdrawal by Subject|1
1269767|NCT00447278|4154860|P2|Period II (6 Month Open-Label)|Protocol Violation|7
1269768|NCT00447278|4154861|P1|Period II (6 Month Open-Label)|Protocol Violation|10
1269769|NCT00447278|4154860|P2|Period II (6 Month Open-Label)|Lost to Follow-up|4
1269770|NCT00447278|4154861|P1|Period II (6 Month Open-Label)|Lost to Follow-up|0
1269771|NCT00447278|4154860|P2|Period II (6 Month Open-Label)|Adverse Event|3
1269772|NCT00447278|4154861|P1|Period II (6 Month Open-Label)|Adverse Event|7
1269773|NCT00447265|4154882|P2|Overall Study|Physician Decision|0
1269774|NCT00447265|4154883|P1|Overall Study|Physician Decision|1
1269775|NCT00447226|4154896|P2|Double-blind Phase|Disease Progression|3
1269776|NCT00447226|4154897|P1|Double-blind Phase|Disease Progression|4
1269777|NCT00447226|4154896|P2|12-Week Open-label Phase|Physician Decision|1
1269778|NCT00447226|4154897|P1|12-Week Open-label Phase|Physician Decision|0
1269779|NCT00447226|4154896|P2|12-Week Open-label Phase|Disease Progression|20
1269780|NCT00447226|4154897|P1|12-Week Open-label Phase|Disease Progression|0
1269781|NCT00447226|4154896|P2|12-Week Open-label Phase|Protocol Violation|1
1269782|NCT00447226|4154897|P1|12-Week Open-label Phase|Protocol Violation|0
1269783|NCT00447226|4154896|P2|12-Week Open-label Phase|Adverse Event|3
1269784|NCT00447226|4154897|P1|12-Week Open-label Phase|Adverse Event|0
1269785|NCT00447057|4154940|P4|Overall Study|Death, study drug related|0
1269786|NCT00447057|4154941|P3|Overall Study|Death, study drug related|0
1269787|NCT00447057|4154942|P2|Overall Study|Death, study drug related|1
1269788|NCT00447057|4154943|P1|Overall Study|Death, study drug related|0
1269789|NCT00447057|4154940|P4|Overall Study|Death due to adverse event|2
1269790|NCT00447057|4154941|P3|Overall Study|Death due to adverse event|1
1269791|NCT00447057|4154942|P2|Overall Study|Death due to adverse event|0
1269792|NCT00447057|4154943|P1|Overall Study|Death due to adverse event|0
1269793|NCT00447057|4154940|P4|Overall Study|Progressive disease|18
1269794|NCT00447057|4154941|P3|Overall Study|Progressive disease|13
1269795|NCT00447057|4154942|P2|Overall Study|Progressive disease|43
1269796|NCT00447057|4154943|P1|Overall Study|Progressive disease|58
1269797|NCT00447057|4154940|P4|Overall Study|Sponsor decision|0
1269798|NCT00447057|4154941|P3|Overall Study|Sponsor decision|0
1269799|NCT00447057|4154942|P2|Overall Study|Sponsor decision|1
1269800|NCT00447057|4154943|P1|Overall Study|Sponsor decision|1
1269801|NCT00447057|4154940|P4|Overall Study|Physician Decision|1
1269802|NCT00447057|4154941|P3|Overall Study|Physician Decision|3
1269803|NCT00447057|4154942|P2|Overall Study|Physician Decision|6
1269804|NCT00447057|4154943|P1|Overall Study|Physician Decision|9
1269805|NCT00447057|4154940|P4|Overall Study|Withdrawal by Subject|1
1269806|NCT00447057|4154941|P3|Overall Study|Withdrawal by Subject|1
1269807|NCT00447057|4154942|P2|Overall Study|Withdrawal by Subject|5
1269808|NCT00447057|4154943|P1|Overall Study|Withdrawal by Subject|4
1269809|NCT00447057|4154940|P4|Overall Study|Protocol Violation|0
1269810|NCT00447057|4154941|P3|Overall Study|Protocol Violation|0
1269811|NCT00447057|4154942|P2|Overall Study|Protocol Violation|1
1269812|NCT00447057|4154943|P1|Overall Study|Protocol Violation|0
1269813|NCT00447057|4154940|P4|Overall Study|Entry criteria not met|0
1269814|NCT00447057|4154941|P3|Overall Study|Entry criteria not met|0
1269815|NCT00447057|4154942|P2|Overall Study|Entry criteria not met|1
1269816|NCT00447057|4154943|P1|Overall Study|Entry criteria not met|1
1269817|NCT00447057|4154940|P4|Overall Study|Lost to Follow-up|0
1269818|NCT00447057|4154941|P3|Overall Study|Lost to Follow-up|0
1269819|NCT00447057|4154942|P2|Overall Study|Lost to Follow-up|1
1269820|NCT00447057|4154943|P1|Overall Study|Lost to Follow-up|0
1269821|NCT00447057|4154940|P4|Overall Study|Death due to study disease|1
1269822|NCT00447057|4154941|P3|Overall Study|Death due to study disease|1
1269823|NCT00447057|4154942|P2|Overall Study|Death due to study disease|4
1269824|NCT00447057|4154943|P1|Overall Study|Death due to study disease|6
1269825|NCT00447057|4154940|P4|Overall Study|Adverse Event|3
1269826|NCT00447057|4154941|P3|Overall Study|Adverse Event|0
1269827|NCT00447057|4154942|P2|Overall Study|Adverse Event|10
1269828|NCT00447057|4154943|P1|Overall Study|Adverse Event|4
1269829|NCT00447005|4154961|P1|Overall Study|Lack of Efficacy|11
1269830|NCT00447005|4154961|P1|Overall Study|Adverse Event|1
1269831|NCT00446992|4154975|P1|Overall Study|Lost to Follow-up|5
1269832|NCT00446992|4154975|P1|Overall Study|Adverse Event|11
1269833|NCT00446966|4154989|P2|Overall Study|Lost to Follow-up|7
1269834|NCT00446966|4154990|P1|Overall Study|Lost to Follow-up|10
1269835|NCT00446849|4154996|P1|Maintenance Phase|concomitant medication use|1
1269836|NCT00446849|4154996|P1|Maintenance Phase|hydrocodone use|1
1269837|NCT00446849|4154996|P1|Maintenance Phase|study closure|1
1269838|NCT00446849|4154996|P1|Maintenance Phase|antibiotic use|1
1269839|NCT00446849|4154996|P1|Maintenance Phase|prohibited medication use|2
1269840|NCT00446849|4154996|P1|Maintenance Phase|noncompliance|2
1269841|NCT00446849|4154996|P1|Maintenance Phase|Pregnancy|1
1269842|NCT00446849|4154996|P1|Maintenance Phase|Lost to Follow-up|3
1269843|NCT00446849|4154996|P1|Maintenance Phase|Consent withdrawn|5
1269844|NCT00446849|4154996|P1|Maintenance Phase|Adverse Event|6
1269845|NCT00446849|4154996|P1|Maintenance Phase|Protocol Violation|7
1269846|NCT00446849|4154996|P1|Maintenance Phase|Lack of Efficacy|40
1269847|NCT00446849|4154996|P1|Acute Phase|noncompliance|1
1269848|NCT00446849|4154996|P1|Acute Phase|Physician Decision|1
1269849|NCT00446849|4154996|P1|Acute Phase|Lost to Follow-up|2
1269850|NCT00446849|4154996|P1|Acute Phase|Consent withdrawn|4
1269851|NCT00446849|4154996|P1|Acute Phase|Protocol Violation|10
1269852|NCT00446849|4154996|P1|Acute Phase|Lack of Efficacy|64
1269853|NCT00446797|4155008|P2|Overall Study|did not meet entrance criteria|1
1269854|NCT00446797|4155009|P1|Overall Study|did not meet entrance criteria|0
1269855|NCT00446797|4155008|P2|Overall Study|subject entered at another site|1
1269856|NCT00446797|4155009|P1|Overall Study|subject entered at another site|0
1269857|NCT00446797|4155008|P2|Overall Study|Protocol Violation|3
1269858|NCT00446797|4155009|P1|Overall Study|Protocol Violation|1
1269859|NCT00446797|4155008|P2|Overall Study|Withdrawal by Subject|2
1269860|NCT00446797|4155009|P1|Overall Study|Withdrawal by Subject|2
1269861|NCT00446797|4155008|P2|Overall Study|Lost to Follow-up|3
1269862|NCT00446797|4155009|P1|Overall Study|Lost to Follow-up|5
1269863|NCT00446797|4155008|P2|Overall Study|Lack of Efficacy|2
1269864|NCT00446797|4155009|P1|Overall Study|Lack of Efficacy|0
1269865|NCT00446654|4155055|P2|Overall Study|Adverse Event|0
1269866|NCT00446654|4155056|P1|Overall Study|Adverse Event|1
1269867|NCT00446654|4155055|P2|Overall Study|Withdrawal by Subject|0
1269868|NCT00446654|4155056|P1|Overall Study|Withdrawal by Subject|1
1269869|NCT00446641|4155064|P2|Overall Study|Lost to Follow-up|1
1269870|NCT00446641|4155065|P1|Overall Study|Lost to Follow-up|1
1269871|NCT00446641|4155064|P2|Overall Study|poor compliance|6
1269872|NCT00446641|4155065|P1|Overall Study|poor compliance|8
1269873|NCT00446641|4155064|P2|Overall Study|Withdrawal by Subject|3
1269874|NCT00446641|4155065|P1|Overall Study|Withdrawal by Subject|8
1269875|NCT00446563|4155085|P2|Overall Study|Administrative problems|1
1269876|NCT00446563|4155086|P1|Overall Study|Administrative problems|0
1269877|NCT00446563|4155085|P2|Overall Study|Withdrawal by Subject|1
1269878|NCT00446563|4155086|P1|Overall Study|Withdrawal by Subject|2
1269879|NCT00446563|4155085|P2|Overall Study|Unsatisfactory therapeutic effect|3
1269880|NCT00446563|4155086|P1|Overall Study|Unsatisfactory therapeutic effect|0
1269881|NCT00446563|4155085|P2|Overall Study|Abnormal test procedure result(s)|0
1269882|NCT00446563|4155086|P1|Overall Study|Abnormal test procedure result(s)|1
1269883|NCT00446563|4155085|P2|Overall Study|Abnormal laboratory value(s)|1
1269884|NCT00446563|4155086|P1|Overall Study|Abnormal laboratory value(s)|0
1269885|NCT00446563|4155085|P2|Overall Study|Adverse Event|3
1269886|NCT00446563|4155086|P1|Overall Study|Adverse Event|4
1269887|NCT00446550|4155122|P2|Overall Study|Adverse Event|0
1269888|NCT00446550|4155123|P1|Overall Study|Adverse Event|1
1269889|NCT00446511|4155135|P4|Overall Study|Administrative Problems|1
1269890|NCT00446511|4155136|P3|Overall Study|Administrative Problems|4
1269891|NCT00446511|4155137|P2|Overall Study|Administrative Problems|0
1269892|NCT00446511|4155138|P1|Overall Study|Administrative Problems|3
1269893|NCT00446511|4155135|P4|Overall Study|Withdrawal by Subject|3
1269894|NCT00446511|4155136|P3|Overall Study|Withdrawal by Subject|0
1269895|NCT00446511|4155137|P2|Overall Study|Withdrawal by Subject|0
1269896|NCT00446511|4155138|P1|Overall Study|Withdrawal by Subject|0
1269897|NCT00446511|4155135|P4|Overall Study|Protocol Violation|1
1269898|NCT00446511|4155136|P3|Overall Study|Protocol Violation|0
1269899|NCT00446511|4155137|P2|Overall Study|Protocol Violation|0
1269900|NCT00446511|4155138|P1|Overall Study|Protocol Violation|0
1269901|NCT00446511|4155135|P4|Overall Study|Adverse Event|1
1269902|NCT00446511|4155136|P3|Overall Study|Adverse Event|3
1269903|NCT00446511|4155137|P2|Overall Study|Adverse Event|2
1269904|NCT00446511|4155138|P1|Overall Study|Adverse Event|7
1269905|NCT00446459|4155162|P1|12 Months|14 subjects to MMF + Rituximab Study|14
1269906|NCT00446459|4155162|P1|12 Months|Protocol Violation|4
1269907|NCT00446459|4155162|P1|8 Months|Protocol Violation|12
1269908|NCT00446446|4155170|P1|Overall Study|On Treatment at Time of Data Cut-off|1
1269909|NCT00446446|4155170|P1|Overall Study|Adverse Event|1
1269910|NCT00446446|4155170|P1|Overall Study|Disease Progession|2
1269911|NCT00446446|4155170|P1|Overall Study|Other|4
1269912|NCT00446446|4155170|P1|Overall Study|Withdrawal by Subject|6
1269913|NCT00446446|4155170|P1|Overall Study|Death|10
1269914|NCT00446251|4155194|P1|Overall Study|Lost to Follow-up|1
1269915|NCT00446251|4155194|P1|Overall Study|Rituximab Infusion Reaction|2
1269916|NCT00446251|4155194|P1|Overall Study|On-study Transplants|2
1269917|NCT00446199|4155204|P4|Overall Study|Move|0
1269918|NCT00446199|4155205|P3|Overall Study|Move|0
1269919|NCT00446199|4155206|P2|Overall Study|Move|1
1269920|NCT00446199|4155207|P1|Overall Study|Move|0
1269921|NCT00446199|4155204|P4|Overall Study|In-/Exclusion criterion violated|1
1269922|NCT00446199|4155205|P3|Overall Study|In-/Exclusion criterion violated|2
1269923|NCT00446199|4155206|P2|Overall Study|In-/Exclusion criterion violated|1
1269924|NCT00446199|4155207|P1|Overall Study|In-/Exclusion criterion violated|2
1269925|NCT00446199|4155204|P4|Overall Study|Lost interest in study participation|0
1269926|NCT00446199|4155205|P3|Overall Study|Lost interest in study participation|0
1269927|NCT00446199|4155206|P2|Overall Study|Lost interest in study participation|1
1269928|NCT00446199|4155207|P1|Overall Study|Lost interest in study participation|0
1269929|NCT00446199|4155204|P4|Overall Study|Hormone fear|1
1269930|NCT00446199|4155205|P3|Overall Study|Hormone fear|0
1269931|NCT00446199|4155206|P2|Overall Study|Hormone fear|0
1269932|NCT00446199|4155207|P1|Overall Study|Hormone fear|0
1269933|NCT00446199|4155204|P4|Overall Study|Non-compliant with visit schedule|2
1269934|NCT00446199|4155205|P3|Overall Study|Non-compliant with visit schedule|1
1269935|NCT00446199|4155206|P2|Overall Study|Non-compliant with visit schedule|1
1270025|NCT00446095|4155334|P1|Phase II (8 Weeks)|Physician Decision|1
1269936|NCT00446199|4155207|P1|Overall Study|Non-compliant with visit schedule|1
1269937|NCT00446199|4155204|P4|Overall Study|Non-compliant with study drug|0
1269938|NCT00446199|4155205|P3|Overall Study|Non-compliant with study drug|5
1269939|NCT00446199|4155206|P2|Overall Study|Non-compliant with study drug|0
1269940|NCT00446199|4155207|P1|Overall Study|Non-compliant with study drug|1
1269941|NCT00446199|4155204|P4|Overall Study|Lack of Efficacy|1
1269942|NCT00446199|4155205|P3|Overall Study|Lack of Efficacy|0
1269943|NCT00446199|4155206|P2|Overall Study|Lack of Efficacy|0
1269944|NCT00446199|4155207|P1|Overall Study|Lack of Efficacy|1
1269945|NCT00446199|4155204|P4|Overall Study|Randomization in Error|1
1269946|NCT00446199|4155205|P3|Overall Study|Randomization in Error|1
1269947|NCT00446199|4155206|P2|Overall Study|Randomization in Error|0
1269948|NCT00446199|4155207|P1|Overall Study|Randomization in Error|2
1269949|NCT00446199|4155204|P4|Overall Study|Site termination|1
1269950|NCT00446199|4155205|P3|Overall Study|Site termination|0
1269951|NCT00446199|4155206|P2|Overall Study|Site termination|0
1269952|NCT00446199|4155207|P1|Overall Study|Site termination|2
1269953|NCT00446199|4155204|P4|Overall Study|Withdrawal by Subject|10
1269954|NCT00446199|4155205|P3|Overall Study|Withdrawal by Subject|9
1269955|NCT00446199|4155206|P2|Overall Study|Withdrawal by Subject|5
1269956|NCT00446199|4155207|P1|Overall Study|Withdrawal by Subject|2
1269957|NCT00446199|4155204|P4|Overall Study|Protocol Violation|3
1269958|NCT00446199|4155205|P3|Overall Study|Protocol Violation|1
1269959|NCT00446199|4155206|P2|Overall Study|Protocol Violation|2
1269960|NCT00446199|4155207|P1|Overall Study|Protocol Violation|1
1269961|NCT00446199|4155204|P4|Overall Study|Lost to Follow-up|6
1269962|NCT00446199|4155205|P3|Overall Study|Lost to Follow-up|2
1269963|NCT00446199|4155206|P2|Overall Study|Lost to Follow-up|5
1269964|NCT00446199|4155207|P1|Overall Study|Lost to Follow-up|4
1269965|NCT00446199|4155204|P4|Overall Study|Adverse Event|4
1269966|NCT00446199|4155205|P3|Overall Study|Adverse Event|6
1269967|NCT00446199|4155206|P2|Overall Study|Adverse Event|4
1269968|NCT00446199|4155207|P1|Overall Study|Adverse Event|7
1269969|NCT00446134|4155300|P4|Overall Study|Reason Not Completed|2
1269970|NCT00446134|4155301|P3|Overall Study|Reason Not Completed|1
1269971|NCT00446134|4155302|P2|Overall Study|Reason Not Completed|0
1269972|NCT00446134|4155303|P1|Overall Study|Reason Not Completed|3
1269973|NCT00446134|4155300|P4|Overall Study|Adverse Event-Diarrhea|0
1269974|NCT00446134|4155301|P3|Overall Study|Adverse Event-Diarrhea|2
1269975|NCT00446134|4155302|P2|Overall Study|Adverse Event-Diarrhea|1
1269976|NCT00446134|4155303|P1|Overall Study|Adverse Event-Diarrhea|1
1269977|NCT00446134|4155300|P4|Overall Study|Physician Decision|2
1269978|NCT00446134|4155301|P3|Overall Study|Physician Decision|0
1269979|NCT00446134|4155302|P2|Overall Study|Physician Decision|0
1269980|NCT00446134|4155303|P1|Overall Study|Physician Decision|0
1269981|NCT00446134|4155300|P4|Overall Study|Withdrawal by Subject|3
1269982|NCT00446134|4155301|P3|Overall Study|Withdrawal by Subject|1
1269983|NCT00446134|4155302|P2|Overall Study|Withdrawal by Subject|3
1269984|NCT00446134|4155303|P1|Overall Study|Withdrawal by Subject|3
1269985|NCT00446134|4155300|P4|Overall Study|Lost to Follow-up|1
1269986|NCT00446134|4155301|P3|Overall Study|Lost to Follow-up|1
1269987|NCT00446134|4155302|P2|Overall Study|Lost to Follow-up|3
1269988|NCT00446134|4155303|P1|Overall Study|Lost to Follow-up|1
1269989|NCT00446134|4155300|P4|Overall Study|Protocol Violation|0
1269990|NCT00446134|4155301|P3|Overall Study|Protocol Violation|1
1269991|NCT00446134|4155302|P2|Overall Study|Protocol Violation|2
1269992|NCT00446134|4155303|P1|Overall Study|Protocol Violation|0
1269993|NCT00446134|4155300|P4|Overall Study|Lack of Efficacy|19
1269994|NCT00446134|4155301|P3|Overall Study|Lack of Efficacy|24
1269995|NCT00446134|4155302|P2|Overall Study|Lack of Efficacy|19
1269996|NCT00446134|4155303|P1|Overall Study|Lack of Efficacy|19
1269997|NCT00446134|4155300|P4|Overall Study|Adverse Event|18
1269998|NCT00446134|4155301|P3|Overall Study|Adverse Event|13
1269999|NCT00446134|4155302|P2|Overall Study|Adverse Event|17
1270000|NCT00446134|4155303|P1|Overall Study|Adverse Event|7
1270001|NCT00446095|4155330|P5|Phase I (28 Days)|Lack of Efficacy|3
1270002|NCT00446095|4155331|P4|Phase I (28 Days)|Lack of Efficacy|0
1270003|NCT00446095|4155332|P3|Phase I (28 Days)|Lack of Efficacy|0
1270004|NCT00446095|4155333|P2|Phase I (28 Days)|Lack of Efficacy|0
1270005|NCT00446095|4155334|P1|Phase I (28 Days)|Lack of Efficacy|0
1270006|NCT00446095|4155330|P5|Phase I (28 Days)|Adverse Event|0
1270007|NCT00446095|4155331|P4|Phase I (28 Days)|Adverse Event|1
1270008|NCT00446095|4155332|P3|Phase I (28 Days)|Adverse Event|0
1270009|NCT00446095|4155333|P2|Phase I (28 Days)|Adverse Event|0
1270010|NCT00446095|4155334|P1|Phase I (28 Days)|Adverse Event|0
1270011|NCT00446095|4155330|P5|Phase II (8 Weeks)|Ongoing|0
1270012|NCT00446095|4155331|P4|Phase II (8 Weeks)|Ongoing|0
1270013|NCT00446095|4155332|P3|Phase II (8 Weeks)|Ongoing|1
1270014|NCT00446095|4155333|P2|Phase II (8 Weeks)|Ongoing|0
1270015|NCT00446095|4155334|P1|Phase II (8 Weeks)|Ongoing|0
1270016|NCT00446095|4155330|P5|Phase II (8 Weeks)|Lack of Efficacy|0
1270017|NCT00446095|4155331|P4|Phase II (8 Weeks)|Lack of Efficacy|0
1270018|NCT00446095|4155332|P3|Phase II (8 Weeks)|Lack of Efficacy|1
1270019|NCT00446095|4155333|P2|Phase II (8 Weeks)|Lack of Efficacy|2
1270020|NCT00446095|4155334|P1|Phase II (8 Weeks)|Lack of Efficacy|9
1270021|NCT00446095|4155330|P5|Phase II (8 Weeks)|Physician Decision|0
1270022|NCT00446095|4155331|P4|Phase II (8 Weeks)|Physician Decision|0
1270023|NCT00446095|4155332|P3|Phase II (8 Weeks)|Physician Decision|0
1270024|NCT00446095|4155333|P2|Phase II (8 Weeks)|Physician Decision|0
1270026|NCT00446095|4155330|P5|Phase II (8 Weeks)|Withdrawal by Subject|0
1270027|NCT00446095|4155331|P4|Phase II (8 Weeks)|Withdrawal by Subject|0
1270028|NCT00446095|4155332|P3|Phase II (8 Weeks)|Withdrawal by Subject|0
1270029|NCT00446095|4155333|P2|Phase II (8 Weeks)|Withdrawal by Subject|0
1270030|NCT00446095|4155334|P1|Phase II (8 Weeks)|Withdrawal by Subject|1
1270031|NCT00446095|4155330|P5|Phase II (8 Weeks)|Adverse Event|0
1270032|NCT00446095|4155331|P4|Phase II (8 Weeks)|Adverse Event|0
1270033|NCT00446095|4155332|P3|Phase II (8 Weeks)|Adverse Event|1
1270034|NCT00446095|4155333|P2|Phase II (8 Weeks)|Adverse Event|1
1270035|NCT00446095|4155334|P1|Phase II (8 Weeks)|Adverse Event|0
1270036|NCT00446095|4155330|P5|Phase II (8 Weeks)|Lost to Follow-up|0
1270037|NCT00446095|4155331|P4|Phase II (8 Weeks)|Lost to Follow-up|0
1270038|NCT00446095|4155332|P3|Phase II (8 Weeks)|Lost to Follow-up|0
1270039|NCT00446095|4155333|P2|Phase II (8 Weeks)|Lost to Follow-up|0
1270040|NCT00446095|4155334|P1|Phase II (8 Weeks)|Lost to Follow-up|1
1270041|NCT00446030|4155357|P2|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1
1270042|NCT00446030|4155358|P1|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0
1270043|NCT00446030|4155357|P2|FOLLOW-UP (up to 2-years)|Right axilla wound|0
1270044|NCT00446030|4155358|P1|FOLLOW-UP (up to 2-years)|Right axilla wound|1
1270045|NCT00446030|4155357|P2|FOLLOW-UP (up to 2-years)|Patient concern|0
1270046|NCT00446030|4155358|P1|FOLLOW-UP (up to 2-years)|Patient concern|1
1270047|NCT00446030|4155357|P2|FOLLOW-UP (up to 2-years)|Protocol Violation|0
1270048|NCT00446030|4155358|P1|FOLLOW-UP (up to 2-years)|Protocol Violation|1
1270049|NCT00446030|4155357|P2|FOLLOW-UP (up to 2-years)|Per physician discretion|0
1270050|NCT00446030|4155358|P1|FOLLOW-UP (up to 2-years)|Per physician discretion|2
1270051|NCT00446030|4155357|P2|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0
1270052|NCT00446030|4155358|P1|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2
1270053|NCT00446030|4155357|P2|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2
1270054|NCT00446030|4155358|P1|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3
1270055|NCT00446030|4155357|P2|FOLLOW-UP (up to 2-years)|Death|2
1270056|NCT00446030|4155358|P1|FOLLOW-UP (up to 2-years)|Death|2
1270057|NCT00446030|4155357|P2|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0
1270058|NCT00446030|4155358|P1|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4
1270059|NCT00446030|4155357|P2|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0
1270060|NCT00446030|4155358|P1|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5
1270061|NCT00446030|4155357|P2|FOLLOW-UP (up to 2-years)|Subject's request|4
1270062|NCT00446030|4155358|P1|FOLLOW-UP (up to 2-years)|Subject's request|9
1270063|NCT00446030|4155357|P2|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0
1270064|NCT00446030|4155358|P1|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1
1270065|NCT00446030|4155357|P2|TREATMENT (up to 52 Weeks)|Patient concern|0
1270066|NCT00446030|4155358|P1|TREATMENT (up to 52 Weeks)|Patient concern|1
1270067|NCT00446030|4155357|P2|TREATMENT (up to 52 Weeks)|Physician Decision|0
1270068|NCT00446030|4155358|P1|TREATMENT (up to 52 Weeks)|Physician Decision|1
1270069|NCT00446030|4155357|P2|TREATMENT (up to 52 Weeks)|Protocol Violation|0
1270070|NCT00446030|4155358|P1|TREATMENT (up to 52 Weeks)|Protocol Violation|1
1270071|NCT00446030|4155357|P2|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0
1270072|NCT00446030|4155358|P1|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1
1270073|NCT00446030|4155357|P2|TREATMENT (up to 52 Weeks)|Poor compliance|0
1270074|NCT00446030|4155358|P1|TREATMENT (up to 52 Weeks)|Poor compliance|1
1270075|NCT00446030|4155357|P2|TREATMENT (up to 52 Weeks)|Subject Request|1
1270076|NCT00446030|4155358|P1|TREATMENT (up to 52 Weeks)|Subject Request|9
1270077|NCT00446030|4155357|P2|TREATMENT (up to 52 Weeks)|Adverse Event|8
1270078|NCT00446030|4155358|P1|TREATMENT (up to 52 Weeks)|Adverse Event|29
1270079|NCT00445939|4155369|P4|Period B - Week 4 - Week 8|Adverse Event|1
1270080|NCT00445939|4155370|P3|Period B - Week 4 - Week 8|Adverse Event|0
1270081|NCT00445939|4155371|P2|Period B - Week 4 - Week 8|Adverse Event|0
1270082|NCT00445939|4155372|P1|Period B - Week 4 - Week 8|Adverse Event|2
1270083|NCT00445939|4155369|P4|Period A - Week 0 - Week 4|Adverse Event|0
1270084|NCT00445939|4155370|P3|Period A - Week 0 - Week 4|Adverse Event|0
1270085|NCT00445939|4155371|P2|Period A - Week 0 - Week 4|Adverse Event|2
1270086|NCT00445939|4155372|P1|Period A - Week 0 - Week 4|Adverse Event|1
1270087|NCT00445848|4155420|P1|Overall Study|Other-Not protocol specified|5
1270088|NCT00445848|4155420|P1|Overall Study|Progression|62
1270089|NCT00445848|4155420|P1|Overall Study|Withdrawal by Subject|4
1270090|NCT00445848|4155420|P1|Overall Study|Adverse Event|14
1270091|NCT00445770|4155430|P3|Overall Study|Not specified|6
1270092|NCT00445770|4155431|P2|Overall Study|Not specified|5
1270093|NCT00445770|4155432|P1|Overall Study|Not specified|6
1270094|NCT00445770|4155430|P3|Overall Study|Lost to Follow-up|0
1270095|NCT00445770|4155431|P2|Overall Study|Lost to Follow-up|2
1270096|NCT00445770|4155432|P1|Overall Study|Lost to Follow-up|0
1270097|NCT00445770|4155430|P3|Overall Study|Lack of Efficacy|6
1270098|NCT00445770|4155431|P2|Overall Study|Lack of Efficacy|13
1270099|NCT00445770|4155432|P1|Overall Study|Lack of Efficacy|38
1270100|NCT00445770|4155430|P3|Overall Study|Adverse Event|19
1270101|NCT00445770|4155431|P2|Overall Study|Adverse Event|15
1270102|NCT00445770|4155432|P1|Overall Study|Adverse Event|9
1270103|NCT00445692|4155533|P1|Overall Study|Lack of Efficacy|5
1270104|NCT00445692|4155533|P1|Overall Study|Adverse Event|11
1270105|NCT00445679|4155543|P4|Overall Study|Lack of Efficacy|0
1270106|NCT00445679|4155544|P3|Overall Study|Lack of Efficacy|2
1270107|NCT00445679|4155545|P2|Overall Study|Lack of Efficacy|6
1270108|NCT00445679|4155546|P1|Overall Study|Lack of Efficacy|2
1270109|NCT00445679|4155543|P4|Overall Study|Withdrawal by Subject|18
1270110|NCT00445679|4155544|P3|Overall Study|Withdrawal by Subject|20
1270111|NCT00445679|4155545|P2|Overall Study|Withdrawal by Subject|14
1270112|NCT00445679|4155546|P1|Overall Study|Withdrawal by Subject|8
1270113|NCT00445679|4155543|P4|Overall Study|Protocol Violation|1
1270114|NCT00445679|4155544|P3|Overall Study|Protocol Violation|3
1270115|NCT00445679|4155545|P2|Overall Study|Protocol Violation|3
1270116|NCT00445679|4155546|P1|Overall Study|Protocol Violation|2
1270117|NCT00445679|4155543|P4|Overall Study|Withdrawal of Informed Consent|0
1270118|NCT00445679|4155544|P3|Overall Study|Withdrawal of Informed Consent|1
1270119|NCT00445679|4155545|P2|Overall Study|Withdrawal of Informed Consent|0
1270120|NCT00445679|4155546|P1|Overall Study|Withdrawal of Informed Consent|0
1270121|NCT00445679|4155543|P4|Overall Study|Compliance|2
1270122|NCT00445679|4155544|P3|Overall Study|Compliance|1
1270123|NCT00445679|4155545|P2|Overall Study|Compliance|2
1270124|NCT00445679|4155546|P1|Overall Study|Compliance|3
1270125|NCT00445679|4155543|P4|Overall Study|Lost to Follow-up|5
1270126|NCT00445679|4155544|P3|Overall Study|Lost to Follow-up|6
1270127|NCT00445679|4155545|P2|Overall Study|Lost to Follow-up|6
1270128|NCT00445679|4155546|P1|Overall Study|Lost to Follow-up|10
1270129|NCT00445679|4155543|P4|Overall Study|Physician Decision|0
1270130|NCT00445679|4155544|P3|Overall Study|Physician Decision|1
1270131|NCT00445679|4155545|P2|Overall Study|Physician Decision|0
1270132|NCT00445679|4155546|P1|Overall Study|Physician Decision|0
1270133|NCT00445679|4155543|P4|Overall Study|Failed to return|2
1270134|NCT00445679|4155544|P3|Overall Study|Failed to return|2
1270135|NCT00445679|4155545|P2|Overall Study|Failed to return|3
1270136|NCT00445679|4155546|P1|Overall Study|Failed to return|1
1270137|NCT00445679|4155543|P4|Overall Study|Adverse Event|19
1270138|NCT00445679|4155544|P3|Overall Study|Adverse Event|30
1270139|NCT00445679|4155545|P2|Overall Study|Adverse Event|12
1270140|NCT00445679|4155546|P1|Overall Study|Adverse Event|22
1270141|NCT00445601|4155582|P2|Overall Study|Death prior to TURBT|1
1270142|NCT00445601|4155583|P1|Overall Study|Death prior to TURBT|0
1270143|NCT00445601|4155582|P2|Overall Study|Adverse Event|0
1270144|NCT00445601|4155583|P1|Overall Study|Adverse Event|2
1270145|NCT00445601|4155582|P2|Overall Study|Drug Delivery Issue|2
1270146|NCT00445601|4155583|P1|Overall Study|Drug Delivery Issue|2
1270147|NCT00445601|4155582|P2|Overall Study|Incorrect Disease Status|6
1270148|NCT00445601|4155583|P1|Overall Study|Incorrect Disease Status|6
1270149|NCT00445601|4155582|P2|Overall Study|TURBT Complication|8
1270150|NCT00445601|4155583|P1|Overall Study|TURBT Complication|12
1270151|NCT00445601|4155582|P2|Overall Study|Withdrawal by Subject|11
1270152|NCT00445601|4155583|P1|Overall Study|Withdrawal by Subject|11
1270153|NCT00445549|4155600|P1|Overall Study|progressive disease|12
1270154|NCT00445458|4155624|P4|Overall Study|Surgery|0
1270155|NCT00445458|4155625|P3|Overall Study|Surgery|1
1270156|NCT00445458|4155626|P2|Overall Study|Surgery|0
1270157|NCT00445458|4155627|P1|Overall Study|Surgery|0
1270158|NCT00445458|4155624|P4|Overall Study|Physician Decision|1
1270159|NCT00445458|4155625|P3|Overall Study|Physician Decision|1
1270160|NCT00445458|4155626|P2|Overall Study|Physician Decision|0
1270161|NCT00445458|4155627|P1|Overall Study|Physician Decision|0
1270162|NCT00445458|4155624|P4|Overall Study|Death|0
1270163|NCT00445458|4155625|P3|Overall Study|Death|2
1270164|NCT00445458|4155626|P2|Overall Study|Death|1
1270165|NCT00445458|4155627|P1|Overall Study|Death|0
1270166|NCT00445458|4155624|P4|Overall Study|Adverse Event|0
1270167|NCT00445458|4155625|P3|Overall Study|Adverse Event|3
1270168|NCT00445458|4155626|P2|Overall Study|Adverse Event|0
1270169|NCT00445458|4155627|P1|Overall Study|Adverse Event|0
1270170|NCT00445458|4155624|P4|Overall Study|Withdrawal by Subject|0
1270171|NCT00445458|4155625|P3|Overall Study|Withdrawal by Subject|7
1270172|NCT00445458|4155626|P2|Overall Study|Withdrawal by Subject|0
1270173|NCT00445458|4155627|P1|Overall Study|Withdrawal by Subject|0
1270174|NCT00445458|4155624|P4|Overall Study|Disease Progression|27
1270175|NCT00445458|4155625|P3|Overall Study|Disease Progression|54
1270176|NCT00445458|4155626|P2|Overall Study|Disease Progression|4
1270177|NCT00445458|4155627|P1|Overall Study|Disease Progression|3
1270178|NCT00445432|4155645|P4|148 Weeks of Adalimumab Treatment|Not specified|9
1270179|NCT00445432|4155646|P3|148 Weeks of Adalimumab Treatment|Not specified|0
1270180|NCT00445432|4155647|P2|148 Weeks of Adalimumab Treatment|Not specified|0
1270181|NCT00445432|4155648|P1|148 Weeks of Adalimumab Treatment|Not specified|0
1270182|NCT00445432|4155645|P4|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3
1270183|NCT00445432|4155646|P3|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
1270184|NCT00445432|4155647|P2|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
1270185|NCT00445432|4155648|P1|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
1270186|NCT00445432|4155645|P4|148 Weeks of Adalimumab Treatment|Adverse Event|32
1270187|NCT00445432|4155646|P3|148 Weeks of Adalimumab Treatment|Adverse Event|0
1270188|NCT00445432|4155647|P2|148 Weeks of Adalimumab Treatment|Adverse Event|0
1270189|NCT00445432|4155648|P1|148 Weeks of Adalimumab Treatment|Adverse Event|0
1270190|NCT00445432|4155645|P4|Through Week 52 of NCT00445432 (M06-837)|Not specified|0
1270191|NCT00445432|4155646|P3|Through Week 52 of NCT00445432 (M06-837)|Not specified|2
1270192|NCT00445432|4155647|P2|Through Week 52 of NCT00445432 (M06-837)|Not specified|1
1270193|NCT00445432|4155648|P1|Through Week 52 of NCT00445432 (M06-837)|Not specified|0
1270194|NCT00445432|4155645|P4|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
1270195|NCT00445432|4155646|P3|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
1270196|NCT00445432|4155647|P2|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20
1270197|NCT00445432|4155648|P1|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14
1270198|NCT00445432|4155645|P4|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
1270199|NCT00445432|4155646|P3|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2
1270200|NCT00445432|4155647|P2|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
1270201|NCT00445432|4155648|P1|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
1270202|NCT00445432|4155645|P4|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0
1270203|NCT00445432|4155646|P3|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7
1270204|NCT00445432|4155647|P2|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2
1270205|NCT00445432|4155648|P1|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1
1270206|NCT00445341|4155681|P1|Overall Study|taken off treatment too early|1
1270207|NCT00445341|4155681|P1|Overall Study|refused further treatment|1
1270208|NCT00445328|4155688|P2|Overall Study|Protocol Violation|0
1270209|NCT00445328|4155689|P1|Overall Study|Protocol Violation|1
1270210|NCT00445328|4155688|P2|Overall Study|Withdrawal by Subject|0
1270211|NCT00445328|4155689|P1|Overall Study|Withdrawal by Subject|2
1270212|NCT00445328|4155688|P2|Overall Study|Other|2
1270213|NCT00445328|4155689|P1|Overall Study|Other|0
1270214|NCT00445328|4155688|P2|Overall Study|Adverse Event|3
1270215|NCT00445328|4155689|P1|Overall Study|Adverse Event|0
1270216|NCT00445328|4155688|P2|Overall Study|Death|1
1270217|NCT00445328|4155689|P1|Overall Study|Death|0
1270218|NCT00445224|4155850|P2|Specific Exercises|Withdrawal by Subject|0
1270219|NCT00445224|4155851|P1|Specific Exercises|Withdrawal by Subject|1
1270220|NCT00445224|4155850|P2|Specific Exercises|Withdrawal by Subject|3
1270221|NCT00445224|4155851|P1|Specific Exercises|Withdrawal by Subject|3
1270222|NCT00445146|4155878|P1|Overall Study|Pregnancy|1
1270223|NCT00445146|4155878|P1|Overall Study|Protocol Violation|4
1270224|NCT00445146|4155878|P1|Overall Study|Death|9
1270225|NCT00445146|4155878|P1|Overall Study|Lost to Follow-up|13
1270226|NCT00445146|4155878|P1|Overall Study|Adverse Event|13
1270227|NCT00445146|4155878|P1|Overall Study|Investigator’s Discretion|22
1270228|NCT00445146|4155878|P1|Overall Study|Lack of Efficacy|28
1270229|NCT00445146|4155878|P1|Overall Study|Withdrew Consent|29
1270230|NCT00445003|4155900|P3|Overall Study|Dropped|2
1270231|NCT00445003|4155901|P2|Overall Study|Dropped|3
1270232|NCT00445003|4155902|P1|Overall Study|Dropped|1
1270233|NCT00445003|4155900|P3|Overall Study|Missed Visit|1
1270234|NCT00445003|4155901|P2|Overall Study|Missed Visit|5
1270235|NCT00445003|4155902|P1|Overall Study|Missed Visit|3
1270236|NCT00445003|4155900|P3|Overall Study|Death|1
1270237|NCT00445003|4155901|P2|Overall Study|Death|2
1270238|NCT00445003|4155902|P1|Overall Study|Death|1
1270239|NCT00444951|4155934|P3|Overall Study|Withdrawal by Subject|3
1270240|NCT00444951|4155935|P2|Overall Study|Withdrawal by Subject|5
1270241|NCT00444951|4155936|P1|Overall Study|Withdrawal by Subject|4
1270242|NCT00444951|4155934|P3|Overall Study|Lost to Follow-up|0
1270243|NCT00444951|4155935|P2|Overall Study|Lost to Follow-up|1
1270244|NCT00444951|4155936|P1|Overall Study|Lost to Follow-up|1
1270245|NCT00444925|4155953|P3|Double-blind Treatment Period|Other|12
1270246|NCT00444925|4155954|P2|Double-blind Treatment Period|Other|7
1270247|NCT00444925|4155955|P1|Double-blind Treatment Period|Other|7
1270248|NCT00444925|4155953|P3|Double-blind Treatment Period|Withdrawal by Subject|7
1270249|NCT00444925|4155954|P2|Double-blind Treatment Period|Withdrawal by Subject|8
1270250|NCT00444925|4155955|P1|Double-blind Treatment Period|Withdrawal by Subject|6
1270251|NCT00444925|4155953|P3|Double-blind Treatment Period|Lost to Follow-up|5
1270252|NCT00444925|4155954|P2|Double-blind Treatment Period|Lost to Follow-up|8
1270253|NCT00444925|4155955|P1|Double-blind Treatment Period|Lost to Follow-up|4
1270254|NCT00444925|4155953|P3|Double-blind Treatment Period|Lack of Efficacy|13
1270255|NCT00444925|4155954|P2|Double-blind Treatment Period|Lack of Efficacy|5
1270256|NCT00444925|4155955|P1|Double-blind Treatment Period|Lack of Efficacy|5
1270257|NCT00444925|4155953|P3|Double-blind Treatment Period|Adverse Event|44
1270258|NCT00444925|4155954|P2|Double-blind Treatment Period|Adverse Event|28
1270259|NCT00444925|4155955|P1|Double-blind Treatment Period|Adverse Event|6
1270260|NCT00444925|4155953|P3|Double-blind Treatment Period|Death|0
1270261|NCT00444925|4155954|P2|Double-blind Treatment Period|Death|0
1270262|NCT00444925|4155955|P1|Double-blind Treatment Period|Death|2
1270263|NCT00444925|4155953|P3|Randomized to Double-blind Treatment|Never returned after randomization|6
1270264|NCT00444925|4155954|P2|Randomized to Double-blind Treatment|Never returned after randomization|6
1270265|NCT00444925|4155955|P1|Randomized to Double-blind Treatment|Never returned after randomization|3
1270266|NCT00444912|4156019|P2|Overall Study|Participant Failed Mobilization|0
1270267|NCT00444912|4156020|P1|Overall Study|Participant Failed Mobilization|1
1270268|NCT00444912|4156019|P2|Overall Study|Lost to Follow-up|0
1270269|NCT00444912|4156020|P1|Overall Study|Lost to Follow-up|1
1270270|NCT00444912|4156019|P2|Overall Study|Death|2
1270271|NCT00444912|4156020|P1|Overall Study|Death|1
1270272|NCT00444795|4156061|P1|Overall Study|Treated Prior to the Contract Date|2
1270273|NCT00444795|4156061|P1|Overall Study|Not Treated|1
1270274|NCT00444626|4156066|P1|Initial Treatment Period|Lost to Follow-up|9
1270275|NCT00444626|4156066|P1|Initial Treatment Period|Adverse Event|1
1270276|NCT00444626|4156066|P1|Initial Treatment Period|Withdrawal by Subject|2
1270277|NCT00444600|4156096|P4|Overall Study|Missed visit|1
1270278|NCT00444600|4156097|P3|Overall Study|Missed visit|0
1270279|NCT00444600|4156098|P2|Overall Study|Missed visit|0
1270280|NCT00444600|4156099|P1|Overall Study|Missed visit|1
1270281|NCT00444600|4156096|P4|Overall Study|Dropped|7
1270282|NCT00444600|4156097|P3|Overall Study|Dropped|7
1270283|NCT00444600|4156098|P2|Overall Study|Dropped|11
1270284|NCT00444600|4156099|P1|Overall Study|Dropped|11
1270285|NCT00444600|4156096|P4|Overall Study|Death|2
1270286|NCT00444600|4156097|P3|Overall Study|Death|3
1270287|NCT00444600|4156098|P2|Overall Study|Death|5
1270288|NCT00444600|4156099|P1|Overall Study|Death|7
1270289|NCT00444587|4156191|P2|Overall Study|Missing|5
1270290|NCT00444587|4156192|P1|Overall Study|Missing|0
1270291|NCT00444587|4156191|P2|Overall Study|Protocol Violation|0
1270292|NCT00444587|4156192|P1|Overall Study|Protocol Violation|1
1270293|NCT00444587|4156191|P2|Overall Study|Investigator decision|0
1270294|NCT00444587|4156192|P1|Overall Study|Investigator decision|3
1270295|NCT00444587|4156191|P2|Overall Study|Refused treatment/did not cooperate|1
1270296|NCT00444587|4156192|P1|Overall Study|Refused treatment/did not cooperate|4
1270297|NCT00444587|4156191|P2|Overall Study|Progression of the disease|8
1270298|NCT00444587|4156192|P1|Overall Study|Progression of the disease|73
1270299|NCT00444587|4156191|P2|Overall Study|Death|1
1270300|NCT00444587|4156192|P1|Overall Study|Death|2
1270301|NCT00444535|4156213|P1|Overall Study|Adverse Event|3
1270302|NCT00444535|4156213|P1|Overall Study|Investigator decision|2
1270303|NCT00444535|4156213|P1|Overall Study|Withdrawal by Subject|3
1270304|NCT00444535|4156213|P1|Overall Study|Treatment is ongoing|16
1270305|NCT00444457|4156224|P4|Toddler Dose|Protocol Violation|1
1270306|NCT00444457|4156225|P3|Toddler Dose|Protocol Violation|0
1270307|NCT00444457|4156226|P2|Toddler Dose|Protocol Violation|0
1270308|NCT00444457|4156227|P1|Toddler Dose|Protocol Violation|1
1270309|NCT00444457|4156224|P4|Toddler Dose|Parent or legal guardian request|1
1270310|NCT00444457|4156225|P3|Toddler Dose|Parent or legal guardian request|2
1270311|NCT00444457|4156226|P2|Toddler Dose|Parent or legal guardian request|3
1270312|NCT00444457|4156227|P1|Toddler Dose|Parent or legal guardian request|0
1270313|NCT00444457|4156224|P4|Toddler Dose|Failed to return|3
1270314|NCT00444457|4156225|P3|Toddler Dose|Failed to return|1
1270315|NCT00444457|4156226|P2|Toddler Dose|Failed to return|2
1270316|NCT00444457|4156227|P1|Toddler Dose|Failed to return|2
1270317|NCT00444457|4156224|P4|Toddler Dose|Lost to Follow-up|3
1270318|NCT00444457|4156225|P3|Toddler Dose|Lost to Follow-up|1
1270319|NCT00444457|4156226|P2|Toddler Dose|Lost to Follow-up|1
1270320|NCT00444457|4156227|P1|Toddler Dose|Lost to Follow-up|4
1270321|NCT00444457|4156224|P4|After Infant Series|Other|0
1270322|NCT00444457|4156225|P3|After Infant Series|Other|0
1270323|NCT00444457|4156226|P2|After Infant Series|Other|1
1270324|NCT00444457|4156227|P1|After Infant Series|Other|0
1270325|NCT00444457|4156224|P4|After Infant Series|Investigator request|1
1270326|NCT00444457|4156225|P3|After Infant Series|Investigator request|0
1270327|NCT00444457|4156226|P2|After Infant Series|Investigator request|0
1270328|NCT00444457|4156227|P1|After Infant Series|Investigator request|0
1270329|NCT00444457|4156224|P4|After Infant Series|Adverse Event|0
1270330|NCT00444457|4156225|P3|After Infant Series|Adverse Event|0
1270331|NCT00444457|4156226|P2|After Infant Series|Adverse Event|2
1270332|NCT00444457|4156227|P1|After Infant Series|Adverse Event|2
1270333|NCT00444457|4156224|P4|After Infant Series|Protocol Violation|2
1270334|NCT00444457|4156225|P3|After Infant Series|Protocol Violation|2
1270335|NCT00444457|4156226|P2|After Infant Series|Protocol Violation|4
1270336|NCT00444457|4156227|P1|After Infant Series|Protocol Violation|2
1270337|NCT00444457|4156224|P4|After Infant Series|Lost to Follow-up|2
1270338|NCT00444457|4156225|P3|After Infant Series|Lost to Follow-up|5
1270339|NCT00444457|4156226|P2|After Infant Series|Lost to Follow-up|5
1270340|NCT00444457|4156227|P1|After Infant Series|Lost to Follow-up|5
1270341|NCT00444457|4156224|P4|After Infant Series|Failed to return|1
1270342|NCT00444457|4156225|P3|After Infant Series|Failed to return|5
1270343|NCT00444457|4156226|P2|After Infant Series|Failed to return|6
1270344|NCT00444457|4156227|P1|After Infant Series|Failed to return|7
1270345|NCT00444457|4156224|P4|After Infant Series|Parent or legal guardian request|3
1270346|NCT00444457|4156225|P3|After Infant Series|Parent or legal guardian request|6
1270347|NCT00444457|4156226|P2|After Infant Series|Parent or legal guardian request|11
1270348|NCT00444457|4156227|P1|After Infant Series|Parent or legal guardian request|4
1270349|NCT00444457|4156224|P4|After Infant Series|Other|1
1270350|NCT00444457|4156225|P3|After Infant Series|Other|1
1270351|NCT00444457|4156226|P2|After Infant Series|Other|1
1270352|NCT00444457|4156227|P1|After Infant Series|Other|0
1270353|NCT00444457|4156224|P4|Infant Series|Death|1
1270354|NCT00444457|4156225|P3|Infant Series|Death|1
1270355|NCT00444457|4156226|P2|Infant Series|Death|1
1270356|NCT00444457|4156227|P1|Infant Series|Death|0
1270357|NCT00444457|4156224|P4|Infant Series|Adverse Event|0
1270358|NCT00444457|4156225|P3|Infant Series|Adverse Event|2
1270359|NCT00444457|4156226|P2|Infant Series|Adverse Event|2
1270360|NCT00444457|4156227|P1|Infant Series|Adverse Event|1
1270361|NCT00444457|4156224|P4|Infant Series|Other|0
1270362|NCT00444457|4156225|P3|Infant Series|Other|4
1270363|NCT00444457|4156226|P2|Infant Series|Other|2
1270364|NCT00444457|4156227|P1|Infant Series|Other|0
1270365|NCT00444457|4156224|P4|Infant Series|Investigator request|2
1270366|NCT00444457|4156225|P3|Infant Series|Investigator request|3
1270367|NCT00444457|4156226|P2|Infant Series|Investigator request|3
1270368|NCT00444457|4156227|P1|Infant Series|Investigator request|4
1270369|NCT00444457|4156224|P4|Infant Series|Failed to return|2
1270370|NCT00444457|4156225|P3|Infant Series|Failed to return|4
1270371|NCT00444457|4156226|P2|Infant Series|Failed to return|4
1270372|NCT00444457|4156227|P1|Infant Series|Failed to return|5
1270373|NCT00444457|4156224|P4|Infant Series|Protocol Violation|3
1270374|NCT00444457|4156225|P3|Infant Series|Protocol Violation|6
1270375|NCT00444457|4156226|P2|Infant Series|Protocol Violation|8
1270376|NCT00444457|4156227|P1|Infant Series|Protocol Violation|16
1270377|NCT00444457|4156224|P4|Infant Series|Lost to Follow-up|6
1270378|NCT00444457|4156225|P3|Infant Series|Lost to Follow-up|7
1270379|NCT00444457|4156226|P2|Infant Series|Lost to Follow-up|11
1270380|NCT00444457|4156227|P1|Infant Series|Lost to Follow-up|10
1270381|NCT00444457|4156224|P4|Infant Series|Parent or legal guardian request|14
1270382|NCT00444457|4156225|P3|Infant Series|Parent or legal guardian request|34
1270383|NCT00444457|4156226|P2|Infant Series|Parent or legal guardian request|29
1270384|NCT00444457|4156227|P1|Infant Series|Parent or legal guardian request|18
1270385|NCT00444457|4156224|P4|Infant Series|Other|0
1270386|NCT00444457|4156225|P3|Infant Series|Other|0
1270387|NCT00444457|4156226|P2|Infant Series|Other|1
1270388|NCT00444457|4156227|P1|Infant Series|Other|0
1270389|NCT00444275|4156292|P5|Maintenance Treatment Phase|Ineffectiveness|14
1270390|NCT00444275|4156293|P4|Maintenance Treatment Phase|Ineffectiveness|3
1270391|NCT00444275|4156294|P3|Maintenance Treatment Phase|Ineffectiveness|5
1270392|NCT00444275|4156295|P2|Maintenance Treatment Phase|Ineffectiveness|0
1270393|NCT00444275|4156296|P1|Maintenance Treatment Phase|Ineffectiveness|0
1270394|NCT00444275|4156292|P5|Maintenance Treatment Phase|Protocol Violation|87
1270395|NCT00444275|4156293|P4|Maintenance Treatment Phase|Protocol Violation|88
1270396|NCT00444275|4156294|P3|Maintenance Treatment Phase|Protocol Violation|103
1270397|NCT00444275|4156295|P2|Maintenance Treatment Phase|Protocol Violation|0
1270398|NCT00444275|4156296|P1|Maintenance Treatment Phase|Protocol Violation|0
1270399|NCT00444275|4156292|P5|Maintenance Treatment Phase|Patient's wish|20
1270400|NCT00444275|4156293|P4|Maintenance Treatment Phase|Patient's wish|9
1270401|NCT00444275|4156294|P3|Maintenance Treatment Phase|Patient's wish|19
1270402|NCT00444275|4156295|P2|Maintenance Treatment Phase|Patient's wish|0
1270403|NCT00444275|4156296|P1|Maintenance Treatment Phase|Patient's wish|0
1270404|NCT00444275|4156292|P5|Maintenance Treatment Phase|Protocol specific criteria's development|6
1270405|NCT00444275|4156293|P4|Maintenance Treatment Phase|Protocol specific criteria's development|0
1270406|NCT00444275|4156294|P3|Maintenance Treatment Phase|Protocol specific criteria's development|1
1270407|NCT00444275|4156295|P2|Maintenance Treatment Phase|Protocol specific criteria's development|0
1270408|NCT00444275|4156296|P1|Maintenance Treatment Phase|Protocol specific criteria's development|0
1270409|NCT00444275|4156292|P5|Maintenance Treatment Phase|Adverse Event|13
1270410|NCT00444275|4156293|P4|Maintenance Treatment Phase|Adverse Event|2
1270411|NCT00444275|4156294|P3|Maintenance Treatment Phase|Adverse Event|3
1270412|NCT00444275|4156295|P2|Maintenance Treatment Phase|Adverse Event|0
1270413|NCT00444275|4156296|P1|Maintenance Treatment Phase|Adverse Event|0
1270414|NCT00444275|4156292|P5|Maintenance Treatment Phase|Lost to Follow-up|10
1270415|NCT00444275|4156293|P4|Maintenance Treatment Phase|Lost to Follow-up|14
1270416|NCT00444275|4156294|P3|Maintenance Treatment Phase|Lost to Follow-up|8
1270417|NCT00444275|4156295|P2|Maintenance Treatment Phase|Lost to Follow-up|0
1270418|NCT00444275|4156296|P1|Maintenance Treatment Phase|Lost to Follow-up|0
1270419|NCT00444275|4156292|P5|Maintenance Treatment Phase|Didn'r receive the treatment|29
1270420|NCT00444275|4156293|P4|Maintenance Treatment Phase|Didn'r receive the treatment|17
1270421|NCT00444275|4156294|P3|Maintenance Treatment Phase|Didn'r receive the treatment|22
1270422|NCT00444275|4156295|P2|Maintenance Treatment Phase|Didn'r receive the treatment|0
1270423|NCT00444275|4156296|P1|Maintenance Treatment Phase|Didn'r receive the treatment|0
1270424|NCT00444145|4156346|P1|Overall Study|Screen Failures|5
1270425|NCT00444145|4156346|P1|Overall Study|non-compliant|11
1270426|NCT00444145|4156346|P1|Overall Study|Lost to Follow-up|1
1270427|NCT00444145|4156346|P1|Overall Study|Withdrawal by Subject|2
1270428|NCT00444106|4156353|P3|Overall Study|Abnormal Test Procedure Results|1
1270429|NCT00444106|4156354|P2|Overall Study|Abnormal Test Procedure Results|0
1270430|NCT00444106|4156355|P1|Overall Study|Abnormal Test Procedure Results|0
1270431|NCT00444106|4156353|P3|Overall Study|Lost to Follow-up|0
1270432|NCT00444106|4156354|P2|Overall Study|Lost to Follow-up|1
1270433|NCT00444106|4156355|P1|Overall Study|Lost to Follow-up|2
1270434|NCT00444067|4156372|P2|Overall Study|Lost to Follow-up|1
1270435|NCT00444067|4156373|P1|Overall Study|Lost to Follow-up|0
1270436|NCT00443898|4156436|P4|Overall Study|Death|0
1270437|NCT00443898|4156437|P3|Overall Study|Death|0
1270438|NCT00443898|4156438|P2|Overall Study|Death|1
1270439|NCT00443898|4156439|P1|Overall Study|Death|0
1270440|NCT00443898|4156436|P4|Overall Study|Lost to Follow-up|10
1270441|NCT00443898|4156437|P3|Overall Study|Lost to Follow-up|14
1270442|NCT00443898|4156438|P2|Overall Study|Lost to Follow-up|10
1270443|NCT00443898|4156439|P1|Overall Study|Lost to Follow-up|10
1270444|NCT00443898|4156436|P4|Overall Study|Withdrawal by Subject|6
1270445|NCT00443898|4156437|P3|Overall Study|Withdrawal by Subject|10
1270446|NCT00443898|4156438|P2|Overall Study|Withdrawal by Subject|10
1270447|NCT00443898|4156439|P1|Overall Study|Withdrawal by Subject|11
1270448|NCT00443898|4156436|P4|Overall Study|Protocol Violation|0
1270449|NCT00443898|4156437|P3|Overall Study|Protocol Violation|1
1270450|NCT00443898|4156438|P2|Overall Study|Protocol Violation|1
1270451|NCT00443898|4156439|P1|Overall Study|Protocol Violation|1
1270452|NCT00443898|4156436|P4|Overall Study|Lack of Efficacy|1
1270453|NCT00443898|4156437|P3|Overall Study|Lack of Efficacy|3
1270454|NCT00443898|4156438|P2|Overall Study|Lack of Efficacy|3
1270455|NCT00443898|4156439|P1|Overall Study|Lack of Efficacy|2
1270456|NCT00443898|4156436|P4|Overall Study|Adverse Event|1
1270457|NCT00443898|4156437|P3|Overall Study|Adverse Event|1
1270458|NCT00443898|4156438|P2|Overall Study|Adverse Event|0
1270459|NCT00443898|4156439|P1|Overall Study|Adverse Event|0
1270460|NCT00443872|4156461|P1|Overall Study|Adverse Event|8
1270461|NCT00443872|4156461|P1|Overall Study|Lost to Follow-up|2
1270462|NCT00443872|4156461|P1|Overall Study|Protocol Violation|7
1270463|NCT00443846|4156476|P2|Overall Study|Lost to Follow-up|2
1270464|NCT00443846|4156477|P1|Overall Study|Lost to Follow-up|1
1270465|NCT00443846|4156476|P2|Overall Study|Personal reason|3
1270466|NCT00443846|4156477|P1|Overall Study|Personal reason|8
1270467|NCT00443846|4156476|P2|Overall Study|Adverse Event|1
1270468|NCT00443846|4156477|P1|Overall Study|Adverse Event|0
1270469|NCT00443846|4156476|P2|Overall Study|Not vaccinated, no blood sample drawn|0
1270470|NCT00443846|4156477|P1|Overall Study|Not vaccinated, no blood sample drawn|1
1270471|NCT00443846|4156476|P2|Overall Study|Withdrawn due to intercurrent disease|0
1270472|NCT00443846|4156477|P1|Overall Study|Withdrawn due to intercurrent disease|1
1270473|NCT00443820|4156487|P4|Overall Study|Death|0
1270474|NCT00443820|4156488|P3|Overall Study|Death|1
1270475|NCT00443820|4156489|P2|Overall Study|Death|0
1270476|NCT00443820|4156490|P1|Overall Study|Death|0
1270477|NCT00443820|4156487|P4|Overall Study|Administrative problems|1
1270478|NCT00443820|4156488|P3|Overall Study|Administrative problems|0
1270479|NCT00443820|4156489|P2|Overall Study|Administrative problems|0
1270480|NCT00443820|4156490|P1|Overall Study|Administrative problems|0
1270481|NCT00443820|4156487|P4|Overall Study|Lost to Follow-up|5
1270482|NCT00443820|4156488|P3|Overall Study|Lost to Follow-up|6
1270483|NCT00443820|4156489|P2|Overall Study|Lost to Follow-up|8
1270484|NCT00443820|4156490|P1|Overall Study|Lost to Follow-up|9
1270485|NCT00443820|4156487|P4|Overall Study|Withdrawal by Subject|9
1270486|NCT00443820|4156488|P3|Overall Study|Withdrawal by Subject|8
1270487|NCT00443820|4156489|P2|Overall Study|Withdrawal by Subject|7
1270488|NCT00443820|4156490|P1|Overall Study|Withdrawal by Subject|6
1270489|NCT00443820|4156487|P4|Overall Study|Protocol Violation|1
1270490|NCT00443820|4156488|P3|Overall Study|Protocol Violation|2
1270491|NCT00443820|4156489|P2|Overall Study|Protocol Violation|1
1270492|NCT00443820|4156490|P1|Overall Study|Protocol Violation|2
1270493|NCT00443820|4156487|P4|Overall Study|Lack of Efficacy|1
1270494|NCT00443820|4156488|P3|Overall Study|Lack of Efficacy|1
1270495|NCT00443820|4156489|P2|Overall Study|Lack of Efficacy|2
1270496|NCT00443820|4156490|P1|Overall Study|Lack of Efficacy|3
1270497|NCT00443820|4156487|P4|Overall Study|Adverse Event|0
1270498|NCT00443820|4156488|P3|Overall Study|Adverse Event|0
1270499|NCT00443820|4156489|P2|Overall Study|Adverse Event|1
1270500|NCT00443820|4156490|P1|Overall Study|Adverse Event|1
1270501|NCT00443781|4156512|P1|Overall Study|PD/FAD not done|1
1270502|NCT00443781|4156512|P1|Overall Study|Insurance not covered|2
1270503|NCT00443781|4156512|P1|Overall Study|Investigator terminated participation|1
1270504|NCT00443781|4156512|P1|Overall Study|Unable to comply with study follow up|2
1270505|NCT00443781|4156512|P1|Overall Study|Withdrawal by Subject|6
1270506|NCT00443781|4156512|P1|Overall Study|Protocol Violation|1
1270507|NCT00443781|4156512|P1|Overall Study|Physician Decision|2
1270508|NCT00443781|4156512|P1|Overall Study|Lost to Follow-up|10
1270509|NCT00443755|4156518|P2|Overall Study|Withdrawal by Subject|1
1270510|NCT00443755|4156519|P1|Overall Study|Withdrawal by Subject|2
1270511|NCT00443729|4156553|P2|Overall Study|Withdrawal by Subject|1
1270512|NCT00443729|4156554|P1|Overall Study|Withdrawal by Subject|3
1270513|NCT00443729|4156553|P2|Overall Study|Protocol Violation|1
1270514|NCT00443729|4156554|P1|Overall Study|Protocol Violation|1
1270515|NCT00443729|4156553|P2|Overall Study|Physician Decision|1
1270516|NCT00443729|4156554|P1|Overall Study|Physician Decision|2
1270517|NCT00443729|4156553|P2|Overall Study|Lost to Follow-up|1
1270518|NCT00443729|4156554|P1|Overall Study|Lost to Follow-up|0
1270519|NCT00443729|4156553|P2|Overall Study|Lack of Efficacy|2
1270520|NCT00443729|4156554|P1|Overall Study|Lack of Efficacy|4
1270521|NCT00443729|4156553|P2|Overall Study|Never Treated|1
1270522|NCT00443729|4156554|P1|Overall Study|Never Treated|0
1270523|NCT00443703|4156602|P2|Overall Study|Progressive Disease|0
1270524|NCT00443703|4156603|P1|Overall Study|Progressive Disease|1
1270525|NCT00443703|4156602|P2|Overall Study|Withdrawal by Subject|6
1270526|NCT00443703|4156603|P1|Overall Study|Withdrawal by Subject|9
1270527|NCT00443703|4156602|P2|Overall Study|Protocol Violation|1
1270528|NCT00443703|4156603|P1|Overall Study|Protocol Violation|1
1270529|NCT00443703|4156602|P2|Overall Study|Physician Decision|2
1270530|NCT00443703|4156603|P1|Overall Study|Physician Decision|4
1270531|NCT00443703|4156602|P2|Overall Study|Lost to Follow-up|4
1270532|NCT00443703|4156603|P1|Overall Study|Lost to Follow-up|0
1270533|NCT00443703|4156602|P2|Overall Study|Lack of Efficacy|1
1270534|NCT00443703|4156603|P1|Overall Study|Lack of Efficacy|3
1270535|NCT00443703|4156602|P2|Overall Study|Adverse Event|3
1270536|NCT00443703|4156603|P1|Overall Study|Adverse Event|7
1270537|NCT00443703|4156602|P2|Overall Study|Never Treated|1
1270538|NCT00443703|4156603|P1|Overall Study|Never Treated|3
1270539|NCT00443651|4156655|P2|Overall Study|Pregnancy|1
1270540|NCT00443651|4156656|P1|Overall Study|Pregnancy|0
1270541|NCT00443651|4156655|P2|Overall Study|Physician Decision|4
1270542|NCT00443651|4156656|P1|Overall Study|Physician Decision|13
1270543|NCT00443651|4156655|P2|Overall Study|Patient's/Guardian's Decision|30
1270544|NCT00443651|4156656|P1|Overall Study|Patient's/Guardian's Decision|58
1270545|NCT00443651|4156655|P2|Overall Study|Lost to Follow-up|12
1270546|NCT00443651|4156656|P1|Overall Study|Lost to Follow-up|18
1270547|NCT00443651|4156655|P2|Overall Study|Adverse Event|6
1270548|NCT00443651|4156656|P1|Overall Study|Adverse Event|5
1270549|NCT00443651|4156655|P2|Overall Study|Death|5
1270550|NCT00443651|4156656|P1|Overall Study|Death|1
1270551|NCT00443599|4156676|P2|Overall Study|Cardiopulmonary bypass canceled|1
1270552|NCT00443599|4156677|P1|Overall Study|Cardiopulmonary bypass canceled|3
1270553|NCT00443599|4156676|P2|Overall Study|Death|1
1270554|NCT00443599|4156677|P1|Overall Study|Death|1
1270555|NCT00443599|4156676|P2|Overall Study|Physician Decision|1
1270556|NCT00443599|4156677|P1|Overall Study|Physician Decision|2
1270557|NCT00443560|4156711|P2|Overall Study|Multiple pregnancies or fetal demise|4
1270558|NCT00443560|4156712|P1|Overall Study|Multiple pregnancies or fetal demise|2
1270559|NCT00443560|4156711|P2|Overall Study|No intrathecal dose|26
1270560|NCT00443560|4156712|P1|Overall Study|No intrathecal dose|58
1270561|NCT00443534|4156722|P1|Overall Study|Enrolled, Not Treated|1
1270562|NCT00443534|4156722|P1|Overall Study|Other|10
1270563|NCT00443534|4156722|P1|Overall Study|Study Terminated by Sponsor|12
1270564|NCT00443534|4156722|P1|Overall Study|Withdrawal by Subject|8
1270565|NCT00443534|4156722|P1|Overall Study|Death|9
1270566|NCT00443534|4156722|P1|Overall Study|Adverse Event|16
1270567|NCT00443534|4156722|P1|Overall Study|Lack of Efficacy|67
1270568|NCT00443456|4156729|P1|Overall Study|Withdrawal by Subject|1
1270569|NCT00443456|4156729|P1|Overall Study|Move|1
1270570|NCT00443456|4156729|P1|Overall Study|Adverse Event|16
1270571|NCT00443430|4156764|P2|Overall Study|Adverse Event|1
1270572|NCT00443430|4156765|P1|Overall Study|Adverse Event|1
1270573|NCT00443430|4156764|P2|Overall Study|Lack of Efficacy|3
1270574|NCT00443430|4156765|P1|Overall Study|Lack of Efficacy|3
1270575|NCT00443261|4156779|P1|Overall Study|Death|1
1270576|NCT00443209|4156785|P2|Months 13 to 18 Treatment Period|Withdrawal by Subject|2
1270577|NCT00443209|4156786|P1|Months 13 to 18 Treatment Period|Withdrawal by Subject|7
1270578|NCT00443209|4156785|P2|Months 13 to 18 Treatment Period|Trial Terminated|43
1270579|NCT00443209|4156786|P1|Months 13 to 18 Treatment Period|Trial Terminated|87
1270580|NCT00443209|4156785|P2|Months 13 to 18 Treatment Period|Lost to Follow-up|2
1270581|NCT00443209|4156786|P1|Months 13 to 18 Treatment Period|Lost to Follow-up|2
1270582|NCT00443209|4156785|P2|Months 13 to 18 Treatment Period|Lack of Efficacy|0
1270583|NCT00443209|4156786|P1|Months 13 to 18 Treatment Period|Lack of Efficacy|1
1270584|NCT00443209|4156785|P2|Months 13 to 18 Treatment Period|Protocol Violation|0
1270585|NCT00443209|4156786|P1|Months 13 to 18 Treatment Period|Protocol Violation|1
1270586|NCT00443209|4156785|P2|Months 13 to 18 Treatment Period|Adverse Event|0
1270587|NCT00443209|4156786|P1|Months 13 to 18 Treatment Period|Adverse Event|1
1270588|NCT00443209|4156785|P2|Months 1 to 12 Treatment Period|Not Treated|43
1270589|NCT00443209|4156786|P1|Months 1 to 12 Treatment Period|Not Treated|71
1270590|NCT00443209|4156785|P2|Months 1 to 12 Treatment Period|Missing|1
1270591|NCT00443209|4156786|P1|Months 1 to 12 Treatment Period|Missing|2
1270592|NCT00443209|4156785|P2|Months 1 to 12 Treatment Period|Withdrawal by Subject|34
1270593|NCT00443209|4156786|P1|Months 1 to 12 Treatment Period|Withdrawal by Subject|95
1270594|NCT00443209|4156785|P2|Months 1 to 12 Treatment Period|Trial Terminated|23
1270595|NCT00443209|4156786|P1|Months 1 to 12 Treatment Period|Trial Terminated|43
1270596|NCT00443209|4156785|P2|Months 1 to 12 Treatment Period|Pregnancy|4
1270597|NCT00443209|4156786|P1|Months 1 to 12 Treatment Period|Pregnancy|3
1270598|NCT00443209|4156785|P2|Months 1 to 12 Treatment Period|Physician Decision|4
1270599|NCT00443209|4156786|P1|Months 1 to 12 Treatment Period|Physician Decision|8
1270600|NCT00443209|4156785|P2|Months 1 to 12 Treatment Period|Lost to Follow-up|15
1270601|NCT00443209|4156786|P1|Months 1 to 12 Treatment Period|Lost to Follow-up|36
1270602|NCT00443209|4156785|P2|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
1270603|NCT00443209|4156786|P1|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
1270604|NCT00443209|4156785|P2|Months 1 to 12 Treatment Period|Lack of Efficacy|11
1270605|NCT00443209|4156786|P1|Months 1 to 12 Treatment Period|Lack of Efficacy|50
1270606|NCT00443209|4156785|P2|Months 1 to 12 Treatment Period|Protocol Violation|7
1270607|NCT00443209|4156786|P1|Months 1 to 12 Treatment Period|Protocol Violation|14
1270608|NCT00443209|4156785|P2|Months 1 to 12 Treatment Period|Adverse Event|11
1270609|NCT00443209|4156786|P1|Months 1 to 12 Treatment Period|Adverse Event|22
1270610|NCT00443118|4156803|P3|Overall Study|Withdrawal by Subject|0
1270611|NCT00443118|4156804|P2|Overall Study|Withdrawal by Subject|0
1270612|NCT00443118|4156805|P1|Overall Study|Withdrawal by Subject|1
1270613|NCT00443118|4156803|P3|Overall Study|unknown primary outcome|0
1270614|NCT00443118|4156804|P2|Overall Study|unknown primary outcome|1
1270615|NCT00443118|4156805|P1|Overall Study|unknown primary outcome|3
1270616|NCT00443053|4156854|P2|Overall Study|Physician Decision|4
1270617|NCT00443053|4156855|P1|Overall Study|Physician Decision|0
1270618|NCT00443053|4156854|P2|Overall Study|Other|4
1270619|NCT00443053|4156855|P1|Overall Study|Other|3
1270620|NCT00443053|4156854|P2|Overall Study|Noncompliance|1
1270621|NCT00443053|4156855|P1|Overall Study|Noncompliance|2
1270622|NCT00443053|4156854|P2|Overall Study|Did Not Meet Eligibility Criteria|0
1270623|NCT00443053|4156855|P1|Overall Study|Did Not Meet Eligibility Criteria|1
1270624|NCT00443053|4156854|P2|Overall Study|Lost to Follow-up|5
1270625|NCT00443053|4156855|P1|Overall Study|Lost to Follow-up|4
1270626|NCT00443053|4156854|P2|Overall Study|Withdrawal by Subject|18
1270627|NCT00443053|4156855|P1|Overall Study|Withdrawal by Subject|9
1270628|NCT00443053|4156854|P2|Overall Study|Adverse Event|1
1270629|NCT00443053|4156855|P1|Overall Study|Adverse Event|2
1270630|NCT00443040|4156876|P3|Overall Study|Converted to an open laparotomy|1
1270631|NCT00443040|4156877|P2|Overall Study|Converted to an open laparotomy|0
1270632|NCT00443040|4156878|P1|Overall Study|Converted to an open laparotomy|3
1270633|NCT00443040|4156876|P3|Overall Study|Withdrawal by Subject|0
1270634|NCT00443040|4156877|P2|Overall Study|Withdrawal by Subject|0
1270635|NCT00443040|4156878|P1|Overall Study|Withdrawal by Subject|1
1270636|NCT00442962|4156886|P1|Overall Study|Lost to Follow-up|7
1270637|NCT00442962|4156886|P1|Overall Study|Pregnancy|1
1270638|NCT00442936|4156904|P4|Overall Study|Protocol Violation|1
1270639|NCT00442936|4156905|P3|Overall Study|Protocol Violation|1
1270640|NCT00442936|4156906|P2|Overall Study|Protocol Violation|0
1270641|NCT00442936|4156907|P1|Overall Study|Protocol Violation|1
1270642|NCT00442897|4156955|P2|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3
1270643|NCT00442897|4156956|P1|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1
1270644|NCT00442897|4156955|P2|24 Weeks Follow-up (3 Centers)|Protocol Violation|1
1270645|NCT00442897|4156956|P1|24 Weeks Follow-up (3 Centers)|Protocol Violation|2
1270646|NCT00442897|4156955|P2|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
1270647|NCT00442897|4156956|P1|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
1270648|NCT00442897|4156955|P2|24 Weeks Follow-up (3 Centers)|Adverse Event|0
1270649|NCT00442897|4156956|P1|24 Weeks Follow-up (3 Centers)|Adverse Event|1
1270650|NCT00442897|4156955|P2|Base Study (12 Week Follow-up)|Withdrawal by Subject|8
1270651|NCT00442897|4156956|P1|Base Study (12 Week Follow-up)|Withdrawal by Subject|9
1270652|NCT00442897|4156955|P2|Base Study (12 Week Follow-up)|Protocol Violation|3
1270653|NCT00442897|4156956|P1|Base Study (12 Week Follow-up)|Protocol Violation|7
1270654|NCT00442897|4156955|P2|Base Study (12 Week Follow-up)|Death|1
1270655|NCT00442897|4156956|P1|Base Study (12 Week Follow-up)|Death|0
1270656|NCT00442897|4156955|P2|Base Study (12 Week Follow-up)|Adverse Event|0
1270657|NCT00442897|4156956|P1|Base Study (12 Week Follow-up)|Adverse Event|1
1270658|NCT00442702|4156974|P2|Evaluation Period|Site closure|1
1270659|NCT00442702|4156975|P1|Evaluation Period|Site closure|0
1270660|NCT00442702|4156974|P2|Evaluation Period|Failure to return|0
1270661|NCT00442702|4156975|P1|Evaluation Period|Failure to return|1
1270662|NCT00442702|4156974|P2|Evaluation Period|Renal transplant|1
1270663|NCT00442702|4156975|P1|Evaluation Period|Renal transplant|0
1270664|NCT00442702|4156974|P2|Evaluation Period|Refused treatment|1
1270665|NCT00442702|4156975|P1|Evaluation Period|Refused treatment|1
1270666|NCT00442702|4156974|P2|Evaluation Period|Insufficient Therapeutic Response|0
1270667|NCT00442702|4156975|P1|Evaluation Period|Insufficient Therapeutic Response|1
1270668|NCT00442702|4156974|P2|Evaluation Period|Death|1
1270669|NCT00442702|4156975|P1|Evaluation Period|Death|1
1270670|NCT00442702|4156974|P2|Evaluation Period|Adverse Event|0
1270671|NCT00442702|4156975|P1|Evaluation Period|Adverse Event|1
1270672|NCT00442702|4156974|P2|Titration Period|Hospitalized in another hospital|0
1270673|NCT00442702|4156975|P1|Titration Period|Hospitalized in another hospital|1
1270674|NCT00442702|4156974|P2|Titration Period|Failure to return|0
1270675|NCT00442702|4156975|P1|Titration Period|Failure to return|1
1270676|NCT00442702|4156974|P2|Titration Period|Refused Treatment|1
1270677|NCT00442702|4156975|P1|Titration Period|Refused Treatment|4
1270678|NCT00442702|4156974|P2|Titration Period|Insufficient Therapeutic Response|0
1270679|NCT00442702|4156975|P1|Titration Period|Insufficient Therapeutic Response|1
1270680|NCT00442702|4156974|P2|Titration Period|Death|2
1270681|NCT00442702|4156975|P1|Titration Period|Death|3
1270682|NCT00442702|4156974|P2|Titration Period|Adverse Event|0
1270683|NCT00442702|4156975|P1|Titration Period|Adverse Event|2
1270684|NCT00442598|4157040|P3|Overall Study|Death|0
1270685|NCT00442598|4157041|P2|Overall Study|Death|1
1270686|NCT00442598|4157042|P1|Overall Study|Death|0
1270687|NCT00442598|4157040|P3|Overall Study|Reduced creatinine clearance|0
1270688|NCT00442598|4157041|P2|Overall Study|Reduced creatinine clearance|0
1270689|NCT00442598|4157042|P1|Overall Study|Reduced creatinine clearance|1
1270690|NCT00442598|4157040|P3|Overall Study|CA125 progression|0
1270691|NCT00442598|4157041|P2|Overall Study|CA125 progression|1
1270692|NCT00442598|4157042|P1|Overall Study|CA125 progression|0
1270693|NCT00442598|4157040|P3|Overall Study|Clinical deterioration|0
1270694|NCT00442598|4157041|P2|Overall Study|Clinical deterioration|2
1270695|NCT00442598|4157042|P1|Overall Study|Clinical deterioration|1
1270696|NCT00442598|4157040|P3|Overall Study|Tumor progression|0
1270697|NCT00442598|4157041|P2|Overall Study|Tumor progression|4
1270698|NCT00442598|4157042|P1|Overall Study|Tumor progression|3
1270699|NCT00442598|4157040|P3|Overall Study|Adverse Event|0
1270700|NCT00442598|4157041|P2|Overall Study|Adverse Event|0
1270701|NCT00442598|4157042|P1|Overall Study|Adverse Event|1
1270702|NCT00442572|4157060|P2|Overall Study|Withdrawal by Subject|1
1270703|NCT00442572|4157061|P1|Overall Study|Withdrawal by Subject|0
1270704|NCT00442572|4157060|P2|Overall Study|Lost to Follow-up|1
1270705|NCT00442572|4157061|P1|Overall Study|Lost to Follow-up|0
1270706|NCT00442572|4157060|P2|Overall Study|Relapse|1
1270707|NCT00442572|4157061|P1|Overall Study|Relapse|8
1270708|NCT00442559|4157101|P2|Overall Study|Withdrawal by Subject|0
1270709|NCT00442559|4157102|P1|Overall Study|Withdrawal by Subject|1
1270710|NCT00442559|4157101|P2|Overall Study|Protocol Violation|1
1270711|NCT00442559|4157102|P1|Overall Study|Protocol Violation|1
1270712|NCT00442559|4157101|P2|Overall Study|Lost to Follow-up|34
1270713|NCT00442559|4157102|P1|Overall Study|Lost to Follow-up|32
1270714|NCT00442546|4157117|P3|Overall Study|Randomized But Not Treated|6
1270715|NCT00442546|4157118|P2|Overall Study|Randomized But Not Treated|4
1270716|NCT00442546|4157119|P1|Overall Study|Randomized But Not Treated|5
1270717|NCT00442546|4157117|P3|Overall Study|Withdrawal by Subject|7
1270718|NCT00442546|4157118|P2|Overall Study|Withdrawal by Subject|5
1270719|NCT00442546|4157119|P1|Overall Study|Withdrawal by Subject|5
1270720|NCT00442546|4157117|P3|Overall Study|Other|6
1270721|NCT00442546|4157118|P2|Overall Study|Other|9
1270722|NCT00442546|4157119|P1|Overall Study|Other|4
1270723|NCT00442546|4157117|P3|Overall Study|Lost to Follow-up|1
1270724|NCT00442546|4157118|P2|Overall Study|Lost to Follow-up|2
1270725|NCT00442546|4157119|P1|Overall Study|Lost to Follow-up|1
1270726|NCT00442546|4157117|P3|Overall Study|Adverse Event|13
1270727|NCT00442546|4157118|P2|Overall Study|Adverse Event|17
1270728|NCT00442546|4157119|P1|Overall Study|Adverse Event|11
1270729|NCT00442468|4157248|P1|Overall Study|Did not complete all study procedures|88
1270730|NCT00442468|4157248|P1|Overall Study|Withdrawal by Subject|91
1270731|NCT00442468|4157248|P1|Overall Study|Adverse Event|4
1270732|NCT00442416|4157278|P2|Overall Study|Administrative/Other|33
1270733|NCT00442416|4157279|P1|Overall Study|Administrative/Other|27
1270734|NCT00442416|4157278|P2|Overall Study|Withdrew consent|2
1270735|NCT00442416|4157279|P1|Overall Study|Withdrew consent|1
1270736|NCT00442416|4157278|P2|Overall Study|Protocol Violation|3
1270737|NCT00442416|4157279|P1|Overall Study|Protocol Violation|2
1270738|NCT00442416|4157278|P2|Overall Study|Lack of Efficacy|0
1270739|NCT00442416|4157279|P1|Overall Study|Lack of Efficacy|2
1270740|NCT00442416|4157278|P2|Overall Study|Death|0
1270741|NCT00442416|4157279|P1|Overall Study|Death|1
1270742|NCT00442416|4157278|P2|Overall Study|Adverse Event|1
1270743|NCT00442416|4157279|P1|Overall Study|Adverse Event|4
1270744|NCT00442351|4157318|P2|Overall Study|Not specified|1
1270745|NCT00442351|4157319|P1|Overall Study|Not specified|0
1270746|NCT00442351|4157318|P2|Overall Study|Did not meet protocol eligibility|0
1270747|NCT00442351|4157319|P1|Overall Study|Did not meet protocol eligibility|1
1270748|NCT00442351|4157318|P2|Overall Study|Administrative|5
1270749|NCT00442351|4157319|P1|Overall Study|Administrative|6
1270750|NCT00442286|4157341|P2|Overall Study|Patient Injury|0
1270751|NCT00442286|4157342|P1|Overall Study|Patient Injury|1
1270752|NCT00442286|4157341|P2|Overall Study|System explanted|0
1270753|NCT00442286|4157342|P1|Overall Study|System explanted|1
1270754|NCT00442286|4157341|P2|Overall Study|Withdrawal by Subject|0
1270755|NCT00442286|4157342|P1|Overall Study|Withdrawal by Subject|2
1270756|NCT00442286|4157341|P2|Overall Study|Lost to Follow-up|0
1270757|NCT00442286|4157342|P1|Overall Study|Lost to Follow-up|1
1270758|NCT00442286|4157341|P2|Overall Study|Death|2
1270759|NCT00442286|4157342|P1|Overall Study|Death|2
1270760|NCT00442117|4157404|P2|Overall Study|Met Withdrawal Criteria|1
1270761|NCT00442117|4157405|P1|Overall Study|Met Withdrawal Criteria|2
1270762|NCT00442117|4157404|P2|Overall Study|Non compliance with protocol|5
1270763|NCT00442117|4157405|P1|Overall Study|Non compliance with protocol|3
1270764|NCT00442117|4157404|P2|Overall Study|Major Deviation|20
1270765|NCT00442117|4157405|P1|Overall Study|Major Deviation|25
1270766|NCT00442117|4157404|P2|Overall Study|Withdrawal by Subject|2
1270767|NCT00442117|4157405|P1|Overall Study|Withdrawal by Subject|2
1270768|NCT00442117|4157404|P2|Overall Study|Lost to Follow-up|2
1270769|NCT00442117|4157405|P1|Overall Study|Lost to Follow-up|1
1270770|NCT00442117|4157404|P2|Overall Study|Lack of Efficacy|6
1270771|NCT00442117|4157405|P1|Overall Study|Lack of Efficacy|2
1270772|NCT00442117|4157404|P2|Overall Study|Adverse Event|2
1270773|NCT00442117|4157405|P1|Overall Study|Adverse Event|3
1270774|NCT00441974|4157436|P1|Overall Study|Protocol Violation|7
1270775|NCT00441974|4157436|P1|Overall Study|Lost to Follow-up|80
1270776|NCT00441974|4157436|P1|Overall Study|Consent Withdrawn|35
1270777|NCT00441974|4157436|P1|Overall Study|Adverse Event|6
1270778|NCT00441792|4157452|P2|Overall Study|Lost to Follow-up|2
1270779|NCT00441792|4157453|P1|Overall Study|Lost to Follow-up|0
1270780|NCT00441727|4157493|P3|Overall Study|Various reason specified|5
1270781|NCT00441727|4157494|P2|Overall Study|Various reason specified|8
1270782|NCT00441727|4157495|P1|Overall Study|Various reason specified|6
1270783|NCT00441727|4157493|P3|Overall Study|Safety Reasons|3
1270784|NCT00441727|4157494|P2|Overall Study|Safety Reasons|1
1270785|NCT00441727|4157495|P1|Overall Study|Safety Reasons|3
1270786|NCT00441727|4157493|P3|Overall Study|Lost to Follow-up|5
1270787|NCT00441727|4157494|P2|Overall Study|Lost to Follow-up|6
1270788|NCT00441727|4157495|P1|Overall Study|Lost to Follow-up|5
1270789|NCT00441727|4157493|P3|Overall Study|Withdrawal by Subject|47
1270790|NCT00441727|4157494|P2|Overall Study|Withdrawal by Subject|34
1270791|NCT00441727|4157495|P1|Overall Study|Withdrawal by Subject|40
1270792|NCT00441727|4157493|P3|Overall Study|Lack of Efficacy|48
1270793|NCT00441727|4157494|P2|Overall Study|Lack of Efficacy|8
1270794|NCT00441727|4157495|P1|Overall Study|Lack of Efficacy|7
1270795|NCT00441727|4157493|P3|Overall Study|Adverse Event|28
1270796|NCT00441727|4157494|P2|Overall Study|Adverse Event|33
1270797|NCT00441727|4157495|P1|Overall Study|Adverse Event|26
1270798|NCT00441727|4157493|P3|Overall Study|Protocol Violation|32
1270799|NCT00441727|4157494|P2|Overall Study|Protocol Violation|28
1270800|NCT00441727|4157495|P1|Overall Study|Protocol Violation|19
1270801|NCT00441701|4157528|P10|Overall Study|Withdrawal by Subject|0
1270802|NCT00441701|4157529|P9|Overall Study|Withdrawal by Subject|0
1270803|NCT00441701|4157530|P8|Overall Study|Withdrawal by Subject|0
1270804|NCT00441701|4157531|P7|Overall Study|Withdrawal by Subject|0
1270805|NCT00441701|4157532|P6|Overall Study|Withdrawal by Subject|0
1270806|NCT00441701|4157533|P5|Overall Study|Withdrawal by Subject|0
1270807|NCT00441701|4157534|P4|Overall Study|Withdrawal by Subject|1
1270808|NCT00441701|4157535|P3|Overall Study|Withdrawal by Subject|1
1270809|NCT00441701|4157536|P2|Overall Study|Withdrawal by Subject|2
1270810|NCT00441701|4157537|P1|Overall Study|Withdrawal by Subject|0
1270811|NCT00441701|4157528|P10|Overall Study|Lack of Efficacy|0
1270812|NCT00441701|4157529|P9|Overall Study|Lack of Efficacy|0
1270813|NCT00441701|4157530|P8|Overall Study|Lack of Efficacy|0
1270814|NCT00441701|4157531|P7|Overall Study|Lack of Efficacy|0
1270815|NCT00441701|4157532|P6|Overall Study|Lack of Efficacy|1
1270816|NCT00441701|4157533|P5|Overall Study|Lack of Efficacy|0
1270817|NCT00441701|4157534|P4|Overall Study|Lack of Efficacy|2
1270818|NCT00441701|4157535|P3|Overall Study|Lack of Efficacy|2
1270819|NCT00441701|4157536|P2|Overall Study|Lack of Efficacy|0
1270820|NCT00441701|4157537|P1|Overall Study|Lack of Efficacy|2
1270821|NCT00441701|4157528|P10|Overall Study|Adverse Event|0
1270822|NCT00441701|4157529|P9|Overall Study|Adverse Event|0
1270823|NCT00441701|4157530|P8|Overall Study|Adverse Event|0
1270824|NCT00441701|4157531|P7|Overall Study|Adverse Event|0
1270825|NCT00441701|4157532|P6|Overall Study|Adverse Event|2
1270826|NCT00441701|4157533|P5|Overall Study|Adverse Event|2
1270827|NCT00441701|4157534|P4|Overall Study|Adverse Event|0
1270828|NCT00441701|4157535|P3|Overall Study|Adverse Event|1
1270829|NCT00441701|4157536|P2|Overall Study|Adverse Event|2
1270830|NCT00441701|4157537|P1|Overall Study|Adverse Event|3
1270831|NCT00441584|4157619|P1|Overall Study|Failure to meet eligibility criteria|3
1270832|NCT00441584|4157619|P1|Overall Study|Lost to Follow-up|4
1270833|NCT00441584|4157619|P1|Overall Study|Protocol Violation|5
1270834|NCT00441584|4157619|P1|Overall Study|Adverse Event|6
1270835|NCT00441584|4157619|P1|Overall Study|Withdrawal by Subject|8
1270836|NCT00441584|4157619|P1|Overall Study|Lack of Efficacy|79
1270837|NCT00441545|4157627|P2|Second Intervention|Subject moved|1
1270838|NCT00441545|4157628|P1|Second Intervention|Subject moved|0
1270839|NCT00441545|4157627|P2|Second Intervention|Subject exceeded safety criteria|0
1270840|NCT00441545|4157628|P1|Second Intervention|Subject exceeded safety criteria|1
1270841|NCT00441545|4157627|P2|Second Intervention|Lack of Efficacy|1
1270842|NCT00441545|4157628|P1|Second Intervention|Lack of Efficacy|0
1270843|NCT00441545|4157627|P2|Second Intervention|Kidney Transplant|1
1270844|NCT00441545|4157628|P1|Second Intervention|Kidney Transplant|1
1270845|NCT00441545|4157627|P2|Second Intervention|Withdrawal by Subject|1
1270846|NCT00441545|4157628|P1|Second Intervention|Withdrawal by Subject|1
1270847|NCT00441545|4157627|P2|Second Intervention|Protocol Violation|1
1270848|NCT00441545|4157628|P1|Second Intervention|Protocol Violation|4
1270849|NCT00441545|4157627|P2|Second Intervention|Adverse Event|2
1270850|NCT00441545|4157628|P1|Second Intervention|Adverse Event|5
1270851|NCT00441545|4157627|P2|First Intervention|Sponsor's request|0
1270852|NCT00441545|4157628|P1|First Intervention|Sponsor's request|1
1270853|NCT00441545|4157627|P2|First Intervention|Site error|0
1270854|NCT00441545|4157628|P1|First Intervention|Site error|1
1270855|NCT00441545|4157627|P2|First Intervention|Extended hospitalization|0
1270856|NCT00441545|4157628|P1|First Intervention|Extended hospitalization|1
1270857|NCT00441545|4157627|P2|First Intervention|Subject met an exclusionary criteria|0
1270858|NCT00441545|4157628|P1|First Intervention|Subject met an exclusionary criteria|1
1270859|NCT00441545|4157627|P2|First Intervention|Subject exceeded safety criteria|1
1270860|NCT00441545|4157628|P1|First Intervention|Subject exceeded safety criteria|0
1270861|NCT00441545|4157627|P2|First Intervention|Lack of Efficacy|0
1270862|NCT00441545|4157628|P1|First Intervention|Lack of Efficacy|2
1270863|NCT00441545|4157627|P2|First Intervention|Kidney transplant|1
1270864|NCT00441545|4157628|P1|First Intervention|Kidney transplant|1
1270865|NCT00441545|4157627|P2|First Intervention|Withdrawal by Subject|3
1270866|NCT00441545|4157628|P1|First Intervention|Withdrawal by Subject|3
1270867|NCT00441545|4157627|P2|First Intervention|Protocol Violation|2
1270868|NCT00441545|4157628|P1|First Intervention|Protocol Violation|2
1270869|NCT00441545|4157627|P2|First Intervention|Adverse Event|5
1270870|NCT00441545|4157628|P1|First Intervention|Adverse Event|6
1270871|NCT00441480|4157642|P2|Overall Study|Withdrawal by Subject|3
1270872|NCT00441480|4157643|P1|Overall Study|Withdrawal by Subject|2
1270873|NCT00441480|4157642|P2|Overall Study|Protocol Violation|1
1270874|NCT00441480|4157643|P1|Overall Study|Protocol Violation|1
1270875|NCT00441467|4157675|P1|Overall Study|Progressive disease|9
1270876|NCT00441467|4157675|P1|Overall Study|Withdrawal by Subject|3
1270877|NCT00441467|4157675|P1|Overall Study|Adverse Event|6
1270878|NCT00441441|4157683|P2|Overall Study|Not specified|3
1270879|NCT00441441|4157684|P1|Overall Study|Not specified|3
1270880|NCT00441441|4157683|P2|Overall Study|Withdrawal by Subject|2
1270881|NCT00441441|4157684|P1|Overall Study|Withdrawal by Subject|1
1270882|NCT00441441|4157683|P2|Overall Study|Exacerbation of asthma|2
1270883|NCT00441441|4157684|P1|Overall Study|Exacerbation of asthma|1
1270884|NCT00441441|4157683|P2|Overall Study|Protocol Violation|6
1270885|NCT00441441|4157684|P1|Overall Study|Protocol Violation|4
1270886|NCT00441441|4157683|P2|Overall Study|Adverse Event|1
1270887|NCT00441441|4157684|P1|Overall Study|Adverse Event|2
1270888|NCT00441363|4157744|P2|Overall Study|not specified|0
1270889|NCT00441363|4157745|P1|Overall Study|not specified|2
1270890|NCT00441363|4157744|P2|Overall Study|Lost to Follow-up|2
1270891|NCT00441363|4157745|P1|Overall Study|Lost to Follow-up|2
1270892|NCT00441363|4157744|P2|Overall Study|Physician Decision|7
1270893|NCT00441363|4157745|P1|Overall Study|Physician Decision|6
1270894|NCT00441363|4157744|P2|Overall Study|Withdrawal by Subject|4
1270895|NCT00441363|4157745|P1|Overall Study|Withdrawal by Subject|3
1270896|NCT00441363|4157744|P2|Overall Study|Adverse Event|2
1270897|NCT00441363|4157745|P1|Overall Study|Adverse Event|4
1270898|NCT00441337|4157757|P4|Overall Study|Did not meet inclusion criteria|0
1270899|NCT00441337|4157758|P3|Overall Study|Did not meet inclusion criteria|1
1270900|NCT00441337|4157759|P2|Overall Study|Did not meet inclusion criteria|0
1270901|NCT00441337|4157760|P1|Overall Study|Did not meet inclusion criteria|0
1270902|NCT00441337|4157757|P4|Overall Study|Sponsor Decision|2
1270903|NCT00441337|4157758|P3|Overall Study|Sponsor Decision|1
1270904|NCT00441337|4157759|P2|Overall Study|Sponsor Decision|0
1270905|NCT00441337|4157760|P1|Overall Study|Sponsor Decision|0
1270906|NCT00441337|4157757|P4|Overall Study|Lost to Follow-up|1
1270907|NCT00441337|4157758|P3|Overall Study|Lost to Follow-up|0
1270908|NCT00441337|4157759|P2|Overall Study|Lost to Follow-up|0
1270909|NCT00441337|4157760|P1|Overall Study|Lost to Follow-up|0
1270910|NCT00441337|4157757|P4|Overall Study|Disease Progression|18
1270911|NCT00441337|4157758|P3|Overall Study|Disease Progression|4
1270912|NCT00441337|4157759|P2|Overall Study|Disease Progression|6
1270913|NCT00441337|4157760|P1|Overall Study|Disease Progression|6
1270914|NCT00441272|4157873|P2|Overall Study|Study terminated prior to enrollment|25
1270915|NCT00441272|4157874|P1|Overall Study|Study terminated prior to enrollment|25
1270916|NCT00441168|4157901|P2|Follow-up Period|Other|3
1270917|NCT00441168|4157902|P1|Follow-up Period|Other|1
1270918|NCT00441168|4157901|P2|Follow-up Period|Withdrawal by Subject|0
1270919|NCT00441168|4157902|P1|Follow-up Period|Withdrawal by Subject|3
1270920|NCT00441168|4157901|P2|Follow-up Period|Lost to Follow-up|6
1270921|NCT00441168|4157902|P1|Follow-up Period|Lost to Follow-up|5
1270922|NCT00441168|4157901|P2|Follow-up Period|Death|0
1270923|NCT00441168|4157902|P1|Follow-up Period|Death|3
1270924|NCT00441168|4157901|P2|Treatment Period|refractory disease|0
1270925|NCT00441168|4157902|P1|Treatment Period|refractory disease|1
1270926|NCT00441168|4157901|P2|Treatment Period|qualified for stem-cell transplantation|0
1270927|NCT00441168|4157902|P1|Treatment Period|qualified for stem-cell transplantation|3
1270928|NCT00441168|4157901|P2|Treatment Period|Withdrawal by Subject|0
1270929|NCT00441168|4157902|P1|Treatment Period|Withdrawal by Subject|3
1270930|NCT00441168|4157901|P2|Treatment Period|Lost to Follow-up|1
1270931|NCT00441168|4157902|P1|Treatment Period|Lost to Follow-up|0
1270932|NCT00441168|4157901|P2|Treatment Period|Protocol Violation|1
1270933|NCT00441168|4157902|P1|Treatment Period|Protocol Violation|0
1270934|NCT00441168|4157901|P2|Treatment Period|Progressive Disease|2
1270935|NCT00441168|4157902|P1|Treatment Period|Progressive Disease|0
1270936|NCT00441168|4157901|P2|Treatment Period|Adverse Event|2
1270937|NCT00441168|4157902|P1|Treatment Period|Adverse Event|1
1270938|NCT00441168|4157901|P2|Treatment Period|Death|0
1270939|NCT00441168|4157902|P1|Treatment Period|Death|3
1270940|NCT00441142|4157916|P4|Overall Study|Death|1
1270941|NCT00441142|4157917|P3|Overall Study|Death|0
1270942|NCT00441142|4157918|P2|Overall Study|Death|0
1270943|NCT00441142|4157919|P1|Overall Study|Death|0
1270944|NCT00441142|4157916|P4|Overall Study|Physician Decision|1
1270945|NCT00441142|4157917|P3|Overall Study|Physician Decision|0
1270946|NCT00441142|4157918|P2|Overall Study|Physician Decision|1
1270947|NCT00441142|4157919|P1|Overall Study|Physician Decision|0
1270948|NCT00441142|4157916|P4|Overall Study|Patient still receiving active study tx|2
1270949|NCT00441142|4157917|P3|Overall Study|Patient still receiving active study tx|0
1270950|NCT00441142|4157918|P2|Overall Study|Patient still receiving active study tx|0
1270951|NCT00441142|4157919|P1|Overall Study|Patient still receiving active study tx|1
1270952|NCT00441142|4157916|P4|Overall Study|Withdrawal by Subject|10
1270953|NCT00441142|4157917|P3|Overall Study|Withdrawal by Subject|2
1270954|NCT00441142|4157918|P2|Overall Study|Withdrawal by Subject|0
1270955|NCT00441142|4157919|P1|Overall Study|Withdrawal by Subject|0
1270956|NCT00441142|4157916|P4|Overall Study|Lack of Efficacy|32
1270957|NCT00441142|4157917|P3|Overall Study|Lack of Efficacy|17
1270958|NCT00441142|4157918|P2|Overall Study|Lack of Efficacy|3
1270959|NCT00441142|4157919|P1|Overall Study|Lack of Efficacy|3
1270960|NCT00441142|4157916|P4|Overall Study|Adverse Event|22
1270961|NCT00441142|4157917|P3|Overall Study|Adverse Event|3
1270962|NCT00441142|4157918|P2|Overall Study|Adverse Event|3
1270963|NCT00441142|4157919|P1|Overall Study|Adverse Event|2
1270964|NCT00441129|4157937|P2|Overall Study|Withdrawal by Subject|14
1270965|NCT00441129|4157938|P1|Overall Study|Withdrawal by Subject|6
1270966|NCT00441116|4157950|P2|Overall Study|Did not meet Eligibility Criteria|1
1270967|NCT00441116|4157951|P1|Overall Study|Did not meet Eligibility Criteria|1
1270968|NCT00441116|4157950|P2|Overall Study|Withdrawal by Subject|0
1270969|NCT00441116|4157951|P1|Overall Study|Withdrawal by Subject|1
1270970|NCT00441116|4157950|P2|Overall Study|Adverse Event|1
1270971|NCT00441116|4157951|P1|Overall Study|Adverse Event|1
1270972|NCT00441103|4158019|P2|Overall Study|Participant decided to stop|1
1270973|NCT00441103|4158020|P1|Overall Study|Participant decided to stop|0
1270974|NCT00441103|4158019|P2|Overall Study|Participant's reason|1
1270975|NCT00441103|4158020|P1|Overall Study|Participant's reason|0
1270976|NCT00441103|4158019|P2|Overall Study|Participant decided to withdraw|0
1270977|NCT00441103|4158020|P1|Overall Study|Participant decided to withdraw|1
1270978|NCT00441103|4158019|P2|Overall Study|Non-compliant|1
1270979|NCT00441103|4158020|P1|Overall Study|Non-compliant|0
1270980|NCT00441103|4158019|P2|Overall Study|Inclusion criteria absent|0
1270981|NCT00441103|4158020|P1|Overall Study|Inclusion criteria absent|1
1270982|NCT00441103|4158019|P2|Overall Study|Participant refused MRI|0
1270983|NCT00441103|4158020|P1|Overall Study|Participant refused MRI|1
1270984|NCT00441103|4158019|P2|Overall Study|Participant unable to use Rebiject II|0
1270985|NCT00441103|4158020|P1|Overall Study|Participant unable to use Rebiject II|1
1270986|NCT00441103|4158019|P2|Overall Study|Protocol Violation|0
1270987|NCT00441103|4158020|P1|Overall Study|Protocol Violation|1
1270988|NCT00441103|4158019|P2|Overall Study|Lost to Follow-up|0
1270989|NCT00441103|4158020|P1|Overall Study|Lost to Follow-up|1
1270990|NCT00441103|4158019|P2|Overall Study|Disease Progression|0
1270991|NCT00441103|4158020|P1|Overall Study|Disease Progression|2
1270992|NCT00441103|4158019|P2|Overall Study|Death|0
1270993|NCT00441103|4158020|P1|Overall Study|Death|1
1270994|NCT00441103|4158019|P2|Overall Study|Adverse Event|1
1270995|NCT00441103|4158020|P1|Overall Study|Adverse Event|2
1270996|NCT00441090|4158036|P5|Overall Study|Lack of Efficacy|0
1270997|NCT00441090|4158037|P4|Overall Study|Lack of Efficacy|0
1270998|NCT00441090|4158038|P3|Overall Study|Lack of Efficacy|0
1270999|NCT00441090|4158039|P2|Overall Study|Lack of Efficacy|0
1271000|NCT00441090|4158040|P1|Overall Study|Lack of Efficacy|1
1271001|NCT00441090|4158036|P5|Overall Study|Withdrawal by Subject|0
1271002|NCT00441090|4158037|P4|Overall Study|Withdrawal by Subject|0
1271003|NCT00441090|4158038|P3|Overall Study|Withdrawal by Subject|1
1271004|NCT00441090|4158039|P2|Overall Study|Withdrawal by Subject|0
1271005|NCT00441090|4158040|P1|Overall Study|Withdrawal by Subject|1
1271006|NCT00441090|4158036|P5|Overall Study|Platelet increase;more than 500,000 mm^3|0
1271007|NCT00441090|4158037|P4|Overall Study|Platelet increase;more than 500,000 mm^3|2
1271008|NCT00441090|4158038|P3|Overall Study|Platelet increase;more than 500,000 mm^3|0
1271009|NCT00441090|4158039|P2|Overall Study|Platelet increase;more than 500,000 mm^3|0
1271010|NCT00441090|4158040|P1|Overall Study|Platelet increase;more than 500,000 mm^3|0
1271011|NCT00441090|4158036|P5|Overall Study|Adverse Event|0
1271012|NCT00441090|4158037|P4|Overall Study|Adverse Event|0
1271013|NCT00441090|4158038|P3|Overall Study|Adverse Event|1
1271014|NCT00441090|4158039|P2|Overall Study|Adverse Event|1
1271015|NCT00441090|4158040|P1|Overall Study|Adverse Event|0
1271016|NCT00441064|4158084|P2|Overall Study|Patient withdrew consent|2
1271017|NCT00441064|4158085|P1|Overall Study|Patient withdrew consent|5
1271018|NCT00441064|4158084|P2|Overall Study|Protocol Deviation|2
1271019|NCT00441064|4158085|P1|Overall Study|Protocol Deviation|3
1271020|NCT00441064|4158084|P2|Overall Study|Unsatisfactory therapeutic effect|0
1271021|NCT00441064|4158085|P1|Overall Study|Unsatisfactory therapeutic effect|1
1271022|NCT00441064|4158084|P2|Overall Study|Abnormal test procedure results|1
1271023|NCT00441064|4158085|P1|Overall Study|Abnormal test procedure results|0
1271024|NCT00441064|4158084|P2|Overall Study|Abnormal laboratory values|2
1271025|NCT00441064|4158085|P1|Overall Study|Abnormal laboratory values|0
1271026|NCT00441064|4158084|P2|Overall Study|Adverse Event|0
1271027|NCT00441064|4158085|P1|Overall Study|Adverse Event|1
1271028|NCT00441012|4158097|P2|Overall Study|Subject Randomized but Not Vaccinated|0
1271029|NCT00441012|4158098|P1|Overall Study|Subject Randomized but Not Vaccinated|1
1271030|NCT00441012|4158097|P2|Overall Study|Withdrawal by Subject|0
1271031|NCT00441012|4158098|P1|Overall Study|Withdrawal by Subject|4
1271032|NCT00441012|4158097|P2|Overall Study|Protocol Violation|9
1271033|NCT00441012|4158098|P1|Overall Study|Protocol Violation|10
1271034|NCT00441012|4158097|P2|Overall Study|Lost to Follow-up|3
1271035|NCT00441012|4158098|P1|Overall Study|Lost to Follow-up|3
1271036|NCT00441012|4158097|P2|Overall Study|Adverse Event|1
1271037|NCT00441012|4158098|P1|Overall Study|Adverse Event|0
1271038|NCT00440947|4158112|P5|Optional 60-Week Extension Phase|Participant Remained in Cuba|1
1271039|NCT00440947|4158113|P4|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
1271040|NCT00440947|4158114|P3|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
1271041|NCT00440947|4158115|P2|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
1271042|NCT00440947|4158116|P1|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
1271043|NCT00440947|4158112|P5|Optional 60-Week Extension Phase|Physician Decision|1
1271044|NCT00440947|4158113|P4|Optional 60-Week Extension Phase|Physician Decision|0
1271045|NCT00440947|4158114|P3|Optional 60-Week Extension Phase|Physician Decision|0
1271046|NCT00440947|4158115|P2|Optional 60-Week Extension Phase|Physician Decision|0
1271047|NCT00440947|4158116|P1|Optional 60-Week Extension Phase|Physician Decision|0
1271048|NCT00440947|4158112|P5|Optional 60-Week Extension Phase|Other|0
1271049|NCT00440947|4158113|P4|Optional 60-Week Extension Phase|Other|1
1271050|NCT00440947|4158114|P3|Optional 60-Week Extension Phase|Other|0
1271051|NCT00440947|4158115|P2|Optional 60-Week Extension Phase|Other|0
1271052|NCT00440947|4158116|P1|Optional 60-Week Extension Phase|Other|0
1271053|NCT00440947|4158112|P5|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
1271054|NCT00440947|4158113|P4|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
1271055|NCT00440947|4158114|P3|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
1271056|NCT00440947|4158115|P2|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
1271057|NCT00440947|4158116|P1|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
1271058|NCT00440947|4158112|P5|Optional 60-Week Extension Phase|Sponsor Request|1
1271059|NCT00440947|4158113|P4|Optional 60-Week Extension Phase|Sponsor Request|1
1271060|NCT00440947|4158114|P3|Optional 60-Week Extension Phase|Sponsor Request|0
1271061|NCT00440947|4158115|P2|Optional 60-Week Extension Phase|Sponsor Request|0
1271062|NCT00440947|4158116|P1|Optional 60-Week Extension Phase|Sponsor Request|0
1271063|NCT00440947|4158112|P5|Optional 60-Week Extension Phase|Participant Moved|1
1271064|NCT00440947|4158113|P4|Optional 60-Week Extension Phase|Participant Moved|1
1271065|NCT00440947|4158114|P3|Optional 60-Week Extension Phase|Participant Moved|0
1271066|NCT00440947|4158115|P2|Optional 60-Week Extension Phase|Participant Moved|0
1271067|NCT00440947|4158116|P1|Optional 60-Week Extension Phase|Participant Moved|0
1271068|NCT00440947|4158112|P5|Optional 60-Week Extension Phase|Pregnancy|0
1271069|NCT00440947|4158113|P4|Optional 60-Week Extension Phase|Pregnancy|3
1271070|NCT00440947|4158114|P3|Optional 60-Week Extension Phase|Pregnancy|0
1271071|NCT00440947|4158115|P2|Optional 60-Week Extension Phase|Pregnancy|0
1271072|NCT00440947|4158116|P1|Optional 60-Week Extension Phase|Pregnancy|0
1271073|NCT00440947|4158112|P5|Optional 60-Week Extension Phase|Withdrawal by Subject|3
1271074|NCT00440947|4158113|P4|Optional 60-Week Extension Phase|Withdrawal by Subject|4
1271075|NCT00440947|4158114|P3|Optional 60-Week Extension Phase|Withdrawal by Subject|0
1271076|NCT00440947|4158115|P2|Optional 60-Week Extension Phase|Withdrawal by Subject|0
1271077|NCT00440947|4158116|P1|Optional 60-Week Extension Phase|Withdrawal by Subject|0
1271078|NCT00440947|4158112|P5|Optional 60-Week Extension Phase|Protocol Violation|0
1271079|NCT00440947|4158113|P4|Optional 60-Week Extension Phase|Protocol Violation|1
1271080|NCT00440947|4158114|P3|Optional 60-Week Extension Phase|Protocol Violation|0
1271081|NCT00440947|4158115|P2|Optional 60-Week Extension Phase|Protocol Violation|0
1271082|NCT00440947|4158116|P1|Optional 60-Week Extension Phase|Protocol Violation|0
1271083|NCT00440947|4158112|P5|Optional 60-Week Extension Phase|Lost to Follow-up|9
1271084|NCT00440947|4158113|P4|Optional 60-Week Extension Phase|Lost to Follow-up|9
1271085|NCT00440947|4158114|P3|Optional 60-Week Extension Phase|Lost to Follow-up|0
1271086|NCT00440947|4158115|P2|Optional 60-Week Extension Phase|Lost to Follow-up|0
1271087|NCT00440947|4158116|P1|Optional 60-Week Extension Phase|Lost to Follow-up|0
1271088|NCT00440947|4158112|P5|Optional 60-Week Extension Phase|Non-compliance|1
1271089|NCT00440947|4158113|P4|Optional 60-Week Extension Phase|Non-compliance|1
1271090|NCT00440947|4158114|P3|Optional 60-Week Extension Phase|Non-compliance|0
1271091|NCT00440947|4158115|P2|Optional 60-Week Extension Phase|Non-compliance|0
1271092|NCT00440947|4158116|P1|Optional 60-Week Extension Phase|Non-compliance|0
1271093|NCT00440947|4158112|P5|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2
1271094|NCT00440947|4158113|P4|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3
1271095|NCT00440947|4158114|P3|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
1271096|NCT00440947|4158115|P2|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
1271097|NCT00440947|4158116|P1|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
1271098|NCT00440947|4158112|P5|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
1271099|NCT00440947|4158113|P4|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
1271100|NCT00440947|4158114|P3|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
1271101|NCT00440947|4158115|P2|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
1271102|NCT00440947|4158116|P1|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
1271103|NCT00440947|4158112|P5|Optional 60-Week Extension Phase|Adverse Event|3
1271104|NCT00440947|4158113|P4|Optional 60-Week Extension Phase|Adverse Event|1
1271105|NCT00440947|4158114|P3|Optional 60-Week Extension Phase|Adverse Event|0
1271106|NCT00440947|4158115|P2|Optional 60-Week Extension Phase|Adverse Event|0
1271107|NCT00440947|4158116|P1|Optional 60-Week Extension Phase|Adverse Event|0
1271108|NCT00440947|4158112|P5|48-Week Randomization Phase|Physician Decision|0
1271109|NCT00440947|4158113|P4|48-Week Randomization Phase|Physician Decision|0
1271110|NCT00440947|4158114|P3|48-Week Randomization Phase|Physician Decision|0
1271111|NCT00440947|4158115|P2|48-Week Randomization Phase|Physician Decision|2
1271112|NCT00440947|4158116|P1|48-Week Randomization Phase|Physician Decision|0
1271113|NCT00440947|4158112|P5|48-Week Randomization Phase|Trying to Get Pregnant|0
1271114|NCT00440947|4158113|P4|48-Week Randomization Phase|Trying to Get Pregnant|0
1271115|NCT00440947|4158114|P3|48-Week Randomization Phase|Trying to Get Pregnant|0
1271116|NCT00440947|4158115|P2|48-Week Randomization Phase|Trying to Get Pregnant|1
1271117|NCT00440947|4158116|P1|48-Week Randomization Phase|Trying to Get Pregnant|0
1271118|NCT00440947|4158112|P5|48-Week Randomization Phase|Incarceration|0
1271119|NCT00440947|4158113|P4|48-Week Randomization Phase|Incarceration|0
1271120|NCT00440947|4158114|P3|48-Week Randomization Phase|Incarceration|0
1271121|NCT00440947|4158115|P2|48-Week Randomization Phase|Incarceration|3
1271122|NCT00440947|4158116|P1|48-Week Randomization Phase|Incarceration|0
1271123|NCT00440947|4158112|P5|48-Week Randomization Phase|Pregnancy|0
1271124|NCT00440947|4158113|P4|48-Week Randomization Phase|Pregnancy|0
1271125|NCT00440947|4158114|P3|48-Week Randomization Phase|Pregnancy|1
1271126|NCT00440947|4158115|P2|48-Week Randomization Phase|Pregnancy|0
1271127|NCT00440947|4158116|P1|48-Week Randomization Phase|Pregnancy|0
1271128|NCT00440947|4158112|P5|48-Week Randomization Phase|Withdrawal by Subject|0
1271129|NCT00440947|4158113|P4|48-Week Randomization Phase|Withdrawal by Subject|0
1271130|NCT00440947|4158114|P3|48-Week Randomization Phase|Withdrawal by Subject|4
1271131|NCT00440947|4158115|P2|48-Week Randomization Phase|Withdrawal by Subject|2
1271132|NCT00440947|4158116|P1|48-Week Randomization Phase|Withdrawal by Subject|0
1271133|NCT00440947|4158112|P5|48-Week Randomization Phase|Protocol Violation|0
1271134|NCT00440947|4158113|P4|48-Week Randomization Phase|Protocol Violation|0
1271135|NCT00440947|4158114|P3|48-Week Randomization Phase|Protocol Violation|1
1271136|NCT00440947|4158115|P2|48-Week Randomization Phase|Protocol Violation|0
1271137|NCT00440947|4158116|P1|48-Week Randomization Phase|Protocol Violation|0
1271138|NCT00440947|4158112|P5|48-Week Randomization Phase|Lost to Follow-up|0
1271139|NCT00440947|4158113|P4|48-Week Randomization Phase|Lost to Follow-up|0
1271140|NCT00440947|4158114|P3|48-Week Randomization Phase|Lost to Follow-up|8
1271141|NCT00440947|4158115|P2|48-Week Randomization Phase|Lost to Follow-up|2
1271142|NCT00440947|4158116|P1|48-Week Randomization Phase|Lost to Follow-up|0
1271143|NCT00440947|4158112|P5|48-Week Randomization Phase|Non-compliance|0
1271144|NCT00440947|4158113|P4|48-Week Randomization Phase|Non-compliance|0
1271145|NCT00440947|4158114|P3|48-Week Randomization Phase|Non-compliance|4
1271146|NCT00440947|4158115|P2|48-Week Randomization Phase|Non-compliance|3
1271147|NCT00440947|4158116|P1|48-Week Randomization Phase|Non-compliance|0
1271148|NCT00440947|4158112|P5|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
1271149|NCT00440947|4158113|P4|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
1271150|NCT00440947|4158114|P3|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
1271151|NCT00440947|4158115|P2|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
1271152|NCT00440947|4158116|P1|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
1271153|NCT00440947|4158112|P5|48-Week Randomization Phase|Adverse Event|0
1271154|NCT00440947|4158113|P4|48-Week Randomization Phase|Adverse Event|0
1271155|NCT00440947|4158114|P3|48-Week Randomization Phase|Adverse Event|5
1271156|NCT00440947|4158115|P2|48-Week Randomization Phase|Adverse Event|2
1271157|NCT00440947|4158116|P1|48-Week Randomization Phase|Adverse Event|0
1271158|NCT00440947|4158112|P5|36-Week Induction Phase|Pregnancy|0
1271159|NCT00440947|4158113|P4|36-Week Induction Phase|Pregnancy|0
1271160|NCT00440947|4158114|P3|36-Week Induction Phase|Pregnancy|0
1271161|NCT00440947|4158115|P2|36-Week Induction Phase|Pregnancy|0
1271162|NCT00440947|4158116|P1|36-Week Induction Phase|Pregnancy|1
1271163|NCT00440947|4158112|P5|36-Week Induction Phase|Incarceration|0
1271164|NCT00440947|4158113|P4|36-Week Induction Phase|Incarceration|0
1271165|NCT00440947|4158114|P3|36-Week Induction Phase|Incarceration|0
1271166|NCT00440947|4158115|P2|36-Week Induction Phase|Incarceration|0
1271167|NCT00440947|4158116|P1|36-Week Induction Phase|Incarceration|3
1271168|NCT00440947|4158112|P5|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
1271169|NCT00440947|4158113|P4|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
1271170|NCT00440947|4158114|P3|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
1271171|NCT00440947|4158115|P2|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
1271172|NCT00440947|4158116|P1|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1
1271173|NCT00440947|4158112|P5|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
1271174|NCT00440947|4158113|P4|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
1271175|NCT00440947|4158114|P3|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
1271176|NCT00440947|4158115|P2|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
1271177|NCT00440947|4158116|P1|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1
1271178|NCT00440947|4158112|P5|36-Week Induction Phase|Took Exclusionary Medications|0
1271179|NCT00440947|4158113|P4|36-Week Induction Phase|Took Exclusionary Medications|0
1271180|NCT00440947|4158114|P3|36-Week Induction Phase|Took Exclusionary Medications|0
1271181|NCT00440947|4158115|P2|36-Week Induction Phase|Took Exclusionary Medications|0
1271182|NCT00440947|4158116|P1|36-Week Induction Phase|Took Exclusionary Medications|1
1271183|NCT00440947|4158112|P5|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
1271184|NCT00440947|4158113|P4|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
1271185|NCT00440947|4158114|P3|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
1271186|NCT00440947|4158115|P2|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
1271187|NCT00440947|4158116|P1|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1
1271188|NCT00440947|4158112|P5|36-Week Induction Phase|Withdrawal by Subject|0
1271189|NCT00440947|4158113|P4|36-Week Induction Phase|Withdrawal by Subject|0
1271190|NCT00440947|4158114|P3|36-Week Induction Phase|Withdrawal by Subject|0
1271191|NCT00440947|4158115|P2|36-Week Induction Phase|Withdrawal by Subject|0
1271192|NCT00440947|4158116|P1|36-Week Induction Phase|Withdrawal by Subject|7
1271193|NCT00440947|4158112|P5|36-Week Induction Phase|Lost to Follow-up|0
1271194|NCT00440947|4158113|P4|36-Week Induction Phase|Lost to Follow-up|0
1271195|NCT00440947|4158114|P3|36-Week Induction Phase|Lost to Follow-up|0
1271196|NCT00440947|4158115|P2|36-Week Induction Phase|Lost to Follow-up|0
1271197|NCT00440947|4158116|P1|36-Week Induction Phase|Lost to Follow-up|16
1271198|NCT00440947|4158112|P5|36-Week Induction Phase|Non-compliance|0
1271199|NCT00440947|4158113|P4|36-Week Induction Phase|Non-compliance|0
1271200|NCT00440947|4158114|P3|36-Week Induction Phase|Non-compliance|0
1271201|NCT00440947|4158115|P2|36-Week Induction Phase|Non-compliance|0
1271202|NCT00440947|4158116|P1|36-Week Induction Phase|Non-compliance|10
1271203|NCT00440947|4158112|P5|36-Week Induction Phase|Protocol-defined Virologic Failure|0
1271204|NCT00440947|4158113|P4|36-Week Induction Phase|Protocol-defined Virologic Failure|0
1271205|NCT00440947|4158114|P3|36-Week Induction Phase|Protocol-defined Virologic Failure|0
1271206|NCT00440947|4158115|P2|36-Week Induction Phase|Protocol-defined Virologic Failure|0
1271207|NCT00440947|4158116|P1|36-Week Induction Phase|Protocol-defined Virologic Failure|5
1271208|NCT00440947|4158112|P5|36-Week Induction Phase|Insufficient Viral Load Response|0
1271209|NCT00440947|4158113|P4|36-Week Induction Phase|Insufficient Viral Load Response|0
1271210|NCT00440947|4158114|P3|36-Week Induction Phase|Insufficient Viral Load Response|0
1271211|NCT00440947|4158115|P2|36-Week Induction Phase|Insufficient Viral Load Response|0
1271212|NCT00440947|4158116|P1|36-Week Induction Phase|Insufficient Viral Load Response|11
1271213|NCT00440947|4158112|P5|36-Week Induction Phase|Adverse Event|0
1271214|NCT00440947|4158113|P4|36-Week Induction Phase|Adverse Event|0
1271215|NCT00440947|4158114|P3|36-Week Induction Phase|Adverse Event|0
1271216|NCT00440947|4158115|P2|36-Week Induction Phase|Adverse Event|0
1271217|NCT00440947|4158116|P1|36-Week Induction Phase|Adverse Event|16
1271218|NCT00440700|4158191|P3|Overall Study|Withdrawal by Subject|4
1271219|NCT00440700|4158192|P2|Overall Study|Withdrawal by Subject|8
1271220|NCT00440700|4158193|P1|Overall Study|Withdrawal by Subject|8
1271221|NCT00440557|4158216|P3|Overall Study|Patient had surgery|0
1271222|NCT00440557|4158217|P2|Overall Study|Patient had surgery|0
1271223|NCT00440557|4158218|P1|Overall Study|Patient had surgery|1
1271224|NCT00440557|4158216|P3|Overall Study|Patient transferred to nursing home|0
1271225|NCT00440557|4158217|P2|Overall Study|Patient transferred to nursing home|1
1271226|NCT00440557|4158218|P1|Overall Study|Patient transferred to nursing home|0
1271227|NCT00440557|4158216|P3|Overall Study|Principal Investigator's office closed|4
1271228|NCT00440557|4158217|P2|Overall Study|Principal Investigator's office closed|6
1271229|NCT00440557|4158218|P1|Overall Study|Principal Investigator's office closed|3
1271230|NCT00440557|4158216|P3|Overall Study|Patient moved|1
1271231|NCT00440557|4158217|P2|Overall Study|Patient moved|2
1271232|NCT00440557|4158218|P1|Overall Study|Patient moved|1
1271233|NCT00440557|4158216|P3|Overall Study|Principal Investigator decision|1
1271234|NCT00440557|4158217|P2|Overall Study|Principal Investigator decision|3
1271235|NCT00440557|4158218|P1|Overall Study|Principal Investigator decision|0
1271236|NCT00440557|4158216|P3|Overall Study|Began Dialysis|4
1271237|NCT00440557|4158217|P2|Overall Study|Began Dialysis|1
1271238|NCT00440557|4158218|P1|Overall Study|Began Dialysis|4
1271239|NCT00440557|4158216|P3|Overall Study|Death|3
1271240|NCT00440557|4158217|P2|Overall Study|Death|6
1271241|NCT00440557|4158218|P1|Overall Study|Death|2
1271242|NCT00440557|4158216|P3|Overall Study|Adverse Event|5
1271243|NCT00440557|4158217|P2|Overall Study|Adverse Event|3
1271244|NCT00440557|4158218|P1|Overall Study|Adverse Event|3
1271245|NCT00440557|4158216|P3|Overall Study|Lost to Follow-up|6
1271246|NCT00440557|4158217|P2|Overall Study|Lost to Follow-up|2
1271247|NCT00440557|4158218|P1|Overall Study|Lost to Follow-up|1
1271248|NCT00440557|4158216|P3|Overall Study|Withdrawal by Subject|11
1271249|NCT00440557|4158217|P2|Overall Study|Withdrawal by Subject|5
1271250|NCT00440557|4158218|P1|Overall Study|Withdrawal by Subject|10
1271251|NCT00440531|4158250|P3|Overall Study|see pre-assignment details|0
1271252|NCT00440531|4158251|P2|Overall Study|see pre-assignment details|0
1271253|NCT00440531|4158252|P1|Overall Study|see pre-assignment details|2
1271254|NCT00440531|4158250|P3|Overall Study|Lost to Follow-up|5
1271255|NCT00440531|4158251|P2|Overall Study|Lost to Follow-up|3
1271256|NCT00440531|4158252|P1|Overall Study|Lost to Follow-up|4
1271257|NCT00440531|4158250|P3|Overall Study|Protocol Violation|0
1271258|NCT00440531|4158251|P2|Overall Study|Protocol Violation|2
1271259|NCT00440531|4158252|P1|Overall Study|Protocol Violation|1
1271260|NCT00440531|4158250|P3|Overall Study|Withdrawal by Subject|0
1271261|NCT00440531|4158251|P2|Overall Study|Withdrawal by Subject|0
1271262|NCT00440531|4158252|P1|Overall Study|Withdrawal by Subject|2
1271263|NCT00440531|4158250|P3|Overall Study|Adverse Event|2
1271264|NCT00440531|4158251|P2|Overall Study|Adverse Event|0
1271265|NCT00440531|4158252|P1|Overall Study|Adverse Event|1
1271266|NCT00440518|4158269|P3|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0
1271267|NCT00440518|4158270|P2|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2
1271268|NCT00440518|4158271|P1|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1
1271269|NCT00440518|4158269|P3|Maintenance and Safety Follow-up Periods|Other|2
1271270|NCT00440518|4158270|P2|Maintenance and Safety Follow-up Periods|Other|0
1271271|NCT00440518|4158271|P1|Maintenance and Safety Follow-up Periods|Other|0
1271272|NCT00440518|4158269|P3|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6
1271273|NCT00440518|4158270|P2|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3
1271274|NCT00440518|4158271|P1|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0
1271275|NCT00440518|4158269|P3|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4
1271276|NCT00440518|4158270|P2|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2
1271277|NCT00440518|4158271|P1|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3
1271278|NCT00440518|4158269|P3|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
1271279|NCT00440518|4158270|P2|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
1271280|NCT00440518|4158271|P1|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0
1271281|NCT00440518|4158269|P3|Maintenance and Safety Follow-up Periods|Adverse Event|2
1271282|NCT00440518|4158270|P2|Maintenance and Safety Follow-up Periods|Adverse Event|4
1271283|NCT00440518|4158271|P1|Maintenance and Safety Follow-up Periods|Adverse Event|3
1271284|NCT00440518|4158269|P3|Randomized /Titration Period|Adverse Event|0
1271285|NCT00440518|4158270|P2|Randomized /Titration Period|Adverse Event|3
1271286|NCT00440518|4158271|P1|Randomized /Titration Period|Adverse Event|2
1271287|NCT00440518|4158269|P3|Randomized /Titration Period|Lost to Follow-up|1
1271288|NCT00440518|4158270|P2|Randomized /Titration Period|Lost to Follow-up|2
1271289|NCT00440518|4158271|P1|Randomized /Titration Period|Lost to Follow-up|2
1271290|NCT00440518|4158269|P3|Randomized /Titration Period|Other|0
1271291|NCT00440518|4158270|P2|Randomized /Titration Period|Other|0
1271292|NCT00440518|4158271|P1|Randomized /Titration Period|Other|1
1271293|NCT00440518|4158269|P3|Randomized /Titration Period|Unsatisfactory Compliance|2
1271294|NCT00440518|4158270|P2|Randomized /Titration Period|Unsatisfactory Compliance|3
1271295|NCT00440518|4158271|P1|Randomized /Titration Period|Unsatisfactory Compliance|2
1271296|NCT00440518|4158269|P3|Randomized /Titration Period|Protocol Deviation|0
1271297|NCT00440518|4158270|P2|Randomized /Titration Period|Protocol Deviation|0
1271298|NCT00440518|4158271|P1|Randomized /Titration Period|Protocol Deviation|1
1271299|NCT00440518|4158269|P3|Randomized /Titration Period|Subject Withdrew Consent|0
1271300|NCT00440518|4158270|P2|Randomized /Titration Period|Subject Withdrew Consent|1
1271301|NCT00440518|4158271|P1|Randomized /Titration Period|Subject Withdrew Consent|4
1271302|NCT00440518|4158269|P3|Randomized /Titration Period|Lack of Efficacy|1
1271303|NCT00440518|4158270|P2|Randomized /Titration Period|Lack of Efficacy|0
1271304|NCT00440518|4158271|P1|Randomized /Titration Period|Lack of Efficacy|1
1271305|NCT00440466|4158316|P3|Overall Study|Met Hemoglobin Withdrawal Criteria|4
1271306|NCT00440466|4158317|P2|Overall Study|Met Hemoglobin Withdrawal Criteria|4
1271307|NCT00440466|4158318|P1|Overall Study|Met Hemoglobin Withdrawal Criteria|0
1271308|NCT00440466|4158316|P3|Overall Study|Began Dialysis|1
1271309|NCT00440466|4158317|P2|Overall Study|Began Dialysis|0
1271310|NCT00440466|4158318|P1|Overall Study|Began Dialysis|0
1271311|NCT00440466|4158316|P3|Overall Study|Withdrawal by Subject|9
1271312|NCT00440466|4158317|P2|Overall Study|Withdrawal by Subject|5
1271313|NCT00440466|4158318|P1|Overall Study|Withdrawal by Subject|2
1271314|NCT00440466|4158316|P3|Overall Study|Protocol Violation|4
1271315|NCT00440466|4158317|P2|Overall Study|Protocol Violation|0
1271316|NCT00440466|4158318|P1|Overall Study|Protocol Violation|2
1271317|NCT00440466|4158316|P3|Overall Study|Physician Decision|1
1271318|NCT00440466|4158317|P2|Overall Study|Physician Decision|0
1271319|NCT00440466|4158318|P1|Overall Study|Physician Decision|2
1271320|NCT00440466|4158316|P3|Overall Study|Lost to Follow-up|2
1271321|NCT00440466|4158317|P2|Overall Study|Lost to Follow-up|0
1271322|NCT00440466|4158318|P1|Overall Study|Lost to Follow-up|1
1271323|NCT00440466|4158316|P3|Overall Study|Adverse Event|11
1271324|NCT00440466|4158317|P2|Overall Study|Adverse Event|4
1271325|NCT00440466|4158318|P1|Overall Study|Adverse Event|3
1271326|NCT00440466|4158316|P3|Overall Study|Death|9
1271327|NCT00440466|4158317|P2|Overall Study|Death|2
1271328|NCT00440466|4158318|P1|Overall Study|Death|3
1271329|NCT00440401|4158352|P2|Overall Study|Not specified|5
1271330|NCT00440401|4158353|P1|Overall Study|Not specified|2
1271331|NCT00440401|4158352|P2|Overall Study|Adverse Event|1
1271332|NCT00440401|4158353|P1|Overall Study|Adverse Event|2
1271333|NCT00440310|4158363|P2|Overall Study|Status Unknown|3
1271334|NCT00440310|4158364|P1|Overall Study|Status Unknown|1
1271335|NCT00440310|4158363|P2|Overall Study|Other|0
1271336|NCT00440310|4158364|P1|Overall Study|Other|1
1271337|NCT00440310|4158363|P2|Overall Study|No Reply at EOS|7
1271338|NCT00440310|4158364|P1|Overall Study|No Reply at EOS|7
1271339|NCT00440310|4158363|P2|Overall Study|Withdrawal by Subject|14
1271340|NCT00440310|4158364|P1|Overall Study|Withdrawal by Subject|15
1271341|NCT00440310|4158363|P2|Overall Study|Protocol Violation|1
1271342|NCT00440310|4158364|P1|Overall Study|Protocol Violation|0
1271343|NCT00440310|4158363|P2|Overall Study|Lost to Follow-up|5
1271344|NCT00440310|4158364|P1|Overall Study|Lost to Follow-up|4
1271345|NCT00440297|4158372|P2|Overall Study|Randomized by mistake|0
1271346|NCT00440297|4158373|P1|Overall Study|Randomized by mistake|1
1271347|NCT00440297|4158372|P2|Overall Study|Withdrawal by Subject|6
1271348|NCT00440297|4158373|P1|Overall Study|Withdrawal by Subject|1
1271349|NCT00440297|4158372|P2|Overall Study|Protocol Violation|7
1271350|NCT00440297|4158373|P1|Overall Study|Protocol Violation|11
1271351|NCT00440297|4158372|P2|Overall Study|Physician Decision|0
1271352|NCT00440297|4158373|P1|Overall Study|Physician Decision|1
1271353|NCT00440297|4158372|P2|Overall Study|Lost to Follow-up|0
1271354|NCT00440297|4158373|P1|Overall Study|Lost to Follow-up|1
1271355|NCT00440297|4158372|P2|Overall Study|Adverse Event|5
1271356|NCT00440297|4158373|P1|Overall Study|Adverse Event|8
1271357|NCT00440271|4158389|P2|Overall Study|Other|0
1271358|NCT00440271|4158390|P1|Overall Study|Other|2
1271359|NCT00440271|4158389|P2|Overall Study|Due to closure of trial|10
1271360|NCT00440271|4158390|P1|Overall Study|Due to closure of trial|8
1271361|NCT00440271|4158389|P2|Overall Study|Lack of Efficacy|1
1271362|NCT00440271|4158390|P1|Overall Study|Lack of Efficacy|0
1271363|NCT00440271|4158389|P2|Overall Study|Withdrawal by Subject|2
1271364|NCT00440271|4158390|P1|Overall Study|Withdrawal by Subject|0
1271365|NCT00440271|4158389|P2|Overall Study|Lost to Follow-up|0
1271366|NCT00440271|4158390|P1|Overall Study|Lost to Follow-up|1
1271367|NCT00440271|4158389|P2|Overall Study|Adverse Event|1
1271368|NCT00440271|4158390|P1|Overall Study|Adverse Event|0
1271369|NCT00440271|4158389|P2|Overall Study|Protocol Violation|1
1271370|NCT00440271|4158390|P1|Overall Study|Protocol Violation|1
1271371|NCT00440232|4158424|P2|Overall Study|Onset of headache within 4 hours of fast|2
1271372|NCT00440232|4158425|P1|Overall Study|Onset of headache within 4 hours of fast|2
1271373|NCT00440232|4158424|P2|Overall Study|Unable to treat within allowed time|1
1271374|NCT00440232|4158425|P1|Overall Study|Unable to treat within allowed time|0
1271375|NCT00440232|4158424|P2|Overall Study|Lost to Follow-up|1
1271376|NCT00440232|4158425|P1|Overall Study|Lost to Follow-up|1
1271377|NCT00440193|4158435|P2|Observational Period|Participant convenience|0
1271378|NCT00440193|4158436|P1|Observational Period|Participant convenience|2
1271379|NCT00440193|4158435|P2|Observational Period|Clinical endpoint reached|0
1271380|NCT00440193|4158436|P1|Observational Period|Clinical endpoint reached|1
1271381|NCT00440193|4158435|P2|Observational Period|Physician Decision|0
1271382|NCT00440193|4158436|P1|Observational Period|Physician Decision|1
1271383|NCT00440193|4158435|P2|Observational Period|Withdrawal by Subject|8
1271384|NCT00440193|4158436|P1|Observational Period|Withdrawal by Subject|11
1271385|NCT00440193|4158435|P2|Observational Period|Protocol Violation|0
1271386|NCT00440193|4158436|P1|Observational Period|Protocol Violation|1
1271387|NCT00440193|4158435|P2|Observational Period|Lost to Follow-up|8
1271388|NCT00440193|4158436|P1|Observational Period|Lost to Follow-up|12
1271389|NCT00440193|4158435|P2|Observational Period|Death|20
1271390|NCT00440193|4158436|P1|Observational Period|Death|15
1271391|NCT00440193|4158435|P2|Observational Period|Adverse Event|2
1271392|NCT00440193|4158436|P1|Observational Period|Adverse Event|2
1271393|NCT00440193|4158435|P2|Treatment Period|Site closed by investigator|2
1271394|NCT00440193|4158436|P1|Treatment Period|Site closed by investigator|0
1271395|NCT00440193|4158435|P2|Treatment Period|Participant did not receive treatment|13
1271396|NCT00440193|4158436|P1|Treatment Period|Participant did not receive treatment|7
1271397|NCT00440193|4158435|P2|Treatment Period|Participant convenience|2
1271398|NCT00440193|4158436|P1|Treatment Period|Participant convenience|5
1271399|NCT00440193|4158435|P2|Treatment Period|Technical problems|1
1271400|NCT00440193|4158436|P1|Treatment Period|Technical problems|1
1271401|NCT00440193|4158435|P2|Treatment Period|Switch to commercial drug|2
1271402|NCT00440193|4158436|P1|Treatment Period|Switch to commercial drug|0
1271403|NCT00440193|4158435|P2|Treatment Period|Protocol driven decision point|2
1271404|NCT00440193|4158436|P1|Treatment Period|Protocol driven decision point|2
1271405|NCT00440193|4158435|P2|Treatment Period|Study terminated by sponsor|94
1271406|NCT00440193|4158436|P1|Treatment Period|Study terminated by sponsor|102
1271407|NCT00440193|4158435|P2|Treatment Period|Clinical endpoint reached|25
1271408|NCT00440193|4158436|P1|Treatment Period|Clinical endpoint reached|28
1271409|NCT00440193|4158435|P2|Treatment Period|Withdrawal by Subject|77
1271410|NCT00440193|4158436|P1|Treatment Period|Withdrawal by Subject|36
1271411|NCT00440193|4158435|P2|Treatment Period|Protocol Violation|19
1271412|NCT00440193|4158436|P1|Treatment Period|Protocol Violation|16
1271413|NCT00440193|4158435|P2|Treatment Period|Physician Decision|6
1271414|NCT00440193|4158436|P1|Treatment Period|Physician Decision|3
1271415|NCT00440193|4158435|P2|Treatment Period|Lost to Follow-up|18
1271416|NCT00440193|4158436|P1|Treatment Period|Lost to Follow-up|12
1271417|NCT00440193|4158435|P2|Treatment Period|Lack of Efficacy|1
1271418|NCT00440193|4158436|P1|Treatment Period|Lack of Efficacy|0
1271419|NCT00440193|4158435|P2|Treatment Period|Death|22
1271420|NCT00440193|4158436|P1|Treatment Period|Death|19
1271421|NCT00440193|4158435|P2|Treatment Period|Adverse Event|67
1271422|NCT00440193|4158436|P1|Treatment Period|Adverse Event|74
1271423|NCT00440115|4158482|P3|Overall Study|Incarceration|1
1271424|NCT00440115|4158483|P2|Overall Study|Incarceration|2
1271425|NCT00440115|4158484|P1|Overall Study|Incarceration|0
1271426|NCT00440115|4158482|P3|Overall Study|Death|5
1271427|NCT00440115|4158483|P2|Overall Study|Death|9
1271428|NCT00440115|4158484|P1|Overall Study|Death|7
1271429|NCT00440011|4158515|P2|Overall Study|Withdrawal by Subject|0
1271430|NCT00440011|4158516|P1|Overall Study|Withdrawal by Subject|1
1271431|NCT00440011|4158515|P2|Overall Study|Protocol Violation|1
1271432|NCT00440011|4158516|P1|Overall Study|Protocol Violation|1
1271433|NCT00440011|4158515|P2|Overall Study|Lost to Follow-up|2
1271434|NCT00440011|4158516|P1|Overall Study|Lost to Follow-up|0
1271435|NCT00440011|4158515|P2|Overall Study|Adverse Event|0
1271436|NCT00440011|4158516|P1|Overall Study|Adverse Event|2
1271437|NCT00439777|4158543|P2|Observational Period|Technical problems|1
1271438|NCT00439777|4158544|P1|Observational Period|Technical problems|0
1271439|NCT00439777|4158543|P2|Observational Period|Lack of Efficacy|0
1271440|NCT00439777|4158544|P1|Observational Period|Lack of Efficacy|1
1271441|NCT00439777|4158543|P2|Observational Period|Protocol driven decision point|1
1271442|NCT00439777|4158544|P1|Observational Period|Protocol driven decision point|0
1271443|NCT00439777|4158543|P2|Observational Period|Study terminated by sponsor|1
1271444|NCT00439777|4158544|P1|Observational Period|Study terminated by sponsor|3
1271445|NCT00439777|4158543|P2|Observational Period|Death|20
1271446|NCT00439777|4158544|P1|Observational Period|Death|27
1271447|NCT00439777|4158543|P2|Observational Period|Lost to Follow-up|11
1271448|NCT00439777|4158544|P1|Observational Period|Lost to Follow-up|1
1271449|NCT00439777|4158543|P2|Observational Period|Withdrawal by Subject|5
1271450|NCT00439777|4158544|P1|Observational Period|Withdrawal by Subject|9
1271451|NCT00439777|4158543|P2|Observational Period|Protocol Violation|2
1271452|NCT00439777|4158544|P1|Observational Period|Protocol Violation|0
1271453|NCT00439777|4158543|P2|Treatment Period|Participant convenience|8
1271454|NCT00439777|4158544|P1|Treatment Period|Participant convenience|12
1271455|NCT00439777|4158543|P2|Treatment Period|Technical problems|1
1271456|NCT00439777|4158544|P1|Treatment Period|Technical problems|3
1271457|NCT00439777|4158543|P2|Treatment Period|Clinical endpoint reached|13
1271458|NCT00439777|4158544|P1|Treatment Period|Clinical endpoint reached|26
1271459|NCT00439777|4158543|P2|Treatment Period|Physician Decision|18
1271460|NCT00439777|4158544|P1|Treatment Period|Physician Decision|7
1271461|NCT00439777|4158543|P2|Treatment Period|Protocol driven decision point|3
1271462|NCT00439777|4158544|P1|Treatment Period|Protocol driven decision point|1
1271463|NCT00439777|4158543|P2|Treatment Period|Lost to Follow-up|10
1271464|NCT00439777|4158544|P1|Treatment Period|Lost to Follow-up|8
1271465|NCT00439777|4158543|P2|Treatment Period|Lack of Efficacy|4
1271466|NCT00439777|4158544|P1|Treatment Period|Lack of Efficacy|1
1271467|NCT00439777|4158543|P2|Treatment Period|Withdrawal by Subject|118
1271468|NCT00439777|4158544|P1|Treatment Period|Withdrawal by Subject|66
1271469|NCT00439777|4158543|P2|Treatment Period|Protocol Violation|30
1271470|NCT00439777|4158544|P1|Treatment Period|Protocol Violation|23
1271471|NCT00439777|4158543|P2|Treatment Period|Adverse Event|92
1271472|NCT00439777|4158544|P1|Treatment Period|Adverse Event|111
1271473|NCT00439777|4158543|P2|Treatment Period|Did not take study treatment|8
1271474|NCT00439777|4158544|P1|Treatment Period|Did not take study treatment|7
1271475|NCT00439777|4158543|P2|Treatment Period|Site closed by investigator|1
1271476|NCT00439777|4158544|P1|Treatment Period|Site closed by investigator|0
1271477|NCT00439777|4158543|P2|Treatment Period|Study terminated by sponsor|132
1271478|NCT00439777|4158544|P1|Treatment Period|Study terminated by sponsor|125
1271479|NCT00439777|4158543|P2|Treatment Period|Death|21
1271480|NCT00439777|4158544|P1|Treatment Period|Death|29
1271481|NCT00439738|4158582|P2|Overall Study|Abnormal Lab Values|0
1271482|NCT00439738|4158583|P1|Overall Study|Abnormal Lab Values|1
1271483|NCT00439738|4158582|P2|Overall Study|Lack of Efficacy|2
1271484|NCT00439738|4158583|P1|Overall Study|Lack of Efficacy|2
1271485|NCT00439738|4158582|P2|Overall Study|Protocol Violation|3
1271486|NCT00439738|4158583|P1|Overall Study|Protocol Violation|6
1271487|NCT00439738|4158582|P2|Overall Study|Lost to Follow-up|6
1271488|NCT00439738|4158583|P1|Overall Study|Lost to Follow-up|5
1271489|NCT00439738|4158582|P2|Overall Study|Adverse Event|4
1271490|NCT00439738|4158583|P1|Overall Study|Adverse Event|6
1271491|NCT00439738|4158582|P2|Overall Study|Withdrawal by Subject|13
1271492|NCT00439738|4158583|P1|Overall Study|Withdrawal by Subject|16
1271493|NCT00439725|4158601|P2|Observational Period|Participant convenience|0
1271494|NCT00439725|4158602|P1|Observational Period|Participant convenience|1
1271495|NCT00439725|4158601|P2|Observational Period|Technical problems|0
1271496|NCT00439725|4158602|P1|Observational Period|Technical problems|1
1271497|NCT00439725|4158601|P2|Observational Period|Clinical endpoint reached|1
1271498|NCT00439725|4158602|P1|Observational Period|Clinical endpoint reached|3
1271499|NCT00439725|4158601|P2|Observational Period|Study termination by sponsor|1
1271500|NCT00439725|4158602|P1|Observational Period|Study termination by sponsor|1
1271501|NCT00439725|4158601|P2|Observational Period|Death|2
1271502|NCT00439725|4158602|P1|Observational Period|Death|0
1271503|NCT00439725|4158601|P2|Observational Period|Lost to Follow-up|1
1271504|NCT00439725|4158602|P1|Observational Period|Lost to Follow-up|0
1271505|NCT00439725|4158601|P2|Observational Period|Withdrawal by Subject|2
1271506|NCT00439725|4158602|P1|Observational Period|Withdrawal by Subject|2
1271507|NCT00439725|4158601|P2|Treatment Period|Participant did not receive treatment|4
1271508|NCT00439725|4158602|P1|Treatment Period|Participant did not receive treatment|4
1271509|NCT00439725|4158601|P2|Treatment Period|Death|1
1271510|NCT00439725|4158602|P1|Treatment Period|Death|1
1271511|NCT00439725|4158601|P2|Treatment Period|Protocol driven decision point|1
1271512|NCT00439725|4158602|P1|Treatment Period|Protocol driven decision point|1
1271513|NCT00439725|4158601|P2|Treatment Period|Participant convenience|0
1271514|NCT00439725|4158602|P1|Treatment Period|Participant convenience|1
1271515|NCT00439725|4158601|P2|Treatment Period|Lost to Follow-up|1
1271516|NCT00439725|4158602|P1|Treatment Period|Lost to Follow-up|1
1271517|NCT00439725|4158601|P2|Treatment Period|Technical problems|0
1271518|NCT00439725|4158602|P1|Treatment Period|Technical problems|1
1271519|NCT00439725|4158601|P2|Treatment Period|Clinical endpoint reached|50
1271520|NCT00439725|4158602|P1|Treatment Period|Clinical endpoint reached|6
1271521|NCT00439725|4158601|P2|Treatment Period|Protocol Violation|1
1271522|NCT00439725|4158602|P1|Treatment Period|Protocol Violation|2
1271523|NCT00439725|4158601|P2|Treatment Period|Physician Decision|1
1271524|NCT00439725|4158602|P1|Treatment Period|Physician Decision|1
1271525|NCT00439725|4158601|P2|Treatment Period|Adverse Event|18
1271526|NCT00439725|4158602|P1|Treatment Period|Adverse Event|39
1271527|NCT00439725|4158601|P2|Treatment Period|Site closed by investigator|2
1271528|NCT00439725|4158602|P1|Treatment Period|Site closed by investigator|1
1271529|NCT00439725|4158601|P2|Treatment Period|Study terminated by sponsor|148
1271530|NCT00439725|4158602|P1|Treatment Period|Study terminated by sponsor|156
1271531|NCT00439725|4158601|P2|Treatment Period|Withdrawal by Subject|19
1271532|NCT00439725|4158602|P1|Treatment Period|Withdrawal by Subject|22
1271533|NCT00439647|4158653|P2|Overall Study|Lack of Efficacy|4
1271534|NCT00439647|4158654|P1|Overall Study|Lack of Efficacy|0
1271535|NCT00439647|4158653|P2|Overall Study|Protocol Violation|4
1271536|NCT00439647|4158654|P1|Overall Study|Protocol Violation|3
1271537|NCT00439647|4158653|P2|Overall Study|Lost to Follow-up|12
1271538|NCT00439647|4158654|P1|Overall Study|Lost to Follow-up|4
1271539|NCT00439647|4158653|P2|Overall Study|Adverse Event|11
1271540|NCT00439647|4158654|P1|Overall Study|Adverse Event|11
1271541|NCT00439647|4158653|P2|Overall Study|Death|18
1271542|NCT00439647|4158654|P1|Overall Study|Death|15
1271543|NCT00439647|4158653|P2|Overall Study|Withdrawal by Subject|22
1271544|NCT00439647|4158654|P1|Overall Study|Withdrawal by Subject|25
1271545|NCT00439569|4158691|P1|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1
1271546|NCT00439569|4158691|P1|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3
1271547|NCT00439569|4158691|P1|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1
1271548|NCT00439517|4158704|P2|Overall Study|Subject in survival follow-up|0
1271549|NCT00439517|4158705|P1|Overall Study|Subject in survival follow-up|1
1271550|NCT00439517|4158704|P2|Overall Study|Subject on treatment|0
1271551|NCT00439517|4158705|P1|Overall Study|Subject on treatment|1
1271552|NCT00439309|4158773|P2|Follow-Up|Late response by subject|1
1271553|NCT00439309|4158774|P1|Follow-Up|Late response by subject|0
1271554|NCT00439309|4158773|P2|Follow-Up|Withdrawal by Subject|1
1271555|NCT00439309|4158774|P1|Follow-Up|Withdrawal by Subject|0
1271556|NCT00439309|4158773|P2|Follow-Up|Lost to Follow-up|0
1271557|NCT00439309|4158774|P1|Follow-Up|Lost to Follow-up|2
1271558|NCT00439309|4158773|P2|Follow-Up|Death|0
1271559|NCT00439309|4158774|P1|Follow-Up|Death|1
1271560|NCT00439270|4158793|P5|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
1271561|NCT00439270|4158794|P4|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1
1271562|NCT00439270|4158795|P3|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
1271563|NCT00439270|4158796|P2|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
1271564|NCT00439270|4158797|P1|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
1271565|NCT00439270|4158793|P5|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
1271566|NCT00439270|4158794|P4|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2
1271567|NCT00439270|4158795|P3|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
1271568|NCT00439270|4158796|P2|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
1271569|NCT00439270|4158797|P1|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
1271570|NCT00439270|4158793|P5|Phase 2 (51.6 Months)|Withdrawal by Subject|0
1271571|NCT00439270|4158794|P4|Phase 2 (51.6 Months)|Withdrawal by Subject|2
1271572|NCT00439270|4158795|P3|Phase 2 (51.6 Months)|Withdrawal by Subject|0
1271573|NCT00439270|4158796|P2|Phase 2 (51.6 Months)|Withdrawal by Subject|0
1271574|NCT00439270|4158797|P1|Phase 2 (51.6 Months)|Withdrawal by Subject|0
1271575|NCT00439270|4158793|P5|Phase 2 (51.6 Months)|No longer meets study criteria|0
1271576|NCT00439270|4158794|P4|Phase 2 (51.6 Months)|No longer meets study criteria|1
1271577|NCT00439270|4158795|P3|Phase 2 (51.6 Months)|No longer meets study criteria|0
1271578|NCT00439270|4158796|P2|Phase 2 (51.6 Months)|No longer meets study criteria|0
1271579|NCT00439270|4158797|P1|Phase 2 (51.6 Months)|No longer meets study criteria|0
1271580|NCT00439270|4158793|P5|Phase 2 (51.6 Months)|Maximum clinical benefit|0
1271581|NCT00439270|4158794|P4|Phase 2 (51.6 Months)|Maximum clinical benefit|3
1271582|NCT00439270|4158795|P3|Phase 2 (51.6 Months)|Maximum clinical benefit|0
1271583|NCT00439270|4158796|P2|Phase 2 (51.6 Months)|Maximum clinical benefit|0
1271584|NCT00439270|4158797|P1|Phase 2 (51.6 Months)|Maximum clinical benefit|0
1271585|NCT00439270|4158793|P5|Phase 2 (51.6 Months)|Study drug toxicity|0
1271586|NCT00439270|4158794|P4|Phase 2 (51.6 Months)|Study drug toxicity|6
1271587|NCT00439270|4158795|P3|Phase 2 (51.6 Months)|Study drug toxicity|0
1271588|NCT00439270|4158796|P2|Phase 2 (51.6 Months)|Study drug toxicity|0
1271589|NCT00439270|4158797|P1|Phase 2 (51.6 Months)|Study drug toxicity|0
1271590|NCT00439270|4158793|P5|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
1271591|NCT00439270|4158794|P4|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1
1271592|NCT00439270|4158795|P3|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
1271593|NCT00439270|4158796|P2|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
1271594|NCT00439270|4158797|P1|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
1271595|NCT00439270|4158793|P5|Phase 2 (51.6 Months)|Disease progression|0
1271596|NCT00439270|4158794|P4|Phase 2 (51.6 Months)|Disease progression|18
1271597|NCT00439270|4158795|P3|Phase 2 (51.6 Months)|Disease progression|0
1271598|NCT00439270|4158796|P2|Phase 2 (51.6 Months)|Disease progression|0
1271599|NCT00439270|4158797|P1|Phase 2 (51.6 Months)|Disease progression|0
1271600|NCT00439270|4158793|P5|Phase 1 (18.1 Months)|Study drug toxicity|0
1271601|NCT00439270|4158794|P4|Phase 1 (18.1 Months)|Study drug toxicity|0
1271602|NCT00439270|4158795|P3|Phase 1 (18.1 Months)|Study drug toxicity|0
1271603|NCT00439270|4158796|P2|Phase 1 (18.1 Months)|Study drug toxicity|1
1271604|NCT00439270|4158797|P1|Phase 1 (18.1 Months)|Study drug toxicity|0
1271605|NCT00439270|4158793|P5|Phase 1 (18.1 Months)|Disease progression|3
1271606|NCT00439270|4158794|P4|Phase 1 (18.1 Months)|Disease progression|0
1271607|NCT00439270|4158795|P3|Phase 1 (18.1 Months)|Disease progression|3
1271608|NCT00439270|4158796|P2|Phase 1 (18.1 Months)|Disease progression|2
1271609|NCT00439270|4158797|P1|Phase 1 (18.1 Months)|Disease progression|3
1271610|NCT00439244|4158839|P3|Overall Study|Administrative problems|0
1271611|NCT00439244|4158840|P2|Overall Study|Administrative problems|0
1271612|NCT00439244|4158841|P1|Overall Study|Administrative problems|1
1271613|NCT00439244|4158839|P3|Overall Study|Protocol Violation|0
1271614|NCT00439244|4158840|P2|Overall Study|Protocol Violation|1
1271615|NCT00439244|4158841|P1|Overall Study|Protocol Violation|0
1271616|NCT00439244|4158839|P3|Overall Study|Death|0
1271617|NCT00439244|4158840|P2|Overall Study|Death|1
1271618|NCT00439244|4158841|P1|Overall Study|Death|0
1271619|NCT00439244|4158839|P3|Overall Study|Lost to Follow-up|2
1271620|NCT00439244|4158840|P2|Overall Study|Lost to Follow-up|1
1271621|NCT00439244|4158841|P1|Overall Study|Lost to Follow-up|2
1271622|NCT00439244|4158839|P3|Overall Study|Withdrawal by Subject|2
1271623|NCT00439244|4158840|P2|Overall Study|Withdrawal by Subject|1
1271624|NCT00439244|4158841|P1|Overall Study|Withdrawal by Subject|3
1271625|NCT00439244|4158839|P3|Overall Study|Adverse Event|3
1271626|NCT00439244|4158840|P2|Overall Study|Adverse Event|2
1271627|NCT00439244|4158841|P1|Overall Study|Adverse Event|5
1271628|NCT00439231|4158861|P1|Overall Study|Lack of Efficacy|28
1271629|NCT00439218|4158865|P1|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1
1271630|NCT00439179|4158880|P4|Overall Study|* 1 pt inelig, 1 pt numb not used|0
1271631|NCT00439179|4158881|P3|Overall Study|* 1 pt inelig, 1 pt numb not used|0
1271632|NCT00439179|4158882|P2|Overall Study|* 1 pt inelig, 1 pt numb not used|2
1271633|NCT00439179|4158883|P1|Overall Study|* 1 pt inelig, 1 pt numb not used|0
1271634|NCT00439140|4158900|P3|Treatment Cycle 2|Lost to Follow-up|0
1271635|NCT00439140|4158901|P2|Treatment Cycle 2|Lost to Follow-up|1
1271636|NCT00439140|4158902|P1|Treatment Cycle 2|Lost to Follow-up|1
1271637|NCT00439140|4158900|P3|Treatment Cycle 2|Withdrawal by Subject|0
1271638|NCT00439140|4158901|P2|Treatment Cycle 2|Withdrawal by Subject|0
1271639|NCT00439140|4158902|P1|Treatment Cycle 2|Withdrawal by Subject|1
1271640|NCT00439140|4158900|P3|Treatment Cycle 1|Withdrawal by Subject|0
1271641|NCT00439140|4158901|P2|Treatment Cycle 1|Withdrawal by Subject|1
1271642|NCT00439140|4158902|P1|Treatment Cycle 1|Withdrawal by Subject|0
1271643|NCT00439140|4158900|P3|Treatment Cycle 1|Personal reasons|0
1271644|NCT00439140|4158901|P2|Treatment Cycle 1|Personal reasons|2
1271645|NCT00439140|4158902|P1|Treatment Cycle 1|Personal reasons|0
1271646|NCT00439140|4158900|P3|Treatment Cycle 1|Lost to Follow-up|1
1271647|NCT00439140|4158901|P2|Treatment Cycle 1|Lost to Follow-up|1
1271648|NCT00439140|4158902|P1|Treatment Cycle 1|Lost to Follow-up|1
1271649|NCT00438815|4158985|P1|Overall Study|Death|1
1271650|NCT00438815|4158985|P1|Overall Study|Withdrawal by Subject|6
1271651|NCT00438815|4158985|P1|Overall Study|Lost to Follow-up|6
1271652|NCT00438815|4158985|P1|Overall Study|Transitioned to commercial C1INH-nf|6
1271653|NCT00438815|4158985|P1|Overall Study|Noncompliance with protocol requirements|9
1271654|NCT00438815|4158985|P1|Overall Study|3-month follow-up no longer required|12
1271655|NCT00438815|4158985|P1|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30
1271656|NCT00438672|4159035|P2|Overall Study|Lost to Follow-up|9
1271657|NCT00438672|4159036|P1|Overall Study|Lost to Follow-up|7
1271658|NCT00438659|4159046|P2|Overall Study|Cancel|2
1271659|NCT00438659|4159047|P1|Overall Study|Cancel|5
1271660|NCT00438659|4159046|P2|Overall Study|Discontinued Mometasone/Placebo|2
1271661|NCT00438659|4159047|P1|Overall Study|Discontinued Mometasone/Placebo|1
1271662|NCT00438464|4159086|P2|Overall Study|Incomplete data submission|2
1271663|NCT00438464|4159087|P1|Overall Study|Incomplete data submission|0
1271664|NCT00438464|4159086|P2|Overall Study|Terminated Early|5
1271665|NCT00438464|4159087|P1|Overall Study|Terminated Early|14
1271666|NCT00438399|4159188|P6|Overall Study|Patien stopped study at visit 4 by error|0
1271667|NCT00438399|4159189|P5|Overall Study|Patien stopped study at visit 4 by error|0
1271668|NCT00438399|4159190|P4|Overall Study|Patien stopped study at visit 4 by error|0
1271669|NCT00438399|4159191|P3|Overall Study|Patien stopped study at visit 4 by error|0
1271670|NCT00438399|4159192|P2|Overall Study|Patien stopped study at visit 4 by error|0
1271671|NCT00438399|4159193|P1|Overall Study|Patien stopped study at visit 4 by error|1
1271672|NCT00438399|4159188|P6|Overall Study|Pregnancy|1
1271673|NCT00438399|4159189|P5|Overall Study|Pregnancy|0
1271674|NCT00438399|4159190|P4|Overall Study|Pregnancy|0
1271675|NCT00438399|4159191|P3|Overall Study|Pregnancy|0
1271676|NCT00438399|4159192|P2|Overall Study|Pregnancy|0
1271677|NCT00438399|4159193|P1|Overall Study|Pregnancy|0
1271678|NCT00438399|4159188|P6|Overall Study|Subje stopped study|0
1271679|NCT00438399|4159189|P5|Overall Study|Subje stopped study|0
1271680|NCT00438399|4159190|P4|Overall Study|Subje stopped study|0
1271681|NCT00438399|4159191|P3|Overall Study|Subje stopped study|1
1271682|NCT00438399|4159192|P2|Overall Study|Subje stopped study|0
1271683|NCT00438399|4159193|P1|Overall Study|Subje stopped study|0
1271684|NCT00438399|4159188|P6|Overall Study|Protocol Violation|1
1271685|NCT00438399|4159189|P5|Overall Study|Protocol Violation|0
1271686|NCT00438399|4159190|P4|Overall Study|Protocol Violation|0
1271687|NCT00438399|4159191|P3|Overall Study|Protocol Violation|1
1271688|NCT00438399|4159192|P2|Overall Study|Protocol Violation|0
1271689|NCT00438399|4159193|P1|Overall Study|Protocol Violation|0
1271690|NCT00438399|4159188|P6|Overall Study|Withdrawal by Subject|2
1271691|NCT00438399|4159189|P5|Overall Study|Withdrawal by Subject|2
1271692|NCT00438399|4159190|P4|Overall Study|Withdrawal by Subject|2
1271693|NCT00438399|4159191|P3|Overall Study|Withdrawal by Subject|3
1271694|NCT00438399|4159192|P2|Overall Study|Withdrawal by Subject|6
1271695|NCT00438399|4159193|P1|Overall Study|Withdrawal by Subject|5
1271696|NCT00438399|4159188|P6|Overall Study|Adverse Event|1
1271697|NCT00438399|4159189|P5|Overall Study|Adverse Event|0
1271698|NCT00438399|4159190|P4|Overall Study|Adverse Event|1
1271699|NCT00438399|4159191|P3|Overall Study|Adverse Event|1
1271700|NCT00438399|4159192|P2|Overall Study|Adverse Event|0
1271701|NCT00438399|4159193|P1|Overall Study|Adverse Event|0
1271702|NCT00438399|4159188|P6|Overall Study|Lost to Follow-up|1
1271703|NCT00438399|4159189|P5|Overall Study|Lost to Follow-up|1
1271704|NCT00438399|4159190|P4|Overall Study|Lost to Follow-up|1
1271705|NCT00438399|4159191|P3|Overall Study|Lost to Follow-up|1
1271706|NCT00438399|4159192|P2|Overall Study|Lost to Follow-up|2
1271707|NCT00438399|4159193|P1|Overall Study|Lost to Follow-up|2
1271708|NCT00438360|4159204|P2|Overall Study|not specified|15
1271709|NCT00438360|4159205|P1|Overall Study|not specified|24
1271710|NCT00438360|4159204|P2|Overall Study|Lack of Efficacy|27
1271711|NCT00438360|4159205|P1|Overall Study|Lack of Efficacy|42
1271712|NCT00438360|4159204|P2|Overall Study|Adverse Event|1
1271713|NCT00438360|4159205|P1|Overall Study|Adverse Event|6
1271714|NCT00437983|4159253|P2|Overall Study|Withdrawal by Subject|6
1271715|NCT00437983|4159254|P1|Overall Study|Withdrawal by Subject|5
1271716|NCT00437983|4159253|P2|Overall Study|Protocol Violation|1
1271717|NCT00437983|4159254|P1|Overall Study|Protocol Violation|2
1271718|NCT00437983|4159253|P2|Overall Study|Adverse Event|6
1271719|NCT00437983|4159254|P1|Overall Study|Adverse Event|6
1271720|NCT00437658|4159267|P3|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1
1271721|NCT00437658|4159268|P2|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0
1271722|NCT00437658|4159269|P1|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3
1271723|NCT00437658|4159267|P3|Post-treatment Period (24 Weeks)|Lost to Follow-up|1
1271724|NCT00437658|4159268|P2|Post-treatment Period (24 Weeks)|Lost to Follow-up|0
1271725|NCT00437658|4159269|P1|Post-treatment Period (24 Weeks)|Lost to Follow-up|5
1271726|NCT00437658|4159267|P3|Post-treatment Period (24 Weeks)|Lack of Efficacy|2
1271727|NCT00437658|4159268|P2|Post-treatment Period (24 Weeks)|Lack of Efficacy|2
1271728|NCT00437658|4159269|P1|Post-treatment Period (24 Weeks)|Lack of Efficacy|0
1271729|NCT00437658|4159267|P3|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8
1271730|NCT00437658|4159268|P2|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6
1271731|NCT00437658|4159269|P1|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12
1271732|NCT00437658|4159267|P3|Post-treatment Period (24 Weeks)|Non-compliance|1
1271733|NCT00437658|4159268|P2|Post-treatment Period (24 Weeks)|Non-compliance|0
1271734|NCT00437658|4159269|P1|Post-treatment Period (24 Weeks)|Non-compliance|3
1271735|NCT00437658|4159267|P3|Post-treatment Period (24 Weeks)|Adverse Event|1
1271736|NCT00437658|4159268|P2|Post-treatment Period (24 Weeks)|Adverse Event|0
1271737|NCT00437658|4159269|P1|Post-treatment Period (24 Weeks)|Adverse Event|1
1271738|NCT00437658|4159267|P3|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0
1271739|NCT00437658|4159268|P2|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1
1271740|NCT00437658|4159269|P1|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5
1271741|NCT00437658|4159267|P3|Treatment Period (24 Weeks)|Lost to Follow-up|5
1271742|NCT00437658|4159268|P2|Treatment Period (24 Weeks)|Lost to Follow-up|4
1271743|NCT00437658|4159269|P1|Treatment Period (24 Weeks)|Lost to Follow-up|5
1271744|NCT00437658|4159267|P3|Treatment Period (24 Weeks)|Lack of Efficacy|3
1271745|NCT00437658|4159268|P2|Treatment Period (24 Weeks)|Lack of Efficacy|2
1271746|NCT00437658|4159269|P1|Treatment Period (24 Weeks)|Lack of Efficacy|4
1271747|NCT00437658|4159267|P3|Treatment Period (24 Weeks)|Withdrawal by Subject|7
1271748|NCT00437658|4159268|P2|Treatment Period (24 Weeks)|Withdrawal by Subject|7
1271749|NCT00437658|4159269|P1|Treatment Period (24 Weeks)|Withdrawal by Subject|9
1271750|NCT00437658|4159267|P3|Treatment Period (24 Weeks)|Non-compliance|4
1271751|NCT00437658|4159268|P2|Treatment Period (24 Weeks)|Non-compliance|1
1271752|NCT00437658|4159269|P1|Treatment Period (24 Weeks)|Non-compliance|1
1271753|NCT00437658|4159267|P3|Treatment Period (24 Weeks)|Adverse Event|14
1271754|NCT00437658|4159268|P2|Treatment Period (24 Weeks)|Adverse Event|7
1271755|NCT00437658|4159269|P1|Treatment Period (24 Weeks)|Adverse Event|4
1271756|NCT00437645|4159363|P2|Overall Study|Condition no longer requires study drug|1
1271757|NCT00437645|4159364|P1|Overall Study|Condition no longer requires study drug|1
1271758|NCT00437645|4159363|P2|Overall Study|Lack of Efficacy|1
1271759|NCT00437645|4159364|P1|Overall Study|Lack of Efficacy|2
1271760|NCT00437645|4159363|P2|Overall Study|Administrative problems|1
1271761|NCT00437645|4159364|P1|Overall Study|Administrative problems|2
1271762|NCT00437645|4159363|P2|Overall Study|Lost to Follow-up|3
1271763|NCT00437645|4159364|P1|Overall Study|Lost to Follow-up|2
1271764|NCT00437645|4159363|P2|Overall Study|Protocol Violation|3
1271765|NCT00437645|4159364|P1|Overall Study|Protocol Violation|3
1271766|NCT00437645|4159363|P2|Overall Study|Withdrawal by Subject|22
1271767|NCT00437645|4159364|P1|Overall Study|Withdrawal by Subject|10
1271768|NCT00437645|4159363|P2|Overall Study|Adverse Event|84
1271769|NCT00437645|4159364|P1|Overall Study|Adverse Event|15
1271770|NCT00437489|4159380|P2|Overall Study|Lost to Follow-up|1
1271771|NCT00437489|4159381|P1|Overall Study|Lost to Follow-up|0
1271772|NCT00437489|4159380|P2|Overall Study|Study terminated by sponsor|21
1271773|NCT00437489|4159381|P1|Overall Study|Study terminated by sponsor|23
1271774|NCT00437281|4159418|P20|Overall Study|Lost to Follow-up|1
1271775|NCT00437281|4159419|P19|Overall Study|Lost to Follow-up|0
1271776|NCT00437281|4159420|P18|Overall Study|Lost to Follow-up|0
1271777|NCT00437281|4159421|P17|Overall Study|Lost to Follow-up|0
1271778|NCT00437281|4159422|P16|Overall Study|Lost to Follow-up|0
1271779|NCT00437281|4159423|P15|Overall Study|Lost to Follow-up|0
1271780|NCT00437281|4159424|P14|Overall Study|Lost to Follow-up|0
1271781|NCT00437281|4159425|P13|Overall Study|Lost to Follow-up|0
1271782|NCT00437281|4159426|P12|Overall Study|Lost to Follow-up|0
1271783|NCT00437281|4159427|P11|Overall Study|Lost to Follow-up|0
1271784|NCT00437281|4159428|P10|Overall Study|Lost to Follow-up|0
1271785|NCT00437281|4159429|P9|Overall Study|Lost to Follow-up|0
1271786|NCT00437281|4159430|P8|Overall Study|Lost to Follow-up|0
1271787|NCT00437281|4159431|P7|Overall Study|Lost to Follow-up|0
1271788|NCT00437281|4159432|P6|Overall Study|Lost to Follow-up|0
1271789|NCT00437281|4159433|P5|Overall Study|Lost to Follow-up|0
1271790|NCT00437281|4159434|P4|Overall Study|Lost to Follow-up|0
1271791|NCT00437281|4159435|P3|Overall Study|Lost to Follow-up|0
1271792|NCT00437281|4159436|P2|Overall Study|Lost to Follow-up|0
1271793|NCT00437281|4159437|P1|Overall Study|Lost to Follow-up|0
1271794|NCT00437281|4159418|P20|Overall Study|Adverse Event|0
1271795|NCT00437281|4159419|P19|Overall Study|Adverse Event|1
1271796|NCT00437281|4159420|P18|Overall Study|Adverse Event|0
1271797|NCT00437281|4159421|P17|Overall Study|Adverse Event|0
1271798|NCT00437281|4159422|P16|Overall Study|Adverse Event|0
1271799|NCT00437281|4159423|P15|Overall Study|Adverse Event|1
1271800|NCT00437281|4159424|P14|Overall Study|Adverse Event|1
1271801|NCT00437281|4159425|P13|Overall Study|Adverse Event|0
1271802|NCT00437281|4159426|P12|Overall Study|Adverse Event|0
1271803|NCT00437281|4159427|P11|Overall Study|Adverse Event|0
1271804|NCT00437281|4159428|P10|Overall Study|Adverse Event|1
1271805|NCT00437281|4159429|P9|Overall Study|Adverse Event|0
1271806|NCT00437281|4159430|P8|Overall Study|Adverse Event|0
1271807|NCT00437281|4159431|P7|Overall Study|Adverse Event|0
1271808|NCT00437281|4159432|P6|Overall Study|Adverse Event|1
1271809|NCT00437281|4159433|P5|Overall Study|Adverse Event|0
1271810|NCT00437281|4159434|P4|Overall Study|Adverse Event|1
1271811|NCT00437281|4159435|P3|Overall Study|Adverse Event|0
1271812|NCT00437281|4159436|P2|Overall Study|Adverse Event|0
1271813|NCT00437281|4159437|P1|Overall Study|Adverse Event|0
1271814|NCT00437203|4159741|P10|Overall Study|Other|0
1271815|NCT00437203|4159742|P9|Overall Study|Other|0
1271816|NCT00437203|4159743|P8|Overall Study|Other|0
1271817|NCT00437203|4159744|P7|Overall Study|Other|1
1271818|NCT00437203|4159745|P6|Overall Study|Other|0
1271819|NCT00437203|4159746|P5|Overall Study|Other|0
1271820|NCT00437203|4159747|P4|Overall Study|Other|0
1271821|NCT00437203|4159748|P3|Overall Study|Other|0
1271822|NCT00437203|4159749|P2|Overall Study|Other|1
1271823|NCT00437203|4159750|P1|Overall Study|Other|0
1271824|NCT00437203|4159741|P10|Overall Study|Objective progression or relapse|2
1271825|NCT00437203|4159742|P9|Overall Study|Objective progression or relapse|2
1271826|NCT00437203|4159743|P8|Overall Study|Objective progression or relapse|1
1271827|NCT00437203|4159744|P7|Overall Study|Objective progression or relapse|6
1271828|NCT00437203|4159745|P6|Overall Study|Objective progression or relapse|3
1271829|NCT00437203|4159746|P5|Overall Study|Objective progression or relapse|3
1271830|NCT00437203|4159747|P4|Overall Study|Objective progression or relapse|3
1271831|NCT00437203|4159748|P3|Overall Study|Objective progression or relapse|2
1271832|NCT00437203|4159749|P2|Overall Study|Objective progression or relapse|6
1271833|NCT00437203|4159750|P1|Overall Study|Objective progression or relapse|5
1271834|NCT00437203|4159741|P10|Overall Study|Study terminated by sponsor|0
1271835|NCT00437203|4159742|P9|Overall Study|Study terminated by sponsor|1
1271836|NCT00437203|4159743|P8|Overall Study|Study terminated by sponsor|0
1271837|NCT00437203|4159744|P7|Overall Study|Study terminated by sponsor|0
1271838|NCT00437203|4159745|P6|Overall Study|Study terminated by sponsor|0
1271839|NCT00437203|4159746|P5|Overall Study|Study terminated by sponsor|0
1271840|NCT00437203|4159747|P4|Overall Study|Study terminated by sponsor|0
1271841|NCT00437203|4159748|P3|Overall Study|Study terminated by sponsor|0
1271842|NCT00437203|4159749|P2|Overall Study|Study terminated by sponsor|0
1271843|NCT00437203|4159750|P1|Overall Study|Study terminated by sponsor|0
1271844|NCT00437203|4159741|P10|Overall Study|Adverse Event|1
1271845|NCT00437203|4159742|P9|Overall Study|Adverse Event|0
1271846|NCT00437203|4159743|P8|Overall Study|Adverse Event|1
1271847|NCT00437203|4159744|P7|Overall Study|Adverse Event|0
1271848|NCT00437203|4159745|P6|Overall Study|Adverse Event|0
1271849|NCT00437203|4159746|P5|Overall Study|Adverse Event|0
1271850|NCT00437203|4159747|P4|Overall Study|Adverse Event|0
1271851|NCT00437203|4159748|P3|Overall Study|Adverse Event|0
1271852|NCT00437203|4159749|P2|Overall Study|Adverse Event|1
1271853|NCT00437203|4159750|P1|Overall Study|Adverse Event|1
1271854|NCT00437203|4159741|P10|Overall Study|Death|1
1271855|NCT00437203|4159742|P9|Overall Study|Death|0
1271856|NCT00437203|4159743|P8|Overall Study|Death|1
1271857|NCT00437203|4159744|P7|Overall Study|Death|0
1271858|NCT00437203|4159745|P6|Overall Study|Death|0
1271859|NCT00437203|4159746|P5|Overall Study|Death|0
1271860|NCT00437203|4159747|P4|Overall Study|Death|0
1271861|NCT00437203|4159748|P3|Overall Study|Death|1
1271862|NCT00437203|4159749|P2|Overall Study|Death|0
1271863|NCT00437203|4159750|P1|Overall Study|Death|0
1271864|NCT00437125|4159854|P1|Overall Study|Physician Decision|1
1271865|NCT00437125|4159854|P1|Overall Study|Withdrawal by Caregiver|2
1271866|NCT00437125|4159854|P1|Overall Study|Withdrawal by Subject|13
1271867|NCT00437125|4159854|P1|Overall Study|Lost to Follow-up|1
1271868|NCT00437125|4159854|P1|Overall Study|Lack of Efficacy|1
1271869|NCT00437125|4159854|P1|Overall Study|Clinical Relapse|1
1271870|NCT00437125|4159854|P1|Overall Study|Death|1
1271871|NCT00437125|4159854|P1|Overall Study|Adverse Event|12
1271872|NCT00437073|4159875|P2|Overall Study|Physician Decision|1
1271873|NCT00437073|4159876|P1|Overall Study|Physician Decision|0
1271874|NCT00437073|4159875|P2|Overall Study|Sponsor Terminated Study|0
1271875|NCT00437073|4159876|P1|Overall Study|Sponsor Terminated Study|1
1271876|NCT00437034|4159904|P1|Overall Study|Disease progression during treatment|5
1271877|NCT00437034|4159904|P1|Overall Study|Adverse Event|1
1271878|NCT00436982|4159910|P2|Overall Study|no RSA data|2
1271879|NCT00436982|4159911|P1|Overall Study|no RSA data|1
1271880|NCT00436982|4159910|P2|Overall Study|Did not receive allocated intervention|1
1271881|NCT00436982|4159911|P1|Overall Study|Did not receive allocated intervention|0
1271882|NCT00436982|4159910|P2|Overall Study|Withdrawal by Subject|1
1271883|NCT00436982|4159911|P1|Overall Study|Withdrawal by Subject|3
1271884|NCT00436956|4159982|P2|Overall Study|Not evaluable|0
1271885|NCT00436956|4159983|P1|Overall Study|Not evaluable|1
1271886|NCT00436917|4159997|P1|Overall Study|Still on treatment|47
1271887|NCT00436917|4159997|P1|Overall Study|Adverse Event|1
1271888|NCT00436917|4159997|P1|Overall Study|Withdrawal by Subject|6
1271889|NCT00436852|4160012|P2|Overall Study|Ineligible|0
1271890|NCT00436852|4160013|P1|Overall Study|Ineligible|1
1271891|NCT00436852|4160012|P2|Overall Study|Withdrawal by Subject|4
1271892|NCT00436852|4160013|P1|Overall Study|Withdrawal by Subject|2
1271893|NCT00436852|4160012|P2|Overall Study|Lack of Efficacy|7
1271894|NCT00436852|4160013|P1|Overall Study|Lack of Efficacy|9
1271895|NCT00436852|4160012|P2|Overall Study|Death|34
1271896|NCT00436852|4160013|P1|Overall Study|Death|23
1271897|NCT00436826|4160023|P6|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7
1271898|NCT00436826|4160024|P5|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51
1271899|NCT00436826|4160025|P4|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
1271900|NCT00436826|4160026|P3|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
1271901|NCT00436826|4160027|P2|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
1271902|NCT00436826|4160028|P1|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
1271903|NCT00436826|4160023|P6|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
1271904|NCT00436826|4160024|P5|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
1271905|NCT00436826|4160025|P4|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|24
1271906|NCT00436826|4160026|P3|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|44
1271907|NCT00436826|4160027|P2|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
1271908|NCT00436826|4160028|P1|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
1271909|NCT00436826|4160023|P6|Double Blind Period|Other|0
1271910|NCT00436826|4160024|P5|Double Blind Period|Other|0
1271911|NCT00436826|4160025|P4|Double Blind Period|Other|0
1271912|NCT00436826|4160026|P3|Double Blind Period|Other|0
1271913|NCT00436826|4160027|P2|Double Blind Period|Other|11
1271914|NCT00436826|4160028|P1|Double Blind Period|Other|10
1271915|NCT00436826|4160023|P6|Double Blind Period|Protocol Violation|0
1271916|NCT00436826|4160024|P5|Double Blind Period|Protocol Violation|0
1271917|NCT00436826|4160025|P4|Double Blind Period|Protocol Violation|0
1271918|NCT00436826|4160026|P3|Double Blind Period|Protocol Violation|0
1271919|NCT00436826|4160027|P2|Double Blind Period|Protocol Violation|0
1271920|NCT00436826|4160028|P1|Double Blind Period|Protocol Violation|1
1271921|NCT00436826|4160023|P6|Double Blind Period|Adverse Event|0
1271922|NCT00436826|4160024|P5|Double Blind Period|Adverse Event|0
1271923|NCT00436826|4160025|P4|Double Blind Period|Adverse Event|0
1271924|NCT00436826|4160026|P3|Double Blind Period|Adverse Event|0
1271925|NCT00436826|4160027|P2|Double Blind Period|Adverse Event|0
1271926|NCT00436826|4160028|P1|Double Blind Period|Adverse Event|2
1271927|NCT00436748|4160050|P2|Overall Study|Other|0
1271928|NCT00436748|4160051|P1|Overall Study|Other|3
1271929|NCT00436748|4160050|P2|Overall Study|Protocol-specified Criteria|4
1271930|NCT00436748|4160051|P1|Overall Study|Protocol-specified Criteria|5
1271931|NCT00436748|4160050|P2|Overall Study|Lost to Follow-up|1
1271932|NCT00436748|4160051|P1|Overall Study|Lost to Follow-up|0
1271933|NCT00436748|4160050|P2|Overall Study|Administrative Decision|0
1271934|NCT00436748|4160051|P1|Overall Study|Administrative Decision|1
1271935|NCT00436748|4160050|P2|Overall Study|Consent Withdrawn|4
1271936|NCT00436748|4160051|P1|Overall Study|Consent Withdrawn|1
1271937|NCT00436748|4160050|P2|Overall Study|Adverse Event|2
1271938|NCT00436748|4160051|P1|Overall Study|Adverse Event|0
1271939|NCT00436748|4160050|P2|Overall Study|Ineligibility Determined|1
1271940|NCT00436748|4160051|P1|Overall Study|Ineligibility Determined|1
1271941|NCT00436644|4160085|P1|Overall Study|Death|1
1271942|NCT00436644|4160085|P1|Overall Study|Adverse Event|2
1271943|NCT00436618|4160095|P3|Overall Study|Still on treatment|7
1271944|NCT00436618|4160096|P2|Overall Study|Still on treatment|2
1271945|NCT00436618|4160097|P1|Overall Study|Still on treatment|1
1271946|NCT00436618|4160095|P3|Overall Study|New Primary or Other Reasons|12
1271947|NCT00436618|4160096|P2|Overall Study|New Primary or Other Reasons|2
1271948|NCT00436618|4160097|P1|Overall Study|New Primary or Other Reasons|6
1271949|NCT00436618|4160095|P3|Overall Study|Death|3
1271950|NCT00436618|4160096|P2|Overall Study|Death|2
1271951|NCT00436618|4160097|P1|Overall Study|Death|4
1271952|NCT00436618|4160095|P3|Overall Study|Other Medical Problems|7
1271953|NCT00436618|4160096|P2|Overall Study|Other Medical Problems|1
1271954|NCT00436618|4160097|P1|Overall Study|Other Medical Problems|3
1271955|NCT00436618|4160095|P3|Overall Study|Alternate Treatment|12
1271956|NCT00436618|4160096|P2|Overall Study|Alternate Treatment|4
1271957|NCT00436618|4160097|P1|Overall Study|Alternate Treatment|3
1271958|NCT00436618|4160095|P3|Overall Study|Adverse Event|9
1271959|NCT00436618|4160096|P2|Overall Study|Adverse Event|8
1271960|NCT00436618|4160097|P1|Overall Study|Adverse Event|8
1271961|NCT00436618|4160095|P3|Overall Study|Withdrawal by Subject|11
1271962|NCT00436618|4160096|P2|Overall Study|Withdrawal by Subject|8
1271963|NCT00436618|4160097|P1|Overall Study|Withdrawal by Subject|5
1271964|NCT00436605|4160114|P1|Overall Study|Protocol Violation|3
1271965|NCT00436566|4160119|P1|Overall Study|Protocol Violation|1
1271966|NCT00436566|4160119|P1|Overall Study|Withdrawal by Subject|2
1271967|NCT00436553|4160126|P3|Overall Study|Withdrawal by Subject|3
1271968|NCT00436553|4160127|P2|Overall Study|Withdrawal by Subject|6
1271969|NCT00436553|4160128|P1|Overall Study|Withdrawal by Subject|5
1271970|NCT00436553|4160126|P3|Overall Study|Protocol Violation|0
1271971|NCT00436553|4160127|P2|Overall Study|Protocol Violation|0
1271972|NCT00436553|4160128|P1|Overall Study|Protocol Violation|1
1271973|NCT00436553|4160126|P3|Overall Study|Lost to Follow-up|0
1271974|NCT00436553|4160127|P2|Overall Study|Lost to Follow-up|2
1271975|NCT00436553|4160128|P1|Overall Study|Lost to Follow-up|0
1271976|NCT00436553|4160126|P3|Overall Study|Death|3
1271977|NCT00436553|4160127|P2|Overall Study|Death|1
1271978|NCT00436553|4160128|P1|Overall Study|Death|3
1271979|NCT00436553|4160126|P3|Overall Study|Adverse Event|4
1271980|NCT00436553|4160127|P2|Overall Study|Adverse Event|3
1271981|NCT00436553|4160128|P1|Overall Study|Adverse Event|4
1271982|NCT00436501|4160149|P2|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1
1271983|NCT00436501|4160150|P1|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0
1271984|NCT00436501|4160149|P2|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2
1271985|NCT00436501|4160150|P1|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0
1271986|NCT00436436|4160161|P1|Overall Study|Death|6
1271987|NCT00436436|4160161|P1|Overall Study|Adverse Event|2
1271988|NCT00436436|4160161|P1|Overall Study|Progression|4
1271989|NCT00436345|4160172|P2|Overall Study|ICU resident beyond follow-up period|0
1271990|NCT00436345|4160173|P1|Overall Study|ICU resident beyond follow-up period|3
1271991|NCT00436332|4160226|P1|Overall Study|Never Received Treatment|3
1271992|NCT00436332|4160226|P1|Overall Study|Ineligible|2
1271993|NCT00436332|4160226|P1|Overall Study|Not Protocol Specified|6
1271994|NCT00436332|4160226|P1|Overall Study|Death|2
1271995|NCT00436332|4160226|P1|Overall Study|Progression|59
1271996|NCT00436332|4160226|P1|Overall Study|Withdrawal by Subject|2
1271997|NCT00436332|4160226|P1|Overall Study|Adverse Event|9
1271998|NCT00436215|4160233|P1|Overall Study|Small bowel obstruction|1
1271999|NCT00436215|4160233|P1|Overall Study|Refused further treatment|3
1272000|NCT00436163|4160239|P1|Overall Study|Adverse Event|1
1272001|NCT00436163|4160239|P1|Overall Study|Lost to Follow-up|2
1272002|NCT00436007|4160287|P3|Overall Study|Other|1
1272003|NCT00436007|4160288|P2|Overall Study|Other|0
1272004|NCT00436007|4160289|P1|Overall Study|Other|0
1272005|NCT00436007|4160287|P3|Overall Study|Death|3
1272006|NCT00436007|4160288|P2|Overall Study|Death|1
1272007|NCT00436007|4160289|P1|Overall Study|Death|0
1272008|NCT00436007|4160287|P3|Overall Study|Physician Decision|2
1272009|NCT00436007|4160288|P2|Overall Study|Physician Decision|0
1272010|NCT00436007|4160289|P1|Overall Study|Physician Decision|0
1272011|NCT00436007|4160287|P3|Overall Study|Lost to Follow-up|13
1272012|NCT00436007|4160288|P2|Overall Study|Lost to Follow-up|10
1272013|NCT00436007|4160289|P1|Overall Study|Lost to Follow-up|14
1272014|NCT00436007|4160287|P3|Overall Study|Withdrawal by Subject|4
1272015|NCT00436007|4160288|P2|Overall Study|Withdrawal by Subject|3
1272016|NCT00436007|4160289|P1|Overall Study|Withdrawal by Subject|5
1272017|NCT00435994|4160337|P3|Overall Study|Lost to Follow-up|0
1272018|NCT00435994|4160338|P2|Overall Study|Lost to Follow-up|0
1272019|NCT00435994|4160339|P1|Overall Study|Lost to Follow-up|7
1272020|NCT00435942|4160350|P2|Overall Study|Other|1
1272021|NCT00435942|4160351|P1|Overall Study|Other|0
1272022|NCT00435942|4160350|P2|Overall Study|Technical Failure|0
1272023|NCT00435942|4160351|P1|Overall Study|Technical Failure|3
1272024|NCT00435942|4160350|P2|Overall Study|Conversion to Open Repair|0
1272025|NCT00435942|4160351|P1|Overall Study|Conversion to Open Repair|1
1272026|NCT00435942|4160350|P2|Overall Study|Lost to Follow-up|16
1272027|NCT00435942|4160351|P1|Overall Study|Lost to Follow-up|0
1272028|NCT00435942|4160350|P2|Overall Study|Withdrawal by Subject|0
1272029|NCT00435942|4160351|P1|Overall Study|Withdrawal by Subject|2
1272030|NCT00435942|4160350|P2|Overall Study|Death|10
1272031|NCT00435942|4160351|P1|Overall Study|Death|17
1272032|NCT00435825|4160391|P4|Overall Study|Did not complete full follow-up period|5
1272033|NCT00435825|4160392|P3|Overall Study|Did not complete full follow-up period|4
1272034|NCT00435825|4160393|P2|Overall Study|Did not complete full follow-up period|6
1272035|NCT00435825|4160394|P1|Overall Study|Did not complete full follow-up period|6
1272036|NCT00435825|4160391|P4|Overall Study|Did not enter follow-up|3
1272037|NCT00435825|4160392|P3|Overall Study|Did not enter follow-up|1
1272038|NCT00435825|4160393|P2|Overall Study|Did not enter follow-up|4
1272039|NCT00435825|4160394|P1|Overall Study|Did not enter follow-up|0
1272040|NCT00435825|4160391|P4|Overall Study|Did not receive study drug|0
1272041|NCT00435825|4160392|P3|Overall Study|Did not receive study drug|2
1272042|NCT00435825|4160393|P2|Overall Study|Did not receive study drug|0
1272043|NCT00435825|4160394|P1|Overall Study|Did not receive study drug|1
1272044|NCT00435825|4160391|P4|Overall Study|Failure to return|0
1272045|NCT00435825|4160392|P3|Overall Study|Failure to return|4
1272046|NCT00435825|4160393|P2|Overall Study|Failure to return|0
1272047|NCT00435825|4160394|P1|Overall Study|Failure to return|5
1272048|NCT00435825|4160391|P4|Overall Study|Refused treatment|5
1272049|NCT00435825|4160392|P3|Overall Study|Refused treatment|0
1272050|NCT00435825|4160393|P2|Overall Study|Refused treatment|0
1272051|NCT00435825|4160394|P1|Overall Study|Refused treatment|2
1272052|NCT00435825|4160391|P4|Overall Study|Other Protocol Violation|0
1272053|NCT00435825|4160392|P3|Overall Study|Other Protocol Violation|0
1272054|NCT00435825|4160393|P2|Overall Study|Other Protocol Violation|0
1272055|NCT00435825|4160394|P1|Overall Study|Other Protocol Violation|1
1272056|NCT00435825|4160391|P4|Overall Study|Insufficient Therapeutic Response|3
1272057|NCT00435825|4160392|P3|Overall Study|Insufficient Therapeutic Response|0
1272058|NCT00435825|4160393|P2|Overall Study|Insufficient Therapeutic Response|1
1272059|NCT00435825|4160394|P1|Overall Study|Insufficient Therapeutic Response|3
1272060|NCT00435825|4160391|P4|Overall Study|Abnormality of Laboratory Test|0
1272061|NCT00435825|4160392|P3|Overall Study|Abnormality of Laboratory Test|0
1272062|NCT00435825|4160393|P2|Overall Study|Abnormality of Laboratory Test|1
1272063|NCT00435825|4160394|P1|Overall Study|Abnormality of Laboratory Test|0
1272064|NCT00435487|4160517|P2|Overall Study|Received Drug in Other Treatment Group|1
1272065|NCT00435487|4160518|P1|Overall Study|Received Drug in Other Treatment Group|0
1272066|NCT00435487|4160517|P2|Overall Study|Withdrawal by Subject Prior to Treatment|2
1272067|NCT00435487|4160518|P1|Overall Study|Withdrawal by Subject Prior to Treatment|0
1272068|NCT00435487|4160517|P2|Overall Study|Withdrawal by Subject|1
1272069|NCT00435487|4160518|P1|Overall Study|Withdrawal by Subject|2
1272070|NCT00435487|4160517|P2|Overall Study|Other|2
1272071|NCT00435487|4160518|P1|Overall Study|Other|5
1272072|NCT00435487|4160517|P2|Overall Study|Lost to Follow-up|2
1272073|NCT00435487|4160518|P1|Overall Study|Lost to Follow-up|2
1272074|NCT00435487|4160517|P2|Overall Study|Adverse Event|3
1272075|NCT00435487|4160518|P1|Overall Study|Adverse Event|0
1272076|NCT00435487|4160517|P2|Overall Study|Death|4
1272077|NCT00435487|4160518|P1|Overall Study|Death|3
1272078|NCT00435461|4160537|P3|Overall Study|Lost to Follow-up|2
1272079|NCT00435461|4160538|P2|Overall Study|Lost to Follow-up|1
1272080|NCT00435461|4160539|P1|Overall Study|Lost to Follow-up|1
1272081|NCT00435461|4160537|P3|Overall Study|Non-Compliance of diary|1
1272082|NCT00435461|4160538|P2|Overall Study|Non-Compliance of diary|0
1272083|NCT00435461|4160539|P1|Overall Study|Non-Compliance of diary|2
1272084|NCT00435461|4160537|P3|Overall Study|Adverse Event|6
1272085|NCT00435461|4160538|P2|Overall Study|Adverse Event|2
1272086|NCT00435461|4160539|P1|Overall Study|Adverse Event|1
1272087|NCT00435461|4160537|P3|Overall Study|Noncompliance with study requirements|1
1272088|NCT00435461|4160538|P2|Overall Study|Noncompliance with study requirements|1
1272089|NCT00435461|4160539|P1|Overall Study|Noncompliance with study requirements|1
1272090|NCT00435461|4160537|P3|Overall Study|Participant ended study one day early|0
1272091|NCT00435461|4160538|P2|Overall Study|Participant ended study one day early|0
1272092|NCT00435461|4160539|P1|Overall Study|Participant ended study one day early|1
1272093|NCT00435461|4160537|P3|Overall Study|Participant moved eDiary,studymedication|0
1272094|NCT00435461|4160538|P2|Overall Study|Participant moved eDiary,studymedication|0
1272095|NCT00435461|4160539|P1|Overall Study|Participant moved eDiary,studymedication|1
1272096|NCT00435461|4160537|P3|Overall Study|Pregnancy|0
1272097|NCT00435461|4160538|P2|Overall Study|Pregnancy|0
1272098|NCT00435461|4160539|P1|Overall Study|Pregnancy|2
1272099|NCT00435461|4160537|P3|Overall Study|Participant could not swallow capsule|1
1272100|NCT00435461|4160538|P2|Overall Study|Participant could not swallow capsule|0
1272101|NCT00435461|4160539|P1|Overall Study|Participant could not swallow capsule|0
1272102|NCT00435461|4160537|P3|Overall Study|Participant could not tolerate symptoms|1
1272103|NCT00435461|4160538|P2|Overall Study|Participant could not tolerate symptoms|0
1272104|NCT00435461|4160539|P1|Overall Study|Participant could not tolerate symptoms|0
1272105|NCT00435461|4160537|P3|Overall Study|Randomized in error|0
1272106|NCT00435461|4160538|P2|Overall Study|Randomized in error|0
1272107|NCT00435461|4160539|P1|Overall Study|Randomized in error|1
1272108|NCT00435461|4160537|P3|Overall Study|Withdrawal by Subject|2
1272109|NCT00435461|4160538|P2|Overall Study|Withdrawal by Subject|0
1272110|NCT00435461|4160539|P1|Overall Study|Withdrawal by Subject|1
1272111|NCT00435461|4160537|P3|Overall Study|Lack of Efficacy|0
1272112|NCT00435461|4160538|P2|Overall Study|Lack of Efficacy|1
1272113|NCT00435461|4160539|P1|Overall Study|Lack of Efficacy|2
1272114|NCT00435461|4160537|P3|Overall Study|In error, two study medications switched|0
1272115|NCT00435461|4160538|P2|Overall Study|In error, two study medications switched|0
1272116|NCT00435461|4160539|P1|Overall Study|In error, two study medications switched|1
1272117|NCT00435461|4160537|P3|Overall Study|Compliance less than 80 percent|0
1272118|NCT00435461|4160538|P2|Overall Study|Compliance less than 80 percent|0
1272119|NCT00435461|4160539|P1|Overall Study|Compliance less than 80 percent|1
1272120|NCT00435461|4160537|P3|Overall Study|Participant randomized(inadequate score)|0
1272121|NCT00435461|4160538|P2|Overall Study|Participant randomized(inadequate score)|0
1272122|NCT00435461|4160539|P1|Overall Study|Participant randomized(inadequate score)|1
1272123|NCT00435461|4160537|P3|Overall Study|Protocol Violation|10
1272124|NCT00435461|4160538|P2|Overall Study|Protocol Violation|9
1272125|NCT00435461|4160539|P1|Overall Study|Protocol Violation|6
1272126|NCT00435461|4160537|P3|Overall Study|Visit changed to EarlyWithdrawn Visit|0
1272127|NCT00435461|4160538|P2|Overall Study|Visit changed to EarlyWithdrawn Visit|0
1272128|NCT00435461|4160539|P1|Overall Study|Visit changed to EarlyWithdrawn Visit|1
1272129|NCT00435409|4160576|P3|Overall Study|Sponsor decision|0
1272130|NCT00435409|4160577|P2|Overall Study|Sponsor decision|3
1272131|NCT00435409|4160578|P1|Overall Study|Sponsor decision|0
1272132|NCT00435409|4160576|P3|Overall Study|Adverse Event|8
1272133|NCT00435409|4160577|P2|Overall Study|Adverse Event|0
1272134|NCT00435409|4160578|P1|Overall Study|Adverse Event|0
1272135|NCT00435409|4160576|P3|Overall Study|Not specified|1
1272136|NCT00435409|4160577|P2|Overall Study|Not specified|30
1272137|NCT00435409|4160578|P1|Overall Study|Not specified|45
1272138|NCT00435409|4160576|P3|Overall Study|Withdrawal by Subject|1
1272139|NCT00435409|4160577|P2|Overall Study|Withdrawal by Subject|7
1272140|NCT00435409|4160578|P1|Overall Study|Withdrawal by Subject|8
1272141|NCT00435409|4160576|P3|Overall Study|Global deterioration of health status|4
1272142|NCT00435409|4160577|P2|Overall Study|Global deterioration of health status|0
1272143|NCT00435409|4160578|P1|Overall Study|Global deterioration of health status|0
1272144|NCT00435409|4160576|P3|Overall Study|Objective progression or relapse|58
1272145|NCT00435409|4160577|P2|Overall Study|Objective progression or relapse|93
1272146|NCT00435409|4160578|P1|Overall Study|Objective progression or relapse|158
1272147|NCT00435409|4160576|P3|Overall Study|Death|6
1272148|NCT00435409|4160577|P2|Overall Study|Death|6
1272149|NCT00435409|4160578|P1|Overall Study|Death|8
1272150|NCT00435409|4160576|P3|Overall Study|Lost to Follow-up|0
1272151|NCT00435409|4160577|P2|Overall Study|Lost to Follow-up|2
1272152|NCT00435409|4160578|P1|Overall Study|Lost to Follow-up|1
1272153|NCT00435409|4160576|P3|Overall Study|Protocol Violation|0
1272154|NCT00435409|4160577|P2|Overall Study|Protocol Violation|2
1272155|NCT00435409|4160578|P1|Overall Study|Protocol Violation|1
1272156|NCT00435370|4160600|P2|Overall Study|Antipsychotic medication changed|2
1272157|NCT00435370|4160601|P1|Overall Study|Antipsychotic medication changed|4
1272158|NCT00435370|4160600|P2|Overall Study|Withdrawal by Subject|10
1272159|NCT00435370|4160601|P1|Overall Study|Withdrawal by Subject|10
1272160|NCT00435370|4160600|P2|Overall Study|Adverse Event|8
1272161|NCT00435370|4160601|P1|Overall Study|Adverse Event|8
1272162|NCT00435188|4160609|P2|Overall Study|Lost to Follow-up|6
1272163|NCT00435188|4160610|P1|Overall Study|Lost to Follow-up|5
1272164|NCT00435188|4160609|P2|Overall Study|Withdrawal by Subject|11
1272165|NCT00435188|4160610|P1|Overall Study|Withdrawal by Subject|16
1272166|NCT00435188|4160609|P2|Overall Study|Death|6
1272167|NCT00435188|4160610|P1|Overall Study|Death|1
1272168|NCT00435162|4160653|P6|Period 2 (2 Weeks)|Adverse Event|0
1272169|NCT00435162|4160654|P5|Period 2 (2 Weeks)|Adverse Event|0
1272170|NCT00435162|4160655|P4|Period 2 (2 Weeks)|Adverse Event|0
1272171|NCT00435162|4160656|P3|Period 2 (2 Weeks)|Adverse Event|0
1272172|NCT00435162|4160657|P2|Period 2 (2 Weeks)|Adverse Event|1
1272173|NCT00435162|4160658|P1|Period 2 (2 Weeks)|Adverse Event|0
1272174|NCT00435045|4160678|P2|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0
1272175|NCT00435045|4160679|P1|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1
1272176|NCT00435045|4160678|P2|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0
1272177|NCT00435045|4160679|P1|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1
1272178|NCT00435045|4160678|P2|Weeks 13-16 / 40mg Dose Level|Adverse Event|2
1272179|NCT00435045|4160679|P1|Weeks 13-16 / 40mg Dose Level|Adverse Event|3
1272180|NCT00435045|4160678|P2|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1
1272181|NCT00435045|4160679|P1|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0
1272182|NCT00435045|4160678|P2|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
1272183|NCT00435045|4160679|P1|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
1272184|NCT00435045|4160678|P2|Weeks 9-12 / 20mg Dose Level|Adverse Event|3
1272185|NCT00435045|4160679|P1|Weeks 9-12 / 20mg Dose Level|Adverse Event|4
1272186|NCT00435045|4160678|P2|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1
1272187|NCT00435045|4160679|P1|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0
1272188|NCT00435045|4160678|P2|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0
1272189|NCT00435045|4160679|P1|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1
1272190|NCT00435045|4160678|P2|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1
1272191|NCT00435045|4160679|P1|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2
1272192|NCT00435045|4160678|P2|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
1272193|NCT00435045|4160679|P1|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
1272194|NCT00435045|4160678|P2|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
1272195|NCT00435045|4160679|P1|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
1272196|NCT00435019|4160735|P2|Overall Study|Personal reasons for withdrawal|7
1272197|NCT00435019|4160736|P1|Overall Study|Personal reasons for withdrawal|8
1272198|NCT00435019|4160735|P2|Overall Study|Protocol Violation|1
1272199|NCT00435019|4160736|P1|Overall Study|Protocol Violation|3
1272200|NCT00435019|4160735|P2|Overall Study|Lack of Efficacy|2
1272201|NCT00435019|4160736|P1|Overall Study|Lack of Efficacy|1
1272202|NCT00435019|4160735|P2|Overall Study|Adverse Event|0
1272203|NCT00435019|4160736|P1|Overall Study|Adverse Event|1
1272204|NCT00434967|4160777|P4|Overall Study|Patient Disposition Challenges|3
1272205|NCT00434967|4160778|P3|Overall Study|Patient Disposition Challenges|0
1272206|NCT00434967|4160779|P2|Overall Study|Patient Disposition Challenges|0
1272207|NCT00434967|4160780|P1|Overall Study|Patient Disposition Challenges|2
1272208|NCT00434967|4160777|P4|Overall Study|Physician Decision|0
1272209|NCT00434967|4160778|P3|Overall Study|Physician Decision|1
1272210|NCT00434967|4160779|P2|Overall Study|Physician Decision|1
1272211|NCT00434967|4160780|P1|Overall Study|Physician Decision|1
1272212|NCT00434967|4160777|P4|Overall Study|Protocol Violation|1
1272213|NCT00434967|4160778|P3|Overall Study|Protocol Violation|0
1272214|NCT00434967|4160779|P2|Overall Study|Protocol Violation|1
1272215|NCT00434967|4160780|P1|Overall Study|Protocol Violation|0
1272216|NCT00434967|4160777|P4|Overall Study|Randomized in error|1
1272217|NCT00434967|4160778|P3|Overall Study|Randomized in error|0
1272218|NCT00434967|4160779|P2|Overall Study|Randomized in error|0
1272219|NCT00434967|4160780|P1|Overall Study|Randomized in error|0
1272220|NCT00434967|4160777|P4|Overall Study|Withdrawal by Subject|6
1272221|NCT00434967|4160778|P3|Overall Study|Withdrawal by Subject|4
1272222|NCT00434967|4160779|P2|Overall Study|Withdrawal by Subject|2
1272223|NCT00434967|4160780|P1|Overall Study|Withdrawal by Subject|2
1272224|NCT00434967|4160777|P4|Overall Study|Lost to Follow-up|0
1272225|NCT00434967|4160778|P3|Overall Study|Lost to Follow-up|1
1272226|NCT00434967|4160779|P2|Overall Study|Lost to Follow-up|0
1272227|NCT00434967|4160780|P1|Overall Study|Lost to Follow-up|0
1272228|NCT00434967|4160777|P4|Overall Study|Adverse Event|3
1272229|NCT00434967|4160778|P3|Overall Study|Adverse Event|3
1272230|NCT00434967|4160779|P2|Overall Study|Adverse Event|4
1272231|NCT00434967|4160780|P1|Overall Study|Adverse Event|2
1272232|NCT00434954|4160800|P2|Overall Study|Subject decision|22
1272233|NCT00434954|4160801|P1|Overall Study|Subject decision|8
1272234|NCT00434954|4160800|P2|Overall Study|Sponsor decision|0
1272235|NCT00434954|4160801|P1|Overall Study|Sponsor decision|1
1272236|NCT00434954|4160800|P2|Overall Study|Protocol Violation|27
1272237|NCT00434954|4160801|P1|Overall Study|Protocol Violation|36
1272238|NCT00434954|4160800|P2|Overall Study|Physician Decision|3
1272239|NCT00434954|4160801|P1|Overall Study|Physician Decision|6
1272240|NCT00434954|4160800|P2|Overall Study|Lost to Follow-up|1
1272241|NCT00434954|4160801|P1|Overall Study|Lost to Follow-up|0
1272242|NCT00434954|4160800|P2|Overall Study|Entry criteria not met|16
1272243|NCT00434954|4160801|P1|Overall Study|Entry criteria not met|14
1272244|NCT00434954|4160800|P2|Overall Study|Adverse Event|2
1272245|NCT00434954|4160801|P1|Overall Study|Adverse Event|17
1272246|NCT00434876|4160831|P2|Overall Study|Lost to Follow-up|1
1272247|NCT00434876|4160832|P1|Overall Study|Lost to Follow-up|1
1272248|NCT00434759|4160846|P2|Overall Study|family affairs|0
1272249|NCT00434759|4160847|P1|Overall Study|family affairs|2
1272250|NCT00434759|4160846|P2|Overall Study|Withdrawal by Subject|1
1272251|NCT00434759|4160847|P1|Overall Study|Withdrawal by Subject|17
1272252|NCT00434759|4160846|P2|Overall Study|Lack of Efficacy|4
1272253|NCT00434759|4160847|P1|Overall Study|Lack of Efficacy|5
1272254|NCT00434642|4160863|P2|Open-label Treatment Phase|Disease Progression Per RECIST|6
1272255|NCT00434642|4160864|P1|Open-label Treatment Phase|Disease Progression Per RECIST|0
1272256|NCT00434642|4160863|P2|Open-label Treatment Phase|Adverse Event|5
1272257|NCT00434642|4160864|P1|Open-label Treatment Phase|Adverse Event|0
1272258|NCT00434642|4160863|P2|Blinded Treatment Phase|Did not Receive Treatment|1
1272259|NCT00434642|4160864|P1|Blinded Treatment Phase|Did not Receive Treatment|4
1272260|NCT00434642|4160863|P2|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29
1272261|NCT00434642|4160864|P1|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32
1272262|NCT00434642|4160863|P2|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0
1272263|NCT00434642|4160864|P1|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3
1272264|NCT00434642|4160863|P2|Blinded Treatment Phase|Physician Decision|27
1272265|NCT00434642|4160864|P1|Blinded Treatment Phase|Physician Decision|19
1272266|NCT00434642|4160863|P2|Blinded Treatment Phase|Disease Progression Per RECIST|109
1272267|NCT00434642|4160864|P1|Blinded Treatment Phase|Disease Progression Per RECIST|168
1272268|NCT00434642|4160863|P2|Blinded Treatment Phase|Clinical Disease Progression|5
1272269|NCT00434642|4160864|P1|Blinded Treatment Phase|Clinical Disease Progression|4
1272270|NCT00434642|4160863|P2|Blinded Treatment Phase|Adverse Event|58
1272271|NCT00434642|4160864|P1|Blinded Treatment Phase|Adverse Event|12
1272272|NCT00434590|4160882|P2|Overall Study|Administrative problems|5
1272273|NCT00434590|4160883|P1|Overall Study|Administrative problems|5
1272274|NCT00434421|4160905|P1|Overall Study|Non-compliance with study treatment|1
1272275|NCT00434421|4160905|P1|Overall Study|Withdrawal by Subject|1
1272276|NCT00434330|4160933|P6|Overall Study|Subject Not Compliant With Study|0
1272277|NCT00434330|4160934|P5|Overall Study|Subject Not Compliant With Study|0
1272278|NCT00434330|4160935|P4|Overall Study|Subject Not Compliant With Study|0
1272279|NCT00434330|4160936|P3|Overall Study|Subject Not Compliant With Study|1
1272280|NCT00434330|4160937|P2|Overall Study|Subject Not Compliant With Study|0
1272281|NCT00434330|4160938|P1|Overall Study|Subject Not Compliant With Study|0
1272282|NCT00434330|4160933|P6|Overall Study|Renal transplant|0
1272283|NCT00434330|4160934|P5|Overall Study|Renal transplant|0
1272284|NCT00434330|4160935|P4|Overall Study|Renal transplant|1
1272285|NCT00434330|4160936|P3|Overall Study|Renal transplant|0
1272286|NCT00434330|4160937|P2|Overall Study|Renal transplant|0
1272287|NCT00434330|4160938|P1|Overall Study|Renal transplant|0
1272288|NCT00434330|4160933|P6|Overall Study|Withdrawal by Subject|0
1272289|NCT00434330|4160934|P5|Overall Study|Withdrawal by Subject|0
1272290|NCT00434330|4160935|P4|Overall Study|Withdrawal by Subject|1
1272291|NCT00434330|4160936|P3|Overall Study|Withdrawal by Subject|1
1272292|NCT00434330|4160937|P2|Overall Study|Withdrawal by Subject|0
1272293|NCT00434330|4160938|P1|Overall Study|Withdrawal by Subject|0
1272294|NCT00434330|4160933|P6|Overall Study|Death|1
1272295|NCT00434330|4160934|P5|Overall Study|Death|1
1272296|NCT00434330|4160935|P4|Overall Study|Death|0
1272297|NCT00434330|4160936|P3|Overall Study|Death|0
1272298|NCT00434330|4160937|P2|Overall Study|Death|0
1272299|NCT00434330|4160938|P1|Overall Study|Death|1
1272300|NCT00434330|4160933|P6|Overall Study|Adverse Event|0
1272301|NCT00434330|4160934|P5|Overall Study|Adverse Event|0
1272302|NCT00434330|4160935|P4|Overall Study|Adverse Event|0
1272303|NCT00434330|4160936|P3|Overall Study|Adverse Event|1
1272304|NCT00434330|4160937|P2|Overall Study|Adverse Event|0
1272305|NCT00434330|4160938|P1|Overall Study|Adverse Event|0
1272306|NCT00434304|4160970|P1|Overall Study|Withdrawal by Subject|4
1272307|NCT00434304|4160970|P1|Overall Study|Lack of Efficacy|2
1272308|NCT00434304|4160970|P1|Overall Study|Adverse Event|14
1272309|NCT00434252|4161019|P2|Overall Study|Withdrawal by Subject|7
1272310|NCT00434252|4161020|P1|Overall Study|Withdrawal by Subject|3
1272311|NCT00434252|4161019|P2|Overall Study|Physician Decision|8
1272312|NCT00434252|4161020|P1|Overall Study|Physician Decision|4
1272313|NCT00434252|4161019|P2|Overall Study|Lost to Follow-up|1
1272314|NCT00434252|4161020|P1|Overall Study|Lost to Follow-up|0
1272315|NCT00434252|4161019|P2|Overall Study|Death|2
1272316|NCT00434252|4161020|P1|Overall Study|Death|1
1272317|NCT00434252|4161019|P2|Overall Study|Adverse Event|13
1272318|NCT00434252|4161020|P1|Overall Study|Adverse Event|6
1272319|NCT00434252|4161019|P2|Overall Study|Lack of Efficacy|100
1272320|NCT00434252|4161020|P1|Overall Study|Lack of Efficacy|50
1272321|NCT00434213|4161054|P1|Overall Study|Non-compliant to study schedule|1
1272322|NCT00434213|4161054|P1|Overall Study|Application site reaction|1
1272323|NCT00434213|4161054|P1|Overall Study|Unable to comply with study visit window|2
1272324|NCT00434213|4161054|P1|Overall Study|Protocol Violation|3
1272325|NCT00434213|4161054|P1|Overall Study|Withdrawal by Subject|7
1272326|NCT00434213|4161054|P1|Overall Study|Lost to Follow-up|14
1272327|NCT00434213|4161054|P1|Overall Study|Lack of Efficacy|9
1272328|NCT00434213|4161054|P1|Overall Study|Adverse Event|12
1272329|NCT00434161|4161062|P3|Overall Study|Logistical error study assessments|3
1272330|NCT00434161|4161063|P2|Overall Study|Logistical error study assessments|0
1272331|NCT00434161|4161064|P1|Overall Study|Logistical error study assessments|1
1272332|NCT00434161|4161062|P3|Overall Study|Withdrawal by Subject|3
1272333|NCT00434161|4161063|P2|Overall Study|Withdrawal by Subject|0
1272334|NCT00434161|4161064|P1|Overall Study|Withdrawal by Subject|2
1272335|NCT00434161|4161062|P3|Overall Study|Non-Compliance|0
1272336|NCT00434161|4161063|P2|Overall Study|Non-Compliance|1
1272337|NCT00434161|4161064|P1|Overall Study|Non-Compliance|1
1272338|NCT00434161|4161062|P3|Overall Study|Death|1
1272339|NCT00434161|4161063|P2|Overall Study|Death|0
1272340|NCT00434161|4161064|P1|Overall Study|Death|1
1272341|NCT00434161|4161062|P3|Overall Study|Lost to Follow-up|0
1272342|NCT00434161|4161063|P2|Overall Study|Lost to Follow-up|1
1272343|NCT00434161|4161064|P1|Overall Study|Lost to Follow-up|0
1272344|NCT00434161|4161062|P3|Overall Study|Adverse Event|4
1272345|NCT00434161|4161063|P2|Overall Study|Adverse Event|1
1272346|NCT00434161|4161064|P1|Overall Study|Adverse Event|5
1272347|NCT00434148|4161108|P2|Overall Study|Abnormal test procedure result|1
1272348|NCT00434148|4161109|P1|Overall Study|Abnormal test procedure result|0
1272349|NCT00434148|4161108|P2|Overall Study|Condition no longer requires study drug|0
1272350|NCT00434148|4161109|P1|Overall Study|Condition no longer requires study drug|1
1272351|NCT00434148|4161108|P2|Overall Study|Lost to Follow-up|1
1272352|NCT00434148|4161109|P1|Overall Study|Lost to Follow-up|0
1272353|NCT00434148|4161108|P2|Overall Study|Administrative problems|10
1272354|NCT00434148|4161109|P1|Overall Study|Administrative problems|6
1272355|NCT00434148|4161108|P2|Overall Study|Protocol Violation|0
1272356|NCT00434148|4161109|P1|Overall Study|Protocol Violation|4
1272357|NCT00434148|4161108|P2|Overall Study|Withdrawal by Subject|15
1272358|NCT00434148|4161109|P1|Overall Study|Withdrawal by Subject|15
1272359|NCT00434148|4161108|P2|Overall Study|Lack of Efficacy|28
1272360|NCT00434148|4161109|P1|Overall Study|Lack of Efficacy|25
1272361|NCT00434148|4161108|P2|Overall Study|Adverse Event|18
1272362|NCT00434148|4161109|P1|Overall Study|Adverse Event|18
1272363|NCT00434122|4161145|P2|Overall Study|Travelling of subject.|0
1272364|NCT00434122|4161146|P1|Overall Study|Travelling of subject.|1
1272365|NCT00434122|4161145|P2|Overall Study|Low follicular response.|2
1272366|NCT00434122|4161146|P1|Overall Study|Low follicular response.|1
1272367|NCT00434122|4161145|P2|Overall Study|Large follicle size|2
1272368|NCT00434122|4161146|P1|Overall Study|Large follicle size|2
1272369|NCT00434122|4161145|P2|Overall Study|Personal reasons|1
1272370|NCT00434122|4161146|P1|Overall Study|Personal reasons|1
1272371|NCT00434122|4161145|P2|Overall Study|loss of subject contact|1
1272372|NCT00434122|4161146|P1|Overall Study|loss of subject contact|1
1272373|NCT00434122|4161145|P2|Overall Study|Non-compliance with protocol|1
1272374|NCT00434122|4161146|P1|Overall Study|Non-compliance with protocol|0
1272375|NCT00434109|4161155|P1|Overall Study|had embolism, did not receive sunitinib|3
1272376|NCT00434109|4161155|P1|Overall Study|Protocol Violation|1
1272377|NCT00434109|4161155|P1|Overall Study|Adverse Event|5
1272378|NCT00434109|4161155|P1|Overall Study|Physician Decision|9
1272379|NCT00434057|4161164|P1|Overall Study|Withdrawal by Subject|1
1272380|NCT00433966|4161202|P4|Stent Intervention/Randomization|Lost to Follow-up|47
1272381|NCT00433966|4161203|P3|Stent Intervention/Randomization|Lost to Follow-up|113
1272382|NCT00433966|4161204|P2|Stent Intervention/Randomization|Lost to Follow-up|0
1272383|NCT00433966|4161205|P1|Stent Intervention/Randomization|Lost to Follow-up|0
1272384|NCT00433966|4161202|P4|Stent Intervention/Randomization|Withdrawal by Subject|15
1272385|NCT00433966|4161203|P3|Stent Intervention/Randomization|Withdrawal by Subject|41
1272386|NCT00433966|4161204|P2|Stent Intervention/Randomization|Withdrawal by Subject|0
1272387|NCT00433966|4161205|P1|Stent Intervention/Randomization|Withdrawal by Subject|0
1272388|NCT00433966|4161202|P4|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
1272389|NCT00433966|4161203|P3|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
1272390|NCT00433966|4161204|P2|Pharmacology Intervention/Randomization|Not true myocardial infarction|28
1272391|NCT00433966|4161205|P1|Pharmacology Intervention/Randomization|Not true myocardial infarction|29
1272392|NCT00433966|4161202|P4|Pharmacology Intervention/Randomization|Lost to Follow-up|0
1272393|NCT00433966|4161203|P3|Pharmacology Intervention/Randomization|Lost to Follow-up|0
1272394|NCT00433966|4161204|P2|Pharmacology Intervention/Randomization|Lost to Follow-up|103
1272395|NCT00433966|4161205|P1|Pharmacology Intervention/Randomization|Lost to Follow-up|97
1272396|NCT00433966|4161202|P4|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
1272397|NCT00433966|4161203|P3|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
1272398|NCT00433966|4161204|P2|Pharmacology Intervention/Randomization|Withdrawal by Subject|43
1272399|NCT00433966|4161205|P1|Pharmacology Intervention/Randomization|Withdrawal by Subject|40
1272400|NCT00433914|4161227|P2|Overall Study|Lost to Follow-up|1
1272401|NCT00433914|4161228|P1|Overall Study|Lost to Follow-up|0
1272402|NCT00433914|4161227|P2|Overall Study|Withdrawal by Subject|2
1272403|NCT00433914|4161228|P1|Overall Study|Withdrawal by Subject|0
1272404|NCT00433836|4161248|P2|Overall Study|Abnormal laboratory values|1
1272405|NCT00433836|4161249|P1|Overall Study|Abnormal laboratory values|0
1272406|NCT00433836|4161248|P2|Overall Study|Condition no longer requires study drug|1
1272407|NCT00433836|4161249|P1|Overall Study|Condition no longer requires study drug|0
1272408|NCT00433836|4161248|P2|Overall Study|Protocol Violation|2
1272409|NCT00433836|4161249|P1|Overall Study|Protocol Violation|0
1272410|NCT00433836|4161248|P2|Overall Study|Unsatisfactory therapeutic effect|1
1272411|NCT00433836|4161249|P1|Overall Study|Unsatisfactory therapeutic effect|1
1272412|NCT00433836|4161248|P2|Overall Study|Withdrawal by Subject|1
1272413|NCT00433836|4161249|P1|Overall Study|Withdrawal by Subject|2
1272414|NCT00433836|4161248|P2|Overall Study|Lost to Follow-up|0
1272415|NCT00433836|4161249|P1|Overall Study|Lost to Follow-up|3
1272416|NCT00433836|4161248|P2|Overall Study|Adverse Event|0
1272417|NCT00433836|4161249|P1|Overall Study|Adverse Event|7
1272418|NCT00433771|4161261|P1|Overall Study|Failure to deploy stent|1
1272419|NCT00433771|4161261|P1|Overall Study|Death|2
1272420|NCT00433771|4161261|P1|Overall Study|Treated and later found to be ineligible|2
1272421|NCT00433771|4161261|P1|Overall Study|screen fail|14
1272422|NCT00433654|4161284|P2|Overall Study|Withdrawal by Subject|2
1272423|NCT00433654|4161285|P1|Overall Study|Withdrawal by Subject|1
1272424|NCT00433654|4161284|P2|Overall Study|Subject not yet due for visit|0
1272425|NCT00433654|4161285|P1|Overall Study|Subject not yet due for visit|4
1272426|NCT00433654|4161284|P2|Overall Study|Missed visit|3
1272427|NCT00433654|4161285|P1|Overall Study|Missed visit|6
1272428|NCT00433654|4161284|P2|Overall Study|Death|0
1272429|NCT00433654|4161285|P1|Overall Study|Death|4
1272430|NCT00433537|4161331|P3|Step 2 - Maintenance Rituximab or ASCT|Other|0
1272431|NCT00433537|4161332|P2|Step 2 - Maintenance Rituximab or ASCT|Other|0
1272432|NCT00433537|4161333|P1|Step 2 - Maintenance Rituximab or ASCT|Other|1
1272433|NCT00433537|4161331|P3|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
1272434|NCT00433537|4161332|P2|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
1272435|NCT00433537|4161333|P1|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4
1272436|NCT00433537|4161331|P3|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
1272437|NCT00433537|4161332|P2|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
1272438|NCT00433537|4161333|P1|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2
1272439|NCT00433537|4161331|P3|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
1272440|NCT00433537|4161332|P2|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
1272441|NCT00433537|4161333|P1|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8
1272442|NCT00433537|4161331|P3|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
1272443|NCT00433537|4161332|P2|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
1272444|NCT00433537|4161333|P1|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1
1272445|NCT00433537|4161331|P3|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2
1272446|NCT00433537|4161332|P2|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
1272447|NCT00433537|4161333|P1|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
1272448|NCT00433537|4161331|P3|Step 1 - VcR-CVAD Induction|Adverse Event|4
1272449|NCT00433537|4161332|P2|Step 1 - VcR-CVAD Induction|Adverse Event|0
1272450|NCT00433537|4161333|P1|Step 1 - VcR-CVAD Induction|Adverse Event|0
1272451|NCT00433537|4161331|P3|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2
1272452|NCT00433537|4161332|P2|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
1272453|NCT00433537|4161333|P1|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
1272454|NCT00433537|4161331|P3|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
1272455|NCT00433537|4161332|P2|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0
1272456|NCT00433537|4161333|P1|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
1272457|NCT00433446|4161342|P1|Overall Study|Ineligible|9
1272458|NCT00433446|4161342|P1|Overall Study|Other - Not Protocol specified|3
1272459|NCT00433446|4161342|P1|Overall Study|Progression|44
1272460|NCT00433446|4161342|P1|Overall Study|Refusal Unrelated to Adverse Event|1
1272461|NCT00433446|4161342|P1|Overall Study|Adverse Event|4
1272462|NCT00433381|4161352|P2|Overall Study|Ineligible / no protocol treatment|3
1272463|NCT00433381|4161353|P1|Overall Study|Ineligible / no protocol treatment|3
1272464|NCT00433329|4161372|P1|Overall Study|Physician Decision|1
1272465|NCT00433329|4161372|P1|Overall Study|Lost to Follow-up|1
1272466|NCT00433329|4161372|P1|Overall Study|Moved out of state|1
1272467|NCT00433329|4161372|P1|Overall Study|Discontinued sildenafil|2
1272468|NCT00433329|4161372|P1|Overall Study|Withdrew consent|3
1272469|NCT00433329|4161372|P1|Overall Study|Death|4
1272470|NCT00433329|4161372|P1|Overall Study|Adverse Event|9
1272471|NCT00433290|4161378|P2|Overall Study|Lost to Follow-up|0
1272472|NCT00433290|4161379|P1|Overall Study|Lost to Follow-up|1
1272473|NCT00433290|4161378|P2|Overall Study|Entry Criteria Not Met|1
1272474|NCT00433290|4161379|P1|Overall Study|Entry Criteria Not Met|0
1272475|NCT00433290|4161378|P2|Overall Study|Physician Decision|0
1272476|NCT00433290|4161379|P1|Overall Study|Physician Decision|2
1272477|NCT00433290|4161378|P2|Overall Study|Protocol Violation|2
1272478|NCT00433290|4161379|P1|Overall Study|Protocol Violation|3
1272479|NCT00433290|4161378|P2|Overall Study|Withdrawal by Subject|2
1272480|NCT00433290|4161379|P1|Overall Study|Withdrawal by Subject|4
1272481|NCT00433290|4161378|P2|Overall Study|Lack of Efficacy|5
1272482|NCT00433290|4161379|P1|Overall Study|Lack of Efficacy|1
1272483|NCT00433290|4161378|P2|Overall Study|Adverse Event|7
1272484|NCT00433290|4161379|P1|Overall Study|Adverse Event|24
1272485|NCT00433199|4161448|P2|Open-Label Period|Administrative|1
1272486|NCT00433199|4161449|P1|Open-Label Period|Administrative|0
1272487|NCT00433199|4161448|P2|Open-Label Period|Protocol Violation|2
1272488|NCT00433199|4161449|P1|Open-Label Period|Protocol Violation|0
1272489|NCT00433199|4161448|P2|Open-Label Period|Withdrawal by Subject|7
1272490|NCT00433199|4161449|P1|Open-Label Period|Withdrawal by Subject|0
1272491|NCT00433199|4161448|P2|Open-Label Period|Lost to Follow-up|3
1272492|NCT00433199|4161449|P1|Open-Label Period|Lost to Follow-up|0
1272493|NCT00433199|4161448|P2|Open-Label Period|Lack of Efficacy|2
1272494|NCT00433199|4161449|P1|Open-Label Period|Lack of Efficacy|0
1272495|NCT00433199|4161448|P2|Open-Label Period|Adverse Event|19
1272496|NCT00433199|4161449|P1|Open-Label Period|Adverse Event|0
1272497|NCT00433199|4161448|P2|Double-Blind Period|Administrative|5
1272498|NCT00433199|4161449|P1|Double-Blind Period|Administrative|1
1272499|NCT00433199|4161448|P2|Double-Blind Period|Protocol Violation|10
1272500|NCT00433199|4161449|P1|Double-Blind Period|Protocol Violation|1
1272501|NCT00433199|4161448|P2|Double-Blind Period|Withdrawal by Subject|19
1272502|NCT00433199|4161449|P1|Double-Blind Period|Withdrawal by Subject|8
1272503|NCT00433199|4161448|P2|Double-Blind Period|Lost to Follow-up|5
1272504|NCT00433199|4161449|P1|Double-Blind Period|Lost to Follow-up|2
1272505|NCT00433199|4161448|P2|Double-Blind Period|Lack of Efficacy|2
1272506|NCT00433199|4161449|P1|Double-Blind Period|Lack of Efficacy|0
1272507|NCT00433199|4161448|P2|Double-Blind Period|Adverse Event|25
1272508|NCT00433199|4161449|P1|Double-Blind Period|Adverse Event|0
1272509|NCT00433160|4161469|P2|104 Weeks, 28-Week OL Period|Physician Decision|1
1272510|NCT00433160|4161470|P1|104 Weeks, 28-Week OL Period|Physician Decision|0
1272511|NCT00433160|4161469|P2|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2
1272512|NCT00433160|4161470|P1|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8
1272513|NCT00433160|4161469|P2|104 Weeks, 28-Week OL Period|Adverse Event|0
1272514|NCT00433160|4161470|P1|104 Weeks, 28-Week OL Period|Adverse Event|2
1272515|NCT00433160|4161469|P2|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1
1272516|NCT00433160|4161470|P1|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0
1272517|NCT00433160|4161469|P2|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0
1272518|NCT00433160|4161470|P1|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2
1272519|NCT00433160|4161469|P2|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2
1272520|NCT00433160|4161470|P1|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1
1272521|NCT00433160|4161469|P2|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1
1272522|NCT00433160|4161470|P1|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3
1272523|NCT00433160|4161469|P2|52-Week Double-Blind (DB) Period|Lack of Efficacy|2
1272524|NCT00433160|4161470|P1|52-Week Double-Blind (DB) Period|Lack of Efficacy|1
1272525|NCT00433160|4161469|P2|52-Week Double-Blind (DB) Period|Sponsor Decision|0
1272526|NCT00433160|4161470|P1|52-Week Double-Blind (DB) Period|Sponsor Decision|0
1272527|NCT00433160|4161469|P2|52-Week Double-Blind (DB) Period|Physician Decision|2
1272528|NCT00433160|4161470|P1|52-Week Double-Blind (DB) Period|Physician Decision|4
1272529|NCT00433160|4161469|P2|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1
1272530|NCT00433160|4161470|P1|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6
1272531|NCT00433160|4161469|P2|52-Week Double-Blind (DB) Period|Protocol Violation|2
1272532|NCT00433160|4161470|P1|52-Week Double-Blind (DB) Period|Protocol Violation|0
1272533|NCT00433160|4161469|P2|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1
1272534|NCT00433160|4161470|P1|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0
1272535|NCT00433160|4161469|P2|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
1272536|NCT00433160|4161470|P1|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
1272537|NCT00433160|4161469|P2|52-Week Double-Blind (DB) Period|Death|0
1272538|NCT00433160|4161470|P1|52-Week Double-Blind (DB) Period|Death|0
1272539|NCT00433160|4161469|P2|52-Week Double-Blind (DB) Period|Adverse Event|2
1272540|NCT00433160|4161470|P1|52-Week Double-Blind (DB) Period|Adverse Event|6
1272541|NCT00433147|4161522|P4|Overall Study|Adverse Event|0
1272542|NCT00433147|4161523|P3|Overall Study|Adverse Event|0
1272543|NCT00433147|4161524|P2|Overall Study|Adverse Event|1
1272544|NCT00433147|4161525|P1|Overall Study|Adverse Event|0
1272545|NCT00433017|4161541|P2|Overall Study|Subject no longer requires study drug|1
1272546|NCT00433017|4161542|P1|Overall Study|Subject no longer requires study drug|1
1272547|NCT00433017|4161541|P2|Overall Study|Death|2
1272548|NCT00433017|4161542|P1|Overall Study|Death|2
1272549|NCT00433017|4161541|P2|Overall Study|Protocol Violation|0
1272550|NCT00433017|4161542|P1|Overall Study|Protocol Violation|1
1272551|NCT00433017|4161541|P2|Overall Study|Administrative problems|86
1272552|NCT00433017|4161542|P1|Overall Study|Administrative problems|80
1272553|NCT00433017|4161541|P2|Overall Study|Lost to Follow-up|4
1272554|NCT00433017|4161542|P1|Overall Study|Lost to Follow-up|3
1272555|NCT00433017|4161541|P2|Overall Study|Withdrawal by Subject|5
1272556|NCT00433017|4161542|P1|Overall Study|Withdrawal by Subject|4
1272557|NCT00433017|4161541|P2|Overall Study|Adverse Event|3
1272558|NCT00433017|4161542|P1|Overall Study|Adverse Event|5
1272559|NCT00433004|4161558|P2|Overall Study|Lost to Follow-up|7
1272560|NCT00433004|4161559|P1|Overall Study|Lost to Follow-up|5
1272561|NCT00432991|4161571|P2|Overall Study|Protocol Violation|12
1272562|NCT00432991|4161572|P1|Overall Study|Protocol Violation|7
1272563|NCT00432965|4161584|P2|Overall Study|Incomplete Data|3
1272564|NCT00432965|4161585|P1|Overall Study|Incomplete Data|4
1272565|NCT00432965|4161584|P2|Overall Study|Exclusionary Methods|2
1272566|NCT00432965|4161585|P1|Overall Study|Exclusionary Methods|1
1272567|NCT00432965|4161584|P2|Overall Study|Death|4
1272568|NCT00432965|4161585|P1|Overall Study|Death|3
1272569|NCT00432965|4161584|P2|Overall Study|Adverse Event|19
1272570|NCT00432965|4161585|P1|Overall Study|Adverse Event|22
1272571|NCT00432965|4161584|P2|Overall Study|Non-compliance|0
1272572|NCT00432965|4161585|P1|Overall Study|Non-compliance|7
1272573|NCT00432965|4161584|P2|Overall Study|Lack of Efficacy|13
1272574|NCT00432965|4161585|P1|Overall Study|Lack of Efficacy|8
1272575|NCT00432965|4161584|P2|Overall Study|Physician Decision|13
1272576|NCT00432965|4161585|P1|Overall Study|Physician Decision|14
1272577|NCT00432965|4161584|P2|Overall Study|Withdrawal by Subject|13
1272578|NCT00432965|4161585|P1|Overall Study|Withdrawal by Subject|13
1272579|NCT00432965|4161584|P2|Overall Study|Lost to Follow-up|19
1272580|NCT00432965|4161585|P1|Overall Study|Lost to Follow-up|22
1272581|NCT00432835|4161593|P2|Overall Study|Adverse event: lead dislodgement.|7
1272582|NCT00432835|4161594|P1|Overall Study|Adverse event: lead dislodgement.|6
1272583|NCT00432809|4161607|P3|1 Year Follow-up|Withdrawal by Subject|1
1272584|NCT00432809|4161608|P2|1 Year Follow-up|Withdrawal by Subject|0
1272585|NCT00432809|4161609|P1|1 Year Follow-up|Withdrawal by Subject|7
1272586|NCT00432809|4161607|P3|1 Year Follow-up|Misses 9 and 12 month visit|0
1272587|NCT00432809|4161608|P2|1 Year Follow-up|Misses 9 and 12 month visit|0
1272588|NCT00432809|4161609|P1|1 Year Follow-up|Misses 9 and 12 month visit|2
1272589|NCT00432744|4161682|P2|Months 7 - 12|Too disabled to score|1
1272590|NCT00432744|4161683|P1|Months 7 - 12|Too disabled to score|0
1272591|NCT00432744|4161682|P2|Months 7 - 12|Withdrawal by Subject|0
1272592|NCT00432744|4161683|P1|Months 7 - 12|Withdrawal by Subject|1
1272593|NCT00432744|4161682|P2|Months 0-6|Too disabled to score|0
1272594|NCT00432744|4161683|P1|Months 0-6|Too disabled to score|1
1272595|NCT00432744|4161682|P2|Months 0-6|Withdrawal by Subject|4
1272596|NCT00432744|4161683|P1|Months 0-6|Withdrawal by Subject|4
1272597|NCT00432666|4161695|P2|Open-Label Extension Period|Physician Decision|0
1272598|NCT00432666|4161696|P1|Open-Label Extension Period|Physician Decision|3
1272599|NCT00432666|4161695|P2|Open-Label Extension Period|Consent withdrawn|0
1272600|NCT00432666|4161696|P1|Open-Label Extension Period|Consent withdrawn|10
1272601|NCT00432666|4161695|P2|Open-Label Extension Period|Adverse Event|0
1272602|NCT00432666|4161696|P1|Open-Label Extension Period|Adverse Event|5
1272603|NCT00432666|4161695|P2|Open-Label Extension Period|Lack of Efficacy|0
1272604|NCT00432666|4161696|P1|Open-Label Extension Period|Lack of Efficacy|6
1272605|NCT00432666|4161695|P2|Open-Label Extension Period|Withdrawal Criteria Occurred|0
1272606|NCT00432666|4161696|P1|Open-Label Extension Period|Withdrawal Criteria Occurred|1
1272607|NCT00432666|4161695|P2|Main Period|Consent Withdrawn|0
1272608|NCT00432666|4161696|P1|Main Period|Consent Withdrawn|1
1272609|NCT00432666|4161695|P2|Main Period|Adverse Event|1
1272610|NCT00432666|4161696|P1|Main Period|Adverse Event|1
1272611|NCT00432562|4161869|P2|Overall Study|Death|0
1272612|NCT00432562|4161870|P1|Overall Study|Death|3
1272613|NCT00432380|4161922|P3|Overall Study|Adverse Event|0
1272614|NCT00432380|4161923|P2|Overall Study|Adverse Event|0
1272615|NCT00432380|4161924|P1|Overall Study|Adverse Event|1
1272616|NCT00432380|4161922|P3|Overall Study|Migrated/moved from study area|1
1272617|NCT00432380|4161923|P2|Overall Study|Migrated/moved from study area|4
1272618|NCT00432380|4161924|P1|Overall Study|Migrated/moved from study area|3
1272619|NCT00432276|4161977|P2|Overall Study|Other|3
1272620|NCT00432276|4161978|P1|Overall Study|Other|2
1272621|NCT00432276|4161977|P2|Overall Study|Physician Decision|8
1272622|NCT00432276|4161978|P1|Overall Study|Physician Decision|6
1272623|NCT00432276|4161977|P2|Overall Study|Withdrawal by Subject|20
1272624|NCT00432276|4161978|P1|Overall Study|Withdrawal by Subject|25
1272625|NCT00432276|4161977|P2|Overall Study|Lost to Follow-up|2
1272626|NCT00432276|4161978|P1|Overall Study|Lost to Follow-up|6
1272627|NCT00432276|4161977|P2|Overall Study|Protocol Violation|20
1272628|NCT00432276|4161978|P1|Overall Study|Protocol Violation|25
1272629|NCT00432276|4161977|P2|Overall Study|Adverse Event|16
1272630|NCT00432276|4161978|P1|Overall Study|Adverse Event|13
1272631|NCT00432276|4161977|P2|Overall Study|Hyperglycemic Rescue|87
1272632|NCT00432276|4161978|P1|Overall Study|Hyperglycemic Rescue|44
1272633|NCT00432237|4162068|P4|Overall Study|Lack of Qualifying Event|84
1272634|NCT00432237|4162069|P3|Overall Study|Lack of Qualifying Event|69
1272635|NCT00432237|4162070|P2|Overall Study|Lack of Qualifying Event|71
1272636|NCT00432237|4162071|P1|Overall Study|Lack of Qualifying Event|38
1272637|NCT00432237|4162068|P4|Overall Study|Withdrawal by Subject|11
1272638|NCT00432237|4162069|P3|Overall Study|Withdrawal by Subject|9
1272639|NCT00432237|4162070|P2|Overall Study|Withdrawal by Subject|6
1272640|NCT00432237|4162071|P1|Overall Study|Withdrawal by Subject|5
1272641|NCT00432237|4162068|P4|Overall Study|Protocol Violation|8
1272642|NCT00432237|4162069|P3|Overall Study|Protocol Violation|11
1272643|NCT00432237|4162070|P2|Overall Study|Protocol Violation|10
1272644|NCT00432237|4162071|P1|Overall Study|Protocol Violation|13
1272645|NCT00432237|4162068|P4|Overall Study|Pregnancy|0
1272646|NCT00432237|4162069|P3|Overall Study|Pregnancy|0
1272647|NCT00432237|4162070|P2|Overall Study|Pregnancy|1
1272648|NCT00432237|4162071|P1|Overall Study|Pregnancy|0
1272649|NCT00432237|4162068|P4|Overall Study|Physician Decision|1
1272650|NCT00432237|4162069|P3|Overall Study|Physician Decision|2
1272651|NCT00432237|4162070|P2|Overall Study|Physician Decision|3
1272652|NCT00432237|4162071|P1|Overall Study|Physician Decision|1
1272653|NCT00432237|4162068|P4|Overall Study|Lost to Follow-up|18
1272654|NCT00432237|4162069|P3|Overall Study|Lost to Follow-up|18
1272655|NCT00432237|4162070|P2|Overall Study|Lost to Follow-up|10
1272656|NCT00432237|4162071|P1|Overall Study|Lost to Follow-up|10
1272657|NCT00432237|4162068|P4|Overall Study|Lack of Efficacy|1
1272658|NCT00432237|4162069|P3|Overall Study|Lack of Efficacy|0
1272659|NCT00432237|4162070|P2|Overall Study|Lack of Efficacy|0
1272660|NCT00432237|4162071|P1|Overall Study|Lack of Efficacy|0
1272661|NCT00432237|4162068|P4|Overall Study|Adverse Event|1
1272662|NCT00432237|4162069|P3|Overall Study|Adverse Event|0
1272663|NCT00432237|4162070|P2|Overall Study|Adverse Event|0
1272664|NCT00432237|4162071|P1|Overall Study|Adverse Event|0
1272665|NCT00432159|4162114|P5|Overall Study|Missing NDI and/or neuro. assessment|7
1272666|NCT00432159|4162115|P4|Overall Study|Missing NDI and/or neuro. assessment|3
1272667|NCT00432159|4162116|P3|Overall Study|Missing NDI and/or neuro. assessment|1
1272668|NCT00432159|4162117|P2|Overall Study|Missing NDI and/or neuro. assessment|24
1272669|NCT00432159|4162118|P1|Overall Study|Missing NDI and/or neuro. assessment|13
1272670|NCT00432159|4162114|P5|Overall Study|Failure|3
1272671|NCT00432159|4162115|P4|Overall Study|Failure|2
1272672|NCT00432159|4162116|P3|Overall Study|Failure|3
1272673|NCT00432159|4162117|P2|Overall Study|Failure|5
1272674|NCT00432159|4162118|P1|Overall Study|Failure|9
1272675|NCT00432159|4162114|P5|Overall Study|Death|0
1272676|NCT00432159|4162115|P4|Overall Study|Death|0
1272677|NCT00432159|4162116|P3|Overall Study|Death|0
1272678|NCT00432159|4162117|P2|Overall Study|Death|1
1272679|NCT00432159|4162118|P1|Overall Study|Death|0
1272680|NCT00432042|4162225|P3|Overall Study|Lost to Follow-up|0
1272681|NCT00432042|4162226|P2|Overall Study|Lost to Follow-up|1
1272682|NCT00432042|4162227|P1|Overall Study|Lost to Follow-up|5
1272683|NCT00432042|4162225|P3|Overall Study|Withdrawal by Subject|2
1272684|NCT00432042|4162226|P2|Overall Study|Withdrawal by Subject|0
1272685|NCT00432042|4162227|P1|Overall Study|Withdrawal by Subject|0
1272686|NCT00432042|4162225|P3|Overall Study|Protocol Violation|0
1272687|NCT00432042|4162226|P2|Overall Study|Protocol Violation|0
1272688|NCT00432042|4162227|P1|Overall Study|Protocol Violation|2
1272689|NCT00431964|4162240|P2|Overall Study|Due to Unstable Health|1
1272690|NCT00431964|4162241|P1|Overall Study|Due to Unstable Health|0
1272691|NCT00431964|4162240|P2|Overall Study|Parental Consent Withdrawn|2
1272692|NCT00431964|4162241|P1|Overall Study|Parental Consent Withdrawn|0
1272693|NCT00431964|4162240|P2|Overall Study|Withdrawal by Subject|1
1272694|NCT00431964|4162241|P1|Overall Study|Withdrawal by Subject|2
1272695|NCT00431964|4162240|P2|Overall Study|Physician Decision|2
1272696|NCT00431964|4162241|P1|Overall Study|Physician Decision|2
1272697|NCT00431964|4162240|P2|Overall Study|Lost to Follow-up|2
1272698|NCT00431964|4162241|P1|Overall Study|Lost to Follow-up|1
1272699|NCT00431964|4162240|P2|Overall Study|Adverse Event|0
1272700|NCT00431964|4162241|P1|Overall Study|Adverse Event|1
1272701|NCT00431951|4162251|P4|Overall Study|Adverse Event|0
1272702|NCT00431951|4162252|P3|Overall Study|Adverse Event|1
1272703|NCT00431951|4162253|P2|Overall Study|Adverse Event|0
1272704|NCT00431951|4162254|P1|Overall Study|Adverse Event|0
1272705|NCT00431951|4162251|P4|Overall Study|Withdrawal by Subject|0
1272706|NCT00431951|4162252|P3|Overall Study|Withdrawal by Subject|0
1272707|NCT00431951|4162253|P2|Overall Study|Withdrawal by Subject|1
1272708|NCT00431951|4162254|P1|Overall Study|Withdrawal by Subject|0
1272709|NCT00431951|4162251|P4|Overall Study|Lost to Follow-up|0
1272710|NCT00431951|4162252|P3|Overall Study|Lost to Follow-up|0
1272711|NCT00431951|4162253|P2|Overall Study|Lost to Follow-up|1
1272712|NCT00431951|4162254|P1|Overall Study|Lost to Follow-up|0
1272713|NCT00431951|4162251|P4|Overall Study|Inability to follow study procedures|2
1272714|NCT00431951|4162252|P3|Overall Study|Inability to follow study procedures|1
1272715|NCT00431951|4162253|P2|Overall Study|Inability to follow study procedures|0
1272716|NCT00431951|4162254|P1|Overall Study|Inability to follow study procedures|1
1272717|NCT00431847|4162316|P5|Overall Study|Protocol Violation|1
1272718|NCT00431847|4162317|P4|Overall Study|Protocol Violation|0
1272719|NCT00431847|4162318|P3|Overall Study|Protocol Violation|0
1272720|NCT00431847|4162319|P2|Overall Study|Protocol Violation|0
1272721|NCT00431847|4162320|P1|Overall Study|Protocol Violation|0
1272722|NCT00431847|4162316|P5|Overall Study|completion of less than two study visits|0
1272723|NCT00431847|4162317|P4|Overall Study|completion of less than two study visits|14
1272724|NCT00431847|4162318|P3|Overall Study|completion of less than two study visits|4
1272725|NCT00431847|4162319|P2|Overall Study|completion of less than two study visits|3
1272726|NCT00431847|4162320|P1|Overall Study|completion of less than two study visits|6
1272727|NCT00431834|4162394|P1|Overall Study|Lost to Follow-up|1
1272728|NCT00431834|4162394|P1|Overall Study|Missed Endpoint Visit|2
1272729|NCT00431834|4162394|P1|Overall Study|Death|3
1272730|NCT00431834|4162394|P1|Overall Study|Withdrawal by Subject|7
1272731|NCT00431496|4162410|P1|Overall Study|Protocol-specified criteria|5
1272732|NCT00431496|4162410|P1|Overall Study|Withdrawal by Subject|2
1272733|NCT00431496|4162410|P1|Overall Study|Lost to Follow-up|1
1272734|NCT00431496|4162410|P1|Overall Study|Adverse Event|3
1272735|NCT00431444|4162421|P2|Overall Study|Administrative Problems|1
1272736|NCT00431444|4162422|P1|Overall Study|Administrative Problems|0
1272737|NCT00431444|4162421|P2|Overall Study|Lost to Follow-up|0
1272738|NCT00431444|4162422|P1|Overall Study|Lost to Follow-up|1
1272739|NCT00431444|4162421|P2|Overall Study|Withdrawal by Subject|1
1272740|NCT00431444|4162422|P1|Overall Study|Withdrawal by Subject|1
1272741|NCT00431444|4162421|P2|Overall Study|Adverse Event|1
1272742|NCT00431444|4162422|P1|Overall Study|Adverse Event|2
1272743|NCT00431444|4162421|P2|Overall Study|Protocol Violation|4
1272744|NCT00431444|4162422|P1|Overall Study|Protocol Violation|1
1272745|NCT00431067|4162462|P1|Overall Study|Non-compliance,lost to follow-up|2
1272746|NCT00431067|4162462|P1|Overall Study|Progressive disease|30
1272747|NCT00431067|4162462|P1|Overall Study|Other Adverse Event|9
1272748|NCT00430950|4162487|P2|Overall Study|concomitant medication,etc.|7
1272749|NCT00430950|4162488|P1|Overall Study|concomitant medication,etc.|5
1272750|NCT00430950|4162487|P2|Overall Study|Withdrawal by Subject|0
1272751|NCT00430950|4162488|P1|Overall Study|Withdrawal by Subject|1
1272752|NCT00430950|4162487|P2|Overall Study|Adverse Event|6
1272753|NCT00430950|4162488|P1|Overall Study|Adverse Event|7
1272754|NCT00430937|4162502|P2|Overall Study|Unable to classify|1
1272755|NCT00430937|4162503|P1|Overall Study|Unable to classify|0
1272756|NCT00430937|4162502|P2|Overall Study|Protocol discontinuation criteria met|2
1272757|NCT00430937|4162503|P1|Overall Study|Protocol discontinuation criteria met|1
1272758|NCT00430937|4162502|P2|Overall Study|Administrative reasons|0
1272759|NCT00430937|4162503|P1|Overall Study|Administrative reasons|1
1272760|NCT00430937|4162502|P2|Overall Study|Inappropriate enrollment|1
1272761|NCT00430937|4162503|P1|Overall Study|Inappropriate enrollment|2
1272762|NCT00430937|4162502|P2|Overall Study|Lack of Efficacy|5
1272763|NCT00430937|4162503|P1|Overall Study|Lack of Efficacy|6
1272764|NCT00430937|4162502|P2|Overall Study|Protocol Violation|2
1272765|NCT00430937|4162503|P1|Overall Study|Protocol Violation|3
1272766|NCT00430937|4162502|P2|Overall Study|Withdrawal by Subject|2
1272767|NCT00430937|4162503|P1|Overall Study|Withdrawal by Subject|5
1272768|NCT00430937|4162502|P2|Overall Study|Lost to Follow-up|6
1272769|NCT00430937|4162503|P1|Overall Study|Lost to Follow-up|6
1272770|NCT00430937|4162502|P2|Overall Study|Death|1
1272771|NCT00430937|4162503|P1|Overall Study|Death|0
1272772|NCT00430937|4162502|P2|Overall Study|Adverse Event|8
1272773|NCT00430937|4162503|P1|Overall Study|Adverse Event|3
1272774|NCT00430781|4162514|P3|End-of-Study Analysis; 28 July 2011|Other|0
1272775|NCT00430781|4162515|P2|End-of-Study Analysis; 28 July 2011|Other|1
1272776|NCT00430781|4162516|P1|End-of-Study Analysis; 28 July 2011|Other|4
1272777|NCT00430781|4162514|P3|End-of-Study Analysis; 28 July 2011|Physician Decision|6
1272778|NCT00430781|4162515|P2|End-of-Study Analysis; 28 July 2011|Physician Decision|6
1272779|NCT00430781|4162516|P1|End-of-Study Analysis; 28 July 2011|Physician Decision|4
1272780|NCT00430781|4162514|P3|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
1272781|NCT00430781|4162515|P2|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5
1272782|NCT00430781|4162516|P1|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
1272783|NCT00430781|4162514|P3|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
1272784|NCT00430781|4162515|P2|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2
1272785|NCT00430781|4162516|P1|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
1272786|NCT00430781|4162514|P3|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
1272787|NCT00430781|4162515|P2|End-of-Study Analysis; 28 July 2011|Protocol Violation|1
1272788|NCT00430781|4162516|P1|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
1272789|NCT00430781|4162514|P3|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
1272790|NCT00430781|4162515|P2|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
1272791|NCT00430781|4162516|P1|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5
1272792|NCT00430781|4162514|P3|Final Analysis; 31 July 2008|Ongoing|32
1272793|NCT00430781|4162515|P2|Final Analysis; 31 July 2008|Ongoing|29
1272794|NCT00430781|4162516|P1|Final Analysis; 31 July 2008|Ongoing|0
1272795|NCT00430781|4162514|P3|Final Analysis; 31 July 2008|Other|0
1272796|NCT00430781|4162515|P2|Final Analysis; 31 July 2008|Other|1
1272797|NCT00430781|4162516|P1|Final Analysis; 31 July 2008|Other|0
1272798|NCT00430781|4162514|P3|Final Analysis; 31 July 2008|Physician Decision|6
1272799|NCT00430781|4162515|P2|Final Analysis; 31 July 2008|Physician Decision|6
1272800|NCT00430781|4162516|P1|Final Analysis; 31 July 2008|Physician Decision|0
1272801|NCT00430781|4162514|P3|Final Analysis; 31 July 2008|Withdrawal by Subject|7
1272802|NCT00430781|4162515|P2|Final Analysis; 31 July 2008|Withdrawal by Subject|2
1272803|NCT00430781|4162516|P1|Final Analysis; 31 July 2008|Withdrawal by Subject|0
1272804|NCT00430781|4162514|P3|Final Analysis; 31 July 2008|Protocol Violation|0
1272805|NCT00430781|4162515|P2|Final Analysis; 31 July 2008|Protocol Violation|1
1272806|NCT00430781|4162516|P1|Final Analysis; 31 July 2008|Protocol Violation|0
1272807|NCT00430781|4162514|P3|Final Analysis; 31 July 2008|Lost to Follow-up|3
1272808|NCT00430781|4162515|P2|Final Analysis; 31 July 2008|Lost to Follow-up|0
1272809|NCT00430781|4162516|P1|Final Analysis; 31 July 2008|Lost to Follow-up|0
1272810|NCT00430781|4162514|P3|Interim Analysis; 11 February 2008|Ongoing|25
1272811|NCT00430781|4162515|P2|Interim Analysis; 11 February 2008|Ongoing|20
1272812|NCT00430781|4162516|P1|Interim Analysis; 11 February 2008|Ongoing|23
1272813|NCT00430781|4162514|P3|Interim Analysis; 11 February 2008|Physician Decision|3
1272814|NCT00430781|4162515|P2|Interim Analysis; 11 February 2008|Physician Decision|3
1272815|NCT00430781|4162516|P1|Interim Analysis; 11 February 2008|Physician Decision|2
1272816|NCT00430781|4162514|P3|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
1272817|NCT00430781|4162515|P2|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
1272818|NCT00430781|4162516|P1|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2
1272819|NCT00430781|4162514|P3|Interim Analysis; 11 February 2008|Death|0
1272820|NCT00430781|4162515|P2|Interim Analysis; 11 February 2008|Death|1
1272821|NCT00430781|4162516|P1|Interim Analysis; 11 February 2008|Death|0
1272822|NCT00430781|4162514|P3|Interim Analysis; 11 February 2008|Disease Progression|22
1272823|NCT00430781|4162515|P2|Interim Analysis; 11 February 2008|Disease Progression|30
1272824|NCT00430781|4162516|P1|Interim Analysis; 11 February 2008|Disease Progression|16
1272825|NCT00430781|4162514|P3|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
1272826|NCT00430781|4162515|P2|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
1272827|NCT00430781|4162516|P1|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1
1272828|NCT00430781|4162514|P3|Interim Analysis; 11 February 2008|Withdrawal by Subject|2
1272829|NCT00430781|4162515|P2|Interim Analysis; 11 February 2008|Withdrawal by Subject|0
1272830|NCT00430781|4162516|P1|Interim Analysis; 11 February 2008|Withdrawal by Subject|4
1272831|NCT00430781|4162514|P3|Interim Analysis; 11 February 2008|Protocol Violation|0
1272832|NCT00430781|4162515|P2|Interim Analysis; 11 February 2008|Protocol Violation|1
1272833|NCT00430781|4162516|P1|Interim Analysis; 11 February 2008|Protocol Violation|0
1272834|NCT00430781|4162514|P3|Interim Analysis; 11 February 2008|Lost to Follow-up|1
1272835|NCT00430781|4162515|P2|Interim Analysis; 11 February 2008|Lost to Follow-up|0
1272836|NCT00430781|4162516|P1|Interim Analysis; 11 February 2008|Lost to Follow-up|1
1272837|NCT00430781|4162514|P3|Interim Analysis; 11 February 2008|Adverse Event|7
1272838|NCT00430781|4162515|P2|Interim Analysis; 11 February 2008|Adverse Event|3
1272839|NCT00430781|4162516|P1|Interim Analysis; 11 February 2008|Adverse Event|10
1272840|NCT00430755|4162558|P1|Overall Study|Withdrawal by Subject|53
1272841|NCT00430716|4162565|P3|Open Label Phase|Study terminated by sponsor|4
1272842|NCT00430716|4162566|P2|Open Label Phase|Study terminated by sponsor|5
1272843|NCT00430716|4162567|P1|Open Label Phase|Study terminated by sponsor|4
1272844|NCT00430716|4162565|P3|Open Label Phase|Protocol Violation|0
1272845|NCT00430716|4162566|P2|Open Label Phase|Protocol Violation|0
1272846|NCT00430716|4162567|P1|Open Label Phase|Protocol Violation|1
1272847|NCT00430716|4162565|P3|Open Label Phase|Other|1
1272848|NCT00430716|4162566|P2|Open Label Phase|Other|1
1272849|NCT00430716|4162567|P1|Open Label Phase|Other|3
1272850|NCT00430716|4162565|P3|Open Label Phase|No longer willing to participate|1
1272851|NCT00430716|4162566|P2|Open Label Phase|No longer willing to participate|1
1272852|NCT00430716|4162567|P1|Open Label Phase|No longer willing to participate|0
1272853|NCT00430716|4162565|P3|Open Label Phase|Lost to Follow-up|1
1272854|NCT00430716|4162566|P2|Open Label Phase|Lost to Follow-up|0
1272855|NCT00430716|4162567|P1|Open Label Phase|Lost to Follow-up|1
1272856|NCT00430716|4162565|P3|Double Blind Phase|Not met eligibility criteria|0
1272857|NCT00430716|4162566|P2|Double Blind Phase|Not met eligibility criteria|0
1272858|NCT00430716|4162567|P1|Double Blind Phase|Not met eligibility criteria|1
1272859|NCT00430716|4162565|P3|Double Blind Phase|Adverse Event|3
1272860|NCT00430716|4162566|P2|Double Blind Phase|Adverse Event|1
1272861|NCT00430716|4162567|P1|Double Blind Phase|Adverse Event|1
1272862|NCT00430716|4162565|P3|Double Blind Phase|Study terminated by sponsor|2
1272863|NCT00430716|4162566|P2|Double Blind Phase|Study terminated by sponsor|1
1272864|NCT00430716|4162567|P1|Double Blind Phase|Study terminated by sponsor|1
1272865|NCT00430716|4162565|P3|Double Blind Phase|Other|0
1272866|NCT00430716|4162566|P2|Double Blind Phase|Other|2
1272867|NCT00430716|4162567|P1|Double Blind Phase|Other|0
1272868|NCT00430716|4162565|P3|Double Blind Phase|No longer willing to participate|1
1272869|NCT00430716|4162566|P2|Double Blind Phase|No longer willing to participate|1
1272870|NCT00430716|4162567|P1|Double Blind Phase|No longer willing to participate|2
1272871|NCT00430716|4162565|P3|Double Blind Phase|Death|0
1272872|NCT00430716|4162566|P2|Double Blind Phase|Death|0
1272873|NCT00430716|4162567|P1|Double Blind Phase|Death|1
1272874|NCT00430677|4162599|P3|Long-term Extension Period|Poor compliance/noncompliance|0
1272875|NCT00430677|4162600|P2|Long-term Extension Period|Poor compliance/noncompliance|0
1272876|NCT00430677|4162601|P1|Long-term Extension Period|Poor compliance/noncompliance|1
1272877|NCT00430677|4162599|P3|Long-term Extension Period|Not specified|1
1272878|NCT00430677|4162600|P2|Long-term Extension Period|Not specified|1
1272879|NCT00430677|4162601|P1|Long-term Extension Period|Not specified|2
1272880|NCT00430677|4162599|P3|Long-term Extension Period|Administrative reason by sponsor|46
1272881|NCT00430677|4162600|P2|Long-term Extension Period|Administrative reason by sponsor|49
1272882|NCT00430677|4162601|P1|Long-term Extension Period|Administrative reason by sponsor|41
1272883|NCT00430677|4162599|P3|Long-term Extension Period|Pregnancy|0
1272884|NCT00430677|4162600|P2|Long-term Extension Period|Pregnancy|1
1272885|NCT00430677|4162601|P1|Long-term Extension Period|Pregnancy|1
1272886|NCT00430677|4162599|P3|Long-term Extension Period|Withdrawal by Subject|2
1272887|NCT00430677|4162600|P2|Long-term Extension Period|Withdrawal by Subject|1
1272888|NCT00430677|4162601|P1|Long-term Extension Period|Withdrawal by Subject|5
1272889|NCT00430677|4162599|P3|Long-term Extension Period|Lost to Follow-up|1
1272890|NCT00430677|4162600|P2|Long-term Extension Period|Lost to Follow-up|1
1272891|NCT00430677|4162601|P1|Long-term Extension Period|Lost to Follow-up|1
1272892|NCT00430677|4162599|P3|Long-term Extension Period|Lack of Efficacy|8
1272893|NCT00430677|4162600|P2|Long-term Extension Period|Lack of Efficacy|3
1272894|NCT00430677|4162601|P1|Long-term Extension Period|Lack of Efficacy|5
1272895|NCT00430677|4162599|P3|Long-term Extension Period|Adverse Event|5
1272896|NCT00430677|4162600|P2|Long-term Extension Period|Adverse Event|2
1272897|NCT00430677|4162601|P1|Long-term Extension Period|Adverse Event|3
1272898|NCT00430677|4162599|P3|Long-term Extension Period|Death|0
1272899|NCT00430677|4162600|P2|Long-term Extension Period|Death|0
1272900|NCT00430677|4162601|P1|Long-term Extension Period|Death|1
1272901|NCT00430677|4162599|P3|Short-term Period|Pregnancy|0
1272902|NCT00430677|4162600|P2|Short-term Period|Pregnancy|2
1272903|NCT00430677|4162601|P1|Short-term Period|Pregnancy|0
1272904|NCT00430677|4162599|P3|Short-term Period|Poor compliance/ noncompliance|0
1272905|NCT00430677|4162600|P2|Short-term Period|Poor compliance/ noncompliance|1
1272906|NCT00430677|4162601|P1|Short-term Period|Poor compliance/ noncompliance|0
1272907|NCT00430677|4162599|P3|Short-term Period|Participant no longer met study criteria|2
1272908|NCT00430677|4162600|P2|Short-term Period|Participant no longer met study criteria|1
1272909|NCT00430677|4162601|P1|Short-term Period|Participant no longer met study criteria|1
1272910|NCT00430677|4162599|P3|Short-term Period|Withdrawal by Subject|2
1272911|NCT00430677|4162600|P2|Short-term Period|Withdrawal by Subject|1
1272912|NCT00430677|4162601|P1|Short-term Period|Withdrawal by Subject|1
1272913|NCT00430677|4162599|P3|Short-term Period|Lack of Efficacy|4
1272914|NCT00430677|4162600|P2|Short-term Period|Lack of Efficacy|6
1272915|NCT00430677|4162601|P1|Short-term Period|Lack of Efficacy|5
1272916|NCT00430677|4162599|P3|Short-term Period|Adverse Event|9
1272917|NCT00430677|4162600|P2|Short-term Period|Adverse Event|13
1272918|NCT00430677|4162601|P1|Short-term Period|Adverse Event|15
1272919|NCT00430677|4162599|P3|Short-term Period|Death|5
1272920|NCT00430677|4162600|P2|Short-term Period|Death|1
1272921|NCT00430677|4162601|P1|Short-term Period|Death|1
1272922|NCT00430638|4162724|P2|Overall Study|Not specified|2
1272923|NCT00430638|4162725|P1|Overall Study|Not specified|2
1272924|NCT00430638|4162724|P2|Overall Study|Non-compliant|1
1272925|NCT00430638|4162725|P1|Overall Study|Non-compliant|2
1272926|NCT00430638|4162724|P2|Overall Study|Withdrawal by Subject|6
1272927|NCT00430638|4162725|P1|Overall Study|Withdrawal by Subject|4
1272928|NCT00430638|4162724|P2|Overall Study|Protocol Violation|4
1272929|NCT00430638|4162725|P1|Overall Study|Protocol Violation|6
1272930|NCT00430638|4162724|P2|Overall Study|Lost to Follow-up|7
1272931|NCT00430638|4162725|P1|Overall Study|Lost to Follow-up|1
1272932|NCT00430638|4162724|P2|Overall Study|Uncontrolled blood pressure|13
1272933|NCT00430638|4162725|P1|Overall Study|Uncontrolled blood pressure|48
1272934|NCT00430638|4162724|P2|Overall Study|Adverse Event|15
1272935|NCT00430638|4162725|P1|Overall Study|Adverse Event|15
1272936|NCT00430573|4162760|P1|Overall Study|Withdrawal by Subject|5
1272937|NCT00430508|4162769|P4|Overall Study|not specified|0
1272938|NCT00430508|4162770|P3|Overall Study|not specified|3
1272939|NCT00430508|4162771|P2|Overall Study|not specified|1
1272940|NCT00430508|4162772|P1|Overall Study|not specified|1
1272941|NCT00430508|4162769|P4|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
1272942|NCT00430508|4162770|P3|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2
1272943|NCT00430508|4162771|P2|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
1272944|NCT00430508|4162772|P1|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0
1272945|NCT00430508|4162769|P4|Overall Study|responder at visit 4|0
1272946|NCT00430508|4162770|P3|Overall Study|responder at visit 4|2
1272947|NCT00430508|4162771|P2|Overall Study|responder at visit 4|0
1272948|NCT00430508|4162772|P1|Overall Study|responder at visit 4|0
1272949|NCT00430508|4162769|P4|Overall Study|Withdrawal by Subject|1
1272950|NCT00430508|4162770|P3|Overall Study|Withdrawal by Subject|1
1272951|NCT00430508|4162771|P2|Overall Study|Withdrawal by Subject|1
1272952|NCT00430508|4162772|P1|Overall Study|Withdrawal by Subject|0
1272953|NCT00430508|4162769|P4|Overall Study|Adverse Event|3
1272954|NCT00430508|4162770|P3|Overall Study|Adverse Event|5
1272955|NCT00430508|4162771|P2|Overall Study|Adverse Event|3
1272956|NCT00430508|4162772|P1|Overall Study|Adverse Event|2
1272957|NCT00430495|4162810|P4|Overall Study|Randomized but not Treated|0
1272958|NCT00430495|4162811|P3|Overall Study|Randomized but not Treated|0
1272959|NCT00430495|4162812|P2|Overall Study|Randomized but not Treated|0
1272960|NCT00430495|4162813|P1|Overall Study|Randomized but not Treated|2
1272961|NCT00430495|4162810|P4|Overall Study|Other|4
1272962|NCT00430495|4162811|P3|Overall Study|Other|5
1272963|NCT00430495|4162812|P2|Overall Study|Other|2
1272964|NCT00430495|4162813|P1|Overall Study|Other|8
1272965|NCT00430495|4162810|P4|Overall Study|Disease Progression|0
1272966|NCT00430495|4162811|P3|Overall Study|Disease Progression|0
1272967|NCT00430495|4162812|P2|Overall Study|Disease Progression|1
1272968|NCT00430495|4162813|P1|Overall Study|Disease Progression|1
1272969|NCT00430495|4162810|P4|Overall Study|Protocol Violation|0
1272970|NCT00430495|4162811|P3|Overall Study|Protocol Violation|1
1272971|NCT00430495|4162812|P2|Overall Study|Protocol Violation|0
1272972|NCT00430495|4162813|P1|Overall Study|Protocol Violation|1
1272973|NCT00430495|4162810|P4|Overall Study|Lost to Follow-up|0
1272974|NCT00430495|4162811|P3|Overall Study|Lost to Follow-up|4
1272975|NCT00430495|4162812|P2|Overall Study|Lost to Follow-up|1
1272976|NCT00430495|4162813|P1|Overall Study|Lost to Follow-up|0
1272977|NCT00430495|4162810|P4|Overall Study|Death|0
1272978|NCT00430495|4162811|P3|Overall Study|Death|1
1272979|NCT00430495|4162812|P2|Overall Study|Death|0
1272980|NCT00430495|4162813|P1|Overall Study|Death|0
1272981|NCT00430495|4162810|P4|Overall Study|Adverse Event|0
1272982|NCT00430495|4162811|P3|Overall Study|Adverse Event|2
1272983|NCT00430495|4162812|P2|Overall Study|Adverse Event|3
1272984|NCT00430495|4162813|P1|Overall Study|Adverse Event|2
1272985|NCT00430352|4162851|P1|Overall Study|Not specified|48
1272986|NCT00430352|4162851|P1|Overall Study|Death|5
1272987|NCT00430352|4162851|P1|Overall Study|Adverse Event|16
1272988|NCT00430352|4162851|P1|Overall Study|Withdrawal by Subject|11
1272989|NCT00430352|4162851|P1|Overall Study|Disease progression|58
1272990|NCT00430300|4162869|P4|Overall Study|Other|1
1272991|NCT00430300|4162870|P3|Overall Study|Other|0
1272992|NCT00430300|4162871|P2|Overall Study|Other|0
1272993|NCT00430300|4162872|P1|Overall Study|Other|0
1272994|NCT00430300|4162869|P4|Overall Study|Laboratory abnormality|0
1272995|NCT00430300|4162870|P3|Overall Study|Laboratory abnormality|0
1272996|NCT00430300|4162871|P2|Overall Study|Laboratory abnormality|0
1272997|NCT00430300|4162872|P1|Overall Study|Laboratory abnormality|1
1272998|NCT00430300|4162869|P4|Overall Study|Withdrawal by Subject|0
1272999|NCT00430300|4162870|P3|Overall Study|Withdrawal by Subject|5
1273000|NCT00430300|4162871|P2|Overall Study|Withdrawal by Subject|0
1273001|NCT00430300|4162872|P1|Overall Study|Withdrawal by Subject|1
1273002|NCT00430300|4162869|P4|Overall Study|Adverse Event|1
1273003|NCT00430300|4162870|P3|Overall Study|Adverse Event|1
1273004|NCT00430300|4162871|P2|Overall Study|Adverse Event|2
1273005|NCT00430300|4162872|P1|Overall Study|Adverse Event|0
1273006|NCT00430248|4162977|P3|Overall Study|Reason Not Specified|11
1273007|NCT00430248|4162978|P2|Overall Study|Reason Not Specified|8
1273008|NCT00430248|4162979|P1|Overall Study|Reason Not Specified|8
1273009|NCT00430248|4162977|P3|Overall Study|Gout Flare|2
1273010|NCT00430248|4162978|P2|Overall Study|Gout Flare|7
1273011|NCT00430248|4162979|P1|Overall Study|Gout Flare|3
1273012|NCT00430248|4162977|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1273013|NCT00430248|4162978|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|2
1273014|NCT00430248|4162979|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1273015|NCT00430248|4162977|P3|Overall Study|Withdrawal by Subject|16
1273016|NCT00430248|4162978|P2|Overall Study|Withdrawal by Subject|20
1273017|NCT00430248|4162979|P1|Overall Study|Withdrawal by Subject|14
1273018|NCT00430248|4162977|P3|Overall Study|Therapeutic Failure|1
1273019|NCT00430248|4162978|P2|Overall Study|Therapeutic Failure|1
1273020|NCT00430248|4162979|P1|Overall Study|Therapeutic Failure|1
1273021|NCT00430248|4162977|P3|Overall Study|Lost to Follow-up|28
1273022|NCT00430248|4162978|P2|Overall Study|Lost to Follow-up|33
1273023|NCT00430248|4162979|P1|Overall Study|Lost to Follow-up|28
1273024|NCT00430248|4162977|P3|Overall Study|Personal Reasons|9
1273025|NCT00430248|4162978|P2|Overall Study|Personal Reasons|24
1273026|NCT00430248|4162979|P1|Overall Study|Personal Reasons|12
1273027|NCT00430248|4162977|P3|Overall Study|Protocol Violation|4
1273028|NCT00430248|4162978|P2|Overall Study|Protocol Violation|2
1273029|NCT00430248|4162979|P1|Overall Study|Protocol Violation|10
1273030|NCT00430248|4162977|P3|Overall Study|Adverse Event|64
1273031|NCT00430248|4162978|P2|Overall Study|Adverse Event|61
1273032|NCT00430248|4162979|P1|Overall Study|Adverse Event|49
1273033|NCT00430092|4163038|P3|Overall Study|Withdrawal by Subject|1
1273034|NCT00430092|4163039|P2|Overall Study|Withdrawal by Subject|1
1273035|NCT00430092|4163040|P1|Overall Study|Withdrawal by Subject|0
1273036|NCT00430092|4163038|P3|Overall Study|Protocol Violation|1
1273037|NCT00430092|4163039|P2|Overall Study|Protocol Violation|1
1273038|NCT00430092|4163040|P1|Overall Study|Protocol Violation|0
1273039|NCT00430092|4163038|P3|Overall Study|Lost to Follow-up|0
1273040|NCT00430092|4163039|P2|Overall Study|Lost to Follow-up|0
1273041|NCT00430092|4163040|P1|Overall Study|Lost to Follow-up|1
1273042|NCT00430092|4163038|P3|Overall Study|Lack of Efficacy|54
1273043|NCT00430092|4163039|P2|Overall Study|Lack of Efficacy|2
1273044|NCT00430092|4163040|P1|Overall Study|Lack of Efficacy|5
1273045|NCT00430092|4163038|P3|Overall Study|Adverse Event|1
1273046|NCT00430092|4163039|P2|Overall Study|Adverse Event|0
1273047|NCT00430092|4163040|P1|Overall Study|Adverse Event|0
1273048|NCT00430027|4163045|P1|Overall Study|Study terminated|8
1273049|NCT00429923|4163062|P3|Overall Study|Early Termination|0
1273050|NCT00429923|4163063|P2|Overall Study|Early Termination|1
1273051|NCT00429923|4163064|P1|Overall Study|Early Termination|0
1273052|NCT00429923|4163062|P3|Overall Study|Withdrew Consent|1
1273053|NCT00429923|4163063|P2|Overall Study|Withdrew Consent|0
1273054|NCT00429923|4163064|P1|Overall Study|Withdrew Consent|1
1273055|NCT00429923|4163062|P3|Overall Study|Lost to Follow-up|2
1273056|NCT00429923|4163063|P2|Overall Study|Lost to Follow-up|0
1273057|NCT00429923|4163064|P1|Overall Study|Lost to Follow-up|0
1273058|NCT00429923|4163062|P3|Overall Study|Lack of Efficacy|33
1273059|NCT00429923|4163063|P2|Overall Study|Lack of Efficacy|1
1273060|NCT00429923|4163064|P1|Overall Study|Lack of Efficacy|4
1273061|NCT00429923|4163062|P3|Overall Study|Adverse Event|3
1273062|NCT00429923|4163063|P2|Overall Study|Adverse Event|2
1273063|NCT00429923|4163064|P1|Overall Study|Adverse Event|0
1273064|NCT00429793|4163069|P1|Overall Study|Non-measurable|1
1273065|NCT00429793|4163069|P1|Overall Study|Never treated|1
1273066|NCT00429793|4163069|P1|Overall Study|Required test not done|1
1273067|NCT00429793|4163069|P1|Overall Study|Improper pre-protocol treatment|3
1273068|NCT00429663|4163096|P2|Overall Study|Death|0
1273069|NCT00429663|4163097|P1|Overall Study|Death|4
1273070|NCT00429663|4163096|P2|Overall Study|Withdrawal by Subject|5
1273071|NCT00429663|4163097|P1|Overall Study|Withdrawal by Subject|2
1273072|NCT00429663|4163096|P2|Overall Study|Physician Decision|3
1273073|NCT00429663|4163097|P1|Overall Study|Physician Decision|6
1273074|NCT00429663|4163096|P2|Overall Study|Lost to Follow-up|31
1273075|NCT00429663|4163097|P1|Overall Study|Lost to Follow-up|24
1273076|NCT00429572|4163111|P1|Overall Study|Disease progression|1
1273077|NCT00429494|4163123|P1|Overall Study|Death|6
1273078|NCT00429494|4163123|P1|Overall Study|Withdrawal by Subject|9
1273079|NCT00429416|4163127|P1|Overall Study|Death|1
1273080|NCT00429364|4163146|P2|Overall Study|Pregnancy|1
1273081|NCT00429364|4163147|P1|Overall Study|Pregnancy|0
1273082|NCT00429364|4163146|P2|Overall Study|Underwent aortic root surgery|18
1273083|NCT00429364|4163147|P1|Overall Study|Underwent aortic root surgery|10
1273084|NCT00429364|4163146|P2|Overall Study|Death|1
1273085|NCT00429364|4163147|P1|Overall Study|Death|0
1273086|NCT00429364|4163146|P2|Overall Study|Lost to Follow-up|6
1273087|NCT00429364|4163147|P1|Overall Study|Lost to Follow-up|7
1273088|NCT00429364|4163146|P2|Overall Study|Physician Decision|2
1273089|NCT00429364|4163147|P1|Overall Study|Physician Decision|4
1273090|NCT00429364|4163146|P2|Overall Study|Withdrawal by Subject|5
1273091|NCT00429364|4163147|P1|Overall Study|Withdrawal by Subject|11
1273092|NCT00429299|4163206|P3|Overall Study|Withdrawal by Subject|3
1273093|NCT00429299|4163207|P2|Overall Study|Withdrawal by Subject|1
1273094|NCT00429299|4163208|P1|Overall Study|Withdrawal by Subject|0
1273095|NCT00429299|4163206|P3|Overall Study|Protocol Violation|0
1273096|NCT00429299|4163207|P2|Overall Study|Protocol Violation|0
1273097|NCT00429299|4163208|P1|Overall Study|Protocol Violation|1
1273098|NCT00429299|4163206|P3|Overall Study|Adverse Event|1
1273099|NCT00429299|4163207|P2|Overall Study|Adverse Event|5
1273100|NCT00429299|4163208|P1|Overall Study|Adverse Event|2
1273101|NCT00429299|4163206|P3|Overall Study|Disease Progression|0
1273102|NCT00429299|4163207|P2|Overall Study|Disease Progression|1
1273103|NCT00429299|4163208|P1|Overall Study|Disease Progression|1
1273104|NCT00429273|4163240|P3|Overall Study|Adverse Event|2
1273105|NCT00429273|4163241|P2|Overall Study|Adverse Event|1
1273106|NCT00429273|4163242|P1|Overall Study|Adverse Event|1
1273107|NCT00429273|4163240|P3|Overall Study|Physician Decision|5
1273108|NCT00429273|4163241|P2|Overall Study|Physician Decision|5
1273109|NCT00429273|4163242|P1|Overall Study|Physician Decision|6
1273110|NCT00429273|4163240|P3|Overall Study|Lost to Follow-up|2
1273111|NCT00429273|4163241|P2|Overall Study|Lost to Follow-up|2
1273112|NCT00429273|4163242|P1|Overall Study|Lost to Follow-up|1
1273113|NCT00429182|4163250|P1|Overall Study|Not eligible|5
1273114|NCT00429182|4163250|P1|Overall Study|Not evaluable, Disease Progression|2
1273115|NCT00429169|4163257|P2|Overall Study|Ineligibility discovered after entry|1
1273116|NCT00429169|4163258|P1|Overall Study|Ineligibility discovered after entry|2
1273117|NCT00429169|4163257|P2|Overall Study|Lost to Follow-up|1
1273118|NCT00429169|4163258|P1|Overall Study|Lost to Follow-up|0
1273119|NCT00429104|4163278|P1|Overall Study|Protocol Violation|1
1273120|NCT00429026|4163283|P1|Overall Study|Inevaluable for response.|40
1273121|NCT00428948|4163310|P2|Overall Study|Protocol Deviation|1
1273122|NCT00428948|4163311|P1|Overall Study|Protocol Deviation|1
1273123|NCT00428948|4163310|P2|Overall Study|Subject Withdrew Consent|30
1273124|NCT00428948|4163311|P1|Overall Study|Subject Withdrew Consent|50
1273125|NCT00428948|4163310|P2|Overall Study|Investigator Withdrew Subject|4
1273126|NCT00428948|4163311|P1|Overall Study|Investigator Withdrew Subject|3
1273127|NCT00428948|4163310|P2|Overall Study|Subject Met Withdrawal Criteria|0
1273128|NCT00428948|4163311|P1|Overall Study|Subject Met Withdrawal Criteria|4
1273129|NCT00428948|4163310|P2|Overall Study|Adverse Event|24
1273130|NCT00428948|4163311|P1|Overall Study|Adverse Event|148
1273131|NCT00428948|4163310|P2|Overall Study|Lost to Follow-up|8
1273132|NCT00428948|4163311|P1|Overall Study|Lost to Follow-up|15
1273133|NCT00428844|4163339|P3|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
1273134|NCT00428844|4163340|P2|Completed Test of Cure (TOC) Visit|Microbiologic failure|1
1273135|NCT00428844|4163341|P1|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
1273136|NCT00428844|4163339|P3|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
1273137|NCT00428844|4163340|P2|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
1273138|NCT00428844|4163341|P1|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2
1273139|NCT00428844|4163339|P3|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
1273140|NCT00428844|4163340|P2|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
1273141|NCT00428844|4163341|P1|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1
1273142|NCT00428844|4163339|P3|Completed Test of Cure (TOC) Visit|Protocol Violation|1
1273143|NCT00428844|4163340|P2|Completed Test of Cure (TOC) Visit|Protocol Violation|0
1273144|NCT00428844|4163341|P1|Completed Test of Cure (TOC) Visit|Protocol Violation|0
1273145|NCT00428844|4163339|P3|Completed Test of Cure (TOC) Visit|Adverse Event|1
1273146|NCT00428844|4163340|P2|Completed Test of Cure (TOC) Visit|Adverse Event|1
1273147|NCT00428844|4163341|P1|Completed Test of Cure (TOC) Visit|Adverse Event|0
1273148|NCT00428844|4163339|P3|Completed Study Drug Treatment|Randomized Not Treated|1
1273149|NCT00428844|4163340|P2|Completed Study Drug Treatment|Randomized Not Treated|0
1273150|NCT00428844|4163341|P1|Completed Study Drug Treatment|Randomized Not Treated|0
1273151|NCT00428844|4163339|P3|Completed Study Drug Treatment|Withdrawal by Subject|1
1273152|NCT00428844|4163340|P2|Completed Study Drug Treatment|Withdrawal by Subject|1
1273153|NCT00428844|4163341|P1|Completed Study Drug Treatment|Withdrawal by Subject|0
1273154|NCT00428844|4163339|P3|Completed Study Drug Treatment|Protocol Violation|1
1273155|NCT00428844|4163340|P2|Completed Study Drug Treatment|Protocol Violation|1
1273156|NCT00428844|4163341|P1|Completed Study Drug Treatment|Protocol Violation|0
1273157|NCT00428844|4163339|P3|Completed Study Drug Treatment|Adverse Event|4
1273158|NCT00428844|4163340|P2|Completed Study Drug Treatment|Adverse Event|4
1273159|NCT00428844|4163341|P1|Completed Study Drug Treatment|Adverse Event|2
1273160|NCT00428792|4163364|P2|Overall Study|Lost to Follow-up|1
1273161|NCT00428792|4163365|P1|Overall Study|Lost to Follow-up|0
1273162|NCT00428792|4163364|P2|Overall Study|Lack of Efficacy|3
1273163|NCT00428792|4163365|P1|Overall Study|Lack of Efficacy|1
1273164|NCT00428610|4163392|P3|Overall Study|Withdrawal by Subject|0
1273165|NCT00428610|4163393|P2|Overall Study|Withdrawal by Subject|0
1273166|NCT00428610|4163394|P1|Overall Study|Withdrawal by Subject|4
1273167|NCT00428610|4163392|P3|Overall Study|Progressive Disease|22
1273168|NCT00428610|4163393|P2|Overall Study|Progressive Disease|14
1273169|NCT00428610|4163394|P1|Overall Study|Progressive Disease|42
1273170|NCT00428610|4163392|P3|Overall Study|Investigator Decision|1
1273171|NCT00428610|4163393|P2|Overall Study|Investigator Decision|1
1273172|NCT00428610|4163394|P1|Overall Study|Investigator Decision|2
1273173|NCT00428610|4163392|P3|Overall Study|Adverse Event|2
1273174|NCT00428610|4163393|P2|Overall Study|Adverse Event|3
1273175|NCT00428610|4163394|P1|Overall Study|Adverse Event|2
1273176|NCT00428610|4163392|P3|Overall Study|Death Due to Progressive Disease|2
1273177|NCT00428610|4163393|P2|Overall Study|Death Due to Progressive Disease|0
1273178|NCT00428610|4163394|P1|Overall Study|Death Due to Progressive Disease|0
1273179|NCT00428610|4163392|P3|Overall Study|Death Due to Adverse Event|5
1273180|NCT00428610|4163393|P2|Overall Study|Death Due to Adverse Event|0
1273181|NCT00428610|4163394|P1|Overall Study|Death Due to Adverse Event|3
1273182|NCT00428597|4163428|P2|Overall Study|Death|3
1273183|NCT00428597|4163429|P1|Overall Study|Death|1
1273184|NCT00428597|4163428|P2|Overall Study|Pregnancy|0
1273185|NCT00428597|4163429|P1|Overall Study|Pregnancy|1
1273186|NCT00428597|4163428|P2|Overall Study|Lost to Follow-up|1
1273187|NCT00428597|4163429|P1|Overall Study|Lost to Follow-up|0
1273188|NCT00428597|4163428|P2|Overall Study|Other|1
1273189|NCT00428597|4163429|P1|Overall Study|Other|1
1273190|NCT00428597|4163428|P2|Overall Study|Withdrawal by Subject|1
1273191|NCT00428597|4163429|P1|Overall Study|Withdrawal by Subject|2
1273192|NCT00428597|4163428|P2|Overall Study|Protocol Violation|1
1273193|NCT00428597|4163429|P1|Overall Study|Protocol Violation|2
1273194|NCT00428597|4163428|P2|Overall Study|Global Deterioration of Health Status|5
1273195|NCT00428597|4163429|P1|Overall Study|Global Deterioration of Health Status|1
1273196|NCT00428597|4163428|P2|Overall Study|Adverse Event|7
1273197|NCT00428597|4163429|P1|Overall Study|Adverse Event|15
1273198|NCT00428597|4163428|P2|Overall Study|Study Terminated by Sponsor|16
1273199|NCT00428597|4163429|P1|Overall Study|Study Terminated by Sponsor|41
1273200|NCT00428597|4163428|P2|Overall Study|Objective Progression or Relapse|47
1273201|NCT00428597|4163429|P1|Overall Study|Objective Progression or Relapse|19
1273202|NCT00428597|4163428|P2|Overall Study|Randomized but not treated|3
1273203|NCT00428597|4163429|P1|Overall Study|Randomized but not treated|3
1273204|NCT00428441|4163496|P1|Overall Study|Lost to Follow-up|1
1273205|NCT00428389|4163502|P2|Extension Phase|Administrative problems|1
1273206|NCT00428389|4163503|P1|Extension Phase|Administrative problems|1
1273207|NCT00428389|4163502|P2|Extension Phase|Protocol Violation|2
1273208|NCT00428389|4163503|P1|Extension Phase|Protocol Violation|3
1273209|NCT00428389|4163502|P2|Extension Phase|Death|0
1273210|NCT00428389|4163503|P1|Extension Phase|Death|1
1273211|NCT00428389|4163502|P2|Extension Phase|Lost to Follow-up|3
1273212|NCT00428389|4163503|P1|Extension Phase|Lost to Follow-up|0
1273213|NCT00428389|4163502|P2|Extension Phase|Withdrawal by Subject|6
1273214|NCT00428389|4163503|P1|Extension Phase|Withdrawal by Subject|6
1273215|NCT00428389|4163502|P2|Extension Phase|Lack of Efficacy|3
1273216|NCT00428389|4163503|P1|Extension Phase|Lack of Efficacy|4
1273217|NCT00428389|4163502|P2|Extension Phase|Adverse Event|11
1273218|NCT00428389|4163503|P1|Extension Phase|Adverse Event|17
1273219|NCT00428389|4163502|P2|Core Phase|Protocol deviation|2
1273220|NCT00428389|4163503|P1|Core Phase|Protocol deviation|0
1273221|NCT00428389|4163502|P2|Core Phase|Withdrawal by Subject|4
1273222|NCT00428389|4163503|P1|Core Phase|Withdrawal by Subject|3
1273223|NCT00428389|4163502|P2|Core Phase|Abnormal test procedure result(s)|1
1273224|NCT00428389|4163503|P1|Core Phase|Abnormal test procedure result(s)|0
1273225|NCT00428389|4163502|P2|Core Phase|Lack of Efficacy|0
1273226|NCT00428389|4163503|P1|Core Phase|Lack of Efficacy|2
1273227|NCT00428389|4163502|P2|Core Phase|Adverse Event|4
1273228|NCT00428389|4163503|P1|Core Phase|Adverse Event|6
1273229|NCT00428246|4163537|P3|Overall Study|Adverse Event|0
1273230|NCT00428246|4163538|P2|Overall Study|Adverse Event|0
1273231|NCT00428246|4163539|P1|Overall Study|Adverse Event|1
1273232|NCT00428246|4163537|P3|Overall Study|Withdrawal by Subject|1
1273233|NCT00428246|4163538|P2|Overall Study|Withdrawal by Subject|0
1273234|NCT00428246|4163539|P1|Overall Study|Withdrawal by Subject|0
1273235|NCT00428220|4163547|P1|Overall Study|Other|23
1273236|NCT00428220|4163547|P1|Overall Study|Adverse Event|51
1273237|NCT00428220|4163547|P1|Overall Study|Participant refused continued treatment|7
1273238|NCT00428220|4163547|P1|Overall Study|Objective progression or relapse|123
1273239|NCT00428220|4163547|P1|Overall Study|Lost to Follow-up|4
1273240|NCT00428220|4163547|P1|Overall Study|Global deterioration of health status|7
1273241|NCT00428220|4163547|P1|Overall Study|Participant died|8
1273242|NCT00428116|4163572|P2|Overall Study|Lost to Follow-up|0
1273243|NCT00428116|4163573|P1|Overall Study|Lost to Follow-up|1
1273244|NCT00428116|4163572|P2|Overall Study|Withdrawal by Subject|0
1273245|NCT00428116|4163573|P1|Overall Study|Withdrawal by Subject|1
1273246|NCT00428116|4163572|P2|Overall Study|Death|0
1273247|NCT00428116|4163573|P1|Overall Study|Death|1
1273248|NCT00428090|4163585|P4|Overall Study|Raised Creatinine Value|1
1273249|NCT00428090|4163586|P3|Overall Study|Raised Creatinine Value|0
1273250|NCT00428090|4163587|P2|Overall Study|Raised Creatinine Value|0
1273251|NCT00428090|4163588|P1|Overall Study|Raised Creatinine Value|0
1273252|NCT00428090|4163585|P4|Overall Study|Excluded for heart insufficiency|0
1273253|NCT00428090|4163586|P3|Overall Study|Excluded for heart insufficiency|1
1273254|NCT00428090|4163587|P2|Overall Study|Excluded for heart insufficiency|0
1273255|NCT00428090|4163588|P1|Overall Study|Excluded for heart insufficiency|0
1273256|NCT00428090|4163585|P4|Overall Study|Serious adverse event|0
1273257|NCT00428090|4163586|P3|Overall Study|Serious adverse event|1
1273258|NCT00428090|4163587|P2|Overall Study|Serious adverse event|0
1273259|NCT00428090|4163588|P1|Overall Study|Serious adverse event|0
1273260|NCT00428090|4163585|P4|Overall Study|Deterioration of cognitive status|0
1273261|NCT00428090|4163586|P3|Overall Study|Deterioration of cognitive status|1
1273262|NCT00428090|4163587|P2|Overall Study|Deterioration of cognitive status|0
1273263|NCT00428090|4163588|P1|Overall Study|Deterioration of cognitive status|0
1273264|NCT00428090|4163585|P4|Overall Study|High MMSE scores|0
1273265|NCT00428090|4163586|P3|Overall Study|High MMSE scores|1
1273266|NCT00428090|4163587|P2|Overall Study|High MMSE scores|0
1273267|NCT00428090|4163588|P1|Overall Study|High MMSE scores|0
1273268|NCT00428090|4163585|P4|Overall Study|Insufficient AD documentation|0
1273269|NCT00428090|4163586|P3|Overall Study|Insufficient AD documentation|1
1273270|NCT00428090|4163587|P2|Overall Study|Insufficient AD documentation|0
1273271|NCT00428090|4163588|P1|Overall Study|Insufficient AD documentation|0
1273272|NCT00428090|4163585|P4|Overall Study|Excluded for concerning QTc value|0
1273273|NCT00428090|4163586|P3|Overall Study|Excluded for concerning QTc value|1
1273274|NCT00428090|4163587|P2|Overall Study|Excluded for concerning QTc value|0
1273275|NCT00428090|4163588|P1|Overall Study|Excluded for concerning QTc value|0
1273276|NCT00428090|4163585|P4|Overall Study|Worsening of AD|0
1273277|NCT00428090|4163586|P3|Overall Study|Worsening of AD|1
1273278|NCT00428090|4163587|P2|Overall Study|Worsening of AD|0
1273279|NCT00428090|4163588|P1|Overall Study|Worsening of AD|0
1273280|NCT00428090|4163585|P4|Overall Study|Mental status of par. was|0
1273281|NCT00428090|4163586|P3|Overall Study|Mental status of par. was|0
1273282|NCT00428090|4163587|P2|Overall Study|Mental status of par. was|1
1273283|NCT00428090|4163588|P1|Overall Study|Mental status of par. was|0
1273284|NCT00428090|4163585|P4|Overall Study|Medical monitor terminated par.|0
1273285|NCT00428090|4163586|P3|Overall Study|Medical monitor terminated par.|0
1273286|NCT00428090|4163587|P2|Overall Study|Medical monitor terminated par.|1
1273287|NCT00428090|4163588|P1|Overall Study|Medical monitor terminated par.|0
1273288|NCT00428090|4163585|P4|Overall Study|Visit 7 exceed the visit window|0
1273289|NCT00428090|4163586|P3|Overall Study|Visit 7 exceed the visit window|0
1273290|NCT00428090|4163587|P2|Overall Study|Visit 7 exceed the visit window|1
1273291|NCT00428090|4163588|P1|Overall Study|Visit 7 exceed the visit window|0
1273292|NCT00428090|4163585|P4|Overall Study|Death of par.|0
1273293|NCT00428090|4163586|P3|Overall Study|Death of par.|1
1273294|NCT00428090|4163587|P2|Overall Study|Death of par.|0
1273295|NCT00428090|4163588|P1|Overall Study|Death of par.|1
1273296|NCT00428090|4163585|P4|Overall Study|Prohibited medication used for SAE|0
1273297|NCT00428090|4163586|P3|Overall Study|Prohibited medication used for SAE|0
1273298|NCT00428090|4163587|P2|Overall Study|Prohibited medication used for SAE|0
1273299|NCT00428090|4163588|P1|Overall Study|Prohibited medication used for SAE|1
1273300|NCT00428090|4163585|P4|Overall Study|Follow-Up visit not possible|0
1273301|NCT00428090|4163586|P3|Overall Study|Follow-Up visit not possible|0
1273302|NCT00428090|4163587|P2|Overall Study|Follow-Up visit not possible|0
1273303|NCT00428090|4163588|P1|Overall Study|Follow-Up visit not possible|1
1273304|NCT00428090|4163585|P4|Overall Study|Par. did not returned to visit|1
1273305|NCT00428090|4163586|P3|Overall Study|Par. did not returned to visit|0
1273306|NCT00428090|4163587|P2|Overall Study|Par. did not returned to visit|0
1273307|NCT00428090|4163588|P1|Overall Study|Par. did not returned to visit|1
1273308|NCT00428090|4163585|P4|Overall Study|Non-compliance|3
1273309|NCT00428090|4163586|P3|Overall Study|Non-compliance|1
1273310|NCT00428090|4163587|P2|Overall Study|Non-compliance|0
1273311|NCT00428090|4163588|P1|Overall Study|Non-compliance|4
1273312|NCT00428090|4163585|P4|Overall Study|Sponsor terminated study|0
1273313|NCT00428090|4163586|P3|Overall Study|Sponsor terminated study|0
1273314|NCT00428090|4163587|P2|Overall Study|Sponsor terminated study|1
1273315|NCT00428090|4163588|P1|Overall Study|Sponsor terminated study|0
1273316|NCT00428090|4163585|P4|Overall Study|Withdrawal by Subject|5
1273317|NCT00428090|4163586|P3|Overall Study|Withdrawal by Subject|15
1273318|NCT00428090|4163587|P2|Overall Study|Withdrawal by Subject|12
1273319|NCT00428090|4163588|P1|Overall Study|Withdrawal by Subject|10
1273320|NCT00428090|4163585|P4|Overall Study|Protocol Violation|3
1273321|NCT00428090|4163586|P3|Overall Study|Protocol Violation|3
1273322|NCT00428090|4163587|P2|Overall Study|Protocol Violation|1
1273323|NCT00428090|4163588|P1|Overall Study|Protocol Violation|3
1273324|NCT00428090|4163585|P4|Overall Study|Lost to Follow-up|4
1273325|NCT00428090|4163586|P3|Overall Study|Lost to Follow-up|1
1273326|NCT00428090|4163587|P2|Overall Study|Lost to Follow-up|6
1273327|NCT00428090|4163588|P1|Overall Study|Lost to Follow-up|3
1273328|NCT00428090|4163585|P4|Overall Study|Adverse Event|11
1273329|NCT00428090|4163586|P3|Overall Study|Adverse Event|10
1273330|NCT00428090|4163587|P2|Overall Study|Adverse Event|8
1273331|NCT00428090|4163588|P1|Overall Study|Adverse Event|10
1273332|NCT00427999|4163706|P1|Overall Study|Death|1
1273333|NCT00427999|4163706|P1|Overall Study|Withdrawal by Subject|9
1273334|NCT00427999|4163706|P1|Overall Study|Protocol Violation|2
1273335|NCT00427999|4163706|P1|Overall Study|Unsatisfactory therapeutic effect|13
1273336|NCT00427999|4163706|P1|Overall Study|Abnormal laboratory values|1
1273337|NCT00427999|4163706|P1|Overall Study|Adverse Event|6
1273338|NCT00427960|4163724|P2|Overall Study|Not Specified|1
1273339|NCT00427960|4163725|P1|Overall Study|Not Specified|0
1273340|NCT00427960|4163724|P2|Overall Study|Withdrawal by Subject|3
1273341|NCT00427960|4163725|P1|Overall Study|Withdrawal by Subject|0
1273342|NCT00427960|4163724|P2|Overall Study|Adverse Event|0
1273343|NCT00427960|4163725|P1|Overall Study|Adverse Event|2
1273344|NCT00427934|4163763|P4|Overall Study|Withdrawal by Subject|3
1273345|NCT00427934|4163764|P3|Overall Study|Withdrawal by Subject|1
1273346|NCT00427934|4163765|P2|Overall Study|Withdrawal by Subject|0
1273347|NCT00427934|4163766|P1|Overall Study|Withdrawal by Subject|0
1273348|NCT00427934|4163763|P4|Overall Study|Other|5
1273349|NCT00427934|4163764|P3|Overall Study|Other|11
1273350|NCT00427934|4163765|P2|Overall Study|Other|0
1273351|NCT00427934|4163766|P1|Overall Study|Other|0
1273352|NCT00427934|4163763|P4|Overall Study|Randomized But Did Not Receive Treatment|1
1273353|NCT00427934|4163764|P3|Overall Study|Randomized But Did Not Receive Treatment|1
1273354|NCT00427934|4163765|P2|Overall Study|Randomized But Did Not Receive Treatment|0
1273355|NCT00427934|4163766|P1|Overall Study|Randomized But Did Not Receive Treatment|0
1273356|NCT00427934|4163763|P4|Overall Study|Lack of Efficacy|2
1273357|NCT00427934|4163764|P3|Overall Study|Lack of Efficacy|5
1273358|NCT00427934|4163765|P2|Overall Study|Lack of Efficacy|0
1273359|NCT00427934|4163766|P1|Overall Study|Lack of Efficacy|0
1273360|NCT00427934|4163763|P4|Overall Study|Adverse Event|4
1273361|NCT00427934|4163764|P3|Overall Study|Adverse Event|5
1273362|NCT00427934|4163765|P2|Overall Study|Adverse Event|0
1273363|NCT00427934|4163766|P1|Overall Study|Adverse Event|1
1273364|NCT00427921|4163834|P1|Overall Study|Withdrew Consent + Lack of Efficacy|1
1273365|NCT00427921|4163834|P1|Overall Study|Adverse Event + Withdrawn from Study|1
1273366|NCT00427921|4163834|P1|Overall Study|Adverse Event + Lost Response|1
1273367|NCT00427921|4163834|P1|Overall Study|Adverse Event + No Therapeutic Benefit|1
1273368|NCT00427921|4163834|P1|Overall Study|Adverse Event + Worsening of CD|1
1273369|NCT00427921|4163834|P1|Overall Study|Adverse Event + No Response|1
1273370|NCT00427921|4163834|P1|Overall Study|Adverse Event + Withdrew Consent|1
1273371|NCT00427921|4163834|P1|Overall Study|Adverse Event + Hospitalization|1
1273372|NCT00427921|4163834|P1|Overall Study|Other reason not specified|10
1273373|NCT00427921|4163834|P1|Overall Study|Lost to Follow-up|2
1273374|NCT00427921|4163834|P1|Overall Study|Withdrawal by Subject|4
1273375|NCT00427921|4163834|P1|Overall Study|Adverse Event|26
1273376|NCT00427908|4163857|P4|Primary Phase|Adverse Event|0
1273377|NCT00427908|4163858|P3|Primary Phase|Adverse Event|0
1273378|NCT00427908|4163859|P2|Primary Phase|Adverse Event|1
1273379|NCT00427908|4163860|P1|Primary Phase|Adverse Event|0
1273380|NCT00427908|4163857|P4|Primary Phase|Withdrawal by Subject|0
1273381|NCT00427908|4163858|P3|Primary Phase|Withdrawal by Subject|1
1273382|NCT00427908|4163859|P2|Primary Phase|Withdrawal by Subject|2
1273383|NCT00427908|4163860|P1|Primary Phase|Withdrawal by Subject|1
1273384|NCT00427908|4163857|P4|Primary Phase|Lost to Follow-up|0
1273385|NCT00427908|4163858|P3|Primary Phase|Lost to Follow-up|2
1273386|NCT00427908|4163859|P2|Primary Phase|Lost to Follow-up|0
1273387|NCT00427908|4163860|P1|Primary Phase|Lost to Follow-up|4
1273388|NCT00427895|4164060|P8|Vax 2/Year 3 to 4|Failed to Return|0
1273389|NCT00427895|4164061|P7|Vax 2/Year 3 to 4|Failed to Return|0
1273390|NCT00427895|4164062|P6|Vax 2/Year 3 to 4|Failed to Return|0
1273391|NCT00427895|4164063|P5|Vax 2/Year 3 to 4|Failed to Return|1
1273392|NCT00427895|4164064|P4|Vax 2/Year 3 to 4|Failed to Return|0
1273393|NCT00427895|4164065|P3|Vax 2/Year 3 to 4|Failed to Return|0
1273394|NCT00427895|4164066|P2|Vax 2/Year 3 to 4|Failed to Return|0
1273395|NCT00427895|4164067|P1|Vax 2/Year 3 to 4|Failed to Return|0
1273396|NCT00427895|4164060|P8|Vax 2/Year 3 to 4|Protocol Violation|1
1273397|NCT00427895|4164061|P7|Vax 2/Year 3 to 4|Protocol Violation|0
1273398|NCT00427895|4164062|P6|Vax 2/Year 3 to 4|Protocol Violation|0
1273399|NCT00427895|4164063|P5|Vax 2/Year 3 to 4|Protocol Violation|0
1273400|NCT00427895|4164064|P4|Vax 2/Year 3 to 4|Protocol Violation|0
1273401|NCT00427895|4164065|P3|Vax 2/Year 3 to 4|Protocol Violation|0
1273402|NCT00427895|4164066|P2|Vax 2/Year 3 to 4|Protocol Violation|0
1273403|NCT00427895|4164067|P1|Vax 2/Year 3 to 4|Protocol Violation|0
1273404|NCT00427895|4164060|P8|Vax 2/Year 3 to 4|Lost to Follow-up|1
1273405|NCT00427895|4164061|P7|Vax 2/Year 3 to 4|Lost to Follow-up|0
1273406|NCT00427895|4164062|P6|Vax 2/Year 3 to 4|Lost to Follow-up|0
1273407|NCT00427895|4164063|P5|Vax 2/Year 3 to 4|Lost to Follow-up|0
1273408|NCT00427895|4164064|P4|Vax 2/Year 3 to 4|Lost to Follow-up|0
1273409|NCT00427895|4164065|P3|Vax 2/Year 3 to 4|Lost to Follow-up|0
1273410|NCT00427895|4164066|P2|Vax 2/Year 3 to 4|Lost to Follow-up|0
1273411|NCT00427895|4164067|P1|Vax 2/Year 3 to 4|Lost to Follow-up|0
1273412|NCT00427895|4164060|P8|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
1273413|NCT00427895|4164061|P7|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
1273414|NCT00427895|4164062|P6|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
1273415|NCT00427895|4164063|P5|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
1273416|NCT00427895|4164064|P4|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469
1273417|NCT00427895|4164065|P3|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159
1273418|NCT00427895|4164066|P2|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207
1273419|NCT00427895|4164067|P1|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188
1273420|NCT00427895|4164060|P8|Vax 1/Year 1 Follow-up|Other|0
1273421|NCT00427895|4164061|P7|Vax 1/Year 1 Follow-up|Other|0
1273422|NCT00427895|4164062|P6|Vax 1/Year 1 Follow-up|Other|0
1273423|NCT00427895|4164063|P5|Vax 1/Year 1 Follow-up|Other|0
1273424|NCT00427895|4164064|P4|Vax 1/Year 1 Follow-up|Other|2
1273425|NCT00427895|4164065|P3|Vax 1/Year 1 Follow-up|Other|0
1273426|NCT00427895|4164066|P2|Vax 1/Year 1 Follow-up|Other|0
1273427|NCT00427895|4164067|P1|Vax 1/Year 1 Follow-up|Other|0
1273428|NCT00427895|4164060|P8|Vax 1/Year 1 Follow-up|Failed to Return|0
1273429|NCT00427895|4164061|P7|Vax 1/Year 1 Follow-up|Failed to Return|0
1273430|NCT00427895|4164062|P6|Vax 1/Year 1 Follow-up|Failed to Return|0
1273431|NCT00427895|4164063|P5|Vax 1/Year 1 Follow-up|Failed to Return|0
1273432|NCT00427895|4164064|P4|Vax 1/Year 1 Follow-up|Failed to Return|5
1273433|NCT00427895|4164065|P3|Vax 1/Year 1 Follow-up|Failed to Return|12
1273434|NCT00427895|4164066|P2|Vax 1/Year 1 Follow-up|Failed to Return|0
1273435|NCT00427895|4164067|P1|Vax 1/Year 1 Follow-up|Failed to Return|0
1273436|NCT00427895|4164060|P8|Vax 1/Year 1 Follow-up|Death|0
1273437|NCT00427895|4164061|P7|Vax 1/Year 1 Follow-up|Death|0
1273438|NCT00427895|4164062|P6|Vax 1/Year 1 Follow-up|Death|0
1273439|NCT00427895|4164063|P5|Vax 1/Year 1 Follow-up|Death|0
1273440|NCT00427895|4164064|P4|Vax 1/Year 1 Follow-up|Death|0
1273441|NCT00427895|4164065|P3|Vax 1/Year 1 Follow-up|Death|0
1273442|NCT00427895|4164066|P2|Vax 1/Year 1 Follow-up|Death|0
1273443|NCT00427895|4164067|P1|Vax 1/Year 1 Follow-up|Death|1
1273444|NCT00427895|4164060|P8|Vax 1/Year 1 Follow-up|Adverse Event|0
1273445|NCT00427895|4164061|P7|Vax 1/Year 1 Follow-up|Adverse Event|0
1273446|NCT00427895|4164062|P6|Vax 1/Year 1 Follow-up|Adverse Event|0
1273447|NCT00427895|4164063|P5|Vax 1/Year 1 Follow-up|Adverse Event|0
1273448|NCT00427895|4164064|P4|Vax 1/Year 1 Follow-up|Adverse Event|0
1273449|NCT00427895|4164065|P3|Vax 1/Year 1 Follow-up|Adverse Event|0
1273450|NCT00427895|4164066|P2|Vax 1/Year 1 Follow-up|Adverse Event|1
1273451|NCT00427895|4164067|P1|Vax 1/Year 1 Follow-up|Adverse Event|0
1273452|NCT00427895|4164060|P8|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
1273453|NCT00427895|4164061|P7|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
1273454|NCT00427895|4164062|P6|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
1273455|NCT00427895|4164063|P5|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
1273456|NCT00427895|4164064|P4|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4
1273457|NCT00427895|4164065|P3|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5
1273458|NCT00427895|4164066|P2|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6
1273459|NCT00427895|4164067|P1|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3
1273460|NCT00427895|4164060|P8|Vax 1/Year 1 Follow-up|Protocol Violation|0
1273461|NCT00427895|4164061|P7|Vax 1/Year 1 Follow-up|Protocol Violation|0
1273462|NCT00427895|4164062|P6|Vax 1/Year 1 Follow-up|Protocol Violation|0
1273463|NCT00427895|4164063|P5|Vax 1/Year 1 Follow-up|Protocol Violation|0
1273464|NCT00427895|4164064|P4|Vax 1/Year 1 Follow-up|Protocol Violation|1
1273465|NCT00427895|4164065|P3|Vax 1/Year 1 Follow-up|Protocol Violation|0
1273466|NCT00427895|4164066|P2|Vax 1/Year 1 Follow-up|Protocol Violation|3
1273467|NCT00427895|4164067|P1|Vax 1/Year 1 Follow-up|Protocol Violation|3
1273468|NCT00427895|4164060|P8|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
1273469|NCT00427895|4164061|P7|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
1273470|NCT00427895|4164062|P6|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
1273471|NCT00427895|4164063|P5|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
1273472|NCT00427895|4164064|P4|Vax 1/Year 1 Follow-up|Lost to Follow-up|21
1273473|NCT00427895|4164065|P3|Vax 1/Year 1 Follow-up|Lost to Follow-up|2
1273474|NCT00427895|4164066|P2|Vax 1/Year 1 Follow-up|Lost to Follow-up|5
1273475|NCT00427895|4164067|P1|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
1273476|NCT00427895|4164060|P8|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
1273477|NCT00427895|4164061|P7|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
1273478|NCT00427895|4164062|P6|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
1273479|NCT00427895|4164063|P5|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
1273480|NCT00427895|4164064|P4|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352
1273481|NCT00427895|4164065|P3|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
1273482|NCT00427895|4164066|P2|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
1273483|NCT00427895|4164067|P1|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
1273484|NCT00427895|4164060|P8|Vax 1 Baseline/6-Month Follow-up|Other|0
1273485|NCT00427895|4164061|P7|Vax 1 Baseline/6-Month Follow-up|Other|0
1273486|NCT00427895|4164062|P6|Vax 1 Baseline/6-Month Follow-up|Other|0
1273487|NCT00427895|4164063|P5|Vax 1 Baseline/6-Month Follow-up|Other|0
1273488|NCT00427895|4164064|P4|Vax 1 Baseline/6-Month Follow-up|Other|2
1273489|NCT00427895|4164065|P3|Vax 1 Baseline/6-Month Follow-up|Other|1
1273490|NCT00427895|4164066|P2|Vax 1 Baseline/6-Month Follow-up|Other|0
1273491|NCT00427895|4164067|P1|Vax 1 Baseline/6-Month Follow-up|Other|0
1273492|NCT00427895|4164060|P8|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
1273493|NCT00427895|4164061|P7|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
1273494|NCT00427895|4164062|P6|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
1273495|NCT00427895|4164063|P5|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
1273496|NCT00427895|4164064|P4|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
1273497|NCT00427895|4164065|P3|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2
1273498|NCT00427895|4164066|P2|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3
1273499|NCT00427895|4164067|P1|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
1273500|NCT00427895|4164060|P8|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
1273501|NCT00427895|4164061|P7|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
1273502|NCT00427895|4164062|P6|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
1273503|NCT00427895|4164063|P5|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
1273504|NCT00427895|4164064|P4|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2
1273505|NCT00427895|4164065|P3|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
1273506|NCT00427895|4164066|P2|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
1273507|NCT00427895|4164067|P1|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
1273508|NCT00427895|4164060|P8|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
1273509|NCT00427895|4164061|P7|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
1273510|NCT00427895|4164062|P6|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
1273511|NCT00427895|4164063|P5|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
1273512|NCT00427895|4164064|P4|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7
1273513|NCT00427895|4164065|P3|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4
1273514|NCT00427895|4164066|P2|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
1273515|NCT00427895|4164067|P1|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
1273516|NCT00427895|4164060|P8|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
1273517|NCT00427895|4164061|P7|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
1273518|NCT00427895|4164062|P6|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
1273519|NCT00427895|4164063|P5|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
1273520|NCT00427895|4164064|P4|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
1273521|NCT00427895|4164065|P3|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
1273522|NCT00427895|4164066|P2|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
1273523|NCT00427895|4164067|P1|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
1273524|NCT00427895|4164060|P8|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
1273525|NCT00427895|4164061|P7|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
1273526|NCT00427895|4164062|P6|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
1273527|NCT00427895|4164063|P5|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
1273528|NCT00427895|4164064|P4|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2
1273529|NCT00427895|4164065|P3|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3
1273530|NCT00427895|4164066|P2|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
1273531|NCT00427895|4164067|P1|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4
1273532|NCT00427895|4164060|P8|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
1273533|NCT00427895|4164061|P7|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
1273534|NCT00427895|4164062|P6|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
1273535|NCT00427895|4164063|P5|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
1273536|NCT00427895|4164064|P4|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32
1273537|NCT00427895|4164065|P3|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4
1273538|NCT00427895|4164066|P2|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1
1273539|NCT00427895|4164067|P1|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
1273540|NCT00427778|4164142|P2|First Intervention (4 Weeks)|anxious about using ring|0
1273541|NCT00427778|4164143|P1|First Intervention (4 Weeks)|anxious about using ring|1
1273542|NCT00427778|4164142|P2|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1
1273543|NCT00427778|4164143|P1|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0
1273544|NCT00427778|4164142|P2|First Intervention (4 Weeks)|Not successfully fitted with ring|0
1273545|NCT00427778|4164143|P1|First Intervention (4 Weeks)|Not successfully fitted with ring|2
1273546|NCT00427778|4164142|P2|First Intervention (4 Weeks)|no longer interested|0
1273547|NCT00427778|4164143|P1|First Intervention (4 Weeks)|no longer interested|1
1273548|NCT00427700|4164168|P2|Overall Study|Pregnancy|2
1273549|NCT00427700|4164169|P1|Overall Study|Pregnancy|0
1273550|NCT00427700|4164168|P2|Overall Study|no induction of menses|4
1273551|NCT00427700|4164169|P1|Overall Study|no induction of menses|1
1273552|NCT00427700|4164168|P2|Overall Study|Lost to Follow-up|5
1273553|NCT00427700|4164169|P1|Overall Study|Lost to Follow-up|2
1273554|NCT00427635|4164185|P2|Study Completion to Safety Follow-up|Lost to Follow-up|1
1273555|NCT00427635|4164186|P1|Study Completion to Safety Follow-up|Lost to Follow-up|0
1273556|NCT00427635|4164185|P2|Treatment Phase|Withdrawal by Subject|0
1273557|NCT00427635|4164186|P1|Treatment Phase|Withdrawal by Subject|1
1273558|NCT00427349|4164218|P1|Overall Study|Never started therapy|1
1273559|NCT00427349|4164218|P1|Overall Study|Ineligible|1
1273560|NCT00427349|4164218|P1|Overall Study|Other|2
1273561|NCT00427349|4164218|P1|Overall Study|Alternative therapy|1
1273562|NCT00427349|4164218|P1|Overall Study|Withdrawal by Subject|3
1273563|NCT00427349|4164218|P1|Overall Study|Death|1
1273564|NCT00427349|4164218|P1|Overall Study|Adverse Event|14
1273565|NCT00427349|4164218|P1|Overall Study|Lack of Efficacy|23
1273566|NCT00427011|4164275|P1|Overall Study|Not specified|12
1273567|NCT00427011|4164275|P1|Overall Study|Lack of Efficacy|2
1273568|NCT00427011|4164275|P1|Overall Study|Withdrawal by Subject|1
1273569|NCT00427011|4164275|P1|Overall Study|Adverse Event|10
1273570|NCT00426842|4164290|P1|Overall Study|Lost to Follow-up|1
1273571|NCT00426764|4164296|P1|Overall Study|Other|2
1273572|NCT00426764|4164296|P1|Overall Study|Protocol Violation|1
1273573|NCT00426764|4164296|P1|Overall Study|Physician Decision|1
1273574|NCT00426764|4164296|P1|Overall Study|Withdrawal by Subject|3
1273575|NCT00426764|4164296|P1|Overall Study|Adverse Event|19
1273576|NCT00426764|4164296|P1|Overall Study|Progressive disease|72
1273577|NCT00426751|4164312|P2|Overall Study|Other Reasons|12
1273578|NCT00426751|4164313|P1|Overall Study|Other Reasons|7
1273579|NCT00426751|4164312|P2|Overall Study|Consent Withdrawn|1
1273580|NCT00426751|4164313|P1|Overall Study|Consent Withdrawn|0
1273581|NCT00426751|4164312|P2|Overall Study|Lost to Follow-up|6
1273582|NCT00426751|4164313|P1|Overall Study|Lost to Follow-up|7
1273583|NCT00426751|4164312|P2|Overall Study|Adverse Event|1
1273584|NCT00426751|4164313|P1|Overall Study|Adverse Event|8
1273585|NCT00426660|4164357|P1|Overall Study|Enrolled Not Treated|15
1273586|NCT00426660|4164357|P1|Overall Study|Protocol Violation|1
1273587|NCT00426660|4164357|P1|Overall Study|Withdrawal by Subject|18
1273588|NCT00426660|4164357|P1|Overall Study|Other|23
1273589|NCT00426660|4164357|P1|Overall Study|Lost to Follow-up|15
1273590|NCT00426660|4164357|P1|Overall Study|Insufficient Clinical Response|22
1273591|NCT00426660|4164357|P1|Overall Study|Adverse Event|23
1273592|NCT00426660|4164357|P1|Overall Study|Death|14
1273593|NCT00426556|4164388|P4|Phase II - Extension Phase|Adverse Event|2
1273594|NCT00426556|4164389|P3|Phase II - Extension Phase|Adverse Event|0
1273595|NCT00426556|4164390|P2|Phase II - Extension Phase|Adverse Event|0
1273596|NCT00426556|4164391|P1|Phase II - Extension Phase|Adverse Event|0
1273597|NCT00426556|4164388|P4|Phase II - Extension Phase|Disease Progression|21
1273598|NCT00426556|4164389|P3|Phase II - Extension Phase|Disease Progression|0
1273599|NCT00426556|4164390|P2|Phase II - Extension Phase|Disease Progression|0
1273600|NCT00426556|4164391|P1|Phase II - Extension Phase|Disease Progression|0
1273601|NCT00426556|4164388|P4|Phase II - Core Phase|Adverse Event|8
1273602|NCT00426556|4164389|P3|Phase II - Core Phase|Adverse Event|0
1273603|NCT00426556|4164390|P2|Phase II - Core Phase|Adverse Event|0
1273604|NCT00426556|4164391|P1|Phase II - Core Phase|Adverse Event|0
1273605|NCT00426556|4164388|P4|Phase II - Core Phase|Disease Progression|16
1273606|NCT00426556|4164389|P3|Phase II - Core Phase|Disease Progression|0
1273607|NCT00426556|4164390|P2|Phase II - Core Phase|Disease Progression|0
1273608|NCT00426556|4164391|P1|Phase II - Core Phase|Disease Progression|0
1273609|NCT00426556|4164388|P4|Phase II - Core Phase|Withdrawal by Subject|3
1273610|NCT00426556|4164389|P3|Phase II - Core Phase|Withdrawal by Subject|0
1273611|NCT00426556|4164390|P2|Phase II - Core Phase|Withdrawal by Subject|0
1273612|NCT00426556|4164391|P1|Phase II - Core Phase|Withdrawal by Subject|0
1273613|NCT00426556|4164388|P4|Phase I - Extension Phase|Disease Progression|0
1273614|NCT00426556|4164389|P3|Phase I - Extension Phase|Disease Progression|6
1273615|NCT00426556|4164390|P2|Phase I - Extension Phase|Disease Progression|5
1273616|NCT00426556|4164391|P1|Phase I - Extension Phase|Disease Progression|5
1273617|NCT00426556|4164388|P4|Phase I - Extension Phase|Adverse Event|0
1273618|NCT00426556|4164389|P3|Phase I - Extension Phase|Adverse Event|1
1273619|NCT00426556|4164390|P2|Phase I - Extension Phase|Adverse Event|1
1273620|NCT00426556|4164391|P1|Phase I - Extension Phase|Adverse Event|0
1273621|NCT00426556|4164388|P4|Phase I - Core Phase|Death|0
1273622|NCT00426556|4164389|P3|Phase I - Core Phase|Death|0
1273623|NCT00426556|4164390|P2|Phase I - Core Phase|Death|1
1273624|NCT00426556|4164391|P1|Phase I - Core Phase|Death|0
1273625|NCT00426556|4164388|P4|Phase I - Core Phase|Adverse Event|0
1273626|NCT00426556|4164389|P3|Phase I - Core Phase|Adverse Event|1
1273627|NCT00426556|4164390|P2|Phase I - Core Phase|Adverse Event|3
1273628|NCT00426556|4164391|P1|Phase I - Core Phase|Adverse Event|1
1273629|NCT00426556|4164388|P4|Phase I - Core Phase|Disease Progression|0
1273630|NCT00426556|4164389|P3|Phase I - Core Phase|Disease Progression|2
1273631|NCT00426556|4164390|P2|Phase I - Core Phase|Disease Progression|6
1273632|NCT00426556|4164391|P1|Phase I - Core Phase|Disease Progression|0
1273633|NCT00426361|4164416|P3|Overall Study|Withdrawal by Subject|0
1273634|NCT00426361|4164417|P2|Overall Study|Withdrawal by Subject|3
1273635|NCT00426361|4164418|P1|Overall Study|Withdrawal by Subject|1
1273636|NCT00426361|4164416|P3|Overall Study|Lost to Follow-up|5
1273637|NCT00426361|4164417|P2|Overall Study|Lost to Follow-up|2
1273638|NCT00426361|4164418|P1|Overall Study|Lost to Follow-up|3
1273639|NCT00426270|4164477|P1|Overall Study|Adverse Event|5
1273640|NCT00426270|4164477|P1|Overall Study|Incorrectly Enrolled in the Study|1
1273641|NCT00426231|4164487|P2|Overall Study|Withdrawal by Subject|12
1273642|NCT00426231|4164488|P1|Overall Study|Withdrawal by Subject|9
1273643|NCT00426127|4164511|P1|Overall Study|Removed due to disease progression|1
1273644|NCT00426127|4164511|P1|Overall Study|Adverse Event|1
1273645|NCT00425945|4164519|P2|Overall Study|Moved from area|1
1273646|NCT00425945|4164520|P1|Overall Study|Moved from area|0
1273647|NCT00425945|4164519|P2|Overall Study|Began cancer treatments|0
1273648|NCT00425945|4164520|P1|Overall Study|Began cancer treatments|1
1273649|NCT00425945|4164519|P2|Overall Study|Began hypertension medication|0
1273650|NCT00425945|4164520|P1|Overall Study|Began hypertension medication|1
1273651|NCT00425945|4164519|P2|Overall Study|Lost to Follow-up|2
1273652|NCT00425945|4164520|P1|Overall Study|Lost to Follow-up|0
1273653|NCT00425945|4164519|P2|Overall Study|Inconvenience|2
1273654|NCT00425945|4164520|P1|Overall Study|Inconvenience|0
1273655|NCT00425945|4164519|P2|Overall Study|Concern about Supplement|0
1273656|NCT00425945|4164520|P1|Overall Study|Concern about Supplement|2
1273657|NCT00425854|4164558|P2|Overall Study|Other Adverse Event|2
1273658|NCT00425854|4164559|P1|Overall Study|Other Adverse Event|2
1273659|NCT00425854|4164558|P2|Overall Study|Dose reduction toxicity AE|7
1273660|NCT00425854|4164559|P1|Overall Study|Dose reduction toxicity AE|8
1273661|NCT00425854|4164558|P2|Overall Study|Progressive Disease|12
1273662|NCT00425854|4164559|P1|Overall Study|Progressive Disease|19
1273663|NCT00425750|4164592|P1|Overall Study|Progression of disease|18
1273664|NCT00425750|4164592|P1|Overall Study|Adverse Event|3
1273665|NCT00425750|4164592|P1|Overall Study|Withdrawal by Subject|3
1273666|NCT00425750|4164592|P1|Overall Study|Death|1
1273667|NCT00425698|4164600|P2|Overall Study|Withdrawal by Subject|1
1273668|NCT00425698|4164601|P1|Overall Study|Withdrawal by Subject|0
1273669|NCT00425698|4164600|P2|Overall Study|Adverse Event|1
1273670|NCT00425698|4164601|P1|Overall Study|Adverse Event|3
1273671|NCT00425607|4164616|P1|Overall Study|Withdrawal by Subject|1
1273672|NCT00425607|4164616|P1|Overall Study|Death|1
1273673|NCT00425503|4164620|P1|Overall Study|Protocol Violation|1
1273674|NCT00425503|4164620|P1|Overall Study|Adverse Event|2
1273675|NCT00425438|4164632|P2|Overall Study|Termination by Sponsor|27
1273676|NCT00425438|4164633|P1|Overall Study|Termination by Sponsor|25
1273677|NCT00425373|4164667|P9|Overall Study|Lack of Efficacy|5
1273678|NCT00425373|4164668|P8|Overall Study|Lack of Efficacy|0
1273679|NCT00425373|4164669|P7|Overall Study|Lack of Efficacy|3
1273680|NCT00425373|4164670|P6|Overall Study|Lack of Efficacy|3
1273681|NCT00425373|4164671|P5|Overall Study|Lack of Efficacy|1
1273682|NCT00425373|4164672|P4|Overall Study|Lack of Efficacy|0
1273683|NCT00425373|4164673|P3|Overall Study|Lack of Efficacy|0
1273684|NCT00425373|4164674|P2|Overall Study|Lack of Efficacy|0
1273685|NCT00425373|4164675|P1|Overall Study|Lack of Efficacy|0
1273686|NCT00425373|4164667|P9|Overall Study|Withdrawal by Subject|2
1273687|NCT00425373|4164668|P8|Overall Study|Withdrawal by Subject|2
1273688|NCT00425373|4164669|P7|Overall Study|Withdrawal by Subject|2
1273689|NCT00425373|4164670|P6|Overall Study|Withdrawal by Subject|0
1273690|NCT00425373|4164671|P5|Overall Study|Withdrawal by Subject|4
1273691|NCT00425373|4164672|P4|Overall Study|Withdrawal by Subject|1
1273692|NCT00425373|4164673|P3|Overall Study|Withdrawal by Subject|2
1273693|NCT00425373|4164674|P2|Overall Study|Withdrawal by Subject|0
1273694|NCT00425373|4164675|P1|Overall Study|Withdrawal by Subject|2
1273695|NCT00425373|4164667|P9|Overall Study|Protocol Violation|3
1273696|NCT00425373|4164668|P8|Overall Study|Protocol Violation|5
1273697|NCT00425373|4164669|P7|Overall Study|Protocol Violation|0
1273698|NCT00425373|4164670|P6|Overall Study|Protocol Violation|0
1273699|NCT00425373|4164671|P5|Overall Study|Protocol Violation|0
1273700|NCT00425373|4164672|P4|Overall Study|Protocol Violation|0
1273701|NCT00425373|4164673|P3|Overall Study|Protocol Violation|1
1273702|NCT00425373|4164674|P2|Overall Study|Protocol Violation|0
1273703|NCT00425373|4164675|P1|Overall Study|Protocol Violation|1
1273704|NCT00425373|4164667|P9|Overall Study|Lost to Follow-up|0
1273705|NCT00425373|4164668|P8|Overall Study|Lost to Follow-up|0
1273706|NCT00425373|4164669|P7|Overall Study|Lost to Follow-up|0
1273707|NCT00425373|4164670|P6|Overall Study|Lost to Follow-up|0
1273708|NCT00425373|4164671|P5|Overall Study|Lost to Follow-up|1
1273709|NCT00425373|4164672|P4|Overall Study|Lost to Follow-up|0
1273710|NCT00425373|4164673|P3|Overall Study|Lost to Follow-up|0
1273711|NCT00425373|4164674|P2|Overall Study|Lost to Follow-up|1
1273712|NCT00425373|4164675|P1|Overall Study|Lost to Follow-up|0
1273713|NCT00425373|4164667|P9|Overall Study|Adverse Event|8
1273714|NCT00425373|4164668|P8|Overall Study|Adverse Event|3
1273715|NCT00425373|4164669|P7|Overall Study|Adverse Event|2
1273716|NCT00425373|4164670|P6|Overall Study|Adverse Event|6
1273717|NCT00425373|4164671|P5|Overall Study|Adverse Event|4
1273718|NCT00425373|4164672|P4|Overall Study|Adverse Event|1
1273719|NCT00425373|4164673|P3|Overall Study|Adverse Event|0
1273720|NCT00425373|4164674|P2|Overall Study|Adverse Event|2
1273721|NCT00425373|4164675|P1|Overall Study|Adverse Event|2
1273722|NCT00425308|4164733|P2|Overall Study|Death|0
1273723|NCT00425308|4164734|P1|Overall Study|Death|1
1273724|NCT00425308|4164733|P2|Overall Study|Withdrawal by Subject|0
1273725|NCT00425308|4164734|P1|Overall Study|Withdrawal by Subject|1
1273726|NCT00425308|4164733|P2|Overall Study|Adverse Event|1
1273727|NCT00425308|4164734|P1|Overall Study|Adverse Event|2
1273728|NCT00425269|4164764|P2|Overall Study|moved or medical reason|4
1273729|NCT00425269|4164765|P1|Overall Study|moved or medical reason|5
1273730|NCT00425269|4164764|P2|Overall Study|Lost to Follow-up|9
1273731|NCT00425269|4164765|P1|Overall Study|Lost to Follow-up|9
1273732|NCT00425269|4164764|P2|Overall Study|Pregnancy|7
1273733|NCT00425269|4164765|P1|Overall Study|Pregnancy|5
1273734|NCT00425113|4164843|P2|Overall Study|Withdrawal by Subject|0
1273735|NCT00425113|4164844|P1|Overall Study|Withdrawal by Subject|1
1273736|NCT00425113|4164843|P2|Overall Study|missing study drug more than 14 days|1
1273737|NCT00425113|4164844|P1|Overall Study|missing study drug more than 14 days|0
1273738|NCT00425113|4164843|P2|Overall Study|diagnosis of abdominal TB|1
1273739|NCT00425113|4164844|P1|Overall Study|diagnosis of abdominal TB|0
1273740|NCT00425113|4164843|P2|Overall Study|uncontrolled diabetes mellitus|0
1273741|NCT00425113|4164844|P1|Overall Study|uncontrolled diabetes mellitus|1
1273742|NCT00425100|4164852|P1|Overall Study|Withdrawal by Subject|7
1273743|NCT00425100|4164852|P1|Overall Study|Protocol Violation|4
1273744|NCT00425100|4164852|P1|Overall Study|Lost to Follow-up|2
1273745|NCT00425100|4164852|P1|Overall Study|Lack of Efficacy|4
1273746|NCT00425100|4164852|P1|Overall Study|Adverse Event|36
1273747|NCT00425061|4164896|P7|Overall Study|Other|1
1273748|NCT00425061|4164897|P6|Overall Study|Other|0
1273749|NCT00425061|4164898|P5|Overall Study|Other|3
1273750|NCT00425061|4164899|P4|Overall Study|Other|0
1273751|NCT00425061|4164900|P3|Overall Study|Other|0
1273752|NCT00425061|4164901|P2|Overall Study|Other|0
1273753|NCT00425061|4164902|P1|Overall Study|Other|0
1273754|NCT00425061|4164896|P7|Overall Study|Physician Decision|0
1273755|NCT00425061|4164897|P6|Overall Study|Physician Decision|0
1273756|NCT00425061|4164898|P5|Overall Study|Physician Decision|1
1273757|NCT00425061|4164899|P4|Overall Study|Physician Decision|0
1273758|NCT00425061|4164900|P3|Overall Study|Physician Decision|0
1273759|NCT00425061|4164901|P2|Overall Study|Physician Decision|0
1273760|NCT00425061|4164902|P1|Overall Study|Physician Decision|0
1273761|NCT00425061|4164896|P7|Overall Study|Sponsor's request|15
1273762|NCT00425061|4164897|P6|Overall Study|Sponsor's request|4
1273763|NCT00425061|4164898|P5|Overall Study|Sponsor's request|19
1273764|NCT00425061|4164899|P4|Overall Study|Sponsor's request|0
1273765|NCT00425061|4164900|P3|Overall Study|Sponsor's request|0
1273766|NCT00425061|4164901|P2|Overall Study|Sponsor's request|0
1273767|NCT00425061|4164902|P1|Overall Study|Sponsor's request|0
1273768|NCT00425061|4164896|P7|Overall Study|Withdrawal by Subject|3
1273769|NCT00425061|4164897|P6|Overall Study|Withdrawal by Subject|0
1273770|NCT00425061|4164898|P5|Overall Study|Withdrawal by Subject|1
1273771|NCT00425061|4164899|P4|Overall Study|Withdrawal by Subject|0
1273772|NCT00425061|4164900|P3|Overall Study|Withdrawal by Subject|0
1273773|NCT00425061|4164901|P2|Overall Study|Withdrawal by Subject|1
1273774|NCT00425061|4164902|P1|Overall Study|Withdrawal by Subject|0
1273775|NCT00425061|4164896|P7|Overall Study|Protocol Violation|0
1273776|NCT00425061|4164897|P6|Overall Study|Protocol Violation|0
1273777|NCT00425061|4164898|P5|Overall Study|Protocol Violation|0
1273778|NCT00425061|4164899|P4|Overall Study|Protocol Violation|0
1273779|NCT00425061|4164900|P3|Overall Study|Protocol Violation|0
1273780|NCT00425061|4164901|P2|Overall Study|Protocol Violation|0
1273781|NCT00425061|4164902|P1|Overall Study|Protocol Violation|1
1273782|NCT00425061|4164896|P7|Overall Study|Lost to Follow-up|0
1273783|NCT00425061|4164897|P6|Overall Study|Lost to Follow-up|0
1273784|NCT00425061|4164898|P5|Overall Study|Lost to Follow-up|0
1273785|NCT00425061|4164899|P4|Overall Study|Lost to Follow-up|0
1273786|NCT00425061|4164900|P3|Overall Study|Lost to Follow-up|0
1273787|NCT00425061|4164901|P2|Overall Study|Lost to Follow-up|1
1273788|NCT00425061|4164902|P1|Overall Study|Lost to Follow-up|0
1273789|NCT00425061|4164896|P7|Overall Study|Adverse Event|0
1273790|NCT00425061|4164897|P6|Overall Study|Adverse Event|0
1273791|NCT00425061|4164898|P5|Overall Study|Adverse Event|2
1273792|NCT00425061|4164899|P4|Overall Study|Adverse Event|2
1273793|NCT00425061|4164900|P3|Overall Study|Adverse Event|0
1273794|NCT00425061|4164901|P2|Overall Study|Adverse Event|0
1273795|NCT00425061|4164902|P1|Overall Study|Adverse Event|1
1273796|NCT00424827|4165018|P1|Overall Study|Adverse Event|1
1273797|NCT00424775|4165026|P2|Overall Study|Lack of Efficacy|0
1273798|NCT00424775|4165027|P1|Overall Study|Lack of Efficacy|1
1273799|NCT00424775|4165026|P2|Overall Study|Adverse Event|0
1273800|NCT00424775|4165027|P1|Overall Study|Adverse Event|2
1273801|NCT00424762|4165037|P2|Overall Study|Lost to Follow-up|3
1273802|NCT00424762|4165038|P1|Overall Study|Lost to Follow-up|2
1273803|NCT00424762|4165037|P2|Overall Study|Withdrawal by Subject|19
1273804|NCT00424762|4165038|P1|Overall Study|Withdrawal by Subject|18
1273805|NCT00424749|4165048|P1|Overall Study|Withdrawal by Subject|1
1273806|NCT00424645|4165055|P2|Overall Study|Death|0
1273807|NCT00424645|4165056|P1|Overall Study|Death|1
1273808|NCT00424632|4165064|P10|Overall Study|Other|0
1273809|NCT00424632|4165065|P9|Overall Study|Other|1
1273810|NCT00424632|4165066|P8|Overall Study|Other|0
1273811|NCT00424632|4165067|P7|Overall Study|Other|0
1273812|NCT00424632|4165068|P6|Overall Study|Other|0
1273813|NCT00424632|4165069|P5|Overall Study|Other|0
1273814|NCT00424632|4165070|P4|Overall Study|Other|1
1273815|NCT00424632|4165071|P3|Overall Study|Other|0
1273816|NCT00424632|4165072|P2|Overall Study|Other|0
1273817|NCT00424632|4165073|P1|Overall Study|Other|0
1273818|NCT00424632|4165064|P10|Overall Study|Objective progression or relapse|4
1273819|NCT00424632|4165065|P9|Overall Study|Objective progression or relapse|12
1273820|NCT00424632|4165066|P8|Overall Study|Objective progression or relapse|3
1273821|NCT00424632|4165067|P7|Overall Study|Objective progression or relapse|7
1273822|NCT00424632|4165068|P6|Overall Study|Objective progression or relapse|13
1273823|NCT00424632|4165069|P5|Overall Study|Objective progression or relapse|2
1273824|NCT00424632|4165070|P4|Overall Study|Objective progression or relapse|2
1273825|NCT00424632|4165071|P3|Overall Study|Objective progression or relapse|1
1273826|NCT00424632|4165072|P2|Overall Study|Objective progression or relapse|1
1273827|NCT00424632|4165073|P1|Overall Study|Objective progression or relapse|1
1273828|NCT00424632|4165064|P10|Overall Study|Global deterioration of health status|0
1273829|NCT00424632|4165065|P9|Overall Study|Global deterioration of health status|0
1273830|NCT00424632|4165066|P8|Overall Study|Global deterioration of health status|0
1273831|NCT00424632|4165067|P7|Overall Study|Global deterioration of health status|0
1273832|NCT00424632|4165068|P6|Overall Study|Global deterioration of health status|0
1273833|NCT00424632|4165069|P5|Overall Study|Global deterioration of health status|1
1273834|NCT00424632|4165070|P4|Overall Study|Global deterioration of health status|1
1273835|NCT00424632|4165071|P3|Overall Study|Global deterioration of health status|0
1273836|NCT00424632|4165072|P2|Overall Study|Global deterioration of health status|0
1273837|NCT00424632|4165073|P1|Overall Study|Global deterioration of health status|0
1273838|NCT00424632|4165064|P10|Overall Study|Adverse Event|2
1273839|NCT00424632|4165065|P9|Overall Study|Adverse Event|3
1273840|NCT00424632|4165066|P8|Overall Study|Adverse Event|0
1273841|NCT00424632|4165067|P7|Overall Study|Adverse Event|0
1273842|NCT00424632|4165068|P6|Overall Study|Adverse Event|0
1273843|NCT00424632|4165069|P5|Overall Study|Adverse Event|0
1273844|NCT00424632|4165070|P4|Overall Study|Adverse Event|0
1273845|NCT00424632|4165071|P3|Overall Study|Adverse Event|0
1273846|NCT00424632|4165072|P2|Overall Study|Adverse Event|0
1273847|NCT00424632|4165073|P1|Overall Study|Adverse Event|0
1273848|NCT00424632|4165064|P10|Overall Study|Death|0
1273849|NCT00424632|4165065|P9|Overall Study|Death|0
1273850|NCT00424632|4165066|P8|Overall Study|Death|0
1273851|NCT00424632|4165067|P7|Overall Study|Death|0
1273852|NCT00424632|4165068|P6|Overall Study|Death|2
1273853|NCT00424632|4165069|P5|Overall Study|Death|0
1273854|NCT00424632|4165070|P4|Overall Study|Death|0
1273855|NCT00424632|4165071|P3|Overall Study|Death|0
1273856|NCT00424632|4165072|P2|Overall Study|Death|0
1273857|NCT00424632|4165073|P1|Overall Study|Death|0
1273858|NCT00424593|4165243|P2|Dose-Blind Extension Period|Physician Decision|0
1273859|NCT00424593|4165244|P1|Dose-Blind Extension Period|Physician Decision|3
1273860|NCT00424593|4165243|P2|Dose-Blind Extension Period|Lost to Follow-up|0
1273861|NCT00424593|4165244|P1|Dose-Blind Extension Period|Lost to Follow-up|6
1273862|NCT00424593|4165243|P2|Dose-Blind Extension Period|Protocol Violation|0
1273863|NCT00424593|4165244|P1|Dose-Blind Extension Period|Protocol Violation|9
1273864|NCT00424593|4165243|P2|Dose-Blind Extension Period|Lack of Efficacy|0
1273865|NCT00424593|4165244|P1|Dose-Blind Extension Period|Lack of Efficacy|9
1273866|NCT00424593|4165243|P2|Dose-Blind Extension Period|Adverse Event|0
1273867|NCT00424593|4165244|P1|Dose-Blind Extension Period|Adverse Event|18
1273868|NCT00424593|4165243|P2|Dose-Blind Extension Period|Withdrawal by Subject|0
1273869|NCT00424593|4165244|P1|Dose-Blind Extension Period|Withdrawal by Subject|19
1273870|NCT00424593|4165243|P2|Acute Double-Blind Period|Lack of Efficacy|1
1273871|NCT00424593|4165244|P1|Acute Double-Blind Period|Lack of Efficacy|0
1273872|NCT00424593|4165243|P2|Acute Double-Blind Period|Lost to Follow-up|1
1273873|NCT00424593|4165244|P1|Acute Double-Blind Period|Lost to Follow-up|1
1273874|NCT00424593|4165243|P2|Acute Double-Blind Period|Physician Decision|2
1273875|NCT00424593|4165244|P1|Acute Double-Blind Period|Physician Decision|1
1273876|NCT00424593|4165243|P2|Acute Double-Blind Period|Protocol Violation|2
1273877|NCT00424593|4165244|P1|Acute Double-Blind Period|Protocol Violation|2
1273878|NCT00424593|4165243|P2|Acute Double-Blind Period|Withdrawal by Subject|10
1273879|NCT00424593|4165244|P1|Acute Double-Blind Period|Withdrawal by Subject|11
1273880|NCT00424593|4165243|P2|Acute Double-Blind Period|Adverse Event|7
1273881|NCT00424593|4165244|P1|Acute Double-Blind Period|Adverse Event|16
1273882|NCT00424528|4165308|P3|Overall Study|noncompliance with study requirements|2
1273883|NCT00424528|4165309|P2|Overall Study|noncompliance with study requirements|1
1273884|NCT00424528|4165310|P1|Overall Study|noncompliance with study requirements|2
1273885|NCT00424528|4165308|P3|Overall Study|Lost to Follow-up|0
1273886|NCT00424528|4165309|P2|Overall Study|Lost to Follow-up|1
1273887|NCT00424528|4165310|P1|Overall Study|Lost to Follow-up|0
1273888|NCT00424528|4165308|P3|Overall Study|Protocol Violation|0
1273889|NCT00424528|4165309|P2|Overall Study|Protocol Violation|1
1273890|NCT00424528|4165310|P1|Overall Study|Protocol Violation|1
1273891|NCT00424528|4165308|P3|Overall Study|Adverse Event|2
1273892|NCT00424528|4165309|P2|Overall Study|Adverse Event|1
1273893|NCT00424528|4165310|P1|Overall Study|Adverse Event|2
1273894|NCT00424515|4165365|P2|Overall Study|Withdrawal by Subject|0
1273895|NCT00424515|4165366|P1|Overall Study|Withdrawal by Subject|1
1273896|NCT00424515|4165365|P2|Overall Study|Intercurrent Illness|1
1273897|NCT00424515|4165366|P1|Overall Study|Intercurrent Illness|0
1273898|NCT00424515|4165365|P2|Overall Study|Adverse Event|1
1273899|NCT00424515|4165366|P1|Overall Study|Adverse Event|0
1273900|NCT00424515|4165365|P2|Overall Study|Progressive Disease|11
1273901|NCT00424515|4165366|P1|Overall Study|Progressive Disease|10
1273902|NCT00424489|4165385|P1|Overall Study|Death|3
1273903|NCT00424476|4165392|P3|Overall Study|Other|9
1273904|NCT00424476|4165393|P2|Overall Study|Other|3
1273905|NCT00424476|4165394|P1|Overall Study|Other|4
1273906|NCT00424476|4165392|P3|Overall Study|Physician Decision|3
1273907|NCT00424476|4165393|P2|Overall Study|Physician Decision|2
1273908|NCT00424476|4165394|P1|Overall Study|Physician Decision|3
1273909|NCT00424476|4165392|P3|Overall Study|Protocol Violation|3
1273910|NCT00424476|4165393|P2|Overall Study|Protocol Violation|2
1273911|NCT00424476|4165394|P1|Overall Study|Protocol Violation|7
1273912|NCT00424476|4165392|P3|Overall Study|Lost to Follow-up|3
1273913|NCT00424476|4165393|P2|Overall Study|Lost to Follow-up|6
1273914|NCT00424476|4165394|P1|Overall Study|Lost to Follow-up|4
1273915|NCT00424476|4165392|P3|Overall Study|Lack of Compliance|1
1273916|NCT00424476|4165393|P2|Overall Study|Lack of Compliance|1
1273917|NCT00424476|4165394|P1|Overall Study|Lack of Compliance|1
1273918|NCT00424476|4165392|P3|Overall Study|Lack of Efficacy|12
1273919|NCT00424476|4165393|P2|Overall Study|Lack of Efficacy|12
1273920|NCT00424476|4165394|P1|Overall Study|Lack of Efficacy|16
1273921|NCT00424476|4165392|P3|Overall Study|Adverse Event|15
1273922|NCT00424476|4165393|P2|Overall Study|Adverse Event|16
1273923|NCT00424476|4165394|P1|Overall Study|Adverse Event|19
1273924|NCT00424476|4165392|P3|Overall Study|Withdrawal by Subject|3
1273925|NCT00424476|4165393|P2|Overall Study|Withdrawal by Subject|6
1273926|NCT00424476|4165394|P1|Overall Study|Withdrawal by Subject|7
1273927|NCT00424463|4165420|P3|Overall Study|Patient’s convenience|1
1273928|NCT00424463|4165421|P2|Overall Study|Patient’s convenience|0
1273929|NCT00424463|4165422|P1|Overall Study|Patient’s convenience|0
1273930|NCT00424463|4165420|P3|Overall Study|Tracheotomy due to worsening of ALS|6
1273931|NCT00424463|4165421|P2|Overall Study|Tracheotomy due to worsening of ALS|7
1273932|NCT00424463|4165422|P1|Overall Study|Tracheotomy due to worsening of ALS|1
1273933|NCT00424463|4165420|P3|Overall Study|Withdrawal by Subject|5
1273934|NCT00424463|4165421|P2|Overall Study|Withdrawal by Subject|2
1273935|NCT00424463|4165422|P1|Overall Study|Withdrawal by Subject|4
1273936|NCT00424463|4165420|P3|Overall Study|Physician Decision|2
1273937|NCT00424463|4165421|P2|Overall Study|Physician Decision|2
1273938|NCT00424463|4165422|P1|Overall Study|Physician Decision|0
1273939|NCT00424463|4165420|P3|Overall Study|Adverse Event|2
1273940|NCT00424463|4165421|P2|Overall Study|Adverse Event|3
1273941|NCT00424463|4165422|P1|Overall Study|Adverse Event|2
1273942|NCT00424398|4165451|P3|Overall Study|Subject met exclusion criteria|0
1273943|NCT00424398|4165452|P2|Overall Study|Subject met exclusion criteria|0
1273944|NCT00424398|4165453|P1|Overall Study|Subject met exclusion criteria|1
1273945|NCT00424398|4165451|P3|Overall Study|Withdrawal by Subject|0
1273946|NCT00424398|4165452|P2|Overall Study|Withdrawal by Subject|1
1273947|NCT00424398|4165453|P1|Overall Study|Withdrawal by Subject|2
1273948|NCT00424385|4165497|P1|Cohort 1|Withdrawal by Subject|1
1273949|NCT00424385|4165497|P1|Cohort 0|Physician Decision|1
1273950|NCT00424385|4165497|P1|Cohort 0|Withdrawal by Subject|5
1273951|NCT00424372|4165504|P1|Overall Study|Lack of Efficacy|6
1273952|NCT00424372|4165504|P1|Overall Study|Protocol Violation|1
1273953|NCT00424372|4165504|P1|Overall Study|Withdrawal by Subject|4
1273954|NCT00424372|4165504|P1|Overall Study|Health deterioration|1
1273955|NCT00424372|4165504|P1|Overall Study|Adverse Event|18
1273956|NCT00424372|4165504|P1|Overall Study|Death|1
1273957|NCT00424346|4165516|P4|Extension Phase|Protocol Violation|0
1273958|NCT00424346|4165517|P3|Extension Phase|Protocol Violation|1
1273959|NCT00424346|4165518|P2|Extension Phase|Protocol Violation|1
1273960|NCT00424346|4165519|P1|Extension Phase|Protocol Violation|0
1273961|NCT00424346|4165516|P4|Extension Phase|Death|1
1273962|NCT00424346|4165517|P3|Extension Phase|Death|0
1273963|NCT00424346|4165518|P2|Extension Phase|Death|0
1273964|NCT00424346|4165519|P1|Extension Phase|Death|0
1273965|NCT00424346|4165516|P4|Extension Phase|Administrative Problems|35
1273966|NCT00424346|4165517|P3|Extension Phase|Administrative Problems|32
1273967|NCT00424346|4165518|P2|Extension Phase|Administrative Problems|69
1273968|NCT00424346|4165519|P1|Extension Phase|Administrative Problems|0
1273969|NCT00424346|4165516|P4|Extension Phase|Lost to Follow-up|0
1273970|NCT00424346|4165517|P3|Extension Phase|Lost to Follow-up|0
1273971|NCT00424346|4165518|P2|Extension Phase|Lost to Follow-up|2
1273972|NCT00424346|4165519|P1|Extension Phase|Lost to Follow-up|0
1273973|NCT00424346|4165516|P4|Extension Phase|Withdrawal by Subject|4
1273974|NCT00424346|4165517|P3|Extension Phase|Withdrawal by Subject|3
1273975|NCT00424346|4165518|P2|Extension Phase|Withdrawal by Subject|5
1273976|NCT00424346|4165519|P1|Extension Phase|Withdrawal by Subject|0
1273977|NCT00424346|4165516|P4|Extension Phase|Lack of Efficacy|11
1273978|NCT00424346|4165517|P3|Extension Phase|Lack of Efficacy|14
1273979|NCT00424346|4165518|P2|Extension Phase|Lack of Efficacy|16
1273980|NCT00424346|4165519|P1|Extension Phase|Lack of Efficacy|0
1273981|NCT00424346|4165516|P4|Extension Phase|Adverse Event|4
1273982|NCT00424346|4165517|P3|Extension Phase|Adverse Event|5
1273983|NCT00424346|4165518|P2|Extension Phase|Adverse Event|9
1273984|NCT00424346|4165519|P1|Extension Phase|Adverse Event|0
1273985|NCT00424346|4165516|P4|Core Study|Protocol Violation|0
1273986|NCT00424346|4165517|P3|Core Study|Protocol Violation|2
1273987|NCT00424346|4165518|P2|Core Study|Protocol Violation|0
1273988|NCT00424346|4165519|P1|Core Study|Protocol Violation|0
1273989|NCT00424346|4165516|P4|Core Study|Administrative Problems|0
1273990|NCT00424346|4165517|P3|Core Study|Administrative Problems|1
1273991|NCT00424346|4165518|P2|Core Study|Administrative Problems|0
1273992|NCT00424346|4165519|P1|Core Study|Administrative Problems|1
1273993|NCT00424346|4165516|P4|Core Study|Lost to Follow-up|0
1273994|NCT00424346|4165517|P3|Core Study|Lost to Follow-up|0
1273995|NCT00424346|4165518|P2|Core Study|Lost to Follow-up|1
1273996|NCT00424346|4165519|P1|Core Study|Lost to Follow-up|1
1273997|NCT00424346|4165516|P4|Core Study|Withdrawal by Subject|2
1273998|NCT00424346|4165517|P3|Core Study|Withdrawal by Subject|0
1273999|NCT00424346|4165518|P2|Core Study|Withdrawal by Subject|0
1274000|NCT00424346|4165519|P1|Core Study|Withdrawal by Subject|1
1274001|NCT00424346|4165516|P4|Core Study|Lack of Efficacy|4
1274002|NCT00424346|4165517|P3|Core Study|Lack of Efficacy|0
1274003|NCT00424346|4165518|P2|Core Study|Lack of Efficacy|3
1274004|NCT00424346|4165519|P1|Core Study|Lack of Efficacy|1
1274005|NCT00424346|4165516|P4|Core Study|Abnormal Laboratory Values|0
1274006|NCT00424346|4165517|P3|Core Study|Abnormal Laboratory Values|0
1274007|NCT00424346|4165518|P2|Core Study|Abnormal Laboratory Values|1
1274008|NCT00424346|4165519|P1|Core Study|Abnormal Laboratory Values|0
1274009|NCT00424346|4165516|P4|Core Study|Adverse Event|1
1274010|NCT00424346|4165517|P3|Core Study|Adverse Event|1
1274011|NCT00424346|4165518|P2|Core Study|Adverse Event|3
1274012|NCT00424346|4165519|P1|Core Study|Adverse Event|5
1274013|NCT00424294|4165634|P2|Overall Study|Randomized but not Treated|0
1274014|NCT00424294|4165635|P1|Overall Study|Randomized but not Treated|1
1274015|NCT00424294|4165634|P2|Overall Study|Other|2
1274016|NCT00424294|4165635|P1|Overall Study|Other|0
1274017|NCT00424294|4165634|P2|Overall Study|Withdrawal by Subject|2
1274018|NCT00424294|4165635|P1|Overall Study|Withdrawal by Subject|1
1274019|NCT00424294|4165634|P2|Overall Study|Lack of Efficacy|1
1274020|NCT00424294|4165635|P1|Overall Study|Lack of Efficacy|2
1274021|NCT00424294|4165634|P2|Overall Study|Adverse Event|10
1274022|NCT00424294|4165635|P1|Overall Study|Adverse Event|4
1274023|NCT00424255|4165702|P2|Overall Study|Sponsor Terminated Study|167
1274024|NCT00424255|4165703|P1|Overall Study|Sponsor Terminated Study|161
1274025|NCT00424255|4165702|P2|Overall Study|Disease Progression|2
1274026|NCT00424255|4165703|P1|Overall Study|Disease Progression|0
1274027|NCT00424255|4165702|P2|Overall Study|Fatigue|0
1274028|NCT00424255|4165703|P1|Overall Study|Fatigue|1
1274029|NCT00424255|4165702|P2|Overall Study|Non-compliance by Participants|0
1274030|NCT00424255|4165703|P1|Overall Study|Non-compliance by Participants|1
1274031|NCT00424255|4165702|P2|Overall Study|Cognitive Disturbance|0
1274032|NCT00424255|4165703|P1|Overall Study|Cognitive Disturbance|1
1274033|NCT00424255|4165702|P2|Overall Study|Physician Decision|7
1274034|NCT00424255|4165703|P1|Overall Study|Physician Decision|3
1274035|NCT00424255|4165702|P2|Overall Study|Withdrawal by Subject|38
1274036|NCT00424255|4165703|P1|Overall Study|Withdrawal by Subject|34
1274037|NCT00424255|4165702|P2|Overall Study|Protocol Violation|1
1274038|NCT00424255|4165703|P1|Overall Study|Protocol Violation|0
1274039|NCT00424255|4165702|P2|Overall Study|Lost to Follow-up|20
1274040|NCT00424255|4165703|P1|Overall Study|Lost to Follow-up|26
1274041|NCT00424255|4165702|P2|Overall Study|Death|111
1274042|NCT00424255|4165703|P1|Overall Study|Death|115
1274043|NCT00424190|4165751|P2|Overall Study|Other|21
1274044|NCT00424190|4165752|P1|Overall Study|Other|15
1274045|NCT00424190|4165751|P2|Overall Study|Diagnosis of osteomyelitis|1
1274046|NCT00424190|4165752|P1|Overall Study|Diagnosis of osteomyelitis|0
1274047|NCT00424190|4165751|P2|Overall Study|Request of sponsor or investigator|2
1274048|NCT00424190|4165752|P1|Overall Study|Request of sponsor or investigator|0
1274049|NCT00424190|4165751|P2|Overall Study|Noncompliance|2
1274050|NCT00424190|4165752|P1|Overall Study|Noncompliance|1
1274051|NCT00424190|4165751|P2|Overall Study|Death|0
1274052|NCT00424190|4165752|P1|Overall Study|Death|3
1274053|NCT00424190|4165751|P2|Overall Study|Withdrew consent|4
1274054|NCT00424190|4165752|P1|Overall Study|Withdrew consent|3
1274055|NCT00424177|4165758|P1|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1
1274056|NCT00424177|4165758|P1|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
1274057|NCT00424177|4165758|P1|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1
1274058|NCT00424177|4165758|P1|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
1274059|NCT00424177|4165758|P1|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1
1274060|NCT00424177|4165758|P1|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2
1274061|NCT00424177|4165758|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1
1274062|NCT00424177|4165758|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1
1274063|NCT00424177|4165758|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1
1274064|NCT00424177|4165758|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8
1274065|NCT00424047|4165787|P2|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0
1274066|NCT00424047|4165788|P1|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1
1274067|NCT00424047|4165787|P2|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3
1274068|NCT00424047|4165788|P1|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7
1274069|NCT00424047|4165787|P2|Long Term Extension (Up to 25 Jun 2013)|Other|4
1274070|NCT00424047|4165788|P1|Long Term Extension (Up to 25 Jun 2013)|Other|12
1274071|NCT00424047|4165787|P2|Long Term Extension (Up to 25 Jun 2013)|Death|1
1274072|NCT00424047|4165788|P1|Long Term Extension (Up to 25 Jun 2013)|Death|0
1274073|NCT00424047|4165787|P2|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0
1274074|NCT00424047|4165788|P1|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1
1274075|NCT00424047|4165787|P2|On Study at Time of Unblinding|Other|4
1274076|NCT00424047|4165788|P1|On Study at Time of Unblinding|Other|5
1274077|NCT00424047|4165787|P2|On Study at Time of Unblinding|Death|11
1274078|NCT00424047|4165788|P1|On Study at Time of Unblinding|Death|11
1274079|NCT00424047|4165787|P2|On Study at Time of Unblinding|Withdrawal by Subject|9
1274080|NCT00424047|4165788|P1|On Study at Time of Unblinding|Withdrawal by Subject|24
1274081|NCT00424047|4165787|P2|On Study at Time of Unblinding|Lack of Efficacy|3
1274082|NCT00424047|4165788|P1|On Study at Time of Unblinding|Lack of Efficacy|1
1274083|NCT00424047|4165787|P2|On Study at Time of Unblinding|Progression of disease|128
1274084|NCT00424047|4165788|P1|On Study at Time of Unblinding|Progression of disease|92
1274085|NCT00424047|4165787|P2|On Study at Time of Unblinding|Adverse Event|12
1274086|NCT00424047|4165788|P1|On Study at Time of Unblinding|Adverse Event|22
1274087|NCT00424047|4165787|P2|Blinded Treatment (Up to 03 Aug 2005)|Other|1
1274088|NCT00424047|4165788|P1|Blinded Treatment (Up to 03 Aug 2005)|Other|2
1274089|NCT00424047|4165787|P2|Blinded Treatment (Up to 03 Aug 2005)|Death|10
1274090|NCT00424047|4165788|P1|Blinded Treatment (Up to 03 Aug 2005)|Death|11
1274091|NCT00424047|4165787|P2|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8
1274092|NCT00424047|4165788|P1|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23
1274093|NCT00424047|4165787|P2|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3
1274094|NCT00424047|4165788|P1|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1
1274095|NCT00424047|4165787|P2|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122
1274096|NCT00424047|4165788|P1|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67
1274097|NCT00424047|4165787|P2|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12
1274098|NCT00424047|4165788|P1|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18
1274099|NCT00424021|4165820|P4|AMB-220-E Study Period|Physician Decision|1
1274100|NCT00424021|4165821|P3|AMB-220-E Study Period|Physician Decision|0
1274101|NCT00424021|4165822|P2|AMB-220-E Study Period|Physician Decision|0
1274102|NCT00424021|4165823|P1|AMB-220-E Study Period|Physician Decision|0
1274103|NCT00424021|4165820|P4|AMB-220-E Study Period|Lost to Follow-up|1
1274104|NCT00424021|4165821|P3|AMB-220-E Study Period|Lost to Follow-up|1
1274105|NCT00424021|4165822|P2|AMB-220-E Study Period|Lost to Follow-up|1
1274106|NCT00424021|4165823|P1|AMB-220-E Study Period|Lost to Follow-up|0
1274107|NCT00424021|4165820|P4|AMB-220-E Study Period|Death|1
1274108|NCT00424021|4165821|P3|AMB-220-E Study Period|Death|1
1274109|NCT00424021|4165822|P2|AMB-220-E Study Period|Death|0
1274110|NCT00424021|4165823|P1|AMB-220-E Study Period|Death|0
1274111|NCT00424021|4165820|P4|AMB-220-E Study Period|Adverse Event|7
1274112|NCT00424021|4165821|P3|AMB-220-E Study Period|Adverse Event|3
1274113|NCT00424021|4165822|P2|AMB-220-E Study Period|Adverse Event|1
1274114|NCT00424021|4165823|P1|AMB-220-E Study Period|Adverse Event|1
1274115|NCT00424021|4165820|P4|NCT00046319 Study Period|Lost to Follow-up|0
1274116|NCT00424021|4165821|P3|NCT00046319 Study Period|Lost to Follow-up|0
1274117|NCT00424021|4165822|P2|NCT00046319 Study Period|Lost to Follow-up|1
1274118|NCT00424021|4165823|P1|NCT00046319 Study Period|Lost to Follow-up|0
1274119|NCT00424021|4165820|P4|NCT00046319 Study Period|Sponsor discretion|0
1274120|NCT00424021|4165821|P3|NCT00046319 Study Period|Sponsor discretion|0
1274121|NCT00424021|4165822|P2|NCT00046319 Study Period|Sponsor discretion|1
1274122|NCT00424021|4165823|P1|NCT00046319 Study Period|Sponsor discretion|0
1274123|NCT00424021|4165820|P4|NCT00046319 Study Period|Withdrawal by Subject|0
1274124|NCT00424021|4165821|P3|NCT00046319 Study Period|Withdrawal by Subject|0
1274125|NCT00424021|4165822|P2|NCT00046319 Study Period|Withdrawal by Subject|1
1274126|NCT00424021|4165823|P1|NCT00046319 Study Period|Withdrawal by Subject|0
1274127|NCT00424021|4165820|P4|NCT00046319 Study Period|Adverse Event|1
1274128|NCT00424021|4165821|P3|NCT00046319 Study Period|Adverse Event|1
1274129|NCT00424021|4165822|P2|NCT00046319 Study Period|Adverse Event|0
1274130|NCT00424021|4165823|P1|NCT00046319 Study Period|Adverse Event|1
1274131|NCT00424008|4165866|P2|Overall Study|Administrative|257
1274132|NCT00424008|4165867|P1|Overall Study|Administrative|266
1274133|NCT00424008|4165866|P2|Overall Study|Did not meet protocol eligibility|21
1274134|NCT00424008|4165867|P1|Overall Study|Did not meet protocol eligibility|16
1274135|NCT00424008|4165866|P2|Overall Study|Noncompliance with protocol|7
1274136|NCT00424008|4165867|P1|Overall Study|Noncompliance with protocol|13
1274137|NCT00424008|4165866|P2|Overall Study|Withdrawal by Subject|8
1274138|NCT00424008|4165867|P1|Overall Study|Withdrawal by Subject|5
1274139|NCT00424008|4165866|P2|Overall Study|Lost to Follow-up|2
1274140|NCT00424008|4165867|P1|Overall Study|Lost to Follow-up|1
1274141|NCT00424008|4165866|P2|Overall Study|Lack of Efficacy|34
1274142|NCT00424008|4165867|P1|Overall Study|Lack of Efficacy|40
1274143|NCT00424008|4165866|P2|Overall Study|Adverse Event|6
1274144|NCT00424008|4165867|P1|Overall Study|Adverse Event|8
1274145|NCT00423943|4165882|P2|Overall Study|Withdrawal by Subject|1
1274146|NCT00423943|4165883|P1|Overall Study|Withdrawal by Subject|3
1274147|NCT00423930|4165897|P1|Overall Study|Withdrawal by Subject|2
1274148|NCT00423917|4165902|P1|Overall Study|Ineligible|1
1274149|NCT00423917|4165902|P1|Overall Study|Cancel|2
1274150|NCT00423891|4165915|P3|Post-Dosing Follow Up|Lost to Follow-up|0
1274151|NCT00423891|4165916|P2|Post-Dosing Follow Up|Lost to Follow-up|0
1274152|NCT00423891|4165917|P1|Post-Dosing Follow Up|Lost to Follow-up|2
1274153|NCT00423891|4165915|P3|Post-Dosing Follow Up|Withdrawal by Subject|2
1274154|NCT00423891|4165916|P2|Post-Dosing Follow Up|Withdrawal by Subject|3
1274155|NCT00423891|4165917|P1|Post-Dosing Follow Up|Withdrawal by Subject|0
1274156|NCT00423891|4165915|P3|Treatment|Lost to Follow-up|0
1274157|NCT00423891|4165916|P2|Treatment|Lost to Follow-up|0
1274158|NCT00423891|4165917|P1|Treatment|Lost to Follow-up|1
1274159|NCT00423891|4165915|P3|Treatment|Withdrawal by Subject|0
1274160|NCT00423891|4165916|P2|Treatment|Withdrawal by Subject|0
1274161|NCT00423891|4165917|P1|Treatment|Withdrawal by Subject|1
1274162|NCT00423891|4165915|P3|Enrolled|No longer met criteria|1
1274163|NCT00423891|4165916|P2|Enrolled|No longer met criteria|2
1274164|NCT00423891|4165917|P1|Enrolled|No longer met criteria|11
1274165|NCT00423891|4165915|P3|Enrolled|Lost to Follow-up|1
1274166|NCT00423891|4165916|P2|Enrolled|Lost to Follow-up|0
1274167|NCT00423891|4165917|P1|Enrolled|Lost to Follow-up|0
1274168|NCT00423891|4165915|P3|Enrolled|Withdrawal by Subject|1
1274169|NCT00423891|4165916|P2|Enrolled|Withdrawal by Subject|0
1274170|NCT00423891|4165917|P1|Enrolled|Withdrawal by Subject|0
1274171|NCT00423852|4165995|P1|Overall Study|Removed pior to the high-dose portion|3
1274172|NCT00423813|4166003|P3|Overall Study|Undergoing tests for Cushings Syndrome|1
1274173|NCT00423813|4166004|P2|Overall Study|Undergoing tests for Cushings Syndrome|0
1274174|NCT00423813|4166005|P1|Overall Study|Undergoing tests for Cushings Syndrome|0
1274175|NCT00423813|4166003|P3|Overall Study|Will start exclusionary medications|0
1274176|NCT00423813|4166004|P2|Overall Study|Will start exclusionary medications|1
1274177|NCT00423813|4166005|P1|Overall Study|Will start exclusionary medications|0
1274178|NCT00423813|4166003|P3|Overall Study|Subject started night shift work|0
1274179|NCT00423813|4166004|P2|Overall Study|Subject started night shift work|0
1274180|NCT00423813|4166005|P1|Overall Study|Subject started night shift work|1
1274181|NCT00423813|4166003|P3|Overall Study|Pregnancy|1
1274182|NCT00423813|4166004|P2|Overall Study|Pregnancy|0
1274183|NCT00423813|4166005|P1|Overall Study|Pregnancy|0
1274184|NCT00423813|4166003|P3|Overall Study|Protocol Violation|4
1274185|NCT00423813|4166004|P2|Overall Study|Protocol Violation|4
1274186|NCT00423813|4166005|P1|Overall Study|Protocol Violation|9
1274187|NCT00423813|4166003|P3|Overall Study|Sponsor Decision|0
1274188|NCT00423813|4166004|P2|Overall Study|Sponsor Decision|1
1274189|NCT00423813|4166005|P1|Overall Study|Sponsor Decision|0
1274190|NCT00423813|4166003|P3|Overall Study|Physician Decision|0
1274191|NCT00423813|4166004|P2|Overall Study|Physician Decision|0
1274192|NCT00423813|4166005|P1|Overall Study|Physician Decision|2
1274193|NCT00423813|4166003|P3|Overall Study|Lack of Efficacy|19
1274194|NCT00423813|4166004|P2|Overall Study|Lack of Efficacy|18
1274195|NCT00423813|4166005|P1|Overall Study|Lack of Efficacy|23
1274196|NCT00423813|4166003|P3|Overall Study|Lost to Follow-up|4
1274197|NCT00423813|4166004|P2|Overall Study|Lost to Follow-up|4
1274198|NCT00423813|4166005|P1|Overall Study|Lost to Follow-up|5
1274199|NCT00423813|4166003|P3|Overall Study|Withdrawal by Subject|5
1274200|NCT00423813|4166004|P2|Overall Study|Withdrawal by Subject|8
1274201|NCT00423813|4166005|P1|Overall Study|Withdrawal by Subject|6
1274202|NCT00423813|4166003|P3|Overall Study|Adverse Event|40
1274203|NCT00423813|4166004|P2|Overall Study|Adverse Event|30
1274204|NCT00423813|4166005|P1|Overall Study|Adverse Event|11
1274205|NCT00423800|4166015|P2|Overall Study|Protocol Violation|1
1274206|NCT00423800|4166016|P1|Overall Study|Protocol Violation|0
1274207|NCT00423735|4166028|P3|Overall Study|Ineligible / No protocol treatment|0
1274208|NCT00423735|4166029|P2|Overall Study|Ineligible / No protocol treatment|6
1274209|NCT00423735|4166030|P1|Overall Study|Ineligible / No protocol treatment|8
1274210|NCT00423722|4166053|P2|Overall Study|Withdrawal by Subject|2
1274211|NCT00423722|4166054|P1|Overall Study|Withdrawal by Subject|4
1274212|NCT00423722|4166053|P2|Overall Study|Unable to complete questionnaires|4
1274213|NCT00423722|4166054|P1|Overall Study|Unable to complete questionnaires|4
1274214|NCT00423722|4166053|P2|Overall Study|Declined to participate|3
1274215|NCT00423722|4166054|P1|Overall Study|Declined to participate|2
1274216|NCT00423722|4166053|P2|Overall Study|Death|4
1274217|NCT00423722|4166054|P1|Overall Study|Death|4
1274218|NCT00423670|4166096|P8|Follow-up Period|Non-compliance with protocol|2
1274219|NCT00423670|4166097|P7|Follow-up Period|Non-compliance with protocol|3
1274220|NCT00423670|4166098|P6|Follow-up Period|Non-compliance with protocol|0
1274221|NCT00423670|4166099|P5|Follow-up Period|Non-compliance with protocol|0
1274222|NCT00423670|4166100|P4|Follow-up Period|Non-compliance with protocol|1
1274223|NCT00423670|4166101|P3|Follow-up Period|Non-compliance with protocol|1
1274224|NCT00423670|4166102|P2|Follow-up Period|Non-compliance with protocol|0
1274225|NCT00423670|4166103|P1|Follow-up Period|Non-compliance with protocol|2
1274226|NCT00423670|4166096|P8|Follow-up Period|Subject withdrew (not treatment related)|1
1274227|NCT00423670|4166097|P7|Follow-up Period|Subject withdrew (not treatment related)|1
1274228|NCT00423670|4166098|P6|Follow-up Period|Subject withdrew (not treatment related)|0
1274229|NCT00423670|4166099|P5|Follow-up Period|Subject withdrew (not treatment related)|1
1274230|NCT00423670|4166100|P4|Follow-up Period|Subject withdrew (not treatment related)|1
1274231|NCT00423670|4166101|P3|Follow-up Period|Subject withdrew (not treatment related)|2
1274232|NCT00423670|4166102|P2|Follow-up Period|Subject withdrew (not treatment related)|4
1274233|NCT00423670|4166103|P1|Follow-up Period|Subject withdrew (not treatment related)|1
1274234|NCT00423670|4166096|P8|Follow-up Period|Lost to Follow-up|0
1274235|NCT00423670|4166097|P7|Follow-up Period|Lost to Follow-up|5
1274236|NCT00423670|4166098|P6|Follow-up Period|Lost to Follow-up|0
1274237|NCT00423670|4166099|P5|Follow-up Period|Lost to Follow-up|1
1274238|NCT00423670|4166100|P4|Follow-up Period|Lost to Follow-up|3
1274239|NCT00423670|4166101|P3|Follow-up Period|Lost to Follow-up|8
1274240|NCT00423670|4166102|P2|Follow-up Period|Lost to Follow-up|12
1274241|NCT00423670|4166103|P1|Follow-up Period|Lost to Follow-up|0
1274242|NCT00423670|4166096|P8|Treatment Period|Non-compliance with protocol|2
1274243|NCT00423670|4166097|P7|Treatment Period|Non-compliance with protocol|2
1274244|NCT00423670|4166098|P6|Treatment Period|Non-compliance with protocol|0
1274245|NCT00423670|4166099|P5|Treatment Period|Non-compliance with protocol|2
1274246|NCT00423670|4166100|P4|Treatment Period|Non-compliance with protocol|3
1274247|NCT00423670|4166101|P3|Treatment Period|Non-compliance with protocol|1
1274248|NCT00423670|4166102|P2|Treatment Period|Non-compliance with protocol|1
1274249|NCT00423670|4166103|P1|Treatment Period|Non-compliance with protocol|3
1274250|NCT00423670|4166096|P8|Treatment Period|Investigator decision|1
1274251|NCT00423670|4166097|P7|Treatment Period|Investigator decision|0
1274252|NCT00423670|4166098|P6|Treatment Period|Investigator decision|0
1274253|NCT00423670|4166099|P5|Treatment Period|Investigator decision|0
1274254|NCT00423670|4166100|P4|Treatment Period|Investigator decision|0
1274255|NCT00423670|4166101|P3|Treatment Period|Investigator decision|0
1274256|NCT00423670|4166102|P2|Treatment Period|Investigator decision|0
1274257|NCT00423670|4166103|P1|Treatment Period|Investigator decision|0
1274258|NCT00423670|4166096|P8|Treatment Period|Subject withdrew (not treatment related)|0
1274259|NCT00423670|4166097|P7|Treatment Period|Subject withdrew (not treatment related)|3
1274260|NCT00423670|4166098|P6|Treatment Period|Subject withdrew (not treatment related)|0
1274261|NCT00423670|4166099|P5|Treatment Period|Subject withdrew (not treatment related)|5
1274262|NCT00423670|4166100|P4|Treatment Period|Subject withdrew (not treatment related)|4
1274263|NCT00423670|4166101|P3|Treatment Period|Subject withdrew (not treatment related)|4
1274264|NCT00423670|4166102|P2|Treatment Period|Subject withdrew (not treatment related)|9
1274265|NCT00423670|4166103|P1|Treatment Period|Subject withdrew (not treatment related)|3
1274266|NCT00423670|4166096|P8|Treatment Period|Lost to Follow-up|1
1274267|NCT00423670|4166097|P7|Treatment Period|Lost to Follow-up|3
1274268|NCT00423670|4166098|P6|Treatment Period|Lost to Follow-up|0
1274269|NCT00423670|4166099|P5|Treatment Period|Lost to Follow-up|6
1274270|NCT00423670|4166100|P4|Treatment Period|Lost to Follow-up|1
1274271|NCT00423670|4166101|P3|Treatment Period|Lost to Follow-up|3
1274272|NCT00423670|4166102|P2|Treatment Period|Lost to Follow-up|1
1274273|NCT00423670|4166103|P1|Treatment Period|Lost to Follow-up|2
1274274|NCT00423670|4166096|P8|Treatment Period|Protocol-defined clinical event|15
1274275|NCT00423670|4166097|P7|Treatment Period|Protocol-defined clinical event|16
1274276|NCT00423670|4166098|P6|Treatment Period|Protocol-defined clinical event|4
1274277|NCT00423670|4166099|P5|Treatment Period|Protocol-defined clinical event|5
1274278|NCT00423670|4166100|P4|Treatment Period|Protocol-defined clinical event|12
1274279|NCT00423670|4166101|P3|Treatment Period|Protocol-defined clinical event|4
1274280|NCT00423670|4166102|P2|Treatment Period|Protocol-defined clinical event|7
1274281|NCT00423670|4166103|P1|Treatment Period|Protocol-defined clinical event|0
1274282|NCT00423670|4166096|P8|Treatment Period|Adverse Event|2
1274283|NCT00423670|4166097|P7|Treatment Period|Adverse Event|7
1274284|NCT00423670|4166098|P6|Treatment Period|Adverse Event|4
1274285|NCT00423670|4166099|P5|Treatment Period|Adverse Event|9
1274286|NCT00423670|4166100|P4|Treatment Period|Adverse Event|20
1274287|NCT00423670|4166101|P3|Treatment Period|Adverse Event|15
1274288|NCT00423670|4166102|P2|Treatment Period|Adverse Event|12
1274289|NCT00423670|4166103|P1|Treatment Period|Adverse Event|8
1274290|NCT00423670|4166096|P8|Treatment Period|Switched to Arm 8 at TW 24|0
1274291|NCT00423670|4166097|P7|Treatment Period|Switched to Arm 8 at TW 24|0
1274292|NCT00423670|4166098|P6|Treatment Period|Switched to Arm 8 at TW 24|0
1274293|NCT00423670|4166099|P5|Treatment Period|Switched to Arm 8 at TW 24|0
1274294|NCT00423670|4166100|P4|Treatment Period|Switched to Arm 8 at TW 24|0
1274295|NCT00423670|4166101|P3|Treatment Period|Switched to Arm 8 at TW 24|0
1274296|NCT00423670|4166102|P2|Treatment Period|Switched to Arm 8 at TW 24|0
1274297|NCT00423670|4166103|P1|Treatment Period|Switched to Arm 8 at TW 24|36
1274298|NCT00423657|4166161|P2|Overall Study|Request of sponsor/investigator|0
1274299|NCT00423657|4166162|P1|Overall Study|Request of sponsor/investigator|1
1274300|NCT00423657|4166161|P2|Overall Study|Other|16
1274301|NCT00423657|4166162|P1|Overall Study|Other|15
1274302|NCT00423657|4166161|P2|Overall Study|Non-compliance|1
1274303|NCT00423657|4166162|P1|Overall Study|Non-compliance|0
1274304|NCT00423657|4166161|P2|Overall Study|Withdrew consent|8
1274305|NCT00423657|4166162|P1|Overall Study|Withdrew consent|10
1274306|NCT00423605|4166168|P1|Overall Study|Not one of the pre-specified options|5
1274307|NCT00423605|4166168|P1|Overall Study|Protocol Violation|7
1274308|NCT00423605|4166168|P1|Overall Study|Physician Decision|8
1274309|NCT00423605|4166168|P1|Overall Study|Sponsor Decision|3
1274310|NCT00423605|4166168|P1|Overall Study|Lack of Efficacy|38
1274311|NCT00423605|4166168|P1|Overall Study|Lost to Follow-up|15
1274312|NCT00423605|4166168|P1|Overall Study|Withdrawal by Subject|36
1274313|NCT00423605|4166168|P1|Overall Study|Adverse Event|129
1274314|NCT00423592|4166172|P1|Overall Study|Adverse Event (post Week 12)|5
1274315|NCT00423592|4166172|P1|Overall Study|Adverse Event (through Week 12)|2
1274316|NCT00423579|4166193|P2|Overall Study|Diagnosis of diabetes|1
1274317|NCT00423579|4166194|P1|Overall Study|Diagnosis of diabetes|0
1274318|NCT00423579|4166193|P2|Overall Study|Protocol Violation|3
1274319|NCT00423579|4166194|P1|Overall Study|Protocol Violation|1
1274320|NCT00423579|4166193|P2|Overall Study|Lost to Follow-up|0
1274321|NCT00423579|4166194|P1|Overall Study|Lost to Follow-up|3
1274322|NCT00423488|4166202|P2|Overall Study|No post baseline data|0
1274323|NCT00423488|4166203|P1|Overall Study|No post baseline data|3
1274324|NCT00423488|4166202|P2|Overall Study|No evidence of study drug intake|1
1274325|NCT00423488|4166203|P1|Overall Study|No evidence of study drug intake|2
1274326|NCT00423449|4166209|P5|Overall Study|Protocol Violation|0
1274327|NCT00423449|4166210|P4|Overall Study|Protocol Violation|1
1274328|NCT00423449|4166211|P3|Overall Study|Protocol Violation|2
1274329|NCT00423449|4166212|P2|Overall Study|Protocol Violation|0
1274330|NCT00423449|4166213|P1|Overall Study|Protocol Violation|0
1274331|NCT00423449|4166209|P5|Overall Study|Not Specified|0
1274332|NCT00423449|4166210|P4|Overall Study|Not Specified|1
1274333|NCT00423449|4166211|P3|Overall Study|Not Specified|0
1274334|NCT00423449|4166212|P2|Overall Study|Not Specified|0
1274335|NCT00423449|4166213|P1|Overall Study|Not Specified|0
1274336|NCT00423449|4166209|P5|Overall Study|Laboratory Adverse Event|0
1274337|NCT00423449|4166210|P4|Overall Study|Laboratory Adverse Event|0
1274338|NCT00423449|4166211|P3|Overall Study|Laboratory Adverse Event|2
1274339|NCT00423449|4166212|P2|Overall Study|Laboratory Adverse Event|1
1274340|NCT00423449|4166213|P1|Overall Study|Laboratory Adverse Event|0
1274341|NCT00423449|4166209|P5|Overall Study|Progressive Disease|4
1274342|NCT00423449|4166210|P4|Overall Study|Progressive Disease|11
1274343|NCT00423449|4166211|P3|Overall Study|Progressive Disease|8
1274344|NCT00423449|4166212|P2|Overall Study|Progressive Disease|3
1274345|NCT00423449|4166213|P1|Overall Study|Progressive Disease|1
1274346|NCT00423449|4166209|P5|Overall Study|Death|1
1274347|NCT00423449|4166210|P4|Overall Study|Death|1
1274348|NCT00423449|4166211|P3|Overall Study|Death|2
1274349|NCT00423449|4166212|P2|Overall Study|Death|0
1274350|NCT00423449|4166213|P1|Overall Study|Death|1
1274351|NCT00423449|4166209|P5|Overall Study|Clinical Adverse Event|2
1274352|NCT00423449|4166210|P4|Overall Study|Clinical Adverse Event|8
1274353|NCT00423449|4166211|P3|Overall Study|Clinical Adverse Event|1
1274354|NCT00423449|4166212|P2|Overall Study|Clinical Adverse Event|0
1274355|NCT00423449|4166213|P1|Overall Study|Clinical Adverse Event|1
1274356|NCT00423332|4166260|P2|Overall Study|Unblinded before 12 weeks|3
1274357|NCT00423332|4166261|P1|Overall Study|Unblinded before 12 weeks|1
1274358|NCT00423332|4166260|P2|Overall Study|Progressive at Week 6|1
1274359|NCT00423332|4166261|P1|Overall Study|Progressive at Week 6|0
1274360|NCT00423332|4166260|P2|Overall Study|Condition under investigation worsened|1
1274361|NCT00423332|4166261|P1|Overall Study|Condition under investigation worsened|1
1274362|NCT00423332|4166260|P2|Overall Study|Withdrawal by Subject|0
1274363|NCT00423332|4166261|P1|Overall Study|Withdrawal by Subject|1
1274364|NCT00423332|4166260|P2|Overall Study|Adverse Event|2
1274365|NCT00423332|4166261|P1|Overall Study|Adverse Event|6
1274366|NCT00423319|4166280|P2|Overall Study|Not specified|22
1274367|NCT00423319|4166281|P1|Overall Study|Not specified|23
1274368|NCT00423319|4166280|P2|Overall Study|No longer meets study criteria|15
1274369|NCT00423319|4166281|P1|Overall Study|No longer meets study criteria|15
1274370|NCT00423319|4166280|P2|Overall Study|Poor compliance or noncompliance|1
1274371|NCT00423319|4166281|P1|Overall Study|Poor compliance or noncompliance|1
1274372|NCT00423319|4166280|P2|Overall Study|Lost to Follow-up|3
1274373|NCT00423319|4166281|P1|Overall Study|Lost to Follow-up|4
1274374|NCT00423319|4166280|P2|Overall Study|Withdrawal by Subject|99
1274375|NCT00423319|4166281|P1|Overall Study|Withdrawal by Subject|86
1274376|NCT00423319|4166280|P2|Overall Study|Adverse Event|112
1274377|NCT00423319|4166281|P1|Overall Study|Adverse Event|93
1274378|NCT00423319|4166280|P2|Overall Study|Death|0
1274379|NCT00423319|4166281|P1|Overall Study|Death|2
1274380|NCT00423293|4166313|P1|Overall Study|Ineligible / No protocol treatment|11
1274381|NCT00423267|4166319|P2|Period A|Administrative|0
1274382|NCT00423267|4166320|P1|Period A|Administrative|1
1274383|NCT00423267|4166319|P2|Period A|Non-compliance with protocol|0
1274384|NCT00423267|4166320|P1|Period A|Non-compliance with protocol|1
1274385|NCT00423267|4166319|P2|Period A|Withdrawal by Subject|1
1274386|NCT00423267|4166320|P1|Period A|Withdrawal by Subject|0
1274387|NCT00423189|4166340|P3|Overall Study|Death|0
1274388|NCT00423189|4166341|P2|Overall Study|Death|1
1274389|NCT00423189|4166342|P1|Overall Study|Death|0
1274390|NCT00423176|4166364|P2|Overall Study|Did not meet protocol eligibility|4
1274391|NCT00423176|4166365|P1|Overall Study|Did not meet protocol eligibility|2
1274392|NCT00423176|4166364|P2|Overall Study|Protocol Violation|3
1274393|NCT00423176|4166365|P1|Overall Study|Protocol Violation|1
1274394|NCT00423176|4166364|P2|Overall Study|Withdrawal by Subject|3
1274395|NCT00423176|4166365|P1|Overall Study|Withdrawal by Subject|4
1274396|NCT00423176|4166364|P2|Overall Study|Lost to Follow-up|7
1274397|NCT00423176|4166365|P1|Overall Study|Lost to Follow-up|4
1274398|NCT00423176|4166364|P2|Overall Study|Treatment Failure|6
1274399|NCT00423176|4166365|P1|Overall Study|Treatment Failure|1
1274400|NCT00423176|4166364|P2|Overall Study|Adverse Event|6
1274401|NCT00423176|4166365|P1|Overall Study|Adverse Event|4
1274402|NCT00423150|4166373|P1|Overall Study|Administrative|4
1274403|NCT00423150|4166373|P1|Overall Study|Non-compliance with protocol|1
1274404|NCT00423150|4166373|P1|Overall Study|Withdrawal by Subject|1
1274405|NCT00423150|4166373|P1|Overall Study|Progression of disease being studied|69
1274406|NCT00423150|4166373|P1|Overall Study|Adverse Event|11
1274407|NCT00423098|4166379|P2|Overall Study|Death|0
1274408|NCT00423098|4166380|P1|Overall Study|Death|2
1274409|NCT00423098|4166379|P2|Overall Study|Administrative problems|1
1274410|NCT00423098|4166380|P1|Overall Study|Administrative problems|0
1274411|NCT00423098|4166379|P2|Overall Study|Unsatisfactory therapeutic effect|1
1274412|NCT00423098|4166380|P1|Overall Study|Unsatisfactory therapeutic effect|0
1274413|NCT00423098|4166379|P2|Overall Study|Adverse Event|2
1274414|NCT00423098|4166380|P1|Overall Study|Adverse Event|1
1274415|NCT00423085|4166407|P4|52-Week Open-Label Extension Phase|Death|2
1274416|NCT00423085|4166408|P3|52-Week Open-Label Extension Phase|Death|0
1274417|NCT00423085|4166409|P2|52-Week Open-Label Extension Phase|Death|0
1274418|NCT00423085|4166410|P1|52-Week Open-Label Extension Phase|Death|0
1274419|NCT00423085|4166407|P4|52-Week Open-Label Extension Phase|Protocol deviation|9
1274420|NCT00423085|4166408|P3|52-Week Open-Label Extension Phase|Protocol deviation|0
1274421|NCT00423085|4166409|P2|52-Week Open-Label Extension Phase|Protocol deviation|0
1274422|NCT00423085|4166410|P1|52-Week Open-Label Extension Phase|Protocol deviation|0
1274423|NCT00423085|4166407|P4|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18
1274424|NCT00423085|4166408|P3|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
1274425|NCT00423085|4166409|P2|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
1274426|NCT00423085|4166410|P1|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
1274427|NCT00423085|4166407|P4|52-Week Open-Label Extension Phase|Withdrawal by Subject|37
1274428|NCT00423085|4166408|P3|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
1274429|NCT00423085|4166409|P2|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
1274430|NCT00423085|4166410|P1|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
1274431|NCT00423085|4166407|P4|52-Week Open-Label Extension Phase|Adverse Event|97
1274432|NCT00423085|4166408|P3|52-Week Open-Label Extension Phase|Adverse Event|0
1274433|NCT00423085|4166409|P2|52-Week Open-Label Extension Phase|Adverse Event|0
1274434|NCT00423085|4166410|P1|52-Week Open-Label Extension Phase|Adverse Event|0
1274435|NCT00423085|4166407|P4|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
1274436|NCT00423085|4166408|P3|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
1274437|NCT00423085|4166409|P2|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
1274438|NCT00423085|4166410|P1|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1
1274439|NCT00423085|4166407|P4|24-Week Double-Blind Treatment Phase|Death|0
1274440|NCT00423085|4166408|P3|24-Week Double-Blind Treatment Phase|Death|0
1274441|NCT00423085|4166409|P2|24-Week Double-Blind Treatment Phase|Death|1
1274442|NCT00423085|4166410|P1|24-Week Double-Blind Treatment Phase|Death|1
1274443|NCT00423085|4166407|P4|24-Week Double-Blind Treatment Phase|Protocol Violation|0
1274444|NCT00423085|4166408|P3|24-Week Double-Blind Treatment Phase|Protocol Violation|7
1274445|NCT00423085|4166409|P2|24-Week Double-Blind Treatment Phase|Protocol Violation|3
1274446|NCT00423085|4166410|P1|24-Week Double-Blind Treatment Phase|Protocol Violation|8
1274447|NCT00423085|4166407|P4|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
1274448|NCT00423085|4166408|P3|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
1274449|NCT00423085|4166409|P2|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6
1274450|NCT00423085|4166410|P1|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
1274451|NCT00423085|4166407|P4|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0
1274452|NCT00423085|4166408|P3|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11
1274453|NCT00423085|4166409|P2|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16
1274454|NCT00423085|4166410|P1|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8
1274455|NCT00423085|4166407|P4|24-Week Double-Blind Treatment Phase|Adverse Event|0
1274456|NCT00423085|4166408|P3|24-Week Double-Blind Treatment Phase|Adverse Event|34
1274457|NCT00423085|4166409|P2|24-Week Double-Blind Treatment Phase|Adverse Event|38
1274458|NCT00423085|4166410|P1|24-Week Double-Blind Treatment Phase|Adverse Event|21
1274459|NCT00423046|4166439|P2|Overall Study|Other|345
1274460|NCT00423046|4166440|P1|Overall Study|Other|340
1274461|NCT00422942|4166506|P1|Overall Study|Study terminated by Sponsor|3
1274462|NCT00422903|4166525|P2|Overall Study|Informed Consent Withdrawn|2
1274463|NCT00422903|4166526|P1|Overall Study|Informed Consent Withdrawn|1
1274464|NCT00422903|4166525|P2|Overall Study|Adverse Event|2
1274465|NCT00422903|4166526|P1|Overall Study|Adverse Event|0
1274466|NCT00422903|4166525|P2|Overall Study|Disease Progression|1
1274467|NCT00422903|4166526|P1|Overall Study|Disease Progression|3
1274468|NCT00422799|4166575|P1|Overall Study|Adverse Event|7
1274469|NCT00422799|4166575|P1|Overall Study|Withdrawal by Subject|6
1274470|NCT00422734|4166584|P2|Overall Study|Partner Decision|3
1274471|NCT00422734|4166585|P1|Overall Study|Partner Decision|0
1274472|NCT00422734|4166584|P2|Overall Study|Adverse Event|3
1274473|NCT00422734|4166585|P1|Overall Study|Adverse Event|0
1274474|NCT00422734|4166584|P2|Overall Study|Withdrawal by Subject|8
1274475|NCT00422734|4166585|P1|Overall Study|Withdrawal by Subject|12
1274476|NCT00422734|4166584|P2|Overall Study|Protocol Violation|6
1274477|NCT00422734|4166585|P1|Overall Study|Protocol Violation|1
1274478|NCT00422734|4166584|P2|Overall Study|Physician Decision|1
1274479|NCT00422734|4166585|P1|Overall Study|Physician Decision|1
1274480|NCT00422669|4166631|P3|Overall Study|The study was terminated early.|7
1274481|NCT00422669|4166632|P2|Overall Study|The study was terminated early.|100
1274482|NCT00422669|4166633|P1|Overall Study|The study was terminated early.|98
1274483|NCT00422591|4166661|P1|Overall Study|Withdrawal by Subject|2
1274484|NCT00422591|4166661|P1|Overall Study|Physician Decision|4
1274485|NCT00422513|4166669|P2|Overall Study|Death|7
1274486|NCT00422513|4166670|P1|Overall Study|Death|3
1274487|NCT00422513|4166669|P2|Overall Study|Adverse Event|4
1274488|NCT00422513|4166670|P1|Overall Study|Adverse Event|4
1274489|NCT00422513|4166669|P2|Overall Study|early termination of the study|80
1274490|NCT00422513|4166670|P1|Overall Study|early termination of the study|67
1274491|NCT00422513|4166669|P2|Overall Study|Withdrawal by Subject|1
1274492|NCT00422513|4166670|P1|Overall Study|Withdrawal by Subject|2
1274493|NCT00422513|4166669|P2|Overall Study|Refused Treatment|2
1274494|NCT00422513|4166670|P1|Overall Study|Refused Treatment|4
1274495|NCT00422513|4166669|P2|Overall Study|Protocol Violation|7
1274496|NCT00422513|4166670|P1|Overall Study|Protocol Violation|23
1274497|NCT00422513|4166669|P2|Overall Study|Lack of Efficacy|5
1274498|NCT00422513|4166670|P1|Overall Study|Lack of Efficacy|4
1274499|NCT00422422|4166687|P1|Overall Study|AE, non-serious non-fatal|5
1274500|NCT00422422|4166687|P1|Overall Study|SAE, non-fatal|1
1274501|NCT00422422|4166687|P1|Overall Study|Withdrawal by Subject|2
1274502|NCT00422422|4166687|P1|Overall Study|Protocol Violation|1
1274503|NCT00422422|4166687|P1|Overall Study|Lack of Efficacy|1
1274504|NCT00422383|4166704|P5|Overall Study|Withdrawal by Subject|1
1274505|NCT00422383|4166705|P4|Overall Study|Withdrawal by Subject|0
1274506|NCT00422383|4166706|P3|Overall Study|Withdrawal by Subject|0
1274507|NCT00422383|4166707|P2|Overall Study|Withdrawal by Subject|5
1274508|NCT00422383|4166708|P1|Overall Study|Withdrawal by Subject|5
1274509|NCT00422383|4166704|P5|Overall Study|Protocol Violation|0
1274510|NCT00422383|4166705|P4|Overall Study|Protocol Violation|0
1274511|NCT00422383|4166706|P3|Overall Study|Protocol Violation|1
1274512|NCT00422383|4166707|P2|Overall Study|Protocol Violation|1
1274513|NCT00422383|4166708|P1|Overall Study|Protocol Violation|1
1274514|NCT00422383|4166704|P5|Overall Study|Lost to Follow-up|1
1274515|NCT00422383|4166705|P4|Overall Study|Lost to Follow-up|0
1274516|NCT00422383|4166706|P3|Overall Study|Lost to Follow-up|0
1274517|NCT00422383|4166707|P2|Overall Study|Lost to Follow-up|1
1274518|NCT00422383|4166708|P1|Overall Study|Lost to Follow-up|0
1274519|NCT00422383|4166704|P5|Overall Study|Lack of Efficacy|1
1274520|NCT00422383|4166705|P4|Overall Study|Lack of Efficacy|1
1274521|NCT00422383|4166706|P3|Overall Study|Lack of Efficacy|2
1274522|NCT00422383|4166707|P2|Overall Study|Lack of Efficacy|4
1274523|NCT00422383|4166708|P1|Overall Study|Lack of Efficacy|4
1274524|NCT00422383|4166704|P5|Overall Study|Adverse Event|0
1274525|NCT00422383|4166705|P4|Overall Study|Adverse Event|1
1274526|NCT00422383|4166706|P3|Overall Study|Adverse Event|1
1274527|NCT00422383|4166707|P2|Overall Study|Adverse Event|3
1274528|NCT00422383|4166708|P1|Overall Study|Adverse Event|5
1274529|NCT00422292|4166851|P4|Overall Study|Withdrawal by Subject|13
1274530|NCT00422292|4166852|P3|Overall Study|Withdrawal by Subject|7
1274531|NCT00422292|4166853|P2|Overall Study|Withdrawal by Subject|25
1274532|NCT00422292|4166854|P1|Overall Study|Withdrawal by Subject|6
1274533|NCT00422292|4166851|P4|Overall Study|Lost to Follow-up|6
1274534|NCT00422292|4166852|P3|Overall Study|Lost to Follow-up|6
1274535|NCT00422292|4166853|P2|Overall Study|Lost to Follow-up|12
1274536|NCT00422292|4166854|P1|Overall Study|Lost to Follow-up|6
1274537|NCT00422292|4166851|P4|Overall Study|Protocol Violation|5
1274538|NCT00422292|4166852|P3|Overall Study|Protocol Violation|8
1274539|NCT00422292|4166853|P2|Overall Study|Protocol Violation|25
1274540|NCT00422292|4166854|P1|Overall Study|Protocol Violation|4
1274541|NCT00422292|4166851|P4|Overall Study|Adverse Event|0
1274542|NCT00422292|4166852|P3|Overall Study|Adverse Event|1
1274543|NCT00422292|4166853|P2|Overall Study|Adverse Event|0
1274544|NCT00422292|4166854|P1|Overall Study|Adverse Event|1
1274545|NCT00422292|4166851|P4|Overall Study|Serious adverse events|0
1274546|NCT00422292|4166852|P3|Overall Study|Serious adverse events|0
1274547|NCT00422292|4166853|P2|Overall Study|Serious adverse events|4
1274548|NCT00422292|4166854|P1|Overall Study|Serious adverse events|1
1274549|NCT00422227|4166893|P2|Overall Study|Withdrawal by Subject|4
1274550|NCT00422227|4166894|P1|Overall Study|Withdrawal by Subject|0
1274551|NCT00422227|4166893|P2|Overall Study|Lost to Follow-up|3
1274552|NCT00422227|4166894|P1|Overall Study|Lost to Follow-up|1
1274553|NCT00422227|4166893|P2|Overall Study|Adverse Event|8
1274554|NCT00422227|4166894|P1|Overall Study|Adverse Event|3
1274555|NCT00422162|4166924|P2|Overall Study|Didn't Receive Treatment|1
1274556|NCT00422162|4166925|P1|Overall Study|Didn't Receive Treatment|0
1274557|NCT00422162|4166924|P2|Overall Study|Not Specified|1
1274558|NCT00422162|4166925|P1|Overall Study|Not Specified|0
1274559|NCT00422162|4166924|P2|Overall Study|Non-Compliant with Protocol|1
1274560|NCT00422162|4166925|P1|Overall Study|Non-Compliant with Protocol|1
1274561|NCT00422162|4166924|P2|Overall Study|Lost to Follow-up|2
1274562|NCT00422162|4166925|P1|Overall Study|Lost to Follow-up|1
1274563|NCT00422162|4166924|P2|Overall Study|Withdrawal by Subject|6
1274564|NCT00422162|4166925|P1|Overall Study|Withdrawal by Subject|7
1274565|NCT00422162|4166924|P2|Overall Study|Lack of Efficacy|10
1274566|NCT00422162|4166925|P1|Overall Study|Lack of Efficacy|4
1274567|NCT00422162|4166924|P2|Overall Study|Adverse Event|9
1274568|NCT00422162|4166925|P1|Overall Study|Adverse Event|11
1274569|NCT00422097|4166985|P8|Dose Level 2|Still on treatment|0
1274570|NCT00422097|4166986|P7|Dose Level 2|Still on treatment|0
1274571|NCT00422097|4166987|P6|Dose Level 2|Still on treatment|0
1274572|NCT00422097|4166988|P5|Dose Level 2|Still on treatment|0
1274573|NCT00422097|4166989|P4|Dose Level 2|Still on treatment|0
1274574|NCT00422097|4166990|P3|Dose Level 2|Still on treatment|0
1274575|NCT00422097|4166991|P2|Dose Level 2|Still on treatment|1
1274576|NCT00422097|4166992|P1|Dose Level 2|Still on treatment|0
1274577|NCT00422058|4167057|P6|Open-Label Extension, Week 20-104|Other|18
1274578|NCT00422058|4167058|P5|Open-Label Extension, Week 20-104|Other|16
1274579|NCT00422058|4167059|P4|Open-Label Extension, Week 20-104|Other|13
1274580|NCT00422058|4167060|P3|Open-Label Extension, Week 20-104|Other|6
1274581|NCT00422058|4167061|P2|Open-Label Extension, Week 20-104|Other|14
1274582|NCT00422058|4167062|P1|Open-Label Extension, Week 20-104|Other|13
1274583|NCT00422058|4167057|P6|Open-Label Extension, Week 20-104|Lack of Efficacy|1
1274584|NCT00422058|4167058|P5|Open-Label Extension, Week 20-104|Lack of Efficacy|0
1274585|NCT00422058|4167059|P4|Open-Label Extension, Week 20-104|Lack of Efficacy|2
1274586|NCT00422058|4167060|P3|Open-Label Extension, Week 20-104|Lack of Efficacy|5
1274587|NCT00422058|4167061|P2|Open-Label Extension, Week 20-104|Lack of Efficacy|2
1274588|NCT00422058|4167062|P1|Open-Label Extension, Week 20-104|Lack of Efficacy|3
1274589|NCT00422058|4167057|P6|Open-Label Extension, Week 20-104|Protocol Violation|3
1274590|NCT00422058|4167058|P5|Open-Label Extension, Week 20-104|Protocol Violation|5
1274591|NCT00422058|4167059|P4|Open-Label Extension, Week 20-104|Protocol Violation|1
1274592|NCT00422058|4167060|P3|Open-Label Extension, Week 20-104|Protocol Violation|3
1274593|NCT00422058|4167061|P2|Open-Label Extension, Week 20-104|Protocol Violation|2
1274594|NCT00422058|4167062|P1|Open-Label Extension, Week 20-104|Protocol Violation|1
1274595|NCT00422058|4167057|P6|Open-Label Extension, Week 20-104|Adverse Event|0
1274596|NCT00422058|4167058|P5|Open-Label Extension, Week 20-104|Adverse Event|4
1274597|NCT00422058|4167059|P4|Open-Label Extension, Week 20-104|Adverse Event|4
1274598|NCT00422058|4167060|P3|Open-Label Extension, Week 20-104|Adverse Event|7
1274599|NCT00422058|4167061|P2|Open-Label Extension, Week 20-104|Adverse Event|4
1274600|NCT00422058|4167062|P1|Open-Label Extension, Week 20-104|Adverse Event|3
1274601|NCT00422058|4167057|P6|Open-Label Extension, Week 20-104|Not giving consent for extension|12
1274602|NCT00422058|4167058|P5|Open-Label Extension, Week 20-104|Not giving consent for extension|10
1274603|NCT00422058|4167059|P4|Open-Label Extension, Week 20-104|Not giving consent for extension|8
1274604|NCT00422058|4167060|P3|Open-Label Extension, Week 20-104|Not giving consent for extension|15
1274605|NCT00422058|4167061|P2|Open-Label Extension, Week 20-104|Not giving consent for extension|17
1274606|NCT00422058|4167062|P1|Open-Label Extension, Week 20-104|Not giving consent for extension|12
1274607|NCT00422058|4167057|P6|Double-Blind, Week 0-20|Other|10
1274608|NCT00422058|4167058|P5|Double-Blind, Week 0-20|Other|4
1274609|NCT00422058|4167059|P4|Double-Blind, Week 0-20|Other|8
1274610|NCT00422058|4167060|P3|Double-Blind, Week 0-20|Other|8
1274611|NCT00422058|4167061|P2|Double-Blind, Week 0-20|Other|3
1274612|NCT00422058|4167062|P1|Double-Blind, Week 0-20|Other|11
1274613|NCT00422058|4167057|P6|Double-Blind, Week 0-20|Lack of Efficacy|1
1274614|NCT00422058|4167058|P5|Double-Blind, Week 0-20|Lack of Efficacy|0
1274615|NCT00422058|4167059|P4|Double-Blind, Week 0-20|Lack of Efficacy|0
1274616|NCT00422058|4167060|P3|Double-Blind, Week 0-20|Lack of Efficacy|1
1274617|NCT00422058|4167061|P2|Double-Blind, Week 0-20|Lack of Efficacy|1
1274618|NCT00422058|4167062|P1|Double-Blind, Week 0-20|Lack of Efficacy|2
1274619|NCT00422058|4167057|P6|Double-Blind, Week 0-20|Protocol Violation|2
1274620|NCT00422058|4167058|P5|Double-Blind, Week 0-20|Protocol Violation|2
1274621|NCT00422058|4167059|P4|Double-Blind, Week 0-20|Protocol Violation|3
1274622|NCT00422058|4167060|P3|Double-Blind, Week 0-20|Protocol Violation|2
1274623|NCT00422058|4167061|P2|Double-Blind, Week 0-20|Protocol Violation|2
1274624|NCT00422058|4167062|P1|Double-Blind, Week 0-20|Protocol Violation|3
1274625|NCT00422058|4167057|P6|Double-Blind, Week 0-20|Adverse Event|3
1274626|NCT00422058|4167058|P5|Double-Blind, Week 0-20|Adverse Event|5
1274627|NCT00422058|4167059|P4|Double-Blind, Week 0-20|Adverse Event|9
1274628|NCT00422058|4167060|P3|Double-Blind, Week 0-20|Adverse Event|5
1274629|NCT00422058|4167061|P2|Double-Blind, Week 0-20|Adverse Event|4
1274630|NCT00422058|4167062|P1|Double-Blind, Week 0-20|Adverse Event|3
1274631|NCT00421993|4167203|P4|Overall Study|Subject transportation issues|1
1274632|NCT00421993|4167204|P3|Overall Study|Subject transportation issues|0
1274633|NCT00421993|4167205|P2|Overall Study|Subject transportation issues|0
1274634|NCT00421993|4167206|P1|Overall Study|Subject transportation issues|0
1274635|NCT00421993|4167203|P4|Overall Study|Pregnancy|2
1274636|NCT00421993|4167204|P3|Overall Study|Pregnancy|1
1274637|NCT00421993|4167205|P2|Overall Study|Pregnancy|1
1274638|NCT00421993|4167206|P1|Overall Study|Pregnancy|0
1274639|NCT00421993|4167203|P4|Overall Study|Lack of Efficacy|5
1274640|NCT00421993|4167204|P3|Overall Study|Lack of Efficacy|0
1274641|NCT00421993|4167205|P2|Overall Study|Lack of Efficacy|3
1274642|NCT00421993|4167206|P1|Overall Study|Lack of Efficacy|0
1274643|NCT00421993|4167203|P4|Overall Study|Protocol Violation|1
1274644|NCT00421993|4167204|P3|Overall Study|Protocol Violation|0
1274645|NCT00421993|4167205|P2|Overall Study|Protocol Violation|2
1274646|NCT00421993|4167206|P1|Overall Study|Protocol Violation|2
1274647|NCT00421993|4167203|P4|Overall Study|Adverse Event|4
1274648|NCT00421993|4167204|P3|Overall Study|Adverse Event|6
1274649|NCT00421993|4167205|P2|Overall Study|Adverse Event|1
1274650|NCT00421993|4167206|P1|Overall Study|Adverse Event|11
1274651|NCT00421993|4167203|P4|Overall Study|Lost to Follow-up|20
1274652|NCT00421993|4167204|P3|Overall Study|Lost to Follow-up|22
1274653|NCT00421993|4167205|P2|Overall Study|Lost to Follow-up|19
1274654|NCT00421993|4167206|P1|Overall Study|Lost to Follow-up|18
1274655|NCT00421993|4167203|P4|Overall Study|Withdrawal by Subject|24
1274656|NCT00421993|4167204|P3|Overall Study|Withdrawal by Subject|23
1274657|NCT00421993|4167205|P2|Overall Study|Withdrawal by Subject|23
1274658|NCT00421993|4167206|P1|Overall Study|Withdrawal by Subject|22
1274659|NCT00421928|4167243|P3|Overall Study|Death|0
1274660|NCT00421928|4167244|P2|Overall Study|Death|1
1274661|NCT00421928|4167245|P1|Overall Study|Death|0
1274662|NCT00421928|4167243|P3|Overall Study|All other|27
1274663|NCT00421928|4167244|P2|Overall Study|All other|21
1274664|NCT00421928|4167245|P1|Overall Study|All other|26
1274665|NCT00421928|4167243|P3|Overall Study|Study drug non-compliant|4
1274666|NCT00421928|4167244|P2|Overall Study|Study drug non-compliant|7
1274667|NCT00421928|4167245|P1|Overall Study|Study drug non-compliant|6
1274668|NCT00421928|4167243|P3|Overall Study|Lack of Efficacy|35
1274669|NCT00421928|4167244|P2|Overall Study|Lack of Efficacy|7
1274670|NCT00421928|4167245|P1|Overall Study|Lack of Efficacy|15
1274671|NCT00421928|4167243|P3|Overall Study|Withdrawal by Subject|43
1274672|NCT00421928|4167244|P2|Overall Study|Withdrawal by Subject|48
1274673|NCT00421928|4167245|P1|Overall Study|Withdrawal by Subject|50
1274674|NCT00421928|4167243|P3|Overall Study|Lost to Follow-up|3
1274675|NCT00421928|4167244|P2|Overall Study|Lost to Follow-up|0
1274676|NCT00421928|4167245|P1|Overall Study|Lost to Follow-up|5
1274677|NCT00421928|4167243|P3|Overall Study|Adverse Event|22
1274678|NCT00421928|4167244|P2|Overall Study|Adverse Event|140
1274679|NCT00421928|4167245|P1|Overall Study|Adverse Event|61
1274680|NCT00421889|4167280|P9|Overall Study|Lost to Follow-up|1
1274681|NCT00421889|4167281|P8|Overall Study|Lost to Follow-up|0
1274682|NCT00421889|4167282|P7|Overall Study|Lost to Follow-up|0
1274683|NCT00421889|4167283|P6|Overall Study|Lost to Follow-up|0
1274684|NCT00421889|4167284|P5|Overall Study|Lost to Follow-up|0
1274685|NCT00421889|4167285|P4|Overall Study|Lost to Follow-up|0
1274686|NCT00421889|4167286|P3|Overall Study|Lost to Follow-up|0
1274687|NCT00421889|4167287|P2|Overall Study|Lost to Follow-up|0
1274688|NCT00421889|4167288|P1|Overall Study|Lost to Follow-up|0
1274689|NCT00421889|4167280|P9|Overall Study|Patient/Investigator request|3
1274690|NCT00421889|4167281|P8|Overall Study|Patient/Investigator request|1
1274691|NCT00421889|4167282|P7|Overall Study|Patient/Investigator request|0
1274692|NCT00421889|4167283|P6|Overall Study|Patient/Investigator request|9
1274693|NCT00421889|4167284|P5|Overall Study|Patient/Investigator request|0
1274694|NCT00421889|4167285|P4|Overall Study|Patient/Investigator request|0
1274695|NCT00421889|4167286|P3|Overall Study|Patient/Investigator request|0
1274696|NCT00421889|4167287|P2|Overall Study|Patient/Investigator request|0
1274697|NCT00421889|4167288|P1|Overall Study|Patient/Investigator request|0
1274698|NCT00421889|4167280|P9|Overall Study|Progressive disease|5
1274699|NCT00421889|4167281|P8|Overall Study|Progressive disease|1
1274700|NCT00421889|4167282|P7|Overall Study|Progressive disease|3
1274701|NCT00421889|4167283|P6|Overall Study|Progressive disease|21
1274702|NCT00421889|4167284|P5|Overall Study|Progressive disease|2
1274703|NCT00421889|4167285|P4|Overall Study|Progressive disease|3
1274704|NCT00421889|4167286|P3|Overall Study|Progressive disease|2
1274705|NCT00421889|4167287|P2|Overall Study|Progressive disease|2
1274706|NCT00421889|4167288|P1|Overall Study|Progressive disease|3
1274707|NCT00421889|4167280|P9|Overall Study|Death|0
1274708|NCT00421889|4167281|P8|Overall Study|Death|0
1274709|NCT00421889|4167282|P7|Overall Study|Death|0
1274710|NCT00421889|4167283|P6|Overall Study|Death|1
1274711|NCT00421889|4167284|P5|Overall Study|Death|1
1274712|NCT00421889|4167285|P4|Overall Study|Death|0
1274713|NCT00421889|4167286|P3|Overall Study|Death|0
1274714|NCT00421889|4167287|P2|Overall Study|Death|0
1274715|NCT00421889|4167288|P1|Overall Study|Death|0
1274716|NCT00421889|4167280|P9|Overall Study|Withdrawal by Subject|0
1274717|NCT00421889|4167281|P8|Overall Study|Withdrawal by Subject|0
1274718|NCT00421889|4167282|P7|Overall Study|Withdrawal by Subject|0
1274719|NCT00421889|4167283|P6|Overall Study|Withdrawal by Subject|0
1274720|NCT00421889|4167284|P5|Overall Study|Withdrawal by Subject|2
1274721|NCT00421889|4167285|P4|Overall Study|Withdrawal by Subject|0
1274722|NCT00421889|4167286|P3|Overall Study|Withdrawal by Subject|0
1274723|NCT00421889|4167287|P2|Overall Study|Withdrawal by Subject|3
1274724|NCT00421889|4167288|P1|Overall Study|Withdrawal by Subject|1
1274725|NCT00421889|4167280|P9|Overall Study|Adverse Event|2
1274726|NCT00421889|4167281|P8|Overall Study|Adverse Event|0
1274727|NCT00421889|4167282|P7|Overall Study|Adverse Event|1
1274728|NCT00421889|4167283|P6|Overall Study|Adverse Event|4
1274729|NCT00421889|4167284|P5|Overall Study|Adverse Event|1
1274730|NCT00421889|4167285|P4|Overall Study|Adverse Event|1
1274731|NCT00421889|4167286|P3|Overall Study|Adverse Event|1
1274732|NCT00421889|4167287|P2|Overall Study|Adverse Event|0
1274733|NCT00421889|4167288|P1|Overall Study|Adverse Event|1
1274734|NCT00421733|4167333|P3|Overall Study|Protocol deviation|2
1274735|NCT00421733|4167334|P2|Overall Study|Protocol deviation|7
1274736|NCT00421733|4167335|P1|Overall Study|Protocol deviation|4
1274737|NCT00421733|4167333|P3|Overall Study|Sponsor request|3
1274738|NCT00421733|4167334|P2|Overall Study|Sponsor request|0
1274739|NCT00421733|4167335|P1|Overall Study|Sponsor request|1
1274740|NCT00421733|4167333|P3|Overall Study|Did not satisfy entry criteria|2
1274741|NCT00421733|4167334|P2|Overall Study|Did not satisfy entry criteria|3
1274742|NCT00421733|4167335|P1|Overall Study|Did not satisfy entry criteria|1
1274743|NCT00421733|4167333|P3|Overall Study|Administrative|0
1274744|NCT00421733|4167334|P2|Overall Study|Administrative|0
1274745|NCT00421733|4167335|P1|Overall Study|Administrative|2
1274746|NCT00421733|4167333|P3|Overall Study|Required dialysis|0
1274747|NCT00421733|4167334|P2|Overall Study|Required dialysis|0
1274748|NCT00421733|4167335|P1|Overall Study|Required dialysis|1
1274749|NCT00421733|4167333|P3|Overall Study|Death|0
1274750|NCT00421733|4167334|P2|Overall Study|Death|3
1274751|NCT00421733|4167335|P1|Overall Study|Death|0
1274752|NCT00421733|4167333|P3|Overall Study|Withdrawal by Subject|7
1274753|NCT00421733|4167334|P2|Overall Study|Withdrawal by Subject|2
1274754|NCT00421733|4167335|P1|Overall Study|Withdrawal by Subject|1
1274755|NCT00421733|4167333|P3|Overall Study|Lost to Follow-up|4
1274756|NCT00421733|4167334|P2|Overall Study|Lost to Follow-up|2
1274757|NCT00421733|4167335|P1|Overall Study|Lost to Follow-up|1
1274758|NCT00421733|4167333|P3|Overall Study|Adverse Event|2
1274759|NCT00421733|4167334|P2|Overall Study|Adverse Event|9
1274760|NCT00421733|4167335|P1|Overall Study|Adverse Event|4
1274761|NCT00421707|4167355|P2|Period 3:Treatment Period 2|Adverse Event|2
1274762|NCT00421707|4167356|P1|Period 3:Treatment Period 2|Adverse Event|0
1274763|NCT00421707|4167355|P2|Period 3:Treatment Period 2|Protocol Violation|0
1274764|NCT00421707|4167356|P1|Period 3:Treatment Period 2|Protocol Violation|1
1274765|NCT00421707|4167355|P2|Period 3:Treatment Period 2|Withdrawal by Subject|1
1274766|NCT00421707|4167356|P1|Period 3:Treatment Period 2|Withdrawal by Subject|1
1274767|NCT00421707|4167355|P2|Period 2: Washout|Other: Pregnancy|1
1274768|NCT00421707|4167356|P1|Period 2: Washout|Other: Pregnancy|0
1274769|NCT00421707|4167355|P2|Period 2: Washout|Lost to Follow-up|1
1274770|NCT00421707|4167356|P1|Period 2: Washout|Lost to Follow-up|0
1274771|NCT00421707|4167355|P2|Period 2: Washout|Withdrawal by Subject|1
1274772|NCT00421707|4167356|P1|Period 2: Washout|Withdrawal by Subject|0
1274773|NCT00421707|4167355|P2|Period 2: Washout|Adverse Event|1
1274774|NCT00421707|4167356|P1|Period 2: Washout|Adverse Event|1
1274775|NCT00421707|4167355|P2|Period 1: Treatment Period 1|Protocol Violation|0
1274776|NCT00421707|4167356|P1|Period 1: Treatment Period 1|Protocol Violation|1
1274777|NCT00421707|4167355|P2|Period 1: Treatment Period 1|Lost to Follow-up|2
1274778|NCT00421707|4167356|P1|Period 1: Treatment Period 1|Lost to Follow-up|2
1274779|NCT00421707|4167355|P2|Period 1: Treatment Period 1|Adverse Event|2
1274780|NCT00421707|4167356|P1|Period 1: Treatment Period 1|Adverse Event|7
1274781|NCT00421707|4167355|P2|Period 1: Treatment Period 1|Withdrawal by Subject|5
1274782|NCT00421707|4167356|P1|Period 1: Treatment Period 1|Withdrawal by Subject|1
1274783|NCT00421408|4167407|P2|Overall Study|Discountinued from treatment/ f/u cont.|25
1274784|NCT00421408|4167408|P1|Overall Study|Discountinued from treatment/ f/u cont.|12
1274785|NCT00421408|4167407|P2|Overall Study|Lost to Follow-up|20
1274786|NCT00421408|4167408|P1|Overall Study|Lost to Follow-up|30
1274787|NCT00421343|4167426|P1|Overall Study|Lost to follow-up|3
1274788|NCT00421343|4167426|P1|Overall Study|Withdrawal by Subject|2
1274789|NCT00421343|4167426|P1|Overall Study|Death|1
1274790|NCT00421174|4167432|P2|Overall Study|Ineligible due to infection|0
1274791|NCT00421174|4167433|P1|Overall Study|Ineligible due to infection|2
1274792|NCT00421174|4167432|P2|Overall Study|Withdrawal by Subject|1
1274793|NCT00421174|4167433|P1|Overall Study|Withdrawal by Subject|0
1274794|NCT00420927|4167478|P7|Period 2|Took prohibited medication|0
1274795|NCT00420927|4167479|P6|Period 2|Took prohibited medication|0
1274796|NCT00420927|4167480|P5|Period 2|Took prohibited medication|1
1274797|NCT00420927|4167481|P4|Period 2|Took prohibited medication|0
1274798|NCT00420927|4167482|P3|Period 2|Took prohibited medication|0
1274799|NCT00420927|4167483|P2|Period 2|Took prohibited medication|0
1274800|NCT00420927|4167484|P1|Period 2|Took prohibited medication|0
1274801|NCT00420927|4167478|P7|Period 2|Methotrexate intolerance|1
1274802|NCT00420927|4167479|P6|Period 2|Methotrexate intolerance|0
1274803|NCT00420927|4167480|P5|Period 2|Methotrexate intolerance|0
1274804|NCT00420927|4167481|P4|Period 2|Methotrexate intolerance|0
1274805|NCT00420927|4167482|P3|Period 2|Methotrexate intolerance|0
1274806|NCT00420927|4167483|P2|Period 2|Methotrexate intolerance|0
1274807|NCT00420927|4167484|P1|Period 2|Methotrexate intolerance|0
1274808|NCT00420927|4167478|P7|Period 2|Noncompliant with study drug|2
1274809|NCT00420927|4167479|P6|Period 2|Noncompliant with study drug|0
1274810|NCT00420927|4167480|P5|Period 2|Noncompliant with study drug|0
1274811|NCT00420927|4167481|P4|Period 2|Noncompliant with study drug|1
1274812|NCT00420927|4167482|P3|Period 2|Noncompliant with study drug|0
1274813|NCT00420927|4167483|P2|Period 2|Noncompliant with study drug|0
1274814|NCT00420927|4167484|P1|Period 2|Noncompliant with study drug|0
1274815|NCT00420927|4167478|P7|Period 2|Randomization error|0
1274816|NCT00420927|4167479|P6|Period 2|Randomization error|1
1274817|NCT00420927|4167480|P5|Period 2|Randomization error|1
1274818|NCT00420927|4167481|P4|Period 2|Randomization error|0
1274819|NCT00420927|4167482|P3|Period 2|Randomization error|0
1274820|NCT00420927|4167483|P2|Period 2|Randomization error|0
1274821|NCT00420927|4167484|P1|Period 2|Randomization error|0
1274822|NCT00420927|4167478|P7|Period 2|Sponsor decision|1
1274823|NCT00420927|4167479|P6|Period 2|Sponsor decision|0
1274824|NCT00420927|4167480|P5|Period 2|Sponsor decision|0
1274825|NCT00420927|4167481|P4|Period 2|Sponsor decision|0
1274826|NCT00420927|4167482|P3|Period 2|Sponsor decision|1
1274827|NCT00420927|4167483|P2|Period 2|Sponsor decision|0
1274828|NCT00420927|4167484|P1|Period 2|Sponsor decision|0
1274829|NCT00420927|4167478|P7|Period 2|Physician Decision|0
1274830|NCT00420927|4167479|P6|Period 2|Physician Decision|1
1274831|NCT00420927|4167480|P5|Period 2|Physician Decision|1
1274832|NCT00420927|4167481|P4|Period 2|Physician Decision|0
1274833|NCT00420927|4167482|P3|Period 2|Physician Decision|0
1274834|NCT00420927|4167483|P2|Period 2|Physician Decision|0
1274835|NCT00420927|4167484|P1|Period 2|Physician Decision|0
1274836|NCT00420927|4167478|P7|Period 2|Subject unable to find transportation|1
1274837|NCT00420927|4167479|P6|Period 2|Subject unable to find transportation|0
1274838|NCT00420927|4167480|P5|Period 2|Subject unable to find transportation|0
1274839|NCT00420927|4167481|P4|Period 2|Subject unable to find transportation|0
1274840|NCT00420927|4167482|P3|Period 2|Subject unable to find transportation|0
1274841|NCT00420927|4167483|P2|Period 2|Subject unable to find transportation|0
1274842|NCT00420927|4167484|P1|Period 2|Subject unable to find transportation|0
1274843|NCT00420927|4167478|P7|Period 2|Received wrong treatment/incorrect dose|1
1274844|NCT00420927|4167479|P6|Period 2|Received wrong treatment/incorrect dose|0
1274845|NCT00420927|4167480|P5|Period 2|Received wrong treatment/incorrect dose|0
1274846|NCT00420927|4167481|P4|Period 2|Received wrong treatment/incorrect dose|0
1274847|NCT00420927|4167482|P3|Period 2|Received wrong treatment/incorrect dose|0
1274848|NCT00420927|4167483|P2|Period 2|Received wrong treatment/incorrect dose|0
1274849|NCT00420927|4167484|P1|Period 2|Received wrong treatment/incorrect dose|0
1274850|NCT00420927|4167478|P7|Period 2|Lack of efficacy/Loss of efficacy|6
1274851|NCT00420927|4167479|P6|Period 2|Lack of efficacy/Loss of efficacy|2
1274852|NCT00420927|4167480|P5|Period 2|Lack of efficacy/Loss of efficacy|6
1274853|NCT00420927|4167481|P4|Period 2|Lack of efficacy/Loss of efficacy|1
1274854|NCT00420927|4167482|P3|Period 2|Lack of efficacy/Loss of efficacy|2
1274855|NCT00420927|4167483|P2|Period 2|Lack of efficacy/Loss of efficacy|0
1274856|NCT00420927|4167484|P1|Period 2|Lack of efficacy/Loss of efficacy|0
1274857|NCT00420927|4167478|P7|Period 2|Lost to Follow-up|9
1274858|NCT00420927|4167479|P6|Period 2|Lost to Follow-up|3
1274859|NCT00420927|4167480|P5|Period 2|Lost to Follow-up|6
1274860|NCT00420927|4167481|P4|Period 2|Lost to Follow-up|2
1274861|NCT00420927|4167482|P3|Period 2|Lost to Follow-up|2
1274862|NCT00420927|4167483|P2|Period 2|Lost to Follow-up|0
1274863|NCT00420927|4167484|P1|Period 2|Lost to Follow-up|0
1274864|NCT00420927|4167478|P7|Period 2|Withdrawal by Subject|12
1274865|NCT00420927|4167479|P6|Period 2|Withdrawal by Subject|2
1274866|NCT00420927|4167480|P5|Period 2|Withdrawal by Subject|11
1274867|NCT00420927|4167481|P4|Period 2|Withdrawal by Subject|3
1274868|NCT00420927|4167482|P3|Period 2|Withdrawal by Subject|1
1274869|NCT00420927|4167483|P2|Period 2|Withdrawal by Subject|0
1274870|NCT00420927|4167484|P1|Period 2|Withdrawal by Subject|0
1274871|NCT00420927|4167478|P7|Period 2|Adverse Event|20
1274872|NCT00420927|4167479|P6|Period 2|Adverse Event|6
1274873|NCT00420927|4167480|P5|Period 2|Adverse Event|17
1274874|NCT00420927|4167481|P4|Period 2|Adverse Event|3
1274875|NCT00420927|4167482|P3|Period 2|Adverse Event|7
1274876|NCT00420927|4167483|P2|Period 2|Adverse Event|0
1274877|NCT00420927|4167484|P1|Period 2|Adverse Event|0
1274878|NCT00420927|4167478|P7|Period 1|Took prohibited medication|0
1274879|NCT00420927|4167479|P6|Period 1|Took prohibited medication|0
1274880|NCT00420927|4167480|P5|Period 1|Took prohibited medication|0
1274881|NCT00420927|4167481|P4|Period 1|Took prohibited medication|0
1274882|NCT00420927|4167482|P3|Period 1|Took prohibited medication|0
1274883|NCT00420927|4167483|P2|Period 1|Took prohibited medication|3
1274884|NCT00420927|4167484|P1|Period 1|Took prohibited medication|1
1274885|NCT00420927|4167478|P7|Period 1|Failed to meet entry criteria|0
1274886|NCT00420927|4167479|P6|Period 1|Failed to meet entry criteria|0
1274887|NCT00420927|4167480|P5|Period 1|Failed to meet entry criteria|0
1274888|NCT00420927|4167481|P4|Period 1|Failed to meet entry criteria|0
1274889|NCT00420927|4167482|P3|Period 1|Failed to meet entry criteria|0
1274890|NCT00420927|4167483|P2|Period 1|Failed to meet entry criteria|7
1274891|NCT00420927|4167484|P1|Period 1|Failed to meet entry criteria|8
1274892|NCT00420927|4167478|P7|Period 1|Received wrong treatment/incorrect dose|0
1274893|NCT00420927|4167479|P6|Period 1|Received wrong treatment/incorrect dose|0
1274894|NCT00420927|4167480|P5|Period 1|Received wrong treatment/incorrect dose|0
1274895|NCT00420927|4167481|P4|Period 1|Received wrong treatment/incorrect dose|0
1274896|NCT00420927|4167482|P3|Period 1|Received wrong treatment/incorrect dose|0
1274897|NCT00420927|4167483|P2|Period 1|Received wrong treatment/incorrect dose|1
1274898|NCT00420927|4167484|P1|Period 1|Received wrong treatment/incorrect dose|0
1274899|NCT00420927|4167478|P7|Period 1|Subject received new diagnosis|0
1274900|NCT00420927|4167479|P6|Period 1|Subject received new diagnosis|0
1274901|NCT00420927|4167480|P5|Period 1|Subject received new diagnosis|0
1274902|NCT00420927|4167481|P4|Period 1|Subject received new diagnosis|0
1274903|NCT00420927|4167482|P3|Period 1|Subject received new diagnosis|0
1274904|NCT00420927|4167483|P2|Period 1|Subject received new diagnosis|2
1274905|NCT00420927|4167484|P1|Period 1|Subject received new diagnosis|0
1274906|NCT00420927|4167478|P7|Period 1|Study site closure|0
1274907|NCT00420927|4167479|P6|Period 1|Study site closure|0
1274908|NCT00420927|4167480|P5|Period 1|Study site closure|0
1274909|NCT00420927|4167481|P4|Period 1|Study site closure|0
1274910|NCT00420927|4167482|P3|Period 1|Study site closure|0
1274911|NCT00420927|4167483|P2|Period 1|Study site closure|1
1274912|NCT00420927|4167484|P1|Period 1|Study site closure|0
1274913|NCT00420927|4167478|P7|Period 1|Suspected tuberculosis/positive test|0
1274914|NCT00420927|4167479|P6|Period 1|Suspected tuberculosis/positive test|0
1274915|NCT00420927|4167480|P5|Period 1|Suspected tuberculosis/positive test|0
1274916|NCT00420927|4167481|P4|Period 1|Suspected tuberculosis/positive test|0
1274917|NCT00420927|4167482|P3|Period 1|Suspected tuberculosis/positive test|0
1274918|NCT00420927|4167483|P2|Period 1|Suspected tuberculosis/positive test|1
1274919|NCT00420927|4167484|P1|Period 1|Suspected tuberculosis/positive test|1
1274920|NCT00420927|4167478|P7|Period 1|Randomization error|0
1274921|NCT00420927|4167479|P6|Period 1|Randomization error|0
1274922|NCT00420927|4167480|P5|Period 1|Randomization error|0
1274923|NCT00420927|4167481|P4|Period 1|Randomization error|0
1274924|NCT00420927|4167482|P3|Period 1|Randomization error|0
1274925|NCT00420927|4167483|P2|Period 1|Randomization error|0
1274926|NCT00420927|4167484|P1|Period 1|Randomization error|1
1274927|NCT00420927|4167478|P7|Period 1|Noncompliant with study drug|0
1274928|NCT00420927|4167479|P6|Period 1|Noncompliant with study drug|0
1274929|NCT00420927|4167480|P5|Period 1|Noncompliant with study drug|0
1274930|NCT00420927|4167481|P4|Period 1|Noncompliant with study drug|0
1274931|NCT00420927|4167482|P3|Period 1|Noncompliant with study drug|0
1274932|NCT00420927|4167483|P2|Period 1|Noncompliant with study drug|1
1274933|NCT00420927|4167484|P1|Period 1|Noncompliant with study drug|1
1274934|NCT00420927|4167478|P7|Period 1|Subject moved/relocated|0
1274935|NCT00420927|4167479|P6|Period 1|Subject moved/relocated|0
1274936|NCT00420927|4167480|P5|Period 1|Subject moved/relocated|0
1274937|NCT00420927|4167481|P4|Period 1|Subject moved/relocated|0
1274938|NCT00420927|4167482|P3|Period 1|Subject moved/relocated|0
1274939|NCT00420927|4167483|P2|Period 1|Subject moved/relocated|2
1274940|NCT00420927|4167484|P1|Period 1|Subject moved/relocated|0
1274941|NCT00420927|4167478|P7|Period 1|Death|0
1274942|NCT00420927|4167479|P6|Period 1|Death|0
1274943|NCT00420927|4167480|P5|Period 1|Death|0
1274944|NCT00420927|4167481|P4|Period 1|Death|0
1274945|NCT00420927|4167482|P3|Period 1|Death|0
1274946|NCT00420927|4167483|P2|Period 1|Death|0
1274947|NCT00420927|4167484|P1|Period 1|Death|2
1274948|NCT00420927|4167478|P7|Period 1|Lack of efficacy/Loss of efficacy|0
1274949|NCT00420927|4167479|P6|Period 1|Lack of efficacy/Loss of efficacy|0
1274950|NCT00420927|4167480|P5|Period 1|Lack of efficacy/Loss of efficacy|0
1274951|NCT00420927|4167481|P4|Period 1|Lack of efficacy/Loss of efficacy|0
1274952|NCT00420927|4167482|P3|Period 1|Lack of efficacy/Loss of efficacy|0
1274953|NCT00420927|4167483|P2|Period 1|Lack of efficacy/Loss of efficacy|6
1274954|NCT00420927|4167484|P1|Period 1|Lack of efficacy/Loss of efficacy|1
1274955|NCT00420927|4167478|P7|Period 1|Lost to Follow-up|0
1274956|NCT00420927|4167479|P6|Period 1|Lost to Follow-up|0
1274957|NCT00420927|4167480|P5|Period 1|Lost to Follow-up|0
1274958|NCT00420927|4167481|P4|Period 1|Lost to Follow-up|0
1274959|NCT00420927|4167482|P3|Period 1|Lost to Follow-up|0
1274960|NCT00420927|4167483|P2|Period 1|Lost to Follow-up|6
1274961|NCT00420927|4167484|P1|Period 1|Lost to Follow-up|8
1274962|NCT00420927|4167478|P7|Period 1|Withdrawal by Subject|0
1274963|NCT00420927|4167479|P6|Period 1|Withdrawal by Subject|0
1274964|NCT00420927|4167480|P5|Period 1|Withdrawal by Subject|0
1274965|NCT00420927|4167481|P4|Period 1|Withdrawal by Subject|0
1274966|NCT00420927|4167482|P3|Period 1|Withdrawal by Subject|0
1274967|NCT00420927|4167483|P2|Period 1|Withdrawal by Subject|12
1274968|NCT00420927|4167484|P1|Period 1|Withdrawal by Subject|7
1274969|NCT00420927|4167478|P7|Period 1|Adverse Event|0
1274970|NCT00420927|4167479|P6|Period 1|Adverse Event|0
1274971|NCT00420927|4167480|P5|Period 1|Adverse Event|0
1274972|NCT00420927|4167481|P4|Period 1|Adverse Event|0
1274973|NCT00420927|4167482|P3|Period 1|Adverse Event|0
1274974|NCT00420927|4167483|P2|Period 1|Adverse Event|15
1274975|NCT00420927|4167484|P1|Period 1|Adverse Event|19
1274976|NCT00420849|4167588|P1|Overall Study|Lost to Follow-up|1
1274977|NCT00420849|4167588|P1|Overall Study|Protocol Violation|1
1274978|NCT00420849|4167588|P1|Overall Study|Transplant|8
1274979|NCT00420849|4167588|P1|Overall Study|Not specified|14
1274980|NCT00420849|4167588|P1|Overall Study|Death|18
1274981|NCT00420849|4167588|P1|Overall Study|Withdrawal by Subject|28
1274982|NCT00420849|4167588|P1|Overall Study|Adverse Event|107
1274983|NCT00420849|4167588|P1|Overall Study|Lack of Efficacy|154
1274984|NCT00420784|4167657|P4|Overall Study|Other|5
1274985|NCT00420784|4167658|P3|Overall Study|Other|0
1274986|NCT00420784|4167659|P2|Overall Study|Other|2
1274987|NCT00420784|4167660|P1|Overall Study|Other|1
1274988|NCT00420784|4167657|P4|Overall Study|Virologic Stopping Rule|67
1274989|NCT00420784|4167658|P3|Overall Study|Virologic Stopping Rule|41
1274990|NCT00420784|4167659|P2|Overall Study|Virologic Stopping Rule|26
1274991|NCT00420784|4167660|P1|Overall Study|Virologic Stopping Rule|17
1274992|NCT00420784|4167657|P4|Overall Study|Lost to Follow-up|1
1274993|NCT00420784|4167658|P3|Overall Study|Lost to Follow-up|2
1274994|NCT00420784|4167659|P2|Overall Study|Lost to Follow-up|0
1274995|NCT00420784|4167660|P1|Overall Study|Lost to Follow-up|0
1274996|NCT00420784|4167657|P4|Overall Study|Withdrawal by Subject|0
1274997|NCT00420784|4167658|P3|Overall Study|Withdrawal by Subject|0
1274998|NCT00420784|4167659|P2|Overall Study|Withdrawal by Subject|1
1274999|NCT00420784|4167660|P1|Overall Study|Withdrawal by Subject|0
1275000|NCT00420784|4167657|P4|Overall Study|Adverse Event|5
1275001|NCT00420784|4167658|P3|Overall Study|Adverse Event|10
1275002|NCT00420784|4167659|P2|Overall Study|Adverse Event|29
1275003|NCT00420784|4167660|P1|Overall Study|Adverse Event|11
1275004|NCT00420745|4167698|P2|Overall Study|Age limit exceeded for Dose 2|0
1275005|NCT00420745|4167699|P1|Overall Study|Age limit exceeded for Dose 2|1
1275006|NCT00420745|4167698|P2|Overall Study|Recurrent pneumonia & bronchitis|1
1275007|NCT00420745|4167699|P1|Overall Study|Recurrent pneumonia & bronchitis|0
1275008|NCT00420745|4167698|P2|Overall Study|Physician Decision|1
1275009|NCT00420745|4167699|P1|Overall Study|Physician Decision|1
1275010|NCT00420745|4167698|P2|Overall Study|Protocol Violation|0
1275011|NCT00420745|4167699|P1|Overall Study|Protocol Violation|1
1275012|NCT00420745|4167698|P2|Overall Study|Lost to Follow-up|2
1275013|NCT00420745|4167699|P1|Overall Study|Lost to Follow-up|10
1275014|NCT00420745|4167698|P2|Overall Study|Adverse Event|2
1275015|NCT00420745|4167699|P1|Overall Study|Adverse Event|2
1275016|NCT00420641|4167718|P3|Overall Study|Other|3
1275017|NCT00420641|4167719|P2|Overall Study|Other|4
1275018|NCT00420641|4167720|P1|Overall Study|Other|4
1275019|NCT00420641|4167718|P3|Overall Study|Non-compliance|4
1275020|NCT00420641|4167719|P2|Overall Study|Non-compliance|5
1275021|NCT00420641|4167720|P1|Overall Study|Non-compliance|7
1275022|NCT00420641|4167718|P3|Overall Study|Lack of Efficacy|4
1275023|NCT00420641|4167719|P2|Overall Study|Lack of Efficacy|5
1275024|NCT00420641|4167720|P1|Overall Study|Lack of Efficacy|6
1275025|NCT00420641|4167718|P3|Overall Study|Withdrawal by Subject|14
1275026|NCT00420641|4167719|P2|Overall Study|Withdrawal by Subject|21
1275027|NCT00420641|4167720|P1|Overall Study|Withdrawal by Subject|15
1275028|NCT00420641|4167718|P3|Overall Study|Protocol Violation|7
1275029|NCT00420641|4167719|P2|Overall Study|Protocol Violation|8
1275030|NCT00420641|4167720|P1|Overall Study|Protocol Violation|8
1275031|NCT00420641|4167718|P3|Overall Study|Lost to Follow-up|2
1275032|NCT00420641|4167719|P2|Overall Study|Lost to Follow-up|4
1275033|NCT00420641|4167720|P1|Overall Study|Lost to Follow-up|2
1275034|NCT00420641|4167718|P3|Overall Study|Adverse Event|10
1275035|NCT00420641|4167719|P2|Overall Study|Adverse Event|25
1275036|NCT00420641|4167720|P1|Overall Study|Adverse Event|3
1275037|NCT00420628|4167796|P2|Overall Study|Adverse Event|0
1275038|NCT00420628|4167797|P1|Overall Study|Adverse Event|1
1275039|NCT00420628|4167796|P2|Overall Study|Lost to Follow-up|2
1275040|NCT00420628|4167797|P1|Overall Study|Lost to Follow-up|3
1275041|NCT00420628|4167796|P2|Overall Study|Withdrawn by parent or gaurdian|2
1275042|NCT00420628|4167797|P1|Overall Study|Withdrawn by parent or gaurdian|5
1275043|NCT00420511|4167813|P2|Overall Study|Lost to Follow-up|0
1275044|NCT00420511|4167814|P1|Overall Study|Lost to Follow-up|1
1275045|NCT00420511|4167813|P2|Overall Study|Adverse Event|1
1275046|NCT00420511|4167814|P1|Overall Study|Adverse Event|1
1275047|NCT00420420|4167835|P2|Overall Study|sponsor decision (abnormal ECG @ screen)|0
1275048|NCT00420420|4167836|P1|Overall Study|sponsor decision (abnormal ECG @ screen)|1
1275049|NCT00420420|4167835|P2|Overall Study|Withdrawal by Subject|0
1275050|NCT00420420|4167836|P1|Overall Study|Withdrawal by Subject|1
1275051|NCT00420420|4167835|P2|Overall Study|Protocol Violation|1
1275052|NCT00420420|4167836|P1|Overall Study|Protocol Violation|1
1275053|NCT00420420|4167835|P2|Overall Study|Adverse Event|3
1275054|NCT00420420|4167836|P1|Overall Study|Adverse Event|5
1275055|NCT00420407|4167854|P2|Overall Study|Withdrawal by Subject|2
1275056|NCT00420407|4167855|P1|Overall Study|Withdrawal by Subject|0
1275057|NCT00420407|4167854|P2|Overall Study|subject identified as Jehovah's witness|0
1275058|NCT00420407|4167855|P1|Overall Study|subject identified as Jehovah's witness|1
1275059|NCT00420407|4167854|P2|Overall Study|subject identified as detainee|0
1275060|NCT00420407|4167855|P1|Overall Study|subject identified as detainee|1
1275061|NCT00420407|4167854|P2|Overall Study|Physician Decision|1
1275062|NCT00420407|4167855|P1|Overall Study|Physician Decision|2
1275063|NCT00420407|4167854|P2|Overall Study|Lost to Follow-up|3
1275064|NCT00420407|4167855|P1|Overall Study|Lost to Follow-up|0
1275065|NCT00420342|4167864|P3|Overall Study|Withdrawal by Subject|0
1275066|NCT00420342|4167865|P2|Overall Study|Withdrawal by Subject|2
1275067|NCT00420342|4167866|P1|Overall Study|Withdrawal by Subject|0
1275068|NCT00420342|4167864|P3|Overall Study|Lost to Follow-up|1
1275069|NCT00420342|4167865|P2|Overall Study|Lost to Follow-up|0
1275070|NCT00420342|4167866|P1|Overall Study|Lost to Follow-up|1
1275071|NCT00420316|4167909|P2|Overall Study|Lost to Follow-up|8
1275072|NCT00420316|4167910|P1|Overall Study|Lost to Follow-up|12
1275073|NCT00420316|4167909|P2|Overall Study|Withdrawal by Subject|1
1275074|NCT00420316|4167910|P1|Overall Study|Withdrawal by Subject|0
1275075|NCT00420303|4167934|P2|Overall Study|Physician Decision|1
1275076|NCT00420303|4167935|P1|Overall Study|Physician Decision|0
1275077|NCT00420303|4167934|P2|Overall Study|Lack of Efficacy|3
1275078|NCT00420303|4167935|P1|Overall Study|Lack of Efficacy|0
1275079|NCT00420303|4167934|P2|Overall Study|Serious Adverse Event|0
1275080|NCT00420303|4167935|P1|Overall Study|Serious Adverse Event|1
1275081|NCT00420290|4167947|P2|Overall Study|did not meet inclusion/exclusion|1
1275082|NCT00420290|4167948|P1|Overall Study|did not meet inclusion/exclusion|1
1275083|NCT00420290|4167947|P2|Overall Study|Withdrawal by Subject|2
1275084|NCT00420290|4167948|P1|Overall Study|Withdrawal by Subject|0
1275085|NCT00420290|4167947|P2|Overall Study|Adverse Event|1
1275086|NCT00420290|4167948|P1|Overall Study|Adverse Event|3
1275087|NCT00420238|4167964|P2|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
1275088|NCT00420238|4167965|P1|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
1275089|NCT00420238|4167964|P2|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0
1275090|NCT00420238|4167965|P1|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1
1275091|NCT00420238|4167964|P2|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1
1275092|NCT00420238|4167965|P1|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0
1275093|NCT00420238|4167964|P2|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1
1275094|NCT00420238|4167965|P1|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0
1275095|NCT00420238|4167964|P2|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2
1275096|NCT00420238|4167965|P1|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0
1275097|NCT00420238|4167964|P2|12 Week Double-Blind Treatment Period 1|Adverse Event|0
1275098|NCT00420238|4167965|P1|12 Week Double-Blind Treatment Period 1|Adverse Event|1
1275099|NCT00420212|4168104|P3|Overall Study|Other-Unspecified|18
1275100|NCT00420212|4168105|P2|Overall Study|Other-Unspecified|14
1275101|NCT00420212|4168106|P1|Overall Study|Other-Unspecified|21
1275102|NCT00420212|4168104|P3|Overall Study|Death|1
1275103|NCT00420212|4168105|P2|Overall Study|Death|0
1275104|NCT00420212|4168106|P1|Overall Study|Death|0
1275105|NCT00420212|4168104|P3|Overall Study|Protocol Violation|8
1275106|NCT00420212|4168105|P2|Overall Study|Protocol Violation|4
1275107|NCT00420212|4168106|P1|Overall Study|Protocol Violation|4
1275108|NCT00420212|4168104|P3|Overall Study|Physician Decision|3
1275109|NCT00420212|4168105|P2|Overall Study|Physician Decision|4
1275110|NCT00420212|4168106|P1|Overall Study|Physician Decision|4
1275111|NCT00420212|4168104|P3|Overall Study|Withdrawal by Subject|19
1275112|NCT00420212|4168105|P2|Overall Study|Withdrawal by Subject|22
1275113|NCT00420212|4168106|P1|Overall Study|Withdrawal by Subject|31
1275114|NCT00420212|4168104|P3|Overall Study|Lost to Follow-up|11
1275115|NCT00420212|4168105|P2|Overall Study|Lost to Follow-up|11
1275116|NCT00420212|4168106|P1|Overall Study|Lost to Follow-up|9
1275117|NCT00420212|4168104|P3|Overall Study|Adverse Event|36
1275118|NCT00420212|4168105|P2|Overall Study|Adverse Event|40
1275119|NCT00420212|4168106|P1|Overall Study|Adverse Event|22
1275120|NCT00420199|4168132|P2|Overall Study|Participant no longer met study criteria|0
1275121|NCT00420199|4168133|P1|Overall Study|Participant no longer met study criteria|1
1275122|NCT00420095|4168199|P2|Overall Study|Lost to Follow-up|0
1275123|NCT00420095|4168200|P1|Overall Study|Lost to Follow-up|1
1275124|NCT00420095|4168199|P2|Overall Study|Protocol Violation|1
1275125|NCT00420095|4168200|P1|Overall Study|Protocol Violation|1
1275126|NCT00420095|4168199|P2|Overall Study|Adverse Event|0
1275127|NCT00420095|4168200|P1|Overall Study|Adverse Event|1
1275128|NCT00420056|4168218|P1|Overall Study|Objective progression or relapse|17
1275129|NCT00420004|4168258|P3|Overall Study|Sponsor Decision|1
1275130|NCT00420004|4168259|P2|Overall Study|Sponsor Decision|3
1275131|NCT00420004|4168260|P1|Overall Study|Sponsor Decision|3
1275132|NCT00420004|4168258|P3|Overall Study|Withdrawal by Subject|14
1275133|NCT00420004|4168259|P2|Overall Study|Withdrawal by Subject|42
1275134|NCT00420004|4168260|P1|Overall Study|Withdrawal by Subject|67
1275135|NCT00420004|4168258|P3|Overall Study|Protocol Violation|3
1275136|NCT00420004|4168259|P2|Overall Study|Protocol Violation|4
1275137|NCT00420004|4168260|P1|Overall Study|Protocol Violation|5
1275138|NCT00420004|4168258|P3|Overall Study|Physician Decision|2
1275139|NCT00420004|4168259|P2|Overall Study|Physician Decision|4
1275140|NCT00420004|4168260|P1|Overall Study|Physician Decision|14
1275141|NCT00420004|4168258|P3|Overall Study|Entry Criteria Not Met|0
1275142|NCT00420004|4168259|P2|Overall Study|Entry Criteria Not Met|1
1275143|NCT00420004|4168260|P1|Overall Study|Entry Criteria Not Met|0
1275144|NCT00420004|4168258|P3|Overall Study|Lost to Follow-up|10
1275145|NCT00420004|4168259|P2|Overall Study|Lost to Follow-up|12
1275146|NCT00420004|4168260|P1|Overall Study|Lost to Follow-up|31
1275147|NCT00420004|4168258|P3|Overall Study|Lack of Efficacy|1
1275148|NCT00420004|4168259|P2|Overall Study|Lack of Efficacy|4
1275149|NCT00420004|4168260|P1|Overall Study|Lack of Efficacy|5
1275150|NCT00420004|4168258|P3|Overall Study|Adverse Event|1
1275151|NCT00420004|4168259|P2|Overall Study|Adverse Event|1
1275152|NCT00420004|4168260|P1|Overall Study|Adverse Event|4
1275153|NCT00419952|4168325|P2|Overall Study|Abnormal ECG|0
1275154|NCT00419952|4168326|P1|Overall Study|Abnormal ECG|1
1275155|NCT00419952|4168325|P2|Overall Study|Diary or medication non-compliance|4
1275156|NCT00419952|4168326|P1|Overall Study|Diary or medication non-compliance|2
1275157|NCT00419952|4168325|P2|Overall Study|Occurence of 2 or more exacerbations|0
1275158|NCT00419952|4168326|P1|Overall Study|Occurence of 2 or more exacerbations|2
1275159|NCT00419952|4168325|P2|Overall Study|Intake of prohibited medication|2
1275160|NCT00419952|4168326|P1|Overall Study|Intake of prohibited medication|2
1275161|NCT00419952|4168325|P2|Overall Study|Incorrectly enrolled|3
1275162|NCT00419952|4168326|P1|Overall Study|Incorrectly enrolled|10
1275163|NCT00419952|4168325|P2|Overall Study|Physician Decision|3
1275164|NCT00419952|4168326|P1|Overall Study|Physician Decision|1
1275165|NCT00419952|4168325|P2|Overall Study|Pregnancy|2
1275166|NCT00419952|4168326|P1|Overall Study|Pregnancy|4
1275167|NCT00419952|4168325|P2|Overall Study|Protocol Violation|24
1275168|NCT00419952|4168326|P1|Overall Study|Protocol Violation|32
1275169|NCT00419952|4168325|P2|Overall Study|Lost to Follow-up|34
1275170|NCT00419952|4168326|P1|Overall Study|Lost to Follow-up|43
1275171|NCT00419952|4168325|P2|Overall Study|Withdrawal by Subject|43
1275172|NCT00419952|4168326|P1|Overall Study|Withdrawal by Subject|44
1275173|NCT00419952|4168325|P2|Overall Study|Adverse Event|10
1275174|NCT00419952|4168326|P1|Overall Study|Adverse Event|8
1275175|NCT00419926|4168360|P2|Overall Study|Death|1
1275176|NCT00419926|4168361|P1|Overall Study|Death|2
1275177|NCT00419926|4168360|P2|Overall Study|Lost to Follow-up|2
1275178|NCT00419926|4168361|P1|Overall Study|Lost to Follow-up|1
1275179|NCT00419926|4168360|P2|Overall Study|Administrative Problem|4
1275180|NCT00419926|4168361|P1|Overall Study|Administrative Problem|4
1275181|NCT00419926|4168360|P2|Overall Study|Withdrawal by Subject|3
1275182|NCT00419926|4168361|P1|Overall Study|Withdrawal by Subject|7
1275183|NCT00419770|4168377|P2|Overall Study|Withdrawal by Subject|1
1275184|NCT00419770|4168378|P1|Overall Study|Withdrawal by Subject|5
1275185|NCT00419757|4168386|P2|Overall Study|Multiple reasons|1
1275186|NCT00419757|4168387|P1|Overall Study|Multiple reasons|3
1275187|NCT00419757|4168386|P2|Overall Study|Study specific discontinuation criteria|8
1275188|NCT00419757|4168387|P1|Overall Study|Study specific discontinuation criteria|4
1275189|NCT00419757|4168386|P2|Overall Study|Protocol Violation|3
1275190|NCT00419757|4168387|P1|Overall Study|Protocol Violation|2
1275191|NCT00419757|4168386|P2|Overall Study|Withdrawal by Subject|1
1275192|NCT00419757|4168387|P1|Overall Study|Withdrawal by Subject|7
1275193|NCT00419757|4168386|P2|Overall Study|Lost to Follow-up|4
1275194|NCT00419757|4168387|P1|Overall Study|Lost to Follow-up|1
1275195|NCT00419757|4168386|P2|Overall Study|Adverse Event|4
1275196|NCT00419757|4168387|P1|Overall Study|Adverse Event|1
1275197|NCT00419744|4168426|P3|Overall Study|Incorrect medication kit dispensed|1
1275198|NCT00419744|4168427|P2|Overall Study|Incorrect medication kit dispensed|0
1275199|NCT00419744|4168428|P1|Overall Study|Incorrect medication kit dispensed|0
1275200|NCT00419744|4168426|P3|Overall Study|Spirometry mouthpiece issues|2
1275201|NCT00419744|4168427|P2|Overall Study|Spirometry mouthpiece issues|1
1275202|NCT00419744|4168428|P1|Overall Study|Spirometry mouthpiece issues|0
1275203|NCT00419744|4168426|P3|Overall Study|Physician Decision|6
1275204|NCT00419744|4168427|P2|Overall Study|Physician Decision|5
1275205|NCT00419744|4168428|P1|Overall Study|Physician Decision|10
1275206|NCT00419744|4168426|P3|Overall Study|Moving out of state|1
1275207|NCT00419744|4168427|P2|Overall Study|Moving out of state|0
1275208|NCT00419744|4168428|P1|Overall Study|Moving out of state|2
1275209|NCT00419744|4168426|P3|Overall Study|Randomized in error|7
1275210|NCT00419744|4168427|P2|Overall Study|Randomized in error|6
1275211|NCT00419744|4168428|P1|Overall Study|Randomized in error|9
1275212|NCT00419744|4168426|P3|Overall Study|Protocol Violation|8
1275213|NCT00419744|4168427|P2|Overall Study|Protocol Violation|7
1275214|NCT00419744|4168428|P1|Overall Study|Protocol Violation|4
1275215|NCT00419744|4168426|P3|Overall Study|Lost to Follow-up|6
1275216|NCT00419744|4168427|P2|Overall Study|Lost to Follow-up|10
1275217|NCT00419744|4168428|P1|Overall Study|Lost to Follow-up|8
1275218|NCT00419744|4168426|P3|Overall Study|Withdrawal by Subject|52
1275219|NCT00419744|4168427|P2|Overall Study|Withdrawal by Subject|49
1275220|NCT00419744|4168428|P1|Overall Study|Withdrawal by Subject|45
1275221|NCT00419744|4168426|P3|Overall Study|Adverse Event|50
1275222|NCT00419744|4168427|P2|Overall Study|Adverse Event|40
1275223|NCT00419744|4168428|P1|Overall Study|Adverse Event|39
1275224|NCT00419393|4168470|P1|Overall Study|Other: Investigator decision|1
1275225|NCT00419393|4168470|P1|Overall Study|Other: Other health problems|1
1275226|NCT00419393|4168470|P1|Overall Study|Other: Site closure|1
1275227|NCT00419393|4168470|P1|Overall Study|Other: Subject had temporal lobectomy|1
1275228|NCT00419393|4168470|P1|Overall Study|Other: Sponsor request|3
1275229|NCT00419393|4168470|P1|Overall Study|Withdrawal by Subject|7
1275230|NCT00419393|4168470|P1|Overall Study|Protocol Violation|5
1275231|NCT00419393|4168470|P1|Overall Study|Adverse Event|5
1275232|NCT00419380|4168480|P2|Overall Study|Withdrawal by Subject|1
1275233|NCT00419380|4168481|P1|Overall Study|Withdrawal by Subject|0
1275234|NCT00419380|4168480|P2|Overall Study|Lost to Follow-up|1
1275235|NCT00419380|4168481|P1|Overall Study|Lost to Follow-up|0
1275236|NCT00419380|4168480|P2|Overall Study|Physician Decision|1
1275237|NCT00419380|4168481|P1|Overall Study|Physician Decision|0
1275238|NCT00419380|4168480|P2|Overall Study|Lack of Efficacy|7
1275239|NCT00419380|4168481|P1|Overall Study|Lack of Efficacy|1
1275240|NCT00419341|4168489|P1|Efficacy Period|Termination of study site|1
1275241|NCT00419341|4168489|P1|Efficacy Period|Non-compliance|1
1275242|NCT00419341|4168489|P1|Efficacy Period|Lost to Follow-up|1
1275243|NCT00419341|4168489|P1|Efficacy Period|Protocol Violation|1
1275244|NCT00419341|4168489|P1|Efficacy Period|Withdrawal by Subject|6
1275245|NCT00419341|4168489|P1|Wash in/Wash Out Period|Disqualifying laboratory results|1
1275246|NCT00419341|4168489|P1|Wash in/Wash Out Period|Adverse Event|2
1275247|NCT00419341|4168489|P1|Wash in/Wash Out Period|Withdrawal by Subject|8
1275248|NCT00419263|4168524|P3|Overall Study|Withdrawal by Subject|1
1275249|NCT00419263|4168525|P2|Overall Study|Withdrawal by Subject|0
1275250|NCT00419263|4168526|P1|Overall Study|Withdrawal by Subject|0
1275251|NCT00419263|4168524|P3|Overall Study|Adverse Event|1
1275252|NCT00419263|4168525|P2|Overall Study|Adverse Event|0
1275253|NCT00419263|4168526|P1|Overall Study|Adverse Event|0
1275254|NCT00419263|4168524|P3|Overall Study|Randomized in Error, Not Treated|0
1275255|NCT00419263|4168525|P2|Overall Study|Randomized in Error, Not Treated|1
1275256|NCT00419263|4168526|P1|Overall Study|Randomized in Error, Not Treated|1
1275257|NCT00419263|4168524|P3|Overall Study|Lost to Follow-up|1
1275258|NCT00419263|4168525|P2|Overall Study|Lost to Follow-up|1
1275259|NCT00419263|4168526|P1|Overall Study|Lost to Follow-up|2
1275260|NCT00419159|4168555|P2|Overall Study|Disease progression|76
1275261|NCT00419159|4168556|P1|Overall Study|Disease progression|79
1275262|NCT00419159|4168555|P2|Overall Study|Death|2
1275263|NCT00419159|4168556|P1|Overall Study|Death|2
1275264|NCT00419159|4168555|P2|Overall Study|Lost to Follow-up|1
1275265|NCT00419159|4168556|P1|Overall Study|Lost to Follow-up|0
1275266|NCT00419159|4168555|P2|Overall Study|Withdrawal by Subject|3
1275267|NCT00419159|4168556|P1|Overall Study|Withdrawal by Subject|10
1275268|NCT00419159|4168555|P2|Overall Study|Protocol Violation|0
1275269|NCT00419159|4168556|P1|Overall Study|Protocol Violation|1
1275270|NCT00419159|4168555|P2|Overall Study|Subject's no longer requires study drug|1
1275271|NCT00419159|4168556|P1|Overall Study|Subject's no longer requires study drug|0
1275272|NCT00419159|4168555|P2|Overall Study|Abnormal laboratory value(s)|2
1275273|NCT00419159|4168556|P1|Overall Study|Abnormal laboratory value(s)|0
1275274|NCT00419159|4168555|P2|Overall Study|Adverse Event|15
1275275|NCT00419159|4168556|P1|Overall Study|Adverse Event|7
1275276|NCT00419120|4168570|P1|Long Term Follow up Period|study ongoing|10
1275277|NCT00419094|4168577|P2|Overall Study|Other: No contact for extended period|1
1275278|NCT00419094|4168578|P1|Overall Study|Other: No contact for extended period|0
1275279|NCT00419094|4168577|P2|Overall Study|Other: Patient non-compliant|1
1275280|NCT00419094|4168578|P1|Overall Study|Other: Patient non-compliant|0
1275281|NCT00419094|4168577|P2|Overall Study|Other: Error determining exit criteria|0
1275282|NCT00419094|4168578|P1|Overall Study|Other: Error determining exit criteria|1
1275283|NCT00419094|4168577|P2|Overall Study|Withdrawal of consent|5
1275284|NCT00419094|4168578|P1|Overall Study|Withdrawal of consent|1
1275285|NCT00419094|4168577|P2|Overall Study|Protocol Violation|14
1275286|NCT00419094|4168578|P1|Overall Study|Protocol Violation|1
1275287|NCT00419094|4168577|P2|Overall Study|Lost to Follow-up|2
1275288|NCT00419094|4168578|P1|Overall Study|Lost to Follow-up|0
1275289|NCT00419094|4168577|P2|Overall Study|Lack of Efficacy|0
1275290|NCT00419094|4168578|P1|Overall Study|Lack of Efficacy|1
1275291|NCT00419094|4168577|P2|Overall Study|Adverse Event|7
1275292|NCT00419094|4168578|P1|Overall Study|Adverse Event|3
1275293|NCT00419003|4168592|P2|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0
1275294|NCT00419003|4168593|P1|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1
1275295|NCT00419003|4168592|P2|Phase I, Ketamine Infusion|Lack of Efficacy|6
1275296|NCT00419003|4168593|P1|Phase I, Ketamine Infusion|Lack of Efficacy|6
1275297|NCT00418938|4168647|P2|Overall Study|Ineligibility Determined|0
1275298|NCT00418938|4168648|P1|Overall Study|Ineligibility Determined|1
1275299|NCT00418938|4168647|P2|Overall Study|On-going|1
1275300|NCT00418938|4168648|P1|Overall Study|On-going|1
1275301|NCT00418938|4168647|P2|Overall Study|Adverse Event|1
1275302|NCT00418938|4168648|P1|Overall Study|Adverse Event|1
1275303|NCT00418938|4168647|P2|Overall Study|Lost to Follow-up|3
1275304|NCT00418938|4168648|P1|Overall Study|Lost to Follow-up|1
1275305|NCT00418938|4168647|P2|Overall Study|Withdrawal by Subject|15
1275306|NCT00418938|4168648|P1|Overall Study|Withdrawal by Subject|16
1275307|NCT00418938|4168647|P2|Overall Study|Administrative decision|3
1275308|NCT00418938|4168648|P1|Overall Study|Administrative decision|3
1275309|NCT00418938|4168647|P2|Overall Study|Reimbursement|0
1275310|NCT00418938|4168648|P1|Overall Study|Reimbursement|1
1275311|NCT00418886|4168668|P2|Overall Study|randomised but no treatment received|1
1275312|NCT00418886|4168669|P1|Overall Study|randomised but no treatment received|0
1275313|NCT00418886|4168668|P2|Overall Study|withdrawn due to other reason|0
1275314|NCT00418886|4168669|P1|Overall Study|withdrawn due to other reason|1
1275315|NCT00418886|4168668|P2|Overall Study|Lost to Follow-up|6
1275316|NCT00418886|4168669|P1|Overall Study|Lost to Follow-up|4
1275317|NCT00418886|4168668|P2|Overall Study|Withdrawal by Subject|10
1275318|NCT00418886|4168669|P1|Overall Study|Withdrawal by Subject|9
1275319|NCT00418886|4168668|P2|Overall Study|Death|147
1275320|NCT00418886|4168669|P1|Overall Study|Death|122
1275321|NCT00418886|4168668|P2|Overall Study|discontinue treatment survival follow up|91
1275322|NCT00418886|4168669|P1|Overall Study|discontinue treatment survival follow up|90
1275323|NCT00418834|4168695|P2|Overall Study|Withdrawal by Subject|7
1275324|NCT00418834|4168696|P1|Overall Study|Withdrawal by Subject|3
1275325|NCT00418834|4168695|P2|Overall Study|Protocol Violation|3
1275326|NCT00418834|4168696|P1|Overall Study|Protocol Violation|4
1275327|NCT00418834|4168695|P2|Overall Study|Lost to Follow-up|1
1275328|NCT00418834|4168696|P1|Overall Study|Lost to Follow-up|0
1275329|NCT00418834|4168695|P2|Overall Study|Adverse Event|9
1275330|NCT00418834|4168696|P1|Overall Study|Adverse Event|16
1275331|NCT00418717|4168756|P1|Treatment Period B - Weeks 5-12|Adverse Event|2
1275332|NCT00418717|4168756|P1|Treatment Period A - Weeks 1-4|Protocol Violation|1
1275333|NCT00418691|4168764|P3|Overall Study|Progressive Disease|1
1275334|NCT00418691|4168765|P2|Overall Study|Progressive Disease|0
1275335|NCT00418691|4168766|P1|Overall Study|Progressive Disease|1
1275336|NCT00418691|4168764|P3|Overall Study|Started new medication voiding entry|1
1275337|NCT00418691|4168765|P2|Overall Study|Started new medication voiding entry|0
1275338|NCT00418691|4168766|P1|Overall Study|Started new medication voiding entry|0
1275339|NCT00418691|4168764|P3|Overall Study|Lost to Follow-up|3
1275340|NCT00418691|4168765|P2|Overall Study|Lost to Follow-up|2
1275341|NCT00418691|4168766|P1|Overall Study|Lost to Follow-up|1
1275342|NCT00418665|4168777|P3|Treatment Extension|Death|1
1275343|NCT00418665|4168778|P2|Treatment Extension|Death|0
1275344|NCT00418665|4168779|P1|Treatment Extension|Death|0
1275345|NCT00418665|4168777|P3|Treatment Extension|Physician Decision|1
1275346|NCT00418665|4168778|P2|Treatment Extension|Physician Decision|2
1275347|NCT00418665|4168779|P1|Treatment Extension|Physician Decision|2
1275348|NCT00418665|4168777|P3|Treatment Extension|Requirement for alternative therapy|0
1275349|NCT00418665|4168778|P2|Treatment Extension|Requirement for alternative therapy|2
1275350|NCT00418665|4168779|P1|Treatment Extension|Requirement for alternative therapy|2
1275351|NCT00418665|4168777|P3|Treatment Extension|Withdrawal by Subject|0
1275352|NCT00418665|4168778|P2|Treatment Extension|Withdrawal by Subject|0
1275353|NCT00418665|4168779|P1|Treatment Extension|Withdrawal by Subject|1
1275354|NCT00418665|4168777|P3|Treatment Extension|Adverse Event|0
1275355|NCT00418665|4168778|P2|Treatment Extension|Adverse Event|0
1275356|NCT00418665|4168779|P1|Treatment Extension|Adverse Event|1
1275357|NCT00418665|4168777|P3|Treatment Period|Physician Decision|3
1275358|NCT00418665|4168778|P2|Treatment Period|Physician Decision|0
1275359|NCT00418665|4168779|P1|Treatment Period|Physician Decision|1
1275360|NCT00418665|4168777|P3|Treatment Period|Requirement for alternative therapy|0
1275361|NCT00418665|4168778|P2|Treatment Period|Requirement for alternative therapy|0
1275362|NCT00418665|4168779|P1|Treatment Period|Requirement for alternative therapy|1
1275363|NCT00418665|4168777|P3|Treatment Period|Withdrawal by Subject|1
1275364|NCT00418665|4168778|P2|Treatment Period|Withdrawal by Subject|3
1275365|NCT00418665|4168779|P1|Treatment Period|Withdrawal by Subject|0
1275366|NCT00418665|4168777|P3|Treatment Period|Adverse Event|0
1275367|NCT00418665|4168778|P2|Treatment Period|Adverse Event|2
1275368|NCT00418665|4168779|P1|Treatment Period|Adverse Event|2
1275369|NCT00418665|4168777|P3|Treatment Period|Ineligibility determined|0
1275370|NCT00418665|4168778|P2|Treatment Period|Ineligibility determined|1
1275371|NCT00418665|4168779|P1|Treatment Period|Ineligibility determined|1
1275372|NCT00418561|4168813|P3|Overall Study|Participant's (guardian's) decision|0
1275373|NCT00418561|4168814|P2|Overall Study|Participant's (guardian's) decision|1
1275374|NCT00418561|4168815|P1|Overall Study|Participant's (guardian's) decision|0
1275375|NCT00418522|4168885|P2|Overall Study|Randomized but did not receive treatment|4
1275376|NCT00418522|4168886|P1|Overall Study|Randomized but did not receive treatment|7
1275377|NCT00418522|4168885|P2|Overall Study|Other|23
1275378|NCT00418522|4168886|P1|Overall Study|Other|27
1275379|NCT00418522|4168885|P2|Overall Study|Withdrawal by Subject|7
1275380|NCT00418522|4168886|P1|Overall Study|Withdrawal by Subject|31
1275381|NCT00418522|4168885|P2|Overall Study|Lost to Follow-up|4
1275382|NCT00418522|4168886|P1|Overall Study|Lost to Follow-up|10
1275383|NCT00418522|4168885|P2|Overall Study|Lack of Efficacy|3
1275384|NCT00418522|4168886|P1|Overall Study|Lack of Efficacy|1
1275385|NCT00418522|4168885|P2|Overall Study|Adverse Event|1
1275386|NCT00418522|4168886|P1|Overall Study|Adverse Event|7
1275387|NCT00418379|4168933|P3|Year 5|Any other reason not above-mentioned|3
1275388|NCT00418379|4168934|P2|Year 5|Any other reason not above-mentioned|4
1275389|NCT00418379|4168935|P1|Year 5|Any other reason not above-mentioned|2
1275390|NCT00418379|4168933|P3|Year 5|Adverse Event|0
1275391|NCT00418379|4168934|P2|Year 5|Adverse Event|1
1275392|NCT00418379|4168935|P1|Year 5|Adverse Event|0
1275393|NCT00418379|4168933|P3|Year 4|Any other reason not above-mentioned|0
1275394|NCT00418379|4168934|P2|Year 4|Any other reason not above-mentioned|1
1275395|NCT00418379|4168935|P1|Year 4|Any other reason not above-mentioned|1
1275396|NCT00418379|4168933|P3|Year 4|Withdrawal by Subject|2
1275397|NCT00418379|4168934|P2|Year 4|Withdrawal by Subject|3
1275398|NCT00418379|4168935|P1|Year 4|Withdrawal by Subject|2
1275399|NCT00418379|4168933|P3|Year 4|Adverse Event|0
1275400|NCT00418379|4168934|P2|Year 4|Adverse Event|1
1275401|NCT00418379|4168935|P1|Year 4|Adverse Event|0
1275402|NCT00418379|4168933|P3|Year 3|Any other reason not above-mentioned|1
1275403|NCT00418379|4168934|P2|Year 3|Any other reason not above-mentioned|1
1275404|NCT00418379|4168935|P1|Year 3|Any other reason not above-mentioned|2
1275405|NCT00418379|4168933|P3|Year 3|Withdrawal by Subject|2
1275406|NCT00418379|4168934|P2|Year 3|Withdrawal by Subject|1
1275407|NCT00418379|4168935|P1|Year 3|Withdrawal by Subject|1
1275408|NCT00418379|4168933|P3|Year 2|Any other reason not above-mentioned|6
1275409|NCT00418379|4168934|P2|Year 2|Any other reason not above-mentioned|1
1275410|NCT00418379|4168935|P1|Year 2|Any other reason not above-mentioned|2
1275411|NCT00418379|4168933|P3|Year 2|Withdrawal by Subject|3
1275412|NCT00418379|4168934|P2|Year 2|Withdrawal by Subject|1
1275413|NCT00418379|4168935|P1|Year 2|Withdrawal by Subject|1
1275414|NCT00418379|4168933|P3|Year 2|Adverse Event|1
1275415|NCT00418379|4168934|P2|Year 2|Adverse Event|2
1275416|NCT00418379|4168935|P1|Year 2|Adverse Event|5
1275417|NCT00418379|4168933|P3|Year 1|Any other reason not above-mentioned|7
1275418|NCT00418379|4168934|P2|Year 1|Any other reason not above-mentioned|5
1275419|NCT00418379|4168935|P1|Year 1|Any other reason not above-mentioned|2
1275420|NCT00418379|4168933|P3|Year 1|Withdrawal by Subject|5
1275421|NCT00418379|4168934|P2|Year 1|Withdrawal by Subject|8
1275422|NCT00418379|4168935|P1|Year 1|Withdrawal by Subject|7
1275423|NCT00418379|4168933|P3|Year 1|Adverse Event|3
1275424|NCT00418379|4168934|P2|Year 1|Adverse Event|15
1275425|NCT00418379|4168935|P1|Year 1|Adverse Event|9
1275426|NCT00418314|4168945|P2|Overall Study|Withdrawal by Subject|2
1275427|NCT00418314|4168946|P1|Overall Study|Withdrawal by Subject|1
1275428|NCT00418184|4168976|P2|Double-blind Phase|Poor compliance|1
1275429|NCT00418184|4168977|P1|Double-blind Phase|Poor compliance|3
1275430|NCT00418184|4168976|P2|Double-blind Phase|Adverse Event|1
1275431|NCT00418184|4168977|P1|Double-blind Phase|Adverse Event|2
1275432|NCT00418184|4168976|P2|Double-blind Phase|Withdrawal by Subject|9
1275433|NCT00418184|4168977|P1|Double-blind Phase|Withdrawal by Subject|22
1275434|NCT00418145|4168985|P1|Overall Study|study terminated|6
1275435|NCT00417989|4169060|P2|Overall Study|Physician Decision|2
1275436|NCT00417989|4169061|P1|Overall Study|Physician Decision|5
1275437|NCT00417989|4169060|P2|Overall Study|Death|1
1275438|NCT00417989|4169061|P1|Overall Study|Death|0
1275439|NCT00417989|4169060|P2|Overall Study|Protocol Violation|0
1275440|NCT00417989|4169061|P1|Overall Study|Protocol Violation|1
1275441|NCT00417989|4169060|P2|Overall Study|Lost to Follow-up|6
1275442|NCT00417989|4169061|P1|Overall Study|Lost to Follow-up|1
1275443|NCT00417989|4169060|P2|Overall Study|Withdrawal by Subject|13
1275444|NCT00417989|4169061|P1|Overall Study|Withdrawal by Subject|13
1275445|NCT00417976|4169083|P1|Overall Study|Treatment -related toxicity|2
1275446|NCT00417976|4169083|P1|Overall Study|Non compliance unrelated to toxicity|1
1275447|NCT00417963|4169088|P1|Overall Study|Study device could not be deployed|3
1275448|NCT00417963|4169088|P1|Overall Study|Death|17
1275449|NCT00417963|4169088|P1|Overall Study|Withdrawal by Subject|18
1275450|NCT00417963|4169088|P1|Overall Study|Lost to Follow-up|3
1275451|NCT00417885|4169105|P1|Overall Study|Transferred to Another Sunitinib Study|2
1275452|NCT00417885|4169105|P1|Overall Study|Objective Progression or Relapse|3
1275453|NCT00417885|4169105|P1|Overall Study|Adverse Event|1
1275454|NCT00417612|4169116|P2|Overall Study|Lost to Follow-up|0
1275455|NCT00417612|4169117|P1|Overall Study|Lost to Follow-up|1
1275456|NCT00417612|4169116|P2|Overall Study|Protocol Violation|2
1275457|NCT00417612|4169117|P1|Overall Study|Protocol Violation|0
1275458|NCT00417612|4169116|P2|Overall Study|Adverse Event|0
1275459|NCT00417612|4169117|P1|Overall Study|Adverse Event|2
1275460|NCT00417612|4169116|P2|Overall Study|Errant diagnosis|1
1275461|NCT00417612|4169117|P1|Overall Study|Errant diagnosis|0
1275462|NCT00417482|4169143|P3|Phase B 2nd 16 Weeks|Death|0
1275463|NCT00417482|4169144|P2|Phase B 2nd 16 Weeks|Death|1
1275464|NCT00417482|4169145|P1|Phase B 2nd 16 Weeks|Death|1
1275465|NCT00417482|4169143|P3|Phase B 2nd 16 Weeks|Moved; unclear reason|0
1275466|NCT00417482|4169144|P2|Phase B 2nd 16 Weeks|Moved; unclear reason|0
1275467|NCT00417482|4169145|P1|Phase B 2nd 16 Weeks|Moved; unclear reason|1
1275468|NCT00417482|4169143|P3|Phase B 2nd 16 Weeks|Adverse Event|1
1275469|NCT00417482|4169144|P2|Phase B 2nd 16 Weeks|Adverse Event|0
1275470|NCT00417482|4169145|P1|Phase B 2nd 16 Weeks|Adverse Event|0
1275471|NCT00417482|4169143|P3|Phase B 2nd 16 Weeks|Lack of Efficacy|2
1275472|NCT00417482|4169144|P2|Phase B 2nd 16 Weeks|Lack of Efficacy|12
1275473|NCT00417482|4169145|P1|Phase B 2nd 16 Weeks|Lack of Efficacy|1
1275474|NCT00417482|4169143|P3|Phase B 1st 16 Weeks|Death|0
1275475|NCT00417482|4169144|P2|Phase B 1st 16 Weeks|Death|0
1275476|NCT00417482|4169145|P1|Phase B 1st 16 Weeks|Death|1
1275477|NCT00417482|4169143|P3|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
1275478|NCT00417482|4169144|P2|Phase B 1st 16 Weeks|Moved, Unclear reasons|3
1275479|NCT00417482|4169145|P1|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
1275480|NCT00417482|4169143|P3|Phase B 1st 16 Weeks|Adverse Event|1
1275481|NCT00417482|4169144|P2|Phase B 1st 16 Weeks|Adverse Event|0
1275482|NCT00417482|4169145|P1|Phase B 1st 16 Weeks|Adverse Event|2
1275483|NCT00417482|4169143|P3|Phase B 1st 16 Weeks|Lack of Efficacy|24
1275484|NCT00417482|4169144|P2|Phase B 1st 16 Weeks|Lack of Efficacy|8
1275485|NCT00417482|4169145|P1|Phase B 1st 16 Weeks|Lack of Efficacy|14
1275486|NCT00417248|4169184|P1|Overall Study|Lack of Efficacy|1
1275487|NCT00417248|4169184|P1|Overall Study|Death|1
1275488|NCT00417248|4169184|P1|Overall Study|Study Terminated|6
1275489|NCT00417170|4169191|P2|Overall Study|Lost to Follow-up|1
1275490|NCT00417170|4169192|P1|Overall Study|Lost to Follow-up|0
1275491|NCT00417170|4169191|P2|Overall Study|Withdrawal by Subject|1
1275492|NCT00417170|4169192|P1|Overall Study|Withdrawal by Subject|1
1275493|NCT00417170|4169191|P2|Overall Study|Adverse Event|1
1275494|NCT00417170|4169192|P1|Overall Study|Adverse Event|1
1275495|NCT00417079|4169208|P2|Overall Study|abnormal liver function tests|1
1275496|NCT00417079|4169209|P1|Overall Study|abnormal liver function tests|0
1275497|NCT00417079|4169208|P2|Overall Study|Patient unable to come to the clinic|1
1275498|NCT00417079|4169209|P1|Overall Study|Patient unable to come to the clinic|0
1275499|NCT00417079|4169208|P2|Overall Study|Withdrawal by subject's family|1
1275500|NCT00417079|4169209|P1|Overall Study|Withdrawal by subject's family|0
1275501|NCT00417079|4169208|P2|Overall Study|Screening error|1
1275502|NCT00417079|4169209|P1|Overall Study|Screening error|2
1275503|NCT00417079|4169208|P2|Overall Study|Clinical deterioration|0
1275504|NCT00417079|4169209|P1|Overall Study|Clinical deterioration|1
1275505|NCT00417079|4169208|P2|Overall Study|Non-confirmed Disease progression|1
1275506|NCT00417079|4169209|P1|Overall Study|Non-confirmed Disease progression|1
1275507|NCT00417079|4169208|P2|Overall Study|Investigator's decision|4
1275508|NCT00417079|4169209|P1|Overall Study|Investigator's decision|1
1275509|NCT00417079|4169208|P2|Overall Study|Screened failure|1
1275510|NCT00417079|4169209|P1|Overall Study|Screened failure|2
1275511|NCT00417079|4169208|P2|Overall Study|Not treated|7
1275512|NCT00417079|4169209|P1|Overall Study|Not treated|6
1275513|NCT00417079|4169208|P2|Overall Study|Withdrawal by Subject|8
1275514|NCT00417079|4169209|P1|Overall Study|Withdrawal by Subject|17
1275515|NCT00417079|4169208|P2|Overall Study|Lost to Follow-up|0
1275516|NCT00417079|4169209|P1|Overall Study|Lost to Follow-up|2
1275517|NCT00417079|4169208|P2|Overall Study|Non-compliance to protocol|1
1275518|NCT00417079|4169209|P1|Overall Study|Non-compliance to protocol|0
1275519|NCT00417079|4169208|P2|Overall Study|Adverse Event|67
1275520|NCT00417079|4169209|P1|Overall Study|Adverse Event|32
1275521|NCT00417079|4169208|P2|Overall Study|Disease progression|180
1275522|NCT00417079|4169209|P1|Overall Study|Disease progression|267
1275523|NCT00417027|4169232|P3|Overall Study|Protocol Violation|5
1275524|NCT00417027|4169233|P2|Overall Study|Protocol Violation|5
1275525|NCT00417027|4169234|P1|Overall Study|Protocol Violation|0
1275526|NCT00416949|4169260|P1|Overall Study|Patients refused to participate|5
1275527|NCT00416884|4169264|P1|Overall Study|Study terminated due to low accrual|1
1275528|NCT00416715|4169272|P1|Overall Study|Vitamin D levels not evaluable|8
1275529|NCT00416715|4169272|P1|Overall Study|Not evaluable for joint aches|7
1275530|NCT00416624|4169283|P4|Overall Study|Cancel|0
1275531|NCT00416624|4169284|P3|Overall Study|Cancel|0
1275532|NCT00416624|4169285|P2|Overall Study|Cancel|0
1275533|NCT00416624|4169286|P1|Overall Study|Cancel|1
1275534|NCT00416624|4169283|P4|Overall Study|Not Specified|5
1275535|NCT00416624|4169284|P3|Overall Study|Not Specified|5
1275536|NCT00416624|4169285|P2|Overall Study|Not Specified|11
1275537|NCT00416624|4169286|P1|Overall Study|Not Specified|8
1275538|NCT00416624|4169283|P4|Overall Study|Adverse Event|2
1275539|NCT00416624|4169284|P3|Overall Study|Adverse Event|2
1275540|NCT00416624|4169285|P2|Overall Study|Adverse Event|3
1275541|NCT00416624|4169286|P1|Overall Study|Adverse Event|8
1275542|NCT00416624|4169283|P4|Overall Study|Death|1
1275543|NCT00416624|4169284|P3|Overall Study|Death|7
1275544|NCT00416624|4169285|P2|Overall Study|Death|7
1275545|NCT00416624|4169286|P1|Overall Study|Death|4
1275546|NCT00416624|4169283|P4|Overall Study|Withdrawal by Subject|9
1275547|NCT00416624|4169284|P3|Overall Study|Withdrawal by Subject|4
1275548|NCT00416624|4169285|P2|Overall Study|Withdrawal by Subject|6
1275549|NCT00416624|4169286|P1|Overall Study|Withdrawal by Subject|1
1275550|NCT00416598|4169340|P1|Decitabine Maintenance|Physician discretion/other medical issue|9
1275551|NCT00416598|4169340|P1|Decitabine Maintenance|Alternative treatment|2
1275552|NCT00416598|4169340|P1|Decitabine Maintenance|Progression/relapse|38
1275553|NCT00416598|4169340|P1|Decitabine Maintenance|Withdrawal by Subject|18
1275554|NCT00416598|4169340|P1|Decitabine Maintenance|Adverse Event|5
1275555|NCT00416598|4169340|P1|Induction & Intensification|Failed induction|87
1275556|NCT00416598|4169340|P1|Induction & Intensification|Relapse/progression|29
1275557|NCT00416598|4169340|P1|Induction & Intensification|Physician discretion/other medical issue|45
1275558|NCT00416598|4169340|P1|Induction & Intensification|Alternative Treatment|135
1275559|NCT00416598|4169340|P1|Induction & Intensification|Withdrawal by Subject|46
1275560|NCT00416598|4169340|P1|Induction & Intensification|Death|32
1275561|NCT00416598|4169340|P1|Induction & Intensification|Adverse Event|38
1275562|NCT00416520|4169366|P4|Placebo-controlled Withdrawal Period|Protocol Violation|1
1275563|NCT00416520|4169367|P3|Placebo-controlled Withdrawal Period|Protocol Violation|1
1275564|NCT00416520|4169368|P2|Placebo-controlled Withdrawal Period|Protocol Violation|0
1275565|NCT00416520|4169369|P1|Placebo-controlled Withdrawal Period|Protocol Violation|0
1275566|NCT00416520|4169366|P4|Placebo-controlled Withdrawal Period|Lack of Efficacy|3
1275567|NCT00416520|4169367|P3|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
1275568|NCT00416520|4169368|P2|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
1275569|NCT00416520|4169369|P1|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
1275570|NCT00416520|4169366|P4|Placebo-controlled Withdrawal Period|Adverse Event|1
1275571|NCT00416520|4169367|P3|Placebo-controlled Withdrawal Period|Adverse Event|0
1275572|NCT00416520|4169368|P2|Placebo-controlled Withdrawal Period|Adverse Event|0
1275573|NCT00416520|4169369|P1|Placebo-controlled Withdrawal Period|Adverse Event|0
1275574|NCT00416520|4169366|P4|Open-label Period|Other Reasons|0
1275575|NCT00416520|4169367|P3|Open-label Period|Other Reasons|0
1275576|NCT00416520|4169368|P2|Open-label Period|Other Reasons|12
1275577|NCT00416520|4169369|P1|Open-label Period|Other Reasons|3
1275578|NCT00416520|4169366|P4|Open-label Period|Withdrawal by Subject|0
1275579|NCT00416520|4169367|P3|Open-label Period|Withdrawal by Subject|0
1275580|NCT00416520|4169368|P2|Open-label Period|Withdrawal by Subject|5
1275581|NCT00416520|4169369|P1|Open-label Period|Withdrawal by Subject|16
1275582|NCT00416520|4169366|P4|Open-label Period|Protocol Violation|0
1275583|NCT00416520|4169367|P3|Open-label Period|Protocol Violation|0
1275584|NCT00416520|4169368|P2|Open-label Period|Protocol Violation|3
1275585|NCT00416520|4169369|P1|Open-label Period|Protocol Violation|3
1275586|NCT00416520|4169366|P4|Open-label Period|Lack of Efficacy|0
1275587|NCT00416520|4169367|P3|Open-label Period|Lack of Efficacy|0
1275588|NCT00416520|4169368|P2|Open-label Period|Lack of Efficacy|1
1275589|NCT00416520|4169369|P1|Open-label Period|Lack of Efficacy|8
1275590|NCT00416520|4169366|P4|Open-label Period|Death|0
1275591|NCT00416520|4169367|P3|Open-label Period|Death|0
1275592|NCT00416520|4169368|P2|Open-label Period|Death|1
1275593|NCT00416520|4169369|P1|Open-label Period|Death|2
1275594|NCT00416520|4169366|P4|Open-label Period|Adverse Event|0
1275595|NCT00416520|4169367|P3|Open-label Period|Adverse Event|0
1275596|NCT00416520|4169368|P2|Open-label Period|Adverse Event|10
1275597|NCT00416520|4169369|P1|Open-label Period|Adverse Event|28
1275598|NCT00416455|4169398|P2|Overall Study|Inadequate pathology|2
1275599|NCT00416455|4169399|P1|Overall Study|Inadequate pathology|11
1275600|NCT00416455|4169398|P2|Overall Study|PET / CT poor quality|1
1275601|NCT00416455|4169399|P1|Overall Study|PET / CT poor quality|2
1275602|NCT00416455|4169398|P2|Overall Study|PET / CT not done|5
1275603|NCT00416455|4169399|P1|Overall Study|PET / CT not done|3
1275604|NCT00416312|4169434|P1|Overall Study|tumors not visible on imaging|2
1275605|NCT00416195|4169440|P2|Overall Study|Not Specified|1
1275606|NCT00416195|4169441|P1|Overall Study|Not Specified|0
1275607|NCT00416195|4169440|P2|Overall Study|Protocol Violation|1
1275608|NCT00416195|4169441|P1|Overall Study|Protocol Violation|1
1275609|NCT00416195|4169440|P2|Overall Study|Adverse Event|2
1275610|NCT00416195|4169441|P1|Overall Study|Adverse Event|1
1275611|NCT00416078|4169466|P2|Overall Study|Lost to Follow-up|2
1275612|NCT00416078|4169467|P1|Overall Study|Lost to Follow-up|4
1275613|NCT00416078|4169466|P2|Overall Study|Physician Decision|0
1275614|NCT00416078|4169467|P1|Overall Study|Physician Decision|1
1275615|NCT00416078|4169466|P2|Overall Study|Withdrawal by Subject|2
1275616|NCT00416078|4169467|P1|Overall Study|Withdrawal by Subject|3
1275617|NCT00416078|4169466|P2|Overall Study|Death|4
1275618|NCT00416078|4169467|P1|Overall Study|Death|3
1275619|NCT00415909|4169483|P1|Overall Study|Death|1
1275620|NCT00415909|4169483|P1|Overall Study|Withdrawal by Subject|2
1275621|NCT00415636|4169513|P6|Overall Study|Disease progression|1
1275622|NCT00415636|4169514|P5|Overall Study|Disease progression|0
1275623|NCT00415636|4169515|P4|Overall Study|Disease progression|3
1275624|NCT00415636|4169516|P3|Overall Study|Disease progression|0
1275625|NCT00415636|4169517|P2|Overall Study|Disease progression|0
1275626|NCT00415636|4169518|P1|Overall Study|Disease progression|0
1275627|NCT00415636|4169513|P6|Overall Study|Withdrawal by Subject|0
1275628|NCT00415636|4169514|P5|Overall Study|Withdrawal by Subject|1
1275629|NCT00415636|4169515|P4|Overall Study|Withdrawal by Subject|0
1275630|NCT00415636|4169516|P3|Overall Study|Withdrawal by Subject|0
1275631|NCT00415636|4169517|P2|Overall Study|Withdrawal by Subject|0
1275632|NCT00415636|4169518|P1|Overall Study|Withdrawal by Subject|0
1275633|NCT00415636|4169513|P6|Overall Study|Adverse Event|0
1275634|NCT00415636|4169514|P5|Overall Study|Adverse Event|1
1275635|NCT00415636|4169515|P4|Overall Study|Adverse Event|1
1275636|NCT00415636|4169516|P3|Overall Study|Adverse Event|0
1275637|NCT00415636|4169517|P2|Overall Study|Adverse Event|0
1275638|NCT00415636|4169518|P1|Overall Study|Adverse Event|0
1275639|NCT00415636|4169513|P6|Overall Study|Symptomatic deterioration|1
1275640|NCT00415636|4169514|P5|Overall Study|Symptomatic deterioration|0
1275641|NCT00415636|4169515|P4|Overall Study|Symptomatic deterioration|2
1275642|NCT00415636|4169516|P3|Overall Study|Symptomatic deterioration|1
1275643|NCT00415636|4169517|P2|Overall Study|Symptomatic deterioration|0
1275644|NCT00415636|4169518|P1|Overall Study|Symptomatic deterioration|1
1275645|NCT00415623|4169552|P2|Overall Study|Withdrawal by Subject|1
1275646|NCT00415623|4169553|P1|Overall Study|Withdrawal by Subject|1
1275647|NCT00415623|4169552|P2|Overall Study|Death|0
1275648|NCT00415623|4169553|P1|Overall Study|Death|1
1275649|NCT00415623|4169552|P2|Overall Study|Adverse Event|4
1275650|NCT00415623|4169553|P1|Overall Study|Adverse Event|3
1275651|NCT00415610|4169580|P3|Overall Study|Death|5
1275652|NCT00415610|4169581|P2|Overall Study|Death|2
1275653|NCT00415610|4169582|P1|Overall Study|Death|3
1275654|NCT00415597|4169602|P1|Treatment|Multiple Reasons|1
1275655|NCT00415597|4169602|P1|Treatment|Sponsor Decision|1
1275656|NCT00415597|4169602|P1|Treatment|Administrative|3
1275657|NCT00415597|4169602|P1|Treatment|Drug Screen|2
1275658|NCT00415597|4169602|P1|Treatment|Lost to Follow-up|28
1275659|NCT00415597|4169602|P1|Treatment|Withdrawal by Subject|51
1275660|NCT00415597|4169602|P1|Treatment|Physician Decision|3
1275661|NCT00415597|4169602|P1|Treatment|Protocol Violation|67
1275662|NCT00415597|4169602|P1|Treatment|Lack of Efficacy|39
1275663|NCT00415597|4169602|P1|Treatment|Adverse Event|110
1275664|NCT00415597|4169602|P1|Enrollment|Protocol Violation|1
1275665|NCT00415597|4169602|P1|Enrollment|Withdrawal by Subject|1
1275666|NCT00415532|4169610|P2|Safety Follow Up Period|Requirement for alternative therapy|1
1275667|NCT00415532|4169611|P1|Safety Follow Up Period|Requirement for alternative therapy|0
1275668|NCT00415532|4169610|P2|Safety Follow Up Period|Noncompliance|0
1275669|NCT00415532|4169611|P1|Safety Follow Up Period|Noncompliance|1
1275670|NCT00415532|4169610|P2|Safety Follow Up Period|Ineligibility determined|1
1275671|NCT00415532|4169611|P1|Safety Follow Up Period|Ineligibility determined|1
1275672|NCT00415532|4169610|P2|Safety Follow Up Period|Other|4
1275673|NCT00415532|4169611|P1|Safety Follow Up Period|Other|1
1275674|NCT00415532|4169610|P2|Safety Follow Up Period|Withdrawal by Subject|3
1275675|NCT00415532|4169611|P1|Safety Follow Up Period|Withdrawal by Subject|2
1275676|NCT00415532|4169610|P2|Safety Follow Up Period|Death|0
1275677|NCT00415532|4169611|P1|Safety Follow Up Period|Death|3
1275678|NCT00415532|4169610|P2|Safety Follow Up Period|Adverse Event|3
1275679|NCT00415532|4169611|P1|Safety Follow Up Period|Adverse Event|1
1275680|NCT00415532|4169610|P2|Treatment Period|Requirement for alternative therapy|0
1275681|NCT00415532|4169611|P1|Treatment Period|Requirement for alternative therapy|1
1275682|NCT00415532|4169610|P2|Treatment Period|Noncompliance|1
1275683|NCT00415532|4169611|P1|Treatment Period|Noncompliance|1
1275684|NCT00415532|4169610|P2|Treatment Period|Ineligibility determined|1
1275685|NCT00415532|4169611|P1|Treatment Period|Ineligibility determined|1
1275686|NCT00415532|4169610|P2|Treatment Period|Other|2
1275687|NCT00415532|4169611|P1|Treatment Period|Other|2
1275688|NCT00415532|4169610|P2|Treatment Period|Withdrawal by Subject|6
1275689|NCT00415532|4169611|P1|Treatment Period|Withdrawal by Subject|6
1275690|NCT00415532|4169610|P2|Treatment Period|Protocol Violation|0
1275691|NCT00415532|4169611|P1|Treatment Period|Protocol Violation|1
1275692|NCT00415532|4169610|P2|Treatment Period|Lost to Follow-up|1
1275693|NCT00415532|4169611|P1|Treatment Period|Lost to Follow-up|1
1275694|NCT00415532|4169610|P2|Treatment Period|Death|1
1275695|NCT00415532|4169611|P1|Treatment Period|Death|2
1275696|NCT00415532|4169610|P2|Treatment Period|Adverse Event|3
1275697|NCT00415532|4169611|P1|Treatment Period|Adverse Event|2
1275698|NCT00415519|4169633|P2|Overall Study|Patient’s convenience|0
1275699|NCT00415519|4169634|P1|Overall Study|Patient’s convenience|1
1275700|NCT00415519|4169633|P2|Overall Study|Withdrawal by Subject|0
1275701|NCT00415519|4169634|P1|Overall Study|Withdrawal by Subject|2
1275702|NCT00415519|4169633|P2|Overall Study|Adverse Event|0
1275703|NCT00415519|4169634|P1|Overall Study|Adverse Event|1
1275704|NCT00415194|4169674|P2|Overall Study|Death Due to AE (Other Causes)|15
1275705|NCT00415194|4169675|P1|Overall Study|Death Due to AE (Other Causes)|27
1275706|NCT00415194|4169674|P2|Overall Study|Death Due to Procedural Related AE|1
1275707|NCT00415194|4169675|P1|Overall Study|Death Due to Procedural Related AE|0
1275708|NCT00415194|4169674|P2|Overall Study|Death Due to Study Drug Related AE|1
1275709|NCT00415194|4169675|P1|Overall Study|Death Due to Study Drug Related AE|11
1275710|NCT00415194|4169674|P2|Overall Study|Death Due to Study Disease|29
1275711|NCT00415194|4169675|P1|Overall Study|Death Due to Study Disease|26
1275712|NCT00415194|4169674|P2|Overall Study|Withdrawal by Subject|21
1275713|NCT00415194|4169675|P1|Overall Study|Withdrawal by Subject|28
1275714|NCT00415194|4169674|P2|Overall Study|Protocol Violation|2
1275715|NCT00415194|4169675|P1|Overall Study|Protocol Violation|4
1275716|NCT00415194|4169674|P2|Overall Study|Progressive Disease|217
1275717|NCT00415194|4169675|P1|Overall Study|Progressive Disease|180
1275718|NCT00415194|4169674|P2|Overall Study|Physician Decision|16
1275719|NCT00415194|4169675|P1|Overall Study|Physician Decision|10
1275720|NCT00415194|4169674|P2|Overall Study|Lost to Follow-up|0
1275721|NCT00415194|4169675|P1|Overall Study|Lost to Follow-up|1
1275722|NCT00415194|4169674|P2|Overall Study|Entry Criteria Not Met|8
1275723|NCT00415194|4169675|P1|Overall Study|Entry Criteria Not Met|4
1275724|NCT00415194|4169674|P2|Overall Study|Adverse Event|32
1275725|NCT00415194|4169675|P1|Overall Study|Adverse Event|37
1275726|NCT00415168|4169691|P1|Overall Study|Withdrawal by Subject|6
1275727|NCT00415168|4169691|P1|Overall Study|Sponsor Decision|4
1275728|NCT00415168|4169691|P1|Overall Study|Physician Decision|13
1275729|NCT00415168|4169691|P1|Overall Study|Lost to Follow-up|3
1275730|NCT00415168|4169691|P1|Overall Study|Death|26
1275731|NCT00415051|4169701|P1|Overall Study|Protocol Violation|1
1275732|NCT00414973|4169712|P4|Overall Study|Death|0
1275733|NCT00414973|4169713|P3|Overall Study|Death|1
1275734|NCT00414973|4169714|P2|Overall Study|Death|0
1275735|NCT00414973|4169715|P1|Overall Study|Death|0
1275736|NCT00414973|4169712|P4|Overall Study|Sponsor Decision|0
1275737|NCT00414973|4169713|P3|Overall Study|Sponsor Decision|0
1275738|NCT00414973|4169714|P2|Overall Study|Sponsor Decision|0
1275739|NCT00414973|4169715|P1|Overall Study|Sponsor Decision|1
1275740|NCT00414973|4169712|P4|Overall Study|Lost to Follow-up|0
1275741|NCT00414973|4169713|P3|Overall Study|Lost to Follow-up|0
1275742|NCT00414973|4169714|P2|Overall Study|Lost to Follow-up|2
1275743|NCT00414973|4169715|P1|Overall Study|Lost to Follow-up|0
1275744|NCT00414973|4169712|P4|Overall Study|Protocol Violation|0
1275745|NCT00414973|4169713|P3|Overall Study|Protocol Violation|0
1275746|NCT00414973|4169714|P2|Overall Study|Protocol Violation|4
1275747|NCT00414973|4169715|P1|Overall Study|Protocol Violation|3
1275748|NCT00414973|4169712|P4|Overall Study|Adverse Event|0
1275749|NCT00414973|4169713|P3|Overall Study|Adverse Event|1
1275750|NCT00414973|4169714|P2|Overall Study|Adverse Event|0
1275751|NCT00414973|4169715|P1|Overall Study|Adverse Event|10
1275752|NCT00414973|4169712|P4|Overall Study|Withdrawal by Subject|0
1275753|NCT00414973|4169713|P3|Overall Study|Withdrawal by Subject|1
1275754|NCT00414973|4169714|P2|Overall Study|Withdrawal by Subject|4
1275755|NCT00414973|4169715|P1|Overall Study|Withdrawal by Subject|14
1275756|NCT00414908|4169735|P2|Overall Study|Protocol Violation|1
1275757|NCT00414908|4169736|P1|Overall Study|Protocol Violation|1
1275758|NCT00414726|4169773|P2|Overall Study|Withdrawal by Subject|1
1275759|NCT00414726|4169774|P1|Overall Study|Withdrawal by Subject|0
1275760|NCT00414661|4169809|P4|Overall Study|Other|0
1275761|NCT00414661|4169810|P3|Overall Study|Other|0
1275762|NCT00414661|4169811|P2|Overall Study|Other|3
1275763|NCT00414661|4169812|P1|Overall Study|Other|6
1275764|NCT00414661|4169809|P4|Overall Study|Withdrawal by Subject|2
1275765|NCT00414661|4169810|P3|Overall Study|Withdrawal by Subject|2
1275766|NCT00414661|4169811|P2|Overall Study|Withdrawal by Subject|2
1275767|NCT00414661|4169812|P1|Overall Study|Withdrawal by Subject|5
1275768|NCT00414661|4169809|P4|Overall Study|Lost to Follow-up|1
1275769|NCT00414661|4169810|P3|Overall Study|Lost to Follow-up|0
1275770|NCT00414661|4169811|P2|Overall Study|Lost to Follow-up|4
1275771|NCT00414661|4169812|P1|Overall Study|Lost to Follow-up|1
1275772|NCT00414661|4169809|P4|Overall Study|Death|0
1275773|NCT00414661|4169810|P3|Overall Study|Death|0
1275774|NCT00414661|4169811|P2|Overall Study|Death|5
1275775|NCT00414661|4169812|P1|Overall Study|Death|2
1275776|NCT00414609|4169857|P3|Extension Study|Death|17
1275777|NCT00414609|4169858|P2|Extension Study|Death|0
1275778|NCT00414609|4169859|P1|Extension Study|Death|0
1275779|NCT00414609|4169857|P3|Extension Study|Administrative problems|1
1275780|NCT00414609|4169858|P2|Extension Study|Administrative problems|0
1275781|NCT00414609|4169859|P1|Extension Study|Administrative problems|0
1275782|NCT00414609|4169857|P3|Extension Study|Lost to Follow-up|10
1275783|NCT00414609|4169858|P2|Extension Study|Lost to Follow-up|0
1275784|NCT00414609|4169859|P1|Extension Study|Lost to Follow-up|0
1275785|NCT00414609|4169857|P3|Extension Study|Withdrawal by Subject|13
1275786|NCT00414609|4169858|P2|Extension Study|Withdrawal by Subject|0
1275787|NCT00414609|4169859|P1|Extension Study|Withdrawal by Subject|0
1275788|NCT00414609|4169857|P3|Extension Study|Unsatisfactory therapeutic effect|2
1275789|NCT00414609|4169858|P2|Extension Study|Unsatisfactory therapeutic effect|0
1275790|NCT00414609|4169859|P1|Extension Study|Unsatisfactory therapeutic effect|0
1275791|NCT00414609|4169857|P3|Extension Study|Adverse Event|14
1275792|NCT00414609|4169858|P2|Extension Study|Adverse Event|0
1275793|NCT00414609|4169859|P1|Extension Study|Adverse Event|0
1275794|NCT00414609|4169857|P3|Core Study|Death|0
1275795|NCT00414609|4169858|P2|Core Study|Death|14
1275796|NCT00414609|4169859|P1|Core Study|Death|7
1275797|NCT00414609|4169857|P3|Core Study|Administrative problems|0
1275798|NCT00414609|4169858|P2|Core Study|Administrative problems|2
1275799|NCT00414609|4169859|P1|Core Study|Administrative problems|0
1275800|NCT00414609|4169857|P3|Core Study|Lost to Follow-up|0
1275801|NCT00414609|4169858|P2|Core Study|Lost to Follow-up|4
1275802|NCT00414609|4169859|P1|Core Study|Lost to Follow-up|7
1275803|NCT00414609|4169857|P3|Core Study|Patient withdrew consent|0
1275804|NCT00414609|4169858|P2|Core Study|Patient withdrew consent|11
1275805|NCT00414609|4169859|P1|Core Study|Patient withdrew consent|10
1275806|NCT00414609|4169857|P3|Core Study|Protocol deviation|0
1275807|NCT00414609|4169858|P2|Core Study|Protocol deviation|1
1275808|NCT00414609|4169859|P1|Core Study|Protocol deviation|0
1275809|NCT00414609|4169857|P3|Core Study|Abnormal test procedure results|0
1275810|NCT00414609|4169858|P2|Core Study|Abnormal test procedure results|1
1275811|NCT00414609|4169859|P1|Core Study|Abnormal test procedure results|1
1275812|NCT00414609|4169857|P3|Core Study|Abnormal laboratory values|0
1275813|NCT00414609|4169858|P2|Core Study|Abnormal laboratory values|1
1275814|NCT00414609|4169859|P1|Core Study|Abnormal laboratory values|0
1275815|NCT00414609|4169857|P3|Core Study|Adverse Event|0
1275816|NCT00414609|4169858|P2|Core Study|Adverse Event|11
1275817|NCT00414609|4169859|P1|Core Study|Adverse Event|9
1275818|NCT00414596|4169882|P1|Overall Study|Protocol Violation|2
1275819|NCT00414544|4169891|P1|Overall Study|Lost to Follow-up|14
1275820|NCT00414466|4169914|P4|Overall Study|Withdrawn by Sponsor|0
1275821|NCT00414466|4169915|P3|Overall Study|Withdrawn by Sponsor|0
1275822|NCT00414466|4169916|P2|Overall Study|Withdrawn by Sponsor|0
1275823|NCT00414466|4169917|P1|Overall Study|Withdrawn by Sponsor|1
1275824|NCT00414466|4169914|P4|Overall Study|Lack of Efficacy|0
1275825|NCT00414466|4169915|P3|Overall Study|Lack of Efficacy|0
1275826|NCT00414466|4169916|P2|Overall Study|Lack of Efficacy|0
1275827|NCT00414466|4169917|P1|Overall Study|Lack of Efficacy|1
1275828|NCT00414466|4169914|P4|Overall Study|Adverse Event|1
1275829|NCT00414466|4169915|P3|Overall Study|Adverse Event|1
1275830|NCT00414466|4169916|P2|Overall Study|Adverse Event|0
1275831|NCT00414466|4169917|P1|Overall Study|Adverse Event|0
1275832|NCT00414453|4169935|P1|Overall Study|Abnormal lab work|16
1275833|NCT00414440|4169983|P2|Extension Period|Not included in follow up period|8
1275834|NCT00414440|4169984|P1|Extension Period|Not included in follow up period|18
1275835|NCT00414440|4169983|P2|Extension Period|Withdrawal by Subject|7
1275836|NCT00414440|4169984|P1|Extension Period|Withdrawal by Subject|9
1275837|NCT00414440|4169983|P2|Extension Period|Death|2
1275838|NCT00414440|4169984|P1|Extension Period|Death|1
1275839|NCT00414440|4169983|P2|Extension Period|Administrative|16
1275840|NCT00414440|4169984|P1|Extension Period|Administrative|16
1275841|NCT00414440|4169983|P2|Extension Period|Other|1
1275842|NCT00414440|4169984|P1|Extension Period|Other|1
1275843|NCT00414440|4169983|P2|Extension Period|Did not consent to continue follow up|54
1275844|NCT00414440|4169984|P1|Extension Period|Did not consent to continue follow up|61
1275845|NCT00414440|4169983|P2|Extension Period|Lost to Follow-up|52
1275846|NCT00414440|4169984|P1|Extension Period|Lost to Follow-up|44
1275847|NCT00414440|4169983|P2|Core Period|Withdrawal by Subject|32
1275848|NCT00414440|4169984|P1|Core Period|Withdrawal by Subject|70
1275849|NCT00414388|4169998|P1|Overall Study|Adverse Event|1
1275850|NCT00414310|4170006|P2|Overall Study|Not treated|0
1275851|NCT00414310|4170007|P1|Overall Study|Not treated|1
1275852|NCT00414076|4170039|P2|Overall Study|Adverse Event|0
1275853|NCT00414076|4170040|P1|Overall Study|Adverse Event|1
1275854|NCT00414076|4170039|P2|Overall Study|Withdrawal by Subject|3
1275855|NCT00414076|4170040|P1|Overall Study|Withdrawal by Subject|1
1275856|NCT00414076|4170039|P2|Overall Study|Progression|2
1275857|NCT00414076|4170040|P1|Overall Study|Progression|1
1275858|NCT00414050|4170050|P4|Overall Study|Subject Moved|1
1275859|NCT00414050|4170051|P3|Overall Study|Subject Moved|0
1275860|NCT00414050|4170052|P2|Overall Study|Subject Moved|0
1275861|NCT00414050|4170053|P1|Overall Study|Subject Moved|0
1275862|NCT00414050|4170050|P4|Overall Study|Subject discontinued for other reason|1
1275863|NCT00414050|4170051|P3|Overall Study|Subject discontinued for other reason|2
1275864|NCT00414050|4170052|P2|Overall Study|Subject discontinued for other reason|2
1275865|NCT00414050|4170053|P1|Overall Study|Subject discontinued for other reason|1
1275866|NCT00414050|4170050|P4|Overall Study|Withdrawal by Subject|4
1275867|NCT00414050|4170051|P3|Overall Study|Withdrawal by Subject|2
1275868|NCT00414050|4170052|P2|Overall Study|Withdrawal by Subject|3
1275869|NCT00414050|4170053|P1|Overall Study|Withdrawal by Subject|5
1275870|NCT00414050|4170050|P4|Overall Study|Lost to Follow-up|1
1275871|NCT00414050|4170051|P3|Overall Study|Lost to Follow-up|1
1275872|NCT00414050|4170052|P2|Overall Study|Lost to Follow-up|2
1275873|NCT00414050|4170053|P1|Overall Study|Lost to Follow-up|2
1275874|NCT00414050|4170050|P4|Overall Study|Adverse Event|1
1275875|NCT00414050|4170051|P3|Overall Study|Adverse Event|1
1275876|NCT00414050|4170052|P2|Overall Study|Adverse Event|1
1275877|NCT00414050|4170053|P1|Overall Study|Adverse Event|1
1275878|NCT00414011|4170067|P1|Overall Study|Withdrawal by Subject|2
1275879|NCT00414011|4170067|P1|Overall Study|Physician Decision|3
1275880|NCT00413972|4170076|P4|Overall Study|Not Specified|1
1275881|NCT00413972|4170077|P3|Overall Study|Not Specified|0
1275882|NCT00413972|4170078|P2|Overall Study|Not Specified|0
1275883|NCT00413972|4170079|P1|Overall Study|Not Specified|0
1275884|NCT00413972|4170076|P4|Overall Study|Protocol Violation|0
1275885|NCT00413972|4170077|P3|Overall Study|Protocol Violation|2
1275886|NCT00413972|4170078|P2|Overall Study|Protocol Violation|0
1275887|NCT00413972|4170079|P1|Overall Study|Protocol Violation|0
1275888|NCT00413972|4170076|P4|Overall Study|Withdrawal by Subject|2
1275889|NCT00413972|4170077|P3|Overall Study|Withdrawal by Subject|7
1275890|NCT00413972|4170078|P2|Overall Study|Withdrawal by Subject|5
1275891|NCT00413972|4170079|P1|Overall Study|Withdrawal by Subject|4
1275892|NCT00413972|4170076|P4|Overall Study|Lost to Follow-up|0
1275893|NCT00413972|4170077|P3|Overall Study|Lost to Follow-up|1
1275894|NCT00413972|4170078|P2|Overall Study|Lost to Follow-up|2
1275895|NCT00413972|4170079|P1|Overall Study|Lost to Follow-up|1
1275896|NCT00413972|4170076|P4|Overall Study|Adverse Event|0
1275897|NCT00413972|4170077|P3|Overall Study|Adverse Event|0
1275898|NCT00413972|4170078|P2|Overall Study|Adverse Event|1
1275899|NCT00413972|4170079|P1|Overall Study|Adverse Event|2
1275900|NCT00413959|4170089|P1|Overall Study|Pt had only one cycle.|1
1275901|NCT00413920|4170096|P2|Overall Study|Graft Loss|3
1275902|NCT00413920|4170097|P1|Overall Study|Graft Loss|5
1275903|NCT00413920|4170096|P2|Overall Study|Death|5
1275904|NCT00413920|4170097|P1|Overall Study|Death|3
1275905|NCT00413920|4170096|P2|Overall Study|Lack of Efficacy|9
1275906|NCT00413920|4170097|P1|Overall Study|Lack of Efficacy|11
1275907|NCT00413920|4170096|P2|Overall Study|Adverse Event|11
1275908|NCT00413920|4170097|P1|Overall Study|Adverse Event|9
1275909|NCT00413894|4170112|P1|Overall Study|Other|18
1275910|NCT00413894|4170112|P1|Overall Study|Protocol Violation|11
1275911|NCT00413894|4170112|P1|Overall Study|Adverse Event|28
1275912|NCT00413894|4170112|P1|Overall Study|Hb <10 grams/deciliter|12
1275913|NCT00413894|4170112|P1|Overall Study|Administrative Reasons|1
1275914|NCT00413894|4170112|P1|Overall Study|Withdrawal by Subject|10
1275915|NCT00413777|4170129|P2|Fixed-dose Period|Withdrew Consent|1
1275916|NCT00413777|4170130|P1|Fixed-dose Period|Withdrew Consent|0
1275917|NCT00413777|4170129|P2|Fixed-dose Period|Met Withdrawal Criteria|0
1275918|NCT00413777|4170130|P1|Fixed-dose Period|Met Withdrawal Criteria|1
1275919|NCT00413777|4170129|P2|Fixed-dose Period|Adverse Event|1
1275920|NCT00413777|4170130|P1|Fixed-dose Period|Adverse Event|2
1275921|NCT00413777|4170129|P2|Fixed-dose Period|Lost to Follow-up|1
1275922|NCT00413777|4170130|P1|Fixed-dose Period|Lost to Follow-up|1
1275923|NCT00413699|4170178|P3|Extension Period|Adverse Event|2
1275924|NCT00413699|4170179|P2|Extension Period|Adverse Event|0
1275925|NCT00413699|4170180|P1|Extension Period|Adverse Event|0
1275926|NCT00413699|4170178|P3|Extension Period|Protocol Violation|1
1275927|NCT00413699|4170179|P2|Extension Period|Protocol Violation|0
1275928|NCT00413699|4170180|P1|Extension Period|Protocol Violation|0
1275929|NCT00413699|4170178|P3|Extension Period|No Longer Willing to Participate|2
1275930|NCT00413699|4170179|P2|Extension Period|No Longer Willing to Participate|0
1275931|NCT00413699|4170180|P1|Extension Period|No Longer Willing to Participate|0
1275932|NCT00413699|4170178|P3|Initial Period|No longer willing to participate|0
1275933|NCT00413699|4170179|P2|Initial Period|No longer willing to participate|368
1275934|NCT00413699|4170180|P1|Initial Period|No longer willing to participate|116
1275935|NCT00413699|4170178|P3|Initial Period|Missing end of study page|0
1275936|NCT00413699|4170179|P2|Initial Period|Missing end of study page|4
1275937|NCT00413699|4170180|P1|Initial Period|Missing end of study page|0
1275938|NCT00413699|4170178|P3|Initial Period|Adverse event not related to study drug|0
1275939|NCT00413699|4170179|P2|Initial Period|Adverse event not related to study drug|248
1275940|NCT00413699|4170180|P1|Initial Period|Adverse event not related to study drug|113
1275941|NCT00413699|4170178|P3|Initial Period|Adverse event related to study drug|0
1275942|NCT00413699|4170179|P2|Initial Period|Adverse event related to study drug|527
1275943|NCT00413699|4170180|P1|Initial Period|Adverse event related to study drug|178
1275944|NCT00413699|4170178|P3|Initial Period|Not specified|0
1275945|NCT00413699|4170179|P2|Initial Period|Not specified|211
1275946|NCT00413699|4170180|P1|Initial Period|Not specified|67
1275947|NCT00413699|4170178|P3|Initial Period|Study terminated by Sponsor|0
1275948|NCT00413699|4170179|P2|Initial Period|Study terminated by Sponsor|1
1275949|NCT00413699|4170180|P1|Initial Period|Study terminated by Sponsor|0
1275950|NCT00413699|4170178|P3|Initial Period|Medication error without adverse event|0
1275951|NCT00413699|4170179|P2|Initial Period|Medication error without adverse event|1
1275952|NCT00413699|4170180|P1|Initial Period|Medication error without adverse event|0
1275953|NCT00413699|4170178|P3|Initial Period|Did not meet entrance criteria|0
1275954|NCT00413699|4170179|P2|Initial Period|Did not meet entrance criteria|2
1275955|NCT00413699|4170180|P1|Initial Period|Did not meet entrance criteria|2
1275956|NCT00413699|4170178|P3|Initial Period|Pregnancy|0
1275957|NCT00413699|4170179|P2|Initial Period|Pregnancy|8
1275958|NCT00413699|4170180|P1|Initial Period|Pregnancy|10
1275959|NCT00413699|4170178|P3|Initial Period|Protocol Violation|0
1275960|NCT00413699|4170179|P2|Initial Period|Protocol Violation|89
1275961|NCT00413699|4170180|P1|Initial Period|Protocol Violation|38
1275962|NCT00413699|4170178|P3|Initial Period|Lost to Follow-up|0
1275963|NCT00413699|4170179|P2|Initial Period|Lost to Follow-up|101
1275964|NCT00413699|4170180|P1|Initial Period|Lost to Follow-up|31
1275965|NCT00413699|4170178|P3|Initial Period|Lack of Efficacy|0
1275966|NCT00413699|4170179|P2|Initial Period|Lack of Efficacy|115
1275967|NCT00413699|4170180|P1|Initial Period|Lack of Efficacy|59
1275968|NCT00413699|4170178|P3|Initial Period|Death|0
1275969|NCT00413699|4170179|P2|Initial Period|Death|30
1275970|NCT00413699|4170180|P1|Initial Period|Death|25
1275971|NCT00413660|4170262|P11|Post Week 12|Other|0
1275972|NCT00413660|4170263|P10|Post Week 12|Other|0
1275973|NCT00413660|4170264|P9|Post Week 12|Other|0
1275974|NCT00413660|4170265|P8|Post Week 12|Other|0
1275975|NCT00413660|4170266|P7|Post Week 12|Other|1
1275976|NCT00413660|4170267|P6|Post Week 12|Other|1
1275977|NCT00413660|4170268|P5|Post Week 12|Other|1
1275978|NCT00413660|4170269|P4|Post Week 12|Other|0
1275979|NCT00413660|4170270|P3|Post Week 12|Other|3
1275980|NCT00413660|4170271|P2|Post Week 12|Other|2
1275981|NCT00413660|4170272|P1|Post Week 12|Other|1
1275982|NCT00413660|4170262|P11|Post Week 12|Withdrawal by Subject|1
1275983|NCT00413660|4170263|P10|Post Week 12|Withdrawal by Subject|0
1275984|NCT00413660|4170264|P9|Post Week 12|Withdrawal by Subject|0
1275985|NCT00413660|4170265|P8|Post Week 12|Withdrawal by Subject|0
1275986|NCT00413660|4170266|P7|Post Week 12|Withdrawal by Subject|0
1275987|NCT00413660|4170267|P6|Post Week 12|Withdrawal by Subject|0
1275988|NCT00413660|4170268|P5|Post Week 12|Withdrawal by Subject|1
1275989|NCT00413660|4170269|P4|Post Week 12|Withdrawal by Subject|0
1275990|NCT00413660|4170270|P3|Post Week 12|Withdrawal by Subject|1
1275991|NCT00413660|4170271|P2|Post Week 12|Withdrawal by Subject|1
1275992|NCT00413660|4170272|P1|Post Week 12|Withdrawal by Subject|0
1275993|NCT00413660|4170262|P11|Post Week 12|Lost to Follow-up|0
1275994|NCT00413660|4170263|P10|Post Week 12|Lost to Follow-up|0
1275995|NCT00413660|4170264|P9|Post Week 12|Lost to Follow-up|0
1275996|NCT00413660|4170265|P8|Post Week 12|Lost to Follow-up|0
1275997|NCT00413660|4170266|P7|Post Week 12|Lost to Follow-up|0
1275998|NCT00413660|4170267|P6|Post Week 12|Lost to Follow-up|0
1275999|NCT00413660|4170268|P5|Post Week 12|Lost to Follow-up|0
1276000|NCT00413660|4170269|P4|Post Week 12|Lost to Follow-up|0
1276001|NCT00413660|4170270|P3|Post Week 12|Lost to Follow-up|1
1276002|NCT00413660|4170271|P2|Post Week 12|Lost to Follow-up|1
1276003|NCT00413660|4170272|P1|Post Week 12|Lost to Follow-up|0
1276004|NCT00413660|4170262|P11|Post Week 12|Lack of Efficacy|0
1276005|NCT00413660|4170263|P10|Post Week 12|Lack of Efficacy|1
1276006|NCT00413660|4170264|P9|Post Week 12|Lack of Efficacy|0
1276007|NCT00413660|4170265|P8|Post Week 12|Lack of Efficacy|0
1276008|NCT00413660|4170266|P7|Post Week 12|Lack of Efficacy|0
1276009|NCT00413660|4170267|P6|Post Week 12|Lack of Efficacy|0
1276010|NCT00413660|4170268|P5|Post Week 12|Lack of Efficacy|0
1276011|NCT00413660|4170269|P4|Post Week 12|Lack of Efficacy|0
1276012|NCT00413660|4170270|P3|Post Week 12|Lack of Efficacy|1
1276013|NCT00413660|4170271|P2|Post Week 12|Lack of Efficacy|0
1276014|NCT00413660|4170272|P1|Post Week 12|Lack of Efficacy|0
1276015|NCT00413660|4170262|P11|Post Week 12|Adverse Event|0
1276016|NCT00413660|4170263|P10|Post Week 12|Adverse Event|0
1276017|NCT00413660|4170264|P9|Post Week 12|Adverse Event|0
1276018|NCT00413660|4170265|P8|Post Week 12|Adverse Event|0
1276019|NCT00413660|4170266|P7|Post Week 12|Adverse Event|2
1276020|NCT00413660|4170267|P6|Post Week 12|Adverse Event|2
1276021|NCT00413660|4170268|P5|Post Week 12|Adverse Event|4
1276022|NCT00413660|4170269|P4|Post Week 12|Adverse Event|1
1276023|NCT00413660|4170270|P3|Post Week 12|Adverse Event|2
1276024|NCT00413660|4170271|P2|Post Week 12|Adverse Event|0
1276025|NCT00413660|4170272|P1|Post Week 12|Adverse Event|2
1276026|NCT00413660|4170262|P11|Up To Week 12|Other|0
1276027|NCT00413660|4170263|P10|Up To Week 12|Other|0
1276028|NCT00413660|4170264|P9|Up To Week 12|Other|0
1276029|NCT00413660|4170265|P8|Up To Week 12|Other|0
1276030|NCT00413660|4170266|P7|Up To Week 12|Other|3
1276031|NCT00413660|4170267|P6|Up To Week 12|Other|4
1276032|NCT00413660|4170268|P5|Up To Week 12|Other|2
1276033|NCT00413660|4170269|P4|Up To Week 12|Other|1
1276034|NCT00413660|4170270|P3|Up To Week 12|Other|6
1276035|NCT00413660|4170271|P2|Up To Week 12|Other|1
1276036|NCT00413660|4170272|P1|Up To Week 12|Other|3
1276037|NCT00413660|4170262|P11|Up To Week 12|Randomized, Not Treated|0
1276038|NCT00413660|4170263|P10|Up To Week 12|Randomized, Not Treated|0
1276039|NCT00413660|4170264|P9|Up To Week 12|Randomized, Not Treated|0
1276040|NCT00413660|4170265|P8|Up To Week 12|Randomized, Not Treated|0
1276041|NCT00413660|4170266|P7|Up To Week 12|Randomized, Not Treated|0
1276042|NCT00413660|4170267|P6|Up To Week 12|Randomized, Not Treated|0
1276043|NCT00413660|4170268|P5|Up To Week 12|Randomized, Not Treated|0
1276044|NCT00413660|4170269|P4|Up To Week 12|Randomized, Not Treated|1
1276045|NCT00413660|4170270|P3|Up To Week 12|Randomized, Not Treated|0
1276046|NCT00413660|4170271|P2|Up To Week 12|Randomized, Not Treated|0
1276047|NCT00413660|4170272|P1|Up To Week 12|Randomized, Not Treated|1
1276048|NCT00413660|4170262|P11|Up To Week 12|Withdrawal by Subject|0
1276049|NCT00413660|4170263|P10|Up To Week 12|Withdrawal by Subject|0
1276050|NCT00413660|4170264|P9|Up To Week 12|Withdrawal by Subject|0
1276051|NCT00413660|4170265|P8|Up To Week 12|Withdrawal by Subject|0
1276052|NCT00413660|4170266|P7|Up To Week 12|Withdrawal by Subject|2
1276053|NCT00413660|4170267|P6|Up To Week 12|Withdrawal by Subject|2
1276054|NCT00413660|4170268|P5|Up To Week 12|Withdrawal by Subject|0
1276055|NCT00413660|4170269|P4|Up To Week 12|Withdrawal by Subject|2
1276056|NCT00413660|4170270|P3|Up To Week 12|Withdrawal by Subject|0
1276057|NCT00413660|4170271|P2|Up To Week 12|Withdrawal by Subject|2
1276058|NCT00413660|4170272|P1|Up To Week 12|Withdrawal by Subject|0
1276059|NCT00413660|4170262|P11|Up To Week 12|Lost to Follow-up|0
1276060|NCT00413660|4170263|P10|Up To Week 12|Lost to Follow-up|0
1276061|NCT00413660|4170264|P9|Up To Week 12|Lost to Follow-up|0
1276062|NCT00413660|4170265|P8|Up To Week 12|Lost to Follow-up|0
1276063|NCT00413660|4170266|P7|Up To Week 12|Lost to Follow-up|0
1276064|NCT00413660|4170267|P6|Up To Week 12|Lost to Follow-up|0
1276065|NCT00413660|4170268|P5|Up To Week 12|Lost to Follow-up|1
1276066|NCT00413660|4170269|P4|Up To Week 12|Lost to Follow-up|0
1276067|NCT00413660|4170270|P3|Up To Week 12|Lost to Follow-up|0
1276068|NCT00413660|4170271|P2|Up To Week 12|Lost to Follow-up|1
1276069|NCT00413660|4170272|P1|Up To Week 12|Lost to Follow-up|0
1276070|NCT00413660|4170262|P11|Up To Week 12|Lack of Efficacy|0
1276071|NCT00413660|4170263|P10|Up To Week 12|Lack of Efficacy|0
1276072|NCT00413660|4170264|P9|Up To Week 12|Lack of Efficacy|0
1276073|NCT00413660|4170265|P8|Up To Week 12|Lack of Efficacy|0
1276074|NCT00413660|4170266|P7|Up To Week 12|Lack of Efficacy|5
1276075|NCT00413660|4170267|P6|Up To Week 12|Lack of Efficacy|0
1276076|NCT00413660|4170268|P5|Up To Week 12|Lack of Efficacy|0
1276077|NCT00413660|4170269|P4|Up To Week 12|Lack of Efficacy|0
1276078|NCT00413660|4170270|P3|Up To Week 12|Lack of Efficacy|0
1276079|NCT00413660|4170271|P2|Up To Week 12|Lack of Efficacy|0
1276080|NCT00413660|4170272|P1|Up To Week 12|Lack of Efficacy|2
1276081|NCT00413660|4170262|P11|Up To Week 12|Adverse Event|0
1276082|NCT00413660|4170263|P10|Up To Week 12|Adverse Event|0
1276083|NCT00413660|4170264|P9|Up To Week 12|Adverse Event|0
1276084|NCT00413660|4170265|P8|Up To Week 12|Adverse Event|0
1276085|NCT00413660|4170266|P7|Up To Week 12|Adverse Event|1
1276086|NCT00413660|4170267|P6|Up To Week 12|Adverse Event|4
1276087|NCT00413660|4170268|P5|Up To Week 12|Adverse Event|6
1276088|NCT00413660|4170269|P4|Up To Week 12|Adverse Event|4
1276089|NCT00413660|4170270|P3|Up To Week 12|Adverse Event|1
1276090|NCT00413660|4170271|P2|Up To Week 12|Adverse Event|3
1276091|NCT00413660|4170272|P1|Up To Week 12|Adverse Event|1
1276092|NCT00413413|4170675|P3|Double-Blind|Lost to Follow-up|2
1276093|NCT00413413|4170676|P2|Double-Blind|Lost to Follow-up|4
1276094|NCT00413413|4170677|P1|Double-Blind|Lost to Follow-up|3
1276095|NCT00413413|4170675|P3|Double-Blind|Subject withdrew consent|9
1276096|NCT00413413|4170676|P2|Double-Blind|Subject withdrew consent|6
1276097|NCT00413413|4170677|P1|Double-Blind|Subject withdrew consent|4
1276098|NCT00413413|4170675|P3|Double-Blind|Protocol deviation|1
1276099|NCT00413413|4170676|P2|Double-Blind|Protocol deviation|2
1276100|NCT00413413|4170677|P1|Double-Blind|Protocol deviation|1
1276101|NCT00413413|4170675|P3|Double-Blind|Unsatisfactory therapeutic effect|1
1276102|NCT00413413|4170676|P2|Double-Blind|Unsatisfactory therapeutic effect|2
1276103|NCT00413413|4170677|P1|Double-Blind|Unsatisfactory therapeutic effect|1
1276104|NCT00413413|4170675|P3|Double-Blind|Adverse Event|5
1276105|NCT00413413|4170676|P2|Double-Blind|Adverse Event|0
1276106|NCT00413413|4170677|P1|Double-Blind|Adverse Event|6
1276107|NCT00413413|4170675|P3|Single-Blind|Lost to Follow-up|0
1276108|NCT00413413|4170676|P2|Single-Blind|Lost to Follow-up|8
1276109|NCT00413413|4170677|P1|Single-Blind|Lost to Follow-up|0
1276110|NCT00413413|4170675|P3|Single-Blind|Withdrawal by Subject|0
1276111|NCT00413413|4170676|P2|Single-Blind|Withdrawal by Subject|27
1276112|NCT00413413|4170677|P1|Single-Blind|Withdrawal by Subject|0
1276113|NCT00413413|4170675|P3|Single-Blind|Protocol Violation|0
1276114|NCT00413413|4170676|P2|Single-Blind|Protocol Violation|16
1276115|NCT00413413|4170677|P1|Single-Blind|Protocol Violation|0
1276116|NCT00413413|4170675|P3|Single-Blind|Subject no longer requires study drug|0
1276117|NCT00413413|4170676|P2|Single-Blind|Subject no longer requires study drug|151
1276118|NCT00413413|4170677|P1|Single-Blind|Subject no longer requires study drug|0
1276119|NCT00413413|4170675|P3|Single-Blind|Lack of Efficacy|0
1276120|NCT00413413|4170676|P2|Single-Blind|Lack of Efficacy|5
1276121|NCT00413413|4170677|P1|Single-Blind|Lack of Efficacy|0
1276122|NCT00413413|4170675|P3|Single-Blind|Adverse Event|0
1276123|NCT00413413|4170676|P2|Single-Blind|Adverse Event|9
1276124|NCT00413413|4170677|P1|Single-Blind|Adverse Event|0
1276125|NCT00413374|4170730|P2|Overall Study|Surgery|0
1276126|NCT00413374|4170731|P1|Overall Study|Surgery|1
1276127|NCT00413374|4170730|P2|Overall Study|Lost to Follow-up|0
1276128|NCT00413374|4170731|P1|Overall Study|Lost to Follow-up|1
1276129|NCT00413374|4170730|P2|Overall Study|Adverse Event|0
1276130|NCT00413374|4170731|P1|Overall Study|Adverse Event|1
1276131|NCT00413374|4170730|P2|Overall Study|Ineligible due to screening criteria.|0
1276132|NCT00413374|4170731|P1|Overall Study|Ineligible due to screening criteria.|3
1276133|NCT00413283|4170762|P4|Overall Study|Not specified|0
1276134|NCT00413283|4170763|P3|Overall Study|Not specified|1
1276135|NCT00413283|4170764|P2|Overall Study|Not specified|0
1276136|NCT00413283|4170765|P1|Overall Study|Not specified|0
1276137|NCT00413283|4170762|P4|Overall Study|Requirement for alternative therapy|0
1276138|NCT00413283|4170763|P3|Overall Study|Requirement for alternative therapy|0
1276139|NCT00413283|4170764|P2|Overall Study|Requirement for alternative therapy|2
1276140|NCT00413283|4170765|P1|Overall Study|Requirement for alternative therapy|0
1276141|NCT00413283|4170762|P4|Overall Study|Protocol deviation|0
1276142|NCT00413283|4170763|P3|Overall Study|Protocol deviation|0
1276143|NCT00413283|4170764|P2|Overall Study|Protocol deviation|1
1276144|NCT00413283|4170765|P1|Overall Study|Protocol deviation|0
1276145|NCT00413283|4170762|P4|Overall Study|Ineligibility determined|1
1276146|NCT00413283|4170763|P3|Overall Study|Ineligibility determined|0
1276147|NCT00413283|4170764|P2|Overall Study|Ineligibility determined|0
1276148|NCT00413283|4170765|P1|Overall Study|Ineligibility determined|0
1276149|NCT00413283|4170762|P4|Overall Study|Adverse Event|1
1276150|NCT00413283|4170763|P3|Overall Study|Adverse Event|0
1276151|NCT00413283|4170764|P2|Overall Study|Adverse Event|0
1276152|NCT00413283|4170765|P1|Overall Study|Adverse Event|0
1276153|NCT00413283|4170762|P4|Overall Study|Death|1
1276154|NCT00413283|4170763|P3|Overall Study|Death|1
1276155|NCT00413283|4170764|P2|Overall Study|Death|0
1276156|NCT00413283|4170765|P1|Overall Study|Death|0
1276157|NCT00413283|4170762|P4|Overall Study|Withdrawal by Subject|1
1276158|NCT00413283|4170763|P3|Overall Study|Withdrawal by Subject|0
1276159|NCT00413283|4170764|P2|Overall Study|Withdrawal by Subject|0
1276160|NCT00413283|4170765|P1|Overall Study|Withdrawal by Subject|1
1276161|NCT00413244|4170797|P2|Overall Study|Withdrawal by Subject|1
1276162|NCT00413244|4170798|P1|Overall Study|Withdrawal by Subject|10
1276163|NCT00413231|4170826|P1|365-day to 60-month Post Treatment|Exited after surgical conversion|1
1276164|NCT00413231|4170826|P1|365-day to 60-month Post Treatment|Lost to Follow-up|4
1276165|NCT00413231|4170826|P1|365-day to 60-month Post Treatment|Withdrawal by Subject|5
1276166|NCT00413231|4170826|P1|365-day to 60-month Post Treatment|Death|36
1276167|NCT00413231|4170826|P1|30-day to 365-day Post Treatment|Death|13
1276168|NCT00413231|4170826|P1|0 to 30-day Post Treatment|Intend to treat, but not implanted|3
1276169|NCT00413231|4170826|P1|0 to 30-day Post Treatment|Death|5
1276170|NCT00413218|4170858|P2|Overall Study|Withdrawal by Subject|1
1276171|NCT00413218|4170859|P1|Overall Study|Withdrawal by Subject|9
1276172|NCT00413218|4170858|P2|Overall Study|Missing|0
1276173|NCT00413218|4170859|P1|Overall Study|Missing|1
1276174|NCT00413218|4170858|P2|Overall Study|Admin|14
1276175|NCT00413218|4170859|P1|Overall Study|Admin|20
1276176|NCT00413218|4170858|P2|Overall Study|Lost to Follow-up|17
1276177|NCT00413218|4170859|P1|Overall Study|Lost to Follow-up|14
1276178|NCT00413218|4170858|P2|Overall Study|Death|56
1276179|NCT00413218|4170859|P1|Overall Study|Death|57
1276180|NCT00413218|4170858|P2|Overall Study|Randomized but didn't receive study drug|8
1276181|NCT00413218|4170859|P1|Overall Study|Randomized but didn't receive study drug|2
1276182|NCT00413192|4170885|P4|Overall Study|Not treated|1
1276183|NCT00413192|4170886|P3|Overall Study|Not treated|0
1276184|NCT00413192|4170887|P2|Overall Study|Not treated|0
1276185|NCT00413192|4170888|P1|Overall Study|Not treated|0
1276186|NCT00413192|4170885|P4|Overall Study|Not specified|2
1276187|NCT00413192|4170886|P3|Overall Study|Not specified|1
1276188|NCT00413192|4170887|P2|Overall Study|Not specified|1
1276189|NCT00413192|4170888|P1|Overall Study|Not specified|5
1276190|NCT00413192|4170885|P4|Overall Study|Intercurrent death|0
1276191|NCT00413192|4170886|P3|Overall Study|Intercurrent death|0
1276192|NCT00413192|4170887|P2|Overall Study|Intercurrent death|1
1276193|NCT00413192|4170888|P1|Overall Study|Intercurrent death|0
1276194|NCT00413192|4170885|P4|Overall Study|Intercurrent illness|1
1276195|NCT00413192|4170886|P3|Overall Study|Intercurrent illness|0
1276196|NCT00413192|4170887|P2|Overall Study|Intercurrent illness|0
1276197|NCT00413192|4170888|P1|Overall Study|Intercurrent illness|0
1276198|NCT00413192|4170885|P4|Overall Study|Withdrawal by Subject|1
1276199|NCT00413192|4170886|P3|Overall Study|Withdrawal by Subject|0
1276200|NCT00413192|4170887|P2|Overall Study|Withdrawal by Subject|5
1276201|NCT00413192|4170888|P1|Overall Study|Withdrawal by Subject|3
1276202|NCT00413192|4170885|P4|Overall Study|Toxicity|2
1276203|NCT00413192|4170886|P3|Overall Study|Toxicity|2
1276204|NCT00413192|4170887|P2|Overall Study|Toxicity|2
1276205|NCT00413192|4170888|P1|Overall Study|Toxicity|3
1276206|NCT00413192|4170885|P4|Overall Study|Disease progression|25
1276207|NCT00413192|4170886|P3|Overall Study|Disease progression|16
1276208|NCT00413192|4170887|P2|Overall Study|Disease progression|31
1276209|NCT00413192|4170888|P1|Overall Study|Disease progression|26
1276210|NCT00413153|4170928|P2|Overall Study|Adverse Event|0
1276211|NCT00413153|4170929|P1|Overall Study|Adverse Event|1
1276212|NCT00413153|4170928|P2|Overall Study|Withdrawal by Subject|1
1276213|NCT00413153|4170929|P1|Overall Study|Withdrawal by Subject|1
1276214|NCT00413062|4170953|P2|Overall Study|Other reason|34
1276215|NCT00413062|4170954|P1|Overall Study|Other reason|70
1276216|NCT00413062|4170953|P2|Overall Study|Lost to Follow-up|73
1276217|NCT00413062|4170954|P1|Overall Study|Lost to Follow-up|175
1276218|NCT00413062|4170953|P2|Overall Study|Pregnancy wish|6
1276219|NCT00413062|4170954|P1|Overall Study|Pregnancy wish|17
1276220|NCT00413062|4170953|P2|Overall Study|Pregnancy|5
1276221|NCT00413062|4170954|P1|Overall Study|Pregnancy|15
1276222|NCT00413062|4170953|P2|Overall Study|Withdrawal of informed consent|36
1276223|NCT00413062|4170954|P1|Overall Study|Withdrawal of informed consent|111
1276224|NCT00413062|4170953|P2|Overall Study|Pre-treatment (serious) adverse event|0
1276225|NCT00413062|4170954|P1|Overall Study|Pre-treatment (serious) adverse event|1
1276226|NCT00413062|4170953|P2|Overall Study|Adverse event/serious adverse event|56
1276227|NCT00413062|4170954|P1|Overall Study|Adverse event/serious adverse event|289
1276228|NCT00413049|4170980|P2|Overall Study|Lack of Efficacy|0
1276229|NCT00413049|4170981|P1|Overall Study|Lack of Efficacy|1
1276230|NCT00413049|4170980|P2|Overall Study|Abnormal laboratory value(s)|0
1276231|NCT00413049|4170981|P1|Overall Study|Abnormal laboratory value(s)|1
1276232|NCT00413049|4170980|P2|Overall Study|Subject no longer requires study drug|1
1276233|NCT00413049|4170981|P1|Overall Study|Subject no longer requires study drug|0
1276234|NCT00413049|4170980|P2|Overall Study|Protocol Violation|1
1276235|NCT00413049|4170981|P1|Overall Study|Protocol Violation|3
1276236|NCT00413049|4170980|P2|Overall Study|Lost to Follow-up|3
1276237|NCT00413049|4170981|P1|Overall Study|Lost to Follow-up|2
1276238|NCT00413049|4170980|P2|Overall Study|Withdrawal by Subject|5
1276239|NCT00413049|4170981|P1|Overall Study|Withdrawal by Subject|7
1276240|NCT00413049|4170980|P2|Overall Study|Adverse Event|8
1276241|NCT00413049|4170981|P1|Overall Study|Adverse Event|10
1276242|NCT00413036|4170997|P1|Overall Study|Missing|2
1276243|NCT00413036|4170997|P1|Overall Study|Other|26
1276244|NCT00413036|4170997|P1|Overall Study|Death|9
1276245|NCT00413036|4170997|P1|Overall Study|Withdrawal by Subject|7
1276246|NCT00413036|4170997|P1|Overall Study|Lack of Efficacy|129
1276247|NCT00413036|4170997|P1|Overall Study|Adverse Event|44
1276248|NCT00413010|4171007|P2|Overall Study|Due to termination of the study|52
1276249|NCT00413010|4171008|P1|Overall Study|Due to termination of the study|54
1276250|NCT00413010|4171007|P2|Overall Study|Withdrawal by Subject|2
1276251|NCT00413010|4171008|P1|Overall Study|Withdrawal by Subject|7
1276252|NCT00413010|4171007|P2|Overall Study|Lost to Follow-up|0
1276253|NCT00413010|4171008|P1|Overall Study|Lost to Follow-up|3
1276254|NCT00413010|4171007|P2|Overall Study|Lack of Efficacy|3
1276255|NCT00413010|4171008|P1|Overall Study|Lack of Efficacy|0
1276256|NCT00413010|4171007|P2|Overall Study|Laboratory abnormality|2
1276257|NCT00413010|4171008|P1|Overall Study|Laboratory abnormality|0
1276258|NCT00413010|4171007|P2|Overall Study|Adverse Event|4
1276259|NCT00413010|4171008|P1|Overall Study|Adverse Event|8
1276260|NCT00412984|4171030|P2|Overall Study|Not Reported|12
1276261|NCT00412984|4171031|P1|Overall Study|Not Reported|11
1276262|NCT00412984|4171030|P2|Overall Study|Other Reason|92
1276263|NCT00412984|4171031|P1|Overall Study|Other Reason|80
1276264|NCT00412984|4171030|P2|Overall Study|Physician Refused to Continue Treatment|89
1276265|NCT00412984|4171031|P1|Overall Study|Physician Refused to Continue Treatment|81
1276266|NCT00412984|4171030|P2|Overall Study|Administrative Reason by Sponsor|8
1276267|NCT00412984|4171031|P1|Overall Study|Administrative Reason by Sponsor|11
1276268|NCT00412984|4171030|P2|Overall Study|Subject No Longer Meets Study Criteria|100
1276269|NCT00412984|4171031|P1|Overall Study|Subject No Longer Meets Study Criteria|87
1276270|NCT00412984|4171030|P2|Overall Study|Pregnancy|0
1276271|NCT00412984|4171031|P1|Overall Study|Pregnancy|1
1276272|NCT00412984|4171030|P2|Overall Study|Poor/Noncompliance|77
1276273|NCT00412984|4171031|P1|Overall Study|Poor/Noncompliance|57
1276274|NCT00412984|4171030|P2|Overall Study|Lost to Follow-up|39
1276275|NCT00412984|4171031|P1|Overall Study|Lost to Follow-up|51
1276276|NCT00412984|4171030|P2|Overall Study|Withdrawal by Subject|989
1276277|NCT00412984|4171031|P1|Overall Study|Withdrawal by Subject|921
1276278|NCT00412984|4171030|P2|Overall Study|Adverse Event|738
1276279|NCT00412984|4171031|P1|Overall Study|Adverse Event|679
1276280|NCT00412984|4171030|P2|Overall Study|Death|349
1276281|NCT00412984|4171031|P1|Overall Study|Death|331
1276282|NCT00412971|4171075|P2|Overall Study|Protocol Violation|1
1276283|NCT00412971|4171076|P1|Overall Study|Protocol Violation|13
1276284|NCT00412971|4171075|P2|Overall Study|Lost to Follow-up|9
1276285|NCT00412971|4171076|P1|Overall Study|Lost to Follow-up|17
1276286|NCT00412958|4171089|P4|Overall Study|Transport issue|0
1276287|NCT00412958|4171090|P3|Overall Study|Transport issue|0
1276288|NCT00412958|4171091|P2|Overall Study|Transport issue|1
1276289|NCT00412958|4171092|P1|Overall Study|Transport issue|0
1276290|NCT00412958|4171089|P4|Overall Study|Death|0
1276291|NCT00412958|4171090|P3|Overall Study|Death|0
1276292|NCT00412958|4171091|P2|Overall Study|Death|1
1276293|NCT00412958|4171092|P1|Overall Study|Death|0
1276294|NCT00412958|4171089|P4|Overall Study|Lost to Follow-up|0
1276295|NCT00412958|4171090|P3|Overall Study|Lost to Follow-up|0
1276296|NCT00412958|4171091|P2|Overall Study|Lost to Follow-up|1
1276297|NCT00412958|4171092|P1|Overall Study|Lost to Follow-up|0
1276298|NCT00412958|4171089|P4|Overall Study|Adverse Event|0
1276299|NCT00412958|4171090|P3|Overall Study|Adverse Event|0
1276300|NCT00412958|4171091|P2|Overall Study|Adverse Event|1
1276301|NCT00412958|4171092|P1|Overall Study|Adverse Event|0
1276302|NCT00412958|4171089|P4|Overall Study|Withdrawal by Subject|1
1276303|NCT00412958|4171090|P3|Overall Study|Withdrawal by Subject|0
1276304|NCT00412958|4171091|P2|Overall Study|Withdrawal by Subject|0
1276305|NCT00412958|4171092|P1|Overall Study|Withdrawal by Subject|3
1276306|NCT00412932|4171102|P1|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1
1276307|NCT00412932|4171102|P1|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1
1276308|NCT00412932|4171102|P1|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3
1276309|NCT00412932|4171102|P1|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3
1276310|NCT00412932|4171102|P1|Olmesartan 40 mg|Withdrawal by Subject|1
1276311|NCT00412932|4171102|P1|Olmesartan 40 mg|Lack of Efficacy|3
1276312|NCT00412932|4171102|P1|Olmesartan 40 mg|Adverse Event|4
1276313|NCT00412932|4171102|P1|Olmesartan (Olm) 20 mg|Other|1
1276314|NCT00412932|4171102|P1|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2
1276315|NCT00412932|4171102|P1|Olmesartan (Olm) 20 mg|Protocol Violation|1
1276316|NCT00412932|4171102|P1|Olmesartan (Olm) 20 mg|Lack of Efficacy|2
1276317|NCT00412932|4171102|P1|Olmesartan (Olm) 20 mg|Adverse Event|1
1276318|NCT00412893|4171113|P2|Overall Study|Randomized but Never Received Study Drug|6
1276319|NCT00412893|4171114|P1|Overall Study|Randomized but Never Received Study Drug|5
1276320|NCT00412893|4171113|P2|Overall Study|Administrative Reason|15
1276321|NCT00412893|4171114|P1|Overall Study|Administrative Reason|12
1276322|NCT00412893|4171113|P2|Overall Study|Did Not Cooperate|9
1276323|NCT00412893|4171114|P1|Overall Study|Did Not Cooperate|12
1276324|NCT00412893|4171113|P2|Overall Study|Other Protocol Violation|6
1276325|NCT00412893|4171114|P1|Overall Study|Other Protocol Violation|10
1276326|NCT00412893|4171113|P2|Overall Study|Violation of Selection at Entry|10
1276327|NCT00412893|4171114|P1|Overall Study|Violation of Selection at Entry|17
1276328|NCT00412893|4171113|P2|Overall Study|Lost to Follow-up|1
1276329|NCT00412893|4171114|P1|Overall Study|Lost to Follow-up|2
1276330|NCT00412893|4171113|P2|Overall Study|Insufficient Therapeutic Response|23
1276331|NCT00412893|4171114|P1|Overall Study|Insufficient Therapeutic Response|39
1276332|NCT00412893|4171113|P2|Overall Study|Death|21
1276333|NCT00412893|4171114|P1|Overall Study|Death|17
1276334|NCT00412893|4171113|P2|Overall Study|Adverse Event|53
1276335|NCT00412893|4171114|P1|Overall Study|Adverse Event|31
1276336|NCT00412854|4171152|P2|Overall Study|Withdrawn for other reasons|11
1276337|NCT00412854|4171153|P1|Overall Study|Withdrawn for other reasons|13
1276338|NCT00412854|4171152|P2|Overall Study|Withdrawn due to adverse events|5
1276339|NCT00412854|4171153|P1|Overall Study|Withdrawn due to adverse events|1
1276340|NCT00412750|4171197|P3|Overall Study|Lack of Efficacy|3
1276341|NCT00412750|4171198|P2|Overall Study|Lack of Efficacy|0
1276342|NCT00412750|4171199|P1|Overall Study|Lack of Efficacy|0
1276343|NCT00412750|4171197|P3|Overall Study|Withdrawal by Subject|2
1276344|NCT00412750|4171198|P2|Overall Study|Withdrawal by Subject|1
1276345|NCT00412750|4171199|P1|Overall Study|Withdrawal by Subject|0
1276346|NCT00412750|4171197|P3|Overall Study|Lost to Follow-up|1
1276347|NCT00412750|4171198|P2|Overall Study|Lost to Follow-up|0
1276348|NCT00412750|4171199|P1|Overall Study|Lost to Follow-up|1
1276349|NCT00412750|4171197|P3|Overall Study|Adverse Event|3
1276350|NCT00412750|4171198|P2|Overall Study|Adverse Event|3
1276351|NCT00412750|4171199|P1|Overall Study|Adverse Event|8
1276352|NCT00412750|4171197|P3|Overall Study|Administrative problems|14
1276353|NCT00412750|4171198|P2|Overall Study|Administrative problems|17
1276354|NCT00412750|4171199|P1|Overall Study|Administrative problems|21
1276355|NCT00412750|4171197|P3|Overall Study|Abnormal laboratory value(s)|0
1276356|NCT00412750|4171198|P2|Overall Study|Abnormal laboratory value(s)|0
1276357|NCT00412750|4171199|P1|Overall Study|Abnormal laboratory value(s)|1
1276358|NCT00412737|4171224|P2|Overall Study|Failure to Return|2
1276359|NCT00412737|4171225|P1|Overall Study|Failure to Return|6
1276360|NCT00412737|4171224|P2|Overall Study|Refused Treatment|2
1276361|NCT00412737|4171225|P1|Overall Study|Refused Treatment|6
1276362|NCT00412737|4171224|P2|Overall Study|Adverse Event|2
1276363|NCT00412737|4171225|P1|Overall Study|Adverse Event|3
1276364|NCT00412737|4171224|P2|Overall Study|Death|0
1276365|NCT00412737|4171225|P1|Overall Study|Death|1
1276366|NCT00412607|4171243|P1|Overall Study|Not meet inclusion/exclusion Criteria|15
1276367|NCT00412607|4171243|P1|Overall Study|Death|61
1276368|NCT00412607|4171243|P1|Overall Study|Lost to Follow-up|19
1276369|NCT00412607|4171243|P1|Overall Study|Withdrawal by Subject|9
1276370|NCT00412542|4171256|P2|Overall Study|Not Eligible|1
1276371|NCT00412542|4171257|P1|Overall Study|Not Eligible|0
1276372|NCT00412542|4171256|P2|Overall Study|Withdrawal by Subject|2
1276373|NCT00412542|4171257|P1|Overall Study|Withdrawal by Subject|0
1276374|NCT00412373|4171342|P2|Overall Study|Not Specified|2
1276375|NCT00412373|4171343|P1|Overall Study|Not Specified|2
1276376|NCT00412373|4171342|P2|Overall Study|Withdrawal by Subject|27
1276377|NCT00412373|4171343|P1|Overall Study|Withdrawal by Subject|8
1276378|NCT00412373|4171342|P2|Overall Study|Lost to Follow-up|13
1276379|NCT00412373|4171343|P1|Overall Study|Lost to Follow-up|7
1276380|NCT00412373|4171342|P2|Overall Study|Lack of Efficacy|22
1276381|NCT00412373|4171343|P1|Overall Study|Lack of Efficacy|16
1276382|NCT00412373|4171342|P2|Overall Study|Adverse Event|13
1276383|NCT00412373|4171343|P1|Overall Study|Adverse Event|8
1276384|NCT00412360|4171385|P2|Overall Study|Not Transplanted|2
1276385|NCT00412360|4171386|P1|Overall Study|Not Transplanted|1
1276386|NCT00412360|4171385|P2|Overall Study|Lost to Follow-up|1
1276387|NCT00412360|4171386|P1|Overall Study|Lost to Follow-up|0
1276388|NCT00412217|4171416|P2|Overall Study|Not Specified|1
1276389|NCT00412217|4171417|P1|Overall Study|Not Specified|1
1276390|NCT00412217|4171416|P2|Overall Study|Study Terminated by Sponsor|33
1276391|NCT00412217|4171417|P1|Overall Study|Study Terminated by Sponsor|26
1276392|NCT00412217|4171416|P2|Overall Study|Lost to Follow-up|4
1276393|NCT00412217|4171417|P1|Overall Study|Lost to Follow-up|1
1276394|NCT00412217|4171416|P2|Overall Study|Withdrawal by Subject|0
1276395|NCT00412217|4171417|P1|Overall Study|Withdrawal by Subject|2
1276396|NCT00412217|4171416|P2|Overall Study|Investigator Decision|0
1276397|NCT00412217|4171417|P1|Overall Study|Investigator Decision|1
1276398|NCT00412217|4171416|P2|Overall Study|Disease Progression|3
1276399|NCT00412217|4171417|P1|Overall Study|Disease Progression|2
1276400|NCT00412217|4171416|P2|Overall Study|Death|4
1276401|NCT00412217|4171417|P1|Overall Study|Death|5
1276402|NCT00412217|4171416|P2|Overall Study|Insufficient Data Available|3
1276403|NCT00412217|4171417|P1|Overall Study|Insufficient Data Available|8
1276404|NCT00412113|4171431|P2|Overall Study|did not receive treatment|0
1276405|NCT00412113|4171432|P1|Overall Study|did not receive treatment|1
1276406|NCT00412113|4171431|P2|Overall Study|Adverse Event|15
1276407|NCT00412113|4171432|P1|Overall Study|Adverse Event|11
1276408|NCT00412061|4171516|P2|Open Label Phase|New Cancer Therapy|1
1276409|NCT00412061|4171517|P1|Open Label Phase|New Cancer Therapy|0
1276410|NCT00412061|4171516|P2|Open Label Phase|Lost to Follow-up|2
1276411|NCT00412061|4171517|P1|Open Label Phase|Lost to Follow-up|0
1276412|NCT00412061|4171516|P2|Open Label Phase|Death|7
1276413|NCT00412061|4171517|P1|Open Label Phase|Death|0
1276414|NCT00412061|4171516|P2|Open Label Phase|Administrative Problems|13
1276415|NCT00412061|4171517|P1|Open Label Phase|Administrative Problems|0
1276416|NCT00412061|4171516|P2|Open Label Phase|Withdrawal by Subject|15
1276417|NCT00412061|4171517|P1|Open Label Phase|Withdrawal by Subject|0
1276418|NCT00412061|4171516|P2|Open Label Phase|Adverse Event|46
1276419|NCT00412061|4171517|P1|Open Label Phase|Adverse Event|0
1276420|NCT00412061|4171516|P2|Open Label Phase|Disease Progression|86
1276421|NCT00412061|4171517|P1|Open Label Phase|Disease Progression|0
1276422|NCT00412061|4171516|P2|Double Blind Phase|Lost to Follow-up|1
1276423|NCT00412061|4171517|P1|Double Blind Phase|Lost to Follow-up|0
1276424|NCT00412061|4171516|P2|Double Blind Phase|New Cander Therapy|1
1276425|NCT00412061|4171517|P1|Double Blind Phase|New Cander Therapy|1
1276426|NCT00412061|4171516|P2|Double Blind Phase|Protocol Violation|4
1276427|NCT00412061|4171517|P1|Double Blind Phase|Protocol Violation|3
1276428|NCT00412061|4171516|P2|Double Blind Phase|Death|3
1276429|NCT00412061|4171517|P1|Double Blind Phase|Death|6
1276430|NCT00412061|4171516|P2|Double Blind Phase|Withdrawal by Subject|20
1276431|NCT00412061|4171517|P1|Double Blind Phase|Withdrawal by Subject|18
1276432|NCT00412061|4171516|P2|Double Blind Phase|Final Primary Analysis|14
1276433|NCT00412061|4171517|P1|Double Blind Phase|Final Primary Analysis|26
1276434|NCT00412061|4171516|P2|Double Blind Phase|Adverse Event|16
1276435|NCT00412061|4171517|P1|Double Blind Phase|Adverse Event|61
1276436|NCT00412061|4171516|P2|Double Blind Phase|Disease Progression|154
1276437|NCT00412061|4171517|P1|Double Blind Phase|Disease Progression|101
1276438|NCT00411788|4171535|P1|Overall Study|Adverse Event|1
1276439|NCT00411788|4171535|P1|Overall Study|Protocol Violation|1
1276440|NCT00411762|4171544|P1|Overall Study|Withdrawal by Subject|5
1276441|NCT00411671|4171568|P1|Overall Study|Lost to Follow-up|3
1276442|NCT00411671|4171568|P1|Overall Study|Death|2
1276443|NCT00411671|4171568|P1|Overall Study|Adverse Event|15
1276444|NCT00411645|4171576|P2|Overall Study|Lost to Follow-up|0
1276445|NCT00411645|4171577|P1|Overall Study|Lost to Follow-up|2
1276446|NCT00411645|4171576|P2|Overall Study|Investigator/Sponsor Decision|7
1276447|NCT00411645|4171577|P1|Overall Study|Investigator/Sponsor Decision|10
1276448|NCT00411645|4171576|P2|Overall Study|Death|135
1276449|NCT00411645|4171577|P1|Overall Study|Death|56
1276450|NCT00411645|4171576|P2|Overall Study|Consent Withdrawn|22
1276451|NCT00411645|4171577|P1|Overall Study|Consent Withdrawn|13
1276452|NCT00411554|4171608|P2|Overall Study|Patient Moved|0
1276453|NCT00411554|4171609|P1|Overall Study|Patient Moved|1
1276454|NCT00411554|4171608|P2|Overall Study|Withdrawal by Subject|0
1276455|NCT00411554|4171609|P1|Overall Study|Withdrawal by Subject|3
1276456|NCT00411554|4171608|P2|Overall Study|Lack of Efficacy|5
1276457|NCT00411554|4171609|P1|Overall Study|Lack of Efficacy|2
1276458|NCT00411554|4171608|P2|Overall Study|Adverse Event|4
1276459|NCT00411554|4171609|P1|Overall Study|Adverse Event|2
1276460|NCT00411450|4171635|P1|Overall Study|Ongoing at time of data cut-off.|3
1276461|NCT00411216|4171678|P2|Overall Study|Ten participants were entered into the c|2
1276462|NCT00411216|4171679|P1|Overall Study|Ten participants were entered into the c|0
1276463|NCT00411151|4171685|P1|Overall Study|Trial prematurely closed|4
1276464|NCT00411151|4171685|P1|Overall Study|Protocol Violation|1
1276465|NCT00411151|4171685|P1|Overall Study|Lost to Follow-up|2
1276466|NCT00411151|4171685|P1|Overall Study|Withdrawal by Subject|2
1276467|NCT00411151|4171685|P1|Overall Study|Death|38
1276468|NCT00410813|4171729|P2|Overall Study|Death|2
1276469|NCT00410813|4171730|P1|Overall Study|Death|0
1276470|NCT00410813|4171729|P2|Overall Study|Ineligible|4
1276471|NCT00410813|4171730|P1|Overall Study|Ineligible|2
1276472|NCT00410813|4171729|P2|Overall Study|Not protocol specified|4
1276473|NCT00410813|4171730|P1|Overall Study|Not protocol specified|3
1276474|NCT00410813|4171729|P2|Overall Study|Progression|21
1276475|NCT00410813|4171730|P1|Overall Study|Progression|32
1276476|NCT00410813|4171729|P2|Overall Study|Adverse Event|11
1276477|NCT00410813|4171730|P1|Overall Study|Adverse Event|6
1276478|NCT00410761|4171767|P2|Overall Study|Never received randomised treatment|1
1276479|NCT00410761|4171768|P1|Overall Study|Never received randomised treatment|0
1276480|NCT00410761|4171767|P2|Overall Study|Other|9
1276481|NCT00410761|4171768|P1|Overall Study|Other|12
1276482|NCT00410761|4171767|P2|Overall Study|Withdrawal by Subject|4
1276483|NCT00410761|4171768|P1|Overall Study|Withdrawal by Subject|8
1276484|NCT00410761|4171767|P2|Overall Study|objective disease progression|55
1276485|NCT00410761|4171768|P1|Overall Study|objective disease progression|71
1276486|NCT00410761|4171767|P2|Overall Study|Adverse Event|3
1276487|NCT00410761|4171768|P1|Overall Study|Adverse Event|29
1276488|NCT00410605|4171788|P1|Overall Study|Transferred to another Institution|1
1276489|NCT00410605|4171788|P1|Overall Study|Stopped treatmen to collect stem cells|1
1276490|NCT00410605|4171788|P1|Overall Study|Started Non-Protocol Therapy|3
1276491|NCT00410605|4171788|P1|Overall Study|Withdrawal by Subject|5
1276492|NCT00410605|4171788|P1|Overall Study|Physician Decision|3
1276493|NCT00410605|4171788|P1|Overall Study|Adverse Event|12
1276494|NCT00410514|4171800|P3|Overall Study|Non-compliant with study procedures|2
1276495|NCT00410514|4171801|P2|Overall Study|Non-compliant with study procedures|0
1276496|NCT00410514|4171802|P1|Overall Study|Non-compliant with study procedures|0
1276497|NCT00410514|4171800|P3|Overall Study|Lost to Follow-up|2
1276498|NCT00410514|4171801|P2|Overall Study|Lost to Follow-up|0
1276499|NCT00410514|4171802|P1|Overall Study|Lost to Follow-up|0
1276500|NCT00410514|4171800|P3|Overall Study|Protocol Violation|1
1276501|NCT00410514|4171801|P2|Overall Study|Protocol Violation|1
1276502|NCT00410514|4171802|P1|Overall Study|Protocol Violation|0
1276503|NCT00410514|4171800|P3|Overall Study|Adverse Event|2
1276504|NCT00410514|4171801|P2|Overall Study|Adverse Event|2
1276505|NCT00410514|4171802|P1|Overall Study|Adverse Event|2
1276506|NCT00410410|4171885|P9|Open-Label Period (OL)|not specified|7
1276507|NCT00410410|4171886|P8|Open-Label Period (OL)|not specified|0
1276508|NCT00410410|4171887|P7|Open-Label Period (OL)|not specified|0
1276509|NCT00410410|4171888|P6|Open-Label Period (OL)|not specified|0
1276510|NCT00410410|4171889|P5|Open-Label Period (OL)|not specified|0
1276511|NCT00410410|4171890|P4|Open-Label Period (OL)|not specified|0
1276512|NCT00410410|4171891|P3|Open-Label Period (OL)|not specified|0
1276513|NCT00410410|4171892|P2|Open-Label Period (OL)|not specified|0
1276514|NCT00410410|4171893|P1|Open-Label Period (OL)|not specified|0
1276515|NCT00410410|4171885|P9|Open-Label Period (OL)|Administrative Reason By Sponsor|145
1276516|NCT00410410|4171886|P8|Open-Label Period (OL)|Administrative Reason By Sponsor|0
1276517|NCT00410410|4171887|P7|Open-Label Period (OL)|Administrative Reason By Sponsor|0
1276518|NCT00410410|4171888|P6|Open-Label Period (OL)|Administrative Reason By Sponsor|0
1276519|NCT00410410|4171889|P5|Open-Label Period (OL)|Administrative Reason By Sponsor|0
1276520|NCT00410410|4171890|P4|Open-Label Period (OL)|Administrative Reason By Sponsor|0
1276521|NCT00410410|4171891|P3|Open-Label Period (OL)|Administrative Reason By Sponsor|0
1276522|NCT00410410|4171892|P2|Open-Label Period (OL)|Administrative Reason By Sponsor|0
1276523|NCT00410410|4171893|P1|Open-Label Period (OL)|Administrative Reason By Sponsor|0
1276524|NCT00410410|4171885|P9|Open-Label Period (OL)|Pregnancy|1
1276525|NCT00410410|4171886|P8|Open-Label Period (OL)|Pregnancy|0
1276526|NCT00410410|4171887|P7|Open-Label Period (OL)|Pregnancy|0
1276527|NCT00410410|4171888|P6|Open-Label Period (OL)|Pregnancy|0
1276528|NCT00410410|4171889|P5|Open-Label Period (OL)|Pregnancy|0
1276529|NCT00410410|4171890|P4|Open-Label Period (OL)|Pregnancy|0
1276530|NCT00410410|4171891|P3|Open-Label Period (OL)|Pregnancy|0
1276531|NCT00410410|4171892|P2|Open-Label Period (OL)|Pregnancy|0
1276532|NCT00410410|4171893|P1|Open-Label Period (OL)|Pregnancy|0
1276533|NCT00410410|4171885|P9|Open-Label Period (OL)|Withdrawal by Subject|20
1276534|NCT00410410|4171886|P8|Open-Label Period (OL)|Withdrawal by Subject|0
1276535|NCT00410410|4171887|P7|Open-Label Period (OL)|Withdrawal by Subject|0
1276536|NCT00410410|4171888|P6|Open-Label Period (OL)|Withdrawal by Subject|0
1276537|NCT00410410|4171889|P5|Open-Label Period (OL)|Withdrawal by Subject|0
1276538|NCT00410410|4171890|P4|Open-Label Period (OL)|Withdrawal by Subject|0
1276539|NCT00410410|4171891|P3|Open-Label Period (OL)|Withdrawal by Subject|0
1276540|NCT00410410|4171892|P2|Open-Label Period (OL)|Withdrawal by Subject|0
1276541|NCT00410410|4171893|P1|Open-Label Period (OL)|Withdrawal by Subject|0
1276542|NCT00410410|4171885|P9|Open-Label Period (OL)|Lost to Follow-up|4
1276543|NCT00410410|4171886|P8|Open-Label Period (OL)|Lost to Follow-up|0
1276544|NCT00410410|4171887|P7|Open-Label Period (OL)|Lost to Follow-up|0
1276545|NCT00410410|4171888|P6|Open-Label Period (OL)|Lost to Follow-up|0
1276546|NCT00410410|4171889|P5|Open-Label Period (OL)|Lost to Follow-up|0
1276547|NCT00410410|4171890|P4|Open-Label Period (OL)|Lost to Follow-up|0
1276548|NCT00410410|4171891|P3|Open-Label Period (OL)|Lost to Follow-up|0
1276549|NCT00410410|4171892|P2|Open-Label Period (OL)|Lost to Follow-up|0
1276550|NCT00410410|4171893|P1|Open-Label Period (OL)|Lost to Follow-up|0
1276551|NCT00410410|4171885|P9|Open-Label Period (OL)|Lack of Efficacy|161
1276552|NCT00410410|4171886|P8|Open-Label Period (OL)|Lack of Efficacy|0
1276553|NCT00410410|4171887|P7|Open-Label Period (OL)|Lack of Efficacy|0
1276554|NCT00410410|4171888|P6|Open-Label Period (OL)|Lack of Efficacy|0
1276555|NCT00410410|4171889|P5|Open-Label Period (OL)|Lack of Efficacy|0
1276556|NCT00410410|4171890|P4|Open-Label Period (OL)|Lack of Efficacy|0
1276557|NCT00410410|4171891|P3|Open-Label Period (OL)|Lack of Efficacy|0
1276558|NCT00410410|4171892|P2|Open-Label Period (OL)|Lack of Efficacy|0
1276559|NCT00410410|4171893|P1|Open-Label Period (OL)|Lack of Efficacy|0
1276560|NCT00410410|4171885|P9|Open-Label Period (OL)|Adverse Event|10
1276561|NCT00410410|4171886|P8|Open-Label Period (OL)|Adverse Event|0
1276562|NCT00410410|4171887|P7|Open-Label Period (OL)|Adverse Event|0
1276563|NCT00410410|4171888|P6|Open-Label Period (OL)|Adverse Event|0
1276564|NCT00410410|4171889|P5|Open-Label Period (OL)|Adverse Event|0
1276565|NCT00410410|4171890|P4|Open-Label Period (OL)|Adverse Event|0
1276566|NCT00410410|4171891|P3|Open-Label Period (OL)|Adverse Event|0
1276567|NCT00410410|4171892|P2|Open-Label Period (OL)|Adverse Event|0
1276568|NCT00410410|4171893|P1|Open-Label Period (OL)|Adverse Event|0
1276569|NCT00410410|4171885|P9|Open-Label Period (OL)|Death|1
1276570|NCT00410410|4171886|P8|Open-Label Period (OL)|Death|0
1276571|NCT00410410|4171887|P7|Open-Label Period (OL)|Death|0
1276572|NCT00410410|4171888|P6|Open-Label Period (OL)|Death|0
1276573|NCT00410410|4171889|P5|Open-Label Period (OL)|Death|0
1276574|NCT00410410|4171890|P4|Open-Label Period (OL)|Death|0
1276575|NCT00410410|4171891|P3|Open-Label Period (OL)|Death|0
1276576|NCT00410410|4171892|P2|Open-Label Period (OL)|Death|0
1276577|NCT00410410|4171893|P1|Open-Label Period (OL)|Death|0
1276578|NCT00410410|4171885|P9|Maintenance Period (MP)|Administrative Reason By Sponsor|0
1276579|NCT00410410|4171886|P8|Maintenance Period (MP)|Administrative Reason By Sponsor|25
1276580|NCT00410410|4171887|P7|Maintenance Period (MP)|Administrative Reason By Sponsor|21
1276581|NCT00410410|4171888|P6|Maintenance Period (MP)|Administrative Reason By Sponsor|0
1276582|NCT00410410|4171889|P5|Maintenance Period (MP)|Administrative Reason By Sponsor|0
1276583|NCT00410410|4171890|P4|Maintenance Period (MP)|Administrative Reason By Sponsor|0
1276584|NCT00410410|4171891|P3|Maintenance Period (MP)|Administrative Reason By Sponsor|0
1276585|NCT00410410|4171892|P2|Maintenance Period (MP)|Administrative Reason By Sponsor|0
1276586|NCT00410410|4171893|P1|Maintenance Period (MP)|Administrative Reason By Sponsor|0
1276587|NCT00410410|4171885|P9|Maintenance Period (MP)|Withdrawal by Subject|0
1276588|NCT00410410|4171886|P8|Maintenance Period (MP)|Withdrawal by Subject|1
1276589|NCT00410410|4171887|P7|Maintenance Period (MP)|Withdrawal by Subject|1
1276590|NCT00410410|4171888|P6|Maintenance Period (MP)|Withdrawal by Subject|0
1276591|NCT00410410|4171889|P5|Maintenance Period (MP)|Withdrawal by Subject|0
1276592|NCT00410410|4171890|P4|Maintenance Period (MP)|Withdrawal by Subject|0
1276593|NCT00410410|4171891|P3|Maintenance Period (MP)|Withdrawal by Subject|0
1276594|NCT00410410|4171892|P2|Maintenance Period (MP)|Withdrawal by Subject|0
1276595|NCT00410410|4171893|P1|Maintenance Period (MP)|Withdrawal by Subject|0
1276596|NCT00410410|4171885|P9|Maintenance Period (MP)|Lost to Follow-up|0
1276597|NCT00410410|4171886|P8|Maintenance Period (MP)|Lost to Follow-up|2
1276598|NCT00410410|4171887|P7|Maintenance Period (MP)|Lost to Follow-up|1
1276599|NCT00410410|4171888|P6|Maintenance Period (MP)|Lost to Follow-up|0
1276600|NCT00410410|4171889|P5|Maintenance Period (MP)|Lost to Follow-up|0
1276601|NCT00410410|4171890|P4|Maintenance Period (MP)|Lost to Follow-up|0
1276602|NCT00410410|4171891|P3|Maintenance Period (MP)|Lost to Follow-up|0
1276603|NCT00410410|4171892|P2|Maintenance Period (MP)|Lost to Follow-up|0
1276604|NCT00410410|4171893|P1|Maintenance Period (MP)|Lost to Follow-up|0
1276605|NCT00410410|4171885|P9|Maintenance Period (MP)|Lack of Efficacy|0
1276606|NCT00410410|4171886|P8|Maintenance Period (MP)|Lack of Efficacy|24
1276607|NCT00410410|4171887|P7|Maintenance Period (MP)|Lack of Efficacy|25
1276608|NCT00410410|4171888|P6|Maintenance Period (MP)|Lack of Efficacy|0
1276609|NCT00410410|4171889|P5|Maintenance Period (MP)|Lack of Efficacy|0
1276610|NCT00410410|4171890|P4|Maintenance Period (MP)|Lack of Efficacy|0
1276611|NCT00410410|4171891|P3|Maintenance Period (MP)|Lack of Efficacy|0
1276612|NCT00410410|4171892|P2|Maintenance Period (MP)|Lack of Efficacy|0
1276613|NCT00410410|4171893|P1|Maintenance Period (MP)|Lack of Efficacy|0
1276614|NCT00410410|4171885|P9|Maintenance Period (MP)|Adverse Event|0
1276615|NCT00410410|4171886|P8|Maintenance Period (MP)|Adverse Event|3
1276616|NCT00410410|4171887|P7|Maintenance Period (MP)|Adverse Event|1
1276617|NCT00410410|4171888|P6|Maintenance Period (MP)|Adverse Event|0
1276618|NCT00410410|4171889|P5|Maintenance Period (MP)|Adverse Event|0
1276619|NCT00410410|4171890|P4|Maintenance Period (MP)|Adverse Event|0
1276620|NCT00410410|4171891|P3|Maintenance Period (MP)|Adverse Event|0
1276621|NCT00410410|4171892|P2|Maintenance Period (MP)|Adverse Event|0
1276622|NCT00410410|4171893|P1|Maintenance Period (MP)|Adverse Event|0
1276623|NCT00410410|4171885|P9|Maintenance Period (MP)|Death|0
1276624|NCT00410410|4171886|P8|Maintenance Period (MP)|Death|0
1276625|NCT00410410|4171887|P7|Maintenance Period (MP)|Death|1
1276626|NCT00410410|4171888|P6|Maintenance Period (MP)|Death|0
1276627|NCT00410410|4171889|P5|Maintenance Period (MP)|Death|0
1276628|NCT00410410|4171890|P4|Maintenance Period (MP)|Death|0
1276629|NCT00410410|4171891|P3|Maintenance Period (MP)|Death|0
1276630|NCT00410410|4171892|P2|Maintenance Period (MP)|Death|0
1276631|NCT00410410|4171893|P1|Maintenance Period (MP)|Death|0
1276632|NCT00410410|4171885|P9|Induction Period (IP)|not specified|0
1276633|NCT00410410|4171886|P8|Induction Period (IP)|not specified|0
1276634|NCT00410410|4171887|P7|Induction Period (IP)|not specified|0
1276635|NCT00410410|4171888|P6|Induction Period (IP)|not specified|0
1276636|NCT00410410|4171889|P5|Induction Period (IP)|not specified|0
1276637|NCT00410410|4171890|P4|Induction Period (IP)|not specified|0
1276638|NCT00410410|4171891|P3|Induction Period (IP)|not specified|1
1276639|NCT00410410|4171892|P2|Induction Period (IP)|not specified|0
1276640|NCT00410410|4171893|P1|Induction Period (IP)|not specified|0
1276641|NCT00410410|4171885|P9|Induction Period (IP)|Administrative Reason By Sponsor|0
1276642|NCT00410410|4171886|P8|Induction Period (IP)|Administrative Reason By Sponsor|0
1276643|NCT00410410|4171887|P7|Induction Period (IP)|Administrative Reason By Sponsor|0
1276644|NCT00410410|4171888|P6|Induction Period (IP)|Administrative Reason By Sponsor|21
1276645|NCT00410410|4171889|P5|Induction Period (IP)|Administrative Reason By Sponsor|22
1276646|NCT00410410|4171890|P4|Induction Period (IP)|Administrative Reason By Sponsor|0
1276647|NCT00410410|4171891|P3|Induction Period (IP)|Administrative Reason By Sponsor|0
1276648|NCT00410410|4171892|P2|Induction Period (IP)|Administrative Reason By Sponsor|0
1276649|NCT00410410|4171893|P1|Induction Period (IP)|Administrative Reason By Sponsor|0
1276650|NCT00410410|4171885|P9|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
1276651|NCT00410410|4171886|P8|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
1276652|NCT00410410|4171887|P7|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
1276653|NCT00410410|4171888|P6|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
1276654|NCT00410410|4171889|P5|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
1276655|NCT00410410|4171890|P4|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
1276656|NCT00410410|4171891|P3|Induction Period (IP)|Subject No Longer Meets Study Criteria|1
1276657|NCT00410410|4171892|P2|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
1276658|NCT00410410|4171893|P1|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
1276659|NCT00410410|4171885|P9|Induction Period (IP)|Withdrawal by Subject|0
1276660|NCT00410410|4171886|P8|Induction Period (IP)|Withdrawal by Subject|0
1276661|NCT00410410|4171887|P7|Induction Period (IP)|Withdrawal by Subject|0
1276662|NCT00410410|4171888|P6|Induction Period (IP)|Withdrawal by Subject|0
1276663|NCT00410410|4171889|P5|Induction Period (IP)|Withdrawal by Subject|2
1276664|NCT00410410|4171890|P4|Induction Period (IP)|Withdrawal by Subject|5
1276665|NCT00410410|4171891|P3|Induction Period (IP)|Withdrawal by Subject|3
1276666|NCT00410410|4171892|P2|Induction Period (IP)|Withdrawal by Subject|5
1276667|NCT00410410|4171893|P1|Induction Period (IP)|Withdrawal by Subject|3
1276668|NCT00410410|4171885|P9|Induction Period (IP)|Lost to Follow-up|0
1276669|NCT00410410|4171886|P8|Induction Period (IP)|Lost to Follow-up|0
1276670|NCT00410410|4171887|P7|Induction Period (IP)|Lost to Follow-up|0
1276671|NCT00410410|4171888|P6|Induction Period (IP)|Lost to Follow-up|1
1276672|NCT00410410|4171889|P5|Induction Period (IP)|Lost to Follow-up|0
1276673|NCT00410410|4171890|P4|Induction Period (IP)|Lost to Follow-up|3
1276674|NCT00410410|4171891|P3|Induction Period (IP)|Lost to Follow-up|2
1276675|NCT00410410|4171892|P2|Induction Period (IP)|Lost to Follow-up|2
1276676|NCT00410410|4171893|P1|Induction Period (IP)|Lost to Follow-up|2
1276677|NCT00410410|4171885|P9|Induction Period (IP)|Lack of Efficacy|0
1276678|NCT00410410|4171886|P8|Induction Period (IP)|Lack of Efficacy|0
1276679|NCT00410410|4171887|P7|Induction Period (IP)|Lack of Efficacy|0
1276680|NCT00410410|4171888|P6|Induction Period (IP)|Lack of Efficacy|7
1276681|NCT00410410|4171889|P5|Induction Period (IP)|Lack of Efficacy|7
1276682|NCT00410410|4171890|P4|Induction Period (IP)|Lack of Efficacy|8
1276683|NCT00410410|4171891|P3|Induction Period (IP)|Lack of Efficacy|8
1276684|NCT00410410|4171892|P2|Induction Period (IP)|Lack of Efficacy|24
1276685|NCT00410410|4171893|P1|Induction Period (IP)|Lack of Efficacy|26
1276686|NCT00410410|4171885|P9|Induction Period (IP)|Adverse Event|0
1276687|NCT00410410|4171886|P8|Induction Period (IP)|Adverse Event|0
1276688|NCT00410410|4171887|P7|Induction Period (IP)|Adverse Event|0
1276689|NCT00410410|4171888|P6|Induction Period (IP)|Adverse Event|0
1276690|NCT00410410|4171889|P5|Induction Period (IP)|Adverse Event|1
1276691|NCT00410410|4171890|P4|Induction Period (IP)|Adverse Event|4
1276692|NCT00410410|4171891|P3|Induction Period (IP)|Adverse Event|2
1276693|NCT00410410|4171892|P2|Induction Period (IP)|Adverse Event|4
1276694|NCT00410410|4171893|P1|Induction Period (IP)|Adverse Event|3
1276695|NCT00410410|4171885|P9|Induction Period (IP)|Death|0
1276696|NCT00410410|4171886|P8|Induction Period (IP)|Death|0
1276697|NCT00410410|4171887|P7|Induction Period (IP)|Death|0
1276698|NCT00410410|4171888|P6|Induction Period (IP)|Death|0
1276699|NCT00410410|4171889|P5|Induction Period (IP)|Death|0
1276700|NCT00410410|4171890|P4|Induction Period (IP)|Death|0
1276701|NCT00410410|4171891|P3|Induction Period (IP)|Death|0
1276702|NCT00410410|4171892|P2|Induction Period (IP)|Death|0
1276703|NCT00410410|4171893|P1|Induction Period (IP)|Death|1
1276704|NCT00410384|4172054|P3|Overall Study|Other|4
1276705|NCT00410384|4172055|P2|Overall Study|Other|8
1276706|NCT00410384|4172056|P1|Overall Study|Other|3
1276707|NCT00410384|4172054|P3|Overall Study|Physician Decision|4
1276708|NCT00410384|4172055|P2|Overall Study|Physician Decision|3
1276709|NCT00410384|4172056|P1|Overall Study|Physician Decision|3
1276710|NCT00410384|4172054|P3|Overall Study|Protocol Violation|6
1276711|NCT00410384|4172055|P2|Overall Study|Protocol Violation|6
1276712|NCT00410384|4172056|P1|Overall Study|Protocol Violation|6
1276713|NCT00410384|4172054|P3|Overall Study|Lost to Follow-up|6
1276714|NCT00410384|4172055|P2|Overall Study|Lost to Follow-up|6
1276715|NCT00410384|4172056|P1|Overall Study|Lost to Follow-up|4
1276716|NCT00410384|4172054|P3|Overall Study|Lack of Compliance|2
1276717|NCT00410384|4172055|P2|Overall Study|Lack of Compliance|2
1276718|NCT00410384|4172056|P1|Overall Study|Lack of Compliance|2
1276719|NCT00410384|4172054|P3|Overall Study|Lack of Efficacy|17
1276720|NCT00410384|4172055|P2|Overall Study|Lack of Efficacy|12
1276721|NCT00410384|4172056|P1|Overall Study|Lack of Efficacy|20
1276722|NCT00410384|4172054|P3|Overall Study|Adverse Event|23
1276723|NCT00410384|4172055|P2|Overall Study|Adverse Event|18
1276724|NCT00410384|4172056|P1|Overall Study|Adverse Event|23
1276725|NCT00410384|4172054|P3|Overall Study|Withdrawal by Subject|20
1276726|NCT00410384|4172055|P2|Overall Study|Withdrawal by Subject|17
1276727|NCT00410384|4172056|P1|Overall Study|Withdrawal by Subject|28
1276728|NCT00410202|4172129|P3|Off-treatment Follow up|Lost to Follow-up|0
1276729|NCT00410202|4172130|P2|Off-treatment Follow up|Lost to Follow-up|0
1276730|NCT00410202|4172131|P1|Off-treatment Follow up|Lost to Follow-up|1
1276731|NCT00410202|4172129|P3|Off-treatment Follow up|Follow up not required per protocol|1
1276732|NCT00410202|4172130|P2|Off-treatment Follow up|Follow up not required per protocol|0
1276733|NCT00410202|4172131|P1|Off-treatment Follow up|Follow up not required per protocol|3
1276734|NCT00410202|4172129|P3|Off-treatment Follow up|Continuing off-treatment follow up|11
1276735|NCT00410202|4172130|P2|Off-treatment Follow up|Continuing off-treatment follow up|8
1276736|NCT00410202|4172131|P1|Off-treatment Follow up|Continuing off-treatment follow up|10
1276737|NCT00410202|4172129|P3|On-Treatment|Other Reason|1
1276738|NCT00410202|4172130|P2|On-Treatment|Other Reason|0
1276739|NCT00410202|4172131|P1|On-Treatment|Other Reason|0
1276740|NCT00410202|4172129|P3|On-Treatment|Withdrawal by Subject|1
1276741|NCT00410202|4172130|P2|On-Treatment|Withdrawal by Subject|1
1276742|NCT00410202|4172131|P1|On-Treatment|Withdrawal by Subject|2
1276743|NCT00410202|4172129|P3|On-Treatment|Lack of Efficacy|0
1276744|NCT00410202|4172130|P2|On-Treatment|Lack of Efficacy|4
1276745|NCT00410202|4172131|P1|On-Treatment|Lack of Efficacy|1
1276746|NCT00410202|4172129|P3|On-Treatment|Lost to Follow-up|1
1276747|NCT00410202|4172130|P2|On-Treatment|Lost to Follow-up|0
1276748|NCT00410202|4172131|P1|On-Treatment|Lost to Follow-up|1
1276749|NCT00410202|4172129|P3|On-Treatment|Death|0
1276750|NCT00410202|4172130|P2|On-Treatment|Death|0
1276751|NCT00410202|4172131|P1|On-Treatment|Death|1
1276752|NCT00410202|4172129|P3|On-Treatment|Adverse Event|2
1276753|NCT00410202|4172130|P2|On-Treatment|Adverse Event|3
1276754|NCT00410202|4172131|P1|On-Treatment|Adverse Event|1
1276755|NCT00410202|4172129|P3|On-Treatment|Continuing treatment|66
1276756|NCT00410202|4172130|P2|On-Treatment|Continuing treatment|71
1276757|NCT00410202|4172131|P1|On-Treatment|Continuing treatment|69
1276758|NCT00410163|4172218|P2|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0
1276759|NCT00410163|4172219|P1|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1
1276760|NCT00410163|4172218|P2|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8
1276761|NCT00410163|4172219|P1|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4
1276762|NCT00410163|4172218|P2|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0
1276763|NCT00410163|4172219|P1|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1
1276764|NCT00410163|4172218|P2|Extended Follow-up (FU) Phase (2-5 Years|Death|1
1276765|NCT00410163|4172219|P1|Extended Follow-up (FU) Phase (2-5 Years|Death|1
1276766|NCT00410163|4172218|P2|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1
1276767|NCT00410163|4172219|P1|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3
1276768|NCT00410163|4172218|P2|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1
1276769|NCT00410163|4172219|P1|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0
1276770|NCT00410163|4172218|P2|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0
1276771|NCT00410163|4172219|P1|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1
1276772|NCT00410163|4172218|P2|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
1276773|NCT00410163|4172219|P1|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
1276774|NCT00410163|4172218|P2|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0
1276775|NCT00410163|4172219|P1|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1
1276776|NCT00410163|4172218|P2|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1
1276777|NCT00410163|4172219|P1|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2
1276778|NCT00410163|4172218|P2|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4
1276779|NCT00410163|4172219|P1|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0
1276780|NCT00410163|4172218|P2|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1
1276781|NCT00410163|4172219|P1|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2
1276782|NCT00410163|4172218|P2|Treatment and Follow-up Phase (2 Years)|Death|1
1276783|NCT00410163|4172219|P1|Treatment and Follow-up Phase (2 Years)|Death|1
1276784|NCT00410163|4172218|P2|Treatment and Follow-up Phase (2 Years)|Adverse Event|2
1276785|NCT00410163|4172219|P1|Treatment and Follow-up Phase (2 Years)|Adverse Event|4
1276786|NCT00410124|4172272|P2|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1
1276787|NCT00410124|4172273|P1|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0
1276788|NCT00410124|4172272|P2|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0
1276789|NCT00410124|4172273|P1|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1
1276790|NCT00410124|4172272|P2|Extension Phase - Open Label (45 Months)|Disease Progression|78
1276791|NCT00410124|4172273|P1|Extension Phase - Open Label (45 Months)|Disease Progression|56
1276792|NCT00410124|4172272|P2|Extension Phase - Open Label (45 Months)|Death|10
1276793|NCT00410124|4172273|P1|Extension Phase - Open Label (45 Months)|Death|2
1276794|NCT00410124|4172272|P2|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
1276795|NCT00410124|4172273|P1|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
1276796|NCT00410124|4172272|P2|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1
1276797|NCT00410124|4172273|P1|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0
1276798|NCT00410124|4172272|P2|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1
1276799|NCT00410124|4172273|P1|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0
1276800|NCT00410124|4172272|P2|Extension Phase - Open Label (45 Months)|Adverse Event|19
1276801|NCT00410124|4172273|P1|Extension Phase - Open Label (45 Months)|Adverse Event|7
1276802|NCT00410124|4172272|P2|Core Phase Double Blind (15 Months)|Disease Progression|124
1276803|NCT00410124|4172273|P1|Core Phase Double Blind (15 Months)|Disease Progression|137
1276804|NCT00410124|4172272|P2|Core Phase Double Blind (15 Months)|Death|4
1276805|NCT00410124|4172273|P1|Core Phase Double Blind (15 Months)|Death|7
1276806|NCT00410124|4172272|P2|Core Phase Double Blind (15 Months)|Administrative Problems|0
1276807|NCT00410124|4172273|P1|Core Phase Double Blind (15 Months)|Administrative Problems|2
1276808|NCT00410124|4172272|P2|Core Phase Double Blind (15 Months)|Lost to Follow-up|0
1276809|NCT00410124|4172273|P1|Core Phase Double Blind (15 Months)|Lost to Follow-up|4
1276810|NCT00410124|4172272|P2|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2
1276811|NCT00410124|4172273|P1|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13
1276812|NCT00410124|4172272|P2|Core Phase Double Blind (15 Months)|Protocol Violation|1
1276813|NCT00410124|4172273|P1|Core Phase Double Blind (15 Months)|Protocol Violation|2
1276814|NCT00410124|4172272|P2|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0
1276815|NCT00410124|4172273|P1|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1
1276816|NCT00410124|4172272|P2|Core Phase Double Blind (15 Months)|Adverse Event|2
1276817|NCT00410124|4172273|P1|Core Phase Double Blind (15 Months)|Adverse Event|36
1276818|NCT00410072|4172304|P2|After Week 48 to Week 96|Withdrawal by Subject|1
1276819|NCT00410072|4172305|P1|After Week 48 to Week 96|Withdrawal by Subject|0
1276820|NCT00410072|4172304|P2|After Week 48 to Week 96|Pregnancy|2
1276821|NCT00410072|4172305|P1|After Week 48 to Week 96|Pregnancy|0
1276822|NCT00410072|4172304|P2|After Week 48 to Week 96|Poor compliance/noncompliance|1
1276823|NCT00410072|4172305|P1|After Week 48 to Week 96|Poor compliance/noncompliance|0
1276824|NCT00410072|4172304|P2|After Week 48 to Week 96|Not specified|0
1276825|NCT00410072|4172305|P1|After Week 48 to Week 96|Not specified|2
1276826|NCT00410072|4172304|P2|After Week 48 to Week 96|Lost to Follow-up|4
1276827|NCT00410072|4172305|P1|After Week 48 to Week 96|Lost to Follow-up|2
1276828|NCT00410072|4172304|P2|After Week 48 to Week 96|Lack of Efficacy|0
1276829|NCT00410072|4172305|P1|After Week 48 to Week 96|Lack of Efficacy|1
1276830|NCT00410072|4172304|P2|After Week 48 to Week 96|Death|1
1276831|NCT00410072|4172305|P1|After Week 48 to Week 96|Death|0
1276832|NCT00410072|4172304|P2|After Week 48 to Week 96|Adverse Event|2
1276833|NCT00410072|4172305|P1|After Week 48 to Week 96|Adverse Event|1
1276834|NCT00410072|4172304|P2|Day 1 to Week 48|Withdrawal by Subject|2
1276835|NCT00410072|4172305|P1|Day 1 to Week 48|Withdrawal by Subject|0
1276836|NCT00410072|4172304|P2|Day 1 to Week 48|Pregnancy|2
1276837|NCT00410072|4172305|P1|Day 1 to Week 48|Pregnancy|0
1276838|NCT00410072|4172304|P2|Day 1 to Week 48|poor compliance/noncompliance|3
1276839|NCT00410072|4172305|P1|Day 1 to Week 48|poor compliance/noncompliance|0
1276840|NCT00410072|4172304|P2|Day 1 to Week 48|Not specified|1
1276841|NCT00410072|4172305|P1|Day 1 to Week 48|Not specified|0
1276842|NCT00410072|4172304|P2|Day 1 to Week 48|Lost to Follow-up|2
1276843|NCT00410072|4172305|P1|Day 1 to Week 48|Lost to Follow-up|5
1276844|NCT00410072|4172304|P2|Day 1 to Week 48|Adverse Event|2
1276845|NCT00410072|4172305|P1|Day 1 to Week 48|Adverse Event|1
1276846|NCT00410046|4172345|P1|Overall Study|Lost to Follow-up|1
1276847|NCT00410046|4172345|P1|Overall Study|Withdrawal by Subject|1
1276848|NCT00410046|4172345|P1|Overall Study|Adverse Event|3
1276849|NCT00409838|4172376|P2|Long-term Extension Period|Pregnancy|0
1276850|NCT00409838|4172377|P1|Long-term Extension Period|Pregnancy|1
1276851|NCT00409838|4172376|P2|Long-term Extension Period|Poor compliance/noncompliance|0
1276852|NCT00409838|4172377|P1|Long-term Extension Period|Poor compliance/noncompliance|1
1276853|NCT00409838|4172376|P2|Long-term Extension Period|Withdrawal by Subject|0
1276854|NCT00409838|4172377|P1|Long-term Extension Period|Withdrawal by Subject|3
1276855|NCT00409838|4172376|P2|Long-term Extension Period|Lack of Efficacy|0
1276856|NCT00409838|4172377|P1|Long-term Extension Period|Lack of Efficacy|2
1276857|NCT00409838|4172376|P2|Long-term Extension Period|Death|0
1276858|NCT00409838|4172377|P1|Long-term Extension Period|Death|1
1276859|NCT00409838|4172376|P2|Long-term Extension Period|Adverse Event|0
1276860|NCT00409838|4172377|P1|Long-term Extension Period|Adverse Event|10
1276861|NCT00409838|4172376|P2|Short-term Period|Never Treated|0
1276862|NCT00409838|4172377|P1|Short-term Period|Never Treated|1
1276863|NCT00409838|4172376|P2|Short-term Period|Withdrawal by Subject|3
1276864|NCT00409838|4172377|P1|Short-term Period|Withdrawal by Subject|2
1276865|NCT00409838|4172376|P2|Short-term Period|Lost to Follow-up|1
1276866|NCT00409838|4172377|P1|Short-term Period|Lost to Follow-up|0
1276867|NCT00409838|4172376|P2|Short-term Period|Adverse Event|1
1276868|NCT00409838|4172377|P1|Short-term Period|Adverse Event|0
1276869|NCT00409786|4172442|P1|Overall Study|Withdrawal by Subject|3
1276870|NCT00409773|4172451|P5|Overall Study|Lack of Eligibility|1
1276871|NCT00409773|4172452|P4|Overall Study|Lack of Eligibility|0
1276872|NCT00409773|4172453|P3|Overall Study|Lack of Eligibility|0
1276873|NCT00409773|4172454|P2|Overall Study|Lack of Eligibility|0
1276874|NCT00409773|4172455|P1|Overall Study|Lack of Eligibility|0
1276875|NCT00409773|4172451|P5|Overall Study|Withdrawal by Subject|1
1276876|NCT00409773|4172452|P4|Overall Study|Withdrawal by Subject|2
1276877|NCT00409773|4172453|P3|Overall Study|Withdrawal by Subject|0
1276878|NCT00409773|4172454|P2|Overall Study|Withdrawal by Subject|0
1276879|NCT00409773|4172455|P1|Overall Study|Withdrawal by Subject|0
1276880|NCT00409773|4172451|P5|Overall Study|Protocol Violation|1
1276881|NCT00409773|4172452|P4|Overall Study|Protocol Violation|3
1276882|NCT00409773|4172453|P3|Overall Study|Protocol Violation|3
1276883|NCT00409773|4172454|P2|Overall Study|Protocol Violation|2
1276884|NCT00409773|4172455|P1|Overall Study|Protocol Violation|0
1276885|NCT00409773|4172451|P5|Overall Study|Physician Decision|0
1276886|NCT00409773|4172452|P4|Overall Study|Physician Decision|2
1276887|NCT00409773|4172453|P3|Overall Study|Physician Decision|0
1276888|NCT00409773|4172454|P2|Overall Study|Physician Decision|0
1276889|NCT00409773|4172455|P1|Overall Study|Physician Decision|0
1276890|NCT00409773|4172451|P5|Overall Study|Lost to Follow-up|1
1276891|NCT00409773|4172452|P4|Overall Study|Lost to Follow-up|3
1276892|NCT00409773|4172453|P3|Overall Study|Lost to Follow-up|2
1276893|NCT00409773|4172454|P2|Overall Study|Lost to Follow-up|1
1276894|NCT00409773|4172455|P1|Overall Study|Lost to Follow-up|6
1276895|NCT00409773|4172451|P5|Overall Study|Adverse Event|6
1276896|NCT00409773|4172452|P4|Overall Study|Adverse Event|2
1276897|NCT00409773|4172453|P3|Overall Study|Adverse Event|4
1276898|NCT00409773|4172454|P2|Overall Study|Adverse Event|4
1276899|NCT00409773|4172455|P1|Overall Study|Adverse Event|3
1276900|NCT00409747|4172537|P1|Overall Study|Withdrawal by Subject|1
1276901|NCT00409708|4172544|P2|Washout|Lost to Follow-up|3
1276902|NCT00409708|4172545|P1|Washout|Lost to Follow-up|1
1276903|NCT00409708|4172544|P2|Washout|Withdrawal by Subject|5
1276904|NCT00409708|4172545|P1|Washout|Withdrawal by Subject|11
1276905|NCT00409708|4172544|P2|Washout|Protocol Violation|1
1276906|NCT00409708|4172545|P1|Washout|Protocol Violation|0
1276907|NCT00409708|4172544|P2|Washout|Lack of Efficacy|1
1276908|NCT00409708|4172545|P1|Washout|Lack of Efficacy|9
1276909|NCT00409708|4172544|P2|Treatment|Administrative problems|0
1276910|NCT00409708|4172545|P1|Treatment|Administrative problems|5
1276911|NCT00409708|4172544|P2|Treatment|Lost to Follow-up|6
1276912|NCT00409708|4172545|P1|Treatment|Lost to Follow-up|0
1276913|NCT00409708|4172544|P2|Treatment|Withdrawal by Subject|8
1276914|NCT00409708|4172545|P1|Treatment|Withdrawal by Subject|3
1276915|NCT00409708|4172544|P2|Treatment|Protocol Violation|2
1276916|NCT00409708|4172545|P1|Treatment|Protocol Violation|6
1276917|NCT00409708|4172544|P2|Treatment|Lack of Efficacy|1
1276918|NCT00409708|4172545|P1|Treatment|Lack of Efficacy|0
1276919|NCT00409708|4172544|P2|Treatment|Abnormal test procedure result(s)|0
1276920|NCT00409708|4172545|P1|Treatment|Abnormal test procedure result(s)|1
1276921|NCT00409682|4172566|P3|EOW Double-blind Maintenance Period|Non-compliance|1
1276922|NCT00409682|4172567|P2|EOW Double-blind Maintenance Period|Non-compliance|0
1276923|NCT00409682|4172568|P1|EOW Double-blind Maintenance Period|Non-compliance|0
1276924|NCT00409682|4172566|P3|EOW Double-blind Maintenance Period|Protocol Violation|1
1276925|NCT00409682|4172567|P2|EOW Double-blind Maintenance Period|Protocol Violation|4
1276926|NCT00409682|4172568|P1|EOW Double-blind Maintenance Period|Protocol Violation|0
1276927|NCT00409682|4172566|P3|EOW Double-blind Maintenance Period|Withdrawal by Subject|2
1276928|NCT00409682|4172567|P2|EOW Double-blind Maintenance Period|Withdrawal by Subject|4
1276929|NCT00409682|4172568|P1|EOW Double-blind Maintenance Period|Withdrawal by Subject|0
1276930|NCT00409682|4172566|P3|EOW Double-blind Maintenance Period|Lost to Follow-up|0
1276931|NCT00409682|4172567|P2|EOW Double-blind Maintenance Period|Lost to Follow-up|1
1276932|NCT00409682|4172568|P1|EOW Double-blind Maintenance Period|Lost to Follow-up|0
1276933|NCT00409682|4172566|P3|EOW Double-blind Maintenance Period|Lack of Efficacy|11
1276934|NCT00409682|4172567|P2|EOW Double-blind Maintenance Period|Lack of Efficacy|18
1276935|NCT00409682|4172568|P1|EOW Double-blind Maintenance Period|Lack of Efficacy|0
1276936|NCT00409682|4172566|P3|EOW Double-blind Maintenance Period|Adverse Event|12
1276937|NCT00409682|4172567|P2|EOW Double-blind Maintenance Period|Adverse Event|10
1276938|NCT00409682|4172568|P1|EOW Double-blind Maintenance Period|Adverse Event|0
1276939|NCT00409682|4172566|P3|Open-label Induction Period|Subject did not satisfy entry criteria|0
1276940|NCT00409682|4172567|P2|Open-label Induction Period|Subject did not satisfy entry criteria|0
1276941|NCT00409682|4172568|P1|Open-label Induction Period|Subject did not satisfy entry criteria|1
1276942|NCT00409682|4172566|P3|Open-label Induction Period|Protocol Violation|0
1276943|NCT00409682|4172567|P2|Open-label Induction Period|Protocol Violation|0
1276944|NCT00409682|4172568|P1|Open-label Induction Period|Protocol Violation|1
1276945|NCT00409682|4172566|P3|Open-label Induction Period|Lack of Efficacy|0
1276946|NCT00409682|4172567|P2|Open-label Induction Period|Lack of Efficacy|0
1276947|NCT00409682|4172568|P1|Open-label Induction Period|Lack of Efficacy|1
1276948|NCT00409682|4172566|P3|Open-label Induction Period|Adverse Event|0
1276949|NCT00409682|4172567|P2|Open-label Induction Period|Adverse Event|0
1276950|NCT00409682|4172568|P1|Open-label Induction Period|Adverse Event|1
1276951|NCT00409617|4172585|P1|Overall Study|Not described|14
1276952|NCT00409617|4172585|P1|Overall Study|Administrative reasons|1
1276953|NCT00409617|4172585|P1|Overall Study|Withdrawal by Subject|8
1276954|NCT00409617|4172585|P1|Overall Study|Protocol Violation|24
1276955|NCT00409617|4172585|P1|Overall Study|Lost to Follow-up|2
1276956|NCT00409617|4172585|P1|Overall Study|Lack of Efficacy|54
1276957|NCT00409617|4172585|P1|Overall Study|Adverse Event|57
1276958|NCT00409578|4172601|P4|Overall Study|Missing|1
1276959|NCT00409578|4172602|P3|Overall Study|Missing|0
1276960|NCT00409578|4172603|P2|Overall Study|Missing|1
1276961|NCT00409578|4172604|P1|Overall Study|Missing|0
1276962|NCT00409578|4172601|P4|Overall Study|Protocol Violation|1
1276963|NCT00409578|4172602|P3|Overall Study|Protocol Violation|3
1276964|NCT00409578|4172603|P2|Overall Study|Protocol Violation|2
1276965|NCT00409578|4172604|P1|Overall Study|Protocol Violation|3
1276966|NCT00409578|4172601|P4|Overall Study|Death|2
1276967|NCT00409578|4172602|P3|Overall Study|Death|4
1276968|NCT00409578|4172603|P2|Overall Study|Death|4
1276969|NCT00409578|4172604|P1|Overall Study|Death|2
1276970|NCT00409578|4172601|P4|Overall Study|Administrative problems|4
1276971|NCT00409578|4172602|P3|Overall Study|Administrative problems|2
1276972|NCT00409578|4172603|P2|Overall Study|Administrative problems|9
1276973|NCT00409578|4172604|P1|Overall Study|Administrative problems|8
1276974|NCT00409578|4172601|P4|Overall Study|Lost to Follow-up|2
1276975|NCT00409578|4172602|P3|Overall Study|Lost to Follow-up|2
1276976|NCT00409578|4172603|P2|Overall Study|Lost to Follow-up|0
1276977|NCT00409578|4172604|P1|Overall Study|Lost to Follow-up|2
1276978|NCT00409578|4172601|P4|Overall Study|Withdrawal by Subject|17
1276979|NCT00409578|4172602|P3|Overall Study|Withdrawal by Subject|16
1276980|NCT00409578|4172603|P2|Overall Study|Withdrawal by Subject|15
1276981|NCT00409578|4172604|P1|Overall Study|Withdrawal by Subject|8
1276982|NCT00409578|4172601|P4|Overall Study|Subject no longer requires study drug|1
1276983|NCT00409578|4172602|P3|Overall Study|Subject no longer requires study drug|0
1276984|NCT00409578|4172603|P2|Overall Study|Subject no longer requires study drug|0
1276985|NCT00409578|4172604|P1|Overall Study|Subject no longer requires study drug|0
1276986|NCT00409578|4172601|P4|Overall Study|Lack of Efficacy|2
1276987|NCT00409578|4172602|P3|Overall Study|Lack of Efficacy|0
1276988|NCT00409578|4172603|P2|Overall Study|Lack of Efficacy|0
1276989|NCT00409578|4172604|P1|Overall Study|Lack of Efficacy|0
1276990|NCT00409578|4172601|P4|Overall Study|Abnormal laboratory value(s)|4
1276991|NCT00409578|4172602|P3|Overall Study|Abnormal laboratory value(s)|2
1276992|NCT00409578|4172603|P2|Overall Study|Abnormal laboratory value(s)|2
1276993|NCT00409578|4172604|P1|Overall Study|Abnormal laboratory value(s)|2
1276994|NCT00409578|4172601|P4|Overall Study|Adverse Event|33
1276995|NCT00409578|4172602|P3|Overall Study|Adverse Event|25
1276996|NCT00409578|4172603|P2|Overall Study|Adverse Event|37
1276997|NCT00409578|4172604|P1|Overall Study|Adverse Event|27
1276998|NCT00409409|4172662|P2|Overall Study|Any other reason not above-mentioned|1
1276999|NCT00409409|4172663|P1|Overall Study|Any other reason not above-mentioned|0
1277000|NCT00409409|4172662|P2|Overall Study|Withdrawal by Subject|1
1277001|NCT00409409|4172663|P1|Overall Study|Withdrawal by Subject|1
1277002|NCT00409409|4172662|P2|Overall Study|Adverse Event|2
1277003|NCT00409409|4172663|P1|Overall Study|Adverse Event|7
1277004|NCT00409344|4172671|P2|Overall Study|no enrollment|0
1277005|NCT00409344|4172672|P1|Overall Study|no enrollment|0
1277006|NCT00409331|4172690|P1|Overall Study|Physician Decision|1
1277007|NCT00409188|4172712|P2|Overall Study|Ongoing at data cut-off|175
1277008|NCT00409188|4172713|P1|Overall Study|Ongoing at data cut-off|383
1277009|NCT00409175|4172729|P2|Overall Study|Liver transplantation|13
1277010|NCT00409175|4172730|P1|Overall Study|Liver transplantation|13
1277011|NCT00409175|4172729|P2|Overall Study|Negative genotype|1
1277012|NCT00409175|4172730|P1|Overall Study|Negative genotype|0
1277013|NCT00409175|4172729|P2|Overall Study|Withdrawal by Subject|2
1277014|NCT00409175|4172730|P1|Overall Study|Withdrawal by Subject|1
1277015|NCT00409175|4172729|P2|Overall Study|Adverse Event|3
1277016|NCT00409175|4172730|P1|Overall Study|Adverse Event|4
1277017|NCT00409006|4172756|P2|Overall Study|Physician Decision|2
1277018|NCT00409006|4172757|P1|Overall Study|Physician Decision|1
1277019|NCT00409006|4172756|P2|Overall Study|Withdrawal by Subject|2
1277020|NCT00409006|4172757|P1|Overall Study|Withdrawal by Subject|3
1277021|NCT00409006|4172756|P2|Overall Study|Lost to Follow-up|2
1277022|NCT00409006|4172757|P1|Overall Study|Lost to Follow-up|1
1277023|NCT00409006|4172756|P2|Overall Study|Death|6
1277024|NCT00409006|4172757|P1|Overall Study|Death|15
1277025|NCT00408993|4172773|P2|Overall Study|Withdrawal by Subject|3
1277026|NCT00408993|4172774|P1|Overall Study|Withdrawal by Subject|2
1277027|NCT00408993|4172773|P2|Overall Study|Lack of Efficacy|4
1277028|NCT00408993|4172774|P1|Overall Study|Lack of Efficacy|1
1277029|NCT00408993|4172773|P2|Overall Study|Protocol Violation|6
1277030|NCT00408993|4172774|P1|Overall Study|Protocol Violation|1
1277031|NCT00408993|4172773|P2|Overall Study|Adverse Event|4
1277032|NCT00408993|4172774|P1|Overall Study|Adverse Event|15
1277033|NCT00408928|4172806|P1|Overall Study|Infection indistinguishable from GVHD|1
1277034|NCT00408928|4172806|P1|Overall Study|Death|1
1277035|NCT00408928|4172806|P1|Overall Study|Withdrawal by Subject|1
1277036|NCT00408902|4172811|P1|Overall Study|Adverse Event|3
1277037|NCT00408902|4172811|P1|Overall Study|Lack of Efficacy|7
1277038|NCT00408876|4172821|P4|Overall Study|Physician Decision|0
1277039|NCT00408876|4172822|P3|Overall Study|Physician Decision|3
1277040|NCT00408876|4172823|P2|Overall Study|Physician Decision|0
1277041|NCT00408876|4172824|P1|Overall Study|Physician Decision|1
1277042|NCT00408876|4172821|P4|Overall Study|Protocol Violation|3
1277043|NCT00408876|4172822|P3|Overall Study|Protocol Violation|4
1277044|NCT00408876|4172823|P2|Overall Study|Protocol Violation|3
1277045|NCT00408876|4172824|P1|Overall Study|Protocol Violation|0
1277046|NCT00408876|4172821|P4|Overall Study|Lost to Follow-up|2
1277047|NCT00408876|4172822|P3|Overall Study|Lost to Follow-up|5
1277048|NCT00408876|4172823|P2|Overall Study|Lost to Follow-up|6
1277049|NCT00408876|4172824|P1|Overall Study|Lost to Follow-up|1
1277050|NCT00408876|4172821|P4|Overall Study|Lack of Efficacy|6
1277051|NCT00408876|4172822|P3|Overall Study|Lack of Efficacy|5
1277052|NCT00408876|4172823|P2|Overall Study|Lack of Efficacy|4
1277053|NCT00408876|4172824|P1|Overall Study|Lack of Efficacy|2
1277054|NCT00408876|4172821|P4|Overall Study|Withdrawal by Subject|14
1277055|NCT00408876|4172822|P3|Overall Study|Withdrawal by Subject|6
1277056|NCT00408876|4172823|P2|Overall Study|Withdrawal by Subject|6
1277057|NCT00408876|4172824|P1|Overall Study|Withdrawal by Subject|3
1277058|NCT00408876|4172821|P4|Overall Study|Adverse Event|10
1277059|NCT00408876|4172822|P3|Overall Study|Adverse Event|27
1277060|NCT00408876|4172823|P2|Overall Study|Adverse Event|17
1277061|NCT00408876|4172824|P1|Overall Study|Adverse Event|9
1277062|NCT00408694|4173074|P1|Overall Study|No protocol treatment|1
1277063|NCT00408694|4173074|P1|Overall Study|Ineligible|1
1277064|NCT00408681|4173086|P1|Overall Study|Adverse Event|7
1277065|NCT00408681|4173086|P1|Overall Study|Lack of Efficacy|2
1277066|NCT00408629|4173105|P2|Overall Study|Miscellaneous|15
1277067|NCT00408629|4173106|P1|Overall Study|Miscellaneous|11
1277068|NCT00408629|4173105|P2|Overall Study|Protocol Violation|5
1277069|NCT00408629|4173106|P1|Overall Study|Protocol Violation|1
1277070|NCT00408629|4173105|P2|Overall Study|Lack of Efficacy|73
1277071|NCT00408629|4173106|P1|Overall Study|Lack of Efficacy|63
1277072|NCT00408629|4173105|P2|Overall Study|Lost to Follow-up|1
1277073|NCT00408629|4173106|P1|Overall Study|Lost to Follow-up|1
1277074|NCT00408629|4173105|P2|Overall Study|Withdrawal by Subject|4
1277075|NCT00408629|4173106|P1|Overall Study|Withdrawal by Subject|8
1277076|NCT00408629|4173105|P2|Overall Study|Adverse Event|27
1277077|NCT00408629|4173106|P1|Overall Study|Adverse Event|13
1277078|NCT00408499|4173202|P5|Phase II- MTD Expansion|treatment delay|3
1277079|NCT00408499|4173203|P4|Phase II- MTD Expansion|treatment delay|0
1277080|NCT00408499|4173204|P3|Phase II- MTD Expansion|treatment delay|0
1277081|NCT00408499|4173205|P2|Phase II- MTD Expansion|treatment delay|0
1277082|NCT00408499|4173206|P1|Phase II- MTD Expansion|treatment delay|0
1277083|NCT00408499|4173202|P5|Phase II- MTD Expansion|Withdrawal by Subject|5
1277084|NCT00408499|4173203|P4|Phase II- MTD Expansion|Withdrawal by Subject|0
1277085|NCT00408499|4173204|P3|Phase II- MTD Expansion|Withdrawal by Subject|0
1277086|NCT00408499|4173205|P2|Phase II- MTD Expansion|Withdrawal by Subject|0
1277087|NCT00408499|4173206|P1|Phase II- MTD Expansion|Withdrawal by Subject|0
1277088|NCT00408499|4173202|P5|Phase II- MTD Expansion|Physician Decision|1
1277089|NCT00408499|4173203|P4|Phase II- MTD Expansion|Physician Decision|0
1277090|NCT00408499|4173204|P3|Phase II- MTD Expansion|Physician Decision|0
1277091|NCT00408499|4173205|P2|Phase II- MTD Expansion|Physician Decision|0
1277092|NCT00408499|4173206|P1|Phase II- MTD Expansion|Physician Decision|0
1277093|NCT00408499|4173202|P5|Phase II- MTD Expansion|Death|2
1277094|NCT00408499|4173203|P4|Phase II- MTD Expansion|Death|0
1277095|NCT00408499|4173204|P3|Phase II- MTD Expansion|Death|0
1277096|NCT00408499|4173205|P2|Phase II- MTD Expansion|Death|0
1277097|NCT00408499|4173206|P1|Phase II- MTD Expansion|Death|0
1277098|NCT00408499|4173202|P5|Phase II- MTD Expansion|Adverse Event|9
1277099|NCT00408499|4173203|P4|Phase II- MTD Expansion|Adverse Event|0
1277100|NCT00408499|4173204|P3|Phase II- MTD Expansion|Adverse Event|0
1277101|NCT00408499|4173205|P2|Phase II- MTD Expansion|Adverse Event|0
1277102|NCT00408499|4173206|P1|Phase II- MTD Expansion|Adverse Event|0
1277103|NCT00408499|4173202|P5|Phase 1: Dose Levels 1-4|Physician Decision|0
1277104|NCT00408499|4173203|P4|Phase 1: Dose Levels 1-4|Physician Decision|0
1277105|NCT00408499|4173204|P3|Phase 1: Dose Levels 1-4|Physician Decision|0
1277106|NCT00408499|4173205|P2|Phase 1: Dose Levels 1-4|Physician Decision|1
1277107|NCT00408499|4173206|P1|Phase 1: Dose Levels 1-4|Physician Decision|1
1277108|NCT00408499|4173202|P5|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
1277109|NCT00408499|4173203|P4|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
1277110|NCT00408499|4173204|P3|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
1277111|NCT00408499|4173205|P2|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
1277112|NCT00408499|4173206|P1|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
1277113|NCT00408499|4173202|P5|Phase 1: Dose Levels 1-4|Adverse Event|0
1277114|NCT00408499|4173203|P4|Phase 1: Dose Levels 1-4|Adverse Event|0
1277115|NCT00408499|4173204|P3|Phase 1: Dose Levels 1-4|Adverse Event|1
1277116|NCT00408499|4173205|P2|Phase 1: Dose Levels 1-4|Adverse Event|0
1277117|NCT00408499|4173206|P1|Phase 1: Dose Levels 1-4|Adverse Event|0
1277118|NCT00408421|4173223|P3|Treatment Re-Randomization|Withdrawal by Subject|0
1277119|NCT00408421|4173224|P2|Treatment Re-Randomization|Withdrawal by Subject|1
1277120|NCT00408421|4173225|P1|Treatment Re-Randomization|Withdrawal by Subject|2
1277121|NCT00408421|4173223|P3|Treatment Re-Randomization|Protocol Violation|0
1277122|NCT00408421|4173224|P2|Treatment Re-Randomization|Protocol Violation|1
1277123|NCT00408421|4173225|P1|Treatment Re-Randomization|Protocol Violation|1
1277124|NCT00408421|4173223|P3|Treatment Re-Randomization|Physician Decision|0
1277125|NCT00408421|4173224|P2|Treatment Re-Randomization|Physician Decision|3
1277126|NCT00408421|4173225|P1|Treatment Re-Randomization|Physician Decision|1
1277127|NCT00408421|4173223|P3|Treatment Re-Randomization|Lost to Follow-up|1
1277128|NCT00408421|4173224|P2|Treatment Re-Randomization|Lost to Follow-up|0
1277129|NCT00408421|4173225|P1|Treatment Re-Randomization|Lost to Follow-up|0
1277130|NCT00408421|4173223|P3|Treatment Re-Randomization|Lack of Efficacy|0
1277131|NCT00408421|4173224|P2|Treatment Re-Randomization|Lack of Efficacy|0
1277132|NCT00408421|4173225|P1|Treatment Re-Randomization|Lack of Efficacy|1
1277133|NCT00408421|4173223|P3|Treatment Re-Randomization|Adverse Event|4
1277134|NCT00408421|4173224|P2|Treatment Re-Randomization|Adverse Event|2
1277135|NCT00408421|4173225|P1|Treatment Re-Randomization|Adverse Event|2
1277136|NCT00408421|4173223|P3|Treatment Initial Randomization|Sponsor Decision|0
1277137|NCT00408421|4173224|P2|Treatment Initial Randomization|Sponsor Decision|0
1277138|NCT00408421|4173225|P1|Treatment Initial Randomization|Sponsor Decision|1
1277139|NCT00408421|4173223|P3|Treatment Initial Randomization|Entry Criteria Not Met|0
1277140|NCT00408421|4173224|P2|Treatment Initial Randomization|Entry Criteria Not Met|0
1277141|NCT00408421|4173225|P1|Treatment Initial Randomization|Entry Criteria Not Met|1
1277142|NCT00408421|4173223|P3|Treatment Initial Randomization|Withdrawal by Subject|0
1277143|NCT00408421|4173224|P2|Treatment Initial Randomization|Withdrawal by Subject|7
1277144|NCT00408421|4173225|P1|Treatment Initial Randomization|Withdrawal by Subject|7
1277145|NCT00408421|4173223|P3|Treatment Initial Randomization|Protocol Violation|0
1277146|NCT00408421|4173224|P2|Treatment Initial Randomization|Protocol Violation|1
1277147|NCT00408421|4173225|P1|Treatment Initial Randomization|Protocol Violation|0
1277148|NCT00408421|4173223|P3|Treatment Initial Randomization|Physician Decision|0
1277149|NCT00408421|4173224|P2|Treatment Initial Randomization|Physician Decision|0
1277150|NCT00408421|4173225|P1|Treatment Initial Randomization|Physician Decision|1
1277151|NCT00408421|4173223|P3|Treatment Initial Randomization|Lost to Follow-up|0
1277152|NCT00408421|4173224|P2|Treatment Initial Randomization|Lost to Follow-up|3
1277153|NCT00408421|4173225|P1|Treatment Initial Randomization|Lost to Follow-up|0
1277154|NCT00408421|4173223|P3|Treatment Initial Randomization|Lack of Efficacy|0
1277155|NCT00408421|4173224|P2|Treatment Initial Randomization|Lack of Efficacy|2
1277156|NCT00408421|4173225|P1|Treatment Initial Randomization|Lack of Efficacy|2
1277157|NCT00408421|4173223|P3|Treatment Initial Randomization|Adverse Event|0
1277158|NCT00408421|4173224|P2|Treatment Initial Randomization|Adverse Event|9
1277159|NCT00408421|4173225|P1|Treatment Initial Randomization|Adverse Event|5
1277160|NCT00408408|4173305|P6|Overall Study|No follow up data|3
1277161|NCT00408408|4173306|P5|Overall Study|No follow up data|5
1277162|NCT00408408|4173307|P4|Overall Study|No follow up data|7
1277163|NCT00408408|4173308|P3|Overall Study|No follow up data|0
1277164|NCT00408408|4173309|P2|Overall Study|No follow up data|3
1277165|NCT00408408|4173310|P1|Overall Study|No follow up data|2
1277166|NCT00408317|4173372|P2|Second Intervention Period|Withdrawal of consent|1
1277167|NCT00408317|4173373|P1|Second Intervention Period|Withdrawal of consent|0
1277168|NCT00408317|4173372|P2|Second Intervention Period|Protocol Violation|1
1277169|NCT00408317|4173373|P1|Second Intervention Period|Protocol Violation|0
1277170|NCT00408317|4173372|P2|Second Intervention Period|Adverse Event|0
1277171|NCT00408317|4173373|P1|Second Intervention Period|Adverse Event|2
1277172|NCT00408317|4173372|P2|First Intervention Period|Adverse Event|1
1277173|NCT00408317|4173373|P1|First Intervention Period|Adverse Event|0
1277174|NCT00407797|4173416|P1|Overall Study|Withdrawal by Subject|3
1277175|NCT00407797|4173416|P1|Overall Study|Other|7
1277176|NCT00407797|4173416|P1|Overall Study|Adverse Event|6
1277177|NCT00407797|4173416|P1|Overall Study|Lost to Follow-up|2
1277178|NCT00407758|4173431|P1|Overall Study|ineligible –improper prior treatment|1
1277179|NCT00407745|4173444|P2|Overall Study|Randomized, unknown if treated|1
1277180|NCT00407745|4173445|P1|Overall Study|Randomized, unknown if treated|0
1277181|NCT00407745|4173444|P2|Overall Study|Other|0
1277182|NCT00407745|4173445|P1|Overall Study|Other|2
1277183|NCT00407745|4173444|P2|Overall Study|Adverse Event|8
1277184|NCT00407745|4173445|P1|Overall Study|Adverse Event|8
1277185|NCT00407745|4173444|P2|Overall Study|Protocol Violation|3
1277186|NCT00407745|4173445|P1|Overall Study|Protocol Violation|5
1277187|NCT00407745|4173444|P2|Overall Study|Withdrawal by Subject|3
1277188|NCT00407745|4173445|P1|Overall Study|Withdrawal by Subject|3
1277189|NCT00407745|4173444|P2|Overall Study|Lack of Efficacy|2
1277190|NCT00407745|4173445|P1|Overall Study|Lack of Efficacy|1
1277191|NCT00407563|4173531|P1|Overall Study|Patient continues on treatment|1
1277192|NCT00407550|4173541|P2|Overall Study|Insurance or Other medical condition|1
1277193|NCT00407550|4173542|P1|Overall Study|Insurance or Other medical condition|2
1277194|NCT00407550|4173541|P2|Overall Study|Death|0
1277195|NCT00407550|4173542|P1|Overall Study|Death|1
1277196|NCT00407550|4173541|P2|Overall Study|Withdrawal by Subject|2
1277197|NCT00407550|4173542|P1|Overall Study|Withdrawal by Subject|0
1277198|NCT00407550|4173541|P2|Overall Study|Adverse Event|1
1277199|NCT00407550|4173542|P1|Overall Study|Adverse Event|0
1277200|NCT00407537|4173550|P2|Overall Study|Withdrawal by Subject|16
1277201|NCT00407537|4173551|P1|Overall Study|Withdrawal by Subject|34
1277202|NCT00407537|4173550|P2|Overall Study|Other|7
1277203|NCT00407537|4173551|P1|Overall Study|Other|6
1277204|NCT00407537|4173550|P2|Overall Study|Lost to Follow-up|19
1277205|NCT00407537|4173551|P1|Overall Study|Lost to Follow-up|12
1277206|NCT00407537|4173550|P2|Overall Study|Adverse Event|0
1277207|NCT00407537|4173551|P1|Overall Study|Adverse Event|36
1277208|NCT00407537|4173550|P2|Overall Study|Death|2
1277209|NCT00407537|4173551|P1|Overall Study|Death|5
1277210|NCT00407511|4173599|P1|Overall Study|Withdrawal by Subject|4
1277211|NCT00407511|4173599|P1|Overall Study|Other|5
1277212|NCT00407511|4173599|P1|Overall Study|Lost to Follow-up|4
1277213|NCT00407511|4173599|P1|Overall Study|Adverse Event|9
1277214|NCT00407030|4173645|P3|Extension Period - up to 68 Weeks|Physician Decision|0
1277215|NCT00407030|4173646|P2|Extension Period - up to 68 Weeks|Physician Decision|2
1277216|NCT00407030|4173647|P1|Extension Period - up to 68 Weeks|Physician Decision|1
1277217|NCT00407030|4173645|P3|Extension Period - up to 68 Weeks|Patient Decision|0
1277218|NCT00407030|4173646|P2|Extension Period - up to 68 Weeks|Patient Decision|2
1277219|NCT00407030|4173647|P1|Extension Period - up to 68 Weeks|Patient Decision|1
1277220|NCT00407030|4173645|P3|Extension Period - up to 68 Weeks|Lost to Follow-up|0
1277221|NCT00407030|4173646|P2|Extension Period - up to 68 Weeks|Lost to Follow-up|5
1277222|NCT00407030|4173647|P1|Extension Period - up to 68 Weeks|Lost to Follow-up|5
1277223|NCT00407030|4173645|P3|Extension Period - up to 68 Weeks|Consent Withdrawn|0
1277224|NCT00407030|4173646|P2|Extension Period - up to 68 Weeks|Consent Withdrawn|4
1277225|NCT00407030|4173647|P1|Extension Period - up to 68 Weeks|Consent Withdrawn|4
1277226|NCT00407030|4173645|P3|Extension Period - up to 68 Weeks|Adverse Event|0
1277227|NCT00407030|4173646|P2|Extension Period - up to 68 Weeks|Adverse Event|0
1277228|NCT00407030|4173647|P1|Extension Period - up to 68 Weeks|Adverse Event|1
1277229|NCT00407030|4173645|P3|Extension Period - up to 68 Weeks|Lack of Efficacy|0
1277230|NCT00407030|4173646|P2|Extension Period - up to 68 Weeks|Lack of Efficacy|11
1277231|NCT00407030|4173647|P1|Extension Period - up to 68 Weeks|Lack of Efficacy|11
1277232|NCT00407030|4173645|P3|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
1277233|NCT00407030|4173646|P2|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5
1277234|NCT00407030|4173647|P1|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
1277235|NCT00407030|4173645|P3|Main Period - 8 to 20 Weeks|Patient Decision|0
1277236|NCT00407030|4173646|P2|Main Period - 8 to 20 Weeks|Patient Decision|0
1277237|NCT00407030|4173647|P1|Main Period - 8 to 20 Weeks|Patient Decision|1
1277238|NCT00407030|4173645|P3|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1
1277239|NCT00407030|4173646|P2|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
1277240|NCT00407030|4173647|P1|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
1277241|NCT00407030|4173645|P3|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
1277242|NCT00407030|4173646|P2|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
1277243|NCT00407030|4173647|P1|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
1277244|NCT00407030|4173645|P3|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
1277245|NCT00407030|4173646|P2|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
1277246|NCT00407030|4173647|P1|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
1277247|NCT00407030|4173645|P3|Main Period - 8 to 20 Weeks|Lack of Efficacy|3
1277248|NCT00407030|4173646|P2|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
1277249|NCT00407030|4173647|P1|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
1277250|NCT00407030|4173645|P3|Main Period - 8 to 20 Weeks|Adverse Event|0
1277251|NCT00407030|4173646|P2|Main Period - 8 to 20 Weeks|Adverse Event|1
1277252|NCT00407030|4173647|P1|Main Period - 8 to 20 Weeks|Adverse Event|2
1277253|NCT00406848|4173675|P2|Overall Study|Sponsor Decision|1
1277254|NCT00406848|4173676|P1|Overall Study|Sponsor Decision|1
1277255|NCT00406848|4173675|P2|Overall Study|Physician Decision|2
1277256|NCT00406848|4173676|P1|Overall Study|Physician Decision|2
1277257|NCT00406848|4173675|P2|Overall Study|Lost to Follow-up|2
1277258|NCT00406848|4173676|P1|Overall Study|Lost to Follow-up|6
1277259|NCT00406848|4173675|P2|Overall Study|Protocol Violation|6
1277260|NCT00406848|4173676|P1|Overall Study|Protocol Violation|10
1277261|NCT00406848|4173675|P2|Overall Study|Lack of Efficacy|14
1277262|NCT00406848|4173676|P1|Overall Study|Lack of Efficacy|9
1277263|NCT00406848|4173675|P2|Overall Study|Adverse Event|7
1277264|NCT00406848|4173676|P1|Overall Study|Adverse Event|38
1277265|NCT00406848|4173675|P2|Overall Study|Withdrawal by Subject|22
1277266|NCT00406848|4173676|P1|Overall Study|Withdrawal by Subject|27
1277267|NCT00406783|4173740|P2|Overall Study|Protocol Violation|4
1277268|NCT00406783|4173741|P1|Overall Study|Protocol Violation|4
1277269|NCT00406783|4173740|P2|Overall Study|Withdrawal by Subject|4
1277270|NCT00406783|4173741|P1|Overall Study|Withdrawal by Subject|1
1277271|NCT00406783|4173740|P2|Overall Study|Lost to Follow-up|0
1277272|NCT00406783|4173741|P1|Overall Study|Lost to Follow-up|3
1277273|NCT00406783|4173740|P2|Overall Study|Treatment Failure|3
1277274|NCT00406783|4173741|P1|Overall Study|Treatment Failure|2
1277275|NCT00406783|4173740|P2|Overall Study|Adverse Event|4
1277276|NCT00406783|4173741|P1|Overall Study|Adverse Event|4
1277277|NCT00406718|4173756|P3|Overall Study|Lost to Follow-up|4
1277278|NCT00406718|4173757|P2|Overall Study|Lost to Follow-up|5
1277279|NCT00406718|4173758|P1|Overall Study|Lost to Follow-up|2
1277280|NCT00406718|4173756|P3|Overall Study|Withdrawal by Subject|4
1277281|NCT00406718|4173757|P2|Overall Study|Withdrawal by Subject|9
1277282|NCT00406718|4173758|P1|Overall Study|Withdrawal by Subject|2
1277283|NCT00406692|4173772|P1|Overall Study|Lack of Efficacy|1
1277284|NCT00406692|4173772|P1|Overall Study|Adverse Event|1
1277285|NCT00406692|4173772|P1|Overall Study|Physician Decision|1
1277286|NCT00406692|4173772|P1|Overall Study|Withdrawal by Subject|4
1277287|NCT00406653|4173782|P7|Open-Label Period|Refused followup|1
1277288|NCT00406653|4173783|P6|Open-Label Period|Refused followup|0
1277289|NCT00406653|4173784|P5|Open-Label Period|Refused followup|0
1277290|NCT00406653|4173785|P4|Open-Label Period|Refused followup|0
1277291|NCT00406653|4173786|P3|Open-Label Period|Refused followup|0
1277292|NCT00406653|4173787|P2|Open-Label Period|Refused followup|0
1277293|NCT00406653|4173788|P1|Open-Label Period|Refused followup|0
1277294|NCT00406653|4173782|P7|Open-Label Period|Discontinued by Sponsor|1
1277295|NCT00406653|4173783|P6|Open-Label Period|Discontinued by Sponsor|0
1277296|NCT00406653|4173784|P5|Open-Label Period|Discontinued by Sponsor|0
1277297|NCT00406653|4173785|P4|Open-Label Period|Discontinued by Sponsor|0
1277298|NCT00406653|4173786|P3|Open-Label Period|Discontinued by Sponsor|0
1277299|NCT00406653|4173787|P2|Open-Label Period|Discontinued by Sponsor|0
1277300|NCT00406653|4173788|P1|Open-Label Period|Discontinued by Sponsor|0
1277301|NCT00406653|4173782|P7|Open-Label Period|Declined participation but followup done|8
1277302|NCT00406653|4173783|P6|Open-Label Period|Declined participation but followup done|0
1277303|NCT00406653|4173784|P5|Open-Label Period|Declined participation but followup done|0
1277304|NCT00406653|4173785|P4|Open-Label Period|Declined participation but followup done|0
1277305|NCT00406653|4173786|P3|Open-Label Period|Declined participation but followup done|0
1277306|NCT00406653|4173787|P2|Open-Label Period|Declined participation but followup done|0
1277307|NCT00406653|4173788|P1|Open-Label Period|Declined participation but followup done|0
1277308|NCT00406653|4173782|P7|Open-Label Period|Administrative Reason By Sponsor|115
1277309|NCT00406653|4173783|P6|Open-Label Period|Administrative Reason By Sponsor|0
1277310|NCT00406653|4173784|P5|Open-Label Period|Administrative Reason By Sponsor|0
1277311|NCT00406653|4173785|P4|Open-Label Period|Administrative Reason By Sponsor|0
1277312|NCT00406653|4173786|P3|Open-Label Period|Administrative Reason By Sponsor|0
1277313|NCT00406653|4173787|P2|Open-Label Period|Administrative Reason By Sponsor|0
1277314|NCT00406653|4173788|P1|Open-Label Period|Administrative Reason By Sponsor|0
1277315|NCT00406653|4173782|P7|Open-Label Period|Pregnancy|2
1277316|NCT00406653|4173783|P6|Open-Label Period|Pregnancy|0
1277317|NCT00406653|4173784|P5|Open-Label Period|Pregnancy|0
1277318|NCT00406653|4173785|P4|Open-Label Period|Pregnancy|0
1277319|NCT00406653|4173786|P3|Open-Label Period|Pregnancy|0
1277320|NCT00406653|4173787|P2|Open-Label Period|Pregnancy|0
1277321|NCT00406653|4173788|P1|Open-Label Period|Pregnancy|0
1277322|NCT00406653|4173782|P7|Open-Label Period|Subject No Longer Meets Study Criteria|1
1277323|NCT00406653|4173783|P6|Open-Label Period|Subject No Longer Meets Study Criteria|0
1277324|NCT00406653|4173784|P5|Open-Label Period|Subject No Longer Meets Study Criteria|0
1277325|NCT00406653|4173785|P4|Open-Label Period|Subject No Longer Meets Study Criteria|0
1277326|NCT00406653|4173786|P3|Open-Label Period|Subject No Longer Meets Study Criteria|0
1277327|NCT00406653|4173787|P2|Open-Label Period|Subject No Longer Meets Study Criteria|0
1277328|NCT00406653|4173788|P1|Open-Label Period|Subject No Longer Meets Study Criteria|0
1277329|NCT00406653|4173782|P7|Open-Label Period|Withdrawal of Consent|11
1277330|NCT00406653|4173783|P6|Open-Label Period|Withdrawal of Consent|0
1277331|NCT00406653|4173784|P5|Open-Label Period|Withdrawal of Consent|0
1277332|NCT00406653|4173785|P4|Open-Label Period|Withdrawal of Consent|0
1277333|NCT00406653|4173786|P3|Open-Label Period|Withdrawal of Consent|0
1277334|NCT00406653|4173787|P2|Open-Label Period|Withdrawal of Consent|0
1277335|NCT00406653|4173788|P1|Open-Label Period|Withdrawal of Consent|0
1277336|NCT00406653|4173782|P7|Open-Label Period|Lost to Follow-up|6
1277337|NCT00406653|4173783|P6|Open-Label Period|Lost to Follow-up|0
1277338|NCT00406653|4173784|P5|Open-Label Period|Lost to Follow-up|0
1277339|NCT00406653|4173785|P4|Open-Label Period|Lost to Follow-up|0
1277340|NCT00406653|4173786|P3|Open-Label Period|Lost to Follow-up|0
1277341|NCT00406653|4173787|P2|Open-Label Period|Lost to Follow-up|0
1277342|NCT00406653|4173788|P1|Open-Label Period|Lost to Follow-up|0
1277343|NCT00406653|4173782|P7|Open-Label Period|Lack of Efficacy|160
1277344|NCT00406653|4173783|P6|Open-Label Period|Lack of Efficacy|0
1277345|NCT00406653|4173784|P5|Open-Label Period|Lack of Efficacy|0
1277346|NCT00406653|4173785|P4|Open-Label Period|Lack of Efficacy|0
1277347|NCT00406653|4173786|P3|Open-Label Period|Lack of Efficacy|0
1277348|NCT00406653|4173787|P2|Open-Label Period|Lack of Efficacy|0
1277349|NCT00406653|4173788|P1|Open-Label Period|Lack of Efficacy|0
1277350|NCT00406653|4173782|P7|Open-Label Period|Adverse Event|18
1277351|NCT00406653|4173783|P6|Open-Label Period|Adverse Event|0
1277352|NCT00406653|4173784|P5|Open-Label Period|Adverse Event|0
1277353|NCT00406653|4173785|P4|Open-Label Period|Adverse Event|0
1277354|NCT00406653|4173786|P3|Open-Label Period|Adverse Event|0
1277355|NCT00406653|4173787|P2|Open-Label Period|Adverse Event|0
1277356|NCT00406653|4173788|P1|Open-Label Period|Adverse Event|0
1277357|NCT00406653|4173782|P7|Open-Label Period|Death|1
1277358|NCT00406653|4173783|P6|Open-Label Period|Death|0
1277359|NCT00406653|4173784|P5|Open-Label Period|Death|0
1277360|NCT00406653|4173785|P4|Open-Label Period|Death|0
1277361|NCT00406653|4173786|P3|Open-Label Period|Death|0
1277362|NCT00406653|4173787|P2|Open-Label Period|Death|0
1277363|NCT00406653|4173788|P1|Open-Label Period|Death|0
1277364|NCT00406653|4173782|P7|Maintenance Period|Error in disease score evaluation|0
1277365|NCT00406653|4173783|P6|Maintenance Period|Error in disease score evaluation|0
1277366|NCT00406653|4173784|P5|Maintenance Period|Error in disease score evaluation|1
1277367|NCT00406653|4173785|P4|Maintenance Period|Error in disease score evaluation|0
1277368|NCT00406653|4173786|P3|Maintenance Period|Error in disease score evaluation|0
1277369|NCT00406653|4173787|P2|Maintenance Period|Error in disease score evaluation|0
1277370|NCT00406653|4173788|P1|Maintenance Period|Error in disease score evaluation|0
1277371|NCT00406653|4173782|P7|Maintenance Period|Administrative Reason By Sponsor|0
1277372|NCT00406653|4173783|P6|Maintenance Period|Administrative Reason By Sponsor|7
1277373|NCT00406653|4173784|P5|Maintenance Period|Administrative Reason By Sponsor|4
1277374|NCT00406653|4173785|P4|Maintenance Period|Administrative Reason By Sponsor|0
1277375|NCT00406653|4173786|P3|Maintenance Period|Administrative Reason By Sponsor|0
1277376|NCT00406653|4173787|P2|Maintenance Period|Administrative Reason By Sponsor|0
1277377|NCT00406653|4173788|P1|Maintenance Period|Administrative Reason By Sponsor|0
1277378|NCT00406653|4173782|P7|Maintenance Period|Pregnancy|0
1277379|NCT00406653|4173783|P6|Maintenance Period|Pregnancy|1
1277380|NCT00406653|4173784|P5|Maintenance Period|Pregnancy|0
1277381|NCT00406653|4173785|P4|Maintenance Period|Pregnancy|0
1277382|NCT00406653|4173786|P3|Maintenance Period|Pregnancy|0
1277383|NCT00406653|4173787|P2|Maintenance Period|Pregnancy|0
1277384|NCT00406653|4173788|P1|Maintenance Period|Pregnancy|0
1277385|NCT00406653|4173782|P7|Maintenance Period|Withdrawal of Consent|0
1277386|NCT00406653|4173783|P6|Maintenance Period|Withdrawal of Consent|0
1277387|NCT00406653|4173784|P5|Maintenance Period|Withdrawal of Consent|2
1277388|NCT00406653|4173785|P4|Maintenance Period|Withdrawal of Consent|0
1277389|NCT00406653|4173786|P3|Maintenance Period|Withdrawal of Consent|0
1277390|NCT00406653|4173787|P2|Maintenance Period|Withdrawal of Consent|0
1277391|NCT00406653|4173788|P1|Maintenance Period|Withdrawal of Consent|0
1277392|NCT00406653|4173782|P7|Maintenance Period|Lost to Follow-up|0
1277393|NCT00406653|4173783|P6|Maintenance Period|Lost to Follow-up|1
1277394|NCT00406653|4173784|P5|Maintenance Period|Lost to Follow-up|2
1277395|NCT00406653|4173785|P4|Maintenance Period|Lost to Follow-up|0
1277396|NCT00406653|4173786|P3|Maintenance Period|Lost to Follow-up|0
1277397|NCT00406653|4173787|P2|Maintenance Period|Lost to Follow-up|0
1277398|NCT00406653|4173788|P1|Maintenance Period|Lost to Follow-up|0
1277399|NCT00406653|4173782|P7|Maintenance Period|Lack of Efficacy|0
1277400|NCT00406653|4173783|P6|Maintenance Period|Lack of Efficacy|26
1277401|NCT00406653|4173784|P5|Maintenance Period|Lack of Efficacy|20
1277402|NCT00406653|4173785|P4|Maintenance Period|Lack of Efficacy|0
1277403|NCT00406653|4173786|P3|Maintenance Period|Lack of Efficacy|0
1277404|NCT00406653|4173787|P2|Maintenance Period|Lack of Efficacy|0
1277405|NCT00406653|4173788|P1|Maintenance Period|Lack of Efficacy|0
1277406|NCT00406653|4173782|P7|Maintenance Period|Adverse Event|0
1277407|NCT00406653|4173783|P6|Maintenance Period|Adverse Event|1
1277408|NCT00406653|4173784|P5|Maintenance Period|Adverse Event|1
1277409|NCT00406653|4173785|P4|Maintenance Period|Adverse Event|0
1277410|NCT00406653|4173786|P3|Maintenance Period|Adverse Event|0
1277411|NCT00406653|4173787|P2|Maintenance Period|Adverse Event|0
1277412|NCT00406653|4173788|P1|Maintenance Period|Adverse Event|0
1277413|NCT00406653|4173782|P7|Induction Period|Patient relocated|0
1277414|NCT00406653|4173783|P6|Induction Period|Patient relocated|0
1277415|NCT00406653|4173784|P5|Induction Period|Patient relocated|0
1277416|NCT00406653|4173785|P4|Induction Period|Patient relocated|0
1277417|NCT00406653|4173786|P3|Induction Period|Patient relocated|1
1277418|NCT00406653|4173787|P2|Induction Period|Patient relocated|0
1277419|NCT00406653|4173788|P1|Induction Period|Patient relocated|0
1277420|NCT00406653|4173782|P7|Induction Period|Incarcerated|0
1277421|NCT00406653|4173783|P6|Induction Period|Incarcerated|0
1277422|NCT00406653|4173784|P5|Induction Period|Incarcerated|0
1277423|NCT00406653|4173785|P4|Induction Period|Incarcerated|0
1277424|NCT00406653|4173786|P3|Induction Period|Incarcerated|1
1277425|NCT00406653|4173787|P2|Induction Period|Incarcerated|0
1277426|NCT00406653|4173788|P1|Induction Period|Incarcerated|0
1277427|NCT00406653|4173782|P7|Induction Period|Given prohibited drug|0
1277428|NCT00406653|4173783|P6|Induction Period|Given prohibited drug|0
1277429|NCT00406653|4173784|P5|Induction Period|Given prohibited drug|0
1277430|NCT00406653|4173785|P4|Induction Period|Given prohibited drug|0
1277431|NCT00406653|4173786|P3|Induction Period|Given prohibited drug|2
1277432|NCT00406653|4173787|P2|Induction Period|Given prohibited drug|1
1277433|NCT00406653|4173788|P1|Induction Period|Given prohibited drug|0
1277434|NCT00406653|4173782|P7|Induction Period|Declined participation but followup done|0
1277435|NCT00406653|4173783|P6|Induction Period|Declined participation but followup done|0
1277436|NCT00406653|4173784|P5|Induction Period|Declined participation but followup done|0
1277437|NCT00406653|4173785|P4|Induction Period|Declined participation but followup done|1
1277438|NCT00406653|4173786|P3|Induction Period|Declined participation but followup done|1
1277439|NCT00406653|4173787|P2|Induction Period|Declined participation but followup done|2
1277440|NCT00406653|4173788|P1|Induction Period|Declined participation but followup done|0
1277441|NCT00406653|4173782|P7|Induction Period|Pregnancy|0
1277442|NCT00406653|4173783|P6|Induction Period|Pregnancy|0
1277443|NCT00406653|4173784|P5|Induction Period|Pregnancy|0
1277444|NCT00406653|4173785|P4|Induction Period|Pregnancy|0
1277445|NCT00406653|4173786|P3|Induction Period|Pregnancy|0
1277446|NCT00406653|4173787|P2|Induction Period|Pregnancy|0
1277447|NCT00406653|4173788|P1|Induction Period|Pregnancy|1
1277448|NCT00406653|4173782|P7|Induction Period|Subject No Longer Meets Study Criteria|0
1277449|NCT00406653|4173783|P6|Induction Period|Subject No Longer Meets Study Criteria|0
1277450|NCT00406653|4173784|P5|Induction Period|Subject No Longer Meets Study Criteria|0
1277451|NCT00406653|4173785|P4|Induction Period|Subject No Longer Meets Study Criteria|2
1277452|NCT00406653|4173786|P3|Induction Period|Subject No Longer Meets Study Criteria|0
1277453|NCT00406653|4173787|P2|Induction Period|Subject No Longer Meets Study Criteria|0
1277454|NCT00406653|4173788|P1|Induction Period|Subject No Longer Meets Study Criteria|0
1277455|NCT00406653|4173782|P7|Induction Period|Withdrawal of Consent|0
1277456|NCT00406653|4173783|P6|Induction Period|Withdrawal of Consent|0
1277457|NCT00406653|4173784|P5|Induction Period|Withdrawal of Consent|0
1277458|NCT00406653|4173785|P4|Induction Period|Withdrawal of Consent|2
1277459|NCT00406653|4173786|P3|Induction Period|Withdrawal of Consent|1
1277460|NCT00406653|4173787|P2|Induction Period|Withdrawal of Consent|5
1277461|NCT00406653|4173788|P1|Induction Period|Withdrawal of Consent|2
1277462|NCT00406653|4173782|P7|Induction Period|Lost to Follow-up|0
1277463|NCT00406653|4173783|P6|Induction Period|Lost to Follow-up|0
1277464|NCT00406653|4173784|P5|Induction Period|Lost to Follow-up|0
1277465|NCT00406653|4173785|P4|Induction Period|Lost to Follow-up|0
1277466|NCT00406653|4173786|P3|Induction Period|Lost to Follow-up|0
1277467|NCT00406653|4173787|P2|Induction Period|Lost to Follow-up|2
1277468|NCT00406653|4173788|P1|Induction Period|Lost to Follow-up|0
1277469|NCT00406653|4173782|P7|Induction Period|Lack of Efficacy|0
1277470|NCT00406653|4173783|P6|Induction Period|Lack of Efficacy|0
1277471|NCT00406653|4173784|P5|Induction Period|Lack of Efficacy|0
1277472|NCT00406653|4173785|P4|Induction Period|Lack of Efficacy|10
1277473|NCT00406653|4173786|P3|Induction Period|Lack of Efficacy|8
1277474|NCT00406653|4173787|P2|Induction Period|Lack of Efficacy|14
1277475|NCT00406653|4173788|P1|Induction Period|Lack of Efficacy|11
1277476|NCT00406653|4173782|P7|Induction Period|Adverse Event|0
1277477|NCT00406653|4173783|P6|Induction Period|Adverse Event|0
1277478|NCT00406653|4173784|P5|Induction Period|Adverse Event|0
1277479|NCT00406653|4173785|P4|Induction Period|Adverse Event|11
1277480|NCT00406653|4173786|P3|Induction Period|Adverse Event|4
1277481|NCT00406653|4173787|P2|Induction Period|Adverse Event|10
1277482|NCT00406653|4173788|P1|Induction Period|Adverse Event|1
1277483|NCT00406640|4173869|P2|OL Extension Phase for Non-Responders|Lack of Efficacy|7
1277484|NCT00406640|4173870|P1|OL Extension Phase for Non-Responders|Lack of Efficacy|6
1277485|NCT00406640|4173869|P2|OL Extension Phase for Non-Responders|Withdrawal by Subject|6
1277486|NCT00406640|4173870|P1|OL Extension Phase for Non-Responders|Withdrawal by Subject|3
1277487|NCT00406640|4173869|P2|OL Extension Phase for Non-Responders|non-compliance|2
1277488|NCT00406640|4173870|P1|OL Extension Phase for Non-Responders|non-compliance|3
1277489|NCT00406640|4173869|P2|OL Extension Phase for Non-Responders|Lost to Follow-up|3
1277490|NCT00406640|4173870|P1|OL Extension Phase for Non-Responders|Lost to Follow-up|2
1277491|NCT00406640|4173869|P2|OL Extension Phase for Non-Responders|Physician Decision|0
1277492|NCT00406640|4173870|P1|OL Extension Phase for Non-Responders|Physician Decision|1
1277493|NCT00406640|4173869|P2|OL Extension Phase for Non-Responders|Failed to Return|0
1277494|NCT00406640|4173870|P1|OL Extension Phase for Non-Responders|Failed to Return|1
1277495|NCT00406640|4173869|P2|OL Extension Phase for Non-Responders|Adverse Event|6
1277496|NCT00406640|4173870|P1|OL Extension Phase for Non-Responders|Adverse Event|6
1277497|NCT00406640|4173869|P2|DB Continuation Phase for Responders|Lack of Efficacy|1
1277498|NCT00406640|4173870|P1|DB Continuation Phase for Responders|Lack of Efficacy|1
1277499|NCT00406640|4173869|P2|DB Continuation Phase for Responders|Withdrawal by Subject|6
1277500|NCT00406640|4173870|P1|DB Continuation Phase for Responders|Withdrawal by Subject|8
1277501|NCT00406640|4173869|P2|DB Continuation Phase for Responders|Protocol Violation|2
1277502|NCT00406640|4173870|P1|DB Continuation Phase for Responders|Protocol Violation|2
1277503|NCT00406640|4173869|P2|DB Continuation Phase for Responders|non-compliance|5
1277504|NCT00406640|4173870|P1|DB Continuation Phase for Responders|non-compliance|7
1277505|NCT00406640|4173869|P2|DB Continuation Phase for Responders|Lost to Follow-up|7
1277506|NCT00406640|4173870|P1|DB Continuation Phase for Responders|Lost to Follow-up|1
1277507|NCT00406640|4173869|P2|DB Continuation Phase for Responders|Physician Decision|3
1277508|NCT00406640|4173870|P1|DB Continuation Phase for Responders|Physician Decision|2
1277509|NCT00406640|4173869|P2|DB Continuation Phase for Responders|Failed to Return|2
1277510|NCT00406640|4173870|P1|DB Continuation Phase for Responders|Failed to Return|0
1277511|NCT00406640|4173869|P2|DB Continuation Phase for Responders|Death|0
1277512|NCT00406640|4173870|P1|DB Continuation Phase for Responders|Death|1
1277513|NCT00406640|4173869|P2|DB Continuation Phase for Responders|Adverse Event|11
1277514|NCT00406640|4173870|P1|DB Continuation Phase for Responders|Adverse Event|11
1277515|NCT00406640|4173869|P2|Acute Phase|Lack of Efficacy|3
1277516|NCT00406640|4173870|P1|Acute Phase|Lack of Efficacy|3
1277517|NCT00406640|4173869|P2|Acute Phase|Withdrawal by Subject|9
1277518|NCT00406640|4173870|P1|Acute Phase|Withdrawal by Subject|11
1277519|NCT00406640|4173869|P2|Acute Phase|Protocol Violation|2
1277520|NCT00406640|4173870|P1|Acute Phase|Protocol Violation|3
1277521|NCT00406640|4173869|P2|Acute Phase|Protocol deviation|10
1277522|NCT00406640|4173870|P1|Acute Phase|Protocol deviation|4
1277523|NCT00406640|4173869|P2|Acute Phase|Lost to Follow-up|4
1277524|NCT00406640|4173870|P1|Acute Phase|Lost to Follow-up|7
1277525|NCT00406640|4173869|P2|Acute Phase|Physician Decision|1
1277526|NCT00406640|4173870|P1|Acute Phase|Physician Decision|0
1277527|NCT00406640|4173869|P2|Acute Phase|Failed to Return|1
1277528|NCT00406640|4173870|P1|Acute Phase|Failed to Return|5
1277529|NCT00406640|4173869|P2|Acute Phase|Adverse Event|13
1277530|NCT00406640|4173870|P1|Acute Phase|Adverse Event|18
1277531|NCT00406393|4173902|P2|Overall Study|Did not undergo transplantation|1
1277532|NCT00406393|4173903|P1|Overall Study|Did not undergo transplantation|2
1277533|NCT00406367|4173933|P2|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0
1277534|NCT00406367|4173934|P1|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1
1277535|NCT00406367|4173933|P2|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0
1277536|NCT00406367|4173934|P1|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1
1277537|NCT00406367|4173933|P2|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0
1277538|NCT00406367|4173934|P1|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1
1277539|NCT00406367|4173933|P2|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0
1277540|NCT00406367|4173934|P1|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1
1277541|NCT00406367|4173933|P2|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0
1277542|NCT00406367|4173934|P1|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4
1277543|NCT00406367|4173933|P2|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
1277544|NCT00406367|4173934|P1|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
1277545|NCT00406367|4173933|P2|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0
1277546|NCT00406367|4173934|P1|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6
1277547|NCT00406367|4173933|P2|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0
1277548|NCT00406367|4173934|P1|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2
1277549|NCT00406367|4173933|P2|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1
1277550|NCT00406367|4173934|P1|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0
1277551|NCT00406367|4173933|P2|Main Period - 6 to 20 Weeks|Lost to Follow-up|1
1277552|NCT00406367|4173934|P1|Main Period - 6 to 20 Weeks|Lost to Follow-up|0
1277553|NCT00406367|4173933|P2|Main Period - 6 to 20 Weeks|Consent Withdrawn|0
1277554|NCT00406367|4173934|P1|Main Period - 6 to 20 Weeks|Consent Withdrawn|1
1277555|NCT00406367|4173933|P2|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0
1277556|NCT00406367|4173934|P1|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4
1277557|NCT00406354|4173949|P3|All Randomized and Treated Patients|Physician Decision|1
1277558|NCT00406354|4173950|P2|All Randomized and Treated Patients|Physician Decision|0
1277559|NCT00406354|4173951|P1|All Randomized and Treated Patients|Physician Decision|0
1277560|NCT00406354|4173949|P3|All Randomized and Treated Patients|Withdrawal by Subject|2
1277561|NCT00406354|4173950|P2|All Randomized and Treated Patients|Withdrawal by Subject|1
1277562|NCT00406354|4173951|P1|All Randomized and Treated Patients|Withdrawal by Subject|1
1277563|NCT00406354|4173949|P3|All Randomized and Treated Patients|Parent/Caregiver Decision|1
1277564|NCT00406354|4173950|P2|All Randomized and Treated Patients|Parent/Caregiver Decision|6
1277565|NCT00406354|4173951|P1|All Randomized and Treated Patients|Parent/Caregiver Decision|2
1277566|NCT00406354|4173949|P3|All Randomized and Treated Patients|Adverse Event|1
1277567|NCT00406354|4173950|P2|All Randomized and Treated Patients|Adverse Event|2
1277568|NCT00406354|4173951|P1|All Randomized and Treated Patients|Adverse Event|6
1277569|NCT00406354|4173949|P3|All Randomized and Treated Patients|Lack of Efficacy|17
1277570|NCT00406354|4173950|P2|All Randomized and Treated Patients|Lack of Efficacy|4
1277571|NCT00406354|4173951|P1|All Randomized and Treated Patients|Lack of Efficacy|7
1277572|NCT00406354|4173949|P3|All Randomized Patients|Protocol Violation|1
1277573|NCT00406354|4173950|P2|All Randomized Patients|Protocol Violation|0
1277574|NCT00406354|4173951|P1|All Randomized Patients|Protocol Violation|0
1277575|NCT00406315|4174022|P1|Overall Study|Withdrawal by Subject|30
1277576|NCT00406315|4174022|P1|Overall Study|Lost to Follow-up|21
1277577|NCT00406315|4174022|P1|Overall Study|Other|33
1277578|NCT00406315|4174022|P1|Overall Study|Lack of Efficacy|13
1277579|NCT00406315|4174022|P1|Overall Study|Laboratory Abnormality|4
1277580|NCT00406315|4174022|P1|Overall Study|Adverse Event|39
1277581|NCT00406315|4174022|P1|Overall Study|Death|1
1277582|NCT00406029|4174132|P5|Overall Study|Randomized in Error|1
1277583|NCT00406029|4174133|P4|Overall Study|Randomized in Error|3
1277584|NCT00406029|4174134|P3|Overall Study|Randomized in Error|2
1277585|NCT00406029|4174135|P2|Overall Study|Randomized in Error|0
1277586|NCT00406029|4174136|P1|Overall Study|Randomized in Error|0
1277587|NCT00406029|4174132|P5|Overall Study|Did Not Meet Eligibility Criteria|0
1277588|NCT00406029|4174133|P4|Overall Study|Did Not Meet Eligibility Criteria|0
1277589|NCT00406029|4174134|P3|Overall Study|Did Not Meet Eligibility Criteria|1
1277590|NCT00406029|4174135|P2|Overall Study|Did Not Meet Eligibility Criteria|0
1277591|NCT00406029|4174136|P1|Overall Study|Did Not Meet Eligibility Criteria|0
1277592|NCT00406029|4174132|P5|Overall Study|Protocol Violation|0
1277593|NCT00406029|4174133|P4|Overall Study|Protocol Violation|2
1277594|NCT00406029|4174134|P3|Overall Study|Protocol Violation|0
1277595|NCT00406029|4174135|P2|Overall Study|Protocol Violation|2
1277596|NCT00406029|4174136|P1|Overall Study|Protocol Violation|1
1277597|NCT00406029|4174132|P5|Overall Study|Withdrawal by Subject|0
1277598|NCT00406029|4174133|P4|Overall Study|Withdrawal by Subject|2
1277599|NCT00406029|4174134|P3|Overall Study|Withdrawal by Subject|2
1277600|NCT00406029|4174135|P2|Overall Study|Withdrawal by Subject|4
1277601|NCT00406029|4174136|P1|Overall Study|Withdrawal by Subject|3
1277602|NCT00406029|4174132|P5|Overall Study|Adverse Event|7
1277603|NCT00406029|4174133|P4|Overall Study|Adverse Event|10
1277604|NCT00406029|4174134|P3|Overall Study|Adverse Event|5
1277605|NCT00406029|4174135|P2|Overall Study|Adverse Event|2
1277606|NCT00406029|4174136|P1|Overall Study|Adverse Event|12
1277607|NCT00405964|4174240|P2|Overall Study|Protocol Violation|6
1277608|NCT00405964|4174241|P1|Overall Study|Protocol Violation|11
1277609|NCT00405964|4174240|P2|Overall Study|Withdrawal by Subject|23
1277610|NCT00405964|4174241|P1|Overall Study|Withdrawal by Subject|19
1277611|NCT00405964|4174240|P2|Overall Study|Lost to Follow-up|5
1277612|NCT00405964|4174241|P1|Overall Study|Lost to Follow-up|5
1277613|NCT00405964|4174240|P2|Overall Study|Adverse Event|16
1277614|NCT00405964|4174241|P1|Overall Study|Adverse Event|7
1277615|NCT00405964|4174240|P2|Overall Study|Treatment Failure|45
1277616|NCT00405964|4174241|P1|Overall Study|Treatment Failure|17
1277617|NCT00405912|4174263|P3|Overall Study|Lost to Follow-up|4
1277618|NCT00405912|4174264|P2|Overall Study|Lost to Follow-up|8
1277619|NCT00405912|4174265|P1|Overall Study|Lost to Follow-up|4
1277620|NCT00405912|4174263|P3|Overall Study|Withdrawal by Subject|12
1277621|NCT00405912|4174264|P2|Overall Study|Withdrawal by Subject|11
1277622|NCT00405912|4174265|P1|Overall Study|Withdrawal by Subject|12
1277623|NCT00405821|4174278|P2|Overall Study|initiated ART|8
1277624|NCT00405821|4174279|P1|Overall Study|initiated ART|9
1277625|NCT00405821|4174278|P2|Overall Study|Protocol Violation|0
1277626|NCT00405821|4174279|P1|Overall Study|Protocol Violation|1
1277627|NCT00405821|4174278|P2|Overall Study|Lost to Follow-up|7
1277628|NCT00405821|4174279|P1|Overall Study|Lost to Follow-up|7
1277629|NCT00405821|4174278|P2|Overall Study|Death|7
1277630|NCT00405821|4174279|P1|Overall Study|Death|5
1277631|NCT00405756|4174292|P3|Follow-up|Lost to Follow-up|4
1277632|NCT00405756|4174293|P2|Follow-up|Lost to Follow-up|8
1277633|NCT00405756|4174294|P1|Follow-up|Lost to Follow-up|2
1277634|NCT00405756|4174292|P3|Follow-up|Death|24
1277635|NCT00405756|4174293|P2|Follow-up|Death|31
1277636|NCT00405756|4174294|P1|Follow-up|Death|21
1277637|NCT00405756|4174292|P3|Follow-up|Ongoing in Follow-up Period|60
1277638|NCT00405756|4174293|P2|Follow-up|Ongoing in Follow-up Period|51
1277639|NCT00405756|4174294|P1|Follow-up|Ongoing in Follow-up Period|52
1277640|NCT00405756|4174292|P3|Open-label Extension|Other|7
1277641|NCT00405756|4174293|P2|Open-label Extension|Other|1
1277642|NCT00405756|4174294|P1|Open-label Extension|Other|0
1277643|NCT00405756|4174292|P3|Open-label Extension|Death|4
1277644|NCT00405756|4174293|P2|Open-label Extension|Death|2
1277645|NCT00405756|4174294|P1|Open-label Extension|Death|1
1277646|NCT00405756|4174292|P3|Open-label Extension|Withdrawal by Subject|3
1277647|NCT00405756|4174293|P2|Open-label Extension|Withdrawal by Subject|3
1277648|NCT00405756|4174294|P1|Open-label Extension|Withdrawal by Subject|2
1277649|NCT00405756|4174292|P3|Open-label Extension|Disease Progression|26
1277650|NCT00405756|4174293|P2|Open-label Extension|Disease Progression|23
1277651|NCT00405756|4174294|P1|Open-label Extension|Disease Progression|8
1277652|NCT00405756|4174292|P3|Open-label Extension|Adverse Event|7
1277653|NCT00405756|4174293|P2|Open-label Extension|Adverse Event|3
1277654|NCT00405756|4174294|P1|Open-label Extension|Adverse Event|1
1277655|NCT00405756|4174292|P3|Open-label Extension|Ongoing in Open Label Period|25
1277656|NCT00405756|4174293|P2|Open-label Extension|Ongoing in Open Label Period|15
1277657|NCT00405756|4174294|P1|Open-label Extension|Ongoing in Open Label Period|7
1277658|NCT00405756|4174292|P3|Double-blind Treatment|Not Specified|4
1277659|NCT00405756|4174293|P2|Double-blind Treatment|Not Specified|4
1277660|NCT00405756|4174294|P1|Double-blind Treatment|Not Specified|7
1277661|NCT00405756|4174292|P3|Double-blind Treatment|Protocol Violation|2
1277662|NCT00405756|4174293|P2|Double-blind Treatment|Protocol Violation|0
1277663|NCT00405756|4174294|P1|Double-blind Treatment|Protocol Violation|1
1277664|NCT00405756|4174292|P3|Double-blind Treatment|Death|4
1277665|NCT00405756|4174293|P2|Double-blind Treatment|Death|4
1277666|NCT00405756|4174294|P1|Double-blind Treatment|Death|4
1277667|NCT00405756|4174292|P3|Double-blind Treatment|Lost to Follow-up|0
1277668|NCT00405756|4174293|P2|Double-blind Treatment|Lost to Follow-up|0
1277669|NCT00405756|4174294|P1|Double-blind Treatment|Lost to Follow-up|1
1277670|NCT00405756|4174292|P3|Double-blind Treatment|Withdrawal by Subject|10
1277671|NCT00405756|4174293|P2|Double-blind Treatment|Withdrawal by Subject|9
1277672|NCT00405756|4174294|P1|Double-blind Treatment|Withdrawal by Subject|15
1277673|NCT00405756|4174292|P3|Double-blind Treatment|Lack of Efficacy|2
1277674|NCT00405756|4174293|P2|Double-blind Treatment|Lack of Efficacy|4
1277675|NCT00405756|4174294|P1|Double-blind Treatment|Lack of Efficacy|1
1277676|NCT00405756|4174292|P3|Double-blind Treatment|Disease Progression|102
1277677|NCT00405756|4174293|P2|Double-blind Treatment|Disease Progression|81
1277678|NCT00405756|4174294|P1|Double-blind Treatment|Disease Progression|47
1277679|NCT00405756|4174292|P3|Double-blind Treatment|Adverse Event|12
1277680|NCT00405756|4174293|P2|Double-blind Treatment|Adverse Event|27
1277681|NCT00405756|4174294|P1|Double-blind Treatment|Adverse Event|31
1277682|NCT00405756|4174292|P3|Double-blind Treatment|Ongoing in Double-blind Treatment|18
1277683|NCT00405756|4174293|P2|Double-blind Treatment|Ongoing in Double-blind Treatment|24
1277684|NCT00405756|4174294|P1|Double-blind Treatment|Ongoing in Double-blind Treatment|45
1277685|NCT00405652|4174405|P1|Overall Study|Adverse Event|4
1277686|NCT00405639|4174412|P2|Overall Study|Seizure prior to receiving BNP|0
1277687|NCT00405639|4174413|P1|Overall Study|Seizure prior to receiving BNP|1
1277688|NCT00405639|4174412|P2|Overall Study|Adverse Event|0
1277689|NCT00405639|4174413|P1|Overall Study|Adverse Event|1
1277690|NCT00405639|4174412|P2|Overall Study|Withdrawal by Subject|0
1277691|NCT00405639|4174413|P1|Overall Study|Withdrawal by Subject|1
1277692|NCT00405587|4174429|P4|Overall Study|Participant not dosed|0
1277693|NCT00405587|4174430|P3|Overall Study|Participant not dosed|0
1277694|NCT00405587|4174431|P2|Overall Study|Participant not dosed|1
1277695|NCT00405587|4174432|P1|Overall Study|Participant not dosed|0
1277696|NCT00405587|4174429|P4|Overall Study|Withdrawal by Subject|2
1277697|NCT00405587|4174430|P3|Overall Study|Withdrawal by Subject|0
1277698|NCT00405587|4174431|P2|Overall Study|Withdrawal by Subject|0
1277699|NCT00405587|4174432|P1|Overall Study|Withdrawal by Subject|0
1277700|NCT00405587|4174429|P4|Overall Study|Radiation induced necrosis|0
1277701|NCT00405587|4174430|P3|Overall Study|Radiation induced necrosis|0
1277702|NCT00405587|4174431|P2|Overall Study|Radiation induced necrosis|1
1277703|NCT00405587|4174432|P1|Overall Study|Radiation induced necrosis|0
1277704|NCT00405587|4174429|P4|Overall Study|Lost to Follow-up|0
1277705|NCT00405587|4174430|P3|Overall Study|Lost to Follow-up|1
1277706|NCT00405587|4174431|P2|Overall Study|Lost to Follow-up|1
1277707|NCT00405587|4174432|P1|Overall Study|Lost to Follow-up|0
1277708|NCT00405587|4174429|P4|Overall Study|Adverse Event|0
1277709|NCT00405587|4174430|P3|Overall Study|Adverse Event|0
1277710|NCT00405587|4174431|P2|Overall Study|Adverse Event|0
1277711|NCT00405587|4174432|P1|Overall Study|Adverse Event|1
1277712|NCT00405587|4174429|P4|Overall Study|Physician Decision|0
1277713|NCT00405587|4174430|P3|Overall Study|Physician Decision|0
1277714|NCT00405587|4174431|P2|Overall Study|Physician Decision|2
1277715|NCT00405587|4174432|P1|Overall Study|Physician Decision|3
1277716|NCT00405587|4174429|P4|Overall Study|Disease Progression|17
1277717|NCT00405587|4174430|P3|Overall Study|Disease Progression|21
1277718|NCT00405587|4174431|P2|Overall Study|Disease Progression|23
1277719|NCT00405587|4174432|P1|Overall Study|Disease Progression|22
1277720|NCT00405587|4174429|P4|Overall Study|Death|1
1277721|NCT00405587|4174430|P3|Overall Study|Death|0
1277722|NCT00405587|4174431|P2|Overall Study|Death|0
1277723|NCT00405587|4174432|P1|Overall Study|Death|0
1277724|NCT00405548|4174550|P2|Overall Study|Withdrawal by Subject|0
1277725|NCT00405548|4174551|P1|Overall Study|Withdrawal by Subject|1
1277726|NCT00405548|4174550|P2|Overall Study|Venous access failed during study day|0
1277727|NCT00405548|4174551|P1|Overall Study|Venous access failed during study day|1
1277728|NCT00405548|4174550|P2|Overall Study|Unable to self-administer shots|0
1277729|NCT00405548|4174551|P1|Overall Study|Unable to self-administer shots|1
1277730|NCT00405548|4174550|P2|Overall Study|Amyloidosis on study echo-exclusionary|1
1277731|NCT00405548|4174551|P1|Overall Study|Amyloidosis on study echo-exclusionary|0
1277732|NCT00405548|4174550|P2|Overall Study|Cognitive Memory problems on study day|0
1277733|NCT00405548|4174551|P1|Overall Study|Cognitive Memory problems on study day|1
1277734|NCT00405392|4174582|P2|Overall Study|Other|5
1277735|NCT00405392|4174583|P1|Overall Study|Other|1
1277736|NCT00405392|4174582|P2|Overall Study|Non-compliance|1
1277737|NCT00405392|4174583|P1|Overall Study|Non-compliance|0
1277738|NCT00405392|4174582|P2|Overall Study|Data missing|0
1277739|NCT00405392|4174583|P1|Overall Study|Data missing|2
1277740|NCT00405392|4174582|P2|Overall Study|Lost to Follow-up|2
1277741|NCT00405392|4174583|P1|Overall Study|Lost to Follow-up|1
1277742|NCT00405392|4174582|P2|Overall Study|Withdrawal by Subject|3
1277743|NCT00405392|4174583|P1|Overall Study|Withdrawal by Subject|4
1277744|NCT00405392|4174582|P2|Overall Study|Did not meet Eligibility criteria|2
1277745|NCT00405392|4174583|P1|Overall Study|Did not meet Eligibility criteria|7
1277746|NCT00405392|4174582|P2|Overall Study|Adverse Event|14
1277747|NCT00405392|4174583|P1|Overall Study|Adverse Event|15
1277748|NCT00405275|4174626|P2|Overall Study|Unwilling to continue|9
1277749|NCT00405275|4174627|P1|Overall Study|Unwilling to continue|10
1277750|NCT00405275|4174626|P2|Overall Study|Withdrawal by Subject|9
1277751|NCT00405275|4174627|P1|Overall Study|Withdrawal by Subject|7
1277752|NCT00405275|4174626|P2|Overall Study|Lost to Follow-up|1
1277753|NCT00405275|4174627|P1|Overall Study|Lost to Follow-up|5
1277754|NCT00405275|4174626|P2|Overall Study|Death|0
1277755|NCT00405275|4174627|P1|Overall Study|Death|1
1277756|NCT00405067|4174636|P3|Overall Study|Lost to Follow-up|1
1277757|NCT00405067|4174637|P2|Overall Study|Lost to Follow-up|0
1277758|NCT00405067|4174638|P1|Overall Study|Lost to Follow-up|0
1277759|NCT00405067|4174636|P3|Overall Study|Adverse Event|4
1277760|NCT00405067|4174637|P2|Overall Study|Adverse Event|9
1277761|NCT00405067|4174638|P1|Overall Study|Adverse Event|4
1277762|NCT00404924|4174675|P2|Overall Study|Randomised but not received treatment|1
1277763|NCT00404924|4174676|P1|Overall Study|Randomised but not received treatment|1
1277764|NCT00404924|4174675|P2|Overall Study|Not Specified|11
1277765|NCT00404924|4174676|P1|Overall Study|Not Specified|25
1277766|NCT00404924|4174675|P2|Overall Study|Withdrawal by Subject|13
1277767|NCT00404924|4174676|P1|Overall Study|Withdrawal by Subject|26
1277768|NCT00404924|4174675|P2|Overall Study|Lost to Follow-up|1
1277769|NCT00404924|4174676|P1|Overall Study|Lost to Follow-up|1
1277770|NCT00404924|4174675|P2|Overall Study|Condition under investigation worsened|264
1277771|NCT00404924|4174676|P1|Overall Study|Condition under investigation worsened|475
1277772|NCT00404924|4174675|P2|Overall Study|Adverse Event|16
1277773|NCT00404924|4174676|P1|Overall Study|Adverse Event|75
1277774|NCT00404820|4174694|P2|Overall Study|Other|2
1277775|NCT00404820|4174695|P1|Overall Study|Other|0
1277776|NCT00404820|4174694|P2|Overall Study|Death|0
1277777|NCT00404820|4174695|P1|Overall Study|Death|1
1277778|NCT00404820|4174694|P2|Overall Study|Administrative problems|0
1277779|NCT00404820|4174695|P1|Overall Study|Administrative problems|2
1277780|NCT00404820|4174694|P2|Overall Study|Lost to Follow-up|3
1277781|NCT00404820|4174695|P1|Overall Study|Lost to Follow-up|7
1277782|NCT00404820|4174694|P2|Overall Study|Withdrawal by Subject|3
1277783|NCT00404820|4174695|P1|Overall Study|Withdrawal by Subject|5
1277784|NCT00404820|4174694|P2|Overall Study|Adverse Event|16
1277785|NCT00404820|4174695|P1|Overall Study|Adverse Event|4
1277786|NCT00404768|4174717|P4|Part C|Researcher suspended study medication|1
1277787|NCT00404768|4174718|P3|Part C|Researcher suspended study medication|0
1277788|NCT00404768|4174719|P2|Part C|Researcher suspended study medication|0
1277789|NCT00404768|4174720|P1|Part C|Researcher suspended study medication|0
1277790|NCT00404768|4174717|P4|Part C|Investigator discretion|1
1277791|NCT00404768|4174718|P3|Part C|Investigator discretion|0
1277792|NCT00404768|4174719|P2|Part C|Investigator discretion|0
1277793|NCT00404768|4174720|P1|Part C|Investigator discretion|0
1277794|NCT00404768|4174717|P4|Part C|Treatment failure|1
1277795|NCT00404768|4174718|P3|Part C|Treatment failure|0
1277796|NCT00404768|4174719|P2|Part C|Treatment failure|0
1277797|NCT00404768|4174720|P1|Part C|Treatment failure|0
1277798|NCT00404768|4174717|P4|Part C|Lack of Efficacy|2
1277799|NCT00404768|4174718|P3|Part C|Lack of Efficacy|0
1277800|NCT00404768|4174719|P2|Part C|Lack of Efficacy|0
1277801|NCT00404768|4174720|P1|Part C|Lack of Efficacy|0
1277802|NCT00404768|4174717|P4|Part C|Active labor|1
1277803|NCT00404768|4174718|P3|Part C|Active labor|0
1277804|NCT00404768|4174719|P2|Part C|Active labor|0
1277805|NCT00404768|4174720|P1|Part C|Active labor|0
1277806|NCT00404768|4174717|P4|Part C|Unsatisfactory uterine response to IP|1
1277807|NCT00404768|4174718|P3|Part C|Unsatisfactory uterine response to IP|0
1277808|NCT00404768|4174719|P2|Part C|Unsatisfactory uterine response to IP|0
1277809|NCT00404768|4174720|P1|Part C|Unsatisfactory uterine response to IP|0
1277810|NCT00404768|4174717|P4|Part C|Participant delivered baby|1
1277811|NCT00404768|4174718|P3|Part C|Participant delivered baby|0
1277812|NCT00404768|4174719|P2|Part C|Participant delivered baby|0
1277813|NCT00404768|4174720|P1|Part C|Participant delivered baby|0
1277814|NCT00404768|4174717|P4|Part C|Physician withdrew the study medication|0
1277815|NCT00404768|4174718|P3|Part C|Physician withdrew the study medication|1
1277816|NCT00404768|4174719|P2|Part C|Physician withdrew the study medication|0
1277817|NCT00404768|4174720|P1|Part C|Physician withdrew the study medication|0
1277818|NCT00404768|4174717|P4|Part C|Participant did not respond to therapy|1
1277819|NCT00404768|4174718|P3|Part C|Participant did not respond to therapy|1
1277820|NCT00404768|4174719|P2|Part C|Participant did not respond to therapy|0
1277821|NCT00404768|4174720|P1|Part C|Participant did not respond to therapy|0
1277822|NCT00404768|4174717|P4|Part C|Early withdrawal from study medication|0
1277823|NCT00404768|4174718|P3|Part C|Early withdrawal from study medication|1
1277824|NCT00404768|4174719|P2|Part C|Early withdrawal from study medication|0
1277825|NCT00404768|4174720|P1|Part C|Early withdrawal from study medication|0
1277826|NCT00404768|4174717|P4|Part C|Withdrawal by Subject|1
1277827|NCT00404768|4174718|P3|Part C|Withdrawal by Subject|2
1277828|NCT00404768|4174719|P2|Part C|Withdrawal by Subject|0
1277829|NCT00404768|4174720|P1|Part C|Withdrawal by Subject|0
1277830|NCT00404768|4174717|P4|Part C|Lost to Follow-up|1
1277831|NCT00404768|4174718|P3|Part C|Lost to Follow-up|3
1277832|NCT00404768|4174719|P2|Part C|Lost to Follow-up|0
1277833|NCT00404768|4174720|P1|Part C|Lost to Follow-up|0
1277834|NCT00404768|4174717|P4|Part C|Adverse Event|3
1277835|NCT00404768|4174718|P3|Part C|Adverse Event|0
1277836|NCT00404768|4174719|P2|Part C|Adverse Event|0
1277837|NCT00404768|4174720|P1|Part C|Adverse Event|0
1277838|NCT00404768|4174717|P4|Part A and B|Withdrawn as delivery imminemnt|0
1277839|NCT00404768|4174718|P3|Part A and B|Withdrawn as delivery imminemnt|0
1277840|NCT00404768|4174719|P2|Part A and B|Withdrawn as delivery imminemnt|1
1277841|NCT00404768|4174720|P1|Part A and B|Withdrawn as delivery imminemnt|0
1277842|NCT00404768|4174717|P4|Part A and B|Withdrawn due to labor progression|0
1277843|NCT00404768|4174718|P3|Part A and B|Withdrawn due to labor progression|0
1277844|NCT00404768|4174719|P2|Part A and B|Withdrawn due to labor progression|0
1277845|NCT00404768|4174720|P1|Part A and B|Withdrawn due to labor progression|1
1277846|NCT00404755|4174781|P1|Phase II (Escitalopram)|Lost to Follow-up|2
1277847|NCT00404755|4174781|P1|Phase I (Bupropion)|Other|1
1277848|NCT00404755|4174781|P1|Phase I (Bupropion)|Adverse Event|3
1277849|NCT00404651|4174796|P4|Overall Study|Withdrawal by Subject|6
1277850|NCT00404651|4174797|P3|Overall Study|Withdrawal by Subject|16
1277851|NCT00404651|4174798|P2|Overall Study|Withdrawal by Subject|12
1277852|NCT00404651|4174799|P1|Overall Study|Withdrawal by Subject|14
1277853|NCT00404651|4174796|P4|Overall Study|Lost to Follow-up|10
1277854|NCT00404651|4174797|P3|Overall Study|Lost to Follow-up|13
1277855|NCT00404651|4174798|P2|Overall Study|Lost to Follow-up|11
1277856|NCT00404651|4174799|P1|Overall Study|Lost to Follow-up|15
1277857|NCT00404651|4174796|P4|Overall Study|Protocol Violation|5
1277858|NCT00404651|4174797|P3|Overall Study|Protocol Violation|14
1277859|NCT00404651|4174798|P2|Overall Study|Protocol Violation|5
1277860|NCT00404651|4174799|P1|Overall Study|Protocol Violation|10
1277861|NCT00404651|4174796|P4|Overall Study|Serious Adverse Event|0
1277862|NCT00404651|4174797|P3|Overall Study|Serious Adverse Event|2
1277863|NCT00404651|4174798|P2|Overall Study|Serious Adverse Event|0
1277864|NCT00404651|4174799|P1|Overall Study|Serious Adverse Event|0
1277865|NCT00404547|4174827|P2|Overall Study|Reason not stated|6
1277866|NCT00404547|4174828|P1|Overall Study|Reason not stated|3
1277867|NCT00404547|4174827|P2|Overall Study|Other|0
1277868|NCT00404547|4174828|P1|Overall Study|Other|4
1277869|NCT00404547|4174827|P2|Overall Study|Lack of compliance|1
1277870|NCT00404547|4174828|P1|Overall Study|Lack of compliance|5
1277871|NCT00404547|4174827|P2|Overall Study|Lost to Follow-up|9
1277872|NCT00404547|4174828|P1|Overall Study|Lost to Follow-up|20
1277873|NCT00404547|4174827|P2|Overall Study|Protocol Violation|1
1277874|NCT00404547|4174828|P1|Overall Study|Protocol Violation|0
1277875|NCT00404547|4174827|P2|Overall Study|Withdrawal by Subject|2
1277876|NCT00404547|4174828|P1|Overall Study|Withdrawal by Subject|19
1277877|NCT00404547|4174827|P2|Overall Study|Adverse Event|6
1277878|NCT00404547|4174828|P1|Overall Study|Adverse Event|39
1277879|NCT00404495|4174838|P2|Overall Study|Withdrawal by Subject|0
1277880|NCT00404495|4174839|P1|Overall Study|Withdrawal by Subject|1
1277881|NCT00404495|4174838|P2|Overall Study|Not specified|0
1277882|NCT00404495|4174839|P1|Overall Study|Not specified|1
1277883|NCT00404495|4174838|P2|Overall Study|Lost to Follow-up|0
1277884|NCT00404495|4174839|P1|Overall Study|Lost to Follow-up|5
1277885|NCT00404495|4174838|P2|Overall Study|Death|11
1277886|NCT00404495|4174839|P1|Overall Study|Death|37
1277887|NCT00404352|4174858|P9|Open Label Extension (up to 36 Months)|Other|2
1277888|NCT00404352|4174859|P8|Open Label Extension (up to 36 Months)|Other|0
1277889|NCT00404352|4174860|P7|Open Label Extension (up to 36 Months)|Other|0
1277890|NCT00404352|4174861|P6|Open Label Extension (up to 36 Months)|Other|0
1277891|NCT00404352|4174862|P5|Open Label Extension (up to 36 Months)|Other|0
1277892|NCT00404352|4174863|P4|Open Label Extension (up to 36 Months)|Other|0
1277893|NCT00404352|4174864|P3|Open Label Extension (up to 36 Months)|Other|0
1277894|NCT00404352|4174865|P2|Open Label Extension (up to 36 Months)|Other|0
1277895|NCT00404352|4174866|P1|Open Label Extension (up to 36 Months)|Other|0
1277896|NCT00404352|4174858|P9|Open Label Extension (up to 36 Months)|Adverse Event|0
1277897|NCT00404352|4174859|P8|Open Label Extension (up to 36 Months)|Adverse Event|1
1277898|NCT00404352|4174860|P7|Open Label Extension (up to 36 Months)|Adverse Event|1
1277899|NCT00404352|4174861|P6|Open Label Extension (up to 36 Months)|Adverse Event|0
1277900|NCT00404352|4174862|P5|Open Label Extension (up to 36 Months)|Adverse Event|0
1277901|NCT00404352|4174863|P4|Open Label Extension (up to 36 Months)|Adverse Event|0
1277902|NCT00404352|4174864|P3|Open Label Extension (up to 36 Months)|Adverse Event|0
1277903|NCT00404352|4174865|P2|Open Label Extension (up to 36 Months)|Adverse Event|0
1277904|NCT00404352|4174866|P1|Open Label Extension (up to 36 Months)|Adverse Event|0
1277905|NCT00404352|4174858|P9|Open Label (up to 24 Month)|Disease progression|0
1277906|NCT00404352|4174859|P8|Open Label (up to 24 Month)|Disease progression|0
1277907|NCT00404352|4174860|P7|Open Label (up to 24 Month)|Disease progression|0
1277908|NCT00404352|4174861|P6|Open Label (up to 24 Month)|Disease progression|0
1277909|NCT00404352|4174862|P5|Open Label (up to 24 Month)|Disease progression|0
1277910|NCT00404352|4174863|P4|Open Label (up to 24 Month)|Disease progression|1
1277911|NCT00404352|4174864|P3|Open Label (up to 24 Month)|Disease progression|0
1277912|NCT00404352|4174865|P2|Open Label (up to 24 Month)|Disease progression|0
1277913|NCT00404352|4174866|P1|Open Label (up to 24 Month)|Disease progression|0
1277914|NCT00404352|4174858|P9|Open Label (up to 24 Month)|Withdrawal by Subject|0
1277915|NCT00404352|4174859|P8|Open Label (up to 24 Month)|Withdrawal by Subject|0
1277916|NCT00404352|4174860|P7|Open Label (up to 24 Month)|Withdrawal by Subject|0
1277917|NCT00404352|4174861|P6|Open Label (up to 24 Month)|Withdrawal by Subject|5
1277918|NCT00404352|4174862|P5|Open Label (up to 24 Month)|Withdrawal by Subject|0
1277919|NCT00404352|4174863|P4|Open Label (up to 24 Month)|Withdrawal by Subject|0
1277920|NCT00404352|4174864|P3|Open Label (up to 24 Month)|Withdrawal by Subject|0
1277921|NCT00404352|4174865|P2|Open Label (up to 24 Month)|Withdrawal by Subject|0
1277922|NCT00404352|4174866|P1|Open Label (up to 24 Month)|Withdrawal by Subject|0
1277923|NCT00404352|4174858|P9|Open Label (up to 24 Month)|Lost to Follow-up|0
1277924|NCT00404352|4174859|P8|Open Label (up to 24 Month)|Lost to Follow-up|0
1277925|NCT00404352|4174860|P7|Open Label (up to 24 Month)|Lost to Follow-up|0
1277926|NCT00404352|4174861|P6|Open Label (up to 24 Month)|Lost to Follow-up|0
1277927|NCT00404352|4174862|P5|Open Label (up to 24 Month)|Lost to Follow-up|1
1277928|NCT00404352|4174863|P4|Open Label (up to 24 Month)|Lost to Follow-up|0
1277929|NCT00404352|4174864|P3|Open Label (up to 24 Month)|Lost to Follow-up|0
1277930|NCT00404352|4174865|P2|Open Label (up to 24 Month)|Lost to Follow-up|0
1277931|NCT00404352|4174866|P1|Open Label (up to 24 Month)|Lost to Follow-up|0
1277932|NCT00404352|4174858|P9|Open Label (up to 24 Month)|Pregnancy|0
1277933|NCT00404352|4174859|P8|Open Label (up to 24 Month)|Pregnancy|0
1277934|NCT00404352|4174860|P7|Open Label (up to 24 Month)|Pregnancy|0
1277935|NCT00404352|4174861|P6|Open Label (up to 24 Month)|Pregnancy|1
1277936|NCT00404352|4174862|P5|Open Label (up to 24 Month)|Pregnancy|0
1277937|NCT00404352|4174863|P4|Open Label (up to 24 Month)|Pregnancy|0
1277938|NCT00404352|4174864|P3|Open Label (up to 24 Month)|Pregnancy|0
1277939|NCT00404352|4174865|P2|Open Label (up to 24 Month)|Pregnancy|0
1277940|NCT00404352|4174866|P1|Open Label (up to 24 Month)|Pregnancy|0
1277941|NCT00404352|4174858|P9|Open Label (up to 24 Month)|Adverse Event|0
1277942|NCT00404352|4174859|P8|Open Label (up to 24 Month)|Adverse Event|0
1277943|NCT00404352|4174860|P7|Open Label (up to 24 Month)|Adverse Event|0
1277944|NCT00404352|4174861|P6|Open Label (up to 24 Month)|Adverse Event|1
1277945|NCT00404352|4174862|P5|Open Label (up to 24 Month)|Adverse Event|1
1277946|NCT00404352|4174863|P4|Open Label (up to 24 Month)|Adverse Event|2
1277947|NCT00404352|4174864|P3|Open Label (up to 24 Month)|Adverse Event|0
1277948|NCT00404352|4174865|P2|Open Label (up to 24 Month)|Adverse Event|0
1277949|NCT00404352|4174866|P1|Open Label (up to 24 Month)|Adverse Event|0
1277950|NCT00404352|4174858|P9|Double Blind (up to 24 Month)|Other|0
1277951|NCT00404352|4174859|P8|Double Blind (up to 24 Month)|Other|0
1277952|NCT00404352|4174860|P7|Double Blind (up to 24 Month)|Other|0
1277953|NCT00404352|4174861|P6|Double Blind (up to 24 Month)|Other|0
1277954|NCT00404352|4174862|P5|Double Blind (up to 24 Month)|Other|0
1277955|NCT00404352|4174863|P4|Double Blind (up to 24 Month)|Other|0
1277956|NCT00404352|4174864|P3|Double Blind (up to 24 Month)|Other|0
1277957|NCT00404352|4174865|P2|Double Blind (up to 24 Month)|Other|1
1277958|NCT00404352|4174866|P1|Double Blind (up to 24 Month)|Other|0
1277959|NCT00404352|4174858|P9|Double Blind (up to 24 Month)|Physician Decision|0
1277960|NCT00404352|4174859|P8|Double Blind (up to 24 Month)|Physician Decision|0
1277961|NCT00404352|4174860|P7|Double Blind (up to 24 Month)|Physician Decision|0
1277962|NCT00404352|4174861|P6|Double Blind (up to 24 Month)|Physician Decision|0
1277963|NCT00404352|4174862|P5|Double Blind (up to 24 Month)|Physician Decision|0
1277964|NCT00404352|4174863|P4|Double Blind (up to 24 Month)|Physician Decision|0
1277965|NCT00404352|4174864|P3|Double Blind (up to 24 Month)|Physician Decision|1
1277966|NCT00404352|4174865|P2|Double Blind (up to 24 Month)|Physician Decision|0
1277967|NCT00404352|4174866|P1|Double Blind (up to 24 Month)|Physician Decision|0
1277968|NCT00404352|4174858|P9|Double Blind (up to 24 Month)|Randomized but not treated|0
1277969|NCT00404352|4174859|P8|Double Blind (up to 24 Month)|Randomized but not treated|0
1277970|NCT00404352|4174860|P7|Double Blind (up to 24 Month)|Randomized but not treated|0
1277971|NCT00404352|4174861|P6|Double Blind (up to 24 Month)|Randomized but not treated|0
1277972|NCT00404352|4174862|P5|Double Blind (up to 24 Month)|Randomized but not treated|0
1277973|NCT00404352|4174863|P4|Double Blind (up to 24 Month)|Randomized but not treated|0
1277974|NCT00404352|4174864|P3|Double Blind (up to 24 Month)|Randomized but not treated|0
1277975|NCT00404352|4174865|P2|Double Blind (up to 24 Month)|Randomized but not treated|2
1277976|NCT00404352|4174866|P1|Double Blind (up to 24 Month)|Randomized but not treated|0
1277977|NCT00404352|4174858|P9|Double Blind (up to 24 Month)|Switched to open label phase|0
1277978|NCT00404352|4174859|P8|Double Blind (up to 24 Month)|Switched to open label phase|0
1277979|NCT00404352|4174860|P7|Double Blind (up to 24 Month)|Switched to open label phase|0
1277980|NCT00404352|4174861|P6|Double Blind (up to 24 Month)|Switched to open label phase|0
1277981|NCT00404352|4174862|P5|Double Blind (up to 24 Month)|Switched to open label phase|0
1277982|NCT00404352|4174863|P4|Double Blind (up to 24 Month)|Switched to open label phase|0
1277983|NCT00404352|4174864|P3|Double Blind (up to 24 Month)|Switched to open label phase|59
1277984|NCT00404352|4174865|P2|Double Blind (up to 24 Month)|Switched to open label phase|30
1277985|NCT00404352|4174866|P1|Double Blind (up to 24 Month)|Switched to open label phase|31
1277986|NCT00404352|4174858|P9|Double Blind (up to 24 Month)|Poor compliance|0
1277987|NCT00404352|4174859|P8|Double Blind (up to 24 Month)|Poor compliance|0
1277988|NCT00404352|4174860|P7|Double Blind (up to 24 Month)|Poor compliance|0
1277989|NCT00404352|4174861|P6|Double Blind (up to 24 Month)|Poor compliance|0
1277990|NCT00404352|4174862|P5|Double Blind (up to 24 Month)|Poor compliance|0
1277991|NCT00404352|4174863|P4|Double Blind (up to 24 Month)|Poor compliance|0
1277992|NCT00404352|4174864|P3|Double Blind (up to 24 Month)|Poor compliance|0
1277993|NCT00404352|4174865|P2|Double Blind (up to 24 Month)|Poor compliance|0
1277994|NCT00404352|4174866|P1|Double Blind (up to 24 Month)|Poor compliance|1
1277995|NCT00404352|4174858|P9|Double Blind (up to 24 Month)|Disease progression|0
1278078|NCT00403845|4174994|P2|Treatment Period 3|Subject withdrew consent|0
1277996|NCT00404352|4174859|P8|Double Blind (up to 24 Month)|Disease progression|0
1277997|NCT00404352|4174860|P7|Double Blind (up to 24 Month)|Disease progression|0
1277998|NCT00404352|4174861|P6|Double Blind (up to 24 Month)|Disease progression|0
1277999|NCT00404352|4174862|P5|Double Blind (up to 24 Month)|Disease progression|0
1278000|NCT00404352|4174863|P4|Double Blind (up to 24 Month)|Disease progression|0
1278001|NCT00404352|4174864|P3|Double Blind (up to 24 Month)|Disease progression|2
1278002|NCT00404352|4174865|P2|Double Blind (up to 24 Month)|Disease progression|0
1278003|NCT00404352|4174866|P1|Double Blind (up to 24 Month)|Disease progression|3
1278004|NCT00404352|4174858|P9|Double Blind (up to 24 Month)|Withdrawal by Subject|0
1278005|NCT00404352|4174859|P8|Double Blind (up to 24 Month)|Withdrawal by Subject|0
1278006|NCT00404352|4174860|P7|Double Blind (up to 24 Month)|Withdrawal by Subject|0
1278007|NCT00404352|4174861|P6|Double Blind (up to 24 Month)|Withdrawal by Subject|0
1278008|NCT00404352|4174862|P5|Double Blind (up to 24 Month)|Withdrawal by Subject|0
1278009|NCT00404352|4174863|P4|Double Blind (up to 24 Month)|Withdrawal by Subject|0
1278010|NCT00404352|4174864|P3|Double Blind (up to 24 Month)|Withdrawal by Subject|7
1278011|NCT00404352|4174865|P2|Double Blind (up to 24 Month)|Withdrawal by Subject|8
1278012|NCT00404352|4174866|P1|Double Blind (up to 24 Month)|Withdrawal by Subject|11
1278013|NCT00404352|4174858|P9|Double Blind (up to 24 Month)|Lost to Follow-up|0
1278014|NCT00404352|4174859|P8|Double Blind (up to 24 Month)|Lost to Follow-up|0
1278015|NCT00404352|4174860|P7|Double Blind (up to 24 Month)|Lost to Follow-up|0
1278016|NCT00404352|4174861|P6|Double Blind (up to 24 Month)|Lost to Follow-up|0
1278017|NCT00404352|4174862|P5|Double Blind (up to 24 Month)|Lost to Follow-up|0
1278018|NCT00404352|4174863|P4|Double Blind (up to 24 Month)|Lost to Follow-up|0
1278019|NCT00404352|4174864|P3|Double Blind (up to 24 Month)|Lost to Follow-up|1
1278020|NCT00404352|4174865|P2|Double Blind (up to 24 Month)|Lost to Follow-up|2
1278021|NCT00404352|4174866|P1|Double Blind (up to 24 Month)|Lost to Follow-up|1
1278022|NCT00404352|4174858|P9|Double Blind (up to 24 Month)|Death|0
1278023|NCT00404352|4174859|P8|Double Blind (up to 24 Month)|Death|0
1278024|NCT00404352|4174860|P7|Double Blind (up to 24 Month)|Death|0
1278025|NCT00404352|4174861|P6|Double Blind (up to 24 Month)|Death|0
1278026|NCT00404352|4174862|P5|Double Blind (up to 24 Month)|Death|0
1278027|NCT00404352|4174863|P4|Double Blind (up to 24 Month)|Death|0
1278028|NCT00404352|4174864|P3|Double Blind (up to 24 Month)|Death|1
1278029|NCT00404352|4174865|P2|Double Blind (up to 24 Month)|Death|0
1278030|NCT00404352|4174866|P1|Double Blind (up to 24 Month)|Death|0
1278031|NCT00404352|4174858|P9|Double Blind (up to 24 Month)|Pregnancy|0
1278032|NCT00404352|4174859|P8|Double Blind (up to 24 Month)|Pregnancy|0
1278033|NCT00404352|4174860|P7|Double Blind (up to 24 Month)|Pregnancy|0
1278034|NCT00404352|4174861|P6|Double Blind (up to 24 Month)|Pregnancy|0
1278035|NCT00404352|4174862|P5|Double Blind (up to 24 Month)|Pregnancy|0
1278036|NCT00404352|4174863|P4|Double Blind (up to 24 Month)|Pregnancy|0
1278037|NCT00404352|4174864|P3|Double Blind (up to 24 Month)|Pregnancy|2
1278038|NCT00404352|4174865|P2|Double Blind (up to 24 Month)|Pregnancy|0
1278039|NCT00404352|4174866|P1|Double Blind (up to 24 Month)|Pregnancy|0
1278040|NCT00404352|4174858|P9|Double Blind (up to 24 Month)|Adverse Event|0
1278041|NCT00404352|4174859|P8|Double Blind (up to 24 Month)|Adverse Event|0
1278042|NCT00404352|4174860|P7|Double Blind (up to 24 Month)|Adverse Event|0
1278043|NCT00404352|4174861|P6|Double Blind (up to 24 Month)|Adverse Event|0
1278044|NCT00404352|4174862|P5|Double Blind (up to 24 Month)|Adverse Event|0
1278045|NCT00404352|4174863|P4|Double Blind (up to 24 Month)|Adverse Event|0
1278046|NCT00404352|4174864|P3|Double Blind (up to 24 Month)|Adverse Event|6
1278047|NCT00404352|4174865|P2|Double Blind (up to 24 Month)|Adverse Event|4
1278048|NCT00404352|4174866|P1|Double Blind (up to 24 Month)|Adverse Event|5
1278049|NCT00404248|4174901|P9|Overall Study|pts declining status|0
1278050|NCT00404248|4174902|P8|Overall Study|pts declining status|0
1278051|NCT00404248|4174903|P7|Overall Study|pts declining status|0
1278052|NCT00404248|4174904|P6|Overall Study|pts declining status|0
1278053|NCT00404248|4174905|P5|Overall Study|pts declining status|0
1278054|NCT00404248|4174906|P4|Overall Study|pts declining status|0
1278055|NCT00404248|4174907|P3|Overall Study|pts declining status|0
1278056|NCT00404248|4174908|P2|Overall Study|pts declining status|1
1278057|NCT00404248|4174909|P1|Overall Study|pts declining status|0
1278058|NCT00404235|4174942|P2|Overall Study|Withdrawal by Subject|2
1278059|NCT00404235|4174943|P1|Overall Study|Withdrawal by Subject|1
1278060|NCT00404092|4174961|P4|Overall Study|Adverse Event|0
1278061|NCT00404092|4174962|P3|Overall Study|Adverse Event|1
1278062|NCT00404092|4174963|P2|Overall Study|Adverse Event|0
1278063|NCT00404092|4174964|P1|Overall Study|Adverse Event|0
1278064|NCT00404092|4174961|P4|Overall Study|Death|0
1278065|NCT00404092|4174962|P3|Overall Study|Death|0
1278066|NCT00404092|4174963|P2|Overall Study|Death|0
1278067|NCT00404092|4174964|P1|Overall Study|Death|1
1278068|NCT00404079|4174980|P2|Overall Study|Lost to follow up, adverse event etc|20
1278069|NCT00404079|4174981|P1|Overall Study|Lost to follow up, adverse event etc|22
1278070|NCT00404066|4174987|P1|Overall Study|Withdrawal by Subject - Adverse event|2
1278071|NCT00404066|4174987|P1|Overall Study|Withdrawal by Subject - Pre-treatment|1
1278072|NCT00403845|4174992|P4|Treatment Period 3|Adverse Event|1
1278073|NCT00403845|4174993|P3|Treatment Period 3|Adverse Event|0
1278074|NCT00403845|4174994|P2|Treatment Period 3|Adverse Event|0
1278075|NCT00403845|4174995|P1|Treatment Period 3|Adverse Event|0
1278076|NCT00403845|4174992|P4|Treatment Period 3|Subject withdrew consent|1
1278077|NCT00403845|4174993|P3|Treatment Period 3|Subject withdrew consent|0
1278079|NCT00403845|4174995|P1|Treatment Period 3|Subject withdrew consent|0
1278080|NCT00403845|4174992|P4|Treatment Period 2|Subject withdrew consent|0
1278081|NCT00403845|4174993|P3|Treatment Period 2|Subject withdrew consent|0
1278082|NCT00403845|4174994|P2|Treatment Period 2|Subject withdrew consent|0
1278083|NCT00403845|4174995|P1|Treatment Period 2|Subject withdrew consent|1
1278084|NCT00403845|4174992|P4|Treatment Period 1|Subject no longer needs study drug|1
1278085|NCT00403845|4174993|P3|Treatment Period 1|Subject no longer needs study drug|0
1278086|NCT00403845|4174994|P2|Treatment Period 1|Subject no longer needs study drug|0
1278087|NCT00403845|4174995|P1|Treatment Period 1|Subject no longer needs study drug|0
1278088|NCT00403845|4174992|P4|Treatment Period 1|Subject withdrew consent|0
1278089|NCT00403845|4174993|P3|Treatment Period 1|Subject withdrew consent|0
1278090|NCT00403845|4174994|P2|Treatment Period 1|Subject withdrew consent|0
1278091|NCT00403845|4174995|P1|Treatment Period 1|Subject withdrew consent|1
1278092|NCT00403767|4175019|P2|Overall Study|Missing/incomplete data|1
1278093|NCT00403767|4175020|P1|Overall Study|Missing/incomplete data|1
1278094|NCT00403767|4175019|P2|Overall Study|Study terminated by sponsor|69
1278095|NCT00403767|4175020|P1|Overall Study|Study terminated by sponsor|82
1278096|NCT00403767|4175019|P2|Overall Study|Clinical efficacy endpoint reached|332
1278097|NCT00403767|4175020|P1|Overall Study|Clinical efficacy endpoint reached|300
1278098|NCT00403767|4175019|P2|Overall Study|Protocol Violation|124
1278099|NCT00403767|4175020|P1|Overall Study|Protocol Violation|142
1278100|NCT00403767|4175019|P2|Overall Study|Lost to Follow-up|8
1278101|NCT00403767|4175020|P1|Overall Study|Lost to Follow-up|6
1278102|NCT00403767|4175019|P2|Overall Study|Investigator dec./not protocol-related|178
1278103|NCT00403767|4175020|P1|Overall Study|Investigator dec./not protocol-related|191
1278104|NCT00403767|4175019|P2|Overall Study|Consent withdrawn|673
1278105|NCT00403767|4175020|P1|Overall Study|Consent withdrawn|671
1278106|NCT00403767|4175019|P2|Overall Study|Non-compliant with study medication|164
1278107|NCT00403767|4175020|P1|Overall Study|Non-compliant with study medication|134
1278108|NCT00403767|4175019|P2|Overall Study|Adverse Event|919
1278109|NCT00403767|4175020|P1|Overall Study|Adverse Event|993
1278110|NCT00403754|4175044|P4|Core Treatment Period 2|Lack of Efficacy|0
1278111|NCT00403754|4175045|P3|Core Treatment Period 2|Lack of Efficacy|1
1278112|NCT00403754|4175046|P2|Core Treatment Period 2|Lack of Efficacy|0
1278113|NCT00403754|4175047|P1|Core Treatment Period 2|Lack of Efficacy|0
1278114|NCT00403754|4175044|P4|Core Treatment Period 1|Withdrawal by Subject|0
1278115|NCT00403754|4175045|P3|Core Treatment Period 1|Withdrawal by Subject|0
1278116|NCT00403754|4175046|P2|Core Treatment Period 1|Withdrawal by Subject|1
1278117|NCT00403754|4175047|P1|Core Treatment Period 1|Withdrawal by Subject|0
1278118|NCT00403585|4175074|P1|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4
1278119|NCT00403585|4175074|P1|Open-Label Phase; Extension Study|Withdrawal by Subject|2
1278120|NCT00403585|4175074|P1|Initial Treatment Phase|Lost to Follow-up|2
1278121|NCT00403546|4175085|P3|Randomized Trial|Early Terminations|16
1278122|NCT00403546|4175086|P2|Randomized Trial|Early Terminations|17
1278123|NCT00403546|4175087|P1|Randomized Trial|Early Terminations|0
1278124|NCT00403546|4175085|P3|Screening Phase|Terminated Prior to Randomization|0
1278125|NCT00403546|4175086|P2|Screening Phase|Terminated Prior to Randomization|0
1278126|NCT00403546|4175087|P1|Screening Phase|Terminated Prior to Randomization|5
1278127|NCT00403546|4175085|P3|Screening Phase|Adverse Event|0
1278128|NCT00403546|4175086|P2|Screening Phase|Adverse Event|0
1278129|NCT00403546|4175087|P1|Screening Phase|Adverse Event|1
1278130|NCT00403546|4175085|P3|Screening Phase|Screening Failure|0
1278131|NCT00403546|4175086|P2|Screening Phase|Screening Failure|0
1278132|NCT00403546|4175087|P1|Screening Phase|Screening Failure|22
1278133|NCT00403546|4175085|P3|Signed Informed Consent/Open-Label|Adverse Event|0
1278134|NCT00403546|4175086|P2|Signed Informed Consent/Open-Label|Adverse Event|0
1278135|NCT00403546|4175087|P1|Signed Informed Consent/Open-Label|Adverse Event|5
1278136|NCT00403546|4175085|P3|Signed Informed Consent/Open-Label|Terminated by Investigator|0
1278137|NCT00403546|4175086|P2|Signed Informed Consent/Open-Label|Terminated by Investigator|0
1278138|NCT00403546|4175087|P1|Signed Informed Consent/Open-Label|Terminated by Investigator|9
1278139|NCT00403546|4175085|P3|Signed Informed Consent/Open-Label|Early Termination|0
1278140|NCT00403546|4175086|P2|Signed Informed Consent/Open-Label|Early Termination|0
1278141|NCT00403546|4175087|P1|Signed Informed Consent/Open-Label|Early Termination|8
1278142|NCT00403546|4175085|P3|Signed Informed Consent/Open-Label|Withdrew Consent|0
1278143|NCT00403546|4175086|P2|Signed Informed Consent/Open-Label|Withdrew Consent|0
1278144|NCT00403546|4175087|P1|Signed Informed Consent/Open-Label|Withdrew Consent|6
1278145|NCT00403481|4175127|P1|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1
1278146|NCT00403481|4175127|P1|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1
1278147|NCT00403481|4175127|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1
1278148|NCT00403481|4175127|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1
1278149|NCT00403481|4175127|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1
1278150|NCT00403481|4175127|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2
1278151|NCT00403481|4175127|P1|Olm 40 mg|Other|1
1278152|NCT00403481|4175127|P1|Olm 40 mg|Withdrawal by Subject|1
1278153|NCT00403481|4175127|P1|Olm 40 mg|Protocol Violation|1
1278154|NCT00403481|4175127|P1|Olm 40 mg|Adverse Event|2
1278155|NCT00403481|4175127|P1|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1
1278156|NCT00403481|4175127|P1|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3
1278157|NCT00403481|4175127|P1|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1
1278158|NCT00403481|4175127|P1|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1
1278159|NCT00403455|4175142|P1|Overall Study|Withdrawal by Subject|1
1278160|NCT00403390|4175165|P2|Overall Study|non-compliant|0
1278161|NCT00403390|4175166|P1|Overall Study|non-compliant|1
1278162|NCT00403390|4175165|P2|Overall Study|samples lost|0
1278163|NCT00403390|4175166|P1|Overall Study|samples lost|1
1278164|NCT00403390|4175165|P2|Overall Study|Withdrawal by Subject|0
1278165|NCT00403390|4175166|P1|Overall Study|Withdrawal by Subject|1
1278166|NCT00403273|4175174|P2|Overall Study|pt. wanted to have a surgical procedure|1
1278167|NCT00403273|4175175|P1|Overall Study|pt. wanted to have a surgical procedure|0
1278168|NCT00403273|4175174|P2|Overall Study|Physician Decision|1
1278169|NCT00403273|4175175|P1|Overall Study|Physician Decision|0
1278170|NCT00403273|4175174|P2|Overall Study|Lost to Follow-up|2
1278171|NCT00403273|4175175|P1|Overall Study|Lost to Follow-up|3
1278172|NCT00403234|4175217|P4|Overall Study|Adverse Event|0
1278173|NCT00403234|4175218|P3|Overall Study|Adverse Event|1
1278174|NCT00403234|4175219|P2|Overall Study|Adverse Event|0
1278175|NCT00403234|4175220|P1|Overall Study|Adverse Event|1
1278176|NCT00403234|4175217|P4|Overall Study|Withdrawal by Subject|0
1278177|NCT00403234|4175218|P3|Overall Study|Withdrawal by Subject|0
1278178|NCT00403234|4175219|P2|Overall Study|Withdrawal by Subject|1
1278179|NCT00403234|4175220|P1|Overall Study|Withdrawal by Subject|0
1278180|NCT00403130|4175230|P1|Overall Study|Withdrawal by Subject|1
1278181|NCT00403130|4175230|P1|Overall Study|Lost to Follow up|1
1278182|NCT00403130|4175230|P1|Overall Study|Not Eligible|3
1278183|NCT00402987|4175283|P4|Overall Study|Lack of Efficacy|0
1278184|NCT00402987|4175284|P3|Overall Study|Lack of Efficacy|1
1278185|NCT00402987|4175285|P2|Overall Study|Lack of Efficacy|0
1278186|NCT00402987|4175286|P1|Overall Study|Lack of Efficacy|0
1278187|NCT00402831|4175458|P2|Overall Study|Non-compliance with protocol|1
1278188|NCT00402831|4175459|P1|Overall Study|Non-compliance with protocol|0
1278189|NCT00402831|4175458|P2|Overall Study|Lost to Follow-up|2
1278190|NCT00402831|4175459|P1|Overall Study|Lost to Follow-up|1
1278191|NCT00402740|4175491|P1|Overall Study|Subject disposition unknown.|1
1278192|NCT00402740|4175491|P1|Overall Study|No stent. Completed FU at 30 days.|5
1278193|NCT00402740|4175491|P1|Overall Study|Lost to Follow-up|6
1278194|NCT00402740|4175491|P1|Overall Study|Death|50
1278195|NCT00402740|4175491|P1|Overall Study|Withdrawal by Subject|18
1278196|NCT00402727|4175503|P2|Overall Study|non-compliance|1
1278197|NCT00402727|4175504|P1|Overall Study|non-compliance|0
1278198|NCT00402727|4175503|P2|Overall Study|supply problems|1
1278199|NCT00402727|4175504|P1|Overall Study|supply problems|2
1278200|NCT00402727|4175503|P2|Overall Study|Withdrawal by Subject|7
1278201|NCT00402727|4175504|P1|Overall Study|Withdrawal by Subject|3
1278202|NCT00402727|4175503|P2|Overall Study|Protocol Violation|4
1278203|NCT00402727|4175504|P1|Overall Study|Protocol Violation|0
1278204|NCT00402727|4175503|P2|Overall Study|Physician Decision|1
1278205|NCT00402727|4175504|P1|Overall Study|Physician Decision|1
1278206|NCT00402727|4175503|P2|Overall Study|Lost to Follow-up|11
1278207|NCT00402727|4175504|P1|Overall Study|Lost to Follow-up|24
1278208|NCT00402727|4175503|P2|Overall Study|Lack of Efficacy|3
1278209|NCT00402727|4175504|P1|Overall Study|Lack of Efficacy|1
1278210|NCT00402727|4175503|P2|Overall Study|Death|0
1278211|NCT00402727|4175504|P1|Overall Study|Death|1
1278212|NCT00402727|4175503|P2|Overall Study|Adverse Event|6
1278213|NCT00402727|4175504|P1|Overall Study|Adverse Event|10
1278214|NCT00402688|4175546|P3|Overall Study|Patient Left Town and Forgot Medication|1
1278215|NCT00402688|4175547|P2|Overall Study|Patient Left Town and Forgot Medication|0
1278216|NCT00402688|4175548|P1|Overall Study|Patient Left Town and Forgot Medication|0
1278217|NCT00402688|4175546|P3|Overall Study|Urine Cult. Yield Resistant to Levaquin|1
1278218|NCT00402688|4175547|P2|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
1278219|NCT00402688|4175548|P1|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
1278220|NCT00402688|4175546|P3|Overall Study|Culture Show Fluoroquinolone Resistance|0
1278221|NCT00402688|4175547|P2|Overall Study|Culture Show Fluoroquinolone Resistance|1
1278222|NCT00402688|4175548|P1|Overall Study|Culture Show Fluoroquinolone Resistance|0
1278223|NCT00402688|4175546|P3|Overall Study|Lost to Follow-up|2
1278224|NCT00402688|4175547|P2|Overall Study|Lost to Follow-up|0
1278225|NCT00402688|4175548|P1|Overall Study|Lost to Follow-up|1
1278226|NCT00402688|4175546|P3|Overall Study|Protocol Violation|1
1278227|NCT00402688|4175547|P2|Overall Study|Protocol Violation|1
1278228|NCT00402688|4175548|P1|Overall Study|Protocol Violation|1
1278229|NCT00402688|4175546|P3|Overall Study|Lack of Efficacy|5
1278230|NCT00402688|4175547|P2|Overall Study|Lack of Efficacy|4
1278231|NCT00402688|4175548|P1|Overall Study|Lack of Efficacy|4
1278232|NCT00402688|4175546|P3|Overall Study|Physician Decision|1
1278233|NCT00402688|4175547|P2|Overall Study|Physician Decision|0
1278234|NCT00402688|4175548|P1|Overall Study|Physician Decision|0
1278235|NCT00402688|4175546|P3|Overall Study|Withdrawal by Subject|1
1278236|NCT00402688|4175547|P2|Overall Study|Withdrawal by Subject|1
1278237|NCT00402688|4175548|P1|Overall Study|Withdrawal by Subject|3
1278238|NCT00402688|4175546|P3|Overall Study|Adverse Event|3
1278239|NCT00402688|4175547|P2|Overall Study|Adverse Event|9
1278240|NCT00402688|4175548|P1|Overall Study|Adverse Event|12
1278241|NCT00402649|4175571|P1|Overall Study|Withdrawal by Subject|1
1278242|NCT00402649|4175571|P1|Overall Study|Lost to Follow-up|1
1278243|NCT00402597|4175586|P5|Overall Study|reason not specified|20
1278244|NCT00402597|4175587|P4|Overall Study|reason not specified|14
1278245|NCT00402597|4175588|P3|Overall Study|reason not specified|27
1278246|NCT00402597|4175589|P2|Overall Study|reason not specified|4
1278247|NCT00402597|4175590|P1|Overall Study|reason not specified|30
1278248|NCT00402597|4175586|P5|Overall Study|Withdrawal by Subject|24
1278249|NCT00402597|4175587|P4|Overall Study|Withdrawal by Subject|15
1278250|NCT00402597|4175588|P3|Overall Study|Withdrawal by Subject|65
1278251|NCT00402597|4175589|P2|Overall Study|Withdrawal by Subject|16
1278252|NCT00402597|4175590|P1|Overall Study|Withdrawal by Subject|57
1278253|NCT00402597|4175586|P5|Overall Study|Lost to Follow-up|3
1278254|NCT00402597|4175587|P4|Overall Study|Lost to Follow-up|2
1278255|NCT00402597|4175588|P3|Overall Study|Lost to Follow-up|8
1278256|NCT00402597|4175589|P2|Overall Study|Lost to Follow-up|1
1278257|NCT00402597|4175590|P1|Overall Study|Lost to Follow-up|8
1278258|NCT00402597|4175586|P5|Overall Study|Adverse Event|71
1278259|NCT00402597|4175587|P4|Overall Study|Adverse Event|39
1278260|NCT00402597|4175588|P3|Overall Study|Adverse Event|106
1278261|NCT00402597|4175589|P2|Overall Study|Adverse Event|18
1278262|NCT00402597|4175590|P1|Overall Study|Adverse Event|81
1278263|NCT00402597|4175586|P5|Overall Study|Death|6
1278264|NCT00402597|4175587|P4|Overall Study|Death|4
1278265|NCT00402597|4175588|P3|Overall Study|Death|6
1278266|NCT00402597|4175589|P2|Overall Study|Death|7
1278267|NCT00402597|4175590|P1|Overall Study|Death|15
1278268|NCT00402363|4175631|P4|Overall Study|"Captured as Other"|2
1278269|NCT00402363|4175632|P3|Overall Study|"Captured as Other"|2
1278270|NCT00402363|4175633|P2|Overall Study|"Captured as Other"|2
1278271|NCT00402363|4175634|P1|Overall Study|"Captured as Other"|6
1278272|NCT00402363|4175631|P4|Overall Study|Lost to Follow-up|2
1278273|NCT00402363|4175632|P3|Overall Study|Lost to Follow-up|0
1278274|NCT00402363|4175633|P2|Overall Study|Lost to Follow-up|4
1278275|NCT00402363|4175634|P1|Overall Study|Lost to Follow-up|5
1278276|NCT00402363|4175631|P4|Overall Study|Protocol Violation|3
1278277|NCT00402363|4175632|P3|Overall Study|Protocol Violation|0
1278278|NCT00402363|4175633|P2|Overall Study|Protocol Violation|5
1278279|NCT00402363|4175634|P1|Overall Study|Protocol Violation|3
1278280|NCT00402363|4175631|P4|Overall Study|Withdrew Consent|1
1278281|NCT00402363|4175632|P3|Overall Study|Withdrew Consent|2
1278282|NCT00402363|4175633|P2|Overall Study|Withdrew Consent|5
1278283|NCT00402363|4175634|P1|Overall Study|Withdrew Consent|10
1278284|NCT00402363|4175631|P4|Overall Study|Adverse Event|2
1278285|NCT00402363|4175632|P3|Overall Study|Adverse Event|2
1278286|NCT00402363|4175633|P2|Overall Study|Adverse Event|14
1278287|NCT00402363|4175634|P1|Overall Study|Adverse Event|9
1278288|NCT00402337|4175697|P5|Overall Study|Other Reason|0
1278289|NCT00402337|4175698|P4|Overall Study|Other Reason|0
1278290|NCT00402337|4175699|P3|Overall Study|Other Reason|0
1278291|NCT00402337|4175700|P2|Overall Study|Other Reason|1
1278292|NCT00402337|4175701|P1|Overall Study|Other Reason|0
1278293|NCT00402337|4175697|P5|Overall Study|Physician Decision|0
1278294|NCT00402337|4175698|P4|Overall Study|Physician Decision|1
1278295|NCT00402337|4175699|P3|Overall Study|Physician Decision|0
1278296|NCT00402337|4175700|P2|Overall Study|Physician Decision|0
1278297|NCT00402337|4175701|P1|Overall Study|Physician Decision|0
1278298|NCT00402337|4175697|P5|Overall Study|Lost to Follow-up|0
1278299|NCT00402337|4175698|P4|Overall Study|Lost to Follow-up|2
1278300|NCT00402337|4175699|P3|Overall Study|Lost to Follow-up|1
1278301|NCT00402337|4175700|P2|Overall Study|Lost to Follow-up|0
1278302|NCT00402337|4175701|P1|Overall Study|Lost to Follow-up|0
1278303|NCT00402337|4175697|P5|Overall Study|Withdrawal by Subject|4
1278304|NCT00402337|4175698|P4|Overall Study|Withdrawal by Subject|6
1278305|NCT00402337|4175699|P3|Overall Study|Withdrawal by Subject|1
1278306|NCT00402337|4175700|P2|Overall Study|Withdrawal by Subject|3
1278307|NCT00402337|4175701|P1|Overall Study|Withdrawal by Subject|5
1278308|NCT00402337|4175697|P5|Overall Study|Noncompliance|2
1278309|NCT00402337|4175698|P4|Overall Study|Noncompliance|0
1278310|NCT00402337|4175699|P3|Overall Study|Noncompliance|0
1278311|NCT00402337|4175700|P2|Overall Study|Noncompliance|0
1278312|NCT00402337|4175701|P1|Overall Study|Noncompliance|0
1278313|NCT00402337|4175697|P5|Overall Study|Adverse Event|2
1278314|NCT00402337|4175698|P4|Overall Study|Adverse Event|3
1278315|NCT00402337|4175699|P3|Overall Study|Adverse Event|2
1278316|NCT00402337|4175700|P2|Overall Study|Adverse Event|2
1278317|NCT00402337|4175701|P1|Overall Study|Adverse Event|0
1278318|NCT00402324|4175740|P2|Overall Study|Death|0
1278319|NCT00402324|4175741|P1|Overall Study|Death|1
1278320|NCT00402324|4175740|P2|Overall Study|Adverse Event|4
1278321|NCT00402324|4175741|P1|Overall Study|Adverse Event|6
1278322|NCT00402324|4175740|P2|Overall Study|Lack of Efficacy|4
1278323|NCT00402324|4175741|P1|Overall Study|Lack of Efficacy|1
1278324|NCT00402324|4175740|P2|Overall Study|Sponsor Decision|5
1278325|NCT00402324|4175741|P1|Overall Study|Sponsor Decision|4
1278326|NCT00402324|4175740|P2|Overall Study|Physician Decision|4
1278327|NCT00402324|4175741|P1|Overall Study|Physician Decision|2
1278328|NCT00402324|4175740|P2|Overall Study|Withdrawal by Subject|2
1278329|NCT00402324|4175741|P1|Overall Study|Withdrawal by Subject|5
1278330|NCT00402324|4175740|P2|Overall Study|Protocol Violation|7
1278331|NCT00402324|4175741|P1|Overall Study|Protocol Violation|8
1278332|NCT00402324|4175740|P2|Overall Study|Protocol Entry Criteria Not Met|4
1278333|NCT00402324|4175741|P1|Overall Study|Protocol Entry Criteria Not Met|5
1278334|NCT00402324|4175740|P2|Overall Study|Lost to Follow-up|11
1278335|NCT00402324|4175741|P1|Overall Study|Lost to Follow-up|11
1278336|NCT00402285|4175774|P3|Overall Study|insufficient RNA quality|2
1278337|NCT00402285|4175775|P2|Overall Study|insufficient RNA quality|6
1278338|NCT00402285|4175776|P1|Overall Study|insufficient RNA quality|7
1278339|NCT00402246|4175784|P2|Overall Study|Deterioriating Condition|2
1278340|NCT00402246|4175785|P1|Overall Study|Deterioriating Condition|3
1278341|NCT00402246|4175784|P2|Overall Study|Center Closure|3
1278342|NCT00402246|4175785|P1|Overall Study|Center Closure|5
1278343|NCT00402246|4175784|P2|Overall Study|Patient's device explanted|2
1278344|NCT00402246|4175785|P1|Overall Study|Patient's device explanted|6
1278345|NCT00402246|4175784|P2|Overall Study|Heart Transplant|1
1278346|NCT00402246|4175785|P1|Overall Study|Heart Transplant|0
1278347|NCT00402246|4175784|P2|Overall Study|Insurance Issues|1
1278348|NCT00402246|4175785|P1|Overall Study|Insurance Issues|2
1278349|NCT00402246|4175784|P2|Overall Study|Missed Final Visit|2
1278350|NCT00402246|4175785|P1|Overall Study|Missed Final Visit|1
1278351|NCT00402246|4175784|P2|Overall Study|Protocol Violation|24
1278352|NCT00402246|4175785|P1|Overall Study|Protocol Violation|25
1278353|NCT00402246|4175784|P2|Overall Study|Physician Decision|26
1278354|NCT00402246|4175785|P1|Overall Study|Physician Decision|24
1278355|NCT00402246|4175784|P2|Overall Study|Withdrawal by Subject|87
1278356|NCT00402246|4175785|P1|Overall Study|Withdrawal by Subject|72
1278357|NCT00402246|4175784|P2|Overall Study|Lost to Follow-up|28
1278358|NCT00402246|4175785|P1|Overall Study|Lost to Follow-up|20
1278359|NCT00402246|4175784|P2|Overall Study|Death|58
1278360|NCT00402246|4175785|P1|Overall Study|Death|62
1278361|NCT00402233|4175819|P4|Overall Study|Worsening of other pre-existing disease|0
1278362|NCT00402233|4175820|P3|Overall Study|Worsening of other pre-existing disease|0
1278363|NCT00402233|4175821|P2|Overall Study|Worsening of other pre-existing disease|1
1278364|NCT00402233|4175822|P1|Overall Study|Worsening of other pre-existing disease|0
1278365|NCT00402233|4175819|P4|Overall Study|Worsening of disease under study|0
1278366|NCT00402233|4175820|P3|Overall Study|Worsening of disease under study|0
1278367|NCT00402233|4175821|P2|Overall Study|Worsening of disease under study|0
1278368|NCT00402233|4175822|P1|Overall Study|Worsening of disease under study|2
1278369|NCT00402233|4175819|P4|Overall Study|Withdrawal by Subject|2
1278370|NCT00402233|4175820|P3|Overall Study|Withdrawal by Subject|2
1278371|NCT00402233|4175821|P2|Overall Study|Withdrawal by Subject|1
1278372|NCT00402233|4175822|P1|Overall Study|Withdrawal by Subject|2
1278373|NCT00402233|4175819|P4|Overall Study|Protocol Violation|0
1278374|NCT00402233|4175820|P3|Overall Study|Protocol Violation|0
1278375|NCT00402233|4175821|P2|Overall Study|Protocol Violation|1
1278376|NCT00402233|4175822|P1|Overall Study|Protocol Violation|0
1278377|NCT00402233|4175819|P4|Overall Study|Adverse Event|9
1278378|NCT00402233|4175820|P3|Overall Study|Adverse Event|9
1278379|NCT00402233|4175821|P2|Overall Study|Adverse Event|7
1278380|NCT00402233|4175822|P1|Overall Study|Adverse Event|1
1278381|NCT00402168|4175857|P2|Switched From CNI to Belatacept in LT|Adverse Event|0
1278382|NCT00402168|4175858|P1|Switched From CNI to Belatacept in LT|Adverse Event|4
1278383|NCT00402168|4175857|P2|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0
1278384|NCT00402168|4175858|P1|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2
1278385|NCT00402168|4175857|P2|Long Term (LT)|non-specified|2
1278386|NCT00402168|4175858|P1|Long Term (LT)|non-specified|1
1278387|NCT00402168|4175857|P2|Long Term (LT)|Lack of Efficacy|2
1278388|NCT00402168|4175858|P1|Long Term (LT)|Lack of Efficacy|0
1278389|NCT00402168|4175857|P2|Long Term (LT)|Death|0
1278390|NCT00402168|4175858|P1|Long Term (LT)|Death|4
1278391|NCT00402168|4175857|P2|Long Term (LT)|Lost to Follow-up|0
1278392|NCT00402168|4175858|P1|Long Term (LT)|Lost to Follow-up|1
1278393|NCT00402168|4175857|P2|Long Term (LT)|Pregnancy|1
1278394|NCT00402168|4175858|P1|Long Term (LT)|Pregnancy|0
1278395|NCT00402168|4175857|P2|Long Term (LT)|Withdrawal by Subject|7
1278396|NCT00402168|4175858|P1|Long Term (LT)|Withdrawal by Subject|4
1278397|NCT00402168|4175857|P2|Long Term (LT)|Adverse Event|5
1278398|NCT00402168|4175858|P1|Long Term (LT)|Adverse Event|1
1278399|NCT00402168|4175857|P2|Treatment (up to 12 Months)|non-specified|1
1278400|NCT00402168|4175858|P1|Treatment (up to 12 Months)|non-specified|0
1278401|NCT00402168|4175857|P2|Treatment (up to 12 Months)|Lack of Efficacy|0
1278402|NCT00402168|4175858|P1|Treatment (up to 12 Months)|Lack of Efficacy|2
1278403|NCT00402168|4175857|P2|Treatment (up to 12 Months)|Death|1
1278404|NCT00402168|4175858|P1|Treatment (up to 12 Months)|Death|0
1278405|NCT00402168|4175857|P2|Randomized|Withdrawal by Subject|1
1278406|NCT00402168|4175858|P1|Randomized|Withdrawal by Subject|0
1278407|NCT00402168|4175857|P2|Randomized|Lost to Follow-up|0
1278408|NCT00402168|4175858|P1|Randomized|Lost to Follow-up|1
1278409|NCT00402103|4175915|P2|Overall Study|Administrative problems|0
1278410|NCT00402103|4175916|P1|Overall Study|Administrative problems|2
1278411|NCT00402103|4175915|P2|Overall Study|Lost to Follow-up|3
1278412|NCT00402103|4175916|P1|Overall Study|Lost to Follow-up|6
1278413|NCT00402103|4175915|P2|Overall Study|Patient withdrew consent|1
1278414|NCT00402103|4175916|P1|Overall Study|Patient withdrew consent|12
1278415|NCT00402103|4175915|P2|Overall Study|Protocol Deviation|0
1278416|NCT00402103|4175916|P1|Overall Study|Protocol Deviation|8
1278417|NCT00402103|4175915|P2|Overall Study|Condition no longer requires study drug|0
1278418|NCT00402103|4175916|P1|Overall Study|Condition no longer requires study drug|2
1278419|NCT00402103|4175915|P2|Overall Study|Unsatisfactory therapeutic effect|2
1278420|NCT00402103|4175916|P1|Overall Study|Unsatisfactory therapeutic effect|1
1278421|NCT00402103|4175915|P2|Overall Study|Adverse Event|7
1278422|NCT00402103|4175916|P1|Overall Study|Adverse Event|60
1278423|NCT00402051|4175932|P2|Overall Study|Lost to Follow-up|0
1278424|NCT00402051|4175933|P1|Overall Study|Lost to Follow-up|1
1278425|NCT00402051|4175932|P2|Overall Study|Death Due to Adverse Event|2
1278426|NCT00402051|4175933|P1|Overall Study|Death Due to Adverse Event|0
1278427|NCT00402051|4175932|P2|Overall Study|Death Due to Study Disease|1
1278428|NCT00402051|4175933|P1|Overall Study|Death Due to Study Disease|2
1278429|NCT00402051|4175932|P2|Overall Study|Death - Related to Study Drug|2
1278430|NCT00402051|4175933|P1|Overall Study|Death - Related to Study Drug|1
1278431|NCT00402051|4175932|P2|Overall Study|Withdrawal by Subject|3
1278432|NCT00402051|4175933|P1|Overall Study|Withdrawal by Subject|3
1278433|NCT00402051|4175932|P2|Overall Study|Physician Decision|3
1278434|NCT00402051|4175933|P1|Overall Study|Physician Decision|7
1278435|NCT00402051|4175932|P2|Overall Study|Adverse Event|4
1278436|NCT00402051|4175933|P1|Overall Study|Adverse Event|11
1278437|NCT00402051|4175932|P2|Overall Study|Progressive Disease|20
1278438|NCT00402051|4175933|P1|Overall Study|Progressive Disease|13
1278439|NCT00402025|4175950|P3|Overall Study|Participant Decision|1
1278440|NCT00402025|4175951|P2|Overall Study|Participant Decision|0
1278441|NCT00402025|4175952|P1|Overall Study|Participant Decision|0
1278442|NCT00402025|4175950|P3|Overall Study|Physician Decision|0
1278443|NCT00402025|4175951|P2|Overall Study|Physician Decision|1
1278444|NCT00402025|4175952|P1|Overall Study|Physician Decision|1
1278445|NCT00402025|4175950|P3|Overall Study|Disease Progression|2
1278446|NCT00402025|4175951|P2|Overall Study|Disease Progression|1
1278447|NCT00402025|4175952|P1|Overall Study|Disease Progression|1
1278448|NCT00402025|4175950|P3|Overall Study|Death|5
1278449|NCT00402025|4175951|P2|Overall Study|Death|1
1278450|NCT00402025|4175952|P1|Overall Study|Death|0
1278451|NCT00402025|4175950|P3|Overall Study|Adverse Event|2
1278452|NCT00402025|4175951|P2|Overall Study|Adverse Event|0
1278453|NCT00402025|4175952|P1|Overall Study|Adverse Event|0
1278454|NCT00401973|4175978|P3|Overall Study|Withdrawal by Subject|9
1278455|NCT00401973|4175979|P2|Overall Study|Withdrawal by Subject|12
1278456|NCT00401973|4175980|P1|Overall Study|Withdrawal by Subject|4
1278457|NCT00401973|4175978|P3|Overall Study|Sponsor Decision|0
1278458|NCT00401973|4175979|P2|Overall Study|Sponsor Decision|1
1278459|NCT00401973|4175980|P1|Overall Study|Sponsor Decision|0
1278460|NCT00401973|4175978|P3|Overall Study|Protocol Violation|3
1278461|NCT00401973|4175979|P2|Overall Study|Protocol Violation|2
1278462|NCT00401973|4175980|P1|Overall Study|Protocol Violation|1
1278463|NCT00401973|4175978|P3|Overall Study|Physician Decision|1
1278464|NCT00401973|4175979|P2|Overall Study|Physician Decision|0
1278465|NCT00401973|4175980|P1|Overall Study|Physician Decision|2
1278466|NCT00401973|4175978|P3|Overall Study|Lost to Follow-up|2
1278467|NCT00401973|4175979|P2|Overall Study|Lost to Follow-up|2
1278468|NCT00401973|4175980|P1|Overall Study|Lost to Follow-up|2
1278469|NCT00401973|4175978|P3|Overall Study|Lack of Efficacy|3
1278470|NCT00401973|4175979|P2|Overall Study|Lack of Efficacy|0
1278471|NCT00401973|4175980|P1|Overall Study|Lack of Efficacy|0
1278472|NCT00401973|4175978|P3|Overall Study|Clinical Relapse|1
1278473|NCT00401973|4175979|P2|Overall Study|Clinical Relapse|1
1278474|NCT00401973|4175980|P1|Overall Study|Clinical Relapse|0
1278475|NCT00401973|4175978|P3|Overall Study|Adverse Event|4
1278476|NCT00401973|4175979|P2|Overall Study|Adverse Event|8
1278477|NCT00401973|4175980|P1|Overall Study|Adverse Event|2
1278478|NCT00401960|4176019|P2|Overall Study|Death|0
1278479|NCT00401960|4176020|P1|Overall Study|Death|2
1278480|NCT00401960|4176019|P2|Overall Study|Lost to Follow-up|0
1278481|NCT00401960|4176020|P1|Overall Study|Lost to Follow-up|3
1278482|NCT00401843|4176050|P3|Overall Study|Received incorrect treatment|0
1278483|NCT00401843|4176051|P2|Overall Study|Received incorrect treatment|3
1278484|NCT00401843|4176052|P1|Overall Study|Received incorrect treatment|0
1278485|NCT00401843|4176050|P3|Overall Study|Randomized but not Treated|3
1278486|NCT00401843|4176051|P2|Overall Study|Randomized but not Treated|2
1278487|NCT00401843|4176052|P1|Overall Study|Randomized but not Treated|0
1278488|NCT00401843|4176050|P3|Overall Study|Withdrawal of consent to study agent|17
1278489|NCT00401843|4176051|P2|Overall Study|Withdrawal of consent to study agent|15
1278490|NCT00401843|4176052|P1|Overall Study|Withdrawal of consent to study agent|1
1278491|NCT00401843|4176050|P3|Overall Study|Withdrawal by Subject|5
1278492|NCT00401843|4176051|P2|Overall Study|Withdrawal by Subject|5
1278493|NCT00401843|4176052|P1|Overall Study|Withdrawal by Subject|1
1278494|NCT00401843|4176050|P3|Overall Study|Protocol Violation|1
1278495|NCT00401843|4176051|P2|Overall Study|Protocol Violation|0
1278496|NCT00401843|4176052|P1|Overall Study|Protocol Violation|0
1278497|NCT00401843|4176050|P3|Overall Study|Physician Decision|10
1278498|NCT00401843|4176051|P2|Overall Study|Physician Decision|16
1278499|NCT00401843|4176052|P1|Overall Study|Physician Decision|0
1278500|NCT00401843|4176050|P3|Overall Study|Other Unspecified|5
1278501|NCT00401843|4176051|P2|Overall Study|Other Unspecified|3
1278502|NCT00401843|4176052|P1|Overall Study|Other Unspecified|0
1278503|NCT00401843|4176050|P3|Overall Study|Lost to Follow-up|2
1278504|NCT00401843|4176051|P2|Overall Study|Lost to Follow-up|0
1278505|NCT00401843|4176052|P1|Overall Study|Lost to Follow-up|0
1278506|NCT00401843|4176050|P3|Overall Study|End of Study|2
1278507|NCT00401843|4176051|P2|Overall Study|End of Study|1
1278508|NCT00401843|4176052|P1|Overall Study|End of Study|1
1278509|NCT00401843|4176050|P3|Overall Study|Disease progression|49
1278510|NCT00401843|4176051|P2|Overall Study|Disease progression|60
1278511|NCT00401843|4176052|P1|Overall Study|Disease progression|10
1278512|NCT00401843|4176050|P3|Overall Study|Death|10
1278513|NCT00401843|4176051|P2|Overall Study|Death|8
1278514|NCT00401843|4176052|P1|Overall Study|Death|0
1278515|NCT00401843|4176050|P3|Overall Study|Adverse Event|27
1278516|NCT00401843|4176051|P2|Overall Study|Adverse Event|26
1278517|NCT00401843|4176052|P1|Overall Study|Adverse Event|7
1278518|NCT00401843|4176050|P3|Overall Study|Achieved Complete Response|11
1278519|NCT00401843|4176051|P2|Overall Study|Achieved Complete Response|5
1278520|NCT00401843|4176052|P1|Overall Study|Achieved Complete Response|1
1278521|NCT00401830|4176070|P2|Overall Study|Other: Personal / Family problems|0
1278522|NCT00401830|4176071|P1|Overall Study|Other: Personal / Family problems|1
1278523|NCT00401830|4176070|P2|Overall Study|Lost to Follow-up|3
1278524|NCT00401830|4176071|P1|Overall Study|Lost to Follow-up|1
1278525|NCT00401830|4176070|P2|Overall Study|Non-compliance with drug study|0
1278526|NCT00401830|4176071|P1|Overall Study|Non-compliance with drug study|1
1278527|NCT00401830|4176070|P2|Overall Study|Protocol Violation|3
1278528|NCT00401830|4176071|P1|Overall Study|Protocol Violation|3
1278529|NCT00401830|4176070|P2|Overall Study|Withdrawal by Subject|3
1278530|NCT00401830|4176071|P1|Overall Study|Withdrawal by Subject|4
1278531|NCT00401830|4176070|P2|Overall Study|Lack of Efficacy|5
1278532|NCT00401830|4176071|P1|Overall Study|Lack of Efficacy|11
1278533|NCT00401830|4176070|P2|Overall Study|Adverse Event|18
1278534|NCT00401830|4176071|P1|Overall Study|Adverse Event|10
1278535|NCT00401752|4176129|P2|Overall Study|Physician Decision|1
1278536|NCT00401752|4176130|P1|Overall Study|Physician Decision|1
1278537|NCT00401752|4176129|P2|Overall Study|Development of any exclusion criteria|2
1278538|NCT00401752|4176130|P1|Overall Study|Development of any exclusion criteria|4
1278539|NCT00401752|4176129|P2|Overall Study|Lost to Follow-up|4
1278540|NCT00401752|4176130|P1|Overall Study|Lost to Follow-up|1
1278541|NCT00401752|4176129|P2|Overall Study|Withdrawal by Subject|6
1278542|NCT00401752|4176130|P1|Overall Study|Withdrawal by Subject|2
1278543|NCT00401752|4176129|P2|Overall Study|Adverse Event|5
1278544|NCT00401752|4176130|P1|Overall Study|Adverse Event|2
1278545|NCT00401726|4176148|P2|Overall Study|Protocol Deviation|4
1278546|NCT00401726|4176149|P1|Overall Study|Protocol Deviation|9
1278547|NCT00401726|4176148|P2|Overall Study|Lack of Efficacy|6
1278548|NCT00401726|4176149|P1|Overall Study|Lack of Efficacy|4
1278549|NCT00401726|4176148|P2|Overall Study|Withdrawal by Subject|24
1278550|NCT00401726|4176149|P1|Overall Study|Withdrawal by Subject|18
1278551|NCT00401726|4176148|P2|Overall Study|Protocol Violation|3
1278552|NCT00401726|4176149|P1|Overall Study|Protocol Violation|6
1278553|NCT00401726|4176148|P2|Overall Study|Lost to Follow-up|20
1278554|NCT00401726|4176149|P1|Overall Study|Lost to Follow-up|23
1278555|NCT00401726|4176148|P2|Overall Study|Physician Decision|6
1278556|NCT00401726|4176149|P1|Overall Study|Physician Decision|3
1278557|NCT00401726|4176148|P2|Overall Study|Sponsor Request|1
1278558|NCT00401726|4176149|P1|Overall Study|Sponsor Request|0
1278559|NCT00401726|4176148|P2|Overall Study|Death|3
1278560|NCT00401726|4176149|P1|Overall Study|Death|0
1278561|NCT00401726|4176148|P2|Overall Study|Adverse Event|45
1278562|NCT00401726|4176149|P1|Overall Study|Adverse Event|34
1278563|NCT00401544|4176184|P4|Overall Study|Other|2
1278564|NCT00401544|4176185|P3|Overall Study|Other|2
1278565|NCT00401544|4176186|P2|Overall Study|Other|0
1278566|NCT00401544|4176187|P1|Overall Study|Other|0
1278567|NCT00401544|4176184|P4|Overall Study|Disease progression|0
1278568|NCT00401544|4176185|P3|Overall Study|Disease progression|0
1278569|NCT00401544|4176186|P2|Overall Study|Disease progression|1
1278570|NCT00401544|4176187|P1|Overall Study|Disease progression|0
1278571|NCT00401544|4176184|P4|Overall Study|Ineligibility determined|2
1278572|NCT00401544|4176185|P3|Overall Study|Ineligibility determined|0
1278573|NCT00401544|4176186|P2|Overall Study|Ineligibility determined|1
1278574|NCT00401544|4176187|P1|Overall Study|Ineligibility determined|0
1278575|NCT00401544|4176184|P4|Overall Study|Physician Decision|0
1278576|NCT00401544|4176185|P3|Overall Study|Physician Decision|0
1278577|NCT00401544|4176186|P2|Overall Study|Physician Decision|3
1278578|NCT00401544|4176187|P1|Overall Study|Physician Decision|1
1278579|NCT00401544|4176184|P4|Overall Study|Withdrawal by Subject|5
1278580|NCT00401544|4176185|P3|Overall Study|Withdrawal by Subject|6
1278581|NCT00401544|4176186|P2|Overall Study|Withdrawal by Subject|6
1278582|NCT00401544|4176187|P1|Overall Study|Withdrawal by Subject|7
1278583|NCT00401544|4176184|P4|Overall Study|Lost to Follow-up|1
1278584|NCT00401544|4176185|P3|Overall Study|Lost to Follow-up|1
1278585|NCT00401544|4176186|P2|Overall Study|Lost to Follow-up|0
1278586|NCT00401544|4176187|P1|Overall Study|Lost to Follow-up|2
1278587|NCT00401544|4176184|P4|Overall Study|Death|5
1278588|NCT00401544|4176185|P3|Overall Study|Death|2
1278589|NCT00401544|4176186|P2|Overall Study|Death|6
1278590|NCT00401544|4176187|P1|Overall Study|Death|3
1278591|NCT00401544|4176184|P4|Overall Study|Adverse Event|1
1278592|NCT00401544|4176185|P3|Overall Study|Adverse Event|1
1278593|NCT00401544|4176186|P2|Overall Study|Adverse Event|1
1278594|NCT00401544|4176187|P1|Overall Study|Adverse Event|5
1278595|NCT00401531|4176227|P2|Overall Study|Withdrawal by Subject|2
1278596|NCT00401531|4176228|P1|Overall Study|Withdrawal by Subject|3
1278597|NCT00401531|4176227|P2|Overall Study|Lost to Follow-up|1
1278598|NCT00401531|4176228|P1|Overall Study|Lost to Follow-up|1
1278599|NCT00401531|4176227|P2|Overall Study|Protocol Violation|7
1278600|NCT00401531|4176228|P1|Overall Study|Protocol Violation|3
1278601|NCT00401531|4176227|P2|Overall Study|Adverse Event|0
1278602|NCT00401531|4176228|P1|Overall Study|Adverse Event|2
1278603|NCT00401258|4176298|P1|Overall Study|Adverse Event|7
1278604|NCT00401245|4176313|P8|Double Blind Tapering Phase|Lack of Efficacy|0
1278605|NCT00401245|4176314|P7|Double Blind Tapering Phase|Lack of Efficacy|0
1278606|NCT00401245|4176315|P6|Double Blind Tapering Phase|Lack of Efficacy|1
1278607|NCT00401245|4176316|P5|Double Blind Tapering Phase|Lack of Efficacy|0
1278608|NCT00401245|4176317|P4|Double Blind Tapering Phase|Lack of Efficacy|0
1278609|NCT00401245|4176318|P3|Double Blind Tapering Phase|Lack of Efficacy|0
1278610|NCT00401245|4176319|P2|Double Blind Tapering Phase|Lack of Efficacy|0
1278611|NCT00401245|4176320|P1|Double Blind Tapering Phase|Lack of Efficacy|0
1278612|NCT00401245|4176313|P8|Double Blind Tapering Phase|Withdrawal by Subject|0
1278613|NCT00401245|4176314|P7|Double Blind Tapering Phase|Withdrawal by Subject|3
1278614|NCT00401245|4176315|P6|Double Blind Tapering Phase|Withdrawal by Subject|2
1278615|NCT00401245|4176316|P5|Double Blind Tapering Phase|Withdrawal by Subject|2
1278616|NCT00401245|4176317|P4|Double Blind Tapering Phase|Withdrawal by Subject|0
1278617|NCT00401245|4176318|P3|Double Blind Tapering Phase|Withdrawal by Subject|0
1278618|NCT00401245|4176319|P2|Double Blind Tapering Phase|Withdrawal by Subject|0
1278619|NCT00401245|4176320|P1|Double Blind Tapering Phase|Withdrawal by Subject|0
1278620|NCT00401245|4176313|P8|Double Blind Tapering Phase|Other|2
1278621|NCT00401245|4176314|P7|Double Blind Tapering Phase|Other|2
1278622|NCT00401245|4176315|P6|Double Blind Tapering Phase|Other|0
1278623|NCT00401245|4176316|P5|Double Blind Tapering Phase|Other|1
1278624|NCT00401245|4176317|P4|Double Blind Tapering Phase|Other|0
1278625|NCT00401245|4176318|P3|Double Blind Tapering Phase|Other|0
1278626|NCT00401245|4176319|P2|Double Blind Tapering Phase|Other|0
1278627|NCT00401245|4176320|P1|Double Blind Tapering Phase|Other|0
1278628|NCT00401245|4176313|P8|Double Blind Tapering Phase|Investigator request|1
1278629|NCT00401245|4176314|P7|Double Blind Tapering Phase|Investigator request|0
1278630|NCT00401245|4176315|P6|Double Blind Tapering Phase|Investigator request|0
1278631|NCT00401245|4176316|P5|Double Blind Tapering Phase|Investigator request|0
1278632|NCT00401245|4176317|P4|Double Blind Tapering Phase|Investigator request|0
1278633|NCT00401245|4176318|P3|Double Blind Tapering Phase|Investigator request|0
1278634|NCT00401245|4176319|P2|Double Blind Tapering Phase|Investigator request|0
1278635|NCT00401245|4176320|P1|Double Blind Tapering Phase|Investigator request|0
1278636|NCT00401245|4176313|P8|Double Blind Tapering Phase|Adverse Event|4
1278637|NCT00401245|4176314|P7|Double Blind Tapering Phase|Adverse Event|2
1278638|NCT00401245|4176315|P6|Double Blind Tapering Phase|Adverse Event|1
1278639|NCT00401245|4176316|P5|Double Blind Tapering Phase|Adverse Event|1
1278640|NCT00401245|4176317|P4|Double Blind Tapering Phase|Adverse Event|0
1278641|NCT00401245|4176318|P3|Double Blind Tapering Phase|Adverse Event|0
1278642|NCT00401245|4176319|P2|Double Blind Tapering Phase|Adverse Event|0
1278643|NCT00401245|4176320|P1|Double Blind Tapering Phase|Adverse Event|0
1278644|NCT00401245|4176313|P8|Open Label Phase|Lack of Efficacy|0
1278645|NCT00401245|4176314|P7|Open Label Phase|Lack of Efficacy|0
1278646|NCT00401245|4176315|P6|Open Label Phase|Lack of Efficacy|0
1278647|NCT00401245|4176316|P5|Open Label Phase|Lack of Efficacy|0
1278648|NCT00401245|4176317|P4|Open Label Phase|Lack of Efficacy|0
1278649|NCT00401245|4176318|P3|Open Label Phase|Lack of Efficacy|3
1278650|NCT00401245|4176319|P2|Open Label Phase|Lack of Efficacy|2
1278651|NCT00401245|4176320|P1|Open Label Phase|Lack of Efficacy|4
1278652|NCT00401245|4176313|P8|Open Label Phase|Withdrawal by Subject|0
1278653|NCT00401245|4176314|P7|Open Label Phase|Withdrawal by Subject|0
1278654|NCT00401245|4176315|P6|Open Label Phase|Withdrawal by Subject|0
1278655|NCT00401245|4176316|P5|Open Label Phase|Withdrawal by Subject|0
1278656|NCT00401245|4176317|P4|Open Label Phase|Withdrawal by Subject|1
1278657|NCT00401245|4176318|P3|Open Label Phase|Withdrawal by Subject|2
1278658|NCT00401245|4176319|P2|Open Label Phase|Withdrawal by Subject|3
1278659|NCT00401245|4176320|P1|Open Label Phase|Withdrawal by Subject|3
1278660|NCT00401245|4176313|P8|Open Label Phase|Protocol Violation|0
1278661|NCT00401245|4176314|P7|Open Label Phase|Protocol Violation|0
1278662|NCT00401245|4176315|P6|Open Label Phase|Protocol Violation|0
1278663|NCT00401245|4176316|P5|Open Label Phase|Protocol Violation|0
1278664|NCT00401245|4176317|P4|Open Label Phase|Protocol Violation|1
1278665|NCT00401245|4176318|P3|Open Label Phase|Protocol Violation|0
1278666|NCT00401245|4176319|P2|Open Label Phase|Protocol Violation|1
1278667|NCT00401245|4176320|P1|Open Label Phase|Protocol Violation|0
1278668|NCT00401245|4176313|P8|Open Label Phase|Other|0
1278669|NCT00401245|4176314|P7|Open Label Phase|Other|0
1278670|NCT00401245|4176315|P6|Open Label Phase|Other|0
1278671|NCT00401245|4176316|P5|Open Label Phase|Other|0
1278672|NCT00401245|4176317|P4|Open Label Phase|Other|8
1278673|NCT00401245|4176318|P3|Open Label Phase|Other|7
1278674|NCT00401245|4176319|P2|Open Label Phase|Other|8
1278675|NCT00401245|4176320|P1|Open Label Phase|Other|4
1278676|NCT00401245|4176313|P8|Open Label Phase|Lost to Follow-up|0
1278677|NCT00401245|4176314|P7|Open Label Phase|Lost to Follow-up|0
1278678|NCT00401245|4176315|P6|Open Label Phase|Lost to Follow-up|0
1278679|NCT00401245|4176316|P5|Open Label Phase|Lost to Follow-up|0
1278680|NCT00401245|4176317|P4|Open Label Phase|Lost to Follow-up|4
1278681|NCT00401245|4176318|P3|Open Label Phase|Lost to Follow-up|5
1278682|NCT00401245|4176319|P2|Open Label Phase|Lost to Follow-up|7
1278683|NCT00401245|4176320|P1|Open Label Phase|Lost to Follow-up|5
1278684|NCT00401245|4176313|P8|Open Label Phase|Adverse Event|0
1278685|NCT00401245|4176314|P7|Open Label Phase|Adverse Event|0
1278686|NCT00401245|4176315|P6|Open Label Phase|Adverse Event|0
1278687|NCT00401245|4176316|P5|Open Label Phase|Adverse Event|0
1278688|NCT00401245|4176317|P4|Open Label Phase|Adverse Event|7
1278689|NCT00401245|4176318|P3|Open Label Phase|Adverse Event|6
1278690|NCT00401245|4176319|P2|Open Label Phase|Adverse Event|14
1278691|NCT00401245|4176320|P1|Open Label Phase|Adverse Event|5
1278692|NCT00401245|4176313|P8|Between Titration and Open Label Phase|Did not enter the open label phase|0
1278693|NCT00401245|4176314|P7|Between Titration and Open Label Phase|Did not enter the open label phase|0
1278694|NCT00401245|4176315|P6|Between Titration and Open Label Phase|Did not enter the open label phase|0
1278695|NCT00401245|4176316|P5|Between Titration and Open Label Phase|Did not enter the open label phase|0
1278696|NCT00401245|4176317|P4|Between Titration and Open Label Phase|Did not enter the open label phase|2
1278697|NCT00401245|4176318|P3|Between Titration and Open Label Phase|Did not enter the open label phase|0
1278698|NCT00401245|4176319|P2|Between Titration and Open Label Phase|Did not enter the open label phase|2
1278699|NCT00401245|4176320|P1|Between Titration and Open Label Phase|Did not enter the open label phase|0
1278700|NCT00401245|4176313|P8|Double Blind Titration Phase|Withdrawal by Subject|0
1278701|NCT00401245|4176314|P7|Double Blind Titration Phase|Withdrawal by Subject|0
1278702|NCT00401245|4176315|P6|Double Blind Titration Phase|Withdrawal by Subject|0
1278703|NCT00401245|4176316|P5|Double Blind Titration Phase|Withdrawal by Subject|0
1278704|NCT00401245|4176317|P4|Double Blind Titration Phase|Withdrawal by Subject|2
1278705|NCT00401245|4176318|P3|Double Blind Titration Phase|Withdrawal by Subject|0
1278706|NCT00401245|4176319|P2|Double Blind Titration Phase|Withdrawal by Subject|1
1278707|NCT00401245|4176320|P1|Double Blind Titration Phase|Withdrawal by Subject|1
1278708|NCT00401245|4176313|P8|Double Blind Titration Phase|Protocol Violation|0
1278709|NCT00401245|4176314|P7|Double Blind Titration Phase|Protocol Violation|0
1278710|NCT00401245|4176315|P6|Double Blind Titration Phase|Protocol Violation|0
1278711|NCT00401245|4176316|P5|Double Blind Titration Phase|Protocol Violation|0
1278712|NCT00401245|4176317|P4|Double Blind Titration Phase|Protocol Violation|1
1278713|NCT00401245|4176318|P3|Double Blind Titration Phase|Protocol Violation|0
1278714|NCT00401245|4176319|P2|Double Blind Titration Phase|Protocol Violation|0
1278715|NCT00401245|4176320|P1|Double Blind Titration Phase|Protocol Violation|0
1278716|NCT00401245|4176313|P8|Double Blind Titration Phase|Other|0
1278717|NCT00401245|4176314|P7|Double Blind Titration Phase|Other|0
1278718|NCT00401245|4176315|P6|Double Blind Titration Phase|Other|0
1278719|NCT00401245|4176316|P5|Double Blind Titration Phase|Other|0
1278720|NCT00401245|4176317|P4|Double Blind Titration Phase|Other|0
1278721|NCT00401245|4176318|P3|Double Blind Titration Phase|Other|1
1278722|NCT00401245|4176319|P2|Double Blind Titration Phase|Other|0
1278723|NCT00401245|4176320|P1|Double Blind Titration Phase|Other|0
1278724|NCT00401245|4176313|P8|Double Blind Titration Phase|Adverse Event|0
1278725|NCT00401245|4176314|P7|Double Blind Titration Phase|Adverse Event|0
1278726|NCT00401245|4176315|P6|Double Blind Titration Phase|Adverse Event|0
1278727|NCT00401245|4176316|P5|Double Blind Titration Phase|Adverse Event|0
1278728|NCT00401245|4176317|P4|Double Blind Titration Phase|Adverse Event|12
1278729|NCT00401245|4176318|P3|Double Blind Titration Phase|Adverse Event|5
1278730|NCT00401245|4176319|P2|Double Blind Titration Phase|Adverse Event|2
1278731|NCT00401245|4176320|P1|Double Blind Titration Phase|Adverse Event|3
1278732|NCT00401193|4176388|P3|Overall Study|Other Event|2
1278733|NCT00401193|4176389|P2|Overall Study|Other Event|2
1278734|NCT00401193|4176390|P1|Overall Study|Other Event|3
1278735|NCT00401193|4176388|P3|Overall Study|Withdrawal by Subject|1
1278736|NCT00401193|4176389|P2|Overall Study|Withdrawal by Subject|0
1278737|NCT00401193|4176390|P1|Overall Study|Withdrawal by Subject|2
1278738|NCT00401193|4176388|P3|Overall Study|Lost to Follow-up|1
1278739|NCT00401193|4176389|P2|Overall Study|Lost to Follow-up|5
1278740|NCT00401193|4176390|P1|Overall Study|Lost to Follow-up|6
1278741|NCT00401193|4176388|P3|Overall Study|Protocol Violation|1
1278742|NCT00401193|4176389|P2|Overall Study|Protocol Violation|1
1278743|NCT00401193|4176390|P1|Overall Study|Protocol Violation|3
1278744|NCT00401193|4176388|P3|Overall Study|Adverse Event|1
1278745|NCT00401193|4176389|P2|Overall Study|Adverse Event|3
1278746|NCT00401193|4176390|P1|Overall Study|Adverse Event|1
1278747|NCT00400985|4176408|P1|Overall Study|Lost to Follow-up|9
1278748|NCT00400985|4176408|P1|Overall Study|Death|30
1278749|NCT00400985|4176408|P1|Overall Study|system modification|8
1278750|NCT00400985|4176408|P1|Overall Study|Withdrawal by Subject|5
1278751|NCT00400946|4176417|P5|Overall Study|Other|1
1278752|NCT00400946|4176418|P4|Overall Study|Other|0
1278753|NCT00400946|4176419|P3|Overall Study|Other|0
1278754|NCT00400946|4176420|P2|Overall Study|Other|0
1278755|NCT00400946|4176421|P1|Overall Study|Other|0
1278756|NCT00400946|4176417|P5|Overall Study|Clinical|9
1278757|NCT00400946|4176418|P4|Overall Study|Clinical|2
1278758|NCT00400946|4176419|P3|Overall Study|Clinical|0
1278759|NCT00400946|4176420|P2|Overall Study|Clinical|2
1278760|NCT00400946|4176421|P1|Overall Study|Clinical|1
1278761|NCT00400946|4176417|P5|Overall Study|Withdrawal by Subject|8
1278762|NCT00400946|4176418|P4|Overall Study|Withdrawal by Subject|5
1278763|NCT00400946|4176419|P3|Overall Study|Withdrawal by Subject|1
1278764|NCT00400946|4176420|P2|Overall Study|Withdrawal by Subject|5
1278765|NCT00400946|4176421|P1|Overall Study|Withdrawal by Subject|2
1278766|NCT00400946|4176417|P5|Overall Study|Transplant in CR1|1
1278767|NCT00400946|4176418|P4|Overall Study|Transplant in CR1|10
1278768|NCT00400946|4176419|P3|Overall Study|Transplant in CR1|0
1278769|NCT00400946|4176420|P2|Overall Study|Transplant in CR1|0
1278770|NCT00400946|4176421|P1|Overall Study|Transplant in CR1|0
1278771|NCT00400946|4176417|P5|Overall Study|Relapse|5
1278772|NCT00400946|4176418|P4|Overall Study|Relapse|1
1278773|NCT00400946|4176419|P3|Overall Study|Relapse|1
1278774|NCT00400946|4176420|P2|Overall Study|Relapse|2
1278775|NCT00400946|4176421|P1|Overall Study|Relapse|9
1278776|NCT00400946|4176417|P5|Overall Study|Remission Death|1
1278777|NCT00400946|4176418|P4|Overall Study|Remission Death|0
1278778|NCT00400946|4176419|P3|Overall Study|Remission Death|0
1278779|NCT00400946|4176420|P2|Overall Study|Remission Death|1
1278780|NCT00400946|4176421|P1|Overall Study|Remission Death|1
1278781|NCT00400946|4176417|P5|Overall Study|Lost to Follow-up|1
1278782|NCT00400946|4176418|P4|Overall Study|Lost to Follow-up|0
1278783|NCT00400946|4176419|P3|Overall Study|Lost to Follow-up|0
1278784|NCT00400946|4176420|P2|Overall Study|Lost to Follow-up|1
1278785|NCT00400946|4176421|P1|Overall Study|Lost to Follow-up|1
1278786|NCT00400946|4176417|P5|Overall Study|Induction Death|3
1278787|NCT00400946|4176418|P4|Overall Study|Induction Death|13
1278788|NCT00400946|4176419|P3|Overall Study|Induction Death|0
1278789|NCT00400946|4176420|P2|Overall Study|Induction Death|0
1278790|NCT00400946|4176421|P1|Overall Study|Induction Death|0
1278791|NCT00400946|4176417|P5|Overall Study|Induction Failure|8
1278792|NCT00400946|4176418|P4|Overall Study|Induction Failure|11
1278793|NCT00400946|4176419|P3|Overall Study|Induction Failure|0
1278794|NCT00400946|4176420|P2|Overall Study|Induction Failure|0
1278795|NCT00400946|4176421|P1|Overall Study|Induction Failure|0
1278796|NCT00400946|4176417|P5|Overall Study|Ineligible|1
1278797|NCT00400946|4176418|P4|Overall Study|Ineligible|5
1278798|NCT00400946|4176419|P3|Overall Study|Ineligible|0
1278799|NCT00400946|4176420|P2|Overall Study|Ineligible|0
1278800|NCT00400946|4176421|P1|Overall Study|Ineligible|0
1278801|NCT00400764|4176480|P5|Phase II|Withdrawal by Subject|0
1278802|NCT00400764|4176481|P4|Phase II|Withdrawal by Subject|1
1278803|NCT00400764|4176482|P3|Phase II|Withdrawal by Subject|1
1278804|NCT00400764|4176483|P2|Phase II|Withdrawal by Subject|0
1278805|NCT00400764|4176484|P1|Phase II|Withdrawal by Subject|0
1278806|NCT00400764|4176480|P5|Phase II|Patient began new, non-protocol, therapy|0
1278807|NCT00400764|4176481|P4|Phase II|Patient began new, non-protocol, therapy|0
1278808|NCT00400764|4176482|P3|Phase II|Patient began new, non-protocol, therapy|1
1278809|NCT00400764|4176483|P2|Phase II|Patient began new, non-protocol, therapy|0
1278810|NCT00400764|4176484|P1|Phase II|Patient began new, non-protocol, therapy|0
1278811|NCT00400764|4176480|P5|Phase II|Sponsor’s decision to terminate|11
1278812|NCT00400764|4176481|P4|Phase II|Sponsor’s decision to terminate|22
1278813|NCT00400764|4176482|P3|Phase II|Sponsor’s decision to terminate|18
1278814|NCT00400764|4176483|P2|Phase II|Sponsor’s decision to terminate|0
1278815|NCT00400764|4176484|P1|Phase II|Sponsor’s decision to terminate|0
1278816|NCT00400764|4176480|P5|Phase II|Physician Decision|0
1278817|NCT00400764|4176481|P4|Phase II|Physician Decision|1
1278818|NCT00400764|4176482|P3|Phase II|Physician Decision|1
1278819|NCT00400764|4176483|P2|Phase II|Physician Decision|0
1278820|NCT00400764|4176484|P1|Phase II|Physician Decision|0
1278821|NCT00400764|4176480|P5|Phase II|Lost to Follow-up|0
1278822|NCT00400764|4176481|P4|Phase II|Lost to Follow-up|0
1278823|NCT00400764|4176482|P3|Phase II|Lost to Follow-up|1
1278824|NCT00400764|4176483|P2|Phase II|Lost to Follow-up|0
1278825|NCT00400764|4176484|P1|Phase II|Lost to Follow-up|0
1278826|NCT00400764|4176480|P5|Phase II|Death|0
1278827|NCT00400764|4176481|P4|Phase II|Death|2
1278828|NCT00400764|4176482|P3|Phase II|Death|1
1278829|NCT00400764|4176483|P2|Phase II|Death|0
1278830|NCT00400764|4176484|P1|Phase II|Death|0
1278831|NCT00400764|4176480|P5|Phase Ib|Disease Progression|0
1278832|NCT00400764|4176481|P4|Phase Ib|Disease Progression|0
1278833|NCT00400764|4176482|P3|Phase Ib|Disease Progression|0
1278834|NCT00400764|4176483|P2|Phase Ib|Disease Progression|4
1278835|NCT00400764|4176484|P1|Phase Ib|Disease Progression|4
1278836|NCT00400764|4176480|P5|Phase Ib|Death|0
1278837|NCT00400764|4176481|P4|Phase Ib|Death|0
1278838|NCT00400764|4176482|P3|Phase Ib|Death|0
1278839|NCT00400764|4176483|P2|Phase Ib|Death|0
1278840|NCT00400764|4176484|P1|Phase Ib|Death|1
1278841|NCT00400764|4176480|P5|Phase Ib|Adverse Event|0
1278842|NCT00400764|4176481|P4|Phase Ib|Adverse Event|0
1278843|NCT00400764|4176482|P3|Phase Ib|Adverse Event|0
1278844|NCT00400764|4176483|P2|Phase Ib|Adverse Event|0
1278845|NCT00400764|4176484|P1|Phase Ib|Adverse Event|1
1278846|NCT00400712|4176537|P2|Overall Study|Physician Decision|4
1278847|NCT00400712|4176538|P1|Overall Study|Physician Decision|5
1278848|NCT00400712|4176537|P2|Overall Study|Withdrawal by Subject|12
1278849|NCT00400712|4176538|P1|Overall Study|Withdrawal by Subject|11
1278850|NCT00400712|4176537|P2|Overall Study|Death|0
1278851|NCT00400712|4176538|P1|Overall Study|Death|1
1278852|NCT00400569|4176573|P1|Overall Study|Death|1
1278853|NCT00400517|4176584|P1|Overall Study|Physician Decision|1
1278854|NCT00400517|4176584|P1|Overall Study|Withdrawal by Subject|1
1278855|NCT00400400|4176593|P2|Overall Study|Did not receive study drug|3
1278856|NCT00400400|4176594|P1|Overall Study|Did not receive study drug|1
1278857|NCT00400400|4176593|P2|Overall Study|Lost to Follow-up|1
1278858|NCT00400400|4176594|P1|Overall Study|Lost to Follow-up|0
1278859|NCT00400400|4176593|P2|Overall Study|Administrative Problem|0
1278860|NCT00400400|4176594|P1|Overall Study|Administrative Problem|1
1278861|NCT00400400|4176593|P2|Overall Study|Withdrawal by Subject|3
1278862|NCT00400400|4176594|P1|Overall Study|Withdrawal by Subject|1
1278863|NCT00400400|4176593|P2|Overall Study|Protocol Violation|0
1278864|NCT00400400|4176594|P1|Overall Study|Protocol Violation|2
1278865|NCT00400400|4176593|P2|Overall Study|Adverse Event|8
1278866|NCT00400400|4176594|P1|Overall Study|Adverse Event|9
1278867|NCT00400179|4176619|P2|Overall Study|Randomization error/patient ineligible|6
1278868|NCT00400179|4176620|P1|Overall Study|Randomization error/patient ineligible|1
1278869|NCT00400179|4176619|P2|Overall Study|Investigator judgment|1
1278870|NCT00400179|4176620|P1|Overall Study|Investigator judgment|0
1278871|NCT00400179|4176619|P2|Overall Study|Intercurrent illness|1
1278872|NCT00400179|4176620|P1|Overall Study|Intercurrent illness|0
1278873|NCT00400179|4176619|P2|Overall Study|Disease progression|1
1278874|NCT00400179|4176620|P1|Overall Study|Disease progression|1
1278875|NCT00400179|4176619|P2|Overall Study|Withdrew Consent|5
1278876|NCT00400179|4176620|P1|Overall Study|Withdrew Consent|1
1278877|NCT00400179|4176619|P2|Overall Study|Death|2
1278878|NCT00400179|4176620|P1|Overall Study|Death|1
1278879|NCT00400179|4176619|P2|Overall Study|Adverse Event|2
1278880|NCT00400179|4176620|P1|Overall Study|Adverse Event|2
1278881|NCT00400153|4176637|P3|Overall Study|Other reasons - not mentioned above|3
1278882|NCT00400153|4176638|P2|Overall Study|Other reasons - not mentioned above|5
1278883|NCT00400153|4176639|P1|Overall Study|Other reasons - not mentioned above|8
1278884|NCT00400153|4176637|P3|Overall Study|Withdrawal by Subject|10
1278885|NCT00400153|4176638|P2|Overall Study|Withdrawal by Subject|11
1278886|NCT00400153|4176639|P1|Overall Study|Withdrawal by Subject|12
1278887|NCT00400153|4176637|P3|Overall Study|Lost to Follow-up|4
1278888|NCT00400153|4176638|P2|Overall Study|Lost to Follow-up|1
1278889|NCT00400153|4176639|P1|Overall Study|Lost to Follow-up|2
1278890|NCT00400153|4176637|P3|Overall Study|Protocol Violation|9
1278891|NCT00400153|4176638|P2|Overall Study|Protocol Violation|4
1278892|NCT00400153|4176639|P1|Overall Study|Protocol Violation|7
1278893|NCT00400153|4176637|P3|Overall Study|AE due to other condition|15
1278894|NCT00400153|4176638|P2|Overall Study|AE due to other condition|14
1278895|NCT00400153|4176639|P1|Overall Study|AE due to other condition|3
1278896|NCT00400153|4176637|P3|Overall Study|AE due to other disease worsening|0
1278897|NCT00400153|4176638|P2|Overall Study|AE due to other disease worsening|1
1278898|NCT00400153|4176639|P1|Overall Study|AE due to other disease worsening|2
1278899|NCT00400153|4176637|P3|Overall Study|AE due to study disease worsening|20
1278900|NCT00400153|4176638|P2|Overall Study|AE due to study disease worsening|19
1278901|NCT00400153|4176639|P1|Overall Study|AE due to study disease worsening|14
1278902|NCT00399893|4176886|P2|Overall Study|Withdrawal by Subject|0
1278903|NCT00399893|4176887|P1|Overall Study|Withdrawal by Subject|1
1278904|NCT00399802|4176926|P2|Overall Study|Participant discontinued by mistake|1
1278905|NCT00399802|4176927|P1|Overall Study|Participant discontinued by mistake|0
1278906|NCT00399802|4176926|P2|Overall Study|Adverse Event|2
1278907|NCT00399802|4176927|P1|Overall Study|Adverse Event|0
1278908|NCT00399763|4176941|P2|Overall Study|Lost to Follow-up|3
1278909|NCT00399763|4176942|P1|Overall Study|Lost to Follow-up|2
1278910|NCT00399568|4176954|P2|Overall Study|Lost to Follow-up|2
1278911|NCT00399568|4176955|P1|Overall Study|Lost to Follow-up|2
1278912|NCT00399568|4176954|P2|Overall Study|Protocol non-compliance|2
1278913|NCT00399568|4176955|P1|Overall Study|Protocol non-compliance|2
1278914|NCT00399568|4176954|P2|Overall Study|Withdrawal by Subject|3
1278915|NCT00399568|4176955|P1|Overall Study|Withdrawal by Subject|7
1278916|NCT00399568|4176954|P2|Overall Study|Adverse Event|2
1278917|NCT00399568|4176955|P1|Overall Study|Adverse Event|1
1278918|NCT00399542|4176969|P2|Overall Study|Physician Decision|1
1278919|NCT00399542|4176970|P1|Overall Study|Physician Decision|0
1278920|NCT00399542|4176969|P2|Overall Study|Other|0
1278921|NCT00399542|4176970|P1|Overall Study|Other|1
1278922|NCT00399542|4176969|P2|Overall Study|Lost to Follow-up|6
1278923|NCT00399542|4176970|P1|Overall Study|Lost to Follow-up|6
1278924|NCT00399542|4176969|P2|Overall Study|Lack of Efficacy|8
1278925|NCT00399542|4176970|P1|Overall Study|Lack of Efficacy|18
1278926|NCT00399542|4176969|P2|Overall Study|Withdrawal by Subject|10
1278927|NCT00399542|4176970|P1|Overall Study|Withdrawal by Subject|28
1278928|NCT00399542|4176969|P2|Overall Study|Protocol Violation|3
1278929|NCT00399542|4176970|P1|Overall Study|Protocol Violation|13
1278930|NCT00399542|4176969|P2|Overall Study|Adverse Event|15
1278931|NCT00399542|4176970|P1|Overall Study|Adverse Event|18
1278932|NCT00399516|4177032|P1|Overall Study|Lost to Follow-up|2
1278933|NCT00399360|4177040|P4|Overall Study|Withdrawal by Subject|2
1278934|NCT00399360|4177041|P3|Overall Study|Withdrawal by Subject|0
1278935|NCT00399360|4177042|P2|Overall Study|Withdrawal by Subject|2
1278936|NCT00399360|4177043|P1|Overall Study|Withdrawal by Subject|0
1278937|NCT00399360|4177040|P4|Overall Study|Adverse Event|0
1278938|NCT00399360|4177041|P3|Overall Study|Adverse Event|1
1278939|NCT00399360|4177042|P2|Overall Study|Adverse Event|0
1278940|NCT00399360|4177043|P1|Overall Study|Adverse Event|0
1278941|NCT00399360|4177040|P4|Overall Study|Lost to Follow-up|4
1278942|NCT00399360|4177041|P3|Overall Study|Lost to Follow-up|2
1278943|NCT00399360|4177042|P2|Overall Study|Lost to Follow-up|1
1278944|NCT00399360|4177043|P1|Overall Study|Lost to Follow-up|2
1278945|NCT00399035|4177114|P3|Overall Study|Severe non-compliance with protocol|0
1278946|NCT00399035|4177115|P2|Overall Study|Severe non-compliance with protocol|1
1278947|NCT00399035|4177116|P1|Overall Study|Severe non-compliance with protocol|2
1278948|NCT00399035|4177114|P3|Overall Study|Incorrect enrolment/eligib not fulfilled|1
1278949|NCT00399035|4177115|P2|Overall Study|Incorrect enrolment/eligib not fulfilled|0
1278950|NCT00399035|4177116|P1|Overall Study|Incorrect enrolment/eligib not fulfilled|1
1278951|NCT00399035|4177114|P3|Overall Study|Withdrawal by Subject|12
1278952|NCT00399035|4177115|P2|Overall Study|Withdrawal by Subject|15
1278953|NCT00399035|4177116|P1|Overall Study|Withdrawal by Subject|19
1278954|NCT00399035|4177114|P3|Overall Study|Lost to Follow-up|5
1278955|NCT00399035|4177115|P2|Overall Study|Lost to Follow-up|1
1278956|NCT00399035|4177116|P1|Overall Study|Lost to Follow-up|2
1278957|NCT00399035|4177114|P3|Overall Study|Death|234
1278958|NCT00399035|4177115|P2|Overall Study|Death|141
1278959|NCT00399035|4177116|P1|Overall Study|Death|289
1278960|NCT00398866|4177152|P3|Overall Study|Unable to complete requirements of study|1
1278961|NCT00398866|4177153|P2|Overall Study|Unable to complete requirements of study|1
1278962|NCT00398866|4177154|P1|Overall Study|Unable to complete requirements of study|1
1278963|NCT00398866|4177152|P3|Overall Study|Withdrawal by Subject|2
1278964|NCT00398866|4177153|P2|Overall Study|Withdrawal by Subject|1
1278965|NCT00398866|4177154|P1|Overall Study|Withdrawal by Subject|5
1278966|NCT00398866|4177152|P3|Overall Study|Lost to Follow-up|4
1278967|NCT00398866|4177153|P2|Overall Study|Lost to Follow-up|6
1278968|NCT00398866|4177154|P1|Overall Study|Lost to Follow-up|7
1278969|NCT00398866|4177152|P3|Overall Study|Lack of Efficacy|1
1278970|NCT00398866|4177153|P2|Overall Study|Lack of Efficacy|0
1278971|NCT00398866|4177154|P1|Overall Study|Lack of Efficacy|0
1278972|NCT00398866|4177152|P3|Overall Study|Adverse Event|0
1278973|NCT00398866|4177153|P2|Overall Study|Adverse Event|0
1278974|NCT00398866|4177154|P1|Overall Study|Adverse Event|1
1278975|NCT00398632|4177165|P1|Overall Study|Lack of Efficacy|1
1278976|NCT00398632|4177165|P1|Overall Study|Withdrawal by Subject|1
1278977|NCT00398567|4177173|P3|Overall Study|Protocol Violation|1
1278978|NCT00398567|4177174|P2|Overall Study|Protocol Violation|0
1278979|NCT00398567|4177175|P1|Overall Study|Protocol Violation|0
1278980|NCT00398567|4177173|P3|Overall Study|Adverse Event|2
1278981|NCT00398567|4177174|P2|Overall Study|Adverse Event|0
1278982|NCT00398567|4177175|P1|Overall Study|Adverse Event|0
1278983|NCT00398567|4177173|P3|Overall Study|Withdrawal by Subject|4
1278984|NCT00398567|4177174|P2|Overall Study|Withdrawal by Subject|0
1278985|NCT00398567|4177175|P1|Overall Study|Withdrawal by Subject|1
1278986|NCT00398567|4177173|P3|Overall Study|Disease Progression|27
1278987|NCT00398567|4177174|P2|Overall Study|Disease Progression|4
1278988|NCT00398567|4177175|P1|Overall Study|Disease Progression|3
1278989|NCT00398411|4177229|P2|Overall Study|Death|1
1278990|NCT00398411|4177230|P1|Overall Study|Death|0
1278991|NCT00398320|4177253|P1|Overall Study|Physician Decision|1
1278992|NCT00398320|4177253|P1|Overall Study|Adverse Event|4
1278993|NCT00398320|4177253|P1|Overall Study|Death|1
1278994|NCT00398216|4177266|P5|Overall Study|entrance criteria|2
1278995|NCT00398216|4177267|P4|Overall Study|entrance criteria|0
1278996|NCT00398216|4177268|P3|Overall Study|entrance criteria|0
1278997|NCT00398216|4177269|P2|Overall Study|entrance criteria|0
1278998|NCT00398216|4177270|P1|Overall Study|entrance criteria|0
1278999|NCT00398216|4177266|P5|Overall Study|administrative reasons|3
1279000|NCT00398216|4177267|P4|Overall Study|administrative reasons|3
1279001|NCT00398216|4177268|P3|Overall Study|administrative reasons|4
1279002|NCT00398216|4177269|P2|Overall Study|administrative reasons|4
1279003|NCT00398216|4177270|P1|Overall Study|administrative reasons|3
1279004|NCT00398216|4177266|P5|Overall Study|Withdrawal by Subject|2
1279005|NCT00398216|4177267|P4|Overall Study|Withdrawal by Subject|1
1279006|NCT00398216|4177268|P3|Overall Study|Withdrawal by Subject|3
1279007|NCT00398216|4177269|P2|Overall Study|Withdrawal by Subject|0
1279008|NCT00398216|4177270|P1|Overall Study|Withdrawal by Subject|1
1279009|NCT00398216|4177266|P5|Overall Study|Death|0
1279010|NCT00398216|4177267|P4|Overall Study|Death|0
1279011|NCT00398216|4177268|P3|Overall Study|Death|0
1279012|NCT00398216|4177269|P2|Overall Study|Death|3
1279013|NCT00398216|4177270|P1|Overall Study|Death|0
1279014|NCT00398216|4177266|P5|Overall Study|Lost to Follow-up|1
1279015|NCT00398216|4177267|P4|Overall Study|Lost to Follow-up|4
1279016|NCT00398216|4177268|P3|Overall Study|Lost to Follow-up|4
1279017|NCT00398216|4177269|P2|Overall Study|Lost to Follow-up|6
1279018|NCT00398216|4177270|P1|Overall Study|Lost to Follow-up|1
1279019|NCT00398216|4177266|P5|Overall Study|Protocol Violation|5
1279020|NCT00398216|4177267|P4|Overall Study|Protocol Violation|7
1279021|NCT00398216|4177268|P3|Overall Study|Protocol Violation|5
1279022|NCT00398216|4177269|P2|Overall Study|Protocol Violation|4
1279023|NCT00398216|4177270|P1|Overall Study|Protocol Violation|2
1279024|NCT00398216|4177266|P5|Overall Study|Adverse Event|2
1279025|NCT00398216|4177267|P4|Overall Study|Adverse Event|7
1279026|NCT00398216|4177268|P3|Overall Study|Adverse Event|5
1279027|NCT00398216|4177269|P2|Overall Study|Adverse Event|2
1279028|NCT00398216|4177270|P1|Overall Study|Adverse Event|4
1279029|NCT00398138|4177297|P1|Overall Study|Adverse Event|2
1279030|NCT00398112|4177302|P1|Overall Study|Death|1
1279031|NCT00398112|4177302|P1|Overall Study|Withdrawal by Subject|3
1279032|NCT00398112|4177302|P1|Overall Study|Alternative treatment|1
1279033|NCT00398112|4177302|P1|Overall Study|Disease progression|9
1279034|NCT00398112|4177302|P1|Overall Study|Adverse Event|4
1279035|NCT00398086|4177313|P3|Overall Study|Withdrawal by Subject|0
1279036|NCT00398086|4177314|P2|Overall Study|Withdrawal by Subject|7
1279037|NCT00398086|4177315|P1|Overall Study|Withdrawal by Subject|5
1279038|NCT00398086|4177313|P3|Overall Study|Physician Decision|0
1279039|NCT00398086|4177314|P2|Overall Study|Physician Decision|4
1279040|NCT00398086|4177315|P1|Overall Study|Physician Decision|1
1279041|NCT00398086|4177313|P3|Overall Study|Adverse Event|0
1279042|NCT00398086|4177314|P2|Overall Study|Adverse Event|4
1279043|NCT00398086|4177315|P1|Overall Study|Adverse Event|1
1279044|NCT00398086|4177313|P3|Overall Study|Unacceptable Toxicity|2
1279045|NCT00398086|4177314|P2|Overall Study|Unacceptable Toxicity|8
1279046|NCT00398086|4177315|P1|Overall Study|Unacceptable Toxicity|2
1279047|NCT00398073|4177349|P2|Overall Study|Withdrawal by Subject|0
1279048|NCT00398073|4177350|P1|Overall Study|Withdrawal by Subject|1
1279049|NCT00398047|4177360|P1|Overall Study|all patient progressed before completion|3
1279050|NCT00397982|4177370|P1|Overall Study|Unrelated health issues|1
1279051|NCT00397982|4177370|P1|Overall Study|noncompliance|1
1279052|NCT00397982|4177370|P1|Overall Study|Adverse Event|1
1279053|NCT00397982|4177370|P1|Overall Study|Withdrawal by Subject|1
1279054|NCT00397943|4177384|P5|Overall Study|Unspecified reasons|0
1279055|NCT00397943|4177385|P4|Overall Study|Unspecified reasons|0
1279056|NCT00397943|4177386|P3|Overall Study|Unspecified reasons|0
1279057|NCT00397943|4177387|P2|Overall Study|Unspecified reasons|9
1279058|NCT00397943|4177388|P1|Overall Study|Unspecified reasons|12
1279059|NCT00397930|4177544|P2|Overall Study|Missing data|4
1279060|NCT00397930|4177545|P1|Overall Study|Missing data|0
1279061|NCT00397930|4177544|P2|Overall Study|Withdrawal by Subject|8
1279062|NCT00397930|4177545|P1|Overall Study|Withdrawal by Subject|0
1279063|NCT00397930|4177544|P2|Overall Study|Did not want to be in control group|1
1279064|NCT00397930|4177545|P1|Overall Study|Did not want to be in control group|0
1279065|NCT00397930|4177544|P2|Overall Study|Started own yoga program|1
1279066|NCT00397930|4177545|P1|Overall Study|Started own yoga program|1
1279067|NCT00397930|4177544|P2|Overall Study|Too time-consuming|9
1279068|NCT00397930|4177545|P1|Overall Study|Too time-consuming|2
1279069|NCT00397930|4177544|P2|Overall Study|Noncompliant|2
1279070|NCT00397930|4177545|P1|Overall Study|Noncompliant|3
1279071|NCT00397930|4177544|P2|Overall Study|Unknown reasons|14
1279072|NCT00397930|4177545|P1|Overall Study|Unknown reasons|9
1279073|NCT00397930|4177544|P2|Overall Study|Other medical|4
1279074|NCT00397930|4177545|P1|Overall Study|Other medical|9
1279075|NCT00397930|4177544|P2|Overall Study|Personal reasons|8
1279076|NCT00397930|4177545|P1|Overall Study|Personal reasons|14
1279077|NCT00397891|4177560|P5|Overall Study|Withdrawal by Subject|1
1279078|NCT00397891|4177561|P4|Overall Study|Withdrawal by Subject|0
1279079|NCT00397891|4177562|P3|Overall Study|Withdrawal by Subject|0
1279080|NCT00397891|4177563|P2|Overall Study|Withdrawal by Subject|0
1279081|NCT00397891|4177564|P1|Overall Study|Withdrawal by Subject|1
1279082|NCT00397631|4177734|P2|Overall Study|protocol discontinuation criteria|4
1279083|NCT00397631|4177735|P1|Overall Study|protocol discontinuation criteria|1
1279084|NCT00397631|4177734|P2|Overall Study|Withdrawal by Subject|14
1279085|NCT00397631|4177735|P1|Overall Study|Withdrawal by Subject|7
1279086|NCT00397631|4177734|P2|Overall Study|Protocol Violation|1
1279087|NCT00397631|4177735|P1|Overall Study|Protocol Violation|0
1279088|NCT00397631|4177734|P2|Overall Study|Physician Decision|0
1279089|NCT00397631|4177735|P1|Overall Study|Physician Decision|2
1279090|NCT00397631|4177734|P2|Overall Study|Lost to Follow-up|9
1279091|NCT00397631|4177735|P1|Overall Study|Lost to Follow-up|8
1279092|NCT00397631|4177734|P2|Overall Study|Lack of Efficacy|10
1279093|NCT00397631|4177735|P1|Overall Study|Lack of Efficacy|7
1279094|NCT00397631|4177734|P2|Overall Study|Adverse Event|6
1279095|NCT00397631|4177735|P1|Overall Study|Adverse Event|5
1279096|NCT00397540|4177747|P2|Overall Study|short follow-up duration < 12 months|0
1279097|NCT00397540|4177748|P1|Overall Study|short follow-up duration < 12 months|1
1279098|NCT00397514|4177754|P1|Overall Study|poor echocardiographic windows|1
1279099|NCT00397514|4177754|P1|Overall Study|early extubation|2
1279100|NCT00397514|4177754|P1|Overall Study|Not able to capture & pace LV intraoper.|4
1279101|NCT00397514|4177754|P1|Overall Study|Pacing wire malfunction|1
1279102|NCT00397514|4177754|P1|Overall Study|Withdrawal by Subject|1
1279103|NCT00397488|4177764|P1|Overall Study|Death|1
1279104|NCT00397488|4177764|P1|Overall Study|Adverse Event|3
1279105|NCT00397488|4177764|P1|Overall Study|Withdrawal by Subject|3
1279106|NCT00397254|4177784|P2|Overall Study|Lost to Follow-up|2
1279107|NCT00397254|4177785|P1|Overall Study|Lost to Follow-up|2
1279108|NCT00397215|4177807|P4|Month 6 (Day 180)|Other|0
1279109|NCT00397215|4177808|P3|Month 6 (Day 180)|Other|3
1279110|NCT00397215|4177809|P2|Month 6 (Day 180)|Other|0
1279111|NCT00397215|4177810|P1|Month 6 (Day 180)|Other|2
1279112|NCT00397215|4177807|P4|Month 6 (Day 180)|Adverse Event|0
1279113|NCT00397215|4177808|P3|Month 6 (Day 180)|Adverse Event|2
1279114|NCT00397215|4177809|P2|Month 6 (Day 180)|Adverse Event|3
1279115|NCT00397215|4177810|P1|Month 6 (Day 180)|Adverse Event|0
1279116|NCT00397215|4177807|P4|Month 0 (Day 0)|Other|3
1279117|NCT00397215|4177808|P3|Month 0 (Day 0)|Other|3
1279118|NCT00397215|4177809|P2|Month 0 (Day 0)|Other|1
1279119|NCT00397215|4177810|P1|Month 0 (Day 0)|Other|4
1279120|NCT00397215|4177807|P4|Month 0 (Day 0)|Withdrawal by Subject|1
1279121|NCT00397215|4177808|P3|Month 0 (Day 0)|Withdrawal by Subject|3
1279122|NCT00397215|4177809|P2|Month 0 (Day 0)|Withdrawal by Subject|3
1279123|NCT00397215|4177810|P1|Month 0 (Day 0)|Withdrawal by Subject|3
1279124|NCT00397215|4177807|P4|Month 0 (Day 0)|Adverse Event|0
1279125|NCT00397215|4177808|P3|Month 0 (Day 0)|Adverse Event|0
1279126|NCT00397215|4177809|P2|Month 0 (Day 0)|Adverse Event|1
1279127|NCT00397215|4177810|P1|Month 0 (Day 0)|Adverse Event|0
1279128|NCT00397189|4177946|P2|3 Weeks Period|Other|2
1279129|NCT00397189|4177947|P1|3 Weeks Period|Other|0
1279130|NCT00397189|4177946|P2|3 Weeks Period|Protocol Violation|3
1279131|NCT00397189|4177947|P1|3 Weeks Period|Protocol Violation|0
1279132|NCT00397189|4177946|P2|3 Weeks Period|Physician Decision|2
1279133|NCT00397189|4177947|P1|3 Weeks Period|Physician Decision|0
1279134|NCT00397189|4177946|P2|3 Weeks Period|Withdrawal by Subject|9
1279135|NCT00397189|4177947|P1|3 Weeks Period|Withdrawal by Subject|13
1279136|NCT00397189|4177946|P2|3 Weeks Period|Adverse Event|2
1279137|NCT00397189|4177947|P1|3 Weeks Period|Adverse Event|3
1279138|NCT00397189|4177946|P2|3 Weeks Period|Lost to Follow-up|4
1279139|NCT00397189|4177947|P1|3 Weeks Period|Lost to Follow-up|5
1279140|NCT00397046|4177974|P4|Overall Study|Disease Progression|5
1279141|NCT00397046|4177975|P3|Overall Study|Disease Progression|10
1279142|NCT00397046|4177976|P2|Overall Study|Disease Progression|3
1279143|NCT00397046|4177977|P1|Overall Study|Disease Progression|3
1279144|NCT00397033|4177999|P3|Overall Study|Other|2
1279145|NCT00397033|4178000|P2|Overall Study|Other|5
1279146|NCT00397033|4178001|P1|Overall Study|Other|0
1279147|NCT00397033|4177999|P3|Overall Study|Withdrawal by Subject|5
1279148|NCT00397033|4178000|P2|Overall Study|Withdrawal by Subject|7
1279149|NCT00397033|4178001|P1|Overall Study|Withdrawal by Subject|12
1279150|NCT00397033|4177999|P3|Overall Study|Lost to Follow-up|3
1279151|NCT00397033|4178000|P2|Overall Study|Lost to Follow-up|3
1279152|NCT00397033|4178001|P1|Overall Study|Lost to Follow-up|3
1279153|NCT00397033|4177999|P3|Overall Study|Lack of Efficacy|9
1279154|NCT00397033|4178000|P2|Overall Study|Lack of Efficacy|12
1279155|NCT00397033|4178001|P1|Overall Study|Lack of Efficacy|22
1279156|NCT00397033|4177999|P3|Overall Study|Adverse Event|4
1279157|NCT00397033|4178000|P2|Overall Study|Adverse Event|10
1279158|NCT00397033|4178001|P1|Overall Study|Adverse Event|7
1279159|NCT00396877|4178083|P2|Overall Study|Parent(s)/guardian(s)'s request|7
1279160|NCT00396877|4178084|P1|Overall Study|Parent(s)/guardian(s)'s request|4
1279161|NCT00396877|4178083|P2|Overall Study|Lost to Follow-up|1
1279162|NCT00396877|4178084|P1|Overall Study|Lost to Follow-up|2
1279163|NCT00396812|4178094|P1|Overall Study|Physician Decision|1
1279164|NCT00396656|4178106|P2|Second Treatment Period|Adverse Event|1
1279165|NCT00396656|4178107|P1|Second Treatment Period|Adverse Event|0
1279166|NCT00396656|4178106|P2|First Treatment Period|Withdrawal by Subject|2
1279167|NCT00396656|4178107|P1|First Treatment Period|Withdrawal by Subject|0
1279168|NCT00396630|4178125|P2|Overall Study|Not vaccinated at Visit 3|3
1279169|NCT00396630|4178126|P1|Overall Study|Not vaccinated at Visit 3|3
1279170|NCT00396630|4178125|P2|Overall Study|Withdrawal by Subject|1
1279171|NCT00396630|4178126|P1|Overall Study|Withdrawal by Subject|1
1279172|NCT00396630|4178125|P2|Overall Study|Lost to Follow-up|1
1279173|NCT00396630|4178126|P1|Overall Study|Lost to Follow-up|1
1279174|NCT00396591|4178146|P1|Overall Study|Participant request|1
1279175|NCT00396591|4178146|P1|Overall Study|Adverse Event|2
1279176|NCT00396591|4178146|P1|Overall Study|Disease Progression|13
1279177|NCT00396565|4178159|P3|Overall Study|Lack of Efficacy|11
1279178|NCT00396565|4178160|P2|Overall Study|Lack of Efficacy|64
1279179|NCT00396565|4178161|P1|Overall Study|Lack of Efficacy|32
1279180|NCT00396565|4178159|P3|Overall Study|Withdrawal by Subject|1
1279181|NCT00396565|4178160|P2|Overall Study|Withdrawal by Subject|13
1279182|NCT00396565|4178161|P1|Overall Study|Withdrawal by Subject|8
1279183|NCT00396565|4178159|P3|Overall Study|Adverse Event|3
1279184|NCT00396565|4178160|P2|Overall Study|Adverse Event|13
1279185|NCT00396565|4178161|P1|Overall Study|Adverse Event|5
1279186|NCT00396565|4178159|P3|Overall Study|Physician Decision|2
1279187|NCT00396565|4178160|P2|Overall Study|Physician Decision|1
1279188|NCT00396565|4178161|P1|Overall Study|Physician Decision|3
1279189|NCT00396409|4178186|P2|Period 2 - 2008|Lost to Follow-up|1
1279190|NCT00396409|4178187|P1|Period 2 - 2008|Lost to Follow-up|3
1279191|NCT00396409|4178186|P2|Period 2 - 2008|Withdrawal by Subject|1
1279192|NCT00396409|4178187|P1|Period 2 - 2008|Withdrawal by Subject|3
1279193|NCT00396409|4178186|P2|Period 2 - 2008|Protocol Violation|0
1279194|NCT00396409|4178187|P1|Period 2 - 2008|Protocol Violation|1
1279195|NCT00396409|4178186|P2|Between Period 1 and Period 2|Withdrawal by Subject|2
1279196|NCT00396409|4178187|P1|Between Period 1 and Period 2|Withdrawal by Subject|3
1279197|NCT00396409|4178186|P2|Period 1 - 2007|Lost to Follow-up|3
1279198|NCT00396409|4178187|P1|Period 1 - 2007|Lost to Follow-up|2
1279199|NCT00396409|4178186|P2|Period 1 - 2007|Withdrawal by Subject|1
1279200|NCT00396409|4178187|P1|Period 1 - 2007|Withdrawal by Subject|1
1279201|NCT00396409|4178186|P2|Period 1 - 2007|Lack of Efficacy|1
1279202|NCT00396409|4178187|P1|Period 1 - 2007|Lack of Efficacy|0
1279203|NCT00396409|4178186|P2|Period 1 - 2007|Adverse Event|1
1279204|NCT00396409|4178187|P1|Period 1 - 2007|Adverse Event|0
1279205|NCT00396383|4178217|P1|Overall Study|Lost to Follow-up|1
1279206|NCT00396383|4178217|P1|Overall Study|Death|2
1279207|NCT00396331|4178230|P1|Overall Study|Death|16
1279208|NCT00396331|4178230|P1|Overall Study|Lost to Follow-up|3
1279209|NCT00396331|4178230|P1|Overall Study|Did not go on to transplant|5
1279210|NCT00396331|4178230|P1|Overall Study|Failed to mobilize - no transplant|8
1279211|NCT00396318|4178283|P1|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5
1279212|NCT00396279|4178303|P1|Overall Study|Physician Decision|1
1279213|NCT00396279|4178303|P1|Overall Study|Withdrawal by Subject|1
1279214|NCT00396279|4178303|P1|Overall Study|Disease progression|2
1279215|NCT00396279|4178303|P1|Overall Study|Ongoing in study|26
1279216|NCT00396253|4178336|P1|Overall Study|Change in eligibility status|1
1279217|NCT00396253|4178336|P1|Overall Study|Physician Decision|1
1279218|NCT00396253|4178336|P1|Overall Study|Death|3
1279219|NCT00396253|4178336|P1|Overall Study|Withdrawal by Subject|7
1279220|NCT00396253|4178336|P1|Overall Study|Protocol Violation|1
1279221|NCT00396162|4178367|P2|Overall Study|Withdrawal by Subject|3
1279222|NCT00396162|4178368|P1|Overall Study|Withdrawal by Subject|2
1279223|NCT00396136|4178380|P1|Overall Study|Study device explanted|8
1279224|NCT00396136|4178380|P1|Overall Study|Lost to Follow-up|15
1279225|NCT00396136|4178380|P1|Overall Study|Withdrawal by Subject|59
1279226|NCT00396136|4178380|P1|Overall Study|Death|43
1279227|NCT00396097|4178387|P2|Overall Study|Insufficient Clinical Response|4
1279228|NCT00396097|4178388|P1|Overall Study|Insufficient Clinical Response|1
1279229|NCT00396097|4178387|P2|Overall Study|Adverse Event|5
1279230|NCT00396097|4178388|P1|Overall Study|Adverse Event|1
1279231|NCT00396097|4178387|P2|Overall Study|Protocol Violation|6
1279232|NCT00396097|4178388|P1|Overall Study|Protocol Violation|0
1279233|NCT00396097|4178387|P2|Overall Study|Not specified|5
1279234|NCT00396097|4178388|P1|Overall Study|Not specified|3
1279235|NCT00396097|4178387|P2|Overall Study|Lost to Follow-up|9
1279236|NCT00396097|4178388|P1|Overall Study|Lost to Follow-up|4
1279237|NCT00396097|4178387|P2|Overall Study|Withdrawal by Subject|17
1279238|NCT00396097|4178388|P1|Overall Study|Withdrawal by Subject|17
1279239|NCT00396084|4178416|P6|Overall Study|Withdrawal by Subject|0
1279240|NCT00396084|4178417|P5|Overall Study|Withdrawal by Subject|0
1279241|NCT00396084|4178418|P4|Overall Study|Withdrawal by Subject|1
1279242|NCT00396084|4178419|P3|Overall Study|Withdrawal by Subject|0
1279243|NCT00396084|4178420|P2|Overall Study|Withdrawal by Subject|0
1279244|NCT00396084|4178421|P1|Overall Study|Withdrawal by Subject|0
1279245|NCT00396084|4178416|P6|Overall Study|Adverse Event|2
1279246|NCT00396084|4178417|P5|Overall Study|Adverse Event|1
1279247|NCT00396084|4178418|P4|Overall Study|Adverse Event|0
1279248|NCT00396084|4178419|P3|Overall Study|Adverse Event|0
1279249|NCT00396084|4178420|P2|Overall Study|Adverse Event|0
1279250|NCT00396084|4178421|P1|Overall Study|Adverse Event|0
1279251|NCT00395967|4178550|P1|Follow-up Period|Lost to Follow-up|1
1279252|NCT00395967|4178550|P1|Follow-up Period|Death|1
1279253|NCT00395967|4178550|P1|Treatment Period|Failed Mobilization|1
1279254|NCT00395863|4178590|P2|Overall Study|Patients did not complete both exams|3
1279255|NCT00395863|4178591|P1|Overall Study|Patients did not complete both exams|2
1279256|NCT00395850|4178626|P4|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
1279257|NCT00395850|4178627|P3|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
1279258|NCT00395850|4178628|P2|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
1279259|NCT00395850|4178629|P1|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1
1279260|NCT00395850|4178626|P4|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
1279261|NCT00395850|4178627|P3|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
1279262|NCT00395850|4178628|P2|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
1279263|NCT00395850|4178629|P1|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1
1279264|NCT00395850|4178626|P4|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
1279265|NCT00395850|4178627|P3|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
1279266|NCT00395850|4178628|P2|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
1279267|NCT00395850|4178629|P1|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1
1279268|NCT00395850|4178626|P4|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4
1279269|NCT00395850|4178627|P3|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6
1279270|NCT00395850|4178628|P2|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
1279271|NCT00395850|4178629|P1|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
1279272|NCT00395850|4178626|P4|Pre-randomization Baseline/Induction|Inconsistent attendance|0
1279273|NCT00395850|4178627|P3|Pre-randomization Baseline/Induction|Inconsistent attendance|0
1279274|NCT00395850|4178628|P2|Pre-randomization Baseline/Induction|Inconsistent attendance|0
1279275|NCT00395850|4178629|P1|Pre-randomization Baseline/Induction|Inconsistent attendance|1
1279276|NCT00395850|4178626|P4|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
1279277|NCT00395850|4178627|P3|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
1279278|NCT00395850|4178628|P2|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
1279279|NCT00395850|4178629|P1|Pre-randomization Baseline/Induction|Withdrawal by Subject|4
1279280|NCT00395850|4178626|P4|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
1279281|NCT00395850|4178627|P3|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
1279282|NCT00395850|4178628|P2|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
1279283|NCT00395850|4178629|P1|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6
1279284|NCT00395746|4178646|P3|Overall Study|Unable to visit site on schedule|0
1279285|NCT00395746|4178647|P2|Overall Study|Unable to visit site on schedule|0
1279286|NCT00395746|4178648|P1|Overall Study|Unable to visit site on schedule|1
1279287|NCT00395746|4178646|P3|Overall Study|Difficultulty in use of device|1
1279288|NCT00395746|4178647|P2|Overall Study|Difficultulty in use of device|0
1279289|NCT00395746|4178648|P1|Overall Study|Difficultulty in use of device|0
1279290|NCT00395746|4178646|P3|Overall Study|Withdrawal of consent|1
1279291|NCT00395746|4178647|P2|Overall Study|Withdrawal of consent|0
1279292|NCT00395746|4178648|P1|Overall Study|Withdrawal of consent|0
1279293|NCT00395746|4178646|P3|Overall Study|Subject decision|1
1279294|NCT00395746|4178647|P2|Overall Study|Subject decision|0
1279295|NCT00395746|4178648|P1|Overall Study|Subject decision|0
1279296|NCT00395746|4178646|P3|Overall Study|Hypoglycaemia|0
1279297|NCT00395746|4178647|P2|Overall Study|Hypoglycaemia|1
1279298|NCT00395746|4178648|P1|Overall Study|Hypoglycaemia|2
1279299|NCT00395746|4178646|P3|Overall Study|Lack of Efficacy|17
1279300|NCT00395746|4178647|P2|Overall Study|Lack of Efficacy|0
1279301|NCT00395746|4178648|P1|Overall Study|Lack of Efficacy|2
1279302|NCT00395746|4178646|P3|Overall Study|Protocol Violation|0
1279303|NCT00395746|4178647|P2|Overall Study|Protocol Violation|1
1279304|NCT00395746|4178648|P1|Overall Study|Protocol Violation|0
1279305|NCT00395746|4178646|P3|Overall Study|Adverse Event|2
1279306|NCT00395746|4178647|P2|Overall Study|Adverse Event|2
1279307|NCT00395746|4178648|P1|Overall Study|Adverse Event|5
1279308|NCT00395733|4178694|P2|Period 2|Technical problems|0
1279309|NCT00395733|4178695|P1|Period 2|Technical problems|1
1279310|NCT00395733|4178694|P2|Period 2|Adverse Event|2
1279311|NCT00395733|4178695|P1|Period 2|Adverse Event|0
1279312|NCT00395733|4178694|P2|Period 2|Protocol Violation|1
1279313|NCT00395733|4178695|P1|Period 2|Protocol Violation|0
1279314|NCT00395733|4178694|P2|Period 2|Withdrawal by Subject|2
1279315|NCT00395733|4178695|P1|Period 2|Withdrawal by Subject|1
1279316|NCT00395694|4178719|P2|Continuation Phase|Withdrawal by Subject|2
1279317|NCT00395694|4178720|P1|Continuation Phase|Withdrawal by Subject|0
1279318|NCT00395694|4178719|P2|Continuation Phase|Poor Compliance|0
1279319|NCT00395694|4178720|P1|Continuation Phase|Poor Compliance|1
1279320|NCT00395694|4178719|P2|Continuation Phase|Withdrawal Due to Wishes of Family|0
1279321|NCT00395694|4178720|P1|Continuation Phase|Withdrawal Due to Wishes of Family|1
1279322|NCT00395694|4178719|P2|Continuation Phase|Lack of Efficacy|11
1279323|NCT00395694|4178720|P1|Continuation Phase|Lack of Efficacy|12
1279324|NCT00395694|4178719|P2|Continuation Phase|Adverse Event|0
1279325|NCT00395694|4178720|P1|Continuation Phase|Adverse Event|1
1279326|NCT00395694|4178719|P2|Escalation Phase + Maintenance Phase|Adverse Event|2
1279327|NCT00395694|4178720|P1|Escalation Phase + Maintenance Phase|Adverse Event|1
1279328|NCT00395642|4178751|P1|Overall Study|Withdrawal by Subject|1
1279329|NCT00395642|4178751|P1|Overall Study|Physician Decision|7
1279330|NCT00395642|4178751|P1|Overall Study|Lost to Follow-up|1
1279331|NCT00395642|4178751|P1|Overall Study|Death|4
1279332|NCT00395629|4178758|P3|Extension Study|Administrative problems|1
1279333|NCT00395629|4178759|P2|Extension Study|Administrative problems|0
1279334|NCT00395629|4178760|P1|Extension Study|Administrative problems|0
1279335|NCT00395629|4178758|P3|Extension Study|Adverse Event|2
1279336|NCT00395629|4178759|P2|Extension Study|Adverse Event|0
1279337|NCT00395629|4178760|P1|Extension Study|Adverse Event|0
1279338|NCT00395629|4178758|P3|Core Study|Lost to Follow-up|1
1279339|NCT00395629|4178759|P2|Core Study|Lost to Follow-up|0
1279340|NCT00395629|4178760|P1|Core Study|Lost to Follow-up|0
1279341|NCT00395629|4178758|P3|Core Study|Withdrawal by Subject|1
1279342|NCT00395629|4178759|P2|Core Study|Withdrawal by Subject|1
1279343|NCT00395629|4178760|P1|Core Study|Withdrawal by Subject|0
1279344|NCT00395629|4178758|P3|Core Study|Protocol Violation|0
1279345|NCT00395629|4178759|P2|Core Study|Protocol Violation|0
1279346|NCT00395629|4178760|P1|Core Study|Protocol Violation|1
1279347|NCT00395629|4178758|P3|Core Study|Abnormal laboratory value(s)|1
1279348|NCT00395629|4178759|P2|Core Study|Abnormal laboratory value(s)|0
1279349|NCT00395629|4178760|P1|Core Study|Abnormal laboratory value(s)|0
1279350|NCT00395629|4178758|P3|Core Study|Adverse Event|4
1279351|NCT00395629|4178759|P2|Core Study|Adverse Event|3
1279352|NCT00395629|4178760|P1|Core Study|Adverse Event|0
1279353|NCT00395512|4178778|P4|Overall Study|Hyperglycemic Rescue|6
1279354|NCT00395512|4178779|P3|Overall Study|Hyperglycemic Rescue|4
1279355|NCT00395512|4178780|P2|Overall Study|Hyperglycemic Rescue|10
1279356|NCT00395512|4178781|P1|Overall Study|Hyperglycemic Rescue|18
1279357|NCT00395512|4178778|P4|Overall Study|Other|0
1279358|NCT00395512|4178779|P3|Overall Study|Other|0
1279359|NCT00395512|4178780|P2|Overall Study|Other|1
1279360|NCT00395512|4178781|P1|Overall Study|Other|1
1279361|NCT00395512|4178778|P4|Overall Study|Physician Decision|2
1279362|NCT00395512|4178779|P3|Overall Study|Physician Decision|2
1279363|NCT00395512|4178780|P2|Overall Study|Physician Decision|4
1279364|NCT00395512|4178781|P1|Overall Study|Physician Decision|6
1279365|NCT00395512|4178778|P4|Overall Study|Withdrawal by Subject|12
1279366|NCT00395512|4178779|P3|Overall Study|Withdrawal by Subject|5
1279367|NCT00395512|4178780|P2|Overall Study|Withdrawal by Subject|5
1279368|NCT00395512|4178781|P1|Overall Study|Withdrawal by Subject|6
1279369|NCT00395512|4178778|P4|Overall Study|Lost to Follow-up|5
1279370|NCT00395512|4178779|P3|Overall Study|Lost to Follow-up|5
1279371|NCT00395512|4178780|P2|Overall Study|Lost to Follow-up|6
1279372|NCT00395512|4178781|P1|Overall Study|Lost to Follow-up|2
1279373|NCT00395512|4178778|P4|Overall Study|Protocol Violation|7
1279374|NCT00395512|4178779|P3|Overall Study|Protocol Violation|6
1279375|NCT00395512|4178780|P2|Overall Study|Protocol Violation|3
1279376|NCT00395512|4178781|P1|Overall Study|Protocol Violation|2
1279377|NCT00395512|4178778|P4|Overall Study|Adverse Event|6
1279378|NCT00395512|4178779|P3|Overall Study|Adverse Event|6
1279379|NCT00395512|4178780|P2|Overall Study|Adverse Event|8
1279380|NCT00395512|4178781|P1|Overall Study|Adverse Event|3
1279381|NCT00395486|4178953|P2|Overall Study|Lost to Follow-up|1
1279382|NCT00395486|4178954|P1|Overall Study|Lost to Follow-up|0
1279383|NCT00395486|4178953|P2|Overall Study|Withdrawal by Subject|2
1279384|NCT00395486|4178954|P1|Overall Study|Withdrawal by Subject|5
1279385|NCT00395486|4178953|P2|Overall Study|Adverse Event|2
1279386|NCT00395486|4178954|P1|Overall Study|Adverse Event|1
1279387|NCT00395460|4178984|P2|Overall Study|Withdrawal by Subject|0
1279388|NCT00395460|4178985|P1|Overall Study|Withdrawal by Subject|1
1279389|NCT00395447|4179009|P2|Overall Study|Withdrawl - Other (not subject)|17
1279390|NCT00395447|4179010|P1|Overall Study|Withdrawl - Other (not subject)|8
1279391|NCT00395447|4179009|P2|Overall Study|Withdrawal by Subject|19
1279392|NCT00395447|4179010|P1|Overall Study|Withdrawal by Subject|24
1279393|NCT00395447|4179009|P2|Overall Study|Lost to Follow-up|43
1279394|NCT00395447|4179010|P1|Overall Study|Lost to Follow-up|52
1279395|NCT00395447|4179009|P2|Overall Study|Death|32
1279396|NCT00395447|4179010|P1|Overall Study|Death|37
1279397|NCT00395343|4179018|P2|Overall Study|Other|2
1279398|NCT00395343|4179019|P1|Overall Study|Other|5
1279399|NCT00395343|4179018|P2|Overall Study|Withdrawal by Subject|12
1279400|NCT00395343|4179019|P1|Overall Study|Withdrawal by Subject|11
1279401|NCT00395343|4179018|P2|Overall Study|Protocol Violation|8
1279402|NCT00395343|4179019|P1|Overall Study|Protocol Violation|6
1279403|NCT00395343|4179018|P2|Overall Study|Physician Decision|4
1279404|NCT00395343|4179019|P1|Overall Study|Physician Decision|2
1279405|NCT00395343|4179018|P2|Overall Study|Lost to Follow-up|4
1279406|NCT00395343|4179019|P1|Overall Study|Lost to Follow-up|4
1279407|NCT00395343|4179018|P2|Overall Study|Lack of Efficacy|1
1279408|NCT00395343|4179019|P1|Overall Study|Lack of Efficacy|0
1279409|NCT00395343|4179018|P2|Overall Study|Adverse Event|5
1279410|NCT00395343|4179019|P1|Overall Study|Adverse Event|13
1279411|NCT00395304|4179037|P6|Treatment Period 3|Other|0
1279412|NCT00395304|4179038|P5|Treatment Period 3|Other|0
1279413|NCT00395304|4179039|P4|Treatment Period 3|Other|1
1279414|NCT00395304|4179040|P3|Treatment Period 3|Other|0
1279415|NCT00395304|4179041|P2|Treatment Period 3|Other|0
1279416|NCT00395304|4179042|P1|Treatment Period 3|Other|0
1279417|NCT00395304|4179037|P6|Treatment Period 3|Physician Decision|0
1279418|NCT00395304|4179038|P5|Treatment Period 3|Physician Decision|0
1279419|NCT00395304|4179039|P4|Treatment Period 3|Physician Decision|0
1279420|NCT00395304|4179040|P3|Treatment Period 3|Physician Decision|0
1279421|NCT00395304|4179041|P2|Treatment Period 3|Physician Decision|1
1279422|NCT00395304|4179042|P1|Treatment Period 3|Physician Decision|0
1279423|NCT00395304|4179037|P6|Treatment Period 3|Lost to Follow-up|0
1279424|NCT00395304|4179038|P5|Treatment Period 3|Lost to Follow-up|0
1279425|NCT00395304|4179039|P4|Treatment Period 3|Lost to Follow-up|0
1279426|NCT00395304|4179040|P3|Treatment Period 3|Lost to Follow-up|0
1279427|NCT00395304|4179041|P2|Treatment Period 3|Lost to Follow-up|1
1279428|NCT00395304|4179042|P1|Treatment Period 3|Lost to Follow-up|1
1279429|NCT00395304|4179037|P6|Treatment Period 3|Withdrawal by Subject|1
1279430|NCT00395304|4179038|P5|Treatment Period 3|Withdrawal by Subject|0
1279431|NCT00395304|4179039|P4|Treatment Period 3|Withdrawal by Subject|1
1279432|NCT00395304|4179040|P3|Treatment Period 3|Withdrawal by Subject|0
1279433|NCT00395304|4179041|P2|Treatment Period 3|Withdrawal by Subject|0
1279434|NCT00395304|4179042|P1|Treatment Period 3|Withdrawal by Subject|0
1279435|NCT00395304|4179037|P6|Treatment Period 2|Other|0
1279436|NCT00395304|4179038|P5|Treatment Period 2|Other|0
1279437|NCT00395304|4179039|P4|Treatment Period 2|Other|0
1279438|NCT00395304|4179040|P3|Treatment Period 2|Other|0
1279439|NCT00395304|4179041|P2|Treatment Period 2|Other|1
1279440|NCT00395304|4179042|P1|Treatment Period 2|Other|0
1279441|NCT00395304|4179037|P6|Treatment Period 2|Physician Decision|0
1279442|NCT00395304|4179038|P5|Treatment Period 2|Physician Decision|0
1279443|NCT00395304|4179039|P4|Treatment Period 2|Physician Decision|0
1279444|NCT00395304|4179040|P3|Treatment Period 2|Physician Decision|1
1279445|NCT00395304|4179041|P2|Treatment Period 2|Physician Decision|0
1279446|NCT00395304|4179042|P1|Treatment Period 2|Physician Decision|0
1279447|NCT00395304|4179037|P6|Treatment Period 2|Lost to Follow-up|0
1279448|NCT00395304|4179038|P5|Treatment Period 2|Lost to Follow-up|0
1279449|NCT00395304|4179039|P4|Treatment Period 2|Lost to Follow-up|0
1279450|NCT00395304|4179040|P3|Treatment Period 2|Lost to Follow-up|0
1279451|NCT00395304|4179041|P2|Treatment Period 2|Lost to Follow-up|3
1279452|NCT00395304|4179042|P1|Treatment Period 2|Lost to Follow-up|0
1279453|NCT00395304|4179037|P6|Treatment Period 2|Withdrawal by Subject|2
1279454|NCT00395304|4179038|P5|Treatment Period 2|Withdrawal by Subject|0
1279455|NCT00395304|4179039|P4|Treatment Period 2|Withdrawal by Subject|1
1279456|NCT00395304|4179040|P3|Treatment Period 2|Withdrawal by Subject|0
1279457|NCT00395304|4179041|P2|Treatment Period 2|Withdrawal by Subject|0
1279458|NCT00395304|4179042|P1|Treatment Period 2|Withdrawal by Subject|0
1279459|NCT00395304|4179037|P6|Treatment Period 1|Physician Decision|0
1279460|NCT00395304|4179038|P5|Treatment Period 1|Physician Decision|0
1279461|NCT00395304|4179039|P4|Treatment Period 1|Physician Decision|0
1279462|NCT00395304|4179040|P3|Treatment Period 1|Physician Decision|0
1279463|NCT00395304|4179041|P2|Treatment Period 1|Physician Decision|1
1279464|NCT00395304|4179042|P1|Treatment Period 1|Physician Decision|0
1279465|NCT00395304|4179037|P6|Treatment Period 1|Lost to Follow-up|1
1279466|NCT00395304|4179038|P5|Treatment Period 1|Lost to Follow-up|0
1279467|NCT00395304|4179039|P4|Treatment Period 1|Lost to Follow-up|1
1279468|NCT00395304|4179040|P3|Treatment Period 1|Lost to Follow-up|0
1279469|NCT00395304|4179041|P2|Treatment Period 1|Lost to Follow-up|0
1279470|NCT00395304|4179042|P1|Treatment Period 1|Lost to Follow-up|1
1279471|NCT00395304|4179037|P6|Treatment Period 1|Withdrawal by Subject|1
1279472|NCT00395304|4179038|P5|Treatment Period 1|Withdrawal by Subject|1
1279473|NCT00395304|4179039|P4|Treatment Period 1|Withdrawal by Subject|2
1279474|NCT00395304|4179040|P3|Treatment Period 1|Withdrawal by Subject|0
1279475|NCT00395304|4179041|P2|Treatment Period 1|Withdrawal by Subject|3
1279476|NCT00395304|4179042|P1|Treatment Period 1|Withdrawal by Subject|0
1279477|NCT00395226|4179118|P2|Overall Study|Lost to Follow-up|1
1279478|NCT00395226|4179119|P1|Overall Study|Lost to Follow-up|0
1279479|NCT00395226|4179118|P2|Overall Study|Withdrawal by Subject|1
1279480|NCT00395226|4179119|P1|Overall Study|Withdrawal by Subject|0
1279481|NCT00395226|4179118|P2|Overall Study|Adverse Event|3
1279482|NCT00395226|4179119|P1|Overall Study|Adverse Event|4
1279483|NCT00395083|4179166|P2|Overall Study|Developed another disease|3
1279484|NCT00395083|4179167|P1|Overall Study|Developed another disease|4
1279485|NCT00395083|4179166|P2|Overall Study|Withdrawal by Subject|5
1279486|NCT00395083|4179167|P1|Overall Study|Withdrawal by Subject|6
1279487|NCT00395018|4179233|P1|Off-Treatment Follow-up|Poor/non-compliance|1
1279488|NCT00395018|4179233|P1|Off-Treatment Follow-up|Lost to Follow-up|2
1279489|NCT00395018|4179233|P1|Off-Treatment Follow-up|Followup no longer required per protocol|1
1279490|NCT00395018|4179233|P1|On-Treatment|Subject no longer meets study criteria|2
1279491|NCT00395018|4179233|P1|On-Treatment|Poor/non-compliance|2
1279492|NCT00395018|4179233|P1|On-Treatment|Other Reason|2
1279493|NCT00395018|4179233|P1|On-Treatment|Death|4
1279494|NCT00394953|4179254|P2|Second Treatment Period|Not defined|8
1279495|NCT00394953|4179255|P1|Second Treatment Period|Not defined|3
1279496|NCT00394953|4179254|P2|Second Treatment Period|Renal transplant|6
1279497|NCT00394953|4179255|P1|Second Treatment Period|Renal transplant|4
1279498|NCT00394953|4179254|P2|Second Treatment Period|Lost to Follow-up|1
1279499|NCT00394953|4179255|P1|Second Treatment Period|Lost to Follow-up|0
1279500|NCT00394953|4179254|P2|Second Treatment Period|Withdrawal by Subject|3
1279501|NCT00394953|4179255|P1|Second Treatment Period|Withdrawal by Subject|3
1279502|NCT00394953|4179254|P2|Second Treatment Period|Lack of Efficacy|47
1279503|NCT00394953|4179255|P1|Second Treatment Period|Lack of Efficacy|9
1279504|NCT00394953|4179254|P2|Second Treatment Period|Death|4
1279505|NCT00394953|4179255|P1|Second Treatment Period|Death|8
1279506|NCT00394953|4179254|P2|Second Treatment Period|Adverse Event|5
1279507|NCT00394953|4179255|P1|Second Treatment Period|Adverse Event|2
1279508|NCT00394953|4179254|P2|First Treatment Period|Not defined|1
1279509|NCT00394953|4179255|P1|First Treatment Period|Not defined|4
1279510|NCT00394953|4179254|P2|First Treatment Period|Renal transplant|7
1279511|NCT00394953|4179255|P1|First Treatment Period|Renal transplant|11
1279512|NCT00394953|4179254|P2|First Treatment Period|Lost to Follow-up|1
1279513|NCT00394953|4179255|P1|First Treatment Period|Lost to Follow-up|0
1279514|NCT00394953|4179254|P2|First Treatment Period|Withdrawal by Subject|3
1279515|NCT00394953|4179255|P1|First Treatment Period|Withdrawal by Subject|6
1279516|NCT00394953|4179254|P2|First Treatment Period|Lack of Efficacy|1
1279517|NCT00394953|4179255|P1|First Treatment Period|Lack of Efficacy|1
1279518|NCT00394953|4179254|P2|First Treatment Period|Death|7
1279519|NCT00394953|4179255|P1|First Treatment Period|Death|6
1279520|NCT00394953|4179254|P2|First Treatment Period|Adverse Event|2
1279521|NCT00394953|4179255|P1|First Treatment Period|Adverse Event|1
1279522|NCT00394914|4179273|P3|Treatment Period|Did not meet protocol eligibility|1
1279523|NCT00394914|4179274|P2|Treatment Period|Did not meet protocol eligibility|1
1279524|NCT00394914|4179275|P1|Treatment Period|Did not meet protocol eligibility|0
1279525|NCT00394914|4179273|P3|Treatment Period|Noncompliance with protocol|2
1279526|NCT00394914|4179274|P2|Treatment Period|Noncompliance with protocol|3
1279527|NCT00394914|4179275|P1|Treatment Period|Noncompliance with protocol|0
1279528|NCT00394914|4179273|P3|Treatment Period|Withdrawal by Subject|2
1279529|NCT00394914|4179274|P2|Treatment Period|Withdrawal by Subject|2
1279530|NCT00394914|4179275|P1|Treatment Period|Withdrawal by Subject|0
1279531|NCT00394914|4179273|P3|Treatment Period|Lost to Follow-up|0
1279532|NCT00394914|4179274|P2|Treatment Period|Lost to Follow-up|1
1279533|NCT00394914|4179275|P1|Treatment Period|Lost to Follow-up|0
1279534|NCT00394914|4179273|P3|Treatment Period|Adverse Event|1
1279535|NCT00394914|4179274|P2|Treatment Period|Adverse Event|3
1279536|NCT00394914|4179275|P1|Treatment Period|Adverse Event|0
1279537|NCT00394901|4179303|P4|Double-blind Phase|Found not to meet entrance criteria|1
1279538|NCT00394901|4179304|P3|Double-blind Phase|Found not to meet entrance criteria|0
1279539|NCT00394901|4179305|P2|Double-blind Phase|Found not to meet entrance criteria|0
1279540|NCT00394901|4179306|P1|Double-blind Phase|Found not to meet entrance criteria|0
1279541|NCT00394901|4179303|P4|Double-blind Phase|Entry into another study was found|0
1279542|NCT00394901|4179304|P3|Double-blind Phase|Entry into another study was found|1
1279543|NCT00394901|4179305|P2|Double-blind Phase|Entry into another study was found|0
1279544|NCT00394901|4179306|P1|Double-blind Phase|Entry into another study was found|0
1279545|NCT00394901|4179303|P4|Double-blind Phase|Lack of Compliance|0
1279546|NCT00394901|4179304|P3|Double-blind Phase|Lack of Compliance|0
1279547|NCT00394901|4179305|P2|Double-blind Phase|Lack of Compliance|3
1279548|NCT00394901|4179306|P1|Double-blind Phase|Lack of Compliance|0
1279549|NCT00394901|4179303|P4|Double-blind Phase|Subject's Personal Reason|1
1279550|NCT00394901|4179304|P3|Double-blind Phase|Subject's Personal Reason|0
1279551|NCT00394901|4179305|P2|Double-blind Phase|Subject's Personal Reason|0
1279552|NCT00394901|4179306|P1|Double-blind Phase|Subject's Personal Reason|1
1279553|NCT00394901|4179303|P4|Double-blind Phase|Death|0
1279554|NCT00394901|4179304|P3|Double-blind Phase|Death|0
1279555|NCT00394901|4179305|P2|Double-blind Phase|Death|0
1279556|NCT00394901|4179306|P1|Double-blind Phase|Death|1
1279557|NCT00394901|4179303|P4|Double-blind Phase|Protocol Violation|1
1279558|NCT00394901|4179304|P3|Double-blind Phase|Protocol Violation|0
1279559|NCT00394901|4179305|P2|Double-blind Phase|Protocol Violation|0
1279560|NCT00394901|4179306|P1|Double-blind Phase|Protocol Violation|0
1279561|NCT00394901|4179303|P4|Double-blind Phase|Lost to Follow-up|1
1279562|NCT00394901|4179304|P3|Double-blind Phase|Lost to Follow-up|0
1279563|NCT00394901|4179305|P2|Double-blind Phase|Lost to Follow-up|0
1279564|NCT00394901|4179306|P1|Double-blind Phase|Lost to Follow-up|0
1279565|NCT00394901|4179303|P4|Double-blind Phase|Withdrawal by Subject|0
1279566|NCT00394901|4179304|P3|Double-blind Phase|Withdrawal by Subject|0
1279567|NCT00394901|4179305|P2|Double-blind Phase|Withdrawal by Subject|0
1279568|NCT00394901|4179306|P1|Double-blind Phase|Withdrawal by Subject|2
1279569|NCT00394901|4179303|P4|Double-blind Phase|Lack of Efficacy|3
1279570|NCT00394901|4179304|P3|Double-blind Phase|Lack of Efficacy|1
1279571|NCT00394901|4179305|P2|Double-blind Phase|Lack of Efficacy|4
1279572|NCT00394901|4179306|P1|Double-blind Phase|Lack of Efficacy|6
1279573|NCT00394901|4179303|P4|Double-blind Phase|Adverse Event|20
1279574|NCT00394901|4179304|P3|Double-blind Phase|Adverse Event|16
1279575|NCT00394901|4179305|P2|Double-blind Phase|Adverse Event|7
1279576|NCT00394901|4179306|P1|Double-blind Phase|Adverse Event|5
1279577|NCT00394901|4179303|P4|Baseline Phase|Protocol Violation|0
1279578|NCT00394901|4179304|P3|Baseline Phase|Protocol Violation|1
1279579|NCT00394901|4179305|P2|Baseline Phase|Protocol Violation|0
1279580|NCT00394901|4179306|P1|Baseline Phase|Protocol Violation|0
1279581|NCT00394836|4179549|P2|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10
1279582|NCT00394836|4179550|P1|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7
1279583|NCT00394836|4179549|P2|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41
1279584|NCT00394836|4179550|P1|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13
1279585|NCT00394836|4179549|P2|Extended Follow-up Phase (2-5 Years)|Death|1
1279586|NCT00394836|4179550|P1|Extended Follow-up Phase (2-5 Years)|Death|0
1279587|NCT00394836|4179549|P2|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1
1279588|NCT00394836|4179550|P1|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0
1279589|NCT00394836|4179549|P2|Teatment or Follow-up Phase|Non compliance|1
1279590|NCT00394836|4179550|P1|Teatment or Follow-up Phase|Non compliance|0
1279591|NCT00394836|4179549|P2|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1
1279592|NCT00394836|4179550|P1|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0
1279593|NCT00394836|4179549|P2|Teatment or Follow-up Phase|Physician Decision|1
1279594|NCT00394836|4179550|P1|Teatment or Follow-up Phase|Physician Decision|0
1279595|NCT00394836|4179549|P2|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1
1279596|NCT00394836|4179550|P1|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0
1279597|NCT00394836|4179549|P2|Teatment or Follow-up Phase|Started alternative treatment|6
1279598|NCT00394836|4179550|P1|Teatment or Follow-up Phase|Started alternative treatment|0
1279599|NCT00394836|4179549|P2|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1
1279600|NCT00394836|4179550|P1|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0
1279601|NCT00394836|4179549|P2|Teatment or Follow-up Phase|Death|1
1279602|NCT00394836|4179550|P1|Teatment or Follow-up Phase|Death|0
1279603|NCT00394836|4179549|P2|Teatment or Follow-up Phase|Patient Refusal|2
1279604|NCT00394836|4179550|P1|Teatment or Follow-up Phase|Patient Refusal|1
1279605|NCT00394836|4179549|P2|Teatment or Follow-up Phase|Disease Progression|60
1279606|NCT00394836|4179550|P1|Teatment or Follow-up Phase|Disease Progression|27
1279607|NCT00394836|4179549|P2|Teatment or Follow-up Phase|Protocol Violation|2
1279608|NCT00394836|4179550|P1|Teatment or Follow-up Phase|Protocol Violation|0
1279609|NCT00394836|4179549|P2|Teatment or Follow-up Phase|Adverse Event|2
1279610|NCT00394836|4179550|P1|Teatment or Follow-up Phase|Adverse Event|0
1279611|NCT00394771|4179596|P4|Overall Study|Not specified|0
1279612|NCT00394771|4179597|P3|Overall Study|Not specified|1
1279613|NCT00394771|4179598|P2|Overall Study|Not specified|3
1279614|NCT00394771|4179599|P1|Overall Study|Not specified|3
1279615|NCT00394771|4179596|P4|Overall Study|Lost to Follow-up|10
1279616|NCT00394771|4179597|P3|Overall Study|Lost to Follow-up|13
1279617|NCT00394771|4179598|P2|Overall Study|Lost to Follow-up|15
1279618|NCT00394771|4179599|P1|Overall Study|Lost to Follow-up|15
1279619|NCT00394771|4179596|P4|Overall Study|Participant pregnant|2
1279620|NCT00394771|4179597|P3|Overall Study|Participant pregnant|2
1279621|NCT00394771|4179598|P2|Overall Study|Participant pregnant|1
1279622|NCT00394771|4179599|P1|Overall Study|Participant pregnant|0
1279623|NCT00394771|4179596|P4|Overall Study|Adverse Event|8
1279624|NCT00394771|4179597|P3|Overall Study|Adverse Event|12
1279625|NCT00394771|4179598|P2|Overall Study|Adverse Event|5
1279626|NCT00394771|4179599|P1|Overall Study|Adverse Event|10
1279627|NCT00394771|4179596|P4|Overall Study|Withdrawal by Subject|12
1279628|NCT00394771|4179597|P3|Overall Study|Withdrawal by Subject|8
1279629|NCT00394771|4179598|P2|Overall Study|Withdrawal by Subject|6
1279630|NCT00394771|4179599|P1|Overall Study|Withdrawal by Subject|10
1279631|NCT00394771|4179596|P4|Overall Study|Protocol Violation|7
1279632|NCT00394771|4179597|P3|Overall Study|Protocol Violation|9
1279633|NCT00394771|4179598|P2|Overall Study|Protocol Violation|4
1279634|NCT00394771|4179599|P1|Overall Study|Protocol Violation|2
1279635|NCT00394771|4179596|P4|Overall Study|Did not meet protocol requirements|0
1279636|NCT00394771|4179597|P3|Overall Study|Did not meet protocol requirements|2
1279637|NCT00394771|4179598|P2|Overall Study|Did not meet protocol requirements|0
1279638|NCT00394771|4179599|P1|Overall Study|Did not meet protocol requirements|1
1279639|NCT00394706|4179669|P8|Overall Study|Lost to Follow-up|0
1279640|NCT00394706|4179670|P7|Overall Study|Lost to Follow-up|2
1279641|NCT00394706|4179671|P6|Overall Study|Lost to Follow-up|5
1279642|NCT00394706|4179672|P5|Overall Study|Lost to Follow-up|2
1279643|NCT00394706|4179673|P4|Overall Study|Lost to Follow-up|1
1279644|NCT00394706|4179674|P3|Overall Study|Lost to Follow-up|8
1279645|NCT00394706|4179675|P2|Overall Study|Lost to Follow-up|2
1279646|NCT00394706|4179676|P1|Overall Study|Lost to Follow-up|2
1279647|NCT00394706|4179669|P8|Overall Study|Withdrawal by Subject|0
1279648|NCT00394706|4179670|P7|Overall Study|Withdrawal by Subject|1
1279649|NCT00394706|4179671|P6|Overall Study|Withdrawal by Subject|2
1279650|NCT00394706|4179672|P5|Overall Study|Withdrawal by Subject|0
1279651|NCT00394706|4179673|P4|Overall Study|Withdrawal by Subject|0
1279652|NCT00394706|4179674|P3|Overall Study|Withdrawal by Subject|1
1279653|NCT00394706|4179675|P2|Overall Study|Withdrawal by Subject|0
1279654|NCT00394706|4179676|P1|Overall Study|Withdrawal by Subject|2
1279655|NCT00394654|4179708|P2|Overall Study|PARTICIPANT LEFT STDUY REGION|0
1279656|NCT00394654|4179709|P1|Overall Study|PARTICIPANT LEFT STDUY REGION|1
1279657|NCT00394654|4179708|P2|Overall Study|Lost to Follow-up|0
1279658|NCT00394654|4179709|P1|Overall Study|Lost to Follow-up|1
1279659|NCT00394589|4179774|P3|Overall Study|Protocol Violation|2
1279660|NCT00394589|4179775|P2|Overall Study|Protocol Violation|0
1279661|NCT00394589|4179776|P1|Overall Study|Protocol Violation|4
1279662|NCT00394589|4179774|P3|Overall Study|Lack of Efficacy|3
1279663|NCT00394589|4179775|P2|Overall Study|Lack of Efficacy|2
1279664|NCT00394589|4179776|P1|Overall Study|Lack of Efficacy|2
1279665|NCT00394589|4179774|P3|Overall Study|Adverse Event|2
1279666|NCT00394589|4179775|P2|Overall Study|Adverse Event|1
1279667|NCT00394589|4179776|P1|Overall Study|Adverse Event|2
1279668|NCT00394524|4179786|P2|Overall Study|Withdrawal by Subject|1
1279669|NCT00394524|4179787|P1|Overall Study|Withdrawal by Subject|0
1279670|NCT00394524|4179786|P2|Overall Study|Death|0
1279671|NCT00394524|4179787|P1|Overall Study|Death|1
1279672|NCT00394524|4179786|P2|Overall Study|Protocol Violation|3
1279673|NCT00394524|4179787|P1|Overall Study|Protocol Violation|2
1279674|NCT00394472|4179801|P2|Overall Study|Lost to Follow-up|1
1279675|NCT00394472|4179802|P1|Overall Study|Lost to Follow-up|0
1279676|NCT00394472|4179801|P2|Overall Study|Physician Decision|1
1279677|NCT00394472|4179802|P1|Overall Study|Physician Decision|0
1279678|NCT00394472|4179801|P2|Overall Study|Withdrawal by Subject|2
1279679|NCT00394472|4179802|P1|Overall Study|Withdrawal by Subject|0
1279680|NCT00394472|4179801|P2|Overall Study|Adverse Event|2
1279681|NCT00394472|4179802|P1|Overall Study|Adverse Event|4
1279682|NCT00394472|4179801|P2|Overall Study|incorrect enrolment|2
1279683|NCT00394472|4179802|P1|Overall Study|incorrect enrolment|4
1279684|NCT00394472|4179801|P2|Overall Study|Protocol Violation|3
1279685|NCT00394472|4179802|P1|Overall Study|Protocol Violation|1
1279686|NCT00394433|4179810|P1|Overall Study|Alternative Therapy|1
1279687|NCT00394433|4179810|P1|Overall Study|Adverse Event|2
1279688|NCT00394355|4179821|P4|Overall Study|Lack of Efficacy|3
1279689|NCT00394355|4179822|P3|Overall Study|Lack of Efficacy|2
1279690|NCT00394355|4179823|P2|Overall Study|Lack of Efficacy|0
1279691|NCT00394355|4179824|P1|Overall Study|Lack of Efficacy|0
1279692|NCT00394355|4179821|P4|Overall Study|Administrative|1
1279693|NCT00394355|4179822|P3|Overall Study|Administrative|1
1279694|NCT00394355|4179823|P2|Overall Study|Administrative|1
1279695|NCT00394355|4179824|P1|Overall Study|Administrative|0
1279696|NCT00394355|4179821|P4|Overall Study|Noncompliance with protocol|8
1279697|NCT00394355|4179822|P3|Overall Study|Noncompliance with protocol|10
1279698|NCT00394355|4179823|P2|Overall Study|Noncompliance with protocol|3
1279699|NCT00394355|4179824|P1|Overall Study|Noncompliance with protocol|4
1279700|NCT00394355|4179821|P4|Overall Study|Lost to Follow-up|3
1279701|NCT00394355|4179822|P3|Overall Study|Lost to Follow-up|4
1279702|NCT00394355|4179823|P2|Overall Study|Lost to Follow-up|5
1279703|NCT00394355|4179824|P1|Overall Study|Lost to Follow-up|7
1279704|NCT00394355|4179821|P4|Overall Study|Subject withdrawal - related to drug|0
1279705|NCT00394355|4179822|P3|Overall Study|Subject withdrawal - related to drug|0
1279706|NCT00394355|4179823|P2|Overall Study|Subject withdrawal - related to drug|0
1279707|NCT00394355|4179824|P1|Overall Study|Subject withdrawal - related to drug|1
1279708|NCT00394355|4179821|P4|Overall Study|Subject withdrawal - unrelated to drug|6
1279709|NCT00394355|4179822|P3|Overall Study|Subject withdrawal - unrelated to drug|10
1279710|NCT00394355|4179823|P2|Overall Study|Subject withdrawal - unrelated to drug|14
1279711|NCT00394355|4179824|P1|Overall Study|Subject withdrawal - unrelated to drug|12
1279712|NCT00394355|4179821|P4|Overall Study|Did not meet protocol eligibility|2
1279713|NCT00394355|4179822|P3|Overall Study|Did not meet protocol eligibility|4
1279714|NCT00394355|4179823|P2|Overall Study|Did not meet protocol eligibility|5
1279715|NCT00394355|4179824|P1|Overall Study|Did not meet protocol eligibility|1
1279716|NCT00394355|4179821|P4|Overall Study|Adverse Event|8
1279717|NCT00394355|4179822|P3|Overall Study|Adverse Event|7
1279718|NCT00394355|4179823|P2|Overall Study|Adverse Event|6
1279719|NCT00394355|4179824|P1|Overall Study|Adverse Event|10
1279720|NCT00394251|4179930|P2|Overall Study|Non-compliance, pt moved, pt/inv agree|2
1279721|NCT00394251|4179931|P1|Overall Study|Non-compliance, pt moved, pt/inv agree|2
1279722|NCT00394251|4179930|P2|Overall Study|Withdrawal by Subject|11
1279723|NCT00394251|4179931|P1|Overall Study|Withdrawal by Subject|7
1279724|NCT00394251|4179930|P2|Overall Study|Protocol Violation|1
1279725|NCT00394251|4179931|P1|Overall Study|Protocol Violation|0
1279726|NCT00394251|4179930|P2|Overall Study|Physician Decision|1
1279727|NCT00394251|4179931|P1|Overall Study|Physician Decision|1
1279728|NCT00394251|4179930|P2|Overall Study|Unacceptable Toxicity|18
1279729|NCT00394251|4179931|P1|Overall Study|Unacceptable Toxicity|20
1279730|NCT00394251|4179930|P2|Overall Study|Adverse Event|5
1279731|NCT00394251|4179931|P1|Overall Study|Adverse Event|7
1279732|NCT00394212|4179959|P2|Overall Study|Withdrawal by Subject|1
1279733|NCT00394212|4179960|P1|Overall Study|Withdrawal by Subject|4
1279734|NCT00394212|4179959|P2|Overall Study|Lost to Follow-up|0
1279735|NCT00394212|4179960|P1|Overall Study|Lost to Follow-up|3
1279736|NCT00394095|4179974|P2|Overall Study|Adverse Event|0
1279737|NCT00394095|4179975|P1|Overall Study|Adverse Event|1
1279738|NCT00394082|4179983|P1|Overall Study|Not specified|1
1279739|NCT00394082|4179983|P1|Overall Study|Withdrawal by Subject|2
1279740|NCT00394082|4179983|P1|Overall Study|Physician Decision|4
1279741|NCT00394082|4179983|P1|Overall Study|Adverse Event|4
1279742|NCT00394082|4179983|P1|Overall Study|Unacceptable toxicity|15
1279743|NCT00393939|4180005|P2|Overall Study|Not specified|45
1279744|NCT00393939|4180006|P1|Overall Study|Not specified|37
1279745|NCT00393939|4180005|P2|Overall Study|Withdrawal by Subject|7
1279746|NCT00393939|4180006|P1|Overall Study|Withdrawal by Subject|2
1279747|NCT00393939|4180005|P2|Overall Study|Objective progression or relapse|223
1279748|NCT00393939|4180006|P1|Overall Study|Objective progression or relapse|239
1279749|NCT00393939|4180005|P2|Overall Study|Sponsor|13
1279750|NCT00393939|4180006|P1|Overall Study|Sponsor|5
1279751|NCT00393939|4180005|P2|Overall Study|Death|4
1279752|NCT00393939|4180006|P1|Overall Study|Death|10
1279753|NCT00393939|4180005|P2|Overall Study|Lost to Follow-up|4
1279754|NCT00393939|4180006|P1|Overall Study|Lost to Follow-up|2
1279755|NCT00393939|4180005|P2|Overall Study|Protocol Violation|1
1279756|NCT00393939|4180006|P1|Overall Study|Protocol Violation|1
1279757|NCT00393913|4180024|P1|CPAP|TEchnical problem with CPAP|3
1279758|NCT00393913|4180024|P1|CPAP|Physician Decision|1
1279759|NCT00393913|4180024|P1|CPAP|Withdrawal by Subject|3
1279760|NCT00393913|4180024|P1|Initial Assessment|Withdrawal by Subject|16
1279761|NCT00393913|4180024|P1|Initial Assessment|diagnosed with other sleep disorder|21
1279762|NCT00393887|4180032|P2|Overall Study|Lost to Follow-up|9
1279763|NCT00393887|4180033|P1|Overall Study|Lost to Follow-up|11
1279764|NCT00393887|4180032|P2|Overall Study|Physician Decision|0
1279765|NCT00393887|4180033|P1|Overall Study|Physician Decision|5
1279766|NCT00393861|4180061|P1|Overall Study|Disease Progression|24
1279767|NCT00393861|4180061|P1|Overall Study|Adverse Event|2
1279768|NCT00393848|4180072|P4|Overall Study|Personal reasons|0
1279769|NCT00393848|4180073|P3|Overall Study|Personal reasons|2
1279770|NCT00393848|4180074|P2|Overall Study|Personal reasons|0
1279771|NCT00393848|4180075|P1|Overall Study|Personal reasons|0
1279772|NCT00393848|4180072|P4|Overall Study|Surgical schedule|1
1279773|NCT00393848|4180073|P3|Overall Study|Surgical schedule|0
1279774|NCT00393848|4180074|P2|Overall Study|Surgical schedule|0
1279775|NCT00393848|4180075|P1|Overall Study|Surgical schedule|0
1279776|NCT00393718|4180098|P2|Overall Study|Move|0
1279777|NCT00393718|4180099|P1|Overall Study|Move|1
1279778|NCT00393718|4180098|P2|Overall Study|Missed measurement|0
1279779|NCT00393718|4180099|P1|Overall Study|Missed measurement|1
1279780|NCT00393718|4180098|P2|Overall Study|Withdrawal of consent|1
1279781|NCT00393718|4180099|P1|Overall Study|Withdrawal of consent|2
1279782|NCT00393718|4180098|P2|Overall Study|Subject decision|0
1279783|NCT00393718|4180099|P1|Overall Study|Subject decision|5
1279784|NCT00393718|4180098|P2|Overall Study|Hypoglycaemia|2
1279785|NCT00393718|4180099|P1|Overall Study|Hypoglycaemia|3
1279786|NCT00393718|4180098|P2|Overall Study|Lack of Efficacy|9
1279787|NCT00393718|4180099|P1|Overall Study|Lack of Efficacy|10
1279788|NCT00393718|4180098|P2|Overall Study|Protocol Violation|2
1279789|NCT00393718|4180099|P1|Overall Study|Protocol Violation|1
1279790|NCT00393718|4180098|P2|Overall Study|Adverse Event|8
1279791|NCT00393718|4180099|P1|Overall Study|Adverse Event|20
1279792|NCT00393705|4180131|P2|Overall Study|Physician Decision|2
1279793|NCT00393705|4180132|P1|Overall Study|Physician Decision|2
1279794|NCT00393705|4180131|P2|Overall Study|Withdrawal by Subject|3
1279795|NCT00393705|4180132|P1|Overall Study|Withdrawal by Subject|5
1279796|NCT00393705|4180131|P2|Overall Study|Protocol Violation|3
1279797|NCT00393705|4180132|P1|Overall Study|Protocol Violation|4
1279798|NCT00393705|4180131|P2|Overall Study|Entry Criteria Not Met|10
1279799|NCT00393705|4180132|P1|Overall Study|Entry Criteria Not Met|10
1279800|NCT00393705|4180131|P2|Overall Study|Lost to Follow-up|2
1279801|NCT00393705|4180132|P1|Overall Study|Lost to Follow-up|2
1279802|NCT00393705|4180131|P2|Overall Study|Death|1
1279803|NCT00393705|4180132|P1|Overall Study|Death|0
1279804|NCT00393705|4180131|P2|Overall Study|Adverse Event|2
1279805|NCT00393705|4180132|P1|Overall Study|Adverse Event|0
1279806|NCT00393523|4180161|P5|Overall Study|Vaccine supply issue|0
1279807|NCT00393523|4180162|P4|Overall Study|Vaccine supply issue|0
1279808|NCT00393523|4180163|P3|Overall Study|Vaccine supply issue|1
1279809|NCT00393523|4180164|P2|Overall Study|Vaccine supply issue|0
1279810|NCT00393523|4180165|P1|Overall Study|Vaccine supply issue|0
1279811|NCT00393523|4180161|P5|Overall Study|Difficulties in specimen collection|0
1279812|NCT00393523|4180162|P4|Overall Study|Difficulties in specimen collection|0
1279813|NCT00393523|4180163|P3|Overall Study|Difficulties in specimen collection|1
1279814|NCT00393523|4180164|P2|Overall Study|Difficulties in specimen collection|0
1279815|NCT00393523|4180165|P1|Overall Study|Difficulties in specimen collection|0
1279816|NCT00393523|4180161|P5|Overall Study|Withdrawal by Subject|0
1279817|NCT00393523|4180162|P4|Overall Study|Withdrawal by Subject|3
1279818|NCT00393523|4180163|P3|Overall Study|Withdrawal by Subject|2
1279819|NCT00393523|4180164|P2|Overall Study|Withdrawal by Subject|7
1279820|NCT00393523|4180165|P1|Overall Study|Withdrawal by Subject|6
1279821|NCT00393523|4180161|P5|Overall Study|Protocol Violation|0
1279822|NCT00393523|4180162|P4|Overall Study|Protocol Violation|1
1279823|NCT00393523|4180163|P3|Overall Study|Protocol Violation|0
1279824|NCT00393523|4180164|P2|Overall Study|Protocol Violation|2
1279825|NCT00393523|4180165|P1|Overall Study|Protocol Violation|6
1279826|NCT00393523|4180161|P5|Overall Study|Lost to Follow-up|1
1279827|NCT00393523|4180162|P4|Overall Study|Lost to Follow-up|2
1279828|NCT00393523|4180163|P3|Overall Study|Lost to Follow-up|0
1279829|NCT00393523|4180164|P2|Overall Study|Lost to Follow-up|0
1279830|NCT00393523|4180165|P1|Overall Study|Lost to Follow-up|0
1279831|NCT00393510|4180182|P2|Overall Study|Physician Decision|9
1279832|NCT00393510|4180183|P1|Overall Study|Physician Decision|3
1279833|NCT00393484|4180195|P2|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18
1279834|NCT00393484|4180196|P1|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0
1279835|NCT00393484|4180195|P2|Open-label Period (Weeks 96 to 240)|Noncompliance|2
1279836|NCT00393484|4180196|P1|Open-label Period (Weeks 96 to 240)|Noncompliance|2
1279837|NCT00393484|4180195|P2|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2
1279838|NCT00393484|4180196|P1|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1
1279839|NCT00393484|4180195|P2|Open-label Period (Weeks 96 to 240)|Death|0
1279840|NCT00393484|4180196|P1|Open-label Period (Weeks 96 to 240)|Death|1
1279841|NCT00393484|4180195|P2|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1
1279842|NCT00393484|4180196|P1|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4
1279843|NCT00393484|4180195|P2|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2
1279844|NCT00393484|4180196|P1|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0
1279845|NCT00393484|4180195|P2|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6
1279846|NCT00393484|4180196|P1|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0
1279847|NCT00393484|4180195|P2|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3
1279848|NCT00393484|4180196|P1|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0
1279849|NCT00393484|4180195|P2|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0
1279850|NCT00393484|4180196|P1|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2
1279851|NCT00393484|4180195|P2|Double-blind Period (Day 1 to Week 96)|Adverse Event|1
1279852|NCT00393484|4180196|P1|Double-blind Period (Day 1 to Week 96)|Adverse Event|0
1279853|NCT00393458|4180232|P4|Overall Study|Subject no longer requires study drug|0
1279854|NCT00393458|4180233|P3|Overall Study|Subject no longer requires study drug|0
1279855|NCT00393458|4180234|P2|Overall Study|Subject no longer requires study drug|1
1279856|NCT00393458|4180235|P1|Overall Study|Subject no longer requires study drug|0
1279857|NCT00393458|4180232|P4|Overall Study|Abnormal test procedure result(s)|2
1279858|NCT00393458|4180233|P3|Overall Study|Abnormal test procedure result(s)|1
1279859|NCT00393458|4180234|P2|Overall Study|Abnormal test procedure result(s)|1
1279860|NCT00393458|4180235|P1|Overall Study|Abnormal test procedure result(s)|0
1279861|NCT00393458|4180232|P4|Overall Study|Death|5
1279862|NCT00393458|4180233|P3|Overall Study|Death|5
1279863|NCT00393458|4180234|P2|Overall Study|Death|1
1279864|NCT00393458|4180235|P1|Overall Study|Death|1
1279865|NCT00393458|4180232|P4|Overall Study|Abnormal laboratory value(s)|0
1279866|NCT00393458|4180233|P3|Overall Study|Abnormal laboratory value(s)|0
1279867|NCT00393458|4180234|P2|Overall Study|Abnormal laboratory value(s)|1
1279868|NCT00393458|4180235|P1|Overall Study|Abnormal laboratory value(s)|1
1279869|NCT00393458|4180232|P4|Overall Study|Lost to Follow-up|3
1279870|NCT00393458|4180233|P3|Overall Study|Lost to Follow-up|5
1279871|NCT00393458|4180234|P2|Overall Study|Lost to Follow-up|6
1279872|NCT00393458|4180235|P1|Overall Study|Lost to Follow-up|5
1279873|NCT00393458|4180232|P4|Overall Study|Administrative problems|2
1279874|NCT00393458|4180233|P3|Overall Study|Administrative problems|5
1279875|NCT00393458|4180234|P2|Overall Study|Administrative problems|8
1279876|NCT00393458|4180235|P1|Overall Study|Administrative problems|7
1279877|NCT00393458|4180232|P4|Overall Study|Protocol deviation|10
1279878|NCT00393458|4180233|P3|Overall Study|Protocol deviation|11
1279879|NCT00393458|4180234|P2|Overall Study|Protocol deviation|11
1279880|NCT00393458|4180235|P1|Overall Study|Protocol deviation|11
1279881|NCT00393458|4180232|P4|Overall Study|Unsatisfactory therapeutic effect|30
1279882|NCT00393458|4180233|P3|Overall Study|Unsatisfactory therapeutic effect|12
1279883|NCT00393458|4180234|P2|Overall Study|Unsatisfactory therapeutic effect|9
1279884|NCT00393458|4180235|P1|Overall Study|Unsatisfactory therapeutic effect|12
1279885|NCT00393458|4180232|P4|Overall Study|Subject withdrew consent|50
1279886|NCT00393458|4180233|P3|Overall Study|Subject withdrew consent|33
1279887|NCT00393458|4180234|P2|Overall Study|Subject withdrew consent|40
1279888|NCT00393458|4180235|P1|Overall Study|Subject withdrew consent|27
1279889|NCT00393458|4180232|P4|Overall Study|Adverse Event|35
1279890|NCT00393458|4180233|P3|Overall Study|Adverse Event|40
1279891|NCT00393458|4180234|P2|Overall Study|Adverse Event|24
1279892|NCT00393458|4180235|P1|Overall Study|Adverse Event|35
1279893|NCT00393367|4180262|P2|Overall Study|Withdrawal by Subject|2
1279894|NCT00393367|4180263|P1|Overall Study|Withdrawal by Subject|0
1279895|NCT00393367|4180262|P2|Overall Study|Protocol Violation|5
1279896|NCT00393367|4180263|P1|Overall Study|Protocol Violation|2
1279897|NCT00393094|4180291|P1|Disease Progression After Trtmt: Onstudy|Refused further treatment|1
1279898|NCT00393094|4180291|P1|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1
1279899|NCT00393042|4180302|P2|Second Intervetion|Protocol Violation|1
1279900|NCT00393042|4180303|P1|Second Intervetion|Protocol Violation|1
1279901|NCT00393042|4180302|P2|Second Intervetion|Lost to Follow-up|2
1279902|NCT00393042|4180303|P1|Second Intervetion|Lost to Follow-up|0
1279903|NCT00393042|4180302|P2|Second Intervetion|Lack of Efficacy|0
1279904|NCT00393042|4180303|P1|Second Intervetion|Lack of Efficacy|1
1279905|NCT00393042|4180302|P2|Second Intervetion|Withdrawal by Subject|2
1279906|NCT00393042|4180303|P1|Second Intervetion|Withdrawal by Subject|0
1279907|NCT00393042|4180302|P2|Second Intervetion|Adverse Event|3
1279908|NCT00393042|4180303|P1|Second Intervetion|Adverse Event|0
1279909|NCT00393042|4180302|P2|First Intervention|Adverse Event|1
1279910|NCT00393042|4180303|P1|First Intervention|Adverse Event|0
1279911|NCT00393042|4180302|P2|First Intervention|Protocol Violation|0
1279912|NCT00393042|4180303|P1|First Intervention|Protocol Violation|1
1279913|NCT00393042|4180302|P2|First Intervention|Lost to Follow-up|3
1279914|NCT00393042|4180303|P1|First Intervention|Lost to Follow-up|3
1279915|NCT00393042|4180302|P2|First Intervention|Withdrawal by Subject|2
1279916|NCT00393042|4180303|P1|First Intervention|Withdrawal by Subject|1
1279917|NCT00393029|4180375|P2|Overall Study|Not treated|1
1279918|NCT00393029|4180376|P1|Overall Study|Not treated|0
1279919|NCT00392925|4180397|P4|Randomization to Treatment Group Period|Lost to Follow-up|4
1279920|NCT00392925|4180398|P3|Randomization to Treatment Group Period|Lost to Follow-up|8
1279921|NCT00392925|4180399|P2|Randomization to Treatment Group Period|Lost to Follow-up|3
1279922|NCT00392925|4180400|P1|Randomization to Treatment Group Period|Lost to Follow-up|0
1279923|NCT00392925|4180397|P4|Randomization to Treatment Group Period|Protocol Violation|1
1279924|NCT00392925|4180398|P3|Randomization to Treatment Group Period|Protocol Violation|2
1279925|NCT00392925|4180399|P2|Randomization to Treatment Group Period|Protocol Violation|0
1279926|NCT00392925|4180400|P1|Randomization to Treatment Group Period|Protocol Violation|0
1279927|NCT00392925|4180397|P4|Randomization to Treatment Group Period|Adverse Event|5
1279928|NCT00392925|4180398|P3|Randomization to Treatment Group Period|Adverse Event|3
1279929|NCT00392925|4180399|P2|Randomization to Treatment Group Period|Adverse Event|3
1279930|NCT00392925|4180400|P1|Randomization to Treatment Group Period|Adverse Event|0
1279931|NCT00392925|4180397|P4|Randomization to Treatment Group Period|Withdrawal by Subject|8
1279932|NCT00392925|4180398|P3|Randomization to Treatment Group Period|Withdrawal by Subject|6
1279933|NCT00392925|4180399|P2|Randomization to Treatment Group Period|Withdrawal by Subject|2
1279934|NCT00392925|4180400|P1|Randomization to Treatment Group Period|Withdrawal by Subject|0
1279935|NCT00392925|4180397|P4|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
1279936|NCT00392925|4180398|P3|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
1279937|NCT00392925|4180399|P2|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
1279938|NCT00392925|4180400|P1|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16
1279939|NCT00392925|4180397|P4|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
1279940|NCT00392925|4180398|P3|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
1279941|NCT00392925|4180399|P2|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
1279942|NCT00392925|4180400|P1|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5
1279943|NCT00392925|4180397|P4|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
1279944|NCT00392925|4180398|P3|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
1279945|NCT00392925|4180399|P2|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
1279946|NCT00392925|4180400|P1|4 Week Lead-In Period - Non-Randomized|Physician Decision|1
1279947|NCT00392925|4180397|P4|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
1279948|NCT00392925|4180398|P3|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
1279949|NCT00392925|4180399|P2|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
1279950|NCT00392925|4180400|P1|4 Week Lead-In Period - Non-Randomized|Adverse Event|5
1279951|NCT00392925|4180397|P4|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
1279952|NCT00392925|4180398|P3|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
1279953|NCT00392925|4180399|P2|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
1279954|NCT00392925|4180400|P1|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11
1279955|NCT00392808|4180514|P4|Overall Study|Unable to withdraw blood|2
1279956|NCT00392808|4180515|P3|Overall Study|Unable to withdraw blood|1
1279957|NCT00392808|4180516|P2|Overall Study|Unable to withdraw blood|1
1279958|NCT00392808|4180517|P1|Overall Study|Unable to withdraw blood|3
1279959|NCT00392808|4180514|P4|Overall Study|Lost to Follow-up|2
1279960|NCT00392808|4180515|P3|Overall Study|Lost to Follow-up|1
1279961|NCT00392808|4180516|P2|Overall Study|Lost to Follow-up|2
1279962|NCT00392808|4180517|P1|Overall Study|Lost to Follow-up|3
1279963|NCT00392769|4180541|P1|Overall Study|Adverse Event|1
1279964|NCT00392769|4180541|P1|Overall Study|Clinical Deterioration|9
1279965|NCT00392665|4180593|P2|Overall Study|Lost to Follow-up|1
1279966|NCT00392665|4180594|P1|Overall Study|Lost to Follow-up|1
1279967|NCT00392665|4180593|P2|Overall Study|Death|14
1279968|NCT00392665|4180594|P1|Overall Study|Death|16
1279969|NCT00392379|4180620|P2|Overall Study|Adverse Event|1
1279970|NCT00392379|4180621|P1|Overall Study|Adverse Event|1
1279971|NCT00392379|4180620|P2|Overall Study|Lost to Follow-up|9
1279972|NCT00392379|4180621|P1|Overall Study|Lost to Follow-up|4
1279973|NCT00392379|4180620|P2|Overall Study|Withdrawal by Subject|28
1279974|NCT00392379|4180621|P1|Overall Study|Withdrawal by Subject|17
1279975|NCT00392288|4180634|P3|Overall Study|Other|1
1279976|NCT00392288|4180635|P2|Overall Study|Other|4
1279977|NCT00392288|4180636|P1|Overall Study|Other|3
1279978|NCT00392288|4180634|P3|Overall Study|Parent/legal guardian withdrawal|1
1279979|NCT00392288|4180635|P2|Overall Study|Parent/legal guardian withdrawal|2
1279980|NCT00392288|4180636|P1|Overall Study|Parent/legal guardian withdrawal|1
1279981|NCT00392288|4180634|P3|Overall Study|Withdrawal by Subject|2
1279982|NCT00392288|4180635|P2|Overall Study|Withdrawal by Subject|0
1279983|NCT00392288|4180636|P1|Overall Study|Withdrawal by Subject|1
1279984|NCT00392288|4180634|P3|Overall Study|Lost to Follow-up|1
1279985|NCT00392288|4180635|P2|Overall Study|Lost to Follow-up|1
1279986|NCT00392288|4180636|P1|Overall Study|Lost to Follow-up|1
1279987|NCT00392288|4180634|P3|Overall Study|Protocol Violation|1
1279988|NCT00392288|4180635|P2|Overall Study|Protocol Violation|3
1279989|NCT00392288|4180636|P1|Overall Study|Protocol Violation|1
1279990|NCT00392288|4180634|P3|Overall Study|Lack of Efficacy|3
1279991|NCT00392288|4180635|P2|Overall Study|Lack of Efficacy|5
1279992|NCT00392288|4180636|P1|Overall Study|Lack of Efficacy|8
1279993|NCT00392288|4180634|P3|Overall Study|Adverse Event|8
1279994|NCT00392288|4180635|P2|Overall Study|Adverse Event|7
1279995|NCT00392288|4180636|P1|Overall Study|Adverse Event|17
1279996|NCT00392223|4180661|P2|Overall Study|Withdrawal by Subject|2
1279997|NCT00392223|4180662|P1|Overall Study|Withdrawal by Subject|3
1279998|NCT00392223|4180661|P2|Overall Study|Protocol Violation|3
1279999|NCT00392223|4180662|P1|Overall Study|Protocol Violation|0
1280000|NCT00392223|4180661|P2|Overall Study|Lost to Follow-up|4
1280001|NCT00392223|4180662|P1|Overall Study|Lost to Follow-up|1
1280002|NCT00392223|4180661|P2|Overall Study|Adverse Event|4
1280003|NCT00392223|4180662|P1|Overall Study|Adverse Event|5
1280004|NCT00392210|4180680|P2|First Voiding Trial|Physician Decision|2
1280005|NCT00392210|4180681|P1|First Voiding Trial|Physician Decision|2
1280006|NCT00392197|4180689|P2|Overall Study|Withdrawal by Subject|6
1280007|NCT00392197|4180690|P1|Overall Study|Withdrawal by Subject|4
1280008|NCT00392197|4180689|P2|Overall Study|Protocol Violation|5
1280009|NCT00392197|4180690|P1|Overall Study|Protocol Violation|7
1280010|NCT00392197|4180689|P2|Overall Study|Physician Decision|2
1280011|NCT00392197|4180690|P1|Overall Study|Physician Decision|3
1280012|NCT00392197|4180689|P2|Overall Study|Lost to Follow-up|1
1280013|NCT00392197|4180690|P1|Overall Study|Lost to Follow-up|0
1280014|NCT00392197|4180689|P2|Overall Study|Lack of Efficacy|4
1280015|NCT00392197|4180690|P1|Overall Study|Lack of Efficacy|3
1280016|NCT00392197|4180689|P2|Overall Study|Adverse Event|12
1280017|NCT00392197|4180690|P1|Overall Study|Adverse Event|4
1280018|NCT00392171|4180698|P1|Overall Study|Disease progression|101
1280019|NCT00392171|4180698|P1|Overall Study|Did not meet inclusion criteria|4
1280020|NCT00391976|4180709|P3|Overall Study|Positive P. aeruginosa antibody test|31
1280021|NCT00391976|4180710|P2|Overall Study|Positive P. aeruginosa antibody test|0
1280022|NCT00391976|4180711|P1|Overall Study|Positive P. aeruginosa antibody test|0
1280023|NCT00391976|4180709|P3|Overall Study|Unable to classify|1
1280024|NCT00391976|4180710|P2|Overall Study|Unable to classify|0
1280025|NCT00391976|4180711|P1|Overall Study|Unable to classify|0
1280026|NCT00391976|4180709|P3|Overall Study|Recurrence/no eradication of infection|0
1280027|NCT00391976|4180710|P2|Overall Study|Recurrence/no eradication of infection|19
1280028|NCT00391976|4180711|P1|Overall Study|Recurrence/no eradication of infection|21
1280029|NCT00391976|4180709|P3|Overall Study|Protocol deviation/violation|1
1280030|NCT00391976|4180710|P2|Overall Study|Protocol deviation/violation|2
1280031|NCT00391976|4180711|P1|Overall Study|Protocol deviation/violation|4
1280032|NCT00391976|4180709|P3|Overall Study|Inappropriate enrollment|0
1280033|NCT00391976|4180710|P2|Overall Study|Inappropriate enrollment|1
1280034|NCT00391976|4180711|P1|Overall Study|Inappropriate enrollment|1
1280035|NCT00391976|4180709|P3|Overall Study|Lost to Follow-up|0
1280036|NCT00391976|4180710|P2|Overall Study|Lost to Follow-up|2
1280037|NCT00391976|4180711|P1|Overall Study|Lost to Follow-up|1
1280038|NCT00391976|4180709|P3|Overall Study|Withdrawal of consent|1
1280039|NCT00391976|4180710|P2|Overall Study|Withdrawal of consent|1
1280040|NCT00391976|4180711|P1|Overall Study|Withdrawal of consent|0
1280041|NCT00391976|4180709|P3|Overall Study|Adverse Event|1
1280042|NCT00391976|4180710|P2|Overall Study|Adverse Event|0
1280043|NCT00391976|4180711|P1|Overall Study|Adverse Event|0
1280044|NCT00391898|4180735|P2|Overall Study|Other|10
1280045|NCT00391898|4180736|P1|Overall Study|Other|8
1280046|NCT00391898|4180735|P2|Overall Study|Adverse Event|0
1280047|NCT00391898|4180736|P1|Overall Study|Adverse Event|3
1280048|NCT00391872|4180756|P2|Overall Study|Lost to Follow-up|0
1280049|NCT00391872|4180757|P1|Overall Study|Lost to Follow-up|2
1280050|NCT00391872|4180756|P2|Overall Study|Reason unknown|4
1280051|NCT00391872|4180757|P1|Overall Study|Reason unknown|2
1280052|NCT00391872|4180756|P2|Overall Study|Withdrawal by Subject|249
1280053|NCT00391872|4180757|P1|Overall Study|Withdrawal by Subject|296
1280054|NCT00391872|4180756|P2|Overall Study|Protocol Violation|2
1280055|NCT00391872|4180757|P1|Overall Study|Protocol Violation|7
1280056|NCT00391846|4180795|P2|Overall Study|Developed study specific DC criteria|1
1280057|NCT00391846|4180796|P1|Overall Study|Developed study specific DC criteria|0
1280058|NCT00391846|4180795|P2|Overall Study|Withdrawal by Subject|3
1280059|NCT00391846|4180796|P1|Overall Study|Withdrawal by Subject|2
1280060|NCT00391846|4180795|P2|Overall Study|Did not meet the required elig. crit|2
1280061|NCT00391846|4180796|P1|Overall Study|Did not meet the required elig. crit|2
1280062|NCT00391846|4180795|P2|Overall Study|Adverse Event|1
1280063|NCT00391846|4180796|P1|Overall Study|Adverse Event|4
1280064|NCT00391807|4180816|P1|Overall Study|Various|96
1280065|NCT00391807|4180816|P1|Overall Study|Protocol Violation|20
1280066|NCT00391807|4180816|P1|Overall Study|Withdrawal by Subject|147
1280067|NCT00391807|4180816|P1|Overall Study|Lost to Follow-up|227
1280068|NCT00391807|4180816|P1|Overall Study|Pregnancy|25
1280069|NCT00391807|4180816|P1|Overall Study|Adverse Event|177
1280070|NCT00391807|4180816|P1|Overall Study|Did not receive study medication|23
1280071|NCT00391768|4180843|P7|Overall Study|Lost to Follow-up|3
1280072|NCT00391768|4180844|P6|Overall Study|Lost to Follow-up|2
1280073|NCT00391768|4180845|P5|Overall Study|Lost to Follow-up|2
1280074|NCT00391768|4180846|P4|Overall Study|Lost to Follow-up|1
1280075|NCT00391768|4180847|P3|Overall Study|Lost to Follow-up|0
1280076|NCT00391768|4180848|P2|Overall Study|Lost to Follow-up|0
1280077|NCT00391768|4180849|P1|Overall Study|Lost to Follow-up|0
1280078|NCT00391768|4180843|P7|Overall Study|Withdrawal by Subject|1
1280079|NCT00391768|4180844|P6|Overall Study|Withdrawal by Subject|1
1280080|NCT00391768|4180845|P5|Overall Study|Withdrawal by Subject|0
1280081|NCT00391768|4180846|P4|Overall Study|Withdrawal by Subject|0
1280082|NCT00391768|4180847|P3|Overall Study|Withdrawal by Subject|1
1280083|NCT00391768|4180848|P2|Overall Study|Withdrawal by Subject|0
1280084|NCT00391768|4180849|P1|Overall Study|Withdrawal by Subject|0
1280085|NCT00391625|4180936|P1|Month 50|Physician Decision|1
1280086|NCT00391625|4180936|P1|Month 14|Withdrawal by Subject|1
1280087|NCT00391586|4180989|P1|Overall Study|Death|4
1280088|NCT00391586|4180989|P1|Overall Study|Physician Decision|2
1280089|NCT00391586|4180989|P1|Overall Study|Adverse Event|5
1280090|NCT00391586|4180989|P1|Overall Study|Progressive disease|13
1280091|NCT00391391|4181026|P4|Overall Study|Withdrawal by Subject|7
1280092|NCT00391391|4181027|P3|Overall Study|Withdrawal by Subject|10
1280093|NCT00391391|4181028|P2|Overall Study|Withdrawal by Subject|4
1280094|NCT00391391|4181029|P1|Overall Study|Withdrawal by Subject|6
1280095|NCT00391391|4181026|P4|Overall Study|Protocol Violation|7
1280096|NCT00391391|4181027|P3|Overall Study|Protocol Violation|6
1280097|NCT00391391|4181028|P2|Overall Study|Protocol Violation|3
1280098|NCT00391391|4181029|P1|Overall Study|Protocol Violation|2
1280099|NCT00391391|4181026|P4|Overall Study|Lost to Follow-up|4
1280100|NCT00391391|4181027|P3|Overall Study|Lost to Follow-up|7
1280101|NCT00391391|4181028|P2|Overall Study|Lost to Follow-up|3
1280102|NCT00391391|4181029|P1|Overall Study|Lost to Follow-up|1
1280103|NCT00391391|4181026|P4|Overall Study|Adverse Event|1
1280104|NCT00391391|4181027|P3|Overall Study|Adverse Event|0
1280105|NCT00391391|4181028|P2|Overall Study|Adverse Event|0
1280106|NCT00391391|4181029|P1|Overall Study|Adverse Event|0
1280107|NCT00391274|4181074|P2|Overall Study|Death Not Study Related|1
1280108|NCT00391274|4181075|P1|Overall Study|Death Not Study Related|0
1280109|NCT00391274|4181074|P2|Overall Study|Death Due to Indeterminate Cause|0
1280110|NCT00391274|4181075|P1|Overall Study|Death Due to Indeterminate Cause|1
1280111|NCT00391274|4181074|P2|Overall Study|Death Due to Adverse Event|3
1280112|NCT00391274|4181075|P1|Overall Study|Death Due to Adverse Event|1
1280113|NCT00391274|4181074|P2|Overall Study|Withdrawal by Subject|3
1280114|NCT00391274|4181075|P1|Overall Study|Withdrawal by Subject|0
1280115|NCT00391274|4181074|P2|Overall Study|Physician Decision|2
1280116|NCT00391274|4181075|P1|Overall Study|Physician Decision|4
1280117|NCT00391274|4181074|P2|Overall Study|Lost to Follow-up|3
1280118|NCT00391274|4181075|P1|Overall Study|Lost to Follow-up|0
1280119|NCT00391274|4181074|P2|Overall Study|Death Due to Study Disease|45
1280120|NCT00391274|4181075|P1|Overall Study|Death Due to Study Disease|55
1280121|NCT00391222|4181094|P4|Period III (Double-Blind Treatment)|Other|0
1280122|NCT00391222|4181095|P3|Period III (Double-Blind Treatment)|Other|6
1280123|NCT00391222|4181096|P2|Period III (Double-Blind Treatment)|Other|1
1280124|NCT00391222|4181097|P1|Period III (Double-Blind Treatment)|Other|6
1280125|NCT00391222|4181094|P4|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
1280126|NCT00391222|4181095|P3|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3
1280127|NCT00391222|4181096|P2|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1
1280128|NCT00391222|4181097|P1|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
1280129|NCT00391222|4181094|P4|Period III (Double-Blind Treatment)|Pregnancy|0
1280130|NCT00391222|4181095|P3|Period III (Double-Blind Treatment)|Pregnancy|0
1280131|NCT00391222|4181096|P2|Period III (Double-Blind Treatment)|Pregnancy|2
1280132|NCT00391222|4181097|P1|Period III (Double-Blind Treatment)|Pregnancy|0
1280133|NCT00391222|4181094|P4|Period III (Double-Blind Treatment)|Adverse Event|0
1280134|NCT00391222|4181095|P3|Period III (Double-Blind Treatment)|Adverse Event|4
1280135|NCT00391222|4181096|P2|Period III (Double-Blind Treatment)|Adverse Event|2
1280136|NCT00391222|4181097|P1|Period III (Double-Blind Treatment)|Adverse Event|5
1280137|NCT00391222|4181094|P4|Period III (Double-Blind Treatment)|Lost to Follow-up|0
1280138|NCT00391222|4181095|P3|Period III (Double-Blind Treatment)|Lost to Follow-up|4
1280139|NCT00391222|4181096|P2|Period III (Double-Blind Treatment)|Lost to Follow-up|4
1280140|NCT00391222|4181097|P1|Period III (Double-Blind Treatment)|Lost to Follow-up|2
1280141|NCT00391222|4181094|P4|Period III (Double-Blind Treatment)|Withdrawal by Subject|0
1280142|NCT00391222|4181095|P3|Period III (Double-Blind Treatment)|Withdrawal by Subject|6
1280143|NCT00391222|4181096|P2|Period III (Double-Blind Treatment)|Withdrawal by Subject|12
1280144|NCT00391222|4181097|P1|Period III (Double-Blind Treatment)|Withdrawal by Subject|15
1280145|NCT00391222|4181094|P4|Period II (Open-label Risperidone LAI)|Other|24
1280146|NCT00391222|4181095|P3|Period II (Open-label Risperidone LAI)|Other|0
1280147|NCT00391222|4181096|P2|Period II (Open-label Risperidone LAI)|Other|0
1280148|NCT00391222|4181097|P1|Period II (Open-label Risperidone LAI)|Other|0
1280149|NCT00391222|4181094|P4|Period II (Open-label Risperidone LAI)|Non-responder|97
1280150|NCT00391222|4181095|P3|Period II (Open-label Risperidone LAI)|Non-responder|0
1280151|NCT00391222|4181096|P2|Period II (Open-label Risperidone LAI)|Non-responder|0
1280152|NCT00391222|4181097|P1|Period II (Open-label Risperidone LAI)|Non-responder|0
1280153|NCT00391222|4181094|P4|Period II (Open-label Risperidone LAI)|Adverse Event|10
1280154|NCT00391222|4181095|P3|Period II (Open-label Risperidone LAI)|Adverse Event|0
1280155|NCT00391222|4181096|P2|Period II (Open-label Risperidone LAI)|Adverse Event|0
1280156|NCT00391222|4181097|P1|Period II (Open-label Risperidone LAI)|Adverse Event|0
1280157|NCT00391222|4181094|P4|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5
1280158|NCT00391222|4181095|P3|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
1280159|NCT00391222|4181096|P2|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
1280160|NCT00391222|4181097|P1|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
1280161|NCT00391222|4181094|P4|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26
1280162|NCT00391222|4181095|P3|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
1280163|NCT00391222|4181096|P2|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
1280164|NCT00391222|4181097|P1|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
1280165|NCT00391092|4181123|P2|Overall Study|Alive in follow-up|84
1280166|NCT00391092|4181124|P1|Overall Study|Alive in follow-up|88
1280167|NCT00391092|4181123|P2|Overall Study|Alive on treatment|33
1280168|NCT00391092|4181124|P1|Overall Study|Alive on treatment|29
1280169|NCT00391092|4181123|P2|Overall Study|Lost to Follow-up|18
1280170|NCT00391092|4181124|P1|Overall Study|Lost to Follow-up|13
1280171|NCT00391092|4181123|P2|Overall Study|Death|81
1280172|NCT00391092|4181124|P1|Overall Study|Death|78
1280173|NCT00391053|4181167|P4|Overall Study|Withdrawal by Subject|1
1280174|NCT00391053|4181168|P3|Overall Study|Withdrawal by Subject|1
1280175|NCT00391053|4181169|P2|Overall Study|Withdrawal by Subject|1
1280176|NCT00391053|4181170|P1|Overall Study|Withdrawal by Subject|5
1280177|NCT00391053|4181167|P4|Overall Study|Lost to Follow-up|5
1280178|NCT00391053|4181168|P3|Overall Study|Lost to Follow-up|0
1280179|NCT00391053|4181169|P2|Overall Study|Lost to Follow-up|0
1280180|NCT00391053|4181170|P1|Overall Study|Lost to Follow-up|1
1280181|NCT00391053|4181167|P4|Overall Study|Protocol Violation|0
1280182|NCT00391053|4181168|P3|Overall Study|Protocol Violation|0
1280183|NCT00391053|4181169|P2|Overall Study|Protocol Violation|0
1280184|NCT00391053|4181170|P1|Overall Study|Protocol Violation|2
1280185|NCT00391053|4181167|P4|Overall Study|Serious Adverse Events|4
1280186|NCT00391053|4181168|P3|Overall Study|Serious Adverse Events|1
1280187|NCT00391053|4181169|P2|Overall Study|Serious Adverse Events|0
1280188|NCT00391053|4181170|P1|Overall Study|Serious Adverse Events|1
1280189|NCT00391027|4181194|P2|Overall Study|Other|3
1280190|NCT00391027|4181195|P1|Overall Study|Other|4
1280191|NCT00391027|4181194|P2|Overall Study|Withdrawal by Subject|1
1280192|NCT00391027|4181195|P1|Overall Study|Withdrawal by Subject|10
1280193|NCT00391027|4181194|P2|Overall Study|Lack of Efficacy|0
1280194|NCT00391027|4181195|P1|Overall Study|Lack of Efficacy|3
1280195|NCT00391027|4181194|P2|Overall Study|Adverse Event|8
1280196|NCT00391027|4181195|P1|Overall Study|Adverse Event|8
1280197|NCT00390910|4181236|P3|Overall Study|Migrated/moved from study area|3
1280198|NCT00390910|4181237|P2|Overall Study|Migrated/moved from study area|0
1280199|NCT00390910|4181238|P1|Overall Study|Migrated/moved from study area|0
1280200|NCT00390910|4181236|P3|Overall Study|Withdrawal by Subject|2
1280201|NCT00390910|4181237|P2|Overall Study|Withdrawal by Subject|3
1280202|NCT00390910|4181238|P1|Overall Study|Withdrawal by Subject|1
1280203|NCT00390910|4181236|P3|Overall Study|Lost to Follow-up|5
1280204|NCT00390910|4181237|P2|Overall Study|Lost to Follow-up|1
1280205|NCT00390910|4181238|P1|Overall Study|Lost to Follow-up|0
1280206|NCT00390910|4181236|P3|Overall Study|Adverse Event|0
1280207|NCT00390910|4181237|P2|Overall Study|Adverse Event|0
1280208|NCT00390910|4181238|P1|Overall Study|Adverse Event|1
1280209|NCT00390884|4181326|P2|Overall Study|Withdrawal by Subject|2
1280210|NCT00390884|4181327|P1|Overall Study|Withdrawal by Subject|2
1280211|NCT00390858|4181339|P2|Overall Study|Withdrawal by Subject|4
1280212|NCT00390858|4181340|P1|Overall Study|Withdrawal by Subject|3
1280213|NCT00390858|4181339|P2|Overall Study|Lack of Efficacy|1
1280214|NCT00390858|4181340|P1|Overall Study|Lack of Efficacy|0
1280215|NCT00390858|4181339|P2|Overall Study|Adverse Event|2
1280216|NCT00390858|4181340|P1|Overall Study|Adverse Event|6
1280217|NCT00390806|4181354|P2|Overall Study|Ongoing|2
1280218|NCT00390806|4181355|P1|Overall Study|Ongoing|4
1280219|NCT00390806|4181354|P2|Overall Study|Physician Decision|1
1280220|NCT00390806|4181355|P1|Overall Study|Physician Decision|0
1280221|NCT00390806|4181354|P2|Overall Study|Death|0
1280222|NCT00390806|4181355|P1|Overall Study|Death|1
1280223|NCT00390806|4181354|P2|Overall Study|Investigator Decision|6
1280224|NCT00390806|4181355|P1|Overall Study|Investigator Decision|4
1280225|NCT00390806|4181354|P2|Overall Study|Withdrawal by Subject|15
1280226|NCT00390806|4181355|P1|Overall Study|Withdrawal by Subject|12
1280227|NCT00390806|4181354|P2|Overall Study|Protocol Violation|2
1280228|NCT00390806|4181355|P1|Overall Study|Protocol Violation|2
1280229|NCT00390806|4181354|P2|Overall Study|Lost to Follow-up|6
1280230|NCT00390806|4181355|P1|Overall Study|Lost to Follow-up|7
1280231|NCT00390780|4181423|P2|Overall Study|SAE, death|1
1280232|NCT00390780|4181424|P1|Overall Study|SAE, death|0
1280233|NCT00390780|4181423|P2|Overall Study|Investigator decision, SAE, other reason|1
1280234|NCT00390780|4181424|P1|Overall Study|Investigator decision, SAE, other reason|0
1280235|NCT00390780|4181423|P2|Overall Study|Lost to follow up and other reasons|1
1280236|NCT00390780|4181424|P1|Overall Study|Lost to follow up and other reasons|0
1280237|NCT00390780|4181423|P2|Overall Study|Inclusion criteria not satisfied|2
1280238|NCT00390780|4181424|P1|Overall Study|Inclusion criteria not satisfied|0
1280239|NCT00390780|4181423|P2|Overall Study|Withdrawal by Subject|2
1280240|NCT00390780|4181424|P1|Overall Study|Withdrawal by Subject|1
1280241|NCT00390780|4181423|P2|Overall Study|Death|3
1280242|NCT00390780|4181424|P1|Overall Study|Death|1
1280243|NCT00390780|4181423|P2|Overall Study|Adverse Event|3
1280244|NCT00390780|4181424|P1|Overall Study|Adverse Event|2
1280245|NCT00390780|4181423|P2|Overall Study|Lost to Follow-up|6
1280246|NCT00390780|4181424|P1|Overall Study|Lost to Follow-up|3
1280247|NCT00390780|4181423|P2|Overall Study|Protocol Violation|4
1280248|NCT00390780|4181424|P1|Overall Study|Protocol Violation|6
1280249|NCT00390780|4181423|P2|Overall Study|Not completed|4
1280250|NCT00390780|4181424|P1|Overall Study|Not completed|10
1280251|NCT00390689|4181457|P3|Overall Study|Investigator's judgement|0
1280252|NCT00390689|4181458|P2|Overall Study|Investigator's judgement|0
1280253|NCT00390689|4181459|P1|Overall Study|Investigator's judgement|2
1280254|NCT00390689|4181457|P3|Overall Study|Protocol Violation|0
1280255|NCT00390689|4181458|P2|Overall Study|Protocol Violation|0
1280256|NCT00390689|4181459|P1|Overall Study|Protocol Violation|1
1280257|NCT00390689|4181457|P3|Overall Study|Lack of Efficacy|1
1280258|NCT00390689|4181458|P2|Overall Study|Lack of Efficacy|0
1280259|NCT00390689|4181459|P1|Overall Study|Lack of Efficacy|0
1280260|NCT00390689|4181457|P3|Overall Study|Adverse Event|2
1280261|NCT00390689|4181458|P2|Overall Study|Adverse Event|5
1280262|NCT00390689|4181459|P1|Overall Study|Adverse Event|2
1280263|NCT00390572|4181534|P2|Overall Study|health condition|1
1280264|NCT00390572|4181535|P1|Overall Study|health condition|0
1280265|NCT00390572|4181534|P2|Overall Study|Lost to Follow-up|4
1280266|NCT00390572|4181535|P1|Overall Study|Lost to Follow-up|8
1280267|NCT00390546|4181561|P2|Overall Study|Physician Decision|5
1280268|NCT00390546|4181562|P1|Overall Study|Physician Decision|5
1280269|NCT00390546|4181561|P2|Overall Study|Renal impairment|0
1280270|NCT00390546|4181562|P1|Overall Study|Renal impairment|1
1280271|NCT00390468|4181572|P1|Overall Study|Lack of Efficacy|1
1280272|NCT00390468|4181572|P1|Overall Study|Protocol Violation|2
1280273|NCT00390455|4181578|P2|Overall Study|Other Medical Reasons|11
1280274|NCT00390455|4181579|P1|Overall Study|Other Medical Reasons|7
1280275|NCT00390455|4181578|P2|Overall Study|Alternate Treatment|1
1280276|NCT00390455|4181579|P1|Overall Study|Alternate Treatment|0
1280277|NCT00390455|4181578|P2|Overall Study|Withdrawal by Subject|8
1280278|NCT00390455|4181579|P1|Overall Study|Withdrawal by Subject|8
1280279|NCT00390455|4181578|P2|Overall Study|Adverse Event|3
1280280|NCT00390455|4181579|P1|Overall Study|Adverse Event|17
1280281|NCT00390416|4181624|P1|Overall Study|Not treated|3
1280282|NCT00390416|4181624|P1|Overall Study|Withdrawal by Subject|1
1280283|NCT00390221|4181668|P3|Overall Study|Not Specified|2
1280284|NCT00390221|4181669|P2|Overall Study|Not Specified|4
1280285|NCT00390221|4181670|P1|Overall Study|Not Specified|3
1280286|NCT00390221|4181668|P3|Overall Study|Subject Non-compliance|2
1280287|NCT00390221|4181669|P2|Overall Study|Subject Non-compliance|0
1280288|NCT00390221|4181670|P1|Overall Study|Subject Non-compliance|1
1280289|NCT00390221|4181668|P3|Overall Study|Withdrawal by Subject|7
1280290|NCT00390221|4181669|P2|Overall Study|Withdrawal by Subject|9
1280291|NCT00390221|4181670|P1|Overall Study|Withdrawal by Subject|13
1280292|NCT00390221|4181668|P3|Overall Study|Investigator Decision|1
1280293|NCT00390221|4181669|P2|Overall Study|Investigator Decision|0
1280294|NCT00390221|4181670|P1|Overall Study|Investigator Decision|0
1280295|NCT00390221|4181668|P3|Overall Study|Adverse Event|3
1280296|NCT00390221|4181669|P2|Overall Study|Adverse Event|4
1280297|NCT00390221|4181670|P1|Overall Study|Adverse Event|1
1280298|NCT00390221|4181668|P3|Overall Study|Lost to Follow-up|0
1280299|NCT00390221|4181669|P2|Overall Study|Lost to Follow-up|3
1280300|NCT00390221|4181670|P1|Overall Study|Lost to Follow-up|0
1280301|NCT00390013|4181700|P4|Phase 2 First Treatment|Withdrawal by Subject|0
1280302|NCT00390013|4181701|P3|Phase 2 First Treatment|Withdrawal by Subject|0
1280303|NCT00390013|4181702|P2|Phase 2 First Treatment|Withdrawal by Subject|1
1280304|NCT00390013|4181703|P1|Phase 2 First Treatment|Withdrawal by Subject|0
1280305|NCT00390013|4181700|P4|Phase 2 First Treatment|tired|0
1280306|NCT00390013|4181701|P3|Phase 2 First Treatment|tired|0
1280307|NCT00390013|4181702|P2|Phase 2 First Treatment|tired|0
1280308|NCT00390013|4181703|P1|Phase 2 First Treatment|tired|1
1280309|NCT00390013|4181700|P4|Phase 1|tired|1
1280310|NCT00390013|4181701|P3|Phase 1|tired|0
1280311|NCT00390013|4181702|P2|Phase 1|tired|0
1280312|NCT00390013|4181703|P1|Phase 1|tired|0
1280313|NCT00389831|4181728|P2|Overall Study|Lost to Follow-up|1
1280314|NCT00389831|4181729|P1|Overall Study|Lost to Follow-up|0
1280315|NCT00389831|4181728|P2|Overall Study|Other reasons|2
1280316|NCT00389831|4181729|P1|Overall Study|Other reasons|0
1280317|NCT00389831|4181728|P2|Overall Study|Did not receive treatment.|2
1280318|NCT00389831|4181729|P1|Overall Study|Did not receive treatment.|0
1280319|NCT00389831|4181728|P2|Overall Study|Lack of Efficacy|2
1280320|NCT00389831|4181729|P1|Overall Study|Lack of Efficacy|0
1280321|NCT00389597|4181792|P4|Overall Study|Lost to Follow-up|6
1280322|NCT00389597|4181793|P3|Overall Study|Lost to Follow-up|4
1280323|NCT00389597|4181794|P2|Overall Study|Lost to Follow-up|6
1280324|NCT00389597|4181795|P1|Overall Study|Lost to Follow-up|8
1280325|NCT00389519|4181820|P4|Treated|Reason not specified|2
1280326|NCT00389519|4181821|P3|Treated|Reason not specified|0
1280327|NCT00389519|4181822|P2|Treated|Reason not specified|1
1280328|NCT00389519|4181823|P1|Treated|Reason not specified|1
1280329|NCT00389519|4181820|P4|Treated|Adverse Event|2
1280330|NCT00389519|4181821|P3|Treated|Adverse Event|0
1280331|NCT00389519|4181822|P2|Treated|Adverse Event|0
1280332|NCT00389519|4181823|P1|Treated|Adverse Event|1
1280333|NCT00389519|4181820|P4|Randomized|Did not receive study drug|0
1280334|NCT00389519|4181821|P3|Randomized|Did not receive study drug|0
1280335|NCT00389519|4181822|P2|Randomized|Did not receive study drug|0
1280336|NCT00389519|4181823|P1|Randomized|Did not receive study drug|2
1280337|NCT00389519|4181820|P4|Placebo Run-In|Reason not specified|0
1280338|NCT00389519|4181821|P3|Placebo Run-In|Reason not specified|0
1280339|NCT00389519|4181822|P2|Placebo Run-In|Reason not specified|0
1280340|NCT00389519|4181823|P1|Placebo Run-In|Reason not specified|40
1280341|NCT00389519|4181820|P4|Placebo Run-In|Withdrawal by Subject|0
1280342|NCT00389519|4181821|P3|Placebo Run-In|Withdrawal by Subject|0
1280343|NCT00389519|4181822|P2|Placebo Run-In|Withdrawal by Subject|0
1280344|NCT00389519|4181823|P1|Placebo Run-In|Withdrawal by Subject|19
1280345|NCT00389519|4181820|P4|Placebo Run-In|Did not meet blood pressure criteria|0
1280346|NCT00389519|4181821|P3|Placebo Run-In|Did not meet blood pressure criteria|0
1280347|NCT00389519|4181822|P2|Placebo Run-In|Did not meet blood pressure criteria|0
1280348|NCT00389519|4181823|P1|Placebo Run-In|Did not meet blood pressure criteria|119
1280349|NCT00389441|4181900|P1|Overall Study|Clinical progression|1
1280350|NCT00389441|4181900|P1|Overall Study|Ongoing in study A4061008 (NCT00828919)|2
1280351|NCT00389441|4181900|P1|Overall Study|Objective progression or relapse|26
1280352|NCT00389441|4181900|P1|Overall Study|Global deterioration of health status|4
1280353|NCT00389441|4181900|P1|Overall Study|Protocol Violation|1
1280354|NCT00389441|4181900|P1|Overall Study|Physician Decision|1
1280355|NCT00389441|4181900|P1|Overall Study|Withdrawal by Subject|4
1280356|NCT00389441|4181900|P1|Overall Study|Lost to Follow-up|2
1280357|NCT00389441|4181900|P1|Overall Study|Death|4
1280358|NCT00389441|4181900|P1|Overall Study|Adverse Event|7
1280359|NCT00389324|4181909|P1|Subcutaneous Phase|Lost to Follow-up|1
1280360|NCT00389324|4181909|P1|Subcutaneous Phase|Withdrawal by Subject|2
1280361|NCT00389324|4181909|P1|Subcutaneous Phase|Non-compliance with study medication|2
1280362|NCT00389324|4181909|P1|Subcutaneous Phase|Adverse Event|2
1280363|NCT00389324|4181909|P1|Run-In Phase|Withdrawal by Subject|1
1280364|NCT00389324|4181909|P1|Run-In Phase|Lost to Follow-up|1
1280365|NCT00389324|4181909|P1|Run-In Phase|Adverse Event|1
1280366|NCT00389207|4181919|P3|Overall Study|Not specified|9
1280367|NCT00389207|4181920|P2|Overall Study|Not specified|23
1280368|NCT00389207|4181921|P1|Overall Study|Not specified|17
1280369|NCT00389207|4181919|P3|Overall Study|Withdrawal by Subject|11
1280370|NCT00389207|4181920|P2|Overall Study|Withdrawal by Subject|7
1280371|NCT00389207|4181921|P1|Overall Study|Withdrawal by Subject|5
1280372|NCT00389207|4181919|P3|Overall Study|Lost to Follow-up|7
1280373|NCT00389207|4181920|P2|Overall Study|Lost to Follow-up|9
1280374|NCT00389207|4181921|P1|Overall Study|Lost to Follow-up|12
1280375|NCT00389207|4181919|P3|Overall Study|Protocol Violation|4
1280376|NCT00389207|4181920|P2|Overall Study|Protocol Violation|1
1280377|NCT00389207|4181921|P1|Overall Study|Protocol Violation|3
1280378|NCT00389207|4181919|P3|Overall Study|Adverse Event|10
1280379|NCT00389207|4181920|P2|Overall Study|Adverse Event|32
1280380|NCT00389207|4181921|P1|Overall Study|Adverse Event|26
1280381|NCT00389064|4182044|P2|Overall Study|Multiple Reasons|11
1280382|NCT00389064|4182045|P1|Overall Study|Multiple Reasons|9
1280383|NCT00389064|4182044|P2|Overall Study|Protocol Violation|0
1280384|NCT00389064|4182045|P1|Overall Study|Protocol Violation|2
1280385|NCT00389064|4182044|P2|Overall Study|Lost to Follow-up|2
1280386|NCT00389064|4182045|P1|Overall Study|Lost to Follow-up|1
1280387|NCT00389064|4182044|P2|Overall Study|Physician Decision|2
1280388|NCT00389064|4182045|P1|Overall Study|Physician Decision|2
1280389|NCT00389064|4182044|P2|Overall Study|Withdrawal by Subject|27
1280390|NCT00389064|4182045|P1|Overall Study|Withdrawal by Subject|17
1280391|NCT00389064|4182044|P2|Overall Study|Lack of Efficacy|14
1280392|NCT00389064|4182045|P1|Overall Study|Lack of Efficacy|3
1280393|NCT00389064|4182044|P2|Overall Study|Adverse Event|3
1280394|NCT00389064|4182045|P1|Overall Study|Adverse Event|11
1280395|NCT00388973|4182073|P2|Overall Study|Did not complete 2-week follow-up visit|17
1280396|NCT00388973|4182074|P1|Overall Study|Did not complete 2-week follow-up visit|17
1280397|NCT00388973|4182073|P2|Overall Study|Left region|1
1280398|NCT00388973|4182074|P1|Overall Study|Left region|0
1280399|NCT00388973|4182073|P2|Overall Study|Did not complete 61 days of treatment|4
1280400|NCT00388973|4182074|P1|Overall Study|Did not complete 61 days of treatment|5
1280401|NCT00388973|4182073|P2|Overall Study|Study specific Discontinuation Criteria|1
1280402|NCT00388973|4182074|P1|Overall Study|Study specific Discontinuation Criteria|0
1280403|NCT00388973|4182073|P2|Overall Study|Withdrawal by Subject|17
1280404|NCT00388973|4182074|P1|Overall Study|Withdrawal by Subject|14
1280405|NCT00388973|4182073|P2|Overall Study|Protocol Violation|0
1280406|NCT00388973|4182074|P1|Overall Study|Protocol Violation|3
1280407|NCT00388973|4182073|P2|Overall Study|Lack of Efficacy|12
1280408|NCT00388973|4182074|P1|Overall Study|Lack of Efficacy|1
1280409|NCT00388973|4182073|P2|Overall Study|Adverse Event|6
1280410|NCT00388973|4182074|P1|Overall Study|Adverse Event|16
1280411|NCT00388947|4182094|P1|Overall Study|Protocol Violation|47
1280412|NCT00388726|4182110|P2|Overall Study|Death|2
1280413|NCT00388726|4182111|P1|Overall Study|Death|3
1280414|NCT00388726|4182110|P2|Overall Study|Physician Decision|13
1280415|NCT00388726|4182111|P1|Overall Study|Physician Decision|18
1280416|NCT00388726|4182110|P2|Overall Study|Administrative|9
1280417|NCT00388726|4182111|P1|Overall Study|Administrative|6
1280418|NCT00388726|4182110|P2|Overall Study|Withdrawal by Subject|7
1280419|NCT00388726|4182111|P1|Overall Study|Withdrawal by Subject|10
1280420|NCT00388726|4182110|P2|Overall Study|Clinical Progression|36
1280421|NCT00388726|4182111|P1|Overall Study|Clinical Progression|61
1280422|NCT00388726|4182110|P2|Overall Study|Progressive Disease|153
1280423|NCT00388726|4182111|P1|Overall Study|Progressive Disease|336
1280424|NCT00388726|4182110|P2|Overall Study|Adverse Event|24
1280425|NCT00388726|4182111|P1|Overall Study|Adverse Event|50
1280426|NCT00388674|4182125|P2|End of Study|Not Reported|1
1280427|NCT00388674|4182126|P1|End of Study|Not Reported|0
1280428|NCT00388674|4182125|P2|End of Study|No Off-Treatment Status Data|30
1280429|NCT00388674|4182126|P1|End of Study|No Off-Treatment Status Data|22
1280430|NCT00388674|4182125|P2|End of Study|Participant Withdrew Consent|673
1280431|NCT00388674|4182126|P1|End of Study|Participant Withdrew Consent|437
1280432|NCT00388674|4182125|P2|End of Study|Not Defined|214
1280433|NCT00388674|4182126|P1|End of Study|Not Defined|135
1280434|NCT00388674|4182125|P2|End of Study|Non-Study Related Comorbidities|4
1280435|NCT00388674|4182126|P1|End of Study|Non-Study Related Comorbidities|3
1280436|NCT00388674|4182125|P2|End of Study|Malignancy (Non-HCC)|1
1280437|NCT00388674|4182126|P1|End of Study|Malignancy (Non-HCC)|1
1280438|NCT00388674|4182125|P2|End of Study|Lost to Follow-up|715
1280439|NCT00388674|4182126|P1|End of Study|Lost to Follow-up|587
1280440|NCT00388674|4182125|P2|End of Study|HCC|7
1280441|NCT00388674|4182126|P1|End of Study|HCC|8
1280442|NCT00388674|4182125|P2|End of Study|HBV Disease Progression (Non-HCC)|9
1280443|NCT00388674|4182126|P1|End of Study|HBV Disease Progression (Non-HCC)|3
1280444|NCT00388674|4182125|P2|End of Study|Death|262
1280445|NCT00388674|4182126|P1|End of Study|Death|239
1280446|NCT00388674|4182125|P2|End of Study|Administrative Reason By Sponsor|253
1280447|NCT00388674|4182126|P1|End of Study|Administrative Reason By Sponsor|299
1280448|NCT00388674|4182125|P2|Initial Treatment|Not Reported|12
1280449|NCT00388674|4182126|P1|Initial Treatment|Not Reported|10
1280450|NCT00388674|4182125|P2|Initial Treatment|No Off-Treatment Status Data|13
1280451|NCT00388674|4182126|P1|Initial Treatment|No Off-Treatment Status Data|11
1280452|NCT00388674|4182125|P2|Initial Treatment|Participant Request|673
1280453|NCT00388674|4182126|P1|Initial Treatment|Participant Request|501
1280454|NCT00388674|4182125|P2|Initial Treatment|Study Drug Toxicity|92
1280455|NCT00388674|4182126|P1|Initial Treatment|Study Drug Toxicity|5
1280456|NCT00388674|4182125|P2|Initial Treatment|Pregnancy|16
1280457|NCT00388674|4182126|P1|Initial Treatment|Pregnancy|26
1280458|NCT00388674|4182125|P2|Initial Treatment|Partial or inadequate Treatment|472
1280459|NCT00388674|4182126|P1|Initial Treatment|Partial or inadequate Treatment|112
1280460|NCT00388674|4182125|P2|Initial Treatment|Not Defined|172
1280461|NCT00388674|4182126|P1|Initial Treatment|Not Defined|125
1280462|NCT00388674|4182125|P2|Initial Treatment|Non-Study related Comorbidities|4
1280463|NCT00388674|4182126|P1|Initial Treatment|Non-Study related Comorbidities|3
1280464|NCT00388674|4182125|P2|Initial Treatment|Never Treated with Study Medication|7
1280465|NCT00388674|4182126|P1|Initial Treatment|Never Treated with Study Medication|1
1280466|NCT00388674|4182125|P2|Initial Treatment|Malignancy (Non-HCC)|3
1280467|NCT00388674|4182126|P1|Initial Treatment|Malignancy (Non-HCC)|7
1280468|NCT00388674|4182125|P2|Initial Treatment|Lost to Follow-up|624
1280469|NCT00388674|4182126|P1|Initial Treatment|Lost to Follow-up|526
1280470|NCT00388674|4182125|P2|Initial Treatment|HCC|20
1280471|NCT00388674|4182126|P1|Initial Treatment|HCC|12
1280472|NCT00388674|4182125|P2|Initial Treatment|Non-HCC HBV Disease Progression|17
1280473|NCT00388674|4182126|P1|Initial Treatment|Non-HCC HBV Disease Progression|11
1280474|NCT00388674|4182125|P2|Initial Treatment|Death|216
1280475|NCT00388674|4182126|P1|Initial Treatment|Death|215
1280476|NCT00388674|4182125|P2|Initial Treatment|Adverse Event|87
1280477|NCT00388674|4182126|P1|Initial Treatment|Adverse Event|22
1280478|NCT00388674|4182125|P2|Initial Treatment|Administrative Reason by Sponsor|158
1280479|NCT00388674|4182126|P1|Initial Treatment|Administrative Reason by Sponsor|241
1280480|NCT00388583|4182144|P2|Overall Study|Did not receive vaccine|1
1280481|NCT00388583|4182145|P1|Overall Study|Did not receive vaccine|0
1280482|NCT00388583|4182144|P2|Overall Study|Serious Adverse Event|0
1280483|NCT00388583|4182145|P1|Overall Study|Serious Adverse Event|2
1280484|NCT00388583|4182144|P2|Overall Study|Withdrawal by Subject|3
1280485|NCT00388583|4182145|P1|Overall Study|Withdrawal by Subject|3
1280486|NCT00388583|4182144|P2|Overall Study|Protocol Violation|0
1280487|NCT00388583|4182145|P1|Overall Study|Protocol Violation|1
1280488|NCT00388505|4182159|P2|Overall Study|Unable to classify|3
1280489|NCT00388505|4182160|P1|Overall Study|Unable to classify|4
1280490|NCT00388505|4182159|P2|Overall Study|Protocol Violation|5
1280491|NCT00388505|4182160|P1|Overall Study|Protocol Violation|6
1280492|NCT00388505|4182159|P2|Overall Study|Administrative Reason|0
1280493|NCT00388505|4182160|P1|Overall Study|Administrative Reason|1
1280494|NCT00388505|4182159|P2|Overall Study|Inappropriate Enrollment|1
1280495|NCT00388505|4182160|P1|Overall Study|Inappropriate Enrollment|0
1280496|NCT00388505|4182159|P2|Overall Study|Lost to Follow-up|3
1280497|NCT00388505|4182160|P1|Overall Study|Lost to Follow-up|5
1280498|NCT00388505|4182159|P2|Overall Study|Withdrawal by Subject|9
1280499|NCT00388505|4182160|P1|Overall Study|Withdrawal by Subject|24
1280500|NCT00388505|4182159|P2|Overall Study|Adverse Event or Death|17
1280501|NCT00388505|4182160|P1|Overall Study|Adverse Event or Death|43
1280502|NCT00388362|4182215|P1|Remained on Study Median of 514 Days|Death|2
1280503|NCT00388362|4182215|P1|Enrolled|Withdrawal by Subject|1
1280504|NCT00388362|4182215|P1|Enrolled|Loss insurance|1
1280505|NCT00388362|4182215|P1|Enrolled|Death|1
1280506|NCT00388362|4182215|P1|Enrolled|Adverse Event|9
1280507|NCT00388362|4182215|P1|Enrolled|Ineligible|1
1280508|NCT00388349|4182220|P2|Phase I Dose Escalation|Dose reduction due to DLT|3
1280509|NCT00388349|4182221|P1|Phase I Dose Escalation|Dose reduction due to DLT|0
1280510|NCT00388154|4182230|P1|Overall Study|Withdrawal by Subject|1
1280511|NCT00388037|4182235|P1|Overall Study|Protocol Violation|1
1280512|NCT00387894|4182243|P1|Overall Study|Withdrawal by Subject|1
1280513|NCT00387881|4182250|P2|Overall Study|Not otherwise specified|7
1280514|NCT00387881|4182251|P1|Overall Study|Not otherwise specified|11
1280515|NCT00387881|4182250|P2|Overall Study|No opportunity to treat headache|34
1280516|NCT00387881|4182251|P1|Overall Study|No opportunity to treat headache|32
1280517|NCT00387881|4182250|P2|Overall Study|Not eligible|7
1280518|NCT00387881|4182251|P1|Overall Study|Not eligible|6
1280519|NCT00387881|4182250|P2|Overall Study|Sponsor terminated Study|1
1280520|NCT00387881|4182251|P1|Overall Study|Sponsor terminated Study|0
1280521|NCT00387881|4182250|P2|Overall Study|Withdrawal by Subject|18
1280522|NCT00387881|4182251|P1|Overall Study|Withdrawal by Subject|15
1280523|NCT00387881|4182250|P2|Overall Study|Protocol Violation|12
1280524|NCT00387881|4182251|P1|Overall Study|Protocol Violation|2
1280525|NCT00387881|4182250|P2|Overall Study|Lost to Follow-up|23
1280526|NCT00387881|4182251|P1|Overall Study|Lost to Follow-up|23
1280527|NCT00387790|4182284|P1|Overall Study|Ineligible for study|2
1280528|NCT00387790|4182284|P1|Overall Study|Withdrawal by Subject|3
1280529|NCT00387790|4182284|P1|Overall Study|Physician Decision|2
1280530|NCT00387790|4182284|P1|Overall Study|Lack of Efficacy|2
1280531|NCT00387790|4182284|P1|Overall Study|Adverse Event|5
1280532|NCT00387764|4182290|P1|Overall Study|Death|7
1280533|NCT00387764|4182290|P1|Overall Study|Other|2
1280534|NCT00387764|4182290|P1|Overall Study|Physician Decision|1
1280535|NCT00387764|4182290|P1|Overall Study|Sponsor Terminated Study|1
1280536|NCT00387764|4182290|P1|Overall Study|Withdrawal by Subject|8
1280537|NCT00387764|4182290|P1|Overall Study|Adverse Event|12
1280538|NCT00387725|4182318|P4|Overall Study|Parent/legal guardian request|1
1280539|NCT00387725|4182319|P3|Overall Study|Parent/legal guardian request|1
1280540|NCT00387725|4182320|P2|Overall Study|Parent/legal guardian request|0
1280541|NCT00387725|4182321|P1|Overall Study|Parent/legal guardian request|0
1280542|NCT00387725|4182318|P4|Overall Study|Withdrawal by Subject|0
1280543|NCT00387725|4182319|P3|Overall Study|Withdrawal by Subject|1
1280544|NCT00387725|4182320|P2|Overall Study|Withdrawal by Subject|0
1280545|NCT00387725|4182321|P1|Overall Study|Withdrawal by Subject|1
1280546|NCT00387725|4182318|P4|Overall Study|Protocol Violation|0
1280547|NCT00387725|4182319|P3|Overall Study|Protocol Violation|0
1280548|NCT00387725|4182320|P2|Overall Study|Protocol Violation|1
1280549|NCT00387725|4182321|P1|Overall Study|Protocol Violation|0
1280550|NCT00387725|4182318|P4|Overall Study|Adverse Event|1
1280551|NCT00387725|4182319|P3|Overall Study|Adverse Event|0
1280552|NCT00387725|4182320|P2|Overall Study|Adverse Event|0
1280553|NCT00387725|4182321|P1|Overall Study|Adverse Event|0
1280554|NCT00387712|4182341|P2|Overall Study|Withdrawal by Subject|12
1280555|NCT00387712|4182342|P1|Overall Study|Withdrawal by Subject|6
1280556|NCT00387712|4182341|P2|Overall Study|Lost to Follow-up|20
1280557|NCT00387712|4182342|P1|Overall Study|Lost to Follow-up|17
1280558|NCT00387712|4182341|P2|Overall Study|Physician Decision|4
1280559|NCT00387712|4182342|P1|Overall Study|Physician Decision|6
1280560|NCT00387647|4182373|P1|Overall Study|Death|18
1280561|NCT00387426|4182413|P1|Overall Study|Disease Progression|3
1280562|NCT00387426|4182413|P1|Overall Study|Toxicities|4
1280563|NCT00387426|4182413|P1|Overall Study|Lack of Response|7
1280564|NCT00387348|4182420|P3|Overall Study|Adverse Event|1
1280565|NCT00387348|4182421|P2|Overall Study|Adverse Event|0
1280566|NCT00387348|4182422|P1|Overall Study|Adverse Event|1
1280567|NCT00387348|4182420|P3|Overall Study|Withdrawal by Subject|2
1280568|NCT00387348|4182421|P2|Overall Study|Withdrawal by Subject|2
1280569|NCT00387348|4182422|P1|Overall Study|Withdrawal by Subject|0
1280570|NCT00387348|4182420|P3|Overall Study|Physician Decision|1
1280571|NCT00387348|4182421|P2|Overall Study|Physician Decision|0
1280572|NCT00387348|4182422|P1|Overall Study|Physician Decision|1
1280573|NCT00387348|4182420|P3|Overall Study|Death|0
1280574|NCT00387348|4182421|P2|Overall Study|Death|1
1280575|NCT00387348|4182422|P1|Overall Study|Death|1
1280576|NCT00387153|4182451|P1|Overall Study|Lack of Response|4
1280577|NCT00387153|4182451|P1|Overall Study|Disease Progression|3
1280578|NCT00387153|4182451|P1|Overall Study|Adverse Event|1
1280579|NCT00387127|4182457|P2|Overall Study|Sponsor Unblinded|0
1280580|NCT00387127|4182458|P1|Overall Study|Sponsor Unblinded|1
1280581|NCT00387127|4182457|P2|Overall Study|Serious Adverse Event|1
1280582|NCT00387127|4182458|P1|Overall Study|Serious Adverse Event|1
1280583|NCT00387127|4182457|P2|Overall Study|Required by Protocol Amendment #4|10
1280584|NCT00387127|4182458|P1|Overall Study|Required by Protocol Amendment #4|12
1280585|NCT00387127|4182457|P2|Overall Study|Withdrawal by Subject|2
1280586|NCT00387127|4182458|P1|Overall Study|Withdrawal by Subject|3
1280587|NCT00387127|4182457|P2|Overall Study|Physician Decision|1
1280588|NCT00387127|4182458|P1|Overall Study|Physician Decision|0
1280589|NCT00387127|4182457|P2|Overall Study|Death|16
1280590|NCT00387127|4182458|P1|Overall Study|Death|16
1280591|NCT00387127|4182457|P2|Overall Study|Lost to Follow-up|4
1280592|NCT00387127|4182458|P1|Overall Study|Lost to Follow-up|0
1280593|NCT00387088|4182500|P2|Overall Study|Other|52
1280594|NCT00387088|4182501|P1|Overall Study|Other|58
1280595|NCT00387088|4182500|P2|Overall Study|Lost to Follow-up|28
1280596|NCT00387088|4182501|P1|Overall Study|Lost to Follow-up|22
1280597|NCT00387088|4182500|P2|Overall Study|Lack of Efficacy|67
1280598|NCT00387088|4182501|P1|Overall Study|Lack of Efficacy|28
1280599|NCT00387088|4182500|P2|Overall Study|Withdrawal by Subject|35
1280600|NCT00387088|4182501|P1|Overall Study|Withdrawal by Subject|20
1280601|NCT00387088|4182500|P2|Overall Study|Protocol Violation|35
1280602|NCT00387088|4182501|P1|Overall Study|Protocol Violation|47
1280603|NCT00387088|4182500|P2|Overall Study|Adverse Event|156
1280604|NCT00387088|4182501|P1|Overall Study|Adverse Event|143
1280605|NCT00387010|4182558|P1|Treatment Period|Participant reported study drug stolen|1
1280606|NCT00387010|4182558|P1|Treatment Period|Noncompliance with study procedures|3
1280607|NCT00387010|4182558|P1|Treatment Period|Noncompliance with study medication|2
1280608|NCT00387010|4182558|P1|Treatment Period|Withdrawal by Subject|1
1280609|NCT00387010|4182558|P1|Treatment Period|Adverse Event|4
1280610|NCT00387010|4182558|P1|Dose Titration Period|Noncompliance with study procedures|7
1280611|NCT00387010|4182558|P1|Dose Titration Period|Noncompliance with study medication|8
1280612|NCT00387010|4182558|P1|Dose Titration Period|Lost to Follow-up|2
1280613|NCT00387010|4182558|P1|Dose Titration Period|Protocol Violation|1
1280614|NCT00387010|4182558|P1|Dose Titration Period|Withdrawal by Subject|3
1280615|NCT00387010|4182558|P1|Dose Titration Period|Lack of Efficacy|5
1280616|NCT00387010|4182558|P1|Dose Titration Period|Adverse Event|12
1280617|NCT00386776|4182585|P1|Overall Study|Withdrawal by Subject|8
1280618|NCT00386607|4182595|P2|Extension|Unsatisfactory therapeutic effect|1
1280619|NCT00386607|4182596|P1|Extension|Unsatisfactory therapeutic effect|0
1280620|NCT00386607|4182595|P2|Extension|Patient withdrew consent|5
1280621|NCT00386607|4182596|P1|Extension|Patient withdrew consent|0
1280622|NCT00386607|4182595|P2|Extension|Lost to Follow-up|3
1280623|NCT00386607|4182596|P1|Extension|Lost to Follow-up|0
1280624|NCT00386607|4182595|P2|Extension|Administrative problems|1
1280625|NCT00386607|4182596|P1|Extension|Administrative problems|0
1280626|NCT00386607|4182595|P2|Extension|Abnormal laboratory value(s)|1
1280627|NCT00386607|4182596|P1|Extension|Abnormal laboratory value(s)|0
1280628|NCT00386607|4182595|P2|Extension|Adverse Event|6
1280629|NCT00386607|4182596|P1|Extension|Adverse Event|0
1280630|NCT00386607|4182595|P2|Core|Protocol Deviation|0
1280631|NCT00386607|4182596|P1|Core|Protocol Deviation|6
1280632|NCT00386607|4182595|P2|Core|Administrative problems|0
1280633|NCT00386607|4182596|P1|Core|Administrative problems|1
1280634|NCT00386607|4182595|P2|Core|Lost to Follow-up|0
1280635|NCT00386607|4182596|P1|Core|Lost to Follow-up|23
1280636|NCT00386607|4182595|P2|Core|Patient withdrew consent|0
1280637|NCT00386607|4182596|P1|Core|Patient withdrew consent|15
1280638|NCT00386607|4182595|P2|Core|Condition no longer requires study drug|0
1280639|NCT00386607|4182596|P1|Core|Condition no longer requires study drug|4
1280640|NCT00386607|4182595|P2|Core|Unsatisfactory therapeutic effect|0
1280641|NCT00386607|4182596|P1|Core|Unsatisfactory therapeutic effect|23
1280642|NCT00386607|4182595|P2|Core|Abnormal laboratory value(s)|0
1280643|NCT00386607|4182596|P1|Core|Abnormal laboratory value(s)|3
1280644|NCT00386607|4182595|P2|Core|Adverse Event|0
1280645|NCT00386607|4182596|P1|Core|Adverse Event|40
1280646|NCT00386425|4182624|P3|Overall Study|Withdrawal by Subject|0
1280647|NCT00386425|4182625|P2|Overall Study|Withdrawal by Subject|1
1280648|NCT00386425|4182626|P1|Overall Study|Withdrawal by Subject|0
1280649|NCT00386425|4182624|P3|Overall Study|Physician Decision|0
1280650|NCT00386425|4182625|P2|Overall Study|Physician Decision|0
1280651|NCT00386425|4182626|P1|Overall Study|Physician Decision|3
1280652|NCT00386360|4182652|P2|Overall Study|Did not take any study medication|2
1280653|NCT00386360|4182653|P1|Overall Study|Did not take any study medication|0
1280654|NCT00386360|4182652|P2|Overall Study|Withdrawal by Subject|6
1280655|NCT00386360|4182653|P1|Overall Study|Withdrawal by Subject|3
1280656|NCT00386360|4182652|P2|Overall Study|Protocol Violation|3
1280657|NCT00386360|4182653|P1|Overall Study|Protocol Violation|0
1280658|NCT00386360|4182652|P2|Overall Study|Lost to Follow-up|2
1280659|NCT00386360|4182653|P1|Overall Study|Lost to Follow-up|0
1280660|NCT00386360|4182652|P2|Overall Study|Physician Decision|2
1280661|NCT00386360|4182653|P1|Overall Study|Physician Decision|2
1280662|NCT00386360|4182652|P2|Overall Study|Adverse Event|2
1280663|NCT00386360|4182653|P1|Overall Study|Adverse Event|4
1280664|NCT00386334|4182687|P2|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1
1280665|NCT00386334|4182688|P1|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3
1280666|NCT00386334|4182687|P2|Double Blind Period|Other|3
1280667|NCT00386334|4182688|P1|Double Blind Period|Other|3
1280668|NCT00386334|4182687|P2|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5
1280669|NCT00386334|4182688|P1|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4
1280670|NCT00386334|4182687|P2|Double Blind Period|Lack of Efficacy|11
1280671|NCT00386334|4182688|P1|Double Blind Period|Lack of Efficacy|20
1280672|NCT00386334|4182687|P2|Double Blind Period|Withdrawal by Subject|13
1280673|NCT00386334|4182688|P1|Double Blind Period|Withdrawal by Subject|9
1280674|NCT00386334|4182687|P2|Double Blind Period|Protocol Violation|1
1280675|NCT00386334|4182688|P1|Double Blind Period|Protocol Violation|1
1280676|NCT00386334|4182687|P2|Double Blind Period|Adverse Event|14
1280677|NCT00386334|4182688|P1|Double Blind Period|Adverse Event|9
1280678|NCT00386308|4182832|P2|Overall Study|Other Event|1
1280679|NCT00386308|4182833|P1|Overall Study|Other Event|8
1280680|NCT00386308|4182832|P2|Overall Study|Withdrawal by Subject|2
1280681|NCT00386308|4182833|P1|Overall Study|Withdrawal by Subject|6
1280682|NCT00386308|4182832|P2|Overall Study|Lost to Follow-up|6
1280683|NCT00386308|4182833|P1|Overall Study|Lost to Follow-up|10
1280684|NCT00386308|4182832|P2|Overall Study|Lack of Efficacy|2
1280685|NCT00386308|4182833|P1|Overall Study|Lack of Efficacy|0
1280686|NCT00386308|4182832|P2|Overall Study|Protocol Violation|5
1280687|NCT00386308|4182833|P1|Overall Study|Protocol Violation|2
1280688|NCT00386308|4182832|P2|Overall Study|Adverse Event|3
1280689|NCT00386308|4182833|P1|Overall Study|Adverse Event|3
1280690|NCT00386152|4182880|P3|Overall Study|Withdrawal by Subject|10
1280691|NCT00386152|4182881|P2|Overall Study|Withdrawal by Subject|6
1280692|NCT00386152|4182882|P1|Overall Study|Withdrawal by Subject|3
1280693|NCT00386152|4182880|P3|Overall Study|Protocol Violation|2
1280694|NCT00386152|4182881|P2|Overall Study|Protocol Violation|5
1280695|NCT00386152|4182882|P1|Overall Study|Protocol Violation|3
1280696|NCT00386152|4182880|P3|Overall Study|Completed chemotherapy|1
1280697|NCT00386152|4182881|P2|Overall Study|Completed chemotherapy|5
1280698|NCT00386152|4182882|P1|Overall Study|Completed chemotherapy|4
1280699|NCT00386152|4182880|P3|Overall Study|Lost to Follow-up|0
1280700|NCT00386152|4182881|P2|Overall Study|Lost to Follow-up|0
1280701|NCT00386152|4182882|P1|Overall Study|Lost to Follow-up|1
1280702|NCT00386152|4182880|P3|Overall Study|Physician Decision|4
1280703|NCT00386152|4182881|P2|Overall Study|Physician Decision|10
1280704|NCT00386152|4182882|P1|Overall Study|Physician Decision|13
1280705|NCT00386152|4182880|P3|Overall Study|Disease progression|5
1280706|NCT00386152|4182881|P2|Overall Study|Disease progression|4
1280707|NCT00386152|4182882|P1|Overall Study|Disease progression|7
1280708|NCT00386152|4182880|P3|Overall Study|Death|1
1280709|NCT00386152|4182881|P2|Overall Study|Death|0
1280710|NCT00386152|4182882|P1|Overall Study|Death|3
1280711|NCT00386152|4182880|P3|Overall Study|Chang from original chemo stratification|6
1280712|NCT00386152|4182881|P2|Overall Study|Chang from original chemo stratification|5
1280713|NCT00386152|4182882|P1|Overall Study|Chang from original chemo stratification|4
1280714|NCT00386152|4182880|P3|Overall Study|Adverse Event|4
1280715|NCT00386152|4182881|P2|Overall Study|Adverse Event|5
1280716|NCT00386152|4182882|P1|Overall Study|Adverse Event|6
1280717|NCT00386100|4182901|P2|Overall Study|Participant randomized in error|0
1280718|NCT00386100|4182902|P1|Overall Study|Participant randomized in error|1
1280719|NCT00386100|4182901|P2|Overall Study|Hb1Ac >8%|1
1280720|NCT00386100|4182902|P1|Overall Study|Hb1Ac >8%|0
1280721|NCT00386100|4182901|P2|Overall Study|Out of country for 5 months|0
1280722|NCT00386100|4182902|P1|Overall Study|Out of country for 5 months|1
1280723|NCT00386100|4182901|P2|Overall Study|Positive pregnancy test|3
1280724|NCT00386100|4182902|P1|Overall Study|Positive pregnancy test|1
1280725|NCT00386100|4182901|P2|Overall Study|Osteoporosis|1
1280726|NCT00386100|4182902|P1|Overall Study|Osteoporosis|0
1280727|NCT00386100|4182901|P2|Overall Study|7.6% bone loss|0
1280728|NCT00386100|4182902|P1|Overall Study|7.6% bone loss|1
1280729|NCT00386100|4182901|P2|Overall Study|DBP 93 mmHg at randomization|0
1280730|NCT00386100|4182902|P1|Overall Study|DBP 93 mmHg at randomization|1
1280731|NCT00386100|4182901|P2|Overall Study|Bone loss by DXA bone scan|0
1280732|NCT00386100|4182902|P1|Overall Study|Bone loss by DXA bone scan|1
1280733|NCT00386100|4182901|P2|Overall Study|Bad metabolic control & patient security|0
1280734|NCT00386100|4182902|P1|Overall Study|Bad metabolic control & patient security|1
1280735|NCT00386100|4182901|P2|Overall Study|Osteoporosis findings on Visit 2 DXA|1
1280736|NCT00386100|4182902|P1|Overall Study|Osteoporosis findings on Visit 2 DXA|0
1280737|NCT00386100|4182901|P2|Overall Study|Participant's PCP wanted to stop drug|0
1280738|NCT00386100|4182902|P1|Overall Study|Participant's PCP wanted to stop drug|1
1280739|NCT00386100|4182901|P2|Overall Study|Didn't meet entry criteria|1
1280740|NCT00386100|4182902|P1|Overall Study|Didn't meet entry criteria|1
1280741|NCT00386100|4182901|P2|Overall Study|Excessive bone loss vs. baseline value|1
1280742|NCT00386100|4182902|P1|Overall Study|Excessive bone loss vs. baseline value|0
1280743|NCT00386100|4182901|P2|Overall Study|Participant moving out of state|0
1280744|NCT00386100|4182902|P1|Overall Study|Participant moving out of state|2
1280745|NCT00386100|4182901|P2|Overall Study|Participant's concern due to CPK levels|0
1280746|NCT00386100|4182902|P1|Overall Study|Participant's concern due to CPK levels|1
1280747|NCT00386100|4182901|P2|Overall Study|Laboratory findings|0
1280748|NCT00386100|4182902|P1|Overall Study|Laboratory findings|1
1280749|NCT00386100|4182901|P2|Overall Study|Visit 11 DXA showed excessive bone loss|1
1280750|NCT00386100|4182902|P1|Overall Study|Visit 11 DXA showed excessive bone loss|0
1280751|NCT00386100|4182901|P2|Overall Study|Consecutive elevated Hba1C|0
1280752|NCT00386100|4182902|P1|Overall Study|Consecutive elevated Hba1C|1
1280753|NCT00386100|4182901|P2|Overall Study|BMD <2.5|0
1280754|NCT00386100|4182902|P1|Overall Study|BMD <2.5|1
1280755|NCT00386100|4182901|P2|Overall Study|Bone mass density (BMD) loss >6%|4
1280756|NCT00386100|4182902|P1|Overall Study|Bone mass density (BMD) loss >6%|4
1280757|NCT00386100|4182901|P2|Overall Study|Withdrawal by Subject|31
1280758|NCT00386100|4182902|P1|Overall Study|Withdrawal by Subject|32
1280759|NCT00386100|4182901|P2|Overall Study|Protocol Violation|3
1280760|NCT00386100|4182902|P1|Overall Study|Protocol Violation|5
1280761|NCT00386100|4182901|P2|Overall Study|Non-compliance|19
1280762|NCT00386100|4182902|P1|Overall Study|Non-compliance|18
1280763|NCT00386100|4182901|P2|Overall Study|Lost to Follow-up|29
1280764|NCT00386100|4182902|P1|Overall Study|Lost to Follow-up|29
1280765|NCT00386100|4182901|P2|Overall Study|Insufficient therapeutic effect|6
1280766|NCT00386100|4182902|P1|Overall Study|Insufficient therapeutic effect|30
1280767|NCT00386100|4182901|P2|Overall Study|Death|1
1280768|NCT00386100|4182902|P1|Overall Study|Death|0
1280769|NCT00386100|4182901|P2|Overall Study|Adverse Event|25
1280770|NCT00386100|4182902|P1|Overall Study|Adverse Event|15
1280771|NCT00386100|4182901|P2|Overall Study|Did not receive study medication|4
1280772|NCT00386100|4182902|P1|Overall Study|Did not receive study medication|6
1280773|NCT00386022|4182966|P2|Plus Estrogen|Adverse Event|1
1280774|NCT00386022|4182967|P1|Plus Estrogen|Adverse Event|0
1280775|NCT00386022|4182966|P2|Plus Estrogen|Lost to Follow-up|0
1280776|NCT00386022|4182967|P1|Plus Estrogen|Lost to Follow-up|2
1280777|NCT00386009|4182977|P2|Overall Study|Withdrawal by Subject|4
1280778|NCT00386009|4182978|P1|Overall Study|Withdrawal by Subject|5
1280779|NCT00386009|4182977|P2|Overall Study|Sponsor Decision|1
1280780|NCT00386009|4182978|P1|Overall Study|Sponsor Decision|1
1280781|NCT00386009|4182977|P2|Overall Study|Protocol Violation|0
1280782|NCT00386009|4182978|P1|Overall Study|Protocol Violation|1
1280783|NCT00386009|4182977|P2|Overall Study|Lost to Follow-up|1
1280784|NCT00386009|4182978|P1|Overall Study|Lost to Follow-up|1
1280785|NCT00386009|4182977|P2|Overall Study|Entry Criteria Not Met|2
1280786|NCT00386009|4182978|P1|Overall Study|Entry Criteria Not Met|0
1280787|NCT00386009|4182977|P2|Overall Study|Death|0
1280788|NCT00386009|4182978|P1|Overall Study|Death|1
1280789|NCT00386009|4182977|P2|Overall Study|Adverse Event|2
1280790|NCT00386009|4182978|P1|Overall Study|Adverse Event|0
1280791|NCT00385944|4183025|P3|2nd Maintenance Dose Period|Invalid PD Data|0
1280792|NCT00385944|4183026|P2|2nd Maintenance Dose Period|Invalid PD Data|3
1280793|NCT00385944|4183027|P1|2nd Maintenance Dose Period|Invalid PD Data|2
1280794|NCT00385944|4183025|P3|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
1280795|NCT00385944|4183026|P2|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
1280796|NCT00385944|4183027|P1|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3
1280797|NCT00385944|4183025|P3|1st Maintenance Dose Period|Entry Criteria Exclusion|0
1280798|NCT00385944|4183026|P2|1st Maintenance Dose Period|Entry Criteria Exclusion|1
1280799|NCT00385944|4183027|P1|1st Maintenance Dose Period|Entry Criteria Exclusion|0
1280800|NCT00385944|4183025|P3|1st Maintenance Dose Period|Physician Decision|0
1280801|NCT00385944|4183026|P2|1st Maintenance Dose Period|Physician Decision|0
1280802|NCT00385944|4183027|P1|1st Maintenance Dose Period|Physician Decision|1
1280803|NCT00385918|4183070|P3|Intervention Phase After Randomization|Lost to Follow-up|0
1280804|NCT00385918|4183071|P2|Intervention Phase After Randomization|Lost to Follow-up|0
1280805|NCT00385918|4183072|P1|Intervention Phase After Randomization|Lost to Follow-up|1
1280806|NCT00385918|4183070|P3|Intervention Phase After Randomization|Physician Decision|0
1280807|NCT00385918|4183071|P2|Intervention Phase After Randomization|Physician Decision|0
1280808|NCT00385918|4183072|P1|Intervention Phase After Randomization|Physician Decision|1
1280809|NCT00385918|4183070|P3|Intervention Phase After Randomization|Withdrawal by Subject|0
1280810|NCT00385918|4183071|P2|Intervention Phase After Randomization|Withdrawal by Subject|0
1280811|NCT00385918|4183072|P1|Intervention Phase After Randomization|Withdrawal by Subject|1
1280812|NCT00385918|4183070|P3|Feasibility & Baseline Measurement Phase|Physician Decision|1
1280813|NCT00385918|4183071|P2|Feasibility & Baseline Measurement Phase|Physician Decision|0
1280814|NCT00385918|4183072|P1|Feasibility & Baseline Measurement Phase|Physician Decision|0
1280815|NCT00385918|4183070|P3|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5
1280816|NCT00385918|4183071|P2|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
1280817|NCT00385918|4183072|P1|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
1280818|NCT00385918|4183070|P3|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8
1280819|NCT00385918|4183071|P2|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
1280820|NCT00385918|4183072|P1|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
1280821|NCT00385840|4183096|P2|Overall Study|Lost to Follow-up|13
1280822|NCT00385840|4183097|P1|Overall Study|Lost to Follow-up|3
1280823|NCT00385840|4183096|P2|Overall Study|Adverse Event|1
1280824|NCT00385840|4183097|P1|Overall Study|Adverse Event|1
1280825|NCT00385827|4183120|P3|Part 2|Other|21
1280826|NCT00385827|4183121|P2|Part 2|Other|11
1280827|NCT00385827|4183122|P1|Part 2|Other|0
1280828|NCT00385827|4183120|P3|Part 2|Randomized but not treated|2
1280829|NCT00385827|4183121|P2|Part 2|Randomized but not treated|2
1280830|NCT00385827|4183122|P1|Part 2|Randomized but not treated|0
1280831|NCT00385827|4183120|P3|Part 2|Lack of Efficacy|13
1280832|NCT00385827|4183121|P2|Part 2|Lack of Efficacy|14
1280833|NCT00385827|4183122|P1|Part 2|Lack of Efficacy|0
1280834|NCT00385827|4183120|P3|Part 2|Death|2
1280835|NCT00385827|4183121|P2|Part 2|Death|0
1280836|NCT00385827|4183122|P1|Part 2|Death|0
1280837|NCT00385827|4183120|P3|Part 2|Adverse Event|10
1280838|NCT00385827|4183121|P2|Part 2|Adverse Event|6
1280839|NCT00385827|4183122|P1|Part 2|Adverse Event|0
1280840|NCT00385827|4183120|P3|Part 1|Other|0
1280841|NCT00385827|4183121|P2|Part 1|Other|0
1280842|NCT00385827|4183122|P1|Part 1|Other|1
1280843|NCT00385827|4183120|P3|Part 1|Lack of Efficacy|0
1280844|NCT00385827|4183121|P2|Part 1|Lack of Efficacy|0
1280845|NCT00385827|4183122|P1|Part 1|Lack of Efficacy|5
1280846|NCT00385827|4183120|P3|Part 1|Death|0
1280847|NCT00385827|4183121|P2|Part 1|Death|0
1280848|NCT00385827|4183122|P1|Part 1|Death|2
1280849|NCT00385827|4183120|P3|Part 1|Adverse Event|0
1280850|NCT00385827|4183121|P2|Part 1|Adverse Event|0
1280851|NCT00385827|4183122|P1|Part 1|Adverse Event|1
1280852|NCT00385762|4183166|P1|Overall Study|Lost to Follow-up|1
1280853|NCT00385762|4183166|P1|Overall Study|Adverse Event|1
1280854|NCT00385736|4183176|P3|Safety Analysis Set|Other|4
1280855|NCT00385736|4183177|P2|Safety Analysis Set|Other|4
1280856|NCT00385736|4183178|P1|Safety Analysis Set|Other|1
1280857|NCT00385736|4183176|P3|Safety Analysis Set|Protocol Violation|6
1280858|NCT00385736|4183177|P2|Safety Analysis Set|Protocol Violation|1
1280859|NCT00385736|4183178|P1|Safety Analysis Set|Protocol Violation|2
1280860|NCT00385736|4183176|P3|Safety Analysis Set|Lack of Efficacy|31
1280861|NCT00385736|4183177|P2|Safety Analysis Set|Lack of Efficacy|16
1280862|NCT00385736|4183178|P1|Safety Analysis Set|Lack of Efficacy|38
1280863|NCT00385736|4183176|P3|Safety Analysis Set|Lost to Follow-up|2
1280864|NCT00385736|4183177|P2|Safety Analysis Set|Lost to Follow-up|2
1280865|NCT00385736|4183178|P1|Safety Analysis Set|Lost to Follow-up|0
1280866|NCT00385736|4183176|P3|Safety Analysis Set|Withdrawal by Subject|14
1280867|NCT00385736|4183177|P2|Safety Analysis Set|Withdrawal by Subject|6
1280868|NCT00385736|4183178|P1|Safety Analysis Set|Withdrawal by Subject|6
1280869|NCT00385736|4183176|P3|Safety Analysis Set|Adverse Event|23
1280870|NCT00385736|4183177|P2|Safety Analysis Set|Adverse Event|15
1280871|NCT00385736|4183178|P1|Safety Analysis Set|Adverse Event|23
1280872|NCT00385736|4183176|P3|Efficacy Analysis Set - Maintenance|Other|4
1280873|NCT00385736|4183177|P2|Efficacy Analysis Set - Maintenance|Other|4
1280874|NCT00385736|4183178|P1|Efficacy Analysis Set - Maintenance|Other|0
1280875|NCT00385736|4183176|P3|Efficacy Analysis Set - Maintenance|Protocol Violation|6
1280876|NCT00385736|4183177|P2|Efficacy Analysis Set - Maintenance|Protocol Violation|1
1280877|NCT00385736|4183178|P1|Efficacy Analysis Set - Maintenance|Protocol Violation|2
1280878|NCT00385736|4183176|P3|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31
1280879|NCT00385736|4183177|P2|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16
1280880|NCT00385736|4183178|P1|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38
1280881|NCT00385736|4183176|P3|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
1280882|NCT00385736|4183177|P2|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
1280883|NCT00385736|4183178|P1|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0
1280884|NCT00385736|4183176|P3|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14
1280885|NCT00385736|4183177|P2|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
1280886|NCT00385736|4183178|P1|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
1280887|NCT00385736|4183176|P3|Efficacy Analysis Set - Maintenance|Adverse Event|23
1280888|NCT00385736|4183177|P2|Efficacy Analysis Set - Maintenance|Adverse Event|15
1280889|NCT00385736|4183178|P1|Efficacy Analysis Set - Maintenance|Adverse Event|23
1280890|NCT00385736|4183176|P3|Efficacy Analysis Set - Induction|Other|1
1280891|NCT00385736|4183177|P2|Efficacy Analysis Set - Induction|Other|0
1280892|NCT00385736|4183178|P1|Efficacy Analysis Set - Induction|Other|0
1280893|NCT00385736|4183176|P3|Efficacy Analysis Set - Induction|Protocol Violation|2
1280894|NCT00385736|4183177|P2|Efficacy Analysis Set - Induction|Protocol Violation|0
1280895|NCT00385736|4183178|P1|Efficacy Analysis Set - Induction|Protocol Violation|0
1280896|NCT00385736|4183176|P3|Efficacy Analysis Set - Induction|Lack of Efficacy|1
1280897|NCT00385736|4183177|P2|Efficacy Analysis Set - Induction|Lack of Efficacy|2
1280898|NCT00385736|4183178|P1|Efficacy Analysis Set - Induction|Lack of Efficacy|4
1280899|NCT00385736|4183176|P3|Efficacy Analysis Set - Induction|Lost to Follow-up|0
1280900|NCT00385736|4183177|P2|Efficacy Analysis Set - Induction|Lost to Follow-up|2
1280901|NCT00385736|4183178|P1|Efficacy Analysis Set - Induction|Lost to Follow-up|0
1280902|NCT00385736|4183176|P3|Efficacy Analysis Set - Induction|Withdrawal by Subject|1
1280903|NCT00385736|4183177|P2|Efficacy Analysis Set - Induction|Withdrawal by Subject|2
1280904|NCT00385736|4183178|P1|Efficacy Analysis Set - Induction|Withdrawal by Subject|0
1280905|NCT00385736|4183176|P3|Efficacy Analysis Set - Induction|Adverse Event|4
1280906|NCT00385736|4183177|P2|Efficacy Analysis Set - Induction|Adverse Event|6
1280907|NCT00385736|4183178|P1|Efficacy Analysis Set - Induction|Adverse Event|5
1280908|NCT00385723|4183223|P3|Overall Study|Withdrawal by Subject|2
1280909|NCT00385723|4183224|P2|Overall Study|Withdrawal by Subject|0
1280910|NCT00385723|4183225|P1|Overall Study|Withdrawal by Subject|1
1280911|NCT00385723|4183223|P3|Overall Study|Lost to Follow-up|0
1280912|NCT00385723|4183224|P2|Overall Study|Lost to Follow-up|1
1280913|NCT00385723|4183225|P1|Overall Study|Lost to Follow-up|1
1280914|NCT00385684|4183239|P2|SECOND INTERVENTION OF PHASE A|study drug recall|1
1280915|NCT00385684|4183240|P1|SECOND INTERVENTION OF PHASE A|study drug recall|0
1280916|NCT00385684|4183239|P2|SECOND INTERVENTION OF PHASE A|Adverse Event|1
1280917|NCT00385684|4183240|P1|SECOND INTERVENTION OF PHASE A|Adverse Event|0
1280918|NCT00385684|4183239|P2|FIRST INTERVENTION OF PHASE A|Death|0
1280919|NCT00385684|4183240|P1|FIRST INTERVENTION OF PHASE A|Death|1
1280920|NCT00385671|4183249|P3|Overall Study|Withdrawal by Subject|4
1280921|NCT00385671|4183250|P2|Overall Study|Withdrawal by Subject|4
1280922|NCT00385671|4183251|P1|Overall Study|Withdrawal by Subject|4
1280923|NCT00385671|4183249|P3|Overall Study|Sponsor Decision|1
1280924|NCT00385671|4183250|P2|Overall Study|Sponsor Decision|2
1280925|NCT00385671|4183251|P1|Overall Study|Sponsor Decision|2
1280926|NCT00385671|4183249|P3|Overall Study|Protocol Violation|1
1280927|NCT00385671|4183250|P2|Overall Study|Protocol Violation|2
1280928|NCT00385671|4183251|P1|Overall Study|Protocol Violation|5
1280929|NCT00385671|4183249|P3|Overall Study|Physician Decision|2
1280930|NCT00385671|4183250|P2|Overall Study|Physician Decision|1
1280931|NCT00385671|4183251|P1|Overall Study|Physician Decision|2
1280932|NCT00385671|4183249|P3|Overall Study|Lost to Follow-up|5
1280933|NCT00385671|4183250|P2|Overall Study|Lost to Follow-up|6
1280934|NCT00385671|4183251|P1|Overall Study|Lost to Follow-up|6
1280935|NCT00385671|4183249|P3|Overall Study|Lack of Efficacy|5
1280936|NCT00385671|4183250|P2|Overall Study|Lack of Efficacy|9
1280937|NCT00385671|4183251|P1|Overall Study|Lack of Efficacy|5
1280938|NCT00385671|4183249|P3|Overall Study|Adverse Event|18
1280939|NCT00385671|4183250|P2|Overall Study|Adverse Event|27
1280940|NCT00385671|4183251|P1|Overall Study|Adverse Event|14
1280941|NCT00385593|4183407|P2|Overall Study|Incorrect randomization|1
1280942|NCT00385593|4183408|P1|Overall Study|Incorrect randomization|0
1280943|NCT00385593|4183407|P2|Overall Study|Incorrect inclusion|0
1280944|NCT00385593|4183408|P1|Overall Study|Incorrect inclusion|2
1280945|NCT00385593|4183407|P2|Overall Study|Several reasons|15
1280946|NCT00385593|4183408|P1|Overall Study|Several reasons|17
1280947|NCT00385593|4183407|P2|Overall Study|Protocol Violation|4
1280948|NCT00385593|4183408|P1|Overall Study|Protocol Violation|7
1280949|NCT00385593|4183407|P2|Overall Study|Lost to Follow-up|8
1280950|NCT00385593|4183408|P1|Overall Study|Lost to Follow-up|12
1280951|NCT00385593|4183407|P2|Overall Study|Withdrawal by Subject|7
1280952|NCT00385593|4183408|P1|Overall Study|Withdrawal by Subject|17
1280953|NCT00385593|4183407|P2|Overall Study|Adverse Event|2
1280954|NCT00385593|4183408|P1|Overall Study|Adverse Event|3
1280955|NCT00385541|4183518|P2|Overall Study|severe pain, clinician requested unblind|1
1280956|NCT00385541|4183519|P1|Overall Study|severe pain, clinician requested unblind|0
1280957|NCT00385255|4183553|P2|Overall Study|Lost to Follow-up|58
1280958|NCT00385255|4183554|P1|Overall Study|Lost to Follow-up|20
1280959|NCT00385255|4183553|P2|Overall Study|Migrated/moved from study area|1
1280960|NCT00385255|4183554|P1|Overall Study|Migrated/moved from study area|0
1280961|NCT00385255|4183553|P2|Overall Study|Withdrawal by Subject|8
1280962|NCT00385255|4183554|P1|Overall Study|Withdrawal by Subject|0
1280963|NCT00385255|4183553|P2|Overall Study|Protocol Violation|4
1280964|NCT00385255|4183554|P1|Overall Study|Protocol Violation|0
1280965|NCT00385255|4183553|P2|Overall Study|Serious Adverse Event|2
1280966|NCT00385255|4183554|P1|Overall Study|Serious Adverse Event|1
1280967|NCT00385203|4183633|P2|Overall Study|Incorrect enrollment|0
1280968|NCT00385203|4183634|P1|Overall Study|Incorrect enrollment|2
1280969|NCT00385203|4183633|P2|Overall Study|Condition under investigation worsened|3
1280970|NCT00385203|4183634|P1|Overall Study|Condition under investigation worsened|18
1280971|NCT00385203|4183633|P2|Overall Study|Death|0
1280972|NCT00385203|4183634|P1|Overall Study|Death|1
1280973|NCT00385203|4183633|P2|Overall Study|Adverse Event|4
1280974|NCT00385203|4183634|P1|Overall Study|Adverse Event|5
1280975|NCT00384956|4183722|P1|Overall Study|Ineligible (acute myeloid leukemia)|3
1280976|NCT00384930|4183739|P5|Overall Study|Didn't Receive Double-Blind Study Drug|0
1280977|NCT00384930|4183740|P4|Overall Study|Didn't Receive Double-Blind Study Drug|0
1280978|NCT00384930|4183741|P3|Overall Study|Didn't Receive Double-Blind Study Drug|0
1280979|NCT00384930|4183742|P2|Overall Study|Didn't Receive Double-Blind Study Drug|1
1280980|NCT00384930|4183743|P1|Overall Study|Didn't Receive Double-Blind Study Drug|1
1280981|NCT00384930|4183739|P5|Overall Study|Withdrawal by Subject|16
1280982|NCT00384930|4183740|P4|Overall Study|Withdrawal by Subject|6
1280983|NCT00384930|4183741|P3|Overall Study|Withdrawal by Subject|7
1280984|NCT00384930|4183742|P2|Overall Study|Withdrawal by Subject|7
1280985|NCT00384930|4183743|P1|Overall Study|Withdrawal by Subject|9
1280986|NCT00384930|4183739|P5|Overall Study|Sponsor Decision|0
1280987|NCT00384930|4183740|P4|Overall Study|Sponsor Decision|5
1280988|NCT00384930|4183741|P3|Overall Study|Sponsor Decision|0
1280989|NCT00384930|4183742|P2|Overall Study|Sponsor Decision|4
1280990|NCT00384930|4183743|P1|Overall Study|Sponsor Decision|3
1280991|NCT00384930|4183739|P5|Overall Study|Protocol Violation|4
1280992|NCT00384930|4183740|P4|Overall Study|Protocol Violation|6
1280993|NCT00384930|4183741|P3|Overall Study|Protocol Violation|1
1280994|NCT00384930|4183742|P2|Overall Study|Protocol Violation|0
1280995|NCT00384930|4183743|P1|Overall Study|Protocol Violation|1
1280996|NCT00384930|4183739|P5|Overall Study|Physician Decision|1
1280997|NCT00384930|4183740|P4|Overall Study|Physician Decision|0
1280998|NCT00384930|4183741|P3|Overall Study|Physician Decision|1
1280999|NCT00384930|4183742|P2|Overall Study|Physician Decision|1
1281000|NCT00384930|4183743|P1|Overall Study|Physician Decision|0
1281001|NCT00384930|4183739|P5|Overall Study|Lost to Follow-up|6
1281002|NCT00384930|4183740|P4|Overall Study|Lost to Follow-up|4
1281003|NCT00384930|4183741|P3|Overall Study|Lost to Follow-up|0
1281004|NCT00384930|4183742|P2|Overall Study|Lost to Follow-up|3
1281005|NCT00384930|4183743|P1|Overall Study|Lost to Follow-up|5
1281006|NCT00384930|4183739|P5|Overall Study|Lack of Efficacy|2
1281007|NCT00384930|4183740|P4|Overall Study|Lack of Efficacy|1
1281008|NCT00384930|4183741|P3|Overall Study|Lack of Efficacy|2
1281009|NCT00384930|4183742|P2|Overall Study|Lack of Efficacy|1
1281010|NCT00384930|4183743|P1|Overall Study|Lack of Efficacy|1
1281011|NCT00384930|4183739|P5|Overall Study|Entry Criteria Not Met|4
1281012|NCT00384930|4183740|P4|Overall Study|Entry Criteria Not Met|8
1281013|NCT00384930|4183741|P3|Overall Study|Entry Criteria Not Met|7
1281014|NCT00384930|4183742|P2|Overall Study|Entry Criteria Not Met|6
1281015|NCT00384930|4183743|P1|Overall Study|Entry Criteria Not Met|2
1281016|NCT00384930|4183739|P5|Overall Study|Adverse Event|14
1281017|NCT00384930|4183740|P4|Overall Study|Adverse Event|11
1281018|NCT00384930|4183741|P3|Overall Study|Adverse Event|12
1281019|NCT00384930|4183742|P2|Overall Study|Adverse Event|4
1281020|NCT00384930|4183743|P1|Overall Study|Adverse Event|5
1281021|NCT00384839|4183822|P1|Overall Study|Ineligible|2
1281022|NCT00384839|4183822|P1|Overall Study|Patient Request|1
1281023|NCT00384839|4183822|P1|Overall Study|Investigator Request|1
1281024|NCT00384839|4183822|P1|Overall Study|Adverse Event|4
1281025|NCT00384397|4183862|P3|Overall Study|Withdrawal by Subject|15
1281026|NCT00384397|4183863|P2|Overall Study|Withdrawal by Subject|17
1281027|NCT00384397|4183864|P1|Overall Study|Withdrawal by Subject|14
1281028|NCT00384397|4183862|P3|Overall Study|Lost to Follow-up|3
1281029|NCT00384397|4183863|P2|Overall Study|Lost to Follow-up|13
1281030|NCT00384397|4183864|P1|Overall Study|Lost to Follow-up|11
1281031|NCT00384397|4183862|P3|Overall Study|Protocol Violation|13
1281032|NCT00384397|4183863|P2|Overall Study|Protocol Violation|15
1281033|NCT00384397|4183864|P1|Overall Study|Protocol Violation|7
1281034|NCT00384397|4183862|P3|Overall Study|Adverse Event|2
1281035|NCT00384397|4183863|P2|Overall Study|Adverse Event|1
1281036|NCT00384397|4183864|P1|Overall Study|Adverse Event|0
1281037|NCT00384332|4183883|P2|Overall Study|Lost to Follow-up|0
1281038|NCT00384332|4183884|P1|Overall Study|Lost to Follow-up|4
1281039|NCT00384293|4183894|P3|Post-randomization Period|Patient Randomized in Error|1
1281040|NCT00384293|4183895|P2|Post-randomization Period|Patient Randomized in Error|0
1281041|NCT00384293|4183896|P1|Post-randomization Period|Patient Randomized in Error|0
1281042|NCT00384293|4183894|P3|Post-randomization Period|Trial Termination|204
1281043|NCT00384293|4183895|P2|Post-randomization Period|Trial Termination|180
1281044|NCT00384293|4183896|P1|Post-randomization Period|Trial Termination|0
1281045|NCT00384293|4183894|P3|Post-randomization Period|Withdrawal by Subject|6
1281046|NCT00384293|4183895|P2|Post-randomization Period|Withdrawal by Subject|8
1281047|NCT00384293|4183896|P1|Post-randomization Period|Withdrawal by Subject|0
1281048|NCT00384293|4183894|P3|Post-randomization Period|Protocol Violation|0
1281049|NCT00384293|4183895|P2|Post-randomization Period|Protocol Violation|1
1281050|NCT00384293|4183896|P1|Post-randomization Period|Protocol Violation|0
1281051|NCT00384293|4183894|P3|Post-randomization Period|Lost to Follow-up|1
1281052|NCT00384293|4183895|P2|Post-randomization Period|Lost to Follow-up|2
1281053|NCT00384293|4183896|P1|Post-randomization Period|Lost to Follow-up|0
1281054|NCT00384293|4183894|P3|Post-randomization Period|Adverse Event|7
1281055|NCT00384293|4183895|P2|Post-randomization Period|Adverse Event|23
1281056|NCT00384293|4183896|P1|Post-randomization Period|Adverse Event|0
1281057|NCT00384293|4183894|P3|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
1281058|NCT00384293|4183895|P2|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
1281059|NCT00384293|4183896|P1|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1
1281060|NCT00384293|4183894|P3|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
1281061|NCT00384293|4183895|P2|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
1281062|NCT00384293|4183896|P1|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2
1281063|NCT00384293|4183894|P3|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
1281064|NCT00384293|4183895|P2|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
1281065|NCT00384293|4183896|P1|MK0524A Active Run-In, Pre-randomization|Trial Termination|16
1281066|NCT00384293|4183894|P3|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
1281067|NCT00384293|4183895|P2|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
1281068|NCT00384293|4183896|P1|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340
1281069|NCT00384293|4183894|P3|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
1281070|NCT00384293|4183895|P2|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
1281071|NCT00384293|4183896|P1|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24
1281072|NCT00384293|4183894|P3|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
1281073|NCT00384293|4183895|P2|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
1281074|NCT00384293|4183896|P1|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1
1281075|NCT00384293|4183894|P3|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
1281076|NCT00384293|4183895|P2|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
1281077|NCT00384293|4183896|P1|MK0524A Active Run-In, Pre-randomization|Adverse Event|120
1281078|NCT00384189|4183920|P4|Overall Study|Reason Not Specified|40
1281079|NCT00384189|4183921|P3|Overall Study|Reason Not Specified|58
1281080|NCT00384189|4183922|P2|Overall Study|Reason Not Specified|57
1281081|NCT00384189|4183923|P1|Overall Study|Reason Not Specified|50
1281082|NCT00384176|4183984|P3|Overall Study|Liver metastases, colon resec. planned|0
1281083|NCT00384176|4183985|P2|Overall Study|Liver metastases, colon resec. planned|0
1281084|NCT00384176|4183986|P1|Overall Study|Liver metastases, colon resec. planned|1
1281085|NCT00384176|4183984|P3|Overall Study|Physician Decision|0
1281086|NCT00384176|4183985|P2|Overall Study|Physician Decision|2
1281087|NCT00384176|4183986|P1|Overall Study|Physician Decision|0
1281088|NCT00384176|4183984|P3|Overall Study|Did not receive study treatment|1
1281089|NCT00384176|4183985|P2|Overall Study|Did not receive study treatment|1
1281090|NCT00384176|4183986|P1|Overall Study|Did not receive study treatment|0
1281091|NCT00384176|4183984|P3|Overall Study|Toxicity of treatment|0
1281092|NCT00384176|4183985|P2|Overall Study|Toxicity of treatment|0
1281093|NCT00384176|4183986|P1|Overall Study|Toxicity of treatment|1
1281094|NCT00384176|4183984|P3|Overall Study|Longer QTC as Visit 1|0
1281095|NCT00384176|4183985|P2|Overall Study|Longer QTC as Visit 1|0
1281096|NCT00384176|4183986|P1|Overall Study|Longer QTC as Visit 1|1
1281097|NCT00384176|4183984|P3|Overall Study|Incorrect enrol/elig crit not fulfilled|0
1281098|NCT00384176|4183985|P2|Overall Study|Incorrect enrol/elig crit not fulfilled|3
1281099|NCT00384176|4183986|P1|Overall Study|Incorrect enrol/elig crit not fulfilled|2
1281100|NCT00384176|4183984|P3|Overall Study|Lost to Follow-up|4
1281101|NCT00384176|4183985|P2|Overall Study|Lost to Follow-up|18
1281102|NCT00384176|4183986|P1|Overall Study|Lost to Follow-up|16
1281103|NCT00384176|4183984|P3|Overall Study|Withdrawal by Subject|22
1281104|NCT00384176|4183985|P2|Overall Study|Withdrawal by Subject|48
1281105|NCT00384176|4183986|P1|Overall Study|Withdrawal by Subject|52
1281106|NCT00384176|4183984|P3|Overall Study|Death|105
1281107|NCT00384176|4183985|P2|Overall Study|Death|247
1281108|NCT00384176|4183986|P1|Overall Study|Death|239
1281109|NCT00384085|4184012|P3|Overall Study|Patient required surgery|0
1281110|NCT00384085|4184013|P2|Overall Study|Patient required surgery|1
1281111|NCT00384085|4184014|P1|Overall Study|Patient required surgery|0
1281112|NCT00384085|4184012|P3|Overall Study|Patient moved|1
1281113|NCT00384085|4184013|P2|Overall Study|Patient moved|0
1281114|NCT00384085|4184014|P1|Overall Study|Patient moved|1
1281115|NCT00384085|4184012|P3|Overall Study|Sponsor decision|1
1281116|NCT00384085|4184013|P2|Overall Study|Sponsor decision|2
1281117|NCT00384085|4184014|P1|Overall Study|Sponsor decision|1
1281118|NCT00384085|4184012|P3|Overall Study|Loss of site personnel|1
1281119|NCT00384085|4184013|P2|Overall Study|Loss of site personnel|0
1281120|NCT00384085|4184014|P1|Overall Study|Loss of site personnel|1
1281121|NCT00384085|4184012|P3|Overall Study|Physician Decision|0
1281122|NCT00384085|4184013|P2|Overall Study|Physician Decision|0
1281123|NCT00384085|4184014|P1|Overall Study|Physician Decision|1
1281124|NCT00384085|4184012|P3|Overall Study|Patient non-compliant|5
1281125|NCT00384085|4184013|P2|Overall Study|Patient non-compliant|4
1281126|NCT00384085|4184014|P1|Overall Study|Patient non-compliant|4
1281127|NCT00384085|4184012|P3|Overall Study|Withdrawal by Subject|29
1281128|NCT00384085|4184013|P2|Overall Study|Withdrawal by Subject|19
1281129|NCT00384085|4184014|P1|Overall Study|Withdrawal by Subject|14
1281130|NCT00384085|4184012|P3|Overall Study|Progressive Disease|0
1281131|NCT00384085|4184013|P2|Overall Study|Progressive Disease|1
1281132|NCT00384085|4184014|P1|Overall Study|Progressive Disease|0
1281133|NCT00384085|4184012|P3|Overall Study|Lost to Follow-up|10
1281134|NCT00384085|4184013|P2|Overall Study|Lost to Follow-up|9
1281135|NCT00384085|4184014|P1|Overall Study|Lost to Follow-up|9
1281136|NCT00384085|4184012|P3|Overall Study|Protocol Violation|2
1281137|NCT00384085|4184013|P2|Overall Study|Protocol Violation|2
1281138|NCT00384085|4184014|P1|Overall Study|Protocol Violation|2
1281139|NCT00384085|4184012|P3|Overall Study|No longer Requires Study Treatment|1
1281140|NCT00384085|4184013|P2|Overall Study|No longer Requires Study Treatment|0
1281141|NCT00384085|4184014|P1|Overall Study|No longer Requires Study Treatment|1
1281142|NCT00384085|4184012|P3|Overall Study|Lack of Efficacy|2
1281143|NCT00384085|4184013|P2|Overall Study|Lack of Efficacy|3
1281144|NCT00384085|4184014|P1|Overall Study|Lack of Efficacy|0
1281145|NCT00384085|4184012|P3|Overall Study|Adverse Event|4
1281146|NCT00384085|4184013|P2|Overall Study|Adverse Event|5
1281147|NCT00384085|4184014|P1|Overall Study|Adverse Event|5
1281148|NCT00384059|4184040|P2|Toddler Dose|Failed to return|1
1281149|NCT00384059|4184041|P1|Toddler Dose|Failed to return|0
1281150|NCT00384059|4184040|P2|Toddler Dose|Lost to Follow-up|1
1281151|NCT00384059|4184041|P1|Toddler Dose|Lost to Follow-up|1
1281152|NCT00384059|4184040|P2|After Infant Series|Lost to Follow-up|1
1281153|NCT00384059|4184041|P1|After Infant Series|Lost to Follow-up|0
1281154|NCT00384059|4184040|P2|After Infant Series|Physician Decision|1
1281155|NCT00384059|4184041|P1|After Infant Series|Physician Decision|0
1281156|NCT00384059|4184040|P2|After Infant Series|Adverse Event|1
1281157|NCT00384059|4184041|P1|After Infant Series|Adverse Event|0
1281158|NCT00384059|4184040|P2|After Infant Series|Failed to Return|2
1281159|NCT00384059|4184041|P1|After Infant Series|Failed to Return|0
1281160|NCT00384059|4184040|P2|After Infant Series|Withdrawal by Subject|2
1281161|NCT00384059|4184041|P1|After Infant Series|Withdrawal by Subject|2
1281162|NCT00384059|4184040|P2|After Infant Series|Protocol Violation|3
1281163|NCT00384059|4184041|P1|After Infant Series|Protocol Violation|2
1281164|NCT00384059|4184040|P2|Infant Series|Lost to Follow-up|1
1281165|NCT00384059|4184041|P1|Infant Series|Lost to Follow-up|0
1281166|NCT00384059|4184040|P2|Infant Series|Protocol Violation|2
1281167|NCT00384059|4184041|P1|Infant Series|Protocol Violation|1
1281168|NCT00384059|4184040|P2|Infant Series|Adverse Event|2
1281169|NCT00384059|4184041|P1|Infant Series|Adverse Event|1
1281170|NCT00384059|4184040|P2|Infant Series|Withdrawal by Subject|2
1281171|NCT00384059|4184041|P1|Infant Series|Withdrawal by Subject|2
1281172|NCT00384059|4184040|P2|Infant Series|Not consented|6
1281173|NCT00384059|4184041|P1|Infant Series|Not consented|2
1281174|NCT00384033|4184091|P4|Overall Study|Randomized but not treated|2
1281175|NCT00384033|4184092|P3|Overall Study|Randomized but not treated|10
1281176|NCT00384033|4184093|P2|Overall Study|Randomized but not treated|7
1281177|NCT00384033|4184094|P1|Overall Study|Randomized but not treated|3
1281178|NCT00384033|4184091|P4|Overall Study|Lack of Efficacy|1
1281179|NCT00384033|4184092|P3|Overall Study|Lack of Efficacy|3
1281180|NCT00384033|4184093|P2|Overall Study|Lack of Efficacy|3
1281181|NCT00384033|4184094|P1|Overall Study|Lack of Efficacy|7
1281182|NCT00384033|4184091|P4|Overall Study|Withdrawal by Subject|2
1281183|NCT00384033|4184092|P3|Overall Study|Withdrawal by Subject|5
1281184|NCT00384033|4184093|P2|Overall Study|Withdrawal by Subject|2
1281185|NCT00384033|4184094|P1|Overall Study|Withdrawal by Subject|6
1281186|NCT00384033|4184091|P4|Overall Study|Protocol Violation|6
1281187|NCT00384033|4184092|P3|Overall Study|Protocol Violation|5
1281188|NCT00384033|4184093|P2|Overall Study|Protocol Violation|0
1281189|NCT00384033|4184094|P1|Overall Study|Protocol Violation|5
1281190|NCT00384033|4184091|P4|Overall Study|Other|0
1281191|NCT00384033|4184092|P3|Overall Study|Other|0
1281192|NCT00384033|4184093|P2|Overall Study|Other|0
1281193|NCT00384033|4184094|P1|Overall Study|Other|2
1281194|NCT00384033|4184091|P4|Overall Study|Lost to Follow-up|7
1281195|NCT00384033|4184092|P3|Overall Study|Lost to Follow-up|7
1281196|NCT00384033|4184093|P2|Overall Study|Lost to Follow-up|12
1281197|NCT00384033|4184094|P1|Overall Study|Lost to Follow-up|6
1281198|NCT00384033|4184091|P4|Overall Study|Physician Decision|0
1281199|NCT00384033|4184092|P3|Overall Study|Physician Decision|0
1281200|NCT00384033|4184093|P2|Overall Study|Physician Decision|0
1281201|NCT00384033|4184094|P1|Overall Study|Physician Decision|1
1281202|NCT00384033|4184091|P4|Overall Study|Failed to return|2
1281203|NCT00384033|4184092|P3|Overall Study|Failed to return|2
1281204|NCT00384033|4184093|P2|Overall Study|Failed to return|3
1281205|NCT00384033|4184094|P1|Overall Study|Failed to return|1
1281206|NCT00384033|4184091|P4|Overall Study|Adverse Event|20
1281207|NCT00384033|4184092|P3|Overall Study|Adverse Event|11
1281208|NCT00384033|4184093|P2|Overall Study|Adverse Event|8
1281209|NCT00384033|4184094|P1|Overall Study|Adverse Event|10
1281210|NCT00383786|4184147|P2|Overall Study|Physician Decision|1
1281211|NCT00383786|4184148|P1|Overall Study|Physician Decision|0
1281212|NCT00383786|4184147|P2|Overall Study|Withdrawal by Subject|5
1281213|NCT00383786|4184148|P1|Overall Study|Withdrawal by Subject|2
1281214|NCT00383786|4184147|P2|Overall Study|Protocol Violation|6
1281215|NCT00383786|4184148|P1|Overall Study|Protocol Violation|2
1281216|NCT00383721|4184198|P5|26-Week Treatment Safety Extension|Administrative|0
1281217|NCT00383721|4184199|P4|26-Week Treatment Safety Extension|Administrative|1
1281218|NCT00383721|4184200|P3|26-Week Treatment Safety Extension|Administrative|3
1281219|NCT00383721|4184201|P2|26-Week Treatment Safety Extension|Administrative|2
1281220|NCT00383721|4184202|P1|26-Week Treatment Safety Extension|Administrative|1
1281221|NCT00383721|4184198|P5|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
1281222|NCT00383721|4184199|P4|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
1281223|NCT00383721|4184200|P3|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
1281224|NCT00383721|4184201|P2|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
1281225|NCT00383721|4184202|P1|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
1281226|NCT00383721|4184198|P5|26-Week Treatment Safety Extension|Non-compliance with protocol|0
1281227|NCT00383721|4184199|P4|26-Week Treatment Safety Extension|Non-compliance with protocol|4
1281228|NCT00383721|4184200|P3|26-Week Treatment Safety Extension|Non-compliance with protocol|1
1281229|NCT00383721|4184201|P2|26-Week Treatment Safety Extension|Non-compliance with protocol|1
1281230|NCT00383721|4184202|P1|26-Week Treatment Safety Extension|Non-compliance with protocol|2
1281231|NCT00383721|4184198|P5|26-Week Treatment Safety Extension|Participant withdrawal related|0
1281232|NCT00383721|4184199|P4|26-Week Treatment Safety Extension|Participant withdrawal related|1
1281233|NCT00383721|4184200|P3|26-Week Treatment Safety Extension|Participant withdrawal related|1
1281234|NCT00383721|4184201|P2|26-Week Treatment Safety Extension|Participant withdrawal related|1
1281235|NCT00383721|4184202|P1|26-Week Treatment Safety Extension|Participant withdrawal related|1
1281236|NCT00383721|4184198|P5|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
1281237|NCT00383721|4184199|P4|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7
1281238|NCT00383721|4184200|P3|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
1281239|NCT00383721|4184201|P2|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4
1281240|NCT00383721|4184202|P1|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
1281241|NCT00383721|4184198|P5|26-Week Treatment Safety Extension|Lost to Follow-up|0
1281242|NCT00383721|4184199|P4|26-Week Treatment Safety Extension|Lost to Follow-up|1
1281243|NCT00383721|4184200|P3|26-Week Treatment Safety Extension|Lost to Follow-up|1
1281244|NCT00383721|4184201|P2|26-Week Treatment Safety Extension|Lost to Follow-up|0
1281245|NCT00383721|4184202|P1|26-Week Treatment Safety Extension|Lost to Follow-up|2
1281246|NCT00383721|4184198|P5|26-Week Treatment Safety Extension|Lack of Efficacy|0
1281247|NCT00383721|4184199|P4|26-Week Treatment Safety Extension|Lack of Efficacy|1
1281248|NCT00383721|4184200|P3|26-Week Treatment Safety Extension|Lack of Efficacy|4
1281249|NCT00383721|4184201|P2|26-Week Treatment Safety Extension|Lack of Efficacy|2
1281250|NCT00383721|4184202|P1|26-Week Treatment Safety Extension|Lack of Efficacy|0
1281251|NCT00383721|4184198|P5|26-Week Treatment Safety Extension|Adverse Event|0
1281252|NCT00383721|4184199|P4|26-Week Treatment Safety Extension|Adverse Event|1
1281253|NCT00383721|4184200|P3|26-Week Treatment Safety Extension|Adverse Event|10
1281254|NCT00383721|4184201|P2|26-Week Treatment Safety Extension|Adverse Event|7
1281255|NCT00383721|4184202|P1|26-Week Treatment Safety Extension|Adverse Event|6
1281256|NCT00383721|4184198|P5|26-Week Double-Blind Treatment Period|Ongoing|0
1281257|NCT00383721|4184199|P4|26-Week Double-Blind Treatment Period|Ongoing|0
1281258|NCT00383721|4184200|P3|26-Week Double-Blind Treatment Period|Ongoing|0
1281259|NCT00383721|4184201|P2|26-Week Double-Blind Treatment Period|Ongoing|0
1281260|NCT00383721|4184202|P1|26-Week Double-Blind Treatment Period|Ongoing|1
1281261|NCT00383721|4184198|P5|26-Week Double-Blind Treatment Period|Administrative|3
1281262|NCT00383721|4184199|P4|26-Week Double-Blind Treatment Period|Administrative|3
1281263|NCT00383721|4184200|P3|26-Week Double-Blind Treatment Period|Administrative|3
1281264|NCT00383721|4184201|P2|26-Week Double-Blind Treatment Period|Administrative|3
1281265|NCT00383721|4184202|P1|26-Week Double-Blind Treatment Period|Administrative|1
1281266|NCT00383721|4184198|P5|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13
1281267|NCT00383721|4184199|P4|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4
1281268|NCT00383721|4184200|P3|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11
1281269|NCT00383721|4184201|P2|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
1281270|NCT00383721|4184202|P1|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
1281271|NCT00383721|4184198|P5|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
1281272|NCT00383721|4184199|P4|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
1281273|NCT00383721|4184200|P3|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
1281274|NCT00383721|4184201|P2|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
1281275|NCT00383721|4184202|P1|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7
1281276|NCT00383721|4184198|P5|26-Week Double-Blind Treatment Period|Participant withdrawal related|9
1281277|NCT00383721|4184199|P4|26-Week Double-Blind Treatment Period|Participant withdrawal related|8
1281278|NCT00383721|4184200|P3|26-Week Double-Blind Treatment Period|Participant withdrawal related|6
1281279|NCT00383721|4184201|P2|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
1281280|NCT00383721|4184202|P1|26-Week Double-Blind Treatment Period|Participant withdrawal related|5
1281281|NCT00383721|4184198|P5|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11
1281282|NCT00383721|4184199|P4|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
1281283|NCT00383721|4184200|P3|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15
1281284|NCT00383721|4184201|P2|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
1281285|NCT00383721|4184202|P1|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4
1281286|NCT00383721|4184198|P5|26-Week Double-Blind Treatment Period|Lost to Follow-up|4
1281287|NCT00383721|4184199|P4|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
1281288|NCT00383721|4184200|P3|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
1281289|NCT00383721|4184201|P2|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
1281290|NCT00383721|4184202|P1|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
1281291|NCT00383721|4184198|P5|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
1281292|NCT00383721|4184199|P4|26-Week Double-Blind Treatment Period|Lack of Efficacy|4
1281293|NCT00383721|4184200|P3|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
1281294|NCT00383721|4184201|P2|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
1281295|NCT00383721|4184202|P1|26-Week Double-Blind Treatment Period|Lack of Efficacy|1
1281296|NCT00383721|4184198|P5|26-Week Double-Blind Treatment Period|Adverse Event|13
1281297|NCT00383721|4184199|P4|26-Week Double-Blind Treatment Period|Adverse Event|14
1281298|NCT00383721|4184200|P3|26-Week Double-Blind Treatment Period|Adverse Event|7
1281299|NCT00383721|4184201|P2|26-Week Double-Blind Treatment Period|Adverse Event|5
1281300|NCT00383721|4184202|P1|26-Week Double-Blind Treatment Period|Adverse Event|11
1281301|NCT00383708|4184239|P1|Co-administration Period|Adverse Event|5
1281302|NCT00383708|4184239|P1|Run-in Period|Claustrophobia|1
1281303|NCT00383708|4184239|P1|Run-in Period|Adverse Event|2
1281304|NCT00383708|4184239|P1|Run-in Period|Protocol Violation|4
1281305|NCT00383708|4184239|P1|Enrolment Through Start Treatment|Did not meet entry criteria|32
1281306|NCT00383708|4184239|P1|Enrolment Through Start Treatment|Withdrawal by Subject|1
1281307|NCT00383552|4184308|P4|Overall Study|Administrative|1
1281308|NCT00383552|4184309|P3|Overall Study|Administrative|1
1281309|NCT00383552|4184310|P2|Overall Study|Administrative|0
1281310|NCT00383552|4184311|P1|Overall Study|Administrative|1
1281311|NCT00383552|4184308|P4|Overall Study|Did not meet protocol eligibility|3
1281312|NCT00383552|4184309|P3|Overall Study|Did not meet protocol eligibility|2
1281313|NCT00383552|4184310|P2|Overall Study|Did not meet protocol eligibility|6
1281314|NCT00383552|4184311|P1|Overall Study|Did not meet protocol eligibility|8
1281315|NCT00383552|4184308|P4|Overall Study|Noncompliance with the protocol|10
1281316|NCT00383552|4184309|P3|Overall Study|Noncompliance with the protocol|8
1281317|NCT00383552|4184310|P2|Overall Study|Noncompliance with the protocol|6
1281318|NCT00383552|4184311|P1|Overall Study|Noncompliance with the protocol|11
1281319|NCT00383552|4184308|P4|Overall Study|Did not wish to continue (related)|3
1281320|NCT00383552|4184309|P3|Overall Study|Did not wish to continue (related)|2
1281321|NCT00383552|4184310|P2|Overall Study|Did not wish to continue (related)|0
1281322|NCT00383552|4184311|P1|Overall Study|Did not wish to continue (related)|1
1281323|NCT00383552|4184308|P4|Overall Study|Did not wish to continue (unrelated)|6
1281324|NCT00383552|4184309|P3|Overall Study|Did not wish to continue (unrelated)|5
1281325|NCT00383552|4184310|P2|Overall Study|Did not wish to continue (unrelated)|9
1281326|NCT00383552|4184311|P1|Overall Study|Did not wish to continue (unrelated)|4
1281327|NCT00383552|4184308|P4|Overall Study|Lost to Follow-up|1
1281328|NCT00383552|4184309|P3|Overall Study|Lost to Follow-up|5
1281329|NCT00383552|4184310|P2|Overall Study|Lost to Follow-up|1
1281330|NCT00383552|4184311|P1|Overall Study|Lost to Follow-up|0
1281331|NCT00383552|4184308|P4|Overall Study|Lack of Efficacy|42
1281332|NCT00383552|4184309|P3|Overall Study|Lack of Efficacy|29
1281333|NCT00383552|4184310|P2|Overall Study|Lack of Efficacy|13
1281334|NCT00383552|4184311|P1|Overall Study|Lack of Efficacy|4
1281335|NCT00383552|4184308|P4|Overall Study|Adverse Event|6
1281336|NCT00383552|4184309|P3|Overall Study|Adverse Event|9
1281337|NCT00383552|4184310|P2|Overall Study|Adverse Event|6
1281338|NCT00383552|4184311|P1|Overall Study|Adverse Event|7
1281339|NCT00383500|4184353|P3|Overall Study|Lost to Follow-up|2
1281340|NCT00383500|4184354|P2|Overall Study|Lost to Follow-up|0
1281341|NCT00383500|4184355|P1|Overall Study|Lost to Follow-up|0
1281342|NCT00383500|4184353|P3|Overall Study|Withdrawal by Subject|0
1281343|NCT00383500|4184354|P2|Overall Study|Withdrawal by Subject|3
1281344|NCT00383500|4184355|P1|Overall Study|Withdrawal by Subject|8
1281345|NCT00383435|4184371|P5|26-Week Treatment Safety Extension|Administrative|0
1281346|NCT00383435|4184372|P4|26-Week Treatment Safety Extension|Administrative|1
1281347|NCT00383435|4184373|P3|26-Week Treatment Safety Extension|Administrative|0
1281348|NCT00383435|4184374|P2|26-Week Treatment Safety Extension|Administrative|1
1281349|NCT00383435|4184375|P1|26-Week Treatment Safety Extension|Administrative|1
1281350|NCT00383435|4184371|P5|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
1281351|NCT00383435|4184372|P4|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
1281352|NCT00383435|4184373|P3|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
1281353|NCT00383435|4184374|P2|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
1281354|NCT00383435|4184375|P1|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
1281355|NCT00383435|4184371|P5|26-Week Treatment Safety Extension|Non-compliance with protocol|0
1281356|NCT00383435|4184372|P4|26-Week Treatment Safety Extension|Non-compliance with protocol|1
1281357|NCT00383435|4184373|P3|26-Week Treatment Safety Extension|Non-compliance with protocol|1
1281358|NCT00383435|4184374|P2|26-Week Treatment Safety Extension|Non-compliance with protocol|1
1281359|NCT00383435|4184375|P1|26-Week Treatment Safety Extension|Non-compliance with protocol|4
1281360|NCT00383435|4184371|P5|26-Week Treatment Safety Extension|Participant withdrawal related|1
1281361|NCT00383435|4184372|P4|26-Week Treatment Safety Extension|Participant withdrawal related|0
1281362|NCT00383435|4184373|P3|26-Week Treatment Safety Extension|Participant withdrawal related|2
1281363|NCT00383435|4184374|P2|26-Week Treatment Safety Extension|Participant withdrawal related|0
1281364|NCT00383435|4184375|P1|26-Week Treatment Safety Extension|Participant withdrawal related|1
1281365|NCT00383435|4184371|P5|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
1281366|NCT00383435|4184372|P4|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
1281367|NCT00383435|4184373|P3|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
1281368|NCT00383435|4184374|P2|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
1281369|NCT00383435|4184375|P1|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
1281370|NCT00383435|4184371|P5|26-Week Treatment Safety Extension|Lost to Follow-up|1
1281371|NCT00383435|4184372|P4|26-Week Treatment Safety Extension|Lost to Follow-up|0
1281372|NCT00383435|4184373|P3|26-Week Treatment Safety Extension|Lost to Follow-up|1
1281373|NCT00383435|4184374|P2|26-Week Treatment Safety Extension|Lost to Follow-up|2
1281374|NCT00383435|4184375|P1|26-Week Treatment Safety Extension|Lost to Follow-up|0
1281375|NCT00383435|4184371|P5|26-Week Treatment Safety Extension|Lack of Efficacy|0
1281376|NCT00383435|4184372|P4|26-Week Treatment Safety Extension|Lack of Efficacy|1
1281377|NCT00383435|4184373|P3|26-Week Treatment Safety Extension|Lack of Efficacy|1
1281378|NCT00383435|4184374|P2|26-Week Treatment Safety Extension|Lack of Efficacy|1
1281379|NCT00383435|4184375|P1|26-Week Treatment Safety Extension|Lack of Efficacy|1
1281380|NCT00383435|4184371|P5|26-Week Treatment Safety Extension|Adverse Event|1
1281381|NCT00383435|4184372|P4|26-Week Treatment Safety Extension|Adverse Event|5
1281382|NCT00383435|4184373|P3|26-Week Treatment Safety Extension|Adverse Event|5
1281383|NCT00383435|4184374|P2|26-Week Treatment Safety Extension|Adverse Event|2
1281384|NCT00383435|4184375|P1|26-Week Treatment Safety Extension|Adverse Event|4
1281385|NCT00383435|4184371|P5|26-Week Double-Blind Treatment Period|Administrative|1
1281386|NCT00383435|4184372|P4|26-Week Double-Blind Treatment Period|Administrative|1
1281387|NCT00383435|4184373|P3|26-Week Double-Blind Treatment Period|Administrative|1
1281388|NCT00383435|4184374|P2|26-Week Double-Blind Treatment Period|Administrative|3
1281389|NCT00383435|4184375|P1|26-Week Double-Blind Treatment Period|Administrative|5
1281390|NCT00383435|4184371|P5|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
1281391|NCT00383435|4184372|P4|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
1281469|NCT00383240|4184480|P1|Overall Study|Treatment Failure|8
1281392|NCT00383435|4184373|P3|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9
1281393|NCT00383435|4184374|P2|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8
1281394|NCT00383435|4184375|P1|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10
1281395|NCT00383435|4184371|P5|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
1281396|NCT00383435|4184372|P4|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
1281397|NCT00383435|4184373|P3|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3
1281398|NCT00383435|4184374|P2|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
1281399|NCT00383435|4184375|P1|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1
1281400|NCT00383435|4184371|P5|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
1281401|NCT00383435|4184372|P4|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
1281402|NCT00383435|4184373|P3|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
1281403|NCT00383435|4184374|P2|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
1281404|NCT00383435|4184375|P1|26-Week Double-Blind Treatment Period|Participant withdrawal related|2
1281405|NCT00383435|4184371|P5|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17
1281406|NCT00383435|4184372|P4|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
1281407|NCT00383435|4184373|P3|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14
1281408|NCT00383435|4184374|P2|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
1281409|NCT00383435|4184375|P1|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7
1281410|NCT00383435|4184371|P5|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
1281411|NCT00383435|4184372|P4|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
1281412|NCT00383435|4184373|P3|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
1281413|NCT00383435|4184374|P2|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
1281414|NCT00383435|4184375|P1|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
1281415|NCT00383435|4184371|P5|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
1281416|NCT00383435|4184372|P4|26-Week Double-Blind Treatment Period|Lack of Efficacy|5
1281417|NCT00383435|4184373|P3|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
1281418|NCT00383435|4184374|P2|26-Week Double-Blind Treatment Period|Lack of Efficacy|2
1281419|NCT00383435|4184375|P1|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
1281420|NCT00383435|4184371|P5|26-Week Double-Blind Treatment Period|Adverse Event|8
1281421|NCT00383435|4184372|P4|26-Week Double-Blind Treatment Period|Adverse Event|6
1281422|NCT00383435|4184373|P3|26-Week Double-Blind Treatment Period|Adverse Event|8
1281423|NCT00383435|4184374|P2|26-Week Double-Blind Treatment Period|Adverse Event|2
1281424|NCT00383435|4184375|P1|26-Week Double-Blind Treatment Period|Adverse Event|10
1281425|NCT00383331|4184414|P2|Overall Study|Protocol Violation|1
1281426|NCT00383331|4184415|P1|Overall Study|Protocol Violation|0
1281427|NCT00383292|4184434|P3|Overall Study|Other|0
1281428|NCT00383292|4184435|P2|Overall Study|Other|0
1281429|NCT00383292|4184436|P1|Overall Study|Other|1
1281430|NCT00383292|4184434|P3|Overall Study|Withdrawal by Subject|2
1281431|NCT00383292|4184435|P2|Overall Study|Withdrawal by Subject|2
1281432|NCT00383292|4184436|P1|Overall Study|Withdrawal by Subject|3
1281433|NCT00383292|4184434|P3|Overall Study|Physician Decision|1
1281434|NCT00383292|4184435|P2|Overall Study|Physician Decision|0
1281435|NCT00383292|4184436|P1|Overall Study|Physician Decision|4
1281436|NCT00383292|4184434|P3|Overall Study|Death|3
1281437|NCT00383292|4184435|P2|Overall Study|Death|3
1281438|NCT00383292|4184436|P1|Overall Study|Death|3
1281439|NCT00383292|4184434|P3|Overall Study|Adverse Event|2
1281440|NCT00383292|4184435|P2|Overall Study|Adverse Event|1
1281441|NCT00383292|4184436|P1|Overall Study|Adverse Event|4
1281442|NCT00383240|4184477|P4|Overall Study|Administrative|0
1281443|NCT00383240|4184478|P3|Overall Study|Administrative|0
1281444|NCT00383240|4184479|P2|Overall Study|Administrative|1
1281445|NCT00383240|4184480|P1|Overall Study|Administrative|1
1281446|NCT00383240|4184477|P4|Overall Study|Did not meet protocol eligibility|3
1281447|NCT00383240|4184478|P3|Overall Study|Did not meet protocol eligibility|9
1281448|NCT00383240|4184479|P2|Overall Study|Did not meet protocol eligibility|4
1281449|NCT00383240|4184480|P1|Overall Study|Did not meet protocol eligibility|9
1281450|NCT00383240|4184477|P4|Overall Study|Protocol Violation|6
1281451|NCT00383240|4184478|P3|Overall Study|Protocol Violation|9
1281452|NCT00383240|4184479|P2|Overall Study|Protocol Violation|5
1281453|NCT00383240|4184480|P1|Overall Study|Protocol Violation|4
1281454|NCT00383240|4184477|P4|Overall Study|Withdrawal by subjects, reasons related|5
1281455|NCT00383240|4184478|P3|Overall Study|Withdrawal by subjects, reasons related|3
1281456|NCT00383240|4184479|P2|Overall Study|Withdrawal by subjects, reasons related|1
1281457|NCT00383240|4184480|P1|Overall Study|Withdrawal by subjects, reasons related|0
1281458|NCT00383240|4184477|P4|Overall Study|Withdrawal by subject, reasons unrelated|8
1281459|NCT00383240|4184478|P3|Overall Study|Withdrawal by subject, reasons unrelated|8
1281460|NCT00383240|4184479|P2|Overall Study|Withdrawal by subject, reasons unrelated|3
1281461|NCT00383240|4184480|P1|Overall Study|Withdrawal by subject, reasons unrelated|6
1281462|NCT00383240|4184477|P4|Overall Study|Lost to Follow-up|2
1281463|NCT00383240|4184478|P3|Overall Study|Lost to Follow-up|0
1281464|NCT00383240|4184479|P2|Overall Study|Lost to Follow-up|0
1281465|NCT00383240|4184480|P1|Overall Study|Lost to Follow-up|3
1281466|NCT00383240|4184477|P4|Overall Study|Treatment Failure|46
1281467|NCT00383240|4184478|P3|Overall Study|Treatment Failure|47
1281468|NCT00383240|4184479|P2|Overall Study|Treatment Failure|13
1281470|NCT00383240|4184477|P4|Overall Study|Adverse Event|7
1281471|NCT00383240|4184478|P3|Overall Study|Adverse Event|9
1281472|NCT00383240|4184479|P2|Overall Study|Adverse Event|6
1281473|NCT00383240|4184480|P1|Overall Study|Adverse Event|4
1281474|NCT00383162|4184511|P2|Migraine Attack 2 (Period 2)|Unknown reason|3
1281475|NCT00383162|4184512|P1|Migraine Attack 2 (Period 2)|Unknown reason|0
1281476|NCT00383162|4184511|P2|Migraine Attack 2 (Period 2)|Adverse Event|0
1281477|NCT00383162|4184512|P1|Migraine Attack 2 (Period 2)|Adverse Event|1
1281478|NCT00383162|4184511|P2|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
1281479|NCT00383162|4184512|P1|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
1281480|NCT00383162|4184511|P2|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3
1281481|NCT00383162|4184512|P1|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1
1281482|NCT00383162|4184511|P2|Migraine Attack 1 (Period 1)|Non-compliant|0
1281483|NCT00383162|4184512|P1|Migraine Attack 1 (Period 1)|Non-compliant|3
1281484|NCT00383162|4184511|P2|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0
1281485|NCT00383162|4184512|P1|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2
1281486|NCT00383162|4184511|P2|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2
1281487|NCT00383162|4184512|P1|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4
1281488|NCT00383162|4184511|P2|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
1281489|NCT00383162|4184512|P1|Migraine Attack 1 (Period 1)|Lost to Follow-up|8
1281490|NCT00383162|4184511|P2|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4
1281491|NCT00383162|4184512|P1|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3
1281492|NCT00383149|4184554|P1|Overall Study|Participant Withdrew Consent|1
1281493|NCT00383149|4184554|P1|Overall Study|Request to Discontinue Treatment|4
1281494|NCT00383149|4184554|P1|Overall Study|Study Drug Toxicity|4
1281495|NCT00383149|4184554|P1|Overall Study|Other|1
1281496|NCT00383149|4184554|P1|Overall Study|Lost to Follow-up|1
1281497|NCT00383149|4184554|P1|Overall Study|Disease Progression|38
1281498|NCT00383149|4184554|P1|Overall Study|Death|2
1281499|NCT00383149|4184554|P1|Overall Study|Adverse Event not Related to Study Drug|3
1281500|NCT00383123|4184573|P2|Overall Study|Other reason|6
1281501|NCT00383123|4184574|P1|Overall Study|Other reason|10
1281502|NCT00383123|4184573|P2|Overall Study|Withdrawal by Subject|18
1281503|NCT00383123|4184574|P1|Overall Study|Withdrawal by Subject|27
1281504|NCT00383123|4184573|P2|Overall Study|Protocol Violation|1
1281505|NCT00383123|4184574|P1|Overall Study|Protocol Violation|5
1281506|NCT00383123|4184573|P2|Overall Study|Lost to Follow-up|61
1281507|NCT00383123|4184574|P1|Overall Study|Lost to Follow-up|68
1281508|NCT00383123|4184573|P2|Overall Study|Adverse Event|0
1281509|NCT00383123|4184574|P1|Overall Study|Adverse Event|1
1281510|NCT00383084|4184615|P2|Overall Study|Withdrawal by Subject|10
1281511|NCT00383084|4184616|P1|Overall Study|Withdrawal by Subject|12
1281512|NCT00383019|4184647|P2|Overall Study|Withdrawal by Subject|1
1281513|NCT00383019|4184648|P1|Overall Study|Withdrawal by Subject|0
1281514|NCT00383019|4184647|P2|Overall Study|Adverse Event|1
1281515|NCT00383019|4184648|P1|Overall Study|Adverse Event|5
1281516|NCT00382993|4184670|P2|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
1281517|NCT00382993|4184671|P1|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
1281518|NCT00382993|4184670|P2|Migraine Attack 2 (Period 2)|Protocol Violation|1
1281519|NCT00382993|4184671|P1|Migraine Attack 2 (Period 2)|Protocol Violation|0
1281520|NCT00382993|4184670|P2|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1
1281521|NCT00382993|4184671|P1|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0
1281522|NCT00382993|4184670|P2|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1
1281523|NCT00382993|4184671|P1|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0
1281524|NCT00382993|4184670|P2|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
1281525|NCT00382993|4184671|P1|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
1281526|NCT00382993|4184670|P2|Migraine Attack 1 (Period 1)|Other (no additional data present)|5
1281527|NCT00382993|4184671|P1|Migraine Attack 1 (Period 1)|Other (no additional data present)|3
1281528|NCT00382993|4184670|P2|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
1281529|NCT00382993|4184671|P1|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
1281530|NCT00382993|4184670|P2|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5
1281531|NCT00382993|4184671|P1|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0
1281532|NCT00382993|4184670|P2|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3
1281533|NCT00382993|4184671|P1|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1
1281534|NCT00382993|4184670|P2|Migraine Attack 1 (Period 1)|Lost to Follow-up|2
1281535|NCT00382993|4184671|P1|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
1281536|NCT00382967|4184715|P2|Overall Study|Protocol Violation|1
1281537|NCT00382967|4184716|P1|Overall Study|Protocol Violation|1
1281538|NCT00382863|4184741|P2|Overall Study|Withdrawal by Subject|25
1281539|NCT00382863|4184742|P1|Overall Study|Withdrawal by Subject|5
1281540|NCT00382863|4184741|P2|Overall Study|Lost to Follow-up|2
1281541|NCT00382863|4184742|P1|Overall Study|Lost to Follow-up|1
1281542|NCT00382863|4184741|P2|Overall Study|Death|9
1281543|NCT00382863|4184742|P1|Overall Study|Death|9
1281544|NCT00382733|4184809|P5|Overall Study|Withdrawal by Subject|0
1281545|NCT00382733|4184810|P4|Overall Study|Withdrawal by Subject|0
1281546|NCT00382733|4184811|P3|Overall Study|Withdrawal by Subject|0
1281547|NCT00382733|4184812|P2|Overall Study|Withdrawal by Subject|1
1281548|NCT00382733|4184813|P1|Overall Study|Withdrawal by Subject|0
1281549|NCT00382720|4184834|P3|Overall Study|Discontinued at end of study|2
1281550|NCT00382720|4184835|P2|Overall Study|Discontinued at end of study|1
1281551|NCT00382720|4184836|P1|Overall Study|Discontinued at end of study|0
1281552|NCT00382720|4184834|P3|Overall Study|Investigator/Clinical decision|6
1281553|NCT00382720|4184835|P2|Overall Study|Investigator/Clinical decision|6
1281554|NCT00382720|4184836|P1|Overall Study|Investigator/Clinical decision|5
1281555|NCT00382720|4184834|P3|Overall Study|Good prognosis|0
1281556|NCT00382720|4184835|P2|Overall Study|Good prognosis|1
1281557|NCT00382720|4184836|P1|Overall Study|Good prognosis|0
1281558|NCT00382720|4184834|P3|Overall Study|Clinically progressive disease|0
1281559|NCT00382720|4184835|P2|Overall Study|Clinically progressive disease|1
1281560|NCT00382720|4184836|P1|Overall Study|Clinically progressive disease|0
1281561|NCT00382720|4184834|P3|Overall Study|Patient did not receive study medication|4
1281562|NCT00382720|4184835|P2|Overall Study|Patient did not receive study medication|1
1281563|NCT00382720|4184836|P1|Overall Study|Patient did not receive study medication|1
1281564|NCT00382720|4184834|P3|Overall Study|Surgery|4
1281565|NCT00382720|4184835|P2|Overall Study|Surgery|1
1281566|NCT00382720|4184836|P1|Overall Study|Surgery|1
1281567|NCT00382720|4184834|P3|Overall Study|Withdrawal by Subject|12
1281568|NCT00382720|4184835|P2|Overall Study|Withdrawal by Subject|20
1281569|NCT00382720|4184836|P1|Overall Study|Withdrawal by Subject|11
1281570|NCT00382720|4184834|P3|Overall Study|Withdrew consent|2
1281571|NCT00382720|4184835|P2|Overall Study|Withdrew consent|1
1281572|NCT00382720|4184836|P1|Overall Study|Withdrew consent|1
1281573|NCT00382720|4184834|P3|Overall Study|Progressive disease|38
1281574|NCT00382720|4184835|P2|Overall Study|Progressive disease|28
1281575|NCT00382720|4184836|P1|Overall Study|Progressive disease|37
1281576|NCT00382720|4184834|P3|Overall Study|Death|2
1281577|NCT00382720|4184835|P2|Overall Study|Death|1
1281578|NCT00382720|4184836|P1|Overall Study|Death|0
1281579|NCT00382720|4184834|P3|Overall Study|Protocol Violation|1
1281580|NCT00382720|4184835|P2|Overall Study|Protocol Violation|5
1281581|NCT00382720|4184836|P1|Overall Study|Protocol Violation|2
1281582|NCT00382720|4184834|P3|Overall Study|Adverse Event|15
1281583|NCT00382720|4184835|P2|Overall Study|Adverse Event|23
1281584|NCT00382720|4184836|P1|Overall Study|Adverse Event|21
1281585|NCT00382408|4184861|P2|Overall Study|Not specified|35
1281586|NCT00382408|4184862|P1|Overall Study|Not specified|100
1281587|NCT00382408|4184861|P2|Overall Study|Lost to Follow-up|8
1281588|NCT00382408|4184862|P1|Overall Study|Lost to Follow-up|19
1281589|NCT00382408|4184861|P2|Overall Study|Pregnancy|0
1281590|NCT00382408|4184862|P1|Overall Study|Pregnancy|2
1281591|NCT00382408|4184861|P2|Overall Study|Withdrawal by Subject|6
1281592|NCT00382408|4184862|P1|Overall Study|Withdrawal by Subject|17
1281593|NCT00382408|4184861|P2|Overall Study|Physician Decision|0
1281594|NCT00382408|4184862|P1|Overall Study|Physician Decision|1
1281595|NCT00382408|4184861|P2|Overall Study|Protocol Violation|2
1281596|NCT00382408|4184862|P1|Overall Study|Protocol Violation|2
1281597|NCT00382408|4184861|P2|Overall Study|Did not meet protocol requirement|3
1281598|NCT00382408|4184862|P1|Overall Study|Did not meet protocol requirement|3
1281599|NCT00382291|4184889|P3|Overall Study|Lack of Efficacy|1
1281600|NCT00382291|4184890|P2|Overall Study|Lack of Efficacy|0
1281601|NCT00382291|4184891|P1|Overall Study|Lack of Efficacy|0
1281602|NCT00382291|4184889|P3|Overall Study|Physician Decision|0
1281603|NCT00382291|4184890|P2|Overall Study|Physician Decision|1
1281604|NCT00382291|4184891|P1|Overall Study|Physician Decision|0
1281605|NCT00382291|4184889|P3|Overall Study|Withdrawal by Subject|0
1281606|NCT00382291|4184890|P2|Overall Study|Withdrawal by Subject|2
1281607|NCT00382291|4184891|P1|Overall Study|Withdrawal by Subject|0
1281608|NCT00382291|4184889|P3|Overall Study|Temporary study suspension|5
1281609|NCT00382291|4184890|P2|Overall Study|Temporary study suspension|2
1281610|NCT00382291|4184891|P1|Overall Study|Temporary study suspension|2
1281611|NCT00382291|4184889|P3|Overall Study|Protocol Violation|0
1281612|NCT00382291|4184890|P2|Overall Study|Protocol Violation|0
1281613|NCT00382291|4184891|P1|Overall Study|Protocol Violation|1
1281614|NCT00382291|4184889|P3|Overall Study|Adverse Event|2
1281615|NCT00382291|4184890|P2|Overall Study|Adverse Event|2
1281616|NCT00382291|4184891|P1|Overall Study|Adverse Event|1
1281617|NCT00382174|4184923|P3|Overall Study|Wounds merged|2
1281618|NCT00382174|4184924|P2|Overall Study|Wounds merged|2
1281619|NCT00382174|4184925|P1|Overall Study|Wounds merged|0
1281620|NCT00382174|4184923|P3|Overall Study|Failed to meet criteria|1
1281621|NCT00382174|4184924|P2|Overall Study|Failed to meet criteria|1
1281622|NCT00382174|4184925|P1|Overall Study|Failed to meet criteria|0
1281623|NCT00382174|4184923|P3|Overall Study|Physician Decision|2
1281624|NCT00382174|4184924|P2|Overall Study|Physician Decision|2
1281625|NCT00382174|4184925|P1|Overall Study|Physician Decision|0
1281626|NCT00382174|4184923|P3|Overall Study|Non compliance|1
1281627|NCT00382174|4184924|P2|Overall Study|Non compliance|0
1281628|NCT00382174|4184925|P1|Overall Study|Non compliance|1
1281629|NCT00382174|4184923|P3|Overall Study|Withdrawal by Subject|5
1281630|NCT00382174|4184924|P2|Overall Study|Withdrawal by Subject|4
1281631|NCT00382174|4184925|P1|Overall Study|Withdrawal by Subject|1
1281632|NCT00382174|4184923|P3|Overall Study|Adverse Event|5
1281633|NCT00382174|4184924|P2|Overall Study|Adverse Event|4
1281634|NCT00382174|4184925|P1|Overall Study|Adverse Event|1
1281635|NCT00382174|4184923|P3|Overall Study|Lost to Follow-up|5
1281636|NCT00382174|4184924|P2|Overall Study|Lost to Follow-up|4
1281637|NCT00382174|4184925|P1|Overall Study|Lost to Follow-up|1
1281638|NCT00382109|4184953|P2|Overall Study|consent withdrawal|1
1281639|NCT00382109|4184954|P1|Overall Study|consent withdrawal|0
1281640|NCT00382109|4184953|P2|Overall Study|Other|2
1281641|NCT00382109|4184954|P1|Overall Study|Other|0
1281642|NCT00382109|4184953|P2|Overall Study|ineligible|0
1281643|NCT00382109|4184954|P1|Overall Study|ineligible|2
1281644|NCT00382109|4184953|P2|Overall Study|Withdrawal by Subject|0
1281645|NCT00382109|4184954|P1|Overall Study|Withdrawal by Subject|1
1281646|NCT00382109|4184953|P2|Overall Study|Physician Decision|1
1281647|NCT00382109|4184954|P1|Overall Study|Physician Decision|6
1281648|NCT00382109|4184953|P2|Overall Study|Adverse Event|0
1281649|NCT00382109|4184954|P1|Overall Study|Adverse Event|3
1281650|NCT00382018|4184993|P4|Overall Study|Other, not protocol specified|1
1281651|NCT00382018|4184994|P3|Overall Study|Other, not protocol specified|3
1281652|NCT00382018|4184995|P2|Overall Study|Other, not protocol specified|16
1281653|NCT00382018|4184996|P1|Overall Study|Other, not protocol specified|0
1281654|NCT00382018|4184993|P4|Overall Study|Withdrawal by Subject|4
1281655|NCT00382018|4184994|P3|Overall Study|Withdrawal by Subject|3
1281656|NCT00382018|4184995|P2|Overall Study|Withdrawal by Subject|4
1281657|NCT00382018|4184996|P1|Overall Study|Withdrawal by Subject|0
1281658|NCT00382018|4184993|P4|Overall Study|Death|11
1281659|NCT00382018|4184994|P3|Overall Study|Death|7
1281660|NCT00382018|4184995|P2|Overall Study|Death|9
1281661|NCT00382018|4184996|P1|Overall Study|Death|0
1281662|NCT00382018|4184993|P4|Overall Study|Progression|43
1281663|NCT00382018|4184994|P3|Overall Study|Progression|51
1281664|NCT00382018|4184995|P2|Overall Study|Progression|136
1281665|NCT00382018|4184996|P1|Overall Study|Progression|0
1281666|NCT00381940|4185019|P1|Overall Study|Ineligible|1
1281667|NCT00381940|4185019|P1|Overall Study|Protocol Violation|1
1281668|NCT00381940|4185019|P1|Overall Study|Lack of Efficacy|3
1281669|NCT00381888|4185023|P1|Overall Study|Adverse Event|1
1281670|NCT00381888|4185023|P1|Overall Study|Surgery was cancelled|2
1281671|NCT00381888|4185023|P1|Overall Study|Had laparoscopic surgery|2
1281672|NCT00381888|4185023|P1|Overall Study|Protocol Violation|9
1281673|NCT00381888|4185023|P1|Overall Study|Physician Decision|1
1281674|NCT00381888|4185023|P1|Overall Study|Withdrawal by Subject|1
1281675|NCT00381888|4185023|P1|Overall Study|Death|1
1281676|NCT00381849|4185034|P2|Wash Out|Withdrawal by Subject|1
1281677|NCT00381849|4185035|P1|Wash Out|Withdrawal by Subject|0
1281678|NCT00381797|4185062|P5|Overall Study|Ineligible|0
1281679|NCT00381797|4185063|P4|Overall Study|Ineligible|1
1281680|NCT00381797|4185064|P3|Overall Study|Ineligible|0
1281681|NCT00381797|4185065|P2|Overall Study|Ineligible|0
1281682|NCT00381797|4185066|P1|Overall Study|Ineligible|0
1281683|NCT00381797|4185062|P5|Overall Study|Withdrawal by Subject|2
1281684|NCT00381797|4185063|P4|Overall Study|Withdrawal by Subject|0
1281685|NCT00381797|4185064|P3|Overall Study|Withdrawal by Subject|0
1281686|NCT00381797|4185065|P2|Overall Study|Withdrawal by Subject|1
1281687|NCT00381797|4185066|P1|Overall Study|Withdrawal by Subject|1
1281688|NCT00381706|4185141|P3|Overall Study|Never treated|1
1281689|NCT00381706|4185142|P2|Overall Study|Never treated|2
1281690|NCT00381706|4185143|P1|Overall Study|Never treated|7
1281691|NCT00381693|4185166|P1|Overall Study|Progression|2
1281692|NCT00381693|4185166|P1|Overall Study|Patient Choice|1
1281693|NCT00381693|4185166|P1|Overall Study|Adverse Event|4
1281694|NCT00381693|4185166|P1|Overall Study|Death|1
1281695|NCT00381680|4185175|P2|Overall Study|Ineligible|1
1281696|NCT00381680|4185176|P1|Overall Study|Ineligible|3
1281697|NCT00381680|4185175|P2|Overall Study|Other not otherwise specified|2
1281698|NCT00381680|4185176|P1|Overall Study|Other not otherwise specified|7
1281699|NCT00381680|4185175|P2|Overall Study|Progression|1
1281700|NCT00381680|4185176|P1|Overall Study|Progression|1
1281701|NCT00381680|4185175|P2|Overall Study|Induction Failure|1
1281702|NCT00381680|4185176|P1|Overall Study|Induction Failure|4
1281703|NCT00381680|4185175|P2|Overall Study|Relapse|9
1281704|NCT00381680|4185176|P1|Overall Study|Relapse|18
1281705|NCT00381680|4185175|P2|Overall Study|Stem Cell Transplant|10
1281706|NCT00381680|4185176|P1|Overall Study|Stem Cell Transplant|26
1281707|NCT00381680|4185175|P2|Overall Study|Delay initiation|0
1281708|NCT00381680|4185176|P1|Overall Study|Delay initiation|1
1281709|NCT00381680|4185175|P2|Overall Study|Secondary Malignancy|0
1281710|NCT00381680|4185176|P1|Overall Study|Secondary Malignancy|3
1281711|NCT00381680|4185175|P2|Overall Study|Alternative Therapy|5
1281712|NCT00381680|4185176|P1|Overall Study|Alternative Therapy|11
1281713|NCT00381680|4185175|P2|Overall Study|Entry onto another COG Trial|2
1281714|NCT00381680|4185176|P1|Overall Study|Entry onto another COG Trial|1
1281715|NCT00381680|4185175|P2|Overall Study|Withdrawal by Subject|1
1281716|NCT00381680|4185176|P1|Overall Study|Withdrawal by Subject|3
1281717|NCT00381680|4185175|P2|Overall Study|Physician Decision|6
1281718|NCT00381680|4185176|P1|Overall Study|Physician Decision|25
1281719|NCT00381680|4185175|P2|Overall Study|Lost to Follow-up|2
1281720|NCT00381680|4185176|P1|Overall Study|Lost to Follow-up|3
1281721|NCT00381680|4185175|P2|Overall Study|Death|7
1281722|NCT00381680|4185176|P1|Overall Study|Death|10
1281723|NCT00381680|4185175|P2|Overall Study|Adverse Event|3
1281724|NCT00381680|4185176|P1|Overall Study|Adverse Event|9
1281725|NCT00381641|4185193|P2|Overall Study|Withdrawal by Subject|2
1281726|NCT00381641|4185194|P1|Overall Study|Withdrawal by Subject|0
1281727|NCT00381615|4185227|P4|Overall Study|Protocol Violation|0
1281728|NCT00381615|4185228|P3|Overall Study|Protocol Violation|1
1281729|NCT00381615|4185229|P2|Overall Study|Protocol Violation|0
1281730|NCT00381615|4185230|P1|Overall Study|Protocol Violation|0
1281731|NCT00381615|4185227|P4|Overall Study|Lost to Follow-up|1
1281732|NCT00381615|4185228|P3|Overall Study|Lost to Follow-up|0
1281733|NCT00381615|4185229|P2|Overall Study|Lost to Follow-up|2
1281734|NCT00381615|4185230|P1|Overall Study|Lost to Follow-up|3
1281735|NCT00381615|4185227|P4|Overall Study|Withdrawal by Subject|1
1281736|NCT00381615|4185228|P3|Overall Study|Withdrawal by Subject|0
1281737|NCT00381615|4185229|P2|Overall Study|Withdrawal by Subject|3
1281738|NCT00381615|4185230|P1|Overall Study|Withdrawal by Subject|1
1281739|NCT00381563|4185282|P2|Overall Study|Protocol Violation|1
1281740|NCT00381563|4185283|P1|Overall Study|Protocol Violation|0
1281741|NCT00381563|4185282|P2|Overall Study|Lost to Follow-up|0
1281742|NCT00381563|4185283|P1|Overall Study|Lost to Follow-up|2
1281743|NCT00381563|4185282|P2|Overall Study|Withdrawal by Subject|5
1281744|NCT00381563|4185283|P1|Overall Study|Withdrawal by Subject|5
1281745|NCT00381485|4185298|P4|Double-Blind Treatment Period|Administrative|1
1281746|NCT00381485|4185299|P3|Double-Blind Treatment Period|Administrative|0
1281747|NCT00381485|4185300|P2|Double-Blind Treatment Period|Administrative|1
1281748|NCT00381485|4185301|P1|Double-Blind Treatment Period|Administrative|0
1281749|NCT00381485|4185298|P4|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1
1281750|NCT00381485|4185299|P3|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
1281751|NCT00381485|4185300|P2|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
1281752|NCT00381485|4185301|P1|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
1281753|NCT00381485|4185298|P4|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4
1281754|NCT00381485|4185299|P3|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1
1281755|NCT00381485|4185300|P2|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2
1281756|NCT00381485|4185301|P1|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0
1281757|NCT00381485|4185298|P4|Double-Blind Treatment Period|Did not meet protocol eligibility|5
1281758|NCT00381485|4185299|P3|Double-Blind Treatment Period|Did not meet protocol eligibility|7
1281759|NCT00381485|4185300|P2|Double-Blind Treatment Period|Did not meet protocol eligibility|5
1281760|NCT00381485|4185301|P1|Double-Blind Treatment Period|Did not meet protocol eligibility|0
1281761|NCT00381485|4185298|P4|Double-Blind Treatment Period|Noncompliance with protocol|3
1281762|NCT00381485|4185299|P3|Double-Blind Treatment Period|Noncompliance with protocol|3
1281763|NCT00381485|4185300|P2|Double-Blind Treatment Period|Noncompliance with protocol|9
1281764|NCT00381485|4185301|P1|Double-Blind Treatment Period|Noncompliance with protocol|0
1281765|NCT00381485|4185298|P4|Double-Blind Treatment Period|Lost to Follow-up|1
1281766|NCT00381485|4185299|P3|Double-Blind Treatment Period|Lost to Follow-up|1
1281767|NCT00381485|4185300|P2|Double-Blind Treatment Period|Lost to Follow-up|0
1281768|NCT00381485|4185301|P1|Double-Blind Treatment Period|Lost to Follow-up|0
1281769|NCT00381485|4185298|P4|Double-Blind Treatment Period|Lack of Efficacy|13
1281770|NCT00381485|4185299|P3|Double-Blind Treatment Period|Lack of Efficacy|11
1281771|NCT00381485|4185300|P2|Double-Blind Treatment Period|Lack of Efficacy|8
1281772|NCT00381485|4185301|P1|Double-Blind Treatment Period|Lack of Efficacy|0
1281773|NCT00381485|4185298|P4|Double-Blind Treatment Period|Adverse Event|5
1281774|NCT00381485|4185299|P3|Double-Blind Treatment Period|Adverse Event|2
1281775|NCT00381485|4185300|P2|Double-Blind Treatment Period|Adverse Event|2
1281776|NCT00381485|4185301|P1|Double-Blind Treatment Period|Adverse Event|0
1281777|NCT00381485|4185298|P4|Open-Label Run-In Period|Treatment failure|0
1281778|NCT00381485|4185299|P3|Open-Label Run-In Period|Treatment failure|0
1281779|NCT00381485|4185300|P2|Open-Label Run-In Period|Treatment failure|0
1281780|NCT00381485|4185301|P1|Open-Label Run-In Period|Treatment failure|1
1281781|NCT00381485|4185298|P4|Open-Label Run-In Period|Lost to Follow-up|0
1281782|NCT00381485|4185299|P3|Open-Label Run-In Period|Lost to Follow-up|0
1281783|NCT00381485|4185300|P2|Open-Label Run-In Period|Lost to Follow-up|0
1281784|NCT00381485|4185301|P1|Open-Label Run-In Period|Lost to Follow-up|3
1281785|NCT00381485|4185298|P4|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
1281786|NCT00381485|4185299|P3|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
1281787|NCT00381485|4185300|P2|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
1281788|NCT00381485|4185301|P1|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1
1281789|NCT00381485|4185298|P4|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
1281790|NCT00381485|4185299|P3|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
1281791|NCT00381485|4185300|P2|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
1281792|NCT00381485|4185301|P1|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16
1281793|NCT00381485|4185298|P4|Open-Label Run-In Period|Did not meet protocol eligibility|0
1281794|NCT00381485|4185299|P3|Open-Label Run-In Period|Did not meet protocol eligibility|0
1281795|NCT00381485|4185300|P2|Open-Label Run-In Period|Did not meet protocol eligibility|0
1281796|NCT00381485|4185301|P1|Open-Label Run-In Period|Did not meet protocol eligibility|76
1281797|NCT00381485|4185298|P4|Open-Label Run-In Period|Adverse Event|0
1281798|NCT00381485|4185299|P3|Open-Label Run-In Period|Adverse Event|0
1281799|NCT00381485|4185300|P2|Open-Label Run-In Period|Adverse Event|0
1281800|NCT00381485|4185301|P1|Open-Label Run-In Period|Adverse Event|9
1281801|NCT00381381|4185319|P1|Overall Study|Withdrawal by Subject|9
1281802|NCT00381381|4185319|P1|Overall Study|Lost to Follow-up|52
1281803|NCT00381381|4185319|P1|Overall Study|Adverse Event|3
1281804|NCT00381303|4185328|P2|Overall Study|Subject primary physician's decision|0
1281805|NCT00381303|4185329|P1|Overall Study|Subject primary physician's decision|1
1281806|NCT00381303|4185328|P2|Overall Study|Subject did not continue visits|0
1281807|NCT00381303|4185329|P1|Overall Study|Subject did not continue visits|1
1281808|NCT00381303|4185328|P2|Overall Study|Subject was too busy for appointments|0
1281809|NCT00381303|4185329|P1|Overall Study|Subject was too busy for appointments|1
1281810|NCT00381303|4185328|P2|Overall Study|No virologic response by week 12|0
1281811|NCT00381303|4185329|P1|Overall Study|No virologic response by week 12|1
1281812|NCT00381303|4185328|P2|Overall Study|Subject taking too many different meds|0
1281813|NCT00381303|4185329|P1|Overall Study|Subject taking too many different meds|1
1281814|NCT00381303|4185328|P2|Overall Study|Subject moved out of state|0
1281815|NCT00381303|4185329|P1|Overall Study|Subject moved out of state|2
1281816|NCT00381303|4185328|P2|Overall Study|Physician's decision to close the site|1
1281817|NCT00381303|4185329|P1|Overall Study|Physician's decision to close the site|3
1281818|NCT00381303|4185328|P2|Overall Study|Physician Decision|0
1281819|NCT00381303|4185329|P1|Overall Study|Physician Decision|1
1281820|NCT00381303|4185328|P2|Overall Study|Pregnancy|0
1281821|NCT00381303|4185329|P1|Overall Study|Pregnancy|2
1281822|NCT00381303|4185328|P2|Overall Study|Ineligible to continue the trial|1
1281823|NCT00381303|4185329|P1|Overall Study|Ineligible to continue the trial|2
1281824|NCT00381303|4185328|P2|Overall Study|Virologic failure|4
1281825|NCT00381303|4185329|P1|Overall Study|Virologic failure|6
1281826|NCT00381303|4185328|P2|Overall Study|Withdrawal by Subject|6
1281827|NCT00381303|4185329|P1|Overall Study|Withdrawal by Subject|13
1281828|NCT00381303|4185328|P2|Overall Study|Non-Adherence|6
1281829|NCT00381303|4185329|P1|Overall Study|Non-Adherence|13
1281830|NCT00381303|4185328|P2|Overall Study|AE/HIV-related event|6
1281831|NCT00381303|4185329|P1|Overall Study|AE/HIV-related event|22
1281832|NCT00381303|4185328|P2|Overall Study|Lost to Follow-up|9
1281833|NCT00381303|4185329|P1|Overall Study|Lost to Follow-up|25
1281834|NCT00381238|4185389|P1|Overall Study|Disease progression|1
1281835|NCT00381238|4185389|P1|Overall Study|Withdrew by physician|1
1281836|NCT00381238|4185389|P1|Overall Study|Lack of Efficacy|2
1281837|NCT00381238|4185389|P1|Overall Study|Withdrawal by Subject|4
1281838|NCT00381238|4185389|P1|Overall Study|Protocol Violation|1
1281839|NCT00381238|4185389|P1|Overall Study|Adverse Event|3
1281840|NCT00381095|4185405|P2|Overall Study|Adverse Event|7
1281841|NCT00381095|4185406|P1|Overall Study|Adverse Event|2
1281842|NCT00381095|4185405|P2|Overall Study|Withdrawal by Subject|3
1281843|NCT00381095|4185406|P1|Overall Study|Withdrawal by Subject|3
1281844|NCT00381095|4185405|P2|Overall Study|Protocol Violation|1
1281845|NCT00381095|4185406|P1|Overall Study|Protocol Violation|1
1281846|NCT00381095|4185405|P2|Overall Study|Other|2
1281847|NCT00381095|4185406|P1|Overall Study|Other|2
1281848|NCT00381095|4185405|P2|Overall Study|Lack of Efficacy|4
1281849|NCT00381095|4185406|P1|Overall Study|Lack of Efficacy|2
1281850|NCT00381095|4185405|P2|Overall Study|Death|4
1281851|NCT00381095|4185406|P1|Overall Study|Death|3
1281852|NCT00381043|4185438|P2|Overall Study|incarcerated|0
1281853|NCT00381043|4185439|P1|Overall Study|incarcerated|1
1281854|NCT00381043|4185438|P2|Overall Study|wanted more care|1
1281855|NCT00381043|4185439|P1|Overall Study|wanted more care|0
1281856|NCT00381043|4185438|P2|Overall Study|Withdrawal by Subject|1
1281857|NCT00381043|4185439|P1|Overall Study|Withdrawal by Subject|3
1281858|NCT00381043|4185438|P2|Overall Study|Lost to Follow-up|6
1281859|NCT00381043|4185439|P1|Overall Study|Lost to Follow-up|8
1281860|NCT00380978|4185465|P2|Overall Study|Parous patient|0
1281861|NCT00380978|4185466|P1|Overall Study|Parous patient|1
1281862|NCT00380978|4185465|P2|Overall Study|Allocation prior to analgesia request|2
1281863|NCT00380978|4185466|P1|Overall Study|Allocation prior to analgesia request|1
1281864|NCT00380978|4185465|P2|Overall Study|Wrong study envelope|2
1281865|NCT00380978|4185466|P1|Overall Study|Wrong study envelope|0
1281866|NCT00380978|4185465|P2|Overall Study|Refused allocated intervention|6
1281867|NCT00380978|4185466|P1|Overall Study|Refused allocated intervention|0
1281868|NCT00380874|4185488|P2|Overall Study|Not related to study drug|2
1281869|NCT00380874|4185489|P1|Overall Study|Not related to study drug|3
1281870|NCT00380874|4185488|P2|Overall Study|Withdrawal by Subject|1
1281871|NCT00380874|4185489|P1|Overall Study|Withdrawal by Subject|2
1281872|NCT00380874|4185488|P2|Overall Study|Death|0
1281873|NCT00380874|4185489|P1|Overall Study|Death|1
1281874|NCT00380874|4185488|P2|Overall Study|Adverse Event|7
1281875|NCT00380874|4185489|P1|Overall Study|Adverse Event|7
1281876|NCT00380718|4185514|P1|Overall Study|Death after 30-day post-therapy followup|17
1281877|NCT00380718|4185514|P1|Overall Study|Adverse Event|1
1281878|NCT00380692|4185526|P2|Study Period III - Open Label|Parent/Caregiver Decision|1
1281879|NCT00380692|4185527|P1|Study Period III - Open Label|Parent/Caregiver Decision|1
1281880|NCT00380692|4185526|P2|Study Period III - Open Label|Lack of Efficacy|4
1281881|NCT00380692|4185527|P1|Study Period III - Open Label|Lack of Efficacy|0
1281882|NCT00380692|4185526|P2|Study Period III - Open Label|Physician Decision|3
1281883|NCT00380692|4185527|P1|Study Period III - Open Label|Physician Decision|0
1281884|NCT00380692|4185526|P2|Study Period III - Open Label|Withdrawal by Subject|1
1281885|NCT00380692|4185527|P1|Study Period III - Open Label|Withdrawal by Subject|0
1281886|NCT00380692|4185526|P2|Study Period III - Open Label|Protocol Violation|0
1281887|NCT00380692|4185527|P1|Study Period III - Open Label|Protocol Violation|0
1281888|NCT00380692|4185526|P2|Study Period III - Open Label|Adverse Event|3
1281889|NCT00380692|4185527|P1|Study Period III - Open Label|Adverse Event|5
1281890|NCT00380692|4185526|P2|Study Period II - Double Blind|Parent/Caregiver Decision|0
1281891|NCT00380692|4185527|P1|Study Period II - Double Blind|Parent/Caregiver Decision|1
1281892|NCT00380692|4185526|P2|Study Period II - Double Blind|Lack of Efficacy|0
1281893|NCT00380692|4185527|P1|Study Period II - Double Blind|Lack of Efficacy|1
1281894|NCT00380692|4185526|P2|Study Period II - Double Blind|Physician Decision|1
1281895|NCT00380692|4185527|P1|Study Period II - Double Blind|Physician Decision|0
1281896|NCT00380692|4185526|P2|Study Period II - Double Blind|Withdrawal by Subject|0
1281897|NCT00380692|4185527|P1|Study Period II - Double Blind|Withdrawal by Subject|0
1281898|NCT00380692|4185526|P2|Study Period II - Double Blind|Protocol Violation|2
1281899|NCT00380692|4185527|P1|Study Period II - Double Blind|Protocol Violation|2
1281900|NCT00380692|4185526|P2|Study Period II - Double Blind|Adverse Event|0
1281901|NCT00380692|4185527|P1|Study Period II - Double Blind|Adverse Event|1
1281902|NCT00380588|4185575|P2|Overall Study|Physician Decision|0
1281903|NCT00380588|4185576|P1|Overall Study|Physician Decision|2
1281904|NCT00380588|4185575|P2|Overall Study|Withdrawal by Subject|3
1281905|NCT00380588|4185576|P1|Overall Study|Withdrawal by Subject|1
1281906|NCT00380588|4185575|P2|Overall Study|Adverse Event|3
1281907|NCT00380588|4185576|P1|Overall Study|Adverse Event|7
1281908|NCT00380588|4185575|P2|Overall Study|Next Cycle Not Started|0
1281909|NCT00380588|4185576|P1|Overall Study|Next Cycle Not Started|4
1281910|NCT00380588|4185575|P2|Overall Study|Unequivocal Disease Progression|34
1281911|NCT00380588|4185576|P1|Overall Study|Unequivocal Disease Progression|25
1281912|NCT00380393|4185590|P2|Month 14|Others|6
1281913|NCT00380393|4185591|P1|Month 14|Others|6
1281914|NCT00380393|4185590|P2|Month 14|Protocol Violation|0
1281915|NCT00380393|4185591|P1|Month 14|Protocol Violation|2
1281916|NCT00380393|4185590|P2|Month 14|Migrated/moved from study area|42
1281917|NCT00380393|4185591|P1|Month 14|Migrated/moved from study area|39
1281918|NCT00380393|4185590|P2|Month 14|Lost to Follow-up|1
1281919|NCT00380393|4185591|P1|Month 14|Lost to Follow-up|0
1281920|NCT00380393|4185590|P2|Month 14|Death|0
1281921|NCT00380393|4185591|P1|Month 14|Death|1
1281922|NCT00380393|4185590|P2|Month 14|Withdrawal by Subject|7
1281923|NCT00380393|4185591|P1|Month 14|Withdrawal by Subject|9
1281924|NCT00380393|4185590|P2|Month 8 (Cross-sectional Visit)|Others|4
1281925|NCT00380393|4185591|P1|Month 8 (Cross-sectional Visit)|Others|5
1281926|NCT00380393|4185590|P2|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1
1281927|NCT00380393|4185591|P1|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1
1281928|NCT00380393|4185590|P2|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29
1281929|NCT00380393|4185591|P1|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37
1281930|NCT00380393|4185590|P2|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1
1281931|NCT00380393|4185591|P1|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0
1281932|NCT00380393|4185590|P2|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5
1281933|NCT00380393|4185591|P1|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6
1281934|NCT00380367|4185639|P1|Overall Study|Withdrawal by Subject|1
1281935|NCT00380367|4185639|P1|Overall Study|Lost to Follow-up|1
1281936|NCT00380250|4185646|P2|Overall Study|Physician Decision|0
1281937|NCT00380250|4185647|P1|Overall Study|Physician Decision|1
1281938|NCT00380250|4185646|P2|Overall Study|Lost to Follow-up|5
1281939|NCT00380250|4185647|P1|Overall Study|Lost to Follow-up|14
1281940|NCT00380250|4185646|P2|Overall Study|Protocol Violation|5
1281941|NCT00380250|4185647|P1|Overall Study|Protocol Violation|15
1281942|NCT00380250|4185646|P2|Overall Study|Lack of Efficacy|8
1281943|NCT00380250|4185647|P1|Overall Study|Lack of Efficacy|10
1281944|NCT00380250|4185646|P2|Overall Study|Adverse Event|9
1281945|NCT00380250|4185647|P1|Overall Study|Adverse Event|20
1281946|NCT00380250|4185646|P2|Overall Study|Withdrawal by Subject|28
1281947|NCT00380250|4185647|P1|Overall Study|Withdrawal by Subject|39
1281948|NCT00380081|4185715|P6|Overall Study|Family Emergency|1
1281949|NCT00380081|4185716|P5|Overall Study|Family Emergency|0
1281950|NCT00380081|4185717|P4|Overall Study|Family Emergency|0
1281951|NCT00380081|4185718|P3|Overall Study|Family Emergency|0
1281952|NCT00380081|4185719|P2|Overall Study|Family Emergency|0
1281953|NCT00380081|4185720|P1|Overall Study|Family Emergency|0
1281954|NCT00380081|4185715|P6|Overall Study|Withdrawal by Subject|0
1281955|NCT00380081|4185716|P5|Overall Study|Withdrawal by Subject|1
1281956|NCT00380081|4185717|P4|Overall Study|Withdrawal by Subject|0
1281957|NCT00380081|4185718|P3|Overall Study|Withdrawal by Subject|0
1281958|NCT00380081|4185719|P2|Overall Study|Withdrawal by Subject|0
1281959|NCT00380081|4185720|P1|Overall Study|Withdrawal by Subject|0
1281960|NCT00380068|4185770|P1|Overall Study|Lack of Efficacy|5
1281961|NCT00380068|4185770|P1|Overall Study|Partipant moved away|1
1281962|NCT00380068|4185770|P1|Overall Study|Physician Decision|2
1281963|NCT00380068|4185770|P1|Overall Study|Lung transplant|3
1281964|NCT00380068|4185770|P1|Overall Study|Addition of other PAH therapeutic agent|1
1281965|NCT00380068|4185770|P1|Overall Study|Lost to Follow-up|1
1281966|NCT00380068|4185770|P1|Overall Study|Not compliant|6
1281967|NCT00380068|4185770|P1|Overall Study|Withdrawal by Subject|10
1281968|NCT00380068|4185770|P1|Overall Study|Adverse Event|40
1281969|NCT00379912|4185802|P2|Overall Study|Lack of Efficacy|0
1281970|NCT00379912|4185803|P1|Overall Study|Lack of Efficacy|1
1281971|NCT00379899|4185825|P2|Overall Study|Other|1
1281972|NCT00379899|4185826|P1|Overall Study|Other|3
1281973|NCT00379899|4185825|P2|Overall Study|Other protocol-specified criteria|4
1281974|NCT00379899|4185826|P1|Overall Study|Other protocol-specified criteria|3
1281975|NCT00379899|4185825|P2|Overall Study|Coronary artery bypass graft|1
1281976|NCT00379899|4185826|P1|Overall Study|Coronary artery bypass graft|1
1281977|NCT00379899|4185825|P2|Overall Study|Renal transplantation|4
1281978|NCT00379899|4185826|P1|Overall Study|Renal transplantation|5
1281979|NCT00379899|4185825|P2|Overall Study|Parathyroidectomy|2
1281980|NCT00379899|4185826|P1|Overall Study|Parathyroidectomy|0
1281981|NCT00379899|4185825|P2|Overall Study|Noncompliance|1
1281982|NCT00379899|4185826|P1|Overall Study|Noncompliance|1
1281983|NCT00379899|4185825|P2|Overall Study|Ineligibility determined|1
1281984|NCT00379899|4185826|P1|Overall Study|Ineligibility determined|0
1281985|NCT00379899|4185825|P2|Overall Study|Withdrawal by Subject|5
1281986|NCT00379899|4185826|P1|Overall Study|Withdrawal by Subject|5
1281987|NCT00379899|4185825|P2|Overall Study|Physician Decision|4
1281988|NCT00379899|4185826|P1|Overall Study|Physician Decision|3
1281989|NCT00379899|4185825|P2|Overall Study|Lost to Follow-up|4
1281990|NCT00379899|4185826|P1|Overall Study|Lost to Follow-up|2
1281991|NCT00379899|4185825|P2|Overall Study|Death|10
1281992|NCT00379899|4185826|P1|Overall Study|Death|10
1281993|NCT00379899|4185825|P2|Overall Study|Adverse Event|3
1281994|NCT00379899|4185826|P1|Overall Study|Adverse Event|7
1281995|NCT00379834|4185854|P1|Overall Study|Time constraints|2
1281996|NCT00379808|4186006|P2|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1
1281997|NCT00379808|4186007|P1|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0
1281998|NCT00379795|4186028|P5|Overall Study|Sponsor's decision|10
1281999|NCT00379795|4186029|P4|Overall Study|Sponsor's decision|47
1282000|NCT00379795|4186030|P3|Overall Study|Sponsor's decision|54
1282001|NCT00379795|4186031|P2|Overall Study|Sponsor's decision|17
1282002|NCT00379795|4186032|P1|Overall Study|Sponsor's decision|257
1282003|NCT00379795|4186028|P5|Overall Study|Subjects condition mandated intervention|7
1282004|NCT00379795|4186029|P4|Overall Study|Subjects condition mandated intervention|5
1282005|NCT00379795|4186030|P3|Overall Study|Subjects condition mandated intervention|7
1282006|NCT00379795|4186031|P2|Overall Study|Subjects condition mandated intervention|9
1282007|NCT00379795|4186032|P1|Overall Study|Subjects condition mandated intervention|34
1282008|NCT00379795|4186028|P5|Overall Study|Verteporfin photodynamic therapy in eye|0
1282009|NCT00379795|4186029|P4|Overall Study|Verteporfin photodynamic therapy in eye|1
1282010|NCT00379795|4186030|P3|Overall Study|Verteporfin photodynamic therapy in eye|0
1282011|NCT00379795|4186031|P2|Overall Study|Verteporfin photodynamic therapy in eye|0
1282012|NCT00379795|4186032|P1|Overall Study|Verteporfin photodynamic therapy in eye|3
1282013|NCT00379795|4186028|P5|Overall Study|Subject non-compliance|1
1282014|NCT00379795|4186029|P4|Overall Study|Subject non-compliance|0
1282015|NCT00379795|4186030|P3|Overall Study|Subject non-compliance|0
1282016|NCT00379795|4186031|P2|Overall Study|Subject non-compliance|2
1282017|NCT00379795|4186032|P1|Overall Study|Subject non-compliance|7
1282018|NCT00379795|4186028|P5|Overall Study|Withdrawal by Subject|14
1282019|NCT00379795|4186029|P4|Overall Study|Withdrawal by Subject|7
1282020|NCT00379795|4186030|P3|Overall Study|Withdrawal by Subject|19
1282021|NCT00379795|4186031|P2|Overall Study|Withdrawal by Subject|11
1282022|NCT00379795|4186032|P1|Overall Study|Withdrawal by Subject|94
1282023|NCT00379795|4186028|P5|Overall Study|Physician Decision|2
1282024|NCT00379795|4186029|P4|Overall Study|Physician Decision|2
1282025|NCT00379795|4186030|P3|Overall Study|Physician Decision|2
1282026|NCT00379795|4186031|P2|Overall Study|Physician Decision|0
1282027|NCT00379795|4186032|P1|Overall Study|Physician Decision|25
1282028|NCT00379795|4186028|P5|Overall Study|Lost to Follow-up|4
1282029|NCT00379795|4186029|P4|Overall Study|Lost to Follow-up|1
1282030|NCT00379795|4186030|P3|Overall Study|Lost to Follow-up|2
1282031|NCT00379795|4186031|P2|Overall Study|Lost to Follow-up|1
1282032|NCT00379795|4186032|P1|Overall Study|Lost to Follow-up|8
1282033|NCT00379795|4186028|P5|Overall Study|Adverse Event|4
1282034|NCT00379795|4186029|P4|Overall Study|Adverse Event|1
1282035|NCT00379795|4186030|P3|Overall Study|Adverse Event|3
1282036|NCT00379795|4186031|P2|Overall Study|Adverse Event|3
1282037|NCT00379795|4186032|P1|Overall Study|Adverse Event|17
1282038|NCT00379795|4186028|P5|Overall Study|Death|7
1282039|NCT00379795|4186029|P4|Overall Study|Death|4
1282040|NCT00379795|4186030|P3|Overall Study|Death|6
1282041|NCT00379795|4186031|P2|Overall Study|Death|8
1282042|NCT00379795|4186032|P1|Overall Study|Death|31
1282043|NCT00379769|4186062|P6|Observational Follow-up|Unknown; Reason Not Provided|1
1282044|NCT00379769|4186063|P5|Observational Follow-up|Unknown; Reason Not Provided|1
1282045|NCT00379769|4186064|P4|Observational Follow-up|Unknown; Reason Not Provided|0
1282046|NCT00379769|4186065|P3|Observational Follow-up|Unknown; Reason Not Provided|0
1282047|NCT00379769|4186066|P2|Observational Follow-up|Unknown; Reason Not Provided|0
1282048|NCT00379769|4186067|P1|Observational Follow-up|Unknown; Reason Not Provided|0
1282049|NCT00379769|4186062|P6|Observational Follow-up|Participant Moved|1
1282050|NCT00379769|4186063|P5|Observational Follow-up|Participant Moved|0
1282051|NCT00379769|4186064|P4|Observational Follow-up|Participant Moved|0
1282052|NCT00379769|4186065|P3|Observational Follow-up|Participant Moved|0
1282053|NCT00379769|4186066|P2|Observational Follow-up|Participant Moved|0
1282054|NCT00379769|4186067|P1|Observational Follow-up|Participant Moved|0
1282055|NCT00379769|4186062|P6|Observational Follow-up|Site Closed Early|7
1282056|NCT00379769|4186063|P5|Observational Follow-up|Site Closed Early|6
1282057|NCT00379769|4186064|P4|Observational Follow-up|Site Closed Early|0
1282058|NCT00379769|4186065|P3|Observational Follow-up|Site Closed Early|0
1282059|NCT00379769|4186066|P2|Observational Follow-up|Site Closed Early|0
1282060|NCT00379769|4186067|P1|Observational Follow-up|Site Closed Early|0
1282061|NCT00379769|4186062|P6|Observational Follow-up|Physician Decision|8
1282062|NCT00379769|4186063|P5|Observational Follow-up|Physician Decision|8
1282063|NCT00379769|4186064|P4|Observational Follow-up|Physician Decision|0
1282064|NCT00379769|4186065|P3|Observational Follow-up|Physician Decision|0
1282065|NCT00379769|4186066|P2|Observational Follow-up|Physician Decision|0
1282066|NCT00379769|4186067|P1|Observational Follow-up|Physician Decision|0
1282067|NCT00379769|4186062|P6|Observational Follow-up|Entered into Another Clinical Trial|22
1282068|NCT00379769|4186063|P5|Observational Follow-up|Entered into Another Clinical Trial|18
1282069|NCT00379769|4186064|P4|Observational Follow-up|Entered into Another Clinical Trial|0
1282070|NCT00379769|4186065|P3|Observational Follow-up|Entered into Another Clinical Trial|0
1282071|NCT00379769|4186066|P2|Observational Follow-up|Entered into Another Clinical Trial|0
1282072|NCT00379769|4186067|P1|Observational Follow-up|Entered into Another Clinical Trial|0
1282073|NCT00379769|4186062|P6|Observational Follow-up|Withdrawal by Subject|12
1282074|NCT00379769|4186063|P5|Observational Follow-up|Withdrawal by Subject|12
1282075|NCT00379769|4186064|P4|Observational Follow-up|Withdrawal by Subject|0
1282076|NCT00379769|4186065|P3|Observational Follow-up|Withdrawal by Subject|0
1282077|NCT00379769|4186066|P2|Observational Follow-up|Withdrawal by Subject|0
1282078|NCT00379769|4186067|P1|Observational Follow-up|Withdrawal by Subject|0
1282079|NCT00379769|4186062|P6|Observational Follow-up|Lost to Follow-up|27
1282080|NCT00379769|4186063|P5|Observational Follow-up|Lost to Follow-up|25
1282081|NCT00379769|4186064|P4|Observational Follow-up|Lost to Follow-up|0
1282082|NCT00379769|4186065|P3|Observational Follow-up|Lost to Follow-up|0
1282083|NCT00379769|4186066|P2|Observational Follow-up|Lost to Follow-up|0
1282084|NCT00379769|4186067|P1|Observational Follow-up|Lost to Follow-up|0
1282085|NCT00379769|4186062|P6|Observational Follow-up|Adverse Event|0
1282086|NCT00379769|4186063|P5|Observational Follow-up|Adverse Event|1
1282087|NCT00379769|4186064|P4|Observational Follow-up|Adverse Event|0
1282088|NCT00379769|4186065|P3|Observational Follow-up|Adverse Event|0
1282089|NCT00379769|4186066|P2|Observational Follow-up|Adverse Event|0
1282090|NCT00379769|4186067|P1|Observational Follow-up|Adverse Event|0
1282091|NCT00379769|4186062|P6|Observational Follow-up|Death|70
1282092|NCT00379769|4186063|P5|Observational Follow-up|Death|78
1282093|NCT00379769|4186064|P4|Observational Follow-up|Death|0
1282094|NCT00379769|4186065|P3|Observational Follow-up|Death|0
1282095|NCT00379769|4186066|P2|Observational Follow-up|Death|0
1282096|NCT00379769|4186067|P1|Observational Follow-up|Death|0
1282097|NCT00379769|4186062|P6|Main Study|Reason unspecified|0
1282098|NCT00379769|4186063|P5|Main Study|Reason unspecified|0
1282099|NCT00379769|4186064|P4|Main Study|Reason unspecified|0
1282100|NCT00379769|4186065|P3|Main Study|Reason unspecified|1
1282101|NCT00379769|4186066|P2|Main Study|Reason unspecified|0
1282102|NCT00379769|4186067|P1|Main Study|Reason unspecified|0
1282103|NCT00379769|4186062|P6|Main Study|Investigator refused to log temperature|0
1282104|NCT00379769|4186063|P5|Main Study|Investigator refused to log temperature|0
1282105|NCT00379769|4186064|P4|Main Study|Investigator refused to log temperature|0
1282106|NCT00379769|4186065|P3|Main Study|Investigator refused to log temperature|1
1282107|NCT00379769|4186066|P2|Main Study|Investigator refused to log temperature|0
1282108|NCT00379769|4186067|P1|Main Study|Investigator refused to log temperature|0
1282109|NCT00379769|4186062|P6|Main Study|Risk of heart failure|0
1282110|NCT00379769|4186063|P5|Main Study|Risk of heart failure|0
1282111|NCT00379769|4186064|P4|Main Study|Risk of heart failure|0
1282112|NCT00379769|4186065|P3|Main Study|Risk of heart failure|0
1282113|NCT00379769|4186066|P2|Main Study|Risk of heart failure|1
1282114|NCT00379769|4186067|P1|Main Study|Risk of heart failure|0
1282115|NCT00379769|4186062|P6|Main Study|Personal reasons|0
1282116|NCT00379769|4186063|P5|Main Study|Personal reasons|0
1282117|NCT00379769|4186064|P4|Main Study|Personal reasons|0
1282118|NCT00379769|4186065|P3|Main Study|Personal reasons|0
1282119|NCT00379769|4186066|P2|Main Study|Personal reasons|0
1282120|NCT00379769|4186067|P1|Main Study|Personal reasons|1
1282121|NCT00379769|4186062|P6|Main Study|Participant completed study at visit 27|0
1282122|NCT00379769|4186063|P5|Main Study|Participant completed study at visit 27|0
1282123|NCT00379769|4186064|P4|Main Study|Participant completed study at visit 27|0
1282124|NCT00379769|4186065|P3|Main Study|Participant completed study at visit 27|0
1282125|NCT00379769|4186066|P2|Main Study|Participant completed study at visit 27|0
1282126|NCT00379769|4186067|P1|Main Study|Participant completed study at visit 27|1
1282127|NCT00379769|4186062|P6|Main Study|Physician Decision|0
1282128|NCT00379769|4186063|P5|Main Study|Physician Decision|0
1282129|NCT00379769|4186064|P4|Main Study|Physician Decision|1
1282130|NCT00379769|4186065|P3|Main Study|Physician Decision|1
1282131|NCT00379769|4186066|P2|Main Study|Physician Decision|2
1282132|NCT00379769|4186067|P1|Main Study|Physician Decision|2
1282133|NCT00379769|4186062|P6|Main Study|Participant did not take study drug|0
1282134|NCT00379769|4186063|P5|Main Study|Participant did not take study drug|0
1282135|NCT00379769|4186064|P4|Main Study|Participant did not take study drug|0
1282136|NCT00379769|4186065|P3|Main Study|Participant did not take study drug|1
1282137|NCT00379769|4186066|P2|Main Study|Participant did not take study drug|0
1282138|NCT00379769|4186067|P1|Main Study|Participant did not take study drug|0
1282139|NCT00379769|4186062|P6|Main Study|Entry criteria violation|0
1282140|NCT00379769|4186063|P5|Main Study|Entry criteria violation|0
1282141|NCT00379769|4186064|P4|Main Study|Entry criteria violation|1
1282142|NCT00379769|4186065|P3|Main Study|Entry criteria violation|1
1282143|NCT00379769|4186066|P2|Main Study|Entry criteria violation|0
1282144|NCT00379769|4186067|P1|Main Study|Entry criteria violation|0
1282145|NCT00379769|4186062|P6|Main Study|Site closed|0
1282146|NCT00379769|4186063|P5|Main Study|Site closed|0
1282147|NCT00379769|4186064|P4|Main Study|Site closed|8
1282148|NCT00379769|4186065|P3|Main Study|Site closed|4
1282149|NCT00379769|4186066|P2|Main Study|Site closed|4
1282150|NCT00379769|4186067|P1|Main Study|Site closed|4
1282151|NCT00379769|4186062|P6|Main Study|Prohibited glucose lowering medication|0
1282152|NCT00379769|4186063|P5|Main Study|Prohibited glucose lowering medication|0
1282153|NCT00379769|4186064|P4|Main Study|Prohibited glucose lowering medication|1
1282154|NCT00379769|4186065|P3|Main Study|Prohibited glucose lowering medication|0
1282155|NCT00379769|4186066|P2|Main Study|Prohibited glucose lowering medication|3
1282156|NCT00379769|4186067|P1|Main Study|Prohibited glucose lowering medication|0
1282157|NCT00379769|4186062|P6|Main Study|Poor compliance|0
1282158|NCT00379769|4186063|P5|Main Study|Poor compliance|0
1282159|NCT00379769|4186064|P4|Main Study|Poor compliance|1
1282160|NCT00379769|4186065|P3|Main Study|Poor compliance|2
1282161|NCT00379769|4186066|P2|Main Study|Poor compliance|2
1282162|NCT00379769|4186067|P1|Main Study|Poor compliance|3
1282163|NCT00379769|4186062|P6|Main Study|Participant moved|0
1282164|NCT00379769|4186063|P5|Main Study|Participant moved|0
1282165|NCT00379769|4186064|P4|Main Study|Participant moved|3
1282166|NCT00379769|4186065|P3|Main Study|Participant moved|3
1282167|NCT00379769|4186066|P2|Main Study|Participant moved|2
1282168|NCT00379769|4186067|P1|Main Study|Participant moved|3
1282169|NCT00379769|4186062|P6|Main Study|Moved to survival status follow-up only|0
1282170|NCT00379769|4186063|P5|Main Study|Moved to survival status follow-up only|0
1282171|NCT00379769|4186064|P4|Main Study|Moved to survival status follow-up only|36
1282172|NCT00379769|4186065|P3|Main Study|Moved to survival status follow-up only|32
1282173|NCT00379769|4186066|P2|Main Study|Moved to survival status follow-up only|25
1282174|NCT00379769|4186067|P1|Main Study|Moved to survival status follow-up only|27
1282175|NCT00379769|4186062|P6|Main Study|Withdrawal by Subject|0
1282176|NCT00379769|4186063|P5|Main Study|Withdrawal by Subject|0
1282177|NCT00379769|4186064|P4|Main Study|Withdrawal by Subject|70
1282178|NCT00379769|4186065|P3|Main Study|Withdrawal by Subject|72
1282179|NCT00379769|4186066|P2|Main Study|Withdrawal by Subject|56
1282180|NCT00379769|4186067|P1|Main Study|Withdrawal by Subject|46
1282181|NCT00379769|4186062|P6|Main Study|Lost to Follow-up|0
1282182|NCT00379769|4186063|P5|Main Study|Lost to Follow-up|0
1282183|NCT00379769|4186064|P4|Main Study|Lost to Follow-up|26
1282184|NCT00379769|4186065|P3|Main Study|Lost to Follow-up|25
1282185|NCT00379769|4186066|P2|Main Study|Lost to Follow-up|29
1282186|NCT00379769|4186067|P1|Main Study|Lost to Follow-up|29
1282187|NCT00379769|4186062|P6|Main Study|Adverse Event|0
1282188|NCT00379769|4186063|P5|Main Study|Adverse Event|0
1282189|NCT00379769|4186064|P4|Main Study|Adverse Event|11
1282190|NCT00379769|4186065|P3|Main Study|Adverse Event|10
1282191|NCT00379769|4186066|P2|Main Study|Adverse Event|8
1282192|NCT00379769|4186067|P1|Main Study|Adverse Event|5
1282193|NCT00379769|4186062|P6|Main Study|Death|0
1282194|NCT00379769|4186063|P5|Main Study|Death|0
1282195|NCT00379769|4186064|P4|Main Study|Death|72
1282196|NCT00379769|4186065|P3|Main Study|Death|54
1282197|NCT00379769|4186066|P2|Main Study|Death|67
1282198|NCT00379769|4186067|P1|Main Study|Death|57
1282199|NCT00379639|4186226|P5|Overall Study|Other|0
1282200|NCT00379639|4186227|P4|Overall Study|Other|0
1282201|NCT00379639|4186228|P3|Overall Study|Other|3
1282202|NCT00379639|4186229|P2|Overall Study|Other|0
1282203|NCT00379639|4186230|P1|Overall Study|Other|0
1282204|NCT00379639|4186226|P5|Overall Study|Lost to Follow-up|0
1282205|NCT00379639|4186227|P4|Overall Study|Lost to Follow-up|1
1282206|NCT00379639|4186228|P3|Overall Study|Lost to Follow-up|0
1282207|NCT00379639|4186229|P2|Overall Study|Lost to Follow-up|0
1282208|NCT00379639|4186230|P1|Overall Study|Lost to Follow-up|0
1282209|NCT00379639|4186226|P5|Overall Study|Adverse Event|1
1282210|NCT00379639|4186227|P4|Overall Study|Adverse Event|0
1282211|NCT00379639|4186228|P3|Overall Study|Adverse Event|1
1282212|NCT00379639|4186229|P2|Overall Study|Adverse Event|0
1282213|NCT00379639|4186230|P1|Overall Study|Adverse Event|0
1282214|NCT00379639|4186226|P5|Overall Study|Symptomatic Deterioration|1
1282215|NCT00379639|4186227|P4|Overall Study|Symptomatic Deterioration|0
1282216|NCT00379639|4186228|P3|Overall Study|Symptomatic Deterioration|1
1282217|NCT00379639|4186229|P2|Overall Study|Symptomatic Deterioration|0
1282218|NCT00379639|4186230|P1|Overall Study|Symptomatic Deterioration|0
1282219|NCT00379639|4186226|P5|Overall Study|Physician Decision|0
1282220|NCT00379639|4186227|P4|Overall Study|Physician Decision|1
1282221|NCT00379639|4186228|P3|Overall Study|Physician Decision|1
1282222|NCT00379639|4186229|P2|Overall Study|Physician Decision|2
1282223|NCT00379639|4186230|P1|Overall Study|Physician Decision|0
1282224|NCT00379639|4186226|P5|Overall Study|Disease Progression|4
1282225|NCT00379639|4186227|P4|Overall Study|Disease Progression|4
1282226|NCT00379639|4186228|P3|Overall Study|Disease Progression|3
1282227|NCT00379639|4186229|P2|Overall Study|Disease Progression|3
1282228|NCT00379639|4186230|P1|Overall Study|Disease Progression|3
1282229|NCT00379587|4186252|P1|Overall Study|Lost to Follow-up|2
1282230|NCT00379353|4186266|P2|Overall Study|Conflicting drug treatment|1
1282231|NCT00379353|4186267|P1|Overall Study|Conflicting drug treatment|0
1282232|NCT00379353|4186266|P2|Overall Study|Non-compliance|0
1282233|NCT00379353|4186267|P1|Overall Study|Non-compliance|1
1282234|NCT00379353|4186266|P2|Overall Study|Cardiac Tamponade|0
1282235|NCT00379353|4186267|P1|Overall Study|Cardiac Tamponade|1
1282236|NCT00379353|4186266|P2|Overall Study|Death|0
1282237|NCT00379353|4186267|P1|Overall Study|Death|1
1282238|NCT00379353|4186266|P2|Overall Study|Withdrawal by Subject|2
1282239|NCT00379353|4186267|P1|Overall Study|Withdrawal by Subject|5
1282240|NCT00379353|4186266|P2|Overall Study|Hospitalization|3
1282241|NCT00379353|4186267|P1|Overall Study|Hospitalization|3
1282242|NCT00379340|4186302|P5|Overall Study|Delayed nephrectomy and anaplasia|1
1282243|NCT00379340|4186303|P4|Overall Study|Delayed nephrectomy and anaplasia|1
1282244|NCT00379340|4186304|P3|Overall Study|Delayed nephrectomy and anaplasia|0
1282245|NCT00379340|4186305|P2|Overall Study|Delayed nephrectomy and anaplasia|0
1282246|NCT00379340|4186306|P1|Overall Study|Delayed nephrectomy and anaplasia|0
1282247|NCT00379340|4186302|P5|Overall Study|On more than 1 tumor therapeutic study|0
1282248|NCT00379340|4186303|P4|Overall Study|On more than 1 tumor therapeutic study|2
1282249|NCT00379340|4186304|P3|Overall Study|On more than 1 tumor therapeutic study|0
1282250|NCT00379340|4186305|P2|Overall Study|On more than 1 tumor therapeutic study|0
1282251|NCT00379340|4186306|P1|Overall Study|On more than 1 tumor therapeutic study|0
1282252|NCT00379340|4186302|P5|Overall Study|Refusal of further protocol therapy|7
1282253|NCT00379340|4186303|P4|Overall Study|Refusal of further protocol therapy|1
1282254|NCT00379340|4186304|P3|Overall Study|Refusal of further protocol therapy|1
1282255|NCT00379340|4186305|P2|Overall Study|Refusal of further protocol therapy|0
1282256|NCT00379340|4186306|P1|Overall Study|Refusal of further protocol therapy|1
1282257|NCT00379340|4186302|P5|Overall Study|Withdrawal by Subject|0
1282258|NCT00379340|4186303|P4|Overall Study|Withdrawal by Subject|1
1282259|NCT00379340|4186304|P3|Overall Study|Withdrawal by Subject|0
1282260|NCT00379340|4186305|P2|Overall Study|Withdrawal by Subject|0
1282261|NCT00379340|4186306|P1|Overall Study|Withdrawal by Subject|0
1282262|NCT00379340|4186302|P5|Overall Study|Physician Decision|3
1282263|NCT00379340|4186303|P4|Overall Study|Physician Decision|2
1282264|NCT00379340|4186304|P3|Overall Study|Physician Decision|1
1282265|NCT00379340|4186305|P2|Overall Study|Physician Decision|2
1282266|NCT00379340|4186306|P1|Overall Study|Physician Decision|6
1282267|NCT00379340|4186302|P5|Overall Study|Lack of Efficacy|3
1282268|NCT00379340|4186303|P4|Overall Study|Lack of Efficacy|4
1282269|NCT00379340|4186304|P3|Overall Study|Lack of Efficacy|0
1282270|NCT00379340|4186305|P2|Overall Study|Lack of Efficacy|1
1282271|NCT00379340|4186306|P1|Overall Study|Lack of Efficacy|6
1282272|NCT00379340|4186302|P5|Overall Study|Death|0
1282273|NCT00379340|4186303|P4|Overall Study|Death|2
1282274|NCT00379340|4186304|P3|Overall Study|Death|0
1282275|NCT00379340|4186305|P2|Overall Study|Death|0
1282276|NCT00379340|4186306|P1|Overall Study|Death|0
1282277|NCT00379288|4186323|P4|Overall Study|Administrative|1
1282278|NCT00379288|4186324|P3|Overall Study|Administrative|0
1282279|NCT00379288|4186325|P2|Overall Study|Administrative|2
1282280|NCT00379288|4186326|P1|Overall Study|Administrative|2
1282281|NCT00379288|4186323|P4|Overall Study|Did not meet protocol eligibility|2
1282282|NCT00379288|4186324|P3|Overall Study|Did not meet protocol eligibility|0
1282283|NCT00379288|4186325|P2|Overall Study|Did not meet protocol eligibility|1
1282284|NCT00379288|4186326|P1|Overall Study|Did not meet protocol eligibility|0
1282285|NCT00379288|4186323|P4|Overall Study|Noncompliance with protocol|1
1282286|NCT00379288|4186324|P3|Overall Study|Noncompliance with protocol|2
1282287|NCT00379288|4186325|P2|Overall Study|Noncompliance with protocol|6
1282288|NCT00379288|4186326|P1|Overall Study|Noncompliance with protocol|8
1282289|NCT00379288|4186323|P4|Overall Study|Subject withdrew-related to study drug|1
1282290|NCT00379288|4186324|P3|Overall Study|Subject withdrew-related to study drug|0
1282291|NCT00379288|4186325|P2|Overall Study|Subject withdrew-related to study drug|0
1282292|NCT00379288|4186326|P1|Overall Study|Subject withdrew-related to study drug|1
1282293|NCT00379288|4186323|P4|Overall Study|Subject withdrew-unrelated to study drug|2
1282294|NCT00379288|4186324|P3|Overall Study|Subject withdrew-unrelated to study drug|4
1282295|NCT00379288|4186325|P2|Overall Study|Subject withdrew-unrelated to study drug|3
1282296|NCT00379288|4186326|P1|Overall Study|Subject withdrew-unrelated to study drug|0
1282297|NCT00379288|4186323|P4|Overall Study|Lost to Follow-up|0
1282298|NCT00379288|4186324|P3|Overall Study|Lost to Follow-up|2
1282299|NCT00379288|4186325|P2|Overall Study|Lost to Follow-up|3
1282300|NCT00379288|4186326|P1|Overall Study|Lost to Follow-up|3
1282301|NCT00379288|4186323|P4|Overall Study|Treatment Failure|1
1282302|NCT00379288|4186324|P3|Overall Study|Treatment Failure|0
1282303|NCT00379288|4186325|P2|Overall Study|Treatment Failure|1
1282304|NCT00379288|4186326|P1|Overall Study|Treatment Failure|0
1282305|NCT00379288|4186323|P4|Overall Study|Adverse Event|0
1282306|NCT00379288|4186324|P3|Overall Study|Adverse Event|2
1282307|NCT00379288|4186325|P2|Overall Study|Adverse Event|6
1282308|NCT00379288|4186326|P1|Overall Study|Adverse Event|5
1282309|NCT00379236|4186338|P3|Open-label Extension|Not specified|7
1282310|NCT00379236|4186339|P2|Open-label Extension|Not specified|0
1282311|NCT00379236|4186340|P1|Open-label Extension|Not specified|0
1282312|NCT00379236|4186338|P3|Open-label Extension|Use of exclusionary medication|3
1282313|NCT00379236|4186339|P2|Open-label Extension|Use of exclusionary medication|0
1282314|NCT00379236|4186340|P1|Open-label Extension|Use of exclusionary medication|0
1282315|NCT00379236|4186338|P3|Open-label Extension|Lost to Follow-up|12
1282316|NCT00379236|4186339|P2|Open-label Extension|Lost to Follow-up|0
1282317|NCT00379236|4186340|P1|Open-label Extension|Lost to Follow-up|0
1282318|NCT00379236|4186338|P3|Open-label Extension|Withdrawal by Subject|13
1282319|NCT00379236|4186339|P2|Open-label Extension|Withdrawal by Subject|0
1282320|NCT00379236|4186340|P1|Open-label Extension|Withdrawal by Subject|0
1282321|NCT00379236|4186338|P3|Open-label Extension|Protocol Violation|7
1282322|NCT00379236|4186339|P2|Open-label Extension|Protocol Violation|0
1282323|NCT00379236|4186340|P1|Open-label Extension|Protocol Violation|0
1282324|NCT00379236|4186338|P3|Open-label Extension|Adverse Event|13
1282325|NCT00379236|4186339|P2|Open-label Extension|Adverse Event|0
1282326|NCT00379236|4186340|P1|Open-label Extension|Adverse Event|0
1282327|NCT00379236|4186338|P3|Double-blind|Data could not be retrieved|0
1282328|NCT00379236|4186339|P2|Double-blind|Data could not be retrieved|2
1282329|NCT00379236|4186340|P1|Double-blind|Data could not be retrieved|2
1282330|NCT00379236|4186338|P3|Double-blind|Not specified|0
1282331|NCT00379236|4186339|P2|Double-blind|Not specified|7
1282332|NCT00379236|4186340|P1|Double-blind|Not specified|3
1282333|NCT00379236|4186338|P3|Double-blind|Use of exclusionary medication|0
1282334|NCT00379236|4186339|P2|Double-blind|Use of exclusionary medication|2
1282335|NCT00379236|4186340|P1|Double-blind|Use of exclusionary medication|1
1282336|NCT00379236|4186338|P3|Double-blind|Lost to Follow-up|0
1282337|NCT00379236|4186339|P2|Double-blind|Lost to Follow-up|3
1282338|NCT00379236|4186340|P1|Double-blind|Lost to Follow-up|4
1282339|NCT00379236|4186338|P3|Double-blind|Withdrawal by Subject|0
1282340|NCT00379236|4186339|P2|Double-blind|Withdrawal by Subject|13
1282341|NCT00379236|4186340|P1|Double-blind|Withdrawal by Subject|12
1282342|NCT00379236|4186338|P3|Double-blind|Protocol Violation|0
1282343|NCT00379236|4186339|P2|Double-blind|Protocol Violation|3
1282344|NCT00379236|4186340|P1|Double-blind|Protocol Violation|3
1282345|NCT00379236|4186338|P3|Double-blind|Adverse Event|0
1282346|NCT00379236|4186339|P2|Double-blind|Adverse Event|6
1282347|NCT00379236|4186340|P1|Double-blind|Adverse Event|11
1282348|NCT00379210|4186385|P2|Overall Study|Withdrawal by Subject|7
1282349|NCT00379210|4186386|P1|Overall Study|Withdrawal by Subject|10
1282350|NCT00379080|4186409|P3|Overall Study|Withdrawal by Subject|0
1282351|NCT00379080|4186410|P2|Overall Study|Withdrawal by Subject|4
1282352|NCT00379080|4186411|P1|Overall Study|Withdrawal by Subject|0
1282353|NCT00378898|4186456|P2|Overall Study|Protocol Violation|1
1282354|NCT00378898|4186457|P1|Overall Study|Protocol Violation|1
1282355|NCT00378898|4186456|P2|Overall Study|Withdrawal by Subject|5
1282356|NCT00378898|4186457|P1|Overall Study|Withdrawal by Subject|10
1282357|NCT00378703|4186469|P4|Overall Study|Other|3
1282358|NCT00378703|4186470|P3|Overall Study|Other|2
1282359|NCT00378703|4186471|P2|Overall Study|Other|1
1282360|NCT00378703|4186472|P1|Overall Study|Other|1
1282361|NCT00378703|4186469|P4|Overall Study|Never started treatment|0
1282362|NCT00378703|4186470|P3|Overall Study|Never started treatment|0
1282363|NCT00378703|4186471|P2|Overall Study|Never started treatment|4
1282364|NCT00378703|4186472|P1|Overall Study|Never started treatment|1
1282365|NCT00378703|4186469|P4|Overall Study|Ineligible|7
1282366|NCT00378703|4186470|P3|Overall Study|Ineligible|7
1282367|NCT00378703|4186471|P2|Overall Study|Ineligible|7
1282368|NCT00378703|4186472|P1|Overall Study|Ineligible|4
1282369|NCT00378703|4186469|P4|Overall Study|Relocation|0
1282370|NCT00378703|4186470|P3|Overall Study|Relocation|1
1282371|NCT00378703|4186471|P2|Overall Study|Relocation|0
1282372|NCT00378703|4186472|P1|Overall Study|Relocation|0
1282373|NCT00378703|4186469|P4|Overall Study|Adverse events and progressive disease|1
1282374|NCT00378703|4186470|P3|Overall Study|Adverse events and progressive disease|0
1282375|NCT00378703|4186471|P2|Overall Study|Adverse events and progressive disease|0
1282376|NCT00378703|4186472|P1|Overall Study|Adverse events and progressive disease|0
1282377|NCT00378703|4186469|P4|Overall Study|Joint decision of physician and patient|0
1282378|NCT00378703|4186470|P3|Overall Study|Joint decision of physician and patient|0
1282379|NCT00378703|4186471|P2|Overall Study|Joint decision of physician and patient|0
1282380|NCT00378703|4186472|P1|Overall Study|Joint decision of physician and patient|1
1282381|NCT00378703|4186469|P4|Overall Study|Surgery|1
1282382|NCT00378703|4186470|P3|Overall Study|Surgery|0
1282383|NCT00378703|4186471|P2|Overall Study|Surgery|0
1282384|NCT00378703|4186472|P1|Overall Study|Surgery|1
1282385|NCT00378703|4186469|P4|Overall Study|Symptomatic deterioration|2
1282386|NCT00378703|4186470|P3|Overall Study|Symptomatic deterioration|0
1282387|NCT00378703|4186471|P2|Overall Study|Symptomatic deterioration|1
1282388|NCT00378703|4186472|P1|Overall Study|Symptomatic deterioration|0
1282389|NCT00378703|4186469|P4|Overall Study|Other complicated disease|0
1282390|NCT00378703|4186470|P3|Overall Study|Other complicated disease|2
1282391|NCT00378703|4186471|P2|Overall Study|Other complicated disease|2
1282392|NCT00378703|4186472|P1|Overall Study|Other complicated disease|0
1282393|NCT00378703|4186469|P4|Overall Study|Alternative therapy|0
1282394|NCT00378703|4186470|P3|Overall Study|Alternative therapy|0
1282395|NCT00378703|4186471|P2|Overall Study|Alternative therapy|2
1282396|NCT00378703|4186472|P1|Overall Study|Alternative therapy|4
1282397|NCT00378703|4186469|P4|Overall Study|Physician Decision|0
1282398|NCT00378703|4186470|P3|Overall Study|Physician Decision|1
1282399|NCT00378703|4186471|P2|Overall Study|Physician Decision|4
1282400|NCT00378703|4186472|P1|Overall Study|Physician Decision|1
1282401|NCT00378703|4186469|P4|Overall Study|Withdrawal by Subject|7
1282402|NCT00378703|4186470|P3|Overall Study|Withdrawal by Subject|5
1282403|NCT00378703|4186471|P2|Overall Study|Withdrawal by Subject|8
1282404|NCT00378703|4186472|P1|Overall Study|Withdrawal by Subject|4
1282405|NCT00378703|4186469|P4|Overall Study|Death|3
1282406|NCT00378703|4186470|P3|Overall Study|Death|4
1282407|NCT00378703|4186471|P2|Overall Study|Death|2
1282408|NCT00378703|4186472|P1|Overall Study|Death|2
1282409|NCT00378703|4186469|P4|Overall Study|Adverse Event|18
1282410|NCT00378703|4186470|P3|Overall Study|Adverse Event|20
1282411|NCT00378703|4186471|P2|Overall Study|Adverse Event|17
1282412|NCT00378703|4186472|P1|Overall Study|Adverse Event|11
1282413|NCT00378703|4186469|P4|Overall Study|Disease progression|49
1282414|NCT00378703|4186470|P3|Overall Study|Disease progression|48
1282415|NCT00378703|4186471|P2|Overall Study|Disease progression|43
1282416|NCT00378703|4186472|P1|Overall Study|Disease progression|59
1282417|NCT00378599|4186494|P1|Overall Study|Withdrawal by Subject|5
1282418|NCT00378599|4186494|P1|Overall Study|Treatment failure|7
1282419|NCT00378599|4186494|P1|Overall Study|Protocol Violation|2
1282420|NCT00378599|4186494|P1|Overall Study|Adverse Event|38
1282421|NCT00378573|4186498|P1|Follow-up|Withdrawal by Subject|1
1282422|NCT00378573|4186498|P1|Follow-up|Lost to Follow-up|1
1282423|NCT00378573|4186498|P1|Follow-up|Death|12
1282424|NCT00378573|4186498|P1|Treatment Period|Sponsor decision to close study|1
1282425|NCT00378573|4186498|P1|Treatment Period|Disease Progression|4
1282426|NCT00378573|4186498|P1|Treatment Period|Withdrawal by Subject|2
1282427|NCT00378573|4186498|P1|Treatment Period|Physician Decision|1
1282428|NCT00378573|4186498|P1|Treatment Period|Adverse Event|9
1282429|NCT00378560|4186506|P2|Overall Study|Laboratory test values abnormal|0
1282430|NCT00378560|4186507|P1|Overall Study|Laboratory test values abnormal|1
1282431|NCT00378560|4186506|P2|Overall Study|Pregnancy|5
1282432|NCT00378560|4186507|P1|Overall Study|Pregnancy|7
1282433|NCT00378560|4186506|P2|Overall Study|Moved|3
1282434|NCT00378560|4186507|P1|Overall Study|Moved|4
1282435|NCT00378560|4186506|P2|Overall Study|Withdrawal by Subject|21
1282436|NCT00378560|4186507|P1|Overall Study|Withdrawal by Subject|17
1282437|NCT00378560|4186506|P2|Overall Study|Protocol Violation|0
1282438|NCT00378560|4186507|P1|Overall Study|Protocol Violation|2
1282439|NCT00378560|4186506|P2|Overall Study|Lost to Follow-up|29
1282440|NCT00378560|4186507|P1|Overall Study|Lost to Follow-up|24
1282441|NCT00378560|4186506|P2|Overall Study|Adverse Event|0
1282442|NCT00378560|4186507|P1|Overall Study|Adverse Event|1
1282443|NCT00378534|4186521|P1|Overall Study|Subjects did not receive a transplant|3
1282444|NCT00378534|4186521|P1|Overall Study|Donors|57
1282445|NCT00378508|4186527|P2|Overall Study|Lost to Follow-up|0
1282446|NCT00378508|4186528|P1|Overall Study|Lost to Follow-up|1
1282447|NCT00378508|4186527|P2|Overall Study|Withdrawal by Subject|3
1282448|NCT00378508|4186528|P1|Overall Study|Withdrawal by Subject|1
1282449|NCT00378378|4186547|P3|Overall Study|Non-compliance with protocol|1
1282450|NCT00378378|4186548|P2|Overall Study|Non-compliance with protocol|0
1282451|NCT00378378|4186549|P1|Overall Study|Non-compliance with protocol|0
1282452|NCT00378378|4186547|P3|Overall Study|Treatment Failure|1
1282453|NCT00378378|4186548|P2|Overall Study|Treatment Failure|0
1282454|NCT00378378|4186549|P1|Overall Study|Treatment Failure|0
1282455|NCT00378378|4186547|P3|Overall Study|Withdrawal by Subject|0
1282456|NCT00378378|4186548|P2|Overall Study|Withdrawal by Subject|1
1282457|NCT00378378|4186549|P1|Overall Study|Withdrawal by Subject|0
1282458|NCT00378209|4186595|P1|Overall Study|Treatment delay|1
1282459|NCT00378209|4186595|P1|Overall Study|Death|1
1282460|NCT00378209|4186595|P1|Overall Study|Physician Decision|3
1282461|NCT00378209|4186595|P1|Overall Study|Initiation of non-protocol therapy|3
1282462|NCT00378209|4186595|P1|Overall Study|Adverse Event|3
1282463|NCT00378209|4186595|P1|Overall Study|Progressive disease|11
1282464|NCT00378105|4186605|P2|Overall Study|necessity to increase lenalidomide dose|1
1282465|NCT00378105|4186606|P1|Overall Study|necessity to increase lenalidomide dose|0
1282466|NCT00378105|4186605|P2|Overall Study|Going non-protocol therapy|1
1282467|NCT00378105|4186606|P1|Overall Study|Going non-protocol therapy|0
1282468|NCT00378105|4186605|P2|Overall Study|Physician Decision|2
1282469|NCT00378105|4186606|P1|Overall Study|Physician Decision|0
1282470|NCT00378105|4186605|P2|Overall Study|remain on study|11
1282471|NCT00378105|4186606|P1|Overall Study|remain on study|3
1282472|NCT00378105|4186605|P2|Overall Study|Progressive disease|3
1282473|NCT00378105|4186606|P1|Overall Study|Progressive disease|3
1282474|NCT00378105|4186605|P2|Overall Study|Going to transplant|8
1282475|NCT00378105|4186606|P1|Overall Study|Going to transplant|7
1282476|NCT00378105|4186605|P2|Overall Study|Death|0
1282477|NCT00378105|4186606|P1|Overall Study|Death|1
1282478|NCT00378105|4186605|P2|Overall Study|Withdrawal by Subject|3
1282479|NCT00378105|4186606|P1|Overall Study|Withdrawal by Subject|3
1282480|NCT00378105|4186605|P2|Overall Study|Adverse Event|1
1282481|NCT00378105|4186606|P1|Overall Study|Adverse Event|3
1282482|NCT00378079|4186618|P3|Overall Study|Lost to Follow-up|0
1282483|NCT00378079|4186619|P2|Overall Study|Lost to Follow-up|1
1282484|NCT00378079|4186620|P1|Overall Study|Lost to Follow-up|6
1282485|NCT00378014|4186642|P2|Extension (Month 12 to Month 59)|Lack of Efficacy|1
1282486|NCT00378014|4186643|P1|Extension (Month 12 to Month 59)|Lack of Efficacy|3
1282487|NCT00378014|4186642|P2|Extension (Month 12 to Month 59)|Withdrawal by Subject|3
1282488|NCT00378014|4186643|P1|Extension (Month 12 to Month 59)|Withdrawal by Subject|0
1282489|NCT00378014|4186642|P2|Extension (Month 12 to Month 59)|Lost to Follow-up|1
1282490|NCT00378014|4186643|P1|Extension (Month 12 to Month 59)|Lost to Follow-up|1
1282491|NCT00378014|4186642|P2|Extension (Month 12 to Month 59)|Administrative problems|0
1282492|NCT00378014|4186643|P1|Extension (Month 12 to Month 59)|Administrative problems|1
1282493|NCT00378014|4186642|P2|Extension (Month 12 to Month 59)|Death|2
1282494|NCT00378014|4186643|P1|Extension (Month 12 to Month 59)|Death|1
1282495|NCT00378014|4186642|P2|Extension (Month 12 to Month 59)|Adverse Event|7
1282496|NCT00378014|4186643|P1|Extension (Month 12 to Month 59)|Adverse Event|8
1282497|NCT00378014|4186642|P2|Core (Randomization to Month 11)|Lack of Efficacy|1
1282498|NCT00378014|4186643|P1|Core (Randomization to Month 11)|Lack of Efficacy|0
1282499|NCT00378014|4186642|P2|Core (Randomization to Month 11)|Protocol deviation|1
1282500|NCT00378014|4186643|P1|Core (Randomization to Month 11)|Protocol deviation|0
1282501|NCT00378014|4186642|P2|Core (Randomization to Month 11)|Withdrawal by Subject|2
1282502|NCT00378014|4186643|P1|Core (Randomization to Month 11)|Withdrawal by Subject|5
1282503|NCT00378014|4186642|P2|Core (Randomization to Month 11)|Lost to Follow-up|1
1282504|NCT00378014|4186643|P1|Core (Randomization to Month 11)|Lost to Follow-up|0
1282505|NCT00378014|4186642|P2|Core (Randomization to Month 11)|Administrative Problems|2
1282506|NCT00378014|4186643|P1|Core (Randomization to Month 11)|Administrative Problems|2
1282507|NCT00378014|4186642|P2|Core (Randomization to Month 11)|Death|3
1282508|NCT00378014|4186643|P1|Core (Randomization to Month 11)|Death|5
1282509|NCT00378014|4186642|P2|Core (Randomization to Month 11)|Graft loss|2
1282510|NCT00378014|4186643|P1|Core (Randomization to Month 11)|Graft loss|1
1282511|NCT00378014|4186642|P2|Core (Randomization to Month 11)|Adverse Event|0
1282512|NCT00378014|4186643|P1|Core (Randomization to Month 11)|Adverse Event|1
1282513|NCT00377962|4186669|P2|Extension Study: 12-24 Months|Unspecified reason|3
1282514|NCT00377962|4186670|P1|Extension Study: 12-24 Months|Unspecified reason|0
1282515|NCT00377962|4186669|P2|Extension Study: 12-24 Months|Abnormal laboratory value|0
1282516|NCT00377962|4186670|P1|Extension Study: 12-24 Months|Abnormal laboratory value|1
1282517|NCT00377962|4186669|P2|Extension Study: 12-24 Months|Adverse Event|0
1282518|NCT00377962|4186670|P1|Extension Study: 12-24 Months|Adverse Event|8
1282519|NCT00377962|4186669|P2|Extension Study: 12-24 Months|Death|1
1282520|NCT00377962|4186670|P1|Extension Study: 12-24 Months|Death|1
1282521|NCT00377962|4186669|P2|Core Study: 0-12 Months|Unspecified reasons|4
1282522|NCT00377962|4186670|P1|Core Study: 0-12 Months|Unspecified reasons|1
1282523|NCT00377962|4186669|P2|Core Study: 0-12 Months|Administrative Reason|1
1282524|NCT00377962|4186670|P1|Core Study: 0-12 Months|Administrative Reason|1
1282525|NCT00377962|4186669|P2|Core Study: 0-12 Months|Withdrew Consent|2
1282526|NCT00377962|4186670|P1|Core Study: 0-12 Months|Withdrew Consent|5
1282527|NCT00377962|4186669|P2|Core Study: 0-12 Months|Death|0
1282528|NCT00377962|4186670|P1|Core Study: 0-12 Months|Death|3
1282529|NCT00377962|4186669|P2|Core Study: 0-12 Months|Adverse Event|2
1282530|NCT00377962|4186670|P1|Core Study: 0-12 Months|Adverse Event|18
1282531|NCT00377858|4186706|P2|Overall Study|Death|3
1282532|NCT00377858|4186707|P1|Overall Study|Death|0
1282533|NCT00377858|4186706|P2|Overall Study|Sponsor Decision|2
1282534|NCT00377858|4186707|P1|Overall Study|Sponsor Decision|1
1282535|NCT00377858|4186706|P2|Overall Study|Entry Criteria Not Met|0
1282536|NCT00377858|4186707|P1|Overall Study|Entry Criteria Not Met|2
1282537|NCT00377858|4186706|P2|Overall Study|Adverse Event|1
1282538|NCT00377858|4186707|P1|Overall Study|Adverse Event|2
1282539|NCT00377858|4186706|P2|Overall Study|Protocol Violation|4
1282540|NCT00377858|4186707|P1|Overall Study|Protocol Violation|3
1282541|NCT00377858|4186706|P2|Overall Study|Physician Decision|5
1282542|NCT00377858|4186707|P1|Overall Study|Physician Decision|5
1282543|NCT00377858|4186706|P2|Overall Study|Lost to Follow-up|1
1282544|NCT00377858|4186707|P1|Overall Study|Lost to Follow-up|6
1282545|NCT00377858|4186706|P2|Overall Study|Withdrawal by Subject|11
1282546|NCT00377858|4186707|P1|Overall Study|Withdrawal by Subject|12
1282547|NCT00377819|4186760|P2|Overall Study|Protocol Violation|1
1282548|NCT00377819|4186761|P1|Overall Study|Protocol Violation|1
1282549|NCT00377819|4186760|P2|Overall Study|Lost to Follow-up|1
1282550|NCT00377819|4186761|P1|Overall Study|Lost to Follow-up|0
1282551|NCT00377819|4186760|P2|Overall Study|Death|1
1282552|NCT00377819|4186761|P1|Overall Study|Death|0
1282553|NCT00377819|4186760|P2|Overall Study|Withdrawal by Subject|4
1282554|NCT00377819|4186761|P1|Overall Study|Withdrawal by Subject|10
1282555|NCT00377819|4186760|P2|Overall Study|Adverse Event|3
1282556|NCT00377819|4186761|P1|Overall Study|Adverse Event|2
1282557|NCT00377676|4186790|P2|Overall Study|not specified|58
1282558|NCT00377676|4186791|P1|Overall Study|not specified|118
1282559|NCT00377676|4186790|P2|Overall Study|Lost to Follow-up|56
1282560|NCT00377676|4186791|P1|Overall Study|Lost to Follow-up|120
1282561|NCT00377676|4186790|P2|Overall Study|Withdrawal by Subject|72
1282562|NCT00377676|4186791|P1|Overall Study|Withdrawal by Subject|187
1282563|NCT00377676|4186790|P2|Overall Study|Death|2
1282564|NCT00377676|4186791|P1|Overall Study|Death|5
1282565|NCT00377676|4186790|P2|Overall Study|Protocol Violation|27
1282566|NCT00377676|4186791|P1|Overall Study|Protocol Violation|33
1282567|NCT00377676|4186790|P2|Overall Study|Adverse Event|107
1282568|NCT00377676|4186791|P1|Overall Study|Adverse Event|498
1282569|NCT00377637|4186807|P4|Maintenance Phase|Death|1
1282570|NCT00377637|4186808|P3|Maintenance Phase|Death|0
1282571|NCT00377637|4186809|P2|Maintenance Phase|Death|0
1282572|NCT00377637|4186810|P1|Maintenance Phase|Death|0
1282573|NCT00377637|4186807|P4|Maintenance Phase|Study medication stopped > 14 days|1
1282574|NCT00377637|4186808|P3|Maintenance Phase|Study medication stopped > 14 days|0
1282575|NCT00377637|4186809|P2|Maintenance Phase|Study medication stopped > 14 days|0
1282576|NCT00377637|4186810|P1|Maintenance Phase|Study medication stopped > 14 days|0
1282577|NCT00377637|4186807|P4|Maintenance Phase|Non-compliance|1
1282578|NCT00377637|4186808|P3|Maintenance Phase|Non-compliance|1
1282579|NCT00377637|4186809|P2|Maintenance Phase|Non-compliance|0
1282580|NCT00377637|4186810|P1|Maintenance Phase|Non-compliance|0
1282581|NCT00377637|4186807|P4|Maintenance Phase|Sponsor decision|3
1282582|NCT00377637|4186808|P3|Maintenance Phase|Sponsor decision|2
1282583|NCT00377637|4186809|P2|Maintenance Phase|Sponsor decision|0
1282584|NCT00377637|4186810|P1|Maintenance Phase|Sponsor decision|0
1282585|NCT00377637|4186807|P4|Maintenance Phase|Withdrawal by Subject|3
1282586|NCT00377637|4186808|P3|Maintenance Phase|Withdrawal by Subject|3
1282587|NCT00377637|4186809|P2|Maintenance Phase|Withdrawal by Subject|0
1282588|NCT00377637|4186810|P1|Maintenance Phase|Withdrawal by Subject|0
1282589|NCT00377637|4186807|P4|Maintenance Phase|Lost to Follow-up|1
1282590|NCT00377637|4186808|P3|Maintenance Phase|Lost to Follow-up|3
1282591|NCT00377637|4186809|P2|Maintenance Phase|Lost to Follow-up|0
1282592|NCT00377637|4186810|P1|Maintenance Phase|Lost to Follow-up|0
1282593|NCT00377637|4186807|P4|Maintenance Phase|Physician Decision|4
1282594|NCT00377637|4186808|P3|Maintenance Phase|Physician Decision|5
1282595|NCT00377637|4186809|P2|Maintenance Phase|Physician Decision|0
1282596|NCT00377637|4186810|P1|Maintenance Phase|Physician Decision|0
1282597|NCT00377637|4186807|P4|Maintenance Phase|Adverse Event|43
1282598|NCT00377637|4186808|P3|Maintenance Phase|Adverse Event|29
1282599|NCT00377637|4186809|P2|Maintenance Phase|Adverse Event|0
1282600|NCT00377637|4186810|P1|Maintenance Phase|Adverse Event|0
1282601|NCT00377637|4186807|P4|Induction Phase|Reason for withdrawal is not noted|0
1282602|NCT00377637|4186808|P3|Induction Phase|Reason for withdrawal is not noted|0
1282603|NCT00377637|4186809|P2|Induction Phase|Reason for withdrawal is not noted|0
1282604|NCT00377637|4186810|P1|Induction Phase|Reason for withdrawal is not noted|2
1282605|NCT00377637|4186807|P4|Induction Phase|Non-Compliance|0
1282606|NCT00377637|4186808|P3|Induction Phase|Non-Compliance|0
1282607|NCT00377637|4186809|P2|Induction Phase|Non-Compliance|0
1282608|NCT00377637|4186810|P1|Induction Phase|Non-Compliance|1
1282609|NCT00377637|4186807|P4|Induction Phase|Sponsor decision|0
1282610|NCT00377637|4186808|P3|Induction Phase|Sponsor decision|0
1282611|NCT00377637|4186809|P2|Induction Phase|Sponsor decision|2
1282612|NCT00377637|4186810|P1|Induction Phase|Sponsor decision|1
1282613|NCT00377637|4186807|P4|Induction Phase|Physician Decision|0
1282614|NCT00377637|4186808|P3|Induction Phase|Physician Decision|0
1282615|NCT00377637|4186809|P2|Induction Phase|Physician Decision|1
1282616|NCT00377637|4186810|P1|Induction Phase|Physician Decision|3
1282617|NCT00377637|4186807|P4|Induction Phase|Withdrawal by Subject|0
1282618|NCT00377637|4186808|P3|Induction Phase|Withdrawal by Subject|0
1282619|NCT00377637|4186809|P2|Induction Phase|Withdrawal by Subject|6
1282620|NCT00377637|4186810|P1|Induction Phase|Withdrawal by Subject|5
1282621|NCT00377637|4186807|P4|Induction Phase|Death|0
1282622|NCT00377637|4186808|P3|Induction Phase|Death|0
1282623|NCT00377637|4186809|P2|Induction Phase|Death|3
1282624|NCT00377637|4186810|P1|Induction Phase|Death|1
1282625|NCT00377637|4186807|P4|Induction Phase|Lost to Follow-up|0
1282626|NCT00377637|4186808|P3|Induction Phase|Lost to Follow-up|0
1282627|NCT00377637|4186809|P2|Induction Phase|Lost to Follow-up|1
1282628|NCT00377637|4186810|P1|Induction Phase|Lost to Follow-up|2
1282629|NCT00377637|4186807|P4|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
1282630|NCT00377637|4186808|P3|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
1282631|NCT00377637|4186809|P2|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1
1282632|NCT00377637|4186810|P1|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
1282633|NCT00377637|4186807|P4|Induction Phase|Deterioration/serum creatinine|0
1282634|NCT00377637|4186808|P3|Induction Phase|Deterioration/serum creatinine|0
1282635|NCT00377637|4186809|P2|Induction Phase|Deterioration/serum creatinine|0
1282636|NCT00377637|4186810|P1|Induction Phase|Deterioration/serum creatinine|2
1282637|NCT00377637|4186807|P4|Induction Phase|Adverse Event|0
1282638|NCT00377637|4186808|P3|Induction Phase|Adverse Event|0
1282639|NCT00377637|4186809|P2|Induction Phase|Adverse Event|21
1282640|NCT00377637|4186810|P1|Induction Phase|Adverse Event|12
1282641|NCT00377611|4186846|P2|Overall Study|Other|3
1282642|NCT00377611|4186847|P1|Overall Study|Other|0
1282643|NCT00377611|4186846|P2|Overall Study|Lost to Follow-up|16
1282644|NCT00377611|4186847|P1|Overall Study|Lost to Follow-up|18
1282645|NCT00377611|4186846|P2|Overall Study|Withdrawal by Subject|5
1282646|NCT00377611|4186847|P1|Overall Study|Withdrawal by Subject|0
1282647|NCT00377611|4186846|P2|Overall Study|Protocol Violation|0
1282648|NCT00377611|4186847|P1|Overall Study|Protocol Violation|2
1282649|NCT00377611|4186846|P2|Overall Study|Adverse Event|9
1282650|NCT00377611|4186847|P1|Overall Study|Adverse Event|2
1282651|NCT00377520|4186949|P1|Overall Study|Ineligible (Prior radiation)|1
1282652|NCT00377455|4186954|P1|Overall Study|Withdrawal by Subject|1
1282653|NCT00377429|4186962|P1|Overall Study|Patient non-compliance|1
1282654|NCT00377429|4186962|P1|Overall Study|Physician Decision|1
1282655|NCT00377429|4186962|P1|Overall Study|Adverse Event|8
1282656|NCT00377429|4186962|P1|Overall Study|Withdrawal by Subject|5
1282657|NCT00377403|4186973|P2|Overall Study|Unable to contact for telephone intervie|7
1282658|NCT00377403|4186974|P1|Overall Study|Unable to contact for telephone intervie|4
1282659|NCT00377364|4186982|P2|Overall Study|Withdrawal by Subject|0
1282660|NCT00377364|4186983|P1|Overall Study|Withdrawal by Subject|1
1282661|NCT00377364|4186982|P2|Overall Study|Lost to Follow-up|0
1282662|NCT00377364|4186983|P1|Overall Study|Lost to Follow-up|1
1282663|NCT00377312|4187009|P2|Overall Study|Adverse Event|1
1282664|NCT00377312|4187010|P1|Overall Study|Adverse Event|1
1282665|NCT00377299|4187042|P2|Overall Study|Withdrawal by Subject|4
1282666|NCT00377299|4187043|P1|Overall Study|Withdrawal by Subject|5
1282667|NCT00377299|4187042|P2|Overall Study|Adverse Event|1
1282668|NCT00377299|4187043|P1|Overall Study|Adverse Event|0
1282669|NCT00377299|4187042|P2|Overall Study|Lost to Follow-up|19
1282670|NCT00377299|4187043|P1|Overall Study|Lost to Follow-up|14
1282671|NCT00377260|4187059|P2|Overall Study|Withdrawal by Subject|4
1282672|NCT00377260|4187060|P1|Overall Study|Withdrawal by Subject|2
1282673|NCT00377260|4187059|P2|Overall Study|Lost to Follow-up|1
1282674|NCT00377260|4187060|P1|Overall Study|Lost to Follow-up|0
1282675|NCT00377234|4187114|P2|Overall Study|Not assigned|2
1282676|NCT00377234|4187115|P1|Overall Study|Not assigned|3
1282677|NCT00377234|4187114|P2|Overall Study|Administrative|1
1282678|NCT00377234|4187115|P1|Overall Study|Administrative|2
1282679|NCT00377234|4187114|P2|Overall Study|Lost to Follow-up|2
1282680|NCT00377234|4187115|P1|Overall Study|Lost to Follow-up|4
1282681|NCT00377234|4187114|P2|Overall Study|Withdrawal by Subject|9
1282682|NCT00377234|4187115|P1|Overall Study|Withdrawal by Subject|11
1282683|NCT00377234|4187114|P2|Overall Study|Adverse Event|17
1282684|NCT00377234|4187115|P1|Overall Study|Adverse Event|14
1282685|NCT00377156|4187133|P2|Overall Study|Other|2
1282686|NCT00377156|4187134|P1|Overall Study|Other|5
1282687|NCT00377156|4187133|P2|Overall Study|Disability or language problem|1
1282688|NCT00377156|4187134|P1|Overall Study|Disability or language problem|0
1282689|NCT00377156|4187133|P2|Overall Study|Ineligible|1
1282690|NCT00377156|4187134|P1|Overall Study|Ineligible|0
1282691|NCT00377156|4187133|P2|Overall Study|Refused testing|1
1282692|NCT00377156|4187134|P1|Overall Study|Refused testing|0
1282693|NCT00377156|4187133|P2|Overall Study|Cancellation|0
1282694|NCT00377156|4187134|P1|Overall Study|Cancellation|1
1282695|NCT00377156|4187133|P2|Overall Study|Had follow-up <90 d|6
1282696|NCT00377156|4187134|P1|Overall Study|Had follow-up <90 d|3
1282697|NCT00377156|4187133|P2|Overall Study|Withdrawal by Subject|24
1282698|NCT00377156|4187134|P1|Overall Study|Withdrawal by Subject|16
1282699|NCT00377156|4187133|P2|Overall Study|Death|19
1282700|NCT00377156|4187134|P1|Overall Study|Death|23
1282701|NCT00376961|4187148|P2|Maintenance|Ineligible|3
1282702|NCT00376961|4187149|P1|Maintenance|Ineligible|0
1282703|NCT00376961|4187148|P2|Maintenance|Progression/relapse|18
1282704|NCT00376961|4187149|P1|Maintenance|Progression/relapse|0
1282705|NCT00376961|4187148|P2|Maintenance|Refusal Unrelated to Adverse Event|1
1282706|NCT00376961|4187149|P1|Maintenance|Refusal Unrelated to Adverse Event|0
1282707|NCT00376961|4187148|P2|Maintenance|Adverse Event|1
1282708|NCT00376961|4187149|P1|Maintenance|Adverse Event|0
1282709|NCT00376961|4187148|P2|Initial Registration|Ineligible|0
1282710|NCT00376961|4187149|P1|Initial Registration|Ineligible|3
1282711|NCT00376961|4187148|P2|Initial Registration|Progression/relapse|0
1282712|NCT00376961|4187149|P1|Initial Registration|Progression/relapse|1
1282713|NCT00376961|4187148|P2|Initial Registration|Refusal Unrelated to Adverse Event|0
1282714|NCT00376961|4187149|P1|Initial Registration|Refusal Unrelated to Adverse Event|2
1282715|NCT00376961|4187148|P2|Initial Registration|Adverse Event|0
1282716|NCT00376961|4187149|P1|Initial Registration|Adverse Event|1
1282717|NCT00376688|4187215|P1|Overall Study|Death|1
1282718|NCT00376688|4187215|P1|Overall Study|Adverse Event|3
1282719|NCT00376675|4187221|P2|Overall Study|Other Reason|7
1282720|NCT00376675|4187222|P1|Overall Study|Other Reason|1
1282721|NCT00376675|4187221|P2|Overall Study|Adverse Event|5
1282722|NCT00376675|4187222|P1|Overall Study|Adverse Event|10
1282723|NCT00376675|4187221|P2|Overall Study|Withdrawal by Subject|2
1282724|NCT00376675|4187222|P1|Overall Study|Withdrawal by Subject|9
1282725|NCT00376532|4187271|P2|Overall Study|Lack sufficient blood sample|6
1282726|NCT00376532|4187272|P1|Overall Study|Lack sufficient blood sample|6
1282727|NCT00376506|4187282|P2|Overall Study|Death|2
1282728|NCT00376506|4187283|P1|Overall Study|Death|0
1282729|NCT00376259|4187314|P2|Overall Study|Patient request|0
1282730|NCT00376259|4187315|P1|Overall Study|Patient request|1
1282731|NCT00376259|4187314|P2|Overall Study|Sponsor request - study termination|21
1282732|NCT00376259|4187315|P1|Overall Study|Sponsor request - study termination|21
1282733|NCT00376220|4187329|P2|Overall Study|Withdrawal by Subject|2
1282734|NCT00376220|4187330|P1|Overall Study|Withdrawal by Subject|3
1282735|NCT00376220|4187329|P2|Overall Study|Lost to Follow-up|10
1282736|NCT00376220|4187330|P1|Overall Study|Lost to Follow-up|7
1282737|NCT00376168|4187338|P2|Overall Study|Pregnancy|0
1282738|NCT00376168|4187339|P1|Overall Study|Pregnancy|1
1282739|NCT00376168|4187338|P2|Overall Study|Adverse Event|1
1282740|NCT00376168|4187339|P1|Overall Study|Adverse Event|1
1282741|NCT00375934|4187380|P2|Overall Study|Physician Decision|1
1282742|NCT00375934|4187381|P1|Overall Study|Physician Decision|0
1282743|NCT00375934|4187380|P2|Overall Study|Lack of Efficacy|2
1282744|NCT00375934|4187381|P1|Overall Study|Lack of Efficacy|0
1282745|NCT00375934|4187380|P2|Overall Study|Withdrawal by Subject|2
1282746|NCT00375934|4187381|P1|Overall Study|Withdrawal by Subject|2
1282747|NCT00375934|4187380|P2|Overall Study|Adverse Event|1
1282748|NCT00375934|4187381|P1|Overall Study|Adverse Event|1
1282749|NCT00375752|4187409|P2|Overall Study|Administrative Problems|1
1282750|NCT00375752|4187410|P1|Overall Study|Administrative Problems|0
1282751|NCT00375752|4187409|P2|Overall Study|Protocol Violation|2
1282752|NCT00375752|4187410|P1|Overall Study|Protocol Violation|0
1282753|NCT00375752|4187409|P2|Overall Study|Abnormal Laboratory Value(s)|1
1282754|NCT00375752|4187410|P1|Overall Study|Abnormal Laboratory Value(s)|1
1282755|NCT00375752|4187409|P2|Overall Study|Withdrawal by Subject|1
1282756|NCT00375752|4187410|P1|Overall Study|Withdrawal by Subject|6
1282757|NCT00375752|4187409|P2|Overall Study|Adverse Event|6
1282758|NCT00375752|4187410|P1|Overall Study|Adverse Event|1
1282759|NCT00375752|4187409|P2|Overall Study|Lack of Efficacy|4
1282760|NCT00375752|4187410|P1|Overall Study|Lack of Efficacy|4
1282761|NCT00375674|4187441|P2|Overall Study|Enrolled but not treated|2
1282762|NCT00375674|4187442|P1|Overall Study|Enrolled but not treated|3
1282763|NCT00375674|4187441|P2|Overall Study|Lost to Follow-up|15
1282764|NCT00375674|4187442|P1|Overall Study|Lost to Follow-up|17
1282765|NCT00375674|4187441|P2|Overall Study|Participants refused further follow-up|30
1282766|NCT00375674|4187442|P1|Overall Study|Participants refused further follow-up|31
1282767|NCT00375674|4187441|P2|Overall Study|Death|76
1282768|NCT00375674|4187442|P1|Overall Study|Death|67
1282769|NCT00375674|4187441|P2|Overall Study|Not specified|18
1282770|NCT00375674|4187442|P1|Overall Study|Not specified|26
1282771|NCT00375609|4187471|P3|Overall Study|Neurologist Wanted Pt to start Plavix|0
1282772|NCT00375609|4187472|P2|Overall Study|Neurologist Wanted Pt to start Plavix|0
1282773|NCT00375609|4187473|P1|Overall Study|Neurologist Wanted Pt to start Plavix|1
1282774|NCT00375609|4187471|P3|Overall Study|Withdrawal by Subject|0
1282775|NCT00375609|4187472|P2|Overall Study|Withdrawal by Subject|4
1282776|NCT00375609|4187473|P1|Overall Study|Withdrawal by Subject|1
1282777|NCT00375609|4187471|P3|Overall Study|Physician Decision|1
1282778|NCT00375609|4187472|P2|Overall Study|Physician Decision|0
1282779|NCT00375609|4187473|P1|Overall Study|Physician Decision|0
1282780|NCT00375609|4187471|P3|Overall Study|Lost to Follow-up|0
1282781|NCT00375609|4187472|P2|Overall Study|Lost to Follow-up|0
1282782|NCT00375609|4187473|P1|Overall Study|Lost to Follow-up|1
1282783|NCT00375609|4187471|P3|Overall Study|Adverse Event|0
1282784|NCT00375609|4187472|P2|Overall Study|Adverse Event|3
1282785|NCT00375609|4187473|P1|Overall Study|Adverse Event|0
1282786|NCT00375609|4187471|P3|Overall Study|Did not receive treatment|0
1282787|NCT00375609|4187472|P2|Overall Study|Did not receive treatment|0
1282788|NCT00375609|4187473|P1|Overall Study|Did not receive treatment|1
1282789|NCT00375518|4187489|P2|Overall Study|Death|1
1282790|NCT00375518|4187490|P1|Overall Study|Death|0
1282791|NCT00375518|4187489|P2|Overall Study|Patient Not Treated|6
1282792|NCT00375518|4187490|P1|Overall Study|Patient Not Treated|6
1282793|NCT00375518|4187489|P2|Overall Study|Withdrawal by Subject|10
1282794|NCT00375518|4187490|P1|Overall Study|Withdrawal by Subject|2
1282795|NCT00375505|4187498|P2|Overall Study|Adverse Event|2
1282796|NCT00375505|4187499|P1|Overall Study|Adverse Event|1
1282797|NCT00375492|4187543|P2|Overall Study|Withdrawal by Subject|6
1282798|NCT00375492|4187544|P1|Overall Study|Withdrawal by Subject|6
1282799|NCT00375492|4187543|P2|Overall Study|Sponsor Decision|1
1282800|NCT00375492|4187544|P1|Overall Study|Sponsor Decision|0
1282801|NCT00375492|4187543|P2|Overall Study|Protocol Violation|3
1282802|NCT00375492|4187544|P1|Overall Study|Protocol Violation|6
1282803|NCT00375492|4187543|P2|Overall Study|Physician Decision|4
1282804|NCT00375492|4187544|P1|Overall Study|Physician Decision|0
1282805|NCT00375492|4187543|P2|Overall Study|Lost to Follow-up|5
1282806|NCT00375492|4187544|P1|Overall Study|Lost to Follow-up|10
1282807|NCT00375492|4187543|P2|Overall Study|Loss of Glucose Control|1
1282808|NCT00375492|4187544|P1|Overall Study|Loss of Glucose Control|0
1282809|NCT00375492|4187543|P2|Overall Study|Entry Criteria Not Met|1
1282810|NCT00375492|4187544|P1|Overall Study|Entry Criteria Not Met|0
1282811|NCT00375492|4187543|P2|Overall Study|Adverse Event|5
1282812|NCT00375492|4187544|P1|Overall Study|Adverse Event|4
1282813|NCT00375427|4187574|P2|Overall Study|Death|10
1282814|NCT00375427|4187575|P1|Overall Study|Death|11
1282815|NCT00375427|4187574|P2|Overall Study|Administrative reasons|1
1282816|NCT00375427|4187575|P1|Overall Study|Administrative reasons|0
1282817|NCT00375427|4187574|P2|Overall Study|Lost to Follow-up|1
1282818|NCT00375427|4187575|P1|Overall Study|Lost to Follow-up|1
1282819|NCT00375427|4187574|P2|Overall Study|Withdrawal by Subject|13
1282820|NCT00375427|4187575|P1|Overall Study|Withdrawal by Subject|9
1282821|NCT00375427|4187574|P2|Overall Study|Protocol Violation|8
1282822|NCT00375427|4187575|P1|Overall Study|Protocol Violation|10
1282823|NCT00375427|4187574|P2|Overall Study|Patient no longer requires study drug|7
1282824|NCT00375427|4187575|P1|Overall Study|Patient no longer requires study drug|3
1282825|NCT00375427|4187574|P2|Overall Study|Unsatisfactory therapeutic effect|4
1282826|NCT00375427|4187575|P1|Overall Study|Unsatisfactory therapeutic effect|4
1282827|NCT00375427|4187574|P2|Overall Study|Abnormal laboratory value(s)|2
1282828|NCT00375427|4187575|P1|Overall Study|Abnormal laboratory value(s)|1
1282829|NCT00375427|4187574|P2|Overall Study|Abnormal test procedure result(s)|1
1282830|NCT00375427|4187575|P1|Overall Study|Abnormal test procedure result(s)|0
1282831|NCT00375427|4187574|P2|Overall Study|Adverse Event|27
1282832|NCT00375427|4187575|P1|Overall Study|Adverse Event|21
1282833|NCT00375219|4187600|P3|Overall Study|Withdrawal by Subject|0
1282834|NCT00375219|4187601|P2|Overall Study|Withdrawal by Subject|0
1282835|NCT00375219|4187602|P1|Overall Study|Withdrawal by Subject|1
1282836|NCT00375219|4187600|P3|Overall Study|Cord blood transplantation|0
1282837|NCT00375219|4187601|P2|Overall Study|Cord blood transplantation|0
1282838|NCT00375219|4187602|P1|Overall Study|Cord blood transplantation|1
1282839|NCT00375219|4187600|P3|Overall Study|Allograft|0
1282840|NCT00375219|4187601|P2|Overall Study|Allograft|0
1282841|NCT00375219|4187602|P1|Overall Study|Allograft|2
1282842|NCT00375219|4187600|P3|Overall Study|Specific tyrosine kinase inhibitor avail|0
1282843|NCT00375219|4187601|P2|Overall Study|Specific tyrosine kinase inhibitor avail|0
1282844|NCT00375219|4187602|P1|Overall Study|Specific tyrosine kinase inhibitor avail|1
1282845|NCT00375219|4187600|P3|Overall Study|Hematologic resistance|0
1282846|NCT00375219|4187601|P2|Overall Study|Hematologic resistance|0
1282847|NCT00375219|4187602|P1|Overall Study|Hematologic resistance|1
1282848|NCT00375219|4187600|P3|Overall Study|Death|7
1282849|NCT00375219|4187601|P2|Overall Study|Death|3
1282850|NCT00375219|4187602|P1|Overall Study|Death|4
1282851|NCT00375219|4187600|P3|Overall Study|Disease progression|12
1282852|NCT00375219|4187601|P2|Overall Study|Disease progression|9
1282853|NCT00375219|4187602|P1|Overall Study|Disease progression|18
1282854|NCT00375219|4187600|P3|Overall Study|Lost to Follow-up|0
1282855|NCT00375219|4187601|P2|Overall Study|Lost to Follow-up|1
1282856|NCT00375219|4187602|P1|Overall Study|Lost to Follow-up|1
1282857|NCT00375219|4187600|P3|Overall Study|Request of Patient, PI, Sponsor or RA|0
1282858|NCT00375219|4187601|P2|Overall Study|Request of Patient, PI, Sponsor or RA|3
1282859|NCT00375219|4187602|P1|Overall Study|Request of Patient, PI, Sponsor or RA|5
1282860|NCT00375219|4187600|P3|Overall Study|Protocol Violation|1
1282861|NCT00375219|4187601|P2|Overall Study|Protocol Violation|0
1282862|NCT00375219|4187602|P1|Overall Study|Protocol Violation|1
1282863|NCT00375219|4187600|P3|Overall Study|Adverse Event|1
1282864|NCT00375219|4187601|P2|Overall Study|Adverse Event|2
1282865|NCT00375219|4187602|P1|Overall Study|Adverse Event|8
1282866|NCT00375219|4187600|P3|Overall Study|Failure to achieve a response|0
1282867|NCT00375219|4187601|P2|Overall Study|Failure to achieve a response|2
1282868|NCT00375219|4187602|P1|Overall Study|Failure to achieve a response|16
1282869|NCT00374907|4187670|P2|116-Week Short-term + Long-term Period|Lost to Follow-up|1
1282870|NCT00374907|4187671|P1|116-Week Short-term + Long-term Period|Lost to Follow-up|1
1282871|NCT00374907|4187670|P2|116-Week Short-term + Long-term Period|Adverse Event|2
1282872|NCT00374907|4187671|P1|116-Week Short-term + Long-term Period|Adverse Event|0
1282873|NCT00374907|4187670|P2|116-Week Short-term + Long-term Period|Lack of Efficacy|2
1282874|NCT00374907|4187671|P1|116-Week Short-term + Long-term Period|Lack of Efficacy|4
1282875|NCT00374907|4187670|P2|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9
1282876|NCT00374907|4187671|P1|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8
1282877|NCT00374907|4187670|P2|12-Week Short-term Period|Subject Withdrew Consent|1
1282878|NCT00374907|4187671|P1|12-Week Short-term Period|Subject Withdrew Consent|3
1282879|NCT00374868|4187683|P1|Overall Study|Other - Not Specified|1
1282880|NCT00374868|4187683|P1|Overall Study|Death|2
1282881|NCT00374868|4187683|P1|Overall Study|Lost to Follow-up|1
1282882|NCT00374868|4187683|P1|Overall Study|Physician Decision|13
1282883|NCT00374868|4187683|P1|Overall Study|Progressive Disease|7
1282884|NCT00374868|4187683|P1|Overall Study|Adverse Event|12
1282885|NCT00374556|4187747|P2|Overall Study|excluded at baseline due to medical cond|1
1282886|NCT00374556|4187748|P1|Overall Study|excluded at baseline due to medical cond|0
1282887|NCT00374556|4187747|P2|Overall Study|Lost to Follow-up|0
1282888|NCT00374556|4187748|P1|Overall Study|Lost to Follow-up|1
1282889|NCT00374452|4187809|P2|Overall Study|Withdrawal by Subject|2
1282890|NCT00374452|4187810|P1|Overall Study|Withdrawal by Subject|0
1282891|NCT00374452|4187809|P2|Overall Study|Left clinic after intervention started|1
1282892|NCT00374452|4187810|P1|Overall Study|Left clinic after intervention started|1
1282893|NCT00374452|4187809|P2|Overall Study|Change in job role before intervention|1
1282894|NCT00374452|4187810|P1|Overall Study|Change in job role before intervention|0
1282895|NCT00374452|4187809|P2|Overall Study|Left clinic before intervention started|1
1282896|NCT00374452|4187810|P1|Overall Study|Left clinic before intervention started|4
1282897|NCT00374322|4187823|P2|Overall Study|Did Not Receive Study Medication|6
1282898|NCT00374322|4187824|P1|Overall Study|Did Not Receive Study Medication|8
1282899|NCT00374322|4187823|P2|Overall Study|Withdrew Consent During Follow-up|5
1282900|NCT00374322|4187824|P1|Overall Study|Withdrew Consent During Follow-up|0
1282901|NCT00374322|4187823|P2|Overall Study|Noncompliance with Study Requirements|1
1282902|NCT00374322|4187824|P1|Overall Study|Noncompliance with Study Requirements|0
1282903|NCT00374322|4187823|P2|Overall Study|Started Another Chemotherapy Regimen|1
1282904|NCT00374322|4187824|P1|Overall Study|Started Another Chemotherapy Regimen|0
1282905|NCT00374322|4187823|P2|Overall Study|Participant Changed Physician|0
1282906|NCT00374322|4187824|P1|Overall Study|Participant Changed Physician|1
1282907|NCT00374322|4187823|P2|Overall Study|Site Closed|2
1282908|NCT00374322|4187824|P1|Overall Study|Site Closed|2
1282909|NCT00374322|4187823|P2|Overall Study|Severe Toxicity|0
1282910|NCT00374322|4187824|P1|Overall Study|Severe Toxicity|1
1282911|NCT00374322|4187823|P2|Overall Study|Seen in FU by a Non-Primary Investigator|0
1282912|NCT00374322|4187824|P1|Overall Study|Seen in FU by a Non-Primary Investigator|1
1282913|NCT00374322|4187823|P2|Overall Study|FU by a Non-Principal Investigator (PI)|3
1282914|NCT00374322|4187824|P1|Overall Study|FU by a Non-Principal Investigator (PI)|2
1282915|NCT00374322|4187823|P2|Overall Study|Sponsor Decision|3
1282916|NCT00374322|4187824|P1|Overall Study|Sponsor Decision|2
1282917|NCT00374322|4187823|P2|Overall Study|Par. Consented to Survival FU Only|1
1282918|NCT00374322|4187824|P1|Overall Study|Par. Consented to Survival FU Only|3
1282919|NCT00374322|4187823|P2|Overall Study|Physician Decision|32
1282920|NCT00374322|4187824|P1|Overall Study|Physician Decision|36
1282921|NCT00374322|4187823|P2|Overall Study|Sponsor Terminated Study|990
1282922|NCT00374322|4187824|P1|Overall Study|Sponsor Terminated Study|866
1282923|NCT00374322|4187823|P2|Overall Study|Withdrawal by Subject|167
1282924|NCT00374322|4187824|P1|Overall Study|Withdrawal by Subject|235
1282925|NCT00374322|4187823|P2|Overall Study|Protocol Violation|3
1282926|NCT00374322|4187824|P1|Overall Study|Protocol Violation|8
1282927|NCT00374322|4187823|P2|Overall Study|Lost to Follow-up|90
1282928|NCT00374322|4187824|P1|Overall Study|Lost to Follow-up|92
1282929|NCT00374140|4187915|P1|Overall Study|Protocol Violation|1
1282930|NCT00374140|4187915|P1|Overall Study|Lost to Follow-up|1
1282931|NCT00374127|4187922|P1|Overall Study|Pregnancy|1
1282932|NCT00374127|4187922|P1|Overall Study|Protocol Violation|5
1282933|NCT00374127|4187922|P1|Overall Study|Blood could not be drawn.|2
1282934|NCT00374127|4187922|P1|Overall Study|Did not inhale during smoking procedure.|3
1282935|NCT00373958|4187971|P2|Toddler Dose|Withdrawn after infant series|25
1282936|NCT00373958|4187972|P1|Toddler Dose|Withdrawn after infant series|22
1282937|NCT00373958|4187971|P2|Toddler Dose|Protocol Violation|1
1282938|NCT00373958|4187972|P1|Toddler Dose|Protocol Violation|0
1282939|NCT00373958|4187971|P2|Toddler Dose|Failed to return|2
1282940|NCT00373958|4187972|P1|Toddler Dose|Failed to return|1
1282941|NCT00373958|4187971|P2|Toddler Dose|Withdrawal by Subject|2
1282942|NCT00373958|4187972|P1|Toddler Dose|Withdrawal by Subject|2
1282943|NCT00373958|4187971|P2|Toddler Dose|Lost to Follow-up|8
1282944|NCT00373958|4187972|P1|Toddler Dose|Lost to Follow-up|5
1282945|NCT00373958|4187971|P2|Infant Series|Physician Decision|1
1282946|NCT00373958|4187972|P1|Infant Series|Physician Decision|1
1282947|NCT00373958|4187971|P2|Infant Series|Adverse Event|1
1282948|NCT00373958|4187972|P1|Infant Series|Adverse Event|3
1282949|NCT00373958|4187971|P2|Infant Series|Consent was not received|0
1282950|NCT00373958|4187972|P1|Infant Series|Consent was not received|1
1282951|NCT00373958|4187971|P2|Infant Series|Child relocated|0
1282952|NCT00373958|4187972|P1|Infant Series|Child relocated|1
1282953|NCT00373958|4187971|P2|Infant Series|Lost Kaiser coverage|0
1282954|NCT00373958|4187972|P1|Infant Series|Lost Kaiser coverage|4
1282955|NCT00373958|4187971|P2|Infant Series|Protocol Violation|7
1282956|NCT00373958|4187972|P1|Infant Series|Protocol Violation|3
1282957|NCT00373958|4187971|P2|Infant Series|Lost to Follow-up|5
1282958|NCT00373958|4187972|P1|Infant Series|Lost to Follow-up|6
1282959|NCT00373958|4187971|P2|Infant Series|Failed to return|13
1282960|NCT00373958|4187972|P1|Infant Series|Failed to return|8
1282961|NCT00373958|4187971|P2|Infant Series|Withdrawal by Subject|15
1282962|NCT00373958|4187972|P1|Infant Series|Withdrawal by Subject|13
1282963|NCT00373880|4188020|P1|Overall Study|Protocol Violation|14
1282964|NCT00373880|4188020|P1|Overall Study|Arrested|1
1282965|NCT00373880|4188020|P1|Overall Study|Physician Decision|3
1282966|NCT00373685|4188065|P2|Overall Study|Randomized, not treated|77
1282967|NCT00373685|4188066|P1|Overall Study|Randomized, not treated|51
1282968|NCT00373685|4188065|P2|Overall Study|Final Status Unknown|4
1282969|NCT00373685|4188066|P1|Overall Study|Final Status Unknown|12
1282970|NCT00373685|4188065|P2|Overall Study|Protocol Violation|182
1282971|NCT00373685|4188066|P1|Overall Study|Protocol Violation|191
1282972|NCT00373685|4188065|P2|Overall Study|Other|146
1282973|NCT00373685|4188066|P1|Overall Study|Other|149
1282974|NCT00373685|4188065|P2|Overall Study|No longer willing to participate|352
1282975|NCT00373685|4188066|P1|Overall Study|No longer willing to participate|337
1282976|NCT00373685|4188065|P2|Overall Study|Lost to follow up|103
1282977|NCT00373685|4188066|P1|Overall Study|Lost to follow up|83
1282978|NCT00373685|4188065|P2|Overall Study|Did not meet entrance criteria|184
1282979|NCT00373685|4188066|P1|Overall Study|Did not meet entrance criteria|167
1282980|NCT00373685|4188065|P2|Overall Study|Insufficient clinical response|119
1282981|NCT00373685|4188066|P1|Overall Study|Insufficient clinical response|169
1282982|NCT00373685|4188065|P2|Overall Study|Adverse Event|253
1282983|NCT00373685|4188066|P1|Overall Study|Adverse Event|278
1282984|NCT00373685|4188065|P2|Overall Study|Death|1
1282985|NCT00373685|4188066|P1|Overall Study|Death|2
1282986|NCT00373529|4188100|P1|Overall Study|Consent violation|1
1282987|NCT00373529|4188100|P1|Overall Study|Failed independent confirmation of AML|3
1282988|NCT00373529|4188100|P1|Overall Study|Not specified|8
1282989|NCT00373529|4188100|P1|Overall Study|Need for treatment prohibited by study|1
1282990|NCT00373529|4188100|P1|Overall Study|Death|16
1282991|NCT00373529|4188100|P1|Overall Study|Disease recurrence|10
1282992|NCT00373529|4188100|P1|Overall Study|Treatment failure|36
1282993|NCT00373529|4188100|P1|Overall Study|Adverse Event|7
1282994|NCT00373529|4188100|P1|Overall Study|Withdrawal by Subject|7
1282995|NCT00373529|4188100|P1|Overall Study|Physician Decision|19
1282996|NCT00373490|4188112|P2|Overall Study|Withdrawal by Subject|1
1282997|NCT00373490|4188113|P1|Overall Study|Withdrawal by Subject|0
1282998|NCT00373490|4188112|P2|Overall Study|Lack of Efficacy|4
1282999|NCT00373490|4188113|P1|Overall Study|Lack of Efficacy|9
1283000|NCT00373490|4188112|P2|Overall Study|Adverse Event|1
1283001|NCT00373490|4188113|P1|Overall Study|Adverse Event|0
1283002|NCT00373425|4188136|P5|Overall Study|Death|0
1283003|NCT00373425|4188137|P4|Overall Study|Death|1
1283004|NCT00373425|4188138|P3|Overall Study|Death|3
1283005|NCT00373425|4188139|P2|Overall Study|Death|0
1283006|NCT00373425|4188140|P1|Overall Study|Death|7
1283007|NCT00373425|4188136|P5|Overall Study|Medical/ethical/noncompliance reason|5
1283008|NCT00373425|4188137|P4|Overall Study|Medical/ethical/noncompliance reason|2
1283009|NCT00373425|4188138|P3|Overall Study|Medical/ethical/noncompliance reason|10
1283010|NCT00373425|4188139|P2|Overall Study|Medical/ethical/noncompliance reason|9
1283011|NCT00373425|4188140|P1|Overall Study|Medical/ethical/noncompliance reason|21
1283012|NCT00373425|4188136|P5|Overall Study|Patient request|7
1283013|NCT00373425|4188137|P4|Overall Study|Patient request|6
1283014|NCT00373425|4188138|P3|Overall Study|Patient request|43
1283015|NCT00373425|4188139|P2|Overall Study|Patient request|18
1283016|NCT00373425|4188140|P1|Overall Study|Patient request|35
1283017|NCT00373425|4188136|P5|Overall Study|Adverse Event|34
1283018|NCT00373425|4188137|P4|Overall Study|Adverse Event|0
1283019|NCT00373425|4188138|P3|Overall Study|Adverse Event|59
1283020|NCT00373425|4188139|P2|Overall Study|Adverse Event|22
1283021|NCT00373425|4188140|P1|Overall Study|Adverse Event|191
1283022|NCT00373425|4188136|P5|Overall Study|Relapse of NSCLC|26
1283023|NCT00373425|4188137|P4|Overall Study|Relapse of NSCLC|2
1283024|NCT00373425|4188138|P3|Overall Study|Relapse of NSCLC|19
1283025|NCT00373425|4188139|P2|Overall Study|Relapse of NSCLC|104
1283026|NCT00373425|4188140|P1|Overall Study|Relapse of NSCLC|116
1283027|NCT00373295|4188235|P6|Intervention 1 (8 Days)|Withdrawal by Subject|0
1283028|NCT00373295|4188236|P5|Intervention 1 (8 Days)|Withdrawal by Subject|1
1283029|NCT00373295|4188237|P4|Intervention 1 (8 Days)|Withdrawal by Subject|0
1283030|NCT00373295|4188238|P3|Intervention 1 (8 Days)|Withdrawal by Subject|0
1283031|NCT00373295|4188239|P2|Intervention 1 (8 Days)|Withdrawal by Subject|2
1283032|NCT00373295|4188240|P1|Intervention 1 (8 Days)|Withdrawal by Subject|0
1283033|NCT00373256|4188261|P2|Overall Study|Study Terminated by Sponsor|13
1283034|NCT00373256|4188262|P1|Overall Study|Study Terminated by Sponsor|41
1283035|NCT00373256|4188261|P2|Overall Study|Protocol Violation|2
1283036|NCT00373256|4188262|P1|Overall Study|Protocol Violation|0
1283037|NCT00373256|4188261|P2|Overall Study|Other|107
1283038|NCT00373256|4188262|P1|Overall Study|Other|73
1283039|NCT00373256|4188261|P2|Overall Study|Refused Treatment-Reason Other Than AE|7
1283040|NCT00373256|4188262|P1|Overall Study|Refused Treatment-Reason Other Than AE|4
1283041|NCT00373256|4188261|P2|Overall Study|Objective Progression or Relapse|104
1283042|NCT00373256|4188262|P1|Overall Study|Objective Progression or Relapse|111
1283043|NCT00373256|4188261|P2|Overall Study|Death|8
1283044|NCT00373256|4188262|P1|Overall Study|Death|9
1283045|NCT00373256|4188261|P2|Overall Study|Lost to Follow-up|1
1283046|NCT00373256|4188262|P1|Overall Study|Lost to Follow-up|2
1283047|NCT00373256|4188261|P2|Overall Study|Adverse Event (AE)|5
1283048|NCT00373256|4188262|P1|Overall Study|Adverse Event (AE)|1
1283049|NCT00373113|4188288|P2|Overall Study|Withdrawal by Subject|15
1283050|NCT00373113|4188289|P1|Overall Study|Withdrawal by Subject|10
1283051|NCT00373113|4188288|P2|Overall Study|Protocol Violation|1
1283052|NCT00373113|4188289|P1|Overall Study|Protocol Violation|5
1283053|NCT00373113|4188288|P2|Overall Study|Other|17
1283054|NCT00373113|4188289|P1|Overall Study|Other|14
1283055|NCT00373113|4188288|P2|Overall Study|Objective progression or relapse|169
1283056|NCT00373113|4188289|P1|Overall Study|Objective progression or relapse|150
1283057|NCT00373113|4188288|P2|Overall Study|Lost to Follow-up|3
1283058|NCT00373113|4188289|P1|Overall Study|Lost to Follow-up|1
1283059|NCT00373113|4188288|P2|Overall Study|Global deterioration of health status|7
1283060|NCT00373113|4188289|P1|Overall Study|Global deterioration of health status|10
1283061|NCT00373113|4188288|P2|Overall Study|Study terminated by sponsor|1
1283062|NCT00373113|4188289|P1|Overall Study|Study terminated by sponsor|9
1283063|NCT00373113|4188288|P2|Overall Study|Adverse Event|24
1283064|NCT00373113|4188289|P1|Overall Study|Adverse Event|38
1283065|NCT00373113|4188288|P2|Overall Study|Death|7
1283066|NCT00373113|4188289|P1|Overall Study|Death|1
1283067|NCT00372996|4188311|P4|Overall Study|Not specified|7
1283068|NCT00372996|4188312|P3|Overall Study|Not specified|7
1283069|NCT00372996|4188313|P2|Overall Study|Not specified|2
1283070|NCT00372996|4188314|P1|Overall Study|Not specified|10
1283071|NCT00372996|4188311|P4|Overall Study|Study Terminated by Sponsor|0
1283072|NCT00372996|4188312|P3|Overall Study|Study Terminated by Sponsor|4
1283073|NCT00372996|4188313|P2|Overall Study|Study Terminated by Sponsor|0
1283074|NCT00372996|4188314|P1|Overall Study|Study Terminated by Sponsor|4
1283075|NCT00372996|4188311|P4|Overall Study|Withdrawal by Subject|5
1283076|NCT00372996|4188312|P3|Overall Study|Withdrawal by Subject|9
1283077|NCT00372996|4188313|P2|Overall Study|Withdrawal by Subject|6
1283078|NCT00372996|4188314|P1|Overall Study|Withdrawal by Subject|12
1283079|NCT00372996|4188311|P4|Overall Study|Lost to Follow-up|1
1283080|NCT00372996|4188312|P3|Overall Study|Lost to Follow-up|0
1283081|NCT00372996|4188313|P2|Overall Study|Lost to Follow-up|2
1283082|NCT00372996|4188314|P1|Overall Study|Lost to Follow-up|0
1283083|NCT00372996|4188311|P4|Overall Study|Death|7
1283084|NCT00372996|4188312|P3|Overall Study|Death|8
1283085|NCT00372996|4188313|P2|Overall Study|Death|4
1283086|NCT00372996|4188314|P1|Overall Study|Death|11
1283087|NCT00372905|4188399|P4|Follow up Until Relapse or Progression|Other|0
1283088|NCT00372905|4188400|P3|Follow up Until Relapse or Progression|Other|0
1283089|NCT00372905|4188401|P2|Follow up Until Relapse or Progression|Other|1
1283090|NCT00372905|4188402|P1|Follow up Until Relapse or Progression|Other|0
1283091|NCT00372905|4188399|P4|Follow up Until Relapse or Progression|Study closed|3
1283092|NCT00372905|4188400|P3|Follow up Until Relapse or Progression|Study closed|0
1283093|NCT00372905|4188401|P2|Follow up Until Relapse or Progression|Study closed|0
1283094|NCT00372905|4188402|P1|Follow up Until Relapse or Progression|Study closed|0
1283095|NCT00372905|4188399|P4|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2
1283184|NCT00372489|4188567|P1|Overall Study|Adverse Event|18
1283096|NCT00372905|4188400|P3|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
1283097|NCT00372905|4188401|P2|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
1283098|NCT00372905|4188402|P1|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
1283099|NCT00372905|4188399|P4|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
1283100|NCT00372905|4188400|P3|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1
1283101|NCT00372905|4188401|P2|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
1283102|NCT00372905|4188402|P1|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
1283103|NCT00372905|4188399|P4|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
1283104|NCT00372905|4188400|P3|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2
1283105|NCT00372905|4188401|P2|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
1283106|NCT00372905|4188402|P1|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
1283107|NCT00372905|4188399|P4|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
1283108|NCT00372905|4188400|P3|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
1283109|NCT00372905|4188401|P2|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
1283110|NCT00372905|4188402|P1|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2
1283111|NCT00372775|4188414|P1|Overall Study|Not Treated|2
1283112|NCT00372775|4188414|P1|Overall Study|Not specified|1
1283113|NCT00372775|4188414|P1|Overall Study|Withdrawal by Subject|1
1283114|NCT00372775|4188414|P1|Overall Study|Global deterioration of health status|6
1283115|NCT00372775|4188414|P1|Overall Study|Objective progression or relapse|30
1283116|NCT00372775|4188414|P1|Overall Study|Death|15
1283117|NCT00372775|4188414|P1|Overall Study|Adverse Event|8
1283118|NCT00372697|4188436|P2|Overall Study|Protocol Violation|1
1283119|NCT00372697|4188437|P1|Overall Study|Protocol Violation|1
1283120|NCT00372619|4188462|P7|Overall Study|Inevaluable|0
1283121|NCT00372619|4188463|P6|Overall Study|Inevaluable|1
1283122|NCT00372619|4188464|P5|Overall Study|Inevaluable|0
1283123|NCT00372619|4188465|P4|Overall Study|Inevaluable|0
1283124|NCT00372619|4188466|P3|Overall Study|Inevaluable|0
1283125|NCT00372619|4188467|P2|Overall Study|Inevaluable|0
1283126|NCT00372619|4188468|P1|Overall Study|Inevaluable|0
1283127|NCT00372619|4188462|P7|Overall Study|Ineligible|0
1283128|NCT00372619|4188463|P6|Overall Study|Ineligible|2
1283129|NCT00372619|4188464|P5|Overall Study|Ineligible|0
1283130|NCT00372619|4188465|P4|Overall Study|Ineligible|0
1283131|NCT00372619|4188466|P3|Overall Study|Ineligible|0
1283132|NCT00372619|4188467|P2|Overall Study|Ineligible|0
1283133|NCT00372619|4188468|P1|Overall Study|Ineligible|0
1283134|NCT00372593|4188501|P3|Overall Study|Ineligible|1
1283135|NCT00372593|4188502|P2|Overall Study|Ineligible|21
1283136|NCT00372593|4188503|P1|Overall Study|Ineligible|20
1283137|NCT00372593|4188501|P3|Overall Study|Physician Decision|0
1283138|NCT00372593|4188502|P2|Overall Study|Physician Decision|41
1283139|NCT00372593|4188503|P1|Overall Study|Physician Decision|42
1283140|NCT00372593|4188501|P3|Overall Study|Lost to Follow-up|0
1283141|NCT00372593|4188502|P2|Overall Study|Lost to Follow-up|0
1283142|NCT00372593|4188503|P1|Overall Study|Lost to Follow-up|1
1283143|NCT00372593|4188501|P3|Overall Study|Lack of Efficacy|2
1283144|NCT00372593|4188502|P2|Overall Study|Lack of Efficacy|71
1283145|NCT00372593|4188503|P1|Overall Study|Lack of Efficacy|82
1283146|NCT00372593|4188501|P3|Overall Study|Death|1
1283147|NCT00372593|4188502|P2|Overall Study|Death|20
1283148|NCT00372593|4188503|P1|Overall Study|Death|16
1283149|NCT00372593|4188501|P3|Overall Study|Adverse Event|0
1283150|NCT00372593|4188502|P2|Overall Study|Adverse Event|45
1283151|NCT00372593|4188503|P1|Overall Study|Adverse Event|43
1283152|NCT00372567|4188532|P3|Phase 3 Study|study terminated by sponsor|5
1283153|NCT00372567|4188533|P2|Phase 3 Study|study terminated by sponsor|8
1283154|NCT00372567|4188534|P1|Phase 3 Study|study terminated by sponsor|13
1283155|NCT00372567|4188532|P3|Phase 3 Study|not specified|1
1283156|NCT00372567|4188533|P2|Phase 3 Study|not specified|2
1283157|NCT00372567|4188534|P1|Phase 3 Study|not specified|2
1283158|NCT00372567|4188532|P3|Phase 3 Study|Global deterioration of health status|0
1283159|NCT00372567|4188533|P2|Phase 3 Study|Global deterioration of health status|1
1283160|NCT00372567|4188534|P1|Phase 3 Study|Global deterioration of health status|0
1283161|NCT00372567|4188532|P3|Phase 3 Study|Objective progression or relapse|4
1283162|NCT00372567|4188533|P2|Phase 3 Study|Objective progression or relapse|13
1283163|NCT00372567|4188534|P1|Phase 3 Study|Objective progression or relapse|10
1283164|NCT00372567|4188532|P3|Phase 3 Study|Protocol Violation|1
1283165|NCT00372567|4188533|P2|Phase 3 Study|Protocol Violation|0
1283166|NCT00372567|4188534|P1|Phase 3 Study|Protocol Violation|0
1283167|NCT00372567|4188532|P3|Phase 3 Study|Death|0
1283168|NCT00372567|4188533|P2|Phase 3 Study|Death|1
1283169|NCT00372567|4188534|P1|Phase 3 Study|Death|1
1283170|NCT00372567|4188532|P3|Phase 3 Study|Adverse Event|1
1283171|NCT00372567|4188533|P2|Phase 3 Study|Adverse Event|1
1283172|NCT00372567|4188534|P1|Phase 3 Study|Adverse Event|5
1283173|NCT00372528|4188562|P1|Overall Study|Other|1
1283174|NCT00372528|4188562|P1|Overall Study|Study Terminated by Sponsor|18
1283175|NCT00372528|4188562|P1|Overall Study|Adverse Event|1
1283176|NCT00372528|4188562|P1|Overall Study|Lack of Efficacy|1
1283177|NCT00372489|4188567|P1|Overall Study|Sponsor Decision to Terminate Study|41
1283178|NCT00372489|4188567|P1|Overall Study|Renal transplant|6
1283179|NCT00372489|4188567|P1|Overall Study|Patient Relocation|2
1283180|NCT00372489|4188567|P1|Overall Study|Withdrawal by Subject|5
1283181|NCT00372489|4188567|P1|Overall Study|Physician Decision|3
1283182|NCT00372489|4188567|P1|Overall Study|Lost to Follow-up|3
1283183|NCT00372489|4188567|P1|Overall Study|Lack of Efficacy|1
1283185|NCT00372424|4188571|P1|Overall Study|Enrolled, Not Treated|1
1283186|NCT00372424|4188571|P1|Overall Study|Other|7
1283187|NCT00372424|4188571|P1|Overall Study|Objective Progression or Relapse|14
1283188|NCT00372424|4188571|P1|Overall Study|Death|1
1283189|NCT00372424|4188571|P1|Overall Study|Withdrawal by Subject|1
1283190|NCT00372424|4188571|P1|Overall Study|Adverse Event|2
1283191|NCT00372411|4188585|P3|Overall Study|Adverse Event|0
1283192|NCT00372411|4188586|P2|Overall Study|Adverse Event|1
1283193|NCT00372411|4188587|P1|Overall Study|Adverse Event|1
1283194|NCT00372411|4188585|P3|Overall Study|Lost to Follow-up|1
1283195|NCT00372411|4188586|P2|Overall Study|Lost to Follow-up|1
1283196|NCT00372411|4188587|P1|Overall Study|Lost to Follow-up|1
1283197|NCT00372411|4188585|P3|Overall Study|Death|1
1283198|NCT00372411|4188586|P2|Overall Study|Death|2
1283199|NCT00372411|4188587|P1|Overall Study|Death|0
1283200|NCT00372411|4188585|P3|Overall Study|Withdrawal by Subject|1
1283201|NCT00372411|4188586|P2|Overall Study|Withdrawal by Subject|4
1283202|NCT00372411|4188587|P1|Overall Study|Withdrawal by Subject|3
1283203|NCT00372385|4188611|P4|Overall Study|Virologic Stopping Rule|0
1283204|NCT00372385|4188612|P3|Overall Study|Virologic Stopping Rule|0
1283205|NCT00372385|4188613|P2|Overall Study|Virologic Stopping Rule|0
1283206|NCT00372385|4188614|P1|Overall Study|Virologic Stopping Rule|17
1283207|NCT00372385|4188611|P4|Overall Study|Ineligibility due to Exclusion Criterion|0
1283208|NCT00372385|4188612|P3|Overall Study|Ineligibility due to Exclusion Criterion|0
1283209|NCT00372385|4188613|P2|Overall Study|Ineligibility due to Exclusion Criterion|0
1283210|NCT00372385|4188614|P1|Overall Study|Ineligibility due to Exclusion Criterion|1
1283211|NCT00372385|4188611|P4|Overall Study|No Response|0
1283212|NCT00372385|4188612|P3|Overall Study|No Response|0
1283213|NCT00372385|4188613|P2|Overall Study|No Response|1
1283214|NCT00372385|4188614|P1|Overall Study|No Response|1
1283215|NCT00372385|4188611|P4|Overall Study|Refusal of Treatment|0
1283216|NCT00372385|4188612|P3|Overall Study|Refusal of Treatment|0
1283217|NCT00372385|4188613|P2|Overall Study|Refusal of Treatment|6
1283218|NCT00372385|4188614|P1|Overall Study|Refusal of Treatment|3
1283219|NCT00372385|4188611|P4|Overall Study|Withdrawal by Subject|0
1283220|NCT00372385|4188612|P3|Overall Study|Withdrawal by Subject|0
1283221|NCT00372385|4188613|P2|Overall Study|Withdrawal by Subject|1
1283222|NCT00372385|4188614|P1|Overall Study|Withdrawal by Subject|2
1283223|NCT00372385|4188611|P4|Overall Study|Lost to Follow-up|0
1283224|NCT00372385|4188612|P3|Overall Study|Lost to Follow-up|0
1283225|NCT00372385|4188613|P2|Overall Study|Lost to Follow-up|0
1283226|NCT00372385|4188614|P1|Overall Study|Lost to Follow-up|2
1283227|NCT00372385|4188611|P4|Overall Study|Physician Decision|0
1283228|NCT00372385|4188612|P3|Overall Study|Physician Decision|0
1283229|NCT00372385|4188613|P2|Overall Study|Physician Decision|0
1283230|NCT00372385|4188614|P1|Overall Study|Physician Decision|1
1283231|NCT00372385|4188611|P4|Overall Study|Noncompliance|1
1283232|NCT00372385|4188612|P3|Overall Study|Noncompliance|1
1283233|NCT00372385|4188613|P2|Overall Study|Noncompliance|1
1283234|NCT00372385|4188614|P1|Overall Study|Noncompliance|0
1283235|NCT00372385|4188611|P4|Overall Study|Adverse Event|7
1283236|NCT00372385|4188612|P3|Overall Study|Adverse Event|9
1283237|NCT00372385|4188613|P2|Overall Study|Adverse Event|11
1283238|NCT00372385|4188614|P1|Overall Study|Adverse Event|6
1283239|NCT00372190|4188643|P2|Overall Study|Lost to Follow-up|1
1283240|NCT00372190|4188644|P1|Overall Study|Lost to Follow-up|3
1283241|NCT00372112|4188660|P4|Overall Study|Other-protocol violation|0
1283242|NCT00372112|4188661|P3|Overall Study|Other-protocol violation|1
1283243|NCT00372112|4188662|P2|Overall Study|Other-protocol violation|0
1283244|NCT00372112|4188663|P1|Overall Study|Other-protocol violation|0
1283245|NCT00372112|4188660|P4|Overall Study|Hepatitis B|0
1283246|NCT00372112|4188661|P3|Overall Study|Hepatitis B|0
1283247|NCT00372112|4188662|P2|Overall Study|Hepatitis B|0
1283248|NCT00372112|4188663|P1|Overall Study|Hepatitis B|1
1283249|NCT00372112|4188660|P4|Overall Study|PR >240 at Visit 3|1
1283250|NCT00372112|4188661|P3|Overall Study|PR >240 at Visit 3|0
1283251|NCT00372112|4188662|P2|Overall Study|PR >240 at Visit 3|0
1283252|NCT00372112|4188663|P1|Overall Study|PR >240 at Visit 3|0
1283253|NCT00372112|4188660|P4|Overall Study|Exacerbation|1
1283254|NCT00372112|4188661|P3|Overall Study|Exacerbation|0
1283255|NCT00372112|4188662|P2|Overall Study|Exacerbation|0
1283256|NCT00372112|4188663|P1|Overall Study|Exacerbation|0
1283257|NCT00372112|4188660|P4|Overall Study|Withdrawal by Subject|1
1283258|NCT00372112|4188661|P3|Overall Study|Withdrawal by Subject|2
1283259|NCT00372112|4188662|P2|Overall Study|Withdrawal by Subject|0
1283260|NCT00372112|4188663|P1|Overall Study|Withdrawal by Subject|0
1283261|NCT00372112|4188660|P4|Overall Study|Adverse Event|1
1283262|NCT00372112|4188661|P3|Overall Study|Adverse Event|1
1283263|NCT00372112|4188662|P2|Overall Study|Adverse Event|1
1283264|NCT00372112|4188663|P1|Overall Study|Adverse Event|0
1283265|NCT00372060|4188794|P2|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0
1283266|NCT00372060|4188795|P1|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2
1283267|NCT00372060|4188794|P2|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8
1283268|NCT00372060|4188795|P1|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9
1283269|NCT00372060|4188794|P2|Period II - Open-label (Weeks 12-52)|Adverse Event|0
1283270|NCT00372060|4188795|P1|Period II - Open-label (Weeks 12-52)|Adverse Event|3
1283271|NCT00372060|4188794|P2|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0
1283272|NCT00372060|4188795|P1|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1
1283273|NCT00372060|4188794|P2|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1
1283274|NCT00372060|4188795|P1|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0
1283275|NCT00372060|4188794|P2|Period I - Double-blind (Weeks 0-12)|Adverse Event|0
1283276|NCT00372060|4188795|P1|Period I - Double-blind (Weeks 0-12)|Adverse Event|2
1283277|NCT00371865|4188810|P2|Overall Study|Withdrawal by Subject|10
1283278|NCT00371865|4188811|P1|Overall Study|Withdrawal by Subject|12
1283279|NCT00371865|4188810|P2|Overall Study|Protocol Violation|2
1283280|NCT00371865|4188811|P1|Overall Study|Protocol Violation|3
1283281|NCT00371865|4188810|P2|Overall Study|Lack of Efficacy|2
1283282|NCT00371865|4188811|P1|Overall Study|Lack of Efficacy|0
1283283|NCT00371839|4188828|P3|Overall Study|Lost to Follow-up|2
1283284|NCT00371839|4188829|P2|Overall Study|Lost to Follow-up|3
1283285|NCT00371839|4188830|P1|Overall Study|Lost to Follow-up|6
1283286|NCT00371839|4188828|P3|Overall Study|Withdrawal by Subject|0
1283287|NCT00371839|4188829|P2|Overall Study|Withdrawal by Subject|4
1283288|NCT00371839|4188830|P1|Overall Study|Withdrawal by Subject|7
1283289|NCT00371839|4188828|P3|Overall Study|Death|0
1283290|NCT00371839|4188829|P2|Overall Study|Death|0
1283291|NCT00371839|4188830|P1|Overall Study|Death|4
1283292|NCT00371826|4188839|P3|Extension Phase (24 Months)|Administrative problems|2
1283293|NCT00371826|4188840|P2|Extension Phase (24 Months)|Administrative problems|0
1283294|NCT00371826|4188841|P1|Extension Phase (24 Months)|Administrative problems|0
1283295|NCT00371826|4188839|P3|Extension Phase (24 Months)|Subject withdrew consent|0
1283296|NCT00371826|4188840|P2|Extension Phase (24 Months)|Subject withdrew consent|2
1283297|NCT00371826|4188841|P1|Extension Phase (24 Months)|Subject withdrew consent|1
1283298|NCT00371826|4188839|P3|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
1283299|NCT00371826|4188840|P2|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2
1283300|NCT00371826|4188841|P1|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
1283301|NCT00371826|4188839|P3|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
1283302|NCT00371826|4188840|P2|Extension Phase (24 Months)|Abnormal test procedure result(s)|1
1283303|NCT00371826|4188841|P1|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
1283304|NCT00371826|4188839|P3|Extension Phase (24 Months)|Adverse Event|0
1283305|NCT00371826|4188840|P2|Extension Phase (24 Months)|Adverse Event|5
1283306|NCT00371826|4188841|P1|Extension Phase (24 Months)|Adverse Event|4
1283307|NCT00371826|4188839|P3|Core Phase (12 Months)|Graft Loss|0
1283308|NCT00371826|4188840|P2|Core Phase (12 Months)|Graft Loss|1
1283309|NCT00371826|4188841|P1|Core Phase (12 Months)|Graft Loss|0
1283310|NCT00371826|4188839|P3|Core Phase (12 Months)|Administrative problems|8
1283311|NCT00371826|4188840|P2|Core Phase (12 Months)|Administrative problems|0
1283312|NCT00371826|4188841|P1|Core Phase (12 Months)|Administrative problems|1
1283313|NCT00371826|4188839|P3|Core Phase (12 Months)|Subject withdrew consent|3
1283314|NCT00371826|4188840|P2|Core Phase (12 Months)|Subject withdrew consent|0
1283315|NCT00371826|4188841|P1|Core Phase (12 Months)|Subject withdrew consent|0
1283316|NCT00371826|4188839|P3|Core Phase (12 Months)|Protocol Violation|1
1283317|NCT00371826|4188840|P2|Core Phase (12 Months)|Protocol Violation|0
1283318|NCT00371826|4188841|P1|Core Phase (12 Months)|Protocol Violation|1
1283319|NCT00371826|4188839|P3|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2
1283320|NCT00371826|4188840|P2|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3
1283321|NCT00371826|4188841|P1|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6
1283322|NCT00371826|4188839|P3|Core Phase (12 Months)|Abnormal test procedure result(s)|1
1283323|NCT00371826|4188840|P2|Core Phase (12 Months)|Abnormal test procedure result(s)|0
1283324|NCT00371826|4188841|P1|Core Phase (12 Months)|Abnormal test procedure result(s)|1
1283325|NCT00371826|4188839|P3|Core Phase (12 Months)|Adverse Event|9
1283326|NCT00371826|4188840|P2|Core Phase (12 Months)|Adverse Event|4
1283327|NCT00371826|4188841|P1|Core Phase (12 Months)|Adverse Event|15
1283328|NCT00371787|4188965|P2|Overall Study|Withdrawal by Subject|1
1283329|NCT00371787|4188966|P1|Overall Study|Withdrawal by Subject|3
1283330|NCT00371761|4188980|P2|Overall Study|Study termination|3
1283331|NCT00371761|4188981|P1|Overall Study|Study termination|4
1283332|NCT00371761|4188980|P2|Overall Study|Investigator Judgment|3
1283333|NCT00371761|4188981|P1|Overall Study|Investigator Judgment|2
1283334|NCT00371761|4188980|P2|Overall Study|Withdrawal by Subject|3
1283335|NCT00371761|4188981|P1|Overall Study|Withdrawal by Subject|1
1283336|NCT00371761|4188980|P2|Overall Study|Adverse Event|1
1283337|NCT00371761|4188981|P1|Overall Study|Adverse Event|1
1283338|NCT00371683|4188989|P2|Follow-Up Period - Randomized Patients|non-specified|12
1283339|NCT00371683|4188990|P1|Follow-Up Period - Randomized Patients|non-specified|6
1283340|NCT00371683|4188989|P2|Follow-Up Period - Randomized Patients|Lost to Follow-up|39
1283341|NCT00371683|4188990|P1|Follow-Up Period - Randomized Patients|Lost to Follow-up|38
1283342|NCT00371683|4188989|P2|Follow-Up Period - Randomized Patients|Death|2
1283343|NCT00371683|4188990|P1|Follow-Up Period - Randomized Patients|Death|0
1283344|NCT00371683|4188989|P2|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19
1283345|NCT00371683|4188990|P1|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17
1283346|NCT00371683|4188989|P2|DB Treatment Period-Randomized Patients|non-specified|8
1283347|NCT00371683|4188990|P1|DB Treatment Period-Randomized Patients|non-specified|9
1283348|NCT00371683|4188989|P2|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0
1283349|NCT00371683|4188990|P1|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1
1283350|NCT00371683|4188989|P2|DB Treatment Period-Randomized Patients|No longer meets study criteria|2
1283351|NCT00371683|4188990|P1|DB Treatment Period-Randomized Patients|No longer meets study criteria|1
1283352|NCT00371683|4188989|P2|DB Treatment Period-Randomized Patients|Lost to Follow-up|1
1283353|NCT00371683|4188990|P1|DB Treatment Period-Randomized Patients|Lost to Follow-up|0
1283354|NCT00371683|4188989|P2|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37
1283355|NCT00371683|4188990|P1|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18
1283356|NCT00371683|4188989|P2|DB Treatment Period-Randomized Patients|Adverse Event|58
1283357|NCT00371683|4188990|P1|DB Treatment Period-Randomized Patients|Adverse Event|60
1283358|NCT00371683|4188989|P2|DB Treatment Period-Randomized Patients|Death|1
1283359|NCT00371683|4188990|P1|DB Treatment Period-Randomized Patients|Death|1
1283360|NCT00371566|4189058|P2|Follow Up Phase|Lost to Follow-up|0
1283361|NCT00371566|4189059|P1|Follow Up Phase|Lost to Follow-up|1
1283362|NCT00371566|4189058|P2|Follow Up Phase|Physician Decision|1
1283363|NCT00371566|4189059|P1|Follow Up Phase|Physician Decision|1
1283364|NCT00371566|4189058|P2|Follow Up Phase|Withdrawal by Subject|1
1283365|NCT00371566|4189059|P1|Follow Up Phase|Withdrawal by Subject|0
1283366|NCT00371566|4189058|P2|Follow Up Phase|Disease progression|0
1283367|NCT00371566|4189059|P1|Follow Up Phase|Disease progression|1
1283368|NCT00371566|4189058|P2|Follow Up Phase|Death|5
1283369|NCT00371566|4189059|P1|Follow Up Phase|Death|0
1283370|NCT00371566|4189058|P2|Chemoradiation Phase|Death|0
1283371|NCT00371566|4189059|P1|Chemoradiation Phase|Death|2
1283372|NCT00371566|4189058|P2|Chemoradiation Phase|Progressive Disease|1
1283373|NCT00371566|4189059|P1|Chemoradiation Phase|Progressive Disease|1
1283374|NCT00371566|4189058|P2|Chemoradiation Phase|Non compliant|1
1283375|NCT00371566|4189059|P1|Chemoradiation Phase|Non compliant|0
1283376|NCT00371566|4189058|P2|Chemoradiation Phase|Withdrawal by Subject|1
1283377|NCT00371566|4189059|P1|Chemoradiation Phase|Withdrawal by Subject|0
1283378|NCT00371566|4189058|P2|Chemoradiation Phase|Physician Decision|0
1283379|NCT00371566|4189059|P1|Chemoradiation Phase|Physician Decision|2
1283380|NCT00371566|4189058|P2|Treatment Phase|Protocol Violation|1
1283381|NCT00371566|4189059|P1|Treatment Phase|Protocol Violation|0
1283382|NCT00371566|4189058|P2|Treatment Phase|Adverse Event|1
1283383|NCT00371566|4189059|P1|Treatment Phase|Adverse Event|0
1283384|NCT00371566|4189058|P2|Treatment Phase|Withdrawal by Subject|1
1283385|NCT00371566|4189059|P1|Treatment Phase|Withdrawal by Subject|0
1283386|NCT00371462|4189144|P2|Overall Study|Other|8
1283387|NCT00371462|4189145|P1|Overall Study|Other|7
1283388|NCT00371462|4189144|P2|Overall Study|Withdrawal by Subject|0
1283389|NCT00371462|4189145|P1|Overall Study|Withdrawal by Subject|1
1283390|NCT00371397|4189169|P12|Session 1|Withdrawal by Subject|0
1283391|NCT00371397|4189170|P11|Session 1|Withdrawal by Subject|0
1283392|NCT00371397|4189171|P10|Session 1|Withdrawal by Subject|0
1283393|NCT00371397|4189172|P9|Session 1|Withdrawal by Subject|0
1283394|NCT00371397|4189173|P8|Session 1|Withdrawal by Subject|1
1283395|NCT00371397|4189174|P7|Session 1|Withdrawal by Subject|0
1283396|NCT00371397|4189175|P6|Session 1|Withdrawal by Subject|0
1283397|NCT00371397|4189176|P5|Session 1|Withdrawal by Subject|0
1283398|NCT00371397|4189177|P4|Session 1|Withdrawal by Subject|0
1283399|NCT00371397|4189178|P3|Session 1|Withdrawal by Subject|0
1283400|NCT00371397|4189179|P2|Session 1|Withdrawal by Subject|0
1283401|NCT00371397|4189180|P1|Session 1|Withdrawal by Subject|1
1283402|NCT00371345|4189188|P2|Overall Study|Participant Withdrew Consent|1
1283403|NCT00371345|4189189|P1|Overall Study|Participant Withdrew Consent|0
1283404|NCT00371345|4189188|P2|Overall Study|Participant Request|1
1283405|NCT00371345|4189189|P1|Overall Study|Participant Request|1
1283406|NCT00371345|4189188|P2|Overall Study|Adverse event(AE Unrelated to Study Drug|2
1283407|NCT00371345|4189189|P1|Overall Study|Adverse event(AE Unrelated to Study Drug|1
1283408|NCT00371345|4189188|P2|Overall Study|Study Drug Toxicity|7
1283409|NCT00371345|4189189|P1|Overall Study|Study Drug Toxicity|1
1283410|NCT00371345|4189188|P2|Overall Study|Disease Progression|35
1283411|NCT00371345|4189189|P1|Overall Study|Disease Progression|21
1283412|NCT00371254|4189290|P2|Overall Study|Withdrawal by Subject|1
1283413|NCT00371254|4189291|P1|Overall Study|Withdrawal by Subject|0
1283414|NCT00371254|4189290|P2|Overall Study|Lost to Follow-up|1
1283415|NCT00371254|4189291|P1|Overall Study|Lost to Follow-up|0
1283416|NCT00371254|4189290|P2|Overall Study|Adverse event unrelated to study drug|1
1283417|NCT00371254|4189291|P1|Overall Study|Adverse event unrelated to study drug|0
1283418|NCT00371254|4189290|P2|Overall Study|Investigator Decision|0
1283419|NCT00371254|4189291|P1|Overall Study|Investigator Decision|2
1283420|NCT00371254|4189290|P2|Overall Study|Subject request|0
1283421|NCT00371254|4189291|P1|Overall Study|Subject request|5
1283422|NCT00371254|4189290|P2|Overall Study|Study drug toxicity|5
1283423|NCT00371254|4189291|P1|Overall Study|Study drug toxicity|3
1283424|NCT00371254|4189290|P2|Overall Study|Disease progression|13
1283425|NCT00371254|4189291|P1|Overall Study|Disease progression|13
1283426|NCT00371150|4189374|P2|Overall Study|Lost to Follow-up|2
1283427|NCT00371150|4189375|P1|Overall Study|Lost to Follow-up|3
1283428|NCT00371137|4189410|P3|Overall Study|Protocol Violation|1
1283429|NCT00371137|4189411|P2|Overall Study|Protocol Violation|1
1283430|NCT00371137|4189412|P1|Overall Study|Protocol Violation|2
1283431|NCT00371137|4189410|P3|Overall Study|Physician Decision|1
1283432|NCT00371137|4189411|P2|Overall Study|Physician Decision|1
1283433|NCT00371137|4189412|P1|Overall Study|Physician Decision|1
1283434|NCT00371137|4189410|P3|Overall Study|Sponsor Decision|2
1283435|NCT00371137|4189411|P2|Overall Study|Sponsor Decision|1
1283436|NCT00371137|4189412|P1|Overall Study|Sponsor Decision|2
1283437|NCT00371137|4189410|P3|Overall Study|Lack of Efficacy|13
1283438|NCT00371137|4189411|P2|Overall Study|Lack of Efficacy|12
1283439|NCT00371137|4189412|P1|Overall Study|Lack of Efficacy|30
1283440|NCT00371137|4189410|P3|Overall Study|Lost to Follow-up|5
1283441|NCT00371137|4189411|P2|Overall Study|Lost to Follow-up|3
1283442|NCT00371137|4189412|P1|Overall Study|Lost to Follow-up|6
1283443|NCT00371137|4189410|P3|Overall Study|Withdrawal by Subject|15
1283444|NCT00371137|4189411|P2|Overall Study|Withdrawal by Subject|10
1283445|NCT00371137|4189412|P1|Overall Study|Withdrawal by Subject|11
1283446|NCT00371137|4189410|P3|Overall Study|Adverse Event|42
1283447|NCT00371137|4189411|P2|Overall Study|Adverse Event|35
1283448|NCT00371137|4189412|P1|Overall Study|Adverse Event|20
1283449|NCT00370682|4189455|P3|Overall Study|Lost to Follow-up|1
1283450|NCT00370682|4189456|P2|Overall Study|Lost to Follow-up|1
1283451|NCT00370682|4189457|P1|Overall Study|Lost to Follow-up|0
1283452|NCT00370682|4189455|P3|Overall Study|Moved from area|0
1283453|NCT00370682|4189456|P2|Overall Study|Moved from area|2
1283454|NCT00370682|4189457|P1|Overall Study|Moved from area|0
1283455|NCT00370552|4189499|P3|Overall Study|Planned radiation for palliation|0
1283456|NCT00370552|4189500|P2|Overall Study|Planned radiation for palliation|1
1283457|NCT00370552|4189501|P1|Overall Study|Planned radiation for palliation|0
1283458|NCT00370552|4189499|P3|Overall Study|High risk of allergic reaction|0
1283459|NCT00370552|4189500|P2|Overall Study|High risk of allergic reaction|1
1283460|NCT00370552|4189501|P1|Overall Study|High risk of allergic reaction|0
1283461|NCT00370552|4189499|P3|Overall Study|Investigator decision|0
1283462|NCT00370552|4189500|P2|Overall Study|Investigator decision|1
1283463|NCT00370552|4189501|P1|Overall Study|Investigator decision|2
1283464|NCT00370552|4189499|P3|Overall Study|Physician Decision|0
1283465|NCT00370552|4189500|P2|Overall Study|Physician Decision|1
1283466|NCT00370552|4189501|P1|Overall Study|Physician Decision|1
1283467|NCT00370552|4189499|P3|Overall Study|Never treated|0
1283468|NCT00370552|4189500|P2|Overall Study|Never treated|0
1283469|NCT00370552|4189501|P1|Overall Study|Never treated|1
1283470|NCT00370552|4189499|P3|Overall Study|Still on treatment|2
1283471|NCT00370552|4189500|P2|Overall Study|Still on treatment|3
1283472|NCT00370552|4189501|P1|Overall Study|Still on treatment|1
1283473|NCT00370552|4189499|P3|Overall Study|Withdrawal by Subject|1
1283474|NCT00370552|4189500|P2|Overall Study|Withdrawal by Subject|0
1283475|NCT00370552|4189501|P1|Overall Study|Withdrawal by Subject|2
1283476|NCT00370552|4189499|P3|Overall Study|Study drug toxicity|6
1283477|NCT00370552|4189500|P2|Overall Study|Study drug toxicity|8
1283478|NCT00370552|4189501|P1|Overall Study|Study drug toxicity|11
1283479|NCT00370552|4189499|P3|Overall Study|Poor or noncompliance|1
1283480|NCT00370552|4189500|P2|Overall Study|Poor or noncompliance|0
1283481|NCT00370552|4189501|P1|Overall Study|Poor or noncompliance|0
1283482|NCT00370552|4189499|P3|Overall Study|Maximum clinical benefit|5
1283483|NCT00370552|4189500|P2|Overall Study|Maximum clinical benefit|5
1283484|NCT00370552|4189501|P1|Overall Study|Maximum clinical benefit|3
1283485|NCT00370552|4189499|P3|Overall Study|Disease progression|15
1283486|NCT00370552|4189500|P2|Overall Study|Disease progression|23
1283487|NCT00370552|4189501|P1|Overall Study|Disease progression|23
1283488|NCT00370552|4189499|P3|Overall Study|Adverse Event|2
1283489|NCT00370552|4189500|P2|Overall Study|Adverse Event|2
1283490|NCT00370552|4189501|P1|Overall Study|Adverse Event|2
1283491|NCT00370396|4189542|P3|Overall Study|Lost to Follow-up|0
1283492|NCT00370396|4189543|P2|Overall Study|Lost to Follow-up|1
1283493|NCT00370396|4189544|P1|Overall Study|Lost to Follow-up|11
1283494|NCT00370396|4189542|P3|Overall Study|Withdrawal by Subject|1
1283495|NCT00370396|4189543|P2|Overall Study|Withdrawal by Subject|0
1283496|NCT00370396|4189544|P1|Overall Study|Withdrawal by Subject|0
1283497|NCT00370331|4189598|P2|Overall Study|Protocol Violation|1
1283498|NCT00370331|4189599|P1|Overall Study|Protocol Violation|1
1283499|NCT00370331|4189598|P2|Overall Study|Non-compliance|1
1283500|NCT00370331|4189599|P1|Overall Study|Non-compliance|0
1283501|NCT00370331|4189598|P2|Overall Study|Lack of Efficacy|1
1283502|NCT00370331|4189599|P1|Overall Study|Lack of Efficacy|0
1283503|NCT00370331|4189598|P2|Overall Study|Lost to Follow-up|3
1283504|NCT00370331|4189599|P1|Overall Study|Lost to Follow-up|0
1283505|NCT00370331|4189598|P2|Overall Study|Withdrawal by Subject|4
1283506|NCT00370331|4189599|P1|Overall Study|Withdrawal by Subject|2
1283507|NCT00370331|4189598|P2|Overall Study|Adverse Event|13
1283508|NCT00370331|4189599|P1|Overall Study|Adverse Event|4
1283509|NCT00370292|4189625|P1|Overall Study|Physician Decision|2
1283510|NCT00370292|4189625|P1|Overall Study|Adverse Event|7
1283511|NCT00370292|4189625|P1|Overall Study|Disease Progression|4
1283512|NCT00370149|4189638|P2|Overall Study|Antibiotic coated dressing placed|1
1283513|NCT00370149|4189639|P1|Overall Study|Antibiotic coated dressing placed|0
1283514|NCT00370149|4189638|P2|Overall Study|Pre-existing infection|1
1283515|NCT00370149|4189639|P1|Overall Study|Pre-existing infection|0
1283516|NCT00370149|4189638|P2|Overall Study|Catheter inserted in wrong vessel-|1
1283517|NCT00370149|4189639|P1|Overall Study|Catheter inserted in wrong vessel-|2
1283518|NCT00370149|4189638|P2|Overall Study|Protocol Violation|0
1283519|NCT00370149|4189639|P1|Overall Study|Protocol Violation|1
1283520|NCT00370149|4189638|P2|Overall Study|Physician Decision|16
1283521|NCT00370149|4189639|P1|Overall Study|Physician Decision|16
1283522|NCT00370071|4189649|P1|Overall Study|Withdrawal by Subject|2
1283523|NCT00370032|4189666|P2|Follow-up Period|Withdrawal by Subject|0
1283524|NCT00370032|4189667|P1|Follow-up Period|Withdrawal by Subject|1
1283525|NCT00370032|4189666|P2|Washout Period|Adverse Event|0
1283526|NCT00370032|4189667|P1|Washout Period|Adverse Event|1
1283527|NCT00370032|4189666|P2|Washout Period|Lost to Follow-up|1
1283528|NCT00370032|4189667|P1|Washout Period|Lost to Follow-up|0
1283529|NCT00370032|4189666|P2|Washout Period|Withdrawal by Subject|1
1283530|NCT00370032|4189667|P1|Washout Period|Withdrawal by Subject|0
1283531|NCT00370032|4189666|P2|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1
1283532|NCT00370032|4189667|P1|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0
1283533|NCT00369967|4189687|P2|Overall Study|Lost to Follow-up|12
1283534|NCT00369967|4189688|P1|Overall Study|Lost to Follow-up|23
1283535|NCT00369941|4189706|P2|Overall Study|Miscellaneous|3
1283536|NCT00369941|4189707|P1|Overall Study|Miscellaneous|3
1283537|NCT00369941|4189706|P2|Overall Study|Study Site Terminated|0
1283538|NCT00369941|4189707|P1|Overall Study|Study Site Terminated|2
1283539|NCT00369941|4189706|P2|Overall Study|Employment Interfered with Study Visits|0
1283540|NCT00369941|4189707|P1|Overall Study|Employment Interfered with Study Visits|1
1283541|NCT00369941|4189706|P2|Overall Study|Treatment with Prohibited Medication|1
1283542|NCT00369941|4189707|P1|Overall Study|Treatment with Prohibited Medication|3
1283543|NCT00369941|4189706|P2|Overall Study|Moved|5
1283544|NCT00369941|4189707|P1|Overall Study|Moved|11
1283545|NCT00369941|4189706|P2|Overall Study|Completed, Did Not Enter Extension|6
1283546|NCT00369941|4189707|P1|Overall Study|Completed, Did Not Enter Extension|5
1283547|NCT00369941|4189706|P2|Overall Study|Pregnancy|2
1283548|NCT00369941|4189707|P1|Overall Study|Pregnancy|4
1283549|NCT00369941|4189706|P2|Overall Study|Withdrawal by Subject|18
1283550|NCT00369941|4189707|P1|Overall Study|Withdrawal by Subject|5
1283551|NCT00369941|4189706|P2|Overall Study|Protocol Violation|3
1283552|NCT00369941|4189707|P1|Overall Study|Protocol Violation|5
1283553|NCT00369941|4189706|P2|Overall Study|Lost to Follow-up|22
1283554|NCT00369941|4189707|P1|Overall Study|Lost to Follow-up|12
1283555|NCT00369941|4189706|P2|Overall Study|Lack of Efficacy|10
1283556|NCT00369941|4189707|P1|Overall Study|Lack of Efficacy|6
1283557|NCT00369941|4189706|P2|Overall Study|Adverse Event|28
1283558|NCT00369941|4189707|P1|Overall Study|Adverse Event|14
1283559|NCT00369941|4189706|P2|Overall Study|Never Treated|2
1283560|NCT00369941|4189707|P1|Overall Study|Never Treated|1
1283561|NCT00369915|4189872|P2|Overall Study|W/drawl by investigators|1
1283562|NCT00369915|4189873|P1|Overall Study|W/drawl by investigators|0
1283563|NCT00369915|4189872|P2|Overall Study|Withdrawal by Subject|1
1283564|NCT00369915|4189873|P1|Overall Study|Withdrawal by Subject|4
1283565|NCT00369915|4189872|P2|Overall Study|expected side effects|1
1283566|NCT00369915|4189873|P1|Overall Study|expected side effects|2
1283567|NCT00369824|4189887|P6|Overall Study|Other|3
1283568|NCT00369824|4189888|P5|Overall Study|Other|1
1283569|NCT00369824|4189889|P4|Overall Study|Other|2
1283570|NCT00369824|4189890|P3|Overall Study|Other|0
1283571|NCT00369824|4189891|P2|Overall Study|Other|0
1283572|NCT00369824|4189892|P1|Overall Study|Other|0
1283573|NCT00369824|4189887|P6|Overall Study|Lost to Follow-up|6
1283574|NCT00369824|4189888|P5|Overall Study|Lost to Follow-up|9
1283575|NCT00369824|4189889|P4|Overall Study|Lost to Follow-up|8
1283576|NCT00369824|4189890|P3|Overall Study|Lost to Follow-up|7
1283577|NCT00369824|4189891|P2|Overall Study|Lost to Follow-up|11
1283578|NCT00369824|4189892|P1|Overall Study|Lost to Follow-up|6
1283579|NCT00369824|4189887|P6|Overall Study|Withdrawal by Subject|2
1283580|NCT00369824|4189888|P5|Overall Study|Withdrawal by Subject|6
1283581|NCT00369824|4189889|P4|Overall Study|Withdrawal by Subject|4
1283582|NCT00369824|4189890|P3|Overall Study|Withdrawal by Subject|5
1283583|NCT00369824|4189891|P2|Overall Study|Withdrawal by Subject|5
1283584|NCT00369824|4189892|P1|Overall Study|Withdrawal by Subject|9
1283585|NCT00369824|4189887|P6|Overall Study|Protocol Violation|0
1283586|NCT00369824|4189888|P5|Overall Study|Protocol Violation|1
1283587|NCT00369824|4189889|P4|Overall Study|Protocol Violation|1
1283588|NCT00369824|4189890|P3|Overall Study|Protocol Violation|0
1283589|NCT00369824|4189891|P2|Overall Study|Protocol Violation|1
1283590|NCT00369824|4189892|P1|Overall Study|Protocol Violation|0
1283591|NCT00369824|4189887|P6|Overall Study|Adverse Event|0
1283592|NCT00369824|4189888|P5|Overall Study|Adverse Event|1
1283593|NCT00369824|4189889|P4|Overall Study|Adverse Event|0
1283594|NCT00369824|4189890|P3|Overall Study|Adverse Event|0
1283595|NCT00369824|4189891|P2|Overall Study|Adverse Event|2
1283596|NCT00369824|4189892|P1|Overall Study|Adverse Event|0
1283597|NCT00369785|4189992|P2|Overall Study|Multiple reasons|5
1283598|NCT00369785|4189993|P1|Overall Study|Multiple reasons|6
1283599|NCT00369785|4189992|P2|Overall Study|Progression|4
1283600|NCT00369785|4189993|P1|Overall Study|Progression|4
1283601|NCT00369785|4189992|P2|Overall Study|Never started|2
1283602|NCT00369785|4189993|P1|Overall Study|Never started|0
1283603|NCT00369785|4189992|P2|Overall Study|Toxicity|4
1283604|NCT00369785|4189993|P1|Overall Study|Toxicity|6
1283605|NCT00369785|4189992|P2|Overall Study|Withdrawal by Subject|6
1283606|NCT00369785|4189993|P1|Overall Study|Withdrawal by Subject|7
1283607|NCT00369785|4189992|P2|Overall Study|Death|2
1283608|NCT00369785|4189993|P1|Overall Study|Death|1
1283609|NCT00369785|4189992|P2|Overall Study|Physician Decision|2
1283610|NCT00369785|4189993|P1|Overall Study|Physician Decision|3
1283611|NCT00369707|4190014|P1|Follow up for 2 Years After Treatment|Other|2
1283612|NCT00369707|4190014|P1|Follow up for 2 Years After Treatment|Death|1
1283613|NCT00369707|4190014|P1|Maintenance Period (up to 4 Cycles)|Progressive disease|4
1283614|NCT00369707|4190014|P1|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2
1283615|NCT00369707|4190014|P1|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2
1283616|NCT00369707|4190014|P1|Induction Part B (2 Cycles)|Progressive disease|1
1283617|NCT00369707|4190014|P1|Induction Part B (2 Cycles)|Inadequate response/MD decision|1
1283618|NCT00369707|4190014|P1|Induction Part B (2 Cycles)|Withdrawal by Subject|2
1283619|NCT00369707|4190014|P1|Induction Part B (2 Cycles)|Adverse Event|3
1283620|NCT00369681|4190027|P1|Overall Study|Death|1
1283621|NCT00369668|4190037|P3|Overall Study|Lack of Efficacy|7
1283622|NCT00369668|4190038|P2|Overall Study|Lack of Efficacy|5
1283623|NCT00369668|4190039|P1|Overall Study|Lack of Efficacy|4
1283624|NCT00369655|4190053|P1|Overall Study|Refusal of further treatment|2
1283625|NCT00369629|4190062|P4|Follow up for 1 Year|stopped being followed as study closed|0
1283626|NCT00369629|4190063|P3|Follow up for 1 Year|stopped being followed as study closed|2
1283627|NCT00369629|4190064|P2|Follow up for 1 Year|stopped being followed as study closed|0
1283628|NCT00369629|4190065|P1|Follow up for 1 Year|stopped being followed as study closed|0
1283629|NCT00369629|4190062|P4|Follow up for 1 Year|Lost to Follow-up|0
1283630|NCT00369629|4190063|P3|Follow up for 1 Year|Lost to Follow-up|0
1283631|NCT00369629|4190064|P2|Follow up for 1 Year|Lost to Follow-up|1
1283632|NCT00369629|4190065|P1|Follow up for 1 Year|Lost to Follow-up|0
1283633|NCT00369629|4190062|P4|Follow up for 1 Year|Death|0
1283634|NCT00369629|4190063|P3|Follow up for 1 Year|Death|1
1283635|NCT00369629|4190064|P2|Follow up for 1 Year|Death|1
1283636|NCT00369629|4190065|P1|Follow up for 1 Year|Death|2
1283637|NCT00369629|4190062|P4|Completed 4 More Cycles|Progressive disease|0
1283638|NCT00369629|4190063|P3|Completed 4 More Cycles|Progressive disease|2
1283639|NCT00369629|4190064|P2|Completed 4 More Cycles|Progressive disease|1
1283640|NCT00369629|4190065|P1|Completed 4 More Cycles|Progressive disease|2
1283641|NCT00369629|4190062|P4|Completed 4 More Cycles|Withdrawal by Subject|0
1283642|NCT00369629|4190063|P3|Completed 4 More Cycles|Withdrawal by Subject|0
1283643|NCT00369629|4190064|P2|Completed 4 More Cycles|Withdrawal by Subject|1
1283644|NCT00369629|4190065|P1|Completed 4 More Cycles|Withdrawal by Subject|2
1283645|NCT00369629|4190062|P4|Moved on to 4 More Cycles|Progressive Disease|0
1283646|NCT00369629|4190063|P3|Moved on to 4 More Cycles|Progressive Disease|1
1283647|NCT00369629|4190064|P2|Moved on to 4 More Cycles|Progressive Disease|0
1283648|NCT00369629|4190065|P1|Moved on to 4 More Cycles|Progressive Disease|0
1283649|NCT00369629|4190062|P4|Treated 2 Cycles/Reached First Response|Progressive disease|0
1283650|NCT00369629|4190063|P3|Treated 2 Cycles/Reached First Response|Progressive disease|0
1283651|NCT00369629|4190064|P2|Treated 2 Cycles/Reached First Response|Progressive disease|0
1283652|NCT00369629|4190065|P1|Treated 2 Cycles/Reached First Response|Progressive disease|2
1283653|NCT00369629|4190062|P4|Treated 2 Cycles/Reached First Response|Adverse Event|0
1283654|NCT00369629|4190063|P3|Treated 2 Cycles/Reached First Response|Adverse Event|1
1283655|NCT00369629|4190064|P2|Treated 2 Cycles/Reached First Response|Adverse Event|0
1283656|NCT00369629|4190065|P1|Treated 2 Cycles/Reached First Response|Adverse Event|0
1283657|NCT00369629|4190062|P4|Treated 2 Cycles/Reached First Response|Physician Decision|0
1283658|NCT00369629|4190063|P3|Treated 2 Cycles/Reached First Response|Physician Decision|1
1283659|NCT00369629|4190064|P2|Treated 2 Cycles/Reached First Response|Physician Decision|1
1283660|NCT00369629|4190065|P1|Treated 2 Cycles/Reached First Response|Physician Decision|0
1283661|NCT00369577|4190096|P3|Overall Study|Withdrawal by Subject|1
1283662|NCT00369577|4190097|P2|Overall Study|Withdrawal by Subject|0
1283663|NCT00369577|4190098|P1|Overall Study|Withdrawal by Subject|0
1283664|NCT00369486|4190135|P5|34-Week Visit|Dropped|3
1283665|NCT00369486|4190136|P4|34-Week Visit|Dropped|3
1283666|NCT00369486|4190137|P3|34-Week Visit|Dropped|1
1283667|NCT00369486|4190138|P2|34-Week Visit|Dropped|1
1283668|NCT00369486|4190139|P1|34-Week Visit|Dropped|0
1283669|NCT00369486|4190135|P5|17-Week Visit|Missed visit|1
1283670|NCT00369486|4190136|P4|17-Week Visit|Missed visit|1
1283671|NCT00369486|4190137|P3|17-Week Visit|Missed visit|1
1283672|NCT00369486|4190138|P2|17-Week Visit|Missed visit|0
1283673|NCT00369486|4190139|P1|17-Week Visit|Missed visit|0
1283674|NCT00369486|4190135|P5|8-Week Visit|Dropped|0
1283675|NCT00369486|4190136|P4|8-Week Visit|Dropped|1
1283676|NCT00369486|4190137|P3|8-Week Visit|Dropped|0
1283677|NCT00369486|4190138|P2|8-Week Visit|Dropped|0
1283678|NCT00369486|4190139|P1|8-Week Visit|Dropped|0
1283679|NCT00369486|4190135|P5|8-Week Visit|Missed visit|1
1283680|NCT00369486|4190136|P4|8-Week Visit|Missed visit|0
1283681|NCT00369486|4190137|P3|8-Week Visit|Missed visit|0
1283682|NCT00369486|4190138|P2|8-Week Visit|Missed visit|1
1283683|NCT00369486|4190139|P1|8-Week Visit|Missed visit|0
1283684|NCT00369486|4190135|P5|4-Week Visit|Dropped|0
1283685|NCT00369486|4190136|P4|4-Week Visit|Dropped|0
1283686|NCT00369486|4190137|P3|4-Week Visit|Dropped|1
1283687|NCT00369486|4190138|P2|4-Week Visit|Dropped|0
1283688|NCT00369486|4190139|P1|4-Week Visit|Dropped|0
1283689|NCT00369486|4190135|P5|4-Week Visit|Missed visit|1
1283690|NCT00369486|4190136|P4|4-Week Visit|Missed visit|2
1283691|NCT00369486|4190137|P3|4-Week Visit|Missed visit|0
1283692|NCT00369486|4190138|P2|4-Week Visit|Missed visit|2
1283693|NCT00369486|4190139|P1|4-Week Visit|Missed visit|2
1283694|NCT00369382|4190178|P2|Overall Study|Other|0
1283695|NCT00369382|4190179|P1|Overall Study|Other|1
1283696|NCT00369382|4190178|P2|Overall Study|Randomized, not treated|0
1283697|NCT00369382|4190179|P1|Overall Study|Randomized, not treated|2
1283698|NCT00369382|4190178|P2|Overall Study|Withdrawal by Subject|0
1283699|NCT00369382|4190179|P1|Overall Study|Withdrawal by Subject|5
1283700|NCT00369382|4190178|P2|Overall Study|Physician Decision|1
1283701|NCT00369382|4190179|P1|Overall Study|Physician Decision|2
1283702|NCT00369382|4190178|P2|Overall Study|Death|2
1283703|NCT00369382|4190179|P1|Overall Study|Death|0
1283704|NCT00369343|4190212|P2|Open-label Phase|did not take study drug|2
1283705|NCT00369343|4190213|P1|Open-label Phase|did not take study drug|1
1283706|NCT00369343|4190212|P2|Open-label Phase|Lack of continuance tolerability|4
1283707|NCT00369343|4190213|P1|Open-label Phase|Lack of continuance tolerability|3
1283708|NCT00369343|4190212|P2|Open-label Phase|Lack of Efficacy|3
1283709|NCT00369343|4190213|P1|Open-label Phase|Lack of Efficacy|4
1283710|NCT00369343|4190212|P2|Open-label Phase|Withdrawal by Subject|6
1283711|NCT00369343|4190213|P1|Open-label Phase|Withdrawal by Subject|15
1283712|NCT00369343|4190212|P2|Open-label Phase|Protocol Violation|3
1283713|NCT00369343|4190213|P1|Open-label Phase|Protocol Violation|1
1283714|NCT00369343|4190212|P2|Open-label Phase|inadvertently reported study completers|2
1283715|NCT00369343|4190213|P1|Open-label Phase|inadvertently reported study completers|3
1283716|NCT00369343|4190212|P2|Open-label Phase|Lost to Follow-up|3
1283717|NCT00369343|4190213|P1|Open-label Phase|Lost to Follow-up|5
1283718|NCT00369343|4190212|P2|Open-label Phase|Physician Decision|0
1283719|NCT00369343|4190213|P1|Open-label Phase|Physician Decision|2
1283720|NCT00369343|4190212|P2|Open-label Phase|Failed to return|0
1283721|NCT00369343|4190213|P1|Open-label Phase|Failed to return|4
1283722|NCT00369343|4190212|P2|Open-label Phase|Adverse Event|7
1283723|NCT00369343|4190213|P1|Open-label Phase|Adverse Event|19
1283724|NCT00369343|4190212|P2|Double-blind Phase|Protocol deviation|0
1283725|NCT00369343|4190213|P1|Double-blind Phase|Protocol deviation|4
1283726|NCT00369343|4190212|P2|Double-blind Phase|Lack of Efficacy|4
1283727|NCT00369343|4190213|P1|Double-blind Phase|Lack of Efficacy|0
1283728|NCT00369343|4190212|P2|Double-blind Phase|Withdrawal by Subject|6
1283729|NCT00369343|4190213|P1|Double-blind Phase|Withdrawal by Subject|8
1283730|NCT00369343|4190212|P2|Double-blind Phase|Protocol Violation|0
1283731|NCT00369343|4190213|P1|Double-blind Phase|Protocol Violation|2
1283732|NCT00369343|4190212|P2|Double-blind Phase|Lost to Follow-up|2
1283733|NCT00369343|4190213|P1|Double-blind Phase|Lost to Follow-up|9
1283734|NCT00369343|4190212|P2|Double-blind Phase|Failed to return|0
1283735|NCT00369343|4190213|P1|Double-blind Phase|Failed to return|2
1283736|NCT00369343|4190212|P2|Double-blind Phase|Adverse Event|4
1283737|NCT00369343|4190213|P1|Double-blind Phase|Adverse Event|19
1283738|NCT00369317|4190246|P1|Overall Study|Ineligible|1
1283739|NCT00369317|4190246|P1|Overall Study|Withdrawal by Subject|8
1283740|NCT00369317|4190246|P1|Overall Study|Physician Decision|2
1283741|NCT00369317|4190246|P1|Overall Study|Lack of Efficacy|5
1283742|NCT00369317|4190246|P1|Overall Study|Death|1
1283743|NCT00369317|4190246|P1|Overall Study|Adverse Event|3
1283744|NCT00369278|4190262|P2|Overall Study|Graft loss|2
1283745|NCT00369278|4190263|P1|Overall Study|Graft loss|1
1283746|NCT00369278|4190262|P2|Overall Study|Lost to Follow-up|0
1283747|NCT00369278|4190263|P1|Overall Study|Lost to Follow-up|1
1283748|NCT00369278|4190262|P2|Overall Study|Withdrawal by Subject|2
1283749|NCT00369278|4190263|P1|Overall Study|Withdrawal by Subject|2
1283750|NCT00369278|4190262|P2|Overall Study|Protocol Violation|1
1283751|NCT00369278|4190263|P1|Overall Study|Protocol Violation|2
1283752|NCT00369278|4190262|P2|Overall Study|Unsatisfactory therapeutic effect|5
1283753|NCT00369278|4190263|P1|Overall Study|Unsatisfactory therapeutic effect|4
1283754|NCT00369278|4190262|P2|Overall Study|Adverse Event|11
1283755|NCT00369278|4190263|P1|Overall Study|Adverse Event|14
1283756|NCT00369265|4190279|P2|Overall Study|Study terminated|7
1283757|NCT00369265|4190280|P1|Overall Study|Study terminated|4
1283758|NCT00369161|4190301|P2|Overall Study|Administrative Problem|2
1283759|NCT00369161|4190302|P1|Overall Study|Administrative Problem|2
1283760|NCT00369161|4190301|P2|Overall Study|Graft loss|0
1283761|NCT00369161|4190302|P1|Overall Study|Graft loss|4
1283762|NCT00369161|4190301|P2|Overall Study|Death|2
1283763|NCT00369161|4190302|P1|Overall Study|Death|1
1283764|NCT00369161|4190301|P2|Overall Study|Withdrawal by Subject|3
1283765|NCT00369161|4190302|P1|Overall Study|Withdrawal by Subject|2
1283766|NCT00369161|4190301|P2|Overall Study|Protocol Violation|2
1283767|NCT00369161|4190302|P1|Overall Study|Protocol Violation|0
1283768|NCT00369161|4190301|P2|Overall Study|Lack of Efficacy|1
1283769|NCT00369161|4190302|P1|Overall Study|Lack of Efficacy|3
1283770|NCT00369161|4190301|P2|Overall Study|Abnormal laboratory value|1
1283771|NCT00369161|4190302|P1|Overall Study|Abnormal laboratory value|0
1283772|NCT00369161|4190301|P2|Overall Study|Adverse Event|13
1283773|NCT00369161|4190302|P1|Overall Study|Adverse Event|15
1283774|NCT00369122|4190312|P1|Overall Study|No protocol treatment|1
1283775|NCT00369122|4190312|P1|Overall Study|Ineligible|10
1283776|NCT00368992|4190319|P1|Overall Study|Not Specified|9
1283777|NCT00368992|4190319|P1|Overall Study|Death|4
1283778|NCT00368992|4190319|P1|Overall Study|Adverse Event|26
1283779|NCT00368992|4190319|P1|Overall Study|Lack of Efficacy|63
1283780|NCT00368992|4190319|P1|Overall Study|Refused treatment|3
1283781|NCT00368992|4190319|P1|Overall Study|Ineligible|5
1283782|NCT00368979|4190328|P2|Overall Study|Withdrawal by Subject|9
1283783|NCT00368979|4190329|P1|Overall Study|Withdrawal by Subject|5
1283784|NCT00368979|4190328|P2|Overall Study|Protocol Violation|1
1283785|NCT00368979|4190329|P1|Overall Study|Protocol Violation|2
1283786|NCT00368979|4190328|P2|Overall Study|Lost to Follow-up|0
1283787|NCT00368979|4190329|P1|Overall Study|Lost to Follow-up|1
1283788|NCT00368979|4190328|P2|Overall Study|Not specified|1
1283789|NCT00368979|4190329|P1|Overall Study|Not specified|3
1283790|NCT00368979|4190328|P2|Overall Study|Lack of Efficacy|3
1283791|NCT00368979|4190329|P1|Overall Study|Lack of Efficacy|5
1283792|NCT00368979|4190328|P2|Overall Study|Adverse Event|16
1283793|NCT00368979|4190329|P1|Overall Study|Adverse Event|9
1283794|NCT00368966|4190345|P2|Toddler Dose|Lost to Follow-up|2
1283795|NCT00368966|4190346|P1|Toddler Dose|Lost to Follow-up|0
1283796|NCT00368966|4190345|P2|Toddler Dose|Withdrawal by Subject|1
1283797|NCT00368966|4190346|P1|Toddler Dose|Withdrawal by Subject|1
1283798|NCT00368966|4190345|P2|After Infant|Lost to Follow-up|1
1283799|NCT00368966|4190346|P1|After Infant|Lost to Follow-up|0
1283800|NCT00368966|4190345|P2|After Infant|Death|0
1283801|NCT00368966|4190346|P1|After Infant|Death|1
1283802|NCT00368966|4190345|P2|After Infant|Withdrawal by Subject|1
1283803|NCT00368966|4190346|P1|After Infant|Withdrawal by Subject|1
1283804|NCT00368966|4190345|P2|After Infant|Adverse Event|2
1283805|NCT00368966|4190346|P1|After Infant|Adverse Event|1
1283806|NCT00368966|4190345|P2|After Infant|Failed to return|1
1283807|NCT00368966|4190346|P1|After Infant|Failed to return|3
1283808|NCT00368966|4190345|P2|Infant Series|Failed to return|0
1283809|NCT00368966|4190346|P1|Infant Series|Failed to return|1
1283810|NCT00368966|4190345|P2|Infant Series|Adverse Event|1
1283811|NCT00368966|4190346|P1|Infant Series|Adverse Event|0
1283812|NCT00368966|4190345|P2|Infant Series|Failed to meet eligibility criteria|1
1283813|NCT00368966|4190346|P1|Infant Series|Failed to meet eligibility criteria|0
1283814|NCT00368966|4190345|P2|Infant Series|Randomization error|1
1283815|NCT00368966|4190346|P1|Infant Series|Randomization error|0
1283816|NCT00368966|4190345|P2|Infant Series|Lost to Follow-up|0
1283817|NCT00368966|4190346|P1|Infant Series|Lost to Follow-up|2
1283818|NCT00368966|4190345|P2|Infant Series|Protocol Violation|1
1283819|NCT00368966|4190346|P1|Infant Series|Protocol Violation|2
1283820|NCT00368966|4190345|P2|Infant Series|Withdrawal by Subject|6
1283821|NCT00368966|4190346|P1|Infant Series|Withdrawal by Subject|11
1283822|NCT00368927|4190417|P2|Overall Study|Physician Decision|0
1283823|NCT00368927|4190418|P1|Overall Study|Physician Decision|1
1283824|NCT00368927|4190417|P2|Overall Study|Withdrawal by Subject|2
1283825|NCT00368927|4190418|P1|Overall Study|Withdrawal by Subject|1
1283826|NCT00368927|4190417|P2|Overall Study|Adverse Event|1
1283827|NCT00368927|4190418|P1|Overall Study|Adverse Event|1
1283828|NCT00368927|4190417|P2|Overall Study|Lost to Follow-up|0
1283829|NCT00368927|4190418|P1|Overall Study|Lost to Follow-up|2
1283830|NCT00368875|4190426|P2|Overall Study|Alternative Therapy|1
1283831|NCT00368875|4190427|P1|Overall Study|Alternative Therapy|1
1283832|NCT00368875|4190426|P2|Overall Study|Other Reason|2
1283833|NCT00368875|4190427|P1|Overall Study|Other Reason|0
1283834|NCT00368875|4190426|P2|Overall Study|Withdrawal by Subject|6
1283835|NCT00368875|4190427|P1|Overall Study|Withdrawal by Subject|2
1283836|NCT00368875|4190426|P2|Overall Study|Progressive disease|27
1283837|NCT00368875|4190427|P1|Overall Study|Progressive disease|3
1283838|NCT00368875|4190426|P2|Overall Study|Adverse Event|12
1283839|NCT00368875|4190427|P1|Overall Study|Adverse Event|0
1283840|NCT00368849|4190435|P2|Overall Study|Physician Decision|1
1283841|NCT00368849|4190436|P1|Overall Study|Physician Decision|0
1283842|NCT00368849|4190435|P2|Overall Study|Withdrawal by Subject|1
1283843|NCT00368849|4190436|P1|Overall Study|Withdrawal by Subject|0
1283844|NCT00368745|4190452|P2|Double-blind Treatment Period|Other|6
1283845|NCT00368745|4190453|P1|Double-blind Treatment Period|Other|7
1283846|NCT00368745|4190452|P2|Double-blind Treatment Period|Withdrawal by Subject|3
1283847|NCT00368745|4190453|P1|Double-blind Treatment Period|Withdrawal by Subject|5
1283848|NCT00368745|4190452|P2|Double-blind Treatment Period|Lost to Follow-up|0
1283849|NCT00368745|4190453|P1|Double-blind Treatment Period|Lost to Follow-up|1
1283850|NCT00368745|4190452|P2|Double-blind Treatment Period|Lack of Efficacy|16
1283851|NCT00368745|4190453|P1|Double-blind Treatment Period|Lack of Efficacy|7
1283852|NCT00368745|4190452|P2|Double-blind Treatment Period|Adverse Event|6
1283853|NCT00368745|4190453|P1|Double-blind Treatment Period|Adverse Event|6
1283854|NCT00368641|4190506|P2|Overall Study|Sponsor decision to terminate study|5
1283855|NCT00368641|4190507|P1|Overall Study|Sponsor decision to terminate study|2
1283856|NCT00368641|4190506|P2|Overall Study|Withdrawal by Subject|0
1283857|NCT00368641|4190507|P1|Overall Study|Withdrawal by Subject|1
1283858|NCT00368641|4190506|P2|Overall Study|Death|0
1283859|NCT00368641|4190507|P1|Overall Study|Death|1
1283860|NCT00368641|4190506|P2|Overall Study|Adverse Event|1
1283861|NCT00368641|4190507|P1|Overall Study|Adverse Event|2
1283862|NCT00368550|4190515|P2|Overall Study|Withdrawal by Subject|10
1283863|NCT00368550|4190516|P1|Overall Study|Withdrawal by Subject|17
1283864|NCT00368550|4190515|P2|Overall Study|Lack of Efficacy|9
1283865|NCT00368550|4190516|P1|Overall Study|Lack of Efficacy|4
1283866|NCT00368550|4190515|P2|Overall Study|Adverse Event|4
1283867|NCT00368550|4190516|P1|Overall Study|Adverse Event|7
1283868|NCT00368537|4190528|P2|Baseline Participants|Patient uncompliant|1
1283869|NCT00368537|4190529|P1|Baseline Participants|Patient uncompliant|0
1283870|NCT00368537|4190528|P2|Baseline Participants|No susceptibility|0
1283871|NCT00368537|4190529|P1|Baseline Participants|No susceptibility|1
1283872|NCT00368537|4190528|P2|Baseline Participants|Death|2
1283873|NCT00368537|4190529|P1|Baseline Participants|Death|1
1283874|NCT00368537|4190528|P2|Baseline Participants|Withdrawal by Subject|4
1283875|NCT00368537|4190529|P1|Baseline Participants|Withdrawal by Subject|6
1283876|NCT00368537|4190528|P2|Baseline Participants|Lost to Follow-up|17
1283877|NCT00368537|4190529|P1|Baseline Participants|Lost to Follow-up|16
1283878|NCT00368537|4190528|P2|Randomization|No study drug dosed|6
1283879|NCT00368537|4190529|P1|Randomization|No study drug dosed|13
1283880|NCT00368472|4190543|P1|Overall Study|Missing Final Disposition Date|1
1283881|NCT00368472|4190543|P1|Overall Study|Not Specified|32
1283882|NCT00368472|4190543|P1|Overall Study|Diary non-compliance|1
1283883|NCT00368472|4190543|P1|Overall Study|Withdrawal by Subject|40
1283884|NCT00368472|4190543|P1|Overall Study|Request of Investigator or Sponsor|3
1283885|NCT00368472|4190543|P1|Overall Study|Protocol Violation|2
1283886|NCT00368472|4190543|P1|Overall Study|Medication non-compliance|4
1283887|NCT00368472|4190543|P1|Overall Study|Adverse Event|22
1283888|NCT00368277|4190602|P2|Overall Study|Lost to Follow-up|6
1283889|NCT00368277|4190603|P1|Overall Study|Lost to Follow-up|8
1283890|NCT00368277|4190602|P2|Overall Study|Patient withdrew consent|28
1283891|NCT00368277|4190603|P1|Overall Study|Patient withdrew consent|32
1283892|NCT00368277|4190602|P2|Overall Study|Protocol deviation|0
1283893|NCT00368277|4190603|P1|Overall Study|Protocol deviation|7
1283894|NCT00368277|4190602|P2|Overall Study|Unsatisfactory therapeutic effect|24
1283895|NCT00368277|4190603|P1|Overall Study|Unsatisfactory therapeutic effect|31
1283896|NCT00368277|4190602|P2|Overall Study|Death|1
1283897|NCT00368277|4190603|P1|Overall Study|Death|2
1283898|NCT00368277|4190602|P2|Overall Study|Adverse Event|49
1283899|NCT00368277|4190603|P1|Overall Study|Adverse Event|33
1283900|NCT00368251|4190618|P3|Overall Study|AE, non-serious non-fatal|1
1283901|NCT00368251|4190619|P2|Overall Study|AE, non-serious non-fatal|0
1283902|NCT00368251|4190620|P1|Overall Study|AE, non-serious non-fatal|0
1283903|NCT00368251|4190618|P3|Overall Study|SAE, non-fatal|0
1283904|NCT00368251|4190619|P2|Overall Study|SAE, non-fatal|0
1283905|NCT00368251|4190620|P1|Overall Study|SAE, non-fatal|1
1283906|NCT00368108|4190643|P3|Overall Study|Not Specified|1
1283907|NCT00368108|4190644|P2|Overall Study|Not Specified|7
1283908|NCT00368108|4190645|P1|Overall Study|Not Specified|3
1283909|NCT00368108|4190643|P3|Overall Study|Physician Decision|1
1283910|NCT00368108|4190644|P2|Overall Study|Physician Decision|0
1283911|NCT00368108|4190645|P1|Overall Study|Physician Decision|2
1283912|NCT00368108|4190643|P3|Overall Study|Lack of Efficacy|5
1283913|NCT00368108|4190644|P2|Overall Study|Lack of Efficacy|8
1283914|NCT00368108|4190645|P1|Overall Study|Lack of Efficacy|7
1283915|NCT00368108|4190643|P3|Overall Study|Withdrawal by Subject|5
1283916|NCT00368108|4190644|P2|Overall Study|Withdrawal by Subject|3
1283917|NCT00368108|4190645|P1|Overall Study|Withdrawal by Subject|9
1283918|NCT00368108|4190643|P3|Overall Study|Protocol Violation|9
1283919|NCT00368108|4190644|P2|Overall Study|Protocol Violation|9
1283920|NCT00368108|4190645|P1|Overall Study|Protocol Violation|5
1283921|NCT00368108|4190643|P3|Overall Study|Abnormal Laboratory Value|3
1283922|NCT00368108|4190644|P2|Overall Study|Abnormal Laboratory Value|0
1283923|NCT00368108|4190645|P1|Overall Study|Abnormal Laboratory Value|0
1283924|NCT00368108|4190643|P3|Overall Study|Adverse Event|44
1283925|NCT00368108|4190644|P2|Overall Study|Adverse Event|26
1283926|NCT00368108|4190645|P1|Overall Study|Adverse Event|38
1283927|NCT00368069|4190664|P2|Overall Study|no blood sampling possible|1
1283928|NCT00368069|4190665|P1|Overall Study|no blood sampling possible|0
1283929|NCT00368069|4190664|P2|Overall Study|Withdrawal of Consent|1
1283930|NCT00368069|4190665|P1|Overall Study|Withdrawal of Consent|2
1283931|NCT00368069|4190664|P2|Overall Study|Protocol Violation|2
1283932|NCT00368069|4190665|P1|Overall Study|Protocol Violation|0
1283933|NCT00368069|4190664|P2|Overall Study|Lost to Follow-up|0
1283934|NCT00368069|4190665|P1|Overall Study|Lost to Follow-up|1
1283935|NCT00368069|4190664|P2|Overall Study|Lack of Efficacy|1
1283936|NCT00368069|4190665|P1|Overall Study|Lack of Efficacy|0
1283937|NCT00368069|4190664|P2|Overall Study|Adverse Event|2
1283938|NCT00368069|4190665|P1|Overall Study|Adverse Event|5
1283939|NCT00367991|4190683|P2|Overall Study|Adverse Event|1
1283940|NCT00367991|4190684|P1|Overall Study|Adverse Event|1
1283941|NCT00367991|4190683|P2|Overall Study|Withdrawal by Subject|1
1283942|NCT00367991|4190684|P1|Overall Study|Withdrawal by Subject|1
1283943|NCT00367835|4190702|P2|Overall Study|History of lead poisoning|1
1283944|NCT00367835|4190703|P1|Overall Study|History of lead poisoning|0
1283945|NCT00367835|4190702|P2|Overall Study|Did not respond to calls|0
1283946|NCT00367835|4190703|P1|Overall Study|Did not respond to calls|1
1283947|NCT00367835|4190702|P2|Overall Study|refused blood collection|0
1283948|NCT00367835|4190703|P1|Overall Study|refused blood collection|1
1283949|NCT00367835|4190702|P2|Overall Study|Subject in juvenile detention center|0
1283950|NCT00367835|4190703|P1|Overall Study|Subject in juvenile detention center|1
1283951|NCT00367835|4190702|P2|Overall Study|Lack of Efficacy|12
1283952|NCT00367835|4190703|P1|Overall Study|Lack of Efficacy|3
1283953|NCT00367835|4190702|P2|Overall Study|Lost to Follow-up|4
1283954|NCT00367835|4190703|P1|Overall Study|Lost to Follow-up|1
1283955|NCT00367835|4190702|P2|Overall Study|Withdrawal by Subject|6
1283956|NCT00367835|4190703|P1|Overall Study|Withdrawal by Subject|7
1283957|NCT00367835|4190702|P2|Overall Study|Protocol Violation|7
1283958|NCT00367835|4190703|P1|Overall Study|Protocol Violation|1
1283959|NCT00367835|4190702|P2|Overall Study|Adverse Event|1
1283960|NCT00367835|4190703|P1|Overall Study|Adverse Event|14
1283961|NCT00367770|4190729|P1|Overall Study|Withdrawal by Subject|1
1283962|NCT00367770|4190729|P1|Overall Study|Adverse Event|1
1283963|NCT00367744|4190737|P2|Overall Study|Lost to Follow-up|5
1283964|NCT00367744|4190738|P1|Overall Study|Lost to Follow-up|4
1283965|NCT00367640|4190767|P4|Overall Study|Any other reason not above-mentioned|4
1283966|NCT00367640|4190768|P3|Overall Study|Any other reason not above-mentioned|3
1283967|NCT00367640|4190769|P2|Overall Study|Any other reason not above-mentioned|5
1283968|NCT00367640|4190770|P1|Overall Study|Any other reason not above-mentioned|7
1283969|NCT00367640|4190767|P4|Overall Study|Withdrawal by Subject|6
1283970|NCT00367640|4190768|P3|Overall Study|Withdrawal by Subject|8
1283971|NCT00367640|4190769|P2|Overall Study|Withdrawal by Subject|11
1283972|NCT00367640|4190770|P1|Overall Study|Withdrawal by Subject|8
1283973|NCT00367640|4190767|P4|Overall Study|Adverse Event|0
1283974|NCT00367640|4190768|P3|Overall Study|Adverse Event|8
1283975|NCT00367640|4190769|P2|Overall Study|Adverse Event|6
1283976|NCT00367640|4190770|P1|Overall Study|Adverse Event|3
1283977|NCT00367484|4190786|P1|Overall Study|Lack of Efficacy|1
1283978|NCT00367484|4190786|P1|Overall Study|The choice of the patient|1
1283979|NCT00367484|4190786|P1|Overall Study|Protocol Violation|1
1283980|NCT00367484|4190786|P1|Overall Study|Lost to Follow-up|1
1283981|NCT00367484|4190786|P1|Overall Study|Travel to USA|1
1283982|NCT00367484|4190786|P1|Overall Study|Withdrew informed consent|5
1283983|NCT00367484|4190786|P1|Overall Study|Adverse Event|7
1283984|NCT00367432|4190790|P2|Second Period (up to 54 Months)|Other Reason|2
1283985|NCT00367432|4190791|P1|Second Period (up to 54 Months)|Other Reason|6
1283986|NCT00367432|4190790|P2|Second Period (up to 54 Months)|Withdrawal by Subject|5
1283987|NCT00367432|4190791|P1|Second Period (up to 54 Months)|Withdrawal by Subject|8
1283988|NCT00367432|4190790|P2|Second Period (up to 54 Months)|Lost to Follow-up|1
1283989|NCT00367432|4190791|P1|Second Period (up to 54 Months)|Lost to Follow-up|0
1283990|NCT00367432|4190790|P2|Second Period (up to 54 Months)|Lack of Efficacy|5
1283991|NCT00367432|4190791|P1|Second Period (up to 54 Months)|Lack of Efficacy|59
1283992|NCT00367432|4190790|P2|Second Period (up to 54 Months)|Adverse Event|3
1283993|NCT00367432|4190791|P1|Second Period (up to 54 Months)|Adverse Event|14
1283994|NCT00367432|4190790|P2|First Period (16 Weeks)|Other Reason|0
1283995|NCT00367432|4190791|P1|First Period (16 Weeks)|Other Reason|2
1283996|NCT00367432|4190790|P2|First Period (16 Weeks)|Withdrawal by Subject|0
1283997|NCT00367432|4190791|P1|First Period (16 Weeks)|Withdrawal by Subject|6
1283998|NCT00367432|4190790|P2|First Period (16 Weeks)|Lack of Efficacy|0
1283999|NCT00367432|4190791|P1|First Period (16 Weeks)|Lack of Efficacy|24
1284000|NCT00367432|4190790|P2|First Period (16 Weeks)|Adverse Event|0
1284001|NCT00367432|4190791|P1|First Period (16 Weeks)|Adverse Event|6
1284002|NCT00367341|4190818|P2|Overall Study|Protocol Violation|0
1284003|NCT00367341|4190819|P1|Overall Study|Protocol Violation|1
1284004|NCT00367341|4190818|P2|Overall Study|Physician Decision|0
1284005|NCT00367341|4190819|P1|Overall Study|Physician Decision|1
1284006|NCT00367237|4190829|P2|Overall Study|Protocol Violation|5
1284007|NCT00367237|4190830|P1|Overall Study|Protocol Violation|2
1284008|NCT00367237|4190829|P2|Overall Study|Withdrawal by Subject|4
1284009|NCT00367237|4190830|P1|Overall Study|Withdrawal by Subject|0
1284010|NCT00367237|4190829|P2|Overall Study|Lost to Follow-up|0
1284011|NCT00367237|4190830|P1|Overall Study|Lost to Follow-up|1
1284012|NCT00367237|4190829|P2|Overall Study|Adverse Event|2
1284013|NCT00367237|4190830|P1|Overall Study|Adverse Event|7
1284014|NCT00367133|4190839|P3|2 Years|Missed visit|4
1284015|NCT00367133|4190840|P2|2 Years|Missed visit|5
1284016|NCT00367133|4190841|P1|2 Years|Missed visit|4
1284017|NCT00367133|4190839|P3|2 Years|Dropped|33
1284018|NCT00367133|4190840|P2|2 Years|Dropped|19
1284019|NCT00367133|4190841|P1|2 Years|Dropped|34
1284020|NCT00367133|4190839|P3|2 Years|Death|12
1284021|NCT00367133|4190840|P2|2 Years|Death|12
1284022|NCT00367133|4190841|P1|2 Years|Death|20
1284023|NCT00367055|4190893|P2|Overall Study|Participant Living too Far from Hospital|1
1284024|NCT00367055|4190894|P1|Overall Study|Participant Living too Far from Hospital|0
1284025|NCT00367055|4190893|P2|Overall Study|Stopping Criterion Met|1
1284026|NCT00367055|4190894|P1|Overall Study|Stopping Criterion Met|0
1284027|NCT00367055|4190893|P2|Overall Study|Protocol Violation|1
1284028|NCT00367055|4190894|P1|Overall Study|Protocol Violation|0
1284029|NCT00367055|4190893|P2|Overall Study|Lost to Follow-up|1
1284030|NCT00367055|4190894|P1|Overall Study|Lost to Follow-up|1
1284031|NCT00367055|4190893|P2|Overall Study|Lack of Efficacy|2
1284032|NCT00367055|4190894|P1|Overall Study|Lack of Efficacy|1
1284033|NCT00367055|4190893|P2|Overall Study|Patient's Willing|2
1284034|NCT00367055|4190894|P1|Overall Study|Patient's Willing|3
1284035|NCT00367055|4190893|P2|Overall Study|Adverse Event|3
1284036|NCT00367055|4190894|P1|Overall Study|Adverse Event|6
1284037|NCT00366899|4190910|P2|Toddler Dose|Protocol Violation|0
1284038|NCT00366899|4190911|P1|Toddler Dose|Protocol Violation|1
1284039|NCT00366899|4190910|P2|Toddler Dose|Withdrawal by Subject|1
1284040|NCT00366899|4190911|P1|Toddler Dose|Withdrawal by Subject|1
1284041|NCT00366899|4190910|P2|After Infant Series|Protocol Violation|0
1284042|NCT00366899|4190911|P1|After Infant Series|Protocol Violation|1
1284043|NCT00366899|4190910|P2|After Infant Series|Adverse Event|2
1284044|NCT00366899|4190911|P1|After Infant Series|Adverse Event|1
1284045|NCT00366899|4190910|P2|After Infant Series|Withdrawal by Subject|4
1284046|NCT00366899|4190911|P1|After Infant Series|Withdrawal by Subject|1
1284047|NCT00366899|4190910|P2|After Infant Series|Lost to Follow-up|3
1284048|NCT00366899|4190911|P1|After Infant Series|Lost to Follow-up|4
1284049|NCT00366899|4190910|P2|Infant Series|Randomized but not consented|0
1284050|NCT00366899|4190911|P1|Infant Series|Randomized but not consented|1
1284051|NCT00366899|4190910|P2|Infant Series|Physician Decision|0
1284052|NCT00366899|4190911|P1|Infant Series|Physician Decision|1
1284053|NCT00366899|4190910|P2|Infant Series|Adverse Event|1
1284054|NCT00366899|4190911|P1|Infant Series|Adverse Event|0
1284055|NCT00366899|4190910|P2|Infant Series|Lost to Follow-up|2
1284056|NCT00366899|4190911|P1|Infant Series|Lost to Follow-up|0
1284057|NCT00366899|4190910|P2|Infant Series|Failed to return|1
1284058|NCT00366899|4190911|P1|Infant Series|Failed to return|1
1284059|NCT00366899|4190910|P2|Infant Series|Protocol Violation|1
1284060|NCT00366899|4190911|P1|Infant Series|Protocol Violation|2
1284061|NCT00366899|4190910|P2|Infant Series|Withdrawal by Subject|7
1284062|NCT00366899|4190911|P1|Infant Series|Withdrawal by Subject|4
1284063|NCT00366678|4190971|P3|Toddler Dose|protocol deviation|0
1284064|NCT00366678|4190972|P2|Toddler Dose|protocol deviation|0
1284065|NCT00366678|4190973|P1|Toddler Dose|protocol deviation|1
1284066|NCT00366678|4190971|P3|Toddler Dose|Withdrawal by Subject|0
1284067|NCT00366678|4190972|P2|Toddler Dose|Withdrawal by Subject|0
1284068|NCT00366678|4190973|P1|Toddler Dose|Withdrawal by Subject|1
1284069|NCT00366678|4190971|P3|Toddler Dose|Failed to return|0
1284070|NCT00366678|4190972|P2|Toddler Dose|Failed to return|0
1284071|NCT00366678|4190973|P1|Toddler Dose|Failed to return|1
1284072|NCT00366678|4190971|P3|Toddler Dose|Protocol Violation|0
1284073|NCT00366678|4190972|P2|Toddler Dose|Protocol Violation|1
1284074|NCT00366678|4190973|P1|Toddler Dose|Protocol Violation|2
1284075|NCT00366678|4190971|P3|After Infant|Protocol Violation|0
1284076|NCT00366678|4190972|P2|After Infant|Protocol Violation|0
1284077|NCT00366678|4190973|P1|After Infant|Protocol Violation|1
1284078|NCT00366678|4190971|P3|After Infant|Adverse Event|0
1284079|NCT00366678|4190972|P2|After Infant|Adverse Event|0
1284080|NCT00366678|4190973|P1|After Infant|Adverse Event|1
1284081|NCT00366678|4190971|P3|After Infant|Failed to return|0
1284082|NCT00366678|4190972|P2|After Infant|Failed to return|5
1284083|NCT00366678|4190973|P1|After Infant|Failed to return|5
1284084|NCT00366678|4190971|P3|After Infant|Lost to Follow-up|0
1284085|NCT00366678|4190972|P2|After Infant|Lost to Follow-up|1
1284086|NCT00366678|4190973|P1|After Infant|Lost to Follow-up|2
1284087|NCT00366678|4190971|P3|After Infant|Withdrawal by Subject|0
1284088|NCT00366678|4190972|P2|After Infant|Withdrawal by Subject|4
1284089|NCT00366678|4190973|P1|After Infant|Withdrawal by Subject|8
1284090|NCT00366678|4190971|P3|Infant Series|Adverse Event|0
1284091|NCT00366678|4190972|P2|Infant Series|Adverse Event|0
1284092|NCT00366678|4190973|P1|Infant Series|Adverse Event|1
1284093|NCT00366678|4190971|P3|Infant Series|Failed to return|0
1284094|NCT00366678|4190972|P2|Infant Series|Failed to return|1
1284095|NCT00366678|4190973|P1|Infant Series|Failed to return|1
1284096|NCT00366678|4190971|P3|Infant Series|Protocol Violation|0
1284097|NCT00366678|4190972|P2|Infant Series|Protocol Violation|3
1284098|NCT00366678|4190973|P1|Infant Series|Protocol Violation|4
1284099|NCT00366678|4190971|P3|Infant Series|Withdrawal by Subject|0
1284100|NCT00366678|4190972|P2|Infant Series|Withdrawal by Subject|6
1284101|NCT00366678|4190973|P1|Infant Series|Withdrawal by Subject|8
1284102|NCT00366548|4191055|P2|After Infant Series|Lost to Follow-up|0
1284103|NCT00366548|4191056|P1|After Infant Series|Lost to Follow-up|1
1284104|NCT00366548|4191055|P2|After Infant Series|Adverse Event|0
1284105|NCT00366548|4191056|P1|After Infant Series|Adverse Event|2
1284106|NCT00366548|4191055|P2|After Infant Series|Withdrawal by Subject|1
1284107|NCT00366548|4191056|P1|After Infant Series|Withdrawal by Subject|3
1284108|NCT00366548|4191055|P2|Infant Series|Withdrawal by Subject|1
1284109|NCT00366548|4191056|P1|Infant Series|Withdrawal by Subject|3
1284110|NCT00366548|4191055|P2|Infant Series|Protocol Violation|1
1284111|NCT00366548|4191056|P1|Infant Series|Protocol Violation|0
1284112|NCT00366548|4191055|P2|Infant Series|Adverse Event|3
1284113|NCT00366548|4191056|P1|Infant Series|Adverse Event|1
1284114|NCT00366535|4191092|P2|Second Phase: 12 Weeks|Withdrawal by Subject|2
1284115|NCT00366535|4191093|P1|Second Phase: 12 Weeks|Withdrawal by Subject|2
1284116|NCT00366535|4191092|P2|Second Phase: 12 Weeks|Adverse Event|1
1284117|NCT00366535|4191093|P1|Second Phase: 12 Weeks|Adverse Event|1
1284118|NCT00366535|4191092|P2|First Phase: 12 Weeks|Withdrawal by Subject|5
1284119|NCT00366535|4191093|P1|First Phase: 12 Weeks|Withdrawal by Subject|2
1284120|NCT00366535|4191092|P2|First Phase: 12 Weeks|Adverse Event|3
1284121|NCT00366535|4191093|P1|First Phase: 12 Weeks|Adverse Event|1
1284122|NCT00366457|4191107|P1|Overall Study|never began study therapy|2
1284123|NCT00366444|4191116|P2|Overall Study|Lack of Efficacy|1
1284124|NCT00366444|4191117|P1|Overall Study|Lack of Efficacy|0
1284125|NCT00366444|4191116|P2|Overall Study|Withdrawal by Subject|1
1284126|NCT00366444|4191117|P1|Overall Study|Withdrawal by Subject|1
1284127|NCT00366340|4191145|P2|Toddler Dose|Parent/legal guardian request|1
1284128|NCT00366340|4191146|P1|Toddler Dose|Parent/legal guardian request|0
1284129|NCT00366340|4191145|P2|Toddler Dose|Failed to return|0
1284130|NCT00366340|4191146|P1|Toddler Dose|Failed to return|1
1284131|NCT00366340|4191145|P2|After the Infant Series|Lost to Follow-up|1
1284132|NCT00366340|4191146|P1|After the Infant Series|Lost to Follow-up|0
1284133|NCT00366340|4191145|P2|After the Infant Series|Adverse Event|1
1284134|NCT00366340|4191146|P1|After the Infant Series|Adverse Event|0
1284135|NCT00366340|4191145|P2|After the Infant Series|Protocol Violation|2
1284136|NCT00366340|4191146|P1|After the Infant Series|Protocol Violation|2
1284137|NCT00366340|4191145|P2|After the Infant Series|Failed to return|1
1284138|NCT00366340|4191146|P1|After the Infant Series|Failed to return|0
1284139|NCT00366340|4191145|P2|After the Infant Series|Parent/legal guardian request|1
1284140|NCT00366340|4191146|P1|After the Infant Series|Parent/legal guardian request|1
1284141|NCT00366340|4191145|P2|Infant Series|Failure to return|0
1284142|NCT00366340|4191146|P1|Infant Series|Failure to return|1
1284143|NCT00366340|4191145|P2|Infant Series|Lost to Follow-up|1
1284144|NCT00366340|4191146|P1|Infant Series|Lost to Follow-up|1
1284145|NCT00366340|4191145|P2|Infant Series|Adverse Event|2
1284146|NCT00366340|4191146|P1|Infant Series|Adverse Event|0
1284147|NCT00366340|4191145|P2|Infant Series|Withdrawal by Subject|3
1284148|NCT00366340|4191146|P1|Infant Series|Withdrawal by Subject|3
1284149|NCT00366340|4191145|P2|Infant Series|Protocol Violation|4
1284150|NCT00366340|4191146|P1|Infant Series|Protocol Violation|3
1284151|NCT00366301|4191204|P4|Overall Study|Withdrawal by Subject|1
1284152|NCT00366301|4191205|P3|Overall Study|Withdrawal by Subject|1
1284153|NCT00366301|4191206|P2|Overall Study|Withdrawal by Subject|2
1284154|NCT00366301|4191207|P1|Overall Study|Withdrawal by Subject|4
1284155|NCT00366301|4191204|P4|Overall Study|Lost to Follow-up|7
1284156|NCT00366301|4191205|P3|Overall Study|Lost to Follow-up|3
1284157|NCT00366301|4191206|P2|Overall Study|Lost to Follow-up|4
1284158|NCT00366301|4191207|P1|Overall Study|Lost to Follow-up|4
1284159|NCT00366249|4191223|P2|Overall Study|Most due to osteomylitis status|20
1284160|NCT00366249|4191224|P1|Overall Study|Most due to osteomylitis status|31
1284161|NCT00366249|4191223|P2|Overall Study|Lack of Efficacy|21
1284162|NCT00366249|4191224|P1|Overall Study|Lack of Efficacy|21
1284163|NCT00366249|4191223|P2|Overall Study|Withdrawal by Subject|4
1284164|NCT00366249|4191224|P1|Overall Study|Withdrawal by Subject|18
1284165|NCT00366249|4191223|P2|Overall Study|Protocol Violation|2
1284166|NCT00366249|4191224|P1|Overall Study|Protocol Violation|1
1284167|NCT00366249|4191223|P2|Overall Study|Lost to Follow-up|0
1284168|NCT00366249|4191224|P1|Overall Study|Lost to Follow-up|2
1284169|NCT00366249|4191223|P2|Overall Study|Physician Decision|2
1284170|NCT00366249|4191224|P1|Overall Study|Physician Decision|5
1284171|NCT00366249|4191223|P2|Overall Study|Death|1
1284172|NCT00366249|4191224|P1|Overall Study|Death|0
1284173|NCT00366249|4191223|P2|Overall Study|Adverse Event|28
1284174|NCT00366249|4191224|P1|Overall Study|Adverse Event|53
1284175|NCT00365976|4191258|P2|Overall Study|Withdrawal by Subject|5
1284176|NCT00365976|4191259|P1|Overall Study|Withdrawal by Subject|1
1284177|NCT00365846|4191397|P1|Overall Study|Lost to Follow-up|1
1284178|NCT00365716|4191422|P7|Extension 2|Withdrawal by Subject|5
1284179|NCT00365716|4191423|P6|Extension 2|Withdrawal by Subject|0
1284180|NCT00365716|4191424|P5|Extension 2|Withdrawal by Subject|0
1284181|NCT00365716|4191425|P4|Extension 2|Withdrawal by Subject|0
1284182|NCT00365716|4191426|P3|Extension 2|Withdrawal by Subject|0
1284183|NCT00365716|4191427|P2|Extension 2|Withdrawal by Subject|0
1284184|NCT00365716|4191428|P1|Extension 2|Withdrawal by Subject|0
1284185|NCT00365716|4191422|P7|Extension 2|Other|3
1284186|NCT00365716|4191423|P6|Extension 2|Other|0
1284187|NCT00365716|4191424|P5|Extension 2|Other|0
1284188|NCT00365716|4191425|P4|Extension 2|Other|0
1284189|NCT00365716|4191426|P3|Extension 2|Other|0
1284190|NCT00365716|4191427|P2|Extension 2|Other|0
1284191|NCT00365716|4191428|P1|Extension 2|Other|0
1284192|NCT00365716|4191422|P7|Extension 2|Lost to Follow-up|2
1284193|NCT00365716|4191423|P6|Extension 2|Lost to Follow-up|0
1284194|NCT00365716|4191424|P5|Extension 2|Lost to Follow-up|0
1284195|NCT00365716|4191425|P4|Extension 2|Lost to Follow-up|0
1284196|NCT00365716|4191426|P3|Extension 2|Lost to Follow-up|0
1284197|NCT00365716|4191427|P2|Extension 2|Lost to Follow-up|0
1284198|NCT00365716|4191428|P1|Extension 2|Lost to Follow-up|0
1284199|NCT00365716|4191422|P7|Extension 1|Protocol Violation|0
1284200|NCT00365716|4191423|P6|Extension 1|Protocol Violation|1
1284201|NCT00365716|4191424|P5|Extension 1|Protocol Violation|0
1284202|NCT00365716|4191425|P4|Extension 1|Protocol Violation|0
1284203|NCT00365716|4191426|P3|Extension 1|Protocol Violation|0
1284204|NCT00365716|4191427|P2|Extension 1|Protocol Violation|0
1284205|NCT00365716|4191428|P1|Extension 1|Protocol Violation|0
1284206|NCT00365716|4191422|P7|Extension 1|Pregnancy|0
1284207|NCT00365716|4191423|P6|Extension 1|Pregnancy|4
1284208|NCT00365716|4191424|P5|Extension 1|Pregnancy|0
1284209|NCT00365716|4191425|P4|Extension 1|Pregnancy|0
1284210|NCT00365716|4191426|P3|Extension 1|Pregnancy|0
1284211|NCT00365716|4191427|P2|Extension 1|Pregnancy|0
1284212|NCT00365716|4191428|P1|Extension 1|Pregnancy|0
1284213|NCT00365716|4191422|P7|Extension 1|Withdrawal by Subject|0
1284214|NCT00365716|4191423|P6|Extension 1|Withdrawal by Subject|3
1284215|NCT00365716|4191424|P5|Extension 1|Withdrawal by Subject|0
1284216|NCT00365716|4191425|P4|Extension 1|Withdrawal by Subject|0
1284217|NCT00365716|4191426|P3|Extension 1|Withdrawal by Subject|0
1284218|NCT00365716|4191427|P2|Extension 1|Withdrawal by Subject|0
1284219|NCT00365716|4191428|P1|Extension 1|Withdrawal by Subject|0
1284220|NCT00365716|4191422|P7|Extension 1|Moved|0
1284221|NCT00365716|4191423|P6|Extension 1|Moved|4
1284222|NCT00365716|4191424|P5|Extension 1|Moved|0
1284223|NCT00365716|4191425|P4|Extension 1|Moved|0
1284224|NCT00365716|4191426|P3|Extension 1|Moved|0
1284225|NCT00365716|4191427|P2|Extension 1|Moved|0
1284226|NCT00365716|4191428|P1|Extension 1|Moved|0
1284227|NCT00365716|4191422|P7|Extension 1|Other|0
1284228|NCT00365716|4191423|P6|Extension 1|Other|9
1284229|NCT00365716|4191424|P5|Extension 1|Other|0
1284230|NCT00365716|4191425|P4|Extension 1|Other|0
1284231|NCT00365716|4191426|P3|Extension 1|Other|0
1284232|NCT00365716|4191427|P2|Extension 1|Other|0
1284233|NCT00365716|4191428|P1|Extension 1|Other|0
1284234|NCT00365716|4191422|P7|Extension 1|Lost to Follow-up|0
1284235|NCT00365716|4191423|P6|Extension 1|Lost to Follow-up|1
1284236|NCT00365716|4191424|P5|Extension 1|Lost to Follow-up|0
1284237|NCT00365716|4191425|P4|Extension 1|Lost to Follow-up|0
1284238|NCT00365716|4191426|P3|Extension 1|Lost to Follow-up|0
1284239|NCT00365716|4191427|P2|Extension 1|Lost to Follow-up|0
1284240|NCT00365716|4191428|P1|Extension 1|Lost to Follow-up|0
1284241|NCT00365716|4191422|P7|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
1284242|NCT00365716|4191423|P6|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
1284243|NCT00365716|4191424|P5|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3
1284244|NCT00365716|4191425|P4|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
1284245|NCT00365716|4191426|P3|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13
1284246|NCT00365716|4191427|P2|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
1284247|NCT00365716|4191428|P1|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7
1284248|NCT00365716|4191422|P7|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
1284249|NCT00365716|4191423|P6|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
1284250|NCT00365716|4191424|P5|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
1284251|NCT00365716|4191425|P4|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
1284252|NCT00365716|4191426|P3|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
1284253|NCT00365716|4191427|P2|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
1284254|NCT00365716|4191428|P1|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
1284255|NCT00365716|4191422|P7|Long Term Follow-up (Month 7 toMonth 36)|Other|0
1284256|NCT00365716|4191423|P6|Long Term Follow-up (Month 7 toMonth 36)|Other|0
1284257|NCT00365716|4191424|P5|Long Term Follow-up (Month 7 toMonth 36)|Other|1
1284258|NCT00365716|4191425|P4|Long Term Follow-up (Month 7 toMonth 36)|Other|0
1284259|NCT00365716|4191426|P3|Long Term Follow-up (Month 7 toMonth 36)|Other|0
1284260|NCT00365716|4191427|P2|Long Term Follow-up (Month 7 toMonth 36)|Other|0
1284261|NCT00365716|4191428|P1|Long Term Follow-up (Month 7 toMonth 36)|Other|2
1284262|NCT00365716|4191422|P7|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
1284263|NCT00365716|4191423|P6|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
1284264|NCT00365716|4191424|P5|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
1284265|NCT00365716|4191425|P4|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
1284266|NCT00365716|4191426|P3|Long Term Follow-up (Month 7 toMonth 36)|Moved|1
1284267|NCT00365716|4191427|P2|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
1284268|NCT00365716|4191428|P1|Long Term Follow-up (Month 7 toMonth 36)|Moved|3
1284269|NCT00365716|4191422|P7|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
1284270|NCT00365716|4191423|P6|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
1284271|NCT00365716|4191424|P5|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3
1284272|NCT00365716|4191425|P4|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4
1284273|NCT00365716|4191426|P3|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5
1284274|NCT00365716|4191427|P2|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8
1284275|NCT00365716|4191428|P1|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6
1284276|NCT00365716|4191422|P7|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
1284277|NCT00365716|4191423|P6|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
1284278|NCT00365716|4191424|P5|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75
1284279|NCT00365716|4191425|P4|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69
1284280|NCT00365716|4191426|P3|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
1284281|NCT00365716|4191427|P2|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
1284282|NCT00365716|4191428|P1|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114
1284283|NCT00365716|4191422|P7|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
1284284|NCT00365716|4191423|P6|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
1284285|NCT00365716|4191424|P5|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3
1284286|NCT00365716|4191425|P4|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4
1284287|NCT00365716|4191426|P3|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
1284288|NCT00365716|4191427|P2|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9
1284289|NCT00365716|4191428|P1|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
1284290|NCT00365716|4191422|P7|Base Study (Day 1 to Month 7)|Protocol Violation|0
1284291|NCT00365716|4191423|P6|Base Study (Day 1 to Month 7)|Protocol Violation|0
1284292|NCT00365716|4191424|P5|Base Study (Day 1 to Month 7)|Protocol Violation|2
1284293|NCT00365716|4191425|P4|Base Study (Day 1 to Month 7)|Protocol Violation|1
1284294|NCT00365716|4191426|P3|Base Study (Day 1 to Month 7)|Protocol Violation|0
1284295|NCT00365716|4191427|P2|Base Study (Day 1 to Month 7)|Protocol Violation|2
1284296|NCT00365716|4191428|P1|Base Study (Day 1 to Month 7)|Protocol Violation|1
1284297|NCT00365716|4191422|P7|Base Study (Day 1 to Month 7)|Pregnancy|0
1284298|NCT00365716|4191423|P6|Base Study (Day 1 to Month 7)|Pregnancy|0
1284299|NCT00365716|4191424|P5|Base Study (Day 1 to Month 7)|Pregnancy|1
1284300|NCT00365716|4191425|P4|Base Study (Day 1 to Month 7)|Pregnancy|1
1284301|NCT00365716|4191426|P3|Base Study (Day 1 to Month 7)|Pregnancy|3
1284302|NCT00365716|4191427|P2|Base Study (Day 1 to Month 7)|Pregnancy|2
1284303|NCT00365716|4191428|P1|Base Study (Day 1 to Month 7)|Pregnancy|3
1284304|NCT00365716|4191422|P7|Base Study (Day 1 to Month 7)|Other|0
1284305|NCT00365716|4191423|P6|Base Study (Day 1 to Month 7)|Other|0
1284306|NCT00365716|4191424|P5|Base Study (Day 1 to Month 7)|Other|0
1284307|NCT00365716|4191425|P4|Base Study (Day 1 to Month 7)|Other|0
1284308|NCT00365716|4191426|P3|Base Study (Day 1 to Month 7)|Other|0
1284309|NCT00365716|4191427|P2|Base Study (Day 1 to Month 7)|Other|1
1284310|NCT00365716|4191428|P1|Base Study (Day 1 to Month 7)|Other|0
1284311|NCT00365716|4191422|P7|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
1284312|NCT00365716|4191423|P6|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
1284313|NCT00365716|4191424|P5|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
1284314|NCT00365716|4191425|P4|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
1284315|NCT00365716|4191426|P3|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
1284316|NCT00365716|4191427|P2|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
1284317|NCT00365716|4191428|P1|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
1284318|NCT00365716|4191422|P7|Base Study (Day 1 to Month 7)|Adverse Event|0
1284319|NCT00365716|4191423|P6|Base Study (Day 1 to Month 7)|Adverse Event|0
1284320|NCT00365716|4191424|P5|Base Study (Day 1 to Month 7)|Adverse Event|1
1284321|NCT00365716|4191425|P4|Base Study (Day 1 to Month 7)|Adverse Event|0
1284322|NCT00365716|4191426|P3|Base Study (Day 1 to Month 7)|Adverse Event|0
1284323|NCT00365716|4191427|P2|Base Study (Day 1 to Month 7)|Adverse Event|2
1284324|NCT00365716|4191428|P1|Base Study (Day 1 to Month 7)|Adverse Event|0
1284325|NCT00365716|4191422|P7|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
1284326|NCT00365716|4191423|P6|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
1284327|NCT00365716|4191424|P5|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
1284328|NCT00365716|4191425|P4|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
1284329|NCT00365716|4191426|P3|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
1284330|NCT00365716|4191427|P2|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2
1284331|NCT00365716|4191428|P1|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1
1284332|NCT00365547|4191449|P1|Overall Study|Withdrawal by Subject|1
1284333|NCT00365547|4191449|P1|Overall Study|Screen failure|1
1284334|NCT00365547|4191449|P1|Overall Study|Insurance did not cover Avastin|1
1284335|NCT00365508|4191459|P2|Overall Study|Lost to Follow-up|154
1284336|NCT00365508|4191460|P1|Overall Study|Lost to Follow-up|139
1284337|NCT00365456|4191468|P2|Trial Period III (12 Months)|Other|1
1284338|NCT00365456|4191469|P1|Trial Period III (12 Months)|Other|1
1284339|NCT00365456|4191468|P2|Trial Period III (12 Months)|Withdrawal by Subject|1
1284340|NCT00365456|4191469|P1|Trial Period III (12 Months)|Withdrawal by Subject|4
1284341|NCT00365456|4191468|P2|Trial Period III (12 Months)|Adverse Event|3
1284342|NCT00365456|4191469|P1|Trial Period III (12 Months)|Adverse Event|13
1284343|NCT00365456|4191468|P2|Trial Period II (12 Months)|Other|1
1284344|NCT00365456|4191469|P1|Trial Period II (12 Months)|Other|0
1284345|NCT00365456|4191468|P2|Trial Period II (12 Months)|Withdrawal by Subject|5
1284346|NCT00365456|4191469|P1|Trial Period II (12 Months)|Withdrawal by Subject|0
1284347|NCT00365456|4191468|P2|Trial Period II (12 Months)|Non-compliance|2
1284348|NCT00365456|4191469|P1|Trial Period II (12 Months)|Non-compliance|0
1284349|NCT00365456|4191468|P2|Trial Period II (12 Months)|Adverse Event|6
1284350|NCT00365456|4191469|P1|Trial Period II (12 Months)|Adverse Event|0
1284351|NCT00365456|4191468|P2|Trial Period I (12 Months)|Other|0
1284352|NCT00365456|4191469|P1|Trial Period I (12 Months)|Other|11
1284353|NCT00365456|4191468|P2|Trial Period I (12 Months)|Withdrawal by Subject|0
1284354|NCT00365456|4191469|P1|Trial Period I (12 Months)|Withdrawal by Subject|27
1284355|NCT00365456|4191468|P2|Trial Period I (12 Months)|Non-compliance|0
1284356|NCT00365456|4191469|P1|Trial Period I (12 Months)|Non-compliance|3
1284357|NCT00365456|4191468|P2|Trial Period I (12 Months)|Adverse Event|0
1284358|NCT00365456|4191469|P1|Trial Period I (12 Months)|Adverse Event|84
1284359|NCT00365378|4191491|P3|Extension|Other|31
1284360|NCT00365378|4191492|P2|Extension|Other|0
1284361|NCT00365378|4191493|P1|Extension|Other|0
1284362|NCT00365378|4191491|P3|Extension|Withdrawal by Subject|98
1284363|NCT00365378|4191492|P2|Extension|Withdrawal by Subject|0
1284364|NCT00365378|4191493|P1|Extension|Withdrawal by Subject|0
1284365|NCT00365378|4191491|P3|Extension|Protocol Violation|2
1284366|NCT00365378|4191492|P2|Extension|Protocol Violation|0
1284367|NCT00365378|4191493|P1|Extension|Protocol Violation|0
1284368|NCT00365378|4191491|P3|Extension|Lost to Follow-up|57
1284369|NCT00365378|4191492|P2|Extension|Lost to Follow-up|0
1284370|NCT00365378|4191493|P1|Extension|Lost to Follow-up|0
1284371|NCT00365378|4191491|P3|Extension|Moved|8
1284372|NCT00365378|4191492|P2|Extension|Moved|0
1284373|NCT00365378|4191493|P1|Extension|Moved|0
1284374|NCT00365378|4191491|P3|Extension|Adverse Event|1
1284375|NCT00365378|4191492|P2|Extension|Adverse Event|0
1284376|NCT00365378|4191493|P1|Extension|Adverse Event|0
1284377|NCT00365378|4191491|P3|Follow-up (Month 7 Though Month 48)|Other|0
1284378|NCT00365378|4191492|P2|Follow-up (Month 7 Though Month 48)|Other|21
1284379|NCT00365378|4191493|P1|Follow-up (Month 7 Though Month 48)|Other|11
1284380|NCT00365378|4191491|P3|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0
1284381|NCT00365378|4191492|P2|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104
1284382|NCT00365378|4191493|P1|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73
1284383|NCT00365378|4191491|P3|Follow-up (Month 7 Though Month 48)|Protocol Violation|0
1284384|NCT00365378|4191492|P2|Follow-up (Month 7 Though Month 48)|Protocol Violation|2
1284385|NCT00365378|4191493|P1|Follow-up (Month 7 Though Month 48)|Protocol Violation|1
1284386|NCT00365378|4191491|P3|Follow-up (Month 7 Though Month 48)|Pregnancy|0
1284387|NCT00365378|4191492|P2|Follow-up (Month 7 Though Month 48)|Pregnancy|1
1284388|NCT00365378|4191493|P1|Follow-up (Month 7 Though Month 48)|Pregnancy|0
1284389|NCT00365378|4191491|P3|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0
1284390|NCT00365378|4191492|P2|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69
1284391|NCT00365378|4191493|P1|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67
1284392|NCT00365378|4191491|P3|Follow-up (Month 7 Though Month 48)|Moved|0
1284393|NCT00365378|4191492|P2|Follow-up (Month 7 Though Month 48)|Moved|5
1284394|NCT00365378|4191493|P1|Follow-up (Month 7 Though Month 48)|Moved|6
1284395|NCT00365378|4191491|P3|Vaccination (Day 1 to Month 7)|Other|0
1284396|NCT00365378|4191492|P2|Vaccination (Day 1 to Month 7)|Other|9
1284397|NCT00365378|4191493|P1|Vaccination (Day 1 to Month 7)|Other|17
1284398|NCT00365378|4191491|P3|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0
1284399|NCT00365378|4191492|P2|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44
1284400|NCT00365378|4191493|P1|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50
1284401|NCT00365378|4191491|P3|Vaccination (Day 1 to Month 7)|Protocol Violation|0
1284402|NCT00365378|4191492|P2|Vaccination (Day 1 to Month 7)|Protocol Violation|13
1284403|NCT00365378|4191493|P1|Vaccination (Day 1 to Month 7)|Protocol Violation|22
1284404|NCT00365378|4191491|P3|Vaccination (Day 1 to Month 7)|Pregnancy|0
1284405|NCT00365378|4191492|P2|Vaccination (Day 1 to Month 7)|Pregnancy|14
1284406|NCT00365378|4191493|P1|Vaccination (Day 1 to Month 7)|Pregnancy|19
1284407|NCT00365378|4191491|P3|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0
1284408|NCT00365378|4191492|P2|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75
1284409|NCT00365378|4191493|P1|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88
1284410|NCT00365378|4191491|P3|Vaccination (Day 1 to Month 7)|Adverse Event|0
1284411|NCT00365378|4191492|P2|Vaccination (Day 1 to Month 7)|Adverse Event|5
1284412|NCT00365378|4191493|P1|Vaccination (Day 1 to Month 7)|Adverse Event|4
1284413|NCT00365378|4191491|P3|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0
1284414|NCT00365378|4191492|P2|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7
1284415|NCT00365378|4191493|P1|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11
1284416|NCT00365365|4191507|P3|Overall Study|Patient/physician decision|1
1284417|NCT00365365|4191508|P2|Overall Study|Patient/physician decision|0
1284418|NCT00365365|4191509|P1|Overall Study|Patient/physician decision|0
1284419|NCT00365365|4191507|P3|Overall Study|Second malignancy|0
1284420|NCT00365365|4191508|P2|Overall Study|Second malignancy|1
1284421|NCT00365365|4191509|P1|Overall Study|Second malignancy|0
1284422|NCT00365365|4191507|P3|Overall Study|Withdrew consent|0
1284423|NCT00365365|4191508|P2|Overall Study|Withdrew consent|1
1284424|NCT00365365|4191509|P1|Overall Study|Withdrew consent|1
1284425|NCT00365365|4191507|P3|Overall Study|New cancer|0
1284426|NCT00365365|4191508|P2|Overall Study|New cancer|0
1284427|NCT00365365|4191509|P1|Overall Study|New cancer|1
1284428|NCT00365365|4191507|P3|Overall Study|Moved|0
1284429|NCT00365365|4191508|P2|Overall Study|Moved|0
1284430|NCT00365365|4191509|P1|Overall Study|Moved|2
1284431|NCT00365365|4191507|P3|Overall Study|Adverse Event|3
1284432|NCT00365365|4191508|P2|Overall Study|Adverse Event|6
1284433|NCT00365365|4191509|P1|Overall Study|Adverse Event|6
1284434|NCT00365365|4191507|P3|Overall Study|Disease progression/relapse|7
1284435|NCT00365365|4191508|P2|Overall Study|Disease progression/relapse|6
1284436|NCT00365365|4191509|P1|Overall Study|Disease progression/relapse|9
1284437|NCT00365365|4191507|P3|Overall Study|Subject's request|1
1284438|NCT00365365|4191508|P2|Overall Study|Subject's request|13
1284439|NCT00365365|4191509|P1|Overall Study|Subject's request|11
1284440|NCT00365365|4191507|P3|Overall Study|Death|0
1284441|NCT00365365|4191508|P2|Overall Study|Death|3
1284442|NCT00365365|4191509|P1|Overall Study|Death|1
1284443|NCT00365365|4191507|P3|Overall Study|Lost to Follow-up|3
1284444|NCT00365365|4191508|P2|Overall Study|Lost to Follow-up|3
1284445|NCT00365365|4191509|P1|Overall Study|Lost to Follow-up|3
1284446|NCT00365365|4191507|P3|Overall Study|Poor compliance to protocol|0
1284447|NCT00365365|4191508|P2|Overall Study|Poor compliance to protocol|1
1284448|NCT00365365|4191509|P1|Overall Study|Poor compliance to protocol|0
1284449|NCT00365365|4191507|P3|Overall Study|Randomized but not treated|0
1284450|NCT00365365|4191508|P2|Overall Study|Randomized but not treated|2
1284451|NCT00365365|4191509|P1|Overall Study|Randomized but not treated|0
1284452|NCT00365352|4191526|P3|Overall Study|Withdrawal of Participant by Sponsor|0
1284453|NCT00365352|4191527|P2|Overall Study|Withdrawal of Participant by Sponsor|0
1284454|NCT00365352|4191528|P1|Overall Study|Withdrawal of Participant by Sponsor|1
1284455|NCT00365352|4191526|P3|Overall Study|Lost to Follow-up|0
1284456|NCT00365352|4191527|P2|Overall Study|Lost to Follow-up|1
1284457|NCT00365352|4191528|P1|Overall Study|Lost to Follow-up|1
1284458|NCT00365352|4191526|P3|Overall Study|Non-Compliance (after Randomization)|1
1284459|NCT00365352|4191527|P2|Overall Study|Non-Compliance (after Randomization)|0
1284460|NCT00365352|4191528|P1|Overall Study|Non-Compliance (after Randomization)|1
1284461|NCT00365352|4191526|P3|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2
1284462|NCT00365352|4191527|P2|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
1284463|NCT00365352|4191528|P1|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
1284464|NCT00365352|4191526|P3|Overall Study|Lack of Efficacy|0
1284465|NCT00365352|4191527|P2|Overall Study|Lack of Efficacy|0
1284466|NCT00365352|4191528|P1|Overall Study|Lack of Efficacy|3
1284467|NCT00365352|4191526|P3|Overall Study|Participant Withdrew Consent|4
1284468|NCT00365352|4191527|P2|Overall Study|Participant Withdrew Consent|3
1284469|NCT00365352|4191528|P1|Overall Study|Participant Withdrew Consent|8
1284470|NCT00365352|4191526|P3|Overall Study|Adverse Event|8
1284471|NCT00365352|4191527|P2|Overall Study|Adverse Event|7
1284472|NCT00365352|4191528|P1|Overall Study|Adverse Event|6
1284473|NCT00365300|4191612|P2|Double-blind Phase|Lack of Efficacy|6
1284474|NCT00365300|4191613|P1|Double-blind Phase|Lack of Efficacy|6
1284475|NCT00365300|4191612|P2|Double-blind Phase|Protocol Violation|1
1284476|NCT00365300|4191613|P1|Double-blind Phase|Protocol Violation|3
1284477|NCT00365300|4191612|P2|Double-blind Phase|Withdrawal by Subject|1
1284478|NCT00365300|4191613|P1|Double-blind Phase|Withdrawal by Subject|0
1284479|NCT00365300|4191612|P2|Double-blind Phase|Noncompliance|1
1284480|NCT00365300|4191613|P1|Double-blind Phase|Noncompliance|1
1284481|NCT00365300|4191612|P2|Double-blind Phase|Failed to return|0
1284482|NCT00365300|4191613|P1|Double-blind Phase|Failed to return|1
1284483|NCT00365300|4191612|P2|Open-label Phase|Patient skipped open label phase|0
1284484|NCT00365300|4191613|P1|Open-label Phase|Patient skipped open label phase|1
1284485|NCT00365300|4191612|P2|Open-label Phase|Lack of Efficacy|0
1284486|NCT00365300|4191613|P1|Open-label Phase|Lack of Efficacy|1
1284487|NCT00365300|4191612|P2|Open-label Phase|Protocol Violation|0
1284488|NCT00365300|4191613|P1|Open-label Phase|Protocol Violation|1
1284489|NCT00365300|4191612|P2|Open-label Phase|Parent/Legal Guardian Request|0
1284490|NCT00365300|4191613|P1|Open-label Phase|Parent/Legal Guardian Request|4
1284491|NCT00365300|4191612|P2|Open-label Phase|Noncompliance|0
1284492|NCT00365300|4191613|P1|Open-label Phase|Noncompliance|9
1284493|NCT00365300|4191612|P2|Open-label Phase|Physician Decision|0
1284494|NCT00365300|4191613|P1|Open-label Phase|Physician Decision|1
1284495|NCT00365300|4191612|P2|Open-label Phase|Failed to Return|0
1284496|NCT00365300|4191613|P1|Open-label Phase|Failed to Return|1
1284497|NCT00365300|4191612|P2|Open-label Phase|Adverse Event|0
1284498|NCT00365300|4191613|P1|Open-label Phase|Adverse Event|4
1284499|NCT00365105|4191678|P2|Overall Study|Lost to Follow-up|0
1284500|NCT00365105|4191679|P1|Overall Study|Lost to Follow-up|1
1284501|NCT00365105|4191678|P2|Overall Study|Withdrawal by Subject|1
1284502|NCT00365105|4191679|P1|Overall Study|Withdrawal by Subject|1
1284503|NCT00365105|4191678|P2|Overall Study|Protocol Violation|3
1284504|NCT00365105|4191679|P1|Overall Study|Protocol Violation|4
1284505|NCT00364923|4191715|P1|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24
1284506|NCT00364923|4191715|P1|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4
1284507|NCT00364858|4191724|P2|Overall Study|Clinical baseline issue|1
1284508|NCT00364858|4191725|P1|Overall Study|Clinical baseline issue|0
1284509|NCT00364858|4191724|P2|Overall Study|Return to Q2 regimen|1
1284510|NCT00364858|4191725|P1|Overall Study|Return to Q2 regimen|0
1284511|NCT00364858|4191724|P2|Overall Study|Non-compliant|0
1284512|NCT00364858|4191725|P1|Overall Study|Non-compliant|1
1284513|NCT00364858|4191724|P2|Overall Study|Discontinuation at baseline|0
1284514|NCT00364858|4191725|P1|Overall Study|Discontinuation at baseline|1
1284515|NCT00364858|4191724|P2|Overall Study|Clinical failure|13
1284516|NCT00364858|4191725|P1|Overall Study|Clinical failure|2
1284517|NCT00364858|4191724|P2|Overall Study|Pregnancy|1
1284518|NCT00364858|4191725|P1|Overall Study|Pregnancy|1
1284519|NCT00364858|4191724|P2|Overall Study|Withdrawal by Subject|1
1284520|NCT00364858|4191725|P1|Overall Study|Withdrawal by Subject|1
1284521|NCT00364858|4191724|P2|Overall Study|Adverse Event|5
1284522|NCT00364858|4191725|P1|Overall Study|Adverse Event|1
1284523|NCT00364845|4191740|P2|Overall Study|Death|1
1284524|NCT00364845|4191741|P1|Overall Study|Death|0
1284525|NCT00364845|4191740|P2|Overall Study|Lost to Follow-up|1
1284526|NCT00364845|4191741|P1|Overall Study|Lost to Follow-up|0
1284527|NCT00364845|4191740|P2|Overall Study|Physician Decision|8
1284528|NCT00364845|4191741|P1|Overall Study|Physician Decision|8
1284529|NCT00364845|4191740|P2|Overall Study|Withdrawal by Subject|1
1284530|NCT00364845|4191741|P1|Overall Study|Withdrawal by Subject|2
1284531|NCT00364845|4191740|P2|Overall Study|Adverse Event|0
1284532|NCT00364845|4191741|P1|Overall Study|Adverse Event|1
1284533|NCT00364832|4191762|P12|Extension Year 2|Early Withdrawals|3
1284534|NCT00364832|4191763|P11|Extension Year 2|Early Withdrawals|5
1284535|NCT00364832|4191764|P10|Extension Year 2|Early Withdrawals|5
1284536|NCT00364832|4191765|P9|Extension Year 2|Early Withdrawals|0
1284537|NCT00364832|4191766|P8|Extension Year 2|Early Withdrawals|0
1284538|NCT00364832|4191767|P7|Extension Year 2|Early Withdrawals|0
1284539|NCT00364832|4191768|P6|Extension Year 2|Early Withdrawals|0
1284540|NCT00364832|4191769|P5|Extension Year 2|Early Withdrawals|0
1284541|NCT00364832|4191770|P4|Extension Year 2|Early Withdrawals|0
1284542|NCT00364832|4191771|P3|Extension Year 2|Early Withdrawals|0
1284543|NCT00364832|4191772|P2|Extension Year 2|Early Withdrawals|0
1284544|NCT00364832|4191773|P1|Extension Year 2|Early Withdrawals|0
1284545|NCT00364832|4191762|P12|Extension Year 1|Early Withdrawals|10
1284546|NCT00364832|4191763|P11|Extension Year 1|Early Withdrawals|2
1284547|NCT00364832|4191764|P10|Extension Year 1|Early Withdrawals|4
1284548|NCT00364832|4191765|P9|Extension Year 1|Early Withdrawals|0
1284549|NCT00364832|4191766|P8|Extension Year 1|Early Withdrawals|0
1284550|NCT00364832|4191767|P7|Extension Year 1|Early Withdrawals|0
1284551|NCT00364832|4191768|P6|Extension Year 1|Early Withdrawals|0
1284552|NCT00364832|4191769|P5|Extension Year 1|Early Withdrawals|0
1284553|NCT00364832|4191770|P4|Extension Year 1|Early Withdrawals|0
1284554|NCT00364832|4191771|P3|Extension Year 1|Early Withdrawals|0
1284555|NCT00364832|4191772|P2|Extension Year 1|Early Withdrawals|0
1284556|NCT00364832|4191773|P1|Extension Year 1|Early Withdrawals|0
1284557|NCT00364832|4191762|P12|Core Period|Early Withdrawals|0
1284558|NCT00364832|4191763|P11|Core Period|Early Withdrawals|0
1284559|NCT00364832|4191764|P10|Core Period|Early Withdrawals|0
1284560|NCT00364832|4191765|P9|Core Period|Early Withdrawals|0
1284561|NCT00364832|4191766|P8|Core Period|Early Withdrawals|1
1284562|NCT00364832|4191767|P7|Core Period|Early Withdrawals|4
1284563|NCT00364832|4191768|P6|Core Period|Early Withdrawals|0
1284564|NCT00364832|4191769|P5|Core Period|Early Withdrawals|0
1284565|NCT00364832|4191770|P4|Core Period|Early Withdrawals|1
1284566|NCT00364832|4191771|P3|Core Period|Early Withdrawals|1
1284567|NCT00364832|4191772|P2|Core Period|Early Withdrawals|2
1284568|NCT00364832|4191773|P1|Core Period|Early Withdrawals|2
1284569|NCT00364793|4191838|P4|Overall Study|Withdrawal by Subject|0
1284570|NCT00364793|4191839|P3|Overall Study|Withdrawal by Subject|0
1284571|NCT00364793|4191840|P2|Overall Study|Withdrawal by Subject|1
1284572|NCT00364793|4191841|P1|Overall Study|Withdrawal by Subject|0
1284573|NCT00364793|4191838|P4|Overall Study|No longer meets criteria|1
1284574|NCT00364793|4191839|P3|Overall Study|No longer meets criteria|0
1284575|NCT00364793|4191840|P2|Overall Study|No longer meets criteria|0
1284576|NCT00364793|4191841|P1|Overall Study|No longer meets criteria|0
1284577|NCT00364793|4191838|P4|Overall Study|Poor or non-compliance|1
1284578|NCT00364793|4191839|P3|Overall Study|Poor or non-compliance|0
1284579|NCT00364793|4191840|P2|Overall Study|Poor or non-compliance|1
1284580|NCT00364793|4191841|P1|Overall Study|Poor or non-compliance|1
1284581|NCT00364793|4191838|P4|Overall Study|Lost to Follow-up|0
1284582|NCT00364793|4191839|P3|Overall Study|Lost to Follow-up|2
1284583|NCT00364793|4191840|P2|Overall Study|Lost to Follow-up|0
1284584|NCT00364793|4191841|P1|Overall Study|Lost to Follow-up|1
1284585|NCT00364793|4191838|P4|Overall Study|Lack of Efficacy|1
1284586|NCT00364793|4191839|P3|Overall Study|Lack of Efficacy|1
1284587|NCT00364793|4191840|P2|Overall Study|Lack of Efficacy|3
1284588|NCT00364793|4191841|P1|Overall Study|Lack of Efficacy|3
1284589|NCT00364793|4191838|P4|Overall Study|Death|0
1284590|NCT00364793|4191839|P3|Overall Study|Death|1
1284591|NCT00364793|4191840|P2|Overall Study|Death|0
1284592|NCT00364793|4191841|P1|Overall Study|Death|1
1284593|NCT00364793|4191838|P4|Overall Study|Adverse Event|0
1284594|NCT00364793|4191839|P3|Overall Study|Adverse Event|0
1284595|NCT00364793|4191840|P2|Overall Study|Adverse Event|0
1284596|NCT00364793|4191841|P1|Overall Study|Adverse Event|2
1284597|NCT00364611|4191977|P2|Overall Study|Receiving Liver Ablation|1
1284598|NCT00364611|4191978|P1|Overall Study|Receiving Liver Ablation|0
1284599|NCT00364611|4191977|P2|Overall Study|Presumed CR on Study|1
1284600|NCT00364611|4191978|P1|Overall Study|Presumed CR on Study|0
1284601|NCT00364611|4191977|P2|Overall Study|Found Ineligible|0
1284602|NCT00364611|4191978|P1|Overall Study|Found Ineligible|1
1284603|NCT00364611|4191977|P2|Overall Study|Investigator decision|2
1284604|NCT00364611|4191978|P1|Overall Study|Investigator decision|2
1284605|NCT00364611|4191977|P2|Overall Study|Disease Progression|8
1284606|NCT00364611|4191978|P1|Overall Study|Disease Progression|38
1284607|NCT00364611|4191977|P2|Overall Study|Participant's Request|4
1284608|NCT00364611|4191978|P1|Overall Study|Participant's Request|3
1284609|NCT00364611|4191977|P2|Overall Study|Adverse Event|4
1284610|NCT00364611|4191978|P1|Overall Study|Adverse Event|7
1284611|NCT00364611|4191977|P2|Overall Study|Did not receive study medication|1
1284612|NCT00364611|4191978|P1|Overall Study|Did not receive study medication|0
1284613|NCT00364533|4192001|P5|Overall Study|Protocol Violation|0
1284614|NCT00364533|4192002|P4|Overall Study|Protocol Violation|0
1284615|NCT00364533|4192003|P3|Overall Study|Protocol Violation|0
1284616|NCT00364533|4192004|P2|Overall Study|Protocol Violation|1
1284617|NCT00364533|4192005|P1|Overall Study|Protocol Violation|1
1284618|NCT00364533|4192001|P5|Overall Study|Non-compliance|0
1284619|NCT00364533|4192002|P4|Overall Study|Non-compliance|0
1284620|NCT00364533|4192003|P3|Overall Study|Non-compliance|0
1284621|NCT00364533|4192004|P2|Overall Study|Non-compliance|0
1284622|NCT00364533|4192005|P1|Overall Study|Non-compliance|1
1284623|NCT00364533|4192001|P5|Overall Study|Variations in drug compliance|0
1284624|NCT00364533|4192002|P4|Overall Study|Variations in drug compliance|0
1284625|NCT00364533|4192003|P3|Overall Study|Variations in drug compliance|1
1284626|NCT00364533|4192004|P2|Overall Study|Variations in drug compliance|1
1284627|NCT00364533|4192005|P1|Overall Study|Variations in drug compliance|2
1284628|NCT00364533|4192001|P5|Overall Study|Subject discharged from hospital|1
1284629|NCT00364533|4192002|P4|Overall Study|Subject discharged from hospital|3
1284630|NCT00364533|4192003|P3|Overall Study|Subject discharged from hospital|2
1284631|NCT00364533|4192004|P2|Overall Study|Subject discharged from hospital|1
1284632|NCT00364533|4192005|P1|Overall Study|Subject discharged from hospital|4
1284633|NCT00364533|4192001|P5|Overall Study|Lack of Efficacy|42
1284634|NCT00364533|4192002|P4|Overall Study|Lack of Efficacy|17
1284635|NCT00364533|4192003|P3|Overall Study|Lack of Efficacy|21
1284636|NCT00364533|4192004|P2|Overall Study|Lack of Efficacy|22
1284637|NCT00364533|4192005|P1|Overall Study|Lack of Efficacy|22
1284638|NCT00364533|4192001|P5|Overall Study|Withdrawal by Subject|6
1284639|NCT00364533|4192002|P4|Overall Study|Withdrawal by Subject|6
1284640|NCT00364533|4192003|P3|Overall Study|Withdrawal by Subject|6
1284641|NCT00364533|4192004|P2|Overall Study|Withdrawal by Subject|8
1284642|NCT00364533|4192005|P1|Overall Study|Withdrawal by Subject|4
1284643|NCT00364533|4192001|P5|Overall Study|Adverse Event|2
1284644|NCT00364533|4192002|P4|Overall Study|Adverse Event|5
1284645|NCT00364533|4192003|P3|Overall Study|Adverse Event|15
1284646|NCT00364533|4192004|P2|Overall Study|Adverse Event|7
1284647|NCT00364533|4192005|P1|Overall Study|Adverse Event|8
1284648|NCT00364351|4192038|P2|Overall Study|Randomised treatment not started|3
1284649|NCT00364351|4192039|P1|Overall Study|Randomised treatment not started|0
1284650|NCT00364351|4192038|P2|Overall Study|Patient could not travel to site|1
1284651|NCT00364351|4192039|P1|Overall Study|Patient could not travel to site|0
1284652|NCT00364351|4192038|P2|Overall Study|Investigator error|2
1284653|NCT00364351|4192039|P1|Overall Study|Investigator error|0
1284654|NCT00364351|4192038|P2|Overall Study|Poor treatment compliance|3
1284655|NCT00364351|4192039|P1|Overall Study|Poor treatment compliance|0
1284656|NCT00364351|4192038|P2|Overall Study|Sponsor decision|0
1284657|NCT00364351|4192039|P1|Overall Study|Sponsor decision|1
1284658|NCT00364351|4192038|P2|Overall Study|Incorrect enrollment|1
1284659|NCT00364351|4192039|P1|Overall Study|Incorrect enrollment|1
1284660|NCT00364351|4192038|P2|Overall Study|Withdrawal by Subject|29
1284661|NCT00364351|4192039|P1|Overall Study|Withdrawal by Subject|30
1284662|NCT00364351|4192038|P2|Overall Study|Lost to Follow-up|1
1284663|NCT00364351|4192039|P1|Overall Study|Lost to Follow-up|1
1284664|NCT00364351|4192038|P2|Overall Study|Prohibited concomitant medication|2
1284665|NCT00364351|4192039|P1|Overall Study|Prohibited concomitant medication|0
1284666|NCT00364351|4192038|P2|Overall Study|Condition under investigation worsened|497
1284667|NCT00364351|4192039|P1|Overall Study|Condition under investigation worsened|469
1284668|NCT00364351|4192038|P2|Overall Study|Adverse Event|44
1284669|NCT00364351|4192039|P1|Overall Study|Adverse Event|90
1284670|NCT00364286|4192057|P1|Overall Study|Adverse Event|2
1284671|NCT00364286|4192057|P1|Overall Study|Withdrawal by Subject|1
1284672|NCT00364182|4192064|P3|Third Intervention|Lost to Follow-up|1
1284673|NCT00364182|4192065|P2|Third Intervention|Lost to Follow-up|0
1284674|NCT00364182|4192066|P1|Third Intervention|Lost to Follow-up|0
1284675|NCT00364182|4192064|P3|Third Intervention|non-compliance|0
1284676|NCT00364182|4192065|P2|Third Intervention|non-compliance|1
1284677|NCT00364182|4192066|P1|Third Intervention|non-compliance|0
1284678|NCT00364182|4192064|P3|Second Intervention|Adverse Event|1
1284679|NCT00364182|4192065|P2|Second Intervention|Adverse Event|0
1284680|NCT00364182|4192066|P1|Second Intervention|Adverse Event|0
1284681|NCT00364182|4192064|P3|Second Intervention|Protocol Violation|0
1284682|NCT00364182|4192065|P2|Second Intervention|Protocol Violation|1
1284683|NCT00364182|4192066|P1|Second Intervention|Protocol Violation|0
1284684|NCT00364182|4192064|P3|Second Intervention|non-compliance|1
1284685|NCT00364182|4192065|P2|Second Intervention|non-compliance|1
1284686|NCT00364182|4192066|P1|Second Intervention|non-compliance|0
1284687|NCT00364182|4192064|P3|First Intervention|Withdrawal by Subject|0
1284688|NCT00364182|4192065|P2|First Intervention|Withdrawal by Subject|0
1284689|NCT00364182|4192066|P1|First Intervention|Withdrawal by Subject|2
1284690|NCT00364182|4192064|P3|First Intervention|Secondary prophylaxis|0
1284691|NCT00364182|4192065|P2|First Intervention|Secondary prophylaxis|0
1284692|NCT00364182|4192066|P1|First Intervention|Secondary prophylaxis|1
1284693|NCT00364156|4192100|P2|Overall Study|Protocol Violation|1
1284694|NCT00364156|4192101|P1|Overall Study|Protocol Violation|6
1284695|NCT00364156|4192100|P2|Overall Study|Withdrawal by Subject|80
1284696|NCT00364156|4192101|P1|Overall Study|Withdrawal by Subject|73
1284697|NCT00364130|4192109|P2|Post Intervention Follow-up Period|Lost to Follow-up|11
1284698|NCT00364130|4192110|P1|Post Intervention Follow-up Period|Lost to Follow-up|5
1284699|NCT00364130|4192109|P2|Intervention Period|Withdrawal by Subject|5
1284700|NCT00364130|4192110|P1|Intervention Period|Withdrawal by Subject|4
1284701|NCT00364130|4192109|P2|Intervention Period|Pregnancy|0
1284702|NCT00364130|4192110|P1|Intervention Period|Pregnancy|1
1284703|NCT00364130|4192109|P2|Intervention Period|Lost to Follow-up|3
1284704|NCT00364130|4192110|P1|Intervention Period|Lost to Follow-up|4
1284705|NCT00364013|4192132|P2|Overall Study|Ongoing|13
1284706|NCT00364013|4192133|P1|Overall Study|Ongoing|20
1284707|NCT00364013|4192132|P2|Overall Study|Other|47
1284708|NCT00364013|4192133|P1|Overall Study|Other|41
1284709|NCT00364013|4192132|P2|Overall Study|Protocol-specified criteria|6
1284710|NCT00364013|4192133|P1|Overall Study|Protocol-specified criteria|6
1284711|NCT00364013|4192132|P2|Overall Study|Lost to Follow-up|3
1284712|NCT00364013|4192133|P1|Overall Study|Lost to Follow-up|10
1284713|NCT00364013|4192132|P2|Overall Study|Physician Decision|3
1284714|NCT00364013|4192133|P1|Overall Study|Physician Decision|3
1284715|NCT00364013|4192132|P2|Overall Study|Withdrawal by Subject|18
1284716|NCT00364013|4192133|P1|Overall Study|Withdrawal by Subject|13
1284717|NCT00364013|4192132|P2|Overall Study|Adverse Event|3
1284718|NCT00364013|4192133|P1|Overall Study|Adverse Event|4
1284719|NCT00364013|4192132|P2|Overall Study|Ineligibility determined|2
1284720|NCT00364013|4192133|P1|Overall Study|Ineligibility determined|4
1284721|NCT00363896|4192161|P2|Overall Study|Other|2
1284722|NCT00363896|4192162|P1|Overall Study|Other|1
1284723|NCT00363896|4192161|P2|Overall Study|Non-fulfilment of entry criteria|0
1284724|NCT00363896|4192162|P1|Overall Study|Non-fulfilment of entry criteria|1
1284725|NCT00363896|4192161|P2|Overall Study|Lost to Follow-up|0
1284726|NCT00363896|4192162|P1|Overall Study|Lost to Follow-up|3
1284727|NCT00363896|4192161|P2|Overall Study|Protocol Violation|1
1284728|NCT00363896|4192162|P1|Overall Study|Protocol Violation|6
1284729|NCT00363896|4192161|P2|Overall Study|Lack of Efficacy|8
1284730|NCT00363896|4192162|P1|Overall Study|Lack of Efficacy|12
1284731|NCT00363896|4192161|P2|Overall Study|COPD exacerbation|7
1284732|NCT00363896|4192162|P1|Overall Study|COPD exacerbation|13
1284733|NCT00363896|4192161|P2|Overall Study|Adverse Event|13
1284734|NCT00363896|4192162|P1|Overall Study|Adverse Event|24
1284735|NCT00363896|4192161|P2|Overall Study|Withdrawal by Subject|16
1284736|NCT00363896|4192162|P1|Overall Study|Withdrawal by Subject|29
1284737|NCT00363766|4192203|P2|Overall Study|Physician Decision|2
1284738|NCT00363766|4192204|P1|Overall Study|Physician Decision|1
1284739|NCT00363766|4192203|P2|Overall Study|Withdrawal by Subject|0
1284740|NCT00363766|4192204|P1|Overall Study|Withdrawal by Subject|2
1284741|NCT00363766|4192203|P2|Overall Study|Not Disease Related Death|4
1284742|NCT00363766|4192204|P1|Overall Study|Not Disease Related Death|3
1284743|NCT00363766|4192203|P2|Overall Study|Disease Related Death|3
1284744|NCT00363766|4192204|P1|Overall Study|Disease Related Death|1
1284745|NCT00363766|4192203|P2|Overall Study|Adverse Event|2
1284746|NCT00363766|4192204|P1|Overall Study|Adverse Event|10
1284747|NCT00363766|4192203|P2|Overall Study|Progressive Disease|9
1284748|NCT00363766|4192204|P1|Overall Study|Progressive Disease|15
1284749|NCT00363649|4192233|P2|Overall Study|Adverse Event|0
1284750|NCT00363649|4192234|P1|Overall Study|Adverse Event|6
1284751|NCT00363649|4192233|P2|Overall Study|Withdrawal by Subject|1
1284752|NCT00363649|4192234|P1|Overall Study|Withdrawal by Subject|1
1284753|NCT00363545|4192250|P2|Overall Study|Others|0
1284754|NCT00363545|4192251|P1|Overall Study|Others|1
1284755|NCT00363545|4192250|P2|Overall Study|Lost to follow-up (complete vaccination)|17
1284756|NCT00363545|4192251|P1|Overall Study|Lost to follow-up (complete vaccination)|14
1284757|NCT00363545|4192250|P2|Overall Study|Lost to follow-up (incompl. vaccination)|18
1284758|NCT00363545|4192251|P1|Overall Study|Lost to follow-up (incompl. vaccination)|14
1284759|NCT00363545|4192250|P2|Overall Study|Migrated/moved from study area|6
1284760|NCT00363545|4192251|P1|Overall Study|Migrated/moved from study area|3
1284761|NCT00363545|4192250|P2|Overall Study|Withdrawal by Subject|15
1284762|NCT00363545|4192251|P1|Overall Study|Withdrawal by Subject|12
1284763|NCT00363545|4192250|P2|Overall Study|Serious Adverse Event|1
1284764|NCT00363545|4192251|P1|Overall Study|Serious Adverse Event|0
1284765|NCT00363480|4192269|P1|Overall Study|Participant discontinued on its own|1
1284766|NCT00363480|4192269|P1|Overall Study|Non-compliance of subject|1
1284767|NCT00363480|4192269|P1|Overall Study|Withdrawal by Subject|5
1284768|NCT00363480|4192269|P1|Overall Study|Lost to Follow-up|5
1284769|NCT00363480|4192269|P1|Overall Study|Adverse Event|4
1284770|NCT00363480|4192269|P1|Overall Study|Criteria for treatment period not fulfil|1
1284771|NCT00363467|4192289|P1|Overall Study|Physician Decision|1
1284772|NCT00363415|4192299|P2|Overall Study|Protocol Violation|4
1284773|NCT00363415|4192300|P1|Overall Study|Protocol Violation|1
1284774|NCT00363415|4192299|P2|Overall Study|Lost to Follow-up|3
1284775|NCT00363415|4192300|P1|Overall Study|Lost to Follow-up|3
1284776|NCT00363415|4192299|P2|Overall Study|Withdrawal by Subject|15
1284777|NCT00363415|4192300|P1|Overall Study|Withdrawal by Subject|9
1284778|NCT00363415|4192299|P2|Overall Study|Entry Criteria Not Met|10
1284779|NCT00363415|4192300|P1|Overall Study|Entry Criteria Not Met|11
1284780|NCT00363415|4192299|P2|Overall Study|Physician Decision|35
1284781|NCT00363415|4192300|P1|Overall Study|Physician Decision|18
1284782|NCT00363415|4192299|P2|Overall Study|Adverse Event|15
1284783|NCT00363415|4192300|P1|Overall Study|Adverse Event|24
1284784|NCT00363415|4192299|P2|Overall Study|Death|29
1284785|NCT00363415|4192300|P1|Overall Study|Death|32
1284786|NCT00363415|4192299|P2|Overall Study|Sponsor Decision|31
1284787|NCT00363415|4192300|P1|Overall Study|Sponsor Decision|67
1284788|NCT00363415|4192299|P2|Overall Study|Progressive Disease|107
1284789|NCT00363415|4192300|P1|Overall Study|Progressive Disease|196
1284790|NCT00363311|4192318|P2|Overall Study|Participant Moved to Louisiana|1
1284791|NCT00363311|4192319|P1|Overall Study|Participant Moved to Louisiana|0
1284792|NCT00363311|4192318|P2|Overall Study|Withdrawn per Instructions of Monitor|1
1284793|NCT00363311|4192319|P1|Overall Study|Withdrawn per Instructions of Monitor|0
1284794|NCT00363311|4192318|P2|Overall Study|Participant Withdrew Waiting for Surgery|1
1284795|NCT00363311|4192319|P1|Overall Study|Participant Withdrew Waiting for Surgery|0
1284796|NCT00363311|4192318|P2|Overall Study|Participant Moved to Another Country|0
1284797|NCT00363311|4192319|P1|Overall Study|Participant Moved to Another Country|1
1284798|NCT00363311|4192318|P2|Overall Study|Participant Opted for Treatment|0
1284799|NCT00363311|4192319|P1|Overall Study|Participant Opted for Treatment|1
1284800|NCT00363311|4192318|P2|Overall Study|Prostate Volume/PSA Doubled|0
1284801|NCT00363311|4192319|P1|Overall Study|Prostate Volume/PSA Doubled|1
1284802|NCT00363311|4192318|P2|Overall Study|Participant Refused Biopsy|0
1284803|NCT00363311|4192319|P1|Overall Study|Participant Refused Biopsy|1
1284804|NCT00363311|4192318|P2|Overall Study|Non-Compliance|1
1284805|NCT00363311|4192319|P1|Overall Study|Non-Compliance|1
1284806|NCT00363311|4192318|P2|Overall Study|Disease Progression|26
1284807|NCT00363311|4192319|P1|Overall Study|Disease Progression|46
1284808|NCT00363311|4192318|P2|Overall Study|Sponsor Terminated Study|2
1284809|NCT00363311|4192319|P1|Overall Study|Sponsor Terminated Study|2
1284810|NCT00363311|4192318|P2|Overall Study|Physician Decision|1
1284811|NCT00363311|4192319|P1|Overall Study|Physician Decision|1
1284812|NCT00363311|4192318|P2|Overall Study|Withdrawal by Subject|6
1284813|NCT00363311|4192319|P1|Overall Study|Withdrawal by Subject|12
1284814|NCT00363311|4192318|P2|Overall Study|Protocol Violation|2
1284815|NCT00363311|4192319|P1|Overall Study|Protocol Violation|1
1284816|NCT00363311|4192318|P2|Overall Study|Lost to Follow-up|0
1284817|NCT00363311|4192319|P1|Overall Study|Lost to Follow-up|3
1284818|NCT00363311|4192318|P2|Overall Study|Adverse Event|4
1284819|NCT00363311|4192319|P1|Overall Study|Adverse Event|6
1284820|NCT00363298|4192385|P2|4-week Study Continuation Phase|Lack of Efficacy|0
1284821|NCT00363298|4192386|P1|4-week Study Continuation Phase|Lack of Efficacy|1
1284822|NCT00363298|4192385|P2|First Study Week|Lack of Efficacy|5
1284823|NCT00363298|4192386|P1|First Study Week|Lack of Efficacy|6
1284824|NCT00363246|4192394|P1|Overall Study|Eligibility changed due to Hospice move|5
1284825|NCT00363246|4192394|P1|Overall Study|Subject expressed security concerns|2
1284826|NCT00363246|4192394|P1|Overall Study|Stopped using wheelchair|11
1284827|NCT00363246|4192394|P1|Overall Study|Bad health|6
1284828|NCT00363246|4192394|P1|Overall Study|Lost to Follow-up|14
1284829|NCT00363246|4192394|P1|Overall Study|Withdrawal by Subject|19
1284830|NCT00363246|4192394|P1|Overall Study|Death|40
1284831|NCT00363142|4192412|P2|Overall Study|Withdrawal by Subject|1
1284832|NCT00363142|4192413|P1|Overall Study|Withdrawal by Subject|3
1284833|NCT00363142|4192412|P2|Overall Study|Non-compliance|1
1284834|NCT00363142|4192413|P1|Overall Study|Non-compliance|1
1284835|NCT00363142|4192412|P2|Overall Study|Lost to Follow-up|0
1284836|NCT00363142|4192413|P1|Overall Study|Lost to Follow-up|1
1284837|NCT00363142|4192412|P2|Overall Study|Lack of Efficacy|1
1284838|NCT00363142|4192413|P1|Overall Study|Lack of Efficacy|0
1284839|NCT00363142|4192412|P2|Overall Study|Adverse Event|0
1284840|NCT00363142|4192413|P1|Overall Study|Adverse Event|2
1284841|NCT00363129|4192442|P2|Overall Study|Other Reasons|3
1284842|NCT00363129|4192443|P1|Overall Study|Other Reasons|6
1284843|NCT00363129|4192442|P2|Overall Study|Death|1
1284844|NCT00363129|4192443|P1|Overall Study|Death|0
1284845|NCT00363129|4192442|P2|Overall Study|Other Medical Problems|4
1284846|NCT00363129|4192443|P1|Overall Study|Other Medical Problems|2
1284847|NCT00363129|4192442|P2|Overall Study|Alternate Treatment|4
1284848|NCT00363129|4192443|P1|Overall Study|Alternate Treatment|2
1284849|NCT00363129|4192442|P2|Overall Study|Adverse Event|3
1284850|NCT00363129|4192443|P1|Overall Study|Adverse Event|8
1284851|NCT00363129|4192442|P2|Overall Study|Withdrawal by Subject|18
1284852|NCT00363129|4192443|P1|Overall Study|Withdrawal by Subject|11
1284853|NCT00363051|4192486|P2|Overall Study|Death|2
1284854|NCT00363051|4192487|P1|Overall Study|Death|3
1284855|NCT00363051|4192486|P2|Overall Study|Protocol Violation|2
1284856|NCT00363051|4192487|P1|Overall Study|Protocol Violation|0
1284857|NCT00363051|4192486|P2|Overall Study|Lost to Follow-up|1
1284858|NCT00363051|4192487|P1|Overall Study|Lost to Follow-up|0
1284859|NCT00363051|4192486|P2|Overall Study|Withdrawal by Subject|3
1284860|NCT00363051|4192487|P1|Overall Study|Withdrawal by Subject|11
1284861|NCT00363051|4192486|P2|Overall Study|New Cancer Therapy|1
1284862|NCT00363051|4192487|P1|Overall Study|New Cancer Therapy|2
1284863|NCT00363051|4192486|P2|Overall Study|Adverse Event|12
1284864|NCT00363051|4192487|P1|Overall Study|Adverse Event|21
1284865|NCT00363051|4192486|P2|Overall Study|Adminstrative problems|1
1284866|NCT00363051|4192487|P1|Overall Study|Adminstrative problems|1
1284867|NCT00362648|4192536|P4|Overall Study|Withdrawal by Subject|6
1284868|NCT00362648|4192537|P3|Overall Study|Withdrawal by Subject|2
1284869|NCT00362648|4192538|P2|Overall Study|Withdrawal by Subject|42
1284870|NCT00362648|4192539|P1|Overall Study|Withdrawal by Subject|48
1284871|NCT00362648|4192536|P4|Overall Study|Protocol Violation|2
1284872|NCT00362648|4192537|P3|Overall Study|Protocol Violation|2
1284873|NCT00362648|4192538|P2|Overall Study|Protocol Violation|2
1284874|NCT00362648|4192539|P1|Overall Study|Protocol Violation|4
1284875|NCT00362648|4192536|P4|Overall Study|Lost to Follow-up|3
1284876|NCT00362648|4192537|P3|Overall Study|Lost to Follow-up|4
1284877|NCT00362648|4192538|P2|Overall Study|Lost to Follow-up|69
1284878|NCT00362648|4192539|P1|Overall Study|Lost to Follow-up|62
1284879|NCT00362648|4192536|P4|Overall Study|Adverse Event|0
1284880|NCT00362648|4192537|P3|Overall Study|Adverse Event|1
1284881|NCT00362648|4192538|P2|Overall Study|Adverse Event|21
1284882|NCT00362648|4192539|P1|Overall Study|Adverse Event|12
1284883|NCT00362609|4192557|P2|Overall Study|Protocol Violation|1
1284884|NCT00362609|4192558|P1|Overall Study|Protocol Violation|0
1284885|NCT00362609|4192557|P2|Overall Study|Withdrawal by Subject|1
1284886|NCT00362609|4192558|P1|Overall Study|Withdrawal by Subject|0
1284887|NCT00362414|4192639|P1|Overall Study|Adverse Event|1
1284888|NCT00362414|4192639|P1|Overall Study|Death|2
1284889|NCT00362375|4192668|P2|Overall Study|Lost to Follow-up|35
1284890|NCT00362375|4192669|P1|Overall Study|Lost to Follow-up|40
1284891|NCT00362336|4192686|P3|Overall Study|Withdrawal by Subject|1
1284892|NCT00362336|4192687|P2|Overall Study|Withdrawal by Subject|3
1284893|NCT00362336|4192688|P1|Overall Study|Withdrawal by Subject|3
1284894|NCT00362336|4192686|P3|Overall Study|Lost to Follow-up|0
1284895|NCT00362336|4192687|P2|Overall Study|Lost to Follow-up|4
1284896|NCT00362336|4192688|P1|Overall Study|Lost to Follow-up|6
1284897|NCT00362336|4192686|P3|Overall Study|Protocol Violation|1
1284898|NCT00362336|4192687|P2|Overall Study|Protocol Violation|0
1284899|NCT00362336|4192688|P1|Overall Study|Protocol Violation|0
1284900|NCT00362336|4192686|P3|Overall Study|Serious Adverse Event|1
1284901|NCT00362336|4192687|P2|Overall Study|Serious Adverse Event|0
1284902|NCT00362336|4192688|P1|Overall Study|Serious Adverse Event|1
1284903|NCT00362297|4192716|P2|Arm 1 (Initial Drug Assignment)|Lost to Follow-up|4
1284904|NCT00362297|4192717|P1|Arm 1 (Initial Drug Assignment)|Lost to Follow-up|0
1284905|NCT00362232|4192725|P2|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7
1284906|NCT00362232|4192726|P1|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8
1284907|NCT00362232|4192725|P2|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28
1284908|NCT00362232|4192726|P1|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27
1284909|NCT00362232|4192725|P2|Follow-up (30 (+ 5) Days)|Death|1
1284910|NCT00362232|4192726|P1|Follow-up (30 (+ 5) Days)|Death|1
1284911|NCT00362232|4192725|P2|Follow-up (30 (+ 5) Days)|Adverse Event|3
1284912|NCT00362232|4192726|P1|Follow-up (30 (+ 5) Days)|Adverse Event|2
1284913|NCT00362232|4192725|P2|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18
1284914|NCT00362232|4192726|P1|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10
1284915|NCT00362232|4192725|P2|Treatment (12 +/- 2 Days)|Technical Problems|0
1284916|NCT00362232|4192726|P1|Treatment (12 +/- 2 Days)|Technical Problems|1
1284917|NCT00362232|4192725|P2|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0
1284918|NCT00362232|4192726|P1|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9
1284919|NCT00362232|4192725|P2|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47
1284920|NCT00362232|4192726|P1|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49
1284921|NCT00362232|4192725|P2|Treatment (12 +/- 2 Days)|Protocol Violation|21
1284922|NCT00362232|4192726|P1|Treatment (12 +/- 2 Days)|Protocol Violation|22
1284923|NCT00362232|4192725|P2|Treatment (12 +/- 2 Days)|Physician Decision|5
1284924|NCT00362232|4192726|P1|Treatment (12 +/- 2 Days)|Physician Decision|2
1284925|NCT00362232|4192725|P2|Treatment (12 +/- 2 Days)|Lost to Follow-up|1
1284926|NCT00362232|4192726|P1|Treatment (12 +/- 2 Days)|Lost to Follow-up|3
1284927|NCT00362232|4192725|P2|Treatment (12 +/- 2 Days)|Death|3
1284928|NCT00362232|4192726|P1|Treatment (12 +/- 2 Days)|Death|1
1284929|NCT00362232|4192725|P2|Treatment (12 +/- 2 Days)|Adverse Event|56
1284930|NCT00362232|4192726|P1|Treatment (12 +/- 2 Days)|Adverse Event|62
1284931|NCT00362180|4192771|P9|Treated Period|Adverse Event|0
1284932|NCT00362180|4192772|P8|Treated Period|Adverse Event|1
1284933|NCT00362180|4192773|P7|Treated Period|Adverse Event|0
1284934|NCT00362180|4192774|P6|Treated Period|Adverse Event|1
1284935|NCT00362180|4192775|P5|Treated Period|Adverse Event|0
1284936|NCT00362180|4192776|P4|Treated Period|Adverse Event|0
1284937|NCT00362180|4192777|P3|Treated Period|Adverse Event|0
1284938|NCT00362180|4192778|P2|Treated Period|Adverse Event|0
1284939|NCT00362180|4192779|P1|Treated Period|Adverse Event|0
1284940|NCT00362180|4192771|P9|Treated Period|Withdrawal by Subject|0
1284941|NCT00362180|4192772|P8|Treated Period|Withdrawal by Subject|0
1284942|NCT00362180|4192773|P7|Treated Period|Withdrawal by Subject|0
1284943|NCT00362180|4192774|P6|Treated Period|Withdrawal by Subject|0
1284944|NCT00362180|4192775|P5|Treated Period|Withdrawal by Subject|0
1284945|NCT00362180|4192776|P4|Treated Period|Withdrawal by Subject|0
1284946|NCT00362180|4192777|P3|Treated Period|Withdrawal by Subject|0
1284947|NCT00362180|4192778|P2|Treated Period|Withdrawal by Subject|0
1284948|NCT00362180|4192779|P1|Treated Period|Withdrawal by Subject|1
1284949|NCT00362115|4192851|P7|Overall Study|Other|0
1284950|NCT00362115|4192852|P6|Overall Study|Other|1
1284951|NCT00362115|4192853|P5|Overall Study|Other|0
1284952|NCT00362115|4192854|P4|Overall Study|Other|1
1284953|NCT00362115|4192855|P3|Overall Study|Other|0
1284954|NCT00362115|4192856|P2|Overall Study|Other|1
1284955|NCT00362115|4192857|P1|Overall Study|Other|0
1284956|NCT00362115|4192851|P7|Overall Study|Physician Decision|3
1284957|NCT00362115|4192852|P6|Overall Study|Physician Decision|0
1284958|NCT00362115|4192853|P5|Overall Study|Physician Decision|0
1284959|NCT00362115|4192854|P4|Overall Study|Physician Decision|0
1284960|NCT00362115|4192855|P3|Overall Study|Physician Decision|0
1284961|NCT00362115|4192856|P2|Overall Study|Physician Decision|0
1284962|NCT00362115|4192857|P1|Overall Study|Physician Decision|0
1284963|NCT00362115|4192851|P7|Overall Study|Lack of Efficacy|3
1284964|NCT00362115|4192852|P6|Overall Study|Lack of Efficacy|0
1284965|NCT00362115|4192853|P5|Overall Study|Lack of Efficacy|2
1284966|NCT00362115|4192854|P4|Overall Study|Lack of Efficacy|2
1284967|NCT00362115|4192855|P3|Overall Study|Lack of Efficacy|5
1284968|NCT00362115|4192856|P2|Overall Study|Lack of Efficacy|0
1284969|NCT00362115|4192857|P1|Overall Study|Lack of Efficacy|1
1284970|NCT00362115|4192851|P7|Overall Study|Withdrawal by Subject|4
1284971|NCT00362115|4192852|P6|Overall Study|Withdrawal by Subject|3
1284972|NCT00362115|4192853|P5|Overall Study|Withdrawal by Subject|1
1284973|NCT00362115|4192854|P4|Overall Study|Withdrawal by Subject|0
1284974|NCT00362115|4192855|P3|Overall Study|Withdrawal by Subject|1
1284975|NCT00362115|4192856|P2|Overall Study|Withdrawal by Subject|3
1284976|NCT00362115|4192857|P1|Overall Study|Withdrawal by Subject|1
1284977|NCT00362115|4192851|P7|Overall Study|Lost to Follow-up|1
1284978|NCT00362115|4192852|P6|Overall Study|Lost to Follow-up|0
1284979|NCT00362115|4192853|P5|Overall Study|Lost to Follow-up|2
1284980|NCT00362115|4192854|P4|Overall Study|Lost to Follow-up|0
1284981|NCT00362115|4192855|P3|Overall Study|Lost to Follow-up|0
1284982|NCT00362115|4192856|P2|Overall Study|Lost to Follow-up|1
1284983|NCT00362115|4192857|P1|Overall Study|Lost to Follow-up|0
1284984|NCT00362115|4192851|P7|Overall Study|Protocol Violation|0
1284985|NCT00362115|4192852|P6|Overall Study|Protocol Violation|1
1284986|NCT00362115|4192853|P5|Overall Study|Protocol Violation|0
1284987|NCT00362115|4192854|P4|Overall Study|Protocol Violation|0
1284988|NCT00362115|4192855|P3|Overall Study|Protocol Violation|0
1284989|NCT00362115|4192856|P2|Overall Study|Protocol Violation|0
1284990|NCT00362115|4192857|P1|Overall Study|Protocol Violation|0
1284991|NCT00362115|4192851|P7|Overall Study|Adverse Event|1
1284992|NCT00362115|4192852|P6|Overall Study|Adverse Event|2
1284993|NCT00362115|4192853|P5|Overall Study|Adverse Event|2
1284994|NCT00362115|4192854|P4|Overall Study|Adverse Event|1
1284995|NCT00362115|4192855|P3|Overall Study|Adverse Event|1
1284996|NCT00362115|4192856|P2|Overall Study|Adverse Event|1
1284997|NCT00362115|4192857|P1|Overall Study|Adverse Event|0
1284998|NCT00361634|4193030|P1|Overall Study|Withdrawal by Subject|1
1284999|NCT00361634|4193030|P1|Overall Study|Lost to Follow-up|1
1285000|NCT00361569|4193059|P4|Overall Study|Not specified by investigator|1
1285001|NCT00361569|4193060|P3|Overall Study|Not specified by investigator|0
1285002|NCT00361569|4193061|P2|Overall Study|Not specified by investigator|0
1285003|NCT00361569|4193062|P1|Overall Study|Not specified by investigator|2
1285004|NCT00361569|4193059|P4|Overall Study|Lost to Follow-up|2
1285005|NCT00361569|4193060|P3|Overall Study|Lost to Follow-up|3
1285006|NCT00361569|4193061|P2|Overall Study|Lost to Follow-up|3
1285007|NCT00361569|4193062|P1|Overall Study|Lost to Follow-up|2
1285008|NCT00361569|4193059|P4|Overall Study|Adverse Event|2
1285009|NCT00361569|4193060|P3|Overall Study|Adverse Event|2
1285010|NCT00361569|4193061|P2|Overall Study|Adverse Event|5
1285011|NCT00361569|4193062|P1|Overall Study|Adverse Event|3
1285012|NCT00361569|4193059|P4|Overall Study|Withdrawal by Subject|14
1285013|NCT00361569|4193060|P3|Overall Study|Withdrawal by Subject|9
1285014|NCT00361569|4193061|P2|Overall Study|Withdrawal by Subject|1
1285015|NCT00361569|4193062|P1|Overall Study|Withdrawal by Subject|2
1285016|NCT00361569|4193059|P4|Overall Study|Protocol Violation|2
1285017|NCT00361569|4193060|P3|Overall Study|Protocol Violation|4
1285018|NCT00361569|4193061|P2|Overall Study|Protocol Violation|2
1285019|NCT00361569|4193062|P1|Overall Study|Protocol Violation|3
1285020|NCT00361504|4193086|P2|Overall Study|All other|3
1285021|NCT00361504|4193087|P1|Overall Study|All other|28
1285022|NCT00361504|4193086|P2|Overall Study|Study medication non compliant|15
1285023|NCT00361504|4193087|P1|Overall Study|Study medication non compliant|42
1285024|NCT00361504|4193086|P2|Overall Study|Resolution of Pain|0
1285025|NCT00361504|4193087|P1|Overall Study|Resolution of Pain|2
1285026|NCT00361504|4193086|P2|Overall Study|Lack of Efficacy|7
1285027|NCT00361504|4193087|P1|Overall Study|Lack of Efficacy|72
1285028|NCT00361504|4193086|P2|Overall Study|Adverse Event|82
1285029|NCT00361504|4193087|P1|Overall Study|Adverse Event|203
1285030|NCT00361504|4193086|P2|Overall Study|Lost to Follow-up|7
1285031|NCT00361504|4193087|P1|Overall Study|Lost to Follow-up|40
1285032|NCT00361504|4193086|P2|Overall Study|Withdrawal by Subject|31
1285033|NCT00361504|4193087|P1|Overall Study|Withdrawal by Subject|94
1285034|NCT00361335|4193128|P7|SC Period: Week E0 to Week E24|Lack of Efficacy|3
1285035|NCT00361335|4193129|P6|SC Period: Week E0 to Week E24|Lack of Efficacy|0
1285036|NCT00361335|4193130|P5|SC Period: Week E0 to Week E24|Lack of Efficacy|0
1285037|NCT00361335|4193131|P4|SC Period: Week E0 to Week E24|Lack of Efficacy|0
1285038|NCT00361335|4193132|P3|SC Period: Week E0 to Week E24|Lack of Efficacy|2
1285039|NCT00361335|4193133|P2|SC Period: Week E0 to Week E24|Lack of Efficacy|0
1285040|NCT00361335|4193134|P1|SC Period: Week E0 to Week E24|Lack of Efficacy|0
1285041|NCT00361335|4193128|P7|SC Period: Week E0 to Week E24|Not specified|2
1285042|NCT00361335|4193129|P6|SC Period: Week E0 to Week E24|Not specified|1
1285043|NCT00361335|4193130|P5|SC Period: Week E0 to Week E24|Not specified|0
1285044|NCT00361335|4193131|P4|SC Period: Week E0 to Week E24|Not specified|1
1285045|NCT00361335|4193132|P3|SC Period: Week E0 to Week E24|Not specified|0
1285046|NCT00361335|4193133|P2|SC Period: Week E0 to Week E24|Not specified|0
1285047|NCT00361335|4193134|P1|SC Period: Week E0 to Week E24|Not specified|1
1285048|NCT00361335|4193128|P7|SC Period: Week E0 to Week E24|Worsening of RA|0
1285049|NCT00361335|4193129|P6|SC Period: Week E0 to Week E24|Worsening of RA|0
1285050|NCT00361335|4193130|P5|SC Period: Week E0 to Week E24|Worsening of RA|0
1285051|NCT00361335|4193131|P4|SC Period: Week E0 to Week E24|Worsening of RA|1
1285052|NCT00361335|4193132|P3|SC Period: Week E0 to Week E24|Worsening of RA|1
1285053|NCT00361335|4193133|P2|SC Period: Week E0 to Week E24|Worsening of RA|1
1285054|NCT00361335|4193134|P1|SC Period: Week E0 to Week E24|Worsening of RA|0
1285055|NCT00361335|4193128|P7|SC Period: Week E0 to Week E24|Death|1
1285056|NCT00361335|4193129|P6|SC Period: Week E0 to Week E24|Death|0
1285057|NCT00361335|4193130|P5|SC Period: Week E0 to Week E24|Death|0
1285058|NCT00361335|4193131|P4|SC Period: Week E0 to Week E24|Death|0
1285059|NCT00361335|4193132|P3|SC Period: Week E0 to Week E24|Death|0
1285060|NCT00361335|4193133|P2|SC Period: Week E0 to Week E24|Death|0
1285061|NCT00361335|4193134|P1|SC Period: Week E0 to Week E24|Death|0
1285062|NCT00361335|4193128|P7|SC Period: Week E0 to Week E24|Lost to Follow-up|1
1285063|NCT00361335|4193129|P6|SC Period: Week E0 to Week E24|Lost to Follow-up|0
1285064|NCT00361335|4193130|P5|SC Period: Week E0 to Week E24|Lost to Follow-up|0
1285065|NCT00361335|4193131|P4|SC Period: Week E0 to Week E24|Lost to Follow-up|0
1285066|NCT00361335|4193132|P3|SC Period: Week E0 to Week E24|Lost to Follow-up|1
1285067|NCT00361335|4193133|P2|SC Period: Week E0 to Week E24|Lost to Follow-up|0
1285068|NCT00361335|4193134|P1|SC Period: Week E0 to Week E24|Lost to Follow-up|1
1285069|NCT00361335|4193128|P7|SC Period: Week E0 to Week E24|Adverse Event|2
1285070|NCT00361335|4193129|P6|SC Period: Week E0 to Week E24|Adverse Event|0
1285071|NCT00361335|4193130|P5|SC Period: Week E0 to Week E24|Adverse Event|0
1285072|NCT00361335|4193131|P4|SC Period: Week E0 to Week E24|Adverse Event|2
1285073|NCT00361335|4193132|P3|SC Period: Week E0 to Week E24|Adverse Event|1
1285074|NCT00361335|4193133|P2|SC Period: Week E0 to Week E24|Adverse Event|2
1285075|NCT00361335|4193134|P1|SC Period: Week E0 to Week E24|Adverse Event|0
1285076|NCT00361335|4193128|P7|IV Period: Baseline to E0|Lack of Efficacy|0
1285077|NCT00361335|4193129|P6|IV Period: Baseline to E0|Lack of Efficacy|0
1285078|NCT00361335|4193130|P5|IV Period: Baseline to E0|Lack of Efficacy|8
1285079|NCT00361335|4193131|P4|IV Period: Baseline to E0|Lack of Efficacy|7
1285080|NCT00361335|4193132|P3|IV Period: Baseline to E0|Lack of Efficacy|3
1285081|NCT00361335|4193133|P2|IV Period: Baseline to E0|Lack of Efficacy|9
1285082|NCT00361335|4193134|P1|IV Period: Baseline to E0|Lack of Efficacy|5
1285083|NCT00361335|4193128|P7|IV Period: Baseline to E0|Not specified|0
1285084|NCT00361335|4193129|P6|IV Period: Baseline to E0|Not specified|0
1285085|NCT00361335|4193130|P5|IV Period: Baseline to E0|Not specified|2
1285086|NCT00361335|4193131|P4|IV Period: Baseline to E0|Not specified|3
1285087|NCT00361335|4193132|P3|IV Period: Baseline to E0|Not specified|9
1285088|NCT00361335|4193133|P2|IV Period: Baseline to E0|Not specified|9
1285089|NCT00361335|4193134|P1|IV Period: Baseline to E0|Not specified|2
1285090|NCT00361335|4193128|P7|IV Period: Baseline to E0|Worsening of RA|0
1285091|NCT00361335|4193129|P6|IV Period: Baseline to E0|Worsening of RA|0
1285092|NCT00361335|4193130|P5|IV Period: Baseline to E0|Worsening of RA|2
1285093|NCT00361335|4193131|P4|IV Period: Baseline to E0|Worsening of RA|4
1285094|NCT00361335|4193132|P3|IV Period: Baseline to E0|Worsening of RA|1
1285095|NCT00361335|4193133|P2|IV Period: Baseline to E0|Worsening of RA|5
1285096|NCT00361335|4193134|P1|IV Period: Baseline to E0|Worsening of RA|0
1285097|NCT00361335|4193128|P7|IV Period: Baseline to E0|Protocol-prohibited medications|0
1285098|NCT00361335|4193129|P6|IV Period: Baseline to E0|Protocol-prohibited medications|0
1285099|NCT00361335|4193130|P5|IV Period: Baseline to E0|Protocol-prohibited medications|0
1285100|NCT00361335|4193131|P4|IV Period: Baseline to E0|Protocol-prohibited medications|0
1285101|NCT00361335|4193132|P3|IV Period: Baseline to E0|Protocol-prohibited medications|1
1285102|NCT00361335|4193133|P2|IV Period: Baseline to E0|Protocol-prohibited medications|0
1285103|NCT00361335|4193134|P1|IV Period: Baseline to E0|Protocol-prohibited medications|0
1285104|NCT00361335|4193128|P7|IV Period: Baseline to E0|Discontinued oral study agent|0
1285105|NCT00361335|4193129|P6|IV Period: Baseline to E0|Discontinued oral study agent|0
1285106|NCT00361335|4193130|P5|IV Period: Baseline to E0|Discontinued oral study agent|2
1285107|NCT00361335|4193131|P4|IV Period: Baseline to E0|Discontinued oral study agent|1
1285108|NCT00361335|4193132|P3|IV Period: Baseline to E0|Discontinued oral study agent|1
1285109|NCT00361335|4193133|P2|IV Period: Baseline to E0|Discontinued oral study agent|1
1285110|NCT00361335|4193134|P1|IV Period: Baseline to E0|Discontinued oral study agent|2
1285111|NCT00361335|4193128|P7|IV Period: Baseline to E0|Death|0
1285112|NCT00361335|4193129|P6|IV Period: Baseline to E0|Death|0
1285113|NCT00361335|4193130|P5|IV Period: Baseline to E0|Death|0
1285114|NCT00361335|4193131|P4|IV Period: Baseline to E0|Death|1
1285115|NCT00361335|4193132|P3|IV Period: Baseline to E0|Death|1
1285116|NCT00361335|4193133|P2|IV Period: Baseline to E0|Death|1
1285117|NCT00361335|4193134|P1|IV Period: Baseline to E0|Death|1
1285118|NCT00361335|4193128|P7|IV Period: Baseline to E0|Lost to Follow-up|0
1285119|NCT00361335|4193129|P6|IV Period: Baseline to E0|Lost to Follow-up|0
1285120|NCT00361335|4193130|P5|IV Period: Baseline to E0|Lost to Follow-up|2
1285121|NCT00361335|4193131|P4|IV Period: Baseline to E0|Lost to Follow-up|2
1285122|NCT00361335|4193132|P3|IV Period: Baseline to E0|Lost to Follow-up|0
1285123|NCT00361335|4193133|P2|IV Period: Baseline to E0|Lost to Follow-up|0
1285124|NCT00361335|4193134|P1|IV Period: Baseline to E0|Lost to Follow-up|1
1285125|NCT00361335|4193128|P7|IV Period: Baseline to E0|Adverse Event|0
1285126|NCT00361335|4193129|P6|IV Period: Baseline to E0|Adverse Event|0
1285127|NCT00361335|4193130|P5|IV Period: Baseline to E0|Adverse Event|8
1285128|NCT00361335|4193131|P4|IV Period: Baseline to E0|Adverse Event|9
1285129|NCT00361335|4193132|P3|IV Period: Baseline to E0|Adverse Event|5
1285130|NCT00361335|4193133|P2|IV Period: Baseline to E0|Adverse Event|4
1285131|NCT00361335|4193134|P1|IV Period: Baseline to E0|Adverse Event|9
1285132|NCT00361296|4193178|P1|Overall Study|Lack of Efficacy|2
1285133|NCT00361296|4193178|P1|Overall Study|Physician Decision|1
1285134|NCT00361283|4193185|P1|Overall Study|Lost to Follow-up|27
1285135|NCT00361270|4193193|P4|Overall Study|Adverse Event|0
1285136|NCT00361270|4193194|P3|Overall Study|Adverse Event|1
1285137|NCT00361270|4193195|P2|Overall Study|Adverse Event|1
1285138|NCT00361270|4193196|P1|Overall Study|Adverse Event|0
1285139|NCT00361270|4193193|P4|Overall Study|Problems with Transportation|0
1285140|NCT00361270|4193194|P3|Overall Study|Problems with Transportation|0
1285141|NCT00361270|4193195|P2|Overall Study|Problems with Transportation|0
1285142|NCT00361270|4193196|P1|Overall Study|Problems with Transportation|4
1285143|NCT00361270|4193193|P4|Overall Study|Afraid of Hypnosis|0
1285144|NCT00361270|4193194|P3|Overall Study|Afraid of Hypnosis|0
1285145|NCT00361270|4193195|P2|Overall Study|Afraid of Hypnosis|2
1285146|NCT00361270|4193196|P1|Overall Study|Afraid of Hypnosis|1
1285147|NCT00361270|4193193|P4|Overall Study|Withdrawal by Subject|7
1285148|NCT00361270|4193194|P3|Overall Study|Withdrawal by Subject|3
1285149|NCT00361270|4193195|P2|Overall Study|Withdrawal by Subject|6
1285150|NCT00361270|4193196|P1|Overall Study|Withdrawal by Subject|6
1285151|NCT00361270|4193193|P4|Overall Study|Protocol Violation|4
1285152|NCT00361270|4193194|P3|Overall Study|Protocol Violation|5
1285153|NCT00361270|4193195|P2|Overall Study|Protocol Violation|4
1285154|NCT00361270|4193196|P1|Overall Study|Protocol Violation|9
1285155|NCT00361270|4193193|P4|Overall Study|Physician Decision|0
1285156|NCT00361270|4193194|P3|Overall Study|Physician Decision|1
1285157|NCT00361270|4193195|P2|Overall Study|Physician Decision|0
1285158|NCT00361270|4193196|P1|Overall Study|Physician Decision|0
1285159|NCT00361270|4193193|P4|Overall Study|Lost to Follow-up|0
1285160|NCT00361270|4193194|P3|Overall Study|Lost to Follow-up|0
1285161|NCT00361270|4193195|P2|Overall Study|Lost to Follow-up|1
1285162|NCT00361270|4193196|P1|Overall Study|Lost to Follow-up|4
1285163|NCT00361270|4193193|P4|Overall Study|Death|2
1285164|NCT00361270|4193194|P3|Overall Study|Death|0
1285165|NCT00361270|4193195|P2|Overall Study|Death|0
1285166|NCT00361270|4193196|P1|Overall Study|Death|0
1285167|NCT00361231|4193269|P1|Overall Study|Adverse Event|6
1285168|NCT00361231|4193269|P1|Overall Study|Withdrawal by Subject|4
1285169|NCT00361231|4193269|P1|Overall Study|Radiographic disease progression|16
1285170|NCT00361231|4193269|P1|Overall Study|Symptomatic deterioration|5
1285171|NCT00361231|4193269|P1|Overall Study|Physician Decision|3
1285172|NCT00361218|4193274|P1|Overall Study|terminated / withdrawn due to toxicity /|5
1285173|NCT00361218|4193274|P1|Overall Study|Personal Reasons|7
1285174|NCT00361218|4193274|P1|Overall Study|Lost to Follow-up|11
1285175|NCT00360698|4193353|P2|Treatment Period|Early termination by error|1
1285176|NCT00360698|4193354|P1|Treatment Period|Early termination by error|0
1285177|NCT00360698|4193353|P2|Treatment Period|Non compliance with treatment procedure|0
1285178|NCT00360698|4193354|P1|Treatment Period|Non compliance with treatment procedure|1
1285179|NCT00360698|4193353|P2|Run-In|Need of insulin with meals|1
1285180|NCT00360698|4193354|P1|Run-In|Need of insulin with meals|0
1285181|NCT00360698|4193353|P2|Run-In|Patient personal reasons|2
1285182|NCT00360698|4193354|P1|Run-In|Patient personal reasons|0
1285183|NCT00360698|4193353|P2|Run-In|Patient did not meet inclusion criteria|1
1285184|NCT00360698|4193354|P1|Run-In|Patient did not meet inclusion criteria|0
1285185|NCT00360698|4193353|P2|Run-In|Sponsor request|2
1285186|NCT00360698|4193354|P1|Run-In|Sponsor request|0
1285187|NCT00360698|4193353|P2|Run-In|Non compliance with treatment procedure|1
1285188|NCT00360698|4193354|P1|Run-In|Non compliance with treatment procedure|0
1285189|NCT00360698|4193353|P2|Run-In|Withdrawal by Subject|2
1285190|NCT00360698|4193354|P1|Run-In|Withdrawal by Subject|0
1285191|NCT00360698|4193353|P2|Run-In|Physician Decision|1
1285192|NCT00360698|4193354|P1|Run-In|Physician Decision|0
1285193|NCT00360568|4193399|P2|Overall Study|Withdrawal by Subject|3
1285194|NCT00360568|4193400|P1|Overall Study|Withdrawal by Subject|0
1285195|NCT00360568|4193399|P2|Overall Study|Lack of Efficacy|0
1285196|NCT00360568|4193400|P1|Overall Study|Lack of Efficacy|1
1285197|NCT00360568|4193399|P2|Overall Study|Adverse Event|2
1285198|NCT00360568|4193400|P1|Overall Study|Adverse Event|1
1285199|NCT00360529|4193531|P3|Overall Study|Reason discontinued not explained above|11
1285200|NCT00360529|4193532|P2|Overall Study|Reason discontinued not explained above|9
1285201|NCT00360529|4193533|P1|Overall Study|Reason discontinued not explained above|4
1285202|NCT00360529|4193531|P3|Overall Study|Lack of Efficacy|5
1285203|NCT00360529|4193532|P2|Overall Study|Lack of Efficacy|6
1285204|NCT00360529|4193533|P1|Overall Study|Lack of Efficacy|8
1285205|NCT00360529|4193531|P3|Overall Study|Withdrawal by Subject|18
1285206|NCT00360529|4193532|P2|Overall Study|Withdrawal by Subject|14
1285207|NCT00360529|4193533|P1|Overall Study|Withdrawal by Subject|22
1285208|NCT00360529|4193531|P3|Overall Study|Lost to Follow-up|13
1285209|NCT00360529|4193532|P2|Overall Study|Lost to Follow-up|10
1285210|NCT00360529|4193533|P1|Overall Study|Lost to Follow-up|14
1285211|NCT00360529|4193531|P3|Overall Study|Protocol Violation|11
1285212|NCT00360529|4193532|P2|Overall Study|Protocol Violation|3
1285213|NCT00360529|4193533|P1|Overall Study|Protocol Violation|3
1285214|NCT00360529|4193531|P3|Overall Study|Adverse Event|33
1285215|NCT00360529|4193532|P2|Overall Study|Adverse Event|23
1285216|NCT00360529|4193533|P1|Overall Study|Adverse Event|10
1285217|NCT00360490|4193561|P2|Overall Study|Withdrawal by Subject|3
1285218|NCT00360490|4193562|P1|Overall Study|Withdrawal by Subject|1
1285219|NCT00360490|4193561|P2|Overall Study|Protocol Violation|4
1285220|NCT00360490|4193562|P1|Overall Study|Protocol Violation|0
1285221|NCT00360490|4193561|P2|Overall Study|Physician Decision|1
1285222|NCT00360490|4193562|P1|Overall Study|Physician Decision|2
1285223|NCT00360490|4193561|P2|Overall Study|Lost to Follow-up|1
1285224|NCT00360490|4193562|P1|Overall Study|Lost to Follow-up|2
1285225|NCT00360490|4193561|P2|Overall Study|Adverse Event|2
1285226|NCT00360490|4193562|P1|Overall Study|Adverse Event|4
1285227|NCT00360412|4193597|P2|Overall Study|Study termination by Sponsor|469
1285228|NCT00360412|4193598|P1|Overall Study|Study termination by Sponsor|214
1285229|NCT00360412|4193597|P2|Overall Study|Not specified|6
1285230|NCT00360412|4193598|P1|Overall Study|Not specified|5
1285231|NCT00360412|4193597|P2|Overall Study|Physician Decision|4
1285232|NCT00360412|4193598|P1|Overall Study|Physician Decision|2
1285233|NCT00360412|4193597|P2|Overall Study|Lack of therapeutic efficacy|61
1285234|NCT00360412|4193598|P1|Overall Study|Lack of therapeutic efficacy|46
1285235|NCT00360412|4193597|P2|Overall Study|Patient withdrew consent|52
1285236|NCT00360412|4193598|P1|Overall Study|Patient withdrew consent|27
1285237|NCT00360412|4193597|P2|Overall Study|Protocol Violation|5
1285238|NCT00360412|4193598|P1|Overall Study|Protocol Violation|2
1285239|NCT00360412|4193597|P2|Overall Study|Adverse Event|65
1285240|NCT00360412|4193598|P1|Overall Study|Adverse Event|37
1285241|NCT00360334|4193645|P2|Overall Study|Subject decision|2
1285242|NCT00360334|4193646|P1|Overall Study|Subject decision|8
1285243|NCT00360334|4193645|P2|Overall Study|Entry criterion not met|2
1285244|NCT00360334|4193646|P1|Overall Study|Entry criterion not met|1
1285245|NCT00360334|4193645|P2|Overall Study|Lack of Efficacy|1
1285246|NCT00360334|4193646|P1|Overall Study|Lack of Efficacy|0
1285247|NCT00360334|4193645|P2|Overall Study|Physician Decision|3
1285248|NCT00360334|4193646|P1|Overall Study|Physician Decision|2
1285249|NCT00360334|4193645|P2|Overall Study|Protocol Violation|1
1285250|NCT00360334|4193646|P1|Overall Study|Protocol Violation|1
1285251|NCT00360334|4193645|P2|Overall Study|Adverse Event|4
1285252|NCT00360334|4193646|P1|Overall Study|Adverse Event|7
1285253|NCT00360308|4193709|P3|Overall Study|Study termination by sponsor|44
1285254|NCT00360308|4193710|P2|Overall Study|Study termination by sponsor|55
1285255|NCT00360308|4193711|P1|Overall Study|Study termination by sponsor|43
1285256|NCT00360308|4193709|P3|Overall Study|Not Specified|1
1285257|NCT00360308|4193710|P2|Overall Study|Not Specified|1
1285258|NCT00360308|4193711|P1|Overall Study|Not Specified|2
1285259|NCT00360308|4193709|P3|Overall Study|Lack of Efficacy|2
1285260|NCT00360308|4193710|P2|Overall Study|Lack of Efficacy|0
1285261|NCT00360308|4193711|P1|Overall Study|Lack of Efficacy|3
1285262|NCT00360308|4193709|P3|Overall Study|Withdrawal by Subject|14
1285263|NCT00360308|4193710|P2|Overall Study|Withdrawal by Subject|7
1285264|NCT00360308|4193711|P1|Overall Study|Withdrawal by Subject|11
1285265|NCT00360308|4193709|P3|Overall Study|Protocol Violation|2
1285266|NCT00360308|4193710|P2|Overall Study|Protocol Violation|1
1285267|NCT00360308|4193711|P1|Overall Study|Protocol Violation|2
1285268|NCT00360308|4193709|P3|Overall Study|Abnormal Laboratory Value(s)|0
1285269|NCT00360308|4193710|P2|Overall Study|Abnormal Laboratory Value(s)|1
1285270|NCT00360308|4193711|P1|Overall Study|Abnormal Laboratory Value(s)|0
1285271|NCT00360308|4193709|P3|Overall Study|Adverse Event|25
1285272|NCT00360308|4193710|P2|Overall Study|Adverse Event|14
1285273|NCT00360308|4193711|P1|Overall Study|Adverse Event|15
1285274|NCT00360282|4193728|P4|Second Intervention|Adverse Event|0
1285275|NCT00360282|4193729|P3|Second Intervention|Adverse Event|0
1285276|NCT00360282|4193730|P2|Second Intervention|Adverse Event|1
1285277|NCT00360282|4193731|P1|Second Intervention|Adverse Event|0
1285278|NCT00360282|4193728|P4|Washout 1-3 Weeks|Lost to Follow-up|0
1285279|NCT00360282|4193729|P3|Washout 1-3 Weeks|Lost to Follow-up|1
1285280|NCT00360282|4193730|P2|Washout 1-3 Weeks|Lost to Follow-up|0
1285281|NCT00360282|4193731|P1|Washout 1-3 Weeks|Lost to Follow-up|0
1285282|NCT00360269|4193743|P2|Overall Study|Withdrawal by Subject|1
1285283|NCT00360269|4193744|P1|Overall Study|Withdrawal by Subject|1
1285284|NCT00360269|4193743|P2|Overall Study|Adverse Event|0
1285285|NCT00360269|4193744|P1|Overall Study|Adverse Event|1
1285286|NCT00360269|4193743|P2|Overall Study|Physician Decision|2
1285287|NCT00360269|4193744|P1|Overall Study|Physician Decision|1
1285288|NCT00360269|4193743|P2|Overall Study|Lost to Follow-up|9
1285289|NCT00360269|4193744|P1|Overall Study|Lost to Follow-up|7
1285290|NCT00360230|4193786|P7|Overall Study|Death|1
1285291|NCT00360230|4193787|P6|Overall Study|Death|1
1285292|NCT00360230|4193788|P5|Overall Study|Death|0
1285293|NCT00360230|4193789|P4|Overall Study|Death|0
1285294|NCT00360230|4193790|P3|Overall Study|Death|0
1285295|NCT00360230|4193791|P2|Overall Study|Death|1
1285296|NCT00360230|4193792|P1|Overall Study|Death|0
1285297|NCT00360230|4193786|P7|Overall Study|Protocol Violation|0
1285298|NCT00360230|4193787|P6|Overall Study|Protocol Violation|1
1285299|NCT00360230|4193788|P5|Overall Study|Protocol Violation|0
1285300|NCT00360230|4193789|P4|Overall Study|Protocol Violation|0
1285301|NCT00360230|4193790|P3|Overall Study|Protocol Violation|0
1285302|NCT00360230|4193791|P2|Overall Study|Protocol Violation|0
1285303|NCT00360230|4193792|P1|Overall Study|Protocol Violation|0
1285304|NCT00360230|4193786|P7|Overall Study|Not specified|0
1285305|NCT00360230|4193787|P6|Overall Study|Not specified|0
1285306|NCT00360230|4193788|P5|Overall Study|Not specified|0
1285307|NCT00360230|4193789|P4|Overall Study|Not specified|0
1285308|NCT00360230|4193790|P3|Overall Study|Not specified|0
1285309|NCT00360230|4193791|P2|Overall Study|Not specified|0
1285310|NCT00360230|4193792|P1|Overall Study|Not specified|1
1285311|NCT00360230|4193786|P7|Overall Study|Migrated|1
1285312|NCT00360230|4193787|P6|Overall Study|Migrated|1
1285313|NCT00360230|4193788|P5|Overall Study|Migrated|4
1285314|NCT00360230|4193789|P4|Overall Study|Migrated|1
1285315|NCT00360230|4193790|P3|Overall Study|Migrated|3
1285316|NCT00360230|4193791|P2|Overall Study|Migrated|1
1285317|NCT00360230|4193792|P1|Overall Study|Migrated|4
1285318|NCT00360230|4193786|P7|Overall Study|Withdrawal by Subject|0
1285319|NCT00360230|4193787|P6|Overall Study|Withdrawal by Subject|1
1285320|NCT00360230|4193788|P5|Overall Study|Withdrawal by Subject|1
1285321|NCT00360230|4193789|P4|Overall Study|Withdrawal by Subject|1
1285322|NCT00360230|4193790|P3|Overall Study|Withdrawal by Subject|0
1285323|NCT00360230|4193791|P2|Overall Study|Withdrawal by Subject|1
1285324|NCT00360230|4193792|P1|Overall Study|Withdrawal by Subject|1
1285325|NCT00359801|4193948|P2|Overall Study|Sponsor Decision|16
1285326|NCT00359801|4193949|P1|Overall Study|Sponsor Decision|17
1285327|NCT00359801|4193948|P2|Overall Study|Final Status Unknown: missing data|4
1285328|NCT00359801|4193949|P1|Overall Study|Final Status Unknown: missing data|7
1285329|NCT00359801|4193948|P2|Overall Study|Other|46
1285330|NCT00359801|4193949|P1|Overall Study|Other|66
1285331|NCT00359801|4193948|P2|Overall Study|Withdrawal by Subject|96
1285332|NCT00359801|4193949|P1|Overall Study|Withdrawal by Subject|143
1285333|NCT00359801|4193948|P2|Overall Study|Lost to Follow-up|58
1285334|NCT00359801|4193949|P1|Overall Study|Lost to Follow-up|72
1285335|NCT00359788|4193983|P2|Overall Study|Protocol Violation|2
1285336|NCT00359788|4193984|P1|Overall Study|Protocol Violation|4
1285337|NCT00359788|4193983|P2|Overall Study|Withdrawal by Subject|1
1285338|NCT00359788|4193984|P1|Overall Study|Withdrawal by Subject|4
1285339|NCT00359788|4193983|P2|Overall Study|Lost to Follow-up|2
1285340|NCT00359788|4193984|P1|Overall Study|Lost to Follow-up|3
1285341|NCT00359788|4193983|P2|Overall Study|Lack of Efficacy|2
1285342|NCT00359788|4193984|P1|Overall Study|Lack of Efficacy|1
1285343|NCT00359788|4193983|P2|Overall Study|Adverse Event|10
1285344|NCT00359788|4193984|P1|Overall Study|Adverse Event|11
1285345|NCT00359762|4194218|P5|Period III|Subject Decision|0
1285346|NCT00359762|4194219|P4|Period III|Subject Decision|20
1285347|NCT00359762|4194220|P3|Period III|Subject Decision|8
1285348|NCT00359762|4194221|P2|Period III|Subject Decision|7
1285349|NCT00359762|4194222|P1|Period III|Subject Decision|0
1285350|NCT00359762|4194218|P5|Period III|Entry Criteria Not Met|0
1285351|NCT00359762|4194219|P4|Period III|Entry Criteria Not Met|1
1285352|NCT00359762|4194220|P3|Period III|Entry Criteria Not Met|0
1285353|NCT00359762|4194221|P2|Period III|Entry Criteria Not Met|1
1285354|NCT00359762|4194222|P1|Period III|Entry Criteria Not Met|0
1285355|NCT00359762|4194218|P5|Period III|Lost to follow up|0
1285356|NCT00359762|4194219|P4|Period III|Lost to follow up|2
1285357|NCT00359762|4194220|P3|Period III|Lost to follow up|1
1285358|NCT00359762|4194221|P2|Period III|Lost to follow up|1
1285359|NCT00359762|4194222|P1|Period III|Lost to follow up|0
1285360|NCT00359762|4194218|P5|Period III|Lack of Efficacy|0
1285361|NCT00359762|4194219|P4|Period III|Lack of Efficacy|9
1285362|NCT00359762|4194220|P3|Period III|Lack of Efficacy|5
1285363|NCT00359762|4194221|P2|Period III|Lack of Efficacy|7
1285364|NCT00359762|4194222|P1|Period III|Lack of Efficacy|0
1285365|NCT00359762|4194218|P5|Period III|Physician Decision|0
1285366|NCT00359762|4194219|P4|Period III|Physician Decision|15
1285367|NCT00359762|4194220|P3|Period III|Physician Decision|9
1285368|NCT00359762|4194221|P2|Period III|Physician Decision|5
1285369|NCT00359762|4194222|P1|Period III|Physician Decision|0
1285370|NCT00359762|4194218|P5|Period III|Adverse Event|0
1285371|NCT00359762|4194219|P4|Period III|Adverse Event|10
1285372|NCT00359762|4194220|P3|Period III|Adverse Event|4
1285373|NCT00359762|4194221|P2|Period III|Adverse Event|3
1285374|NCT00359762|4194222|P1|Period III|Adverse Event|0
1285375|NCT00359762|4194218|P5|Period III|Protocol Violation|0
1285376|NCT00359762|4194219|P4|Period III|Protocol Violation|8
1285377|NCT00359762|4194220|P3|Period III|Protocol Violation|3
1285378|NCT00359762|4194221|P2|Period III|Protocol Violation|5
1285379|NCT00359762|4194222|P1|Period III|Protocol Violation|0
1285380|NCT00359762|4194218|P5|Period II|Subject Decision|70
1285381|NCT00359762|4194219|P4|Period II|Subject Decision|0
1285382|NCT00359762|4194220|P3|Period II|Subject Decision|0
1285383|NCT00359762|4194221|P2|Period II|Subject Decision|0
1285384|NCT00359762|4194222|P1|Period II|Subject Decision|50
1285385|NCT00359762|4194218|P5|Period II|Entry Criteria Not Met|4
1285386|NCT00359762|4194219|P4|Period II|Entry Criteria Not Met|0
1285387|NCT00359762|4194220|P3|Period II|Entry Criteria Not Met|0
1285388|NCT00359762|4194221|P2|Period II|Entry Criteria Not Met|0
1285389|NCT00359762|4194222|P1|Period II|Entry Criteria Not Met|8
1285390|NCT00359762|4194218|P5|Period II|Lost to follow up|5
1285391|NCT00359762|4194219|P4|Period II|Lost to follow up|0
1285392|NCT00359762|4194220|P3|Period II|Lost to follow up|0
1285393|NCT00359762|4194221|P2|Period II|Lost to follow up|0
1285394|NCT00359762|4194222|P1|Period II|Lost to follow up|5
1285395|NCT00359762|4194218|P5|Period II|Lack of Efficacy|8
1285396|NCT00359762|4194219|P4|Period II|Lack of Efficacy|0
1285397|NCT00359762|4194220|P3|Period II|Lack of Efficacy|0
1285398|NCT00359762|4194221|P2|Period II|Lack of Efficacy|0
1285399|NCT00359762|4194222|P1|Period II|Lack of Efficacy|11
1285400|NCT00359762|4194218|P5|Period II|Death|4
1285401|NCT00359762|4194219|P4|Period II|Death|0
1285402|NCT00359762|4194220|P3|Period II|Death|0
1285403|NCT00359762|4194221|P2|Period II|Death|0
1285404|NCT00359762|4194222|P1|Period II|Death|2
1285405|NCT00359762|4194218|P5|Period II|Physician Decision|23
1285406|NCT00359762|4194219|P4|Period II|Physician Decision|0
1285407|NCT00359762|4194220|P3|Period II|Physician Decision|0
1285408|NCT00359762|4194221|P2|Period II|Physician Decision|0
1285409|NCT00359762|4194222|P1|Period II|Physician Decision|17
1285410|NCT00359762|4194218|P5|Period II|Protocol Violation|11
1285411|NCT00359762|4194219|P4|Period II|Protocol Violation|0
1285412|NCT00359762|4194220|P3|Period II|Protocol Violation|0
1285413|NCT00359762|4194221|P2|Period II|Protocol Violation|0
1285414|NCT00359762|4194222|P1|Period II|Protocol Violation|18
1285415|NCT00359762|4194218|P5|Period II|Adverse Event|49
1285416|NCT00359762|4194219|P4|Period II|Adverse Event|0
1285417|NCT00359762|4194220|P3|Period II|Adverse Event|0
1285418|NCT00359762|4194221|P2|Period II|Adverse Event|0
1285419|NCT00359762|4194222|P1|Period II|Adverse Event|17
1285420|NCT00359632|4194296|P2|Overall Study|Non-compliance with visit schedule|0
1285421|NCT00359632|4194297|P1|Overall Study|Non-compliance with visit schedule|1
1285422|NCT00359632|4194296|P2|Overall Study|Adverse Event|0
1285423|NCT00359632|4194297|P1|Overall Study|Adverse Event|1
1285424|NCT00359632|4194296|P2|Overall Study|Death|0
1285425|NCT00359632|4194297|P1|Overall Study|Death|2
1285426|NCT00359619|4194311|P7|Overall Study|Lost to Follow-up|0
1285427|NCT00359619|4194312|P6|Overall Study|Lost to Follow-up|5
1285428|NCT00359619|4194313|P5|Overall Study|Lost to Follow-up|1
1285429|NCT00359619|4194314|P4|Overall Study|Lost to Follow-up|1
1285430|NCT00359619|4194315|P3|Overall Study|Lost to Follow-up|2
1285431|NCT00359619|4194316|P2|Overall Study|Lost to Follow-up|4
1285432|NCT00359619|4194317|P1|Overall Study|Lost to Follow-up|4
1285433|NCT00359619|4194311|P7|Overall Study|Other|0
1285434|NCT00359619|4194312|P6|Overall Study|Other|0
1285435|NCT00359619|4194313|P5|Overall Study|Other|0
1285436|NCT00359619|4194314|P4|Overall Study|Other|0
1285437|NCT00359619|4194315|P3|Overall Study|Other|0
1285438|NCT00359619|4194316|P2|Overall Study|Other|0
1285439|NCT00359619|4194317|P1|Overall Study|Other|1
1285440|NCT00359619|4194311|P7|Overall Study|Withdrawal by Subject|3
1285441|NCT00359619|4194312|P6|Overall Study|Withdrawal by Subject|0
1285442|NCT00359619|4194313|P5|Overall Study|Withdrawal by Subject|2
1285443|NCT00359619|4194314|P4|Overall Study|Withdrawal by Subject|2
1285444|NCT00359619|4194315|P3|Overall Study|Withdrawal by Subject|4
1285445|NCT00359619|4194316|P2|Overall Study|Withdrawal by Subject|1
1285446|NCT00359619|4194317|P1|Overall Study|Withdrawal by Subject|3
1285447|NCT00359619|4194311|P7|Overall Study|Adverse Event|1
1285448|NCT00359619|4194312|P6|Overall Study|Adverse Event|0
1285449|NCT00359619|4194313|P5|Overall Study|Adverse Event|0
1285450|NCT00359619|4194314|P4|Overall Study|Adverse Event|0
1285451|NCT00359619|4194315|P3|Overall Study|Adverse Event|1
1285452|NCT00359619|4194316|P2|Overall Study|Adverse Event|0
1285453|NCT00359619|4194317|P1|Overall Study|Adverse Event|0
1285454|NCT00359424|4194447|P2|Overall Study|follow up not conducted|0
1285455|NCT00359424|4194448|P1|Overall Study|follow up not conducted|2
1285456|NCT00359424|4194447|P2|Overall Study|Withdrawal by Subject|2
1285457|NCT00359424|4194448|P1|Overall Study|Withdrawal by Subject|10
1285458|NCT00359424|4194447|P2|Overall Study|Lost to Follow-up|7
1285459|NCT00359424|4194448|P1|Overall Study|Lost to Follow-up|19
1285460|NCT00359424|4194447|P2|Overall Study|Death|58
1285461|NCT00359424|4194448|P1|Overall Study|Death|99
1285462|NCT00359281|4194487|P9|Overall Study|Withdrawal by Subject|0
1285463|NCT00359281|4194488|P8|Overall Study|Withdrawal by Subject|0
1285464|NCT00359281|4194489|P7|Overall Study|Withdrawal by Subject|1
1285465|NCT00359281|4194490|P6|Overall Study|Withdrawal by Subject|0
1285466|NCT00359281|4194491|P5|Overall Study|Withdrawal by Subject|0
1285467|NCT00359281|4194492|P4|Overall Study|Withdrawal by Subject|0
1285468|NCT00359281|4194493|P3|Overall Study|Withdrawal by Subject|0
1285469|NCT00359281|4194494|P2|Overall Study|Withdrawal by Subject|0
1285470|NCT00359281|4194495|P1|Overall Study|Withdrawal by Subject|0
1285471|NCT00359281|4194487|P9|Overall Study|Adverse Event|0
1285472|NCT00359281|4194488|P8|Overall Study|Adverse Event|0
1285473|NCT00359281|4194489|P7|Overall Study|Adverse Event|1
1285474|NCT00359281|4194490|P6|Overall Study|Adverse Event|0
1285475|NCT00359281|4194491|P5|Overall Study|Adverse Event|0
1285476|NCT00359281|4194492|P4|Overall Study|Adverse Event|0
1285477|NCT00359281|4194493|P3|Overall Study|Adverse Event|0
1285478|NCT00359281|4194494|P2|Overall Study|Adverse Event|0
1285479|NCT00359281|4194495|P1|Overall Study|Adverse Event|1
1285480|NCT00359073|4194558|P2|Overall Study|developed RV16 antibody|1
1285481|NCT00359073|4194559|P1|Overall Study|developed RV16 antibody|0
1285482|NCT00359073|4194558|P2|Overall Study|Eligibility criteria no longer met|0
1285483|NCT00359073|4194559|P1|Overall Study|Eligibility criteria no longer met|3
1285484|NCT00359073|4194558|P2|Overall Study|Withdrawal by Subject|1
1285485|NCT00359073|4194559|P1|Overall Study|Withdrawal by Subject|1
1285486|NCT00359021|4194571|P2|Overall Study|Pregnancy|0
1285487|NCT00359021|4194572|P1|Overall Study|Pregnancy|1
1285488|NCT00359021|4194571|P2|Overall Study|Not specified|1
1285489|NCT00359021|4194572|P1|Overall Study|Not specified|4
1285490|NCT00359021|4194571|P2|Overall Study|Lost to Follow-up|0
1285491|NCT00359021|4194572|P1|Overall Study|Lost to Follow-up|1
1285492|NCT00359021|4194571|P2|Overall Study|Withdrawal by Subject|9
1285493|NCT00359021|4194572|P1|Overall Study|Withdrawal by Subject|2
1285494|NCT00359021|4194571|P2|Overall Study|Subject Reached A Virologic Endpoint|32
1285495|NCT00359021|4194572|P1|Overall Study|Subject Reached A Virologic Endpoint|45
1285496|NCT00359021|4194571|P2|Overall Study|Subject Ineligible To Continue The Trial|0
1285497|NCT00359021|4194572|P1|Overall Study|Subject Ineligible To Continue The Trial|1
1285498|NCT00359021|4194571|P2|Overall Study|Subject Non-Compliant|2
1285499|NCT00359021|4194572|P1|Overall Study|Subject Non-Compliant|1
1285500|NCT00359021|4194571|P2|Overall Study|Adverse Event|8
1285501|NCT00359021|4194572|P1|Overall Study|Adverse Event|26
1285502|NCT00358956|4194584|P1|Overall Study|Withdrawal by Subject|1
1285503|NCT00358956|4194584|P1|Overall Study|condition under investigation worsened|4
1285504|NCT00358956|4194584|P1|Overall Study|Adverse Event|3
1285505|NCT00358917|4194596|P2|Overall Study|Unable to Continue Participation|2
1285506|NCT00358917|4194597|P1|Overall Study|Unable to Continue Participation|2
1285507|NCT00358917|4194596|P2|Overall Study|Virologic failure|8
1285508|NCT00358917|4194597|P1|Overall Study|Virologic failure|11
1285509|NCT00358917|4194596|P2|Overall Study|Death|3
1285510|NCT00358917|4194597|P1|Overall Study|Death|2
1285511|NCT00358917|4194596|P2|Overall Study|Noncompliance|11
1285512|NCT00358917|4194597|P1|Overall Study|Noncompliance|12
1285513|NCT00358917|4194596|P2|Overall Study|Lost to Follow-up|17
1285514|NCT00358917|4194597|P1|Overall Study|Lost to Follow-up|20
1285515|NCT00358917|4194596|P2|Overall Study|Withdrawal by Subject|7
1285516|NCT00358917|4194597|P1|Overall Study|Withdrawal by Subject|5
1285517|NCT00358917|4194596|P2|Overall Study|Adverse Event|21
1285518|NCT00358917|4194597|P1|Overall Study|Adverse Event|14
1285519|NCT00358826|4194615|P8|MDCT Substudy|Withdrawal by Subject|0
1285520|NCT00358826|4194616|P7|MDCT Substudy|Withdrawal by Subject|0
1285521|NCT00358826|4194617|P6|MDCT Substudy|Withdrawal by Subject|1
1285522|NCT00358826|4194618|P5|MDCT Substudy|Withdrawal by Subject|0
1285523|NCT00358826|4194619|P4|MDCT Substudy|Withdrawal by Subject|0
1285524|NCT00358826|4194620|P3|MDCT Substudy|Withdrawal by Subject|0
1285525|NCT00358826|4194621|P2|MDCT Substudy|Withdrawal by Subject|0
1285526|NCT00358826|4194622|P1|MDCT Substudy|Withdrawal by Subject|0
1285527|NCT00358826|4194615|P8|MDCT Substudy|Lost to Follow-up|0
1285528|NCT00358826|4194616|P7|MDCT Substudy|Lost to Follow-up|0
1285529|NCT00358826|4194617|P6|MDCT Substudy|Lost to Follow-up|1
1285530|NCT00358826|4194618|P5|MDCT Substudy|Lost to Follow-up|0
1285531|NCT00358826|4194619|P4|MDCT Substudy|Lost to Follow-up|0
1285532|NCT00358826|4194620|P3|MDCT Substudy|Lost to Follow-up|0
1285533|NCT00358826|4194621|P2|MDCT Substudy|Lost to Follow-up|0
1285534|NCT00358826|4194622|P1|MDCT Substudy|Lost to Follow-up|0
1285535|NCT00358826|4194615|P8|MDCT Substudy|Adverse Event|0
1285536|NCT00358826|4194616|P7|MDCT Substudy|Adverse Event|0
1285537|NCT00358826|4194617|P6|MDCT Substudy|Adverse Event|0
1285538|NCT00358826|4194618|P5|MDCT Substudy|Adverse Event|1
1285539|NCT00358826|4194619|P4|MDCT Substudy|Adverse Event|0
1285540|NCT00358826|4194620|P3|MDCT Substudy|Adverse Event|0
1285541|NCT00358826|4194621|P2|MDCT Substudy|Adverse Event|0
1285542|NCT00358826|4194622|P1|MDCT Substudy|Adverse Event|0
1285543|NCT00358826|4194615|P8|Core Study|Physician Decision|0
1285544|NCT00358826|4194616|P7|Core Study|Physician Decision|0
1285545|NCT00358826|4194617|P6|Core Study|Physician Decision|0
1285546|NCT00358826|4194618|P5|Core Study|Physician Decision|0
1285547|NCT00358826|4194619|P4|Core Study|Physician Decision|0
1285548|NCT00358826|4194620|P3|Core Study|Physician Decision|1
1285549|NCT00358826|4194621|P2|Core Study|Physician Decision|0
1285550|NCT00358826|4194622|P1|Core Study|Physician Decision|0
1285551|NCT00358826|4194615|P8|Core Study|Lost to Follow-up|0
1285552|NCT00358826|4194616|P7|Core Study|Lost to Follow-up|0
1285553|NCT00358826|4194617|P6|Core Study|Lost to Follow-up|0
1285554|NCT00358826|4194618|P5|Core Study|Lost to Follow-up|0
1285555|NCT00358826|4194619|P4|Core Study|Lost to Follow-up|1
1285556|NCT00358826|4194620|P3|Core Study|Lost to Follow-up|0
1285557|NCT00358826|4194621|P2|Core Study|Lost to Follow-up|0
1285558|NCT00358826|4194622|P1|Core Study|Lost to Follow-up|0
1285559|NCT00358826|4194615|P8|Core Study|Withdrawal by Subject|0
1285560|NCT00358826|4194616|P7|Core Study|Withdrawal by Subject|0
1285561|NCT00358826|4194617|P6|Core Study|Withdrawal by Subject|0
1285562|NCT00358826|4194618|P5|Core Study|Withdrawal by Subject|0
1285563|NCT00358826|4194619|P4|Core Study|Withdrawal by Subject|0
1285564|NCT00358826|4194620|P3|Core Study|Withdrawal by Subject|0
1285565|NCT00358826|4194621|P2|Core Study|Withdrawal by Subject|2
1285566|NCT00358826|4194622|P1|Core Study|Withdrawal by Subject|2
1285567|NCT00358826|4194615|P8|Core Study|Adverse Event|0
1285568|NCT00358826|4194616|P7|Core Study|Adverse Event|0
1285569|NCT00358826|4194617|P6|Core Study|Adverse Event|0
1285570|NCT00358826|4194618|P5|Core Study|Adverse Event|0
1285571|NCT00358826|4194619|P4|Core Study|Adverse Event|1
1285572|NCT00358826|4194620|P3|Core Study|Adverse Event|1
1285573|NCT00358826|4194621|P2|Core Study|Adverse Event|3
1285574|NCT00358826|4194622|P1|Core Study|Adverse Event|1
1285575|NCT00358670|4194689|P2|Overall Study|Administrative|125
1285576|NCT00358670|4194690|P1|Overall Study|Administrative|153
1285577|NCT00358670|4194689|P2|Overall Study|Did Not Meet Protocol Eligibility|3
1285578|NCT00358670|4194690|P1|Overall Study|Did Not Meet Protocol Eligibility|0
1285579|NCT00358670|4194689|P2|Overall Study|Protocol Defined Clinical Event|1
1285580|NCT00358670|4194690|P1|Overall Study|Protocol Defined Clinical Event|0
1285581|NCT00358670|4194689|P2|Overall Study|Withdrawal by Subject|24
1285582|NCT00358670|4194690|P1|Overall Study|Withdrawal by Subject|13
1285583|NCT00358670|4194689|P2|Overall Study|Lost to Follow-up|5
1285584|NCT00358670|4194690|P1|Overall Study|Lost to Follow-up|4
1285585|NCT00358670|4194689|P2|Overall Study|Protocol Violation|9
1285586|NCT00358670|4194690|P1|Overall Study|Protocol Violation|6
1285587|NCT00358670|4194689|P2|Overall Study|Lack of Efficacy|23
1285588|NCT00358670|4194690|P1|Overall Study|Lack of Efficacy|20
1285589|NCT00358670|4194689|P2|Overall Study|Adverse Event|29
1285590|NCT00358670|4194690|P1|Overall Study|Adverse Event|26
1285591|NCT00358644|4194704|P1|Overall Study|Patient not eligible for study|1
1285592|NCT00358644|4194704|P1|Overall Study|Physician Decision|6
1285593|NCT00358644|4194704|P1|Overall Study|Withdrawal by Subject|4
1285594|NCT00358644|4194704|P1|Overall Study|Death|11
1285595|NCT00358644|4194704|P1|Overall Study|Adverse Event|7
1285596|NCT00358644|4194704|P1|Overall Study|Progressive Disease|21
1285597|NCT00358527|4194727|P2|Overall Study|Administrative|1
1285598|NCT00358527|4194728|P1|Overall Study|Administrative|2
1285599|NCT00358527|4194727|P2|Overall Study|Non-compliance with protocol|1
1285600|NCT00358527|4194728|P1|Overall Study|Non-compliance with protocol|6
1285601|NCT00358527|4194727|P2|Overall Study|Withdrawal by Subject|1
1285602|NCT00358527|4194728|P1|Overall Study|Withdrawal by Subject|1
1285603|NCT00358527|4194727|P2|Overall Study|Adverse Event|0
1285604|NCT00358527|4194728|P1|Overall Study|Adverse Event|4
1285605|NCT00358449|4194778|P3|Overall Study|Steriod Inhaler was Increased|1
1285606|NCT00358449|4194779|P2|Overall Study|Steriod Inhaler was Increased|0
1285607|NCT00358449|4194780|P1|Overall Study|Steriod Inhaler was Increased|0
1285608|NCT00358449|4194778|P3|Overall Study|Lack of Efficacy|0
1285609|NCT00358449|4194779|P2|Overall Study|Lack of Efficacy|1
1285610|NCT00358449|4194780|P1|Overall Study|Lack of Efficacy|0
1285611|NCT00358449|4194778|P3|Overall Study|Withdrawal by Subject|0
1285612|NCT00358449|4194779|P2|Overall Study|Withdrawal by Subject|0
1285613|NCT00358449|4194780|P1|Overall Study|Withdrawal by Subject|2
1285614|NCT00358449|4194778|P3|Overall Study|Lost to Follow-up|0
1285615|NCT00358449|4194779|P2|Overall Study|Lost to Follow-up|0
1285616|NCT00358449|4194780|P1|Overall Study|Lost to Follow-up|1
1285617|NCT00358449|4194778|P3|Overall Study|Adverse Event|1
1285618|NCT00358449|4194779|P2|Overall Study|Adverse Event|0
1285619|NCT00358449|4194780|P1|Overall Study|Adverse Event|1
1285620|NCT00358436|4194883|P2|Overall Study|Other|1
1285621|NCT00358436|4194884|P1|Overall Study|Other|6
1285622|NCT00358436|4194883|P2|Overall Study|COPD exacerbation|10
1285623|NCT00358436|4194884|P1|Overall Study|COPD exacerbation|22
1285624|NCT00358436|4194883|P2|Overall Study|Non-fulfilment of inclusion/exclusion|0
1285625|NCT00358436|4194884|P1|Overall Study|Non-fulfilment of inclusion/exclusion|4
1285626|NCT00358436|4194883|P2|Overall Study|Withdrawal by Subject|17
1285627|NCT00358436|4194884|P1|Overall Study|Withdrawal by Subject|40
1285628|NCT00358436|4194883|P2|Overall Study|Protocol Violation|3
1285629|NCT00358436|4194884|P1|Overall Study|Protocol Violation|8
1285630|NCT00358436|4194883|P2|Overall Study|Lost to Follow-up|6
1285631|NCT00358436|4194884|P1|Overall Study|Lost to Follow-up|11
1285632|NCT00358436|4194883|P2|Overall Study|Lack of Efficacy|36
1285633|NCT00358436|4194884|P1|Overall Study|Lack of Efficacy|34
1285634|NCT00358436|4194883|P2|Overall Study|Adverse Event|13
1285635|NCT00358436|4194884|P1|Overall Study|Adverse Event|29
1285636|NCT00358215|4194955|P2|Overall Study|Did not receive investigational product|3
1285637|NCT00358215|4194956|P1|Overall Study|Did not receive investigational product|2
1285638|NCT00358215|4194955|P2|Overall Study|Other|14
1285639|NCT00358215|4194956|P1|Overall Study|Other|21
1285640|NCT00358215|4194955|P2|Overall Study|Pregnancy|0
1285641|NCT00358215|4194956|P1|Overall Study|Pregnancy|1
1285642|NCT00358215|4194955|P2|Overall Study|Protocol Violation|59
1285643|NCT00358215|4194956|P1|Overall Study|Protocol Violation|64
1285644|NCT00358215|4194955|P2|Overall Study|Death|281
1285645|NCT00358215|4194956|P1|Overall Study|Death|265
1285646|NCT00358215|4194955|P2|Overall Study|Lost to Follow-up|22
1285647|NCT00358215|4194956|P1|Overall Study|Lost to Follow-up|16
1285648|NCT00358215|4194955|P2|Overall Study|Physician Decision|39
1285649|NCT00358215|4194956|P1|Overall Study|Physician Decision|47
1285650|NCT00358215|4194955|P2|Overall Study|Participant request|64
1285651|NCT00358215|4194956|P1|Overall Study|Participant request|65
1285652|NCT00358215|4194955|P2|Overall Study|Withdrawal by Subject|102
1285653|NCT00358215|4194956|P1|Overall Study|Withdrawal by Subject|111
1285654|NCT00358215|4194955|P2|Overall Study|Adverse Event|65
1285655|NCT00358215|4194956|P1|Overall Study|Adverse Event|83
1285656|NCT00358215|4194955|P2|Overall Study|Ineligibility determined|3
1285657|NCT00358215|4194956|P1|Overall Study|Ineligibility determined|4
1285658|NCT00358150|4194970|P1|Overall Study|Undefined|3
1285659|NCT00358150|4194970|P1|Overall Study|Withdrawal by Subject|1
1285660|NCT00358150|4194970|P1|Overall Study|Adverse Event|3
1285661|NCT00357994|4194999|P2|Overall Study|Protocol Violation|0
1285662|NCT00357994|4195000|P1|Overall Study|Protocol Violation|1
1285663|NCT00357994|4194999|P2|Overall Study|Lack of Efficacy|1
1285664|NCT00357994|4195000|P1|Overall Study|Lack of Efficacy|0
1285665|NCT00357994|4194999|P2|Overall Study|Adverse Event|2
1285666|NCT00357994|4195000|P1|Overall Study|Adverse Event|1
1285667|NCT00357968|4195054|P2|First Maintenance Dose Phase|Withdrawal by Subject|2
1285668|NCT00357968|4195055|P1|First Maintenance Dose Phase|Withdrawal by Subject|1
1285669|NCT00357968|4195054|P2|First Maintenance Dose Phase|Not a PCI patient|42
1285670|NCT00357968|4195055|P1|First Maintenance Dose Phase|Not a PCI patient|47
1285671|NCT00357903|4195108|P2|Overall Study|Other|10
1285672|NCT00357903|4195109|P1|Overall Study|Other|49
1285673|NCT00357903|4195108|P2|Overall Study|Response status|9
1285674|NCT00357903|4195109|P1|Overall Study|Response status|61
1285675|NCT00357903|4195108|P2|Overall Study|Protocol issues|3
1285676|NCT00357903|4195109|P1|Overall Study|Protocol issues|14
1285677|NCT00357903|4195108|P2|Overall Study|Completed month 12 only|1
1285678|NCT00357903|4195109|P1|Overall Study|Completed month 12 only|0
1285679|NCT00357903|4195108|P2|Overall Study|Withdrawal by Subject|7
1285680|NCT00357903|4195109|P1|Overall Study|Withdrawal by Subject|57
1285681|NCT00357903|4195108|P2|Overall Study|Physician Decision|5
1285682|NCT00357903|4195109|P1|Overall Study|Physician Decision|39
1285683|NCT00357903|4195108|P2|Overall Study|Lost to Follow-up|4
1285684|NCT00357903|4195109|P1|Overall Study|Lost to Follow-up|23
1285685|NCT00357903|4195108|P2|Overall Study|Death|0
1285686|NCT00357903|4195109|P1|Overall Study|Death|33
1285687|NCT00357903|4195108|P2|Overall Study|Adverse Event|4
1285688|NCT00357903|4195109|P1|Overall Study|Adverse Event|87
1285689|NCT00357877|4195149|P2|Overall Study|Other|2
1285690|NCT00357877|4195150|P1|Overall Study|Other|0
1285691|NCT00357877|4195149|P2|Overall Study|Administrative withdrawal|1
1285692|NCT00357877|4195150|P1|Overall Study|Administrative withdrawal|1
1285693|NCT00357877|4195149|P2|Overall Study|Withdrawal by Subject|3
1285694|NCT00357877|4195150|P1|Overall Study|Withdrawal by Subject|3
1285695|NCT00357877|4195149|P2|Overall Study|Lost to Follow-up|23
1285696|NCT00357877|4195150|P1|Overall Study|Lost to Follow-up|20
1285697|NCT00357877|4195149|P2|Overall Study|Death|1
1285698|NCT00357877|4195150|P1|Overall Study|Death|2
1285699|NCT00357760|4195164|P2|Overall Study|To receive hospice care|1
1285700|NCT00357760|4195165|P1|Overall Study|To receive hospice care|0
1285701|NCT00357760|4195164|P2|Overall Study|Protocol Violation|1
1285702|NCT00357760|4195165|P1|Overall Study|Protocol Violation|0
1285703|NCT00357760|4195164|P2|Overall Study|Physician Decision|1
1285704|NCT00357760|4195165|P1|Overall Study|Physician Decision|2
1285705|NCT00357760|4195164|P2|Overall Study|Ineligible|2
1285706|NCT00357760|4195165|P1|Overall Study|Ineligible|0
1285707|NCT00357760|4195164|P2|Overall Study|Never started treatment|1
1285708|NCT00357760|4195165|P1|Overall Study|Never started treatment|2
1285709|NCT00357760|4195164|P2|Overall Study|Withdrawal by Subject|2
1285710|NCT00357760|4195165|P1|Overall Study|Withdrawal by Subject|0
1285711|NCT00357760|4195164|P2|Overall Study|Alternative therapy|0
1285712|NCT00357760|4195165|P1|Overall Study|Alternative therapy|1
1285713|NCT00357760|4195164|P2|Overall Study|Death|3
1285714|NCT00357760|4195165|P1|Overall Study|Death|0
1285715|NCT00357760|4195164|P2|Overall Study|Adverse Event|7
1285716|NCT00357760|4195165|P1|Overall Study|Adverse Event|10
1285717|NCT00357760|4195164|P2|Overall Study|Disease progression|17
1285718|NCT00357760|4195165|P1|Overall Study|Disease progression|44
1285719|NCT00357656|4195186|P2|Overall Study|Other, No surgery performed|3
1285720|NCT00357656|4195187|P1|Overall Study|Other, No surgery performed|0
1285721|NCT00357552|4195238|P1|Weeks 24 to 104|Not able to get to clinic|2
1285722|NCT00357552|4195238|P1|Weeks 24 to 104|Death|3
1285723|NCT00357552|4195238|P1|Weeks 0 to 24|Death|1
1285724|NCT00357552|4195238|P1|Screening|Did not meet eligibility criteria|84
1285725|NCT00357500|4195253|P1|Overall Study|Not Started Protocol Therapy|4
1285726|NCT00357500|4195253|P1|Overall Study|Progressive Disease|65
1285727|NCT00357500|4195253|P1|Overall Study|Withdrawal by Subject|5
1285728|NCT00357500|4195253|P1|Overall Study|Adverse Event|3
1285729|NCT00357396|4195262|P2|Overall Study|Adverse Event|0
1285730|NCT00357396|4195263|P1|Overall Study|Adverse Event|1
1285731|NCT00357370|4195271|P3|Cohort 2|Withdrawal by Subject|0
1285732|NCT00357370|4195272|P2|Cohort 2|Withdrawal by Subject|2
1285733|NCT00357370|4195273|P1|Cohort 2|Withdrawal by Subject|0
1285734|NCT00357370|4195271|P3|Cohort 2|non-compliance, not met criteria, etc|0
1285735|NCT00357370|4195272|P2|Cohort 2|non-compliance, not met criteria, etc|1
1285736|NCT00357370|4195273|P1|Cohort 2|non-compliance, not met criteria, etc|1
1285737|NCT00357370|4195271|P3|Cohort 2|Lost to Follow-up|0
1285738|NCT00357370|4195272|P2|Cohort 2|Lost to Follow-up|1
1285739|NCT00357370|4195273|P1|Cohort 2|Lost to Follow-up|0
1285740|NCT00357370|4195271|P3|Cohort 2|Adverse Event|1
1285741|NCT00357370|4195272|P2|Cohort 2|Adverse Event|1
1285742|NCT00357370|4195273|P1|Cohort 2|Adverse Event|1
1285743|NCT00357370|4195271|P3|Cohort 2|Lack of Efficacy|1
1285744|NCT00357370|4195272|P2|Cohort 2|Lack of Efficacy|2
1285745|NCT00357370|4195273|P1|Cohort 2|Lack of Efficacy|0
1285746|NCT00357110|4195319|P2|Overall Study|Early study termination|5
1285747|NCT00357110|4195320|P1|Overall Study|Early study termination|5
1285748|NCT00357097|4195328|P2|Overall Study|Increase of RLS Symptoms|1
1285749|NCT00357097|4195329|P1|Overall Study|Increase of RLS Symptoms|0
1285750|NCT00357097|4195328|P2|Overall Study|Other|1
1285751|NCT00357097|4195329|P1|Overall Study|Other|1
1285752|NCT00357097|4195328|P2|Overall Study|Met Exclusion Criteria|1
1285753|NCT00357097|4195329|P1|Overall Study|Met Exclusion Criteria|3
1285754|NCT00357097|4195328|P2|Overall Study|Lack of Efficacy|8
1285755|NCT00357097|4195329|P1|Overall Study|Lack of Efficacy|2
1285756|NCT00357097|4195328|P2|Overall Study|Non-compliance|2
1285757|NCT00357097|4195329|P1|Overall Study|Non-compliance|1
1285758|NCT00357097|4195328|P2|Overall Study|Withdrawal by Subject|7
1285759|NCT00357097|4195329|P1|Overall Study|Withdrawal by Subject|8
1285760|NCT00357097|4195328|P2|Overall Study|Adverse Event|6
1285761|NCT00357097|4195329|P1|Overall Study|Adverse Event|34
1285762|NCT00357097|4195328|P2|Overall Study|Did not meet inclusion criteria|3
1285763|NCT00357097|4195329|P1|Overall Study|Did not meet inclusion criteria|5
1285764|NCT00357006|4195383|P3|Overall Study|Withdrawal by Subject|2
1285765|NCT00357006|4195384|P2|Overall Study|Withdrawal by Subject|3
1285766|NCT00357006|4195385|P1|Overall Study|Withdrawal by Subject|1
1285767|NCT00357006|4195383|P3|Overall Study|Lost to Follow-up|1
1285768|NCT00357006|4195384|P2|Overall Study|Lost to Follow-up|2
1285769|NCT00357006|4195385|P1|Overall Study|Lost to Follow-up|1
1285770|NCT00356915|4195396|P3|Overall Study|Miscellaneous reasons|3
1285771|NCT00356915|4195397|P2|Overall Study|Miscellaneous reasons|8
1285772|NCT00356915|4195398|P1|Overall Study|Miscellaneous reasons|11
1285773|NCT00356915|4195396|P3|Overall Study|Adverse Event|8
1285774|NCT00356915|4195397|P2|Overall Study|Adverse Event|31
1285775|NCT00356915|4195398|P1|Overall Study|Adverse Event|21
1285776|NCT00356915|4195396|P3|Overall Study|Physician Decision|0
1285777|NCT00356915|4195397|P2|Overall Study|Physician Decision|2
1285778|NCT00356915|4195398|P1|Overall Study|Physician Decision|0
1285779|NCT00356915|4195396|P3|Overall Study|Administrative Decision|1
1285780|NCT00356915|4195397|P2|Overall Study|Administrative Decision|0
1285781|NCT00356915|4195398|P1|Overall Study|Administrative Decision|0
1285782|NCT00356915|4195396|P3|Overall Study|Lost to Follow-up|14
1285783|NCT00356915|4195397|P2|Overall Study|Lost to Follow-up|34
1285784|NCT00356915|4195398|P1|Overall Study|Lost to Follow-up|27
1285785|NCT00356915|4195396|P3|Overall Study|Lack of Efficacy|3
1285786|NCT00356915|4195397|P2|Overall Study|Lack of Efficacy|0
1285787|NCT00356915|4195398|P1|Overall Study|Lack of Efficacy|0
1285788|NCT00356915|4195396|P3|Overall Study|Withdrawal by Subject|10
1285789|NCT00356915|4195397|P2|Overall Study|Withdrawal by Subject|14
1285790|NCT00356915|4195398|P1|Overall Study|Withdrawal by Subject|14
1285791|NCT00356915|4195396|P3|Overall Study|Protocol Violation|2
1285792|NCT00356915|4195397|P2|Overall Study|Protocol Violation|3
1285793|NCT00356915|4195398|P1|Overall Study|Protocol Violation|2
1285794|NCT00356915|4195396|P3|Overall Study|Non compliance|1
1285795|NCT00356915|4195397|P2|Overall Study|Non compliance|2
1285796|NCT00356915|4195398|P1|Overall Study|Non compliance|1
1285797|NCT00356889|4195415|P1|Overall Study|Adverse Event|1
1285798|NCT00356889|4195415|P1|Overall Study|Protocol Violation|2
1285799|NCT00356863|4195424|P2|Overall Study|Lost to Follow-up|43
1285800|NCT00356863|4195425|P1|Overall Study|Lost to Follow-up|76
1285801|NCT00356863|4195424|P2|Overall Study|Death|32
1285802|NCT00356863|4195425|P1|Overall Study|Death|16
1285803|NCT00356811|4195451|P1|Overall Study|Site Closed during Follow-up|2
1285804|NCT00356811|4195451|P1|Overall Study|Study Is Terminating|3
1285805|NCT00356811|4195451|P1|Overall Study|Participant Could Not Make a Checkup|1
1285806|NCT00356811|4195451|P1|Overall Study|Withdrawal by Subject|6
1285807|NCT00356811|4195451|P1|Overall Study|Lost to Follow-up|2
1285808|NCT00356811|4195451|P1|Overall Study|Death|35
1285809|NCT00356759|4195466|P2|Overall Study|Intercurrent disease or persistent extre|2
1285810|NCT00356759|4195467|P1|Overall Study|Intercurrent disease or persistent extre|5
1285811|NCT00356759|4195466|P2|Overall Study|Lost to Follow-up|1
1285812|NCT00356759|4195467|P1|Overall Study|Lost to Follow-up|1
1285813|NCT00356759|4195466|P2|Overall Study|Adverse Event|3
1285814|NCT00356759|4195467|P1|Overall Study|Adverse Event|1
1285815|NCT00356759|4195466|P2|Overall Study|Withdrawal by Subject|2
1285816|NCT00356759|4195467|P1|Overall Study|Withdrawal by Subject|2
1285817|NCT00356759|4195466|P2|Overall Study|Death|2
1285818|NCT00356759|4195467|P1|Overall Study|Death|5
1285819|NCT00356603|4195485|P2|Overall Study|Other|3
1285820|NCT00356603|4195486|P1|Overall Study|Other|6
1285821|NCT00356590|4195500|P1|Overall Study|Other|52
1285822|NCT00356590|4195500|P1|Overall Study|Response status|28
1285823|NCT00356590|4195500|P1|Overall Study|Protocol issues|6
1285824|NCT00356590|4195500|P1|Overall Study|Completed month 12 only|2
1285825|NCT00356590|4195500|P1|Overall Study|Withdrawal by Subject|41
1285826|NCT00356590|4195500|P1|Overall Study|Physician Decision|46
1285827|NCT00356590|4195500|P1|Overall Study|Lost to Follow-up|35
1285828|NCT00356590|4195500|P1|Overall Study|Death|10
1285829|NCT00356590|4195500|P1|Overall Study|Adverse Event|54
1285830|NCT00356525|4195536|P4|Overall Study|Sponsor Decision|1
1285831|NCT00356525|4195537|P3|Overall Study|Sponsor Decision|0
1285832|NCT00356525|4195538|P2|Overall Study|Sponsor Decision|0
1285833|NCT00356525|4195539|P1|Overall Study|Sponsor Decision|0
1285834|NCT00356525|4195536|P4|Overall Study|Death|1
1285835|NCT00356525|4195537|P3|Overall Study|Death|0
1285836|NCT00356525|4195538|P2|Overall Study|Death|0
1285837|NCT00356525|4195539|P1|Overall Study|Death|0
1285838|NCT00356525|4195536|P4|Overall Study|Withdrawal by Subject|3
1285839|NCT00356525|4195537|P3|Overall Study|Withdrawal by Subject|0
1285840|NCT00356525|4195538|P2|Overall Study|Withdrawal by Subject|1
1285841|NCT00356525|4195539|P1|Overall Study|Withdrawal by Subject|1
1285842|NCT00356525|4195536|P4|Overall Study|Protocol Entry Criteria Not Met|0
1285843|NCT00356525|4195537|P3|Overall Study|Protocol Entry Criteria Not Met|0
1285844|NCT00356525|4195538|P2|Overall Study|Protocol Entry Criteria Not Met|0
1285845|NCT00356525|4195539|P1|Overall Study|Protocol Entry Criteria Not Met|1
1285846|NCT00356525|4195536|P4|Overall Study|Physician Decision|1
1285847|NCT00356525|4195537|P3|Overall Study|Physician Decision|2
1285848|NCT00356525|4195538|P2|Overall Study|Physician Decision|2
1285849|NCT00356525|4195539|P1|Overall Study|Physician Decision|2
1285850|NCT00356525|4195536|P4|Overall Study|Lost to Follow-up|0
1285851|NCT00356525|4195537|P3|Overall Study|Lost to Follow-up|0
1285852|NCT00356525|4195538|P2|Overall Study|Lost to Follow-up|0
1285853|NCT00356525|4195539|P1|Overall Study|Lost to Follow-up|1
1285854|NCT00356525|4195536|P4|Overall Study|Adverse Event|1
1285855|NCT00356525|4195537|P3|Overall Study|Adverse Event|1
1285856|NCT00356525|4195538|P2|Overall Study|Adverse Event|3
1285857|NCT00356525|4195539|P1|Overall Study|Adverse Event|1
1285858|NCT00356525|4195536|P4|Overall Study|Progressive Disease|2
1285859|NCT00356525|4195537|P3|Overall Study|Progressive Disease|4
1285860|NCT00356525|4195538|P2|Overall Study|Progressive Disease|5
1285861|NCT00356525|4195539|P1|Overall Study|Progressive Disease|8
1285862|NCT00356421|4195580|P2|Overall Study|Not related to study drug|3
1285863|NCT00356421|4195581|P1|Overall Study|Not related to study drug|5
1285864|NCT00356421|4195580|P2|Overall Study|Related to study drug|12
1285865|NCT00356421|4195581|P1|Overall Study|Related to study drug|15
1285866|NCT00356421|4195580|P2|Overall Study|Withdrawal by Subject|2
1285867|NCT00356421|4195581|P1|Overall Study|Withdrawal by Subject|9
1285868|NCT00356421|4195580|P2|Overall Study|Lack of Efficacy|0
1285869|NCT00356421|4195581|P1|Overall Study|Lack of Efficacy|3
1285870|NCT00356408|4195621|P1|Overall Study|Other: Subject chose commerical dosing|1
1285871|NCT00356408|4195621|P1|Overall Study|Other: Failed to meet Inc/Exc criteria|1
1285872|NCT00356408|4195621|P1|Overall Study|Other: Azathioprine stopped|1
1285873|NCT00356408|4195621|P1|Overall Study|Other: Sponsor request|1
1285874|NCT00356408|4195621|P1|Overall Study|Other: Principal investigator discretion|3
1285875|NCT00356408|4195621|P1|Overall Study|Withdrawal by Subject|6
1285876|NCT00356408|4195621|P1|Overall Study|Lost to Follow-up|2
1285877|NCT00356408|4195621|P1|Overall Study|Lack of Efficacy|36
1285878|NCT00356408|4195621|P1|Overall Study|Adverse Event|9
1285879|NCT00356369|4195638|P2|Active Phase|Withdrawal by Subject|1
1285880|NCT00356369|4195639|P1|Active Phase|Withdrawal by Subject|2
1285881|NCT00356278|4195721|P3|Overall Study|Withdrawal by Subject|19
1285882|NCT00356278|4195722|P2|Overall Study|Withdrawal by Subject|15
1285883|NCT00356278|4195723|P1|Overall Study|Withdrawal by Subject|25
1285884|NCT00356265|4195761|P3|Overall Study|Withdrawal by Subject|1
1285885|NCT00356265|4195762|P2|Overall Study|Withdrawal by Subject|0
1285886|NCT00356265|4195763|P1|Overall Study|Withdrawal by Subject|0
1285887|NCT00356200|4195775|P2|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2
1285888|NCT00356200|4195776|P1|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0
1285889|NCT00356200|4195775|P2|Cohort 1: 10 ug/ml|Lack of Efficacy|0
1285890|NCT00356200|4195776|P1|Cohort 1: 10 ug/ml|Lack of Efficacy|1
1285891|NCT00356148|4195805|P2|Overall Study|Reoperation within 30 days|1
1285892|NCT00356148|4195806|P1|Overall Study|Reoperation within 30 days|2
1285893|NCT00356135|4195817|P3|Overall Study|Subject non-compliance|3
1285894|NCT00356135|4195818|P2|Overall Study|Subject non-compliance|1
1285895|NCT00356135|4195819|P1|Overall Study|Subject non-compliance|1
1285896|NCT00356135|4195817|P3|Overall Study|Physician Decision|1
1285897|NCT00356135|4195818|P2|Overall Study|Physician Decision|1
1285898|NCT00356135|4195819|P1|Overall Study|Physician Decision|1
1285899|NCT00356135|4195817|P3|Overall Study|Lost to Follow-up|1
1285900|NCT00356135|4195818|P2|Overall Study|Lost to Follow-up|0
1285901|NCT00356135|4195819|P1|Overall Study|Lost to Follow-up|0
1285902|NCT00356135|4195817|P3|Overall Study|Adverse Event|0
1285903|NCT00356135|4195818|P2|Overall Study|Adverse Event|0
1285904|NCT00356135|4195819|P1|Overall Study|Adverse Event|1
1285905|NCT00356135|4195817|P3|Overall Study|Protocol Violation|0
1285906|NCT00356135|4195818|P2|Overall Study|Protocol Violation|0
1285907|NCT00356135|4195819|P1|Overall Study|Protocol Violation|1
1285908|NCT00356122|4195841|P1|FOLLOW-UP|Other|2
1285909|NCT00356122|4195841|P1|FOLLOW-UP|Lost to Follow-up|2
1285910|NCT00356122|4195841|P1|FOLLOW-UP|Death|37
1285911|NCT00356122|4195841|P1|TREATMENT|Did not receive study medication|1
1285912|NCT00356122|4195841|P1|TREATMENT|Other|4
1285913|NCT00356122|4195841|P1|TREATMENT|Subject's request|4
1285914|NCT00356122|4195841|P1|TREATMENT|Adverse Event|10
1285915|NCT00356122|4195841|P1|TREATMENT|Lack of Efficacy|26
1285916|NCT00355784|4195949|P3|Overall Study|Withdrawal by Subject|2
1285917|NCT00355784|4195950|P2|Overall Study|Withdrawal by Subject|0
1285918|NCT00355784|4195951|P1|Overall Study|Withdrawal by Subject|0
1285919|NCT00355615|4196000|P5|40-week Rosuvastatin Open Label Period|investigational site closed|1
1285920|NCT00355615|4196001|P4|40-week Rosuvastatin Open Label Period|investigational site closed|0
1285921|NCT00355615|4196002|P3|40-week Rosuvastatin Open Label Period|investigational site closed|0
1285922|NCT00355615|4196003|P2|40-week Rosuvastatin Open Label Period|investigational site closed|0
1285923|NCT00355615|4196004|P1|40-week Rosuvastatin Open Label Period|investigational site closed|0
1285924|NCT00355615|4196000|P5|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3
1285925|NCT00355615|4196001|P4|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
1285926|NCT00355615|4196002|P3|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
1285927|NCT00355615|4196003|P2|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
1285928|NCT00355615|4196004|P1|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
1285929|NCT00355615|4196000|P5|40-week Rosuvastatin Open Label Period|Protocol Violation|1
1285930|NCT00355615|4196001|P4|40-week Rosuvastatin Open Label Period|Protocol Violation|0
1285931|NCT00355615|4196002|P3|40-week Rosuvastatin Open Label Period|Protocol Violation|0
1285932|NCT00355615|4196003|P2|40-week Rosuvastatin Open Label Period|Protocol Violation|0
1285933|NCT00355615|4196004|P1|40-week Rosuvastatin Open Label Period|Protocol Violation|0
1285934|NCT00355615|4196000|P5|40-week Rosuvastatin Open Label Period|Adverse Event|4
1285935|NCT00355615|4196001|P4|40-week Rosuvastatin Open Label Period|Adverse Event|0
1285936|NCT00355615|4196002|P3|40-week Rosuvastatin Open Label Period|Adverse Event|0
1285937|NCT00355615|4196003|P2|40-week Rosuvastatin Open Label Period|Adverse Event|0
1285938|NCT00355615|4196004|P1|40-week Rosuvastatin Open Label Period|Adverse Event|0
1285939|NCT00355615|4196000|P5|Randomized Double Blind Period|Protocol Violation|0
1285940|NCT00355615|4196001|P4|Randomized Double Blind Period|Protocol Violation|1
1285941|NCT00355615|4196002|P3|Randomized Double Blind Period|Protocol Violation|1
1285942|NCT00355615|4196003|P2|Randomized Double Blind Period|Protocol Violation|0
1285943|NCT00355615|4196004|P1|Randomized Double Blind Period|Protocol Violation|0
1285944|NCT00355615|4196000|P5|Randomized Double Blind Period|Adverse Event|0
1285945|NCT00355615|4196001|P4|Randomized Double Blind Period|Adverse Event|0
1285946|NCT00355615|4196002|P3|Randomized Double Blind Period|Adverse Event|0
1285947|NCT00355615|4196003|P2|Randomized Double Blind Period|Adverse Event|0
1285948|NCT00355615|4196004|P1|Randomized Double Blind Period|Adverse Event|1
1285949|NCT00355472|4196063|P1|Overall Study|Physician Decision|1
1285950|NCT00355368|4196109|P2|Overall Study|cardiac arrest prior to intubation|2
1285951|NCT00355368|4196110|P1|Overall Study|cardiac arrest prior to intubation|2
1285952|NCT00355368|4196109|P2|Overall Study|Protocol Violation|7
1285953|NCT00355368|4196110|P1|Overall Study|Protocol Violation|8
1285954|NCT00355342|4196124|P2|Overall Study|Use of protocol excluded medication|1
1285955|NCT00355342|4196125|P1|Overall Study|Use of protocol excluded medication|0
1285956|NCT00355342|4196124|P2|Overall Study|Protocol Violation|1
1285957|NCT00355342|4196125|P1|Overall Study|Protocol Violation|0
1285958|NCT00355342|4196124|P2|Overall Study|Study management|1
1285959|NCT00355342|4196125|P1|Overall Study|Study management|0
1286042|NCT00355134|4196176|P1|Core Phase|Protocol Violation|3
1285960|NCT00355342|4196124|P2|Overall Study|Participant discontinued study drug|1
1285961|NCT00355342|4196125|P1|Overall Study|Participant discontinued study drug|0
1285962|NCT00355342|4196124|P2|Overall Study|Participant relocated|1
1285963|NCT00355342|4196125|P1|Overall Study|Participant relocated|0
1285964|NCT00355342|4196124|P2|Overall Study|Withdrawal by participant and physician|0
1285965|NCT00355342|4196125|P1|Overall Study|Withdrawal by participant and physician|1
1285966|NCT00355342|4196124|P2|Overall Study|Non-compliance with Dexa scans|0
1285967|NCT00355342|4196125|P1|Overall Study|Non-compliance with Dexa scans|1
1285968|NCT00355342|4196124|P2|Overall Study|Dispensed wrong study drug kit|0
1285969|NCT00355342|4196125|P1|Overall Study|Dispensed wrong study drug kit|1
1285970|NCT00355342|4196124|P2|Overall Study|COPD exacerbation|1
1285971|NCT00355342|4196125|P1|Overall Study|COPD exacerbation|1
1285972|NCT00355342|4196124|P2|Overall Study|Use of prohibited medication|0
1285973|NCT00355342|4196125|P1|Overall Study|Use of prohibited medication|1
1285974|NCT00355342|4196124|P2|Overall Study|Overcompliant-PI discretion|0
1285975|NCT00355342|4196125|P1|Overall Study|Overcompliant-PI discretion|1
1285976|NCT00355342|4196124|P2|Overall Study|Sponsor terminated study|2
1285977|NCT00355342|4196125|P1|Overall Study|Sponsor terminated study|2
1285978|NCT00355342|4196124|P2|Overall Study|Withdrawal by Subject|11
1285979|NCT00355342|4196125|P1|Overall Study|Withdrawal by Subject|14
1285980|NCT00355342|4196124|P2|Overall Study|Lost to Follow-up|2
1285981|NCT00355342|4196125|P1|Overall Study|Lost to Follow-up|4
1285982|NCT00355342|4196124|P2|Overall Study|Adverse Event|15
1285983|NCT00355342|4196125|P1|Overall Study|Adverse Event|13
1285984|NCT00355147|4196152|P2|Overall Study|Withdrawal by Subject|12
1285985|NCT00355147|4196153|P1|Overall Study|Withdrawal by Subject|8
1285986|NCT00355147|4196152|P2|Overall Study|Lost to Follow-up|8
1285987|NCT00355147|4196153|P1|Overall Study|Lost to Follow-up|10
1285988|NCT00355134|4196172|P5|Extension Phase|Protocol Violation|0
1285989|NCT00355134|4196173|P4|Extension Phase|Protocol Violation|1
1285990|NCT00355134|4196174|P3|Extension Phase|Protocol Violation|0
1285991|NCT00355134|4196175|P2|Extension Phase|Protocol Violation|0
1285992|NCT00355134|4196176|P1|Extension Phase|Protocol Violation|0
1285993|NCT00355134|4196172|P5|Extension Phase|Abnormal test procedure result(s)|1
1285994|NCT00355134|4196173|P4|Extension Phase|Abnormal test procedure result(s)|0
1285995|NCT00355134|4196174|P3|Extension Phase|Abnormal test procedure result(s)|0
1285996|NCT00355134|4196175|P2|Extension Phase|Abnormal test procedure result(s)|1
1285997|NCT00355134|4196176|P1|Extension Phase|Abnormal test procedure result(s)|0
1285998|NCT00355134|4196172|P5|Extension Phase|Unsatisfactory therapeutic effect|1
1285999|NCT00355134|4196173|P4|Extension Phase|Unsatisfactory therapeutic effect|0
1286000|NCT00355134|4196174|P3|Extension Phase|Unsatisfactory therapeutic effect|0
1286001|NCT00355134|4196175|P2|Extension Phase|Unsatisfactory therapeutic effect|4
1286002|NCT00355134|4196176|P1|Extension Phase|Unsatisfactory therapeutic effect|3
1286003|NCT00355134|4196172|P5|Extension Phase|Administrative problems|1
1286004|NCT00355134|4196173|P4|Extension Phase|Administrative problems|1
1286005|NCT00355134|4196174|P3|Extension Phase|Administrative problems|0
1286006|NCT00355134|4196175|P2|Extension Phase|Administrative problems|4
1286007|NCT00355134|4196176|P1|Extension Phase|Administrative problems|2
1286008|NCT00355134|4196172|P5|Extension Phase|Abnormal laboratory value(s)|2
1286009|NCT00355134|4196173|P4|Extension Phase|Abnormal laboratory value(s)|2
1286010|NCT00355134|4196174|P3|Extension Phase|Abnormal laboratory value(s)|0
1286011|NCT00355134|4196175|P2|Extension Phase|Abnormal laboratory value(s)|2
1286012|NCT00355134|4196176|P1|Extension Phase|Abnormal laboratory value(s)|4
1286013|NCT00355134|4196172|P5|Extension Phase|Lost to Follow-up|4
1286014|NCT00355134|4196173|P4|Extension Phase|Lost to Follow-up|2
1286015|NCT00355134|4196174|P3|Extension Phase|Lost to Follow-up|0
1286016|NCT00355134|4196175|P2|Extension Phase|Lost to Follow-up|6
1286017|NCT00355134|4196176|P1|Extension Phase|Lost to Follow-up|2
1286018|NCT00355134|4196172|P5|Extension Phase|Adverse Event|5
1286019|NCT00355134|4196173|P4|Extension Phase|Adverse Event|3
1286020|NCT00355134|4196174|P3|Extension Phase|Adverse Event|0
1286021|NCT00355134|4196175|P2|Extension Phase|Adverse Event|9
1286022|NCT00355134|4196176|P1|Extension Phase|Adverse Event|13
1286023|NCT00355134|4196172|P5|Extension Phase|Withdrawal by Subject|5
1286024|NCT00355134|4196173|P4|Extension Phase|Withdrawal by Subject|7
1286025|NCT00355134|4196174|P3|Extension Phase|Withdrawal by Subject|0
1286026|NCT00355134|4196175|P2|Extension Phase|Withdrawal by Subject|11
1286027|NCT00355134|4196176|P1|Extension Phase|Withdrawal by Subject|7
1286028|NCT00355134|4196172|P5|Core Phase|Condition no longer requires study drug|0
1286029|NCT00355134|4196173|P4|Core Phase|Condition no longer requires study drug|0
1286030|NCT00355134|4196174|P3|Core Phase|Condition no longer requires study drug|1
1286031|NCT00355134|4196175|P2|Core Phase|Condition no longer requires study drug|0
1286032|NCT00355134|4196176|P1|Core Phase|Condition no longer requires study drug|1
1286033|NCT00355134|4196172|P5|Core Phase|Abnormal test procedure result(s)|0
1286034|NCT00355134|4196173|P4|Core Phase|Abnormal test procedure result(s)|0
1286035|NCT00355134|4196174|P3|Core Phase|Abnormal test procedure result(s)|1
1286036|NCT00355134|4196175|P2|Core Phase|Abnormal test procedure result(s)|2
1286037|NCT00355134|4196176|P1|Core Phase|Abnormal test procedure result(s)|1
1286038|NCT00355134|4196172|P5|Core Phase|Protocol Violation|0
1286039|NCT00355134|4196173|P4|Core Phase|Protocol Violation|0
1286040|NCT00355134|4196174|P3|Core Phase|Protocol Violation|2
1286041|NCT00355134|4196175|P2|Core Phase|Protocol Violation|2
1286043|NCT00355134|4196172|P5|Core Phase|Administrative problems|0
1286044|NCT00355134|4196173|P4|Core Phase|Administrative problems|0
1286045|NCT00355134|4196174|P3|Core Phase|Administrative problems|5
1286046|NCT00355134|4196175|P2|Core Phase|Administrative problems|3
1286047|NCT00355134|4196176|P1|Core Phase|Administrative problems|5
1286048|NCT00355134|4196172|P5|Core Phase|Unsatisfactory therapeutic effect|0
1286049|NCT00355134|4196173|P4|Core Phase|Unsatisfactory therapeutic effect|0
1286050|NCT00355134|4196174|P3|Core Phase|Unsatisfactory therapeutic effect|17
1286051|NCT00355134|4196175|P2|Core Phase|Unsatisfactory therapeutic effect|6
1286052|NCT00355134|4196176|P1|Core Phase|Unsatisfactory therapeutic effect|10
1286053|NCT00355134|4196172|P5|Core Phase|Abnormal laboratory value(s)|0
1286054|NCT00355134|4196173|P4|Core Phase|Abnormal laboratory value(s)|0
1286055|NCT00355134|4196174|P3|Core Phase|Abnormal laboratory value(s)|2
1286056|NCT00355134|4196175|P2|Core Phase|Abnormal laboratory value(s)|14
1286057|NCT00355134|4196176|P1|Core Phase|Abnormal laboratory value(s)|19
1286058|NCT00355134|4196172|P5|Core Phase|Lost to Follow-up|0
1286059|NCT00355134|4196173|P4|Core Phase|Lost to Follow-up|0
1286060|NCT00355134|4196174|P3|Core Phase|Lost to Follow-up|21
1286061|NCT00355134|4196175|P2|Core Phase|Lost to Follow-up|13
1286062|NCT00355134|4196176|P1|Core Phase|Lost to Follow-up|17
1286063|NCT00355134|4196172|P5|Core Phase|Adverse Event|0
1286064|NCT00355134|4196173|P4|Core Phase|Adverse Event|0
1286065|NCT00355134|4196174|P3|Core Phase|Adverse Event|16
1286066|NCT00355134|4196175|P2|Core Phase|Adverse Event|22
1286067|NCT00355134|4196176|P1|Core Phase|Adverse Event|28
1286068|NCT00355134|4196172|P5|Core Phase|Withdrawal by Subject|0
1286069|NCT00355134|4196173|P4|Core Phase|Withdrawal by Subject|0
1286070|NCT00355134|4196174|P3|Core Phase|Withdrawal by Subject|35
1286071|NCT00355134|4196175|P2|Core Phase|Withdrawal by Subject|24
1286072|NCT00355134|4196176|P1|Core Phase|Withdrawal by Subject|35
1286073|NCT00355121|4196219|P3|Overall Study|Serious adverse events|0
1286074|NCT00355121|4196220|P2|Overall Study|Serious adverse events|2
1286075|NCT00355121|4196221|P1|Overall Study|Serious adverse events|0
1286076|NCT00355121|4196219|P3|Overall Study|Withdrawal by Subject|2
1286077|NCT00355121|4196220|P2|Overall Study|Withdrawal by Subject|10
1286078|NCT00355121|4196221|P1|Overall Study|Withdrawal by Subject|9
1286079|NCT00355121|4196219|P3|Overall Study|Lost to Follow-up|1
1286080|NCT00355121|4196220|P2|Overall Study|Lost to Follow-up|7
1286081|NCT00355121|4196221|P1|Overall Study|Lost to Follow-up|4
1286082|NCT00355121|4196219|P3|Overall Study|Protocol Violation|1
1286083|NCT00355121|4196220|P2|Overall Study|Protocol Violation|9
1286084|NCT00355121|4196221|P1|Overall Study|Protocol Violation|7
1286085|NCT00355121|4196219|P3|Overall Study|Adverse Event|0
1286086|NCT00355121|4196220|P2|Overall Study|Adverse Event|1
1286087|NCT00355121|4196221|P1|Overall Study|Adverse Event|0
1286088|NCT00355121|4196219|P3|Overall Study|Did not receive study vaccine|1
1286089|NCT00355121|4196220|P2|Overall Study|Did not receive study vaccine|0
1286090|NCT00355121|4196221|P1|Overall Study|Did not receive study vaccine|1
1286091|NCT00355082|4196252|P3|Continuation Phase|Ran Out of Drug Due to Travel|0
1286092|NCT00355082|4196253|P2|Continuation Phase|Ran Out of Drug Due to Travel|0
1286093|NCT00355082|4196254|P1|Continuation Phase|Ran Out of Drug Due to Travel|1
1286094|NCT00355082|4196252|P3|Continuation Phase|Scheduling Error|0
1286095|NCT00355082|4196253|P2|Continuation Phase|Scheduling Error|0
1286096|NCT00355082|4196254|P1|Continuation Phase|Scheduling Error|1
1286097|NCT00355082|4196252|P3|Continuation Phase|Site Closed by Sponsor|0
1286098|NCT00355082|4196253|P2|Continuation Phase|Site Closed by Sponsor|0
1286099|NCT00355082|4196254|P1|Continuation Phase|Site Closed by Sponsor|8
1286100|NCT00355082|4196252|P3|Continuation Phase|Lack of Efficacy|0
1286101|NCT00355082|4196253|P2|Continuation Phase|Lack of Efficacy|0
1286102|NCT00355082|4196254|P1|Continuation Phase|Lack of Efficacy|5
1286103|NCT00355082|4196252|P3|Continuation Phase|Withdrawal by Subject|0
1286104|NCT00355082|4196253|P2|Continuation Phase|Withdrawal by Subject|0
1286105|NCT00355082|4196254|P1|Continuation Phase|Withdrawal by Subject|4
1286106|NCT00355082|4196252|P3|Continuation Phase|Protocol Violation|1
1286107|NCT00355082|4196253|P2|Continuation Phase|Protocol Violation|0
1286108|NCT00355082|4196254|P1|Continuation Phase|Protocol Violation|1
1286109|NCT00355082|4196252|P3|Continuation Phase|Lost to Follow-up|1
1286110|NCT00355082|4196253|P2|Continuation Phase|Lost to Follow-up|0
1286111|NCT00355082|4196254|P1|Continuation Phase|Lost to Follow-up|2
1286112|NCT00355082|4196252|P3|Continuation Phase|Adverse Event|1
1286113|NCT00355082|4196253|P2|Continuation Phase|Adverse Event|0
1286114|NCT00355082|4196254|P1|Continuation Phase|Adverse Event|2
1286115|NCT00355082|4196252|P3|Double-Blind (DB) Treatment Phase|Pregnancy|0
1286116|NCT00355082|4196253|P2|Double-Blind (DB) Treatment Phase|Pregnancy|1
1286117|NCT00355082|4196254|P1|Double-Blind (DB) Treatment Phase|Pregnancy|0
1286118|NCT00355082|4196252|P3|Double-Blind (DB) Treatment Phase|Protocol Violation|0
1286119|NCT00355082|4196253|P2|Double-Blind (DB) Treatment Phase|Protocol Violation|4
1286120|NCT00355082|4196254|P1|Double-Blind (DB) Treatment Phase|Protocol Violation|0
1286121|NCT00355082|4196252|P3|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
1286122|NCT00355082|4196253|P2|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4
1286123|NCT00355082|4196254|P1|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
1286124|NCT00355082|4196252|P3|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0
1286125|NCT00355082|4196253|P2|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7
1286126|NCT00355082|4196254|P1|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6
1286127|NCT00355082|4196252|P3|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0
1286128|NCT00355082|4196253|P2|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8
1286129|NCT00355082|4196254|P1|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9
1286130|NCT00355082|4196252|P3|Double-Blind (DB) Treatment Phase|Adverse Event|0
1286131|NCT00355082|4196253|P2|Double-Blind (DB) Treatment Phase|Adverse Event|10
1286132|NCT00355082|4196254|P1|Double-Blind (DB) Treatment Phase|Adverse Event|4
1286133|NCT00355030|4196276|P2|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
1286134|NCT00355030|4196277|P1|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
1286135|NCT00355030|4196276|P2|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1
1286136|NCT00355030|4196277|P1|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0
1286137|NCT00355030|4196276|P2|Study Period 1 Treatment|Other|6
1286138|NCT00355030|4196277|P1|Study Period 1 Treatment|Other|2
1286139|NCT00355030|4196276|P2|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1
1286140|NCT00355030|4196277|P1|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0
1286141|NCT00355030|4196276|P2|Study Period 1 Treatment|Sponsor Decision|32
1286142|NCT00355030|4196277|P1|Study Period 1 Treatment|Sponsor Decision|34
1286143|NCT00355030|4196276|P2|Study Period 1 Treatment|Physician Decision|1
1286144|NCT00355030|4196277|P1|Study Period 1 Treatment|Physician Decision|0
1286145|NCT00355030|4196276|P2|Study Period 1 Treatment|Parent/Caregiver Decision|2
1286146|NCT00355030|4196277|P1|Study Period 1 Treatment|Parent/Caregiver Decision|1
1286147|NCT00355030|4196276|P2|Study Period 1 Treatment|Withdrawal by Subject|1
1286148|NCT00355030|4196277|P1|Study Period 1 Treatment|Withdrawal by Subject|4
1286149|NCT00355030|4196276|P2|Study Period 1 Treatment|Lost to Follow-up|0
1286150|NCT00355030|4196277|P1|Study Period 1 Treatment|Lost to Follow-up|3
1286151|NCT00355030|4196276|P2|Study Period 1 Treatment|Adverse Event|1
1286152|NCT00355030|4196277|P1|Study Period 1 Treatment|Adverse Event|1
1286153|NCT00354835|4196316|P2|Overall Study|Refusal of further therapy|8
1286154|NCT00354835|4196317|P1|Overall Study|Refusal of further therapy|3
1286155|NCT00354835|4196316|P2|Overall Study|Adverse Event|0
1286156|NCT00354835|4196317|P1|Overall Study|Adverse Event|6
1286157|NCT00354835|4196316|P2|Overall Study|Disease progression or relapse|22
1286158|NCT00354835|4196317|P1|Overall Study|Disease progression or relapse|15
1286159|NCT00354835|4196316|P2|Overall Study|Ineligible|16
1286160|NCT00354835|4196317|P1|Overall Study|Ineligible|17
1286161|NCT00354835|4196316|P2|Overall Study|Withdrawal by Subject|1
1286162|NCT00354835|4196317|P1|Overall Study|Withdrawal by Subject|2
1286163|NCT00354835|4196316|P2|Overall Study|Physician Decision|13
1286164|NCT00354835|4196317|P1|Overall Study|Physician Decision|8
1286165|NCT00354835|4196316|P2|Overall Study|Death|1
1286166|NCT00354835|4196317|P1|Overall Study|Death|1
1286167|NCT00354744|4196356|P1|Overall Study|Withdrawal by Subject|14
1286168|NCT00354744|4196356|P1|Overall Study|Physician Decision|11
1286169|NCT00354744|4196356|P1|Overall Study|Lost to Follow-up|2
1286170|NCT00354744|4196356|P1|Overall Study|Lack of Efficacy|11
1286171|NCT00354744|4196356|P1|Overall Study|Death|2
1286172|NCT00354744|4196356|P1|Overall Study|Adverse Event|2
1286173|NCT00354679|4196361|P1|Overall Study|Patient Not Treated|1
1286174|NCT00354614|4196370|P1|Overall Study|Lack of Efficacy|28
1286175|NCT00354601|4196374|P1|Overall Study|progression|1
1286176|NCT00354601|4196374|P1|Overall Study|Protocol Violation|1
1286177|NCT00354432|4196394|P4|Overall Study|Off/Toxicity|5
1286178|NCT00354432|4196395|P3|Overall Study|Off/Toxicity|5
1286179|NCT00354432|4196396|P2|Overall Study|Off/Toxicity|7
1286180|NCT00354432|4196397|P1|Overall Study|Off/Toxicity|3
1286181|NCT00354432|4196394|P4|Overall Study|Adverse Event|5
1286182|NCT00354432|4196395|P3|Overall Study|Adverse Event|5
1286183|NCT00354432|4196396|P2|Overall Study|Adverse Event|1
1286184|NCT00354432|4196397|P1|Overall Study|Adverse Event|3
1286185|NCT00354341|4196413|P2|Overall Study|Other|2
1286186|NCT00354341|4196414|P1|Overall Study|Other|1
1286187|NCT00354341|4196413|P2|Overall Study|Failure to return|1
1286188|NCT00354341|4196414|P1|Overall Study|Failure to return|0
1286189|NCT00354341|4196413|P2|Overall Study|Refused treatment|2
1286190|NCT00354341|4196414|P1|Overall Study|Refused treatment|1
1286191|NCT00354341|4196413|P2|Overall Study|Death|2
1286192|NCT00354341|4196414|P1|Overall Study|Death|0
1286193|NCT00354341|4196413|P2|Overall Study|Adverse Event|0
1286194|NCT00354341|4196414|P1|Overall Study|Adverse Event|1
1286195|NCT00354172|4196436|P1|Overall Study|Did not receive transplant|1
1286196|NCT00354159|4196456|P2|Long-term Follow-up|Study Closed|34
1286197|NCT00354159|4196457|P1|Long-term Follow-up|Study Closed|29
1286198|NCT00354159|4196456|P2|Long-term Follow-up|Death|11
1286199|NCT00354159|4196457|P1|Long-term Follow-up|Death|14
1286200|NCT00354159|4196456|P2|Long-term Follow-up|Lost to Follow-up|0
1286201|NCT00354159|4196457|P1|Long-term Follow-up|Lost to Follow-up|1
1286202|NCT00354159|4196456|P2|Long-term Follow-up|Physician Decision|122
1286203|NCT00354159|4196457|P1|Long-term Follow-up|Physician Decision|127
1286204|NCT00354159|4196456|P2|Long-term Follow-up|Withdrawal by Subject|9
1286205|NCT00354159|4196457|P1|Long-term Follow-up|Withdrawal by Subject|9
1286206|NCT00354159|4196456|P2|Randomized Study Period|Death|9
1286207|NCT00354159|4196457|P1|Randomized Study Period|Death|7
1286208|NCT00354159|4196456|P2|Randomized Study Period|Lost to Follow-up|0
1286209|NCT00354159|4196457|P1|Randomized Study Period|Lost to Follow-up|4
1286210|NCT00354159|4196456|P2|Randomized Study Period|Physician Decision|10
1286211|NCT00354159|4196457|P1|Randomized Study Period|Physician Decision|6
1286212|NCT00354159|4196456|P2|Randomized Study Period|Withdrawal by Subject|3
1286213|NCT00354159|4196457|P1|Randomized Study Period|Withdrawal by Subject|5
1286214|NCT00354107|4196500|P1|Overall Study|Withdrawal by Subject|1
1286215|NCT00354107|4196500|P1|Overall Study|Physician Decision|2
1286216|NCT00354107|4196500|P1|Overall Study|Adverse Event|2
1286217|NCT00354029|4196510|P2|Overall Study|Protocol Violation|2
1286218|NCT00354029|4196511|P1|Overall Study|Protocol Violation|4
1286219|NCT00353873|4196523|P2|Overall Study|Withdrawal by Subject|1
1286220|NCT00353873|4196524|P1|Overall Study|Withdrawal by Subject|1
1286221|NCT00353873|4196523|P2|Overall Study|Physician Decision|0
1286222|NCT00353873|4196524|P1|Overall Study|Physician Decision|2
1286223|NCT00353873|4196523|P2|Overall Study|Adverse Event|0
1286224|NCT00353873|4196524|P1|Overall Study|Adverse Event|1
1286225|NCT00353873|4196523|P2|Overall Study|Exacerbation|0
1286226|NCT00353873|4196524|P1|Overall Study|Exacerbation|1
1286227|NCT00353873|4196523|P2|Overall Study|Protocol Violation|2
1286228|NCT00353873|4196524|P1|Overall Study|Protocol Violation|1
1286229|NCT00353704|4196553|P2|Overall Study|Protocol Violation|1
1286230|NCT00353704|4196554|P1|Overall Study|Protocol Violation|3
1286231|NCT00353496|4196589|P2|Overall Study|Not otherwise specified|2
1286232|NCT00353496|4196590|P1|Overall Study|Not otherwise specified|4
1286233|NCT00353496|4196589|P2|Overall Study|Physician Decision|9
1286234|NCT00353496|4196590|P1|Overall Study|Physician Decision|6
1286235|NCT00353496|4196589|P2|Overall Study|Withdrawal by Subject|4
1286236|NCT00353496|4196590|P1|Overall Study|Withdrawal by Subject|3
1286237|NCT00353496|4196589|P2|Overall Study|Protocol Violation|2
1286238|NCT00353496|4196590|P1|Overall Study|Protocol Violation|2
1286239|NCT00353496|4196589|P2|Overall Study|Adverse Event|0
1286240|NCT00353496|4196590|P1|Overall Study|Adverse Event|1
1286241|NCT00353366|4196643|P1|Overall Study|Other|135
1286242|NCT00353366|4196643|P1|Overall Study|Adverse Event|8
1286243|NCT00353262|4196670|P1|Overall Study|Break from Chemotherapy|1
1286244|NCT00353262|4196670|P1|Overall Study|Surgery|4
1286245|NCT00353262|4196670|P1|Overall Study|Progression|1
1286246|NCT00353262|4196670|P1|Overall Study|Insufficient Therapeutic Response|13
1286247|NCT00353262|4196670|P1|Overall Study|Withdrawal by Subject|2
1286248|NCT00353262|4196670|P1|Overall Study|Adverse Event|8
1286249|NCT00352885|4196711|P2|Overall Study|Side effects of IL-2 administration|0
1286250|NCT00352885|4196712|P1|Overall Study|Side effects of IL-2 administration|1
1286251|NCT00352885|4196711|P2|Overall Study|Progression of metastatic melanoma|3
1286252|NCT00352885|4196712|P1|Overall Study|Progression of metastatic melanoma|5
1286253|NCT00352885|4196711|P2|Overall Study|Development of major depression|1
1286254|NCT00352885|4196712|P1|Overall Study|Development of major depression|0
1286255|NCT00352885|4196711|P2|Overall Study|Withdrawal by Subject|3
1286256|NCT00352885|4196712|P1|Overall Study|Withdrawal by Subject|0
1286257|NCT00352846|4196730|P2|Overall Study|Death|1
1286258|NCT00352846|4196731|P1|Overall Study|Death|0
1286259|NCT00352846|4196730|P2|Overall Study|Non-compliance|0
1286260|NCT00352846|4196731|P1|Overall Study|Non-compliance|2
1286261|NCT00352846|4196730|P2|Overall Study|Ineligible|2
1286262|NCT00352846|4196731|P1|Overall Study|Ineligible|3
1286263|NCT00352846|4196730|P2|Overall Study|Withdrawal by Subject|8
1286264|NCT00352846|4196731|P1|Overall Study|Withdrawal by Subject|3
1286265|NCT00352846|4196730|P2|Overall Study|Disease progression|2
1286266|NCT00352846|4196731|P1|Overall Study|Disease progression|0
1286267|NCT00352755|4196742|P1|Overall Study|Adverse Event|1
1286268|NCT00352755|4196742|P1|Overall Study|Physician Decision|1
1286269|NCT00352690|4196752|P2|Overall Study|Determined to be ineligible|0
1286270|NCT00352690|4196753|P1|Overall Study|Determined to be ineligible|2
1286271|NCT00352664|4196773|P2|Overall Study|Withdrawal by Subject|0
1286272|NCT00352664|4196774|P1|Overall Study|Withdrawal by Subject|7
1286273|NCT00352534|4196791|P7|Final Risk Group Assignment|Death|0
1286274|NCT00352534|4196792|P6|Final Risk Group Assignment|Death|2
1286275|NCT00352534|4196793|P5|Final Risk Group Assignment|Death|0
1286276|NCT00352534|4196794|P4|Final Risk Group Assignment|Death|0
1286277|NCT00352534|4196795|P3|Final Risk Group Assignment|Death|0
1286278|NCT00352534|4196796|P2|Final Risk Group Assignment|Death|0
1286279|NCT00352534|4196797|P1|Final Risk Group Assignment|Death|0
1286280|NCT00352534|4196791|P7|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11
1286281|NCT00352534|4196792|P6|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
1286282|NCT00352534|4196793|P5|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
1286283|NCT00352534|4196794|P4|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
1286284|NCT00352534|4196795|P3|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
1286285|NCT00352534|4196796|P2|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
1286286|NCT00352534|4196797|P1|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
1286287|NCT00352534|4196791|P7|Final Risk Group Assignment|Enrollment onto another COG study|28
1286288|NCT00352534|4196792|P6|Final Risk Group Assignment|Enrollment onto another COG study|0
1286289|NCT00352534|4196793|P5|Final Risk Group Assignment|Enrollment onto another COG study|0
1286290|NCT00352534|4196794|P4|Final Risk Group Assignment|Enrollment onto another COG study|0
1286291|NCT00352534|4196795|P3|Final Risk Group Assignment|Enrollment onto another COG study|0
1286292|NCT00352534|4196796|P2|Final Risk Group Assignment|Enrollment onto another COG study|0
1286293|NCT00352534|4196797|P1|Final Risk Group Assignment|Enrollment onto another COG study|0
1286294|NCT00352534|4196791|P7|Final Risk Group Assignment|Ineligible|0
1286295|NCT00352534|4196792|P6|Final Risk Group Assignment|Ineligible|13
1286296|NCT00352534|4196793|P5|Final Risk Group Assignment|Ineligible|0
1286297|NCT00352534|4196794|P4|Final Risk Group Assignment|Ineligible|1
1286298|NCT00352534|4196795|P3|Final Risk Group Assignment|Ineligible|3
1286299|NCT00352534|4196796|P2|Final Risk Group Assignment|Ineligible|0
1286300|NCT00352534|4196797|P1|Final Risk Group Assignment|Ineligible|0
1286301|NCT00352534|4196791|P7|Final Risk Group Assignment|Withdrawal by Subject|0
1286302|NCT00352534|4196792|P6|Final Risk Group Assignment|Withdrawal by Subject|3
1286303|NCT00352534|4196793|P5|Final Risk Group Assignment|Withdrawal by Subject|0
1286304|NCT00352534|4196794|P4|Final Risk Group Assignment|Withdrawal by Subject|0
1286305|NCT00352534|4196795|P3|Final Risk Group Assignment|Withdrawal by Subject|0
1286306|NCT00352534|4196796|P2|Final Risk Group Assignment|Withdrawal by Subject|0
1286307|NCT00352534|4196797|P1|Final Risk Group Assignment|Withdrawal by Subject|0
1286308|NCT00352534|4196791|P7|Final Risk Group Assignment|Physician Decision|0
1286309|NCT00352534|4196792|P6|Final Risk Group Assignment|Physician Decision|8
1286310|NCT00352534|4196793|P5|Final Risk Group Assignment|Physician Decision|0
1286311|NCT00352534|4196794|P4|Final Risk Group Assignment|Physician Decision|0
1286312|NCT00352534|4196795|P3|Final Risk Group Assignment|Physician Decision|0
1286313|NCT00352534|4196796|P2|Final Risk Group Assignment|Physician Decision|0
1286314|NCT00352534|4196797|P1|Final Risk Group Assignment|Physician Decision|0
1286315|NCT00352534|4196791|P7|Final Risk Group Assignment|Lack of Efficacy|0
1286316|NCT00352534|4196792|P6|Final Risk Group Assignment|Lack of Efficacy|19
1286317|NCT00352534|4196793|P5|Final Risk Group Assignment|Lack of Efficacy|1
1286318|NCT00352534|4196794|P4|Final Risk Group Assignment|Lack of Efficacy|2
1286319|NCT00352534|4196795|P3|Final Risk Group Assignment|Lack of Efficacy|0
1286320|NCT00352534|4196796|P2|Final Risk Group Assignment|Lack of Efficacy|0
1286321|NCT00352534|4196797|P1|Final Risk Group Assignment|Lack of Efficacy|0
1286322|NCT00352534|4196791|P7|Initial Staging|Ineligible|0
1286323|NCT00352534|4196792|P6|Initial Staging|Ineligible|0
1286324|NCT00352534|4196793|P5|Initial Staging|Ineligible|0
1286325|NCT00352534|4196794|P4|Initial Staging|Ineligible|0
1286326|NCT00352534|4196795|P3|Initial Staging|Ineligible|0
1286327|NCT00352534|4196796|P2|Initial Staging|Ineligible|9
1286328|NCT00352534|4196797|P1|Initial Staging|Ineligible|8
1286329|NCT00352417|4196814|P2|Overall Study|Schedule Change|1
1286330|NCT00352417|4196815|P1|Overall Study|Schedule Change|2
1286331|NCT00352417|4196814|P2|Overall Study|Lost to Follow-up|0
1286332|NCT00352417|4196815|P1|Overall Study|Lost to Follow-up|1
1286333|NCT00352417|4196814|P2|Overall Study|Withdrawal by Subject|2
1286334|NCT00352417|4196815|P1|Overall Study|Withdrawal by Subject|1
1286335|NCT00352417|4196814|P2|Overall Study|Protocol Violation|2
1286336|NCT00352417|4196815|P1|Overall Study|Protocol Violation|0
1286337|NCT00352417|4196814|P2|Overall Study|Adverse Event|0
1286338|NCT00352417|4196815|P1|Overall Study|Adverse Event|1
1286339|NCT00352365|4196829|P1|Maintenance Therapy|Not eligible|4
1286340|NCT00352365|4196829|P1|Maintenance Therapy|Not protocol specified|3
1286341|NCT00352365|4196829|P1|Maintenance Therapy|Death|2
1286342|NCT00352365|4196829|P1|Maintenance Therapy|Progression/Relapse|3
1286343|NCT00352365|4196829|P1|Induction Therapy|Death before starting protocol therapy|1
1286344|NCT00352365|4196829|P1|Induction Therapy|Not eligible|3
1286345|NCT00352365|4196829|P1|Induction Therapy|Not protocol specified|1
1286346|NCT00352365|4196829|P1|Induction Therapy|Death|7
1286347|NCT00352365|4196829|P1|Induction Therapy|Progression/Relapse|8
1286348|NCT00352365|4196829|P1|Induction Therapy|Adverse Event|7
1286349|NCT00352118|4196839|P1|Overall Study|Physician Decision|4
1286350|NCT00352105|4196849|P1|Overall Study|Protocol Violation|2
1286351|NCT00352105|4196849|P1|Overall Study|Adverse Event|19
1286352|NCT00352105|4196849|P1|Overall Study|Lack of Efficacy|9
1286353|NCT00352105|4196849|P1|Overall Study|Withdrawal by Subject|5
1286354|NCT00352105|4196849|P1|Overall Study|Death|5
1286355|NCT00352053|4196860|P2|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1
1286356|NCT00352053|4196861|P1|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0
1286357|NCT00352053|4196860|P2|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
1286358|NCT00352053|4196861|P1|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
1286359|NCT00352053|4196860|P2|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
1286360|NCT00352053|4196861|P1|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
1286361|NCT00352053|4196860|P2|Second Extension Phase (Weeks 144-240)|Physician Decision|4
1286362|NCT00352053|4196861|P1|Second Extension Phase (Weeks 144-240)|Physician Decision|4
1286363|NCT00352053|4196860|P2|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0
1286364|NCT00352053|4196861|P1|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1
1286365|NCT00352053|4196860|P2|First Extension Phase (Weeks 48-144)|Pregnancy|0
1286366|NCT00352053|4196861|P1|First Extension Phase (Weeks 48-144)|Pregnancy|1
1286367|NCT00352053|4196860|P2|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4
1286368|NCT00352053|4196861|P1|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1
1286369|NCT00352053|4196860|P2|First Extension Phase (Weeks 48-144)|Physician Decision|13
1286370|NCT00352053|4196861|P1|First Extension Phase (Weeks 48-144)|Physician Decision|9
1286371|NCT00352053|4196860|P2|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0
1286372|NCT00352053|4196861|P1|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1
1286373|NCT00352053|4196860|P2|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1
1286374|NCT00352053|4196861|P1|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0
1286375|NCT00352053|4196860|P2|Double-Blind Phase (Through Week 48)|Adverse Event|0
1286376|NCT00352053|4196861|P1|Double-Blind Phase (Through Week 48)|Adverse Event|1
1286377|NCT00352053|4196860|P2|Double-Blind Phase (Through Week 48)|Physician Decision|2
1286378|NCT00352053|4196861|P1|Double-Blind Phase (Through Week 48)|Physician Decision|2
1286379|NCT00352053|4196860|P2|Double-Blind Phase (Through Week 48)|Virologic Failure|10
1286380|NCT00352053|4196861|P1|Double-Blind Phase (Through Week 48)|Virologic Failure|14
1286381|NCT00352027|4197028|P1|Overall Study|Progressive disease|3
1286382|NCT00351819|4197327|P2|Overall Study|Enrolled in another trial|1
1286383|NCT00351819|4197328|P1|Overall Study|Enrolled in another trial|0
1286384|NCT00351819|4197327|P2|Overall Study|Incarcerated|1
1286385|NCT00351819|4197328|P1|Overall Study|Incarcerated|0
1286386|NCT00351819|4197327|P2|Overall Study|Non-compliance|1
1286387|NCT00351819|4197328|P1|Overall Study|Non-compliance|0
1286388|NCT00351819|4197327|P2|Overall Study|Unprofessional behavior|0
1286389|NCT00351819|4197328|P1|Overall Study|Unprofessional behavior|1
1286390|NCT00351819|4197327|P2|Overall Study|Traumatic ankle fracture|0
1286391|NCT00351819|4197328|P1|Overall Study|Traumatic ankle fracture|1
1286392|NCT00351819|4197327|P2|Overall Study|Elevated PSA|1
1286393|NCT00351819|4197328|P1|Overall Study|Elevated PSA|1
1286394|NCT00351819|4197327|P2|Overall Study|Withdrawal by Subject|4
1286395|NCT00351819|4197328|P1|Overall Study|Withdrawal by Subject|0
1286396|NCT00351819|4197327|P2|Overall Study|Lost to Follow-up|4
1286397|NCT00351819|4197328|P1|Overall Study|Lost to Follow-up|4
1286398|NCT00351533|4197399|P2|Overall Study|Withdrawal by Subject|1
1286399|NCT00351533|4197400|P1|Overall Study|Withdrawal by Subject|0
1286400|NCT00351533|4197399|P2|Overall Study|Physician Decision|1
1286401|NCT00351533|4197400|P1|Overall Study|Physician Decision|0
1286402|NCT00351533|4197399|P2|Overall Study|Lost to Follow-up|3
1286403|NCT00351533|4197400|P1|Overall Study|Lost to Follow-up|1
1286404|NCT00351533|4197399|P2|Overall Study|Extubated before first BAL|0
1286405|NCT00351533|4197400|P1|Overall Study|Extubated before first BAL|1
1286406|NCT00351468|4197460|P1|Overall Study|Protocol Violation|3
1286407|NCT00351468|4197460|P1|Overall Study|Lost to Follow-up|4
1286408|NCT00351468|4197460|P1|Overall Study|Non-compliance|8
1286409|NCT00351468|4197460|P1|Overall Study|Lack of Efficacy|32
1286410|NCT00351468|4197460|P1|Overall Study|Various -follow up w clinical team|39
1286411|NCT00351468|4197460|P1|Overall Study|Withdrawal by Subject|39
1286412|NCT00351468|4197460|P1|Overall Study|Adverse Event|42
1286413|NCT00351377|4197484|P1|Overall Study|Unsatisfactory therapeutic effect|1
1286414|NCT00351377|4197484|P1|Overall Study|Death|1
1286415|NCT00351377|4197484|P1|Overall Study|Adverse Event|5
1286416|NCT00351351|4197498|P2|Overall Study|surgical access pbs; device issues|4
1286417|NCT00351351|4197499|P1|Overall Study|surgical access pbs; device issues|9
1286418|NCT00351273|4197525|P3|Overall Study|Lost to Follow-up|5
1286419|NCT00351273|4197526|P2|Overall Study|Lost to Follow-up|2
1286420|NCT00351273|4197527|P1|Overall Study|Lost to Follow-up|1
1286421|NCT00350870|4197570|P4|Overall Study|Physician Decision|1
1286422|NCT00350870|4197571|P3|Overall Study|Physician Decision|1
1286423|NCT00350870|4197572|P2|Overall Study|Physician Decision|0
1286424|NCT00350870|4197573|P1|Overall Study|Physician Decision|1
1286425|NCT00350870|4197570|P4|Overall Study|Withdrawal by Subject|14
1286426|NCT00350870|4197571|P3|Overall Study|Withdrawal by Subject|15
1286427|NCT00350870|4197572|P2|Overall Study|Withdrawal by Subject|17
1286428|NCT00350870|4197573|P1|Overall Study|Withdrawal by Subject|21
1286429|NCT00350844|4197587|P1|Overall Study|Lost to Follow-up|1
1286430|NCT00350792|4197591|P1|Overall Study|Lack of Efficacy|11
1286431|NCT00350792|4197591|P1|Overall Study|Physician Decision|2
1286432|NCT00350792|4197591|P1|Overall Study|Withdrawal by Subject|4
1286433|NCT00350792|4197591|P1|Overall Study|Protocol Violation|1
1286434|NCT00350792|4197591|P1|Overall Study|Death Not Study Drug Related|2
1286435|NCT00350792|4197591|P1|Overall Study|Death from Study Drug Toxicity|1
1286436|NCT00350792|4197591|P1|Overall Study|Death from Study Disease|1
1286437|NCT00350792|4197591|P1|Overall Study|Adverse Event|11
1286438|NCT00350779|4197601|P2|Overall Study|Non-compliance with study procedures|1
1286439|NCT00350779|4197602|P1|Overall Study|Non-compliance with study procedures|0
1286440|NCT00350779|4197601|P2|Overall Study|Patient Moved|1
1286441|NCT00350779|4197602|P1|Overall Study|Patient Moved|2
1286442|NCT00350779|4197601|P2|Overall Study|Withdrawal by Subject|8
1286443|NCT00350779|4197602|P1|Overall Study|Withdrawal by Subject|9
1286444|NCT00350779|4197601|P2|Overall Study|Protocol Violation|1
1286445|NCT00350779|4197602|P1|Overall Study|Protocol Violation|3
1286446|NCT00350779|4197601|P2|Overall Study|Physician Decision|4
1286447|NCT00350779|4197602|P1|Overall Study|Physician Decision|2
1286448|NCT00350779|4197601|P2|Overall Study|Lost to Follow-up|0
1286449|NCT00350779|4197602|P1|Overall Study|Lost to Follow-up|2
1286450|NCT00350779|4197601|P2|Overall Study|Lack of Efficacy|4
1286451|NCT00350779|4197602|P1|Overall Study|Lack of Efficacy|0
1286452|NCT00350779|4197601|P2|Overall Study|Adverse Event|2
1286453|NCT00350779|4197602|P1|Overall Study|Adverse Event|4
1286454|NCT00350727|4197623|P3|Phase II|Enrolled in Rollover Study|1
1286455|NCT00350727|4197624|P2|Phase II|Enrolled in Rollover Study|0
1286456|NCT00350727|4197625|P1|Phase II|Enrolled in Rollover Study|0
1286457|NCT00350727|4197623|P3|Phase II|Sponsor Terminated Study|1
1286458|NCT00350727|4197624|P2|Phase II|Sponsor Terminated Study|0
1286459|NCT00350727|4197625|P1|Phase II|Sponsor Terminated Study|0
1286460|NCT00350727|4197623|P3|Phase II|Death|2
1286461|NCT00350727|4197624|P2|Phase II|Death|0
1286462|NCT00350727|4197625|P1|Phase II|Death|0
1286463|NCT00350727|4197623|P3|Phase II|Adverse Event|1
1286464|NCT00350727|4197624|P2|Phase II|Adverse Event|1
1286465|NCT00350727|4197625|P1|Phase II|Adverse Event|0
1286466|NCT00350727|4197623|P3|Phase II|Withdrawal by Subject|1
1286467|NCT00350727|4197624|P2|Phase II|Withdrawal by Subject|2
1286468|NCT00350727|4197625|P1|Phase II|Withdrawal by Subject|0
1286469|NCT00350727|4197623|P3|Phase II|Clinical Deterioration|0
1286470|NCT00350727|4197624|P2|Phase II|Clinical Deterioration|1
1286471|NCT00350727|4197625|P1|Phase II|Clinical Deterioration|0
1286472|NCT00350727|4197623|P3|Phase II|Disease Progression|16
1286473|NCT00350727|4197624|P2|Phase II|Disease Progression|15
1286474|NCT00350727|4197625|P1|Phase II|Disease Progression|0
1286475|NCT00350727|4197623|P3|Phase I: Dose Escalation|Transition to Extension Phase|0
1286476|NCT00350727|4197624|P2|Phase I: Dose Escalation|Transition to Extension Phase|0
1286477|NCT00350727|4197625|P1|Phase I: Dose Escalation|Transition to Extension Phase|3
1286478|NCT00350727|4197623|P3|Phase I: Dose Escalation|Physician Decision|0
1286479|NCT00350727|4197624|P2|Phase I: Dose Escalation|Physician Decision|0
1286480|NCT00350727|4197625|P1|Phase I: Dose Escalation|Physician Decision|1
1286481|NCT00350727|4197623|P3|Phase I: Dose Escalation|Death|0
1286482|NCT00350727|4197624|P2|Phase I: Dose Escalation|Death|0
1286483|NCT00350727|4197625|P1|Phase I: Dose Escalation|Death|1
1286484|NCT00350727|4197623|P3|Phase I: Dose Escalation|Lack of Efficacy|0
1286485|NCT00350727|4197624|P2|Phase I: Dose Escalation|Lack of Efficacy|0
1286486|NCT00350727|4197625|P1|Phase I: Dose Escalation|Lack of Efficacy|25
1286487|NCT00350727|4197623|P3|Phase I: Dose Escalation|Adverse Event|0
1286488|NCT00350727|4197624|P2|Phase I: Dose Escalation|Adverse Event|0
1286489|NCT00350727|4197625|P1|Phase I: Dose Escalation|Adverse Event|4
1286490|NCT00350636|4197769|P2|Overall Study|Other|2
1286491|NCT00350636|4197770|P1|Overall Study|Other|1
1286492|NCT00350636|4197769|P2|Overall Study|Physician Decision|2
1286493|NCT00350636|4197770|P1|Overall Study|Physician Decision|0
1286494|NCT00350636|4197769|P2|Overall Study|Lost to Follow-up|8
1286495|NCT00350636|4197770|P1|Overall Study|Lost to Follow-up|9
1286496|NCT00350636|4197769|P2|Overall Study|Withdrawal by Subject|17
1286497|NCT00350636|4197770|P1|Overall Study|Withdrawal by Subject|13
1286498|NCT00350636|4197769|P2|Overall Study|Protocol Violation|3
1286499|NCT00350636|4197770|P1|Overall Study|Protocol Violation|1
1286500|NCT00350636|4197769|P2|Overall Study|Adverse Event|13
1286501|NCT00350636|4197770|P1|Overall Study|Adverse Event|19
1286502|NCT00350623|4197789|P3|Overall Study|patient traveling outside the country|1
1286503|NCT00350623|4197790|P2|Overall Study|patient traveling outside the country|0
1286504|NCT00350623|4197791|P1|Overall Study|patient traveling outside the country|0
1286505|NCT00350623|4197789|P3|Overall Study|Withdrawal by Subject|1
1286506|NCT00350623|4197790|P2|Overall Study|Withdrawal by Subject|1
1286507|NCT00350623|4197791|P1|Overall Study|Withdrawal by Subject|0
1286508|NCT00350623|4197789|P3|Overall Study|Lost to Follow-up|4
1286509|NCT00350623|4197790|P2|Overall Study|Lost to Follow-up|3
1286510|NCT00350623|4197791|P1|Overall Study|Lost to Follow-up|8
1286511|NCT00350545|4197799|P1|Overall Study|Withdrawal by Subject|2
1286512|NCT00350519|4197818|P2|Overall Study|Withdrawal by Subject|2
1286513|NCT00350519|4197819|P1|Overall Study|Withdrawal by Subject|3
1286514|NCT00350519|4197818|P2|Overall Study|Protocol Violation|2
1286515|NCT00350519|4197819|P1|Overall Study|Protocol Violation|1
1286516|NCT00350519|4197818|P2|Overall Study|Physician Decision|1
1286517|NCT00350519|4197819|P1|Overall Study|Physician Decision|0
1286518|NCT00350519|4197818|P2|Overall Study|Death|1
1286519|NCT00350519|4197819|P1|Overall Study|Death|0
1286520|NCT00350402|4197833|P2|Overall Study|Lost to Follow-up|1
1286521|NCT00350402|4197834|P1|Overall Study|Lost to Follow-up|1
1286522|NCT00350272|4197907|P2|Open-Label 84 Week Treatment|Sponsor decision|1
1286523|NCT00350272|4197908|P1|Open-Label 84 Week Treatment|Sponsor decision|2
1286524|NCT00350272|4197907|P2|Open-Label 84 Week Treatment|Physician Decision|2
1286525|NCT00350272|4197908|P1|Open-Label 84 Week Treatment|Physician Decision|1
1286526|NCT00350272|4197907|P2|Open-Label 84 Week Treatment|Withdrawal by Subject|2
1286527|NCT00350272|4197908|P1|Open-Label 84 Week Treatment|Withdrawal by Subject|1
1286528|NCT00350272|4197907|P2|Open-Label 84 Week Treatment|Lost to Follow-up|2
1286529|NCT00350272|4197908|P1|Open-Label 84 Week Treatment|Lost to Follow-up|3
1286530|NCT00350272|4197907|P2|Open-Label 84 Week Treatment|Adverse Event|1
1286531|NCT00350272|4197908|P1|Open-Label 84 Week Treatment|Adverse Event|2
1286532|NCT00350272|4197907|P2|Blinded 12 Week Treatment|Sponsor decision|1
1286533|NCT00350272|4197908|P1|Blinded 12 Week Treatment|Sponsor decision|0
1286534|NCT00350272|4197907|P2|Blinded 12 Week Treatment|Physician Decision|1
1286535|NCT00350272|4197908|P1|Blinded 12 Week Treatment|Physician Decision|2
1286536|NCT00350272|4197907|P2|Blinded 12 Week Treatment|Withdrawal by Subject|0
1286537|NCT00350272|4197908|P1|Blinded 12 Week Treatment|Withdrawal by Subject|3
1286538|NCT00350272|4197907|P2|Blinded 12 Week Treatment|Lost to Follow-up|0
1286539|NCT00350272|4197908|P1|Blinded 12 Week Treatment|Lost to Follow-up|2
1286540|NCT00350272|4197907|P2|Blinded 12 Week Treatment|Death|0
1286541|NCT00350272|4197908|P1|Blinded 12 Week Treatment|Death|1
1286542|NCT00350272|4197907|P2|Blinded 12 Week Treatment|Adverse Event|0
1286543|NCT00350272|4197908|P1|Blinded 12 Week Treatment|Adverse Event|1
1286544|NCT00350207|4197930|P3|Overall Study|Other|1
1286545|NCT00350207|4197931|P2|Overall Study|Other|3
1286546|NCT00350207|4197932|P1|Overall Study|Other|1
1286547|NCT00350207|4197930|P3|Overall Study|Withdrawal by Subject|1
1286548|NCT00350207|4197931|P2|Overall Study|Withdrawal by Subject|1
1286549|NCT00350207|4197932|P1|Overall Study|Withdrawal by Subject|0
1286550|NCT00350207|4197930|P3|Overall Study|Lost to Follow-up|1
1286551|NCT00350207|4197931|P2|Overall Study|Lost to Follow-up|0
1286552|NCT00350207|4197932|P1|Overall Study|Lost to Follow-up|1
1286553|NCT00350207|4197930|P3|Overall Study|Lack of Efficacy|2
1286554|NCT00350207|4197931|P2|Overall Study|Lack of Efficacy|0
1286555|NCT00350207|4197932|P1|Overall Study|Lack of Efficacy|1
1286556|NCT00350207|4197930|P3|Overall Study|Adverse Event|2
1286557|NCT00350207|4197931|P2|Overall Study|Adverse Event|2
1286558|NCT00350207|4197932|P1|Overall Study|Adverse Event|5
1286559|NCT00349973|4198144|P2|Overall Study|Withdrawal by Subject|0
1286560|NCT00349973|4198145|P1|Overall Study|Withdrawal by Subject|1
1286561|NCT00349973|4198144|P2|Overall Study|Adverse Event|3
1286562|NCT00349973|4198145|P1|Overall Study|Adverse Event|3
1286563|NCT00349921|4198159|P4|First Spinal Injection|Adverse Event|0
1286564|NCT00349921|4198160|P3|First Spinal Injection|Adverse Event|1
1286565|NCT00349921|4198161|P2|First Spinal Injection|Adverse Event|0
1286566|NCT00349921|4198162|P1|First Spinal Injection|Adverse Event|0
1286567|NCT00349921|4198159|P4|First Spinal Injection|Physician Decision|0
1286568|NCT00349921|4198160|P3|First Spinal Injection|Physician Decision|0
1286569|NCT00349921|4198161|P2|First Spinal Injection|Physician Decision|0
1286570|NCT00349921|4198162|P1|First Spinal Injection|Physician Decision|1
1286571|NCT00349908|4198173|P2|Overall Study|Withdrawal by Subject|4
1286572|NCT00349908|4198174|P1|Overall Study|Withdrawal by Subject|0
1286573|NCT00349752|4198200|P2|Overall Study|Other:History of squamous cell carcinoma|0
1286574|NCT00349752|4198201|P1|Overall Study|Other:History of squamous cell carcinoma|1
1286575|NCT00349752|4198200|P2|Overall Study|Other: Inadvertently unblinded|0
1286576|NCT00349752|4198201|P1|Overall Study|Other: Inadvertently unblinded|1
1286577|NCT00349752|4198200|P2|Overall Study|Other: Ineligible|0
1286578|NCT00349752|4198201|P1|Overall Study|Other: Ineligible|1
1286579|NCT00349752|4198200|P2|Overall Study|Other: Patient's steroid use|0
1286580|NCT00349752|4198201|P1|Overall Study|Other: Patient's steroid use|1
1286581|NCT00349752|4198200|P2|Overall Study|Other: Patient stopped steroids|1
1286582|NCT00349752|4198201|P1|Overall Study|Other: Patient stopped steroids|0
1286583|NCT00349752|4198200|P2|Overall Study|Other: Non compliance|1
1286584|NCT00349752|4198201|P1|Overall Study|Other: Non compliance|0
1286585|NCT00349752|4198200|P2|Overall Study|Other: Required exclusionary medication|1
1286586|NCT00349752|4198201|P1|Overall Study|Other: Required exclusionary medication|0
1286587|NCT00349752|4198200|P2|Overall Study|Personal reasons|5
1286588|NCT00349752|4198201|P1|Overall Study|Personal reasons|6
1286589|NCT00349752|4198200|P2|Overall Study|Lost to Follow-up|2
1286590|NCT00349752|4198201|P1|Overall Study|Lost to Follow-up|4
1286591|NCT00349752|4198200|P2|Overall Study|Lack of Efficacy|42
1286592|NCT00349752|4198201|P1|Overall Study|Lack of Efficacy|37
1286593|NCT00349752|4198200|P2|Overall Study|Adverse Event|12
1286594|NCT00349752|4198201|P1|Overall Study|Adverse Event|8
1286595|NCT00349622|4198254|P2|Overall Study|Withdrawal by Subject|9
1286596|NCT00349622|4198255|P1|Overall Study|Withdrawal by Subject|5
1286597|NCT00349622|4198254|P2|Overall Study|Lost to Follow-up|1
1286598|NCT00349622|4198255|P1|Overall Study|Lost to Follow-up|5
1286599|NCT00349622|4198254|P2|Overall Study|Death|86
1286600|NCT00349622|4198255|P1|Overall Study|Death|168
1286601|NCT00349349|4198292|P3|Overall Study|New Malignancy (Bladder Cancer)|0
1286602|NCT00349349|4198293|P2|Overall Study|New Malignancy (Bladder Cancer)|1
1286603|NCT00349349|4198294|P1|Overall Study|New Malignancy (Bladder Cancer)|0
1286604|NCT00349349|4198292|P3|Overall Study|No Response|0
1286605|NCT00349349|4198293|P2|Overall Study|No Response|3
1286606|NCT00349349|4198294|P1|Overall Study|No Response|0
1286607|NCT00349349|4198292|P3|Overall Study|Physician Decision|1
1286608|NCT00349349|4198293|P2|Overall Study|Physician Decision|2
1286609|NCT00349349|4198294|P1|Overall Study|Physician Decision|1
1286610|NCT00349349|4198292|P3|Overall Study|Participant Reduced General Condition|0
1286611|NCT00349349|4198293|P2|Overall Study|Participant Reduced General Condition|1
1286612|NCT00349349|4198294|P1|Overall Study|Participant Reduced General Condition|0
1286613|NCT00349349|4198292|P3|Overall Study|Other Treatment Selected|0
1286614|NCT00349349|4198293|P2|Overall Study|Other Treatment Selected|0
1286615|NCT00349349|4198294|P1|Overall Study|Other Treatment Selected|2
1286616|NCT00349349|4198292|P3|Overall Study|Death|1
1286617|NCT00349349|4198293|P2|Overall Study|Death|10
1286618|NCT00349349|4198294|P1|Overall Study|Death|13
1286619|NCT00349349|4198292|P3|Overall Study|Withdrawn due to Disease Progression|1
1286620|NCT00349349|4198293|P2|Overall Study|Withdrawn due to Disease Progression|37
1286621|NCT00349349|4198294|P1|Overall Study|Withdrawn due to Disease Progression|27
1286622|NCT00349349|4198292|P3|Overall Study|Withdrawal by Subject|1
1286623|NCT00349349|4198293|P2|Overall Study|Withdrawal by Subject|2
1286624|NCT00349349|4198294|P1|Overall Study|Withdrawal by Subject|5
1286625|NCT00349349|4198292|P3|Overall Study|Adverse Event|2
1286626|NCT00349349|4198293|P2|Overall Study|Adverse Event|6
1286627|NCT00349349|4198294|P1|Overall Study|Adverse Event|5
1286628|NCT00348933|4198383|P1|Overall Study|Adverse Event|7
1286629|NCT00348933|4198383|P1|Overall Study|Protocol Violation|2
1286630|NCT00348933|4198383|P1|Overall Study|Lost to Follow-up|6
1286631|NCT00348933|4198383|P1|Overall Study|Withdrawal by Subject|10
1286632|NCT00348881|4198391|P2|Overall Study|Serious Adverse Event|2
1286633|NCT00348881|4198392|P1|Overall Study|Serious Adverse Event|0
1286634|NCT00348881|4198391|P2|Overall Study|Adverse Event|0
1286635|NCT00348881|4198392|P1|Overall Study|Adverse Event|2
1286636|NCT00348881|4198391|P2|Overall Study|Withdrawal by Subject|4
1286637|NCT00348881|4198392|P1|Overall Study|Withdrawal by Subject|3
1286638|NCT00348881|4198391|P2|Overall Study|Lost to Follow-up|6
1286639|NCT00348881|4198392|P1|Overall Study|Lost to Follow-up|12
1286640|NCT00348816|4198404|P1|Overall Study|Noncompliance with radiation treatment|1
1286641|NCT00348790|4198411|P1|Completed Treatment|Unable to travel to study site|1
1286642|NCT00348790|4198411|P1|Completed Treatment|Required surgery|2
1286643|NCT00348790|4198411|P1|Completed Treatment|Adverse Event|4
1286644|NCT00348790|4198411|P1|Completed Treatment|Disease progression|14
1286645|NCT00348790|4198411|P1|Completed Treatment|Withdrawal by Subject|4
1286646|NCT00348686|4198423|P1|Overall Study|Multiple Reasons|8
1286647|NCT00348686|4198423|P1|Overall Study|Lost to Follow-up|2
1286648|NCT00348686|4198423|P1|Overall Study|Protocol Violation|6
1286649|NCT00348686|4198423|P1|Overall Study|Adverse Event|5
1286650|NCT00348686|4198423|P1|Overall Study|Withdrawal by Subject|45
1286651|NCT00348673|4198440|P9|Stage 1|Randomized but not Treated|0
1286652|NCT00348673|4198441|P8|Stage 1|Randomized but not Treated|0
1286653|NCT00348673|4198442|P7|Stage 1|Randomized but not Treated|0
1286654|NCT00348673|4198443|P6|Stage 1|Randomized but not Treated|0
1286655|NCT00348673|4198444|P5|Stage 1|Randomized but not Treated|0
1286656|NCT00348673|4198445|P4|Stage 1|Randomized but not Treated|0
1286657|NCT00348673|4198446|P3|Stage 1|Randomized but not Treated|1
1286658|NCT00348673|4198447|P2|Stage 1|Randomized but not Treated|0
1286659|NCT00348673|4198448|P1|Stage 1|Randomized but not Treated|0
1286660|NCT00348556|4198495|P1|Overall Study|Adverse Event|1
1286661|NCT00348374|4198502|P2|Overall Study|randomized but did not receive treatment|7
1286662|NCT00348374|4198503|P1|Overall Study|randomized but did not receive treatment|0
1286663|NCT00348374|4198502|P2|Overall Study|ongoing at date of cutoff|1
1286664|NCT00348374|4198503|P1|Overall Study|ongoing at date of cutoff|1
1286665|NCT00348374|4198502|P2|Overall Study|Other|12
1286666|NCT00348374|4198503|P1|Overall Study|Other|11
1286667|NCT00348374|4198502|P2|Overall Study|Withdrawal by Subject|5
1286668|NCT00348374|4198503|P1|Overall Study|Withdrawal by Subject|5
1286669|NCT00348374|4198502|P2|Overall Study|Lost to Follow-up|3
1286670|NCT00348374|4198503|P1|Overall Study|Lost to Follow-up|1
1286671|NCT00348374|4198502|P2|Overall Study|Adverse Event|4
1286672|NCT00348374|4198503|P1|Overall Study|Adverse Event|1
1286673|NCT00348348|4198550|P2|Overall Study|Adverse event probably related to study|0
1286674|NCT00348348|4198551|P1|Overall Study|Adverse event probably related to study|1
1286675|NCT00348348|4198550|P2|Overall Study|Worsening of BC - Unlikely related|2
1286676|NCT00348348|4198551|P1|Overall Study|Worsening of BC - Unlikely related|1
1286677|NCT00348348|4198550|P2|Overall Study|Worsening of BC - Unrelated to study|3
1286678|NCT00348348|4198551|P1|Overall Study|Worsening of BC - Unrelated to study|0
1286679|NCT00348348|4198550|P2|Overall Study|Dissallowed Meds - possibly releated|1
1286680|NCT00348348|4198551|P1|Overall Study|Dissallowed Meds - possibly releated|1
1286681|NCT00348348|4198550|P2|Overall Study|Dissallowed Meds - unlikley related|1
1286682|NCT00348348|4198551|P1|Overall Study|Dissallowed Meds - unlikley related|1
1286683|NCT00348348|4198550|P2|Overall Study|Dissallowed Meds - unrelated to study|3
1286684|NCT00348348|4198551|P1|Overall Study|Dissallowed Meds - unrelated to study|1
1286685|NCT00348348|4198550|P2|Overall Study|Not specified|4
1286686|NCT00348348|4198551|P1|Overall Study|Not specified|7
1286687|NCT00348348|4198550|P2|Overall Study|Withdrawal by Subject|1
1286688|NCT00348348|4198551|P1|Overall Study|Withdrawal by Subject|4
1286689|NCT00348348|4198550|P2|Overall Study|Lost to Follow-up|10
1286690|NCT00348348|4198551|P1|Overall Study|Lost to Follow-up|8
1286691|NCT00348348|4198550|P2|Overall Study|Lack of Efficacy|1
1286692|NCT00348348|4198551|P1|Overall Study|Lack of Efficacy|1
1286693|NCT00348348|4198550|P2|Overall Study|Adverse event - unrelated to study drug|1
1286694|NCT00348348|4198551|P1|Overall Study|Adverse event - unrelated to study drug|0
1286695|NCT00348309|4198566|P3|Overall Study|HCV career|1
1286696|NCT00348309|4198567|P2|Overall Study|HCV career|0
1286697|NCT00348309|4198568|P1|Overall Study|HCV career|0
1286698|NCT00348309|4198566|P3|Overall Study|Cardiologist recommendations|1
1286699|NCT00348309|4198567|P2|Overall Study|Cardiologist recommendations|0
1286700|NCT00348309|4198568|P1|Overall Study|Cardiologist recommendations|0
1286701|NCT00348309|4198566|P3|Overall Study|ECG abnormal|2
1286702|NCT00348309|4198567|P2|Overall Study|ECG abnormal|0
1286703|NCT00348309|4198568|P1|Overall Study|ECG abnormal|0
1286704|NCT00348309|4198566|P3|Overall Study|Adverse event not attended|1
1286705|NCT00348309|4198567|P2|Overall Study|Adverse event not attended|0
1286706|NCT00348309|4198568|P1|Overall Study|Adverse event not attended|0
1286707|NCT00348309|4198566|P3|Overall Study|Site closure|1
1286708|NCT00348309|4198567|P2|Overall Study|Site closure|0
1286709|NCT00348309|4198568|P1|Overall Study|Site closure|0
1286710|NCT00348309|4198566|P3|Overall Study|Increased dose of Aricept|1
1286711|NCT00348309|4198567|P2|Overall Study|Increased dose of Aricept|0
1286712|NCT00348309|4198568|P1|Overall Study|Increased dose of Aricept|0
1286713|NCT00348309|4198566|P3|Overall Study|Medical Monitor decision|1
1286714|NCT00348309|4198567|P2|Overall Study|Medical Monitor decision|0
1286715|NCT00348309|4198568|P1|Overall Study|Medical Monitor decision|0
1286716|NCT00348309|4198566|P3|Overall Study|Forgot often medication|0
1286717|NCT00348309|4198567|P2|Overall Study|Forgot often medication|1
1286718|NCT00348309|4198568|P1|Overall Study|Forgot often medication|0
1286719|NCT00348309|4198566|P3|Overall Study|Sponsor refuseal|1
1286720|NCT00348309|4198567|P2|Overall Study|Sponsor refuseal|1
1286721|NCT00348309|4198568|P1|Overall Study|Sponsor refuseal|0
1286722|NCT00348309|4198566|P3|Overall Study|Participant was hospitalized|0
1286723|NCT00348309|4198567|P2|Overall Study|Participant was hospitalized|1
1286724|NCT00348309|4198568|P1|Overall Study|Participant was hospitalized|0
1286725|NCT00348309|4198566|P3|Overall Study|A foul of exclusion criteria|0
1286726|NCT00348309|4198567|P2|Overall Study|A foul of exclusion criteria|1
1286727|NCT00348309|4198568|P1|Overall Study|A foul of exclusion criteria|0
1286728|NCT00348309|4198566|P3|Overall Study|Ineffectiveness of treatment|0
1286729|NCT00348309|4198567|P2|Overall Study|Ineffectiveness of treatment|1
1286730|NCT00348309|4198568|P1|Overall Study|Ineffectiveness of treatment|0
1286731|NCT00348309|4198566|P3|Overall Study|Decision of sponsor|0
1286732|NCT00348309|4198567|P2|Overall Study|Decision of sponsor|0
1286733|NCT00348309|4198568|P1|Overall Study|Decision of sponsor|1
1286734|NCT00348309|4198566|P3|Overall Study|Participant died|1
1286735|NCT00348309|4198567|P2|Overall Study|Participant died|1
1286736|NCT00348309|4198568|P1|Overall Study|Participant died|2
1286737|NCT00348309|4198566|P3|Overall Study|Did not appear in time for Visit 3|0
1286738|NCT00348309|4198567|P2|Overall Study|Did not appear in time for Visit 3|0
1286739|NCT00348309|4198568|P1|Overall Study|Did not appear in time for Visit 3|1
1286740|NCT00348309|4198566|P3|Overall Study|Worsening of alzheimer|1
1286741|NCT00348309|4198567|P2|Overall Study|Worsening of alzheimer|0
1286742|NCT00348309|4198568|P1|Overall Study|Worsening of alzheimer|1
1286743|NCT00348309|4198566|P3|Overall Study|Cognitive and behaviour worsening|0
1286744|NCT00348309|4198567|P2|Overall Study|Cognitive and behaviour worsening|0
1286745|NCT00348309|4198568|P1|Overall Study|Cognitive and behaviour worsening|2
1286746|NCT00348309|4198566|P3|Overall Study|Worsened neurodegenerative disease|0
1286747|NCT00348309|4198567|P2|Overall Study|Worsened neurodegenerative disease|0
1286748|NCT00348309|4198568|P1|Overall Study|Worsened neurodegenerative disease|1
1286749|NCT00348309|4198566|P3|Overall Study|No disponibility of medication|0
1286750|NCT00348309|4198567|P2|Overall Study|No disponibility of medication|0
1286751|NCT00348309|4198568|P1|Overall Study|No disponibility of medication|1
1286752|NCT00348309|4198566|P3|Overall Study|Principal investigator's decision|0
1286753|NCT00348309|4198567|P2|Overall Study|Principal investigator's decision|0
1286754|NCT00348309|4198568|P1|Overall Study|Principal investigator's decision|1
1286755|NCT00348309|4198566|P3|Overall Study|PI closing medical practice|0
1286756|NCT00348309|4198567|P2|Overall Study|PI closing medical practice|0
1286757|NCT00348309|4198568|P1|Overall Study|PI closing medical practice|1
1286758|NCT00348309|4198566|P3|Overall Study|Unable to complete ET visit|0
1286759|NCT00348309|4198567|P2|Overall Study|Unable to complete ET visit|0
1286760|NCT00348309|4198568|P1|Overall Study|Unable to complete ET visit|1
1286761|NCT00348309|4198566|P3|Overall Study|Caregiver withdrawal|7
1286762|NCT00348309|4198567|P2|Overall Study|Caregiver withdrawal|0
1286763|NCT00348309|4198568|P1|Overall Study|Caregiver withdrawal|3
1286764|NCT00348309|4198566|P3|Overall Study|Use of prohibited medication|2
1286765|NCT00348309|4198567|P2|Overall Study|Use of prohibited medication|2
1286766|NCT00348309|4198568|P1|Overall Study|Use of prohibited medication|5
1286767|NCT00348309|4198566|P3|Overall Study|Caregiver sick|0
1286768|NCT00348309|4198567|P2|Overall Study|Caregiver sick|0
1286769|NCT00348309|4198568|P1|Overall Study|Caregiver sick|1
1286770|NCT00348309|4198566|P3|Overall Study|Wrong bottle allocated|0
1286771|NCT00348309|4198567|P2|Overall Study|Wrong bottle allocated|0
1286772|NCT00348309|4198568|P1|Overall Study|Wrong bottle allocated|1
1286773|NCT00348309|4198566|P3|Overall Study|Lack of insight, dementia|0
1286774|NCT00348309|4198567|P2|Overall Study|Lack of insight, dementia|0
1286775|NCT00348309|4198568|P1|Overall Study|Lack of insight, dementia|1
1286776|NCT00348309|4198566|P3|Overall Study|Death of caregiver|1
1286777|NCT00348309|4198567|P2|Overall Study|Death of caregiver|0
1286778|NCT00348309|4198568|P1|Overall Study|Death of caregiver|1
1286779|NCT00348309|4198566|P3|Overall Study|Non-compliance|8
1286780|NCT00348309|4198567|P2|Overall Study|Non-compliance|6
1286781|NCT00348309|4198568|P1|Overall Study|Non-compliance|8
1286782|NCT00348309|4198566|P3|Overall Study|Withdrawal by Subject|40
1286783|NCT00348309|4198567|P2|Overall Study|Withdrawal by Subject|37
1286784|NCT00348309|4198568|P1|Overall Study|Withdrawal by Subject|33
1286785|NCT00348309|4198566|P3|Overall Study|Protocol Violation|7
1286786|NCT00348309|4198567|P2|Overall Study|Protocol Violation|12
1286787|NCT00348309|4198568|P1|Overall Study|Protocol Violation|7
1286788|NCT00348309|4198566|P3|Overall Study|Lost to Follow-up|4
1286789|NCT00348309|4198567|P2|Overall Study|Lost to Follow-up|7
1286790|NCT00348309|4198568|P1|Overall Study|Lost to Follow-up|6
1286791|NCT00348309|4198566|P3|Overall Study|Adverse Event|63
1286792|NCT00348309|4198567|P2|Overall Study|Adverse Event|28
1286793|NCT00348309|4198568|P1|Overall Study|Adverse Event|56
1286794|NCT00348283|4198641|P2|Open Label|Sponsor decision|1
1286795|NCT00348283|4198642|P1|Open Label|Sponsor decision|0
1286796|NCT00348283|4198641|P2|Open Label|Pregnancy|1
1286797|NCT00348283|4198642|P1|Open Label|Pregnancy|0
1286798|NCT00348283|4198641|P2|Open Label|Subject moved to the United States|1
1286799|NCT00348283|4198642|P1|Open Label|Subject moved to the United States|0
1286800|NCT00348283|4198641|P2|Open Label|Administrative reasons|5
1286801|NCT00348283|4198642|P1|Open Label|Administrative reasons|0
1286802|NCT00348283|4198641|P2|Open Label|Lack of Efficacy|13
1286803|NCT00348283|4198642|P1|Open Label|Lack of Efficacy|0
1286804|NCT00348283|4198641|P2|Open Label|Lost to Follow-up|1
1286805|NCT00348283|4198642|P1|Open Label|Lost to Follow-up|0
1286806|NCT00348283|4198641|P2|Open Label|Withdrawal by Subject|4
1286807|NCT00348283|4198642|P1|Open Label|Withdrawal by Subject|0
1286808|NCT00348283|4198641|P2|Open Label|Adverse Event|8
1286809|NCT00348283|4198642|P1|Open Label|Adverse Event|0
1286810|NCT00348283|4198641|P2|Double Blind|Pregnancy|1
1286811|NCT00348283|4198642|P1|Double Blind|Pregnancy|0
1286812|NCT00348283|4198641|P2|Double Blind|Lack of Efficacy|2
1286813|NCT00348283|4198642|P1|Double Blind|Lack of Efficacy|2
1286814|NCT00348283|4198641|P2|Double Blind|Protocol Violation|1
1286815|NCT00348283|4198642|P1|Double Blind|Protocol Violation|0
1286816|NCT00348283|4198641|P2|Double Blind|Withdrawal by Subject|1
1286817|NCT00348283|4198642|P1|Double Blind|Withdrawal by Subject|1
1286818|NCT00348283|4198641|P2|Double Blind|Adverse Event|5
1286819|NCT00348283|4198642|P1|Double Blind|Adverse Event|2
1286820|NCT00348283|4198641|P2|Induction|Protocol Violation|4
1286821|NCT00348283|4198642|P1|Induction|Protocol Violation|0
1286822|NCT00348283|4198641|P2|Induction|Adverse Event|2
1286823|NCT00348283|4198642|P1|Induction|Adverse Event|0
1286824|NCT00348140|4198661|P3|Overall Study|Memory declined|1
1286825|NCT00348140|4198662|P2|Overall Study|Memory declined|0
1286826|NCT00348140|4198663|P1|Overall Study|Memory declined|0
1286827|NCT00348140|4198661|P3|Overall Study|Exclusion criteria met|1
1286828|NCT00348140|4198662|P2|Overall Study|Exclusion criteria met|0
1286829|NCT00348140|4198663|P1|Overall Study|Exclusion criteria met|0
1286830|NCT00348140|4198661|P3|Overall Study|Participant died|0
1286831|NCT00348140|4198662|P2|Overall Study|Participant died|1
1286832|NCT00348140|4198663|P1|Overall Study|Participant died|0
1286833|NCT00348140|4198661|P3|Overall Study|Abnormal ECG|3
1286834|NCT00348140|4198662|P2|Overall Study|Abnormal ECG|1
1286835|NCT00348140|4198663|P1|Overall Study|Abnormal ECG|0
1286836|NCT00348140|4198661|P3|Overall Study|Serious adverse event|0
1286837|NCT00348140|4198662|P2|Overall Study|Serious adverse event|1
1286838|NCT00348140|4198663|P1|Overall Study|Serious adverse event|0
1286839|NCT00348140|4198661|P3|Overall Study|Increased risk of cardiac infarction|0
1286840|NCT00348140|4198662|P2|Overall Study|Increased risk of cardiac infarction|1
1286841|NCT00348140|4198663|P1|Overall Study|Increased risk of cardiac infarction|0
1286842|NCT00348140|4198661|P3|Overall Study|Disease progression|5
1286843|NCT00348140|4198662|P2|Overall Study|Disease progression|2
1286844|NCT00348140|4198663|P1|Overall Study|Disease progression|1
1286845|NCT00348140|4198661|P3|Overall Study|Use of prohibited drug|2
1286846|NCT00348140|4198662|P2|Overall Study|Use of prohibited drug|0
1286847|NCT00348140|4198663|P1|Overall Study|Use of prohibited drug|1
1286848|NCT00348140|4198661|P3|Overall Study|Decided to discontinue on their own|1
1286849|NCT00348140|4198662|P2|Overall Study|Decided to discontinue on their own|4
1286850|NCT00348140|4198663|P1|Overall Study|Decided to discontinue on their own|1
1286851|NCT00348140|4198661|P3|Overall Study|Investigator decided to discontinue|4
1286852|NCT00348140|4198662|P2|Overall Study|Investigator decided to discontinue|1
1286853|NCT00348140|4198663|P1|Overall Study|Investigator decided to discontinue|4
1286854|NCT00348140|4198661|P3|Overall Study|Screen failure|0
1286855|NCT00348140|4198662|P2|Overall Study|Screen failure|0
1286856|NCT00348140|4198663|P1|Overall Study|Screen failure|1
1286857|NCT00348140|4198661|P3|Overall Study|Participant unwell|0
1286858|NCT00348140|4198662|P2|Overall Study|Participant unwell|0
1286859|NCT00348140|4198663|P1|Overall Study|Participant unwell|1
1286860|NCT00348140|4198661|P3|Overall Study|Unmet inclusion-exclusion criteria|1
1286861|NCT00348140|4198662|P2|Overall Study|Unmet inclusion-exclusion criteria|0
1286862|NCT00348140|4198663|P1|Overall Study|Unmet inclusion-exclusion criteria|1
1286863|NCT00348140|4198661|P3|Overall Study|Administration related|1
1286864|NCT00348140|4198662|P2|Overall Study|Administration related|1
1286865|NCT00348140|4198663|P1|Overall Study|Administration related|3
1286866|NCT00348140|4198661|P3|Overall Study|Efficacy related|0
1286867|NCT00348140|4198662|P2|Overall Study|Efficacy related|1
1286868|NCT00348140|4198663|P1|Overall Study|Efficacy related|1
1286869|NCT00348140|4198661|P3|Overall Study|Participant hospitalised|0
1286870|NCT00348140|4198662|P2|Overall Study|Participant hospitalised|0
1286871|NCT00348140|4198663|P1|Overall Study|Participant hospitalised|3
1286872|NCT00348140|4198661|P3|Overall Study|Caregiver related|3
1286873|NCT00348140|4198662|P2|Overall Study|Caregiver related|7
1286874|NCT00348140|4198663|P1|Overall Study|Caregiver related|4
1286875|NCT00348140|4198661|P3|Overall Study|Conditional medication increased dose|0
1286876|NCT00348140|4198662|P2|Overall Study|Conditional medication increased dose|0
1286877|NCT00348140|4198663|P1|Overall Study|Conditional medication increased dose|1
1286878|NCT00348140|4198661|P3|Overall Study|Participant at risk due to study drug|0
1286879|NCT00348140|4198662|P2|Overall Study|Participant at risk due to study drug|0
1286880|NCT00348140|4198663|P1|Overall Study|Participant at risk due to study drug|2
1286881|NCT00348140|4198661|P3|Overall Study|Non-compliance|5
1286882|NCT00348140|4198662|P2|Overall Study|Non-compliance|13
1286883|NCT00348140|4198663|P1|Overall Study|Non-compliance|8
1286884|NCT00348140|4198661|P3|Overall Study|Withdrawal by Subject|40
1286885|NCT00348140|4198662|P2|Overall Study|Withdrawal by Subject|40
1286886|NCT00348140|4198663|P1|Overall Study|Withdrawal by Subject|32
1286887|NCT00348140|4198661|P3|Overall Study|Protocol Violation|14
1286888|NCT00348140|4198662|P2|Overall Study|Protocol Violation|13
1286889|NCT00348140|4198663|P1|Overall Study|Protocol Violation|12
1286890|NCT00348140|4198661|P3|Overall Study|Lost to Follow-up|4
1286891|NCT00348140|4198662|P2|Overall Study|Lost to Follow-up|4
1286892|NCT00348140|4198663|P1|Overall Study|Lost to Follow-up|4
1286893|NCT00348140|4198661|P3|Overall Study|Adverse Event|78
1286894|NCT00348140|4198662|P2|Overall Study|Adverse Event|49
1286895|NCT00348140|4198663|P1|Overall Study|Adverse Event|46
1286896|NCT00347958|4198761|P1|Overall Study|Withdrawal by Subject|1
1286897|NCT00347958|4198761|P1|Overall Study|Protocol Violation|2
1286898|NCT00347958|4198761|P1|Overall Study|Adverse Event|1
1286899|NCT00347932|4198770|P2|Overall Study|Did not meet inclusion criteria|8
1286900|NCT00347932|4198771|P1|Overall Study|Did not meet inclusion criteria|4
1286901|NCT00347932|4198770|P2|Overall Study|Withdrawal by Subject|16
1286902|NCT00347932|4198771|P1|Overall Study|Withdrawal by Subject|10
1286903|NCT00347932|4198770|P2|Overall Study|Lost to Follow-up|9
1286904|NCT00347932|4198771|P1|Overall Study|Lost to Follow-up|10
1286905|NCT00347932|4198770|P2|Overall Study|Lack of Efficacy|14
1286906|NCT00347932|4198771|P1|Overall Study|Lack of Efficacy|3
1286907|NCT00347932|4198770|P2|Overall Study|Adverse Event|5
1286908|NCT00347932|4198771|P1|Overall Study|Adverse Event|4
1286909|NCT00347919|4198786|P3|Overall Study|Missing|2
1286910|NCT00347919|4198787|P2|Overall Study|Missing|1
1286911|NCT00347919|4198788|P1|Overall Study|Missing|2
1286912|NCT00347919|4198786|P3|Overall Study|Par. Started Other Treatment|1
1286913|NCT00347919|4198787|P2|Overall Study|Par. Started Other Treatment|1
1286914|NCT00347919|4198788|P1|Overall Study|Par. Started Other Treatment|1
1286915|NCT00347919|4198786|P3|Overall Study|Death|19
1286916|NCT00347919|4198787|P2|Overall Study|Death|42
1286917|NCT00347919|4198788|P1|Overall Study|Death|35
1286918|NCT00347919|4198786|P3|Overall Study|Sponsor terminated study|16
1286919|NCT00347919|4198787|P2|Overall Study|Sponsor terminated study|10
1286920|NCT00347919|4198788|P1|Overall Study|Sponsor terminated study|15
1286921|NCT00347919|4198786|P3|Overall Study|Physician Decision|0
1286922|NCT00347919|4198787|P2|Overall Study|Physician Decision|1
1286923|NCT00347919|4198788|P1|Overall Study|Physician Decision|1
1286924|NCT00347919|4198786|P3|Overall Study|Withdrawal by Subject|0
1286925|NCT00347919|4198787|P2|Overall Study|Withdrawal by Subject|8
1286926|NCT00347919|4198788|P1|Overall Study|Withdrawal by Subject|6
1286927|NCT00347919|4198786|P3|Overall Study|Lost to Follow-up|0
1286928|NCT00347919|4198787|P2|Overall Study|Lost to Follow-up|13
1286929|NCT00347919|4198788|P1|Overall Study|Lost to Follow-up|11
1286930|NCT00347776|4198811|P3|12 Month Follow-up|Reached endpoint|9
1286931|NCT00347776|4198812|P2|12 Month Follow-up|Reached endpoint|6
1286932|NCT00347776|4198813|P1|12 Month Follow-up|Reached endpoint|13
1286933|NCT00347776|4198811|P3|12 Month Follow-up|Death|4
1286934|NCT00347776|4198812|P2|12 Month Follow-up|Death|4
1286935|NCT00347776|4198813|P1|12 Month Follow-up|Death|3
1286936|NCT00347776|4198811|P3|12 Month Follow-up|Lost to Follow-up|6
1286937|NCT00347776|4198812|P2|12 Month Follow-up|Lost to Follow-up|6
1286938|NCT00347776|4198813|P1|12 Month Follow-up|Lost to Follow-up|7
1286939|NCT00347776|4198811|P3|6 Month Follow-up|reached endpont|15
1286940|NCT00347776|4198812|P2|6 Month Follow-up|reached endpont|12
1286941|NCT00347776|4198813|P1|6 Month Follow-up|reached endpont|20
1286942|NCT00347776|4198811|P3|6 Month Follow-up|Death|3
1286943|NCT00347776|4198812|P2|6 Month Follow-up|Death|1
1286944|NCT00347776|4198813|P1|6 Month Follow-up|Death|2
1286945|NCT00347776|4198811|P3|1.5 Month Follow-up|reached the endpoint|12
1286946|NCT00347776|4198812|P2|1.5 Month Follow-up|reached the endpoint|8
1286947|NCT00347776|4198813|P1|1.5 Month Follow-up|reached the endpoint|12
1286948|NCT00347776|4198811|P3|1.5 Month Follow-up|Death|0
1286949|NCT00347776|4198812|P2|1.5 Month Follow-up|Death|0
1286950|NCT00347776|4198813|P1|1.5 Month Follow-up|Death|2
1286951|NCT00347438|4198825|P1|Overall Study|Physician Decision|1
1286952|NCT00347438|4198825|P1|Overall Study|Withdrawal by Subject|1
1286953|NCT00347360|4198847|P15|Overall Study|Visits conflicted with new job|0
1286954|NCT00347360|4198848|P14|Overall Study|Visits conflicted with new job|0
1286955|NCT00347360|4198849|P13|Overall Study|Visits conflicted with new job|0
1286956|NCT00347360|4198850|P12|Overall Study|Visits conflicted with new job|0
1286957|NCT00347360|4198851|P11|Overall Study|Visits conflicted with new job|0
1286958|NCT00347360|4198852|P10|Overall Study|Visits conflicted with new job|0
1286959|NCT00347360|4198853|P9|Overall Study|Visits conflicted with new job|0
1286960|NCT00347360|4198854|P8|Overall Study|Visits conflicted with new job|0
1286961|NCT00347360|4198855|P7|Overall Study|Visits conflicted with new job|1
1286962|NCT00347360|4198856|P6|Overall Study|Visits conflicted with new job|0
1286963|NCT00347360|4198857|P5|Overall Study|Visits conflicted with new job|0
1286964|NCT00347360|4198858|P4|Overall Study|Visits conflicted with new job|0
1286965|NCT00347360|4198859|P3|Overall Study|Visits conflicted with new job|0
1286966|NCT00347360|4198860|P2|Overall Study|Visits conflicted with new job|0
1286967|NCT00347360|4198861|P1|Overall Study|Visits conflicted with new job|0
1286968|NCT00347360|4198847|P15|Overall Study|Subject refuse to sign updated consent|1
1286969|NCT00347360|4198848|P14|Overall Study|Subject refuse to sign updated consent|0
1286970|NCT00347360|4198849|P13|Overall Study|Subject refuse to sign updated consent|0
1286971|NCT00347360|4198850|P12|Overall Study|Subject refuse to sign updated consent|0
1286972|NCT00347360|4198851|P11|Overall Study|Subject refuse to sign updated consent|0
1286973|NCT00347360|4198852|P10|Overall Study|Subject refuse to sign updated consent|0
1286974|NCT00347360|4198853|P9|Overall Study|Subject refuse to sign updated consent|0
1286975|NCT00347360|4198854|P8|Overall Study|Subject refuse to sign updated consent|0
1286976|NCT00347360|4198855|P7|Overall Study|Subject refuse to sign updated consent|0
1286977|NCT00347360|4198856|P6|Overall Study|Subject refuse to sign updated consent|0
1286978|NCT00347360|4198857|P5|Overall Study|Subject refuse to sign updated consent|0
1286979|NCT00347360|4198858|P4|Overall Study|Subject refuse to sign updated consent|0
1286980|NCT00347360|4198859|P3|Overall Study|Subject refuse to sign updated consent|0
1286981|NCT00347360|4198860|P2|Overall Study|Subject refuse to sign updated consent|0
1286982|NCT00347360|4198861|P1|Overall Study|Subject refuse to sign updated consent|0
1286983|NCT00347360|4198847|P15|Overall Study|Subject left town, ran out of study drug|0
1286984|NCT00347360|4198848|P14|Overall Study|Subject left town, ran out of study drug|1
1286985|NCT00347360|4198849|P13|Overall Study|Subject left town, ran out of study drug|0
1286986|NCT00347360|4198850|P12|Overall Study|Subject left town, ran out of study drug|0
1286987|NCT00347360|4198851|P11|Overall Study|Subject left town, ran out of study drug|0
1286988|NCT00347360|4198852|P10|Overall Study|Subject left town, ran out of study drug|0
1286989|NCT00347360|4198853|P9|Overall Study|Subject left town, ran out of study drug|0
1286990|NCT00347360|4198854|P8|Overall Study|Subject left town, ran out of study drug|0
1286991|NCT00347360|4198855|P7|Overall Study|Subject left town, ran out of study drug|0
1286992|NCT00347360|4198856|P6|Overall Study|Subject left town, ran out of study drug|0
1286993|NCT00347360|4198857|P5|Overall Study|Subject left town, ran out of study drug|0
1286994|NCT00347360|4198858|P4|Overall Study|Subject left town, ran out of study drug|0
1286995|NCT00347360|4198859|P3|Overall Study|Subject left town, ran out of study drug|0
1286996|NCT00347360|4198860|P2|Overall Study|Subject left town, ran out of study drug|0
1286997|NCT00347360|4198861|P1|Overall Study|Subject left town, ran out of study drug|0
1286998|NCT00347360|4198847|P15|Overall Study|Prolonged duration between visits|0
1286999|NCT00347360|4198848|P14|Overall Study|Prolonged duration between visits|0
1287000|NCT00347360|4198849|P13|Overall Study|Prolonged duration between visits|1
1287001|NCT00347360|4198850|P12|Overall Study|Prolonged duration between visits|0
1287002|NCT00347360|4198851|P11|Overall Study|Prolonged duration between visits|0
1287003|NCT00347360|4198852|P10|Overall Study|Prolonged duration between visits|0
1287004|NCT00347360|4198853|P9|Overall Study|Prolonged duration between visits|0
1287005|NCT00347360|4198854|P8|Overall Study|Prolonged duration between visits|0
1287006|NCT00347360|4198855|P7|Overall Study|Prolonged duration between visits|0
1287007|NCT00347360|4198856|P6|Overall Study|Prolonged duration between visits|0
1287008|NCT00347360|4198857|P5|Overall Study|Prolonged duration between visits|0
1287009|NCT00347360|4198858|P4|Overall Study|Prolonged duration between visits|0
1287010|NCT00347360|4198859|P3|Overall Study|Prolonged duration between visits|0
1287011|NCT00347360|4198860|P2|Overall Study|Prolonged duration between visits|0
1287012|NCT00347360|4198861|P1|Overall Study|Prolonged duration between visits|0
1287013|NCT00347360|4198847|P15|Overall Study|Failed inclusion criteria #4|0
1287014|NCT00347360|4198848|P14|Overall Study|Failed inclusion criteria #4|0
1287015|NCT00347360|4198849|P13|Overall Study|Failed inclusion criteria #4|0
1287016|NCT00347360|4198850|P12|Overall Study|Failed inclusion criteria #4|1
1287017|NCT00347360|4198851|P11|Overall Study|Failed inclusion criteria #4|0
1287018|NCT00347360|4198852|P10|Overall Study|Failed inclusion criteria #4|0
1287019|NCT00347360|4198853|P9|Overall Study|Failed inclusion criteria #4|0
1287020|NCT00347360|4198854|P8|Overall Study|Failed inclusion criteria #4|0
1287021|NCT00347360|4198855|P7|Overall Study|Failed inclusion criteria #4|0
1287022|NCT00347360|4198856|P6|Overall Study|Failed inclusion criteria #4|0
1287023|NCT00347360|4198857|P5|Overall Study|Failed inclusion criteria #4|0
1287024|NCT00347360|4198858|P4|Overall Study|Failed inclusion criteria #4|0
1287025|NCT00347360|4198859|P3|Overall Study|Failed inclusion criteria #4|0
1287026|NCT00347360|4198860|P2|Overall Study|Failed inclusion criteria #4|0
1287027|NCT00347360|4198861|P1|Overall Study|Failed inclusion criteria #4|0
1287028|NCT00347360|4198847|P15|Overall Study|Randomized in error|0
1287029|NCT00347360|4198848|P14|Overall Study|Randomized in error|0
1287030|NCT00347360|4198849|P13|Overall Study|Randomized in error|0
1287031|NCT00347360|4198850|P12|Overall Study|Randomized in error|1
1287032|NCT00347360|4198851|P11|Overall Study|Randomized in error|0
1287033|NCT00347360|4198852|P10|Overall Study|Randomized in error|0
1287034|NCT00347360|4198853|P9|Overall Study|Randomized in error|0
1287035|NCT00347360|4198854|P8|Overall Study|Randomized in error|0
1287036|NCT00347360|4198855|P7|Overall Study|Randomized in error|0
1287037|NCT00347360|4198856|P6|Overall Study|Randomized in error|0
1287038|NCT00347360|4198857|P5|Overall Study|Randomized in error|0
1287039|NCT00347360|4198858|P4|Overall Study|Randomized in error|0
1287040|NCT00347360|4198859|P3|Overall Study|Randomized in error|0
1287041|NCT00347360|4198860|P2|Overall Study|Randomized in error|0
1287042|NCT00347360|4198861|P1|Overall Study|Randomized in error|0
1287043|NCT00347360|4198847|P15|Overall Study|Did not meet criteria before ABPM|0
1287044|NCT00347360|4198848|P14|Overall Study|Did not meet criteria before ABPM|0
1287045|NCT00347360|4198849|P13|Overall Study|Did not meet criteria before ABPM|0
1287046|NCT00347360|4198850|P12|Overall Study|Did not meet criteria before ABPM|0
1287047|NCT00347360|4198851|P11|Overall Study|Did not meet criteria before ABPM|1
1287048|NCT00347360|4198852|P10|Overall Study|Did not meet criteria before ABPM|0
1287049|NCT00347360|4198853|P9|Overall Study|Did not meet criteria before ABPM|0
1287050|NCT00347360|4198854|P8|Overall Study|Did not meet criteria before ABPM|0
1287051|NCT00347360|4198855|P7|Overall Study|Did not meet criteria before ABPM|0
1287052|NCT00347360|4198856|P6|Overall Study|Did not meet criteria before ABPM|0
1287053|NCT00347360|4198857|P5|Overall Study|Did not meet criteria before ABPM|0
1287054|NCT00347360|4198858|P4|Overall Study|Did not meet criteria before ABPM|0
1287055|NCT00347360|4198859|P3|Overall Study|Did not meet criteria before ABPM|0
1287056|NCT00347360|4198860|P2|Overall Study|Did not meet criteria before ABPM|0
1287057|NCT00347360|4198861|P1|Overall Study|Did not meet criteria before ABPM|0
1287058|NCT00347360|4198847|P15|Overall Study|PI recommended early withdrawal|0
1287059|NCT00347360|4198848|P14|Overall Study|PI recommended early withdrawal|0
1287060|NCT00347360|4198849|P13|Overall Study|PI recommended early withdrawal|0
1287061|NCT00347360|4198850|P12|Overall Study|PI recommended early withdrawal|0
1287062|NCT00347360|4198851|P11|Overall Study|PI recommended early withdrawal|0
1287063|NCT00347360|4198852|P10|Overall Study|PI recommended early withdrawal|1
1287064|NCT00347360|4198853|P9|Overall Study|PI recommended early withdrawal|0
1287065|NCT00347360|4198854|P8|Overall Study|PI recommended early withdrawal|0
1287066|NCT00347360|4198855|P7|Overall Study|PI recommended early withdrawal|0
1287067|NCT00347360|4198856|P6|Overall Study|PI recommended early withdrawal|0
1287068|NCT00347360|4198857|P5|Overall Study|PI recommended early withdrawal|0
1287069|NCT00347360|4198858|P4|Overall Study|PI recommended early withdrawal|0
1287070|NCT00347360|4198859|P3|Overall Study|PI recommended early withdrawal|0
1287071|NCT00347360|4198860|P2|Overall Study|PI recommended early withdrawal|0
1287072|NCT00347360|4198861|P1|Overall Study|PI recommended early withdrawal|0
1287073|NCT00347360|4198847|P15|Overall Study|Abnormal lab values|0
1287074|NCT00347360|4198848|P14|Overall Study|Abnormal lab values|0
1287075|NCT00347360|4198849|P13|Overall Study|Abnormal lab values|0
1287076|NCT00347360|4198850|P12|Overall Study|Abnormal lab values|0
1287077|NCT00347360|4198851|P11|Overall Study|Abnormal lab values|0
1287078|NCT00347360|4198852|P10|Overall Study|Abnormal lab values|0
1287079|NCT00347360|4198853|P9|Overall Study|Abnormal lab values|0
1287080|NCT00347360|4198854|P8|Overall Study|Abnormal lab values|0
1287081|NCT00347360|4198855|P7|Overall Study|Abnormal lab values|1
1287082|NCT00347360|4198856|P6|Overall Study|Abnormal lab values|0
1287083|NCT00347360|4198857|P5|Overall Study|Abnormal lab values|0
1287084|NCT00347360|4198858|P4|Overall Study|Abnormal lab values|0
1287085|NCT00347360|4198859|P3|Overall Study|Abnormal lab values|0
1287086|NCT00347360|4198860|P2|Overall Study|Abnormal lab values|0
1287087|NCT00347360|4198861|P1|Overall Study|Abnormal lab values|0
1287088|NCT00347360|4198847|P15|Overall Study|Subject did not meet end of study ABPM|0
1287089|NCT00347360|4198848|P14|Overall Study|Subject did not meet end of study ABPM|1
1287090|NCT00347360|4198849|P13|Overall Study|Subject did not meet end of study ABPM|1
1287091|NCT00347360|4198850|P12|Overall Study|Subject did not meet end of study ABPM|0
1287092|NCT00347360|4198851|P11|Overall Study|Subject did not meet end of study ABPM|1
1287093|NCT00347360|4198852|P10|Overall Study|Subject did not meet end of study ABPM|0
1287094|NCT00347360|4198853|P9|Overall Study|Subject did not meet end of study ABPM|0
1287095|NCT00347360|4198854|P8|Overall Study|Subject did not meet end of study ABPM|0
1287096|NCT00347360|4198855|P7|Overall Study|Subject did not meet end of study ABPM|1
1287097|NCT00347360|4198856|P6|Overall Study|Subject did not meet end of study ABPM|0
1287098|NCT00347360|4198857|P5|Overall Study|Subject did not meet end of study ABPM|0
1287099|NCT00347360|4198858|P4|Overall Study|Subject did not meet end of study ABPM|0
1287100|NCT00347360|4198859|P3|Overall Study|Subject did not meet end of study ABPM|0
1287101|NCT00347360|4198860|P2|Overall Study|Subject did not meet end of study ABPM|0
1287102|NCT00347360|4198861|P1|Overall Study|Subject did not meet end of study ABPM|0
1287103|NCT00347360|4198847|P15|Overall Study|P.I. recommended due to blood pressure|0
1287104|NCT00347360|4198848|P14|Overall Study|P.I. recommended due to blood pressure|0
1287105|NCT00347360|4198849|P13|Overall Study|P.I. recommended due to blood pressure|0
1287106|NCT00347360|4198850|P12|Overall Study|P.I. recommended due to blood pressure|0
1287107|NCT00347360|4198851|P11|Overall Study|P.I. recommended due to blood pressure|0
1287108|NCT00347360|4198852|P10|Overall Study|P.I. recommended due to blood pressure|0
1287109|NCT00347360|4198853|P9|Overall Study|P.I. recommended due to blood pressure|0
1287110|NCT00347360|4198854|P8|Overall Study|P.I. recommended due to blood pressure|0
1287111|NCT00347360|4198855|P7|Overall Study|P.I. recommended due to blood pressure|0
1287112|NCT00347360|4198856|P6|Overall Study|P.I. recommended due to blood pressure|0
1287113|NCT00347360|4198857|P5|Overall Study|P.I. recommended due to blood pressure|1
1287114|NCT00347360|4198858|P4|Overall Study|P.I. recommended due to blood pressure|0
1287115|NCT00347360|4198859|P3|Overall Study|P.I. recommended due to blood pressure|0
1287116|NCT00347360|4198860|P2|Overall Study|P.I. recommended due to blood pressure|0
1287117|NCT00347360|4198861|P1|Overall Study|P.I. recommended due to blood pressure|0
1287118|NCT00347360|4198847|P15|Overall Study|Per sponsors instruction|0
1287119|NCT00347360|4198848|P14|Overall Study|Per sponsors instruction|0
1287120|NCT00347360|4198849|P13|Overall Study|Per sponsors instruction|0
1287121|NCT00347360|4198850|P12|Overall Study|Per sponsors instruction|0
1287122|NCT00347360|4198851|P11|Overall Study|Per sponsors instruction|0
1287123|NCT00347360|4198852|P10|Overall Study|Per sponsors instruction|0
1287124|NCT00347360|4198853|P9|Overall Study|Per sponsors instruction|0
1287125|NCT00347360|4198854|P8|Overall Study|Per sponsors instruction|0
1287126|NCT00347360|4198855|P7|Overall Study|Per sponsors instruction|0
1287127|NCT00347360|4198856|P6|Overall Study|Per sponsors instruction|0
1287128|NCT00347360|4198857|P5|Overall Study|Per sponsors instruction|0
1287129|NCT00347360|4198858|P4|Overall Study|Per sponsors instruction|0
1287130|NCT00347360|4198859|P3|Overall Study|Per sponsors instruction|0
1287131|NCT00347360|4198860|P2|Overall Study|Per sponsors instruction|1
1287132|NCT00347360|4198861|P1|Overall Study|Per sponsors instruction|0
1287133|NCT00347360|4198847|P15|Overall Study|Reason not listed/blank|0
1287134|NCT00347360|4198848|P14|Overall Study|Reason not listed/blank|1
1287135|NCT00347360|4198849|P13|Overall Study|Reason not listed/blank|0
1287136|NCT00347360|4198850|P12|Overall Study|Reason not listed/blank|0
1287137|NCT00347360|4198851|P11|Overall Study|Reason not listed/blank|0
1287138|NCT00347360|4198852|P10|Overall Study|Reason not listed/blank|0
1287139|NCT00347360|4198853|P9|Overall Study|Reason not listed/blank|0
1287140|NCT00347360|4198854|P8|Overall Study|Reason not listed/blank|0
1287141|NCT00347360|4198855|P7|Overall Study|Reason not listed/blank|1
1287142|NCT00347360|4198856|P6|Overall Study|Reason not listed/blank|0
1287143|NCT00347360|4198857|P5|Overall Study|Reason not listed/blank|0
1287144|NCT00347360|4198858|P4|Overall Study|Reason not listed/blank|0
1287145|NCT00347360|4198859|P3|Overall Study|Reason not listed/blank|0
1287146|NCT00347360|4198860|P2|Overall Study|Reason not listed/blank|0
1287147|NCT00347360|4198861|P1|Overall Study|Reason not listed/blank|1
1287148|NCT00347360|4198847|P15|Overall Study|Lack of Efficacy|0
1287149|NCT00347360|4198848|P14|Overall Study|Lack of Efficacy|0
1287150|NCT00347360|4198849|P13|Overall Study|Lack of Efficacy|0
1287151|NCT00347360|4198850|P12|Overall Study|Lack of Efficacy|0
1287152|NCT00347360|4198851|P11|Overall Study|Lack of Efficacy|0
1287153|NCT00347360|4198852|P10|Overall Study|Lack of Efficacy|0
1287154|NCT00347360|4198853|P9|Overall Study|Lack of Efficacy|1
1287155|NCT00347360|4198854|P8|Overall Study|Lack of Efficacy|1
1287156|NCT00347360|4198855|P7|Overall Study|Lack of Efficacy|0
1287157|NCT00347360|4198856|P6|Overall Study|Lack of Efficacy|1
1287158|NCT00347360|4198857|P5|Overall Study|Lack of Efficacy|0
1287159|NCT00347360|4198858|P4|Overall Study|Lack of Efficacy|1
1287160|NCT00347360|4198859|P3|Overall Study|Lack of Efficacy|3
1287161|NCT00347360|4198860|P2|Overall Study|Lack of Efficacy|1
1287162|NCT00347360|4198861|P1|Overall Study|Lack of Efficacy|1
1287163|NCT00347360|4198847|P15|Overall Study|Withdrawal by Subject|1
1287164|NCT00347360|4198848|P14|Overall Study|Withdrawal by Subject|2
1287165|NCT00347360|4198849|P13|Overall Study|Withdrawal by Subject|4
1287166|NCT00347360|4198850|P12|Overall Study|Withdrawal by Subject|3
1287167|NCT00347360|4198851|P11|Overall Study|Withdrawal by Subject|0
1287168|NCT00347360|4198852|P10|Overall Study|Withdrawal by Subject|1
1287169|NCT00347360|4198853|P9|Overall Study|Withdrawal by Subject|1
1287170|NCT00347360|4198854|P8|Overall Study|Withdrawal by Subject|1
1287171|NCT00347360|4198855|P7|Overall Study|Withdrawal by Subject|1
1287172|NCT00347360|4198856|P6|Overall Study|Withdrawal by Subject|2
1287173|NCT00347360|4198857|P5|Overall Study|Withdrawal by Subject|1
1287174|NCT00347360|4198858|P4|Overall Study|Withdrawal by Subject|4
1287175|NCT00347360|4198859|P3|Overall Study|Withdrawal by Subject|2
1287176|NCT00347360|4198860|P2|Overall Study|Withdrawal by Subject|1
1287177|NCT00347360|4198861|P1|Overall Study|Withdrawal by Subject|0
1287178|NCT00347360|4198847|P15|Overall Study|Protocol Violation|0
1287179|NCT00347360|4198848|P14|Overall Study|Protocol Violation|1
1287180|NCT00347360|4198849|P13|Overall Study|Protocol Violation|0
1287181|NCT00347360|4198850|P12|Overall Study|Protocol Violation|0
1287182|NCT00347360|4198851|P11|Overall Study|Protocol Violation|0
1287183|NCT00347360|4198852|P10|Overall Study|Protocol Violation|2
1287184|NCT00347360|4198853|P9|Overall Study|Protocol Violation|1
1287185|NCT00347360|4198854|P8|Overall Study|Protocol Violation|0
1287186|NCT00347360|4198855|P7|Overall Study|Protocol Violation|0
1287187|NCT00347360|4198856|P6|Overall Study|Protocol Violation|2
1287188|NCT00347360|4198857|P5|Overall Study|Protocol Violation|1
1287189|NCT00347360|4198858|P4|Overall Study|Protocol Violation|2
1287190|NCT00347360|4198859|P3|Overall Study|Protocol Violation|1
1287191|NCT00347360|4198860|P2|Overall Study|Protocol Violation|3
1287192|NCT00347360|4198861|P1|Overall Study|Protocol Violation|2
1287193|NCT00347360|4198847|P15|Overall Study|Lost to Follow-up|0
1287194|NCT00347360|4198848|P14|Overall Study|Lost to Follow-up|0
1287195|NCT00347360|4198849|P13|Overall Study|Lost to Follow-up|1
1287196|NCT00347360|4198850|P12|Overall Study|Lost to Follow-up|0
1287197|NCT00347360|4198851|P11|Overall Study|Lost to Follow-up|0
1287198|NCT00347360|4198852|P10|Overall Study|Lost to Follow-up|2
1287199|NCT00347360|4198853|P9|Overall Study|Lost to Follow-up|1
1287200|NCT00347360|4198854|P8|Overall Study|Lost to Follow-up|1
1287201|NCT00347360|4198855|P7|Overall Study|Lost to Follow-up|0
1287202|NCT00347360|4198856|P6|Overall Study|Lost to Follow-up|1
1287203|NCT00347360|4198857|P5|Overall Study|Lost to Follow-up|1
1287204|NCT00347360|4198858|P4|Overall Study|Lost to Follow-up|2
1287205|NCT00347360|4198859|P3|Overall Study|Lost to Follow-up|0
1287206|NCT00347360|4198860|P2|Overall Study|Lost to Follow-up|0
1287207|NCT00347360|4198861|P1|Overall Study|Lost to Follow-up|0
1287208|NCT00347360|4198847|P15|Overall Study|Adverse Event|2
1287209|NCT00347360|4198848|P14|Overall Study|Adverse Event|2
1287210|NCT00347360|4198849|P13|Overall Study|Adverse Event|3
1287211|NCT00347360|4198850|P12|Overall Study|Adverse Event|1
1287212|NCT00347360|4198851|P11|Overall Study|Adverse Event|3
1287213|NCT00347360|4198852|P10|Overall Study|Adverse Event|3
1287214|NCT00347360|4198853|P9|Overall Study|Adverse Event|2
1287215|NCT00347360|4198854|P8|Overall Study|Adverse Event|0
1287216|NCT00347360|4198855|P7|Overall Study|Adverse Event|2
1287217|NCT00347360|4198856|P6|Overall Study|Adverse Event|2
1287218|NCT00347360|4198857|P5|Overall Study|Adverse Event|1
1287219|NCT00347360|4198858|P4|Overall Study|Adverse Event|4
1287220|NCT00347360|4198859|P3|Overall Study|Adverse Event|0
1287221|NCT00347360|4198860|P2|Overall Study|Adverse Event|2
1287222|NCT00347360|4198861|P1|Overall Study|Adverse Event|1
1287223|NCT00347269|4199049|P2|Overall Study|Death|3
1287224|NCT00347269|4199050|P1|Overall Study|Death|2
1287225|NCT00347269|4199049|P2|Overall Study|Withdrawal by Subject|38
1287226|NCT00347269|4199050|P1|Overall Study|Withdrawal by Subject|18
1287227|NCT00347269|4199049|P2|Overall Study|Lost to Follow-up|65
1287228|NCT00347269|4199050|P1|Overall Study|Lost to Follow-up|74
1287229|NCT00347009|4199065|P1|Overall Study|Serious Adverse Event|1
1287230|NCT00347009|4199065|P1|Overall Study|Increased ALT/HBV DNA|1
1287231|NCT00347009|4199065|P1|Overall Study|Insufficient Viral Suppression|3
1287232|NCT00347009|4199065|P1|Overall Study|Adverse Laboratory Experience|1
1287233|NCT00347009|4199065|P1|Overall Study|Protocol Violation|2
1287234|NCT00347009|4199065|P1|Overall Study|Lost to Follow-up|4
1287235|NCT00347009|4199065|P1|Overall Study|Physician Decision|5
1287236|NCT00347009|4199065|P1|Overall Study|Withdrawal by Subject|3
1287237|NCT00347009|4199065|P1|Overall Study|Adverse Event|6
1287238|NCT00347009|4199065|P1|Overall Study|Death|1
1287239|NCT00346775|4199086|P2|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0
1287240|NCT00346775|4199087|P1|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1
1287241|NCT00346775|4199086|P2|Period 1: Intervention Period 1|Protocol Violation|2
1287242|NCT00346775|4199087|P1|Period 1: Intervention Period 1|Protocol Violation|3
1287243|NCT00346775|4199086|P2|Period 1: Intervention Period 1|Lost to Follow-up|1
1287244|NCT00346775|4199087|P1|Period 1: Intervention Period 1|Lost to Follow-up|1
1287245|NCT00346697|4199099|P2|Overall Study|Lost to Follow-up|1
1287246|NCT00346697|4199100|P1|Overall Study|Lost to Follow-up|0
1287247|NCT00346632|4199136|P10|Overall Study|Not Stated|1
1287248|NCT00346632|4199137|P9|Overall Study|Not Stated|2
1287249|NCT00346632|4199138|P8|Overall Study|Not Stated|2
1287250|NCT00346632|4199139|P7|Overall Study|Not Stated|0
1287251|NCT00346632|4199140|P6|Overall Study|Not Stated|0
1287252|NCT00346632|4199141|P5|Overall Study|Not Stated|0
1287253|NCT00346632|4199142|P4|Overall Study|Not Stated|0
1287254|NCT00346632|4199143|P3|Overall Study|Not Stated|0
1287255|NCT00346632|4199144|P2|Overall Study|Not Stated|1
1287256|NCT00346632|4199145|P1|Overall Study|Not Stated|1
1287257|NCT00346632|4199136|P10|Overall Study|Switched to alternative treatment|0
1287258|NCT00346632|4199137|P9|Overall Study|Switched to alternative treatment|0
1287259|NCT00346632|4199138|P8|Overall Study|Switched to alternative treatment|0
1287260|NCT00346632|4199139|P7|Overall Study|Switched to alternative treatment|0
1287261|NCT00346632|4199140|P6|Overall Study|Switched to alternative treatment|0
1287262|NCT00346632|4199141|P5|Overall Study|Switched to alternative treatment|0
1287263|NCT00346632|4199142|P4|Overall Study|Switched to alternative treatment|0
1287264|NCT00346632|4199143|P3|Overall Study|Switched to alternative treatment|1
1287265|NCT00346632|4199144|P2|Overall Study|Switched to alternative treatment|0
1287266|NCT00346632|4199145|P1|Overall Study|Switched to alternative treatment|0
1287267|NCT00346632|4199136|P10|Overall Study|Withdrawal by Subject|0
1287268|NCT00346632|4199137|P9|Overall Study|Withdrawal by Subject|0
1287269|NCT00346632|4199138|P8|Overall Study|Withdrawal by Subject|0
1287270|NCT00346632|4199139|P7|Overall Study|Withdrawal by Subject|1
1287271|NCT00346632|4199140|P6|Overall Study|Withdrawal by Subject|0
1287272|NCT00346632|4199141|P5|Overall Study|Withdrawal by Subject|0
1287273|NCT00346632|4199142|P4|Overall Study|Withdrawal by Subject|0
1287274|NCT00346632|4199143|P3|Overall Study|Withdrawal by Subject|0
1287275|NCT00346632|4199144|P2|Overall Study|Withdrawal by Subject|0
1287276|NCT00346632|4199145|P1|Overall Study|Withdrawal by Subject|0
1287277|NCT00346632|4199136|P10|Overall Study|Protocol Violation|0
1287278|NCT00346632|4199137|P9|Overall Study|Protocol Violation|0
1287279|NCT00346632|4199138|P8|Overall Study|Protocol Violation|0
1287280|NCT00346632|4199139|P7|Overall Study|Protocol Violation|1
1287281|NCT00346632|4199140|P6|Overall Study|Protocol Violation|0
1287282|NCT00346632|4199141|P5|Overall Study|Protocol Violation|0
1287283|NCT00346632|4199142|P4|Overall Study|Protocol Violation|0
1287284|NCT00346632|4199143|P3|Overall Study|Protocol Violation|0
1287285|NCT00346632|4199144|P2|Overall Study|Protocol Violation|0
1287286|NCT00346632|4199145|P1|Overall Study|Protocol Violation|0
1287287|NCT00346632|4199136|P10|Overall Study|Death|0
1287288|NCT00346632|4199137|P9|Overall Study|Death|0
1287289|NCT00346632|4199138|P8|Overall Study|Death|0
1287290|NCT00346632|4199139|P7|Overall Study|Death|0
1287291|NCT00346632|4199140|P6|Overall Study|Death|0
1287292|NCT00346632|4199141|P5|Overall Study|Death|0
1287293|NCT00346632|4199142|P4|Overall Study|Death|0
1287294|NCT00346632|4199143|P3|Overall Study|Death|1
1287295|NCT00346632|4199144|P2|Overall Study|Death|0
1287296|NCT00346632|4199145|P1|Overall Study|Death|0
1287297|NCT00346632|4199136|P10|Overall Study|Adverse Event|0
1287298|NCT00346632|4199137|P9|Overall Study|Adverse Event|0
1287299|NCT00346632|4199138|P8|Overall Study|Adverse Event|0
1287300|NCT00346632|4199139|P7|Overall Study|Adverse Event|1
1287301|NCT00346632|4199140|P6|Overall Study|Adverse Event|1
1287302|NCT00346632|4199141|P5|Overall Study|Adverse Event|1
1287303|NCT00346632|4199142|P4|Overall Study|Adverse Event|0
1287304|NCT00346632|4199143|P3|Overall Study|Adverse Event|0
1287305|NCT00346632|4199144|P2|Overall Study|Adverse Event|0
1287306|NCT00346632|4199145|P1|Overall Study|Adverse Event|0
1287307|NCT00346632|4199136|P10|Overall Study|Progressive Disease|2
1287308|NCT00346632|4199137|P9|Overall Study|Progressive Disease|2
1287309|NCT00346632|4199138|P8|Overall Study|Progressive Disease|2
1287310|NCT00346632|4199139|P7|Overall Study|Progressive Disease|2
1287311|NCT00346632|4199140|P6|Overall Study|Progressive Disease|1
1287312|NCT00346632|4199141|P5|Overall Study|Progressive Disease|3
1287313|NCT00346632|4199142|P4|Overall Study|Progressive Disease|3
1287314|NCT00346632|4199143|P3|Overall Study|Progressive Disease|4
1287315|NCT00346632|4199144|P2|Overall Study|Progressive Disease|2
1287316|NCT00346632|4199145|P1|Overall Study|Progressive Disease|2
1287317|NCT00346398|4199295|P2|Overall Study|Withdrawal by Subject|2
1287318|NCT00346398|4199296|P1|Overall Study|Withdrawal by Subject|0
1287319|NCT00346398|4199295|P2|Overall Study|Lost to Follow-up|0
1287320|NCT00346398|4199296|P1|Overall Study|Lost to Follow-up|3
1287321|NCT00346333|4199308|P2|Overall Study|unwilling or unable to continue|8
1287322|NCT00346333|4199309|P1|Overall Study|unwilling or unable to continue|4
1287323|NCT00346333|4199308|P2|Overall Study|Death|0
1287324|NCT00346333|4199309|P1|Overall Study|Death|1
1287325|NCT00346268|4199325|P2|Overall Study|Participant refused|3
1287326|NCT00346268|4199326|P1|Overall Study|Participant refused|0
1287327|NCT00346268|4199325|P2|Overall Study|Protocol Violation|0
1287328|NCT00346268|4199326|P1|Overall Study|Protocol Violation|1
1287329|NCT00346268|4199325|P2|Overall Study|Adverse Event|0
1287330|NCT00346268|4199326|P1|Overall Study|Adverse Event|1
1287331|NCT00346216|4199361|P3|Overall Study|Missing Subject Summary Status|62
1287332|NCT00346216|4199362|P2|Overall Study|Missing Subject Summary Status|61
1287333|NCT00346216|4199363|P1|Overall Study|Missing Subject Summary Status|62
1287334|NCT00346216|4199361|P3|Overall Study|Study terminated by sponsor|8
1287335|NCT00346216|4199362|P2|Overall Study|Study terminated by sponsor|4
1287336|NCT00346216|4199363|P1|Overall Study|Study terminated by sponsor|11
1287337|NCT00346216|4199361|P3|Overall Study|Death|228
1287338|NCT00346216|4199362|P2|Overall Study|Death|192
1287339|NCT00346216|4199363|P1|Overall Study|Death|189
1287340|NCT00346216|4199361|P3|Overall Study|Does not meet entrance criteria|8
1287341|NCT00346216|4199362|P2|Overall Study|Does not meet entrance criteria|10
1287342|NCT00346216|4199363|P1|Overall Study|Does not meet entrance criteria|13
1287343|NCT00346216|4199361|P3|Overall Study|Physician Decision|59
1287344|NCT00346216|4199362|P2|Overall Study|Physician Decision|76
1287345|NCT00346216|4199363|P1|Overall Study|Physician Decision|80
1287346|NCT00346216|4199361|P3|Overall Study|Lost to Follow-up|542
1287347|NCT00346216|4199362|P2|Overall Study|Lost to Follow-up|588
1287348|NCT00346216|4199363|P1|Overall Study|Lost to Follow-up|611
1287349|NCT00346216|4199361|P3|Overall Study|Withdrawal by Subject|651
1287350|NCT00346216|4199362|P2|Overall Study|Withdrawal by Subject|692
1287351|NCT00346216|4199363|P1|Overall Study|Withdrawal by Subject|661
1287352|NCT00346216|4199361|P3|Overall Study|No longer willing to participate|585
1287353|NCT00346216|4199362|P2|Overall Study|No longer willing to participate|606
1287354|NCT00346216|4199363|P1|Overall Study|No longer willing to participate|600
1287355|NCT00346216|4199361|P3|Overall Study|Not specified|205
1287356|NCT00346216|4199362|P2|Overall Study|Not specified|231
1287357|NCT00346216|4199363|P1|Overall Study|Not specified|181
1287358|NCT00346164|4199384|P4|Overall Study|Inability to start week 16 tx on time|11
1287359|NCT00346164|4199385|P3|Overall Study|Inability to start week 16 tx on time|0
1287360|NCT00346164|4199386|P2|Overall Study|Inability to start week 16 tx on time|0
1287361|NCT00346164|4199387|P1|Overall Study|Inability to start week 16 tx on time|0
1287362|NCT00346164|4199384|P4|Overall Study|Refusal of further protocol therapy|15
1287363|NCT00346164|4199385|P3|Overall Study|Refusal of further protocol therapy|3
1287364|NCT00346164|4199386|P2|Overall Study|Refusal of further protocol therapy|1
1287365|NCT00346164|4199387|P1|Overall Study|Refusal of further protocol therapy|0
1287366|NCT00346164|4199384|P4|Overall Study|Ineligible|23
1287367|NCT00346164|4199385|P3|Overall Study|Ineligible|2
1287368|NCT00346164|4199386|P2|Overall Study|Ineligible|2
1287369|NCT00346164|4199387|P1|Overall Study|Ineligible|11
1287370|NCT00346164|4199384|P4|Overall Study|Withdrawal by Subject|0
1287371|NCT00346164|4199385|P3|Overall Study|Withdrawal by Subject|2
1287372|NCT00346164|4199386|P2|Overall Study|Withdrawal by Subject|0
1287373|NCT00346164|4199387|P1|Overall Study|Withdrawal by Subject|0
1287374|NCT00346164|4199384|P4|Overall Study|Protocol Violation|4
1287375|NCT00346164|4199385|P3|Overall Study|Protocol Violation|10
1287376|NCT00346164|4199386|P2|Overall Study|Protocol Violation|2
1287377|NCT00346164|4199387|P1|Overall Study|Protocol Violation|6
1287378|NCT00346164|4199384|P4|Overall Study|Physician Decision|27
1287379|NCT00346164|4199385|P3|Overall Study|Physician Decision|2
1287380|NCT00346164|4199386|P2|Overall Study|Physician Decision|1
1287381|NCT00346164|4199387|P1|Overall Study|Physician Decision|0
1287382|NCT00346164|4199384|P4|Overall Study|Lack of Efficacy|25
1287383|NCT00346164|4199385|P3|Overall Study|Lack of Efficacy|7
1287384|NCT00346164|4199386|P2|Overall Study|Lack of Efficacy|1
1287385|NCT00346164|4199387|P1|Overall Study|Lack of Efficacy|0
1287386|NCT00346164|4199384|P4|Overall Study|Adverse Event|1
1287387|NCT00346164|4199385|P3|Overall Study|Adverse Event|0
1287388|NCT00346164|4199386|P2|Overall Study|Adverse Event|0
1287389|NCT00346164|4199387|P1|Overall Study|Adverse Event|0
1287390|NCT00346151|4199422|P1|Overall Study|Withdrawal by Subject|3
1287391|NCT00346073|4199442|P2|Overall Study|Lost to Follow-up|24
1287392|NCT00346073|4199443|P1|Overall Study|Lost to Follow-up|39
1287393|NCT00346073|4199442|P2|Overall Study|Serious Adverse Event|0
1287394|NCT00346073|4199443|P1|Overall Study|Serious Adverse Event|2
1287395|NCT00346034|4199477|P1|Overall Study|Not Willing to Follow Dosing Regimen|1
1287396|NCT00346034|4199477|P1|Overall Study|Patient Stopped Taking Study Drug|1
1287397|NCT00346034|4199477|P1|Overall Study|Withdrawal by Subject|13
1287398|NCT00346034|4199477|P1|Overall Study|Lack of Efficacy|8
1287399|NCT00346034|4199477|P1|Overall Study|Adverse Event|34
1287400|NCT00345878|4199517|P2|Overall Study|Other|0
1287401|NCT00345878|4199518|P1|Overall Study|Other|1
1287402|NCT00345878|4199517|P2|Overall Study|Lost to Follow-up|1
1287403|NCT00345878|4199518|P1|Overall Study|Lost to Follow-up|2
1287404|NCT00345878|4199517|P2|Overall Study|Adverse Event|0
1287405|NCT00345878|4199518|P1|Overall Study|Adverse Event|1
1287406|NCT00345839|4199536|P2|Overall Study|Lost to Follow-up|61
1287407|NCT00345839|4199537|P1|Overall Study|Lost to Follow-up|58
1287408|NCT00345839|4199536|P2|Overall Study|Withdrawal by Subject|98
1287409|NCT00345839|4199537|P1|Overall Study|Withdrawal by Subject|91
1287410|NCT00345683|4199563|P2|Overall Study|Other|2
1287411|NCT00345683|4199564|P1|Overall Study|Other|6
1287412|NCT00345683|4199563|P2|Overall Study|Lost to Follow-up|7
1287413|NCT00345683|4199564|P1|Overall Study|Lost to Follow-up|19
1287414|NCT00345631|4199587|P3|Overall Study|Other reasons|1
1287415|NCT00345631|4199588|P2|Overall Study|Other reasons|0
1287416|NCT00345631|4199589|P1|Overall Study|Other reasons|0
1287417|NCT00345631|4199587|P3|Overall Study|Lost to Follow-up|4
1287418|NCT00345631|4199588|P2|Overall Study|Lost to Follow-up|7
1287419|NCT00345631|4199589|P1|Overall Study|Lost to Follow-up|3
1287420|NCT00345631|4199587|P3|Overall Study|Adverse Event|0
1287421|NCT00345631|4199588|P2|Overall Study|Adverse Event|1
1287422|NCT00345631|4199589|P1|Overall Study|Adverse Event|0
1287423|NCT00345631|4199587|P3|Overall Study|Withdrawal by Subject|1
1287424|NCT00345631|4199588|P2|Overall Study|Withdrawal by Subject|0
1287425|NCT00345631|4199589|P1|Overall Study|Withdrawal by Subject|1
1287426|NCT00345605|4199621|P2|Arm 2, Opposite Treatment|Adverse Event|0
1287427|NCT00345605|4199622|P1|Arm 2, Opposite Treatment|Adverse Event|1
1287428|NCT00345605|4199621|P2|Arm 1|Adverse Event|1
1287429|NCT00345605|4199622|P1|Arm 1|Adverse Event|0
1287430|NCT00345592|4199642|P2|Overall Study|Withdrawal by Subject|8
1287431|NCT00345592|4199643|P1|Overall Study|Withdrawal by Subject|11
1287432|NCT00345592|4199642|P2|Overall Study|Death|16
1287433|NCT00345592|4199643|P1|Overall Study|Death|14
1287434|NCT00345579|4199651|P2|Overall Study|Other|1
1287435|NCT00345579|4199652|P1|Overall Study|Other|9
1287436|NCT00345579|4199651|P2|Overall Study|Lost to Follow-up|36
1287437|NCT00345579|4199652|P1|Overall Study|Lost to Follow-up|82
1287438|NCT00345579|4199651|P2|Overall Study|Withdrawal by Subject|17
1287439|NCT00345579|4199652|P1|Overall Study|Withdrawal by Subject|50
1287440|NCT00345579|4199651|P2|Overall Study|Protocol Violation|5
1287441|NCT00345579|4199652|P1|Overall Study|Protocol Violation|14
1287442|NCT00345579|4199651|P2|Overall Study|Adverse Event|6
1287443|NCT00345579|4199652|P1|Overall Study|Adverse Event|9
1287444|NCT00345540|4199672|P1|Overall Study|Withdrawal by Subject|1
1287445|NCT00345397|4199678|P1|Overall Study|Death|1
1287446|NCT00345293|4199716|P2|Overall Study|Withdrawal by Subject|0
1287447|NCT00345293|4199717|P1|Overall Study|Withdrawal by Subject|1
1287448|NCT00345293|4199716|P2|Overall Study|Unable to access line for sample|0
1287449|NCT00345293|4199717|P1|Overall Study|Unable to access line for sample|1
1287450|NCT00345046|4199763|P3|Overall Study|Protocol Violation|2
1287451|NCT00345046|4199764|P2|Overall Study|Protocol Violation|1
1287452|NCT00345046|4199765|P1|Overall Study|Protocol Violation|1
1287453|NCT00344968|4199795|P3|Overall Study|Other|0
1287454|NCT00344968|4199796|P2|Overall Study|Other|1
1287455|NCT00344968|4199797|P1|Overall Study|Other|0
1287456|NCT00344968|4199795|P3|Overall Study|Death|31
1287457|NCT00344968|4199796|P2|Overall Study|Death|27
1287458|NCT00344968|4199797|P1|Overall Study|Death|11
1287459|NCT00344968|4199795|P3|Overall Study|Lost to Follow-up|37
1287460|NCT00344968|4199796|P2|Overall Study|Lost to Follow-up|37
1287461|NCT00344968|4199797|P1|Overall Study|Lost to Follow-up|24
1287462|NCT00344968|4199795|P3|Overall Study|Withdrawal by Subject|27
1287463|NCT00344968|4199796|P2|Overall Study|Withdrawal by Subject|31
1287464|NCT00344968|4199797|P1|Overall Study|Withdrawal by Subject|14
1287465|NCT00344968|4199795|P3|Overall Study|Protocol Violation|5
1287466|NCT00344968|4199796|P2|Overall Study|Protocol Violation|2
1287467|NCT00344968|4199797|P1|Overall Study|Protocol Violation|2
1287468|NCT00344968|4199795|P3|Overall Study|Unsatisfactory Therapeutic Effect|1
1287469|NCT00344968|4199796|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
1287470|NCT00344968|4199797|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
1287471|NCT00344968|4199795|P3|Overall Study|Adverse Event|15
1287472|NCT00344968|4199796|P2|Overall Study|Adverse Event|4
1287473|NCT00344968|4199797|P1|Overall Study|Adverse Event|5
1287474|NCT00344773|4199808|P1|Overall Study|Not Eligible for the study|2
1287475|NCT00344773|4199808|P1|Overall Study|Withdrawal by Subject|1
1287476|NCT00344773|4199808|P1|Overall Study|Objective Disease Progression|16
1287477|NCT00344773|4199808|P1|Overall Study|Adverse Event|2
1287478|NCT00344500|4199831|P3|Overall Study|Not Noted|0
1287479|NCT00344500|4199832|P2|Overall Study|Not Noted|3
1287480|NCT00344500|4199833|P1|Overall Study|Not Noted|1
1287481|NCT00344500|4199831|P3|Overall Study|Protocol Violation|1
1287482|NCT00344500|4199832|P2|Overall Study|Protocol Violation|7
1287483|NCT00344500|4199833|P1|Overall Study|Protocol Violation|4
1287484|NCT00344500|4199831|P3|Overall Study|Withdrawal by Subject|0
1287485|NCT00344500|4199832|P2|Overall Study|Withdrawal by Subject|10
1287486|NCT00344500|4199833|P1|Overall Study|Withdrawal by Subject|7
1287487|NCT00344500|4199831|P3|Overall Study|Lost to Follow-up|1
1287488|NCT00344500|4199832|P2|Overall Study|Lost to Follow-up|13
1287489|NCT00344500|4199833|P1|Overall Study|Lost to Follow-up|5
1287490|NCT00344500|4199831|P3|Overall Study|Adverse Event|0
1287491|NCT00344500|4199832|P2|Overall Study|Adverse Event|2
1287492|NCT00344500|4199833|P1|Overall Study|Adverse Event|6
1287493|NCT00344487|4199844|P1|Overall Study|immunologic failure|1
1287494|NCT00344461|4199848|P1|Overall Study|Withdrawal by Subject|2
1287495|NCT00344461|4199848|P1|Overall Study|Protocol Violation|6
1287496|NCT00344461|4199848|P1|Overall Study|Physician Decision|2
1287497|NCT00344461|4199848|P1|Overall Study|Lost to Follow-up|2
1287498|NCT00344461|4199848|P1|Overall Study|Lack of Efficacy|2
1287499|NCT00344461|4199848|P1|Overall Study|Death|1
1287500|NCT00344461|4199848|P1|Overall Study|Adverse Event|6
1287501|NCT00344448|4199859|P2|Open Label|Study terminated|0
1287502|NCT00344448|4199860|P1|Open Label|Study terminated|1
1287503|NCT00344448|4199859|P2|Open Label|Withdrawal by Subject|1
1287504|NCT00344448|4199860|P1|Open Label|Withdrawal by Subject|1
1287505|NCT00344448|4199859|P2|Double Blind, Placebo Controlled|Study terminated|0
1287506|NCT00344448|4199860|P1|Double Blind, Placebo Controlled|Study terminated|1
1287507|NCT00344448|4199859|P2|Double Blind, Placebo Controlled|Withdrawal by Subject|0
1287508|NCT00344448|4199860|P1|Double Blind, Placebo Controlled|Withdrawal by Subject|1
1287509|NCT00344448|4199859|P2|Screening|Withdrawal by Subject|1
1287510|NCT00344448|4199860|P1|Screening|Withdrawal by Subject|0
1287511|NCT00344318|4199881|P4|Overall Study|Lost to Follow-up|0
1287512|NCT00344318|4199882|P3|Overall Study|Lost to Follow-up|1
1287513|NCT00344318|4199883|P2|Overall Study|Lost to Follow-up|0
1287514|NCT00344318|4199884|P1|Overall Study|Lost to Follow-up|2
1287515|NCT00344318|4199881|P4|Overall Study|Withdrawal by Subject|2
1287516|NCT00344318|4199882|P3|Overall Study|Withdrawal by Subject|0
1287517|NCT00344318|4199883|P2|Overall Study|Withdrawal by Subject|2
1287518|NCT00344318|4199884|P1|Overall Study|Withdrawal by Subject|2
1287519|NCT00344318|4199881|P4|Overall Study|Adverse Event|1
1287520|NCT00344318|4199882|P3|Overall Study|Adverse Event|0
1287521|NCT00344318|4199883|P2|Overall Study|Adverse Event|3
1287522|NCT00344318|4199884|P1|Overall Study|Adverse Event|0
1287523|NCT00344305|4200006|P2|Overall Study|Participant was not contacted in window|1
1287524|NCT00344305|4200007|P1|Overall Study|Participant was not contacted in window|0
1287525|NCT00344305|4200006|P2|Overall Study|Lost to Follow-up|0
1287526|NCT00344305|4200007|P1|Overall Study|Lost to Follow-up|2
1287527|NCT00344032|4200057|P2|Overall Study|Physician Decision|1
1287528|NCT00344032|4200058|P1|Overall Study|Physician Decision|4
1287529|NCT00344032|4200057|P2|Overall Study|Lost to Follow-up|6
1287530|NCT00344032|4200058|P1|Overall Study|Lost to Follow-up|4
1287531|NCT00344032|4200057|P2|Overall Study|Withdrawal by Subject|2
1287532|NCT00344032|4200058|P1|Overall Study|Withdrawal by Subject|6
1287533|NCT00344032|4200057|P2|Overall Study|Adverse Event|1
1287534|NCT00344032|4200058|P1|Overall Study|Adverse Event|0
1287535|NCT00344019|4200077|P3|Overall Study|did not meet final inclusion criteria|74
1287536|NCT00344019|4200078|P2|Overall Study|did not meet final inclusion criteria|0
1287537|NCT00344019|4200079|P1|Overall Study|did not meet final inclusion criteria|0
1287538|NCT00343915|4200097|P2|Primary Study|Other|0
1287539|NCT00343915|4200098|P1|Primary Study|Other|1
1287540|NCT00343915|4200097|P2|Primary Study|Lost to Follow-up|3
1287541|NCT00343915|4200098|P1|Primary Study|Lost to Follow-up|2
1287542|NCT00343915|4200097|P2|Primary Study|Withdrawal by Subject|0
1287543|NCT00343915|4200098|P1|Primary Study|Withdrawal by Subject|1
1287544|NCT00343889|4200124|P2|Overall Study|Protocol Violation|0
1287545|NCT00343889|4200125|P1|Overall Study|Protocol Violation|1
1287546|NCT00343889|4200124|P2|Overall Study|Withdrawal by Subject|1
1287547|NCT00343889|4200125|P1|Overall Study|Withdrawal by Subject|0
1287548|NCT00343889|4200124|P2|Overall Study|Lost to Follow-up|0
1287549|NCT00343889|4200125|P1|Overall Study|Lost to Follow-up|2
1287550|NCT00343512|4200208|P1|Overall Study|Withdrawal by Subject|2
1287551|NCT00343382|4200296|P3|Overall Study|Other Reason Not Specified|4
1287552|NCT00343382|4200297|P2|Overall Study|Other Reason Not Specified|2
1287553|NCT00343382|4200298|P1|Overall Study|Other Reason Not Specified|1
1287554|NCT00343382|4200296|P3|Overall Study|Withdrawal by Subject|6
1287555|NCT00343382|4200297|P2|Overall Study|Withdrawal by Subject|2
1287556|NCT00343382|4200298|P1|Overall Study|Withdrawal by Subject|1
1287557|NCT00343382|4200296|P3|Overall Study|Adverse Event|7
1287558|NCT00343382|4200297|P2|Overall Study|Adverse Event|10
1287559|NCT00343382|4200298|P1|Overall Study|Adverse Event|2
1287560|NCT00343291|4200317|P2|Overall Study|Other|5
1287561|NCT00343291|4200318|P1|Overall Study|Other|8
1287562|NCT00343291|4200317|P2|Overall Study|Withdrawal by Subject|2
1287563|NCT00343291|4200318|P1|Overall Study|Withdrawal by Subject|0
1287564|NCT00343291|4200317|P2|Overall Study|Progressive disease|34
1287565|NCT00343291|4200318|P1|Overall Study|Progressive disease|33
1287566|NCT00343291|4200317|P2|Overall Study|Death|2
1287567|NCT00343291|4200318|P1|Overall Study|Death|3
1287568|NCT00343291|4200317|P2|Overall Study|Adverse Event|13
1287569|NCT00343291|4200318|P1|Overall Study|Adverse Event|13
1287570|NCT00343252|4200334|P2|18 Months (All Treated Participants)|Withdrawal by Subject|20
1287571|NCT00343252|4200335|P1|18 Months (All Treated Participants)|Withdrawal by Subject|36
1287572|NCT00343252|4200334|P2|18 Months (All Treated Participants)|Sponsor Decision|5
1287573|NCT00343252|4200335|P1|18 Months (All Treated Participants)|Sponsor Decision|8
1287574|NCT00343252|4200334|P2|18 Months (All Treated Participants)|Protocol Violation|3
1287575|NCT00343252|4200335|P1|18 Months (All Treated Participants)|Protocol Violation|3
1287576|NCT00343252|4200334|P2|18 Months (All Treated Participants)|Physician Decision|7
1287577|NCT00343252|4200335|P1|18 Months (All Treated Participants)|Physician Decision|4
1287578|NCT00343252|4200334|P2|18 Months (All Treated Participants)|Lost to Follow-up|7
1287579|NCT00343252|4200335|P1|18 Months (All Treated Participants)|Lost to Follow-up|3
1287580|NCT00343252|4200334|P2|18 Months (All Treated Participants)|Lack of Efficacy|1
1287581|NCT00343252|4200335|P1|18 Months (All Treated Participants)|Lack of Efficacy|1
1287582|NCT00343252|4200334|P2|18 Months (All Treated Participants)|Entry Criteria Not Met|10
1287583|NCT00343252|4200335|P1|18 Months (All Treated Participants)|Entry Criteria Not Met|11
1287584|NCT00343252|4200334|P2|18 Months (All Treated Participants)|Death|5
1287585|NCT00343252|4200335|P1|18 Months (All Treated Participants)|Death|4
1287586|NCT00343252|4200334|P2|18 Months (All Treated Participants)|Adverse Event|23
1287587|NCT00343252|4200335|P1|18 Months (All Treated Participants)|Adverse Event|31
1287588|NCT00343252|4200334|P2|12 Months (All Treated Participants)|Withdrawal by Subject|17
1287589|NCT00343252|4200335|P1|12 Months (All Treated Participants)|Withdrawal by Subject|33
1287590|NCT00343252|4200334|P2|12 Months (All Treated Participants)|Sponsor Decision|6
1287591|NCT00343252|4200335|P1|12 Months (All Treated Participants)|Sponsor Decision|9
1287592|NCT00343252|4200334|P2|12 Months (All Treated Participants)|Protocol Violation|2
1287593|NCT00343252|4200335|P1|12 Months (All Treated Participants)|Protocol Violation|3
1287594|NCT00343252|4200334|P2|12 Months (All Treated Participants)|Physician Decision|5
1287595|NCT00343252|4200335|P1|12 Months (All Treated Participants)|Physician Decision|4
1287596|NCT00343252|4200334|P2|12 Months (All Treated Participants)|Lost to Follow-up|5
1287597|NCT00343252|4200335|P1|12 Months (All Treated Participants)|Lost to Follow-up|1
1287598|NCT00343252|4200334|P2|12 Months (All Treated Participants)|Lack of Efficacy|1
1287599|NCT00343252|4200335|P1|12 Months (All Treated Participants)|Lack of Efficacy|1
1287600|NCT00343252|4200334|P2|12 Months (All Treated Participants)|Entry Criteria Not Met|10
1287601|NCT00343252|4200335|P1|12 Months (All Treated Participants)|Entry Criteria Not Met|10
1287602|NCT00343252|4200334|P2|12 Months (All Treated Participants)|Death|3
1287603|NCT00343252|4200335|P1|12 Months (All Treated Participants)|Death|3
1287604|NCT00343252|4200334|P2|12 Months (All Treated Participants)|Adverse Event|20
1287605|NCT00343252|4200335|P1|12 Months (All Treated Participants)|Adverse Event|22
1287606|NCT00343252|4200334|P2|6 Months (All Treated Participants)|Withdrawal by Subject|9
1287607|NCT00343252|4200335|P1|6 Months (All Treated Participants)|Withdrawal by Subject|19
1287608|NCT00343252|4200334|P2|6 Months (All Treated Participants)|Sponsor Decision|4
1287609|NCT00343252|4200335|P1|6 Months (All Treated Participants)|Sponsor Decision|7
1287610|NCT00343252|4200334|P2|6 Months (All Treated Participants)|Protocol Violation|2
1287611|NCT00343252|4200335|P1|6 Months (All Treated Participants)|Protocol Violation|2
1287612|NCT00343252|4200334|P2|6 Months (All Treated Participants)|Physician Decision|3
1287613|NCT00343252|4200335|P1|6 Months (All Treated Participants)|Physician Decision|1
1287614|NCT00343252|4200334|P2|6 Months (All Treated Participants)|Lost to Follow-up|4
1287615|NCT00343252|4200335|P1|6 Months (All Treated Participants)|Lost to Follow-up|0
1287616|NCT00343252|4200334|P2|6 Months (All Treated Participants)|Lack of Efficacy|1
1287617|NCT00343252|4200335|P1|6 Months (All Treated Participants)|Lack of Efficacy|0
1287618|NCT00343252|4200334|P2|6 Months (All Treated Participants)|Entry Criteria Not Met|8
1287619|NCT00343252|4200335|P1|6 Months (All Treated Participants)|Entry Criteria Not Met|10
1287620|NCT00343252|4200334|P2|6 Months (All Treated Participants)|Death|2
1287621|NCT00343252|4200335|P1|6 Months (All Treated Participants)|Death|0
1287622|NCT00343252|4200334|P2|6 Months (All Treated Participants)|Adverse Event|11
1287623|NCT00343252|4200335|P1|6 Months (All Treated Participants)|Adverse Event|17
1287624|NCT00342628|4200400|P3|Overall Study|moved residence|1
1287625|NCT00342628|4200401|P2|Overall Study|moved residence|1
1287626|NCT00342628|4200402|P1|Overall Study|moved residence|0
1287627|NCT00342628|4200400|P3|Overall Study|Death|0
1287628|NCT00342628|4200401|P2|Overall Study|Death|1
1287629|NCT00342628|4200402|P1|Overall Study|Death|1
1287630|NCT00342628|4200400|P3|Overall Study|Withdrawal by Subject|18
1287631|NCT00342628|4200401|P2|Overall Study|Withdrawal by Subject|19
1287632|NCT00342628|4200402|P1|Overall Study|Withdrawal by Subject|19
1287633|NCT00340834|4200468|P5|Extension Phase of Study|Death|1
1287634|NCT00340834|4200469|P4|Extension Phase of Study|Death|0
1287635|NCT00340834|4200470|P3|Extension Phase of Study|Death|0
1287636|NCT00340834|4200471|P2|Extension Phase of Study|Death|0
1287637|NCT00340834|4200472|P1|Extension Phase of Study|Death|0
1287638|NCT00340834|4200468|P5|Extension Phase of Study|Protocol Violation|0
1287639|NCT00340834|4200469|P4|Extension Phase of Study|Protocol Violation|0
1287640|NCT00340834|4200470|P3|Extension Phase of Study|Protocol Violation|0
1287641|NCT00340834|4200471|P2|Extension Phase of Study|Protocol Violation|0
1287642|NCT00340834|4200472|P1|Extension Phase of Study|Protocol Violation|3
1287643|NCT00340834|4200468|P5|Extension Phase of Study|Abnormal test procedure result(s)|2
1287644|NCT00340834|4200469|P4|Extension Phase of Study|Abnormal test procedure result(s)|0
1287645|NCT00340834|4200470|P3|Extension Phase of Study|Abnormal test procedure result(s)|0
1287646|NCT00340834|4200471|P2|Extension Phase of Study|Abnormal test procedure result(s)|1
1287647|NCT00340834|4200472|P1|Extension Phase of Study|Abnormal test procedure result(s)|0
1287648|NCT00340834|4200468|P5|Extension Phase of Study|Administrative problems|1
1287649|NCT00340834|4200469|P4|Extension Phase of Study|Administrative problems|1
1287650|NCT00340834|4200470|P3|Extension Phase of Study|Administrative problems|0
1287651|NCT00340834|4200471|P2|Extension Phase of Study|Administrative problems|0
1287652|NCT00340834|4200472|P1|Extension Phase of Study|Administrative problems|3
1287653|NCT00340834|4200468|P5|Extension Phase of Study|Subject no longer requires study drug|2
1287654|NCT00340834|4200469|P4|Extension Phase of Study|Subject no longer requires study drug|0
1287655|NCT00340834|4200470|P3|Extension Phase of Study|Subject no longer requires study drug|0
1287656|NCT00340834|4200471|P2|Extension Phase of Study|Subject no longer requires study drug|0
1287657|NCT00340834|4200472|P1|Extension Phase of Study|Subject no longer requires study drug|4
1287658|NCT00340834|4200468|P5|Extension Phase of Study|Lost to Follow-up|3
1287659|NCT00340834|4200469|P4|Extension Phase of Study|Lost to Follow-up|2
1287660|NCT00340834|4200470|P3|Extension Phase of Study|Lost to Follow-up|0
1287661|NCT00340834|4200471|P2|Extension Phase of Study|Lost to Follow-up|1
1287662|NCT00340834|4200472|P1|Extension Phase of Study|Lost to Follow-up|1
1287663|NCT00340834|4200468|P5|Extension Phase of Study|Unsatisfactory therapeutic effect|9
1287664|NCT00340834|4200469|P4|Extension Phase of Study|Unsatisfactory therapeutic effect|4
1287665|NCT00340834|4200470|P3|Extension Phase of Study|Unsatisfactory therapeutic effect|0
1287666|NCT00340834|4200471|P2|Extension Phase of Study|Unsatisfactory therapeutic effect|7
1287667|NCT00340834|4200472|P1|Extension Phase of Study|Unsatisfactory therapeutic effect|13
1287668|NCT00340834|4200468|P5|Extension Phase of Study|Abnormal laboratory value(s)|4
1287669|NCT00340834|4200469|P4|Extension Phase of Study|Abnormal laboratory value(s)|13
1287670|NCT00340834|4200470|P3|Extension Phase of Study|Abnormal laboratory value(s)|0
1287671|NCT00340834|4200471|P2|Extension Phase of Study|Abnormal laboratory value(s)|13
1287672|NCT00340834|4200472|P1|Extension Phase of Study|Abnormal laboratory value(s)|14
1287673|NCT00340834|4200468|P5|Extension Phase of Study|Adverse Event|7
1287674|NCT00340834|4200469|P4|Extension Phase of Study|Adverse Event|19
1287675|NCT00340834|4200470|P3|Extension Phase of Study|Adverse Event|0
1287676|NCT00340834|4200471|P2|Extension Phase of Study|Adverse Event|22
1287677|NCT00340834|4200472|P1|Extension Phase of Study|Adverse Event|21
1287678|NCT00340834|4200468|P5|Extension Phase of Study|Subject withdrew consent|15
1287679|NCT00340834|4200469|P4|Extension Phase of Study|Subject withdrew consent|12
1287680|NCT00340834|4200470|P3|Extension Phase of Study|Subject withdrew consent|0
1287681|NCT00340834|4200471|P2|Extension Phase of Study|Subject withdrew consent|31
1287682|NCT00340834|4200472|P1|Extension Phase of Study|Subject withdrew consent|26
1287683|NCT00340834|4200468|P5|Extension Phase of Study|Subject did not receive study drug|0
1287684|NCT00340834|4200469|P4|Extension Phase of Study|Subject did not receive study drug|2
1287685|NCT00340834|4200470|P3|Extension Phase of Study|Subject did not receive study drug|0
1287686|NCT00340834|4200471|P2|Extension Phase of Study|Subject did not receive study drug|1
1287687|NCT00340834|4200472|P1|Extension Phase of Study|Subject did not receive study drug|0
1287688|NCT00340834|4200468|P5|Core Phase of Study|Protocol Violation|0
1287689|NCT00340834|4200469|P4|Core Phase of Study|Protocol Violation|0
1287690|NCT00340834|4200470|P3|Core Phase of Study|Protocol Violation|2
1287691|NCT00340834|4200471|P2|Core Phase of Study|Protocol Violation|0
1287692|NCT00340834|4200472|P1|Core Phase of Study|Protocol Violation|0
1287693|NCT00340834|4200468|P5|Core Phase of Study|Death|0
1287694|NCT00340834|4200469|P4|Core Phase of Study|Death|0
1287695|NCT00340834|4200470|P3|Core Phase of Study|Death|0
1287696|NCT00340834|4200471|P2|Core Phase of Study|Death|0
1287697|NCT00340834|4200472|P1|Core Phase of Study|Death|2
1287698|NCT00340834|4200468|P5|Core Phase of Study|Lost to Follow-up|0
1287699|NCT00340834|4200469|P4|Core Phase of Study|Lost to Follow-up|0
1287700|NCT00340834|4200470|P3|Core Phase of Study|Lost to Follow-up|4
1287701|NCT00340834|4200471|P2|Core Phase of Study|Lost to Follow-up|1
1287702|NCT00340834|4200472|P1|Core Phase of Study|Lost to Follow-up|1
1287703|NCT00340834|4200468|P5|Core Phase of Study|Abnormal test procedure result(s)|0
1287704|NCT00340834|4200469|P4|Core Phase of Study|Abnormal test procedure result(s)|0
1287705|NCT00340834|4200470|P3|Core Phase of Study|Abnormal test procedure result(s)|3
1287706|NCT00340834|4200471|P2|Core Phase of Study|Abnormal test procedure result(s)|3
1287707|NCT00340834|4200472|P1|Core Phase of Study|Abnormal test procedure result(s)|4
1287708|NCT00340834|4200468|P5|Core Phase of Study|Abnormal laboratory value(s)|0
1287709|NCT00340834|4200469|P4|Core Phase of Study|Abnormal laboratory value(s)|0
1287710|NCT00340834|4200470|P3|Core Phase of Study|Abnormal laboratory value(s)|1
1287711|NCT00340834|4200471|P2|Core Phase of Study|Abnormal laboratory value(s)|6
1287712|NCT00340834|4200472|P1|Core Phase of Study|Abnormal laboratory value(s)|4
1287713|NCT00340834|4200468|P5|Core Phase of Study|Lack of Efficacy|0
1287714|NCT00340834|4200469|P4|Core Phase of Study|Lack of Efficacy|0
1287715|NCT00340834|4200470|P3|Core Phase of Study|Lack of Efficacy|7
1287716|NCT00340834|4200471|P2|Core Phase of Study|Lack of Efficacy|3
1287717|NCT00340834|4200472|P1|Core Phase of Study|Lack of Efficacy|3
1287718|NCT00340834|4200468|P5|Core Phase of Study|Administrative Problems|0
1287719|NCT00340834|4200469|P4|Core Phase of Study|Administrative Problems|0
1287720|NCT00340834|4200470|P3|Core Phase of Study|Administrative Problems|7
1287721|NCT00340834|4200471|P2|Core Phase of Study|Administrative Problems|2
1287722|NCT00340834|4200472|P1|Core Phase of Study|Administrative Problems|6
1287723|NCT00340834|4200468|P5|Core Phase of Study|Withdrawal by Subject|0
1287724|NCT00340834|4200469|P4|Core Phase of Study|Withdrawal by Subject|0
1287725|NCT00340834|4200470|P3|Core Phase of Study|Withdrawal by Subject|16
1287726|NCT00340834|4200471|P2|Core Phase of Study|Withdrawal by Subject|9
1287727|NCT00340834|4200472|P1|Core Phase of Study|Withdrawal by Subject|11
1287728|NCT00340834|4200468|P5|Core Phase of Study|Adverse Event|0
1287729|NCT00340834|4200469|P4|Core Phase of Study|Adverse Event|0
1287730|NCT00340834|4200470|P3|Core Phase of Study|Adverse Event|9
1287731|NCT00340834|4200471|P2|Core Phase of Study|Adverse Event|9
1287732|NCT00340834|4200472|P1|Core Phase of Study|Adverse Event|26
1287733|NCT00340704|4200506|P9|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28
1287734|NCT00340704|4200507|P8|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11
1287735|NCT00340704|4200508|P7|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53
1287736|NCT00340704|4200509|P6|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3
1287737|NCT00340704|4200510|P5|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
1287738|NCT00340704|4200511|P4|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
1287739|NCT00340704|4200512|P3|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
1287740|NCT00340704|4200513|P2|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
1287741|NCT00340704|4200514|P1|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
1287742|NCT00340704|4200506|P9|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
1287743|NCT00340704|4200507|P8|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
1287744|NCT00340704|4200508|P7|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
1287745|NCT00340704|4200509|P6|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3
1287746|NCT00340704|4200510|P5|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1
1287747|NCT00340704|4200511|P4|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
1287748|NCT00340704|4200512|P3|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
1287749|NCT00340704|4200513|P2|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
1287750|NCT00340704|4200514|P1|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
1287751|NCT00340704|4200506|P9|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
1287752|NCT00340704|4200507|P8|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
1287753|NCT00340704|4200508|P7|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
1287754|NCT00340704|4200509|P6|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1
1287755|NCT00340704|4200510|P5|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
1287756|NCT00340704|4200511|P4|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
1287757|NCT00340704|4200512|P3|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
1287758|NCT00340704|4200513|P2|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
1287759|NCT00340704|4200514|P1|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
1287760|NCT00340704|4200506|P9|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
1287761|NCT00340704|4200507|P8|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
1287762|NCT00340704|4200508|P7|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
1287763|NCT00340704|4200509|P6|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
1287764|NCT00340704|4200510|P5|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4
1287765|NCT00340704|4200511|P4|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2
1287766|NCT00340704|4200512|P3|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
1287767|NCT00340704|4200513|P2|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
1287768|NCT00340704|4200514|P1|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
1287769|NCT00340704|4200506|P9|PK Study|Not treated|0
1287770|NCT00340704|4200507|P8|PK Study|Not treated|0
1287771|NCT00340704|4200508|P7|PK Study|Not treated|0
1287772|NCT00340704|4200509|P6|PK Study|Not treated|0
1287773|NCT00340704|4200510|P5|PK Study|Not treated|0
1287774|NCT00340704|4200511|P4|PK Study|Not treated|0
1287775|NCT00340704|4200512|P3|PK Study|Not treated|1
1287776|NCT00340704|4200513|P2|PK Study|Not treated|0
1287777|NCT00340704|4200514|P1|PK Study|Not treated|0
1287778|NCT00340704|4200506|P9|PK Study|Adverse Event|0
1287779|NCT00340704|4200507|P8|PK Study|Adverse Event|0
1287780|NCT00340704|4200508|P7|PK Study|Adverse Event|0
1287781|NCT00340704|4200509|P6|PK Study|Adverse Event|0
1287782|NCT00340704|4200510|P5|PK Study|Adverse Event|0
1287783|NCT00340704|4200511|P4|PK Study|Adverse Event|0
1287784|NCT00340704|4200512|P3|PK Study|Adverse Event|0
1287785|NCT00340704|4200513|P2|PK Study|Adverse Event|1
1287786|NCT00340704|4200514|P1|PK Study|Adverse Event|0
1287787|NCT00340678|4200620|P4|Overall Study|Lost to Follow-up|0
1287788|NCT00340678|4200621|P3|Overall Study|Lost to Follow-up|0
1287789|NCT00340678|4200622|P2|Overall Study|Lost to Follow-up|0
1287790|NCT00340678|4200623|P1|Overall Study|Lost to Follow-up|1
1287791|NCT00339833|4200650|P2|Overall Study|Error in data records|0
1287792|NCT00339833|4200651|P1|Overall Study|Error in data records|1
1287793|NCT00339833|4200650|P2|Overall Study|anaemia or excess drop in glycaemia|0
1287794|NCT00339833|4200651|P1|Overall Study|anaemia or excess drop in glycaemia|2
1287795|NCT00339833|4200650|P2|Overall Study|Poor venous access|2
1287796|NCT00339833|4200651|P1|Overall Study|Poor venous access|2
1287797|NCT00339833|4200650|P2|Overall Study|minor infection|1
1287798|NCT00339833|4200651|P1|Overall Study|minor infection|0
1287799|NCT00339833|4200650|P2|Overall Study|Chest pain|1
1287800|NCT00339833|4200651|P1|Overall Study|Chest pain|0
1287801|NCT00339833|4200650|P2|Overall Study|indigestion|1
1287802|NCT00339833|4200651|P1|Overall Study|indigestion|0
1287803|NCT00339833|4200650|P2|Overall Study|toothache|1
1287804|NCT00339833|4200651|P1|Overall Study|toothache|0
1287805|NCT00339833|4200650|P2|Overall Study|Withdrawal by Subject|2
1287806|NCT00339833|4200651|P1|Overall Study|Withdrawal by Subject|1
1287807|NCT00339183|4200661|P2|Overall Study|Ongoing|13
1287808|NCT00339183|4200662|P1|Overall Study|Ongoing|20
1287809|NCT00339183|4200661|P2|Overall Study|Other|40
1287810|NCT00339183|4200662|P1|Overall Study|Other|46
1287811|NCT00339183|4200661|P2|Overall Study|Missing reason|1
1287812|NCT00339183|4200662|P1|Overall Study|Missing reason|3
1287813|NCT00339183|4200661|P2|Overall Study|Protocol-specified criteria|8
1287814|NCT00339183|4200662|P1|Overall Study|Protocol-specified criteria|12
1287815|NCT00339183|4200661|P2|Overall Study|Lost to Follow-up|17
1287816|NCT00339183|4200662|P1|Overall Study|Lost to Follow-up|17
1287817|NCT00339183|4200661|P2|Overall Study|Physician Decision|4
1287818|NCT00339183|4200662|P1|Overall Study|Physician Decision|2
1287819|NCT00339183|4200661|P2|Overall Study|Withdrawal by Subject|19
1287820|NCT00339183|4200662|P1|Overall Study|Withdrawal by Subject|16
1287821|NCT00339183|4200661|P2|Overall Study|Adverse Event|3
1287822|NCT00339183|4200662|P1|Overall Study|Adverse Event|5
1287823|NCT00339144|4200691|P3|Overall Study|Participant's request to discontinuation|1
1287824|NCT00339144|4200692|P2|Overall Study|Participant's request to discontinuation|0
1287825|NCT00339144|4200693|P1|Overall Study|Participant's request to discontinuation|1
1287826|NCT00339144|4200691|P3|Overall Study|Study drug toxicity|1
1287827|NCT00339144|4200692|P2|Overall Study|Study drug toxicity|1
1287828|NCT00339144|4200693|P1|Overall Study|Study drug toxicity|3
1287829|NCT00339144|4200691|P3|Overall Study|Disease progression|2
1287830|NCT00339144|4200692|P2|Overall Study|Disease progression|2
1287831|NCT00339144|4200693|P1|Overall Study|Disease progression|5
1287832|NCT00339040|4200798|P2|Stage II|Site closing|0
1287833|NCT00339040|4200799|P1|Stage II|Site closing|2
1287834|NCT00339040|4200798|P2|Stage II|Not able to attend clinic|0
1287835|NCT00339040|4200799|P1|Stage II|Not able to attend clinic|1
1287836|NCT00339040|4200798|P2|Stage II|Protocol Violation|0
1287837|NCT00339040|4200799|P1|Stage II|Protocol Violation|3
1287838|NCT00339040|4200798|P2|Stage II|Withdrawal by Subject|2
1287839|NCT00339040|4200799|P1|Stage II|Withdrawal by Subject|1
1287840|NCT00339040|4200798|P2|Stage II|Lost to Follow-up|0
1287841|NCT00339040|4200799|P1|Stage II|Lost to Follow-up|3
1287842|NCT00339040|4200798|P2|Stage I|Protocol Violation|1
1287843|NCT00339040|4200799|P1|Stage I|Protocol Violation|1
1287844|NCT00339040|4200798|P2|Stage I|Not able to attend clinic|0
1287845|NCT00339040|4200799|P1|Stage I|Not able to attend clinic|1
1287846|NCT00338962|4200826|P4|Overall Study|Poor Compliance|0
1287847|NCT00338962|4200827|P3|Overall Study|Poor Compliance|2
1287848|NCT00338962|4200828|P2|Overall Study|Poor Compliance|0
1287849|NCT00338962|4200829|P1|Overall Study|Poor Compliance|0
1287850|NCT00338962|4200826|P4|Overall Study|Adverse Event|0
1287851|NCT00338962|4200827|P3|Overall Study|Adverse Event|2
1287852|NCT00338962|4200828|P2|Overall Study|Adverse Event|0
1287853|NCT00338962|4200829|P1|Overall Study|Adverse Event|0
1287854|NCT00338962|4200826|P4|Overall Study|Moved|0
1287855|NCT00338962|4200827|P3|Overall Study|Moved|0
1287856|NCT00338962|4200828|P2|Overall Study|Moved|1
1287857|NCT00338962|4200829|P1|Overall Study|Moved|0
1287858|NCT00338962|4200826|P4|Overall Study|Time Constraint|0
1287859|NCT00338962|4200827|P3|Overall Study|Time Constraint|0
1287860|NCT00338962|4200828|P2|Overall Study|Time Constraint|0
1287861|NCT00338962|4200829|P1|Overall Study|Time Constraint|2
1287862|NCT00338962|4200826|P4|Overall Study|No Transportation|0
1287863|NCT00338962|4200827|P3|Overall Study|No Transportation|0
1287864|NCT00338962|4200828|P2|Overall Study|No Transportation|0
1287865|NCT00338962|4200829|P1|Overall Study|No Transportation|2
1287866|NCT00338962|4200826|P4|Overall Study|Withdrawal by Subject|0
1287867|NCT00338962|4200827|P3|Overall Study|Withdrawal by Subject|0
1287868|NCT00338962|4200828|P2|Overall Study|Withdrawal by Subject|0
1287869|NCT00338962|4200829|P1|Overall Study|Withdrawal by Subject|1
1287870|NCT00338962|4200826|P4|Overall Study|Lost to Follow-up|3
1287871|NCT00338962|4200827|P3|Overall Study|Lost to Follow-up|2
1287872|NCT00338962|4200828|P2|Overall Study|Lost to Follow-up|3
1287873|NCT00338962|4200829|P1|Overall Study|Lost to Follow-up|3
1287874|NCT00338884|4200851|P1|Overall Study|Randomized But Did Not Receive Treatment|1
1287875|NCT00338884|4200851|P1|Overall Study|Lost to Follow-up|1
1287876|NCT00338884|4200851|P1|Overall Study|Withdrawal by Subject|3
1287877|NCT00338884|4200851|P1|Overall Study|Global Deterioration of Health Status|3
1287878|NCT00338884|4200851|P1|Overall Study|Other|4
1287879|NCT00338884|4200851|P1|Overall Study|Death|8
1287880|NCT00338884|4200851|P1|Overall Study|Adverse Event|14
1287881|NCT00338884|4200851|P1|Overall Study|Objective Disease Progression or Relapse|44
1287882|NCT00338806|4200885|P2|Follow-up|Lost to Follow-up|3
1287883|NCT00338806|4200886|P1|Follow-up|Lost to Follow-up|1
1287884|NCT00338806|4200885|P2|Acute Phase|Withdrawal by Subject|1
1287885|NCT00338806|4200886|P1|Acute Phase|Withdrawal by Subject|0
1287886|NCT00338741|4200948|P2|Overall Study|Lost to Follow-up|0
1287887|NCT00338741|4200949|P1|Overall Study|Lost to Follow-up|2
1287888|NCT00338455|4200980|P2|Overall Study|Physician Decision|0
1287889|NCT00338455|4200981|P1|Overall Study|Physician Decision|1
1287890|NCT00338455|4200980|P2|Overall Study|Death|1
1287891|NCT00338455|4200981|P1|Overall Study|Death|2
1287892|NCT00338286|4200995|P2|Overall Study|Other|93
1287893|NCT00338286|4200996|P1|Overall Study|Other|103
1287894|NCT00338286|4200995|P2|Overall Study|Lost to Follow-up|66
1287895|NCT00338286|4200996|P1|Overall Study|Lost to Follow-up|80
1287896|NCT00338286|4200995|P2|Overall Study|Withdrawal by Subject|54
1287897|NCT00338286|4200996|P1|Overall Study|Withdrawal by Subject|50
1287898|NCT00338104|4201013|P3|Overall Study|Protocol Violation|3
1287899|NCT00338104|4201014|P2|Overall Study|Protocol Violation|1
1287900|NCT00338104|4201015|P1|Overall Study|Protocol Violation|2
1287901|NCT00337935|4201038|P2|Overall Study|Lack of Efficacy|1
1287902|NCT00337935|4201039|P1|Overall Study|Lack of Efficacy|0
1287903|NCT00337935|4201038|P2|Overall Study|Other|1
1287904|NCT00337935|4201039|P1|Overall Study|Other|0
1287905|NCT00337935|4201038|P2|Overall Study|Withdrawal by Subject|7
1287906|NCT00337935|4201039|P1|Overall Study|Withdrawal by Subject|1
1287907|NCT00337935|4201038|P2|Overall Study|Protocol Violation|3
1287908|NCT00337935|4201039|P1|Overall Study|Protocol Violation|4
1287909|NCT00337935|4201038|P2|Overall Study|Lost to Follow-up|1
1287910|NCT00337935|4201039|P1|Overall Study|Lost to Follow-up|0
1287911|NCT00337935|4201038|P2|Overall Study|Physician Decision|1
1287912|NCT00337935|4201039|P1|Overall Study|Physician Decision|1
1287913|NCT00337935|4201038|P2|Overall Study|Death|8
1287914|NCT00337935|4201039|P1|Overall Study|Death|2
1287915|NCT00337935|4201038|P2|Overall Study|Adverse Event|5
1287916|NCT00337935|4201039|P1|Overall Study|Adverse Event|2
1287917|NCT00337818|4201052|P3|Overall Study|Lost to Follow-up|107
1287918|NCT00337818|4201053|P2|Overall Study|Lost to Follow-up|91
1287919|NCT00337818|4201054|P1|Overall Study|Lost to Follow-up|289
1287920|NCT00337779|4201076|P2|Overall Study|Death|1
1287921|NCT00337779|4201077|P1|Overall Study|Death|0
1287922|NCT00337779|4201076|P2|Overall Study|Pregnancy|2
1287923|NCT00337779|4201077|P1|Overall Study|Pregnancy|3
1287924|NCT00337779|4201076|P2|Overall Study|Adverse Event|51
1287925|NCT00337779|4201077|P1|Overall Study|Adverse Event|28
1287926|NCT00337779|4201076|P2|Overall Study|Lost to Follow-up|5
1287927|NCT00337779|4201077|P1|Overall Study|Lost to Follow-up|6
1287928|NCT00337779|4201076|P2|Overall Study|Protocol Violation|1
1287929|NCT00337779|4201077|P1|Overall Study|Protocol Violation|1
1287930|NCT00337779|4201076|P2|Overall Study|Physician Decision|6
1287931|NCT00337779|4201077|P1|Overall Study|Physician Decision|3
1287932|NCT00337779|4201076|P2|Overall Study|Sponsor decision|1
1287933|NCT00337779|4201077|P1|Overall Study|Sponsor decision|1
1287934|NCT00337779|4201076|P2|Overall Study|Withdrawal by Subject|12
1287935|NCT00337779|4201077|P1|Overall Study|Withdrawal by Subject|10
1287936|NCT00337727|4201089|P2|Overall Study|Withdrawal by Subject|5
1287937|NCT00337727|4201090|P1|Overall Study|Withdrawal by Subject|3
1287938|NCT00337727|4201089|P2|Overall Study|Protocol Violation|0
1287939|NCT00337727|4201090|P1|Overall Study|Protocol Violation|4
1287940|NCT00337727|4201089|P2|Overall Study|Physician Decision|0
1287941|NCT00337727|4201090|P1|Overall Study|Physician Decision|1
1287942|NCT00337727|4201089|P2|Overall Study|Lost to Follow-up|4
1287943|NCT00337727|4201090|P1|Overall Study|Lost to Follow-up|5
1287944|NCT00337727|4201089|P2|Overall Study|Adverse Event|3
1287945|NCT00337727|4201090|P1|Overall Study|Adverse Event|5
1287946|NCT00337675|4201101|P3|Overall Study|Trial Terminated|2
1287947|NCT00337675|4201102|P2|Overall Study|Trial Terminated|0
1287948|NCT00337675|4201103|P1|Overall Study|Trial Terminated|0
1287949|NCT00337675|4201101|P3|Overall Study|Progressive Disease|0
1287950|NCT00337675|4201102|P2|Overall Study|Progressive Disease|2
1287951|NCT00337675|4201103|P1|Overall Study|Progressive Disease|0
1287952|NCT00337675|4201101|P3|Overall Study|Withdrawal by Subject|19
1287953|NCT00337675|4201102|P2|Overall Study|Withdrawal by Subject|25
1287954|NCT00337675|4201103|P1|Overall Study|Withdrawal by Subject|25
1287955|NCT00337675|4201101|P3|Overall Study|Protocol Violation|19
1287956|NCT00337675|4201102|P2|Overall Study|Protocol Violation|24
1287957|NCT00337675|4201103|P1|Overall Study|Protocol Violation|21
1287958|NCT00337675|4201101|P3|Overall Study|Physician Decision|14
1287959|NCT00337675|4201102|P2|Overall Study|Physician Decision|17
1287960|NCT00337675|4201103|P1|Overall Study|Physician Decision|9
1287961|NCT00337675|4201101|P3|Overall Study|Lost to Follow-up|17
1287962|NCT00337675|4201102|P2|Overall Study|Lost to Follow-up|19
1287963|NCT00337675|4201103|P1|Overall Study|Lost to Follow-up|22
1287964|NCT00337675|4201101|P3|Overall Study|Lack of Efficacy|9
1287965|NCT00337675|4201102|P2|Overall Study|Lack of Efficacy|7
1287966|NCT00337675|4201103|P1|Overall Study|Lack of Efficacy|10
1287967|NCT00337675|4201101|P3|Overall Study|Adverse Event|19
1287968|NCT00337675|4201102|P2|Overall Study|Adverse Event|9
1287969|NCT00337675|4201103|P1|Overall Study|Adverse Event|10
1287970|NCT00337662|4201120|P4|Study Period III|Clinical Relapse|0
1287971|NCT00337662|4201121|P3|Study Period III|Clinical Relapse|0
1287972|NCT00337662|4201122|P2|Study Period III|Clinical Relapse|0
1287973|NCT00337662|4201123|P1|Study Period III|Clinical Relapse|1
1287974|NCT00337662|4201120|P4|Study Period III|Sponsor Decision|0
1287975|NCT00337662|4201121|P3|Study Period III|Sponsor Decision|1
1287976|NCT00337662|4201122|P2|Study Period III|Sponsor Decision|0
1287977|NCT00337662|4201123|P1|Study Period III|Sponsor Decision|1
1287978|NCT00337662|4201120|P4|Study Period III|Parent/Caregiver Decision|0
1287979|NCT00337662|4201121|P3|Study Period III|Parent/Caregiver Decision|2
1287980|NCT00337662|4201122|P2|Study Period III|Parent/Caregiver Decision|0
1287981|NCT00337662|4201123|P1|Study Period III|Parent/Caregiver Decision|0
1287982|NCT00337662|4201120|P4|Study Period III|Lack of Efficacy|0
1287983|NCT00337662|4201121|P3|Study Period III|Lack of Efficacy|2
1287984|NCT00337662|4201122|P2|Study Period III|Lack of Efficacy|4
1287985|NCT00337662|4201123|P1|Study Period III|Lack of Efficacy|4
1287986|NCT00337662|4201120|P4|Study Period III|Entry Criteria Not Met|0
1287987|NCT00337662|4201121|P3|Study Period III|Entry Criteria Not Met|3
1287988|NCT00337662|4201122|P2|Study Period III|Entry Criteria Not Met|1
1287989|NCT00337662|4201123|P1|Study Period III|Entry Criteria Not Met|4
1287990|NCT00337662|4201120|P4|Study Period III|Physician Decision|0
1287991|NCT00337662|4201121|P3|Study Period III|Physician Decision|0
1287992|NCT00337662|4201122|P2|Study Period III|Physician Decision|5
1287993|NCT00337662|4201123|P1|Study Period III|Physician Decision|6
1287994|NCT00337662|4201120|P4|Study Period III|Protocol Violation|0
1287995|NCT00337662|4201121|P3|Study Period III|Protocol Violation|2
1287996|NCT00337662|4201122|P2|Study Period III|Protocol Violation|8
1287997|NCT00337662|4201123|P1|Study Period III|Protocol Violation|3
1287998|NCT00337662|4201120|P4|Study Period III|Adverse Event|0
1287999|NCT00337662|4201121|P3|Study Period III|Adverse Event|8
1288000|NCT00337662|4201122|P2|Study Period III|Adverse Event|10
1288001|NCT00337662|4201123|P1|Study Period III|Adverse Event|9
1288002|NCT00337662|4201120|P4|Study Period III|Withdrawal by Subject|0
1288003|NCT00337662|4201121|P3|Study Period III|Withdrawal by Subject|12
1288004|NCT00337662|4201122|P2|Study Period III|Withdrawal by Subject|14
1288005|NCT00337662|4201123|P1|Study Period III|Withdrawal by Subject|18
1288006|NCT00337662|4201120|P4|Study Period III|Lost to Follow-up|0
1288007|NCT00337662|4201121|P3|Study Period III|Lost to Follow-up|14
1288008|NCT00337662|4201122|P2|Study Period III|Lost to Follow-up|16
1288009|NCT00337662|4201123|P1|Study Period III|Lost to Follow-up|14
1288010|NCT00337662|4201120|P4|Study Period II|Parent/Caregiver Decision|1
1288011|NCT00337662|4201121|P3|Study Period II|Parent/Caregiver Decision|0
1288012|NCT00337662|4201122|P2|Study Period II|Parent/Caregiver Decision|0
1288013|NCT00337662|4201123|P1|Study Period II|Parent/Caregiver Decision|0
1288014|NCT00337662|4201120|P4|Study Period II|Sponsor Decision|2
1288015|NCT00337662|4201121|P3|Study Period II|Sponsor Decision|0
1288016|NCT00337662|4201122|P2|Study Period II|Sponsor Decision|0
1288017|NCT00337662|4201123|P1|Study Period II|Sponsor Decision|0
1288018|NCT00337662|4201120|P4|Study Period II|Lack of Efficacy|7
1288019|NCT00337662|4201121|P3|Study Period II|Lack of Efficacy|0
1288020|NCT00337662|4201122|P2|Study Period II|Lack of Efficacy|0
1288021|NCT00337662|4201123|P1|Study Period II|Lack of Efficacy|0
1288022|NCT00337662|4201120|P4|Study Period II|Protocol Violation|6
1288023|NCT00337662|4201121|P3|Study Period II|Protocol Violation|0
1288024|NCT00337662|4201122|P2|Study Period II|Protocol Violation|0
1288025|NCT00337662|4201123|P1|Study Period II|Protocol Violation|0
1288026|NCT00337662|4201120|P4|Study Period II|Entry Criteria Not Met|6
1288027|NCT00337662|4201121|P3|Study Period II|Entry Criteria Not Met|0
1288028|NCT00337662|4201122|P2|Study Period II|Entry Criteria Not Met|0
1288029|NCT00337662|4201123|P1|Study Period II|Entry Criteria Not Met|0
1288030|NCT00337662|4201120|P4|Study Period II|Physician Decision|13
1288031|NCT00337662|4201121|P3|Study Period II|Physician Decision|0
1288032|NCT00337662|4201122|P2|Study Period II|Physician Decision|0
1288033|NCT00337662|4201123|P1|Study Period II|Physician Decision|0
1288034|NCT00337662|4201120|P4|Study Period II|Adverse Event|16
1288035|NCT00337662|4201121|P3|Study Period II|Adverse Event|0
1288036|NCT00337662|4201122|P2|Study Period II|Adverse Event|0
1288037|NCT00337662|4201123|P1|Study Period II|Adverse Event|0
1288038|NCT00337662|4201120|P4|Study Period II|Withdrawal by Subject|20
1288039|NCT00337662|4201121|P3|Study Period II|Withdrawal by Subject|0
1288040|NCT00337662|4201122|P2|Study Period II|Withdrawal by Subject|0
1288041|NCT00337662|4201123|P1|Study Period II|Withdrawal by Subject|0
1288042|NCT00337662|4201120|P4|Study Period II|Lost to Follow-up|35
1288043|NCT00337662|4201121|P3|Study Period II|Lost to Follow-up|0
1288044|NCT00337662|4201122|P2|Study Period II|Lost to Follow-up|0
1288045|NCT00337662|4201123|P1|Study Period II|Lost to Follow-up|0
1288046|NCT00337610|4201177|P2|Overall Study|Withdrawal by Subject|5
1288047|NCT00337610|4201178|P1|Overall Study|Withdrawal by Subject|6
1288048|NCT00337610|4201177|P2|Overall Study|Lost to Follow-up|3
1288049|NCT00337610|4201178|P1|Overall Study|Lost to Follow-up|3
1288050|NCT00337610|4201177|P2|Overall Study|Lack of Efficacy|3
1288051|NCT00337610|4201178|P1|Overall Study|Lack of Efficacy|6
1288052|NCT00337610|4201177|P2|Overall Study|Death|1
1288053|NCT00337610|4201178|P1|Overall Study|Death|0
1288054|NCT00337610|4201177|P2|Overall Study|Adverse Event|2
1288055|NCT00337610|4201178|P1|Overall Study|Adverse Event|2
1288056|NCT00337571|4201194|P4|Overall Study|High Potassium level|1
1288057|NCT00337571|4201195|P3|Overall Study|High Potassium level|0
1288058|NCT00337571|4201196|P2|Overall Study|High Potassium level|0
1288059|NCT00337571|4201197|P1|Overall Study|High Potassium level|0
1288060|NCT00337571|4201194|P4|Overall Study|No longer met study criteria|0
1288061|NCT00337571|4201195|P3|Overall Study|No longer met study criteria|0
1288062|NCT00337571|4201196|P2|Overall Study|No longer met study criteria|0
1288063|NCT00337571|4201197|P1|Overall Study|No longer met study criteria|1
1288064|NCT00337571|4201194|P4|Overall Study|Poor/noncompliance|1
1288065|NCT00337571|4201195|P3|Overall Study|Poor/noncompliance|1
1288066|NCT00337571|4201196|P2|Overall Study|Poor/noncompliance|1
1288067|NCT00337571|4201197|P1|Overall Study|Poor/noncompliance|1
1288068|NCT00337571|4201194|P4|Overall Study|Lost to Follow-up|1
1288069|NCT00337571|4201195|P3|Overall Study|Lost to Follow-up|0
1288070|NCT00337571|4201196|P2|Overall Study|Lost to Follow-up|1
1288071|NCT00337571|4201197|P1|Overall Study|Lost to Follow-up|3
1288072|NCT00337571|4201194|P4|Overall Study|Withdrawal by Subject|0
1288073|NCT00337571|4201195|P3|Overall Study|Withdrawal by Subject|1
1288074|NCT00337571|4201196|P2|Overall Study|Withdrawal by Subject|2
1288075|NCT00337571|4201197|P1|Overall Study|Withdrawal by Subject|2
1288076|NCT00337571|4201194|P4|Overall Study|Adverse Event|4
1288077|NCT00337571|4201195|P3|Overall Study|Adverse Event|8
1288078|NCT00337571|4201196|P2|Overall Study|Adverse Event|5
1288079|NCT00337571|4201197|P1|Overall Study|Adverse Event|4
1288080|NCT00337571|4201194|P4|Overall Study|Lack of Efficacy|0
1288081|NCT00337571|4201195|P3|Overall Study|Lack of Efficacy|0
1288082|NCT00337571|4201196|P2|Overall Study|Lack of Efficacy|0
1288083|NCT00337571|4201197|P1|Overall Study|Lack of Efficacy|3
1288084|NCT00337467|4201235|P1|Overall Study|Subject No Longer Met Study Criteria|2
1288085|NCT00337467|4201235|P1|Overall Study|Lost to Follow-up|2
1288086|NCT00337467|4201235|P1|Overall Study|Pregnancy|1
1288087|NCT00337467|4201235|P1|Overall Study|Subject Withdrew Consent|2
1288088|NCT00337467|4201235|P1|Overall Study|Adverse Event|3
1288089|NCT00337428|4201254|P2|Overall Study|Anorexia|0
1288090|NCT00337428|4201255|P1|Overall Study|Anorexia|1
1288091|NCT00337428|4201254|P2|Overall Study|Unwilling to Continue|0
1288092|NCT00337428|4201255|P1|Overall Study|Unwilling to Continue|1
1288093|NCT00337428|4201254|P2|Overall Study|Lack of Time|1
1288094|NCT00337428|4201255|P1|Overall Study|Lack of Time|1
1288095|NCT00337428|4201254|P2|Overall Study|Withdrawal by Subject|2
1288096|NCT00337428|4201255|P1|Overall Study|Withdrawal by Subject|1
1288097|NCT00337285|4201306|P1|Overall Study|Lack of protocol compliance|7
1288098|NCT00337285|4201306|P1|Overall Study|Physician Decision|1
1288099|NCT00337285|4201306|P1|Overall Study|Death|1
1288100|NCT00337285|4201306|P1|Overall Study|Lack of Efficacy|11
1288101|NCT00337285|4201306|P1|Overall Study|Protocol Violation|27
1288102|NCT00337285|4201306|P1|Overall Study|Adverse Event|28
1288103|NCT00337285|4201306|P1|Overall Study|Lost to Follow-up|41
1288104|NCT00337285|4201306|P1|Overall Study|Withdrawal by Subject|42
1288105|NCT00337272|4201314|P2|Withdrawal Period|Non-compliance|1
1288106|NCT00337272|4201315|P1|Withdrawal Period|Non-compliance|0
1288107|NCT00337272|4201314|P2|Treatment Period|Withdrawal by Subject|1
1288108|NCT00337272|4201315|P1|Treatment Period|Withdrawal by Subject|0
1288109|NCT00337272|4201314|P2|Treatment Period|Non-compliance|1
1288110|NCT00337272|4201315|P1|Treatment Period|Non-compliance|1
1288111|NCT00337272|4201314|P2|Screening Period (Pre-randomization)|Screen failure|0
1288112|NCT00337272|4201315|P1|Screening Period (Pre-randomization)|Screen failure|3
1288113|NCT00337272|4201314|P2|Screening Period (Pre-randomization)|Non-compliance|0
1288114|NCT00337272|4201315|P1|Screening Period (Pre-randomization)|Non-compliance|1
1288115|NCT00337272|4201314|P2|Screening Period (Pre-randomization)|Withdrawal by Subject|0
1288116|NCT00337272|4201315|P1|Screening Period (Pre-randomization)|Withdrawal by Subject|2
1288117|NCT00337207|4201335|P1|Overall Study|Withdrawal by Subject|3
1288118|NCT00337194|4201343|P2|Overall Study|Subsequent non-protocol therapy|1
1288119|NCT00337194|4201344|P1|Overall Study|Subsequent non-protocol therapy|3
1288120|NCT00337194|4201343|P2|Overall Study|Disease progression|2
1288121|NCT00337194|4201344|P1|Overall Study|Disease progression|1
1288122|NCT00337194|4201343|P2|Overall Study|Withdrawal by Subject|0
1288123|NCT00337194|4201344|P1|Overall Study|Withdrawal by Subject|1
1288124|NCT00337194|4201343|P2|Overall Study|Death|0
1288125|NCT00337194|4201344|P1|Overall Study|Death|2
1288126|NCT00337194|4201343|P2|Overall Study|Adverse Event|1
1288127|NCT00337194|4201344|P1|Overall Study|Adverse Event|5
1288128|NCT00337168|4201368|P1|Overall Study|Did not start therapy|1
1288129|NCT00337168|4201368|P1|Overall Study|Not protocol specified|2
1288130|NCT00337168|4201368|P1|Overall Study|Death|5
1288131|NCT00337129|4201375|P1|Overall Study|not protocol specified|1
1288132|NCT00337129|4201375|P1|Overall Study|Death|2
1288133|NCT00337129|4201375|P1|Overall Study|Lack of Efficacy|32
1288134|NCT00337129|4201375|P1|Overall Study|Withdrawal by Subject|1
1288135|NCT00337129|4201375|P1|Overall Study|Adverse Event|4
1288136|NCT00337103|4201384|P2|Overall Study|Death|0
1288137|NCT00337103|4201385|P1|Overall Study|Death|1
1288138|NCT00337103|4201384|P2|Overall Study|Lost to Follow-up|2
1288139|NCT00337103|4201385|P1|Overall Study|Lost to Follow-up|1
1288140|NCT00337103|4201384|P2|Overall Study|Entry Criteria Not Met|1
1288141|NCT00337103|4201385|P1|Overall Study|Entry Criteria Not Met|4
1288142|NCT00337103|4201384|P2|Overall Study|Not specified|6
1288143|NCT00337103|4201385|P1|Overall Study|Not specified|5
1288144|NCT00337103|4201384|P2|Overall Study|Withdrawal by Subject|5
1288145|NCT00337103|4201385|P1|Overall Study|Withdrawal by Subject|8
1288146|NCT00337103|4201384|P2|Overall Study|Physician Decision|14
1288147|NCT00337103|4201385|P1|Overall Study|Physician Decision|15
1288148|NCT00337103|4201384|P2|Overall Study|Clinical Progression|24
1288149|NCT00337103|4201385|P1|Overall Study|Clinical Progression|27
1288150|NCT00337103|4201384|P2|Overall Study|Subject Choice|27
1288151|NCT00337103|4201385|P1|Overall Study|Subject Choice|34
1288152|NCT00337103|4201384|P2|Overall Study|Adverse Event|59
1288153|NCT00337103|4201385|P1|Overall Study|Adverse Event|45
1288154|NCT00337103|4201384|P2|Overall Study|Progressive Disease|405
1288155|NCT00337103|4201385|P1|Overall Study|Progressive Disease|409
1288156|NCT00337077|4201396|P3|Overall Study|Ineligible|1
1288157|NCT00337077|4201397|P2|Overall Study|Ineligible|1
1288158|NCT00337077|4201398|P1|Overall Study|Ineligible|1
1288159|NCT00337077|4201396|P3|Overall Study|Never started treatment|0
1288160|NCT00337077|4201397|P2|Overall Study|Never started treatment|1
1288161|NCT00337077|4201398|P1|Overall Study|Never started treatment|1
1288162|NCT00337077|4201396|P3|Overall Study|Physician Decision|2
1288163|NCT00337077|4201397|P2|Overall Study|Physician Decision|4
1288164|NCT00337077|4201398|P1|Overall Study|Physician Decision|1
1288165|NCT00337077|4201396|P3|Overall Study|Alternative therapy|0
1288166|NCT00337077|4201397|P2|Overall Study|Alternative therapy|0
1288167|NCT00337077|4201398|P1|Overall Study|Alternative therapy|1
1288168|NCT00337077|4201396|P3|Overall Study|Withdrawal by Subject|2
1288169|NCT00337077|4201397|P2|Overall Study|Withdrawal by Subject|2
1288170|NCT00337077|4201398|P1|Overall Study|Withdrawal by Subject|7
1288171|NCT00337077|4201396|P3|Overall Study|Death|0
1288172|NCT00337077|4201397|P2|Overall Study|Death|1
1288173|NCT00337077|4201398|P1|Overall Study|Death|0
1288174|NCT00337077|4201396|P3|Overall Study|Adverse Event|1
1288175|NCT00337077|4201397|P2|Overall Study|Adverse Event|7
1288176|NCT00337077|4201398|P1|Overall Study|Adverse Event|7
1288177|NCT00337077|4201396|P3|Overall Study|Progressive disease|19
1288178|NCT00337077|4201397|P2|Overall Study|Progressive disease|37
1288179|NCT00337077|4201398|P1|Overall Study|Progressive disease|25
1288180|NCT00336895|4201413|P1|Overall Study|screen failed|1
1288181|NCT00336895|4201413|P1|Overall Study|Physician Decision|1
1288182|NCT00336895|4201413|P1|Overall Study|nausea and upset stomach|1
1288183|NCT00336895|4201413|P1|Overall Study|diarrhea|1
1288184|NCT00336856|4201419|P1|Overall Study|Found ineligible at time of analysis|1
1288185|NCT00336856|4201419|P1|Overall Study|Withdrawal by Subject|3
1288186|NCT00336583|4201467|P1|Overall Study|Death|1
1288187|NCT00336583|4201467|P1|Overall Study|Lost to Follow-up|1
1288188|NCT00336544|4201474|P2|Overall Study|Other|5
1288189|NCT00336544|4201475|P1|Overall Study|Other|3
1288190|NCT00336544|4201474|P2|Overall Study|Withdrawal by Subject|3
1288191|NCT00336544|4201475|P1|Overall Study|Withdrawal by Subject|4
1288192|NCT00336544|4201474|P2|Overall Study|Adverse Event|9
1288193|NCT00336544|4201475|P1|Overall Study|Adverse Event|4
1288194|NCT00336544|4201474|P2|Overall Study|Lack of Efficacy|5
1288195|NCT00336544|4201475|P1|Overall Study|Lack of Efficacy|8
1288196|NCT00336505|4201489|P2|Overall Study|Other|7
1288197|NCT00336505|4201490|P1|Overall Study|Other|7
1288198|NCT00336505|4201489|P2|Overall Study|Withdrawal by Subject|3
1288199|NCT00336505|4201490|P1|Overall Study|Withdrawal by Subject|5
1288200|NCT00336505|4201489|P2|Overall Study|Lost to Follow-up|4
1288201|NCT00336505|4201490|P1|Overall Study|Lost to Follow-up|7
1288202|NCT00336505|4201489|P2|Overall Study|Lack of Efficacy|4
1288203|NCT00336505|4201490|P1|Overall Study|Lack of Efficacy|8
1288204|NCT00336505|4201489|P2|Overall Study|Adverse Event|9
1288205|NCT00336505|4201490|P1|Overall Study|Adverse Event|10
1288206|NCT00336492|4201505|P3|Overall Study|Other|1
1288207|NCT00336492|4201506|P2|Overall Study|Other|0
1288208|NCT00336492|4201507|P1|Overall Study|Other|5
1288209|NCT00336492|4201505|P3|Overall Study|Lack of Efficacy|4
1288210|NCT00336492|4201506|P2|Overall Study|Lack of Efficacy|1
1288211|NCT00336492|4201507|P1|Overall Study|Lack of Efficacy|6
1288212|NCT00336492|4201505|P3|Overall Study|Adverse Event|6
1288213|NCT00336492|4201506|P2|Overall Study|Adverse Event|3
1288214|NCT00336492|4201507|P1|Overall Study|Adverse Event|4
1288215|NCT00336479|4201519|P4|Overall Study|Virologic Stopping Rule|0
1288216|NCT00336479|4201520|P3|Overall Study|Virologic Stopping Rule|0
1288217|NCT00336479|4201521|P2|Overall Study|Virologic Stopping Rule|0
1288218|NCT00336479|4201522|P1|Overall Study|Virologic Stopping Rule|20
1288219|NCT00336479|4201519|P4|Overall Study|Other|0
1288220|NCT00336479|4201520|P3|Overall Study|Other|1
1288221|NCT00336479|4201521|P2|Overall Study|Other|0
1288222|NCT00336479|4201522|P1|Overall Study|Other|0
1288223|NCT00336479|4201519|P4|Overall Study|Withdrawal by Subject|0
1288224|NCT00336479|4201520|P3|Overall Study|Withdrawal by Subject|3
1288225|NCT00336479|4201521|P2|Overall Study|Withdrawal by Subject|2
1288226|NCT00336479|4201522|P1|Overall Study|Withdrawal by Subject|3
1288227|NCT00336479|4201519|P4|Overall Study|Lost to Follow-up|0
1288228|NCT00336479|4201520|P3|Overall Study|Lost to Follow-up|0
1288229|NCT00336479|4201521|P2|Overall Study|Lost to Follow-up|2
1288230|NCT00336479|4201522|P1|Overall Study|Lost to Follow-up|3
1288231|NCT00336479|4201519|P4|Overall Study|Physician Decision|0
1288232|NCT00336479|4201520|P3|Overall Study|Physician Decision|1
1288233|NCT00336479|4201521|P2|Overall Study|Physician Decision|3
1288234|NCT00336479|4201522|P1|Overall Study|Physician Decision|2
1288235|NCT00336479|4201519|P4|Overall Study|Noncompliant|0
1288236|NCT00336479|4201520|P3|Overall Study|Noncompliant|3
1288237|NCT00336479|4201521|P2|Overall Study|Noncompliant|7
1288238|NCT00336479|4201522|P1|Overall Study|Noncompliant|1
1288239|NCT00336479|4201519|P4|Overall Study|Adverse Event|4
1288240|NCT00336479|4201520|P3|Overall Study|Adverse Event|18
1288241|NCT00336479|4201521|P2|Overall Study|Adverse Event|11
1288242|NCT00336479|4201522|P1|Overall Study|Adverse Event|8
1288243|NCT00336284|4201611|P2|Overall Study|Withdrawal by Physician or Subject|64
1288244|NCT00336284|4201612|P1|Overall Study|Withdrawal by Physician or Subject|102
1288245|NCT00336284|4201611|P2|Overall Study|Lost to Follow-up|61
1288246|NCT00336284|4201612|P1|Overall Study|Lost to Follow-up|82
1288247|NCT00336284|4201611|P2|Overall Study|Death|26
1288248|NCT00336284|4201612|P1|Overall Study|Death|52
1288249|NCT00336024|4201630|P2|Overall Study|Ineligible|7
1288250|NCT00336024|4201631|P1|Overall Study|Ineligible|7
1288251|NCT00336024|4201630|P2|Overall Study|Progressive Disease|7
1288252|NCT00336024|4201631|P1|Overall Study|Progressive Disease|4
1288253|NCT00336024|4201630|P2|Overall Study|Failure to fulfill consolidation|1
1288254|NCT00336024|4201631|P1|Overall Study|Failure to fulfill consolidation|1
1288255|NCT00336024|4201630|P2|Overall Study|Withdrawal by Subject|2
1288256|NCT00336024|4201631|P1|Overall Study|Withdrawal by Subject|1
1288257|NCT00336024|4201630|P2|Overall Study|Protocol Violation|0
1288258|NCT00336024|4201631|P1|Overall Study|Protocol Violation|1
1288259|NCT00336024|4201630|P2|Overall Study|Physician Decision|1
1288260|NCT00336024|4201631|P1|Overall Study|Physician Decision|4
1288261|NCT00336024|4201630|P2|Overall Study|Death|1
1288262|NCT00336024|4201631|P1|Overall Study|Death|2
1288263|NCT00335972|4201665|P2|Overall Study|not given treatments|3
1288264|NCT00335972|4201666|P1|Overall Study|not given treatments|0
1288265|NCT00335959|4201676|P1|Overall Study|Ineligible|1
1288266|NCT00335959|4201676|P1|Overall Study|Adverse Event|2
1288267|NCT00335829|4201681|P1|Overall Study|Adverse Event|1
1288268|NCT00335829|4201681|P1|Overall Study|Lost to Follow-up|1
1288269|NCT00335829|4201681|P1|Overall Study|Withdrawal by Subject|1
1288270|NCT00335777|4201695|P1|Treated 2 Headaches Per Protocol|Treated 1 early and 1 late out of protoc|12
1288271|NCT00335777|4201695|P1|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1
1288272|NCT00335777|4201695|P1|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18
1288273|NCT00335777|4201695|P1|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6
1288274|NCT00335777|4201695|P1|Enrolled and Dispensed Study Medication|Lost to Follow-up|5
1288275|NCT00335764|4201705|P5|Overall Study|wrong histology|1
1288276|NCT00335764|4201706|P4|Overall Study|wrong histology|0
1288277|NCT00335764|4201707|P3|Overall Study|wrong histology|0
1288278|NCT00335764|4201708|P2|Overall Study|wrong histology|0
1288279|NCT00335764|4201709|P1|Overall Study|wrong histology|1
1288280|NCT00335738|4201758|P2|Overall Study|Ineligible|4
1288281|NCT00335738|4201759|P1|Overall Study|Ineligible|3
1288282|NCT00335738|4201758|P2|Overall Study|Withdrawal by Subject|0
1288283|NCT00335738|4201759|P1|Overall Study|Withdrawal by Subject|2
1288284|NCT00335738|4201758|P2|Overall Study|Physician Decision|0
1288285|NCT00335738|4201759|P1|Overall Study|Physician Decision|6
1288286|NCT00335556|4201791|P6|Overall Study|Refusal of further protocol therapy|0
1288287|NCT00335556|4201792|P5|Overall Study|Refusal of further protocol therapy|0
1288288|NCT00335556|4201793|P4|Overall Study|Refusal of further protocol therapy|1
1288289|NCT00335556|4201794|P3|Overall Study|Refusal of further protocol therapy|0
1288290|NCT00335556|4201795|P2|Overall Study|Refusal of further protocol therapy|4
1288291|NCT00335556|4201796|P1|Overall Study|Refusal of further protocol therapy|0
1288292|NCT00335556|4201791|P6|Overall Study|Ineligible|0
1288293|NCT00335556|4201792|P5|Overall Study|Ineligible|0
1288294|NCT00335556|4201793|P4|Overall Study|Ineligible|0
1288295|NCT00335556|4201794|P3|Overall Study|Ineligible|0
1288296|NCT00335556|4201795|P2|Overall Study|Ineligible|0
1288297|NCT00335556|4201796|P1|Overall Study|Ineligible|2
1288298|NCT00335556|4201791|P6|Overall Study|Physician Decision|0
1288299|NCT00335556|4201792|P5|Overall Study|Physician Decision|0
1288300|NCT00335556|4201793|P4|Overall Study|Physician Decision|1
1288301|NCT00335556|4201794|P3|Overall Study|Physician Decision|2
1288302|NCT00335556|4201795|P2|Overall Study|Physician Decision|6
1288303|NCT00335556|4201796|P1|Overall Study|Physician Decision|0
1288304|NCT00335556|4201791|P6|Overall Study|Lack of Efficacy|1
1288305|NCT00335556|4201792|P5|Overall Study|Lack of Efficacy|0
1288306|NCT00335556|4201793|P4|Overall Study|Lack of Efficacy|3
1288307|NCT00335556|4201794|P3|Overall Study|Lack of Efficacy|3
1288308|NCT00335556|4201795|P2|Overall Study|Lack of Efficacy|19
1288309|NCT00335556|4201796|P1|Overall Study|Lack of Efficacy|0
1288310|NCT00335556|4201791|P6|Overall Study|Death|0
1288311|NCT00335556|4201792|P5|Overall Study|Death|1
1288312|NCT00335556|4201793|P4|Overall Study|Death|0
1288313|NCT00335556|4201794|P3|Overall Study|Death|0
1288314|NCT00335556|4201795|P2|Overall Study|Death|5
1288315|NCT00335556|4201796|P1|Overall Study|Death|0
1288316|NCT00335452|4201858|P4|Overall Study|Lost to Follow-up|2
1288317|NCT00335452|4201859|P3|Overall Study|Lost to Follow-up|1
1288318|NCT00335452|4201860|P2|Overall Study|Lost to Follow-up|3
1288319|NCT00335452|4201861|P1|Overall Study|Lost to Follow-up|2
1288320|NCT00335452|4201858|P4|Overall Study|Death|129
1288321|NCT00335452|4201859|P3|Overall Study|Death|158
1288322|NCT00335452|4201860|P2|Overall Study|Death|144
1288323|NCT00335452|4201861|P1|Overall Study|Death|156
1288324|NCT00335322|4201886|P3|Overall Study|Randomised but withdrew prior to ART sta|2
1288325|NCT00335322|4201887|P2|Overall Study|Randomised but withdrew prior to ART sta|2
1288326|NCT00335322|4201888|P1|Overall Study|Randomised but withdrew prior to ART sta|1
1288327|NCT00335153|4201933|P1|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2
1288328|NCT00335153|4201933|P1|Post-PEG-J Long-Term Treatment Period|Administrative|13
1288329|NCT00335153|4201933|P1|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13
1288330|NCT00335153|4201933|P1|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2
1288331|NCT00335153|4201933|P1|Post-PEG-J Long-Term Treatment Period|Adverse Event|22
1288332|NCT00335153|4201933|P1|Nasojejunal (NJ) Test Period|Protocol Violation|7
1288333|NCT00335153|4201933|P1|Nasojejunal (NJ) Test Period|Administrative|1
1288334|NCT00335153|4201933|P1|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12
1288335|NCT00335153|4201933|P1|Nasojejunal (NJ) Test Period|Lack of Efficacy|5
1288336|NCT00335153|4201933|P1|Nasojejunal (NJ) Test Period|Adverse Event|5
1288337|NCT00335140|4201970|P1|Overall Study|Ineligible|1
1288338|NCT00334958|4201976|P2|Overall Study|Not specified|2
1288339|NCT00334958|4201977|P1|Overall Study|Not specified|1
1288340|NCT00334958|4201976|P2|Overall Study|Adverse Event|12
1288341|NCT00334958|4201977|P1|Overall Study|Adverse Event|27
1288342|NCT00334958|4201976|P2|Overall Study|Withdrawal by Subject|4
1288343|NCT00334958|4201977|P1|Overall Study|Withdrawal by Subject|7
1288344|NCT00334958|4201976|P2|Overall Study|Request of the investigator or sponsor|1
1288345|NCT00334958|4201977|P1|Overall Study|Request of the investigator or sponsor|0
1288346|NCT00334958|4201976|P2|Overall Study|Protocol Violation|2
1288347|NCT00334958|4201977|P1|Overall Study|Protocol Violation|2
1288348|NCT00334958|4201976|P2|Overall Study|Medication Noncompliance|3
1288349|NCT00334958|4201977|P1|Overall Study|Medication Noncompliance|0
1288350|NCT00334893|4201991|P2|Overall Study|Not Treated|0
1288351|NCT00334893|4201992|P1|Overall Study|Not Treated|1
1288352|NCT00334815|4202002|P2|Overall Study|Physician Decision|4
1288353|NCT00334815|4202003|P1|Overall Study|Physician Decision|2
1288354|NCT00334815|4202002|P2|Overall Study|patient refused treatment|1
1288355|NCT00334815|4202003|P1|Overall Study|patient refused treatment|0
1288356|NCT00334815|4202002|P2|Overall Study|ineligible|1
1288357|NCT00334815|4202003|P1|Overall Study|ineligible|1
1288358|NCT00334815|4202002|P2|Overall Study|Progression|0
1288359|NCT00334815|4202003|P1|Overall Study|Progression|1
1288360|NCT00334815|4202002|P2|Overall Study|Death|2
1288361|NCT00334815|4202003|P1|Overall Study|Death|0
1288362|NCT00334815|4202002|P2|Overall Study|Adverse Event|2
1288363|NCT00334815|4202003|P1|Overall Study|Adverse Event|3
1288364|NCT00334802|4202017|P2|Overall Study|Criteria for Starting Next Cycle Not Met|1
1288365|NCT00334802|4202018|P1|Overall Study|Criteria for Starting Next Cycle Not Met|0
1288366|NCT00334802|4202017|P2|Overall Study|Adverse Event|3
1288367|NCT00334802|4202018|P1|Overall Study|Adverse Event|0
1288368|NCT00334802|4202017|P2|Overall Study|Withdrawal by Subject|4
1288369|NCT00334802|4202018|P1|Overall Study|Withdrawal by Subject|0
1288370|NCT00334802|4202017|P2|Overall Study|Physician Decision|0
1288371|NCT00334802|4202018|P1|Overall Study|Physician Decision|1
1288372|NCT00334802|4202017|P2|Overall Study|Patient Condition Aggrevated|0
1288373|NCT00334802|4202018|P1|Overall Study|Patient Condition Aggrevated|1
1288374|NCT00334802|4202017|P2|Overall Study|Lack of Efficacy|3
1288375|NCT00334802|4202018|P1|Overall Study|Lack of Efficacy|1
1288376|NCT00334802|4202017|P2|Overall Study|Toxicity|5
1288377|NCT00334802|4202018|P1|Overall Study|Toxicity|1
1288378|NCT00334802|4202017|P2|Overall Study|Progressive Disease|24
1288379|NCT00334802|4202018|P1|Overall Study|Progressive Disease|2
1288380|NCT00334542|4202051|P1|Overall Study|New cancer diagnosis|1
1288381|NCT00334542|4202051|P1|Overall Study|Withdrawal by Subject|1
1288382|NCT00334542|4202051|P1|Overall Study|Adverse Event|3
1288383|NCT00334295|4202056|P1|Overall Study|Patients received fewer than 3 injection|5
1288384|NCT00334282|4202066|P2|Overall Study|Death|100
1288385|NCT00334282|4202067|P1|Overall Study|Death|194
1288386|NCT00334282|4202066|P2|Overall Study|Withdrawal by Subject|3
1288387|NCT00334282|4202067|P1|Overall Study|Withdrawal by Subject|17
1288388|NCT00334282|4202066|P2|Overall Study|Lost to Follow-up|5
1288389|NCT00334282|4202067|P1|Overall Study|Lost to Follow-up|11
1288390|NCT00334113|4202098|P2|Overall Study|Withdrawal by Subject|1
1288391|NCT00334113|4202099|P1|Overall Study|Withdrawal by Subject|0
1288392|NCT00334113|4202098|P2|Overall Study|Lost to Follow-up|2
1288393|NCT00334113|4202099|P1|Overall Study|Lost to Follow-up|2
1288394|NCT00333983|4202122|P3|Overall Study|Withdrawal by Subject|1
1288395|NCT00333983|4202123|P2|Overall Study|Withdrawal by Subject|3
1288396|NCT00333983|4202124|P1|Overall Study|Withdrawal by Subject|0
1288397|NCT00333983|4202122|P3|Overall Study|Adverse Event|1
1288398|NCT00333983|4202123|P2|Overall Study|Adverse Event|1
1288399|NCT00333983|4202124|P1|Overall Study|Adverse Event|1
1288400|NCT00333983|4202122|P3|Overall Study|Lost to Follow-up|0
1288401|NCT00333983|4202123|P2|Overall Study|Lost to Follow-up|1
1288402|NCT00333983|4202124|P1|Overall Study|Lost to Follow-up|2
1288403|NCT00333970|4202134|P2|Overall Study|Withdrawal by Subject|7
1288404|NCT00333970|4202135|P1|Overall Study|Withdrawal by Subject|13
1288405|NCT00333866|4202150|P4|Overall Study|Randomized but not Treated|1
1288406|NCT00333866|4202151|P3|Overall Study|Randomized but not Treated|2
1288407|NCT00333866|4202152|P2|Overall Study|Randomized but not Treated|3
1288408|NCT00333866|4202153|P1|Overall Study|Randomized but not Treated|5
1288409|NCT00333866|4202150|P4|Overall Study|Withdrawal by Subject|9
1288410|NCT00333866|4202151|P3|Overall Study|Withdrawal by Subject|4
1288411|NCT00333866|4202152|P2|Overall Study|Withdrawal by Subject|14
1288412|NCT00333866|4202153|P1|Overall Study|Withdrawal by Subject|8
1288413|NCT00333866|4202150|P4|Overall Study|Lost to Follow-up|2
1288414|NCT00333866|4202151|P3|Overall Study|Lost to Follow-up|2
1288415|NCT00333866|4202152|P2|Overall Study|Lost to Follow-up|2
1288416|NCT00333866|4202153|P1|Overall Study|Lost to Follow-up|1
1288417|NCT00333866|4202150|P4|Overall Study|Lack of Efficacy|5
1288418|NCT00333866|4202151|P3|Overall Study|Lack of Efficacy|3
1288419|NCT00333866|4202152|P2|Overall Study|Lack of Efficacy|6
1288420|NCT00333866|4202153|P1|Overall Study|Lack of Efficacy|8
1288421|NCT00333866|4202150|P4|Overall Study|Other|2
1288422|NCT00333866|4202151|P3|Overall Study|Other|2
1288423|NCT00333866|4202152|P2|Overall Study|Other|2
1288424|NCT00333866|4202153|P1|Overall Study|Other|3
1288425|NCT00333866|4202150|P4|Overall Study|Adverse Event|47
1288426|NCT00333866|4202151|P3|Overall Study|Adverse Event|38
1288427|NCT00333866|4202152|P2|Overall Study|Adverse Event|37
1288428|NCT00333866|4202153|P1|Overall Study|Adverse Event|23
1288429|NCT00333840|4202213|P4|Second-line Treatment Period|Death|9
1288430|NCT00333840|4202214|P3|Second-line Treatment Period|Death|0
1288431|NCT00333840|4202215|P2|Second-line Treatment Period|Death|0
1288432|NCT00333840|4202216|P1|Second-line Treatment Period|Death|0
1288433|NCT00333840|4202213|P4|Second-line Treatment Period|Administrative problems|7
1288434|NCT00333840|4202214|P3|Second-line Treatment Period|Administrative problems|0
1288435|NCT00333840|4202215|P2|Second-line Treatment Period|Administrative problems|0
1288436|NCT00333840|4202216|P1|Second-line Treatment Period|Administrative problems|0
1288437|NCT00333840|4202213|P4|Second-line Treatment Period|Lost to Follow-up|6
1288438|NCT00333840|4202214|P3|Second-line Treatment Period|Lost to Follow-up|0
1288439|NCT00333840|4202215|P2|Second-line Treatment Period|Lost to Follow-up|0
1288440|NCT00333840|4202216|P1|Second-line Treatment Period|Lost to Follow-up|0
1288441|NCT00333840|4202213|P4|Second-line Treatment Period|Subject withdrew consent|34
1288442|NCT00333840|4202214|P3|Second-line Treatment Period|Subject withdrew consent|0
1288443|NCT00333840|4202215|P2|Second-line Treatment Period|Subject withdrew consent|0
1288444|NCT00333840|4202216|P1|Second-line Treatment Period|Subject withdrew consent|0
1288445|NCT00333840|4202213|P4|Second-line Treatment Period|Protocol Violation|10
1288446|NCT00333840|4202214|P3|Second-line Treatment Period|Protocol Violation|1
1288447|NCT00333840|4202215|P2|Second-line Treatment Period|Protocol Violation|0
1288448|NCT00333840|4202216|P1|Second-line Treatment Period|Protocol Violation|0
1288449|NCT00333840|4202213|P4|Second-line Treatment Period|No longer required study drug|14
1288450|NCT00333840|4202214|P3|Second-line Treatment Period|No longer required study drug|1
1288451|NCT00333840|4202215|P2|Second-line Treatment Period|No longer required study drug|0
1288452|NCT00333840|4202216|P1|Second-line Treatment Period|No longer required study drug|0
1288453|NCT00333840|4202213|P4|Second-line Treatment Period|Unsatisfactory therapeutic effect|70
1288454|NCT00333840|4202214|P3|Second-line Treatment Period|Unsatisfactory therapeutic effect|9
1288455|NCT00333840|4202215|P2|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
1288456|NCT00333840|4202216|P1|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
1288457|NCT00333840|4202213|P4|Second-line Treatment Period|Abnormal procedure|1
1288458|NCT00333840|4202214|P3|Second-line Treatment Period|Abnormal procedure|0
1288459|NCT00333840|4202215|P2|Second-line Treatment Period|Abnormal procedure|0
1288460|NCT00333840|4202216|P1|Second-line Treatment Period|Abnormal procedure|0
1288461|NCT00333840|4202213|P4|Second-line Treatment Period|Abnormal Laboratory Values|3
1288462|NCT00333840|4202214|P3|Second-line Treatment Period|Abnormal Laboratory Values|0
1288463|NCT00333840|4202215|P2|Second-line Treatment Period|Abnormal Laboratory Values|0
1288464|NCT00333840|4202216|P1|Second-line Treatment Period|Abnormal Laboratory Values|0
1288465|NCT00333840|4202213|P4|Second-line Treatment Period|Adverse Event|34
1288466|NCT00333840|4202214|P3|Second-line Treatment Period|Adverse Event|3
1288467|NCT00333840|4202215|P2|Second-line Treatment Period|Adverse Event|0
1288468|NCT00333840|4202216|P1|Second-line Treatment Period|Adverse Event|0
1288469|NCT00333840|4202213|P4|First-line Treatment Period|Crossed over to other treatment arm|0
1288470|NCT00333840|4202214|P3|First-line Treatment Period|Crossed over to other treatment arm|0
1288471|NCT00333840|4202215|P2|First-line Treatment Period|Crossed over to other treatment arm|363
1288472|NCT00333840|4202216|P1|First-line Treatment Period|Crossed over to other treatment arm|14
1288473|NCT00333840|4202213|P4|First-line Treatment Period|Death|0
1288474|NCT00333840|4202214|P3|First-line Treatment Period|Death|0
1288475|NCT00333840|4202215|P2|First-line Treatment Period|Death|2
1288476|NCT00333840|4202216|P1|First-line Treatment Period|Death|19
1288477|NCT00333840|4202213|P4|First-line Treatment Period|Administrative problems|0
1288478|NCT00333840|4202214|P3|First-line Treatment Period|Administrative problems|0
1288479|NCT00333840|4202215|P2|First-line Treatment Period|Administrative problems|6
1288480|NCT00333840|4202216|P1|First-line Treatment Period|Administrative problems|12
1288481|NCT00333840|4202213|P4|First-line Treatment Period|Lost to Follow-up|0
1288482|NCT00333840|4202214|P3|First-line Treatment Period|Lost to Follow-up|0
1288483|NCT00333840|4202215|P2|First-line Treatment Period|Lost to Follow-up|6
1288484|NCT00333840|4202216|P1|First-line Treatment Period|Lost to Follow-up|15
1288485|NCT00333840|4202213|P4|First-line Treatment Period|Subject withdrew consent|0
1288486|NCT00333840|4202214|P3|First-line Treatment Period|Subject withdrew consent|0
1288487|NCT00333840|4202215|P2|First-line Treatment Period|Subject withdrew consent|77
1288488|NCT00333840|4202216|P1|First-line Treatment Period|Subject withdrew consent|57
1288489|NCT00333840|4202213|P4|First-line Treatment Period|Protocol Violation|0
1288490|NCT00333840|4202214|P3|First-line Treatment Period|Protocol Violation|0
1288491|NCT00333840|4202215|P2|First-line Treatment Period|Protocol Violation|17
1288492|NCT00333840|4202216|P1|First-line Treatment Period|Protocol Violation|17
1288493|NCT00333840|4202213|P4|First-line Treatment Period|No longer required study drug|0
1288494|NCT00333840|4202214|P3|First-line Treatment Period|No longer required study drug|0
1288495|NCT00333840|4202215|P2|First-line Treatment Period|No longer required study drug|8
1288496|NCT00333840|4202216|P1|First-line Treatment Period|No longer required study drug|21
1288497|NCT00333840|4202213|P4|First-line Treatment Period|Unsatisfactory therapeutic effect|0
1288498|NCT00333840|4202214|P3|First-line Treatment Period|Unsatisfactory therapeutic effect|0
1288499|NCT00333840|4202215|P2|First-line Treatment Period|Unsatisfactory therapeutic effect|29
1288500|NCT00333840|4202216|P1|First-line Treatment Period|Unsatisfactory therapeutic effect|88
1288501|NCT00333840|4202213|P4|First-line Treatment Period|Abnormal procedure|0
1288502|NCT00333840|4202214|P3|First-line Treatment Period|Abnormal procedure|0
1288503|NCT00333840|4202215|P2|First-line Treatment Period|Abnormal procedure|0
1288504|NCT00333840|4202216|P1|First-line Treatment Period|Abnormal procedure|2
1288505|NCT00333840|4202213|P4|First-line Treatment Period|Abnormal laboratory values|0
1288506|NCT00333840|4202214|P3|First-line Treatment Period|Abnormal laboratory values|0
1288507|NCT00333840|4202215|P2|First-line Treatment Period|Abnormal laboratory values|1
1288508|NCT00333840|4202216|P1|First-line Treatment Period|Abnormal laboratory values|3
1288509|NCT00333840|4202213|P4|First-line Treatment Period|Adverse Event|0
1288510|NCT00333840|4202214|P3|First-line Treatment Period|Adverse Event|0
1288511|NCT00333840|4202215|P2|First-line Treatment Period|Adverse Event|37
1288512|NCT00333840|4202216|P1|First-line Treatment Period|Adverse Event|38
1288513|NCT00333801|4202262|P2|Overall Study|Withdrawal by Subject|1
1288514|NCT00333801|4202263|P1|Overall Study|Withdrawal by Subject|0
1288515|NCT00333801|4202262|P2|Overall Study|Incarcerated|2
1288516|NCT00333801|4202263|P1|Overall Study|Incarcerated|1
1288517|NCT00333801|4202262|P2|Overall Study|Lost to Follow-up|0
1288518|NCT00333801|4202263|P1|Overall Study|Lost to Follow-up|2
1288519|NCT00333801|4202262|P2|Overall Study|Moved to another state|3
1288520|NCT00333801|4202263|P1|Overall Study|Moved to another state|5
1288521|NCT00333788|4202281|P1|Overall Study|Other: Signed consent for another study|1
1288522|NCT00333788|4202281|P1|Overall Study|Other: Physician decision|1
1288523|NCT00333788|4202281|P1|Overall Study|Other: Medical monitor decision|1
1288524|NCT00333788|4202281|P1|Overall Study|Other: Subject in need of an Entocort|1
1288525|NCT00333788|4202281|P1|Overall Study|Other: Sponsor decision|1
1288526|NCT00333788|4202281|P1|Overall Study|Other: Quality of life concern|1
1288527|NCT00333788|4202281|P1|Overall Study|Other: Investigator decision|1
1288528|NCT00333788|4202281|P1|Overall Study|Other: Recurrent squamaous cell cancer|1
1288529|NCT00333788|4202281|P1|Overall Study|Other: Moved|2
1288530|NCT00333788|4202281|P1|Overall Study|Other: Non-compliance|2
1288531|NCT00333788|4202281|P1|Overall Study|Withdrawal by Subject|24
1288532|NCT00333788|4202281|P1|Overall Study|Lost to Follow-up|2
1288533|NCT00333788|4202281|P1|Overall Study|Lack of Efficacy|80
1288534|NCT00333788|4202281|P1|Overall Study|Adverse Event|44
1288535|NCT00333775|4202311|P3|Overall Study|Lost to Follow-up|8
1288536|NCT00333775|4202312|P2|Overall Study|Lost to Follow-up|7
1288537|NCT00333775|4202313|P1|Overall Study|Lost to Follow-up|10
1288538|NCT00333775|4202311|P3|Overall Study|In Follow−up When Study Stopped|96
1288539|NCT00333775|4202312|P2|Overall Study|In Follow−up When Study Stopped|92
1288540|NCT00333775|4202313|P1|Overall Study|In Follow−up When Study Stopped|87
1288541|NCT00333775|4202311|P3|Overall Study|Death|143
1288542|NCT00333775|4202312|P2|Overall Study|Death|149
1288543|NCT00333775|4202313|P1|Overall Study|Death|144
1288544|NCT00333619|4202352|P2|Overall Study|Lost to Follow-up|3
1288545|NCT00333619|4202353|P1|Overall Study|Lost to Follow-up|3
1288546|NCT00333619|4202352|P2|Overall Study|Withdrawal by Subject|1
1288547|NCT00333619|4202353|P1|Overall Study|Withdrawal by Subject|6
1288548|NCT00333619|4202352|P2|Overall Study|Death|6
1288549|NCT00333619|4202353|P1|Overall Study|Death|12
1288550|NCT00333359|4202371|P2|Overall Study|Withdrew before Receiving One Dose|6
1288551|NCT00333359|4202372|P1|Overall Study|Withdrew before Receiving One Dose|2
1288552|NCT00333359|4202371|P2|Overall Study|Treatment Failure|8
1288553|NCT00333359|4202372|P1|Overall Study|Treatment Failure|3
1288554|NCT00333359|4202371|P2|Overall Study|Termination or Withdrawal by Sponsor|1
1288555|NCT00333359|4202372|P1|Overall Study|Termination or Withdrawal by Sponsor|1
1288556|NCT00333359|4202371|P2|Overall Study|Lost to Follow-up|25
1288557|NCT00333359|4202372|P1|Overall Study|Lost to Follow-up|15
1288558|NCT00333359|4202371|P2|Overall Study|Protocol Non-compliance|8
1288559|NCT00333359|4202372|P1|Overall Study|Protocol Non-compliance|2
1288560|NCT00333359|4202371|P2|Overall Study|Physician Decision|2
1288561|NCT00333359|4202372|P1|Overall Study|Physician Decision|2
1288562|NCT00333359|4202371|P2|Overall Study|Withdrawal by Subject|37
1288563|NCT00333359|4202372|P1|Overall Study|Withdrawal by Subject|19
1288564|NCT00333359|4202371|P2|Overall Study|Adverse Event|35
1288565|NCT00333359|4202372|P1|Overall Study|Adverse Event|29
1288566|NCT00333229|4202415|P2|Overall Study|Lack of Efficacy|1
1288567|NCT00333229|4202416|P1|Overall Study|Lack of Efficacy|0
1288568|NCT00333138|4202433|P3|Extension Study (Month6 to End of Study)|Death|0
1288569|NCT00333138|4202434|P2|Extension Study (Month6 to End of Study)|Death|1
1288570|NCT00333138|4202435|P1|Extension Study (Month6 to End of Study)|Death|0
1288571|NCT00333138|4202433|P3|Extension Study (Month6 to End of Study)|Lost to Follow-up|0
1288572|NCT00333138|4202434|P2|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
1288573|NCT00333138|4202435|P1|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
1288574|NCT00333138|4202433|P3|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0
1288575|NCT00333138|4202434|P2|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1
1288576|NCT00333138|4202435|P1|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2
1288577|NCT00333138|4202433|P3|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
1288578|NCT00333138|4202434|P2|Extension Study (Month6 to End of Study)|Lack of Efficacy|4
1288579|NCT00333138|4202435|P1|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
1288580|NCT00333138|4202433|P3|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
1288581|NCT00333138|4202434|P2|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13
1288582|NCT00333138|4202435|P1|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
1288583|NCT00333138|4202433|P3|Extension Study (Month6 to End of Study)|Protocol Violation|3
1288584|NCT00333138|4202434|P2|Extension Study (Month6 to End of Study)|Protocol Violation|0
1288585|NCT00333138|4202435|P1|Extension Study (Month6 to End of Study)|Protocol Violation|0
1288586|NCT00333138|4202433|P3|Extension Study (Month6 to End of Study)|Adverse Event|15
1288587|NCT00333138|4202434|P2|Extension Study (Month6 to End of Study)|Adverse Event|19
1288588|NCT00333138|4202435|P1|Extension Study (Month6 to End of Study)|Adverse Event|15
1288589|NCT00333138|4202433|P3|Extension Study (Month6 to End of Study)|Administrative problems|2
1288590|NCT00333138|4202434|P2|Extension Study (Month6 to End of Study)|Administrative problems|1
1288591|NCT00333138|4202435|P1|Extension Study (Month6 to End of Study)|Administrative problems|1
1288592|NCT00333138|4202433|P3|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
1288593|NCT00333138|4202434|P2|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
1288594|NCT00333138|4202435|P1|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3
1288595|NCT00333138|4202433|P3|Core Study (6 Months)|Laboratory abnormality|1
1288596|NCT00333138|4202434|P2|Core Study (6 Months)|Laboratory abnormality|0
1288597|NCT00333138|4202435|P1|Core Study (6 Months)|Laboratory abnormality|0
1288598|NCT00333138|4202433|P3|Core Study (6 Months)|Protocol Violation|1
1288599|NCT00333138|4202434|P2|Core Study (6 Months)|Protocol Violation|0
1288600|NCT00333138|4202435|P1|Core Study (6 Months)|Protocol Violation|1
1288601|NCT00333138|4202433|P3|Core Study (6 Months)|Lack of Efficacy|0
1288602|NCT00333138|4202434|P2|Core Study (6 Months)|Lack of Efficacy|0
1288603|NCT00333138|4202435|P1|Core Study (6 Months)|Lack of Efficacy|1
1288604|NCT00333138|4202433|P3|Core Study (6 Months)|Withdrawal by Subject|2
1288605|NCT00333138|4202434|P2|Core Study (6 Months)|Withdrawal by Subject|1
1288606|NCT00333138|4202435|P1|Core Study (6 Months)|Withdrawal by Subject|1
1288607|NCT00333138|4202433|P3|Core Study (6 Months)|Adverse Event|8
1288608|NCT00333138|4202434|P2|Core Study (6 Months)|Adverse Event|5
1288609|NCT00333138|4202435|P1|Core Study (6 Months)|Adverse Event|4
1288610|NCT00332839|4202474|P2|Follow-up (Months 12 - 60)|Death|1
1288611|NCT00332839|4202475|P1|Follow-up (Months 12 - 60)|Death|1
1288612|NCT00332839|4202474|P2|Follow-up (Months 12 - 60)|Lost to Follow-up|1
1288613|NCT00332839|4202475|P1|Follow-up (Months 12 - 60)|Lost to Follow-up|2
1288614|NCT00332839|4202474|P2|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
1288615|NCT00332839|4202475|P1|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
1288616|NCT00332839|4202474|P2|Core (Months 0 - 12)|Adverse Event|15
1288617|NCT00332839|4202475|P1|Core (Months 0 - 12)|Adverse Event|5
1288618|NCT00332839|4202474|P2|Core (Months 0 - 12)|Protocol deviation|1
1288619|NCT00332839|4202475|P1|Core (Months 0 - 12)|Protocol deviation|1
1288620|NCT00332839|4202474|P2|Core (Months 0 - 12)|Withdrawal by Subject|1
1288621|NCT00332839|4202475|P1|Core (Months 0 - 12)|Withdrawal by Subject|3
1288622|NCT00332839|4202474|P2|Core (Months 0 - 12)|Administrative problems|1
1288623|NCT00332839|4202475|P1|Core (Months 0 - 12)|Administrative problems|1
1288624|NCT00332709|4202506|P2|Overall Study|Abnormal test procedure result|0
1288625|NCT00332709|4202507|P1|Overall Study|Abnormal test procedure result|1
1288626|NCT00332709|4202506|P2|Overall Study|Administrative Problems|3
1288627|NCT00332709|4202507|P1|Overall Study|Administrative Problems|0
1288628|NCT00332709|4202506|P2|Overall Study|Lost to Follow-up|0
1288629|NCT00332709|4202507|P1|Overall Study|Lost to Follow-up|2
1288630|NCT00332709|4202506|P2|Overall Study|Withdrawal by Subject|3
1288631|NCT00332709|4202507|P1|Overall Study|Withdrawal by Subject|2
1288632|NCT00332709|4202506|P2|Overall Study|Adverse Event|14
1288633|NCT00332709|4202507|P1|Overall Study|Adverse Event|11
1288634|NCT00332696|4202531|P2|Overall Study|Withdrawal by Subject|0
1288635|NCT00332696|4202532|P1|Overall Study|Withdrawal by Subject|1
1288636|NCT00332696|4202531|P2|Overall Study|Lost to Follow-up|1
1288637|NCT00332696|4202532|P1|Overall Study|Lost to Follow-up|0
1288638|NCT00332696|4202531|P2|Overall Study|Condition does not justify treatment|2
1288639|NCT00332696|4202532|P1|Overall Study|Condition does not justify treatment|0
1288640|NCT00332696|4202531|P2|Overall Study|Adverse Event|2
1288641|NCT00332696|4202532|P1|Overall Study|Adverse Event|1
1288642|NCT00332696|4202531|P2|Overall Study|Insufficient therapeutic effect|11
1288643|NCT00332696|4202532|P1|Overall Study|Insufficient therapeutic effect|4
1288644|NCT00332696|4202531|P2|Overall Study|Death|14
1288645|NCT00332696|4202532|P1|Overall Study|Death|24
1288646|NCT00332488|4202608|P3|Transfer Treatment Phase (Weeks 12 – 24)|Various|5
1288647|NCT00332488|4202609|P2|Transfer Treatment Phase (Weeks 12 – 24)|Various|0
1288648|NCT00332488|4202610|P1|Transfer Treatment Phase (Weeks 12 – 24)|Various|0
1288649|NCT00332488|4202608|P3|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|8
1288650|NCT00332488|4202609|P2|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|2
1288651|NCT00332488|4202610|P1|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|2
1288652|NCT00332488|4202608|P3|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|1
1288653|NCT00332488|4202609|P2|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|0
1288654|NCT00332488|4202610|P1|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|0
1288655|NCT00332488|4202608|P3|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|3
1288656|NCT00332488|4202609|P2|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|0
1288657|NCT00332488|4202610|P1|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|0
1288658|NCT00332488|4202608|P3|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|1
1288659|NCT00332488|4202609|P2|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|0
1288660|NCT00332488|4202610|P1|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|0
1288661|NCT00332488|4202608|P3|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|3
1288662|NCT00332488|4202609|P2|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|0
1288663|NCT00332488|4202610|P1|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|0
1288664|NCT00332488|4202608|P3|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0
1288665|NCT00332488|4202609|P2|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1
1288666|NCT00332488|4202610|P1|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3
1288667|NCT00332488|4202608|P3|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0
1288668|NCT00332488|4202609|P2|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3
1288669|NCT00332488|4202610|P1|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1
1288670|NCT00332488|4202608|P3|Initial Treatment Phase (Weeks 0 - 12)|Various|20
1288671|NCT00332488|4202609|P2|Initial Treatment Phase (Weeks 0 - 12)|Various|0
1288672|NCT00332488|4202610|P1|Initial Treatment Phase (Weeks 0 - 12)|Various|4
1288673|NCT00332488|4202608|P3|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20
1288674|NCT00332488|4202609|P2|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10
1288675|NCT00332488|4202610|P1|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21
1288676|NCT00332488|4202608|P3|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10
1288677|NCT00332488|4202609|P2|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2
1288678|NCT00332488|4202610|P1|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13
1288679|NCT00332488|4202608|P3|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6
1288680|NCT00332488|4202609|P2|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2
1288681|NCT00332488|4202610|P1|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8
1288682|NCT00332462|4202622|P1|Overall Study|Graft Loss|2
1288683|NCT00332462|4202622|P1|Overall Study|Death|3
1288684|NCT00332462|4202622|P1|Overall Study|no longer requires study drug|1
1288685|NCT00332462|4202622|P1|Overall Study|Unsatisfactory therapeutic effect|4
1288686|NCT00332462|4202622|P1|Overall Study|Abnormal Lab Value|1
1288687|NCT00332462|4202622|P1|Overall Study|Adverse Event|5
1288688|NCT00332332|4202629|P1|Overall Study|Did not receive study treatment|16
1288689|NCT00332332|4202629|P1|Overall Study|Not specified|18
1288690|NCT00332332|4202629|P1|Overall Study|Disease progression|2
1288691|NCT00332332|4202629|P1|Overall Study|Noncompliance|2
1288692|NCT00332332|4202629|P1|Overall Study|Protocol deviation|4
1288693|NCT00332332|4202629|P1|Overall Study|Lost to Follow-up|3
1288694|NCT00332332|4202629|P1|Overall Study|Physician Decision|1
1288695|NCT00332332|4202629|P1|Overall Study|Withdrawal by Subject|8
1288696|NCT00332332|4202629|P1|Overall Study|Death|1
1288697|NCT00332332|4202629|P1|Overall Study|Adverse Event|13
1288698|NCT00332241|4202638|P2|Overall Study|Lost to Follow-up|1
1288699|NCT00332241|4202639|P1|Overall Study|Lost to Follow-up|4
1288700|NCT00332241|4202638|P2|Overall Study|Withdrawal by Subject|1
1288701|NCT00332241|4202639|P1|Overall Study|Withdrawal by Subject|2
1288702|NCT00332241|4202638|P2|Overall Study|Adverse Event|5
1288703|NCT00332241|4202639|P1|Overall Study|Adverse Event|3
1288704|NCT00332241|4202638|P2|Overall Study|Lack of Efficacy|1
1288705|NCT00332241|4202639|P1|Overall Study|Lack of Efficacy|6
1288706|NCT00332202|4202661|P2|Overall Study|Death|2
1288707|NCT00332202|4202662|P1|Overall Study|Death|5
1288708|NCT00332202|4202661|P2|Overall Study|Progressive Disease|60
1288709|NCT00332202|4202662|P1|Overall Study|Progressive Disease|106
1288710|NCT00332202|4202661|P2|Overall Study|Withdrawal by Subject|17
1288711|NCT00332202|4202662|P1|Overall Study|Withdrawal by Subject|36
1288712|NCT00332202|4202661|P2|Overall Study|Sponsor Decision|2
1288713|NCT00332202|4202662|P1|Overall Study|Sponsor Decision|1
1288714|NCT00332202|4202661|P2|Overall Study|Protocol Violation|2
1288715|NCT00332202|4202662|P1|Overall Study|Protocol Violation|7
1288716|NCT00332202|4202661|P2|Overall Study|Protocol Entry Criteria Not Met|5
1288717|NCT00332202|4202662|P1|Overall Study|Protocol Entry Criteria Not Met|6
1288718|NCT00332202|4202661|P2|Overall Study|Physician Decision|8
1288719|NCT00332202|4202662|P1|Overall Study|Physician Decision|6
1288720|NCT00332202|4202661|P2|Overall Study|Lost to Follow-up|1
1288721|NCT00332202|4202662|P1|Overall Study|Lost to Follow-up|2
1288722|NCT00332202|4202661|P2|Overall Study|Adverse Event|28
1288723|NCT00332202|4202662|P1|Overall Study|Adverse Event|72
1288724|NCT00332189|4202691|P1|Overall Study|Moved out of country|2
1288725|NCT00332189|4202691|P1|Overall Study|Lack of Efficacy|4
1288726|NCT00332189|4202691|P1|Overall Study|Withdrawal by Subject|9
1288727|NCT00332189|4202691|P1|Overall Study|Uncooperative/Noncompliant|3
1288728|NCT00332189|4202691|P1|Overall Study|Adverse Event|3
1288729|NCT00331864|4202733|P2|Overall Study|Death|0
1288730|NCT00331864|4202734|P1|Overall Study|Death|6
1288731|NCT00331864|4202733|P2|Overall Study|Administrative Problems|0
1288732|NCT00331864|4202734|P1|Overall Study|Administrative Problems|1
1288733|NCT00331864|4202733|P2|Overall Study|Lost to Follow-up|3
1288734|NCT00331864|4202734|P1|Overall Study|Lost to Follow-up|4
1288735|NCT00331864|4202733|P2|Overall Study|Withdrawal by Subject|0
1288736|NCT00331864|4202734|P1|Overall Study|Withdrawal by Subject|10
1288737|NCT00331864|4202733|P2|Overall Study|Protocol Violation|0
1288738|NCT00331864|4202734|P1|Overall Study|Protocol Violation|3
1288739|NCT00331864|4202733|P2|Overall Study|Lack of Efficacy|0
1288740|NCT00331864|4202734|P1|Overall Study|Lack of Efficacy|4
1288741|NCT00331864|4202733|P2|Overall Study|Adverse Event|1
1288742|NCT00331864|4202734|P1|Overall Study|Adverse Event|30
1288743|NCT00331799|4202753|P1|Overall Study|Sedation|1
1288744|NCT00331799|4202753|P1|Overall Study|Withdrawal by Subject|2
1288745|NCT00331773|4202759|P2|Overall Study|Protocol Violation|3
1288746|NCT00331773|4202760|P1|Overall Study|Protocol Violation|10
1288747|NCT00331773|4202759|P2|Overall Study|Withdrawal by Subject|4
1288748|NCT00331773|4202760|P1|Overall Study|Withdrawal by Subject|6
1288749|NCT00331760|4202788|P2|Overall Study|Ineligible / no protocol treatment|8
1288750|NCT00331760|4202789|P1|Overall Study|Ineligible / no protocol treatment|15
1288751|NCT00331682|4202795|P1|Overall Study|Adverse Event|1
1288752|NCT00331552|4202803|P2|Period 3: Phase II|Severe Nausea|0
1288753|NCT00331552|4202804|P1|Period 3: Phase II|Severe Nausea|1
1288754|NCT00331552|4202803|P2|Period 3: Phase II|Neurological Symptoms|0
1288755|NCT00331552|4202804|P1|Period 3: Phase II|Neurological Symptoms|1
1288756|NCT00331422|4202818|P1|Overall Study|Did not receive entire study regimen|5
1288757|NCT00331409|4202827|P1|Overall Study|Lack of Efficacy|4
1288758|NCT00331344|4202835|P9|Phase II|Death|4
1288759|NCT00331344|4202836|P8|Phase II|Death|0
1288760|NCT00331344|4202837|P7|Phase II|Death|0
1288761|NCT00331344|4202838|P6|Phase II|Death|0
1288762|NCT00331344|4202839|P5|Phase II|Death|0
1288763|NCT00331344|4202840|P4|Phase II|Death|0
1288764|NCT00331344|4202841|P3|Phase II|Death|0
1288765|NCT00331344|4202842|P2|Phase II|Death|0
1288766|NCT00331344|4202843|P1|Phase II|Death|0
1288767|NCT00331344|4202835|P9|Phase I|Adverse Event|0
1288768|NCT00331344|4202836|P8|Phase I|Adverse Event|1
1288769|NCT00331344|4202837|P7|Phase I|Adverse Event|0
1288770|NCT00331344|4202838|P6|Phase I|Adverse Event|2
1288771|NCT00331344|4202839|P5|Phase I|Adverse Event|2
1288772|NCT00331344|4202840|P4|Phase I|Adverse Event|1
1288773|NCT00331344|4202841|P3|Phase I|Adverse Event|0
1288774|NCT00331344|4202842|P2|Phase I|Adverse Event|0
1288775|NCT00331344|4202843|P1|Phase I|Adverse Event|0
1288776|NCT00331006|4202880|P1|Follow-Up Phase II|Lost to Follow-up|3
1288777|NCT00331006|4202880|P1|Follow-Up Phase I|Lost to Follow-up|1
1288778|NCT00331006|4202880|P1|Treatment Phase|Withdrawal by Subject|1
1288779|NCT00331006|4202880|P1|Screening Phase|Ineligible for treatment phase|4
1288780|NCT00331006|4202880|P1|Screening Phase|Lost to Follow-up|1
1288781|NCT00331006|4202880|P1|Screening Phase|enrollment halted|1
1288782|NCT00331006|4202880|P1|Screening Phase|Withdrawal by Subject|1
1288783|NCT00330967|4202893|P2|Overall Study|Physician Decision|9
1288784|NCT00330967|4202894|P1|Overall Study|Physician Decision|0
1288785|NCT00330967|4202893|P2|Overall Study|Withdrawal by Subject|5
1288786|NCT00330967|4202894|P1|Overall Study|Withdrawal by Subject|0
1288787|NCT00330928|4202905|P1|Overall Study|IVUS could not be performed.|1
1288788|NCT00330928|4202905|P1|Overall Study|Death|1
1288789|NCT00330928|4202905|P1|Overall Study|Physician Decision|9
1288790|NCT00330928|4202905|P1|Overall Study|Lost to Follow-up|6
1288791|NCT00330759|4202947|P2|Overall Study|Other|44
1288792|NCT00330759|4202948|P1|Overall Study|Other|36
1288793|NCT00330759|4202947|P2|Overall Study|Ineligibility determined|1
1288794|NCT00330759|4202948|P1|Overall Study|Ineligibility determined|2
1288795|NCT00330759|4202947|P2|Overall Study|Protocol deviation|2
1288796|NCT00330759|4202948|P1|Overall Study|Protocol deviation|0
1288797|NCT00330759|4202947|P2|Overall Study|Physician Decision|2
1288798|NCT00330759|4202948|P1|Overall Study|Physician Decision|1
1288799|NCT00330759|4202947|P2|Overall Study|Noncompliance|17
1288800|NCT00330759|4202948|P1|Overall Study|Noncompliance|15
1288801|NCT00330759|4202947|P2|Overall Study|Lost to Follow-up|22
1288802|NCT00330759|4202948|P1|Overall Study|Lost to Follow-up|16
1288803|NCT00330759|4202947|P2|Overall Study|Participant request|22
1288804|NCT00330759|4202948|P1|Overall Study|Participant request|31
1288805|NCT00330759|4202947|P2|Overall Study|Adverse Event|36
1288806|NCT00330759|4202948|P1|Overall Study|Adverse Event|48
1288807|NCT00330759|4202947|P2|Overall Study|Withdrawal by Subject|124
1288808|NCT00330759|4202948|P1|Overall Study|Withdrawal by Subject|143
1288809|NCT00330759|4202947|P2|Overall Study|Disease progression|126
1288810|NCT00330759|4202948|P1|Overall Study|Disease progression|104
1288811|NCT00330759|4202947|P2|Overall Study|Death|310
1288812|NCT00330759|4202948|P1|Overall Study|Death|316
1288813|NCT00330681|4202969|P2|Overall Study|Tracheotomy due to worsening of ALS|2
1288814|NCT00330681|4202970|P1|Overall Study|Tracheotomy due to worsening of ALS|1
1288815|NCT00330681|4202969|P2|Overall Study|Withdrawal by Subject|5
1288816|NCT00330681|4202970|P1|Overall Study|Withdrawal by Subject|5
1288817|NCT00330681|4202969|P2|Overall Study|Protocol Violation|1
1288818|NCT00330681|4202970|P1|Overall Study|Protocol Violation|0
1288819|NCT00330681|4202969|P2|Overall Study|Adverse Event|6
1288820|NCT00330681|4202970|P1|Overall Study|Adverse Event|3
1288821|NCT00330668|4202992|P1|Overall Study|Patient started Lupron|1
1288822|NCT00330668|4202992|P1|Overall Study|Use of exclusionary medication|1
1288823|NCT00330668|4202992|P1|Overall Study|Lack of Efficacy|1
1288824|NCT00330668|4202992|P1|Overall Study|Sponsor's decision|76
1288825|NCT00330668|4202992|P1|Overall Study|Withdrawal by Subject|20
1288826|NCT00330668|4202992|P1|Overall Study|Non-Compliance|5
1288827|NCT00330668|4202992|P1|Overall Study|Lost to Follow-up|9
1288828|NCT00330668|4202992|P1|Overall Study|Adverse Event|1
1288829|NCT00330616|4202999|P1|Overall Study|Not specified|1
1288830|NCT00330616|4202999|P1|Overall Study|Withdrawal by Subject|4
1288831|NCT00330616|4202999|P1|Overall Study|Lost to Follow-up|2
1288832|NCT00330616|4202999|P1|Overall Study|Lack of Efficacy|1
1288833|NCT00330616|4202999|P1|Overall Study|Adverse Event|13
1288834|NCT00330460|4203025|P2|Overall Study|Other|0
1288835|NCT00330460|4203026|P1|Overall Study|Other|1
1288836|NCT00330460|4203025|P2|Overall Study|Noncompliance|1
1288837|NCT00330460|4203026|P1|Overall Study|Noncompliance|2
1288838|NCT00330460|4203025|P2|Overall Study|Lost to Follow-up|3
1288839|NCT00330460|4203026|P1|Overall Study|Lost to Follow-up|8
1288840|NCT00330460|4203025|P2|Overall Study|Ineligibility determined|3
1288841|NCT00330460|4203026|P1|Overall Study|Ineligibility determined|1
1288842|NCT00330460|4203025|P2|Overall Study|Death|1
1288843|NCT00330460|4203026|P1|Overall Study|Death|1
1288844|NCT00330460|4203025|P2|Overall Study|Withdrawal by Subject|17
1288845|NCT00330460|4203026|P1|Overall Study|Withdrawal by Subject|18
1288846|NCT00330460|4203025|P2|Overall Study|Adverse Event|8
1288847|NCT00330460|4203026|P1|Overall Study|Adverse Event|10
1288848|NCT00330460|4203025|P2|Overall Study|Physician Decision|0
1288849|NCT00330460|4203026|P1|Overall Study|Physician Decision|1
1288850|NCT00330343|4203069|P1|Overall Study|Lost to Follow-up|5
1288851|NCT00330187|4203077|P4|Overall Study|Withdrawal by Subject|4
1288852|NCT00330187|4203078|P3|Overall Study|Withdrawal by Subject|4
1288853|NCT00330187|4203079|P2|Overall Study|Withdrawal by Subject|5
1288854|NCT00330187|4203080|P1|Overall Study|Withdrawal by Subject|8
1288855|NCT00330187|4203077|P4|Overall Study|Lost to Follow-up|10
1288856|NCT00330187|4203078|P3|Overall Study|Lost to Follow-up|14
1288857|NCT00330187|4203079|P2|Overall Study|Lost to Follow-up|13
1288858|NCT00330187|4203080|P1|Overall Study|Lost to Follow-up|12
1288859|NCT00330174|4203092|P2|Overall Study|Miscellaneous reasons|1
1288860|NCT00330174|4203093|P1|Overall Study|Miscellaneous reasons|7
1288861|NCT00330174|4203092|P2|Overall Study|Excessive missed visits|8
1288862|NCT00330174|4203093|P1|Overall Study|Excessive missed visits|3
1288863|NCT00330174|4203092|P2|Overall Study|Clinical deterioration|2
1288864|NCT00330174|4203093|P1|Overall Study|Clinical deterioration|1
1288865|NCT00330174|4203092|P2|Overall Study|Lost to Follow-up|1
1288866|NCT00330174|4203093|P1|Overall Study|Lost to Follow-up|4
1288867|NCT00330174|4203092|P2|Overall Study|Withdrawal by Subject|7
1288868|NCT00330174|4203093|P1|Overall Study|Withdrawal by Subject|7
1288869|NCT00329901|4203117|P3|Overall Study|Unable to classify|0
1288870|NCT00329901|4203118|P2|Overall Study|Unable to classify|2
1288871|NCT00329901|4203119|P1|Overall Study|Unable to classify|2
1288872|NCT00329901|4203117|P3|Overall Study|Protocol Violation|1
1288873|NCT00329901|4203118|P2|Overall Study|Protocol Violation|0
1288874|NCT00329901|4203119|P1|Overall Study|Protocol Violation|1
1288875|NCT00329901|4203117|P3|Overall Study|Lost to Follow-up|1
1288876|NCT00329901|4203118|P2|Overall Study|Lost to Follow-up|0
1288877|NCT00329901|4203119|P1|Overall Study|Lost to Follow-up|2
1288878|NCT00329901|4203117|P3|Overall Study|Withdrawal by Subject|2
1288879|NCT00329901|4203118|P2|Overall Study|Withdrawal by Subject|3
1288880|NCT00329901|4203119|P1|Overall Study|Withdrawal by Subject|4
1288881|NCT00329849|4203149|P2|Overall Study|Withdrawal by Subject|4
1288882|NCT00329849|4203150|P1|Overall Study|Withdrawal by Subject|6
1288883|NCT00329797|4203176|P2|Overall Study|Withdrawal by Subject|6
1288884|NCT00329797|4203177|P1|Overall Study|Withdrawal by Subject|6
1288885|NCT00329797|4203176|P2|Overall Study|Protocol Violation|0
1288886|NCT00329797|4203177|P1|Overall Study|Protocol Violation|1
1288887|NCT00329784|4203193|P4|Overall Study|Other|0
1288888|NCT00329784|4203194|P3|Overall Study|Other|0
1288889|NCT00329784|4203195|P2|Overall Study|Other|2
1288890|NCT00329784|4203196|P1|Overall Study|Other|1
1288891|NCT00329784|4203193|P4|Overall Study|Withdrawal by Subject|0
1288892|NCT00329784|4203194|P3|Overall Study|Withdrawal by Subject|0
1288893|NCT00329784|4203195|P2|Overall Study|Withdrawal by Subject|2
1288894|NCT00329784|4203196|P1|Overall Study|Withdrawal by Subject|4
1288895|NCT00329784|4203193|P4|Overall Study|Lost to Follow-up|0
1288896|NCT00329784|4203194|P3|Overall Study|Lost to Follow-up|0
1288897|NCT00329784|4203195|P2|Overall Study|Lost to Follow-up|1
1288898|NCT00329784|4203196|P1|Overall Study|Lost to Follow-up|0
1288899|NCT00329745|4203224|P2|Overall Study|Lost to Follow-up|101
1288900|NCT00329745|4203225|P1|Overall Study|Lost to Follow-up|86
1288901|NCT00329745|4203224|P2|Overall Study|Withdrawal by Subject|1
1288902|NCT00329745|4203225|P1|Overall Study|Withdrawal by Subject|0
1288903|NCT00329745|4203224|P2|Overall Study|Protocol Violation|0
1288904|NCT00329745|4203225|P1|Overall Study|Protocol Violation|1
1288905|NCT00329719|4203245|P4|Overall Study|Lost to Follow-up|1
1288906|NCT00329719|4203246|P3|Overall Study|Lost to Follow-up|0
1288907|NCT00329719|4203247|P2|Overall Study|Lost to Follow-up|0
1288908|NCT00329719|4203248|P1|Overall Study|Lost to Follow-up|0
1288909|NCT00329641|4203270|P1|Overall Study|Other reason, not protocol specified|1
1288910|NCT00329641|4203270|P1|Overall Study|Adverse Event|3
1288911|NCT00329641|4203270|P1|Overall Study|Not eligible|1
1288912|NCT00329641|4203270|P1|Overall Study|Did not start treatment|1
1288913|NCT00329602|4203279|P3|40-Week Open-Label Treatment Phase|Captured as Other|4
1288914|NCT00329602|4203280|P2|40-Week Open-Label Treatment Phase|Captured as Other|0
1288915|NCT00329602|4203281|P1|40-Week Open-Label Treatment Phase|Captured as Other|0
1288916|NCT00329602|4203279|P3|40-Week Open-Label Treatment Phase|Lack of Efficacy|9
1288917|NCT00329602|4203280|P2|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
1288918|NCT00329602|4203281|P1|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
1288919|NCT00329602|4203279|P3|40-Week Open-Label Treatment Phase|Protocol Violation|2
1288920|NCT00329602|4203280|P2|40-Week Open-Label Treatment Phase|Protocol Violation|0
1288921|NCT00329602|4203281|P1|40-Week Open-Label Treatment Phase|Protocol Violation|0
1288922|NCT00329602|4203279|P3|40-Week Open-Label Treatment Phase|Lost to Follow-up|1
1288923|NCT00329602|4203280|P2|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
1288924|NCT00329602|4203281|P1|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
1288925|NCT00329602|4203279|P3|40-Week Open-Label Treatment Phase|Adverse Event|20
1288926|NCT00329602|4203280|P2|40-Week Open-Label Treatment Phase|Adverse Event|0
1288927|NCT00329602|4203281|P1|40-Week Open-Label Treatment Phase|Adverse Event|0
1288928|NCT00329602|4203279|P3|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0
1289012|NCT00328783|4204088|P1|Overall Study|No heart in RT field|4
1288929|NCT00329602|4203280|P2|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99
1288930|NCT00329602|4203281|P1|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119
1288931|NCT00329550|4203319|P3|Overall Study|Due to Relocation|1
1288932|NCT00329550|4203320|P2|Overall Study|Due to Relocation|0
1288933|NCT00329550|4203321|P1|Overall Study|Due to Relocation|0
1288934|NCT00329550|4203319|P3|Overall Study|Withdrawal of Consent|1
1288935|NCT00329550|4203320|P2|Overall Study|Withdrawal of Consent|0
1288936|NCT00329550|4203321|P1|Overall Study|Withdrawal of Consent|1
1288937|NCT00329550|4203319|P3|Overall Study|Adverse Event|2
1288938|NCT00329550|4203320|P2|Overall Study|Adverse Event|4
1288939|NCT00329550|4203321|P1|Overall Study|Adverse Event|3
1288940|NCT00329420|4203586|P3|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
1288941|NCT00329420|4203587|P2|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
1288942|NCT00329420|4203588|P1|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1
1288943|NCT00329420|4203586|P3|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0
1288944|NCT00329420|4203587|P2|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
1288945|NCT00329420|4203588|P1|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
1288946|NCT00329420|4203586|P3|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
1288947|NCT00329420|4203587|P2|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
1288948|NCT00329420|4203588|P1|4-weekly Dosing Phase (Responders Only)|Adverse Event|2
1288949|NCT00329420|4203586|P3|Re-induction Phase|Did not respond to re-induction|7
1288950|NCT00329420|4203587|P2|Re-induction Phase|Did not respond to re-induction|5
1288951|NCT00329420|4203588|P1|Re-induction Phase|Did not respond to re-induction|6
1288952|NCT00329420|4203586|P3|Re-induction Phase|Withdrawal of Consent|1
1288953|NCT00329420|4203587|P2|Re-induction Phase|Withdrawal of Consent|0
1288954|NCT00329420|4203588|P1|Re-induction Phase|Withdrawal of Consent|0
1288955|NCT00329420|4203586|P3|Re-induction Phase|Lack of Efficacy|0
1288956|NCT00329420|4203587|P2|Re-induction Phase|Lack of Efficacy|1
1288957|NCT00329420|4203588|P1|Re-induction Phase|Lack of Efficacy|0
1288958|NCT00329407|4203967|P1|Overall Study|Withdrawal by Subject|1
1288959|NCT00329238|4203974|P2|Overall Study|Other reason (not specified)|54
1288960|NCT00329238|4203975|P1|Overall Study|Other reason (not specified)|40
1288961|NCT00329238|4203974|P2|Overall Study|Withdrawal by Subject|58
1288962|NCT00329238|4203975|P1|Overall Study|Withdrawal by Subject|64
1288963|NCT00329238|4203974|P2|Overall Study|Lost to Follow-up|6
1288964|NCT00329238|4203975|P1|Overall Study|Lost to Follow-up|2
1288965|NCT00329238|4203974|P2|Overall Study|Protocol Violation|34
1288966|NCT00329238|4203975|P1|Overall Study|Protocol Violation|23
1288967|NCT00329238|4203974|P2|Overall Study|Adverse Event|129
1288968|NCT00329238|4203975|P1|Overall Study|Adverse Event|147
1288969|NCT00329160|4204011|P1|Overall Study|Incomplete IVUS|45
1288970|NCT00329160|4204011|P1|Overall Study|Did not Receive Study Drug|1
1288971|NCT00329160|4204011|P1|Overall Study|Protocol Violation|2
1288972|NCT00329160|4204011|P1|Overall Study|Withdrawal by Subject|13
1288973|NCT00329160|4204011|P1|Overall Study|Adverse Event|27
1288974|NCT00329108|4204020|P2|Overall Study|Protocol Violation|2
1288975|NCT00329108|4204021|P1|Overall Study|Protocol Violation|0
1288976|NCT00329108|4204020|P2|Overall Study|withdrew patient after SAE resolved|0
1288977|NCT00329108|4204021|P1|Overall Study|withdrew patient after SAE resolved|1
1288978|NCT00329108|4204020|P2|Overall Study|study terminated by sponsor|0
1288979|NCT00329108|4204021|P1|Overall Study|study terminated by sponsor|1
1288980|NCT00329108|4204020|P2|Overall Study|Subject no longer willing to participate|2
1288981|NCT00329108|4204021|P1|Overall Study|Subject no longer willing to participate|2
1288982|NCT00329108|4204020|P2|Overall Study|symptomatic deterioration|1
1288983|NCT00329108|4204021|P1|Overall Study|symptomatic deterioration|1
1288984|NCT00329108|4204020|P2|Overall Study|Withdrawal by Subject|2
1288985|NCT00329108|4204021|P1|Overall Study|Withdrawal by Subject|0
1288986|NCT00329108|4204020|P2|Overall Study|Lack of Efficacy|3
1288987|NCT00329108|4204021|P1|Overall Study|Lack of Efficacy|3
1288988|NCT00329108|4204020|P2|Overall Study|Adverse Event|2
1288989|NCT00329108|4204021|P1|Overall Study|Adverse Event|2
1288990|NCT00329030|4204029|P2|Overall Study|Ineligible Pathology|1
1288991|NCT00329030|4204030|P1|Overall Study|Ineligible Pathology|1
1288992|NCT00329030|4204029|P2|Overall Study|Progressive Disease|2
1288993|NCT00329030|4204030|P1|Overall Study|Progressive Disease|6
1288994|NCT00329030|4204029|P2|Overall Study|Withdrawal by Subject|3
1288995|NCT00329030|4204030|P1|Overall Study|Withdrawal by Subject|1
1288996|NCT00328926|4204061|P3|Overall Study|Lack of ovarian response|0
1288997|NCT00328926|4204062|P2|Overall Study|Lack of ovarian response|1
1288998|NCT00328926|4204063|P1|Overall Study|Lack of ovarian response|0
1288999|NCT00328926|4204061|P3|Overall Study|In vitro fertilization treatment|1
1289000|NCT00328926|4204062|P2|Overall Study|In vitro fertilization treatment|0
1289001|NCT00328926|4204063|P1|Overall Study|In vitro fertilization treatment|0
1289002|NCT00328926|4204061|P3|Overall Study|Death|1
1289003|NCT00328926|4204062|P2|Overall Study|Death|0
1289004|NCT00328926|4204063|P1|Overall Study|Death|0
1289005|NCT00328926|4204061|P3|Overall Study|Lost to Follow-up|0
1289006|NCT00328926|4204062|P2|Overall Study|Lost to Follow-up|1
1289007|NCT00328926|4204063|P1|Overall Study|Lost to Follow-up|0
1289008|NCT00328926|4204061|P3|Overall Study|Pregnancy|0
1289009|NCT00328926|4204062|P2|Overall Study|Pregnancy|1
1289010|NCT00328926|4204063|P1|Overall Study|Pregnancy|2
1289011|NCT00328783|4204088|P1|Overall Study|Withdrawal by Subject|1
1289013|NCT00328783|4204088|P1|Overall Study|Could not tolerate ABC|21
1289014|NCT00328627|4204114|P12|Overall Study|Other|0
1289015|NCT00328627|4204115|P11|Overall Study|Other|1
1289016|NCT00328627|4204116|P10|Overall Study|Other|1
1289017|NCT00328627|4204117|P9|Overall Study|Other|0
1289018|NCT00328627|4204118|P8|Overall Study|Other|0
1289019|NCT00328627|4204119|P7|Overall Study|Other|1
1289020|NCT00328627|4204120|P6|Overall Study|Other|0
1289021|NCT00328627|4204121|P5|Overall Study|Other|0
1289022|NCT00328627|4204122|P4|Overall Study|Other|1
1289023|NCT00328627|4204123|P3|Overall Study|Other|0
1289024|NCT00328627|4204124|P2|Overall Study|Other|0
1289025|NCT00328627|4204125|P1|Overall Study|Other|0
1289026|NCT00328627|4204114|P12|Overall Study|Physician Decision|0
1289027|NCT00328627|4204115|P11|Overall Study|Physician Decision|1
1289028|NCT00328627|4204116|P10|Overall Study|Physician Decision|2
1289029|NCT00328627|4204117|P9|Overall Study|Physician Decision|3
1289030|NCT00328627|4204118|P8|Overall Study|Physician Decision|0
1289031|NCT00328627|4204119|P7|Overall Study|Physician Decision|1
1289032|NCT00328627|4204120|P6|Overall Study|Physician Decision|1
1289033|NCT00328627|4204121|P5|Overall Study|Physician Decision|1
1289034|NCT00328627|4204122|P4|Overall Study|Physician Decision|2
1289035|NCT00328627|4204123|P3|Overall Study|Physician Decision|1
1289036|NCT00328627|4204124|P2|Overall Study|Physician Decision|3
1289037|NCT00328627|4204125|P1|Overall Study|Physician Decision|4
1289038|NCT00328627|4204114|P12|Overall Study|Pregnancy|0
1289039|NCT00328627|4204115|P11|Overall Study|Pregnancy|0
1289040|NCT00328627|4204116|P10|Overall Study|Pregnancy|0
1289041|NCT00328627|4204117|P9|Overall Study|Pregnancy|0
1289042|NCT00328627|4204118|P8|Overall Study|Pregnancy|0
1289043|NCT00328627|4204119|P7|Overall Study|Pregnancy|0
1289044|NCT00328627|4204120|P6|Overall Study|Pregnancy|0
1289045|NCT00328627|4204121|P5|Overall Study|Pregnancy|0
1289046|NCT00328627|4204122|P4|Overall Study|Pregnancy|0
1289047|NCT00328627|4204123|P3|Overall Study|Pregnancy|0
1289048|NCT00328627|4204124|P2|Overall Study|Pregnancy|1
1289049|NCT00328627|4204125|P1|Overall Study|Pregnancy|0
1289050|NCT00328627|4204114|P12|Overall Study|Withdrawal by Subject|7
1289051|NCT00328627|4204115|P11|Overall Study|Withdrawal by Subject|2
1289052|NCT00328627|4204116|P10|Overall Study|Withdrawal by Subject|5
1289053|NCT00328627|4204117|P9|Overall Study|Withdrawal by Subject|4
1289054|NCT00328627|4204118|P8|Overall Study|Withdrawal by Subject|4
1289055|NCT00328627|4204119|P7|Overall Study|Withdrawal by Subject|4
1289056|NCT00328627|4204120|P6|Overall Study|Withdrawal by Subject|5
1289057|NCT00328627|4204121|P5|Overall Study|Withdrawal by Subject|2
1289058|NCT00328627|4204122|P4|Overall Study|Withdrawal by Subject|6
1289059|NCT00328627|4204123|P3|Overall Study|Withdrawal by Subject|5
1289060|NCT00328627|4204124|P2|Overall Study|Withdrawal by Subject|4
1289061|NCT00328627|4204125|P1|Overall Study|Withdrawal by Subject|5
1289062|NCT00328627|4204114|P12|Overall Study|Lost to Follow-up|1
1289063|NCT00328627|4204115|P11|Overall Study|Lost to Follow-up|0
1289064|NCT00328627|4204116|P10|Overall Study|Lost to Follow-up|2
1289065|NCT00328627|4204117|P9|Overall Study|Lost to Follow-up|3
1289066|NCT00328627|4204118|P8|Overall Study|Lost to Follow-up|0
1289067|NCT00328627|4204119|P7|Overall Study|Lost to Follow-up|3
1289068|NCT00328627|4204120|P6|Overall Study|Lost to Follow-up|2
1289069|NCT00328627|4204121|P5|Overall Study|Lost to Follow-up|0
1289070|NCT00328627|4204122|P4|Overall Study|Lost to Follow-up|4
1289071|NCT00328627|4204123|P3|Overall Study|Lost to Follow-up|2
1289072|NCT00328627|4204124|P2|Overall Study|Lost to Follow-up|2
1289073|NCT00328627|4204125|P1|Overall Study|Lost to Follow-up|4
1289074|NCT00328627|4204114|P12|Overall Study|Protocol Violation|2
1289075|NCT00328627|4204115|P11|Overall Study|Protocol Violation|6
1289076|NCT00328627|4204116|P10|Overall Study|Protocol Violation|4
1289077|NCT00328627|4204117|P9|Overall Study|Protocol Violation|1
1289078|NCT00328627|4204118|P8|Overall Study|Protocol Violation|2
1289079|NCT00328627|4204119|P7|Overall Study|Protocol Violation|6
1289080|NCT00328627|4204120|P6|Overall Study|Protocol Violation|5
1289081|NCT00328627|4204121|P5|Overall Study|Protocol Violation|5
1289082|NCT00328627|4204122|P4|Overall Study|Protocol Violation|8
1289083|NCT00328627|4204123|P3|Overall Study|Protocol Violation|2
1289084|NCT00328627|4204124|P2|Overall Study|Protocol Violation|2
1289085|NCT00328627|4204125|P1|Overall Study|Protocol Violation|2
1289086|NCT00328627|4204114|P12|Overall Study|Adverse Event|4
1289087|NCT00328627|4204115|P11|Overall Study|Adverse Event|5
1289088|NCT00328627|4204116|P10|Overall Study|Adverse Event|7
1289089|NCT00328627|4204117|P9|Overall Study|Adverse Event|0
1289090|NCT00328627|4204118|P8|Overall Study|Adverse Event|2
1289091|NCT00328627|4204119|P7|Overall Study|Adverse Event|1
1289092|NCT00328627|4204120|P6|Overall Study|Adverse Event|2
1289093|NCT00328627|4204121|P5|Overall Study|Adverse Event|1
1289094|NCT00328627|4204122|P4|Overall Study|Adverse Event|3
1289095|NCT00328627|4204123|P3|Overall Study|Adverse Event|2
1289096|NCT00328627|4204124|P2|Overall Study|Adverse Event|1
1289097|NCT00328627|4204125|P1|Overall Study|Adverse Event|3
1289098|NCT00328627|4204114|P12|Overall Study|Hyperglycemic Rescue|2
1289099|NCT00328627|4204115|P11|Overall Study|Hyperglycemic Rescue|3
1289100|NCT00328627|4204116|P10|Overall Study|Hyperglycemic Rescue|11
1289101|NCT00328627|4204117|P9|Overall Study|Hyperglycemic Rescue|6
1289102|NCT00328627|4204118|P8|Overall Study|Hyperglycemic Rescue|6
1289103|NCT00328627|4204119|P7|Overall Study|Hyperglycemic Rescue|19
1289104|NCT00328627|4204120|P6|Overall Study|Hyperglycemic Rescue|5
1289105|NCT00328627|4204121|P5|Overall Study|Hyperglycemic Rescue|6
1289106|NCT00328627|4204122|P4|Overall Study|Hyperglycemic Rescue|13
1289107|NCT00328627|4204123|P3|Overall Study|Hyperglycemic Rescue|16
1289108|NCT00328627|4204124|P2|Overall Study|Hyperglycemic Rescue|18
1289109|NCT00328627|4204125|P1|Overall Study|Hyperglycemic Rescue|41
1289110|NCT00328562|4205662|P1|Overall Study|Disease progression|1
1289111|NCT00328510|4205671|P2|Overall Study|Treatment changed to a single fraction|1
1289112|NCT00328510|4205672|P1|Overall Study|Treatment changed to a single fraction|1
1289113|NCT00328510|4205671|P2|Overall Study|Severe kyphosis, could not use mask|1
1289114|NCT00328510|4205672|P1|Overall Study|Severe kyphosis, could not use mask|0
1289115|NCT00328510|4205671|P2|Overall Study|Withdrawal by Subject|2
1289116|NCT00328510|4205672|P1|Overall Study|Withdrawal by Subject|4
1289117|NCT00328510|4205671|P2|Overall Study|Dentition problems, could not use frame|0
1289118|NCT00328510|4205672|P1|Overall Study|Dentition problems, could not use frame|1
1289119|NCT00328510|4205671|P2|Overall Study|Gag disorder, could not use frame|0
1289120|NCT00328510|4205672|P1|Overall Study|Gag disorder, could not use frame|4
1289121|NCT00328198|4205687|P1|Follow-up|Death|31
1289122|NCT00328198|4205687|P1|Follow-up|Lost to Follow-up|4
1289123|NCT00328198|4205687|P1|Treatment|Confirmed complete response, MRD -|3
1289124|NCT00328198|4205687|P1|Treatment|Non-compliance|1
1289125|NCT00328198|4205687|P1|Treatment|Evidence of disease progression|2
1289126|NCT00328198|4205687|P1|Treatment|Withdrawal by Subject|5
1289127|NCT00328198|4205687|P1|Treatment|Physician Decision|5
1289128|NCT00328198|4205687|P1|Treatment|Death|1
1289129|NCT00328198|4205687|P1|Treatment|Adverse Event|21
1289130|NCT00328172|4205702|P5|Overall Study|Other reason (not specified)|0
1289131|NCT00328172|4205703|P4|Overall Study|Other reason (not specified)|0
1289132|NCT00328172|4205704|P3|Overall Study|Other reason (not specified)|1
1289133|NCT00328172|4205705|P2|Overall Study|Other reason (not specified)|0
1289134|NCT00328172|4205706|P1|Overall Study|Other reason (not specified)|3
1289135|NCT00328172|4205702|P5|Overall Study|Lack of Efficacy|3
1289136|NCT00328172|4205703|P4|Overall Study|Lack of Efficacy|4
1289137|NCT00328172|4205704|P3|Overall Study|Lack of Efficacy|4
1289138|NCT00328172|4205705|P2|Overall Study|Lack of Efficacy|9
1289139|NCT00328172|4205706|P1|Overall Study|Lack of Efficacy|14
1289140|NCT00328172|4205702|P5|Overall Study|Withdrawal by Subject|0
1289141|NCT00328172|4205703|P4|Overall Study|Withdrawal by Subject|6
1289142|NCT00328172|4205704|P3|Overall Study|Withdrawal by Subject|1
1289143|NCT00328172|4205705|P2|Overall Study|Withdrawal by Subject|1
1289144|NCT00328172|4205706|P1|Overall Study|Withdrawal by Subject|1
1289145|NCT00328172|4205702|P5|Overall Study|Lost to Follow-up|1
1289146|NCT00328172|4205703|P4|Overall Study|Lost to Follow-up|1
1289147|NCT00328172|4205704|P3|Overall Study|Lost to Follow-up|2
1289148|NCT00328172|4205705|P2|Overall Study|Lost to Follow-up|1
1289149|NCT00328172|4205706|P1|Overall Study|Lost to Follow-up|1
1289150|NCT00328172|4205702|P5|Overall Study|Protocol Violation|0
1289151|NCT00328172|4205703|P4|Overall Study|Protocol Violation|0
1289152|NCT00328172|4205704|P3|Overall Study|Protocol Violation|1
1289153|NCT00328172|4205705|P2|Overall Study|Protocol Violation|1
1289154|NCT00328172|4205706|P1|Overall Study|Protocol Violation|0
1289155|NCT00328172|4205702|P5|Overall Study|Adverse Event|1
1289156|NCT00328172|4205703|P4|Overall Study|Adverse Event|2
1289157|NCT00328172|4205704|P3|Overall Study|Adverse Event|1
1289158|NCT00328172|4205705|P2|Overall Study|Adverse Event|2
1289159|NCT00328172|4205706|P1|Overall Study|Adverse Event|3
1289160|NCT00328094|4205730|P2|Overall Study|Physician Decision|3
1289161|NCT00328094|4205731|P1|Overall Study|Physician Decision|3
1289162|NCT00327717|4205765|P2|Overall Study|Withdrawal by Subject|7
1289163|NCT00327717|4205766|P1|Overall Study|Withdrawal by Subject|3
1289164|NCT00327717|4205765|P2|Overall Study|Lack of Efficacy|1
1289165|NCT00327717|4205766|P1|Overall Study|Lack of Efficacy|0
1289166|NCT00327717|4205765|P2|Overall Study|Adverse Event|6
1289167|NCT00327717|4205766|P1|Overall Study|Adverse Event|6
1289168|NCT00327470|4205792|P2|Overall Study|Death|4
1289169|NCT00327470|4205793|P1|Overall Study|Death|1
1289170|NCT00327470|4205792|P2|Overall Study|Withdrawal by Subject|12
1289171|NCT00327470|4205793|P1|Overall Study|Withdrawal by Subject|6
1289172|NCT00327470|4205792|P2|Overall Study|Lost to Follow-up|3
1289173|NCT00327470|4205793|P1|Overall Study|Lost to Follow-up|1
1289174|NCT00327470|4205792|P2|Overall Study|Other|9
1289175|NCT00327470|4205793|P1|Overall Study|Other|5
1289176|NCT00327470|4205792|P2|Overall Study|Lack of Efficacy|19
1289177|NCT00327470|4205793|P1|Overall Study|Lack of Efficacy|7
1289178|NCT00327470|4205792|P2|Overall Study|Adverse Event|14
1289179|NCT00327470|4205793|P1|Overall Study|Adverse Event|9
1289180|NCT00327470|4205792|P2|Overall Study|Randomized, but not treated|2
1289181|NCT00327470|4205793|P1|Overall Study|Randomized, but not treated|0
1289182|NCT00327444|4205813|P2|Open Label Treatment (OL) Period|Ongoing Treatment|0
1289183|NCT00327444|4205814|P1|Open Label Treatment (OL) Period|Ongoing Treatment|1
1289184|NCT00327444|4205813|P2|Open Label Treatment (OL) Period|Worsening dyspnea|1
1289185|NCT00327444|4205814|P1|Open Label Treatment (OL) Period|Worsening dyspnea|0
1289186|NCT00327444|4205813|P2|Open Label Treatment (OL) Period|Adverse Event|2
1289187|NCT00327444|4205814|P1|Open Label Treatment (OL) Period|Adverse Event|2
1289188|NCT00327444|4205813|P2|Open Label Treatment (OL) Period|Disease progression|7
1289189|NCT00327444|4205814|P1|Open Label Treatment (OL) Period|Disease progression|8
1289190|NCT00327444|4205813|P2|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10
1289191|NCT00327444|4205814|P1|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11
1289192|NCT00327444|4205813|P2|Double Blind Treatment (DB) Period|Subject request|1
1289193|NCT00327444|4205814|P1|Double Blind Treatment (DB) Period|Subject request|0
1289194|NCT00327444|4205813|P2|Double Blind Treatment (DB) Period|Adverse Event|5
1289195|NCT00327444|4205814|P1|Double Blind Treatment (DB) Period|Adverse Event|5
1289196|NCT00327444|4205813|P2|Double Blind Treatment (DB) Period|Disease progression|13
1289197|NCT00327444|4205814|P1|Double Blind Treatment (DB) Period|Disease progression|10
1289198|NCT00327340|4205832|P2|Overall Study|Adverse Event|3
1289199|NCT00327340|4205833|P1|Overall Study|Adverse Event|3
1289200|NCT00327340|4205832|P2|Overall Study|Symptomatic Disease|2
1289201|NCT00327340|4205833|P1|Overall Study|Symptomatic Disease|0
1289202|NCT00327340|4205832|P2|Overall Study|Disease Progression|19
1289203|NCT00327340|4205833|P1|Overall Study|Disease Progression|10
1289204|NCT00327340|4205832|P2|Overall Study|Physician Decision|1
1289205|NCT00327340|4205833|P1|Overall Study|Physician Decision|1
1289206|NCT00327340|4205832|P2|Overall Study|Withdrawal by Subject|5
1289207|NCT00327340|4205833|P1|Overall Study|Withdrawal by Subject|1
1289208|NCT00327171|4205847|P2|Overall Study|Other|0
1289209|NCT00327171|4205848|P1|Overall Study|Other|1
1289210|NCT00327171|4205847|P2|Overall Study|Undisclosed history of ischemia|1
1289211|NCT00327171|4205848|P1|Overall Study|Undisclosed history of ischemia|0
1289212|NCT00327171|4205847|P2|Overall Study|Clinical progression|8
1289213|NCT00327171|4205848|P1|Overall Study|Clinical progression|12
1289214|NCT00327171|4205847|P2|Overall Study|Investigator/participant request|8
1289215|NCT00327171|4205848|P1|Overall Study|Investigator/participant request|1
1289216|NCT00327171|4205847|P2|Overall Study|Disease progression/lack of efficacy|69
1289217|NCT00327171|4205848|P1|Overall Study|Disease progression/lack of efficacy|68
1289218|NCT00327171|4205847|P2|Overall Study|Adverse Event|23
1289219|NCT00327171|4205848|P1|Overall Study|Adverse Event|23
1289220|NCT00327171|4205847|P2|Overall Study|Did not receive study medication|0
1289221|NCT00327171|4205848|P1|Overall Study|Did not receive study medication|3
1289222|NCT00327015|4205880|P4|Overall Study|Administrative Reason by Sponsor|1
1289223|NCT00327015|4205881|P3|Overall Study|Administrative Reason by Sponsor|2
1289224|NCT00327015|4205882|P2|Overall Study|Administrative Reason by Sponsor|2
1289225|NCT00327015|4205883|P1|Overall Study|Administrative Reason by Sponsor|1
1289226|NCT00327015|4205880|P4|Overall Study|Pregnancy|1
1289227|NCT00327015|4205881|P3|Overall Study|Pregnancy|1
1289228|NCT00327015|4205882|P2|Overall Study|Pregnancy|2
1289229|NCT00327015|4205883|P1|Overall Study|Pregnancy|0
1289230|NCT00327015|4205880|P4|Overall Study|Death|3
1289231|NCT00327015|4205881|P3|Overall Study|Death|2
1289232|NCT00327015|4205882|P2|Overall Study|Death|2
1289233|NCT00327015|4205883|P1|Overall Study|Death|1
1289234|NCT00327015|4205880|P4|Overall Study|Physician Decision|2
1289235|NCT00327015|4205881|P3|Overall Study|Physician Decision|3
1289236|NCT00327015|4205882|P2|Overall Study|Physician Decision|1
1289237|NCT00327015|4205883|P1|Overall Study|Physician Decision|0
1289238|NCT00327015|4205880|P4|Overall Study|Poor/Noncompliance|5
1289239|NCT00327015|4205881|P3|Overall Study|Poor/Noncompliance|4
1289240|NCT00327015|4205882|P2|Overall Study|Poor/Noncompliance|8
1289241|NCT00327015|4205883|P1|Overall Study|Poor/Noncompliance|11
1289242|NCT00327015|4205880|P4|Overall Study|Subject no longer meets study criteria|7
1289243|NCT00327015|4205881|P3|Overall Study|Subject no longer meets study criteria|8
1289244|NCT00327015|4205882|P2|Overall Study|Subject no longer meets study criteria|2
1289245|NCT00327015|4205883|P1|Overall Study|Subject no longer meets study criteria|4
1289246|NCT00327015|4205880|P4|Overall Study|Adverse Event|14
1289247|NCT00327015|4205881|P3|Overall Study|Adverse Event|14
1289248|NCT00327015|4205882|P2|Overall Study|Adverse Event|10
1289249|NCT00327015|4205883|P1|Overall Study|Adverse Event|14
1289250|NCT00327015|4205880|P4|Overall Study|Lost to Follow-up|22
1289251|NCT00327015|4205881|P3|Overall Study|Lost to Follow-up|29
1289252|NCT00327015|4205882|P2|Overall Study|Lost to Follow-up|23
1289253|NCT00327015|4205883|P1|Overall Study|Lost to Follow-up|22
1289254|NCT00327015|4205880|P4|Overall Study|Withdrawal of Consent by Subject|25
1289255|NCT00327015|4205881|P3|Overall Study|Withdrawal of Consent by Subject|28
1289256|NCT00327015|4205882|P2|Overall Study|Withdrawal of Consent by Subject|24
1289257|NCT00327015|4205883|P1|Overall Study|Withdrawal of Consent by Subject|20
1289258|NCT00327015|4205880|P4|Overall Study|Lack of Efficacy|29
1289259|NCT00327015|4205881|P3|Overall Study|Lack of Efficacy|35
1289260|NCT00327015|4205882|P2|Overall Study|Lack of Efficacy|18
1289261|NCT00327015|4205883|P1|Overall Study|Lack of Efficacy|18
1289262|NCT00326963|4205925|P1|Overall Study|Administrative / other|1
1289263|NCT00326963|4205925|P1|Overall Study|Other protocol violation|1
1289264|NCT00326963|4205925|P1|Overall Study|Violation of selection criteria at entry|2
1289265|NCT00326963|4205925|P1|Overall Study|Refused treatment / did not cooperate|5
1289266|NCT00326963|4205925|P1|Overall Study|Withdrawal by Subject|10
1289267|NCT00326963|4205925|P1|Overall Study|Failure to return|10
1289268|NCT00326963|4205925|P1|Overall Study|Death|1
1289269|NCT00326963|4205925|P1|Overall Study|Injection site reaction|1
1289270|NCT00326963|4205925|P1|Overall Study|Adverse Event|2
1289271|NCT00326950|4205945|P1|Overall Study|Progressive Disease|1
1289272|NCT00326911|4205967|P2|Overall Study|Withdrawal by subject prior to treatment|1
1289273|NCT00326911|4205968|P1|Overall Study|Withdrawal by subject prior to treatment|0
1289274|NCT00326911|4205967|P2|Overall Study|Physician decision prior to treatment|0
1289275|NCT00326911|4205968|P1|Overall Study|Physician decision prior to treatment|1
1289276|NCT00326911|4205967|P2|Overall Study|Hospitalization prior to treatment|1
1289277|NCT00326911|4205968|P1|Overall Study|Hospitalization prior to treatment|0
1289278|NCT00326898|4206021|P3|Overall Study|Other/Missing/Unknown|32
1289279|NCT00326898|4206022|P2|Overall Study|Other/Missing/Unknown|28
1289280|NCT00326898|4206023|P1|Overall Study|Other/Missing/Unknown|33
1289281|NCT00326898|4206021|P3|Overall Study|Other complicating disease|4
1289282|NCT00326898|4206022|P2|Overall Study|Other complicating disease|5
1289283|NCT00326898|4206023|P1|Overall Study|Other complicating disease|5
1289284|NCT00326898|4206021|P3|Overall Study|Alternative therapy|0
1289285|NCT00326898|4206022|P2|Overall Study|Alternative therapy|0
1289286|NCT00326898|4206023|P1|Overall Study|Alternative therapy|1
1289287|NCT00326898|4206021|P3|Overall Study|Withdrawal by Subject|32
1289288|NCT00326898|4206022|P2|Overall Study|Withdrawal by Subject|128
1289289|NCT00326898|4206023|P1|Overall Study|Withdrawal by Subject|134
1289290|NCT00326898|4206021|P3|Overall Study|Death|0
1289291|NCT00326898|4206022|P2|Overall Study|Death|0
1289292|NCT00326898|4206023|P1|Overall Study|Death|2
1289293|NCT00326898|4206021|P3|Overall Study|Adverse Event|33
1289294|NCT00326898|4206022|P2|Overall Study|Adverse Event|128
1289295|NCT00326898|4206023|P1|Overall Study|Adverse Event|124
1289296|NCT00326898|4206021|P3|Overall Study|Disease progression|102
1289297|NCT00326898|4206022|P2|Overall Study|Disease progression|54
1289298|NCT00326898|4206023|P1|Overall Study|Disease progression|52
1289299|NCT00326885|4206040|P1|Overall Study|Hospice withdrew consent|2
1289300|NCT00326885|4206040|P1|Overall Study|Physician Decision|1
1289301|NCT00326885|4206040|P1|Overall Study|Withdrawal by Subject|3
1289302|NCT00326885|4206040|P1|Overall Study|Adverse Event|1
1289303|NCT00326716|4206071|P4|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
1289304|NCT00326716|4206072|P3|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
1289305|NCT00326716|4206073|P2|Pre-Natal Mothers|Discontinued ATV Before Delivery|2
1289306|NCT00326716|4206074|P1|Pre-Natal Mothers|Discontinued ATV Before Delivery|1
1289307|NCT00326612|4206146|P2|Overall Study|They did not have a seizure requiring tx|137
1289308|NCT00326612|4206147|P1|Overall Study|They did not have a seizure requiring tx|129
1289309|NCT00326599|4206169|P4|Overall Study|Other Unspecified Reason|1
1289310|NCT00326599|4206170|P3|Overall Study|Other Unspecified Reason|2
1289311|NCT00326599|4206171|P2|Overall Study|Other Unspecified Reason|0
1289312|NCT00326599|4206172|P1|Overall Study|Other Unspecified Reason|0
1289313|NCT00326599|4206169|P4|Overall Study|Death|2
1289314|NCT00326599|4206170|P3|Overall Study|Death|1
1289315|NCT00326599|4206171|P2|Overall Study|Death|0
1289316|NCT00326599|4206172|P1|Overall Study|Death|0
1289317|NCT00326599|4206169|P4|Overall Study|Alternate Treatment|0
1289318|NCT00326599|4206170|P3|Overall Study|Alternate Treatment|0
1289319|NCT00326599|4206171|P2|Overall Study|Alternate Treatment|0
1289320|NCT00326599|4206172|P1|Overall Study|Alternate Treatment|1
1289321|NCT00326599|4206169|P4|Overall Study|Disease Progression|11
1289322|NCT00326599|4206170|P3|Overall Study|Disease Progression|13
1289323|NCT00326599|4206171|P2|Overall Study|Disease Progression|1
1289324|NCT00326599|4206172|P1|Overall Study|Disease Progression|3
1289325|NCT00326599|4206169|P4|Overall Study|Adverse Event|3
1289326|NCT00326599|4206170|P3|Overall Study|Adverse Event|32
1289327|NCT00326599|4206171|P2|Overall Study|Adverse Event|0
1289328|NCT00326599|4206172|P1|Overall Study|Adverse Event|1
1289329|NCT00326599|4206169|P4|Overall Study|Withdrawal by Subject|2
1289330|NCT00326599|4206170|P3|Overall Study|Withdrawal by Subject|5
1289331|NCT00326599|4206171|P2|Overall Study|Withdrawal by Subject|0
1289332|NCT00326599|4206172|P1|Overall Study|Withdrawal by Subject|1
1289333|NCT00326495|4206191|P1|Overall Study|Subject off study before assessment|1
1289334|NCT00326495|4206191|P1|Overall Study|Refused further treatment|2
1289335|NCT00326495|4206191|P1|Overall Study|Disease progression before treatment|1
1289336|NCT00326495|4206191|P1|Overall Study|Switched to alternative treatment|1
1289337|NCT00326417|4206198|P4|Overall Study|Death|0
1289338|NCT00326417|4206199|P3|Overall Study|Death|0
1289339|NCT00326417|4206200|P2|Overall Study|Death|0
1289340|NCT00326417|4206201|P1|Overall Study|Death|7
1289341|NCT00326417|4206198|P4|Overall Study|Arm Closed|3
1289342|NCT00326417|4206199|P3|Overall Study|Arm Closed|0
1289343|NCT00326417|4206200|P2|Overall Study|Arm Closed|0
1289344|NCT00326417|4206201|P1|Overall Study|Arm Closed|7
1289345|NCT00326417|4206198|P4|Overall Study|Withdrawal by Subject|0
1289346|NCT00326417|4206199|P3|Overall Study|Withdrawal by Subject|1
1289347|NCT00326417|4206200|P2|Overall Study|Withdrawal by Subject|0
1289348|NCT00326417|4206201|P1|Overall Study|Withdrawal by Subject|0
1289349|NCT00326183|4206228|P2|Overall Study|Adverse Event|0
1289350|NCT00326183|4206229|P1|Overall Study|Adverse Event|1
1289351|NCT00326183|4206228|P2|Overall Study|Other|13
1289352|NCT00326183|4206229|P1|Overall Study|Other|47
1289353|NCT00326183|4206228|P2|Overall Study|Subject Moved|4
1289354|NCT00326183|4206229|P1|Overall Study|Subject Moved|7
1289355|NCT00326183|4206228|P2|Overall Study|Withdrawal by Subject|7
1289356|NCT00326183|4206229|P1|Overall Study|Withdrawal by Subject|35
1289357|NCT00326183|4206228|P2|Overall Study|Protocol Violation|3
1289358|NCT00326183|4206229|P1|Overall Study|Protocol Violation|6
1289359|NCT00326183|4206228|P2|Overall Study|Lost to Follow-up|56
1289360|NCT00326183|4206229|P1|Overall Study|Lost to Follow-up|104
1289361|NCT00326118|4206261|P2|Active Phase|Withdrawal by Subject|1
1289362|NCT00326118|4206262|P1|Active Phase|Withdrawal by Subject|4
1289363|NCT00326001|4206298|P2|Overall Study|Physician Decision|3
1289364|NCT00326001|4206299|P1|Overall Study|Physician Decision|3
1289365|NCT00326001|4206298|P2|Overall Study|Adverse Event|5
1289366|NCT00326001|4206299|P1|Overall Study|Adverse Event|4
1289367|NCT00325897|4206313|P2|Overall Study|Lost to Follow-up|13
1289368|NCT00325897|4206314|P1|Overall Study|Lost to Follow-up|12
1289369|NCT00325819|4206334|P2|Overall Study|Lost to Follow-up|3
1289370|NCT00325819|4206335|P1|Overall Study|Lost to Follow-up|3
1289371|NCT00325819|4206334|P2|Overall Study|Did not take a dose of study product|9
1289372|NCT00325819|4206335|P1|Overall Study|Did not take a dose of study product|4
1289373|NCT00325819|4206334|P2|Overall Study|Study product lost in mail|1
1289374|NCT00325819|4206335|P1|Overall Study|Study product lost in mail|2
1289375|NCT00325754|4206362|P2|Overall Study|Adverse Event|1
1289376|NCT00325754|4206363|P1|Overall Study|Adverse Event|4
1289377|NCT00325468|4206409|P5|Overall Study|site closure etc|1
1289378|NCT00325468|4206410|P4|Overall Study|site closure etc|8
1289379|NCT00325468|4206411|P3|Overall Study|site closure etc|1
1289380|NCT00325468|4206412|P2|Overall Study|site closure etc|2
1289381|NCT00325468|4206413|P1|Overall Study|site closure etc|4
1289382|NCT00325468|4206409|P5|Overall Study|Withdrawal by Subject|4
1289383|NCT00325468|4206410|P4|Overall Study|Withdrawal by Subject|14
1289384|NCT00325468|4206411|P3|Overall Study|Withdrawal by Subject|0
1289385|NCT00325468|4206412|P2|Overall Study|Withdrawal by Subject|1
1289386|NCT00325468|4206413|P1|Overall Study|Withdrawal by Subject|3
1289387|NCT00325468|4206409|P5|Overall Study|Physician Decision|0
1289388|NCT00325468|4206410|P4|Overall Study|Physician Decision|1
1289389|NCT00325468|4206411|P3|Overall Study|Physician Decision|0
1289390|NCT00325468|4206412|P2|Overall Study|Physician Decision|1
1289391|NCT00325468|4206413|P1|Overall Study|Physician Decision|1
1289392|NCT00325468|4206409|P5|Overall Study|Lost to Follow-up|2
1289393|NCT00325468|4206410|P4|Overall Study|Lost to Follow-up|2
1289394|NCT00325468|4206411|P3|Overall Study|Lost to Follow-up|1
1289395|NCT00325468|4206412|P2|Overall Study|Lost to Follow-up|0
1289396|NCT00325468|4206413|P1|Overall Study|Lost to Follow-up|0
1289397|NCT00325468|4206409|P5|Overall Study|Death|0
1289398|NCT00325468|4206410|P4|Overall Study|Death|4
1289399|NCT00325468|4206411|P3|Overall Study|Death|2
1289400|NCT00325468|4206412|P2|Overall Study|Death|0
1289401|NCT00325468|4206413|P1|Overall Study|Death|2
1289402|NCT00325468|4206409|P5|Overall Study|Adverse Event|1
1289403|NCT00325468|4206410|P4|Overall Study|Adverse Event|5
1289404|NCT00325468|4206411|P3|Overall Study|Adverse Event|0
1289405|NCT00325468|4206412|P2|Overall Study|Adverse Event|1
1289406|NCT00325468|4206413|P1|Overall Study|Adverse Event|1
1289407|NCT00325416|4206496|P2|Phase II: Treatment at MTD|Withdrawal by Subject|1
1289408|NCT00325416|4206497|P1|Phase II: Treatment at MTD|Withdrawal by Subject|0
1289409|NCT00325416|4206496|P2|Phase II: Treatment at MTD|denial of insurance coverage|1
1289410|NCT00325416|4206497|P1|Phase II: Treatment at MTD|denial of insurance coverage|0
1289411|NCT00325416|4206496|P2|Phase I: Dose Escalation|Inability to collect adequate stem cells|1
1289412|NCT00325416|4206497|P1|Phase I: Dose Escalation|Inability to collect adequate stem cells|0
1289413|NCT00325416|4206496|P2|Phase I: Dose Escalation|Withdrawal by Subject|2
1289414|NCT00325416|4206497|P1|Phase I: Dose Escalation|Withdrawal by Subject|7
1289415|NCT00325416|4206496|P2|Phase I: Dose Escalation|Denial of insurance coverage|4
1289416|NCT00325416|4206497|P1|Phase I: Dose Escalation|Denial of insurance coverage|7
1289417|NCT00325416|4206496|P2|Phase I: Dose Escalation|Pre-transplant screen failure|9
1289418|NCT00325416|4206497|P1|Phase I: Dose Escalation|Pre-transplant screen failure|8
1289419|NCT00325234|4206550|P2|Overall Study|Progressive Disease|37
1289420|NCT00325234|4206551|P1|Overall Study|Progressive Disease|34
1289421|NCT00325234|4206550|P2|Overall Study|Physician Decision|12
1289422|NCT00325234|4206551|P1|Overall Study|Physician Decision|17
1289423|NCT00325234|4206550|P2|Overall Study|Subject Decision|8
1289424|NCT00325234|4206551|P1|Overall Study|Subject Decision|6
1289425|NCT00325234|4206550|P2|Overall Study|Entry Criteria Not Met|2
1289426|NCT00325234|4206551|P1|Overall Study|Entry Criteria Not Met|1
1289427|NCT00325234|4206550|P2|Overall Study|Death due to Study Disease|0
1289428|NCT00325234|4206551|P1|Overall Study|Death due to Study Disease|1
1289429|NCT00325234|4206550|P2|Overall Study|Adverse Event|7
1289430|NCT00325234|4206551|P1|Overall Study|Adverse Event|10
1289431|NCT00325195|4206570|P3|Received Intervention: ITT Population|Protocol violation/non-compliance|0
1289432|NCT00325195|4206571|P2|Received Intervention: ITT Population|Protocol violation/non-compliance|1
1289433|NCT00325195|4206572|P1|Received Intervention: ITT Population|Protocol violation/non-compliance|1
1289434|NCT00325195|4206570|P3|Received Intervention: ITT Population|Lost to Follow-up|2
1289435|NCT00325195|4206571|P2|Received Intervention: ITT Population|Lost to Follow-up|0
1289436|NCT00325195|4206572|P1|Received Intervention: ITT Population|Lost to Follow-up|0
1289437|NCT00325195|4206570|P3|Received Intervention: ITT Population|Withdrawal by Subject|1
1289438|NCT00325195|4206571|P2|Received Intervention: ITT Population|Withdrawal by Subject|6
1289439|NCT00325195|4206572|P1|Received Intervention: ITT Population|Withdrawal by Subject|7
1289440|NCT00325195|4206570|P3|Received Intervention: ITT Population|Death|0
1289441|NCT00325195|4206571|P2|Received Intervention: ITT Population|Death|1
1289442|NCT00325195|4206572|P1|Received Intervention: ITT Population|Death|3
1289443|NCT00325195|4206570|P3|Received Intervention: ITT Population|Adverse Event|1
1289444|NCT00325195|4206571|P2|Received Intervention: ITT Population|Adverse Event|17
1289445|NCT00325195|4206572|P1|Received Intervention: ITT Population|Adverse Event|15
1289446|NCT00325195|4206570|P3|Randomized|Not dosed|3
1289447|NCT00325195|4206571|P2|Randomized|Not dosed|5
1289448|NCT00325195|4206572|P1|Randomized|Not dosed|5
1289449|NCT00325156|4206595|P1|Overall Study|Withdrawal by Subject|31
1289450|NCT00325156|4206595|P1|Overall Study|Other|1
1289451|NCT00325156|4206595|P1|Overall Study|Lost to follow-up (incompl. vaccination)|16
1289452|NCT00325156|4206595|P1|Overall Study|Adverse event, non-fatal|3
1289453|NCT00325156|4206595|P1|Overall Study|Migrated/moved from study area|12
1289454|NCT00325156|4206595|P1|Overall Study|Lost to follow-up (complete vaccination)|41
1289455|NCT00325156|4206595|P1|Overall Study|Protocol Violation|8
1289456|NCT00325143|4206602|P1|Overall Study|Withdrawal by Subject|8
1289457|NCT00325143|4206602|P1|Overall Study|Lost to follow-up(incompl. vacc. course)|4
1289458|NCT00325143|4206602|P1|Overall Study|Migrated/moved from study area|1
1289459|NCT00325143|4206602|P1|Overall Study|Lost to follow-up(complete vacc. course)|13
1289460|NCT00325130|4206612|P2|Overall Study|Patient Discontinued for Other|0
1289461|NCT00325130|4206613|P1|Overall Study|Patient Discontinued for Other|1
1289462|NCT00325130|4206612|P2|Overall Study|Moved|1
1289463|NCT00325130|4206613|P1|Overall Study|Moved|0
1289464|NCT00325130|4206612|P2|Overall Study|Protocol Deviation|1
1289465|NCT00325130|4206613|P1|Overall Study|Protocol Deviation|0
1289466|NCT00325130|4206612|P2|Overall Study|Withdrawal by Subject|14
1289467|NCT00325130|4206613|P1|Overall Study|Withdrawal by Subject|12
1289468|NCT00325130|4206612|P2|Overall Study|Lost to Follow-up|14
1289469|NCT00325130|4206613|P1|Overall Study|Lost to Follow-up|6
1289470|NCT00325039|4206670|P2|Overall Study|Lost to Follow-up|14
1289471|NCT00325039|4206671|P1|Overall Study|Lost to Follow-up|18
1289472|NCT00324987|4206687|P2|Overall Study|symptomatic deterioration, toxicity, etc|3
1289473|NCT00324987|4206688|P1|Overall Study|symptomatic deterioration, toxicity, etc|2
1289474|NCT00324987|4206687|P2|Overall Study|Progression|1
1289475|NCT00324987|4206688|P1|Overall Study|Progression|1
1289476|NCT00324987|4206687|P2|Overall Study|Withdrawal by Subject|1
1289477|NCT00324987|4206688|P1|Overall Study|Withdrawal by Subject|1
1289478|NCT00324987|4206687|P2|Overall Study|Adverse Event|1
1289479|NCT00324987|4206688|P1|Overall Study|Adverse Event|2
1289480|NCT00324961|4206702|P1|Overall Study|Other|2
1289481|NCT00324961|4206702|P1|Overall Study|Protocol Violation|3
1289482|NCT00324961|4206702|P1|Overall Study|Lost to Follow-up|22
1289483|NCT00324961|4206702|P1|Overall Study|Consent Withdrawn|11
1289484|NCT00324961|4206702|P1|Overall Study|Adverse Event|5
1289485|NCT00324805|4206753|P2|Overall Study|Did not start therapy|17
1289486|NCT00324805|4206754|P1|Overall Study|Did not start therapy|12
1289487|NCT00324805|4206753|P2|Overall Study|Other|2
1289488|NCT00324805|4206754|P1|Overall Study|Other|0
1289489|NCT00324805|4206753|P2|Overall Study|Other reasons|26
1289490|NCT00324805|4206754|P1|Overall Study|Other reasons|7
1289491|NCT00324805|4206753|P2|Overall Study|Other complicating disease|9
1289492|NCT00324805|4206754|P1|Overall Study|Other complicating disease|1
1289493|NCT00324805|4206753|P2|Overall Study|Alternative therapy|8
1289494|NCT00324805|4206754|P1|Overall Study|Alternative therapy|4
1289495|NCT00324805|4206753|P2|Overall Study|Death|9
1289496|NCT00324805|4206754|P1|Overall Study|Death|6
1289497|NCT00324805|4206753|P2|Overall Study|Withdrawal by Subject|174
1289498|NCT00324805|4206754|P1|Overall Study|Withdrawal by Subject|51
1289499|NCT00324805|4206753|P2|Overall Study|Progression|35
1289500|NCT00324805|4206754|P1|Overall Study|Progression|7
1289501|NCT00324805|4206753|P2|Overall Study|Adverse Event|203
1289502|NCT00324805|4206754|P1|Overall Study|Adverse Event|62
1289503|NCT00324740|4206779|P3|Overall Study|Withdrawal by Subject|1
1289504|NCT00324740|4206780|P2|Overall Study|Withdrawal by Subject|0
1289505|NCT00324740|4206781|P1|Overall Study|Withdrawal by Subject|1
1289506|NCT00324675|4206801|P2|Overall Study|Adverse Event|0
1289507|NCT00324675|4206802|P1|Overall Study|Adverse Event|1
1289508|NCT00324649|4206810|P2|Overall Study|Noncompliance|0
1289509|NCT00324649|4206811|P1|Overall Study|Noncompliance|1
1289510|NCT00324649|4206810|P2|Overall Study|Withdrawal by Subject|1
1289511|NCT00324649|4206811|P1|Overall Study|Withdrawal by Subject|0
1289512|NCT00324649|4206810|P2|Overall Study|Adverse Event|4
1289513|NCT00324649|4206811|P1|Overall Study|Adverse Event|1
1289514|NCT00324233|4206942|P2|Second Period|Protocol Violation|6
1289515|NCT00324233|4206943|P1|Second Period|Protocol Violation|4
1289516|NCT00324233|4206942|P2|Second Period|unable to insert catheter|1
1289517|NCT00324233|4206943|P1|Second Period|unable to insert catheter|1
1289518|NCT00324233|4206942|P2|First Period|unable to insert catheter|0
1289519|NCT00324233|4206943|P1|First Period|unable to insert catheter|1
1289520|NCT00324168|4206951|P2|Overall Study|Patient did not visit in f/u window|9
1289521|NCT00324168|4206952|P1|Overall Study|Patient did not visit in f/u window|6
1289522|NCT00324168|4206951|P2|Overall Study|Death|3
1289523|NCT00324168|4206952|P1|Overall Study|Death|3
1289524|NCT00324168|4206951|P2|Overall Study|Lost to Follow-up|18
1289525|NCT00324168|4206952|P1|Overall Study|Lost to Follow-up|19
1289526|NCT00324155|4206980|P2|Follow-up Phase|On-going participants still on drug|6
1289527|NCT00324155|4206981|P1|Follow-up Phase|On-going participants still on drug|11
1289528|NCT00324155|4206980|P2|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0
1289529|NCT00324155|4206981|P1|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1
1289530|NCT00324155|4206980|P2|Received Treatment in Maintenance Phase|Adverse Event|3
1289531|NCT00324155|4206981|P1|Received Treatment in Maintenance Phase|Adverse Event|0
1289532|NCT00324155|4206980|P2|Received Treatment in Maintenance Phase|Withdrawal by Subject|3
1289868|NCT00321984|4208017|P1|Overall Study|Noncompliant|0
1289533|NCT00324155|4206981|P1|Received Treatment in Maintenance Phase|Withdrawal by Subject|1
1289534|NCT00324155|4206980|P2|Received Treatment in Maintenance Phase|Study Drug Toxicity|0
1289535|NCT00324155|4206981|P1|Received Treatment in Maintenance Phase|Study Drug Toxicity|4
1289536|NCT00324155|4206980|P2|Received Treatment in Maintenance Phase|Disease Progression|41
1289537|NCT00324155|4206981|P1|Received Treatment in Maintenance Phase|Disease Progression|26
1289538|NCT00324155|4206980|P2|Received Treatment in Induction Phase|Physician Decision|0
1289539|NCT00324155|4206981|P1|Received Treatment in Induction Phase|Physician Decision|2
1289540|NCT00324155|4206980|P2|Received Treatment in Induction Phase|Withdrawal by Subject|5
1289541|NCT00324155|4206981|P1|Received Treatment in Induction Phase|Withdrawal by Subject|6
1289542|NCT00324155|4206980|P2|Received Treatment in Induction Phase|Adverse Event|7
1289543|NCT00324155|4206981|P1|Received Treatment in Induction Phase|Adverse Event|6
1289544|NCT00324155|4206980|P2|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8
1289545|NCT00324155|4206981|P1|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9
1289546|NCT00324155|4206980|P2|Received Treatment in Induction Phase|Death|15
1289547|NCT00324155|4206981|P1|Received Treatment in Induction Phase|Death|8
1289548|NCT00324155|4206980|P2|Received Treatment in Induction Phase|Study Drug Toxicity|10
1289549|NCT00324155|4206981|P1|Received Treatment in Induction Phase|Study Drug Toxicity|83
1289550|NCT00324155|4206980|P2|Received Treatment in Induction Phase|Disease Progression|152
1289551|NCT00324155|4206981|P1|Received Treatment in Induction Phase|Disease Progression|88
1289552|NCT00324155|4206980|P2|Enrolled and Randomized|Lost to Follow-up|1
1289553|NCT00324155|4206981|P1|Enrolled and Randomized|Lost to Follow-up|0
1289554|NCT00324155|4206980|P2|Enrolled and Randomized|No longer met study criteria|0
1289555|NCT00324155|4206981|P1|Enrolled and Randomized|No longer met study criteria|3
1289556|NCT00324116|4207011|P1|Overall Study|Other|5
1289557|NCT00324116|4207011|P1|Overall Study|Withdrawal by Subject|5
1289558|NCT00324116|4207011|P1|Overall Study|Lack of Efficacy|17
1289559|NCT00324116|4207011|P1|Overall Study|Adverse Event|5
1289560|NCT00324038|4207023|P2|Overall Study|Other|13
1289561|NCT00324038|4207024|P1|Overall Study|Other|6
1289562|NCT00324038|4207023|P2|Overall Study|Lost to Follow-up|2
1289563|NCT00324038|4207024|P1|Overall Study|Lost to Follow-up|0
1289564|NCT00324038|4207023|P2|Overall Study|Lack of Efficacy|13
1289565|NCT00324038|4207024|P1|Overall Study|Lack of Efficacy|5
1289566|NCT00324038|4207023|P2|Overall Study|Adverse Event|23
1289567|NCT00324038|4207024|P1|Overall Study|Adverse Event|38
1289568|NCT00323882|4207035|P5|Overall Study|Not Specified|1
1289569|NCT00323882|4207036|P4|Overall Study|Not Specified|1
1289570|NCT00323882|4207037|P3|Overall Study|Not Specified|0
1289571|NCT00323882|4207038|P2|Overall Study|Not Specified|0
1289572|NCT00323882|4207039|P1|Overall Study|Not Specified|0
1289573|NCT00323882|4207035|P5|Overall Study|Lost to Follow-up|1
1289574|NCT00323882|4207036|P4|Overall Study|Lost to Follow-up|0
1289575|NCT00323882|4207037|P3|Overall Study|Lost to Follow-up|1
1289576|NCT00323882|4207038|P2|Overall Study|Lost to Follow-up|0
1289577|NCT00323882|4207039|P1|Overall Study|Lost to Follow-up|0
1289578|NCT00323882|4207035|P5|Overall Study|Death|5
1289579|NCT00323882|4207036|P4|Overall Study|Death|0
1289580|NCT00323882|4207037|P3|Overall Study|Death|1
1289581|NCT00323882|4207038|P2|Overall Study|Death|1
1289582|NCT00323882|4207039|P1|Overall Study|Death|0
1289583|NCT00323882|4207035|P5|Overall Study|Disease Progression|22
1289584|NCT00323882|4207036|P4|Overall Study|Disease Progression|5
1289585|NCT00323882|4207037|P3|Overall Study|Disease Progression|10
1289586|NCT00323882|4207038|P2|Overall Study|Disease Progression|4
1289587|NCT00323882|4207039|P1|Overall Study|Disease Progression|6
1289588|NCT00323882|4207035|P5|Overall Study|Adverse Event|3
1289589|NCT00323882|4207036|P4|Overall Study|Adverse Event|1
1289590|NCT00323882|4207037|P3|Overall Study|Adverse Event|1
1289591|NCT00323882|4207038|P2|Overall Study|Adverse Event|1
1289592|NCT00323882|4207039|P1|Overall Study|Adverse Event|2
1289593|NCT00323869|4207110|P1|Overall Study|Death|1
1289594|NCT00323622|4207166|P8|Overall Study|Death|2
1289595|NCT00323622|4207167|P7|Overall Study|Death|0
1289596|NCT00323622|4207168|P6|Overall Study|Death|0
1289597|NCT00323622|4207169|P5|Overall Study|Death|7
1289598|NCT00323622|4207170|P4|Overall Study|Death|0
1289599|NCT00323622|4207171|P3|Overall Study|Death|0
1289600|NCT00323622|4207172|P2|Overall Study|Death|1
1289601|NCT00323622|4207173|P1|Overall Study|Death|1
1289602|NCT00323622|4207166|P8|Overall Study|Other|13
1289603|NCT00323622|4207167|P7|Overall Study|Other|5
1289604|NCT00323622|4207168|P6|Overall Study|Other|74
1289605|NCT00323622|4207169|P5|Overall Study|Other|32
1289606|NCT00323622|4207170|P4|Overall Study|Other|12
1289607|NCT00323622|4207171|P3|Overall Study|Other|4
1289608|NCT00323622|4207172|P2|Overall Study|Other|91
1289609|NCT00323622|4207173|P1|Overall Study|Other|30
1289610|NCT00323609|4207215|P4|Overall Study|Other reason|9
1289611|NCT00323609|4207216|P3|Overall Study|Other reason|4
1289612|NCT00323609|4207217|P2|Overall Study|Other reason|8
1289613|NCT00323609|4207218|P1|Overall Study|Other reason|11
1289614|NCT00323609|4207215|P4|Overall Study|Logistical withdrawal|1
1289615|NCT00323609|4207216|P3|Overall Study|Logistical withdrawal|0
1289616|NCT00323609|4207217|P2|Overall Study|Logistical withdrawal|5
1289617|NCT00323609|4207218|P1|Overall Study|Logistical withdrawal|9
1289618|NCT00323609|4207215|P4|Overall Study|Unrelenting or severe back pain|0
1289619|NCT00323609|4207216|P3|Overall Study|Unrelenting or severe back pain|0
1289620|NCT00323609|4207217|P2|Overall Study|Unrelenting or severe back pain|1
1289621|NCT00323609|4207218|P1|Overall Study|Unrelenting or severe back pain|1
1289622|NCT00323609|4207215|P4|Overall Study|Sponsor discontinued trial|0
1289623|NCT00323609|4207216|P3|Overall Study|Sponsor discontinued trial|0
1289624|NCT00323609|4207217|P2|Overall Study|Sponsor discontinued trial|29
1289625|NCT00323609|4207218|P1|Overall Study|Sponsor discontinued trial|29
1289626|NCT00323609|4207215|P4|Overall Study|Other non-VCF-related medical condition|0
1289627|NCT00323609|4207216|P3|Overall Study|Other non-VCF-related medical condition|0
1289628|NCT00323609|4207217|P2|Overall Study|Other non-VCF-related medical condition|2
1289629|NCT00323609|4207218|P1|Overall Study|Other non-VCF-related medical condition|3
1289630|NCT00323609|4207215|P4|Overall Study|Withdrawal by Subject|4
1289631|NCT00323609|4207216|P3|Overall Study|Withdrawal by Subject|4
1289632|NCT00323609|4207217|P2|Overall Study|Withdrawal by Subject|23
1289633|NCT00323609|4207218|P1|Overall Study|Withdrawal by Subject|11
1289634|NCT00323609|4207215|P4|Overall Study|Physician Decision|1
1289635|NCT00323609|4207216|P3|Overall Study|Physician Decision|0
1289636|NCT00323609|4207217|P2|Overall Study|Physician Decision|0
1289637|NCT00323609|4207218|P1|Overall Study|Physician Decision|2
1289638|NCT00323609|4207215|P4|Overall Study|Lost to Follow-up|0
1289639|NCT00323609|4207216|P3|Overall Study|Lost to Follow-up|0
1289640|NCT00323609|4207217|P2|Overall Study|Lost to Follow-up|10
1289641|NCT00323609|4207218|P1|Overall Study|Lost to Follow-up|9
1289642|NCT00323609|4207215|P4|Overall Study|Death|0
1289643|NCT00323609|4207216|P3|Overall Study|Death|0
1289644|NCT00323609|4207217|P2|Overall Study|Death|21
1289645|NCT00323609|4207218|P1|Overall Study|Death|16
1289646|NCT00323557|4207254|P2|Overall Study|Physician Decision|0
1289647|NCT00323557|4207255|P1|Overall Study|Physician Decision|1
1289648|NCT00323492|4207264|P3|Study Phase 2|Protocol Violation|0
1289649|NCT00323492|4207265|P2|Study Phase 2|Protocol Violation|0
1289650|NCT00323492|4207266|P1|Study Phase 2|Protocol Violation|1
1289651|NCT00323492|4207264|P3|Study Phase 2|Noncompliance with study schedule|1
1289652|NCT00323492|4207265|P2|Study Phase 2|Noncompliance with study schedule|0
1289653|NCT00323492|4207266|P1|Study Phase 2|Noncompliance with study schedule|0
1289654|NCT00323492|4207264|P3|Study Phase 2|Withdrawal by Subject|0
1289655|NCT00323492|4207265|P2|Study Phase 2|Withdrawal by Subject|1
1289656|NCT00323492|4207266|P1|Study Phase 2|Withdrawal by Subject|0
1289657|NCT00323492|4207264|P3|Study Phase 2|Lost to Follow-up|0
1289658|NCT00323492|4207265|P2|Study Phase 2|Lost to Follow-up|0
1289659|NCT00323492|4207266|P1|Study Phase 2|Lost to Follow-up|1
1289660|NCT00323492|4207264|P3|Study Phase 2|Physician Decision|0
1289661|NCT00323492|4207265|P2|Study Phase 2|Physician Decision|0
1289662|NCT00323492|4207266|P1|Study Phase 2|Physician Decision|1
1289663|NCT00323492|4207264|P3|Study Phase 2|Adverse Event|0
1289664|NCT00323492|4207265|P2|Study Phase 2|Adverse Event|0
1289665|NCT00323492|4207266|P1|Study Phase 2|Adverse Event|1
1289666|NCT00323492|4207264|P3|Study Phase 1|Adverse Event|0
1289667|NCT00323492|4207265|P2|Study Phase 1|Adverse Event|0
1289668|NCT00323492|4207266|P1|Study Phase 1|Adverse Event|2
1289669|NCT00323479|4207297|P1|Overall Study|house moving|1
1289670|NCT00323479|4207297|P1|Overall Study|Protocol Violation|3
1289671|NCT00323479|4207297|P1|Overall Study|Withdrawal by Subject|2
1289672|NCT00323479|4207297|P1|Overall Study|Adverse Event|2
1289673|NCT00323414|4207330|P2|Overall Study|Withdrawal by Subject|1
1289674|NCT00323414|4207331|P1|Overall Study|Withdrawal by Subject|0
1289675|NCT00323310|4207353|P1|Overall Study|did not complete the 24-hr f-up visit|1
1289676|NCT00323310|4207353|P1|Overall Study|a parent refused blood draw|1
1289677|NCT00323310|4207353|P1|Overall Study|Withdrawal by Subject|1
1289678|NCT00323297|4207368|P2|Part B (Open-label)|Protocol Violation|1
1289679|NCT00323297|4207369|P1|Part B (Open-label)|Protocol Violation|0
1289680|NCT00323297|4207368|P2|Part B (Open-label)|Adverse Event|5
1289681|NCT00323297|4207369|P1|Part B (Open-label)|Adverse Event|5
1289682|NCT00323297|4207368|P2|Part B (Open-label)|Lack of Efficacy|1
1289683|NCT00323297|4207369|P1|Part B (Open-label)|Lack of Efficacy|3
1289684|NCT00323297|4207368|P2|Part B (Open-label)|Withdrawal by Subject|3
1289685|NCT00323297|4207369|P1|Part B (Open-label)|Withdrawal by Subject|1
1289686|NCT00323297|4207368|P2|Part B (Open-label)|Reason unspecified|1
1289687|NCT00323297|4207369|P1|Part B (Open-label)|Reason unspecified|0
1289688|NCT00323297|4207368|P2|Part B (Open-label)|Death|1
1289689|NCT00323297|4207369|P1|Part B (Open-label)|Death|0
1289690|NCT00323297|4207368|P2|Part A (Double Blind Randomized)|Related adverse event|2
1289691|NCT00323297|4207369|P1|Part A (Double Blind Randomized)|Related adverse event|2
1289692|NCT00323297|4207368|P2|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0
1289693|NCT00323297|4207369|P1|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1
1289694|NCT00323297|4207368|P2|Part A (Double Blind Randomized)|Unrelated adverse event|0
1289695|NCT00323297|4207369|P1|Part A (Double Blind Randomized)|Unrelated adverse event|1
1289696|NCT00323297|4207368|P2|Part A (Double Blind Randomized)|Protocol Violation|3
1289697|NCT00323297|4207369|P1|Part A (Double Blind Randomized)|Protocol Violation|1
1289698|NCT00323297|4207368|P2|Part A (Double Blind Randomized)|Death|1
1289699|NCT00323297|4207369|P1|Part A (Double Blind Randomized)|Death|0
1289700|NCT00323297|4207368|P2|Part A (Double Blind Randomized)|Reason unspecified|1
1289701|NCT00323297|4207369|P1|Part A (Double Blind Randomized)|Reason unspecified|0
1289702|NCT00323258|4207409|P2|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2
1289703|NCT00323258|4207410|P1|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1
1289869|NCT00321984|4208015|P3|Overall Study|Lack of Efficacy|3
1289704|NCT00323258|4207409|P2|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10
1289705|NCT00323258|4207410|P1|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12
1289706|NCT00323258|4207409|P2|Secondary Outcome (6 Mon Refill Records)|Death|2
1289707|NCT00323258|4207410|P1|Secondary Outcome (6 Mon Refill Records)|Death|1
1289708|NCT00323258|4207409|P2|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1
1289709|NCT00323258|4207410|P1|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2
1289710|NCT00323258|4207409|P2|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5
1289711|NCT00323258|4207410|P1|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1
1289712|NCT00323258|4207409|P2|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11
1289713|NCT00323258|4207410|P1|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12
1289714|NCT00323258|4207409|P2|Primary Outcome (Phone Call at 6 Months)|Death|2
1289715|NCT00323258|4207410|P1|Primary Outcome (Phone Call at 6 Months)|Death|1
1289716|NCT00323115|4207435|P1|Adjuvant Therapy & Survival Follow-Up|Death|8
1289717|NCT00323115|4207435|P1|Vaccine Administration|Adverse Event|1
1289718|NCT00323063|4207462|P2|Overall Study|brain mets discovered prior to treatment|0
1289719|NCT00323063|4207463|P1|Overall Study|brain mets discovered prior to treatment|1
1289720|NCT00323063|4207462|P2|Overall Study|Adverse Event|0
1289721|NCT00323063|4207463|P1|Overall Study|Adverse Event|1
1289722|NCT00322881|4207480|P1|Overall Study|Disease Progression|2
1289723|NCT00322881|4207480|P1|Overall Study|Adverse Event|1
1289724|NCT00322881|4207480|P1|Overall Study|Death|2
1289725|NCT00322868|4207484|P1|Overall Study|disease progression|1
1289726|NCT00322842|4207509|P2|Overall Study|Death|0
1289727|NCT00322842|4207510|P1|Overall Study|Death|1
1289728|NCT00322842|4207509|P2|Overall Study|Refused transplant|0
1289729|NCT00322842|4207510|P1|Overall Study|Refused transplant|1
1289730|NCT00322842|4207509|P2|Overall Study|Lost to Follow-up|1
1289731|NCT00322842|4207510|P1|Overall Study|Lost to Follow-up|0
1289732|NCT00322842|4207509|P2|Overall Study|Withdrawal by Subject|1
1289733|NCT00322842|4207510|P1|Overall Study|Withdrawal by Subject|0
1289734|NCT00322712|4207548|P1|Overall Study|treated with bevacizumab not cetuximab|1
1289735|NCT00322621|4207552|P3|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
1289736|NCT00322621|4207553|P2|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
1289737|NCT00322621|4207554|P1|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0
1289738|NCT00322621|4207552|P3|Period III - Maintenance / Rescue Phase|Death|0
1289739|NCT00322621|4207553|P2|Period III - Maintenance / Rescue Phase|Death|1
1289740|NCT00322621|4207554|P1|Period III - Maintenance / Rescue Phase|Death|0
1289741|NCT00322621|4207552|P3|Period III - Maintenance / Rescue Phase|Protocol Violation|5
1289742|NCT00322621|4207553|P2|Period III - Maintenance / Rescue Phase|Protocol Violation|2
1289743|NCT00322621|4207554|P1|Period III - Maintenance / Rescue Phase|Protocol Violation|0
1289744|NCT00322621|4207552|P3|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1
1289745|NCT00322621|4207553|P2|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7
1289746|NCT00322621|4207554|P1|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0
1289747|NCT00322621|4207552|P3|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24
1289748|NCT00322621|4207553|P2|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4
1289749|NCT00322621|4207554|P1|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0
1289750|NCT00322621|4207552|P3|Period III - Maintenance / Rescue Phase|Adverse Event|5
1289751|NCT00322621|4207553|P2|Period III - Maintenance / Rescue Phase|Adverse Event|14
1289752|NCT00322621|4207554|P1|Period III - Maintenance / Rescue Phase|Adverse Event|0
1289753|NCT00322621|4207552|P3|Period II - Acute Therapy Phase|Physician Decision|0
1289754|NCT00322621|4207553|P2|Period II - Acute Therapy Phase|Physician Decision|0
1289755|NCT00322621|4207554|P1|Period II - Acute Therapy Phase|Physician Decision|1
1289756|NCT00322621|4207552|P3|Period II - Acute Therapy Phase|Protocol Violation|0
1289757|NCT00322621|4207553|P2|Period II - Acute Therapy Phase|Protocol Violation|0
1289758|NCT00322621|4207554|P1|Period II - Acute Therapy Phase|Protocol Violation|2
1289759|NCT00322621|4207552|P3|Period II - Acute Therapy Phase|Withdrawal by Subject|0
1289760|NCT00322621|4207553|P2|Period II - Acute Therapy Phase|Withdrawal by Subject|0
1289761|NCT00322621|4207554|P1|Period II - Acute Therapy Phase|Withdrawal by Subject|8
1289762|NCT00322621|4207552|P3|Period II - Acute Therapy Phase|Lack of Efficacy|0
1289763|NCT00322621|4207553|P2|Period II - Acute Therapy Phase|Lack of Efficacy|0
1289764|NCT00322621|4207554|P1|Period II - Acute Therapy Phase|Lack of Efficacy|1
1289765|NCT00322621|4207552|P3|Period II - Acute Therapy Phase|Adverse Event|0
1289766|NCT00322621|4207553|P2|Period II - Acute Therapy Phase|Adverse Event|0
1289767|NCT00322621|4207554|P1|Period II - Acute Therapy Phase|Adverse Event|20
1289768|NCT00322556|4207606|P1|Overall Study|Other Reason|7
1289769|NCT00322556|4207606|P1|Overall Study|Lost to Follow-up|3
1289770|NCT00322556|4207606|P1|Overall Study|Withdrawal by Subject|1
1289771|NCT00322556|4207606|P1|Overall Study|Adverse Event|1
1289772|NCT00322491|4207622|P2|Overall Study|Death|2
1289773|NCT00322491|4207623|P1|Overall Study|Death|1
1289774|NCT00322491|4207622|P2|Overall Study|Adverse Event|0
1289775|NCT00322491|4207623|P1|Overall Study|Adverse Event|1
1289776|NCT00322452|4207713|P2|Overall Study|Death|227
1289777|NCT00322452|4207714|P1|Overall Study|Death|223
1289778|NCT00322452|4207713|P2|Overall Study|Withdrawal by Subject|46
1289779|NCT00322452|4207714|P1|Overall Study|Withdrawal by Subject|19
1289780|NCT00322452|4207713|P2|Overall Study|Lost to Follow-up|2
1289781|NCT00322452|4207714|P1|Overall Study|Lost to Follow-up|5
1289782|NCT00322452|4207713|P2|Overall Study|Eligibility criteria not fulfilled|1
1289783|NCT00322452|4207714|P1|Overall Study|Eligibility criteria not fulfilled|0
1289784|NCT00322387|4207765|P2|Follow-up Period|Death|0
1289785|NCT00322387|4207766|P1|Follow-up Period|Death|1
1289786|NCT00322387|4207765|P2|Follow-up Period|Final assessment not done|3
1289787|NCT00322387|4207766|P1|Follow-up Period|Final assessment not done|1
1289788|NCT00322387|4207765|P2|Treatment Period|Adverse Event|1
1289789|NCT00322387|4207766|P1|Treatment Period|Adverse Event|0
1289790|NCT00322374|4207800|P4|Second Escalation|Study Drug Toxicity|0
1289791|NCT00322374|4207801|P3|Second Escalation|Study Drug Toxicity|1
1289792|NCT00322374|4207802|P2|Second Escalation|Study Drug Toxicity|0
1289793|NCT00322374|4207803|P1|Second Escalation|Study Drug Toxicity|0
1289794|NCT00322374|4207800|P4|Second Escalation|Physician Decision|0
1289795|NCT00322374|4207801|P3|Second Escalation|Physician Decision|5
1289796|NCT00322374|4207802|P2|Second Escalation|Physician Decision|0
1289797|NCT00322374|4207803|P1|Second Escalation|Physician Decision|0
1289798|NCT00322374|4207800|P4|First Escalation|Participant Request|0
1289799|NCT00322374|4207801|P3|First Escalation|Participant Request|0
1289800|NCT00322374|4207802|P2|First Escalation|Participant Request|1
1289801|NCT00322374|4207803|P1|First Escalation|Participant Request|0
1289802|NCT00322374|4207800|P4|First Escalation|Study Drug Toxicity|0
1289803|NCT00322374|4207801|P3|First Escalation|Study Drug Toxicity|0
1289804|NCT00322374|4207802|P2|First Escalation|Study Drug Toxicity|11
1289805|NCT00322374|4207803|P1|First Escalation|Study Drug Toxicity|0
1289806|NCT00322374|4207800|P4|First Escalation|Physician Decision|0
1289807|NCT00322374|4207801|P3|First Escalation|Physician Decision|0
1289808|NCT00322374|4207802|P2|First Escalation|Physician Decision|12
1289809|NCT00322374|4207803|P1|First Escalation|Physician Decision|0
1289810|NCT00322374|4207800|P4|First Escalation|Documented Disease Progression|0
1289811|NCT00322374|4207801|P3|First Escalation|Documented Disease Progression|0
1289812|NCT00322374|4207802|P2|First Escalation|Documented Disease Progression|6
1289813|NCT00322374|4207803|P1|First Escalation|Documented Disease Progression|0
1289814|NCT00322374|4207800|P4|Starting Dose|Study Drug Toxicity|0
1289815|NCT00322374|4207801|P3|Starting Dose|Study Drug Toxicity|0
1289816|NCT00322374|4207802|P2|Starting Dose|Study Drug Toxicity|0
1289817|NCT00322374|4207803|P1|Starting Dose|Study Drug Toxicity|4
1289818|NCT00322374|4207800|P4|Starting Dose|Physician Decision|0
1289819|NCT00322374|4207801|P3|Starting Dose|Physician Decision|0
1289820|NCT00322374|4207802|P2|Starting Dose|Physician Decision|0
1289821|NCT00322374|4207803|P1|Starting Dose|Physician Decision|2
1289822|NCT00322348|4207853|P2|Overall Study|Reasons not specified|1
1289823|NCT00322348|4207854|P1|Overall Study|Reasons not specified|5
1289824|NCT00322348|4207853|P2|Overall Study|Disease Progression|25
1289825|NCT00322348|4207854|P1|Overall Study|Disease Progression|30
1289826|NCT00322348|4207853|P2|Overall Study|Death|2
1289827|NCT00322348|4207854|P1|Overall Study|Death|0
1289828|NCT00322348|4207853|P2|Overall Study|Lost to Follow-up|0
1289829|NCT00322348|4207854|P1|Overall Study|Lost to Follow-up|1
1289830|NCT00322348|4207853|P2|Overall Study|Withdrawal by Subject|4
1289831|NCT00322348|4207854|P1|Overall Study|Withdrawal by Subject|1
1289832|NCT00322348|4207853|P2|Overall Study|Adverse Event|1
1289833|NCT00322348|4207854|P1|Overall Study|Adverse Event|0
1289834|NCT00322153|4207945|P2|Overall Study|Withdrawn for other reasons|4
1289835|NCT00322153|4207946|P1|Overall Study|Withdrawn for other reasons|5
1289836|NCT00322153|4207945|P2|Overall Study|Lost to Follow-up|4
1289837|NCT00322153|4207946|P1|Overall Study|Lost to Follow-up|5
1289838|NCT00322153|4207945|P2|Overall Study|Lack of Efficacy|3
1289839|NCT00322153|4207946|P1|Overall Study|Lack of Efficacy|8
1289840|NCT00322153|4207945|P2|Overall Study|Withdrawal by Subject|10
1289841|NCT00322153|4207946|P1|Overall Study|Withdrawal by Subject|18
1289842|NCT00322153|4207945|P2|Overall Study|Protocol Violation|14
1289843|NCT00322153|4207946|P1|Overall Study|Protocol Violation|6
1289844|NCT00322153|4207945|P2|Overall Study|Adverse Event|34
1289845|NCT00322153|4207946|P1|Overall Study|Adverse Event|21
1289846|NCT00322049|4207979|P4|Overall Study|Infected with Dengue during study|0
1289847|NCT00322049|4207980|P3|Overall Study|Infected with Dengue during study|0
1289848|NCT00322049|4207981|P2|Overall Study|Infected with Dengue during study|1
1289849|NCT00322049|4207982|P1|Overall Study|Infected with Dengue during study|0
1289850|NCT00322049|4207979|P4|Overall Study|Moved out of area|1
1289851|NCT00322049|4207980|P3|Overall Study|Moved out of area|0
1289852|NCT00322049|4207981|P2|Overall Study|Moved out of area|0
1289853|NCT00322049|4207982|P1|Overall Study|Moved out of area|0
1289854|NCT00321984|4208015|P3|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
1289855|NCT00321984|4208016|P2|Overall Study|Per Sponsor Due to High Baseline Gastrin|1
1289856|NCT00321984|4208017|P1|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
1289857|NCT00321984|4208015|P3|Overall Study|Per Investigator Request|0
1289858|NCT00321984|4208016|P2|Overall Study|Per Investigator Request|0
1289859|NCT00321984|4208017|P1|Overall Study|Per Investigator Request|1
1289860|NCT00321984|4208015|P3|Overall Study|Per Subject Request|0
1289861|NCT00321984|4208016|P2|Overall Study|Per Subject Request|0
1289862|NCT00321984|4208017|P1|Overall Study|Per Subject Request|1
1289863|NCT00321984|4208015|P3|Overall Study|Pregnancy|0
1289864|NCT00321984|4208016|P2|Overall Study|Pregnancy|1
1289865|NCT00321984|4208017|P1|Overall Study|Pregnancy|0
1289866|NCT00321984|4208015|P3|Overall Study|Noncompliant|2
1289867|NCT00321984|4208016|P2|Overall Study|Noncompliant|0
1289870|NCT00321984|4208016|P2|Overall Study|Lack of Efficacy|1
1289871|NCT00321984|4208017|P1|Overall Study|Lack of Efficacy|3
1289872|NCT00321984|4208015|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
1289873|NCT00321984|4208016|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|1
1289874|NCT00321984|4208017|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|3
1289875|NCT00321984|4208015|P3|Overall Study|Withdrawal by Subject|5
1289876|NCT00321984|4208016|P2|Overall Study|Withdrawal by Subject|6
1289877|NCT00321984|4208017|P1|Overall Study|Withdrawal by Subject|8
1289878|NCT00321984|4208015|P3|Overall Study|Lost to Follow-up|2
1289879|NCT00321984|4208016|P2|Overall Study|Lost to Follow-up|4
1289880|NCT00321984|4208017|P1|Overall Study|Lost to Follow-up|2
1289881|NCT00321984|4208015|P3|Overall Study|Protocol Violation|1
1289882|NCT00321984|4208016|P2|Overall Study|Protocol Violation|1
1289883|NCT00321984|4208017|P1|Overall Study|Protocol Violation|0
1289884|NCT00321984|4208015|P3|Overall Study|Adverse Event|8
1289885|NCT00321984|4208016|P2|Overall Study|Adverse Event|6
1289886|NCT00321984|4208017|P1|Overall Study|Adverse Event|9
1289887|NCT00321932|4208045|P2|Overall Study|Missing data|1
1289888|NCT00321932|4208046|P1|Overall Study|Missing data|2
1289889|NCT00321932|4208045|P2|Overall Study|Early relapse|8
1289890|NCT00321932|4208046|P1|Overall Study|Early relapse|2
1289891|NCT00321932|4208045|P2|Overall Study|Withdrawal by Subject|6
1289892|NCT00321932|4208046|P1|Overall Study|Withdrawal by Subject|3
1289893|NCT00321932|4208045|P2|Overall Study|Death|6
1289894|NCT00321932|4208046|P1|Overall Study|Death|3
1289895|NCT00321919|4208070|P2|Overall Study|Other withdrawal reason|6
1289896|NCT00321919|4208071|P1|Overall Study|Other withdrawal reason|7
1289897|NCT00321919|4208070|P2|Overall Study|Failure to Return|1
1289898|NCT00321919|4208071|P1|Overall Study|Failure to Return|3
1289899|NCT00321919|4208070|P2|Overall Study|Other Protocol Violation|3
1289900|NCT00321919|4208071|P1|Overall Study|Other Protocol Violation|2
1289901|NCT00321919|4208070|P2|Overall Study|Refused Treatment|14
1289902|NCT00321919|4208071|P1|Overall Study|Refused Treatment|23
1289903|NCT00321919|4208070|P2|Overall Study|Violation of Selection Criteria at Entry|1
1289904|NCT00321919|4208071|P1|Overall Study|Violation of Selection Criteria at Entry|1
1289905|NCT00321919|4208070|P2|Overall Study|Insufficient Therapeutic Response|0
1289906|NCT00321919|4208071|P1|Overall Study|Insufficient Therapeutic Response|1
1289907|NCT00321919|4208070|P2|Overall Study|Death|17
1289908|NCT00321919|4208071|P1|Overall Study|Death|21
1289909|NCT00321919|4208070|P2|Overall Study|Adverse Event|10
1289910|NCT00321919|4208071|P1|Overall Study|Adverse Event|17
1289911|NCT00321906|4208113|P2|Overall Study|Withdrawal by Subject|4
1289912|NCT00321906|4208114|P1|Overall Study|Withdrawal by Subject|0
1289913|NCT00321906|4208113|P2|Overall Study|Lost to Follow-up|2
1289914|NCT00321906|4208114|P1|Overall Study|Lost to Follow-up|1
1289915|NCT00321906|4208113|P2|Overall Study|Death|6
1289916|NCT00321906|4208114|P1|Overall Study|Death|9
1289917|NCT00321906|4208113|P2|Overall Study|Adverse Event|44
1289918|NCT00321906|4208114|P1|Overall Study|Adverse Event|36
1289919|NCT00321893|4208136|P2|Overall Study|Adverse Event|3
1289920|NCT00321893|4208137|P1|Overall Study|Adverse Event|6
1289921|NCT00321893|4208136|P2|Overall Study|Lost to Follow-up|1
1289922|NCT00321893|4208137|P1|Overall Study|Lost to Follow-up|2
1289923|NCT00321893|4208136|P2|Overall Study|Non-Compliance/Refusal|10
1289924|NCT00321893|4208137|P1|Overall Study|Non-Compliance/Refusal|16
1289925|NCT00321854|4208151|P2|Overall Study|Other|1
1289926|NCT00321854|4208152|P1|Overall Study|Other|1
1289927|NCT00321854|4208151|P2|Overall Study|Withdrawal by Subject|17
1289928|NCT00321854|4208152|P1|Overall Study|Withdrawal by Subject|6
1289929|NCT00321854|4208151|P2|Overall Study|Lost to Follow-up|2
1289930|NCT00321854|4208152|P1|Overall Study|Lost to Follow-up|0
1289931|NCT00321854|4208151|P2|Overall Study|Protocol Violation|5
1289932|NCT00321854|4208152|P1|Overall Study|Protocol Violation|6
1289933|NCT00321854|4208151|P2|Overall Study|Lack of Efficacy|14
1289934|NCT00321854|4208152|P1|Overall Study|Lack of Efficacy|9
1289935|NCT00321854|4208151|P2|Overall Study|Adverse Event|43
1289936|NCT00321854|4208152|P1|Overall Study|Adverse Event|41
1289937|NCT00321828|4208270|P1|Overall Study|No follow up data|1
1289938|NCT00321828|4208270|P1|Overall Study|Ineligible|3
1289939|NCT00321789|4208276|P2|Overall Study|Protocol Violation|3
1289940|NCT00321789|4208277|P1|Overall Study|Protocol Violation|5
1289941|NCT00321789|4208276|P2|Overall Study|Withdrawal by Subject|6
1289942|NCT00321789|4208277|P1|Overall Study|Withdrawal by Subject|6
1289943|NCT00321789|4208276|P2|Overall Study|Lost to Follow-up|7
1289944|NCT00321789|4208277|P1|Overall Study|Lost to Follow-up|4
1289945|NCT00321763|4208309|P4|Overall Study|Lost to Follow-up|4
1289946|NCT00321763|4208310|P3|Overall Study|Lost to Follow-up|5
1289947|NCT00321763|4208311|P2|Overall Study|Lost to Follow-up|1
1289948|NCT00321763|4208312|P1|Overall Study|Lost to Follow-up|3
1289949|NCT00321763|4208309|P4|Overall Study|Withdrawal by Subject|0
1289950|NCT00321763|4208310|P3|Overall Study|Withdrawal by Subject|1
1289951|NCT00321763|4208311|P2|Overall Study|Withdrawal by Subject|0
1289952|NCT00321763|4208312|P1|Overall Study|Withdrawal by Subject|2
1289953|NCT00321763|4208309|P4|Overall Study|Adverse Event|1
1289954|NCT00321763|4208310|P3|Overall Study|Adverse Event|0
1289955|NCT00321763|4208311|P2|Overall Study|Adverse Event|1
1289956|NCT00321763|4208312|P1|Overall Study|Adverse Event|1
1289957|NCT00321737|4208372|P3|Overall Study|Subject Request/ Subject Unavailable|2
1289958|NCT00321737|4208373|P2|Overall Study|Subject Request/ Subject Unavailable|0
1289959|NCT00321737|4208374|P1|Overall Study|Subject Request/ Subject Unavailable|0
1289960|NCT00321737|4208372|P3|Overall Study|Noncompliance|0
1289961|NCT00321737|4208373|P2|Overall Study|Noncompliance|0
1289962|NCT00321737|4208374|P1|Overall Study|Noncompliance|2
1289963|NCT00321737|4208372|P3|Overall Study|Pregnancy|0
1289964|NCT00321737|4208373|P2|Overall Study|Pregnancy|2
1289965|NCT00321737|4208374|P1|Overall Study|Pregnancy|0
1289966|NCT00321737|4208372|P3|Overall Study|Therapeutic Failure|2
1289967|NCT00321737|4208373|P2|Overall Study|Therapeutic Failure|0
1289968|NCT00321737|4208374|P1|Overall Study|Therapeutic Failure|6
1289969|NCT00321737|4208372|P3|Overall Study|Possible Barrett's Esophagus|1
1289970|NCT00321737|4208373|P2|Overall Study|Possible Barrett's Esophagus|1
1289971|NCT00321737|4208374|P1|Overall Study|Possible Barrett's Esophagus|2
1289972|NCT00321737|4208372|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|0
1289973|NCT00321737|4208373|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|0
1289974|NCT00321737|4208374|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|1
1289975|NCT00321737|4208372|P3|Overall Study|Protocol Violation|1
1289976|NCT00321737|4208373|P2|Overall Study|Protocol Violation|0
1289977|NCT00321737|4208374|P1|Overall Study|Protocol Violation|0
1289978|NCT00321737|4208372|P3|Overall Study|Withdrawal by Subject|17
1289979|NCT00321737|4208373|P2|Overall Study|Withdrawal by Subject|12
1289980|NCT00321737|4208374|P1|Overall Study|Withdrawal by Subject|19
1289981|NCT00321737|4208372|P3|Overall Study|Lost to Follow-up|6
1289982|NCT00321737|4208373|P2|Overall Study|Lost to Follow-up|5
1289983|NCT00321737|4208374|P1|Overall Study|Lost to Follow-up|5
1289984|NCT00321737|4208372|P3|Overall Study|Adverse Event|6
1289985|NCT00321737|4208373|P2|Overall Study|Adverse Event|3
1289986|NCT00321737|4208374|P1|Overall Study|Adverse Event|11
1289987|NCT00321737|4208372|P3|Overall Study|Relapse of Erosive Esophagitis|19
1289988|NCT00321737|4208373|P2|Overall Study|Relapse of Erosive Esophagitis|25
1289989|NCT00321737|4208374|P1|Overall Study|Relapse of Erosive Esophagitis|76
1289990|NCT00321711|4208402|P5|Part B|Death|1
1289991|NCT00321711|4208403|P4|Part B|Death|2
1289992|NCT00321711|4208404|P3|Part B|Death|0
1289993|NCT00321711|4208405|P2|Part B|Death|0
1289994|NCT00321711|4208406|P1|Part B|Death|0
1289995|NCT00321711|4208402|P5|Part B|Physician Decision|2
1289996|NCT00321711|4208403|P4|Part B|Physician Decision|1
1289997|NCT00321711|4208404|P3|Part B|Physician Decision|0
1289998|NCT00321711|4208405|P2|Part B|Physician Decision|0
1289999|NCT00321711|4208406|P1|Part B|Physician Decision|0
1290000|NCT00321711|4208402|P5|Part B|Disease progression|0
1290001|NCT00321711|4208403|P4|Part B|Disease progression|1
1290002|NCT00321711|4208404|P3|Part B|Disease progression|0
1290003|NCT00321711|4208405|P2|Part B|Disease progression|0
1290004|NCT00321711|4208406|P1|Part B|Disease progression|0
1290005|NCT00321711|4208402|P5|Part B|Adverse Event|1
1290006|NCT00321711|4208403|P4|Part B|Adverse Event|2
1290007|NCT00321711|4208404|P3|Part B|Adverse Event|0
1290008|NCT00321711|4208405|P2|Part B|Adverse Event|0
1290009|NCT00321711|4208406|P1|Part B|Adverse Event|0
1290010|NCT00321711|4208402|P5|Part B|Noncompliance|1
1290011|NCT00321711|4208403|P4|Part B|Noncompliance|0
1290012|NCT00321711|4208404|P3|Part B|Noncompliance|0
1290013|NCT00321711|4208405|P2|Part B|Noncompliance|0
1290014|NCT00321711|4208406|P1|Part B|Noncompliance|0
1290015|NCT00321711|4208402|P5|Part A|Protocol deviation|0
1290016|NCT00321711|4208403|P4|Part A|Protocol deviation|0
1290017|NCT00321711|4208404|P3|Part A|Protocol deviation|1
1290018|NCT00321711|4208405|P2|Part A|Protocol deviation|0
1290019|NCT00321711|4208406|P1|Part A|Protocol deviation|0
1290020|NCT00321711|4208402|P5|Part A|Other|0
1290021|NCT00321711|4208403|P4|Part A|Other|0
1290022|NCT00321711|4208404|P3|Part A|Other|3
1290023|NCT00321711|4208405|P2|Part A|Other|2
1290024|NCT00321711|4208406|P1|Part A|Other|1
1290025|NCT00321711|4208402|P5|Part A|Physician Decision|0
1290026|NCT00321711|4208403|P4|Part A|Physician Decision|0
1290027|NCT00321711|4208404|P3|Part A|Physician Decision|3
1290028|NCT00321711|4208405|P2|Part A|Physician Decision|1
1290029|NCT00321711|4208406|P1|Part A|Physician Decision|0
1290030|NCT00321711|4208402|P5|Part A|Requirement for alternative therapy|0
1290031|NCT00321711|4208403|P4|Part A|Requirement for alternative therapy|0
1290032|NCT00321711|4208404|P3|Part A|Requirement for alternative therapy|1
1290033|NCT00321711|4208405|P2|Part A|Requirement for alternative therapy|2
1290034|NCT00321711|4208406|P1|Part A|Requirement for alternative therapy|0
1290035|NCT00321711|4208402|P5|Part A|Disease progression|0
1290036|NCT00321711|4208403|P4|Part A|Disease progression|0
1290037|NCT00321711|4208404|P3|Part A|Disease progression|0
1290038|NCT00321711|4208405|P2|Part A|Disease progression|1
1290039|NCT00321711|4208406|P1|Part A|Disease progression|0
1290040|NCT00321711|4208402|P5|Part A|Withdrawal by Subject|0
1290041|NCT00321711|4208403|P4|Part A|Withdrawal by Subject|0
1290042|NCT00321711|4208404|P3|Part A|Withdrawal by Subject|1
1290043|NCT00321711|4208405|P2|Part A|Withdrawal by Subject|1
1290044|NCT00321711|4208406|P1|Part A|Withdrawal by Subject|1
1290045|NCT00321711|4208402|P5|Part A|Adverse Event|0
1290046|NCT00321711|4208403|P4|Part A|Adverse Event|0
1290047|NCT00321711|4208404|P3|Part A|Adverse Event|2
1290048|NCT00321711|4208405|P2|Part A|Adverse Event|3
1290049|NCT00321711|4208406|P1|Part A|Adverse Event|3
1290050|NCT00321685|4208456|P1|Overall Study|Ineligible|2
1290051|NCT00321685|4208456|P1|Overall Study|Not start protocol therapy|2
1290052|NCT00321685|4208456|P1|Overall Study|Other|5
1290053|NCT00321685|4208456|P1|Overall Study|Complicating disese|1
1290054|NCT00321685|4208456|P1|Overall Study|Alternative therapy|1
1290055|NCT00321685|4208456|P1|Overall Study|Withdrawal by Subject|8
1290056|NCT00321685|4208456|P1|Overall Study|Death|2
1290057|NCT00321685|4208456|P1|Overall Study|Adverse Event|18
1290058|NCT00321672|4208468|P4|Overall Study|Extensive travel required for new job|0
1290059|NCT00321672|4208469|P3|Overall Study|Extensive travel required for new job|0
1290060|NCT00321672|4208470|P2|Overall Study|Extensive travel required for new job|1
1290061|NCT00321672|4208471|P1|Overall Study|Extensive travel required for new job|0
1290062|NCT00321672|4208468|P4|Overall Study|Diagnosis of testicular cancer|0
1290063|NCT00321672|4208469|P3|Overall Study|Diagnosis of testicular cancer|0
1290064|NCT00321672|4208470|P2|Overall Study|Diagnosis of testicular cancer|1
1290065|NCT00321672|4208471|P1|Overall Study|Diagnosis of testicular cancer|0
1290066|NCT00321672|4208468|P4|Overall Study|Protocol Violation|0
1290067|NCT00321672|4208469|P3|Overall Study|Protocol Violation|1
1290068|NCT00321672|4208470|P2|Overall Study|Protocol Violation|0
1290069|NCT00321672|4208471|P1|Overall Study|Protocol Violation|0
1290070|NCT00321672|4208468|P4|Overall Study|Moved out of state|0
1290071|NCT00321672|4208469|P3|Overall Study|Moved out of state|1
1290072|NCT00321672|4208470|P2|Overall Study|Moved out of state|1
1290073|NCT00321672|4208471|P1|Overall Study|Moved out of state|0
1290074|NCT00321672|4208468|P4|Overall Study|Incarcerated|0
1290075|NCT00321672|4208469|P3|Overall Study|Incarcerated|2
1290076|NCT00321672|4208470|P2|Overall Study|Incarcerated|0
1290077|NCT00321672|4208471|P1|Overall Study|Incarcerated|0
1290078|NCT00321672|4208468|P4|Overall Study|Too far to travel for visits|0
1290079|NCT00321672|4208469|P3|Overall Study|Too far to travel for visits|0
1290080|NCT00321672|4208470|P2|Overall Study|Too far to travel for visits|0
1290081|NCT00321672|4208471|P1|Overall Study|Too far to travel for visits|1
1290082|NCT00321672|4208468|P4|Overall Study|Death|0
1290083|NCT00321672|4208469|P3|Overall Study|Death|0
1290084|NCT00321672|4208470|P2|Overall Study|Death|0
1290085|NCT00321672|4208471|P1|Overall Study|Death|1
1290086|NCT00321672|4208468|P4|Overall Study|Lost to Follow-up|2
1290087|NCT00321672|4208469|P3|Overall Study|Lost to Follow-up|4
1290088|NCT00321672|4208470|P2|Overall Study|Lost to Follow-up|0
1290089|NCT00321672|4208471|P1|Overall Study|Lost to Follow-up|2
1290090|NCT00321672|4208468|P4|Overall Study|Lack of Efficacy|0
1290091|NCT00321672|4208469|P3|Overall Study|Lack of Efficacy|0
1290092|NCT00321672|4208470|P2|Overall Study|Lack of Efficacy|1
1290093|NCT00321672|4208471|P1|Overall Study|Lack of Efficacy|1
1290094|NCT00321672|4208468|P4|Overall Study|Adverse Event|0
1290095|NCT00321672|4208469|P3|Overall Study|Adverse Event|0
1290096|NCT00321672|4208470|P2|Overall Study|Adverse Event|1
1290097|NCT00321672|4208471|P1|Overall Study|Adverse Event|1
1290098|NCT00321672|4208468|P4|Overall Study|Noncompliance|0
1290099|NCT00321672|4208469|P3|Overall Study|Noncompliance|1
1290100|NCT00321672|4208470|P2|Overall Study|Noncompliance|2
1290101|NCT00321672|4208471|P1|Overall Study|Noncompliance|1
1290102|NCT00321672|4208468|P4|Overall Study|Withdrawal by Subject|0
1290103|NCT00321672|4208469|P3|Overall Study|Withdrawal by Subject|2
1290104|NCT00321672|4208470|P2|Overall Study|Withdrawal by Subject|1
1290105|NCT00321672|4208471|P1|Overall Study|Withdrawal by Subject|5
1290106|NCT00321646|4208497|P1|Neoadjuvant Chemotherapy|Disease progression|1
1290107|NCT00321646|4208497|P1|Neoadjuvant Chemotherapy|Adverse Event|2
1290108|NCT00321646|4208497|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
1290109|NCT00321620|4208504|P2|Overall Study|Other|33
1290110|NCT00321620|4208505|P1|Overall Study|Other|42
1290111|NCT00321620|4208504|P2|Overall Study|Participant request|52
1290112|NCT00321620|4208505|P1|Overall Study|Participant request|75
1290113|NCT00321620|4208504|P2|Overall Study|Ineligibility determined|3
1290114|NCT00321620|4208505|P1|Overall Study|Ineligibility determined|2
1290115|NCT00321620|4208504|P2|Overall Study|Protocol deviation|3
1290116|NCT00321620|4208505|P1|Overall Study|Protocol deviation|4
1290117|NCT00321620|4208504|P2|Overall Study|Noncompliance|7
1290118|NCT00321620|4208505|P1|Overall Study|Noncompliance|14
1290119|NCT00321620|4208504|P2|Overall Study|Physician Decision|1
1290120|NCT00321620|4208505|P1|Overall Study|Physician Decision|4
1290121|NCT00321620|4208504|P2|Overall Study|Lost to Follow-up|9
1290122|NCT00321620|4208505|P1|Overall Study|Lost to Follow-up|13
1290123|NCT00321620|4208504|P2|Overall Study|Adverse Event|56
1290124|NCT00321620|4208505|P1|Overall Study|Adverse Event|43
1290125|NCT00321620|4208504|P2|Overall Study|Disease progression|117
1290126|NCT00321620|4208505|P1|Overall Study|Disease progression|113
1290127|NCT00321620|4208504|P2|Overall Study|Withdrawal by Subject|147
1290128|NCT00321620|4208505|P1|Overall Study|Withdrawal by Subject|164
1290129|NCT00321620|4208504|P2|Overall Study|Death|294
1290130|NCT00321620|4208505|P1|Overall Study|Death|269
1290131|NCT00321464|4208535|P2|Overall Study|Other|18
1290132|NCT00321464|4208536|P1|Overall Study|Other|21
1290133|NCT00321464|4208535|P2|Overall Study|Ineligibility determined|1
1290134|NCT00321464|4208536|P1|Overall Study|Ineligibility determined|2
1290135|NCT00321464|4208535|P2|Overall Study|Protocol deviation|2
1290136|NCT00321464|4208536|P1|Overall Study|Protocol deviation|0
1290137|NCT00321464|4208535|P2|Overall Study|Lost to Follow-up|8
1290138|NCT00321464|4208536|P1|Overall Study|Lost to Follow-up|7
1290139|NCT00321464|4208535|P2|Overall Study|Noncompliance|10
1290140|NCT00321464|4208536|P1|Overall Study|Noncompliance|4
1290141|NCT00321464|4208535|P2|Overall Study|Physician Decision|14
1290142|NCT00321464|4208536|P1|Overall Study|Physician Decision|15
1290143|NCT00321464|4208535|P2|Overall Study|Adverse Event|28
1290144|NCT00321464|4208536|P1|Overall Study|Adverse Event|43
1290145|NCT00321464|4208535|P2|Overall Study|Participant request|61
1290146|NCT00321464|4208536|P1|Overall Study|Participant request|57
1290147|NCT00321464|4208535|P2|Overall Study|Withdrawal by Subject|118
1290148|NCT00321464|4208536|P1|Overall Study|Withdrawal by Subject|117
1290149|NCT00321464|4208535|P2|Overall Study|Disease progression|124
1290150|NCT00321464|4208536|P1|Overall Study|Disease progression|124
1290151|NCT00321464|4208535|P2|Overall Study|Death|174
1290152|NCT00321464|4208536|P1|Overall Study|Death|169
1290153|NCT00321373|4208549|P3|Overall Study|Other|1
1290154|NCT00321373|4208550|P2|Overall Study|Other|0
1290155|NCT00321373|4208551|P1|Overall Study|Other|0
1290156|NCT00321373|4208549|P3|Overall Study|Withdrawal by Subject|0
1290157|NCT00321373|4208550|P2|Overall Study|Withdrawal by Subject|0
1290158|NCT00321373|4208551|P1|Overall Study|Withdrawal by Subject|1
1290159|NCT00321373|4208549|P3|Overall Study|Lost to Follow-up|1
1290160|NCT00321373|4208550|P2|Overall Study|Lost to Follow-up|0
1290161|NCT00321373|4208551|P1|Overall Study|Lost to Follow-up|1
1290162|NCT00321373|4208549|P3|Overall Study|Adverse Event|1
1290163|NCT00321373|4208550|P2|Overall Study|Adverse Event|0
1290164|NCT00321373|4208551|P1|Overall Study|Adverse Event|0
1290165|NCT00320801|4208591|P4|Extension Phase|Lost to Follow-up|3
1290166|NCT00320801|4208592|P3|Extension Phase|Lost to Follow-up|0
1290167|NCT00320801|4208593|P2|Extension Phase|Lost to Follow-up|0
1290168|NCT00320801|4208594|P1|Extension Phase|Lost to Follow-up|0
1290169|NCT00320801|4208591|P4|Extension Phase|Lack of Efficacy|2
1290170|NCT00320801|4208592|P3|Extension Phase|Lack of Efficacy|0
1290171|NCT00320801|4208593|P2|Extension Phase|Lack of Efficacy|0
1290172|NCT00320801|4208594|P1|Extension Phase|Lack of Efficacy|0
1290173|NCT00320801|4208591|P4|Extension Phase|Administrative|29
1290174|NCT00320801|4208592|P3|Extension Phase|Administrative|0
1290175|NCT00320801|4208593|P2|Extension Phase|Administrative|0
1290176|NCT00320801|4208594|P1|Extension Phase|Administrative|0
1290177|NCT00320801|4208591|P4|Extension Phase|Adverse Event|8
1290178|NCT00320801|4208592|P3|Extension Phase|Adverse Event|0
1290179|NCT00320801|4208593|P2|Extension Phase|Adverse Event|0
1290180|NCT00320801|4208594|P1|Extension Phase|Adverse Event|0
1290181|NCT00320801|4208591|P4|Extension Phase|Withdrawal by Subject|6
1290182|NCT00320801|4208592|P3|Extension Phase|Withdrawal by Subject|0
1290183|NCT00320801|4208593|P2|Extension Phase|Withdrawal by Subject|0
1290184|NCT00320801|4208594|P1|Extension Phase|Withdrawal by Subject|0
1290185|NCT00320801|4208591|P4|Double-blind Phase|Lack of Efficacy|0
1290186|NCT00320801|4208592|P3|Double-blind Phase|Lack of Efficacy|1
1290187|NCT00320801|4208593|P2|Double-blind Phase|Lack of Efficacy|9
1290188|NCT00320801|4208594|P1|Double-blind Phase|Lack of Efficacy|0
1290189|NCT00320801|4208591|P4|Double-blind Phase|Administrative|0
1290190|NCT00320801|4208592|P3|Double-blind Phase|Administrative|4
1290191|NCT00320801|4208593|P2|Double-blind Phase|Administrative|0
1290192|NCT00320801|4208594|P1|Double-blind Phase|Administrative|0
1290193|NCT00320801|4208591|P4|Double-blind Phase|Adverse Event|0
1290194|NCT00320801|4208592|P3|Double-blind Phase|Adverse Event|8
1290195|NCT00320801|4208593|P2|Double-blind Phase|Adverse Event|2
1290196|NCT00320801|4208594|P1|Double-blind Phase|Adverse Event|0
1290197|NCT00320801|4208591|P4|Double-blind Phase|Withdrawal by Subject|0
1290198|NCT00320801|4208592|P3|Double-blind Phase|Withdrawal by Subject|1
1290199|NCT00320801|4208593|P2|Double-blind Phase|Withdrawal by Subject|0
1290200|NCT00320801|4208594|P1|Double-blind Phase|Withdrawal by Subject|0
1290201|NCT00320801|4208591|P4|Open-label Run-in Period|Did not qualify|0
1290202|NCT00320801|4208592|P3|Open-label Run-in Period|Did not qualify|0
1290203|NCT00320801|4208593|P2|Open-label Run-in Period|Did not qualify|0
1290204|NCT00320801|4208594|P1|Open-label Run-in Period|Did not qualify|1
1290205|NCT00320801|4208591|P4|Open-label Run-in Period|Lost to Follow-up|0
1290206|NCT00320801|4208592|P3|Open-label Run-in Period|Lost to Follow-up|0
1290207|NCT00320801|4208593|P2|Open-label Run-in Period|Lost to Follow-up|0
1290208|NCT00320801|4208594|P1|Open-label Run-in Period|Lost to Follow-up|2
1290209|NCT00320801|4208591|P4|Open-label Run-in Period|Lack of Efficacy|0
1290210|NCT00320801|4208592|P3|Open-label Run-in Period|Lack of Efficacy|0
1290211|NCT00320801|4208593|P2|Open-label Run-in Period|Lack of Efficacy|0
1290212|NCT00320801|4208594|P1|Open-label Run-in Period|Lack of Efficacy|44
1290213|NCT00320801|4208591|P4|Open-label Run-in Period|Administrative|0
1290214|NCT00320801|4208592|P3|Open-label Run-in Period|Administrative|0
1290215|NCT00320801|4208593|P2|Open-label Run-in Period|Administrative|0
1290216|NCT00320801|4208594|P1|Open-label Run-in Period|Administrative|10
1290217|NCT00320801|4208591|P4|Open-label Run-in Period|Adverse Event|0
1290218|NCT00320801|4208592|P3|Open-label Run-in Period|Adverse Event|0
1290219|NCT00320801|4208593|P2|Open-label Run-in Period|Adverse Event|0
1290220|NCT00320801|4208594|P1|Open-label Run-in Period|Adverse Event|33
1290221|NCT00320801|4208591|P4|Open-label Run-in Period|Withdrawal by Subject|0
1290222|NCT00320801|4208592|P3|Open-label Run-in Period|Withdrawal by Subject|0
1290223|NCT00320801|4208593|P2|Open-label Run-in Period|Withdrawal by Subject|0
1290224|NCT00320801|4208594|P1|Open-label Run-in Period|Withdrawal by Subject|2
1290225|NCT00320788|4208609|P5|Overall Study|Withdrawal by Subject|1
1290226|NCT00320788|4208610|P4|Overall Study|Withdrawal by Subject|3
1290227|NCT00320788|4208611|P3|Overall Study|Withdrawal by Subject|0
1290228|NCT00320788|4208612|P2|Overall Study|Withdrawal by Subject|0
1290229|NCT00320788|4208613|P1|Overall Study|Withdrawal by Subject|3
1290230|NCT00320788|4208609|P5|Overall Study|Protocol Violation|1
1290231|NCT00320788|4208610|P4|Overall Study|Protocol Violation|0
1290232|NCT00320788|4208611|P3|Overall Study|Protocol Violation|0
1290233|NCT00320788|4208612|P2|Overall Study|Protocol Violation|0
1290234|NCT00320788|4208613|P1|Overall Study|Protocol Violation|0
1290235|NCT00320788|4208609|P5|Overall Study|Physician Decision|0
1290236|NCT00320788|4208610|P4|Overall Study|Physician Decision|0
1290237|NCT00320788|4208611|P3|Overall Study|Physician Decision|0
1290238|NCT00320788|4208612|P2|Overall Study|Physician Decision|1
1290239|NCT00320788|4208613|P1|Overall Study|Physician Decision|1
1290240|NCT00320788|4208609|P5|Overall Study|Other|1
1290241|NCT00320788|4208610|P4|Overall Study|Other|1
1290242|NCT00320788|4208611|P3|Overall Study|Other|1
1290243|NCT00320788|4208612|P2|Overall Study|Other|2
1290244|NCT00320788|4208613|P1|Overall Study|Other|1
1290245|NCT00320788|4208609|P5|Overall Study|Decision by the Sponsor|1
1290246|NCT00320788|4208610|P4|Overall Study|Decision by the Sponsor|0
1290247|NCT00320788|4208611|P3|Overall Study|Decision by the Sponsor|0
1290248|NCT00320788|4208612|P2|Overall Study|Decision by the Sponsor|1
1290249|NCT00320788|4208613|P1|Overall Study|Decision by the Sponsor|1
1290250|NCT00320788|4208609|P5|Overall Study|Lost to Follow-up|0
1290251|NCT00320788|4208610|P4|Overall Study|Lost to Follow-up|0
1290252|NCT00320788|4208611|P3|Overall Study|Lost to Follow-up|1
1290253|NCT00320788|4208612|P2|Overall Study|Lost to Follow-up|2
1290254|NCT00320788|4208613|P1|Overall Study|Lost to Follow-up|0
1290255|NCT00320788|4208609|P5|Overall Study|Death|1
1290256|NCT00320788|4208610|P4|Overall Study|Death|0
1290257|NCT00320788|4208611|P3|Overall Study|Death|1
1290258|NCT00320788|4208612|P2|Overall Study|Death|0
1290259|NCT00320788|4208613|P1|Overall Study|Death|0
1290260|NCT00320788|4208609|P5|Overall Study|Adverse Event|0
1290261|NCT00320788|4208610|P4|Overall Study|Adverse Event|1
1290262|NCT00320788|4208611|P3|Overall Study|Adverse Event|0
1290263|NCT00320788|4208612|P2|Overall Study|Adverse Event|0
1290264|NCT00320788|4208613|P1|Overall Study|Adverse Event|0
1290265|NCT00320710|4208667|P3|Overall Study|Lost to Follow-up|0
1290266|NCT00320710|4208668|P2|Overall Study|Lost to Follow-up|0
1290267|NCT00320710|4208669|P1|Overall Study|Lost to Follow-up|1
1290268|NCT00320710|4208667|P3|Overall Study|Adverse Event|1
1290269|NCT00320710|4208668|P2|Overall Study|Adverse Event|14
1290270|NCT00320710|4208669|P1|Overall Study|Adverse Event|18
1290271|NCT00320710|4208667|P3|Overall Study|Abnormal laboratory value(s)|0
1290272|NCT00320710|4208668|P2|Overall Study|Abnormal laboratory value(s)|3
1290273|NCT00320710|4208669|P1|Overall Study|Abnormal laboratory value(s)|12
1290274|NCT00320710|4208667|P3|Overall Study|Abnormal test procedure result(s)|0
1290275|NCT00320710|4208668|P2|Overall Study|Abnormal test procedure result(s)|0
1290276|NCT00320710|4208669|P1|Overall Study|Abnormal test procedure result(s)|2
1290277|NCT00320710|4208667|P3|Overall Study|Protocol Violation|0
1290278|NCT00320710|4208668|P2|Overall Study|Protocol Violation|5
1290279|NCT00320710|4208669|P1|Overall Study|Protocol Violation|6
1290280|NCT00320710|4208667|P3|Overall Study|Withdrawal by Subject|1
1290281|NCT00320710|4208668|P2|Overall Study|Withdrawal by Subject|26
1290282|NCT00320710|4208669|P1|Overall Study|Withdrawal by Subject|20
1290283|NCT00320710|4208667|P3|Overall Study|Administrative problems|0
1290284|NCT00320710|4208668|P2|Overall Study|Administrative problems|2
1290285|NCT00320710|4208669|P1|Overall Study|Administrative problems|1
1290286|NCT00320710|4208667|P3|Overall Study|Death|1
1290287|NCT00320710|4208668|P2|Overall Study|Death|7
1290288|NCT00320710|4208669|P1|Overall Study|Death|10
1290289|NCT00320710|4208667|P3|Overall Study|Disease progression|2
1290290|NCT00320710|4208668|P2|Overall Study|Disease progression|19
1290291|NCT00320710|4208669|P1|Overall Study|Disease progression|24
1290292|NCT00320606|4208699|P1|Overall Study|Withdrawal by Subject|1
1290293|NCT00320606|4208699|P1|Overall Study|Protocol Violation|1
1290294|NCT00320606|4208699|P1|Overall Study|Adverse Event|1
1290295|NCT00320593|4208715|P2|Overall Study|Withdrawal by clinical center|0
1290296|NCT00320593|4208716|P1|Overall Study|Withdrawal by clinical center|1
1290297|NCT00320593|4208715|P2|Overall Study|Withdrawal by Subject|1
1290298|NCT00320593|4208716|P1|Overall Study|Withdrawal by Subject|2
1290299|NCT00320593|4208715|P2|Overall Study|Moved to another state|0
1290300|NCT00320593|4208716|P1|Overall Study|Moved to another state|1
1290301|NCT00320593|4208715|P2|Overall Study|Lost to Follow-up|0
1290302|NCT00320593|4208716|P1|Overall Study|Lost to Follow-up|3
1290303|NCT00320541|4208740|P2|Overall Study|Protocol Entry Criterion Not Met|0
1290304|NCT00320541|4208741|P1|Overall Study|Protocol Entry Criterion Not Met|1
1290305|NCT00320541|4208740|P2|Overall Study|Death due to Adverse Event(s)|0
1290306|NCT00320541|4208741|P1|Overall Study|Death due to Adverse Event(s)|1
1290307|NCT00320541|4208740|P2|Overall Study|Death due to Study Disease|3
1290308|NCT00320541|4208741|P1|Overall Study|Death due to Study Disease|1
1290309|NCT00320541|4208740|P2|Overall Study|Sponsor Decision|1
1290310|NCT00320541|4208741|P1|Overall Study|Sponsor Decision|2
1290311|NCT00320541|4208740|P2|Overall Study|Other|4
1290312|NCT00320541|4208741|P1|Overall Study|Other|3
1290313|NCT00320541|4208740|P2|Overall Study|Physician Decision|13
1290314|NCT00320541|4208741|P1|Overall Study|Physician Decision|9
1290315|NCT00320541|4208740|P2|Overall Study|Withdrawal by Subject|16
1290316|NCT00320541|4208741|P1|Overall Study|Withdrawal by Subject|12
1290317|NCT00320541|4208740|P2|Overall Study|Protocol Violation|1
1290318|NCT00320541|4208741|P1|Overall Study|Protocol Violation|0
1290319|NCT00320541|4208740|P2|Overall Study|Adverse Event|19
1290320|NCT00320541|4208741|P1|Overall Study|Adverse Event|21
1290321|NCT00320528|4208768|P3|Study Period III|Atomoxetine Commercially Available|90
1290322|NCT00320528|4208769|P2|Study Period III|Atomoxetine Commercially Available|25
1290323|NCT00320528|4208770|P1|Study Period III|Atomoxetine Commercially Available|68
1290324|NCT00320528|4208768|P3|Study Period III|Sponsor Decision|1
1290325|NCT00320528|4208769|P2|Study Period III|Sponsor Decision|0
1290326|NCT00320528|4208770|P1|Study Period III|Sponsor Decision|0
1290327|NCT00320528|4208768|P3|Study Period III|Physician Decision|2
1290328|NCT00320528|4208769|P2|Study Period III|Physician Decision|1
1290329|NCT00320528|4208770|P1|Study Period III|Physician Decision|0
1290330|NCT00320528|4208768|P3|Study Period III|Protocol Violation|0
1290331|NCT00320528|4208769|P2|Study Period III|Protocol Violation|1
1290332|NCT00320528|4208770|P1|Study Period III|Protocol Violation|0
1290333|NCT00320528|4208768|P3|Study Period III|Parent/Caregiver Decision|11
1290334|NCT00320528|4208769|P2|Study Period III|Parent/Caregiver Decision|3
1290335|NCT00320528|4208770|P1|Study Period III|Parent/Caregiver Decision|14
1290336|NCT00320528|4208768|P3|Study Period III|Lack of Efficacy|0
1290337|NCT00320528|4208769|P2|Study Period III|Lack of Efficacy|0
1290338|NCT00320528|4208770|P1|Study Period III|Lack of Efficacy|2
1290339|NCT00320528|4208768|P3|Study Period III|Withdrawal by Subject|2
1290340|NCT00320528|4208769|P2|Study Period III|Withdrawal by Subject|1
1290341|NCT00320528|4208770|P1|Study Period III|Withdrawal by Subject|1
1290342|NCT00320528|4208768|P3|Study Period III|Lost to Follow-up|0
1290343|NCT00320528|4208769|P2|Study Period III|Lost to Follow-up|0
1290344|NCT00320528|4208770|P1|Study Period III|Lost to Follow-up|1
1290345|NCT00320528|4208768|P3|Study Period III|Adverse Event|0
1290346|NCT00320528|4208769|P2|Study Period III|Adverse Event|0
1290347|NCT00320528|4208770|P1|Study Period III|Adverse Event|1
1290348|NCT00320528|4208768|P3|Study Period II|Entry Criteria Exclusion|2
1290349|NCT00320528|4208769|P2|Study Period II|Entry Criteria Exclusion|2
1290350|NCT00320528|4208770|P1|Study Period II|Entry Criteria Exclusion|0
1290351|NCT00320528|4208768|P3|Study Period II|Withdrawal by Subject|1
1290352|NCT00320528|4208769|P2|Study Period II|Withdrawal by Subject|1
1290353|NCT00320528|4208770|P1|Study Period II|Withdrawal by Subject|0
1290354|NCT00320528|4208768|P3|Study Period II|Parent/Caregiver Decision|11
1290355|NCT00320528|4208769|P2|Study Period II|Parent/Caregiver Decision|3
1290356|NCT00320528|4208770|P1|Study Period II|Parent/Caregiver Decision|8
1290357|NCT00320528|4208768|P3|Study Period II|Adverse Event|8
1290358|NCT00320528|4208769|P2|Study Period II|Adverse Event|4
1290359|NCT00320528|4208770|P1|Study Period II|Adverse Event|3
1290360|NCT00320515|4208805|P1|Overall Study|Withdrawal by Subject|8
1290361|NCT00320515|4208805|P1|Overall Study|Physician Decision|2
1290362|NCT00320515|4208805|P1|Overall Study|Lost to Follow-up|6
1290363|NCT00320515|4208805|P1|Overall Study|Death|33
1290364|NCT00320489|4208814|P2|Overall Study|Withdrawal by Subject|41
1290365|NCT00320489|4208815|P1|Overall Study|Withdrawal by Subject|39
1290366|NCT00320489|4208814|P2|Overall Study|Sponsor Decision|3
1290367|NCT00320489|4208815|P1|Overall Study|Sponsor Decision|3
1290368|NCT00320489|4208814|P2|Overall Study|Protocol Violation|4
1290369|NCT00320489|4208815|P1|Overall Study|Protocol Violation|4
1290370|NCT00320489|4208814|P2|Overall Study|Physician Decision|8
1290371|NCT00320489|4208815|P1|Overall Study|Physician Decision|8
1290372|NCT00320489|4208814|P2|Overall Study|Lost to Follow-up|22
1290373|NCT00320489|4208815|P1|Overall Study|Lost to Follow-up|21
1290374|NCT00320489|4208814|P2|Overall Study|Lack of Efficacy|7
1290375|NCT00320489|4208815|P1|Overall Study|Lack of Efficacy|16
1290376|NCT00320489|4208814|P2|Overall Study|Entry Criteria Exclusion|4
1290377|NCT00320489|4208815|P1|Overall Study|Entry Criteria Exclusion|2
1290378|NCT00320489|4208814|P2|Overall Study|Death|2
1290379|NCT00320489|4208815|P1|Overall Study|Death|0
1290380|NCT00320489|4208814|P2|Overall Study|Clinical Relapse|20
1290381|NCT00320489|4208815|P1|Overall Study|Clinical Relapse|26
1290382|NCT00320489|4208814|P2|Overall Study|Adverse Event|25
1290383|NCT00320489|4208815|P1|Overall Study|Adverse Event|26
1290384|NCT00320424|4208871|P1|Overall Study|Other|3
1290385|NCT00320424|4208871|P1|Overall Study|Adverse Event|3
1290386|NCT00320411|4208885|P1|Overall Study|No investigational product admin.|4
1290387|NCT00320398|4208908|P2|Overall Study|Other|0
1290388|NCT00320398|4208909|P1|Overall Study|Other|1
1290389|NCT00320398|4208908|P2|Overall Study|Adverse Event|4
1290390|NCT00320398|4208909|P1|Overall Study|Adverse Event|1
1290391|NCT00320385|4208937|P2|Overall Study|Adverse Event|1
1290392|NCT00320385|4208938|P1|Overall Study|Adverse Event|0
1290393|NCT00320385|4208937|P2|Overall Study|Withdrew Consent|0
1290394|NCT00320385|4208938|P1|Overall Study|Withdrew Consent|1
1290395|NCT00320385|4208937|P2|Overall Study|Serious Adverse Event|0
1290396|NCT00320385|4208938|P1|Overall Study|Serious Adverse Event|1
1290397|NCT00320385|4208937|P2|Overall Study|Death|2
1290398|NCT00320385|4208938|P1|Overall Study|Death|1
1290399|NCT00320385|4208937|P2|Overall Study|Investigator Decision|1
1290400|NCT00320385|4208938|P1|Overall Study|Investigator Decision|0
1290401|NCT00320385|4208937|P2|Overall Study|Sponsor Terminated Study|1
1290402|NCT00320385|4208938|P1|Overall Study|Sponsor Terminated Study|2
1290403|NCT00320385|4208937|P2|Overall Study|Withdrawal by Subject|7
1290404|NCT00320385|4208938|P1|Overall Study|Withdrawal by Subject|6
1290405|NCT00320385|4208937|P2|Overall Study|Lost to Follow-up|10
1290406|NCT00320385|4208938|P1|Overall Study|Lost to Follow-up|7
1290407|NCT00320372|4208961|P2|Overall Study|Other (i.e. lost to f/u, site closure)|71
1290408|NCT00320372|4208962|P1|Overall Study|Other (i.e. lost to f/u, site closure)|86
1290409|NCT00320372|4208961|P2|Overall Study|Did not Meet (I/E)|1
1290410|NCT00320372|4208962|P1|Overall Study|Did not Meet (I/E)|3
1290411|NCT00320372|4208961|P2|Overall Study|Non-Compliance|39
1290412|NCT00320372|4208962|P1|Overall Study|Non-Compliance|40
1290413|NCT00320372|4208961|P2|Overall Study|Withdrawal by Subject|37
1290414|NCT00320372|4208962|P1|Overall Study|Withdrawal by Subject|55
1290415|NCT00320372|4208961|P2|Overall Study|Death|8
1290416|NCT00320372|4208962|P1|Overall Study|Death|7
1290417|NCT00320372|4208961|P2|Overall Study|Physician Decision|7
1290418|NCT00320372|4208962|P1|Overall Study|Physician Decision|4
1290419|NCT00320255|4209002|P6|Overall Study|Not specified|0
1290420|NCT00320255|4209003|P5|Overall Study|Not specified|0
1290421|NCT00320255|4209004|P4|Overall Study|Not specified|0
1290422|NCT00320255|4209005|P3|Overall Study|Not specified|1
1290423|NCT00320255|4209006|P2|Overall Study|Not specified|2
1290424|NCT00320255|4209007|P1|Overall Study|Not specified|3
1290425|NCT00320255|4209002|P6|Overall Study|No longer meets study criteria|0
1290426|NCT00320255|4209003|P5|Overall Study|No longer meets study criteria|0
1290427|NCT00320255|4209004|P4|Overall Study|No longer meets study criteria|1
1290428|NCT00320255|4209005|P3|Overall Study|No longer meets study criteria|0
1290429|NCT00320255|4209006|P2|Overall Study|No longer meets study criteria|0
1290430|NCT00320255|4209007|P1|Overall Study|No longer meets study criteria|0
1290431|NCT00320255|4209002|P6|Overall Study|Poor compliance/noncompliance|0
1290432|NCT00320255|4209003|P5|Overall Study|Poor compliance/noncompliance|0
1290433|NCT00320255|4209004|P4|Overall Study|Poor compliance/noncompliance|1
1290434|NCT00320255|4209005|P3|Overall Study|Poor compliance/noncompliance|0
1290435|NCT00320255|4209006|P2|Overall Study|Poor compliance/noncompliance|1
1290436|NCT00320255|4209007|P1|Overall Study|Poor compliance/noncompliance|1
1290437|NCT00320255|4209002|P6|Overall Study|Withdrawal by Subject|0
1290438|NCT00320255|4209003|P5|Overall Study|Withdrawal by Subject|0
1290439|NCT00320255|4209004|P4|Overall Study|Withdrawal by Subject|4
1290440|NCT00320255|4209005|P3|Overall Study|Withdrawal by Subject|2
1290441|NCT00320255|4209006|P2|Overall Study|Withdrawal by Subject|2
1290442|NCT00320255|4209007|P1|Overall Study|Withdrawal by Subject|1
1290443|NCT00320255|4209002|P6|Overall Study|Adverse Event|0
1290444|NCT00320255|4209003|P5|Overall Study|Adverse Event|0
1290445|NCT00320255|4209004|P4|Overall Study|Adverse Event|2
1290446|NCT00320255|4209005|P3|Overall Study|Adverse Event|3
1290447|NCT00320255|4209006|P2|Overall Study|Adverse Event|2
1290448|NCT00320255|4209007|P1|Overall Study|Adverse Event|5
1290449|NCT00320255|4209002|P6|Overall Study|Lack of Efficacy|0
1290450|NCT00320255|4209003|P5|Overall Study|Lack of Efficacy|0
1290451|NCT00320255|4209004|P4|Overall Study|Lack of Efficacy|0
1290452|NCT00320255|4209005|P3|Overall Study|Lack of Efficacy|0
1290453|NCT00320255|4209006|P2|Overall Study|Lack of Efficacy|0
1290454|NCT00320255|4209007|P1|Overall Study|Lack of Efficacy|1
1290455|NCT00320216|4209100|P5|Overall Study|Other|3
1290456|NCT00320216|4209101|P4|Overall Study|Other|1
1290457|NCT00320216|4209102|P3|Overall Study|Other|5
1290458|NCT00320216|4209103|P2|Overall Study|Other|2
1290459|NCT00320216|4209104|P1|Overall Study|Other|7
1290460|NCT00320216|4209100|P5|Overall Study|Lost to Follow-up|0
1290461|NCT00320216|4209101|P4|Overall Study|Lost to Follow-up|0
1290462|NCT00320216|4209102|P3|Overall Study|Lost to Follow-up|0
1290463|NCT00320216|4209103|P2|Overall Study|Lost to Follow-up|0
1290464|NCT00320216|4209104|P1|Overall Study|Lost to Follow-up|3
1290465|NCT00320216|4209100|P5|Overall Study|Lack of Efficacy|1
1290466|NCT00320216|4209101|P4|Overall Study|Lack of Efficacy|0
1290467|NCT00320216|4209102|P3|Overall Study|Lack of Efficacy|1
1290468|NCT00320216|4209103|P2|Overall Study|Lack of Efficacy|2
1290469|NCT00320216|4209104|P1|Overall Study|Lack of Efficacy|6
1290470|NCT00320216|4209100|P5|Overall Study|Adverse Event|2
1290471|NCT00320216|4209101|P4|Overall Study|Adverse Event|2
1290472|NCT00320216|4209102|P3|Overall Study|Adverse Event|0
1290473|NCT00320216|4209103|P2|Overall Study|Adverse Event|6
1290474|NCT00320216|4209104|P1|Overall Study|Adverse Event|0
1290475|NCT00320190|4209138|P2|Long-term (12-month) Extension|Withdrawal by Subject|0
1290476|NCT00320190|4209139|P1|Long-term (12-month) Extension|Withdrawal by Subject|1
1290477|NCT00320190|4209138|P2|Long-term (12-month) Extension|Lack of major molecular response|2
1290478|NCT00320190|4209139|P1|Long-term (12-month) Extension|Lack of major molecular response|1
1290479|NCT00320190|4209138|P2|Long-term (12-month) Extension|Sponsor terminated study|0
1290480|NCT00320190|4209139|P1|Long-term (12-month) Extension|Sponsor terminated study|7
1290481|NCT00320190|4209138|P2|First 12 Months|Withdrawal by Subject|1
1290482|NCT00320190|4209139|P1|First 12 Months|Withdrawal by Subject|0
1290483|NCT00320190|4209138|P2|First 12 Months|Study drug toxicity|1
1290484|NCT00320190|4209139|P1|First 12 Months|Study drug toxicity|0
1290485|NCT00320190|4209138|P2|First 12 Months|Investigator request|1
1290486|NCT00320190|4209139|P1|First 12 Months|Investigator request|0
1290487|NCT00320190|4209138|P2|First 12 Months|Adverse event unrelated to study drug|0
1290488|NCT00320190|4209139|P1|First 12 Months|Adverse event unrelated to study drug|1
1290489|NCT00320190|4209138|P2|First 12 Months|Enrollment failure|1
1290490|NCT00320190|4209139|P1|First 12 Months|Enrollment failure|0
1290491|NCT00320190|4209138|P2|First 12 Months|Lost to Follow-up|1
1290492|NCT00320190|4209139|P1|First 12 Months|Lost to Follow-up|0
1290493|NCT00320190|4209138|P2|First 12 Months|Sponsor terminated study|2
1290494|NCT00320190|4209139|P1|First 12 Months|Sponsor terminated study|2
1290495|NCT00320190|4209138|P2|First 12 Months|Completed but did not enter extension|3
1290496|NCT00320190|4209139|P1|First 12 Months|Completed but did not enter extension|5
1290497|NCT00320112|4209159|P2|Overall Study|Death|1
1290498|NCT00320112|4209160|P1|Overall Study|Death|2
1290499|NCT00320112|4209159|P2|Overall Study|Withdrawal by Subject|0
1290500|NCT00320112|4209160|P1|Overall Study|Withdrawal by Subject|3
1290501|NCT00320112|4209159|P2|Overall Study|Lost to Follow-up|4
1290502|NCT00320112|4209160|P1|Overall Study|Lost to Follow-up|3
1290503|NCT00319982|4209174|P2|Overall Study|Withdrawal by Subject|0
1290504|NCT00319982|4209175|P1|Overall Study|Withdrawal by Subject|1
1290505|NCT00319956|4209195|P2|Overall Study|Death|24
1290506|NCT00319956|4209196|P1|Overall Study|Death|20
1290507|NCT00319839|4209208|P1|Overall Study|Withdrawal by Subject|1
1290508|NCT00319839|4209208|P1|Overall Study|Adverse Event|5
1290509|NCT00319735|4209224|P1|Overall Study|Death|2
1290510|NCT00319696|4209237|P1|Overall Study|Lost to Follow-up|3
1290511|NCT00319696|4209237|P1|Overall Study|administrative|7
1290512|NCT00319696|4209237|P1|Overall Study|withdrawal of consent|14
1290513|NCT00319696|4209237|P1|Overall Study|Adverse Event|36
1290514|NCT00319592|4209273|P2|Overall Study|Physician Decision|1
1290515|NCT00319592|4209274|P1|Overall Study|Physician Decision|0
1290516|NCT00319592|4209273|P2|Overall Study|Protocol Violation|0
1290517|NCT00319592|4209274|P1|Overall Study|Protocol Violation|1
1290518|NCT00319553|4209290|P2|Overall Study|Withdrawal by Subject|1
1290519|NCT00319553|4209291|P1|Overall Study|Withdrawal by Subject|1
1290520|NCT00319553|4209290|P2|Overall Study|Lost to Follow-up|1
1290521|NCT00319553|4209291|P1|Overall Study|Lost to Follow-up|2
1290522|NCT00319553|4209290|P2|Overall Study|Protocol Violation|2
1290523|NCT00319553|4209291|P1|Overall Study|Protocol Violation|1
1290524|NCT00319501|4209305|P2|Open-label Extension Period|Withdrawal by Subject|0
1290525|NCT00319501|4209306|P1|Open-label Extension Period|Withdrawal by Subject|2
1290526|NCT00319501|4209305|P2|Open-label Extension Period|Sponsor request|0
1290527|NCT00319501|4209306|P1|Open-label Extension Period|Sponsor request|26
1290528|NCT00319501|4209305|P2|Open-label Extension Period|Principal investigator decision|0
1290529|NCT00319501|4209306|P1|Open-label Extension Period|Principal investigator decision|2
1290530|NCT00319501|4209305|P2|Open-label Extension Period|Not specified|0
1290531|NCT00319501|4209306|P1|Open-label Extension Period|Not specified|1
1290532|NCT00319501|4209305|P2|Open-label Extension Period|Did not receive treatment|0
1290533|NCT00319501|4209306|P1|Open-label Extension Period|Did not receive treatment|18
1290534|NCT00319501|4209305|P2|Open-label Extension Period|Adverse Event|0
1290535|NCT00319501|4209306|P1|Open-label Extension Period|Adverse Event|2
1290536|NCT00319501|4209305|P2|Open-label Period|Not specified|0
1290537|NCT00319501|4209306|P1|Open-label Period|Not specified|11
1290538|NCT00319501|4209305|P2|Open-label Period|Did not receive treatment|0
1290539|NCT00319501|4209306|P1|Open-label Period|Did not receive treatment|33
1290540|NCT00319501|4209305|P2|Open-label Period|Lost to Follow-up|0
1290541|NCT00319501|4209306|P1|Open-label Period|Lost to Follow-up|5
1290542|NCT00319501|4209305|P2|Open-label Period|Sponsor request|0
1290543|NCT00319501|4209306|P1|Open-label Period|Sponsor request|12
1290544|NCT00319501|4209305|P2|Open-label Period|Principal Investigator decision|0
1290545|NCT00319501|4209306|P1|Open-label Period|Principal Investigator decision|6
1290546|NCT00319501|4209305|P2|Open-label Period|Withdrawal by Subject|0
1290547|NCT00319501|4209306|P1|Open-label Period|Withdrawal by Subject|38
1290548|NCT00319501|4209305|P2|Open-label Period|Protocol Violation|0
1290549|NCT00319501|4209306|P1|Open-label Period|Protocol Violation|6
1290550|NCT00319501|4209305|P2|Open-label Period|Adverse Event|0
1290551|NCT00319501|4209306|P1|Open-label Period|Adverse Event|5
1290552|NCT00319501|4209305|P2|Double-blind Period|Did not receive treatment|29
1290553|NCT00319501|4209306|P1|Double-blind Period|Did not receive treatment|42
1290554|NCT00319501|4209305|P2|Double-blind Period|Sponsor Request|0
1290555|NCT00319501|4209306|P1|Double-blind Period|Sponsor Request|1
1290556|NCT00319501|4209305|P2|Double-blind Period|Withdrawal by Subject|3
1290557|NCT00319501|4209306|P1|Double-blind Period|Withdrawal by Subject|0
1290558|NCT00319449|4209332|P2|Overall Study|Noncompliance with the protocol|0
1290559|NCT00319449|4209333|P1|Overall Study|Noncompliance with the protocol|1
1290560|NCT00319449|4209332|P2|Overall Study|Subject did not wish to continue|0
1290561|NCT00319449|4209333|P1|Overall Study|Subject did not wish to continue|1
1290562|NCT00319436|4209345|P2|Overall Study|Withdrawal by Subject|7
1290563|NCT00319436|4209346|P1|Overall Study|Withdrawal by Subject|6
1290564|NCT00319254|4209364|P1|Overall Study|Enrolled, Not Treated|2
1290565|NCT00319254|4209364|P1|Overall Study|Lost to Follow-up|2
1290566|NCT00319254|4209364|P1|Overall Study|Death|46
1290567|NCT00319254|4209364|P1|Overall Study|Withdrawal by Subject|4
1290568|NCT00319111|4209377|P1|Overall Study|Treatment failure|1
1290569|NCT00319111|4209377|P1|Overall Study|Administrative|2
1290570|NCT00319111|4209377|P1|Overall Study|Lack of clinical improvement|4
1290571|NCT00319111|4209377|P1|Overall Study|Death|9
1290572|NCT00319111|4209377|P1|Overall Study|Withdrawal of consent|11
1290573|NCT00319111|4209377|P1|Overall Study|Adverse Event|20
1290574|NCT00319098|4209391|P2|Overall Study|Protocol Violation|1
1290575|NCT00319098|4209392|P1|Overall Study|Protocol Violation|3
1290576|NCT00319098|4209391|P2|Overall Study|Others|8
1290577|NCT00319098|4209392|P1|Overall Study|Others|33
1290578|NCT00319098|4209391|P2|Overall Study|Lost to Follow-up|13
1290579|NCT00319098|4209392|P1|Overall Study|Lost to Follow-up|37
1290580|NCT00319098|4209391|P2|Overall Study|Migrated/moved from study area|1
1290581|NCT00319098|4209392|P1|Overall Study|Migrated/moved from study area|2
1290582|NCT00319098|4209391|P2|Overall Study|Withdrawal by Subject|8
1290583|NCT00319098|4209392|P1|Overall Study|Withdrawal by Subject|37
1290584|NCT00319098|4209391|P2|Overall Study|Adverse Event|1
1290585|NCT00319098|4209392|P1|Overall Study|Adverse Event|20
1290586|NCT00319098|4209391|P2|Overall Study|Serious adverse event|0
1290587|NCT00319098|4209392|P1|Overall Study|Serious adverse event|3
1290588|NCT00319046|4209450|P1|Overall Study|administrative reason|1
1290589|NCT00319046|4209450|P1|Overall Study|withdrawal of subject's consent|7
1290590|NCT00319020|4209459|P2|Overall Study|Adverse Event|1
1290591|NCT00319020|4209460|P1|Overall Study|Adverse Event|0
1290592|NCT00319020|4209459|P2|Overall Study|Treatment failure|1
1290593|NCT00319020|4209460|P1|Overall Study|Treatment failure|0
1290594|NCT00319020|4209459|P2|Overall Study|Transplant|1
1290595|NCT00319020|4209460|P1|Overall Study|Transplant|0
1290596|NCT00319020|4209459|P2|Overall Study|Disease progression|2
1290597|NCT00319020|4209460|P1|Overall Study|Disease progression|0
1290598|NCT00319020|4209459|P2|Overall Study|Administrative reason|5
1290599|NCT00319020|4209460|P1|Overall Study|Administrative reason|0
1290600|NCT00319020|4209459|P2|Overall Study|F-1 completed but not enrolled in F-2|0
1290601|NCT00319020|4209460|P1|Overall Study|F-1 completed but not enrolled in F-2|1
1290602|NCT00319020|4209459|P2|Overall Study|Withdrawal by Subject|1
1290603|NCT00319020|4209460|P1|Overall Study|Withdrawal by Subject|4
1290604|NCT00319020|4209459|P2|Overall Study|Death|2
1290605|NCT00319020|4209460|P1|Overall Study|Death|2
1290606|NCT00318656|4209532|P2|Overall Study|Did not receive any treatment|1
1290607|NCT00318656|4209533|P1|Overall Study|Did not receive any treatment|0
1290608|NCT00318656|4209532|P2|Overall Study|Took Avandamet instead of Glim/Met|1
1290609|NCT00318656|4209533|P1|Overall Study|Took Avandamet instead of Glim/Met|0
1290610|NCT00318565|4209590|P1|Overall Study|Excluded per protocol|24
1290611|NCT00318474|4209597|P2|Overall Study|Trial terminated|7
1290612|NCT00318474|4209598|P1|Overall Study|Trial terminated|10
1290613|NCT00318474|4209597|P2|Overall Study|Post-therapy hyperflycemia|1
1290614|NCT00318474|4209598|P1|Overall Study|Post-therapy hyperflycemia|0
1290615|NCT00318474|4209597|P2|Overall Study|Fall in GFR|3
1290616|NCT00318474|4209598|P1|Overall Study|Fall in GFR|3
1290617|NCT00318474|4209597|P2|Overall Study|Withdrawal by Subject|2
1290618|NCT00318474|4209598|P1|Overall Study|Withdrawal by Subject|3
1290619|NCT00318474|4209597|P2|Overall Study|Protocol Violation|0
1290620|NCT00318474|4209598|P1|Overall Study|Protocol Violation|1
1290621|NCT00318474|4209597|P2|Overall Study|Pregnancy|2
1290622|NCT00318474|4209598|P1|Overall Study|Pregnancy|0
1290623|NCT00318474|4209597|P2|Overall Study|Lost to Follow-up|1
1290624|NCT00318474|4209598|P1|Overall Study|Lost to Follow-up|0
1290625|NCT00318474|4209597|P2|Overall Study|Adverse Event|1
1290626|NCT00318474|4209598|P1|Overall Study|Adverse Event|1
1290627|NCT00318461|4209609|P5|Open-Label Extension, 18 Months|Protocol Violation|6
1290628|NCT00318461|4209610|P4|Open-Label Extension, 18 Months|Protocol Violation|4
1290629|NCT00318461|4209611|P3|Open-Label Extension, 18 Months|Protocol Violation|3
1290630|NCT00318461|4209612|P2|Open-Label Extension, 18 Months|Protocol Violation|5
1290631|NCT00318461|4209613|P1|Open-Label Extension, 18 Months|Protocol Violation|7
1290632|NCT00318461|4209609|P5|Open-Label Extension, 18 Months|Lack of Efficacy|63
1290633|NCT00318461|4209610|P4|Open-Label Extension, 18 Months|Lack of Efficacy|27
1290634|NCT00318461|4209611|P3|Open-Label Extension, 18 Months|Lack of Efficacy|37
1290635|NCT00318461|4209612|P2|Open-Label Extension, 18 Months|Lack of Efficacy|33
1290636|NCT00318461|4209613|P1|Open-Label Extension, 18 Months|Lack of Efficacy|41
1290637|NCT00318461|4209609|P5|Open-Label Extension, 18 Months|Adverse Event|6
1290638|NCT00318461|4209610|P4|Open-Label Extension, 18 Months|Adverse Event|1
1290639|NCT00318461|4209611|P3|Open-Label Extension, 18 Months|Adverse Event|6
1290640|NCT00318461|4209612|P2|Open-Label Extension, 18 Months|Adverse Event|8
1290641|NCT00318461|4209613|P1|Open-Label Extension, 18 Months|Adverse Event|11
1290642|NCT00318461|4209609|P5|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22
1290643|NCT00318461|4209610|P4|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11
1290644|NCT00318461|4209611|P3|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27
1290645|NCT00318461|4209612|P2|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14
1290646|NCT00318461|4209613|P1|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19
1290647|NCT00318461|4209609|P5|Double-Blind, 6 Months|Fear of experiencing AE again|0
1290648|NCT00318461|4209610|P4|Double-Blind, 6 Months|Fear of experiencing AE again|0
1290649|NCT00318461|4209611|P3|Double-Blind, 6 Months|Fear of experiencing AE again|0
1290650|NCT00318461|4209612|P2|Double-Blind, 6 Months|Fear of experiencing AE again|1
1290651|NCT00318461|4209613|P1|Double-Blind, 6 Months|Fear of experiencing AE again|0
1290652|NCT00318461|4209609|P5|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1
1290653|NCT00318461|4209610|P4|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
1290654|NCT00318461|4209611|P3|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
1290655|NCT00318461|4209612|P2|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
1290656|NCT00318461|4209613|P1|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
1290657|NCT00318461|4209609|P5|Double-Blind, 6 Months|Hyperglicaemia|0
1290658|NCT00318461|4209610|P4|Double-Blind, 6 Months|Hyperglicaemia|1
1290659|NCT00318461|4209611|P3|Double-Blind, 6 Months|Hyperglicaemia|0
1290660|NCT00318461|4209612|P2|Double-Blind, 6 Months|Hyperglicaemia|0
1290661|NCT00318461|4209613|P1|Double-Blind, 6 Months|Hyperglicaemia|0
1290662|NCT00318461|4209609|P5|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2
1290663|NCT00318461|4209610|P4|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
1290664|NCT00318461|4209611|P3|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
1290665|NCT00318461|4209612|P2|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
1290666|NCT00318461|4209613|P1|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
1290667|NCT00318461|4209609|P5|Double-Blind, 6 Months|Lack of time|0
1290668|NCT00318461|4209610|P4|Double-Blind, 6 Months|Lack of time|0
1290669|NCT00318461|4209611|P3|Double-Blind, 6 Months|Lack of time|0
1290670|NCT00318461|4209612|P2|Double-Blind, 6 Months|Lack of time|0
1290671|NCT00318461|4209613|P1|Double-Blind, 6 Months|Lack of time|1
1290672|NCT00318461|4209609|P5|Double-Blind, 6 Months|Investigator decision|1
1290673|NCT00318461|4209610|P4|Double-Blind, 6 Months|Investigator decision|0
1290674|NCT00318461|4209611|P3|Double-Blind, 6 Months|Investigator decision|0
1290675|NCT00318461|4209612|P2|Double-Blind, 6 Months|Investigator decision|0
1290676|NCT00318461|4209613|P1|Double-Blind, 6 Months|Investigator decision|0
1290677|NCT00318461|4209609|P5|Double-Blind, 6 Months|Work commitment|1
1290678|NCT00318461|4209610|P4|Double-Blind, 6 Months|Work commitment|0
1290679|NCT00318461|4209611|P3|Double-Blind, 6 Months|Work commitment|0
1290680|NCT00318461|4209612|P2|Double-Blind, 6 Months|Work commitment|0
1290681|NCT00318461|4209613|P1|Double-Blind, 6 Months|Work commitment|0
1290682|NCT00318461|4209609|P5|Double-Blind, 6 Months|FPG exceeds limits/too high|0
1290683|NCT00318461|4209610|P4|Double-Blind, 6 Months|FPG exceeds limits/too high|2
1290684|NCT00318461|4209611|P3|Double-Blind, 6 Months|FPG exceeds limits/too high|0
1290685|NCT00318461|4209612|P2|Double-Blind, 6 Months|FPG exceeds limits/too high|0
1290686|NCT00318461|4209613|P1|Double-Blind, 6 Months|FPG exceeds limits/too high|1
1290687|NCT00318461|4209609|P5|Double-Blind, 6 Months|Tendency to low blood glucose levels|1
1290688|NCT00318461|4209610|P4|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
1290689|NCT00318461|4209611|P3|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
1290690|NCT00318461|4209612|P2|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
1290691|NCT00318461|4209613|P1|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
1290692|NCT00318461|4209609|P5|Double-Blind, 6 Months|Move|0
1290693|NCT00318461|4209610|P4|Double-Blind, 6 Months|Move|0
1290694|NCT00318461|4209611|P3|Double-Blind, 6 Months|Move|0
1290695|NCT00318461|4209612|P2|Double-Blind, 6 Months|Move|1
1290696|NCT00318461|4209613|P1|Double-Blind, 6 Months|Move|0
1290697|NCT00318461|4209609|P5|Double-Blind, 6 Months|Subject decision/No wish to continue|2
1290698|NCT00318461|4209610|P4|Double-Blind, 6 Months|Subject decision/No wish to continue|0
1290699|NCT00318461|4209611|P3|Double-Blind, 6 Months|Subject decision/No wish to continue|1
1290700|NCT00318461|4209612|P2|Double-Blind, 6 Months|Subject decision/No wish to continue|2
1290701|NCT00318461|4209613|P1|Double-Blind, 6 Months|Subject decision/No wish to continue|0
1290702|NCT00318461|4209609|P5|Double-Blind, 6 Months|Consent withdrawn|4
1290703|NCT00318461|4209610|P4|Double-Blind, 6 Months|Consent withdrawn|10
1290704|NCT00318461|4209611|P3|Double-Blind, 6 Months|Consent withdrawn|4
1290705|NCT00318461|4209612|P2|Double-Blind, 6 Months|Consent withdrawn|3
1290706|NCT00318461|4209613|P1|Double-Blind, 6 Months|Consent withdrawn|0
1290707|NCT00318461|4209609|P5|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
1290708|NCT00318461|4209610|P4|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
1290709|NCT00318461|4209611|P3|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
1290710|NCT00318461|4209612|P2|Double-Blind, 6 Months|Poor compliance/Non-compliance|1
1290711|NCT00318461|4209613|P1|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
1290712|NCT00318461|4209609|P5|Double-Blind, 6 Months|Lost to follow up|0
1290713|NCT00318461|4209610|P4|Double-Blind, 6 Months|Lost to follow up|0
1290714|NCT00318461|4209611|P3|Double-Blind, 6 Months|Lost to follow up|0
1290715|NCT00318461|4209612|P2|Double-Blind, 6 Months|Lost to follow up|1
1290716|NCT00318461|4209613|P1|Double-Blind, 6 Months|Lost to follow up|0
1290717|NCT00318461|4209609|P5|Double-Blind, 6 Months|Protocol Violation|5
1290718|NCT00318461|4209610|P4|Double-Blind, 6 Months|Protocol Violation|4
1290719|NCT00318461|4209611|P3|Double-Blind, 6 Months|Protocol Violation|4
1290720|NCT00318461|4209612|P2|Double-Blind, 6 Months|Protocol Violation|4
1290721|NCT00318461|4209613|P1|Double-Blind, 6 Months|Protocol Violation|2
1290722|NCT00318461|4209609|P5|Double-Blind, 6 Months|Lack of Efficacy|9
1290723|NCT00318461|4209610|P4|Double-Blind, 6 Months|Lack of Efficacy|29
1290724|NCT00318461|4209611|P3|Double-Blind, 6 Months|Lack of Efficacy|13
1290725|NCT00318461|4209612|P2|Double-Blind, 6 Months|Lack of Efficacy|8
1290726|NCT00318461|4209613|P1|Double-Blind, 6 Months|Lack of Efficacy|19
1290727|NCT00318461|4209609|P5|Double-Blind, 6 Months|Adverse Event|8
1290728|NCT00318461|4209610|P4|Double-Blind, 6 Months|Adverse Event|2
1290729|NCT00318461|4209611|P3|Double-Blind, 6 Months|Adverse Event|29
1290730|NCT00318461|4209612|P2|Double-Blind, 6 Months|Adverse Event|23
1290731|NCT00318461|4209613|P1|Double-Blind, 6 Months|Adverse Event|11
1290732|NCT00318370|4209712|P3|Period 3|Other|3
1290733|NCT00318370|4209713|P2|Period 3|Other|0
1290734|NCT00318370|4209714|P1|Period 3|Other|0
1290735|NCT00318370|4209712|P3|Period 3|Withdrawal by Subject|3
1290736|NCT00318370|4209713|P2|Period 3|Withdrawal by Subject|0
1290737|NCT00318370|4209714|P1|Period 3|Withdrawal by Subject|0
1290738|NCT00318370|4209712|P3|Period 3|Physician Decision|1
1290739|NCT00318370|4209713|P2|Period 3|Physician Decision|0
1290740|NCT00318370|4209714|P1|Period 3|Physician Decision|0
1290741|NCT00318370|4209712|P3|Period 3|Death|1
1290742|NCT00318370|4209713|P2|Period 3|Death|0
1290743|NCT00318370|4209714|P1|Period 3|Death|0
1290744|NCT00318370|4209712|P3|Period 3|Lack of Efficacy|24
1290745|NCT00318370|4209713|P2|Period 3|Lack of Efficacy|0
1290746|NCT00318370|4209714|P1|Period 3|Lack of Efficacy|0
1290747|NCT00318370|4209712|P3|Period 3|Adverse Event|1
1290748|NCT00318370|4209713|P2|Period 3|Adverse Event|0
1290749|NCT00318370|4209714|P1|Period 3|Adverse Event|0
1290750|NCT00318370|4209712|P3|Period 2|Other|0
1290751|NCT00318370|4209713|P2|Period 2|Other|1
1290752|NCT00318370|4209714|P1|Period 2|Other|0
1290753|NCT00318370|4209712|P3|Period 2|Withdrawal by Subject|0
1290754|NCT00318370|4209713|P2|Period 2|Withdrawal by Subject|1
1290755|NCT00318370|4209714|P1|Period 2|Withdrawal by Subject|0
1290756|NCT00318370|4209712|P3|Period 2|Physician Decision|0
1290757|NCT00318370|4209713|P2|Period 2|Physician Decision|1
1290758|NCT00318370|4209714|P1|Period 2|Physician Decision|0
1290759|NCT00318370|4209712|P3|Period 2|Lack of Efficacy|0
1290760|NCT00318370|4209713|P2|Period 2|Lack of Efficacy|5
1290761|NCT00318370|4209714|P1|Period 2|Lack of Efficacy|0
1290762|NCT00318370|4209712|P3|Period 2|Adverse Event|0
1290763|NCT00318370|4209713|P2|Period 2|Adverse Event|3
1290764|NCT00318370|4209714|P1|Period 2|Adverse Event|0
1290765|NCT00318370|4209712|P3|Period 1|Withdrawal by Subject|0
1290766|NCT00318370|4209713|P2|Period 1|Withdrawal by Subject|0
1290767|NCT00318370|4209714|P1|Period 1|Withdrawal by Subject|1
1290768|NCT00318370|4209712|P3|Period 1|Physician Decision|0
1290769|NCT00318370|4209713|P2|Period 1|Physician Decision|0
1290770|NCT00318370|4209714|P1|Period 1|Physician Decision|1
1290771|NCT00318370|4209712|P3|Period 1|Lack of Efficacy|0
1290772|NCT00318370|4209713|P2|Period 1|Lack of Efficacy|0
1290773|NCT00318370|4209714|P1|Period 1|Lack of Efficacy|5
1290774|NCT00318149|4209739|P6|Overall Study|Adverse Event|2
1290775|NCT00318149|4209740|P5|Overall Study|Adverse Event|0
1290776|NCT00318149|4209741|P4|Overall Study|Adverse Event|0
1290777|NCT00318149|4209742|P3|Overall Study|Adverse Event|0
1290778|NCT00318149|4209743|P2|Overall Study|Adverse Event|0
1290779|NCT00318149|4209744|P1|Overall Study|Adverse Event|0
1290780|NCT00317642|4209890|P2|Overall Study|AML Not Centrally Confirmed|5
1290781|NCT00317642|4209891|P1|Overall Study|AML Not Centrally Confirmed|1
1290782|NCT00317642|4209890|P2|Overall Study|Referred For Transplantation|0
1290783|NCT00317642|4209891|P1|Overall Study|Referred For Transplantation|1
1290784|NCT00317642|4209890|P2|Overall Study|Withdrawal by Subject|1
1290785|NCT00317642|4209891|P1|Overall Study|Withdrawal by Subject|0
1290786|NCT00317642|4209890|P2|Overall Study|Not Continue to Consolidation|0
1290787|NCT00317642|4209891|P1|Overall Study|Not Continue to Consolidation|2
1290788|NCT00317642|4209890|P2|Overall Study|Death|7
1290789|NCT00317642|4209891|P1|Overall Study|Death|14
1290790|NCT00317642|4209890|P2|Overall Study|Disease Recurrence|2
1290791|NCT00317642|4209891|P1|Overall Study|Disease Recurrence|1
1290792|NCT00317642|4209890|P2|Overall Study|Treatment Failure|102
1290793|NCT00317642|4209891|P1|Overall Study|Treatment Failure|56
1290794|NCT00317642|4209890|P2|Overall Study|Adverse Event|5
1290795|NCT00317642|4209891|P1|Overall Study|Adverse Event|17
1290796|NCT00317642|4209890|P2|Overall Study|Participant declined treatment|3
1290797|NCT00317642|4209891|P1|Overall Study|Participant declined treatment|14
1290798|NCT00317642|4209890|P2|Overall Study|Physician Decision|7
1290799|NCT00317642|4209891|P1|Overall Study|Physician Decision|15
1290800|NCT00317642|4209890|P2|Overall Study|Not Received Either Study Drug|3
1290801|NCT00317642|4209891|P1|Overall Study|Not Received Either Study Drug|1
1290802|NCT00317473|4209970|P6|Overall Study|Other|0
1290803|NCT00317473|4209971|P5|Overall Study|Other|0
1290804|NCT00317473|4209972|P4|Overall Study|Other|0
1290805|NCT00317473|4209973|P3|Overall Study|Other|0
1290806|NCT00317473|4209974|P2|Overall Study|Other|2
1290807|NCT00317473|4209975|P1|Overall Study|Other|0
1290808|NCT00317473|4209970|P6|Overall Study|Death|0
1290809|NCT00317473|4209971|P5|Overall Study|Death|0
1290810|NCT00317473|4209972|P4|Overall Study|Death|0
1290811|NCT00317473|4209973|P3|Overall Study|Death|0
1290812|NCT00317473|4209974|P2|Overall Study|Death|0
1290813|NCT00317473|4209975|P1|Overall Study|Death|1
1290814|NCT00317473|4209970|P6|Overall Study|Relocation|2
1290815|NCT00317473|4209971|P5|Overall Study|Relocation|5
1290816|NCT00317473|4209972|P4|Overall Study|Relocation|1
1290817|NCT00317473|4209973|P3|Overall Study|Relocation|1
1290818|NCT00317473|4209974|P2|Overall Study|Relocation|0
1290819|NCT00317473|4209975|P1|Overall Study|Relocation|1
1290820|NCT00317473|4209970|P6|Overall Study|Withdrawal by Subject|1
1290821|NCT00317473|4209971|P5|Overall Study|Withdrawal by Subject|3
1290822|NCT00317473|4209972|P4|Overall Study|Withdrawal by Subject|1
1290823|NCT00317473|4209973|P3|Overall Study|Withdrawal by Subject|2
1290824|NCT00317473|4209974|P2|Overall Study|Withdrawal by Subject|1
1290825|NCT00317473|4209975|P1|Overall Study|Withdrawal by Subject|2
1290826|NCT00317109|4210014|P2|Overall Study|Migated/moved from study area|0
1290827|NCT00317109|4210015|P1|Overall Study|Migated/moved from study area|1
1290828|NCT00317109|4210014|P2|Overall Study|Withdrawal by Subject|0
1290829|NCT00317109|4210015|P1|Overall Study|Withdrawal by Subject|2
1290830|NCT00317044|4210052|P3|Overall Study|Multiple Reasons|6
1290831|NCT00317044|4210053|P2|Overall Study|Multiple Reasons|2
1290832|NCT00317044|4210054|P1|Overall Study|Multiple Reasons|6
1290833|NCT00317044|4210052|P3|Overall Study|Lost to Follow-up|3
1290834|NCT00317044|4210053|P2|Overall Study|Lost to Follow-up|2
1290835|NCT00317044|4210054|P1|Overall Study|Lost to Follow-up|0
1290836|NCT00317044|4210052|P3|Overall Study|Withdrawal by Subject|12
1290837|NCT00317044|4210053|P2|Overall Study|Withdrawal by Subject|7
1290838|NCT00317044|4210054|P1|Overall Study|Withdrawal by Subject|10
1290839|NCT00317044|4210052|P3|Overall Study|Adverse Event|4
1290840|NCT00317044|4210053|P2|Overall Study|Adverse Event|7
1290841|NCT00317044|4210054|P1|Overall Study|Adverse Event|4
1290842|NCT00317044|4210052|P3|Overall Study|Protocol Violation|20
1290843|NCT00317044|4210053|P2|Overall Study|Protocol Violation|22
1290844|NCT00317044|4210054|P1|Overall Study|Protocol Violation|28
1290845|NCT00316914|4210100|P2|Overall Study|Missing end of treatment documentation|15
1290846|NCT00316914|4210101|P1|Overall Study|Missing end of treatment documentation|14
1290847|NCT00316914|4210100|P2|Overall Study|Other Problems|11
1290848|NCT00316914|4210101|P1|Overall Study|Other Problems|6
1290849|NCT00316914|4210100|P2|Overall Study|Adverse Event|7
1290850|NCT00316914|4210101|P1|Overall Study|Adverse Event|8
1290851|NCT00316914|4210100|P2|Overall Study|Withdrawal by Subject|3
1290852|NCT00316914|4210101|P1|Overall Study|Withdrawal by Subject|5
1290853|NCT00316888|4210131|P2|Overall Study|Not start protocol therapy|1
1290854|NCT00316888|4210132|P1|Overall Study|Not start protocol therapy|0
1290855|NCT00316888|4210131|P2|Overall Study|Withdrawal by Subject|2
1290856|NCT00316888|4210132|P1|Overall Study|Withdrawal by Subject|2
1290857|NCT00316888|4210131|P2|Overall Study|Adverse Event|5
1290858|NCT00316888|4210132|P1|Overall Study|Adverse Event|4
1290859|NCT00316719|4210154|P2|Overall Study|Consent withdrawn|0
1290860|NCT00316719|4210155|P1|Overall Study|Consent withdrawn|2
1290861|NCT00316719|4210154|P2|Overall Study|Adverse Event|6
1290862|NCT00316719|4210155|P1|Overall Study|Adverse Event|0
1290863|NCT00316706|4210181|P2|Overall Study|Lost to Follow-up|48
1290864|NCT00316706|4210182|P1|Overall Study|Lost to Follow-up|38
1290865|NCT00316693|4210198|P2|Overall Study|Other|44
1290866|NCT00316693|4210199|P1|Overall Study|Other|38
1290867|NCT00316693|4210198|P2|Overall Study|Lost to Follow-up|34
1290868|NCT00316693|4210199|P1|Overall Study|Lost to Follow-up|26
1290869|NCT00316693|4210198|P2|Overall Study|Withdrawal by Subject|6
1290870|NCT00316693|4210199|P1|Overall Study|Withdrawal by Subject|6
1290871|NCT00316693|4210198|P2|Overall Study|Protocol Violation|0
1290872|NCT00316693|4210199|P1|Overall Study|Protocol Violation|1
1290873|NCT00316693|4210198|P2|Overall Study|Adverse Event|1
1290874|NCT00316693|4210199|P1|Overall Study|Adverse Event|6
1290875|NCT00316303|4210252|P2|Overall Study|Lost to Follow-up|16
1290876|NCT00316303|4210253|P1|Overall Study|Lost to Follow-up|11
1290877|NCT00316277|4210269|P2|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1
1290878|NCT00316277|4210270|P1|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0
1290879|NCT00316277|4210269|P2|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18
1290880|NCT00316277|4210270|P1|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19
1290881|NCT00316277|4210269|P2|Phase 1 (12 Weeks)|Eligible for Phase 2|225
1290882|NCT00316277|4210270|P1|Phase 1 (12 Weeks)|Eligible for Phase 2|220
1290883|NCT00316277|4210269|P2|Phase 1 (12 Weeks)|Investigator-initiated termination|0
1290884|NCT00316277|4210270|P1|Phase 1 (12 Weeks)|Investigator-initiated termination|2
1290885|NCT00316277|4210269|P2|Phase 1 (12 Weeks)|Lost to Follow-up|75
1290886|NCT00316277|4210270|P1|Phase 1 (12 Weeks)|Lost to Follow-up|88
1290887|NCT00316264|4210291|P3|Overall Study|not specified|0
1290888|NCT00316264|4210292|P2|Overall Study|not specified|1
1290889|NCT00316264|4210293|P1|Overall Study|not specified|1
1290890|NCT00316264|4210291|P3|Overall Study|Death|0
1290891|NCT00316264|4210292|P2|Overall Study|Death|0
1290892|NCT00316264|4210293|P1|Overall Study|Death|2
1290893|NCT00316264|4210291|P3|Overall Study|Withdrawal of Consent|6
1290894|NCT00316264|4210292|P2|Overall Study|Withdrawal of Consent|5
1290895|NCT00316264|4210293|P1|Overall Study|Withdrawal of Consent|3
1290896|NCT00316264|4210291|P3|Overall Study|Lost to Follow-up|0
1290897|NCT00316264|4210292|P2|Overall Study|Lost to Follow-up|1
1290898|NCT00316264|4210293|P1|Overall Study|Lost to Follow-up|0
1290899|NCT00316225|4210361|P1|Overall Study|Death|2
1290900|NCT00316225|4210361|P1|Overall Study|Withdrawal by Subject|3
1290901|NCT00316225|4210361|P1|Overall Study|Progressive Disease|15
1290902|NCT00316225|4210361|P1|Overall Study|Physician Decision|3
1290903|NCT00316225|4210361|P1|Overall Study|Adverse Event|2
1290904|NCT00316199|4210370|P1|Overall Study|Lost to Follow-up|2
1290905|NCT00316199|4210370|P1|Overall Study|Death|8
1290906|NCT00316199|4210370|P1|Overall Study|Adverse Event|2
1290907|NCT00316186|4210378|P1|Overall Study|Other|1
1290908|NCT00316186|4210378|P1|Overall Study|Lost to Follow-up|1
1290909|NCT00316186|4210378|P1|Overall Study|Disease Progression|4
1290910|NCT00316186|4210378|P1|Overall Study|Adverse Event|6
1290911|NCT00316173|4210392|P2|Treatment Phase|Study Follow-up Stopped|34
1290912|NCT00316173|4210393|P1|Treatment Phase|Study Follow-up Stopped|0
1290913|NCT00316173|4210392|P2|Treatment Phase|Withdrawal by Subject|1
1290914|NCT00316173|4210393|P1|Treatment Phase|Withdrawal by Subject|0
1290915|NCT00316173|4210392|P2|Treatment Phase|Lost to Follow-up|3
1290916|NCT00316173|4210393|P1|Treatment Phase|Lost to Follow-up|0
1290917|NCT00316173|4210392|P2|Treatment Phase|Lack of Efficacy|3
1290918|NCT00316173|4210393|P1|Treatment Phase|Lack of Efficacy|0
1290919|NCT00316173|4210392|P2|Treatment Phase|Adverse Event|1
1290920|NCT00316173|4210393|P1|Treatment Phase|Adverse Event|0
1290921|NCT00316173|4210392|P2|Run-in Phase|Study Follow-up Stopped|0
1290922|NCT00316173|4210393|P1|Run-in Phase|Study Follow-up Stopped|5
1290923|NCT00316173|4210392|P2|Run-in Phase|Protocol Violation|0
1290924|NCT00316173|4210393|P1|Run-in Phase|Protocol Violation|1
1290925|NCT00316173|4210392|P2|Run-in Phase|Adverse Event|0
1290926|NCT00316173|4210393|P1|Run-in Phase|Adverse Event|1
1290927|NCT00316121|4210406|P2|Overall Study|Subject did not have 24 month visit|0
1290928|NCT00316121|4210407|P1|Overall Study|Subject did not have 24 month visit|1
1290929|NCT00316121|4210406|P2|Overall Study|Subject no show for visit x 3|0
1290930|NCT00316121|4210407|P1|Overall Study|Subject no show for visit x 3|1
1290931|NCT00316121|4210406|P2|Overall Study|Subject refused to return|0
1290932|NCT00316121|4210407|P1|Overall Study|Subject refused to return|1
1290933|NCT00316121|4210406|P2|Overall Study|Subject relocated|1
1290934|NCT00316121|4210407|P1|Overall Study|Subject relocated|1
1290935|NCT00316121|4210406|P2|Overall Study|Reason is missing|0
1290936|NCT00316121|4210407|P1|Overall Study|Reason is missing|1
1290937|NCT00316121|4210406|P2|Overall Study|Withdrawal by Subject|0
1290938|NCT00316121|4210407|P1|Overall Study|Withdrawal by Subject|2
1290939|NCT00316121|4210406|P2|Overall Study|Lost to Follow-up|8
1290940|NCT00316121|4210407|P1|Overall Study|Lost to Follow-up|14
1290941|NCT00316121|4210406|P2|Overall Study|Death|0
1290942|NCT00316121|4210407|P1|Overall Study|Death|1
1290943|NCT00316082|4210418|P5|Overall Study|Administrative reason by sponsor|0
1290944|NCT00316082|4210419|P4|Overall Study|Administrative reason by sponsor|0
1290945|NCT00316082|4210420|P3|Overall Study|Administrative reason by sponsor|1
1290946|NCT00316082|4210421|P2|Overall Study|Administrative reason by sponsor|0
1290947|NCT00316082|4210422|P1|Overall Study|Administrative reason by sponsor|0
1290948|NCT00316082|4210418|P5|Overall Study|Death|0
1290949|NCT00316082|4210419|P4|Overall Study|Death|0
1290950|NCT00316082|4210420|P3|Overall Study|Death|1
1290951|NCT00316082|4210421|P2|Overall Study|Death|0
1290952|NCT00316082|4210422|P1|Overall Study|Death|0
1290953|NCT00316082|4210418|P5|Overall Study|Physician Decision|1
1290954|NCT00316082|4210419|P4|Overall Study|Physician Decision|1
1290955|NCT00316082|4210420|P3|Overall Study|Physician Decision|2
1290956|NCT00316082|4210421|P2|Overall Study|Physician Decision|1
1290957|NCT00316082|4210422|P1|Overall Study|Physician Decision|1
1290958|NCT00316082|4210418|P5|Overall Study|Subject no longer meets study criteria|1
1290959|NCT00316082|4210419|P4|Overall Study|Subject no longer meets study criteria|2
1290960|NCT00316082|4210420|P3|Overall Study|Subject no longer meets study criteria|2
1290961|NCT00316082|4210421|P2|Overall Study|Subject no longer meets study criteria|1
1290962|NCT00316082|4210422|P1|Overall Study|Subject no longer meets study criteria|3
1290963|NCT00316082|4210418|P5|Overall Study|Adverse Event|3
1290964|NCT00316082|4210419|P4|Overall Study|Adverse Event|1
1290965|NCT00316082|4210420|P3|Overall Study|Adverse Event|5
1290966|NCT00316082|4210421|P2|Overall Study|Adverse Event|2
1290967|NCT00316082|4210422|P1|Overall Study|Adverse Event|4
1290968|NCT00316082|4210418|P5|Overall Study|Poor/noncompliance|4
1290969|NCT00316082|4210419|P4|Overall Study|Poor/noncompliance|1
1290970|NCT00316082|4210420|P3|Overall Study|Poor/noncompliance|4
1290971|NCT00316082|4210421|P2|Overall Study|Poor/noncompliance|1
1290972|NCT00316082|4210422|P1|Overall Study|Poor/noncompliance|6
1290973|NCT00316082|4210418|P5|Overall Study|Lost to Follow-up|6
1290974|NCT00316082|4210419|P4|Overall Study|Lost to Follow-up|8
1290975|NCT00316082|4210420|P3|Overall Study|Lost to Follow-up|7
1290976|NCT00316082|4210421|P2|Overall Study|Lost to Follow-up|6
1290977|NCT00316082|4210422|P1|Overall Study|Lost to Follow-up|7
1290978|NCT00316082|4210418|P5|Overall Study|Withdrawal of Consent by Subject|5
1290979|NCT00316082|4210419|P4|Overall Study|Withdrawal of Consent by Subject|9
1290980|NCT00316082|4210420|P3|Overall Study|Withdrawal of Consent by Subject|2
1290981|NCT00316082|4210421|P2|Overall Study|Withdrawal of Consent by Subject|8
1290982|NCT00316082|4210422|P1|Overall Study|Withdrawal of Consent by Subject|10
1290983|NCT00316082|4210418|P5|Overall Study|Lack of Efficacy|6
1290984|NCT00316082|4210419|P4|Overall Study|Lack of Efficacy|4
1290985|NCT00316082|4210420|P3|Overall Study|Lack of Efficacy|3
1290986|NCT00316082|4210421|P2|Overall Study|Lack of Efficacy|3
1290987|NCT00316082|4210422|P1|Overall Study|Lack of Efficacy|2
1290988|NCT00316017|4210453|P3|Overall Study|Protocol Violation|19
1290989|NCT00316017|4210454|P2|Overall Study|Protocol Violation|13
1290990|NCT00316017|4210455|P1|Overall Study|Protocol Violation|11
1290991|NCT00316004|4210529|P3|Overall Study|Subject was not given study fluid.|21
1290992|NCT00316004|4210530|P2|Overall Study|Subject was not given study fluid.|14
1290993|NCT00316004|4210531|P1|Overall Study|Subject was not given study fluid.|14
1290994|NCT00315731|4210602|P1|Overall Study|Death|5
1290995|NCT00315731|4210602|P1|Overall Study|Lost to Follow-up|1
1290996|NCT00315705|4210630|P1|Phase 2|Death|7
1290997|NCT00315705|4210630|P1|Phase 2|Other|1
1290998|NCT00315705|4210630|P1|Phase 2|Scheduled for transplant|8
1290999|NCT00315705|4210630|P1|Phase 2|Disease relapse|1
1291000|NCT00315705|4210630|P1|Phase 2|Failure to achieve response|3
1291001|NCT00315705|4210630|P1|Phase 2|Adverse Event|1
1291002|NCT00315705|4210630|P1|Phase 2|Physician Decision|4
1291003|NCT00315705|4210630|P1|Phase 1|Death|3
1291004|NCT00315705|4210630|P1|Phase 1|Scheduled for transplant|9
1291005|NCT00315705|4210630|P1|Phase 1|Disease relapse|4
1291006|NCT00315705|4210630|P1|Phase 1|Failure to achieve response|8
1291007|NCT00315705|4210630|P1|Phase 1|Refused further treatment|1
1291008|NCT00315458|4210691|P4|Overall Study|Did not qualify|0
1291009|NCT00315458|4210692|P3|Overall Study|Did not qualify|1
1291010|NCT00315458|4210693|P2|Overall Study|Did not qualify|0
1291011|NCT00315458|4210694|P1|Overall Study|Did not qualify|0
1291012|NCT00315458|4210691|P4|Overall Study|Lack of Efficacy|1
1291013|NCT00315458|4210692|P3|Overall Study|Lack of Efficacy|20
1291014|NCT00315458|4210693|P2|Overall Study|Lack of Efficacy|0
1291015|NCT00315458|4210694|P1|Overall Study|Lack of Efficacy|0
1291016|NCT00315458|4210691|P4|Overall Study|Withdrawal by Subject|2
1291017|NCT00315458|4210692|P3|Overall Study|Withdrawal by Subject|0
1291018|NCT00315458|4210693|P2|Overall Study|Withdrawal by Subject|3
1291019|NCT00315458|4210694|P1|Overall Study|Withdrawal by Subject|0
1291020|NCT00315458|4210691|P4|Overall Study|Lost to Follow-up|2
1291021|NCT00315458|4210692|P3|Overall Study|Lost to Follow-up|0
1291022|NCT00315458|4210693|P2|Overall Study|Lost to Follow-up|2
1291023|NCT00315458|4210694|P1|Overall Study|Lost to Follow-up|1
1291024|NCT00315458|4210691|P4|Overall Study|Adverse Event|3
1291025|NCT00315458|4210692|P3|Overall Study|Adverse Event|23
1291026|NCT00315458|4210693|P2|Overall Study|Adverse Event|4
1291027|NCT00315458|4210694|P1|Overall Study|Adverse Event|2
1291028|NCT00315458|4210691|P4|Overall Study|Administrative|21
1291029|NCT00315458|4210692|P3|Overall Study|Administrative|8
1291030|NCT00315458|4210693|P2|Overall Study|Administrative|3
1291031|NCT00315458|4210694|P1|Overall Study|Administrative|0
1291032|NCT00315445|4210707|P3|Overall Study|Other|0
1291033|NCT00315445|4210708|P2|Overall Study|Other|3
1291034|NCT00315445|4210709|P1|Overall Study|Other|1
1291035|NCT00315445|4210707|P3|Overall Study|Protocol Violation|1
1291036|NCT00315445|4210708|P2|Overall Study|Protocol Violation|0
1291037|NCT00315445|4210709|P1|Overall Study|Protocol Violation|2
1291038|NCT00315445|4210707|P3|Overall Study|Lost to Follow-up|1
1291039|NCT00315445|4210708|P2|Overall Study|Lost to Follow-up|0
1291040|NCT00315445|4210709|P1|Overall Study|Lost to Follow-up|1
1291041|NCT00315445|4210707|P3|Overall Study|Lack of Efficacy|7
1291042|NCT00315445|4210708|P2|Overall Study|Lack of Efficacy|1
1291043|NCT00315445|4210709|P1|Overall Study|Lack of Efficacy|16
1291044|NCT00315445|4210707|P3|Overall Study|Adverse Event|15
1291045|NCT00315445|4210708|P2|Overall Study|Adverse Event|12
1291046|NCT00315445|4210709|P1|Overall Study|Adverse Event|7
1291047|NCT00315055|4210999|P2|Overall Study|Lost to Follow-up|1
1291048|NCT00315055|4211000|P1|Overall Study|Lost to Follow-up|1
1291049|NCT00315055|4210999|P2|Overall Study|Protocol Violation|4
1291050|NCT00315055|4211000|P1|Overall Study|Protocol Violation|2
1291051|NCT00314951|4211018|P2|Follow-up|mITT failure|34
1291052|NCT00314951|4211019|P1|Follow-up|mITT failure|44
1291053|NCT00314951|4211018|P2|Treatment|Didn't meet criteria for mITT population|11
1291054|NCT00314951|4211019|P1|Treatment|Didn't meet criteria for mITT population|16
1291055|NCT00314808|4211029|P1|Overall Study|Withdrawal by Subject/PI without AE|4
1291056|NCT00314808|4211029|P1|Overall Study|Disease Progression without AE|4
1291057|NCT00314574|4211039|P2|Overall Study|Data unknown at database lock|1
1291058|NCT00314574|4211040|P1|Overall Study|Data unknown at database lock|0
1291059|NCT00314574|4211039|P2|Overall Study|Pregnancy|4
1291060|NCT00314574|4211040|P1|Overall Study|Pregnancy|6
1291061|NCT00314574|4211039|P2|Overall Study|Physician Decision|15
1291062|NCT00314574|4211040|P1|Overall Study|Physician Decision|22
1291063|NCT00314574|4211039|P2|Overall Study|Withdrawal by Subject|22
1291064|NCT00314574|4211040|P1|Overall Study|Withdrawal by Subject|33
1291065|NCT00314574|4211039|P2|Overall Study|Lost to Follow-up|25
1291066|NCT00314574|4211040|P1|Overall Study|Lost to Follow-up|19
1291067|NCT00314574|4211039|P2|Overall Study|Adverse Event|16
1291068|NCT00314574|4211040|P1|Overall Study|Adverse Event|11
1291069|NCT00314574|4211039|P2|Overall Study|Death|0
1291070|NCT00314574|4211040|P1|Overall Study|Death|3
1291071|NCT00314366|4211056|P2|Overall Study|not treated due to patient medical condi|0
1291072|NCT00314366|4211057|P1|Overall Study|not treated due to patient medical condi|1
1291073|NCT00314340|4211102|P1|Overall Study|lost interest|1
1291074|NCT00314327|4211108|P1|Overall Study|Withdrawal by Subject|1
1291075|NCT00314262|4211113|P1|Overall Study|Physician Decision|1
1291076|NCT00314262|4211113|P1|Overall Study|Withdrawal by Subject|2
1291077|NCT00314262|4211113|P1|Overall Study|Adverse Event|2
1291078|NCT00314249|4211121|P2|Overall Study|Non-Compliant|6
1291079|NCT00314249|4211122|P1|Overall Study|Non-Compliant|5
1291080|NCT00314249|4211121|P2|Overall Study|Withdrawn for other reasons|1
1291081|NCT00314249|4211122|P1|Overall Study|Withdrawn for other reasons|4
1291082|NCT00314249|4211121|P2|Overall Study|Physician Decision|1
1291083|NCT00314249|4211122|P1|Overall Study|Physician Decision|1
1291084|NCT00314249|4211121|P2|Overall Study|Lost to Follow-up|9
1291085|NCT00314249|4211122|P1|Overall Study|Lost to Follow-up|15
1291086|NCT00314249|4211121|P2|Overall Study|Withdrawal by Subject|28
1291087|NCT00314249|4211122|P1|Overall Study|Withdrawal by Subject|21
1291088|NCT00314249|4211121|P2|Overall Study|Lack of Efficacy|24
1291089|NCT00314249|4211122|P1|Overall Study|Lack of Efficacy|33
1291090|NCT00314249|4211121|P2|Overall Study|Adverse Event|94
1291091|NCT00314249|4211122|P1|Overall Study|Adverse Event|73
1291092|NCT00314145|4211155|P2|Overall Study|Sponsor Decision|0
1291093|NCT00314145|4211156|P1|Overall Study|Sponsor Decision|2
1291094|NCT00314145|4211155|P2|Overall Study|Protocol Violation|0
1291095|NCT00314145|4211156|P1|Overall Study|Protocol Violation|3
1291096|NCT00314145|4211155|P2|Overall Study|Adverse Event|3
1291097|NCT00314145|4211156|P1|Overall Study|Adverse Event|0
1291098|NCT00314145|4211155|P2|Overall Study|Physician Decision|4
1291099|NCT00314145|4211156|P1|Overall Study|Physician Decision|3
1291100|NCT00314145|4211155|P2|Overall Study|Lost to Follow-up|12
1291101|NCT00314145|4211156|P1|Overall Study|Lost to Follow-up|5
1291102|NCT00314145|4211155|P2|Overall Study|Withdrawal by Subject|10
1291103|NCT00314145|4211156|P1|Overall Study|Withdrawal by Subject|8
1291104|NCT00314132|4211170|P2|Overall Study|Physician Decision|0
1291105|NCT00314132|4211171|P1|Overall Study|Physician Decision|1
1291106|NCT00314132|4211170|P2|Overall Study|Adverse Event|0
1291107|NCT00314132|4211171|P1|Overall Study|Adverse Event|1
1291108|NCT00314132|4211170|P2|Overall Study|Withdrawal by Subject|5
1291109|NCT00314132|4211171|P1|Overall Study|Withdrawal by Subject|3
1291110|NCT00314132|4211170|P2|Overall Study|Lost to Follow-up|13
1291111|NCT00314132|4211171|P1|Overall Study|Lost to Follow-up|3
1291112|NCT00313911|4211192|P2|Overall Study|Did not meet age criteria|1
1291113|NCT00313911|4211193|P1|Overall Study|Did not meet age criteria|1
1291114|NCT00313911|4211192|P2|Overall Study|Withdrawal by Subject|12
1291115|NCT00313911|4211193|P1|Overall Study|Withdrawal by Subject|39
1291116|NCT00313911|4211192|P2|Overall Study|Lost to Follow-up|14
1291117|NCT00313911|4211193|P1|Overall Study|Lost to Follow-up|27
1291118|NCT00313911|4211192|P2|Overall Study|Protocol Violation|10
1291119|NCT00313911|4211193|P1|Overall Study|Protocol Violation|19
1291120|NCT00313911|4211192|P2|Overall Study|Adverse Event|3
1291121|NCT00313911|4211193|P1|Overall Study|Adverse Event|2
1291122|NCT00313911|4211192|P2|Overall Study|Serious adverse event|1
1291123|NCT00313911|4211193|P1|Overall Study|Serious adverse event|6
1291124|NCT00313846|4211207|P2|Overall Study|Administrative|3
1291125|NCT00313846|4211208|P1|Overall Study|Administrative|2
1291126|NCT00313846|4211207|P2|Overall Study|Adverse Event|8
1291127|NCT00313846|4211208|P1|Overall Study|Adverse Event|1
1291128|NCT00313846|4211207|P2|Overall Study|Withdrawal by Subject|0
1291129|NCT00313846|4211208|P1|Overall Study|Withdrawal by Subject|2
1291130|NCT00313820|4211219|P2|Pregabalin or Placebo Treatment Period|Other|3
1291131|NCT00313820|4211220|P1|Pregabalin or Placebo Treatment Period|Other|2
1291132|NCT00313820|4211219|P2|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4
1291133|NCT00313820|4211220|P1|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6
1291134|NCT00313820|4211219|P2|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7
1291135|NCT00313820|4211220|P1|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0
1291136|NCT00313820|4211219|P2|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1
1291137|NCT00313820|4211220|P1|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0
1291138|NCT00313820|4211219|P2|Pregabalin or Placebo Treatment Period|Adverse Event|4
1291139|NCT00313820|4211220|P1|Pregabalin or Placebo Treatment Period|Adverse Event|9
1291140|NCT00313820|4211219|P2|Assigned to Treatment|Other|0
1291141|NCT00313820|4211220|P1|Assigned to Treatment|Other|1
1291142|NCT00313781|4211258|P3|After Crossover|Other|18
1291143|NCT00313781|4211259|P2|After Crossover|Other|0
1291144|NCT00313781|4211260|P1|After Crossover|Other|0
1291145|NCT00313781|4211258|P3|After Crossover|Withdrawal by Subject|3
1291146|NCT00313781|4211259|P2|After Crossover|Withdrawal by Subject|0
1291147|NCT00313781|4211260|P1|After Crossover|Withdrawal by Subject|0
1291148|NCT00313781|4211258|P3|After Crossover|Death|6
1291149|NCT00313781|4211259|P2|After Crossover|Death|0
1291150|NCT00313781|4211260|P1|After Crossover|Death|0
1291151|NCT00313781|4211258|P3|Before Crossover|Randomized, not treated|0
1291152|NCT00313781|4211259|P2|Before Crossover|Randomized, not treated|0
1291153|NCT00313781|4211260|P1|Before Crossover|Randomized, not treated|5
1291154|NCT00313781|4211258|P3|Before Crossover|Crossover|0
1291155|NCT00313781|4211259|P2|Before Crossover|Crossover|37
1291156|NCT00313781|4211260|P1|Before Crossover|Crossover|0
1291157|NCT00313781|4211258|P3|Before Crossover|Other|0
1291158|NCT00313781|4211259|P2|Before Crossover|Other|30
1291159|NCT00313781|4211260|P1|Before Crossover|Other|45
1291160|NCT00313781|4211258|P3|Before Crossover|Withdrawal by Subject|0
1291161|NCT00313781|4211259|P2|Before Crossover|Withdrawal by Subject|1
1291162|NCT00313781|4211260|P1|Before Crossover|Withdrawal by Subject|3
1291163|NCT00313781|4211258|P3|Before Crossover|Lost to Follow-up|0
1291164|NCT00313781|4211259|P2|Before Crossover|Lost to Follow-up|3
1291165|NCT00313781|4211260|P1|Before Crossover|Lost to Follow-up|0
1291166|NCT00313781|4211258|P3|Before Crossover|Death|0
1291167|NCT00313781|4211259|P2|Before Crossover|Death|8
1291168|NCT00313781|4211260|P1|Before Crossover|Death|22
1291169|NCT00313716|4211300|P6|Overall Study|Withdrawal by Subject|0
1291170|NCT00313716|4211301|P5|Overall Study|Withdrawal by Subject|1
1291171|NCT00313716|4211302|P4|Overall Study|Withdrawal by Subject|0
1291172|NCT00313716|4211303|P3|Overall Study|Withdrawal by Subject|1
1291173|NCT00313716|4211304|P2|Overall Study|Withdrawal by Subject|1
1291174|NCT00313716|4211305|P1|Overall Study|Withdrawal by Subject|0
1291175|NCT00313716|4211300|P6|Overall Study|Lost to Follow-up|4
1291176|NCT00313716|4211301|P5|Overall Study|Lost to Follow-up|0
1291177|NCT00313716|4211302|P4|Overall Study|Lost to Follow-up|1
1291178|NCT00313716|4211303|P3|Overall Study|Lost to Follow-up|2
1291179|NCT00313716|4211304|P2|Overall Study|Lost to Follow-up|5
1291180|NCT00313716|4211305|P1|Overall Study|Lost to Follow-up|2
1291181|NCT00313716|4211300|P6|Overall Study|Death|9
1291182|NCT00313716|4211301|P5|Overall Study|Death|5
1291183|NCT00313716|4211302|P4|Overall Study|Death|3
1291184|NCT00313716|4211303|P3|Overall Study|Death|9
1291185|NCT00313716|4211304|P2|Overall Study|Death|2
1291186|NCT00313716|4211305|P1|Overall Study|Death|3
1291187|NCT00313703|4211332|P4|Overall Study|Lost to Follow-up|12
1291188|NCT00313703|4211333|P3|Overall Study|Lost to Follow-up|5
1291189|NCT00313703|4211334|P2|Overall Study|Lost to Follow-up|2
1291190|NCT00313703|4211335|P1|Overall Study|Lost to Follow-up|11
1291191|NCT00313612|4211351|P2|Overall Study|Patient never received treatment|1
1291192|NCT00313612|4211352|P1|Overall Study|Patient never received treatment|0
1291193|NCT00313586|4211364|P4|Overall Study|Death before starting treatment|0
1291194|NCT00313586|4211365|P3|Overall Study|Death before starting treatment|0
1291195|NCT00313586|4211366|P2|Overall Study|Death before starting treatment|0
1291196|NCT00313586|4211367|P1|Overall Study|Death before starting treatment|1
1291197|NCT00313586|4211364|P4|Overall Study|Moved|0
1291198|NCT00313586|4211365|P3|Overall Study|Moved|0
1291199|NCT00313586|4211366|P2|Overall Study|Moved|1
1291200|NCT00313586|4211367|P1|Overall Study|Moved|0
1291201|NCT00313586|4211364|P4|Overall Study|Lost insurance|0
1291202|NCT00313586|4211365|P3|Overall Study|Lost insurance|0
1291203|NCT00313586|4211366|P2|Overall Study|Lost insurance|1
1291204|NCT00313586|4211367|P1|Overall Study|Lost insurance|0
1291205|NCT00313586|4211364|P4|Overall Study|Absolute neutrophil count not recovered|0
1291206|NCT00313586|4211365|P3|Overall Study|Absolute neutrophil count not recovered|0
1291207|NCT00313586|4211366|P2|Overall Study|Absolute neutrophil count not recovered|1
1291208|NCT00313586|4211367|P1|Overall Study|Absolute neutrophil count not recovered|2
1291209|NCT00313586|4211364|P4|Overall Study|Physician Decision|0
1291210|NCT00313586|4211365|P3|Overall Study|Physician Decision|0
1291211|NCT00313586|4211366|P2|Overall Study|Physician Decision|1
1291212|NCT00313586|4211367|P1|Overall Study|Physician Decision|2
1291213|NCT00313586|4211364|P4|Overall Study|Did not achieve HI-major/better response|1
1291214|NCT00313586|4211365|P3|Overall Study|Did not achieve HI-major/better response|2
1291215|NCT00313586|4211366|P2|Overall Study|Did not achieve HI-major/better response|7
1291216|NCT00313586|4211367|P1|Overall Study|Did not achieve HI-major/better response|10
1291217|NCT00313586|4211364|P4|Overall Study|Other complicating disease|0
1291218|NCT00313586|4211365|P3|Overall Study|Other complicating disease|0
1291219|NCT00313586|4211366|P2|Overall Study|Other complicating disease|2
1291220|NCT00313586|4211367|P1|Overall Study|Other complicating disease|2
1291221|NCT00313586|4211364|P4|Overall Study|Alternative therapy|0
1291222|NCT00313586|4211365|P3|Overall Study|Alternative therapy|2
1291223|NCT00313586|4211366|P2|Overall Study|Alternative therapy|6
1291224|NCT00313586|4211367|P1|Overall Study|Alternative therapy|3
1291225|NCT00313586|4211364|P4|Overall Study|Withdrawal by Subject|2
1291226|NCT00313586|4211365|P3|Overall Study|Withdrawal by Subject|6
1291227|NCT00313586|4211366|P2|Overall Study|Withdrawal by Subject|6
1291228|NCT00313586|4211367|P1|Overall Study|Withdrawal by Subject|13
1291229|NCT00313586|4211364|P4|Overall Study|Death|7
1291230|NCT00313586|4211365|P3|Overall Study|Death|1
1291231|NCT00313586|4211366|P2|Overall Study|Death|8
1291232|NCT00313586|4211367|P1|Overall Study|Death|11
1291233|NCT00313586|4211364|P4|Overall Study|Adverse Event|10
1291234|NCT00313586|4211365|P3|Overall Study|Adverse Event|3
1291235|NCT00313586|4211366|P2|Overall Study|Adverse Event|18
1291236|NCT00313586|4211367|P1|Overall Study|Adverse Event|12
1291237|NCT00313586|4211364|P4|Overall Study|Disease progression|3
1291238|NCT00313586|4211365|P3|Overall Study|Disease progression|10
1291239|NCT00313586|4211366|P2|Overall Study|Disease progression|19
1291240|NCT00313586|4211367|P1|Overall Study|Disease progression|14
1291241|NCT00313313|4211386|P3|Overall Study|Subject No Longer Meets Study Criteria|2
1291242|NCT00313313|4211387|P2|Overall Study|Subject No Longer Meets Study Criteria|3
1291243|NCT00313313|4211388|P1|Overall Study|Subject No Longer Meets Study Criteria|0
1291244|NCT00313313|4211386|P3|Overall Study|Death|2
1291245|NCT00313313|4211387|P2|Overall Study|Death|0
1291246|NCT00313313|4211388|P1|Overall Study|Death|0
1291247|NCT00313313|4211386|P3|Overall Study|Pregnancy|0
1291248|NCT00313313|4211387|P2|Overall Study|Pregnancy|2
1291249|NCT00313313|4211388|P1|Overall Study|Pregnancy|1
1291250|NCT00313313|4211386|P3|Overall Study|Poor/Noncompliance|2
1291251|NCT00313313|4211387|P2|Overall Study|Poor/Noncompliance|6
1291252|NCT00313313|4211388|P1|Overall Study|Poor/Noncompliance|3
1291253|NCT00313313|4211386|P3|Overall Study|Physician Decision|4
1291254|NCT00313313|4211387|P2|Overall Study|Physician Decision|6
1291255|NCT00313313|4211388|P1|Overall Study|Physician Decision|2
1291256|NCT00313313|4211386|P3|Overall Study|Adverse Event|12
1291257|NCT00313313|4211387|P2|Overall Study|Adverse Event|16
1291258|NCT00313313|4211388|P1|Overall Study|Adverse Event|15
1291259|NCT00313313|4211386|P3|Overall Study|Lost to Follow-up|9
1291260|NCT00313313|4211387|P2|Overall Study|Lost to Follow-up|7
1291261|NCT00313313|4211388|P1|Overall Study|Lost to Follow-up|10
1291262|NCT00313313|4211386|P3|Overall Study|Withdrawal of consent by subject|31
1291263|NCT00313313|4211387|P2|Overall Study|Withdrawal of consent by subject|17
1291264|NCT00313313|4211388|P1|Overall Study|Withdrawal of consent by subject|18
1291265|NCT00313313|4211386|P3|Overall Study|Lack of Efficacy|20
1291266|NCT00313313|4211387|P2|Overall Study|Lack of Efficacy|9
1291267|NCT00313313|4211388|P1|Overall Study|Lack of Efficacy|14
1291268|NCT00313300|4211410|P5|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
1291269|NCT00313300|4211411|P4|Follow-Up(30days)-Randomized Phase B|missing end of study status|2
1291270|NCT00313300|4211412|P3|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
1291271|NCT00313300|4211413|P2|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
1291272|NCT00313300|4211414|P1|Follow-Up(30days)-Randomized Phase B|missing end of study status|1
1291273|NCT00313300|4211410|P5|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1
1291274|NCT00313300|4211411|P4|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2
1291275|NCT00313300|4211412|P3|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
1291276|NCT00313300|4211413|P2|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
1291277|NCT00313300|4211414|P1|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
1291278|NCT00313300|4211410|P5|Follow-Up(30days)-Randomized Phase B|Death|0
1291279|NCT00313300|4211411|P4|Follow-Up(30days)-Randomized Phase B|Death|0
1291280|NCT00313300|4211412|P3|Follow-Up(30days)-Randomized Phase B|Death|0
1291281|NCT00313300|4211413|P2|Follow-Up(30days)-Randomized Phase B|Death|0
1291282|NCT00313300|4211414|P1|Follow-Up(30days)-Randomized Phase B|Death|1
1291283|NCT00313300|4211410|P5|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
1291284|NCT00313300|4211411|P4|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
1291285|NCT00313300|4211412|P3|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2
1291286|NCT00313300|4211413|P2|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0
1291287|NCT00313300|4211414|P1|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
1291288|NCT00313300|4211410|P5|Follow-Up(30days)-Randomized Phase A|Death|0
1291289|NCT00313300|4211411|P4|Follow-Up(30days)-Randomized Phase A|Death|0
1291290|NCT00313300|4211412|P3|Follow-Up(30days)-Randomized Phase A|Death|0
1291291|NCT00313300|4211413|P2|Follow-Up(30days)-Randomized Phase A|Death|1
1291292|NCT00313300|4211414|P1|Follow-Up(30days)-Randomized Phase A|Death|0
1291293|NCT00313300|4211410|P5|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
1291294|NCT00313300|4211411|P4|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
1291295|NCT00313300|4211412|P3|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2
1291296|NCT00313300|4211413|P2|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
1291297|NCT00313300|4211414|P1|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
1291298|NCT00313300|4211410|P5|Randomized in Phase B (26 Weeks)|non-specified|0
1291299|NCT00313300|4211411|P4|Randomized in Phase B (26 Weeks)|non-specified|0
1291300|NCT00313300|4211412|P3|Randomized in Phase B (26 Weeks)|non-specified|0
1291301|NCT00313300|4211413|P2|Randomized in Phase B (26 Weeks)|non-specified|0
1291302|NCT00313300|4211414|P1|Randomized in Phase B (26 Weeks)|non-specified|1
1291303|NCT00313300|4211410|P5|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164
1291304|NCT00313300|4211411|P4|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193
1291305|NCT00313300|4211412|P3|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0
1291306|NCT00313300|4211413|P2|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1
1291307|NCT00313300|4211414|P1|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2
1291308|NCT00313300|4211410|P5|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
1291309|NCT00313300|4211411|P4|Randomized in Phase B (26 Weeks)|no longer meets criteria|0
1291310|NCT00313300|4211412|P3|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
1291311|NCT00313300|4211413|P2|Randomized in Phase B (26 Weeks)|no longer meets criteria|3
1291312|NCT00313300|4211414|P1|Randomized in Phase B (26 Weeks)|no longer meets criteria|9
1291313|NCT00313300|4211410|P5|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
1291314|NCT00313300|4211411|P4|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
1291315|NCT00313300|4211412|P3|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
1291316|NCT00313300|4211413|P2|Randomized in Phase B (26 Weeks)|poor/non-compliance|1
1291317|NCT00313300|4211414|P1|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
1291318|NCT00313300|4211410|P5|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
1291319|NCT00313300|4211411|P4|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
1291320|NCT00313300|4211412|P3|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
1291321|NCT00313300|4211413|P2|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
1291322|NCT00313300|4211414|P1|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5
1291323|NCT00313300|4211410|P5|Randomized in Phase B (26 Weeks)|Death|1
1291324|NCT00313300|4211411|P4|Randomized in Phase B (26 Weeks)|Death|0
1291325|NCT00313300|4211412|P3|Randomized in Phase B (26 Weeks)|Death|1
1291326|NCT00313300|4211413|P2|Randomized in Phase B (26 Weeks)|Death|3
1291327|NCT00313300|4211414|P1|Randomized in Phase B (26 Weeks)|Death|5
1291328|NCT00313300|4211410|P5|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
1291329|NCT00313300|4211411|P4|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15
1291330|NCT00313300|4211412|P3|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
1291331|NCT00313300|4211413|P2|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14
1291332|NCT00313300|4211414|P1|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35
1291333|NCT00313300|4211410|P5|Randomized in Phase B (26 Weeks)|Adverse Event|19
1291334|NCT00313300|4211411|P4|Randomized in Phase B (26 Weeks)|Adverse Event|23
1291335|NCT00313300|4211412|P3|Randomized in Phase B (26 Weeks)|Adverse Event|12
1291336|NCT00313300|4211413|P2|Randomized in Phase B (26 Weeks)|Adverse Event|9
1291337|NCT00313300|4211414|P1|Randomized in Phase B (26 Weeks)|Adverse Event|34
1291338|NCT00313300|4211410|P5|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
1291339|NCT00313300|4211411|P4|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
1291340|NCT00313300|4211412|P3|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
1291341|NCT00313300|4211413|P2|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
1291342|NCT00313300|4211414|P1|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1
1291343|NCT00313300|4211410|P5|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
1291344|NCT00313300|4211411|P4|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
1291345|NCT00313300|4211412|P3|Randomized in Phase A (26 Weeks)|no longer meets criteria|2
1291346|NCT00313300|4211413|P2|Randomized in Phase A (26 Weeks)|no longer meets criteria|3
1291347|NCT00313300|4211414|P1|Randomized in Phase A (26 Weeks)|no longer meets criteria|4
1291348|NCT00313300|4211410|P5|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
1291349|NCT00313300|4211411|P4|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
1291350|NCT00313300|4211412|P3|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1
1291351|NCT00313300|4211413|P2|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2
1291352|NCT00313300|4211414|P1|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3
1291353|NCT00313300|4211410|P5|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
1291354|NCT00313300|4211411|P4|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
1291355|NCT00313300|4211412|P3|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2
1291356|NCT00313300|4211413|P2|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
1291357|NCT00313300|4211414|P1|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
1291358|NCT00313300|4211410|P5|Randomized in Phase A (26 Weeks)|Death|0
1291359|NCT00313300|4211411|P4|Randomized in Phase A (26 Weeks)|Death|0
1291360|NCT00313300|4211412|P3|Randomized in Phase A (26 Weeks)|Death|0
1291361|NCT00313300|4211413|P2|Randomized in Phase A (26 Weeks)|Death|4
1291362|NCT00313300|4211414|P1|Randomized in Phase A (26 Weeks)|Death|3
1291363|NCT00313300|4211410|P5|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
1291364|NCT00313300|4211411|P4|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
1291365|NCT00313300|4211412|P3|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13
1291366|NCT00313300|4211413|P2|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12
1291367|NCT00313300|4211414|P1|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20
1291368|NCT00313300|4211410|P5|Randomized in Phase A (26 Weeks)|Adverse Event|0
1291369|NCT00313300|4211411|P4|Randomized in Phase A (26 Weeks)|Adverse Event|0
1291370|NCT00313300|4211412|P3|Randomized in Phase A (26 Weeks)|Adverse Event|17
1291371|NCT00313300|4211413|P2|Randomized in Phase A (26 Weeks)|Adverse Event|14
1291372|NCT00313300|4211414|P1|Randomized in Phase A (26 Weeks)|Adverse Event|19
1291373|NCT00313170|4211484|P3|Overall Study|brain mets. after randomisation|1
1291374|NCT00313170|4211485|P2|Overall Study|brain mets. after randomisation|0
1291375|NCT00313170|4211486|P1|Overall Study|brain mets. after randomisation|0
1291376|NCT00313170|4211484|P3|Overall Study|dosing error|1
1291377|NCT00313170|4211485|P2|Overall Study|dosing error|0
1291378|NCT00313170|4211486|P1|Overall Study|dosing error|0
1291379|NCT00313170|4211484|P3|Overall Study|Clinical progression|0
1291380|NCT00313170|4211485|P2|Overall Study|Clinical progression|0
1291381|NCT00313170|4211486|P1|Overall Study|Clinical progression|1
1291382|NCT00313170|4211484|P3|Overall Study|Lost to Follow-up|1
1291383|NCT00313170|4211485|P2|Overall Study|Lost to Follow-up|0
1291384|NCT00313170|4211486|P1|Overall Study|Lost to Follow-up|0
1291385|NCT00313170|4211484|P3|Overall Study|Incorrect enrollment|1
1291386|NCT00313170|4211485|P2|Overall Study|Incorrect enrollment|1
1291387|NCT00313170|4211486|P1|Overall Study|Incorrect enrollment|0
1291388|NCT00313170|4211484|P3|Overall Study|Withdrawal by Subject|1
1291389|NCT00313170|4211485|P2|Overall Study|Withdrawal by Subject|1
1291390|NCT00313170|4211486|P1|Overall Study|Withdrawal by Subject|1
1291391|NCT00313170|4211484|P3|Overall Study|Disease progression|27
1291392|NCT00313170|4211485|P2|Overall Study|Disease progression|26
1291393|NCT00313170|4211486|P1|Overall Study|Disease progression|31
1291394|NCT00313170|4211484|P3|Overall Study|Adverse Event|0
1291395|NCT00313170|4211485|P2|Overall Study|Adverse Event|2
1291396|NCT00313170|4211486|P1|Overall Study|Adverse Event|2
1291397|NCT00313170|4211484|P3|Overall Study|Death|0
1291398|NCT00313170|4211485|P2|Overall Study|Death|4
1291399|NCT00313170|4211486|P1|Overall Study|Death|1
1291400|NCT00313144|4211502|P1|Overall Study|Due to termination of the study|66
1291401|NCT00313144|4211502|P1|Overall Study|Change to different product|1
1291402|NCT00313144|4211502|P1|Overall Study|Insurance (homecare provider) change|1
1291403|NCT00313144|4211502|P1|Overall Study|Liver transplant|1
1291404|NCT00313144|4211502|P1|Overall Study|Adverse event - transient|5
1291405|NCT00313144|4211502|P1|Overall Study|Physician Decision|4
1291406|NCT00313144|4211502|P1|Overall Study|Terminated by sponsor/ homecare provider|4
1291407|NCT00313144|4211502|P1|Overall Study|Withdrawal by Subject|4
1291408|NCT00313144|4211502|P1|Overall Study|Lost to Follow-up|5
1291409|NCT00313144|4211502|P1|Overall Study|Death|7
1291410|NCT00313144|4211502|P1|Overall Study|Discontinue Aralast ≥4 consecutive doses|12
1291411|NCT00313014|4211589|P3|Overall Study|Lack of Efficacy|16
1291412|NCT00313014|4211590|P2|Overall Study|Lack of Efficacy|25
1291413|NCT00313014|4211591|P1|Overall Study|Lack of Efficacy|52
1291414|NCT00313014|4211589|P3|Overall Study|Administrative|14
1291415|NCT00313014|4211590|P2|Overall Study|Administrative|6
1291416|NCT00313014|4211591|P1|Overall Study|Administrative|9
1291417|NCT00313014|4211589|P3|Overall Study|Lost to Follow-up|10
1291418|NCT00313014|4211590|P2|Overall Study|Lost to Follow-up|6
1291419|NCT00313014|4211591|P1|Overall Study|Lost to Follow-up|7
1291420|NCT00313014|4211589|P3|Overall Study|Adverse Event|16
1291421|NCT00313014|4211590|P2|Overall Study|Adverse Event|29
1291422|NCT00313014|4211591|P1|Overall Study|Adverse Event|14
1291423|NCT00313014|4211589|P3|Overall Study|Withdrawal by Subject|5
1291424|NCT00313014|4211590|P2|Overall Study|Withdrawal by Subject|7
1291425|NCT00313014|4211591|P1|Overall Study|Withdrawal by Subject|11
1291426|NCT00312897|4211622|P2|Overall Study|discontinued prior to getting treatment|3
1291427|NCT00312897|4211623|P1|Overall Study|discontinued prior to getting treatment|0
1291428|NCT00312897|4211622|P2|Overall Study|Pregnancy|0
1291429|NCT00312897|4211623|P1|Overall Study|Pregnancy|1
1291430|NCT00312897|4211622|P2|Overall Study|Withdrawal by Subject|3
1291431|NCT00312897|4211623|P1|Overall Study|Withdrawal by Subject|1
1291432|NCT00312897|4211622|P2|Overall Study|Physician Decision|0
1291433|NCT00312897|4211623|P1|Overall Study|Physician Decision|1
1291434|NCT00312897|4211622|P2|Overall Study|Lost to Follow-up|0
1291435|NCT00312897|4211623|P1|Overall Study|Lost to Follow-up|2
1291436|NCT00312897|4211622|P2|Overall Study|Adverse Event|0
1291437|NCT00312897|4211623|P1|Overall Study|Adverse Event|1
1291438|NCT00312858|4211648|P2|Overall Study|Other|12
1291439|NCT00312858|4211649|P1|Overall Study|Other|9
1291440|NCT00312858|4211648|P2|Overall Study|Participant Moved|10
1291441|NCT00312858|4211649|P1|Overall Study|Participant Moved|11
1291442|NCT00312858|4211648|P2|Overall Study|Withdraw by Participant|20
1291443|NCT00312858|4211649|P1|Overall Study|Withdraw by Participant|20
1291444|NCT00312858|4211648|P2|Overall Study|Protocol Violation|8
1291445|NCT00312858|4211649|P1|Overall Study|Protocol Violation|3
1291446|NCT00312858|4211648|P2|Overall Study|Lost to Follow-up|42
1291447|NCT00312858|4211649|P1|Overall Study|Lost to Follow-up|25
1291448|NCT00312858|4211648|P2|Overall Study|Adverse Event|1
1291449|NCT00312858|4211649|P1|Overall Study|Adverse Event|0
1291450|NCT00312845|4211703|P2|Overall Study|Other|5
1291451|NCT00312845|4211704|P1|Overall Study|Other|6
1291452|NCT00312845|4211703|P2|Overall Study|Lost to Follow-up|0
1291453|NCT00312845|4211704|P1|Overall Study|Lost to Follow-up|2
1291454|NCT00312845|4211703|P2|Overall Study|Disease Progression|77
1291455|NCT00312845|4211704|P1|Overall Study|Disease Progression|56
1291456|NCT00312845|4211703|P2|Overall Study|Withdrawal by Subject|6
1291457|NCT00312845|4211704|P1|Overall Study|Withdrawal by Subject|14
1291458|NCT00312845|4211703|P2|Overall Study|Death|2
1291459|NCT00312845|4211704|P1|Overall Study|Death|2
1291460|NCT00312845|4211703|P2|Overall Study|Adverse Event|5
1291461|NCT00312845|4211704|P1|Overall Study|Adverse Event|19
1291462|NCT00312728|4211712|P1|Overall Study|Other|1
1291463|NCT00312728|4211712|P1|Overall Study|Other|10
1291464|NCT00312728|4211712|P1|Overall Study|Protocol Violation|2
1291465|NCT00312728|4211712|P1|Overall Study|Required non-protocol cancer treatment|2
1291466|NCT00312728|4211712|P1|Overall Study|Withdrawal by Subject|10
1291467|NCT00312728|4211712|P1|Overall Study|Adverse Event|32
1291468|NCT00312728|4211712|P1|Overall Study|Progressive disease|53
1291469|NCT00312702|4211724|P3|Immunization Phase|Lost to Follow-up|0
1291470|NCT00312702|4211725|P2|Immunization Phase|Lost to Follow-up|1
1291471|NCT00312702|4211726|P1|Immunization Phase|Lost to Follow-up|0
1291472|NCT00312663|4211739|P3|Immunization Phase|Adverse Event|0
1291473|NCT00312663|4211740|P2|Immunization Phase|Adverse Event|1
1291474|NCT00312663|4211741|P1|Immunization Phase|Adverse Event|0
1291475|NCT00312572|4211754|P2|Overall Study|Lack of Efficacy|2
1291476|NCT00312572|4211755|P1|Overall Study|Lack of Efficacy|1
1291477|NCT00312572|4211754|P2|Overall Study|Administrative|2
1291478|NCT00312572|4211755|P1|Overall Study|Administrative|4
1291479|NCT00312572|4211754|P2|Overall Study|Lost to Follow-up|1
1291480|NCT00312572|4211755|P1|Overall Study|Lost to Follow-up|1
1291481|NCT00312572|4211754|P2|Overall Study|Adverse Event|16
1291482|NCT00312572|4211755|P1|Overall Study|Adverse Event|10
1291483|NCT00312494|4211766|P3|Overall Study|Other|1
1291484|NCT00312494|4211767|P2|Overall Study|Other|10
1291485|NCT00312494|4211768|P1|Overall Study|Other|10
1291486|NCT00312494|4211766|P3|Overall Study|Withdrawal by Subject|10
1291487|NCT00312494|4211767|P2|Overall Study|Withdrawal by Subject|9
1291488|NCT00312494|4211768|P1|Overall Study|Withdrawal by Subject|6
1291489|NCT00312494|4211766|P3|Overall Study|Lost to Follow-up|8
1291490|NCT00312494|4211767|P2|Overall Study|Lost to Follow-up|8
1291491|NCT00312494|4211768|P1|Overall Study|Lost to Follow-up|8
1291492|NCT00312494|4211766|P3|Overall Study|Laboratory abnormality|0
1291493|NCT00312494|4211767|P2|Overall Study|Laboratory abnormality|0
1291494|NCT00312494|4211768|P1|Overall Study|Laboratory abnormality|1
1291495|NCT00312494|4211766|P3|Overall Study|Lack of Efficacy|8
1291496|NCT00312494|4211767|P2|Overall Study|Lack of Efficacy|6
1291497|NCT00312494|4211768|P1|Overall Study|Lack of Efficacy|4
1291498|NCT00312494|4211766|P3|Overall Study|Adverse Event|11
1291499|NCT00312494|4211767|P2|Overall Study|Adverse Event|15
1291500|NCT00312494|4211768|P1|Overall Study|Adverse Event|33
1291501|NCT00312494|4211766|P3|Overall Study|Randomized; not treated with study drug|5
1291502|NCT00312494|4211767|P2|Overall Study|Randomized; not treated with study drug|10
1291503|NCT00312494|4211768|P1|Overall Study|Randomized; not treated with study drug|9
1291504|NCT00312377|4211802|P2|Overall Study|Site ended participation in study|0
1291505|NCT00312377|4211803|P1|Overall Study|Site ended participation in study|1
1291506|NCT00312377|4211802|P2|Overall Study|Discontinue treatment survival follow up|200
1291507|NCT00312377|4211803|P1|Overall Study|Discontinue treatment survival follow up|202
1291508|NCT00312377|4211802|P2|Overall Study|Randomised but never received treatment|6
1291509|NCT00312377|4211803|P1|Overall Study|Randomised but never received treatment|6
1291510|NCT00312377|4211802|P2|Overall Study|Non-compliance|2
1291511|NCT00312377|4211803|P1|Overall Study|Non-compliance|0
1291512|NCT00312377|4211802|P2|Overall Study|Lost to Follow-up|12
1291513|NCT00312377|4211803|P1|Overall Study|Lost to Follow-up|9
1291514|NCT00312377|4211802|P2|Overall Study|Withdrawal by Subject|30
1291515|NCT00312377|4211803|P1|Overall Study|Withdrawal by Subject|23
1291516|NCT00312377|4211802|P2|Overall Study|Death|418
1291517|NCT00312377|4211803|P1|Overall Study|Death|403
1291518|NCT00312338|4211827|P2|Overall Study|Subsequent infection|0
1291519|NCT00312338|4211828|P1|Overall Study|Subsequent infection|2
1291520|NCT00312338|4211827|P2|Overall Study|Withdrawal by Subject|0
1291521|NCT00312338|4211828|P1|Overall Study|Withdrawal by Subject|4
1291522|NCT00312338|4211827|P2|Overall Study|Lost to Follow-up|1
1291523|NCT00312338|4211828|P1|Overall Study|Lost to Follow-up|9
1291524|NCT00312338|4211827|P2|Overall Study|Adverse Event|2
1291525|NCT00312338|4211828|P1|Overall Study|Adverse Event|7
1291526|NCT00312221|4211841|P4|Double-blind Phase|Lack of Efficacy|10
1291527|NCT00312221|4211842|P3|Double-blind Phase|Lack of Efficacy|6
1291528|NCT00312221|4211843|P2|Double-blind Phase|Lack of Efficacy|17
1291529|NCT00312221|4211844|P1|Double-blind Phase|Lack of Efficacy|0
1291530|NCT00312221|4211841|P4|Double-blind Phase|Administrative|33
1291531|NCT00312221|4211842|P3|Double-blind Phase|Administrative|37
1291532|NCT00312221|4211843|P2|Double-blind Phase|Administrative|26
1291533|NCT00312221|4211844|P1|Double-blind Phase|Administrative|0
1291534|NCT00312221|4211841|P4|Double-blind Phase|Lost to Follow-up|2
1291535|NCT00312221|4211842|P3|Double-blind Phase|Lost to Follow-up|2
1291536|NCT00312221|4211843|P2|Double-blind Phase|Lost to Follow-up|0
1291537|NCT00312221|4211844|P1|Double-blind Phase|Lost to Follow-up|0
1291538|NCT00312221|4211841|P4|Double-blind Phase|Adverse Event|18
1291539|NCT00312221|4211842|P3|Double-blind Phase|Adverse Event|19
1291540|NCT00312221|4211843|P2|Double-blind Phase|Adverse Event|10
1291541|NCT00312221|4211844|P1|Double-blind Phase|Adverse Event|0
1291542|NCT00312221|4211841|P4|Double-blind Phase|Withdrawal by Subject|7
1291543|NCT00312221|4211842|P3|Double-blind Phase|Withdrawal by Subject|8
1291544|NCT00312221|4211843|P2|Double-blind Phase|Withdrawal by Subject|6
1291545|NCT00312221|4211844|P1|Double-blind Phase|Withdrawal by Subject|0
1291546|NCT00312221|4211841|P4|Open-label Run-in Period|Did not qualify|0
1291547|NCT00312221|4211842|P3|Open-label Run-in Period|Did not qualify|0
1291548|NCT00312221|4211843|P2|Open-label Run-in Period|Did not qualify|0
1291549|NCT00312221|4211844|P1|Open-label Run-in Period|Did not qualify|5
1291550|NCT00312221|4211841|P4|Open-label Run-in Period|Lack of Efficacy|0
1291551|NCT00312221|4211842|P3|Open-label Run-in Period|Lack of Efficacy|0
1291552|NCT00312221|4211843|P2|Open-label Run-in Period|Lack of Efficacy|0
1291553|NCT00312221|4211844|P1|Open-label Run-in Period|Lack of Efficacy|102
1291554|NCT00312221|4211841|P4|Open-label Run-in Period|Administrative|0
1291555|NCT00312221|4211842|P3|Open-label Run-in Period|Administrative|0
1291556|NCT00312221|4211843|P2|Open-label Run-in Period|Administrative|0
1291557|NCT00312221|4211844|P1|Open-label Run-in Period|Administrative|42
1291558|NCT00312221|4211841|P4|Open-label Run-in Period|Lost to Follow-up|0
1291559|NCT00312221|4211842|P3|Open-label Run-in Period|Lost to Follow-up|0
1291560|NCT00312221|4211843|P2|Open-label Run-in Period|Lost to Follow-up|0
1291561|NCT00312221|4211844|P1|Open-label Run-in Period|Lost to Follow-up|5
1291562|NCT00312221|4211841|P4|Open-label Run-in Period|Adverse Event|0
1291563|NCT00312221|4211842|P3|Open-label Run-in Period|Adverse Event|0
1291564|NCT00312221|4211843|P2|Open-label Run-in Period|Adverse Event|0
1291565|NCT00312221|4211844|P1|Open-label Run-in Period|Adverse Event|74
1291566|NCT00312221|4211841|P4|Open-label Run-in Period|Withdrawal by Subject|0
1291567|NCT00312221|4211842|P3|Open-label Run-in Period|Withdrawal by Subject|0
1291568|NCT00312221|4211843|P2|Open-label Run-in Period|Withdrawal by Subject|0
1291569|NCT00312221|4211844|P1|Open-label Run-in Period|Withdrawal by Subject|6
1291570|NCT00312208|4211864|P2|Overall Study|Not specified|7
1291571|NCT00312208|4211865|P1|Overall Study|Not specified|5
1291572|NCT00312208|4211864|P2|Overall Study|Withdrawal by Subject|42
1291573|NCT00312208|4211865|P1|Overall Study|Withdrawal by Subject|53
1291574|NCT00312208|4211864|P2|Overall Study|Lost to Follow-up|5
1291575|NCT00312208|4211865|P1|Overall Study|Lost to Follow-up|3
1291576|NCT00312208|4211864|P2|Overall Study|Lack of Efficacy|4
1291577|NCT00312208|4211865|P1|Overall Study|Lack of Efficacy|7
1291578|NCT00312208|4211864|P2|Overall Study|Death|1
1291579|NCT00312208|4211865|P1|Overall Study|Death|2
1291580|NCT00312208|4211864|P2|Overall Study|Protocol Violation|3
1291581|NCT00312208|4211865|P1|Overall Study|Protocol Violation|5
1291582|NCT00312208|4211864|P2|Overall Study|Adverse Event|61
1291583|NCT00312208|4211865|P1|Overall Study|Adverse Event|97
1291584|NCT00312195|4211875|P2|Overall Study|Protocol Violation|0
1291585|NCT00312195|4211876|P1|Overall Study|Protocol Violation|1
1291586|NCT00312195|4211875|P2|Overall Study|Lost to Follow-up|0
1291587|NCT00312195|4211876|P1|Overall Study|Lost to Follow-up|1
1291588|NCT00312195|4211875|P2|Overall Study|Adverse Event|6
1291589|NCT00312195|4211876|P1|Overall Study|Adverse Event|4
1291590|NCT00311584|4211903|P2|Overall Study|ineligible|2
1291591|NCT00311584|4211904|P1|Overall Study|ineligible|2
1291592|NCT00311584|4211903|P2|Overall Study|Withdrawal by Subject|1
1291593|NCT00311584|4211904|P1|Overall Study|Withdrawal by Subject|1
1291594|NCT00311584|4211903|P2|Overall Study|Physician Decision|5
1291595|NCT00311584|4211904|P1|Overall Study|Physician Decision|4
1291596|NCT00311584|4211903|P2|Overall Study|Lack of Efficacy|15
1291597|NCT00311584|4211904|P1|Overall Study|Lack of Efficacy|12
1291598|NCT00311584|4211903|P2|Overall Study|Death|0
1291599|NCT00311584|4211904|P1|Overall Study|Death|1
1291600|NCT00311402|4211912|P2|Overall Study|IRB's rejection etc.|3
1291601|NCT00311402|4211913|P1|Overall Study|IRB's rejection etc.|10
1291602|NCT00311402|4211912|P2|Overall Study|Protocol Violation|6
1291603|NCT00311402|4211913|P1|Overall Study|Protocol Violation|7
1291604|NCT00311402|4211912|P2|Overall Study|Lack of Efficacy|42
1291605|NCT00311402|4211913|P1|Overall Study|Lack of Efficacy|58
1291606|NCT00311402|4211912|P2|Overall Study|Withdrawal by Subject|18
1291607|NCT00311402|4211913|P1|Overall Study|Withdrawal by Subject|17
1291608|NCT00311402|4211912|P2|Overall Study|Lost to Follow-up|3
1291609|NCT00311402|4211913|P1|Overall Study|Lost to Follow-up|0
1291610|NCT00311402|4211912|P2|Overall Study|Adverse Event|105
1291611|NCT00311402|4211913|P1|Overall Study|Adverse Event|118
1291612|NCT00311363|4211962|P3|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
1291613|NCT00311363|4211963|P2|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1
1291614|NCT00311363|4211964|P1|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
1291615|NCT00311363|4211962|P3|12-Week Double-Blind Treatment Period|Protocol Violation|2
1291616|NCT00311363|4211963|P2|12-Week Double-Blind Treatment Period|Protocol Violation|1
1291617|NCT00311363|4211964|P1|12-Week Double-Blind Treatment Period|Protocol Violation|0
1291618|NCT00311363|4211962|P3|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4
1291619|NCT00311363|4211963|P2|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2
1291620|NCT00311363|4211964|P1|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0
1291621|NCT00311363|4211962|P3|12-Week Double-Blind Treatment Period|Lack of Efficacy|4
1291622|NCT00311363|4211963|P2|12-Week Double-Blind Treatment Period|Lack of Efficacy|6
1291623|NCT00311363|4211964|P1|12-Week Double-Blind Treatment Period|Lack of Efficacy|0
1291624|NCT00311363|4211962|P3|12-Week Double-Blind Treatment Period|Lost to Follow-up|2
1291625|NCT00311363|4211963|P2|12-Week Double-Blind Treatment Period|Lost to Follow-up|1
1291626|NCT00311363|4211964|P1|12-Week Double-Blind Treatment Period|Lost to Follow-up|0
1291627|NCT00311363|4211962|P3|12-Week Double-Blind Treatment Period|Adverse Event|0
1291628|NCT00311363|4211963|P2|12-Week Double-Blind Treatment Period|Adverse Event|3
1291629|NCT00311363|4211964|P1|12-Week Double-Blind Treatment Period|Adverse Event|0
1291630|NCT00311363|4211962|P3|24-Week Single-Blind Treatment Period|Death|0
1291631|NCT00311363|4211963|P2|24-Week Single-Blind Treatment Period|Death|0
1291632|NCT00311363|4211964|P1|24-Week Single-Blind Treatment Period|Death|1
1291633|NCT00311363|4211962|P3|24-Week Single-Blind Treatment Period|Pregnancy|0
1291634|NCT00311363|4211963|P2|24-Week Single-Blind Treatment Period|Pregnancy|0
1291635|NCT00311363|4211964|P1|24-Week Single-Blind Treatment Period|Pregnancy|1
1291636|NCT00311363|4211962|P3|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
1291637|NCT00311363|4211963|P2|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
1291638|NCT00311363|4211964|P1|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1
1291639|NCT00311363|4211962|P3|24-Week Single-Blind Treatment Period|Elective Surgery|0
1291640|NCT00311363|4211963|P2|24-Week Single-Blind Treatment Period|Elective Surgery|0
1291641|NCT00311363|4211964|P1|24-Week Single-Blind Treatment Period|Elective Surgery|1
1291642|NCT00311363|4211962|P3|24-Week Single-Blind Treatment Period|Protocol Violation|0
1291643|NCT00311363|4211963|P2|24-Week Single-Blind Treatment Period|Protocol Violation|0
1291644|NCT00311363|4211964|P1|24-Week Single-Blind Treatment Period|Protocol Violation|8
1291645|NCT00311363|4211962|P3|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
1291646|NCT00311363|4211963|P2|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
1291647|NCT00311363|4211964|P1|24-Week Single-Blind Treatment Period|Lost to Follow-up|12
1291648|NCT00311363|4211962|P3|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
1291649|NCT00311363|4211963|P2|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
1291650|NCT00311363|4211964|P1|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27
1291651|NCT00311363|4211962|P3|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
1291652|NCT00311363|4211963|P2|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
1291653|NCT00311363|4211964|P1|24-Week Single-Blind Treatment Period|Lack of Efficacy|13
1291654|NCT00311363|4211962|P3|24-Week Single-Blind Treatment Period|Adverse Event|0
1291655|NCT00311363|4211963|P2|24-Week Single-Blind Treatment Period|Adverse Event|0
1291656|NCT00311363|4211964|P1|24-Week Single-Blind Treatment Period|Adverse Event|42
1291657|NCT00311311|4212024|P2|Overall Study|Lack of ancillary assistance|1
1291658|NCT00311311|4212025|P1|Overall Study|Lack of ancillary assistance|0
1291659|NCT00311311|4212024|P2|Overall Study|Death|0
1291660|NCT00311311|4212025|P1|Overall Study|Death|1
1291661|NCT00311311|4212024|P2|Overall Study|Study Termination by Sponsor|4
1291662|NCT00311311|4212025|P1|Overall Study|Study Termination by Sponsor|3
1291663|NCT00311311|4212024|P2|Overall Study|Noncompliance|1
1291664|NCT00311311|4212025|P1|Overall Study|Noncompliance|0
1291665|NCT00311311|4212024|P2|Overall Study|Withdrawal by Subject|1
1291666|NCT00311311|4212025|P1|Overall Study|Withdrawal by Subject|1
1291667|NCT00311311|4212024|P2|Overall Study|Adverse Event|2
1291668|NCT00311311|4212025|P1|Overall Study|Adverse Event|3
1291669|NCT00311181|4212075|P1|Overall Study|Final DFTs were not obtained|96
1291670|NCT00311155|4212081|P1|Overall Study|Did not meet entry criteria|55
1291671|NCT00311155|4212081|P1|Overall Study|Withdrawal by Subject|17
1291672|NCT00311155|4212081|P1|Overall Study|Adverse Event|21
1291673|NCT00310856|4212093|P3|Overall Study|Unable to classify|0
1291674|NCT00310856|4212094|P2|Overall Study|Unable to classify|0
1291675|NCT00310856|4212095|P1|Overall Study|Unable to classify|1
1291676|NCT00310856|4212093|P3|Overall Study|Inappropriate enrollment|0
1291677|NCT00310856|4212094|P2|Overall Study|Inappropriate enrollment|1
1291678|NCT00310856|4212095|P1|Overall Study|Inappropriate enrollment|1
1291679|NCT00310856|4212093|P3|Overall Study|Lost to Follow-up|6
1291680|NCT00310856|4212094|P2|Overall Study|Lost to Follow-up|2
1291681|NCT00310856|4212095|P1|Overall Study|Lost to Follow-up|1
1291682|NCT00310856|4212093|P3|Overall Study|Withdrawal by Subject|2
1291683|NCT00310856|4212094|P2|Overall Study|Withdrawal by Subject|2
1291684|NCT00310856|4212095|P1|Overall Study|Withdrawal by Subject|2
1291685|NCT00310817|4212119|P4|Overall Study|Unable to classify|0
1291686|NCT00310817|4212120|P3|Overall Study|Unable to classify|0
1291687|NCT00310817|4212121|P2|Overall Study|Unable to classify|1
1291688|NCT00310817|4212122|P1|Overall Study|Unable to classify|3
1291689|NCT00310817|4212119|P4|Overall Study|Protocol Violation|1
1291690|NCT00310817|4212120|P3|Overall Study|Protocol Violation|1
1291691|NCT00310817|4212121|P2|Overall Study|Protocol Violation|1
1291692|NCT00310817|4212122|P1|Overall Study|Protocol Violation|1
1291693|NCT00310817|4212119|P4|Overall Study|Inappropriate Enrollment|0
1291694|NCT00310817|4212120|P3|Overall Study|Inappropriate Enrollment|1
1291695|NCT00310817|4212121|P2|Overall Study|Inappropriate Enrollment|0
1291696|NCT00310817|4212122|P1|Overall Study|Inappropriate Enrollment|1
1291697|NCT00310817|4212119|P4|Overall Study|Lost to Follow-up|0
1291698|NCT00310817|4212120|P3|Overall Study|Lost to Follow-up|0
1291699|NCT00310817|4212121|P2|Overall Study|Lost to Follow-up|1
1291700|NCT00310817|4212122|P1|Overall Study|Lost to Follow-up|2
1291701|NCT00310817|4212119|P4|Overall Study|Withdrawal by Subject|7
1291702|NCT00310817|4212120|P3|Overall Study|Withdrawal by Subject|6
1291703|NCT00310817|4212121|P2|Overall Study|Withdrawal by Subject|4
1291704|NCT00310817|4212122|P1|Overall Study|Withdrawal by Subject|1
1291705|NCT00310817|4212119|P4|Overall Study|AE or Death|0
1291706|NCT00310817|4212120|P3|Overall Study|AE or Death|0
1291707|NCT00310817|4212121|P2|Overall Study|AE or Death|1
1291708|NCT00310817|4212122|P1|Overall Study|AE or Death|3
1291709|NCT00310804|4212210|P2|Overall Study|Withdrawal by Subject|0
1291710|NCT00310804|4212211|P1|Overall Study|Withdrawal by Subject|3
1291711|NCT00310804|4212210|P2|Overall Study|Lost to Follow-up|0
1291712|NCT00310804|4212211|P1|Overall Study|Lost to Follow-up|2
1291713|NCT00310440|4212270|P2|Overall Study|Missed 12 Month Visit|4
1291714|NCT00310440|4212271|P1|Overall Study|Missed 12 Month Visit|7
1291715|NCT00310440|4212270|P2|Overall Study|Withdrawal by Subject|1
1291716|NCT00310440|4212271|P1|Overall Study|Withdrawal by Subject|2
1291717|NCT00310440|4212270|P2|Overall Study|Lost to Follow-up|8
1291718|NCT00310440|4212271|P1|Overall Study|Lost to Follow-up|17
1291719|NCT00310388|4212335|P2|Safety Follow-up Continuation Phase|Study Closed/Terminated|2
1291720|NCT00310388|4212336|P1|Safety Follow-up Continuation Phase|Study Closed/Terminated|0
1291721|NCT00310388|4212335|P2|Safety Follow-up Continuation Phase|Withdrawal by Subject|5
1291722|NCT00310388|4212336|P1|Safety Follow-up Continuation Phase|Withdrawal by Subject|0
1291723|NCT00310388|4212335|P2|Safety Follow-up Continuation Phase|Adverse Event|1
1291724|NCT00310388|4212336|P1|Safety Follow-up Continuation Phase|Adverse Event|0
1291725|NCT00310388|4212335|P2|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5
1291726|NCT00310388|4212336|P1|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0
1291727|NCT00310388|4212335|P2|Primary Reporting Phase|Other|0
1291728|NCT00310388|4212336|P1|Primary Reporting Phase|Other|1
1291729|NCT00310388|4212335|P2|Primary Reporting Phase|Missing|0
1291730|NCT00310388|4212336|P1|Primary Reporting Phase|Missing|1
1291731|NCT00310388|4212335|P2|Primary Reporting Phase|Participant retired the informed consent|0
1291732|NCT00310388|4212336|P1|Primary Reporting Phase|Participant retired the informed consent|1
1291733|NCT00310388|4212335|P2|Primary Reporting Phase|Participant passed away|0
1291734|NCT00310388|4212336|P1|Primary Reporting Phase|Participant passed away|1
1291735|NCT00310388|4212335|P2|Primary Reporting Phase|Due to pigmentation risk concerns|0
1291736|NCT00310388|4212336|P1|Primary Reporting Phase|Due to pigmentation risk concerns|2
1291737|NCT00310388|4212335|P2|Primary Reporting Phase|Ongoing SAE from parent study|0
1291738|NCT00310388|4212336|P1|Primary Reporting Phase|Ongoing SAE from parent study|1
1291739|NCT00310388|4212335|P2|Primary Reporting Phase|Termination of study at sponsor request|0
1291740|NCT00310388|4212336|P1|Primary Reporting Phase|Termination of study at sponsor request|3
1291741|NCT00310388|4212335|P2|Primary Reporting Phase|Participant Immigrated to New Zealand|0
1291742|NCT00310388|4212336|P1|Primary Reporting Phase|Participant Immigrated to New Zealand|1
1291743|NCT00310388|4212335|P2|Primary Reporting Phase|Discontinuation of study|0
1291744|NCT00310388|4212336|P1|Primary Reporting Phase|Discontinuation of study|1
1291745|NCT00310388|4212335|P2|Primary Reporting Phase|Ministry of Health decision|0
1291746|NCT00310388|4212336|P1|Primary Reporting Phase|Ministry of Health decision|25
1291747|NCT00310388|4212335|P2|Primary Reporting Phase|Participant request|0
1291748|NCT00310388|4212336|P1|Primary Reporting Phase|Participant request|2
1291749|NCT00310388|4212335|P2|Primary Reporting Phase|Participant request unrelated to study|0
1291750|NCT00310388|4212336|P1|Primary Reporting Phase|Participant request unrelated to study|2
1291751|NCT00310388|4212335|P2|Primary Reporting Phase|Failed to return|0
1291752|NCT00310388|4212336|P1|Primary Reporting Phase|Failed to return|8
1291753|NCT00310388|4212335|P2|Primary Reporting Phase|Request of the sponsor|0
1291754|NCT00310388|4212336|P1|Primary Reporting Phase|Request of the sponsor|19
1291755|NCT00310388|4212335|P2|Primary Reporting Phase|Physician Decision|0
1291756|NCT00310388|4212336|P1|Primary Reporting Phase|Physician Decision|2
1291757|NCT00310388|4212335|P2|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0
1291758|NCT00310388|4212336|P1|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3
1291759|NCT00310388|4212335|P2|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0
1291760|NCT00310388|4212336|P1|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3
1291761|NCT00310388|4212335|P2|Primary Reporting Phase|Change in participant medical condition|0
1291762|NCT00310388|4212336|P1|Primary Reporting Phase|Change in participant medical condition|3
1291763|NCT00310388|4212335|P2|Primary Reporting Phase|Pregnancy|0
1291764|NCT00310388|4212336|P1|Primary Reporting Phase|Pregnancy|3
1291765|NCT00310388|4212335|P2|Primary Reporting Phase|Protocol Violation|0
1291766|NCT00310388|4212336|P1|Primary Reporting Phase|Protocol Violation|10
1291767|NCT00310388|4212335|P2|Primary Reporting Phase|Withdrawal by Subject|0
1291768|NCT00310388|4212336|P1|Primary Reporting Phase|Withdrawal by Subject|97
1291769|NCT00310388|4212335|P2|Primary Reporting Phase|Lack of Efficacy|0
1291770|NCT00310388|4212336|P1|Primary Reporting Phase|Lack of Efficacy|56
1291771|NCT00310388|4212335|P2|Primary Reporting Phase|Adverse Event|0
1291772|NCT00310388|4212336|P1|Primary Reporting Phase|Adverse Event|101
1291773|NCT00310375|4212378|P3|Safety Follow-up Continuation Phase|Lost to Follow-up|1
1291774|NCT00310375|4212379|P2|Safety Follow-up Continuation Phase|Lost to Follow-up|0
1291775|NCT00310375|4212380|P1|Safety Follow-up Continuation Phase|Lost to Follow-up|0
1291776|NCT00310375|4212378|P3|Primary Reporting Phase|Request of Ethics Committee|0
1291777|NCT00310375|4212379|P2|Primary Reporting Phase|Request of Ethics Committee|1
1291778|NCT00310375|4212380|P1|Primary Reporting Phase|Request of Ethics Committee|0
1291779|NCT00310375|4212378|P3|Primary Reporting Phase|Par. switched to commercial product|0
1291780|NCT00310375|4212379|P2|Primary Reporting Phase|Par. switched to commercial product|1
1291781|NCT00310375|4212380|P1|Primary Reporting Phase|Par. switched to commercial product|0
1291782|NCT00310375|4212378|P3|Primary Reporting Phase|Missed study drug for 2 months|0
1291783|NCT00310375|4212379|P2|Primary Reporting Phase|Missed study drug for 2 months|0
1291784|NCT00310375|4212380|P1|Primary Reporting Phase|Missed study drug for 2 months|1
1291785|NCT00310375|4212378|P3|Primary Reporting Phase|Site closure|0
1291786|NCT00310375|4212379|P2|Primary Reporting Phase|Site closure|0
1291787|NCT00310375|4212380|P1|Primary Reporting Phase|Site closure|3
1291788|NCT00310375|4212378|P3|Primary Reporting Phase|Missed study drug >5 days|0
1291789|NCT00310375|4212379|P2|Primary Reporting Phase|Missed study drug >5 days|0
1291790|NCT00310375|4212380|P1|Primary Reporting Phase|Missed study drug >5 days|1
1291791|NCT00310375|4212378|P3|Primary Reporting Phase|Going for temporal lobectomy|0
1291792|NCT00310375|4212379|P2|Primary Reporting Phase|Going for temporal lobectomy|0
1291793|NCT00310375|4212380|P1|Primary Reporting Phase|Going for temporal lobectomy|1
1291794|NCT00310375|4212378|P3|Primary Reporting Phase|Participant request unrelated to study|0
1291795|NCT00310375|4212379|P2|Primary Reporting Phase|Participant request unrelated to study|2
1291796|NCT00310375|4212380|P1|Primary Reporting Phase|Participant request unrelated to study|1
1291797|NCT00310375|4212378|P3|Primary Reporting Phase|Failed to return|0
1291798|NCT00310375|4212379|P2|Primary Reporting Phase|Failed to return|3
1291799|NCT00310375|4212380|P1|Primary Reporting Phase|Failed to return|1
1291800|NCT00310375|4212378|P3|Primary Reporting Phase|Request of the sponsor|0
1291801|NCT00310375|4212379|P2|Primary Reporting Phase|Request of the sponsor|2
1291802|NCT00310375|4212380|P1|Primary Reporting Phase|Request of the sponsor|2
1291803|NCT00310375|4212378|P3|Primary Reporting Phase|Physician Decision|0
1291804|NCT00310375|4212379|P2|Primary Reporting Phase|Physician Decision|3
1291805|NCT00310375|4212380|P1|Primary Reporting Phase|Physician Decision|5
1291806|NCT00310375|4212378|P3|Primary Reporting Phase|Transaminase >5 upper limit of normal|0
1291807|NCT00310375|4212379|P2|Primary Reporting Phase|Transaminase >5 upper limit of normal|1
1291808|NCT00310375|4212380|P1|Primary Reporting Phase|Transaminase >5 upper limit of normal|2
1291809|NCT00310375|4212378|P3|Primary Reporting Phase|Change in Par medical condition|0
1291810|NCT00310375|4212379|P2|Primary Reporting Phase|Change in Par medical condition|0
1291811|NCT00310375|4212380|P1|Primary Reporting Phase|Change in Par medical condition|2
1291812|NCT00310375|4212378|P3|Primary Reporting Phase|Protocol Violation|0
1291813|NCT00310375|4212379|P2|Primary Reporting Phase|Protocol Violation|5
1291814|NCT00310375|4212380|P1|Primary Reporting Phase|Protocol Violation|8
1291815|NCT00310375|4212378|P3|Primary Reporting Phase|Withdrawal by Subject|0
1291816|NCT00310375|4212379|P2|Primary Reporting Phase|Withdrawal by Subject|7
1291817|NCT00310375|4212380|P1|Primary Reporting Phase|Withdrawal by Subject|10
1291818|NCT00310375|4212378|P3|Primary Reporting Phase|Pregnancy|0
1291819|NCT00310375|4212379|P2|Primary Reporting Phase|Pregnancy|2
1291820|NCT00310375|4212380|P1|Primary Reporting Phase|Pregnancy|2
1291821|NCT00310375|4212378|P3|Primary Reporting Phase|Lack of Efficacy|0
1291822|NCT00310375|4212379|P2|Primary Reporting Phase|Lack of Efficacy|19
1291823|NCT00310375|4212380|P1|Primary Reporting Phase|Lack of Efficacy|24
1291824|NCT00310375|4212378|P3|Primary Reporting Phase|Adverse Event|0
1291825|NCT00310375|4212379|P2|Primary Reporting Phase|Adverse Event|22
1291826|NCT00310375|4212380|P1|Primary Reporting Phase|Adverse Event|28
1291827|NCT00310037|4212479|P2|Overall Study|Non-protocol treatment|0
1291828|NCT00310037|4212480|P1|Overall Study|Non-protocol treatment|1
1291829|NCT00310037|4212479|P2|Overall Study|Progression|0
1291830|NCT00310037|4212480|P1|Overall Study|Progression|6
1291831|NCT00310037|4212479|P2|Overall Study|Withdrawal by Subject|3
1291832|NCT00310037|4212480|P1|Overall Study|Withdrawal by Subject|4
1291833|NCT00310037|4212479|P2|Overall Study|Adverse Event|14
1291834|NCT00310037|4212480|P1|Overall Study|Adverse Event|7
1291835|NCT00309985|4212494|P2|Overall Study|Chemotherapy discontinued only|0
1291836|NCT00309985|4212495|P1|Overall Study|Chemotherapy discontinued only|1
1291837|NCT00309985|4212494|P2|Overall Study|Non-compliance|0
1291838|NCT00309985|4212495|P1|Overall Study|Non-compliance|1
1291839|NCT00309985|4212494|P2|Overall Study|Complicating disease|0
1291840|NCT00309985|4212495|P1|Overall Study|Complicating disease|1
1291841|NCT00309985|4212494|P2|Overall Study|Never started treatment|0
1291842|NCT00309985|4212495|P1|Overall Study|Never started treatment|7
1291843|NCT00309985|4212494|P2|Overall Study|Physician Decision|0
1291844|NCT00309985|4212495|P1|Overall Study|Physician Decision|3
1291845|NCT00309985|4212494|P2|Overall Study|Withdrawal by Subject|1
1291846|NCT00309985|4212495|P1|Overall Study|Withdrawal by Subject|5
1291847|NCT00309985|4212494|P2|Overall Study|Death|0
1291848|NCT00309985|4212495|P1|Overall Study|Death|2
1291849|NCT00309985|4212494|P2|Overall Study|Adverse Event|0
1291850|NCT00309985|4212495|P1|Overall Study|Adverse Event|30
1291851|NCT00309985|4212494|P2|Overall Study|Disease progression|0
1291852|NCT00309985|4212495|P1|Overall Study|Disease progression|12
1291853|NCT00309946|4212511|P1|Overall Study|Withdrawal by Subject|1
1291854|NCT00309907|4212517|P1|Overall Study|Major infectious event|4
1291855|NCT00309907|4212517|P1|Overall Study|Ineligible|11
1291856|NCT00309907|4212517|P1|Overall Study|Physician Decision|1
1291857|NCT00309907|4212517|P1|Overall Study|Death|4
1291858|NCT00309777|4212530|P4|Overall Study|Death|0
1291859|NCT00309777|4212531|P3|Overall Study|Death|0
1291860|NCT00309777|4212532|P2|Overall Study|Death|1
1291861|NCT00309777|4212533|P1|Overall Study|Death|0
1291862|NCT00309777|4212530|P4|Overall Study|Lost to Follow-up|0
1291863|NCT00309777|4212531|P3|Overall Study|Lost to Follow-up|1
1291864|NCT00309777|4212532|P2|Overall Study|Lost to Follow-up|0
1291865|NCT00309777|4212533|P1|Overall Study|Lost to Follow-up|0
1291866|NCT00309777|4212530|P4|Overall Study|Withdrawal by Subject|2
1291867|NCT00309777|4212531|P3|Overall Study|Withdrawal by Subject|7
1291868|NCT00309777|4212532|P2|Overall Study|Withdrawal by Subject|5
1291869|NCT00309777|4212533|P1|Overall Study|Withdrawal by Subject|6
1291870|NCT00309777|4212530|P4|Overall Study|Protocol Violation|1
1291871|NCT00309777|4212531|P3|Overall Study|Protocol Violation|3
1291872|NCT00309777|4212532|P2|Overall Study|Protocol Violation|1
1291873|NCT00309777|4212533|P1|Overall Study|Protocol Violation|4
1291874|NCT00309777|4212530|P4|Overall Study|Adverse Event|1
1291875|NCT00309777|4212531|P3|Overall Study|Adverse Event|8
1291876|NCT00309777|4212532|P2|Overall Study|Adverse Event|2
1291877|NCT00309777|4212533|P1|Overall Study|Adverse Event|13
1291878|NCT00309608|4212574|P5|Overall Study|Other incl. Lack of efficacy|0
1291879|NCT00309608|4212575|P4|Overall Study|Other incl. Lack of efficacy|4
1291880|NCT00309608|4212576|P3|Overall Study|Other incl. Lack of efficacy|3
1291881|NCT00309608|4212577|P2|Overall Study|Other incl. Lack of efficacy|4
1291882|NCT00309608|4212578|P1|Overall Study|Other incl. Lack of efficacy|10
1291883|NCT00309608|4212574|P5|Overall Study|Withdrawal by Subject|0
1291884|NCT00309608|4212575|P4|Overall Study|Withdrawal by Subject|0
1291885|NCT00309608|4212576|P3|Overall Study|Withdrawal by Subject|2
1291886|NCT00309608|4212577|P2|Overall Study|Withdrawal by Subject|4
1291887|NCT00309608|4212578|P1|Overall Study|Withdrawal by Subject|1
1291888|NCT00309608|4212574|P5|Overall Study|Lost to Follow-up|1
1291889|NCT00309608|4212575|P4|Overall Study|Lost to Follow-up|0
1291890|NCT00309608|4212576|P3|Overall Study|Lost to Follow-up|2
1291891|NCT00309608|4212577|P2|Overall Study|Lost to Follow-up|0
1291892|NCT00309608|4212578|P1|Overall Study|Lost to Follow-up|0
1291893|NCT00309608|4212574|P5|Overall Study|Protocol Violation|0
1291894|NCT00309608|4212575|P4|Overall Study|Protocol Violation|0
1291895|NCT00309608|4212576|P3|Overall Study|Protocol Violation|0
1291896|NCT00309608|4212577|P2|Overall Study|Protocol Violation|0
1291897|NCT00309608|4212578|P1|Overall Study|Protocol Violation|2
1291898|NCT00309608|4212574|P5|Overall Study|Adverse Event|3
1291899|NCT00309608|4212575|P4|Overall Study|Adverse Event|2
1291900|NCT00309608|4212576|P3|Overall Study|Adverse Event|3
1291901|NCT00309608|4212577|P2|Overall Study|Adverse Event|5
1291902|NCT00309608|4212578|P1|Overall Study|Adverse Event|1
1291903|NCT00309452|4212626|P2|Overall Study|Withdrawal by Subject|0
1291904|NCT00309452|4212627|P1|Overall Study|Withdrawal by Subject|3
1291905|NCT00309387|4212655|P2|Overall Study|Lost to Follow-up|86
1291906|NCT00309387|4212656|P1|Overall Study|Lost to Follow-up|70
1291907|NCT00309387|4212655|P2|Overall Study|Death|73
1291908|NCT00309387|4212656|P1|Overall Study|Death|72
1291909|NCT00309244|4212674|P2|Overall Study|Death|1
1291910|NCT00309244|4212675|P1|Overall Study|Death|4
1291911|NCT00309244|4212674|P2|Overall Study|Randomized but not dosed|12
1291912|NCT00309244|4212675|P1|Overall Study|Randomized but not dosed|11
1291913|NCT00309244|4212674|P2|Overall Study|Various|7
1291914|NCT00309244|4212675|P1|Overall Study|Various|7
1291915|NCT00309244|4212674|P2|Overall Study|Withdrawal by Subject|32
1291916|NCT00309244|4212675|P1|Overall Study|Withdrawal by Subject|50
1291917|NCT00309244|4212674|P2|Overall Study|Protocol Violation|3
1291918|NCT00309244|4212675|P1|Overall Study|Protocol Violation|6
1291919|NCT00309244|4212674|P2|Overall Study|Physician Decision|8
1291920|NCT00309244|4212675|P1|Overall Study|Physician Decision|5
1291921|NCT00309244|4212674|P2|Overall Study|Lost to Follow-up|22
1291922|NCT00309244|4212675|P1|Overall Study|Lost to Follow-up|6
1291923|NCT00309244|4212674|P2|Overall Study|Adverse Event|12
1291924|NCT00309244|4212675|P1|Overall Study|Adverse Event|29
1291925|NCT00309166|4212697|P2|Overall Study|Withdrawal by Subject|3
1291926|NCT00309166|4212698|P1|Overall Study|Withdrawal by Subject|4
1291927|NCT00309166|4212697|P2|Overall Study|Adverse event, non-fatal|0
1291928|NCT00309166|4212698|P1|Overall Study|Adverse event, non-fatal|1
1291929|NCT00308997|4212726|P2|Overall Study|Unable to tolerate intervention|0
1291930|NCT00308997|4212727|P1|Overall Study|Unable to tolerate intervention|1
1291931|NCT00308997|4212726|P2|Overall Study|Subject feigned clinical data|1
1291932|NCT00308997|4212727|P1|Overall Study|Subject feigned clinical data|0
1291933|NCT00308737|4212746|P3|Overall Study|Various|8
1291934|NCT00308737|4212747|P2|Overall Study|Various|20
1291935|NCT00308737|4212748|P1|Overall Study|Various|32
1291936|NCT00308737|4212746|P3|Overall Study|Withdrawal by Subject|18
1291937|NCT00308737|4212747|P2|Overall Study|Withdrawal by Subject|166
1291938|NCT00308737|4212748|P1|Overall Study|Withdrawal by Subject|218
1291939|NCT00308737|4212746|P3|Overall Study|Protocol Violation|5
1291940|NCT00308737|4212747|P2|Overall Study|Protocol Violation|9
1291941|NCT00308737|4212748|P1|Overall Study|Protocol Violation|34
1291942|NCT00308737|4212746|P3|Overall Study|Physician Decision|1
1291943|NCT00308737|4212747|P2|Overall Study|Physician Decision|2
1291944|NCT00308737|4212748|P1|Overall Study|Physician Decision|15
1291945|NCT00308737|4212746|P3|Overall Study|Lost to Follow-up|5
1291946|NCT00308737|4212747|P2|Overall Study|Lost to Follow-up|80
1291947|NCT00308737|4212748|P1|Overall Study|Lost to Follow-up|56
1291948|NCT00308737|4212746|P3|Overall Study|Death|0
1291949|NCT00308737|4212747|P2|Overall Study|Death|3
1291950|NCT00308737|4212748|P1|Overall Study|Death|4
1291951|NCT00308737|4212746|P3|Overall Study|Adverse Event|0
1291952|NCT00308737|4212747|P2|Overall Study|Adverse Event|9
1291953|NCT00308737|4212748|P1|Overall Study|Adverse Event|104
1291954|NCT00308711|4212788|P3|Overall Study|Subject incarcerated, data not allowed|1
1291955|NCT00308711|4212789|P2|Overall Study|Subject incarcerated, data not allowed|0
1291956|NCT00308711|4212790|P1|Overall Study|Subject incarcerated, data not allowed|0
1291957|NCT00308711|4212788|P3|Overall Study|Baby not born within 7 days of treatment|2
1291958|NCT00308711|4212789|P2|Overall Study|Baby not born within 7 days of treatment|2
1291959|NCT00308711|4212790|P1|Overall Study|Baby not born within 7 days of treatment|1
1291960|NCT00308711|4212788|P3|Overall Study|Lost to Follow-up|0
1291961|NCT00308711|4212789|P2|Overall Study|Lost to Follow-up|1
1291962|NCT00308711|4212790|P1|Overall Study|Lost to Follow-up|0
1291963|NCT00308711|4212788|P3|Overall Study|Protocol Violation|1
1291964|NCT00308711|4212789|P2|Overall Study|Protocol Violation|1
1291965|NCT00308711|4212790|P1|Overall Study|Protocol Violation|0
1291966|NCT00308711|4212788|P3|Overall Study|Withdrawal by Subject|1
1291967|NCT00308711|4212789|P2|Overall Study|Withdrawal by Subject|0
1291968|NCT00308711|4212790|P1|Overall Study|Withdrawal by Subject|1
1291969|NCT00308620|4212825|P3|Overall Study|Lost to Follow-up|1
1291970|NCT00308620|4212826|P2|Overall Study|Lost to Follow-up|0
1291971|NCT00308620|4212827|P1|Overall Study|Lost to Follow-up|0
1291972|NCT00308620|4212825|P3|Overall Study|Death|0
1291973|NCT00308620|4212826|P2|Overall Study|Death|1
1291974|NCT00308620|4212827|P1|Overall Study|Death|1
1291975|NCT00308581|4212836|P3|Randomized Maintenance Phase|Unknown reason|0
1291976|NCT00308581|4212837|P2|Randomized Maintenance Phase|Unknown reason|0
1291977|NCT00308581|4212838|P1|Randomized Maintenance Phase|Unknown reason|3
1291978|NCT00308581|4212836|P3|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0
1291979|NCT00308581|4212837|P2|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59
1291980|NCT00308581|4212838|P1|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82
1291981|NCT00308581|4212836|P3|Randomized Maintenance Phase|Withdrawal by Subject|0
1291982|NCT00308581|4212837|P2|Randomized Maintenance Phase|Withdrawal by Subject|4
1291983|NCT00308581|4212838|P1|Randomized Maintenance Phase|Withdrawal by Subject|1
1291984|NCT00308581|4212836|P3|Randomized Maintenance Phase|Lost to Follow-up|0
1291985|NCT00308581|4212837|P2|Randomized Maintenance Phase|Lost to Follow-up|2
1291986|NCT00308581|4212838|P1|Randomized Maintenance Phase|Lost to Follow-up|0
1291987|NCT00308581|4212836|P3|Randomized Maintenance Phase|Lack of Efficacy|0
1291988|NCT00308581|4212837|P2|Randomized Maintenance Phase|Lack of Efficacy|21
1291989|NCT00308581|4212838|P1|Randomized Maintenance Phase|Lack of Efficacy|9
1291990|NCT00308581|4212836|P3|Randomized Maintenance Phase|Adverse Event|0
1291991|NCT00308581|4212837|P2|Randomized Maintenance Phase|Adverse Event|17
1291992|NCT00308581|4212838|P1|Randomized Maintenance Phase|Adverse Event|10
1291993|NCT00308581|4212836|P3|Induction Phase|Unknown reason|3
1291994|NCT00308581|4212837|P2|Induction Phase|Unknown reason|0
1291995|NCT00308581|4212838|P1|Induction Phase|Unknown reason|0
1291996|NCT00308581|4212836|P3|Induction Phase|Withdrawal by Subject|5
1291997|NCT00308581|4212837|P2|Induction Phase|Withdrawal by Subject|0
1291998|NCT00308581|4212838|P1|Induction Phase|Withdrawal by Subject|0
1291999|NCT00308581|4212836|P3|Induction Phase|Lack of Efficacy|121
1292000|NCT00308581|4212837|P2|Induction Phase|Lack of Efficacy|0
1292001|NCT00308581|4212838|P1|Induction Phase|Lack of Efficacy|0
1292002|NCT00308581|4212836|P3|Induction Phase|Adverse Event|37
1292003|NCT00308581|4212837|P2|Induction Phase|Adverse Event|0
1292004|NCT00308581|4212838|P1|Induction Phase|Adverse Event|0
1292005|NCT00308555|4212964|P2|Overall Study|Physician Decision|0
1292006|NCT00308555|4212965|P1|Overall Study|Physician Decision|2
1292007|NCT00308555|4212964|P2|Overall Study|Withdrawal by Subject|0
1292008|NCT00308555|4212965|P1|Overall Study|Withdrawal by Subject|1
1292009|NCT00308308|4212982|P2|Overall Study|Other|0
1292010|NCT00308308|4212983|P1|Overall Study|Other|1
1292011|NCT00308308|4212982|P2|Overall Study|Randomized but not dosed|16
1292012|NCT00308308|4212983|P1|Overall Study|Randomized but not dosed|8
1292013|NCT00308308|4212982|P2|Overall Study|Various|5
1292014|NCT00308308|4212983|P1|Overall Study|Various|7
1292015|NCT00308308|4212982|P2|Overall Study|Withdrawal by Subject|19
1292016|NCT00308308|4212983|P1|Overall Study|Withdrawal by Subject|47
1292017|NCT00308308|4212982|P2|Overall Study|Protocol Violation|14
1292018|NCT00308308|4212983|P1|Overall Study|Protocol Violation|3
1292019|NCT00308308|4212982|P2|Overall Study|Physician Decision|7
1292020|NCT00308308|4212983|P1|Overall Study|Physician Decision|15
1292021|NCT00308308|4212982|P2|Overall Study|Lost to Follow-up|5
1292022|NCT00308308|4212983|P1|Overall Study|Lost to Follow-up|5
1292023|NCT00308308|4212982|P2|Overall Study|Adverse Event|2
1292024|NCT00308308|4212983|P1|Overall Study|Adverse Event|17
1292025|NCT00308139|4213018|P2|Overall Study|Other|0
1292026|NCT00308139|4213019|P1|Overall Study|Other|1
1292027|NCT00308139|4213018|P2|Overall Study|Administrative|4
1292028|NCT00308139|4213019|P1|Overall Study|Administrative|1
1292029|NCT00308139|4213018|P2|Overall Study|Loss of Glucose Control|7
1292030|NCT00308139|4213019|P1|Overall Study|Loss of Glucose Control|5
1292031|NCT00308139|4213018|P2|Overall Study|Investigator Decision|10
1292032|NCT00308139|4213019|P1|Overall Study|Investigator Decision|11
1292033|NCT00308139|4213018|P2|Overall Study|Withdrawal of Consent|42
1292034|NCT00308139|4213019|P1|Overall Study|Withdrawal of Consent|40
1292035|NCT00308139|4213018|P2|Overall Study|Protocol Violation|2
1292036|NCT00308139|4213019|P1|Overall Study|Protocol Violation|3
1292037|NCT00308139|4213018|P2|Overall Study|Lost to Follow-up|8
1292038|NCT00308139|4213019|P1|Overall Study|Lost to Follow-up|13
1292039|NCT00308139|4213018|P2|Overall Study|Adverse Event|14
1292040|NCT00308139|4213019|P1|Overall Study|Adverse Event|20
1292041|NCT00308113|4213093|P4|Overall Study|Protocol closure|1
1292042|NCT00308113|4213094|P3|Overall Study|Protocol closure|0
1292043|NCT00308113|4213095|P2|Overall Study|Protocol closure|0
1292044|NCT00308113|4213096|P1|Overall Study|Protocol closure|0
1292045|NCT00308087|4213116|P2|Overall Study|Not Specified|3
1292046|NCT00308087|4213117|P1|Overall Study|Not Specified|4
1292047|NCT00308087|4213116|P2|Overall Study|Withdrawal by Subject|1
1292048|NCT00308087|4213117|P1|Overall Study|Withdrawal by Subject|2
1292049|NCT00308087|4213116|P2|Overall Study|Study Closure|12
1292050|NCT00308087|4213117|P1|Overall Study|Study Closure|11
1292051|NCT00308087|4213116|P2|Overall Study|Progressive Disease|21
1292052|NCT00308087|4213117|P1|Overall Study|Progressive Disease|19
1292053|NCT00308074|4213133|P1|Overall Study|Withdrawal by Subject|1
1292054|NCT00307931|4213150|P1|Overall Study|Adverse Event|1
1292055|NCT00307801|4213167|P2|Overall Study|Pregnancy|1
1292056|NCT00307801|4213168|P1|Overall Study|Pregnancy|0
1292057|NCT00307801|4213167|P2|Overall Study|No reason specified|0
1292058|NCT00307801|4213168|P1|Overall Study|No reason specified|2
1292059|NCT00307801|4213167|P2|Overall Study|Protocol Violation|2
1292060|NCT00307801|4213168|P1|Overall Study|Protocol Violation|3
1292061|NCT00307801|4213167|P2|Overall Study|Frustration with e-diary|0
1292062|NCT00307801|4213168|P1|Overall Study|Frustration with e-diary|1
1292063|NCT00307801|4213167|P2|Overall Study|Lost to Follow-up, moved abroad|1
1292064|NCT00307801|4213168|P1|Overall Study|Lost to Follow-up, moved abroad|1
1292065|NCT00307801|4213167|P2|Overall Study|Lack of Efficacy|2
1292066|NCT00307801|4213168|P1|Overall Study|Lack of Efficacy|0
1292067|NCT00307801|4213167|P2|Overall Study|Wrong Randomization|0
1292068|NCT00307801|4213168|P1|Overall Study|Wrong Randomization|1
1292069|NCT00307801|4213167|P2|Overall Study|Decreased Libido (AE at discontinuation)|1
1292070|NCT00307801|4213168|P1|Overall Study|Decreased Libido (AE at discontinuation)|0
1292071|NCT00307801|4213167|P2|Overall Study|Adverse event (AE)/Withdrawal of consent|0
1292072|NCT00307801|4213168|P1|Overall Study|Adverse event (AE)/Withdrawal of consent|2
1292073|NCT00307801|4213167|P2|Overall Study|Non-compliance, not taken all tablets|2
1292074|NCT00307801|4213168|P1|Overall Study|Non-compliance, not taken all tablets|1
1292075|NCT00307801|4213167|P2|Overall Study|Withdrawal by Subject|4
1292076|NCT00307801|4213168|P1|Overall Study|Withdrawal by Subject|9
1292077|NCT00307801|4213167|P2|Overall Study|Adverse Event|4
1292078|NCT00307801|4213168|P1|Overall Study|Adverse Event|12
1292079|NCT00307736|4213280|P4|Overall Study|Withdrawal by Subject|0
1292080|NCT00307736|4213281|P3|Overall Study|Withdrawal by Subject|2
1292081|NCT00307736|4213282|P2|Overall Study|Withdrawal by Subject|0
1292082|NCT00307736|4213283|P1|Overall Study|Withdrawal by Subject|0
1292083|NCT00307736|4213280|P4|Overall Study|Adverse Event|3
1292084|NCT00307736|4213281|P3|Overall Study|Adverse Event|1
1292085|NCT00307736|4213282|P2|Overall Study|Adverse Event|0
1292086|NCT00307736|4213283|P1|Overall Study|Adverse Event|0
1292087|NCT00307684|4213294|P3|Double Blind Phase|Lack of Efficacy|0
1292088|NCT00307684|4213295|P2|Double Blind Phase|Lack of Efficacy|5
1292089|NCT00307684|4213296|P1|Double Blind Phase|Lack of Efficacy|2
1292090|NCT00307684|4213294|P3|Open Label Phase|other|6
1292091|NCT00307684|4213295|P2|Open Label Phase|other|0
1292092|NCT00307684|4213296|P1|Open Label Phase|other|0
1292093|NCT00307684|4213294|P3|Open Label Phase|non compliance|5
1292094|NCT00307684|4213295|P2|Open Label Phase|non compliance|0
1292095|NCT00307684|4213296|P1|Open Label Phase|non compliance|0
1292096|NCT00307684|4213294|P3|Open Label Phase|Lost to Follow-up|11
1292097|NCT00307684|4213295|P2|Open Label Phase|Lost to Follow-up|0
1292098|NCT00307684|4213296|P1|Open Label Phase|Lost to Follow-up|0
1292099|NCT00307684|4213294|P3|Open Label Phase|Withdrawal by Subject|15
1292100|NCT00307684|4213295|P2|Open Label Phase|Withdrawal by Subject|0
1292101|NCT00307684|4213296|P1|Open Label Phase|Withdrawal by Subject|0
1292102|NCT00307684|4213294|P3|Open Label Phase|Adverse Event|16
1292103|NCT00307684|4213295|P2|Open Label Phase|Adverse Event|0
1292104|NCT00307684|4213296|P1|Open Label Phase|Adverse Event|0
1292105|NCT00307684|4213294|P3|Open Label Phase|Lack of Efficacy|3
1292106|NCT00307684|4213295|P2|Open Label Phase|Lack of Efficacy|0
1292107|NCT00307684|4213296|P1|Open Label Phase|Lack of Efficacy|0
1292108|NCT00307489|4213324|P2|Week 48 Through Week 168|Seroconversion|0
1292109|NCT00307489|4213325|P1|Week 48 Through Week 168|Seroconversion|1
1292110|NCT00307489|4213324|P2|Week 48 Through Week 168|Lost to Follow-up|1
1292111|NCT00307489|4213325|P1|Week 48 Through Week 168|Lost to Follow-up|0
1292112|NCT00307489|4213324|P2|Week 48 Through Week 168|Death|1
1292113|NCT00307489|4213325|P1|Week 48 Through Week 168|Death|0
1292114|NCT00307489|4213324|P2|Week 48 Through Week 168|Lack of Efficacy|2
1292115|NCT00307489|4213325|P1|Week 48 Through Week 168|Lack of Efficacy|2
1292116|NCT00307489|4213324|P2|Week 48 Through Week 168|Withdrawal by Subject|2
1292117|NCT00307489|4213325|P1|Week 48 Through Week 168|Withdrawal by Subject|1
1292118|NCT00307489|4213324|P2|Week 48 Through Week 168|Physician Decision|0
1292119|NCT00307489|4213325|P1|Week 48 Through Week 168|Physician Decision|1
1292120|NCT00307489|4213324|P2|Week 48 Through Week 168|Adverse Event|0
1292121|NCT00307489|4213325|P1|Week 48 Through Week 168|Adverse Event|1
1292122|NCT00307489|4213324|P2|Baseline Through Week 48|Withdrawal by Subject|1
1292123|NCT00307489|4213325|P1|Baseline Through Week 48|Withdrawal by Subject|0
1292124|NCT00307489|4213324|P2|Baseline Through Week 48|Physician Decision|0
1292125|NCT00307489|4213325|P1|Baseline Through Week 48|Physician Decision|1
1292126|NCT00307489|4213324|P2|Baseline Through Week 48|Lost to Follow-up|1
1292127|NCT00307489|4213325|P1|Baseline Through Week 48|Lost to Follow-up|0
1292128|NCT00307437|4213370|P7|After Controlled Period|Other|28
1292129|NCT00307437|4213371|P6|After Controlled Period|Other|40
1292130|NCT00307437|4213372|P5|After Controlled Period|Other|9
1292131|NCT00307437|4213373|P4|After Controlled Period|Other|15
1292132|NCT00307437|4213374|P3|After Controlled Period|Other|0
1292133|NCT00307437|4213375|P2|After Controlled Period|Other|0
1292134|NCT00307437|4213376|P1|After Controlled Period|Other|0
1292135|NCT00307437|4213370|P7|After Controlled Period|Lost to Follow-up|18
1292136|NCT00307437|4213371|P6|After Controlled Period|Lost to Follow-up|13
1292137|NCT00307437|4213372|P5|After Controlled Period|Lost to Follow-up|12
1292138|NCT00307437|4213373|P4|After Controlled Period|Lost to Follow-up|7
1292139|NCT00307437|4213374|P3|After Controlled Period|Lost to Follow-up|0
1292140|NCT00307437|4213375|P2|After Controlled Period|Lost to Follow-up|0
1292141|NCT00307437|4213376|P1|After Controlled Period|Lost to Follow-up|0
1292142|NCT00307437|4213370|P7|After Controlled Period|Lack of Efficacy|24
1292143|NCT00307437|4213371|P6|After Controlled Period|Lack of Efficacy|37
1292144|NCT00307437|4213372|P5|After Controlled Period|Lack of Efficacy|17
1292145|NCT00307437|4213373|P4|After Controlled Period|Lack of Efficacy|15
1292146|NCT00307437|4213374|P3|After Controlled Period|Lack of Efficacy|0
1292147|NCT00307437|4213375|P2|After Controlled Period|Lack of Efficacy|0
1292148|NCT00307437|4213376|P1|After Controlled Period|Lack of Efficacy|0
1292149|NCT00307437|4213370|P7|After Controlled Period|Death|3
1292150|NCT00307437|4213371|P6|After Controlled Period|Death|1
1292151|NCT00307437|4213372|P5|After Controlled Period|Death|1
1292152|NCT00307437|4213373|P4|After Controlled Period|Death|3
1292153|NCT00307437|4213374|P3|After Controlled Period|Death|0
1292154|NCT00307437|4213375|P2|After Controlled Period|Death|0
1292155|NCT00307437|4213376|P1|After Controlled Period|Death|0
1292156|NCT00307437|4213370|P7|After Controlled Period|Adverse Event|40
1292157|NCT00307437|4213371|P6|After Controlled Period|Adverse Event|31
1292158|NCT00307437|4213372|P5|After Controlled Period|Adverse Event|16
1292159|NCT00307437|4213373|P4|After Controlled Period|Adverse Event|18
1292160|NCT00307437|4213374|P3|After Controlled Period|Adverse Event|0
1292161|NCT00307437|4213375|P2|After Controlled Period|Adverse Event|0
1292162|NCT00307437|4213376|P1|After Controlled Period|Adverse Event|0
1292163|NCT00307437|4213370|P7|Controlled Period|Other|0
1292164|NCT00307437|4213371|P6|Controlled Period|Other|0
1292165|NCT00307437|4213372|P5|Controlled Period|Other|0
1292166|NCT00307437|4213373|P4|Controlled Period|Other|0
1292167|NCT00307437|4213374|P3|Controlled Period|Other|3
1292168|NCT00307437|4213375|P2|Controlled Period|Other|1
1292169|NCT00307437|4213376|P1|Controlled Period|Other|5
1292170|NCT00307437|4213370|P7|Controlled Period|Lost to Follow-up|0
1292171|NCT00307437|4213371|P6|Controlled Period|Lost to Follow-up|0
1292172|NCT00307437|4213372|P5|Controlled Period|Lost to Follow-up|0
1292173|NCT00307437|4213373|P4|Controlled Period|Lost to Follow-up|0
1292174|NCT00307437|4213374|P3|Controlled Period|Lost to Follow-up|0
1292175|NCT00307437|4213375|P2|Controlled Period|Lost to Follow-up|3
1292176|NCT00307437|4213376|P1|Controlled Period|Lost to Follow-up|2
1292177|NCT00307437|4213370|P7|Controlled Period|Lack of Efficacy|0
1292178|NCT00307437|4213371|P6|Controlled Period|Lack of Efficacy|0
1292179|NCT00307437|4213372|P5|Controlled Period|Lack of Efficacy|0
1292180|NCT00307437|4213373|P4|Controlled Period|Lack of Efficacy|0
1292181|NCT00307437|4213374|P3|Controlled Period|Lack of Efficacy|0
1292182|NCT00307437|4213375|P2|Controlled Period|Lack of Efficacy|0
1292183|NCT00307437|4213376|P1|Controlled Period|Lack of Efficacy|2
1292184|NCT00307437|4213370|P7|Controlled Period|Death|0
1292185|NCT00307437|4213371|P6|Controlled Period|Death|0
1292186|NCT00307437|4213372|P5|Controlled Period|Death|0
1292187|NCT00307437|4213373|P4|Controlled Period|Death|0
1292188|NCT00307437|4213374|P3|Controlled Period|Death|1
1292189|NCT00307437|4213375|P2|Controlled Period|Death|0
1292190|NCT00307437|4213376|P1|Controlled Period|Death|0
1292191|NCT00307437|4213370|P7|Controlled Period|Adverse Event|0
1292192|NCT00307437|4213371|P6|Controlled Period|Adverse Event|0
1292193|NCT00307437|4213372|P5|Controlled Period|Adverse Event|0
1292194|NCT00307437|4213373|P4|Controlled Period|Adverse Event|0
1292195|NCT00307437|4213374|P3|Controlled Period|Adverse Event|5
1292196|NCT00307437|4213375|P2|Controlled Period|Adverse Event|2
1292197|NCT00307437|4213376|P1|Controlled Period|Adverse Event|7
1292198|NCT00307333|4213402|P2|Overall Study|Lost to Follow-up|3
1292199|NCT00307333|4213403|P1|Overall Study|Lost to Follow-up|11
1292200|NCT00307294|4213415|P1|Overall Study|Withdrawal by Subject|1
1292201|NCT00307164|4213424|P2|Overall Study|Lost to Follow-up|1
1292202|NCT00307164|4213425|P1|Overall Study|Lost to Follow-up|6
1292203|NCT00307164|4213424|P2|Overall Study|Not compliant with requirements|4
1292204|NCT00307164|4213425|P1|Overall Study|Not compliant with requirements|4
1292205|NCT00307164|4213424|P2|Overall Study|Withdrawal by Subject|8
1292206|NCT00307164|4213425|P1|Overall Study|Withdrawal by Subject|1
1292207|NCT00307164|4213424|P2|Overall Study|Subject/parent not able to get to clinic|1
1292208|NCT00307164|4213425|P1|Overall Study|Subject/parent not able to get to clinic|2
1292209|NCT00307164|4213424|P2|Overall Study|Severe debilitation, unable to continue|0
1292210|NCT00307164|4213425|P1|Overall Study|Severe debilitation, unable to continue|1
1292211|NCT00307164|4213424|P2|Overall Study|Death|0
1292212|NCT00307164|4213425|P1|Overall Study|Death|1
1292213|NCT00307151|4213465|P4|Overall Study|Clinic unable to contact subject|1
1292214|NCT00307151|4213466|P3|Overall Study|Clinic unable to contact subject|1
1292215|NCT00307151|4213467|P2|Overall Study|Clinic unable to contact subject|3
1292216|NCT00307151|4213468|P1|Overall Study|Clinic unable to contact subject|3
1292217|NCT00307151|4213465|P4|Overall Study|Not willing to adhere to study reqs|2
1292218|NCT00307151|4213466|P3|Overall Study|Not willing to adhere to study reqs|2
1292219|NCT00307151|4213467|P2|Overall Study|Not willing to adhere to study reqs|0
1292220|NCT00307151|4213468|P1|Overall Study|Not willing to adhere to study reqs|2
1292221|NCT00307151|4213465|P4|Overall Study|Withdrew consent|3
1292222|NCT00307151|4213466|P3|Overall Study|Withdrew consent|1
1292223|NCT00307151|4213467|P2|Overall Study|Withdrew consent|1
1292224|NCT00307151|4213468|P1|Overall Study|Withdrew consent|0
1292225|NCT00307151|4213465|P4|Overall Study|Subject unable to get to clinic|2
1292226|NCT00307151|4213466|P3|Overall Study|Subject unable to get to clinic|6
1292227|NCT00307151|4213467|P2|Overall Study|Subject unable to get to clinic|0
1292228|NCT00307151|4213468|P1|Overall Study|Subject unable to get to clinic|1
1292229|NCT00307151|4213465|P4|Overall Study|Severe debilitation, unable to continue|0
1292230|NCT00307151|4213466|P3|Overall Study|Severe debilitation, unable to continue|0
1292231|NCT00307151|4213467|P2|Overall Study|Severe debilitation, unable to continue|0
1292232|NCT00307151|4213468|P1|Overall Study|Severe debilitation, unable to continue|1
1292233|NCT00307151|4213465|P4|Overall Study|Death|3
1292234|NCT00307151|4213466|P3|Overall Study|Death|10
1292235|NCT00307151|4213467|P2|Overall Study|Death|3
1292236|NCT00307151|4213468|P1|Overall Study|Death|4
1292237|NCT00307125|4213512|P3|Pilot Phase|Withdrawal by Subject|1
1292238|NCT00307125|4213513|P2|Pilot Phase|Withdrawal by Subject|1
1292239|NCT00307125|4213514|P1|Pilot Phase|Withdrawal by Subject|0
1292240|NCT00307125|4213512|P3|Pilot Phase|Lost to Follow-up|0
1292241|NCT00307125|4213513|P2|Pilot Phase|Lost to Follow-up|1
1292242|NCT00307125|4213514|P1|Pilot Phase|Lost to Follow-up|0
1292243|NCT00307125|4213512|P3|Screening Phase|Coronary artery bypass|0
1292244|NCT00307125|4213513|P2|Screening Phase|Coronary artery bypass|0
1292245|NCT00307125|4213514|P1|Screening Phase|Coronary artery bypass|1
1292246|NCT00307125|4213512|P3|Screening Phase|AMR and treated with rituximab|0
1292247|NCT00307125|4213513|P2|Screening Phase|AMR and treated with rituximab|0
1292248|NCT00307125|4213514|P1|Screening Phase|AMR and treated with rituximab|1
1292249|NCT00307125|4213512|P3|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
1292250|NCT00307125|4213513|P2|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
1292251|NCT00307125|4213514|P1|Screening Phase|Sample of Anti-HLA Ab was not obtained|1
1292252|NCT00307125|4213512|P3|Screening Phase|Screen Error|0
1292253|NCT00307125|4213513|P2|Screening Phase|Screen Error|0
1292254|NCT00307125|4213514|P1|Screening Phase|Screen Error|1
1292255|NCT00307125|4213512|P3|Screening Phase|Ineligible|0
1292256|NCT00307125|4213513|P2|Screening Phase|Ineligible|0
1292257|NCT00307125|4213514|P1|Screening Phase|Ineligible|1
1292258|NCT00307125|4213512|P3|Screening Phase|PAK|0
1292259|NCT00307125|4213513|P2|Screening Phase|PAK|0
1292260|NCT00307125|4213514|P1|Screening Phase|PAK|1
1292261|NCT00307125|4213512|P3|Screening Phase|Malignancy|0
1292262|NCT00307125|4213513|P2|Screening Phase|Malignancy|0
1292263|NCT00307125|4213514|P1|Screening Phase|Malignancy|1
1292264|NCT00307125|4213512|P3|Screening Phase|Metastatic colon cancer|0
1292265|NCT00307125|4213513|P2|Screening Phase|Metastatic colon cancer|0
1292266|NCT00307125|4213514|P1|Screening Phase|Metastatic colon cancer|1
1292267|NCT00307125|4213512|P3|Screening Phase|Developed acute leukemia|0
1292268|NCT00307125|4213513|P2|Screening Phase|Developed acute leukemia|0
1292269|NCT00307125|4213514|P1|Screening Phase|Developed acute leukemia|1
1292270|NCT00307125|4213512|P3|Screening Phase|Try to get pregnant|0
1292271|NCT00307125|4213513|P2|Screening Phase|Try to get pregnant|0
1292272|NCT00307125|4213514|P1|Screening Phase|Try to get pregnant|1
1292273|NCT00307125|4213512|P3|Screening Phase|Ineligible for pilot|0
1292274|NCT00307125|4213513|P2|Screening Phase|Ineligible for pilot|0
1292275|NCT00307125|4213514|P1|Screening Phase|Ineligible for pilot|4
1292276|NCT00307125|4213512|P3|Screening Phase|Received Pancreas Transplant|0
1292277|NCT00307125|4213513|P2|Screening Phase|Received Pancreas Transplant|0
1292278|NCT00307125|4213514|P1|Screening Phase|Received Pancreas Transplant|8
1292279|NCT00307125|4213512|P3|Screening Phase|Moved or transferred facilities|0
1292280|NCT00307125|4213513|P2|Screening Phase|Moved or transferred facilities|0
1292281|NCT00307125|4213514|P1|Screening Phase|Moved or transferred facilities|34
1292282|NCT00307125|4213512|P3|Screening Phase|Scheduling issues/Non-compliance|0
1292283|NCT00307125|4213513|P2|Screening Phase|Scheduling issues/Non-compliance|0
1292284|NCT00307125|4213514|P1|Screening Phase|Scheduling issues/Non-compliance|55
1292285|NCT00307125|4213512|P3|Screening Phase|Follow-up period ended on Dec 31, 2011|0
1292286|NCT00307125|4213513|P2|Screening Phase|Follow-up period ended on Dec 31, 2011|0
1292287|NCT00307125|4213514|P1|Screening Phase|Follow-up period ended on Dec 31, 2011|83
1292288|NCT00307125|4213512|P3|Screening Phase|Graft Failure|0
1292289|NCT00307125|4213513|P2|Screening Phase|Graft Failure|0
1292290|NCT00307125|4213514|P1|Screening Phase|Graft Failure|8
1292291|NCT00307125|4213512|P3|Screening Phase|Graft Loss|0
1292292|NCT00307125|4213513|P2|Screening Phase|Graft Loss|0
1292293|NCT00307125|4213514|P1|Screening Phase|Graft Loss|3
1292294|NCT00307125|4213512|P3|Screening Phase|Study Terminated|0
1292295|NCT00307125|4213513|P2|Screening Phase|Study Terminated|0
1292296|NCT00307125|4213514|P1|Screening Phase|Study Terminated|17
1292297|NCT00307125|4213512|P3|Screening Phase|Sponsor Decision|0
1292298|NCT00307125|4213513|P2|Screening Phase|Sponsor Decision|0
1292299|NCT00307125|4213514|P1|Screening Phase|Sponsor Decision|4
1292300|NCT00307125|4213512|P3|Screening Phase|Physician Decision|0
1292301|NCT00307125|4213513|P2|Screening Phase|Physician Decision|0
1292302|NCT00307125|4213514|P1|Screening Phase|Physician Decision|26
1292303|NCT00307125|4213512|P3|Screening Phase|Withdrawal by Subject|0
1292304|NCT00307125|4213513|P2|Screening Phase|Withdrawal by Subject|0
1292305|NCT00307125|4213514|P1|Screening Phase|Withdrawal by Subject|77
1292306|NCT00307125|4213512|P3|Screening Phase|Death|0
1292307|NCT00307125|4213513|P2|Screening Phase|Death|0
1292308|NCT00307125|4213514|P1|Screening Phase|Death|10
1292309|NCT00307125|4213512|P3|Screening Phase|Lost to Follow-up|0
1292310|NCT00307125|4213513|P2|Screening Phase|Lost to Follow-up|0
1292311|NCT00307125|4213514|P1|Screening Phase|Lost to Follow-up|87
1292312|NCT00307125|4213512|P3|Screening Phase|Protocol Violation|0
1292313|NCT00307125|4213513|P2|Screening Phase|Protocol Violation|0
1292314|NCT00307125|4213514|P1|Screening Phase|Protocol Violation|27
1292315|NCT00307125|4213512|P3|Screening Phase|Adverse Event|0
1292316|NCT00307125|4213513|P2|Screening Phase|Adverse Event|0
1292317|NCT00307125|4213514|P1|Screening Phase|Adverse Event|1
1292318|NCT00307086|4213536|P1|Overall Study|ineligible|5
1292319|NCT00307047|4213542|P2|Overall Study|All death, all MI, all Revascularization|16
1292320|NCT00307047|4213543|P1|Overall Study|All death, all MI, all Revascularization|27
1292321|NCT00307047|4213542|P2|Overall Study|Lost to follow-up for other reasons|1
1292322|NCT00307047|4213543|P1|Overall Study|Lost to follow-up for other reasons|0
1292323|NCT00307047|4213542|P2|Overall Study|Physician Decision|2
1292324|NCT00307047|4213543|P1|Overall Study|Physician Decision|1
1292325|NCT00307047|4213542|P2|Overall Study|Withdrawal by Subject|6
1292326|NCT00307047|4213543|P1|Overall Study|Withdrawal by Subject|6
1292327|NCT00307047|4213542|P2|Overall Study|Lost to Follow-up|24
1292328|NCT00307047|4213543|P1|Overall Study|Lost to Follow-up|35
1292329|NCT00307034|4213681|P2|Overall Study|Lost to Follow-up|3
1292330|NCT00307034|4213682|P1|Overall Study|Lost to Follow-up|0
1292331|NCT00307034|4213681|P2|Overall Study|Withdrawal by Subject|2
1292332|NCT00307034|4213682|P1|Overall Study|Withdrawal by Subject|1
1292333|NCT00307034|4213681|P2|Overall Study|Adverse Event|2
1292334|NCT00307034|4213682|P1|Overall Study|Adverse Event|1
1292335|NCT00306891|4213733|P4|Part B|Development of study specific disc crit.|1
1292336|NCT00306891|4213734|P3|Part B|Development of study specific disc crit.|0
1292337|NCT00306891|4213735|P2|Part B|Development of study specific disc crit.|0
1292338|NCT00306891|4213736|P1|Part B|Development of study specific disc crit.|0
1292339|NCT00306891|4213733|P4|Part B|Condition under investigation worsened|8
1292340|NCT00306891|4213734|P3|Part B|Condition under investigation worsened|2
1292341|NCT00306891|4213735|P2|Part B|Condition under investigation worsened|0
1292342|NCT00306891|4213736|P1|Part B|Condition under investigation worsened|0
1292343|NCT00306891|4213733|P4|Part B|Withdrawal by Subject|1
1292344|NCT00306891|4213734|P3|Part B|Withdrawal by Subject|3
1292345|NCT00306891|4213735|P2|Part B|Withdrawal by Subject|0
1292346|NCT00306891|4213736|P1|Part B|Withdrawal by Subject|0
1292347|NCT00306891|4213733|P4|Part B|Adverse Event|5
1292348|NCT00306891|4213734|P3|Part B|Adverse Event|5
1292349|NCT00306891|4213735|P2|Part B|Adverse Event|0
1292350|NCT00306891|4213736|P1|Part B|Adverse Event|0
1292351|NCT00306891|4213733|P4|Part B|Death|2
1292352|NCT00306891|4213734|P3|Part B|Death|1
1292353|NCT00306891|4213735|P2|Part B|Death|0
1292354|NCT00306891|4213736|P1|Part B|Death|0
1292355|NCT00306891|4213733|P4|Part A|QTC interval outwith elig. criteria|0
1292356|NCT00306891|4213734|P3|Part A|QTC interval outwith elig. criteria|0
1292357|NCT00306891|4213735|P2|Part A|QTC interval outwith elig. criteria|0
1292358|NCT00306891|4213736|P1|Part A|QTC interval outwith elig. criteria|1
1292359|NCT00306891|4213733|P4|Part A|Suspicion of second malignancy|0
1292360|NCT00306891|4213734|P3|Part A|Suspicion of second malignancy|0
1292361|NCT00306891|4213735|P2|Part A|Suspicion of second malignancy|1
1292362|NCT00306891|4213736|P1|Part A|Suspicion of second malignancy|0
1292363|NCT00306891|4213733|P4|Part A|Reaccumul. of ascites following drainage|0
1292364|NCT00306891|4213734|P3|Part A|Reaccumul. of ascites following drainage|0
1292365|NCT00306891|4213735|P2|Part A|Reaccumul. of ascites following drainage|1
1292366|NCT00306891|4213736|P1|Part A|Reaccumul. of ascites following drainage|0
1292367|NCT00306891|4213733|P4|Part A|Partial bowel obstruction|0
1292368|NCT00306891|4213734|P3|Part A|Partial bowel obstruction|0
1292369|NCT00306891|4213735|P2|Part A|Partial bowel obstruction|0
1292370|NCT00306891|4213736|P1|Part A|Partial bowel obstruction|1
1292371|NCT00306891|4213733|P4|Part A|Incorrect enrol/entry crit not fulfilled|0
1292372|NCT00306891|4213734|P3|Part A|Incorrect enrol/entry crit not fulfilled|0
1292373|NCT00306891|4213735|P2|Part A|Incorrect enrol/entry crit not fulfilled|1
1292374|NCT00306891|4213736|P1|Part A|Incorrect enrol/entry crit not fulfilled|0
1292375|NCT00306891|4213733|P4|Part A|Condition under investigation worsened|0
1292376|NCT00306891|4213734|P3|Part A|Condition under investigation worsened|0
1292377|NCT00306891|4213735|P2|Part A|Condition under investigation worsened|2
1292378|NCT00306891|4213736|P1|Part A|Condition under investigation worsened|2
1292379|NCT00306891|4213733|P4|Part A|Withdrawal by Subject|0
1292380|NCT00306891|4213734|P3|Part A|Withdrawal by Subject|0
1292381|NCT00306891|4213735|P2|Part A|Withdrawal by Subject|1
1292382|NCT00306891|4213736|P1|Part A|Withdrawal by Subject|1
1292383|NCT00306852|4213759|P2|Overall Study|Lost to Follow-up|24
1292384|NCT00306852|4213760|P1|Overall Study|Lost to Follow-up|15
1292385|NCT00306852|4213759|P2|Overall Study|Death|14
1292386|NCT00306852|4213760|P1|Overall Study|Death|14
1292387|NCT00306787|4213778|P2|Overall Study|Abnormal laboratory value(s)|0
1292388|NCT00306787|4213779|P1|Overall Study|Abnormal laboratory value(s)|1
1292389|NCT00306787|4213778|P2|Overall Study|Administrative problems|0
1292390|NCT00306787|4213779|P1|Overall Study|Administrative problems|4
1292391|NCT00306787|4213778|P2|Overall Study|Lost to Follow-up|6
1292392|NCT00306787|4213779|P1|Overall Study|Lost to Follow-up|9
1292393|NCT00306787|4213778|P2|Overall Study|Withdrawal by Subject|9
1292394|NCT00306787|4213779|P1|Overall Study|Withdrawal by Subject|2
1292395|NCT00306787|4213778|P2|Overall Study|Protocol Violation|10
1292396|NCT00306787|4213779|P1|Overall Study|Protocol Violation|8
1292397|NCT00306787|4213778|P2|Overall Study|Lack of Efficacy|0
1292398|NCT00306787|4213779|P1|Overall Study|Lack of Efficacy|1
1292399|NCT00306787|4213778|P2|Overall Study|Adverse Event|1
1292400|NCT00306787|4213779|P1|Overall Study|Adverse Event|1
1292401|NCT00306787|4213778|P2|Overall Study|Discontinued without taking study drug|215
1292402|NCT00306787|4213779|P1|Overall Study|Discontinued without taking study drug|208
1292403|NCT00306670|4213797|P2|Overall Study|patients recruited; Genentech, the st|2
1292404|NCT00306670|4213798|P1|Overall Study|patients recruited; Genentech, the st|0
1292405|NCT00306592|4213804|P2|Overall Study|48-week Treatment Period Ongoing|20
1292406|NCT00306592|4213805|P1|Overall Study|48-week Treatment Period Ongoing|0
1292407|NCT00306592|4213804|P2|Overall Study|Other|2
1292408|NCT00306592|4213805|P1|Overall Study|Other|1
1292409|NCT00306592|4213804|P2|Overall Study|Not Specified|10
1292410|NCT00306592|4213805|P1|Overall Study|Not Specified|5
1292411|NCT00306592|4213804|P2|Overall Study|Voluntary|6
1292412|NCT00306592|4213805|P1|Overall Study|Voluntary|10
1292413|NCT00306592|4213804|P2|Overall Study|Persistent Antibodies|3
1292414|NCT00306592|4213805|P1|Overall Study|Persistent Antibodies|6
1292415|NCT00306592|4213804|P2|Overall Study|Noncompliance|2
1292416|NCT00306592|4213805|P1|Overall Study|Noncompliance|0
1292417|NCT00306592|4213804|P2|Overall Study|Lost to Follow-up|0
1292418|NCT00306592|4213805|P1|Overall Study|Lost to Follow-up|1
1292419|NCT00306592|4213804|P2|Overall Study|Adverse Event|15
1292420|NCT00306592|4213805|P1|Overall Study|Adverse Event|8
1292421|NCT00306527|4213815|P4|Overall Study|Death|2
1292422|NCT00306527|4213816|P3|Overall Study|Death|1
1292423|NCT00306527|4213817|P2|Overall Study|Death|0
1292424|NCT00306527|4213818|P1|Overall Study|Death|1
1292425|NCT00306527|4213815|P4|Overall Study|Adverse Event|1
1292426|NCT00306527|4213816|P3|Overall Study|Adverse Event|1
1292427|NCT00306527|4213817|P2|Overall Study|Adverse Event|0
1292428|NCT00306527|4213818|P1|Overall Study|Adverse Event|0
1292429|NCT00306527|4213815|P4|Overall Study|Withdrawal by Subject|3
1292430|NCT00306527|4213816|P3|Overall Study|Withdrawal by Subject|0
1292431|NCT00306527|4213817|P2|Overall Study|Withdrawal by Subject|3
1292432|NCT00306527|4213818|P1|Overall Study|Withdrawal by Subject|2
1292433|NCT00306527|4213815|P4|Overall Study|Lost to Follow-up|0
1292434|NCT00306527|4213816|P3|Overall Study|Lost to Follow-up|3
1292435|NCT00306527|4213817|P2|Overall Study|Lost to Follow-up|4
1292436|NCT00306527|4213818|P1|Overall Study|Lost to Follow-up|3
1292437|NCT00306384|4213887|P3|Overall Study|Site closure|0
1292438|NCT00306384|4213888|P2|Overall Study|Site closure|0
1292439|NCT00306384|4213889|P1|Overall Study|Site closure|2
1292440|NCT00306384|4213887|P3|Overall Study|Other|32
1292441|NCT00306384|4213888|P2|Overall Study|Other|70
1292442|NCT00306384|4213889|P1|Overall Study|Other|80
1292443|NCT00306384|4213887|P3|Overall Study|Investigator discretion|21
1292444|NCT00306384|4213888|P2|Overall Study|Investigator discretion|31
1292445|NCT00306384|4213889|P1|Overall Study|Investigator discretion|28
1292446|NCT00306384|4213887|P3|Overall Study|Lack of Efficacy|38
1292447|NCT00306384|4213888|P2|Overall Study|Lack of Efficacy|40
1292448|NCT00306384|4213889|P1|Overall Study|Lack of Efficacy|26
1292449|NCT00306384|4213887|P3|Overall Study|Pregnancy|1
1292450|NCT00306384|4213888|P2|Overall Study|Pregnancy|1
1292451|NCT00306384|4213889|P1|Overall Study|Pregnancy|3
1292452|NCT00306384|4213887|P3|Overall Study|Study termination|1
1292453|NCT00306384|4213888|P2|Overall Study|Study termination|0
1292454|NCT00306384|4213889|P1|Overall Study|Study termination|1
1292455|NCT00306384|4213887|P3|Overall Study|Voluntary withdrawal|91
1292456|NCT00306384|4213888|P2|Overall Study|Voluntary withdrawal|187
1292457|NCT00306384|4213889|P1|Overall Study|Voluntary withdrawal|199
1292458|NCT00306384|4213887|P3|Overall Study|Lost to Follow-up|35
1292459|NCT00306384|4213888|P2|Overall Study|Lost to Follow-up|41
1292460|NCT00306384|4213889|P1|Overall Study|Lost to Follow-up|57
1292461|NCT00306384|4213887|P3|Overall Study|Major protocol deviation|18
1292462|NCT00306384|4213888|P2|Overall Study|Major protocol deviation|51
1292463|NCT00306384|4213889|P1|Overall Study|Major protocol deviation|43
1292464|NCT00306384|4213887|P3|Overall Study|Adverse Event|40
1292465|NCT00306384|4213888|P2|Overall Study|Adverse Event|87
1292466|NCT00306384|4213889|P1|Overall Study|Adverse Event|103
1292467|NCT00306293|4213921|P2|Period 2 (Day 67 to Day 126 )|Pregnancy|0
1292468|NCT00306293|4213922|P1|Period 2 (Day 67 to Day 126 )|Pregnancy|1
1292469|NCT00306293|4213921|P2|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1
1292470|NCT00306293|4213922|P1|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0
1292471|NCT00306293|4213921|P2|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0
1292472|NCT00306293|4213922|P1|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1
1292473|NCT00306293|4213921|P2|Period 2 (Day 67 to Day 126 )|Adverse Event|0
1292474|NCT00306293|4213922|P1|Period 2 (Day 67 to Day 126 )|Adverse Event|1
1292475|NCT00306293|4213921|P2|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
1292476|NCT00306293|4213922|P1|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
1292477|NCT00306293|4213921|P2|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
1292478|NCT00306293|4213922|P1|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
1292479|NCT00306293|4213921|P2|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4
1292480|NCT00306293|4213922|P1|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3
1292481|NCT00306293|4213921|P2|Period 1 (Day 1 to Day 60)|Adverse Event|0
1292482|NCT00306293|4213922|P1|Period 1 (Day 1 to Day 60)|Adverse Event|1
1292483|NCT00306202|4213943|P3|Overall Study|Still on treatment|0
1292484|NCT00306202|4213944|P2|Overall Study|Still on treatment|1
1292485|NCT00306202|4213945|P1|Overall Study|Still on treatment|6
1292486|NCT00306189|4214105|P4|Overall Study|Other|0
1292487|NCT00306189|4214106|P3|Overall Study|Other|0
1292488|NCT00306189|4214107|P2|Overall Study|Other|0
1292489|NCT00306189|4214108|P1|Overall Study|Other|1
1292490|NCT00306189|4214105|P4|Overall Study|Ineligibility determined|1
1292491|NCT00306189|4214106|P3|Overall Study|Ineligibility determined|1
1292492|NCT00306189|4214107|P2|Overall Study|Ineligibility determined|1
1292493|NCT00306189|4214108|P1|Overall Study|Ineligibility determined|1
1292494|NCT00306189|4214105|P4|Overall Study|Withdrawal by Subject|1
1292495|NCT00306189|4214106|P3|Overall Study|Withdrawal by Subject|8
1292496|NCT00306189|4214107|P2|Overall Study|Withdrawal by Subject|2
1292497|NCT00306189|4214108|P1|Overall Study|Withdrawal by Subject|4
1292498|NCT00306189|4214105|P4|Overall Study|Adverse Event|2
1292499|NCT00306189|4214106|P3|Overall Study|Adverse Event|2
1292500|NCT00306189|4214107|P2|Overall Study|Adverse Event|3
1292501|NCT00306189|4214108|P1|Overall Study|Adverse Event|3
1292502|NCT00306189|4214105|P4|Overall Study|Physician Decision|1
1292503|NCT00306189|4214106|P3|Overall Study|Physician Decision|0
1292504|NCT00306189|4214107|P2|Overall Study|Physician Decision|0
1292505|NCT00306189|4214108|P1|Overall Study|Physician Decision|0
1292506|NCT00305877|4214135|P2|Overall Study|Transportation issue with daily RT|1
1292507|NCT00305877|4214136|P1|Overall Study|Transportation issue with daily RT|0
1292508|NCT00305877|4214135|P2|Overall Study|Ineligible|1
1292509|NCT00305877|4214136|P1|Overall Study|Ineligible|2
1292510|NCT00305877|4214135|P2|Overall Study|Never start treatment|5
1292511|NCT00305877|4214136|P1|Overall Study|Never start treatment|2
1292512|NCT00305877|4214135|P2|Overall Study|Physician Decision|1
1292513|NCT00305877|4214136|P1|Overall Study|Physician Decision|1
1292514|NCT00305877|4214135|P2|Overall Study|Withdrawal by Subject|2
1292515|NCT00305877|4214136|P1|Overall Study|Withdrawal by Subject|4
1292516|NCT00305877|4214135|P2|Overall Study|Death|1
1292517|NCT00305877|4214136|P1|Overall Study|Death|0
1292518|NCT00305877|4214135|P2|Overall Study|Adverse Event|14
1292519|NCT00305877|4214136|P1|Overall Study|Adverse Event|9
1292520|NCT00305877|4214135|P2|Overall Study|Lack of Efficacy|9
1292521|NCT00305877|4214136|P1|Overall Study|Lack of Efficacy|6
1292522|NCT00305864|4214150|P4|Overall Study|Ineligible / No protocol treatment|13
1292523|NCT00305864|4214151|P3|Overall Study|Ineligible / No protocol treatment|1
1292524|NCT00305864|4214152|P2|Overall Study|Ineligible / No protocol treatment|1
1292525|NCT00305864|4214153|P1|Overall Study|Ineligible / No protocol treatment|0
1292526|NCT00305773|4214166|P2|Overall Study|All other reasons|2
1292527|NCT00305773|4214167|P1|Overall Study|All other reasons|3
1292528|NCT00305773|4214166|P2|Overall Study|Disease Progression|3
1292529|NCT00305773|4214167|P1|Overall Study|Disease Progression|1
1292530|NCT00305773|4214166|P2|Overall Study|Withdrawal by Subject|4
1292531|NCT00305773|4214167|P1|Overall Study|Withdrawal by Subject|1
1292532|NCT00305773|4214166|P2|Overall Study|Physician Decision|1
1292533|NCT00305773|4214167|P1|Overall Study|Physician Decision|1
1292534|NCT00305773|4214166|P2|Overall Study|Alternative Treatment|4
1292535|NCT00305773|4214167|P1|Overall Study|Alternative Treatment|4
1292536|NCT00305773|4214166|P2|Overall Study|Adverse Event|2
1292537|NCT00305773|4214167|P1|Overall Study|Adverse Event|1
1292538|NCT00305773|4214166|P2|Overall Study|Death|2
1292539|NCT00305773|4214167|P1|Overall Study|Death|3
1292540|NCT00305604|4214198|P2|Overall Study|Patient moved|0
1292541|NCT00305604|4214199|P1|Overall Study|Patient moved|1
1292542|NCT00305604|4214198|P2|Overall Study|Withdrawal by Subject|21
1292543|NCT00305604|4214199|P1|Overall Study|Withdrawal by Subject|12
1292544|NCT00305604|4214198|P2|Overall Study|Protocol Violation|1
1292545|NCT00305604|4214199|P1|Overall Study|Protocol Violation|2
1292546|NCT00305604|4214198|P2|Overall Study|Lost to Follow-up|4
1292547|NCT00305604|4214199|P1|Overall Study|Lost to Follow-up|0
1292548|NCT00305604|4214198|P2|Overall Study|Lack of Efficacy|18
1292549|NCT00305604|4214199|P1|Overall Study|Lack of Efficacy|11
1292550|NCT00305604|4214198|P2|Overall Study|Adverse Event|3
1292551|NCT00305604|4214199|P1|Overall Study|Adverse Event|6
1292552|NCT00305448|4214343|P3|Overall Study|Tumor Marker Elevation|1
1292553|NCT00305448|4214344|P2|Overall Study|Tumor Marker Elevation|0
1292554|NCT00305448|4214345|P1|Overall Study|Tumor Marker Elevation|0
1292555|NCT00305448|4214343|P3|Overall Study|Subjective Disease Progression|2
1292556|NCT00305448|4214344|P2|Overall Study|Subjective Disease Progression|2
1292557|NCT00305448|4214345|P1|Overall Study|Subjective Disease Progression|1
1292558|NCT00305448|4214343|P3|Overall Study|Disease Progression|28
1292559|NCT00305448|4214344|P2|Overall Study|Disease Progression|31
1292560|NCT00305448|4214345|P1|Overall Study|Disease Progression|27
1292561|NCT00305448|4214343|P3|Overall Study|Adverse Event|1
1292562|NCT00305448|4214344|P2|Overall Study|Adverse Event|0
1292563|NCT00305448|4214345|P1|Overall Study|Adverse Event|1
1292564|NCT00305448|4214343|P3|Overall Study|Withdrawal by Subject|1
1292565|NCT00305448|4214344|P2|Overall Study|Withdrawal by Subject|0
1292566|NCT00305448|4214345|P1|Overall Study|Withdrawal by Subject|2
1292567|NCT00305448|4214343|P3|Overall Study|Protocol Violation|0
1292568|NCT00305448|4214344|P2|Overall Study|Protocol Violation|1
1292569|NCT00305448|4214345|P1|Overall Study|Protocol Violation|0
1292570|NCT00305253|4214367|P2|Overall Study|Withdrawal by Subject|1
1292571|NCT00305253|4214368|P1|Overall Study|Withdrawal by Subject|0
1292572|NCT00305227|4214380|P2|Overall Study|Lost to Follow-up|6
1292573|NCT00305227|4214381|P1|Overall Study|Lost to Follow-up|7
1292574|NCT00305110|4214428|P1|Overall Study|Missing data|29
1292575|NCT00305058|4214439|P2|Overall Study|Missing outcome data|2
1292576|NCT00305058|4214440|P1|Overall Study|Missing outcome data|3
1292577|NCT00305058|4214439|P2|Overall Study|Missing data collection instrument|2
1292578|NCT00305058|4214440|P1|Overall Study|Missing data collection instrument|3
1292579|NCT00305058|4214439|P2|Overall Study|Participant too young|0
1292580|NCT00305058|4214440|P1|Overall Study|Participant too young|1
1292581|NCT00304954|4214456|P4|Overall Study|Adverse Event|0
1292582|NCT00304954|4214457|P3|Overall Study|Adverse Event|0
1292583|NCT00304954|4214458|P2|Overall Study|Adverse Event|0
1292584|NCT00304954|4214459|P1|Overall Study|Adverse Event|1
1292585|NCT00304954|4214456|P4|Overall Study|Withdrawal by Subject|0
1292586|NCT00304954|4214457|P3|Overall Study|Withdrawal by Subject|1
1292587|NCT00304954|4214458|P2|Overall Study|Withdrawal by Subject|0
1292588|NCT00304954|4214459|P1|Overall Study|Withdrawal by Subject|0
1292589|NCT00304915|4214479|P2|Overall Study|Withdrawal by Subject|0
1292590|NCT00304915|4214480|P1|Overall Study|Withdrawal by Subject|3
1292591|NCT00304915|4214479|P2|Overall Study|Death|5
1292592|NCT00304915|4214480|P1|Overall Study|Death|4
1292593|NCT00304915|4214479|P2|Overall Study|Lost to Follow-up|11
1292594|NCT00304915|4214480|P1|Overall Study|Lost to Follow-up|11
1292595|NCT00304356|4214525|P1|Nitazoxanide|Physician Decision|1
1292596|NCT00304356|4214525|P1|Nitazoxanide|Physician Decision|1
1292597|NCT00304356|4214525|P1|Nitazoxanide|Physician Decision|1
1292598|NCT00304356|4214525|P1|Nitazoxanide|number is 0|1
1292599|NCT00304356|4214525|P1|Nitazoxanide|Physician Decision|1
1292600|NCT00304356|4214525|P1|Nitazoxanide|Physician Decision|5
1292601|NCT00304278|4214529|P1|Overall Study|PT had medical condition preventing TX|1
1292602|NCT00304278|4214529|P1|Overall Study|lack of insurance coverage for chemoRT|1
1292603|NCT00304083|4214578|P2|Overall Study|Other|2
1292604|NCT00304083|4214579|P1|Overall Study|Other|5
1292605|NCT00304083|4214578|P2|Overall Study|Disease Progression|1
1292606|NCT00304083|4214579|P1|Overall Study|Disease Progression|5
1292607|NCT00304083|4214578|P2|Overall Study|Physician Decision|3
1292608|NCT00304083|4214579|P1|Overall Study|Physician Decision|8
1292609|NCT00304083|4214578|P2|Overall Study|Withdrawal by Subject|2
1292610|NCT00304083|4214579|P1|Overall Study|Withdrawal by Subject|4
1292611|NCT00304070|4214598|P3|Overall Study|Progressive Disease|4
1292612|NCT00304070|4214599|P2|Overall Study|Progressive Disease|7
1292613|NCT00304070|4214600|P1|Overall Study|Progressive Disease|3
1292614|NCT00304070|4214598|P3|Overall Study|Withdrawal by Subject|1
1292615|NCT00304070|4214599|P2|Overall Study|Withdrawal by Subject|0
1292616|NCT00304070|4214600|P1|Overall Study|Withdrawal by Subject|0
1292617|NCT00304070|4214598|P3|Overall Study|Physician Decision|3
1292618|NCT00304070|4214599|P2|Overall Study|Physician Decision|0
1292619|NCT00304070|4214600|P1|Overall Study|Physician Decision|0
1292620|NCT00304070|4214598|P3|Overall Study|Lost to Follow-up|1
1292621|NCT00304070|4214599|P2|Overall Study|Lost to Follow-up|0
1292622|NCT00304070|4214600|P1|Overall Study|Lost to Follow-up|0
1292623|NCT00304070|4214598|P3|Overall Study|Death|3
1292624|NCT00304070|4214599|P2|Overall Study|Death|0
1292625|NCT00304070|4214600|P1|Overall Study|Death|0
1292626|NCT00304031|4214615|P3|Randomization to Adjuvant TMZ Arm|No follow-up collected|2
1292627|NCT00304031|4214616|P2|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
1292628|NCT00304031|4214617|P1|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
1292629|NCT00304031|4214615|P3|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|0
1292630|NCT00304031|4214616|P2|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|0
1292631|NCT00304031|4214617|P1|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|37
1292632|NCT00304031|4214615|P3|Concomitant Radiation Therapy and TMZ|Other complicating disease|0
1292633|NCT00304031|4214616|P2|Concomitant Radiation Therapy and TMZ|Other complicating disease|0
1292634|NCT00304031|4214617|P1|Concomitant Radiation Therapy and TMZ|Other complicating disease|1
1292635|NCT00304031|4214615|P3|Concomitant Radiation Therapy and TMZ|Toxicity|0
1292636|NCT00304031|4214616|P2|Concomitant Radiation Therapy and TMZ|Toxicity|0
1292637|NCT00304031|4214617|P1|Concomitant Radiation Therapy and TMZ|Toxicity|10
1292638|NCT00304031|4214615|P3|Concomitant Radiation Therapy and TMZ|Physician preference|0
1292639|NCT00304031|4214616|P2|Concomitant Radiation Therapy and TMZ|Physician preference|0
1292640|NCT00304031|4214617|P1|Concomitant Radiation Therapy and TMZ|Physician preference|15
1292641|NCT00304031|4214615|P3|Concomitant Radiation Therapy and TMZ|Death|0
1292642|NCT00304031|4214616|P2|Concomitant Radiation Therapy and TMZ|Death|0
1292643|NCT00304031|4214617|P1|Concomitant Radiation Therapy and TMZ|Death|18
1292644|NCT00304031|4214615|P3|Concomitant Radiation Therapy and TMZ|Patient refusal|0
1292645|NCT00304031|4214616|P2|Concomitant Radiation Therapy and TMZ|Patient refusal|0
1292646|NCT00304031|4214617|P1|Concomitant Radiation Therapy and TMZ|Patient refusal|19
1292647|NCT00304031|4214615|P3|Concomitant Radiation Therapy and TMZ|Disease progression|0
1292648|NCT00304031|4214616|P2|Concomitant Radiation Therapy and TMZ|Disease progression|0
1292649|NCT00304031|4214617|P1|Concomitant Radiation Therapy and TMZ|Disease progression|48
1292650|NCT00304031|4214615|P3|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|0
1292651|NCT00304031|4214616|P2|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|0
1292652|NCT00304031|4214617|P1|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|144
1292653|NCT00304031|4214615|P3|Registration|Ineligible|0
1292654|NCT00304031|4214616|P2|Registration|Ineligible|0
1292655|NCT00304031|4214617|P1|Registration|Ineligible|48
1292656|NCT00303953|4214648|P1|Overall Study|Physician Decision|1
1292657|NCT00303953|4214648|P1|Overall Study|Lack of Efficacy|12
1292658|NCT00303953|4214648|P1|Overall Study|Adverse Event|4
1292659|NCT00303953|4214648|P1|Overall Study|Death|1
1292660|NCT00303953|4214648|P1|Overall Study|Ineligible|1
1292661|NCT00303667|4214683|P2|Overall Study|Death|4
1292662|NCT00303667|4214684|P1|Overall Study|Death|0
1292663|NCT00303628|4214708|P2|Overall Study|Other|9
1292664|NCT00303628|4214709|P1|Overall Study|Other|8
1292665|NCT00303628|4214708|P2|Overall Study|Not start protocol therapy|5
1292666|NCT00303628|4214709|P1|Overall Study|Not start protocol therapy|3
1292667|NCT00303628|4214708|P2|Overall Study|Other complicating disease|1
1292668|NCT00303628|4214709|P1|Overall Study|Other complicating disease|0
1292669|NCT00303628|4214708|P2|Overall Study|Alternative therapy|0
1292670|NCT00303628|4214709|P1|Overall Study|Alternative therapy|2
1292671|NCT00303628|4214708|P2|Overall Study|Withdrawal by Subject|20
1292672|NCT00303628|4214709|P1|Overall Study|Withdrawal by Subject|11
1292673|NCT00303628|4214708|P2|Overall Study|Death|1
1292674|NCT00303628|4214709|P1|Overall Study|Death|0
1292675|NCT00303628|4214708|P2|Overall Study|Adverse Event|36
1292676|NCT00303628|4214709|P1|Overall Study|Adverse Event|26
1292677|NCT00303628|4214708|P2|Overall Study|Disease progression|1
1292678|NCT00303628|4214709|P1|Overall Study|Disease progression|0
1292679|NCT00303602|4214727|P2|Overall Study|Protocol Violation|0
1292680|NCT00303602|4214728|P1|Overall Study|Protocol Violation|1
1292681|NCT00303602|4214727|P2|Overall Study|Noncompliance|2
1292682|NCT00303602|4214728|P1|Overall Study|Noncompliance|2
1292683|NCT00303602|4214727|P2|Overall Study|Physician Decision|1
1292684|NCT00303602|4214728|P1|Overall Study|Physician Decision|2
1292685|NCT00303602|4214727|P2|Overall Study|Protocol entry criteria not met|2
1292686|NCT00303602|4214728|P1|Overall Study|Protocol entry criteria not met|2
1292687|NCT00303602|4214727|P2|Overall Study|Lost to Follow-up|2
1292688|NCT00303602|4214728|P1|Overall Study|Lost to Follow-up|5
1292689|NCT00303602|4214727|P2|Overall Study|Withdrawal by Subject|6
1292690|NCT00303602|4214728|P1|Overall Study|Withdrawal by Subject|5
1292691|NCT00303602|4214727|P2|Overall Study|Adverse Event|2
1292692|NCT00303602|4214728|P1|Overall Study|Adverse Event|2
1292693|NCT00303485|4214774|P2|Overall Study|Withdrawal by Subject|0
1292694|NCT00303485|4214775|P1|Overall Study|Withdrawal by Subject|1
1292695|NCT00303485|4214774|P2|Overall Study|Failure to return|1
1292696|NCT00303485|4214775|P1|Overall Study|Failure to return|0
1292697|NCT00303485|4214774|P2|Overall Study|Adverse Event/Intercurrent Illness|1
1292698|NCT00303485|4214775|P1|Overall Study|Adverse Event/Intercurrent Illness|0
1292699|NCT00303472|4214806|P7|Treatment Extension (Optional)|Disease Progression (to AML)|0
1292700|NCT00303472|4214807|P6|Treatment Extension (Optional)|Disease Progression (to AML)|1
1292701|NCT00303472|4214808|P5|Treatment Extension (Optional)|Disease Progression (to AML)|0
1292702|NCT00303472|4214809|P4|Treatment Extension (Optional)|Disease Progression (to AML)|0
1292703|NCT00303472|4214810|P3|Treatment Extension (Optional)|Disease Progression (to AML)|0
1292704|NCT00303472|4214811|P2|Treatment Extension (Optional)|Disease Progression (to AML)|0
1292787|NCT00303459|4214872|P2|Overall Study|Administrative reason|7
1292705|NCT00303472|4214812|P1|Treatment Extension (Optional)|Disease Progression (to AML)|1
1292706|NCT00303472|4214806|P7|Treatment Extension (Optional)|Not specified|0
1292707|NCT00303472|4214807|P6|Treatment Extension (Optional)|Not specified|0
1292708|NCT00303472|4214808|P5|Treatment Extension (Optional)|Not specified|1
1292709|NCT00303472|4214809|P4|Treatment Extension (Optional)|Not specified|2
1292710|NCT00303472|4214810|P3|Treatment Extension (Optional)|Not specified|4
1292711|NCT00303472|4214811|P2|Treatment Extension (Optional)|Not specified|2
1292712|NCT00303472|4214812|P1|Treatment Extension (Optional)|Not specified|0
1292713|NCT00303472|4214806|P7|Treatment Extension (Optional)|Withdrawal by Subject|0
1292714|NCT00303472|4214807|P6|Treatment Extension (Optional)|Withdrawal by Subject|0
1292715|NCT00303472|4214808|P5|Treatment Extension (Optional)|Withdrawal by Subject|1
1292716|NCT00303472|4214809|P4|Treatment Extension (Optional)|Withdrawal by Subject|2
1292717|NCT00303472|4214810|P3|Treatment Extension (Optional)|Withdrawal by Subject|1
1292718|NCT00303472|4214811|P2|Treatment Extension (Optional)|Withdrawal by Subject|0
1292719|NCT00303472|4214812|P1|Treatment Extension (Optional)|Withdrawal by Subject|1
1292720|NCT00303472|4214806|P7|Treatment Extension (Optional)|Physician Decision|0
1292721|NCT00303472|4214807|P6|Treatment Extension (Optional)|Physician Decision|0
1292722|NCT00303472|4214808|P5|Treatment Extension (Optional)|Physician Decision|2
1292723|NCT00303472|4214809|P4|Treatment Extension (Optional)|Physician Decision|3
1292724|NCT00303472|4214810|P3|Treatment Extension (Optional)|Physician Decision|2
1292725|NCT00303472|4214811|P2|Treatment Extension (Optional)|Physician Decision|4
1292726|NCT00303472|4214812|P1|Treatment Extension (Optional)|Physician Decision|0
1292727|NCT00303472|4214806|P7|Treatment Extension (Optional)|Lost to Follow-up|0
1292728|NCT00303472|4214807|P6|Treatment Extension (Optional)|Lost to Follow-up|0
1292729|NCT00303472|4214808|P5|Treatment Extension (Optional)|Lost to Follow-up|0
1292730|NCT00303472|4214809|P4|Treatment Extension (Optional)|Lost to Follow-up|1
1292731|NCT00303472|4214810|P3|Treatment Extension (Optional)|Lost to Follow-up|0
1292732|NCT00303472|4214811|P2|Treatment Extension (Optional)|Lost to Follow-up|0
1292733|NCT00303472|4214812|P1|Treatment Extension (Optional)|Lost to Follow-up|0
1292734|NCT00303472|4214806|P7|Treatment Extension (Optional)|Death|0
1292735|NCT00303472|4214807|P6|Treatment Extension (Optional)|Death|0
1292736|NCT00303472|4214808|P5|Treatment Extension (Optional)|Death|0
1292737|NCT00303472|4214809|P4|Treatment Extension (Optional)|Death|0
1292738|NCT00303472|4214810|P3|Treatment Extension (Optional)|Death|1
1292739|NCT00303472|4214811|P2|Treatment Extension (Optional)|Death|0
1292740|NCT00303472|4214812|P1|Treatment Extension (Optional)|Death|2
1292741|NCT00303472|4214806|P7|Treatment Extension (Optional)|Adverse Event|0
1292742|NCT00303472|4214807|P6|Treatment Extension (Optional)|Adverse Event|0
1292743|NCT00303472|4214808|P5|Treatment Extension (Optional)|Adverse Event|0
1292744|NCT00303472|4214809|P4|Treatment Extension (Optional)|Adverse Event|0
1292745|NCT00303472|4214810|P3|Treatment Extension (Optional)|Adverse Event|1
1292746|NCT00303472|4214811|P2|Treatment Extension (Optional)|Adverse Event|0
1292747|NCT00303472|4214812|P1|Treatment Extension (Optional)|Adverse Event|1
1292748|NCT00303472|4214806|P7|Treatment Period|Disease Progression (to AML)|0
1292749|NCT00303472|4214807|P6|Treatment Period|Disease Progression (to AML)|0
1292750|NCT00303472|4214808|P5|Treatment Period|Disease Progression (to AML)|1
1292751|NCT00303472|4214809|P4|Treatment Period|Disease Progression (to AML)|0
1292752|NCT00303472|4214810|P3|Treatment Period|Disease Progression (to AML)|0
1292753|NCT00303472|4214811|P2|Treatment Period|Disease Progression (to AML)|0
1292754|NCT00303472|4214812|P1|Treatment Period|Disease Progression (to AML)|0
1292755|NCT00303472|4214806|P7|Treatment Period|Not specified|1
1292756|NCT00303472|4214807|P6|Treatment Period|Not specified|0
1292757|NCT00303472|4214808|P5|Treatment Period|Not specified|1
1292758|NCT00303472|4214809|P4|Treatment Period|Not specified|0
1292759|NCT00303472|4214810|P3|Treatment Period|Not specified|0
1292760|NCT00303472|4214811|P2|Treatment Period|Not specified|0
1292761|NCT00303472|4214812|P1|Treatment Period|Not specified|0
1292762|NCT00303472|4214806|P7|Treatment Period|Withdrawal by Subject|0
1292763|NCT00303472|4214807|P6|Treatment Period|Withdrawal by Subject|1
1292764|NCT00303472|4214808|P5|Treatment Period|Withdrawal by Subject|0
1292765|NCT00303472|4214809|P4|Treatment Period|Withdrawal by Subject|1
1292766|NCT00303472|4214810|P3|Treatment Period|Withdrawal by Subject|0
1292767|NCT00303472|4214811|P2|Treatment Period|Withdrawal by Subject|0
1292768|NCT00303472|4214812|P1|Treatment Period|Withdrawal by Subject|0
1292769|NCT00303472|4214806|P7|Treatment Period|Death|1
1292770|NCT00303472|4214807|P6|Treatment Period|Death|0
1292771|NCT00303472|4214808|P5|Treatment Period|Death|0
1292772|NCT00303472|4214809|P4|Treatment Period|Death|1
1292773|NCT00303472|4214810|P3|Treatment Period|Death|0
1292774|NCT00303472|4214811|P2|Treatment Period|Death|0
1292775|NCT00303472|4214812|P1|Treatment Period|Death|0
1292776|NCT00303472|4214806|P7|Treatment Period|Adverse Event|0
1292777|NCT00303472|4214807|P6|Treatment Period|Adverse Event|0
1292778|NCT00303472|4214808|P5|Treatment Period|Adverse Event|1
1292779|NCT00303472|4214809|P4|Treatment Period|Adverse Event|0
1292780|NCT00303472|4214810|P3|Treatment Period|Adverse Event|0
1292781|NCT00303472|4214811|P2|Treatment Period|Adverse Event|0
1292782|NCT00303472|4214812|P1|Treatment Period|Adverse Event|0
1292783|NCT00303459|4214872|P2|Overall Study|Lung transplantation|1
1292784|NCT00303459|4214873|P1|Overall Study|Lung transplantation|1
1292785|NCT00303459|4214872|P2|Overall Study|Decision by the investigator|7
1292786|NCT00303459|4214873|P1|Overall Study|Decision by the investigator|5
1292788|NCT00303459|4214873|P1|Overall Study|Administrative reason|7
1292789|NCT00303459|4214872|P2|Overall Study|Lost to Follow-up|4
1292790|NCT00303459|4214873|P1|Overall Study|Lost to Follow-up|5
1292791|NCT00303459|4214872|P2|Overall Study|Withdrawal of consent|26
1292792|NCT00303459|4214873|P1|Overall Study|Withdrawal of consent|32
1292793|NCT00303459|4214872|P2|Overall Study|Death|44
1292794|NCT00303459|4214873|P1|Overall Study|Death|33
1292795|NCT00303446|4214899|P2|Overall Study|Physician Decision|1
1292796|NCT00303446|4214900|P1|Overall Study|Physician Decision|0
1292797|NCT00303446|4214899|P2|Overall Study|Death|1
1292798|NCT00303446|4214900|P1|Overall Study|Death|0
1292799|NCT00303446|4214899|P2|Overall Study|Withdrawal by Subject|2
1292800|NCT00303446|4214900|P1|Overall Study|Withdrawal by Subject|2
1292801|NCT00303329|4214936|P2|Overall Study|Stopped at end of extension 1|0
1292802|NCT00303329|4214937|P1|Overall Study|Stopped at end of extension 1|1
1292803|NCT00303329|4214936|P2|Overall Study|Stopped at end of core|9
1292804|NCT00303329|4214937|P1|Overall Study|Stopped at end of core|3
1292805|NCT00303329|4214936|P2|Overall Study|Death|12
1292806|NCT00303329|4214937|P1|Overall Study|Death|2
1292807|NCT00303329|4214936|P2|Overall Study|Administrative problems|0
1292808|NCT00303329|4214937|P1|Overall Study|Administrative problems|1
1292809|NCT00303329|4214936|P2|Overall Study|Lost to Follow-up|1
1292810|NCT00303329|4214937|P1|Overall Study|Lost to Follow-up|0
1292811|NCT00303329|4214936|P2|Overall Study|Withdrawal by Subject|15
1292812|NCT00303329|4214937|P1|Overall Study|Withdrawal by Subject|9
1292813|NCT00303329|4214936|P2|Overall Study|Protocol Violation|0
1292814|NCT00303329|4214937|P1|Overall Study|Protocol Violation|3
1292815|NCT00303329|4214936|P2|Overall Study|Condition no longer requires study drug|8
1292816|NCT00303329|4214937|P1|Overall Study|Condition no longer requires study drug|0
1292817|NCT00303329|4214936|P2|Overall Study|Unsatisfactory therapeutic effect|2
1292818|NCT00303329|4214937|P1|Overall Study|Unsatisfactory therapeutic effect|9
1292819|NCT00303329|4214936|P2|Overall Study|Abnormal Laboratory Values|1
1292820|NCT00303329|4214937|P1|Overall Study|Abnormal Laboratory Values|0
1292821|NCT00303329|4214936|P2|Overall Study|Adverse Event|14
1292822|NCT00303329|4214937|P1|Overall Study|Adverse Event|7
1292823|NCT00303316|4214951|P2|Overall Study|Withdrawal by Subject|2
1292824|NCT00303316|4214952|P1|Overall Study|Withdrawal by Subject|1
1292825|NCT00303316|4214951|P2|Overall Study|Lost to Follow-up|1
1292826|NCT00303316|4214952|P1|Overall Study|Lost to Follow-up|0
1292827|NCT00303316|4214951|P2|Overall Study|Protocol Violation|0
1292828|NCT00303316|4214952|P1|Overall Study|Protocol Violation|1
1292829|NCT00303186|4214964|P1|Overall Study|Other|52
1292830|NCT00303108|4214998|P3|Overall Study|ineligible|0
1292831|NCT00303108|4214999|P2|Overall Study|ineligible|1
1292832|NCT00303108|4215000|P1|Overall Study|ineligible|2
1292833|NCT00303108|4214998|P3|Overall Study|Failed Entry|1
1292834|NCT00303108|4214999|P2|Overall Study|Failed Entry|0
1292835|NCT00303108|4215000|P1|Overall Study|Failed Entry|1
1292836|NCT00303108|4214998|P3|Overall Study|Patient Request|8
1292837|NCT00303108|4214999|P2|Overall Study|Patient Request|2
1292838|NCT00303108|4215000|P1|Overall Study|Patient Request|4
1292839|NCT00303108|4214998|P3|Overall Study|Adverse Event|7
1292840|NCT00303108|4214999|P2|Overall Study|Adverse Event|6
1292841|NCT00303108|4215000|P1|Overall Study|Adverse Event|5
1292842|NCT00303069|4215020|P4|Overall Study|Recruitment into Army Reserves|0
1292843|NCT00303069|4215021|P3|Overall Study|Recruitment into Army Reserves|1
1292844|NCT00303069|4215022|P2|Overall Study|Recruitment into Army Reserves|0
1292845|NCT00303069|4215023|P1|Overall Study|Recruitment into Army Reserves|0
1292846|NCT00303069|4215020|P4|Overall Study|subject moved|0
1292847|NCT00303069|4215021|P3|Overall Study|subject moved|0
1292848|NCT00303069|4215022|P2|Overall Study|subject moved|0
1292849|NCT00303069|4215023|P1|Overall Study|subject moved|1
1292850|NCT00303069|4215020|P4|Overall Study|Lost to Follow-up|2
1292851|NCT00303069|4215021|P3|Overall Study|Lost to Follow-up|0
1292852|NCT00303069|4215022|P2|Overall Study|Lost to Follow-up|0
1292853|NCT00303069|4215023|P1|Overall Study|Lost to Follow-up|1
1292854|NCT00302952|4215043|P2|Overall Study|Elevated SGOT (AST) lab value|1
1292855|NCT00302952|4215044|P1|Overall Study|Elevated SGOT (AST) lab value|0
1292856|NCT00302952|4215043|P2|Overall Study|Withdrawal by Subject|3
1292857|NCT00302952|4215044|P1|Overall Study|Withdrawal by Subject|2
1292858|NCT00302952|4215043|P2|Overall Study|Physician Decision|1
1292859|NCT00302952|4215044|P1|Overall Study|Physician Decision|1
1292860|NCT00302731|4215094|P4|Overall Study|cancer unrelated to study discovered|0
1292861|NCT00302731|4215095|P3|Overall Study|cancer unrelated to study discovered|1
1292862|NCT00302731|4215096|P2|Overall Study|cancer unrelated to study discovered|0
1292863|NCT00302731|4215097|P1|Overall Study|cancer unrelated to study discovered|1
1292864|NCT00302731|4215094|P4|Overall Study|Protocol Violation|0
1292865|NCT00302731|4215095|P3|Overall Study|Protocol Violation|0
1292866|NCT00302731|4215096|P2|Overall Study|Protocol Violation|0
1292867|NCT00302731|4215097|P1|Overall Study|Protocol Violation|1
1292868|NCT00302731|4215094|P4|Overall Study|Withdrawal by Subject|0
1292869|NCT00302731|4215095|P3|Overall Study|Withdrawal by Subject|0
1292870|NCT00302731|4215096|P2|Overall Study|Withdrawal by Subject|1
1292871|NCT00302731|4215097|P1|Overall Study|Withdrawal by Subject|1
1292872|NCT00302731|4215094|P4|Overall Study|Adverse Event|0
1292873|NCT00302731|4215095|P3|Overall Study|Adverse Event|2
1292874|NCT00302731|4215096|P2|Overall Study|Adverse Event|2
1292875|NCT00302731|4215097|P1|Overall Study|Adverse Event|0
1292876|NCT00302731|4215094|P4|Overall Study|Lost to Follow-up|0
1292877|NCT00302731|4215095|P3|Overall Study|Lost to Follow-up|0
1292878|NCT00302731|4215096|P2|Overall Study|Lost to Follow-up|2
1292879|NCT00302731|4215097|P1|Overall Study|Lost to Follow-up|1
1292880|NCT00302718|4215123|P4|Overall Study|Participant left primary care setting|1
1292881|NCT00302718|4215124|P3|Overall Study|Participant left primary care setting|2
1292882|NCT00302718|4215125|P2|Overall Study|Participant left primary care setting|0
1292883|NCT00302718|4215126|P1|Overall Study|Participant left primary care setting|0
1292884|NCT00302718|4215123|P4|Overall Study|Withdrawal by Subject|0
1292885|NCT00302718|4215124|P3|Overall Study|Withdrawal by Subject|0
1292886|NCT00302718|4215125|P2|Overall Study|Withdrawal by Subject|1
1292887|NCT00302718|4215126|P1|Overall Study|Withdrawal by Subject|0
1292888|NCT00302718|4215123|P4|Overall Study|Participant left the hospital|1
1292889|NCT00302718|4215124|P3|Overall Study|Participant left the hospital|0
1292890|NCT00302718|4215125|P2|Overall Study|Participant left the hospital|0
1292891|NCT00302718|4215126|P1|Overall Study|Participant left the hospital|1
1292892|NCT00302458|4215158|P1|Overall Study|Withdrawal by Subject|1
1292893|NCT00302458|4215158|P1|Overall Study|Ineligible after screening|1
1292894|NCT00302458|4215158|P1|Overall Study|Lost to Follow-up|1
1292895|NCT00302328|4215169|P3|Overall Study|Physician Decision|0
1292896|NCT00302328|4215170|P2|Overall Study|Physician Decision|1
1292897|NCT00302328|4215171|P1|Overall Study|Physician Decision|0
1292898|NCT00302211|4215188|P5|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
1292899|NCT00302211|4215189|P4|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1
1292900|NCT00302211|4215190|P3|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
1292901|NCT00302211|4215191|P2|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
1292902|NCT00302211|4215192|P1|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
1292903|NCT00302211|4215188|P5|Open Label-Patients From Double-Blind|PH requiring lung transplant|1
1292904|NCT00302211|4215189|P4|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
1292905|NCT00302211|4215190|P3|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
1292906|NCT00302211|4215191|P2|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
1292907|NCT00302211|4215192|P1|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
1292908|NCT00302211|4215188|P5|Open Label-Patients From Double-Blind|Lost to Follow-up|1
1292909|NCT00302211|4215189|P4|Open Label-Patients From Double-Blind|Lost to Follow-up|0
1292910|NCT00302211|4215190|P3|Open Label-Patients From Double-Blind|Lost to Follow-up|0
1292911|NCT00302211|4215191|P2|Open Label-Patients From Double-Blind|Lost to Follow-up|0
1292912|NCT00302211|4215192|P1|Open Label-Patients From Double-Blind|Lost to Follow-up|0
1292913|NCT00302211|4215188|P5|Open Label-Patients From Double-Blind|Death|1
1292914|NCT00302211|4215189|P4|Open Label-Patients From Double-Blind|Death|1
1292915|NCT00302211|4215190|P3|Open Label-Patients From Double-Blind|Death|0
1292916|NCT00302211|4215191|P2|Open Label-Patients From Double-Blind|Death|0
1292917|NCT00302211|4215192|P1|Open Label-Patients From Double-Blind|Death|0
1292918|NCT00302211|4215188|P5|Open Label-Patients From Double-Blind|Disease progression|2
1292919|NCT00302211|4215189|P4|Open Label-Patients From Double-Blind|Disease progression|1
1292920|NCT00302211|4215190|P3|Open Label-Patients From Double-Blind|Disease progression|0
1292921|NCT00302211|4215191|P2|Open Label-Patients From Double-Blind|Disease progression|0
1292922|NCT00302211|4215192|P1|Open Label-Patients From Double-Blind|Disease progression|0
1292923|NCT00302211|4215188|P5|Open Label-Patients From Double-Blind|Investigator's judgement|0
1292924|NCT00302211|4215189|P4|Open Label-Patients From Double-Blind|Investigator's judgement|1
1292925|NCT00302211|4215190|P3|Open Label-Patients From Double-Blind|Investigator's judgement|0
1292926|NCT00302211|4215191|P2|Open Label-Patients From Double-Blind|Investigator's judgement|0
1292927|NCT00302211|4215192|P1|Open Label-Patients From Double-Blind|Investigator's judgement|0
1292928|NCT00302211|4215188|P5|Open Label-Patients From Double-Blind|Adverse Event|0
1292929|NCT00302211|4215189|P4|Open Label-Patients From Double-Blind|Adverse Event|1
1292930|NCT00302211|4215190|P3|Open Label-Patients From Double-Blind|Adverse Event|0
1292931|NCT00302211|4215191|P2|Open Label-Patients From Double-Blind|Adverse Event|0
1292932|NCT00302211|4215192|P1|Open Label-Patients From Double-Blind|Adverse Event|0
1292933|NCT00302211|4215188|P5|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
1292934|NCT00302211|4215189|P4|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
1292935|NCT00302211|4215190|P3|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
1292936|NCT00302211|4215191|P2|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
1292937|NCT00302211|4215192|P1|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
1292938|NCT00302211|4215188|P5|Double Blind Period (New Patients)|Disease progression|0
1292939|NCT00302211|4215189|P4|Double Blind Period (New Patients)|Disease progression|0
1292940|NCT00302211|4215190|P3|Double Blind Period (New Patients)|Disease progression|1
1292941|NCT00302211|4215191|P2|Double Blind Period (New Patients)|Disease progression|1
1292942|NCT00302211|4215192|P1|Double Blind Period (New Patients)|Disease progression|0
1292943|NCT00302211|4215188|P5|Double Blind Period (New Patients)|Investigator's judgement|0
1292944|NCT00302211|4215189|P4|Double Blind Period (New Patients)|Investigator's judgement|0
1292945|NCT00302211|4215190|P3|Double Blind Period (New Patients)|Investigator's judgement|0
1292946|NCT00302211|4215191|P2|Double Blind Period (New Patients)|Investigator's judgement|0
1292947|NCT00302211|4215192|P1|Double Blind Period (New Patients)|Investigator's judgement|1
1292948|NCT00302211|4215188|P5|Double Blind Period (New Patients)|Adverse Event|0
1292949|NCT00302211|4215189|P4|Double Blind Period (New Patients)|Adverse Event|0
1292950|NCT00302211|4215190|P3|Double Blind Period (New Patients)|Adverse Event|3
1292951|NCT00302211|4215191|P2|Double Blind Period (New Patients)|Adverse Event|0
1292952|NCT00302211|4215192|P1|Double Blind Period (New Patients)|Adverse Event|0
1292953|NCT00302211|4215188|P5|Double Blind Period (New Patients)|Withdrawal by Subject|0
1292954|NCT00302211|4215189|P4|Double Blind Period (New Patients)|Withdrawal by Subject|0
1292955|NCT00302211|4215190|P3|Double Blind Period (New Patients)|Withdrawal by Subject|0
1292956|NCT00302211|4215191|P2|Double Blind Period (New Patients)|Withdrawal by Subject|1
1292957|NCT00302211|4215192|P1|Double Blind Period (New Patients)|Withdrawal by Subject|2
1292958|NCT00302159|4215204|P1|Overall Study|pt started Avastin|1
1292959|NCT00302159|4215204|P1|Overall Study|pt declined before treatment started|1
1292960|NCT00302107|4215226|P2|Overall Study|Adverse Event|0
1292961|NCT00302107|4215227|P1|Overall Study|Adverse Event|1
1292962|NCT00302107|4215226|P2|Overall Study|Withdrawal by Subject|3
1292963|NCT00302107|4215227|P1|Overall Study|Withdrawal by Subject|0
1292964|NCT00302107|4215226|P2|Overall Study|Relocation|1
1292965|NCT00302107|4215227|P1|Overall Study|Relocation|0
1292966|NCT00302107|4215226|P2|Overall Study|Protocol Violation|0
1292967|NCT00302107|4215227|P1|Overall Study|Protocol Violation|1
1292968|NCT00302107|4215226|P2|Overall Study|Lost to Follow-up|5
1292969|NCT00302107|4215227|P1|Overall Study|Lost to Follow-up|6
1292970|NCT00302081|4215236|P3|Overall Study|Other|5
1292971|NCT00302081|4215237|P2|Overall Study|Other|6
1292972|NCT00302081|4215238|P1|Overall Study|Other|13
1292973|NCT00302081|4215236|P3|Overall Study|Death|0
1292974|NCT00302081|4215237|P2|Overall Study|Death|1
1292975|NCT00302081|4215238|P1|Overall Study|Death|2
1292976|NCT00302081|4215236|P3|Overall Study|Lack of Efficacy|5
1292977|NCT00302081|4215237|P2|Overall Study|Lack of Efficacy|0
1292978|NCT00302081|4215238|P1|Overall Study|Lack of Efficacy|1
1292979|NCT00302081|4215236|P3|Overall Study|Protocol Violation|2
1292980|NCT00302081|4215237|P2|Overall Study|Protocol Violation|1
1292981|NCT00302081|4215238|P1|Overall Study|Protocol Violation|5
1292982|NCT00302081|4215236|P3|Overall Study|Withdrawal by Subject|8
1292983|NCT00302081|4215237|P2|Overall Study|Withdrawal by Subject|12
1292984|NCT00302081|4215238|P1|Overall Study|Withdrawal by Subject|8
1292985|NCT00302081|4215236|P3|Overall Study|Lost to Follow-up|28
1292986|NCT00302081|4215237|P2|Overall Study|Lost to Follow-up|18
1292987|NCT00302081|4215238|P1|Overall Study|Lost to Follow-up|21
1292988|NCT00302081|4215236|P3|Overall Study|Adverse Event|4
1292989|NCT00302081|4215237|P2|Overall Study|Adverse Event|5
1292990|NCT00302081|4215238|P1|Overall Study|Adverse Event|6
1292991|NCT00302003|4215295|P1|Overall Study|Protocol Violation|1
1292992|NCT00302003|4215295|P1|Overall Study|Ineligible|9
1292993|NCT00302003|4215295|P1|Overall Study|Withdrawal by Subject|5
1292994|NCT00302003|4215295|P1|Overall Study|Physician Decision|2
1292995|NCT00302003|4215295|P1|Overall Study|Lost to Follow-up|1
1292996|NCT00302003|4215295|P1|Overall Study|Lack of Efficacy|62
1292997|NCT00301964|4215302|P1|Overall Study|Inadequate pathology|1
1292998|NCT00301964|4215302|P1|Overall Study|Wrong primary|1
1292999|NCT00301964|4215302|P1|Overall Study|Second primary|2
1293000|NCT00301834|4215323|P1|Overall Study|Death|1
1293001|NCT00301821|4215332|P1|Overall Study|Cancel|1
1293002|NCT00301821|4215332|P1|Overall Study|Ineligible|25
1293003|NCT00301808|4215339|P1|Overall Study|Lack of Efficacy|4
1293004|NCT00301808|4215339|P1|Overall Study|Death|3
1293005|NCT00301808|4215339|P1|Overall Study|Adverse Event|5
1293006|NCT00301366|4215364|P1|Overall Study|Adverse Event|1
1293007|NCT00301262|4215370|P2|Open Label Phase (OL)|Other|0
1293008|NCT00301262|4215371|P1|Open Label Phase (OL)|Other|2
1293009|NCT00301262|4215370|P2|Open Label Phase (OL)|Lost to Follow-up|2
1293010|NCT00301262|4215371|P1|Open Label Phase (OL)|Lost to Follow-up|1
1293011|NCT00301262|4215370|P2|Open Label Phase (OL)|Adverse Event|0
1293012|NCT00301262|4215371|P1|Open Label Phase (OL)|Adverse Event|1
1293013|NCT00301262|4215370|P2|Double Blind Phase (DB)|Other|4
1293014|NCT00301262|4215371|P1|Double Blind Phase (DB)|Other|1
1293015|NCT00301262|4215370|P2|Double Blind Phase (DB)|Withdrawal by Subject|5
1293016|NCT00301262|4215371|P1|Double Blind Phase (DB)|Withdrawal by Subject|5
1293017|NCT00301262|4215370|P2|Double Blind Phase (DB)|Lost to Follow-up|3
1293018|NCT00301262|4215371|P1|Double Blind Phase (DB)|Lost to Follow-up|3
1293019|NCT00301262|4215370|P2|Double Blind Phase (DB)|Lack of Efficacy|1
1293020|NCT00301262|4215371|P1|Double Blind Phase (DB)|Lack of Efficacy|0
1293021|NCT00301262|4215370|P2|Double Blind Phase (DB)|Adverse Event|0
1293022|NCT00301262|4215371|P1|Double Blind Phase (DB)|Adverse Event|1
1293023|NCT00301080|4215529|P5|Original Version (2 Arms & 4 Weeks)|Never received drug|0
1293024|NCT00301080|4215530|P4|Original Version (2 Arms & 4 Weeks)|Never received drug|0
1293025|NCT00301080|4215531|P3|Original Version (2 Arms & 4 Weeks)|Never received drug|0
1293026|NCT00301080|4215532|P2|Original Version (2 Arms & 4 Weeks)|Never received drug|0
1293027|NCT00301080|4215533|P1|Original Version (2 Arms & 4 Weeks)|Never received drug|1
1293028|NCT00301067|4215562|P4|Follow up Until Death|Alive at last data cut point|1
1293029|NCT00301067|4215563|P3|Follow up Until Death|Alive at last data cut point|0
1293030|NCT00301067|4215564|P2|Follow up Until Death|Alive at last data cut point|0
1293031|NCT00301067|4215565|P1|Follow up Until Death|Alive at last data cut point|1
1293032|NCT00301067|4215562|P4|Completed 12 Cycles of Treatment|Adverse Event|1
1293033|NCT00301067|4215563|P3|Completed 12 Cycles of Treatment|Adverse Event|0
1293034|NCT00301067|4215564|P2|Completed 12 Cycles of Treatment|Adverse Event|0
1293123|NCT00299975|4216000|P3|Overall Study|Physician Decision|1
1293035|NCT00301067|4215565|P1|Completed 12 Cycles of Treatment|Adverse Event|0
1293036|NCT00301067|4215562|P4|Completed 12 Cycles of Treatment|Progressive Disease|1
1293037|NCT00301067|4215563|P3|Completed 12 Cycles of Treatment|Progressive Disease|0
1293038|NCT00301067|4215564|P2|Completed 12 Cycles of Treatment|Progressive Disease|1
1293039|NCT00301067|4215565|P1|Completed 12 Cycles of Treatment|Progressive Disease|0
1293040|NCT00301067|4215562|P4|Completed 4 Cycles of Treatment|Progressive disease|5
1293041|NCT00301067|4215563|P3|Completed 4 Cycles of Treatment|Progressive disease|2
1293042|NCT00301067|4215564|P2|Completed 4 Cycles of Treatment|Progressive disease|1
1293043|NCT00301067|4215565|P1|Completed 4 Cycles of Treatment|Progressive disease|1
1293044|NCT00301067|4215562|P4|Reached 1st Response/2 Cycles|Progressive Disease|2
1293045|NCT00301067|4215563|P3|Reached 1st Response/2 Cycles|Progressive Disease|1
1293046|NCT00301067|4215564|P2|Reached 1st Response/2 Cycles|Progressive Disease|1
1293047|NCT00301067|4215565|P1|Reached 1st Response/2 Cycles|Progressive Disease|2
1293048|NCT00301067|4215562|P4|Completed DLT Period/1st Cycle|Progressive Disease|1
1293049|NCT00301067|4215563|P3|Completed DLT Period/1st Cycle|Progressive Disease|0
1293050|NCT00301067|4215564|P2|Completed DLT Period/1st Cycle|Progressive Disease|0
1293051|NCT00301067|4215565|P1|Completed DLT Period/1st Cycle|Progressive Disease|1
1293052|NCT00300885|4215590|P2|Follow-up|Withdrawal by Subject|25
1293053|NCT00300885|4215591|P1|Follow-up|Withdrawal by Subject|26
1293054|NCT00300885|4215590|P2|Follow-up|Lost to Follow-up|7
1293055|NCT00300885|4215591|P1|Follow-up|Lost to Follow-up|11
1293056|NCT00300885|4215590|P2|Follow-up|Death|163
1293057|NCT00300885|4215591|P1|Follow-up|Death|141
1293058|NCT00300885|4215590|P2|Treatment|Non-compliant with study medication|4
1293059|NCT00300885|4215591|P1|Treatment|Non-compliant with study medication|3
1293060|NCT00300885|4215590|P2|Treatment|Random code broken (subject died)|1
1293061|NCT00300885|4215591|P1|Treatment|Random code broken (subject died)|0
1293062|NCT00300885|4215590|P2|Treatment|Disease progression|238
1293063|NCT00300885|4215591|P1|Treatment|Disease progression|171
1293064|NCT00300885|4215590|P2|Treatment|Withdrawal by Subject|23
1293065|NCT00300885|4215591|P1|Treatment|Withdrawal by Subject|26
1293066|NCT00300885|4215590|P2|Treatment|Protocol Violation|11
1293067|NCT00300885|4215591|P1|Treatment|Protocol Violation|11
1293068|NCT00300885|4215590|P2|Treatment|Physician Decision|5
1293069|NCT00300885|4215591|P1|Treatment|Physician Decision|4
1293070|NCT00300885|4215590|P2|Treatment|Lost to Follow-up|2
1293071|NCT00300885|4215591|P1|Treatment|Lost to Follow-up|3
1293072|NCT00300885|4215590|P2|Treatment|Lack of Efficacy|1
1293073|NCT00300885|4215591|P1|Treatment|Lack of Efficacy|1
1293074|NCT00300885|4215590|P2|Treatment|Death|7
1293075|NCT00300885|4215591|P1|Treatment|Death|20
1293076|NCT00300885|4215590|P2|Treatment|Adverse Event|82
1293077|NCT00300885|4215591|P1|Treatment|Adverse Event|134
1293078|NCT00300781|4215609|P2|Overall Study|Lost to Follow-up|1
1293079|NCT00300781|4215610|P1|Overall Study|Lost to Follow-up|0
1293080|NCT00300781|4215609|P2|Overall Study|Symptomatic Deterioration|0
1293081|NCT00300781|4215610|P1|Overall Study|Symptomatic Deterioration|1
1293082|NCT00300781|4215609|P2|Overall Study|Not Recorded|1
1293083|NCT00300781|4215610|P1|Overall Study|Not Recorded|0
1293084|NCT00300781|4215609|P2|Overall Study|Physician Decision|0
1293085|NCT00300781|4215610|P1|Overall Study|Physician Decision|1
1293086|NCT00300781|4215609|P2|Overall Study|Withdrawal by Subject|2
1293087|NCT00300781|4215610|P1|Overall Study|Withdrawal by Subject|1
1293088|NCT00300781|4215609|P2|Overall Study|Adverse Event|6
1293089|NCT00300781|4215610|P1|Overall Study|Adverse Event|5
1293090|NCT00300781|4215609|P2|Overall Study|Disease Progression|52
1293091|NCT00300781|4215610|P1|Overall Study|Disease Progression|55
1293092|NCT00300755|4215625|P3|Overall Study|Protocol Violation|1
1293093|NCT00300755|4215626|P2|Overall Study|Protocol Violation|0
1293094|NCT00300755|4215627|P1|Overall Study|Protocol Violation|0
1293095|NCT00300755|4215625|P3|Overall Study|Withdrawal by Subject|0
1293096|NCT00300755|4215626|P2|Overall Study|Withdrawal by Subject|2
1293097|NCT00300755|4215627|P1|Overall Study|Withdrawal by Subject|0
1293098|NCT00300755|4215625|P3|Overall Study|Adverse Event|1
1293099|NCT00300755|4215626|P2|Overall Study|Adverse Event|2
1293100|NCT00300755|4215627|P1|Overall Study|Adverse Event|1
1293101|NCT00300495|4215661|P2|Overall Study|Protocol Violation|1
1293102|NCT00300495|4215662|P1|Overall Study|Protocol Violation|4
1293103|NCT00300365|4215929|P2|Overall Study|Adverse Event|2
1293104|NCT00300365|4215930|P1|Overall Study|Adverse Event|0
1293105|NCT00300365|4215929|P2|Overall Study|Withdrawal by Subject|0
1293106|NCT00300365|4215930|P1|Overall Study|Withdrawal by Subject|1
1293107|NCT00300365|4215929|P2|Overall Study|Physician Decision|0
1293108|NCT00300365|4215930|P1|Overall Study|Physician Decision|2
1293109|NCT00300365|4215929|P2|Overall Study|Lost to Follow-up|0
1293110|NCT00300365|4215930|P1|Overall Study|Lost to Follow-up|1
1293111|NCT00300274|4215939|P3|Overall Study|Re-transplant|1
1293112|NCT00300274|4215940|P2|Overall Study|Re-transplant|0
1293113|NCT00300274|4215941|P1|Overall Study|Re-transplant|0
1293114|NCT00300274|4215939|P3|Overall Study|Death|25
1293115|NCT00300274|4215940|P2|Overall Study|Death|20
1293116|NCT00300274|4215941|P1|Overall Study|Death|31
1293117|NCT00300274|4215939|P3|Overall Study|Lost to Follow-up|5
1293118|NCT00300274|4215940|P2|Overall Study|Lost to Follow-up|4
1293119|NCT00300274|4215941|P1|Overall Study|Lost to Follow-up|3
1293120|NCT00300274|4215939|P3|Overall Study|Withdrawal by Subject|14
1293121|NCT00300274|4215940|P2|Overall Study|Withdrawal by Subject|3
1293122|NCT00300274|4215941|P1|Overall Study|Withdrawal by Subject|12
1293124|NCT00299975|4216001|P2|Overall Study|Physician Decision|0
1293125|NCT00299975|4216002|P1|Overall Study|Physician Decision|0
1293126|NCT00299975|4216000|P3|Overall Study|Withdrawal by Subject|3
1293127|NCT00299975|4216001|P2|Overall Study|Withdrawal by Subject|1
1293128|NCT00299975|4216002|P1|Overall Study|Withdrawal by Subject|0
1293129|NCT00299975|4216000|P3|Overall Study|Lost to Follow-up|0
1293130|NCT00299975|4216001|P2|Overall Study|Lost to Follow-up|0
1293131|NCT00299975|4216002|P1|Overall Study|Lost to Follow-up|1
1293132|NCT00299975|4216000|P3|Overall Study|Lack of Efficacy|1
1293133|NCT00299975|4216001|P2|Overall Study|Lack of Efficacy|0
1293134|NCT00299975|4216002|P1|Overall Study|Lack of Efficacy|1
1293135|NCT00299975|4216000|P3|Overall Study|Pregnancy|1
1293136|NCT00299975|4216001|P2|Overall Study|Pregnancy|0
1293137|NCT00299975|4216002|P1|Overall Study|Pregnancy|0
1293138|NCT00299975|4216000|P3|Overall Study|Adverse Event|2
1293139|NCT00299975|4216001|P2|Overall Study|Adverse Event|0
1293140|NCT00299975|4216002|P1|Overall Study|Adverse Event|1
1293141|NCT00299702|4216059|P2|Overall Study|Admin issues, sponsor decision, etc.|9
1293142|NCT00299702|4216060|P1|Overall Study|Admin issues, sponsor decision, etc.|5
1293143|NCT00299702|4216059|P2|Overall Study|Insufficient Response|3
1293144|NCT00299702|4216060|P1|Overall Study|Insufficient Response|4
1293145|NCT00299702|4216059|P2|Overall Study|Pregnancy|1
1293146|NCT00299702|4216060|P1|Overall Study|Pregnancy|0
1293147|NCT00299702|4216059|P2|Overall Study|Withdrawal by Subject|23
1293148|NCT00299702|4216060|P1|Overall Study|Withdrawal by Subject|25
1293149|NCT00299702|4216059|P2|Overall Study|Lost to Follow-up|10
1293150|NCT00299702|4216060|P1|Overall Study|Lost to Follow-up|18
1293151|NCT00299702|4216059|P2|Overall Study|Adverse Event|4
1293152|NCT00299702|4216060|P1|Overall Study|Adverse Event|0
1293153|NCT00299702|4216059|P2|Overall Study|Death|0
1293154|NCT00299702|4216060|P1|Overall Study|Death|1
1293155|NCT00299546|4216075|P3|Overall Study|Not treated|1
1293156|NCT00299546|4216076|P2|Overall Study|Not treated|1
1293157|NCT00299546|4216077|P1|Overall Study|Not treated|0
1293158|NCT00299546|4216075|P3|Overall Study|Not specified|19
1293159|NCT00299546|4216076|P2|Overall Study|Not specified|26
1293160|NCT00299546|4216077|P1|Overall Study|Not specified|24
1293161|NCT00299546|4216075|P3|Overall Study|Unsatisfactory therapeutic effect|34
1293162|NCT00299546|4216076|P2|Overall Study|Unsatisfactory therapeutic effect|39
1293163|NCT00299546|4216077|P1|Overall Study|Unsatisfactory therapeutic effect|34
1293164|NCT00299546|4216075|P3|Overall Study|Adverse Event|27
1293165|NCT00299546|4216076|P2|Overall Study|Adverse Event|22
1293166|NCT00299546|4216077|P1|Overall Study|Adverse Event|37
1293167|NCT00299546|4216075|P3|Overall Study|Lost to Follow-up|5
1293168|NCT00299546|4216076|P2|Overall Study|Lost to Follow-up|2
1293169|NCT00299546|4216077|P1|Overall Study|Lost to Follow-up|2
1293170|NCT00299546|4216075|P3|Overall Study|Death|0
1293171|NCT00299546|4216076|P2|Overall Study|Death|2
1293172|NCT00299546|4216077|P1|Overall Study|Death|3
1293173|NCT00299494|4216108|P6|Overall Study|Other - site closure|1
1293174|NCT00299494|4216109|P5|Overall Study|Other - site closure|1
1293175|NCT00299494|4216110|P4|Overall Study|Other - site closure|1
1293176|NCT00299494|4216111|P3|Overall Study|Other - site closure|0
1293177|NCT00299494|4216112|P2|Overall Study|Other - site closure|0
1293178|NCT00299494|4216113|P1|Overall Study|Other - site closure|0
1293179|NCT00299494|4216108|P6|Overall Study|Other - Unspecified|1
1293180|NCT00299494|4216109|P5|Overall Study|Other - Unspecified|3
1293181|NCT00299494|4216110|P4|Overall Study|Other - Unspecified|0
1293182|NCT00299494|4216111|P3|Overall Study|Other - Unspecified|0
1293183|NCT00299494|4216112|P2|Overall Study|Other - Unspecified|0
1293184|NCT00299494|4216113|P1|Overall Study|Other - Unspecified|0
1293185|NCT00299494|4216108|P6|Overall Study|Lost to Follow-up|1
1293186|NCT00299494|4216109|P5|Overall Study|Lost to Follow-up|3
1293187|NCT00299494|4216110|P4|Overall Study|Lost to Follow-up|0
1293188|NCT00299494|4216111|P3|Overall Study|Lost to Follow-up|0
1293189|NCT00299494|4216112|P2|Overall Study|Lost to Follow-up|0
1293190|NCT00299494|4216113|P1|Overall Study|Lost to Follow-up|0
1293191|NCT00299494|4216108|P6|Overall Study|Death|19
1293192|NCT00299494|4216109|P5|Overall Study|Death|18
1293193|NCT00299494|4216110|P4|Overall Study|Death|6
1293194|NCT00299494|4216111|P3|Overall Study|Death|4
1293195|NCT00299494|4216112|P2|Overall Study|Death|1
1293196|NCT00299494|4216113|P1|Overall Study|Death|3
1293197|NCT00299494|4216108|P6|Overall Study|Physician Decision|0
1293198|NCT00299494|4216109|P5|Overall Study|Physician Decision|1
1293199|NCT00299494|4216110|P4|Overall Study|Physician Decision|0
1293200|NCT00299494|4216111|P3|Overall Study|Physician Decision|0
1293201|NCT00299494|4216112|P2|Overall Study|Physician Decision|0
1293202|NCT00299494|4216113|P1|Overall Study|Physician Decision|0
1293203|NCT00299494|4216108|P6|Overall Study|Withdrawal by Subject|4
1293204|NCT00299494|4216109|P5|Overall Study|Withdrawal by Subject|1
1293205|NCT00299494|4216110|P4|Overall Study|Withdrawal by Subject|3
1293206|NCT00299494|4216111|P3|Overall Study|Withdrawal by Subject|0
1293207|NCT00299494|4216112|P2|Overall Study|Withdrawal by Subject|0
1293208|NCT00299494|4216113|P1|Overall Study|Withdrawal by Subject|0
1293209|NCT00299156|4216242|P3|Period 2 (Randomized)|Screen Failure|0
1293210|NCT00299156|4216243|P2|Period 2 (Randomized)|Screen Failure|1
1293211|NCT00299156|4216244|P1|Period 2 (Randomized)|Screen Failure|0
1293212|NCT00299130|4216255|P3|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4
1293213|NCT00299130|4216256|P2|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3
1293214|NCT00299130|4216257|P1|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0
1293215|NCT00299130|4216255|P3|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
1293216|NCT00299130|4216256|P2|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
1293217|NCT00299130|4216257|P1|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0
1293218|NCT00299130|4216255|P3|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
1293219|NCT00299130|4216256|P2|Extended SFU (ESFU) (up to 5.1 Years)|Death|3
1293220|NCT00299130|4216257|P1|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
1293221|NCT00299130|4216255|P3|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21
1293222|NCT00299130|4216256|P2|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
1293223|NCT00299130|4216257|P1|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
1293224|NCT00299130|4216255|P3|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
1293225|NCT00299130|4216256|P2|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1
1293226|NCT00299130|4216257|P1|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
1293227|NCT00299130|4216255|P3|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15
1293228|NCT00299130|4216256|P2|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7
1293229|NCT00299130|4216257|P1|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14
1293230|NCT00299130|4216255|P3|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2
1293231|NCT00299130|4216256|P2|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
1293232|NCT00299130|4216257|P1|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
1293233|NCT00299130|4216255|P3|Safety Follow-up (SFU) (48 Weeks)|Death|3
1293234|NCT00299130|4216256|P2|Safety Follow-up (SFU) (48 Weeks)|Death|5
1293235|NCT00299130|4216257|P1|Safety Follow-up (SFU) (48 Weeks)|Death|4
1293236|NCT00299130|4216255|P3|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
1293237|NCT00299130|4216256|P2|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9
1293238|NCT00299130|4216257|P1|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
1293239|NCT00299130|4216255|P3|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
1293240|NCT00299130|4216256|P2|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
1293241|NCT00299130|4216257|P1|Treatment Period (up to 5 Years)|Withdrawal by Subject|0
1293242|NCT00299130|4216255|P3|Treatment Period (up to 5 Years)|Reason not Specified|4
1293243|NCT00299130|4216256|P2|Treatment Period (up to 5 Years)|Reason not Specified|6
1293244|NCT00299130|4216257|P1|Treatment Period (up to 5 Years)|Reason not Specified|4
1293245|NCT00299130|4216255|P3|Treatment Period (up to 5 Years)|Failure to Return|6
1293246|NCT00299130|4216256|P2|Treatment Period (up to 5 Years)|Failure to Return|6
1293247|NCT00299130|4216257|P1|Treatment Period (up to 5 Years)|Failure to Return|4
1293248|NCT00299130|4216255|P3|Treatment Period (up to 5 Years)|Refused Treatment|19
1293249|NCT00299130|4216256|P2|Treatment Period (up to 5 Years)|Refused Treatment|12
1293250|NCT00299130|4216257|P1|Treatment Period (up to 5 Years)|Refused Treatment|12
1293251|NCT00299130|4216255|P3|Treatment Period (up to 5 Years)|Protocol Violation|0
1293252|NCT00299130|4216256|P2|Treatment Period (up to 5 Years)|Protocol Violation|1
1293253|NCT00299130|4216257|P1|Treatment Period (up to 5 Years)|Protocol Violation|0
1293254|NCT00299130|4216255|P3|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
1293255|NCT00299130|4216256|P2|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
1293256|NCT00299130|4216257|P1|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19
1293257|NCT00299130|4216255|P3|Treatment Period (up to 5 Years)|Death|1
1293258|NCT00299130|4216256|P2|Treatment Period (up to 5 Years)|Death|3
1293259|NCT00299130|4216257|P1|Treatment Period (up to 5 Years)|Death|1
1293260|NCT00299130|4216255|P3|Treatment Period (up to 5 Years)|Adverse Event|13
1293261|NCT00299130|4216256|P2|Treatment Period (up to 5 Years)|Adverse Event|8
1293262|NCT00299130|4216257|P1|Treatment Period (up to 5 Years)|Adverse Event|13
1293263|NCT00299104|4216362|P3|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
1293264|NCT00299104|4216363|P2|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
1293265|NCT00299104|4216364|P1|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1
1293266|NCT00299104|4216362|P3|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8
1293267|NCT00299104|4216363|P2|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4
1293268|NCT00299104|4216364|P1|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2
1293269|NCT00299104|4216362|P3|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
1293270|NCT00299104|4216363|P2|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
1293271|NCT00299104|4216364|P1|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
1293272|NCT00299104|4216362|P3|Extended Safety Follow-Up (ESFU) Period|Death|0
1293273|NCT00299104|4216363|P2|Extended Safety Follow-Up (ESFU) Period|Death|1
1293274|NCT00299104|4216364|P1|Extended Safety Follow-Up (ESFU) Period|Death|0
1293275|NCT00299104|4216362|P3|Safety Follow-Up (SFU) Period|Administrative reasons|5
1293276|NCT00299104|4216363|P2|Safety Follow-Up (SFU) Period|Administrative reasons|7
1293277|NCT00299104|4216364|P1|Safety Follow-Up (SFU) Period|Administrative reasons|27
1293278|NCT00299104|4216362|P3|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11
1293279|NCT00299104|4216363|P2|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21
1293280|NCT00299104|4216364|P1|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16
1293281|NCT00299104|4216362|P3|Safety Follow-Up (SFU) Period|Lost to Follow-up|20
1293282|NCT00299104|4216363|P2|Safety Follow-Up (SFU) Period|Lost to Follow-up|11
1293283|NCT00299104|4216364|P1|Safety Follow-Up (SFU) Period|Lost to Follow-up|9
1293284|NCT00299104|4216362|P3|Safety Follow-Up (SFU) Period|Death|1
1293285|NCT00299104|4216363|P2|Safety Follow-Up (SFU) Period|Death|2
1293286|NCT00299104|4216364|P1|Safety Follow-Up (SFU) Period|Death|3
1293287|NCT00299104|4216362|P3|Treatment Period|Administrative reasons|137
1293288|NCT00299104|4216363|P2|Treatment Period|Administrative reasons|120
1293289|NCT00299104|4216364|P1|Treatment Period|Administrative reasons|106
1293290|NCT00299104|4216362|P3|Treatment Period|Withdrew consent|9
1293291|NCT00299104|4216363|P2|Treatment Period|Withdrew consent|19
1293292|NCT00299104|4216364|P1|Treatment Period|Withdrew consent|14
1293293|NCT00299104|4216362|P3|Treatment Period|Refused treatment|2
1293294|NCT00299104|4216363|P2|Treatment Period|Refused treatment|2
1293295|NCT00299104|4216364|P1|Treatment Period|Refused treatment|9
1293296|NCT00299104|4216362|P3|Treatment Period|Protocol Violation|0
1293297|NCT00299104|4216363|P2|Treatment Period|Protocol Violation|1
1293298|NCT00299104|4216364|P1|Treatment Period|Protocol Violation|1
1293299|NCT00299104|4216362|P3|Treatment Period|Violation of selection criteria|0
1293300|NCT00299104|4216363|P2|Treatment Period|Violation of selection criteria|2
1293301|NCT00299104|4216364|P1|Treatment Period|Violation of selection criteria|1
1293302|NCT00299104|4216362|P3|Treatment Period|Failure to return|8
1293303|NCT00299104|4216363|P2|Treatment Period|Failure to return|8
1293304|NCT00299104|4216364|P1|Treatment Period|Failure to return|9
1293305|NCT00299104|4216362|P3|Treatment Period|Insufficient therapeutic response|8
1293306|NCT00299104|4216363|P2|Treatment Period|Insufficient therapeutic response|13
1293307|NCT00299104|4216364|P1|Treatment Period|Insufficient therapeutic response|34
1293308|NCT00299104|4216362|P3|Treatment Period|Death|1
1293309|NCT00299104|4216363|P2|Treatment Period|Death|1
1293310|NCT00299104|4216364|P1|Treatment Period|Death|1
1293311|NCT00299104|4216362|P3|Treatment Period|Adverse Event|7
1293312|NCT00299104|4216363|P2|Treatment Period|Adverse Event|9
1293313|NCT00299104|4216364|P1|Treatment Period|Adverse Event|14
1293314|NCT00298896|4216474|P1|Overall Study|Assigned to treatment in error|1
1293315|NCT00298896|4216474|P1|Overall Study|Withdrawal by Subject|2
1293316|NCT00298896|4216474|P1|Overall Study|Disease Progression|41
1293317|NCT00298896|4216474|P1|Overall Study|Intercurrent Illness|1
1293318|NCT00298896|4216474|P1|Overall Study|Physician Decision|2
1293319|NCT00298896|4216474|P1|Overall Study|Death|3
1293320|NCT00298766|4216479|P1|Overall Study|Other|4
1293321|NCT00298766|4216479|P1|Overall Study|Subjects overall condition deterioration|4
1293322|NCT00298766|4216479|P1|Overall Study|Deterioration in KPS and organ function|1
1293323|NCT00298766|4216479|P1|Overall Study|Progression of amyloid markers|4
1293324|NCT00298766|4216479|P1|Overall Study|Treatment ongoing|4
1293325|NCT00298766|4216479|P1|Overall Study|Withdrawal by Subject|9
1293326|NCT00298766|4216479|P1|Overall Study|Death|2
1293327|NCT00298766|4216479|P1|Overall Study|Adverse Event|18
1293328|NCT00298740|4216488|P1|Overall Study|Withdrawal by Subject|3
1293329|NCT00298740|4216488|P1|Overall Study|Lack of Efficacy|6
1293330|NCT00298363|4216542|P3|Overall Study|Lack of Efficacy|0
1293331|NCT00298363|4216543|P2|Overall Study|Lack of Efficacy|3
1293332|NCT00298363|4216544|P1|Overall Study|Lack of Efficacy|2
1293333|NCT00298363|4216542|P3|Overall Study|Adverse Event|2
1293334|NCT00298363|4216543|P2|Overall Study|Adverse Event|2
1293335|NCT00298363|4216544|P1|Overall Study|Adverse Event|5
1293336|NCT00298363|4216542|P3|Overall Study|Withdrawal by Subject|3
1293337|NCT00298363|4216543|P2|Overall Study|Withdrawal by Subject|1
1293338|NCT00298363|4216544|P1|Overall Study|Withdrawal by Subject|5
1293339|NCT00298363|4216542|P3|Overall Study|Protocol Violation|0
1293340|NCT00298363|4216543|P2|Overall Study|Protocol Violation|1
1293341|NCT00298363|4216544|P1|Overall Study|Protocol Violation|1
1293342|NCT00298363|4216542|P3|Overall Study|Physician Decision|0
1293343|NCT00298363|4216543|P2|Overall Study|Physician Decision|1
1293344|NCT00298363|4216544|P1|Overall Study|Physician Decision|4
1293345|NCT00298363|4216542|P3|Overall Study|Lost to Follow-up|1
1293346|NCT00298363|4216543|P2|Overall Study|Lost to Follow-up|0
1293347|NCT00298363|4216544|P1|Overall Study|Lost to Follow-up|0
1293348|NCT00298272|4216702|P2|Safety Follow-up Phase|Administrative/Other Reason|1
1293349|NCT00298272|4216703|P1|Safety Follow-up Phase|Administrative/Other Reason|1
1293350|NCT00298272|4216702|P2|Safety Follow-up Phase|Withdrawal by Subject|2
1293351|NCT00298272|4216703|P1|Safety Follow-up Phase|Withdrawal by Subject|2
1293352|NCT00298272|4216702|P2|Safety Follow-up Phase|Failure to Return|1
1293353|NCT00298272|4216703|P1|Safety Follow-up Phase|Failure to Return|1
1293354|NCT00298272|4216702|P2|Open Label Retreatment Phase|Administrative/Other Reason|0
1293355|NCT00298272|4216703|P1|Open Label Retreatment Phase|Administrative/Other Reason|2
1293356|NCT00298272|4216702|P2|Open Label Retreatment Phase|Withdrawal by Subject|0
1293357|NCT00298272|4216703|P1|Open Label Retreatment Phase|Withdrawal by Subject|1
1293358|NCT00298272|4216702|P2|Open Label Retreatment Phase|Protocol Violation|1
1293359|NCT00298272|4216703|P1|Open Label Retreatment Phase|Protocol Violation|2
1293360|NCT00298272|4216702|P2|Open Label Retreatment Phase|Failure to Return|0
1293361|NCT00298272|4216703|P1|Open Label Retreatment Phase|Failure to Return|1
1293362|NCT00298272|4216702|P2|Open Label Retreatment Phase|Insufficient Therapeutic Response|1
1293363|NCT00298272|4216703|P1|Open Label Retreatment Phase|Insufficient Therapeutic Response|2
1293364|NCT00298272|4216702|P2|Open Label Retreatment Phase|Adverse Event|2
1293365|NCT00298272|4216703|P1|Open Label Retreatment Phase|Adverse Event|1
1293366|NCT00298272|4216702|P2|Double-blind Phase|Withdrawal by Subject|0
1293367|NCT00298272|4216703|P1|Double-blind Phase|Withdrawal by Subject|2
1293368|NCT00298272|4216702|P2|Double-blind Phase|Protocol Violation|0
1293369|NCT00298272|4216703|P1|Double-blind Phase|Protocol Violation|2
1293370|NCT00298272|4216702|P2|Double-blind Phase|Failure to Return|0
1293371|NCT00298272|4216703|P1|Double-blind Phase|Failure to Return|2
1293372|NCT00298272|4216702|P2|Double-blind Phase|Adverse Event|0
1293373|NCT00298272|4216703|P1|Double-blind Phase|Adverse Event|2
1293374|NCT00297830|4216768|P3|12 Month Visit|Withdrawal by Subject|0
1293375|NCT00297830|4216769|P2|12 Month Visit|Withdrawal by Subject|3
1293376|NCT00297830|4216770|P1|12 Month Visit|Withdrawal by Subject|0
1293377|NCT00297830|4216768|P3|12 Month Visit|Adverse Event|0
1293378|NCT00297830|4216769|P2|12 Month Visit|Adverse Event|3
1293379|NCT00297830|4216770|P1|12 Month Visit|Adverse Event|0
1293380|NCT00297830|4216768|P3|12 Month Visit|Lost to Follow-up|0
1293381|NCT00297830|4216769|P2|12 Month Visit|Lost to Follow-up|0
1293382|NCT00297830|4216770|P1|12 Month Visit|Lost to Follow-up|1
1293383|NCT00297830|4216768|P3|6 Month Visit|Adverse Event|0
1293384|NCT00297830|4216769|P2|6 Month Visit|Adverse Event|1
1293385|NCT00297830|4216770|P1|6 Month Visit|Adverse Event|0
1293386|NCT00297830|4216768|P3|6 Month Visit|Withdrawal by Subject|1
1293387|NCT00297830|4216769|P2|6 Month Visit|Withdrawal by Subject|1
1293388|NCT00297830|4216770|P1|6 Month Visit|Withdrawal by Subject|2
1293389|NCT00297830|4216768|P3|6 Month Visit|Death|2
1293390|NCT00297830|4216769|P2|6 Month Visit|Death|0
1293391|NCT00297830|4216770|P1|6 Month Visit|Death|1
1293392|NCT00297778|4216789|P2|Overall Study|Other|1
1293393|NCT00297778|4216790|P1|Overall Study|Other|0
1293394|NCT00297778|4216789|P2|Overall Study|Non-compliant with trial protocol|3
1293395|NCT00297778|4216790|P1|Overall Study|Non-compliant with trial protocol|0
1293396|NCT00297778|4216789|P2|Overall Study|Lack of Efficacy|1
1293397|NCT00297778|4216790|P1|Overall Study|Lack of Efficacy|2
1293398|NCT00297778|4216789|P2|Overall Study|Withdrawal by Subject|5
1293399|NCT00297778|4216790|P1|Overall Study|Withdrawal by Subject|1
1293400|NCT00297778|4216789|P2|Overall Study|Adverse Event|10
1293401|NCT00297778|4216790|P1|Overall Study|Adverse Event|16
1293402|NCT00297648|4216824|P1|Overall Study|Other: Incompliance|1
1293403|NCT00297648|4216824|P1|Overall Study|Withdrawal by Subject|3
1293404|NCT00297648|4216824|P1|Overall Study|Lost to Follow-up|1
1293405|NCT00297648|4216824|P1|Overall Study|Lack of Efficacy|18
1293406|NCT00297648|4216824|P1|Overall Study|Adverse Event|13
1293407|NCT00297492|4216870|P3|6 Month Follow-up|Lost to Follow-up|27
1293408|NCT00297492|4216871|P2|6 Month Follow-up|Lost to Follow-up|49
1293409|NCT00297492|4216872|P1|6 Month Follow-up|Lost to Follow-up|63
1293410|NCT00297492|4216870|P3|Set Quit Date|Lost to Follow-up|5
1293411|NCT00297492|4216871|P2|Set Quit Date|Lost to Follow-up|13
1293412|NCT00297492|4216872|P1|Set Quit Date|Lost to Follow-up|7
1293413|NCT00297427|4216882|P2|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0
1293414|NCT00297427|4216883|P1|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2
1293415|NCT00297427|4216882|P2|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0
1293416|NCT00297427|4216883|P1|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3
1293417|NCT00297427|4216882|P2|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0
1293418|NCT00297427|4216883|P1|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29
1293419|NCT00297427|4216882|P2|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0
1293420|NCT00297427|4216883|P1|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1
1293421|NCT00297427|4216882|P2|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0
1293422|NCT00297427|4216883|P1|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15
1293423|NCT00297427|4216882|P2|Phase 1: Initial Intervention|Death|1
1293424|NCT00297427|4216883|P1|Phase 1: Initial Intervention|Death|0
1293425|NCT00297427|4216882|P2|Phase 1: Initial Intervention|Lost to Follow-up|3
1293426|NCT00297427|4216883|P1|Phase 1: Initial Intervention|Lost to Follow-up|0
1293427|NCT00297427|4216882|P2|Phase 1: Initial Intervention|Withdrawal by Subject|5
1293428|NCT00297427|4216883|P1|Phase 1: Initial Intervention|Withdrawal by Subject|8
1293429|NCT00297258|4216924|P1|Overall Study|Interruption: Cold/Flu-like Symptoms|1
1293430|NCT00297258|4216924|P1|Overall Study|Switch to Commercial Treatment|1
1293431|NCT00297258|4216924|P1|Overall Study|Surgery Performed on Target Lesion|1
1293432|NCT00297258|4216924|P1|Overall Study|Radiotherapy to Destroy Last Lesion|1
1293433|NCT00297258|4216924|P1|Overall Study|Deteriorization of General Condition|1
1293434|NCT00297258|4216924|P1|Overall Study|Intercurrent Death|2
1293435|NCT00297258|4216924|P1|Overall Study|Intercurrent Illness|3
1293436|NCT00297258|4216924|P1|Overall Study|Patient Refusal: Not Related to Toxicity|2
1293437|NCT00297258|4216924|P1|Overall Study|Toxicity (or Toxic Death)|10
1293438|NCT00297258|4216924|P1|Overall Study|Disease Progression, Relapse, Death|120
1293439|NCT00297232|4216943|P1|Overall Study|Other|1
1293440|NCT00297232|4216943|P1|Overall Study|No data available after Week 264|161
1293441|NCT00297232|4216943|P1|Overall Study|Did Not Enroll to Week 480|17
1293442|NCT00297232|4216943|P1|Overall Study|Did Not Enroll to Week 264|34
1293443|NCT00297232|4216943|P1|Overall Study|Investigator Withdrew From Program|19
1293444|NCT00297232|4216943|P1|Overall Study|Persistently Positive Antibodies|11
1293445|NCT00297232|4216943|P1|Overall Study|Subject Withdrew Consent|37
1293446|NCT00297232|4216943|P1|Overall Study|Subject Relocated|7
1293447|NCT00297232|4216943|P1|Overall Study|Sponsor Decision|34
1293448|NCT00297232|4216943|P1|Overall Study|Miscellaneous|5
1293449|NCT00297232|4216943|P1|Overall Study|Anti-JCV Antibody Positive|13
1293450|NCT00297232|4216943|P1|Overall Study|Fear of PML|10
1293451|NCT00297232|4216943|P1|Overall Study|Disease Progression|8
1293452|NCT00297232|4216943|P1|Overall Study|Switched to Commercial Tysabri|22
1293453|NCT00297232|4216943|P1|Overall Study|Anti-natalizumab Positive|8
1293454|NCT00297232|4216943|P1|Overall Study|Death|9
1293455|NCT00297232|4216943|P1|Overall Study|Subject was Noncompliant|9
1293456|NCT00297232|4216943|P1|Overall Study|Voluntary Withdrawal|120
1293457|NCT00297232|4216943|P1|Overall Study|Adverse Event|63
1293458|NCT00297232|4216943|P1|Overall Study|Lost to Follow-up|10
1293459|NCT00297232|4216943|P1|Overall Study|Lack of Efficacy|7
1293460|NCT00297167|4216949|P3|Second Double-blind Intervention Period|Protocol Violation|0
1293461|NCT00297167|4216950|P2|Second Double-blind Intervention Period|Protocol Violation|0
1293462|NCT00297167|4216951|P1|Second Double-blind Intervention Period|Protocol Violation|1
1293463|NCT00297167|4216949|P3|Open-label Dose Normalization Period 1|Withdrawal by Subject|1
1293464|NCT00297167|4216950|P2|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
1293465|NCT00297167|4216951|P1|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
1293466|NCT00297037|4217015|P2|Overall Study|Withdrawal by Subject|0
1293467|NCT00297037|4217016|P1|Overall Study|Withdrawal by Subject|2
1293468|NCT00296816|4217028|P1|Overall Study|ineligibility due to radiation treatment|1
1293469|NCT00296816|4217028|P1|Overall Study|Proteinuria|1
1293470|NCT00296816|4217028|P1|Overall Study|Neuropathy/patient preference|1
1293471|NCT00296816|4217028|P1|Overall Study|Urine protein/creatinine ratio delay|1
1293472|NCT00296816|4217028|P1|Overall Study|Noncompliance/decision to discontinue|1
1293473|NCT00296816|4217028|P1|Overall Study|Relocation to Florida|1
1293474|NCT00296816|4217028|P1|Overall Study|Poor performance status|1
1293475|NCT00296816|4217028|P1|Overall Study|Progression based on CA-125 (biomarker)|2
1293476|NCT00296816|4217028|P1|Overall Study|Missing for end of treatment|4
1293477|NCT00296816|4217028|P1|Overall Study|Non-compliance|1
1293478|NCT00296816|4217028|P1|Overall Study|Investigator/Participant request|5
1293479|NCT00296816|4217028|P1|Overall Study|Adverse Event|18
1293480|NCT00296816|4217028|P1|Overall Study|Disease Progression|37
1293481|NCT00296647|4217045|P5|Overall Study|Withdrawal by Subject|19
1293482|NCT00296647|4217046|P4|Overall Study|Withdrawal by Subject|16
1293483|NCT00296647|4217047|P3|Overall Study|Withdrawal by Subject|32
1293484|NCT00296647|4217048|P2|Overall Study|Withdrawal by Subject|27
1293485|NCT00296647|4217049|P1|Overall Study|Withdrawal by Subject|28
1293486|NCT00296647|4217045|P5|Overall Study|Death|1
1293487|NCT00296647|4217046|P4|Overall Study|Death|1
1293488|NCT00296647|4217047|P3|Overall Study|Death|2
1293489|NCT00296647|4217048|P2|Overall Study|Death|1
1293490|NCT00296647|4217049|P1|Overall Study|Death|4
1293491|NCT00296517|4217063|P2|Dose Level 3 - Weeks 3-12|Not specified|2
1293492|NCT00296517|4217064|P1|Dose Level 3 - Weeks 3-12|Not specified|0
1293493|NCT00296517|4217063|P2|Dose Level 3 - Weeks 3-12|Non - Compliance|0
1293494|NCT00296517|4217064|P1|Dose Level 3 - Weeks 3-12|Non - Compliance|1
1293495|NCT00296517|4217063|P2|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18
1293496|NCT00296517|4217064|P1|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7
1293497|NCT00296517|4217063|P2|Dose Level 3 - Weeks 3-12|Protocol Violation|0
1293498|NCT00296517|4217064|P1|Dose Level 3 - Weeks 3-12|Protocol Violation|1
1293499|NCT00296517|4217063|P2|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2
1293500|NCT00296517|4217064|P1|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3
1293501|NCT00296517|4217063|P2|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6
1293502|NCT00296517|4217064|P1|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3
1293503|NCT00296517|4217063|P2|Dose Level 3 - Weeks 3-12|Adverse Event|34
1293504|NCT00296517|4217064|P1|Dose Level 3 - Weeks 3-12|Adverse Event|30
1293505|NCT00296517|4217063|P2|Dose Level 2 - Week 2|Withdrawal by Subject|0
1293506|NCT00296517|4217064|P1|Dose Level 2 - Week 2|Withdrawal by Subject|1
1293507|NCT00296517|4217063|P2|Dose Level 2 - Week 2|Adverse Event|5
1293508|NCT00296517|4217064|P1|Dose Level 2 - Week 2|Adverse Event|1
1293509|NCT00296504|4217100|P9|Final Analysis|Poor Adherence|1
1293510|NCT00296504|4217101|P8|Final Analysis|Poor Adherence|0
1293511|NCT00296504|4217102|P7|Final Analysis|Poor Adherence|0
1293512|NCT00296504|4217103|P6|Final Analysis|Poor Adherence|0
1293513|NCT00296504|4217104|P5|Final Analysis|Poor Adherence|0
1293514|NCT00296504|4217105|P4|Final Analysis|Poor Adherence|0
1293515|NCT00296504|4217106|P3|Final Analysis|Poor Adherence|0
1293516|NCT00296504|4217107|P2|Final Analysis|Poor Adherence|0
1293517|NCT00296504|4217108|P1|Final Analysis|Poor Adherence|0
1293518|NCT00296504|4217100|P9|Final Analysis|Participant Moved to Another Country|1
1293519|NCT00296504|4217101|P8|Final Analysis|Participant Moved to Another Country|0
1293520|NCT00296504|4217102|P7|Final Analysis|Participant Moved to Another Country|0
1293521|NCT00296504|4217103|P6|Final Analysis|Participant Moved to Another Country|0
1293522|NCT00296504|4217104|P5|Final Analysis|Participant Moved to Another Country|0
1293523|NCT00296504|4217105|P4|Final Analysis|Participant Moved to Another Country|0
1293524|NCT00296504|4217106|P3|Final Analysis|Participant Moved to Another Country|0
1293525|NCT00296504|4217107|P2|Final Analysis|Participant Moved to Another Country|0
1293526|NCT00296504|4217108|P1|Final Analysis|Participant Moved to Another Country|0
1293527|NCT00296504|4217100|P9|Final Analysis|Tuberculosis|1
1293528|NCT00296504|4217101|P8|Final Analysis|Tuberculosis|0
1293529|NCT00296504|4217102|P7|Final Analysis|Tuberculosis|0
1293530|NCT00296504|4217103|P6|Final Analysis|Tuberculosis|0
1293531|NCT00296504|4217104|P5|Final Analysis|Tuberculosis|0
1293532|NCT00296504|4217105|P4|Final Analysis|Tuberculosis|0
1293533|NCT00296504|4217106|P3|Final Analysis|Tuberculosis|0
1293534|NCT00296504|4217107|P2|Final Analysis|Tuberculosis|0
1293535|NCT00296504|4217108|P1|Final Analysis|Tuberculosis|0
1293536|NCT00296504|4217100|P9|Final Analysis|Pregnancy|4
1293537|NCT00296504|4217101|P8|Final Analysis|Pregnancy|0
1293538|NCT00296504|4217102|P7|Final Analysis|Pregnancy|0
1293539|NCT00296504|4217103|P6|Final Analysis|Pregnancy|0
1293540|NCT00296504|4217104|P5|Final Analysis|Pregnancy|0
1293541|NCT00296504|4217105|P4|Final Analysis|Pregnancy|0
1293542|NCT00296504|4217106|P3|Final Analysis|Pregnancy|0
1293543|NCT00296504|4217107|P2|Final Analysis|Pregnancy|0
1293544|NCT00296504|4217108|P1|Final Analysis|Pregnancy|0
1293545|NCT00296504|4217100|P9|Final Analysis|Adverse Event|2
1293546|NCT00296504|4217101|P8|Final Analysis|Adverse Event|0
1293547|NCT00296504|4217102|P7|Final Analysis|Adverse Event|0
1293548|NCT00296504|4217103|P6|Final Analysis|Adverse Event|0
1293549|NCT00296504|4217104|P5|Final Analysis|Adverse Event|0
1293550|NCT00296504|4217105|P4|Final Analysis|Adverse Event|0
1293551|NCT00296504|4217106|P3|Final Analysis|Adverse Event|0
1293552|NCT00296504|4217107|P2|Final Analysis|Adverse Event|0
1293553|NCT00296504|4217108|P1|Final Analysis|Adverse Event|0
1293554|NCT00296504|4217100|P9|Final Analysis|Insufficient Viral Load Response|6
1293555|NCT00296504|4217101|P8|Final Analysis|Insufficient Viral Load Response|0
1293556|NCT00296504|4217102|P7|Final Analysis|Insufficient Viral Load Response|0
1293557|NCT00296504|4217103|P6|Final Analysis|Insufficient Viral Load Response|0
1293558|NCT00296504|4217104|P5|Final Analysis|Insufficient Viral Load Response|0
1293559|NCT00296504|4217105|P4|Final Analysis|Insufficient Viral Load Response|0
1293560|NCT00296504|4217106|P3|Final Analysis|Insufficient Viral Load Response|0
1293561|NCT00296504|4217107|P2|Final Analysis|Insufficient Viral Load Response|0
1293562|NCT00296504|4217108|P1|Final Analysis|Insufficient Viral Load Response|0
1293563|NCT00296504|4217100|P9|Final Analysis|Lost to Follow-up|5
1293564|NCT00296504|4217101|P8|Final Analysis|Lost to Follow-up|0
1293565|NCT00296504|4217102|P7|Final Analysis|Lost to Follow-up|0
1293566|NCT00296504|4217103|P6|Final Analysis|Lost to Follow-up|0
1293567|NCT00296504|4217104|P5|Final Analysis|Lost to Follow-up|0
1293568|NCT00296504|4217105|P4|Final Analysis|Lost to Follow-up|0
1293569|NCT00296504|4217106|P3|Final Analysis|Lost to Follow-up|0
1293570|NCT00296504|4217107|P2|Final Analysis|Lost to Follow-up|0
1293571|NCT00296504|4217108|P1|Final Analysis|Lost to Follow-up|0
1293572|NCT00296504|4217100|P9|Final Analysis|Withdrawal by Subject|1
1293573|NCT00296504|4217101|P8|Final Analysis|Withdrawal by Subject|0
1293574|NCT00296504|4217102|P7|Final Analysis|Withdrawal by Subject|0
1293575|NCT00296504|4217103|P6|Final Analysis|Withdrawal by Subject|0
1293576|NCT00296504|4217104|P5|Final Analysis|Withdrawal by Subject|0
1293577|NCT00296504|4217105|P4|Final Analysis|Withdrawal by Subject|0
1293578|NCT00296504|4217106|P3|Final Analysis|Withdrawal by Subject|0
1293579|NCT00296504|4217107|P2|Final Analysis|Withdrawal by Subject|0
1293580|NCT00296504|4217108|P1|Final Analysis|Withdrawal by Subject|0
1293581|NCT00296504|4217100|P9|Interim Analysis|Ongoing|0
1293582|NCT00296504|4217101|P8|Interim Analysis|Ongoing|1
1293583|NCT00296504|4217102|P7|Interim Analysis|Ongoing|30
1293584|NCT00296504|4217103|P6|Interim Analysis|Ongoing|0
1293585|NCT00296504|4217104|P5|Interim Analysis|Ongoing|0
1293586|NCT00296504|4217105|P4|Interim Analysis|Ongoing|22
1293587|NCT00296504|4217106|P3|Interim Analysis|Ongoing|16
1293588|NCT00296504|4217107|P2|Interim Analysis|Ongoing|12
1293589|NCT00296504|4217108|P1|Interim Analysis|Ongoing|32
1293590|NCT00296504|4217100|P9|Interim Analysis|Participant Needed Interferon|0
1293591|NCT00296504|4217101|P8|Interim Analysis|Participant Needed Interferon|1
1293592|NCT00296504|4217102|P7|Interim Analysis|Participant Needed Interferon|0
1293593|NCT00296504|4217103|P6|Interim Analysis|Participant Needed Interferon|0
1293594|NCT00296504|4217104|P5|Interim Analysis|Participant Needed Interferon|0
1293595|NCT00296504|4217105|P4|Interim Analysis|Participant Needed Interferon|0
1293596|NCT00296504|4217106|P3|Interim Analysis|Participant Needed Interferon|0
1293597|NCT00296504|4217107|P2|Interim Analysis|Participant Needed Interferon|0
1293598|NCT00296504|4217108|P1|Interim Analysis|Participant Needed Interferon|0
1293599|NCT00296504|4217100|P9|Interim Analysis|Study Ended|0
1293600|NCT00296504|4217101|P8|Interim Analysis|Study Ended|0
1293601|NCT00296504|4217102|P7|Interim Analysis|Study Ended|1
1293602|NCT00296504|4217103|P6|Interim Analysis|Study Ended|0
1293603|NCT00296504|4217104|P5|Interim Analysis|Study Ended|0
1293604|NCT00296504|4217105|P4|Interim Analysis|Study Ended|0
1293605|NCT00296504|4217106|P3|Interim Analysis|Study Ended|0
1293606|NCT00296504|4217107|P2|Interim Analysis|Study Ended|0
1293607|NCT00296504|4217108|P1|Interim Analysis|Study Ended|0
1293608|NCT00296504|4217100|P9|Interim Analysis|Participant Stopped HIV Medications|0
1293609|NCT00296504|4217101|P8|Interim Analysis|Participant Stopped HIV Medications|0
1293610|NCT00296504|4217102|P7|Interim Analysis|Participant Stopped HIV Medications|1
1293611|NCT00296504|4217103|P6|Interim Analysis|Participant Stopped HIV Medications|0
1293612|NCT00296504|4217104|P5|Interim Analysis|Participant Stopped HIV Medications|0
1293613|NCT00296504|4217105|P4|Interim Analysis|Participant Stopped HIV Medications|0
1293614|NCT00296504|4217106|P3|Interim Analysis|Participant Stopped HIV Medications|0
1293615|NCT00296504|4217107|P2|Interim Analysis|Participant Stopped HIV Medications|0
1293616|NCT00296504|4217108|P1|Interim Analysis|Participant Stopped HIV Medications|0
1293617|NCT00296504|4217100|P9|Interim Analysis|Physician and Participant Decision|0
1293618|NCT00296504|4217101|P8|Interim Analysis|Physician and Participant Decision|0
1293619|NCT00296504|4217102|P7|Interim Analysis|Physician and Participant Decision|0
1293620|NCT00296504|4217103|P6|Interim Analysis|Physician and Participant Decision|1
1293621|NCT00296504|4217104|P5|Interim Analysis|Physician and Participant Decision|0
1293622|NCT00296504|4217105|P4|Interim Analysis|Physician and Participant Decision|0
1293623|NCT00296504|4217106|P3|Interim Analysis|Physician and Participant Decision|0
1293624|NCT00296504|4217107|P2|Interim Analysis|Physician and Participant Decision|0
1293625|NCT00296504|4217108|P1|Interim Analysis|Physician and Participant Decision|0
1293626|NCT00296504|4217100|P9|Interim Analysis|Participant Stopped|0
1293627|NCT00296504|4217101|P8|Interim Analysis|Participant Stopped|0
1293628|NCT00296504|4217102|P7|Interim Analysis|Participant Stopped|0
1293629|NCT00296504|4217103|P6|Interim Analysis|Participant Stopped|0
1293630|NCT00296504|4217104|P5|Interim Analysis|Participant Stopped|1
1293631|NCT00296504|4217105|P4|Interim Analysis|Participant Stopped|0
1293632|NCT00296504|4217106|P3|Interim Analysis|Participant Stopped|0
1293633|NCT00296504|4217107|P2|Interim Analysis|Participant Stopped|0
1293634|NCT00296504|4217108|P1|Interim Analysis|Participant Stopped|0
1293635|NCT00296504|4217100|P9|Interim Analysis|Inclusion in Other Protocol|0
1293636|NCT00296504|4217101|P8|Interim Analysis|Inclusion in Other Protocol|0
1293637|NCT00296504|4217102|P7|Interim Analysis|Inclusion in Other Protocol|0
1293638|NCT00296504|4217103|P6|Interim Analysis|Inclusion in Other Protocol|0
1293639|NCT00296504|4217104|P5|Interim Analysis|Inclusion in Other Protocol|0
1293640|NCT00296504|4217105|P4|Interim Analysis|Inclusion in Other Protocol|1
1293641|NCT00296504|4217106|P3|Interim Analysis|Inclusion in Other Protocol|0
1293642|NCT00296504|4217107|P2|Interim Analysis|Inclusion in Other Protocol|0
1293643|NCT00296504|4217108|P1|Interim Analysis|Inclusion in Other Protocol|0
1293644|NCT00296504|4217100|P9|Interim Analysis|Missed Schedule Date|0
1293645|NCT00296504|4217101|P8|Interim Analysis|Missed Schedule Date|0
1293646|NCT00296504|4217102|P7|Interim Analysis|Missed Schedule Date|0
1293647|NCT00296504|4217103|P6|Interim Analysis|Missed Schedule Date|0
1293648|NCT00296504|4217104|P5|Interim Analysis|Missed Schedule Date|0
1293649|NCT00296504|4217105|P4|Interim Analysis|Missed Schedule Date|0
1293650|NCT00296504|4217106|P3|Interim Analysis|Missed Schedule Date|0
1293651|NCT00296504|4217107|P2|Interim Analysis|Missed Schedule Date|0
1293652|NCT00296504|4217108|P1|Interim Analysis|Missed Schedule Date|1
1293653|NCT00296504|4217100|P9|Interim Analysis|Lack of Personnel at Site|0
1293654|NCT00296504|4217101|P8|Interim Analysis|Lack of Personnel at Site|0
1293655|NCT00296504|4217102|P7|Interim Analysis|Lack of Personnel at Site|0
1293656|NCT00296504|4217103|P6|Interim Analysis|Lack of Personnel at Site|0
1293657|NCT00296504|4217104|P5|Interim Analysis|Lack of Personnel at Site|0
1293658|NCT00296504|4217105|P4|Interim Analysis|Lack of Personnel at Site|0
1293659|NCT00296504|4217106|P3|Interim Analysis|Lack of Personnel at Site|0
1293660|NCT00296504|4217107|P2|Interim Analysis|Lack of Personnel at Site|0
1293661|NCT00296504|4217108|P1|Interim Analysis|Lack of Personnel at Site|1
1293662|NCT00296504|4217100|P9|Interim Analysis|Site Closing|0
1293663|NCT00296504|4217101|P8|Interim Analysis|Site Closing|0
1293664|NCT00296504|4217102|P7|Interim Analysis|Site Closing|2
1293665|NCT00296504|4217103|P6|Interim Analysis|Site Closing|1
1293666|NCT00296504|4217104|P5|Interim Analysis|Site Closing|0
1293667|NCT00296504|4217105|P4|Interim Analysis|Site Closing|0
1293668|NCT00296504|4217106|P3|Interim Analysis|Site Closing|0
1293669|NCT00296504|4217107|P2|Interim Analysis|Site Closing|0
1293670|NCT00296504|4217108|P1|Interim Analysis|Site Closing|1
1293671|NCT00296504|4217100|P9|Interim Analysis|Non-adherence|0
1293672|NCT00296504|4217101|P8|Interim Analysis|Non-adherence|1
1293673|NCT00296504|4217102|P7|Interim Analysis|Non-adherence|0
1293674|NCT00296504|4217103|P6|Interim Analysis|Non-adherence|0
1293675|NCT00296504|4217104|P5|Interim Analysis|Non-adherence|1
1293676|NCT00296504|4217105|P4|Interim Analysis|Non-adherence|0
1293677|NCT00296504|4217106|P3|Interim Analysis|Non-adherence|0
1293678|NCT00296504|4217107|P2|Interim Analysis|Non-adherence|0
1293679|NCT00296504|4217108|P1|Interim Analysis|Non-adherence|2
1293680|NCT00296504|4217100|P9|Interim Analysis|Principle Investigator Terminated Study|0
1293681|NCT00296504|4217101|P8|Interim Analysis|Principle Investigator Terminated Study|0
1293682|NCT00296504|4217102|P7|Interim Analysis|Principle Investigator Terminated Study|0
1293683|NCT00296504|4217103|P6|Interim Analysis|Principle Investigator Terminated Study|0
1293684|NCT00296504|4217104|P5|Interim Analysis|Principle Investigator Terminated Study|0
1293685|NCT00296504|4217105|P4|Interim Analysis|Principle Investigator Terminated Study|0
1293686|NCT00296504|4217106|P3|Interim Analysis|Principle Investigator Terminated Study|1
1293687|NCT00296504|4217107|P2|Interim Analysis|Principle Investigator Terminated Study|0
1293688|NCT00296504|4217108|P1|Interim Analysis|Principle Investigator Terminated Study|0
1293689|NCT00296504|4217100|P9|Interim Analysis|Principle Investigator Discretion|0
1293690|NCT00296504|4217101|P8|Interim Analysis|Principle Investigator Discretion|0
1293691|NCT00296504|4217102|P7|Interim Analysis|Principle Investigator Discretion|0
1293692|NCT00296504|4217103|P6|Interim Analysis|Principle Investigator Discretion|0
1293693|NCT00296504|4217104|P5|Interim Analysis|Principle Investigator Discretion|0
1293694|NCT00296504|4217105|P4|Interim Analysis|Principle Investigator Discretion|1
1293695|NCT00296504|4217106|P3|Interim Analysis|Principle Investigator Discretion|1
1293696|NCT00296504|4217107|P2|Interim Analysis|Principle Investigator Discretion|0
1293697|NCT00296504|4217108|P1|Interim Analysis|Principle Investigator Discretion|2
1293698|NCT00296504|4217100|P9|Interim Analysis|Physician Decision|0
1293699|NCT00296504|4217101|P8|Interim Analysis|Physician Decision|0
1293700|NCT00296504|4217102|P7|Interim Analysis|Physician Decision|0
1293701|NCT00296504|4217103|P6|Interim Analysis|Physician Decision|0
1293702|NCT00296504|4217104|P5|Interim Analysis|Physician Decision|0
1293703|NCT00296504|4217105|P4|Interim Analysis|Physician Decision|0
1293704|NCT00296504|4217106|P3|Interim Analysis|Physician Decision|1
1293705|NCT00296504|4217107|P2|Interim Analysis|Physician Decision|0
1293706|NCT00296504|4217108|P1|Interim Analysis|Physician Decision|0
1293707|NCT00296504|4217100|P9|Interim Analysis|Resistance to FPV|0
1293708|NCT00296504|4217101|P8|Interim Analysis|Resistance to FPV|0
1293709|NCT00296504|4217102|P7|Interim Analysis|Resistance to FPV|0
1293710|NCT00296504|4217103|P6|Interim Analysis|Resistance to FPV|0
1293711|NCT00296504|4217104|P5|Interim Analysis|Resistance to FPV|0
1293712|NCT00296504|4217105|P4|Interim Analysis|Resistance to FPV|0
1293713|NCT00296504|4217106|P3|Interim Analysis|Resistance to FPV|1
1293714|NCT00296504|4217107|P2|Interim Analysis|Resistance to FPV|0
1293715|NCT00296504|4217108|P1|Interim Analysis|Resistance to FPV|0
1293716|NCT00296504|4217100|P9|Interim Analysis|Participant Was Incarcerated|0
1293717|NCT00296504|4217101|P8|Interim Analysis|Participant Was Incarcerated|0
1293718|NCT00296504|4217102|P7|Interim Analysis|Participant Was Incarcerated|0
1293719|NCT00296504|4217103|P6|Interim Analysis|Participant Was Incarcerated|0
1293720|NCT00296504|4217104|P5|Interim Analysis|Participant Was Incarcerated|0
1293721|NCT00296504|4217105|P4|Interim Analysis|Participant Was Incarcerated|0
1293722|NCT00296504|4217106|P3|Interim Analysis|Participant Was Incarcerated|1
1293723|NCT00296504|4217107|P2|Interim Analysis|Participant Was Incarcerated|0
1293724|NCT00296504|4217108|P1|Interim Analysis|Participant Was Incarcerated|2
1293725|NCT00296504|4217100|P9|Interim Analysis|Participant Moved|0
1293726|NCT00296504|4217101|P8|Interim Analysis|Participant Moved|0
1293727|NCT00296504|4217102|P7|Interim Analysis|Participant Moved|1
1293728|NCT00296504|4217103|P6|Interim Analysis|Participant Moved|1
1293729|NCT00296504|4217104|P5|Interim Analysis|Participant Moved|0
1293730|NCT00296504|4217105|P4|Interim Analysis|Participant Moved|0
1293731|NCT00296504|4217106|P3|Interim Analysis|Participant Moved|1
1293732|NCT00296504|4217107|P2|Interim Analysis|Participant Moved|0
1293733|NCT00296504|4217108|P1|Interim Analysis|Participant Moved|1
1293734|NCT00296504|4217100|P9|Interim Analysis|Participant Had Problems with Alcohol|0
1293735|NCT00296504|4217101|P8|Interim Analysis|Participant Had Problems with Alcohol|0
1293736|NCT00296504|4217102|P7|Interim Analysis|Participant Had Problems with Alcohol|0
1293737|NCT00296504|4217103|P6|Interim Analysis|Participant Had Problems with Alcohol|0
1293738|NCT00296504|4217104|P5|Interim Analysis|Participant Had Problems with Alcohol|0
1293739|NCT00296504|4217105|P4|Interim Analysis|Participant Had Problems with Alcohol|0
1293740|NCT00296504|4217106|P3|Interim Analysis|Participant Had Problems with Alcohol|1
1293741|NCT00296504|4217107|P2|Interim Analysis|Participant Had Problems with Alcohol|0
1293742|NCT00296504|4217108|P1|Interim Analysis|Participant Had Problems with Alcohol|0
1293743|NCT00296504|4217100|P9|Interim Analysis|To Simplify Treatment|0
1293744|NCT00296504|4217101|P8|Interim Analysis|To Simplify Treatment|0
1293745|NCT00296504|4217102|P7|Interim Analysis|To Simplify Treatment|2
1293746|NCT00296504|4217103|P6|Interim Analysis|To Simplify Treatment|0
1293747|NCT00296504|4217104|P5|Interim Analysis|To Simplify Treatment|0
1293748|NCT00296504|4217105|P4|Interim Analysis|To Simplify Treatment|0
1293749|NCT00296504|4217106|P3|Interim Analysis|To Simplify Treatment|1
1293750|NCT00296504|4217107|P2|Interim Analysis|To Simplify Treatment|0
1293751|NCT00296504|4217108|P1|Interim Analysis|To Simplify Treatment|0
1293752|NCT00296504|4217100|P9|Interim Analysis|Participant Wanted to Become Pregnant|0
1293753|NCT00296504|4217101|P8|Interim Analysis|Participant Wanted to Become Pregnant|0
1293754|NCT00296504|4217102|P7|Interim Analysis|Participant Wanted to Become Pregnant|0
1293755|NCT00296504|4217103|P6|Interim Analysis|Participant Wanted to Become Pregnant|1
1293756|NCT00296504|4217104|P5|Interim Analysis|Participant Wanted to Become Pregnant|0
1293757|NCT00296504|4217105|P4|Interim Analysis|Participant Wanted to Become Pregnant|0
1293758|NCT00296504|4217106|P3|Interim Analysis|Participant Wanted to Become Pregnant|2
1293759|NCT00296504|4217107|P2|Interim Analysis|Participant Wanted to Become Pregnant|0
1293760|NCT00296504|4217108|P1|Interim Analysis|Participant Wanted to Become Pregnant|0
1293761|NCT00296504|4217100|P9|Interim Analysis|Participant Non-compliant|0
1293762|NCT00296504|4217101|P8|Interim Analysis|Participant Non-compliant|2
1293763|NCT00296504|4217102|P7|Interim Analysis|Participant Non-compliant|6
1293764|NCT00296504|4217103|P6|Interim Analysis|Participant Non-compliant|3
1293765|NCT00296504|4217104|P5|Interim Analysis|Participant Non-compliant|1
1293766|NCT00296504|4217105|P4|Interim Analysis|Participant Non-compliant|1
1293767|NCT00296504|4217106|P3|Interim Analysis|Participant Non-compliant|2
1293768|NCT00296504|4217107|P2|Interim Analysis|Participant Non-compliant|1
1293769|NCT00296504|4217108|P1|Interim Analysis|Participant Non-compliant|0
1293770|NCT00296504|4217100|P9|Interim Analysis|Death|0
1293771|NCT00296504|4217101|P8|Interim Analysis|Death|0
1293772|NCT00296504|4217102|P7|Interim Analysis|Death|0
1293773|NCT00296504|4217103|P6|Interim Analysis|Death|0
1293774|NCT00296504|4217104|P5|Interim Analysis|Death|0
1293775|NCT00296504|4217105|P4|Interim Analysis|Death|0
1293776|NCT00296504|4217106|P3|Interim Analysis|Death|3
1293777|NCT00296504|4217107|P2|Interim Analysis|Death|0
1293778|NCT00296504|4217108|P1|Interim Analysis|Death|1
1293779|NCT00296504|4217100|P9|Interim Analysis|Pregnancy|0
1293780|NCT00296504|4217101|P8|Interim Analysis|Pregnancy|1
1293781|NCT00296504|4217102|P7|Interim Analysis|Pregnancy|1
1293782|NCT00296504|4217103|P6|Interim Analysis|Pregnancy|1
1293783|NCT00296504|4217104|P5|Interim Analysis|Pregnancy|0
1293784|NCT00296504|4217105|P4|Interim Analysis|Pregnancy|2
1293785|NCT00296504|4217106|P3|Interim Analysis|Pregnancy|4
1293786|NCT00296504|4217107|P2|Interim Analysis|Pregnancy|1
1293787|NCT00296504|4217108|P1|Interim Analysis|Pregnancy|4
1293788|NCT00296504|4217100|P9|Interim Analysis|Switched to Commercially Available Drug|0
1293789|NCT00296504|4217101|P8|Interim Analysis|Switched to Commercially Available Drug|4
1293790|NCT00296504|4217102|P7|Interim Analysis|Switched to Commercially Available Drug|3
1293791|NCT00296504|4217103|P6|Interim Analysis|Switched to Commercially Available Drug|5
1293792|NCT00296504|4217104|P5|Interim Analysis|Switched to Commercially Available Drug|0
1293793|NCT00296504|4217105|P4|Interim Analysis|Switched to Commercially Available Drug|1
1293794|NCT00296504|4217106|P3|Interim Analysis|Switched to Commercially Available Drug|4
1293795|NCT00296504|4217107|P2|Interim Analysis|Switched to Commercially Available Drug|0
1293796|NCT00296504|4217108|P1|Interim Analysis|Switched to Commercially Available Drug|2
1293797|NCT00296504|4217100|P9|Interim Analysis|Insufficient CD4 Response|0
1293798|NCT00296504|4217101|P8|Interim Analysis|Insufficient CD4 Response|0
1293799|NCT00296504|4217102|P7|Interim Analysis|Insufficient CD4 Response|0
1293800|NCT00296504|4217103|P6|Interim Analysis|Insufficient CD4 Response|1
1293801|NCT00296504|4217104|P5|Interim Analysis|Insufficient CD4 Response|1
1293802|NCT00296504|4217105|P4|Interim Analysis|Insufficient CD4 Response|0
1293803|NCT00296504|4217106|P3|Interim Analysis|Insufficient CD4 Response|0
1293804|NCT00296504|4217107|P2|Interim Analysis|Insufficient CD4 Response|0
1293805|NCT00296504|4217108|P1|Interim Analysis|Insufficient CD4 Response|0
1293806|NCT00296504|4217100|P9|Interim Analysis|Protocol Violation|0
1293807|NCT00296504|4217101|P8|Interim Analysis|Protocol Violation|1
1293808|NCT00296504|4217102|P7|Interim Analysis|Protocol Violation|0
1293809|NCT00296504|4217103|P6|Interim Analysis|Protocol Violation|0
1293810|NCT00296504|4217104|P5|Interim Analysis|Protocol Violation|1
1293811|NCT00296504|4217105|P4|Interim Analysis|Protocol Violation|0
1293812|NCT00296504|4217106|P3|Interim Analysis|Protocol Violation|2
1293813|NCT00296504|4217107|P2|Interim Analysis|Protocol Violation|0
1293814|NCT00296504|4217108|P1|Interim Analysis|Protocol Violation|0
1293815|NCT00296504|4217100|P9|Interim Analysis|Adverse Event|0
1293816|NCT00296504|4217101|P8|Interim Analysis|Adverse Event|5
1293817|NCT00296504|4217102|P7|Interim Analysis|Adverse Event|4
1293818|NCT00296504|4217103|P6|Interim Analysis|Adverse Event|3
1293819|NCT00296504|4217104|P5|Interim Analysis|Adverse Event|6
1293820|NCT00296504|4217105|P4|Interim Analysis|Adverse Event|4
1293821|NCT00296504|4217106|P3|Interim Analysis|Adverse Event|13
1293822|NCT00296504|4217107|P2|Interim Analysis|Adverse Event|0
1293823|NCT00296504|4217108|P1|Interim Analysis|Adverse Event|0
1293824|NCT00296504|4217100|P9|Interim Analysis|Insufficient Viral Load Response|0
1293825|NCT00296504|4217101|P8|Interim Analysis|Insufficient Viral Load Response|24
1293826|NCT00296504|4217102|P7|Interim Analysis|Insufficient Viral Load Response|2
1293827|NCT00296504|4217103|P6|Interim Analysis|Insufficient Viral Load Response|9
1293828|NCT00296504|4217104|P5|Interim Analysis|Insufficient Viral Load Response|7
1293829|NCT00296504|4217105|P4|Interim Analysis|Insufficient Viral Load Response|2
1293830|NCT00296504|4217106|P3|Interim Analysis|Insufficient Viral Load Response|12
1293831|NCT00296504|4217107|P2|Interim Analysis|Insufficient Viral Load Response|1
1293832|NCT00296504|4217108|P1|Interim Analysis|Insufficient Viral Load Response|5
1293833|NCT00296504|4217100|P9|Interim Analysis|Clinical Progression|0
1293834|NCT00296504|4217101|P8|Interim Analysis|Clinical Progression|2
1293835|NCT00296504|4217102|P7|Interim Analysis|Clinical Progression|1
1293836|NCT00296504|4217103|P6|Interim Analysis|Clinical Progression|2
1293837|NCT00296504|4217104|P5|Interim Analysis|Clinical Progression|0
1293838|NCT00296504|4217105|P4|Interim Analysis|Clinical Progression|1
1293839|NCT00296504|4217106|P3|Interim Analysis|Clinical Progression|1
1293840|NCT00296504|4217107|P2|Interim Analysis|Clinical Progression|0
1293841|NCT00296504|4217108|P1|Interim Analysis|Clinical Progression|1
1293842|NCT00296504|4217100|P9|Interim Analysis|Lost to Follow-up|0
1293843|NCT00296504|4217101|P8|Interim Analysis|Lost to Follow-up|4
1293844|NCT00296504|4217102|P7|Interim Analysis|Lost to Follow-up|11
1293845|NCT00296504|4217103|P6|Interim Analysis|Lost to Follow-up|4
1293846|NCT00296504|4217104|P5|Interim Analysis|Lost to Follow-up|14
1293847|NCT00296504|4217105|P4|Interim Analysis|Lost to Follow-up|8
1293848|NCT00296504|4217106|P3|Interim Analysis|Lost to Follow-up|26
1293849|NCT00296504|4217107|P2|Interim Analysis|Lost to Follow-up|3
1293850|NCT00296504|4217108|P1|Interim Analysis|Lost to Follow-up|13
1293851|NCT00296504|4217100|P9|Interim Analysis|Withdrawal by Subject|0
1293852|NCT00296504|4217101|P8|Interim Analysis|Withdrawal by Subject|3
1293853|NCT00296504|4217102|P7|Interim Analysis|Withdrawal by Subject|9
1293854|NCT00296504|4217103|P6|Interim Analysis|Withdrawal by Subject|5
1293855|NCT00296504|4217104|P5|Interim Analysis|Withdrawal by Subject|5
1293856|NCT00296504|4217105|P4|Interim Analysis|Withdrawal by Subject|0
1293857|NCT00296504|4217106|P3|Interim Analysis|Withdrawal by Subject|12
1293858|NCT00296504|4217107|P2|Interim Analysis|Withdrawal by Subject|0
1293859|NCT00296504|4217108|P1|Interim Analysis|Withdrawal by Subject|8
1293860|NCT00296491|4217201|P4|Overall Study|Lost to Follow-up|0
1293861|NCT00296491|4217202|P3|Overall Study|Lost to Follow-up|2
1293862|NCT00296491|4217203|P2|Overall Study|Lost to Follow-up|2
1293863|NCT00296491|4217204|P1|Overall Study|Lost to Follow-up|0
1293864|NCT00296491|4217201|P4|Overall Study|Non-Compliance|14
1293865|NCT00296491|4217202|P3|Overall Study|Non-Compliance|10
1293866|NCT00296491|4217203|P2|Overall Study|Non-Compliance|13
1293867|NCT00296491|4217204|P1|Overall Study|Non-Compliance|12
1293868|NCT00296491|4217201|P4|Overall Study|Withdrawal by Subject|2
1293869|NCT00296491|4217202|P3|Overall Study|Withdrawal by Subject|3
1293870|NCT00296491|4217203|P2|Overall Study|Withdrawal by Subject|3
1293871|NCT00296491|4217204|P1|Overall Study|Withdrawal by Subject|7
1293872|NCT00296491|4217201|P4|Overall Study|Withdrawn due to Asthma|4
1293873|NCT00296491|4217202|P3|Overall Study|Withdrawn due to Asthma|0
1293874|NCT00296491|4217203|P2|Overall Study|Withdrawn due to Asthma|0
1293875|NCT00296491|4217204|P1|Overall Study|Withdrawn due to Asthma|0
1293876|NCT00296491|4217201|P4|Overall Study|Adverse Event|4
1293877|NCT00296491|4217202|P3|Overall Study|Adverse Event|1
1293878|NCT00296491|4217203|P2|Overall Study|Adverse Event|3
1293879|NCT00296491|4217204|P1|Overall Study|Adverse Event|1
1293880|NCT00296491|4217201|P4|Overall Study|Protocol Violation|3
1293881|NCT00296491|4217202|P3|Overall Study|Protocol Violation|2
1293882|NCT00296491|4217203|P2|Overall Study|Protocol Violation|6
1293883|NCT00296491|4217204|P1|Overall Study|Protocol Violation|4
1293884|NCT00296491|4217201|P4|Overall Study|Low Pollen Counts|16
1293885|NCT00296491|4217202|P3|Overall Study|Low Pollen Counts|25
1293886|NCT00296491|4217203|P2|Overall Study|Low Pollen Counts|26
1293887|NCT00296491|4217204|P1|Overall Study|Low Pollen Counts|18
1293888|NCT00296400|4217233|P3|Overall Study|Pregnancy|0
1293889|NCT00296400|4217234|P2|Overall Study|Pregnancy|2
1293890|NCT00296400|4217235|P1|Overall Study|Pregnancy|1
1293891|NCT00296400|4217233|P3|Overall Study|Visit 10 was performed earlier|0
1293892|NCT00296400|4217234|P2|Overall Study|Visit 10 was performed earlier|1
1293893|NCT00296400|4217235|P1|Overall Study|Visit 10 was performed earlier|0
1293894|NCT00296400|4217233|P3|Overall Study|Study specific discontinuation criteria|1
1293895|NCT00296400|4217234|P2|Overall Study|Study specific discontinuation criteria|0
1293896|NCT00296400|4217235|P1|Overall Study|Study specific discontinuation criteria|0
1293897|NCT00296400|4217233|P3|Overall Study|Lost to Follow-up|2
1293898|NCT00296400|4217234|P2|Overall Study|Lost to Follow-up|1
1293899|NCT00296400|4217235|P1|Overall Study|Lost to Follow-up|1
1293900|NCT00296400|4217233|P3|Overall Study|Protocol Violation|1
1293901|NCT00296400|4217234|P2|Overall Study|Protocol Violation|1
1293902|NCT00296400|4217235|P1|Overall Study|Protocol Violation|1
1293903|NCT00296400|4217233|P3|Overall Study|Incorrect enrollment|0
1293904|NCT00296400|4217234|P2|Overall Study|Incorrect enrollment|0
1293905|NCT00296400|4217235|P1|Overall Study|Incorrect enrollment|2
1293906|NCT00296400|4217233|P3|Overall Study|Withdrawal by Subject|2
1293907|NCT00296400|4217234|P2|Overall Study|Withdrawal by Subject|6
1293908|NCT00296400|4217235|P1|Overall Study|Withdrawal by Subject|5
1293909|NCT00296400|4217233|P3|Overall Study|Adverse Event|7
1293910|NCT00296400|4217234|P2|Overall Study|Adverse Event|7
1293911|NCT00296400|4217235|P1|Overall Study|Adverse Event|7
1293912|NCT00296374|4217459|P3|Overall Study|Not specified|1
1293913|NCT00296374|4217460|P2|Overall Study|Not specified|0
1293914|NCT00296374|4217461|P1|Overall Study|Not specified|0
1293915|NCT00296374|4217459|P3|Overall Study|Pregnancy|2
1293916|NCT00296374|4217460|P2|Overall Study|Pregnancy|0
1293917|NCT00296374|4217461|P1|Overall Study|Pregnancy|0
1293918|NCT00296374|4217459|P3|Overall Study|Nephrologist introduced ACE|0
1293919|NCT00296374|4217460|P2|Overall Study|Nephrologist introduced ACE|1
1293920|NCT00296374|4217461|P1|Overall Study|Nephrologist introduced ACE|0
1293921|NCT00296374|4217459|P3|Overall Study|Stopped drug before end of study visit|0
1293922|NCT00296374|4217460|P2|Overall Study|Stopped drug before end of study visit|1
1293923|NCT00296374|4217461|P1|Overall Study|Stopped drug before end of study visit|0
1293924|NCT00296374|4217459|P3|Overall Study|Relocated to another state|0
1293925|NCT00296374|4217460|P2|Overall Study|Relocated to another state|0
1293926|NCT00296374|4217461|P1|Overall Study|Relocated to another state|1
1293927|NCT00296374|4217459|P3|Overall Study|Lost to Follow-up|1
1293928|NCT00296374|4217460|P2|Overall Study|Lost to Follow-up|1
1293929|NCT00296374|4217461|P1|Overall Study|Lost to Follow-up|3
1293930|NCT00296374|4217459|P3|Overall Study|Protocol Violation|3
1293931|NCT00296374|4217460|P2|Overall Study|Protocol Violation|2
1293932|NCT00296374|4217461|P1|Overall Study|Protocol Violation|1
1293933|NCT00296374|4217459|P3|Overall Study|Incorrect enrollment|4
1293934|NCT00296374|4217460|P2|Overall Study|Incorrect enrollment|3
1293935|NCT00296374|4217461|P1|Overall Study|Incorrect enrollment|3
1293936|NCT00296374|4217459|P3|Overall Study|Withdrawal by Subject|11
1293937|NCT00296374|4217460|P2|Overall Study|Withdrawal by Subject|5
1293938|NCT00296374|4217461|P1|Overall Study|Withdrawal by Subject|3
1293939|NCT00296374|4217459|P3|Overall Study|Adverse Event|7
1293940|NCT00296374|4217460|P2|Overall Study|Adverse Event|10
1293941|NCT00296374|4217461|P1|Overall Study|Adverse Event|14
1293942|NCT00296335|4217684|P2|Overall Study|Physician Decision|11
1293943|NCT00296335|4217685|P1|Overall Study|Physician Decision|3
1293944|NCT00296335|4217684|P2|Overall Study|Lost to Follow-up|33
1293945|NCT00296335|4217685|P1|Overall Study|Lost to Follow-up|7
1293946|NCT00296335|4217684|P2|Overall Study|Adverse Event|27
1293947|NCT00296335|4217685|P1|Overall Study|Adverse Event|17
1293948|NCT00296335|4217684|P2|Overall Study|Recurrence|51
1293949|NCT00296335|4217685|P1|Overall Study|Recurrence|3
1293950|NCT00296244|4217725|P2|Overall Study|Underwent retransplant|1
1293951|NCT00296244|4217726|P1|Overall Study|Underwent retransplant|0
1293952|NCT00296140|4217790|P2|Overall Study|Discharge to Nursing Home|0
1293953|NCT00296140|4217791|P1|Overall Study|Discharge to Nursing Home|1
1293954|NCT00296140|4217790|P2|Overall Study|Withdrawal by Subject|0
1293955|NCT00296140|4217791|P1|Overall Study|Withdrawal by Subject|1
1293956|NCT00296140|4217790|P2|Overall Study|Lost to Follow-up|0
1293957|NCT00296140|4217791|P1|Overall Study|Lost to Follow-up|1
1293958|NCT00296036|4217803|P6|Overall Study|Protocol Violation|3
1293959|NCT00296036|4217804|P5|Overall Study|Protocol Violation|0
1293960|NCT00296036|4217805|P4|Overall Study|Protocol Violation|0
1293961|NCT00296036|4217806|P3|Overall Study|Protocol Violation|0
1293962|NCT00296036|4217807|P2|Overall Study|Protocol Violation|0
1293963|NCT00296036|4217808|P1|Overall Study|Protocol Violation|0
1293964|NCT00296036|4217803|P6|Overall Study|Withdrawal by Subject|1
1293965|NCT00296036|4217804|P5|Overall Study|Withdrawal by Subject|2
1293966|NCT00296036|4217805|P4|Overall Study|Withdrawal by Subject|1
1293967|NCT00296036|4217806|P3|Overall Study|Withdrawal by Subject|2
1293968|NCT00296036|4217807|P2|Overall Study|Withdrawal by Subject|0
1293969|NCT00296036|4217808|P1|Overall Study|Withdrawal by Subject|1
1293970|NCT00295932|4217845|P11|Overall Study|Not Treated|1
1293971|NCT00295932|4217846|P10|Overall Study|Not Treated|0
1293972|NCT00295932|4217847|P9|Overall Study|Not Treated|0
1293973|NCT00295932|4217848|P8|Overall Study|Not Treated|0
1293974|NCT00295932|4217849|P7|Overall Study|Not Treated|0
1293975|NCT00295932|4217850|P6|Overall Study|Not Treated|0
1293976|NCT00295932|4217851|P5|Overall Study|Not Treated|0
1293977|NCT00295932|4217852|P4|Overall Study|Not Treated|0
1293978|NCT00295932|4217853|P3|Overall Study|Not Treated|0
1293979|NCT00295932|4217854|P2|Overall Study|Not Treated|0
1293980|NCT00295932|4217855|P1|Overall Study|Not Treated|0
1293981|NCT00295880|4217889|P1|Overall Study|Unit randomization did not occur|1
1293982|NCT00295880|4217889|P1|Overall Study|IBMI unit could not be volume reduced|1
1293983|NCT00295854|4217903|P3|Overall Study|not specified|1
1293984|NCT00295854|4217904|P2|Overall Study|not specified|5
1293985|NCT00295854|4217905|P1|Overall Study|not specified|3
1293986|NCT00295854|4217903|P3|Overall Study|required a prohibited medication|0
1293987|NCT00295854|4217904|P2|Overall Study|required a prohibited medication|0
1293988|NCT00295854|4217905|P1|Overall Study|required a prohibited medication|1
1293989|NCT00295854|4217903|P3|Overall Study|did not continue to meet criteria|2
1293990|NCT00295854|4217904|P2|Overall Study|did not continue to meet criteria|1
1293991|NCT00295854|4217905|P1|Overall Study|did not continue to meet criteria|1
1293992|NCT00295854|4217903|P3|Overall Study|Withdrawal by Subject|4
1293993|NCT00295854|4217904|P2|Overall Study|Withdrawal by Subject|7
1293994|NCT00295854|4217905|P1|Overall Study|Withdrawal by Subject|3
1293995|NCT00295854|4217903|P3|Overall Study|Lost to Follow-up|1
1293996|NCT00295854|4217904|P2|Overall Study|Lost to Follow-up|0
1293997|NCT00295854|4217905|P1|Overall Study|Lost to Follow-up|2
1293998|NCT00295854|4217903|P3|Overall Study|Protocol Violation|1
1293999|NCT00295854|4217904|P2|Overall Study|Protocol Violation|1
1294000|NCT00295854|4217905|P1|Overall Study|Protocol Violation|1
1294001|NCT00295854|4217903|P3|Overall Study|Adverse Event|6
1294002|NCT00295854|4217904|P2|Overall Study|Adverse Event|7
1294003|NCT00295854|4217905|P1|Overall Study|Adverse Event|7
1294004|NCT00295750|4217919|P3|Overall Study|Protocol Violation|2
1294005|NCT00295750|4217920|P2|Overall Study|Protocol Violation|4
1294006|NCT00295750|4217921|P1|Overall Study|Protocol Violation|2
1294007|NCT00295750|4217919|P3|Overall Study|Withdrawal by Subject|7
1294008|NCT00295750|4217920|P2|Overall Study|Withdrawal by Subject|4
1294009|NCT00295750|4217921|P1|Overall Study|Withdrawal by Subject|9
1294010|NCT00295750|4217919|P3|Overall Study|Randomized but never received trial drug|3
1294011|NCT00295750|4217920|P2|Overall Study|Randomized but never received trial drug|3
1294012|NCT00295750|4217921|P1|Overall Study|Randomized but never received trial drug|4
1294013|NCT00295750|4217919|P3|Overall Study|Personal reasons|0
1294014|NCT00295750|4217920|P2|Overall Study|Personal reasons|1
1294015|NCT00295750|4217921|P1|Overall Study|Personal reasons|0
1294016|NCT00295750|4217919|P3|Overall Study|Disease progression|0
1294017|NCT00295750|4217920|P2|Overall Study|Disease progression|1
1294018|NCT00295750|4217921|P1|Overall Study|Disease progression|2
1294019|NCT00295750|4217919|P3|Overall Study|Trial drug errors|0
1294020|NCT00295750|4217920|P2|Overall Study|Trial drug errors|1
1294021|NCT00295750|4217921|P1|Overall Study|Trial drug errors|1
1294022|NCT00295750|4217919|P3|Overall Study|Administrative errors|5
1294023|NCT00295750|4217920|P2|Overall Study|Administrative errors|4
1294024|NCT00295750|4217921|P1|Overall Study|Administrative errors|2
1294025|NCT00295750|4217919|P3|Overall Study|Taking prohibited therapy|2
1294026|NCT00295750|4217920|P2|Overall Study|Taking prohibited therapy|3
1294027|NCT00295750|4217921|P1|Overall Study|Taking prohibited therapy|2
1294028|NCT00295750|4217919|P3|Overall Study|Lost to Follow-up|1
1294029|NCT00295750|4217920|P2|Overall Study|Lost to Follow-up|4
1294030|NCT00295750|4217921|P1|Overall Study|Lost to Follow-up|1
1294031|NCT00295750|4217919|P3|Overall Study|Lack of Efficacy|0
1294032|NCT00295750|4217920|P2|Overall Study|Lack of Efficacy|1
1294033|NCT00295750|4217921|P1|Overall Study|Lack of Efficacy|1
1294034|NCT00295750|4217919|P3|Overall Study|Adverse Event|12
1294035|NCT00295750|4217920|P2|Overall Study|Adverse Event|15
1294036|NCT00295750|4217921|P1|Overall Study|Adverse Event|19
1294037|NCT00295633|4217956|P3|Overall Study|Administrative reason by sponsor|1
1294038|NCT00295633|4217957|P2|Overall Study|Administrative reason by sponsor|0
1294039|NCT00295633|4217958|P1|Overall Study|Administrative reason by sponsor|0
1294040|NCT00295633|4217956|P3|Overall Study|Death|0
1294041|NCT00295633|4217957|P2|Overall Study|Death|1
1294042|NCT00295633|4217958|P1|Overall Study|Death|1
1294043|NCT00295633|4217956|P3|Overall Study|Subject No Longer Meets Study Criteria|3
1294044|NCT00295633|4217957|P2|Overall Study|Subject No Longer Meets Study Criteria|3
1294045|NCT00295633|4217958|P1|Overall Study|Subject No Longer Meets Study Criteria|0
1294046|NCT00295633|4217956|P3|Overall Study|Poor/Noncompliance|6
1294047|NCT00295633|4217957|P2|Overall Study|Poor/Noncompliance|2
1294048|NCT00295633|4217958|P1|Overall Study|Poor/Noncompliance|2
1294049|NCT00295633|4217956|P3|Overall Study|Physician Decision|8
1294050|NCT00295633|4217957|P2|Overall Study|Physician Decision|10
1294051|NCT00295633|4217958|P1|Overall Study|Physician Decision|9
1294052|NCT00295633|4217956|P3|Overall Study|Lost to Follow-up|7
1294053|NCT00295633|4217957|P2|Overall Study|Lost to Follow-up|11
1294054|NCT00295633|4217958|P1|Overall Study|Lost to Follow-up|6
1294055|NCT00295633|4217956|P3|Overall Study|Adverse Event|9
1294056|NCT00295633|4217957|P2|Overall Study|Adverse Event|17
1294057|NCT00295633|4217958|P1|Overall Study|Adverse Event|9
1294058|NCT00295633|4217956|P3|Overall Study|Withdrawal of consent by subject|26
1294059|NCT00295633|4217957|P2|Overall Study|Withdrawal of consent by subject|16
1294060|NCT00295633|4217958|P1|Overall Study|Withdrawal of consent by subject|16
1294061|NCT00295633|4217956|P3|Overall Study|Lack of Efficacy|16
1294062|NCT00295633|4217957|P2|Overall Study|Lack of Efficacy|7
1294063|NCT00295633|4217958|P1|Overall Study|Lack of Efficacy|19
1294064|NCT00295490|4217985|P4|Overall Study|Other|1
1294065|NCT00295490|4217986|P3|Overall Study|Other|0
1294066|NCT00295490|4217987|P2|Overall Study|Other|2
1294067|NCT00295490|4217988|P1|Overall Study|Other|0
1294068|NCT00295490|4217985|P4|Overall Study|Adverse Event|0
1294069|NCT00295490|4217986|P3|Overall Study|Adverse Event|0
1294070|NCT00295490|4217987|P2|Overall Study|Adverse Event|0
1294071|NCT00295490|4217988|P1|Overall Study|Adverse Event|1
1294072|NCT00295490|4217985|P4|Overall Study|Lost to Follow-up|0
1294073|NCT00295490|4217986|P3|Overall Study|Lost to Follow-up|1
1294074|NCT00295490|4217987|P2|Overall Study|Lost to Follow-up|0
1294075|NCT00295490|4217988|P1|Overall Study|Lost to Follow-up|0
1294076|NCT00295490|4217985|P4|Overall Study|Withdrawal by Subject|1
1294077|NCT00295490|4217986|P3|Overall Study|Withdrawal by Subject|0
1294078|NCT00295490|4217987|P2|Overall Study|Withdrawal by Subject|2
1294079|NCT00295490|4217988|P1|Overall Study|Withdrawal by Subject|0
1294080|NCT00295490|4217985|P4|Overall Study|Protocol Violation|3
1294081|NCT00295490|4217986|P3|Overall Study|Protocol Violation|3
1294082|NCT00295490|4217987|P2|Overall Study|Protocol Violation|0
1294083|NCT00295490|4217988|P1|Overall Study|Protocol Violation|0
1294084|NCT00295022|4218038|P3|Overall Study|Withdrawal by Subject|2
1294085|NCT00295022|4218039|P2|Overall Study|Withdrawal by Subject|0
1294086|NCT00295022|4218040|P1|Overall Study|Withdrawal by Subject|0
1294087|NCT00295022|4218038|P3|Overall Study|Lost to Follow-up|1
1294088|NCT00295022|4218039|P2|Overall Study|Lost to Follow-up|0
1294089|NCT00295022|4218040|P1|Overall Study|Lost to Follow-up|0
1294090|NCT00295022|4218038|P3|Overall Study|Adverse Event|2
1294091|NCT00295022|4218039|P2|Overall Study|Adverse Event|1
1294092|NCT00295022|4218040|P1|Overall Study|Adverse Event|1
1294093|NCT00294762|4218156|P2|Overall Study|Did not receive study treatment|3
1294094|NCT00294762|4218157|P1|Overall Study|Did not receive study treatment|3
1294095|NCT00294723|4218176|P3|Additional Open-Label Extension 91 Weeks|Not specified in study report|3
1294096|NCT00294723|4218177|P2|Additional Open-Label Extension 91 Weeks|Not specified in study report|5
1294097|NCT00294723|4218178|P1|Additional Open-Label Extension 91 Weeks|Not specified in study report|2
1294098|NCT00294723|4218176|P3|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
1294099|NCT00294723|4218177|P2|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
1294100|NCT00294723|4218178|P1|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
1294101|NCT00294723|4218176|P3|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16
1294102|NCT00294723|4218177|P2|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14
1294103|NCT00294723|4218178|P1|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24
1294104|NCT00294723|4218176|P3|Additional Open-Label Extension 91 Weeks|Adverse Event|0
1294105|NCT00294723|4218177|P2|Additional Open-Label Extension 91 Weeks|Adverse Event|1
1294106|NCT00294723|4218178|P1|Additional Open-Label Extension 91 Weeks|Adverse Event|1
1294107|NCT00294723|4218176|P3|Open-Label Extension 52 Weeks|Not specified in study report|14
1294108|NCT00294723|4218177|P2|Open-Label Extension 52 Weeks|Not specified in study report|16
1294109|NCT00294723|4218178|P1|Open-Label Extension 52 Weeks|Not specified in study report|19
1294110|NCT00294723|4218176|P3|Open-Label Extension 52 Weeks|Protocol Violation|3
1294111|NCT00294723|4218177|P2|Open-Label Extension 52 Weeks|Protocol Violation|3
1294112|NCT00294723|4218178|P1|Open-Label Extension 52 Weeks|Protocol Violation|4
1294113|NCT00294723|4218176|P3|Open-Label Extension 52 Weeks|Lack of Efficacy|21
1294114|NCT00294723|4218177|P2|Open-Label Extension 52 Weeks|Lack of Efficacy|15
1294115|NCT00294723|4218178|P1|Open-Label Extension 52 Weeks|Lack of Efficacy|12
1294116|NCT00294723|4218176|P3|Open-Label Extension 52 Weeks|Adverse Event|2
1294117|NCT00294723|4218177|P2|Open-Label Extension 52 Weeks|Adverse Event|5
1294118|NCT00294723|4218178|P1|Open-Label Extension 52 Weeks|Adverse Event|5
1294119|NCT00294723|4218176|P3|Double-Blind Period 52 Weeks|Not specified in study report|51
1294120|NCT00294723|4218177|P2|Double-Blind Period 52 Weeks|Not specified in study report|38
1294121|NCT00294723|4218178|P1|Double-Blind Period 52 Weeks|Not specified in study report|36
1294122|NCT00294723|4218176|P3|Double-Blind Period 52 Weeks|Protocol Violation|5
1294123|NCT00294723|4218177|P2|Double-Blind Period 52 Weeks|Protocol Violation|11
1294124|NCT00294723|4218178|P1|Double-Blind Period 52 Weeks|Protocol Violation|11
1294125|NCT00294723|4218176|P3|Double-Blind Period 52 Weeks|Lack of Efficacy|25
1294126|NCT00294723|4218177|P2|Double-Blind Period 52 Weeks|Lack of Efficacy|15
1294127|NCT00294723|4218178|P1|Double-Blind Period 52 Weeks|Lack of Efficacy|9
1294128|NCT00294723|4218176|P3|Double-Blind Period 52 Weeks|Adverse Event|15
1294129|NCT00294723|4218177|P2|Double-Blind Period 52 Weeks|Adverse Event|25
1294130|NCT00294723|4218178|P1|Double-Blind Period 52 Weeks|Adverse Event|18
1294131|NCT00294684|4218239|P2|Overall Study|Lost to Follow-up|8
1294132|NCT00294684|4218240|P1|Overall Study|Lost to Follow-up|5
1294133|NCT00294671|4218280|P2|Overall Study|Death|1
1294134|NCT00294671|4218281|P1|Overall Study|Death|0
1294135|NCT00294671|4218280|P2|Overall Study|Non-compliance|0
1294136|NCT00294671|4218281|P1|Overall Study|Non-compliance|1
1294137|NCT00294671|4218280|P2|Overall Study|Lost to Follow-up|3
1294138|NCT00294671|4218281|P1|Overall Study|Lost to Follow-up|1
1294139|NCT00294671|4218280|P2|Overall Study|Non-drug related AE|2
1294140|NCT00294671|4218281|P1|Overall Study|Non-drug related AE|3
1294141|NCT00294671|4218280|P2|Overall Study|Drug related adverse event (AE)|2
1294142|NCT00294671|4218281|P1|Overall Study|Drug related adverse event (AE)|4
1294143|NCT00294671|4218280|P2|Overall Study|Liver transplant|9
1294144|NCT00294671|4218281|P1|Overall Study|Liver transplant|7
1294145|NCT00294671|4218280|P2|Overall Study|Lack of Efficacy|23
1294146|NCT00294671|4218281|P1|Overall Study|Lack of Efficacy|11
1294147|NCT00294658|4218297|P2|Overall Study|Patient and family were not satisfied|1
1294148|NCT00294658|4218298|P1|Overall Study|Patient and family were not satisfied|0
1294149|NCT00294658|4218297|P2|Overall Study|Found to have invasive thymoma|0
1294150|NCT00294658|4218298|P1|Overall Study|Found to have invasive thymoma|1
1294151|NCT00294658|4218297|P2|Overall Study|Withdrawal by Subject|4
1294152|NCT00294658|4218298|P1|Overall Study|Withdrawal by Subject|0
1294153|NCT00294658|4218297|P2|Overall Study|Pregnancy|1
1294154|NCT00294658|4218298|P1|Overall Study|Pregnancy|0
1294155|NCT00294658|4218297|P2|Overall Study|Physician Decision|2
1294156|NCT00294658|4218298|P1|Overall Study|Physician Decision|1
1294157|NCT00294658|4218297|P2|Overall Study|Lost to Follow-up|0
1294158|NCT00294658|4218298|P1|Overall Study|Lost to Follow-up|4
1294159|NCT00294658|4218297|P2|Overall Study|Death|1
1294160|NCT00294658|4218298|P1|Overall Study|Death|0
1294161|NCT00294645|4218362|P2|Overall Study|Other|10
1294162|NCT00294645|4218363|P1|Overall Study|Other|4
1294163|NCT00294645|4218362|P2|Overall Study|Physician Decision|20
1294164|NCT00294645|4218363|P1|Overall Study|Physician Decision|15
1294165|NCT00294645|4218362|P2|Overall Study|Withdrawal by Subject|34
1294166|NCT00294645|4218363|P1|Overall Study|Withdrawal by Subject|18
1294167|NCT00294645|4218362|P2|Overall Study|Lost to Follow-up|10
1294168|NCT00294645|4218363|P1|Overall Study|Lost to Follow-up|1
1294169|NCT00294645|4218362|P2|Overall Study|Death|18
1294170|NCT00294645|4218363|P1|Overall Study|Death|10
1294171|NCT00294554|4218397|P2|Overall Study|Physician Decision|1
1294172|NCT00294554|4218398|P1|Overall Study|Physician Decision|0
1294173|NCT00294554|4218397|P2|Overall Study|Lack of Efficacy|1
1294174|NCT00294554|4218398|P1|Overall Study|Lack of Efficacy|0
1294175|NCT00294398|4218425|P2|Overall Study|Lost to Follow-up|26
1294176|NCT00294398|4218426|P1|Overall Study|Lost to Follow-up|21
1294177|NCT00294060|4218434|P1|Overall Study|Device explanted/not replaced|23
1294178|NCT00294060|4218434|P1|Overall Study|Medical condition|3
1294179|NCT00294060|4218434|P1|Overall Study|Physician Decision|797
1294180|NCT00294060|4218434|P1|Overall Study|Withdrawal by Subject|11
1294181|NCT00294060|4218434|P1|Overall Study|Lost to Follow-up|55
1294182|NCT00294060|4218434|P1|Overall Study|Other|59
1294183|NCT00294060|4218434|P1|Overall Study|Death|225
1294184|NCT00294047|4218442|P2|Month 84|No consent for Month 84 Follow-up|754
1294185|NCT00294047|4218443|P1|Month 84|No consent for Month 84 Follow-up|731
1294186|NCT00294047|4218442|P2|Month 84|Visit missed|1
1294187|NCT00294047|4218443|P1|Month 84|Visit missed|0
1294188|NCT00294047|4218442|P2|Month 84|Under investigation locally|0
1294189|NCT00294047|4218443|P1|Month 84|Under investigation locally|1
1294190|NCT00294047|4218442|P2|Month 84|Unable to reach study site|0
1294191|NCT00294047|4218443|P1|Month 84|Unable to reach study site|1
1294192|NCT00294047|4218442|P2|Month 84|Transport reimbursement delayed|1
1294193|NCT00294047|4218443|P1|Month 84|Transport reimbursement delayed|0
1294194|NCT00294047|4218442|P2|Month 84|Subject does not want male physician|0
1294195|NCT00294047|4218443|P1|Month 84|Subject does not want male physician|1
1294196|NCT00294047|4218442|P2|Month 84|Personal reason|4
1294197|NCT00294047|4218443|P1|Month 84|Personal reason|2
1294198|NCT00294047|4218442|P2|Month 84|Lack of time|1
1294199|NCT00294047|4218443|P1|Month 84|Lack of time|3
1294200|NCT00294047|4218442|P2|Month 84|Family problems|2
1294201|NCT00294047|4218443|P1|Month 84|Family problems|2
1294202|NCT00294047|4218442|P2|Month 84|Center closed, subject did not transfer|0
1294203|NCT00294047|4218443|P1|Month 84|Center closed, subject did not transfer|1
1294204|NCT00294047|4218442|P2|Month 84|Work related reasons|2
1294205|NCT00294047|4218443|P1|Month 84|Work related reasons|4
1294206|NCT00294047|4218442|P2|Month 84|Absent Cervix|0
1294207|NCT00294047|4218443|P1|Month 84|Absent Cervix|2
1294208|NCT00294047|4218442|P2|Month 84|Lost to Follow-up|190
1294209|NCT00294047|4218443|P1|Month 84|Lost to Follow-up|187
1294210|NCT00294047|4218442|P2|Month 84|Withdrawal by Subject|31
1294211|NCT00294047|4218443|P1|Month 84|Withdrawal by Subject|33
1294212|NCT00294047|4218442|P2|Month 84|Protocol Violation|1
1294213|NCT00294047|4218443|P1|Month 84|Protocol Violation|1
1294214|NCT00294047|4218442|P2|Month 84|Adverse Event|2
1294215|NCT00294047|4218443|P1|Month 84|Adverse Event|4
1294216|NCT00294047|4218442|P2|Month 48|Other|14
1294217|NCT00294047|4218443|P1|Month 48|Other|10
1294218|NCT00294047|4218442|P2|Month 48|Lost to Follow-up|287
1294219|NCT00294047|4218443|P1|Month 48|Lost to Follow-up|272
1294220|NCT00294047|4218442|P2|Month 48|Withdrawal by Subject|115
1294221|NCT00294047|4218443|P1|Month 48|Withdrawal by Subject|111
1294222|NCT00294047|4218442|P2|Month 48|Protocol Violation|4
1294223|NCT00294047|4218443|P1|Month 48|Protocol Violation|4
1294224|NCT00294047|4218442|P2|Month 48|Adverse Event|13
1294225|NCT00294047|4218443|P1|Month 48|Adverse Event|28
1294226|NCT00293813|4218548|P3|Overall Study|Noncompliance|0
1294227|NCT00293813|4218549|P2|Overall Study|Noncompliance|1
1294228|NCT00293813|4218550|P1|Overall Study|Noncompliance|0
1294229|NCT00293813|4218548|P3|Overall Study|Lost to Follow-up|3
1294230|NCT00293813|4218549|P2|Overall Study|Lost to Follow-up|2
1294231|NCT00293813|4218550|P1|Overall Study|Lost to Follow-up|3
1294232|NCT00293813|4218548|P3|Overall Study|Withdrawal by Subject|4
1294233|NCT00293813|4218549|P2|Overall Study|Withdrawal by Subject|4
1294234|NCT00293813|4218550|P1|Overall Study|Withdrawal by Subject|7
1294235|NCT00293813|4218548|P3|Overall Study|Adverse Event|1
1294236|NCT00293813|4218549|P2|Overall Study|Adverse Event|1
1294237|NCT00293813|4218550|P1|Overall Study|Adverse Event|3
1294238|NCT00293813|4218548|P3|Overall Study|Physician Decision|0
1294239|NCT00293813|4218549|P2|Overall Study|Physician Decision|1
1294240|NCT00293813|4218550|P1|Overall Study|Physician Decision|0
1294241|NCT00293722|4218561|P1|Overall Study|Other|427
1294242|NCT00293709|4218575|P1|Overall Study|Other|47
1294243|NCT00293579|4218589|P1|Overall Study|Withdrawal by Subject|1
1294244|NCT00293462|4218608|P3|Overall Study|Physician Decision|0
1294245|NCT00293462|4218609|P2|Overall Study|Physician Decision|1
1294246|NCT00293462|4218610|P1|Overall Study|Physician Decision|0
1294247|NCT00293462|4218608|P3|Overall Study|Low radiation dose in oral cavity|0
1294248|NCT00293462|4218609|P2|Overall Study|Low radiation dose in oral cavity|1
1294249|NCT00293462|4218610|P1|Overall Study|Low radiation dose in oral cavity|0
1294250|NCT00293462|4218608|P3|Overall Study|Possible Tracheostomy leakage|0
1294251|NCT00293462|4218609|P2|Overall Study|Possible Tracheostomy leakage|1
1294252|NCT00293462|4218610|P1|Overall Study|Possible Tracheostomy leakage|0
1294253|NCT00293462|4218608|P3|Overall Study|Ischemic stroke after chemotherapy|1
1294254|NCT00293462|4218609|P2|Overall Study|Ischemic stroke after chemotherapy|0
1294255|NCT00293462|4218610|P1|Overall Study|Ischemic stroke after chemotherapy|0
1294256|NCT00293462|4218608|P3|Overall Study|Blood clot after chemotherapy|1
1294257|NCT00293462|4218609|P2|Overall Study|Blood clot after chemotherapy|0
1294258|NCT00293462|4218610|P1|Overall Study|Blood clot after chemotherapy|0
1294259|NCT00293462|4218608|P3|Overall Study|Went back to his home country|1
1294260|NCT00293462|4218609|P2|Overall Study|Went back to his home country|0
1294261|NCT00293462|4218610|P1|Overall Study|Went back to his home country|0
1294262|NCT00293462|4218608|P3|Overall Study|No Show|1
1294263|NCT00293462|4218609|P2|Overall Study|No Show|0
1294264|NCT00293462|4218610|P1|Overall Study|No Show|0
1294265|NCT00293462|4218608|P3|Overall Study|Refuse Radiation Treatment|0
1294266|NCT00293462|4218609|P2|Overall Study|Refuse Radiation Treatment|0
1294267|NCT00293462|4218610|P1|Overall Study|Refuse Radiation Treatment|1
1294268|NCT00293462|4218608|P3|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
1294269|NCT00293462|4218609|P2|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1
1294270|NCT00293462|4218610|P1|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
1294271|NCT00293462|4218608|P3|Overall Study|Change Treatment Regimen (ineligible)|0
1294272|NCT00293462|4218609|P2|Overall Study|Change Treatment Regimen (ineligible)|0
1294273|NCT00293462|4218610|P1|Overall Study|Change Treatment Regimen (ineligible)|1
1294274|NCT00293462|4218608|P3|Overall Study|Lost to Follow-up|0
1294275|NCT00293462|4218609|P2|Overall Study|Lost to Follow-up|1
1294276|NCT00293462|4218610|P1|Overall Study|Lost to Follow-up|0
1294277|NCT00293462|4218608|P3|Overall Study|Death|0
1294278|NCT00293462|4218609|P2|Overall Study|Death|0
1294279|NCT00293462|4218610|P1|Overall Study|Death|1
1294280|NCT00293462|4218608|P3|Overall Study|Withdrawal by Subject|6
1294281|NCT00293462|4218609|P2|Overall Study|Withdrawal by Subject|3
1294282|NCT00293462|4218610|P1|Overall Study|Withdrawal by Subject|4
1294283|NCT00293397|4218629|P1|Overall Study|Death|2
1294284|NCT00293384|4218639|P1|Overall Study|Ineligible|2
1294285|NCT00293384|4218639|P1|Overall Study|Missed dosage/study drug|1
1294286|NCT00293384|4218639|P1|Overall Study|Non-compliance|2
1294287|NCT00293293|4218648|P2|Overall Study|Patient discontinued chemotherapy|1
1294288|NCT00293293|4218649|P1|Overall Study|Patient discontinued chemotherapy|0
1294289|NCT00293293|4218648|P2|Overall Study|"Patient too anxious to complete trial"|0
1294290|NCT00293293|4218649|P1|Overall Study|"Patient too anxious to complete trial"|1
1294291|NCT00293293|4218648|P2|Overall Study|Withdrawal by Subject|1
1294292|NCT00293293|4218649|P1|Overall Study|Withdrawal by Subject|1
1294293|NCT00293267|4218677|P2|Open-Label Post Virologic Failure Phase|Other Reason|5
1294294|NCT00293267|4218678|P1|Open-Label Post Virologic Failure Phase|Other Reason|4
1294295|NCT00293267|4218677|P2|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2
1294296|NCT00293267|4218678|P1|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0
1294297|NCT00293267|4218677|P2|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2
1294298|NCT00293267|4218678|P1|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0
1294299|NCT00293267|4218677|P2|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
1294300|NCT00293267|4218678|P1|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
1294301|NCT00293267|4218677|P2|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4
1294302|NCT00293267|4218678|P1|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2
1294303|NCT00293267|4218677|P2|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19
1294304|NCT00293267|4218678|P1|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23
1294305|NCT00293267|4218677|P2|Open-Label Post Virologic Failure Phase|Adverse Event|3
1294306|NCT00293267|4218678|P1|Open-Label Post Virologic Failure Phase|Adverse Event|2
1294307|NCT00293267|4218677|P2|Extension - Open-Label Week 157-240|Other Reason|1
1294308|NCT00293267|4218678|P1|Extension - Open-Label Week 157-240|Other Reason|3
1294309|NCT00293267|4218677|P2|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0
1294310|NCT00293267|4218678|P1|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2
1294311|NCT00293267|4218677|P2|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
1294312|NCT00293267|4218678|P1|Extension - Open-Label Week 157-240|Withdrawal by Subject|2
1294313|NCT00293267|4218677|P2|Extension - Open-Label Week 157-240|Lost to Follow-up|0
1294314|NCT00293267|4218678|P1|Extension - Open-Label Week 157-240|Lost to Follow-up|1
1294315|NCT00293267|4218677|P2|Extension - Open-Label Week 157-240|Lack of Efficacy|0
1294316|NCT00293267|4218678|P1|Extension - Open-Label Week 157-240|Lack of Efficacy|7
1294317|NCT00293267|4218677|P2|Extension - Open-Label Week 157-240|Adverse Event|0
1294318|NCT00293267|4218678|P1|Extension - Open-Label Week 157-240|Adverse Event|5
1294319|NCT00293267|4218677|P2|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6
1294320|NCT00293267|4218678|P1|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
1294321|NCT00293267|4218677|P2|Extension - Double-Blind Week 49-156|Other Reason|0
1294322|NCT00293267|4218678|P1|Extension - Double-Blind Week 49-156|Other Reason|7
1294323|NCT00293267|4218677|P2|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0
1294324|NCT00293267|4218678|P1|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2
1294325|NCT00293267|4218677|P2|Extension - Double-Blind Week 49-156|Death|0
1294326|NCT00293267|4218678|P1|Extension - Double-Blind Week 49-156|Death|3
1294327|NCT00293267|4218677|P2|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4
1294328|NCT00293267|4218678|P1|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13
1294329|NCT00293267|4218677|P2|Extension - Double-Blind Week 49-156|Lost to Follow-up|0
1294330|NCT00293267|4218678|P1|Extension - Double-Blind Week 49-156|Lost to Follow-up|4
1294331|NCT00293267|4218677|P2|Extension - Double-Blind Week 49-156|Lack of Efficacy|1
1294332|NCT00293267|4218678|P1|Extension - Double-Blind Week 49-156|Lack of Efficacy|7
1294333|NCT00293267|4218677|P2|Extension - Double-Blind Week 49-156|Adverse Event|4
1294334|NCT00293267|4218678|P1|Extension - Double-Blind Week 49-156|Adverse Event|1
1294335|NCT00293267|4218677|P2|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60
1294336|NCT00293267|4218678|P1|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33
1294337|NCT00293267|4218677|P2|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
1294338|NCT00293267|4218678|P1|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
1294339|NCT00293267|4218677|P2|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
1294340|NCT00293267|4218678|P1|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
1294341|NCT00293267|4218677|P2|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
1294342|NCT00293267|4218678|P1|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0
1294343|NCT00293267|4218677|P2|Primary Study - Double-Blind Week 0-48|Death|3
1294344|NCT00293267|4218678|P1|Primary Study - Double-Blind Week 0-48|Death|3
1294345|NCT00293267|4218677|P2|Primary Study - Double-Blind Week 0-48|Adverse Event|1
1294346|NCT00293267|4218678|P1|Primary Study - Double-Blind Week 0-48|Adverse Event|1
1294347|NCT00293267|4218677|P2|Primary Study - Double-Blind Week 0-48|Never Treated|0
1294348|NCT00293267|4218678|P1|Primary Study - Double-Blind Week 0-48|Never Treated|2
1294349|NCT00293254|4218718|P2|Open-Label Post Virologic Failure Phase|Other Reason|2
1294350|NCT00293254|4218719|P1|Open-Label Post Virologic Failure Phase|Other Reason|1
1294351|NCT00293254|4218718|P2|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
1294352|NCT00293254|4218719|P1|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
1294353|NCT00293254|4218718|P2|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0
1294354|NCT00293254|4218719|P1|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3
1294355|NCT00293254|4218718|P2|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3
1294356|NCT00293254|4218719|P1|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6
1294357|NCT00293254|4218718|P2|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14
1294358|NCT00293254|4218719|P1|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16
1294359|NCT00293254|4218718|P2|Open-Label Post Virologic Failure Phase|Adverse Event|7
1294360|NCT00293254|4218719|P1|Open-Label Post Virologic Failure Phase|Adverse Event|4
1294361|NCT00293254|4218718|P2|Extension - Open-Label Week 157-240|Other Reason|0
1294362|NCT00293254|4218719|P1|Extension - Open-Label Week 157-240|Other Reason|4
1294363|NCT00293254|4218718|P2|Extension - Open-Label Week 157-240|Lost to Follow-up|0
1294364|NCT00293254|4218719|P1|Extension - Open-Label Week 157-240|Lost to Follow-up|2
1294365|NCT00293254|4218718|P2|Extension - Open-Label Week 157-240|Withdrawal by Subject|0
1294366|NCT00293254|4218719|P1|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
1294367|NCT00293254|4218718|P2|Extension - Open-Label Week 157-240|Lack of Efficacy|0
1294368|NCT00293254|4218719|P1|Extension - Open-Label Week 157-240|Lack of Efficacy|1
1294369|NCT00293254|4218718|P2|Extension - Open-Label Week 157-240|Adverse Event|1
1294370|NCT00293254|4218719|P1|Extension - Open-Label Week 157-240|Adverse Event|2
1294371|NCT00293254|4218718|P2|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7
1294372|NCT00293254|4218719|P1|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
1294373|NCT00293254|4218718|P2|Extension - Double-Blind Week 49-156|Other Reason|2
1294374|NCT00293254|4218719|P1|Extension - Double-Blind Week 49-156|Other Reason|10
1294375|NCT00293254|4218718|P2|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3
1294376|NCT00293254|4218719|P1|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6
1294377|NCT00293254|4218718|P2|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8
1294378|NCT00293254|4218719|P1|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12
1294379|NCT00293254|4218718|P2|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
1294380|NCT00293254|4218719|P1|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
1294381|NCT00293254|4218718|P2|Extension - Double-Blind Week 49-156|Lack of Efficacy|4
1294382|NCT00293254|4218719|P1|Extension - Double-Blind Week 49-156|Lack of Efficacy|3
1294383|NCT00293254|4218718|P2|Extension - Double-Blind Week 49-156|Death|1
1294384|NCT00293254|4218719|P1|Extension - Double-Blind Week 49-156|Death|4
1294385|NCT00293254|4218718|P2|Extension - Double-Blind Week 49-156|Adverse Event|1
1294386|NCT00293254|4218719|P1|Extension - Double-Blind Week 49-156|Adverse Event|4
1294387|NCT00293254|4218718|P2|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57
1294388|NCT00293254|4218719|P1|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35
1294389|NCT00293254|4218718|P2|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0
1294390|NCT00293254|4218719|P1|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1
1294391|NCT00293254|4218718|P2|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
1294392|NCT00293254|4218719|P1|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5
1294393|NCT00293254|4218718|P2|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
1294394|NCT00293254|4218719|P1|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3
1294395|NCT00293254|4218718|P2|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
1294396|NCT00293254|4218719|P1|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
1294397|NCT00293254|4218718|P2|Primary Study - Double-Blind Week 0-48|Death|2
1294398|NCT00293254|4218719|P1|Primary Study - Double-Blind Week 0-48|Death|5
1294399|NCT00293254|4218718|P2|Primary Study - Double-Blind Week 0-48|Adverse Event|1
1294400|NCT00293254|4218719|P1|Primary Study - Double-Blind Week 0-48|Adverse Event|2
1294401|NCT00293254|4218718|P2|Primary Study - Double-Blind Week 0-48|Never Treated|0
1294402|NCT00293254|4218719|P1|Primary Study - Double-Blind Week 0-48|Never Treated|2
1294403|NCT00293241|4218759|P2|Overall Study|Withdrawal by Subject|8
1294404|NCT00293241|4218760|P1|Overall Study|Withdrawal by Subject|4
1294405|NCT00293241|4218759|P2|Overall Study|Physician Decision|17
1294406|NCT00293241|4218760|P1|Overall Study|Physician Decision|23
1294407|NCT00293241|4218759|P2|Overall Study|Lost to Follow-up|16
1294408|NCT00293241|4218760|P1|Overall Study|Lost to Follow-up|9
1294409|NCT00293059|4218804|P2|Overall Study|missing|5
1294410|NCT00293059|4218805|P1|Overall Study|missing|3
1294411|NCT00293059|4218804|P2|Overall Study|Noncompliant - sanitary pads collection|1
1294412|NCT00293059|4218805|P1|Overall Study|Noncompliant - sanitary pads collection|0
1294413|NCT00293059|4218804|P2|Overall Study|Participant stopped study drug|0
1294414|NCT00293059|4218805|P1|Overall Study|Participant stopped study drug|1
1294415|NCT00293059|4218804|P2|Overall Study|Participant moved out of state|0
1294416|NCT00293059|4218805|P1|Overall Study|Participant moved out of state|1
1294417|NCT00293059|4218804|P2|Overall Study|Withdrawal by Subject|5
1294418|NCT00293059|4218805|P1|Overall Study|Withdrawal by Subject|11
1294419|NCT00293059|4218804|P2|Overall Study|Protocol Violation|0
1294420|NCT00293059|4218805|P1|Overall Study|Protocol Violation|2
1294421|NCT00293059|4218804|P2|Overall Study|Pregnancy|1
1294422|NCT00293059|4218805|P1|Overall Study|Pregnancy|1
1294423|NCT00293059|4218804|P2|Overall Study|Lost to Follow-up|3
1294424|NCT00293059|4218805|P1|Overall Study|Lost to Follow-up|2
1294425|NCT00293059|4218804|P2|Overall Study|Lack of Efficacy|0
1294426|NCT00293059|4218805|P1|Overall Study|Lack of Efficacy|2
1294427|NCT00293059|4218804|P2|Overall Study|Adverse Event|4
1294428|NCT00293059|4218805|P1|Overall Study|Adverse Event|12
1294429|NCT00293020|4218917|P1|Overall Study|No dose taken|1
1294430|NCT00293020|4218917|P1|Overall Study|Other Reason|22
1294431|NCT00293020|4218917|P1|Overall Study|Physician Decision|21
1294432|NCT00293020|4218917|P1|Overall Study|Protocol Violation|6
1294433|NCT00293020|4218917|P1|Overall Study|Lost to Follow-up|4
1294434|NCT00293020|4218917|P1|Overall Study|Lack of Efficacy|12
1294435|NCT00293020|4218917|P1|Overall Study|Death|32
1294436|NCT00293020|4218917|P1|Overall Study|Adverse Event|30
1294437|NCT00293020|4218917|P1|Overall Study|Withdrawal by Subject|34
1294438|NCT00292981|4218921|P1|Overall Study|Not specified|3
1294439|NCT00292981|4218921|P1|Overall Study|Withdrawal by Subject|22
1294440|NCT00292981|4218921|P1|Overall Study|Lost to Follow-up|13
1294441|NCT00292981|4218921|P1|Overall Study|Adverse Event|1
1294442|NCT00292942|4218932|P4|Overall Study|Adverse Event|1
1294443|NCT00292942|4218933|P3|Overall Study|Adverse Event|0
1294444|NCT00292942|4218934|P2|Overall Study|Adverse Event|0
1294445|NCT00292942|4218935|P1|Overall Study|Adverse Event|0
1294446|NCT00292942|4218932|P4|Overall Study|Withdrawal by Subject|0
1294447|NCT00292942|4218933|P3|Overall Study|Withdrawal by Subject|1
1294448|NCT00292942|4218934|P2|Overall Study|Withdrawal by Subject|0
1294449|NCT00292942|4218935|P1|Overall Study|Withdrawal by Subject|0
1294450|NCT00292461|4218981|P2|Overall Study|Lost to Follow-up|0
1294451|NCT00292461|4218982|P1|Overall Study|Lost to Follow-up|1
1294452|NCT00292461|4218981|P2|Overall Study|Protocol Violation|3
1294453|NCT00292461|4218982|P1|Overall Study|Protocol Violation|4
1294454|NCT00292461|4218981|P2|Overall Study|Withdrawal by Subject|1
1294455|NCT00292461|4218982|P1|Overall Study|Withdrawal by Subject|0
1294456|NCT00292461|4218981|P2|Overall Study|Lack of Efficacy|0
1294457|NCT00292461|4218982|P1|Overall Study|Lack of Efficacy|1
1294458|NCT00292461|4218981|P2|Overall Study|Adverse Event|2
1294459|NCT00292461|4218982|P1|Overall Study|Adverse Event|4
1294460|NCT00292370|4218997|P3|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5
1294461|NCT00292370|4218998|P2|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1
1294462|NCT00292370|4218999|P1|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0
1294463|NCT00292370|4218997|P3|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2
1294464|NCT00292370|4218998|P2|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3
1294465|NCT00292370|4218999|P1|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0
1294466|NCT00292370|4218997|P3|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
1294467|NCT00292370|4218998|P2|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
1294468|NCT00292370|4218999|P1|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4
1294469|NCT00292370|4218997|P3|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
1294470|NCT00292370|4218998|P2|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
1294471|NCT00292370|4218999|P1|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8
1294472|NCT00292370|4218997|P3|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
1294473|NCT00292370|4218998|P2|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
1294474|NCT00292370|4218999|P1|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22
1294475|NCT00292370|4218997|P3|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
1294476|NCT00292370|4218998|P2|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
1294477|NCT00292370|4218999|P1|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12
1294478|NCT00292318|4219008|P2|Overall Study|Study terminated by officials|1
1294479|NCT00292318|4219009|P1|Overall Study|Study terminated by officials|2
1294480|NCT00292227|4219019|P3|Patch Period|Withdrawal by Subject|1
1294481|NCT00292227|4219020|P2|Patch Period|Withdrawal by Subject|0
1294482|NCT00292227|4219021|P1|Patch Period|Withdrawal by Subject|0
1294483|NCT00292227|4219019|P3|Patch Period|Adverse Event|2
1294484|NCT00292227|4219020|P2|Patch Period|Adverse Event|0
1294485|NCT00292227|4219021|P1|Patch Period|Adverse Event|1
1294486|NCT00292188|4219103|P3|Double-Blind|Laboratory Abnormality|1
1294487|NCT00292188|4219104|P2|Double-Blind|Laboratory Abnormality|0
1294488|NCT00292188|4219105|P1|Double-Blind|Laboratory Abnormality|0
1294489|NCT00292188|4219103|P3|Double-Blind|Withdrawal by Subject|3
1294490|NCT00292188|4219104|P2|Double-Blind|Withdrawal by Subject|0
1294491|NCT00292188|4219105|P1|Double-Blind|Withdrawal by Subject|0
1294492|NCT00292188|4219103|P3|Double-Blind|Other|4
1294493|NCT00292188|4219104|P2|Double-Blind|Other|3
1294494|NCT00292188|4219105|P1|Double-Blind|Other|0
1294495|NCT00292188|4219103|P3|Double-Blind|Lost to Follow-up|0
1294496|NCT00292188|4219104|P2|Double-Blind|Lost to Follow-up|1
1294497|NCT00292188|4219105|P1|Double-Blind|Lost to Follow-up|0
1294498|NCT00292188|4219103|P3|Double-Blind|Lack of Efficacy|12
1294499|NCT00292188|4219104|P2|Double-Blind|Lack of Efficacy|2
1294500|NCT00292188|4219105|P1|Double-Blind|Lack of Efficacy|0
1294501|NCT00292188|4219103|P3|Double-Blind|Adverse Event|9
1294502|NCT00292188|4219104|P2|Double-Blind|Adverse Event|25
1294503|NCT00292188|4219105|P1|Double-Blind|Adverse Event|0
1294504|NCT00292188|4219103|P3|Single-Blind|Did not receive treatment|0
1294505|NCT00292188|4219104|P2|Single-Blind|Did not receive treatment|0
1294506|NCT00292188|4219105|P1|Single-Blind|Did not receive treatment|1
1294507|NCT00292188|4219103|P3|Single-Blind|Withdrawal by Subject|0
1294508|NCT00292188|4219104|P2|Single-Blind|Withdrawal by Subject|0
1294509|NCT00292188|4219105|P1|Single-Blind|Withdrawal by Subject|12
1294510|NCT00292188|4219103|P3|Single-Blind|Other|0
1294511|NCT00292188|4219104|P2|Single-Blind|Other|0
1294512|NCT00292188|4219105|P1|Single-Blind|Other|77
1294513|NCT00292188|4219103|P3|Single-Blind|Lost to Follow-up|0
1294514|NCT00292188|4219104|P2|Single-Blind|Lost to Follow-up|0
1294515|NCT00292188|4219105|P1|Single-Blind|Lost to Follow-up|3
1294516|NCT00292188|4219103|P3|Single-Blind|Laboratory Abnormality|0
1294517|NCT00292188|4219104|P2|Single-Blind|Laboratory Abnormality|0
1294518|NCT00292188|4219105|P1|Single-Blind|Laboratory Abnormality|5
1294519|NCT00292188|4219103|P3|Single-Blind|Lack of Efficacy|0
1294520|NCT00292188|4219104|P2|Single-Blind|Lack of Efficacy|0
1294521|NCT00292188|4219105|P1|Single-Blind|Lack of Efficacy|2
1294522|NCT00292188|4219103|P3|Single-Blind|Adverse Event|0
1294523|NCT00292188|4219104|P2|Single-Blind|Adverse Event|0
1294524|NCT00292188|4219105|P1|Single-Blind|Adverse Event|14
1294525|NCT00291642|4219222|P5|Overall Study|Intake of prohibited medication|0
1294526|NCT00291642|4219223|P4|Overall Study|Intake of prohibited medication|0
1294527|NCT00291642|4219224|P3|Overall Study|Intake of prohibited medication|0
1294528|NCT00291642|4219225|P2|Overall Study|Intake of prohibited medication|0
1294529|NCT00291642|4219226|P1|Overall Study|Intake of prohibited medication|1
1294530|NCT00291642|4219222|P5|Overall Study|Patient missed visit|0
1294531|NCT00291642|4219223|P4|Overall Study|Patient missed visit|0
1294532|NCT00291642|4219224|P3|Overall Study|Patient missed visit|1
1294533|NCT00291642|4219225|P2|Overall Study|Patient missed visit|0
1294534|NCT00291642|4219226|P1|Overall Study|Patient missed visit|0
1294535|NCT00291642|4219222|P5|Overall Study|Adverse Event|1
1294536|NCT00291642|4219223|P4|Overall Study|Adverse Event|0
1294537|NCT00291642|4219224|P3|Overall Study|Adverse Event|1
1294538|NCT00291642|4219225|P2|Overall Study|Adverse Event|0
1294539|NCT00291642|4219226|P1|Overall Study|Adverse Event|1
1294540|NCT00291577|4219278|P1|Overall Study|Lack of Efficacy|14
1294541|NCT00291577|4219278|P1|Overall Study|Withdrawal by Subject|2
1294542|NCT00291577|4219278|P1|Overall Study|Other|4
1294543|NCT00291577|4219278|P1|Overall Study|Adverse Event|1
1294544|NCT00291551|4219297|P1|Overall Study|Withdrawal by Subject|6
1294545|NCT00291551|4219297|P1|Overall Study|Death|7
1294546|NCT00291330|4219345|P2|Overall Study|Other|1
1294547|NCT00291330|4219346|P1|Overall Study|Other|3
1294548|NCT00291330|4219345|P2|Overall Study|Withdrawal by Subject|25
1294549|NCT00291330|4219346|P1|Overall Study|Withdrawal by Subject|22
1294550|NCT00291330|4219345|P2|Overall Study|Lost to Follow-up|11
1294551|NCT00291330|4219346|P1|Overall Study|Lost to Follow-up|16
1294552|NCT00291330|4219345|P2|Overall Study|Protocol Violation|20
1294553|NCT00291330|4219346|P1|Overall Study|Protocol Violation|13
1294554|NCT00291330|4219345|P2|Overall Study|Adverse Event|40
1294555|NCT00291330|4219346|P1|Overall Study|Adverse Event|47
1294556|NCT00291187|4219388|P4|Overall Study|Protocol Violation- No Drug Administered|0
1294557|NCT00291187|4219389|P3|Overall Study|Protocol Violation- No Drug Administered|1
1294558|NCT00291187|4219390|P2|Overall Study|Protocol Violation- No Drug Administered|0
1294559|NCT00291187|4219391|P1|Overall Study|Protocol Violation- No Drug Administered|0
1294560|NCT00291018|4219435|P3|Overall Study|Lost to Follow-up|18
1294561|NCT00291018|4219436|P2|Overall Study|Lost to Follow-up|4
1294562|NCT00291018|4219437|P1|Overall Study|Lost to Follow-up|3
1294563|NCT00291018|4219435|P3|Overall Study|Failures|5
1294564|NCT00291018|4219436|P2|Overall Study|Failures|12
1294565|NCT00291018|4219437|P1|Overall Study|Failures|5
1294566|NCT00291018|4219435|P3|Overall Study|Withdrawal by Subject|1
1294567|NCT00291018|4219436|P2|Overall Study|Withdrawal by Subject|8
1294568|NCT00291018|4219437|P1|Overall Study|Withdrawal by Subject|2
1294569|NCT00291018|4219435|P3|Overall Study|Death|4
1294570|NCT00291018|4219436|P2|Overall Study|Death|3
1294571|NCT00291018|4219437|P1|Overall Study|Death|3
1294572|NCT00291018|4219435|P3|Overall Study|Not Consented or Declined PAS|15
1294573|NCT00291018|4219436|P2|Overall Study|Not Consented or Declined PAS|15
1294574|NCT00291018|4219437|P1|Overall Study|Not Consented or Declined PAS|12
1294575|NCT00290888|4219477|P2|Overall Study|Physician Decision|1
1294576|NCT00290888|4219478|P1|Overall Study|Physician Decision|3
1294577|NCT00290771|4219495|P2|Overall Study|Lost to Follow-up|1
1294578|NCT00290771|4219496|P1|Overall Study|Lost to Follow-up|0
1294579|NCT00290771|4219495|P2|Overall Study|Protocol Violation|0
1294580|NCT00290771|4219496|P1|Overall Study|Protocol Violation|2
1294581|NCT00290771|4219495|P2|Overall Study|Administrative problems|1
1294582|NCT00290771|4219496|P1|Overall Study|Administrative problems|2
1294583|NCT00290771|4219495|P2|Overall Study|Withdrawal by Subject|6
1294584|NCT00290771|4219496|P1|Overall Study|Withdrawal by Subject|5
1294585|NCT00290771|4219495|P2|Overall Study|Adverse Event|6
1294586|NCT00290771|4219496|P1|Overall Study|Adverse Event|12
1294587|NCT00290771|4219495|P2|Overall Study|Death|10
1294588|NCT00290771|4219496|P1|Overall Study|Death|11
1294589|NCT00290771|4219495|P2|Overall Study|Disease progression|73
1294590|NCT00290771|4219496|P1|Overall Study|Disease progression|95
1294591|NCT00290758|4219520|P2|Post Intervention rFNA|<4000 Epithelial Cells|5
1294592|NCT00290758|4219521|P1|Post Intervention rFNA|<4000 Epithelial Cells|6
1294593|NCT00290758|4219520|P2|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1
1294594|NCT00290758|4219521|P1|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0
1294595|NCT00290758|4219520|P2|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0
1294596|NCT00290758|4219521|P1|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1
1294597|NCT00290758|4219520|P2|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5
1294598|NCT00290758|4219521|P1|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0
1294599|NCT00290758|4219520|P2|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
1294600|NCT00290758|4219521|P1|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
1294601|NCT00290758|4219520|P2|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1
1294602|NCT00290758|4219521|P1|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3
1294603|NCT00290758|4219520|P2|Pre-Intervention rFNA Through Follow-Up|ConMeds|0
1294604|NCT00290758|4219521|P1|Pre-Intervention rFNA Through Follow-Up|ConMeds|1
1294605|NCT00290758|4219520|P2|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2
1294606|NCT00290758|4219521|P1|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1
1294607|NCT00290732|4219543|P5|Overall Study|Inability to instill drug intraductally.|0
1294608|NCT00290732|4219544|P4|Overall Study|Inability to instill drug intraductally.|0
1294609|NCT00290732|4219545|P3|Overall Study|Inability to instill drug intraductally.|1
1294610|NCT00290732|4219546|P2|Overall Study|Inability to instill drug intraductally.|1
1294611|NCT00290732|4219547|P1|Overall Study|Inability to instill drug intraductally.|0
1294612|NCT00290693|4219565|P1|Overall Study|Withdrawal by Subject|2
1294613|NCT00290407|4219614|P1|Overall Study|Physician Decision|2
1294614|NCT00290342|4219621|P2|Overall Study|Lost to Follow-up|0
1294615|NCT00290342|4219622|P1|Overall Study|Lost to Follow-up|1
1294616|NCT00290342|4219621|P2|Overall Study|Withdrawal by Subject|4
1294617|NCT00290342|4219622|P1|Overall Study|Withdrawal by Subject|6
1294618|NCT00290342|4219621|P2|Overall Study|Other|1
1294619|NCT00290342|4219622|P1|Overall Study|Other|0
1294620|NCT00290290|4219677|P2|Overall Study|Underwent clean surgical procedure|12
1294621|NCT00290290|4219678|P1|Overall Study|Underwent clean surgical procedure|13
1294622|NCT00290290|4219677|P2|Overall Study|Withdrawal by Subject|2
1294623|NCT00290290|4219678|P1|Overall Study|Withdrawal by Subject|2
1294624|NCT00290290|4219677|P2|Overall Study|Death|4
1294625|NCT00290290|4219678|P1|Overall Study|Death|3
1294626|NCT00290251|4219684|P3|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
1294627|NCT00290251|4219685|P2|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
1294628|NCT00290251|4219686|P1|Treatment 2 (Months 4 - 6)|Lost to Follow-up|2
1294629|NCT00290251|4219684|P3|Treatment 1 (Months 1 - 3)|Out of body experience|0
1294630|NCT00290251|4219685|P2|Treatment 1 (Months 1 - 3)|Out of body experience|0
1294631|NCT00290251|4219686|P1|Treatment 1 (Months 1 - 3)|Out of body experience|1
1294632|NCT00290251|4219684|P3|Treatment 1 (Months 1 - 3)|headache|0
1294633|NCT00290251|4219685|P2|Treatment 1 (Months 1 - 3)|headache|1
1294634|NCT00290251|4219686|P1|Treatment 1 (Months 1 - 3)|headache|0
1294635|NCT00290251|4219684|P3|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|2
1294636|NCT00290251|4219685|P2|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
1294637|NCT00290251|4219686|P1|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
1294638|NCT00290238|4219698|P2|Overall Study|Withdrawal by Subject|13
1294639|NCT00290238|4219699|P1|Overall Study|Withdrawal by Subject|15
1294640|NCT00290238|4219698|P2|Overall Study|Lost to Follow-up|1
1294641|NCT00290238|4219699|P1|Overall Study|Lost to Follow-up|0
1294642|NCT00290238|4219698|P2|Overall Study|Study terminated|27
1294643|NCT00290238|4219699|P1|Overall Study|Study terminated|27
1294644|NCT00290186|4219724|P2|Overall Study|Withdrawal by Subject|1
1294645|NCT00290186|4219725|P1|Overall Study|Withdrawal by Subject|0
1294646|NCT00290186|4219724|P2|Overall Study|Study was terminated prior to 3-month te|1
1294647|NCT00290186|4219725|P1|Overall Study|Study was terminated prior to 3-month te|1
1294648|NCT00290186|4219724|P2|Overall Study|Lost to Follow-up|2
1294649|NCT00290186|4219725|P1|Overall Study|Lost to Follow-up|3
1294650|NCT00290186|4219724|P2|Overall Study|Adverse Event|1
1294651|NCT00290186|4219725|P1|Overall Study|Adverse Event|1
1294652|NCT00289991|4219776|P2|Overall Study|Other|14
1294653|NCT00289991|4219777|P1|Overall Study|Other|5
1294654|NCT00289991|4219776|P2|Overall Study|Withdrawal by Subject|12
1294655|NCT00289991|4219777|P1|Overall Study|Withdrawal by Subject|2
1294656|NCT00289991|4219776|P2|Overall Study|Lost to Follow-up|1
1294657|NCT00289991|4219777|P1|Overall Study|Lost to Follow-up|0
1294658|NCT00289991|4219776|P2|Overall Study|Fungal breakthrough infection|1
1294659|NCT00289991|4219777|P1|Overall Study|Fungal breakthrough infection|0
1294660|NCT00289991|4219776|P2|Overall Study|Failure of prophylaxis|1
1294661|NCT00289991|4219777|P1|Overall Study|Failure of prophylaxis|1
1294662|NCT00289991|4219776|P2|Overall Study|Adverse Event|13
1294663|NCT00289991|4219777|P1|Overall Study|Adverse Event|15
1294664|NCT00289991|4219776|P2|Overall Study|Death|38
1294665|NCT00289991|4219777|P1|Overall Study|Death|35
1294666|NCT00289978|4219802|P3|Overall Study|Death|2
1294667|NCT00289978|4219803|P2|Overall Study|Death|0
1294668|NCT00289978|4219804|P1|Overall Study|Death|1
1294669|NCT00289978|4219802|P3|Overall Study|Abnormal test procedure result(s)|1
1294670|NCT00289978|4219803|P2|Overall Study|Abnormal test procedure result(s)|1
1294671|NCT00289978|4219804|P1|Overall Study|Abnormal test procedure result(s)|2
1294672|NCT00289978|4219802|P3|Overall Study|Protocol Violation|4
1294673|NCT00289978|4219803|P2|Overall Study|Protocol Violation|5
1294674|NCT00289978|4219804|P1|Overall Study|Protocol Violation|5
1294675|NCT00289978|4219802|P3|Overall Study|Lost to Follow-up|7
1294676|NCT00289978|4219803|P2|Overall Study|Lost to Follow-up|5
1294677|NCT00289978|4219804|P1|Overall Study|Lost to Follow-up|3
1294678|NCT00289978|4219802|P3|Overall Study|Abnormal laboratory value(s)|1
1294679|NCT00289978|4219803|P2|Overall Study|Abnormal laboratory value(s)|9
1294680|NCT00289978|4219804|P1|Overall Study|Abnormal laboratory value(s)|20
1294681|NCT00289978|4219802|P3|Overall Study|Lack of Efficacy|25
1294682|NCT00289978|4219803|P2|Overall Study|Lack of Efficacy|6
1294683|NCT00289978|4219804|P1|Overall Study|Lack of Efficacy|13
1294684|NCT00289978|4219802|P3|Overall Study|Adverse Event|18
1294685|NCT00289978|4219803|P2|Overall Study|Adverse Event|13
1294686|NCT00289978|4219804|P1|Overall Study|Adverse Event|22
1294687|NCT00289978|4219802|P3|Overall Study|Withdrawal by Subject|28
1294688|NCT00289978|4219803|P2|Overall Study|Withdrawal by Subject|17
1294689|NCT00289978|4219804|P1|Overall Study|Withdrawal by Subject|31
1294690|NCT00289913|4219823|P5|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
1294691|NCT00289913|4219824|P4|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
1294692|NCT00289913|4219825|P3|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
1294693|NCT00289913|4219826|P2|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1
1294694|NCT00289913|4219827|P1|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
1294695|NCT00289913|4219823|P5|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1
1294696|NCT00289913|4219824|P4|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
1294697|NCT00289913|4219825|P3|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
1294698|NCT00289913|4219826|P2|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
1294699|NCT00289913|4219827|P1|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
1294700|NCT00289913|4219823|P5|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
1294701|NCT00289913|4219824|P4|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
1294702|NCT00289913|4219825|P3|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
1294703|NCT00289913|4219826|P2|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
1294704|NCT00289913|4219827|P1|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
1294705|NCT00289913|4219823|P5|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4
1294706|NCT00289913|4219824|P4|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
1294707|NCT00289913|4219825|P3|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0
1294708|NCT00289913|4219826|P2|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2
1294709|NCT00289913|4219827|P1|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
1294710|NCT00289913|4219823|P5|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1
1294711|NCT00289913|4219824|P4|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
1294712|NCT00289913|4219825|P3|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
1294713|NCT00289913|4219826|P2|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
1294714|NCT00289913|4219827|P1|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
1294715|NCT00289913|4219823|P5|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
1294716|NCT00289913|4219824|P4|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1
1294717|NCT00289913|4219825|P3|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
1294718|NCT00289913|4219826|P2|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
1294719|NCT00289913|4219827|P1|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
1294720|NCT00289913|4219823|P5|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
1294721|NCT00289913|4219824|P4|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
1294722|NCT00289913|4219825|P3|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1
1294723|NCT00289913|4219826|P2|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3
1294724|NCT00289913|4219827|P1|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8
1294725|NCT00289913|4219823|P5|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1294726|NCT00289913|4219824|P4|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1294727|NCT00289913|4219825|P3|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1294728|NCT00289913|4219826|P2|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1
1294729|NCT00289913|4219827|P1|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1294730|NCT00289913|4219823|P5|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9
1294731|NCT00289913|4219824|P4|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
1294732|NCT00289913|4219825|P3|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
1294733|NCT00289913|4219826|P2|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
1294734|NCT00289913|4219827|P1|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
1294735|NCT00289913|4219823|P5|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7
1294736|NCT00289913|4219824|P4|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
1294737|NCT00289913|4219825|P3|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
1294738|NCT00289913|4219826|P2|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
1294739|NCT00289913|4219827|P1|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
1294740|NCT00289913|4219823|P5|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6
1294741|NCT00289913|4219824|P4|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
1294742|NCT00289913|4219825|P3|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
1294743|NCT00289913|4219826|P2|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
1294744|NCT00289913|4219827|P1|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
1294745|NCT00289913|4219823|P5|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11
1294746|NCT00289913|4219824|P4|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
1294747|NCT00289913|4219825|P3|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
1294748|NCT00289913|4219826|P2|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
1294749|NCT00289913|4219827|P1|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
1294750|NCT00289913|4219823|P5|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7
1294751|NCT00289913|4219824|P4|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
1294752|NCT00289913|4219825|P3|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
1294753|NCT00289913|4219826|P2|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
1294754|NCT00289913|4219827|P1|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
1294755|NCT00289913|4219823|P5|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
1294756|NCT00289913|4219824|P4|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
1294757|NCT00289913|4219825|P3|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
1294758|NCT00289913|4219826|P2|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
1294759|NCT00289913|4219827|P1|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1
1294760|NCT00289913|4219823|P5|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
1294761|NCT00289913|4219824|P4|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
1294762|NCT00289913|4219825|P3|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2
1294763|NCT00289913|4219826|P2|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1
1294764|NCT00289913|4219827|P1|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
1294765|NCT00289913|4219823|P5|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
1294766|NCT00289913|4219824|P4|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3
1294767|NCT00289913|4219825|P3|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
1294768|NCT00289913|4219826|P2|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5
1294769|NCT00289913|4219827|P1|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2
1294770|NCT00289913|4219823|P5|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
1294771|NCT00289913|4219824|P4|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
1294772|NCT00289913|4219825|P3|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3
1294773|NCT00289913|4219826|P2|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
1294774|NCT00289913|4219827|P1|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
1294775|NCT00289913|4219823|P5|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
1294776|NCT00289913|4219824|P4|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
1294777|NCT00289913|4219825|P3|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
1294778|NCT00289913|4219826|P2|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
1294779|NCT00289913|4219827|P1|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
1294780|NCT00289913|4219823|P5|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
1294781|NCT00289913|4219824|P4|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
1294782|NCT00289913|4219825|P3|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1
1294783|NCT00289913|4219826|P2|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2
1294784|NCT00289913|4219827|P1|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3
1294785|NCT00289913|4219823|P5|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
1294786|NCT00289913|4219824|P4|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
1294787|NCT00289913|4219825|P3|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
1294788|NCT00289913|4219826|P2|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1
1294789|NCT00289913|4219827|P1|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
1294790|NCT00289913|4219823|P5|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0
1294791|NCT00289913|4219824|P4|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
1294792|NCT00289913|4219825|P3|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
1294793|NCT00289913|4219826|P2|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11
1294794|NCT00289913|4219827|P1|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8
1294795|NCT00289913|4219823|P5|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1294796|NCT00289913|4219824|P4|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1294797|NCT00289913|4219825|P3|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1
1294798|NCT00289913|4219826|P2|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1294799|NCT00289913|4219827|P1|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1294800|NCT00289913|4219823|P5|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
1294801|NCT00289913|4219824|P4|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
1294802|NCT00289913|4219825|P3|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2
1294803|NCT00289913|4219826|P2|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
1294804|NCT00289913|4219827|P1|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1
1294805|NCT00289913|4219823|P5|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
1294806|NCT00289913|4219824|P4|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6
1294807|NCT00289913|4219825|P3|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5
1294808|NCT00289913|4219826|P2|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8
1294809|NCT00289913|4219827|P1|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
1294810|NCT00289913|4219823|P5|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5
1294811|NCT00289913|4219824|P4|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
1294812|NCT00289913|4219825|P3|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
1294813|NCT00289913|4219826|P2|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1
1294814|NCT00289913|4219827|P1|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2
1294815|NCT00289913|4219823|P5|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
1294816|NCT00289913|4219824|P4|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
1294817|NCT00289913|4219825|P3|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
1294818|NCT00289913|4219826|P2|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2
1294819|NCT00289913|4219827|P1|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1
1294820|NCT00289913|4219823|P5|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
1294821|NCT00289913|4219824|P4|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1
1294822|NCT00289913|4219825|P3|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
1294823|NCT00289913|4219826|P2|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
1294824|NCT00289913|4219827|P1|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
1294825|NCT00289913|4219823|P5|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1
1294826|NCT00289913|4219824|P4|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
1294827|NCT00289913|4219825|P3|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
1294828|NCT00289913|4219826|P2|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
1294829|NCT00289913|4219827|P1|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
1294830|NCT00289913|4219823|P5|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
1294831|NCT00289913|4219824|P4|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
1294832|NCT00289913|4219825|P3|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0
1294833|NCT00289913|4219826|P2|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
1294834|NCT00289913|4219827|P1|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
1294835|NCT00289913|4219823|P5|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1
1294836|NCT00289913|4219824|P4|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
1294837|NCT00289913|4219825|P3|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
1294838|NCT00289913|4219826|P2|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
1294839|NCT00289913|4219827|P1|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3
1294840|NCT00289913|4219823|P5|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1294841|NCT00289913|4219824|P4|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1294842|NCT00289913|4219825|P3|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1294843|NCT00289913|4219826|P2|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1
1294844|NCT00289913|4219827|P1|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1294845|NCT00289900|4219858|P6|Overall Study|Not treated|0
1294846|NCT00289900|4219859|P5|Overall Study|Not treated|0
1294847|NCT00289900|4219860|P4|Overall Study|Not treated|0
1294848|NCT00289900|4219861|P3|Overall Study|Not treated|0
1294849|NCT00289900|4219862|P2|Overall Study|Not treated|1
1294850|NCT00289900|4219863|P1|Overall Study|Not treated|0
1294851|NCT00289900|4219858|P6|Overall Study|site terminated|0
1294852|NCT00289900|4219859|P5|Overall Study|site terminated|0
1294853|NCT00289900|4219860|P4|Overall Study|site terminated|0
1294854|NCT00289900|4219861|P3|Overall Study|site terminated|1
1294855|NCT00289900|4219862|P2|Overall Study|site terminated|0
1294856|NCT00289900|4219863|P1|Overall Study|site terminated|1
1294857|NCT00289900|4219858|P6|Overall Study|Protocol Violation|4
1294858|NCT00289900|4219859|P5|Overall Study|Protocol Violation|7
1294859|NCT00289900|4219860|P4|Overall Study|Protocol Violation|6
1294860|NCT00289900|4219861|P3|Overall Study|Protocol Violation|2
1294861|NCT00289900|4219862|P2|Overall Study|Protocol Violation|9
1294862|NCT00289900|4219863|P1|Overall Study|Protocol Violation|3
1294863|NCT00289900|4219858|P6|Overall Study|Withdrawal by Subject|11
1294864|NCT00289900|4219859|P5|Overall Study|Withdrawal by Subject|12
1294865|NCT00289900|4219860|P4|Overall Study|Withdrawal by Subject|18
1294866|NCT00289900|4219861|P3|Overall Study|Withdrawal by Subject|8
1294867|NCT00289900|4219862|P2|Overall Study|Withdrawal by Subject|21
1294868|NCT00289900|4219863|P1|Overall Study|Withdrawal by Subject|10
1294869|NCT00289900|4219858|P6|Overall Study|Participant moved|1
1294870|NCT00289900|4219859|P5|Overall Study|Participant moved|1
1294871|NCT00289900|4219860|P4|Overall Study|Participant moved|1
1294872|NCT00289900|4219861|P3|Overall Study|Participant moved|0
1294873|NCT00289900|4219862|P2|Overall Study|Participant moved|0
1294874|NCT00289900|4219863|P1|Overall Study|Participant moved|1
1294875|NCT00289900|4219858|P6|Overall Study|Other|0
1294876|NCT00289900|4219859|P5|Overall Study|Other|1
1294877|NCT00289900|4219860|P4|Overall Study|Other|5
1294878|NCT00289900|4219861|P3|Overall Study|Other|0
1294879|NCT00289900|4219862|P2|Overall Study|Other|0
1294880|NCT00289900|4219863|P1|Overall Study|Other|0
1294881|NCT00289900|4219858|P6|Overall Study|Participant had flushing|4
1294882|NCT00289900|4219859|P5|Overall Study|Participant had flushing|0
1294883|NCT00289900|4219860|P4|Overall Study|Participant had flushing|2
1294884|NCT00289900|4219861|P3|Overall Study|Participant had flushing|1
1294885|NCT00289900|4219862|P2|Overall Study|Participant had flushing|42
1294886|NCT00289900|4219863|P1|Overall Study|Participant had flushing|18
1294887|NCT00289900|4219858|P6|Overall Study|Lost to Follow-up|8
1294888|NCT00289900|4219859|P5|Overall Study|Lost to Follow-up|4
1294889|NCT00289900|4219860|P4|Overall Study|Lost to Follow-up|8
1294890|NCT00289900|4219861|P3|Overall Study|Lost to Follow-up|8
1294891|NCT00289900|4219862|P2|Overall Study|Lost to Follow-up|7
1294892|NCT00289900|4219863|P1|Overall Study|Lost to Follow-up|7
1294893|NCT00289900|4219858|P6|Overall Study|Adverse Event|33
1294894|NCT00289900|4219859|P5|Overall Study|Adverse Event|20
1294895|NCT00289900|4219860|P4|Overall Study|Adverse Event|19
1294896|NCT00289900|4219861|P3|Overall Study|Adverse Event|13
1294897|NCT00289900|4219862|P2|Overall Study|Adverse Event|40
1294898|NCT00289900|4219863|P1|Overall Study|Adverse Event|28
1294899|NCT00289887|4219967|P2|Overall Study|Other|3
1294900|NCT00289887|4219968|P1|Overall Study|Other|7
1294901|NCT00289887|4219967|P2|Overall Study|Withdrawal by Subject|8
1294902|NCT00289887|4219968|P1|Overall Study|Withdrawal by Subject|3
1294903|NCT00289887|4219967|P2|Overall Study|Protocol Violation|1
1294904|NCT00289887|4219968|P1|Overall Study|Protocol Violation|3
1294905|NCT00289887|4219967|P2|Overall Study|Lost to Follow-up|3
1294906|NCT00289887|4219968|P1|Overall Study|Lost to Follow-up|3
1294907|NCT00289887|4219967|P2|Overall Study|Lack of Efficacy|11
1294908|NCT00289887|4219968|P1|Overall Study|Lack of Efficacy|3
1294909|NCT00289887|4219967|P2|Overall Study|Adverse Event|3
1294910|NCT00289887|4219968|P1|Overall Study|Adverse Event|3
1294911|NCT00289874|4219986|P2|Overall Study|Did not meet eligibility|0
1294912|NCT00289874|4219987|P1|Overall Study|Did not meet eligibility|1
1294913|NCT00289874|4219986|P2|Overall Study|Protocol Violation|2
1294914|NCT00289874|4219987|P1|Overall Study|Protocol Violation|3
1294915|NCT00289874|4219986|P2|Overall Study|Lost to Follow-up|1
1294916|NCT00289874|4219987|P1|Overall Study|Lost to Follow-up|1
1294917|NCT00289874|4219986|P2|Overall Study|Adverse Event|5
1294918|NCT00289874|4219987|P1|Overall Study|Adverse Event|1
1294919|NCT00289848|4219997|P2|Overall Study|Open-Label AHA Treatment Requested|1
1294920|NCT00289848|4219998|P1|Overall Study|Open-Label AHA Treatment Requested|0
1294921|NCT00289848|4219997|P2|Overall Study|Patient Moved|2
1294922|NCT00289848|4219998|P1|Overall Study|Patient Moved|6
1294923|NCT00289848|4219997|P2|Overall Study|Withdrawal by Subject|11
1294924|NCT00289848|4219998|P1|Overall Study|Withdrawal by Subject|5
1294925|NCT00289848|4219997|P2|Overall Study|Protocol Violation|2
1294926|NCT00289848|4219998|P1|Overall Study|Protocol Violation|5
1294927|NCT00289848|4219997|P2|Overall Study|Lost to Follow-up|1
1294928|NCT00289848|4219998|P1|Overall Study|Lost to Follow-up|3
1294929|NCT00289848|4219997|P2|Overall Study|Lack of Efficacy|24
1294930|NCT00289848|4219998|P1|Overall Study|Lack of Efficacy|20
1294931|NCT00289848|4219997|P2|Overall Study|Death|0
1294932|NCT00289848|4219998|P1|Overall Study|Death|1
1294933|NCT00289848|4219997|P2|Overall Study|Adverse Event|4
1294934|NCT00289848|4219998|P1|Overall Study|Adverse Event|6
1294935|NCT00289783|4220010|P2|Fourth Dose Phase|Other|10
1294936|NCT00289783|4220011|P1|Fourth Dose Phase|Other|22
1294937|NCT00289783|4220010|P2|Fourth Dose Phase|Migration from the study area|1
1294938|NCT00289783|4220011|P1|Fourth Dose Phase|Migration from the study area|1
1294939|NCT00289783|4220010|P2|Fourth Dose Phase|Lost to Follow-up|12
1294940|NCT00289783|4220011|P1|Fourth Dose Phase|Lost to Follow-up|53
1294941|NCT00289783|4220010|P2|Fourth Dose Phase|Withdrawal by Subject|1
1294942|NCT00289783|4220011|P1|Fourth Dose Phase|Withdrawal by Subject|10
1294943|NCT00289783|4220010|P2|Fourth Dose Phase|Adverse Event|0
1294944|NCT00289783|4220011|P1|Fourth Dose Phase|Adverse Event|1
1294945|NCT00289783|4220010|P2|Primary Phase|Other|12
1294946|NCT00289783|4220011|P1|Primary Phase|Other|32
1294947|NCT00289783|4220010|P2|Primary Phase|Migration from the study area|10
1294948|NCT00289783|4220011|P1|Primary Phase|Migration from the study area|26
1294949|NCT00289783|4220010|P2|Primary Phase|Lost to Follow-up|14
1294950|NCT00289783|4220011|P1|Primary Phase|Lost to Follow-up|60
1294951|NCT00289783|4220010|P2|Primary Phase|Withdrawal by Subject|40
1294952|NCT00289783|4220011|P1|Primary Phase|Withdrawal by Subject|93
1294953|NCT00289783|4220010|P2|Primary Phase|Protocol Violation|6
1294954|NCT00289783|4220011|P1|Primary Phase|Protocol Violation|27
1294955|NCT00289783|4220010|P2|Primary Phase|Adverse Event|1
1294956|NCT00289783|4220011|P1|Primary Phase|Adverse Event|10
1294957|NCT00289770|4220189|P1|Year 15|Withdrawal by Subject|1
1294958|NCT00289731|4220235|P3|Overall Study|Other|0
1294959|NCT00289731|4220236|P2|Overall Study|Other|0
1294960|NCT00289731|4220237|P1|Overall Study|Other|1
1294961|NCT00289731|4220235|P3|Overall Study|Adverse Event|2
1294962|NCT00289731|4220236|P2|Overall Study|Adverse Event|2
1294963|NCT00289731|4220237|P1|Overall Study|Adverse Event|1
1294964|NCT00289536|4220349|P3|Period 3|Lost to Follow-up|1
1294965|NCT00289536|4220350|P2|Period 3|Lost to Follow-up|0
1294966|NCT00289536|4220351|P1|Period 3|Lost to Follow-up|0
1294967|NCT00289458|4220397|P3|Overall Study|Withdrawal by Subject|4
1294968|NCT00289458|4220398|P2|Overall Study|Withdrawal by Subject|2
1294969|NCT00289458|4220399|P1|Overall Study|Withdrawal by Subject|2
1294970|NCT00289458|4220397|P3|Overall Study|Physician Decision|2
1294971|NCT00289458|4220398|P2|Overall Study|Physician Decision|4
1294972|NCT00289458|4220399|P1|Overall Study|Physician Decision|3
1294973|NCT00289458|4220397|P3|Overall Study|Death|0
1294974|NCT00289458|4220398|P2|Overall Study|Death|0
1294975|NCT00289458|4220399|P1|Overall Study|Death|1
1294976|NCT00289289|4220460|P3|Overall Study|Other Exit Reason|12
1294977|NCT00289289|4220461|P2|Overall Study|Other Exit Reason|4
1294978|NCT00289289|4220462|P1|Overall Study|Other Exit Reason|6
1294979|NCT00289289|4220460|P3|Overall Study|Did not meet inclusion/exclusion|6
1294980|NCT00289289|4220461|P2|Overall Study|Did not meet inclusion/exclusion|0
1294981|NCT00289289|4220462|P1|Overall Study|Did not meet inclusion/exclusion|0
1294982|NCT00289289|4220460|P3|Overall Study|Non-study device implanted|3
1294983|NCT00289289|4220461|P2|Overall Study|Non-study device implanted|1
1294984|NCT00289289|4220462|P1|Overall Study|Non-study device implanted|2
1294985|NCT00289289|4220460|P3|Overall Study|Physician Decision|6
1294986|NCT00289289|4220461|P2|Overall Study|Physician Decision|0
1294987|NCT00289289|4220462|P1|Overall Study|Physician Decision|1
1294988|NCT00289289|4220460|P3|Overall Study|No implant attempted|1
1294989|NCT00289289|4220461|P2|Overall Study|No implant attempted|0
1294990|NCT00289289|4220462|P1|Overall Study|No implant attempted|0
1294991|NCT00289289|4220460|P3|Overall Study|Death|5
1294992|NCT00289289|4220461|P2|Overall Study|Death|2
1294993|NCT00289289|4220462|P1|Overall Study|Death|4
1294994|NCT00289289|4220460|P3|Overall Study|Lost to Follow-up|1
1294995|NCT00289289|4220461|P2|Overall Study|Lost to Follow-up|0
1294996|NCT00289289|4220462|P1|Overall Study|Lost to Follow-up|1
1294997|NCT00289289|4220460|P3|Overall Study|Withdrawal by Subject|15
1294998|NCT00289289|4220461|P2|Overall Study|Withdrawal by Subject|3
1294999|NCT00289289|4220462|P1|Overall Study|Withdrawal by Subject|5
1295000|NCT00289276|4220477|P2|Second Part of FAST Study (Expansion)|Lost to Follow-up|1
1295001|NCT00289276|4220478|P1|Second Part of FAST Study (Expansion)|Lost to Follow-up|0
1295002|NCT00289276|4220477|P2|Second Part of FAST Study (Expansion)|Death|2
1295003|NCT00289276|4220478|P1|Second Part of FAST Study (Expansion)|Death|0
1295004|NCT00289198|4220513|P2|Overall Study|Other: Impossible to come on visit|1
1295005|NCT00289198|4220514|P1|Overall Study|Other: Impossible to come on visit|0
1295006|NCT00289198|4220513|P2|Overall Study|Other: Miscalculation of the visit date|22
1295007|NCT00289198|4220514|P1|Overall Study|Other: Miscalculation of the visit date|21
1295008|NCT00289198|4220513|P2|Overall Study|Other: Unable to attend on schedule|1
1295009|NCT00289198|4220514|P1|Overall Study|Other: Unable to attend on schedule|2
1295010|NCT00289198|4220513|P2|Overall Study|Other: Physician's decision|1
1295011|NCT00289198|4220514|P1|Overall Study|Other: Physician's decision|0
1295012|NCT00289198|4220513|P2|Overall Study|Other: Low compliance|1
1295013|NCT00289198|4220514|P1|Overall Study|Other: Low compliance|0
1295014|NCT00289198|4220513|P2|Overall Study|Lack of Efficacy|0
1295015|NCT00289198|4220514|P1|Overall Study|Lack of Efficacy|2
1295016|NCT00289198|4220513|P2|Overall Study|Withdrawal by Subject|1
1295017|NCT00289198|4220514|P1|Overall Study|Withdrawal by Subject|4
1295018|NCT00289198|4220513|P2|Overall Study|Protocol Violation|1
1295019|NCT00289198|4220514|P1|Overall Study|Protocol Violation|2
1295020|NCT00289198|4220513|P2|Overall Study|Adverse Event|2
1295021|NCT00289198|4220514|P1|Overall Study|Adverse Event|0
1295022|NCT00289185|4220564|P2|Overall Study|Death|1
1295023|NCT00289185|4220565|P1|Overall Study|Death|1
1295024|NCT00289185|4220564|P2|Overall Study|Lost to Follow-up|17
1295025|NCT00289185|4220565|P1|Overall Study|Lost to Follow-up|23
1295026|NCT00289185|4220564|P2|Overall Study|Withdrawal by Subject|8
1295027|NCT00289185|4220565|P1|Overall Study|Withdrawal by Subject|4
1295028|NCT00289133|4220612|P2|Overall Study|Lost to Follow-up|115
1295029|NCT00289133|4220613|P1|Overall Study|Lost to Follow-up|92
1295030|NCT00289133|4220612|P2|Overall Study|Revision|6
1295031|NCT00289133|4220613|P1|Overall Study|Revision|8
1295032|NCT00289133|4220612|P2|Overall Study|Physician Decision|45
1295033|NCT00289133|4220613|P1|Overall Study|Physician Decision|41
1295034|NCT00289133|4220612|P2|Overall Study|Lost to Follow-up - Hurricane Katri|74
1295035|NCT00289133|4220613|P1|Overall Study|Lost to Follow-up - Hurricane Katri|73
1295036|NCT00289133|4220612|P2|Overall Study|Death|10
1295037|NCT00289133|4220613|P1|Overall Study|Death|5
1295038|NCT00289133|4220612|P2|Overall Study|Withdrawal by Subject|10
1295039|NCT00289133|4220613|P1|Overall Study|Withdrawal by Subject|9
1295040|NCT00289133|4220612|P2|Overall Study|Protocol Violation|38
1295041|NCT00289133|4220613|P1|Overall Study|Protocol Violation|32
1295042|NCT00289133|4220612|P2|Overall Study|Non-study device implanted|0
1295043|NCT00289133|4220613|P1|Overall Study|Non-study device implanted|12
1295044|NCT00289016|4220669|P1|Overall Study|Other|1
1295045|NCT00289016|4220669|P1|Overall Study|Adverse Event|1
1295046|NCT00289016|4220669|P1|Overall Study|Withdrawal by Subject|2
1295047|NCT00289016|4220669|P1|Overall Study|Unrelated Medical Condition or Accident|2
1295048|NCT00289016|4220669|P1|Overall Study|Death|2
1295049|NCT00289016|4220669|P1|Overall Study|Disease Progression|29
1295050|NCT00288912|4220681|P3|Overall Study|Withdrawal by Subject|12
1295051|NCT00288912|4220682|P2|Overall Study|Withdrawal by Subject|5
1295052|NCT00288912|4220683|P1|Overall Study|Withdrawal by Subject|4
1295053|NCT00288912|4220681|P3|Overall Study|Lost to Follow-up|9
1295054|NCT00288912|4220682|P2|Overall Study|Lost to Follow-up|6
1295055|NCT00288912|4220683|P1|Overall Study|Lost to Follow-up|9
1295056|NCT00288912|4220681|P3|Overall Study|Developed exclusion criterion|7
1295057|NCT00288912|4220682|P2|Overall Study|Developed exclusion criterion|6
1295058|NCT00288912|4220683|P1|Overall Study|Developed exclusion criterion|4
1295059|NCT00288860|4220723|P2|Overall Study|Lost to Follow-up|71
1295060|NCT00288860|4220724|P1|Overall Study|Lost to Follow-up|74
1295061|NCT00288860|4220723|P2|Overall Study|Withdrawal by Subject|15
1295062|NCT00288860|4220724|P1|Overall Study|Withdrawal by Subject|20
1295063|NCT00288860|4220723|P2|Overall Study|Death|3
1295064|NCT00288860|4220724|P1|Overall Study|Death|4
1295065|NCT00288860|4220723|P2|Overall Study|Did not complete intake|8
1295066|NCT00288860|4220724|P1|Overall Study|Did not complete intake|4
1295067|NCT00288704|4220737|P3|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1
1295068|NCT00288704|4220738|P2|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
1295069|NCT00288704|4220739|P1|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
1295070|NCT00288704|4220737|P3|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15
1295071|NCT00288704|4220738|P2|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
1295072|NCT00288704|4220739|P1|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
1295073|NCT00288704|4220737|P3|Open-Label Extension (OLE) Weeks 24-117|Death|2
1295074|NCT00288704|4220738|P2|Open-Label Extension (OLE) Weeks 24-117|Death|0
1295075|NCT00288704|4220739|P1|Open-Label Extension (OLE) Weeks 24-117|Death|0
1295076|NCT00288704|4220737|P3|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1
1295077|NCT00288704|4220738|P2|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
1295078|NCT00288704|4220739|P1|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
1295079|NCT00288704|4220737|P3|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1
1295080|NCT00288704|4220738|P2|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
1295081|NCT00288704|4220739|P1|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
1295082|NCT00288704|4220737|P3|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
1295083|NCT00288704|4220738|P2|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1
1295084|NCT00288704|4220739|P1|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
1295085|NCT00288704|4220737|P3|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
1295086|NCT00288704|4220738|P2|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1
1295087|NCT00288704|4220739|P1|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
1295088|NCT00288639|4220766|P1|Overall Study|Other|1
1295089|NCT00288639|4220766|P1|Overall Study|Withdrawal by Subject|2
1295090|NCT00288639|4220766|P1|Overall Study|Lack of Efficacy|4
1295091|NCT00288639|4220766|P1|Overall Study|Adverse Event|5
1295092|NCT00288626|4220783|P1|Overall Study|Withdrawal by Subject|4
1295093|NCT00288626|4220783|P1|Overall Study|Death|3
1295094|NCT00288587|4220817|P2|Overall Study|Severe Aortic Stenosis|0
1295095|NCT00288587|4220818|P1|Overall Study|Severe Aortic Stenosis|1
1295096|NCT00288587|4220817|P2|Overall Study|Physician Decision|2
1295097|NCT00288587|4220818|P1|Overall Study|Physician Decision|0
1295098|NCT00288587|4220817|P2|Overall Study|Adverse Event|1
1295099|NCT00288587|4220818|P1|Overall Study|Adverse Event|0
1295100|NCT00288587|4220817|P2|Overall Study|Transplant|3
1295101|NCT00288587|4220818|P1|Overall Study|Transplant|0
1295102|NCT00288587|4220817|P2|Overall Study|Death|4
1295103|NCT00288587|4220818|P1|Overall Study|Death|4
1295104|NCT00288509|4220861|P1|Treatment Cycle 4|Treatment stopped according to protocol|1
1295105|NCT00288509|4220861|P1|Treatment Cycle 4|Physician Decision|4
1295106|NCT00288509|4220861|P1|Treatment Cycle 4|Withdrawal by Subject|3
1295107|NCT00288509|4220861|P1|Treatment Cycle 3|Treatment stopped according to protocol|1
1295108|NCT00288509|4220861|P1|Treatment Cycle 3|Lost to Follow-up|2
1295109|NCT00288509|4220861|P1|Treatment Cycle 3|Withdrawal by Subject|1
1295110|NCT00288509|4220861|P1|Treatment Cycle 3|Lack of Efficacy|1
1295111|NCT00288509|4220861|P1|Treatment Cycle 2|Withdrawal by Subject|2
1295112|NCT00288509|4220861|P1|Treatment Cycle 2|Lack of Efficacy|1
1295113|NCT00288509|4220861|P1|Treatment Cycle 1|Treatment stopped according to protocol|1
1295114|NCT00288509|4220861|P1|Treatment Cycle 1|Lost to Follow-up|2
1295115|NCT00288509|4220861|P1|Treatment Cycle 1|Withdrawal by Subject|1
1295116|NCT00288509|4220861|P1|Treatment Cycle 1|Lack of Efficacy|1
1295117|NCT00288509|4220861|P1|Treatment Cycle 1|Adverse Event|1
1295118|NCT00288080|4220870|P2|Overall Study|Protocol Violation|20
1295119|NCT00288080|4220871|P1|Overall Study|Protocol Violation|25
1295120|NCT00288080|4220870|P2|Overall Study|Withdrawal by Subject|3
1295121|NCT00288080|4220871|P1|Overall Study|Withdrawal by Subject|1
1295122|NCT00288054|4220893|P1|Overall Study|Not protocol specified|2
1295123|NCT00288054|4220893|P1|Overall Study|Withdrawal by Subject|1
1295124|NCT00288054|4220893|P1|Overall Study|Adverse Event|3
1295125|NCT00288054|4220893|P1|Overall Study|Lack of Efficacy|16
1295126|NCT00288054|4220893|P1|Overall Study|Protocol Violation|2
1295127|NCT00288015|4220901|P1|Follow up for Survival x 2 Years|Other|9
1295128|NCT00288015|4220901|P1|Follow up for Survival x 2 Years|Lost to Follow-up|4
1295129|NCT00288015|4220901|P1|Follow up for Survival x 2 Years|Death|13
1295130|NCT00288015|4220901|P1|Continued Bevacizumab Cycle 3+|Disease progressed|7
1295131|NCT00288015|4220901|P1|First Response Assessment|Physician Decision|2
1295132|NCT00288015|4220901|P1|First Response Assessment|Death|1
1295133|NCT00288015|4220901|P1|First Response Assessment|Withdrawal by Subject|1
1295134|NCT00288015|4220901|P1|Bevacizumab Treatment Cycles 1-2|Physician Decision|1
1295135|NCT00288015|4220901|P1|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1
1295136|NCT00287586|4220993|P2|Overall Study|Recurrent Melanoma|1
1295137|NCT00287586|4220994|P1|Overall Study|Recurrent Melanoma|0
1295138|NCT00287586|4220993|P2|Overall Study|Itchy Swollen Eyes|1
1295139|NCT00287586|4220994|P1|Overall Study|Itchy Swollen Eyes|0
1295140|NCT00287586|4220993|P2|Overall Study|Bradycardia|1
1295141|NCT00287586|4220994|P1|Overall Study|Bradycardia|0
1295142|NCT00287586|4220993|P2|Overall Study|Mood Swings and Irritability|1
1295143|NCT00287586|4220994|P1|Overall Study|Mood Swings and Irritability|0
1295144|NCT00287586|4220993|P2|Overall Study|Mastodynia and Gynecomastia|1
1295145|NCT00287586|4220994|P1|Overall Study|Mastodynia and Gynecomastia|0
1295146|NCT00287586|4220993|P2|Overall Study|Retroperitoneal Cancer|1
1295147|NCT00287586|4220994|P1|Overall Study|Retroperitoneal Cancer|0
1295148|NCT00287586|4220993|P2|Overall Study|Elevated IPSS Score|1
1295149|NCT00287586|4220994|P1|Overall Study|Elevated IPSS Score|0
1295150|NCT00287586|4220993|P2|Overall Study|Lung Cancer|2
1295151|NCT00287586|4220994|P1|Overall Study|Lung Cancer|0
1295152|NCT00287586|4220993|P2|Overall Study|Major Depression|2
1295153|NCT00287586|4220994|P1|Overall Study|Major Depression|0
1295154|NCT00287586|4220993|P2|Overall Study|Enrolled in Another Study|0
1295155|NCT00287586|4220994|P1|Overall Study|Enrolled in Another Study|1
1295156|NCT00287586|4220993|P2|Overall Study|Nonadherence|1
1295157|NCT00287586|4220994|P1|Overall Study|Nonadherence|1
1295158|NCT00287586|4220993|P2|Overall Study|Inappropriate Behaviour with Staff|0
1295159|NCT00287586|4220994|P1|Overall Study|Inappropriate Behaviour with Staff|1
1295160|NCT00287586|4220993|P2|Overall Study|Shoulder Pain|0
1295161|NCT00287586|4220994|P1|Overall Study|Shoulder Pain|1
1295162|NCT00287586|4220993|P2|Overall Study|Sleep Apnea|0
1295163|NCT00287586|4220994|P1|Overall Study|Sleep Apnea|1
1295164|NCT00287586|4220993|P2|Overall Study|Pancreatic Cancer|3
1295165|NCT00287586|4220994|P1|Overall Study|Pancreatic Cancer|1
1295166|NCT00287586|4220993|P2|Overall Study|Cognitive Impairment|0
1295167|NCT00287586|4220994|P1|Overall Study|Cognitive Impairment|1
1295168|NCT00287586|4220993|P2|Overall Study|Lower Urinary Tract Symptoms|0
1295169|NCT00287586|4220994|P1|Overall Study|Lower Urinary Tract Symptoms|1
1295170|NCT00287586|4220993|P2|Overall Study|Myocardial Infarction|0
1295171|NCT00287586|4220994|P1|Overall Study|Myocardial Infarction|1
1295172|NCT00287586|4220993|P2|Overall Study|Stroke|0
1295173|NCT00287586|4220994|P1|Overall Study|Stroke|2
1295174|NCT00287586|4220993|P2|Overall Study|Elevated Prostate Specific Antigen|0
1295175|NCT00287586|4220994|P1|Overall Study|Elevated Prostate Specific Antigen|2
1295176|NCT00287586|4220993|P2|Overall Study|Rash|0
1295177|NCT00287586|4220994|P1|Overall Study|Rash|3
1295178|NCT00287586|4220993|P2|Overall Study|Elevated Hematocrit|0
1295179|NCT00287586|4220994|P1|Overall Study|Elevated Hematocrit|3
1295180|NCT00287586|4220993|P2|Overall Study|Death|3
1295181|NCT00287586|4220994|P1|Overall Study|Death|2
1295182|NCT00287586|4220993|P2|Overall Study|Lost to Follow-up|4
1295183|NCT00287586|4220994|P1|Overall Study|Lost to Follow-up|5
1295184|NCT00287586|4220993|P2|Overall Study|Withdrew Consent|30
1295185|NCT00287586|4220994|P1|Overall Study|Withdrew Consent|19
1295186|NCT00287365|4221030|P1|Overall Study|sample not acquired|13
1295187|NCT00287118|4221052|P1|Overall Study|Not specified|7
1295188|NCT00287118|4221052|P1|Overall Study|Protocol Violation|2
1295189|NCT00287118|4221052|P1|Overall Study|Lost to Follow-up|1
1295190|NCT00287118|4221052|P1|Overall Study|Lack of Efficacy|11
1295191|NCT00287118|4221052|P1|Overall Study|Death|1
1295192|NCT00287118|4221052|P1|Overall Study|Adverse Event|30
1295193|NCT00287079|4221058|P2|Overall Study|Other|0
1295194|NCT00287079|4221059|P1|Overall Study|Other|3
1295195|NCT00287079|4221058|P2|Overall Study|Protocol Violation|0
1295196|NCT00287079|4221059|P1|Overall Study|Protocol Violation|1
1295197|NCT00287079|4221058|P2|Overall Study|Adverse Event|0
1295198|NCT00287079|4221059|P1|Overall Study|Adverse Event|5
1295199|NCT00287079|4221058|P2|Overall Study|Non-qualifying relapse|0
1295200|NCT00287079|4221059|P1|Overall Study|Non-qualifying relapse|1
1295201|NCT00287079|4221058|P2|Overall Study|Qualifying relapse|1
1295202|NCT00287079|4221059|P1|Overall Study|Qualifying relapse|12
1295203|NCT00286754|4221087|P3|Overall Study|Moved out of state|1
1295204|NCT00286754|4221088|P2|Overall Study|Moved out of state|0
1295205|NCT00286754|4221089|P1|Overall Study|Moved out of state|0
1295206|NCT00286754|4221087|P3|Overall Study|Lost to Follow-up|6
1295207|NCT00286754|4221088|P2|Overall Study|Lost to Follow-up|14
1295208|NCT00286754|4221089|P1|Overall Study|Lost to Follow-up|12
1295209|NCT00286754|4221087|P3|Overall Study|Withdrawal by Subject|0
1295210|NCT00286754|4221088|P2|Overall Study|Withdrawal by Subject|2
1295211|NCT00286754|4221089|P1|Overall Study|Withdrawal by Subject|6
1295212|NCT00286754|4221087|P3|Overall Study|Adverse Event|3
1295213|NCT00286754|4221088|P2|Overall Study|Adverse Event|2
1295214|NCT00286754|4221089|P1|Overall Study|Adverse Event|2
1295215|NCT00286494|4221144|P3|Overall Study|Protocol Violation|2
1295216|NCT00286494|4221145|P2|Overall Study|Protocol Violation|1
1295217|NCT00286494|4221146|P1|Overall Study|Protocol Violation|1
1295218|NCT00286494|4221144|P3|Overall Study|Lost to Follow-up|3
1295219|NCT00286494|4221145|P2|Overall Study|Lost to Follow-up|1
1295220|NCT00286494|4221146|P1|Overall Study|Lost to Follow-up|3
1295221|NCT00286494|4221144|P3|Overall Study|Physician Decision|1
1295222|NCT00286494|4221145|P2|Overall Study|Physician Decision|5
1295223|NCT00286494|4221146|P1|Overall Study|Physician Decision|5
1295224|NCT00286494|4221144|P3|Overall Study|Adverse Event|6
1295225|NCT00286494|4221145|P2|Overall Study|Adverse Event|8
1295226|NCT00286494|4221146|P1|Overall Study|Adverse Event|3
1295227|NCT00286494|4221144|P3|Overall Study|Withdrawal by Subject|9
1295228|NCT00286494|4221145|P2|Overall Study|Withdrawal by Subject|10
1295229|NCT00286494|4221146|P1|Overall Study|Withdrawal by Subject|2
1295230|NCT00286494|4221144|P3|Overall Study|Hyperglycemic rescue|18
1295231|NCT00286494|4221145|P2|Overall Study|Hyperglycemic rescue|19
1295232|NCT00286494|4221146|P1|Overall Study|Hyperglycemic rescue|12
1295233|NCT00286468|4221307|P3|Overall Study|Physician Decision|1
1295234|NCT00286468|4221308|P2|Overall Study|Physician Decision|2
1295235|NCT00286468|4221309|P1|Overall Study|Physician Decision|3
1295236|NCT00286468|4221307|P3|Overall Study|Withdrawal by Subject|11
1295237|NCT00286468|4221308|P2|Overall Study|Withdrawal by Subject|8
1295238|NCT00286468|4221309|P1|Overall Study|Withdrawal by Subject|3
1295239|NCT00286468|4221307|P3|Overall Study|Lost to Follow-up|2
1295240|NCT00286468|4221308|P2|Overall Study|Lost to Follow-up|1
1295241|NCT00286468|4221309|P1|Overall Study|Lost to Follow-up|1
1295242|NCT00286468|4221307|P3|Overall Study|Protocol Violation|1
1295243|NCT00286468|4221308|P2|Overall Study|Protocol Violation|3
1295244|NCT00286468|4221309|P1|Overall Study|Protocol Violation|0
1295245|NCT00286468|4221307|P3|Overall Study|Adverse Event|4
1295246|NCT00286468|4221308|P2|Overall Study|Adverse Event|6
1295247|NCT00286468|4221309|P1|Overall Study|Adverse Event|2
1295248|NCT00286468|4221307|P3|Overall Study|Hyperglycemic Rescue|31
1295249|NCT00286468|4221308|P2|Overall Study|Hyperglycemic Rescue|30
1295250|NCT00286468|4221309|P1|Overall Study|Hyperglycemic Rescue|28
1295251|NCT00286455|4221470|P3|Overall Study|Withdrawal by Subject|7
1295252|NCT00286455|4221471|P2|Overall Study|Withdrawal by Subject|8
1295253|NCT00286455|4221472|P1|Overall Study|Withdrawal by Subject|0
1295254|NCT00286455|4221470|P3|Overall Study|Participant Non-compliance|0
1295255|NCT00286455|4221471|P2|Overall Study|Participant Non-compliance|0
1295256|NCT00286455|4221472|P1|Overall Study|Participant Non-compliance|1
1295257|NCT00286455|4221470|P3|Overall Study|Protocol Violation|0
1295258|NCT00286455|4221471|P2|Overall Study|Protocol Violation|1
1295259|NCT00286455|4221472|P1|Overall Study|Protocol Violation|1
1295260|NCT00286455|4221470|P3|Overall Study|Physician Decision|2
1295261|NCT00286455|4221471|P2|Overall Study|Physician Decision|0
1295262|NCT00286455|4221472|P1|Overall Study|Physician Decision|3
1295263|NCT00286455|4221470|P3|Overall Study|Lost to Follow-up|3
1295264|NCT00286455|4221471|P2|Overall Study|Lost to Follow-up|3
1295265|NCT00286455|4221472|P1|Overall Study|Lost to Follow-up|0
1295266|NCT00286455|4221470|P3|Overall Study|Adverse Event|2
1295267|NCT00286455|4221471|P2|Overall Study|Adverse Event|3
1295268|NCT00286455|4221472|P1|Overall Study|Adverse Event|1
1295269|NCT00286455|4221470|P3|Overall Study|Hyperglycemia rescue|10
1295270|NCT00286455|4221471|P2|Overall Study|Hyperglycemia rescue|13
1295271|NCT00286455|4221472|P1|Overall Study|Hyperglycemia rescue|19
1295272|NCT00286442|4221651|P3|Overall Study|Withdrawal by Subject|2
1295273|NCT00286442|4221652|P2|Overall Study|Withdrawal by Subject|14
1295274|NCT00286442|4221653|P1|Overall Study|Withdrawal by Subject|2
1295275|NCT00286442|4221651|P3|Overall Study|Administrative Error|0
1295276|NCT00286442|4221652|P2|Overall Study|Administrative Error|1
1295277|NCT00286442|4221653|P1|Overall Study|Administrative Error|1
1295278|NCT00286442|4221651|P3|Overall Study|Physician Decision|1
1295279|NCT00286442|4221652|P2|Overall Study|Physician Decision|1
1295280|NCT00286442|4221653|P1|Overall Study|Physician Decision|1
1295281|NCT00286442|4221651|P3|Overall Study|Lost to Follow-up|1
1295282|NCT00286442|4221652|P2|Overall Study|Lost to Follow-up|2
1295283|NCT00286442|4221653|P1|Overall Study|Lost to Follow-up|5
1295284|NCT00286442|4221651|P3|Overall Study|Protocol Violation|2
1295285|NCT00286442|4221652|P2|Overall Study|Protocol Violation|4
1295286|NCT00286442|4221653|P1|Overall Study|Protocol Violation|2
1295287|NCT00286442|4221651|P3|Overall Study|Adverse Event|1
1295288|NCT00286442|4221652|P2|Overall Study|Adverse Event|6
1295289|NCT00286442|4221653|P1|Overall Study|Adverse Event|7
1295290|NCT00286442|4221651|P3|Overall Study|Hyperglycemic Rescue|25
1295291|NCT00286442|4221652|P2|Overall Study|Hyperglycemic Rescue|17
1295292|NCT00286442|4221653|P1|Overall Study|Hyperglycemic Rescue|19
1295293|NCT00286429|4221814|P3|Overall Study|Administrative Decision|0
1295294|NCT00286429|4221815|P2|Overall Study|Administrative Decision|1
1295295|NCT00286429|4221816|P1|Overall Study|Administrative Decision|0
1295296|NCT00286429|4221814|P3|Overall Study|Administrative Error|1
1295297|NCT00286429|4221815|P2|Overall Study|Administrative Error|1
1295298|NCT00286429|4221816|P1|Overall Study|Administrative Error|1
1295299|NCT00286429|4221814|P3|Overall Study|Withdrawal by Subject|6
1295300|NCT00286429|4221815|P2|Overall Study|Withdrawal by Subject|2
1295301|NCT00286429|4221816|P1|Overall Study|Withdrawal by Subject|3
1295302|NCT00286429|4221814|P3|Overall Study|Protocol Violation|4
1295303|NCT00286429|4221815|P2|Overall Study|Protocol Violation|5
1295304|NCT00286429|4221816|P1|Overall Study|Protocol Violation|3
1295305|NCT00286429|4221814|P3|Overall Study|Physician Decision|7
1295306|NCT00286429|4221815|P2|Overall Study|Physician Decision|7
1295307|NCT00286429|4221816|P1|Overall Study|Physician Decision|10
1295308|NCT00286429|4221814|P3|Overall Study|Lost to Follow-up|3
1295309|NCT00286429|4221815|P2|Overall Study|Lost to Follow-up|4
1295310|NCT00286429|4221816|P1|Overall Study|Lost to Follow-up|2
1295311|NCT00286429|4221814|P3|Overall Study|Lack of Efficacy|25
1295312|NCT00286429|4221815|P2|Overall Study|Lack of Efficacy|27
1295313|NCT00286429|4221816|P1|Overall Study|Lack of Efficacy|52
1295314|NCT00286429|4221814|P3|Overall Study|Adverse Event|6
1295315|NCT00286429|4221815|P2|Overall Study|Adverse Event|1
1295316|NCT00286429|4221816|P1|Overall Study|Adverse Event|4
1295317|NCT00286221|4221932|P4|Overall Study|Unrecognized exclusion criteria met|0
1295318|NCT00286221|4221933|P3|Overall Study|Unrecognized exclusion criteria met|0
1295319|NCT00286221|4221934|P2|Overall Study|Unrecognized exclusion criteria met|1
1295320|NCT00286221|4221935|P1|Overall Study|Unrecognized exclusion criteria met|0
1295321|NCT00286221|4221932|P4|Overall Study|Inability to trigger PCA|0
1295322|NCT00286221|4221933|P3|Overall Study|Inability to trigger PCA|0
1295323|NCT00286221|4221934|P2|Overall Study|Inability to trigger PCA|0
1295324|NCT00286221|4221935|P1|Overall Study|Inability to trigger PCA|2
1295325|NCT00286221|4221932|P4|Overall Study|Unanticipated Neurosurgical Complication|2
1295326|NCT00286221|4221933|P3|Overall Study|Unanticipated Neurosurgical Complication|3
1295327|NCT00286221|4221934|P2|Overall Study|Unanticipated Neurosurgical Complication|3
1295328|NCT00286221|4221935|P1|Overall Study|Unanticipated Neurosurgical Complication|6
1295329|NCT00286221|4221932|P4|Overall Study|Protocol Violation|4
1295330|NCT00286221|4221933|P3|Overall Study|Protocol Violation|6
1295331|NCT00286221|4221934|P2|Overall Study|Protocol Violation|1
1295332|NCT00286221|4221935|P1|Overall Study|Protocol Violation|2
1295333|NCT00286156|4221961|P3|Overall Study|AE: pneumonia|0
1295334|NCT00286156|4221962|P2|Overall Study|AE: pneumonia|0
1295335|NCT00286156|4221963|P1|Overall Study|AE: pneumonia|1
1295336|NCT00286156|4221961|P3|Overall Study|AE: nephrotic-range proteinuruia|0
1295337|NCT00286156|4221962|P2|Overall Study|AE: nephrotic-range proteinuruia|0
1295338|NCT00286156|4221963|P1|Overall Study|AE: nephrotic-range proteinuruia|1
1295339|NCT00286156|4221961|P3|Overall Study|AE: pulmonary embolus|0
1295340|NCT00286156|4221962|P2|Overall Study|AE: pulmonary embolus|1
1295341|NCT00286156|4221963|P1|Overall Study|AE: pulmonary embolus|0
1295342|NCT00286156|4221961|P3|Overall Study|Missed 12 month visit|1
1295343|NCT00286156|4221962|P2|Overall Study|Missed 12 month visit|0
1295344|NCT00286156|4221963|P1|Overall Study|Missed 12 month visit|0
1295345|NCT00286091|4221976|P2|Open-label Treatment Phase|Missing End of Study Information|1
1295346|NCT00286091|4221977|P1|Open-label Treatment Phase|Missing End of Study Information|0
1295347|NCT00286091|4221976|P2|Open-label Treatment Phase|Protocol-specified Criteria|0
1295348|NCT00286091|4221977|P1|Open-label Treatment Phase|Protocol-specified Criteria|1
1295349|NCT00286091|4221976|P2|Open-label Treatment Phase|Lost to Follow-up|1
1295350|NCT00286091|4221977|P1|Open-label Treatment Phase|Lost to Follow-up|0
1295351|NCT00286091|4221976|P2|Open-label Treatment Phase|Noncompliance|1
1295352|NCT00286091|4221977|P1|Open-label Treatment Phase|Noncompliance|3
1295353|NCT00286091|4221976|P2|Open-label Treatment Phase|Disease Progression|3
1295354|NCT00286091|4221977|P1|Open-label Treatment Phase|Disease Progression|9
1295355|NCT00286091|4221976|P2|Open-label Treatment Phase|Death|7
1295356|NCT00286091|4221977|P1|Open-label Treatment Phase|Death|10
1295357|NCT00286091|4221976|P2|Open-label Treatment Phase|Withdrawal by Subject|10
1295358|NCT00286091|4221977|P1|Open-label Treatment Phase|Withdrawal by Subject|14
1295359|NCT00286091|4221976|P2|Open-label Treatment Phase|Other|11
1295360|NCT00286091|4221977|P1|Open-label Treatment Phase|Other|11
1295361|NCT00286091|4221976|P2|Open-label Treatment Phase|Adverse Event|16
1295362|NCT00286091|4221977|P1|Open-label Treatment Phase|Adverse Event|5
1295363|NCT00286091|4221976|P2|Open-label Treatment Phase|Physician Decision|21
1295364|NCT00286091|4221977|P1|Open-label Treatment Phase|Physician Decision|24
1295365|NCT00286091|4221976|P2|Double-blind Treatment Phase|Ineligibility Determined|2
1295366|NCT00286091|4221977|P1|Double-blind Treatment Phase|Ineligibility Determined|1
1295367|NCT00286091|4221976|P2|Double-blind Treatment Phase|Protocol Deviation|3
1295368|NCT00286091|4221977|P1|Double-blind Treatment Phase|Protocol Deviation|1
1295369|NCT00286091|4221976|P2|Double-blind Treatment Phase|Lost to Follow-up|4
1295370|NCT00286091|4221977|P1|Double-blind Treatment Phase|Lost to Follow-up|11
1295371|NCT00286091|4221976|P2|Double-blind Treatment Phase|Noncompliance|8
1295372|NCT00286091|4221977|P1|Double-blind Treatment Phase|Noncompliance|8
1295373|NCT00286091|4221976|P2|Double-blind Treatment Phase|Administrative Decision|21
1295374|NCT00286091|4221977|P1|Double-blind Treatment Phase|Administrative Decision|20
1295375|NCT00286091|4221976|P2|Double-blind Treatment Phase|Other|33
1295376|NCT00286091|4221977|P1|Double-blind Treatment Phase|Other|25
1295377|NCT00286091|4221976|P2|Double-blind Treatment Phase|Disease Progression|35
1295378|NCT00286091|4221977|P1|Double-blind Treatment Phase|Disease Progression|22
1295379|NCT00286091|4221976|P2|Double-blind Treatment Phase|Adverse Event|40
1295380|NCT00286091|4221977|P1|Double-blind Treatment Phase|Adverse Event|28
1295381|NCT00286091|4221976|P2|Double-blind Treatment Phase|Death|65
1295382|NCT00286091|4221977|P1|Double-blind Treatment Phase|Death|58
1295383|NCT00286091|4221976|P2|Double-blind Treatment Phase|Protocol-Specified Criteria|269
1295384|NCT00286091|4221977|P1|Double-blind Treatment Phase|Protocol-Specified Criteria|307
1295385|NCT00286091|4221976|P2|Double-blind Treatment Phase|Withdrawal by Subject|113
1295386|NCT00286091|4221977|P1|Double-blind Treatment Phase|Withdrawal by Subject|103
1295387|NCT00285857|4222000|P1|Overall Study|Adverse Event|1
1295388|NCT00285857|4222000|P1|Overall Study|Inadequate initial breast cytology|1
1295389|NCT00285857|4222000|P1|Overall Study|Withdrawal by Subject|2
1295390|NCT00285818|4222013|P2|Overall Study|Lost to Follow-up|0
1295391|NCT00285818|4222014|P1|Overall Study|Lost to Follow-up|1
1295392|NCT00285818|4222013|P2|Overall Study|Withdrawal by Subject|2
1295393|NCT00285818|4222014|P1|Overall Study|Withdrawal by Subject|3
1295394|NCT00285649|4222059|P3|Overall Study|Withdrawal by Subject|2
1295395|NCT00285649|4222060|P2|Overall Study|Withdrawal by Subject|2
1295396|NCT00285649|4222061|P1|Overall Study|Withdrawal by Subject|3
1295397|NCT00285649|4222059|P3|Overall Study|Lost to Follow-up|4
1295398|NCT00285649|4222060|P2|Overall Study|Lost to Follow-up|4
1295399|NCT00285649|4222061|P1|Overall Study|Lost to Follow-up|6
1295400|NCT00285584|4222071|P2|Month 6|Lost to Follow-up|1
1295401|NCT00285584|4222072|P1|Month 6|Lost to Follow-up|0
1295402|NCT00285584|4222071|P2|Month 3|Withdrawal by Subject|0
1295403|NCT00285584|4222072|P1|Month 3|Withdrawal by Subject|1
1295404|NCT00285584|4222071|P2|Month 3|Lost to Follow-up|3
1295405|NCT00285584|4222072|P1|Month 3|Lost to Follow-up|3
1295406|NCT00285207|4222104|P2|Overall Study|non-compliance|1
1295407|NCT00285207|4222105|P1|Overall Study|non-compliance|0
1295408|NCT00285207|4222104|P2|Overall Study|Pregnancy|1
1295409|NCT00285207|4222105|P1|Overall Study|Pregnancy|1
1295410|NCT00285207|4222104|P2|Overall Study|Withdrawal by Subject|2
1295411|NCT00285207|4222105|P1|Overall Study|Withdrawal by Subject|5
1295412|NCT00285207|4222104|P2|Overall Study|Lost to Follow-up|2
1295413|NCT00285207|4222105|P1|Overall Study|Lost to Follow-up|3
1295414|NCT00285012|4222113|P2|Received Study Tx|Other|5
1295415|NCT00285012|4222114|P1|Received Study Tx|Other|5
1295416|NCT00285012|4222113|P2|Received Study Tx|Withdrawal by Subject|43
1295417|NCT00285012|4222114|P1|Received Study Tx|Withdrawal by Subject|31
1295418|NCT00285012|4222113|P2|Received Study Tx|Lost to Follow-up|31
1295419|NCT00285012|4222114|P1|Received Study Tx|Lost to Follow-up|29
1295420|NCT00285012|4222113|P2|Received Study Tx|Lack of Efficacy|3
1295421|NCT00285012|4222114|P1|Received Study Tx|Lack of Efficacy|0
1295422|NCT00285012|4222113|P2|Received Study Tx|Adverse Event|11
1295423|NCT00285012|4222114|P1|Received Study Tx|Adverse Event|5
1295424|NCT00285012|4222113|P2|Received Study Tx|Death|1
1295425|NCT00285012|4222114|P1|Received Study Tx|Death|2
1295426|NCT00285012|4222113|P2|Assigned to Study Treatment (Tx)|Other|3
1295427|NCT00285012|4222114|P1|Assigned to Study Treatment (Tx)|Other|2
1295428|NCT00284934|4222140|P2|Overall Study|Other reasons|1
1295429|NCT00284934|4222141|P1|Overall Study|Other reasons|3
1295430|NCT00284934|4222140|P2|Overall Study|Adverse Event|2
1295431|NCT00284934|4222141|P1|Overall Study|Adverse Event|1
1295432|NCT00284856|4222156|P3|Overall Study|Other|4
1295433|NCT00284856|4222157|P2|Overall Study|Other|5
1295434|NCT00284856|4222158|P1|Overall Study|Other|4
1295435|NCT00284856|4222156|P3|Overall Study|Withdrawal by Subject|18
1295436|NCT00284856|4222157|P2|Overall Study|Withdrawal by Subject|16
1295437|NCT00284856|4222158|P1|Overall Study|Withdrawal by Subject|12
1295438|NCT00284856|4222156|P3|Overall Study|Protocol Violation|5
1295439|NCT00284856|4222157|P2|Overall Study|Protocol Violation|4
1295440|NCT00284856|4222158|P1|Overall Study|Protocol Violation|5
1295441|NCT00284856|4222156|P3|Overall Study|Lost to Follow-up|22
1295442|NCT00284856|4222157|P2|Overall Study|Lost to Follow-up|21
1295443|NCT00284856|4222158|P1|Overall Study|Lost to Follow-up|25
1295444|NCT00284856|4222156|P3|Overall Study|Lack of Efficacy|8
1295445|NCT00284856|4222157|P2|Overall Study|Lack of Efficacy|1
1295446|NCT00284856|4222158|P1|Overall Study|Lack of Efficacy|2
1295447|NCT00284856|4222156|P3|Overall Study|Adverse Event|3
1295448|NCT00284856|4222157|P2|Overall Study|Adverse Event|3
1295449|NCT00284856|4222158|P1|Overall Study|Adverse Event|3
1295450|NCT00284141|4222257|P1|Overall Study|Ongoing treatment|2
1295451|NCT00284141|4222257|P1|Overall Study|Did not take study medication|2
1295452|NCT00284141|4222257|P1|Overall Study|Pneumonia|1
1295453|NCT00284141|4222257|P1|Overall Study|General decline|1
1295454|NCT00284141|4222257|P1|Overall Study|Clinical deterioration / death|2
1295455|NCT00284141|4222257|P1|Overall Study|Symptomatic / Clinical Progression|11
1295456|NCT00284141|4222257|P1|Overall Study|Participant's request|9
1295457|NCT00284141|4222257|P1|Overall Study|Adverse Event|19
1295458|NCT00284141|4222257|P1|Overall Study|Disease Progression / Lack of efficacy|51
1295459|NCT00284089|4222280|P4|Extension Phase|Withdrawal by Subject|3
1295460|NCT00284089|4222281|P3|Extension Phase|Withdrawal by Subject|1
1295461|NCT00284089|4222282|P2|Extension Phase|Withdrawal by Subject|0
1295462|NCT00284089|4222283|P1|Extension Phase|Withdrawal by Subject|0
1295463|NCT00284089|4222280|P4|Extension Phase|Protocol Violation|0
1295464|NCT00284089|4222281|P3|Extension Phase|Protocol Violation|1
1295465|NCT00284089|4222282|P2|Extension Phase|Protocol Violation|0
1295466|NCT00284089|4222283|P1|Extension Phase|Protocol Violation|0
1295467|NCT00284089|4222280|P4|Extension Phase|condition no longer requires study drug|7
1295468|NCT00284089|4222281|P3|Extension Phase|condition no longer requires study drug|2
1295469|NCT00284089|4222282|P2|Extension Phase|condition no longer requires study drug|0
1295470|NCT00284089|4222283|P1|Extension Phase|condition no longer requires study drug|2
1295471|NCT00284089|4222280|P4|Extension Phase|Adverse Event|2
1295472|NCT00284089|4222281|P3|Extension Phase|Adverse Event|2
1295473|NCT00284089|4222282|P2|Extension Phase|Adverse Event|0
1295474|NCT00284089|4222283|P1|Extension Phase|Adverse Event|0
1295475|NCT00284089|4222280|P4|Multiple Dose Phase|Death|1
1295476|NCT00284089|4222281|P3|Multiple Dose Phase|Death|1
1295477|NCT00284089|4222282|P2|Multiple Dose Phase|Death|0
1295478|NCT00284089|4222283|P1|Multiple Dose Phase|Death|0
1295479|NCT00284089|4222280|P4|Multiple Dose Phase|Withdrawal by Subject|2
1295480|NCT00284089|4222281|P3|Multiple Dose Phase|Withdrawal by Subject|1
1295481|NCT00284089|4222282|P2|Multiple Dose Phase|Withdrawal by Subject|0
1295482|NCT00284089|4222283|P1|Multiple Dose Phase|Withdrawal by Subject|0
1295483|NCT00284089|4222280|P4|Multiple Dose Phase|Protocol Violation|0
1295484|NCT00284089|4222281|P3|Multiple Dose Phase|Protocol Violation|1
1295485|NCT00284089|4222282|P2|Multiple Dose Phase|Protocol Violation|0
1295486|NCT00284089|4222283|P1|Multiple Dose Phase|Protocol Violation|0
1295487|NCT00284089|4222280|P4|Multiple Dose Phase|Adverse Event|1
1295488|NCT00284089|4222281|P3|Multiple Dose Phase|Adverse Event|1
1295489|NCT00284089|4222282|P2|Multiple Dose Phase|Adverse Event|0
1295490|NCT00284089|4222283|P1|Multiple Dose Phase|Adverse Event|1
1295491|NCT00284050|4222312|P3|Overall Study|Death|0
1295492|NCT00284050|4222313|P2|Overall Study|Death|0
1295493|NCT00284050|4222314|P1|Overall Study|Death|1
1295494|NCT00284050|4222312|P3|Overall Study|Lost to Follow-up|1
1295495|NCT00284050|4222313|P2|Overall Study|Lost to Follow-up|0
1295496|NCT00284050|4222314|P1|Overall Study|Lost to Follow-up|1
1295497|NCT00284050|4222312|P3|Overall Study|Withdrawal by Subject|2
1295498|NCT00284050|4222313|P2|Overall Study|Withdrawal by Subject|2
1295499|NCT00284050|4222314|P1|Overall Study|Withdrawal by Subject|2
1295500|NCT00284050|4222312|P3|Overall Study|Protocol Violation|2
1295501|NCT00284050|4222313|P2|Overall Study|Protocol Violation|1
1295502|NCT00284050|4222314|P1|Overall Study|Protocol Violation|0
1295503|NCT00284050|4222312|P3|Overall Study|Lack of Efficacy|3
1295504|NCT00284050|4222313|P2|Overall Study|Lack of Efficacy|1
1295505|NCT00284050|4222314|P1|Overall Study|Lack of Efficacy|0
1295506|NCT00284050|4222312|P3|Overall Study|Adverse Event|1
1295507|NCT00284050|4222313|P2|Overall Study|Adverse Event|1
1295508|NCT00284050|4222314|P1|Overall Study|Adverse Event|1
1295509|NCT00283959|4222328|P1|Extension Period|Low Compliance|1
1295510|NCT00283868|4222340|P2|Overall Study|Lost to Follow-up|8
1295511|NCT00283868|4222341|P1|Overall Study|Lost to Follow-up|7
1295512|NCT00283842|4222358|P5|Overall Study|Lost to Follow-up|1
1295513|NCT00283842|4222359|P4|Overall Study|Lost to Follow-up|1
1295514|NCT00283842|4222360|P3|Overall Study|Lost to Follow-up|4
1295515|NCT00283842|4222361|P2|Overall Study|Lost to Follow-up|2
1295516|NCT00283842|4222362|P1|Overall Study|Lost to Follow-up|0
1295517|NCT00283842|4222358|P5|Overall Study|Lack of Efficacy|3
1295518|NCT00283842|4222359|P4|Overall Study|Lack of Efficacy|0
1295519|NCT00283842|4222360|P3|Overall Study|Lack of Efficacy|1
1295520|NCT00283842|4222361|P2|Overall Study|Lack of Efficacy|3
1295521|NCT00283842|4222362|P1|Overall Study|Lack of Efficacy|1
1295522|NCT00283842|4222358|P5|Overall Study|Withdrawal by Subject|4
1295523|NCT00283842|4222359|P4|Overall Study|Withdrawal by Subject|5
1295524|NCT00283842|4222360|P3|Overall Study|Withdrawal by Subject|1
1295525|NCT00283842|4222361|P2|Overall Study|Withdrawal by Subject|1
1295526|NCT00283842|4222362|P1|Overall Study|Withdrawal by Subject|2
1295527|NCT00283842|4222358|P5|Overall Study|Protocol deviation|2
1295528|NCT00283842|4222359|P4|Overall Study|Protocol deviation|0
1295529|NCT00283842|4222360|P3|Overall Study|Protocol deviation|0
1295530|NCT00283842|4222361|P2|Overall Study|Protocol deviation|0
1295531|NCT00283842|4222362|P1|Overall Study|Protocol deviation|0
1295532|NCT00283842|4222358|P5|Overall Study|Protocol Violation|0
1295533|NCT00283842|4222359|P4|Overall Study|Protocol Violation|0
1295534|NCT00283842|4222360|P3|Overall Study|Protocol Violation|4
1295535|NCT00283842|4222361|P2|Overall Study|Protocol Violation|5
1295536|NCT00283842|4222362|P1|Overall Study|Protocol Violation|1
1295537|NCT00283842|4222358|P5|Overall Study|Adverse Event|5
1295538|NCT00283842|4222359|P4|Overall Study|Adverse Event|21
1295539|NCT00283842|4222360|P3|Overall Study|Adverse Event|21
1295540|NCT00283842|4222361|P2|Overall Study|Adverse Event|7
1295541|NCT00283842|4222362|P1|Overall Study|Adverse Event|8
1295542|NCT00283803|4222394|P1|Overall Study|Withdrawal by Subject|4
1295543|NCT00283803|4222394|P1|Overall Study|Physician Decision|9
1295544|NCT00283712|4222402|P2|Overall Study|Death|1
1295545|NCT00283712|4222403|P1|Overall Study|Death|0
1295546|NCT00283686|4222441|P4|Overall Study|Less than full participation|12
1295547|NCT00283686|4222442|P3|Overall Study|Less than full participation|6
1295548|NCT00283686|4222443|P2|Overall Study|Less than full participation|9
1295549|NCT00283686|4222444|P1|Overall Study|Less than full participation|7
1295550|NCT00283686|4222441|P4|Overall Study|Lost to Follow-up|20
1295551|NCT00283686|4222442|P3|Overall Study|Lost to Follow-up|26
1295552|NCT00283686|4222443|P2|Overall Study|Lost to Follow-up|31
1295553|NCT00283686|4222444|P1|Overall Study|Lost to Follow-up|21
1295554|NCT00283686|4222441|P4|Overall Study|Death|0
1295555|NCT00283686|4222442|P3|Overall Study|Death|1
1295556|NCT00283686|4222443|P2|Overall Study|Death|1
1295557|NCT00283686|4222444|P1|Overall Study|Death|1
1295558|NCT00283595|4222488|P2|Overall Study|Withdrawal by Subject|2
1295559|NCT00283595|4222489|P1|Overall Study|Withdrawal by Subject|1
1295560|NCT00283439|4222514|P4|Overall Study|Not specified|0
1295561|NCT00283439|4222515|P3|Overall Study|Not specified|0
1295562|NCT00283439|4222516|P2|Overall Study|Not specified|0
1295563|NCT00283439|4222517|P1|Overall Study|Not specified|1
1295564|NCT00283439|4222514|P4|Overall Study|Treatment discontinued|3
1295565|NCT00283439|4222515|P3|Overall Study|Treatment discontinued|1
1295566|NCT00283439|4222516|P2|Overall Study|Treatment discontinued|2
1295567|NCT00283439|4222517|P1|Overall Study|Treatment discontinued|0
1295568|NCT00283439|4222514|P4|Overall Study|Stem cell transplant|3
1295569|NCT00283439|4222515|P3|Overall Study|Stem cell transplant|4
1295570|NCT00283439|4222516|P2|Overall Study|Stem cell transplant|6
1295571|NCT00283439|4222517|P1|Overall Study|Stem cell transplant|6
1295572|NCT00283439|4222514|P4|Overall Study|Requirement for alternative therapy|2
1295573|NCT00283439|4222515|P3|Overall Study|Requirement for alternative therapy|5
1295574|NCT00283439|4222516|P2|Overall Study|Requirement for alternative therapy|2
1295575|NCT00283439|4222517|P1|Overall Study|Requirement for alternative therapy|1
1295576|NCT00283439|4222514|P4|Overall Study|Disease progression|0
1295577|NCT00283439|4222515|P3|Overall Study|Disease progression|0
1295578|NCT00283439|4222516|P2|Overall Study|Disease progression|1
1295579|NCT00283439|4222517|P1|Overall Study|Disease progression|0
1295580|NCT00283439|4222514|P4|Overall Study|Death|0
1295581|NCT00283439|4222515|P3|Overall Study|Death|1
1295582|NCT00283439|4222516|P2|Overall Study|Death|0
1295583|NCT00283439|4222517|P1|Overall Study|Death|0
1295584|NCT00283439|4222514|P4|Overall Study|Adverse Event|1
1295585|NCT00283439|4222515|P3|Overall Study|Adverse Event|0
1295586|NCT00283439|4222516|P2|Overall Study|Adverse Event|0
1295587|NCT00283439|4222517|P1|Overall Study|Adverse Event|0
1295588|NCT00283400|4222543|P4|Overall Study|Death|0
1295589|NCT00283400|4222544|P3|Overall Study|Death|1
1295590|NCT00283400|4222545|P2|Overall Study|Death|0
1295591|NCT00283400|4222546|P1|Overall Study|Death|1
1295592|NCT00283400|4222543|P4|Overall Study|Withdrawal by Subject|0
1295593|NCT00283400|4222544|P3|Overall Study|Withdrawal by Subject|0
1295594|NCT00283400|4222545|P2|Overall Study|Withdrawal by Subject|1
1295595|NCT00283400|4222546|P1|Overall Study|Withdrawal by Subject|1
1295596|NCT00283387|4222564|P2|First Intervention|Withdrawal by Subject|1
1295597|NCT00283387|4222565|P1|First Intervention|Withdrawal by Subject|0
1295598|NCT00283387|4222564|P2|First Intervention|Subject non-compliant|1
1295599|NCT00283387|4222565|P1|First Intervention|Subject non-compliant|1
1295600|NCT00283296|4222571|P1|Overall Study|in-home trial not completed|5
1295601|NCT00283244|4222580|P3|Overall Study|Clinical deterioration|3
1295602|NCT00283244|4222581|P2|Overall Study|Clinical deterioration|3
1295603|NCT00283244|4222582|P1|Overall Study|Clinical deterioration|1
1295604|NCT00283244|4222580|P3|Overall Study|Medical illness (other complicating dz)|6
1295605|NCT00283244|4222581|P2|Overall Study|Medical illness (other complicating dz)|3
1295606|NCT00283244|4222582|P1|Overall Study|Medical illness (other complicating dz)|4
1295607|NCT00283244|4222580|P3|Overall Study|Physician Decision|1
1295608|NCT00283244|4222581|P2|Overall Study|Physician Decision|0
1295609|NCT00283244|4222582|P1|Overall Study|Physician Decision|0
1295610|NCT00283244|4222580|P3|Overall Study|Withdrawal by Subject|2
1295611|NCT00283244|4222581|P2|Overall Study|Withdrawal by Subject|2
1295612|NCT00283244|4222582|P1|Overall Study|Withdrawal by Subject|1
1295613|NCT00283244|4222580|P3|Overall Study|Lack of Efficacy|26
1295614|NCT00283244|4222581|P2|Overall Study|Lack of Efficacy|32
1295615|NCT00283244|4222582|P1|Overall Study|Lack of Efficacy|8
1295616|NCT00283244|4222580|P3|Overall Study|Death|2
1295617|NCT00283244|4222581|P2|Overall Study|Death|3
1295618|NCT00283244|4222582|P1|Overall Study|Death|4
1295619|NCT00283244|4222580|P3|Overall Study|Adverse Event|11
1295620|NCT00283244|4222581|P2|Overall Study|Adverse Event|8
1295621|NCT00283244|4222582|P1|Overall Study|Adverse Event|0
1295622|NCT00283062|4222618|P4|Overall Study|chemotherapy not completed (cycle 6)|0
1295623|NCT00283062|4222619|P3|Overall Study|chemotherapy not completed (cycle 6)|0
1295624|NCT00283062|4222620|P2|Overall Study|chemotherapy not completed (cycle 6)|0
1295625|NCT00283062|4222621|P1|Overall Study|chemotherapy not completed (cycle 6)|1
1295626|NCT00283062|4222618|P4|Overall Study|Undefined|4
1295627|NCT00283062|4222619|P3|Overall Study|Undefined|1
1295628|NCT00283062|4222620|P2|Overall Study|Undefined|1
1295629|NCT00283062|4222621|P1|Overall Study|Undefined|0
1295630|NCT00283062|4222618|P4|Overall Study|Participant did not wish to continue|0
1295631|NCT00283062|4222619|P3|Overall Study|Participant did not wish to continue|1
1295632|NCT00283062|4222620|P2|Overall Study|Participant did not wish to continue|2
1295633|NCT00283062|4222621|P1|Overall Study|Participant did not wish to continue|3
1295634|NCT00283062|4222618|P4|Overall Study|Progressive disease|0
1295635|NCT00283062|4222619|P3|Overall Study|Progressive disease|1
1295636|NCT00283062|4222620|P2|Overall Study|Progressive disease|0
1295637|NCT00283062|4222621|P1|Overall Study|Progressive disease|0
1295638|NCT00283062|4222618|P4|Overall Study|Lost to Follow-up|0
1295639|NCT00283062|4222619|P3|Overall Study|Lost to Follow-up|1
1295640|NCT00283062|4222620|P2|Overall Study|Lost to Follow-up|0
1295641|NCT00283062|4222621|P1|Overall Study|Lost to Follow-up|1
1295642|NCT00283062|4222618|P4|Overall Study|Adverse Event|0
1295643|NCT00283062|4222619|P3|Overall Study|Adverse Event|1
1295644|NCT00283062|4222620|P2|Overall Study|Adverse Event|0
1295645|NCT00283062|4222621|P1|Overall Study|Adverse Event|2
1295646|NCT00283062|4222618|P4|Overall Study|Did not receive any study medication|45
1295647|NCT00283062|4222619|P3|Overall Study|Did not receive any study medication|36
1295648|NCT00283062|4222620|P2|Overall Study|Did not receive any study medication|4
1295649|NCT00283062|4222621|P1|Overall Study|Did not receive any study medication|5
1295650|NCT00283049|4222654|P3|Overall Study|No longer requires study treatment|1
1295651|NCT00283049|4222655|P2|Overall Study|No longer requires study treatment|0
1295652|NCT00283049|4222656|P1|Overall Study|No longer requires study treatment|0
1295653|NCT00283049|4222654|P3|Overall Study|Discontinuation of Study|20
1295654|NCT00283049|4222655|P2|Overall Study|Discontinuation of Study|16
1295655|NCT00283049|4222656|P1|Overall Study|Discontinuation of Study|18
1295656|NCT00283049|4222654|P3|Overall Study|Withdrawal by Subject|19
1295657|NCT00283049|4222655|P2|Overall Study|Withdrawal by Subject|24
1295658|NCT00283049|4222656|P1|Overall Study|Withdrawal by Subject|26
1295659|NCT00283049|4222654|P3|Overall Study|Lost to Follow-up|5
1295660|NCT00283049|4222655|P2|Overall Study|Lost to Follow-up|2
1295661|NCT00283049|4222656|P1|Overall Study|Lost to Follow-up|4
1295662|NCT00283049|4222654|P3|Overall Study|Lack of Efficacy|1
1295663|NCT00283049|4222655|P2|Overall Study|Lack of Efficacy|1
1295664|NCT00283049|4222656|P1|Overall Study|Lack of Efficacy|0
1295665|NCT00283049|4222654|P3|Overall Study|Death|1
1295666|NCT00283049|4222655|P2|Overall Study|Death|1
1295667|NCT00283049|4222656|P1|Overall Study|Death|1
1295668|NCT00283049|4222654|P3|Overall Study|Protocol Violation|3
1295669|NCT00283049|4222655|P2|Overall Study|Protocol Violation|0
1295670|NCT00283049|4222656|P1|Overall Study|Protocol Violation|3
1295671|NCT00283049|4222654|P3|Overall Study|Adverse Event|4
1295672|NCT00283049|4222655|P2|Overall Study|Adverse Event|1
1295673|NCT00283049|4222656|P1|Overall Study|Adverse Event|6
1295674|NCT00282984|4222684|P2|Overall Study|Protocol Violation|0
1295675|NCT00282984|4222685|P1|Overall Study|Protocol Violation|2
1295676|NCT00282984|4222684|P2|Overall Study|in prison|1
1295677|NCT00282984|4222685|P1|Overall Study|in prison|0
1295678|NCT00282984|4222684|P2|Overall Study|lack of motivation|0
1295679|NCT00282984|4222685|P1|Overall Study|lack of motivation|1
1295680|NCT00282984|4222684|P2|Overall Study|Participant used antipsychosis meds|1
1295681|NCT00282984|4222685|P1|Overall Study|Participant used antipsychosis meds|0
1295682|NCT00282984|4222684|P2|Overall Study|Participant only allowed phone follow-up|1
1295683|NCT00282984|4222685|P1|Overall Study|Participant only allowed phone follow-up|0
1295684|NCT00282984|4222684|P2|Overall Study|Participant stopped study medication|2
1295685|NCT00282984|4222685|P1|Overall Study|Participant stopped study medication|2
1295686|NCT00282984|4222684|P2|Overall Study|Withdrawal by Participant|34
1295687|NCT00282984|4222685|P1|Overall Study|Withdrawal by Participant|22
1295688|NCT00282984|4222684|P2|Overall Study|Lost to Follow-up|10
1295689|NCT00282984|4222685|P1|Overall Study|Lost to Follow-up|14
1295690|NCT00282984|4222684|P2|Overall Study|Lack of Efficacy|2
1295691|NCT00282984|4222685|P1|Overall Study|Lack of Efficacy|0
1295692|NCT00282984|4222684|P2|Overall Study|Adverse Event|5
1295693|NCT00282984|4222685|P1|Overall Study|Adverse Event|8
1295694|NCT00282984|4222684|P2|Overall Study|Death|5
1295695|NCT00282984|4222685|P1|Overall Study|Death|2
1295696|NCT00282919|4222722|P1|Overall Study|Asymptomatic Parasitemia|2
1295697|NCT00282919|4222722|P1|Overall Study|Withdrawal by Subject|1
1295698|NCT00282919|4222722|P1|Overall Study|Lack of Efficacy|4
1295699|NCT00282867|4222737|P3|Overall Study|d/c prior to prim outcome, 3 m f/u done|0
1295700|NCT00282867|4222738|P2|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
1295701|NCT00282867|4222739|P1|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
1295702|NCT00282568|4222836|P1|Extended Treatment Period|Lost to Follow-up|2
1295703|NCT00282568|4222836|P1|Extended Treatment Period|Physician Decision|1
1295704|NCT00282568|4222836|P1|Extended Treatment Period|Non-compliance|4
1295705|NCT00282568|4222836|P1|Extended Treatment Period|Adverse Event|17
1295706|NCT00282568|4222836|P1|Pharmacokinetic Treatment Period|Enrolled erroneously|1
1295707|NCT00282568|4222836|P1|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2
1295708|NCT00282464|4222862|P2|Overall Study|dropped due to missed visits|1
1295709|NCT00282464|4222863|P1|Overall Study|dropped due to missed visits|0
1295710|NCT00282464|4222862|P2|Overall Study|dispensed wrong kit|1
1295711|NCT00282464|4222863|P1|Overall Study|dispensed wrong kit|0
1295712|NCT00282464|4222862|P2|Overall Study|family crisis|1
1295713|NCT00282464|4222863|P1|Overall Study|family crisis|0
1295714|NCT00282464|4222862|P2|Overall Study|patient incarcerated|1
1295715|NCT00282464|4222863|P1|Overall Study|patient incarcerated|0
1295716|NCT00282464|4222862|P2|Overall Study|patient no show|1
1295717|NCT00282464|4222863|P1|Overall Study|patient no show|0
1295718|NCT00282464|4222862|P2|Overall Study|patient non-compliant|0
1295719|NCT00282464|4222863|P1|Overall Study|patient non-compliant|3
1295720|NCT00282464|4222862|P2|Overall Study|Patient moved|0
1295721|NCT00282464|4222863|P1|Overall Study|Patient moved|1
1295722|NCT00282464|4222862|P2|Overall Study|Protocol Violation|7
1295723|NCT00282464|4222863|P1|Overall Study|Protocol Violation|0
1295724|NCT00282464|4222862|P2|Overall Study|laboratory abnormality|2
1295725|NCT00282464|4222863|P1|Overall Study|laboratory abnormality|1
1295726|NCT00282464|4222862|P2|Overall Study|Withdrawal by Subject|10
1295727|NCT00282464|4222863|P1|Overall Study|Withdrawal by Subject|24
1295728|NCT00282464|4222862|P2|Overall Study|Lost to Follow-up|10
1295729|NCT00282464|4222863|P1|Overall Study|Lost to Follow-up|10
1295730|NCT00282464|4222862|P2|Overall Study|Lack of Efficacy|8
1295731|NCT00282464|4222863|P1|Overall Study|Lack of Efficacy|8
1295732|NCT00282464|4222862|P2|Overall Study|Adverse Event|20
1295733|NCT00282464|4222863|P1|Overall Study|Adverse Event|26
1295734|NCT00282438|4222913|P2|Overall Study|Death|1
1295735|NCT00282438|4222914|P1|Overall Study|Death|0
1295736|NCT00282438|4222913|P2|Overall Study|Lack of Efficacy|0
1295737|NCT00282438|4222914|P1|Overall Study|Lack of Efficacy|1
1295738|NCT00282412|4222924|P1|Overall Study|Death|2
1295739|NCT00282347|4222930|P2|B Cell Follow-up Period|Reason Not Specified|0
1295740|NCT00282347|4222931|P1|B Cell Follow-up Period|Reason Not Specified|2
1295741|NCT00282347|4222930|P2|B Cell Follow-up Period|Physician Decision|0
1295742|NCT00282347|4222931|P1|B Cell Follow-up Period|Physician Decision|1
1295743|NCT00282347|4222930|P2|B Cell Follow-up Period|Withdrawal by Subject|0
1295744|NCT00282347|4222931|P1|B Cell Follow-up Period|Withdrawal by Subject|2
1295745|NCT00282347|4222930|P2|Safety Follow-up Period|Protocol Deviation|2
1295746|NCT00282347|4222931|P1|Safety Follow-up Period|Protocol Deviation|0
1295747|NCT00282347|4222930|P2|Safety Follow-up Period|Physician Decision|1
1295748|NCT00282347|4222931|P1|Safety Follow-up Period|Physician Decision|1
1295749|NCT00282347|4222930|P2|Safety Follow-up Period|Withdrawal by Subject|1
1295750|NCT00282347|4222931|P1|Safety Follow-up Period|Withdrawal by Subject|2
1295751|NCT00282347|4222930|P2|Safety Follow-up Period|Lost to Follow-up|2
1295752|NCT00282347|4222931|P1|Safety Follow-up Period|Lost to Follow-up|0
1295753|NCT00282347|4222930|P2|Treatment Period|Physician Decision|1
1295754|NCT00282347|4222931|P1|Treatment Period|Physician Decision|0
1295755|NCT00282347|4222930|P2|Treatment Period|Withdrawal by Subject|3
1295756|NCT00282347|4222931|P1|Treatment Period|Withdrawal by Subject|1
1295757|NCT00282347|4222930|P2|Treatment Period|Lost to Follow-up|5
1295758|NCT00282347|4222931|P1|Treatment Period|Lost to Follow-up|2
1295759|NCT00282347|4222930|P2|Treatment Period|Death|0
1295760|NCT00282347|4222931|P1|Treatment Period|Death|2
1295761|NCT00282334|4222957|P2|Overall Study|Withdrawal by Subject|5
1295762|NCT00282334|4222958|P1|Overall Study|Withdrawal by Subject|8
1295763|NCT00282308|4222966|P3|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12
1295764|NCT00282308|4222967|P2|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
1295765|NCT00282308|4222968|P1|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
1295766|NCT00282308|4222966|P3|Safety Follow-up Period|Physician Decision to Withdraw|1
1295767|NCT00282308|4222967|P2|Safety Follow-up Period|Physician Decision to Withdraw|0
1295768|NCT00282308|4222968|P1|Safety Follow-up Period|Physician Decision to Withdraw|0
1295769|NCT00282308|4222966|P3|Safety Follow-up Period|Lost to Follow-up|5
1295770|NCT00282308|4222967|P2|Safety Follow-up Period|Lost to Follow-up|0
1295771|NCT00282308|4222968|P1|Safety Follow-up Period|Lost to Follow-up|0
1295772|NCT00282308|4222966|P3|Safety Follow-up Period|Adverse Event|1
1295773|NCT00282308|4222967|P2|Safety Follow-up Period|Adverse Event|0
1295774|NCT00282308|4222968|P1|Safety Follow-up Period|Adverse Event|0
1295775|NCT00282308|4222966|P3|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1
1295776|NCT00282308|4222967|P2|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
1295777|NCT00282308|4222968|P1|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
1295778|NCT00282308|4222966|P3|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1
1295779|NCT00282308|4222967|P2|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
1295780|NCT00282308|4222968|P1|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
1295781|NCT00282308|4222966|P3|Optional Extension Re-treatment Period|Adverse Event|4
1295782|NCT00282308|4222967|P2|Optional Extension Re-treatment Period|Adverse Event|0
1295783|NCT00282308|4222968|P1|Optional Extension Re-treatment Period|Adverse Event|0
1295784|NCT00282308|4222966|P3|Treatment Period|Not Treated with Study Drug|0
1295785|NCT00282308|4222967|P2|Treatment Period|Not Treated with Study Drug|0
1295786|NCT00282308|4222968|P1|Treatment Period|Not Treated with Study Drug|1
1295787|NCT00282308|4222966|P3|Treatment Period|Adverse Event|0
1295788|NCT00282308|4222967|P2|Treatment Period|Adverse Event|2
1295789|NCT00282308|4222968|P1|Treatment Period|Adverse Event|0
1295790|NCT00282308|4222966|P3|Treatment Period|Subject/Guardian Decision to Withdraw|0
1295791|NCT00282308|4222967|P2|Treatment Period|Subject/Guardian Decision to Withdraw|4
1295792|NCT00282308|4222968|P1|Treatment Period|Subject/Guardian Decision to Withdraw|2
1295793|NCT00282308|4222966|P3|Treatment Period|Lost to Follow-up|0
1295794|NCT00282308|4222967|P2|Treatment Period|Lost to Follow-up|0
1295795|NCT00282308|4222968|P1|Treatment Period|Lost to Follow-up|1
1295796|NCT00282295|4222998|P3|Overall Study|Other|0
1295797|NCT00282295|4222999|P2|Overall Study|Other|1
1295798|NCT00282295|4223000|P1|Overall Study|Other|0
1295799|NCT00282295|4222998|P3|Overall Study|Lost to Follow-up|2
1295800|NCT00282295|4222999|P2|Overall Study|Lost to Follow-up|7
1295801|NCT00282295|4223000|P1|Overall Study|Lost to Follow-up|1
1295802|NCT00282295|4222998|P3|Overall Study|Withdrawal by Subject|4
1295803|NCT00282295|4222999|P2|Overall Study|Withdrawal by Subject|6
1295804|NCT00282295|4223000|P1|Overall Study|Withdrawal by Subject|2
1295805|NCT00282295|4222998|P3|Overall Study|Protocol Violation|1
1295806|NCT00282295|4222999|P2|Overall Study|Protocol Violation|2
1295807|NCT00282295|4223000|P1|Overall Study|Protocol Violation|0
1295808|NCT00282295|4222998|P3|Overall Study|Serious Adverse Events|1
1295809|NCT00282295|4222999|P2|Overall Study|Serious Adverse Events|0
1295810|NCT00282295|4223000|P1|Overall Study|Serious Adverse Events|0
1295811|NCT00282295|4222998|P3|Overall Study|Adverse Event|0
1295812|NCT00282295|4222999|P2|Overall Study|Adverse Event|1
1295813|NCT00282295|4223000|P1|Overall Study|Adverse Event|0
1295814|NCT00282256|4223055|P1|Extension Treatment Period|Adverse Event|2
1295815|NCT00282256|4223055|P1|Pharmacokinetic Treatment Period|Poor venous access|1
1295816|NCT00282243|4223076|P1|Extension Treatment Period|Physician Decision|1
1295817|NCT00282243|4223076|P1|Extension Treatment Period|Non-compliance|2
1295818|NCT00282243|4223076|P1|Extension Treatment Period|Withdrawal by Subject|4
1295819|NCT00282243|4223076|P1|Extension Treatment Period|Adverse Event|15
1295820|NCT00282243|4223076|P1|Pharmacokinetic Treatment Period|Withdrawal by Subject|2
1295821|NCT00282243|4223076|P1|Pharmacokinetic Treatment Period|Adverse Event|3
1295822|NCT00282152|4223102|P2|Overall Study|Withdrawal by Subject|0
1295823|NCT00282152|4223103|P1|Overall Study|Withdrawal by Subject|1
1295824|NCT00282113|4223124|P3|Overall Study|Removed at parents request|0
1295825|NCT00282113|4223125|P2|Overall Study|Removed at parents request|0
1295826|NCT00282113|4223126|P1|Overall Study|Removed at parents request|1
1295827|NCT00282087|4223140|P1|Overall Study|Death|1
1295828|NCT00282048|4223153|P1|Overall Study|Ongoing|1
1295829|NCT00282048|4223153|P1|Overall Study|Other|8
1295830|NCT00282048|4223153|P1|Overall Study|Withdrawal by Subject|1
1295831|NCT00282048|4223153|P1|Overall Study|Adverse Event|22
1295832|NCT00282048|4223153|P1|Overall Study|Lack of Efficacy|30
1295833|NCT00281957|4223167|P2|Overall Study|Refusal unrelated to adverse events|1
1295834|NCT00281957|4223168|P1|Overall Study|Refusal unrelated to adverse events|0
1295835|NCT00281957|4223167|P2|Overall Study|Did not start treatment|1
1295836|NCT00281957|4223168|P1|Overall Study|Did not start treatment|3
1295837|NCT00281957|4223167|P2|Overall Study|Not eligible|2
1295838|NCT00281957|4223168|P1|Overall Study|Not eligible|1
1295839|NCT00281957|4223167|P2|Overall Study|Not protocol specified|1
1295840|NCT00281957|4223168|P1|Overall Study|Not protocol specified|8
1295841|NCT00281957|4223167|P2|Overall Study|Progression/relapse|35
1295842|NCT00281957|4223168|P1|Overall Study|Progression/relapse|47
1295843|NCT00281957|4223167|P2|Overall Study|Death|0
1295844|NCT00281957|4223168|P1|Overall Study|Death|1
1295845|NCT00281957|4223167|P2|Overall Study|Adverse Event|2
1295846|NCT00281957|4223168|P1|Overall Study|Adverse Event|7
1295847|NCT00281840|4223242|P1|Overall Study|Complicating Disease|1
1295848|NCT00281840|4223242|P1|Overall Study|exceed maximum delay in treatment|1
1295849|NCT00281840|4223242|P1|Overall Study|Disease Progression|2
1295850|NCT00281840|4223242|P1|Overall Study|Withdrawal by Subject|3
1295851|NCT00281840|4223242|P1|Overall Study|Physician Decision|6
1295852|NCT00281840|4223242|P1|Overall Study|Adverse Event|12
1295853|NCT00281697|4223258|P2|Overall Study|Did not receive study drug|2
1295854|NCT00281697|4223259|P1|Overall Study|Did not receive study drug|3
1295855|NCT00281697|4223258|P2|Overall Study|Subject/guardian's decision to withdraw|6
1295856|NCT00281697|4223259|P1|Overall Study|Subject/guardian's decision to withdraw|33
1295857|NCT00281697|4223258|P2|Overall Study|Physician's decision to withdraw|12
1295858|NCT00281697|4223259|P1|Overall Study|Physician's decision to withdraw|15
1295859|NCT00281697|4223258|P2|Overall Study|Not specified|6
1295860|NCT00281697|4223259|P1|Overall Study|Not specified|5
1295861|NCT00281697|4223258|P2|Overall Study|Disease progression|149
1295862|NCT00281697|4223259|P1|Overall Study|Disease progression|279
1295863|NCT00281697|4223258|P2|Overall Study|Death|3
1295864|NCT00281697|4223259|P1|Overall Study|Death|8
1295865|NCT00281697|4223258|P2|Overall Study|Adverse Event|15
1295866|NCT00281697|4223259|P1|Overall Study|Adverse Event|54
1295867|NCT00281697|4223258|P2|Overall Study|> 60 days since last dose of study drug|4
1295868|NCT00281697|4223259|P1|Overall Study|> 60 days since last dose of study drug|4
1295869|NCT00281658|4223277|P3|Open-label Monotherapy Extension Phase|Withdrawal by Subject|1
1295870|NCT00281658|4223278|P2|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
1295871|NCT00281658|4223279|P1|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
1295872|NCT00281658|4223277|P3|Open-label Monotherapy Extension Phase|Lost to Follow-up|3
1295873|NCT00281658|4223278|P2|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
1295874|NCT00281658|4223279|P1|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
1295875|NCT00281658|4223277|P3|Open-label Monotherapy Extension Phase|Death|97
1295876|NCT00281658|4223278|P2|Open-label Monotherapy Extension Phase|Death|0
1295877|NCT00281658|4223279|P1|Open-label Monotherapy Extension Phase|Death|0
1295878|NCT00281658|4223277|P3|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
1295879|NCT00281658|4223278|P2|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|1
1295963|NCT00281580|4223338|P16|Overall Study|Protocol Violation|3
1295880|NCT00281658|4223279|P1|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
1295881|NCT00281658|4223277|P3|Double-blind, Randomized Phase|Participant Entered New Protocol|0
1295882|NCT00281658|4223278|P2|Double-blind, Randomized Phase|Participant Entered New Protocol|1
1295883|NCT00281658|4223279|P1|Double-blind, Randomized Phase|Participant Entered New Protocol|1
1295884|NCT00281658|4223277|P3|Double-blind, Randomized Phase|Withdrawal by Subject|0
1295885|NCT00281658|4223278|P2|Double-blind, Randomized Phase|Withdrawal by Subject|1
1295886|NCT00281658|4223279|P1|Double-blind, Randomized Phase|Withdrawal by Subject|4
1295887|NCT00281658|4223277|P3|Double-blind, Randomized Phase|Lost to Follow-up|0
1295888|NCT00281658|4223278|P2|Double-blind, Randomized Phase|Lost to Follow-up|5
1295889|NCT00281658|4223279|P1|Double-blind, Randomized Phase|Lost to Follow-up|12
1295890|NCT00281658|4223277|P3|Double-blind, Randomized Phase|Death|0
1295891|NCT00281658|4223278|P2|Double-blind, Randomized Phase|Death|46
1295892|NCT00281658|4223279|P1|Double-blind, Randomized Phase|Death|120
1295893|NCT00281632|4223296|P1|Overall Study|Ongoing|3
1295894|NCT00281632|4223296|P1|Overall Study|Physician Decision|1
1295895|NCT00281632|4223296|P1|Overall Study|Death|1
1295896|NCT00281632|4223296|P1|Overall Study|Disease Progression|22
1295897|NCT00281632|4223296|P1|Overall Study|Withdrawal by Subject|2
1295898|NCT00281632|4223296|P1|Overall Study|Adverse Event|7
1295899|NCT00281580|4223338|P16|Overall Study|Randomised in error; pregnancy; moving|2
1295900|NCT00281580|4223339|P15|Overall Study|Randomised in error; pregnancy; moving|1
1295901|NCT00281580|4223340|P14|Overall Study|Randomised in error; pregnancy; moving|0
1295902|NCT00281580|4223341|P13|Overall Study|Randomised in error; pregnancy; moving|2
1295903|NCT00281580|4223342|P12|Overall Study|Randomised in error; pregnancy; moving|1
1295904|NCT00281580|4223343|P11|Overall Study|Randomised in error; pregnancy; moving|1
1295905|NCT00281580|4223344|P10|Overall Study|Randomised in error; pregnancy; moving|1
1295906|NCT00281580|4223345|P9|Overall Study|Randomised in error; pregnancy; moving|2
1295907|NCT00281580|4223346|P8|Overall Study|Randomised in error; pregnancy; moving|0
1295908|NCT00281580|4223347|P7|Overall Study|Randomised in error; pregnancy; moving|1
1295909|NCT00281580|4223348|P6|Overall Study|Randomised in error; pregnancy; moving|0
1295910|NCT00281580|4223349|P5|Overall Study|Randomised in error; pregnancy; moving|0
1295911|NCT00281580|4223350|P4|Overall Study|Randomised in error; pregnancy; moving|2
1295912|NCT00281580|4223351|P3|Overall Study|Randomised in error; pregnancy; moving|0
1295913|NCT00281580|4223352|P2|Overall Study|Randomised in error; pregnancy; moving|0
1295914|NCT00281580|4223353|P1|Overall Study|Randomised in error; pregnancy; moving|0
1295915|NCT00281580|4223338|P16|Overall Study|Lost to Follow-up|0
1295916|NCT00281580|4223339|P15|Overall Study|Lost to Follow-up|0
1295917|NCT00281580|4223340|P14|Overall Study|Lost to Follow-up|0
1295918|NCT00281580|4223341|P13|Overall Study|Lost to Follow-up|1
1295919|NCT00281580|4223342|P12|Overall Study|Lost to Follow-up|0
1295920|NCT00281580|4223343|P11|Overall Study|Lost to Follow-up|1
1295921|NCT00281580|4223344|P10|Overall Study|Lost to Follow-up|1
1295922|NCT00281580|4223345|P9|Overall Study|Lost to Follow-up|2
1295923|NCT00281580|4223346|P8|Overall Study|Lost to Follow-up|1
1295924|NCT00281580|4223347|P7|Overall Study|Lost to Follow-up|0
1295925|NCT00281580|4223348|P6|Overall Study|Lost to Follow-up|1
1295926|NCT00281580|4223349|P5|Overall Study|Lost to Follow-up|0
1295927|NCT00281580|4223350|P4|Overall Study|Lost to Follow-up|3
1295928|NCT00281580|4223351|P3|Overall Study|Lost to Follow-up|0
1295929|NCT00281580|4223352|P2|Overall Study|Lost to Follow-up|0
1295930|NCT00281580|4223353|P1|Overall Study|Lost to Follow-up|0
1295931|NCT00281580|4223338|P16|Overall Study|Lack of Efficacy|0
1295932|NCT00281580|4223339|P15|Overall Study|Lack of Efficacy|1
1295933|NCT00281580|4223340|P14|Overall Study|Lack of Efficacy|2
1295934|NCT00281580|4223341|P13|Overall Study|Lack of Efficacy|0
1295935|NCT00281580|4223342|P12|Overall Study|Lack of Efficacy|1
1295936|NCT00281580|4223343|P11|Overall Study|Lack of Efficacy|0
1295937|NCT00281580|4223344|P10|Overall Study|Lack of Efficacy|0
1295938|NCT00281580|4223345|P9|Overall Study|Lack of Efficacy|0
1295939|NCT00281580|4223346|P8|Overall Study|Lack of Efficacy|0
1295940|NCT00281580|4223347|P7|Overall Study|Lack of Efficacy|0
1295941|NCT00281580|4223348|P6|Overall Study|Lack of Efficacy|0
1295942|NCT00281580|4223349|P5|Overall Study|Lack of Efficacy|2
1295943|NCT00281580|4223350|P4|Overall Study|Lack of Efficacy|6
1295944|NCT00281580|4223351|P3|Overall Study|Lack of Efficacy|1
1295945|NCT00281580|4223352|P2|Overall Study|Lack of Efficacy|1
1295946|NCT00281580|4223353|P1|Overall Study|Lack of Efficacy|2
1295947|NCT00281580|4223338|P16|Overall Study|Withdrawal by Subject|5
1295948|NCT00281580|4223339|P15|Overall Study|Withdrawal by Subject|1
1295949|NCT00281580|4223340|P14|Overall Study|Withdrawal by Subject|2
1295950|NCT00281580|4223341|P13|Overall Study|Withdrawal by Subject|2
1295951|NCT00281580|4223342|P12|Overall Study|Withdrawal by Subject|1
1295952|NCT00281580|4223343|P11|Overall Study|Withdrawal by Subject|1
1295953|NCT00281580|4223344|P10|Overall Study|Withdrawal by Subject|4
1295954|NCT00281580|4223345|P9|Overall Study|Withdrawal by Subject|1
1295955|NCT00281580|4223346|P8|Overall Study|Withdrawal by Subject|0
1295956|NCT00281580|4223347|P7|Overall Study|Withdrawal by Subject|2
1295957|NCT00281580|4223348|P6|Overall Study|Withdrawal by Subject|2
1295958|NCT00281580|4223349|P5|Overall Study|Withdrawal by Subject|1
1295959|NCT00281580|4223350|P4|Overall Study|Withdrawal by Subject|1
1295960|NCT00281580|4223351|P3|Overall Study|Withdrawal by Subject|1
1295961|NCT00281580|4223352|P2|Overall Study|Withdrawal by Subject|0
1295962|NCT00281580|4223353|P1|Overall Study|Withdrawal by Subject|3
1295964|NCT00281580|4223339|P15|Overall Study|Protocol Violation|1
1295965|NCT00281580|4223340|P14|Overall Study|Protocol Violation|1
1295966|NCT00281580|4223341|P13|Overall Study|Protocol Violation|0
1295967|NCT00281580|4223342|P12|Overall Study|Protocol Violation|2
1295968|NCT00281580|4223343|P11|Overall Study|Protocol Violation|1
1295969|NCT00281580|4223344|P10|Overall Study|Protocol Violation|0
1295970|NCT00281580|4223345|P9|Overall Study|Protocol Violation|2
1295971|NCT00281580|4223346|P8|Overall Study|Protocol Violation|0
1295972|NCT00281580|4223347|P7|Overall Study|Protocol Violation|1
1295973|NCT00281580|4223348|P6|Overall Study|Protocol Violation|0
1295974|NCT00281580|4223349|P5|Overall Study|Protocol Violation|0
1295975|NCT00281580|4223350|P4|Overall Study|Protocol Violation|1
1295976|NCT00281580|4223351|P3|Overall Study|Protocol Violation|1
1295977|NCT00281580|4223352|P2|Overall Study|Protocol Violation|0
1295978|NCT00281580|4223353|P1|Overall Study|Protocol Violation|0
1295979|NCT00281580|4223338|P16|Overall Study|Adverse Event|3
1295980|NCT00281580|4223339|P15|Overall Study|Adverse Event|3
1295981|NCT00281580|4223340|P14|Overall Study|Adverse Event|2
1295982|NCT00281580|4223341|P13|Overall Study|Adverse Event|8
1295983|NCT00281580|4223342|P12|Overall Study|Adverse Event|5
1295984|NCT00281580|4223343|P11|Overall Study|Adverse Event|0
1295985|NCT00281580|4223344|P10|Overall Study|Adverse Event|6
1295986|NCT00281580|4223345|P9|Overall Study|Adverse Event|1
1295987|NCT00281580|4223346|P8|Overall Study|Adverse Event|0
1295988|NCT00281580|4223347|P7|Overall Study|Adverse Event|1
1295989|NCT00281580|4223348|P6|Overall Study|Adverse Event|0
1295990|NCT00281580|4223349|P5|Overall Study|Adverse Event|1
1295991|NCT00281580|4223350|P4|Overall Study|Adverse Event|4
1295992|NCT00281580|4223351|P3|Overall Study|Adverse Event|2
1295993|NCT00281580|4223352|P2|Overall Study|Adverse Event|0
1295994|NCT00281580|4223353|P1|Overall Study|Adverse Event|2
1295995|NCT00281528|4223700|P3|Overall Study|Other|5
1295996|NCT00281528|4223701|P2|Overall Study|Other|3
1295997|NCT00281528|4223702|P1|Overall Study|Other|6
1295998|NCT00281528|4223700|P3|Overall Study|Withdrawal by Subject|7
1295999|NCT00281528|4223701|P2|Overall Study|Withdrawal by Subject|5
1296000|NCT00281528|4223702|P1|Overall Study|Withdrawal by Subject|5
1296001|NCT00281528|4223700|P3|Overall Study|Protocol Violation|1
1296002|NCT00281528|4223701|P2|Overall Study|Protocol Violation|0
1296003|NCT00281528|4223702|P1|Overall Study|Protocol Violation|1
1296004|NCT00281528|4223700|P3|Overall Study|Physician Decision|5
1296005|NCT00281528|4223701|P2|Overall Study|Physician Decision|4
1296006|NCT00281528|4223702|P1|Overall Study|Physician Decision|11
1296007|NCT00281528|4223700|P3|Overall Study|Adverse Event-unrelated to treatment|2
1296008|NCT00281528|4223701|P2|Overall Study|Adverse Event-unrelated to treatment|0
1296009|NCT00281528|4223702|P1|Overall Study|Adverse Event-unrelated to treatment|3
1296010|NCT00281528|4223700|P3|Overall Study|Unacceptable Toxicity-related to trt|32
1296011|NCT00281528|4223701|P2|Overall Study|Unacceptable Toxicity-related to trt|24
1296012|NCT00281528|4223702|P1|Overall Study|Unacceptable Toxicity-related to trt|21
1296013|NCT00281528|4223700|P3|Overall Study|Progressive Disease|27
1296014|NCT00281528|4223701|P2|Overall Study|Progressive Disease|18
1296015|NCT00281528|4223702|P1|Overall Study|Progressive Disease|28
1296016|NCT00281320|4223753|P2|Overall Study|Not specified|1
1296017|NCT00281320|4223754|P1|Overall Study|Not specified|3
1296018|NCT00281320|4223753|P2|Overall Study|Lost to Follow-up|2
1296019|NCT00281320|4223754|P1|Overall Study|Lost to Follow-up|1
1296020|NCT00281320|4223753|P2|Overall Study|Withdrawal by Subject|6
1296021|NCT00281320|4223754|P1|Overall Study|Withdrawal by Subject|5
1296022|NCT00281320|4223753|P2|Overall Study|Lack of Efficacy|3
1296023|NCT00281320|4223754|P1|Overall Study|Lack of Efficacy|4
1296024|NCT00281320|4223753|P2|Overall Study|Adverse Event|9
1296025|NCT00281320|4223754|P1|Overall Study|Adverse Event|12
1296026|NCT00281099|4223776|P2|Overall Study|Heart Transplant/Device Exit/Changeout|4
1296027|NCT00281099|4223777|P1|Overall Study|Heart Transplant/Device Exit/Changeout|5
1296028|NCT00281099|4223776|P2|Overall Study|Physician Decision|72
1296029|NCT00281099|4223777|P1|Overall Study|Physician Decision|79
1296030|NCT00281099|4223776|P2|Overall Study|Withdrawal by Subject|70
1296031|NCT00281099|4223777|P1|Overall Study|Withdrawal by Subject|65
1296032|NCT00281099|4223776|P2|Overall Study|Lost to Follow-up|19
1296033|NCT00281099|4223777|P1|Overall Study|Lost to Follow-up|10
1296034|NCT00281099|4223776|P2|Overall Study|Death|57
1296035|NCT00281099|4223777|P1|Overall Study|Death|46
1296036|NCT00280917|4223826|P4|Overall Study|Noncompliance|0
1296037|NCT00280917|4223827|P3|Overall Study|Noncompliance|2
1296038|NCT00280917|4223828|P2|Overall Study|Noncompliance|1
1296039|NCT00280917|4223829|P1|Overall Study|Noncompliance|0
1296040|NCT00280917|4223826|P4|Overall Study|Withdrawal by Subject|1
1296041|NCT00280917|4223827|P3|Overall Study|Withdrawal by Subject|0
1296042|NCT00280917|4223828|P2|Overall Study|Withdrawal by Subject|2
1296043|NCT00280917|4223829|P1|Overall Study|Withdrawal by Subject|0
1296044|NCT00280917|4223826|P4|Overall Study|Change Therapy|0
1296045|NCT00280917|4223827|P3|Overall Study|Change Therapy|0
1296046|NCT00280917|4223828|P2|Overall Study|Change Therapy|2
1296047|NCT00280917|4223829|P1|Overall Study|Change Therapy|1
1296048|NCT00280917|4223826|P4|Overall Study|Adverse Event|1
1296049|NCT00280917|4223827|P3|Overall Study|Adverse Event|4
1296050|NCT00280917|4223828|P2|Overall Study|Adverse Event|1
1296051|NCT00280917|4223829|P1|Overall Study|Adverse Event|1
1296052|NCT00280748|4223852|P1|Overall Study|Extra-cranial disease progression|1
1296053|NCT00280748|4223852|P1|Overall Study|Decline in performance|3
1296054|NCT00280735|4223862|P1|Overall Study|Intercurrent Illness|2
1296055|NCT00280735|4223862|P1|Overall Study|Withdrawal by Subject|8
1296056|NCT00280735|4223862|P1|Overall Study|Lack of Efficacy|3
1296057|NCT00280735|4223862|P1|Overall Study|Adverse Event|5
1296058|NCT00280683|4223874|P2|Overall Study|Adverse Event|1
1296059|NCT00280683|4223875|P1|Overall Study|Adverse Event|1
1296060|NCT00280683|4223874|P2|Overall Study|Withdrawal by Subject|2
1296061|NCT00280683|4223875|P1|Overall Study|Withdrawal by Subject|1
1296062|NCT00280566|4223885|P3|Period 2 Double Blind|miscellaneous|5
1296063|NCT00280566|4223886|P2|Period 2 Double Blind|miscellaneous|10
1296064|NCT00280566|4223887|P1|Period 2 Double Blind|miscellaneous|0
1296065|NCT00280566|4223885|P3|Period 2 Double Blind|Withdrawal by Subject|9
1296066|NCT00280566|4223886|P2|Period 2 Double Blind|Withdrawal by Subject|9
1296067|NCT00280566|4223887|P1|Period 2 Double Blind|Withdrawal by Subject|0
1296068|NCT00280566|4223885|P3|Period 2 Double Blind|Lost to Follow-up|6
1296069|NCT00280566|4223886|P2|Period 2 Double Blind|Lost to Follow-up|3
1296070|NCT00280566|4223887|P1|Period 2 Double Blind|Lost to Follow-up|0
1296071|NCT00280566|4223885|P3|Period 2 Double Blind|Adverse Event|15
1296072|NCT00280566|4223886|P2|Period 2 Double Blind|Adverse Event|11
1296073|NCT00280566|4223887|P1|Period 2 Double Blind|Adverse Event|0
1296074|NCT00280566|4223885|P3|Period 2 Double Blind|Laboratory Abnormality|0
1296075|NCT00280566|4223886|P2|Period 2 Double Blind|Laboratory Abnormality|1
1296076|NCT00280566|4223887|P1|Period 2 Double Blind|Laboratory Abnormality|0
1296077|NCT00280566|4223885|P3|Period 2 Double Blind|Lack of Efficacy|22
1296078|NCT00280566|4223886|P2|Period 2 Double Blind|Lack of Efficacy|9
1296079|NCT00280566|4223887|P1|Period 2 Double Blind|Lack of Efficacy|0
1296080|NCT00280566|4223885|P3|Period 1 Open Label Ziprasidone|Miscellaneous|0
1296081|NCT00280566|4223886|P2|Period 1 Open Label Ziprasidone|Miscellaneous|0
1296082|NCT00280566|4223887|P1|Period 1 Open Label Ziprasidone|Miscellaneous|50
1296083|NCT00280566|4223885|P3|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
1296084|NCT00280566|4223886|P2|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
1296085|NCT00280566|4223887|P1|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76
1296086|NCT00280566|4223885|P3|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
1296087|NCT00280566|4223886|P2|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
1296088|NCT00280566|4223887|P1|Period 1 Open Label Ziprasidone|Lost to Follow-up|35
1296089|NCT00280566|4223885|P3|Period 1 Open Label Ziprasidone|Adverse Event|0
1296090|NCT00280566|4223886|P2|Period 1 Open Label Ziprasidone|Adverse Event|0
1296091|NCT00280566|4223887|P1|Period 1 Open Label Ziprasidone|Adverse Event|148
1296092|NCT00280566|4223885|P3|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
1296093|NCT00280566|4223886|P2|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
1296094|NCT00280566|4223887|P1|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3
1296095|NCT00280566|4223885|P3|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
1296096|NCT00280566|4223886|P2|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
1296097|NCT00280566|4223887|P1|Period 1 Open Label Ziprasidone|Lack of Efficacy|31
1296098|NCT00280397|4223912|P1|Overall Study|Adverse Event|1
1296099|NCT00280293|4223978|P2|Overall Study|Adverse Event|1
1296100|NCT00280293|4223979|P1|Overall Study|Adverse Event|0
1296101|NCT00280293|4223978|P2|Overall Study|Incarceration/Legal Reasons|1
1296102|NCT00280293|4223979|P1|Overall Study|Incarceration/Legal Reasons|1
1296103|NCT00280293|4223978|P2|Overall Study|Withdrawal by Subject|5
1296104|NCT00280293|4223979|P1|Overall Study|Withdrawal by Subject|3
1296105|NCT00280293|4223978|P2|Overall Study|Lost to Follow-up|12
1296106|NCT00280293|4223979|P1|Overall Study|Lost to Follow-up|14
1296107|NCT00280293|4223978|P2|Overall Study|Physician Decision|4
1296108|NCT00280293|4223979|P1|Overall Study|Physician Decision|5
1296109|NCT00280293|4223978|P2|Overall Study|Protocol Violation|0
1296110|NCT00280293|4223979|P1|Overall Study|Protocol Violation|3
1296111|NCT00280150|4224002|P4|Overall Study|Declining Performance Status|1
1296112|NCT00280150|4224003|P3|Overall Study|Declining Performance Status|0
1296113|NCT00280150|4224004|P2|Overall Study|Declining Performance Status|0
1296114|NCT00280150|4224005|P1|Overall Study|Declining Performance Status|0
1296115|NCT00280150|4224002|P4|Overall Study|Did not get consolidation therapy|0
1296116|NCT00280150|4224003|P3|Overall Study|Did not get consolidation therapy|3
1296117|NCT00280150|4224004|P2|Overall Study|Did not get consolidation therapy|0
1296118|NCT00280150|4224005|P1|Overall Study|Did not get consolidation therapy|3
1296119|NCT00280150|4224002|P4|Overall Study|Withdrawal by Subject|1
1296120|NCT00280150|4224003|P3|Overall Study|Withdrawal by Subject|0
1296121|NCT00280150|4224004|P2|Overall Study|Withdrawal by Subject|0
1296122|NCT00280150|4224005|P1|Overall Study|Withdrawal by Subject|0
1296123|NCT00280150|4224002|P4|Overall Study|Protocol Violation|1
1296124|NCT00280150|4224003|P3|Overall Study|Protocol Violation|0
1296125|NCT00280150|4224004|P2|Overall Study|Protocol Violation|0
1296126|NCT00280150|4224005|P1|Overall Study|Protocol Violation|0
1296127|NCT00280150|4224002|P4|Overall Study|Physician Decision|1
1296128|NCT00280150|4224003|P3|Overall Study|Physician Decision|0
1296129|NCT00280150|4224004|P2|Overall Study|Physician Decision|0
1296130|NCT00280150|4224005|P1|Overall Study|Physician Decision|0
1296131|NCT00280150|4224002|P4|Overall Study|Lack of Efficacy|3
1296132|NCT00280150|4224003|P3|Overall Study|Lack of Efficacy|0
1296133|NCT00280150|4224004|P2|Overall Study|Lack of Efficacy|0
1296134|NCT00280150|4224005|P1|Overall Study|Lack of Efficacy|0
1296135|NCT00280150|4224002|P4|Overall Study|Adverse Event|3
1296136|NCT00280150|4224003|P3|Overall Study|Adverse Event|2
1296137|NCT00280150|4224004|P2|Overall Study|Adverse Event|1
1296138|NCT00280150|4224005|P1|Overall Study|Adverse Event|0
1296139|NCT00280059|4224020|P2|Efficacy Assessment Phase|Withdrawal by Subject|25
1296140|NCT00280059|4224021|P1|Efficacy Assessment Phase|Withdrawal by Subject|26
1296141|NCT00280059|4224020|P2|Efficacy Assessment Phase|Other|8
1296142|NCT00280059|4224021|P1|Efficacy Assessment Phase|Other|7
1296143|NCT00280059|4224020|P2|Efficacy Assessment Phase|Lost to Follow-up|13
1296144|NCT00280059|4224021|P1|Efficacy Assessment Phase|Lost to Follow-up|6
1296145|NCT00280059|4224020|P2|Efficacy Assessment Phase|Lack of Efficacy|3
1296146|NCT00280059|4224021|P1|Efficacy Assessment Phase|Lack of Efficacy|19
1296147|NCT00280059|4224020|P2|Efficacy Assessment Phase|Laboratory abnormaility|0
1296148|NCT00280059|4224021|P1|Efficacy Assessment Phase|Laboratory abnormaility|1
1296149|NCT00280059|4224020|P2|Efficacy Assessment Phase|Adverse Event|31
1296150|NCT00280059|4224021|P1|Efficacy Assessment Phase|Adverse Event|33
1296151|NCT00280059|4224020|P2|Efficacy Assessment Phase|Death|0
1296152|NCT00280059|4224021|P1|Efficacy Assessment Phase|Death|2
1296153|NCT00279916|4224085|P2|Overall Study|Lost to Follow-up|2
1296154|NCT00279916|4224086|P1|Overall Study|Lost to Follow-up|3
1296155|NCT00279916|4224085|P2|Overall Study|Withdrawal by Subject|3
1296156|NCT00279916|4224086|P1|Overall Study|Withdrawal by Subject|4
1296157|NCT00279812|4224112|P6|Overall Study|Adverse Event|1
1296158|NCT00279812|4224113|P5|Overall Study|Adverse Event|2
1296159|NCT00279812|4224114|P4|Overall Study|Adverse Event|0
1296160|NCT00279812|4224115|P3|Overall Study|Adverse Event|1
1296161|NCT00279812|4224116|P2|Overall Study|Adverse Event|1
1296162|NCT00279812|4224117|P1|Overall Study|Adverse Event|0
1296163|NCT00279812|4224112|P6|Overall Study|Withdrawal by Subject|0
1296164|NCT00279812|4224113|P5|Overall Study|Withdrawal by Subject|0
1296165|NCT00279812|4224114|P4|Overall Study|Withdrawal by Subject|0
1296166|NCT00279812|4224115|P3|Overall Study|Withdrawal by Subject|2
1296167|NCT00279812|4224116|P2|Overall Study|Withdrawal by Subject|4
1296168|NCT00279812|4224117|P1|Overall Study|Withdrawal by Subject|0
1296169|NCT00279812|4224112|P6|Overall Study|Protocol Violation|0
1296170|NCT00279812|4224113|P5|Overall Study|Protocol Violation|1
1296171|NCT00279812|4224114|P4|Overall Study|Protocol Violation|0
1296172|NCT00279812|4224115|P3|Overall Study|Protocol Violation|0
1296173|NCT00279812|4224116|P2|Overall Study|Protocol Violation|1
1296174|NCT00279812|4224117|P1|Overall Study|Protocol Violation|1
1296175|NCT00279708|4224145|P2|Overall Study|Adverse Event|1
1296176|NCT00279708|4224146|P1|Overall Study|Adverse Event|1
1296177|NCT00279708|4224145|P2|Overall Study|Withdrawal by Subject|3
1296178|NCT00279708|4224146|P1|Overall Study|Withdrawal by Subject|2
1296179|NCT00279305|4224175|P2|Overall Study|FDA Safety Alert|1
1296180|NCT00279305|4224176|P1|Overall Study|FDA Safety Alert|4
1296181|NCT00279305|4224175|P2|Overall Study|Dificulting establishing IV|0
1296182|NCT00279305|4224176|P1|Overall Study|Dificulting establishing IV|1
1296183|NCT00279305|4224175|P2|Overall Study|Withdrawal by Subject|0
1296184|NCT00279305|4224176|P1|Overall Study|Withdrawal by Subject|2
1296185|NCT00279305|4224175|P2|Overall Study|Pregnancy|0
1296186|NCT00279305|4224176|P1|Overall Study|Pregnancy|1
1296187|NCT00279214|4224184|P2|Overall Study|Physician Decision|2
1296188|NCT00279214|4224185|P1|Overall Study|Physician Decision|3
1296189|NCT00279201|4224215|P6|Intensification Addendum|Death|0
1296190|NCT00279201|4224216|P5|Intensification Addendum|Death|1
1296191|NCT00279201|4224217|P4|Intensification Addendum|Death|0
1296192|NCT00279201|4224218|P3|Intensification Addendum|Death|0
1296193|NCT00279201|4224219|P2|Intensification Addendum|Death|0
1296194|NCT00279201|4224220|P1|Intensification Addendum|Death|0
1296195|NCT00279201|4224215|P6|Intensification Addendum|Lack of Efficacy|0
1296196|NCT00279201|4224216|P5|Intensification Addendum|Lack of Efficacy|1
1296197|NCT00279201|4224217|P4|Intensification Addendum|Lack of Efficacy|1
1296198|NCT00279201|4224218|P3|Intensification Addendum|Lack of Efficacy|0
1296199|NCT00279201|4224219|P2|Intensification Addendum|Lack of Efficacy|0
1296200|NCT00279201|4224220|P1|Intensification Addendum|Lack of Efficacy|0
1296201|NCT00279201|4224215|P6|Intensification Addendum|Entry Criteria Exclusion|0
1296202|NCT00279201|4224216|P5|Intensification Addendum|Entry Criteria Exclusion|0
1296203|NCT00279201|4224217|P4|Intensification Addendum|Entry Criteria Exclusion|0
1296204|NCT00279201|4224218|P3|Intensification Addendum|Entry Criteria Exclusion|1
1296205|NCT00279201|4224219|P2|Intensification Addendum|Entry Criteria Exclusion|0
1296206|NCT00279201|4224220|P1|Intensification Addendum|Entry Criteria Exclusion|0
1296207|NCT00279201|4224215|P6|Intensification Addendum|Sponsor Decision|1
1296208|NCT00279201|4224216|P5|Intensification Addendum|Sponsor Decision|1
1296209|NCT00279201|4224217|P4|Intensification Addendum|Sponsor Decision|0
1296210|NCT00279201|4224218|P3|Intensification Addendum|Sponsor Decision|0
1296211|NCT00279201|4224219|P2|Intensification Addendum|Sponsor Decision|0
1296212|NCT00279201|4224220|P1|Intensification Addendum|Sponsor Decision|0
1296213|NCT00279201|4224215|P6|Intensification Addendum|Physician Decision|2
1296214|NCT00279201|4224216|P5|Intensification Addendum|Physician Decision|3
1296215|NCT00279201|4224217|P4|Intensification Addendum|Physician Decision|1
1296216|NCT00279201|4224218|P3|Intensification Addendum|Physician Decision|4
1296217|NCT00279201|4224219|P2|Intensification Addendum|Physician Decision|0
1296218|NCT00279201|4224220|P1|Intensification Addendum|Physician Decision|0
1296219|NCT00279201|4224215|P6|Intensification Addendum|Adverse Event|3
1296220|NCT00279201|4224216|P5|Intensification Addendum|Adverse Event|1
1296221|NCT00279201|4224217|P4|Intensification Addendum|Adverse Event|4
1296222|NCT00279201|4224218|P3|Intensification Addendum|Adverse Event|0
1296223|NCT00279201|4224219|P2|Intensification Addendum|Adverse Event|0
1296224|NCT00279201|4224220|P1|Intensification Addendum|Adverse Event|0
1296225|NCT00279201|4224215|P6|Intensification Addendum|Protocol Violation|6
1296226|NCT00279201|4224216|P5|Intensification Addendum|Protocol Violation|6
1296227|NCT00279201|4224217|P4|Intensification Addendum|Protocol Violation|2
1296228|NCT00279201|4224218|P3|Intensification Addendum|Protocol Violation|2
1296229|NCT00279201|4224219|P2|Intensification Addendum|Protocol Violation|0
1296230|NCT00279201|4224220|P1|Intensification Addendum|Protocol Violation|0
1296231|NCT00279201|4224215|P6|Intensification Addendum|Lost to Follow-up|7
1296232|NCT00279201|4224216|P5|Intensification Addendum|Lost to Follow-up|7
1296233|NCT00279201|4224217|P4|Intensification Addendum|Lost to Follow-up|6
1296234|NCT00279201|4224218|P3|Intensification Addendum|Lost to Follow-up|4
1296235|NCT00279201|4224219|P2|Intensification Addendum|Lost to Follow-up|0
1296236|NCT00279201|4224220|P1|Intensification Addendum|Lost to Follow-up|0
1296237|NCT00279201|4224215|P6|Intensification Addendum|Withdrawal by Subject|18
1296238|NCT00279201|4224216|P5|Intensification Addendum|Withdrawal by Subject|9
1296239|NCT00279201|4224217|P4|Intensification Addendum|Withdrawal by Subject|14
1296240|NCT00279201|4224218|P3|Intensification Addendum|Withdrawal by Subject|12
1296241|NCT00279201|4224219|P2|Intensification Addendum|Withdrawal by Subject|0
1296242|NCT00279201|4224220|P1|Intensification Addendum|Withdrawal by Subject|0
1296243|NCT00279201|4224215|P6|Maintenance|HbA1c>7.5%|0
1296244|NCT00279201|4224216|P5|Maintenance|HbA1c>7.5%|0
1296245|NCT00279201|4224217|P4|Maintenance|HbA1c>7.5%|0
1296246|NCT00279201|4224218|P3|Maintenance|HbA1c>7.5%|0
1296247|NCT00279201|4224219|P2|Maintenance|HbA1c>7.5%|126
1296248|NCT00279201|4224220|P1|Maintenance|HbA1c>7.5%|123
1296249|NCT00279201|4224215|P6|Maintenance|Sponsor Decision|0
1296250|NCT00279201|4224216|P5|Maintenance|Sponsor Decision|0
1296251|NCT00279201|4224217|P4|Maintenance|Sponsor Decision|0
1296252|NCT00279201|4224218|P3|Maintenance|Sponsor Decision|0
1296253|NCT00279201|4224219|P2|Maintenance|Sponsor Decision|0
1296254|NCT00279201|4224220|P1|Maintenance|Sponsor Decision|4
1296255|NCT00279201|4224215|P6|Maintenance|Physician Decision|0
1296256|NCT00279201|4224216|P5|Maintenance|Physician Decision|0
1296257|NCT00279201|4224217|P4|Maintenance|Physician Decision|0
1296258|NCT00279201|4224218|P3|Maintenance|Physician Decision|0
1296259|NCT00279201|4224219|P2|Maintenance|Physician Decision|9
1296260|NCT00279201|4224220|P1|Maintenance|Physician Decision|9
1296261|NCT00279201|4224215|P6|Maintenance|Withdrawal by Subject|0
1296262|NCT00279201|4224216|P5|Maintenance|Withdrawal by Subject|0
1296263|NCT00279201|4224217|P4|Maintenance|Withdrawal by Subject|0
1296264|NCT00279201|4224218|P3|Maintenance|Withdrawal by Subject|0
1296265|NCT00279201|4224219|P2|Maintenance|Withdrawal by Subject|18
1296266|NCT00279201|4224220|P1|Maintenance|Withdrawal by Subject|18
1296267|NCT00279201|4224215|P6|Maintenance|Protocol Violation|0
1296268|NCT00279201|4224216|P5|Maintenance|Protocol Violation|0
1296269|NCT00279201|4224217|P4|Maintenance|Protocol Violation|0
1296270|NCT00279201|4224218|P3|Maintenance|Protocol Violation|0
1296271|NCT00279201|4224219|P2|Maintenance|Protocol Violation|24
1296272|NCT00279201|4224220|P1|Maintenance|Protocol Violation|16
1296273|NCT00279201|4224215|P6|Maintenance|Entry Criteria Exclusion|0
1296274|NCT00279201|4224216|P5|Maintenance|Entry Criteria Exclusion|0
1296275|NCT00279201|4224217|P4|Maintenance|Entry Criteria Exclusion|0
1296276|NCT00279201|4224218|P3|Maintenance|Entry Criteria Exclusion|0
1296277|NCT00279201|4224219|P2|Maintenance|Entry Criteria Exclusion|4
1296278|NCT00279201|4224220|P1|Maintenance|Entry Criteria Exclusion|1
1296279|NCT00279201|4224215|P6|Maintenance|Lost to Follow-up|0
1296280|NCT00279201|4224216|P5|Maintenance|Lost to Follow-up|0
1296281|NCT00279201|4224217|P4|Maintenance|Lost to Follow-up|0
1296282|NCT00279201|4224218|P3|Maintenance|Lost to Follow-up|0
1296283|NCT00279201|4224219|P2|Maintenance|Lost to Follow-up|13
1296284|NCT00279201|4224220|P1|Maintenance|Lost to Follow-up|17
1296285|NCT00279201|4224215|P6|Maintenance|Death|0
1296286|NCT00279201|4224216|P5|Maintenance|Death|0
1296287|NCT00279201|4224217|P4|Maintenance|Death|0
1296288|NCT00279201|4224218|P3|Maintenance|Death|0
1296289|NCT00279201|4224219|P2|Maintenance|Death|4
1296290|NCT00279201|4224220|P1|Maintenance|Death|4
1296291|NCT00279201|4224215|P6|Maintenance|Adverse Event|0
1296292|NCT00279201|4224216|P5|Maintenance|Adverse Event|0
1296293|NCT00279201|4224217|P4|Maintenance|Adverse Event|0
1296294|NCT00279201|4224218|P3|Maintenance|Adverse Event|0
1296295|NCT00279201|4224219|P2|Maintenance|Adverse Event|4
1296296|NCT00279201|4224220|P1|Maintenance|Adverse Event|4
1296297|NCT00279201|4224215|P6|Maintenance|Discontinuation Antihyperglycemic Drugs|0
1296298|NCT00279201|4224216|P5|Maintenance|Discontinuation Antihyperglycemic Drugs|0
1296299|NCT00279201|4224217|P4|Maintenance|Discontinuation Antihyperglycemic Drugs|0
1296300|NCT00279201|4224218|P3|Maintenance|Discontinuation Antihyperglycemic Drugs|0
1296301|NCT00279201|4224219|P2|Maintenance|Discontinuation Antihyperglycemic Drugs|2
1296302|NCT00279201|4224220|P1|Maintenance|Discontinuation Antihyperglycemic Drugs|3
1296303|NCT00279201|4224215|P6|Maintenance|Lack of Efficacy|0
1296304|NCT00279201|4224216|P5|Maintenance|Lack of Efficacy|0
1296305|NCT00279201|4224217|P4|Maintenance|Lack of Efficacy|0
1296306|NCT00279201|4224218|P3|Maintenance|Lack of Efficacy|0
1296307|NCT00279201|4224219|P2|Maintenance|Lack of Efficacy|30
1296308|NCT00279201|4224220|P1|Maintenance|Lack of Efficacy|32
1296309|NCT00279201|4224215|P6|Initiation|Discontinuation Oral Antihyperglycemics|0
1296310|NCT00279201|4224216|P5|Initiation|Discontinuation Oral Antihyperglycemics|0
1296311|NCT00279201|4224217|P4|Initiation|Discontinuation Oral Antihyperglycemics|0
1296312|NCT00279201|4224218|P3|Initiation|Discontinuation Oral Antihyperglycemics|0
1296313|NCT00279201|4224219|P2|Initiation|Discontinuation Oral Antihyperglycemics|1
1296314|NCT00279201|4224220|P1|Initiation|Discontinuation Oral Antihyperglycemics|0
1296315|NCT00279201|4224215|P6|Initiation|Sponsor Decision|0
1296316|NCT00279201|4224216|P5|Initiation|Sponsor Decision|0
1296317|NCT00279201|4224217|P4|Initiation|Sponsor Decision|0
1296318|NCT00279201|4224218|P3|Initiation|Sponsor Decision|0
1296319|NCT00279201|4224219|P2|Initiation|Sponsor Decision|5
1296320|NCT00279201|4224220|P1|Initiation|Sponsor Decision|13
1296321|NCT00279201|4224215|P6|Initiation|Physician Decision|0
1296322|NCT00279201|4224216|P5|Initiation|Physician Decision|0
1296323|NCT00279201|4224217|P4|Initiation|Physician Decision|0
1296324|NCT00279201|4224218|P3|Initiation|Physician Decision|0
1296325|NCT00279201|4224219|P2|Initiation|Physician Decision|18
1296326|NCT00279201|4224220|P1|Initiation|Physician Decision|15
1296327|NCT00279201|4224215|P6|Initiation|Withdrawal by Subject|0
1296328|NCT00279201|4224216|P5|Initiation|Withdrawal by Subject|0
1296329|NCT00279201|4224217|P4|Initiation|Withdrawal by Subject|0
1296330|NCT00279201|4224218|P3|Initiation|Withdrawal by Subject|0
1296331|NCT00279201|4224219|P2|Initiation|Withdrawal by Subject|41
1296332|NCT00279201|4224220|P1|Initiation|Withdrawal by Subject|35
1296333|NCT00279201|4224215|P6|Initiation|Protocol Violation|0
1296334|NCT00279201|4224216|P5|Initiation|Protocol Violation|0
1296335|NCT00279201|4224217|P4|Initiation|Protocol Violation|0
1296336|NCT00279201|4224218|P3|Initiation|Protocol Violation|0
1296337|NCT00279201|4224219|P2|Initiation|Protocol Violation|10
1296338|NCT00279201|4224220|P1|Initiation|Protocol Violation|9
1296339|NCT00279201|4224215|P6|Initiation|Entry Criteria Exclusion|0
1296340|NCT00279201|4224216|P5|Initiation|Entry Criteria Exclusion|0
1296341|NCT00279201|4224217|P4|Initiation|Entry Criteria Exclusion|0
1296342|NCT00279201|4224218|P3|Initiation|Entry Criteria Exclusion|0
1296343|NCT00279201|4224219|P2|Initiation|Entry Criteria Exclusion|9
1296344|NCT00279201|4224220|P1|Initiation|Entry Criteria Exclusion|7
1296345|NCT00279201|4224215|P6|Initiation|Lost to Follow-up|0
1296346|NCT00279201|4224216|P5|Initiation|Lost to Follow-up|0
1296347|NCT00279201|4224217|P4|Initiation|Lost to Follow-up|0
1296348|NCT00279201|4224218|P3|Initiation|Lost to Follow-up|0
1296349|NCT00279201|4224219|P2|Initiation|Lost to Follow-up|41
1296350|NCT00279201|4224220|P1|Initiation|Lost to Follow-up|42
1296351|NCT00279201|4224215|P6|Initiation|Adverse Event|0
1296352|NCT00279201|4224216|P5|Initiation|Adverse Event|0
1296353|NCT00279201|4224217|P4|Initiation|Adverse Event|0
1296354|NCT00279201|4224218|P3|Initiation|Adverse Event|0
1296355|NCT00279201|4224219|P2|Initiation|Adverse Event|15
1296356|NCT00279201|4224220|P1|Initiation|Adverse Event|6
1296357|NCT00279201|4224215|P6|Initiation|Death|0
1296358|NCT00279201|4224216|P5|Initiation|Death|0
1296359|NCT00279201|4224217|P4|Initiation|Death|0
1296360|NCT00279201|4224218|P3|Initiation|Death|0
1296361|NCT00279201|4224219|P2|Initiation|Death|5
1296362|NCT00279201|4224220|P1|Initiation|Death|1
1296363|NCT00278993|4224364|P1|Overall Study|Not Otherwise Specified|4
1296364|NCT00278993|4224364|P1|Overall Study|Physician Decision|9
1296365|NCT00278993|4224364|P1|Overall Study|Progressive Disease|65
1296366|NCT00278993|4224364|P1|Overall Study|Withdrawal by Subject|5
1296367|NCT00278993|4224364|P1|Overall Study|Adverse Event|24
1296368|NCT00278954|4224372|P1|Overall Study|Withdrawal by Subject|1
1296369|NCT00278954|4224372|P1|Overall Study|Lost to Follow-up|1
1296370|NCT00278954|4224372|P1|Overall Study|Adverse Event|3
1296371|NCT00278915|4224380|P1|Overall Study|Lack of Efficacy|1
1296372|NCT00278889|4224416|P3|Overall Study|Death|17
1296373|NCT00278889|4224417|P2|Overall Study|Death|21
1296374|NCT00278889|4224418|P1|Overall Study|Death|24
1296375|NCT00278889|4224416|P3|Overall Study|Lost to Follow-up|0
1296376|NCT00278889|4224417|P2|Overall Study|Lost to Follow-up|1
1296377|NCT00278889|4224418|P1|Overall Study|Lost to Follow-up|1
1296378|NCT00278889|4224416|P3|Overall Study|Withdrawal by Subject|3
1296379|NCT00278889|4224417|P2|Overall Study|Withdrawal by Subject|5
1296380|NCT00278889|4224418|P1|Overall Study|Withdrawal by Subject|0
1296381|NCT00278564|4224466|P1|Overall Study|Lack of Efficacy|4
1296382|NCT00278512|4224483|P2|Overall Study|Death|0
1296383|NCT00278512|4224484|P1|Overall Study|Death|1
1296384|NCT00278473|4224492|P2|Overall Study|drop out|3
1296385|NCT00278473|4224493|P1|Overall Study|drop out|4
1296386|NCT00278395|4224509|P1|Overall Study|Nonevaluable|1
1296387|NCT00278395|4224509|P1|Overall Study|Adverse Event|2
1296388|NCT00278161|4224525|P1|Overall Study|Death|11
1296389|NCT00277355|4224573|P2|Overall Study|Physician Decision|0
1296390|NCT00277355|4224574|P1|Overall Study|Physician Decision|1
1296391|NCT00277355|4224573|P2|Overall Study|Death|0
1296392|NCT00277355|4224574|P1|Overall Study|Death|3
1296393|NCT00277355|4224573|P2|Overall Study|Adverse Event|0
1296394|NCT00277355|4224574|P1|Overall Study|Adverse Event|5
1296395|NCT00277355|4224573|P2|Overall Study|Lost to Follow-up|2
1296396|NCT00277355|4224574|P1|Overall Study|Lost to Follow-up|2
1296397|NCT00277355|4224573|P2|Overall Study|Withdrawal by Subject|3
1296398|NCT00277355|4224574|P1|Overall Study|Withdrawal by Subject|3
1296399|NCT00277212|4224582|P3|Phase 2 - Double-Blind Treatment|Other reasons|5
1296400|NCT00277212|4224583|P2|Phase 2 - Double-Blind Treatment|Other reasons|7
1296401|NCT00277212|4224584|P1|Phase 2 - Double-Blind Treatment|Other reasons|0
1296402|NCT00277212|4224582|P3|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3
1296403|NCT00277212|4224583|P2|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1
1296404|NCT00277212|4224584|P1|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0
1296405|NCT00277212|4224582|P3|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6
1296406|NCT00277212|4224583|P2|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4
1296407|NCT00277212|4224584|P1|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0
1296408|NCT00277212|4224582|P3|Phase 2 - Double-Blind Treatment|Pregnancy|2
1296409|NCT00277212|4224583|P2|Phase 2 - Double-Blind Treatment|Pregnancy|2
1296410|NCT00277212|4224584|P1|Phase 2 - Double-Blind Treatment|Pregnancy|0
1296411|NCT00277212|4224582|P3|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8
1296412|NCT00277212|4224583|P2|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7
1296413|NCT00277212|4224584|P1|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0
1296414|NCT00277212|4224582|P3|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
1296415|NCT00277212|4224583|P2|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
1296416|NCT00277212|4224584|P1|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0
1296417|NCT00277212|4224582|P3|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16
1296418|NCT00277212|4224583|P2|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17
1296419|NCT00277212|4224584|P1|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0
1296420|NCT00277212|4224582|P3|Phase 2 - Double-Blind Treatment|Adverse Event|16
1296421|NCT00277212|4224583|P2|Phase 2 - Double-Blind Treatment|Adverse Event|10
1296422|NCT00277212|4224584|P1|Phase 2 - Double-Blind Treatment|Adverse Event|0
1296423|NCT00277212|4224582|P3|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39
1296424|NCT00277212|4224583|P2|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54
1296425|NCT00277212|4224584|P1|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0
1296426|NCT00277212|4224582|P3|Phase 1 - Single-Blind Treatment|Other Reasons|0
1296427|NCT00277212|4224583|P2|Phase 1 - Single-Blind Treatment|Other Reasons|0
1296428|NCT00277212|4224584|P1|Phase 1 - Single-Blind Treatment|Other Reasons|12
1296429|NCT00277212|4224582|P3|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
1296430|NCT00277212|4224583|P2|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
1296431|NCT00277212|4224584|P1|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1
1296432|NCT00277212|4224582|P3|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
1296433|NCT00277212|4224583|P2|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
1296434|NCT00277212|4224584|P1|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44
1296435|NCT00277212|4224582|P3|Phase 1 - Single-Blind Treatment|Pregnancy|0
1296436|NCT00277212|4224583|P2|Phase 1 - Single-Blind Treatment|Pregnancy|0
1296437|NCT00277212|4224584|P1|Phase 1 - Single-Blind Treatment|Pregnancy|6
1296438|NCT00277212|4224582|P3|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
1296439|NCT00277212|4224583|P2|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
1296440|NCT00277212|4224584|P1|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35
1296441|NCT00277212|4224582|P3|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
1296442|NCT00277212|4224583|P2|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
1296443|NCT00277212|4224584|P1|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87
1296444|NCT00277212|4224582|P3|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
1296445|NCT00277212|4224583|P2|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
1296446|NCT00277212|4224584|P1|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96
1296447|NCT00277212|4224582|P3|Phase 1 - Single-Blind Treatment|Adverse Event|0
1296448|NCT00277212|4224583|P2|Phase 1 - Single-Blind Treatment|Adverse Event|0
1296449|NCT00277212|4224584|P1|Phase 1 - Single-Blind Treatment|Adverse Event|93
1296450|NCT00277212|4224582|P3|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
1296451|NCT00277212|4224583|P2|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
1296452|NCT00277212|4224584|P1|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61
1296453|NCT00277095|4224622|P1|Overall Study|Physician Decision|1
1296454|NCT00277095|4224622|P1|Overall Study|Missed Follow-up|9
1296455|NCT00277095|4224622|P1|Overall Study|Lost to Follow-up|2
1296456|NCT00277095|4224622|P1|Overall Study|Explanted|7
1296457|NCT00277095|4224622|P1|Overall Study|Death|2
1296458|NCT00276744|4224631|P1|PART A|Reason unknown|98
1296459|NCT00276614|4224635|P1|Overall Study|Progression of disease under study|3
1296460|NCT00276484|4224646|P2|Overall Study|Could not take time off work|1
1296461|NCT00276484|4224647|P1|Overall Study|Could not take time off work|0
1296462|NCT00276484|4224646|P2|Overall Study|Withdrawal by Subject|3
1296463|NCT00276484|4224647|P1|Overall Study|Withdrawal by Subject|4
1296464|NCT00276484|4224646|P2|Overall Study|Protocol Violation|1
1296465|NCT00276484|4224647|P1|Overall Study|Protocol Violation|0
1296466|NCT00276484|4224646|P2|Overall Study|Lost to Follow-up|1
1296467|NCT00276484|4224647|P1|Overall Study|Lost to Follow-up|1
1296468|NCT00276484|4224646|P2|Overall Study|Adverse Event|7
1296469|NCT00276484|4224647|P1|Overall Study|Adverse Event|4
1296470|NCT00276458|4224679|P2|Overall Study|Protocol Violation|3
1296471|NCT00276458|4224680|P1|Overall Study|Protocol Violation|4
1296472|NCT00276458|4224679|P2|Overall Study|Lost to Follow-up|2
1296473|NCT00276458|4224680|P1|Overall Study|Lost to Follow-up|2
1296474|NCT00276458|4224679|P2|Overall Study|Adverse Event|2
1296475|NCT00276458|4224680|P1|Overall Study|Adverse Event|0
1296476|NCT00276419|4224714|P2|First Intervention|Withdrawal by Subject|2
1296477|NCT00276419|4224715|P1|First Intervention|Withdrawal by Subject|0
1296478|NCT00276419|4224714|P2|First Intervention|Adverse Event|0
1296479|NCT00276419|4224715|P1|First Intervention|Adverse Event|1
1296480|NCT00276380|4224758|P2|Overall Study|Abnormal aPPT Levels|1
1296481|NCT00276380|4224759|P1|Overall Study|Abnormal aPPT Levels|0
1296482|NCT00276380|4224758|P2|Overall Study|Death|3
1296483|NCT00276380|4224759|P1|Overall Study|Death|5
1296484|NCT00276380|4224758|P2|Overall Study|Withdrawal by Subject|6
1296485|NCT00276380|4224759|P1|Overall Study|Withdrawal by Subject|3
1296486|NCT00276380|4224758|P2|Overall Study|Lost to Follow-up|1
1296487|NCT00276380|4224759|P1|Overall Study|Lost to Follow-up|1
1296488|NCT00276380|4224758|P2|Overall Study|Adverse Event|3
1296489|NCT00276380|4224759|P1|Overall Study|Adverse Event|5
1296490|NCT00276159|4224814|P1|Overall Study|Did not receive all 24 doses of 852A|6
1296491|NCT00276094|4224824|P3|Overall Study|Other-Study medication lost|1
1296492|NCT00276094|4224825|P2|Overall Study|Other-Study medication lost|0
1296493|NCT00276094|4224826|P1|Overall Study|Other-Study medication lost|0
1296494|NCT00276094|4224824|P3|Overall Study|Other-Relocation|0
1296495|NCT00276094|4224825|P2|Overall Study|Other-Relocation|1
1296496|NCT00276094|4224826|P1|Overall Study|Other-Relocation|0
1296497|NCT00276094|4224824|P3|Overall Study|Other-Repeat safety labs-exclusionary|0
1296498|NCT00276094|4224825|P2|Overall Study|Other-Repeat safety labs-exclusionary|1
1296499|NCT00276094|4224826|P1|Overall Study|Other-Repeat safety labs-exclusionary|0
1296500|NCT00276094|4224824|P3|Overall Study|Other-Refused follow-up visit|0
1296501|NCT00276094|4224825|P2|Overall Study|Other-Refused follow-up visit|0
1296502|NCT00276094|4224826|P1|Overall Study|Other-Refused follow-up visit|1
1296503|NCT00276094|4224824|P3|Overall Study|Other-Lack of efficacy|0
1296504|NCT00276094|4224825|P2|Overall Study|Other-Lack of efficacy|0
1296505|NCT00276094|4224826|P1|Overall Study|Other-Lack of efficacy|1
1296506|NCT00276094|4224824|P3|Overall Study|Other-Scheduled gastroplasty|0
1296507|NCT00276094|4224825|P2|Overall Study|Other-Scheduled gastroplasty|0
1296508|NCT00276094|4224826|P1|Overall Study|Other-Scheduled gastroplasty|1
1296509|NCT00276094|4224824|P3|Overall Study|Other-Subject moved out of country|0
1296510|NCT00276094|4224825|P2|Overall Study|Other-Subject moved out of country|0
1296511|NCT00276094|4224826|P1|Overall Study|Other-Subject moved out of country|1
1296512|NCT00276094|4224824|P3|Overall Study|Lost to Follow-up|4
1296513|NCT00276094|4224825|P2|Overall Study|Lost to Follow-up|6
1296514|NCT00276094|4224826|P1|Overall Study|Lost to Follow-up|8
1296515|NCT00276094|4224824|P3|Overall Study|Protocol Violation|10
1296516|NCT00276094|4224825|P2|Overall Study|Protocol Violation|7
1296517|NCT00276094|4224826|P1|Overall Study|Protocol Violation|16
1296518|NCT00276094|4224824|P3|Overall Study|Withdrawal by Subject|12
1296519|NCT00276094|4224825|P2|Overall Study|Withdrawal by Subject|14
1296520|NCT00276094|4224826|P1|Overall Study|Withdrawal by Subject|14
1296521|NCT00276094|4224824|P3|Overall Study|Adverse Event|11
1296522|NCT00276094|4224825|P2|Overall Study|Adverse Event|13
1296523|NCT00276094|4224826|P1|Overall Study|Adverse Event|15
1296524|NCT00276016|4224879|P6|Intervention 1|Withdrawal by Subject|0
1296525|NCT00276016|4224880|P5|Intervention 1|Withdrawal by Subject|0
1296526|NCT00276016|4224881|P4|Intervention 1|Withdrawal by Subject|0
1296527|NCT00276016|4224882|P3|Intervention 1|Withdrawal by Subject|0
1296528|NCT00276016|4224883|P2|Intervention 1|Withdrawal by Subject|1
1296529|NCT00276016|4224884|P1|Intervention 1|Withdrawal by Subject|0
1296530|NCT00275821|4224930|P3|Overall Study|Protocol Violation|0
1296531|NCT00275821|4224931|P2|Overall Study|Protocol Violation|1
1296532|NCT00275821|4224932|P1|Overall Study|Protocol Violation|5
1296533|NCT00275821|4224930|P3|Overall Study|Lack of Efficacy|0
1296534|NCT00275821|4224931|P2|Overall Study|Lack of Efficacy|1
1296535|NCT00275821|4224932|P1|Overall Study|Lack of Efficacy|2
1296536|NCT00275821|4224930|P3|Overall Study|Death|1
1296537|NCT00275821|4224931|P2|Overall Study|Death|2
1296538|NCT00275821|4224932|P1|Overall Study|Death|0
1296539|NCT00275821|4224930|P3|Overall Study|Lost to Follow-up|1
1296540|NCT00275821|4224931|P2|Overall Study|Lost to Follow-up|1
1296541|NCT00275821|4224932|P1|Overall Study|Lost to Follow-up|0
1296542|NCT00275821|4224930|P3|Overall Study|Withdrawal by Subject|1
1296543|NCT00275821|4224931|P2|Overall Study|Withdrawal by Subject|2
1296544|NCT00275821|4224932|P1|Overall Study|Withdrawal by Subject|0
1296545|NCT00275821|4224930|P3|Overall Study|Administrative problems|4
1296546|NCT00275821|4224931|P2|Overall Study|Administrative problems|4
1296547|NCT00275821|4224932|P1|Overall Study|Administrative problems|3
1296548|NCT00275821|4224930|P3|Overall Study|Adverse Event|5
1296549|NCT00275821|4224931|P2|Overall Study|Adverse Event|12
1296550|NCT00275821|4224932|P1|Overall Study|Adverse Event|4
1296551|NCT00275561|4224951|P2|Overall Study|Family Issues|2
1296552|NCT00275561|4224952|P1|Overall Study|Family Issues|0
1296553|NCT00275561|4224951|P2|Overall Study|Scheduling|2
1296554|NCT00275561|4224952|P1|Overall Study|Scheduling|1
1296555|NCT00275561|4224951|P2|Overall Study|Travel|1
1296556|NCT00275561|4224952|P1|Overall Study|Travel|1
1296557|NCT00275561|4224951|P2|Overall Study|Withdrawal by Subject|1
1296558|NCT00275561|4224952|P1|Overall Study|Withdrawal by Subject|0
1296559|NCT00275509|4224964|P2|Overall Study|graft thrombosis, post-operative day #8|1
1296560|NCT00275509|4224965|P1|Overall Study|graft thrombosis, post-operative day #8|0
1296561|NCT00275340|4224988|P2|Overall Study|Lost to Follow-up|4
1296562|NCT00275340|4224989|P1|Overall Study|Lost to Follow-up|2
1296563|NCT00275301|4224993|P1|Overall Study|Adverse Event|5
1296564|NCT00275262|4225012|P2|Overall Study|Started Chemotherapy|0
1296565|NCT00275262|4225013|P1|Overall Study|Started Chemotherapy|1
1296566|NCT00275262|4225012|P2|Overall Study|Death|0
1296567|NCT00275262|4225013|P1|Overall Study|Death|1
1296568|NCT00275262|4225012|P2|Overall Study|Protocol Violation|2
1296569|NCT00275262|4225013|P1|Overall Study|Protocol Violation|0
1296570|NCT00275262|4225012|P2|Overall Study|Lost to Follow-up|2
1296571|NCT00275262|4225013|P1|Overall Study|Lost to Follow-up|0
1296572|NCT00275262|4225012|P2|Overall Study|Disease progression|5
1296573|NCT00275262|4225013|P1|Overall Study|Disease progression|2
1296574|NCT00275262|4225012|P2|Overall Study|Adverse Event|0
1296575|NCT00275262|4225013|P1|Overall Study|Adverse Event|2
1296576|NCT00275028|4225027|P1|Overall Study|Physician Decision|2
1296577|NCT00275028|4225027|P1|Overall Study|Progressive Disease|30
1296578|NCT00275028|4225027|P1|Overall Study|Adverse Event|9
1296579|NCT00275028|4225027|P1|Overall Study|Withdrawal by Subject|5
1296580|NCT00275028|4225027|P1|Overall Study|Withdrew consent before treatment began|1
1296581|NCT00275002|4225034|P2|Overall Study|Adverse Event|1
1296582|NCT00275002|4225035|P1|Overall Study|Adverse Event|0
1296583|NCT00275002|4225034|P2|Overall Study|Disease progression|15
1296584|NCT00275002|4225035|P1|Overall Study|Disease progression|21
1296585|NCT00275002|4225034|P2|Overall Study|Death|0
1296586|NCT00275002|4225035|P1|Overall Study|Death|1
1296587|NCT00274937|4225043|P1|Overall Study|Progressive Disease|4
1296588|NCT00274937|4225043|P1|Overall Study|Withdrawal by Subject|6
1296589|NCT00274937|4225043|P1|Overall Study|Physician Decision|10
1296590|NCT00274924|4225055|P3|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
1296591|NCT00274924|4225056|P2|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1
1296592|NCT00274924|4225057|P1|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
1296593|NCT00274924|4225055|P3|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
1296594|NCT00274924|4225056|P2|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1
1296595|NCT00274924|4225057|P1|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
1296596|NCT00274924|4225055|P3|Step 2 (Tx Based on Mid-treatment PET)|Death|0
1296597|NCT00274924|4225056|P2|Step 2 (Tx Based on Mid-treatment PET)|Death|1
1296598|NCT00274924|4225057|P1|Step 2 (Tx Based on Mid-treatment PET)|Death|0
1296599|NCT00274924|4225055|P3|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
1296600|NCT00274924|4225056|P2|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
1296601|NCT00274924|4225057|P1|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1
1296602|NCT00274924|4225055|P3|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
1296603|NCT00274924|4225056|P2|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
1296604|NCT00274924|4225057|P1|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1
1296605|NCT00274924|4225055|P3|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
1296606|NCT00274924|4225056|P2|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
1296607|NCT00274924|4225057|P1|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1
1296608|NCT00274924|4225055|P3|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0
1296609|NCT00274924|4225056|P2|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15
1296610|NCT00274924|4225057|P1|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4
1296611|NCT00274924|4225055|P3|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1
1296612|NCT00274924|4225056|P2|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
1296613|NCT00274924|4225057|P1|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
1296614|NCT00274924|4225055|P3|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1
1296615|NCT00274924|4225056|P2|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
1296616|NCT00274924|4225057|P1|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
1296617|NCT00274924|4225055|P3|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1
1296618|NCT00274924|4225056|P2|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
1296619|NCT00274924|4225057|P1|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
1296620|NCT00274924|4225055|P3|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1
1296621|NCT00274924|4225056|P2|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
1296622|NCT00274924|4225057|P1|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
1296623|NCT00274924|4225055|P3|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1
1296624|NCT00274924|4225056|P2|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
1296625|NCT00274924|4225057|P1|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
1296626|NCT00274924|4225055|P3|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1
1296627|NCT00274924|4225056|P2|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14
1296628|NCT00274924|4225057|P1|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4
1296629|NCT00274846|4225066|P1|Overall Study|Did not receive adequate NK cells|1
1296630|NCT00274742|4225090|P6|Overall Study|Other|0
1296631|NCT00274742|4225091|P5|Overall Study|Other|2
1296632|NCT00274742|4225092|P4|Overall Study|Other|0
1296633|NCT00274742|4225093|P3|Overall Study|Other|0
1296634|NCT00274742|4225094|P2|Overall Study|Other|3
1296635|NCT00274742|4225095|P1|Overall Study|Other|0
1296636|NCT00274742|4225090|P6|Overall Study|Disease Progression|0
1296637|NCT00274742|4225091|P5|Overall Study|Disease Progression|1
1296638|NCT00274742|4225092|P4|Overall Study|Disease Progression|0
1296639|NCT00274742|4225093|P3|Overall Study|Disease Progression|1
1296640|NCT00274742|4225094|P2|Overall Study|Disease Progression|1
1296641|NCT00274742|4225095|P1|Overall Study|Disease Progression|0
1296642|NCT00274742|4225090|P6|Overall Study|End of Study|0
1296643|NCT00274742|4225091|P5|Overall Study|End of Study|0
1296644|NCT00274742|4225092|P4|Overall Study|End of Study|1
1296645|NCT00274742|4225093|P3|Overall Study|End of Study|0
1296646|NCT00274742|4225094|P2|Overall Study|End of Study|0
1296647|NCT00274742|4225095|P1|Overall Study|End of Study|0
1296648|NCT00274742|4225090|P6|Overall Study|Lost to Follow-up|0
1296649|NCT00274742|4225091|P5|Overall Study|Lost to Follow-up|1
1296650|NCT00274742|4225092|P4|Overall Study|Lost to Follow-up|0
1296651|NCT00274742|4225093|P3|Overall Study|Lost to Follow-up|0
1296652|NCT00274742|4225094|P2|Overall Study|Lost to Follow-up|0
1296653|NCT00274742|4225095|P1|Overall Study|Lost to Follow-up|0
1296654|NCT00274742|4225090|P6|Overall Study|Adverse Event|3
1296655|NCT00274742|4225091|P5|Overall Study|Adverse Event|12
1296656|NCT00274742|4225092|P4|Overall Study|Adverse Event|4
1296657|NCT00274742|4225093|P3|Overall Study|Adverse Event|1
1296658|NCT00274742|4225094|P2|Overall Study|Adverse Event|4
1296659|NCT00274742|4225095|P1|Overall Study|Adverse Event|0
1296660|NCT00274716|4225133|P6|Phase B|Lost to Follow-up|0
1296661|NCT00274716|4225134|P5|Phase B|Lost to Follow-up|0
1296662|NCT00274716|4225135|P4|Phase B|Lost to Follow-up|0
1296663|NCT00274716|4225136|P3|Phase B|Lost to Follow-up|0
1296664|NCT00274716|4225137|P2|Phase B|Lost to Follow-up|1
1296665|NCT00274716|4225138|P1|Phase B|Lost to Follow-up|0
1296666|NCT00274716|4225133|P6|Phase B|Other non-reported reason|0
1296667|NCT00274716|4225134|P5|Phase B|Other non-reported reason|0
1296668|NCT00274716|4225135|P4|Phase B|Other non-reported reason|1
1296669|NCT00274716|4225136|P3|Phase B|Other non-reported reason|1
1296670|NCT00274716|4225137|P2|Phase B|Other non-reported reason|0
1296671|NCT00274716|4225138|P1|Phase B|Other non-reported reason|0
1296672|NCT00274716|4225133|P6|Phase B|Participant moved|0
1296673|NCT00274716|4225134|P5|Phase B|Participant moved|0
1296674|NCT00274716|4225135|P4|Phase B|Participant moved|0
1296675|NCT00274716|4225136|P3|Phase B|Participant moved|0
1296676|NCT00274716|4225137|P2|Phase B|Participant moved|0
1296677|NCT00274716|4225138|P1|Phase B|Participant moved|1
1296678|NCT00274716|4225133|P6|Phase B|Withdrawal by Subject|0
1296679|NCT00274716|4225134|P5|Phase B|Withdrawal by Subject|0
1296680|NCT00274716|4225135|P4|Phase B|Withdrawal by Subject|0
1296681|NCT00274716|4225136|P3|Phase B|Withdrawal by Subject|0
1296682|NCT00274716|4225137|P2|Phase B|Withdrawal by Subject|1
1296683|NCT00274716|4225138|P1|Phase B|Withdrawal by Subject|0
1296684|NCT00274716|4225133|P6|Phase B|Protocol Violation|0
1296685|NCT00274716|4225134|P5|Phase B|Protocol Violation|0
1296686|NCT00274716|4225135|P4|Phase B|Protocol Violation|0
1296687|NCT00274716|4225136|P3|Phase B|Protocol Violation|0
1296688|NCT00274716|4225137|P2|Phase B|Protocol Violation|2
1296689|NCT00274716|4225138|P1|Phase B|Protocol Violation|0
1296690|NCT00274716|4225133|P6|Phase B|Adverse Event|1
1296691|NCT00274716|4225134|P5|Phase B|Adverse Event|0
1296692|NCT00274716|4225135|P4|Phase B|Adverse Event|0
1296693|NCT00274716|4225136|P3|Phase B|Adverse Event|2
1296694|NCT00274716|4225137|P2|Phase B|Adverse Event|0
1296695|NCT00274716|4225138|P1|Phase B|Adverse Event|0
1296696|NCT00274716|4225133|P6|Phase A|Completed but did not enter Phase B|1
1296697|NCT00274716|4225134|P5|Phase A|Completed but did not enter Phase B|1
1296698|NCT00274716|4225135|P4|Phase A|Completed but did not enter Phase B|2
1296699|NCT00274716|4225136|P3|Phase A|Completed but did not enter Phase B|2
1296700|NCT00274716|4225137|P2|Phase A|Completed but did not enter Phase B|2
1296701|NCT00274716|4225138|P1|Phase A|Completed but did not enter Phase B|1
1296702|NCT00274716|4225133|P6|Phase A|Adverse Event|0
1296703|NCT00274716|4225134|P5|Phase A|Adverse Event|2
1296704|NCT00274716|4225135|P4|Phase A|Adverse Event|0
1296705|NCT00274716|4225136|P3|Phase A|Adverse Event|3
1296706|NCT00274716|4225137|P2|Phase A|Adverse Event|3
1296707|NCT00274716|4225138|P1|Phase A|Adverse Event|2
1296708|NCT00274716|4225133|P6|Phase A|Withdrawal by Subject|1
1296709|NCT00274716|4225134|P5|Phase A|Withdrawal by Subject|0
1296710|NCT00274716|4225135|P4|Phase A|Withdrawal by Subject|3
1296711|NCT00274716|4225136|P3|Phase A|Withdrawal by Subject|1
1296712|NCT00274716|4225137|P2|Phase A|Withdrawal by Subject|2
1296713|NCT00274716|4225138|P1|Phase A|Withdrawal by Subject|2
1296714|NCT00274716|4225133|P6|Phase A|Met criteria for discontinuation|0
1296715|NCT00274716|4225134|P5|Phase A|Met criteria for discontinuation|0
1296716|NCT00274716|4225135|P4|Phase A|Met criteria for discontinuation|0
1296717|NCT00274716|4225136|P3|Phase A|Met criteria for discontinuation|0
1296718|NCT00274716|4225137|P2|Phase A|Met criteria for discontinuation|1
1296719|NCT00274716|4225138|P1|Phase A|Met criteria for discontinuation|1
1296720|NCT00274716|4225133|P6|Phase A|Protocol Violation|0
1296721|NCT00274716|4225134|P5|Phase A|Protocol Violation|0
1296722|NCT00274716|4225135|P4|Phase A|Protocol Violation|1
1296723|NCT00274716|4225136|P3|Phase A|Protocol Violation|0
1296724|NCT00274716|4225137|P2|Phase A|Protocol Violation|0
1296725|NCT00274716|4225138|P1|Phase A|Protocol Violation|1
1296726|NCT00274716|4225133|P6|Phase A|Site Terminated|0
1296727|NCT00274716|4225134|P5|Phase A|Site Terminated|0
1296728|NCT00274716|4225135|P4|Phase A|Site Terminated|1
1296729|NCT00274716|4225136|P3|Phase A|Site Terminated|0
1296730|NCT00274716|4225137|P2|Phase A|Site Terminated|0
1296731|NCT00274716|4225138|P1|Phase A|Site Terminated|0
1296732|NCT00274716|4225133|P6|Phase A|Participant moved|1
1296733|NCT00274716|4225134|P5|Phase A|Participant moved|0
1296734|NCT00274716|4225135|P4|Phase A|Participant moved|0
1296735|NCT00274716|4225136|P3|Phase A|Participant moved|1
1296736|NCT00274716|4225137|P2|Phase A|Participant moved|0
1296737|NCT00274716|4225138|P1|Phase A|Participant moved|0
1296738|NCT00274716|4225133|P6|Phase A|Other non-reported reason|1
1296739|NCT00274716|4225134|P5|Phase A|Other non-reported reason|0
1296740|NCT00274716|4225135|P4|Phase A|Other non-reported reason|2
1296741|NCT00274716|4225136|P3|Phase A|Other non-reported reason|1
1296742|NCT00274716|4225137|P2|Phase A|Other non-reported reason|2
1296743|NCT00274716|4225138|P1|Phase A|Other non-reported reason|4
1296744|NCT00274651|4225200|P2|Overall Study|Physician Decision|7
1296745|NCT00274651|4225201|P1|Overall Study|Physician Decision|8
1296746|NCT00274651|4225200|P2|Overall Study|Withdrawal by Subject|1
1296747|NCT00274651|4225201|P1|Overall Study|Withdrawal by Subject|0
1296748|NCT00274651|4225200|P2|Overall Study|Death|3
1296749|NCT00274651|4225201|P1|Overall Study|Death|1
1296750|NCT00274651|4225200|P2|Overall Study|Lack of Efficacy|6
1296751|NCT00274651|4225201|P1|Overall Study|Lack of Efficacy|13
1296752|NCT00274651|4225200|P2|Overall Study|Adverse Event|3
1296753|NCT00274651|4225201|P1|Overall Study|Adverse Event|6
1296754|NCT00274625|4225216|P2|Overall Study|Excluded from analysis|8
1296755|NCT00274625|4225217|P1|Overall Study|Excluded from analysis|14
1296756|NCT00274625|4225216|P2|Overall Study|Lost to Follow-up|54
1296757|NCT00274625|4225217|P1|Overall Study|Lost to Follow-up|46
1296758|NCT00274469|4225225|P2|Overall Study|Reasons not specified|8
1296759|NCT00274469|4225226|P1|Overall Study|Reasons not specified|5
1296760|NCT00274469|4225225|P2|Overall Study|Withdrawal by Subject|0
1296761|NCT00274469|4225226|P1|Overall Study|Withdrawal by Subject|2
1296762|NCT00274469|4225225|P2|Overall Study|Condition under investigation worsened|38
1296763|NCT00274469|4225226|P1|Overall Study|Condition under investigation worsened|28
1296764|NCT00274469|4225225|P2|Overall Study|Adverse Event|3
1296765|NCT00274469|4225226|P1|Overall Study|Adverse Event|2
1296766|NCT00274469|4225225|P2|Overall Study|Death|1
1296767|NCT00274469|4225226|P1|Overall Study|Death|1
1296768|NCT00274456|4225244|P4|Overall Study|Withdrawal by Subject|13
1296769|NCT00274456|4225245|P3|Overall Study|Withdrawal by Subject|9
1296770|NCT00274456|4225246|P2|Overall Study|Withdrawal by Subject|13
1296771|NCT00274456|4225247|P1|Overall Study|Withdrawal by Subject|18
1296772|NCT00274456|4225244|P4|Overall Study|Lost to Follow-up|0
1296773|NCT00274456|4225245|P3|Overall Study|Lost to Follow-up|1
1296774|NCT00274456|4225246|P2|Overall Study|Lost to Follow-up|0
1296775|NCT00274456|4225247|P1|Overall Study|Lost to Follow-up|0
1296776|NCT00274456|4225244|P4|Overall Study|Physician Decision|13
1296777|NCT00274456|4225245|P3|Overall Study|Physician Decision|6
1296778|NCT00274456|4225246|P2|Overall Study|Physician Decision|5
1296779|NCT00274456|4225247|P1|Overall Study|Physician Decision|7
1296780|NCT00274456|4225244|P4|Overall Study|Adverse Event|2
1296781|NCT00274456|4225245|P3|Overall Study|Adverse Event|2
1296782|NCT00274456|4225246|P2|Overall Study|Adverse Event|1
1296783|NCT00274456|4225247|P1|Overall Study|Adverse Event|0
1296784|NCT00274456|4225244|P4|Overall Study|Unacceptable toxicity|16
1296785|NCT00274456|4225245|P3|Overall Study|Unacceptable toxicity|12
1296786|NCT00274456|4225246|P2|Overall Study|Unacceptable toxicity|5
1296787|NCT00274456|4225247|P1|Overall Study|Unacceptable toxicity|10
1296788|NCT00274456|4225244|P4|Overall Study|Still on treatment|1
1296789|NCT00274456|4225245|P3|Overall Study|Still on treatment|5
1296790|NCT00274456|4225246|P2|Overall Study|Still on treatment|3
1296791|NCT00274456|4225247|P1|Overall Study|Still on treatment|2
1296792|NCT00274287|4225289|P1|Overall Study|subject non-compliance|1
1296793|NCT00274287|4225289|P1|Overall Study|Withdrawal by Subject|1
1296794|NCT00274261|4225295|P2|Overall Study|Lost to Follow-up|75
1296795|NCT00274261|4225296|P1|Overall Study|Lost to Follow-up|106
1296796|NCT00274261|4225295|P2|Overall Study|Protocol Violation|42
1296797|NCT00274261|4225296|P1|Overall Study|Protocol Violation|71
1296798|NCT00274261|4225295|P2|Overall Study|Withdrawal by Subject|126
1296799|NCT00274261|4225296|P1|Overall Study|Withdrawal by Subject|179
1296800|NCT00274261|4225295|P2|Overall Study|Pregnancy|83
1296801|NCT00274261|4225296|P1|Overall Study|Pregnancy|114
1296802|NCT00274261|4225295|P2|Overall Study|Adverse Event|11
1296803|NCT00274261|4225296|P1|Overall Study|Adverse Event|19
1296804|NCT00273858|4225335|P1|Overall Study|Adverse Event|81
1296805|NCT00273858|4225335|P1|Overall Study|Withdrawal by Subject|21
1296806|NCT00273858|4225335|P1|Overall Study|Lost to Follow-up|101
1296807|NCT00273858|4225335|P1|Overall Study|Not completed 24 month observation time|334
1296808|NCT00273182|4225394|P1|Overall Study|Site exit, system change, 36 m FU missed|36
1296809|NCT00273182|4225394|P1|Overall Study|Device/System Explant|154
1296810|NCT00273182|4225394|P1|Overall Study|Withdrawal by Subject|257
1296811|NCT00273182|4225394|P1|Overall Study|Lost to Follow-up|88
1296812|NCT00273182|4225394|P1|Overall Study|Death|450
1296813|NCT00273052|4225404|P2|Overall Study|Worsening serum lipid levels|2
1296814|NCT00273052|4225405|P1|Overall Study|Worsening serum lipid levels|0
1296815|NCT00273052|4225404|P2|Overall Study|Not specified|0
1296816|NCT00273052|4225405|P1|Overall Study|Not specified|2
1296817|NCT00273052|4225404|P2|Overall Study|Non-Compliance|1
1296818|NCT00273052|4225405|P1|Overall Study|Non-Compliance|3
1296819|NCT00273052|4225404|P2|Overall Study|Lack of Efficacy|4
1296820|NCT00273052|4225405|P1|Overall Study|Lack of Efficacy|6
1296821|NCT00273052|4225404|P2|Overall Study|Lost to Follow-up|25
1296822|NCT00273052|4225405|P1|Overall Study|Lost to Follow-up|7
1296823|NCT00273052|4225404|P2|Overall Study|Protocol Violation|18
1296824|NCT00273052|4225405|P1|Overall Study|Protocol Violation|14
1296825|NCT00273052|4225404|P2|Overall Study|Adverse Event|19
1296826|NCT00273052|4225405|P1|Overall Study|Adverse Event|21
1296827|NCT00273052|4225404|P2|Overall Study|Withdrawal by Subject|19
1296828|NCT00273052|4225405|P1|Overall Study|Withdrawal by Subject|16
1296829|NCT00272987|4225440|P3|Overall Study|Ongoing|15
1296830|NCT00272987|4225441|P2|Overall Study|Ongoing|14
1296831|NCT00272987|4225442|P1|Overall Study|Ongoing|20
1296832|NCT00272987|4225440|P3|Overall Study|Missed >3 Visits|1
1296833|NCT00272987|4225441|P2|Overall Study|Missed >3 Visits|0
1296834|NCT00272987|4225442|P1|Overall Study|Missed >3 Visits|0
1296835|NCT00272987|4225440|P3|Overall Study|Withdrawal by Subject|3
1296836|NCT00272987|4225441|P2|Overall Study|Withdrawal by Subject|0
1296837|NCT00272987|4225442|P1|Overall Study|Withdrawal by Subject|0
1296838|NCT00272987|4225440|P3|Overall Study|Adverse Event|0
1296839|NCT00272987|4225441|P2|Overall Study|Adverse Event|0
1296840|NCT00272987|4225442|P1|Overall Study|Adverse Event|1
1296841|NCT00272961|4225506|P5|Treatment Phase: Week 3 Up to Week 12|Other|2
1296842|NCT00272961|4225507|P4|Treatment Phase: Week 3 Up to Week 12|Other|2
1296843|NCT00272961|4225508|P3|Treatment Phase: Week 3 Up to Week 12|Other|3
1296844|NCT00272961|4225509|P2|Treatment Phase: Week 3 Up to Week 12|Other|3
1296845|NCT00272961|4225510|P1|Treatment Phase: Week 3 Up to Week 12|Other|1
1296846|NCT00272961|4225506|P5|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
1296847|NCT00272961|4225507|P4|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
1296848|NCT00272961|4225508|P3|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
1296849|NCT00272961|4225509|P2|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
1296850|NCT00272961|4225510|P1|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
1296851|NCT00272961|4225506|P5|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2
1296852|NCT00272961|4225507|P4|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
1296853|NCT00272961|4225508|P3|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
1296854|NCT00272961|4225509|P2|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
1296855|NCT00272961|4225510|P1|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
1296856|NCT00272961|4225506|P5|Placebo Run-in Phase: Up to Week 2|Other|0
1296857|NCT00272961|4225507|P4|Placebo Run-in Phase: Up to Week 2|Other|0
1296858|NCT00272961|4225508|P3|Placebo Run-in Phase: Up to Week 2|Other|0
1296859|NCT00272961|4225509|P2|Placebo Run-in Phase: Up to Week 2|Other|0
1296860|NCT00272961|4225510|P1|Placebo Run-in Phase: Up to Week 2|Other|2
1296861|NCT00272961|4225506|P5|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
1296862|NCT00272961|4225507|P4|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
1296863|NCT00272961|4225508|P3|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
1296864|NCT00272961|4225509|P2|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
1296865|NCT00272961|4225510|P1|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2
1296866|NCT00272961|4225506|P5|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
1296867|NCT00272961|4225507|P4|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
1296868|NCT00272961|4225508|P3|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
1296869|NCT00272961|4225509|P2|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
1296870|NCT00272961|4225510|P1|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5
1296871|NCT00272961|4225506|P5|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
1296872|NCT00272961|4225507|P4|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
1296873|NCT00272961|4225508|P3|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
1296874|NCT00272961|4225509|P2|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
1296875|NCT00272961|4225510|P1|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1
1296876|NCT00272961|4225506|P5|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
1296877|NCT00272961|4225507|P4|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
1296878|NCT00272961|4225508|P3|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
1296879|NCT00272961|4225509|P2|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
1296880|NCT00272961|4225510|P1|Placebo Run-in Phase: Up to Week 2|Physician Decision|1
1296881|NCT00272844|4225567|P1|Overall Study|Withdrawal by Subject|5
1296882|NCT00272792|4225575|P2|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1
1296883|NCT00272792|4225576|P1|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0
1296884|NCT00272792|4225575|P2|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0
1296885|NCT00272792|4225576|P1|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1
1296886|NCT00272792|4225575|P2|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2
1296887|NCT00272792|4225576|P1|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0
1296888|NCT00272792|4225575|P2|Part 1: Responsiveness|Lost to Follow-up|0
1296889|NCT00272792|4225576|P1|Part 1: Responsiveness|Lost to Follow-up|1
1296890|NCT00272779|4225586|P2|Baseline Through Week 96|Continuing on treatment|38
1296891|NCT00272779|4225587|P1|Baseline Through Week 96|Continuing on treatment|61
1296892|NCT00272779|4225586|P2|Baseline Through Week 96|Never treated|3
1296893|NCT00272779|4225587|P1|Baseline Through Week 96|Never treated|2
1296894|NCT00272779|4225586|P2|Baseline Through Week 96|Pregnancy at Week 96|0
1296895|NCT00272779|4225587|P1|Baseline Through Week 96|Pregnancy at Week 96|1
1296896|NCT00272779|4225586|P2|Baseline Through Week 96|Poor/non compliance at Week 96]|0
1296897|NCT00272779|4225587|P1|Baseline Through Week 96|Poor/non compliance at Week 96]|2
1296898|NCT00272779|4225586|P2|Baseline Through Week 96|Lost to follow-up at Week 96|0
1296899|NCT00272779|4225587|P1|Baseline Through Week 96|Lost to follow-up at Week 96|1
1296900|NCT00272779|4225586|P2|Baseline Through Week 96|Changed address before Week 96|1
1296901|NCT00272779|4225587|P1|Baseline Through Week 96|Changed address before Week 96|0
1296902|NCT00272779|4225586|P2|Baseline Through Week 96|Withdrew consent before Week 96|18
1296903|NCT00272779|4225587|P1|Baseline Through Week 96|Withdrew consent before Week 96|5
1296904|NCT00272779|4225586|P2|Baseline Through Week 96|No longer meets criteria before Week 96|3
1296905|NCT00272779|4225587|P1|Baseline Through Week 96|No longer meets criteria before Week 96|4
1296906|NCT00272779|4225586|P2|Baseline Through Week 96|Pregnancy before Week 96|7
1296907|NCT00272779|4225587|P1|Baseline Through Week 96|Pregnancy before Week 96|5
1296908|NCT00272779|4225586|P2|Baseline Through Week 96|Poor/non compliance before Week 96|16
1296909|NCT00272779|4225587|P1|Baseline Through Week 96|Poor/non compliance before Week 96|12
1296910|NCT00272779|4225586|P2|Baseline Through Week 96|Participant Imprisoned before Week 96|0
1296911|NCT00272779|4225587|P1|Baseline Through Week 96|Participant Imprisoned before Week 96|1
1296912|NCT00272779|4225586|P2|Baseline Through Week 96|Lost to follow up before Week 96|13
1296913|NCT00272779|4225587|P1|Baseline Through Week 96|Lost to follow up before Week 96|10
1296914|NCT00272779|4225586|P2|Baseline Through Week 96|Lack of efficacy before Week 96|10
1296915|NCT00272779|4225587|P1|Baseline Through Week 96|Lack of efficacy before Week 96|16
1296916|NCT00272779|4225586|P2|Baseline Through Week 96|Death before Week 96|5
1296917|NCT00272779|4225587|P1|Baseline Through Week 96|Death before Week 96|6
1296918|NCT00272779|4225586|P2|Baseline Through Week 96|Adverse event before Week 96|22
1296919|NCT00272779|4225587|P1|Baseline Through Week 96|Adverse event before Week 96|13
1296920|NCT00272779|4225586|P2|Baseline Through Week 48|Never treated|3
1296921|NCT00272779|4225587|P1|Baseline Through Week 48|Never treated|2
1296922|NCT00272779|4225586|P2|Baseline Through Week 48|Lost to follow-up on/after Week 48|3
1296923|NCT00272779|4225587|P1|Baseline Through Week 48|Lost to follow-up on/after Week 48|0
1296924|NCT00272779|4225586|P2|Baseline Through Week 48|Continuing treatment|368
1296925|NCT00272779|4225587|P1|Baseline Through Week 48|Continuing treatment|385
1296926|NCT00272779|4225586|P2|Baseline Through Week 48|Withdrew consent on/after Week 48|2
1296927|NCT00272779|4225587|P1|Baseline Through Week 48|Withdrew consent on/after Week 48|0
1296928|NCT00272779|4225586|P2|Baseline Through Week 48|Pregnancy on/after Week 48|2
1296929|NCT00272779|4225587|P1|Baseline Through Week 48|Pregnancy on/after Week 48|1
1296930|NCT00272779|4225586|P2|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
1296931|NCT00272779|4225587|P1|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
1296932|NCT00272779|4225586|P2|Baseline Through Week 48|Poor/non compliance on/after Week|2
1296933|NCT00272779|4225587|P1|Baseline Through Week 48|Poor/non compliance on/after Week|2
1296934|NCT00272779|4225586|P2|Baseline Through Week 48|Lack of efficacy on/after Week 48|1
1296935|NCT00272779|4225587|P1|Baseline Through Week 48|Lack of efficacy on/after Week 48|7
1296936|NCT00272779|4225586|P2|Baseline Through Week 48|Death on/after Week 48|1
1296937|NCT00272779|4225587|P1|Baseline Through Week 48|Death on/after Week 48|1
1296938|NCT00272779|4225586|P2|Baseline Through Week 48|Adverse event on/after Week 48|1
1296939|NCT00272779|4225587|P1|Baseline Through Week 48|Adverse event on/after Week 48|1
1296940|NCT00272779|4225586|P2|Baseline Through Week 48|Chose different site before wk 48|1
1296941|NCT00272779|4225587|P1|Baseline Through Week 48|Chose different site before wk 48|0
1296942|NCT00272779|4225586|P2|Baseline Through Week 48|Participant's decision before wk 48|1
1296943|NCT00272779|4225587|P1|Baseline Through Week 48|Participant's decision before wk 48|0
1296944|NCT00272779|4225586|P2|Baseline Through Week 48|Withdrew consent before Week 48|13
1296945|NCT00272779|4225587|P1|Baseline Through Week 48|Withdrew consent before Week 48|4
1296946|NCT00272779|4225586|P2|Baseline Through Week 48|No longer meets criteria before Week 48|0
1296947|NCT00272779|4225587|P1|Baseline Through Week 48|No longer meets criteria before Week 48|1
1296948|NCT00272779|4225586|P2|Baseline Through Week 48|Pregnancy before Week 48|2
1296949|NCT00272779|4225587|P1|Baseline Through Week 48|Pregnancy before Week 48|2
1296950|NCT00272779|4225586|P2|Baseline Through Week 48|Poor/non compliance before Week 48|9
1296951|NCT00272779|4225587|P1|Baseline Through Week 48|Poor/non compliance before Week 48|6
1296952|NCT00272779|4225586|P2|Baseline Through Week 48|Viral load rebound before Week 48|0
1296953|NCT00272779|4225587|P1|Baseline Through Week 48|Viral load rebound before Week 48|1
1296954|NCT00272779|4225586|P2|Baseline Through Week 48|Lost to follow-up before Week 48|6
1296955|NCT00272779|4225587|P1|Baseline Through Week 48|Lost to follow-up before Week 48|6
1296956|NCT00272779|4225586|P2|Baseline Through Week 48|Lack of efficacy before Week 48|8
1296957|NCT00272779|4225587|P1|Baseline Through Week 48|Lack of efficacy before Week 48|5
1296958|NCT00272779|4225586|P2|Baseline Through Week 48|Death before Week 48|4
1296959|NCT00272779|4225587|P1|Baseline Through Week 48|Death before Week 48|4
1296960|NCT00272779|4225586|P2|Baseline Through Week 48|Adverse event before Week 48|14
1296961|NCT00272779|4225587|P1|Baseline Through Week 48|Adverse event before Week 48|10
1296962|NCT00272038|4225837|P1|Overall Study|withdrew before they received 2 cycles|7
1296963|NCT00271947|4225843|P1|Overall Study|Lost to Follow-up|1
1296964|NCT00271856|4225849|P2|Overall Study|Lost to Follow-up|11
1296965|NCT00271856|4225850|P1|Overall Study|Lost to Follow-up|10
1296966|NCT00271856|4225849|P2|Overall Study|Withdrawal by Subject|7
1296967|NCT00271856|4225850|P1|Overall Study|Withdrawal by Subject|1
1296968|NCT00271817|4225869|P3|Part 2|LDL < 50 mg/dL|4
1296969|NCT00271817|4225870|P2|Part 2|LDL < 50 mg/dL|3
1296970|NCT00271817|4225871|P1|Part 2|LDL < 50 mg/dL|0
1296971|NCT00271817|4225869|P3|Part 2|Withdrawal by Subject|13
1296972|NCT00271817|4225870|P2|Part 2|Withdrawal by Subject|2
1296973|NCT00271817|4225871|P1|Part 2|Withdrawal by Subject|0
1296974|NCT00271817|4225869|P3|Part 2|Patient Moved|5
1296975|NCT00271817|4225870|P2|Part 2|Patient Moved|0
1296976|NCT00271817|4225871|P1|Part 2|Patient Moved|0
1296977|NCT00271817|4225869|P3|Part 2|Protocol Violation|5
1296978|NCT00271817|4225870|P2|Part 2|Protocol Violation|3
1296979|NCT00271817|4225871|P1|Part 2|Protocol Violation|0
1296980|NCT00271817|4225869|P3|Part 2|Lost to Follow-up|18
1296981|NCT00271817|4225870|P2|Part 2|Lost to Follow-up|6
1296982|NCT00271817|4225871|P1|Part 2|Lost to Follow-up|0
1296983|NCT00271817|4225869|P3|Part 2|Lack of Efficacy|6
1296984|NCT00271817|4225870|P2|Part 2|Lack of Efficacy|1
1296985|NCT00271817|4225871|P1|Part 2|Lack of Efficacy|0
1296986|NCT00271817|4225869|P3|Part 2|Adverse Event|33
1296987|NCT00271817|4225870|P2|Part 2|Adverse Event|17
1296988|NCT00271817|4225871|P1|Part 2|Adverse Event|0
1296989|NCT00271817|4225869|P3|Part 1|LDL < 50 mg/dL|48
1296990|NCT00271817|4225870|P2|Part 1|LDL < 50 mg/dL|4
1296991|NCT00271817|4225871|P1|Part 1|LDL < 50 mg/dL|1
1296992|NCT00271817|4225869|P3|Part 1|Withdrawal by Subject|45
1296993|NCT00271817|4225870|P2|Part 1|Withdrawal by Subject|17
1296994|NCT00271817|4225871|P1|Part 1|Withdrawal by Subject|23
1296995|NCT00271817|4225869|P3|Part 1|Patient Moved|5
1296996|NCT00271817|4225870|P2|Part 1|Patient Moved|1
1296997|NCT00271817|4225871|P1|Part 1|Patient Moved|3
1296998|NCT00271817|4225869|P3|Part 1|Protocol Violation|7
1296999|NCT00271817|4225870|P2|Part 1|Protocol Violation|4
1297000|NCT00271817|4225871|P1|Part 1|Protocol Violation|5
1297001|NCT00271817|4225869|P3|Part 1|Lost to Follow-up|24
1297002|NCT00271817|4225870|P2|Part 1|Lost to Follow-up|8
1297003|NCT00271817|4225871|P1|Part 1|Lost to Follow-up|6
1297004|NCT00271817|4225869|P3|Part 1|Adverse Event|156
1297005|NCT00271817|4225870|P2|Part 1|Adverse Event|25
1297006|NCT00271817|4225871|P1|Part 1|Adverse Event|68
1297007|NCT00271609|4225913|P2|Overall Study|Withdrawal by Subject|0
1297008|NCT00271609|4225914|P1|Overall Study|Withdrawal by Subject|2
1297009|NCT00271609|4225913|P2|Overall Study|Adverse Event|3
1297010|NCT00271609|4225914|P1|Overall Study|Adverse Event|11
1297011|NCT00271596|4225924|P2|Overall Study|Withdrawal by Subject|1
1297012|NCT00271596|4225925|P1|Overall Study|Withdrawal by Subject|0
1297013|NCT00271596|4225924|P2|Overall Study|Protocol Violation|0
1297014|NCT00271596|4225925|P1|Overall Study|Protocol Violation|1
1297015|NCT00271544|4225960|P1|Overall Study|Implant not attempted|4
1297016|NCT00271544|4225960|P1|Overall Study|Model 4196 lead not attempted|9
1297017|NCT00271544|4225960|P1|Overall Study|Subjects did not receive a 4196 lead|7
1297018|NCT00271024|4226065|P4|Overall Study|Time Commitment, Scheduling, or Travel|4
1297019|NCT00271024|4226066|P3|Overall Study|Time Commitment, Scheduling, or Travel|4
1297020|NCT00271024|4226067|P2|Overall Study|Time Commitment, Scheduling, or Travel|2
1297021|NCT00271024|4226068|P1|Overall Study|Time Commitment, Scheduling, or Travel|6
1297022|NCT00271024|4226065|P4|Overall Study|Unpleasant Reaction To Tablet|2
1297023|NCT00271024|4226066|P3|Overall Study|Unpleasant Reaction To Tablet|4
1297024|NCT00271024|4226067|P2|Overall Study|Unpleasant Reaction To Tablet|3
1297025|NCT00271024|4226068|P1|Overall Study|Unpleasant Reaction To Tablet|1
1297026|NCT00271024|4226065|P4|Overall Study|Protocol Violation|11
1297027|NCT00271024|4226066|P3|Overall Study|Protocol Violation|5
1297028|NCT00271024|4226067|P2|Overall Study|Protocol Violation|6
1297029|NCT00271024|4226068|P1|Overall Study|Protocol Violation|1
1297030|NCT00271024|4226065|P4|Overall Study|Unknown/Unspecified|4
1297031|NCT00271024|4226066|P3|Overall Study|Unknown/Unspecified|8
1297032|NCT00271024|4226067|P2|Overall Study|Unknown/Unspecified|11
1297033|NCT00271024|4226068|P1|Overall Study|Unknown/Unspecified|11
1297034|NCT00271024|4226065|P4|Overall Study|Lost Interest|3
1297035|NCT00271024|4226066|P3|Overall Study|Lost Interest|2
1297036|NCT00271024|4226067|P2|Overall Study|Lost Interest|4
1297037|NCT00271024|4226068|P1|Overall Study|Lost Interest|3
1297038|NCT00270998|4226118|P3|12 Month Follow-up|Received/desired alternate treatment|1
1297039|NCT00270998|4226119|P2|12 Month Follow-up|Received/desired alternate treatment|4
1297040|NCT00270998|4226120|P1|12 Month Follow-up|Received/desired alternate treatment|1
1297041|NCT00270998|4226118|P3|12 Month Follow-up|Personal/family health|1
1297042|NCT00270998|4226119|P2|12 Month Follow-up|Personal/family health|5
1297043|NCT00270998|4226120|P1|12 Month Follow-up|Personal/family health|0
1297044|NCT00270998|4226118|P3|12 Month Follow-up|Pessary did not fit|0
1297045|NCT00270998|4226119|P2|12 Month Follow-up|Pessary did not fit|0
1297046|NCT00270998|4226120|P1|12 Month Follow-up|Pessary did not fit|1
1297047|NCT00270998|4226118|P3|12 Month Follow-up|Withdrawal by Subject|16
1297048|NCT00270998|4226119|P2|12 Month Follow-up|Withdrawal by Subject|12
1297049|NCT00270998|4226120|P1|12 Month Follow-up|Withdrawal by Subject|7
1297050|NCT00270998|4226118|P3|12 Month Follow-up|Lack of Efficacy|3
1297051|NCT00270998|4226119|P2|12 Month Follow-up|Lack of Efficacy|4
1297052|NCT00270998|4226120|P1|12 Month Follow-up|Lack of Efficacy|5
1297053|NCT00270998|4226118|P3|3 Month Follow-up|Received/desired alternate treatment|2
1297054|NCT00270998|4226119|P2|3 Month Follow-up|Received/desired alternate treatment|5
1297055|NCT00270998|4226120|P1|3 Month Follow-up|Received/desired alternate treatment|13
1297056|NCT00270998|4226118|P3|3 Month Follow-up|Personal/family health|0
1297057|NCT00270998|4226119|P2|3 Month Follow-up|Personal/family health|1
1297058|NCT00270998|4226120|P1|3 Month Follow-up|Personal/family health|1
1297059|NCT00270998|4226118|P3|3 Month Follow-up|Pessary did not fit|0
1297060|NCT00270998|4226119|P2|3 Month Follow-up|Pessary did not fit|0
1297061|NCT00270998|4226120|P1|3 Month Follow-up|Pessary did not fit|12
1297062|NCT00270998|4226118|P3|3 Month Follow-up|Withdrawal by Subject|15
1297063|NCT00270998|4226119|P2|3 Month Follow-up|Withdrawal by Subject|14
1297064|NCT00270998|4226120|P1|3 Month Follow-up|Withdrawal by Subject|11
1297065|NCT00270998|4226118|P3|3 Month Follow-up|Lack of Efficacy|1
1297066|NCT00270998|4226119|P2|3 Month Follow-up|Lack of Efficacy|2
1297067|NCT00270998|4226120|P1|3 Month Follow-up|Lack of Efficacy|1
1297068|NCT00270998|4226118|P3|3 Month Follow-up|Adverse Event|0
1297069|NCT00270998|4226119|P2|3 Month Follow-up|Adverse Event|0
1297070|NCT00270998|4226120|P1|3 Month Follow-up|Adverse Event|1
1297071|NCT00270894|4226149|P1|Overall Study|Withdrawal by Subject|1
1297072|NCT00270894|4226149|P1|Overall Study|Adverse Event|1
1297073|NCT00270855|4226161|P2|Overall Study|Withdrawal by Subject|8
1297074|NCT00270855|4226162|P1|Overall Study|Withdrawal by Subject|8
1297075|NCT00270257|4226298|P2|Overall Study|Data Safety Monitoring Board (DSMB) halt|424
1297076|NCT00270257|4226299|P1|Overall Study|Data Safety Monitoring Board (DSMB) halt|412
1297077|NCT00270231|4226317|P2|Second Intervention|Lost to Follow-up|1
1297078|NCT00270231|4226318|P1|Second Intervention|Lost to Follow-up|0
1297079|NCT00270231|4226317|P2|Washout Period|Lost to Follow-up|0
1297080|NCT00270231|4226318|P1|Washout Period|Lost to Follow-up|1
1297081|NCT00270231|4226317|P2|First Intervention|Lost to Follow-up|1
1297082|NCT00270231|4226318|P1|First Intervention|Lost to Follow-up|1
1297083|NCT00270205|4226328|P4|Overall Study|Lost to Follow-up|1
1297084|NCT00270205|4226329|P3|Overall Study|Lost to Follow-up|0
1297085|NCT00270205|4226330|P2|Overall Study|Lost to Follow-up|0
1297086|NCT00270205|4226331|P1|Overall Study|Lost to Follow-up|1
1297087|NCT00269919|4226449|P1|Overall Study|Started but not treated|1
1297088|NCT00269919|4226449|P1|Overall Study|Other|26
1297089|NCT00269633|4226468|P2|Overall Study|Withdrawal by Subject|0
1297090|NCT00269633|4226469|P1|Overall Study|Withdrawal by Subject|1
1297091|NCT00269477|4226479|P4|Overall Study|Missed post-vaccination blood draw|0
1297092|NCT00269477|4226480|P3|Overall Study|Missed post-vaccination blood draw|0
1297093|NCT00269477|4226481|P2|Overall Study|Missed post-vaccination blood draw|1
1297094|NCT00269477|4226482|P1|Overall Study|Missed post-vaccination blood draw|0
1297095|NCT00269477|4226479|P4|Overall Study|Protocol Violation|0
1297096|NCT00269477|4226480|P3|Overall Study|Protocol Violation|1
1297097|NCT00269477|4226481|P2|Overall Study|Protocol Violation|5
1297098|NCT00269477|4226482|P1|Overall Study|Protocol Violation|5
1297099|NCT00269152|4226498|P2|Overall Study|Protocol Violation|1
1297100|NCT00269152|4226499|P1|Overall Study|Protocol Violation|0
1297101|NCT00269152|4226498|P2|Overall Study|Physician Decision|3
1297102|NCT00269152|4226499|P1|Overall Study|Physician Decision|2
1297103|NCT00269152|4226498|P2|Overall Study|Withdrawal by Subject|3
1297104|NCT00269152|4226499|P1|Overall Study|Withdrawal by Subject|7
1297105|NCT00269152|4226498|P2|Overall Study|Adverse Event|3
1297106|NCT00269152|4226499|P1|Overall Study|Adverse Event|9
1297107|NCT00269113|4226515|P2|Overall Study|Not specified|2
1297108|NCT00269113|4226516|P1|Overall Study|Not specified|0
1297109|NCT00269113|4226515|P2|Overall Study|Protocol Violation|5
1297110|NCT00269113|4226516|P1|Overall Study|Protocol Violation|15
1297111|NCT00269113|4226515|P2|Overall Study|Lost to Follow-up|1
1297112|NCT00269113|4226516|P1|Overall Study|Lost to Follow-up|2
1297113|NCT00269113|4226515|P2|Overall Study|Death|2
1297114|NCT00269113|4226516|P1|Overall Study|Death|6
1297115|NCT00269113|4226515|P2|Overall Study|Withdrawal by Subject|2
1297116|NCT00269113|4226516|P1|Overall Study|Withdrawal by Subject|0
1297117|NCT00269113|4226515|P2|Overall Study|Early Improvement|0
1297118|NCT00269113|4226516|P1|Overall Study|Early Improvement|2
1297119|NCT00269113|4226515|P2|Overall Study|Lack of Efficacy|18
1297120|NCT00269113|4226516|P1|Overall Study|Lack of Efficacy|35
1297121|NCT00269113|4226515|P2|Overall Study|Adverse Event|7
1297122|NCT00269113|4226516|P1|Overall Study|Adverse Event|14
1297123|NCT00268996|4226536|P2|Overall Study|Other|1
1297124|NCT00268996|4226537|P1|Overall Study|Other|1
1297125|NCT00268996|4226536|P2|Overall Study|Non-compliance|0
1297126|NCT00268996|4226537|P1|Overall Study|Non-compliance|1
1297127|NCT00268996|4226536|P2|Overall Study|Withdrawal by Subject|11
1297128|NCT00268996|4226537|P1|Overall Study|Withdrawal by Subject|5
1297129|NCT00268996|4226536|P2|Overall Study|Lost to Follow-up|1
1297130|NCT00268996|4226537|P1|Overall Study|Lost to Follow-up|3
1297131|NCT00268996|4226536|P2|Overall Study|Adverse Event|7
1297132|NCT00268996|4226537|P1|Overall Study|Adverse Event|11
1297133|NCT00268983|4226581|P2|Overall Study|Death|0
1297134|NCT00268983|4226582|P1|Overall Study|Death|3
1297135|NCT00268905|4226625|P3|Overall Study|Clinical Progression|1
1297136|NCT00268905|4226626|P2|Overall Study|Clinical Progression|4
1297137|NCT00268905|4226627|P1|Overall Study|Clinical Progression|9
1297138|NCT00268905|4226625|P3|Overall Study|Physician Decision|1
1297139|NCT00268905|4226626|P2|Overall Study|Physician Decision|0
1297140|NCT00268905|4226627|P1|Overall Study|Physician Decision|3
1297141|NCT00268905|4226625|P3|Overall Study|Progressive Disease|3
1297142|NCT00268905|4226626|P2|Overall Study|Progressive Disease|4
1297143|NCT00268905|4226627|P1|Overall Study|Progressive Disease|28
1297144|NCT00268905|4226625|P3|Overall Study|Withdrawal by Subject|3
1297145|NCT00268905|4226626|P2|Overall Study|Withdrawal by Subject|0
1297146|NCT00268905|4226627|P1|Overall Study|Withdrawal by Subject|0
1297147|NCT00268905|4226625|P3|Overall Study|Lost to Follow-up|0
1297148|NCT00268905|4226626|P2|Overall Study|Lost to Follow-up|1
1297149|NCT00268905|4226627|P1|Overall Study|Lost to Follow-up|0
1297150|NCT00268905|4226625|P3|Overall Study|Adverse Event|4
1297151|NCT00268905|4226626|P2|Overall Study|Adverse Event|0
1297152|NCT00268905|4226627|P1|Overall Study|Adverse Event|3
1297153|NCT00268892|4226644|P3|Overall Study|Trial Site Closed|2
1297154|NCT00268892|4226645|P2|Overall Study|Trial Site Closed|2
1297155|NCT00268892|4226646|P1|Overall Study|Trial Site Closed|4
1297156|NCT00268892|4226644|P3|Overall Study|Disease Progression|0
1297157|NCT00268892|4226645|P2|Overall Study|Disease Progression|1
1297158|NCT00268892|4226646|P1|Overall Study|Disease Progression|1
1297159|NCT00268892|4226644|P3|Overall Study|Protocol Violation|0
1297160|NCT00268892|4226645|P2|Overall Study|Protocol Violation|1
1297161|NCT00268892|4226646|P1|Overall Study|Protocol Violation|0
1297162|NCT00268892|4226644|P3|Overall Study|Lost to Follow-up|4
1297163|NCT00268892|4226645|P2|Overall Study|Lost to Follow-up|2
1297164|NCT00268892|4226646|P1|Overall Study|Lost to Follow-up|5
1297165|NCT00268892|4226644|P3|Overall Study|Physician Decision|0
1297166|NCT00268892|4226645|P2|Overall Study|Physician Decision|1
1297167|NCT00268892|4226646|P1|Overall Study|Physician Decision|0
1297168|NCT00268892|4226644|P3|Overall Study|Withdrawal by Subject|13
1297169|NCT00268892|4226645|P2|Overall Study|Withdrawal by Subject|15
1297170|NCT00268892|4226646|P1|Overall Study|Withdrawal by Subject|14
1297171|NCT00268892|4226644|P3|Overall Study|Lack of Efficacy|0
1297172|NCT00268892|4226645|P2|Overall Study|Lack of Efficacy|3
1297173|NCT00268892|4226646|P1|Overall Study|Lack of Efficacy|1
1297174|NCT00268892|4226644|P3|Overall Study|Adverse Event|20
1297175|NCT00268892|4226645|P2|Overall Study|Adverse Event|17
1297176|NCT00268892|4226646|P1|Overall Study|Adverse Event|14
1297177|NCT00268463|4226665|P2|Overall Study|study terminated due to low accrual|12
1297178|NCT00268463|4226666|P1|Overall Study|study terminated due to low accrual|10
1297179|NCT00268437|4226682|P1|Overall Study|Ineligible|1
1297180|NCT00268346|4226689|P2|Overall Study|Withdrawal by Subject|1
1297181|NCT00268346|4226690|P1|Overall Study|Withdrawal by Subject|0
1297182|NCT00268346|4226689|P2|Overall Study|Death|1
1297183|NCT00268346|4226690|P1|Overall Study|Death|0
1297184|NCT00268346|4226689|P2|Overall Study|Adverse Event|1
1297185|NCT00268346|4226690|P1|Overall Study|Adverse Event|0
1297186|NCT00268242|4226696|P1|Overall Study|Death|1
1297187|NCT00268203|4226705|P1|Overall Study|Completed 2 Years of Follow-up|62
1297188|NCT00268203|4226705|P1|Overall Study|Reason Not Specified|34
1297189|NCT00268203|4226705|P1|Overall Study|Death|84
1297190|NCT00268203|4226705|P1|Overall Study|Progressive Disease|359
1297191|NCT00268203|4226705|P1|Overall Study|Received Other NHL Therapy|7
1297192|NCT00268203|4226705|P1|Overall Study|Withdrawal by Subject|9
1297193|NCT00268203|4226705|P1|Overall Study|Lost to Follow-up|92
1297194|NCT00267969|4226719|P7|After Controlled Period|Not specified|25
1297195|NCT00267969|4226720|P6|After Controlled Period|Not specified|22
1297196|NCT00267969|4226721|P5|After Controlled Period|Not specified|11
1297197|NCT00267969|4226722|P4|After Controlled Period|Not specified|13
1297198|NCT00267969|4226723|P3|After Controlled Period|Not specified|0
1297199|NCT00267969|4226724|P2|After Controlled Period|Not specified|0
1297200|NCT00267969|4226725|P1|After Controlled Period|Not specified|0
1297201|NCT00267969|4226719|P7|After Controlled Period|Lost to Follow-up|10
1297202|NCT00267969|4226720|P6|After Controlled Period|Lost to Follow-up|9
1297203|NCT00267969|4226721|P5|After Controlled Period|Lost to Follow-up|8
1297204|NCT00267969|4226722|P4|After Controlled Period|Lost to Follow-up|5
1297205|NCT00267969|4226723|P3|After Controlled Period|Lost to Follow-up|0
1297206|NCT00267969|4226724|P2|After Controlled Period|Lost to Follow-up|0
1297207|NCT00267969|4226725|P1|After Controlled Period|Lost to Follow-up|0
1297208|NCT00267969|4226719|P7|After Controlled Period|Lack of Efficacy|15
1297209|NCT00267969|4226720|P6|After Controlled Period|Lack of Efficacy|28
1297210|NCT00267969|4226721|P5|After Controlled Period|Lack of Efficacy|6
1297211|NCT00267969|4226722|P4|After Controlled Period|Lack of Efficacy|10
1297212|NCT00267969|4226723|P3|After Controlled Period|Lack of Efficacy|0
1297213|NCT00267969|4226724|P2|After Controlled Period|Lack of Efficacy|0
1297214|NCT00267969|4226725|P1|After Controlled Period|Lack of Efficacy|0
1297215|NCT00267969|4226719|P7|After Controlled Period|Death|1
1297216|NCT00267969|4226720|P6|After Controlled Period|Death|0
1297217|NCT00267969|4226721|P5|After Controlled Period|Death|2
1297218|NCT00267969|4226722|P4|After Controlled Period|Death|1
1297219|NCT00267969|4226723|P3|After Controlled Period|Death|0
1297220|NCT00267969|4226724|P2|After Controlled Period|Death|0
1297221|NCT00267969|4226725|P1|After Controlled Period|Death|0
1297222|NCT00267969|4226719|P7|After Controlled Period|Adverse Event|21
1297223|NCT00267969|4226720|P6|After Controlled Period|Adverse Event|23
1297224|NCT00267969|4226721|P5|After Controlled Period|Adverse Event|8
1297225|NCT00267969|4226722|P4|After Controlled Period|Adverse Event|7
1297226|NCT00267969|4226723|P3|After Controlled Period|Adverse Event|0
1297227|NCT00267969|4226724|P2|After Controlled Period|Adverse Event|0
1297228|NCT00267969|4226725|P1|After Controlled Period|Adverse Event|0
1297229|NCT00267969|4226719|P7|Controlled Period|Not specified|0
1297230|NCT00267969|4226720|P6|Controlled Period|Not specified|0
1297231|NCT00267969|4226721|P5|Controlled Period|Not specified|0
1297232|NCT00267969|4226722|P4|Controlled Period|Not specified|0
1297233|NCT00267969|4226723|P3|Controlled Period|Not specified|6
1297234|NCT00267969|4226724|P2|Controlled Period|Not specified|1
1297235|NCT00267969|4226725|P1|Controlled Period|Not specified|2
1297236|NCT00267969|4226719|P7|Controlled Period|Randomized but not treated|0
1297237|NCT00267969|4226720|P6|Controlled Period|Randomized but not treated|0
1297238|NCT00267969|4226721|P5|Controlled Period|Randomized but not treated|0
1297239|NCT00267969|4226722|P4|Controlled Period|Randomized but not treated|0
1297240|NCT00267969|4226723|P3|Controlled Period|Randomized but not treated|1
1297241|NCT00267969|4226724|P2|Controlled Period|Randomized but not treated|0
1297242|NCT00267969|4226725|P1|Controlled Period|Randomized but not treated|0
1297243|NCT00267969|4226719|P7|Controlled Period|Lost to Follow-up|0
1297244|NCT00267969|4226720|P6|Controlled Period|Lost to Follow-up|0
1297245|NCT00267969|4226721|P5|Controlled Period|Lost to Follow-up|0
1297246|NCT00267969|4226722|P4|Controlled Period|Lost to Follow-up|0
1297247|NCT00267969|4226723|P3|Controlled Period|Lost to Follow-up|1
1297248|NCT00267969|4226724|P2|Controlled Period|Lost to Follow-up|0
1297249|NCT00267969|4226725|P1|Controlled Period|Lost to Follow-up|1
1297250|NCT00267969|4226719|P7|Controlled Period|Lack of Efficacy|0
1297251|NCT00267969|4226720|P6|Controlled Period|Lack of Efficacy|0
1297252|NCT00267969|4226721|P5|Controlled Period|Lack of Efficacy|0
1297253|NCT00267969|4226722|P4|Controlled Period|Lack of Efficacy|0
1297254|NCT00267969|4226723|P3|Controlled Period|Lack of Efficacy|1
1297255|NCT00267969|4226724|P2|Controlled Period|Lack of Efficacy|0
1297256|NCT00267969|4226725|P1|Controlled Period|Lack of Efficacy|3
1297257|NCT00267969|4226719|P7|Controlled Period|Adverse Event|0
1297258|NCT00267969|4226720|P6|Controlled Period|Adverse Event|0
1297259|NCT00267969|4226721|P5|Controlled Period|Adverse Event|0
1297260|NCT00267969|4226722|P4|Controlled Period|Adverse Event|0
1297261|NCT00267969|4226723|P3|Controlled Period|Adverse Event|2
1297262|NCT00267969|4226724|P2|Controlled Period|Adverse Event|0
1297263|NCT00267969|4226725|P1|Controlled Period|Adverse Event|6
1297264|NCT00267956|4226751|P4|After Controlled Period|Withdrew consent|0
1297265|NCT00267956|4226752|P3|After Controlled Period|Withdrew consent|1
1297266|NCT00267956|4226753|P2|After Controlled Period|Withdrew consent|0
1297267|NCT00267956|4226754|P1|After Controlled Period|Withdrew consent|0
1297268|NCT00267956|4226751|P4|After Controlled Period|Lost to Follow-up|0
1297269|NCT00267956|4226752|P3|After Controlled Period|Lost to Follow-up|1
1297270|NCT00267956|4226753|P2|After Controlled Period|Lost to Follow-up|0
1297271|NCT00267956|4226754|P1|After Controlled Period|Lost to Follow-up|0
1297272|NCT00267956|4226751|P4|After Controlled Period|Lack of Efficacy|1
1297273|NCT00267956|4226752|P3|After Controlled Period|Lack of Efficacy|1
1297274|NCT00267956|4226753|P2|After Controlled Period|Lack of Efficacy|0
1297275|NCT00267956|4226754|P1|After Controlled Period|Lack of Efficacy|0
1297276|NCT00267956|4226751|P4|After Controlled Period|Adverse Event|1
1297277|NCT00267956|4226752|P3|After Controlled Period|Adverse Event|2
1297278|NCT00267956|4226753|P2|After Controlled Period|Adverse Event|0
1297279|NCT00267956|4226754|P1|After Controlled Period|Adverse Event|0
1297280|NCT00267956|4226751|P4|Controlled Period|Withdrew consent|0
1297281|NCT00267956|4226752|P3|Controlled Period|Withdrew consent|0
1297282|NCT00267956|4226753|P2|Controlled Period|Withdrew consent|1
1297283|NCT00267956|4226754|P1|Controlled Period|Withdrew consent|3
1297284|NCT00267956|4226751|P4|Controlled Period|Lost to Follow-up|0
1297285|NCT00267956|4226752|P3|Controlled Period|Lost to Follow-up|0
1297286|NCT00267956|4226753|P2|Controlled Period|Lost to Follow-up|0
1297287|NCT00267956|4226754|P1|Controlled Period|Lost to Follow-up|2
1297288|NCT00267956|4226751|P4|Controlled Period|Lack of Efficacy|0
1297289|NCT00267956|4226752|P3|Controlled Period|Lack of Efficacy|0
1297290|NCT00267956|4226753|P2|Controlled Period|Lack of Efficacy|2
1297291|NCT00267956|4226754|P1|Controlled Period|Lack of Efficacy|4
1297292|NCT00267956|4226751|P4|Controlled Period|Adverse Event|0
1297293|NCT00267956|4226752|P3|Controlled Period|Adverse Event|0
1297294|NCT00267956|4226753|P2|Controlled Period|Adverse Event|1
1297295|NCT00267956|4226754|P1|Controlled Period|Adverse Event|4
1297296|NCT00267748|4226786|P3|Randomized Period|randomized but not treated|3
1297297|NCT00267748|4226787|P2|Randomized Period|randomized but not treated|0
1297298|NCT00267748|4226788|P1|Randomized Period|randomized but not treated|0
1297299|NCT00267748|4226786|P3|Randomized Period|Other|6
1297300|NCT00267748|4226787|P2|Randomized Period|Other|9
1297301|NCT00267748|4226788|P1|Randomized Period|Other|0
1297302|NCT00267748|4226786|P3|Randomized Period|Withdrawal by Subject|2
1297303|NCT00267748|4226787|P2|Randomized Period|Withdrawal by Subject|9
1297304|NCT00267748|4226788|P1|Randomized Period|Withdrawal by Subject|0
1297305|NCT00267748|4226786|P3|Randomized Period|Objective progression or relapse|86
1297306|NCT00267748|4226787|P2|Randomized Period|Objective progression or relapse|77
1297307|NCT00267748|4226788|P1|Randomized Period|Objective progression or relapse|0
1297308|NCT00267748|4226786|P3|Randomized Period|Lost to Follow-up|0
1297309|NCT00267748|4226787|P2|Randomized Period|Lost to Follow-up|1
1297310|NCT00267748|4226788|P1|Randomized Period|Lost to Follow-up|0
1297311|NCT00267748|4226786|P3|Randomized Period|Global deterioration of health status|7
1297312|NCT00267748|4226787|P2|Randomized Period|Global deterioration of health status|6
1297313|NCT00267748|4226788|P1|Randomized Period|Global deterioration of health status|0
1297314|NCT00267748|4226786|P3|Randomized Period|Adverse Event|25
1297315|NCT00267748|4226787|P2|Randomized Period|Adverse Event|23
1297316|NCT00267748|4226788|P1|Randomized Period|Adverse Event|0
1297317|NCT00267748|4226786|P3|Randomized Period|Death|3
1297318|NCT00267748|4226787|P2|Randomized Period|Death|2
1297319|NCT00267748|4226788|P1|Randomized Period|Death|0
1297320|NCT00267748|4226786|P3|Non-randomized Period|Other|0
1297321|NCT00267748|4226787|P2|Non-randomized Period|Other|0
1297322|NCT00267748|4226788|P1|Non-randomized Period|Other|3
1297323|NCT00267748|4226786|P3|Non-randomized Period|Participant not willing to participate|0
1297324|NCT00267748|4226787|P2|Non-randomized Period|Participant not willing to participate|0
1297325|NCT00267748|4226788|P1|Non-randomized Period|Participant not willing to participate|1
1297326|NCT00267748|4226786|P3|Non-randomized Period|Death|0
1297327|NCT00267748|4226787|P2|Non-randomized Period|Death|0
1297328|NCT00267748|4226788|P1|Non-randomized Period|Death|1
1297329|NCT00267748|4226786|P3|Non-randomized Period|Adverse Event|0
1297330|NCT00267748|4226787|P2|Non-randomized Period|Adverse Event|0
1297331|NCT00267748|4226788|P1|Non-randomized Period|Adverse Event|8
1297332|NCT00267748|4226786|P3|Non-randomized Period|Progressive disease|0
1297333|NCT00267748|4226787|P2|Non-randomized Period|Progressive disease|0
1297334|NCT00267748|4226788|P1|Non-randomized Period|Progressive disease|10
1297335|NCT00267488|4226845|P1|Overall Study|Other (Disease Progression)|1
1297336|NCT00267488|4226845|P1|Overall Study|Protocol Violation|1
1297337|NCT00267488|4226845|P1|Overall Study|Sponsor Terminated Study|9
1297338|NCT00267202|4226869|P2|Overall Study|Lost to Follow-up|0
1297339|NCT00267202|4226870|P1|Overall Study|Lost to Follow-up|3
1297340|NCT00267202|4226869|P2|Overall Study|Administrative problems|1
1297341|NCT00267202|4226870|P1|Overall Study|Administrative problems|2
1297342|NCT00267202|4226869|P2|Overall Study|Protocol Violation|3
1297343|NCT00267202|4226870|P1|Overall Study|Protocol Violation|2
1297344|NCT00267202|4226869|P2|Overall Study|Adverse Event|7
1297345|NCT00267202|4226870|P1|Overall Study|Adverse Event|13
1297346|NCT00267202|4226869|P2|Overall Study|Withdrawal by Subject|15
1297347|NCT00267202|4226870|P1|Overall Study|Withdrawal by Subject|12
1297348|NCT00267202|4226869|P2|Overall Study|Unsatisfactory therapeutic effect|8
1297349|NCT00267202|4226870|P1|Overall Study|Unsatisfactory therapeutic effect|21
1297350|NCT00267189|4226891|P2|Overall Study|Missing|0
1297351|NCT00267189|4226892|P1|Overall Study|Missing|3
1297352|NCT00267189|4226891|P2|Overall Study|Death|0
1297353|NCT00267189|4226892|P1|Overall Study|Death|1
1297354|NCT00267189|4226891|P2|Overall Study|Patient withdrew consent|1
1297355|NCT00267189|4226892|P1|Overall Study|Patient withdrew consent|1
1297356|NCT00267150|4226902|P1|Overall Study|Adverse Event|1
1297357|NCT00267098|4226926|P8|Overall Study|Sponsor withdrew subject|0
1297358|NCT00267098|4226927|P7|Overall Study|Sponsor withdrew subject|0
1297359|NCT00267098|4226928|P6|Overall Study|Sponsor withdrew subject|0
1297360|NCT00267098|4226929|P5|Overall Study|Sponsor withdrew subject|0
1297361|NCT00267098|4226930|P4|Overall Study|Sponsor withdrew subject|1
1297362|NCT00267098|4226931|P3|Overall Study|Sponsor withdrew subject|0
1297363|NCT00267098|4226932|P2|Overall Study|Sponsor withdrew subject|0
1297364|NCT00267098|4226933|P1|Overall Study|Sponsor withdrew subject|0
1297365|NCT00267098|4226926|P8|Overall Study|Subject listed for heart transplant|0
1297366|NCT00267098|4226927|P7|Overall Study|Subject listed for heart transplant|1
1297367|NCT00267098|4226928|P6|Overall Study|Subject listed for heart transplant|0
1297368|NCT00267098|4226929|P5|Overall Study|Subject listed for heart transplant|0
1297369|NCT00267098|4226930|P4|Overall Study|Subject listed for heart transplant|0
1297370|NCT00267098|4226931|P3|Overall Study|Subject listed for heart transplant|0
1297371|NCT00267098|4226932|P2|Overall Study|Subject listed for heart transplant|0
1297372|NCT00267098|4226933|P1|Overall Study|Subject listed for heart transplant|0
1297373|NCT00267098|4226926|P8|Overall Study|Non-Medtronic LV Lead Implanted|0
1297374|NCT00267098|4226927|P7|Overall Study|Non-Medtronic LV Lead Implanted|0
1297375|NCT00267098|4226928|P6|Overall Study|Non-Medtronic LV Lead Implanted|0
1297376|NCT00267098|4226929|P5|Overall Study|Non-Medtronic LV Lead Implanted|2
1297377|NCT00267098|4226930|P4|Overall Study|Non-Medtronic LV Lead Implanted|0
1297378|NCT00267098|4226931|P3|Overall Study|Non-Medtronic LV Lead Implanted|0
1297379|NCT00267098|4226932|P2|Overall Study|Non-Medtronic LV Lead Implanted|0
1297380|NCT00267098|4226933|P1|Overall Study|Non-Medtronic LV Lead Implanted|0
1297381|NCT00267098|4226926|P8|Overall Study|Explanted Medtronic device|0
1297382|NCT00267098|4226927|P7|Overall Study|Explanted Medtronic device|0
1297383|NCT00267098|4226928|P6|Overall Study|Explanted Medtronic device|0
1297384|NCT00267098|4226929|P5|Overall Study|Explanted Medtronic device|0
1297385|NCT00267098|4226930|P4|Overall Study|Explanted Medtronic device|1
1297386|NCT00267098|4226931|P3|Overall Study|Explanted Medtronic device|0
1297387|NCT00267098|4226932|P2|Overall Study|Explanted Medtronic device|0
1297388|NCT00267098|4226933|P1|Overall Study|Explanted Medtronic device|0
1297389|NCT00267098|4226926|P8|Overall Study|Site closure|0
1297390|NCT00267098|4226927|P7|Overall Study|Site closure|1
1297391|NCT00267098|4226928|P6|Overall Study|Site closure|1
1297392|NCT00267098|4226929|P5|Overall Study|Site closure|0
1297393|NCT00267098|4226930|P4|Overall Study|Site closure|1
1297394|NCT00267098|4226931|P3|Overall Study|Site closure|0
1297395|NCT00267098|4226932|P2|Overall Study|Site closure|0
1297396|NCT00267098|4226933|P1|Overall Study|Site closure|0
1297397|NCT00267098|4226926|P8|Overall Study|Unsuccessful Implant Exit Per Protocol|0
1297398|NCT00267098|4226927|P7|Overall Study|Unsuccessful Implant Exit Per Protocol|0
1297399|NCT00267098|4226928|P6|Overall Study|Unsuccessful Implant Exit Per Protocol|0
1297400|NCT00267098|4226929|P5|Overall Study|Unsuccessful Implant Exit Per Protocol|0
1297401|NCT00267098|4226930|P4|Overall Study|Unsuccessful Implant Exit Per Protocol|0
1297402|NCT00267098|4226931|P3|Overall Study|Unsuccessful Implant Exit Per Protocol|0
1297403|NCT00267098|4226932|P2|Overall Study|Unsuccessful Implant Exit Per Protocol|51
1297404|NCT00267098|4226933|P1|Overall Study|Unsuccessful Implant Exit Per Protocol|0
1297405|NCT00267098|4226926|P8|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1297406|NCT00267098|4226927|P7|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1297407|NCT00267098|4226928|P6|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1297408|NCT00267098|4226929|P5|Overall Study|Inclusion/Exclusion Criteria Not Met|2
1297409|NCT00267098|4226930|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1297410|NCT00267098|4226931|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1297411|NCT00267098|4226932|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1297412|NCT00267098|4226933|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|96
1297413|NCT00267098|4226926|P8|Overall Study|Physician Decision|0
1297414|NCT00267098|4226927|P7|Overall Study|Physician Decision|3
1297415|NCT00267098|4226928|P6|Overall Study|Physician Decision|4
1297416|NCT00267098|4226929|P5|Overall Study|Physician Decision|5
1297417|NCT00267098|4226930|P4|Overall Study|Physician Decision|11
1297418|NCT00267098|4226931|P3|Overall Study|Physician Decision|7
1297419|NCT00267098|4226932|P2|Overall Study|Physician Decision|0
1297420|NCT00267098|4226933|P1|Overall Study|Physician Decision|5
1297421|NCT00267098|4226926|P8|Overall Study|Withdrawal by Subject|5
1297422|NCT00267098|4226927|P7|Overall Study|Withdrawal by Subject|12
1297423|NCT00267098|4226928|P6|Overall Study|Withdrawal by Subject|9
1297424|NCT00267098|4226929|P5|Overall Study|Withdrawal by Subject|12
1297425|NCT00267098|4226930|P4|Overall Study|Withdrawal by Subject|21
1297426|NCT00267098|4226931|P3|Overall Study|Withdrawal by Subject|24
1297427|NCT00267098|4226932|P2|Overall Study|Withdrawal by Subject|0
1297428|NCT00267098|4226933|P1|Overall Study|Withdrawal by Subject|8
1297429|NCT00267098|4226926|P8|Overall Study|Lost to Follow-up|1
1297430|NCT00267098|4226927|P7|Overall Study|Lost to Follow-up|1
1297431|NCT00267098|4226928|P6|Overall Study|Lost to Follow-up|3
1297432|NCT00267098|4226929|P5|Overall Study|Lost to Follow-up|2
1297433|NCT00267098|4226930|P4|Overall Study|Lost to Follow-up|5
1297434|NCT00267098|4226931|P3|Overall Study|Lost to Follow-up|6
1297435|NCT00267098|4226932|P2|Overall Study|Lost to Follow-up|0
1297436|NCT00267098|4226933|P1|Overall Study|Lost to Follow-up|0
1297437|NCT00267098|4226926|P8|Overall Study|Death|9
1297438|NCT00267098|4226927|P7|Overall Study|Death|28
1297439|NCT00267098|4226928|P6|Overall Study|Death|23
1297440|NCT00267098|4226929|P5|Overall Study|Death|14
1297441|NCT00267098|4226930|P4|Overall Study|Death|66
1297442|NCT00267098|4226931|P3|Overall Study|Death|57
1297443|NCT00267098|4226932|P2|Overall Study|Death|0
1297444|NCT00267098|4226933|P1|Overall Study|Death|0
1297445|NCT00267046|4227076|P2|Overall Study|Radiation|1
1297446|NCT00267046|4227077|P1|Overall Study|Radiation|0
1297447|NCT00267046|4227076|P2|Overall Study|Withdrawal by Subject|0
1297448|NCT00267046|4227077|P1|Overall Study|Withdrawal by Subject|1
1297449|NCT00267046|4227076|P2|Overall Study|Surgery|1
1297450|NCT00267046|4227077|P1|Overall Study|Surgery|3
1297451|NCT00267046|4227076|P2|Overall Study|Open-label palifermin|7
1297452|NCT00267046|4227077|P1|Overall Study|Open-label palifermin|2
1297453|NCT00267046|4227076|P2|Overall Study|Chemotoxicity|0
1297454|NCT00267046|4227077|P1|Overall Study|Chemotoxicity|2
1297455|NCT00267046|4227076|P2|Overall Study|Disease progression|2
1297456|NCT00267046|4227077|P1|Overall Study|Disease progression|4
1297457|NCT00267007|4227087|P2|Overall Study|Adverse Event|0
1297458|NCT00267007|4227088|P1|Overall Study|Adverse Event|1
1297459|NCT00267007|4227087|P2|Overall Study|Non-compliance|1
1297460|NCT00267007|4227088|P1|Overall Study|Non-compliance|0
1297461|NCT00267007|4227087|P2|Overall Study|Lost to Follow-up|0
1297462|NCT00267007|4227088|P1|Overall Study|Lost to Follow-up|1
1297463|NCT00267007|4227087|P2|Overall Study|Withdrawal by Subject|0
1297464|NCT00267007|4227088|P1|Overall Study|Withdrawal by Subject|6
1297465|NCT00266877|4227099|P3|Overall Study|Concomitant Radiotherapy|0
1297466|NCT00266877|4227100|P2|Overall Study|Concomitant Radiotherapy|1
1297467|NCT00266877|4227101|P1|Overall Study|Concomitant Radiotherapy|0
1297468|NCT00266877|4227099|P3|Overall Study|Hospitalization|0
1297469|NCT00266877|4227100|P2|Overall Study|Hospitalization|0
1297470|NCT00266877|4227101|P1|Overall Study|Hospitalization|1
1297471|NCT00266877|4227099|P3|Overall Study|Symptomatic Deterioration|1
1297472|NCT00266877|4227100|P2|Overall Study|Symptomatic Deterioration|3
1297473|NCT00266877|4227101|P1|Overall Study|Symptomatic Deterioration|6
1297474|NCT00266877|4227099|P3|Overall Study|Disease Progression|23
1297475|NCT00266877|4227100|P2|Overall Study|Disease Progression|37
1297476|NCT00266877|4227101|P1|Overall Study|Disease Progression|72
1297477|NCT00266877|4227099|P3|Overall Study|Withdrawal by Subject|1
1297478|NCT00266877|4227100|P2|Overall Study|Withdrawal by Subject|1
1297479|NCT00266877|4227101|P1|Overall Study|Withdrawal by Subject|3
1297480|NCT00266877|4227099|P3|Overall Study|Physician Decision|1
1297481|NCT00266877|4227100|P2|Overall Study|Physician Decision|1
1297482|NCT00266877|4227101|P1|Overall Study|Physician Decision|2
1297483|NCT00266877|4227099|P3|Overall Study|Adverse Event|1
1297484|NCT00266877|4227100|P2|Overall Study|Adverse Event|4
1297485|NCT00266877|4227101|P1|Overall Study|Adverse Event|6
1297486|NCT00266877|4227099|P3|Overall Study|Death|1
1297487|NCT00266877|4227100|P2|Overall Study|Death|1
1297488|NCT00266877|4227101|P1|Overall Study|Death|1
1297489|NCT00266864|4227120|P2|Overall Study|Withdrawal by Subject|1
1297490|NCT00266864|4227121|P1|Overall Study|Withdrawal by Subject|1
1297491|NCT00266864|4227120|P2|Overall Study|Lost to Follow-up|1
1297492|NCT00266864|4227121|P1|Overall Study|Lost to Follow-up|4
1297493|NCT00266825|4227130|P2|Completed Follow-Up|Withdrawal by Subject|5
1297494|NCT00266825|4227131|P1|Completed Follow-Up|Withdrawal by Subject|11
1297495|NCT00266825|4227130|P2|Completed Follow-Up|Lost to Follow-up|19
1297496|NCT00266825|4227131|P1|Completed Follow-Up|Lost to Follow-up|14
1297497|NCT00266812|4227157|P2|Overall Study|Discontinued before starting study drug|0
1297498|NCT00266812|4227158|P1|Overall Study|Discontinued before starting study drug|4
1297499|NCT00266812|4227157|P2|Overall Study|Withdrawal by Subject|2
1297500|NCT00266812|4227158|P1|Overall Study|Withdrawal by Subject|0
1297501|NCT00266812|4227157|P2|Overall Study|Protocol Violation|1
1297502|NCT00266812|4227158|P1|Overall Study|Protocol Violation|0
1297503|NCT00266812|4227157|P2|Overall Study|Adverse Event|1
1297504|NCT00266812|4227158|P1|Overall Study|Adverse Event|3
1297505|NCT00266812|4227157|P2|Overall Study|Death|4
1297506|NCT00266812|4227158|P1|Overall Study|Death|5
1297507|NCT00266812|4227157|P2|Overall Study|Disease Progression|3
1297508|NCT00266812|4227158|P1|Overall Study|Disease Progression|9
1297509|NCT00266695|4227181|P1|Overall Study|Withdrawal by Subject|15
1297510|NCT00266695|4227181|P1|Overall Study|Lost to Follow-up|3
1297511|NCT00266695|4227181|P1|Overall Study|Physician Decision|1
1297512|NCT00266695|4227181|P1|Overall Study|Death|9
1297513|NCT00266695|4227181|P1|Overall Study|Adverse Event|1
1297514|NCT00266656|4227193|P2|Overall Study|Parent/Caregiver Decision|2
1297515|NCT00266656|4227194|P1|Overall Study|Parent/Caregiver Decision|1
1297516|NCT00266656|4227193|P2|Overall Study|Did Not Reach Final Height|8
1297517|NCT00266656|4227194|P1|Overall Study|Did Not Reach Final Height|4
1297518|NCT00266656|4227193|P2|Overall Study|Withdrawal by Subject|2
1297519|NCT00266656|4227194|P1|Overall Study|Withdrawal by Subject|4
1297520|NCT00266656|4227193|P2|Overall Study|Lost to Follow-up|1
1297521|NCT00266656|4227194|P1|Overall Study|Lost to Follow-up|4
1297522|NCT00266656|4227193|P2|Overall Study|Death|0
1297523|NCT00266656|4227194|P1|Overall Study|Death|1
1297524|NCT00266630|4227218|P2|Overall Study|Not Specified|11
1297525|NCT00266630|4227219|P1|Overall Study|Not Specified|19
1297526|NCT00266630|4227218|P2|Overall Study|Lost to Follow-up|0
1297527|NCT00266630|4227219|P1|Overall Study|Lost to Follow-up|1
1297528|NCT00266630|4227218|P2|Overall Study|Withdrawal by Subject|2
1297529|NCT00266630|4227219|P1|Overall Study|Withdrawal by Subject|10
1297530|NCT00266630|4227218|P2|Overall Study|Physician Decision|2
1297531|NCT00266630|4227219|P1|Overall Study|Physician Decision|1
1297532|NCT00266630|4227218|P2|Overall Study|Protocol Violation|3
1297533|NCT00266630|4227219|P1|Overall Study|Protocol Violation|1
1297534|NCT00266630|4227218|P2|Overall Study|Entry Criteria not met|0
1297535|NCT00266630|4227219|P1|Overall Study|Entry Criteria not met|1
1297536|NCT00266630|4227218|P2|Overall Study|Lack of Efficacy|4
1297537|NCT00266630|4227219|P1|Overall Study|Lack of Efficacy|1
1297538|NCT00266630|4227218|P2|Overall Study|Adverse Event|6
1297539|NCT00266630|4227219|P1|Overall Study|Adverse Event|8
1297540|NCT00266409|4227261|P4|Overall Study|Other|0
1297541|NCT00266409|4227262|P3|Overall Study|Other|2
1297542|NCT00266409|4227263|P2|Overall Study|Other|4
1297543|NCT00266409|4227264|P1|Overall Study|Other|7
1297544|NCT00266409|4227261|P4|Overall Study|Protocol Violation|2
1297545|NCT00266409|4227262|P3|Overall Study|Protocol Violation|4
1297546|NCT00266409|4227263|P2|Overall Study|Protocol Violation|3
1297547|NCT00266409|4227264|P1|Overall Study|Protocol Violation|5
1297548|NCT00266409|4227261|P4|Overall Study|Withdrawal by Subject|9
1297549|NCT00266409|4227262|P3|Overall Study|Withdrawal by Subject|3
1297550|NCT00266409|4227263|P2|Overall Study|Withdrawal by Subject|10
1297551|NCT00266409|4227264|P1|Overall Study|Withdrawal by Subject|6
1297552|NCT00266409|4227261|P4|Overall Study|Lost to Follow-up|8
1297553|NCT00266409|4227262|P3|Overall Study|Lost to Follow-up|6
1297554|NCT00266409|4227263|P2|Overall Study|Lost to Follow-up|21
1297555|NCT00266409|4227264|P1|Overall Study|Lost to Follow-up|18
1297556|NCT00266409|4227261|P4|Overall Study|Adverse Event|1
1297557|NCT00266409|4227262|P3|Overall Study|Adverse Event|1
1297558|NCT00266409|4227263|P2|Overall Study|Adverse Event|2
1297559|NCT00266409|4227264|P1|Overall Study|Adverse Event|7
1297560|NCT00266409|4227261|P4|Overall Study|Lack of Efficacy|2
1297561|NCT00266409|4227262|P3|Overall Study|Lack of Efficacy|1
1297562|NCT00266409|4227263|P2|Overall Study|Lack of Efficacy|6
1297563|NCT00266409|4227264|P1|Overall Study|Lack of Efficacy|2
1297564|NCT00266227|4227552|P3|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0
1297565|NCT00266227|4227553|P2|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10
1297566|NCT00266227|4227554|P1|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15
1297567|NCT00266227|4227552|P3|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0
1297568|NCT00266227|4227553|P2|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29
1297569|NCT00266227|4227554|P1|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41
1297570|NCT00266227|4227552|P3|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
1297571|NCT00266227|4227553|P2|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
1297572|NCT00266227|4227554|P1|Retreatment: Week 48 to Week 72|Lost to Follow-up|1
1297573|NCT00266227|4227552|P3|Retreatment: Week 48 to Week 72|Adverse Event|0
1297574|NCT00266227|4227553|P2|Retreatment: Week 48 to Week 72|Adverse Event|2
1297575|NCT00266227|4227554|P1|Retreatment: Week 48 to Week 72|Adverse Event|6
1297576|NCT00266227|4227552|P3|Retreatment: Week 48 to Week 72|Death|0
1297577|NCT00266227|4227553|P2|Retreatment: Week 48 to Week 72|Death|1
1297578|NCT00266227|4227554|P1|Retreatment: Week 48 to Week 72|Death|1
1297579|NCT00266227|4227552|P3|Retreatment: Up to Week 48|Pregnancy|0
1297580|NCT00266227|4227553|P2|Retreatment: Up to Week 48|Pregnancy|0
1297581|NCT00266227|4227554|P1|Retreatment: Up to Week 48|Pregnancy|1
1297582|NCT00266227|4227552|P3|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0
1297583|NCT00266227|4227553|P2|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2
1297584|NCT00266227|4227554|P1|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4
1297585|NCT00266227|4227552|P3|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0
1297669|NCT00265759|4227713|P4|Overall Study|Ineligible|1
1297586|NCT00266227|4227553|P2|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14
1297587|NCT00266227|4227554|P1|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11
1297588|NCT00266227|4227552|P3|Retreatment: Up to Week 48|Lost to Follow-up|0
1297589|NCT00266227|4227553|P2|Retreatment: Up to Week 48|Lost to Follow-up|0
1297590|NCT00266227|4227554|P1|Retreatment: Up to Week 48|Lost to Follow-up|3
1297591|NCT00266227|4227552|P3|Retreatment: Up to Week 48|Adverse Event|0
1297592|NCT00266227|4227553|P2|Retreatment: Up to Week 48|Adverse Event|7
1297593|NCT00266227|4227554|P1|Retreatment: Up to Week 48|Adverse Event|7
1297594|NCT00266227|4227552|P3|Retreatment: Up to Week 48|Death|0
1297595|NCT00266227|4227553|P2|Retreatment: Up to Week 48|Death|0
1297596|NCT00266227|4227554|P1|Retreatment: Up to Week 48|Death|1
1297597|NCT00266227|4227552|P3|Initial Treatment|Pregnancy|1
1297598|NCT00266227|4227553|P2|Initial Treatment|Pregnancy|0
1297599|NCT00266227|4227554|P1|Initial Treatment|Pregnancy|0
1297600|NCT00266227|4227552|P3|Initial Treatment|Physician decision to withdraw|12
1297601|NCT00266227|4227553|P2|Initial Treatment|Physician decision to withdraw|0
1297602|NCT00266227|4227554|P1|Initial Treatment|Physician decision to withdraw|0
1297603|NCT00266227|4227552|P3|Initial Treatment|Subject/Guardian decision to withdraw|45
1297604|NCT00266227|4227553|P2|Initial Treatment|Subject/Guardian decision to withdraw|0
1297605|NCT00266227|4227554|P1|Initial Treatment|Subject/Guardian decision to withdraw|0
1297606|NCT00266227|4227552|P3|Initial Treatment|Lost to Follow-up|6
1297607|NCT00266227|4227553|P2|Initial Treatment|Lost to Follow-up|0
1297608|NCT00266227|4227554|P1|Initial Treatment|Lost to Follow-up|0
1297609|NCT00266227|4227552|P3|Initial Treatment|Adverse Event|13
1297610|NCT00266227|4227553|P2|Initial Treatment|Adverse Event|0
1297611|NCT00266227|4227554|P1|Initial Treatment|Adverse Event|0
1297612|NCT00266032|4227608|P3|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1
1297613|NCT00266032|4227609|P2|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2
1297614|NCT00266032|4227610|P1|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10
1297615|NCT00266032|4227608|P3|Open-label Safety Extension|Withdrawal by Subject|12
1297616|NCT00266032|4227609|P2|Open-label Safety Extension|Withdrawal by Subject|3
1297617|NCT00266032|4227610|P1|Open-label Safety Extension|Withdrawal by Subject|19
1297618|NCT00266032|4227608|P3|Open-label Safety Extension|Protocol Violation|2
1297619|NCT00266032|4227609|P2|Open-label Safety Extension|Protocol Violation|3
1297620|NCT00266032|4227610|P1|Open-label Safety Extension|Protocol Violation|1
1297621|NCT00266032|4227608|P3|Open-label Safety Extension|Pregnancy|2
1297622|NCT00266032|4227609|P2|Open-label Safety Extension|Pregnancy|1
1297623|NCT00266032|4227610|P1|Open-label Safety Extension|Pregnancy|4
1297624|NCT00266032|4227608|P3|Open-label Safety Extension|Lost to Follow-up|4
1297625|NCT00266032|4227609|P2|Open-label Safety Extension|Lost to Follow-up|5
1297626|NCT00266032|4227610|P1|Open-label Safety Extension|Lost to Follow-up|2
1297627|NCT00266032|4227608|P3|Open-label Safety Extension|Adverse Event|4
1297628|NCT00266032|4227609|P2|Open-label Safety Extension|Adverse Event|0
1297629|NCT00266032|4227610|P1|Open-label Safety Extension|Adverse Event|5
1297630|NCT00266032|4227608|P3|Treatment|patient moved/wish for pregnancy/no need|8
1297631|NCT00266032|4227609|P2|Treatment|patient moved/wish for pregnancy/no need|5
1297632|NCT00266032|4227610|P1|Treatment|patient moved/wish for pregnancy/no need|13
1297633|NCT00266032|4227608|P3|Treatment|Withdrawal by Subject|12
1297634|NCT00266032|4227609|P2|Treatment|Withdrawal by Subject|13
1297635|NCT00266032|4227610|P1|Treatment|Withdrawal by Subject|28
1297636|NCT00266032|4227608|P3|Treatment|Protocol Violation|13
1297637|NCT00266032|4227609|P2|Treatment|Protocol Violation|14
1297638|NCT00266032|4227610|P1|Treatment|Protocol Violation|6
1297639|NCT00266032|4227608|P3|Treatment|Pregnancy|2
1297640|NCT00266032|4227609|P2|Treatment|Pregnancy|2
1297641|NCT00266032|4227610|P1|Treatment|Pregnancy|3
1297642|NCT00266032|4227608|P3|Treatment|Lost to Follow-up|2
1297643|NCT00266032|4227609|P2|Treatment|Lost to Follow-up|4
1297644|NCT00266032|4227610|P1|Treatment|Lost to Follow-up|19
1297645|NCT00266032|4227608|P3|Treatment|Adverse Event|10
1297646|NCT00266032|4227609|P2|Treatment|Adverse Event|26
1297647|NCT00266032|4227610|P1|Treatment|Adverse Event|42
1297648|NCT00265941|4227640|P2|Overall Study|Lost to Follow-up|1
1297649|NCT00265941|4227641|P1|Overall Study|Lost to Follow-up|1
1297650|NCT00265941|4227640|P2|Overall Study|Protocol Violation|25
1297651|NCT00265941|4227641|P1|Overall Study|Protocol Violation|22
1297652|NCT00265889|4227673|P1|Overall Study|Insurance denied the request|3
1297653|NCT00265889|4227673|P1|Overall Study|Protocol Violation|1
1297654|NCT00265889|4227673|P1|Overall Study|Physician Decision|1
1297655|NCT00265785|4227700|P1|Overall Study|Did not receive protocol treatment|2
1297656|NCT00265785|4227700|P1|Overall Study|Ineligible|1
1297657|NCT00265785|4227700|P1|Overall Study|Not protocol specified|2
1297658|NCT00265785|4227700|P1|Overall Study|Progression/Relapse|15
1297659|NCT00265785|4227700|P1|Overall Study|Withdrawal by Subject|3
1297660|NCT00265785|4227700|P1|Overall Study|Adverse Event|4
1297661|NCT00265759|4227713|P4|Overall Study|Discontinued due to intolerability|1
1297662|NCT00265759|4227714|P3|Overall Study|Discontinued due to intolerability|0
1297663|NCT00265759|4227715|P2|Overall Study|Discontinued due to intolerability|0
1297664|NCT00265759|4227716|P1|Overall Study|Discontinued due to intolerability|0
1297665|NCT00265759|4227713|P4|Overall Study|Bilateral disease|2
1297666|NCT00265759|4227714|P3|Overall Study|Bilateral disease|0
1297667|NCT00265759|4227715|P2|Overall Study|Bilateral disease|0
1297668|NCT00265759|4227716|P1|Overall Study|Bilateral disease|0
1297670|NCT00265759|4227714|P3|Overall Study|Ineligible|0
1297671|NCT00265759|4227715|P2|Overall Study|Ineligible|0
1297672|NCT00265759|4227716|P1|Overall Study|Ineligible|0
1297673|NCT00265759|4227713|P4|Overall Study|Cancel|3
1297674|NCT00265759|4227714|P3|Overall Study|Cancel|0
1297675|NCT00265759|4227715|P2|Overall Study|Cancel|0
1297676|NCT00265759|4227716|P1|Overall Study|Cancel|0
1297677|NCT00265759|4227713|P4|Overall Study|Withdrawal by Subject|2
1297678|NCT00265759|4227714|P3|Overall Study|Withdrawal by Subject|2
1297679|NCT00265759|4227715|P2|Overall Study|Withdrawal by Subject|1
1297680|NCT00265759|4227716|P1|Overall Study|Withdrawal by Subject|0
1297681|NCT00265395|4227783|P2|Overall Study|Administrative|1
1297682|NCT00265395|4227784|P1|Overall Study|Administrative|0
1297683|NCT00265395|4227783|P2|Overall Study|Lack of Efficacy|1
1297684|NCT00265395|4227784|P1|Overall Study|Lack of Efficacy|0
1297685|NCT00265395|4227783|P2|Overall Study|Protocol Violation|2
1297686|NCT00265395|4227784|P1|Overall Study|Protocol Violation|2
1297687|NCT00265395|4227783|P2|Overall Study|Withdrawal by Subject|6
1297688|NCT00265395|4227784|P1|Overall Study|Withdrawal by Subject|1
1297689|NCT00265395|4227783|P2|Overall Study|Lost to Follow-up|1
1297690|NCT00265395|4227784|P1|Overall Study|Lost to Follow-up|2
1297691|NCT00265395|4227783|P2|Overall Study|Adverse Event|6
1297692|NCT00265395|4227784|P1|Overall Study|Adverse Event|3
1297693|NCT00265382|4227789|P1|Overall Study|Death|1
1297694|NCT00265382|4227789|P1|Overall Study|Study terminated by sponsor|94
1297695|NCT00265382|4227789|P1|Overall Study|Withdrawal by Subject|13
1297696|NCT00265382|4227789|P1|Overall Study|Miscellaneous|6
1297697|NCT00265382|4227789|P1|Overall Study|Lack of Efficacy|6
1297698|NCT00265382|4227789|P1|Overall Study|Lost to Follow-up|3
1297699|NCT00265382|4227789|P1|Overall Study|Laboratory Abnormality|1
1297700|NCT00265382|4227789|P1|Overall Study|Adverse Event|21
1297701|NCT00265343|4227809|P2|Overall Study|Other|3
1297702|NCT00265343|4227810|P1|Overall Study|Other|8
1297703|NCT00265343|4227809|P2|Overall Study|Withdrawal by Subject|9
1297704|NCT00265343|4227810|P1|Overall Study|Withdrawal by Subject|3
1297705|NCT00265343|4227809|P2|Overall Study|Adverse Event|7
1297706|NCT00265343|4227810|P1|Overall Study|Adverse Event|10
1297707|NCT00265330|4227818|P1|Overall Study|Protocol Violation|1
1297708|NCT00265330|4227818|P1|Overall Study|Withdrew Consent|1
1297709|NCT00265330|4227818|P1|Overall Study|Principal Investigators Request|1
1297710|NCT00265330|4227818|P1|Overall Study|Site Closed by Sponsor|1
1297711|NCT00265330|4227818|P1|Overall Study|Discharged from Unit for Long Term Care|1
1297712|NCT00265330|4227818|P1|Overall Study|Began Taking Formulary Geodon|1
1297713|NCT00265330|4227818|P1|Overall Study|Family Scheduling Conflicts|1
1297714|NCT00265330|4227818|P1|Overall Study|Lack of Efficacy|4
1297715|NCT00265330|4227818|P1|Overall Study|Patient Wanted to Start Psychotherapy|1
1297716|NCT00265330|4227818|P1|Overall Study|Withdrawal by Subject|34
1297717|NCT00265330|4227818|P1|Overall Study|Lost to Follow-up|8
1297718|NCT00265330|4227818|P1|Overall Study|Adverse Event|41
1297719|NCT00265317|4227844|P4|Phase 2|Other|1
1297720|NCT00265317|4227845|P3|Phase 2|Other|1
1297721|NCT00265317|4227846|P2|Phase 2|Other|0
1297722|NCT00265317|4227847|P1|Phase 2|Other|0
1297723|NCT00265317|4227844|P4|Phase 2|Study terminated by sponsor|0
1297724|NCT00265317|4227845|P3|Phase 2|Study terminated by sponsor|1
1297725|NCT00265317|4227846|P2|Phase 2|Study terminated by sponsor|0
1297726|NCT00265317|4227847|P1|Phase 2|Study terminated by sponsor|0
1297727|NCT00265317|4227844|P4|Phase 2|Withdrawal/other than adverse event|1
1297728|NCT00265317|4227845|P3|Phase 2|Withdrawal/other than adverse event|2
1297729|NCT00265317|4227846|P2|Phase 2|Withdrawal/other than adverse event|0
1297730|NCT00265317|4227847|P1|Phase 2|Withdrawal/other than adverse event|0
1297731|NCT00265317|4227844|P4|Phase 2|Lost to Follow-up|1
1297732|NCT00265317|4227845|P3|Phase 2|Lost to Follow-up|0
1297733|NCT00265317|4227846|P2|Phase 2|Lost to Follow-up|0
1297734|NCT00265317|4227847|P1|Phase 2|Lost to Follow-up|0
1297735|NCT00265317|4227844|P4|Phase 2|Protocol Violation|4
1297736|NCT00265317|4227845|P3|Phase 2|Protocol Violation|1
1297737|NCT00265317|4227846|P2|Phase 2|Protocol Violation|0
1297738|NCT00265317|4227847|P1|Phase 2|Protocol Violation|0
1297739|NCT00265317|4227844|P4|Phase 2|Death|15
1297740|NCT00265317|4227845|P3|Phase 2|Death|12
1297741|NCT00265317|4227846|P2|Phase 2|Death|0
1297742|NCT00265317|4227847|P1|Phase 2|Death|0
1297743|NCT00265317|4227844|P4|Phase 2|Adverse Event|5
1297744|NCT00265317|4227845|P3|Phase 2|Adverse Event|7
1297745|NCT00265317|4227846|P2|Phase 2|Adverse Event|0
1297746|NCT00265317|4227847|P1|Phase 2|Adverse Event|0
1297747|NCT00265317|4227844|P4|Phase 2|Global deterioration of health status|0
1297748|NCT00265317|4227845|P3|Phase 2|Global deterioration of health status|3
1297749|NCT00265317|4227846|P2|Phase 2|Global deterioration of health status|0
1297750|NCT00265317|4227847|P1|Phase 2|Global deterioration of health status|0
1297751|NCT00265317|4227844|P4|Phase 2|Objective progression or relapse|38
1297752|NCT00265317|4227845|P3|Phase 2|Objective progression or relapse|37
1297753|NCT00265317|4227846|P2|Phase 2|Objective progression or relapse|0
1297754|NCT00265317|4227847|P1|Phase 2|Objective progression or relapse|0
1297755|NCT00265317|4227844|P4|Lead-In|Withdrawal/other than adverse event|0
1297756|NCT00265317|4227845|P3|Lead-In|Withdrawal/other than adverse event|0
1297757|NCT00265317|4227846|P2|Lead-In|Withdrawal/other than adverse event|0
1297758|NCT00265317|4227847|P1|Lead-In|Withdrawal/other than adverse event|1
1297759|NCT00265317|4227844|P4|Lead-In|Death|0
1297760|NCT00265317|4227845|P3|Lead-In|Death|0
1297761|NCT00265317|4227846|P2|Lead-In|Death|5
1297762|NCT00265317|4227847|P1|Lead-In|Death|3
1297763|NCT00265317|4227844|P4|Lead-In|Adverse Event|0
1297764|NCT00265317|4227845|P3|Lead-In|Adverse Event|0
1297765|NCT00265317|4227846|P2|Lead-In|Adverse Event|1
1297766|NCT00265317|4227847|P1|Lead-In|Adverse Event|2
1297767|NCT00265317|4227844|P4|Lead-In|Objective progression or relapse|0
1297768|NCT00265317|4227845|P3|Lead-In|Objective progression or relapse|0
1297769|NCT00265317|4227846|P2|Lead-In|Objective progression or relapse|11
1297770|NCT00265317|4227847|P1|Lead-In|Objective progression or relapse|6
1297771|NCT00265239|4227962|P2|Overall Study|Adverse Event|1
1297772|NCT00265239|4227963|P1|Overall Study|Adverse Event|2
1297773|NCT00265122|4227985|P6|Intervention Period 2 (Weeks 8 to 28):|Not specified|0
1297774|NCT00265122|4227986|P5|Intervention Period 2 (Weeks 8 to 28):|Not specified|0
1297775|NCT00265122|4227987|P4|Intervention Period 2 (Weeks 8 to 28):|Not specified|1
1297776|NCT00265122|4227988|P3|Intervention Period 2 (Weeks 8 to 28):|Not specified|1
1297777|NCT00265122|4227989|P2|Intervention Period 2 (Weeks 8 to 28):|Not specified|0
1297778|NCT00265122|4227990|P1|Intervention Period 2 (Weeks 8 to 28):|Not specified|4
1297779|NCT00265122|4227985|P6|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
1297780|NCT00265122|4227986|P5|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
1297781|NCT00265122|4227987|P4|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
1297782|NCT00265122|4227988|P3|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
1297783|NCT00265122|4227989|P2|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
1297784|NCT00265122|4227990|P1|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
1297785|NCT00265122|4227985|P6|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0
1297786|NCT00265122|4227986|P5|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
1297787|NCT00265122|4227987|P4|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
1297788|NCT00265122|4227988|P3|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
1297789|NCT00265122|4227989|P2|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
1297790|NCT00265122|4227990|P1|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2
1297791|NCT00265122|4227985|P6|Intervention Period 1 (Weeks 0 to 8):|Not specified|0
1297792|NCT00265122|4227986|P5|Intervention Period 1 (Weeks 0 to 8):|Not specified|0
1297793|NCT00265122|4227987|P4|Intervention Period 1 (Weeks 0 to 8):|Not specified|1
1297794|NCT00265122|4227988|P3|Intervention Period 1 (Weeks 0 to 8):|Not specified|2
1297795|NCT00265122|4227989|P2|Intervention Period 1 (Weeks 0 to 8):|Not specified|1
1297796|NCT00265122|4227990|P1|Intervention Period 1 (Weeks 0 to 8):|Not specified|0
1297797|NCT00265122|4227985|P6|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
1297798|NCT00265122|4227986|P5|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
1297799|NCT00265122|4227987|P4|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
1297800|NCT00265122|4227988|P3|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
1297801|NCT00265122|4227989|P2|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
1297802|NCT00265122|4227990|P1|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
1297803|NCT00265122|4227985|P6|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
1297804|NCT00265122|4227986|P5|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
1297805|NCT00265122|4227987|P4|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
1297806|NCT00265122|4227988|P3|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3
1297807|NCT00265122|4227989|P2|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
1297808|NCT00265122|4227990|P1|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
1297809|NCT00265109|4228012|P1|Overall Study|Adverse Event|1
1297810|NCT00265109|4228012|P1|Overall Study|Withdrawal by Subject|5
1297811|NCT00265096|4228019|P3|Overall Study|Not Specified|10
1297812|NCT00265096|4228020|P2|Overall Study|Not Specified|19
1297813|NCT00265096|4228021|P1|Overall Study|Not Specified|11
1297814|NCT00265096|4228019|P3|Overall Study|Unsatisfactory therapeutic effect|6
1297815|NCT00265096|4228020|P2|Overall Study|Unsatisfactory therapeutic effect|8
1297816|NCT00265096|4228021|P1|Overall Study|Unsatisfactory therapeutic effect|9
1297817|NCT00265096|4228019|P3|Overall Study|Death|2
1297818|NCT00265096|4228020|P2|Overall Study|Death|1
1297819|NCT00265096|4228021|P1|Overall Study|Death|0
1297820|NCT00265096|4228019|P3|Overall Study|Lost to Follow-up|3
1297821|NCT00265096|4228020|P2|Overall Study|Lost to Follow-up|5
1297822|NCT00265096|4228021|P1|Overall Study|Lost to Follow-up|2
1297823|NCT00265096|4228019|P3|Overall Study|Adverse Event|18
1297824|NCT00265096|4228020|P2|Overall Study|Adverse Event|18
1297825|NCT00265096|4228021|P1|Overall Study|Adverse Event|14
1297826|NCT00265083|4228053|P3|Overall Study|Not specified|9
1297827|NCT00265083|4228054|P2|Overall Study|Not specified|12
1297828|NCT00265083|4228055|P1|Overall Study|Not specified|1
1297829|NCT00265083|4228053|P3|Overall Study|Unsatisfactory therapeutic effect|14
1297830|NCT00265083|4228054|P2|Overall Study|Unsatisfactory therapeutic effect|13
1297831|NCT00265083|4228055|P1|Overall Study|Unsatisfactory therapeutic effect|8
1297832|NCT00265083|4228053|P3|Overall Study|Lost to Follow-up|4
1297833|NCT00265083|4228054|P2|Overall Study|Lost to Follow-up|4
1297834|NCT00265083|4228055|P1|Overall Study|Lost to Follow-up|3
1297835|NCT00265083|4228053|P3|Overall Study|Adverse Event|15
1297836|NCT00265083|4228054|P2|Overall Study|Adverse Event|13
1297837|NCT00265083|4228055|P1|Overall Study|Adverse Event|5
1297838|NCT00264875|4228076|P1|Overall Study|Withdrawal by Subject|7
1297839|NCT00264875|4228076|P1|Overall Study|Protocol Violation|11
1297840|NCT00264875|4228076|P1|Overall Study|Lost to Follow-up|6
1297841|NCT00264875|4228076|P1|Overall Study|Adverse Event|6
1297842|NCT00264849|4228082|P2|Overall Study|Administrative Problems|0
1297843|NCT00264849|4228083|P1|Overall Study|Administrative Problems|2
1297844|NCT00264849|4228082|P2|Overall Study|Death|1
1297845|NCT00264849|4228083|P1|Overall Study|Death|0
1297846|NCT00264849|4228082|P2|Overall Study|Lost to Follow-up|2
1297847|NCT00264849|4228083|P1|Overall Study|Lost to Follow-up|0
1297848|NCT00264849|4228082|P2|Overall Study|Lack of Efficacy|6
1297849|NCT00264849|4228083|P1|Overall Study|Lack of Efficacy|1
1297850|NCT00264849|4228082|P2|Overall Study|Protocol Violation|3
1297851|NCT00264849|4228083|P1|Overall Study|Protocol Violation|5
1297852|NCT00264849|4228082|P2|Overall Study|Withdrawal by Subject|11
1297853|NCT00264849|4228083|P1|Overall Study|Withdrawal by Subject|7
1297854|NCT00264849|4228082|P2|Overall Study|Adverse Event|2
1297855|NCT00264849|4228083|P1|Overall Study|Adverse Event|7
1297856|NCT00264810|4228117|P2|Open Label Evaluation Period|Pursue Other Treatment Options|3
1297857|NCT00264810|4228118|P1|Open Label Evaluation Period|Pursue Other Treatment Options|2
1297858|NCT00264810|4228117|P2|Open Label Evaluation Period|Death|2
1297859|NCT00264810|4228118|P1|Open Label Evaluation Period|Death|3
1297860|NCT00264810|4228117|P2|Open Label Evaluation Period|Explant due to infection|1
1297861|NCT00264810|4228118|P1|Open Label Evaluation Period|Explant due to infection|1
1297862|NCT00264810|4228117|P2|Blinded Evaluation Period|Explant due to infection|1
1297863|NCT00264810|4228118|P1|Blinded Evaluation Period|Explant due to infection|1
1297864|NCT00264810|4228117|P2|Stimulation Optimization Period|Death|1
1297865|NCT00264810|4228118|P1|Stimulation Optimization Period|Death|0
1297866|NCT00264810|4228117|P2|Stimulation Optimization Period|Withdrawal by Subject|0
1297867|NCT00264810|4228118|P1|Stimulation Optimization Period|Withdrawal by Subject|1
1297868|NCT00264810|4228117|P2|Baseline|Other|1
1297869|NCT00264810|4228118|P1|Baseline|Other|0
1297870|NCT00264810|4228117|P2|Baseline|Did not Meet/Maintain Study I/E Criteria|2
1297871|NCT00264810|4228118|P1|Baseline|Did not Meet/Maintain Study I/E Criteria|1
1297872|NCT00264810|4228117|P2|Baseline|Insufficient Seizure Frequency|2
1297873|NCT00264810|4228118|P1|Baseline|Insufficient Seizure Frequency|2
1297874|NCT00264810|4228117|P2|Baseline|Subject Compliance Failure|3
1297875|NCT00264810|4228118|P1|Baseline|Subject Compliance Failure|3
1297876|NCT00264810|4228117|P2|Baseline|Physician Decision|8
1297877|NCT00264810|4228118|P1|Baseline|Physician Decision|7
1297878|NCT00264810|4228117|P2|Baseline|Withdrawal by Subject|10
1297879|NCT00264810|4228118|P1|Baseline|Withdrawal by Subject|10
1297880|NCT00264797|4228128|P2|Overall Study|Other|4
1297881|NCT00264797|4228129|P1|Overall Study|Other|3
1297882|NCT00264797|4228128|P2|Overall Study|Feels treatment not necessary, not worki|1
1297883|NCT00264797|4228129|P1|Overall Study|Feels treatment not necessary, not worki|0
1297884|NCT00264797|4228128|P2|Overall Study|Pressure/advice from Outsiders|1
1297885|NCT00264797|4228129|P1|Overall Study|Pressure/advice from Outsiders|1
1297886|NCT00264797|4228128|P2|Overall Study|Incarceration|5
1297887|NCT00264797|4228129|P1|Overall Study|Incarceration|4
1297888|NCT00264797|4228128|P2|Overall Study|Practical Problems|3
1297889|NCT00264797|4228129|P1|Overall Study|Practical Problems|2
1297890|NCT00264797|4228128|P2|Overall Study|Moved from area|1
1297891|NCT00264797|4228129|P1|Overall Study|Moved from area|3
1297892|NCT00264797|4228128|P2|Overall Study|Lost to Follow-up|17
1297893|NCT00264797|4228129|P1|Overall Study|Lost to Follow-up|9
1297894|NCT00264797|4228128|P2|Overall Study|Withdrawal by Subject|11
1297895|NCT00264797|4228129|P1|Overall Study|Withdrawal by Subject|11
1297896|NCT00264576|4228151|P2|Overall Study|Lost to Follow-up|1
1297897|NCT00264576|4228152|P1|Overall Study|Lost to Follow-up|1
1297898|NCT00264550|4228176|P4|Overall Study|Not specified|9
1297899|NCT00264550|4228177|P3|Overall Study|Not specified|3
1297900|NCT00264550|4228178|P2|Overall Study|Not specified|7
1297901|NCT00264550|4228179|P1|Overall Study|Not specified|13
1297902|NCT00264550|4228176|P4|Overall Study|Discontinued oral study agent|0
1297903|NCT00264550|4228177|P3|Overall Study|Discontinued oral study agent|0
1297904|NCT00264550|4228178|P2|Overall Study|Discontinued oral study agent|1
1297905|NCT00264550|4228179|P1|Overall Study|Discontinued oral study agent|0
1297906|NCT00264550|4228176|P4|Overall Study|Unsatisfactory therapeutic effect|6
1297907|NCT00264550|4228177|P3|Overall Study|Unsatisfactory therapeutic effect|4
1297908|NCT00264550|4228178|P2|Overall Study|Unsatisfactory therapeutic effect|11
1297909|NCT00264550|4228179|P1|Overall Study|Unsatisfactory therapeutic effect|4
1297910|NCT00264550|4228176|P4|Overall Study|Adverse Event|14
1297911|NCT00264550|4228177|P3|Overall Study|Adverse Event|9
1297912|NCT00264550|4228178|P2|Overall Study|Adverse Event|18
1297913|NCT00264550|4228179|P1|Overall Study|Adverse Event|23
1297914|NCT00264550|4228176|P4|Overall Study|Lost to Follow-up|1
1297915|NCT00264550|4228177|P3|Overall Study|Lost to Follow-up|1
1297916|NCT00264550|4228178|P2|Overall Study|Lost to Follow-up|1
1297917|NCT00264550|4228179|P1|Overall Study|Lost to Follow-up|3
1297918|NCT00264550|4228176|P4|Overall Study|Death|0
1297919|NCT00264550|4228177|P3|Overall Study|Death|0
1297920|NCT00264550|4228178|P2|Overall Study|Death|3
1297921|NCT00264550|4228179|P1|Overall Study|Death|0
1297922|NCT00264537|4228218|P4|Overall Study|Not treated|0
1297923|NCT00264537|4228219|P3|Overall Study|Not treated|1
1297924|NCT00264537|4228220|P2|Overall Study|Not treated|2
1297925|NCT00264537|4228221|P1|Overall Study|Not treated|0
1297926|NCT00264537|4228218|P4|Overall Study|Not specified|11
1297927|NCT00264537|4228219|P3|Overall Study|Not specified|10
1297928|NCT00264537|4228220|P2|Overall Study|Not specified|11
1297929|NCT00264537|4228221|P1|Overall Study|Not specified|21
1297930|NCT00264537|4228218|P4|Overall Study|Unsatisfactory therapeutic effect|7
1297931|NCT00264537|4228219|P3|Overall Study|Unsatisfactory therapeutic effect|5
1297932|NCT00264537|4228220|P2|Overall Study|Unsatisfactory therapeutic effect|6
1297933|NCT00264537|4228221|P1|Overall Study|Unsatisfactory therapeutic effect|5
1297934|NCT00264537|4228218|P4|Overall Study|Adverse Event|34
1297935|NCT00264537|4228219|P3|Overall Study|Adverse Event|24
1297936|NCT00264537|4228220|P2|Overall Study|Adverse Event|32
1297937|NCT00264537|4228221|P1|Overall Study|Adverse Event|21
1297938|NCT00264537|4228218|P4|Overall Study|Lost to Follow-up|6
1297939|NCT00264537|4228219|P3|Overall Study|Lost to Follow-up|7
1297940|NCT00264537|4228220|P2|Overall Study|Lost to Follow-up|4
1297941|NCT00264537|4228221|P1|Overall Study|Lost to Follow-up|3
1297942|NCT00264537|4228218|P4|Overall Study|Death|2
1297943|NCT00264537|4228219|P3|Overall Study|Death|3
1297944|NCT00264537|4228220|P2|Overall Study|Death|3
1297945|NCT00264537|4228221|P1|Overall Study|Death|0
1297946|NCT00264498|4228253|P2|Crossover Treatment|Withdrawal by Subject|0
1297947|NCT00264498|4228254|P1|Crossover Treatment|Withdrawal by Subject|1
1297948|NCT00264498|4228253|P2|Crossover Treatment|Study closure|1
1297949|NCT00264498|4228254|P1|Crossover Treatment|Study closure|0
1297950|NCT00264498|4228253|P2|Crossover Treatment|Objective disease progression|5
1297951|NCT00264498|4228254|P1|Crossover Treatment|Objective disease progression|4
1297952|NCT00264498|4228253|P2|Crossover Treatment|Death|3
1297953|NCT00264498|4228254|P1|Crossover Treatment|Death|1
1297954|NCT00264498|4228253|P2|Randomized Treatment|Protocol Violation|0
1297955|NCT00264498|4228254|P1|Randomized Treatment|Protocol Violation|1
1297956|NCT00264498|4228253|P2|Randomized Treatment|Study Closure|0
1297957|NCT00264498|4228254|P1|Randomized Treatment|Study Closure|1
1297958|NCT00264498|4228253|P2|Randomized Treatment|Incorrectly randomized|0
1297959|NCT00264498|4228254|P1|Randomized Treatment|Incorrectly randomized|1
1297960|NCT00264498|4228253|P2|Randomized Treatment|Physician Decision|0
1297961|NCT00264498|4228254|P1|Randomized Treatment|Physician Decision|1
1297962|NCT00264498|4228253|P2|Randomized Treatment|Objective disease Progression|14
1297963|NCT00264498|4228254|P1|Randomized Treatment|Objective disease Progression|13
1297964|NCT00264498|4228253|P2|Randomized Treatment|Withdrawal by Subject|1
1297965|NCT00264498|4228254|P1|Randomized Treatment|Withdrawal by Subject|0
1297966|NCT00264498|4228253|P2|Randomized Treatment|Death|3
1297967|NCT00264498|4228254|P1|Randomized Treatment|Death|0
1297968|NCT00264303|4228277|P2|Overall Study|Various reasons listed in study report|7
1297969|NCT00264303|4228278|P1|Overall Study|Various reasons listed in study report|6
1297970|NCT00264303|4228277|P2|Overall Study|Withdrawal by Subject|3
1297971|NCT00264303|4228278|P1|Overall Study|Withdrawal by Subject|2
1297972|NCT00264303|4228277|P2|Overall Study|Lost to Follow-up|3
1297973|NCT00264303|4228278|P1|Overall Study|Lost to Follow-up|3
1297974|NCT00264303|4228277|P2|Overall Study|Lack of Efficacy|13
1297975|NCT00264303|4228278|P1|Overall Study|Lack of Efficacy|10
1297976|NCT00264303|4228277|P2|Overall Study|Adverse Event|3
1297977|NCT00264303|4228278|P1|Overall Study|Adverse Event|4
1297978|NCT00264290|4228296|P2|Intervention (8 Weeks)|Adverse Event|0
1297979|NCT00264290|4228297|P1|Intervention (8 Weeks)|Adverse Event|1
1297980|NCT00264238|4228303|P1|Overall Study|Protocol Violation|1
1297981|NCT00264147|4228315|P6|Treatment II Period|Pre-scheduled total hip replacement|1
1297982|NCT00264147|4228316|P5|Treatment II Period|Pre-scheduled total hip replacement|0
1297983|NCT00264147|4228317|P4|Treatment II Period|Pre-scheduled total hip replacement|0
1297984|NCT00264147|4228318|P3|Treatment II Period|Pre-scheduled total hip replacement|0
1297985|NCT00264147|4228319|P2|Treatment II Period|Pre-scheduled total hip replacement|0
1297986|NCT00264147|4228320|P1|Treatment II Period|Pre-scheduled total hip replacement|0
1297987|NCT00264147|4228315|P6|Treatment II Period|Withdrawal by Subject|2
1297988|NCT00264147|4228316|P5|Treatment II Period|Withdrawal by Subject|3
1297989|NCT00264147|4228317|P4|Treatment II Period|Withdrawal by Subject|0
1297990|NCT00264147|4228318|P3|Treatment II Period|Withdrawal by Subject|0
1297991|NCT00264147|4228319|P2|Treatment II Period|Withdrawal by Subject|0
1297992|NCT00264147|4228320|P1|Treatment II Period|Withdrawal by Subject|0
1297993|NCT00264147|4228315|P6|Treatment II Period|Lost to Follow-up|1
1297994|NCT00264147|4228316|P5|Treatment II Period|Lost to Follow-up|1
1297995|NCT00264147|4228317|P4|Treatment II Period|Lost to Follow-up|0
1297996|NCT00264147|4228318|P3|Treatment II Period|Lost to Follow-up|0
1297997|NCT00264147|4228319|P2|Treatment II Period|Lost to Follow-up|0
1297998|NCT00264147|4228320|P1|Treatment II Period|Lost to Follow-up|0
1297999|NCT00264147|4228315|P6|Treatment II Period|Lack of Efficacy|19
1298000|NCT00264147|4228316|P5|Treatment II Period|Lack of Efficacy|20
1298001|NCT00264147|4228317|P4|Treatment II Period|Lack of Efficacy|0
1298002|NCT00264147|4228318|P3|Treatment II Period|Lack of Efficacy|0
1298003|NCT00264147|4228319|P2|Treatment II Period|Lack of Efficacy|0
1298004|NCT00264147|4228320|P1|Treatment II Period|Lack of Efficacy|0
1298005|NCT00264147|4228315|P6|Treatment II Period|Laboratory Adverse Event|1
1298006|NCT00264147|4228316|P5|Treatment II Period|Laboratory Adverse Event|0
1298007|NCT00264147|4228317|P4|Treatment II Period|Laboratory Adverse Event|0
1298008|NCT00264147|4228318|P3|Treatment II Period|Laboratory Adverse Event|0
1298009|NCT00264147|4228319|P2|Treatment II Period|Laboratory Adverse Event|0
1298010|NCT00264147|4228320|P1|Treatment II Period|Laboratory Adverse Event|0
1298011|NCT00264147|4228315|P6|Treatment II Period|Adverse Event|9
1298012|NCT00264147|4228316|P5|Treatment II Period|Adverse Event|9
1298013|NCT00264147|4228317|P4|Treatment II Period|Adverse Event|0
1298014|NCT00264147|4228318|P3|Treatment II Period|Adverse Event|0
1298015|NCT00264147|4228319|P2|Treatment II Period|Adverse Event|0
1298016|NCT00264147|4228320|P1|Treatment II Period|Adverse Event|0
1298017|NCT00264147|4228315|P6|Treatment I Period|Reassigned to Treatment II Period|0
1298018|NCT00264147|4228316|P5|Treatment I Period|Reassigned to Treatment II Period|45
1298019|NCT00264147|4228317|P4|Treatment I Period|Reassigned to Treatment II Period|63
1298020|NCT00264147|4228318|P3|Treatment I Period|Reassigned to Treatment II Period|65
1298021|NCT00264147|4228319|P2|Treatment I Period|Reassigned to Treatment II Period|72
1298022|NCT00264147|4228320|P1|Treatment I Period|Reassigned to Treatment II Period|84
1298023|NCT00264147|4228315|P6|Treatment I Period|Unblinded due to Serious Adverse Event|0
1298024|NCT00264147|4228316|P5|Treatment I Period|Unblinded due to Serious Adverse Event|0
1298025|NCT00264147|4228317|P4|Treatment I Period|Unblinded due to Serious Adverse Event|0
1298026|NCT00264147|4228318|P3|Treatment I Period|Unblinded due to Serious Adverse Event|1
1298027|NCT00264147|4228319|P2|Treatment I Period|Unblinded due to Serious Adverse Event|0
1298028|NCT00264147|4228320|P1|Treatment I Period|Unblinded due to Serious Adverse Event|0
1298029|NCT00264147|4228315|P6|Treatment I Period|Patient out of town for an extended time|0
1298030|NCT00264147|4228316|P5|Treatment I Period|Patient out of town for an extended time|0
1298031|NCT00264147|4228317|P4|Treatment I Period|Patient out of town for an extended time|0
1298032|NCT00264147|4228318|P3|Treatment I Period|Patient out of town for an extended time|0
1298033|NCT00264147|4228319|P2|Treatment I Period|Patient out of town for an extended time|1
1298034|NCT00264147|4228320|P1|Treatment I Period|Patient out of town for an extended time|0
1298035|NCT00264147|4228315|P6|Treatment I Period|Withdrawal by Subject|0
1298036|NCT00264147|4228316|P5|Treatment I Period|Withdrawal by Subject|2
1298037|NCT00264147|4228317|P4|Treatment I Period|Withdrawal by Subject|2
1298038|NCT00264147|4228318|P3|Treatment I Period|Withdrawal by Subject|0
1298039|NCT00264147|4228319|P2|Treatment I Period|Withdrawal by Subject|0
1298040|NCT00264147|4228320|P1|Treatment I Period|Withdrawal by Subject|2
1298041|NCT00264147|4228315|P6|Treatment I Period|Protocol Violation|0
1298042|NCT00264147|4228316|P5|Treatment I Period|Protocol Violation|0
1298043|NCT00264147|4228317|P4|Treatment I Period|Protocol Violation|0
1298044|NCT00264147|4228318|P3|Treatment I Period|Protocol Violation|0
1298045|NCT00264147|4228319|P2|Treatment I Period|Protocol Violation|2
1298046|NCT00264147|4228320|P1|Treatment I Period|Protocol Violation|2
1298047|NCT00264147|4228315|P6|Treatment I Period|Lost to Follow-up|0
1298048|NCT00264147|4228316|P5|Treatment I Period|Lost to Follow-up|1
1298049|NCT00264147|4228317|P4|Treatment I Period|Lost to Follow-up|1
1298050|NCT00264147|4228318|P3|Treatment I Period|Lost to Follow-up|0
1298051|NCT00264147|4228319|P2|Treatment I Period|Lost to Follow-up|0
1298052|NCT00264147|4228320|P1|Treatment I Period|Lost to Follow-up|1
1298053|NCT00264147|4228315|P6|Treatment I Period|Lack of Efficacy|0
1298054|NCT00264147|4228316|P5|Treatment I Period|Lack of Efficacy|1
1298055|NCT00264147|4228317|P4|Treatment I Period|Lack of Efficacy|0
1298056|NCT00264147|4228318|P3|Treatment I Period|Lack of Efficacy|8
1298057|NCT00264147|4228319|P2|Treatment I Period|Lack of Efficacy|2
1298058|NCT00264147|4228320|P1|Treatment I Period|Lack of Efficacy|6
1298059|NCT00264147|4228315|P6|Treatment I Period|Laboratory Adverse Event|0
1298060|NCT00264147|4228316|P5|Treatment I Period|Laboratory Adverse Event|0
1298061|NCT00264147|4228317|P4|Treatment I Period|Laboratory Adverse Event|1
1298062|NCT00264147|4228318|P3|Treatment I Period|Laboratory Adverse Event|0
1298063|NCT00264147|4228319|P2|Treatment I Period|Laboratory Adverse Event|0
1298064|NCT00264147|4228320|P1|Treatment I Period|Laboratory Adverse Event|0
1298065|NCT00264147|4228315|P6|Treatment I Period|Adverse Event|0
1298066|NCT00264147|4228316|P5|Treatment I Period|Adverse Event|7
1298067|NCT00264147|4228317|P4|Treatment I Period|Adverse Event|5
1298068|NCT00264147|4228318|P3|Treatment I Period|Adverse Event|3
1298069|NCT00264147|4228319|P2|Treatment I Period|Adverse Event|6
1298070|NCT00264147|4228320|P1|Treatment I Period|Adverse Event|3
1298071|NCT00264004|4228363|P4|Overall Study|Not treated|2
1298072|NCT00264004|4228364|P3|Overall Study|Not treated|2
1298073|NCT00264004|4228365|P2|Overall Study|Not treated|0
1298074|NCT00264004|4228366|P1|Overall Study|Not treated|3
1298075|NCT00264004|4228363|P4|Overall Study|Cond. under inv. worsened|4
1298076|NCT00264004|4228364|P3|Overall Study|Cond. under inv. worsened|3
1298077|NCT00264004|4228365|P2|Overall Study|Cond. under inv. worsened|5
1298078|NCT00264004|4228366|P1|Overall Study|Cond. under inv. worsened|9
1298079|NCT00264004|4228363|P4|Overall Study|Development study specific disc. crit.|0
1298080|NCT00264004|4228364|P3|Overall Study|Development study specific disc. crit.|1
1298081|NCT00264004|4228365|P2|Overall Study|Development study specific disc. crit.|0
1298082|NCT00264004|4228366|P1|Overall Study|Development study specific disc. crit.|1
1298083|NCT00264004|4228363|P4|Overall Study|Not specified|3
1298084|NCT00264004|4228364|P3|Overall Study|Not specified|0
1298085|NCT00264004|4228365|P2|Overall Study|Not specified|2
1298086|NCT00264004|4228366|P1|Overall Study|Not specified|2
1298087|NCT00264004|4228363|P4|Overall Study|Withdrawal by Subject|2
1298088|NCT00264004|4228364|P3|Overall Study|Withdrawal by Subject|2
1298089|NCT00264004|4228365|P2|Overall Study|Withdrawal by Subject|1
1298090|NCT00264004|4228366|P1|Overall Study|Withdrawal by Subject|0
1298091|NCT00264004|4228363|P4|Overall Study|Adverse Event|4
1298092|NCT00264004|4228364|P3|Overall Study|Adverse Event|6
1298093|NCT00264004|4228365|P2|Overall Study|Adverse Event|3
1298094|NCT00264004|4228366|P1|Overall Study|Adverse Event|2
1298095|NCT00263887|4228394|P2|Overall Study|Lack of Efficacy|1
1298096|NCT00263887|4228395|P1|Overall Study|Lack of Efficacy|0
1298097|NCT00263887|4228394|P2|Overall Study|Disease progression|1
1298098|NCT00263887|4228395|P1|Overall Study|Disease progression|0
1298099|NCT00263887|4228394|P2|Overall Study|Adverse Event|2
1298100|NCT00263887|4228395|P1|Overall Study|Adverse Event|0
1298101|NCT00263887|4228394|P2|Overall Study|Too ill to attend visit|0
1298102|NCT00263887|4228395|P1|Overall Study|Too ill to attend visit|1
1298103|NCT00263887|4228394|P2|Overall Study|Lung transplantation|2
1298104|NCT00263887|4228395|P1|Overall Study|Lung transplantation|1
1298105|NCT00263887|4228394|P2|Overall Study|Withdrawal by Subject|1
1298106|NCT00263887|4228395|P1|Overall Study|Withdrawal by Subject|1
1298107|NCT00263757|4228403|P2|Overall Study|Adverse Event|3
1298108|NCT00263757|4228404|P1|Overall Study|Adverse Event|3
1298109|NCT00263757|4228403|P2|Overall Study|Screen failure|1
1298110|NCT00263757|4228404|P1|Overall Study|Screen failure|0
1298111|NCT00263757|4228403|P2|Overall Study|Withdrawal by Subject|4
1298112|NCT00263757|4228404|P1|Overall Study|Withdrawal by Subject|5
1298113|NCT00263666|4228416|P2|Overall Study|Withdrawal by Subject|1
1298114|NCT00263666|4228417|P1|Overall Study|Withdrawal by Subject|0
1298115|NCT00263666|4228416|P2|Overall Study|Lost to Follow-up|2
1298116|NCT00263666|4228417|P1|Overall Study|Lost to Follow-up|1
1298117|NCT00263666|4228416|P2|Overall Study|Adverse Event|8
1298118|NCT00263666|4228417|P1|Overall Study|Adverse Event|6
1298119|NCT00263328|4228471|P3|Overall Study|Adverse Event|4
1298120|NCT00263328|4228472|P2|Overall Study|Adverse Event|1
1298121|NCT00263328|4228473|P1|Overall Study|Adverse Event|1
1298122|NCT00263328|4228471|P3|Overall Study|Not specified|1
1298123|NCT00263328|4228472|P2|Overall Study|Not specified|0
1298124|NCT00263328|4228473|P1|Overall Study|Not specified|3
1298125|NCT00263328|4228471|P3|Overall Study|Withdrawal by Subject|1
1298126|NCT00263328|4228472|P2|Overall Study|Withdrawal by Subject|0
1298127|NCT00263328|4228473|P1|Overall Study|Withdrawal by Subject|3
1298128|NCT00263328|4228471|P3|Overall Study|Lost to Follow-up|0
1298129|NCT00263328|4228472|P2|Overall Study|Lost to Follow-up|1
1298130|NCT00263328|4228473|P1|Overall Study|Lost to Follow-up|1
1298131|NCT00263328|4228471|P3|Overall Study|Death|1
1298132|NCT00263328|4228472|P2|Overall Study|Death|0
1298133|NCT00263328|4228473|P1|Overall Study|Death|0
1298134|NCT00263211|4228631|P2|Overall Study|Disease Progression|1
1298135|NCT00263211|4228632|P1|Overall Study|Disease Progression|0
1298136|NCT00263211|4228631|P2|Overall Study|Protocol Violation|0
1298137|NCT00263211|4228632|P1|Overall Study|Protocol Violation|1
1298138|NCT00263211|4228631|P2|Overall Study|Withdrawal by Subject|0
1298139|NCT00263211|4228632|P1|Overall Study|Withdrawal by Subject|3
1298140|NCT00263211|4228631|P2|Overall Study|Death|0
1298141|NCT00263211|4228632|P1|Overall Study|Death|1
1298142|NCT00262951|4228683|P1|Overall Study|Off treatment for other disease|1
1298143|NCT00262951|4228683|P1|Overall Study|Alternative treatment|3
1298144|NCT00262951|4228683|P1|Overall Study|Withdrawal by Subject|1
1298145|NCT00262951|4228683|P1|Overall Study|Death|1
1298146|NCT00262951|4228683|P1|Overall Study|Adverse Event|7
1298147|NCT00262951|4228683|P1|Overall Study|Progressive disease/relapse|3
1298148|NCT00262925|4228688|P1|Overall Study|Other|1
1298149|NCT00262925|4228688|P1|Overall Study|alternative therapy|1
1298150|NCT00262925|4228688|P1|Overall Study|Death|2
1298151|NCT00262925|4228688|P1|Overall Study|Adverse Event|4
1298152|NCT00262925|4228688|P1|Overall Study|Lack of Efficacy|3
1298153|NCT00262873|4228694|P1|Overall Study|Withdrawal by Subject|5
1298154|NCT00262873|4228694|P1|Overall Study|Adverse Event|3
1298155|NCT00262860|4228705|P1|Overall Study|Adverse Event|2
1298156|NCT00262847|4228714|P3|Overall Study|Did not receive study treatment|4
1298157|NCT00262847|4228715|P2|Overall Study|Did not receive study treatment|1
1298158|NCT00262847|4228716|P1|Overall Study|Did not receive study treatment|4
1298159|NCT00262847|4228714|P3|Overall Study|Other Reasons|27
1298160|NCT00262847|4228715|P2|Overall Study|Other Reasons|88
1298161|NCT00262847|4228716|P1|Overall Study|Other Reasons|79
1298162|NCT00262847|4228714|P3|Overall Study|Concomitant disease|4
1298163|NCT00262847|4228715|P2|Overall Study|Concomitant disease|2
1298164|NCT00262847|4228716|P1|Overall Study|Concomitant disease|3
1298165|NCT00262847|4228714|P3|Overall Study|Death|11
1298166|NCT00262847|4228715|P2|Overall Study|Death|8
1298167|NCT00262847|4228716|P1|Overall Study|Death|8
1298168|NCT00262847|4228714|P3|Overall Study|Adverse Event|108
1298169|NCT00262847|4228715|P2|Overall Study|Adverse Event|88
1298170|NCT00262847|4228716|P1|Overall Study|Adverse Event|74
1298171|NCT00262847|4228714|P3|Overall Study|Patient Refusal|47
1298172|NCT00262847|4228715|P2|Overall Study|Patient Refusal|52
1298173|NCT00262847|4228716|P1|Overall Study|Patient Refusal|41
1298174|NCT00262847|4228714|P3|Overall Study|Disease Progression|195
1298175|NCT00262847|4228715|P2|Overall Study|Disease Progression|274
1298176|NCT00262847|4228716|P1|Overall Study|Disease Progression|309
1298177|NCT00262834|4228735|P2|Overall Study|Surgery delayed/tissue not collected|4
1298178|NCT00262834|4228736|P1|Overall Study|Surgery delayed/tissue not collected|1
1298179|NCT00262821|4228749|P2|Overall Study|Inevaluable - inadequate data|4
1298180|NCT00262821|4228750|P1|Overall Study|Inevaluable - inadequate data|0
1298181|NCT00262821|4228749|P2|Overall Study|Ineligible - required test not done|4
1298182|NCT00262821|4228750|P1|Overall Study|Ineligible - required test not done|1
1298183|NCT00262821|4228749|P2|Overall Study|Ineligible - elevated creatinine|2
1298184|NCT00262821|4228750|P1|Overall Study|Ineligible - elevated creatinine|0
1298185|NCT00262821|4228749|P2|Overall Study|Ineligible - inadequate pathology|3
1298186|NCT00262821|4228750|P1|Overall Study|Ineligible - inadequate pathology|1
1298187|NCT00262821|4228749|P2|Overall Study|Ineligible - wrong primary|1
1298188|NCT00262821|4228750|P1|Overall Study|Ineligible - wrong primary|0
1298189|NCT00262821|4228749|P2|Overall Study|Ineligible - wrong cell type|2
1298190|NCT00262821|4228750|P1|Overall Study|Ineligible - wrong cell type|2
1298191|NCT00262821|4228749|P2|Overall Study|Ineligible - wrong stage|3
1298192|NCT00262821|4228750|P1|Overall Study|Ineligible - wrong stage|0
1298193|NCT00262743|4228762|P2|Overall Study|Disease progression|3
1298194|NCT00262743|4228763|P1|Overall Study|Disease progression|0
1298195|NCT00262743|4228762|P2|Overall Study|Adverse Event|9
1298196|NCT00262743|4228763|P1|Overall Study|Adverse Event|0
1298197|NCT00262600|4228798|P3|Overall Study|Not Specified|62
1298198|NCT00262600|4228799|P2|Overall Study|Not Specified|59
1298199|NCT00262600|4228800|P1|Overall Study|Not Specified|58
1298200|NCT00262600|4228798|P3|Overall Study|Not Treated|24
1298201|NCT00262600|4228799|P2|Overall Study|Not Treated|17
1298202|NCT00262600|4228800|P1|Overall Study|Not Treated|32
1298203|NCT00262600|4228798|P3|Overall Study|Withdrawal by Subject|139
1298204|NCT00262600|4228799|P2|Overall Study|Withdrawal by Subject|145
1298205|NCT00262600|4228800|P1|Overall Study|Withdrawal by Subject|128
1298206|NCT00262600|4228798|P3|Overall Study|Lost to Follow-up|41
1298207|NCT00262600|4228799|P2|Overall Study|Lost to Follow-up|31
1298208|NCT00262600|4228800|P1|Overall Study|Lost to Follow-up|17
1298209|NCT00262522|4228827|P4|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
1298210|NCT00262522|4228828|P3|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9
1298211|NCT00262522|4228829|P2|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
1298212|NCT00262522|4228830|P1|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10
1298213|NCT00262522|4228827|P4|Study Start Through 96 Weeks|Virologic failure|0
1298214|NCT00262522|4228828|P3|Study Start Through 96 Weeks|Virologic failure|8
1298215|NCT00262522|4228829|P2|Study Start Through 96 Weeks|Virologic failure|0
1298216|NCT00262522|4228830|P1|Study Start Through 96 Weeks|Virologic failure|5
1298217|NCT00262522|4228827|P4|Study Start Through 96 Weeks|Death|0
1298218|NCT00262522|4228828|P3|Study Start Through 96 Weeks|Death|2
1298219|NCT00262522|4228829|P2|Study Start Through 96 Weeks|Death|0
1298220|NCT00262522|4228830|P1|Study Start Through 96 Weeks|Death|2
1298221|NCT00262522|4228827|P4|Study Start Through 96 Weeks|Noncompliance|0
1298222|NCT00262522|4228828|P3|Study Start Through 96 Weeks|Noncompliance|11
1298223|NCT00262522|4228829|P2|Study Start Through 96 Weeks|Noncompliance|0
1298224|NCT00262522|4228830|P1|Study Start Through 96 Weeks|Noncompliance|6
1298225|NCT00262522|4228827|P4|Study Start Through 96 Weeks|Lost to Follow-up|0
1298226|NCT00262522|4228828|P3|Study Start Through 96 Weeks|Lost to Follow-up|18
1298227|NCT00262522|4228829|P2|Study Start Through 96 Weeks|Lost to Follow-up|0
1298228|NCT00262522|4228830|P1|Study Start Through 96 Weeks|Lost to Follow-up|19
1298229|NCT00262522|4228827|P4|Study Start Through 96 Weeks|Withdrawal by Subject|0
1298230|NCT00262522|4228828|P3|Study Start Through 96 Weeks|Withdrawal by Subject|13
1298231|NCT00262522|4228829|P2|Study Start Through 96 Weeks|Withdrawal by Subject|0
1298232|NCT00262522|4228830|P1|Study Start Through 96 Weeks|Withdrawal by Subject|15
1298233|NCT00262522|4228827|P4|Study Start Through 96 Weeks|Adverse Event|0
1298234|NCT00262522|4228828|P3|Study Start Through 96 Weeks|Adverse Event|16
1298235|NCT00262522|4228829|P2|Study Start Through 96 Weeks|Adverse Event|0
1298236|NCT00262522|4228830|P1|Study Start Through 96 Weeks|Adverse Event|20
1298237|NCT00262522|4228827|P4|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
1298238|NCT00262522|4228828|P3|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7
1298239|NCT00262522|4228829|P2|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
1298240|NCT00262522|4228830|P1|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8
1298241|NCT00262522|4228827|P4|Study Start Through 48 Weeks|Virologic failure|0
1298242|NCT00262522|4228828|P3|Study Start Through 48 Weeks|Virologic failure|4
1298243|NCT00262522|4228829|P2|Study Start Through 48 Weeks|Virologic failure|0
1298244|NCT00262522|4228830|P1|Study Start Through 48 Weeks|Virologic failure|2
1298245|NCT00262522|4228827|P4|Study Start Through 48 Weeks|Death|0
1298246|NCT00262522|4228828|P3|Study Start Through 48 Weeks|Death|1
1298247|NCT00262522|4228829|P2|Study Start Through 48 Weeks|Death|0
1298248|NCT00262522|4228830|P1|Study Start Through 48 Weeks|Death|2
1298249|NCT00262522|4228827|P4|Study Start Through 48 Weeks|Noncompliance|0
1298250|NCT00262522|4228828|P3|Study Start Through 48 Weeks|Noncompliance|8
1298251|NCT00262522|4228829|P2|Study Start Through 48 Weeks|Noncompliance|0
1298252|NCT00262522|4228830|P1|Study Start Through 48 Weeks|Noncompliance|3
1298253|NCT00262522|4228827|P4|Study Start Through 48 Weeks|Lost to Follow-up|0
1298254|NCT00262522|4228828|P3|Study Start Through 48 Weeks|Lost to Follow-up|14
1298255|NCT00262522|4228829|P2|Study Start Through 48 Weeks|Lost to Follow-up|0
1298256|NCT00262522|4228830|P1|Study Start Through 48 Weeks|Lost to Follow-up|8
1298257|NCT00262522|4228827|P4|Study Start Through 48 Weeks|Withdrawal by Subject|0
1298258|NCT00262522|4228828|P3|Study Start Through 48 Weeks|Withdrawal by Subject|11
1298259|NCT00262522|4228829|P2|Study Start Through 48 Weeks|Withdrawal by Subject|0
1298260|NCT00262522|4228830|P1|Study Start Through 48 Weeks|Withdrawal by Subject|10
1298261|NCT00262522|4228827|P4|Study Start Through 48 Weeks|Adverse Event|0
1298262|NCT00262522|4228828|P3|Study Start Through 48 Weeks|Adverse Event|10
1298263|NCT00262522|4228829|P2|Study Start Through 48 Weeks|Adverse Event|0
1298264|NCT00262522|4228830|P1|Study Start Through 48 Weeks|Adverse Event|16
1298265|NCT00262522|4228827|P4|Study Start Through 8 Weeks|Death|0
1298266|NCT00262522|4228828|P3|Study Start Through 8 Weeks|Death|0
1298267|NCT00262522|4228829|P2|Study Start Through 8 Weeks|Death|0
1298268|NCT00262522|4228830|P1|Study Start Through 8 Weeks|Death|1
1298269|NCT00262522|4228827|P4|Study Start Through 8 Weeks|Noncompliance|2
1298270|NCT00262522|4228828|P3|Study Start Through 8 Weeks|Noncompliance|2
1298271|NCT00262522|4228829|P2|Study Start Through 8 Weeks|Noncompliance|0
1298272|NCT00262522|4228830|P1|Study Start Through 8 Weeks|Noncompliance|0
1298273|NCT00262522|4228827|P4|Study Start Through 8 Weeks|Lost to Follow-up|2
1298274|NCT00262522|4228828|P3|Study Start Through 8 Weeks|Lost to Follow-up|3
1298275|NCT00262522|4228829|P2|Study Start Through 8 Weeks|Lost to Follow-up|2
1298276|NCT00262522|4228830|P1|Study Start Through 8 Weeks|Lost to Follow-up|1
1298277|NCT00262522|4228827|P4|Study Start Through 8 Weeks|Withdrawal by Subject|0
1298278|NCT00262522|4228828|P3|Study Start Through 8 Weeks|Withdrawal by Subject|3
1298279|NCT00262522|4228829|P2|Study Start Through 8 Weeks|Withdrawal by Subject|1
1298280|NCT00262522|4228830|P1|Study Start Through 8 Weeks|Withdrawal by Subject|1
1298281|NCT00262522|4228827|P4|Study Start Through 8 Weeks|Adverse Event|1
1298282|NCT00262522|4228828|P3|Study Start Through 8 Weeks|Adverse Event|3
1298283|NCT00262522|4228829|P2|Study Start Through 8 Weeks|Adverse Event|2
1298284|NCT00262522|4228830|P1|Study Start Through 8 Weeks|Adverse Event|1
1298285|NCT00262314|4228859|P1|Overall Study|Administrative withdrawal|30
1298286|NCT00262314|4228859|P1|Overall Study|Lost to Follow-up|70
1298287|NCT00262314|4228859|P1|Overall Study|Not specified|95
1298288|NCT00262314|4228859|P1|Overall Study|Patient's decision|92
1298289|NCT00262314|4228859|P1|Overall Study|Death|12
1298290|NCT00262314|4228859|P1|Overall Study|Changing physicians|38
1298291|NCT00262301|4228877|P3|Double-blind Phase|"worsening of HAE symptoms"|0
1298292|NCT00262301|4228878|P2|Double-blind Phase|"worsening of HAE symptoms"|1
1298293|NCT00262301|4228879|P1|Double-blind Phase|"worsening of HAE symptoms"|0
1298294|NCT00262301|4228877|P3|Double-blind Phase|Lost to Follow-up|0
1298295|NCT00262301|4228878|P2|Double-blind Phase|Lost to Follow-up|0
1298296|NCT00262301|4228879|P1|Double-blind Phase|Lost to Follow-up|1
1298297|NCT00262223|4228892|P2|12-month Post-treatment Follow-up|Lost to Follow-up|7
1298298|NCT00262223|4228893|P1|12-month Post-treatment Follow-up|Lost to Follow-up|7
1298299|NCT00262223|4228892|P2|6-month Post-treatment Follow-up|Lost to Follow-up|1
1298300|NCT00262223|4228893|P1|6-month Post-treatment Follow-up|Lost to Follow-up|6
1298301|NCT00262223|4228892|P2|1-week Post-treatment Follow-up|Lost to Follow-up|4
1298302|NCT00262223|4228893|P1|1-week Post-treatment Follow-up|Lost to Follow-up|4
1298303|NCT00262223|4228892|P2|Treatment Phase|Adverse Event|2
1298304|NCT00262223|4228893|P1|Treatment Phase|Adverse Event|1
1298305|NCT00262223|4228892|P2|Treatment Phase|Withdrawal by Subject|6
1298306|NCT00262223|4228893|P1|Treatment Phase|Withdrawal by Subject|3
1298307|NCT00262119|4228904|P3|Overall Study|Death|16
1298308|NCT00262119|4228905|P2|Overall Study|Death|19
1298309|NCT00262119|4228906|P1|Overall Study|Death|20
1298310|NCT00262119|4228904|P3|Overall Study|Lost to Follow-up|42
1298311|NCT00262119|4228905|P2|Overall Study|Lost to Follow-up|51
1298312|NCT00262119|4228906|P1|Overall Study|Lost to Follow-up|38
1298313|NCT00262080|4228926|P3|Repeat Dose Treatment Period|enrolled in EDEMA4|0
1298314|NCT00262080|4228927|P2|Repeat Dose Treatment Period|enrolled in EDEMA4|0
1298315|NCT00262080|4228928|P1|Repeat Dose Treatment Period|enrolled in EDEMA4|1
1298316|NCT00262080|4228926|P3|Repeat Dose Treatment Period|Decision to discontinue the study|2
1298317|NCT00262080|4228927|P2|Repeat Dose Treatment Period|Decision to discontinue the study|0
1298318|NCT00262080|4228928|P1|Repeat Dose Treatment Period|Decision to discontinue the study|0
1298319|NCT00262080|4228926|P3|Repeat Dose Treatment Period|Lost to Follow-up|2
1298320|NCT00262080|4228927|P2|Repeat Dose Treatment Period|Lost to Follow-up|0
1298321|NCT00262080|4228928|P1|Repeat Dose Treatment Period|Lost to Follow-up|2
1298322|NCT00262080|4228926|P3|Repeat Dose Treatment Period|Withdrawal by Subject|1
1298323|NCT00262080|4228927|P2|Repeat Dose Treatment Period|Withdrawal by Subject|1
1298324|NCT00262080|4228928|P1|Repeat Dose Treatment Period|Withdrawal by Subject|0
1298325|NCT00262080|4228926|P3|Repeat Dose Treatment Period|Adverse Event|0
1298326|NCT00262080|4228927|P2|Repeat Dose Treatment Period|Adverse Event|0
1298327|NCT00262080|4228928|P1|Repeat Dose Treatment Period|Adverse Event|1
1298328|NCT00262080|4228926|P3|Double Blind Treatment Period|Lost to Follow-up|0
1298329|NCT00262080|4228927|P2|Double Blind Treatment Period|Lost to Follow-up|0
1298330|NCT00262080|4228928|P1|Double Blind Treatment Period|Lost to Follow-up|1
1298331|NCT00262067|4228948|P4|Overall Study|Patient Withdrew for Survival Follow-up|9
1298332|NCT00262067|4228949|P3|Overall Study|Patient Withdrew for Survival Follow-up|23
1298333|NCT00262067|4228950|P2|Overall Study|Patient Withdrew for Survival Follow-up|7
1298334|NCT00262067|4228951|P1|Overall Study|Patient Withdrew for Survival Follow-up|23
1298335|NCT00262067|4228948|P4|Overall Study|Sponsor's Decision to Terminate Study|0
1298336|NCT00262067|4228949|P3|Overall Study|Sponsor's Decision to Terminate Study|0
1298337|NCT00262067|4228950|P2|Overall Study|Sponsor's Decision to Terminate Study|0
1298338|NCT00262067|4228951|P1|Overall Study|Sponsor's Decision to Terminate Study|1
1298339|NCT00262067|4228948|P4|Overall Study|Lost to Follow-up|5
1298340|NCT00262067|4228949|P3|Overall Study|Lost to Follow-up|7
1298341|NCT00262067|4228950|P2|Overall Study|Lost to Follow-up|4
1298342|NCT00262067|4228951|P1|Overall Study|Lost to Follow-up|5
1298343|NCT00262067|4228948|P4|Overall Study|Death|99
1298344|NCT00262067|4228949|P3|Overall Study|Death|186
1298345|NCT00262067|4228950|P2|Overall Study|Death|89
1298346|NCT00262067|4228951|P1|Overall Study|Death|190
1298347|NCT00262041|4228985|P3|Overall Study|Unable to classify|0
1298348|NCT00262041|4228986|P2|Overall Study|Unable to classify|0
1298349|NCT00262041|4228987|P1|Overall Study|Unable to classify|1
1298350|NCT00262041|4228985|P3|Overall Study|Lost to Follow-up|5
1298351|NCT00262041|4228986|P2|Overall Study|Lost to Follow-up|1
1298352|NCT00262041|4228987|P1|Overall Study|Lost to Follow-up|1
1298353|NCT00262041|4228985|P3|Overall Study|Withdrawal by Subject|1
1298354|NCT00262041|4228986|P2|Overall Study|Withdrawal by Subject|3
1298355|NCT00262041|4228987|P1|Overall Study|Withdrawal by Subject|0
1298356|NCT00262028|4229016|P9|Overall Study|Unable to classify|1
1298357|NCT00262028|4229017|P8|Overall Study|Unable to classify|0
1298358|NCT00262028|4229018|P7|Overall Study|Unable to classify|0
1298359|NCT00262028|4229019|P6|Overall Study|Unable to classify|0
1298360|NCT00262028|4229020|P5|Overall Study|Unable to classify|0
1298361|NCT00262028|4229021|P4|Overall Study|Unable to classify|0
1298362|NCT00262028|4229022|P3|Overall Study|Unable to classify|0
1298363|NCT00262028|4229023|P2|Overall Study|Unable to classify|3
1298364|NCT00262028|4229024|P1|Overall Study|Unable to classify|0
1298365|NCT00262028|4229016|P9|Overall Study|Protocol Violation|0
1298366|NCT00262028|4229017|P8|Overall Study|Protocol Violation|0
1298367|NCT00262028|4229018|P7|Overall Study|Protocol Violation|0
1298368|NCT00262028|4229019|P6|Overall Study|Protocol Violation|0
1298369|NCT00262028|4229020|P5|Overall Study|Protocol Violation|0
1298370|NCT00262028|4229021|P4|Overall Study|Protocol Violation|1
1298371|NCT00262028|4229022|P3|Overall Study|Protocol Violation|0
1298372|NCT00262028|4229023|P2|Overall Study|Protocol Violation|0
1298373|NCT00262028|4229024|P1|Overall Study|Protocol Violation|0
1298374|NCT00262028|4229016|P9|Overall Study|Administrative Reason|10
1298375|NCT00262028|4229017|P8|Overall Study|Administrative Reason|6
1298376|NCT00262028|4229018|P7|Overall Study|Administrative Reason|4
1298377|NCT00262028|4229019|P6|Overall Study|Administrative Reason|7
1298378|NCT00262028|4229020|P5|Overall Study|Administrative Reason|6
1298379|NCT00262028|4229021|P4|Overall Study|Administrative Reason|12
1298380|NCT00262028|4229022|P3|Overall Study|Administrative Reason|9
1298381|NCT00262028|4229023|P2|Overall Study|Administrative Reason|14
1298382|NCT00262028|4229024|P1|Overall Study|Administrative Reason|11
1298383|NCT00262028|4229016|P9|Overall Study|Lost to Follow-up|6
1298384|NCT00262028|4229017|P8|Overall Study|Lost to Follow-up|5
1298385|NCT00262028|4229018|P7|Overall Study|Lost to Follow-up|3
1298386|NCT00262028|4229019|P6|Overall Study|Lost to Follow-up|3
1298387|NCT00262028|4229020|P5|Overall Study|Lost to Follow-up|4
1298388|NCT00262028|4229021|P4|Overall Study|Lost to Follow-up|5
1298389|NCT00262028|4229022|P3|Overall Study|Lost to Follow-up|5
1298390|NCT00262028|4229023|P2|Overall Study|Lost to Follow-up|7
1298391|NCT00262028|4229024|P1|Overall Study|Lost to Follow-up|7
1298392|NCT00262028|4229016|P9|Overall Study|Withdrawal by Subject|2
1298393|NCT00262028|4229017|P8|Overall Study|Withdrawal by Subject|7
1298394|NCT00262028|4229018|P7|Overall Study|Withdrawal by Subject|5
1298395|NCT00262028|4229019|P6|Overall Study|Withdrawal by Subject|3
1298396|NCT00262028|4229020|P5|Overall Study|Withdrawal by Subject|2
1298397|NCT00262028|4229021|P4|Overall Study|Withdrawal by Subject|5
1298398|NCT00262028|4229022|P3|Overall Study|Withdrawal by Subject|6
1298399|NCT00262028|4229023|P2|Overall Study|Withdrawal by Subject|3
1298400|NCT00262028|4229024|P1|Overall Study|Withdrawal by Subject|6
1298401|NCT00262002|4229086|P7|Overall Study|Unable to classify|2
1298402|NCT00262002|4229087|P6|Overall Study|Unable to classify|0
1298403|NCT00262002|4229088|P5|Overall Study|Unable to classify|0
1298404|NCT00262002|4229089|P4|Overall Study|Unable to classify|0
1298405|NCT00262002|4229090|P3|Overall Study|Unable to classify|0
1298406|NCT00262002|4229091|P2|Overall Study|Unable to classify|0
1298407|NCT00262002|4229092|P1|Overall Study|Unable to classify|0
1298408|NCT00262002|4229086|P7|Overall Study|Protocol Violation|2
1298409|NCT00262002|4229087|P6|Overall Study|Protocol Violation|3
1298410|NCT00262002|4229088|P5|Overall Study|Protocol Violation|5
1298411|NCT00262002|4229089|P4|Overall Study|Protocol Violation|2
1298412|NCT00262002|4229090|P3|Overall Study|Protocol Violation|0
1298413|NCT00262002|4229091|P2|Overall Study|Protocol Violation|2
1298414|NCT00262002|4229092|P1|Overall Study|Protocol Violation|3
1298415|NCT00262002|4229086|P7|Overall Study|Inapropriate enrollment|0
1298416|NCT00262002|4229087|P6|Overall Study|Inapropriate enrollment|0
1298417|NCT00262002|4229088|P5|Overall Study|Inapropriate enrollment|0
1298418|NCT00262002|4229089|P4|Overall Study|Inapropriate enrollment|0
1298419|NCT00262002|4229090|P3|Overall Study|Inapropriate enrollment|0
1298420|NCT00262002|4229091|P2|Overall Study|Inapropriate enrollment|1
1298421|NCT00262002|4229092|P1|Overall Study|Inapropriate enrollment|0
1298422|NCT00262002|4229086|P7|Overall Study|Lost to Follow-up|0
1298423|NCT00262002|4229087|P6|Overall Study|Lost to Follow-up|1
1298424|NCT00262002|4229088|P5|Overall Study|Lost to Follow-up|0
1298425|NCT00262002|4229089|P4|Overall Study|Lost to Follow-up|2
1298426|NCT00262002|4229090|P3|Overall Study|Lost to Follow-up|0
1298427|NCT00262002|4229091|P2|Overall Study|Lost to Follow-up|0
1298428|NCT00262002|4229092|P1|Overall Study|Lost to Follow-up|2
1298429|NCT00262002|4229086|P7|Overall Study|Withdrawal by Subject|2
1298430|NCT00262002|4229087|P6|Overall Study|Withdrawal by Subject|2
1298431|NCT00262002|4229088|P5|Overall Study|Withdrawal by Subject|2
1298432|NCT00262002|4229089|P4|Overall Study|Withdrawal by Subject|1
1298433|NCT00262002|4229090|P3|Overall Study|Withdrawal by Subject|0
1298434|NCT00262002|4229091|P2|Overall Study|Withdrawal by Subject|2
1298435|NCT00262002|4229092|P1|Overall Study|Withdrawal by Subject|4
1298436|NCT00262002|4229086|P7|Overall Study|Adverse Event|0
1298437|NCT00262002|4229087|P6|Overall Study|Adverse Event|1
1298438|NCT00262002|4229088|P5|Overall Study|Adverse Event|0
1298439|NCT00262002|4229089|P4|Overall Study|Adverse Event|0
1298440|NCT00262002|4229090|P3|Overall Study|Adverse Event|0
1298441|NCT00262002|4229091|P2|Overall Study|Adverse Event|1
1298442|NCT00262002|4229092|P1|Overall Study|Adverse Event|2
1298443|NCT00261950|4229185|P1|Overall Study|Protocol specified Criteria|11
1298444|NCT00261950|4229185|P1|Overall Study|Physician Decision|1
1298445|NCT00261950|4229185|P1|Overall Study|not specified|1
1298446|NCT00261950|4229185|P1|Overall Study|Withdrawal by Subject|5
1298447|NCT00261950|4229185|P1|Overall Study|Death|6
1298448|NCT00261950|4229185|P1|Overall Study|Lost to Follow-up|2
1298449|NCT00261846|4229210|P12|Period 2: Part 2 (Efficacy)|Extension study|1
1298450|NCT00261846|4229211|P11|Period 2: Part 2 (Efficacy)|Extension study|1
1298451|NCT00261846|4229212|P10|Period 2: Part 2 (Efficacy)|Extension study|9
1298452|NCT00261846|4229213|P9|Period 2: Part 2 (Efficacy)|Extension study|5
1298453|NCT00261846|4229214|P8|Period 2: Part 2 (Efficacy)|Extension study|9
1298454|NCT00261846|4229215|P7|Period 2: Part 2 (Efficacy)|Extension study|4
1298455|NCT00261846|4229216|P6|Period 2: Part 2 (Efficacy)|Extension study|0
1298456|NCT00261846|4229217|P5|Period 2: Part 2 (Efficacy)|Extension study|27
1298457|NCT00261846|4229218|P4|Period 2: Part 2 (Efficacy)|Extension study|61
1298458|NCT00261846|4229219|P3|Period 2: Part 2 (Efficacy)|Extension study|0
1298459|NCT00261846|4229220|P2|Period 2: Part 2 (Efficacy)|Extension study|0
1298460|NCT00261846|4229221|P1|Period 2: Part 2 (Efficacy)|Extension study|0
1298461|NCT00261846|4229210|P12|Period 2: Part 2 (Efficacy)|Death|22
1298462|NCT00261846|4229211|P11|Period 2: Part 2 (Efficacy)|Death|44
1298463|NCT00261846|4229212|P10|Period 2: Part 2 (Efficacy)|Death|30
1298464|NCT00261846|4229213|P9|Period 2: Part 2 (Efficacy)|Death|3
1298465|NCT00261846|4229214|P8|Period 2: Part 2 (Efficacy)|Death|12
1298466|NCT00261846|4229215|P7|Period 2: Part 2 (Efficacy)|Death|10
1298467|NCT00261846|4229216|P6|Period 2: Part 2 (Efficacy)|Death|1
1298468|NCT00261846|4229217|P5|Period 2: Part 2 (Efficacy)|Death|7
1298469|NCT00261846|4229218|P4|Period 2: Part 2 (Efficacy)|Death|37
1298470|NCT00261846|4229219|P3|Period 2: Part 2 (Efficacy)|Death|0
1298471|NCT00261846|4229220|P2|Period 2: Part 2 (Efficacy)|Death|0
1298472|NCT00261846|4229221|P1|Period 2: Part 2 (Efficacy)|Death|0
1298473|NCT00261846|4229210|P12|Period 2: Part 2 (Efficacy)|Other|0
1298474|NCT00261846|4229211|P11|Period 2: Part 2 (Efficacy)|Other|0
1298475|NCT00261846|4229212|P10|Period 2: Part 2 (Efficacy)|Other|4
1298476|NCT00261846|4229213|P9|Period 2: Part 2 (Efficacy)|Other|4
1298477|NCT00261846|4229214|P8|Period 2: Part 2 (Efficacy)|Other|5
1298478|NCT00261846|4229215|P7|Period 2: Part 2 (Efficacy)|Other|1
1298479|NCT00261846|4229216|P6|Period 2: Part 2 (Efficacy)|Other|0
1298480|NCT00261846|4229217|P5|Period 2: Part 2 (Efficacy)|Other|4
1298481|NCT00261846|4229218|P4|Period 2: Part 2 (Efficacy)|Other|15
1298482|NCT00261846|4229219|P3|Period 2: Part 2 (Efficacy)|Other|0
1298483|NCT00261846|4229220|P2|Period 2: Part 2 (Efficacy)|Other|0
1298484|NCT00261846|4229221|P1|Period 2: Part 2 (Efficacy)|Other|0
1298485|NCT00261846|4229210|P12|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
1298486|NCT00261846|4229211|P11|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
1298487|NCT00261846|4229212|P10|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
1298488|NCT00261846|4229213|P9|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1
1298489|NCT00261846|4229214|P8|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
1298490|NCT00261846|4229215|P7|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
1298491|NCT00261846|4229216|P6|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
1298492|NCT00261846|4229217|P5|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
1298493|NCT00261846|4229218|P4|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12
1298494|NCT00261846|4229219|P3|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
1298495|NCT00261846|4229220|P2|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
1298496|NCT00261846|4229221|P1|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
1298497|NCT00261846|4229210|P12|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
1298498|NCT00261846|4229211|P11|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
1298499|NCT00261846|4229212|P10|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2
1298500|NCT00261846|4229213|P9|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
1298501|NCT00261846|4229214|P8|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
1298502|NCT00261846|4229215|P7|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
1298503|NCT00261846|4229216|P6|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1
1298504|NCT00261846|4229217|P5|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8
1298505|NCT00261846|4229218|P4|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9
1298506|NCT00261846|4229219|P3|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
1298507|NCT00261846|4229220|P2|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
1298508|NCT00261846|4229221|P1|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
1298509|NCT00261846|4229210|P12|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1298510|NCT00261846|4229211|P11|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1298511|NCT00261846|4229212|P10|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1298512|NCT00261846|4229213|P9|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
1298513|NCT00261846|4229214|P8|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1298514|NCT00261846|4229215|P7|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1298515|NCT00261846|4229216|P6|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1298516|NCT00261846|4229217|P5|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1298517|NCT00261846|4229218|P4|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
1298518|NCT00261846|4229219|P3|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1298519|NCT00261846|4229220|P2|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1298520|NCT00261846|4229221|P1|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1298521|NCT00261846|4229210|P12|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
1298522|NCT00261846|4229211|P11|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
1298523|NCT00261846|4229212|P10|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
1298524|NCT00261846|4229213|P9|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
1298525|NCT00261846|4229214|P8|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
1298526|NCT00261846|4229215|P7|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
1298527|NCT00261846|4229216|P6|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
1298528|NCT00261846|4229217|P5|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
1298529|NCT00261846|4229218|P4|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
1298530|NCT00261846|4229219|P3|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12
1298531|NCT00261846|4229220|P2|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
1298532|NCT00261846|4229221|P1|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
1298533|NCT00261833|4229480|P2|Overall Study|Not interested in being participant|1
1298534|NCT00261833|4229481|P1|Overall Study|Not interested in being participant|0
1298535|NCT00261833|4229480|P2|Overall Study|Missing reason|0
1298536|NCT00261833|4229481|P1|Overall Study|Missing reason|1
1298537|NCT00261833|4229480|P2|Overall Study|Lung transplantation|1
1298538|NCT00261833|4229481|P1|Overall Study|Lung transplantation|1
1298539|NCT00261833|4229480|P2|Overall Study|Suspicion of pulmonary cancer|1
1298540|NCT00261833|4229481|P1|Overall Study|Suspicion of pulmonary cancer|0
1298541|NCT00261833|4229480|P2|Overall Study|Protocol Violation|1
1298542|NCT00261833|4229481|P1|Overall Study|Protocol Violation|0
1298543|NCT00261833|4229480|P2|Overall Study|Withdrawal by Subject|7
1298544|NCT00261833|4229481|P1|Overall Study|Withdrawal by Subject|5
1298545|NCT00261833|4229480|P2|Overall Study|Adverse Event|4
1298546|NCT00261833|4229481|P1|Overall Study|Adverse Event|1
1298547|NCT00261833|4229480|P2|Overall Study|Death|3
1298548|NCT00261833|4229481|P1|Overall Study|Death|1
1298549|NCT00261716|4229515|P2|Overall Study|Lost to Follow-up|2
1298550|NCT00261716|4229516|P1|Overall Study|Lost to Follow-up|0
1298551|NCT00261716|4229515|P2|Overall Study|Withdrawal by Subject|8
1298552|NCT00261716|4229516|P1|Overall Study|Withdrawal by Subject|6
1298553|NCT00261495|4229536|P2|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
1298554|NCT00261495|4229537|P1|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
1298555|NCT00261495|4229536|P2|Extension Phase (Weeks 24 to 52)|Non-compliance|0
1298556|NCT00261495|4229537|P1|Extension Phase (Weeks 24 to 52)|Non-compliance|1
1298557|NCT00261495|4229536|P2|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
1298558|NCT00261495|4229537|P1|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
1298559|NCT00261495|4229536|P2|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
1298560|NCT00261495|4229537|P1|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
1298561|NCT00261495|4229536|P2|Extension Phase (Weeks 24 to 52)|Adverse Event|1
1298562|NCT00261495|4229537|P1|Extension Phase (Weeks 24 to 52)|Adverse Event|4
1298563|NCT00261495|4229536|P2|Extension Phase (Weeks 24 to 52)|Other|2
1298564|NCT00261495|4229537|P1|Extension Phase (Weeks 24 to 52)|Other|4
1298565|NCT00261495|4229536|P2|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0
1298566|NCT00261495|4229537|P1|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2
1298567|NCT00261495|4229536|P2|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0
1298568|NCT00261495|4229537|P1|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2
1298569|NCT00261495|4229536|P2|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
1298570|NCT00261495|4229537|P1|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
1298571|NCT00261495|4229536|P2|Maintenance Phase (Weeks 4 to 24)|Other|5
1298572|NCT00261495|4229537|P1|Maintenance Phase (Weeks 4 to 24)|Other|6
1298573|NCT00261495|4229536|P2|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2
1298574|NCT00261495|4229537|P1|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5
1298575|NCT00261495|4229536|P2|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5
1298576|NCT00261495|4229537|P1|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1
1298577|NCT00261495|4229536|P2|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5
1298578|NCT00261495|4229537|P1|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6
1298579|NCT00261495|4229536|P2|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10
1298580|NCT00261495|4229537|P1|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14
1298581|NCT00261495|4229536|P2|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20
1298582|NCT00261495|4229537|P1|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29
1298583|NCT00261495|4229536|P2|Titration Phase (Weeks 0 to 4)|Protocol Violation|4
1298584|NCT00261495|4229537|P1|Titration Phase (Weeks 0 to 4)|Protocol Violation|1
1298585|NCT00261495|4229536|P2|Titration Phase (Weeks 0 to 4)|Non-compliance|5
1298586|NCT00261495|4229537|P1|Titration Phase (Weeks 0 to 4)|Non-compliance|2
1298587|NCT00261495|4229536|P2|Titration Phase (Weeks 0 to 4)|Physician Decision|1
1298588|NCT00261495|4229537|P1|Titration Phase (Weeks 0 to 4)|Physician Decision|3
1298589|NCT00261495|4229536|P2|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
1298590|NCT00261495|4229537|P1|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
1298591|NCT00261495|4229536|P2|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11
1298592|NCT00261495|4229537|P1|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6
1298593|NCT00261495|4229536|P2|Titration Phase (Weeks 0 to 4)|Adverse Event|36
1298594|NCT00261495|4229537|P1|Titration Phase (Weeks 0 to 4)|Adverse Event|28
1298595|NCT00261443|4229701|P3|4: Extension Phase|Lost to Follow-up|0
1298596|NCT00261443|4229702|P2|4: Extension Phase|Lost to Follow-up|1
1298597|NCT00261443|4229703|P1|4: Extension Phase|Lost to Follow-up|0
1298598|NCT00261443|4229701|P3|4: Extension Phase|Withdrawal by Subject|2
1298599|NCT00261443|4229702|P2|4: Extension Phase|Withdrawal by Subject|1
1298600|NCT00261443|4229703|P1|4: Extension Phase|Withdrawal by Subject|0
1298601|NCT00261443|4229701|P3|4: Extension Phase|Adverse Event|0
1298602|NCT00261443|4229702|P2|4: Extension Phase|Adverse Event|1
1298603|NCT00261443|4229703|P1|4: Extension Phase|Adverse Event|0
1298604|NCT00261443|4229701|P3|3: Assessment of Relapse|Other Reasons|3
1298605|NCT00261443|4229702|P2|3: Assessment of Relapse|Other Reasons|4
1298606|NCT00261443|4229703|P1|3: Assessment of Relapse|Other Reasons|0
1298607|NCT00261443|4229701|P3|3: Assessment of Relapse|Administrative Reason By Sponsor|2
1298608|NCT00261443|4229702|P2|3: Assessment of Relapse|Administrative Reason By Sponsor|0
1298609|NCT00261443|4229703|P1|3: Assessment of Relapse|Administrative Reason By Sponsor|0
1298610|NCT00261443|4229701|P3|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1
1298611|NCT00261443|4229702|P2|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2
1298612|NCT00261443|4229703|P1|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0
1298613|NCT00261443|4229701|P3|3: Assessment of Relapse|Pregnancy|1
1298614|NCT00261443|4229702|P2|3: Assessment of Relapse|Pregnancy|2
1298615|NCT00261443|4229703|P1|3: Assessment of Relapse|Pregnancy|0
1298616|NCT00261443|4229701|P3|3: Assessment of Relapse|Poor/Noncompliance|3
1298617|NCT00261443|4229702|P2|3: Assessment of Relapse|Poor/Noncompliance|5
1298618|NCT00261443|4229703|P1|3: Assessment of Relapse|Poor/Noncompliance|0
1298619|NCT00261443|4229701|P3|3: Assessment of Relapse|Lost to Follow-up|6
1298620|NCT00261443|4229702|P2|3: Assessment of Relapse|Lost to Follow-up|7
1298621|NCT00261443|4229703|P1|3: Assessment of Relapse|Lost to Follow-up|0
1298622|NCT00261443|4229701|P3|3: Assessment of Relapse|Death|1
1298623|NCT00261443|4229702|P2|3: Assessment of Relapse|Death|0
1298624|NCT00261443|4229703|P1|3: Assessment of Relapse|Death|0
1298625|NCT00261443|4229701|P3|3: Assessment of Relapse|Withdrawal by Subject|15
1298626|NCT00261443|4229702|P2|3: Assessment of Relapse|Withdrawal by Subject|14
1298627|NCT00261443|4229703|P1|3: Assessment of Relapse|Withdrawal by Subject|0
1298628|NCT00261443|4229701|P3|3: Assessment of Relapse|Adverse Event|19
1298629|NCT00261443|4229702|P2|3: Assessment of Relapse|Adverse Event|15
1298630|NCT00261443|4229703|P1|3: Assessment of Relapse|Adverse Event|0
1298631|NCT00261443|4229701|P3|3: Assessment of Relapse|Lack of Efficacy|14
1298632|NCT00261443|4229702|P2|3: Assessment of Relapse|Lack of Efficacy|31
1298633|NCT00261443|4229703|P1|3: Assessment of Relapse|Lack of Efficacy|0
1298634|NCT00261443|4229701|P3|2: Stability & Maintenance of Stability|Other Reasons|0
1298635|NCT00261443|4229702|P2|2: Stability & Maintenance of Stability|Other Reasons|0
1298636|NCT00261443|4229703|P1|2: Stability & Maintenance of Stability|Other Reasons|13
1298637|NCT00261443|4229701|P3|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
1298638|NCT00261443|4229702|P2|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
1298639|NCT00261443|4229703|P1|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1
1298640|NCT00261443|4229701|P3|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
1298641|NCT00261443|4229702|P2|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
1298642|NCT00261443|4229703|P1|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32
1298643|NCT00261443|4229701|P3|2: Stability & Maintenance of Stability|Pregnancy|0
1298644|NCT00261443|4229702|P2|2: Stability & Maintenance of Stability|Pregnancy|0
1298645|NCT00261443|4229703|P1|2: Stability & Maintenance of Stability|Pregnancy|1
1298646|NCT00261443|4229701|P3|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
1298647|NCT00261443|4229702|P2|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
1298648|NCT00261443|4229703|P1|2: Stability & Maintenance of Stability|Poor/Noncompliance|33
1298649|NCT00261443|4229701|P3|2: Stability & Maintenance of Stability|Lost to Follow-up|0
1298650|NCT00261443|4229702|P2|2: Stability & Maintenance of Stability|Lost to Follow-up|0
1298651|NCT00261443|4229703|P1|2: Stability & Maintenance of Stability|Lost to Follow-up|59
1298652|NCT00261443|4229701|P3|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
1298653|NCT00261443|4229702|P2|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
1298654|NCT00261443|4229703|P1|2: Stability & Maintenance of Stability|Withdrawal by Subject|65
1298655|NCT00261443|4229701|P3|2: Stability & Maintenance of Stability|Adverse Event|0
1298656|NCT00261443|4229702|P2|2: Stability & Maintenance of Stability|Adverse Event|0
1298657|NCT00261443|4229703|P1|2: Stability & Maintenance of Stability|Adverse Event|93
1298658|NCT00261443|4229701|P3|2: Stability & Maintenance of Stability|Lack of Efficacy|0
1298659|NCT00261443|4229702|P2|2: Stability & Maintenance of Stability|Lack of Efficacy|0
1298660|NCT00261443|4229703|P1|2: Stability & Maintenance of Stability|Lack of Efficacy|43
1298661|NCT00261443|4229701|P3|1: Confirmation of Partial Nonresponse|Other Reasons|0
1298662|NCT00261443|4229702|P2|1: Confirmation of Partial Nonresponse|Other Reasons|0
1298663|NCT00261443|4229703|P1|1: Confirmation of Partial Nonresponse|Other Reasons|16
1298664|NCT00261443|4229701|P3|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
1298665|NCT00261443|4229702|P2|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
1298666|NCT00261443|4229703|P1|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307
1298667|NCT00261443|4229701|P3|1: Confirmation of Partial Nonresponse|Pregnancy|0
1298668|NCT00261443|4229702|P2|1: Confirmation of Partial Nonresponse|Pregnancy|0
1298669|NCT00261443|4229703|P1|1: Confirmation of Partial Nonresponse|Pregnancy|1
1298670|NCT00261443|4229701|P3|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
1298671|NCT00261443|4229702|P2|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
1298672|NCT00261443|4229703|P1|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23
1298673|NCT00261443|4229701|P3|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
1298674|NCT00261443|4229702|P2|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
1298675|NCT00261443|4229703|P1|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111
1298676|NCT00261443|4229701|P3|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
1298677|NCT00261443|4229702|P2|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
1298678|NCT00261443|4229703|P1|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93
1298679|NCT00261443|4229701|P3|1: Confirmation of Partial Nonresponse|Adverse Event|0
1298680|NCT00261443|4229702|P2|1: Confirmation of Partial Nonresponse|Adverse Event|0
1298681|NCT00261443|4229703|P1|1: Confirmation of Partial Nonresponse|Adverse Event|33
1298682|NCT00260832|4229971|P2|Overall Study|Protocol Violation|1
1298683|NCT00260832|4229972|P1|Overall Study|Protocol Violation|3
1298684|NCT00260832|4229971|P2|Overall Study|Not Specified|7
1298685|NCT00260832|4229972|P1|Overall Study|Not Specified|10
1298686|NCT00260832|4229971|P2|Overall Study|Death|62
1298687|NCT00260832|4229972|P1|Overall Study|Death|43
1298688|NCT00260832|4229971|P2|Overall Study|Physician Decision|9
1298689|NCT00260832|4229972|P1|Overall Study|Physician Decision|15
1298690|NCT00260832|4229971|P2|Overall Study|Withdrawal by Subject|17
1298691|NCT00260832|4229972|P1|Overall Study|Withdrawal by Subject|15
1298692|NCT00260832|4229971|P2|Overall Study|Progression|96
1298693|NCT00260832|4229972|P1|Overall Study|Progression|116
1298694|NCT00260832|4229971|P2|Overall Study|Adverse Event|19
1298695|NCT00260832|4229972|P1|Overall Study|Adverse Event|26
1298696|NCT00260533|4229999|P2|Overall Study|Other|3
1298697|NCT00260533|4230000|P1|Overall Study|Other|3
1298698|NCT00260429|4230008|P2|Overall Study|scheduled hand surgery|0
1298699|NCT00260429|4230009|P1|Overall Study|scheduled hand surgery|1
1298700|NCT00260429|4230008|P2|Overall Study|failure to follow appointments|0
1298701|NCT00260429|4230009|P1|Overall Study|failure to follow appointments|1
1298702|NCT00260208|4230017|P2|Overall Study|Missing|16
1298703|NCT00260208|4230018|P1|Overall Study|Missing|18
1298704|NCT00260208|4230017|P2|Overall Study|Death|10
1298705|NCT00260208|4230018|P1|Overall Study|Death|12
1298706|NCT00260208|4230017|P2|Overall Study|Lost to Follow-up|1
1298707|NCT00260208|4230018|P1|Overall Study|Lost to Follow-up|6
1298708|NCT00260208|4230017|P2|Overall Study|Subject withdrew consent|7
1298709|NCT00260208|4230018|P1|Overall Study|Subject withdrew consent|11
1298710|NCT00260065|4230061|P1|Overall Study|Medication Noncompliance|1
1298711|NCT00260065|4230061|P1|Overall Study|Not otherwise specified|8
1298712|NCT00260065|4230061|P1|Overall Study|Physician Decision|19
1298713|NCT00260065|4230061|P1|Overall Study|Withdrawal by Subject|13
1298714|NCT00260065|4230061|P1|Overall Study|Death|13
1298715|NCT00260065|4230061|P1|Overall Study|Adverse Event|17
1298716|NCT00260065|4230061|P1|Overall Study|Progressive Disease|22
1298717|NCT00259857|4230068|P2|24 Months Treatment|Lost to Follow-up|3
1298718|NCT00259857|4230069|P1|24 Months Treatment|Lost to Follow-up|0
1298719|NCT00259857|4230068|P2|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2
1298720|NCT00259857|4230069|P1|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1
1298721|NCT00259740|4230087|P2|Overall Study|Requirement for alternative therapy|4
1298722|NCT00259740|4230088|P1|Overall Study|Requirement for alternative therapy|0
1298723|NCT00259740|4230087|P2|Overall Study|Other|0
1298724|NCT00259740|4230088|P1|Overall Study|Other|3
1298725|NCT00259740|4230087|P2|Overall Study|Ongoing|3
1298726|NCT00259740|4230088|P1|Overall Study|Ongoing|17
1298727|NCT00259740|4230087|P2|Overall Study|Disease progression|36
1298728|NCT00259740|4230088|P1|Overall Study|Disease progression|19
1298729|NCT00259740|4230087|P2|Overall Study|Death|1
1298730|NCT00259740|4230088|P1|Overall Study|Death|1
1298731|NCT00259740|4230087|P2|Overall Study|Withdrawal by Subject|6
1298732|NCT00259740|4230088|P1|Overall Study|Withdrawal by Subject|2
1298733|NCT00259740|4230087|P2|Overall Study|Adverse Event|2
1298734|NCT00259740|4230088|P1|Overall Study|Adverse Event|0
1298735|NCT00259740|4230087|P2|Overall Study|Physician Decision|1
1298736|NCT00259740|4230088|P1|Overall Study|Physician Decision|1
1298737|NCT00259649|4230098|P1|Overall Study|irregular menses|3
1298738|NCT00259649|4230098|P1|Overall Study|Lost to Follow-up|7
1298739|NCT00259610|4230106|P4|Overall Study|Serious Adverse Event|2
1298740|NCT00259610|4230107|P3|Overall Study|Serious Adverse Event|2
1298741|NCT00259610|4230108|P2|Overall Study|Serious Adverse Event|2
1298742|NCT00259610|4230109|P1|Overall Study|Serious Adverse Event|8
1298743|NCT00259610|4230106|P4|Overall Study|Adverse Event|2
1298744|NCT00259610|4230107|P3|Overall Study|Adverse Event|5
1298745|NCT00259610|4230108|P2|Overall Study|Adverse Event|4
1298746|NCT00259610|4230109|P1|Overall Study|Adverse Event|3
1298747|NCT00259610|4230106|P4|Overall Study|non medical reason|3
1298748|NCT00259610|4230107|P3|Overall Study|non medical reason|10
1298749|NCT00259610|4230108|P2|Overall Study|non medical reason|2
1298750|NCT00259610|4230109|P1|Overall Study|non medical reason|6
1298751|NCT00259610|4230106|P4|Overall Study|Death|0
1298752|NCT00259610|4230107|P3|Overall Study|Death|2
1298753|NCT00259610|4230108|P2|Overall Study|Death|1
1298754|NCT00259610|4230109|P1|Overall Study|Death|1
1298755|NCT00259610|4230106|P4|Overall Study|Physician Decision|2
1298756|NCT00259610|4230107|P3|Overall Study|Physician Decision|7
1298757|NCT00259610|4230108|P2|Overall Study|Physician Decision|4
1298758|NCT00259610|4230109|P1|Overall Study|Physician Decision|6
1298759|NCT00259610|4230106|P4|Overall Study|Lost to Follow-up|15
1298760|NCT00259610|4230107|P3|Overall Study|Lost to Follow-up|18
1298761|NCT00259610|4230108|P2|Overall Study|Lost to Follow-up|8
1298762|NCT00259610|4230109|P1|Overall Study|Lost to Follow-up|19
1298763|NCT00259610|4230106|P4|Overall Study|Withdrawal by Subject|19
1298764|NCT00259610|4230107|P3|Overall Study|Withdrawal by Subject|29
1298765|NCT00259610|4230108|P2|Overall Study|Withdrawal by Subject|25
1298766|NCT00259610|4230109|P1|Overall Study|Withdrawal by Subject|33
1298767|NCT00259298|4230123|P1|Overall Study|Physician Decision|2
1298768|NCT00259298|4230123|P1|Overall Study|Withdrawal by Subject|1
1298769|NCT00259272|4230141|P4|Overall Study|Lost to Follow-up|1
1298770|NCT00259272|4230142|P3|Overall Study|Lost to Follow-up|0
1298771|NCT00259272|4230143|P2|Overall Study|Lost to Follow-up|0
1298772|NCT00259272|4230144|P1|Overall Study|Lost to Follow-up|1
1298773|NCT00259272|4230141|P4|Overall Study|Withdrawal by Subject|7
1298774|NCT00259272|4230142|P3|Overall Study|Withdrawal by Subject|2
1298775|NCT00259272|4230143|P2|Overall Study|Withdrawal by Subject|2
1298776|NCT00259272|4230144|P1|Overall Study|Withdrawal by Subject|4
1298777|NCT00259272|4230141|P4|Overall Study|Sponsor Decision|0
1298778|NCT00259272|4230142|P3|Overall Study|Sponsor Decision|0
1298779|NCT00259272|4230143|P2|Overall Study|Sponsor Decision|1
1298780|NCT00259272|4230144|P1|Overall Study|Sponsor Decision|0
1298781|NCT00259272|4230141|P4|Overall Study|Protocol Violation|1
1298782|NCT00259272|4230142|P3|Overall Study|Protocol Violation|0
1298783|NCT00259272|4230143|P2|Overall Study|Protocol Violation|0
1298784|NCT00259272|4230144|P1|Overall Study|Protocol Violation|2
1298785|NCT00259272|4230141|P4|Overall Study|Physician Decision|3
1298786|NCT00259272|4230142|P3|Overall Study|Physician Decision|1
1298787|NCT00259272|4230143|P2|Overall Study|Physician Decision|2
1298788|NCT00259272|4230144|P1|Overall Study|Physician Decision|1
1298789|NCT00259272|4230141|P4|Overall Study|Lack of Efficacy|6
1298790|NCT00259272|4230142|P3|Overall Study|Lack of Efficacy|2
1298791|NCT00259272|4230143|P2|Overall Study|Lack of Efficacy|1
1298792|NCT00259272|4230144|P1|Overall Study|Lack of Efficacy|5
1298793|NCT00259272|4230141|P4|Overall Study|Adverse Event|3
1298794|NCT00259272|4230142|P3|Overall Study|Adverse Event|0
1298795|NCT00259272|4230143|P2|Overall Study|Adverse Event|1
1298796|NCT00259272|4230144|P1|Overall Study|Adverse Event|2
1298797|NCT00259012|4230240|P2|Overall Study|Protocol Violation|1
1298798|NCT00259012|4230241|P1|Overall Study|Protocol Violation|1
1298799|NCT00259012|4230240|P2|Overall Study|Lost to Follow-up|1
1298800|NCT00259012|4230241|P1|Overall Study|Lost to Follow-up|0
1298801|NCT00259012|4230240|P2|Overall Study|Physician Decision|1
1298802|NCT00259012|4230241|P1|Overall Study|Physician Decision|0
1298803|NCT00259012|4230240|P2|Overall Study|Withdrawal by Subject|0
1298804|NCT00259012|4230241|P1|Overall Study|Withdrawal by Subject|1
1298805|NCT00259012|4230240|P2|Overall Study|Adverse Event|1
1298806|NCT00259012|4230241|P1|Overall Study|Adverse Event|0
1298807|NCT00258895|4230281|P2|Overall Study|Withdrawal by Subject|0
1298808|NCT00258895|4230282|P1|Overall Study|Withdrawal by Subject|1
1298809|NCT00258895|4230281|P2|Overall Study|Protocol Violation|2
1298810|NCT00258895|4230282|P1|Overall Study|Protocol Violation|6
1298811|NCT00258895|4230281|P2|Overall Study|Lost to Follow-up|1
1298812|NCT00258895|4230282|P1|Overall Study|Lost to Follow-up|3
1298813|NCT00258856|4230318|P4|Overall Study|Non-compliance|1
1298814|NCT00258856|4230319|P3|Overall Study|Non-compliance|0
1298815|NCT00258856|4230320|P2|Overall Study|Non-compliance|0
1298816|NCT00258856|4230321|P1|Overall Study|Non-compliance|2
1298817|NCT00258856|4230318|P4|Overall Study|Lost to Follow-up|0
1298818|NCT00258856|4230319|P3|Overall Study|Lost to Follow-up|2
1298819|NCT00258856|4230320|P2|Overall Study|Lost to Follow-up|0
1298820|NCT00258856|4230321|P1|Overall Study|Lost to Follow-up|1
1298821|NCT00258674|4230362|P3|Overall Study|Death|34
1298822|NCT00258674|4230363|P2|Overall Study|Death|53
1298823|NCT00258674|4230364|P1|Overall Study|Death|32
1298824|NCT00258440|4230423|P3|Overall Study|Withdrawal by Subject|1
1298825|NCT00258440|4230424|P2|Overall Study|Withdrawal by Subject|0
1298826|NCT00258440|4230425|P1|Overall Study|Withdrawal by Subject|0
1298827|NCT00258154|4230458|P2|Overall Study|Patient Moved|1
1298828|NCT00258154|4230459|P1|Overall Study|Patient Moved|3
1298829|NCT00258154|4230458|P2|Overall Study|Withdrawal by Subject|4
1298830|NCT00258154|4230459|P1|Overall Study|Withdrawal by Subject|3
1298831|NCT00258154|4230458|P2|Overall Study|Protocol Violation|1
1298832|NCT00258154|4230459|P1|Overall Study|Protocol Violation|2
1298833|NCT00258154|4230458|P2|Overall Study|Lost to Follow-up|1
1298834|NCT00258154|4230459|P1|Overall Study|Lost to Follow-up|0
1298835|NCT00258154|4230458|P2|Overall Study|Adverse Event|0
1298836|NCT00258154|4230459|P1|Overall Study|Adverse Event|1
1298837|NCT00257920|4230543|P2|Period: Second Intervention|Other|1
1298838|NCT00257920|4230544|P1|Period: Second Intervention|Other|2
1298839|NCT00257920|4230543|P2|Period: Washout Period of Two Weeks|Lost to Follow-up|1
1298840|NCT00257920|4230544|P1|Period: Washout Period of Two Weeks|Lost to Follow-up|0
1298841|NCT00257660|4230600|P2|Overall Study|No longer wanted to do blood draws|0
1298842|NCT00257660|4230601|P1|Overall Study|No longer wanted to do blood draws|1
1298843|NCT00257660|4230600|P2|Overall Study|PI & Subject Schedule Conflicts|0
1298844|NCT00257660|4230601|P1|Overall Study|PI & Subject Schedule Conflicts|1
1298845|NCT00257660|4230600|P2|Overall Study|Lost to Follow-up|0
1298846|NCT00257660|4230601|P1|Overall Study|Lost to Follow-up|1
1298847|NCT00257660|4230600|P2|Overall Study|Withdrawal by Subject|0
1298848|NCT00257660|4230601|P1|Overall Study|Withdrawal by Subject|2
1298849|NCT00257660|4230600|P2|Overall Study|Lack of Efficacy|23
1298850|NCT00257660|4230601|P1|Overall Study|Lack of Efficacy|5
1298851|NCT00257608|4230631|P3|Post Chemotherapy Phase|Not treated|7
1298852|NCT00257608|4230632|P2|Post Chemotherapy Phase|Not treated|4
1298853|NCT00257608|4230633|P1|Post Chemotherapy Phase|Not treated|0
1298854|NCT00257608|4230631|P3|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
1298855|NCT00257608|4230632|P2|Post Chemotherapy Phase|Sponsor's decision to terminate study|1
1298856|NCT00257608|4230633|P1|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
1298857|NCT00257608|4230631|P3|Post Chemotherapy Phase|Physician Decision|11
1298858|NCT00257608|4230632|P2|Post Chemotherapy Phase|Physician Decision|8
1298859|NCT00257608|4230633|P1|Post Chemotherapy Phase|Physician Decision|0
1298860|NCT00257608|4230631|P3|Post Chemotherapy Phase|Lost to Follow-up|1
1298861|NCT00257608|4230632|P2|Post Chemotherapy Phase|Lost to Follow-up|0
1298862|NCT00257608|4230633|P1|Post Chemotherapy Phase|Lost to Follow-up|0
1298863|NCT00257608|4230631|P3|Post Chemotherapy Phase|Unrelated intercurrent illness|1
1298864|NCT00257608|4230632|P2|Post Chemotherapy Phase|Unrelated intercurrent illness|0
1298865|NCT00257608|4230633|P1|Post Chemotherapy Phase|Unrelated intercurrent illness|0
1298866|NCT00257608|4230631|P3|Post Chemotherapy Phase|Patient's decision to discontinue|8
1298867|NCT00257608|4230632|P2|Post Chemotherapy Phase|Patient's decision to discontinue|4
1298868|NCT00257608|4230633|P1|Post Chemotherapy Phase|Patient's decision to discontinue|0
1298869|NCT00257608|4230631|P3|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
1298870|NCT00257608|4230632|P2|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
1298871|NCT00257608|4230633|P1|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0
1298872|NCT00257608|4230631|P3|Post Chemotherapy Phase|Unwillingness or inability to comply|5
1298873|NCT00257608|4230632|P2|Post Chemotherapy Phase|Unwillingness or inability to comply|4
1298874|NCT00257608|4230633|P1|Post Chemotherapy Phase|Unwillingness or inability to comply|0
1298875|NCT00257608|4230631|P3|Post Chemotherapy Phase|Disease progression|168
1298876|NCT00257608|4230632|P2|Post Chemotherapy Phase|Disease progression|204
1298877|NCT00257608|4230633|P1|Post Chemotherapy Phase|Disease progression|0
1298878|NCT00257608|4230631|P3|Post Chemotherapy Phase|Adverse Event|38
1298879|NCT00257608|4230632|P2|Post Chemotherapy Phase|Adverse Event|34
1298880|NCT00257608|4230633|P1|Post Chemotherapy Phase|Adverse Event|0
1298881|NCT00257608|4230631|P3|Chemotherapy Phase|Physician Decision|0
1298882|NCT00257608|4230632|P2|Chemotherapy Phase|Physician Decision|0
1298883|NCT00257608|4230633|P1|Chemotherapy Phase|Physician Decision|28
1298884|NCT00257608|4230631|P3|Chemotherapy Phase|Unrelated intercurrent illness|0
1298885|NCT00257608|4230632|P2|Chemotherapy Phase|Unrelated intercurrent illness|0
1298886|NCT00257608|4230633|P1|Chemotherapy Phase|Unrelated intercurrent illness|3
1298887|NCT00257608|4230631|P3|Chemotherapy Phase|Patient's decision to discontinue|0
1298888|NCT00257608|4230632|P2|Chemotherapy Phase|Patient's decision to discontinue|0
1298889|NCT00257608|4230633|P1|Chemotherapy Phase|Patient's decision to discontinue|35
1298890|NCT00257608|4230631|P3|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
1298891|NCT00257608|4230632|P2|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
1298892|NCT00257608|4230633|P1|Chemotherapy Phase|Need for concomitant/ancillary therapy|27
1298893|NCT00257608|4230631|P3|Chemotherapy Phase|Unwillingness or inability to comply|0
1298894|NCT00257608|4230632|P2|Chemotherapy Phase|Unwillingness or inability to comply|0
1298895|NCT00257608|4230633|P1|Chemotherapy Phase|Unwillingness or inability to comply|6
1298896|NCT00257608|4230631|P3|Chemotherapy Phase|Disease progression|0
1298897|NCT00257608|4230632|P2|Chemotherapy Phase|Disease progression|0
1298898|NCT00257608|4230633|P1|Chemotherapy Phase|Disease progression|139
1298899|NCT00257608|4230631|P3|Chemotherapy Phase|Adverse Event|0
1298900|NCT00257608|4230632|P2|Chemotherapy Phase|Adverse Event|0
1298901|NCT00257608|4230633|P1|Chemotherapy Phase|Adverse Event|138
1298902|NCT00257556|4230659|P2|Overall Study|other reason|6
1298903|NCT00257556|4230660|P1|Overall Study|other reason|4
1298904|NCT00257556|4230659|P2|Overall Study|Did not meet hCG criterion|0
1298905|NCT00257556|4230660|P1|Overall Study|Did not meet hCG criterion|3
1298906|NCT00257556|4230659|P2|Overall Study|Physician Decision|0
1298907|NCT00257556|4230660|P1|Overall Study|Physician Decision|6
1298908|NCT00257556|4230659|P2|Overall Study|Adverse Event|4
1298909|NCT00257556|4230660|P1|Overall Study|Adverse Event|1
1298910|NCT00257192|4230704|P2|Overall Study|Miscellaneous|4
1298911|NCT00257192|4230705|P1|Overall Study|Miscellaneous|0
1298912|NCT00257192|4230704|P2|Overall Study|Study terminated by sponsor|0
1298913|NCT00257192|4230705|P1|Overall Study|Study terminated by sponsor|1
1298914|NCT00257192|4230704|P2|Overall Study|Randomized but not treated|1
1298915|NCT00257192|4230705|P1|Overall Study|Randomized but not treated|0
1298916|NCT00257192|4230704|P2|Overall Study|Withdrawal by Subject|2
1298917|NCT00257192|4230705|P1|Overall Study|Withdrawal by Subject|14
1298918|NCT00257192|4230704|P2|Overall Study|Insufficient clinical response|18
1298919|NCT00257192|4230705|P1|Overall Study|Insufficient clinical response|18
1298920|NCT00257192|4230704|P2|Overall Study|Lost to Follow-up|3
1298921|NCT00257192|4230705|P1|Overall Study|Lost to Follow-up|3
1298922|NCT00257192|4230704|P2|Overall Study|Laboratory abnormality|1
1298923|NCT00257192|4230705|P1|Overall Study|Laboratory abnormality|1
1298924|NCT00257192|4230704|P2|Overall Study|Adverse Event|10
1298925|NCT00257192|4230705|P1|Overall Study|Adverse Event|21
1298926|NCT00257166|4230749|P2|Overall Study|Randomized, but not treated|0
1298927|NCT00257166|4230750|P1|Overall Study|Randomized, but not treated|1
1298928|NCT00257166|4230749|P2|Overall Study|Other|21
1298929|NCT00257166|4230750|P1|Overall Study|Other|16
1298930|NCT00257166|4230749|P2|Overall Study|Withdrawal by Subject|2
1298931|NCT00257166|4230750|P1|Overall Study|Withdrawal by Subject|9
1298932|NCT00257166|4230749|P2|Overall Study|Lost to Follow-up|1
1298933|NCT00257166|4230750|P1|Overall Study|Lost to Follow-up|8
1298934|NCT00257166|4230749|P2|Overall Study|Laboratory abnormality|0
1298935|NCT00257166|4230750|P1|Overall Study|Laboratory abnormality|1
1298936|NCT00257166|4230749|P2|Overall Study|Adverse Event|13
1298937|NCT00257166|4230750|P1|Overall Study|Adverse Event|18
1298938|NCT00257010|4230762|P1|Overall Study|no headache reported|9
1298939|NCT00257010|4230762|P1|Overall Study|various|11
1298940|NCT00257010|4230762|P1|Overall Study|Adverse Event|10
1298941|NCT00257010|4230762|P1|Overall Study|Withdrawal by Subject|34
1298942|NCT00257010|4230762|P1|Overall Study|Lost to Follow-up|53
1298943|NCT00257010|4230762|P1|Overall Study|Lack of Efficacy|11
1298944|NCT00256997|4230773|P2|Overall Study|Investigator Withdrew Participant|1
1298945|NCT00256997|4230774|P1|Overall Study|Investigator Withdrew Participant|2
1298946|NCT00256997|4230773|P2|Overall Study|Participant Non-compliant|6
1298947|NCT00256997|4230774|P1|Overall Study|Participant Non-compliant|3
1298948|NCT00256997|4230773|P2|Overall Study|End of Study (As Per Sponsor)|24
1298949|NCT00256997|4230774|P1|Overall Study|End of Study (As Per Sponsor)|12
1298950|NCT00256997|4230773|P2|Overall Study|Other|8
1298951|NCT00256997|4230774|P1|Overall Study|Other|5
1298952|NCT00256997|4230773|P2|Overall Study|Started but not treated|0
1298953|NCT00256997|4230774|P1|Overall Study|Started but not treated|2
1298954|NCT00256997|4230773|P2|Overall Study|Withdrawal by Subject|3
1298955|NCT00256997|4230774|P1|Overall Study|Withdrawal by Subject|13
1298956|NCT00256997|4230773|P2|Overall Study|Lost to Follow-up|5
1298957|NCT00256997|4230774|P1|Overall Study|Lost to Follow-up|3
1298958|NCT00256997|4230773|P2|Overall Study|Adverse Event|0
1298959|NCT00256997|4230774|P1|Overall Study|Adverse Event|4
1298960|NCT00256997|4230773|P2|Overall Study|Death|0
1298961|NCT00256997|4230774|P1|Overall Study|Death|2
1298962|NCT00256997|4230773|P2|Overall Study|Lack of Efficacy|4
1298963|NCT00256997|4230774|P1|Overall Study|Lack of Efficacy|1
1298964|NCT00256997|4230773|P2|Overall Study|Protocol Violation|4
1298965|NCT00256997|4230774|P1|Overall Study|Protocol Violation|1
1298966|NCT00256867|4230816|P8|Overall Study|Withdrawal by participant|0
1298967|NCT00256867|4230817|P7|Overall Study|Withdrawal by participant|0
1298968|NCT00256867|4230818|P6|Overall Study|Withdrawal by participant|1
1298969|NCT00256867|4230819|P5|Overall Study|Withdrawal by participant|0
1298970|NCT00256867|4230820|P4|Overall Study|Withdrawal by participant|0
1298971|NCT00256867|4230821|P3|Overall Study|Withdrawal by participant|0
1298972|NCT00256867|4230822|P2|Overall Study|Withdrawal by participant|0
1298973|NCT00256867|4230823|P1|Overall Study|Withdrawal by participant|0
1298974|NCT00256867|4230816|P8|Overall Study|Participant out of assessment window|0
1298975|NCT00256867|4230817|P7|Overall Study|Participant out of assessment window|0
1298976|NCT00256867|4230818|P6|Overall Study|Participant out of assessment window|0
1298977|NCT00256867|4230819|P5|Overall Study|Participant out of assessment window|0
1298978|NCT00256867|4230820|P4|Overall Study|Participant out of assessment window|0
1298979|NCT00256867|4230821|P3|Overall Study|Participant out of assessment window|1
1298980|NCT00256867|4230822|P2|Overall Study|Participant out of assessment window|0
1298981|NCT00256867|4230823|P1|Overall Study|Participant out of assessment window|0
1298982|NCT00256867|4230816|P8|Overall Study|Participant travelled Overseas|0
1298983|NCT00256867|4230817|P7|Overall Study|Participant travelled Overseas|0
1298984|NCT00256867|4230818|P6|Overall Study|Participant travelled Overseas|0
1298985|NCT00256867|4230819|P5|Overall Study|Participant travelled Overseas|0
1298986|NCT00256867|4230820|P4|Overall Study|Participant travelled Overseas|0
1298987|NCT00256867|4230821|P3|Overall Study|Participant travelled Overseas|0
1298988|NCT00256867|4230822|P2|Overall Study|Participant travelled Overseas|1
1298989|NCT00256867|4230823|P1|Overall Study|Participant travelled Overseas|0
1298990|NCT00256867|4230816|P8|Overall Study|Non-compliance with study medication|1
1298991|NCT00256867|4230817|P7|Overall Study|Non-compliance with study medication|0
1298992|NCT00256867|4230818|P6|Overall Study|Non-compliance with study medication|0
1298993|NCT00256867|4230819|P5|Overall Study|Non-compliance with study medication|0
1298994|NCT00256867|4230820|P4|Overall Study|Non-compliance with study medication|0
1298995|NCT00256867|4230821|P3|Overall Study|Non-compliance with study medication|0
1298996|NCT00256867|4230822|P2|Overall Study|Non-compliance with study medication|0
1298997|NCT00256867|4230823|P1|Overall Study|Non-compliance with study medication|0
1298998|NCT00256867|4230816|P8|Overall Study|Investigator's Decision|0
1298999|NCT00256867|4230817|P7|Overall Study|Investigator's Decision|0
1299000|NCT00256867|4230818|P6|Overall Study|Investigator's Decision|0
1299001|NCT00256867|4230819|P5|Overall Study|Investigator's Decision|1
1299002|NCT00256867|4230820|P4|Overall Study|Investigator's Decision|0
1299003|NCT00256867|4230821|P3|Overall Study|Investigator's Decision|0
1299004|NCT00256867|4230822|P2|Overall Study|Investigator's Decision|0
1299005|NCT00256867|4230823|P1|Overall Study|Investigator's Decision|0
1299006|NCT00256867|4230816|P8|Overall Study|Glycemia over 13.3 millimole per litre|1
1299007|NCT00256867|4230817|P7|Overall Study|Glycemia over 13.3 millimole per litre|0
1299008|NCT00256867|4230818|P6|Overall Study|Glycemia over 13.3 millimole per litre|0
1299009|NCT00256867|4230819|P5|Overall Study|Glycemia over 13.3 millimole per litre|0
1299010|NCT00256867|4230820|P4|Overall Study|Glycemia over 13.3 millimole per litre|0
1299011|NCT00256867|4230821|P3|Overall Study|Glycemia over 13.3 millimole per litre|0
1299012|NCT00256867|4230822|P2|Overall Study|Glycemia over 13.3 millimole per litre|0
1299013|NCT00256867|4230823|P1|Overall Study|Glycemia over 13.3 millimole per litre|0
1299014|NCT00256867|4230816|P8|Overall Study|Fasting plasma glucose >240 mg/dL|0
1299015|NCT00256867|4230817|P7|Overall Study|Fasting plasma glucose >240 mg/dL|0
1299016|NCT00256867|4230818|P6|Overall Study|Fasting plasma glucose >240 mg/dL|0
1299017|NCT00256867|4230819|P5|Overall Study|Fasting plasma glucose >240 mg/dL|0
1299018|NCT00256867|4230820|P4|Overall Study|Fasting plasma glucose >240 mg/dL|0
1299019|NCT00256867|4230821|P3|Overall Study|Fasting plasma glucose >240 mg/dL|0
1299020|NCT00256867|4230822|P2|Overall Study|Fasting plasma glucose >240 mg/dL|1
1299021|NCT00256867|4230823|P1|Overall Study|Fasting plasma glucose >240 mg/dL|0
1299022|NCT00256867|4230816|P8|Overall Study|Withdrawal by Subject|2
1299023|NCT00256867|4230817|P7|Overall Study|Withdrawal by Subject|3
1299024|NCT00256867|4230818|P6|Overall Study|Withdrawal by Subject|2
1299025|NCT00256867|4230819|P5|Overall Study|Withdrawal by Subject|2
1299026|NCT00256867|4230820|P4|Overall Study|Withdrawal by Subject|1
1299027|NCT00256867|4230821|P3|Overall Study|Withdrawal by Subject|1
1299028|NCT00256867|4230822|P2|Overall Study|Withdrawal by Subject|0
1299029|NCT00256867|4230823|P1|Overall Study|Withdrawal by Subject|0
1299030|NCT00256867|4230816|P8|Overall Study|Protocol Violation|1
1299031|NCT00256867|4230817|P7|Overall Study|Protocol Violation|0
1299032|NCT00256867|4230818|P6|Overall Study|Protocol Violation|1
1299033|NCT00256867|4230819|P5|Overall Study|Protocol Violation|0
1299034|NCT00256867|4230820|P4|Overall Study|Protocol Violation|1
1299035|NCT00256867|4230821|P3|Overall Study|Protocol Violation|0
1299036|NCT00256867|4230822|P2|Overall Study|Protocol Violation|0
1299037|NCT00256867|4230823|P1|Overall Study|Protocol Violation|0
1299038|NCT00256867|4230816|P8|Overall Study|Lost to Follow-up|2
1299039|NCT00256867|4230817|P7|Overall Study|Lost to Follow-up|1
1299040|NCT00256867|4230818|P6|Overall Study|Lost to Follow-up|0
1299041|NCT00256867|4230819|P5|Overall Study|Lost to Follow-up|2
1299042|NCT00256867|4230820|P4|Overall Study|Lost to Follow-up|3
1299043|NCT00256867|4230821|P3|Overall Study|Lost to Follow-up|2
1299044|NCT00256867|4230822|P2|Overall Study|Lost to Follow-up|2
1299045|NCT00256867|4230823|P1|Overall Study|Lost to Follow-up|2
1299046|NCT00256867|4230816|P8|Overall Study|Adverse Event|4
1299047|NCT00256867|4230817|P7|Overall Study|Adverse Event|1
1299048|NCT00256867|4230818|P6|Overall Study|Adverse Event|2
1299049|NCT00256867|4230819|P5|Overall Study|Adverse Event|2
1299050|NCT00256867|4230820|P4|Overall Study|Adverse Event|1
1299051|NCT00256867|4230821|P3|Overall Study|Adverse Event|1
1299052|NCT00256867|4230822|P2|Overall Study|Adverse Event|1
1299053|NCT00256867|4230823|P1|Overall Study|Adverse Event|0
1299054|NCT00256750|4230910|P3|Long Term Extension (LTE; 84 Months)|Not Specified|5
1299055|NCT00256750|4230911|P2|Long Term Extension (LTE; 84 Months)|Not Specified|4
1299056|NCT00256750|4230912|P1|Long Term Extension (LTE; 84 Months)|Not Specified|5
1299057|NCT00256750|4230910|P3|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0
1299058|NCT00256750|4230911|P2|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
1299059|NCT00256750|4230912|P1|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
1299060|NCT00256750|4230910|P3|Long Term Extension (LTE; 84 Months)|Pregnancy|2
1299061|NCT00256750|4230911|P2|Long Term Extension (LTE; 84 Months)|Pregnancy|1
1299062|NCT00256750|4230912|P1|Long Term Extension (LTE; 84 Months)|Pregnancy|0
1299063|NCT00256750|4230910|P3|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
1299064|NCT00256750|4230911|P2|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
1299065|NCT00256750|4230912|P1|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4
1299066|NCT00256750|4230910|P3|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0
1299067|NCT00256750|4230911|P2|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3
1299068|NCT00256750|4230912|P1|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6
1299069|NCT00256750|4230910|P3|Long Term Extension (LTE; 84 Months)|Death|4
1299070|NCT00256750|4230911|P2|Long Term Extension (LTE; 84 Months)|Death|4
1299071|NCT00256750|4230912|P1|Long Term Extension (LTE; 84 Months)|Death|9
1299072|NCT00256750|4230910|P3|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
1299073|NCT00256750|4230911|P2|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
1299074|NCT00256750|4230912|P1|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4
1299075|NCT00256750|4230910|P3|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1
1299076|NCT00256750|4230911|P2|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4
1299077|NCT00256750|4230912|P1|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5
1299078|NCT00256750|4230910|P3|Long Term Extension (LTE; 84 Months)|Adverse Event|14
1299079|NCT00256750|4230911|P2|Long Term Extension (LTE; 84 Months)|Adverse Event|11
1299080|NCT00256750|4230912|P1|Long Term Extension (LTE; 84 Months)|Adverse Event|13
1299081|NCT00256750|4230910|P3|Post-Transplant Treated (36 Months)|Not specified|1
1299082|NCT00256750|4230911|P2|Post-Transplant Treated (36 Months)|Not specified|1
1299083|NCT00256750|4230912|P1|Post-Transplant Treated (36 Months)|Not specified|0
1299084|NCT00256750|4230910|P3|Post-Transplant Treated (36 Months)|Protocol Violation|0
1299085|NCT00256750|4230911|P2|Post-Transplant Treated (36 Months)|Protocol Violation|1
1299086|NCT00256750|4230912|P1|Post-Transplant Treated (36 Months)|Protocol Violation|0
1299087|NCT00256750|4230910|P3|Post-Transplant Treated (36 Months)|Lack of Efficacy|0
1299088|NCT00256750|4230911|P2|Post-Transplant Treated (36 Months)|Lack of Efficacy|1
1299089|NCT00256750|4230912|P1|Post-Transplant Treated (36 Months)|Lack of Efficacy|4
1299090|NCT00256750|4230910|P3|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1
1299091|NCT00256750|4230911|P2|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
1299092|NCT00256750|4230912|P1|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
1299093|NCT00256750|4230910|P3|Post-Transplant Treated (36 Months)|Death|1
1299094|NCT00256750|4230911|P2|Post-Transplant Treated (36 Months)|Death|2
1299095|NCT00256750|4230912|P1|Post-Transplant Treated (36 Months)|Death|0
1299096|NCT00256750|4230910|P3|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
1299097|NCT00256750|4230911|P2|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0
1299098|NCT00256750|4230912|P1|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
1299099|NCT00256750|4230910|P3|Post-Transplant Treated (36 Months)|Adverse Event|2
1299100|NCT00256750|4230911|P2|Post-Transplant Treated (36 Months)|Adverse Event|1
1299101|NCT00256750|4230912|P1|Post-Transplant Treated (36 Months)|Adverse Event|5
1299102|NCT00256750|4230910|P3|Post-Transplant Treated (24 Months)|Not Specified|1
1299103|NCT00256750|4230911|P2|Post-Transplant Treated (24 Months)|Not Specified|0
1299104|NCT00256750|4230912|P1|Post-Transplant Treated (24 Months)|Not Specified|2
1299105|NCT00256750|4230910|P3|Post-Transplant Treated (24 Months)|Lack of Efficacy|2
1299106|NCT00256750|4230911|P2|Post-Transplant Treated (24 Months)|Lack of Efficacy|3
1299107|NCT00256750|4230912|P1|Post-Transplant Treated (24 Months)|Lack of Efficacy|4
1299108|NCT00256750|4230910|P3|Post-Transplant Treated (24 Months)|Death|0
1299109|NCT00256750|4230911|P2|Post-Transplant Treated (24 Months)|Death|0
1299110|NCT00256750|4230912|P1|Post-Transplant Treated (24 Months)|Death|3
1299111|NCT00256750|4230910|P3|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0
1299112|NCT00256750|4230911|P2|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1
1299113|NCT00256750|4230912|P1|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5
1299114|NCT00256750|4230910|P3|Post-Transplant Treated (24 Months)|Adverse Event|6
1299115|NCT00256750|4230911|P2|Post-Transplant Treated (24 Months)|Adverse Event|3
1299116|NCT00256750|4230912|P1|Post-Transplant Treated (24 Months)|Adverse Event|7
1299117|NCT00256750|4230910|P3|Post-Transplant Treated (12 Months)|Protocol Violation|0
1299118|NCT00256750|4230911|P2|Post-Transplant Treated (12 Months)|Protocol Violation|0
1299119|NCT00256750|4230912|P1|Post-Transplant Treated (12 Months)|Protocol Violation|2
1299120|NCT00256750|4230910|P3|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5
1299121|NCT00256750|4230911|P2|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3
1299122|NCT00256750|4230912|P1|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0
1299123|NCT00256750|4230910|P3|Post-Transplant Treated (12 Months)|Not Specified|2
1299124|NCT00256750|4230911|P2|Post-Transplant Treated (12 Months)|Not Specified|4
1299125|NCT00256750|4230912|P1|Post-Transplant Treated (12 Months)|Not Specified|5
1299126|NCT00256750|4230910|P3|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
1299127|NCT00256750|4230911|P2|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
1299128|NCT00256750|4230912|P1|Post-Transplant Treated (12 Months)|Lost to Follow-up|1
1299129|NCT00256750|4230910|P3|Post-Transplant Treated (12 Months)|Lack of Efficacy|27
1299130|NCT00256750|4230911|P2|Post-Transplant Treated (12 Months)|Lack of Efficacy|22
1299131|NCT00256750|4230912|P1|Post-Transplant Treated (12 Months)|Lack of Efficacy|10
1299132|NCT00256750|4230910|P3|Post-Transplant Treated (12 Months)|Death|4
1299133|NCT00256750|4230911|P2|Post-Transplant Treated (12 Months)|Death|2
1299134|NCT00256750|4230912|P1|Post-Transplant Treated (12 Months)|Death|3
1299135|NCT00256750|4230910|P3|Post-Transplant Treated (12 Months)|Adverse Event|8
1299136|NCT00256750|4230911|P2|Post-Transplant Treated (12 Months)|Adverse Event|12
1299137|NCT00256750|4230912|P1|Post-Transplant Treated (12 Months)|Adverse Event|20
1299138|NCT00256750|4230910|P3|Transplanted Pre-Treatment|Death|0
1299139|NCT00256750|4230911|P2|Transplanted Pre-Treatment|Death|0
1299140|NCT00256750|4230912|P1|Transplanted Pre-Treatment|Death|1
1299141|NCT00256750|4230910|P3|Transplanted Pre-Treatment|Not Specified|0
1299142|NCT00256750|4230911|P2|Transplanted Pre-Treatment|Not Specified|0
1299143|NCT00256750|4230912|P1|Transplanted Pre-Treatment|Not Specified|2
1299144|NCT00256750|4230910|P3|Transplanted Pre-Treatment|Withdrawal by Subject|0
1299145|NCT00256750|4230911|P2|Transplanted Pre-Treatment|Withdrawal by Subject|0
1299146|NCT00256750|4230912|P1|Transplanted Pre-Treatment|Withdrawal by Subject|3
1299147|NCT00256724|4231048|P2|Overall Study|Protocol Violation|3
1299148|NCT00256724|4231049|P1|Overall Study|Protocol Violation|3
1299149|NCT00256724|4231048|P2|Overall Study|Physician Decision|5
1299150|NCT00256724|4231049|P1|Overall Study|Physician Decision|2
1299151|NCT00256698|4231059|P2|Overall Study|Prematurely Discontinued|0
1299152|NCT00256698|4231060|P1|Overall Study|Prematurely Discontinued|1
1299153|NCT00256698|4231059|P2|Overall Study|withdrawn due to osteoporosis|0
1299154|NCT00256698|4231060|P1|Overall Study|withdrawn due to osteoporosis|1
1299155|NCT00256698|4231059|P2|Overall Study|still ongoing at data cut-off|46
1299156|NCT00256698|4231060|P1|Overall Study|still ongoing at data cut-off|41
1299157|NCT00256698|4231059|P2|Overall Study|disease progression|105
1299158|NCT00256698|4231060|P1|Overall Study|disease progression|97
1299159|NCT00256698|4231059|P2|Overall Study|Lost to Follow-up|3
1299160|NCT00256698|4231060|P1|Overall Study|Lost to Follow-up|1
1299161|NCT00256698|4231059|P2|Overall Study|Protocol Violation|5
1299162|NCT00256698|4231060|P1|Overall Study|Protocol Violation|6
1299163|NCT00256698|4231059|P2|Overall Study|Adverse Event|6
1299164|NCT00256698|4231060|P1|Overall Study|Adverse Event|13
1299165|NCT00256698|4231059|P2|Overall Study|Withdrawal by Subject|7
1299166|NCT00256698|4231060|P1|Overall Study|Withdrawal by Subject|7
1299167|NCT00256308|4231078|P1|Overall Study|Death|2
1299168|NCT00256295|4231086|P1|Overall Study|Death|1
1299169|NCT00256295|4231086|P1|Overall Study|Withdrawal by Subject|3
1299170|NCT00256282|4231092|P1|Overall Study|Physician Decision|1
1299171|NCT00256282|4231092|P1|Overall Study|Adverse Event|3
1299172|NCT00256282|4231092|P1|Overall Study|Disease progression, relapse during acti|12
1299173|NCT00256243|4231097|P1|Overall Study|Not treated|1
1299174|NCT00256243|4231097|P1|Overall Study|Death|7
1299175|NCT00256243|4231097|P1|Overall Study|Lost to Follow-up|2
1299176|NCT00256204|4231106|P4|Overall Study|Need for additional prohibited treatment|25
1299177|NCT00256204|4231107|P3|Overall Study|Need for additional prohibited treatment|27
1299178|NCT00256204|4231108|P2|Overall Study|Need for additional prohibited treatment|28
1299179|NCT00256204|4231109|P1|Overall Study|Need for additional prohibited treatment|38
1299180|NCT00256204|4231106|P4|Overall Study|Withdrawal by Subject|5
1299181|NCT00256204|4231107|P3|Overall Study|Withdrawal by Subject|7
1299182|NCT00256204|4231108|P2|Overall Study|Withdrawal by Subject|6
1299183|NCT00256204|4231109|P1|Overall Study|Withdrawal by Subject|17
1299184|NCT00256204|4231106|P4|Overall Study|Physician Decision|2
1299185|NCT00256204|4231107|P3|Overall Study|Physician Decision|1
1299186|NCT00256204|4231108|P2|Overall Study|Physician Decision|0
1299187|NCT00256204|4231109|P1|Overall Study|Physician Decision|0
1299188|NCT00256204|4231106|P4|Overall Study|Protocol Violation|1
1299189|NCT00256204|4231107|P3|Overall Study|Protocol Violation|2
1299190|NCT00256204|4231108|P2|Overall Study|Protocol Violation|0
1299191|NCT00256204|4231109|P1|Overall Study|Protocol Violation|1
1299192|NCT00256204|4231106|P4|Overall Study|Lost to Follow-up|2
1299193|NCT00256204|4231107|P3|Overall Study|Lost to Follow-up|1
1299194|NCT00256204|4231108|P2|Overall Study|Lost to Follow-up|1
1299195|NCT00256204|4231109|P1|Overall Study|Lost to Follow-up|1
1299196|NCT00256204|4231106|P4|Overall Study|Death|0
1299197|NCT00256204|4231107|P3|Overall Study|Death|0
1299198|NCT00256204|4231108|P2|Overall Study|Death|1
1299199|NCT00256204|4231109|P1|Overall Study|Death|0
1299200|NCT00256204|4231106|P4|Overall Study|Adverse Event|14
1299201|NCT00256204|4231107|P3|Overall Study|Adverse Event|16
1299202|NCT00256204|4231108|P2|Overall Study|Adverse Event|14
1299203|NCT00256204|4231109|P1|Overall Study|Adverse Event|10
1299204|NCT00256126|4231124|P2|Overall Study|Other|2
1299205|NCT00256126|4231125|P1|Overall Study|Other|1
1299206|NCT00256126|4231124|P2|Overall Study|Adverse Event|0
1299207|NCT00256126|4231125|P1|Overall Study|Adverse Event|1
1299208|NCT00255840|4231164|P2|Overall Study|Discontinued intervention|56
1299209|NCT00255840|4231165|P1|Overall Study|Discontinued intervention|53
1299210|NCT00255840|4231164|P2|Overall Study|Lost to Follow-up|14
1299211|NCT00255840|4231165|P1|Overall Study|Lost to Follow-up|10
1299212|NCT00255723|4231178|P2|Overall Study|Response Data Not Available|0
1299213|NCT00255723|4231179|P1|Overall Study|Response Data Not Available|1
1299214|NCT00255723|4231178|P2|Overall Study|Death|1
1299215|NCT00255723|4231179|P1|Overall Study|Death|0
1299216|NCT00255723|4231178|P2|Overall Study|Adverse Event|1
1299217|NCT00255723|4231179|P1|Overall Study|Adverse Event|1
1299218|NCT00255190|4231192|P2|Overall Study|Various|23
1299219|NCT00255190|4231193|P1|Overall Study|Various|4
1299220|NCT00255190|4231192|P2|Overall Study|Erosive esophagitis not healed|20
1299221|NCT00255190|4231193|P1|Overall Study|Erosive esophagitis not healed|0
1299222|NCT00255190|4231192|P2|Overall Study|Inclusion/Exclusion criteria not met|1
1299223|NCT00255190|4231193|P1|Overall Study|Inclusion/Exclusion criteria not met|0
1299224|NCT00255190|4231192|P2|Overall Study|Withdrew Consent|48
1299225|NCT00255190|4231193|P1|Overall Study|Withdrew Consent|17
1299226|NCT00255190|4231192|P2|Overall Study|Lost to Follow-up|27
1299227|NCT00255190|4231193|P1|Overall Study|Lost to Follow-up|10
1299228|NCT00255190|4231192|P2|Overall Study|Protocol Violation|2
1299229|NCT00255190|4231193|P1|Overall Study|Protocol Violation|2
1299230|NCT00255190|4231192|P2|Overall Study|Adverse Event|36
1299231|NCT00255190|4231193|P1|Overall Study|Adverse Event|17
1299232|NCT00255164|4231277|P3|Overall Study|Therapeutic Failure|3
1299233|NCT00255164|4231278|P2|Overall Study|Therapeutic Failure|2
1299234|NCT00255164|4231279|P1|Overall Study|Therapeutic Failure|11
1299235|NCT00255164|4231277|P3|Overall Study|Esophageal Stricture|1
1299236|NCT00255164|4231278|P2|Overall Study|Esophageal Stricture|0
1299237|NCT00255164|4231279|P1|Overall Study|Esophageal Stricture|0
1299238|NCT00255164|4231277|P3|Overall Study|Possible Barrett's Esophagus|8
1299239|NCT00255164|4231278|P2|Overall Study|Possible Barrett's Esophagus|3
1299240|NCT00255164|4231279|P1|Overall Study|Possible Barrett's Esophagus|1
1299241|NCT00255164|4231277|P3|Overall Study|Relapse of Erosive Esophagitis|12
1299242|NCT00255164|4231278|P2|Overall Study|Relapse of Erosive Esophagitis|16
1299243|NCT00255164|4231279|P1|Overall Study|Relapse of Erosive Esophagitis|78
1299244|NCT00255164|4231277|P3|Overall Study|Subject Request/Subject Unavailable|2
1299245|NCT00255164|4231278|P2|Overall Study|Subject Request/Subject Unavailable|1
1299246|NCT00255164|4231279|P1|Overall Study|Subject Request/Subject Unavailable|1
1299247|NCT00255164|4231277|P3|Overall Study|Noncompliance|2
1299248|NCT00255164|4231278|P2|Overall Study|Noncompliance|1
1299249|NCT00255164|4231279|P1|Overall Study|Noncompliance|0
1299250|NCT00255164|4231277|P3|Overall Study|Withdrawal by Subject|8
1299251|NCT00255164|4231278|P2|Overall Study|Withdrawal by Subject|17
1299252|NCT00255164|4231279|P1|Overall Study|Withdrawal by Subject|18
1299253|NCT00255164|4231277|P3|Overall Study|Lost to Follow-up|4
1299254|NCT00255164|4231278|P2|Overall Study|Lost to Follow-up|3
1299255|NCT00255164|4231279|P1|Overall Study|Lost to Follow-up|4
1299256|NCT00255164|4231277|P3|Overall Study|Adverse Event|9
1299257|NCT00255164|4231278|P2|Overall Study|Adverse Event|6
1299258|NCT00255164|4231279|P1|Overall Study|Adverse Event|10
1299259|NCT00255151|4231305|P3|Overall Study|Therapeutic Failure|3
1299260|NCT00255151|4231306|P2|Overall Study|Therapeutic Failure|2
1299261|NCT00255151|4231307|P1|Overall Study|Therapeutic Failure|11
1299262|NCT00255151|4231305|P3|Overall Study|Esophageal Stricture|1
1299263|NCT00255151|4231306|P2|Overall Study|Esophageal Stricture|0
1299264|NCT00255151|4231307|P1|Overall Study|Esophageal Stricture|0
1299265|NCT00255151|4231305|P3|Overall Study|Possible Barrett's Esophagus|8
1299266|NCT00255151|4231306|P2|Overall Study|Possible Barrett's Esophagus|3
1299267|NCT00255151|4231307|P1|Overall Study|Possible Barrett's Esophagus|1
1299268|NCT00255151|4231305|P3|Overall Study|Relapse of Erosive Esophagitis|12
1299269|NCT00255151|4231306|P2|Overall Study|Relapse of Erosive Esophagitis|16
1299270|NCT00255151|4231307|P1|Overall Study|Relapse of Erosive Esophagitis|78
1299271|NCT00255151|4231305|P3|Overall Study|Subject Request/Subject Unavailable|2
1299272|NCT00255151|4231306|P2|Overall Study|Subject Request/Subject Unavailable|1
1299273|NCT00255151|4231307|P1|Overall Study|Subject Request/Subject Unavailable|1
1299274|NCT00255151|4231305|P3|Overall Study|Noncompliance|2
1299275|NCT00255151|4231306|P2|Overall Study|Noncompliance|1
1299276|NCT00255151|4231307|P1|Overall Study|Noncompliance|0
1299277|NCT00255151|4231305|P3|Overall Study|Withdrawal by Subject|8
1299278|NCT00255151|4231306|P2|Overall Study|Withdrawal by Subject|17
1299279|NCT00255151|4231307|P1|Overall Study|Withdrawal by Subject|18
1299280|NCT00255151|4231305|P3|Overall Study|Lost to Follow-up|4
1299281|NCT00255151|4231306|P2|Overall Study|Lost to Follow-up|3
1299282|NCT00255151|4231307|P1|Overall Study|Lost to Follow-up|4
1299283|NCT00255151|4231305|P3|Overall Study|Adverse Event|9
1299284|NCT00255151|4231306|P2|Overall Study|Adverse Event|6
1299285|NCT00255151|4231307|P1|Overall Study|Adverse Event|10
1299286|NCT00255086|4231341|P2|Overall Study|Protocol Violation|1
1299287|NCT00255086|4231342|P1|Overall Study|Protocol Violation|1
1299288|NCT00255086|4231341|P2|Overall Study|Adverse Event|1
1299289|NCT00255086|4231342|P1|Overall Study|Adverse Event|1
1299290|NCT00255047|4231354|P4|Overall Study|Withdrawal by Subject|18
1299291|NCT00255047|4231355|P3|Overall Study|Withdrawal by Subject|25
1299292|NCT00255047|4231356|P2|Overall Study|Withdrawal by Subject|23
1299293|NCT00255047|4231357|P1|Overall Study|Withdrawal by Subject|24
1299294|NCT00255047|4231354|P4|Overall Study|Lost to Follow-up|6
1299295|NCT00255047|4231355|P3|Overall Study|Lost to Follow-up|5
1299296|NCT00255047|4231356|P2|Overall Study|Lost to Follow-up|8
1299297|NCT00255047|4231357|P1|Overall Study|Lost to Follow-up|9
1299298|NCT00255047|4231354|P4|Overall Study|Protocol Violation|20
1299299|NCT00255047|4231355|P3|Overall Study|Protocol Violation|16
1299300|NCT00255047|4231356|P2|Overall Study|Protocol Violation|13
1299301|NCT00255047|4231357|P1|Overall Study|Protocol Violation|13
1299302|NCT00255047|4231354|P4|Overall Study|Adverse Event|1
1299303|NCT00255047|4231355|P3|Overall Study|Adverse Event|2
1299304|NCT00255047|4231356|P2|Overall Study|Adverse Event|3
1299305|NCT00255047|4231357|P1|Overall Study|Adverse Event|0
1299306|NCT00255047|4231354|P4|Overall Study|Serious Adverse Events|1
1299307|NCT00255047|4231355|P3|Overall Study|Serious Adverse Events|2
1299308|NCT00255047|4231356|P2|Overall Study|Serious Adverse Events|1
1299309|NCT00255047|4231357|P1|Overall Study|Serious Adverse Events|2
1299310|NCT00255034|4231381|P2|Overall Study|Withdrawal by Subject|38
1299311|NCT00255034|4231382|P1|Overall Study|Withdrawal by Subject|15
1299312|NCT00255008|4231392|P4|Overall Study|Other|2
1299313|NCT00255008|4231393|P3|Overall Study|Other|3
1299314|NCT00255008|4231394|P2|Overall Study|Other|0
1299315|NCT00255008|4231395|P1|Overall Study|Other|7
1299316|NCT00255008|4231392|P4|Overall Study|Adverse lab experience|0
1299317|NCT00255008|4231393|P3|Overall Study|Adverse lab experience|0
1299318|NCT00255008|4231394|P2|Overall Study|Adverse lab experience|0
1299319|NCT00255008|4231395|P1|Overall Study|Adverse lab experience|1
1299320|NCT00255008|4231392|P4|Overall Study|Sponsor request|17
1299321|NCT00255008|4231393|P3|Overall Study|Sponsor request|8
1299322|NCT00255008|4231394|P2|Overall Study|Sponsor request|3
1299323|NCT00255008|4231395|P1|Overall Study|Sponsor request|18
1299324|NCT00255008|4231392|P4|Overall Study|Withdrew consent|0
1299325|NCT00255008|4231393|P3|Overall Study|Withdrew consent|2
1299326|NCT00255008|4231394|P2|Overall Study|Withdrew consent|0
1299327|NCT00255008|4231395|P1|Overall Study|Withdrew consent|0
1299328|NCT00255008|4231392|P4|Overall Study|Did not meet viral reduction criteria|1
1299329|NCT00255008|4231393|P3|Overall Study|Did not meet viral reduction criteria|0
1299330|NCT00255008|4231394|P2|Overall Study|Did not meet viral reduction criteria|5
1299331|NCT00255008|4231395|P1|Overall Study|Did not meet viral reduction criteria|4
1299332|NCT00255008|4231392|P4|Overall Study|Lost to Follow-up|2
1299333|NCT00255008|4231393|P3|Overall Study|Lost to Follow-up|1
1299334|NCT00255008|4231394|P2|Overall Study|Lost to Follow-up|0
1299335|NCT00255008|4231395|P1|Overall Study|Lost to Follow-up|1
1299336|NCT00255008|4231392|P4|Overall Study|Adverse Event|0
1299337|NCT00255008|4231393|P3|Overall Study|Adverse Event|2
1299338|NCT00255008|4231394|P2|Overall Study|Adverse Event|1
1299339|NCT00255008|4231395|P1|Overall Study|Adverse Event|1
1299340|NCT00254982|4231431|P2|Overall Study|Abnormal liver function tests|1
1299341|NCT00254982|4231432|P1|Overall Study|Abnormal liver function tests|2
1299342|NCT00254982|4231431|P2|Overall Study|Opportunistic infection|0
1299343|NCT00254982|4231432|P1|Overall Study|Opportunistic infection|1
1299344|NCT00254982|4231431|P2|Overall Study|Malignancy|2
1299345|NCT00254982|4231432|P1|Overall Study|Malignancy|0
1299346|NCT00254982|4231431|P2|Overall Study|Diagnosis of Tuberculosis|1
1299347|NCT00254982|4231432|P1|Overall Study|Diagnosis of Tuberculosis|1
1299348|NCT00254982|4231431|P2|Overall Study|Protocol deviation|1
1299349|NCT00254982|4231432|P1|Overall Study|Protocol deviation|1
1299350|NCT00254982|4231431|P2|Overall Study|Inclusion/exclusion criteria violation|2
1299351|NCT00254982|4231432|P1|Overall Study|Inclusion/exclusion criteria violation|0
1299352|NCT00254982|4231431|P2|Overall Study|Withdrawal by Subject|1
1299353|NCT00254982|4231432|P1|Overall Study|Withdrawal by Subject|1
1299354|NCT00254982|4231431|P2|Overall Study|Adverse Event|16
1299355|NCT00254982|4231432|P1|Overall Study|Adverse Event|18
1299356|NCT00254982|4231431|P2|Overall Study|Lost to Follow-up|3
1299357|NCT00254982|4231432|P1|Overall Study|Lost to Follow-up|5
1299358|NCT00254982|4231431|P2|Overall Study|Lack of Efficacy|3
1299359|NCT00254982|4231432|P1|Overall Study|Lack of Efficacy|5
1299360|NCT00254982|4231431|P2|Overall Study|Not specified|1
1299361|NCT00254982|4231432|P1|Overall Study|Not specified|2
1299362|NCT00254566|4231444|P2|Overall Study|Lost to Follow-up|2
1299363|NCT00254566|4231445|P1|Overall Study|Lost to Follow-up|7
1299364|NCT00254566|4231444|P2|Overall Study|Withdrawal by Subject|6
1299365|NCT00254566|4231445|P1|Overall Study|Withdrawal by Subject|5
1299366|NCT00254566|4231444|P2|Overall Study|Other|5
1299367|NCT00254566|4231445|P1|Overall Study|Other|1
1299368|NCT00254566|4231444|P2|Overall Study|Lack of Efficacy|9
1299369|NCT00254566|4231445|P1|Overall Study|Lack of Efficacy|12
1299370|NCT00254566|4231444|P2|Overall Study|Adverse Event|4
1299371|NCT00254566|4231445|P1|Overall Study|Adverse Event|5
1299372|NCT00254566|4231444|P2|Overall Study|Death|0
1299373|NCT00254566|4231445|P1|Overall Study|Death|1
1299374|NCT00254540|4231469|P2|Overall Study|Laboratory Test Abnormality|1
1299375|NCT00254540|4231470|P1|Overall Study|Laboratory Test Abnormality|0
1299376|NCT00254540|4231469|P2|Overall Study|Death|1
1299377|NCT00254540|4231470|P1|Overall Study|Death|0
1299378|NCT00254540|4231469|P2|Overall Study|Lack of Efficacy|13
1299379|NCT00254540|4231470|P1|Overall Study|Lack of Efficacy|13
1299380|NCT00254540|4231469|P2|Overall Study|Adverse Event|7
1299381|NCT00254540|4231470|P1|Overall Study|Adverse Event|6
1299382|NCT00254501|4231499|P2|Overall Study|Lost to Follow-up|1
1299383|NCT00254501|4231500|P1|Overall Study|Lost to Follow-up|1
1299384|NCT00254293|4231547|P7|LTE Open Label Fixed Dosing|not specified|1
1299385|NCT00254293|4231548|P6|LTE Open Label Fixed Dosing|not specified|0
1299386|NCT00254293|4231549|P5|LTE Open Label Fixed Dosing|not specified|0
1299387|NCT00254293|4231550|P4|LTE Open Label Fixed Dosing|not specified|0
1299388|NCT00254293|4231551|P3|LTE Open Label Fixed Dosing|not specified|0
1299389|NCT00254293|4231552|P2|LTE Open Label Fixed Dosing|not specified|0
1299390|NCT00254293|4231553|P1|LTE Open Label Fixed Dosing|not specified|0
1299391|NCT00254293|4231547|P7|LTE Open Label Fixed Dosing|Poor or non-compliance|1
1299392|NCT00254293|4231548|P6|LTE Open Label Fixed Dosing|Poor or non-compliance|0
1299393|NCT00254293|4231549|P5|LTE Open Label Fixed Dosing|Poor or non-compliance|0
1299394|NCT00254293|4231550|P4|LTE Open Label Fixed Dosing|Poor or non-compliance|0
1299395|NCT00254293|4231551|P3|LTE Open Label Fixed Dosing|Poor or non-compliance|0
1299396|NCT00254293|4231552|P2|LTE Open Label Fixed Dosing|Poor or non-compliance|0
1299397|NCT00254293|4231553|P1|LTE Open Label Fixed Dosing|Poor or non-compliance|0
1299398|NCT00254293|4231547|P7|LTE Open Label Fixed Dosing|Withdrawal by Subject|3
1299399|NCT00254293|4231548|P6|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
1299400|NCT00254293|4231549|P5|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
1299401|NCT00254293|4231550|P4|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
1299402|NCT00254293|4231551|P3|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
1299403|NCT00254293|4231552|P2|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
1299404|NCT00254293|4231553|P1|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
1299405|NCT00254293|4231547|P7|LTE Open Label Fixed Dosing|Lost to Follow-up|1
1299406|NCT00254293|4231548|P6|LTE Open Label Fixed Dosing|Lost to Follow-up|0
1299407|NCT00254293|4231549|P5|LTE Open Label Fixed Dosing|Lost to Follow-up|0
1299408|NCT00254293|4231550|P4|LTE Open Label Fixed Dosing|Lost to Follow-up|0
1299409|NCT00254293|4231551|P3|LTE Open Label Fixed Dosing|Lost to Follow-up|0
1299410|NCT00254293|4231552|P2|LTE Open Label Fixed Dosing|Lost to Follow-up|0
1299411|NCT00254293|4231553|P1|LTE Open Label Fixed Dosing|Lost to Follow-up|0
1299412|NCT00254293|4231547|P7|LTE Open Label Fixed Dosing|Lack of Efficacy|3
1299413|NCT00254293|4231548|P6|LTE Open Label Fixed Dosing|Lack of Efficacy|0
1299414|NCT00254293|4231549|P5|LTE Open Label Fixed Dosing|Lack of Efficacy|0
1299415|NCT00254293|4231550|P4|LTE Open Label Fixed Dosing|Lack of Efficacy|0
1299416|NCT00254293|4231551|P3|LTE Open Label Fixed Dosing|Lack of Efficacy|0
1299417|NCT00254293|4231552|P2|LTE Open Label Fixed Dosing|Lack of Efficacy|0
1299418|NCT00254293|4231553|P1|LTE Open Label Fixed Dosing|Lack of Efficacy|0
1299419|NCT00254293|4231547|P7|LTE Open Label Fixed Dosing|Adverse Event|1
1299420|NCT00254293|4231548|P6|LTE Open Label Fixed Dosing|Adverse Event|0
1299421|NCT00254293|4231549|P5|LTE Open Label Fixed Dosing|Adverse Event|0
1299422|NCT00254293|4231550|P4|LTE Open Label Fixed Dosing|Adverse Event|0
1299423|NCT00254293|4231551|P3|LTE Open Label Fixed Dosing|Adverse Event|0
1299424|NCT00254293|4231552|P2|LTE Open Label Fixed Dosing|Adverse Event|0
1299425|NCT00254293|4231553|P1|LTE Open Label Fixed Dosing|Adverse Event|0
1299426|NCT00254293|4231547|P7|LTE Open Label Fixed Dosing|Death|3
1299427|NCT00254293|4231548|P6|LTE Open Label Fixed Dosing|Death|0
1299428|NCT00254293|4231549|P5|LTE Open Label Fixed Dosing|Death|0
1299429|NCT00254293|4231550|P4|LTE Open Label Fixed Dosing|Death|0
1299430|NCT00254293|4231551|P3|LTE Open Label Fixed Dosing|Death|0
1299431|NCT00254293|4231552|P2|LTE Open Label Fixed Dosing|Death|0
1299432|NCT00254293|4231553|P1|LTE Open Label Fixed Dosing|Death|0
1299433|NCT00254293|4231547|P7|LTE Open Label Variable SC Dosing|not specified|0
1299434|NCT00254293|4231548|P6|LTE Open Label Variable SC Dosing|not specified|0
1299435|NCT00254293|4231549|P5|LTE Open Label Variable SC Dosing|not specified|0
1299436|NCT00254293|4231550|P4|LTE Open Label Variable SC Dosing|not specified|0
1299437|NCT00254293|4231551|P3|LTE Open Label Variable SC Dosing|not specified|2
1299438|NCT00254293|4231552|P2|LTE Open Label Variable SC Dosing|not specified|0
1299439|NCT00254293|4231553|P1|LTE Open Label Variable SC Dosing|not specified|0
1299440|NCT00254293|4231547|P7|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
1299441|NCT00254293|4231548|P6|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
1299442|NCT00254293|4231549|P5|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
1299443|NCT00254293|4231550|P4|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
1299444|NCT00254293|4231551|P3|LTE Open Label Variable SC Dosing|Poor or non-compliance|1
1299445|NCT00254293|4231552|P2|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
1299446|NCT00254293|4231553|P1|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
1299447|NCT00254293|4231547|P7|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
1299448|NCT00254293|4231548|P6|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
1299449|NCT00254293|4231549|P5|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
1299450|NCT00254293|4231550|P4|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
1299451|NCT00254293|4231551|P3|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1
1299452|NCT00254293|4231552|P2|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
1299453|NCT00254293|4231553|P1|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
1299454|NCT00254293|4231547|P7|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
1299455|NCT00254293|4231548|P6|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
1299456|NCT00254293|4231549|P5|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
1299457|NCT00254293|4231550|P4|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
1299458|NCT00254293|4231551|P3|LTE Open Label Variable SC Dosing|Lost to Follow-up|1
1299459|NCT00254293|4231552|P2|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
1299460|NCT00254293|4231553|P1|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
1299461|NCT00254293|4231547|P7|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
1299462|NCT00254293|4231548|P6|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
1299463|NCT00254293|4231549|P5|LTE Open Label Variable SC Dosing|Lack of Efficacy|1
1299464|NCT00254293|4231550|P4|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
1299465|NCT00254293|4231551|P3|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
1299466|NCT00254293|4231552|P2|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
1299467|NCT00254293|4231553|P1|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
1299468|NCT00254293|4231547|P7|LTE Open Label Variable SC Dosing|Adverse Event|0
1299469|NCT00254293|4231548|P6|LTE Open Label Variable SC Dosing|Adverse Event|0
1299470|NCT00254293|4231549|P5|LTE Open Label Variable SC Dosing|Adverse Event|1
1299471|NCT00254293|4231550|P4|LTE Open Label Variable SC Dosing|Adverse Event|0
1299472|NCT00254293|4231551|P3|LTE Open Label Variable SC Dosing|Adverse Event|2
1299473|NCT00254293|4231552|P2|LTE Open Label Variable SC Dosing|Adverse Event|0
1299474|NCT00254293|4231553|P1|LTE Open Label Variable SC Dosing|Adverse Event|1
1299475|NCT00254293|4231547|P7|LTE Open Label Variable SC Dosing|Death|0
1299476|NCT00254293|4231548|P6|LTE Open Label Variable SC Dosing|Death|0
1299477|NCT00254293|4231549|P5|LTE Open Label Variable SC Dosing|Death|0
1299478|NCT00254293|4231550|P4|LTE Open Label Variable SC Dosing|Death|0
1299479|NCT00254293|4231551|P3|LTE Open Label Variable SC Dosing|Death|1
1299480|NCT00254293|4231552|P2|LTE Open Label Variable SC Dosing|Death|0
1299481|NCT00254293|4231553|P1|LTE Open Label Variable SC Dosing|Death|0
1299482|NCT00254293|4231547|P7|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
1299483|NCT00254293|4231548|P6|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
1299484|NCT00254293|4231549|P5|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
1299485|NCT00254293|4231550|P4|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
1299486|NCT00254293|4231551|P3|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2
1299487|NCT00254293|4231552|P2|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
1299488|NCT00254293|4231553|P1|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
1299489|NCT00254293|4231547|P7|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
1299490|NCT00254293|4231548|P6|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
1299491|NCT00254293|4231549|P5|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
1299492|NCT00254293|4231550|P4|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
1299493|NCT00254293|4231551|P3|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1
1299494|NCT00254293|4231552|P2|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
1299495|NCT00254293|4231553|P1|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
1299496|NCT00254293|4231547|P7|Short Term (12 Week) Randomized Dosing|Adverse Event|0
1299497|NCT00254293|4231548|P6|Short Term (12 Week) Randomized Dosing|Adverse Event|0
1299498|NCT00254293|4231549|P5|Short Term (12 Week) Randomized Dosing|Adverse Event|0
1299499|NCT00254293|4231550|P4|Short Term (12 Week) Randomized Dosing|Adverse Event|1
1299500|NCT00254293|4231551|P3|Short Term (12 Week) Randomized Dosing|Adverse Event|0
1299501|NCT00254293|4231552|P2|Short Term (12 Week) Randomized Dosing|Adverse Event|1
1299502|NCT00254293|4231553|P1|Short Term (12 Week) Randomized Dosing|Adverse Event|0
1299503|NCT00254163|4231636|P2|Overall Study|Other|8
1299504|NCT00254163|4231637|P1|Overall Study|Other|8
1299505|NCT00254163|4231636|P2|Overall Study|Death|1
1299506|NCT00254163|4231637|P1|Overall Study|Death|0
1299507|NCT00254163|4231636|P2|Overall Study|Progressive disease|1
1299508|NCT00254163|4231637|P1|Overall Study|Progressive disease|0
1299509|NCT00254163|4231636|P2|Overall Study|Failed entry|3
1299510|NCT00254163|4231637|P1|Overall Study|Failed entry|1
1299511|NCT00254163|4231636|P2|Overall Study|Investigator request|3
1299512|NCT00254163|4231637|P1|Overall Study|Investigator request|1
1299513|NCT00254163|4231636|P2|Overall Study|Patient request/withdrew consent|4
1299514|NCT00254163|4231637|P1|Overall Study|Patient request/withdrew consent|6
1299515|NCT00254163|4231636|P2|Overall Study|Adverse Event|26
1299516|NCT00254163|4231637|P1|Overall Study|Adverse Event|29
1299517|NCT00253747|4231688|P2|Overall Study|Administrative Discharge (1), Other (2)|2
1299518|NCT00253747|4231689|P1|Overall Study|Administrative Discharge (1), Other (2)|1
1299519|NCT00253747|4231688|P2|Overall Study|Withdrawal by Subject|11
1299520|NCT00253747|4231689|P1|Overall Study|Withdrawal by Subject|10
1299521|NCT00253747|4231688|P2|Overall Study|Lost to Follow-up|14
1299522|NCT00253747|4231689|P1|Overall Study|Lost to Follow-up|13
1299523|NCT00253643|4231742|P4|Overall Study|Non-Compliance|2
1299524|NCT00253643|4231743|P3|Overall Study|Non-Compliance|0
1299525|NCT00253643|4231744|P2|Overall Study|Non-Compliance|0
1299526|NCT00253643|4231745|P1|Overall Study|Non-Compliance|0
1299527|NCT00253643|4231742|P4|Overall Study|Withdrawal by Subject|1
1299528|NCT00253643|4231743|P3|Overall Study|Withdrawal by Subject|1
1299529|NCT00253643|4231744|P2|Overall Study|Withdrawal by Subject|0
1299530|NCT00253643|4231745|P1|Overall Study|Withdrawal by Subject|0
1299531|NCT00253630|4231759|P1|Overall Study|ineligible|2
1299532|NCT00253448|4231775|P1|Overall Study|Withdrawal by Subject|1
1299533|NCT00253370|4231794|P1|Overall Study|Abdominal pain due to disease|1
1299534|NCT00253370|4231794|P1|Overall Study|Protocol Violation|1
1299535|NCT00253370|4231794|P1|Overall Study|Physician Decision|1
1299536|NCT00253370|4231794|P1|Overall Study|Non-protocol therapy|1
1299537|NCT00253370|4231794|P1|Overall Study|Withdrawal by Subject|6
1299538|NCT00253370|4231794|P1|Overall Study|Death|2
1299539|NCT00253370|4231794|P1|Overall Study|Disease progression|13
1299540|NCT00253370|4231794|P1|Overall Study|Adverse Event|18
1299541|NCT00252733|4231840|P2|Overall Study|Multiple Reasons|14
1299542|NCT00252733|4231841|P1|Overall Study|Multiple Reasons|14
1299543|NCT00252733|4231840|P2|Overall Study|Lost to Follow-up|6
1299544|NCT00252733|4231841|P1|Overall Study|Lost to Follow-up|12
1299545|NCT00252733|4231840|P2|Overall Study|Death|5
1299546|NCT00252733|4231841|P1|Overall Study|Death|7
1299547|NCT00252733|4231840|P2|Overall Study|Withdrawal by Subject|67
1299548|NCT00252733|4231841|P1|Overall Study|Withdrawal by Subject|73
1299549|NCT00252720|4231851|P2|Overall Study|Mainly patients lost to follow-up|18
1299550|NCT00252720|4231852|P1|Overall Study|Mainly patients lost to follow-up|7
1299551|NCT00252720|4231851|P2|Overall Study|Moving|42
1299552|NCT00252720|4231852|P1|Overall Study|Moving|23
1299553|NCT00252720|4231851|P2|Overall Study|Death|8
1299554|NCT00252720|4231852|P1|Overall Study|Death|7
1299555|NCT00252720|4231851|P2|Overall Study|Withdrawal by Subject|97
1299556|NCT00252720|4231852|P1|Overall Study|Withdrawal by Subject|95
1299557|NCT00252694|4231866|P2|Overall Study|Patient Moving|16
1299558|NCT00252694|4231867|P1|Overall Study|Patient Moving|17
1299559|NCT00252694|4231866|P2|Overall Study|Mostly Lost to Follow Up|13
1299560|NCT00252694|4231867|P1|Overall Study|Mostly Lost to Follow Up|8
1299561|NCT00252694|4231866|P2|Overall Study|Death|34
1299562|NCT00252694|4231867|P1|Overall Study|Death|36
1299563|NCT00252694|4231866|P2|Overall Study|Withdrawal by Subject|91
1299564|NCT00252694|4231867|P1|Overall Study|Withdrawal by Subject|83
1299565|NCT00252564|4231915|P2|Overall Study|Withdrawal by Subject|2
1299566|NCT00252564|4231916|P1|Overall Study|Withdrawal by Subject|0
1299567|NCT00252564|4231915|P2|Overall Study|Patient Request|5
1299568|NCT00252564|4231916|P1|Overall Study|Patient Request|4
1299569|NCT00252564|4231915|P2|Overall Study|Lost to Follow-up|0
1299570|NCT00252564|4231916|P1|Overall Study|Lost to Follow-up|1
1299571|NCT00252564|4231915|P2|Overall Study|Physician Decision|0
1299572|NCT00252564|4231916|P1|Overall Study|Physician Decision|1
1299573|NCT00252564|4231915|P2|Overall Study|Protocol Violation|0
1299574|NCT00252564|4231916|P1|Overall Study|Protocol Violation|0
1299575|NCT00252564|4231915|P2|Overall Study|Death|3
1299576|NCT00252564|4231916|P1|Overall Study|Death|0
1299577|NCT00252564|4231915|P2|Overall Study|Disease Progression|20
1299578|NCT00252564|4231916|P1|Overall Study|Disease Progression|14
1299579|NCT00252564|4231915|P2|Overall Study|Unrelated Complication|1
1299580|NCT00252564|4231916|P1|Overall Study|Unrelated Complication|2
1299581|NCT00252564|4231915|P2|Overall Study|Adverse Event|13
1299582|NCT00252564|4231916|P1|Overall Study|Adverse Event|17
1299583|NCT00252499|4231956|P3|Overall Study|Lost to Follow-up|0
1299584|NCT00252499|4231957|P2|Overall Study|Lost to Follow-up|0
1299585|NCT00252499|4231958|P1|Overall Study|Lost to Follow-up|1
1299586|NCT00252239|4231990|P4|Overall Study|Lost to Follow-up|0
1299587|NCT00252239|4231991|P3|Overall Study|Lost to Follow-up|2
1299588|NCT00252239|4231992|P2|Overall Study|Lost to Follow-up|0
1299589|NCT00252239|4231993|P1|Overall Study|Lost to Follow-up|0
1299590|NCT00252239|4231990|P4|Overall Study|Withdrawal by Subject|1
1299591|NCT00252239|4231991|P3|Overall Study|Withdrawal by Subject|0
1299592|NCT00252239|4231992|P2|Overall Study|Withdrawal by Subject|0
1299593|NCT00252239|4231993|P1|Overall Study|Withdrawal by Subject|1
1299594|NCT00252187|4232005|P2|Overall Study|Withdrawal by Subject|0
1299595|NCT00252187|4232006|P1|Overall Study|Withdrawal by Subject|1
1299596|NCT00252187|4232005|P2|Overall Study|Adverse Event|1
1299597|NCT00252187|4232006|P1|Overall Study|Adverse Event|3
1299598|NCT00252174|4232029|P3|Overall Study|Withdrawal by Subject|0
1299599|NCT00252174|4232030|P2|Overall Study|Withdrawal by Subject|1
1299600|NCT00252174|4232031|P1|Overall Study|Withdrawal by Subject|0
1299601|NCT00252057|4232071|P2|Overall Study|Participant previously enrolled|1
1299602|NCT00252057|4232072|P1|Overall Study|Participant previously enrolled|0
1299603|NCT00252057|4232071|P2|Overall Study|Death|2
1299604|NCT00252057|4232072|P1|Overall Study|Death|1
1299605|NCT00252057|4232071|P2|Overall Study|Withdrawal by Subject|5
1299606|NCT00252057|4232072|P1|Overall Study|Withdrawal by Subject|2
1299607|NCT00251979|4232080|P2|Overall Study|Death|5
1299608|NCT00251979|4232081|P1|Overall Study|Death|3
1299609|NCT00251979|4232080|P2|Overall Study|Lost to Follow-up|6
1299610|NCT00251979|4232081|P1|Overall Study|Lost to Follow-up|8
1299611|NCT00251979|4232080|P2|Overall Study|Withdrawal by Subject|7
1299612|NCT00251979|4232081|P1|Overall Study|Withdrawal by Subject|13
1299613|NCT00251979|4232080|P2|Overall Study|Adverse Event|17
1299614|NCT00251979|4232081|P1|Overall Study|Adverse Event|11
1299615|NCT00251979|4232080|P2|Overall Study|Protocol Violation|5
1299616|NCT00251979|4232081|P1|Overall Study|Protocol Violation|3
1299617|NCT00251927|4232113|P2|Overall Study|Study procedure non-compliance|6
1299618|NCT00251927|4232114|P1|Overall Study|Study procedure non-compliance|5
1299619|NCT00251927|4232113|P2|Overall Study|Study-specific discont. achieved|2
1299620|NCT00251927|4232114|P1|Overall Study|Study-specific discont. achieved|13
1299621|NCT00251927|4232113|P2|Overall Study|Withdrawal by Subject|25
1299622|NCT00251927|4232114|P1|Overall Study|Withdrawal by Subject|40
1299623|NCT00251927|4232113|P2|Overall Study|Pregnancy|0
1299624|NCT00251927|4232114|P1|Overall Study|Pregnancy|2
1299625|NCT00251927|4232113|P2|Overall Study|Protocol Violation|2
1299626|NCT00251927|4232114|P1|Overall Study|Protocol Violation|1
1299627|NCT00251927|4232113|P2|Overall Study|Lost to Follow-up|8
1299628|NCT00251927|4232114|P1|Overall Study|Lost to Follow-up|22
1299629|NCT00251927|4232113|P2|Overall Study|Lack of Efficacy|16
1299630|NCT00251927|4232114|P1|Overall Study|Lack of Efficacy|22
1299631|NCT00251927|4232113|P2|Overall Study|Adverse Event|15
1299632|NCT00251927|4232114|P1|Overall Study|Adverse Event|3
1299633|NCT00251758|4232166|P3|Overall Study|Per Investigator Request|0
1299634|NCT00251758|4232167|P2|Overall Study|Per Investigator Request|0
1299635|NCT00251758|4232168|P1|Overall Study|Per Investigator Request|1
1299636|NCT00251758|4232166|P3|Overall Study|Per Subject Request|1
1299637|NCT00251758|4232167|P2|Overall Study|Per Subject Request|0
1299638|NCT00251758|4232168|P1|Overall Study|Per Subject Request|0
1299639|NCT00251758|4232166|P3|Overall Study|Pregnancy|0
1299640|NCT00251758|4232167|P2|Overall Study|Pregnancy|1
1299641|NCT00251758|4232168|P1|Overall Study|Pregnancy|0
1299642|NCT00251758|4232166|P3|Overall Study|Noncompliant|2
1299643|NCT00251758|4232167|P2|Overall Study|Noncompliant|2
1299644|NCT00251758|4232168|P1|Overall Study|Noncompliant|0
1299645|NCT00251758|4232166|P3|Overall Study|Lack of Efficacy|0
1299646|NCT00251758|4232167|P2|Overall Study|Lack of Efficacy|0
1299647|NCT00251758|4232168|P1|Overall Study|Lack of Efficacy|3
1299648|NCT00251758|4232166|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
1299649|NCT00251758|4232167|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|6
1299650|NCT00251758|4232168|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|0
1299651|NCT00251758|4232166|P3|Overall Study|Withdrawal by Subject|3
1299652|NCT00251758|4232167|P2|Overall Study|Withdrawal by Subject|7
1299653|NCT00251758|4232168|P1|Overall Study|Withdrawal by Subject|13
1299654|NCT00251758|4232166|P3|Overall Study|Lost to Follow-up|5
1299655|NCT00251758|4232167|P2|Overall Study|Lost to Follow-up|2
1299656|NCT00251758|4232168|P1|Overall Study|Lost to Follow-up|4
1299657|NCT00251758|4232166|P3|Overall Study|Adverse Event|11
1299658|NCT00251758|4232167|P2|Overall Study|Adverse Event|9
1299659|NCT00251758|4232168|P1|Overall Study|Adverse Event|7
1299660|NCT00251745|4232188|P3|Overall Study|Per Investigator Request|0
1299661|NCT00251745|4232189|P2|Overall Study|Per Investigator Request|0
1299662|NCT00251745|4232190|P1|Overall Study|Per Investigator Request|1
1299663|NCT00251745|4232188|P3|Overall Study|Per Subject Request|1
1299664|NCT00251745|4232189|P2|Overall Study|Per Subject Request|0
1299665|NCT00251745|4232190|P1|Overall Study|Per Subject Request|0
1299666|NCT00251745|4232188|P3|Overall Study|Pregnancy|0
1299667|NCT00251745|4232189|P2|Overall Study|Pregnancy|1
1299668|NCT00251745|4232190|P1|Overall Study|Pregnancy|0
1299669|NCT00251745|4232188|P3|Overall Study|Noncompliant|2
1299670|NCT00251745|4232189|P2|Overall Study|Noncompliant|2
1299671|NCT00251745|4232190|P1|Overall Study|Noncompliant|0
1299672|NCT00251745|4232188|P3|Overall Study|Lack of Efficacy|0
1299673|NCT00251745|4232189|P2|Overall Study|Lack of Efficacy|0
1299674|NCT00251745|4232190|P1|Overall Study|Lack of Efficacy|3
1299675|NCT00251745|4232188|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
1299676|NCT00251745|4232189|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|6
1299677|NCT00251745|4232190|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|0
1299678|NCT00251745|4232188|P3|Overall Study|Withdrawal by Subject|3
1299679|NCT00251745|4232189|P2|Overall Study|Withdrawal by Subject|7
1299680|NCT00251745|4232190|P1|Overall Study|Withdrawal by Subject|13
1299681|NCT00251745|4232188|P3|Overall Study|Lost to Follow-up|5
1299682|NCT00251745|4232189|P2|Overall Study|Lost to Follow-up|2
1299683|NCT00251745|4232190|P1|Overall Study|Lost to Follow-up|4
1299684|NCT00251745|4232188|P3|Overall Study|Adverse Event|11
1299685|NCT00251745|4232189|P2|Overall Study|Adverse Event|9
1299686|NCT00251745|4232190|P1|Overall Study|Adverse Event|7
1299687|NCT00251719|4232210|P3|Overall Study|Barrett's esophagus|0
1299688|NCT00251719|4232211|P2|Overall Study|Barrett's esophagus|2
1299689|NCT00251719|4232212|P1|Overall Study|Barrett's esophagus|2
1299690|NCT00251719|4232210|P3|Overall Study|Noncompliance|1
1299691|NCT00251719|4232211|P2|Overall Study|Noncompliance|3
1299692|NCT00251719|4232212|P1|Overall Study|Noncompliance|2
1299693|NCT00251719|4232210|P3|Overall Study|Investigator decision|0
1299694|NCT00251719|4232211|P2|Overall Study|Investigator decision|1
1299695|NCT00251719|4232212|P1|Overall Study|Investigator decision|1
1299696|NCT00251719|4232210|P3|Overall Study|Inclusion/exclusion criteria not met|2
1299697|NCT00251719|4232211|P2|Overall Study|Inclusion/exclusion criteria not met|6
1299698|NCT00251719|4232212|P1|Overall Study|Inclusion/exclusion criteria not met|12
1299699|NCT00251719|4232210|P3|Overall Study|Lack of Efficacy|0
1299700|NCT00251719|4232211|P2|Overall Study|Lack of Efficacy|1
1299701|NCT00251719|4232212|P1|Overall Study|Lack of Efficacy|2
1299702|NCT00251719|4232210|P3|Overall Study|Withdrawal by Subject|11
1299703|NCT00251719|4232211|P2|Overall Study|Withdrawal by Subject|12
1299704|NCT00251719|4232212|P1|Overall Study|Withdrawal by Subject|14
1299705|NCT00251719|4232210|P3|Overall Study|Lost to Follow-up|8
1299706|NCT00251719|4232211|P2|Overall Study|Lost to Follow-up|11
1299707|NCT00251719|4232212|P1|Overall Study|Lost to Follow-up|5
1299708|NCT00251719|4232210|P3|Overall Study|Protocol Violation|1
1299709|NCT00251719|4232211|P2|Overall Study|Protocol Violation|1
1299710|NCT00251719|4232212|P1|Overall Study|Protocol Violation|1
1299711|NCT00251719|4232210|P3|Overall Study|Adverse Event|7
1299712|NCT00251719|4232211|P2|Overall Study|Adverse Event|8
1299713|NCT00251719|4232212|P1|Overall Study|Adverse Event|14
1299714|NCT00251693|4232238|P3|Overall Study|Abnormal laboratory findings|1
1299715|NCT00251693|4232239|P2|Overall Study|Abnormal laboratory findings|0
1299716|NCT00251693|4232240|P1|Overall Study|Abnormal laboratory findings|0
1299717|NCT00251693|4232238|P3|Overall Study|Subject request/subject unavailable|0
1299718|NCT00251693|4232239|P2|Overall Study|Subject request/subject unavailable|2
1299719|NCT00251693|4232240|P1|Overall Study|Subject request/subject unavailable|1
1299720|NCT00251693|4232238|P3|Overall Study|Possible Barrett's esophagus|2
1299721|NCT00251693|4232239|P2|Overall Study|Possible Barrett's esophagus|5
1299722|NCT00251693|4232240|P1|Overall Study|Possible Barrett's esophagus|3
1299723|NCT00251693|4232238|P3|Overall Study|Noncompliant|2
1299724|NCT00251693|4232239|P2|Overall Study|Noncompliant|0
1299725|NCT00251693|4232240|P1|Overall Study|Noncompliant|0
1299726|NCT00251693|4232238|P3|Overall Study|Inclusion/exclusion criteria not met|8
1299727|NCT00251693|4232239|P2|Overall Study|Inclusion/exclusion criteria not met|3
1299728|NCT00251693|4232240|P1|Overall Study|Inclusion/exclusion criteria not met|5
1299729|NCT00251693|4232238|P3|Overall Study|Lack of Efficacy|0
1299730|NCT00251693|4232239|P2|Overall Study|Lack of Efficacy|1
1299731|NCT00251693|4232240|P1|Overall Study|Lack of Efficacy|0
1299732|NCT00251693|4232238|P3|Overall Study|Withdrawal by Subject|14
1299733|NCT00251693|4232239|P2|Overall Study|Withdrawal by Subject|17
1299734|NCT00251693|4232240|P1|Overall Study|Withdrawal by Subject|11
1299735|NCT00251693|4232238|P3|Overall Study|Lost to Follow-up|8
1299736|NCT00251693|4232239|P2|Overall Study|Lost to Follow-up|7
1299737|NCT00251693|4232240|P1|Overall Study|Lost to Follow-up|12
1299738|NCT00251693|4232238|P3|Overall Study|Protocol Violation|2
1299739|NCT00251693|4232239|P2|Overall Study|Protocol Violation|0
1299740|NCT00251693|4232240|P1|Overall Study|Protocol Violation|2
1299741|NCT00251693|4232238|P3|Overall Study|Adverse Event|9
1299742|NCT00251693|4232239|P2|Overall Study|Adverse Event|9
1299743|NCT00251693|4232240|P1|Overall Study|Adverse Event|17
1299744|NCT00251641|4232265|P2|Overall Study|Switched Treatment|63
1299745|NCT00251641|4232266|P1|Overall Study|Switched Treatment|9
1299746|NCT00251641|4232265|P2|Overall Study|Did not Meet protocol Eligibility|1
1299747|NCT00251641|4232266|P1|Overall Study|Did not Meet protocol Eligibility|2
1299748|NCT00251641|4232265|P2|Overall Study|Protocol Violation|2
1299749|NCT00251641|4232266|P1|Overall Study|Protocol Violation|10
1299750|NCT00251641|4232265|P2|Overall Study|Withdrawal by Subject|8
1299751|NCT00251641|4232266|P1|Overall Study|Withdrawal by Subject|6
1299752|NCT00251641|4232265|P2|Overall Study|Lost to Follow-up|3
1299753|NCT00251641|4232266|P1|Overall Study|Lost to Follow-up|3
1299754|NCT00251641|4232265|P2|Overall Study|Progression of Disease|2
1299755|NCT00251641|4232266|P1|Overall Study|Progression of Disease|0
1299756|NCT00251641|4232265|P2|Overall Study|Lack of Efficacy|1
1299757|NCT00251641|4232266|P1|Overall Study|Lack of Efficacy|2
1299758|NCT00251641|4232265|P2|Overall Study|Adverse Event|8
1299759|NCT00251641|4232266|P1|Overall Study|Adverse Event|80
1299760|NCT00251589|4232284|P4|Overall Study|Discontinued due to progressive disease|1
1299761|NCT00251589|4232285|P3|Overall Study|Discontinued due to progressive disease|0
1299762|NCT00251589|4232286|P2|Overall Study|Discontinued due to progressive disease|1
1299763|NCT00251589|4232287|P1|Overall Study|Discontinued due to progressive disease|9
1299764|NCT00251589|4232284|P4|Overall Study|Withdrawal by Subject|0
1299765|NCT00251589|4232285|P3|Overall Study|Withdrawal by Subject|0
1299766|NCT00251589|4232286|P2|Overall Study|Withdrawal by Subject|1
1299767|NCT00251589|4232287|P1|Overall Study|Withdrawal by Subject|1
1299768|NCT00251589|4232284|P4|Overall Study|Adverse Event|1
1299769|NCT00251589|4232285|P3|Overall Study|Adverse Event|2
1299770|NCT00251589|4232286|P2|Overall Study|Adverse Event|1
1299771|NCT00251589|4232287|P1|Overall Study|Adverse Event|5
1299772|NCT00251316|4232324|P2|Overall Study|Physician Decision|3
1299773|NCT00251316|4232325|P1|Overall Study|Physician Decision|2
1299774|NCT00251004|4232364|P3|Overall Study|Graft Loss|8
1299775|NCT00251004|4232365|P2|Overall Study|Graft Loss|13
1299776|NCT00251004|4232366|P1|Overall Study|Graft Loss|12
1299777|NCT00251004|4232364|P3|Overall Study|Lost to Follow-up|1
1299778|NCT00251004|4232365|P2|Overall Study|Lost to Follow-up|2
1299779|NCT00251004|4232366|P1|Overall Study|Lost to Follow-up|1
1299780|NCT00251004|4232364|P3|Overall Study|Death|8
1299781|NCT00251004|4232365|P2|Overall Study|Death|10
1299782|NCT00251004|4232366|P1|Overall Study|Death|9
1299783|NCT00251004|4232364|P3|Overall Study|Withdrawal by Subject|14
1299784|NCT00251004|4232365|P2|Overall Study|Withdrawal by Subject|16
1299785|NCT00251004|4232366|P1|Overall Study|Withdrawal by Subject|23
1299786|NCT00250835|4232390|P1|Overall Study|Withdrawal by Subject|1
1299787|NCT00250718|4232399|P1|Overall Study|Withdrawal by Subject|1
1299788|NCT00250718|4232399|P1|Overall Study|Adverse Event|1
1299789|NCT00250718|4232399|P1|Overall Study|Death|1
1299790|NCT00250705|4232404|P1|Overall Study|Lack of Efficacy|2
1299791|NCT00250679|4232415|P3|Overall Study|various single events: hip surgery,diary|1
1299792|NCT00250679|4232416|P2|Overall Study|various single events: hip surgery,diary|1
1299793|NCT00250679|4232417|P1|Overall Study|various single events: hip surgery,diary|3
1299794|NCT00250679|4232415|P3|Overall Study|Non-compliance|0
1299795|NCT00250679|4232416|P2|Overall Study|Non-compliance|1
1299796|NCT00250679|4232417|P1|Overall Study|Non-compliance|1
1299797|NCT00250679|4232415|P3|Overall Study|Moved|0
1299798|NCT00250679|4232416|P2|Overall Study|Moved|1
1299799|NCT00250679|4232417|P1|Overall Study|Moved|1
1299800|NCT00250679|4232415|P3|Overall Study|Technical Holter issues|2
1299801|NCT00250679|4232416|P2|Overall Study|Technical Holter issues|0
1299802|NCT00250679|4232417|P1|Overall Study|Technical Holter issues|1
1299803|NCT00250679|4232415|P3|Overall Study|Lack of Efficacy|3
1299804|NCT00250679|4232416|P2|Overall Study|Lack of Efficacy|1
1299805|NCT00250679|4232417|P1|Overall Study|Lack of Efficacy|0
1299806|NCT00250679|4232415|P3|Overall Study|Does Not Meet Entry Criteria|2
1299807|NCT00250679|4232416|P2|Overall Study|Does Not Meet Entry Criteria|4
1299808|NCT00250679|4232417|P1|Overall Study|Does Not Meet Entry Criteria|1
1299809|NCT00250679|4232415|P3|Overall Study|Lost to Follow-up|2
1299810|NCT00250679|4232416|P2|Overall Study|Lost to Follow-up|4
1299811|NCT00250679|4232417|P1|Overall Study|Lost to Follow-up|3
1299812|NCT00250679|4232415|P3|Overall Study|Withdrawal by Subject|15
1299813|NCT00250679|4232416|P2|Overall Study|Withdrawal by Subject|18
1299814|NCT00250679|4232417|P1|Overall Study|Withdrawal by Subject|15
1299815|NCT00250679|4232415|P3|Overall Study|Protocol Violation|3
1299816|NCT00250679|4232416|P2|Overall Study|Protocol Violation|4
1299817|NCT00250679|4232417|P1|Overall Study|Protocol Violation|2
1299818|NCT00250679|4232415|P3|Overall Study|Adverse Event|16
1299819|NCT00250679|4232416|P2|Overall Study|Adverse Event|15
1299820|NCT00250679|4232417|P1|Overall Study|Adverse Event|12
1299821|NCT00250588|4232518|P3|Overall Study|Lost to Follow-up|13
1299822|NCT00250588|4232519|P2|Overall Study|Lost to Follow-up|13
1299823|NCT00250588|4232520|P1|Overall Study|Lost to Follow-up|6
1299824|NCT00250588|4232518|P3|Overall Study|Withdrawal by Subject|0
1299825|NCT00250588|4232519|P2|Overall Study|Withdrawal by Subject|6
1299826|NCT00250588|4232520|P1|Overall Study|Withdrawal by Subject|3
1299827|NCT00250458|4232568|P2|Overall Study|Not Specified|0
1299828|NCT00250458|4232569|P1|Overall Study|Not Specified|1
1299829|NCT00250458|4232568|P2|Overall Study|Qualifying migraine but did not treat|3
1299830|NCT00250458|4232569|P1|Overall Study|Qualifying migraine but did not treat|3
1299831|NCT00250458|4232568|P2|Overall Study|Lack of Migraine Attack|9
1299832|NCT00250458|4232569|P1|Overall Study|Lack of Migraine Attack|20
1299833|NCT00250458|4232568|P2|Overall Study|Withdrawal by Subject|2
1299834|NCT00250458|4232569|P1|Overall Study|Withdrawal by Subject|4
1299835|NCT00250458|4232568|P2|Overall Study|Protocol Violation|1
1299836|NCT00250458|4232569|P1|Overall Study|Protocol Violation|0
1299837|NCT00250458|4232568|P2|Overall Study|Lost to Follow-up|2
1299838|NCT00250458|4232569|P1|Overall Study|Lost to Follow-up|4
1299839|NCT00250432|4232579|P2|Overall Study|Pt was considered untreatable|1
1299840|NCT00250432|4232580|P1|Overall Study|Pt was considered untreatable|0
1299841|NCT00250432|4232579|P2|Overall Study|Pt died out of posttherapy report period|5
1299842|NCT00250432|4232580|P1|Overall Study|Pt died out of posttherapy report period|6
1299843|NCT00250432|4232579|P2|Overall Study|Withdrawal by Subject|2
1299844|NCT00250432|4232580|P1|Overall Study|Withdrawal by Subject|6
1299845|NCT00250432|4232579|P2|Overall Study|Protocol Violation|3
1299846|NCT00250432|4232580|P1|Overall Study|Protocol Violation|0
1299847|NCT00250432|4232579|P2|Overall Study|Patient Moved|1
1299848|NCT00250432|4232580|P1|Overall Study|Patient Moved|0
1299849|NCT00250432|4232579|P2|Overall Study|Lost to Follow-up|5
1299850|NCT00250432|4232580|P1|Overall Study|Lost to Follow-up|6
1299851|NCT00250432|4232579|P2|Overall Study|Lack of Efficacy|1
1299852|NCT00250432|4232580|P1|Overall Study|Lack of Efficacy|2
1299853|NCT00250432|4232579|P2|Overall Study|Adverse Event|29
1299854|NCT00250432|4232580|P1|Overall Study|Adverse Event|25
1299855|NCT00250276|4232592|P4|Overall Study|Lost to Follow-up|8
1299856|NCT00250276|4232593|P3|Overall Study|Lost to Follow-up|13
1299857|NCT00250276|4232594|P2|Overall Study|Lost to Follow-up|18
1299858|NCT00250276|4232595|P1|Overall Study|Lost to Follow-up|11
1299859|NCT00250276|4232592|P4|Overall Study|Migrated/moved from study area|7
1299860|NCT00250276|4232593|P3|Overall Study|Migrated/moved from study area|2
1299861|NCT00250276|4232594|P2|Overall Study|Migrated/moved from study area|0
1299862|NCT00250276|4232595|P1|Overall Study|Migrated/moved from study area|3
1299863|NCT00250276|4232592|P4|Overall Study|Withdrawal by Subject|2
1299864|NCT00250276|4232593|P3|Overall Study|Withdrawal by Subject|3
1299865|NCT00250276|4232594|P2|Overall Study|Withdrawal by Subject|2
1299866|NCT00250276|4232595|P1|Overall Study|Withdrawal by Subject|1
1299867|NCT00250276|4232592|P4|Overall Study|Protocol Violation|0
1299868|NCT00250276|4232593|P3|Overall Study|Protocol Violation|0
1299869|NCT00250276|4232594|P2|Overall Study|Protocol Violation|1
1299870|NCT00250276|4232595|P1|Overall Study|Protocol Violation|0
1299871|NCT00250276|4232592|P4|Overall Study|Non-serious Adverse Event|2
1299872|NCT00250276|4232593|P3|Overall Study|Non-serious Adverse Event|0
1299873|NCT00250276|4232594|P2|Overall Study|Non-serious Adverse Event|0
1299874|NCT00250276|4232595|P1|Overall Study|Non-serious Adverse Event|2
1299875|NCT00250276|4232592|P4|Overall Study|Serious Adverse Event|0
1299876|NCT00250276|4232593|P3|Overall Study|Serious Adverse Event|1
1299877|NCT00250276|4232594|P2|Overall Study|Serious Adverse Event|0
1299878|NCT00250276|4232595|P1|Overall Study|Serious Adverse Event|0
1299879|NCT00249873|4232675|P2|Overall Study|Thromboembolic/outcome event|122
1299880|NCT00249873|4232676|P1|Overall Study|Thromboembolic/outcome event|82
1299881|NCT00249873|4232675|P2|Overall Study|Event related to cardiac condition|21
1299882|NCT00249873|4232676|P1|Overall Study|Event related to cardiac condition|12
1299883|NCT00249873|4232675|P2|Overall Study|Surgery/ procedure|9
1299884|NCT00249873|4232676|P1|Overall Study|Surgery/ procedure|9
1299885|NCT00249873|4232675|P2|Overall Study|Study drug intolerance|0
1299886|NCT00249873|4232676|P1|Overall Study|Study drug intolerance|5
1299887|NCT00249873|4232675|P2|Overall Study|Oral anticoagulant required|157
1299888|NCT00249873|4232676|P1|Overall Study|Oral anticoagulant required|159
1299889|NCT00249873|4232675|P2|Overall Study|Angiotensin II receptor blocker required|0
1299890|NCT00249873|4232676|P1|Overall Study|Angiotensin II receptor blocker required|1
1299891|NCT00249873|4232675|P2|Overall Study|Open label clopidogrel required|42
1299892|NCT00249873|4232676|P1|Overall Study|Open label clopidogrel required|31
1299893|NCT00249873|4232675|P2|Overall Study|Physician withdrew consent|60
1299894|NCT00249873|4232676|P1|Overall Study|Physician withdrew consent|59
1299895|NCT00249873|4232675|P2|Overall Study|Patient not wish to continue after May08|4
1299896|NCT00249873|4232676|P1|Overall Study|Patient not wish to continue after May08|3
1299897|NCT00249873|4232675|P2|Overall Study|Other contraindicated medication|0
1299898|NCT00249873|4232676|P1|Overall Study|Other contraindicated medication|1
1299899|NCT00249873|4232675|P2|Overall Study|Other non serious Adverse Event|108
1299900|NCT00249873|4232676|P1|Overall Study|Other non serious Adverse Event|112
1299901|NCT00249873|4232675|P2|Overall Study|Non-compliance|46
1299902|NCT00249873|4232676|P1|Overall Study|Non-compliance|41
1299903|NCT00249873|4232675|P2|Overall Study|Minor bleeding|37
1299904|NCT00249873|4232676|P1|Overall Study|Minor bleeding|99
1299905|NCT00249873|4232675|P2|Overall Study|Lost to Follow-up|7
1299906|NCT00249873|4232676|P1|Overall Study|Lost to Follow-up|4
1299907|NCT00249873|4232675|P2|Overall Study|Withdrawal by Subject|466
1299908|NCT00249873|4232676|P1|Overall Study|Withdrawal by Subject|504
1299909|NCT00249873|4232675|P2|Overall Study|Contraindication to oral anticoagulant|8
1299910|NCT00249873|4232676|P1|Overall Study|Contraindication to oral anticoagulant|4
1299911|NCT00249873|4232675|P2|Overall Study|Qualifying condition not present|23
1299912|NCT00249873|4232676|P1|Overall Study|Qualifying condition not present|20
1299913|NCT00249873|4232675|P2|Overall Study|Other Serious Adverse Event|97
1299914|NCT00249873|4232676|P1|Overall Study|Other Serious Adverse Event|86
1299915|NCT00249873|4232675|P2|Overall Study|Serious haemorrhagic Adverse Event|30
1299916|NCT00249873|4232676|P1|Overall Study|Serious haemorrhagic Adverse Event|74
1299917|NCT00249873|4232675|P2|Overall Study|Severe allergic reaction|1
1299918|NCT00249873|4232676|P1|Overall Study|Severe allergic reaction|8
1299919|NCT00249873|4232675|P2|Overall Study|Significant thrombocytopenia|8
1299920|NCT00249873|4232676|P1|Overall Study|Significant thrombocytopenia|9
1299921|NCT00249873|4232675|P2|Overall Study|Not treated|8
1299922|NCT00249873|4232676|P1|Overall Study|Not treated|7
1299923|NCT00249834|4232696|P8|Overall Study|Protocol Violation|0
1299924|NCT00249834|4232697|P7|Overall Study|Protocol Violation|0
1299925|NCT00249834|4232698|P6|Overall Study|Protocol Violation|2
1299926|NCT00249834|4232699|P5|Overall Study|Protocol Violation|5
1299927|NCT00249834|4232700|P4|Overall Study|Protocol Violation|8
1299928|NCT00249834|4232701|P3|Overall Study|Protocol Violation|14
1299929|NCT00249834|4232702|P2|Overall Study|Protocol Violation|19
1299930|NCT00249834|4232703|P1|Overall Study|Protocol Violation|0
1299931|NCT00249834|4232696|P8|Overall Study|Failure of down-regulation|0
1299932|NCT00249834|4232697|P7|Overall Study|Failure of down-regulation|1
1299933|NCT00249834|4232698|P6|Overall Study|Failure of down-regulation|0
1299934|NCT00249834|4232699|P5|Overall Study|Failure of down-regulation|0
1299935|NCT00249834|4232700|P4|Overall Study|Failure of down-regulation|0
1299936|NCT00249834|4232701|P3|Overall Study|Failure of down-regulation|0
1299937|NCT00249834|4232702|P2|Overall Study|Failure of down-regulation|0
1299938|NCT00249834|4232703|P1|Overall Study|Failure of down-regulation|0
1299939|NCT00249834|4232696|P8|Overall Study|Ovarian stimulation failed|0
1299940|NCT00249834|4232697|P7|Overall Study|Ovarian stimulation failed|0
1299941|NCT00249834|4232698|P6|Overall Study|Ovarian stimulation failed|0
1299942|NCT00249834|4232699|P5|Overall Study|Ovarian stimulation failed|0
1299943|NCT00249834|4232700|P4|Overall Study|Ovarian stimulation failed|0
1299944|NCT00249834|4232701|P3|Overall Study|Ovarian stimulation failed|0
1299945|NCT00249834|4232702|P2|Overall Study|Ovarian stimulation failed|0
1299946|NCT00249834|4232703|P1|Overall Study|Ovarian stimulation failed|1
1299947|NCT00249821|4232752|P2|Overall Study|Technical problem|1
1299948|NCT00249821|4232753|P1|Overall Study|Technical problem|0
1299949|NCT00249808|4232773|P1|Overall Study|Did Not Provide Post-Baseline Data|11
1299950|NCT00249808|4232773|P1|Overall Study|Lack of Efficacy|52
1299951|NCT00249808|4232773|P1|Overall Study|Adverse Event|81
1299952|NCT00249808|4232773|P1|Overall Study|Lost to Follow-up|8
1299953|NCT00249808|4232773|P1|Overall Study|Protocol Violation|3
1299954|NCT00249808|4232773|P1|Overall Study|Other|27
1299955|NCT00249795|4232781|P2|Overall Study|Missing|1
1299956|NCT00249795|4232782|P1|Overall Study|Missing|0
1299957|NCT00249795|4232781|P2|Overall Study|Lost to Follow-up|2
1299958|NCT00249795|4232782|P1|Overall Study|Lost to Follow-up|0
1299959|NCT00249795|4232781|P2|Overall Study|Site not agree to continue after May08|1
1299960|NCT00249795|4232782|P1|Overall Study|Site not agree to continue after May08|1
1299961|NCT00249795|4232781|P2|Overall Study|Patient not wish to continue after May08|6
1299962|NCT00249795|4232782|P1|Overall Study|Patient not wish to continue after May08|4
1299963|NCT00249795|4232781|P2|Overall Study|Event related to cardiac condition|16
1299964|NCT00249795|4232782|P1|Overall Study|Event related to cardiac condition|17
1299965|NCT00249795|4232781|P2|Overall Study|Other contraindicated medication|1
1299966|NCT00249795|4232782|P1|Overall Study|Other contraindicated medication|1
1299967|NCT00249795|4232781|P2|Overall Study|Hypotension (non-symptomatic)|5
1299968|NCT00249795|4232782|P1|Overall Study|Hypotension (non-symptomatic)|5
1299969|NCT00249795|4232781|P2|Overall Study|Lightheadedness / dizziness|11
1299970|NCT00249795|4232782|P1|Overall Study|Lightheadedness / dizziness|15
1299971|NCT00249795|4232781|P2|Overall Study|Angiotensin II receptor blocker required|58
1299972|NCT00249795|4232782|P1|Overall Study|Angiotensin II receptor blocker required|35
1299973|NCT00249795|4232781|P2|Overall Study|Surgery / procedure|5
1299974|NCT00249795|4232782|P1|Overall Study|Surgery / procedure|4
1299975|NCT00249795|4232781|P2|Overall Study|Physician withdrew consent|63
1299976|NCT00249795|4232782|P1|Overall Study|Physician withdrew consent|71
1299977|NCT00249795|4232781|P2|Overall Study|Other adverse events (non-serious)|159
1299978|NCT00249795|4232782|P1|Overall Study|Other adverse events (non-serious)|188
1299979|NCT00249795|4232781|P2|Overall Study|Study drug intolerance|3
1299980|NCT00249795|4232782|P1|Overall Study|Study drug intolerance|3
1299981|NCT00249795|4232781|P2|Overall Study|Non-compliance|69
1299982|NCT00249795|4232782|P1|Overall Study|Non-compliance|71
1299983|NCT00249795|4232781|P2|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3
1299984|NCT00249795|4232782|P1|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7
1299985|NCT00249795|4232781|P2|Overall Study|Oral anticoagulant required|0
1299986|NCT00249795|4232782|P1|Overall Study|Oral anticoagulant required|2
1299987|NCT00249795|4232781|P2|Overall Study|Thromboembolic / outcome event|45
1299988|NCT00249795|4232782|P1|Overall Study|Thromboembolic / outcome event|39
1299989|NCT00249795|4232781|P2|Overall Study|Withdrawal by Subject|742
1299990|NCT00249795|4232782|P1|Overall Study|Withdrawal by Subject|678
1299991|NCT00249795|4232781|P2|Overall Study|Qualifying condition not present|29
1299992|NCT00249795|4232782|P1|Overall Study|Qualifying condition not present|26
1299993|NCT00249795|4232781|P2|Overall Study|Other Serious Adverse Event|93
1299994|NCT00249795|4232782|P1|Overall Study|Other Serious Adverse Event|84
1299995|NCT00249795|4232781|P2|Overall Study|Symptomatic hypotension|64
1299996|NCT00249795|4232782|P1|Overall Study|Symptomatic hypotension|127
1299997|NCT00249795|4232781|P2|Overall Study|Not treated|14
1299998|NCT00249795|4232782|P1|Overall Study|Not treated|16
1299999|NCT00249613|4232802|P2|12 Month Follow-up|Lost to Follow-up|8
1300000|NCT00249613|4232803|P1|12 Month Follow-up|Lost to Follow-up|10
1300001|NCT00249613|4232802|P2|12 Month Follow-up|Withdrawal by Subject|6
1300002|NCT00249613|4232803|P1|12 Month Follow-up|Withdrawal by Subject|6
1300003|NCT00249613|4232802|P2|12 Month Follow-up|Death|1
1300004|NCT00249613|4232803|P1|12 Month Follow-up|Death|1
1300005|NCT00249444|4232844|P2|Overall Study|life event|1
1300006|NCT00249444|4232845|P1|Overall Study|life event|0
1300007|NCT00249444|4232844|P2|Overall Study|Adverse Event|1
1300008|NCT00249444|4232845|P1|Overall Study|Adverse Event|1
1300009|NCT00249444|4232844|P2|Overall Study|non-compliant|11
1300010|NCT00249444|4232845|P1|Overall Study|non-compliant|9
1300011|NCT00249444|4232844|P2|Overall Study|Lost to Follow-up|2
1300012|NCT00249444|4232845|P1|Overall Study|Lost to Follow-up|2
1300013|NCT00249288|4232870|P2|Overall Study|Withdrawal by Subject|2
1300014|NCT00249288|4232871|P1|Overall Study|Withdrawal by Subject|2
1300015|NCT00249288|4232870|P2|Overall Study|Lost to Follow-up|3
1300016|NCT00249288|4232871|P1|Overall Study|Lost to Follow-up|3
1300017|NCT00249002|4232963|P1|Overall Study|Other|2
1300018|NCT00249002|4232963|P1|Overall Study|Study cancellation|3
1300019|NCT00249002|4232963|P1|Overall Study|Adverse Event|2
1300020|NCT00248833|4232982|P3|Overall Study|Other|0
1300021|NCT00248833|4232983|P2|Overall Study|Other|1
1300022|NCT00248833|4232984|P1|Overall Study|Other|0
1300023|NCT00248833|4232982|P3|Overall Study|Lost to Follow-up|1
1300024|NCT00248833|4232983|P2|Overall Study|Lost to Follow-up|1
1300025|NCT00248833|4232984|P1|Overall Study|Lost to Follow-up|1
1300026|NCT00248833|4232982|P3|Overall Study|Withdrawal by Subject|1
1300027|NCT00248833|4232983|P2|Overall Study|Withdrawal by Subject|1
1300028|NCT00248833|4232984|P1|Overall Study|Withdrawal by Subject|0
1300029|NCT00248833|4232982|P3|Overall Study|Adverse Event|0
1300030|NCT00248833|4232983|P2|Overall Study|Adverse Event|0
1300031|NCT00248833|4232984|P1|Overall Study|Adverse Event|2
1300032|NCT00248794|4233020|P3|Overall Study|Lost to Follow-up|3
1300033|NCT00248794|4233021|P2|Overall Study|Lost to Follow-up|8
1300034|NCT00248794|4233022|P1|Overall Study|Lost to Follow-up|6
1300035|NCT00248651|4233072|P3|Overall Study|Withdrawal by Subject|32
1300036|NCT00248651|4233073|P2|Overall Study|Withdrawal by Subject|40
1300037|NCT00248651|4233074|P1|Overall Study|Withdrawal by Subject|28
1300038|NCT00248625|4233110|P2|Overall Study|Withdrawal by Subject|2
1300039|NCT00248625|4233111|P1|Overall Study|Withdrawal by Subject|0
1300040|NCT00248495|4233200|P1|Overall Study|Withdrawal by Subject|1
1300041|NCT00248287|4233211|P2|Overall Study|Other|2
1300042|NCT00248287|4233212|P1|Overall Study|Other|3
1300043|NCT00248287|4233211|P2|Overall Study|Patient Request|3
1300044|NCT00248287|4233212|P1|Overall Study|Patient Request|5
1300045|NCT00248287|4233211|P2|Overall Study|Investigator Request|3
1300046|NCT00248287|4233212|P1|Overall Study|Investigator Request|4
1300047|NCT00248287|4233211|P2|Overall Study|Lost to Follow-up|1
1300048|NCT00248287|4233212|P1|Overall Study|Lost to Follow-up|0
1300049|NCT00248287|4233211|P2|Overall Study|Death|0
1300050|NCT00248287|4233212|P1|Overall Study|Death|1
1300051|NCT00248287|4233211|P2|Overall Study|Adverse Event|10
1300052|NCT00248287|4233212|P1|Overall Study|Adverse Event|11
1300053|NCT00248170|4233226|P2|Overall Study|Protocol deviation|19
1300054|NCT00248170|4233227|P1|Overall Study|Protocol deviation|17
1300055|NCT00248170|4233226|P2|Overall Study|Abnormal laboratory values|0
1300056|NCT00248170|4233227|P1|Overall Study|Abnormal laboratory values|4
1300057|NCT00248170|4233226|P2|Overall Study|Abnormal test procedure(s) result|61
1300058|NCT00248170|4233227|P1|Overall Study|Abnormal test procedure(s) result|49
1300059|NCT00248170|4233226|P2|Overall Study|Administrative problems|25
1300060|NCT00248170|4233227|P1|Overall Study|Administrative problems|22
1300061|NCT00248170|4233226|P2|Overall Study|Adverse Event|296
1300062|NCT00248170|4233227|P1|Overall Study|Adverse Event|311
1300063|NCT00248170|4233226|P2|Overall Study|Death|47
1300064|NCT00248170|4233227|P1|Overall Study|Death|28
1300065|NCT00248170|4233226|P2|Overall Study|Disease progression|216
1300066|NCT00248170|4233227|P1|Overall Study|Disease progression|196
1300067|NCT00248170|4233226|P2|Overall Study|Lost to Follow-up|35
1300068|NCT00248170|4233227|P1|Overall Study|Lost to Follow-up|28
1300069|NCT00248170|4233226|P2|Overall Study|Protocol Violation|30
1300070|NCT00248170|4233227|P1|Overall Study|Protocol Violation|35
1300071|NCT00248170|4233226|P2|Overall Study|Withdrawal by Subject|79
1300072|NCT00248170|4233227|P1|Overall Study|Withdrawal by Subject|71
1300073|NCT00247962|4233249|P2|Overall Study|Lack of Efficacy|2
1300074|NCT00247962|4233250|P1|Overall Study|Lack of Efficacy|4
1300075|NCT00247962|4233249|P2|Overall Study|Withdrawal by Subject|2
1300076|NCT00247962|4233250|P1|Overall Study|Withdrawal by Subject|3
1300077|NCT00247962|4233249|P2|Overall Study|Protocol Violation|1
1300078|NCT00247962|4233250|P1|Overall Study|Protocol Violation|1
1300079|NCT00247962|4233249|P2|Overall Study|Physician Decision|1
1300080|NCT00247962|4233250|P1|Overall Study|Physician Decision|0
1300081|NCT00247962|4233249|P2|Overall Study|Lost to Follow-up|1
1300082|NCT00247962|4233250|P1|Overall Study|Lost to Follow-up|3
1300083|NCT00247962|4233249|P2|Overall Study|Adverse Event|12
1300084|NCT00247962|4233250|P1|Overall Study|Adverse Event|15
1300085|NCT00247676|4233258|P1|Overall Study|Withdrawal by Subject|2
1300086|NCT00247676|4233258|P1|Overall Study|Other|3
1300087|NCT00247676|4233258|P1|Overall Study|Lack of Efficacy|15
1300088|NCT00247676|4233258|P1|Overall Study|Adverse Event|11
1300089|NCT00247676|4233258|P1|Overall Study|Death|5
1300090|NCT00247611|4233303|P2|Baselined|Completed baseline only|8
1300091|NCT00247611|4233304|P1|Baselined|Completed baseline only|9
1300092|NCT00247611|4233303|P2|Baselined|Completed baseline, never placed on ARVs|5
1300093|NCT00247611|4233304|P1|Baselined|Completed baseline, never placed on ARVs|8
1300094|NCT00247416|4233322|P2|Overall Study|3 patients were found to be ineligible|2
1300095|NCT00247416|4233323|P1|Overall Study|3 patients were found to be ineligible|1
1300096|NCT00247273|4233364|P2|Overall Study|Did not take any study drug|0
1300097|NCT00247273|4233365|P1|Overall Study|Did not take any study drug|2
1300098|NCT00247273|4233364|P2|Overall Study|Withdrawal by Subject|47
1300099|NCT00247273|4233365|P1|Overall Study|Withdrawal by Subject|46
1300100|NCT00247273|4233364|P2|Overall Study|Lost to Follow-up|7
1300101|NCT00247273|4233365|P1|Overall Study|Lost to Follow-up|7
1300102|NCT00247273|4233364|P2|Overall Study|Physician Decision|3
1300103|NCT00247273|4233365|P1|Overall Study|Physician Decision|6
1300104|NCT00247273|4233364|P2|Overall Study|Adverse Event|80
1300105|NCT00247273|4233365|P1|Overall Study|Adverse Event|85
1300106|NCT00246805|4233411|P2|Phase 1|Lost to Follow-up|0
1300107|NCT00246805|4233412|P1|Phase 1|Lost to Follow-up|1
1300108|NCT00246753|4233418|P1|Overall Study|Unacceptable toxicity|2
1300109|NCT00246753|4233418|P1|Overall Study|Adverse Event|2
1300110|NCT00246753|4233418|P1|Overall Study|Physician Decision|2
1300111|NCT00246753|4233418|P1|Overall Study|Withdrawal by Subject|2
1300112|NCT00246740|4233426|P2|Initial Enrollment|Other|2
1300113|NCT00246740|4233427|P1|Initial Enrollment|Other|1
1300114|NCT00246740|4233426|P2|Initial Enrollment|Surgery schedule change|4
1300115|NCT00246740|4233427|P1|Initial Enrollment|Surgery schedule change|4
1300116|NCT00246740|4233426|P2|Initial Enrollment|Additional surgery scheduled|2
1300117|NCT00246740|4233427|P1|Initial Enrollment|Additional surgery scheduled|0
1300118|NCT00246740|4233426|P2|Initial Enrollment|Death|0
1300119|NCT00246740|4233427|P1|Initial Enrollment|Death|1
1300120|NCT00246571|4233451|P2|Overall Study|Crossover participants|74
1300121|NCT00246571|4233452|P1|Overall Study|Crossover participants|0
1300122|NCT00246571|4233451|P2|Overall Study|Laboratory abnormalities|0
1300123|NCT00246571|4233452|P1|Overall Study|Laboratory abnormalities|1
1300124|NCT00246571|4233451|P2|Overall Study|Did not meet entrance criteria|1
1300125|NCT00246571|4233452|P1|Overall Study|Did not meet entrance criteria|2
1300126|NCT00246571|4233451|P2|Overall Study|Sponsor|1
1300127|NCT00246571|4233452|P1|Overall Study|Sponsor|0
1300128|NCT00246571|4233451|P2|Overall Study|Death|3
1300129|NCT00246571|4233452|P1|Overall Study|Death|17
1300130|NCT00246571|4233451|P2|Overall Study|Lack of Efficacy|21
1300131|NCT00246571|4233452|P1|Overall Study|Lack of Efficacy|84
1300132|NCT00246571|4233451|P2|Overall Study|Withdrawal by Subject|3
1300133|NCT00246571|4233452|P1|Overall Study|Withdrawal by Subject|2
1300134|NCT00246571|4233451|P2|Overall Study|Protocol Violation|1
1300135|NCT00246571|4233452|P1|Overall Study|Protocol Violation|0
1300136|NCT00246571|4233451|P2|Overall Study|Adverse Event|0
1300137|NCT00246571|4233452|P1|Overall Study|Adverse Event|7
1300138|NCT00246376|4233517|P5|Overall Study|Lost to Follow-up|13
1300139|NCT00246376|4233518|P4|Overall Study|Lost to Follow-up|16
1300140|NCT00246376|4233519|P3|Overall Study|Lost to Follow-up|11
1300141|NCT00246376|4233520|P2|Overall Study|Lost to Follow-up|11
1300142|NCT00246376|4233521|P1|Overall Study|Lost to Follow-up|2
1300143|NCT00246376|4233517|P5|Overall Study|Adverse Event|1
1300144|NCT00246376|4233518|P4|Overall Study|Adverse Event|3
1300145|NCT00246376|4233519|P3|Overall Study|Adverse Event|1
1300146|NCT00246376|4233520|P2|Overall Study|Adverse Event|3
1300147|NCT00246376|4233521|P1|Overall Study|Adverse Event|2
1300148|NCT00246376|4233517|P5|Overall Study|Dropped/withdrew during dietary run-in|3
1300149|NCT00246376|4233518|P4|Overall Study|Dropped/withdrew during dietary run-in|7
1300150|NCT00246376|4233519|P3|Overall Study|Dropped/withdrew during dietary run-in|4
1300151|NCT00246376|4233520|P2|Overall Study|Dropped/withdrew during dietary run-in|5
1300152|NCT00246376|4233521|P1|Overall Study|Dropped/withdrew during dietary run-in|11
1300153|NCT00246337|4233572|P9|Overall Study|Reported as completing trial in error|0
1300154|NCT00246337|4233573|P8|Overall Study|Reported as completing trial in error|1
1300155|NCT00246337|4233574|P7|Overall Study|Reported as completing trial in error|0
1300156|NCT00246337|4233575|P6|Overall Study|Reported as completing trial in error|0
1300157|NCT00246337|4233576|P5|Overall Study|Reported as completing trial in error|0
1300158|NCT00246337|4233577|P4|Overall Study|Reported as completing trial in error|0
1300159|NCT00246337|4233578|P3|Overall Study|Reported as completing trial in error|0
1300160|NCT00246337|4233579|P2|Overall Study|Reported as completing trial in error|0
1300161|NCT00246337|4233580|P1|Overall Study|Reported as completing trial in error|0
1300162|NCT00246337|4233572|P9|Overall Study|Protocol Violator|0
1300163|NCT00246337|4233573|P8|Overall Study|Protocol Violator|0
1300164|NCT00246337|4233574|P7|Overall Study|Protocol Violator|0
1300165|NCT00246337|4233575|P6|Overall Study|Protocol Violator|0
1300166|NCT00246337|4233576|P5|Overall Study|Protocol Violator|0
1300167|NCT00246337|4233577|P4|Overall Study|Protocol Violator|0
1300168|NCT00246337|4233578|P3|Overall Study|Protocol Violator|0
1300169|NCT00246337|4233579|P2|Overall Study|Protocol Violator|0
1300170|NCT00246337|4233580|P1|Overall Study|Protocol Violator|1
1300171|NCT00246337|4233572|P9|Overall Study|Overwhelmed|0
1300172|NCT00246337|4233573|P8|Overall Study|Overwhelmed|0
1300173|NCT00246337|4233574|P7|Overall Study|Overwhelmed|0
1300174|NCT00246337|4233575|P6|Overall Study|Overwhelmed|1
1300175|NCT00246337|4233576|P5|Overall Study|Overwhelmed|0
1300176|NCT00246337|4233577|P4|Overall Study|Overwhelmed|0
1300177|NCT00246337|4233578|P3|Overall Study|Overwhelmed|0
1300178|NCT00246337|4233579|P2|Overall Study|Overwhelmed|0
1300179|NCT00246337|4233580|P1|Overall Study|Overwhelmed|0
1300180|NCT00246337|4233572|P9|Overall Study|Abnormal baseline lab values|4
1300181|NCT00246337|4233573|P8|Overall Study|Abnormal baseline lab values|0
1300182|NCT00246337|4233574|P7|Overall Study|Abnormal baseline lab values|2
1300183|NCT00246337|4233575|P6|Overall Study|Abnormal baseline lab values|2
1300184|NCT00246337|4233576|P5|Overall Study|Abnormal baseline lab values|0
1300185|NCT00246337|4233577|P4|Overall Study|Abnormal baseline lab values|0
1300186|NCT00246337|4233578|P3|Overall Study|Abnormal baseline lab values|2
1300187|NCT00246337|4233579|P2|Overall Study|Abnormal baseline lab values|0
1300188|NCT00246337|4233580|P1|Overall Study|Abnormal baseline lab values|7
1300189|NCT00246337|4233572|P9|Overall Study|Site Terminated|2
1300190|NCT00246337|4233573|P8|Overall Study|Site Terminated|6
1300191|NCT00246337|4233574|P7|Overall Study|Site Terminated|1
1300192|NCT00246337|4233575|P6|Overall Study|Site Terminated|7
1300193|NCT00246337|4233576|P5|Overall Study|Site Terminated|0
1300194|NCT00246337|4233577|P4|Overall Study|Site Terminated|0
1300195|NCT00246337|4233578|P3|Overall Study|Site Terminated|0
1300196|NCT00246337|4233579|P2|Overall Study|Site Terminated|0
1300197|NCT00246337|4233580|P1|Overall Study|Site Terminated|10
1300198|NCT00246337|4233572|P9|Overall Study|Lack of Qualifying Event|5
1300199|NCT00246337|4233573|P8|Overall Study|Lack of Qualifying Event|2
1300200|NCT00246337|4233574|P7|Overall Study|Lack of Qualifying Event|3
1300201|NCT00246337|4233575|P6|Overall Study|Lack of Qualifying Event|3
1300202|NCT00246337|4233576|P5|Overall Study|Lack of Qualifying Event|1
1300203|NCT00246337|4233577|P4|Overall Study|Lack of Qualifying Event|1
1300204|NCT00246337|4233578|P3|Overall Study|Lack of Qualifying Event|1
1300205|NCT00246337|4233579|P2|Overall Study|Lack of Qualifying Event|2
1300206|NCT00246337|4233580|P1|Overall Study|Lack of Qualifying Event|8
1300207|NCT00246337|4233572|P9|Overall Study|Withdrawal by Subject|0
1300208|NCT00246337|4233573|P8|Overall Study|Withdrawal by Subject|1
1300209|NCT00246337|4233574|P7|Overall Study|Withdrawal by Subject|1
1300210|NCT00246337|4233575|P6|Overall Study|Withdrawal by Subject|0
1300211|NCT00246337|4233576|P5|Overall Study|Withdrawal by Subject|0
1300212|NCT00246337|4233577|P4|Overall Study|Withdrawal by Subject|0
1300213|NCT00246337|4233578|P3|Overall Study|Withdrawal by Subject|0
1300214|NCT00246337|4233579|P2|Overall Study|Withdrawal by Subject|0
1300215|NCT00246337|4233580|P1|Overall Study|Withdrawal by Subject|2
1300216|NCT00246337|4233572|P9|Overall Study|Protocol Violation|0
1300217|NCT00246337|4233573|P8|Overall Study|Protocol Violation|1
1300218|NCT00246337|4233574|P7|Overall Study|Protocol Violation|1
1300219|NCT00246337|4233575|P6|Overall Study|Protocol Violation|0
1300220|NCT00246337|4233576|P5|Overall Study|Protocol Violation|1
1300221|NCT00246337|4233577|P4|Overall Study|Protocol Violation|0
1300222|NCT00246337|4233578|P3|Overall Study|Protocol Violation|0
1300223|NCT00246337|4233579|P2|Overall Study|Protocol Violation|0
1300224|NCT00246337|4233580|P1|Overall Study|Protocol Violation|1
1300225|NCT00246337|4233572|P9|Overall Study|Lost to Follow-up|0
1300226|NCT00246337|4233573|P8|Overall Study|Lost to Follow-up|2
1300227|NCT00246337|4233574|P7|Overall Study|Lost to Follow-up|1
1300228|NCT00246337|4233575|P6|Overall Study|Lost to Follow-up|2
1300229|NCT00246337|4233576|P5|Overall Study|Lost to Follow-up|2
1300230|NCT00246337|4233577|P4|Overall Study|Lost to Follow-up|0
1300231|NCT00246337|4233578|P3|Overall Study|Lost to Follow-up|0
1300232|NCT00246337|4233579|P2|Overall Study|Lost to Follow-up|0
1300233|NCT00246337|4233580|P1|Overall Study|Lost to Follow-up|3
1300234|NCT00246324|4233627|P1|Overall Study|Withdrawal by Subject|1
1300235|NCT00246259|4233634|P2|Overall Study|randomly assigned, not eligible for ITT|6
1300236|NCT00246259|4233635|P1|Overall Study|randomly assigned, not eligible for ITT|2
1300237|NCT00246259|4233634|P2|Overall Study|Withdrawal by Subject|1
1300238|NCT00246259|4233635|P1|Overall Study|Withdrawal by Subject|5
1300239|NCT00246259|4233634|P2|Overall Study|Lost to Follow-up|4
1300240|NCT00246259|4233635|P1|Overall Study|Lost to Follow-up|3
1300241|NCT00246259|4233634|P2|Overall Study|Adverse Event|0
1300242|NCT00246259|4233635|P1|Overall Study|Adverse Event|5
1300243|NCT00246259|4233634|P2|Overall Study|Investigator withdrew participant|0
1300244|NCT00246259|4233635|P1|Overall Study|Investigator withdrew participant|2
1300245|NCT00246259|4233634|P2|Overall Study|Lack of Efficacy|2
1300246|NCT00246259|4233635|P1|Overall Study|Lack of Efficacy|2
1300247|NCT00246259|4233634|P2|Overall Study|Participant non-compliant|9
1300248|NCT00246259|4233635|P1|Overall Study|Participant non-compliant|4
1300249|NCT00246259|4233634|P2|Overall Study|Not stable by Week 18|1
1300250|NCT00246259|4233635|P1|Overall Study|Not stable by Week 18|2
1300251|NCT00246259|4233634|P2|Overall Study|Other|3
1300252|NCT00246259|4233635|P1|Overall Study|Other|3
1300253|NCT00246090|4233669|P1|Overall Study|Not Otherwise Specified|10
1300254|NCT00246090|4233669|P1|Overall Study|Physician Decision|11
1300255|NCT00246090|4233669|P1|Overall Study|Clinical Progression|30
1300256|NCT00246090|4233669|P1|Overall Study|Progressive Disease|212
1300257|NCT00246090|4233669|P1|Overall Study|Withdrawal by Subject|7
1300258|NCT00246090|4233669|P1|Overall Study|Adverse Event|25
1300259|NCT00246025|4233678|P4|Overall Study|unsuitable medical history was found|1
1300260|NCT00246025|4233679|P3|Overall Study|unsuitable medical history was found|0
1300261|NCT00246025|4233680|P2|Overall Study|unsuitable medical history was found|0
1300262|NCT00246025|4233681|P1|Overall Study|unsuitable medical history was found|0
1300263|NCT00246025|4233678|P4|Overall Study|Withdrawal by Subject|2
1300264|NCT00246025|4233679|P3|Overall Study|Withdrawal by Subject|1
1300265|NCT00246025|4233680|P2|Overall Study|Withdrawal by Subject|0
1300266|NCT00246025|4233681|P1|Overall Study|Withdrawal by Subject|3
1300267|NCT00246025|4233678|P4|Overall Study|Adverse Event|10
1300268|NCT00246025|4233679|P3|Overall Study|Adverse Event|9
1300269|NCT00246025|4233680|P2|Overall Study|Adverse Event|9
1300270|NCT00246025|4233681|P1|Overall Study|Adverse Event|7
1300271|NCT00246012|4233740|P9|Overall Study|Randomly assigned but not treated|0
1300272|NCT00246012|4233741|P8|Overall Study|Randomly assigned but not treated|0
1300273|NCT00246012|4233742|P7|Overall Study|Randomly assigned but not treated|1
1300274|NCT00246012|4233743|P6|Overall Study|Randomly assigned but not treated|1
1300275|NCT00246012|4233744|P5|Overall Study|Randomly assigned but not treated|0
1300276|NCT00246012|4233745|P4|Overall Study|Randomly assigned but not treated|0
1300277|NCT00246012|4233746|P3|Overall Study|Randomly assigned but not treated|0
1300278|NCT00246012|4233747|P2|Overall Study|Randomly assigned but not treated|0
1300279|NCT00246012|4233748|P1|Overall Study|Randomly assigned but not treated|0
1300280|NCT00246012|4233740|P9|Overall Study|Other|0
1300281|NCT00246012|4233741|P8|Overall Study|Other|1
1300282|NCT00246012|4233742|P7|Overall Study|Other|0
1300283|NCT00246012|4233743|P6|Overall Study|Other|0
1300284|NCT00246012|4233744|P5|Overall Study|Other|0
1300285|NCT00246012|4233745|P4|Overall Study|Other|0
1300286|NCT00246012|4233746|P3|Overall Study|Other|0
1300287|NCT00246012|4233747|P2|Overall Study|Other|0
1300288|NCT00246012|4233748|P1|Overall Study|Other|0
1300289|NCT00246012|4233740|P9|Overall Study|Disease progression|26
1300290|NCT00246012|4233741|P8|Overall Study|Disease progression|27
1300291|NCT00246012|4233742|P7|Overall Study|Disease progression|30
1300292|NCT00246012|4233743|P6|Overall Study|Disease progression|25
1300293|NCT00246012|4233744|P5|Overall Study|Disease progression|3
1300294|NCT00246012|4233745|P4|Overall Study|Disease progression|3
1300295|NCT00246012|4233746|P3|Overall Study|Disease progression|2
1300296|NCT00246012|4233747|P2|Overall Study|Disease progression|1
1300297|NCT00246012|4233748|P1|Overall Study|Disease progression|3
1300298|NCT00246012|4233740|P9|Overall Study|Withdrawal by Subject|0
1300299|NCT00246012|4233741|P8|Overall Study|Withdrawal by Subject|0
1300300|NCT00246012|4233742|P7|Overall Study|Withdrawal by Subject|0
1300301|NCT00246012|4233743|P6|Overall Study|Withdrawal by Subject|1
1300302|NCT00246012|4233744|P5|Overall Study|Withdrawal by Subject|0
1300303|NCT00246012|4233745|P4|Overall Study|Withdrawal by Subject|0
1300304|NCT00246012|4233746|P3|Overall Study|Withdrawal by Subject|0
1300305|NCT00246012|4233747|P2|Overall Study|Withdrawal by Subject|0
1300306|NCT00246012|4233748|P1|Overall Study|Withdrawal by Subject|0
1300307|NCT00246012|4233740|P9|Overall Study|Adverse Event|2
1300308|NCT00246012|4233741|P8|Overall Study|Adverse Event|0
1300309|NCT00246012|4233742|P7|Overall Study|Adverse Event|0
1300310|NCT00246012|4233743|P6|Overall Study|Adverse Event|1
1300311|NCT00246012|4233744|P5|Overall Study|Adverse Event|0
1300312|NCT00246012|4233745|P4|Overall Study|Adverse Event|0
1300313|NCT00246012|4233746|P3|Overall Study|Adverse Event|0
1300314|NCT00246012|4233747|P2|Overall Study|Adverse Event|0
1300315|NCT00246012|4233748|P1|Overall Study|Adverse Event|0
1300316|NCT00245960|4233843|P2|Overall Study|Lack of Efficacy|6
1300317|NCT00245960|4233844|P1|Overall Study|Lack of Efficacy|4
1300318|NCT00245960|4233843|P2|Overall Study|Withdrawal by Subject|7
1300319|NCT00245960|4233844|P1|Overall Study|Withdrawal by Subject|5
1300320|NCT00245960|4233843|P2|Overall Study|Protocol Violation|3
1300321|NCT00245960|4233844|P1|Overall Study|Protocol Violation|4
1300322|NCT00245960|4233843|P2|Overall Study|Lost to Follow-up|2
1300323|NCT00245960|4233844|P1|Overall Study|Lost to Follow-up|2
1300324|NCT00245960|4233843|P2|Overall Study|Adverse Event|10
1300325|NCT00245960|4233844|P1|Overall Study|Adverse Event|14
1300326|NCT00245856|4233852|P2|Period Two|Withdrawal by Subject|1
1300327|NCT00245856|4233853|P1|Period Two|Withdrawal by Subject|0
1300328|NCT00245570|4233869|P6|Washout Between Periods III and IV|Adverse Event|0
1300329|NCT00245570|4233870|P5|Washout Between Periods III and IV|Adverse Event|0
1300330|NCT00245570|4233871|P4|Washout Between Periods III and IV|Adverse Event|0
1300331|NCT00245570|4233872|P3|Washout Between Periods III and IV|Adverse Event|0
1300332|NCT00245570|4233873|P2|Washout Between Periods III and IV|Adverse Event|1
1300333|NCT00245570|4233874|P1|Washout Between Periods III and IV|Adverse Event|0
1300334|NCT00245466|4234008|P3|Overall Study|Administrative reasons|0
1300335|NCT00245466|4234009|P2|Overall Study|Administrative reasons|1
1300336|NCT00245466|4234010|P1|Overall Study|Administrative reasons|0
1300337|NCT00245466|4234008|P3|Overall Study|Death|0
1300338|NCT00245466|4234009|P2|Overall Study|Death|2
1300339|NCT00245466|4234010|P1|Overall Study|Death|0
1300340|NCT00245466|4234008|P3|Overall Study|Protocol Violation|2
1300341|NCT00245466|4234009|P2|Overall Study|Protocol Violation|2
1300342|NCT00245466|4234010|P1|Overall Study|Protocol Violation|1
1300343|NCT00245466|4234008|P3|Overall Study|Disease progression|1
1300344|NCT00245466|4234009|P2|Overall Study|Disease progression|3
1300345|NCT00245466|4234010|P1|Overall Study|Disease progression|0
1300346|NCT00245466|4234008|P3|Overall Study|Lost to Follow-up|0
1300347|NCT00245466|4234009|P2|Overall Study|Lost to Follow-up|0
1300348|NCT00245466|4234010|P1|Overall Study|Lost to Follow-up|3
1300349|NCT00245466|4234008|P3|Overall Study|Withdrawal by Subject|1
1300350|NCT00245466|4234009|P2|Overall Study|Withdrawal by Subject|2
1300351|NCT00245466|4234010|P1|Overall Study|Withdrawal by Subject|2
1300352|NCT00245466|4234008|P3|Overall Study|Insufficient PSA and testosterone suppr|3
1300353|NCT00245466|4234009|P2|Overall Study|Insufficient PSA and testosterone suppr|0
1300354|NCT00245466|4234010|P1|Overall Study|Insufficient PSA and testosterone suppr|0
1300355|NCT00245466|4234008|P3|Overall Study|Insufficient testosterone suppr|21
1300356|NCT00245466|4234009|P2|Overall Study|Insufficient testosterone suppr|12
1300357|NCT00245466|4234010|P1|Overall Study|Insufficient testosterone suppr|12
1300358|NCT00245466|4234008|P3|Overall Study|Low prostate specific antigen suppr|5
1300359|NCT00245466|4234009|P2|Overall Study|Low prostate specific antigen suppr|14
1300360|NCT00245466|4234010|P1|Overall Study|Low prostate specific antigen suppr|16
1300361|NCT00245466|4234008|P3|Overall Study|Adverse Event|4
1300362|NCT00245466|4234009|P2|Overall Study|Adverse Event|8
1300363|NCT00245466|4234010|P1|Overall Study|Adverse Event|2
1300364|NCT00245102|4234053|P6|Overall Study|Clinical progression|0
1300365|NCT00245102|4234054|P5|Overall Study|Clinical progression|0
1300366|NCT00245102|4234055|P4|Overall Study|Clinical progression|0
1300367|NCT00245102|4234056|P3|Overall Study|Clinical progression|0
1300368|NCT00245102|4234057|P2|Overall Study|Clinical progression|0
1300369|NCT00245102|4234058|P1|Overall Study|Clinical progression|1
1300370|NCT00245102|4234053|P6|Overall Study|Participant needed surgery|0
1300371|NCT00245102|4234054|P5|Overall Study|Participant needed surgery|0
1300372|NCT00245102|4234055|P4|Overall Study|Participant needed surgery|0
1300373|NCT00245102|4234056|P3|Overall Study|Participant needed surgery|1
1300374|NCT00245102|4234057|P2|Overall Study|Participant needed surgery|0
1300375|NCT00245102|4234058|P1|Overall Study|Participant needed surgery|0
1300376|NCT00245102|4234053|P6|Overall Study|Decline in performance|2
1300377|NCT00245102|4234054|P5|Overall Study|Decline in performance|0
1300378|NCT00245102|4234055|P4|Overall Study|Decline in performance|1
1300379|NCT00245102|4234056|P3|Overall Study|Decline in performance|0
1300380|NCT00245102|4234057|P2|Overall Study|Decline in performance|2
1300381|NCT00245102|4234058|P1|Overall Study|Decline in performance|0
1300382|NCT00245102|4234053|P6|Overall Study|Adverse Event|2
1300383|NCT00245102|4234054|P5|Overall Study|Adverse Event|0
1300384|NCT00245102|4234055|P4|Overall Study|Adverse Event|1
1300385|NCT00245102|4234056|P3|Overall Study|Adverse Event|5
1300386|NCT00245102|4234057|P2|Overall Study|Adverse Event|2
1300387|NCT00245102|4234058|P1|Overall Study|Adverse Event|4
1300388|NCT00245102|4234053|P6|Overall Study|Death|0
1300389|NCT00245102|4234054|P5|Overall Study|Death|0
1300390|NCT00245102|4234055|P4|Overall Study|Death|1
1300391|NCT00245102|4234056|P3|Overall Study|Death|0
1300392|NCT00245102|4234057|P2|Overall Study|Death|0
1300393|NCT00245102|4234058|P1|Overall Study|Death|0
1300394|NCT00245102|4234053|P6|Overall Study|Protocol Violation|0
1300395|NCT00245102|4234054|P5|Overall Study|Protocol Violation|0
1300396|NCT00245102|4234055|P4|Overall Study|Protocol Violation|0
1300397|NCT00245102|4234056|P3|Overall Study|Protocol Violation|0
1300398|NCT00245102|4234057|P2|Overall Study|Protocol Violation|0
1300399|NCT00245102|4234058|P1|Overall Study|Protocol Violation|1
1300400|NCT00245102|4234053|P6|Overall Study|Not Treated|0
1300401|NCT00245102|4234054|P5|Overall Study|Not Treated|0
1300402|NCT00245102|4234055|P4|Overall Study|Not Treated|0
1300403|NCT00245102|4234056|P3|Overall Study|Not Treated|1
1300404|NCT00245102|4234057|P2|Overall Study|Not Treated|0
1300405|NCT00245102|4234058|P1|Overall Study|Not Treated|1
1300406|NCT00245063|4234074|P2|Overall Study|Death|0
1300407|NCT00245063|4234075|P1|Overall Study|Death|1
1300408|NCT00245063|4234074|P2|Overall Study|Adverse Event|5
1300409|NCT00245063|4234075|P1|Overall Study|Adverse Event|6
1300410|NCT00245050|4234083|P2|Overall Study|Adverse Event|2
1300411|NCT00245050|4234084|P1|Overall Study|Adverse Event|3
1300412|NCT00245037|4234092|P1|Overall Study|Death|17
1300413|NCT00245011|4234102|P1|Overall Study|Lack of Efficacy|1
1300414|NCT00244933|4234114|P1|Overall Study|Not response evaluable|2
1300415|NCT00244881|4234118|P1|Overall Study|Withdrawal by Subject|3
1300416|NCT00244855|4234126|P2|Overall Study|Withdrawal by Subject|1
1300417|NCT00244855|4234127|P1|Overall Study|Withdrawal by Subject|0
1300418|NCT00244764|4234135|P1|Overall Study|Developed Secondary Malignancy|1
1300419|NCT00244764|4234135|P1|Overall Study|Sponsor Terminated Study|2
1300420|NCT00244764|4234135|P1|Overall Study|Primary Investigator Discretion|2
1300421|NCT00244764|4234135|P1|Overall Study|Participant was Hospitalized until Death|1
1300422|NCT00244764|4234135|P1|Overall Study|Declining Performance Status|1
1300423|NCT00244764|4234135|P1|Overall Study|Off Study Medication for >21 Days|1
1300424|NCT00244764|4234135|P1|Overall Study|Death|1
1300425|NCT00244764|4234135|P1|Overall Study|Protocol Violation|2
1300426|NCT00244764|4234135|P1|Overall Study|Disease Progression|13
1300427|NCT00244764|4234135|P1|Overall Study|Withdrawal by Subject|12
1300428|NCT00244764|4234135|P1|Overall Study|Lost to Follow-up|23
1300429|NCT00244764|4234135|P1|Overall Study|Adverse Event|37
1300430|NCT00244751|4234145|P3|Overall Study|Participant randomized by mistake|1
1300431|NCT00244751|4234146|P2|Overall Study|Participant randomized by mistake|0
1300432|NCT00244751|4234147|P1|Overall Study|Participant randomized by mistake|0
1300433|NCT00244751|4234145|P3|Overall Study|Safety reasons|0
1300434|NCT00244751|4234146|P2|Overall Study|Safety reasons|1
1300435|NCT00244751|4234147|P1|Overall Study|Safety reasons|0
1300436|NCT00244751|4234145|P3|Overall Study|Lack of compliance with protocol|0
1300437|NCT00244751|4234146|P2|Overall Study|Lack of compliance with protocol|1
1300438|NCT00244751|4234147|P1|Overall Study|Lack of compliance with protocol|0
1300439|NCT00244751|4234145|P3|Overall Study|Elevated liver enzymes|0
1300440|NCT00244751|4234146|P2|Overall Study|Elevated liver enzymes|0
1300441|NCT00244751|4234147|P1|Overall Study|Elevated liver enzymes|1
1300442|NCT00244751|4234145|P3|Overall Study|Withdrawal by Subject|3
1300443|NCT00244751|4234146|P2|Overall Study|Withdrawal by Subject|5
1300444|NCT00244751|4234147|P1|Overall Study|Withdrawal by Subject|7
1300445|NCT00244751|4234145|P3|Overall Study|Protocol Violation|1
1300446|NCT00244751|4234146|P2|Overall Study|Protocol Violation|0
1300447|NCT00244751|4234147|P1|Overall Study|Protocol Violation|1
1300448|NCT00244751|4234145|P3|Overall Study|Lost to Follow-up|0
1300449|NCT00244751|4234146|P2|Overall Study|Lost to Follow-up|1
1300450|NCT00244751|4234147|P1|Overall Study|Lost to Follow-up|0
1300451|NCT00244751|4234145|P3|Overall Study|Adverse Event|5
1300452|NCT00244751|4234146|P2|Overall Study|Adverse Event|7
1300453|NCT00244751|4234147|P1|Overall Study|Adverse Event|7
1300454|NCT00244725|4234248|P4|Overall Study|Failed to follow-up|1
1300455|NCT00244725|4234249|P3|Overall Study|Failed to follow-up|1
1300456|NCT00244725|4234250|P2|Overall Study|Failed to follow-up|0
1300457|NCT00244725|4234251|P1|Overall Study|Failed to follow-up|0
1300458|NCT00244725|4234248|P4|Overall Study|Vomit|0
1300459|NCT00244725|4234249|P3|Overall Study|Vomit|1
1300460|NCT00244725|4234250|P2|Overall Study|Vomit|0
1300461|NCT00244725|4234251|P1|Overall Study|Vomit|0
1300462|NCT00244725|4234248|P4|Overall Study|Administrative reason|0
1300463|NCT00244725|4234249|P3|Overall Study|Administrative reason|1
1300464|NCT00244725|4234250|P2|Overall Study|Administrative reason|0
1300465|NCT00244725|4234251|P1|Overall Study|Administrative reason|0
1300466|NCT00244725|4234248|P4|Overall Study|Confirmed venous thromboembolism (VTE)|0
1300467|NCT00244725|4234249|P3|Overall Study|Confirmed venous thromboembolism (VTE)|0
1300468|NCT00244725|4234250|P2|Overall Study|Confirmed venous thromboembolism (VTE)|1
1300469|NCT00244725|4234251|P1|Overall Study|Confirmed venous thromboembolism (VTE)|0
1300470|NCT00244725|4234248|P4|Overall Study|Received prohibited medication|1
1300471|NCT00244725|4234249|P3|Overall Study|Received prohibited medication|0
1300472|NCT00244725|4234250|P2|Overall Study|Received prohibited medication|1
1300473|NCT00244725|4234251|P1|Overall Study|Received prohibited medication|0
1300474|NCT00244725|4234248|P4|Overall Study|Headache|0
1300475|NCT00244725|4234249|P3|Overall Study|Headache|0
1300476|NCT00244725|4234250|P2|Overall Study|Headache|1
1300477|NCT00244725|4234251|P1|Overall Study|Headache|0
1300478|NCT00244725|4234248|P4|Overall Study|Rehab Refused to allow participantion|0
1300479|NCT00244725|4234249|P3|Overall Study|Rehab Refused to allow participantion|0
1300480|NCT00244725|4234250|P2|Overall Study|Rehab Refused to allow participantion|1
1300481|NCT00244725|4234251|P1|Overall Study|Rehab Refused to allow participantion|0
1300482|NCT00244725|4234248|P4|Overall Study|Mediciation Error|0
1300483|NCT00244725|4234249|P3|Overall Study|Mediciation Error|0
1300484|NCT00244725|4234250|P2|Overall Study|Mediciation Error|1
1300485|NCT00244725|4234251|P1|Overall Study|Mediciation Error|0
1300486|NCT00244725|4234248|P4|Overall Study|Sponsor withdrew the participant|1
1300487|NCT00244725|4234249|P3|Overall Study|Sponsor withdrew the participant|0
1300488|NCT00244725|4234250|P2|Overall Study|Sponsor withdrew the participant|0
1300489|NCT00244725|4234251|P1|Overall Study|Sponsor withdrew the participant|1
1300490|NCT00244725|4234248|P4|Overall Study|Liver function test abnormality|1
1300491|NCT00244725|4234249|P3|Overall Study|Liver function test abnormality|0
1300492|NCT00244725|4234250|P2|Overall Study|Liver function test abnormality|0
1300493|NCT00244725|4234251|P1|Overall Study|Liver function test abnormality|2
1300494|NCT00244725|4234248|P4|Overall Study|Withdrwal by participant|1
1300495|NCT00244725|4234249|P3|Overall Study|Withdrwal by participant|0
1300496|NCT00244725|4234250|P2|Overall Study|Withdrwal by participant|0
1300497|NCT00244725|4234251|P1|Overall Study|Withdrwal by participant|1
1300498|NCT00244725|4234248|P4|Overall Study|Adverse Events|4
1300499|NCT00244725|4234249|P3|Overall Study|Adverse Events|4
1300500|NCT00244725|4234250|P2|Overall Study|Adverse Events|1
1300501|NCT00244725|4234251|P1|Overall Study|Adverse Events|3
1300502|NCT00244725|4234248|P4|Overall Study|Physician Decision|2
1300503|NCT00244725|4234249|P3|Overall Study|Physician Decision|1
1300504|NCT00244725|4234250|P2|Overall Study|Physician Decision|0
1300505|NCT00244725|4234251|P1|Overall Study|Physician Decision|3
1300506|NCT00244725|4234248|P4|Overall Study|Not meet treatment eligibility criteria|0
1300507|NCT00244725|4234249|P3|Overall Study|Not meet treatment eligibility criteria|0
1300508|NCT00244725|4234250|P2|Overall Study|Not meet treatment eligibility criteria|2
1300509|NCT00244725|4234251|P1|Overall Study|Not meet treatment eligibility criteria|1
1300510|NCT00244725|4234248|P4|Overall Study|Withdrawal by Subject|8
1300511|NCT00244725|4234249|P3|Overall Study|Withdrawal by Subject|7
1300512|NCT00244725|4234250|P2|Overall Study|Withdrawal by Subject|7
1300513|NCT00244725|4234251|P1|Overall Study|Withdrawal by Subject|9
1300514|NCT00244725|4234248|P4|Overall Study|Lost to Follow-up|2
1300515|NCT00244725|4234249|P3|Overall Study|Lost to Follow-up|9
1300516|NCT00244725|4234250|P2|Overall Study|Lost to Follow-up|4
1300517|NCT00244725|4234251|P1|Overall Study|Lost to Follow-up|3
1300518|NCT00244712|4234307|P2|Overall Study|Protocol Violation, disease progression|11
1300519|NCT00244712|4234308|P1|Overall Study|Protocol Violation, disease progression|13
1300520|NCT00244712|4234307|P2|Overall Study|Withdrawal by Subject|23
1300521|NCT00244712|4234308|P1|Overall Study|Withdrawal by Subject|13
1300522|NCT00244712|4234307|P2|Overall Study|Lost to Follow-up|52
1300523|NCT00244712|4234308|P1|Overall Study|Lost to Follow-up|45
1300524|NCT00244712|4234307|P2|Overall Study|Lack of Compliance|11
1300525|NCT00244712|4234308|P1|Overall Study|Lack of Compliance|10
1300526|NCT00244712|4234307|P2|Overall Study|Protocol-Defined Virologic Failure|6
1300527|NCT00244712|4234308|P1|Overall Study|Protocol-Defined Virologic Failure|8
1300528|NCT00244712|4234307|P2|Overall Study|Adverse Event|21
1300529|NCT00244712|4234308|P1|Overall Study|Adverse Event|20
1300530|NCT00244621|4234343|P3|Open-label Treatment Period|Moved abroad|1
1300531|NCT00244621|4234344|P2|Open-label Treatment Period|Moved abroad|0
1300532|NCT00244621|4234345|P1|Open-label Treatment Period|Moved abroad|0
1300533|NCT00244621|4234343|P3|Open-label Treatment Period|Adverse Event|1
1300534|NCT00244621|4234344|P2|Open-label Treatment Period|Adverse Event|0
1300535|NCT00244621|4234345|P1|Open-label Treatment Period|Adverse Event|0
1300536|NCT00244621|4234343|P3|Open-label Treatment Period|Withdrawal by Subject|0
1300537|NCT00244621|4234344|P2|Open-label Treatment Period|Withdrawal by Subject|0
1300538|NCT00244621|4234345|P1|Open-label Treatment Period|Withdrawal by Subject|1
1300539|NCT00244621|4234343|P3|Open-label Treatment Period|Lost to Follow-up|0
1300540|NCT00244621|4234344|P2|Open-label Treatment Period|Lost to Follow-up|1
1300541|NCT00244621|4234345|P1|Open-label Treatment Period|Lost to Follow-up|0
1300542|NCT00244621|4234343|P3|Double-blind Treatment Period|Multiple Reasons|1
1300543|NCT00244621|4234344|P2|Double-blind Treatment Period|Multiple Reasons|1
1300544|NCT00244621|4234345|P1|Double-blind Treatment Period|Multiple Reasons|2
1300545|NCT00244621|4234343|P3|Double-blind Treatment Period|Lack of Efficacy|0
1300546|NCT00244621|4234344|P2|Double-blind Treatment Period|Lack of Efficacy|1
1300547|NCT00244621|4234345|P1|Double-blind Treatment Period|Lack of Efficacy|0
1300548|NCT00244621|4234343|P3|Double-blind Treatment Period|Withdrawal by Subject|0
1300549|NCT00244621|4234344|P2|Double-blind Treatment Period|Withdrawal by Subject|1
1300550|NCT00244621|4234345|P1|Double-blind Treatment Period|Withdrawal by Subject|0
1300551|NCT00244621|4234343|P3|Double-blind Treatment Period|Lost to Follow-up|1
1300552|NCT00244621|4234344|P2|Double-blind Treatment Period|Lost to Follow-up|0
1300553|NCT00244621|4234345|P1|Double-blind Treatment Period|Lost to Follow-up|0
1300554|NCT00244374|4234362|P5|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
1300555|NCT00244374|4234363|P4|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
1300556|NCT00244374|4234364|P3|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
1300557|NCT00244374|4234365|P2|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
1300558|NCT00244374|4234366|P1|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12
1300559|NCT00244374|4234362|P5|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
1300560|NCT00244374|4234363|P4|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
1300561|NCT00244374|4234364|P3|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
1300562|NCT00244374|4234365|P2|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
1300563|NCT00244374|4234366|P1|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4
1300564|NCT00244374|4234362|P5|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
1300565|NCT00244374|4234363|P4|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
1300566|NCT00244374|4234364|P3|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
1300567|NCT00244374|4234365|P2|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
1300568|NCT00244374|4234366|P1|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34
1300569|NCT00244374|4234362|P5|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
1300570|NCT00244374|4234363|P4|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
1300571|NCT00244374|4234364|P3|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
1300572|NCT00244374|4234365|P2|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
1300573|NCT00244374|4234366|P1|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51
1300574|NCT00244374|4234362|P5|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
1300575|NCT00244374|4234363|P4|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
1300576|NCT00244374|4234364|P3|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
1300577|NCT00244374|4234365|P2|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
1300578|NCT00244374|4234366|P1|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172
1300579|NCT00244374|4234362|P5|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
1300580|NCT00244374|4234363|P4|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
1300581|NCT00244374|4234364|P3|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
1300582|NCT00244374|4234365|P2|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
1300583|NCT00244374|4234366|P1|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1
1300584|NCT00244374|4234362|P5|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
1300585|NCT00244374|4234363|P4|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
1300586|NCT00244374|4234364|P3|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
1300587|NCT00244374|4234365|P2|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
1300588|NCT00244374|4234366|P1|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14
1300589|NCT00244374|4234362|P5|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
1300590|NCT00244374|4234363|P4|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
1300591|NCT00244374|4234364|P3|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
1300592|NCT00244374|4234365|P2|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
1300593|NCT00244374|4234366|P1|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17
1300594|NCT00244374|4234362|P5|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
1300595|NCT00244374|4234363|P4|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
1300596|NCT00244374|4234364|P3|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
1300597|NCT00244374|4234365|P2|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
1300598|NCT00244374|4234366|P1|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105
1300599|NCT00243932|4234422|P3|Stage 1: Dose Selection|Lost to Follow-up|0
1300600|NCT00243932|4234423|P2|Stage 1: Dose Selection|Lost to Follow-up|0
1300601|NCT00243932|4234424|P1|Stage 1: Dose Selection|Lost to Follow-up|2
1300602|NCT00243919|4234435|P3|Overall Study|Physician Decision|0
1300603|NCT00243919|4234436|P2|Overall Study|Physician Decision|1
1300604|NCT00243919|4234437|P1|Overall Study|Physician Decision|1
1300605|NCT00243919|4234435|P3|Overall Study|Administrative Error|0
1300606|NCT00243919|4234436|P2|Overall Study|Administrative Error|0
1300607|NCT00243919|4234437|P1|Overall Study|Administrative Error|1
1300608|NCT00243919|4234435|P3|Overall Study|Lost to Follow-up|3
1300609|NCT00243919|4234436|P2|Overall Study|Lost to Follow-up|7
1300610|NCT00243919|4234437|P1|Overall Study|Lost to Follow-up|6
1300611|NCT00243919|4234435|P3|Overall Study|Withdrawal by Subject|2
1300612|NCT00243919|4234436|P2|Overall Study|Withdrawal by Subject|6
1300613|NCT00243919|4234437|P1|Overall Study|Withdrawal by Subject|6
1300614|NCT00243919|4234435|P3|Overall Study|Death|6
1300615|NCT00243919|4234436|P2|Overall Study|Death|4
1300616|NCT00243919|4234437|P1|Overall Study|Death|3
1300617|NCT00243841|4234481|P6|Overall Study|Physician Decision|2
1300618|NCT00243841|4234482|P5|Overall Study|Physician Decision|0
1300619|NCT00243841|4234483|P4|Overall Study|Physician Decision|0
1300620|NCT00243841|4234484|P3|Overall Study|Physician Decision|1
1300621|NCT00243841|4234485|P2|Overall Study|Physician Decision|0
1300622|NCT00243841|4234486|P1|Overall Study|Physician Decision|0
1300623|NCT00243659|4234508|P2|Overall Study|Protocol Violation|2
1300624|NCT00243659|4234509|P1|Overall Study|Protocol Violation|1
1300625|NCT00243659|4234508|P2|Overall Study|Withdrawal by Subject|1
1300626|NCT00243659|4234509|P1|Overall Study|Withdrawal by Subject|1
1300627|NCT00243503|4234517|P1|Overall Study|Other|1
1300628|NCT00243503|4234517|P1|Overall Study|Death|1
1300629|NCT00243503|4234517|P1|Overall Study|Lack of Efficacy|44
1300630|NCT00243503|4234517|P1|Overall Study|Withdrawal by Subject|1
1300631|NCT00243503|4234517|P1|Overall Study|Adverse Event|11
1300632|NCT00243412|4234534|P2|Overall Study|not specified|1
1300633|NCT00243412|4234535|P1|Overall Study|not specified|1
1300634|NCT00243412|4234534|P2|Overall Study|Withdrawal by Subject|5
1300635|NCT00243412|4234535|P1|Overall Study|Withdrawal by Subject|4
1300636|NCT00243412|4234534|P2|Overall Study|Physician Decision|1
1300637|NCT00243412|4234535|P1|Overall Study|Physician Decision|1
1300638|NCT00243412|4234534|P2|Overall Study|Lost to Follow-up|1
1300639|NCT00243412|4234535|P1|Overall Study|Lost to Follow-up|0
1300640|NCT00243412|4234534|P2|Overall Study|Adverse Event|2
1300641|NCT00243412|4234535|P1|Overall Study|Adverse Event|4
1300642|NCT00243412|4234534|P2|Overall Study|Death|1
1300643|NCT00243412|4234535|P1|Overall Study|Death|0
1300644|NCT00243386|4234561|P3|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
1300645|NCT00243386|4234562|P2|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1
1300646|NCT00243386|4234563|P1|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
1300647|NCT00243386|4234561|P3|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
1300648|NCT00243386|4234562|P2|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2
1300649|NCT00243386|4234563|P1|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
1300650|NCT00243386|4234561|P3|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
1300651|NCT00243386|4234562|P2|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
1300652|NCT00243386|4234563|P1|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1
1300653|NCT00243386|4234561|P3|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
1300654|NCT00243386|4234562|P2|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
1300655|NCT00243386|4234563|P1|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1
1300656|NCT00243386|4234561|P3|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
1300657|NCT00243386|4234562|P2|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
1300658|NCT00243386|4234563|P1|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1
1300659|NCT00243386|4234561|P3|On-Demand Regimen (Study Part 1)|Screen Failures|0
1300660|NCT00243386|4234562|P2|On-Demand Regimen (Study Part 1)|Screen Failures|0
1300661|NCT00243386|4234563|P1|On-Demand Regimen (Study Part 1)|Screen Failures|2
1300662|NCT00243386|4234561|P3|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
1300663|NCT00243386|4234562|P2|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
1300664|NCT00243386|4234563|P1|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1
1300665|NCT00243386|4234561|P3|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
1300666|NCT00243386|4234562|P2|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
1300667|NCT00243386|4234563|P1|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1
1300668|NCT00243347|4234628|P1|Overall Study|Condition worsened|7
1300669|NCT00243347|4234628|P1|Overall Study|Withdrawal by Subject|5
1300670|NCT00243347|4234628|P1|Overall Study|Death|1
1300671|NCT00243347|4234628|P1|Overall Study|Adverse Event|2
1300672|NCT00243347|4234628|P1|Overall Study|Lack of Efficacy|4
1300673|NCT00243269|4234637|P4|Overall Study|Lost to Follow-up|3
1300674|NCT00243269|4234638|P3|Overall Study|Lost to Follow-up|1
1300675|NCT00243269|4234639|P2|Overall Study|Lost to Follow-up|0
1300676|NCT00243269|4234640|P1|Overall Study|Lost to Follow-up|1
1300677|NCT00243269|4234637|P4|Overall Study|Protocol Violation|1
1300678|NCT00243269|4234638|P3|Overall Study|Protocol Violation|0
1300679|NCT00243269|4234639|P2|Overall Study|Protocol Violation|1
1300680|NCT00243269|4234640|P1|Overall Study|Protocol Violation|2
1300681|NCT00243074|4234675|P1|Overall Study|Did not receive any treatment|1
1300682|NCT00243074|4234675|P1|Overall Study|not protocol specified|1
1300683|NCT00243074|4234675|P1|Overall Study|Death|2
1300684|NCT00243074|4234675|P1|Overall Study|Lack of Efficacy|36
1300685|NCT00243074|4234675|P1|Overall Study|Withdrawal by Subject|2
1300686|NCT00243074|4234675|P1|Overall Study|Adverse Event|6
1300687|NCT00243074|4234675|P1|Overall Study|Ineligible|6
1300688|NCT00243022|4234701|P2|Overall Study|Difficult Travel Distance|1
1300689|NCT00243022|4234702|P1|Overall Study|Difficult Travel Distance|0
1300690|NCT00243022|4234701|P2|Overall Study|Death|0
1300691|NCT00243022|4234702|P1|Overall Study|Death|1
1300692|NCT00243022|4234701|P2|Overall Study|Withdrawal by Subject|0
1300693|NCT00243022|4234702|P1|Overall Study|Withdrawal by Subject|1
1300694|NCT00242710|4234724|P4|Study Extension (up to Year 2)|Withdrawal by Subject|1
1300695|NCT00242710|4234725|P3|Study Extension (up to Year 2)|Withdrawal by Subject|4
1300696|NCT00242710|4234726|P2|Study Extension (up to Year 2)|Withdrawal by Subject|6
1300697|NCT00242710|4234727|P1|Study Extension (up to Year 2)|Withdrawal by Subject|10
1300698|NCT00242710|4234724|P4|Study Extension (up to Year 2)|Protocol Violation|1
1300699|NCT00242710|4234725|P3|Study Extension (up to Year 2)|Protocol Violation|0
1300700|NCT00242710|4234726|P2|Study Extension (up to Year 2)|Protocol Violation|2
1300701|NCT00242710|4234727|P1|Study Extension (up to Year 2)|Protocol Violation|0
1300702|NCT00242710|4234724|P4|Study Extension (up to Year 2)|Other|3
1300703|NCT00242710|4234725|P3|Study Extension (up to Year 2)|Other|4
1300704|NCT00242710|4234726|P2|Study Extension (up to Year 2)|Other|5
1300705|NCT00242710|4234727|P1|Study Extension (up to Year 2)|Other|3
1300706|NCT00242710|4234724|P4|Study Extension (up to Year 2)|Lost to Follow-up|0
1300707|NCT00242710|4234725|P3|Study Extension (up to Year 2)|Lost to Follow-up|5
1300708|NCT00242710|4234726|P2|Study Extension (up to Year 2)|Lost to Follow-up|7
1300709|NCT00242710|4234727|P1|Study Extension (up to Year 2)|Lost to Follow-up|7
1300710|NCT00242710|4234724|P4|Study Extension (up to Year 2)|Death|1
1300711|NCT00242710|4234725|P3|Study Extension (up to Year 2)|Death|0
1300712|NCT00242710|4234726|P2|Study Extension (up to Year 2)|Death|0
1300713|NCT00242710|4234727|P1|Study Extension (up to Year 2)|Death|0
1300714|NCT00242710|4234724|P4|Study Extension (up to Year 2)|Adverse Event|4
1300715|NCT00242710|4234725|P3|Study Extension (up to Year 2)|Adverse Event|2
1300716|NCT00242710|4234726|P2|Study Extension (up to Year 2)|Adverse Event|9
1300717|NCT00242710|4234727|P1|Study Extension (up to Year 2)|Adverse Event|7
1300718|NCT00242710|4234724|P4|Period Between Core Study and Extension|Withdrawal by Subject|28
1300719|NCT00242710|4234725|P3|Period Between Core Study and Extension|Withdrawal by Subject|24
1300720|NCT00242710|4234726|P2|Period Between Core Study and Extension|Withdrawal by Subject|63
1300721|NCT00242710|4234727|P1|Period Between Core Study and Extension|Withdrawal by Subject|75
1300722|NCT00242710|4234724|P4|Period Between Core Study and Extension|Protocol Violation|1
1300723|NCT00242710|4234725|P3|Period Between Core Study and Extension|Protocol Violation|2
1300724|NCT00242710|4234726|P2|Period Between Core Study and Extension|Protocol Violation|0
1300725|NCT00242710|4234727|P1|Period Between Core Study and Extension|Protocol Violation|0
1300726|NCT00242710|4234724|P4|Period Between Core Study and Extension|Extension not Available|7
1300727|NCT00242710|4234725|P3|Period Between Core Study and Extension|Extension not Available|8
1300728|NCT00242710|4234726|P2|Period Between Core Study and Extension|Extension not Available|21
1300729|NCT00242710|4234727|P1|Period Between Core Study and Extension|Extension not Available|17
1300730|NCT00242710|4234724|P4|Period Between Core Study and Extension|Other|11
1300731|NCT00242710|4234725|P3|Period Between Core Study and Extension|Other|9
1300732|NCT00242710|4234726|P2|Period Between Core Study and Extension|Other|24
1300733|NCT00242710|4234727|P1|Period Between Core Study and Extension|Other|24
1300734|NCT00242710|4234724|P4|Period Between Core Study and Extension|Physician Decision|0
1300735|NCT00242710|4234725|P3|Period Between Core Study and Extension|Physician Decision|0
1300736|NCT00242710|4234726|P2|Period Between Core Study and Extension|Physician Decision|1
1300737|NCT00242710|4234727|P1|Period Between Core Study and Extension|Physician Decision|1
1300738|NCT00242710|4234724|P4|Period Between Core Study and Extension|Adverse Event|2
1300739|NCT00242710|4234725|P3|Period Between Core Study and Extension|Adverse Event|5
1300740|NCT00242710|4234726|P2|Period Between Core Study and Extension|Adverse Event|3
1300741|NCT00242710|4234727|P1|Period Between Core Study and Extension|Adverse Event|2
1300742|NCT00242710|4234724|P4|Core Study (up to Year 1)|Randomized but not Treated|2
1300743|NCT00242710|4234725|P3|Core Study (up to Year 1)|Randomized but not Treated|4
1300744|NCT00242710|4234726|P2|Core Study (up to Year 1)|Randomized but not Treated|4
1300745|NCT00242710|4234727|P1|Core Study (up to Year 1)|Randomized but not Treated|12
1300746|NCT00242710|4234724|P4|Core Study (up to Year 1)|Lack of Efficacy|0
1300747|NCT00242710|4234725|P3|Core Study (up to Year 1)|Lack of Efficacy|0
1300748|NCT00242710|4234726|P2|Core Study (up to Year 1)|Lack of Efficacy|0
1300749|NCT00242710|4234727|P1|Core Study (up to Year 1)|Lack of Efficacy|1
1300750|NCT00242710|4234724|P4|Core Study (up to Year 1)|Withdrawal by Subject|6
1300751|NCT00242710|4234725|P3|Core Study (up to Year 1)|Withdrawal by Subject|15
1300752|NCT00242710|4234726|P2|Core Study (up to Year 1)|Withdrawal by Subject|16
1300753|NCT00242710|4234727|P1|Core Study (up to Year 1)|Withdrawal by Subject|27
1300754|NCT00242710|4234724|P4|Core Study (up to Year 1)|Protocol Violation|3
1300755|NCT00242710|4234725|P3|Core Study (up to Year 1)|Protocol Violation|1
1300756|NCT00242710|4234726|P2|Core Study (up to Year 1)|Protocol Violation|9
1300757|NCT00242710|4234727|P1|Core Study (up to Year 1)|Protocol Violation|2
1300758|NCT00242710|4234724|P4|Core Study (up to Year 1)|Other|2
1300759|NCT00242710|4234725|P3|Core Study (up to Year 1)|Other|0
1300760|NCT00242710|4234726|P2|Core Study (up to Year 1)|Other|1
1300761|NCT00242710|4234727|P1|Core Study (up to Year 1)|Other|6
1300762|NCT00242710|4234724|P4|Core Study (up to Year 1)|Lost to Follow-up|3
1300763|NCT00242710|4234725|P3|Core Study (up to Year 1)|Lost to Follow-up|7
1300764|NCT00242710|4234726|P2|Core Study (up to Year 1)|Lost to Follow-up|8
1300765|NCT00242710|4234727|P1|Core Study (up to Year 1)|Lost to Follow-up|8
1300766|NCT00242710|4234724|P4|Core Study (up to Year 1)|Physician Decision|1
1300767|NCT00242710|4234725|P3|Core Study (up to Year 1)|Physician Decision|0
1300768|NCT00242710|4234726|P2|Core Study (up to Year 1)|Physician Decision|1
1300769|NCT00242710|4234727|P1|Core Study (up to Year 1)|Physician Decision|0
1300770|NCT00242710|4234724|P4|Core Study (up to Year 1)|Death|0
1300771|NCT00242710|4234725|P3|Core Study (up to Year 1)|Death|1
1300772|NCT00242710|4234726|P2|Core Study (up to Year 1)|Death|0
1300773|NCT00242710|4234727|P1|Core Study (up to Year 1)|Death|0
1300774|NCT00242710|4234724|P4|Core Study (up to Year 1)|Adverse Event|14
1300775|NCT00242710|4234725|P3|Core Study (up to Year 1)|Adverse Event|23
1300776|NCT00242710|4234726|P2|Core Study (up to Year 1)|Adverse Event|25
1300777|NCT00242710|4234727|P1|Core Study (up to Year 1)|Adverse Event|30
1300778|NCT00242658|4234784|P2|Overall Study|Lost to Follow-up|19
1300779|NCT00242658|4234785|P1|Overall Study|Lost to Follow-up|22
1300780|NCT00242580|4234816|P3|Overall Study|Death|1
1300781|NCT00242580|4234817|P2|Overall Study|Death|2
1300782|NCT00242580|4234818|P1|Overall Study|Death|1
1300783|NCT00242580|4234816|P3|Overall Study|Lost to Follow-up|0
1300784|NCT00242580|4234817|P2|Overall Study|Lost to Follow-up|3
1300785|NCT00242580|4234818|P1|Overall Study|Lost to Follow-up|0
1300786|NCT00242580|4234816|P3|Overall Study|Subject withdrew consent|5
1300787|NCT00242580|4234817|P2|Overall Study|Subject withdrew consent|2
1300788|NCT00242580|4234818|P1|Overall Study|Subject withdrew consent|2
1300789|NCT00242580|4234816|P3|Overall Study|Protocol Violation|1
1300790|NCT00242580|4234817|P2|Overall Study|Protocol Violation|0
1300791|NCT00242580|4234818|P1|Overall Study|Protocol Violation|0
1300792|NCT00242580|4234816|P3|Overall Study|Unsatisfactory therapeutic effect|5
1300793|NCT00242580|4234817|P2|Overall Study|Unsatisfactory therapeutic effect|5
1300794|NCT00242580|4234818|P1|Overall Study|Unsatisfactory therapeutic effect|4
1300795|NCT00242580|4234816|P3|Overall Study|Adverse Event|2
1300796|NCT00242580|4234817|P2|Overall Study|Adverse Event|0
1300797|NCT00242580|4234818|P1|Overall Study|Adverse Event|3
1300798|NCT00242567|4234843|P2|Overall Study|Other|9
1300799|NCT00242567|4234844|P1|Overall Study|Other|14
1300800|NCT00242567|4234843|P2|Overall Study|Use of an inhibitor of bone resorption|2
1300801|NCT00242567|4234844|P1|Overall Study|Use of an inhibitor of bone resorption|0
1300802|NCT00242567|4234843|P2|Overall Study|Protocol Violation|12
1300803|NCT00242567|4234844|P1|Overall Study|Protocol Violation|12
1300804|NCT00242567|4234843|P2|Overall Study|Withdrawal by Subject|28
1300805|NCT00242567|4234844|P1|Overall Study|Withdrawal by Subject|33
1300806|NCT00242567|4234843|P2|Overall Study|Lost to Follow-up|19
1300807|NCT00242567|4234844|P1|Overall Study|Lost to Follow-up|9
1300808|NCT00242567|4234843|P2|Overall Study|Lack of Efficacy|2
1300809|NCT00242567|4234844|P1|Overall Study|Lack of Efficacy|2
1300810|NCT00242567|4234843|P2|Overall Study|Symptomatic deterioration|3
1300811|NCT00242567|4234844|P1|Overall Study|Symptomatic deterioration|9
1300812|NCT00242567|4234843|P2|Overall Study|Disease Progression|22
1300813|NCT00242567|4234844|P1|Overall Study|Disease Progression|17
1300814|NCT00242567|4234843|P2|Overall Study|Adverse Event|43
1300815|NCT00242567|4234844|P1|Overall Study|Adverse Event|70
1300816|NCT00242216|4234891|P2|Overall Study|no medicaiton dispensed|1
1300817|NCT00242216|4234892|P1|Overall Study|no medicaiton dispensed|1
1300818|NCT00242216|4234891|P2|Overall Study|Lack of Efficacy|2
1300819|NCT00242216|4234892|P1|Overall Study|Lack of Efficacy|1
1300820|NCT00242216|4234891|P2|Overall Study|Death|2
1300821|NCT00242216|4234892|P1|Overall Study|Death|4
1300822|NCT00242216|4234891|P2|Overall Study|Lost to Follow-up|17
1300823|NCT00242216|4234892|P1|Overall Study|Lost to Follow-up|12
1300824|NCT00241839|4234930|P2|Overall Study|Adverse Event|1
1300825|NCT00241839|4234931|P1|Overall Study|Adverse Event|1
1300826|NCT00241839|4234930|P2|Overall Study|Withdrawal by Subject|17
1300827|NCT00241839|4234931|P1|Overall Study|Withdrawal by Subject|18
1300828|NCT00241644|4234947|P4|Second Efficacy Period (Year 2)|Consenting parent passed away|2
1300829|NCT00241644|4234948|P3|Second Efficacy Period (Year 2)|Consenting parent passed away|2
1300830|NCT00241644|4234949|P2|Second Efficacy Period (Year 2)|Consenting parent passed away|1
1300831|NCT00241644|4234950|P1|Second Efficacy Period (Year 2)|Consenting parent passed away|1
1300832|NCT00241644|4234947|P4|Second Efficacy Period (Year 2)|Lost to Follow-up|86
1300833|NCT00241644|4234948|P3|Second Efficacy Period (Year 2)|Lost to Follow-up|46
1300834|NCT00241644|4234949|P2|Second Efficacy Period (Year 2)|Lost to Follow-up|43
1300835|NCT00241644|4234950|P1|Second Efficacy Period (Year 2)|Lost to Follow-up|43
1300836|NCT00241644|4234947|P4|Second Efficacy Period (Year 2)|Withdrawal by Subject|7
1300837|NCT00241644|4234948|P3|Second Efficacy Period (Year 2)|Withdrawal by Subject|2
1300838|NCT00241644|4234949|P2|Second Efficacy Period (Year 2)|Withdrawal by Subject|3
1300839|NCT00241644|4234950|P1|Second Efficacy Period (Year 2)|Withdrawal by Subject|4
1300840|NCT00241644|4234947|P4|Second Efficacy Period (Year 2)|Protocol Violation|3
1300841|NCT00241644|4234948|P3|Second Efficacy Period (Year 2)|Protocol Violation|2
1300842|NCT00241644|4234949|P2|Second Efficacy Period (Year 2)|Protocol Violation|1
1300843|NCT00241644|4234950|P1|Second Efficacy Period (Year 2)|Protocol Violation|2
1300844|NCT00241644|4234947|P4|Second Efficacy Period (Year 2)|Adverse Event|20
1300845|NCT00241644|4234948|P3|Second Efficacy Period (Year 2)|Adverse Event|12
1300846|NCT00241644|4234949|P2|Second Efficacy Period (Year 2)|Adverse Event|9
1300847|NCT00241644|4234950|P1|Second Efficacy Period (Year 2)|Adverse Event|11
1300848|NCT00241644|4234947|P4|First Efficacy Period (Year 1)|Subject's parent passed away|1
1300849|NCT00241644|4234948|P3|First Efficacy Period (Year 1)|Subject's parent passed away|0
1300850|NCT00241644|4234949|P2|First Efficacy Period (Year 1)|Subject's parent passed away|1
1300851|NCT00241644|4234950|P1|First Efficacy Period (Year 1)|Subject's parent passed away|0
1300852|NCT00241644|4234947|P4|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
1300853|NCT00241644|4234948|P3|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1
1300854|NCT00241644|4234949|P2|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
1300855|NCT00241644|4234950|P1|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
1300856|NCT00241644|4234947|P4|First Efficacy Period (Year 1)|Return dates not reliable|1
1300857|NCT00241644|4234948|P3|First Efficacy Period (Year 1)|Return dates not reliable|0
1300858|NCT00241644|4234949|P2|First Efficacy Period (Year 1)|Return dates not reliable|0
1300859|NCT00241644|4234950|P1|First Efficacy Period (Year 1)|Return dates not reliable|1
1300860|NCT00241644|4234947|P4|First Efficacy Period (Year 1)|Non-compliance|3
1300861|NCT00241644|4234948|P3|First Efficacy Period (Year 1)|Non-compliance|2
1300862|NCT00241644|4234949|P2|First Efficacy Period (Year 1)|Non-compliance|1
1300863|NCT00241644|4234950|P1|First Efficacy Period (Year 1)|Non-compliance|2
1300864|NCT00241644|4234947|P4|First Efficacy Period (Year 1)|Lost to Follow-up|258
1300865|NCT00241644|4234948|P3|First Efficacy Period (Year 1)|Lost to Follow-up|116
1300866|NCT00241644|4234949|P2|First Efficacy Period (Year 1)|Lost to Follow-up|142
1300867|NCT00241644|4234950|P1|First Efficacy Period (Year 1)|Lost to Follow-up|116
1300868|NCT00241644|4234947|P4|First Efficacy Period (Year 1)|Withdrawal by Subject|133
1300869|NCT00241644|4234948|P3|First Efficacy Period (Year 1)|Withdrawal by Subject|81
1300870|NCT00241644|4234949|P2|First Efficacy Period (Year 1)|Withdrawal by Subject|74
1300871|NCT00241644|4234950|P1|First Efficacy Period (Year 1)|Withdrawal by Subject|59
1300872|NCT00241644|4234947|P4|First Efficacy Period (Year 1)|Protocol Violation|8
1300873|NCT00241644|4234948|P3|First Efficacy Period (Year 1)|Protocol Violation|4
1300874|NCT00241644|4234949|P2|First Efficacy Period (Year 1)|Protocol Violation|5
1300875|NCT00241644|4234950|P1|First Efficacy Period (Year 1)|Protocol Violation|3
1300876|NCT00241644|4234947|P4|First Efficacy Period (Year 1)|Adverse Event|91
1300877|NCT00241644|4234948|P3|First Efficacy Period (Year 1)|Adverse Event|45
1300878|NCT00241644|4234949|P2|First Efficacy Period (Year 1)|Adverse Event|45
1300879|NCT00241644|4234950|P1|First Efficacy Period (Year 1)|Adverse Event|46
1300880|NCT00241358|4235035|P3|Overall Study|Determined to be not ineligible|1
1300881|NCT00241358|4235036|P2|Overall Study|Determined to be not ineligible|1
1300882|NCT00241358|4235037|P1|Overall Study|Determined to be not ineligible|0
1300883|NCT00241280|4235070|P2|Overall Study|Excessive Dryness|1
1300884|NCT00241280|4235071|P1|Overall Study|Excessive Dryness|0
1300885|NCT00241280|4235070|P2|Overall Study|Coating on Lens|0
1300886|NCT00241280|4235071|P1|Overall Study|Coating on Lens|1
1300887|NCT00241280|4235070|P2|Overall Study|History of Ocular Surgery|1
1300888|NCT00241280|4235071|P1|Overall Study|History of Ocular Surgery|0
1300889|NCT00241280|4235070|P2|Overall Study|Scheduling Conflict|2
1300890|NCT00241280|4235071|P1|Overall Study|Scheduling Conflict|0
1300891|NCT00241280|4235070|P2|Overall Study|Unacceptable Fit|1
1300892|NCT00241280|4235071|P1|Overall Study|Unacceptable Fit|0
1300893|NCT00241280|4235070|P2|Overall Study|Dispensed incorrect test article|2
1300894|NCT00241280|4235071|P1|Overall Study|Dispensed incorrect test article|1
1300895|NCT00241280|4235070|P2|Overall Study|Subject Ineligible/Dispensed|6
1300896|NCT00241280|4235071|P1|Overall Study|Subject Ineligible/Dispensed|9
1300897|NCT00241280|4235070|P2|Overall Study|Diabetic|0
1300898|NCT00241280|4235071|P1|Overall Study|Diabetic|1
1300899|NCT00241280|4235070|P2|Overall Study|Unsatisfactory Visual Response|1
1300900|NCT00241280|4235071|P1|Overall Study|Unsatisfactory Visual Response|1
1300901|NCT00241280|4235070|P2|Overall Study|Unsatisfactory Physiological Response|1
1300902|NCT00241280|4235071|P1|Overall Study|Unsatisfactory Physiological Response|1
1300903|NCT00241280|4235070|P2|Overall Study|Relocation|4
1300904|NCT00241280|4235071|P1|Overall Study|Relocation|4
1300905|NCT00241280|4235070|P2|Overall Study|Protocol Violation|10
1300906|NCT00241280|4235071|P1|Overall Study|Protocol Violation|4
1300907|NCT00241280|4235070|P2|Overall Study|Withdrawal by Subject|4
1300908|NCT00241280|4235071|P1|Overall Study|Withdrawal by Subject|7
1300909|NCT00241280|4235070|P2|Overall Study|Lost to Follow-up|8
1300910|NCT00241280|4235071|P1|Overall Study|Lost to Follow-up|5
1300911|NCT00241280|4235070|P2|Overall Study|Pregnancy|5
1300912|NCT00241280|4235071|P1|Overall Study|Pregnancy|1
1300913|NCT00241280|4235070|P2|Overall Study|Discomfort|16
1300914|NCT00241280|4235071|P1|Overall Study|Discomfort|11
1300915|NCT00241280|4235070|P2|Overall Study|Adverse Event|6
1300916|NCT00241280|4235071|P1|Overall Study|Adverse Event|2
1300917|NCT00240994|4235086|P1|Overall Study|Graft failure|1
1300918|NCT00240994|4235086|P1|Overall Study|Protocol Violation|1
1300919|NCT00240994|4235086|P1|Overall Study|Lost to Follow-up|1
1300920|NCT00240331|4235221|P2|Overall Study|Option selected by investigator|2
1300921|NCT00240331|4235222|P1|Overall Study|Option selected by investigator|1
1300922|NCT00240331|4235221|P2|Overall Study|Withdrawal by Subject|132
1300923|NCT00240331|4235222|P1|Overall Study|Withdrawal by Subject|125
1300924|NCT00240110|4235265|P2|Overall Study|Lost to Follow-up|7
1300925|NCT00240110|4235266|P1|Overall Study|Lost to Follow-up|6
1300926|NCT00240097|4235274|P1|Part II|did not continue from Part I|23
1300927|NCT00240097|4235274|P1|Part I|unevaluable|1
1300928|NCT00240097|4235274|P1|Part I|histology|1
1300929|NCT00240097|4235274|P1|Part I|Death|1
1300930|NCT00240097|4235274|P1|Part I|Adverse Event|1
1300931|NCT00240071|4235284|P1|Overall Study|Withdrawal by Subject|3
1300932|NCT00239928|4235289|P1|Overall Study|Withdrawal by Subject|2
1300933|NCT00239928|4235289|P1|Overall Study|Not need to continue study|3
1300934|NCT00239928|4235289|P1|Overall Study|Adverse Event|4
1300935|NCT00239928|4235289|P1|Overall Study|Lack of Efficacy|1
1300936|NCT00239837|4235301|P2|Overall Study|Lost to Follow-up|7
1300937|NCT00239837|4235302|P1|Overall Study|Lost to Follow-up|3
1300938|NCT00239720|4235329|P2|Overall Study|Lost to Follow-up|1
1300939|NCT00239720|4235330|P1|Overall Study|Lost to Follow-up|0
1300940|NCT00239720|4235329|P2|Overall Study|Adverse Event|0
1300941|NCT00239720|4235330|P1|Overall Study|Adverse Event|1
1300942|NCT00239681|4235338|P2|Overall Study|No information chacked on CaseReportForm|84
1300943|NCT00239681|4235339|P1|Overall Study|No information chacked on CaseReportForm|90
1300944|NCT00239681|4235338|P2|Overall Study|Physician Decision|17
1300945|NCT00239681|4235339|P1|Overall Study|Physician Decision|13
1300946|NCT00239681|4235338|P2|Overall Study|Protocol Violation|4
1300947|NCT00239681|4235339|P1|Overall Study|Protocol Violation|4
1300948|NCT00239681|4235338|P2|Overall Study|Lost to Follow-up|22
1300949|NCT00239681|4235339|P1|Overall Study|Lost to Follow-up|28
1300950|NCT00239681|4235338|P2|Overall Study|Withdrawal by Subject|489
1300951|NCT00239681|4235339|P1|Overall Study|Withdrawal by Subject|458
1300952|NCT00239681|4235338|P2|Overall Study|Adverse Event|99
1300953|NCT00239681|4235339|P1|Overall Study|Adverse Event|100
1300954|NCT00239356|4235394|P2|Overall Study|Drug available on market|2
1300955|NCT00239356|4235395|P1|Overall Study|Drug available on market|11
1300956|NCT00239356|4235394|P2|Overall Study|Administrative reason|1
1300957|NCT00239356|4235395|P1|Overall Study|Administrative reason|0
1300958|NCT00239356|4235394|P2|Overall Study|Pregnancy|0
1300959|NCT00239356|4235395|P1|Overall Study|Pregnancy|1
1300960|NCT00239356|4235394|P2|Overall Study|poor/non-compliance|0
1300961|NCT00239356|4235395|P1|Overall Study|poor/non-compliance|2
1300962|NCT00239356|4235394|P2|Overall Study|Lost to Follow-up|0
1300963|NCT00239356|4235395|P1|Overall Study|Lost to Follow-up|3
1300964|NCT00239356|4235394|P2|Overall Study|Withdrawal by Subject|6
1300965|NCT00239356|4235395|P1|Overall Study|Withdrawal by Subject|15
1300966|NCT00239356|4235394|P2|Overall Study|Adverse Event|0
1300967|NCT00239356|4235395|P1|Overall Study|Adverse Event|6
1300968|NCT00239356|4235394|P2|Overall Study|Lack of Efficacy|0
1300969|NCT00239356|4235395|P1|Overall Study|Lack of Efficacy|1
1300970|NCT00239226|4235417|P4|Overall Study|Lost to Follow-up|0
1300971|NCT00239226|4235418|P3|Overall Study|Lost to Follow-up|1
1300972|NCT00239226|4235419|P2|Overall Study|Lost to Follow-up|0
1300973|NCT00239226|4235420|P1|Overall Study|Lost to Follow-up|1
1300974|NCT00239226|4235417|P4|Overall Study|permAF during stabilization period|3
1300975|NCT00239226|4235418|P3|Overall Study|permAF during stabilization period|0
1300976|NCT00239226|4235419|P2|Overall Study|permAF during stabilization period|0
1300977|NCT00239226|4235420|P1|Overall Study|permAF during stabilization period|0
1300978|NCT00239005|4235432|P2|Overall Study|Lost to Follow-up|1
1300979|NCT00239005|4235433|P1|Overall Study|Lost to Follow-up|0
1300980|NCT00239005|4235432|P2|Overall Study|Subj. cond. no longer needs study drug|1
1300981|NCT00239005|4235433|P1|Overall Study|Subj. cond. no longer needs study drug|0
1300982|NCT00239005|4235432|P2|Overall Study|Protocol Violation|0
1300983|NCT00239005|4235433|P1|Overall Study|Protocol Violation|1
1300984|NCT00239005|4235432|P2|Overall Study|Unsatisfactory Therapeutic effect|0
1300985|NCT00239005|4235433|P1|Overall Study|Unsatisfactory Therapeutic effect|2
1300986|NCT00239005|4235432|P2|Overall Study|Withdrawal by Subject|4
1300987|NCT00239005|4235433|P1|Overall Study|Withdrawal by Subject|3
1300988|NCT00239005|4235432|P2|Overall Study|Adverse Event|6
1300989|NCT00239005|4235433|P1|Overall Study|Adverse Event|6
1300990|NCT00238433|4235449|P1|Overall Study|Death|1
1300991|NCT00238433|4235449|P1|Overall Study|Lost to Follow-up|1
1300992|NCT00238433|4235449|P1|Overall Study|Screen failure|1
1300993|NCT00238420|4235456|P2|Overall Study|Protocol Violation|1
1300994|NCT00238420|4235457|P1|Overall Study|Protocol Violation|1
1300995|NCT00238303|4235474|P3|Overall Study|Adverse Event|3
1300996|NCT00238303|4235475|P2|Overall Study|Adverse Event|1
1300997|NCT00238303|4235476|P1|Overall Study|Adverse Event|0
1300998|NCT00238303|4235474|P3|Overall Study|Poor tolerance of study treatment|1
1300999|NCT00238303|4235475|P2|Overall Study|Poor tolerance of study treatment|0
1301000|NCT00238303|4235476|P1|Overall Study|Poor tolerance of study treatment|1
1301001|NCT00238303|4235474|P3|Overall Study|Other Medical Problems|2
1301002|NCT00238303|4235475|P2|Overall Study|Other Medical Problems|0
1301003|NCT00238303|4235476|P1|Overall Study|Other Medical Problems|2
1301004|NCT00238303|4235474|P3|Overall Study|Death|1
1301005|NCT00238303|4235475|P2|Overall Study|Death|0
1301006|NCT00238303|4235476|P1|Overall Study|Death|1
1301007|NCT00238303|4235474|P3|Overall Study|Withdrawal by Subject|2
1301008|NCT00238303|4235475|P2|Overall Study|Withdrawal by Subject|1
1301009|NCT00238303|4235476|P1|Overall Study|Withdrawal by Subject|11
1301010|NCT00238264|4235493|P1|Overall Study|Ineligible|7
1301011|NCT00238264|4235493|P1|Overall Study|Withdrawal by Subject|4
1301012|NCT00238264|4235493|P1|Overall Study|Lost to Follow-up|18
1301013|NCT00238264|4235493|P1|Overall Study|Death|7
1301014|NCT00238238|4235506|P3|Overall Study|Withdrawal by Subject|0
1301015|NCT00238238|4235507|P2|Overall Study|Withdrawal by Subject|3
1301016|NCT00238238|4235508|P1|Overall Study|Withdrawal by Subject|0
1301017|NCT00238121|4235521|P2|Overall Study|Adverse Event|1
1301018|NCT00238121|4235522|P1|Overall Study|Adverse Event|2
1301019|NCT00238121|4235521|P2|Overall Study|Withdrawal by Subject|1
1301020|NCT00238121|4235522|P1|Overall Study|Withdrawal by Subject|1
1301021|NCT00237809|4235548|P4|Overall Study|Lost to Follow-up|9
1301022|NCT00237809|4235549|P3|Overall Study|Lost to Follow-up|9
1301023|NCT00237809|4235550|P2|Overall Study|Lost to Follow-up|10
1301024|NCT00237809|4235551|P1|Overall Study|Lost to Follow-up|11
1301025|NCT00237796|4235587|P2|Overall Study|Baseline and one other ILSS required|5
1301026|NCT00237796|4235588|P1|Overall Study|Baseline and one other ILSS required|10
1301027|NCT00237744|4235622|P3|Overall Study|Withdrawal by Subject|0
1301028|NCT00237744|4235623|P2|Overall Study|Withdrawal by Subject|1
1301029|NCT00237744|4235624|P1|Overall Study|Withdrawal by Subject|3
1301030|NCT00237692|4235650|P4|Overall Study|Withdrawal by Subject|4
1301031|NCT00237692|4235651|P3|Overall Study|Withdrawal by Subject|10
1301032|NCT00237692|4235652|P2|Overall Study|Withdrawal by Subject|6
1301033|NCT00237692|4235653|P1|Overall Study|Withdrawal by Subject|4
1301034|NCT00237692|4235650|P4|Overall Study|Excluded - did not meet criteria|9
1301035|NCT00237692|4235651|P3|Overall Study|Excluded - did not meet criteria|5
1301036|NCT00237692|4235652|P2|Overall Study|Excluded - did not meet criteria|3
1301037|NCT00237692|4235653|P1|Overall Study|Excluded - did not meet criteria|4
1301038|NCT00237692|4235650|P4|Overall Study|Death|3
1301039|NCT00237692|4235651|P3|Overall Study|Death|2
1301040|NCT00237692|4235652|P2|Overall Study|Death|2
1301041|NCT00237692|4235653|P1|Overall Study|Death|1
1301042|NCT00237692|4235650|P4|Overall Study|Lost to Follow-up|3
1301043|NCT00237692|4235651|P3|Overall Study|Lost to Follow-up|5
1301044|NCT00237692|4235652|P2|Overall Study|Lost to Follow-up|3
1301045|NCT00237692|4235653|P1|Overall Study|Lost to Follow-up|9
1301046|NCT00237458|4235693|P1|Overall Study|Withdrawal by Subject|1
1301047|NCT00237458|4235693|P1|Overall Study|Adverse Event|1
1301048|NCT00237458|4235693|P1|Overall Study|Lack of Efficacy|1
1301049|NCT00237185|4235711|P2|Extension|Death|1
1301050|NCT00237185|4235712|P1|Extension|Death|1
1301051|NCT00237185|4235711|P2|Extension|Administrative problems|0
1301052|NCT00237185|4235712|P1|Extension|Administrative problems|1
1301053|NCT00237185|4235711|P2|Extension|Lost to Follow-up|0
1301054|NCT00237185|4235712|P1|Extension|Lost to Follow-up|1
1301055|NCT00237185|4235711|P2|Extension|Withdrawal by Subject|2
1301056|NCT00237185|4235712|P1|Extension|Withdrawal by Subject|3
1301057|NCT00237185|4235711|P2|Extension|Condition no longer required study drug|1
1301058|NCT00237185|4235712|P1|Extension|Condition no longer required study drug|0
1301059|NCT00237185|4235711|P2|Extension|Lack of Efficacy|14
1301060|NCT00237185|4235712|P1|Extension|Lack of Efficacy|9
1301061|NCT00237185|4235711|P2|Extension|Abnormal laboratory value|1
1301062|NCT00237185|4235712|P1|Extension|Abnormal laboratory value|0
1301063|NCT00237185|4235711|P2|Extension|Adverse Event|0
1301064|NCT00237185|4235712|P1|Extension|Adverse Event|1
1301065|NCT00237185|4235711|P2|Core|Determined ineligible post randomization|0
1301066|NCT00237185|4235712|P1|Core|Determined ineligible post randomization|1
1301067|NCT00237185|4235711|P2|Core|Death|0
1301068|NCT00237185|4235712|P1|Core|Death|4
1301069|NCT00237185|4235711|P2|Core|Administrative problems|1
1301070|NCT00237185|4235712|P1|Core|Administrative problems|0
1301071|NCT00237185|4235711|P2|Core|Withdrawal by Subject|4
1301072|NCT00237185|4235712|P1|Core|Withdrawal by Subject|4
1301073|NCT00237185|4235711|P2|Core|Protocol Violation|1
1301074|NCT00237185|4235712|P1|Core|Protocol Violation|1
1301075|NCT00237185|4235711|P2|Core|Lack of Efficacy|23
1301076|NCT00237185|4235712|P1|Core|Lack of Efficacy|30
1301077|NCT00237185|4235711|P2|Core|Abnormal test procedure results|0
1301078|NCT00237185|4235712|P1|Core|Abnormal test procedure results|1
1301079|NCT00237185|4235711|P2|Core|Abnormal laboratory value|4
1301080|NCT00237185|4235712|P1|Core|Abnormal laboratory value|0
1301081|NCT00237185|4235711|P2|Core|Adverse Event|4
1301082|NCT00237185|4235712|P1|Core|Adverse Event|3
1301083|NCT00237042|4235743|P3|Long Term (12 Month) Follow up|Lost to Follow-up|9
1301084|NCT00237042|4235744|P2|Long Term (12 Month) Follow up|Lost to Follow-up|9
1301085|NCT00237042|4235745|P1|Long Term (12 Month) Follow up|Lost to Follow-up|11
1301086|NCT00237042|4235743|P3|Short Term (6 Month) Follow up|Lost to Follow-up|11
1301087|NCT00237042|4235744|P2|Short Term (6 Month) Follow up|Lost to Follow-up|8
1301088|NCT00237042|4235745|P1|Short Term (6 Month) Follow up|Lost to Follow-up|9
1301089|NCT00237042|4235743|P3|Treatment|Completed no treatment|21
1301090|NCT00237042|4235744|P2|Treatment|Completed no treatment|5
1301091|NCT00237042|4235745|P1|Treatment|Completed no treatment|5
1301092|NCT00237042|4235743|P3|Treatment|Moved out of state|1
1301093|NCT00237042|4235744|P2|Treatment|Moved out of state|1
1301094|NCT00237042|4235745|P1|Treatment|Moved out of state|1
1301095|NCT00237042|4235743|P3|Treatment|Became ineligible post-randomization|16
1301096|NCT00237042|4235744|P2|Treatment|Became ineligible post-randomization|1
1301097|NCT00237042|4235745|P1|Treatment|Became ineligible post-randomization|0
1301098|NCT00236899|4235819|P4|Overall Study|Lack of Efficacy|23
1301099|NCT00236899|4235820|P3|Overall Study|Lack of Efficacy|25
1301100|NCT00236899|4235821|P2|Overall Study|Lack of Efficacy|18
1301101|NCT00236899|4235822|P1|Overall Study|Lack of Efficacy|18
1301102|NCT00236899|4235819|P4|Overall Study|Satisfactory Response|1
1301103|NCT00236899|4235820|P3|Overall Study|Satisfactory Response|0
1301104|NCT00236899|4235821|P2|Overall Study|Satisfactory Response|0
1301105|NCT00236899|4235822|P1|Overall Study|Satisfactory Response|2
1301106|NCT00236899|4235819|P4|Overall Study|Physician Decision|6
1301107|NCT00236899|4235820|P3|Overall Study|Physician Decision|7
1301108|NCT00236899|4235821|P2|Overall Study|Physician Decision|8
1301109|NCT00236899|4235822|P1|Overall Study|Physician Decision|7
1301110|NCT00236899|4235819|P4|Overall Study|Withdrawal by Subject|2
1301111|NCT00236899|4235820|P3|Overall Study|Withdrawal by Subject|5
1301112|NCT00236899|4235821|P2|Overall Study|Withdrawal by Subject|4
1301113|NCT00236899|4235822|P1|Overall Study|Withdrawal by Subject|6
1301114|NCT00236899|4235819|P4|Overall Study|Protocol Violation|0
1301115|NCT00236899|4235820|P3|Overall Study|Protocol Violation|0
1301116|NCT00236899|4235821|P2|Overall Study|Protocol Violation|0
1301117|NCT00236899|4235822|P1|Overall Study|Protocol Violation|1
1301118|NCT00236899|4235819|P4|Overall Study|Entry Criteria Exclusion|0
1301119|NCT00236899|4235820|P3|Overall Study|Entry Criteria Exclusion|1
1301120|NCT00236899|4235821|P2|Overall Study|Entry Criteria Exclusion|1
1301121|NCT00236899|4235822|P1|Overall Study|Entry Criteria Exclusion|0
1301122|NCT00236899|4235819|P4|Overall Study|Lost to Follow-up|0
1301123|NCT00236899|4235820|P3|Overall Study|Lost to Follow-up|0
1301124|NCT00236899|4235821|P2|Overall Study|Lost to Follow-up|1
1301125|NCT00236899|4235822|P1|Overall Study|Lost to Follow-up|0
1301126|NCT00236899|4235819|P4|Overall Study|Death (Study Drug Toxicity)|0
1301127|NCT00236899|4235820|P3|Overall Study|Death (Study Drug Toxicity)|0
1301128|NCT00236899|4235821|P2|Overall Study|Death (Study Drug Toxicity)|0
1301129|NCT00236899|4235822|P1|Overall Study|Death (Study Drug Toxicity)|1
1301130|NCT00236899|4235819|P4|Overall Study|Death (Not Study Related)|0
1301131|NCT00236899|4235820|P3|Overall Study|Death (Not Study Related)|0
1301132|NCT00236899|4235821|P2|Overall Study|Death (Not Study Related)|0
1301133|NCT00236899|4235822|P1|Overall Study|Death (Not Study Related)|2
1301134|NCT00236899|4235819|P4|Overall Study|Death (Study Disease)|0
1301135|NCT00236899|4235820|P3|Overall Study|Death (Study Disease)|0
1301136|NCT00236899|4235821|P2|Overall Study|Death (Study Disease)|4
1301137|NCT00236899|4235822|P1|Overall Study|Death (Study Disease)|1
1301138|NCT00236899|4235819|P4|Overall Study|Adverse Event (Not Study Related)|7
1301139|NCT00236899|4235820|P3|Overall Study|Adverse Event (Not Study Related)|4
1301140|NCT00236899|4235821|P2|Overall Study|Adverse Event (Not Study Related)|3
1301141|NCT00236899|4235822|P1|Overall Study|Adverse Event (Not Study Related)|3
1301142|NCT00236899|4235819|P4|Overall Study|Adverse Event (Study Related)|1
1301143|NCT00236899|4235820|P3|Overall Study|Adverse Event (Study Related)|2
1301144|NCT00236899|4235821|P2|Overall Study|Adverse Event (Study Related)|1
1301145|NCT00236899|4235822|P1|Overall Study|Adverse Event (Study Related)|1
1301146|NCT00236197|4235854|P2|Overall Study|Other|2
1301147|NCT00236197|4235855|P1|Overall Study|Other|0
1301148|NCT00236197|4235854|P2|Overall Study|Medication non-compliance|2
1301149|NCT00236197|4235855|P1|Overall Study|Medication non-compliance|1
1301150|NCT00236197|4235854|P2|Overall Study|Protocol Violation|3
1301151|NCT00236197|4235855|P1|Overall Study|Protocol Violation|0
1301152|NCT00236197|4235854|P2|Overall Study|Lost to Follow-up|5
1301153|NCT00236197|4235855|P1|Overall Study|Lost to Follow-up|1
1301154|NCT00236197|4235854|P2|Overall Study|Withdrawal by Subject|2
1301155|NCT00236197|4235855|P1|Overall Study|Withdrawal by Subject|3
1301156|NCT00236184|4235863|P2|Overall Study|other|2
1301157|NCT00236184|4235864|P1|Overall Study|other|1
1301158|NCT00236184|4235863|P2|Overall Study|non-compliance with study drug|1
1301159|NCT00236184|4235864|P1|Overall Study|non-compliance with study drug|2
1301160|NCT00236184|4235863|P2|Overall Study|Protocol Violation|0
1301161|NCT00236184|4235864|P1|Overall Study|Protocol Violation|3
1301162|NCT00236184|4235863|P2|Overall Study|Withdrawal by Subject|0
1301163|NCT00236184|4235864|P1|Overall Study|Withdrawal by Subject|3
1301164|NCT00236184|4235863|P2|Overall Study|Physician Decision|1
1301165|NCT00236184|4235864|P1|Overall Study|Physician Decision|1
1301166|NCT00236184|4235863|P2|Overall Study|Lost to Follow-up|4
1301167|NCT00236184|4235864|P1|Overall Study|Lost to Follow-up|3
1301168|NCT00236184|4235863|P2|Overall Study|Lack of Efficacy|1
1301169|NCT00236184|4235864|P1|Overall Study|Lack of Efficacy|0
1301170|NCT00236184|4235863|P2|Overall Study|Adverse Event|2
1301171|NCT00236184|4235864|P1|Overall Study|Adverse Event|5
1301172|NCT00236080|4235875|P5|Overall Study|Miscellaneous|0
1301173|NCT00236080|4235876|P4|Overall Study|Miscellaneous|0
1301174|NCT00236080|4235877|P3|Overall Study|Miscellaneous|1
1301175|NCT00236080|4235878|P2|Overall Study|Miscellaneous|0
1301176|NCT00236080|4235879|P1|Overall Study|Miscellaneous|0
1301177|NCT00236080|4235875|P5|Overall Study|Withdrawal by Subject|0
1301178|NCT00236080|4235876|P4|Overall Study|Withdrawal by Subject|0
1301179|NCT00236080|4235877|P3|Overall Study|Withdrawal by Subject|0
1301180|NCT00236080|4235878|P2|Overall Study|Withdrawal by Subject|0
1301181|NCT00236080|4235879|P1|Overall Study|Withdrawal by Subject|1
1301182|NCT00236080|4235875|P5|Overall Study|Physician Decision|1
1301183|NCT00236080|4235876|P4|Overall Study|Physician Decision|1
1301184|NCT00236080|4235877|P3|Overall Study|Physician Decision|1
1301185|NCT00236080|4235878|P2|Overall Study|Physician Decision|0
1301186|NCT00236080|4235879|P1|Overall Study|Physician Decision|1
1301187|NCT00236080|4235875|P5|Overall Study|Lost to Follow-up|0
1301188|NCT00236080|4235876|P4|Overall Study|Lost to Follow-up|0
1301189|NCT00236080|4235877|P3|Overall Study|Lost to Follow-up|0
1301190|NCT00236080|4235878|P2|Overall Study|Lost to Follow-up|1
1301191|NCT00236080|4235879|P1|Overall Study|Lost to Follow-up|0
1301192|NCT00236080|4235875|P5|Overall Study|Adverse Event|0
1301193|NCT00236080|4235876|P4|Overall Study|Adverse Event|1
1301194|NCT00236080|4235877|P3|Overall Study|Adverse Event|3
1301195|NCT00236080|4235878|P2|Overall Study|Adverse Event|0
1301196|NCT00236080|4235879|P1|Overall Study|Adverse Event|0
1301197|NCT00235989|4235900|P6|Extension Treatment Period (ET)|´Other´ not further itemized|0
1301198|NCT00235989|4235901|P5|Extension Treatment Period (ET)|´Other´ not further itemized|0
1301199|NCT00235989|4235902|P4|Extension Treatment Period (ET)|´Other´ not further itemized|2
1301200|NCT00235989|4235903|P3|Extension Treatment Period (ET)|´Other´ not further itemized|1
1301201|NCT00235989|4235904|P2|Extension Treatment Period (ET)|´Other´ not further itemized|3
1301202|NCT00235989|4235905|P1|Extension Treatment Period (ET)|´Other´ not further itemized|2
1301203|NCT00235989|4235900|P6|Extension Treatment Period (ET)|Withdrawal by Subject|0
1301204|NCT00235989|4235901|P5|Extension Treatment Period (ET)|Withdrawal by Subject|0
1301205|NCT00235989|4235902|P4|Extension Treatment Period (ET)|Withdrawal by Subject|4
1301206|NCT00235989|4235903|P3|Extension Treatment Period (ET)|Withdrawal by Subject|1
1301207|NCT00235989|4235904|P2|Extension Treatment Period (ET)|Withdrawal by Subject|1
1301208|NCT00235989|4235905|P1|Extension Treatment Period (ET)|Withdrawal by Subject|1
1301209|NCT00235989|4235900|P6|Extension Treatment Period (ET)|Lost to Follow-up|0
1301210|NCT00235989|4235901|P5|Extension Treatment Period (ET)|Lost to Follow-up|0
1301211|NCT00235989|4235902|P4|Extension Treatment Period (ET)|Lost to Follow-up|0
1301212|NCT00235989|4235903|P3|Extension Treatment Period (ET)|Lost to Follow-up|1
1301213|NCT00235989|4235904|P2|Extension Treatment Period (ET)|Lost to Follow-up|0
1301214|NCT00235989|4235905|P1|Extension Treatment Period (ET)|Lost to Follow-up|2
1301215|NCT00235989|4235900|P6|Extension Treatment Period (ET)|Adverse Event|0
1301216|NCT00235989|4235901|P5|Extension Treatment Period (ET)|Adverse Event|0
1301217|NCT00235989|4235902|P4|Extension Treatment Period (ET)|Adverse Event|0
1301218|NCT00235989|4235903|P3|Extension Treatment Period (ET)|Adverse Event|2
1301219|NCT00235989|4235904|P2|Extension Treatment Period (ET)|Adverse Event|0
1301220|NCT00235989|4235905|P1|Extension Treatment Period (ET)|Adverse Event|3
1301221|NCT00235989|4235900|P6|Core Treatment Period (CT)|Lost to Follow-up|2
1301222|NCT00235989|4235901|P5|Core Treatment Period (CT)|Lost to Follow-up|0
1301223|NCT00235989|4235902|P4|Core Treatment Period (CT)|Lost to Follow-up|0
1301224|NCT00235989|4235903|P3|Core Treatment Period (CT)|Lost to Follow-up|0
1301225|NCT00235989|4235904|P2|Core Treatment Period (CT)|Lost to Follow-up|0
1301226|NCT00235989|4235905|P1|Core Treatment Period (CT)|Lost to Follow-up|0
1301227|NCT00235872|4235919|P1|Overall Study|Administrative reason|61
1301228|NCT00235872|4235919|P1|Overall Study|Withdrawal by Subject|50
1301229|NCT00235872|4235919|P1|Overall Study|Lost to Follow-up|1
1301230|NCT00235872|4235919|P1|Overall Study|Death|1
1301231|NCT00235872|4235919|P1|Overall Study|Adverse Event|34
1301232|NCT00235755|4235950|P3|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
1301233|NCT00235755|4235951|P2|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
1301234|NCT00235755|4235952|P1|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1
1301235|NCT00235755|4235950|P3|12-Week Maintenance Phase|Withdrawal by Subject|3
1301236|NCT00235755|4235951|P2|12-Week Maintenance Phase|Withdrawal by Subject|8
1301237|NCT00235755|4235952|P1|12-Week Maintenance Phase|Withdrawal by Subject|0
1301238|NCT00235755|4235950|P3|12-Week Maintenance Phase|Protocol Violation|2
1301239|NCT00235755|4235951|P2|12-Week Maintenance Phase|Protocol Violation|4
1301240|NCT00235755|4235952|P1|12-Week Maintenance Phase|Protocol Violation|0
1301241|NCT00235755|4235950|P3|12-Week Maintenance Phase|Lack of Efficacy|0
1301242|NCT00235755|4235951|P2|12-Week Maintenance Phase|Lack of Efficacy|0
1301243|NCT00235755|4235952|P1|12-Week Maintenance Phase|Lack of Efficacy|5
1301244|NCT00235755|4235950|P3|12-Week Maintenance Phase|Lost to Follow-up|0
1301245|NCT00235755|4235951|P2|12-Week Maintenance Phase|Lost to Follow-up|3
1301246|NCT00235755|4235952|P1|12-Week Maintenance Phase|Lost to Follow-up|2
1301247|NCT00235755|4235950|P3|12-Week Maintenance Phase|Adverse Event|26
1301248|NCT00235755|4235951|P2|12-Week Maintenance Phase|Adverse Event|12
1301249|NCT00235755|4235952|P1|12-Week Maintenance Phase|Adverse Event|8
1301250|NCT00235755|4235950|P3|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
1301251|NCT00235755|4235951|P2|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
1301252|NCT00235755|4235952|P1|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1
1301253|NCT00235755|4235950|P3|4-Week Titration Phase|Randomization Occurred in Error|0
1301254|NCT00235755|4235951|P2|4-Week Titration Phase|Randomization Occurred in Error|0
1301255|NCT00235755|4235952|P1|4-Week Titration Phase|Randomization Occurred in Error|1
1301256|NCT00235755|4235950|P3|4-Week Titration Phase|Participant Did Not Receive Study Drug|1
1301257|NCT00235755|4235951|P2|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
1301258|NCT00235755|4235952|P1|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
1301259|NCT00235755|4235950|P3|4-Week Titration Phase|Withdrawal by Subject|3
1301260|NCT00235755|4235951|P2|4-Week Titration Phase|Withdrawal by Subject|2
1301261|NCT00235755|4235952|P1|4-Week Titration Phase|Withdrawal by Subject|1
1301262|NCT00235755|4235950|P3|4-Week Titration Phase|Protocol Violation|1
1301263|NCT00235755|4235951|P2|4-Week Titration Phase|Protocol Violation|2
1301264|NCT00235755|4235952|P1|4-Week Titration Phase|Protocol Violation|2
1301265|NCT00235755|4235950|P3|4-Week Titration Phase|Lost to Follow-up|1
1301266|NCT00235755|4235951|P2|4-Week Titration Phase|Lost to Follow-up|1
1301267|NCT00235755|4235952|P1|4-Week Titration Phase|Lost to Follow-up|0
1301268|NCT00235755|4235950|P3|4-Week Titration Phase|Adverse Event|20
1301269|NCT00235755|4235951|P2|4-Week Titration Phase|Adverse Event|14
1301270|NCT00235755|4235952|P1|4-Week Titration Phase|Adverse Event|6
1301271|NCT00235716|4236030|P4|Overall Study|Physician Decision|3
1301272|NCT00235716|4236031|P3|Overall Study|Physician Decision|1
1301273|NCT00235716|4236032|P2|Overall Study|Physician Decision|1
1301274|NCT00235716|4236033|P1|Overall Study|Physician Decision|0
1301275|NCT00235716|4236030|P4|Overall Study|Adverse Event|0
1301276|NCT00235716|4236031|P3|Overall Study|Adverse Event|1
1301277|NCT00235716|4236032|P2|Overall Study|Adverse Event|1
1301278|NCT00235716|4236033|P1|Overall Study|Adverse Event|1
1301279|NCT00235716|4236030|P4|Overall Study|Lost to Follow-up|10
1301280|NCT00235716|4236031|P3|Overall Study|Lost to Follow-up|14
1301281|NCT00235716|4236032|P2|Overall Study|Lost to Follow-up|7
1301282|NCT00235716|4236033|P1|Overall Study|Lost to Follow-up|12
1301283|NCT00235716|4236030|P4|Overall Study|Withdrawal by Subject|18
1301284|NCT00235716|4236031|P3|Overall Study|Withdrawal by Subject|17
1301285|NCT00235716|4236032|P2|Overall Study|Withdrawal by Subject|19
1301286|NCT00235716|4236033|P1|Overall Study|Withdrawal by Subject|23
1301287|NCT00235716|4236030|P4|Overall Study|Death|31
1301288|NCT00235716|4236031|P3|Overall Study|Death|32
1301289|NCT00235716|4236032|P2|Overall Study|Death|39
1301290|NCT00235716|4236033|P1|Overall Study|Death|26
1301291|NCT00235443|4236096|P6|Overall Study|Other reasons for premature termination|6
1301292|NCT00235443|4236097|P5|Overall Study|Other reasons for premature termination|3
1301293|NCT00235443|4236098|P4|Overall Study|Other reasons for premature termination|7
1301294|NCT00235443|4236099|P3|Overall Study|Other reasons for premature termination|6
1301295|NCT00235443|4236100|P2|Overall Study|Other reasons for premature termination|6
1301296|NCT00235443|4236101|P1|Overall Study|Other reasons for premature termination|1
1301297|NCT00235443|4236096|P6|Overall Study|Unsatisfactory compliance|0
1301298|NCT00235443|4236097|P5|Overall Study|Unsatisfactory compliance|1
1301299|NCT00235443|4236098|P4|Overall Study|Unsatisfactory compliance|4
1301300|NCT00235443|4236099|P3|Overall Study|Unsatisfactory compliance|3
1301301|NCT00235443|4236100|P2|Overall Study|Unsatisfactory compliance|2
1301302|NCT00235443|4236101|P1|Overall Study|Unsatisfactory compliance|0
1301303|NCT00235443|4236096|P6|Overall Study|Lost to Follow-up|3
1301304|NCT00235443|4236097|P5|Overall Study|Lost to Follow-up|4
1301305|NCT00235443|4236098|P4|Overall Study|Lost to Follow-up|6
1301306|NCT00235443|4236099|P3|Overall Study|Lost to Follow-up|6
1301307|NCT00235443|4236100|P2|Overall Study|Lost to Follow-up|8
1301308|NCT00235443|4236101|P1|Overall Study|Lost to Follow-up|0
1301309|NCT00235443|4236096|P6|Overall Study|Withdrawal by Subject|12
1301310|NCT00235443|4236097|P5|Overall Study|Withdrawal by Subject|10
1301311|NCT00235443|4236098|P4|Overall Study|Withdrawal by Subject|24
1301312|NCT00235443|4236099|P3|Overall Study|Withdrawal by Subject|25
1301313|NCT00235443|4236100|P2|Overall Study|Withdrawal by Subject|9
1301314|NCT00235443|4236101|P1|Overall Study|Withdrawal by Subject|3
1301315|NCT00235443|4236096|P6|Overall Study|Lack of Efficacy|9
1301316|NCT00235443|4236097|P5|Overall Study|Lack of Efficacy|2
1301317|NCT00235443|4236098|P4|Overall Study|Lack of Efficacy|12
1301318|NCT00235443|4236099|P3|Overall Study|Lack of Efficacy|5
1301319|NCT00235443|4236100|P2|Overall Study|Lack of Efficacy|1
1301320|NCT00235443|4236101|P1|Overall Study|Lack of Efficacy|0
1301321|NCT00235443|4236096|P6|Overall Study|Adverse Event|15
1301322|NCT00235443|4236097|P5|Overall Study|Adverse Event|10
1301323|NCT00235443|4236098|P4|Overall Study|Adverse Event|44
1301324|NCT00235443|4236099|P3|Overall Study|Adverse Event|17
1301325|NCT00235443|4236100|P2|Overall Study|Adverse Event|12
1301326|NCT00235443|4236101|P1|Overall Study|Adverse Event|4
1301327|NCT00235391|4236242|P6|Overall Study|Death|0
1301328|NCT00235391|4236243|P5|Overall Study|Death|0
1301329|NCT00235391|4236244|P4|Overall Study|Death|4
1301330|NCT00235391|4236245|P3|Overall Study|Death|1
1301331|NCT00235391|4236246|P2|Overall Study|Death|0
1301332|NCT00235391|4236247|P1|Overall Study|Death|0
1301333|NCT00235391|4236242|P6|Overall Study|Administrative problems|0
1301334|NCT00235391|4236243|P5|Overall Study|Administrative problems|0
1301335|NCT00235391|4236244|P4|Overall Study|Administrative problems|1
1301336|NCT00235391|4236245|P3|Overall Study|Administrative problems|0
1301337|NCT00235391|4236246|P2|Overall Study|Administrative problems|0
1301338|NCT00235391|4236247|P1|Overall Study|Administrative problems|0
1301339|NCT00235391|4236242|P6|Overall Study|Lost to Follow-up|0
1301340|NCT00235391|4236243|P5|Overall Study|Lost to Follow-up|0
1301341|NCT00235391|4236244|P4|Overall Study|Lost to Follow-up|16
1301342|NCT00235391|4236245|P3|Overall Study|Lost to Follow-up|3
1301343|NCT00235391|4236246|P2|Overall Study|Lost to Follow-up|3
1301344|NCT00235391|4236247|P1|Overall Study|Lost to Follow-up|0
1301345|NCT00235391|4236242|P6|Overall Study|Withdrawal by Subject|0
1301346|NCT00235391|4236243|P5|Overall Study|Withdrawal by Subject|5
1301347|NCT00235391|4236244|P4|Overall Study|Withdrawal by Subject|61
1301348|NCT00235391|4236245|P3|Overall Study|Withdrawal by Subject|3
1301349|NCT00235391|4236246|P2|Overall Study|Withdrawal by Subject|3
1301350|NCT00235391|4236247|P1|Overall Study|Withdrawal by Subject|2
1301351|NCT00235391|4236242|P6|Overall Study|Protocol deviation|0
1301352|NCT00235391|4236243|P5|Overall Study|Protocol deviation|0
1301353|NCT00235391|4236244|P4|Overall Study|Protocol deviation|11
1301354|NCT00235391|4236245|P3|Overall Study|Protocol deviation|1
1301355|NCT00235391|4236246|P2|Overall Study|Protocol deviation|0
1301356|NCT00235391|4236247|P1|Overall Study|Protocol deviation|0
1301357|NCT00235391|4236242|P6|Overall Study|Condition no longer requires treatment|0
1301358|NCT00235391|4236243|P5|Overall Study|Condition no longer requires treatment|1
1301359|NCT00235391|4236244|P4|Overall Study|Condition no longer requires treatment|11
1301360|NCT00235391|4236245|P3|Overall Study|Condition no longer requires treatment|0
1301361|NCT00235391|4236246|P2|Overall Study|Condition no longer requires treatment|0
1301362|NCT00235391|4236247|P1|Overall Study|Condition no longer requires treatment|3
1301363|NCT00235391|4236242|P6|Overall Study|Unsatisfactory therapeutic effect|0
1301364|NCT00235391|4236243|P5|Overall Study|Unsatisfactory therapeutic effect|0
1301365|NCT00235391|4236244|P4|Overall Study|Unsatisfactory therapeutic effect|17
1301366|NCT00235391|4236245|P3|Overall Study|Unsatisfactory therapeutic effect|2
1301367|NCT00235391|4236246|P2|Overall Study|Unsatisfactory therapeutic effect|2
1301368|NCT00235391|4236247|P1|Overall Study|Unsatisfactory therapeutic effect|0
1301369|NCT00235391|4236242|P6|Overall Study|Abnormal laboratory value(s)|2
1301370|NCT00235391|4236243|P5|Overall Study|Abnormal laboratory value(s)|1
1301371|NCT00235391|4236244|P4|Overall Study|Abnormal laboratory value(s)|27
1301372|NCT00235391|4236245|P3|Overall Study|Abnormal laboratory value(s)|4
1301373|NCT00235391|4236246|P2|Overall Study|Abnormal laboratory value(s)|5
1301374|NCT00235391|4236247|P1|Overall Study|Abnormal laboratory value(s)|3
1301375|NCT00235391|4236242|P6|Overall Study|Adverse Event|2
1301376|NCT00235391|4236243|P5|Overall Study|Adverse Event|5
1301377|NCT00235391|4236244|P4|Overall Study|Adverse Event|72
1301378|NCT00235391|4236245|P3|Overall Study|Adverse Event|10
1301379|NCT00235391|4236246|P2|Overall Study|Adverse Event|5
1301380|NCT00235391|4236247|P1|Overall Study|Adverse Event|4
1301381|NCT00235326|4236264|P2|Overall Study|Lost to Follow-up|1400
1301382|NCT00235326|4236265|P1|Overall Study|Lost to Follow-up|746
1301383|NCT00234533|4236305|P1|Overall Study|Enrolled but not treated|3
1301384|NCT00234533|4236305|P1|Overall Study|Adverse Event|2
1301385|NCT00234533|4236305|P1|Overall Study|Withdrawal by Subject|6
1301386|NCT00234494|4236324|P1|Overall Study|Protocol Violation|2
1301387|NCT00234104|4236370|P4|Overall Study|Physician Decision|2
1301388|NCT00234104|4236371|P3|Overall Study|Physician Decision|2
1301389|NCT00234104|4236372|P2|Overall Study|Physician Decision|1
1301390|NCT00234104|4236373|P1|Overall Study|Physician Decision|0
1301391|NCT00234104|4236370|P4|Overall Study|Protocol Violation|1
1301392|NCT00234104|4236371|P3|Overall Study|Protocol Violation|0
1301393|NCT00234104|4236372|P2|Overall Study|Protocol Violation|0
1301394|NCT00234104|4236373|P1|Overall Study|Protocol Violation|0
1301395|NCT00234104|4236370|P4|Overall Study|Adverse Event|5
1301396|NCT00234104|4236371|P3|Overall Study|Adverse Event|3
1301397|NCT00234104|4236372|P2|Overall Study|Adverse Event|0
1301398|NCT00234104|4236373|P1|Overall Study|Adverse Event|4
1301399|NCT00234065|4236414|P2|Overall Study|Not Classified|112
1301400|NCT00234065|4236415|P1|Overall Study|Not Classified|111
1301401|NCT00234065|4236414|P2|Overall Study|Physician Decision|22
1301402|NCT00234065|4236415|P1|Overall Study|Physician Decision|23
1301403|NCT00234065|4236414|P2|Overall Study|Withdrawal by Subject|56
1301404|NCT00234065|4236415|P1|Overall Study|Withdrawal by Subject|73
1301405|NCT00234065|4236414|P2|Overall Study|Adverse Event|166
1301406|NCT00234065|4236415|P1|Overall Study|Adverse Event|268
1301407|NCT00234039|4236431|P1|Overall Study|No Protocol Treatment Received|2
1301408|NCT00234039|4236431|P1|Overall Study|Ineligible|9
1301409|NCT00234039|4236431|P1|Overall Study|Other - Not Protocol Specified|3
1301410|NCT00234039|4236431|P1|Overall Study|Progression/relapse|34
1301411|NCT00234039|4236431|P1|Overall Study|Adverse Event|2
1301412|NCT00233987|4236438|P1|Overall Study|Ineligible|4
1301413|NCT00233987|4236438|P1|Overall Study|Eligible but No Treatment Received|2
1301414|NCT00233987|4236438|P1|Overall Study|Other - Not Protocol Specified|5
1301415|NCT00233987|4236438|P1|Overall Study|Reason Under Review|1
1301416|NCT00233987|4236438|P1|Overall Study|Lack of Efficacy|2
1301417|NCT00233987|4236438|P1|Overall Study|Withdrawal by Subject|1
1301418|NCT00233948|4236447|P6|Overall Study|Adverse Event|0
1301419|NCT00233948|4236448|P5|Overall Study|Adverse Event|0
1301420|NCT00233948|4236449|P4|Overall Study|Adverse Event|0
1301421|NCT00233948|4236450|P3|Overall Study|Adverse Event|0
1301422|NCT00233948|4236451|P2|Overall Study|Adverse Event|0
1301423|NCT00233948|4236452|P1|Overall Study|Adverse Event|1
1301424|NCT00233454|4236476|P1|Overall Study|Death|6
1301425|NCT00233402|4236484|P2|Overall Study|Lost to follow up etc|21
1301426|NCT00233402|4236485|P1|Overall Study|Lost to follow up etc|3
1301427|NCT00233402|4236484|P2|Overall Study|No Ta/T1|94
1301428|NCT00233402|4236485|P1|Overall Study|No Ta/T1|89
1301429|NCT00233402|4236484|P2|Overall Study|No pathology data|9
1301430|NCT00233402|4236485|P1|Overall Study|No pathology data|12
1301431|NCT00233324|4236500|P4|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
1301432|NCT00233324|4236501|P3|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13
1301433|NCT00233324|4236502|P2|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
1301434|NCT00233324|4236503|P1|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8
1301435|NCT00233324|4236500|P4|Follow up at 18-22 Months Corrected Age|Death|4
1301436|NCT00233324|4236501|P3|Follow up at 18-22 Months Corrected Age|Death|5
1301437|NCT00233324|4236502|P2|Follow up at 18-22 Months Corrected Age|Death|7
1301438|NCT00233324|4236503|P1|Follow up at 18-22 Months Corrected Age|Death|5
1301439|NCT00233324|4236500|P4|Main Study|Death|47
1301440|NCT00233324|4236501|P3|Main Study|Death|62
1301441|NCT00233324|4236502|P2|Main Study|Death|60
1301442|NCT00233324|4236503|P1|Main Study|Death|68
1301443|NCT00233064|4236557|P2|Overall Study|Moved to Dom. Republic|0
1301444|NCT00233064|4236558|P1|Overall Study|Moved to Dom. Republic|1
1301445|NCT00233064|4236557|P2|Overall Study|Protocol Violation|0
1301446|NCT00233064|4236558|P1|Overall Study|Protocol Violation|1
1301447|NCT00233064|4236557|P2|Overall Study|Relocation|1
1301448|NCT00233064|4236558|P1|Overall Study|Relocation|0
1301449|NCT00233064|4236557|P2|Overall Study|Death|1
1301450|NCT00233064|4236558|P1|Overall Study|Death|0
1301451|NCT00233064|4236557|P2|Overall Study|Withdrawal by Subject|3
1301452|NCT00233064|4236558|P1|Overall Study|Withdrawal by Subject|5
1301453|NCT00233064|4236557|P2|Overall Study|Lost to Follow-up|7
1301454|NCT00233064|4236558|P1|Overall Study|Lost to Follow-up|7
1301455|NCT00232596|4236584|P2|12-Week Maintenance Phase|Other|3
1301456|NCT00232596|4236585|P1|12-Week Maintenance Phase|Other|1
1301457|NCT00232596|4236584|P2|12-Week Maintenance Phase|Protocol Violation|1
1301458|NCT00232596|4236585|P1|12-Week Maintenance Phase|Protocol Violation|3
1301459|NCT00232596|4236584|P2|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2
1301460|NCT00232596|4236585|P1|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1
1301461|NCT00232596|4236584|P2|12-Week Maintenance Phase|Adverse Event|22
1301462|NCT00232596|4236585|P1|12-Week Maintenance Phase|Adverse Event|7
1301463|NCT00232596|4236584|P2|6-Week Titration Phase|Participant Did Not Receive Study Drug|1
1301464|NCT00232596|4236585|P1|6-Week Titration Phase|Participant Did Not Receive Study Drug|0
1301465|NCT00232596|4236584|P2|6-Week Titration Phase|Other|3
1301466|NCT00232596|4236585|P1|6-Week Titration Phase|Other|3
1301467|NCT00232596|4236584|P2|6-Week Titration Phase|Participant Request Unrelated to Study|0
1301468|NCT00232596|4236585|P1|6-Week Titration Phase|Participant Request Unrelated to Study|1
1301469|NCT00232596|4236584|P2|6-Week Titration Phase|Protocol Violation|3
1301470|NCT00232596|4236585|P1|6-Week Titration Phase|Protocol Violation|1
1301471|NCT00232596|4236584|P2|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2
1301472|NCT00232596|4236585|P1|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1
1301473|NCT00232596|4236584|P2|6-Week Titration Phase|Failed to Return|1
1301474|NCT00232596|4236585|P1|6-Week Titration Phase|Failed to Return|2
1301475|NCT00232596|4236584|P2|6-Week Titration Phase|Adverse Event|19
1301476|NCT00232596|4236585|P1|6-Week Titration Phase|Adverse Event|6
1301477|NCT00232557|4236676|P2|Overall Study|Lost to Follow-up|5
1301478|NCT00232557|4236677|P1|Overall Study|Lost to Follow-up|3
1301479|NCT00232544|4236687|P2|Overall Study|Lost to Follow-up|15
1301480|NCT00232544|4236688|P1|Overall Study|Lost to Follow-up|20
1301481|NCT00232180|4236719|P3|Open Label Phase|Randomized but not treated|1
1301482|NCT00232180|4236720|P2|Open Label Phase|Randomized but not treated|0
1301483|NCT00232180|4236721|P1|Open Label Phase|Randomized but not treated|0
1301484|NCT00232180|4236719|P3|Open Label Phase|Laboratory abnormality|10
1301485|NCT00232180|4236720|P2|Open Label Phase|Laboratory abnormality|0
1301486|NCT00232180|4236721|P1|Open Label Phase|Laboratory abnormality|0
1301487|NCT00232180|4236719|P3|Open Label Phase|Adverse Event|25
1301488|NCT00232180|4236720|P2|Open Label Phase|Adverse Event|0
1301489|NCT00232180|4236721|P1|Open Label Phase|Adverse Event|0
1301490|NCT00232180|4236719|P3|Open Label Phase|Other|16
1301491|NCT00232180|4236720|P2|Open Label Phase|Other|0
1301492|NCT00232180|4236721|P1|Open Label Phase|Other|0
1301493|NCT00232180|4236719|P3|Open Label Phase|Withdrawal by Subject|37
1301494|NCT00232180|4236720|P2|Open Label Phase|Withdrawal by Subject|0
1301495|NCT00232180|4236721|P1|Open Label Phase|Withdrawal by Subject|0
1301496|NCT00232180|4236719|P3|Open Label Phase|Study terminated by sponsor|3
1301497|NCT00232180|4236720|P2|Open Label Phase|Study terminated by sponsor|0
1301498|NCT00232180|4236721|P1|Open Label Phase|Study terminated by sponsor|0
1301499|NCT00232180|4236719|P3|Open Label Phase|Protocol Violation|3
1301500|NCT00232180|4236720|P2|Open Label Phase|Protocol Violation|0
1301501|NCT00232180|4236721|P1|Open Label Phase|Protocol Violation|0
1301502|NCT00232180|4236719|P3|Open Label Phase|Lost to Follow-up|5
1301503|NCT00232180|4236720|P2|Open Label Phase|Lost to Follow-up|0
1301504|NCT00232180|4236721|P1|Open Label Phase|Lost to Follow-up|0
1301505|NCT00232180|4236719|P3|Open Label Phase|Death|48
1301506|NCT00232180|4236720|P2|Open Label Phase|Death|0
1301507|NCT00232180|4236721|P1|Open Label Phase|Death|0
1301508|NCT00232180|4236719|P3|Double-blind (DB) Phase|Laboratory abnormality|0
1301509|NCT00232180|4236720|P2|Double-blind (DB) Phase|Laboratory abnormality|7
1301510|NCT00232180|4236721|P1|Double-blind (DB) Phase|Laboratory abnormality|6
1301511|NCT00232180|4236719|P3|Double-blind (DB) Phase|Randomized but not treated|0
1301512|NCT00232180|4236720|P2|Double-blind (DB) Phase|Randomized but not treated|4
1301513|NCT00232180|4236721|P1|Double-blind (DB) Phase|Randomized but not treated|3
1301514|NCT00232180|4236719|P3|Double-blind (DB) Phase|Other|0
1301515|NCT00232180|4236720|P2|Double-blind (DB) Phase|Other|75
1301516|NCT00232180|4236721|P1|Double-blind (DB) Phase|Other|70
1301517|NCT00232180|4236719|P3|Double-blind (DB) Phase|Adverse Event|0
1301518|NCT00232180|4236720|P2|Double-blind (DB) Phase|Adverse Event|100
1301519|NCT00232180|4236721|P1|Double-blind (DB) Phase|Adverse Event|83
1301520|NCT00232180|4236719|P3|Double-blind (DB) Phase|Protocol Violation|0
1301521|NCT00232180|4236720|P2|Double-blind (DB) Phase|Protocol Violation|21
1301522|NCT00232180|4236721|P1|Double-blind (DB) Phase|Protocol Violation|28
1301523|NCT00232180|4236719|P3|Double-blind (DB) Phase|Withdrawal by Subject|0
1301524|NCT00232180|4236720|P2|Double-blind (DB) Phase|Withdrawal by Subject|148
1301525|NCT00232180|4236721|P1|Double-blind (DB) Phase|Withdrawal by Subject|131
1301526|NCT00232180|4236719|P3|Double-blind (DB) Phase|Lost to Follow-up|0
1301527|NCT00232180|4236720|P2|Double-blind (DB) Phase|Lost to Follow-up|28
1301528|NCT00232180|4236721|P1|Double-blind (DB) Phase|Lost to Follow-up|34
1301529|NCT00232180|4236719|P3|Double-blind (DB) Phase|Death|0
1301530|NCT00232180|4236720|P2|Double-blind (DB) Phase|Death|222
1301531|NCT00232180|4236721|P1|Double-blind (DB) Phase|Death|186
1301532|NCT00232141|4236766|P2|Overall Study|Withdrawal by Subject|3
1301533|NCT00232141|4236767|P1|Overall Study|Withdrawal by Subject|5
1301534|NCT00232141|4236766|P2|Overall Study|Other|10
1301535|NCT00232141|4236767|P1|Overall Study|Other|8
1301536|NCT00232141|4236766|P2|Overall Study|Lost to Follow-up|6
1301537|NCT00232141|4236767|P1|Overall Study|Lost to Follow-up|9
1301538|NCT00232141|4236766|P2|Overall Study|Lack of Efficacy|3
1301539|NCT00232141|4236767|P1|Overall Study|Lack of Efficacy|0
1301540|NCT00232141|4236766|P2|Overall Study|Adverse Event|4
1301541|NCT00232141|4236767|P1|Overall Study|Adverse Event|9
1301542|NCT00231894|4236837|P2|Overall Study|Withdrawal by Subject|1
1301543|NCT00231894|4236838|P1|Overall Study|Withdrawal by Subject|1
1301544|NCT00231816|4236862|P2|Overall Study|Not Specified|1
1301545|NCT00231816|4236863|P1|Overall Study|Not Specified|2
1301546|NCT00231816|4236862|P2|Overall Study|Withdrawal by Subject|3
1301547|NCT00231816|4236863|P1|Overall Study|Withdrawal by Subject|3
1301548|NCT00231816|4236862|P2|Overall Study|Protocol Violation|3
1301549|NCT00231816|4236863|P1|Overall Study|Protocol Violation|2
1301550|NCT00231816|4236862|P2|Overall Study|Lost to Follow-up|5
1301551|NCT00231816|4236863|P1|Overall Study|Lost to Follow-up|8
1301552|NCT00231816|4236862|P2|Overall Study|Adverse Event|0
1301553|NCT00231816|4236863|P1|Overall Study|Adverse Event|1
1301554|NCT00231777|4236878|P2|Overall Study|Other|2
1301555|NCT00231777|4236879|P1|Overall Study|Other|3
1301556|NCT00231777|4236878|P2|Overall Study|Lost to Follow-up|0
1301557|NCT00231777|4236879|P1|Overall Study|Lost to Follow-up|3
1301558|NCT00231478|4236893|P2|Overall Study|Administrative|2
1301559|NCT00231478|4236894|P1|Overall Study|Administrative|3
1301560|NCT00231478|4236893|P2|Overall Study|Adverse Event|1
1301561|NCT00231478|4236894|P1|Overall Study|Adverse Event|0
1301562|NCT00231478|4236893|P2|Overall Study|Withdrawal by Subject|0
1301563|NCT00231478|4236894|P1|Overall Study|Withdrawal by Subject|1
1301564|NCT00231478|4236893|P2|Overall Study|Refused Treatment|1
1301565|NCT00231478|4236894|P1|Overall Study|Refused Treatment|1
1301566|NCT00231478|4236893|P2|Overall Study|Protocol Violation|2
1301567|NCT00231478|4236894|P1|Overall Study|Protocol Violation|3
1301568|NCT00231465|4236906|P1|Overall Study|Did not have follow up CT scans|1
1301569|NCT00231465|4236906|P1|Overall Study|Completed only one cycle|1
1301570|NCT00231179|4236926|P2|Overall Study|Withdrawal by Subject|3
1301571|NCT00231179|4236927|P1|Overall Study|Withdrawal by Subject|3
1301572|NCT00231179|4236926|P2|Overall Study|Lost to Follow-up|21
1301573|NCT00231179|4236927|P1|Overall Study|Lost to Follow-up|21
1301574|NCT00231114|4236954|P2|Post-Treatment Period|Withdrawal by Subject|0
1301575|NCT00231114|4236955|P1|Post-Treatment Period|Withdrawal by Subject|1
1301576|NCT00231114|4236954|P2|Post-Treatment Period|Physician Decision|0
1301577|NCT00231114|4236955|P1|Post-Treatment Period|Physician Decision|1
1301578|NCT00231114|4236954|P2|Post-Treatment Period|Lost to Follow-up|1
1301579|NCT00231114|4236955|P1|Post-Treatment Period|Lost to Follow-up|6
1301580|NCT00231114|4236954|P2|Treatment Period|Death: Motor Vehicle Accident|0
1301581|NCT00231114|4236955|P1|Treatment Period|Death: Motor Vehicle Accident|1
1301582|NCT00231114|4236954|P2|Randomized|Withdrawal by Subject|3
1301583|NCT00231114|4236955|P1|Randomized|Withdrawal by Subject|6
1301584|NCT00231062|4236991|P1|Overall Study|Physician Decision|6
1301585|NCT00230971|4236999|P2|Baseline Participants|Reintervention|0
1301586|NCT00230971|4237000|P1|Baseline Participants|Reintervention|1
1301587|NCT00230971|4236999|P2|Baseline Participants|Failure to return|1
1301588|NCT00230971|4237000|P1|Baseline Participants|Failure to return|1
1301589|NCT00230971|4236999|P2|Baseline Participants|No bacteria observed|0
1301590|NCT00230971|4237000|P1|Baseline Participants|No bacteria observed|1
1301591|NCT00230971|4236999|P2|Baseline Participants|Adverse Event|0
1301592|NCT00230971|4237000|P1|Baseline Participants|Adverse Event|1
1301593|NCT00230971|4236999|P2|Baseline Participants|Withdrawal by Subject|1
1301594|NCT00230971|4237000|P1|Baseline Participants|Withdrawal by Subject|7
1301595|NCT00230971|4236999|P2|Baseline Participants|Death|5
1301596|NCT00230971|4237000|P1|Baseline Participants|Death|6
1301597|NCT00230971|4236999|P2|Baseline Participants|Lost to Follow-up|12
1301598|NCT00230971|4237000|P1|Baseline Participants|Lost to Follow-up|5
1301599|NCT00230971|4236999|P2|Randomization|No study drug administered|3
1301600|NCT00230971|4237000|P1|Randomization|No study drug administered|3
1301601|NCT00230282|4237038|P1|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2
1301602|NCT00230282|4237038|P1|Fludarabine + Cyclophosphamide|Change in diagnosis|1
1301603|NCT00230282|4237038|P1|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1
1301604|NCT00230282|4237038|P1|Fludarabine + Cyclophosphamide|Lost to Follow-up|4
1301605|NCT00230178|4237046|P3|Overall Study|Various other reasons|4
1301606|NCT00230178|4237047|P2|Overall Study|Various other reasons|2
1301607|NCT00230178|4237048|P1|Overall Study|Various other reasons|3
1301608|NCT00230178|4237046|P3|Overall Study|Withdrawal by Subject|1
1301609|NCT00230178|4237047|P2|Overall Study|Withdrawal by Subject|0
1301610|NCT00230178|4237048|P1|Overall Study|Withdrawal by Subject|0
1301611|NCT00230178|4237046|P3|Overall Study|Adverse Event|2
1301612|NCT00230178|4237047|P2|Overall Study|Adverse Event|5
1301613|NCT00230178|4237048|P1|Overall Study|Adverse Event|1
1301614|NCT00230048|4237100|P2|Overall Study|Lost to Follow-up|18
1301615|NCT00230048|4237101|P1|Overall Study|Lost to Follow-up|13
1301616|NCT00229931|4237159|P2|Overall Study|Lost to Follow-up|2
1301617|NCT00229931|4237160|P1|Overall Study|Lost to Follow-up|3
1301618|NCT00229931|4237159|P2|Overall Study|Death|0
1301619|NCT00229931|4237160|P1|Overall Study|Death|1
1301620|NCT00229723|4237175|P7|Maintenance Phase|Other|1
1301621|NCT00229723|4237176|P6|Maintenance Phase|Other|3
1301622|NCT00229723|4237177|P5|Maintenance Phase|Other|3
1301623|NCT00229723|4237178|P4|Maintenance Phase|Other|2
1301624|NCT00229723|4237179|P3|Maintenance Phase|Other|1
1301625|NCT00229723|4237180|P2|Maintenance Phase|Other|4
1301626|NCT00229723|4237181|P1|Maintenance Phase|Other|5
1301627|NCT00229723|4237175|P7|Maintenance Phase|Severe non-compliance|0
1301628|NCT00229723|4237176|P6|Maintenance Phase|Severe non-compliance|0
1301629|NCT00229723|4237177|P5|Maintenance Phase|Severe non-compliance|1
1301630|NCT00229723|4237178|P4|Maintenance Phase|Severe non-compliance|0
1301631|NCT00229723|4237179|P3|Maintenance Phase|Severe non-compliance|0
1301632|NCT00229723|4237180|P2|Maintenance Phase|Severe non-compliance|1
1301633|NCT00229723|4237181|P1|Maintenance Phase|Severe non-compliance|3
1301634|NCT00229723|4237175|P7|Maintenance Phase|Informed consent withdrawn|0
1301635|NCT00229723|4237176|P6|Maintenance Phase|Informed consent withdrawn|1
1301636|NCT00229723|4237177|P5|Maintenance Phase|Informed consent withdrawn|1
1301637|NCT00229723|4237178|P4|Maintenance Phase|Informed consent withdrawn|1
1301638|NCT00229723|4237179|P3|Maintenance Phase|Informed consent withdrawn|0
1301639|NCT00229723|4237180|P2|Maintenance Phase|Informed consent withdrawn|0
1301640|NCT00229723|4237181|P1|Maintenance Phase|Informed consent withdrawn|1
1301641|NCT00229723|4237175|P7|Maintenance Phase|Lost to Follow-up|1
1301642|NCT00229723|4237176|P6|Maintenance Phase|Lost to Follow-up|0
1301643|NCT00229723|4237177|P5|Maintenance Phase|Lost to Follow-up|0
1301644|NCT00229723|4237178|P4|Maintenance Phase|Lost to Follow-up|2
1301645|NCT00229723|4237179|P3|Maintenance Phase|Lost to Follow-up|2
1301646|NCT00229723|4237180|P2|Maintenance Phase|Lost to Follow-up|1
1301647|NCT00229723|4237181|P1|Maintenance Phase|Lost to Follow-up|0
1301648|NCT00229723|4237175|P7|Maintenance Phase|Clinical progression|1
1301649|NCT00229723|4237176|P6|Maintenance Phase|Clinical progression|1
1301650|NCT00229723|4237177|P5|Maintenance Phase|Clinical progression|1
1301651|NCT00229723|4237178|P4|Maintenance Phase|Clinical progression|2
1301652|NCT00229723|4237179|P3|Maintenance Phase|Clinical progression|2
1301653|NCT00229723|4237180|P2|Maintenance Phase|Clinical progression|1
1301654|NCT00229723|4237181|P1|Maintenance Phase|Clinical progression|4
1301655|NCT00229723|4237175|P7|Maintenance Phase|Objective disease progression|5
1301656|NCT00229723|4237176|P6|Maintenance Phase|Objective disease progression|9
1301657|NCT00229723|4237177|P5|Maintenance Phase|Objective disease progression|2
1301658|NCT00229723|4237178|P4|Maintenance Phase|Objective disease progression|6
1301659|NCT00229723|4237179|P3|Maintenance Phase|Objective disease progression|3
1301660|NCT00229723|4237180|P2|Maintenance Phase|Objective disease progression|5
1301661|NCT00229723|4237181|P1|Maintenance Phase|Objective disease progression|5
1301662|NCT00229723|4237175|P7|Maintenance Phase|Adverse Event|2
1301663|NCT00229723|4237176|P6|Maintenance Phase|Adverse Event|5
1301664|NCT00229723|4237177|P5|Maintenance Phase|Adverse Event|7
1301665|NCT00229723|4237178|P4|Maintenance Phase|Adverse Event|4
1301666|NCT00229723|4237179|P3|Maintenance Phase|Adverse Event|1
1301667|NCT00229723|4237180|P2|Maintenance Phase|Adverse Event|2
1301668|NCT00229723|4237181|P1|Maintenance Phase|Adverse Event|7
1301669|NCT00229723|4237175|P7|Concomitant Phase|Other|0
1301670|NCT00229723|4237176|P6|Concomitant Phase|Other|2
1301671|NCT00229723|4237177|P5|Concomitant Phase|Other|0
1301672|NCT00229723|4237178|P4|Concomitant Phase|Other|1
1301673|NCT00229723|4237179|P3|Concomitant Phase|Other|1
1301674|NCT00229723|4237180|P2|Concomitant Phase|Other|0
1301675|NCT00229723|4237181|P1|Concomitant Phase|Other|3
1301676|NCT00229723|4237175|P7|Concomitant Phase|Severe non-compliance|0
1301677|NCT00229723|4237176|P6|Concomitant Phase|Severe non-compliance|0
1301678|NCT00229723|4237177|P5|Concomitant Phase|Severe non-compliance|1
1301679|NCT00229723|4237178|P4|Concomitant Phase|Severe non-compliance|0
1301680|NCT00229723|4237179|P3|Concomitant Phase|Severe non-compliance|0
1301681|NCT00229723|4237180|P2|Concomitant Phase|Severe non-compliance|1
1301682|NCT00229723|4237181|P1|Concomitant Phase|Severe non-compliance|0
1301683|NCT00229723|4237175|P7|Concomitant Phase|Informed consent withdrawn|0
1301684|NCT00229723|4237176|P6|Concomitant Phase|Informed consent withdrawn|0
1301685|NCT00229723|4237177|P5|Concomitant Phase|Informed consent withdrawn|0
1301686|NCT00229723|4237178|P4|Concomitant Phase|Informed consent withdrawn|2
1301687|NCT00229723|4237179|P3|Concomitant Phase|Informed consent withdrawn|0
1301688|NCT00229723|4237180|P2|Concomitant Phase|Informed consent withdrawn|2
1301689|NCT00229723|4237181|P1|Concomitant Phase|Informed consent withdrawn|3
1301690|NCT00229723|4237175|P7|Concomitant Phase|Lost to Follow-up|0
1301691|NCT00229723|4237176|P6|Concomitant Phase|Lost to Follow-up|0
1301692|NCT00229723|4237177|P5|Concomitant Phase|Lost to Follow-up|1
1301693|NCT00229723|4237178|P4|Concomitant Phase|Lost to Follow-up|0
1301694|NCT00229723|4237179|P3|Concomitant Phase|Lost to Follow-up|0
1301695|NCT00229723|4237180|P2|Concomitant Phase|Lost to Follow-up|0
1301696|NCT00229723|4237181|P1|Concomitant Phase|Lost to Follow-up|0
1301697|NCT00229723|4237175|P7|Concomitant Phase|Clinical progression|1
1301698|NCT00229723|4237176|P6|Concomitant Phase|Clinical progression|0
1301699|NCT00229723|4237177|P5|Concomitant Phase|Clinical progression|0
1301700|NCT00229723|4237178|P4|Concomitant Phase|Clinical progression|0
1301701|NCT00229723|4237179|P3|Concomitant Phase|Clinical progression|0
1301702|NCT00229723|4237180|P2|Concomitant Phase|Clinical progression|0
1301703|NCT00229723|4237181|P1|Concomitant Phase|Clinical progression|0
1301704|NCT00229723|4237175|P7|Concomitant Phase|Objective disease progression|0
1301705|NCT00229723|4237176|P6|Concomitant Phase|Objective disease progression|0
1301706|NCT00229723|4237177|P5|Concomitant Phase|Objective disease progression|0
1301707|NCT00229723|4237178|P4|Concomitant Phase|Objective disease progression|0
1301708|NCT00229723|4237179|P3|Concomitant Phase|Objective disease progression|0
1301709|NCT00229723|4237180|P2|Concomitant Phase|Objective disease progression|0
1301710|NCT00229723|4237181|P1|Concomitant Phase|Objective disease progression|0
1301711|NCT00229723|4237175|P7|Concomitant Phase|Adverse Event|2
1301712|NCT00229723|4237176|P6|Concomitant Phase|Adverse Event|1
1301713|NCT00229723|4237177|P5|Concomitant Phase|Adverse Event|0
1301714|NCT00229723|4237178|P4|Concomitant Phase|Adverse Event|2
1301715|NCT00229723|4237179|P3|Concomitant Phase|Adverse Event|5
1301716|NCT00229723|4237180|P2|Concomitant Phase|Adverse Event|2
1301717|NCT00229723|4237181|P1|Concomitant Phase|Adverse Event|4
1301718|NCT00229658|4237234|P2|Overall Study|Withdrawal of consent|39
1301719|NCT00229658|4237235|P1|Overall Study|Withdrawal of consent|46
1301720|NCT00229658|4237234|P2|Overall Study|Serious Adverse Event|2
1301721|NCT00229658|4237235|P1|Overall Study|Serious Adverse Event|2
1301722|NCT00229658|4237234|P2|Overall Study|Lost to Follow-up|55
1301723|NCT00229658|4237235|P1|Overall Study|Lost to Follow-up|82
1301724|NCT00229658|4237234|P2|Overall Study|Other|60
1301725|NCT00229658|4237235|P1|Overall Study|Other|80
1301726|NCT00229658|4237234|P2|Overall Study|Investigator decision|10
1301727|NCT00229658|4237235|P1|Overall Study|Investigator decision|13
1301728|NCT00229658|4237234|P2|Overall Study|Administrative|1
1301729|NCT00229658|4237235|P1|Overall Study|Administrative|2
1301730|NCT00229203|4237271|P2|Overall Study|Withdrawal by Subject|4
1301731|NCT00229203|4237272|P1|Overall Study|Withdrawal by Subject|1
1301732|NCT00229203|4237271|P2|Overall Study|Other|3
1301733|NCT00229203|4237272|P1|Overall Study|Other|3
1301734|NCT00229203|4237271|P2|Overall Study|Death|2
1301735|NCT00229203|4237272|P1|Overall Study|Death|4
1301736|NCT00229203|4237271|P2|Overall Study|Toxicity|1
1301737|NCT00229203|4237272|P1|Overall Study|Toxicity|6
1301738|NCT00229203|4237271|P2|Overall Study|Progressive disease|9
1301739|NCT00229203|4237272|P1|Overall Study|Progressive disease|18
1301740|NCT00228917|4237296|P4|Overall Study|Migrated/moved from study area|0
1301741|NCT00228917|4237297|P3|Overall Study|Migrated/moved from study area|0
1301742|NCT00228917|4237298|P2|Overall Study|Migrated/moved from study area|3
1301743|NCT00228917|4237299|P1|Overall Study|Migrated/moved from study area|0
1301744|NCT00228917|4237296|P4|Overall Study|Lost to Follow-up|0
1301745|NCT00228917|4237297|P3|Overall Study|Lost to Follow-up|0
1301746|NCT00228917|4237298|P2|Overall Study|Lost to Follow-up|0
1301747|NCT00228917|4237299|P1|Overall Study|Lost to Follow-up|1
1301748|NCT00228813|4237325|P1|Overall Study|Death|4
1301749|NCT00228566|4237331|P1|Overall Study|Miscellaneous|1
1301750|NCT00228566|4237331|P1|Overall Study|Withdrawal by Subject|4
1301751|NCT00228566|4237331|P1|Overall Study|Physician Decision|5
1301752|NCT00228566|4237331|P1|Overall Study|Lost to Follow-up|16
1301753|NCT00228566|4237331|P1|Overall Study|Lack of Efficacy|14
1301754|NCT00228566|4237331|P1|Overall Study|Adverse Event|31
1301755|NCT00228553|4237335|P1|Overall Study|Miscellaneous|46
1301756|NCT00228553|4237335|P1|Overall Study|Pregnancy|2
1301757|NCT00228553|4237335|P1|Overall Study|Withdrawal by Subject|115
1301758|NCT00228553|4237335|P1|Overall Study|Protocol Violation|6
1301759|NCT00228553|4237335|P1|Overall Study|Physician Decision|48
1301760|NCT00228553|4237335|P1|Overall Study|Lost to Follow-up|67
1301761|NCT00228553|4237335|P1|Overall Study|Lack of Efficacy|34
1301762|NCT00228553|4237335|P1|Overall Study|Adverse Event|112
1301763|NCT00228384|4237341|P2|Overall Study|Physician Decision|1
1301764|NCT00228384|4237342|P1|Overall Study|Physician Decision|0
1301765|NCT00228384|4237341|P2|Overall Study|Withdrawal by Subject|10
1301766|NCT00228384|4237342|P1|Overall Study|Withdrawal by Subject|9
1301767|NCT00228384|4237341|P2|Overall Study|Surgical Intervention (bypass)|5
1301768|NCT00228384|4237342|P1|Overall Study|Surgical Intervention (bypass)|5
1301769|NCT00228384|4237341|P2|Overall Study|Lost to Follow-up|10
1301770|NCT00228384|4237342|P1|Overall Study|Lost to Follow-up|6
1301771|NCT00228384|4237341|P2|Overall Study|Death|3
1301772|NCT00228384|4237342|P1|Overall Study|Death|9
1301773|NCT00227903|4237393|P2|Overall Study|Miscarriage|0
1301774|NCT00227903|4237394|P1|Overall Study|Miscarriage|1
1301775|NCT00227903|4237393|P2|Overall Study|Lost to Follow-up|3
1301776|NCT00227903|4237394|P1|Overall Study|Lost to Follow-up|1
1301777|NCT00227903|4237393|P2|Overall Study|Subject moved out of area|2
1301778|NCT00227903|4237394|P1|Overall Study|Subject moved out of area|1
1301779|NCT00227903|4237393|P2|Overall Study|Withdrawal by Subject|5
1301780|NCT00227903|4237394|P1|Overall Study|Withdrawal by Subject|2
1301781|NCT00227877|4237458|P4|12-months Follow-up|Lost to Follow-up|26
1301782|NCT00227877|4237459|P3|12-months Follow-up|Lost to Follow-up|30
1301783|NCT00227877|4237460|P2|12-months Follow-up|Lost to Follow-up|189
1301784|NCT00227877|4237461|P1|12-months Follow-up|Lost to Follow-up|232
1301785|NCT00227877|4237458|P4|12-months Follow-up|Completed late|0
1301786|NCT00227877|4237459|P3|12-months Follow-up|Completed late|1
1301787|NCT00227877|4237460|P2|12-months Follow-up|Completed late|74
1301788|NCT00227877|4237461|P1|12-months Follow-up|Completed late|78
1301789|NCT00227877|4237458|P4|3-months Follow-up|Lost to Follow-up|13
1301790|NCT00227877|4237459|P3|3-months Follow-up|Lost to Follow-up|18
1301791|NCT00227877|4237460|P2|3-months Follow-up|Lost to Follow-up|139
1301792|NCT00227877|4237461|P1|3-months Follow-up|Lost to Follow-up|178
1301793|NCT00227877|4237458|P4|3-months Follow-up|Completed late|8
1301794|NCT00227877|4237459|P3|3-months Follow-up|Completed late|34
1301795|NCT00227877|4237460|P2|3-months Follow-up|Completed late|128
1301796|NCT00227877|4237461|P1|3-months Follow-up|Completed late|135
1301797|NCT00227877|4237458|P4|Post-visit Checklist|Lost to Follow-up|0
1301798|NCT00227877|4237459|P3|Post-visit Checklist|Lost to Follow-up|1
1301799|NCT00227877|4237460|P2|Post-visit Checklist|Lost to Follow-up|13
1301800|NCT00227877|4237461|P1|Post-visit Checklist|Lost to Follow-up|24
1301801|NCT00227877|4237458|P4|Pre-visit Assessment|Technical difficulties|0
1301802|NCT00227877|4237459|P3|Pre-visit Assessment|Technical difficulties|0
1301803|NCT00227877|4237460|P2|Pre-visit Assessment|Technical difficulties|3
1301804|NCT00227877|4237461|P1|Pre-visit Assessment|Technical difficulties|7
1301805|NCT00227721|4237497|P1|Overall Study|On study, but never treated.|1
1301806|NCT00227591|4237501|P1|Overall Study|Withdrawal by Subject|1
1301807|NCT00227539|4237505|P1|Overall Study|Protocol Violation|1
1301808|NCT00227370|4237513|P2|Overall Study|Other reasons|1
1301809|NCT00227370|4237514|P1|Overall Study|Other reasons|2
1301810|NCT00227370|4237513|P2|Overall Study|Physician Decision|6
1301811|NCT00227370|4237514|P1|Overall Study|Physician Decision|9
1301812|NCT00227370|4237513|P2|Overall Study|Adverse Event|11
1301813|NCT00227370|4237514|P1|Overall Study|Adverse Event|6
1301814|NCT00227370|4237513|P2|Overall Study|Death|4
1301815|NCT00227370|4237514|P1|Overall Study|Death|3
1301816|NCT00227370|4237513|P2|Overall Study|Withdrawal by Subject|2
1301817|NCT00227370|4237514|P1|Overall Study|Withdrawal by Subject|1
1301818|NCT00227344|4237534|P2|Overall Study|study terminated early|5
1301819|NCT00227344|4237535|P1|Overall Study|study terminated early|12
1301820|NCT00227305|4237555|P1|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1
1301821|NCT00227305|4237555|P1|Overall Study|LEAVING TOWN FOR 6 WEEKS|1
1301822|NCT00227305|4237555|P1|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1
1301823|NCT00227305|4237555|P1|Overall Study|Physician Decision|3
1301824|NCT00227305|4237555|P1|Overall Study|Lack of Efficacy|7
1301825|NCT00227305|4237555|P1|Overall Study|MOVED OUT OF AREA|3
1301826|NCT00227305|4237555|P1|Overall Study|Study specific discontinuation|13
1301827|NCT00227305|4237555|P1|Overall Study|Lost to Follow-up|33
1301828|NCT00227305|4237555|P1|Overall Study|Withdrawal by Subject|42
1301829|NCT00227305|4237555|P1|Overall Study|Adverse Event|40
1301830|NCT00227266|4237572|P3|Overall Study|Excessive weight gain|2
1301831|NCT00227266|4237573|P2|Overall Study|Excessive weight gain|0
1301832|NCT00227266|4237574|P1|Overall Study|Excessive weight gain|0
1301833|NCT00227266|4237572|P3|Overall Study|Protocol Violation|1
1301834|NCT00227266|4237573|P2|Overall Study|Protocol Violation|0
1301835|NCT00227266|4237574|P1|Overall Study|Protocol Violation|1
1301836|NCT00227266|4237572|P3|Overall Study|Withdrawal by Subject|1
1301837|NCT00227266|4237573|P2|Overall Study|Withdrawal by Subject|0
1301838|NCT00227266|4237574|P1|Overall Study|Withdrawal by Subject|0
1301839|NCT00226941|4237604|P4|Overall Study|Withdrawn by investigator - unrelated AE|1
1301840|NCT00226941|4237605|P3|Overall Study|Withdrawn by investigator - unrelated AE|0
1301841|NCT00226941|4237606|P2|Overall Study|Withdrawn by investigator - unrelated AE|0
1301842|NCT00226941|4237607|P1|Overall Study|Withdrawn by investigator - unrelated AE|0
1301843|NCT00226941|4237604|P4|Overall Study|Withdrawal by subject - toxicity|1
1301844|NCT00226941|4237605|P3|Overall Study|Withdrawal by subject - toxicity|0
1301845|NCT00226941|4237606|P2|Overall Study|Withdrawal by subject - toxicity|0
1301846|NCT00226941|4237607|P1|Overall Study|Withdrawal by subject - toxicity|0
1301847|NCT00226811|4237641|P1|Overall Study|Withdrawal by Subject|2
1301848|NCT00226811|4237641|P1|Overall Study|Lack of Efficacy|55
1301849|NCT00226811|4237641|P1|Overall Study|Adverse Event|11
1301850|NCT00226811|4237641|P1|Overall Study|Death|8
1301851|NCT00226655|4237651|P1|Overall Study|Clinical deterioration|10
1301852|NCT00226655|4237651|P1|Overall Study|Physician Decision|6
1301853|NCT00226655|4237651|P1|Overall Study|Adverse Event|35
1301854|NCT00226655|4237651|P1|Overall Study|Withdrawal by Subject|15
1301855|NCT00226655|4237651|P1|Overall Study|Death|13
1301856|NCT00225758|4237690|P1|Overall Study|Adverse Event|4
1301857|NCT00225277|4237722|P2|Overall Study|Other|9
1301858|NCT00225277|4237723|P1|Overall Study|Other|7
1301859|NCT00225277|4237722|P2|Overall Study|Withdrawal by Subject|34
1301860|NCT00225277|4237723|P1|Overall Study|Withdrawal by Subject|40
1301861|NCT00225277|4237722|P2|Overall Study|Protocol Violation|3
1301862|NCT00225277|4237723|P1|Overall Study|Protocol Violation|6
1301863|NCT00225277|4237722|P2|Overall Study|Physician Decision|8
1301864|NCT00225277|4237723|P1|Overall Study|Physician Decision|6
1301865|NCT00225277|4237722|P2|Overall Study|Lost to Follow-up|6
1301866|NCT00225277|4237723|P1|Overall Study|Lost to Follow-up|4
1301867|NCT00225277|4237722|P2|Overall Study|Lack of Efficacy|1
1301868|NCT00225277|4237723|P1|Overall Study|Lack of Efficacy|4
1301869|NCT00225277|4237722|P2|Overall Study|Adverse Event|34
1301870|NCT00225277|4237723|P1|Overall Study|Adverse Event|30
1301871|NCT00225251|4237741|P2|Overall Study|Withdrawal by Subject|1
1301872|NCT00225251|4237742|P1|Overall Study|Withdrawal by Subject|1
1301873|NCT00225212|4237756|P1|Overall Study|Intercurrent illness|1
1301874|NCT00225212|4237756|P1|Overall Study|Adverse Event|2
1301875|NCT00225212|4237756|P1|Overall Study|Death|1
1301876|NCT00225212|4237756|P1|Overall Study|Disease progression|2
1301877|NCT00225147|4237765|P4|Open-label Phase|Withdrawal by Subject|6
1301878|NCT00225147|4237766|P3|Open-label Phase|Withdrawal by Subject|0
1301879|NCT00225147|4237767|P2|Open-label Phase|Withdrawal by Subject|0
1301880|NCT00225147|4237768|P1|Open-label Phase|Withdrawal by Subject|0
1301881|NCT00225147|4237765|P4|Open-label Phase|Lost to Follow-up|4
1301882|NCT00225147|4237766|P3|Open-label Phase|Lost to Follow-up|0
1301883|NCT00225147|4237767|P2|Open-label Phase|Lost to Follow-up|0
1301884|NCT00225147|4237768|P1|Open-label Phase|Lost to Follow-up|0
1301885|NCT00224874|4237815|P4|Overall Study|Withdrawal by Subject|0
1301886|NCT00224874|4237816|P3|Overall Study|Withdrawal by Subject|1
1301887|NCT00224874|4237817|P2|Overall Study|Withdrawal by Subject|0
1301888|NCT00224874|4237818|P1|Overall Study|Withdrawal by Subject|0
1301889|NCT00224770|4237863|P3|Overall Study|Lost to Follow-up|0
1301890|NCT00224770|4237864|P2|Overall Study|Lost to Follow-up|2
1301891|NCT00224770|4237865|P1|Overall Study|Lost to Follow-up|4
1301892|NCT00224484|4237900|P3|Overall Study|Reaon not specified|2
1301893|NCT00224484|4237901|P2|Overall Study|Reaon not specified|4
1301894|NCT00224484|4237902|P1|Overall Study|Reaon not specified|5
1301895|NCT00224484|4237900|P3|Overall Study|Lost to Follow-up|36
1301896|NCT00224484|4237901|P2|Overall Study|Lost to Follow-up|28
1301897|NCT00224484|4237902|P1|Overall Study|Lost to Follow-up|66
1301898|NCT00224484|4237900|P3|Overall Study|Migrated/moved from study area|5
1301899|NCT00224484|4237901|P2|Overall Study|Migrated/moved from study area|5
1301900|NCT00224484|4237902|P1|Overall Study|Migrated/moved from study area|18
1301901|NCT00224484|4237900|P3|Overall Study|Withdrawal by Subject|16
1301902|NCT00224484|4237901|P2|Overall Study|Withdrawal by Subject|18
1301903|NCT00224484|4237902|P1|Overall Study|Withdrawal by Subject|49
1301904|NCT00224484|4237900|P3|Overall Study|Protocol Violation|0
1301905|NCT00224484|4237901|P2|Overall Study|Protocol Violation|2
1301906|NCT00224484|4237902|P1|Overall Study|Protocol Violation|2
1301907|NCT00224484|4237900|P3|Overall Study|Non-Serious Adverse Event|3
1301908|NCT00224484|4237901|P2|Overall Study|Non-Serious Adverse Event|7
1301909|NCT00224484|4237902|P1|Overall Study|Non-Serious Adverse Event|5
1301910|NCT00224484|4237900|P3|Overall Study|Serious Adverse Event|0
1301911|NCT00224484|4237901|P2|Overall Study|Serious Adverse Event|1
1301912|NCT00224484|4237902|P1|Overall Study|Serious Adverse Event|1
1301913|NCT00224133|4237966|P1|Overall Study|Not specified|14
1301914|NCT00224133|4237966|P1|Overall Study|Physician Decision|1
1301915|NCT00224133|4237966|P1|Overall Study|Lost to Follow-up|21
1301916|NCT00224133|4237966|P1|Overall Study|Lack of Efficacy|58
1301917|NCT00224133|4237966|P1|Overall Study|Withdrawal by Subject|33
1301918|NCT00224133|4237966|P1|Overall Study|Protocol Violation|6
1301919|NCT00224133|4237966|P1|Overall Study|Adverse Event|93
1301920|NCT00224120|4237972|P2|Overall Study|Not specified|5
1301921|NCT00224120|4237973|P1|Overall Study|Not specified|4
1301922|NCT00224120|4237972|P2|Overall Study|Lost to Follow-up|3
1301923|NCT00224120|4237973|P1|Overall Study|Lost to Follow-up|2
1301924|NCT00224120|4237972|P2|Overall Study|Lack of Efficacy|2
1301925|NCT00224120|4237973|P1|Overall Study|Lack of Efficacy|0
1301926|NCT00224120|4237972|P2|Overall Study|Withdrawal by Subject|10
1301927|NCT00224120|4237973|P1|Overall Study|Withdrawal by Subject|5
1301928|NCT00224120|4237972|P2|Overall Study|Protocol Violation|0
1301929|NCT00224120|4237973|P1|Overall Study|Protocol Violation|1
1301930|NCT00224120|4237972|P2|Overall Study|Adverse Event|4
1301931|NCT00224120|4237973|P1|Overall Study|Adverse Event|10
1301932|NCT00224107|4237983|P2|Overall Study|Not specified|1
1301933|NCT00224107|4237984|P1|Overall Study|Not specified|1
1301934|NCT00224107|4237983|P2|Overall Study|Physician Decision|0
1301935|NCT00224107|4237984|P1|Overall Study|Physician Decision|1
1301936|NCT00224107|4237983|P2|Overall Study|Lost to Follow-up|0
1301937|NCT00224107|4237984|P1|Overall Study|Lost to Follow-up|4
1301938|NCT00224107|4237983|P2|Overall Study|Lack of Efficacy|0
1301939|NCT00224107|4237984|P1|Overall Study|Lack of Efficacy|2
1301940|NCT00224107|4237983|P2|Overall Study|Withdrawal by Subject|4
1301941|NCT00224107|4237984|P1|Overall Study|Withdrawal by Subject|1
1301942|NCT00224107|4237983|P2|Overall Study|Protocol Violation|3
1301943|NCT00224107|4237984|P1|Overall Study|Protocol Violation|2
1301944|NCT00224107|4237983|P2|Overall Study|Adverse Event|6
1301945|NCT00224107|4237984|P1|Overall Study|Adverse Event|20
1301946|NCT00224055|4237994|P2|Overall Study|Not Specified|0
1301947|NCT00224055|4237995|P1|Overall Study|Not Specified|1
1301948|NCT00224055|4237994|P2|Overall Study|Withdrawal by Subject|2
1301949|NCT00224055|4237995|P1|Overall Study|Withdrawal by Subject|0
1301950|NCT00224055|4237994|P2|Overall Study|Inclusion Violation|6
1301951|NCT00224055|4237995|P1|Overall Study|Inclusion Violation|3
1301952|NCT00224055|4237994|P2|Overall Study|Protocol Violation|1
1301953|NCT00224055|4237995|P1|Overall Study|Protocol Violation|1
1301954|NCT00224055|4237994|P2|Overall Study|Lost to Follow-up|2
1301955|NCT00224055|4237995|P1|Overall Study|Lost to Follow-up|1
1301956|NCT00224055|4237994|P2|Overall Study|Adverse Event|3
1301957|NCT00224055|4237995|P1|Overall Study|Adverse Event|9
1301958|NCT00224042|4238005|P2|Overall Study|Not specified|0
1301959|NCT00224042|4238006|P1|Overall Study|Not specified|2
1301960|NCT00224042|4238005|P2|Overall Study|Did not meet lab incusion criteria|3
1301961|NCT00224042|4238006|P1|Overall Study|Did not meet lab incusion criteria|2
1301962|NCT00224042|4238005|P2|Overall Study|Physician Decision|1
1301963|NCT00224042|4238006|P1|Overall Study|Physician Decision|0
1301964|NCT00224042|4238005|P2|Overall Study|Protocol Violation|1
1301965|NCT00224042|4238006|P1|Overall Study|Protocol Violation|0
1301966|NCT00224042|4238005|P2|Overall Study|Adverse Event|1
1301967|NCT00224042|4238006|P1|Overall Study|Adverse Event|2
1301968|NCT00224029|4238018|P1|Overall Study|Other|1
1301969|NCT00224029|4238018|P1|Overall Study|Withdrawal by Subject|4
1301970|NCT00224029|4238018|P1|Overall Study|Lost to Follow-up|1
1301971|NCT00224016|4238024|P2|Maintenance Period|Lost to Follow-up|1
1301972|NCT00224016|4238025|P1|Maintenance Period|Lost to Follow-up|0
1301973|NCT00224016|4238024|P2|Maintenance Period|Withdrawal by Subject|0
1301974|NCT00224016|4238025|P1|Maintenance Period|Withdrawal by Subject|2
1301975|NCT00224016|4238024|P2|Titration Period|Lost to Follow-up|0
1301976|NCT00224016|4238025|P1|Titration Period|Lost to Follow-up|1
1301977|NCT00224016|4238024|P2|Titration Period|Withdrawal by Subject|1
1301978|NCT00224016|4238025|P1|Titration Period|Withdrawal by Subject|0
1301979|NCT00224003|4238033|P1|Overall Study|unk|3
1301980|NCT00224003|4238033|P1|Overall Study|Withdrawal by Subject|1
1301981|NCT00224003|4238033|P1|Overall Study|Protocol Violation|2
1301982|NCT00224003|4238033|P1|Overall Study|Adverse Event|1
1301983|NCT00223977|4238040|P3|Overall Study|not specified|0
1301984|NCT00223977|4238041|P2|Overall Study|not specified|0
1301985|NCT00223977|4238042|P1|Overall Study|not specified|1
1301986|NCT00223977|4238040|P3|Overall Study|Withdrawal by Subject|2
1301987|NCT00223977|4238041|P2|Overall Study|Withdrawal by Subject|1
1301988|NCT00223977|4238042|P1|Overall Study|Withdrawal by Subject|1
1301989|NCT00223977|4238040|P3|Overall Study|Protocol Violation|1
1301990|NCT00223977|4238041|P2|Overall Study|Protocol Violation|0
1301991|NCT00223977|4238042|P1|Overall Study|Protocol Violation|0
1301992|NCT00223977|4238040|P3|Overall Study|Adverse Event|0
1301993|NCT00223977|4238041|P2|Overall Study|Adverse Event|10
1301994|NCT00223977|4238042|P1|Overall Study|Adverse Event|7
1301995|NCT00223808|4238076|P3|Overall Study|<5 hrs therapy before discharge|5
1301996|NCT00223808|4238077|P2|Overall Study|<5 hrs therapy before discharge|5
1301997|NCT00223808|4238078|P1|Overall Study|<5 hrs therapy before discharge|3
1301998|NCT00223795|4238095|P2|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
1301999|NCT00223795|4238096|P1|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
1302000|NCT00223795|4238095|P2|First Intervention - Eight Weeks|Lost to Follow-up|9
1302001|NCT00223795|4238096|P1|First Intervention - Eight Weeks|Lost to Follow-up|7
1302002|NCT00223496|4238174|P1|Overall Study|Physician Decision|2
1302003|NCT00223496|4238174|P1|Overall Study|Withdrawal by Subject|1
1302004|NCT00223496|4238174|P1|Overall Study|Lack of Efficacy|6
1302005|NCT00223496|4238174|P1|Overall Study|Lost to Follow-up|4
1302006|NCT00223496|4238174|P1|Overall Study|screen failure|9
1302007|NCT00223080|4238195|P2|Overall Study|Adverse Event|1
1302008|NCT00223080|4238196|P1|Overall Study|Adverse Event|0
1302009|NCT00223080|4238195|P2|Overall Study|Reason not provided|140
1302010|NCT00223080|4238196|P1|Overall Study|Reason not provided|141
1302011|NCT00223080|4238195|P2|Overall Study|Other|11
1302012|NCT00223080|4238196|P1|Overall Study|Other|14
1302013|NCT00223080|4238195|P2|Overall Study|Death|74
1302014|NCT00223080|4238196|P1|Overall Study|Death|85
1302015|NCT00223080|4238195|P2|Overall Study|Lost to Follow-up|284
1302016|NCT00223080|4238196|P1|Overall Study|Lost to Follow-up|259
1302017|NCT00223080|4238195|P2|Overall Study|Moved from study area|47
1302018|NCT00223080|4238196|P1|Overall Study|Moved from study area|37
1302019|NCT00223080|4238195|P2|Overall Study|Non-compliant|7
1302020|NCT00223080|4238196|P1|Overall Study|Non-compliant|7
1302021|NCT00223080|4238195|P2|Overall Study|Required contraindicated med|1
1302022|NCT00223080|4238196|P1|Overall Study|Required contraindicated med|0
1302023|NCT00223080|4238195|P2|Overall Study|Withdrawal by Subject|232
1302024|NCT00223080|4238196|P1|Overall Study|Withdrawal by Subject|253
1302025|NCT00222729|4238214|P1|Overall Study|Adverse Event|3
1302026|NCT00222105|4238221|P1|Overall Study|Death|2
1302027|NCT00222105|4238221|P1|Overall Study|Treatment delays|2
1302028|NCT00222105|4238221|P1|Overall Study|Adverse Event|8
1302029|NCT00222105|4238221|P1|Overall Study|Withdrawal by Subject|1
1302030|NCT00222105|4238221|P1|Overall Study|Removed due to wrong diagnosis|1
1302031|NCT00221195|4238242|P2|Overall Study|Lost to Follow-up|1
1302032|NCT00221195|4238243|P1|Overall Study|Lost to Follow-up|0
1302033|NCT00221195|4238242|P2|Overall Study|Death|1
1302034|NCT00221195|4238243|P1|Overall Study|Death|1
1302035|NCT00221195|4238242|P2|Overall Study|Withdrawal by Subject|1
1302036|NCT00221195|4238243|P1|Overall Study|Withdrawal by Subject|4
1302037|NCT00221104|4238265|P2|Overall Study|Others|47
1302038|NCT00221104|4238266|P1|Overall Study|Others|37
1302039|NCT00221104|4238265|P2|Overall Study|Withdrawal by Subject|29
1302040|NCT00221104|4238266|P1|Overall Study|Withdrawal by Subject|42
1302041|NCT00221104|4238265|P2|Overall Study|Protocol Violation|0
1302042|NCT00221104|4238266|P1|Overall Study|Protocol Violation|2
1302043|NCT00221104|4238265|P2|Overall Study|Physician Decision|0
1302044|NCT00221104|4238266|P1|Overall Study|Physician Decision|1
1302045|NCT00221104|4238265|P2|Overall Study|Adverse Event|0
1302046|NCT00221104|4238266|P1|Overall Study|Adverse Event|1
1302047|NCT00220805|4238299|P2|Overall Study|Develop. of choroidal neovascularization|8
1302048|NCT00220805|4238300|P1|Overall Study|Develop. of choroidal neovascularization|3
1302049|NCT00220805|4238299|P2|Overall Study|Lack of Efficacy|0
1302050|NCT00220805|4238300|P1|Overall Study|Lack of Efficacy|1
1302051|NCT00220805|4238299|P2|Overall Study|Withdrawal by Subject|0
1302052|NCT00220805|4238300|P1|Overall Study|Withdrawal by Subject|3
1302053|NCT00220805|4238299|P2|Overall Study|Adverse Event|3
1302054|NCT00220805|4238300|P1|Overall Study|Adverse Event|1
1302055|NCT00220779|4238321|P3|Overall Study|Lack of Efficacy|1
1302056|NCT00220779|4238322|P2|Overall Study|Lack of Efficacy|0
1302057|NCT00220779|4238323|P1|Overall Study|Lack of Efficacy|3
1302058|NCT00220779|4238321|P3|Overall Study|Pregnancy|2
1302059|NCT00220779|4238322|P2|Overall Study|Pregnancy|0
1302060|NCT00220779|4238323|P1|Overall Study|Pregnancy|0
1302061|NCT00220779|4238321|P3|Overall Study|Too time consuming|0
1302062|NCT00220779|4238322|P2|Overall Study|Too time consuming|0
1302063|NCT00220779|4238323|P1|Overall Study|Too time consuming|1
1302064|NCT00220779|4238321|P3|Overall Study|Non-compliance|0
1302065|NCT00220779|4238322|P2|Overall Study|Non-compliance|0
1302066|NCT00220779|4238323|P1|Overall Study|Non-compliance|1
1302067|NCT00220779|4238321|P3|Overall Study|Withdrawal by Subject|1
1302068|NCT00220779|4238322|P2|Overall Study|Withdrawal by Subject|4
1302069|NCT00220779|4238323|P1|Overall Study|Withdrawal by Subject|1
1302070|NCT00220779|4238321|P3|Overall Study|Adverse Event|0
1302071|NCT00220779|4238322|P2|Overall Study|Adverse Event|0
1302072|NCT00220779|4238323|P1|Overall Study|Adverse Event|1
1302073|NCT00220740|4238333|P2|Efficacy Period|Entered Rescue Treatment with IGIV-C|45
1302074|NCT00220740|4238334|P1|Efficacy Period|Entered Rescue Treatment with IGIV-C|0
1302075|NCT00220740|4238333|P2|Efficacy Period|Protocol Violation|0
1302076|NCT00220740|4238334|P1|Efficacy Period|Protocol Violation|1
1302077|NCT00220740|4238333|P2|Efficacy Period|Withdrawal by Subject|0
1302078|NCT00220740|4238334|P1|Efficacy Period|Withdrawal by Subject|1
1302079|NCT00220740|4238333|P2|Efficacy Period|Adverse Event|1
1302080|NCT00220740|4238334|P1|Efficacy Period|Adverse Event|1
1302081|NCT00220740|4238333|P2|Efficacy Period|Entered rescue treatment with placebo|0
1302082|NCT00220740|4238334|P1|Efficacy Period|Entered rescue treatment with placebo|23
1302083|NCT00220727|4238348|P2|Second Infusion (Week <6)|Pt did not meet study requirement|0
1302084|NCT00220727|4238349|P1|Second Infusion (Week <6)|Pt did not meet study requirement|1
1302085|NCT00220701|4238365|P2|Overall Study|Lost to Follow-up|4
1302086|NCT00220701|4238366|P1|Overall Study|Lost to Follow-up|5
1302087|NCT00220636|4238382|P1|Overall Study|Withdrawal by Subject|4
1302088|NCT00219557|4238392|P3|Phase 2|Treatment not received|3
1302089|NCT00219557|4238393|P2|Phase 2|Treatment not received|1
1302090|NCT00219557|4238394|P1|Phase 2|Treatment not received|0
1302091|NCT00219557|4238392|P3|Phase 2|Withdrawal by Subject|5
1302092|NCT00219557|4238393|P2|Phase 2|Withdrawal by Subject|9
1302093|NCT00219557|4238394|P1|Phase 2|Withdrawal by Subject|0
1302094|NCT00219557|4238392|P3|Phase 2|Other|6
1302095|NCT00219557|4238393|P2|Phase 2|Other|8
1302096|NCT00219557|4238394|P1|Phase 2|Other|0
1302097|NCT00219557|4238392|P3|Phase 2|Death|2
1302098|NCT00219557|4238393|P2|Phase 2|Death|8
1302099|NCT00219557|4238394|P1|Phase 2|Death|0
1302100|NCT00219557|4238392|P3|Phase 2|Adverse Event|2
1302101|NCT00219557|4238393|P2|Phase 2|Adverse Event|22
1302102|NCT00219557|4238394|P1|Phase 2|Adverse Event|0
1302103|NCT00219557|4238392|P3|Phase 2|Lack of Efficacy|15
1302104|NCT00219557|4238393|P2|Phase 2|Lack of Efficacy|21
1302105|NCT00219557|4238394|P1|Phase 2|Lack of Efficacy|0
1302106|NCT00219557|4238392|P3|Phase 1|Started chemotherapy at other institute|0
1302107|NCT00219557|4238393|P2|Phase 1|Started chemotherapy at other institute|0
1302108|NCT00219557|4238394|P1|Phase 1|Started chemotherapy at other institute|1
1302109|NCT00219557|4238392|P3|Phase 1|Withdrawal by Subject|0
1302110|NCT00219557|4238393|P2|Phase 1|Withdrawal by Subject|0
1302111|NCT00219557|4238394|P1|Phase 1|Withdrawal by Subject|1
1302112|NCT00219557|4238392|P3|Phase 1|Adverse Event|0
1302113|NCT00219557|4238393|P2|Phase 1|Adverse Event|0
1302114|NCT00219557|4238394|P1|Phase 1|Adverse Event|2
1302115|NCT00219557|4238392|P3|Phase 1|Lack of Efficacy|0
1302116|NCT00219557|4238393|P2|Phase 1|Lack of Efficacy|0
1302117|NCT00219557|4238394|P1|Phase 1|Lack of Efficacy|3
1302118|NCT00219544|4238422|P2|Single Blind Treatment Period|Withdrawal by Subject|0
1302119|NCT00219544|4238423|P1|Single Blind Treatment Period|Withdrawal by Subject|1
1302120|NCT00219544|4238422|P2|Single Blind Treatment Period|Investigator decision to withdraw|0
1302121|NCT00219544|4238423|P1|Single Blind Treatment Period|Investigator decision to withdraw|1
1302122|NCT00219544|4238422|P2|Single Blind Treatment Period|Lost to Follow-up|0
1302123|NCT00219544|4238423|P1|Single Blind Treatment Period|Lost to Follow-up|2
1302124|NCT00219544|4238422|P2|Single Blind Treatment Period|Protocol Violation|0
1302125|NCT00219544|4238423|P1|Single Blind Treatment Period|Protocol Violation|4
1302126|NCT00219544|4238422|P2|Single Blind Treatment Period|Adverse Event|0
1302127|NCT00219544|4238423|P1|Single Blind Treatment Period|Adverse Event|9
1302128|NCT00219544|4238422|P2|Single Blind Treatment Period|Lack of Efficacy|0
1302129|NCT00219544|4238423|P1|Single Blind Treatment Period|Lack of Efficacy|5
1302130|NCT00219349|4238461|P1|Escitalopram Phase|Withdrawal by Subject|3
1302131|NCT00219349|4238461|P1|Cognitive Behavioral Therapy Phase|Protocol Violation|2
1302132|NCT00219349|4238461|P1|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2
1302133|NCT00219349|4238461|P1|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6
1302134|NCT00219284|4238474|P2|Extension Phase - 8 Weeks|Lost to Follow-up|2
1302135|NCT00219284|4238475|P1|Extension Phase - 8 Weeks|Lost to Follow-up|0
1302136|NCT00219284|4238474|P2|Extension Phase - 8 Weeks|Withdrawal by Subject|2
1302137|NCT00219284|4238475|P1|Extension Phase - 8 Weeks|Withdrawal by Subject|0
1302138|NCT00219284|4238474|P2|Extension Phase - 8 Weeks|Adverse Event|3
1302139|NCT00219284|4238475|P1|Extension Phase - 8 Weeks|Adverse Event|2
1302140|NCT00219284|4238474|P2|Treatment Phase - 16 Weeks|Lost to Follow-up|2
1302141|NCT00219284|4238475|P1|Treatment Phase - 16 Weeks|Lost to Follow-up|1
1302142|NCT00219284|4238474|P2|Treatment Phase - 16 Weeks|Withdrawal by Subject|9
1302143|NCT00219284|4238475|P1|Treatment Phase - 16 Weeks|Withdrawal by Subject|5
1302144|NCT00219284|4238474|P2|Treatment Phase - 16 Weeks|Protocol Violation|5
1302145|NCT00219284|4238475|P1|Treatment Phase - 16 Weeks|Protocol Violation|9
1302146|NCT00219284|4238474|P2|Treatment Phase - 16 Weeks|Lack of Efficacy|10
1302147|NCT00219284|4238475|P1|Treatment Phase - 16 Weeks|Lack of Efficacy|3
1302148|NCT00219284|4238474|P2|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1
1302149|NCT00219284|4238475|P1|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0
1302150|NCT00219284|4238474|P2|Treatment Phase - 16 Weeks|Adverse Event|24
1302151|NCT00219284|4238475|P1|Treatment Phase - 16 Weeks|Adverse Event|26
1302152|NCT00219141|4238500|P3|Overall Study|Condition no longer requires study drug|0
1302153|NCT00219141|4238501|P2|Overall Study|Condition no longer requires study drug|0
1302154|NCT00219141|4238502|P1|Overall Study|Condition no longer requires study drug|1
1302155|NCT00219141|4238500|P3|Overall Study|Withdrawal by Subject|5
1302156|NCT00219141|4238501|P2|Overall Study|Withdrawal by Subject|3
1302157|NCT00219141|4238502|P1|Overall Study|Withdrawal by Subject|1
1302158|NCT00219141|4238500|P3|Overall Study|Protocol Violation|1
1302159|NCT00219141|4238501|P2|Overall Study|Protocol Violation|1
1302160|NCT00219141|4238502|P1|Overall Study|Protocol Violation|3
1302161|NCT00219141|4238500|P3|Overall Study|Lost to Follow-up|1
1302162|NCT00219141|4238501|P2|Overall Study|Lost to Follow-up|4
1302163|NCT00219141|4238502|P1|Overall Study|Lost to Follow-up|2
1302164|NCT00219141|4238500|P3|Overall Study|Administrative problems|0
1302165|NCT00219141|4238501|P2|Overall Study|Administrative problems|1
1302166|NCT00219141|4238502|P1|Overall Study|Administrative problems|0
1302167|NCT00219141|4238500|P3|Overall Study|Lack of Efficacy|0
1302168|NCT00219141|4238501|P2|Overall Study|Lack of Efficacy|2
1302169|NCT00219141|4238502|P1|Overall Study|Lack of Efficacy|3
1302170|NCT00219141|4238500|P3|Overall Study|Adverse Event|5
1302171|NCT00219141|4238501|P2|Overall Study|Adverse Event|10
1302172|NCT00219141|4238502|P1|Overall Study|Adverse Event|4
1302173|NCT00218634|4238548|P2|Overall Study|Lost to Follow-up|15
1302174|NCT00218634|4238549|P1|Overall Study|Lost to Follow-up|8
1302175|NCT00218543|4238569|P1|Overall Study|Adverse Event|2
1302176|NCT00218543|4238569|P1|Overall Study|Physician Decision|3
1302177|NCT00218543|4238569|P1|Overall Study|Withdrawal by Subject|1
1302178|NCT00218543|4238569|P1|Overall Study|relocated|1
1302179|NCT00218543|4238569|P1|Overall Study|Lost to Follow-up|8
1302180|NCT00218296|4238675|P2|Overall Study|Randomized but did not enter treatment|67
1302181|NCT00218296|4238676|P1|Overall Study|Randomized but did not enter treatment|66
1302182|NCT00218296|4238675|P2|Overall Study|Withdrawal by Subject|47
1302183|NCT00218296|4238676|P1|Overall Study|Withdrawal by Subject|36
1302184|NCT00218296|4238675|P2|Overall Study|Lost to Follow-up|7
1302185|NCT00218296|4238676|P1|Overall Study|Lost to Follow-up|9
1302186|NCT00217971|4238779|P2|Overall Study|non compliant|0
1302187|NCT00217971|4238780|P1|Overall Study|non compliant|1
1302188|NCT00217971|4238779|P2|Overall Study|Withdrawal by Subject|12
1302189|NCT00217971|4238780|P1|Overall Study|Withdrawal by Subject|7
1302190|NCT00217971|4238779|P2|Overall Study|Physician Decision|1
1302191|NCT00217971|4238780|P1|Overall Study|Physician Decision|0
1302192|NCT00217971|4238779|P2|Overall Study|Lost to Follow-up|19
1302193|NCT00217971|4238780|P1|Overall Study|Lost to Follow-up|15
1302194|NCT00217971|4238779|P2|Overall Study|Adverse Event|1
1302195|NCT00217971|4238780|P1|Overall Study|Adverse Event|1
1302196|NCT00217672|4238795|P2|Follow-up|Lost to Follow-up|0
1302197|NCT00217672|4238796|P1|Follow-up|Lost to Follow-up|1
1302198|NCT00217672|4238795|P2|Follow-up|Withdrawal by Subject|0
1302199|NCT00217672|4238796|P1|Follow-up|Withdrawal by Subject|4
1302200|NCT00217672|4238795|P2|Treatment|secondary malignancy|0
1302201|NCT00217672|4238796|P1|Treatment|secondary malignancy|1
1302202|NCT00217672|4238795|P2|Treatment|Death|0
1302203|NCT00217672|4238796|P1|Treatment|Death|2
1302204|NCT00217672|4238795|P2|Treatment|insurance issues|1
1302205|NCT00217672|4238796|P1|Treatment|insurance issues|1
1302206|NCT00217672|4238795|P2|Treatment|Physician Decision|0
1302207|NCT00217672|4238796|P1|Treatment|Physician Decision|6
1302208|NCT00217672|4238795|P2|Treatment|reqd treatment not permitted by protocol|0
1302209|NCT00217672|4238796|P1|Treatment|reqd treatment not permitted by protocol|6
1302210|NCT00217672|4238795|P2|Treatment|Adverse Event|2
1302211|NCT00217672|4238796|P1|Treatment|Adverse Event|18
1302212|NCT00217672|4238795|P2|Treatment|disease progression|4
1302213|NCT00217672|4238796|P1|Treatment|disease progression|33
1302214|NCT00217672|4238795|P2|Allocation|Ineligible|0
1302215|NCT00217672|4238796|P1|Allocation|Ineligible|2
1302216|NCT00217620|4238802|P1|Overall Study|Never received treatment|1
1302217|NCT00217620|4238802|P1|Overall Study|Ineligible|13
1302218|NCT00217620|4238802|P1|Overall Study|Not Protocol Specified|4
1302219|NCT00217620|4238802|P1|Overall Study|Progression|31
1302220|NCT00217620|4238802|P1|Overall Study|Adverse Event|2
1302221|NCT00217581|4238817|P1|Overall Study|Withdrawal by Subject|1
1302222|NCT00217464|4238846|P1|Overall Study|not specified|2
1302223|NCT00217464|4238846|P1|Overall Study|Progression|15
1302224|NCT00217425|4238862|P1|Overall Study|Other|4
1302225|NCT00217425|4238862|P1|Overall Study|Other complicating disease|1
1302226|NCT00217425|4238862|P1|Overall Study|Withdrawal by Subject|4
1302227|NCT00217425|4238862|P1|Overall Study|Adverse Event|8
1302228|NCT00217425|4238862|P1|Overall Study|Lack of Efficacy|13
1302229|NCT00217425|4238862|P1|Overall Study|Patient ineligible|5
1302230|NCT00217425|4238862|P1|Overall Study|Never started treatment|2
1302231|NCT00217087|4238876|P2|Overall Study|completed less than 12 months return|18
1302232|NCT00217087|4238877|P1|Overall Study|completed less than 12 months return|10
1302233|NCT00217087|4238876|P2|Overall Study|decided to have esophagectomy|2
1302234|NCT00217087|4238877|P1|Overall Study|decided to have esophagectomy|1
1302235|NCT00217022|4238891|P2|Overall Study|Withdrawal by Subject|1
1302236|NCT00217022|4238892|P1|Overall Study|Withdrawal by Subject|1
1302237|NCT00216736|4238902|P2|Overall Study|Lost to Follow-up|1
1302238|NCT00216736|4238903|P1|Overall Study|Lost to Follow-up|1
1302239|NCT00216671|4238917|P2|Overall Study|Insufficient Response Adverse Event|1
1302240|NCT00216671|4238918|P1|Overall Study|Insufficient Response Adverse Event|2
1302241|NCT00216671|4238917|P2|Overall Study|Ineligible, no efficacy data|2
1302242|NCT00216671|4238918|P1|Overall Study|Ineligible, no efficacy data|2
1302243|NCT00216671|4238917|P2|Overall Study|Patient Moved|1
1302244|NCT00216671|4238918|P1|Overall Study|Patient Moved|0
1302245|NCT00216671|4238917|P2|Overall Study|Investigator Illness|1
1302246|NCT00216671|4238918|P1|Overall Study|Investigator Illness|0
1302247|NCT00216671|4238917|P2|Overall Study|Relapse|0
1302248|NCT00216671|4238918|P1|Overall Study|Relapse|1
1302249|NCT00216671|4238917|P2|Overall Study|Protocol Violation|5
1302250|NCT00216671|4238918|P1|Overall Study|Protocol Violation|3
1302251|NCT00216671|4238917|P2|Overall Study|Physician Decision|1
1302252|NCT00216671|4238918|P1|Overall Study|Physician Decision|1
1302253|NCT00216671|4238917|P2|Overall Study|Ineligible|2
1302254|NCT00216671|4238918|P1|Overall Study|Ineligible|0
1302255|NCT00216671|4238917|P2|Overall Study|Non compliant|2
1302256|NCT00216671|4238918|P1|Overall Study|Non compliant|2
1302257|NCT00216671|4238917|P2|Overall Study|Lost to Follow-up|5
1302258|NCT00216671|4238918|P1|Overall Study|Lost to Follow-up|3
1302259|NCT00216671|4238917|P2|Overall Study|Insufficient Response|4
1302260|NCT00216671|4238918|P1|Overall Study|Insufficient Response|9
1302261|NCT00216671|4238917|P2|Overall Study|No Need to Continue Medication|1
1302262|NCT00216671|4238918|P1|Overall Study|No Need to Continue Medication|1
1302263|NCT00216671|4238917|P2|Overall Study|Refused Injections|13
1302264|NCT00216671|4238918|P1|Overall Study|Refused Injections|3
1302265|NCT00216671|4238917|P2|Overall Study|Withdrawal by Subject|2
1302266|NCT00216671|4238918|P1|Overall Study|Withdrawal by Subject|4
1302267|NCT00216671|4238917|P2|Overall Study|Pregnancy|1
1302268|NCT00216671|4238918|P1|Overall Study|Pregnancy|0
1302269|NCT00216671|4238917|P2|Overall Study|Adverse Event|9
1302270|NCT00216671|4238918|P1|Overall Study|Adverse Event|4
1302271|NCT00216476|4238936|P3|Overall Study|Patient Moved|0
1302272|NCT00216476|4238937|P2|Overall Study|Patient Moved|2
1302273|NCT00216476|4238938|P1|Overall Study|Patient Moved|2
1302274|NCT00216476|4238936|P3|Overall Study|Protocol Deviation|0
1302275|NCT00216476|4238937|P2|Overall Study|Protocol Deviation|1
1302276|NCT00216476|4238938|P1|Overall Study|Protocol Deviation|5
1302277|NCT00216476|4238936|P3|Overall Study|Administrative Reasons|0
1302278|NCT00216476|4238937|P2|Overall Study|Administrative Reasons|1
1302279|NCT00216476|4238938|P1|Overall Study|Administrative Reasons|1
1302280|NCT00216476|4238936|P3|Overall Study|Higher dose/Extra Medication Required|2
1302281|NCT00216476|4238937|P2|Overall Study|Higher dose/Extra Medication Required|0
1302282|NCT00216476|4238938|P1|Overall Study|Higher dose/Extra Medication Required|2
1302283|NCT00216476|4238936|P3|Overall Study|Non-compliance|1
1302284|NCT00216476|4238937|P2|Overall Study|Non-compliance|4
1302285|NCT00216476|4238938|P1|Overall Study|Non-compliance|0
1302286|NCT00216476|4238936|P3|Overall Study|No Further Need for Treatment|1
1302287|NCT00216476|4238937|P2|Overall Study|No Further Need for Treatment|4
1302288|NCT00216476|4238938|P1|Overall Study|No Further Need for Treatment|3
1302289|NCT00216476|4238936|P3|Overall Study|Refuses Injection|0
1302290|NCT00216476|4238937|P2|Overall Study|Refuses Injection|0
1302291|NCT00216476|4238938|P1|Overall Study|Refuses Injection|11
1302292|NCT00216476|4238936|P3|Overall Study|Other|1
1302293|NCT00216476|4238937|P2|Overall Study|Other|0
1302294|NCT00216476|4238938|P1|Overall Study|Other|0
1302295|NCT00216476|4238936|P3|Overall Study|Pregnancy|1
1302296|NCT00216476|4238937|P2|Overall Study|Pregnancy|1
1302297|NCT00216476|4238938|P1|Overall Study|Pregnancy|0
1302298|NCT00216476|4238936|P3|Overall Study|Death|0
1302299|NCT00216476|4238937|P2|Overall Study|Death|0
1302300|NCT00216476|4238938|P1|Overall Study|Death|2
1302301|NCT00216476|4238936|P3|Overall Study|Lack of Efficacy|0
1302302|NCT00216476|4238937|P2|Overall Study|Lack of Efficacy|3
1302303|NCT00216476|4238938|P1|Overall Study|Lack of Efficacy|4
1302304|NCT00216476|4238936|P3|Overall Study|Adverse Event|1
1302305|NCT00216476|4238937|P2|Overall Study|Adverse Event|10
1302306|NCT00216476|4238938|P1|Overall Study|Adverse Event|6
1302307|NCT00216476|4238936|P3|Overall Study|Lost to Follow-up|1
1302308|NCT00216476|4238937|P2|Overall Study|Lost to Follow-up|9
1302309|NCT00216476|4238938|P1|Overall Study|Lost to Follow-up|10
1302310|NCT00216476|4238936|P3|Overall Study|Withdrawal by Subject|9
1302311|NCT00216476|4238937|P2|Overall Study|Withdrawal by Subject|72
1302312|NCT00216476|4238938|P1|Overall Study|Withdrawal by Subject|59
1302313|NCT00216203|4238975|P1|Overall Study|Withdrawal by Subject|2
1302314|NCT00216086|4239005|P1|Overall Study|Social Reasons|2
1302315|NCT00216086|4239005|P1|Overall Study|Diagnosis of Metastatic Disease|1
1302316|NCT00216086|4239005|P1|Overall Study|Protocol Violation|1
1302317|NCT00215943|4239037|P2|Overall Study|Other complications|1
1302318|NCT00215943|4239038|P1|Overall Study|Other complications|3
1302319|NCT00215943|4239037|P2|Overall Study|Other disease|1
1302320|NCT00215943|4239038|P1|Overall Study|Other disease|0
1302321|NCT00215943|4239037|P2|Overall Study|Adverse Event|6
1302322|NCT00215943|4239038|P1|Overall Study|Adverse Event|3
1302323|NCT00215943|4239037|P2|Overall Study|Alternate therapy|1
1302324|NCT00215943|4239038|P1|Overall Study|Alternate therapy|0
1302325|NCT00215943|4239037|P2|Overall Study|Disease Progression|5
1302326|NCT00215943|4239038|P1|Overall Study|Disease Progression|3
1302327|NCT00215683|4239063|P3|Overall Study|Intermittent therapy required|0
1302328|NCT00215683|4239064|P2|Overall Study|Intermittent therapy required|1
1302329|NCT00215683|4239065|P1|Overall Study|Intermittent therapy required|0
1302330|NCT00215683|4239063|P3|Overall Study|No study drug available|0
1302331|NCT00215683|4239064|P2|Overall Study|No study drug available|1
1302332|NCT00215683|4239065|P1|Overall Study|No study drug available|0
1302333|NCT00215683|4239063|P3|Overall Study|Difficult to attend visits|0
1302334|NCT00215683|4239064|P2|Overall Study|Difficult to attend visits|1
1302335|NCT00215683|4239065|P1|Overall Study|Difficult to attend visits|0
1302336|NCT00215683|4239063|P3|Overall Study|Physician Decision|1
1302337|NCT00215683|4239064|P2|Overall Study|Physician Decision|0
1302338|NCT00215683|4239065|P1|Overall Study|Physician Decision|0
1302339|NCT00215683|4239063|P3|Overall Study|Withdrawal by Subject|13
1302340|NCT00215683|4239064|P2|Overall Study|Withdrawal by Subject|4
1302341|NCT00215683|4239065|P1|Overall Study|Withdrawal by Subject|9
1302342|NCT00215683|4239063|P3|Overall Study|Lost to Follow-up|1
1302343|NCT00215683|4239064|P2|Overall Study|Lost to Follow-up|2
1302344|NCT00215683|4239065|P1|Overall Study|Lost to Follow-up|0
1302345|NCT00215683|4239063|P3|Overall Study|Lack of Efficacy|2
1302346|NCT00215683|4239064|P2|Overall Study|Lack of Efficacy|1
1302347|NCT00215683|4239065|P1|Overall Study|Lack of Efficacy|5
1302348|NCT00215683|4239063|P3|Overall Study|Adverse Event|15
1302349|NCT00215683|4239064|P2|Overall Study|Adverse Event|16
1302350|NCT00215683|4239065|P1|Overall Study|Adverse Event|15
1302351|NCT00215657|4239084|P8|Overall Study|Not specified|1
1302352|NCT00215657|4239085|P7|Overall Study|Not specified|6
1302353|NCT00215657|4239086|P6|Overall Study|Not specified|4
1302354|NCT00215657|4239087|P5|Overall Study|Not specified|5
1302355|NCT00215657|4239088|P4|Overall Study|Not specified|3
1302356|NCT00215657|4239089|P3|Overall Study|Not specified|2
1302357|NCT00215657|4239090|P2|Overall Study|Not specified|1
1302358|NCT00215657|4239091|P1|Overall Study|Not specified|3
1302359|NCT00215657|4239084|P8|Overall Study|Insufficient testosterone response|7
1302360|NCT00215657|4239085|P7|Overall Study|Insufficient testosterone response|4
1302361|NCT00215657|4239086|P6|Overall Study|Insufficient testosterone response|12
1302362|NCT00215657|4239087|P5|Overall Study|Insufficient testosterone response|8
1302363|NCT00215657|4239088|P4|Overall Study|Insufficient testosterone response|12
1302364|NCT00215657|4239089|P3|Overall Study|Insufficient testosterone response|1
1302365|NCT00215657|4239090|P2|Overall Study|Insufficient testosterone response|4
1302366|NCT00215657|4239091|P1|Overall Study|Insufficient testosterone response|5
1302367|NCT00215657|4239084|P8|Overall Study|Insuff prostate specific antigen resp|2
1302368|NCT00215657|4239085|P7|Overall Study|Insuff prostate specific antigen resp|3
1302369|NCT00215657|4239086|P6|Overall Study|Insuff prostate specific antigen resp|2
1302370|NCT00215657|4239087|P5|Overall Study|Insuff prostate specific antigen resp|1
1302371|NCT00215657|4239088|P4|Overall Study|Insuff prostate specific antigen resp|2
1302372|NCT00215657|4239089|P3|Overall Study|Insuff prostate specific antigen resp|2
1302373|NCT00215657|4239090|P2|Overall Study|Insuff prostate specific antigen resp|2
1302374|NCT00215657|4239091|P1|Overall Study|Insuff prostate specific antigen resp|3
1302375|NCT00215657|4239084|P8|Overall Study|Withdrawal by Subject|3
1302376|NCT00215657|4239085|P7|Overall Study|Withdrawal by Subject|10
1302377|NCT00215657|4239086|P6|Overall Study|Withdrawal by Subject|1
1302378|NCT00215657|4239087|P5|Overall Study|Withdrawal by Subject|6
1302379|NCT00215657|4239088|P4|Overall Study|Withdrawal by Subject|1
1302380|NCT00215657|4239089|P3|Overall Study|Withdrawal by Subject|3
1302381|NCT00215657|4239090|P2|Overall Study|Withdrawal by Subject|3
1302382|NCT00215657|4239091|P1|Overall Study|Withdrawal by Subject|6
1302383|NCT00215657|4239084|P8|Overall Study|Adverse Event|3
1302384|NCT00215657|4239085|P7|Overall Study|Adverse Event|0
1302385|NCT00215657|4239086|P6|Overall Study|Adverse Event|1
1302386|NCT00215657|4239087|P5|Overall Study|Adverse Event|3
1302387|NCT00215657|4239088|P4|Overall Study|Adverse Event|0
1302388|NCT00215657|4239089|P3|Overall Study|Adverse Event|3
1302389|NCT00215657|4239090|P2|Overall Study|Adverse Event|1
1302390|NCT00215657|4239091|P1|Overall Study|Adverse Event|5
1302391|NCT00215644|4239119|P2|Overall Study|Randomized but Not Treated|0
1302392|NCT00215644|4239120|P1|Overall Study|Randomized but Not Treated|1
1302393|NCT00215644|4239119|P2|Overall Study|Other|15
1302394|NCT00215644|4239120|P1|Overall Study|Other|3
1302395|NCT00215644|4239119|P2|Overall Study|Withdrawal by Subject|0
1302396|NCT00215644|4239120|P1|Overall Study|Withdrawal by Subject|1
1302397|NCT00215644|4239119|P2|Overall Study|Death|2
1302398|NCT00215644|4239120|P1|Overall Study|Death|1
1302399|NCT00215644|4239119|P2|Overall Study|Adverse Event|9
1302400|NCT00215644|4239120|P1|Overall Study|Adverse Event|2
1302401|NCT00215644|4239119|P2|Overall Study|Disease Progression|10
1302402|NCT00215644|4239120|P1|Overall Study|Disease Progression|28
1302403|NCT00215553|4239147|P7|Overall Study|Adverse Event|0
1302404|NCT00215553|4239148|P6|Overall Study|Adverse Event|6
1302405|NCT00215553|4239149|P5|Overall Study|Adverse Event|2
1302406|NCT00215553|4239150|P4|Overall Study|Adverse Event|1
1302407|NCT00215553|4239151|P3|Overall Study|Adverse Event|2
1302408|NCT00215553|4239152|P2|Overall Study|Adverse Event|1
1302409|NCT00215553|4239153|P1|Overall Study|Adverse Event|0
1302410|NCT00215540|4239186|P3|Overall Study|Withdrew from study medication|0
1302411|NCT00215540|4239187|P2|Overall Study|Withdrew from study medication|0
1302412|NCT00215540|4239188|P1|Overall Study|Withdrew from study medication|1
1302413|NCT00215150|4239223|P1|Randomization Phase Placebo|Withdrawal by Subject|1
1302414|NCT00215150|4239223|P1|Randomization Phase Ziprasidone|Withdrawal by Subject|1
1302415|NCT00215150|4239223|P1|Randomization Phase Ziprasidone|Lost to Follow-up|2
1302416|NCT00215150|4239223|P1|Open Label Phase|Did not meet randomization criteria|9
1302417|NCT00215150|4239223|P1|Open Label Phase|Did not complete a post base visit|13
1302418|NCT00215150|4239223|P1|Open Label Phase|Withdrawal by Subject|1
1302419|NCT00215150|4239223|P1|Open Label Phase|Lost to Follow-up|7
1302420|NCT00215137|4239231|P3|Randomization Period|Withdrawal by Subject|0
1302421|NCT00215137|4239232|P2|Randomization Period|Withdrawal by Subject|1
1302422|NCT00215137|4239233|P1|Randomization Period|Withdrawal by Subject|0
1302423|NCT00215137|4239231|P3|Randomization Period|Lost to Follow-up|0
1302424|NCT00215137|4239232|P2|Randomization Period|Lost to Follow-up|1
1302425|NCT00215137|4239233|P1|Randomization Period|Lost to Follow-up|0
1302426|NCT00215137|4239231|P3|Open Label Escitalopram|Lack of Efficacy|0
1302427|NCT00215137|4239232|P2|Open Label Escitalopram|Lack of Efficacy|0
1302428|NCT00215137|4239233|P1|Open Label Escitalopram|Lack of Efficacy|1
1302429|NCT00214500|4239331|P1|Extension Period|Withdrawal by Subject|2
1302430|NCT00214500|4239331|P1|Treatment Period|Adverse Event|1
1302431|NCT00214461|4239352|P4|Overall Study|Withdrawal by Subject|0
1302432|NCT00214461|4239353|P3|Overall Study|Withdrawal by Subject|1
1302433|NCT00214461|4239354|P2|Overall Study|Withdrawal by Subject|0
1302434|NCT00214461|4239355|P1|Overall Study|Withdrawal by Subject|0
1302435|NCT00214461|4239352|P4|Overall Study|Adverse Event|1
1302436|NCT00214461|4239353|P3|Overall Study|Adverse Event|1
1302437|NCT00214461|4239354|P2|Overall Study|Adverse Event|0
1302438|NCT00214461|4239355|P1|Overall Study|Adverse Event|0
1302439|NCT00214383|4239371|P2|Overall Study|Lost to Follow-up|26
1302440|NCT00214383|4239372|P1|Overall Study|Lost to Follow-up|16
1302441|NCT00214201|4239384|P2|Overall Study|Death|2
1302442|NCT00214201|4239385|P1|Overall Study|Death|0
1302443|NCT00214201|4239384|P2|Overall Study|Withdrawal by Subject|0
1302444|NCT00214201|4239385|P1|Overall Study|Withdrawal by Subject|2
1302445|NCT00214136|4239400|P1|Overall Study|Death|5
1302446|NCT00214019|4239405|P1|Overall Study|Screen Failed prior to randomization|17
1302447|NCT00214019|4239405|P1|Overall Study|Withdrawal by Subject|2
1302448|NCT00214019|4239405|P1|Overall Study|Lost to Follow-up|11
1302449|NCT00213980|4239414|P2|Overall Study|Failed to obtain all 3 DXAs|3
1302450|NCT00213980|4239415|P1|Overall Study|Failed to obtain all 3 DXAs|1
1302451|NCT00213980|4239414|P2|Overall Study|Developed ovarian cancer|0
1302452|NCT00213980|4239415|P1|Overall Study|Developed ovarian cancer|1
1302453|NCT00213980|4239414|P2|Overall Study|Disease progression|2
1302454|NCT00213980|4239415|P1|Overall Study|Disease progression|0
1302455|NCT00213980|4239414|P2|Overall Study|Adverse Event|1
1302456|NCT00213980|4239415|P1|Overall Study|Adverse Event|1
1302457|NCT00213980|4239414|P2|Overall Study|Withdrawal by Subject|1
1302458|NCT00213980|4239415|P1|Overall Study|Withdrawal by Subject|3
1302459|NCT00213148|4239442|P5|Cycle 3 (1 Month)|Other|0
1302460|NCT00213148|4239443|P4|Cycle 3 (1 Month)|Other|1
1302461|NCT00213148|4239444|P3|Cycle 3 (1 Month)|Other|1
1302462|NCT00213148|4239445|P2|Cycle 3 (1 Month)|Other|0
1302463|NCT00213148|4239446|P1|Cycle 3 (1 Month)|Other|0
1302464|NCT00213148|4239442|P5|Cycle 3 (1 Month)|Lost to Follow-up|1
1302465|NCT00213148|4239443|P4|Cycle 3 (1 Month)|Lost to Follow-up|0
1302466|NCT00213148|4239444|P3|Cycle 3 (1 Month)|Lost to Follow-up|0
1302467|NCT00213148|4239445|P2|Cycle 3 (1 Month)|Lost to Follow-up|2
1302468|NCT00213148|4239446|P1|Cycle 3 (1 Month)|Lost to Follow-up|0
1302469|NCT00213148|4239442|P5|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6
1302470|NCT00213148|4239443|P4|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3
1302471|NCT00213148|4239444|P3|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3
1302472|NCT00213148|4239445|P2|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1
1302473|NCT00213148|4239446|P1|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10
1302474|NCT00213148|4239442|P5|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
1302475|NCT00213148|4239443|P4|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
1302476|NCT00213148|4239444|P3|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
1302477|NCT00213148|4239445|P2|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
1302478|NCT00213148|4239446|P1|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1
1302479|NCT00213148|4239442|P5|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
1302480|NCT00213148|4239443|P4|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
1302481|NCT00213148|4239444|P3|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
1302482|NCT00213148|4239445|P2|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1
1302483|NCT00213148|4239446|P1|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
1302484|NCT00213148|4239442|P5|Cycle 2 (1 Month)|Other|7
1302485|NCT00213148|4239443|P4|Cycle 2 (1 Month)|Other|8
1302486|NCT00213148|4239444|P3|Cycle 2 (1 Month)|Other|2
1302487|NCT00213148|4239445|P2|Cycle 2 (1 Month)|Other|1
1302488|NCT00213148|4239446|P1|Cycle 2 (1 Month)|Other|2
1302489|NCT00213148|4239442|P5|Cycle 2 (1 Month)|Lack of Efficacy|16
1302490|NCT00213148|4239443|P4|Cycle 2 (1 Month)|Lack of Efficacy|6
1302491|NCT00213148|4239444|P3|Cycle 2 (1 Month)|Lack of Efficacy|7
1302492|NCT00213148|4239445|P2|Cycle 2 (1 Month)|Lack of Efficacy|3
1302493|NCT00213148|4239446|P1|Cycle 2 (1 Month)|Lack of Efficacy|1
1302494|NCT00213148|4239442|P5|Cycle 2 (1 Month)|Lost to Follow-up|1
1302495|NCT00213148|4239443|P4|Cycle 2 (1 Month)|Lost to Follow-up|2
1302496|NCT00213148|4239444|P3|Cycle 2 (1 Month)|Lost to Follow-up|2
1302497|NCT00213148|4239445|P2|Cycle 2 (1 Month)|Lost to Follow-up|0
1302498|NCT00213148|4239446|P1|Cycle 2 (1 Month)|Lost to Follow-up|0
1302499|NCT00213148|4239442|P5|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5
1302500|NCT00213148|4239443|P4|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8
1302501|NCT00213148|4239444|P3|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5
1302502|NCT00213148|4239445|P2|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0
1302503|NCT00213148|4239446|P1|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15
1302504|NCT00213148|4239442|P5|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1
1302505|NCT00213148|4239443|P4|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
1302506|NCT00213148|4239444|P3|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
1302507|NCT00213148|4239445|P2|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
1302508|NCT00213148|4239446|P1|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
1302509|NCT00213148|4239442|P5|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
1302510|NCT00213148|4239443|P4|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1
1302511|NCT00213148|4239444|P3|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
1302512|NCT00213148|4239445|P2|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
1302513|NCT00213148|4239446|P1|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
1302514|NCT00213148|4239442|P5|Cycle 1 (1 Month)|Other|7
1302515|NCT00213148|4239443|P4|Cycle 1 (1 Month)|Other|2
1302516|NCT00213148|4239444|P3|Cycle 1 (1 Month)|Other|2
1302517|NCT00213148|4239445|P2|Cycle 1 (1 Month)|Other|0
1302518|NCT00213148|4239446|P1|Cycle 1 (1 Month)|Other|3
1302519|NCT00213148|4239442|P5|Cycle 1 (1 Month)|Protocol Violation|0
1302520|NCT00213148|4239443|P4|Cycle 1 (1 Month)|Protocol Violation|0
1302521|NCT00213148|4239444|P3|Cycle 1 (1 Month)|Protocol Violation|1
1302522|NCT00213148|4239445|P2|Cycle 1 (1 Month)|Protocol Violation|0
1302523|NCT00213148|4239446|P1|Cycle 1 (1 Month)|Protocol Violation|1
1302524|NCT00213148|4239442|P5|Cycle 1 (1 Month)|Lack of Efficacy|8
1302525|NCT00213148|4239443|P4|Cycle 1 (1 Month)|Lack of Efficacy|5
1302526|NCT00213148|4239444|P3|Cycle 1 (1 Month)|Lack of Efficacy|8
1302527|NCT00213148|4239445|P2|Cycle 1 (1 Month)|Lack of Efficacy|0
1302528|NCT00213148|4239446|P1|Cycle 1 (1 Month)|Lack of Efficacy|4
1302529|NCT00213148|4239442|P5|Cycle 1 (1 Month)|Adverse Event|0
1302530|NCT00213148|4239443|P4|Cycle 1 (1 Month)|Adverse Event|0
1302531|NCT00213148|4239444|P3|Cycle 1 (1 Month)|Adverse Event|1
1302532|NCT00213148|4239445|P2|Cycle 1 (1 Month)|Adverse Event|0
1302533|NCT00213148|4239446|P1|Cycle 1 (1 Month)|Adverse Event|0
1302534|NCT00213148|4239442|P5|Cycle 1 (1 Month)|Lost to Follow-up|1
1302535|NCT00213148|4239443|P4|Cycle 1 (1 Month)|Lost to Follow-up|2
1302536|NCT00213148|4239444|P3|Cycle 1 (1 Month)|Lost to Follow-up|2
1302537|NCT00213148|4239445|P2|Cycle 1 (1 Month)|Lost to Follow-up|0
1302538|NCT00213148|4239446|P1|Cycle 1 (1 Month)|Lost to Follow-up|1
1302539|NCT00213135|4239473|P3|Overall Study|Other|15
1302540|NCT00213135|4239474|P2|Overall Study|Other|12
1302541|NCT00213135|4239475|P1|Overall Study|Other|21
1302542|NCT00213135|4239473|P3|Overall Study|Disease progression|21
1302543|NCT00213135|4239474|P2|Overall Study|Disease progression|5
1302544|NCT00213135|4239475|P1|Overall Study|Disease progression|4
1302545|NCT00213135|4239473|P3|Overall Study|Death|2
1302546|NCT00213135|4239474|P2|Overall Study|Death|1
1302547|NCT00213135|4239475|P1|Overall Study|Death|1
1302548|NCT00213135|4239473|P3|Overall Study|Protocol Violation|10
1302549|NCT00213135|4239474|P2|Overall Study|Protocol Violation|4
1302550|NCT00213135|4239475|P1|Overall Study|Protocol Violation|4
1302551|NCT00213135|4239473|P3|Overall Study|Lost to Follow-up|4
1302552|NCT00213135|4239474|P2|Overall Study|Lost to Follow-up|8
1302553|NCT00213135|4239475|P1|Overall Study|Lost to Follow-up|11
1302554|NCT00213135|4239473|P3|Overall Study|Adverse Event|5
1302555|NCT00213135|4239474|P2|Overall Study|Adverse Event|5
1302556|NCT00213135|4239475|P1|Overall Study|Adverse Event|9
1302557|NCT00212758|4239492|P2|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
1302558|NCT00212758|4239493|P1|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
1302559|NCT00212758|4239492|P2|Standard Therapy of GH (12 Months)|Adverse Event|0
1302560|NCT00212758|4239493|P1|Standard Therapy of GH (12 Months)|Adverse Event|1
1302561|NCT00212355|4239509|P1|Overall Study|A change of address|1
1302562|NCT00212355|4239509|P1|Overall Study|Withdrawal by Subject|1
1302563|NCT00212355|4239509|P1|Overall Study|Adverse Event|1
1302564|NCT00212134|4239530|P2|Phase 3 (Age 10 Years)|On Going|21
1302565|NCT00212134|4239531|P1|Phase 3 (Age 10 Years)|On Going|21
1302566|NCT00211887|4239552|P3|Overall Study|Side effects|5
1302567|NCT00211887|4239553|P2|Overall Study|Side effects|13
1302568|NCT00211887|4239554|P1|Overall Study|Side effects|19
1302569|NCT00211887|4239552|P3|Overall Study|Other medical reason|7
1302570|NCT00211887|4239553|P2|Overall Study|Other medical reason|11
1302571|NCT00211887|4239554|P1|Overall Study|Other medical reason|15
1302572|NCT00211887|4239552|P3|Overall Study|Non-medical reason|8
1302573|NCT00211887|4239553|P2|Overall Study|Non-medical reason|14
1302574|NCT00211887|4239554|P1|Overall Study|Non-medical reason|31
1302575|NCT00211887|4239552|P3|Overall Study|Lost to Follow-up|9
1302576|NCT00211887|4239553|P2|Overall Study|Lost to Follow-up|13
1302577|NCT00211887|4239554|P1|Overall Study|Lost to Follow-up|28
1302578|NCT00211887|4239552|P3|Overall Study|Death|1
1302579|NCT00211887|4239553|P2|Overall Study|Death|1
1302580|NCT00211887|4239554|P1|Overall Study|Death|1
1302581|NCT00211887|4239552|P3|Overall Study|Adverse Event|6
1302582|NCT00211887|4239553|P2|Overall Study|Adverse Event|4
1302583|NCT00211887|4239554|P1|Overall Study|Adverse Event|8
1302584|NCT00211809|4239571|P1|Overall Study|side effects|2
1302585|NCT00211809|4239571|P1|Overall Study|Pregnancy|1
1302586|NCT00211809|4239571|P1|Overall Study|Lost to Follow-up|2
1302587|NCT00211809|4239571|P1|Overall Study|Lack of Efficacy|1
1302588|NCT00211757|4239587|P2|Overall Study|Lack of Efficacy|1
1302589|NCT00211757|4239588|P1|Overall Study|Lack of Efficacy|0
1302590|NCT00211757|4239587|P2|Overall Study|Withdrawal by Subject|1
1302591|NCT00211757|4239588|P1|Overall Study|Withdrawal by Subject|1
1302592|NCT00211536|4239609|P2|Overall Study|Adverse Event|0
1302593|NCT00211536|4239610|P1|Overall Study|Adverse Event|2
1302594|NCT00211536|4239609|P2|Overall Study|Physician Decision|5
1302595|NCT00211536|4239610|P1|Overall Study|Physician Decision|0
1302596|NCT00211536|4239609|P2|Overall Study|Withdrawal by Subject|2
1302597|NCT00211536|4239610|P1|Overall Study|Withdrawal by Subject|2
1302598|NCT00211510|4239626|P2|Overall Study|Withdrawal by Subject|1
1302599|NCT00211510|4239627|P1|Overall Study|Withdrawal by Subject|3
1302600|NCT00211510|4239626|P2|Overall Study|Physician Decision|1
1302601|NCT00211510|4239627|P1|Overall Study|Physician Decision|3
1302602|NCT00211237|4239645|P3|12 Months|unrelated medical problem|1
1302603|NCT00211237|4239646|P2|12 Months|unrelated medical problem|0
1302604|NCT00211237|4239647|P1|12 Months|unrelated medical problem|0
1302605|NCT00211237|4239645|P3|12 Months|Withdrew|1
1302606|NCT00211237|4239646|P2|12 Months|Withdrew|0
1302607|NCT00211237|4239647|P1|12 Months|Withdrew|0
1302608|NCT00211237|4239645|P3|12 Months|Lost to Follow-up|1
1302609|NCT00211237|4239646|P2|12 Months|Lost to Follow-up|0
1302610|NCT00211237|4239647|P1|12 Months|Lost to Follow-up|1
1302611|NCT00211237|4239645|P3|12 Months|Death|3
1302612|NCT00211237|4239646|P2|12 Months|Death|2
1302613|NCT00211237|4239647|P1|12 Months|Death|8
1302614|NCT00211237|4239645|P3|6 Months|Could not comply with protocol|0
1302615|NCT00211237|4239646|P2|6 Months|Could not comply with protocol|2
1302616|NCT00211237|4239647|P1|6 Months|Could not comply with protocol|0
1302617|NCT00211237|4239645|P3|6 Months|Lost to Follow-up|0
1302618|NCT00211237|4239646|P2|6 Months|Lost to Follow-up|0
1302619|NCT00211237|4239647|P1|6 Months|Lost to Follow-up|2
1302620|NCT00211237|4239645|P3|6 Months|Death|3
1302621|NCT00211237|4239646|P2|6 Months|Death|0
1302622|NCT00211237|4239647|P1|6 Months|Death|6
1302623|NCT00211237|4239645|P3|3 Months|Non-medical problem|1
1302624|NCT00211237|4239646|P2|3 Months|Non-medical problem|0
1302625|NCT00211237|4239647|P1|3 Months|Non-medical problem|0
1302626|NCT00211237|4239645|P3|3 Months|Withdrew|0
1302627|NCT00211237|4239646|P2|3 Months|Withdrew|1
1302628|NCT00211237|4239647|P1|3 Months|Withdrew|0
1302629|NCT00211237|4239645|P3|3 Months|Could not comply with protocol|0
1302630|NCT00211237|4239646|P2|3 Months|Could not comply with protocol|0
1302631|NCT00211237|4239647|P1|3 Months|Could not comply with protocol|1
1302632|NCT00211237|4239645|P3|3 Months|Death|0
1302633|NCT00211237|4239646|P2|3 Months|Death|3
1302634|NCT00211237|4239647|P1|3 Months|Death|7
1302635|NCT00211237|4239645|P3|1 Month|Non-medical problem|0
1302636|NCT00211237|4239646|P2|1 Month|Non-medical problem|2
1302637|NCT00211237|4239647|P1|1 Month|Non-medical problem|0
1302638|NCT00211237|4239645|P3|1 Month|Additional surgery needed|0
1302639|NCT00211237|4239646|P2|1 Month|Additional surgery needed|0
1302640|NCT00211237|4239647|P1|1 Month|Additional surgery needed|1
1302641|NCT00211237|4239645|P3|1 Month|Withdrew|0
1302642|NCT00211237|4239646|P2|1 Month|Withdrew|4
1302643|NCT00211237|4239647|P1|1 Month|Withdrew|0
1302644|NCT00211237|4239645|P3|1 Month|Lost to Follow-up|0
1302645|NCT00211237|4239646|P2|1 Month|Lost to Follow-up|2
1302646|NCT00211237|4239647|P1|1 Month|Lost to Follow-up|0
1302647|NCT00211237|4239645|P3|1 Month|Death|0
1302648|NCT00211237|4239646|P2|1 Month|Death|1
1302649|NCT00211237|4239647|P1|1 Month|Death|2
1302650|NCT00211237|4239645|P3|Baseline|Refused random assignment|0
1302651|NCT00211237|4239646|P2|Baseline|Refused random assignment|0
1302652|NCT00211237|4239647|P1|Baseline|Refused random assignment|1
1302653|NCT00211237|4239645|P3|Baseline|Withdrew|0
1302654|NCT00211237|4239646|P2|Baseline|Withdrew|3
1302655|NCT00211237|4239647|P1|Baseline|Withdrew|1
1302656|NCT00211172|4239739|P2|Overall Study|Died or lost health plan eligibility|32
1302657|NCT00211172|4239740|P1|Overall Study|Died or lost health plan eligibility|39
1302658|NCT00211081|4239746|P1|Overall Study|Withdrawal by Subject|2
1302659|NCT00210639|4239758|P2|Overall Study|Not specified|12
1302660|NCT00210639|4239759|P1|Overall Study|Not specified|18
1302661|NCT00210639|4239758|P2|Overall Study|Withdrawal by Subject|1
1302662|NCT00210639|4239759|P1|Overall Study|Withdrawal by Subject|8
1302663|NCT00210639|4239758|P2|Overall Study|Lost to Follow-up|29
1302664|NCT00210639|4239759|P1|Overall Study|Lost to Follow-up|37
1302665|NCT00210626|4239767|P2|Overall Study|Not Specified|5
1302666|NCT00210626|4239768|P1|Overall Study|Not Specified|4
1302667|NCT00210626|4239767|P2|Overall Study|Sponser Request|0
1302668|NCT00210626|4239768|P1|Overall Study|Sponser Request|1
1302669|NCT00210626|4239767|P2|Overall Study|Physician Decision|2
1302670|NCT00210626|4239768|P1|Overall Study|Physician Decision|0
1302671|NCT00210626|4239767|P2|Overall Study|Withdrawal by Subject|20
1302672|NCT00210626|4239768|P1|Overall Study|Withdrawal by Subject|29
1302673|NCT00210626|4239767|P2|Overall Study|Death|0
1302674|NCT00210626|4239768|P1|Overall Study|Death|1
1302675|NCT00210626|4239767|P2|Overall Study|Lost to Follow-up|11
1302676|NCT00210626|4239768|P1|Overall Study|Lost to Follow-up|11
1302677|NCT00210626|4239767|P2|Overall Study|Protocol Violation|5
1302678|NCT00210626|4239768|P1|Overall Study|Protocol Violation|1
1302679|NCT00210626|4239767|P2|Overall Study|Adverse Event|2
1302680|NCT00210626|4239768|P1|Overall Study|Adverse Event|1
1302681|NCT00210470|4239776|P1|Overall Study|Subject did not continue to surgery|1
1302682|NCT00209560|4239782|P2|Overall Study|Lack of Efficacy|0
1302683|NCT00209560|4239783|P1|Overall Study|Lack of Efficacy|1
1302684|NCT00209339|4239802|P1|At 5 Years Follow-up|Death|1
1302685|NCT00209339|4239802|P1|At 5 Years Follow-up|Withdrawal because of other reasons|5
1302686|NCT00209339|4239802|P1|At 5 Years Follow-up|Withdrawal by Subject|2
1302687|NCT00209339|4239802|P1|At 4 Years Follow-up|Death|1
1302688|NCT00209339|4239802|P1|At 4 Years Follow-up|Withdrawal by Subject|4
1302689|NCT00209339|4239802|P1|At 3 Years Follow-up|Withdrawal by Subject|1
1302690|NCT00209339|4239802|P1|At 24 Months Follow-up|Death|1
1302691|NCT00209339|4239802|P1|At 24 Months Follow-up|Withdrawal because of other reasons|6
1302692|NCT00209339|4239802|P1|At 24 Months Follow-up|Withdrawal by Subject|4
1302693|NCT00209339|4239802|P1|At 12 Months Follow-up|No MitraClip Device Implanted|6
1302694|NCT00209339|4239802|P1|At 12 Months Follow-up|Death|1
1302695|NCT00209339|4239802|P1|At 12 Months Follow-up|Withdrawal by Subject|8
1302696|NCT00209274|4239886|P2|Overall Study|Randomized not treated (RNT)|15
1302697|NCT00209274|4239887|P1|Overall Study|Randomized not treated (RNT)|6
1302698|NCT00209274|4239886|P2|Overall Study|Withdrawal by Subject|15
1302699|NCT00209274|4239887|P1|Overall Study|Withdrawal by Subject|30
1302700|NCT00209274|4239886|P2|Overall Study|Death|15
1302701|NCT00209274|4239887|P1|Overall Study|Death|32
1302702|NCT00209274|4239886|P2|Overall Study|Missed visit|2
1302703|NCT00209274|4239887|P1|Overall Study|Missed visit|3
1302704|NCT00209170|4240207|P2|Overall Study|Lack of Efficacy|1
1302705|NCT00209170|4240208|P1|Overall Study|Lack of Efficacy|0
1302706|NCT00209170|4240207|P2|Overall Study|Withdrawal by Subject|1
1302707|NCT00209170|4240208|P1|Overall Study|Withdrawal by Subject|2
1302708|NCT00209170|4240207|P2|Overall Study|Adverse Event|1
1302709|NCT00209170|4240208|P1|Overall Study|Adverse Event|0
1302710|NCT00209131|4240216|P2|Overall Study|Lack of personnel due to turnovers.|11
1302711|NCT00209131|4240217|P1|Overall Study|Lack of personnel due to turnovers.|15
1302712|NCT00209092|4240227|P2|Overall Study|Withdrawal by Subject|0
1302713|NCT00209092|4240228|P1|Overall Study|Withdrawal by Subject|1
1302714|NCT00209092|4240227|P2|Overall Study|Adverse Event|1
1302715|NCT00209092|4240228|P1|Overall Study|Adverse Event|0
1302716|NCT00209092|4240227|P2|Overall Study|Progression of disease|1
1302717|NCT00209092|4240228|P1|Overall Study|Progression of disease|7
1302718|NCT00209027|4240238|P2|Overall Study|study terminated|0
1302719|NCT00209027|4240239|P1|Overall Study|study terminated|10
1302720|NCT00208767|4240263|P2|Overall Study|Lost to Follow-up|3
1302721|NCT00208767|4240264|P1|Overall Study|Lost to Follow-up|3
1302722|NCT00208767|4240263|P2|Overall Study|Death|0
1302723|NCT00208767|4240264|P1|Overall Study|Death|1
1302724|NCT00208767|4240263|P2|Overall Study|Withdrawal by Subject|3
1302725|NCT00208767|4240264|P1|Overall Study|Withdrawal by Subject|14
1302726|NCT00208767|4240263|P2|Overall Study|Adverse Event|1
1302727|NCT00208767|4240264|P1|Overall Study|Adverse Event|9
1302728|NCT00208325|4240292|P4|Overall Study|Mis-Randomized|0
1302729|NCT00208325|4240293|P3|Overall Study|Mis-Randomized|0
1302730|NCT00208325|4240294|P2|Overall Study|Mis-Randomized|20
1302731|NCT00208325|4240295|P1|Overall Study|Mis-Randomized|17
1302732|NCT00208325|4240292|P4|Overall Study|Other|0
1302733|NCT00208325|4240293|P3|Overall Study|Other|1
1302734|NCT00208325|4240294|P2|Overall Study|Other|1
1302735|NCT00208325|4240295|P1|Overall Study|Other|2
1302736|NCT00208325|4240292|P4|Overall Study|Does not wish to Continue in Study|2
1302737|NCT00208325|4240293|P3|Overall Study|Does not wish to Continue in Study|3
1302738|NCT00208325|4240294|P2|Overall Study|Does not wish to Continue in Study|8
1302739|NCT00208325|4240295|P1|Overall Study|Does not wish to Continue in Study|5
1302740|NCT00208325|4240292|P4|Overall Study|Unsurfaced to Resurfaced Patella|3
1302741|NCT00208325|4240293|P3|Overall Study|Unsurfaced to Resurfaced Patella|1
1302742|NCT00208325|4240294|P2|Overall Study|Unsurfaced to Resurfaced Patella|4
1302743|NCT00208325|4240295|P1|Overall Study|Unsurfaced to Resurfaced Patella|4
1302744|NCT00208325|4240292|P4|Overall Study|Lost to Follow-up|0
1302745|NCT00208325|4240293|P3|Overall Study|Lost to Follow-up|2
1302746|NCT00208325|4240294|P2|Overall Study|Lost to Follow-up|0
1302747|NCT00208325|4240295|P1|Overall Study|Lost to Follow-up|1
1302748|NCT00208325|4240292|P4|Overall Study|Revision|4
1302749|NCT00208325|4240293|P3|Overall Study|Revision|0
1302750|NCT00208325|4240294|P2|Overall Study|Revision|1
1302751|NCT00208325|4240295|P1|Overall Study|Revision|4
1302752|NCT00208325|4240292|P4|Overall Study|Withdrawal by Subject|0
1302753|NCT00208325|4240293|P3|Overall Study|Withdrawal by Subject|0
1302754|NCT00208325|4240294|P2|Overall Study|Withdrawal by Subject|1
1302755|NCT00208325|4240295|P1|Overall Study|Withdrawal by Subject|0
1302756|NCT00208325|4240292|P4|Overall Study|Death|5
1302757|NCT00208325|4240293|P3|Overall Study|Death|7
1302758|NCT00208325|4240294|P2|Overall Study|Death|19
1302759|NCT00208325|4240295|P1|Overall Study|Death|18
1302760|NCT00207740|4240430|P4|Overall Study|Not Specified|5
1302761|NCT00207740|4240431|P3|Overall Study|Not Specified|7
1302762|NCT00207740|4240432|P2|Overall Study|Not Specified|10
1302763|NCT00207740|4240433|P1|Overall Study|Not Specified|2
1302764|NCT00207740|4240430|P4|Overall Study|Sponsor Directive|21
1302765|NCT00207740|4240431|P3|Overall Study|Sponsor Directive|16
1302766|NCT00207740|4240432|P2|Overall Study|Sponsor Directive|15
1302767|NCT00207740|4240433|P1|Overall Study|Sponsor Directive|22
1302768|NCT00207740|4240430|P4|Overall Study|Death|1
1302769|NCT00207740|4240431|P3|Overall Study|Death|0
1302770|NCT00207740|4240432|P2|Overall Study|Death|0
1302771|NCT00207740|4240433|P1|Overall Study|Death|0
1302772|NCT00207740|4240430|P4|Overall Study|Lost to Follow-up|1
1302773|NCT00207740|4240431|P3|Overall Study|Lost to Follow-up|1
1302774|NCT00207740|4240432|P2|Overall Study|Lost to Follow-up|2
1302775|NCT00207740|4240433|P1|Overall Study|Lost to Follow-up|0
1302776|NCT00207740|4240430|P4|Overall Study|Unsatisfactory therapeutic effect|4
1302777|NCT00207740|4240431|P3|Overall Study|Unsatisfactory therapeutic effect|2
1302778|NCT00207740|4240432|P2|Overall Study|Unsatisfactory therapeutic effect|0
1302779|NCT00207740|4240433|P1|Overall Study|Unsatisfactory therapeutic effect|1
1302780|NCT00207740|4240430|P4|Overall Study|Adverse Event|11
1302781|NCT00207740|4240431|P3|Overall Study|Adverse Event|14
1302782|NCT00207740|4240432|P2|Overall Study|Adverse Event|14
1302783|NCT00207740|4240433|P1|Overall Study|Adverse Event|4
1302784|NCT00207727|4240479|P5|Overall Study|Not specified|33
1302785|NCT00207727|4240480|P4|Overall Study|Not specified|37
1302786|NCT00207727|4240481|P3|Overall Study|Not specified|41
1302787|NCT00207727|4240482|P2|Overall Study|Not specified|41
1302788|NCT00207727|4240483|P1|Overall Study|Not specified|38
1302789|NCT00207727|4240479|P5|Overall Study|Lost to Follow-up|0
1302790|NCT00207727|4240480|P4|Overall Study|Lost to Follow-up|0
1302791|NCT00207727|4240481|P3|Overall Study|Lost to Follow-up|0
1302792|NCT00207727|4240482|P2|Overall Study|Lost to Follow-up|1
1302793|NCT00207727|4240483|P1|Overall Study|Lost to Follow-up|0
1302794|NCT00207727|4240479|P5|Overall Study|Withdrawal by Subject|1
1302795|NCT00207727|4240480|P4|Overall Study|Withdrawal by Subject|0
1302796|NCT00207727|4240481|P3|Overall Study|Withdrawal by Subject|0
1302797|NCT00207727|4240482|P2|Overall Study|Withdrawal by Subject|0
1302798|NCT00207727|4240483|P1|Overall Study|Withdrawal by Subject|0
1302799|NCT00207714|4240510|P5|Overall Study|Other|0
1302800|NCT00207714|4240511|P4|Overall Study|Other|1
1302801|NCT00207714|4240512|P3|Overall Study|Other|5
1302802|NCT00207714|4240513|P2|Overall Study|Other|2
1302803|NCT00207714|4240514|P1|Overall Study|Other|3
1302804|NCT00207714|4240510|P5|Overall Study|Unsatisfactory therapeutic effect|4
1302805|NCT00207714|4240511|P4|Overall Study|Unsatisfactory therapeutic effect|4
1302806|NCT00207714|4240512|P3|Overall Study|Unsatisfactory therapeutic effect|1
1302807|NCT00207714|4240513|P2|Overall Study|Unsatisfactory therapeutic effect|3
1302808|NCT00207714|4240514|P1|Overall Study|Unsatisfactory therapeutic effect|5
1302809|NCT00207714|4240510|P5|Overall Study|Adverse Event|1
1302810|NCT00207714|4240511|P4|Overall Study|Adverse Event|3
1302811|NCT00207714|4240512|P3|Overall Study|Adverse Event|4
1302812|NCT00207714|4240513|P2|Overall Study|Adverse Event|2
1302813|NCT00207714|4240514|P1|Overall Study|Adverse Event|6
1302814|NCT00207142|4240536|P4|Maintenance Phase/Rescue Phase|Lack of Efficacy|1
1302815|NCT00207142|4240537|P3|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
1302816|NCT00207142|4240538|P2|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
1302817|NCT00207142|4240539|P1|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
1302818|NCT00207142|4240536|P4|Maintenance Phase/Rescue Phase|Death|1
1302819|NCT00207142|4240537|P3|Maintenance Phase/Rescue Phase|Death|0
1302820|NCT00207142|4240538|P2|Maintenance Phase/Rescue Phase|Death|0
1302821|NCT00207142|4240539|P1|Maintenance Phase/Rescue Phase|Death|0
1302822|NCT00207142|4240536|P4|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1
1302823|NCT00207142|4240537|P3|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
1302824|NCT00207142|4240538|P2|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
1302825|NCT00207142|4240539|P1|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0
1302826|NCT00207142|4240536|P4|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
1302827|NCT00207142|4240537|P3|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1
1302828|NCT00207142|4240538|P2|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
1302829|NCT00207142|4240539|P1|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
1302830|NCT00207142|4240536|P4|Maintenance Phase/Rescue Phase|Pregnancy|0
1302831|NCT00207142|4240537|P3|Maintenance Phase/Rescue Phase|Pregnancy|2
1302832|NCT00207142|4240538|P2|Maintenance Phase/Rescue Phase|Pregnancy|2
1302833|NCT00207142|4240539|P1|Maintenance Phase/Rescue Phase|Pregnancy|0
1302834|NCT00207142|4240536|P4|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
1302835|NCT00207142|4240537|P3|Maintenance Phase/Rescue Phase|Poor/noncompliance|2
1302836|NCT00207142|4240538|P2|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
1302837|NCT00207142|4240539|P1|Maintenance Phase/Rescue Phase|Poor/noncompliance|0
1302838|NCT00207142|4240536|P4|Maintenance Phase/Rescue Phase|RTV intake impossible|0
1302839|NCT00207142|4240537|P3|Maintenance Phase/Rescue Phase|RTV intake impossible|1
1302840|NCT00207142|4240538|P2|Maintenance Phase/Rescue Phase|RTV intake impossible|0
1302841|NCT00207142|4240539|P1|Maintenance Phase/Rescue Phase|RTV intake impossible|0
1302842|NCT00207142|4240536|P4|Maintenance Phase/Rescue Phase|Lost to Follow-up|2
1302843|NCT00207142|4240537|P3|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
1302844|NCT00207142|4240538|P2|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
1302845|NCT00207142|4240539|P1|Maintenance Phase/Rescue Phase|Lost to Follow-up|0
1302846|NCT00207142|4240536|P4|Maintenance Phase/Rescue Phase|Adverse Event|1
1302847|NCT00207142|4240537|P3|Maintenance Phase/Rescue Phase|Adverse Event|4
1302848|NCT00207142|4240538|P2|Maintenance Phase/Rescue Phase|Adverse Event|1
1302849|NCT00207142|4240539|P1|Maintenance Phase/Rescue Phase|Adverse Event|0
1302850|NCT00207142|4240536|P4|Induction Phase|Missing lab data|0
1302851|NCT00207142|4240537|P3|Induction Phase|Missing lab data|0
1302852|NCT00207142|4240538|P2|Induction Phase|Missing lab data|0
1302853|NCT00207142|4240539|P1|Induction Phase|Missing lab data|1
1302854|NCT00207142|4240536|P4|Induction Phase|Incarceration|0
1302855|NCT00207142|4240537|P3|Induction Phase|Incarceration|0
1302856|NCT00207142|4240538|P2|Induction Phase|Incarceration|0
1302857|NCT00207142|4240539|P1|Induction Phase|Incarceration|1
1302858|NCT00207142|4240536|P4|Induction Phase|Withdrawal by Subject|0
1302859|NCT00207142|4240537|P3|Induction Phase|Withdrawal by Subject|0
1302860|NCT00207142|4240538|P2|Induction Phase|Withdrawal by Subject|0
1302861|NCT00207142|4240539|P1|Induction Phase|Withdrawal by Subject|4
1302862|NCT00207142|4240536|P4|Induction Phase|Subject no longer meets study criteria|0
1302863|NCT00207142|4240537|P3|Induction Phase|Subject no longer meets study criteria|0
1302864|NCT00207142|4240538|P2|Induction Phase|Subject no longer meets study criteria|0
1302865|NCT00207142|4240539|P1|Induction Phase|Subject no longer meets study criteria|3
1302866|NCT00207142|4240536|P4|Induction Phase|Pregnancy|0
1302867|NCT00207142|4240537|P3|Induction Phase|Pregnancy|0
1302868|NCT00207142|4240538|P2|Induction Phase|Pregnancy|0
1302869|NCT00207142|4240539|P1|Induction Phase|Pregnancy|1
1302870|NCT00207142|4240536|P4|Induction Phase|Poor/noncompliance|0
1302871|NCT00207142|4240537|P3|Induction Phase|Poor/noncompliance|0
1302872|NCT00207142|4240538|P2|Induction Phase|Poor/noncompliance|0
1302873|NCT00207142|4240539|P1|Induction Phase|Poor/noncompliance|2
1302874|NCT00207142|4240536|P4|Induction Phase|Physician Decision|0
1302875|NCT00207142|4240537|P3|Induction Phase|Physician Decision|0
1302876|NCT00207142|4240538|P2|Induction Phase|Physician Decision|0
1302877|NCT00207142|4240539|P1|Induction Phase|Physician Decision|2
1302878|NCT00207142|4240536|P4|Induction Phase|Lost to Follow-up|0
1302879|NCT00207142|4240537|P3|Induction Phase|Lost to Follow-up|0
1302880|NCT00207142|4240538|P2|Induction Phase|Lost to Follow-up|0
1302881|NCT00207142|4240539|P1|Induction Phase|Lost to Follow-up|5
1302882|NCT00207142|4240536|P4|Induction Phase|Lack of Efficacy|0
1302883|NCT00207142|4240537|P3|Induction Phase|Lack of Efficacy|0
1302884|NCT00207142|4240538|P2|Induction Phase|Lack of Efficacy|0
1302885|NCT00207142|4240539|P1|Induction Phase|Lack of Efficacy|1
1302886|NCT00207142|4240536|P4|Induction Phase|Death|0
1302887|NCT00207142|4240537|P3|Induction Phase|Death|0
1302888|NCT00207142|4240538|P2|Induction Phase|Death|0
1302889|NCT00207142|4240539|P1|Induction Phase|Death|1
1302890|NCT00207142|4240536|P4|Induction Phase|Adverse Event|0
1302891|NCT00207142|4240537|P3|Induction Phase|Adverse Event|0
1302892|NCT00207142|4240538|P2|Induction Phase|Adverse Event|0
1302893|NCT00207142|4240539|P1|Induction Phase|Adverse Event|9
1302894|NCT00207090|4240576|P1|Overall Study|Physician Decision|1
1302895|NCT00207090|4240576|P1|Overall Study|Disease progression/relapse|2
1302896|NCT00207090|4240576|P1|Overall Study|Chest wall mass larger|1
1302897|NCT00207090|4240576|P1|Overall Study|Study drug toxicity|3
1302898|NCT00206726|4240605|P1|Overall Study|Withdrawal by Subject|8
1302899|NCT00206726|4240605|P1|Overall Study|Protocol Violation|1
1302900|NCT00206726|4240605|P1|Overall Study|Death|4
1302901|NCT00206726|4240605|P1|Overall Study|Adverse Event|17
1302902|NCT00206726|4240605|P1|Overall Study|Bone marrow transplant|1
1302903|NCT00206726|4240605|P1|Overall Study|Placed on new protocol|1
1302904|NCT00206726|4240605|P1|Overall Study|Progressive disease or relapsed disease|18
1302905|NCT00206726|4240605|P1|Overall Study|Delayed recovery of blood counts|1
1302906|NCT00206518|4240616|P2|Overall Study|Protocol Violation|1
1302907|NCT00206518|4240617|P1|Overall Study|Protocol Violation|1
1302908|NCT00206518|4240616|P2|Overall Study|Physician Decision|0
1302909|NCT00206518|4240617|P1|Overall Study|Physician Decision|1
1302910|NCT00206518|4240616|P2|Overall Study|Adverse Event|1
1302911|NCT00206518|4240617|P1|Overall Study|Adverse Event|2
1302912|NCT00206518|4240616|P2|Overall Study|Lack of Efficacy|4
1302913|NCT00206518|4240617|P1|Overall Study|Lack of Efficacy|6
1302914|NCT00206440|4240629|P2|Overall Study|Adverse Event|2
1302915|NCT00206440|4240630|P1|Overall Study|Adverse Event|4
1302916|NCT00206440|4240629|P2|Overall Study|Protocol Violation|2
1302917|NCT00206440|4240630|P1|Overall Study|Protocol Violation|1
1302918|NCT00206427|4240636|P1|Overall Study|Adverse Event|2
1302919|NCT00206323|4240646|P2|Overall Study|Lost to Follow-up|1
1302920|NCT00206323|4240647|P1|Overall Study|Lost to Follow-up|1
1302921|NCT00206323|4240646|P2|Overall Study|Adverse Event|1
1302922|NCT00206323|4240647|P1|Overall Study|Adverse Event|1
1302923|NCT00206323|4240646|P2|Overall Study|Lack of Efficacy|1
1302924|NCT00206323|4240647|P1|Overall Study|Lack of Efficacy|4
1302925|NCT00206102|4240655|P2|Overall Study|None of those categories|36
1302926|NCT00206102|4240656|P1|Overall Study|None of those categories|42
1302927|NCT00206102|4240655|P2|Overall Study|Study-specific discontinuation criteria|17
1302928|NCT00206102|4240656|P1|Overall Study|Study-specific discontinuation criteria|18
1302929|NCT00206102|4240655|P2|Overall Study|Withdrawal by Subject|101
1302930|NCT00206102|4240656|P1|Overall Study|Withdrawal by Subject|118
1302931|NCT00206102|4240655|P2|Overall Study|Lost to Follow-up|66
1302932|NCT00206102|4240656|P1|Overall Study|Lost to Follow-up|95
1302933|NCT00206102|4240655|P2|Overall Study|Lack of therapeutic response|11
1302934|NCT00206102|4240656|P1|Overall Study|Lack of therapeutic response|16
1302935|NCT00206102|4240655|P2|Overall Study|Protocol Violation|2
1302936|NCT00206102|4240656|P1|Overall Study|Protocol Violation|0
1302937|NCT00206102|4240655|P2|Overall Study|Adverse Event|82
1302938|NCT00206102|4240656|P1|Overall Study|Adverse Event|119
1302939|NCT00206076|4240692|P2|Overall Study|Withdrawal by Subject|1
1302940|NCT00206076|4240693|P1|Overall Study|Withdrawal by Subject|1
1302941|NCT00206076|4240692|P2|Overall Study|Physician Decision|0
1302942|NCT00206076|4240693|P1|Overall Study|Physician Decision|2
1302943|NCT00205881|4240703|P1|Overall Study|Withdrawal by Subject|16
1302944|NCT00205855|4240708|P1|Overall Study|Withdrawal by Subject|5
1302945|NCT00205855|4240708|P1|Overall Study|Only received temporary implants|16
1302946|NCT00205803|4240714|P2|Toddler Dose|Lost to Follow-up|3
1302947|NCT00205803|4240715|P1|Toddler Dose|Lost to Follow-up|2
1302948|NCT00205803|4240714|P2|After Infant Series|Other|4
1302949|NCT00205803|4240715|P1|After Infant Series|Other|10
1302950|NCT00205803|4240714|P2|After Infant Series|Withdrawal by Subject|4
1302951|NCT00205803|4240715|P1|After Infant Series|Withdrawal by Subject|1
1302952|NCT00205803|4240714|P2|After Infant Series|Physician Decision|2
1302953|NCT00205803|4240715|P1|After Infant Series|Physician Decision|3
1302954|NCT00205803|4240714|P2|After Infant Series|Lost to Follow-up|1
1302955|NCT00205803|4240715|P1|After Infant Series|Lost to Follow-up|2
1302956|NCT00205803|4240714|P2|After Infant Series|Protocol Violation|1
1302957|NCT00205803|4240715|P1|After Infant Series|Protocol Violation|1
1302958|NCT00205803|4240714|P2|After Infant Series|Adverse Event|1
1302959|NCT00205803|4240715|P1|After Infant Series|Adverse Event|1
1302960|NCT00205803|4240714|P2|Infant Series|Sponsor request|0
1302961|NCT00205803|4240715|P1|Infant Series|Sponsor request|1
1302962|NCT00205803|4240714|P2|Infant Series|Non-compliant|0
1302963|NCT00205803|4240715|P1|Infant Series|Non-compliant|1
1302964|NCT00205803|4240714|P2|Infant Series|Lost Kaiser coverage|1
1302965|NCT00205803|4240715|P1|Infant Series|Lost Kaiser coverage|0
1302966|NCT00205803|4240714|P2|Infant Series|Protocol Violation|0
1302967|NCT00205803|4240715|P1|Infant Series|Protocol Violation|1
1302968|NCT00205803|4240714|P2|Infant Series|Physician Decision|1
1302969|NCT00205803|4240715|P1|Infant Series|Physician Decision|3
1302970|NCT00205803|4240714|P2|Infant Series|Withdrawal by Subject|5
1302971|NCT00205803|4240715|P1|Infant Series|Withdrawal by Subject|2
1302972|NCT00205803|4240714|P2|Infant Series|Lost to Follow-up|4
1302973|NCT00205803|4240715|P1|Infant Series|Lost to Follow-up|10
1302974|NCT00205777|4240771|P6|Study Extension II|Enrolled but not treated|131
1302975|NCT00205777|4240772|P5|Study Extension II|Enrolled but not treated|0
1302976|NCT00205777|4240773|P4|Study Extension II|Enrolled but not treated|71
1302977|NCT00205777|4240774|P3|Study Extension II|Enrolled but not treated|0
1302978|NCT00205777|4240775|P2|Study Extension II|Enrolled but not treated|0
1302979|NCT00205777|4240776|P1|Study Extension II|Enrolled but not treated|0
1302980|NCT00205777|4240771|P6|Study Extension II|Other Event|20
1302981|NCT00205777|4240772|P5|Study Extension II|Other Event|0
1302982|NCT00205777|4240773|P4|Study Extension II|Other Event|12
1302983|NCT00205777|4240774|P3|Study Extension II|Other Event|0
1302984|NCT00205777|4240775|P2|Study Extension II|Other Event|0
1302985|NCT00205777|4240776|P1|Study Extension II|Other Event|0
1302986|NCT00205777|4240771|P6|Study Extension II|Failed to return|26
1302987|NCT00205777|4240772|P5|Study Extension II|Failed to return|0
1302988|NCT00205777|4240773|P4|Study Extension II|Failed to return|14
1302989|NCT00205777|4240774|P3|Study Extension II|Failed to return|0
1302990|NCT00205777|4240775|P2|Study Extension II|Failed to return|0
1302991|NCT00205777|4240776|P1|Study Extension II|Failed to return|0
1302992|NCT00205777|4240771|P6|Study Extension II|Lack of Efficacy|1
1302993|NCT00205777|4240772|P5|Study Extension II|Lack of Efficacy|0
1302994|NCT00205777|4240773|P4|Study Extension II|Lack of Efficacy|0
1302995|NCT00205777|4240774|P3|Study Extension II|Lack of Efficacy|0
1302996|NCT00205777|4240775|P2|Study Extension II|Lack of Efficacy|0
1302997|NCT00205777|4240776|P1|Study Extension II|Lack of Efficacy|0
1302998|NCT00205777|4240771|P6|Study Extension II|Protocol Violation|10
1302999|NCT00205777|4240772|P5|Study Extension II|Protocol Violation|0
1303000|NCT00205777|4240773|P4|Study Extension II|Protocol Violation|1
1303001|NCT00205777|4240774|P3|Study Extension II|Protocol Violation|0
1303002|NCT00205777|4240775|P2|Study Extension II|Protocol Violation|0
1303003|NCT00205777|4240776|P1|Study Extension II|Protocol Violation|0
1303004|NCT00205777|4240771|P6|Study Extension II|Withdrawal by Subject|59
1303005|NCT00205777|4240772|P5|Study Extension II|Withdrawal by Subject|0
1303006|NCT00205777|4240773|P4|Study Extension II|Withdrawal by Subject|35
1303007|NCT00205777|4240774|P3|Study Extension II|Withdrawal by Subject|0
1303008|NCT00205777|4240775|P2|Study Extension II|Withdrawal by Subject|0
1303009|NCT00205777|4240776|P1|Study Extension II|Withdrawal by Subject|0
1303010|NCT00205777|4240771|P6|Study Extension II|Death|5
1303011|NCT00205777|4240772|P5|Study Extension II|Death|0
1303012|NCT00205777|4240773|P4|Study Extension II|Death|2
1303013|NCT00205777|4240774|P3|Study Extension II|Death|0
1303014|NCT00205777|4240775|P2|Study Extension II|Death|0
1303015|NCT00205777|4240776|P1|Study Extension II|Death|0
1303016|NCT00205777|4240771|P6|Study Extension II|Adverse Event|30
1303017|NCT00205777|4240772|P5|Study Extension II|Adverse Event|0
1303018|NCT00205777|4240773|P4|Study Extension II|Adverse Event|14
1303019|NCT00205777|4240774|P3|Study Extension II|Adverse Event|0
1303020|NCT00205777|4240775|P2|Study Extension II|Adverse Event|0
1303021|NCT00205777|4240776|P1|Study Extension II|Adverse Event|0
1303022|NCT00205777|4240771|P6|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
1303023|NCT00205777|4240772|P5|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258
1303024|NCT00205777|4240773|P4|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240
1303025|NCT00205777|4240774|P3|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
1303026|NCT00205777|4240775|P2|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
1303027|NCT00205777|4240776|P1|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273
1303028|NCT00205777|4240771|P6|Study Extension I|Withdrawn as per protocol|0
1303029|NCT00205777|4240772|P5|Study Extension I|Withdrawn as per protocol|0
1303030|NCT00205777|4240773|P4|Study Extension I|Withdrawn as per protocol|0
1303031|NCT00205777|4240774|P3|Study Extension I|Withdrawn as per protocol|1070
1303032|NCT00205777|4240775|P2|Study Extension I|Withdrawn as per protocol|0
1303033|NCT00205777|4240776|P1|Study Extension I|Withdrawn as per protocol|0
1303034|NCT00205777|4240771|P6|Study Extension I|Other Event|0
1303035|NCT00205777|4240772|P5|Study Extension I|Other Event|29
1303036|NCT00205777|4240773|P4|Study Extension I|Other Event|34
1303037|NCT00205777|4240774|P3|Study Extension I|Other Event|0
1303038|NCT00205777|4240775|P2|Study Extension I|Other Event|0
1303039|NCT00205777|4240776|P1|Study Extension I|Other Event|34
1303040|NCT00205777|4240771|P6|Study Extension I|Failed to return|0
1303041|NCT00205777|4240772|P5|Study Extension I|Failed to return|13
1303042|NCT00205777|4240773|P4|Study Extension I|Failed to return|17
1303043|NCT00205777|4240774|P3|Study Extension I|Failed to return|0
1303044|NCT00205777|4240775|P2|Study Extension I|Failed to return|0
1303045|NCT00205777|4240776|P1|Study Extension I|Failed to return|15
1303046|NCT00205777|4240771|P6|Study Extension I|Lack of Efficacy|0
1303047|NCT00205777|4240772|P5|Study Extension I|Lack of Efficacy|2
1303048|NCT00205777|4240773|P4|Study Extension I|Lack of Efficacy|1
1303049|NCT00205777|4240774|P3|Study Extension I|Lack of Efficacy|0
1303050|NCT00205777|4240775|P2|Study Extension I|Lack of Efficacy|0
1303051|NCT00205777|4240776|P1|Study Extension I|Lack of Efficacy|0
1303052|NCT00205777|4240771|P6|Study Extension I|Protocol Violation|0
1303053|NCT00205777|4240772|P5|Study Extension I|Protocol Violation|8
1303054|NCT00205777|4240773|P4|Study Extension I|Protocol Violation|8
1303055|NCT00205777|4240774|P3|Study Extension I|Protocol Violation|0
1303056|NCT00205777|4240775|P2|Study Extension I|Protocol Violation|0
1303057|NCT00205777|4240776|P1|Study Extension I|Protocol Violation|4
1303058|NCT00205777|4240771|P6|Study Extension I|Withdrawal by Subject|0
1303059|NCT00205777|4240772|P5|Study Extension I|Withdrawal by Subject|89
1303060|NCT00205777|4240773|P4|Study Extension I|Withdrawal by Subject|106
1303061|NCT00205777|4240774|P3|Study Extension I|Withdrawal by Subject|0
1303062|NCT00205777|4240775|P2|Study Extension I|Withdrawal by Subject|0
1303063|NCT00205777|4240776|P1|Study Extension I|Withdrawal by Subject|99
1303064|NCT00205777|4240771|P6|Study Extension I|Death|0
1303065|NCT00205777|4240772|P5|Study Extension I|Death|2
1303066|NCT00205777|4240773|P4|Study Extension I|Death|1
1303067|NCT00205777|4240774|P3|Study Extension I|Death|0
1303068|NCT00205777|4240775|P2|Study Extension I|Death|0
1303069|NCT00205777|4240776|P1|Study Extension I|Death|5
1303070|NCT00205777|4240771|P6|Study Extension I|Adverse Event|0
1303071|NCT00205777|4240772|P5|Study Extension I|Adverse Event|58
1303072|NCT00205777|4240773|P4|Study Extension I|Adverse Event|61
1303073|NCT00205777|4240774|P3|Study Extension I|Adverse Event|0
1303074|NCT00205777|4240775|P2|Study Extension I|Adverse Event|0
1303075|NCT00205777|4240776|P1|Study Extension I|Adverse Event|57
1303076|NCT00205777|4240771|P6|Completed Core Study, Entered SE I|Other Event|0
1303077|NCT00205777|4240772|P5|Completed Core Study, Entered SE I|Other Event|0
1303078|NCT00205777|4240773|P4|Completed Core Study, Entered SE I|Other Event|50
1303079|NCT00205777|4240774|P3|Completed Core Study, Entered SE I|Other Event|47
1303080|NCT00205777|4240775|P2|Completed Core Study, Entered SE I|Other Event|46
1303081|NCT00205777|4240776|P1|Completed Core Study, Entered SE I|Other Event|52
1303082|NCT00205777|4240771|P6|Completed Core Study, Entered SE I|Withdrawal by Subject|0
1303083|NCT00205777|4240772|P5|Completed Core Study, Entered SE I|Withdrawal by Subject|0
1303084|NCT00205777|4240773|P4|Completed Core Study, Entered SE I|Withdrawal by Subject|174
1303085|NCT00205777|4240774|P3|Completed Core Study, Entered SE I|Withdrawal by Subject|160
1303086|NCT00205777|4240775|P2|Completed Core Study, Entered SE I|Withdrawal by Subject|158
1303087|NCT00205777|4240776|P1|Completed Core Study, Entered SE I|Withdrawal by Subject|180
1303088|NCT00205777|4240771|P6|Core Study (Up to 3 Years)|Randomized but not treated|0
1303089|NCT00205777|4240772|P5|Core Study (Up to 3 Years)|Randomized but not treated|0
1303090|NCT00205777|4240773|P4|Core Study (Up to 3 Years)|Randomized but not treated|29
1303091|NCT00205777|4240774|P3|Core Study (Up to 3 Years)|Randomized but not treated|35
1303092|NCT00205777|4240775|P2|Core Study (Up to 3 Years)|Randomized but not treated|32
1303093|NCT00205777|4240776|P1|Core Study (Up to 3 Years)|Randomized but not treated|21
1303094|NCT00205777|4240771|P6|Core Study (Up to 3 Years)|Lack of Efficacy|0
1303095|NCT00205777|4240772|P5|Core Study (Up to 3 Years)|Lack of Efficacy|0
1303096|NCT00205777|4240773|P4|Core Study (Up to 3 Years)|Lack of Efficacy|75
1303097|NCT00205777|4240774|P3|Core Study (Up to 3 Years)|Lack of Efficacy|39
1303098|NCT00205777|4240775|P2|Core Study (Up to 3 Years)|Lack of Efficacy|52
1303099|NCT00205777|4240776|P1|Core Study (Up to 3 Years)|Lack of Efficacy|52
1303100|NCT00205777|4240771|P6|Core Study (Up to 3 Years)|Protocol Violation|0
1303101|NCT00205777|4240772|P5|Core Study (Up to 3 Years)|Protocol Violation|0
1303102|NCT00205777|4240773|P4|Core Study (Up to 3 Years)|Protocol Violation|42
1303103|NCT00205777|4240774|P3|Core Study (Up to 3 Years)|Protocol Violation|50
1303104|NCT00205777|4240775|P2|Core Study (Up to 3 Years)|Protocol Violation|55
1303105|NCT00205777|4240776|P1|Core Study (Up to 3 Years)|Protocol Violation|53
1303106|NCT00205777|4240771|P6|Core Study (Up to 3 Years)|Withdrawal by Subject|0
1303107|NCT00205777|4240772|P5|Core Study (Up to 3 Years)|Withdrawal by Subject|0
1303108|NCT00205777|4240773|P4|Core Study (Up to 3 Years)|Withdrawal by Subject|162
1303109|NCT00205777|4240774|P3|Core Study (Up to 3 Years)|Withdrawal by Subject|149
1303110|NCT00205777|4240775|P2|Core Study (Up to 3 Years)|Withdrawal by Subject|169
1303111|NCT00205777|4240776|P1|Core Study (Up to 3 Years)|Withdrawal by Subject|144
1303112|NCT00205777|4240771|P6|Core Study (Up to 3 Years)|Other Event|0
1303113|NCT00205777|4240772|P5|Core Study (Up to 3 Years)|Other Event|0
1303114|NCT00205777|4240773|P4|Core Study (Up to 3 Years)|Other Event|58
1303115|NCT00205777|4240774|P3|Core Study (Up to 3 Years)|Other Event|41
1303116|NCT00205777|4240775|P2|Core Study (Up to 3 Years)|Other Event|52
1303117|NCT00205777|4240776|P1|Core Study (Up to 3 Years)|Other Event|49
1303118|NCT00205777|4240771|P6|Core Study (Up to 3 Years)|Failed to return|0
1303119|NCT00205777|4240772|P5|Core Study (Up to 3 Years)|Failed to return|0
1303120|NCT00205777|4240773|P4|Core Study (Up to 3 Years)|Failed to return|27
1303121|NCT00205777|4240774|P3|Core Study (Up to 3 Years)|Failed to return|27
1303122|NCT00205777|4240775|P2|Core Study (Up to 3 Years)|Failed to return|25
1303123|NCT00205777|4240776|P1|Core Study (Up to 3 Years)|Failed to return|40
1303124|NCT00205777|4240771|P6|Core Study (Up to 3 Years)|Death|0
1303125|NCT00205777|4240772|P5|Core Study (Up to 3 Years)|Death|0
1303126|NCT00205777|4240773|P4|Core Study (Up to 3 Years)|Death|7
1303127|NCT00205777|4240774|P3|Core Study (Up to 3 Years)|Death|14
1303128|NCT00205777|4240775|P2|Core Study (Up to 3 Years)|Death|7
1303129|NCT00205777|4240776|P1|Core Study (Up to 3 Years)|Death|9
1303130|NCT00205777|4240771|P6|Core Study (Up to 3 Years)|Adverse Event|0
1303131|NCT00205777|4240772|P5|Core Study (Up to 3 Years)|Adverse Event|0
1303132|NCT00205777|4240773|P4|Core Study (Up to 3 Years)|Adverse Event|232
1303133|NCT00205777|4240774|P3|Core Study (Up to 3 Years)|Adverse Event|252
1303134|NCT00205777|4240775|P2|Core Study (Up to 3 Years)|Adverse Event|267
1303135|NCT00205777|4240776|P1|Core Study (Up to 3 Years)|Adverse Event|260
1303136|NCT00205712|4240985|P2|Overall Study|Lost to Follow-up|1
1303137|NCT00205712|4240986|P1|Overall Study|Lost to Follow-up|0
1303138|NCT00205699|4240999|P3|Overall Study|Lack of Efficacy|0
1303139|NCT00205699|4241000|P2|Overall Study|Lack of Efficacy|1
1303140|NCT00205699|4241001|P1|Overall Study|Lack of Efficacy|0
1303141|NCT00205699|4240999|P3|Overall Study|Withdrawal by Subject|1
1303142|NCT00205699|4241000|P2|Overall Study|Withdrawal by Subject|2
1303143|NCT00205699|4241001|P1|Overall Study|Withdrawal by Subject|1
1303144|NCT00205699|4240999|P3|Overall Study|Adverse Event|0
1303145|NCT00205699|4241000|P2|Overall Study|Adverse Event|0
1303146|NCT00205699|4241001|P1|Overall Study|Adverse Event|1
1303147|NCT00205699|4240999|P3|Overall Study|Lost to Follow-up|5
1303148|NCT00205699|4241000|P2|Overall Study|Lost to Follow-up|3
1303149|NCT00205699|4241001|P1|Overall Study|Lost to Follow-up|1
1303150|NCT00203996|4241095|P10|Overall Study|Scheduling issue|0
1303151|NCT00203996|4241096|P9|Overall Study|Scheduling issue|0
1303152|NCT00203996|4241097|P8|Overall Study|Scheduling issue|2
1303153|NCT00203996|4241098|P7|Overall Study|Scheduling issue|0
1303154|NCT00203996|4241099|P6|Overall Study|Scheduling issue|0
1303155|NCT00203996|4241100|P5|Overall Study|Scheduling issue|0
1303156|NCT00203996|4241101|P4|Overall Study|Scheduling issue|0
1303157|NCT00203996|4241102|P3|Overall Study|Scheduling issue|0
1303158|NCT00203996|4241103|P2|Overall Study|Scheduling issue|0
1303159|NCT00203996|4241104|P1|Overall Study|Scheduling issue|0
1303160|NCT00203996|4241095|P10|Overall Study|CPAP machine malfunction|0
1303161|NCT00203996|4241096|P9|Overall Study|CPAP machine malfunction|0
1303162|NCT00203996|4241097|P8|Overall Study|CPAP machine malfunction|0
1303163|NCT00203996|4241098|P7|Overall Study|CPAP machine malfunction|0
1303164|NCT00203996|4241099|P6|Overall Study|CPAP machine malfunction|0
1303165|NCT00203996|4241100|P5|Overall Study|CPAP machine malfunction|0
1303166|NCT00203996|4241101|P4|Overall Study|CPAP machine malfunction|1
1303167|NCT00203996|4241102|P3|Overall Study|CPAP machine malfunction|0
1303168|NCT00203996|4241103|P2|Overall Study|CPAP machine malfunction|0
1303169|NCT00203996|4241104|P1|Overall Study|CPAP machine malfunction|0
1303170|NCT00203996|4241095|P10|Overall Study|Physician Decision|1
1303171|NCT00203996|4241096|P9|Overall Study|Physician Decision|0
1303172|NCT00203996|4241097|P8|Overall Study|Physician Decision|0
1303173|NCT00203996|4241098|P7|Overall Study|Physician Decision|0
1303174|NCT00203996|4241099|P6|Overall Study|Physician Decision|0
1303175|NCT00203996|4241100|P5|Overall Study|Physician Decision|0
1303176|NCT00203996|4241101|P4|Overall Study|Physician Decision|2
1303177|NCT00203996|4241102|P3|Overall Study|Physician Decision|0
1303178|NCT00203996|4241103|P2|Overall Study|Physician Decision|0
1303179|NCT00203996|4241104|P1|Overall Study|Physician Decision|0
1303180|NCT00203996|4241095|P10|Overall Study|Protocol Violation|0
1303181|NCT00203996|4241096|P9|Overall Study|Protocol Violation|0
1303182|NCT00203996|4241097|P8|Overall Study|Protocol Violation|0
1303183|NCT00203996|4241098|P7|Overall Study|Protocol Violation|0
1303184|NCT00203996|4241099|P6|Overall Study|Protocol Violation|0
1303185|NCT00203996|4241100|P5|Overall Study|Protocol Violation|1
1303186|NCT00203996|4241101|P4|Overall Study|Protocol Violation|6
1303187|NCT00203996|4241102|P3|Overall Study|Protocol Violation|0
1303188|NCT00203996|4241103|P2|Overall Study|Protocol Violation|0
1303189|NCT00203996|4241104|P1|Overall Study|Protocol Violation|0
1303190|NCT00203996|4241095|P10|Overall Study|Lost to Follow-up|0
1303191|NCT00203996|4241096|P9|Overall Study|Lost to Follow-up|0
1303192|NCT00203996|4241097|P8|Overall Study|Lost to Follow-up|0
1303193|NCT00203996|4241098|P7|Overall Study|Lost to Follow-up|0
1303194|NCT00203996|4241099|P6|Overall Study|Lost to Follow-up|0
1303195|NCT00203996|4241100|P5|Overall Study|Lost to Follow-up|0
1303196|NCT00203996|4241101|P4|Overall Study|Lost to Follow-up|1
1303197|NCT00203996|4241102|P3|Overall Study|Lost to Follow-up|0
1303198|NCT00203996|4241103|P2|Overall Study|Lost to Follow-up|0
1303199|NCT00203996|4241104|P1|Overall Study|Lost to Follow-up|0
1303200|NCT00203892|4241171|P3|Overall Study|Death|0
1303201|NCT00203892|4241172|P2|Overall Study|Death|0
1303202|NCT00203892|4241173|P1|Overall Study|Death|1
1303203|NCT00203892|4241171|P3|Overall Study|Physician Decision|0
1303204|NCT00203892|4241172|P2|Overall Study|Physician Decision|2
1303205|NCT00203892|4241173|P1|Overall Study|Physician Decision|1
1303206|NCT00203502|4241184|P1|Overall Study|Death|1
1303207|NCT00203476|4241195|P3|Overall Study|Withdrawal by Subject|0
1303208|NCT00203476|4241196|P2|Overall Study|Withdrawal by Subject|1
1303209|NCT00203476|4241197|P1|Overall Study|Withdrawal by Subject|0
1303210|NCT00203476|4241195|P3|Overall Study|Lost to Follow-up|0
1303211|NCT00203476|4241196|P2|Overall Study|Lost to Follow-up|0
1303212|NCT00203476|4241197|P1|Overall Study|Lost to Follow-up|1
1303213|NCT00203424|4241214|P1|Follow-up Period|Lost to Follow-up|1
1303214|NCT00203424|4241214|P1|Follow-up Period|progressive disease|4
1303215|NCT00203424|4241214|P1|Follow-up Period|Withdrawal by Subject|1
1303216|NCT00203424|4241214|P1|Treatment Period|progressive disease|2
1303217|NCT00203424|4241214|P1|Treatment Period|Adverse Event|5
1303218|NCT00203424|4241214|P1|Treatment Period|Withdrawal by Subject|4
1303219|NCT00203411|4241221|P1|Follow-up|Progressive Disease|4
1303220|NCT00203307|4241230|P2|First Intervention|Adverse Event|0
1303221|NCT00203307|4241231|P1|First Intervention|Adverse Event|2
1303222|NCT00203294|4241239|P2|Overall Study|Withdrawal by Subject|13
1303223|NCT00203294|4241240|P1|Overall Study|Withdrawal by Subject|8
1303224|NCT00203268|4241246|P1|Early Treatment|Withdrawal by Subject|1
1303225|NCT00203268|4241246|P1|Early Treatment|Lost to Follow-up|1
1303226|NCT00203268|4241246|P1|Early Treatment|only treated one headache|2
1303227|NCT00203242|4241252|P1|Overall Study|Lost to Follow-up|1
1303228|NCT00203047|4241304|P2|Overall Study|Not specified|5
1303229|NCT00203047|4241305|P1|Overall Study|Not specified|5
1303230|NCT00203047|4241304|P2|Overall Study|Pregnancy|0
1303231|NCT00203047|4241305|P1|Overall Study|Pregnancy|3
1303232|NCT00203047|4241304|P2|Overall Study|Death|2
1303233|NCT00203047|4241305|P1|Overall Study|Death|1
1303234|NCT00203047|4241304|P2|Overall Study|Adverse Event|18
1303235|NCT00203047|4241305|P1|Overall Study|Adverse Event|8
1303236|NCT00203047|4241304|P2|Overall Study|Lost to Follow-up|5
1303237|NCT00203047|4241305|P1|Overall Study|Lost to Follow-up|11
1303238|NCT00203047|4241304|P2|Overall Study|Protocol Violation|0
1303239|NCT00203047|4241305|P1|Overall Study|Protocol Violation|1
1303240|NCT00203047|4241304|P2|Overall Study|Non-compliance|8
1303241|NCT00203047|4241305|P1|Overall Study|Non-compliance|4
1303242|NCT00203047|4241304|P2|Overall Study|Physician Decision|7
1303243|NCT00203047|4241305|P1|Overall Study|Physician Decision|8
1303244|NCT00203047|4241304|P2|Overall Study|Teva requested participant withdrawal|1
1303245|NCT00203047|4241305|P1|Overall Study|Teva requested participant withdrawal|1
1303246|NCT00203047|4241304|P2|Overall Study|Withdrawal by Subject|47
1303247|NCT00203047|4241305|P1|Overall Study|Withdrawal by Subject|13
1303248|NCT00203047|4241304|P2|Overall Study|Ongoing: not in database - Jan 29, 2009|1
1303249|NCT00203047|4241305|P1|Overall Study|Ongoing: not in database - Jan 29, 2009|5
1303250|NCT00203047|4241304|P2|Overall Study|Ongoing: in database - January 29, 2009|109
1303251|NCT00203047|4241305|P1|Overall Study|Ongoing: in database - January 29, 2009|131
1303252|NCT00202878|4241319|P2|Overall Study|Withdrawal by Subject|808
1303253|NCT00202878|4241320|P1|Overall Study|Withdrawal by Subject|795
1303254|NCT00202878|4241319|P2|Overall Study|Site Closure|36
1303255|NCT00202878|4241320|P1|Overall Study|Site Closure|39
1303256|NCT00202878|4241319|P2|Overall Study|Lost to Follow-up|49
1303257|NCT00202878|4241320|P1|Overall Study|Lost to Follow-up|44
1303258|NCT00202878|4241319|P2|Overall Study|Only Vital Status Known|356
1303259|NCT00202878|4241320|P1|Overall Study|Only Vital Status Known|357
1303260|NCT00202878|4241319|P2|Overall Study|Death|968
1303261|NCT00202878|4241320|P1|Overall Study|Death|964
1303262|NCT00202839|4241334|P2|Overall Study|Lost to Follow-up|2
1303263|NCT00202839|4241335|P1|Overall Study|Lost to Follow-up|3
1303264|NCT00202839|4241334|P2|Overall Study|Protocol Violation|1
1303265|NCT00202839|4241335|P1|Overall Study|Protocol Violation|2
1303266|NCT00202839|4241334|P2|Overall Study|Withdrawal by Subject|2
1303267|NCT00202839|4241335|P1|Overall Study|Withdrawal by Subject|6
1303268|NCT00202839|4241334|P2|Overall Study|Physician Decision|0
1303269|NCT00202839|4241335|P1|Overall Study|Physician Decision|12
1303270|NCT00202839|4241334|P2|Overall Study|Adverse Event|5
1303271|NCT00202839|4241335|P1|Overall Study|Adverse Event|1
1303272|NCT00202644|4241350|P2|Overall Study|Other|1
1303273|NCT00202644|4241351|P1|Overall Study|Other|9
1303274|NCT00202644|4241350|P2|Overall Study|Lost to Follow-up|1
1303275|NCT00202644|4241351|P1|Overall Study|Lost to Follow-up|0
1303276|NCT00202644|4241350|P2|Overall Study|Lack of Efficacy|6
1303277|NCT00202644|4241351|P1|Overall Study|Lack of Efficacy|6
1303278|NCT00202644|4241350|P2|Overall Study|Withdrawal by Subject|6
1303279|NCT00202644|4241351|P1|Overall Study|Withdrawal by Subject|8
1303280|NCT00202644|4241350|P2|Overall Study|Adverse Event|13
1303281|NCT00202644|4241351|P1|Overall Study|Adverse Event|12
1303282|NCT00201851|4241412|P3|Overall Study|Ineligible post enrollment|1
1303283|NCT00201851|4241413|P2|Overall Study|Ineligible post enrollment|1
1303284|NCT00201851|4241414|P1|Overall Study|Ineligible post enrollment|6
1303285|NCT00201851|4241412|P3|Overall Study|Lost to Follow-up|0
1303286|NCT00201851|4241413|P2|Overall Study|Lost to Follow-up|1
1303287|NCT00201851|4241414|P1|Overall Study|Lost to Follow-up|2
1303288|NCT00201643|4241486|P2|Overall Study|Withdrawal by Subject|4
1303289|NCT00201643|4241487|P1|Overall Study|Withdrawal by Subject|5
1303290|NCT00201201|4241551|P2|Overall Study|Withdrawal by Subject|5
1303291|NCT00201201|4241552|P1|Overall Study|Withdrawal by Subject|5
1303292|NCT00201201|4241551|P2|Overall Study|Death|2
1303293|NCT00201201|4241552|P1|Overall Study|Death|0
1303294|NCT00201006|4241590|P3|Overall Study|Adverse Event|1
1303295|NCT00201006|4241591|P2|Overall Study|Adverse Event|0
1303296|NCT00201006|4241592|P1|Overall Study|Adverse Event|1
1303297|NCT00201006|4241590|P3|Overall Study|Withdrawal by Subject|3
1303298|NCT00201006|4241591|P2|Overall Study|Withdrawal by Subject|2
1303299|NCT00201006|4241592|P1|Overall Study|Withdrawal by Subject|7
1303300|NCT00200967|4241602|P2|Run-out Period|Lost to Follow-up|0
1303301|NCT00200967|4241603|P1|Run-out Period|Lost to Follow-up|1
1303302|NCT00200967|4241602|P2|Second Treatment Period|Withdrawal by Subject|2
1303303|NCT00200967|4241603|P1|Second Treatment Period|Withdrawal by Subject|1
1303304|NCT00200967|4241602|P2|Wash-out Period|Lost to Follow-up|1
1303305|NCT00200967|4241603|P1|Wash-out Period|Lost to Follow-up|0
1303306|NCT00200967|4241602|P2|First Treatment Period|Pregnancy|0
1303307|NCT00200967|4241603|P1|First Treatment Period|Pregnancy|1
1303308|NCT00200967|4241602|P2|First Treatment Period|Withdrawal by Subject|1
1303309|NCT00200967|4241603|P1|First Treatment Period|Withdrawal by Subject|5
1303310|NCT00200356|4241644|P2|Overall Study|Nontreatment|0
1303311|NCT00200356|4241645|P1|Overall Study|Nontreatment|1
1303312|NCT00200356|4241644|P2|Overall Study|Protocol Violation|4
1303313|NCT00200356|4241645|P1|Overall Study|Protocol Violation|4
1303314|NCT00200356|4241644|P2|Overall Study|Lack of Efficacy|3
1303315|NCT00200356|4241645|P1|Overall Study|Lack of Efficacy|3
1303316|NCT00200057|4241712|P1|Overall Study|Death|1
1303317|NCT00200057|4241712|P1|Overall Study|Infection|1
1303318|NCT00200057|4241712|P1|Overall Study|Change in medical condition|1
1303319|NCT00200057|4241712|P1|Overall Study|Withdrawal by Subject|1
1303320|NCT00200057|4241712|P1|Overall Study|Exited due to terminal illness of PI|2
1303321|NCT00200057|4241712|P1|Overall Study|Lack of Efficacy|3
1303322|NCT00199875|4241736|P5|Overall Study|Withdrawal by Subject|1
1303323|NCT00199875|4241737|P4|Overall Study|Withdrawal by Subject|0
1303324|NCT00199875|4241738|P3|Overall Study|Withdrawal by Subject|0
1303325|NCT00199875|4241739|P2|Overall Study|Withdrawal by Subject|0
1303326|NCT00199875|4241740|P1|Overall Study|Withdrawal by Subject|0
1303327|NCT00199381|4241762|P1|Overall Study|Study termination by Sponsor|323
1303328|NCT00199381|4241762|P1|Overall Study|Not including due to early termination|37
1303329|NCT00199381|4241762|P1|Overall Study|Lack of Efficacy|27
1303330|NCT00199381|4241762|P1|Overall Study|Protocol Violation|6
1303331|NCT00199381|4241762|P1|Overall Study|Adverse Event|73
1303332|NCT00199381|4241762|P1|Overall Study|Withdrawal by Subject|38
1303333|NCT00198822|4241769|P3|Overall Study|Lost to Follow-up|21
1303334|NCT00198822|4241770|P2|Overall Study|Lost to Follow-up|20
1303335|NCT00198822|4241771|P1|Overall Study|Lost to Follow-up|14
1303336|NCT00198133|4241790|P2|Overall Study|Physician Decision|0
1303337|NCT00198133|4241791|P1|Overall Study|Physician Decision|1
1303338|NCT00198133|4241790|P2|Overall Study|Withdrawal by Subject|0
1303339|NCT00198133|4241791|P1|Overall Study|Withdrawal by Subject|1
1303340|NCT00198133|4241790|P2|Overall Study|Adverse Event|3
1303341|NCT00198133|4241791|P1|Overall Study|Adverse Event|1
1303342|NCT00198133|4241790|P2|Overall Study|Disease progression|5
1303343|NCT00198133|4241791|P1|Overall Study|Disease progression|2
1303344|NCT00198029|4241834|P1|Overall Study|Withdrawal by Subject|4
1303345|NCT00197496|4241841|P2|Follow-up|Lost to Follow-up|1
1303346|NCT00197496|4241842|P1|Follow-up|Lost to Follow-up|2
1303347|NCT00197496|4241841|P2|Baseline to Discharge|Protocol Violation|1
1303348|NCT00197496|4241842|P1|Baseline to Discharge|Protocol Violation|0
1303349|NCT00197496|4241841|P2|Baseline to Discharge|Physician Decision|1
1303350|NCT00197496|4241842|P1|Baseline to Discharge|Physician Decision|0
1303351|NCT00197496|4241841|P2|Baseline to Discharge|MRSA|0
1303352|NCT00197496|4241842|P1|Baseline to Discharge|MRSA|1
1303353|NCT00197496|4241841|P2|Baseline to Discharge|not interested|0
1303354|NCT00197496|4241842|P1|Baseline to Discharge|not interested|1
1303355|NCT00197236|4241890|P3|Overall Study|Returned out of specified time window|1
1303356|NCT00197236|4241891|P2|Overall Study|Returned out of specified time window|0
1303357|NCT00197236|4241892|P1|Overall Study|Returned out of specified time window|0
1303358|NCT00197236|4241890|P3|Overall Study|Study drug/medication expiration|3
1303359|NCT00197236|4241891|P2|Overall Study|Study drug/medication expiration|0
1303360|NCT00197236|4241892|P1|Overall Study|Study drug/medication expiration|1
1303361|NCT00197236|4241890|P3|Overall Study|Withdrawal by Subject|11
1303362|NCT00197236|4241891|P2|Overall Study|Withdrawal by Subject|3
1303363|NCT00197236|4241892|P1|Overall Study|Withdrawal by Subject|7
1303364|NCT00197236|4241890|P3|Overall Study|Protocol Violation|1
1303365|NCT00197236|4241891|P2|Overall Study|Protocol Violation|0
1303366|NCT00197236|4241892|P1|Overall Study|Protocol Violation|0
1303367|NCT00197236|4241890|P3|Overall Study|Lost to Follow-up|6
1303368|NCT00197236|4241891|P2|Overall Study|Lost to Follow-up|14
1303369|NCT00197236|4241892|P1|Overall Study|Lost to Follow-up|5
1303370|NCT00197236|4241890|P3|Overall Study|Adverse Event|1
1303371|NCT00197236|4241891|P2|Overall Study|Adverse Event|0
1303372|NCT00197236|4241892|P1|Overall Study|Adverse Event|1
1303373|NCT00197145|4241966|P2|Period 2 : Open Label Phase|Other|0
1303374|NCT00197145|4241967|P1|Period 2 : Open Label Phase|Other|1
1303375|NCT00197145|4241966|P2|Period 2 : Open Label Phase|Were ongoing till data freeze|0
1303376|NCT00197145|4241967|P1|Period 2 : Open Label Phase|Were ongoing till data freeze|3
1303377|NCT00197145|4241966|P2|Period 2 : Open Label Phase|Availability of alternative ART|0
1303378|NCT00197145|4241967|P1|Period 2 : Open Label Phase|Availability of alternative ART|2
1303379|NCT00197145|4241966|P2|Period 2 : Open Label Phase|Protocol defined virological failure|0
1303380|NCT00197145|4241967|P1|Period 2 : Open Label Phase|Protocol defined virological failure|3
1303381|NCT00197145|4241966|P2|Period 2 : Open Label Phase|Insufficient viral load response|0
1303382|NCT00197145|4241967|P1|Period 2 : Open Label Phase|Insufficient viral load response|1
1303383|NCT00197145|4241966|P2|Period 1: Randomized Treatment Phase|Other|2
1303384|NCT00197145|4241967|P1|Period 1: Randomized Treatment Phase|Other|2
1303385|NCT00197145|4241966|P2|Period 1: Randomized Treatment Phase|Sponsor terminated study|8
1303386|NCT00197145|4241967|P1|Period 1: Randomized Treatment Phase|Sponsor terminated study|10
1303387|NCT00197145|4241966|P2|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1
1303388|NCT00197145|4241967|P1|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1
1303389|NCT00197106|4242038|P3|Overall Treatment Period|Withdrawal by Subject|2
1303390|NCT00197106|4242039|P2|Overall Treatment Period|Withdrawal by Subject|0
1303391|NCT00197106|4242040|P1|Overall Treatment Period|Withdrawal by Subject|0
1303392|NCT00197106|4242038|P3|Overall Treatment Period|Protocol Violation|2
1303393|NCT00197106|4242039|P2|Overall Treatment Period|Protocol Violation|0
1303394|NCT00197106|4242040|P1|Overall Treatment Period|Protocol Violation|0
1303395|NCT00197106|4242038|P3|Overall Treatment Period|Lost to Follow-up|2
1303396|NCT00197106|4242039|P2|Overall Treatment Period|Lost to Follow-up|0
1303397|NCT00197106|4242040|P1|Overall Treatment Period|Lost to Follow-up|0
1303398|NCT00197106|4242038|P3|Overall Treatment Period|Lack of Efficacy|0
1303399|NCT00197106|4242039|P2|Overall Treatment Period|Lack of Efficacy|1
1303400|NCT00197106|4242040|P1|Overall Treatment Period|Lack of Efficacy|0
1303401|NCT00197106|4242038|P3|4-Week Run-In Period|Did not meet entry criteria|0
1303402|NCT00197106|4242039|P2|4-Week Run-In Period|Did not meet entry criteria|0
1303403|NCT00197106|4242040|P1|4-Week Run-In Period|Did not meet entry criteria|99
1303404|NCT00197028|4242076|P2|Overall Study|Other|6
1303405|NCT00197028|4242077|P1|Overall Study|Other|3
1303406|NCT00197028|4242076|P2|Overall Study|Lost to Follow-up|0
1303407|NCT00197028|4242077|P1|Overall Study|Lost to Follow-up|1
1303408|NCT00197028|4242076|P2|Overall Study|Withdrawal by Subject|12
1303409|NCT00197028|4242077|P1|Overall Study|Withdrawal by Subject|8
1303410|NCT00197028|4242076|P2|Overall Study|Protocol Violation|1
1303411|NCT00197028|4242077|P1|Overall Study|Protocol Violation|2
1303412|NCT00197028|4242076|P2|Overall Study|Adverse Event|2
1303413|NCT00197028|4242077|P1|Overall Study|Adverse Event|2
1303414|NCT00197015|4242120|P3|Overall Study|Other|2
1303415|NCT00197015|4242121|P2|Overall Study|Other|3
1303416|NCT00197015|4242122|P1|Overall Study|Other|2
1303417|NCT00197015|4242120|P3|Overall Study|Lost to Follow-up|37
1303418|NCT00197015|4242121|P2|Overall Study|Lost to Follow-up|46
1303419|NCT00197015|4242122|P1|Overall Study|Lost to Follow-up|28
1303420|NCT00197015|4242120|P3|Overall Study|Withdrawal by Subject|34
1303421|NCT00197015|4242121|P2|Overall Study|Withdrawal by Subject|37
1303422|NCT00197015|4242122|P1|Overall Study|Withdrawal by Subject|17
1303423|NCT00197015|4242120|P3|Overall Study|Protocol Violation|3
1303424|NCT00197015|4242121|P2|Overall Study|Protocol Violation|3
1303425|NCT00197015|4242122|P1|Overall Study|Protocol Violation|0
1303426|NCT00197015|4242120|P3|Overall Study|Adverse Event|1
1303427|NCT00197015|4242121|P2|Overall Study|Adverse Event|0
1303428|NCT00197015|4242122|P1|Overall Study|Adverse Event|3
1303429|NCT00197002|4242181|P3|Overall Study|Others|1
1303430|NCT00197002|4242182|P2|Overall Study|Others|1
1303431|NCT00197002|4242183|P1|Overall Study|Others|3
1303432|NCT00197002|4242181|P3|Overall Study|Lost to follow-up (compl. vaccination)|1
1303433|NCT00197002|4242182|P2|Overall Study|Lost to follow-up (compl. vaccination)|2
1303434|NCT00197002|4242183|P1|Overall Study|Lost to follow-up (compl. vaccination)|2
1303435|NCT00197002|4242181|P3|Overall Study|Lost to follow-up (incompl. vaccination)|5
1303436|NCT00197002|4242182|P2|Overall Study|Lost to follow-up (incompl. vaccination)|4
1303437|NCT00197002|4242183|P1|Overall Study|Lost to follow-up (incompl. vaccination)|4
1303438|NCT00197002|4242181|P3|Overall Study|Migrated/moved from study area|1
1303439|NCT00197002|4242182|P2|Overall Study|Migrated/moved from study area|5
1303440|NCT00197002|4242183|P1|Overall Study|Migrated/moved from study area|3
1303441|NCT00197002|4242181|P3|Overall Study|Withdrawal by Subject|7
1303442|NCT00197002|4242182|P2|Overall Study|Withdrawal by Subject|5
1303443|NCT00197002|4242183|P1|Overall Study|Withdrawal by Subject|9
1303444|NCT00197002|4242181|P3|Overall Study|Protocol Violation|2
1303445|NCT00197002|4242182|P2|Overall Study|Protocol Violation|0
1303446|NCT00197002|4242183|P1|Overall Study|Protocol Violation|1
1303447|NCT00197002|4242181|P3|Overall Study|Adverse Event|0
1303448|NCT00197002|4242182|P2|Overall Study|Adverse Event|1
1303449|NCT00197002|4242183|P1|Overall Study|Adverse Event|0
1303450|NCT00196976|4242234|P14|Booster Study|Lost to Follow-up|0
1303451|NCT00196976|4242235|P13|Booster Study|Lost to Follow-up|0
1303452|NCT00196976|4242236|P12|Booster Study|Lost to Follow-up|2
1303453|NCT00196976|4242237|P11|Booster Study|Lost to Follow-up|1
1303454|NCT00196976|4242238|P10|Booster Study|Lost to Follow-up|0
1303455|NCT00196976|4242239|P9|Booster Study|Lost to Follow-up|0
1303456|NCT00196976|4242240|P8|Booster Study|Lost to Follow-up|0
1303457|NCT00196976|4242241|P7|Booster Study|Lost to Follow-up|0
1303458|NCT00196976|4242242|P6|Booster Study|Lost to Follow-up|0
1303459|NCT00196976|4242243|P5|Booster Study|Lost to Follow-up|0
1303460|NCT00196976|4242244|P4|Booster Study|Lost to Follow-up|0
1303461|NCT00196976|4242245|P3|Booster Study|Lost to Follow-up|0
1303462|NCT00196976|4242246|P2|Booster Study|Lost to Follow-up|0
1303463|NCT00196976|4242247|P1|Booster Study|Lost to Follow-up|0
1303464|NCT00196976|4242234|P14|Booster Study|Withdrawal by Subject|0
1303465|NCT00196976|4242235|P13|Booster Study|Withdrawal by Subject|0
1303466|NCT00196976|4242236|P12|Booster Study|Withdrawal by Subject|0
1303467|NCT00196976|4242237|P11|Booster Study|Withdrawal by Subject|1
1303468|NCT00196976|4242238|P10|Booster Study|Withdrawal by Subject|0
1303469|NCT00196976|4242239|P9|Booster Study|Withdrawal by Subject|0
1303470|NCT00196976|4242240|P8|Booster Study|Withdrawal by Subject|0
1303471|NCT00196976|4242241|P7|Booster Study|Withdrawal by Subject|0
1303472|NCT00196976|4242242|P6|Booster Study|Withdrawal by Subject|0
1303473|NCT00196976|4242243|P5|Booster Study|Withdrawal by Subject|0
1303474|NCT00196976|4242244|P4|Booster Study|Withdrawal by Subject|0
1303475|NCT00196976|4242245|P3|Booster Study|Withdrawal by Subject|0
1303476|NCT00196976|4242246|P2|Booster Study|Withdrawal by Subject|0
1303477|NCT00196976|4242247|P1|Booster Study|Withdrawal by Subject|0
1303478|NCT00196976|4242234|P14|Primary Study|Other|0
1303479|NCT00196976|4242235|P13|Primary Study|Other|0
1303480|NCT00196976|4242236|P12|Primary Study|Other|0
1303481|NCT00196976|4242237|P11|Primary Study|Other|0
1303482|NCT00196976|4242238|P10|Primary Study|Other|0
1303483|NCT00196976|4242239|P9|Primary Study|Other|0
1303484|NCT00196976|4242240|P8|Primary Study|Other|0
1303485|NCT00196976|4242241|P7|Primary Study|Other|0
1303486|NCT00196976|4242242|P6|Primary Study|Other|0
1303487|NCT00196976|4242243|P5|Primary Study|Other|0
1303488|NCT00196976|4242244|P4|Primary Study|Other|0
1303489|NCT00196976|4242245|P3|Primary Study|Other|2
1303490|NCT00196976|4242246|P2|Primary Study|Other|0
1303491|NCT00196976|4242247|P1|Primary Study|Other|0
1303492|NCT00196976|4242234|P14|Primary Study|Lost to Follow-up|0
1303493|NCT00196976|4242235|P13|Primary Study|Lost to Follow-up|0
1303494|NCT00196976|4242236|P12|Primary Study|Lost to Follow-up|0
1303495|NCT00196976|4242237|P11|Primary Study|Lost to Follow-up|0
1303496|NCT00196976|4242238|P10|Primary Study|Lost to Follow-up|0
1303497|NCT00196976|4242239|P9|Primary Study|Lost to Follow-up|0
1303498|NCT00196976|4242240|P8|Primary Study|Lost to Follow-up|2
1303499|NCT00196976|4242241|P7|Primary Study|Lost to Follow-up|0
1303500|NCT00196976|4242242|P6|Primary Study|Lost to Follow-up|1
1303501|NCT00196976|4242243|P5|Primary Study|Lost to Follow-up|1
1303502|NCT00196976|4242244|P4|Primary Study|Lost to Follow-up|0
1303503|NCT00196976|4242245|P3|Primary Study|Lost to Follow-up|0
1303504|NCT00196976|4242246|P2|Primary Study|Lost to Follow-up|0
1303505|NCT00196976|4242247|P1|Primary Study|Lost to Follow-up|0
1303506|NCT00196976|4242234|P14|Primary Study|Withdrawal by Subject|0
1303507|NCT00196976|4242235|P13|Primary Study|Withdrawal by Subject|0
1303508|NCT00196976|4242236|P12|Primary Study|Withdrawal by Subject|0
1303509|NCT00196976|4242237|P11|Primary Study|Withdrawal by Subject|0
1303510|NCT00196976|4242238|P10|Primary Study|Withdrawal by Subject|1
1303511|NCT00196976|4242239|P9|Primary Study|Withdrawal by Subject|0
1303512|NCT00196976|4242240|P8|Primary Study|Withdrawal by Subject|0
1303513|NCT00196976|4242241|P7|Primary Study|Withdrawal by Subject|0
1303514|NCT00196976|4242242|P6|Primary Study|Withdrawal by Subject|1
1303515|NCT00196976|4242243|P5|Primary Study|Withdrawal by Subject|2
1303516|NCT00196976|4242244|P4|Primary Study|Withdrawal by Subject|1
1303517|NCT00196976|4242245|P3|Primary Study|Withdrawal by Subject|1
1303518|NCT00196976|4242246|P2|Primary Study|Withdrawal by Subject|0
1303519|NCT00196976|4242247|P1|Primary Study|Withdrawal by Subject|1
1303520|NCT00196976|4242234|P14|Primary Study|Protocol Violation|0
1303521|NCT00196976|4242235|P13|Primary Study|Protocol Violation|0
1303522|NCT00196976|4242236|P12|Primary Study|Protocol Violation|0
1303523|NCT00196976|4242237|P11|Primary Study|Protocol Violation|0
1303524|NCT00196976|4242238|P10|Primary Study|Protocol Violation|0
1303525|NCT00196976|4242239|P9|Primary Study|Protocol Violation|0
1303526|NCT00196976|4242240|P8|Primary Study|Protocol Violation|0
1303527|NCT00196976|4242241|P7|Primary Study|Protocol Violation|0
1303528|NCT00196976|4242242|P6|Primary Study|Protocol Violation|0
1303529|NCT00196976|4242243|P5|Primary Study|Protocol Violation|0
1303530|NCT00196976|4242244|P4|Primary Study|Protocol Violation|0
1303531|NCT00196976|4242245|P3|Primary Study|Protocol Violation|1
1303532|NCT00196976|4242246|P2|Primary Study|Protocol Violation|1
1303533|NCT00196976|4242247|P1|Primary Study|Protocol Violation|0
1303534|NCT00196976|4242234|P14|Primary Study|Migrated from study area|0
1303535|NCT00196976|4242235|P13|Primary Study|Migrated from study area|0
1303536|NCT00196976|4242236|P12|Primary Study|Migrated from study area|0
1303537|NCT00196976|4242237|P11|Primary Study|Migrated from study area|0
1303538|NCT00196976|4242238|P10|Primary Study|Migrated from study area|0
1303539|NCT00196976|4242239|P9|Primary Study|Migrated from study area|0
1303540|NCT00196976|4242240|P8|Primary Study|Migrated from study area|1
1303541|NCT00196976|4242241|P7|Primary Study|Migrated from study area|0
1303542|NCT00196976|4242242|P6|Primary Study|Migrated from study area|0
1303543|NCT00196976|4242243|P5|Primary Study|Migrated from study area|0
1303544|NCT00196976|4242244|P4|Primary Study|Migrated from study area|0
1303545|NCT00196976|4242245|P3|Primary Study|Migrated from study area|0
1303546|NCT00196976|4242246|P2|Primary Study|Migrated from study area|0
1303547|NCT00196976|4242247|P1|Primary Study|Migrated from study area|0
1303548|NCT00196937|4242443|P3|Overall Study|Withdrawal by Subject|3
1303549|NCT00196937|4242444|P2|Overall Study|Withdrawal by Subject|0
1303550|NCT00196937|4242445|P1|Overall Study|Withdrawal by Subject|0
1303551|NCT00196937|4242443|P3|Overall Study|Lost to Follow-up|3
1303552|NCT00196937|4242444|P2|Overall Study|Lost to Follow-up|3
1303553|NCT00196937|4242445|P1|Overall Study|Lost to Follow-up|4
1303554|NCT00196937|4242443|P3|Overall Study|Subject did not come due to holidays|0
1303555|NCT00196937|4242444|P2|Overall Study|Subject did not come due to holidays|1
1303556|NCT00196937|4242445|P1|Overall Study|Subject did not come due to holidays|3
1303557|NCT00196937|4242443|P3|Overall Study|Adverse Event|1
1303558|NCT00196937|4242444|P2|Overall Study|Adverse Event|1
1303559|NCT00196937|4242445|P1|Overall Study|Adverse Event|2
1303560|NCT00196326|4242493|P1|Overall Study|Not specified|22
1303561|NCT00196326|4242493|P1|Overall Study|Lost to Follow-up|304
1303562|NCT00196326|4242493|P1|Overall Study|Pregnancy|34
1303563|NCT00196326|4242493|P1|Overall Study|Adverse Event|253
1303564|NCT00196326|4242493|P1|Overall Study|Withdrawal by Subject|225
1303565|NCT00196326|4242493|P1|Overall Study|Physician Decision|3
1303566|NCT00196326|4242493|P1|Overall Study|Non-compliance with the protocol|81
1303567|NCT00196326|4242493|P1|Overall Study|Did not meet protocol requirements|64
1303568|NCT00196313|4242501|P2|Overall Study|Lost to Follow-up|2
1303569|NCT00196313|4242502|P1|Overall Study|Lost to Follow-up|2
1303570|NCT00196313|4242501|P2|Overall Study|Subject Pregnant|1
1303571|NCT00196313|4242502|P1|Overall Study|Subject Pregnant|1
1303572|NCT00196313|4242501|P2|Overall Study|Adverse Event|1
1303573|NCT00196313|4242502|P1|Overall Study|Adverse Event|3
1303574|NCT00196313|4242501|P2|Overall Study|Withdrawal by Subject|1
1303575|NCT00196313|4242502|P1|Overall Study|Withdrawal by Subject|3
1303576|NCT00196313|4242501|P2|Overall Study|Protocol Violation|3
1303577|NCT00196313|4242502|P1|Overall Study|Protocol Violation|2
1303578|NCT00196196|4242516|P1|Overall Study|Did not have required condition (hydroce|5
1303579|NCT00196196|4242516|P1|Overall Study|Withdrawal by Subject|2
1303580|NCT00196105|4242524|P3|Overall Study|Lost to Follow-up|7
1303581|NCT00196105|4242525|P2|Overall Study|Lost to Follow-up|5
1303582|NCT00196105|4242526|P1|Overall Study|Lost to Follow-up|4
1303583|NCT00195819|4242546|P2|Open-label|Withdrawal by Subject|5
1303584|NCT00195819|4242547|P1|Open-label|Withdrawal by Subject|0
1303585|NCT00195819|4242546|P2|Open-label|Moved|1
1303586|NCT00195819|4242547|P1|Open-label|Moved|0
1303587|NCT00195819|4242546|P2|Open-label|Protocol Violation|2
1303588|NCT00195819|4242547|P1|Open-label|Protocol Violation|0
1303589|NCT00195819|4242546|P2|Open-label|Pregnancy|1
1303590|NCT00195819|4242547|P1|Open-label|Pregnancy|0
1303591|NCT00195819|4242546|P2|Open-label|Lack of Efficacy|2
1303592|NCT00195819|4242547|P1|Open-label|Lack of Efficacy|0
1303593|NCT00195819|4242546|P2|Open-label|Adverse Event|9
1303594|NCT00195819|4242547|P1|Open-label|Adverse Event|0
1303595|NCT00195819|4242546|P2|Double-Blind|Moved|0
1303596|NCT00195819|4242547|P1|Double-Blind|Moved|1
1303597|NCT00195819|4242546|P2|Double-Blind|Withdrawal by Subject|0
1303598|NCT00195819|4242547|P1|Double-Blind|Withdrawal by Subject|1
1303599|NCT00195715|4242597|P1|Overall Study|Sponsor discretion - trial ended early|1
1303600|NCT00195715|4242597|P1|Overall Study|Sponsor discontinued trial|1
1303601|NCT00195715|4242597|P1|Overall Study|Colonic stricture|1
1303602|NCT00195715|4242597|P1|Overall Study|Ineligible|1
1303603|NCT00195715|4242597|P1|Overall Study|Increased infection rate|1
1303604|NCT00195715|4242597|P1|Overall Study|Planned surgery|2
1303605|NCT00195715|4242597|P1|Overall Study|Use of prohibited medication|2
1303606|NCT00195715|4242597|P1|Overall Study|Subject wants to get pregnant|4
1303607|NCT00195715|4242597|P1|Overall Study|Investigator's decision|2
1303608|NCT00195715|4242597|P1|Overall Study|Administrative reasons|2
1303609|NCT00195715|4242597|P1|Overall Study|Sponsor stopped study|1
1303610|NCT00195715|4242597|P1|Overall Study|Loss of response/no improvement|3
1303611|NCT00195715|4242597|P1|Overall Study|Subject choice|3
1303612|NCT00195715|4242597|P1|Overall Study|Subject started commercial Humira|5
1303613|NCT00195715|4242597|P1|Overall Study|Subject non-compliance|6
1303614|NCT00195715|4242597|P1|Overall Study|Subject moved/relocated|7
1303615|NCT00195715|4242597|P1|Overall Study|Investigative site closure|8
1303616|NCT00195715|4242597|P1|Overall Study|Pregnancy|14
1303617|NCT00195715|4242597|P1|Overall Study|Lack of Efficacy|93
1303618|NCT00195715|4242597|P1|Overall Study|Protocol Violation|13
1303619|NCT00195715|4242597|P1|Overall Study|Lost to Follow-up|27
1303620|NCT00195715|4242597|P1|Overall Study|Withdrawal by Subject|58
1303621|NCT00195715|4242597|P1|Overall Study|Adverse Event|122
1303622|NCT00195676|4242697|P1|Period R - Retreatment 16 Weeks|Other reasons|6
1303623|NCT00195676|4242697|P1|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9
1303624|NCT00195676|4242697|P1|Period R - Retreatment 16 Weeks|Lost to Follow-up|11
1303625|NCT00195676|4242697|P1|Period R - Retreatment 16 Weeks|Lack of Efficacy|5
1303626|NCT00195676|4242697|P1|Period R - Retreatment 16 Weeks|Adverse Event|4
1303627|NCT00195676|4242697|P1|Period W (Withdrawal) - No Treatment|Other reasons|18
1303628|NCT00195676|4242697|P1|Period W (Withdrawal) - No Treatment|Administrative reasons|1
1303629|NCT00195676|4242697|P1|Period W (Withdrawal) - No Treatment|Period W Close-out|129
1303630|NCT00195676|4242697|P1|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397
1303631|NCT00195676|4242697|P1|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46
1303632|NCT00195676|4242697|P1|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11
1303633|NCT00195676|4242697|P1|Period W (Withdrawal) - No Treatment|Death|2
1303634|NCT00195676|4242697|P1|Period W (Withdrawal) - No Treatment|Adverse Event|4
1303635|NCT00195676|4242697|P1|Period O - Open-label Treatment|Other reasons|68
1303636|NCT00195676|4242697|P1|Period O - Open-label Treatment|Administrative reasons|2
1303637|NCT00195676|4242697|P1|Period O - Open-label Treatment|Withdrawal by Subject|147
1303638|NCT00195676|4242697|P1|Period O - Open-label Treatment|Protocol Violation|12
1303639|NCT00195676|4242697|P1|Period O - Open-label Treatment|Lost to Follow-up|91
1303640|NCT00195676|4242697|P1|Period O - Open-label Treatment|Lack of Efficacy|198
1303641|NCT00195676|4242697|P1|Period O - Open-label Treatment|Death|6
1303642|NCT00195676|4242697|P1|Period O - Open-label Treatment|Adverse Event|82
1303643|NCT00195663|4242711|P3|Open-Label Extension Period|Administrative reasons|13
1303644|NCT00195663|4242712|P2|Open-Label Extension Period|Administrative reasons|11
1303645|NCT00195663|4242713|P1|Open-Label Extension Period|Administrative reasons|11
1303646|NCT00195663|4242711|P3|Open-Label Extension Period|Lack of Efficacy|12
1303647|NCT00195663|4242712|P2|Open-Label Extension Period|Lack of Efficacy|6
1303648|NCT00195663|4242713|P1|Open-Label Extension Period|Lack of Efficacy|14
1303649|NCT00195663|4242711|P3|Open-Label Extension Period|Withdrawal by Subject|22
1303650|NCT00195663|4242712|P2|Open-Label Extension Period|Withdrawal by Subject|15
1303651|NCT00195663|4242713|P1|Open-Label Extension Period|Withdrawal by Subject|16
1303652|NCT00195663|4242711|P3|Open-Label Extension Period|Death|2
1303653|NCT00195663|4242712|P2|Open-Label Extension Period|Death|2
1303654|NCT00195663|4242713|P1|Open-Label Extension Period|Death|2
1303655|NCT00195663|4242711|P3|Open-Label Extension Period|Protocol Violation|4
1303656|NCT00195663|4242712|P2|Open-Label Extension Period|Protocol Violation|4
1303657|NCT00195663|4242713|P1|Open-Label Extension Period|Protocol Violation|3
1303658|NCT00195663|4242711|P3|Open-Label Extension Period|Recovery|2
1303659|NCT00195663|4242712|P2|Open-Label Extension Period|Recovery|2
1303660|NCT00195663|4242713|P1|Open-Label Extension Period|Recovery|0
1303661|NCT00195663|4242711|P3|Open-Label Extension Period|Lost to Follow-up|6
1303662|NCT00195663|4242712|P2|Open-Label Extension Period|Lost to Follow-up|2
1303663|NCT00195663|4242713|P1|Open-Label Extension Period|Lost to Follow-up|9
1303664|NCT00195663|4242711|P3|Open-Label Extension Period|Adverse Event|36
1303665|NCT00195663|4242712|P2|Open-Label Extension Period|Adverse Event|32
1303666|NCT00195663|4242713|P1|Open-Label Extension Period|Adverse Event|21
1303667|NCT00195663|4242711|P3|2-year Double-blind Treatment Period|Administrative reasons|9
1303668|NCT00195663|4242712|P2|2-year Double-blind Treatment Period|Administrative reasons|2
1303669|NCT00195663|4242713|P1|2-year Double-blind Treatment Period|Administrative reasons|3
1303670|NCT00195663|4242711|P3|2-year Double-blind Treatment Period|Recovery|1
1303671|NCT00195663|4242712|P2|2-year Double-blind Treatment Period|Recovery|0
1303672|NCT00195663|4242713|P1|2-year Double-blind Treatment Period|Recovery|1
1303673|NCT00195663|4242711|P3|2-year Double-blind Treatment Period|Planned selection criteria|0
1303674|NCT00195663|4242712|P2|2-year Double-blind Treatment Period|Planned selection criteria|1
1303675|NCT00195663|4242713|P1|2-year Double-blind Treatment Period|Planned selection criteria|0
1303676|NCT00195663|4242711|P3|2-year Double-blind Treatment Period|Protocol Violation|4
1303677|NCT00195663|4242712|P2|2-year Double-blind Treatment Period|Protocol Violation|6
1303678|NCT00195663|4242713|P1|2-year Double-blind Treatment Period|Protocol Violation|6
1303679|NCT00195663|4242711|P3|2-year Double-blind Treatment Period|Lack of Efficacy|13
1303680|NCT00195663|4242712|P2|2-year Double-blind Treatment Period|Lack of Efficacy|52
1303681|NCT00195663|4242713|P1|2-year Double-blind Treatment Period|Lack of Efficacy|47
1303682|NCT00195663|4242711|P3|2-year Double-blind Treatment Period|Withdrawal by Subject|12
1303683|NCT00195663|4242712|P2|2-year Double-blind Treatment Period|Withdrawal by Subject|18
1303684|NCT00195663|4242713|P1|2-year Double-blind Treatment Period|Withdrawal by Subject|15
1303685|NCT00195663|4242711|P3|2-year Double-blind Treatment Period|Lost to Follow-up|1
1303686|NCT00195663|4242712|P2|2-year Double-blind Treatment Period|Lost to Follow-up|0
1303687|NCT00195663|4242713|P1|2-year Double-blind Treatment Period|Lost to Follow-up|0
1303688|NCT00195663|4242711|P3|2-year Double-blind Treatment Period|Death|0
1303689|NCT00195663|4242712|P2|2-year Double-blind Treatment Period|Death|2
1303690|NCT00195663|4242713|P1|2-year Double-blind Treatment Period|Death|0
1303691|NCT00195663|4242711|P3|2-year Double-blind Treatment Period|Adverse Event|32
1303692|NCT00195663|4242712|P2|2-year Double-blind Treatment Period|Adverse Event|27
1303693|NCT00195663|4242713|P1|2-year Double-blind Treatment Period|Adverse Event|21
1303694|NCT00195650|4242807|P1|Overall Study|Administrative reasons|83
1303695|NCT00195650|4242807|P1|Overall Study|Protocol Violation|15
1303696|NCT00195650|4242807|P1|Overall Study|Death|23
1303697|NCT00195650|4242807|P1|Overall Study|Lost to Follow-up|44
1303698|NCT00195650|4242807|P1|Overall Study|Withdrawal by Subject|67
1303699|NCT00195650|4242807|P1|Overall Study|Lack of Efficacy|99
1303700|NCT00195650|4242807|P1|Overall Study|Adverse Event|194
1303701|NCT00195507|4242823|P2|Overall Study|Protocol Deviation|3
1303702|NCT00195507|4242824|P1|Overall Study|Protocol Deviation|6
1303703|NCT00195507|4242823|P2|Overall Study|Withdrawal by Subject|23
1303704|NCT00195507|4242824|P1|Overall Study|Withdrawal by Subject|16
1303705|NCT00195507|4242823|P2|Overall Study|Lack of Efficacy|67
1303706|NCT00195507|4242824|P1|Overall Study|Lack of Efficacy|40
1303707|NCT00195507|4242823|P2|Overall Study|Protocol Violation|4
1303708|NCT00195507|4242824|P1|Overall Study|Protocol Violation|5
1303709|NCT00195507|4242823|P2|Overall Study|Lost to Follow-up|2
1303710|NCT00195507|4242824|P1|Overall Study|Lost to Follow-up|3
1303711|NCT00195507|4242823|P2|Overall Study|Physician Decision|2
1303712|NCT00195507|4242824|P1|Overall Study|Physician Decision|1
1303713|NCT00195507|4242823|P2|Overall Study|Failed to Return|3
1303714|NCT00195507|4242824|P1|Overall Study|Failed to Return|4
1303715|NCT00195507|4242823|P2|Overall Study|Death|1
1303716|NCT00195507|4242824|P1|Overall Study|Death|0
1303717|NCT00195507|4242823|P2|Overall Study|Adverse Event|13
1303718|NCT00195507|4242824|P1|Overall Study|Adverse Event|24
1303719|NCT00195494|4242838|P6|Year 2|System toxicity|0
1303720|NCT00195494|4242839|P5|Year 2|System toxicity|0
1303721|NCT00195494|4242840|P4|Year 2|System toxicity|1
1303722|NCT00195494|4242841|P3|Year 2|System toxicity|0
1303723|NCT00195494|4242842|P2|Year 2|System toxicity|0
1303724|NCT00195494|4242843|P1|Year 2|System toxicity|0
1303725|NCT00195494|4242838|P6|Year 2|Withdrawal by Subject|0
1303726|NCT00195494|4242839|P5|Year 2|Withdrawal by Subject|0
1303727|NCT00195494|4242840|P4|Year 2|Withdrawal by Subject|3
1303728|NCT00195494|4242841|P3|Year 2|Withdrawal by Subject|4
1303729|NCT00195494|4242842|P2|Year 2|Withdrawal by Subject|5
1303730|NCT00195494|4242843|P1|Year 2|Withdrawal by Subject|1
1303731|NCT00195494|4242838|P6|Year 2|Physician Decision|0
1303732|NCT00195494|4242839|P5|Year 2|Physician Decision|0
1303733|NCT00195494|4242840|P4|Year 2|Physician Decision|0
1303734|NCT00195494|4242841|P3|Year 2|Physician Decision|0
1303735|NCT00195494|4242842|P2|Year 2|Physician Decision|1
1303736|NCT00195494|4242843|P1|Year 2|Physician Decision|1
1303737|NCT00195494|4242838|P6|Year 2|Protocol deviation|0
1303738|NCT00195494|4242839|P5|Year 2|Protocol deviation|0
1303739|NCT00195494|4242840|P4|Year 2|Protocol deviation|0
1303740|NCT00195494|4242841|P3|Year 2|Protocol deviation|0
1303741|NCT00195494|4242842|P2|Year 2|Protocol deviation|1
1303742|NCT00195494|4242843|P1|Year 2|Protocol deviation|0
1303743|NCT00195494|4242838|P6|Year 2|Missed >4 consecutive doses|0
1303744|NCT00195494|4242839|P5|Year 2|Missed >4 consecutive doses|0
1303745|NCT00195494|4242840|P4|Year 2|Missed >4 consecutive doses|0
1303746|NCT00195494|4242841|P3|Year 2|Missed >4 consecutive doses|1
1303747|NCT00195494|4242842|P2|Year 2|Missed >4 consecutive doses|1
1303748|NCT00195494|4242843|P1|Year 2|Missed >4 consecutive doses|1
1303749|NCT00195494|4242838|P6|Year 2|Lost to Follow-up|0
1303750|NCT00195494|4242839|P5|Year 2|Lost to Follow-up|0
1303751|NCT00195494|4242840|P4|Year 2|Lost to Follow-up|1
1303752|NCT00195494|4242841|P3|Year 2|Lost to Follow-up|1
1303753|NCT00195494|4242842|P2|Year 2|Lost to Follow-up|0
1303754|NCT00195494|4242843|P1|Year 2|Lost to Follow-up|0
1303755|NCT00195494|4242838|P6|Year 2|Compliance|0
1303756|NCT00195494|4242839|P5|Year 2|Compliance|0
1303757|NCT00195494|4242840|P4|Year 2|Compliance|2
1303758|NCT00195494|4242841|P3|Year 2|Compliance|0
1303759|NCT00195494|4242842|P2|Year 2|Compliance|0
1303760|NCT00195494|4242843|P1|Year 2|Compliance|1
1303761|NCT00195494|4242838|P6|Year 2|Lack of Efficacy|0
1303762|NCT00195494|4242839|P5|Year 2|Lack of Efficacy|0
1303763|NCT00195494|4242840|P4|Year 2|Lack of Efficacy|7
1303764|NCT00195494|4242841|P3|Year 2|Lack of Efficacy|7
1303765|NCT00195494|4242842|P2|Year 2|Lack of Efficacy|1
1303766|NCT00195494|4242843|P1|Year 2|Lack of Efficacy|0
1303767|NCT00195494|4242838|P6|Year 2|Adverse Event|0
1303768|NCT00195494|4242839|P5|Year 2|Adverse Event|0
1303769|NCT00195494|4242840|P4|Year 2|Adverse Event|9
1303770|NCT00195494|4242841|P3|Year 2|Adverse Event|5
1303771|NCT00195494|4242842|P2|Year 2|Adverse Event|7
1303772|NCT00195494|4242843|P1|Year 2|Adverse Event|3
1303773|NCT00195494|4242838|P6|Year 1|Protocol Violation|1
1303774|NCT00195494|4242839|P5|Year 1|Protocol Violation|1
1303775|NCT00195494|4242840|P4|Year 1|Protocol Violation|0
1303776|NCT00195494|4242841|P3|Year 1|Protocol Violation|0
1303777|NCT00195494|4242842|P2|Year 1|Protocol Violation|0
1303778|NCT00195494|4242843|P1|Year 1|Protocol Violation|0
1303779|NCT00195494|4242838|P6|Year 1|Withdrawal by Subject|9
1303780|NCT00195494|4242839|P5|Year 1|Withdrawal by Subject|8
1303781|NCT00195494|4242840|P4|Year 1|Withdrawal by Subject|0
1303782|NCT00195494|4242841|P3|Year 1|Withdrawal by Subject|0
1303783|NCT00195494|4242842|P2|Year 1|Withdrawal by Subject|0
1303784|NCT00195494|4242843|P1|Year 1|Withdrawal by Subject|0
1303785|NCT00195494|4242838|P6|Year 1|Physician Decision|0
1303786|NCT00195494|4242839|P5|Year 1|Physician Decision|1
1303787|NCT00195494|4242840|P4|Year 1|Physician Decision|0
1303788|NCT00195494|4242841|P3|Year 1|Physician Decision|0
1303789|NCT00195494|4242842|P2|Year 1|Physician Decision|0
1303790|NCT00195494|4242843|P1|Year 1|Physician Decision|0
1303791|NCT00195494|4242838|P6|Year 1|Protocol deviation|3
1303792|NCT00195494|4242839|P5|Year 1|Protocol deviation|2
1303793|NCT00195494|4242840|P4|Year 1|Protocol deviation|0
1303794|NCT00195494|4242841|P3|Year 1|Protocol deviation|0
1303795|NCT00195494|4242842|P2|Year 1|Protocol deviation|0
1303796|NCT00195494|4242843|P1|Year 1|Protocol deviation|0
1303797|NCT00195494|4242838|P6|Year 1|Missed >4 consecutive doses|2
1303798|NCT00195494|4242839|P5|Year 1|Missed >4 consecutive doses|3
1303799|NCT00195494|4242840|P4|Year 1|Missed >4 consecutive doses|0
1303800|NCT00195494|4242841|P3|Year 1|Missed >4 consecutive doses|0
1303801|NCT00195494|4242842|P2|Year 1|Missed >4 consecutive doses|0
1303802|NCT00195494|4242843|P1|Year 1|Missed >4 consecutive doses|0
1303803|NCT00195494|4242838|P6|Year 1|Lost to Follow-up|0
1303804|NCT00195494|4242839|P5|Year 1|Lost to Follow-up|1
1303805|NCT00195494|4242840|P4|Year 1|Lost to Follow-up|0
1303806|NCT00195494|4242841|P3|Year 1|Lost to Follow-up|0
1303807|NCT00195494|4242842|P2|Year 1|Lost to Follow-up|0
1303808|NCT00195494|4242843|P1|Year 1|Lost to Follow-up|0
1303809|NCT00195494|4242838|P6|Year 1|Compliance|1
1303810|NCT00195494|4242839|P5|Year 1|Compliance|5
1303811|NCT00195494|4242840|P4|Year 1|Compliance|0
1303812|NCT00195494|4242841|P3|Year 1|Compliance|0
1303813|NCT00195494|4242842|P2|Year 1|Compliance|0
1303814|NCT00195494|4242843|P1|Year 1|Compliance|0
1303815|NCT00195494|4242838|P6|Year 1|Lack of Efficacy|9
1303816|NCT00195494|4242839|P5|Year 1|Lack of Efficacy|24
1303817|NCT00195494|4242840|P4|Year 1|Lack of Efficacy|0
1303818|NCT00195494|4242841|P3|Year 1|Lack of Efficacy|0
1303819|NCT00195494|4242842|P2|Year 1|Lack of Efficacy|0
1303820|NCT00195494|4242843|P1|Year 1|Lack of Efficacy|0
1303821|NCT00195494|4242838|P6|Year 1|System Toxicity|1
1303822|NCT00195494|4242839|P5|Year 1|System Toxicity|0
1303823|NCT00195494|4242840|P4|Year 1|System Toxicity|0
1303824|NCT00195494|4242841|P3|Year 1|System Toxicity|0
1303825|NCT00195494|4242842|P2|Year 1|System Toxicity|0
1303826|NCT00195494|4242843|P1|Year 1|System Toxicity|0
1303827|NCT00195494|4242838|P6|Year 1|Adverse Event|27
1303828|NCT00195494|4242839|P5|Year 1|Adverse Event|34
1303829|NCT00195494|4242840|P4|Year 1|Adverse Event|0
1303830|NCT00195494|4242841|P3|Year 1|Adverse Event|0
1303831|NCT00195494|4242842|P2|Year 1|Adverse Event|0
1303832|NCT00195494|4242843|P1|Year 1|Adverse Event|0
1303833|NCT00195442|4242861|P1|Overall Study|Other|14
1303834|NCT00195442|4242861|P1|Overall Study|Poor cooperation|2
1303835|NCT00195442|4242861|P1|Overall Study|No reason specified|4
1303836|NCT00195442|4242861|P1|Overall Study|Death|7
1303837|NCT00195442|4242861|P1|Overall Study|Intermittent product shortage|21
1303838|NCT00195442|4242861|P1|Overall Study|Switch to other Factor VIII preparation|23
1303839|NCT00195442|4242861|P1|Overall Study|Lost to Follow-up|27
1303840|NCT00195442|4242861|P1|Overall Study|Less than expected therapeutic effect|38
1303841|NCT00195429|4242880|P2|Overall Study|Lost to Follow-up|0
1303842|NCT00195429|4242881|P1|Overall Study|Lost to Follow-up|1
1303843|NCT00195429|4242880|P2|Overall Study|Lack of Efficacy|1
1303844|NCT00195429|4242881|P1|Overall Study|Lack of Efficacy|2
1303845|NCT00195429|4242880|P2|Overall Study|Adverse Event|4
1303846|NCT00195429|4242881|P1|Overall Study|Adverse Event|2
1303847|NCT00195351|4242897|P2|Overall Study|Lack of Efficacy|1
1303848|NCT00195351|4242898|P1|Overall Study|Lack of Efficacy|0
1303849|NCT00195351|4242897|P2|Overall Study|Death|1
1303850|NCT00195351|4242898|P1|Overall Study|Death|3
1303851|NCT00195351|4242897|P2|Overall Study|Protocol Deviation|2
1303852|NCT00195351|4242898|P1|Overall Study|Protocol Deviation|3
1303853|NCT00195351|4242897|P2|Overall Study|Withdrawal by Subject|3
1303854|NCT00195351|4242898|P1|Overall Study|Withdrawal by Subject|6
1303855|NCT00195351|4242897|P2|Overall Study|Lost to Follow-up|9
1303856|NCT00195351|4242898|P1|Overall Study|Lost to Follow-up|9
1303857|NCT00195338|4242908|P1|Overall Study|Early closure of the site|4
1303858|NCT00195338|4242908|P1|Overall Study|Lack of Efficacy|1
1303859|NCT00195338|4242908|P1|Overall Study|Adverse Event|5
1303860|NCT00195338|4242908|P1|Overall Study|Lost to Follow-up|2
1303861|NCT00195273|4242918|P2|Overall Study|Procedural complications|3
1303862|NCT00195273|4242919|P1|Overall Study|Procedural complications|9
1303863|NCT00195273|4242918|P2|Overall Study|Lack of Efficacy|1
1303864|NCT00195273|4242919|P1|Overall Study|Lack of Efficacy|3
1303865|NCT00195273|4242918|P2|Overall Study|Protocol deviation|1
1303866|NCT00195273|4242919|P1|Overall Study|Protocol deviation|0
1303867|NCT00195273|4242918|P2|Overall Study|Adverse Event|9
1303868|NCT00195273|4242919|P1|Overall Study|Adverse Event|9
1303869|NCT00195260|4242933|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3
1303870|NCT00195260|4242934|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4
1303871|NCT00195260|4242935|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6
1303872|NCT00195260|4242936|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
1303873|NCT00195260|4242937|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
1303874|NCT00195260|4242938|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
1303875|NCT00195260|4242939|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
1303876|NCT00195260|4242940|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
1303877|NCT00195260|4242941|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
1303878|NCT00195260|4242942|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
1303879|NCT00195260|4242943|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
1303880|NCT00195260|4242933|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3
1303881|NCT00195260|4242934|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2
1303882|NCT00195260|4242935|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1
1303883|NCT00195260|4242936|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
1303884|NCT00195260|4242937|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
1303885|NCT00195260|4242938|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
1303886|NCT00195260|4242939|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
1303887|NCT00195260|4242940|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
1303888|NCT00195260|4242941|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
1303889|NCT00195260|4242942|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
1303890|NCT00195260|4242943|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
1303891|NCT00195260|4242933|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2
1303892|NCT00195260|4242934|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3
1303893|NCT00195260|4242935|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5
1303894|NCT00195260|4242936|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
1303895|NCT00195260|4242937|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
1303896|NCT00195260|4242938|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
1303897|NCT00195260|4242939|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
1303898|NCT00195260|4242940|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
1303899|NCT00195260|4242941|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
1303900|NCT00195260|4242942|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
1303901|NCT00195260|4242943|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
1303902|NCT00195260|4242933|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15
1303903|NCT00195260|4242934|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29
1303904|NCT00195260|4242935|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21
1303905|NCT00195260|4242936|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
1303906|NCT00195260|4242937|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
1303907|NCT00195260|4242938|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
1303908|NCT00195260|4242939|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
1303909|NCT00195260|4242940|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
1303910|NCT00195260|4242941|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
1303911|NCT00195260|4242942|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
1303912|NCT00195260|4242943|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
1303913|NCT00195260|4242933|P11|Part 1: Dose Escalation|Symptomatic Deterioration|0
1303914|NCT00195260|4242934|P10|Part 1: Dose Escalation|Symptomatic Deterioration|0
1303915|NCT00195260|4242935|P9|Part 1: Dose Escalation|Symptomatic Deterioration|0
1303916|NCT00195260|4242936|P8|Part 1: Dose Escalation|Symptomatic Deterioration|0
1303917|NCT00195260|4242937|P7|Part 1: Dose Escalation|Symptomatic Deterioration|0
1303918|NCT00195260|4242938|P6|Part 1: Dose Escalation|Symptomatic Deterioration|1
1303919|NCT00195260|4242939|P5|Part 1: Dose Escalation|Symptomatic Deterioration|0
1303920|NCT00195260|4242940|P4|Part 1: Dose Escalation|Symptomatic Deterioration|0
1303921|NCT00195260|4242941|P3|Part 1: Dose Escalation|Symptomatic Deterioration|1
1303922|NCT00195260|4242942|P2|Part 1: Dose Escalation|Symptomatic Deterioration|1
1303923|NCT00195260|4242943|P1|Part 1: Dose Escalation|Symptomatic Deterioration|1
1303924|NCT00195260|4242933|P11|Part 1: Dose Escalation|Disease Progression|0
1303925|NCT00195260|4242934|P10|Part 1: Dose Escalation|Disease Progression|0
1303926|NCT00195260|4242935|P9|Part 1: Dose Escalation|Disease Progression|0
1303927|NCT00195260|4242936|P8|Part 1: Dose Escalation|Disease Progression|4
1303928|NCT00195260|4242937|P7|Part 1: Dose Escalation|Disease Progression|7
1303929|NCT00195260|4242938|P6|Part 1: Dose Escalation|Disease Progression|6
1303930|NCT00195260|4242939|P5|Part 1: Dose Escalation|Disease Progression|4
1303931|NCT00195260|4242940|P4|Part 1: Dose Escalation|Disease Progression|6
1303932|NCT00195260|4242941|P3|Part 1: Dose Escalation|Disease Progression|5
1303933|NCT00195260|4242942|P2|Part 1: Dose Escalation|Disease Progression|2
1303934|NCT00195260|4242943|P1|Part 1: Dose Escalation|Disease Progression|3
1303935|NCT00195260|4242933|P11|Part 1: Dose Escalation|Death|0
1303936|NCT00195260|4242934|P10|Part 1: Dose Escalation|Death|0
1303937|NCT00195260|4242935|P9|Part 1: Dose Escalation|Death|0
1303938|NCT00195260|4242936|P8|Part 1: Dose Escalation|Death|1
1303939|NCT00195260|4242937|P7|Part 1: Dose Escalation|Death|0
1303940|NCT00195260|4242938|P6|Part 1: Dose Escalation|Death|0
1303941|NCT00195260|4242939|P5|Part 1: Dose Escalation|Death|0
1303942|NCT00195260|4242940|P4|Part 1: Dose Escalation|Death|0
1303943|NCT00195260|4242941|P3|Part 1: Dose Escalation|Death|0
1303944|NCT00195260|4242942|P2|Part 1: Dose Escalation|Death|0
1303945|NCT00195260|4242943|P1|Part 1: Dose Escalation|Death|0
1303946|NCT00195260|4242933|P11|Part 1: Dose Escalation|Withdrawal by Subject|0
1303947|NCT00195260|4242934|P10|Part 1: Dose Escalation|Withdrawal by Subject|0
1303948|NCT00195260|4242935|P9|Part 1: Dose Escalation|Withdrawal by Subject|0
1303949|NCT00195260|4242936|P8|Part 1: Dose Escalation|Withdrawal by Subject|1
1303950|NCT00195260|4242937|P7|Part 1: Dose Escalation|Withdrawal by Subject|0
1303951|NCT00195260|4242938|P6|Part 1: Dose Escalation|Withdrawal by Subject|0
1303952|NCT00195260|4242939|P5|Part 1: Dose Escalation|Withdrawal by Subject|2
1303953|NCT00195260|4242940|P4|Part 1: Dose Escalation|Withdrawal by Subject|0
1303954|NCT00195260|4242941|P3|Part 1: Dose Escalation|Withdrawal by Subject|0
1303955|NCT00195260|4242942|P2|Part 1: Dose Escalation|Withdrawal by Subject|0
1303956|NCT00195260|4242943|P1|Part 1: Dose Escalation|Withdrawal by Subject|0
1303957|NCT00195260|4242933|P11|Part 1: Dose Escalation|Adverse Event|0
1303958|NCT00195260|4242934|P10|Part 1: Dose Escalation|Adverse Event|0
1303959|NCT00195260|4242935|P9|Part 1: Dose Escalation|Adverse Event|0
1303960|NCT00195260|4242936|P8|Part 1: Dose Escalation|Adverse Event|0
1303961|NCT00195260|4242937|P7|Part 1: Dose Escalation|Adverse Event|3
1303962|NCT00195260|4242938|P6|Part 1: Dose Escalation|Adverse Event|0
1303963|NCT00195260|4242939|P5|Part 1: Dose Escalation|Adverse Event|1
1303964|NCT00195260|4242940|P4|Part 1: Dose Escalation|Adverse Event|1
1303965|NCT00195260|4242941|P3|Part 1: Dose Escalation|Adverse Event|0
1303966|NCT00195260|4242942|P2|Part 1: Dose Escalation|Adverse Event|1
1303967|NCT00195260|4242943|P1|Part 1: Dose Escalation|Adverse Event|0
1303968|NCT00194987|4243111|P2|Overall Study|Withdrawal by Subject|3
1303969|NCT00194987|4243112|P1|Overall Study|Withdrawal by Subject|0
1303970|NCT00194792|4243145|P1|Overall Study|Withdrawal by Subject|1
1303971|NCT00194675|4243169|P2|Overall Study|Death|0
1303972|NCT00194675|4243170|P1|Overall Study|Death|1
1303973|NCT00194675|4243169|P2|Overall Study|Protocol Violation|0
1303974|NCT00194675|4243170|P1|Overall Study|Protocol Violation|1
1303975|NCT00194675|4243169|P2|Overall Study|"withdrew due to edgy feeling"|0
1303976|NCT00194675|4243170|P1|Overall Study|"withdrew due to edgy feeling"|1
1303977|NCT00194675|4243169|P2|Overall Study|lack of interest|1
1303978|NCT00194675|4243170|P1|Overall Study|lack of interest|1
1303979|NCT00194675|4243169|P2|Overall Study|Lost to Follow-up|1
1303980|NCT00194675|4243170|P1|Overall Study|Lost to Follow-up|1
1303981|NCT00194077|4243224|P2|Overall Study|Withdrawal by Subject|1
1303982|NCT00194077|4243225|P1|Overall Study|Withdrawal by Subject|1
1303983|NCT00194077|4243224|P2|Overall Study|Study nonadherence|0
1303984|NCT00194077|4243225|P1|Overall Study|Study nonadherence|1
1303985|NCT00194077|4243224|P2|Overall Study|Lack of Efficacy|29
1303986|NCT00194077|4243225|P1|Overall Study|Lack of Efficacy|22
1303987|NCT00194025|4243231|P1|Overall Study|non-adherence with study medication|4
1303988|NCT00194025|4243231|P1|Overall Study|Adverse Event|1
1303989|NCT00194012|4243246|P2|Open Label Extension (OLE)|Lack of Efficacy|0
1303990|NCT00194012|4243247|P1|Open Label Extension (OLE)|Lack of Efficacy|1
1303991|NCT00194012|4243246|P2|Open Label Extension (OLE)|Lost to Follow-up|5
1303992|NCT00194012|4243247|P1|Open Label Extension (OLE)|Lost to Follow-up|3
1303993|NCT00194012|4243246|P2|Open Label Extension (OLE)|Drowsiness; Jittery|1
1303994|NCT00194012|4243247|P1|Open Label Extension (OLE)|Drowsiness; Jittery|0
1303995|NCT00194012|4243246|P2|Open Label Extension (OLE)|Weight Gain|0
1303996|NCT00194012|4243247|P1|Open Label Extension (OLE)|Weight Gain|1
1303997|NCT00194012|4243246|P2|Randomized Phase|Oral/nasal twitching|1
1303998|NCT00194012|4243247|P1|Randomized Phase|Oral/nasal twitching|0
1303999|NCT00194012|4243246|P2|Randomized Phase|Emesis and enuresis|1
1304000|NCT00194012|4243247|P1|Randomized Phase|Emesis and enuresis|0
1304001|NCT00194012|4243246|P2|Randomized Phase|Participant reported having a rash|0
1304002|NCT00194012|4243247|P1|Randomized Phase|Participant reported having a rash|1
1304003|NCT00194012|4243246|P2|Randomized Phase|Adverse Event|1
1304004|NCT00194012|4243247|P1|Randomized Phase|Adverse Event|2
1304005|NCT00194012|4243246|P2|Randomized Phase|Withdrawal by Subject|3
1304006|NCT00194012|4243247|P1|Randomized Phase|Withdrawal by Subject|3
1304007|NCT00194012|4243246|P2|Randomized Phase|Study nonadherence|1
1304008|NCT00194012|4243247|P1|Randomized Phase|Study nonadherence|2
1304009|NCT00194012|4243246|P2|Randomized Phase|Lack of Efficacy|18
1304010|NCT00194012|4243247|P1|Randomized Phase|Lack of Efficacy|8
1304011|NCT00193609|4243283|P1|Overall Study|Adverse Event|2
1304012|NCT00193609|4243283|P1|Overall Study|Lack of Efficacy|2
1304013|NCT00193479|4243310|P1|Induction Chemotherapy|Disease Progression|1
1304014|NCT00193479|4243310|P1|Induction Chemotherapy|Adverse Event|2
1304015|NCT00193206|4243351|P1|Postoperative Therapy|Protocol Violation|1
1304016|NCT00193206|4243351|P1|Postoperative Therapy|Lack of Efficacy|1
1304017|NCT00193206|4243351|P1|Postoperative Therapy|Intercurrent Illness|2
1304018|NCT00193206|4243351|P1|Postoperative Therapy|Physician Decision|3
1304019|NCT00193206|4243351|P1|Postoperative Therapy|Withdrawal by Subject|7
1304020|NCT00193206|4243351|P1|Preoperative Therapy|False Positive Pregnancy Test|1
1304021|NCT00193206|4243351|P1|Preoperative Therapy|Withdrawal by Subject|2
1304022|NCT00193206|4243351|P1|Preoperative Therapy|Adverse Event|2
1304023|NCT00193206|4243351|P1|Preoperative Therapy|Lack of Efficacy|2
1304024|NCT00193180|4243355|P1|Overall Study|Protocol Violation|1
1304025|NCT00193180|4243355|P1|Overall Study|Adverse Event|8
1304026|NCT00193180|4243355|P1|Overall Study|Lack of Efficacy|1
1304027|NCT00193063|4243370|P1|Overall Study|Adverse Event|1
1304028|NCT00193063|4243370|P1|Overall Study|Lack of Efficacy|3
1304029|NCT00193050|4243376|P1|Adjuvant|Lack of Efficacy|2
1304030|NCT00193050|4243376|P1|Adjuvant|Intercurrent Hospitalization|3
1304031|NCT00193050|4243376|P1|Adjuvant|Physician Decision|5
1304032|NCT00193050|4243376|P1|Neoadjuvant Treatment|Adverse Event|2
1304033|NCT00193050|4243376|P1|Neoadjuvant Treatment|Physician Decision|2
1304034|NCT00193050|4243376|P1|Neoadjuvant Treatment|Intercurrent Illness|3
1304035|NCT00193050|4243376|P1|Neoadjuvant Treatment|Lack of Efficacy|2
1304036|NCT00192647|4243393|P2|Overall Study|Other/Administrative|3
1304037|NCT00192647|4243394|P1|Overall Study|Other/Administrative|5
1304038|NCT00192647|4243393|P2|Overall Study|Failure to Return|13
1304039|NCT00192647|4243394|P1|Overall Study|Failure to Return|11
1304040|NCT00192647|4243393|P2|Overall Study|Refused Treatment/Did not Cooperate|8
1304041|NCT00192647|4243394|P1|Overall Study|Refused Treatment/Did not Cooperate|10
1304042|NCT00192647|4243393|P2|Overall Study|Protocol Violation|1
1304043|NCT00192647|4243394|P1|Overall Study|Protocol Violation|3
1304044|NCT00192647|4243393|P2|Overall Study|Entry Criteria Violation|6
1304045|NCT00192647|4243394|P1|Overall Study|Entry Criteria Violation|6
1304046|NCT00192647|4243393|P2|Overall Study|Insufficient Therapeutic Response|83
1304047|NCT00192647|4243394|P1|Overall Study|Insufficient Therapeutic Response|53
1304048|NCT00192647|4243393|P2|Overall Study|Laboratory Test Abnormality|2
1304049|NCT00192647|4243394|P1|Overall Study|Laboratory Test Abnormality|4
1304050|NCT00192647|4243393|P2|Overall Study|Adverse Event|29
1304051|NCT00192647|4243394|P1|Overall Study|Adverse Event|35
1304052|NCT00192647|4243393|P2|Overall Study|Death|1
1304053|NCT00192647|4243394|P1|Overall Study|Death|1
1304054|NCT00192296|4243414|P4|Overall Study|Withdrawal by Subject|0
1304055|NCT00192296|4243415|P3|Overall Study|Withdrawal by Subject|0
1304056|NCT00192296|4243416|P2|Overall Study|Withdrawal by Subject|1
1304057|NCT00192296|4243417|P1|Overall Study|Withdrawal by Subject|0
1304058|NCT00192075|4243473|P2|Overall Study|Other|2
1304059|NCT00192075|4243474|P1|Overall Study|Other|5
1304060|NCT00192075|4243473|P2|Overall Study|Unacceptable Toxicity Exhibited by Drug|1
1304061|NCT00192075|4243474|P1|Overall Study|Unacceptable Toxicity Exhibited by Drug|2
1304062|NCT00192075|4243473|P2|Overall Study|Patient Non-Compliance|1
1304063|NCT00192075|4243474|P1|Overall Study|Patient Non-Compliance|0
1304064|NCT00192075|4243473|P2|Overall Study|Withdrawal by Subject|5
1304065|NCT00192075|4243474|P1|Overall Study|Withdrawal by Subject|5
1304066|NCT00192075|4243473|P2|Overall Study|Physician Decision|0
1304067|NCT00192075|4243474|P1|Overall Study|Physician Decision|3
1304068|NCT00192075|4243473|P2|Overall Study|Lack of Efficacy|0
1304069|NCT00192075|4243474|P1|Overall Study|Lack of Efficacy|0
1304070|NCT00192075|4243473|P2|Overall Study|Death|1
1304071|NCT00192075|4243474|P1|Overall Study|Death|0
1304072|NCT00192075|4243473|P2|Overall Study|Adverse Event|3
1304073|NCT00192075|4243474|P1|Overall Study|Adverse Event|1
1304074|NCT00192075|4243473|P2|Overall Study|Disease Progression|6
1304075|NCT00192075|4243474|P1|Overall Study|Disease Progression|23
1304076|NCT00192036|4243499|P1|Overall Study|Unknown or Not Specified|5
1304077|NCT00192036|4243499|P1|Overall Study|Death|1
1304078|NCT00192036|4243499|P1|Overall Study|Clinical Disease Progression|1
1304079|NCT00192036|4243499|P1|Overall Study|Objective Tumor Progression|4
1304080|NCT00192036|4243499|P1|Overall Study|Patient/Physician Perception|1
1304081|NCT00192036|4243499|P1|Overall Study|Adverse Event|6
1304082|NCT00192036|4243499|P1|Overall Study|Protocol Violation|3
1304083|NCT00192023|4243509|P2|Period IV - Optional Open-Label|Physician Decision|0
1304084|NCT00192023|4243510|P1|Period IV - Optional Open-Label|Physician Decision|9
1304085|NCT00192023|4243509|P2|Period IV - Optional Open-Label|Withdrawal by Subject|0
1304086|NCT00192023|4243510|P1|Period IV - Optional Open-Label|Withdrawal by Subject|4
1304087|NCT00192023|4243509|P2|Period IV - Optional Open-Label|Protocol Violation|0
1304088|NCT00192023|4243510|P1|Period IV - Optional Open-Label|Protocol Violation|1
1304089|NCT00192023|4243509|P2|Period IV - Optional Open-Label|Lost to Follow-up|0
1304090|NCT00192023|4243510|P1|Period IV - Optional Open-Label|Lost to Follow-up|2
1304091|NCT00192023|4243509|P2|Period IV - Optional Open-Label|Patient/Caregiver Decision|0
1304092|NCT00192023|4243510|P1|Period IV - Optional Open-Label|Patient/Caregiver Decision|46
1304093|NCT00192023|4243509|P2|Period IV - Optional Open-Label|Lack of Efficacy|0
1304094|NCT00192023|4243510|P1|Period IV - Optional Open-Label|Lack of Efficacy|7
1304095|NCT00192023|4243509|P2|Period IV - Optional Open-Label|Adverse Event|0
1304096|NCT00192023|4243510|P1|Period IV - Optional Open-Label|Adverse Event|6
1304097|NCT00192023|4243509|P2|Period III - Double-Blind|Parent/Caregiver Decision|0
1304098|NCT00192023|4243510|P1|Period III - Double-Blind|Parent/Caregiver Decision|2
1304099|NCT00192023|4243509|P2|Period III - Double-Blind|Physician Decision|0
1304100|NCT00192023|4243510|P1|Period III - Double-Blind|Physician Decision|2
1304101|NCT00192023|4243509|P2|Period III - Double-Blind|Adverse Event|0
1304102|NCT00192023|4243510|P1|Period III - Double-Blind|Adverse Event|3
1304103|NCT00191984|4243532|P1|Overall Study|Physician Decision|4
1304104|NCT00191984|4243532|P1|Overall Study|Withdrawal by Subject|7
1304105|NCT00191984|4243532|P1|Overall Study|Entry Criteria Exclusion|1
1304106|NCT00191984|4243532|P1|Overall Study|Death|2
1304107|NCT00191984|4243532|P1|Overall Study|Adverse Event|4
1304108|NCT00191984|4243532|P1|Overall Study|Disease Progression|21
1304109|NCT00191945|4243542|P2|Double-Blind Acute Treatment|Physician Decision|2
1304110|NCT00191945|4243543|P1|Double-Blind Acute Treatment|Physician Decision|0
1304111|NCT00191945|4243542|P2|Double-Blind Acute Treatment|Non Protocol Compliance|0
1304112|NCT00191945|4243543|P1|Double-Blind Acute Treatment|Non Protocol Compliance|3
1304113|NCT00191945|4243542|P2|Double-Blind Acute Treatment|Lost to Follow-up|1
1304114|NCT00191945|4243543|P1|Double-Blind Acute Treatment|Lost to Follow-up|0
1304115|NCT00191945|4243542|P2|Double-Blind Acute Treatment|Parent's Decision|0
1304116|NCT00191945|4243543|P1|Double-Blind Acute Treatment|Parent's Decision|3
1304117|NCT00191906|4243579|P4|Study Period III|Lack of Efficacy|0
1304118|NCT00191906|4243580|P3|Study Period III|Lack of Efficacy|0
1304119|NCT00191906|4243581|P2|Study Period III|Lack of Efficacy|3
1304120|NCT00191906|4243582|P1|Study Period III|Lack of Efficacy|3
1304121|NCT00191906|4243579|P4|Study Period III|Parent/Caregiver Decision|0
1304122|NCT00191906|4243580|P3|Study Period III|Parent/Caregiver Decision|0
1304123|NCT00191906|4243581|P2|Study Period III|Parent/Caregiver Decision|0
1304124|NCT00191906|4243582|P1|Study Period III|Parent/Caregiver Decision|1
1304125|NCT00191906|4243579|P4|Study Period III|Lost to Follow-up|0
1304126|NCT00191906|4243580|P3|Study Period III|Lost to Follow-up|0
1304127|NCT00191906|4243581|P2|Study Period III|Lost to Follow-up|1
1304128|NCT00191906|4243582|P1|Study Period III|Lost to Follow-up|0
1304129|NCT00191906|4243579|P4|Study Period III|Adverse Event|0
1304130|NCT00191906|4243580|P3|Study Period III|Adverse Event|0
1304131|NCT00191906|4243581|P2|Study Period III|Adverse Event|0
1304132|NCT00191906|4243582|P1|Study Period III|Adverse Event|1
1304133|NCT00191906|4243579|P4|Study Period II|Entry Criteria Exclusion|0
1304134|NCT00191906|4243580|P3|Study Period II|Entry Criteria Exclusion|1
1304135|NCT00191906|4243581|P2|Study Period II|Entry Criteria Exclusion|0
1304136|NCT00191906|4243582|P1|Study Period II|Entry Criteria Exclusion|0
1304137|NCT00191906|4243579|P4|Study Period II|Parent/Caregiver Decision|0
1304138|NCT00191906|4243580|P3|Study Period II|Parent/Caregiver Decision|0
1304139|NCT00191906|4243581|P2|Study Period II|Parent/Caregiver Decision|1
1304140|NCT00191906|4243582|P1|Study Period II|Parent/Caregiver Decision|0
1304141|NCT00191906|4243579|P4|Study Period II|Withdrawal by Subject|0
1304142|NCT00191906|4243580|P3|Study Period II|Withdrawal by Subject|0
1304143|NCT00191906|4243581|P2|Study Period II|Withdrawal by Subject|3
1304144|NCT00191906|4243582|P1|Study Period II|Withdrawal by Subject|0
1304145|NCT00191906|4243579|P4|Study Period II|Adverse Event|0
1304146|NCT00191906|4243580|P3|Study Period II|Adverse Event|0
1304147|NCT00191906|4243581|P2|Study Period II|Adverse Event|1
1304148|NCT00191906|4243582|P1|Study Period II|Adverse Event|0
1304149|NCT00191854|4243625|P3|Overall Study|Screen Failure|1
1304150|NCT00191854|4243626|P2|Overall Study|Screen Failure|0
1304151|NCT00191854|4243627|P1|Overall Study|Screen Failure|0
1304152|NCT00191854|4243625|P3|Overall Study|Sponsor Decision|1
1304153|NCT00191854|4243626|P2|Overall Study|Sponsor Decision|0
1304154|NCT00191854|4243627|P1|Overall Study|Sponsor Decision|0
1304155|NCT00191854|4243625|P3|Overall Study|Withdrawal by Subject|3
1304156|NCT00191854|4243626|P2|Overall Study|Withdrawal by Subject|2
1304157|NCT00191854|4243627|P1|Overall Study|Withdrawal by Subject|4
1304158|NCT00191854|4243625|P3|Overall Study|Lost to Follow-up|5
1304159|NCT00191854|4243626|P2|Overall Study|Lost to Follow-up|5
1304160|NCT00191854|4243627|P1|Overall Study|Lost to Follow-up|7
1304161|NCT00191854|4243625|P3|Overall Study|Death|29
1304162|NCT00191854|4243626|P2|Overall Study|Death|23
1304163|NCT00191854|4243627|P1|Overall Study|Death|26
1304164|NCT00191815|4243647|P1|Overall Study|Withdrawal by Subject|7
1304165|NCT00191815|4243647|P1|Overall Study|Physician Decision|2
1304166|NCT00191815|4243647|P1|Overall Study|Protocol Violation|3
1304167|NCT00191815|4243647|P1|Overall Study|Death|2
1304168|NCT00191815|4243647|P1|Overall Study|Disease progression or relapse|24
1304169|NCT00191815|4243647|P1|Overall Study|Adverse Event|2
1304170|NCT00191789|4243659|P1|Overall Study|Death - Not Study-Drug Related|1
1304171|NCT00191789|4243659|P1|Overall Study|Progressive Disease/Lack of Efficacy|2
1304172|NCT00191789|4243659|P1|Overall Study|Death - Possibly Study Drug Related|4
1304173|NCT00191789|4243659|P1|Overall Study|Withdrawal by Subject|4
1304174|NCT00191789|4243659|P1|Overall Study|Patient/Physician: Satisfactory Response|4
1304175|NCT00191789|4243659|P1|Overall Study|Patient: Satisfactory Response|5
1304176|NCT00191789|4243659|P1|Overall Study|Adverse Event|5
1304177|NCT00191724|4243676|P5|Overall Study|Withdrawal by Subject|0
1304178|NCT00191724|4243677|P4|Overall Study|Withdrawal by Subject|1
1304179|NCT00191724|4243678|P3|Overall Study|Withdrawal by Subject|0
1304180|NCT00191724|4243679|P2|Overall Study|Withdrawal by Subject|0
1304181|NCT00191724|4243680|P1|Overall Study|Withdrawal by Subject|0
1304182|NCT00191724|4243676|P5|Overall Study|Lost to Follow-up|3
1304183|NCT00191724|4243677|P4|Overall Study|Lost to Follow-up|2
1304184|NCT00191724|4243678|P3|Overall Study|Lost to Follow-up|0
1304185|NCT00191724|4243679|P2|Overall Study|Lost to Follow-up|1
1304186|NCT00191724|4243680|P1|Overall Study|Lost to Follow-up|1
1304187|NCT00191724|4243676|P5|Overall Study|Adverse Event|0
1304188|NCT00191724|4243677|P4|Overall Study|Adverse Event|0
1304189|NCT00191724|4243678|P3|Overall Study|Adverse Event|1
1304190|NCT00191724|4243679|P2|Overall Study|Adverse Event|0
1304191|NCT00191724|4243680|P1|Overall Study|Adverse Event|0
1304192|NCT00191646|4243709|P2|Overall Study|Missing Data|11
1304193|NCT00191646|4243710|P1|Overall Study|Missing Data|18
1304194|NCT00191646|4243709|P2|Overall Study|Other|34
1304195|NCT00191646|4243710|P1|Overall Study|Other|33
1304196|NCT00191646|4243709|P2|Overall Study|Death|8
1304197|NCT00191646|4243710|P1|Overall Study|Death|6
1304198|NCT00191646|4243709|P2|Overall Study|Protocol Violation|7
1304199|NCT00191646|4243710|P1|Overall Study|Protocol Violation|5
1304200|NCT00191646|4243709|P2|Overall Study|Withdrawal by Subject|39
1304201|NCT00191646|4243710|P1|Overall Study|Withdrawal by Subject|58
1304202|NCT00191646|4243709|P2|Overall Study|Physician Decision|11
1304203|NCT00191646|4243710|P1|Overall Study|Physician Decision|20
1304204|NCT00191646|4243709|P2|Overall Study|Disease Progression|6
1304205|NCT00191646|4243710|P1|Overall Study|Disease Progression|5
1304206|NCT00191646|4243709|P2|Overall Study|Toxicity|37
1304207|NCT00191646|4243710|P1|Overall Study|Toxicity|26
1304208|NCT00191477|4243730|P2|Overall Study|Discontinued Prior to Instillation|14
1304209|NCT00191477|4243731|P1|Overall Study|Discontinued Prior to Instillation|13
1304210|NCT00191477|4243730|P2|Overall Study|Pathological Specimen Lost|0
1304211|NCT00191477|4243731|P1|Overall Study|Pathological Specimen Lost|1
1304212|NCT00191477|4243730|P2|Overall Study|Not Eligible|38
1304213|NCT00191477|4243731|P1|Overall Study|Not Eligible|41
1304214|NCT00191477|4243730|P2|Overall Study|Other|0
1304215|NCT00191477|4243731|P1|Overall Study|Other|2
1304216|NCT00191477|4243730|P2|Overall Study|Withdrawal by Subject|0
1304217|NCT00191477|4243731|P1|Overall Study|Withdrawal by Subject|2
1304218|NCT00191477|4243730|P2|Overall Study|Treatment Change|0
1304219|NCT00191477|4243731|P1|Overall Study|Treatment Change|2
1304220|NCT00191477|4243730|P2|Overall Study|Protocol Violation|1
1304221|NCT00191477|4243731|P1|Overall Study|Protocol Violation|1
1304222|NCT00191477|4243730|P2|Overall Study|Lost to Follow-up|21
1304223|NCT00191477|4243731|P1|Overall Study|Lost to Follow-up|23
1304224|NCT00191477|4243730|P2|Overall Study|Death, Other Cause|6
1304225|NCT00191477|4243731|P1|Overall Study|Death, Other Cause|3
1304226|NCT00191477|4243730|P2|Overall Study|Death, Study Disease|1
1304227|NCT00191477|4243731|P1|Overall Study|Death, Study Disease|1
1304228|NCT00191477|4243730|P2|Overall Study|Tumor Recurrence|48
1304229|NCT00191477|4243731|P1|Overall Study|Tumor Recurrence|49
1304230|NCT00191451|4243750|P3|Overall Study|Reason Not Specified|3
1304231|NCT00191451|4243751|P2|Overall Study|Reason Not Specified|1
1304232|NCT00191451|4243752|P1|Overall Study|Reason Not Specified|2
1304233|NCT00191451|4243750|P3|Overall Study|Ineligible|0
1304234|NCT00191451|4243751|P2|Overall Study|Ineligible|1
1304235|NCT00191451|4243752|P1|Overall Study|Ineligible|0
1304236|NCT00191451|4243750|P3|Overall Study|Sponsor Decision|0
1304237|NCT00191451|4243751|P2|Overall Study|Sponsor Decision|0
1304238|NCT00191451|4243752|P1|Overall Study|Sponsor Decision|1
1304239|NCT00191451|4243750|P3|Overall Study|Physician Decision|6
1304240|NCT00191451|4243751|P2|Overall Study|Physician Decision|9
1304241|NCT00191451|4243752|P1|Overall Study|Physician Decision|2
1304242|NCT00191451|4243750|P3|Overall Study|Withdrawal by Subject|5
1304243|NCT00191451|4243751|P2|Overall Study|Withdrawal by Subject|3
1304244|NCT00191451|4243752|P1|Overall Study|Withdrawal by Subject|2
1304245|NCT00191386|4243772|P1|Overall Study|Lack of Efficacy|15
1304246|NCT00191386|4243772|P1|Overall Study|Physician Decision|11
1304247|NCT00191386|4243772|P1|Overall Study|Withdrawal by Subject|96
1304248|NCT00191386|4243772|P1|Overall Study|Protocol Violation|18
1304249|NCT00191386|4243772|P1|Overall Study|Entry Criteria Exclusion|3
1304250|NCT00191386|4243772|P1|Overall Study|Lost to Follow-up|1
1304251|NCT00191386|4243772|P1|Overall Study|Adverse Event|16
1304252|NCT00191334|4243779|P1|Overall Study|Withdrawal by Subject|4
1304253|NCT00191334|4243779|P1|Overall Study|Physician Decision|1
1304254|NCT00191334|4243779|P1|Overall Study|Disease Progression or Relapse|8
1304255|NCT00191334|4243779|P1|Overall Study|Adverse Event|4
1304256|NCT00191308|4243787|P1|Overall Study|Adverse Event|1
1304257|NCT00191282|4243797|P2|Overall Study|Lost to Follow-up|31
1304258|NCT00191282|4243798|P1|Overall Study|Lost to Follow-up|24
1304259|NCT00191282|4243797|P2|Overall Study|Sponsor's decision|2
1304260|NCT00191282|4243798|P1|Overall Study|Sponsor's decision|2
1304261|NCT00191282|4243797|P2|Overall Study|Severity of outcome|5
1304262|NCT00191282|4243798|P1|Overall Study|Severity of outcome|2
1304263|NCT00191282|4243797|P2|Overall Study|Protocol Violation|12
1304264|NCT00191282|4243798|P1|Overall Study|Protocol Violation|9
1304265|NCT00191282|4243797|P2|Overall Study|Protocol entry criteria not met|9
1304266|NCT00191282|4243798|P1|Overall Study|Protocol entry criteria not met|14
1304267|NCT00191282|4243797|P2|Overall Study|Physician Decision|15
1304268|NCT00191282|4243798|P1|Overall Study|Physician Decision|18
1304269|NCT00191282|4243797|P2|Overall Study|Withdrawal by Subject|44
1304270|NCT00191282|4243798|P1|Overall Study|Withdrawal by Subject|59
1304271|NCT00191282|4243797|P2|Overall Study|Patient moved|14
1304272|NCT00191282|4243798|P1|Overall Study|Patient moved|11
1304273|NCT00191282|4243797|P2|Overall Study|Noncompliance|17
1304274|NCT00191282|4243798|P1|Overall Study|Noncompliance|14
1304275|NCT00191282|4243797|P2|Overall Study|Lack of Efficacy|6
1304276|NCT00191282|4243798|P1|Overall Study|Lack of Efficacy|11
1304277|NCT00191282|4243797|P2|Overall Study|Death|51
1304278|NCT00191282|4243798|P1|Overall Study|Death|51
1304279|NCT00191282|4243797|P2|Overall Study|Adverse Event|6
1304280|NCT00191282|4243798|P1|Overall Study|Adverse Event|5
1304281|NCT00191269|4243858|P2|Overall Study|Physician Decision|3
1304282|NCT00191269|4243859|P1|Overall Study|Physician Decision|0
1304283|NCT00191269|4243858|P2|Overall Study|Pathologic Aggrevation|1
1304284|NCT00191269|4243859|P1|Overall Study|Pathologic Aggrevation|0
1304285|NCT00191269|4243858|P2|Overall Study|Withdrawal by Subject|1
1304286|NCT00191269|4243859|P1|Overall Study|Withdrawal by Subject|0
1304287|NCT00191269|4243858|P2|Overall Study|Lack of Efficacy|5
1304288|NCT00191269|4243859|P1|Overall Study|Lack of Efficacy|1
1304289|NCT00191269|4243858|P2|Overall Study|Progression of Disease|42
1304290|NCT00191269|4243859|P1|Overall Study|Progression of Disease|4
1304291|NCT00191269|4243858|P2|Overall Study|Adverse Event|4
1304292|NCT00191269|4243859|P1|Overall Study|Adverse Event|1
1304293|NCT00191269|4243858|P2|Overall Study|Protocol Violation|2
1304294|NCT00191269|4243859|P1|Overall Study|Protocol Violation|0
1304295|NCT00191191|4243875|P2|Overall Study|Good Clinical Practice Violation|1
1304296|NCT00191191|4243876|P1|Overall Study|Good Clinical Practice Violation|0
1304297|NCT00191191|4243875|P2|Overall Study|Physician Decision|2
1304298|NCT00191191|4243876|P1|Overall Study|Physician Decision|3
1304299|NCT00191191|4243875|P2|Overall Study|Lost to Follow-up|0
1304300|NCT00191191|4243876|P1|Overall Study|Lost to Follow-up|1
1304301|NCT00191191|4243875|P2|Overall Study|Family/Caregiver Decision|7
1304302|NCT00191191|4243876|P1|Overall Study|Family/Caregiver Decision|5
1304303|NCT00191191|4243875|P2|Overall Study|Toxicity After Dose Reduction|8
1304304|NCT00191191|4243876|P1|Overall Study|Toxicity After Dose Reduction|7
1304305|NCT00191191|4243875|P2|Overall Study|Progressive Disease|72
1304306|NCT00191191|4243876|P1|Overall Study|Progressive Disease|84
1304307|NCT00191191|4243875|P2|Overall Study|Adverse Event|21
1304308|NCT00191191|4243876|P1|Overall Study|Adverse Event|11
1304309|NCT00191191|4243875|P2|Overall Study|Treated with Another Systemic Agent|1
1304310|NCT00191191|4243876|P1|Overall Study|Treated with Another Systemic Agent|1
1304311|NCT00191191|4243875|P2|Overall Study|Entry Criteria Exclusion|0
1304312|NCT00191191|4243876|P1|Overall Study|Entry Criteria Exclusion|2
1304313|NCT00191165|4243892|P2|Overall Study|Participant Moved Away|1
1304314|NCT00191165|4243893|P1|Overall Study|Participant Moved Away|0
1304315|NCT00191165|4243892|P2|Overall Study|Protocol Violation|1
1304316|NCT00191165|4243893|P1|Overall Study|Protocol Violation|0
1304317|NCT00191165|4243892|P2|Overall Study|Adverse Event|0
1304318|NCT00191165|4243893|P1|Overall Study|Adverse Event|2
1304319|NCT00191152|4243905|P2|Crossover Treatment|Not Specified|3
1304320|NCT00191152|4243906|P1|Crossover Treatment|Not Specified|4
1304321|NCT00191152|4243905|P2|Crossover Treatment|Lost to Follow-up|1
1304322|NCT00191152|4243906|P1|Crossover Treatment|Lost to Follow-up|2
1304323|NCT00191152|4243905|P2|Crossover Treatment|Withdrawal by Subject|9
1304324|NCT00191152|4243906|P1|Crossover Treatment|Withdrawal by Subject|6
1304325|NCT00191152|4243905|P2|Crossover Treatment|Physician Decision|7
1304326|NCT00191152|4243906|P1|Crossover Treatment|Physician Decision|7
1304327|NCT00191152|4243905|P2|Crossover Treatment|Adverse Event|8
1304328|NCT00191152|4243906|P1|Crossover Treatment|Adverse Event|8
1304329|NCT00191152|4243905|P2|Initial Treatment|not specified|21
1304330|NCT00191152|4243906|P1|Initial Treatment|not specified|18
1304331|NCT00191152|4243905|P2|Initial Treatment|Lost to Follow-up|6
1304332|NCT00191152|4243906|P1|Initial Treatment|Lost to Follow-up|0
1304333|NCT00191152|4243905|P2|Initial Treatment|Withdrawal by Subject|28
1304334|NCT00191152|4243906|P1|Initial Treatment|Withdrawal by Subject|40
1304335|NCT00191152|4243905|P2|Initial Treatment|Physician Decision|31
1304336|NCT00191152|4243906|P1|Initial Treatment|Physician Decision|40
1304337|NCT00191152|4243905|P2|Initial Treatment|Adverse Event|67
1304338|NCT00191152|4243906|P1|Initial Treatment|Adverse Event|43
1304339|NCT00191139|4243938|P2|Overall Study|Other|2
1304340|NCT00191139|4243939|P1|Overall Study|Other|1
1304341|NCT00191139|4243938|P2|Overall Study|Disease Progression|1
1304342|NCT00191139|4243939|P1|Overall Study|Disease Progression|0
1304343|NCT00191139|4243938|P2|Overall Study|Withdrawal by Subject|3
1304344|NCT00191139|4243939|P1|Overall Study|Withdrawal by Subject|0
1304345|NCT00191139|4243938|P2|Overall Study|Death|0
1304346|NCT00191139|4243939|P1|Overall Study|Death|2
1304347|NCT00191139|4243938|P2|Overall Study|Adverse Event|6
1304348|NCT00191139|4243939|P1|Overall Study|Adverse Event|2
1304349|NCT00191113|4243955|P2|Core Study|Death|0
1304350|NCT00191113|4243956|P1|Core Study|Death|1
1304351|NCT00191113|4243955|P2|Core Study|Lack of Efficacy|2
1304352|NCT00191113|4243956|P1|Core Study|Lack of Efficacy|0
1304353|NCT00191113|4243955|P2|Core Study|Adverse Event|2
1304354|NCT00191113|4243956|P1|Core Study|Adverse Event|0
1304355|NCT00191113|4243955|P2|Core Study|Lost to Follow-up|0
1304356|NCT00191113|4243956|P1|Core Study|Lost to Follow-up|3
1304357|NCT00191113|4243955|P2|Core Study|Protocol Violation|2
1304358|NCT00191113|4243956|P1|Core Study|Protocol Violation|6
1304359|NCT00191113|4243955|P2|Core Study|Withdrawal by Subject|9
1304360|NCT00191113|4243956|P1|Core Study|Withdrawal by Subject|25
1304361|NCT00191100|4243998|P2|Overall Study|Reason Not Specified|1
1304362|NCT00191100|4243999|P1|Overall Study|Reason Not Specified|0
1304363|NCT00191100|4243998|P2|Overall Study|Death from Other Cause|0
1304364|NCT00191100|4243999|P1|Overall Study|Death from Other Cause|1
1304365|NCT00191100|4243998|P2|Overall Study|Protocol Violation|1
1304366|NCT00191100|4243999|P1|Overall Study|Protocol Violation|1
1304367|NCT00191100|4243998|P2|Overall Study|Death from Study Drug Toxicity|0
1304368|NCT00191100|4243999|P1|Overall Study|Death from Study Drug Toxicity|2
1304369|NCT00191100|4243998|P2|Overall Study|Physician Decision|1
1304370|NCT00191100|4243999|P1|Overall Study|Physician Decision|3
1304371|NCT00191100|4243998|P2|Overall Study|Lack of Efficacy, Stable Disease|0
1304372|NCT00191100|4243999|P1|Overall Study|Lack of Efficacy, Stable Disease|1
1304373|NCT00191100|4243998|P2|Overall Study|Lack of Efficacy, Progressive Disease|2
1304374|NCT00191100|4243999|P1|Overall Study|Lack of Efficacy, Progressive Disease|1
1304375|NCT00191100|4243998|P2|Overall Study|Clinical Relapse|1
1304376|NCT00191100|4243999|P1|Overall Study|Clinical Relapse|2
1304377|NCT00191100|4243998|P2|Overall Study|Protocol Entry Criteria Not Met|1
1304378|NCT00191100|4243999|P1|Overall Study|Protocol Entry Criteria Not Met|2
1304379|NCT00191100|4243998|P2|Overall Study|Withdrawal by Subject|3
1304380|NCT00191100|4243999|P1|Overall Study|Withdrawal by Subject|9
1304381|NCT00191100|4243998|P2|Overall Study|Patient Moved|1
1304382|NCT00191100|4243999|P1|Overall Study|Patient Moved|0
1304383|NCT00191100|4243998|P2|Overall Study|Lost to Follow-up|0
1304384|NCT00191100|4243999|P1|Overall Study|Lost to Follow-up|2
1304385|NCT00191100|4243998|P2|Overall Study|Adverse Event|1
1304386|NCT00191100|4243999|P1|Overall Study|Adverse Event|18
1304387|NCT00190983|4244015|P1|Overall Study|Inevaluable (never treated)|2
1304388|NCT00190775|4244024|P2|Overall Study|Exclusion Criteria Met|3
1304389|NCT00190775|4244025|P1|Overall Study|Exclusion Criteria Met|1
1304390|NCT00190775|4244024|P2|Overall Study|Protocol Violation|1
1304391|NCT00190775|4244025|P1|Overall Study|Protocol Violation|0
1304392|NCT00190775|4244024|P2|Overall Study|Noncompliance|5
1304393|NCT00190775|4244025|P1|Overall Study|Noncompliance|3
1304394|NCT00190775|4244024|P2|Overall Study|Physician Decision|0
1304395|NCT00190775|4244025|P1|Overall Study|Physician Decision|3
1304396|NCT00190775|4244024|P2|Overall Study|Sponsor Decision|0
1304397|NCT00190775|4244025|P1|Overall Study|Sponsor Decision|1
1304398|NCT00190775|4244024|P2|Overall Study|Withdrawal by Subject|13
1304399|NCT00190775|4244025|P1|Overall Study|Withdrawal by Subject|24
1304400|NCT00190775|4244024|P2|Overall Study|Participant Moved|1
1304401|NCT00190775|4244025|P1|Overall Study|Participant Moved|0
1304402|NCT00190775|4244024|P2|Overall Study|Lost to Follow-up|23
1304403|NCT00190775|4244025|P1|Overall Study|Lost to Follow-up|31
1304404|NCT00190775|4244024|P2|Overall Study|Lack of Efficacy|32
1304405|NCT00190775|4244025|P1|Overall Study|Lack of Efficacy|28
1304406|NCT00190775|4244024|P2|Overall Study|Satisfactory Response|0
1304407|NCT00190775|4244025|P1|Overall Study|Satisfactory Response|1
1304408|NCT00190775|4244024|P2|Overall Study|Adverse Event|22
1304409|NCT00190775|4244025|P1|Overall Study|Adverse Event|57
1304410|NCT00190749|4244096|P2|Overall Study|Sponsor Decision|0
1304411|NCT00190749|4244097|P1|Overall Study|Sponsor Decision|1
1304412|NCT00190749|4244096|P2|Overall Study|Reason Not Specified|2
1304413|NCT00190749|4244097|P1|Overall Study|Reason Not Specified|0
1304414|NCT00190749|4244096|P2|Overall Study|Lack of Efficacy|3
1304415|NCT00190749|4244097|P1|Overall Study|Lack of Efficacy|2
1304416|NCT00190749|4244096|P2|Overall Study|Adverse Event|5
1304417|NCT00190749|4244097|P1|Overall Study|Adverse Event|0
1304418|NCT00190749|4244096|P2|Overall Study|Protocol Violation|4
1304419|NCT00190749|4244097|P1|Overall Study|Protocol Violation|5
1304420|NCT00190749|4244096|P2|Overall Study|Withdrawal by Subject|6
1304421|NCT00190749|4244097|P1|Overall Study|Withdrawal by Subject|10
1304422|NCT00190749|4244096|P2|Overall Study|Lost to Follow-up|11
1304423|NCT00190749|4244097|P1|Overall Study|Lost to Follow-up|8
1304424|NCT00190684|4244161|P1|Overall Study|Study Period V Completed|1
1304425|NCT00190684|4244161|P1|Overall Study|Study Period III Completed|103
1304426|NCT00190684|4244161|P1|Overall Study|Protocol Violation|123
1304427|NCT00190684|4244161|P1|Overall Study|Physician Decision|84
1304428|NCT00190684|4244161|P1|Overall Study|Sponsor's decision|17
1304429|NCT00190684|4244161|P1|Overall Study|Clinical relapse|67
1304430|NCT00190684|4244161|P1|Overall Study|Patient Decision|432
1304431|NCT00190684|4244161|P1|Overall Study|Patient moved|60
1304432|NCT00190684|4244161|P1|Overall Study|Lost to Follow-up|232
1304433|NCT00190684|4244161|P1|Overall Study|Lack of efficacy|204
1304434|NCT00190684|4244161|P1|Overall Study|Satisfactory response|80
1304435|NCT00190684|4244161|P1|Overall Study|Adverse Event|86
1304436|NCT00190671|4244182|P2|Overall Study|Withdrawal by Subject|2
1304437|NCT00190671|4244183|P1|Overall Study|Withdrawal by Subject|0
1304438|NCT00190671|4244182|P2|Overall Study|Protocol Violation|1
1304439|NCT00190671|4244183|P1|Overall Study|Protocol Violation|0
1304440|NCT00190671|4244182|P2|Overall Study|Death from Other Causes|2
1304441|NCT00190671|4244183|P1|Overall Study|Death from Other Causes|0
1304442|NCT00190671|4244182|P2|Overall Study|Death from Study-Drug Toxicity|2
1304443|NCT00190671|4244183|P1|Overall Study|Death from Study-Drug Toxicity|0
1304444|NCT00190671|4244182|P2|Overall Study|Clinical Relapse|1
1304445|NCT00190671|4244183|P1|Overall Study|Clinical Relapse|0
1304446|NCT00190671|4244182|P2|Overall Study|Adverse Event|2
1304447|NCT00190671|4244183|P1|Overall Study|Adverse Event|3
1304448|NCT00190671|4244182|P2|Overall Study|Death from Study Disease|1
1304449|NCT00190671|4244183|P1|Overall Study|Death from Study Disease|1
1304450|NCT00190671|4244182|P2|Overall Study|Lack of Efficacy|24
1304451|NCT00190671|4244183|P1|Overall Study|Lack of Efficacy|19
1304452|NCT00190671|4244182|P2|Overall Study|Satisfactory Response|7
1304453|NCT00190671|4244183|P1|Overall Study|Satisfactory Response|4
1304454|NCT00189540|4244203|P2|Overall Study|Death|1
1304455|NCT00189540|4244204|P1|Overall Study|Death|4
1304456|NCT00189540|4244203|P2|Overall Study|Withdrawal by Subject|0
1304457|NCT00189540|4244204|P1|Overall Study|Withdrawal by Subject|3
1304458|NCT00189488|4244222|P2|Overall Study|Other|0
1304459|NCT00189488|4244223|P1|Overall Study|Other|1
1304460|NCT00189488|4244222|P2|Overall Study|Death|8
1304461|NCT00189488|4244223|P1|Overall Study|Death|5
1304462|NCT00189488|4244222|P2|Overall Study|Administrative Decision|2
1304463|NCT00189488|4244223|P1|Overall Study|Administrative Decision|0
1304464|NCT00189488|4244222|P2|Overall Study|Disease progression|4
1304465|NCT00189488|4244223|P1|Overall Study|Disease progression|2
1304466|NCT00189488|4244222|P2|Overall Study|Withdrawal by Subject|6
1304467|NCT00189488|4244223|P1|Overall Study|Withdrawal by Subject|2
1304468|NCT00189488|4244222|P2|Overall Study|Adverse Event|1
1304469|NCT00189488|4244223|P1|Overall Study|Adverse Event|2
1304470|NCT00189488|4244222|P2|Overall Study|Protocol deviation|1
1304471|NCT00189488|4244223|P1|Overall Study|Protocol deviation|2
1304472|NCT00189488|4244222|P2|Overall Study|Ineligibility determined|0
1304473|NCT00189488|4244223|P1|Overall Study|Ineligibility determined|1
1304474|NCT00189462|4244254|P2|Overall Study|Lost to Follow-up|20
1304475|NCT00189462|4244255|P1|Overall Study|Lost to Follow-up|18
1304476|NCT00189462|4244254|P2|Overall Study|Lack of Efficacy|1
1304477|NCT00189462|4244255|P1|Overall Study|Lack of Efficacy|5
1304478|NCT00189423|4244272|P2|Overall Study|Lost to Follow-up|10
1304479|NCT00189423|4244273|P1|Overall Study|Lost to Follow-up|10
1304480|NCT00189423|4244272|P2|Overall Study|Withdrawal by Subject|9
1304481|NCT00189423|4244273|P1|Overall Study|Withdrawal by Subject|9
1304482|NCT00189423|4244272|P2|Overall Study|Death|747
1304483|NCT00189423|4244273|P1|Overall Study|Death|746
1304484|NCT00189306|4244295|P1|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20
1304485|NCT00189306|4244295|P1|Long-Term Follow-up|Lost to Follow-up|9
1304486|NCT00189306|4244295|P1|Long-Term Follow-up|Intercurrent disease|2
1304487|NCT00189306|4244295|P1|Long-Term Follow-up|Withdrawal by Subject|1
1304488|NCT00189306|4244295|P1|Long-Term Follow-up|Death|4
1304489|NCT00189306|4244295|P1|Long-Term Follow-up|Adverse Event|2
1304490|NCT00189306|4244295|P1|Posttreatment Period|Local skin reaction/sign|1
1304491|NCT00189306|4244295|P1|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5
1304492|NCT00189306|4244295|P1|Posttreatment Period|Protocol Violation|1
1304493|NCT00189306|4244295|P1|Posttreatment Period|Target lesion excised|1
1304494|NCT00189306|4244295|P1|Posttreatment Period|Noncompliance|1
1304495|NCT00189306|4244295|P1|Posttreatment Period|Withdrawal by Subject|2
1304496|NCT00189306|4244295|P1|Posttreatment Period|Death|1
1304497|NCT00189306|4244295|P1|Treatment Period|Protocol Violation|1
1304498|NCT00189306|4244295|P1|Treatment Period|Adverse Event|2
1304499|NCT00189306|4244295|P1|Treatment Period|Withdrawal by Subject|2
1304500|NCT00189202|4244300|P1|Overall Study|Physician Decision|5
1304501|NCT00187889|4244341|P2|Overall Study|Withdrawal by Subject|4
1304502|NCT00187889|4244342|P1|Overall Study|Withdrawal by Subject|6
1304503|NCT00187486|4244384|P1|Overall Study|Protocol Violation|1
1304504|NCT00187135|4244435|P6|Visit Three|Study Discontinued|6
1304505|NCT00187135|4244436|P5|Visit Three|Study Discontinued|7
1304506|NCT00187135|4244437|P4|Visit Three|Study Discontinued|7
1304507|NCT00187135|4244438|P3|Visit Three|Study Discontinued|7
1304508|NCT00187135|4244439|P2|Visit Three|Study Discontinued|6
1304509|NCT00187135|4244440|P1|Visit Three|Study Discontinued|7
1304510|NCT00187135|4244435|P6|Visit Three|Withdrawal by Subject|0
1304511|NCT00187135|4244436|P5|Visit Three|Withdrawal by Subject|0
1304512|NCT00187135|4244437|P4|Visit Three|Withdrawal by Subject|2
1304513|NCT00187135|4244438|P3|Visit Three|Withdrawal by Subject|1
1304514|NCT00187135|4244439|P2|Visit Three|Withdrawal by Subject|1
1304515|NCT00187135|4244440|P1|Visit Three|Withdrawal by Subject|0
1304516|NCT00187135|4244435|P6|Visit Three|Death|0
1304517|NCT00187135|4244436|P5|Visit Three|Death|1
1304518|NCT00187135|4244437|P4|Visit Three|Death|0
1304519|NCT00187135|4244438|P3|Visit Three|Death|1
1304520|NCT00187135|4244439|P2|Visit Three|Death|0
1304521|NCT00187135|4244440|P1|Visit Three|Death|0
1304522|NCT00187135|4244435|P6|Visit Two|Study Discontinued|6
1304523|NCT00187135|4244436|P5|Visit Two|Study Discontinued|5
1304524|NCT00187135|4244437|P4|Visit Two|Study Discontinued|7
1304525|NCT00187135|4244438|P3|Visit Two|Study Discontinued|1
1304526|NCT00187135|4244439|P2|Visit Two|Study Discontinued|2
1304527|NCT00187135|4244440|P1|Visit Two|Study Discontinued|3
1304528|NCT00187135|4244435|P6|Visit Two|Withdrawal by Subject|1
1304529|NCT00187135|4244436|P5|Visit Two|Withdrawal by Subject|1
1304530|NCT00187135|4244437|P4|Visit Two|Withdrawal by Subject|0
1304531|NCT00187135|4244438|P3|Visit Two|Withdrawal by Subject|1
1304532|NCT00187135|4244439|P2|Visit Two|Withdrawal by Subject|1
1304533|NCT00187135|4244440|P1|Visit Two|Withdrawal by Subject|1
1304534|NCT00187135|4244435|P6|Visit Two|Physician Decision|0
1304535|NCT00187135|4244436|P5|Visit Two|Physician Decision|0
1304536|NCT00187135|4244437|P4|Visit Two|Physician Decision|0
1304537|NCT00187135|4244438|P3|Visit Two|Physician Decision|0
1304538|NCT00187135|4244439|P2|Visit Two|Physician Decision|0
1304539|NCT00187135|4244440|P1|Visit Two|Physician Decision|1
1304540|NCT00187135|4244435|P6|Visit Two|Death|1
1304541|NCT00187135|4244436|P5|Visit Two|Death|0
1304542|NCT00187135|4244437|P4|Visit Two|Death|1
1304543|NCT00187135|4244438|P3|Visit Two|Death|0
1304544|NCT00187135|4244439|P2|Visit Two|Death|0
1304545|NCT00187135|4244440|P1|Visit Two|Death|0
1304546|NCT00187135|4244435|P6|Visit One|Physician Decision|1
1304547|NCT00187135|4244436|P5|Visit One|Physician Decision|0
1304548|NCT00187135|4244437|P4|Visit One|Physician Decision|0
1304549|NCT00187135|4244438|P3|Visit One|Physician Decision|0
1304550|NCT00187135|4244439|P2|Visit One|Physician Decision|1
1304551|NCT00187135|4244440|P1|Visit One|Physician Decision|3
1304552|NCT00187135|4244435|P6|Visit One|Withdrawal by Subject|1
1304553|NCT00187135|4244436|P5|Visit One|Withdrawal by Subject|0
1304554|NCT00187135|4244437|P4|Visit One|Withdrawal by Subject|0
1304555|NCT00187135|4244438|P3|Visit One|Withdrawal by Subject|0
1304556|NCT00187135|4244439|P2|Visit One|Withdrawal by Subject|0
1304557|NCT00187135|4244440|P1|Visit One|Withdrawal by Subject|1
1304558|NCT00187096|4244463|P3|Overall Study|unacceptable toxicity|1
1304559|NCT00187096|4244464|P2|Overall Study|unacceptable toxicity|0
1304560|NCT00187096|4244465|P1|Overall Study|unacceptable toxicity|0
1304561|NCT00186901|4244503|P3|Overall Study|Bone Mineral Density > 0|149
1304562|NCT00186901|4244504|P2|Overall Study|Bone Mineral Density > 0|0
1304563|NCT00186901|4244505|P1|Overall Study|Bone Mineral Density > 0|0
1304564|NCT00186901|4244503|P3|Overall Study|Limited adherence to study requirements|0
1304565|NCT00186901|4244504|P2|Overall Study|Limited adherence to study requirements|23
1304566|NCT00186901|4244505|P1|Overall Study|Limited adherence to study requirements|20
1304567|NCT00186901|4244503|P3|Overall Study|Open label|0
1304568|NCT00186901|4244504|P2|Overall Study|Open label|2
1304569|NCT00186901|4244505|P1|Overall Study|Open label|3
1304570|NCT00186901|4244503|P3|Overall Study|Withdrawal by Subject|0
1304571|NCT00186901|4244504|P2|Overall Study|Withdrawal by Subject|5
1304572|NCT00186901|4244505|P1|Overall Study|Withdrawal by Subject|4
1304573|NCT00186901|4244503|P3|Overall Study|ALL relapse or second malignancy|0
1304574|NCT00186901|4244504|P2|Overall Study|ALL relapse or second malignancy|2
1304575|NCT00186901|4244505|P1|Overall Study|ALL relapse or second malignancy|1
1304576|NCT00186901|4244503|P3|Overall Study|Bone Mineral Density dropped > 5%|0
1304577|NCT00186901|4244504|P2|Overall Study|Bone Mineral Density dropped > 5%|7
1304578|NCT00186901|4244505|P1|Overall Study|Bone Mineral Density dropped > 5%|9
1304579|NCT00186901|4244503|P3|Overall Study|Lost to Follow-up|0
1304580|NCT00186901|4244504|P2|Overall Study|Lost to Follow-up|3
1304581|NCT00186901|4244505|P1|Overall Study|Lost to Follow-up|6
1304582|NCT00186901|4244503|P3|Overall Study|Pregnancy|0
1304583|NCT00186901|4244504|P2|Overall Study|Pregnancy|3
1304584|NCT00186901|4244505|P1|Overall Study|Pregnancy|6
1304585|NCT00186888|4244545|P3|Overall Study|Relapse or progression of disease|0
1304586|NCT00186888|4244546|P2|Overall Study|Relapse or progression of disease|2
1304587|NCT00186888|4244547|P1|Overall Study|Relapse or progression of disease|4
1304588|NCT00186888|4244545|P3|Overall Study|Toxicity|0
1304589|NCT00186888|4244546|P2|Overall Study|Toxicity|1
1304590|NCT00186888|4244547|P1|Overall Study|Toxicity|0
1304591|NCT00186628|4244639|P1|Overall Study|Withdrawal by subject (before treatment)|1
1304592|NCT00186628|4244639|P1|Overall Study|Death|2
1304593|NCT00186537|4244650|P3|Overall Study|ALT > 1.5 x ULN|0
1304594|NCT00186537|4244651|P2|Overall Study|ALT > 1.5 x ULN|0
1304595|NCT00186537|4244652|P1|Overall Study|ALT > 1.5 x ULN|3
1304596|NCT00186537|4244650|P3|Overall Study|Withdrawal by Subject|3
1304597|NCT00186537|4244651|P2|Overall Study|Withdrawal by Subject|0
1304598|NCT00186537|4244652|P1|Overall Study|Withdrawal by Subject|4
1304599|NCT00186485|4244666|P1|Overall Study|Lost to Follow-up|3
1304600|NCT00186186|4244678|P1|Overall Study|Not reported as to reason|2
1304601|NCT00186186|4244678|P1|Overall Study|Withdrawal by Subject|3
1304602|NCT00186186|4244678|P1|Overall Study|Lack of Efficacy|3
1304603|NCT00186121|4244683|P1|Overall Study|Not eligible (no treatment)|1
1304604|NCT00186121|4244683|P1|Overall Study|Underwent oophorectomy (no treatment)|1
1304605|NCT00186121|4244683|P1|Overall Study|Subject withdrawal (no treatment)|1
1304606|NCT00186043|4244717|P2|Overall Study|Protocol Violation|1
1304607|NCT00186043|4244718|P1|Overall Study|Protocol Violation|2
1304608|NCT00186043|4244717|P2|Overall Study|Adverse Event|3
1304609|NCT00186043|4244718|P1|Overall Study|Adverse Event|7
1304610|NCT00186043|4244717|P2|Overall Study|Withdrawal by Subject|0
1304611|NCT00186043|4244718|P1|Overall Study|Withdrawal by Subject|1
1304612|NCT00186043|4244717|P2|Overall Study|Lost to Follow-up|6
1304613|NCT00186043|4244718|P1|Overall Study|Lost to Follow-up|4
1304614|NCT00186043|4244717|P2|Overall Study|Lack of Efficacy|3
1304615|NCT00186043|4244718|P1|Overall Study|Lack of Efficacy|1
1304616|NCT00185965|4244745|P2|Overall Study|Adverse Event|1
1304617|NCT00185965|4244746|P1|Overall Study|Adverse Event|0
1304618|NCT00185731|4244771|P1|Overall Study|Not Eligible|1
1304619|NCT00185731|4244771|P1|Overall Study|Withdrawal by Subject|1
1304620|NCT00185640|4244788|P1|Overall Study|Death|138
1304621|NCT00185640|4244788|P1|Overall Study|Withdrawal by Subject|3
1304622|NCT00185640|4244788|P1|Overall Study|Not Eligible|4
1304623|NCT00185614|4244797|P1|Inter-treatment Period|Lack of allogenic donor|1
1304624|NCT00185614|4244797|P1|Inter-treatment Period|Relapse|2
1304625|NCT00185614|4244797|P1|Inter-treatment Period|Physician Decision|1
1304626|NCT00185588|4244809|P4|Overall Study|Physician Decision|0
1304627|NCT00185588|4244810|P3|Overall Study|Physician Decision|1
1304628|NCT00185588|4244811|P2|Overall Study|Physician Decision|0
1304629|NCT00185588|4244812|P1|Overall Study|Physician Decision|0
1304630|NCT00185588|4244809|P4|Overall Study|Withdrawal by Subject|0
1304631|NCT00185588|4244810|P3|Overall Study|Withdrawal by Subject|0
1304632|NCT00185588|4244811|P2|Overall Study|Withdrawal by Subject|1
1304633|NCT00185588|4244812|P1|Overall Study|Withdrawal by Subject|0
1304634|NCT00185588|4244809|P4|Overall Study|Lost to Follow-up|2
1304635|NCT00185588|4244810|P3|Overall Study|Lost to Follow-up|1
1304636|NCT00185588|4244811|P2|Overall Study|Lost to Follow-up|0
1304637|NCT00185588|4244812|P1|Overall Study|Lost to Follow-up|0
1304638|NCT00185588|4244809|P4|Overall Study|Adverse Event|2
1304639|NCT00185588|4244810|P3|Overall Study|Adverse Event|4
1304640|NCT00185588|4244811|P2|Overall Study|Adverse Event|1
1304641|NCT00185588|4244812|P1|Overall Study|Adverse Event|3
1304642|NCT00185458|4244826|P1|HRT Phase|Withdrawal by Subject|3
1304643|NCT00185458|4244826|P1|HRT Phase|Protocol Violation|2
1304644|NCT00185458|4244826|P1|HRT Phase|Lost to Follow-up|4
1304645|NCT00185458|4244826|P1|HRT Phase|Adverse Event|18
1304646|NCT00185458|4244826|P1|Contraception Phase|Withdrawal by Subject|7
1304647|NCT00185458|4244826|P1|Contraception Phase|Physician Decision|2
1304648|NCT00185458|4244826|P1|Contraception Phase|Protocol Violation|2
1304649|NCT00185458|4244826|P1|Contraception Phase|Lost to Follow-up|10
1304650|NCT00185458|4244826|P1|Contraception Phase|Adverse Event|37
1304651|NCT00185380|4244889|P3|Overall Study|personal reason|1
1304652|NCT00185380|4244890|P2|Overall Study|personal reason|1
1304653|NCT00185380|4244891|P1|Overall Study|personal reason|6
1304654|NCT00185380|4244889|P3|Overall Study|Could not attend visits|4
1304655|NCT00185380|4244890|P2|Overall Study|Could not attend visits|0
1304656|NCT00185380|4244891|P1|Overall Study|Could not attend visits|2
1304657|NCT00185380|4244889|P3|Overall Study|No need for contraception|3
1304658|NCT00185380|4244890|P2|Overall Study|No need for contraception|3
1304659|NCT00185380|4244891|P1|Overall Study|No need for contraception|3
1304660|NCT00185380|4244889|P3|Overall Study|Planned pregnancy|12
1304661|NCT00185380|4244890|P2|Overall Study|Planned pregnancy|12
1304662|NCT00185380|4244891|P1|Overall Study|Planned pregnancy|9
1304663|NCT00185380|4244889|P3|Overall Study|Failed insertion|2
1304664|NCT00185380|4244890|P2|Overall Study|Failed insertion|1
1304665|NCT00185380|4244891|P1|Overall Study|Failed insertion|1
1304666|NCT00185380|4244889|P3|Overall Study|Withdrawal by Subject|0
1304667|NCT00185380|4244890|P2|Overall Study|Withdrawal by Subject|2
1304668|NCT00185380|4244891|P1|Overall Study|Withdrawal by Subject|1
1304669|NCT00185380|4244889|P3|Overall Study|Protocol Violation|1
1304670|NCT00185380|4244890|P2|Overall Study|Protocol Violation|2
1304671|NCT00185380|4244891|P1|Overall Study|Protocol Violation|2
1304672|NCT00185380|4244889|P3|Overall Study|Pregnancy|0
1304673|NCT00185380|4244890|P2|Overall Study|Pregnancy|4
1304674|NCT00185380|4244891|P1|Overall Study|Pregnancy|1
1304675|NCT00185380|4244889|P3|Overall Study|Lost to Follow-up|3
1304676|NCT00185380|4244890|P2|Overall Study|Lost to Follow-up|4
1304677|NCT00185380|4244891|P1|Overall Study|Lost to Follow-up|0
1304678|NCT00185380|4244889|P3|Overall Study|Adverse Event|48
1304679|NCT00185380|4244890|P2|Overall Study|Adverse Event|43
1304680|NCT00185380|4244891|P1|Overall Study|Adverse Event|41
1304681|NCT00185211|4244919|P2|Follow-up Study (91031 - This Study)|other disease modif. treatment|2
1304682|NCT00185211|4244920|P1|Follow-up Study (91031 - This Study)|other disease modif. treatment|0
1304683|NCT00185211|4244919|P2|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21
1304684|NCT00185211|4244920|P1|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13
1304685|NCT00185211|4244919|P2|Follow-up Study (91031 - This Study)|Pregnancy|1
1304686|NCT00185211|4244920|P1|Follow-up Study (91031 - This Study)|Pregnancy|0
1304687|NCT00185211|4244919|P2|Follow-up Study (91031 - This Study)|Physician Decision|0
1304688|NCT00185211|4244920|P1|Follow-up Study (91031 - This Study)|Physician Decision|1
1304689|NCT00185211|4244919|P2|Follow-up Study (91031 - This Study)|Lost to Follow-up|4
1304690|NCT00185211|4244920|P1|Follow-up Study (91031 - This Study)|Lost to Follow-up|6
1304691|NCT00185211|4244919|P2|Follow-up Study (91031 - This Study)|Lack of Efficacy|0
1304692|NCT00185211|4244920|P1|Follow-up Study (91031 - This Study)|Lack of Efficacy|1
1304693|NCT00185211|4244919|P2|Follow-up Study (91031 - This Study)|Adverse Event|6
1304694|NCT00185211|4244920|P1|Follow-up Study (91031 - This Study)|Adverse Event|5
1304695|NCT00185211|4244919|P2|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0
1304696|NCT00185211|4244920|P1|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1
1304697|NCT00185211|4244919|P2|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1
1304698|NCT00185211|4244920|P1|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0
1304699|NCT00185211|4244919|P2|Placebo-controlled Study (92012)|Withdrawal by Subject|7
1304700|NCT00185211|4244920|P1|Placebo-controlled Study (92012)|Withdrawal by Subject|9
1304701|NCT00185211|4244919|P2|Placebo-controlled Study (92012)|Lost to Follow-up|2
1304702|NCT00185211|4244920|P1|Placebo-controlled Study (92012)|Lost to Follow-up|3
1304703|NCT00185211|4244919|P2|Placebo-controlled Study (92012)|Adverse Event|0
1304704|NCT00185211|4244920|P1|Placebo-controlled Study (92012)|Adverse Event|8
1304705|NCT00184600|4244993|P3|Overall Study|Unclassified|3
1304706|NCT00184600|4244994|P2|Overall Study|Unclassified|5
1304707|NCT00184600|4244995|P1|Overall Study|Unclassified|4
1304708|NCT00184600|4244993|P3|Overall Study|Withdrawal by Subject|12
1304709|NCT00184600|4244994|P2|Overall Study|Withdrawal by Subject|28
1304710|NCT00184600|4244995|P1|Overall Study|Withdrawal by Subject|20
1304711|NCT00184600|4244993|P3|Overall Study|Protocol Violation|3
1304712|NCT00184600|4244994|P2|Overall Study|Protocol Violation|2
1304713|NCT00184600|4244995|P1|Overall Study|Protocol Violation|2
1304714|NCT00184600|4244993|P3|Overall Study|Lost to Follow-up|1
1304715|NCT00184600|4244994|P2|Overall Study|Lost to Follow-up|6
1304716|NCT00184600|4244995|P1|Overall Study|Lost to Follow-up|4
1304717|NCT00184600|4244993|P3|Overall Study|Lack of Efficacy|3
1304718|NCT00184600|4244994|P2|Overall Study|Lack of Efficacy|1
1304719|NCT00184600|4244995|P1|Overall Study|Lack of Efficacy|3
1304720|NCT00184600|4244993|P3|Overall Study|Death|7
1304721|NCT00184600|4244994|P2|Overall Study|Death|9
1304722|NCT00184600|4244995|P1|Overall Study|Death|3
1304723|NCT00184600|4244993|P3|Overall Study|Adverse Event|5
1304724|NCT00184600|4244994|P2|Overall Study|Adverse Event|0
1304725|NCT00184600|4244995|P1|Overall Study|Adverse Event|9
1304726|NCT00184093|4245086|P1|Overall Study|Withdrawal by Subject|2
1304727|NCT00184093|4245086|P1|Overall Study|Physician Decision|1
1304728|NCT00184093|4245086|P1|Overall Study|Lost to Follow-up|3
1304729|NCT00184093|4245086|P1|Overall Study|Adverse Event|3
1304730|NCT00184054|4245091|P1|Overall Study|Adverse Event|1
1304731|NCT00184028|4245096|P1|Overall Study|Non-compliance|2
1304732|NCT00184028|4245096|P1|Overall Study|Withdrawal by Subject|1
1304733|NCT00184028|4245096|P1|Overall Study|Adverse Event|2
1304734|NCT00184028|4245096|P1|Overall Study|Lack of Efficacy|4
1304735|NCT00184028|4245096|P1|Overall Study|Death|1
1304736|NCT00184002|4245101|P1|Overall Study|Withdrawal by Subject|4
1304737|NCT00184002|4245101|P1|Overall Study|Physician Decision|1
1304738|NCT00184002|4245101|P1|Overall Study|Death|3
1304739|NCT00184002|4245101|P1|Overall Study|Adverse Event|9
1304740|NCT00183872|4245127|P1|Overall Study|Drug delayed more than 28 days|2
1304741|NCT00183872|4245127|P1|Overall Study|Withdrawal by Subject|2
1304742|NCT00183872|4245127|P1|Overall Study|Adverse Event|9
1304743|NCT00183872|4245127|P1|Overall Study|Death|3
1304744|NCT00183625|4245156|P4|Overall Study|Withdrawal by Subject|14
1304745|NCT00183625|4245157|P3|Overall Study|Withdrawal by Subject|19
1304746|NCT00183625|4245158|P2|Overall Study|Withdrawal by Subject|18
1304747|NCT00183625|4245159|P1|Overall Study|Withdrawal by Subject|18
1304748|NCT00183430|4245256|P2|Overall Study|Withdrawal by Subject|0
1304749|NCT00183430|4245257|P1|Overall Study|Withdrawal by Subject|1
1304750|NCT00183430|4245256|P2|Overall Study|did not meet inclusion criteria|0
1304751|NCT00183430|4245257|P1|Overall Study|did not meet inclusion criteria|1
1304752|NCT00183430|4245256|P2|Overall Study|Lost to Follow-up|0
1304753|NCT00183430|4245257|P1|Overall Study|Lost to Follow-up|3
1304754|NCT00183430|4245256|P2|Overall Study|Adverse Event|0
1304755|NCT00183430|4245257|P1|Overall Study|Adverse Event|1
1304756|NCT00183391|4245269|P2|Block 2 - 5 Weeks|Withdrawal by Subject|2
1304757|NCT00183391|4245270|P1|Block 2 - 5 Weeks|Withdrawal by Subject|4
1304758|NCT00183391|4245269|P2|Block 1 - 5 Weeks|Withdrawal by Subject|14
1304759|NCT00183391|4245270|P1|Block 1 - 5 Weeks|Withdrawal by Subject|13
1304760|NCT00183274|4245343|P6|Phase 3: Double-Blind|Relapsed|2
1304761|NCT00183274|4245344|P5|Phase 3: Double-Blind|Relapsed|11
1304762|NCT00183274|4245345|P4|Phase 3: Double-Blind|Relapsed|1
1304763|NCT00183274|4245346|P3|Phase 3: Double-Blind|Relapsed|0
1304764|NCT00183274|4245347|P2|Phase 3: Double-Blind|Relapsed|0
1304765|NCT00183274|4245348|P1|Phase 3: Double-Blind|Relapsed|0
1304766|NCT00183274|4245343|P6|Phase 3: Double-Blind|Withdrawal by Subject|2
1304767|NCT00183274|4245344|P5|Phase 3: Double-Blind|Withdrawal by Subject|9
1304768|NCT00183274|4245345|P4|Phase 3: Double-Blind|Withdrawal by Subject|1
1304769|NCT00183274|4245346|P3|Phase 3: Double-Blind|Withdrawal by Subject|0
1304770|NCT00183274|4245347|P2|Phase 3: Double-Blind|Withdrawal by Subject|0
1304771|NCT00183274|4245348|P1|Phase 3: Double-Blind|Withdrawal by Subject|0
1304772|NCT00183274|4245343|P6|Phase 2: Double-Blind|Withdrawal by Subject|0
1304773|NCT00183274|4245344|P5|Phase 2: Double-Blind|Withdrawal by Subject|0
1304774|NCT00183274|4245345|P4|Phase 2: Double-Blind|Withdrawal by Subject|0
1304775|NCT00183274|4245346|P3|Phase 2: Double-Blind|Withdrawal by Subject|14
1304776|NCT00183274|4245347|P2|Phase 2: Double-Blind|Withdrawal by Subject|18
1304777|NCT00183274|4245348|P1|Phase 2: Double-Blind|Withdrawal by Subject|0
1304778|NCT00183274|4245343|P6|Phase 2: Double-Blind|Relapsed|0
1304779|NCT00183274|4245344|P5|Phase 2: Double-Blind|Relapsed|0
1304780|NCT00183274|4245345|P4|Phase 2: Double-Blind|Relapsed|0
1304781|NCT00183274|4245346|P3|Phase 2: Double-Blind|Relapsed|29
1304782|NCT00183274|4245347|P2|Phase 2: Double-Blind|Relapsed|8
1304783|NCT00183274|4245348|P1|Phase 2: Double-Blind|Relapsed|0
1304784|NCT00183274|4245343|P6|Phase 1: Open-Label|Other|0
1304785|NCT00183274|4245344|P5|Phase 1: Open-Label|Other|0
1304786|NCT00183274|4245345|P4|Phase 1: Open-Label|Other|0
1304787|NCT00183274|4245346|P3|Phase 1: Open-Label|Other|0
1304788|NCT00183274|4245347|P2|Phase 1: Open-Label|Other|0
1304789|NCT00183274|4245348|P1|Phase 1: Open-Label|Other|9
1304790|NCT00183274|4245343|P6|Phase 1: Open-Label|Lost to Follow-up|0
1304791|NCT00183274|4245344|P5|Phase 1: Open-Label|Lost to Follow-up|0
1304792|NCT00183274|4245345|P4|Phase 1: Open-Label|Lost to Follow-up|0
1304793|NCT00183274|4245346|P3|Phase 1: Open-Label|Lost to Follow-up|0
1304794|NCT00183274|4245347|P2|Phase 1: Open-Label|Lost to Follow-up|0
1304795|NCT00183274|4245348|P1|Phase 1: Open-Label|Lost to Follow-up|33
1304796|NCT00183274|4245343|P6|Phase 1: Open-Label|Withdrawal by Subject|0
1304797|NCT00183274|4245344|P5|Phase 1: Open-Label|Withdrawal by Subject|0
1304798|NCT00183274|4245345|P4|Phase 1: Open-Label|Withdrawal by Subject|0
1304799|NCT00183274|4245346|P3|Phase 1: Open-Label|Withdrawal by Subject|0
1304800|NCT00183274|4245347|P2|Phase 1: Open-Label|Withdrawal by Subject|0
1304801|NCT00183274|4245348|P1|Phase 1: Open-Label|Withdrawal by Subject|13
1304802|NCT00183274|4245343|P6|Phase 1: Open-Label|Protocol Violation|0
1304803|NCT00183274|4245344|P5|Phase 1: Open-Label|Protocol Violation|0
1304804|NCT00183274|4245345|P4|Phase 1: Open-Label|Protocol Violation|0
1304805|NCT00183274|4245346|P3|Phase 1: Open-Label|Protocol Violation|0
1304806|NCT00183274|4245347|P2|Phase 1: Open-Label|Protocol Violation|0
1304807|NCT00183274|4245348|P1|Phase 1: Open-Label|Protocol Violation|11
1304808|NCT00183274|4245343|P6|Phase 1: Open-Label|Lack of Efficacy|0
1304809|NCT00183274|4245344|P5|Phase 1: Open-Label|Lack of Efficacy|0
1304810|NCT00183274|4245345|P4|Phase 1: Open-Label|Lack of Efficacy|0
1304811|NCT00183274|4245346|P3|Phase 1: Open-Label|Lack of Efficacy|0
1304812|NCT00183274|4245347|P2|Phase 1: Open-Label|Lack of Efficacy|0
1304813|NCT00183274|4245348|P1|Phase 1: Open-Label|Lack of Efficacy|13
1304814|NCT00183274|4245343|P6|Phase 1: Open-Label|Adverse Event|0
1304815|NCT00183274|4245344|P5|Phase 1: Open-Label|Adverse Event|0
1304816|NCT00183274|4245345|P4|Phase 1: Open-Label|Adverse Event|0
1304817|NCT00183274|4245346|P3|Phase 1: Open-Label|Adverse Event|0
1304818|NCT00183274|4245347|P2|Phase 1: Open-Label|Adverse Event|0
1304819|NCT00183274|4245348|P1|Phase 1: Open-Label|Adverse Event|31
1304820|NCT00183248|4245365|P2|Overall Study|Focal glomerulosclerosis proteinuria|0
1304821|NCT00183248|4245366|P1|Overall Study|Focal glomerulosclerosis proteinuria|1
1304822|NCT00183248|4245365|P2|Overall Study|Lost to Follow-up|1
1304823|NCT00183248|4245366|P1|Overall Study|Lost to Follow-up|0
1304824|NCT00183196|4245387|P3|Overall Study|Required more intensive care|2
1304825|NCT00183196|4245388|P2|Overall Study|Required more intensive care|1
1304826|NCT00183196|4245389|P1|Overall Study|Required more intensive care|0
1304827|NCT00183196|4245387|P3|Overall Study|Legal event|1
1304828|NCT00183196|4245388|P2|Overall Study|Legal event|1
1304829|NCT00183196|4245389|P1|Overall Study|Legal event|1
1304830|NCT00183196|4245387|P3|Overall Study|Adverse Event|2
1304831|NCT00183196|4245388|P2|Overall Study|Adverse Event|2
1304832|NCT00183196|4245389|P1|Overall Study|Adverse Event|1
1304833|NCT00183196|4245387|P3|Overall Study|Withdrawal by Subject|13
1304834|NCT00183196|4245388|P2|Overall Study|Withdrawal by Subject|11
1304835|NCT00183196|4245389|P1|Overall Study|Withdrawal by Subject|18
1304836|NCT00182689|4245472|P2|Overall Study|Never received treatment|0
1304837|NCT00182689|4245473|P1|Overall Study|Never received treatment|1
1304838|NCT00182689|4245472|P2|Overall Study|Ineligible|4
1304839|NCT00182689|4245473|P1|Overall Study|Ineligible|1
1304840|NCT00182689|4245472|P2|Overall Study|not protocol specified|3
1304841|NCT00182689|4245473|P1|Overall Study|not protocol specified|0
1304842|NCT00182689|4245472|P2|Overall Study|Death|0
1304843|NCT00182689|4245473|P1|Overall Study|Death|1
1304844|NCT00182689|4245472|P2|Overall Study|Progression|29
1304845|NCT00182689|4245473|P1|Overall Study|Progression|27
1304846|NCT00182689|4245472|P2|Overall Study|Withdrawal by Subject|2
1304847|NCT00182689|4245473|P1|Overall Study|Withdrawal by Subject|2
1304848|NCT00182689|4245472|P2|Overall Study|Adverse Event|11
1304849|NCT00182689|4245473|P1|Overall Study|Adverse Event|8
1304850|NCT00182637|4245483|P1|Overall Study|Disease Progression|1
1304851|NCT00182637|4245483|P1|Overall Study|Adverse Event|2
1304852|NCT00182091|4245493|P4|Overall Study|Withdrawal by Subject|0
1304853|NCT00182091|4245494|P3|Overall Study|Withdrawal by Subject|0
1304854|NCT00182091|4245495|P2|Overall Study|Withdrawal by Subject|0
1304855|NCT00182091|4245496|P1|Overall Study|Withdrawal by Subject|1
1304856|NCT00182078|4245512|P2|Overall Study|Withdrawal by Subject|0
1304857|NCT00182078|4245513|P1|Overall Study|Withdrawal by Subject|1
1304858|NCT00181883|4245532|P1|Overall Study|Lost to Follow-up|1
1304859|NCT00181883|4245532|P1|Overall Study|Withdrawal by Subject|4
1304860|NCT00181883|4245532|P1|Overall Study|Treatment Limiting AEs|3
1304861|NCT00181883|4245532|P1|Overall Study|Lack of Efficacy|2
1304862|NCT00181844|4245536|P1|Exposed to Study Medication|Difficulty meeting study schedule|2
1304863|NCT00181844|4245536|P1|Exposed to Study Medication|Withdrawal by Subject|1
1304864|NCT00181844|4245536|P1|Exposed to Study Medication|Non-compliance|2
1304865|NCT00181844|4245536|P1|Exposed to Study Medication|Lack of Efficacy|2
1304866|NCT00181844|4245536|P1|Exposed to Study Medication|Adverse Event|10
1304867|NCT00181844|4245536|P1|Signed Consent|Did not meet entrance criteria|7
1304868|NCT00181844|4245536|P1|Signed Consent|Withdrawal by Subject|5
1304869|NCT00181766|4245540|P1|Overall Study|non-compliance|2
1304870|NCT00181766|4245540|P1|Overall Study|Adverse Event|4
1304871|NCT00181766|4245540|P1|Overall Study|Lost to Follow-up|6
1304872|NCT00181155|4245601|P2|Overall Study|Withdrawal by Subject|0
1304873|NCT00181155|4245602|P1|Overall Study|Withdrawal by Subject|1
1304874|NCT00181155|4245601|P2|Overall Study|Physician Decision|0
1304875|NCT00181155|4245602|P1|Overall Study|Physician Decision|1
1304876|NCT00180479|4245641|P2|Overall Study|Informed consent not signed|1
1304877|NCT00180479|4245642|P1|Overall Study|Informed consent not signed|0
1304878|NCT00180479|4245641|P2|Overall Study|Withdrawal by Subject|3
1304879|NCT00180479|4245642|P1|Overall Study|Withdrawal by Subject|3
1304880|NCT00180479|4245641|P2|Overall Study|Lost to Follow-up|7
1304881|NCT00180479|4245642|P1|Overall Study|Lost to Follow-up|9
1304882|NCT00180479|4245641|P2|Overall Study|Death|2
1304883|NCT00180479|4245642|P1|Overall Study|Death|4
1304884|NCT00179959|4245754|P2|Overall Study|Withdrawal by Subject|2
1304885|NCT00179959|4245755|P1|Overall Study|Withdrawal by Subject|3
1304886|NCT00179959|4245754|P2|Overall Study|Lost to Follow-up|1
1304887|NCT00179959|4245755|P1|Overall Study|Lost to Follow-up|3
1304888|NCT00179673|4245761|P1|Overall Study|Other Observations and options|14
1304889|NCT00179673|4245761|P1|Overall Study|Death|4
1304890|NCT00179673|4245761|P1|Overall Study|Withdrawal by Subject|3
1304891|NCT00179673|4245761|P1|Overall Study|Lack of Efficacy|15
1304892|NCT00179673|4245761|P1|Overall Study|Adverse Event|7
1304893|NCT00179660|4245769|P1|Overall Study|Other - Unspecified|9
1304894|NCT00179660|4245769|P1|Overall Study|Death|3
1304895|NCT00179660|4245769|P1|Overall Study|Lost to Follow-up|1
1304896|NCT00179660|4245769|P1|Overall Study|Withdrawal by Subject|2
1304897|NCT00179660|4245769|P1|Overall Study|Lack of therapeutic effect|28
1304898|NCT00179660|4245769|P1|Overall Study|Adverse Event|7
1304899|NCT00179647|4245778|P1|Overall Study|Not specified|960
1304900|NCT00179647|4245778|P1|Overall Study|Death|94
1304901|NCT00179647|4245778|P1|Overall Study|Lost to Follow-up|4
1304902|NCT00179647|4245778|P1|Overall Study|Withdrawal by Subject|83
1304903|NCT00179647|4245778|P1|Overall Study|Lack of Efficacy|478
1304904|NCT00179647|4245778|P1|Overall Study|Adverse Event|294
1304905|NCT00179621|4245785|P4|Open-Label Period|Other|2
1304906|NCT00179621|4245786|P3|Open-Label Period|Other|1
1304907|NCT00179621|4245787|P2|Open-Label Period|Other|1
1304908|NCT00179621|4245788|P1|Open-Label Period|Other|0
1304909|NCT00179621|4245785|P4|Open-Label Period|Death|2
1304910|NCT00179621|4245786|P3|Open-Label Period|Death|1
1304911|NCT00179621|4245787|P2|Open-Label Period|Death|0
1304912|NCT00179621|4245788|P1|Open-Label Period|Death|0
1304913|NCT00179621|4245785|P4|Open-Label Period|Withdrawal by Subject|2
1304914|NCT00179621|4245786|P3|Open-Label Period|Withdrawal by Subject|2
1304915|NCT00179621|4245787|P2|Open-Label Period|Withdrawal by Subject|2
1304916|NCT00179621|4245788|P1|Open-Label Period|Withdrawal by Subject|0
1304917|NCT00179621|4245785|P4|Open-Label Period|Adverse Event|6
1304918|NCT00179621|4245786|P3|Open-Label Period|Adverse Event|5
1304919|NCT00179621|4245787|P2|Open-Label Period|Adverse Event|6
1304920|NCT00179621|4245788|P1|Open-Label Period|Adverse Event|0
1304921|NCT00179621|4245785|P4|Open-Label Period|Lack of Therapeutic Effect|31
1304922|NCT00179621|4245786|P3|Open-Label Period|Lack of Therapeutic Effect|19
1304923|NCT00179621|4245787|P2|Open-Label Period|Lack of Therapeutic Effect|19
1304924|NCT00179621|4245788|P1|Open-Label Period|Lack of Therapeutic Effect|0
1304925|NCT00179621|4245785|P4|Double-Blind Period|Other|0
1304926|NCT00179621|4245786|P3|Double-Blind Period|Other|2
1304927|NCT00179621|4245787|P2|Double-Blind Period|Other|2
1304928|NCT00179621|4245788|P1|Double-Blind Period|Other|0
1304929|NCT00179621|4245785|P4|Double-Blind Period|Protocol Violation|0
1304930|NCT00179621|4245786|P3|Double-Blind Period|Protocol Violation|0
1304931|NCT00179621|4245787|P2|Double-Blind Period|Protocol Violation|0
1304932|NCT00179621|4245788|P1|Double-Blind Period|Protocol Violation|1
1304933|NCT00179621|4245785|P4|Double-Blind Period|Death|0
1304934|NCT00179621|4245786|P3|Double-Blind Period|Death|2
1304935|NCT00179621|4245787|P2|Double-Blind Period|Death|1
1304936|NCT00179621|4245788|P1|Double-Blind Period|Death|0
1304937|NCT00179621|4245785|P4|Double-Blind Period|Withdrawal by Subject|0
1304938|NCT00179621|4245786|P3|Double-Blind Period|Withdrawal by Subject|3
1304939|NCT00179621|4245787|P2|Double-Blind Period|Withdrawal by Subject|1
1304940|NCT00179621|4245788|P1|Double-Blind Period|Withdrawal by Subject|2
1304941|NCT00179621|4245785|P4|Double-Blind Period|Adverse Event|0
1304942|NCT00179621|4245786|P3|Double-Blind Period|Adverse Event|4
1304943|NCT00179621|4245787|P2|Double-Blind Period|Adverse Event|7
1304944|NCT00179621|4245788|P1|Double-Blind Period|Adverse Event|2
1304945|NCT00179621|4245785|P4|Double-Blind Period|Lack of Therapeutic Effect|0
1304946|NCT00179621|4245786|P3|Double-Blind Period|Lack of Therapeutic Effect|19
1304947|NCT00179621|4245787|P2|Double-Blind Period|Lack of Therapeutic Effect|35
1304948|NCT00179621|4245788|P1|Double-Blind Period|Lack of Therapeutic Effect|59
1304949|NCT00179517|4245841|P2|Overall Study|Withdrawal by Subject|1
1304950|NCT00179517|4245842|P1|Overall Study|Withdrawal by Subject|2
1304951|NCT00179413|4245880|P2|Overall Study|Withdrawal by Subject|95
1304952|NCT00179413|4245881|P1|Overall Study|Withdrawal by Subject|87
1304953|NCT00179413|4245880|P2|Overall Study|Adverse Event|20
1304954|NCT00179413|4245881|P1|Overall Study|Adverse Event|38
1304955|NCT00179309|4245893|P2|Treatment|Allergy|0
1304956|NCT00179309|4245894|P1|Treatment|Allergy|1
1304957|NCT00179309|4245893|P2|Treatment|Withdrawal by Subject|2
1304958|NCT00179309|4245894|P1|Treatment|Withdrawal by Subject|1
1304959|NCT00179309|4245893|P2|Treatment|Toxicity|3
1304960|NCT00179309|4245894|P1|Treatment|Toxicity|2
1304961|NCT00178685|4245946|P3|Overall Study|Withdrawal by Subject|7
1304962|NCT00178685|4245947|P2|Overall Study|Withdrawal by Subject|14
1304963|NCT00178685|4245948|P1|Overall Study|Withdrawal by Subject|8
1304964|NCT00178685|4245946|P3|Overall Study|Lost to Follow-up|183
1304965|NCT00178685|4245947|P2|Overall Study|Lost to Follow-up|187
1304966|NCT00178685|4245948|P1|Overall Study|Lost to Follow-up|100
1304967|NCT00178685|4245946|P3|Overall Study|Death|6
1304968|NCT00178685|4245947|P2|Overall Study|Death|3
1304969|NCT00178685|4245948|P1|Overall Study|Death|3
1304970|NCT00178633|4245959|P1|Overall Study|Lost to Follow-up|6
1304971|NCT00178464|4245989|P1|Overall Study|Physician Decision|1
1304972|NCT00178464|4245989|P1|Overall Study|Withdrawal by Subject|1
1304973|NCT00178399|4245994|P1|Overall Study|Lost to Follow-up|1
1304974|NCT00178399|4245994|P1|Overall Study|Withdrawal by Subject|8
1304975|NCT00178399|4245994|P1|Overall Study|Physician Decision|4
1304976|NCT00178256|4246001|P4|Overall Study|Cancer progression|1
1304977|NCT00178256|4246002|P3|Overall Study|Cancer progression|0
1304978|NCT00178256|4246003|P2|Overall Study|Cancer progression|0
1304979|NCT00178256|4246004|P1|Overall Study|Cancer progression|2
1304980|NCT00178256|4246001|P4|Overall Study|Death|1
1304981|NCT00178256|4246002|P3|Overall Study|Death|0
1304982|NCT00178256|4246003|P2|Overall Study|Death|1
1304983|NCT00178256|4246004|P1|Overall Study|Death|0
1304984|NCT00178256|4246001|P4|Overall Study|Adverse Event|0
1304985|NCT00178256|4246002|P3|Overall Study|Adverse Event|0
1304986|NCT00178256|4246003|P2|Overall Study|Adverse Event|0
1304987|NCT00178256|4246004|P1|Overall Study|Adverse Event|2
1304988|NCT00178126|4246043|P2|Overall Study|did not receive intervention|6
1304989|NCT00178126|4246044|P1|Overall Study|did not receive intervention|4
1304990|NCT00178126|4246043|P2|Overall Study|Lost to Follow-up|21
1304991|NCT00178126|4246044|P1|Overall Study|Lost to Follow-up|21
1304992|NCT00177671|4246086|P2|Overall Study|Physician Decision|8
1304993|NCT00177671|4246087|P1|Overall Study|Physician Decision|12
1304994|NCT00177671|4246086|P2|Overall Study|Adverse Event|0
1304995|NCT00177671|4246087|P1|Overall Study|Adverse Event|6
1304996|NCT00177671|4246086|P2|Overall Study|medical complications|0
1304997|NCT00177671|4246087|P1|Overall Study|medical complications|2
1304998|NCT00177671|4246086|P2|Overall Study|Withdrawal by Subject|6
1304999|NCT00177671|4246087|P1|Overall Study|Withdrawal by Subject|5
1305000|NCT00177307|4246099|P1|Overall Study|Withdrawal by Subject|1
1305001|NCT00177294|4246108|P2|Overall Study|Withdrawal by Subject|5
1305002|NCT00177294|4246109|P1|Overall Study|Withdrawal by Subject|7
1305003|NCT00177216|4246123|P3|Overall Study|Withdrawal by Subject|1
1305004|NCT00177216|4246124|P2|Overall Study|Withdrawal by Subject|3
1305005|NCT00177216|4246125|P1|Overall Study|Withdrawal by Subject|6
1305006|NCT00177164|4246141|P2|Overall Study|Pregnancy|1
1305007|NCT00177164|4246142|P1|Overall Study|Pregnancy|0
1305008|NCT00177164|4246141|P2|Overall Study|Lack of Efficacy|1
1305009|NCT00177164|4246142|P1|Overall Study|Lack of Efficacy|2
1305010|NCT00177164|4246141|P2|Overall Study|discharge from hospital|0
1305011|NCT00177164|4246142|P1|Overall Study|discharge from hospital|1
1305012|NCT00177164|4246141|P2|Overall Study|Adverse Event|0
1305013|NCT00177164|4246142|P1|Overall Study|Adverse Event|1
1305014|NCT00177164|4246141|P2|Overall Study|increase in alcohol and drug use|2
1305015|NCT00177164|4246142|P1|Overall Study|increase in alcohol and drug use|1
1305016|NCT00177164|4246141|P2|Overall Study|Lost to Follow-up|5
1305017|NCT00177164|4246142|P1|Overall Study|Lost to Follow-up|4
1305018|NCT00177164|4246141|P2|Overall Study|Protocol Violation|7
1305019|NCT00177164|4246142|P1|Overall Study|Protocol Violation|0
1305020|NCT00176644|4246307|P1|Overall Study|Withdrawal by Subject|1
1305021|NCT00176605|4246320|P1|Overall Study|Withdrawal by Subject|2
1305022|NCT00176488|4246331|P1|Overall Study|Initiated Cycle 1 Day 1 only|1
1305023|NCT00176462|4246339|P2|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3
1305024|NCT00176462|4246340|P1|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0
1305025|NCT00176462|4246339|P2|Intensive Continuation (8X8-week Cycles)|Death|0
1305026|NCT00176462|4246340|P1|Intensive Continuation (8X8-week Cycles)|Death|1
1305027|NCT00176462|4246339|P2|Consolidation (12 Weeks)|Not documented|1
1305028|NCT00176462|4246340|P1|Consolidation (12 Weeks)|Not documented|0
1305029|NCT00176462|4246339|P2|Consolidation (12 Weeks)|Lack of Efficacy|2
1305030|NCT00176462|4246340|P1|Consolidation (12 Weeks)|Lack of Efficacy|0
1305031|NCT00176462|4246339|P2|Consolidation (12 Weeks)|Adverse Event|1
1305032|NCT00176462|4246340|P1|Consolidation (12 Weeks)|Adverse Event|0
1305033|NCT00176462|4246339|P2|Consolidation (12 Weeks)|Patient moved to another state|1
1305034|NCT00176462|4246340|P1|Consolidation (12 Weeks)|Patient moved to another state|0
1305035|NCT00176462|4246339|P2|Induction (4 Weeks)|Lack of Efficacy|1
1305036|NCT00176462|4246340|P1|Induction (4 Weeks)|Lack of Efficacy|0
1305037|NCT00176462|4246339|P2|Induction (4 Weeks)|Death|2
1305038|NCT00176462|4246340|P1|Induction (4 Weeks)|Death|1
1305039|NCT00176462|4246339|P2|Induction (4 Weeks)|Withdrawal by Subject|2
1305040|NCT00176462|4246340|P1|Induction (4 Weeks)|Withdrawal by Subject|0
1305041|NCT00176254|4246360|P1|Overall Study|Lost to Follow-up|1
1305042|NCT00175877|4246388|P1|Overall Study|Withdrawal by subject & Other|1
1305043|NCT00175877|4246388|P1|Overall Study|AE & Other|1
1305044|NCT00175877|4246388|P1|Overall Study|Other Reason|20
1305045|NCT00175877|4246388|P1|Overall Study|Protocol Violation|15
1305046|NCT00175877|4246388|P1|Overall Study|Lack of Efficacy|26
1305047|NCT00175877|4246388|P1|Overall Study|Lost to Follow-up|9
1305048|NCT00175877|4246388|P1|Overall Study|Withdrawal by Subject|141
1305049|NCT00175877|4246388|P1|Overall Study|Adverse Event|136
1305050|NCT00175825|4246423|P4|Overall Study|Withdrawal by Subject|0
1305051|NCT00175825|4246424|P3|Overall Study|Withdrawal by Subject|0
1305052|NCT00175825|4246425|P2|Overall Study|Withdrawal by Subject|0
1305053|NCT00175825|4246426|P1|Overall Study|Withdrawal by Subject|1
1305054|NCT00175825|4246423|P4|Overall Study|Lost to Follow-up|0
1305055|NCT00175825|4246424|P3|Overall Study|Lost to Follow-up|0
1305056|NCT00175825|4246425|P2|Overall Study|Lost to Follow-up|2
1305057|NCT00175825|4246426|P1|Overall Study|Lost to Follow-up|1
1305058|NCT00175825|4246423|P4|Overall Study|Adverse Event|1
1305059|NCT00175825|4246424|P3|Overall Study|Adverse Event|1
1305060|NCT00175825|4246425|P2|Overall Study|Adverse Event|2
1305061|NCT00175825|4246426|P1|Overall Study|Adverse Event|3
1305062|NCT00175019|4246479|P3|Overall Study|Reason Not Specified|11
1305063|NCT00175019|4246480|P2|Overall Study|Reason Not Specified|34
1305064|NCT00175019|4246481|P1|Overall Study|Reason Not Specified|40
1305065|NCT00175019|4246479|P3|Overall Study|Gout Flare|0
1305066|NCT00175019|4246480|P2|Overall Study|Gout Flare|3
1305067|NCT00175019|4246481|P1|Overall Study|Gout Flare|2
1305068|NCT00175019|4246479|P3|Overall Study|Therapeutic Failure|22
1305069|NCT00175019|4246480|P2|Overall Study|Therapeutic Failure|38
1305070|NCT00175019|4246481|P1|Overall Study|Therapeutic Failure|10
1305071|NCT00175019|4246479|P3|Overall Study|Personal Reason(s)|8
1305072|NCT00175019|4246480|P2|Overall Study|Personal Reason(s)|31
1305073|NCT00175019|4246481|P1|Overall Study|Personal Reason(s)|39
1305074|NCT00175019|4246479|P3|Overall Study|Did not continue under Amendment 4|2
1305075|NCT00175019|4246480|P2|Overall Study|Did not continue under Amendment 4|1
1305076|NCT00175019|4246481|P1|Overall Study|Did not continue under Amendment 4|1
1305077|NCT00175019|4246479|P3|Overall Study|Lost to Follow-up|9
1305078|NCT00175019|4246480|P2|Overall Study|Lost to Follow-up|39
1305079|NCT00175019|4246481|P1|Overall Study|Lost to Follow-up|42
1305080|NCT00175019|4246479|P3|Overall Study|Protocol Violation|3
1305081|NCT00175019|4246480|P2|Overall Study|Protocol Violation|3
1305082|NCT00175019|4246481|P1|Overall Study|Protocol Violation|6
1305083|NCT00175019|4246479|P3|Overall Study|Adverse Event|2
1305084|NCT00175019|4246480|P2|Overall Study|Adverse Event|22
1305085|NCT00175019|4246481|P1|Overall Study|Adverse Event|54
1305086|NCT00174967|4246534|P4|Overall Study|Not Specified|0
1305087|NCT00174967|4246535|P3|Overall Study|Not Specified|0
1305088|NCT00174967|4246536|P2|Overall Study|Not Specified|1
1305089|NCT00174967|4246537|P1|Overall Study|Not Specified|0
1305090|NCT00174967|4246534|P4|Overall Study|Gout Flare|1
1305091|NCT00174967|4246535|P3|Overall Study|Gout Flare|0
1305092|NCT00174967|4246536|P2|Overall Study|Gout Flare|0
1305093|NCT00174967|4246537|P1|Overall Study|Gout Flare|0
1305094|NCT00174967|4246534|P4|Overall Study|Adverse Event|1
1305095|NCT00174967|4246535|P3|Overall Study|Adverse Event|2
1305096|NCT00174967|4246536|P2|Overall Study|Adverse Event|2
1305097|NCT00174967|4246537|P1|Overall Study|Adverse Event|1
1305098|NCT00174954|4246583|P1|Overall Study|Physician Decision|1
1305099|NCT00174954|4246583|P1|Overall Study|No tophi found in MRI|1
1305100|NCT00174954|4246583|P1|Overall Study|Adverse Event|2
1305101|NCT00174941|4246591|P4|Overall Study|Reason Not Specified|9
1305102|NCT00174941|4246592|P3|Overall Study|Reason Not Specified|2
1305103|NCT00174941|4246593|P2|Overall Study|Reason Not Specified|6
1305104|NCT00174941|4246594|P1|Overall Study|Reason Not Specified|1
1305105|NCT00174941|4246591|P4|Overall Study|Gout Flare|8
1305106|NCT00174941|4246592|P3|Overall Study|Gout Flare|4
1305107|NCT00174941|4246593|P2|Overall Study|Gout Flare|4
1305108|NCT00174941|4246594|P1|Overall Study|Gout Flare|0
1305109|NCT00174941|4246591|P4|Overall Study|Personal Reason(s)|22
1305110|NCT00174941|4246592|P3|Overall Study|Personal Reason(s)|8
1305111|NCT00174941|4246593|P2|Overall Study|Personal Reason(s)|14
1305112|NCT00174941|4246594|P1|Overall Study|Personal Reason(s)|0
1305113|NCT00174941|4246591|P4|Overall Study|Lost to Follow-up|5
1305114|NCT00174941|4246592|P3|Overall Study|Lost to Follow-up|2
1305115|NCT00174941|4246593|P2|Overall Study|Lost to Follow-up|3
1305116|NCT00174941|4246594|P1|Overall Study|Lost to Follow-up|0
1305117|NCT00174941|4246591|P4|Overall Study|Protocol Violation|1
1305118|NCT00174941|4246592|P3|Overall Study|Protocol Violation|0
1305119|NCT00174941|4246593|P2|Overall Study|Protocol Violation|1
1305120|NCT00174941|4246594|P1|Overall Study|Protocol Violation|0
1305121|NCT00174941|4246591|P4|Overall Study|Adverse Event|13
1305122|NCT00174941|4246592|P3|Overall Study|Adverse Event|2
1305123|NCT00174941|4246593|P2|Overall Study|Adverse Event|10
1305124|NCT00174941|4246594|P1|Overall Study|Adverse Event|1
1305125|NCT00174915|4246669|P5|Overall Study|Therapeutic Failure|3
1305126|NCT00174915|4246670|P4|Overall Study|Therapeutic Failure|1
1305127|NCT00174915|4246671|P3|Overall Study|Therapeutic Failure|2
1305128|NCT00174915|4246672|P2|Overall Study|Therapeutic Failure|3
1305129|NCT00174915|4246673|P1|Overall Study|Therapeutic Failure|6
1305130|NCT00174915|4246669|P5|Overall Study|Protocol Violation|3
1305131|NCT00174915|4246670|P4|Overall Study|Protocol Violation|6
1305132|NCT00174915|4246671|P3|Overall Study|Protocol Violation|3
1305133|NCT00174915|4246672|P2|Overall Study|Protocol Violation|3
1305134|NCT00174915|4246673|P1|Overall Study|Protocol Violation|6
1305135|NCT00174915|4246669|P5|Overall Study|Gout Flare|0
1305136|NCT00174915|4246670|P4|Overall Study|Gout Flare|1
1305137|NCT00174915|4246671|P3|Overall Study|Gout Flare|8
1305138|NCT00174915|4246672|P2|Overall Study|Gout Flare|6
1305139|NCT00174915|4246673|P1|Overall Study|Gout Flare|13
1305140|NCT00174915|4246669|P5|Overall Study|Other|3
1305141|NCT00174915|4246670|P4|Overall Study|Other|5
1305142|NCT00174915|4246671|P3|Overall Study|Other|6
1305143|NCT00174915|4246672|P2|Overall Study|Other|8
1305144|NCT00174915|4246673|P1|Overall Study|Other|15
1305145|NCT00174915|4246669|P5|Overall Study|Personal Reason(s)|9
1305146|NCT00174915|4246670|P4|Overall Study|Personal Reason(s)|9
1305147|NCT00174915|4246671|P3|Overall Study|Personal Reason(s)|9
1305148|NCT00174915|4246672|P2|Overall Study|Personal Reason(s)|16
1305149|NCT00174915|4246673|P1|Overall Study|Personal Reason(s)|16
1305150|NCT00174915|4246669|P5|Overall Study|Adverse Event|5
1305151|NCT00174915|4246670|P4|Overall Study|Adverse Event|18
1305152|NCT00174915|4246671|P3|Overall Study|Adverse Event|11
1305153|NCT00174915|4246672|P2|Overall Study|Adverse Event|16
1305154|NCT00174915|4246673|P1|Overall Study|Adverse Event|18
1305155|NCT00174915|4246669|P5|Overall Study|Lost to Follow-up|10
1305156|NCT00174915|4246670|P4|Overall Study|Lost to Follow-up|17
1305157|NCT00174915|4246671|P3|Overall Study|Lost to Follow-up|9
1305158|NCT00174915|4246672|P2|Overall Study|Lost to Follow-up|17
1305159|NCT00174915|4246673|P1|Overall Study|Lost to Follow-up|19
1305160|NCT00174785|4246732|P2|Overall Study|Not pre-specified/Not coded|70
1305161|NCT00174785|4246733|P1|Overall Study|Not pre-specified/Not coded|56
1305162|NCT00174785|4246732|P2|Overall Study|Family request|8
1305163|NCT00174785|4246733|P1|Overall Study|Family request|6
1305164|NCT00174785|4246732|P2|Overall Study|Other prohibited medication|3
1305165|NCT00174785|4246733|P1|Overall Study|Other prohibited medication|5
1305166|NCT00174785|4246732|P2|Overall Study|Prohibited antiarrhythmic medication|88
1305167|NCT00174785|4246733|P1|Overall Study|Prohibited antiarrhythmic medication|39
1305168|NCT00174785|4246732|P2|Overall Study|Atrial Fibrillation/Flutter recurrence|167
1305169|NCT00174785|4246733|P1|Overall Study|Atrial Fibrillation/Flutter recurrence|110
1305170|NCT00174785|4246732|P2|Overall Study|Withdrawal by Subject|175
1305171|NCT00174785|4246733|P1|Overall Study|Withdrawal by Subject|173
1305172|NCT00174785|4246732|P2|Overall Study|Protocol Violation|14
1305173|NCT00174785|4246733|P1|Overall Study|Protocol Violation|14
1305174|NCT00174785|4246732|P2|Overall Study|Adverse Event|191
1305175|NCT00174785|4246733|P1|Overall Study|Adverse Event|293
1305176|NCT00174460|4246749|P2|Overall Study|Withdrawal by Subject|1
1305177|NCT00174460|4246750|P1|Overall Study|Withdrawal by Subject|0
1305178|NCT00174447|4246796|P1|Overall Study|Administrative reason/Other|2
1305179|NCT00174447|4246796|P1|Overall Study|Lack of Efficacy|1
1305180|NCT00174447|4246796|P1|Overall Study|Protocol Violation|1
1305181|NCT00174447|4246796|P1|Overall Study|Withdrawal by Subject|15
1305182|NCT00174447|4246796|P1|Overall Study|Adverse Event|19
1305183|NCT00174382|4246805|P1|Overall Study|Lost to Follow-up|1
1305184|NCT00174382|4246805|P1|Overall Study|Subject felt pill not effective enough|1
1305185|NCT00174382|4246805|P1|Overall Study|Arrived early for last visit in error|1
1305186|NCT00174382|4246805|P1|Overall Study|Protocol Violation|3
1305187|NCT00174382|4246805|P1|Overall Study|Withdrawal by Subject|6
1305188|NCT00174382|4246805|P1|Overall Study|Adverse Event|19
1305189|NCT00174382|4246805|P1|Overall Study|Death|2
1305190|NCT00174291|4246824|P2|Overall Study|Withdrawal by Subject|3
1305191|NCT00174291|4246825|P1|Overall Study|Withdrawal by Subject|3
1305192|NCT00174291|4246824|P2|Overall Study|Study terminated by sponsor|0
1305193|NCT00174291|4246825|P1|Overall Study|Study terminated by sponsor|1
1305194|NCT00174291|4246824|P2|Overall Study|Protocol Violation|2
1305195|NCT00174291|4246825|P1|Overall Study|Protocol Violation|0
1305196|NCT00174291|4246824|P2|Overall Study|Lost to Follow-up|1
1305197|NCT00174291|4246825|P1|Overall Study|Lost to Follow-up|1
1305198|NCT00174265|4246855|P2|Overall Study|Other (Not specified)|10
1305199|NCT00174265|4246856|P1|Overall Study|Other (Not specified)|16
1305200|NCT00174265|4246855|P2|Overall Study|Lost to Follow-up|0
1305201|NCT00174265|4246856|P1|Overall Study|Lost to Follow-up|1
1305202|NCT00174265|4246855|P2|Overall Study|Withdrawal by Subject|5
1305203|NCT00174265|4246856|P1|Overall Study|Withdrawal by Subject|3
1305204|NCT00174265|4246855|P2|Overall Study|Lack of Efficacy|2
1305205|NCT00174265|4246856|P1|Overall Study|Lack of Efficacy|2
1305206|NCT00174265|4246855|P2|Overall Study|Adverse Event|4
1305207|NCT00174265|4246856|P1|Overall Study|Adverse Event|7
1305208|NCT00174252|4246864|P1|Overall Study|Protocol Violation|2
1305209|NCT00174187|4246899|P3|Period 2 (After 3 Years)|Other|5
1305210|NCT00174187|4246900|P2|Period 2 (After 3 Years)|Other|0
1305211|NCT00174187|4246901|P1|Period 2 (After 3 Years)|Other|0
1305212|NCT00174187|4246899|P3|Period 2 (After 3 Years)|Withdrawal by Subject|1
1305213|NCT00174187|4246900|P2|Period 2 (After 3 Years)|Withdrawal by Subject|0
1305214|NCT00174187|4246901|P1|Period 2 (After 3 Years)|Withdrawal by Subject|0
1305215|NCT00174187|4246899|P3|Period 2 (After 3 Years)|Lost to Follow-up|2
1305216|NCT00174187|4246900|P2|Period 2 (After 3 Years)|Lost to Follow-up|0
1305217|NCT00174187|4246901|P1|Period 2 (After 3 Years)|Lost to Follow-up|0
1305218|NCT00174187|4246899|P3|Between Period 1 and Period 2|Consented, not assigned to treatment|3
1305219|NCT00174187|4246900|P2|Between Period 1 and Period 2|Consented, not assigned to treatment|0
1305220|NCT00174187|4246901|P1|Between Period 1 and Period 2|Consented, not assigned to treatment|0
1305221|NCT00174187|4246899|P3|Between Period 1 and Period 2|Did not consent to continue treatment|2
1305222|NCT00174187|4246900|P2|Between Period 1 and Period 2|Did not consent to continue treatment|0
1305223|NCT00174187|4246901|P1|Between Period 1 and Period 2|Did not consent to continue treatment|0
1305224|NCT00174187|4246899|P3|Period 1 (up to 3 Years)|Other|0
1305225|NCT00174187|4246900|P2|Period 1 (up to 3 Years)|Other|1
1305226|NCT00174187|4246901|P1|Period 1 (up to 3 Years)|Other|0
1305227|NCT00174187|4246899|P3|Period 1 (up to 3 Years)|Withdrawal by Subject|0
1305228|NCT00174187|4246900|P2|Period 1 (up to 3 Years)|Withdrawal by Subject|1
1305229|NCT00174187|4246901|P1|Period 1 (up to 3 Years)|Withdrawal by Subject|0
1305230|NCT00174187|4246899|P3|Period 1 (up to 3 Years)|Non compliance|0
1305231|NCT00174187|4246900|P2|Period 1 (up to 3 Years)|Non compliance|1
1305232|NCT00174187|4246901|P1|Period 1 (up to 3 Years)|Non compliance|0
1305233|NCT00174187|4246899|P3|Period 1 (up to 3 Years)|Serious adverse event|0
1305234|NCT00174187|4246900|P2|Period 1 (up to 3 Years)|Serious adverse event|1
1305235|NCT00174187|4246901|P1|Period 1 (up to 3 Years)|Serious adverse event|0
1305236|NCT00172185|4246966|P4|Overall Study|Withdrawal by Subject|0
1305237|NCT00172185|4246967|P3|Overall Study|Withdrawal by Subject|1
1305238|NCT00172185|4246968|P2|Overall Study|Withdrawal by Subject|0
1305239|NCT00172185|4246969|P1|Overall Study|Withdrawal by Subject|0
1305240|NCT00172185|4246966|P4|Overall Study|SPONSOR Decision|0
1305241|NCT00172185|4246967|P3|Overall Study|SPONSOR Decision|0
1305242|NCT00172185|4246968|P2|Overall Study|SPONSOR Decision|1
1305243|NCT00172185|4246969|P1|Overall Study|SPONSOR Decision|0
1305244|NCT00172185|4246966|P4|Overall Study|Physician Decision|0
1305245|NCT00172185|4246967|P3|Overall Study|Physician Decision|1
1305246|NCT00172185|4246968|P2|Overall Study|Physician Decision|0
1305247|NCT00172185|4246969|P1|Overall Study|Physician Decision|0
1305248|NCT00172185|4246966|P4|Overall Study|Adverse Event|4
1305249|NCT00172185|4246967|P3|Overall Study|Adverse Event|3
1305250|NCT00172185|4246968|P2|Overall Study|Adverse Event|1
1305251|NCT00172185|4246969|P1|Overall Study|Adverse Event|0
1305252|NCT00172042|4246985|P2|Overall Study|Death|42
1305253|NCT00172042|4246986|P1|Overall Study|Death|42
1305254|NCT00172042|4246985|P2|Overall Study|Administrative problems|10
1305255|NCT00172042|4246986|P1|Overall Study|Administrative problems|13
1305256|NCT00172042|4246985|P2|Overall Study|Lost to Follow-up|5
1305257|NCT00172042|4246986|P1|Overall Study|Lost to Follow-up|3
1305258|NCT00172042|4246985|P2|Overall Study|Withdrawal by Subject|25
1305259|NCT00172042|4246986|P1|Overall Study|Withdrawal by Subject|37
1305260|NCT00172042|4246985|P2|Overall Study|Protocol Violation|7
1305261|NCT00172042|4246986|P1|Overall Study|Protocol Violation|8
1305262|NCT00172042|4246985|P2|Overall Study|Patient no longer requires study drug|8
1305263|NCT00172042|4246986|P1|Overall Study|Patient no longer requires study drug|10
1305264|NCT00172042|4246985|P2|Overall Study|Unsatisfactory therapeutic effect|11
1305265|NCT00172042|4246986|P1|Overall Study|Unsatisfactory therapeutic effect|13
1305266|NCT00172042|4246985|P2|Overall Study|Abnormal test procedure(s)|3
1305267|NCT00172042|4246986|P1|Overall Study|Abnormal test procedure(s)|0
1305268|NCT00172042|4246985|P2|Overall Study|Abnormal laboratory value(s)|1
1305269|NCT00172042|4246986|P1|Overall Study|Abnormal laboratory value(s)|5
1305270|NCT00172042|4246985|P2|Overall Study|Adverse Event|13
1305271|NCT00172042|4246986|P1|Overall Study|Adverse Event|27
1305272|NCT00171925|4247008|P2|Overall Study|Death|2
1305273|NCT00171925|4247009|P1|Overall Study|Death|1
1305274|NCT00171925|4247008|P2|Overall Study|Administrative problems|11
1305275|NCT00171925|4247009|P1|Overall Study|Administrative problems|10
1305276|NCT00171925|4247008|P2|Overall Study|Lost to Follow-up|2
1305277|NCT00171925|4247009|P1|Overall Study|Lost to Follow-up|2
1305278|NCT00171925|4247008|P2|Overall Study|Withdrawal by Subject|9
1305279|NCT00171925|4247009|P1|Overall Study|Withdrawal by Subject|6
1305280|NCT00171925|4247008|P2|Overall Study|Protocol Violation|1
1305281|NCT00171925|4247009|P1|Overall Study|Protocol Violation|1
1305282|NCT00171925|4247008|P2|Overall Study|Adverse Event|6
1305283|NCT00171925|4247009|P1|Overall Study|Adverse Event|10
1305284|NCT00171873|4247021|P2|Overall Study|Switched to Octreotide|1
1305285|NCT00171873|4247022|P1|Overall Study|Switched to Octreotide|0
1305286|NCT00171873|4247021|P2|Overall Study|Adverse Event|0
1305287|NCT00171873|4247022|P1|Overall Study|Adverse Event|5
1305288|NCT00171873|4247021|P2|Overall Study|Withdrawal by Subject|2
1305289|NCT00171873|4247022|P1|Overall Study|Withdrawal by Subject|4
1305290|NCT00171834|4247035|P7|Overall Study|Treatment Duration Completed|0
1305291|NCT00171834|4247036|P6|Overall Study|Treatment Duration Completed|1
1305292|NCT00171834|4247037|P5|Overall Study|Treatment Duration Completed|2
1305293|NCT00171834|4247038|P4|Overall Study|Treatment Duration Completed|0
1305294|NCT00171834|4247039|P3|Overall Study|Treatment Duration Completed|1
1305295|NCT00171834|4247040|P2|Overall Study|Treatment Duration Completed|0
1305296|NCT00171834|4247041|P1|Overall Study|Treatment Duration Completed|0
1305297|NCT00171834|4247035|P7|Overall Study|Disease Progression|3
1305298|NCT00171834|4247036|P6|Overall Study|Disease Progression|18
1305299|NCT00171834|4247037|P5|Overall Study|Disease Progression|2
1305300|NCT00171834|4247038|P4|Overall Study|Disease Progression|9
1305301|NCT00171834|4247039|P3|Overall Study|Disease Progression|8
1305302|NCT00171834|4247040|P2|Overall Study|Disease Progression|8
1305303|NCT00171834|4247041|P1|Overall Study|Disease Progression|4
1305304|NCT00171834|4247035|P7|Overall Study|Death from study indication|0
1305305|NCT00171834|4247036|P6|Overall Study|Death from study indication|0
1305306|NCT00171834|4247037|P5|Overall Study|Death from study indication|1
1305307|NCT00171834|4247038|P4|Overall Study|Death from study indication|0
1305308|NCT00171834|4247039|P3|Overall Study|Death from study indication|0
1305309|NCT00171834|4247040|P2|Overall Study|Death from study indication|1
1305310|NCT00171834|4247041|P1|Overall Study|Death from study indication|0
1305311|NCT00171834|4247035|P7|Overall Study|Withdrawal by Subject|0
1305312|NCT00171834|4247036|P6|Overall Study|Withdrawal by Subject|1
1305313|NCT00171834|4247037|P5|Overall Study|Withdrawal by Subject|1
1305314|NCT00171834|4247038|P4|Overall Study|Withdrawal by Subject|1
1305315|NCT00171834|4247039|P3|Overall Study|Withdrawal by Subject|0
1305316|NCT00171834|4247040|P2|Overall Study|Withdrawal by Subject|2
1305317|NCT00171834|4247041|P1|Overall Study|Withdrawal by Subject|0
1305318|NCT00171834|4247035|P7|Overall Study|Adverse Event|1
1305319|NCT00171834|4247036|P6|Overall Study|Adverse Event|15
1305320|NCT00171834|4247037|P5|Overall Study|Adverse Event|2
1305321|NCT00171834|4247038|P4|Overall Study|Adverse Event|2
1305322|NCT00171834|4247039|P3|Overall Study|Adverse Event|3
1305323|NCT00171834|4247040|P2|Overall Study|Adverse Event|1
1305324|NCT00171834|4247041|P1|Overall Study|Adverse Event|2
1305325|NCT00171704|4247081|P2|Overall Study|Protocol Violation|1
1305326|NCT00171704|4247082|P1|Overall Study|Protocol Violation|0
1305327|NCT00171704|4247081|P2|Overall Study|Withdrawal by Subject|3
1305328|NCT00171704|4247082|P1|Overall Study|Withdrawal by Subject|1
1305329|NCT00171704|4247081|P2|Overall Study|Death|2
1305330|NCT00171704|4247082|P1|Overall Study|Death|2
1305331|NCT00171704|4247081|P2|Overall Study|Administrative Problems|1
1305332|NCT00171704|4247082|P1|Overall Study|Administrative Problems|2
1305333|NCT00171704|4247081|P2|Overall Study|New therapy for 2nd non-breast prim canc|0
1305334|NCT00171704|4247082|P1|Overall Study|New therapy for 2nd non-breast prim canc|1
1305335|NCT00171704|4247081|P2|Overall Study|Disease Progression|9
1305336|NCT00171704|4247082|P1|Overall Study|Disease Progression|14
1305337|NCT00171704|4247081|P2|Overall Study|Adverse Event|33
1305338|NCT00171704|4247082|P1|Overall Study|Adverse Event|24
1305339|NCT00171340|4247104|P2|Overall Study|Death|6
1305340|NCT00171340|4247105|P1|Overall Study|Death|6
1305341|NCT00171340|4247104|P2|Overall Study|Administrative Problems|2
1305342|NCT00171340|4247105|P1|Overall Study|Administrative Problems|5
1305343|NCT00171340|4247104|P2|Overall Study|No Longer Required Study Drug|1
1305344|NCT00171340|4247105|P1|Overall Study|No Longer Required Study Drug|1
1305345|NCT00171340|4247104|P2|Overall Study|Abnormal Test Procedure Results|11
1305346|NCT00171340|4247105|P1|Overall Study|Abnormal Test Procedure Results|6
1305347|NCT00171340|4247104|P2|Overall Study|Abnormal Laboratory Results|0
1305348|NCT00171340|4247105|P1|Overall Study|Abnormal Laboratory Results|2
1305349|NCT00171340|4247104|P2|Overall Study|Lost to Follow-up|5
1305350|NCT00171340|4247105|P1|Overall Study|Lost to Follow-up|0
1305351|NCT00171340|4247104|P2|Overall Study|Withdrawal by Subject|19
1305352|NCT00171340|4247105|P1|Overall Study|Withdrawal by Subject|22
1305353|NCT00171340|4247104|P2|Overall Study|Protocol Violation|8
1305354|NCT00171340|4247105|P1|Overall Study|Protocol Violation|7
1305355|NCT00171340|4247104|P2|Overall Study|Lack of Efficacy|41
1305356|NCT00171340|4247105|P1|Overall Study|Lack of Efficacy|29
1305357|NCT00171340|4247104|P2|Overall Study|Adverse Event|42
1305358|NCT00171340|4247105|P1|Overall Study|Adverse Event|46
1305359|NCT00171314|4247121|P2|Overall Study|Death|1
1305360|NCT00171314|4247122|P1|Overall Study|Death|2
1305361|NCT00171314|4247121|P2|Overall Study|Lost to Follow-up|3
1305362|NCT00171314|4247122|P1|Overall Study|Lost to Follow-up|1
1305363|NCT00171314|4247121|P2|Overall Study|Administrative Problems|3
1305364|NCT00171314|4247122|P1|Overall Study|Administrative Problems|4
1305365|NCT00171314|4247121|P2|Overall Study|Protocol Violation|7
1305366|NCT00171314|4247122|P1|Overall Study|Protocol Violation|3
1305367|NCT00171314|4247121|P2|Overall Study|Abnormal Test Procedure Results|3
1305368|NCT00171314|4247122|P1|Overall Study|Abnormal Test Procedure Results|9
1305369|NCT00171314|4247121|P2|Overall Study|Withdrawal by Subject|6
1305370|NCT00171314|4247122|P1|Overall Study|Withdrawal by Subject|9
1305371|NCT00171314|4247121|P2|Overall Study|Lack of Efficacy|14
1305372|NCT00171314|4247122|P1|Overall Study|Lack of Efficacy|19
1305373|NCT00171314|4247121|P2|Overall Study|Adverse Event|41
1305374|NCT00171314|4247122|P1|Overall Study|Adverse Event|44
1305375|NCT00171301|4247138|P2|Overall Study|Withdrawal by Subject|1
1305376|NCT00171301|4247139|P1|Overall Study|Withdrawal by Subject|0
1305377|NCT00171301|4247138|P2|Overall Study|Protocol Violation|2
1305378|NCT00171301|4247139|P1|Overall Study|Protocol Violation|0
1305379|NCT00171301|4247138|P2|Overall Study|Lost to Follow-up|2
1305380|NCT00171301|4247139|P1|Overall Study|Lost to Follow-up|6
1305381|NCT00171301|4247138|P2|Overall Study|Adverse Event|2
1305382|NCT00171301|4247139|P1|Overall Study|Adverse Event|1
1305383|NCT00171301|4247138|P2|Overall Study|Death|2
1305384|NCT00171301|4247139|P1|Overall Study|Death|1
1305385|NCT00171210|4247152|P2|Overall Study|Stopped at end of extension 1|1
1305386|NCT00171210|4247153|P1|Overall Study|Stopped at end of extension 1|0
1305387|NCT00171210|4247152|P2|Overall Study|Stopped at end of core|32
1305388|NCT00171210|4247153|P1|Overall Study|Stopped at end of core|0
1305389|NCT00171210|4247152|P2|Overall Study|Death|3
1305390|NCT00171210|4247153|P1|Overall Study|Death|2
1305391|NCT00171210|4247152|P2|Overall Study|Administrative problems|1
1305392|NCT00171210|4247153|P1|Overall Study|Administrative problems|1
1305393|NCT00171210|4247152|P2|Overall Study|Lost to Follow-up|0
1305394|NCT00171210|4247153|P1|Overall Study|Lost to Follow-up|1
1305395|NCT00171210|4247152|P2|Overall Study|Withdrawal by Subject|30
1305396|NCT00171210|4247153|P1|Overall Study|Withdrawal by Subject|32
1305397|NCT00171210|4247152|P2|Overall Study|Protocol Violation|2
1305398|NCT00171210|4247153|P1|Overall Study|Protocol Violation|0
1305399|NCT00171210|4247152|P2|Overall Study|Unsatisfactory therapeutic effect|15
1305400|NCT00171210|4247153|P1|Overall Study|Unsatisfactory therapeutic effect|11
1305401|NCT00171210|4247152|P2|Overall Study|Abnormal test procedure result(s)|1
1305402|NCT00171210|4247153|P1|Overall Study|Abnormal test procedure result(s)|0
1305403|NCT00171210|4247152|P2|Overall Study|Abnormal laboratory value(s)|3
1305404|NCT00171210|4247153|P1|Overall Study|Abnormal laboratory value(s)|6
1305405|NCT00171210|4247152|P2|Overall Study|Adverse Event|27
1305406|NCT00171210|4247153|P1|Overall Study|Adverse Event|16
1305407|NCT00171054|4247183|P2|Overall Study|Condition no longer required study drug|1
1305408|NCT00171054|4247184|P1|Overall Study|Condition no longer required study drug|0
1305409|NCT00171054|4247183|P2|Overall Study|Adverse Event|8
1305410|NCT00171054|4247184|P1|Overall Study|Adverse Event|8
1305411|NCT00171054|4247183|P2|Overall Study|Lost to Follow-up|1
1305412|NCT00171054|4247184|P1|Overall Study|Lost to Follow-up|0
1305413|NCT00171054|4247183|P2|Overall Study|Patient withdrew consent|0
1305414|NCT00171054|4247184|P1|Overall Study|Patient withdrew consent|1
1305415|NCT00171054|4247183|P2|Overall Study|Protocol Violation|2
1305416|NCT00171054|4247184|P1|Overall Study|Protocol Violation|1
1305417|NCT00170950|4247216|P2|Overall Study|Termination Data Not Recorded|22
1305418|NCT00170950|4247217|P1|Overall Study|Termination Data Not Recorded|17
1305419|NCT00170950|4247216|P2|Overall Study|Missing|1
1305420|NCT00170950|4247217|P1|Overall Study|Missing|2
1305421|NCT00170950|4247216|P2|Overall Study|Lost to Follow-up|115
1305422|NCT00170950|4247217|P1|Overall Study|Lost to Follow-up|134
1305423|NCT00170950|4247216|P2|Overall Study|Withdrawal by Subject|498
1305424|NCT00170950|4247217|P1|Overall Study|Withdrawal by Subject|496
1305425|NCT00170950|4247216|P2|Overall Study|Death|274
1305426|NCT00170950|4247217|P1|Overall Study|Death|236
1305427|NCT00170846|4247230|P3|Overall Study|Reason Missing|0
1305428|NCT00170846|4247231|P2|Overall Study|Reason Missing|1
1305429|NCT00170846|4247232|P1|Overall Study|Reason Missing|0
1305430|NCT00170846|4247230|P3|Overall Study|Death|3
1305431|NCT00170846|4247231|P2|Overall Study|Death|3
1305432|NCT00170846|4247232|P1|Overall Study|Death|0
1305433|NCT00170846|4247230|P3|Overall Study|Lost to Follow-up|2
1305434|NCT00170846|4247231|P2|Overall Study|Lost to Follow-up|3
1305435|NCT00170846|4247232|P1|Overall Study|Lost to Follow-up|6
1305436|NCT00170846|4247230|P3|Overall Study|Subject withdrew Informed Consent|8
1305437|NCT00170846|4247231|P2|Overall Study|Subject withdrew Informed Consent|12
1305438|NCT00170846|4247232|P1|Overall Study|Subject withdrew Informed Consent|5
1305439|NCT00169442|4247264|P6|Overall Study|Lost to follow-up (compl. vaccination)|0
1305440|NCT00169442|4247265|P5|Overall Study|Lost to follow-up (compl. vaccination)|0
1305441|NCT00169442|4247266|P4|Overall Study|Lost to follow-up (compl. vaccination)|0
1305442|NCT00169442|4247267|P3|Overall Study|Lost to follow-up (compl. vaccination)|0
1305443|NCT00169442|4247268|P2|Overall Study|Lost to follow-up (compl. vaccination)|1
1305444|NCT00169442|4247269|P1|Overall Study|Lost to follow-up (compl. vaccination)|0
1305445|NCT00169442|4247264|P6|Overall Study|Lost to follow-up (incompl. vaccination)|0
1305446|NCT00169442|4247265|P5|Overall Study|Lost to follow-up (incompl. vaccination)|1
1305447|NCT00169442|4247266|P4|Overall Study|Lost to follow-up (incompl. vaccination)|0
1305448|NCT00169442|4247267|P3|Overall Study|Lost to follow-up (incompl. vaccination)|0
1305449|NCT00169442|4247268|P2|Overall Study|Lost to follow-up (incompl. vaccination)|0
1305450|NCT00169442|4247269|P1|Overall Study|Lost to follow-up (incompl. vaccination)|0
1305451|NCT00169442|4247264|P6|Overall Study|Migrated/moved from study area|2
1305452|NCT00169442|4247265|P5|Overall Study|Migrated/moved from study area|0
1305453|NCT00169442|4247266|P4|Overall Study|Migrated/moved from study area|0
1305454|NCT00169442|4247267|P3|Overall Study|Migrated/moved from study area|0
1305455|NCT00169442|4247268|P2|Overall Study|Migrated/moved from study area|0
1305456|NCT00169442|4247269|P1|Overall Study|Migrated/moved from study area|0
1305457|NCT00169442|4247264|P6|Overall Study|Withdrawal by Subject|0
1305458|NCT00169442|4247265|P5|Overall Study|Withdrawal by Subject|0
1305459|NCT00169442|4247266|P4|Overall Study|Withdrawal by Subject|0
1305460|NCT00169442|4247267|P3|Overall Study|Withdrawal by Subject|1
1305461|NCT00169442|4247268|P2|Overall Study|Withdrawal by Subject|0
1305462|NCT00169442|4247269|P1|Overall Study|Withdrawal by Subject|0
1305463|NCT00169104|4247378|P2|Overall Study|Physician Decision|1
1305464|NCT00169104|4247379|P1|Overall Study|Physician Decision|0
1305465|NCT00169104|4247378|P2|Overall Study|Protocol Violation|1
1305466|NCT00169104|4247379|P1|Overall Study|Protocol Violation|0
1305467|NCT00169104|4247378|P2|Overall Study|Withdrawal by Subject|0
1305468|NCT00169104|4247379|P1|Overall Study|Withdrawal by Subject|2
1305469|NCT00168844|4247393|P3|Overall Study|Other|9
1305470|NCT00168844|4247394|P2|Overall Study|Other|7
1305471|NCT00168844|4247395|P1|Overall Study|Other|6
1305472|NCT00168844|4247393|P3|Overall Study|Protocol Violation|4
1305473|NCT00168844|4247394|P2|Overall Study|Protocol Violation|2
1305474|NCT00168844|4247395|P1|Overall Study|Protocol Violation|2
1305475|NCT00168844|4247393|P3|Overall Study|Withdrawal by Subject|19
1305476|NCT00168844|4247394|P2|Overall Study|Withdrawal by Subject|9
1305477|NCT00168844|4247395|P1|Overall Study|Withdrawal by Subject|12
1305478|NCT00168844|4247393|P3|Overall Study|Lost to Follow-up|11
1305479|NCT00168844|4247394|P2|Overall Study|Lost to Follow-up|5
1305480|NCT00168844|4247395|P1|Overall Study|Lost to Follow-up|4
1305481|NCT00168844|4247393|P3|Overall Study|Adverse Event|48
1305482|NCT00168844|4247394|P2|Overall Study|Adverse Event|32
1305483|NCT00168844|4247395|P1|Overall Study|Adverse Event|31
1305484|NCT00168831|4247577|P3|Overall Study|Other|6
1305485|NCT00168831|4247578|P2|Overall Study|Other|3
1305486|NCT00168831|4247579|P1|Overall Study|Other|6
1305487|NCT00168831|4247577|P3|Overall Study|Protocol Violation|11
1305488|NCT00168831|4247578|P2|Overall Study|Protocol Violation|11
1305489|NCT00168831|4247579|P1|Overall Study|Protocol Violation|6
1305490|NCT00168831|4247577|P3|Overall Study|Withdrawal by Subject|19
1305491|NCT00168831|4247578|P2|Overall Study|Withdrawal by Subject|14
1305492|NCT00168831|4247579|P1|Overall Study|Withdrawal by Subject|7
1305493|NCT00168831|4247577|P3|Overall Study|Lost to Follow-up|4
1305494|NCT00168831|4247578|P2|Overall Study|Lost to Follow-up|6
1305495|NCT00168831|4247579|P1|Overall Study|Lost to Follow-up|5
1305496|NCT00168831|4247577|P3|Overall Study|Adverse Event|74
1305497|NCT00168831|4247578|P2|Overall Study|Adverse Event|47
1305498|NCT00168831|4247579|P1|Overall Study|Adverse Event|36
1305499|NCT00168818|4247761|P3|Treatment|not specified|31
1305500|NCT00168818|4247762|P2|Treatment|not specified|29
1305501|NCT00168818|4247763|P1|Treatment|not specified|23
1305502|NCT00168818|4247761|P3|Treatment|Withdrawal by Subject|22
1305503|NCT00168818|4247762|P2|Treatment|Withdrawal by Subject|20
1305504|NCT00168818|4247763|P1|Treatment|Withdrawal by Subject|25
1305505|NCT00168818|4247761|P3|Treatment|Lost to Follow-up|1
1305506|NCT00168818|4247762|P2|Treatment|Lost to Follow-up|2
1305507|NCT00168818|4247763|P1|Treatment|Lost to Follow-up|0
1305508|NCT00168818|4247761|P3|Treatment|Protocol Violation|11
1305509|NCT00168818|4247762|P2|Treatment|Protocol Violation|11
1305510|NCT00168818|4247763|P1|Treatment|Protocol Violation|8
1305511|NCT00168818|4247761|P3|Treatment|Adverse Event|68
1305512|NCT00168818|4247762|P2|Treatment|Adverse Event|89
1305513|NCT00168818|4247763|P1|Treatment|Adverse Event|77
1305514|NCT00168818|4247761|P3|Overall Study|not specified|30
1305515|NCT00168818|4247762|P2|Overall Study|not specified|24
1305516|NCT00168818|4247763|P1|Overall Study|not specified|22
1305517|NCT00168818|4247761|P3|Overall Study|Withdrawal by Subject|37
1305518|NCT00168818|4247762|P2|Overall Study|Withdrawal by Subject|41
1305519|NCT00168818|4247763|P1|Overall Study|Withdrawal by Subject|43
1305520|NCT00168818|4247761|P3|Overall Study|Lost to Follow-up|15
1305521|NCT00168818|4247762|P2|Overall Study|Lost to Follow-up|4
1305522|NCT00168818|4247763|P1|Overall Study|Lost to Follow-up|13
1305523|NCT00168818|4247761|P3|Overall Study|Protocol Violation|11
1305524|NCT00168818|4247762|P2|Overall Study|Protocol Violation|11
1305525|NCT00168818|4247763|P1|Overall Study|Protocol Violation|16
1305526|NCT00168818|4247761|P3|Overall Study|Adverse Event|31
1305527|NCT00168818|4247762|P2|Overall Study|Adverse Event|29
1305528|NCT00168818|4247763|P1|Overall Study|Adverse Event|23
1305529|NCT00168805|4247807|P3|Treatment|not specified|17
1305530|NCT00168805|4247808|P2|Treatment|not specified|18
1305531|NCT00168805|4247809|P1|Treatment|not specified|18
1305532|NCT00168805|4247807|P3|Treatment|Withdrawal by Subject|8
1305533|NCT00168805|4247808|P2|Treatment|Withdrawal by Subject|7
1305534|NCT00168805|4247809|P1|Treatment|Withdrawal by Subject|3
1305535|NCT00168805|4247807|P3|Treatment|Protocol Violation|5
1305536|NCT00168805|4247808|P2|Treatment|Protocol Violation|5
1305537|NCT00168805|4247809|P1|Treatment|Protocol Violation|3
1305538|NCT00168805|4247807|P3|Treatment|Adverse Event|32
1305539|NCT00168805|4247808|P2|Treatment|Adverse Event|26
1305540|NCT00168805|4247809|P1|Treatment|Adverse Event|25
1305541|NCT00168805|4247807|P3|Overall Study|not specified|22
1305542|NCT00168805|4247808|P2|Overall Study|not specified|21
1305543|NCT00168805|4247809|P1|Overall Study|not specified|24
1305544|NCT00168805|4247807|P3|Overall Study|Withdrawal by Subject|21
1305545|NCT00168805|4247808|P2|Overall Study|Withdrawal by Subject|18
1305546|NCT00168805|4247809|P1|Overall Study|Withdrawal by Subject|16
1305547|NCT00168805|4247807|P3|Overall Study|Lost to Follow-up|11
1305548|NCT00168805|4247808|P2|Overall Study|Lost to Follow-up|17
1305549|NCT00168805|4247809|P1|Overall Study|Lost to Follow-up|12
1305550|NCT00168805|4247807|P3|Overall Study|Protocol Violation|8
1305551|NCT00168805|4247808|P2|Overall Study|Protocol Violation|11
1305552|NCT00168805|4247809|P1|Overall Study|Protocol Violation|12
1305553|NCT00168805|4247807|P3|Overall Study|Adverse Event|16
1305554|NCT00168805|4247808|P2|Overall Study|Adverse Event|11
1305555|NCT00168805|4247809|P1|Overall Study|Adverse Event|7
1305556|NCT00168103|4248045|P4|Overall Study|Lost to Follow-up|0
1305557|NCT00168103|4248046|P3|Overall Study|Lost to Follow-up|0
1305558|NCT00168103|4248047|P2|Overall Study|Lost to Follow-up|3
1305559|NCT00168103|4248048|P1|Overall Study|Lost to Follow-up|1
1305560|NCT00168103|4248045|P4|Overall Study|Withdrawal by Subject|0
1305561|NCT00168103|4248046|P3|Overall Study|Withdrawal by Subject|1
1305562|NCT00168103|4248047|P2|Overall Study|Withdrawal by Subject|2
1305563|NCT00168103|4248048|P1|Overall Study|Withdrawal by Subject|1
1305564|NCT00168064|4248070|P2|Overall Study|Various|3
1305565|NCT00168064|4248071|P1|Overall Study|Various|4
1305566|NCT00168064|4248070|P2|Overall Study|Subject's Best interest|2
1305567|NCT00168064|4248071|P1|Overall Study|Subject's Best interest|2
1305568|NCT00168064|4248070|P2|Overall Study|Concurrent Illness|3
1305569|NCT00168064|4248071|P1|Overall Study|Concurrent Illness|4
1305570|NCT00168064|4248070|P2|Overall Study|Non-compliance|3
1305571|NCT00168064|4248071|P1|Overall Study|Non-compliance|2
1305572|NCT00168064|4248070|P2|Overall Study|Lost to Follow-up|3
1305573|NCT00168064|4248071|P1|Overall Study|Lost to Follow-up|4
1305574|NCT00168064|4248070|P2|Overall Study|Lack of Efficacy|4
1305575|NCT00168064|4248071|P1|Overall Study|Lack of Efficacy|4
1305576|NCT00168064|4248070|P2|Overall Study|Withdrawal by Subject|4
1305577|NCT00168064|4248071|P1|Overall Study|Withdrawal by Subject|3
1305578|NCT00168064|4248070|P2|Overall Study|Adverse Event|22
1305579|NCT00168064|4248071|P1|Overall Study|Adverse Event|26
1305580|NCT00168038|4248079|P1|Overall Study|Therapy failure|1
1305581|NCT00168038|4248079|P1|Overall Study|Adverse Event|1
1305582|NCT00167778|4248091|P1|Overall Study|Withdrawal by Subject|1
1305583|NCT00167414|4248157|P1|Overall Study|Death|10
1305584|NCT00167310|4248182|P2|Overall Study|Withdrawal by Subject|7
1305585|NCT00167310|4248183|P1|Overall Study|Withdrawal by Subject|3
1305586|NCT00167310|4248182|P2|Overall Study|Protocol Violation|3
1305587|NCT00167310|4248183|P1|Overall Study|Protocol Violation|5
1305588|NCT00167245|4248193|P2|Overall Study|Drowsy|0
1305589|NCT00167245|4248194|P1|Overall Study|Drowsy|1
1305590|NCT00167245|4248193|P2|Overall Study|Incarcerated|2
1305591|NCT00167245|4248194|P1|Overall Study|Incarcerated|3
1305592|NCT00167245|4248193|P2|Overall Study|Withdrawal by Subject|8
1305593|NCT00167245|4248194|P1|Overall Study|Withdrawal by Subject|5
1305594|NCT00167245|4248193|P2|Overall Study|Lost to Follow-up|31
1305595|NCT00167245|4248194|P1|Overall Study|Lost to Follow-up|20
1305596|NCT00166712|4248244|P2|Overall Study|Physician Decision|2
1305597|NCT00166712|4248245|P1|Overall Study|Physician Decision|0
1305598|NCT00166712|4248244|P2|Overall Study|Withdrawal by Subject|2
1305599|NCT00166712|4248245|P1|Overall Study|Withdrawal by Subject|1
1305600|NCT00166712|4248244|P2|Overall Study|Adverse Event|0
1305601|NCT00166712|4248245|P1|Overall Study|Adverse Event|1
1305602|NCT00166712|4248244|P2|Overall Study|Death|1
1305603|NCT00166712|4248245|P1|Overall Study|Death|0
1305604|NCT00166517|4248262|P2|Overall Study|Withdrawal by Subject|1
1305605|NCT00166517|4248263|P1|Overall Study|Withdrawal by Subject|0
1305606|NCT00166517|4248262|P2|Overall Study|Protocol Violation|1
1305607|NCT00166517|4248263|P1|Overall Study|Protocol Violation|4
1305608|NCT00166517|4248262|P2|Overall Study|Lost to Follow-up|0
1305609|NCT00166517|4248263|P1|Overall Study|Lost to Follow-up|1
1305610|NCT00166504|4248273|P2|Overall Study|Withdrawal by Subject|0
1305611|NCT00166504|4248274|P1|Overall Study|Withdrawal by Subject|1
1305612|NCT00166504|4248273|P2|Overall Study|Lost to Follow-up|1
1305613|NCT00166504|4248274|P1|Overall Study|Lost to Follow-up|1
1305614|NCT00166504|4248273|P2|Overall Study|Adverse Event|3
1305615|NCT00166504|4248274|P1|Overall Study|Adverse Event|3
1305616|NCT00166296|4248291|P2|Overall Study|Lost to Follow-up|2
1305617|NCT00166296|4248292|P1|Overall Study|Lost to Follow-up|4
1305618|NCT00166296|4248291|P2|Overall Study|Adverse Event|4
1305619|NCT00166296|4248292|P1|Overall Study|Adverse Event|2
1305620|NCT00166296|4248291|P2|Overall Study|Withdrawal by Subject|3
1305621|NCT00166296|4248292|P1|Overall Study|Withdrawal by Subject|1
1305622|NCT00166114|4248344|P2|Overall Study|Adverse Event|1
1305623|NCT00166114|4248345|P1|Overall Study|Adverse Event|2
1305624|NCT00166114|4248344|P2|Overall Study|Withdrawal by Subject|4
1305625|NCT00166114|4248345|P1|Overall Study|Withdrawal by Subject|10
1305626|NCT00166114|4248344|P2|Overall Study|Protocol Violation|1
1305627|NCT00166114|4248345|P1|Overall Study|Protocol Violation|2
1305628|NCT00165984|4248362|P1|Overall Study|Death|15
1305629|NCT00165841|4248380|P2|Overall Study|Medication Noncompliance|1
1305630|NCT00165841|4248381|P1|Overall Study|Medication Noncompliance|1
1305631|NCT00165841|4248380|P2|Overall Study|Other|5
1305632|NCT00165841|4248381|P1|Overall Study|Other|3
1305633|NCT00165841|4248380|P2|Overall Study|Protocol Violation|8
1305634|NCT00165841|4248381|P1|Overall Study|Protocol Violation|6
1305635|NCT00165841|4248380|P2|Overall Study|Physician Decision|0
1305636|NCT00165841|4248381|P1|Overall Study|Physician Decision|1
1305637|NCT00165841|4248380|P2|Overall Study|Withdrawal by Subject|8
1305638|NCT00165841|4248381|P1|Overall Study|Withdrawal by Subject|7
1305639|NCT00165841|4248380|P2|Overall Study|Lost to Follow-up|4
1305640|NCT00165841|4248381|P1|Overall Study|Lost to Follow-up|4
1305641|NCT00165841|4248380|P2|Overall Study|Lack of Efficacy|33
1305642|NCT00165841|4248381|P1|Overall Study|Lack of Efficacy|6
1305643|NCT00165841|4248380|P2|Overall Study|Adverse Event|3
1305644|NCT00165841|4248381|P1|Overall Study|Adverse Event|2
1305645|NCT00165789|4248391|P4|Overall Study|Withdrawal by Subject|2
1305646|NCT00165789|4248392|P3|Overall Study|Withdrawal by Subject|1
1305647|NCT00165789|4248393|P2|Overall Study|Withdrawal by Subject|1
1305648|NCT00165789|4248394|P1|Overall Study|Withdrawal by Subject|0
1305649|NCT00165789|4248391|P4|Overall Study|Adverse Event|12
1305650|NCT00165789|4248392|P3|Overall Study|Adverse Event|0
1305651|NCT00165789|4248393|P2|Overall Study|Adverse Event|3
1305652|NCT00165789|4248394|P1|Overall Study|Adverse Event|0
1305653|NCT00165776|4248448|P4|Overall Study|Worsening of Cervical Dystonia|1
1305654|NCT00165776|4248449|P3|Overall Study|Worsening of Cervical Dystonia|0
1305655|NCT00165776|4248450|P2|Overall Study|Worsening of Cervical Dystonia|0
1305656|NCT00165776|4248451|P1|Overall Study|Worsening of Cervical Dystonia|0
1305657|NCT00165776|4248448|P4|Overall Study|Withdrawal by Subject|0
1305658|NCT00165776|4248449|P3|Overall Study|Withdrawal by Subject|2
1305659|NCT00165776|4248450|P2|Overall Study|Withdrawal by Subject|1
1305660|NCT00165776|4248451|P1|Overall Study|Withdrawal by Subject|4
1305661|NCT00165776|4248448|P4|Overall Study|Lack of Efficacy|1
1305662|NCT00165776|4248449|P3|Overall Study|Lack of Efficacy|0
1305663|NCT00165776|4248450|P2|Overall Study|Lack of Efficacy|0
1305664|NCT00165776|4248451|P1|Overall Study|Lack of Efficacy|0
1305665|NCT00165698|4248487|P2|Overall Study|Not Taken/Lost the medicine|2
1305666|NCT00165698|4248488|P1|Overall Study|Not Taken/Lost the medicine|1
1305667|NCT00165698|4248487|P2|Overall Study|Protocol Violation|0
1305668|NCT00165698|4248488|P1|Overall Study|Protocol Violation|1
1305669|NCT00165698|4248487|P2|Overall Study|Withdrawal by Subject|1
1305670|NCT00165698|4248488|P1|Overall Study|Withdrawal by Subject|2
1305671|NCT00165698|4248487|P2|Overall Study|Lost to Follow-up|2
1305672|NCT00165698|4248488|P1|Overall Study|Lost to Follow-up|2
1305673|NCT00165698|4248487|P2|Overall Study|Adverse Event|10
1305674|NCT00165698|4248488|P1|Overall Study|Adverse Event|2
1305675|NCT00165672|4248514|P2|Overall Study|Adverse Event|1
1305676|NCT00165672|4248515|P1|Overall Study|Adverse Event|0
1305677|NCT00165646|4248524|P3|Overall Study|Protocol Violation|0
1305678|NCT00165646|4248525|P2|Overall Study|Protocol Violation|0
1305679|NCT00165646|4248526|P1|Overall Study|Protocol Violation|1
1305680|NCT00165646|4248524|P3|Overall Study|Physician Decision|2
1305681|NCT00165646|4248525|P2|Overall Study|Physician Decision|0
1305682|NCT00165646|4248526|P1|Overall Study|Physician Decision|2
1305683|NCT00165646|4248524|P3|Overall Study|Withdrawal by Subject|1
1305684|NCT00165646|4248525|P2|Overall Study|Withdrawal by Subject|2
1305685|NCT00165646|4248526|P1|Overall Study|Withdrawal by Subject|0
1305686|NCT00165646|4248524|P3|Overall Study|Lack of Efficacy|0
1305687|NCT00165646|4248525|P2|Overall Study|Lack of Efficacy|2
1305688|NCT00165646|4248526|P1|Overall Study|Lack of Efficacy|1
1305689|NCT00165646|4248524|P3|Overall Study|Adverse Event|1
1305690|NCT00165646|4248525|P2|Overall Study|Adverse Event|1
1305691|NCT00165646|4248526|P1|Overall Study|Adverse Event|1
1305692|NCT00165503|4248534|P1|Overall Study|Unresectable|3
1305693|NCT00165503|4248534|P1|Overall Study|Lost to Follow-up|12
1305694|NCT00165503|4248534|P1|Overall Study|Death|1
1305695|NCT00163657|4248541|P3|Overall Study|Other reason|3
1305696|NCT00163657|4248542|P2|Overall Study|Other reason|1
1305697|NCT00163657|4248543|P1|Overall Study|Other reason|0
1305698|NCT00163657|4248541|P3|Overall Study|Lost to Follow-up|10
1305699|NCT00163657|4248542|P2|Overall Study|Lost to Follow-up|3
1305700|NCT00163657|4248543|P1|Overall Study|Lost to Follow-up|1
1305701|NCT00163657|4248541|P3|Overall Study|Non Compliance|0
1305702|NCT00163657|4248542|P2|Overall Study|Non Compliance|0
1305703|NCT00163657|4248543|P1|Overall Study|Non Compliance|1
1305704|NCT00163657|4248541|P3|Overall Study|Physician Decision|1
1305705|NCT00163657|4248542|P2|Overall Study|Physician Decision|1
1305706|NCT00163657|4248543|P1|Overall Study|Physician Decision|0
1305707|NCT00163657|4248541|P3|Overall Study|Withdrawal by Subject|2
1305708|NCT00163657|4248542|P2|Overall Study|Withdrawal by Subject|3
1305709|NCT00163657|4248543|P1|Overall Study|Withdrawal by Subject|2
1305710|NCT00163657|4248541|P3|Overall Study|graft loss|2
1305711|NCT00163657|4248542|P2|Overall Study|graft loss|1
1305712|NCT00163657|4248543|P1|Overall Study|graft loss|4
1305713|NCT00163657|4248541|P3|Overall Study|Death|19
1305714|NCT00163657|4248542|P2|Overall Study|Death|14
1305715|NCT00163657|4248543|P1|Overall Study|Death|12
1305716|NCT00163215|4248633|P1|Overall Study|Other|7
1305717|NCT00163215|4248633|P1|Overall Study|Withdrawal by Subject|5
1305718|NCT00163215|4248633|P1|Overall Study|Lack of Efficacy|3
1305719|NCT00163189|4248653|P1|Overall Study|Did not meet continuation criterion|16
1305720|NCT00163189|4248653|P1|Overall Study|Withdrawal by Subject|11
1305721|NCT00163189|4248653|P1|Overall Study|Study terminated by sponsor|11
1305722|NCT00163189|4248653|P1|Overall Study|Lack of Efficacy|7
1305723|NCT00163189|4248653|P1|Overall Study|Adverse Event|6
1305724|NCT00163189|4248653|P1|Overall Study|Death|3
1305725|NCT00163189|4248653|P1|Overall Study|Protocol Violation|2
1305726|NCT00163189|4248653|P1|Overall Study|Lost to Follow-up|1
1305727|NCT00163189|4248653|P1|Overall Study|Other|6
1305728|NCT00163020|4248677|P2|Overall Study|Lost to Follow-up|2
1305729|NCT00163020|4248678|P1|Overall Study|Lost to Follow-up|0
1305730|NCT00162981|4248718|P2|Overall Study|Physician Decision|0
1305731|NCT00162981|4248719|P1|Overall Study|Physician Decision|1
1305732|NCT00162981|4248718|P2|Overall Study|Withdrawal by Subject|1
1305733|NCT00162981|4248719|P1|Overall Study|Withdrawal by Subject|1
1305734|NCT00162981|4248718|P2|Overall Study|Adverse Event|5
1305735|NCT00162981|4248719|P1|Overall Study|Adverse Event|2
1305736|NCT00162942|4248735|P2|Overall Study|2 or more consecutive treatments missed|0
1305737|NCT00162942|4248736|P1|Overall Study|2 or more consecutive treatments missed|1
1305738|NCT00162942|4248735|P2|Overall Study|Flare During Active Treatment|3
1305739|NCT00162942|4248736|P1|Overall Study|Flare During Active Treatment|7
1305740|NCT00162942|4248735|P2|Overall Study|Lack of Efficacy|0
1305741|NCT00162942|4248736|P1|Overall Study|Lack of Efficacy|1
1305742|NCT00162942|4248735|P2|Overall Study|Alternate Therapy|2
1305743|NCT00162942|4248736|P1|Overall Study|Alternate Therapy|6
1305744|NCT00162942|4248735|P2|Overall Study|Enter Open-Label Study|35
1305745|NCT00162942|4248736|P1|Overall Study|Enter Open-Label Study|76
1305746|NCT00162942|4248735|P2|Overall Study|Physician Decision|0
1305747|NCT00162942|4248736|P1|Overall Study|Physician Decision|1
1305748|NCT00162942|4248735|P2|Overall Study|Withdrawal by Subject|6
1305749|NCT00162942|4248736|P1|Overall Study|Withdrawal by Subject|3
1305750|NCT00162942|4248735|P2|Overall Study|Death|0
1305751|NCT00162942|4248736|P1|Overall Study|Death|1
1305752|NCT00162942|4248735|P2|Overall Study|Adverse Event|6
1305753|NCT00162942|4248736|P1|Overall Study|Adverse Event|10
1305754|NCT00162773|4248784|P1|Overall Study|P.I, Left institution. Study terminated|22
1305755|NCT00162370|4248788|P1|Efficacy Population|Lost to Follow-up|51
1305756|NCT00162266|4248796|P4|Open-Label Period|Other Reasons|15
1305757|NCT00162266|4248797|P3|Open-Label Period|Other Reasons|0
1305758|NCT00162266|4248798|P2|Open-Label Period|Other Reasons|0
1305759|NCT00162266|4248799|P1|Open-Label Period|Other Reasons|0
1305760|NCT00162266|4248796|P4|Open-Label Period|Administrative Reason By Sponsor|9
1305761|NCT00162266|4248797|P3|Open-Label Period|Administrative Reason By Sponsor|0
1305762|NCT00162266|4248798|P2|Open-Label Period|Administrative Reason By Sponsor|0
1305763|NCT00162266|4248799|P1|Open-Label Period|Administrative Reason By Sponsor|0
1305764|NCT00162266|4248796|P4|Open-Label Period|Withdrawal by Subject|31
1305765|NCT00162266|4248797|P3|Open-Label Period|Withdrawal by Subject|0
1305766|NCT00162266|4248798|P2|Open-Label Period|Withdrawal by Subject|0
1305767|NCT00162266|4248799|P1|Open-Label Period|Withdrawal by Subject|0
1305768|NCT00162266|4248796|P4|Open-Label Period|Lost to Follow-up|3
1305769|NCT00162266|4248797|P3|Open-Label Period|Lost to Follow-up|0
1305770|NCT00162266|4248798|P2|Open-Label Period|Lost to Follow-up|0
1305771|NCT00162266|4248799|P1|Open-Label Period|Lost to Follow-up|0
1305772|NCT00162266|4248796|P4|Open-Label Period|Lack of Efficacy|26
1305773|NCT00162266|4248797|P3|Open-Label Period|Lack of Efficacy|0
1305774|NCT00162266|4248798|P2|Open-Label Period|Lack of Efficacy|0
1305775|NCT00162266|4248799|P1|Open-Label Period|Lack of Efficacy|0
1305776|NCT00162266|4248796|P4|Open-Label Period|Adverse Event|46
1305777|NCT00162266|4248797|P3|Open-Label Period|Adverse Event|0
1305778|NCT00162266|4248798|P2|Open-Label Period|Adverse Event|0
1305779|NCT00162266|4248799|P1|Open-Label Period|Adverse Event|0
1305780|NCT00162266|4248796|P4|Open-Label Period|Death|7
1305781|NCT00162266|4248797|P3|Open-Label Period|Death|0
1305782|NCT00162266|4248798|P2|Open-Label Period|Death|0
1305783|NCT00162266|4248799|P1|Open-Label Period|Death|0
1305784|NCT00162266|4248796|P4|Double-Blind Period|Withdrawal by Subject|0
1305785|NCT00162266|4248797|P3|Double-Blind Period|Withdrawal by Subject|6
1305786|NCT00162266|4248798|P2|Double-Blind Period|Withdrawal by Subject|2
1305787|NCT00162266|4248799|P1|Double-Blind Period|Withdrawal by Subject|5
1305788|NCT00162266|4248796|P4|Double-Blind Period|Lack of Efficacy|0
1305789|NCT00162266|4248797|P3|Double-Blind Period|Lack of Efficacy|30
1305790|NCT00162266|4248798|P2|Double-Blind Period|Lack of Efficacy|17
1305791|NCT00162266|4248799|P1|Double-Blind Period|Lack of Efficacy|13
1305792|NCT00162266|4248796|P4|Double-Blind Period|Other Reason|0
1305793|NCT00162266|4248797|P3|Double-Blind Period|Other Reason|1
1305794|NCT00162266|4248798|P2|Double-Blind Period|Other Reason|0
1305795|NCT00162266|4248799|P1|Double-Blind Period|Other Reason|1
1305796|NCT00162266|4248796|P4|Double-Blind Period|Lost to Follow-up|0
1305797|NCT00162266|4248797|P3|Double-Blind Period|Lost to Follow-up|0
1305798|NCT00162266|4248798|P2|Double-Blind Period|Lost to Follow-up|2
1305799|NCT00162266|4248799|P1|Double-Blind Period|Lost to Follow-up|1
1305800|NCT00162266|4248796|P4|Double-Blind Period|Death|0
1305801|NCT00162266|4248797|P3|Double-Blind Period|Death|0
1305802|NCT00162266|4248798|P2|Double-Blind Period|Death|1
1305803|NCT00162266|4248799|P1|Double-Blind Period|Death|0
1305804|NCT00162266|4248796|P4|Double-Blind Period|Adverse Event|0
1305805|NCT00162266|4248797|P3|Double-Blind Period|Adverse Event|11
1305806|NCT00162266|4248798|P2|Double-Blind Period|Adverse Event|9
1305807|NCT00162266|4248799|P1|Double-Blind Period|Adverse Event|5
1305808|NCT00162136|4249000|P1|Overall Study|Withdrawal by Subject|1
1305809|NCT00162136|4249000|P1|Overall Study|Study Drug Toxicity|4
1305810|NCT00162136|4249000|P1|Overall Study|Investigator Request|5
1305811|NCT00162136|4249000|P1|Overall Study|Disease Progression/Relapse|23
1305812|NCT00162136|4249000|P1|Overall Study|Death|1
1305813|NCT00162136|4249000|P1|Overall Study|Adverse Event|1
1305814|NCT00162123|4249032|P8|Overall Study|Follow-up only (not treated or assessed)|57
1305815|NCT00162123|4249033|P7|Overall Study|Follow-up only (not treated or assessed)|0
1305816|NCT00162123|4249034|P6|Overall Study|Follow-up only (not treated or assessed)|0
1305817|NCT00162123|4249035|P5|Overall Study|Follow-up only (not treated or assessed)|0
1305818|NCT00162123|4249036|P4|Overall Study|Follow-up only (not treated or assessed)|0
1305819|NCT00162123|4249037|P3|Overall Study|Follow-up only (not treated or assessed)|0
1305820|NCT00162123|4249038|P2|Overall Study|Follow-up only (not treated or assessed)|0
1305821|NCT00162123|4249039|P1|Overall Study|Follow-up only (not treated or assessed)|0
1305822|NCT00162123|4249032|P8|Overall Study|Tumor assessment only (not treated)|1
1305823|NCT00162123|4249033|P7|Overall Study|Tumor assessment only (not treated)|0
1305824|NCT00162123|4249034|P6|Overall Study|Tumor assessment only (not treated)|0
1305825|NCT00162123|4249035|P5|Overall Study|Tumor assessment only (not treated)|0
1305826|NCT00162123|4249036|P4|Overall Study|Tumor assessment only (not treated)|0
1305827|NCT00162123|4249037|P3|Overall Study|Tumor assessment only (not treated)|0
1305828|NCT00162123|4249038|P2|Overall Study|Tumor assessment only (not treated)|0
1305829|NCT00162123|4249039|P1|Overall Study|Tumor assessment only (not treated)|0
1305830|NCT00162123|4249032|P8|Overall Study|Physician Decision|0
1305831|NCT00162123|4249033|P7|Overall Study|Physician Decision|1
1305832|NCT00162123|4249034|P6|Overall Study|Physician Decision|1
1305833|NCT00162123|4249035|P5|Overall Study|Physician Decision|0
1305834|NCT00162123|4249036|P4|Overall Study|Physician Decision|0
1305835|NCT00162123|4249037|P3|Overall Study|Physician Decision|0
1305836|NCT00162123|4249038|P2|Overall Study|Physician Decision|2
1305837|NCT00162123|4249039|P1|Overall Study|Physician Decision|1
1305838|NCT00162123|4249032|P8|Overall Study|Not specified (after start of treatment)|0
1305839|NCT00162123|4249033|P7|Overall Study|Not specified (after start of treatment)|0
1305840|NCT00162123|4249034|P6|Overall Study|Not specified (after start of treatment)|0
1305841|NCT00162123|4249035|P5|Overall Study|Not specified (after start of treatment)|3
1305842|NCT00162123|4249036|P4|Overall Study|Not specified (after start of treatment)|0
1305843|NCT00162123|4249037|P3|Overall Study|Not specified (after start of treatment)|0
1305844|NCT00162123|4249038|P2|Overall Study|Not specified (after start of treatment)|0
1305845|NCT00162123|4249039|P1|Overall Study|Not specified (after start of treatment)|0
1305846|NCT00162123|4249032|P8|Overall Study|Not specified (before treatment)|0
1305847|NCT00162123|4249033|P7|Overall Study|Not specified (before treatment)|0
1305848|NCT00162123|4249034|P6|Overall Study|Not specified (before treatment)|1
1305849|NCT00162123|4249035|P5|Overall Study|Not specified (before treatment)|12
1305850|NCT00162123|4249036|P4|Overall Study|Not specified (before treatment)|0
1305851|NCT00162123|4249037|P3|Overall Study|Not specified (before treatment)|0
1305852|NCT00162123|4249038|P2|Overall Study|Not specified (before treatment)|0
1305853|NCT00162123|4249039|P1|Overall Study|Not specified (before treatment)|2
1305854|NCT00162123|4249032|P8|Overall Study|Adverse Event|0
1305855|NCT00162123|4249033|P7|Overall Study|Adverse Event|0
1305856|NCT00162123|4249034|P6|Overall Study|Adverse Event|0
1305857|NCT00162123|4249035|P5|Overall Study|Adverse Event|1
1305858|NCT00162123|4249036|P4|Overall Study|Adverse Event|2
1305859|NCT00162123|4249037|P3|Overall Study|Adverse Event|0
1305860|NCT00162123|4249038|P2|Overall Study|Adverse Event|2
1305861|NCT00162123|4249039|P1|Overall Study|Adverse Event|1
1305862|NCT00162123|4249032|P8|Overall Study|Deterioration without progression|0
1305863|NCT00162123|4249033|P7|Overall Study|Deterioration without progression|0
1305864|NCT00162123|4249034|P6|Overall Study|Deterioration without progression|0
1305865|NCT00162123|4249035|P5|Overall Study|Deterioration without progression|1
1305866|NCT00162123|4249036|P4|Overall Study|Deterioration without progression|0
1305867|NCT00162123|4249037|P3|Overall Study|Deterioration without progression|3
1305868|NCT00162123|4249038|P2|Overall Study|Deterioration without progression|2
1305869|NCT00162123|4249039|P1|Overall Study|Deterioration without progression|2
1305870|NCT00162123|4249032|P8|Overall Study|Withdrawal by Subject|0
1305871|NCT00162123|4249033|P7|Overall Study|Withdrawal by Subject|1
1305872|NCT00162123|4249034|P6|Overall Study|Withdrawal by Subject|2
1305873|NCT00162123|4249035|P5|Overall Study|Withdrawal by Subject|1
1305874|NCT00162123|4249036|P4|Overall Study|Withdrawal by Subject|1
1305875|NCT00162123|4249037|P3|Overall Study|Withdrawal by Subject|2
1305876|NCT00162123|4249038|P2|Overall Study|Withdrawal by Subject|0
1305877|NCT00162123|4249039|P1|Overall Study|Withdrawal by Subject|2
1305878|NCT00162123|4249032|P8|Overall Study|Death|0
1305879|NCT00162123|4249033|P7|Overall Study|Death|0
1305880|NCT00162123|4249034|P6|Overall Study|Death|1
1305881|NCT00162123|4249035|P5|Overall Study|Death|1
1305882|NCT00162123|4249036|P4|Overall Study|Death|1
1305883|NCT00162123|4249037|P3|Overall Study|Death|1
1305884|NCT00162123|4249038|P2|Overall Study|Death|3
1305885|NCT00162123|4249039|P1|Overall Study|Death|3
1305886|NCT00162123|4249032|P8|Overall Study|Study drug toxicity|0
1305887|NCT00162123|4249033|P7|Overall Study|Study drug toxicity|1
1305888|NCT00162123|4249034|P6|Overall Study|Study drug toxicity|1
1305889|NCT00162123|4249035|P5|Overall Study|Study drug toxicity|4
1305890|NCT00162123|4249036|P4|Overall Study|Study drug toxicity|0
1305891|NCT00162123|4249037|P3|Overall Study|Study drug toxicity|5
1305892|NCT00162123|4249038|P2|Overall Study|Study drug toxicity|1
1305893|NCT00162123|4249039|P1|Overall Study|Study drug toxicity|6
1305894|NCT00162123|4249032|P8|Overall Study|Disease progression|0
1305895|NCT00162123|4249033|P7|Overall Study|Disease progression|1
1305896|NCT00162123|4249034|P6|Overall Study|Disease progression|3
1305897|NCT00162123|4249035|P5|Overall Study|Disease progression|8
1305898|NCT00162123|4249036|P4|Overall Study|Disease progression|4
1305899|NCT00162123|4249037|P3|Overall Study|Disease progression|10
1305900|NCT00162123|4249038|P2|Overall Study|Disease progression|19
1305901|NCT00162123|4249039|P1|Overall Study|Disease progression|27
1305902|NCT00162097|4249072|P4|Overall Study|Participant no longer met study criteria|1
1305903|NCT00162097|4249073|P3|Overall Study|Participant no longer met study criteria|0
1305904|NCT00162097|4249074|P2|Overall Study|Participant no longer met study criteria|0
1305905|NCT00162097|4249075|P1|Overall Study|Participant no longer met study criteria|0
1305906|NCT00162032|4249137|P2|Overall Study|Reason not specified|0
1305907|NCT00162032|4249138|P1|Overall Study|Reason not specified|1
1305908|NCT00162032|4249137|P2|Overall Study|Lost to Follow-up|2
1305909|NCT00162032|4249138|P1|Overall Study|Lost to Follow-up|4
1305910|NCT00161616|4249148|P2|Overall Study|Protocol deviation|0
1305911|NCT00161616|4249149|P1|Overall Study|Protocol deviation|1
1305912|NCT00161616|4249148|P2|Overall Study|Lost to Follow-up|13
1305913|NCT00161616|4249149|P1|Overall Study|Lost to Follow-up|17
1305914|NCT00161616|4249148|P2|Overall Study|Death|1
1305915|NCT00161616|4249149|P1|Overall Study|Death|1
1305916|NCT00161616|4249148|P2|Overall Study|Physician Decision|0
1305917|NCT00161616|4249149|P1|Overall Study|Physician Decision|1
1305918|NCT00161616|4249148|P2|Overall Study|Withdrawal by Subject|5
1305919|NCT00161616|4249149|P1|Overall Study|Withdrawal by Subject|6
1305920|NCT00161213|4249181|P1|Overall Study|Evaluable for toxicity but not response|1
1305921|NCT00161213|4249181|P1|Overall Study|Withdrawal by Subject|1
1305922|NCT00160706|4249188|P1|Overall Study|Other Reason|11
1305923|NCT00160706|4249188|P1|Overall Study|Lack of Efficacy and Other|1
1305924|NCT00160706|4249188|P1|Overall Study|Lack of Efficacy|42
1305925|NCT00160706|4249188|P1|Overall Study|Lost to Follow-up and Other|1
1305926|NCT00160706|4249188|P1|Overall Study|Lost to Follow-up|4
1305927|NCT00160706|4249188|P1|Overall Study|Physician Decision and Other|3
1305928|NCT00160706|4249188|P1|Overall Study|Physician Decision|10
1305929|NCT00160706|4249188|P1|Overall Study|Withdrawal by Subject and Other|12
1305930|NCT00160706|4249188|P1|Overall Study|Withdrawal by Subject|41
1305931|NCT00160706|4249188|P1|Overall Study|Protocol Violation|3
1305932|NCT00160706|4249188|P1|Overall Study|Adverse Event and Other Reason|105
1305933|NCT00160706|4249188|P1|Overall Study|Adverse Event|53
1305934|NCT00160693|4249200|P1|Overall Study|Study terminated by sponsor|15
1305935|NCT00160693|4249200|P1|Overall Study|Withdrawal by Subject|54
1305936|NCT00160693|4249200|P1|Overall Study|Lost to Follow-up|15
1305937|NCT00160693|4249200|P1|Overall Study|Protocol Violation|24
1305938|NCT00160693|4249200|P1|Overall Study|Lack of Efficacy|30
1305939|NCT00160693|4249200|P1|Overall Study|Adverse Event|97
1305940|NCT00160641|4249217|P1|Overall Study|Other|9
1305941|NCT00160641|4249217|P1|Overall Study|Protocol Violation|3
1305942|NCT00160641|4249217|P1|Overall Study|Lack of Efficacy|12
1305943|NCT00160641|4249217|P1|Overall Study|Lost to Follow-up|8
1305944|NCT00160641|4249217|P1|Overall Study|Withdrawal by Subject|87
1305945|NCT00160641|4249217|P1|Overall Study|Adverse Event|102
1305946|NCT00160563|4249251|P3|Overall Study|Missing reason|0
1305947|NCT00160563|4249252|P2|Overall Study|Missing reason|1
1305948|NCT00160563|4249253|P1|Overall Study|Missing reason|0
1305949|NCT00160563|4249251|P3|Overall Study|Other (listed in the study report)|81
1305950|NCT00160563|4249252|P2|Overall Study|Other (listed in the study report)|40
1305951|NCT00160563|4249253|P1|Overall Study|Other (listed in the study report)|48
1305952|NCT00160563|4249251|P3|Overall Study|Withdrawal by Subject|3
1305953|NCT00160563|4249252|P2|Overall Study|Withdrawal by Subject|2
1305954|NCT00160563|4249253|P1|Overall Study|Withdrawal by Subject|1
1305955|NCT00160563|4249251|P3|Overall Study|Protocol Violation|3
1305956|NCT00160563|4249252|P2|Overall Study|Protocol Violation|0
1305957|NCT00160563|4249253|P1|Overall Study|Protocol Violation|0
1305958|NCT00160563|4249251|P3|Overall Study|Lost to Follow-up|2
1305959|NCT00160563|4249252|P2|Overall Study|Lost to Follow-up|1
1305960|NCT00160563|4249253|P1|Overall Study|Lost to Follow-up|1
1305961|NCT00160563|4249251|P3|Overall Study|Adverse Event|1
1305962|NCT00160563|4249252|P2|Overall Study|Adverse Event|1
1305963|NCT00160563|4249253|P1|Overall Study|Adverse Event|1
1305964|NCT00160524|4249265|P1|Overall Study|Other|20
1305965|NCT00160524|4249265|P1|Overall Study|Lack of Efficacy and Other|1
1305966|NCT00160524|4249265|P1|Overall Study|Lack of Efficacy|21
1305967|NCT00160524|4249265|P1|Overall Study|Lost to Follow-up and Other|1
1305968|NCT00160524|4249265|P1|Overall Study|Lost to Follow-up|13
1305969|NCT00160524|4249265|P1|Overall Study|Physician Decision and Other|6
1305970|NCT00160524|4249265|P1|Overall Study|Physician Decision|27
1305971|NCT00160524|4249265|P1|Overall Study|Withdrawal by Subject and Other|17
1305972|NCT00160524|4249265|P1|Overall Study|Withdrawal by Subject|141
1305973|NCT00160524|4249265|P1|Overall Study|Protocol Violation and Other|2
1305974|NCT00160524|4249265|P1|Overall Study|Protocol Violation|16
1305975|NCT00160524|4249265|P1|Overall Study|Adverse Event and Other|94
1305976|NCT00160524|4249265|P1|Overall Study|Adverse Event|119
1305977|NCT00160251|4249282|P8|Post-amendment 2|Lost to follow-up/withdrawal by subject|11
1305978|NCT00160251|4249283|P7|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
1305979|NCT00160251|4249284|P6|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
1305980|NCT00160251|4249285|P5|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
1305981|NCT00160251|4249286|P4|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
1305982|NCT00160251|4249287|P3|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
1305983|NCT00160251|4249288|P2|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
1305984|NCT00160251|4249289|P1|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
1305985|NCT00160251|4249282|P8|Post-amendment 2|Lack of Efficacy|24
1305986|NCT00160251|4249283|P7|Post-amendment 2|Lack of Efficacy|0
1305987|NCT00160251|4249284|P6|Post-amendment 2|Lack of Efficacy|0
1305988|NCT00160251|4249285|P5|Post-amendment 2|Lack of Efficacy|0
1305989|NCT00160251|4249286|P4|Post-amendment 2|Lack of Efficacy|0
1305990|NCT00160251|4249287|P3|Post-amendment 2|Lack of Efficacy|0
1305991|NCT00160251|4249288|P2|Post-amendment 2|Lack of Efficacy|0
1305992|NCT00160251|4249289|P1|Post-amendment 2|Lack of Efficacy|0
1305993|NCT00160251|4249282|P8|Post-amendment 2|Adverse Event|20
1305994|NCT00160251|4249283|P7|Post-amendment 2|Adverse Event|0
1305995|NCT00160251|4249284|P6|Post-amendment 2|Adverse Event|0
1305996|NCT00160251|4249285|P5|Post-amendment 2|Adverse Event|0
1305997|NCT00160251|4249286|P4|Post-amendment 2|Adverse Event|0
1305998|NCT00160251|4249287|P3|Post-amendment 2|Adverse Event|0
1305999|NCT00160251|4249288|P2|Post-amendment 2|Adverse Event|0
1306000|NCT00160251|4249289|P1|Post-amendment 2|Adverse Event|0
1306001|NCT00160251|4249282|P8|Prior to Amendment 2|Completed Treatment Phase|0
1306002|NCT00160251|4249283|P7|Prior to Amendment 2|Completed Treatment Phase|0
1306003|NCT00160251|4249284|P6|Prior to Amendment 2|Completed Treatment Phase|23
1306004|NCT00160251|4249285|P5|Prior to Amendment 2|Completed Treatment Phase|0
1306005|NCT00160251|4249286|P4|Prior to Amendment 2|Completed Treatment Phase|0
1306006|NCT00160251|4249287|P3|Prior to Amendment 2|Completed Treatment Phase|0
1306007|NCT00160251|4249288|P2|Prior to Amendment 2|Completed Treatment Phase|0
1306008|NCT00160251|4249289|P1|Prior to Amendment 2|Completed Treatment Phase|3
1306009|NCT00160251|4249282|P8|Prior to Amendment 2|Noncompliance with protocol|0
1306010|NCT00160251|4249283|P7|Prior to Amendment 2|Noncompliance with protocol|0
1306011|NCT00160251|4249284|P6|Prior to Amendment 2|Noncompliance with protocol|0
1306012|NCT00160251|4249285|P5|Prior to Amendment 2|Noncompliance with protocol|0
1306013|NCT00160251|4249286|P4|Prior to Amendment 2|Noncompliance with protocol|0
1306014|NCT00160251|4249287|P3|Prior to Amendment 2|Noncompliance with protocol|0
1306015|NCT00160251|4249288|P2|Prior to Amendment 2|Noncompliance with protocol|0
1306016|NCT00160251|4249289|P1|Prior to Amendment 2|Noncompliance with protocol|1
1306017|NCT00160251|4249282|P8|Prior to Amendment 2|Withdrawal by Subject|0
1306018|NCT00160251|4249283|P7|Prior to Amendment 2|Withdrawal by Subject|3
1306019|NCT00160251|4249284|P6|Prior to Amendment 2|Withdrawal by Subject|3
1306020|NCT00160251|4249285|P5|Prior to Amendment 2|Withdrawal by Subject|2
1306021|NCT00160251|4249286|P4|Prior to Amendment 2|Withdrawal by Subject|4
1306022|NCT00160251|4249287|P3|Prior to Amendment 2|Withdrawal by Subject|3
1306023|NCT00160251|4249288|P2|Prior to Amendment 2|Withdrawal by Subject|1
1306024|NCT00160251|4249289|P1|Prior to Amendment 2|Withdrawal by Subject|3
1306025|NCT00160251|4249282|P8|Prior to Amendment 2|Lost to Follow-up|0
1306026|NCT00160251|4249283|P7|Prior to Amendment 2|Lost to Follow-up|0
1306027|NCT00160251|4249284|P6|Prior to Amendment 2|Lost to Follow-up|1
1306028|NCT00160251|4249285|P5|Prior to Amendment 2|Lost to Follow-up|1
1306029|NCT00160251|4249286|P4|Prior to Amendment 2|Lost to Follow-up|0
1306030|NCT00160251|4249287|P3|Prior to Amendment 2|Lost to Follow-up|1
1306031|NCT00160251|4249288|P2|Prior to Amendment 2|Lost to Follow-up|0
1306032|NCT00160251|4249289|P1|Prior to Amendment 2|Lost to Follow-up|0
1306033|NCT00160251|4249282|P8|Prior to Amendment 2|Lack of Efficacy|0
1306034|NCT00160251|4249283|P7|Prior to Amendment 2|Lack of Efficacy|0
1306035|NCT00160251|4249284|P6|Prior to Amendment 2|Lack of Efficacy|55
1306036|NCT00160251|4249285|P5|Prior to Amendment 2|Lack of Efficacy|24
1306037|NCT00160251|4249286|P4|Prior to Amendment 2|Lack of Efficacy|35
1306038|NCT00160251|4249287|P3|Prior to Amendment 2|Lack of Efficacy|37
1306039|NCT00160251|4249288|P2|Prior to Amendment 2|Lack of Efficacy|4
1306040|NCT00160251|4249289|P1|Prior to Amendment 2|Lack of Efficacy|0
1306041|NCT00160251|4249282|P8|Prior to Amendment 2|Adverse Event|0
1306042|NCT00160251|4249283|P7|Prior to Amendment 2|Adverse Event|1
1306043|NCT00160251|4249284|P6|Prior to Amendment 2|Adverse Event|1
1306044|NCT00160251|4249285|P5|Prior to Amendment 2|Adverse Event|1
1306045|NCT00160251|4249286|P4|Prior to Amendment 2|Adverse Event|1
1306046|NCT00160251|4249287|P3|Prior to Amendment 2|Adverse Event|3
1306047|NCT00160251|4249288|P2|Prior to Amendment 2|Adverse Event|1
1306048|NCT00160251|4249289|P1|Prior to Amendment 2|Adverse Event|2
1306049|NCT00160199|4249365|P2|Overall Study|Protocol Violation|8
1306050|NCT00160199|4249366|P1|Overall Study|Protocol Violation|8
1306051|NCT00160199|4249365|P2|Overall Study|Administrative|1
1306052|NCT00160199|4249366|P1|Overall Study|Administrative|0
1306053|NCT00160199|4249365|P2|Overall Study|Withdrawal by Subject|6
1306054|NCT00160199|4249366|P1|Overall Study|Withdrawal by Subject|4
1306055|NCT00160199|4249365|P2|Overall Study|Lost to Follow-up|7
1306056|NCT00160199|4249366|P1|Overall Study|Lost to Follow-up|7
1306057|NCT00160199|4249365|P2|Overall Study|Lack of Efficacy|1
1306058|NCT00160199|4249366|P1|Overall Study|Lack of Efficacy|0
1306059|NCT00160199|4249365|P2|Overall Study|Adverse Event|14
1306060|NCT00160199|4249366|P1|Overall Study|Adverse Event|5
1306061|NCT00159913|4249423|P4|Overall Study|Protocol Violation|0
1306062|NCT00159913|4249424|P3|Overall Study|Protocol Violation|1
1306063|NCT00159913|4249425|P2|Overall Study|Protocol Violation|0
1306064|NCT00159913|4249426|P1|Overall Study|Protocol Violation|1
1306065|NCT00159913|4249423|P4|Overall Study|Lost to Follow-up|1
1306066|NCT00159913|4249424|P3|Overall Study|Lost to Follow-up|0
1306067|NCT00159913|4249425|P2|Overall Study|Lost to Follow-up|0
1306068|NCT00159913|4249426|P1|Overall Study|Lost to Follow-up|0
1306069|NCT00159913|4249423|P4|Overall Study|Withdrawal by Subject|1
1306070|NCT00159913|4249424|P3|Overall Study|Withdrawal by Subject|0
1306071|NCT00159913|4249425|P2|Overall Study|Withdrawal by Subject|0
1306072|NCT00159913|4249426|P1|Overall Study|Withdrawal by Subject|0
1306073|NCT00159913|4249423|P4|Overall Study|Adverse Event|0
1306074|NCT00159913|4249424|P3|Overall Study|Adverse Event|1
1306075|NCT00159913|4249425|P2|Overall Study|Adverse Event|0
1306076|NCT00159913|4249426|P1|Overall Study|Adverse Event|1
1306077|NCT00159874|4249500|P7|Overall Study|Pregnancy|0
1306078|NCT00159874|4249501|P6|Overall Study|Pregnancy|0
1306079|NCT00159874|4249502|P5|Overall Study|Pregnancy|0
1306080|NCT00159874|4249503|P4|Overall Study|Pregnancy|0
1306081|NCT00159874|4249504|P3|Overall Study|Pregnancy|0
1306082|NCT00159874|4249505|P2|Overall Study|Pregnancy|1
1306083|NCT00159874|4249506|P1|Overall Study|Pregnancy|1
1306084|NCT00159874|4249500|P7|Overall Study|Withdrawal by Subject|1
1306085|NCT00159874|4249501|P6|Overall Study|Withdrawal by Subject|2
1306086|NCT00159874|4249502|P5|Overall Study|Withdrawal by Subject|3
1306087|NCT00159874|4249503|P4|Overall Study|Withdrawal by Subject|4
1306088|NCT00159874|4249504|P3|Overall Study|Withdrawal by Subject|8
1306089|NCT00159874|4249505|P2|Overall Study|Withdrawal by Subject|6
1306090|NCT00159874|4249506|P1|Overall Study|Withdrawal by Subject|2
1306091|NCT00159874|4249500|P7|Overall Study|Death|0
1306092|NCT00159874|4249501|P6|Overall Study|Death|2
1306093|NCT00159874|4249502|P5|Overall Study|Death|1
1306094|NCT00159874|4249503|P4|Overall Study|Death|0
1306095|NCT00159874|4249504|P3|Overall Study|Death|15
1306096|NCT00159874|4249505|P2|Overall Study|Death|8
1306097|NCT00159874|4249506|P1|Overall Study|Death|3
1306098|NCT00159874|4249500|P7|Overall Study|Protocol Violation|0
1306099|NCT00159874|4249501|P6|Overall Study|Protocol Violation|0
1306100|NCT00159874|4249502|P5|Overall Study|Protocol Violation|0
1306101|NCT00159874|4249503|P4|Overall Study|Protocol Violation|0
1306102|NCT00159874|4249504|P3|Overall Study|Protocol Violation|2
1306103|NCT00159874|4249505|P2|Overall Study|Protocol Violation|5
1306104|NCT00159874|4249506|P1|Overall Study|Protocol Violation|0
1306105|NCT00159874|4249500|P7|Overall Study|Not specified|3
1306106|NCT00159874|4249501|P6|Overall Study|Not specified|1
1306107|NCT00159874|4249502|P5|Overall Study|Not specified|2
1306108|NCT00159874|4249503|P4|Overall Study|Not specified|0
1306109|NCT00159874|4249504|P3|Overall Study|Not specified|8
1306110|NCT00159874|4249505|P2|Overall Study|Not specified|8
1306111|NCT00159874|4249506|P1|Overall Study|Not specified|8
1306112|NCT00159874|4249500|P7|Overall Study|Lost to Follow-up|1
1306113|NCT00159874|4249501|P6|Overall Study|Lost to Follow-up|2
1306114|NCT00159874|4249502|P5|Overall Study|Lost to Follow-up|1
1306115|NCT00159874|4249503|P4|Overall Study|Lost to Follow-up|0
1306116|NCT00159874|4249504|P3|Overall Study|Lost to Follow-up|3
1306117|NCT00159874|4249505|P2|Overall Study|Lost to Follow-up|0
1306118|NCT00159874|4249506|P1|Overall Study|Lost to Follow-up|1
1306119|NCT00159874|4249500|P7|Overall Study|Lack of Efficacy|0
1306120|NCT00159874|4249501|P6|Overall Study|Lack of Efficacy|3
1306121|NCT00159874|4249502|P5|Overall Study|Lack of Efficacy|0
1306122|NCT00159874|4249503|P4|Overall Study|Lack of Efficacy|1
1306123|NCT00159874|4249504|P3|Overall Study|Lack of Efficacy|1
1306124|NCT00159874|4249505|P2|Overall Study|Lack of Efficacy|0
1306125|NCT00159874|4249506|P1|Overall Study|Lack of Efficacy|2
1306126|NCT00159874|4249500|P7|Overall Study|Does Not Meet Entrance Criteria|0
1306127|NCT00159874|4249501|P6|Overall Study|Does Not Meet Entrance Criteria|0
1306128|NCT00159874|4249502|P5|Overall Study|Does Not Meet Entrance Criteria|0
1306129|NCT00159874|4249503|P4|Overall Study|Does Not Meet Entrance Criteria|0
1306130|NCT00159874|4249504|P3|Overall Study|Does Not Meet Entrance Criteria|1
1306131|NCT00159874|4249505|P2|Overall Study|Does Not Meet Entrance Criteria|0
1306132|NCT00159874|4249506|P1|Overall Study|Does Not Meet Entrance Criteria|1
1306133|NCT00159874|4249500|P7|Overall Study|Adverse Event|0
1306134|NCT00159874|4249501|P6|Overall Study|Adverse Event|2
1306135|NCT00159874|4249502|P5|Overall Study|Adverse Event|1
1306136|NCT00159874|4249503|P4|Overall Study|Adverse Event|1
1306137|NCT00159874|4249504|P3|Overall Study|Adverse Event|5
1306138|NCT00159874|4249505|P2|Overall Study|Adverse Event|2
1306139|NCT00159874|4249506|P1|Overall Study|Adverse Event|2
1306140|NCT00159861|4249676|P2|Extension Study - up to 3 Years|Withdrawal by Subject|9
1306141|NCT00159861|4249677|P1|Extension Study - up to 3 Years|Withdrawal by Subject|7
1306142|NCT00159861|4249676|P2|Extension Study - up to 3 Years|Reason Unspecified|19
1306143|NCT00159861|4249677|P1|Extension Study - up to 3 Years|Reason Unspecified|12
1306144|NCT00159861|4249676|P2|Extension Study - up to 3 Years|Lack of Efficacy|1
1306145|NCT00159861|4249677|P1|Extension Study - up to 3 Years|Lack of Efficacy|5
1306146|NCT00159861|4249676|P2|Extension Study - up to 3 Years|Adverse Event|14
1306147|NCT00159861|4249677|P1|Extension Study - up to 3 Years|Adverse Event|14
1306148|NCT00159861|4249676|P2|Extension Study - up to 3 Years|Death|28
1306149|NCT00159861|4249677|P1|Extension Study - up to 3 Years|Death|24
1306150|NCT00159861|4249676|P2|Core Study - 16 Weeks|Randomized but not Treated|0
1306151|NCT00159861|4249677|P1|Core Study - 16 Weeks|Randomized but not Treated|2
1306152|NCT00159861|4249676|P2|Core Study - 16 Weeks|Subject Defaulted|0
1306153|NCT00159861|4249677|P1|Core Study - 16 Weeks|Subject Defaulted|1
1306154|NCT00159861|4249676|P2|Core Study - 16 Weeks|Reason Unspecified|3
1306155|NCT00159861|4249677|P1|Core Study - 16 Weeks|Reason Unspecified|5
1306156|NCT00159861|4249676|P2|Core Study - 16 Weeks|Lack of Efficacy|3
1306157|NCT00159861|4249677|P1|Core Study - 16 Weeks|Lack of Efficacy|2
1306158|NCT00159861|4249676|P2|Core Study - 16 Weeks|Adverse Event|6
1306159|NCT00159861|4249677|P1|Core Study - 16 Weeks|Adverse Event|12
1306160|NCT00159861|4249676|P2|Core Study - 16 Weeks|Death|0
1306161|NCT00159861|4249677|P1|Core Study - 16 Weeks|Death|3
1306162|NCT00159822|4249698|P1|Post-treatment Follow-up Period|Reason unspecified|1
1306163|NCT00159822|4249698|P1|Post-treatment Follow-up Period|Withdrawal by Subject|1
1306164|NCT00159822|4249698|P1|Post-treatment Follow-up Period|Death|1
1306165|NCT00159822|4249698|P1|Voriconazole Treatment Period|Withdrawal by Subject|2
1306166|NCT00159822|4249698|P1|Voriconazole Treatment Period|Lost to Follow-up|2
1306167|NCT00159822|4249698|P1|Voriconazole Treatment Period|Protocol Violation|2
1306168|NCT00159822|4249698|P1|Voriconazole Treatment Period|Death|4
1306169|NCT00159822|4249698|P1|Voriconazole Treatment Period|Adverse Event|9
1306170|NCT00159822|4249698|P1|Voriconazole Treatment Period|Lack of Efficacy|3
1306171|NCT00159783|4249716|P3|Overall Study|not specified|4
1306172|NCT00159783|4249717|P2|Overall Study|not specified|2
1306173|NCT00159783|4249718|P1|Overall Study|not specified|0
1306174|NCT00159783|4249716|P3|Overall Study|Lost to Follow-up|11
1306175|NCT00159783|4249717|P2|Overall Study|Lost to Follow-up|5
1306176|NCT00159783|4249718|P1|Overall Study|Lost to Follow-up|6
1306177|NCT00159783|4249716|P3|Overall Study|Withdrawal by Subject|12
1306178|NCT00159783|4249717|P2|Overall Study|Withdrawal by Subject|11
1306179|NCT00159783|4249718|P1|Overall Study|Withdrawal by Subject|7
1306180|NCT00159783|4249716|P3|Overall Study|Lack of Efficacy|3
1306181|NCT00159783|4249717|P2|Overall Study|Lack of Efficacy|2
1306182|NCT00159783|4249718|P1|Overall Study|Lack of Efficacy|1
1306183|NCT00159783|4249716|P3|Overall Study|Adverse Event|9
1306184|NCT00159783|4249717|P2|Overall Study|Adverse Event|7
1306185|NCT00159783|4249718|P1|Overall Study|Adverse Event|5
1306186|NCT00159432|4249748|P1|Overall Study|Lack of Efficacy|8
1306187|NCT00159432|4249748|P1|Overall Study|Death|1
1306188|NCT00159432|4249748|P1|Overall Study|Adverse Event|1
1306189|NCT00158756|4249775|P5|Overall Study|Serious adverse event|0
1306190|NCT00158756|4249776|P4|Overall Study|Serious adverse event|0
1306191|NCT00158756|4249777|P3|Overall Study|Serious adverse event|1
1306192|NCT00158756|4249778|P2|Overall Study|Serious adverse event|0
1306193|NCT00158756|4249779|P1|Overall Study|Serious adverse event|0
1306194|NCT00158756|4249775|P5|Overall Study|Adverse Event|0
1306195|NCT00158756|4249776|P4|Overall Study|Adverse Event|0
1306196|NCT00158756|4249777|P3|Overall Study|Adverse Event|1
1306197|NCT00158756|4249778|P2|Overall Study|Adverse Event|0
1306198|NCT00158756|4249779|P1|Overall Study|Adverse Event|0
1306199|NCT00158756|4249775|P5|Overall Study|Withdrawal by Subject|3
1306200|NCT00158756|4249776|P4|Overall Study|Withdrawal by Subject|1
1306201|NCT00158756|4249777|P3|Overall Study|Withdrawal by Subject|6
1306202|NCT00158756|4249778|P2|Overall Study|Withdrawal by Subject|0
1306203|NCT00158756|4249779|P1|Overall Study|Withdrawal by Subject|5
1306204|NCT00158600|4249885|P2|Overall Study|Withdrawal by Subject|2
1306205|NCT00158600|4249886|P1|Overall Study|Withdrawal by Subject|2
1306206|NCT00158600|4249885|P2|Overall Study|Death|0
1306207|NCT00158600|4249886|P1|Overall Study|Death|1
1306208|NCT00158600|4249885|P2|Overall Study|Adverse Event|1
1306209|NCT00158600|4249886|P1|Overall Study|Adverse Event|2
1306210|NCT00158600|4249885|P2|Overall Study|unable to commit time to study|1
1306211|NCT00158600|4249886|P1|Overall Study|unable to commit time to study|0
1306212|NCT00158262|4249911|P2|Overall Study|Lost to Follow-up|1
1306213|NCT00158262|4249912|P1|Overall Study|Lost to Follow-up|1
1306214|NCT00158184|4249973|P2|Overall Study|Adverse Event|1
1306215|NCT00158184|4249974|P1|Overall Study|Adverse Event|1
1306216|NCT00158184|4249973|P2|Overall Study|failed for follow unit/study rules|0
1306217|NCT00158184|4249974|P1|Overall Study|failed for follow unit/study rules|2
1306218|NCT00158184|4249973|P2|Overall Study|personal issues|1
1306219|NCT00158184|4249974|P1|Overall Study|personal issues|3
1306220|NCT00158054|4249984|P2|Overall Study|Unavailable for follow up|3
1306221|NCT00158054|4249985|P1|Overall Study|Unavailable for follow up|7
1306222|NCT00158054|4249984|P2|Overall Study|Refused to continue|0
1306223|NCT00158054|4249985|P1|Overall Study|Refused to continue|3
1306224|NCT00157950|4249999|P2|Overall Study|Death|0
1306225|NCT00157950|4250000|P1|Overall Study|Death|1
1306226|NCT00157820|4250017|P3|2nd 8 Months|Premature cross-over|9
1306227|NCT00157820|4250018|P2|2nd 8 Months|Premature cross-over|7
1306228|NCT00157820|4250019|P1|2nd 8 Months|Premature cross-over|1
1306229|NCT00157820|4250017|P3|2nd 8 Months|Lost to Follow-up|2
1306230|NCT00157820|4250018|P2|2nd 8 Months|Lost to Follow-up|5
1306231|NCT00157820|4250019|P1|2nd 8 Months|Lost to Follow-up|1
1306232|NCT00157820|4250017|P3|2nd 8 Months|Death|3
1306233|NCT00157820|4250018|P2|2nd 8 Months|Death|1
1306234|NCT00157820|4250019|P1|2nd 8 Months|Death|3
1306235|NCT00157820|4250017|P3|1st 8 Month|Premature cross-over|2
1306236|NCT00157820|4250018|P2|1st 8 Month|Premature cross-over|2
1306237|NCT00157820|4250019|P1|1st 8 Month|Premature cross-over|0
1306238|NCT00157820|4250017|P3|1st 8 Month|Lost to Follow-up|1
1306239|NCT00157820|4250018|P2|1st 8 Month|Lost to Follow-up|2
1306240|NCT00157820|4250019|P1|1st 8 Month|Lost to Follow-up|1
1306241|NCT00157820|4250017|P3|1st 8 Month|Death|3
1306242|NCT00157820|4250018|P2|1st 8 Month|Death|8
1306243|NCT00157820|4250019|P1|1st 8 Month|Death|7
1306244|NCT00157820|4250017|P3|Randomized|Protocol Violation|2
1306245|NCT00157820|4250018|P2|Randomized|Protocol Violation|1
1306246|NCT00157820|4250019|P1|Randomized|Protocol Violation|2
1306247|NCT00157820|4250017|P3|Randomized|Withdrawal by Subject|3
1306248|NCT00157820|4250018|P2|Randomized|Withdrawal by Subject|2
1306249|NCT00157820|4250019|P1|Randomized|Withdrawal by Subject|1
1306250|NCT00157820|4250017|P3|Randomized|Physician Decision|3
1306251|NCT00157820|4250018|P2|Randomized|Physician Decision|2
1306252|NCT00157820|4250019|P1|Randomized|Physician Decision|4
1306253|NCT00157755|4250032|P6|Overall Study|Study completion|2
1306254|NCT00157755|4250033|P5|Overall Study|Study completion|1
1306255|NCT00157755|4250034|P4|Overall Study|Study completion|0
1306256|NCT00157755|4250035|P3|Overall Study|Study completion|0
1306257|NCT00157755|4250036|P2|Overall Study|Study completion|0
1306258|NCT00157755|4250037|P1|Overall Study|Study completion|0
1306259|NCT00157755|4250032|P6|Overall Study|Subject non-compliance|1
1306260|NCT00157755|4250033|P5|Overall Study|Subject non-compliance|0
1306261|NCT00157755|4250034|P4|Overall Study|Subject non-compliance|0
1306262|NCT00157755|4250035|P3|Overall Study|Subject non-compliance|0
1306263|NCT00157755|4250036|P2|Overall Study|Subject non-compliance|0
1306264|NCT00157755|4250037|P1|Overall Study|Subject non-compliance|0
1306265|NCT00157755|4250032|P6|Overall Study|Study site closure|0
1306266|NCT00157755|4250033|P5|Overall Study|Study site closure|0
1306267|NCT00157755|4250034|P4|Overall Study|Study site closure|0
1306268|NCT00157755|4250035|P3|Overall Study|Study site closure|0
1306269|NCT00157755|4250036|P2|Overall Study|Study site closure|1
1306270|NCT00157755|4250037|P1|Overall Study|Study site closure|0
1306271|NCT00157755|4250032|P6|Overall Study|Medical reason|0
1306272|NCT00157755|4250033|P5|Overall Study|Medical reason|0
1306273|NCT00157755|4250034|P4|Overall Study|Medical reason|1
1306274|NCT00157755|4250035|P3|Overall Study|Medical reason|1
1306275|NCT00157755|4250036|P2|Overall Study|Medical reason|0
1306276|NCT00157755|4250037|P1|Overall Study|Medical reason|0
1306277|NCT00157755|4250032|P6|Overall Study|Explant due to infection|0
1306278|NCT00157755|4250033|P5|Overall Study|Explant due to infection|0
1306279|NCT00157755|4250034|P4|Overall Study|Explant due to infection|0
1306280|NCT00157755|4250035|P3|Overall Study|Explant due to infection|1
1306281|NCT00157755|4250036|P2|Overall Study|Explant due to infection|0
1306282|NCT00157755|4250037|P1|Overall Study|Explant due to infection|0
1306283|NCT00157755|4250032|P6|Overall Study|Withdrawal by Subject|2
1306284|NCT00157755|4250033|P5|Overall Study|Withdrawal by Subject|1
1306285|NCT00157755|4250034|P4|Overall Study|Withdrawal by Subject|1
1306286|NCT00157755|4250035|P3|Overall Study|Withdrawal by Subject|1
1306287|NCT00157755|4250036|P2|Overall Study|Withdrawal by Subject|0
1306288|NCT00157755|4250037|P1|Overall Study|Withdrawal by Subject|0
1306289|NCT00157755|4250032|P6|Overall Study|Lost to Follow-up|0
1306290|NCT00157755|4250033|P5|Overall Study|Lost to Follow-up|0
1306291|NCT00157755|4250034|P4|Overall Study|Lost to Follow-up|0
1306292|NCT00157755|4250035|P3|Overall Study|Lost to Follow-up|1
1306293|NCT00157755|4250036|P2|Overall Study|Lost to Follow-up|0
1306294|NCT00157755|4250037|P1|Overall Study|Lost to Follow-up|0
1306295|NCT00157755|4250032|P6|Overall Study|Death|0
1306296|NCT00157755|4250033|P5|Overall Study|Death|0
1306297|NCT00157755|4250034|P4|Overall Study|Death|2
1306298|NCT00157755|4250035|P3|Overall Study|Death|3
1306299|NCT00157755|4250036|P2|Overall Study|Death|3
1306300|NCT00157755|4250037|P1|Overall Study|Death|2
1306301|NCT00157248|4250073|P4|Overall Study|site closures, subject moving|9
1306302|NCT00157248|4250074|P3|Overall Study|site closures, subject moving|3
1306303|NCT00157248|4250075|P2|Overall Study|site closures, subject moving|7
1306304|NCT00157248|4250076|P1|Overall Study|site closures, subject moving|7
1306305|NCT00157248|4250073|P4|Overall Study|Withdrawal by Subject|3
1306306|NCT00157248|4250074|P3|Overall Study|Withdrawal by Subject|3
1306307|NCT00157248|4250075|P2|Overall Study|Withdrawal by Subject|4
1306308|NCT00157248|4250076|P1|Overall Study|Withdrawal by Subject|1
1306309|NCT00157248|4250073|P4|Overall Study|Lost to Follow-up|0
1306310|NCT00157248|4250074|P3|Overall Study|Lost to Follow-up|0
1306311|NCT00157248|4250075|P2|Overall Study|Lost to Follow-up|1
1306312|NCT00157248|4250076|P1|Overall Study|Lost to Follow-up|0
1306313|NCT00157248|4250073|P4|Overall Study|Protocol Violation|2
1306314|NCT00157248|4250074|P3|Overall Study|Protocol Violation|2
1306315|NCT00157248|4250075|P2|Overall Study|Protocol Violation|0
1306316|NCT00157248|4250076|P1|Overall Study|Protocol Violation|4
1306317|NCT00157248|4250073|P4|Overall Study|Adverse Event|33
1306318|NCT00157248|4250074|P3|Overall Study|Adverse Event|13
1306319|NCT00157248|4250075|P2|Overall Study|Adverse Event|25
1306320|NCT00157248|4250076|P1|Overall Study|Adverse Event|36
1306321|NCT00157209|4250182|P2|Overall Study|Ongoing at data cut-off|0
1306322|NCT00157209|4250183|P1|Overall Study|Ongoing at data cut-off|10
1306323|NCT00157196|4250197|P1|Overall Study|Ongoing at data cut-off|9
1306324|NCT00157157|4250203|P1|Overall Study|Inclusion not met- baseline FVIII value|1
1306325|NCT00157157|4250203|P1|Overall Study|Met exclusion criteria|1
1306326|NCT00157157|4250203|P1|Overall Study|Enrolled in another study|1
1306327|NCT00157157|4250203|P1|Overall Study|Lost to Follow-up|1
1306328|NCT00157157|4250203|P1|Overall Study|Physician Decision|1
1306329|NCT00157157|4250203|P1|Overall Study|Withdrawal by Subject|6
1306330|NCT00157014|4250230|P4|Overall Study|Withdrawal by Subject|0
1306331|NCT00157014|4250231|P3|Overall Study|Withdrawal by Subject|0
1306332|NCT00157014|4250232|P2|Overall Study|Withdrawal by Subject|0
1306333|NCT00157014|4250233|P1|Overall Study|Withdrawal by Subject|1
1306334|NCT00157014|4250230|P4|Overall Study|Patient would not receive transplant|0
1306335|NCT00157014|4250231|P3|Overall Study|Patient would not receive transplant|0
1306336|NCT00157014|4250232|P2|Overall Study|Patient would not receive transplant|1
1306337|NCT00157014|4250233|P1|Overall Study|Patient would not receive transplant|0
1306338|NCT00157014|4250230|P4|Overall Study|Patient unable to return in nursing home|0
1306339|NCT00157014|4250231|P3|Overall Study|Patient unable to return in nursing home|0
1306340|NCT00157014|4250232|P2|Overall Study|Patient unable to return in nursing home|0
1306341|NCT00157014|4250233|P1|Overall Study|Patient unable to return in nursing home|1
1306342|NCT00157014|4250230|P4|Overall Study|Patient withdrawn by investigator|0
1306343|NCT00157014|4250231|P3|Overall Study|Patient withdrawn by investigator|0
1306344|NCT00157014|4250232|P2|Overall Study|Patient withdrawn by investigator|0
1306345|NCT00157014|4250233|P1|Overall Study|Patient withdrawn by investigator|1
1306346|NCT00157014|4250230|P4|Overall Study|Medications withdrawn on family request|0
1306347|NCT00157014|4250231|P3|Overall Study|Medications withdrawn on family request|0
1306348|NCT00157014|4250232|P2|Overall Study|Medications withdrawn on family request|1
1306349|NCT00157014|4250233|P1|Overall Study|Medications withdrawn on family request|0
1306350|NCT00157014|4250230|P4|Overall Study|Physician Decision|0
1306351|NCT00157014|4250231|P3|Overall Study|Physician Decision|0
1306352|NCT00157014|4250232|P2|Overall Study|Physician Decision|1
1306353|NCT00157014|4250233|P1|Overall Study|Physician Decision|0
1306354|NCT00157014|4250230|P4|Overall Study|Death|1
1306355|NCT00157014|4250231|P3|Overall Study|Death|1
1306356|NCT00157014|4250232|P2|Overall Study|Death|2
1306357|NCT00157014|4250233|P1|Overall Study|Death|4
1306358|NCT00156819|4250349|P3|Overall Study|Lost to Follow-up|3
1306359|NCT00156819|4250350|P2|Overall Study|Lost to Follow-up|1
1306360|NCT00156819|4250351|P1|Overall Study|Lost to Follow-up|1
1306361|NCT00156533|4250368|P4|Overall Study|Failed Screening|1
1306362|NCT00156533|4250369|P3|Overall Study|Failed Screening|1
1306363|NCT00156533|4250370|P2|Overall Study|Failed Screening|0
1306364|NCT00156533|4250371|P1|Overall Study|Failed Screening|1
1306365|NCT00156533|4250368|P4|Overall Study|Withdrawal by Subject|1
1306366|NCT00156533|4250369|P3|Overall Study|Withdrawal by Subject|0
1306367|NCT00156533|4250370|P2|Overall Study|Withdrawal by Subject|0
1306368|NCT00156533|4250371|P1|Overall Study|Withdrawal by Subject|1
1306369|NCT00156533|4250368|P4|Overall Study|Withdrawn - Medication Expiration|0
1306370|NCT00156533|4250369|P3|Overall Study|Withdrawn - Medication Expiration|1
1306371|NCT00156533|4250370|P2|Overall Study|Withdrawn - Medication Expiration|2
1306372|NCT00156533|4250371|P1|Overall Study|Withdrawn - Medication Expiration|0
1306373|NCT00156065|4250405|P3|Overall Study|Other|3
1306374|NCT00156065|4250406|P2|Overall Study|Other|9
1306375|NCT00156065|4250407|P1|Overall Study|Other|2
1306376|NCT00156065|4250405|P3|Overall Study|Lost to Follow-up|1
1306377|NCT00156065|4250406|P2|Overall Study|Lost to Follow-up|7
1306378|NCT00156065|4250407|P1|Overall Study|Lost to Follow-up|5
1306379|NCT00156065|4250405|P3|Overall Study|Withdrawal by Subject|16
1306380|NCT00156065|4250406|P2|Overall Study|Withdrawal by Subject|26
1306381|NCT00156065|4250407|P1|Overall Study|Withdrawal by Subject|13
1306382|NCT00156065|4250405|P3|Overall Study|Lack of Efficacy|3
1306383|NCT00156065|4250406|P2|Overall Study|Lack of Efficacy|9
1306384|NCT00156065|4250407|P1|Overall Study|Lack of Efficacy|2
1306385|NCT00156065|4250405|P3|Overall Study|Adverse Event|4
1306386|NCT00156065|4250406|P2|Overall Study|Adverse Event|11
1306387|NCT00156065|4250407|P1|Overall Study|Adverse Event|8
1306388|NCT00156065|4250405|P3|Overall Study|Enrolled But Never Received Treatment|0
1306389|NCT00156065|4250406|P2|Overall Study|Enrolled But Never Received Treatment|1
1306390|NCT00156065|4250407|P1|Overall Study|Enrolled But Never Received Treatment|1
1306391|NCT00154375|4250441|P2|Overall Study|Suspected progression of disease|30
1306392|NCT00154375|4250442|P1|Overall Study|Suspected progression of disease|44
1306393|NCT00154375|4250441|P2|Overall Study|Protocol Violation|1
1306394|NCT00154375|4250442|P1|Overall Study|Protocol Violation|0
1306395|NCT00154375|4250441|P2|Overall Study|Abnormal laboratory value(s)|2
1306396|NCT00154375|4250442|P1|Overall Study|Abnormal laboratory value(s)|0
1306397|NCT00154375|4250441|P2|Overall Study|Lost to Follow-up|1
1306398|NCT00154375|4250442|P1|Overall Study|Lost to Follow-up|2
1306399|NCT00154375|4250441|P2|Overall Study|Study drug no longer required|3
1306400|NCT00154375|4250442|P1|Overall Study|Study drug no longer required|5
1306401|NCT00154375|4250441|P2|Overall Study|Death|13
1306402|NCT00154375|4250442|P1|Overall Study|Death|5
1306403|NCT00154375|4250441|P2|Overall Study|Withdrawal by Subject|10
1306404|NCT00154375|4250442|P1|Overall Study|Withdrawal by Subject|14
1306405|NCT00154375|4250441|P2|Overall Study|Adverse Event|20
1306406|NCT00154375|4250442|P1|Overall Study|Adverse Event|18
1306407|NCT00154375|4250441|P2|Overall Study|Unsatisfactory therapeutic effect|26
1306408|NCT00154375|4250442|P1|Overall Study|Unsatisfactory therapeutic effect|25
1306409|NCT00154310|4250453|P2|Overall Study|Death|1
1306410|NCT00154310|4250454|P1|Overall Study|Death|0
1306411|NCT00154310|4250453|P2|Overall Study|Administrative problems|1
1306412|NCT00154310|4250454|P1|Overall Study|Administrative problems|0
1306413|NCT00154310|4250453|P2|Overall Study|Lost to Follow-up|8
1306414|NCT00154310|4250454|P1|Overall Study|Lost to Follow-up|0
1306415|NCT00154310|4250453|P2|Overall Study|Withdrawal by Subject|3
1306416|NCT00154310|4250454|P1|Overall Study|Withdrawal by Subject|9
1306417|NCT00154310|4250453|P2|Overall Study|Protocol Violation|2
1306418|NCT00154310|4250454|P1|Overall Study|Protocol Violation|4
1306419|NCT00154310|4250453|P2|Overall Study|Lack of Efficacy|4
1306420|NCT00154310|4250454|P1|Overall Study|Lack of Efficacy|5
1306421|NCT00154310|4250453|P2|Overall Study|Adverse Event|9
1306422|NCT00154310|4250454|P1|Overall Study|Adverse Event|19
1306423|NCT00154297|4250470|P2|Overall Study|Lost to Follow-up|0
1306424|NCT00154297|4250471|P1|Overall Study|Lost to Follow-up|3
1306425|NCT00154297|4250470|P2|Overall Study|Withdrawal by Subject|5
1306426|NCT00154297|4250471|P1|Overall Study|Withdrawal by Subject|0
1306427|NCT00154297|4250470|P2|Overall Study|Death|2
1306428|NCT00154297|4250471|P1|Overall Study|Death|5
1306429|NCT00154284|4250489|P2|Overall Study|Protocol Violation|1
1306430|NCT00154284|4250490|P1|Overall Study|Protocol Violation|0
1306431|NCT00154284|4250489|P2|Overall Study|Lack of Efficacy|2
1306432|NCT00154284|4250490|P1|Overall Study|Lack of Efficacy|1
1306433|NCT00154284|4250489|P2|Overall Study|Abnormal laboratory value(s)|1
1306434|NCT00154284|4250490|P1|Overall Study|Abnormal laboratory value(s)|0
1306435|NCT00154284|4250489|P2|Overall Study|Adverse Event|9
1306436|NCT00154284|4250490|P1|Overall Study|Adverse Event|6
1306437|NCT00154102|4250504|P2|Overall Study|investigational study phase ongoing|2
1306438|NCT00154102|4250505|P1|Overall Study|investigational study phase ongoing|7
1306439|NCT00154063|4250541|P2|Overall Study|Not specified|3
1306440|NCT00154063|4250542|P1|Overall Study|Not specified|3
1306441|NCT00154063|4250541|P2|Overall Study|Withdrawal by Subject|9
1306442|NCT00154063|4250542|P1|Overall Study|Withdrawal by Subject|4
1306443|NCT00154063|4250541|P2|Overall Study|Investigator or Sponsor Request|1
1306444|NCT00154063|4250542|P1|Overall Study|Investigator or Sponsor Request|0
1306445|NCT00154063|4250541|P2|Overall Study|Protocol Violation|1
1306446|NCT00154063|4250542|P1|Overall Study|Protocol Violation|1
1306447|NCT00154063|4250541|P2|Overall Study|Adverse Event|8
1306448|NCT00154063|4250542|P1|Overall Study|Adverse Event|4
1306449|NCT00153920|4250604|P1|Overall Study|Progressive Disease before Trt|1
1306450|NCT00153920|4250604|P1|Overall Study|Withdrawal of Consent before Trt|1
1306451|NCT00153920|4250604|P1|Overall Study|Non-Protocol Therapy|1
1306452|NCT00153920|4250604|P1|Overall Study|Withdrawal by Subject|1
1306453|NCT00153920|4250604|P1|Overall Study|Death|2
1306454|NCT00153920|4250604|P1|Overall Study|Lack of Response|3
1306455|NCT00153920|4250604|P1|Overall Study|Physician Decision|3
1306456|NCT00153920|4250604|P1|Overall Study|Progressive Disease|9
1306457|NCT00153920|4250604|P1|Overall Study|Adverse Event|9
1306458|NCT00153816|4250619|P6|Overall Study|Follow-up exam done, histology missing|2
1306459|NCT00153816|4250620|P5|Overall Study|Follow-up exam done, histology missing|1
1306460|NCT00153816|4250621|P4|Overall Study|Follow-up exam done, histology missing|3
1306461|NCT00153816|4250622|P3|Overall Study|Follow-up exam done, histology missing|3
1306462|NCT00153816|4250623|P2|Overall Study|Follow-up exam done, histology missing|3
1306463|NCT00153816|4250624|P1|Overall Study|Follow-up exam done, histology missing|2
1306464|NCT00153816|4250619|P6|Overall Study|Follow-up exam not done|9
1306465|NCT00153816|4250620|P5|Overall Study|Follow-up exam not done|8
1306466|NCT00153816|4250621|P4|Overall Study|Follow-up exam not done|10
1306467|NCT00153816|4250622|P3|Overall Study|Follow-up exam not done|11
1306468|NCT00153816|4250623|P2|Overall Study|Follow-up exam not done|7
1306469|NCT00153816|4250624|P1|Overall Study|Follow-up exam not done|8
1306470|NCT00153816|4250619|P6|Overall Study|Withdrawal by Subject|5
1306471|NCT00153816|4250620|P5|Overall Study|Withdrawal by Subject|1
1306472|NCT00153816|4250621|P4|Overall Study|Withdrawal by Subject|4
1306473|NCT00153816|4250622|P3|Overall Study|Withdrawal by Subject|9
1306474|NCT00153816|4250623|P2|Overall Study|Withdrawal by Subject|9
1306475|NCT00153816|4250624|P1|Overall Study|Withdrawal by Subject|9
1306476|NCT00153816|4250619|P6|Overall Study|Lost to Follow-up|9
1306477|NCT00153816|4250620|P5|Overall Study|Lost to Follow-up|7
1306478|NCT00153816|4250621|P4|Overall Study|Lost to Follow-up|8
1306479|NCT00153816|4250622|P3|Overall Study|Lost to Follow-up|5
1306480|NCT00153816|4250623|P2|Overall Study|Lost to Follow-up|8
1306481|NCT00153816|4250624|P1|Overall Study|Lost to Follow-up|7
1306482|NCT00153816|4250619|P6|Overall Study|Death|2
1306483|NCT00153816|4250620|P5|Overall Study|Death|0
1306484|NCT00153816|4250621|P4|Overall Study|Death|6
1306485|NCT00153816|4250622|P3|Overall Study|Death|4
1306486|NCT00153816|4250623|P2|Overall Study|Death|5
1306487|NCT00153816|4250624|P1|Overall Study|Death|6
1306488|NCT00153179|4250646|P4|Study Visit Day 2|Withdrawal by Subject|2
1306489|NCT00153179|4250647|P3|Study Visit Day 2|Withdrawal by Subject|2
1306490|NCT00153179|4250648|P2|Study Visit Day 2|Withdrawal by Subject|0
1306491|NCT00153179|4250649|P1|Study Visit Day 2|Withdrawal by Subject|1
1306492|NCT00153101|4250681|P5|Overall Study|Withdrawal by Subject|5
1306493|NCT00153101|4250682|P4|Overall Study|Withdrawal by Subject|3
1306494|NCT00153101|4250683|P3|Overall Study|Withdrawal by Subject|3
1306495|NCT00153101|4250684|P2|Overall Study|Withdrawal by Subject|4
1306496|NCT00153101|4250685|P1|Overall Study|Withdrawal by Subject|3
1306497|NCT00153101|4250681|P5|Overall Study|Lost to Follow-up|5
1306498|NCT00153101|4250682|P4|Overall Study|Lost to Follow-up|5
1306499|NCT00153101|4250683|P3|Overall Study|Lost to Follow-up|12
1306500|NCT00153101|4250684|P2|Overall Study|Lost to Follow-up|14
1306501|NCT00153101|4250685|P1|Overall Study|Lost to Follow-up|14
1306502|NCT00153062|4250793|P4|Overall Study|Other|0
1306503|NCT00153062|4250794|P3|Overall Study|Other|1
1306504|NCT00153062|4250795|P2|Overall Study|Other|0
1306505|NCT00153062|4250796|P1|Overall Study|Other|0
1306506|NCT00153062|4250793|P4|Overall Study|No disposition data available|1
1306507|NCT00153062|4250794|P3|Overall Study|No disposition data available|1
1306508|NCT00153062|4250795|P2|Overall Study|No disposition data available|1
1306509|NCT00153062|4250796|P1|Overall Study|No disposition data available|1
1306510|NCT00153062|4250793|P4|Overall Study|Protocol Violation|1
1306511|NCT00153062|4250794|P3|Overall Study|Protocol Violation|1
1306512|NCT00153062|4250795|P2|Overall Study|Protocol Violation|2
1306513|NCT00153062|4250796|P1|Overall Study|Protocol Violation|0
1306514|NCT00153062|4250793|P4|Overall Study|Adverse Event|0
1306515|NCT00153062|4250794|P3|Overall Study|Adverse Event|1
1306516|NCT00153062|4250795|P2|Overall Study|Adverse Event|1
1306517|NCT00153062|4250796|P1|Overall Study|Adverse Event|0
1306518|NCT00153062|4250793|P4|Overall Study|Lost to Follow-up|16
1306519|NCT00153062|4250794|P3|Overall Study|Lost to Follow-up|15
1306520|NCT00153062|4250795|P2|Overall Study|Lost to Follow-up|20
1306521|NCT00153062|4250796|P1|Overall Study|Lost to Follow-up|12
1306522|NCT00153062|4250793|P4|Overall Study|Withdrawal by Subject|28
1306523|NCT00153062|4250794|P3|Overall Study|Withdrawal by Subject|27
1306524|NCT00153062|4250795|P2|Overall Study|Withdrawal by Subject|30
1306525|NCT00153062|4250796|P1|Overall Study|Withdrawal by Subject|14
1306526|NCT00153062|4250793|P4|Overall Study|Death|365
1306527|NCT00153062|4250794|P3|Overall Study|Death|369
1306528|NCT00153062|4250795|P2|Overall Study|Death|352
1306529|NCT00153062|4250796|P1|Overall Study|Death|360
1306530|NCT00152971|4250815|P3|Treatment|not specified|10
1306531|NCT00152971|4250816|P2|Treatment|not specified|11
1306532|NCT00152971|4250817|P1|Treatment|not specified|9
1306533|NCT00152971|4250815|P3|Treatment|Withdrawal by Subject|5
1306534|NCT00152971|4250816|P2|Treatment|Withdrawal by Subject|4
1306535|NCT00152971|4250817|P1|Treatment|Withdrawal by Subject|4
1306536|NCT00152971|4250815|P3|Treatment|Lost to Follow-up|1
1306537|NCT00152971|4250816|P2|Treatment|Lost to Follow-up|2
1306538|NCT00152971|4250817|P1|Treatment|Lost to Follow-up|1
1306539|NCT00152971|4250815|P3|Treatment|Protocol Violation|10
1306540|NCT00152971|4250816|P2|Treatment|Protocol Violation|6
1306541|NCT00152971|4250817|P1|Treatment|Protocol Violation|8
1306542|NCT00152971|4250815|P3|Treatment|Adverse Event|54
1306543|NCT00152971|4250816|P2|Treatment|Adverse Event|40
1306544|NCT00152971|4250817|P1|Treatment|Adverse Event|49
1306545|NCT00152971|4250815|P3|Overall Study|not specified|5
1306546|NCT00152971|4250816|P2|Overall Study|not specified|5
1306547|NCT00152971|4250817|P1|Overall Study|not specified|3
1306548|NCT00152971|4250815|P3|Overall Study|Withdrawal by Subject|14
1306549|NCT00152971|4250816|P2|Overall Study|Withdrawal by Subject|8
1306550|NCT00152971|4250817|P1|Overall Study|Withdrawal by Subject|9
1306551|NCT00152971|4250815|P3|Overall Study|Lost to Follow-up|13
1306552|NCT00152971|4250816|P2|Overall Study|Lost to Follow-up|14
1306553|NCT00152971|4250817|P1|Overall Study|Lost to Follow-up|17
1306554|NCT00152971|4250815|P3|Overall Study|Protocol Violation|8
1306555|NCT00152971|4250816|P2|Overall Study|Protocol Violation|11
1306556|NCT00152971|4250817|P1|Overall Study|Protocol Violation|10
1306557|NCT00152971|4250815|P3|Overall Study|Adverse Event|9
1306558|NCT00152971|4250816|P2|Overall Study|Adverse Event|10
1306559|NCT00152971|4250817|P1|Overall Study|Adverse Event|12
1306560|NCT00152763|4250853|P4|Overall Study|Lost to Follow-up|13
1306561|NCT00152763|4250854|P3|Overall Study|Lost to Follow-up|2
1306562|NCT00152763|4250855|P2|Overall Study|Lost to Follow-up|4
1306563|NCT00152763|4250856|P1|Overall Study|Lost to Follow-up|6
1306564|NCT00152763|4250853|P4|Overall Study|Death|1
1306565|NCT00152763|4250854|P3|Overall Study|Death|2
1306566|NCT00152763|4250855|P2|Overall Study|Death|1
1306567|NCT00152763|4250856|P1|Overall Study|Death|4
1306568|NCT00152516|4250972|P1|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1
1306569|NCT00152516|4250972|P1|Overall Study|Other: Underwent Surgery for Epilepsy|1
1306570|NCT00152516|4250972|P1|Overall Study|Other: Moved Out Of State|1
1306571|NCT00152516|4250972|P1|Overall Study|Other: Primary Care Physician's Decision|1
1306572|NCT00152516|4250972|P1|Overall Study|Other: Non-Compliance|2
1306573|NCT00152516|4250972|P1|Overall Study|Other: Parents Withdrew Consent|2
1306574|NCT00152516|4250972|P1|Overall Study|Other: Given Commercial Drug in Error|2
1306575|NCT00152516|4250972|P1|Overall Study|Other: Mother Refused To Cooperate|1
1306576|NCT00152516|4250972|P1|Overall Study|Protocol Violation|3
1306577|NCT00152516|4250972|P1|Overall Study|Withdrawal by Subject|8
1306578|NCT00152516|4250972|P1|Overall Study|Lost to Follow-up|5
1306579|NCT00152516|4250972|P1|Overall Study|Lack and Loss of Efficacy|30
1306580|NCT00152516|4250972|P1|Overall Study|Adverse Event|18
1306581|NCT00152009|4251000|P4|Overall Study|Sponsor's decision|3
1306582|NCT00152009|4251001|P3|Overall Study|Sponsor's decision|1
1306583|NCT00152009|4251002|P2|Overall Study|Sponsor's decision|3
1306584|NCT00152009|4251003|P1|Overall Study|Sponsor's decision|3
1306585|NCT00152009|4251000|P4|Overall Study|ECG abnormalities|1
1306586|NCT00152009|4251001|P3|Overall Study|ECG abnormalities|2
1306587|NCT00152009|4251002|P2|Overall Study|ECG abnormalities|2
1306588|NCT00152009|4251003|P1|Overall Study|ECG abnormalities|2
1306589|NCT00152009|4251000|P4|Overall Study|Lack of Efficacy|15
1306590|NCT00152009|4251001|P3|Overall Study|Lack of Efficacy|7
1306591|NCT00152009|4251002|P2|Overall Study|Lack of Efficacy|6
1306592|NCT00152009|4251003|P1|Overall Study|Lack of Efficacy|8
1306593|NCT00152009|4251000|P4|Overall Study|Lost to Follow-up|3
1306594|NCT00152009|4251001|P3|Overall Study|Lost to Follow-up|3
1306595|NCT00152009|4251002|P2|Overall Study|Lost to Follow-up|4
1306596|NCT00152009|4251003|P1|Overall Study|Lost to Follow-up|2
1306597|NCT00152009|4251000|P4|Overall Study|Withdrawal by Subject|9
1306598|NCT00152009|4251001|P3|Overall Study|Withdrawal by Subject|4
1306599|NCT00152009|4251002|P2|Overall Study|Withdrawal by Subject|3
1306600|NCT00152009|4251003|P1|Overall Study|Withdrawal by Subject|2
1306601|NCT00152009|4251000|P4|Overall Study|Protocol Violation|1
1306602|NCT00152009|4251001|P3|Overall Study|Protocol Violation|0
1306603|NCT00152009|4251002|P2|Overall Study|Protocol Violation|0
1306604|NCT00152009|4251003|P1|Overall Study|Protocol Violation|3
1306605|NCT00152009|4251000|P4|Overall Study|Adverse Event|1
1306606|NCT00152009|4251001|P3|Overall Study|Adverse Event|20
1306607|NCT00152009|4251002|P2|Overall Study|Adverse Event|13
1306608|NCT00152009|4251003|P1|Overall Study|Adverse Event|9
1306609|NCT00151996|4251035|P2|Overall Study|Sponsor's decision|2
1306610|NCT00151996|4251036|P1|Overall Study|Sponsor's decision|0
1306611|NCT00151996|4251035|P2|Overall Study|Protocol Violation|2
1306612|NCT00151996|4251036|P1|Overall Study|Protocol Violation|1
1306613|NCT00151996|4251035|P2|Overall Study|Withdrawal by Subject|1
1306614|NCT00151996|4251036|P1|Overall Study|Withdrawal by Subject|1
1306615|NCT00151996|4251035|P2|Overall Study|Adverse Event|2
1306616|NCT00151996|4251036|P1|Overall Study|Adverse Event|3
1306617|NCT00151892|4251052|P2|Overall Study|Lack of study medication at center|1
1306618|NCT00151892|4251053|P1|Overall Study|Lack of study medication at center|0
1306619|NCT00151892|4251052|P2|Overall Study|Used prohibited corticosteroids|0
1306620|NCT00151892|4251053|P1|Overall Study|Used prohibited corticosteroids|1
1306621|NCT00151892|4251052|P2|Overall Study|Did not return for a visit|0
1306622|NCT00151892|4251053|P1|Overall Study|Did not return for a visit|1
1306623|NCT00151892|4251052|P2|Overall Study|Pregnancy|1
1306624|NCT00151892|4251053|P1|Overall Study|Pregnancy|0
1306625|NCT00151892|4251052|P2|Overall Study|Non-compliance|1
1306626|NCT00151892|4251053|P1|Overall Study|Non-compliance|0
1306627|NCT00151892|4251052|P2|Overall Study|Protocol Violation|3
1306628|NCT00151892|4251053|P1|Overall Study|Protocol Violation|3
1306629|NCT00151892|4251052|P2|Overall Study|Adverse Event|3
1306630|NCT00151892|4251053|P1|Overall Study|Adverse Event|6
1306631|NCT00151892|4251052|P2|Overall Study|Lost to Follow-up|10
1306632|NCT00151892|4251053|P1|Overall Study|Lost to Follow-up|5
1306633|NCT00151892|4251052|P2|Overall Study|Patient request|7
1306634|NCT00151892|4251053|P1|Overall Study|Patient request|10
1306635|NCT00151892|4251052|P2|Overall Study|Lack of Efficacy|57
1306636|NCT00151892|4251053|P1|Overall Study|Lack of Efficacy|50
1306637|NCT00151775|4251098|P12|Period 4: Open Label|Protocol Violation|0
1306638|NCT00151775|4251099|P11|Period 4: Open Label|Protocol Violation|0
1306639|NCT00151775|4251100|P10|Period 4: Open Label|Protocol Violation|0
1306640|NCT00151775|4251101|P9|Period 4: Open Label|Protocol Violation|0
1306641|NCT00151775|4251102|P8|Period 4: Open Label|Protocol Violation|0
1306642|NCT00151775|4251103|P7|Period 4: Open Label|Protocol Violation|0
1306643|NCT00151775|4251104|P6|Period 4: Open Label|Protocol Violation|0
1306644|NCT00151775|4251105|P5|Period 4: Open Label|Protocol Violation|1
1306645|NCT00151775|4251106|P4|Period 4: Open Label|Protocol Violation|0
1306646|NCT00151775|4251107|P3|Period 4: Open Label|Protocol Violation|0
1306647|NCT00151775|4251108|P2|Period 4: Open Label|Protocol Violation|0
1306648|NCT00151775|4251109|P1|Period 4: Open Label|Protocol Violation|0
1306649|NCT00151775|4251098|P12|Period 4: Open Label|Physician Decision|0
1306650|NCT00151775|4251099|P11|Period 4: Open Label|Physician Decision|0
1306651|NCT00151775|4251100|P10|Period 4: Open Label|Physician Decision|2
1306652|NCT00151775|4251101|P9|Period 4: Open Label|Physician Decision|0
1306653|NCT00151775|4251102|P8|Period 4: Open Label|Physician Decision|0
1306654|NCT00151775|4251103|P7|Period 4: Open Label|Physician Decision|0
1306655|NCT00151775|4251104|P6|Period 4: Open Label|Physician Decision|0
1306656|NCT00151775|4251105|P5|Period 4: Open Label|Physician Decision|0
1306657|NCT00151775|4251106|P4|Period 4: Open Label|Physician Decision|0
1306658|NCT00151775|4251107|P3|Period 4: Open Label|Physician Decision|0
1306659|NCT00151775|4251108|P2|Period 4: Open Label|Physician Decision|0
1306660|NCT00151775|4251109|P1|Period 4: Open Label|Physician Decision|0
1306661|NCT00151775|4251098|P12|Period 4: Open Label|Other|0
1306662|NCT00151775|4251099|P11|Period 4: Open Label|Other|0
1306663|NCT00151775|4251100|P10|Period 4: Open Label|Other|3
1306664|NCT00151775|4251101|P9|Period 4: Open Label|Other|0
1306665|NCT00151775|4251102|P8|Period 4: Open Label|Other|0
1306666|NCT00151775|4251103|P7|Period 4: Open Label|Other|0
1306667|NCT00151775|4251104|P6|Period 4: Open Label|Other|0
1306668|NCT00151775|4251105|P5|Period 4: Open Label|Other|1
1306669|NCT00151775|4251106|P4|Period 4: Open Label|Other|0
1306670|NCT00151775|4251107|P3|Period 4: Open Label|Other|0
1306671|NCT00151775|4251108|P2|Period 4: Open Label|Other|0
1306672|NCT00151775|4251109|P1|Period 4: Open Label|Other|0
1306673|NCT00151775|4251098|P12|Period 4: Open Label|Non-compliance with protocol|0
1306674|NCT00151775|4251099|P11|Period 4: Open Label|Non-compliance with protocol|0
1306675|NCT00151775|4251100|P10|Period 4: Open Label|Non-compliance with protocol|4
1306676|NCT00151775|4251101|P9|Period 4: Open Label|Non-compliance with protocol|0
1306677|NCT00151775|4251102|P8|Period 4: Open Label|Non-compliance with protocol|0
1306678|NCT00151775|4251103|P7|Period 4: Open Label|Non-compliance with protocol|0
1306679|NCT00151775|4251104|P6|Period 4: Open Label|Non-compliance with protocol|0
1306680|NCT00151775|4251105|P5|Period 4: Open Label|Non-compliance with protocol|4
1306681|NCT00151775|4251106|P4|Period 4: Open Label|Non-compliance with protocol|0
1306682|NCT00151775|4251107|P3|Period 4: Open Label|Non-compliance with protocol|0
1306683|NCT00151775|4251108|P2|Period 4: Open Label|Non-compliance with protocol|0
1306684|NCT00151775|4251109|P1|Period 4: Open Label|Non-compliance with protocol|0
1306685|NCT00151775|4251098|P12|Period 4: Open Label|Lost to Follow-up|0
1306686|NCT00151775|4251099|P11|Period 4: Open Label|Lost to Follow-up|0
1306687|NCT00151775|4251100|P10|Period 4: Open Label|Lost to Follow-up|7
1306688|NCT00151775|4251101|P9|Period 4: Open Label|Lost to Follow-up|0
1306689|NCT00151775|4251102|P8|Period 4: Open Label|Lost to Follow-up|0
1306690|NCT00151775|4251103|P7|Period 4: Open Label|Lost to Follow-up|0
1306691|NCT00151775|4251104|P6|Period 4: Open Label|Lost to Follow-up|0
1306692|NCT00151775|4251105|P5|Period 4: Open Label|Lost to Follow-up|17
1306693|NCT00151775|4251106|P4|Period 4: Open Label|Lost to Follow-up|0
1306694|NCT00151775|4251107|P3|Period 4: Open Label|Lost to Follow-up|0
1306695|NCT00151775|4251108|P2|Period 4: Open Label|Lost to Follow-up|0
1306696|NCT00151775|4251109|P1|Period 4: Open Label|Lost to Follow-up|0
1306697|NCT00151775|4251098|P12|Period 4: Open Label|Adverse Event|0
1306698|NCT00151775|4251099|P11|Period 4: Open Label|Adverse Event|0
1306699|NCT00151775|4251100|P10|Period 4: Open Label|Adverse Event|2
1306700|NCT00151775|4251101|P9|Period 4: Open Label|Adverse Event|0
1306701|NCT00151775|4251102|P8|Period 4: Open Label|Adverse Event|0
1306702|NCT00151775|4251103|P7|Period 4: Open Label|Adverse Event|0
1306703|NCT00151775|4251104|P6|Period 4: Open Label|Adverse Event|0
1306704|NCT00151775|4251105|P5|Period 4: Open Label|Adverse Event|1
1306705|NCT00151775|4251106|P4|Period 4: Open Label|Adverse Event|0
1306706|NCT00151775|4251107|P3|Period 4: Open Label|Adverse Event|0
1306707|NCT00151775|4251108|P2|Period 4: Open Label|Adverse Event|0
1306708|NCT00151775|4251109|P1|Period 4: Open Label|Adverse Event|0
1306709|NCT00151775|4251098|P12|Period 4: Open Label|Withdrawal by Subject|0
1306710|NCT00151775|4251099|P11|Period 4: Open Label|Withdrawal by Subject|0
1306711|NCT00151775|4251100|P10|Period 4: Open Label|Withdrawal by Subject|2
1306712|NCT00151775|4251101|P9|Period 4: Open Label|Withdrawal by Subject|0
1306713|NCT00151775|4251102|P8|Period 4: Open Label|Withdrawal by Subject|0
1306714|NCT00151775|4251103|P7|Period 4: Open Label|Withdrawal by Subject|0
1306715|NCT00151775|4251104|P6|Period 4: Open Label|Withdrawal by Subject|0
1306716|NCT00151775|4251105|P5|Period 4: Open Label|Withdrawal by Subject|5
1306717|NCT00151775|4251106|P4|Period 4: Open Label|Withdrawal by Subject|0
1306718|NCT00151775|4251107|P3|Period 4: Open Label|Withdrawal by Subject|0
1306719|NCT00151775|4251108|P2|Period 4: Open Label|Withdrawal by Subject|0
1306720|NCT00151775|4251109|P1|Period 4: Open Label|Withdrawal by Subject|0
1306721|NCT00151775|4251098|P12|Period 4: Open Label|Increased blood pressure|0
1306722|NCT00151775|4251099|P11|Period 4: Open Label|Increased blood pressure|0
1306723|NCT00151775|4251100|P10|Period 4: Open Label|Increased blood pressure|1
1306724|NCT00151775|4251101|P9|Period 4: Open Label|Increased blood pressure|0
1306725|NCT00151775|4251102|P8|Period 4: Open Label|Increased blood pressure|0
1306726|NCT00151775|4251103|P7|Period 4: Open Label|Increased blood pressure|0
1306727|NCT00151775|4251104|P6|Period 4: Open Label|Increased blood pressure|0
1306728|NCT00151775|4251105|P5|Period 4: Open Label|Increased blood pressure|1
1306729|NCT00151775|4251106|P4|Period 4: Open Label|Increased blood pressure|0
1306730|NCT00151775|4251107|P3|Period 4: Open Label|Increased blood pressure|0
1306731|NCT00151775|4251108|P2|Period 4: Open Label|Increased blood pressure|0
1306732|NCT00151775|4251109|P1|Period 4: Open Label|Increased blood pressure|0
1306733|NCT00151775|4251098|P12|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1
1306734|NCT00151775|4251099|P11|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1306735|NCT00151775|4251100|P10|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1306736|NCT00151775|4251101|P9|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1306737|NCT00151775|4251102|P8|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1306738|NCT00151775|4251103|P7|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1306739|NCT00151775|4251104|P6|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1306740|NCT00151775|4251105|P5|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1306741|NCT00151775|4251106|P4|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1306742|NCT00151775|4251107|P3|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1306743|NCT00151775|4251108|P2|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1306744|NCT00151775|4251109|P1|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1306745|NCT00151775|4251098|P12|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1306746|NCT00151775|4251099|P11|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1306747|NCT00151775|4251100|P10|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1306748|NCT00151775|4251101|P9|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1306749|NCT00151775|4251102|P8|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1306750|NCT00151775|4251103|P7|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1306751|NCT00151775|4251104|P6|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1306752|NCT00151775|4251105|P5|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1306753|NCT00151775|4251106|P4|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1306754|NCT00151775|4251107|P3|Period 3: Double-blind, Withdrawal|Protocol Violation|1
1306755|NCT00151775|4251108|P2|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1306756|NCT00151775|4251109|P1|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1306757|NCT00151775|4251098|P12|Period 3: Double-blind, Withdrawal|Adverse Event|0
1306758|NCT00151775|4251099|P11|Period 3: Double-blind, Withdrawal|Adverse Event|0
1306759|NCT00151775|4251100|P10|Period 3: Double-blind, Withdrawal|Adverse Event|0
1306760|NCT00151775|4251101|P9|Period 3: Double-blind, Withdrawal|Adverse Event|0
1306761|NCT00151775|4251102|P8|Period 3: Double-blind, Withdrawal|Adverse Event|0
1306762|NCT00151775|4251103|P7|Period 3: Double-blind, Withdrawal|Adverse Event|0
1306763|NCT00151775|4251104|P6|Period 3: Double-blind, Withdrawal|Adverse Event|0
1306764|NCT00151775|4251105|P5|Period 3: Double-blind, Withdrawal|Adverse Event|0
1306765|NCT00151775|4251106|P4|Period 3: Double-blind, Withdrawal|Adverse Event|0
1306766|NCT00151775|4251107|P3|Period 3: Double-blind, Withdrawal|Adverse Event|1
1306767|NCT00151775|4251108|P2|Period 3: Double-blind, Withdrawal|Adverse Event|0
1306768|NCT00151775|4251109|P1|Period 3: Double-blind, Withdrawal|Adverse Event|0
1306769|NCT00151775|4251098|P12|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1306770|NCT00151775|4251099|P11|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1306771|NCT00151775|4251100|P10|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1306772|NCT00151775|4251101|P9|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1306773|NCT00151775|4251102|P8|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1306774|NCT00151775|4251103|P7|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1
1306775|NCT00151775|4251104|P6|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1306776|NCT00151775|4251105|P5|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1306777|NCT00151775|4251106|P4|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1306778|NCT00151775|4251107|P3|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1306779|NCT00151775|4251108|P2|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1306780|NCT00151775|4251109|P1|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1306781|NCT00151775|4251098|P12|Period 3: Double-blind, Withdrawal|Other|0
1306782|NCT00151775|4251099|P11|Period 3: Double-blind, Withdrawal|Other|0
1306783|NCT00151775|4251100|P10|Period 3: Double-blind, Withdrawal|Other|0
1306784|NCT00151775|4251101|P9|Period 3: Double-blind, Withdrawal|Other|0
1306785|NCT00151775|4251102|P8|Period 3: Double-blind, Withdrawal|Other|1
1306786|NCT00151775|4251103|P7|Period 3: Double-blind, Withdrawal|Other|0
1306787|NCT00151775|4251104|P6|Period 3: Double-blind, Withdrawal|Other|0
1306788|NCT00151775|4251105|P5|Period 3: Double-blind, Withdrawal|Other|0
1306789|NCT00151775|4251106|P4|Period 3: Double-blind, Withdrawal|Other|0
1306790|NCT00151775|4251107|P3|Period 3: Double-blind, Withdrawal|Other|1
1306791|NCT00151775|4251108|P2|Period 3: Double-blind, Withdrawal|Other|0
1306792|NCT00151775|4251109|P1|Period 3: Double-blind, Withdrawal|Other|0
1306793|NCT00151775|4251098|P12|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1306794|NCT00151775|4251099|P11|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1306795|NCT00151775|4251100|P10|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1306796|NCT00151775|4251101|P9|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1306797|NCT00151775|4251102|P8|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1306798|NCT00151775|4251103|P7|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1306799|NCT00151775|4251104|P6|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1
1306800|NCT00151775|4251105|P5|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1306801|NCT00151775|4251106|P4|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1306802|NCT00151775|4251107|P3|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1306803|NCT00151775|4251108|P2|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1306804|NCT00151775|4251109|P1|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1306805|NCT00151775|4251098|P12|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1306806|NCT00151775|4251099|P11|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1306807|NCT00151775|4251100|P10|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1306808|NCT00151775|4251101|P9|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1306809|NCT00151775|4251102|P8|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1306810|NCT00151775|4251103|P7|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1
1306811|NCT00151775|4251104|P6|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1306812|NCT00151775|4251105|P5|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1306813|NCT00151775|4251106|P4|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1306814|NCT00151775|4251107|P3|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1306815|NCT00151775|4251108|P2|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1306816|NCT00151775|4251109|P1|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1306817|NCT00151775|4251098|P12|Period 2 - Double-Blind Dose Response|Physician Decision|0
1306818|NCT00151775|4251099|P11|Period 2 - Double-Blind Dose Response|Physician Decision|0
1306819|NCT00151775|4251100|P10|Period 2 - Double-Blind Dose Response|Physician Decision|0
1306820|NCT00151775|4251101|P9|Period 2 - Double-Blind Dose Response|Physician Decision|0
1306821|NCT00151775|4251102|P8|Period 2 - Double-Blind Dose Response|Physician Decision|0
1306822|NCT00151775|4251103|P7|Period 2 - Double-Blind Dose Response|Physician Decision|0
1306823|NCT00151775|4251104|P6|Period 2 - Double-Blind Dose Response|Physician Decision|1
1306824|NCT00151775|4251105|P5|Period 2 - Double-Blind Dose Response|Physician Decision|0
1306825|NCT00151775|4251106|P4|Period 2 - Double-Blind Dose Response|Physician Decision|0
1306826|NCT00151775|4251107|P3|Period 2 - Double-Blind Dose Response|Physician Decision|0
1306827|NCT00151775|4251108|P2|Period 2 - Double-Blind Dose Response|Physician Decision|0
1306828|NCT00151775|4251109|P1|Period 2 - Double-Blind Dose Response|Physician Decision|0
1306829|NCT00151775|4251098|P12|Period 2 - Double-Blind Dose Response|non-compliance|0
1306830|NCT00151775|4251099|P11|Period 2 - Double-Blind Dose Response|non-compliance|0
1306831|NCT00151775|4251100|P10|Period 2 - Double-Blind Dose Response|non-compliance|0
1306832|NCT00151775|4251101|P9|Period 2 - Double-Blind Dose Response|non-compliance|0
1306833|NCT00151775|4251102|P8|Period 2 - Double-Blind Dose Response|non-compliance|0
1306834|NCT00151775|4251103|P7|Period 2 - Double-Blind Dose Response|non-compliance|0
1306835|NCT00151775|4251104|P6|Period 2 - Double-Blind Dose Response|non-compliance|1
1306836|NCT00151775|4251105|P5|Period 2 - Double-Blind Dose Response|non-compliance|0
1306837|NCT00151775|4251106|P4|Period 2 - Double-Blind Dose Response|non-compliance|0
1306838|NCT00151775|4251107|P3|Period 2 - Double-Blind Dose Response|non-compliance|0
1306839|NCT00151775|4251108|P2|Period 2 - Double-Blind Dose Response|non-compliance|0
1306840|NCT00151775|4251109|P1|Period 2 - Double-Blind Dose Response|non-compliance|0
1306841|NCT00151775|4251098|P12|Period 2 - Double-Blind Dose Response|Other|0
1306842|NCT00151775|4251099|P11|Period 2 - Double-Blind Dose Response|Other|0
1306843|NCT00151775|4251100|P10|Period 2 - Double-Blind Dose Response|Other|0
1306844|NCT00151775|4251101|P9|Period 2 - Double-Blind Dose Response|Other|0
1306845|NCT00151775|4251102|P8|Period 2 - Double-Blind Dose Response|Other|0
1306846|NCT00151775|4251103|P7|Period 2 - Double-Blind Dose Response|Other|1
1306847|NCT00151775|4251104|P6|Period 2 - Double-Blind Dose Response|Other|0
1306848|NCT00151775|4251105|P5|Period 2 - Double-Blind Dose Response|Other|0
1306849|NCT00151775|4251106|P4|Period 2 - Double-Blind Dose Response|Other|0
1306850|NCT00151775|4251107|P3|Period 2 - Double-Blind Dose Response|Other|0
1306851|NCT00151775|4251108|P2|Period 2 - Double-Blind Dose Response|Other|0
1306852|NCT00151775|4251109|P1|Period 2 - Double-Blind Dose Response|Other|0
1306853|NCT00151775|4251098|P12|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1306854|NCT00151775|4251099|P11|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1306855|NCT00151775|4251100|P10|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1306856|NCT00151775|4251101|P9|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1306857|NCT00151775|4251102|P8|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1306858|NCT00151775|4251103|P7|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1306859|NCT00151775|4251104|P6|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1306860|NCT00151775|4251105|P5|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1306861|NCT00151775|4251106|P4|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1306862|NCT00151775|4251107|P3|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1306863|NCT00151775|4251108|P2|Period 2 - Double-Blind Dose Response|Protocol Violation|4
1306864|NCT00151775|4251109|P1|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1306865|NCT00151775|4251098|P12|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
1306866|NCT00151775|4251099|P11|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
1306867|NCT00151775|4251100|P10|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
1306868|NCT00151775|4251101|P9|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
1306869|NCT00151775|4251102|P8|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
1306870|NCT00151775|4251103|P7|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
1306871|NCT00151775|4251104|P6|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
1306872|NCT00151775|4251105|P5|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
1306873|NCT00151775|4251106|P4|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
1306874|NCT00151775|4251107|P3|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
1306875|NCT00151775|4251108|P2|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
1306876|NCT00151775|4251109|P1|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
1306877|NCT00151775|4251098|P12|Period 2 - Double-Blind Dose Response|Adverse Event|0
1306878|NCT00151775|4251099|P11|Period 2 - Double-Blind Dose Response|Adverse Event|0
1306879|NCT00151775|4251100|P10|Period 2 - Double-Blind Dose Response|Adverse Event|0
1306880|NCT00151775|4251101|P9|Period 2 - Double-Blind Dose Response|Adverse Event|0
1306881|NCT00151775|4251102|P8|Period 2 - Double-Blind Dose Response|Adverse Event|0
1306882|NCT00151775|4251103|P7|Period 2 - Double-Blind Dose Response|Adverse Event|0
1306883|NCT00151775|4251104|P6|Period 2 - Double-Blind Dose Response|Adverse Event|0
1306884|NCT00151775|4251105|P5|Period 2 - Double-Blind Dose Response|Adverse Event|0
1306885|NCT00151775|4251106|P4|Period 2 - Double-Blind Dose Response|Adverse Event|0
1306886|NCT00151775|4251107|P3|Period 2 - Double-Blind Dose Response|Adverse Event|0
1306887|NCT00151775|4251108|P2|Period 2 - Double-Blind Dose Response|Adverse Event|2
1306888|NCT00151775|4251109|P1|Period 2 - Double-Blind Dose Response|Adverse Event|1
1306889|NCT00151476|4251153|P2|FAP Analyzed Subjects|Other study participation|1
1306890|NCT00151476|4251154|P1|FAP Analyzed Subjects|Other study participation|0
1306891|NCT00151476|4251153|P2|FAP Analyzed Subjects|Lost to Follow-up|2
1306892|NCT00151476|4251154|P1|FAP Analyzed Subjects|Lost to Follow-up|0
1306893|NCT00151476|4251153|P2|FAP Identified Subjects|Protocol Violation|1
1306894|NCT00151476|4251154|P1|FAP Identified Subjects|Protocol Violation|0
1306895|NCT00151411|4251211|P2|Overall Study|Pregnancy|4
1306896|NCT00151411|4251212|P1|Overall Study|Pregnancy|0
1306897|NCT00151411|4251211|P2|Overall Study|Adverse Event|0
1306898|NCT00151411|4251212|P1|Overall Study|Adverse Event|6
1306899|NCT00151411|4251211|P2|Overall Study|Withdrawal by Subject|20
1306900|NCT00151411|4251212|P1|Overall Study|Withdrawal by Subject|12
1306901|NCT00151411|4251211|P2|Overall Study|Lost to Follow-up|19
1306902|NCT00151411|4251212|P1|Overall Study|Lost to Follow-up|15
1306903|NCT00151372|4251224|P2|Overall Study|Withdrawal by Subject|7
1306904|NCT00151372|4251225|P1|Overall Study|Withdrawal by Subject|7
1306905|NCT00151372|4251224|P2|Overall Study|Too sick medically to continue|6
1306906|NCT00151372|4251225|P1|Overall Study|Too sick medically to continue|5
1306907|NCT00151372|4251224|P2|Overall Study|Lost to Follow-up|5
1306908|NCT00151372|4251225|P1|Overall Study|Lost to Follow-up|5
1306909|NCT00151372|4251224|P2|Overall Study|Death|11
1306910|NCT00151372|4251225|P1|Overall Study|Death|12
1306911|NCT00151281|4251240|P1|Overall Study|Not evaluable|3
1306912|NCT00150969|4251249|P2|24-48 Month Extension|Other Reason|91
1306913|NCT00150969|4251250|P1|24-48 Month Extension|Other Reason|81
1306914|NCT00150969|4251249|P2|24-48 Month Extension|Adverse Event|3
1306915|NCT00150969|4251250|P1|24-48 Month Extension|Adverse Event|1
1306916|NCT00150969|4251249|P2|24-48 Month Extension|Lack of Efficacy|1
1306917|NCT00150969|4251250|P1|24-48 Month Extension|Lack of Efficacy|0
1306918|NCT00150969|4251249|P2|24-48 Month Extension|Withdrawal by Subject|5
1306919|NCT00150969|4251250|P1|24-48 Month Extension|Withdrawal by Subject|6
1306920|NCT00150969|4251249|P2|24 Month Main Study|Withdrawal by Subject|4
1306921|NCT00150969|4251250|P1|24 Month Main Study|Withdrawal by Subject|7
1306922|NCT00150969|4251249|P2|24 Month Main Study|Protocol Violation|2
1306923|NCT00150969|4251250|P1|24 Month Main Study|Protocol Violation|4
1306924|NCT00150969|4251249|P2|24 Month Main Study|Lost to Follow-up|2
1306925|NCT00150969|4251250|P1|24 Month Main Study|Lost to Follow-up|3
1306926|NCT00150969|4251249|P2|24 Month Main Study|Lack of Efficacy|8
1306927|NCT00150969|4251250|P1|24 Month Main Study|Lack of Efficacy|1
1306928|NCT00150969|4251249|P2|24 Month Main Study|Death|1
1306929|NCT00150969|4251250|P1|24 Month Main Study|Death|1
1306930|NCT00150969|4251249|P2|24 Month Main Study|Adverse Event|4
1306931|NCT00150969|4251250|P1|24 Month Main Study|Adverse Event|3
1306932|NCT00150813|4251282|P1|Overall Study|Switch to commercially available LEV|2
1306933|NCT00150813|4251282|P1|Overall Study|Planned pregancy|1
1306934|NCT00150813|4251282|P1|Overall Study|Remission|3
1306935|NCT00150813|4251282|P1|Overall Study|Withdrawal by Subject|5
1306936|NCT00150813|4251282|P1|Overall Study|Lost to Follow-up|5
1306937|NCT00150813|4251282|P1|Overall Study|Lack of Efficacy|1
1306938|NCT00150813|4251282|P1|Overall Study|Adverse Event|1
1306939|NCT00150800|4251286|P1|Overall Study|PI discontinuation request|1
1306940|NCT00150800|4251286|P1|Overall Study|Pregnancy planned|1
1306941|NCT00150800|4251286|P1|Overall Study|Surgical intervention|4
1306942|NCT00150800|4251286|P1|Overall Study|Patient insurance|1
1306943|NCT00150800|4251286|P1|Overall Study|PI leaving site|2
1306944|NCT00150800|4251286|P1|Overall Study|PI retiring|2
1306945|NCT00150800|4251286|P1|Overall Study|Moved from area/country|8
1306946|NCT00150800|4251286|P1|Overall Study|Generalized Epilepsy|1
1306947|NCT00150800|4251286|P1|Overall Study|Sponsor's request|2
1306948|NCT00150800|4251286|P1|Overall Study|Visit refusal|3
1306949|NCT00150800|4251286|P1|Overall Study|BRV monotherapy|1
1306950|NCT00150800|4251286|P1|Overall Study|Neurosurgery|2
1306951|NCT00150800|4251286|P1|Overall Study|Distance too long for patient|1
1306952|NCT00150800|4251286|P1|Overall Study|Nobody to accompany patient|1
1306953|NCT00150800|4251286|P1|Overall Study|Protocol non-adherence|2
1306954|NCT00150800|4251286|P1|Overall Study|Site closure|24
1306955|NCT00150800|4251286|P1|Overall Study|IP misshandling|1
1306956|NCT00150800|4251286|P1|Overall Study|No compliance|18
1306957|NCT00150800|4251286|P1|Overall Study|Subject's choice|90
1306958|NCT00150800|4251286|P1|Overall Study|Lost to Follow-up|58
1306959|NCT00150800|4251286|P1|Overall Study|Lack of Efficacy|166
1306960|NCT00150800|4251286|P1|Overall Study|Death|18
1306961|NCT00150800|4251286|P1|Overall Study|Adverse Event|89
1306962|NCT00150618|4251300|P5|Overall Study|Sponsor's decision|0
1306963|NCT00150618|4251301|P4|Overall Study|Sponsor's decision|1
1306964|NCT00150618|4251302|P3|Overall Study|Sponsor's decision|0
1306965|NCT00150618|4251303|P2|Overall Study|Sponsor's decision|0
1306966|NCT00150618|4251304|P1|Overall Study|Sponsor's decision|0
1306967|NCT00150618|4251300|P5|Overall Study|Abnormal ECG|0
1306968|NCT00150618|4251301|P4|Overall Study|Abnormal ECG|0
1306969|NCT00150618|4251302|P3|Overall Study|Abnormal ECG|0
1306970|NCT00150618|4251303|P2|Overall Study|Abnormal ECG|0
1306971|NCT00150618|4251304|P1|Overall Study|Abnormal ECG|1
1306972|NCT00150618|4251300|P5|Overall Study|Lack of compliance|1
1306973|NCT00150618|4251301|P4|Overall Study|Lack of compliance|0
1306974|NCT00150618|4251302|P3|Overall Study|Lack of compliance|1
1306975|NCT00150618|4251303|P2|Overall Study|Lack of compliance|1
1306976|NCT00150618|4251304|P1|Overall Study|Lack of compliance|2
1306977|NCT00150618|4251300|P5|Overall Study|Physician Decision|1
1306978|NCT00150618|4251301|P4|Overall Study|Physician Decision|0
1306979|NCT00150618|4251302|P3|Overall Study|Physician Decision|0
1306980|NCT00150618|4251303|P2|Overall Study|Physician Decision|2
1306981|NCT00150618|4251304|P1|Overall Study|Physician Decision|0
1306982|NCT00150618|4251300|P5|Overall Study|No study meds|2
1306983|NCT00150618|4251301|P4|Overall Study|No study meds|0
1306984|NCT00150618|4251302|P3|Overall Study|No study meds|0
1306985|NCT00150618|4251303|P2|Overall Study|No study meds|0
1306986|NCT00150618|4251304|P1|Overall Study|No study meds|0
1306987|NCT00150618|4251300|P5|Overall Study|Lack of Efficacy|6
1306988|NCT00150618|4251301|P4|Overall Study|Lack of Efficacy|4
1306989|NCT00150618|4251302|P3|Overall Study|Lack of Efficacy|7
1306990|NCT00150618|4251303|P2|Overall Study|Lack of Efficacy|4
1306991|NCT00150618|4251304|P1|Overall Study|Lack of Efficacy|1
1306992|NCT00150618|4251300|P5|Overall Study|Protocol Violation|1
1306993|NCT00150618|4251301|P4|Overall Study|Protocol Violation|0
1306994|NCT00150618|4251302|P3|Overall Study|Protocol Violation|0
1306995|NCT00150618|4251303|P2|Overall Study|Protocol Violation|0
1306996|NCT00150618|4251304|P1|Overall Study|Protocol Violation|1
1306997|NCT00150618|4251300|P5|Overall Study|Lost to Follow-up|4
1306998|NCT00150618|4251301|P4|Overall Study|Lost to Follow-up|8
1306999|NCT00150618|4251302|P3|Overall Study|Lost to Follow-up|5
1307000|NCT00150618|4251303|P2|Overall Study|Lost to Follow-up|1
1307001|NCT00150618|4251304|P1|Overall Study|Lost to Follow-up|4
1307002|NCT00150618|4251300|P5|Overall Study|Withdrawal by Subject|5
1307003|NCT00150618|4251301|P4|Overall Study|Withdrawal by Subject|4
1307004|NCT00150618|4251302|P3|Overall Study|Withdrawal by Subject|8
1307005|NCT00150618|4251303|P2|Overall Study|Withdrawal by Subject|8
1307006|NCT00150618|4251304|P1|Overall Study|Withdrawal by Subject|6
1307007|NCT00150618|4251300|P5|Overall Study|Adverse Event|5
1307008|NCT00150618|4251301|P4|Overall Study|Adverse Event|9
1307009|NCT00150618|4251302|P3|Overall Study|Adverse Event|6
1307010|NCT00150618|4251303|P2|Overall Study|Adverse Event|2
1307011|NCT00150618|4251304|P1|Overall Study|Adverse Event|2
1307012|NCT00150592|4251338|P2|Overall Study|Non-compliance|0
1307013|NCT00150592|4251339|P1|Overall Study|Non-compliance|1
1307014|NCT00150592|4251338|P2|Overall Study|Withdrawal by Subject|2
1307015|NCT00150592|4251339|P1|Overall Study|Withdrawal by Subject|1
1307016|NCT00150592|4251338|P2|Overall Study|Protocol Violation|0
1307017|NCT00150592|4251339|P1|Overall Study|Protocol Violation|1
1307018|NCT00150592|4251338|P2|Overall Study|Adverse Event|1
1307019|NCT00150592|4251339|P1|Overall Study|Adverse Event|4
1307020|NCT00150462|4251370|P11|Overall Study|Other|1
1307021|NCT00150462|4251371|P10|Overall Study|Other|1
1307022|NCT00150462|4251372|P9|Overall Study|Other|0
1307023|NCT00150462|4251373|P8|Overall Study|Other|0
1307024|NCT00150462|4251374|P7|Overall Study|Other|0
1307025|NCT00150462|4251375|P6|Overall Study|Other|0
1307026|NCT00150462|4251376|P5|Overall Study|Other|0
1307027|NCT00150462|4251377|P4|Overall Study|Other|0
1307028|NCT00150462|4251378|P3|Overall Study|Other|0
1307029|NCT00150462|4251379|P2|Overall Study|Other|0
1307030|NCT00150462|4251380|P1|Overall Study|Other|0
1307031|NCT00150462|4251370|P11|Overall Study|Physician Decision|0
1307032|NCT00150462|4251371|P10|Overall Study|Physician Decision|0
1307033|NCT00150462|4251372|P9|Overall Study|Physician Decision|0
1307034|NCT00150462|4251373|P8|Overall Study|Physician Decision|0
1307035|NCT00150462|4251374|P7|Overall Study|Physician Decision|0
1307036|NCT00150462|4251375|P6|Overall Study|Physician Decision|0
1307037|NCT00150462|4251376|P5|Overall Study|Physician Decision|0
1307038|NCT00150462|4251377|P4|Overall Study|Physician Decision|1
1307039|NCT00150462|4251378|P3|Overall Study|Physician Decision|1
1307040|NCT00150462|4251379|P2|Overall Study|Physician Decision|0
1307041|NCT00150462|4251380|P1|Overall Study|Physician Decision|0
1307042|NCT00150462|4251370|P11|Overall Study|Adverse Event|0
1307043|NCT00150462|4251371|P10|Overall Study|Adverse Event|1
1307044|NCT00150462|4251372|P9|Overall Study|Adverse Event|0
1307045|NCT00150462|4251373|P8|Overall Study|Adverse Event|2
1307046|NCT00150462|4251374|P7|Overall Study|Adverse Event|0
1307047|NCT00150462|4251375|P6|Overall Study|Adverse Event|0
1307048|NCT00150462|4251376|P5|Overall Study|Adverse Event|0
1307049|NCT00150462|4251377|P4|Overall Study|Adverse Event|1
1307050|NCT00150462|4251378|P3|Overall Study|Adverse Event|0
1307051|NCT00150462|4251379|P2|Overall Study|Adverse Event|0
1307052|NCT00150462|4251380|P1|Overall Study|Adverse Event|0
1307053|NCT00150462|4251370|P11|Overall Study|Death|0
1307054|NCT00150462|4251371|P10|Overall Study|Death|0
1307055|NCT00150462|4251372|P9|Overall Study|Death|1
1307056|NCT00150462|4251373|P8|Overall Study|Death|0
1307057|NCT00150462|4251374|P7|Overall Study|Death|0
1307058|NCT00150462|4251375|P6|Overall Study|Death|0
1307059|NCT00150462|4251376|P5|Overall Study|Death|0
1307060|NCT00150462|4251377|P4|Overall Study|Death|0
1307061|NCT00150462|4251378|P3|Overall Study|Death|0
1307062|NCT00150462|4251379|P2|Overall Study|Death|1
1307063|NCT00150462|4251380|P1|Overall Study|Death|0
1307064|NCT00150462|4251370|P11|Overall Study|Withdrawal by Subject|0
1307065|NCT00150462|4251371|P10|Overall Study|Withdrawal by Subject|1
1307066|NCT00150462|4251372|P9|Overall Study|Withdrawal by Subject|0
1307067|NCT00150462|4251373|P8|Overall Study|Withdrawal by Subject|1
1307068|NCT00150462|4251374|P7|Overall Study|Withdrawal by Subject|0
1307069|NCT00150462|4251375|P6|Overall Study|Withdrawal by Subject|2
1307070|NCT00150462|4251376|P5|Overall Study|Withdrawal by Subject|1
1307071|NCT00150462|4251377|P4|Overall Study|Withdrawal by Subject|0
1307072|NCT00150462|4251378|P3|Overall Study|Withdrawal by Subject|1
1307073|NCT00150462|4251379|P2|Overall Study|Withdrawal by Subject|1
1307074|NCT00150462|4251380|P1|Overall Study|Withdrawal by Subject|0
1307075|NCT00150462|4251370|P11|Overall Study|Disease Progression or Relapse|2
1307076|NCT00150462|4251371|P10|Overall Study|Disease Progression or Relapse|3
1307077|NCT00150462|4251372|P9|Overall Study|Disease Progression or Relapse|5
1307078|NCT00150462|4251373|P8|Overall Study|Disease Progression or Relapse|5
1307079|NCT00150462|4251374|P7|Overall Study|Disease Progression or Relapse|3
1307080|NCT00150462|4251375|P6|Overall Study|Disease Progression or Relapse|2
1307081|NCT00150462|4251376|P5|Overall Study|Disease Progression or Relapse|2
1307082|NCT00150462|4251377|P4|Overall Study|Disease Progression or Relapse|1
1307083|NCT00150462|4251378|P3|Overall Study|Disease Progression or Relapse|2
1307084|NCT00150462|4251379|P2|Overall Study|Disease Progression or Relapse|1
1307085|NCT00150462|4251380|P1|Overall Study|Disease Progression or Relapse|3
1307086|NCT00150345|4251490|P2|Overall Study|Other|14
1307087|NCT00150345|4251491|P1|Overall Study|Other|12
1307088|NCT00150345|4251490|P2|Overall Study|Laboratory abnormality|2
1307089|NCT00150345|4251491|P1|Overall Study|Laboratory abnormality|1
1307090|NCT00150345|4251490|P2|Overall Study|Withdrawal by Subject|4
1307091|NCT00150345|4251491|P1|Overall Study|Withdrawal by Subject|3
1307092|NCT00150345|4251490|P2|Overall Study|Lack of Efficacy|4
1307093|NCT00150345|4251491|P1|Overall Study|Lack of Efficacy|5
1307094|NCT00150345|4251490|P2|Overall Study|Adverse Event|6
1307095|NCT00150345|4251491|P1|Overall Study|Adverse Event|8
1307096|NCT00150345|4251490|P2|Overall Study|Death|2
1307097|NCT00150345|4251491|P1|Overall Study|Death|5
1307098|NCT00150176|4251555|P2|Overall Study|OTHER|13
1307099|NCT00150176|4251556|P1|Overall Study|OTHER|11
1307100|NCT00150176|4251555|P2|Overall Study|Lost to Follow-up|3
1307101|NCT00150176|4251556|P1|Overall Study|Lost to Follow-up|3
1307102|NCT00150176|4251555|P2|Overall Study|Withdrawal by Subject|12
1307103|NCT00150176|4251556|P1|Overall Study|Withdrawal by Subject|19
1307104|NCT00150176|4251555|P2|Overall Study|Relapse/Impending relapse, non-AE|39
1307105|NCT00150176|4251556|P1|Overall Study|Relapse/Impending relapse, non-AE|10
1307106|NCT00150176|4251555|P2|Overall Study|Adverse Event|53
1307107|NCT00150176|4251556|P1|Overall Study|Adverse Event|16
1307108|NCT00149994|4251567|P2|Overall Study|Protocol Violation|1
1307109|NCT00149994|4251568|P1|Overall Study|Protocol Violation|0
1307110|NCT00149994|4251567|P2|Overall Study|Administrative problems:|0
1307111|NCT00149994|4251568|P1|Overall Study|Administrative problems:|1
1307112|NCT00149890|4251576|P2|Overall Study|Graft Loss|1
1307113|NCT00149890|4251577|P1|Overall Study|Graft Loss|2
1307114|NCT00149890|4251576|P2|Overall Study|Lost to Follow-up|0
1307115|NCT00149890|4251577|P1|Overall Study|Lost to Follow-up|1
1307116|NCT00149890|4251576|P2|Overall Study|Protocol Violation|0
1307117|NCT00149890|4251577|P1|Overall Study|Protocol Violation|1
1307118|NCT00149890|4251576|P2|Overall Study|Lack of Efficacy|9
1307119|NCT00149890|4251577|P1|Overall Study|Lack of Efficacy|8
1307120|NCT00149890|4251576|P2|Overall Study|Adverse Event|8
1307121|NCT00149890|4251577|P1|Overall Study|Adverse Event|1
1307122|NCT00149825|4251612|P2|Overall Study|Other|0
1307123|NCT00149825|4251613|P1|Overall Study|Other|1
1307124|NCT00149825|4251612|P2|Overall Study|Not liking insomnia therapy|0
1307125|NCT00149825|4251613|P1|Overall Study|Not liking insomnia therapy|1
1307126|NCT00149825|4251612|P2|Overall Study|Time commitments|1
1307127|NCT00149825|4251613|P1|Overall Study|Time commitments|2
1307128|NCT00149825|4251612|P2|Overall Study|Intolerance to medication side effects|2
1307129|NCT00149825|4251613|P1|Overall Study|Intolerance to medication side effects|1
1307130|NCT00149747|4251641|P2|Overall Study|Withdrawal by Subject|3
1307131|NCT00149747|4251642|P1|Overall Study|Withdrawal by Subject|3
1307132|NCT00149747|4251641|P2|Overall Study|Death|0
1307133|NCT00149747|4251642|P1|Overall Study|Death|1
1307134|NCT00149630|4251688|P2|Overall Study|Adverse Event|0
1307135|NCT00149630|4251689|P1|Overall Study|Adverse Event|2
1307136|NCT00149630|4251688|P2|Overall Study|Treatment Programs|5
1307137|NCT00149630|4251689|P1|Overall Study|Treatment Programs|4
1307138|NCT00149630|4251688|P2|Overall Study|Incarceration|0
1307139|NCT00149630|4251689|P1|Overall Study|Incarceration|2
1307140|NCT00149396|4251699|P1|Overall Study|other treatment|5
1307141|NCT00149396|4251699|P1|Overall Study|Subject noncompliance|2
1307142|NCT00149396|4251699|P1|Overall Study|Withdrawal by Subject|1
1307143|NCT00149396|4251699|P1|Overall Study|Death|15
1307144|NCT00149214|4251769|P2|Overall Study|Progressive Disease|3
1307145|NCT00149214|4251770|P1|Overall Study|Progressive Disease|7
1307146|NCT00149214|4251769|P2|Overall Study|Sponsor Decision|1
1307147|NCT00149214|4251770|P1|Overall Study|Sponsor Decision|0
1307148|NCT00149214|4251769|P2|Overall Study|Physician Decision|3
1307149|NCT00149214|4251770|P1|Overall Study|Physician Decision|3
1307150|NCT00149214|4251769|P2|Overall Study|Withdrawal by Subject|1
1307151|NCT00149214|4251770|P1|Overall Study|Withdrawal by Subject|4
1307152|NCT00149214|4251769|P2|Overall Study|Adverse Event|9
1307153|NCT00149214|4251770|P1|Overall Study|Adverse Event|12
1307154|NCT00148759|4251818|P2|Overall Study|Lost to Follow-up|0
1307155|NCT00148759|4251819|P1|Overall Study|Lost to Follow-up|1
1307156|NCT00148759|4251818|P2|Overall Study|Withdrawal by Subject|1
1307157|NCT00148759|4251819|P1|Overall Study|Withdrawal by Subject|1
1307158|NCT00148343|4251847|P2|Overall Study|Physician Decision|4
1307159|NCT00148343|4251848|P1|Overall Study|Physician Decision|3
1307160|NCT00148343|4251847|P2|Overall Study|Withdrawal by Subject|7
1307161|NCT00148343|4251848|P1|Overall Study|Withdrawal by Subject|12
1307162|NCT00148317|4251862|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1
1307163|NCT00148317|4251862|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2
1307164|NCT00148317|4251862|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8
1307165|NCT00148122|4251869|P1|Overall Study|Withdrawal by Subject|2
1307166|NCT00148109|4251877|P2|Overall Study|Withdrawal by Subject|0
1307167|NCT00148109|4251878|P1|Overall Study|Withdrawal by Subject|2
1307168|NCT00148109|4251877|P2|Overall Study|Adverse Event|2
1307169|NCT00148109|4251878|P1|Overall Study|Adverse Event|0
1307170|NCT00148109|4251877|P2|Overall Study|Lack of Efficacy|18
1307171|NCT00148109|4251878|P1|Overall Study|Lack of Efficacy|10
1307172|NCT00147823|4251894|P2|Overall Study|Did not receive vitoss due to infection|2
1307173|NCT00147823|4251895|P1|Overall Study|Did not receive vitoss due to infection|6
1307174|NCT00147823|4251894|P2|Overall Study|Withdrawal by Subject|1
1307175|NCT00147823|4251895|P1|Overall Study|Withdrawal by Subject|0
1307176|NCT00147823|4251894|P2|Overall Study|Physician Decision|0
1307177|NCT00147823|4251895|P1|Overall Study|Physician Decision|1
1307178|NCT00147823|4251894|P2|Overall Study|Lost to Follow-up|12
1307179|NCT00147823|4251895|P1|Overall Study|Lost to Follow-up|6
1307180|NCT00147745|4251926|P3|Overall Study|Withdrawal by Subject|0
1307181|NCT00147745|4251927|P2|Overall Study|Withdrawal by Subject|0
1307182|NCT00147745|4251928|P1|Overall Study|Withdrawal by Subject|1
1307183|NCT00147537|4251950|P11|Phase 2|Randomized but not treated|1
1307184|NCT00147537|4251951|P10|Phase 2|Randomized but not treated|1
1307185|NCT00147537|4251952|P9|Phase 2|Randomized but not treated|0
1307186|NCT00147537|4251953|P8|Phase 2|Randomized but not treated|0
1307187|NCT00147537|4251954|P7|Phase 2|Randomized but not treated|0
1307188|NCT00147537|4251955|P6|Phase 2|Randomized but not treated|0
1307189|NCT00147537|4251956|P5|Phase 2|Randomized but not treated|0
1307190|NCT00147537|4251957|P4|Phase 2|Randomized but not treated|0
1307191|NCT00147537|4251958|P3|Phase 2|Randomized but not treated|0
1307192|NCT00147537|4251959|P2|Phase 2|Randomized but not treated|0
1307193|NCT00147537|4251960|P1|Phase 2|Randomized but not treated|0
1307194|NCT00147537|4251950|P11|Phase 2|Withdrawal by Subject|4
1307195|NCT00147537|4251951|P10|Phase 2|Withdrawal by Subject|16
1307196|NCT00147537|4251952|P9|Phase 2|Withdrawal by Subject|0
1307197|NCT00147537|4251953|P8|Phase 2|Withdrawal by Subject|0
1307198|NCT00147537|4251954|P7|Phase 2|Withdrawal by Subject|0
1307199|NCT00147537|4251955|P6|Phase 2|Withdrawal by Subject|0
1307200|NCT00147537|4251956|P5|Phase 2|Withdrawal by Subject|0
1307201|NCT00147537|4251957|P4|Phase 2|Withdrawal by Subject|0
1307202|NCT00147537|4251958|P3|Phase 2|Withdrawal by Subject|0
1307203|NCT00147537|4251959|P2|Phase 2|Withdrawal by Subject|0
1307204|NCT00147537|4251960|P1|Phase 2|Withdrawal by Subject|0
1307205|NCT00147537|4251950|P11|Phase 2|Other|12
1307206|NCT00147537|4251951|P10|Phase 2|Other|47
1307207|NCT00147537|4251952|P9|Phase 2|Other|0
1307208|NCT00147537|4251953|P8|Phase 2|Other|0
1307209|NCT00147537|4251954|P7|Phase 2|Other|0
1307210|NCT00147537|4251955|P6|Phase 2|Other|0
1307211|NCT00147537|4251956|P5|Phase 2|Other|0
1307212|NCT00147537|4251957|P4|Phase 2|Other|0
1307213|NCT00147537|4251958|P3|Phase 2|Other|0
1307214|NCT00147537|4251959|P2|Phase 2|Other|0
1307215|NCT00147537|4251960|P1|Phase 2|Other|0
1307216|NCT00147537|4251950|P11|Phase 2|Lost to Follow-up|4
1307217|NCT00147537|4251951|P10|Phase 2|Lost to Follow-up|12
1307218|NCT00147537|4251952|P9|Phase 2|Lost to Follow-up|0
1307219|NCT00147537|4251953|P8|Phase 2|Lost to Follow-up|0
1307220|NCT00147537|4251954|P7|Phase 2|Lost to Follow-up|0
1307221|NCT00147537|4251955|P6|Phase 2|Lost to Follow-up|0
1307222|NCT00147537|4251956|P5|Phase 2|Lost to Follow-up|0
1307223|NCT00147537|4251957|P4|Phase 2|Lost to Follow-up|0
1307224|NCT00147537|4251958|P3|Phase 2|Lost to Follow-up|0
1307225|NCT00147537|4251959|P2|Phase 2|Lost to Follow-up|0
1307226|NCT00147537|4251960|P1|Phase 2|Lost to Follow-up|0
1307227|NCT00147537|4251950|P11|Phase 2|Death|31
1307228|NCT00147537|4251951|P10|Phase 2|Death|85
1307229|NCT00147537|4251952|P9|Phase 2|Death|0
1307230|NCT00147537|4251953|P8|Phase 2|Death|0
1307231|NCT00147537|4251954|P7|Phase 2|Death|0
1307232|NCT00147537|4251955|P6|Phase 2|Death|0
1307233|NCT00147537|4251956|P5|Phase 2|Death|0
1307234|NCT00147537|4251957|P4|Phase 2|Death|0
1307235|NCT00147537|4251958|P3|Phase 2|Death|0
1307236|NCT00147537|4251959|P2|Phase 2|Death|0
1307237|NCT00147537|4251960|P1|Phase 2|Death|0
1307238|NCT00147537|4251950|P11|Phase 1b|Randomized but not treated|0
1307239|NCT00147537|4251951|P10|Phase 1b|Randomized but not treated|0
1307240|NCT00147537|4251952|P9|Phase 1b|Randomized but not treated|1
1307241|NCT00147537|4251953|P8|Phase 1b|Randomized but not treated|0
1307242|NCT00147537|4251954|P7|Phase 1b|Randomized but not treated|1
1307243|NCT00147537|4251955|P6|Phase 1b|Randomized but not treated|0
1307244|NCT00147537|4251956|P5|Phase 1b|Randomized but not treated|0
1307245|NCT00147537|4251957|P4|Phase 1b|Randomized but not treated|0
1307246|NCT00147537|4251958|P3|Phase 1b|Randomized but not treated|0
1307247|NCT00147537|4251959|P2|Phase 1b|Randomized but not treated|0
1307248|NCT00147537|4251960|P1|Phase 1b|Randomized but not treated|0
1307249|NCT00147537|4251950|P11|Phase 1b|Withdrawal by Subject|0
1307250|NCT00147537|4251951|P10|Phase 1b|Withdrawal by Subject|0
1307251|NCT00147537|4251952|P9|Phase 1b|Withdrawal by Subject|2
1307252|NCT00147537|4251953|P8|Phase 1b|Withdrawal by Subject|0
1307253|NCT00147537|4251954|P7|Phase 1b|Withdrawal by Subject|0
1307254|NCT00147537|4251955|P6|Phase 1b|Withdrawal by Subject|0
1307255|NCT00147537|4251956|P5|Phase 1b|Withdrawal by Subject|0
1307256|NCT00147537|4251957|P4|Phase 1b|Withdrawal by Subject|0
1307257|NCT00147537|4251958|P3|Phase 1b|Withdrawal by Subject|0
1307258|NCT00147537|4251959|P2|Phase 1b|Withdrawal by Subject|0
1307259|NCT00147537|4251960|P1|Phase 1b|Withdrawal by Subject|0
1307260|NCT00147537|4251950|P11|Phase 1b|Other|0
1307261|NCT00147537|4251951|P10|Phase 1b|Other|0
1307262|NCT00147537|4251952|P9|Phase 1b|Other|4
1307263|NCT00147537|4251953|P8|Phase 1b|Other|4
1307264|NCT00147537|4251954|P7|Phase 1b|Other|14
1307265|NCT00147537|4251955|P6|Phase 1b|Other|1
1307266|NCT00147537|4251956|P5|Phase 1b|Other|1
1307267|NCT00147537|4251957|P4|Phase 1b|Other|1
1307268|NCT00147537|4251958|P3|Phase 1b|Other|2
1307269|NCT00147537|4251959|P2|Phase 1b|Other|0
1307270|NCT00147537|4251960|P1|Phase 1b|Other|0
1307271|NCT00147537|4251950|P11|Phase 1b|Lost to Follow-up|0
1307272|NCT00147537|4251951|P10|Phase 1b|Lost to Follow-up|0
1307273|NCT00147537|4251952|P9|Phase 1b|Lost to Follow-up|1
1307274|NCT00147537|4251953|P8|Phase 1b|Lost to Follow-up|0
1307275|NCT00147537|4251954|P7|Phase 1b|Lost to Follow-up|2
1307276|NCT00147537|4251955|P6|Phase 1b|Lost to Follow-up|0
1307277|NCT00147537|4251956|P5|Phase 1b|Lost to Follow-up|0
1307278|NCT00147537|4251957|P4|Phase 1b|Lost to Follow-up|0
1307279|NCT00147537|4251958|P3|Phase 1b|Lost to Follow-up|0
1307280|NCT00147537|4251959|P2|Phase 1b|Lost to Follow-up|1
1307281|NCT00147537|4251960|P1|Phase 1b|Lost to Follow-up|2
1307282|NCT00147537|4251950|P11|Phase 1b|Death|0
1307283|NCT00147537|4251951|P10|Phase 1b|Death|0
1307284|NCT00147537|4251952|P9|Phase 1b|Death|9
1307285|NCT00147537|4251953|P8|Phase 1b|Death|3
1307286|NCT00147537|4251954|P7|Phase 1b|Death|1
1307287|NCT00147537|4251955|P6|Phase 1b|Death|2
1307288|NCT00147537|4251956|P5|Phase 1b|Death|2
1307289|NCT00147537|4251957|P4|Phase 1b|Death|1
1307290|NCT00147537|4251958|P3|Phase 1b|Death|2
1307291|NCT00147537|4251959|P2|Phase 1b|Death|1
1307292|NCT00147537|4251960|P1|Phase 1b|Death|0
1307293|NCT00147498|4252143|P4|Overall Study|Other|3
1307294|NCT00147498|4252144|P3|Overall Study|Other|3
1307295|NCT00147498|4252145|P2|Overall Study|Other|1
1307296|NCT00147498|4252146|P1|Overall Study|Other|1
1307297|NCT00147498|4252143|P4|Overall Study|Participant defaulted|3
1307298|NCT00147498|4252144|P3|Overall Study|Participant defaulted|4
1307299|NCT00147498|4252145|P2|Overall Study|Participant defaulted|1
1307300|NCT00147498|4252146|P1|Overall Study|Participant defaulted|0
1307301|NCT00147498|4252143|P4|Overall Study|Laboratory abnormality|0
1307302|NCT00147498|4252144|P3|Overall Study|Laboratory abnormality|2
1307303|NCT00147498|4252145|P2|Overall Study|Laboratory abnormality|0
1307304|NCT00147498|4252146|P1|Overall Study|Laboratory abnormality|0
1307305|NCT00147498|4252143|P4|Overall Study|Lack of Efficacy|8
1307306|NCT00147498|4252144|P3|Overall Study|Lack of Efficacy|1
1307307|NCT00147498|4252145|P2|Overall Study|Lack of Efficacy|1
1307308|NCT00147498|4252146|P1|Overall Study|Lack of Efficacy|1
1307309|NCT00147498|4252143|P4|Overall Study|Adverse Event|3
1307310|NCT00147498|4252144|P3|Overall Study|Adverse Event|7
1307311|NCT00147498|4252145|P2|Overall Study|Adverse Event|6
1307312|NCT00147498|4252146|P1|Overall Study|Adverse Event|1
1307313|NCT00147238|4252270|P1|Overall Study|Inevaluable|8
1307314|NCT00147225|4252280|P6|Overall Study|Chemotherapy Changed|1
1307315|NCT00147225|4252281|P5|Overall Study|Chemotherapy Changed|0
1307316|NCT00147225|4252282|P4|Overall Study|Chemotherapy Changed|0
1307317|NCT00147225|4252283|P3|Overall Study|Chemotherapy Changed|0
1307318|NCT00147225|4252284|P2|Overall Study|Chemotherapy Changed|0
1307319|NCT00147225|4252285|P1|Overall Study|Chemotherapy Changed|0
1307320|NCT00147225|4252280|P6|Overall Study|Screen Failure|0
1307321|NCT00147225|4252281|P5|Overall Study|Screen Failure|1
1307322|NCT00147225|4252282|P4|Overall Study|Screen Failure|0
1307323|NCT00147225|4252283|P3|Overall Study|Screen Failure|0
1307324|NCT00147225|4252284|P2|Overall Study|Screen Failure|0
1307325|NCT00147225|4252285|P1|Overall Study|Screen Failure|0
1307326|NCT00147225|4252280|P6|Overall Study|Adverse Event|0
1307327|NCT00147225|4252281|P5|Overall Study|Adverse Event|0
1307328|NCT00147225|4252282|P4|Overall Study|Adverse Event|1
1307329|NCT00147225|4252283|P3|Overall Study|Adverse Event|1
1307330|NCT00147225|4252284|P2|Overall Study|Adverse Event|0
1307331|NCT00147225|4252285|P1|Overall Study|Adverse Event|0
1307332|NCT00147225|4252280|P6|Overall Study|Withdrawal by Subject|1
1307333|NCT00147225|4252281|P5|Overall Study|Withdrawal by Subject|0
1307334|NCT00147225|4252282|P4|Overall Study|Withdrawal by Subject|0
1307335|NCT00147225|4252283|P3|Overall Study|Withdrawal by Subject|1
1307336|NCT00147225|4252284|P2|Overall Study|Withdrawal by Subject|0
1307337|NCT00147225|4252285|P1|Overall Study|Withdrawal by Subject|1
1307338|NCT00146848|4252388|P3|Post-randomization|Withdrawn|27
1307339|NCT00146848|4252389|P2|Post-randomization|Withdrawn|32
1307340|NCT00146848|4252390|P1|Post-randomization|Withdrawn|26
1307341|NCT00146848|4252388|P3|Post-randomization|Lost to Follow-up|12
1307342|NCT00146848|4252389|P2|Post-randomization|Lost to Follow-up|15
1307343|NCT00146848|4252390|P1|Post-randomization|Lost to Follow-up|12
1307344|NCT00146848|4252388|P3|Pre-randomization|Withdrawal by Subject|0
1307345|NCT00146848|4252389|P2|Pre-randomization|Withdrawal by Subject|0
1307346|NCT00146848|4252390|P1|Pre-randomization|Withdrawal by Subject|40
1307347|NCT00146848|4252388|P3|Pre-randomization|Protocol Violation|0
1307348|NCT00146848|4252389|P2|Pre-randomization|Protocol Violation|0
1307349|NCT00146848|4252390|P1|Pre-randomization|Protocol Violation|172
1307350|NCT00146848|4252388|P3|Pre-randomization|Physician Decision|0
1307351|NCT00146848|4252389|P2|Pre-randomization|Physician Decision|0
1307352|NCT00146848|4252390|P1|Pre-randomization|Physician Decision|8
1307353|NCT00146848|4252388|P3|Pre-randomization|Lost to Follow-up|0
1307354|NCT00146848|4252389|P2|Pre-randomization|Lost to Follow-up|0
1307355|NCT00146848|4252390|P1|Pre-randomization|Lost to Follow-up|70
1307356|NCT00146848|4252388|P3|Pre-randomization|Death|0
1307357|NCT00146848|4252389|P2|Pre-randomization|Death|0
1307358|NCT00146848|4252390|P1|Pre-randomization|Death|19
1307359|NCT00146770|4252406|P2|Overall Study|Withdrawal by Subject|0
1307360|NCT00146770|4252407|P1|Overall Study|Withdrawal by Subject|2
1307361|NCT00146770|4252406|P2|Overall Study|Pregnancy|0
1307362|NCT00146770|4252407|P1|Overall Study|Pregnancy|1
1307363|NCT00146770|4252406|P2|Overall Study|Adverse Event|0
1307364|NCT00146770|4252407|P1|Overall Study|Adverse Event|2
1307365|NCT00146757|4252425|P2|Overall Study|Adverse Event|0
1307366|NCT00146757|4252426|P1|Overall Study|Adverse Event|1
1307367|NCT00146757|4252425|P2|Overall Study|Death|0
1307368|NCT00146757|4252426|P1|Overall Study|Death|1
1307369|NCT00146640|4252445|P2|Overall Study|Non-Medical Reasons|4
1307370|NCT00146640|4252446|P1|Overall Study|Non-Medical Reasons|8
1307371|NCT00146640|4252445|P2|Overall Study|Medical Reasons|0
1307372|NCT00146640|4252446|P1|Overall Study|Medical Reasons|3
1307373|NCT00146640|4252445|P2|Overall Study|Adverse Event|10
1307374|NCT00146640|4252446|P1|Overall Study|Adverse Event|12
1307375|NCT00146328|4252469|P3|Overall Study|Interaction with other medication|1
1307376|NCT00146328|4252470|P2|Overall Study|Interaction with other medication|0
1307377|NCT00146328|4252471|P1|Overall Study|Interaction with other medication|2
1307378|NCT00146328|4252469|P3|Overall Study|Moved|0
1307379|NCT00146328|4252470|P2|Overall Study|Moved|0
1307380|NCT00146328|4252471|P1|Overall Study|Moved|2
1307381|NCT00146328|4252469|P3|Overall Study|Death|1
1307382|NCT00146328|4252470|P2|Overall Study|Death|1
1307383|NCT00146328|4252471|P1|Overall Study|Death|0
1307384|NCT00146328|4252469|P3|Overall Study|Enroll into other trial|2
1307385|NCT00146328|4252470|P2|Overall Study|Enroll into other trial|4
1307386|NCT00146328|4252471|P1|Overall Study|Enroll into other trial|2
1307387|NCT00146328|4252469|P3|Overall Study|Patient decision to end|6
1307388|NCT00146328|4252470|P2|Overall Study|Patient decision to end|1
1307389|NCT00146328|4252471|P1|Overall Study|Patient decision to end|0
1307390|NCT00146328|4252469|P3|Overall Study|Trial ended/site closed|19
1307391|NCT00146328|4252470|P2|Overall Study|Trial ended/site closed|2
1307392|NCT00146328|4252471|P1|Overall Study|Trial ended/site closed|8
1307393|NCT00146328|4252469|P3|Overall Study|Virologic Failure/lack of efficacy|142
1307394|NCT00146328|4252470|P2|Overall Study|Virologic Failure/lack of efficacy|72
1307395|NCT00146328|4252471|P1|Overall Study|Virologic Failure/lack of efficacy|54
1307396|NCT00146328|4252469|P3|Overall Study|Withdrawal by Subject|22
1307397|NCT00146328|4252470|P2|Overall Study|Withdrawal by Subject|16
1307398|NCT00146328|4252471|P1|Overall Study|Withdrawal by Subject|16
1307399|NCT00146328|4252469|P3|Overall Study|Lost to Follow-up|7
1307400|NCT00146328|4252470|P2|Overall Study|Lost to Follow-up|4
1307401|NCT00146328|4252471|P1|Overall Study|Lost to Follow-up|7
1307402|NCT00146328|4252469|P3|Overall Study|Protocol Violation|12
1307403|NCT00146328|4252470|P2|Overall Study|Protocol Violation|6
1307404|NCT00146328|4252471|P1|Overall Study|Protocol Violation|11
1307405|NCT00146328|4252469|P3|Overall Study|Adverse Event|79
1307406|NCT00146328|4252470|P2|Overall Study|Adverse Event|48
1307407|NCT00146328|4252471|P1|Overall Study|Adverse Event|39
1307408|NCT00146172|4252562|P8|Overall Study|Symptomatic Deterioration|2
1307409|NCT00146172|4252563|P7|Overall Study|Symptomatic Deterioration|0
1307410|NCT00146172|4252564|P6|Overall Study|Symptomatic Deterioration|2
1307411|NCT00146172|4252565|P5|Overall Study|Symptomatic Deterioration|1
1307412|NCT00146172|4252566|P4|Overall Study|Symptomatic Deterioration|0
1307413|NCT00146172|4252567|P3|Overall Study|Symptomatic Deterioration|1
1307414|NCT00146172|4252568|P2|Overall Study|Symptomatic Deterioration|0
1307415|NCT00146172|4252569|P1|Overall Study|Symptomatic Deterioration|1
1307416|NCT00146172|4252562|P8|Overall Study|Withdrawal by Subject|4
1307417|NCT00146172|4252563|P7|Overall Study|Withdrawal by Subject|1
1307418|NCT00146172|4252564|P6|Overall Study|Withdrawal by Subject|1
1307419|NCT00146172|4252565|P5|Overall Study|Withdrawal by Subject|0
1307420|NCT00146172|4252566|P4|Overall Study|Withdrawal by Subject|0
1307421|NCT00146172|4252567|P3|Overall Study|Withdrawal by Subject|0
1307422|NCT00146172|4252568|P2|Overall Study|Withdrawal by Subject|0
1307423|NCT00146172|4252569|P1|Overall Study|Withdrawal by Subject|0
1307424|NCT00146172|4252562|P8|Overall Study|Physician Decision|1
1307425|NCT00146172|4252563|P7|Overall Study|Physician Decision|0
1307426|NCT00146172|4252564|P6|Overall Study|Physician Decision|0
1307427|NCT00146172|4252565|P5|Overall Study|Physician Decision|0
1307428|NCT00146172|4252566|P4|Overall Study|Physician Decision|0
1307429|NCT00146172|4252567|P3|Overall Study|Physician Decision|0
1307430|NCT00146172|4252568|P2|Overall Study|Physician Decision|0
1307431|NCT00146172|4252569|P1|Overall Study|Physician Decision|0
1307432|NCT00146172|4252562|P8|Overall Study|Death|0
1307433|NCT00146172|4252563|P7|Overall Study|Death|1
1307434|NCT00146172|4252564|P6|Overall Study|Death|0
1307435|NCT00146172|4252565|P5|Overall Study|Death|0
1307436|NCT00146172|4252566|P4|Overall Study|Death|0
1307437|NCT00146172|4252567|P3|Overall Study|Death|0
1307438|NCT00146172|4252568|P2|Overall Study|Death|0
1307439|NCT00146172|4252569|P1|Overall Study|Death|0
1307440|NCT00146172|4252562|P8|Overall Study|Disease Progression|22
1307441|NCT00146172|4252563|P7|Overall Study|Disease Progression|1
1307442|NCT00146172|4252564|P6|Overall Study|Disease Progression|2
1307443|NCT00146172|4252565|P5|Overall Study|Disease Progression|2
1307444|NCT00146172|4252566|P4|Overall Study|Disease Progression|5
1307445|NCT00146172|4252567|P3|Overall Study|Disease Progression|2
1307446|NCT00146172|4252568|P2|Overall Study|Disease Progression|4
1307447|NCT00146172|4252569|P1|Overall Study|Disease Progression|2
1307448|NCT00146172|4252562|P8|Overall Study|Lost to Follow-up|1
1307449|NCT00146172|4252563|P7|Overall Study|Lost to Follow-up|0
1307450|NCT00146172|4252564|P6|Overall Study|Lost to Follow-up|0
1307451|NCT00146172|4252565|P5|Overall Study|Lost to Follow-up|0
1307452|NCT00146172|4252566|P4|Overall Study|Lost to Follow-up|0
1307453|NCT00146172|4252567|P3|Overall Study|Lost to Follow-up|0
1307454|NCT00146172|4252568|P2|Overall Study|Lost to Follow-up|0
1307455|NCT00146172|4252569|P1|Overall Study|Lost to Follow-up|0
1307456|NCT00146172|4252562|P8|Overall Study|Adverse Event|10
1307457|NCT00146172|4252563|P7|Overall Study|Adverse Event|3
1307458|NCT00146172|4252564|P6|Overall Study|Adverse Event|2
1307459|NCT00146172|4252565|P5|Overall Study|Adverse Event|0
1307460|NCT00146172|4252566|P4|Overall Study|Adverse Event|1
1307461|NCT00146172|4252567|P3|Overall Study|Adverse Event|1
1307462|NCT00146172|4252568|P2|Overall Study|Adverse Event|0
1307463|NCT00146172|4252569|P1|Overall Study|Adverse Event|0
1307464|NCT00145977|4252604|P2|Overall Study|Withdrawal by Subject|0
1307465|NCT00145977|4252605|P1|Overall Study|Withdrawal by Subject|1
1307466|NCT00145977|4252604|P2|Overall Study|Lost to Follow-up|0
1307467|NCT00145977|4252605|P1|Overall Study|Lost to Follow-up|1
1307468|NCT00145977|4252604|P2|Overall Study|Lack of Efficacy|4
1307469|NCT00145977|4252605|P1|Overall Study|Lack of Efficacy|0
1307470|NCT00145795|4252631|P2|Overall Study|Adverse Event|0
1307471|NCT00145795|4252632|P1|Overall Study|Adverse Event|1
1307472|NCT00145626|4252667|P1|Overall Study|Withdrawal by Subject|1
1307473|NCT00145626|4252667|P1|Overall Study|Death|1
1307474|NCT00145626|4252667|P1|Overall Study|Turned 2 years old before treatment|1
1307475|NCT00145626|4252667|P1|Overall Study|Did not have NK infusions|2
1307476|NCT00145600|4252713|P4|Overall Study|Withdrawal by Subject|1
1307477|NCT00145600|4252714|P3|Overall Study|Withdrawal by Subject|0
1307478|NCT00145600|4252715|P2|Overall Study|Withdrawal by Subject|2
1307479|NCT00145600|4252716|P1|Overall Study|Withdrawal by Subject|1
1307480|NCT00145600|4252713|P4|Overall Study|Noncompliance|0
1307481|NCT00145600|4252714|P3|Overall Study|Noncompliance|0
1307482|NCT00145600|4252715|P2|Overall Study|Noncompliance|0
1307483|NCT00145600|4252716|P1|Overall Study|Noncompliance|1
1307484|NCT00145600|4252713|P4|Overall Study|Lost to Follow-up|4
1307485|NCT00145600|4252714|P3|Overall Study|Lost to Follow-up|2
1307486|NCT00145600|4252715|P2|Overall Study|Lost to Follow-up|6
1307487|NCT00145600|4252716|P1|Overall Study|Lost to Follow-up|2
1307488|NCT00145600|4252713|P4|Overall Study|Ineligible|5
1307489|NCT00145600|4252714|P3|Overall Study|Ineligible|1
1307490|NCT00145600|4252715|P2|Overall Study|Ineligible|0
1307491|NCT00145600|4252716|P1|Overall Study|Ineligible|3
1307492|NCT00145600|4252713|P4|Overall Study|Death|6
1307493|NCT00145600|4252714|P3|Overall Study|Death|2
1307494|NCT00145600|4252715|P2|Overall Study|Death|2
1307495|NCT00145600|4252716|P1|Overall Study|Death|1
1307496|NCT00145574|4252840|P3|Open Label Long-term Extension|required restricted medicine|1
1307497|NCT00145574|4252841|P2|Open Label Long-term Extension|required restricted medicine|0
1307498|NCT00145574|4252842|P1|Open Label Long-term Extension|required restricted medicine|0
1307499|NCT00145574|4252840|P3|Open Label Long-term Extension|Withdrawal by Subject|4
1307500|NCT00145574|4252841|P2|Open Label Long-term Extension|Withdrawal by Subject|0
1307501|NCT00145574|4252842|P1|Open Label Long-term Extension|Withdrawal by Subject|0
1307502|NCT00145574|4252840|P3|Open Label Long-term Extension|Lost to Follow-up|1
1307503|NCT00145574|4252841|P2|Open Label Long-term Extension|Lost to Follow-up|0
1307504|NCT00145574|4252842|P1|Open Label Long-term Extension|Lost to Follow-up|0
1307505|NCT00145574|4252840|P3|Open Label Long-term Extension|Adverse Event|5
1307506|NCT00145574|4252841|P2|Open Label Long-term Extension|Adverse Event|0
1307507|NCT00145574|4252842|P1|Open Label Long-term Extension|Adverse Event|0
1307508|NCT00145574|4252840|P3|Double Blind|required restricted medicine|0
1307509|NCT00145574|4252841|P2|Double Blind|required restricted medicine|1
1307510|NCT00145574|4252842|P1|Double Blind|required restricted medicine|0
1307511|NCT00145574|4252840|P3|Double Blind|Withdrawal by Subject|1
1307512|NCT00145574|4252841|P2|Double Blind|Withdrawal by Subject|1
1307513|NCT00145574|4252842|P1|Double Blind|Withdrawal by Subject|1
1307514|NCT00145574|4252840|P3|Double Blind|Adverse Event|1
1307515|NCT00145574|4252841|P2|Double Blind|Adverse Event|3
1307516|NCT00145574|4252842|P1|Double Blind|Adverse Event|0
1307517|NCT00145509|4252899|P2|Overall Study|Reason not provided|1
1307518|NCT00145509|4252900|P1|Overall Study|Reason not provided|2
1307519|NCT00145509|4252899|P2|Overall Study|Withdrew Consent|7
1307520|NCT00145509|4252900|P1|Overall Study|Withdrew Consent|2
1307521|NCT00145509|4252899|P2|Overall Study|Lost to Follow-up|9
1307522|NCT00145509|4252900|P1|Overall Study|Lost to Follow-up|5
1307523|NCT00145509|4252899|P2|Overall Study|Lack of Efficacy|1
1307524|NCT00145509|4252900|P1|Overall Study|Lack of Efficacy|3
1307525|NCT00145509|4252899|P2|Overall Study|Adverse Event|3
1307526|NCT00145509|4252900|P1|Overall Study|Adverse Event|10
1307527|NCT00145496|4252914|P2|Overall Study|Other|13
1307528|NCT00145496|4252915|P1|Overall Study|Other|25
1307529|NCT00145496|4252914|P2|Overall Study|Lost to Follow-up|5
1307530|NCT00145496|4252915|P1|Overall Study|Lost to Follow-up|12
1307531|NCT00145496|4252914|P2|Overall Study|Withdrawal by Subject|26
1307532|NCT00145496|4252915|P1|Overall Study|Withdrawal by Subject|32
1307533|NCT00145496|4252914|P2|Overall Study|Lack of Efficacy|7
1307534|NCT00145496|4252915|P1|Overall Study|Lack of Efficacy|12
1307535|NCT00145496|4252914|P2|Overall Study|Adverse Event|30
1307536|NCT00145496|4252915|P1|Overall Study|Adverse Event|42
1307537|NCT00145327|4252935|P3|Overall Study|Missing – not stated|1
1307538|NCT00145327|4252936|P2|Overall Study|Missing – not stated|0
1307539|NCT00145327|4252937|P1|Overall Study|Missing – not stated|1
1307540|NCT00145327|4252935|P3|Overall Study|Abnormal laboratory value(s)|2
1307541|NCT00145327|4252936|P2|Overall Study|Abnormal laboratory value(s)|0
1307542|NCT00145327|4252937|P1|Overall Study|Abnormal laboratory value(s)|1
1307543|NCT00145327|4252935|P3|Overall Study|Protocol Violation|2
1307544|NCT00145327|4252936|P2|Overall Study|Protocol Violation|0
1307545|NCT00145327|4252937|P1|Overall Study|Protocol Violation|2
1307546|NCT00145327|4252935|P3|Overall Study|Administrative problems|13
1307547|NCT00145327|4252936|P2|Overall Study|Administrative problems|9
1307548|NCT00145327|4252937|P1|Overall Study|Administrative problems|12
1307549|NCT00145327|4252935|P3|Overall Study|Lost to Follow-up|14
1307550|NCT00145327|4252936|P2|Overall Study|Lost to Follow-up|14
1307551|NCT00145327|4252937|P1|Overall Study|Lost to Follow-up|9
1307552|NCT00145327|4252935|P3|Overall Study|Adverse Event|22
1307553|NCT00145327|4252936|P2|Overall Study|Adverse Event|11
1307554|NCT00145327|4252937|P1|Overall Study|Adverse Event|14
1307555|NCT00145327|4252935|P3|Overall Study|Death|30
1307556|NCT00145327|4252936|P2|Overall Study|Death|18
1307557|NCT00145327|4252937|P1|Overall Study|Death|26
1307558|NCT00145327|4252935|P3|Overall Study|Withdrawal by Subject|164
1307559|NCT00145327|4252936|P2|Overall Study|Withdrawal by Subject|72
1307560|NCT00145327|4252937|P1|Overall Study|Withdrawal by Subject|77
1307561|NCT00145119|4253036|P1|Overall Study|Death|45
1307562|NCT00144781|4253054|P4|Overall Study|Non-compliant|0
1307563|NCT00144781|4253055|P3|Overall Study|Non-compliant|0
1307564|NCT00144781|4253056|P2|Overall Study|Non-compliant|1
1307565|NCT00144781|4253057|P1|Overall Study|Non-compliant|0
1307566|NCT00144781|4253054|P4|Overall Study|Adverse Event|0
1307567|NCT00144781|4253055|P3|Overall Study|Adverse Event|0
1307568|NCT00144781|4253056|P2|Overall Study|Adverse Event|1
1307569|NCT00144781|4253057|P1|Overall Study|Adverse Event|0
1307570|NCT00144339|4253086|P2|Overall Study|Other|60
1307571|NCT00144339|4253087|P1|Overall Study|Other|58
1307572|NCT00144339|4253086|P2|Overall Study|Lost to Follow-up|64
1307573|NCT00144339|4253087|P1|Overall Study|Lost to Follow-up|76
1307574|NCT00144339|4253086|P2|Overall Study|Withdrawal by Subject|300
1307575|NCT00144339|4253087|P1|Overall Study|Withdrawal by Subject|403
1307576|NCT00144339|4253086|P2|Overall Study|Protocol Violation|48
1307577|NCT00144339|4253087|P1|Overall Study|Protocol Violation|75
1307578|NCT00144339|4253086|P2|Overall Study|Adverse Event|627
1307579|NCT00144339|4253087|P1|Overall Study|Adverse Event|746
1307580|NCT00144300|4253295|P2|Overall Study|Other reason (not specified)|3
1307581|NCT00144300|4253296|P1|Overall Study|Other reason (not specified)|1
1307582|NCT00144300|4253295|P2|Overall Study|Withdrawal by Subject|6
1307583|NCT00144300|4253296|P1|Overall Study|Withdrawal by Subject|6
1307584|NCT00144300|4253295|P2|Overall Study|Lost to Follow-up|0
1307585|NCT00144300|4253296|P1|Overall Study|Lost to Follow-up|3
1307586|NCT00144300|4253295|P2|Overall Study|Protocol Violation|3
1307587|NCT00144300|4253296|P1|Overall Study|Protocol Violation|1
1307588|NCT00144300|4253295|P2|Overall Study|Adverse Event|16
1307589|NCT00144300|4253296|P1|Overall Study|Adverse Event|18
1307590|NCT00144170|4253344|P2|Overall Study|Other reason not defined above|316
1307591|NCT00144170|4253345|P1|Overall Study|Other reason not defined above|211
1307592|NCT00144170|4253344|P2|Overall Study|Withdrawal by Subject|13
1307593|NCT00144170|4253345|P1|Overall Study|Withdrawal by Subject|29
1307594|NCT00144170|4253344|P2|Overall Study|Lost to Follow-up|10
1307595|NCT00144170|4253345|P1|Overall Study|Lost to Follow-up|5
1307596|NCT00144170|4253344|P2|Overall Study|Protocol Violation|16
1307597|NCT00144170|4253345|P1|Overall Study|Protocol Violation|23
1307598|NCT00144170|4253344|P2|Overall Study|Adverse Event|41
1307599|NCT00144170|4253345|P1|Overall Study|Adverse Event|84
1307600|NCT00144027|4253535|P2|Overall Study|did not complete baseline assessment|6
1307601|NCT00144027|4253536|P1|Overall Study|did not complete baseline assessment|0
1307602|NCT00144027|4253535|P2|Overall Study|Withdrawal by Subject|2
1307603|NCT00144027|4253536|P1|Overall Study|Withdrawal by Subject|2
1307604|NCT00144027|4253535|P2|Overall Study|Lost to Follow-up|3
1307605|NCT00144027|4253536|P1|Overall Study|Lost to Follow-up|1
1307606|NCT00143598|4253566|P2|Overall Study|Death|36
1307607|NCT00143598|4253567|P1|Overall Study|Death|36
1307608|NCT00143598|4253566|P2|Overall Study|Withdrawal by Subject|37
1307609|NCT00143598|4253567|P1|Overall Study|Withdrawal by Subject|33
1307610|NCT00143598|4253566|P2|Overall Study|Lost to Follow-up|21
1307611|NCT00143598|4253567|P1|Overall Study|Lost to Follow-up|23
1307612|NCT00143507|4253581|P2|Overall Study|Withdrawn by sponsor's decision|3
1307613|NCT00143507|4253582|P1|Overall Study|Withdrawn by sponsor's decision|0
1307614|NCT00143507|4253581|P2|Overall Study|Lost to Follow-up|0
1307615|NCT00143507|4253582|P1|Overall Study|Lost to Follow-up|1
1307616|NCT00143507|4253581|P2|Overall Study|Withdrawal by Subject|102
1307617|NCT00143507|4253582|P1|Overall Study|Withdrawal by Subject|114
1307618|NCT00143507|4253581|P2|Overall Study|Death|547
1307619|NCT00143507|4253582|P1|Overall Study|Death|572
1307620|NCT00143455|4253616|P4|Cohort 2|Randomized But Not Treated|1
1307621|NCT00143455|4253617|P3|Cohort 2|Randomized But Not Treated|1
1307622|NCT00143455|4253618|P2|Cohort 2|Randomized But Not Treated|0
1307623|NCT00143455|4253619|P1|Cohort 2|Randomized But Not Treated|0
1307624|NCT00143455|4253616|P4|Cohort 2|Other|6
1307625|NCT00143455|4253617|P3|Cohort 2|Other|7
1307626|NCT00143455|4253618|P2|Cohort 2|Other|0
1307627|NCT00143455|4253619|P1|Cohort 2|Other|0
1307628|NCT00143455|4253616|P4|Cohort 2|Withdrawal by Subject|12
1307629|NCT00143455|4253617|P3|Cohort 2|Withdrawal by Subject|13
1307630|NCT00143455|4253618|P2|Cohort 2|Withdrawal by Subject|0
1307631|NCT00143455|4253619|P1|Cohort 2|Withdrawal by Subject|0
1307632|NCT00143455|4253616|P4|Cohort 2|Progressive Disease|27
1307633|NCT00143455|4253617|P3|Cohort 2|Progressive Disease|20
1307634|NCT00143455|4253618|P2|Cohort 2|Progressive Disease|0
1307635|NCT00143455|4253619|P1|Cohort 2|Progressive Disease|0
1307636|NCT00143455|4253616|P4|Cohort 2|Death|12
1307637|NCT00143455|4253617|P3|Cohort 2|Death|20
1307638|NCT00143455|4253618|P2|Cohort 2|Death|0
1307639|NCT00143455|4253619|P1|Cohort 2|Death|0
1307640|NCT00143455|4253616|P4|Cohort 2|Lost to Follow-up|4
1307641|NCT00143455|4253617|P3|Cohort 2|Lost to Follow-up|1
1307642|NCT00143455|4253618|P2|Cohort 2|Lost to Follow-up|0
1307643|NCT00143455|4253619|P1|Cohort 2|Lost to Follow-up|0
1307644|NCT00143455|4253616|P4|Cohort 2|Protocol Violation|1
1307645|NCT00143455|4253617|P3|Cohort 2|Protocol Violation|1
1307646|NCT00143455|4253618|P2|Cohort 2|Protocol Violation|0
1307647|NCT00143455|4253619|P1|Cohort 2|Protocol Violation|0
1307648|NCT00143455|4253616|P4|Cohort 2|No Longer Required Study Treatment|0
1307649|NCT00143455|4253617|P3|Cohort 2|No Longer Required Study Treatment|1
1307650|NCT00143455|4253618|P2|Cohort 2|No Longer Required Study Treatment|0
1307651|NCT00143455|4253619|P1|Cohort 2|No Longer Required Study Treatment|0
1307652|NCT00143455|4253616|P4|Cohort 2|Adverse Event|30
1307653|NCT00143455|4253617|P3|Cohort 2|Adverse Event|42
1307654|NCT00143455|4253618|P2|Cohort 2|Adverse Event|0
1307655|NCT00143455|4253619|P1|Cohort 2|Adverse Event|0
1307656|NCT00143455|4253616|P4|Cohort 1|Randomized But Not Treated|0
1307657|NCT00143455|4253617|P3|Cohort 1|Randomized But Not Treated|0
1307658|NCT00143455|4253618|P2|Cohort 1|Randomized But Not Treated|1
1307659|NCT00143455|4253619|P1|Cohort 1|Randomized But Not Treated|0
1307660|NCT00143455|4253616|P4|Cohort 1|Withdrawal by Subject|0
1307661|NCT00143455|4253617|P3|Cohort 1|Withdrawal by Subject|0
1307662|NCT00143455|4253618|P2|Cohort 1|Withdrawal by Subject|4
1307663|NCT00143455|4253619|P1|Cohort 1|Withdrawal by Subject|1
1307664|NCT00143455|4253616|P4|Cohort 1|Progressive Disease|0
1307665|NCT00143455|4253617|P3|Cohort 1|Progressive Disease|0
1307666|NCT00143455|4253618|P2|Cohort 1|Progressive Disease|6
1307667|NCT00143455|4253619|P1|Cohort 1|Progressive Disease|0
1307668|NCT00143455|4253616|P4|Cohort 1|Death|0
1307669|NCT00143455|4253617|P3|Cohort 1|Death|0
1307670|NCT00143455|4253618|P2|Cohort 1|Death|2
1307671|NCT00143455|4253619|P1|Cohort 1|Death|5
1307672|NCT00143455|4253616|P4|Cohort 1|Adverse Event|0
1307673|NCT00143455|4253617|P3|Cohort 1|Adverse Event|0
1307674|NCT00143455|4253618|P2|Cohort 1|Adverse Event|4
1307675|NCT00143455|4253619|P1|Cohort 1|Adverse Event|8
1307676|NCT00143403|4253653|P2|Overall Study|Randomized Not Treated|8
1307677|NCT00143403|4253654|P1|Overall Study|Randomized Not Treated|7
1307678|NCT00143403|4253653|P2|Overall Study|specified by site|9
1307679|NCT00143403|4253654|P1|Overall Study|specified by site|4
1307680|NCT00143403|4253653|P2|Overall Study|Protocol Violation|2
1307681|NCT00143403|4253654|P1|Overall Study|Protocol Violation|2
1307682|NCT00143403|4253653|P2|Overall Study|Relapse|7
1307683|NCT00143403|4253654|P1|Overall Study|Relapse|15
1307684|NCT00143403|4253653|P2|Overall Study|Withdrawal by Subject|12
1307685|NCT00143403|4253654|P1|Overall Study|Withdrawal by Subject|3
1307686|NCT00143403|4253653|P2|Overall Study|Death|0
1307687|NCT00143403|4253654|P1|Overall Study|Death|1
1307688|NCT00143403|4253653|P2|Overall Study|Adverse Event|8
1307689|NCT00143403|4253654|P1|Overall Study|Adverse Event|3
1307690|NCT00143390|4253664|P2|Overall Study|Other|2
1307691|NCT00143390|4253665|P1|Overall Study|Other|1
1307692|NCT00143390|4253664|P2|Overall Study|Adverse Event|8
1307693|NCT00143390|4253665|P1|Overall Study|Adverse Event|9
1307694|NCT00143390|4253664|P2|Overall Study|Study termination|15
1307695|NCT00143390|4253665|P1|Overall Study|Study termination|10
1307696|NCT00143390|4253664|P2|Overall Study|Protocol Violation|0
1307697|NCT00143390|4253665|P1|Overall Study|Protocol Violation|2
1307698|NCT00143390|4253664|P2|Overall Study|Progressive disease|115
1307699|NCT00143390|4253665|P1|Overall Study|Progressive disease|119
1307700|NCT00143390|4253664|P2|Overall Study|Withdrawal by Subject|4
1307701|NCT00143390|4253665|P1|Overall Study|Withdrawal by Subject|4
1307702|NCT00143390|4253664|P2|Overall Study|Not meeting entry criteria|5
1307703|NCT00143390|4253665|P1|Overall Study|Not meeting entry criteria|2
1307704|NCT00143390|4253664|P2|Overall Study|Death|0
1307705|NCT00143390|4253665|P1|Overall Study|Death|2
1307706|NCT00143312|4253681|P1|Overall Study|Withdrawal by Subject|1
1307707|NCT00143312|4253681|P1|Overall Study|Other|1
1307708|NCT00143312|4253681|P1|Overall Study|Lost to Follow-up|1
1307709|NCT00143312|4253681|P1|Overall Study|Adverse Event|2
1307710|NCT00143312|4253681|P1|Overall Study|Death|11
1307711|NCT00143247|4253691|P1|Overall Study|Other|12
1307712|NCT00143247|4253691|P1|Overall Study|following inaccurate lab adverse event|1
1307713|NCT00143247|4253691|P1|Overall Study|Lost to Follow-up|12
1307714|NCT00143247|4253691|P1|Overall Study|Protocol Violation|15
1307715|NCT00143247|4253691|P1|Overall Study|Study terminated by sponsor|31
1307716|NCT00143247|4253691|P1|Overall Study|Withdrawal by Subject|55
1307717|NCT00143247|4253691|P1|Overall Study|Lack of Efficacy|3
1307718|NCT00143247|4253691|P1|Overall Study|Adverse Event|19
1307719|NCT00143247|4253691|P1|Overall Study|Death|8
1307720|NCT00142935|4253708|P3|Overall Study|Death|1
1307721|NCT00142935|4253709|P2|Overall Study|Death|2
1307722|NCT00142935|4253710|P1|Overall Study|Death|0
1307723|NCT00142935|4253708|P3|Overall Study|Lost to Follow-up|5
1307724|NCT00142935|4253709|P2|Overall Study|Lost to Follow-up|5
1307725|NCT00142935|4253710|P1|Overall Study|Lost to Follow-up|2
1307726|NCT00142935|4253708|P3|Overall Study|Other reason|1
1307727|NCT00142935|4253709|P2|Overall Study|Other reason|1
1307728|NCT00142935|4253710|P1|Overall Study|Other reason|1
1307729|NCT00142909|4253735|P2|Medications Begin|Withdrawal by Subject|0
1307730|NCT00142909|4253736|P1|Medications Begin|Withdrawal by Subject|2
1307731|NCT00142909|4253735|P2|Medications Begin|Withdrawal by Subject|3
1307732|NCT00142909|4253736|P1|Medications Begin|Withdrawal by Subject|5
1307733|NCT00142909|4253735|P2|Medications Begin|Protocol Violation|0
1307734|NCT00142909|4253736|P1|Medications Begin|Protocol Violation|2
1307735|NCT00142909|4253735|P2|Randomization|Various Reasons|10
1307736|NCT00142909|4253736|P1|Randomization|Various Reasons|7
1307737|NCT00142792|4253772|P3|Overall Study|No category|1
1307738|NCT00142792|4253773|P2|Overall Study|No category|2
1307739|NCT00142792|4253774|P1|Overall Study|No category|1
1307740|NCT00142792|4253772|P3|Overall Study|Lost to Follow-up|7
1307741|NCT00142792|4253773|P2|Overall Study|Lost to Follow-up|11
1307742|NCT00142792|4253774|P1|Overall Study|Lost to Follow-up|8
1307743|NCT00142792|4253772|P3|Overall Study|Withdrawal by Subject|3
1307744|NCT00142792|4253773|P2|Overall Study|Withdrawal by Subject|2
1307745|NCT00142792|4253774|P1|Overall Study|Withdrawal by Subject|3
1307746|NCT00142792|4253772|P3|Overall Study|Death|1
1307747|NCT00142792|4253773|P2|Overall Study|Death|0
1307748|NCT00142792|4253774|P1|Overall Study|Death|0
1307749|NCT00142415|4253809|P6|Overall Study|Physician Decision|2
1307750|NCT00142415|4253810|P5|Overall Study|Physician Decision|1
1307751|NCT00142415|4253811|P4|Overall Study|Physician Decision|0
1307752|NCT00142415|4253812|P3|Overall Study|Physician Decision|0
1307753|NCT00142415|4253813|P2|Overall Study|Physician Decision|0
1307754|NCT00142415|4253814|P1|Overall Study|Physician Decision|0
1307755|NCT00142298|4253852|P10|Overall Study|Treatment Failure|0
1307756|NCT00142298|4253853|P9|Overall Study|Treatment Failure|0
1307757|NCT00142298|4253854|P8|Overall Study|Treatment Failure|0
1307758|NCT00142298|4253855|P7|Overall Study|Treatment Failure|2
1307759|NCT00142298|4253856|P6|Overall Study|Treatment Failure|2
1307760|NCT00142298|4253857|P5|Overall Study|Treatment Failure|0
1307761|NCT00142298|4253858|P4|Overall Study|Treatment Failure|0
1307762|NCT00142298|4253859|P3|Overall Study|Treatment Failure|0
1307763|NCT00142298|4253860|P2|Overall Study|Treatment Failure|0
1307764|NCT00142298|4253861|P1|Overall Study|Treatment Failure|0
1307765|NCT00142298|4253852|P10|Overall Study|Lost to Follow-up|0
1307766|NCT00142298|4253853|P9|Overall Study|Lost to Follow-up|0
1307767|NCT00142298|4253854|P8|Overall Study|Lost to Follow-up|0
1307768|NCT00142298|4253855|P7|Overall Study|Lost to Follow-up|2
1307769|NCT00142298|4253856|P6|Overall Study|Lost to Follow-up|0
1307770|NCT00142298|4253857|P5|Overall Study|Lost to Follow-up|0
1307771|NCT00142298|4253858|P4|Overall Study|Lost to Follow-up|0
1307772|NCT00142298|4253859|P3|Overall Study|Lost to Follow-up|0
1307773|NCT00142298|4253860|P2|Overall Study|Lost to Follow-up|0
1307774|NCT00142298|4253861|P1|Overall Study|Lost to Follow-up|0
1307775|NCT00142298|4253852|P10|Overall Study|Other- not specified|0
1307776|NCT00142298|4253853|P9|Overall Study|Other- not specified|0
1307777|NCT00142298|4253854|P8|Overall Study|Other- not specified|0
1307778|NCT00142298|4253855|P7|Overall Study|Other- not specified|0
1307779|NCT00142298|4253856|P6|Overall Study|Other- not specified|0
1307780|NCT00142298|4253857|P5|Overall Study|Other- not specified|0
1307781|NCT00142298|4253858|P4|Overall Study|Other- not specified|1
1307782|NCT00142298|4253859|P3|Overall Study|Other- not specified|0
1307783|NCT00142298|4253860|P2|Overall Study|Other- not specified|3
1307784|NCT00142298|4253861|P1|Overall Study|Other- not specified|0
1307785|NCT00142298|4253852|P10|Overall Study|Virologic breakthrough|0
1307786|NCT00142298|4253853|P9|Overall Study|Virologic breakthrough|0
1307787|NCT00142298|4253854|P8|Overall Study|Virologic breakthrough|0
1307788|NCT00142298|4253855|P7|Overall Study|Virologic breakthrough|3
1307789|NCT00142298|4253856|P6|Overall Study|Virologic breakthrough|3
1307790|NCT00142298|4253857|P5|Overall Study|Virologic breakthrough|2
1307791|NCT00142298|4253858|P4|Overall Study|Virologic breakthrough|7
1307792|NCT00142298|4253859|P3|Overall Study|Virologic breakthrough|9
1307793|NCT00142298|4253860|P2|Overall Study|Virologic breakthrough|23
1307794|NCT00142298|4253861|P1|Overall Study|Virologic breakthrough|19
1307795|NCT00142298|4253852|P10|Overall Study|Pregnancy|0
1307796|NCT00142298|4253853|P9|Overall Study|Pregnancy|1
1307797|NCT00142298|4253854|P8|Overall Study|Pregnancy|0
1307798|NCT00142298|4253855|P7|Overall Study|Pregnancy|0
1307799|NCT00142298|4253856|P6|Overall Study|Pregnancy|0
1307800|NCT00142298|4253857|P5|Overall Study|Pregnancy|0
1307801|NCT00142298|4253858|P4|Overall Study|Pregnancy|3
1307802|NCT00142298|4253859|P3|Overall Study|Pregnancy|2
1307803|NCT00142298|4253860|P2|Overall Study|Pregnancy|4
1307804|NCT00142298|4253861|P1|Overall Study|Pregnancy|4
1307805|NCT00142298|4253852|P10|Overall Study|Patient, Investigator,or Sponsor request|0
1307806|NCT00142298|4253853|P9|Overall Study|Patient, Investigator,or Sponsor request|1
1307807|NCT00142298|4253854|P8|Overall Study|Patient, Investigator,or Sponsor request|4
1307808|NCT00142298|4253855|P7|Overall Study|Patient, Investigator,or Sponsor request|1
1307809|NCT00142298|4253856|P6|Overall Study|Patient, Investigator,or Sponsor request|3
1307810|NCT00142298|4253857|P5|Overall Study|Patient, Investigator,or Sponsor request|4
1307811|NCT00142298|4253858|P4|Overall Study|Patient, Investigator,or Sponsor request|51
1307812|NCT00142298|4253859|P3|Overall Study|Patient, Investigator,or Sponsor request|11
1307813|NCT00142298|4253860|P2|Overall Study|Patient, Investigator,or Sponsor request|60
1307814|NCT00142298|4253861|P1|Overall Study|Patient, Investigator,or Sponsor request|66
1307815|NCT00142298|4253852|P10|Overall Study|Non-compliance|0
1307816|NCT00142298|4253853|P9|Overall Study|Non-compliance|3
1307817|NCT00142298|4253854|P8|Overall Study|Non-compliance|3
1307818|NCT00142298|4253855|P7|Overall Study|Non-compliance|0
1307819|NCT00142298|4253856|P6|Overall Study|Non-compliance|0
1307820|NCT00142298|4253857|P5|Overall Study|Non-compliance|1
1307821|NCT00142298|4253858|P4|Overall Study|Non-compliance|6
1307822|NCT00142298|4253859|P3|Overall Study|Non-compliance|0
1307823|NCT00142298|4253860|P2|Overall Study|Non-compliance|13
1307824|NCT00142298|4253861|P1|Overall Study|Non-compliance|15
1307825|NCT00142298|4253852|P10|Overall Study|Lack of Efficacy|0
1307826|NCT00142298|4253853|P9|Overall Study|Lack of Efficacy|0
1307827|NCT00142298|4253854|P8|Overall Study|Lack of Efficacy|1
1307828|NCT00142298|4253855|P7|Overall Study|Lack of Efficacy|0
1307829|NCT00142298|4253856|P6|Overall Study|Lack of Efficacy|0
1307830|NCT00142298|4253857|P5|Overall Study|Lack of Efficacy|1
1307831|NCT00142298|4253858|P4|Overall Study|Lack of Efficacy|12
1307832|NCT00142298|4253859|P3|Overall Study|Lack of Efficacy|9
1307833|NCT00142298|4253860|P2|Overall Study|Lack of Efficacy|62
1307834|NCT00142298|4253861|P1|Overall Study|Lack of Efficacy|44
1307835|NCT00142298|4253852|P10|Overall Study|Death|0
1307836|NCT00142298|4253853|P9|Overall Study|Death|0
1307837|NCT00142298|4253854|P8|Overall Study|Death|0
1307838|NCT00142298|4253855|P7|Overall Study|Death|0
1307839|NCT00142298|4253856|P6|Overall Study|Death|6
1307840|NCT00142298|4253857|P5|Overall Study|Death|0
1307841|NCT00142298|4253858|P4|Overall Study|Death|0
1307842|NCT00142298|4253859|P3|Overall Study|Death|1
1307843|NCT00142298|4253860|P2|Overall Study|Death|1
1307844|NCT00142298|4253861|P1|Overall Study|Death|1
1307845|NCT00142298|4253852|P10|Overall Study|Clinical disease progression|0
1307846|NCT00142298|4253853|P9|Overall Study|Clinical disease progression|0
1307847|NCT00142298|4253854|P8|Overall Study|Clinical disease progression|0
1307848|NCT00142298|4253855|P7|Overall Study|Clinical disease progression|0
1307849|NCT00142298|4253856|P6|Overall Study|Clinical disease progression|0
1307850|NCT00142298|4253857|P5|Overall Study|Clinical disease progression|0
1307851|NCT00142298|4253858|P4|Overall Study|Clinical disease progression|0
1307852|NCT00142298|4253859|P3|Overall Study|Clinical disease progression|0
1307853|NCT00142298|4253860|P2|Overall Study|Clinical disease progression|0
1307854|NCT00142298|4253861|P1|Overall Study|Clinical disease progression|1
1307855|NCT00142298|4253852|P10|Overall Study|Adverse Event|0
1307856|NCT00142298|4253853|P9|Overall Study|Adverse Event|0
1307857|NCT00142298|4253854|P8|Overall Study|Adverse Event|0
1307858|NCT00142298|4253855|P7|Overall Study|Adverse Event|0
1307859|NCT00142298|4253856|P6|Overall Study|Adverse Event|2
1307860|NCT00142298|4253857|P5|Overall Study|Adverse Event|2
1307861|NCT00142298|4253858|P4|Overall Study|Adverse Event|5
1307862|NCT00142298|4253859|P3|Overall Study|Adverse Event|1
1307863|NCT00142298|4253860|P2|Overall Study|Adverse Event|10
1307864|NCT00142298|4253861|P1|Overall Study|Adverse Event|10
1307865|NCT00141921|4253895|P1|Overall Study|Other|8
1307866|NCT00141921|4253895|P1|Overall Study|Ineligibility Determined|2
1307867|NCT00141921|4253895|P1|Overall Study|Pregnancy|4
1307868|NCT00141921|4253895|P1|Overall Study|Administrative Decision|2
1307869|NCT00141921|4253895|P1|Overall Study|Adverse Event|5
1307870|NCT00141921|4253895|P1|Overall Study|Protocol Deviation|7
1307871|NCT00141921|4253895|P1|Overall Study|Disease Progression|7
1307872|NCT00141921|4253895|P1|Overall Study|Noncompliance|17
1307873|NCT00141921|4253895|P1|Overall Study|Lost to Follow-up|19
1307874|NCT00141921|4253895|P1|Overall Study|Withdrawal by Subject|42
1307875|NCT00141921|4253895|P1|Overall Study|Remain on Study|28
1307876|NCT00141817|4253921|P4|Overall Study|Parent request|0
1307877|NCT00141817|4253922|P3|Overall Study|Parent request|0
1307878|NCT00141817|4253923|P2|Overall Study|Parent request|0
1307879|NCT00141817|4253924|P1|Overall Study|Parent request|1
1307880|NCT00141817|4253921|P4|Overall Study|Protocol Violation|0
1307881|NCT00141817|4253922|P3|Overall Study|Protocol Violation|1
1307882|NCT00141817|4253923|P2|Overall Study|Protocol Violation|0
1307883|NCT00141817|4253924|P1|Overall Study|Protocol Violation|0
1307884|NCT00141778|4253965|P3|Started Study Medication|Chest Discomfort|1
1307885|NCT00141778|4253966|P2|Started Study Medication|Chest Discomfort|0
1307886|NCT00141778|4253967|P1|Started Study Medication|Chest Discomfort|0
1307887|NCT00141778|4253965|P3|Started Study Medication|Difficulty Swallowing|0
1307888|NCT00141778|4253966|P2|Started Study Medication|Difficulty Swallowing|1
1307889|NCT00141778|4253967|P1|Started Study Medication|Difficulty Swallowing|0
1307890|NCT00141778|4253965|P3|Started Study Medication|Withdrawal by Subject|0
1307891|NCT00141778|4253966|P2|Started Study Medication|Withdrawal by Subject|2
1307892|NCT00141778|4253967|P1|Started Study Medication|Withdrawal by Subject|0
1307893|NCT00141778|4253965|P3|Started Study Medication|Met safety criteria for discontinuation|3
1307894|NCT00141778|4253966|P2|Started Study Medication|Met safety criteria for discontinuation|4
1307895|NCT00141778|4253967|P1|Started Study Medication|Met safety criteria for discontinuation|2
1307896|NCT00141778|4253965|P3|Randomization Prior to Study Med|Withdrawal by Subject|6
1307897|NCT00141778|4253966|P2|Randomization Prior to Study Med|Withdrawal by Subject|2
1307898|NCT00141778|4253967|P1|Randomization Prior to Study Med|Withdrawal by Subject|5
1307899|NCT00141726|4254020|P1|Overall Study|Completed <50% Scheduled Dosing|3
1307900|NCT00141518|4254028|P3|Overall Study|Lack of Efficacy|0
1307901|NCT00141518|4254029|P2|Overall Study|Lack of Efficacy|0
1307902|NCT00141518|4254030|P1|Overall Study|Lack of Efficacy|5
1307903|NCT00141518|4254028|P3|Overall Study|Protocol Violation|2
1307904|NCT00141518|4254029|P2|Overall Study|Protocol Violation|1
1307905|NCT00141518|4254030|P1|Overall Study|Protocol Violation|1
1307906|NCT00141518|4254028|P3|Overall Study|Withdrawal by Subject|2
1307907|NCT00141518|4254029|P2|Overall Study|Withdrawal by Subject|0
1307908|NCT00141518|4254030|P1|Overall Study|Withdrawal by Subject|2
1307909|NCT00141518|4254028|P3|Overall Study|Adverse Event|2
1307910|NCT00141518|4254029|P2|Overall Study|Adverse Event|5
1307911|NCT00141518|4254030|P1|Overall Study|Adverse Event|7
1307912|NCT00141518|4254028|P3|Overall Study|Withdrew Consent Prior to Treatment|0
1307913|NCT00141518|4254029|P2|Overall Study|Withdrew Consent Prior to Treatment|0
1307914|NCT00141518|4254030|P1|Overall Study|Withdrew Consent Prior to Treatment|1
1307915|NCT00141453|4254219|P2|Overall Study|Protocol Violation|5
1307916|NCT00141453|4254220|P1|Overall Study|Protocol Violation|6
1307917|NCT00141297|4254234|P10|Overall Study|Transitioned|0
1307918|NCT00141297|4254235|P9|Overall Study|Transitioned|0
1307919|NCT00141297|4254236|P8|Overall Study|Transitioned|0
1307920|NCT00141297|4254237|P7|Overall Study|Transitioned|0
1307921|NCT00141297|4254238|P6|Overall Study|Transitioned|0
1307922|NCT00141297|4254239|P5|Overall Study|Transitioned|1
1307923|NCT00141297|4254240|P4|Overall Study|Transitioned|0
1307924|NCT00141297|4254241|P3|Overall Study|Transitioned|0
1307925|NCT00141297|4254242|P2|Overall Study|Transitioned|0
1307926|NCT00141297|4254243|P1|Overall Study|Transitioned|0
1307927|NCT00141297|4254234|P10|Overall Study|Progressive Disease|6
1307928|NCT00141297|4254235|P9|Overall Study|Progressive Disease|15
1307929|NCT00141297|4254236|P8|Overall Study|Progressive Disease|3
1307930|NCT00141297|4254237|P7|Overall Study|Progressive Disease|3
1307931|NCT00141297|4254238|P6|Overall Study|Progressive Disease|2
1307932|NCT00141297|4254239|P5|Overall Study|Progressive Disease|15
1307933|NCT00141297|4254240|P4|Overall Study|Progressive Disease|2
1307934|NCT00141297|4254241|P3|Overall Study|Progressive Disease|6
1307935|NCT00141297|4254242|P2|Overall Study|Progressive Disease|3
1307936|NCT00141297|4254243|P1|Overall Study|Progressive Disease|2
1307937|NCT00141297|4254234|P10|Overall Study|Other|0
1307938|NCT00141297|4254235|P9|Overall Study|Other|2
1307939|NCT00141297|4254236|P8|Overall Study|Other|0
1307940|NCT00141297|4254237|P7|Overall Study|Other|0
1307941|NCT00141297|4254238|P6|Overall Study|Other|0
1307942|NCT00141297|4254239|P5|Overall Study|Other|5
1307943|NCT00141297|4254240|P4|Overall Study|Other|1
1307944|NCT00141297|4254241|P3|Overall Study|Other|0
1307945|NCT00141297|4254242|P2|Overall Study|Other|0
1307946|NCT00141297|4254243|P1|Overall Study|Other|0
1307947|NCT00141297|4254234|P10|Overall Study|Withdrawal by Subject|0
1307948|NCT00141297|4254235|P9|Overall Study|Withdrawal by Subject|1
1307949|NCT00141297|4254236|P8|Overall Study|Withdrawal by Subject|0
1307950|NCT00141297|4254237|P7|Overall Study|Withdrawal by Subject|0
1307951|NCT00141297|4254238|P6|Overall Study|Withdrawal by Subject|0
1307952|NCT00141297|4254239|P5|Overall Study|Withdrawal by Subject|0
1307953|NCT00141297|4254240|P4|Overall Study|Withdrawal by Subject|0
1307954|NCT00141297|4254241|P3|Overall Study|Withdrawal by Subject|0
1307955|NCT00141297|4254242|P2|Overall Study|Withdrawal by Subject|0
1307956|NCT00141297|4254243|P1|Overall Study|Withdrawal by Subject|0
1307957|NCT00141297|4254234|P10|Overall Study|Death|0
1307958|NCT00141297|4254235|P9|Overall Study|Death|1
1307959|NCT00141297|4254236|P8|Overall Study|Death|0
1307960|NCT00141297|4254237|P7|Overall Study|Death|0
1307961|NCT00141297|4254238|P6|Overall Study|Death|0
1307962|NCT00141297|4254239|P5|Overall Study|Death|0
1307963|NCT00141297|4254240|P4|Overall Study|Death|0
1307964|NCT00141297|4254241|P3|Overall Study|Death|0
1307965|NCT00141297|4254242|P2|Overall Study|Death|0
1307966|NCT00141297|4254243|P1|Overall Study|Death|1
1307967|NCT00141297|4254234|P10|Overall Study|Adverse Event|0
1307968|NCT00141297|4254235|P9|Overall Study|Adverse Event|1
1307969|NCT00141297|4254236|P8|Overall Study|Adverse Event|1
1307970|NCT00141297|4254237|P7|Overall Study|Adverse Event|0
1307971|NCT00141297|4254238|P6|Overall Study|Adverse Event|1
1307972|NCT00141297|4254239|P5|Overall Study|Adverse Event|1
1307973|NCT00141297|4254240|P4|Overall Study|Adverse Event|0
1307974|NCT00141297|4254241|P3|Overall Study|Adverse Event|1
1307975|NCT00141297|4254242|P2|Overall Study|Adverse Event|0
1307976|NCT00141297|4254243|P1|Overall Study|Adverse Event|0
1307977|NCT00141271|4254521|P3|Overall Study|Other|5
1307978|NCT00141271|4254522|P2|Overall Study|Other|12
1307979|NCT00141271|4254523|P1|Overall Study|Other|11
1307980|NCT00141271|4254521|P3|Overall Study|Withdrawal by Subject|10
1307981|NCT00141271|4254522|P2|Overall Study|Withdrawal by Subject|9
1307982|NCT00141271|4254523|P1|Overall Study|Withdrawal by Subject|14
1307983|NCT00141271|4254521|P3|Overall Study|Lost to Follow-up|21
1307984|NCT00141271|4254522|P2|Overall Study|Lost to Follow-up|15
1307985|NCT00141271|4254523|P1|Overall Study|Lost to Follow-up|15
1307986|NCT00141271|4254521|P3|Overall Study|Lack of Efficacy|3
1307987|NCT00141271|4254522|P2|Overall Study|Lack of Efficacy|7
1307988|NCT00141271|4254523|P1|Overall Study|Lack of Efficacy|7
1307989|NCT00141271|4254521|P3|Overall Study|Laboratory Abnormality|1
1307990|NCT00141271|4254522|P2|Overall Study|Laboratory Abnormality|1
1307991|NCT00141271|4254523|P1|Overall Study|Laboratory Abnormality|2
1307992|NCT00141271|4254521|P3|Overall Study|Adverse Event|17
1307993|NCT00141271|4254522|P2|Overall Study|Adverse Event|19
1307994|NCT00141271|4254523|P1|Overall Study|Adverse Event|31
1307995|NCT00141219|4254644|P2|Overall Study|Withdrawal by Subject|2
1307996|NCT00141219|4254645|P1|Overall Study|Withdrawal by Subject|6
1307997|NCT00141219|4254644|P2|Overall Study|Lack of Efficacy|4
1307998|NCT00141219|4254645|P1|Overall Study|Lack of Efficacy|5
1307999|NCT00141219|4254644|P2|Overall Study|Adverse Event|6
1308000|NCT00141219|4254645|P1|Overall Study|Adverse Event|8
1308001|NCT00141219|4254644|P2|Overall Study|Protocol violations|4
1308002|NCT00141219|4254645|P1|Overall Study|Protocol violations|5
1308003|NCT00141102|4254702|P2|Overall Study|Death|2
1308004|NCT00141102|4254703|P1|Overall Study|Death|2
1308005|NCT00141102|4254702|P2|Overall Study|Randomized But Did Not Receive Treatment|9
1308006|NCT00141102|4254703|P1|Overall Study|Randomized But Did Not Receive Treatment|15
1308007|NCT00141102|4254702|P2|Overall Study|Withdrawal by Subject|142
1308008|NCT00141102|4254703|P1|Overall Study|Withdrawal by Subject|112
1308009|NCT00141102|4254702|P2|Overall Study|Other|76
1308010|NCT00141102|4254703|P1|Overall Study|Other|87
1308011|NCT00141102|4254702|P2|Overall Study|Lost to Follow-up|32
1308012|NCT00141102|4254703|P1|Overall Study|Lost to Follow-up|29
1308013|NCT00141102|4254702|P2|Overall Study|Lack of Efficacy|26
1308014|NCT00141102|4254703|P1|Overall Study|Lack of Efficacy|21
1308015|NCT00141102|4254702|P2|Overall Study|Laboratory Abnormality|33
1308016|NCT00141102|4254703|P1|Overall Study|Laboratory Abnormality|9
1308017|NCT00141102|4254702|P2|Overall Study|Adverse Event|305
1308018|NCT00141102|4254703|P1|Overall Study|Adverse Event|233
1308019|NCT00141037|4254743|P2|Overall Study|Graft Failure|4
1308020|NCT00141037|4254744|P1|Overall Study|Graft Failure|3
1308021|NCT00141037|4254743|P2|Overall Study|Moved from area|7
1308022|NCT00141037|4254744|P1|Overall Study|Moved from area|1
1308023|NCT00141037|4254743|P2|Overall Study|Other|1
1308024|NCT00141037|4254744|P1|Overall Study|Other|0
1308025|NCT00141037|4254743|P2|Overall Study|Withdrawal by Subject|1
1308026|NCT00141037|4254744|P1|Overall Study|Withdrawal by Subject|2
1308027|NCT00141037|4254743|P2|Overall Study|Protocol Violation|2
1308028|NCT00141037|4254744|P1|Overall Study|Protocol Violation|0
1308029|NCT00141037|4254743|P2|Overall Study|Lost to Follow-up|1
1308030|NCT00141037|4254744|P1|Overall Study|Lost to Follow-up|3
1308031|NCT00141037|4254743|P2|Overall Study|Physician Decision|2
1308032|NCT00141037|4254744|P1|Overall Study|Physician Decision|1
1308033|NCT00140426|4254779|P2|Overall Study|Withdrawal by Subject|3
1308034|NCT00140426|4254780|P1|Overall Study|Withdrawal by Subject|0
1308035|NCT00140413|4254813|P2|Overall Study|Withdrawal by Subject|0
1308036|NCT00140413|4254814|P1|Overall Study|Withdrawal by Subject|2
1308037|NCT00140413|4254813|P2|Overall Study|Lost to Follow-up|0
1308038|NCT00140413|4254814|P1|Overall Study|Lost to Follow-up|1
1308039|NCT00140140|4254945|P3|Overall Study|Physician Decision|0
1308040|NCT00140140|4254946|P2|Overall Study|Physician Decision|1
1308041|NCT00140140|4254947|P1|Overall Study|Physician Decision|1
1308042|NCT00140140|4254945|P3|Overall Study|Unacceptable toxicity|2
1308043|NCT00140140|4254946|P2|Overall Study|Unacceptable toxicity|1
1308044|NCT00140140|4254947|P1|Overall Study|Unacceptable toxicity|1
1308045|NCT00139776|4254997|P4|Period III|Withdrawal by Subject|21
1308046|NCT00139776|4254998|P3|Period III|Withdrawal by Subject|16
1308047|NCT00139776|4254999|P2|Period III|Withdrawal by Subject|0
1308048|NCT00139776|4255000|P1|Period III|Withdrawal by Subject|0
1308049|NCT00139776|4254997|P4|Period III|Lost to Follow-up|4
1308050|NCT00139776|4254998|P3|Period III|Lost to Follow-up|5
1308051|NCT00139776|4254999|P2|Period III|Lost to Follow-up|0
1308052|NCT00139776|4255000|P1|Period III|Lost to Follow-up|0
1308053|NCT00139776|4254997|P4|Period III|Lack of Efficacy|24
1308054|NCT00139776|4254998|P3|Period III|Lack of Efficacy|10
1308055|NCT00139776|4254999|P2|Period III|Lack of Efficacy|0
1308056|NCT00139776|4255000|P1|Period III|Lack of Efficacy|0
1308057|NCT00139776|4254997|P4|Period III|Other|34
1308058|NCT00139776|4254998|P3|Period III|Other|23
1308059|NCT00139776|4254999|P2|Period III|Other|0
1308060|NCT00139776|4255000|P1|Period III|Other|0
1308061|NCT00139776|4254997|P4|Period III|Adverse Event|23
1308062|NCT00139776|4254998|P3|Period III|Adverse Event|22
1308063|NCT00139776|4254999|P2|Period III|Adverse Event|0
1308064|NCT00139776|4255000|P1|Period III|Adverse Event|0
1308065|NCT00139776|4254997|P4|Period II|Not Randomized into Period III|0
1308066|NCT00139776|4254998|P3|Period II|Not Randomized into Period III|0
1308067|NCT00139776|4254999|P2|Period II|Not Randomized into Period III|322
1308068|NCT00139776|4255000|P1|Period II|Not Randomized into Period III|0
1308069|NCT00139776|4254997|P4|Period I|Did not enter Period II|0
1308070|NCT00139776|4254998|P3|Period I|Did not enter Period II|0
1308071|NCT00139776|4254999|P2|Period I|Did not enter Period II|0
1308072|NCT00139776|4255000|P1|Period I|Did not enter Period II|575
1308073|NCT00139737|4255035|P1|Overall Study|Screened, Not Treated|13
1308074|NCT00139737|4255035|P1|Overall Study|Did Not Meet Entrance Criteria|1
1308075|NCT00139737|4255035|P1|Overall Study|Withdrew During Screening Phase|8
1308076|NCT00139737|4255035|P1|Overall Study|Protocol Violation|18
1308077|NCT00139737|4255035|P1|Overall Study|Laboratory Abnormality|2
1308078|NCT00139737|4255035|P1|Overall Study|Death|3
1308079|NCT00139737|4255035|P1|Overall Study|Lost to Follow-up|8
1308080|NCT00139737|4255035|P1|Overall Study|Lack of Efficacy|40
1308081|NCT00139737|4255035|P1|Overall Study|Adverse Event|58
1308082|NCT00139737|4255035|P1|Overall Study|Withdrawal by Subject|190
1308083|NCT00139659|4255041|P2|Overall Study|Withdrawal by Subject|10
1308084|NCT00139659|4255042|P1|Overall Study|Withdrawal by Subject|14
1308085|NCT00139659|4255041|P2|Overall Study|Reason not Specified|3
1308086|NCT00139659|4255042|P1|Overall Study|Reason not Specified|6
1308087|NCT00139659|4255041|P2|Overall Study|Lost to Follow-up|3
1308088|NCT00139659|4255042|P1|Overall Study|Lost to Follow-up|7
1308089|NCT00139659|4255041|P2|Overall Study|Lack of Efficacy|1
1308090|NCT00139659|4255042|P1|Overall Study|Lack of Efficacy|1
1308091|NCT00139659|4255041|P2|Overall Study|Adverse Event|1
1308092|NCT00139659|4255042|P1|Overall Study|Adverse Event|12
1308093|NCT00139477|4255120|P2|Second Intervention -6Months to 12Months|Lost to Follow-up|3
1308094|NCT00139477|4255121|P1|Second Intervention -6Months to 12Months|Lost to Follow-up|4
1308095|NCT00139477|4255120|P2|Second Intervention -6Months to 12Months|Relocation|0
1308096|NCT00139477|4255121|P1|Second Intervention -6Months to 12Months|Relocation|1
1308097|NCT00139477|4255120|P2|Second Intervention -6Months to 12Months|No Longer Interested|2
1308098|NCT00139477|4255121|P1|Second Intervention -6Months to 12Months|No Longer Interested|0
1308099|NCT00139477|4255120|P2|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0
1308100|NCT00139477|4255121|P1|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2
1308101|NCT00139477|4255120|P2|First Intervention -Baseline to 6Months|Lost to Follow-up|3
1308102|NCT00139477|4255121|P1|First Intervention -Baseline to 6Months|Lost to Follow-up|3
1308103|NCT00139477|4255120|P2|First Intervention -Baseline to 6Months|Relocation|2
1308104|NCT00139477|4255121|P1|First Intervention -Baseline to 6Months|Relocation|1
1308105|NCT00139477|4255120|P2|First Intervention -Baseline to 6Months|No Longer Interested|7
1308106|NCT00139477|4255121|P1|First Intervention -Baseline to 6Months|No Longer Interested|6
1308107|NCT00138671|4255143|P2|Overall Study|Other|3
1308108|NCT00138671|4255144|P1|Overall Study|Other|3
1308109|NCT00138671|4255143|P2|Overall Study|Withdrawal by Subject|5
1308110|NCT00138671|4255144|P1|Overall Study|Withdrawal by Subject|3
1308111|NCT00138671|4255143|P2|Overall Study|Lost to Follow-up|2
1308112|NCT00138671|4255144|P1|Overall Study|Lost to Follow-up|1
1308113|NCT00138671|4255143|P2|Overall Study|Adverse Event|3
1308114|NCT00138671|4255144|P1|Overall Study|Adverse Event|6
1308115|NCT00138671|4255143|P2|Overall Study|Death|3
1308116|NCT00138671|4255144|P1|Overall Study|Death|0
1308117|NCT00138658|4255194|P1|Overall Study|Withdrawal by Subject|5
1308118|NCT00138658|4255194|P1|Overall Study|Physician Decision|11
1308119|NCT00138658|4255194|P1|Overall Study|Disease Progression|21
1308120|NCT00138658|4255194|P1|Overall Study|Death|1
1308121|NCT00138658|4255194|P1|Overall Study|Adverse Event|23
1308122|NCT00138424|4255217|P4|Overall Study|Physician Decision|0
1308123|NCT00138424|4255218|P3|Overall Study|Physician Decision|0
1308124|NCT00138424|4255219|P2|Overall Study|Physician Decision|1
1308125|NCT00138424|4255220|P1|Overall Study|Physician Decision|0
1308126|NCT00138151|4255303|P1|Overall Study|Physician Decision|1
1308127|NCT00138151|4255303|P1|Overall Study|Withdrawal by Subject|3
1308128|NCT00138073|4255313|P1|Overall Study|lack of resources|55
1308129|NCT00137631|4255354|P2|Overall Study|Lost to Follow-up|41
1308130|NCT00137631|4255355|P1|Overall Study|Lost to Follow-up|37
1308131|NCT00137449|4255371|P2|Overall Study|Withdrawal by Subject|1
1308132|NCT00137449|4255372|P1|Overall Study|Withdrawal by Subject|1
1308133|NCT00137449|4255371|P2|Overall Study|Adverse Event|1
1308134|NCT00137449|4255372|P1|Overall Study|Adverse Event|3
1308135|NCT00137449|4255371|P2|Overall Study|Death|3
1308136|NCT00137449|4255372|P1|Overall Study|Death|4
1308137|NCT00137449|4255371|P2|Overall Study|Disease Progression|13
1308138|NCT00137449|4255372|P1|Overall Study|Disease Progression|8
1308139|NCT00137436|4255409|P1|Overall Study|Other|5
1308140|NCT00137436|4255409|P1|Overall Study|Withdrawal by Subject|6
1308141|NCT00137436|4255409|P1|Overall Study|Lack of Efficacy|17
1308142|NCT00137436|4255409|P1|Overall Study|Death|2
1308143|NCT00137436|4255409|P1|Overall Study|Adverse Event|13
1308144|NCT00137423|4255428|P2|Overall Study|Death|1
1308145|NCT00137423|4255429|P1|Overall Study|Death|0
1308146|NCT00137423|4255428|P2|Overall Study|Lack of Efficacy|33
1308147|NCT00137423|4255429|P1|Overall Study|Lack of Efficacy|31
1308148|NCT00137423|4255428|P2|Overall Study|consent withdrawn|1
1308149|NCT00137423|4255429|P1|Overall Study|consent withdrawn|1
1308150|NCT00137423|4255428|P2|Overall Study|Adverse Event|9
1308151|NCT00137423|4255429|P1|Overall Study|Adverse Event|7
1308152|NCT00137267|4255466|P2|Overall Study|Lost to Follow-up|21
1308153|NCT00137267|4255467|P1|Overall Study|Lost to Follow-up|15
1308154|NCT00137111|4255479|P4|Total Therapy|Non Compliance|0
1308155|NCT00137111|4255480|P3|Total Therapy|Non Compliance|0
1308156|NCT00137111|4255481|P2|Total Therapy|Non Compliance|0
1308157|NCT00137111|4255482|P1|Total Therapy|Non Compliance|5
1308158|NCT00137111|4255479|P4|Total Therapy|Death|0
1308159|NCT00137111|4255480|P3|Total Therapy|Death|0
1308160|NCT00137111|4255481|P2|Total Therapy|Death|0
1308161|NCT00137111|4255482|P1|Total Therapy|Death|35
1308162|NCT00137046|4255496|P2|Overall Study|Withdrew prior to study treatment|1
1308163|NCT00137046|4255497|P1|Overall Study|Withdrew prior to study treatment|1
1308164|NCT00137046|4255496|P2|Overall Study|Adverse Event 4 Days after Last Dose|0
1308165|NCT00137046|4255497|P1|Overall Study|Adverse Event 4 Days after Last Dose|1
1308166|NCT00137046|4255496|P2|Overall Study|Withdrawal by Subject|42
1308167|NCT00137046|4255497|P1|Overall Study|Withdrawal by Subject|33
1308168|NCT00137046|4255496|P2|Overall Study|Other|19
1308169|NCT00137046|4255497|P1|Overall Study|Other|23
1308170|NCT00137046|4255496|P2|Overall Study|Lost to Follow-up|24
1308171|NCT00137046|4255497|P1|Overall Study|Lost to Follow-up|8
1308172|NCT00137046|4255496|P2|Overall Study|Lack of Efficacy|1
1308173|NCT00137046|4255497|P1|Overall Study|Lack of Efficacy|13
1308174|NCT00137046|4255496|P2|Overall Study|Laboratory Abnormality|0
1308175|NCT00137046|4255497|P1|Overall Study|Laboratory Abnormality|2
1308176|NCT00137046|4255496|P2|Overall Study|Adverse Event|5
1308177|NCT00137046|4255497|P1|Overall Study|Adverse Event|16
1308178|NCT00137046|4255496|P2|Overall Study|Death|1
1308179|NCT00137046|4255497|P1|Overall Study|Death|2
1308180|NCT00136955|4255545|P1|Overall Study|Incl. prog. disease, protocol violation|12
1308181|NCT00136955|4255545|P1|Overall Study|Withdrawal by Subject|2
1308182|NCT00136955|4255545|P1|Overall Study|Lost to Follow-up|1
1308183|NCT00136955|4255545|P1|Overall Study|Adverse Event|8
1308184|NCT00136916|4255554|P2|Overall Study|Discontinued in follow up period|0
1308185|NCT00136916|4255555|P1|Overall Study|Discontinued in follow up period|3
1308186|NCT00136916|4255554|P2|Overall Study|Other|24
1308187|NCT00136916|4255555|P1|Overall Study|Other|22
1308188|NCT00136916|4255554|P2|Overall Study|Withdrawal by Subject|46
1308189|NCT00136916|4255555|P1|Overall Study|Withdrawal by Subject|44
1308190|NCT00136916|4255554|P2|Overall Study|Lost to Follow-up|14
1308191|NCT00136916|4255555|P1|Overall Study|Lost to Follow-up|12
1308192|NCT00136916|4255554|P2|Overall Study|Lack of Efficacy|3
1308193|NCT00136916|4255555|P1|Overall Study|Lack of Efficacy|13
1308194|NCT00136916|4255554|P2|Overall Study|Laboratory abnormality|1
1308195|NCT00136916|4255555|P1|Overall Study|Laboratory abnormality|0
1308196|NCT00136916|4255554|P2|Overall Study|Adverse Event|8
1308197|NCT00136916|4255555|P1|Overall Study|Adverse Event|27
1308198|NCT00136916|4255554|P2|Overall Study|Death|3
1308199|NCT00136916|4255555|P1|Overall Study|Death|1
1308200|NCT00136916|4255554|P2|Overall Study|Never received study treatment|5
1308201|NCT00136916|4255555|P1|Overall Study|Never received study treatment|3
1308202|NCT00136604|4255662|P5|Overall Study|Migrated/moved from study area|0
1308203|NCT00136604|4255663|P4|Overall Study|Migrated/moved from study area|0
1308204|NCT00136604|4255664|P3|Overall Study|Migrated/moved from study area|0
1308205|NCT00136604|4255665|P2|Overall Study|Migrated/moved from study area|1
1308206|NCT00136604|4255666|P1|Overall Study|Migrated/moved from study area|0
1308207|NCT00136604|4255662|P5|Overall Study|Lost to Follow-up|1
1308208|NCT00136604|4255663|P4|Overall Study|Lost to Follow-up|0
1308209|NCT00136604|4255664|P3|Overall Study|Lost to Follow-up|0
1308210|NCT00136604|4255665|P2|Overall Study|Lost to Follow-up|0
1308211|NCT00136604|4255666|P1|Overall Study|Lost to Follow-up|1
1308212|NCT00136357|4255774|P2|Overall Study|Withdrawal by Subject|2
1308213|NCT00136357|4255775|P1|Overall Study|Withdrawal by Subject|3
1308214|NCT00136318|4255783|P2|Overall Study|Withdrawal by Subject|2
1308215|NCT00136318|4255784|P1|Overall Study|Withdrawal by Subject|2
1308216|NCT00136318|4255783|P2|Overall Study|Adverse Event|5
1308217|NCT00136318|4255784|P1|Overall Study|Adverse Event|5
1308218|NCT00136084|4255811|P2|Overall Study|Withdrawal by Subject|1
1308219|NCT00136084|4255812|P1|Overall Study|Withdrawal by Subject|5
1308220|NCT00136084|4255811|P2|Overall Study|No Response|2
1308221|NCT00136084|4255812|P1|Overall Study|No Response|1
1308222|NCT00136084|4255811|P2|Overall Study|Lost to Follow-up|0
1308223|NCT00136084|4255812|P1|Overall Study|Lost to Follow-up|2
1308224|NCT00136084|4255811|P2|Overall Study|Relapse|23
1308225|NCT00136084|4255812|P1|Overall Study|Relapse|20
1308226|NCT00136084|4255811|P2|Overall Study|Unacceptable toxicity|11
1308227|NCT00136084|4255812|P1|Overall Study|Unacceptable toxicity|8
1308228|NCT00136084|4255811|P2|Overall Study|Death|5
1308229|NCT00136084|4255812|P1|Overall Study|Death|12
1308230|NCT00135707|4255848|P2|Overall Study|Institutional review board request|0
1308231|NCT00135707|4255849|P1|Overall Study|Institutional review board request|1
1308232|NCT00135707|4255848|P2|Overall Study|Withdrawal by Subject|1
1308233|NCT00135707|4255849|P1|Overall Study|Withdrawal by Subject|0
1308234|NCT00135707|4255848|P2|Overall Study|Lost to Follow-up|89
1308235|NCT00135707|4255849|P1|Overall Study|Lost to Follow-up|94
1308236|NCT00135694|4255932|P3|Overall Study|Ineligible for Random assignment|0
1308237|NCT00135694|4255933|P2|Overall Study|Ineligible for Random assignment|0
1308238|NCT00135694|4255934|P1|Overall Study|Ineligible for Random assignment|42
1308239|NCT00135694|4255932|P3|Overall Study|Hepatitis C related reasons|0
1308240|NCT00135694|4255933|P2|Overall Study|Hepatitis C related reasons|1
1308241|NCT00135694|4255934|P1|Overall Study|Hepatitis C related reasons|39
1308242|NCT00135694|4255932|P3|Overall Study|Protocol Violation|0
1308243|NCT00135694|4255933|P2|Overall Study|Protocol Violation|1
1308244|NCT00135694|4255934|P1|Overall Study|Protocol Violation|19
1308245|NCT00135694|4255932|P3|Overall Study|Withdrawal by Subject|4
1308246|NCT00135694|4255933|P2|Overall Study|Withdrawal by Subject|7
1308247|NCT00135694|4255934|P1|Overall Study|Withdrawal by Subject|41
1308248|NCT00135694|4255932|P3|Overall Study|Lost to Follow-up|1
1308249|NCT00135694|4255933|P2|Overall Study|Lost to Follow-up|7
1308250|NCT00135694|4255934|P1|Overall Study|Lost to Follow-up|8
1308251|NCT00135694|4255932|P3|Overall Study|Death|2
1308252|NCT00135694|4255933|P2|Overall Study|Death|1
1308253|NCT00135694|4255934|P1|Overall Study|Death|14
1308254|NCT00135694|4255932|P3|Overall Study|Adverse Event|0
1308255|NCT00135694|4255933|P2|Overall Study|Adverse Event|4
1308256|NCT00135694|4255934|P1|Overall Study|Adverse Event|17
1308257|NCT00135356|4255954|P2|Overall Study|Withdrawal by Subject|4
1308258|NCT00135356|4255955|P1|Overall Study|Withdrawal by Subject|2
1308259|NCT00135356|4255954|P2|Overall Study|No longer meets study criteria|0
1308260|NCT00135356|4255955|P1|Overall Study|No longer meets study criteria|2
1308261|NCT00135356|4255954|P2|Overall Study|Poor/noncompliance|1
1308262|NCT00135356|4255955|P1|Overall Study|Poor/noncompliance|1
1308263|NCT00135356|4255954|P2|Overall Study|Change in antiviral regimen|1
1308264|NCT00135356|4255955|P1|Overall Study|Change in antiviral regimen|0
1308265|NCT00135356|4255954|P2|Overall Study|Surgery for abdominal fat|0
1308266|NCT00135356|4255955|P1|Overall Study|Surgery for abdominal fat|1
1308267|NCT00135356|4255954|P2|Overall Study|Lost to Follow-up|1
1308268|NCT00135356|4255955|P1|Overall Study|Lost to Follow-up|3
1308269|NCT00135356|4255954|P2|Overall Study|Lack of Efficacy|0
1308270|NCT00135356|4255955|P1|Overall Study|Lack of Efficacy|2
1308271|NCT00135356|4255954|P2|Overall Study|Adverse Event|2
1308272|NCT00135356|4255955|P1|Overall Study|Adverse Event|6
1308273|NCT00135330|4255998|P3|Overall Study|Sponsor Decision|0
1308274|NCT00135330|4255999|P2|Overall Study|Sponsor Decision|1
1308275|NCT00135330|4256000|P1|Overall Study|Sponsor Decision|0
1308276|NCT00135330|4255998|P3|Overall Study|Patient Decision|4
1308277|NCT00135330|4255999|P2|Overall Study|Patient Decision|1
1308278|NCT00135330|4256000|P1|Overall Study|Patient Decision|5
1308279|NCT00135330|4255998|P3|Overall Study|Protocol Violation|3
1308280|NCT00135330|4255999|P2|Overall Study|Protocol Violation|3
1308281|NCT00135330|4256000|P1|Overall Study|Protocol Violation|4
1308282|NCT00135330|4255998|P3|Overall Study|Physician Decision|0
1308283|NCT00135330|4255999|P2|Overall Study|Physician Decision|1
1308284|NCT00135330|4256000|P1|Overall Study|Physician Decision|1
1308285|NCT00135330|4255998|P3|Overall Study|Lost to Follow-up|3
1308286|NCT00135330|4255999|P2|Overall Study|Lost to Follow-up|2
1308287|NCT00135330|4256000|P1|Overall Study|Lost to Follow-up|0
1308288|NCT00135330|4255998|P3|Overall Study|Adverse Event|1
1308289|NCT00135330|4255999|P2|Overall Study|Adverse Event|5
1308290|NCT00135330|4256000|P1|Overall Study|Adverse Event|2
1308291|NCT00134901|4256099|P2|Overall Study|discontinued intervention|10
1308292|NCT00134901|4256100|P1|Overall Study|discontinued intervention|12
1308293|NCT00134901|4256099|P2|Overall Study|Lost to Follow-up|5
1308294|NCT00134901|4256100|P1|Overall Study|Lost to Follow-up|5
1308295|NCT00134784|4256112|P4|Overall Study|Withdrawal by Subject|1
1308296|NCT00134784|4256113|P3|Overall Study|Withdrawal by Subject|2
1308297|NCT00134784|4256114|P2|Overall Study|Withdrawal by Subject|2
1308298|NCT00134784|4256115|P1|Overall Study|Withdrawal by Subject|2
1308299|NCT00134719|4256125|P3|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
1308300|NCT00134719|4256126|P2|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
1308301|NCT00134719|4256127|P1|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1
1308302|NCT00134719|4256125|P3|Fourth Dose Vaccination Phase|Lost to Follow-up|1
1308303|NCT00134719|4256126|P2|Fourth Dose Vaccination Phase|Lost to Follow-up|3
1308304|NCT00134719|4256127|P1|Fourth Dose Vaccination Phase|Lost to Follow-up|1
1308305|NCT00134719|4256125|P3|Primary Vaccination Phase|Lost to Follow-up|3
1308306|NCT00134719|4256126|P2|Primary Vaccination Phase|Lost to Follow-up|3
1308307|NCT00134719|4256127|P1|Primary Vaccination Phase|Lost to Follow-up|7
1308308|NCT00134719|4256125|P3|Primary Vaccination Phase|Withdrawal by Subject|2
1308309|NCT00134719|4256126|P2|Primary Vaccination Phase|Withdrawal by Subject|3
1308310|NCT00134719|4256127|P1|Primary Vaccination Phase|Withdrawal by Subject|2
1308311|NCT00134719|4256125|P3|Primary Vaccination Phase|Protocol Violation|0
1308312|NCT00134719|4256126|P2|Primary Vaccination Phase|Protocol Violation|0
1308313|NCT00134719|4256127|P1|Primary Vaccination Phase|Protocol Violation|1
1308314|NCT00134719|4256125|P3|Primary Vaccination Phase|Adverse Event|0
1308315|NCT00134719|4256126|P2|Primary Vaccination Phase|Adverse Event|0
1308316|NCT00134719|4256127|P1|Primary Vaccination Phase|Adverse Event|4
1308317|NCT00134563|4256258|P3|Overall Study|Reason other than above|5
1308318|NCT00134563|4256259|P2|Overall Study|Reason other than above|2
1308319|NCT00134563|4256260|P1|Overall Study|Reason other than above|0
1308320|NCT00134563|4256258|P3|Overall Study|did not wish to continue|26
1308321|NCT00134563|4256259|P2|Overall Study|did not wish to continue|32
1308322|NCT00134563|4256260|P1|Overall Study|did not wish to continue|33
1308323|NCT00134563|4256258|P3|Overall Study|progressive disease|2
1308324|NCT00134563|4256259|P2|Overall Study|progressive disease|4
1308325|NCT00134563|4256260|P1|Overall Study|progressive disease|11
1308326|NCT00134563|4256258|P3|Overall Study|Lost to Follow-up|2
1308327|NCT00134563|4256259|P2|Overall Study|Lost to Follow-up|0
1308328|NCT00134563|4256260|P1|Overall Study|Lost to Follow-up|4
1308329|NCT00134563|4256258|P3|Overall Study|Protocol Violation|5
1308330|NCT00134563|4256259|P2|Overall Study|Protocol Violation|2
1308331|NCT00134563|4256260|P1|Overall Study|Protocol Violation|3
1308332|NCT00134563|4256258|P3|Overall Study|Lack of Efficacy|17
1308333|NCT00134563|4256259|P2|Overall Study|Lack of Efficacy|14
1308334|NCT00134563|4256260|P1|Overall Study|Lack of Efficacy|24
1308335|NCT00134563|4256258|P3|Overall Study|Adverse Event|38
1308336|NCT00134563|4256259|P2|Overall Study|Adverse Event|37
1308337|NCT00134563|4256260|P1|Overall Study|Adverse Event|29
1308338|NCT00134563|4256258|P3|Overall Study|Not treated due to protocol violation|1
1308339|NCT00134563|4256259|P2|Overall Study|Not treated due to protocol violation|1
1308340|NCT00134563|4256260|P1|Overall Study|Not treated due to protocol violation|0
1308341|NCT00134056|4256323|P2|Eligible for Protocol Assigned Treatment|Not specified|56
1308342|NCT00134056|4256324|P1|Eligible for Protocol Assigned Treatment|Not specified|55
1308343|NCT00134056|4256323|P2|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21
1308344|NCT00134056|4256324|P1|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20
1308345|NCT00134056|4256323|P2|Eligible for Protocol Assigned Treatment|Adverse Event|67
1308346|NCT00134056|4256324|P1|Eligible for Protocol Assigned Treatment|Adverse Event|81
1308347|NCT00134056|4256323|P2|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
1308348|NCT00134056|4256324|P1|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
1308349|NCT00134056|4256323|P2|Randomization|Not eligible for assigned treatment|20
1308350|NCT00134056|4256324|P1|Randomization|Not eligible for assigned treatment|22
1308351|NCT00133991|4256368|P1|Overall Study|Death|4
1308352|NCT00133952|4256407|P2|Overall Study|Sponsor Decision|1
1308353|NCT00133952|4256408|P1|Overall Study|Sponsor Decision|0
1308354|NCT00133952|4256407|P2|Overall Study|Physician Decision|3
1308355|NCT00133952|4256408|P1|Overall Study|Physician Decision|4
1308356|NCT00133952|4256407|P2|Overall Study|Withdrawal by Subject|4
1308357|NCT00133952|4256408|P1|Overall Study|Withdrawal by Subject|20
1308358|NCT00133952|4256407|P2|Overall Study|Protocol Violation|1
1308359|NCT00133952|4256408|P1|Overall Study|Protocol Violation|1
1308360|NCT00133952|4256407|P2|Overall Study|Protocol Entry Criteria Exclusion|1
1308361|NCT00133952|4256408|P1|Overall Study|Protocol Entry Criteria Exclusion|4
1308362|NCT00133952|4256407|P2|Overall Study|Lost to Follow-up|14
1308363|NCT00133952|4256408|P1|Overall Study|Lost to Follow-up|9
1308364|NCT00133952|4256407|P2|Overall Study|Death|2
1308365|NCT00133952|4256408|P1|Overall Study|Death|3
1308366|NCT00133952|4256407|P2|Overall Study|Adverse Event|2
1308367|NCT00133952|4256408|P1|Overall Study|Adverse Event|1
1308368|NCT00133705|4256439|P2|Overall Study|Withdrawal by Subject|3
1308369|NCT00133705|4256440|P1|Overall Study|Withdrawal by Subject|2
1308370|NCT00132873|4256566|P1|Overall Study|Planned Pregnancy|1
1308371|NCT00132873|4256566|P1|Overall Study|Withdrawal by Subject|3
1308372|NCT00132873|4256566|P1|Overall Study|Lack of Efficacy|1
1308373|NCT00132873|4256566|P1|Overall Study|Lost to Follow-up|1
1308374|NCT00132873|4256566|P1|Overall Study|Adverse Event|3
1308375|NCT00132808|4256574|P3|Stratum II|Withdrawal by Subject|6
1308376|NCT00132808|4256575|P2|Stratum II|Withdrawal by Subject|9
1308377|NCT00132808|4256576|P1|Stratum II|Withdrawal by Subject|4
1308378|NCT00132808|4256574|P3|Stratum II|Protocol Violation|1
1308379|NCT00132808|4256575|P2|Stratum II|Protocol Violation|2
1308380|NCT00132808|4256576|P1|Stratum II|Protocol Violation|0
1308381|NCT00132808|4256574|P3|Stratum II|Lost to Follow-up|1
1308382|NCT00132808|4256575|P2|Stratum II|Lost to Follow-up|2
1308383|NCT00132808|4256576|P1|Stratum II|Lost to Follow-up|2
1308384|NCT00132808|4256574|P3|Stratum II|Death|0
1308385|NCT00132808|4256575|P2|Stratum II|Death|0
1308386|NCT00132808|4256576|P1|Stratum II|Death|1
1308387|NCT00132808|4256574|P3|Stratum II|Adverse Event|1
1308388|NCT00132808|4256575|P2|Stratum II|Adverse Event|2
1308389|NCT00132808|4256576|P1|Stratum II|Adverse Event|1
1308390|NCT00132808|4256574|P3|Stratum I|Abnormal test procedure result (s)|1
1308391|NCT00132808|4256575|P2|Stratum I|Abnormal test procedure result (s)|0
1308392|NCT00132808|4256576|P1|Stratum I|Abnormal test procedure result (s)|0
1308393|NCT00132808|4256574|P3|Stratum I|Withdrawal by Subject|3
1308394|NCT00132808|4256575|P2|Stratum I|Withdrawal by Subject|7
1308395|NCT00132808|4256576|P1|Stratum I|Withdrawal by Subject|4
1308396|NCT00132808|4256574|P3|Stratum I|Lost to Follow-up|1
1308397|NCT00132808|4256575|P2|Stratum I|Lost to Follow-up|4
1308398|NCT00132808|4256576|P1|Stratum I|Lost to Follow-up|3
1308399|NCT00132808|4256574|P3|Stratum I|Adverse Event|0
1308400|NCT00132808|4256575|P2|Stratum I|Adverse Event|1
1308401|NCT00132808|4256576|P1|Stratum I|Adverse Event|2
1308402|NCT00132769|4256601|P2|Overall Study|Protocol Violation|1
1308403|NCT00132769|4256602|P1|Overall Study|Protocol Violation|1
1308404|NCT00132769|4256601|P2|Overall Study|Adverse Event|1
1308405|NCT00132769|4256602|P1|Overall Study|Adverse Event|2
1308406|NCT00132769|4256601|P2|Overall Study|Lack of Efficacy|6
1308407|NCT00132769|4256602|P1|Overall Study|Lack of Efficacy|7
1308408|NCT00132769|4256601|P2|Overall Study|Withdrawal by Subject|3
1308409|NCT00132769|4256602|P1|Overall Study|Withdrawal by Subject|1
1308410|NCT00132730|4256628|P6|Period V - Open-label Extension (EXT2)|Site terminated|2
1308411|NCT00132730|4256629|P5|Period V - Open-label Extension (EXT2)|Site terminated|7
1308412|NCT00132730|4256630|P4|Period V - Open-label Extension (EXT2)|Site terminated|0
1308413|NCT00132730|4256631|P3|Period V - Open-label Extension (EXT2)|Site terminated|0
1308414|NCT00132730|4256632|P2|Period V - Open-label Extension (EXT2)|Site terminated|0
1308415|NCT00132730|4256633|P1|Period V - Open-label Extension (EXT2)|Site terminated|0
1308416|NCT00132730|4256628|P6|Period IV - Open-label Extension (EXT2)|Other reasons|0
1308417|NCT00132730|4256629|P5|Period IV - Open-label Extension (EXT2)|Other reasons|6
1308418|NCT00132730|4256630|P4|Period IV - Open-label Extension (EXT2)|Other reasons|0
1308419|NCT00132730|4256631|P3|Period IV - Open-label Extension (EXT2)|Other reasons|0
1308420|NCT00132730|4256632|P2|Period IV - Open-label Extension (EXT2)|Other reasons|0
1308421|NCT00132730|4256633|P1|Period IV - Open-label Extension (EXT2)|Other reasons|0
1308422|NCT00132730|4256628|P6|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
1308423|NCT00132730|4256629|P5|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1
1308424|NCT00132730|4256630|P4|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
1308425|NCT00132730|4256631|P3|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
1308426|NCT00132730|4256632|P2|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
1308427|NCT00132730|4256633|P1|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
1308428|NCT00132730|4256628|P6|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
1308429|NCT00132730|4256629|P5|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3
1308430|NCT00132730|4256630|P4|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
1308431|NCT00132730|4256631|P3|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
1308432|NCT00132730|4256632|P2|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
1308433|NCT00132730|4256633|P1|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
1308434|NCT00132730|4256628|P6|Period IV - Open-label Extension (EXT2)|Site terminated|68
1308435|NCT00132730|4256629|P5|Period IV - Open-label Extension (EXT2)|Site terminated|169
1308436|NCT00132730|4256630|P4|Period IV - Open-label Extension (EXT2)|Site terminated|0
1308437|NCT00132730|4256631|P3|Period IV - Open-label Extension (EXT2)|Site terminated|0
1308438|NCT00132730|4256632|P2|Period IV - Open-label Extension (EXT2)|Site terminated|0
1308439|NCT00132730|4256633|P1|Period IV - Open-label Extension (EXT2)|Site terminated|0
1308440|NCT00132730|4256628|P6|Period III - Blinded Extension (EXT1)|Other reasons|0
1308441|NCT00132730|4256629|P5|Period III - Blinded Extension (EXT1)|Other reasons|0
1308442|NCT00132730|4256630|P4|Period III - Blinded Extension (EXT1)|Other reasons|3
1308443|NCT00132730|4256631|P3|Period III - Blinded Extension (EXT1)|Other reasons|14
1308444|NCT00132730|4256632|P2|Period III - Blinded Extension (EXT1)|Other reasons|0
1308445|NCT00132730|4256633|P1|Period III - Blinded Extension (EXT1)|Other reasons|0
1308446|NCT00132730|4256628|P6|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
1308447|NCT00132730|4256629|P5|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
1308448|NCT00132730|4256630|P4|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1
1308449|NCT00132730|4256631|P3|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
1308450|NCT00132730|4256632|P2|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
1308451|NCT00132730|4256633|P1|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
1308452|NCT00132730|4256628|P6|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
1308453|NCT00132730|4256629|P5|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
1308454|NCT00132730|4256630|P4|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1
1308455|NCT00132730|4256631|P3|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11
1308456|NCT00132730|4256632|P2|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
1308457|NCT00132730|4256633|P1|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
1308458|NCT00132730|4256628|P6|Period III - Blinded Extension (EXT1)|Site terminated|0
1308459|NCT00132730|4256629|P5|Period III - Blinded Extension (EXT1)|Site terminated|0
1308460|NCT00132730|4256630|P4|Period III - Blinded Extension (EXT1)|Site terminated|20
1308461|NCT00132730|4256631|P3|Period III - Blinded Extension (EXT1)|Site terminated|57
1308462|NCT00132730|4256632|P2|Period III - Blinded Extension (EXT1)|Site terminated|0
1308463|NCT00132730|4256633|P1|Period III - Blinded Extension (EXT1)|Site terminated|0
1308464|NCT00132730|4256628|P6|Period II - 12-week Treatment (Base)|Other reasons|0
1308465|NCT00132730|4256629|P5|Period II - 12-week Treatment (Base)|Other reasons|0
1308466|NCT00132730|4256630|P4|Period II - 12-week Treatment (Base)|Other reasons|13
1308467|NCT00132730|4256631|P3|Period II - 12-week Treatment (Base)|Other reasons|9
1308468|NCT00132730|4256632|P2|Period II - 12-week Treatment (Base)|Other reasons|10
1308469|NCT00132730|4256633|P1|Period II - 12-week Treatment (Base)|Other reasons|11
1308470|NCT00132730|4256628|P6|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
1308471|NCT00132730|4256629|P5|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
1308472|NCT00132730|4256630|P4|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
1308473|NCT00132730|4256631|P3|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
1308474|NCT00132730|4256632|P2|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
1308475|NCT00132730|4256633|P1|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
1308476|NCT00132730|4256628|P6|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
1308477|NCT00132730|4256629|P5|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
1308478|NCT00132730|4256630|P4|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
1308479|NCT00132730|4256631|P3|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
1308480|NCT00132730|4256632|P2|Period II - 12-week Treatment (Base)|Clinical adverse experience|4
1308481|NCT00132730|4256633|P1|Period II - 12-week Treatment (Base)|Clinical adverse experience|11
1308482|NCT00132691|4256677|P2|Overall Study|Death|0
1308483|NCT00132691|4256678|P1|Overall Study|Death|2
1308484|NCT00132691|4256677|P2|Overall Study|Missed 2-year visit|4
1308485|NCT00132691|4256678|P1|Overall Study|Missed 2-year visit|4
1308486|NCT00132691|4256677|P2|Overall Study|Lost to Follow-up|8
1308487|NCT00132691|4256678|P1|Overall Study|Lost to Follow-up|5
1308488|NCT00132678|4256718|P3|Period IV (Double-Blind Treatment)|Pregnancy|0
1308489|NCT00132678|4256719|P2|Period IV (Double-Blind Treatment)|Pregnancy|2
1308490|NCT00132678|4256720|P1|Period IV (Double-Blind Treatment)|Pregnancy|0
1308491|NCT00132678|4256718|P3|Period IV (Double-Blind Treatment)|Subject Non-compliant|0
1308492|NCT00132678|4256719|P2|Period IV (Double-Blind Treatment)|Subject Non-compliant|1
1308493|NCT00132678|4256720|P1|Period IV (Double-Blind Treatment)|Subject Non-compliant|2
1308494|NCT00132678|4256718|P3|Period IV (Double-Blind Treatment)|Physician Decision|0
1308495|NCT00132678|4256719|P2|Period IV (Double-Blind Treatment)|Physician Decision|14
1308496|NCT00132678|4256720|P1|Period IV (Double-Blind Treatment)|Physician Decision|10
1308497|NCT00132678|4256718|P3|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0
1308498|NCT00132678|4256719|P2|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15
1308499|NCT00132678|4256720|P1|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14
1308500|NCT00132678|4256718|P3|Period IV (Double-Blind Treatment)|Lost to Follow-up|0
1308501|NCT00132678|4256719|P2|Period IV (Double-Blind Treatment)|Lost to Follow-up|3
1308502|NCT00132678|4256720|P1|Period IV (Double-Blind Treatment)|Lost to Follow-up|6
1308503|NCT00132678|4256718|P3|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0
1308504|NCT00132678|4256719|P2|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
1308505|NCT00132678|4256720|P1|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
1308506|NCT00132678|4256718|P3|Period IV (Double-Blind Treatment)|Adverse Event|0
1308507|NCT00132678|4256719|P2|Period IV (Double-Blind Treatment)|Adverse Event|1
1308508|NCT00132678|4256720|P1|Period IV (Double-Blind Treatment)|Adverse Event|1
1308509|NCT00132678|4256718|P3|Period III (Open-Label Stabilization)|Pregnancy|0
1308510|NCT00132678|4256719|P2|Period III (Open-Label Stabilization)|Pregnancy|0
1308511|NCT00132678|4256720|P1|Period III (Open-Label Stabilization)|Pregnancy|2
1308512|NCT00132678|4256718|P3|Period III (Open-Label Stabilization)|Physician Decision|0
1308513|NCT00132678|4256719|P2|Period III (Open-Label Stabilization)|Physician Decision|0
1308514|NCT00132678|4256720|P1|Period III (Open-Label Stabilization)|Physician Decision|1
1308515|NCT00132678|4256718|P3|Period III (Open-Label Stabilization)|Subject non-compliant|0
1308516|NCT00132678|4256719|P2|Period III (Open-Label Stabilization)|Subject non-compliant|0
1308517|NCT00132678|4256720|P1|Period III (Open-Label Stabilization)|Subject non-compliant|1
1308518|NCT00132678|4256718|P3|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
1308519|NCT00132678|4256719|P2|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
1308520|NCT00132678|4256720|P1|Period III (Open-Label Stabilization)|Withdrawal by Subject|49
1308521|NCT00132678|4256718|P3|Period III (Open-Label Stabilization)|Lost to Follow-up|0
1308522|NCT00132678|4256719|P2|Period III (Open-Label Stabilization)|Lost to Follow-up|0
1308523|NCT00132678|4256720|P1|Period III (Open-Label Stabilization)|Lost to Follow-up|19
1308524|NCT00132678|4256718|P3|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
1308525|NCT00132678|4256719|P2|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
1308526|NCT00132678|4256720|P1|Period III (Open-Label Stabilization)|Ineligible to continue trial|5
1308527|NCT00132678|4256718|P3|Period III (Open-Label Stabilization)|Non responder|0
1308528|NCT00132678|4256719|P2|Period III (Open-Label Stabilization)|Non responder|0
1308529|NCT00132678|4256720|P1|Period III (Open-Label Stabilization)|Non responder|107
1308530|NCT00132678|4256718|P3|Period III (Open-Label Stabilization)|Adverse Event|0
1308531|NCT00132678|4256719|P2|Period III (Open-Label Stabilization)|Adverse Event|0
1308532|NCT00132678|4256720|P1|Period III (Open-Label Stabilization)|Adverse Event|12
1308533|NCT00132678|4256718|P3|Period III (Open-Label Stabilization)|Death|0
1308534|NCT00132678|4256719|P2|Period III (Open-Label Stabilization)|Death|0
1308535|NCT00132678|4256720|P1|Period III (Open-Label Stabilization)|Death|2
1308536|NCT00132678|4256718|P3|Period II (Open-Label Oral Risperidone)|Physician Decision|1
1308537|NCT00132678|4256719|P2|Period II (Open-Label Oral Risperidone)|Physician Decision|0
1308538|NCT00132678|4256720|P1|Period II (Open-Label Oral Risperidone)|Physician Decision|0
1308539|NCT00132678|4256718|P3|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16
1308540|NCT00132678|4256719|P2|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
1308541|NCT00132678|4256720|P1|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
1308542|NCT00132678|4256718|P3|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14
1308543|NCT00132678|4256719|P2|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
1308544|NCT00132678|4256720|P1|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
1308545|NCT00132678|4256718|P3|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7
1308546|NCT00132678|4256719|P2|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
1308547|NCT00132678|4256720|P1|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
1308548|NCT00132678|4256718|P3|Period II (Open-Label Oral Risperidone)|Non responder|6
1308549|NCT00132678|4256719|P2|Period II (Open-Label Oral Risperidone)|Non responder|0
1308550|NCT00132678|4256720|P1|Period II (Open-Label Oral Risperidone)|Non responder|0
1308551|NCT00132678|4256718|P3|Period II (Open-Label Oral Risperidone)|Adverse Event|13
1308552|NCT00132678|4256719|P2|Period II (Open-Label Oral Risperidone)|Adverse Event|0
1308553|NCT00132678|4256720|P1|Period II (Open-Label Oral Risperidone)|Adverse Event|0
1308554|NCT00132678|4256718|P3|Period II (Open-Label Oral Risperidone)|Death|1
1308555|NCT00132678|4256719|P2|Period II (Open-Label Oral Risperidone)|Death|0
1308556|NCT00132678|4256720|P1|Period II (Open-Label Oral Risperidone)|Death|0
1308557|NCT00132496|4256734|P2|Overall Study|Physician Decision|0
1308558|NCT00132496|4256735|P1|Overall Study|Physician Decision|1
1308559|NCT00132496|4256734|P2|Overall Study|Withdrawal by Subject|2
1308560|NCT00132496|4256735|P1|Overall Study|Withdrawal by Subject|1
1308561|NCT00132314|4256743|P2|Overall Study|Refused intervention at baseline|7
1308562|NCT00132314|4256744|P1|Overall Study|Refused intervention at baseline|2
1308563|NCT00132314|4256743|P2|Overall Study|Lacked SSN|3
1308564|NCT00132314|4256744|P1|Overall Study|Lacked SSN|1
1308565|NCT00132314|4256743|P2|Overall Study|Lost to Follow-up|62
1308566|NCT00132314|4256744|P1|Overall Study|Lost to Follow-up|70
1308567|NCT00132301|4256754|P2|Overall Study|Excluded by Data Monitoring Committee|0
1308568|NCT00132301|4256755|P1|Overall Study|Excluded by Data Monitoring Committee|1
1308569|NCT00132301|4256754|P2|Overall Study|Other|1
1308570|NCT00132301|4256755|P1|Overall Study|Other|1
1308571|NCT00132301|4256754|P2|Overall Study|Lost to Follow-up|3
1308572|NCT00132301|4256755|P1|Overall Study|Lost to Follow-up|5
1308573|NCT00132301|4256754|P2|Overall Study|Physician Decision|1
1308574|NCT00132301|4256755|P1|Overall Study|Physician Decision|1
1308575|NCT00132301|4256754|P2|Overall Study|Withdrawal by Subject|2
1308576|NCT00132301|4256755|P1|Overall Study|Withdrawal by Subject|5
1308577|NCT00132301|4256754|P2|Overall Study|Death|6
1308578|NCT00132301|4256755|P1|Overall Study|Death|7
1308579|NCT00132132|4256763|P2|Overall Study|Lost to Follow-up|2
1308580|NCT00132132|4256764|P1|Overall Study|Lost to Follow-up|7
1308581|NCT00132028|4256772|P1|Overall Study|Physician Decision|3
1308582|NCT00132028|4256772|P1|Overall Study|not eligible|2
1308583|NCT00132028|4256772|P1|Overall Study|Withdrawal by Subject|2
1308584|NCT00132028|4256772|P1|Overall Study|Lack of Efficacy|11
1308585|NCT00132028|4256772|P1|Overall Study|Death|2
1308586|NCT00132028|4256772|P1|Overall Study|Adverse Event|7
1308587|NCT00131937|4256784|P1|Overall Study|Alternative therapy|1
1308588|NCT00131937|4256784|P1|Overall Study|Disease Progression|7
1308589|NCT00131937|4256784|P1|Overall Study|Physician Decision|1
1308590|NCT00131937|4256784|P1|Overall Study|Withdrawal by Subject|2
1308591|NCT00131937|4256784|P1|Overall Study|Adverse Event|3
1308592|NCT00131911|4256792|P2|Overall Study|Withdrawal by Subject|0
1308593|NCT00131911|4256793|P1|Overall Study|Withdrawal by Subject|1
1308594|NCT00131664|4256863|P6|Second Period (Additional Drug Added)|Administrative reasons|0
1308595|NCT00131664|4256864|P5|Second Period (Additional Drug Added)|Administrative reasons|1
1308596|NCT00131664|4256865|P4|Second Period (Additional Drug Added)|Administrative reasons|0
1308597|NCT00131664|4256866|P3|Second Period (Additional Drug Added)|Administrative reasons|0
1308598|NCT00131664|4256867|P2|Second Period (Additional Drug Added)|Administrative reasons|2
1308599|NCT00131664|4256868|P1|Second Period (Additional Drug Added)|Administrative reasons|4
1308600|NCT00131664|4256863|P6|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
1308601|NCT00131664|4256864|P5|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
1308602|NCT00131664|4256865|P4|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1
1308603|NCT00131664|4256866|P3|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
1308604|NCT00131664|4256867|P2|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
1308605|NCT00131664|4256868|P1|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
1308606|NCT00131664|4256863|P6|Second Period (Additional Drug Added)|Adverse Event|1
1308607|NCT00131664|4256864|P5|Second Period (Additional Drug Added)|Adverse Event|0
1308608|NCT00131664|4256865|P4|Second Period (Additional Drug Added)|Adverse Event|0
1308609|NCT00131664|4256866|P3|Second Period (Additional Drug Added)|Adverse Event|0
1308610|NCT00131664|4256867|P2|Second Period (Additional Drug Added)|Adverse Event|1
1308611|NCT00131664|4256868|P1|Second Period (Additional Drug Added)|Adverse Event|0
1308612|NCT00131664|4256863|P6|Second Period (Additional Drug Added)|Withdrawal by Subject|0
1308613|NCT00131664|4256864|P5|Second Period (Additional Drug Added)|Withdrawal by Subject|0
1308614|NCT00131664|4256865|P4|Second Period (Additional Drug Added)|Withdrawal by Subject|0
1308615|NCT00131664|4256866|P3|Second Period (Additional Drug Added)|Withdrawal by Subject|0
1308616|NCT00131664|4256867|P2|Second Period (Additional Drug Added)|Withdrawal by Subject|0
1308617|NCT00131664|4256868|P1|Second Period (Additional Drug Added)|Withdrawal by Subject|2
1308618|NCT00131664|4256863|P6|Second Period (Additional Drug Added)|Protocol Violation|0
1308619|NCT00131664|4256864|P5|Second Period (Additional Drug Added)|Protocol Violation|0
1308620|NCT00131664|4256865|P4|Second Period (Additional Drug Added)|Protocol Violation|0
1308621|NCT00131664|4256866|P3|Second Period (Additional Drug Added)|Protocol Violation|1
1308622|NCT00131664|4256867|P2|Second Period (Additional Drug Added)|Protocol Violation|1
1308623|NCT00131664|4256868|P1|Second Period (Additional Drug Added)|Protocol Violation|0
1308624|NCT00131664|4256863|P6|Second Period (Additional Drug Added)|Lost to Follow-up|2
1308625|NCT00131664|4256864|P5|Second Period (Additional Drug Added)|Lost to Follow-up|0
1308626|NCT00131664|4256865|P4|Second Period (Additional Drug Added)|Lost to Follow-up|1
1308627|NCT00131664|4256866|P3|Second Period (Additional Drug Added)|Lost to Follow-up|2
1308628|NCT00131664|4256867|P2|Second Period (Additional Drug Added)|Lost to Follow-up|0
1308629|NCT00131664|4256868|P1|Second Period (Additional Drug Added)|Lost to Follow-up|3
1308630|NCT00131664|4256863|P6|First Period (First 6 Months)|Administrative reasons|0
1308631|NCT00131664|4256864|P5|First Period (First 6 Months)|Administrative reasons|0
1308632|NCT00131664|4256865|P4|First Period (First 6 Months)|Administrative reasons|0
1308633|NCT00131664|4256866|P3|First Period (First 6 Months)|Administrative reasons|5
1308634|NCT00131664|4256867|P2|First Period (First 6 Months)|Administrative reasons|0
1308635|NCT00131664|4256868|P1|First Period (First 6 Months)|Administrative reasons|2
1308636|NCT00131664|4256863|P6|First Period (First 6 Months)|Clinically significant lab abnormalities|0
1308637|NCT00131664|4256864|P5|First Period (First 6 Months)|Clinically significant lab abnormalities|0
1308638|NCT00131664|4256865|P4|First Period (First 6 Months)|Clinically significant lab abnormalities|0
1308639|NCT00131664|4256866|P3|First Period (First 6 Months)|Clinically significant lab abnormalities|0
1308640|NCT00131664|4256867|P2|First Period (First 6 Months)|Clinically significant lab abnormalities|2
1308641|NCT00131664|4256868|P1|First Period (First 6 Months)|Clinically significant lab abnormalities|1
1308642|NCT00131664|4256863|P6|First Period (First 6 Months)|Adverse Event|0
1308643|NCT00131664|4256864|P5|First Period (First 6 Months)|Adverse Event|0
1308644|NCT00131664|4256865|P4|First Period (First 6 Months)|Adverse Event|0
1308645|NCT00131664|4256866|P3|First Period (First 6 Months)|Adverse Event|5
1308646|NCT00131664|4256867|P2|First Period (First 6 Months)|Adverse Event|4
1308647|NCT00131664|4256868|P1|First Period (First 6 Months)|Adverse Event|9
1308648|NCT00131664|4256863|P6|First Period (First 6 Months)|Withdrawal by Subject|0
1308649|NCT00131664|4256864|P5|First Period (First 6 Months)|Withdrawal by Subject|0
1308650|NCT00131664|4256865|P4|First Period (First 6 Months)|Withdrawal by Subject|0
1308651|NCT00131664|4256866|P3|First Period (First 6 Months)|Withdrawal by Subject|2
1308652|NCT00131664|4256867|P2|First Period (First 6 Months)|Withdrawal by Subject|6
1308653|NCT00131664|4256868|P1|First Period (First 6 Months)|Withdrawal by Subject|4
1308654|NCT00131664|4256863|P6|First Period (First 6 Months)|Protocol Violation|0
1308655|NCT00131664|4256864|P5|First Period (First 6 Months)|Protocol Violation|0
1308656|NCT00131664|4256865|P4|First Period (First 6 Months)|Protocol Violation|0
1308657|NCT00131664|4256866|P3|First Period (First 6 Months)|Protocol Violation|1
1308658|NCT00131664|4256867|P2|First Period (First 6 Months)|Protocol Violation|2
1308659|NCT00131664|4256868|P1|First Period (First 6 Months)|Protocol Violation|2
1308660|NCT00131664|4256863|P6|First Period (First 6 Months)|Death|0
1308661|NCT00131664|4256864|P5|First Period (First 6 Months)|Death|0
1308662|NCT00131664|4256865|P4|First Period (First 6 Months)|Death|0
1308663|NCT00131664|4256866|P3|First Period (First 6 Months)|Death|0
1308664|NCT00131664|4256867|P2|First Period (First 6 Months)|Death|1
1308665|NCT00131664|4256868|P1|First Period (First 6 Months)|Death|0
1308666|NCT00131664|4256863|P6|First Period (First 6 Months)|Lost to Follow-up|0
1308667|NCT00131664|4256864|P5|First Period (First 6 Months)|Lost to Follow-up|0
1308668|NCT00131664|4256865|P4|First Period (First 6 Months)|Lost to Follow-up|0
1308669|NCT00131664|4256866|P3|First Period (First 6 Months)|Lost to Follow-up|3
1308670|NCT00131664|4256867|P2|First Period (First 6 Months)|Lost to Follow-up|3
1308671|NCT00131664|4256868|P1|First Period (First 6 Months)|Lost to Follow-up|7
1308672|NCT00131508|4256940|P2|Overall Study|Withdrawal by Subject|2
1308673|NCT00131508|4256941|P1|Overall Study|Withdrawal by Subject|1
1308674|NCT00131508|4256940|P2|Overall Study|Non-Compliance|4
1308675|NCT00131508|4256941|P1|Overall Study|Non-Compliance|2
1308676|NCT00131508|4256940|P2|Overall Study|Disease progression|2
1308677|NCT00131508|4256941|P1|Overall Study|Disease progression|0
1308678|NCT00131352|4257003|P2|Repeat Treatment Period|Other|0
1308679|NCT00131352|4257004|P1|Repeat Treatment Period|Other|1
1308680|NCT00131352|4257003|P2|Repeat Treatment Period|Adverse Event|0
1308681|NCT00131352|4257004|P1|Repeat Treatment Period|Adverse Event|1
1308682|NCT00131352|4257003|P2|Initial Treatment Period|Other|2
1308683|NCT00131352|4257004|P1|Initial Treatment Period|Other|0
1308684|NCT00131352|4257003|P2|Initial Treatment Period|Lack of Efficacy|4
1308685|NCT00131352|4257004|P1|Initial Treatment Period|Lack of Efficacy|6
1308686|NCT00131352|4257003|P2|Initial Treatment Period|Withdrawal by Subject|1
1308687|NCT00131352|4257004|P1|Initial Treatment Period|Withdrawal by Subject|1
1308688|NCT00131352|4257003|P2|Initial Treatment Period|Non-compliant|2
1308689|NCT00131352|4257004|P1|Initial Treatment Period|Non-compliant|1
1308690|NCT00131352|4257003|P2|Initial Treatment Period|Adverse Event|3
1308691|NCT00131352|4257004|P1|Initial Treatment Period|Adverse Event|1
1308692|NCT00131248|4257026|P2|Intervention 1 (3-day Course)|Withdrawal by Subject|0
1308693|NCT00131248|4257027|P1|Intervention 1 (3-day Course)|Withdrawal by Subject|1
1308694|NCT00130832|4257044|P2|Overall Study|Other|3
1308695|NCT00130832|4257045|P1|Overall Study|Other|0
1308696|NCT00130832|4257044|P2|Overall Study|Moved|2
1308697|NCT00130832|4257045|P1|Overall Study|Moved|2
1308698|NCT00130832|4257044|P2|Overall Study|Withdrawal by Subject|1
1308699|NCT00130832|4257045|P1|Overall Study|Withdrawal by Subject|6
1308700|NCT00130832|4257044|P2|Overall Study|Protocol Violation|8
1308701|NCT00130832|4257045|P1|Overall Study|Protocol Violation|6
1308702|NCT00130832|4257044|P2|Overall Study|Lost to Follow-up|2
1308703|NCT00130832|4257045|P1|Overall Study|Lost to Follow-up|1
1308704|NCT00130832|4257044|P2|Overall Study|Adverse Event|1
1308705|NCT00130832|4257045|P1|Overall Study|Adverse Event|1
1308706|NCT00130793|4257057|P2|Overall Study|Withdrew consent|0
1308707|NCT00130793|4257058|P1|Overall Study|Withdrew consent|2
1308708|NCT00130793|4257057|P2|Overall Study|Lost to Follow-up|4
1308709|NCT00130793|4257058|P1|Overall Study|Lost to Follow-up|1
1308710|NCT00130728|4257079|P2|Overall Study|Withdrawal by Subject|2
1308711|NCT00130728|4257080|P1|Overall Study|Withdrawal by Subject|0
1308712|NCT00130728|4257079|P2|Overall Study|Lost to Follow-up|0
1308713|NCT00130728|4257080|P1|Overall Study|Lost to Follow-up|4
1308714|NCT00130728|4257079|P2|Overall Study|Death|211
1308715|NCT00130728|4257080|P1|Overall Study|Death|207
1308716|NCT00130689|4257092|P1|Overall Study|Ineligible|6
1308717|NCT00130689|4257092|P1|Overall Study|Withdrawal by Subject|3
1308718|NCT00130689|4257092|P1|Overall Study|Clinical Deterioration|4
1308719|NCT00130689|4257092|P1|Overall Study|Death|1
1308720|NCT00130689|4257092|P1|Overall Study|Progressive Disease|29
1308721|NCT00130637|4257096|P1|Overall Study|Withdrawal by Subject|1
1308722|NCT00130637|4257096|P1|Overall Study|Adverse Event|2
1308723|NCT00130520|4257101|P1|Overall Study|Did not meet re-treatment criteria|1
1308724|NCT00130520|4257101|P1|Overall Study|Protocol non-compliance|1
1308725|NCT00130520|4257101|P1|Overall Study|Disease Progression|23
1308726|NCT00130520|4257101|P1|Overall Study|Withdrawal by Subject|1
1308727|NCT00130520|4257101|P1|Overall Study|Physician Decision|1
1308728|NCT00130520|4257101|P1|Overall Study|Death|1
1308729|NCT00130520|4257101|P1|Overall Study|Adverse Event|11
1308730|NCT00130286|4257111|P4|Overall Study|Missing lab specimens|0
1308731|NCT00130286|4257112|P3|Overall Study|Missing lab specimens|0
1308732|NCT00130286|4257113|P2|Overall Study|Missing lab specimens|2
1308733|NCT00130286|4257114|P1|Overall Study|Missing lab specimens|0
1308734|NCT00130286|4257111|P4|Overall Study|Adverse Event|0
1308735|NCT00130286|4257112|P3|Overall Study|Adverse Event|2
1308736|NCT00130286|4257113|P2|Overall Study|Adverse Event|0
1308737|NCT00130286|4257114|P1|Overall Study|Adverse Event|0
1308738|NCT00130286|4257111|P4|Overall Study|Withdrawal by Subject|2
1308739|NCT00130286|4257112|P3|Overall Study|Withdrawal by Subject|2
1308740|NCT00130286|4257113|P2|Overall Study|Withdrawal by Subject|1
1308741|NCT00130286|4257114|P1|Overall Study|Withdrawal by Subject|0
1308742|NCT00130247|4257134|P2|Overall Study|Not compliant with DOT|2
1308743|NCT00130247|4257135|P1|Overall Study|Not compliant with DOT|0
1308744|NCT00130247|4257134|P2|Overall Study|Post-randomization exclusion|2
1308745|NCT00130247|4257135|P1|Overall Study|Post-randomization exclusion|1
1308746|NCT00130247|4257134|P2|Overall Study|Pregnancy|0
1308747|NCT00130247|4257135|P1|Overall Study|Pregnancy|1
1308748|NCT00130208|4257153|P2|Washout Period (8 Weeks)|Other|1
1308749|NCT00130208|4257154|P1|Washout Period (8 Weeks)|Other|1
1308750|NCT00130208|4257153|P2|Washout Period (8 Weeks)|Lost to Follow-up|1
1308751|NCT00130208|4257154|P1|Washout Period (8 Weeks)|Lost to Follow-up|0
1308752|NCT00130208|4257153|P2|Washout Period (8 Weeks)|Withdrawal by Subject|4
1308753|NCT00130208|4257154|P1|Washout Period (8 Weeks)|Withdrawal by Subject|2
1308754|NCT00130208|4257153|P2|Washout Period (8 Weeks)|Adverse Event|6
1308755|NCT00130208|4257154|P1|Washout Period (8 Weeks)|Adverse Event|3
1308756|NCT00130208|4257153|P2|Maintenance Period (26 Weeks)|Other|1
1308757|NCT00130208|4257154|P1|Maintenance Period (26 Weeks)|Other|1
1308758|NCT00130208|4257153|P2|Maintenance Period (26 Weeks)|Lost to Follow-up|4
1308759|NCT00130208|4257154|P1|Maintenance Period (26 Weeks)|Lost to Follow-up|5
1308760|NCT00130208|4257153|P2|Maintenance Period (26 Weeks)|Withdrawal by Subject|11
1308761|NCT00130208|4257154|P1|Maintenance Period (26 Weeks)|Withdrawal by Subject|8
1308762|NCT00130208|4257153|P2|Maintenance Period (26 Weeks)|Physician Decision|2
1308763|NCT00130208|4257154|P1|Maintenance Period (26 Weeks)|Physician Decision|0
1308764|NCT00130208|4257153|P2|Maintenance Period (26 Weeks)|Adverse Event|12
1308765|NCT00130208|4257154|P1|Maintenance Period (26 Weeks)|Adverse Event|10
1308766|NCT00130039|4257190|P2|Overall Study|clinical events without follow up MRI|4
1308767|NCT00130039|4257191|P1|Overall Study|clinical events without follow up MRI|5
1308768|NCT00130039|4257190|P2|Overall Study|Physician Decision|0
1308769|NCT00130039|4257191|P1|Overall Study|Physician Decision|3
1308770|NCT00130039|4257190|P2|Overall Study|Adverse Event|2
1308771|NCT00130039|4257191|P1|Overall Study|Adverse Event|4
1308772|NCT00130039|4257190|P2|Overall Study|Lost to Follow-up|1
1308773|NCT00130039|4257191|P1|Overall Study|Lost to Follow-up|3
1308774|NCT00130039|4257190|P2|Overall Study|Withdrawal by Subject|11
1308775|NCT00130039|4257191|P1|Overall Study|Withdrawal by Subject|15
1308776|NCT00129974|4257207|P1|Overall Study|Other|1
1308777|NCT00129961|4257214|P2|Overall Study|Missing Record|1
1308778|NCT00129961|4257215|P1|Overall Study|Missing Record|0
1308779|NCT00129961|4257214|P2|Overall Study|Withdrawal by Subject|1
1308780|NCT00129961|4257215|P1|Overall Study|Withdrawal by Subject|2
1308781|NCT00129961|4257214|P2|Overall Study|Physician Decision|0
1308782|NCT00129961|4257215|P1|Overall Study|Physician Decision|1
1308783|NCT00129961|4257214|P2|Overall Study|Withdrawal by Sponsor|20
1308784|NCT00129961|4257215|P1|Overall Study|Withdrawal by Sponsor|14
1308785|NCT00129961|4257214|P2|Overall Study|Death|1
1308786|NCT00129961|4257215|P1|Overall Study|Death|1
1308787|NCT00129961|4257214|P2|Overall Study|Adverse Event|0
1308788|NCT00129961|4257215|P1|Overall Study|Adverse Event|1
1308789|NCT00129766|4257251|P2|Overall Study|Lost to Follow-up|21
1308790|NCT00129766|4257252|P1|Overall Study|Lost to Follow-up|26
1308791|NCT00129766|4257251|P2|Overall Study|Withdrawal of consent|30
1308792|NCT00129766|4257252|P1|Overall Study|Withdrawal of consent|31
1308793|NCT00129766|4257251|P2|Overall Study|Death|8
1308794|NCT00129766|4257252|P1|Overall Study|Death|3
1308795|NCT00129623|4257298|P2|Overall Study|Uncertainty to return|1
1308796|NCT00129623|4257299|P1|Overall Study|Uncertainty to return|0
1308797|NCT00129623|4257298|P2|Overall Study|Relocated job out of state|0
1308798|NCT00129623|4257299|P1|Overall Study|Relocated job out of state|1
1308799|NCT00129623|4257298|P2|Overall Study|Failure to Return|1
1308800|NCT00129623|4257299|P1|Overall Study|Failure to Return|1
1308801|NCT00129623|4257298|P2|Overall Study|Refused Treatment|3
1308802|NCT00129623|4257299|P1|Overall Study|Refused Treatment|5
1308803|NCT00129623|4257298|P2|Overall Study|Adverse Event|7
1308804|NCT00129623|4257299|P1|Overall Study|Adverse Event|3
1308805|NCT00129545|4257324|P3|Overall Study|Device not implanted|0
1308806|NCT00129545|4257325|P2|Overall Study|Device not implanted|61
1308807|NCT00129545|4257326|P1|Overall Study|Device not implanted|16
1308808|NCT00129545|4257324|P3|Overall Study|Physician Decision|10
1308809|NCT00129545|4257325|P2|Overall Study|Physician Decision|3
1308810|NCT00129545|4257326|P1|Overall Study|Physician Decision|0
1308811|NCT00129545|4257324|P3|Overall Study|Lost to Follow-up|13
1308812|NCT00129545|4257325|P2|Overall Study|Lost to Follow-up|22
1308813|NCT00129545|4257326|P1|Overall Study|Lost to Follow-up|2
1308814|NCT00129545|4257324|P3|Overall Study|Withdrawal by Subject|44
1308815|NCT00129545|4257325|P2|Overall Study|Withdrawal by Subject|18
1308816|NCT00129545|4257326|P1|Overall Study|Withdrawal by Subject|3
1308817|NCT00129545|4257324|P3|Overall Study|Death|44
1308818|NCT00129545|4257325|P2|Overall Study|Death|60
1308819|NCT00129545|4257326|P1|Overall Study|Death|5
1308820|NCT00129467|4257347|P2|Open Label for SSRI+Methylphenidate Arm|Delirium|0
1308821|NCT00129467|4257348|P1|Open Label for SSRI+Methylphenidate Arm|Delirium|1
1308822|NCT00129467|4257347|P2|Open Label for SSRI+Methylphenidate Arm|Death|0
1308823|NCT00129467|4257348|P1|Open Label for SSRI+Methylphenidate Arm|Death|1
1308824|NCT00129467|4257347|P2|Received Intervention|Dizzyness, fatigue|1
1308825|NCT00129467|4257348|P1|Received Intervention|Dizzyness, fatigue|0
1308826|NCT00129467|4257347|P2|Received Intervention|Intolerance to citalopram|1
1308827|NCT00129467|4257348|P1|Received Intervention|Intolerance to citalopram|0
1308828|NCT00129467|4257347|P2|Received Intervention|Nausea|0
1308829|NCT00129467|4257348|P1|Received Intervention|Nausea|1
1308830|NCT00129467|4257347|P2|Received Intervention|Withdrawal by Subject|0
1308831|NCT00129467|4257348|P1|Received Intervention|Withdrawal by Subject|1
1308832|NCT00129467|4257347|P2|Received Intervention|Delirium|0
1308833|NCT00129467|4257348|P1|Received Intervention|Delirium|2
1308834|NCT00129467|4257347|P2|Received Intervention|Cardiac SAE (hypertension)|1
1308835|NCT00129467|4257348|P1|Received Intervention|Cardiac SAE (hypertension)|1
1308836|NCT00129467|4257347|P2|Received Intervention|Death|1
1308837|NCT00129467|4257348|P1|Received Intervention|Death|1
1308838|NCT00129402|4257379|P7|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1
1308839|NCT00129402|4257380|P6|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
1308840|NCT00129402|4257381|P5|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
1308841|NCT00129402|4257382|P4|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
1308842|NCT00129402|4257383|P3|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
1308843|NCT00129402|4257384|P2|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
1308844|NCT00129402|4257385|P1|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
1308845|NCT00129402|4257379|P7|Start Period3 to End Period3(Week 34-53)|Subject moved|1
1308846|NCT00129402|4257380|P6|Start Period3 to End Period3(Week 34-53)|Subject moved|0
1308847|NCT00129402|4257381|P5|Start Period3 to End Period3(Week 34-53)|Subject moved|0
1308848|NCT00129402|4257382|P4|Start Period3 to End Period3(Week 34-53)|Subject moved|0
1308849|NCT00129402|4257383|P3|Start Period3 to End Period3(Week 34-53)|Subject moved|0
1308850|NCT00129402|4257384|P2|Start Period3 to End Period3(Week 34-53)|Subject moved|0
1308851|NCT00129402|4257385|P1|Start Period3 to End Period3(Week 34-53)|Subject moved|0
1308852|NCT00129402|4257379|P7|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3
1308853|NCT00129402|4257380|P6|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
1308854|NCT00129402|4257381|P5|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
1308855|NCT00129402|4257382|P4|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
1308856|NCT00129402|4257383|P3|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
1308857|NCT00129402|4257384|P2|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
1308858|NCT00129402|4257385|P1|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
1308859|NCT00129402|4257379|P7|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1
1308860|NCT00129402|4257380|P6|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
1308861|NCT00129402|4257381|P5|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
1308862|NCT00129402|4257382|P4|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
1308863|NCT00129402|4257383|P3|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
1308864|NCT00129402|4257384|P2|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
1308865|NCT00129402|4257385|P1|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
1308866|NCT00129402|4257379|P7|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
1308867|NCT00129402|4257380|P6|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
1308868|NCT00129402|4257381|P5|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
1308869|NCT00129402|4257382|P4|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
1308870|NCT00129402|4257383|P3|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
1308871|NCT00129402|4257384|P2|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
1308872|NCT00129402|4257385|P1|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
1308873|NCT00129402|4257379|P7|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
1308874|NCT00129402|4257380|P6|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3
1308875|NCT00129402|4257381|P5|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
1308876|NCT00129402|4257382|P4|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
1308877|NCT00129402|4257383|P3|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1
1308878|NCT00129402|4257384|P2|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
1308879|NCT00129402|4257385|P1|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
1308880|NCT00129402|4257379|P7|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
1308881|NCT00129402|4257380|P6|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
1308882|NCT00129402|4257381|P5|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
1308883|NCT00129402|4257382|P4|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
1308884|NCT00129402|4257383|P3|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1
1308885|NCT00129402|4257384|P2|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
1308886|NCT00129402|4257385|P1|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
1308887|NCT00129402|4257379|P7|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
1308888|NCT00129402|4257380|P6|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1
1308889|NCT00129402|4257381|P5|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
1308890|NCT00129402|4257382|P4|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
1308891|NCT00129402|4257383|P3|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3
1308892|NCT00129402|4257384|P2|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
1308893|NCT00129402|4257385|P1|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
1308894|NCT00129402|4257379|P7|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
1308895|NCT00129402|4257380|P6|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
1308896|NCT00129402|4257381|P5|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
1308897|NCT00129402|4257382|P4|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
1308898|NCT00129402|4257383|P3|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2
1308899|NCT00129402|4257384|P2|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
1308900|NCT00129402|4257385|P1|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
1308901|NCT00129402|4257379|P7|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
1308902|NCT00129402|4257380|P6|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
1308903|NCT00129402|4257381|P5|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
1308904|NCT00129402|4257382|P4|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
1308905|NCT00129402|4257383|P3|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
1308906|NCT00129402|4257384|P2|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
1308907|NCT00129402|4257385|P1|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
1308908|NCT00129402|4257379|P7|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
1308909|NCT00129402|4257380|P6|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
1308910|NCT00129402|4257381|P5|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
1308911|NCT00129402|4257382|P4|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1
1308912|NCT00129402|4257383|P3|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
1308913|NCT00129402|4257384|P2|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
1308914|NCT00129402|4257385|P1|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
1308915|NCT00129402|4257379|P7|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
1308916|NCT00129402|4257380|P6|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1
1308917|NCT00129402|4257381|P5|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
1308918|NCT00129402|4257382|P4|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
1308919|NCT00129402|4257383|P3|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
1308920|NCT00129402|4257384|P2|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
1308921|NCT00129402|4257385|P1|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
1308922|NCT00129402|4257379|P7|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
1308923|NCT00129402|4257380|P6|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
1308924|NCT00129402|4257381|P5|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
1308925|NCT00129402|4257382|P4|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
1308926|NCT00129402|4257383|P3|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
1308927|NCT00129402|4257384|P2|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
1308928|NCT00129402|4257385|P1|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
1308929|NCT00129311|4257404|P2|Overall Study|Withdrawal by Subject|19
1308930|NCT00129311|4257405|P1|Overall Study|Withdrawal by Subject|12
1308931|NCT00129272|4257434|P2|Overall Study|Withdrawal by Subject|11
1308932|NCT00129272|4257435|P1|Overall Study|Withdrawal by Subject|5
1308933|NCT00129272|4257434|P2|Overall Study|Lost to Follow-up|11
1308934|NCT00129272|4257435|P1|Overall Study|Lost to Follow-up|12
1308935|NCT00129259|4257445|P2|Overall Study|Only available minimal phone assessments|1
1308936|NCT00129259|4257446|P1|Overall Study|Only available minimal phone assessments|0
1308937|NCT00129259|4257445|P2|Overall Study|Withdrawal by Subject|1
1308938|NCT00129259|4257446|P1|Overall Study|Withdrawal by Subject|2
1308939|NCT00129259|4257445|P2|Overall Study|Lost to Follow-up|1
1308940|NCT00129259|4257446|P1|Overall Study|Lost to Follow-up|1
1308941|NCT00129220|4257474|P3|Study Period III|Reason Not Specified|2
1308942|NCT00129220|4257475|P2|Study Period III|Reason Not Specified|0
1308943|NCT00129220|4257476|P1|Study Period III|Reason Not Specified|9
1308944|NCT00129220|4257474|P3|Study Period III|Sponsor Decision|0
1308945|NCT00129220|4257475|P2|Study Period III|Sponsor Decision|0
1308946|NCT00129220|4257476|P1|Study Period III|Sponsor Decision|1
1308947|NCT00129220|4257474|P3|Study Period III|Withdrawal by Subject|3
1308948|NCT00129220|4257475|P2|Study Period III|Withdrawal by Subject|0
1308949|NCT00129220|4257476|P1|Study Period III|Withdrawal by Subject|1
1308950|NCT00129220|4257474|P3|Study Period III|Protocol Violation|2
1308951|NCT00129220|4257475|P2|Study Period III|Protocol Violation|1
1308952|NCT00129220|4257476|P1|Study Period III|Protocol Violation|1
1308953|NCT00129220|4257474|P3|Study Period III|Adverse Event|3
1308954|NCT00129220|4257475|P2|Study Period III|Adverse Event|0
1308955|NCT00129220|4257476|P1|Study Period III|Adverse Event|1
1308956|NCT00129220|4257474|P3|Study Period II|Reason Not Specified|5
1308957|NCT00129220|4257475|P2|Study Period II|Reason Not Specified|0
1308958|NCT00129220|4257476|P1|Study Period II|Reason Not Specified|2
1308959|NCT00129220|4257474|P3|Study Period II|Withdrawal by Subject|4
1308960|NCT00129220|4257475|P2|Study Period II|Withdrawal by Subject|3
1308961|NCT00129220|4257476|P1|Study Period II|Withdrawal by Subject|1
1308962|NCT00129220|4257474|P3|Study Period II|Physician Decision|0
1308963|NCT00129220|4257475|P2|Study Period II|Physician Decision|1
1308964|NCT00129220|4257476|P1|Study Period II|Physician Decision|0
1308965|NCT00129220|4257474|P3|Study Period II|Protocol Violation|1
1308966|NCT00129220|4257475|P2|Study Period II|Protocol Violation|2
1308967|NCT00129220|4257476|P1|Study Period II|Protocol Violation|4
1308968|NCT00129220|4257474|P3|Study Period II|Entry Criteria Not Met|2
1308969|NCT00129220|4257475|P2|Study Period II|Entry Criteria Not Met|0
1308970|NCT00129220|4257476|P1|Study Period II|Entry Criteria Not Met|2
1308971|NCT00129220|4257474|P3|Study Period II|Lack of Efficacy|28
1308972|NCT00129220|4257475|P2|Study Period II|Lack of Efficacy|1
1308973|NCT00129220|4257476|P1|Study Period II|Lack of Efficacy|15
1308974|NCT00129220|4257474|P3|Study Period II|Adverse Event|7
1308975|NCT00129220|4257475|P2|Study Period II|Adverse Event|5
1308976|NCT00129220|4257476|P1|Study Period II|Adverse Event|9
1308977|NCT00129129|4257516|P5|Fourth Dose Phase|Protocol Violation|0
1308978|NCT00129129|4257517|P4|Fourth Dose Phase|Protocol Violation|1
1308979|NCT00129129|4257518|P3|Fourth Dose Phase|Protocol Violation|0
1308980|NCT00129129|4257519|P2|Fourth Dose Phase|Protocol Violation|0
1308981|NCT00129129|4257520|P1|Fourth Dose Phase|Protocol Violation|0
1308982|NCT00129129|4257516|P5|Fourth Dose Phase|Other|1
1308983|NCT00129129|4257517|P4|Fourth Dose Phase|Other|1
1308984|NCT00129129|4257518|P3|Fourth Dose Phase|Other|0
1308985|NCT00129129|4257519|P2|Fourth Dose Phase|Other|0
1308986|NCT00129129|4257520|P1|Fourth Dose Phase|Other|0
1308987|NCT00129129|4257516|P5|Fourth Dose Phase|Migration from study area|2
1308988|NCT00129129|4257517|P4|Fourth Dose Phase|Migration from study area|0
1308989|NCT00129129|4257518|P3|Fourth Dose Phase|Migration from study area|0
1308990|NCT00129129|4257519|P2|Fourth Dose Phase|Migration from study area|0
1308991|NCT00129129|4257520|P1|Fourth Dose Phase|Migration from study area|0
1308992|NCT00129129|4257516|P5|Fourth Dose Phase|Withdrawal by Subject|1
1308993|NCT00129129|4257517|P4|Fourth Dose Phase|Withdrawal by Subject|0
1308994|NCT00129129|4257518|P3|Fourth Dose Phase|Withdrawal by Subject|0
1308995|NCT00129129|4257519|P2|Fourth Dose Phase|Withdrawal by Subject|0
1308996|NCT00129129|4257520|P1|Fourth Dose Phase|Withdrawal by Subject|0
1308997|NCT00129129|4257516|P5|Fourth Dose Phase|Lost to Follow-up|2
1308998|NCT00129129|4257517|P4|Fourth Dose Phase|Lost to Follow-up|2
1308999|NCT00129129|4257518|P3|Fourth Dose Phase|Lost to Follow-up|0
1309000|NCT00129129|4257519|P2|Fourth Dose Phase|Lost to Follow-up|0
1309001|NCT00129129|4257520|P1|Fourth Dose Phase|Lost to Follow-up|4
1309002|NCT00129129|4257516|P5|Primary Phase|Other|0
1309003|NCT00129129|4257517|P4|Primary Phase|Other|0
1309004|NCT00129129|4257518|P3|Primary Phase|Other|0
1309005|NCT00129129|4257519|P2|Primary Phase|Other|5
1309006|NCT00129129|4257520|P1|Primary Phase|Other|2
1309007|NCT00129129|4257516|P5|Primary Phase|Lost to Follow-up|0
1309008|NCT00129129|4257517|P4|Primary Phase|Lost to Follow-up|0
1309009|NCT00129129|4257518|P3|Primary Phase|Lost to Follow-up|0
1309010|NCT00129129|4257519|P2|Primary Phase|Lost to Follow-up|6
1309011|NCT00129129|4257520|P1|Primary Phase|Lost to Follow-up|8
1309012|NCT00129129|4257516|P5|Primary Phase|Migration from study area|0
1309013|NCT00129129|4257517|P4|Primary Phase|Migration from study area|0
1309014|NCT00129129|4257518|P3|Primary Phase|Migration from study area|0
1309015|NCT00129129|4257519|P2|Primary Phase|Migration from study area|3
1309016|NCT00129129|4257520|P1|Primary Phase|Migration from study area|1
1309017|NCT00129129|4257516|P5|Primary Phase|Withdrawal by Subject|0
1309018|NCT00129129|4257517|P4|Primary Phase|Withdrawal by Subject|0
1309019|NCT00129129|4257518|P3|Primary Phase|Withdrawal by Subject|0
1309020|NCT00129129|4257519|P2|Primary Phase|Withdrawal by Subject|10
1309021|NCT00129129|4257520|P1|Primary Phase|Withdrawal by Subject|12
1309022|NCT00129129|4257516|P5|Primary Phase|Adverse Event|0
1309023|NCT00129129|4257517|P4|Primary Phase|Adverse Event|0
1309024|NCT00129129|4257518|P3|Primary Phase|Adverse Event|0
1309025|NCT00129129|4257519|P2|Primary Phase|Adverse Event|1
1309026|NCT00129129|4257520|P1|Primary Phase|Adverse Event|2
1309027|NCT00129116|4257727|P5|Booster Phase|Lost to Follow-up|1
1309028|NCT00129116|4257728|P4|Booster Phase|Lost to Follow-up|0
1309029|NCT00129116|4257729|P3|Booster Phase|Lost to Follow-up|0
1309030|NCT00129116|4257730|P2|Booster Phase|Lost to Follow-up|0
1309031|NCT00129116|4257731|P1|Booster Phase|Lost to Follow-up|2
1309032|NCT00129116|4257727|P5|Primary Phase|Other|0
1309033|NCT00129116|4257728|P4|Primary Phase|Other|0
1309034|NCT00129116|4257729|P3|Primary Phase|Other|1
1309035|NCT00129116|4257730|P2|Primary Phase|Other|0
1309036|NCT00129116|4257731|P1|Primary Phase|Other|0
1309037|NCT00129116|4257727|P5|Primary Phase|Withdrawal by Subject|0
1309038|NCT00129116|4257728|P4|Primary Phase|Withdrawal by Subject|0
1309039|NCT00129116|4257729|P3|Primary Phase|Withdrawal by Subject|0
1309040|NCT00129116|4257730|P2|Primary Phase|Withdrawal by Subject|1
1309041|NCT00129116|4257731|P1|Primary Phase|Withdrawal by Subject|0
1309042|NCT00129116|4257727|P5|Primary Phase|Adverse Event|0
1309043|NCT00129116|4257728|P4|Primary Phase|Adverse Event|0
1309044|NCT00129116|4257729|P3|Primary Phase|Adverse Event|0
1309045|NCT00129116|4257730|P2|Primary Phase|Adverse Event|1
1309046|NCT00129116|4257731|P1|Primary Phase|Adverse Event|1
1309047|NCT00129116|4257727|P5|Primary Phase|Protocol Violation|0
1309048|NCT00129116|4257728|P4|Primary Phase|Protocol Violation|0
1309049|NCT00129116|4257729|P3|Primary Phase|Protocol Violation|0
1309050|NCT00129116|4257730|P2|Primary Phase|Protocol Violation|1
1309051|NCT00129116|4257731|P1|Primary Phase|Protocol Violation|0
1309052|NCT00129116|4257727|P5|Primary Phase|Lost to Follow-up|1
1309053|NCT00129116|4257728|P4|Primary Phase|Lost to Follow-up|1
1309054|NCT00129116|4257729|P3|Primary Phase|Lost to Follow-up|0
1309055|NCT00129116|4257730|P2|Primary Phase|Lost to Follow-up|1
1309056|NCT00129116|4257731|P1|Primary Phase|Lost to Follow-up|1
1309057|NCT00128830|4258015|P1|Overall Study|Other|9
1309058|NCT00128830|4258015|P1|Overall Study|Discontinued or ineligible for study|2
1309059|NCT00128830|4258015|P1|Overall Study|Non-compliant|4
1309060|NCT00128830|4258015|P1|Overall Study|Reached a virologic endpoint|29
1309061|NCT00128830|4258015|P1|Overall Study|Lost to Follow-up|4
1309062|NCT00128830|4258015|P1|Overall Study|Withdrawal by Subject|14
1309063|NCT00128830|4258015|P1|Overall Study|Adverse Event|10
1309064|NCT00128661|4258057|P2|Overall Study|Other|8
1309065|NCT00128661|4258058|P1|Overall Study|Other|7
1309066|NCT00128661|4258057|P2|Overall Study|Withdrawal by Subject|232
1309067|NCT00128661|4258058|P1|Overall Study|Withdrawal by Subject|243
1309068|NCT00128661|4258057|P2|Overall Study|Lost to Follow-up|7
1309069|NCT00128661|4258058|P1|Overall Study|Lost to Follow-up|10
1309070|NCT00128661|4258057|P2|Overall Study|Adverse Event|11
1309071|NCT00128661|4258058|P1|Overall Study|Adverse Event|14
1309072|NCT00128492|4258104|P2|Overall Study|Pregnancy|1
1309073|NCT00128492|4258105|P1|Overall Study|Pregnancy|0
1309074|NCT00128492|4258104|P2|Overall Study|Withdrawal by Subject|5
1309075|NCT00128492|4258105|P1|Overall Study|Withdrawal by Subject|3
1309076|NCT00128492|4258104|P2|Overall Study|Personal or administrative|22
1309077|NCT00128492|4258105|P1|Overall Study|Personal or administrative|10
1309078|NCT00128492|4258104|P2|Overall Study|Noncompliance|5
1309079|NCT00128492|4258105|P1|Overall Study|Noncompliance|0
1309080|NCT00128492|4258104|P2|Overall Study|Lost to Follow-up|5
1309081|NCT00128492|4258105|P1|Overall Study|Lost to Follow-up|1
1309082|NCT00128492|4258104|P2|Overall Study|Death|0
1309083|NCT00128492|4258105|P1|Overall Study|Death|1
1309084|NCT00128492|4258104|P2|Overall Study|AE related to study|4
1309085|NCT00128492|4258105|P1|Overall Study|AE related to study|1
1309086|NCT00128492|4258104|P2|Overall Study|Study drug intolerance (AE)|8
1309087|NCT00128492|4258105|P1|Overall Study|Study drug intolerance (AE)|2
1309088|NCT00128492|4258104|P2|Overall Study|AE unrelated to study|9
1309089|NCT00128492|4258105|P1|Overall Study|AE unrelated to study|2
1309090|NCT00128206|4258262|P2|Overall Study|Adverse Event|2
1309091|NCT00128206|4258263|P1|Overall Study|Adverse Event|0
1309092|NCT00128206|4258262|P2|Overall Study|Lost to Follow-up|118
1309093|NCT00128206|4258263|P1|Overall Study|Lost to Follow-up|137
1309094|NCT00127933|4258555|P2|Overall Study|Randomized but not dosed|0
1309095|NCT00127933|4258556|P1|Overall Study|Randomized but not dosed|1
1309096|NCT00127855|4258577|P5|Primary Vaccination Course|Other|1
1309097|NCT00127855|4258578|P4|Primary Vaccination Course|Other|0
1309098|NCT00127855|4258579|P3|Primary Vaccination Course|Other|0
1309099|NCT00127855|4258580|P2|Primary Vaccination Course|Other|0
1309100|NCT00127855|4258581|P1|Primary Vaccination Course|Other|0
1309101|NCT00127855|4258577|P5|Primary Vaccination Course|Lost to Follow-up|2
1309102|NCT00127855|4258578|P4|Primary Vaccination Course|Lost to Follow-up|0
1309103|NCT00127855|4258579|P3|Primary Vaccination Course|Lost to Follow-up|1
1309104|NCT00127855|4258580|P2|Primary Vaccination Course|Lost to Follow-up|1
1309105|NCT00127855|4258581|P1|Primary Vaccination Course|Lost to Follow-up|1
1309106|NCT00127855|4258577|P5|Primary Vaccination Course|Withdrawal by Subject|1
1309107|NCT00127855|4258578|P4|Primary Vaccination Course|Withdrawal by Subject|0
1309108|NCT00127855|4258579|P3|Primary Vaccination Course|Withdrawal by Subject|0
1309109|NCT00127855|4258580|P2|Primary Vaccination Course|Withdrawal by Subject|0
1309110|NCT00127855|4258581|P1|Primary Vaccination Course|Withdrawal by Subject|1
1309111|NCT00127855|4258577|P5|Primary Vaccination Course|Adverse Event|0
1309112|NCT00127855|4258578|P4|Primary Vaccination Course|Adverse Event|0
1309113|NCT00127855|4258579|P3|Primary Vaccination Course|Adverse Event|1
1309114|NCT00127855|4258580|P2|Primary Vaccination Course|Adverse Event|0
1309115|NCT00127855|4258581|P1|Primary Vaccination Course|Adverse Event|0
1309116|NCT00127842|4258763|P1|Overall Study|Other|5
1309117|NCT00127842|4258763|P1|Overall Study|Protocol Violation|1
1309118|NCT00127842|4258763|P1|Overall Study|Noncompliance|2
1309119|NCT00127842|4258763|P1|Overall Study|Lack of Efficacy|12
1309120|NCT00127842|4258763|P1|Overall Study|Lost to Follow-up|1
1309121|NCT00127842|4258763|P1|Overall Study|Withdrawal by Subject|3
1309122|NCT00127842|4258763|P1|Overall Study|Adverse Event|15
1309123|NCT00127803|4258781|P4|Overall Study|Lost to Follow-up|1
1309124|NCT00127803|4258782|P3|Overall Study|Lost to Follow-up|0
1309125|NCT00127803|4258783|P2|Overall Study|Lost to Follow-up|0
1309126|NCT00127803|4258784|P1|Overall Study|Lost to Follow-up|0
1309127|NCT00127803|4258781|P4|Overall Study|Withdrawal by Subject|0
1309128|NCT00127803|4258782|P3|Overall Study|Withdrawal by Subject|0
1309129|NCT00127803|4258783|P2|Overall Study|Withdrawal by Subject|0
1309130|NCT00127803|4258784|P1|Overall Study|Withdrawal by Subject|1
1309131|NCT00127803|4258781|P4|Overall Study|Adverse Event|0
1309132|NCT00127803|4258782|P3|Overall Study|Adverse Event|0
1309133|NCT00127803|4258783|P2|Overall Study|Adverse Event|0
1309134|NCT00127803|4258784|P1|Overall Study|Adverse Event|2
1309135|NCT00127712|4258833|P2|Overall Study|Lack of GI access to continue|0
1309136|NCT00127712|4258834|P1|Overall Study|Lack of GI access to continue|2
1309137|NCT00127712|4258833|P2|Overall Study|Adverse Event|0
1309138|NCT00127712|4258834|P1|Overall Study|Adverse Event|3
1309139|NCT00127660|4258850|P4|Overall Study|Protocol Violation|0
1309140|NCT00127660|4258851|P3|Overall Study|Protocol Violation|5
1309141|NCT00127660|4258852|P2|Overall Study|Protocol Violation|3
1309142|NCT00127660|4258853|P1|Overall Study|Protocol Violation|3
1309143|NCT00127413|4258901|P4|Overall Study|Lost to Follow-up|2
1309144|NCT00127413|4258902|P3|Overall Study|Lost to Follow-up|8
1309145|NCT00127413|4258903|P2|Overall Study|Lost to Follow-up|4
1309146|NCT00127413|4258904|P1|Overall Study|Lost to Follow-up|6
1309147|NCT00127192|4258947|P5|Overall Study|Adverse event in pre-treatment period|0
1309148|NCT00127192|4258948|P4|Overall Study|Adverse event in pre-treatment period|0
1309149|NCT00127192|4258949|P3|Overall Study|Adverse event in pre-treatment period|0
1309150|NCT00127192|4258950|P2|Overall Study|Adverse event in pre-treatment period|0
1309151|NCT00127192|4258951|P1|Overall Study|Adverse event in pre-treatment period|1
1309152|NCT00127192|4258947|P5|Overall Study|Withdrawal by Subject|3
1309153|NCT00127192|4258948|P4|Overall Study|Withdrawal by Subject|0
1309154|NCT00127192|4258949|P3|Overall Study|Withdrawal by Subject|1
1309155|NCT00127192|4258950|P2|Overall Study|Withdrawal by Subject|0
1309156|NCT00127192|4258951|P1|Overall Study|Withdrawal by Subject|0
1309157|NCT00127192|4258947|P5|Overall Study|Lack of Efficacy|2
1309158|NCT00127192|4258948|P4|Overall Study|Lack of Efficacy|0
1309159|NCT00127192|4258949|P3|Overall Study|Lack of Efficacy|0
1309160|NCT00127192|4258950|P2|Overall Study|Lack of Efficacy|0
1309161|NCT00127192|4258951|P1|Overall Study|Lack of Efficacy|2
1309162|NCT00127192|4258947|P5|Overall Study|Adverse Event|0
1309163|NCT00127192|4258948|P4|Overall Study|Adverse Event|1
1309164|NCT00127192|4258949|P3|Overall Study|Adverse Event|1
1309165|NCT00127192|4258950|P2|Overall Study|Adverse Event|1
1309166|NCT00127192|4258951|P1|Overall Study|Adverse Event|0
1309167|NCT00127166|4258975|P2|Period II|Patient did not perform Visit 6 exercise|0
1309168|NCT00127166|4258976|P1|Period II|Patient did not perform Visit 6 exercise|1
1309169|NCT00127166|4258975|P2|Period II|Withdrawal by Subject|0
1309170|NCT00127166|4258976|P1|Period II|Withdrawal by Subject|2
1309171|NCT00127166|4258975|P2|Washout Period|Patient did not meet inclusion criteria|1
1309172|NCT00127166|4258976|P1|Washout Period|Patient did not meet inclusion criteria|0
1309173|NCT00127166|4258975|P2|Period I|Patient did not meet inclusion criteria|0
1309174|NCT00127166|4258976|P1|Period I|Patient did not meet inclusion criteria|1
1309175|NCT00127166|4258975|P2|Period I|Withdrawal by Subject|0
1309176|NCT00127166|4258976|P1|Period I|Withdrawal by Subject|2
1309177|NCT00127166|4258975|P2|Period I|Protocol Violation|2
1309178|NCT00127166|4258976|P1|Period I|Protocol Violation|0
1309179|NCT00127101|4258996|P6|Continuation Phase|Withdrawal by Subject|1
1309180|NCT00127101|4258997|P5|Continuation Phase|Withdrawal by Subject|2
1309181|NCT00127101|4258998|P4|Continuation Phase|Withdrawal by Subject|0
1309182|NCT00127101|4258999|P3|Continuation Phase|Withdrawal by Subject|1
1309183|NCT00127101|4259000|P2|Continuation Phase|Withdrawal by Subject|0
1309184|NCT00127101|4259001|P1|Continuation Phase|Withdrawal by Subject|0
1309185|NCT00127101|4258996|P6|Continuation Phase|Lack of Efficacy|1
1309186|NCT00127101|4258997|P5|Continuation Phase|Lack of Efficacy|0
1309187|NCT00127101|4258998|P4|Continuation Phase|Lack of Efficacy|0
1309188|NCT00127101|4258999|P3|Continuation Phase|Lack of Efficacy|0
1309189|NCT00127101|4259000|P2|Continuation Phase|Lack of Efficacy|0
1309190|NCT00127101|4259001|P1|Continuation Phase|Lack of Efficacy|0
1309191|NCT00127101|4258996|P6|Continuation Phase|Adverse Event|1
1309192|NCT00127101|4258997|P5|Continuation Phase|Adverse Event|1
1309193|NCT00127101|4258998|P4|Continuation Phase|Adverse Event|0
1309194|NCT00127101|4258999|P3|Continuation Phase|Adverse Event|0
1309195|NCT00127101|4259000|P2|Continuation Phase|Adverse Event|0
1309196|NCT00127101|4259001|P1|Continuation Phase|Adverse Event|0
1309197|NCT00127101|4258996|P6|Base Protocol|Withdrawal by Subject|1
1309198|NCT00127101|4258997|P5|Base Protocol|Withdrawal by Subject|0
1309199|NCT00127101|4258998|P4|Base Protocol|Withdrawal by Subject|0
1309200|NCT00127101|4258999|P3|Base Protocol|Withdrawal by Subject|1
1309201|NCT00127101|4259000|P2|Base Protocol|Withdrawal by Subject|2
1309202|NCT00127101|4259001|P1|Base Protocol|Withdrawal by Subject|1
1309203|NCT00127101|4258996|P6|Base Protocol|Lack of Efficacy|0
1309204|NCT00127101|4258997|P5|Base Protocol|Lack of Efficacy|2
1309205|NCT00127101|4258998|P4|Base Protocol|Lack of Efficacy|0
1309206|NCT00127101|4258999|P3|Base Protocol|Lack of Efficacy|0
1309207|NCT00127101|4259000|P2|Base Protocol|Lack of Efficacy|0
1309208|NCT00127101|4259001|P1|Base Protocol|Lack of Efficacy|1
1309209|NCT00127101|4258996|P6|Base Protocol|Adverse Event|0
1309210|NCT00127101|4258997|P5|Base Protocol|Adverse Event|0
1309211|NCT00127101|4258998|P4|Base Protocol|Adverse Event|0
1309212|NCT00127101|4258999|P3|Base Protocol|Adverse Event|1
1309213|NCT00127101|4259000|P2|Base Protocol|Adverse Event|2
1309214|NCT00127101|4259001|P1|Base Protocol|Adverse Event|0
1309215|NCT00127036|4259023|P2|Overall Study|Screen Failure|0
1309216|NCT00127036|4259024|P1|Overall Study|Screen Failure|2
1309217|NCT00127036|4259023|P2|Overall Study|Insufficient Data for Analysis|11
1309218|NCT00127036|4259024|P1|Overall Study|Insufficient Data for Analysis|6
1309219|NCT00126776|4259036|P2|Overall Study|follow up complete on all patients|0
1309220|NCT00126776|4259037|P1|Overall Study|follow up complete on all patients|0
1309221|NCT00126659|4259086|P3|Overall Study|Adverse Event|2
1309222|NCT00126659|4259087|P2|Overall Study|Adverse Event|0
1309223|NCT00126659|4259088|P1|Overall Study|Adverse Event|0
1309224|NCT00126594|4259096|P2|Overall Study|Disease Progression|24
1309225|NCT00126594|4259097|P1|Overall Study|Disease Progression|29
1309226|NCT00126594|4259096|P2|Overall Study|Non-compliance|1
1309227|NCT00126594|4259097|P1|Overall Study|Non-compliance|0
1309228|NCT00126594|4259096|P2|Overall Study|Adverse Event|5
1309229|NCT00126594|4259097|P1|Overall Study|Adverse Event|7
1309230|NCT00126594|4259096|P2|Overall Study|Physician Decision|3
1309231|NCT00126594|4259097|P1|Overall Study|Physician Decision|1
1309232|NCT00126594|4259096|P2|Overall Study|Withdrawal by Subject|4
1309233|NCT00126594|4259097|P1|Overall Study|Withdrawal by Subject|0
1309234|NCT00126594|4259096|P2|Overall Study|Ineligible|0
1309235|NCT00126594|4259097|P1|Overall Study|Ineligible|2
1309236|NCT00126581|4259114|P2|Overall Study|Other illness/MD discretion|4
1309237|NCT00126581|4259115|P1|Overall Study|Other illness/MD discretion|3
1309238|NCT00126581|4259114|P2|Overall Study|Alternative therapy|3
1309239|NCT00126581|4259115|P1|Overall Study|Alternative therapy|3
1309240|NCT00126581|4259114|P2|Overall Study|Withdrawal by Subject|4
1309241|NCT00126581|4259115|P1|Overall Study|Withdrawal by Subject|1
1309242|NCT00126581|4259114|P2|Overall Study|Death|2
1309243|NCT00126581|4259115|P1|Overall Study|Death|3
1309244|NCT00126581|4259114|P2|Overall Study|Adverse Event|7
1309245|NCT00126581|4259115|P1|Overall Study|Adverse Event|3
1309246|NCT00126568|4259135|P1|Overall Study|Death|2
1309247|NCT00126555|4259142|P1|Overall Study|Progressive Disease|3
1309248|NCT00126555|4259142|P1|Overall Study|Adverse Event|2
1309249|NCT00126555|4259142|P1|Overall Study|Withdrawal by Subject|1
1309250|NCT00126503|4259158|P2|Overall Study|Physician Decision|1
1309251|NCT00126503|4259159|P1|Overall Study|Physician Decision|2
1309252|NCT00126503|4259158|P2|Overall Study|non-compliant|0
1309253|NCT00126503|4259159|P1|Overall Study|non-compliant|1
1309254|NCT00126503|4259158|P2|Overall Study|Adverse Event|3
1309255|NCT00126503|4259159|P1|Overall Study|Adverse Event|13
1309256|NCT00126503|4259158|P2|Overall Study|Death|0
1309257|NCT00126503|4259159|P1|Overall Study|Death|3
1309258|NCT00126503|4259158|P2|Overall Study|other complicating disease|1
1309259|NCT00126503|4259159|P1|Overall Study|other complicating disease|4
1309260|NCT00126503|4259158|P2|Overall Study|alternative therapy|1
1309261|NCT00126503|4259159|P1|Overall Study|alternative therapy|1
1309262|NCT00126503|4259158|P2|Overall Study|Withdrawal by Subject|1
1309263|NCT00126503|4259159|P1|Overall Study|Withdrawal by Subject|0
1309264|NCT00126503|4259158|P2|Overall Study|disease progression|14
1309265|NCT00126503|4259159|P1|Overall Study|disease progression|23
1309266|NCT00126490|4259171|P1|Overall Study|Stopped after 1 infusion (fall/injury)|1
1309267|NCT00126438|4259181|P2|Overall Study|Withdrawal by Subject|2
1309268|NCT00126438|4259182|P1|Overall Study|Withdrawal by Subject|3
1309269|NCT00126438|4259181|P2|Overall Study|Protocol Violation|8
1309270|NCT00126438|4259182|P1|Overall Study|Protocol Violation|8
1309271|NCT00126438|4259181|P2|Overall Study|Lost to Follow-up|0
1309272|NCT00126438|4259182|P1|Overall Study|Lost to Follow-up|22
1309273|NCT00126438|4259181|P2|Overall Study|Withdrawal due to adverse event|0
1309274|NCT00126438|4259182|P1|Overall Study|Withdrawal due to adverse event|1
1309275|NCT00126425|4259190|P2|Overall Study|Other|0
1309276|NCT00126425|4259191|P1|Overall Study|Other|5
1309277|NCT00126425|4259190|P2|Overall Study|Failed Inclusion Exclusion Criteria|0
1309278|NCT00126425|4259191|P1|Overall Study|Failed Inclusion Exclusion Criteria|1
1309279|NCT00126425|4259190|P2|Overall Study|Adverse Event|0
1309280|NCT00126425|4259191|P1|Overall Study|Adverse Event|1
1309281|NCT00126425|4259190|P2|Overall Study|Protocol Violation|6
1309282|NCT00126425|4259191|P1|Overall Study|Protocol Violation|9
1309283|NCT00126425|4259190|P2|Overall Study|Lost to Follow-up|4
1309284|NCT00126425|4259191|P1|Overall Study|Lost to Follow-up|8
1309285|NCT00126425|4259190|P2|Overall Study|Withdrawal by Subject|1
1309286|NCT00126425|4259191|P1|Overall Study|Withdrawal by Subject|17
1309287|NCT00126191|4259199|P2|Overall Study|Death|1
1309288|NCT00126191|4259200|P1|Overall Study|Death|0
1309289|NCT00126191|4259199|P2|Overall Study|Physician Decision|1
1309290|NCT00126191|4259200|P1|Overall Study|Physician Decision|0
1309291|NCT00126126|4259210|P2|Overall Study|Lost to Follow-up|2
1309292|NCT00126126|4259211|P1|Overall Study|Lost to Follow-up|0
1309293|NCT00125359|4259350|P1|Overall Study|Physician Decision|14
1309294|NCT00125359|4259350|P1|Overall Study|Adverse Event|5
1309295|NCT00125359|4259350|P1|Overall Study|Death|4
1309296|NCT00125268|4259359|P2|Overall Study|Withdrawal by Subject|1
1309297|NCT00125268|4259360|P1|Overall Study|Withdrawal by Subject|1
1309298|NCT00125242|4259372|P2|Overall Study|did not qualify|2
1309299|NCT00125242|4259373|P1|Overall Study|did not qualify|7
1309300|NCT00125190|4259378|P1|Overall Study|Non-compliance|2
1309301|NCT00125190|4259378|P1|Overall Study|other|1
1309302|NCT00125190|4259378|P1|Overall Study|Patient/Parent Decision|7
1309303|NCT00125190|4259378|P1|Overall Study|Lost to Follow-up|4
1309304|NCT00125190|4259378|P1|Overall Study|Adverse Event|1
1309305|NCT00125164|4259396|P4|Overall Study|Withdrawal by Subject|1
1309306|NCT00125164|4259397|P3|Overall Study|Withdrawal by Subject|1
1309307|NCT00125164|4259398|P2|Overall Study|Withdrawal by Subject|0
1309308|NCT00125164|4259399|P1|Overall Study|Withdrawal by Subject|2
1309309|NCT00125164|4259396|P4|Overall Study|Lost to Follow-up|1
1309310|NCT00125164|4259397|P3|Overall Study|Lost to Follow-up|1
1309311|NCT00125164|4259398|P2|Overall Study|Lost to Follow-up|0
1309312|NCT00125164|4259399|P1|Overall Study|Lost to Follow-up|0
1309313|NCT00125164|4259396|P4|Overall Study|Adverse Event|4
1309314|NCT00125164|4259397|P3|Overall Study|Adverse Event|2
1309315|NCT00125164|4259398|P2|Overall Study|Adverse Event|0
1309316|NCT00125164|4259399|P1|Overall Study|Adverse Event|0
1309317|NCT00125138|4259453|P4|Overall Study|Sponsor decision-pt moved to assist care|1
1309318|NCT00125138|4259454|P3|Overall Study|Sponsor decision-pt moved to assist care|0
1309319|NCT00125138|4259455|P2|Overall Study|Sponsor decision-pt moved to assist care|0
1309320|NCT00125138|4259456|P1|Overall Study|Sponsor decision-pt moved to assist care|0
1309321|NCT00125138|4259453|P4|Overall Study|Lack of Efficacy|1
1309322|NCT00125138|4259454|P3|Overall Study|Lack of Efficacy|0
1309323|NCT00125138|4259455|P2|Overall Study|Lack of Efficacy|0
1309324|NCT00125138|4259456|P1|Overall Study|Lack of Efficacy|0
1309325|NCT00125138|4259453|P4|Overall Study|Withdrawal by Subject|1
1309326|NCT00125138|4259454|P3|Overall Study|Withdrawal by Subject|1
1309327|NCT00125138|4259455|P2|Overall Study|Withdrawal by Subject|3
1309328|NCT00125138|4259456|P1|Overall Study|Withdrawal by Subject|2
1309329|NCT00125138|4259453|P4|Overall Study|Adverse Event|2
1309330|NCT00125138|4259454|P3|Overall Study|Adverse Event|3
1309331|NCT00125138|4259455|P2|Overall Study|Adverse Event|0
1309332|NCT00125138|4259456|P1|Overall Study|Adverse Event|1
1309333|NCT00124982|4259505|P3|Long-term Period|Neurologist Recommendation|1
1309334|NCT00124982|4259506|P2|Long-term Period|Neurologist Recommendation|0
1309335|NCT00124982|4259507|P1|Long-term Period|Neurologist Recommendation|0
1309336|NCT00124982|4259505|P3|Long-term Period|Administrative Reason by Sponsor|1
1309337|NCT00124982|4259506|P2|Long-term Period|Administrative Reason by Sponsor|0
1309338|NCT00124982|4259507|P1|Long-term Period|Administrative Reason by Sponsor|0
1309339|NCT00124982|4259505|P3|Long-term Period|Poor/Non-compliance|2
1309340|NCT00124982|4259506|P2|Long-term Period|Poor/Non-compliance|0
1309341|NCT00124982|4259507|P1|Long-term Period|Poor/Non-compliance|0
1309342|NCT00124982|4259505|P3|Long-term Period|Pregnancy|1
1309343|NCT00124982|4259506|P2|Long-term Period|Pregnancy|0
1309344|NCT00124982|4259507|P1|Long-term Period|Pregnancy|0
1309345|NCT00124982|4259505|P3|Long-term Period|Withdrawal by Subject|16
1309346|NCT00124982|4259506|P2|Long-term Period|Withdrawal by Subject|0
1309347|NCT00124982|4259507|P1|Long-term Period|Withdrawal by Subject|0
1309348|NCT00124982|4259505|P3|Long-term Period|Lost to Follow-up|4
1309349|NCT00124982|4259506|P2|Long-term Period|Lost to Follow-up|0
1309350|NCT00124982|4259507|P1|Long-term Period|Lost to Follow-up|0
1309351|NCT00124982|4259505|P3|Long-term Period|Lack of Efficacy|46
1309352|NCT00124982|4259506|P2|Long-term Period|Lack of Efficacy|0
1309353|NCT00124982|4259507|P1|Long-term Period|Lack of Efficacy|0
1309354|NCT00124982|4259505|P3|Long-term Period|Adverse Event|17
1309355|NCT00124982|4259506|P2|Long-term Period|Adverse Event|0
1309356|NCT00124982|4259507|P1|Long-term Period|Adverse Event|0
1309357|NCT00124982|4259505|P3|Long-term Period|Death|1
1309358|NCT00124982|4259506|P2|Long-term Period|Death|0
1309359|NCT00124982|4259507|P1|Long-term Period|Death|0
1309360|NCT00124982|4259505|P3|Short-term Period|Participant Had Lymphopenia|0
1309361|NCT00124982|4259506|P2|Short-term Period|Participant Had Lymphopenia|0
1309362|NCT00124982|4259507|P1|Short-term Period|Participant Had Lymphopenia|1
1309363|NCT00124982|4259505|P3|Short-term Period|Investigator Decision-No Specific AE|0
1309364|NCT00124982|4259506|P2|Short-term Period|Investigator Decision-No Specific AE|0
1309365|NCT00124982|4259507|P1|Short-term Period|Investigator Decision-No Specific AE|1
1309366|NCT00124982|4259505|P3|Short-term Period|Participant Chose Own Doctor|0
1309367|NCT00124982|4259506|P2|Short-term Period|Participant Chose Own Doctor|1
1309368|NCT00124982|4259507|P1|Short-term Period|Participant Chose Own Doctor|0
1309369|NCT00124982|4259505|P3|Short-term Period|Participant Decision|0
1309370|NCT00124982|4259506|P2|Short-term Period|Participant Decision|0
1309371|NCT00124982|4259507|P1|Short-term Period|Participant Decision|1
1309372|NCT00124982|4259505|P3|Short-term Period|No Longer Meets Study Criteria|0
1309373|NCT00124982|4259506|P2|Short-term Period|No Longer Meets Study Criteria|2
1309374|NCT00124982|4259507|P1|Short-term Period|No Longer Meets Study Criteria|1
1309375|NCT00124982|4259505|P3|Short-term Period|Poor/Non-compliance|0
1309376|NCT00124982|4259506|P2|Short-term Period|Poor/Non-compliance|1
1309377|NCT00124982|4259507|P1|Short-term Period|Poor/Non-compliance|3
1309378|NCT00124982|4259505|P3|Short-term Period|Withdrawal of Consent|0
1309379|NCT00124982|4259506|P2|Short-term Period|Withdrawal of Consent|9
1309380|NCT00124982|4259507|P1|Short-term Period|Withdrawal of Consent|7
1309381|NCT00124982|4259505|P3|Short-term Period|Lost to Follow-up|0
1309382|NCT00124982|4259506|P2|Short-term Period|Lost to Follow-up|5
1309383|NCT00124982|4259507|P1|Short-term Period|Lost to Follow-up|8
1309384|NCT00124982|4259505|P3|Short-term Period|Lack of Efficacy|0
1309385|NCT00124982|4259506|P2|Short-term Period|Lack of Efficacy|73
1309386|NCT00124982|4259507|P1|Short-term Period|Lack of Efficacy|32
1309387|NCT00124982|4259505|P3|Short-term Period|Adverse Event|0
1309388|NCT00124982|4259506|P2|Short-term Period|Adverse Event|22
1309389|NCT00124982|4259507|P1|Short-term Period|Adverse Event|17
1309390|NCT00124982|4259505|P3|Short-term Period|Death|0
1309391|NCT00124982|4259506|P2|Short-term Period|Death|1
1309392|NCT00124982|4259507|P1|Short-term Period|Death|1
1309393|NCT00124943|4259589|P4|Phase II|Withdrawal by Subject|2
1309394|NCT00124943|4259590|P3|Phase II|Withdrawal by Subject|0
1309395|NCT00124943|4259591|P2|Phase II|Withdrawal by Subject|0
1309396|NCT00124943|4259592|P1|Phase II|Withdrawal by Subject|0
1309397|NCT00124943|4259589|P4|Phase II|Lost to Follow-up|1
1309398|NCT00124943|4259590|P3|Phase II|Lost to Follow-up|0
1309399|NCT00124943|4259591|P2|Phase II|Lost to Follow-up|0
1309400|NCT00124943|4259592|P1|Phase II|Lost to Follow-up|0
1309401|NCT00124943|4259589|P4|Phase II|Protocol Violation|1
1309402|NCT00124943|4259590|P3|Phase II|Protocol Violation|0
1309403|NCT00124943|4259591|P2|Phase II|Protocol Violation|0
1309404|NCT00124943|4259592|P1|Phase II|Protocol Violation|0
1309405|NCT00124943|4259589|P4|Phase II|Adverse Event|1
1309406|NCT00124943|4259590|P3|Phase II|Adverse Event|0
1309407|NCT00124943|4259591|P2|Phase II|Adverse Event|2
1309408|NCT00124943|4259592|P1|Phase II|Adverse Event|0
1309409|NCT00124748|4259632|P2|Overall Study|Death|3
1309410|NCT00124748|4259633|P1|Overall Study|Death|1
1309411|NCT00124748|4259632|P2|Overall Study|Administrative Problem(Study Terminated)|174
1309412|NCT00124748|4259633|P1|Overall Study|Administrative Problem(Study Terminated)|101
1309413|NCT00124748|4259632|P2|Overall Study|Lost to Follow-up|7
1309414|NCT00124748|4259633|P1|Overall Study|Lost to Follow-up|2
1309415|NCT00124748|4259632|P2|Overall Study|Withdrawal by Subject|15
1309416|NCT00124748|4259633|P1|Overall Study|Withdrawal by Subject|5
1309417|NCT00124748|4259632|P2|Overall Study|Protocol Violation|1
1309418|NCT00124748|4259633|P1|Overall Study|Protocol Violation|3
1309419|NCT00124748|4259632|P2|Overall Study|No longer requires study drug|1
1309420|NCT00124748|4259633|P1|Overall Study|No longer requires study drug|1
1309421|NCT00124748|4259632|P2|Overall Study|Lack of Efficacy|41
1309422|NCT00124748|4259633|P1|Overall Study|Lack of Efficacy|20
1309423|NCT00124748|4259632|P2|Overall Study|Abnormal Procedure|1
1309424|NCT00124748|4259633|P1|Overall Study|Abnormal Procedure|0
1309425|NCT00124748|4259632|P2|Overall Study|Abnormal laboratory Value|2
1309426|NCT00124748|4259633|P1|Overall Study|Abnormal laboratory Value|2
1309427|NCT00124748|4259632|P2|Overall Study|Adverse Event|39
1309428|NCT00124748|4259633|P1|Overall Study|Adverse Event|8
1309429|NCT00124709|4259740|P2|Overall Study|Lost to Follow-up|120
1309430|NCT00124709|4259741|P1|Overall Study|Lost to Follow-up|114
1309431|NCT00124709|4259740|P2|Overall Study|Withdrawal by Subject|136
1309432|NCT00124709|4259741|P1|Overall Study|Withdrawal by Subject|127
1309433|NCT00124709|4259740|P2|Overall Study|Protocol Violation|5
1309434|NCT00124709|4259741|P1|Overall Study|Protocol Violation|3
1309435|NCT00124709|4259740|P2|Overall Study|Lack of Efficacy|10
1309436|NCT00124709|4259741|P1|Overall Study|Lack of Efficacy|5
1309437|NCT00124709|4259740|P2|Overall Study|Adverse Event|0
1309438|NCT00124709|4259741|P1|Overall Study|Adverse Event|3
1309439|NCT00124709|4259740|P2|Overall Study|Randomized but did not take medication|1
1309440|NCT00124709|4259741|P1|Overall Study|Randomized but did not take medication|3
1309441|NCT00124657|4259758|P3|Overall Study|Intercurrent illness|0
1309442|NCT00124657|4259759|P2|Overall Study|Intercurrent illness|0
1309443|NCT00124657|4259760|P1|Overall Study|Intercurrent illness|1
1309444|NCT00124657|4259758|P3|Overall Study|Progressive disease|27
1309445|NCT00124657|4259759|P2|Overall Study|Progressive disease|5
1309446|NCT00124657|4259760|P1|Overall Study|Progressive disease|14
1309447|NCT00124657|4259758|P3|Overall Study|Non-compliance|4
1309448|NCT00124657|4259759|P2|Overall Study|Non-compliance|0
1309449|NCT00124657|4259760|P1|Overall Study|Non-compliance|1
1309450|NCT00124657|4259758|P3|Overall Study|Toxicity|1
1309451|NCT00124657|4259759|P2|Overall Study|Toxicity|0
1309452|NCT00124657|4259760|P1|Overall Study|Toxicity|0
1309453|NCT00124618|4259795|P1|Overall Study|Ineligible|1
1309454|NCT00124462|4259810|P2|Overall Study|Device fitting, n=2, other hlth issues|1
1309455|NCT00124462|4259811|P1|Overall Study|Device fitting, n=2, other hlth issues|1
1309456|NCT00124462|4259810|P2|Overall Study|Withdrawal by Subject|5
1309457|NCT00124462|4259811|P1|Overall Study|Withdrawal by Subject|4
1309458|NCT00124462|4259810|P2|Overall Study|Physician Decision|4
1309459|NCT00124462|4259811|P1|Overall Study|Physician Decision|3
1309460|NCT00124462|4259810|P2|Overall Study|Lost to Follow-up|3
1309461|NCT00124462|4259811|P1|Overall Study|Lost to Follow-up|3
1309462|NCT00124449|4259821|P2|18-Month Untreated Observation Period|Relocated|0
1309463|NCT00124449|4259822|P1|18-Month Untreated Observation Period|Relocated|1
1309464|NCT00124449|4259821|P2|18-Month Untreated Observation Period|Poor/Noncompliance|0
1309465|NCT00124449|4259822|P1|18-Month Untreated Observation Period|Poor/Noncompliance|1
1309466|NCT00124449|4259821|P2|18-Month Untreated Observation Period|Pregnancy|0
1309467|NCT00124449|4259822|P1|18-Month Untreated Observation Period|Pregnancy|1
1309468|NCT00124449|4259821|P2|18-Month Untreated Observation Period|Lost to Follow-up|0
1309469|NCT00124449|4259822|P1|18-Month Untreated Observation Period|Lost to Follow-up|1
1309470|NCT00124449|4259821|P2|18-Month Untreated Observation Period|Lack of Efficacy|12
1309471|NCT00124449|4259822|P1|18-Month Untreated Observation Period|Lack of Efficacy|11
1309472|NCT00124449|4259821|P2|18-Month Untreated Observation Period|Adverse Event|1
1309473|NCT00124449|4259822|P1|18-Month Untreated Observation Period|Adverse Event|0
1309474|NCT00124449|4259821|P2|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1
1309475|NCT00124449|4259822|P1|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0
1309476|NCT00124449|4259821|P2|6-month Double-Blind Treatment Period|Sponsor request|1
1309477|NCT00124449|4259822|P1|6-month Double-Blind Treatment Period|Sponsor request|0
1309478|NCT00124449|4259821|P2|6-month Double-Blind Treatment Period|Poor/Noncompliance|0
1309479|NCT00124449|4259822|P1|6-month Double-Blind Treatment Period|Poor/Noncompliance|1
1309480|NCT00124449|4259821|P2|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
1309481|NCT00124449|4259822|P1|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
1309482|NCT00124449|4259821|P2|6-month Double-Blind Treatment Period|Lack of Efficacy|8
1309483|NCT00124449|4259822|P1|6-month Double-Blind Treatment Period|Lack of Efficacy|3
1309484|NCT00124449|4259821|P2|6-month Double-Blind Treatment Period|Adverse Event|0
1309485|NCT00124449|4259822|P1|6-month Double-Blind Treatment Period|Adverse Event|1
1309486|NCT00124072|4259876|P4|Overall Study|Death|480
1309487|NCT00124072|4259877|P3|Overall Study|Death|471
1309488|NCT00124072|4259878|P2|Overall Study|Death|484
1309489|NCT00124072|4259879|P1|Overall Study|Death|499
1309490|NCT00124072|4259876|P4|Overall Study|Lost to Follow-up for Morbidity|18
1309491|NCT00124072|4259877|P3|Overall Study|Lost to Follow-up for Morbidity|19
1309492|NCT00124072|4259878|P2|Overall Study|Lost to Follow-up for Morbidity|25
1309493|NCT00124072|4259879|P1|Overall Study|Lost to Follow-up for Morbidity|15
1309494|NCT00124072|4259876|P4|Overall Study|Lost to Follow-up for Mortality|2
1309495|NCT00124072|4259877|P3|Overall Study|Lost to Follow-up for Mortality|2
1309496|NCT00124072|4259878|P2|Overall Study|Lost to Follow-up for Mortality|3
1309497|NCT00124072|4259879|P1|Overall Study|Lost to Follow-up for Mortality|0
1309498|NCT00124020|4259891|P2|Overall Study|Transfer to another hospital|0
1309499|NCT00124020|4259892|P1|Overall Study|Transfer to another hospital|2
1309500|NCT00124020|4259891|P2|Overall Study|Other|1
1309501|NCT00124020|4259892|P1|Overall Study|Other|1
1309502|NCT00124020|4259891|P2|Overall Study|Lost to Follow-up|8
1309503|NCT00124020|4259892|P1|Overall Study|Lost to Follow-up|5
1309504|NCT00124020|4259891|P2|Overall Study|Withdrawal by Subject|11
1309505|NCT00124020|4259892|P1|Overall Study|Withdrawal by Subject|13
1309506|NCT00124020|4259891|P2|Overall Study|Death|71
1309507|NCT00124020|4259892|P1|Overall Study|Death|67
1309508|NCT00123955|4259900|P2|Overall Study|Death|1
1309509|NCT00123955|4259901|P1|Overall Study|Death|0
1309510|NCT00123955|4259900|P2|Overall Study|Withdrawal by Subject|3
1309511|NCT00123955|4259901|P1|Overall Study|Withdrawal by Subject|4
1309512|NCT00123955|4259900|P2|Overall Study|Adverse Event|0
1309513|NCT00123955|4259901|P1|Overall Study|Adverse Event|1
1309514|NCT00123734|4259913|P1|Overall Study|Withdrawal by Subject|1
1309515|NCT00123734|4259913|P1|Overall Study|Dropout|1
1309516|NCT00123734|4259913|P1|Overall Study|Lost to Follow-up|3
1309517|NCT00123734|4259913|P1|Overall Study|Death|3
1309518|NCT00123487|4259998|P2|Treated With Study Drug|Unknown (case report form lost)|1
1309519|NCT00123487|4259999|P1|Treated With Study Drug|Unknown (case report form lost)|0
1309520|NCT00123487|4259998|P2|Treated With Study Drug|Withdrawal by Subject|13
1309521|NCT00123487|4259999|P1|Treated With Study Drug|Withdrawal by Subject|11
1309522|NCT00123487|4259998|P2|Treated With Study Drug|Study Drug Toxicity|80
1309523|NCT00123487|4259999|P1|Treated With Study Drug|Study Drug Toxicity|62
1309524|NCT00123487|4259998|P2|Treated With Study Drug|Not Specified|58
1309525|NCT00123487|4259999|P1|Treated With Study Drug|Not Specified|59
1309526|NCT00123487|4259998|P2|Treated With Study Drug|Physician Decision|9
1309527|NCT00123487|4259999|P1|Treated With Study Drug|Physician Decision|8
1309528|NCT00123487|4259998|P2|Treated With Study Drug|Disease Progression|122
1309529|NCT00123487|4259999|P1|Treated With Study Drug|Disease Progression|141
1309530|NCT00123487|4259998|P2|Treated With Study Drug|Adverse Event|22
1309531|NCT00123487|4259999|P1|Treated With Study Drug|Adverse Event|23
1309532|NCT00123487|4259998|P2|Randomized|SAE prior to starting treatment|0
1309533|NCT00123487|4259999|P1|Randomized|SAE prior to starting treatment|1
1309534|NCT00123487|4259998|P2|Randomized|Death prior to starting treatment|1
1309535|NCT00123487|4259999|P1|Randomized|Death prior to starting treatment|0
1309536|NCT00123474|4260043|P4|As Treated at Study Closure|Withdrawal by Subject|16
1309537|NCT00123474|4260044|P3|As Treated at Study Closure|Withdrawal by Subject|18
1309538|NCT00123474|4260045|P2|As Treated at Study Closure|Withdrawal by Subject|19
1309539|NCT00123474|4260046|P1|As Treated at Study Closure|Withdrawal by Subject|14
1309540|NCT00123474|4260043|P4|As Treated at Study Closure|Study Drug Toxicity|51
1309541|NCT00123474|4260044|P3|As Treated at Study Closure|Study Drug Toxicity|45
1309542|NCT00123474|4260045|P2|As Treated at Study Closure|Study Drug Toxicity|45
1309543|NCT00123474|4260046|P1|As Treated at Study Closure|Study Drug Toxicity|39
1309544|NCT00123474|4260043|P4|As Treated at Study Closure|non-specified|60
1309545|NCT00123474|4260044|P3|As Treated at Study Closure|non-specified|57
1309546|NCT00123474|4260045|P2|As Treated at Study Closure|non-specified|47
1309547|NCT00123474|4260046|P1|As Treated at Study Closure|non-specified|54
1309548|NCT00123474|4260043|P4|As Treated at Study Closure|Investigator Request|5
1309549|NCT00123474|4260044|P3|As Treated at Study Closure|Investigator Request|7
1309550|NCT00123474|4260045|P2|As Treated at Study Closure|Investigator Request|6
1309551|NCT00123474|4260046|P1|As Treated at Study Closure|Investigator Request|12
1309552|NCT00123474|4260043|P4|As Treated at Study Closure|Disease Progression|27
1309553|NCT00123474|4260044|P3|As Treated at Study Closure|Disease Progression|29
1309554|NCT00123474|4260045|P2|As Treated at Study Closure|Disease Progression|42
1309555|NCT00123474|4260046|P1|As Treated at Study Closure|Disease Progression|35
1309556|NCT00123474|4260043|P4|As Treated at Study Closure|Adverse Event|8
1309557|NCT00123474|4260044|P3|As Treated at Study Closure|Adverse Event|10
1309558|NCT00123474|4260045|P2|As Treated at Study Closure|Adverse Event|4
1309559|NCT00123474|4260046|P1|As Treated at Study Closure|Adverse Event|10
1309560|NCT00123474|4260043|P4|As Treated at Study Closure|not reported when site closed|0
1309561|NCT00123474|4260044|P3|As Treated at Study Closure|not reported when site closed|1
1309562|NCT00123474|4260045|P2|As Treated at Study Closure|not reported when site closed|0
1309563|NCT00123474|4260046|P1|As Treated at Study Closure|not reported when site closed|1
1309564|NCT00123474|4260043|P4|Randomized to Treatment|Randomized, never treated|1
1309565|NCT00123474|4260044|P3|Randomized to Treatment|Randomized, never treated|2
1309566|NCT00123474|4260045|P2|Randomized to Treatment|Randomized, never treated|4
1309567|NCT00123474|4260046|P1|Randomized to Treatment|Randomized, never treated|1
1309568|NCT00123422|4260140|P3|Overall Study|Lost to Follow-up|2
1309569|NCT00123422|4260141|P2|Overall Study|Lost to Follow-up|2
1309570|NCT00123422|4260142|P1|Overall Study|Lost to Follow-up|1
1309571|NCT00123422|4260140|P3|Overall Study|Withdrawal by Subject|2
1309572|NCT00123422|4260141|P2|Overall Study|Withdrawal by Subject|2
1309573|NCT00123422|4260142|P1|Overall Study|Withdrawal by Subject|1
1309574|NCT00123422|4260140|P3|Overall Study|Physician Decision|6
1309575|NCT00123422|4260141|P2|Overall Study|Physician Decision|2
1309576|NCT00123422|4260142|P1|Overall Study|Physician Decision|2
1309577|NCT00122980|4260193|P2|Overall Study|Study termination|35
1309578|NCT00122980|4260194|P1|Overall Study|Study termination|27
1309579|NCT00122980|4260193|P2|Overall Study|Adjudicated stroke (study endpoint)|0
1309580|NCT00122980|4260194|P1|Overall Study|Adjudicated stroke (study endpoint)|7
1309581|NCT00122980|4260193|P2|Overall Study|Withdrawal by Subject|3
1309582|NCT00122980|4260194|P1|Overall Study|Withdrawal by Subject|2
1309583|NCT00122980|4260193|P2|Overall Study|Protocol Violation|1
1309584|NCT00122980|4260194|P1|Overall Study|Protocol Violation|5
1309585|NCT00122980|4260193|P2|Overall Study|Physician Decision|0
1309586|NCT00122980|4260194|P1|Overall Study|Physician Decision|2
1309587|NCT00122980|4260193|P2|Overall Study|Death|1
1309588|NCT00122980|4260194|P1|Overall Study|Death|0
1309589|NCT00122954|4260218|P2|Overall Study|Protocol Violation|1
1309590|NCT00122954|4260219|P1|Overall Study|Protocol Violation|0
1309591|NCT00122954|4260218|P2|Overall Study|Withdrawal by Subject|2
1309592|NCT00122954|4260219|P1|Overall Study|Withdrawal by Subject|2
1309593|NCT00122681|4260229|P2|Overall Study|Personal reasons|147
1309594|NCT00122681|4260230|P1|Overall Study|Personal reasons|150
1309595|NCT00122681|4260229|P2|Overall Study|Withdrawal by Subject|251
1309596|NCT00122681|4260230|P1|Overall Study|Withdrawal by Subject|257
1309597|NCT00122681|4260229|P2|Overall Study|Protocol Violation|10
1309598|NCT00122681|4260230|P1|Overall Study|Protocol Violation|7
1309599|NCT00122681|4260229|P2|Overall Study|Lost to Follow-up|1097
1309600|NCT00122681|4260230|P1|Overall Study|Lost to Follow-up|1080
1309601|NCT00122681|4260229|P2|Overall Study|Adverse Event|16
1309602|NCT00122681|4260230|P1|Overall Study|Adverse Event|20
1309603|NCT00122460|4260304|P2|Overall Study|investigational study phase ongoing|1
1309604|NCT00122460|4260305|P1|Overall Study|investigational study phase ongoing|7
1309605|NCT00122382|4260354|P3|Open-Label Study|Withdrawal of Consent|4
1309606|NCT00122382|4260355|P2|Open-Label Study|Withdrawal of Consent|0
1309607|NCT00122382|4260356|P1|Open-Label Study|Withdrawal of Consent|0
1309608|NCT00122382|4260354|P3|Open-Label Study|Poor/Non-Compliance|1
1309609|NCT00122382|4260355|P2|Open-Label Study|Poor/Non-Compliance|0
1309610|NCT00122382|4260356|P1|Open-Label Study|Poor/Non-Compliance|0
1309611|NCT00122382|4260354|P3|Open-Label Study|Pregnancy|2
1309612|NCT00122382|4260355|P2|Open-Label Study|Pregnancy|0
1309613|NCT00122382|4260356|P1|Open-Label Study|Pregnancy|0
1309614|NCT00122382|4260354|P3|Open-Label Study|Lost to Follow-up|3
1309615|NCT00122382|4260355|P2|Open-Label Study|Lost to Follow-up|0
1309616|NCT00122382|4260356|P1|Open-Label Study|Lost to Follow-up|0
1309617|NCT00122382|4260354|P3|Open-Label Study|Lack of Efficacy|3
1309618|NCT00122382|4260355|P2|Open-Label Study|Lack of Efficacy|0
1309619|NCT00122382|4260356|P1|Open-Label Study|Lack of Efficacy|0
1309620|NCT00122382|4260354|P3|Open-Label Study|Death|2
1309621|NCT00122382|4260355|P2|Open-Label Study|Death|0
1309622|NCT00122382|4260356|P1|Open-Label Study|Death|0
1309623|NCT00122382|4260354|P3|Open-Label Study|Adverse Event|11
1309624|NCT00122382|4260355|P2|Open-Label Study|Adverse Event|0
1309625|NCT00122382|4260356|P1|Open-Label Study|Adverse Event|0
1309626|NCT00122382|4260354|P3|Double-Blind Study|Randomized but not treated|0
1309627|NCT00122382|4260355|P2|Double-Blind Study|Randomized but not treated|2
1309628|NCT00122382|4260356|P1|Double-Blind Study|Randomized but not treated|0
1309629|NCT00122382|4260354|P3|Double-Blind Study|Methotrexate Discontinued|0
1309630|NCT00122382|4260355|P2|Double-Blind Study|Methotrexate Discontinued|1
1309631|NCT00122382|4260356|P1|Double-Blind Study|Methotrexate Discontinued|0
1309632|NCT00122382|4260354|P3|Double-Blind Study|Protocol Violation|0
1309633|NCT00122382|4260355|P2|Double-Blind Study|Protocol Violation|0
1309634|NCT00122382|4260356|P1|Double-Blind Study|Protocol Violation|1
1309635|NCT00122382|4260354|P3|Double-Blind Study|Withdrawal of Consent|0
1309636|NCT00122382|4260355|P2|Double-Blind Study|Withdrawal of Consent|3
1309637|NCT00122382|4260356|P1|Double-Blind Study|Withdrawal of Consent|7
1309638|NCT00122382|4260354|P3|Double-Blind Study|Subject No Longer Meets Study Criteria|0
1309639|NCT00122382|4260355|P2|Double-Blind Study|Subject No Longer Meets Study Criteria|0
1309640|NCT00122382|4260356|P1|Double-Blind Study|Subject No Longer Meets Study Criteria|1
1309641|NCT00122382|4260354|P3|Double-Blind Study|Pregnancy|0
1309642|NCT00122382|4260355|P2|Double-Blind Study|Pregnancy|0
1309643|NCT00122382|4260356|P1|Double-Blind Study|Pregnancy|2
1309644|NCT00122382|4260354|P3|Double-Blind Study|Lost to Follow-up|0
1309645|NCT00122382|4260355|P2|Double-Blind Study|Lost to Follow-up|1
1309646|NCT00122382|4260356|P1|Double-Blind Study|Lost to Follow-up|2
1309647|NCT00122382|4260354|P3|Double-Blind Study|Lack of Efficacy|0
1309648|NCT00122382|4260355|P2|Double-Blind Study|Lack of Efficacy|8
1309649|NCT00122382|4260356|P1|Double-Blind Study|Lack of Efficacy|0
1309650|NCT00122382|4260354|P3|Double-Blind Study|Death|0
1309651|NCT00122382|4260355|P2|Double-Blind Study|Death|2
1309652|NCT00122382|4260356|P1|Double-Blind Study|Death|2
1309653|NCT00122382|4260354|P3|Double-Blind Study|Adverse Event|0
1309654|NCT00122382|4260355|P2|Double-Blind Study|Adverse Event|11
1309655|NCT00122382|4260356|P1|Double-Blind Study|Adverse Event|9
1309656|NCT00122317|4260500|P1|Overall Study|Withdrawal by Subject|1
1309657|NCT00122317|4260500|P1|Overall Study|patient non-compliance|1
1309658|NCT00122317|4260500|P1|Overall Study|Physician Decision|2
1309659|NCT00122317|4260500|P1|Overall Study|Adverse Event|4
1309660|NCT00122317|4260500|P1|Overall Study|Death|3
1309661|NCT00122278|4260509|P2|Overall Study|Lost to Follow-up|0
1309662|NCT00122278|4260510|P1|Overall Study|Lost to Follow-up|2
1309663|NCT00122187|4260520|P2|Overall Study|Withdrew because of resource limitations|2
1309664|NCT00122187|4260521|P1|Overall Study|Withdrew because of resource limitations|2
1309665|NCT00122135|4260535|P2|Overall Study|Withdrawal by Subject|0
1309666|NCT00122135|4260536|P1|Overall Study|Withdrawal by Subject|3
1309667|NCT00122109|4260544|P2|Overall Study|Did not meet criteria|7
1309668|NCT00122109|4260545|P1|Overall Study|Did not meet criteria|6
1309669|NCT00121719|4260609|P14|Overall Study|Continuing/ongoing patients|0
1309670|NCT00121719|4260610|P13|Overall Study|Continuing/ongoing patients|3
1309671|NCT00121719|4260611|P12|Overall Study|Continuing/ongoing patients|1
1309672|NCT00121719|4260612|P11|Overall Study|Continuing/ongoing patients|1
1309673|NCT00121719|4260613|P10|Overall Study|Continuing/ongoing patients|0
1309674|NCT00121719|4260614|P9|Overall Study|Continuing/ongoing patients|0
1309675|NCT00121719|4260615|P8|Overall Study|Continuing/ongoing patients|1
1309676|NCT00121719|4260616|P7|Overall Study|Continuing/ongoing patients|0
1309677|NCT00121719|4260617|P6|Overall Study|Continuing/ongoing patients|0
1309678|NCT00121719|4260618|P5|Overall Study|Continuing/ongoing patients|0
1309679|NCT00121719|4260619|P4|Overall Study|Continuing/ongoing patients|0
1309680|NCT00121719|4260620|P3|Overall Study|Continuing/ongoing patients|0
1309681|NCT00121719|4260621|P2|Overall Study|Continuing/ongoing patients|0
1309682|NCT00121719|4260622|P1|Overall Study|Continuing/ongoing patients|0
1309683|NCT00121719|4260609|P14|Overall Study|Not specified|1
1309684|NCT00121719|4260610|P13|Overall Study|Not specified|1
1309685|NCT00121719|4260611|P12|Overall Study|Not specified|0
1309686|NCT00121719|4260612|P11|Overall Study|Not specified|0
1309687|NCT00121719|4260613|P10|Overall Study|Not specified|0
1309688|NCT00121719|4260614|P9|Overall Study|Not specified|1
1309689|NCT00121719|4260615|P8|Overall Study|Not specified|0
1309690|NCT00121719|4260616|P7|Overall Study|Not specified|1
1309691|NCT00121719|4260617|P6|Overall Study|Not specified|0
1309692|NCT00121719|4260618|P5|Overall Study|Not specified|0
1309693|NCT00121719|4260619|P4|Overall Study|Not specified|1
1309694|NCT00121719|4260620|P3|Overall Study|Not specified|1
1309695|NCT00121719|4260621|P2|Overall Study|Not specified|0
1309696|NCT00121719|4260622|P1|Overall Study|Not specified|0
1309697|NCT00121719|4260609|P14|Overall Study|Physician Decision|0
1309698|NCT00121719|4260610|P13|Overall Study|Physician Decision|1
1309699|NCT00121719|4260611|P12|Overall Study|Physician Decision|0
1309700|NCT00121719|4260612|P11|Overall Study|Physician Decision|0
1309701|NCT00121719|4260613|P10|Overall Study|Physician Decision|0
1309702|NCT00121719|4260614|P9|Overall Study|Physician Decision|0
1309703|NCT00121719|4260615|P8|Overall Study|Physician Decision|0
1309704|NCT00121719|4260616|P7|Overall Study|Physician Decision|0
1309705|NCT00121719|4260617|P6|Overall Study|Physician Decision|0
1309706|NCT00121719|4260618|P5|Overall Study|Physician Decision|0
1309707|NCT00121719|4260619|P4|Overall Study|Physician Decision|0
1309708|NCT00121719|4260620|P3|Overall Study|Physician Decision|0
1309709|NCT00121719|4260621|P2|Overall Study|Physician Decision|1
1309710|NCT00121719|4260622|P1|Overall Study|Physician Decision|0
1309711|NCT00121719|4260609|P14|Overall Study|Clinical deterioration|2
1309712|NCT00121719|4260610|P13|Overall Study|Clinical deterioration|2
1309713|NCT00121719|4260611|P12|Overall Study|Clinical deterioration|1
1309714|NCT00121719|4260612|P11|Overall Study|Clinical deterioration|0
1309715|NCT00121719|4260613|P10|Overall Study|Clinical deterioration|2
1309716|NCT00121719|4260614|P9|Overall Study|Clinical deterioration|2
1309717|NCT00121719|4260615|P8|Overall Study|Clinical deterioration|1
1309718|NCT00121719|4260616|P7|Overall Study|Clinical deterioration|2
1309719|NCT00121719|4260617|P6|Overall Study|Clinical deterioration|0
1309720|NCT00121719|4260618|P5|Overall Study|Clinical deterioration|1
1309721|NCT00121719|4260619|P4|Overall Study|Clinical deterioration|0
1309722|NCT00121719|4260620|P3|Overall Study|Clinical deterioration|1
1309723|NCT00121719|4260621|P2|Overall Study|Clinical deterioration|1
1309724|NCT00121719|4260622|P1|Overall Study|Clinical deterioration|0
1309725|NCT00121719|4260609|P14|Overall Study|Progressive disease|4
1309726|NCT00121719|4260610|P13|Overall Study|Progressive disease|13
1309727|NCT00121719|4260611|P12|Overall Study|Progressive disease|3
1309728|NCT00121719|4260612|P11|Overall Study|Progressive disease|4
1309729|NCT00121719|4260613|P10|Overall Study|Progressive disease|1
1309730|NCT00121719|4260614|P9|Overall Study|Progressive disease|3
1309731|NCT00121719|4260615|P8|Overall Study|Progressive disease|5
1309732|NCT00121719|4260616|P7|Overall Study|Progressive disease|7
1309733|NCT00121719|4260617|P6|Overall Study|Progressive disease|1
1309734|NCT00121719|4260618|P5|Overall Study|Progressive disease|2
1309735|NCT00121719|4260619|P4|Overall Study|Progressive disease|2
1309736|NCT00121719|4260620|P3|Overall Study|Progressive disease|0
1309737|NCT00121719|4260621|P2|Overall Study|Progressive disease|1
1309738|NCT00121719|4260622|P1|Overall Study|Progressive disease|2
1309739|NCT00121719|4260609|P14|Overall Study|Withdrawal by Subject|0
1309740|NCT00121719|4260610|P13|Overall Study|Withdrawal by Subject|0
1309741|NCT00121719|4260611|P12|Overall Study|Withdrawal by Subject|0
1309742|NCT00121719|4260612|P11|Overall Study|Withdrawal by Subject|0
1309743|NCT00121719|4260613|P10|Overall Study|Withdrawal by Subject|0
1309744|NCT00121719|4260614|P9|Overall Study|Withdrawal by Subject|0
1309745|NCT00121719|4260615|P8|Overall Study|Withdrawal by Subject|0
1309746|NCT00121719|4260616|P7|Overall Study|Withdrawal by Subject|0
1309747|NCT00121719|4260617|P6|Overall Study|Withdrawal by Subject|0
1309748|NCT00121719|4260618|P5|Overall Study|Withdrawal by Subject|0
1309749|NCT00121719|4260619|P4|Overall Study|Withdrawal by Subject|0
1309750|NCT00121719|4260620|P3|Overall Study|Withdrawal by Subject|0
1309751|NCT00121719|4260621|P2|Overall Study|Withdrawal by Subject|0
1309752|NCT00121719|4260622|P1|Overall Study|Withdrawal by Subject|1
1309753|NCT00121719|4260609|P14|Overall Study|Protocol deviation|0
1309754|NCT00121719|4260610|P13|Overall Study|Protocol deviation|0
1309755|NCT00121719|4260611|P12|Overall Study|Protocol deviation|0
1309756|NCT00121719|4260612|P11|Overall Study|Protocol deviation|0
1309757|NCT00121719|4260613|P10|Overall Study|Protocol deviation|0
1309758|NCT00121719|4260614|P9|Overall Study|Protocol deviation|0
1309759|NCT00121719|4260615|P8|Overall Study|Protocol deviation|0
1309760|NCT00121719|4260616|P7|Overall Study|Protocol deviation|0
1309761|NCT00121719|4260617|P6|Overall Study|Protocol deviation|0
1309762|NCT00121719|4260618|P5|Overall Study|Protocol deviation|0
1309763|NCT00121719|4260619|P4|Overall Study|Protocol deviation|0
1309764|NCT00121719|4260620|P3|Overall Study|Protocol deviation|1
1309765|NCT00121719|4260621|P2|Overall Study|Protocol deviation|0
1309766|NCT00121719|4260622|P1|Overall Study|Protocol deviation|0
1309767|NCT00121719|4260609|P14|Overall Study|Abnormal laboratory value|0
1309768|NCT00121719|4260610|P13|Overall Study|Abnormal laboratory value|1
1309769|NCT00121719|4260611|P12|Overall Study|Abnormal laboratory value|0
1309770|NCT00121719|4260612|P11|Overall Study|Abnormal laboratory value|0
1309771|NCT00121719|4260613|P10|Overall Study|Abnormal laboratory value|0
1309772|NCT00121719|4260614|P9|Overall Study|Abnormal laboratory value|0
1309773|NCT00121719|4260615|P8|Overall Study|Abnormal laboratory value|1
1309774|NCT00121719|4260616|P7|Overall Study|Abnormal laboratory value|0
1309775|NCT00121719|4260617|P6|Overall Study|Abnormal laboratory value|0
1309776|NCT00121719|4260618|P5|Overall Study|Abnormal laboratory value|0
1309777|NCT00121719|4260619|P4|Overall Study|Abnormal laboratory value|0
1309778|NCT00121719|4260620|P3|Overall Study|Abnormal laboratory value|0
1309779|NCT00121719|4260621|P2|Overall Study|Abnormal laboratory value|1
1309780|NCT00121719|4260622|P1|Overall Study|Abnormal laboratory value|1
1309781|NCT00121719|4260609|P14|Overall Study|Adverse Event|0
1309782|NCT00121719|4260610|P13|Overall Study|Adverse Event|3
1309783|NCT00121719|4260611|P12|Overall Study|Adverse Event|0
1309784|NCT00121719|4260612|P11|Overall Study|Adverse Event|1
1309785|NCT00121719|4260613|P10|Overall Study|Adverse Event|0
1309786|NCT00121719|4260614|P9|Overall Study|Adverse Event|0
1309787|NCT00121719|4260615|P8|Overall Study|Adverse Event|1
1309788|NCT00121719|4260616|P7|Overall Study|Adverse Event|2
1309789|NCT00121719|4260617|P6|Overall Study|Adverse Event|2
1309790|NCT00121719|4260618|P5|Overall Study|Adverse Event|0
1309791|NCT00121719|4260619|P4|Overall Study|Adverse Event|0
1309792|NCT00121719|4260620|P3|Overall Study|Adverse Event|1
1309793|NCT00121719|4260621|P2|Overall Study|Adverse Event|0
1309794|NCT00121719|4260622|P1|Overall Study|Adverse Event|0
1309795|NCT00121667|4260799|P4|Short Term (ST) + Long Term (LT) Period|Death|2
1309796|NCT00121667|4260800|P3|Short Term (ST) + Long Term (LT) Period|Death|0
1309797|NCT00121667|4260801|P2|Short Term (ST) + Long Term (LT) Period|Death|0
1309798|NCT00121667|4260802|P1|Short Term (ST) + Long Term (LT) Period|Death|1
1309799|NCT00121667|4260799|P4|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
1309800|NCT00121667|4260800|P3|Short Term (ST) + Long Term (LT) Period|Pregnancy|0
1309801|NCT00121667|4260801|P2|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
1309802|NCT00121667|4260802|P1|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
1309803|NCT00121667|4260799|P4|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4
1309804|NCT00121667|4260800|P3|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8
1309805|NCT00121667|4260801|P2|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5
1309806|NCT00121667|4260802|P1|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3
1309807|NCT00121667|4260799|P4|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9
1309808|NCT00121667|4260800|P3|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5
1309809|NCT00121667|4260801|P2|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6
1309810|NCT00121667|4260802|P1|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3
1309811|NCT00121667|4260799|P4|Short Term (ST) + Long Term (LT) Period|Other Reason|3
1309812|NCT00121667|4260800|P3|Short Term (ST) + Long Term (LT) Period|Other Reason|6
1309813|NCT00121667|4260801|P2|Short Term (ST) + Long Term (LT) Period|Other Reason|7
1309814|NCT00121667|4260802|P1|Short Term (ST) + Long Term (LT) Period|Other Reason|5
1309815|NCT00121667|4260799|P4|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16
1309816|NCT00121667|4260800|P3|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13
1309817|NCT00121667|4260801|P2|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
1309818|NCT00121667|4260802|P1|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
1309819|NCT00121667|4260799|P4|Short Term (ST) + Long Term (LT) Period|Adverse Event|10
1309820|NCT00121667|4260800|P3|Short Term (ST) + Long Term (LT) Period|Adverse Event|13
1309821|NCT00121667|4260801|P2|Short Term (ST) + Long Term (LT) Period|Adverse Event|18
1309822|NCT00121667|4260802|P1|Short Term (ST) + Long Term (LT) Period|Adverse Event|12
1309823|NCT00121667|4260799|P4|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30
1309824|NCT00121667|4260800|P3|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26
1309825|NCT00121667|4260801|P2|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34
1309826|NCT00121667|4260802|P1|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38
1309827|NCT00121667|4260799|P4|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65
1309828|NCT00121667|4260800|P3|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42
1309829|NCT00121667|4260801|P2|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51
1309830|NCT00121667|4260802|P1|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54
1309831|NCT00121667|4260799|P4|Short Term (ST) Period|Pregnancy|1
1309832|NCT00121667|4260800|P3|Short Term (ST) Period|Pregnancy|0
1309833|NCT00121667|4260801|P2|Short Term (ST) Period|Pregnancy|0
1309834|NCT00121667|4260802|P1|Short Term (ST) Period|Pregnancy|0
1309835|NCT00121667|4260799|P4|Short Term (ST) Period|Death|1
1309836|NCT00121667|4260800|P3|Short Term (ST) Period|Death|0
1309837|NCT00121667|4260801|P2|Short Term (ST) Period|Death|0
1309838|NCT00121667|4260802|P1|Short Term (ST) Period|Death|0
1309839|NCT00121667|4260799|P4|Short Term (ST) Period|Other Reason|0
1309840|NCT00121667|4260800|P3|Short Term (ST) Period|Other Reason|0
1309841|NCT00121667|4260801|P2|Short Term (ST) Period|Other Reason|0
1309842|NCT00121667|4260802|P1|Short Term (ST) Period|Other Reason|3
1309843|NCT00121667|4260799|P4|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
1309844|NCT00121667|4260800|P3|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
1309845|NCT00121667|4260801|P2|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
1309846|NCT00121667|4260802|P1|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
1309847|NCT00121667|4260799|P4|Short Term (ST) Period|Poor / Non-compliance|2
1309848|NCT00121667|4260800|P3|Short Term (ST) Period|Poor / Non-compliance|1
1309849|NCT00121667|4260801|P2|Short Term (ST) Period|Poor / Non-compliance|1
1309850|NCT00121667|4260802|P1|Short Term (ST) Period|Poor / Non-compliance|0
1309851|NCT00121667|4260799|P4|Short Term (ST) Period|Lost to Follow-up|3
1309852|NCT00121667|4260800|P3|Short Term (ST) Period|Lost to Follow-up|4
1309853|NCT00121667|4260801|P2|Short Term (ST) Period|Lost to Follow-up|4
1309854|NCT00121667|4260802|P1|Short Term (ST) Period|Lost to Follow-up|3
1309855|NCT00121667|4260799|P4|Short Term (ST) Period|Adverse Event|3
1309856|NCT00121667|4260800|P3|Short Term (ST) Period|Adverse Event|5
1309857|NCT00121667|4260801|P2|Short Term (ST) Period|Adverse Event|6
1309858|NCT00121667|4260802|P1|Short Term (ST) Period|Adverse Event|5
1309859|NCT00121667|4260799|P4|Short Term (ST) Period|Subject Withdrew Consent|11
1309860|NCT00121667|4260800|P3|Short Term (ST) Period|Subject Withdrew Consent|4
1309861|NCT00121667|4260801|P2|Short Term (ST) Period|Subject Withdrew Consent|13
1309862|NCT00121667|4260802|P1|Short Term (ST) Period|Subject Withdrew Consent|8
1309863|NCT00121667|4260799|P4|Short Term (ST) Period|Lack of Efficacy|44
1309864|NCT00121667|4260800|P3|Short Term (ST) Period|Lack of Efficacy|27
1309865|NCT00121667|4260801|P2|Short Term (ST) Period|Lack of Efficacy|22
1309866|NCT00121667|4260802|P1|Short Term (ST) Period|Lack of Efficacy|25
1309867|NCT00121641|4260900|P5|48-month Short Term + Long Term Period|Other Reason|1
1309868|NCT00121641|4260901|P4|48-month Short Term + Long Term Period|Other Reason|0
1309869|NCT00121641|4260902|P3|48-month Short Term + Long Term Period|Other Reason|2
1309870|NCT00121641|4260903|P2|48-month Short Term + Long Term Period|Other Reason|3
1309871|NCT00121641|4260904|P1|48-month Short Term + Long Term Period|Other Reason|5
1309872|NCT00121641|4260900|P5|48-month Short Term + Long Term Period|Missing|0
1309873|NCT00121641|4260901|P4|48-month Short Term + Long Term Period|Missing|0
1309874|NCT00121641|4260902|P3|48-month Short Term + Long Term Period|Missing|1
1309875|NCT00121641|4260903|P2|48-month Short Term + Long Term Period|Missing|0
1309876|NCT00121641|4260904|P1|48-month Short Term + Long Term Period|Missing|0
1309877|NCT00121641|4260900|P5|48-month Short Term + Long Term Period|Death|0
1309878|NCT00121641|4260901|P4|48-month Short Term + Long Term Period|Death|1
1309879|NCT00121641|4260902|P3|48-month Short Term + Long Term Period|Death|0
1309880|NCT00121641|4260903|P2|48-month Short Term + Long Term Period|Death|0
1309881|NCT00121641|4260904|P1|48-month Short Term + Long Term Period|Death|0
1309882|NCT00121641|4260900|P5|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
1309883|NCT00121641|4260901|P4|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
1309884|NCT00121641|4260902|P3|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
1309885|NCT00121641|4260903|P2|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2
1309886|NCT00121641|4260904|P1|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
1309887|NCT00121641|4260900|P5|48-month Short Term + Long Term Period|Pregnancy|0
1309888|NCT00121641|4260901|P4|48-month Short Term + Long Term Period|Pregnancy|1
1309889|NCT00121641|4260902|P3|48-month Short Term + Long Term Period|Pregnancy|0
1309890|NCT00121641|4260903|P2|48-month Short Term + Long Term Period|Pregnancy|1
1309891|NCT00121641|4260904|P1|48-month Short Term + Long Term Period|Pregnancy|0
1309892|NCT00121641|4260900|P5|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
1309893|NCT00121641|4260901|P4|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
1309894|NCT00121641|4260902|P3|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
1309895|NCT00121641|4260903|P2|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3
1309896|NCT00121641|4260904|P1|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
1309897|NCT00121641|4260900|P5|48-month Short Term + Long Term Period|Poor / Non-compliance|2
1309898|NCT00121641|4260901|P4|48-month Short Term + Long Term Period|Poor / Non-compliance|2
1309899|NCT00121641|4260902|P3|48-month Short Term + Long Term Period|Poor / Non-compliance|4
1309900|NCT00121641|4260903|P2|48-month Short Term + Long Term Period|Poor / Non-compliance|1
1309901|NCT00121641|4260904|P1|48-month Short Term + Long Term Period|Poor / Non-compliance|4
1309902|NCT00121641|4260900|P5|48-month Short Term + Long Term Period|Lost to Follow-up|12
1309903|NCT00121641|4260901|P4|48-month Short Term + Long Term Period|Lost to Follow-up|11
1309904|NCT00121641|4260902|P3|48-month Short Term + Long Term Period|Lost to Follow-up|12
1309905|NCT00121641|4260903|P2|48-month Short Term + Long Term Period|Lost to Follow-up|7
1309906|NCT00121641|4260904|P1|48-month Short Term + Long Term Period|Lost to Follow-up|9
1309907|NCT00121641|4260900|P5|48-month Short Term + Long Term Period|Adverse Event|5
1309908|NCT00121641|4260901|P4|48-month Short Term + Long Term Period|Adverse Event|5
1309909|NCT00121641|4260902|P3|48-month Short Term + Long Term Period|Adverse Event|10
1309910|NCT00121641|4260903|P2|48-month Short Term + Long Term Period|Adverse Event|10
1309911|NCT00121641|4260904|P1|48-month Short Term + Long Term Period|Adverse Event|9
1309912|NCT00121641|4260900|P5|48-month Short Term + Long Term Period|Subject Withdrew Consent|10
1309913|NCT00121641|4260901|P4|48-month Short Term + Long Term Period|Subject Withdrew Consent|24
1309914|NCT00121641|4260902|P3|48-month Short Term + Long Term Period|Subject Withdrew Consent|17
1309915|NCT00121641|4260903|P2|48-month Short Term + Long Term Period|Subject Withdrew Consent|28
1309916|NCT00121641|4260904|P1|48-month Short Term + Long Term Period|Subject Withdrew Consent|25
1309917|NCT00121641|4260900|P5|48-month Short Term + Long Term Period|Lack of Efficacy|25
1309918|NCT00121641|4260901|P4|48-month Short Term + Long Term Period|Lack of Efficacy|26
1309919|NCT00121641|4260902|P3|48-month Short Term + Long Term Period|Lack of Efficacy|21
1309920|NCT00121641|4260903|P2|48-month Short Term + Long Term Period|Lack of Efficacy|27
1309921|NCT00121641|4260904|P1|48-month Short Term + Long Term Period|Lack of Efficacy|26
1309922|NCT00121641|4260900|P5|24-week Short-term Treatment Period|Other Reason|0
1309923|NCT00121641|4260901|P4|24-week Short-term Treatment Period|Other Reason|0
1309924|NCT00121641|4260902|P3|24-week Short-term Treatment Period|Other Reason|0
1309925|NCT00121641|4260903|P2|24-week Short-term Treatment Period|Other Reason|0
1309926|NCT00121641|4260904|P1|24-week Short-term Treatment Period|Other Reason|1
1309927|NCT00121641|4260900|P5|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
1309928|NCT00121641|4260901|P4|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
1309929|NCT00121641|4260902|P3|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
1309930|NCT00121641|4260903|P2|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
1309931|NCT00121641|4260904|P1|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
1309932|NCT00121641|4260900|P5|24-week Short-term Treatment Period|Poor / Non-compliance|1
1309933|NCT00121641|4260901|P4|24-week Short-term Treatment Period|Poor / Non-compliance|1
1309934|NCT00121641|4260902|P3|24-week Short-term Treatment Period|Poor / Non-compliance|3
1309935|NCT00121641|4260903|P2|24-week Short-term Treatment Period|Poor / Non-compliance|0
1309936|NCT00121641|4260904|P1|24-week Short-term Treatment Period|Poor / Non-compliance|0
1309937|NCT00121641|4260900|P5|24-week Short-term Treatment Period|Lost to Follow-up|4
1309938|NCT00121641|4260901|P4|24-week Short-term Treatment Period|Lost to Follow-up|4
1309939|NCT00121641|4260902|P3|24-week Short-term Treatment Period|Lost to Follow-up|3
1309940|NCT00121641|4260903|P2|24-week Short-term Treatment Period|Lost to Follow-up|2
1309941|NCT00121641|4260904|P1|24-week Short-term Treatment Period|Lost to Follow-up|0
1309942|NCT00121641|4260900|P5|24-week Short-term Treatment Period|Adverse Event|2
1309943|NCT00121641|4260901|P4|24-week Short-term Treatment Period|Adverse Event|0
1309944|NCT00121641|4260902|P3|24-week Short-term Treatment Period|Adverse Event|4
1309945|NCT00121641|4260903|P2|24-week Short-term Treatment Period|Adverse Event|3
1309946|NCT00121641|4260904|P1|24-week Short-term Treatment Period|Adverse Event|3
1309947|NCT00121641|4260900|P5|24-week Short-term Treatment Period|Subject Withdrew Consent|3
1309948|NCT00121641|4260901|P4|24-week Short-term Treatment Period|Subject Withdrew Consent|10
1309949|NCT00121641|4260902|P3|24-week Short-term Treatment Period|Subject Withdrew Consent|5
1309950|NCT00121641|4260903|P2|24-week Short-term Treatment Period|Subject Withdrew Consent|11
1309951|NCT00121641|4260904|P1|24-week Short-term Treatment Period|Subject Withdrew Consent|9
1309952|NCT00121641|4260900|P5|24-week Short-term Treatment Period|Lack of Efficacy|30
1309953|NCT00121641|4260901|P4|24-week Short-term Treatment Period|Lack of Efficacy|25
1309954|NCT00121641|4260902|P3|24-week Short-term Treatment Period|Lack of Efficacy|14
1309955|NCT00121641|4260903|P2|24-week Short-term Treatment Period|Lack of Efficacy|21
1309956|NCT00121641|4260904|P1|24-week Short-term Treatment Period|Lack of Efficacy|15
1309957|NCT00121485|4261017|P2|Overall Study|Crossover|2
1309958|NCT00121485|4261018|P1|Overall Study|Crossover|0
1309959|NCT00121485|4261017|P2|Overall Study|Not implanted|5
1309960|NCT00121485|4261018|P1|Overall Study|Not implanted|1
1309961|NCT00121238|4261063|P1|Overall Study|Protocol Violation|2
1309962|NCT00121238|4261063|P1|Overall Study|disease progression before intervention|1
1309963|NCT00121199|4261075|P1|Overall Study|Ineligible|9
1309964|NCT00121199|4261075|P1|Overall Study|Other - Not Protocol Specified|3
1309965|NCT00121199|4261075|P1|Overall Study|Death|3
1309966|NCT00121199|4261075|P1|Overall Study|Progression/Relapse|1
1309967|NCT00121199|4261075|P1|Overall Study|Refusal Unrelated to Adverse Event|1
1309968|NCT00121199|4261075|P1|Overall Study|Adverse Event|11
1309969|NCT00121134|4261119|P4|Overall Study|Patient Personal Reasons|0
1309970|NCT00121134|4261120|P3|Overall Study|Patient Personal Reasons|0
1309971|NCT00121134|4261121|P2|Overall Study|Patient Personal Reasons|1
1309972|NCT00121134|4261122|P1|Overall Study|Patient Personal Reasons|0
1309973|NCT00121134|4261119|P4|Overall Study|Intercurrent Illness|1
1309974|NCT00121134|4261120|P3|Overall Study|Intercurrent Illness|0
1309975|NCT00121134|4261121|P2|Overall Study|Intercurrent Illness|0
1309976|NCT00121134|4261122|P1|Overall Study|Intercurrent Illness|0
1309977|NCT00121134|4261119|P4|Overall Study|Treatment Delay|0
1309978|NCT00121134|4261120|P3|Overall Study|Treatment Delay|0
1309979|NCT00121134|4261121|P2|Overall Study|Treatment Delay|0
1309980|NCT00121134|4261122|P1|Overall Study|Treatment Delay|1
1309981|NCT00121134|4261119|P4|Overall Study|Physician Decision|1
1309982|NCT00121134|4261120|P3|Overall Study|Physician Decision|4
1309983|NCT00121134|4261121|P2|Overall Study|Physician Decision|4
1309984|NCT00121134|4261122|P1|Overall Study|Physician Decision|6
1309985|NCT00121134|4261119|P4|Overall Study|Toxicity|5
1309986|NCT00121134|4261120|P3|Overall Study|Toxicity|13
1309987|NCT00121134|4261121|P2|Overall Study|Toxicity|7
1309988|NCT00121134|4261122|P1|Overall Study|Toxicity|4
1309989|NCT00121134|4261119|P4|Overall Study|Progression of Disease|2
1309990|NCT00121134|4261120|P3|Overall Study|Progression of Disease|4
1309991|NCT00121134|4261121|P2|Overall Study|Progression of Disease|3
1309992|NCT00121134|4261122|P1|Overall Study|Progression of Disease|5
1309993|NCT00120874|4261134|P2|Overall Study|Death|1
1309994|NCT00120874|4261135|P1|Overall Study|Death|0
1309995|NCT00120627|4261173|P2|Overall Study|Withdrawal by Subject|5
1309996|NCT00120627|4261174|P1|Overall Study|Withdrawal by Subject|5
1309997|NCT00120406|4261225|P2|Overall Study|patient moved but has not withdrawn|1
1309998|NCT00120406|4261226|P1|Overall Study|patient moved but has not withdrawn|0
1309999|NCT00120406|4261225|P2|Overall Study|received non-study stent|2
1310000|NCT00120406|4261226|P1|Overall Study|received non-study stent|0
1310001|NCT00120406|4261225|P2|Overall Study|Lost to Follow-up|2
1310002|NCT00120406|4261226|P1|Overall Study|Lost to Follow-up|5
1310003|NCT00120406|4261225|P2|Overall Study|Withdrawal by Subject|7
1310004|NCT00120406|4261226|P1|Overall Study|Withdrawal by Subject|5
1310005|NCT00120406|4261225|P2|Overall Study|Death|4
1310006|NCT00120406|4261226|P1|Overall Study|Death|9
1310007|NCT00120289|4261236|P2|Overall Study|Withdrawal by Subject|13
1310008|NCT00120289|4261237|P1|Overall Study|Withdrawal by Subject|14
1310009|NCT00120289|4261236|P2|Overall Study|Lost to Follow-up|14
1310010|NCT00120289|4261237|P1|Overall Study|Lost to Follow-up|11
1310011|NCT00120289|4261236|P2|Overall Study|Death|82
1310012|NCT00120289|4261237|P1|Overall Study|Death|96
1310013|NCT00120250|4261249|P2|Overall Study|Protocol Violation|1
1310014|NCT00120250|4261250|P1|Overall Study|Protocol Violation|0
1310015|NCT00120250|4261249|P2|Overall Study|Lost to Follow-up|1
1310016|NCT00120250|4261250|P1|Overall Study|Lost to Follow-up|1
1310017|NCT00120042|4261266|P3|Overall Study|all completed protocl|0
1310018|NCT00120042|4261267|P2|Overall Study|all completed protocl|0
1310019|NCT00120042|4261268|P1|Overall Study|all completed protocl|0
1310020|NCT00119678|4261291|P2|Open-label Treatment Period|Administrative reasons by sponsor|0
1310021|NCT00119678|4261292|P1|Open-label Treatment Period|Administrative reasons by sponsor|87
1310022|NCT00119678|4261291|P2|Open-label Treatment Period|Pregnancy|0
1310023|NCT00119678|4261292|P1|Open-label Treatment Period|Pregnancy|1
1310024|NCT00119678|4261291|P2|Open-label Treatment Period|Participants not meeting study criteria|0
1310025|NCT00119678|4261292|P1|Open-label Treatment Period|Participants not meeting study criteria|2
1310026|NCT00119678|4261291|P2|Open-label Treatment Period|Participant withdrew consent|0
1310027|NCT00119678|4261292|P1|Open-label Treatment Period|Participant withdrew consent|4
1310028|NCT00119678|4261291|P2|Open-label Treatment Period|Lost to Follow-up|0
1310029|NCT00119678|4261292|P1|Open-label Treatment Period|Lost to Follow-up|3
1310030|NCT00119678|4261291|P2|Open-label Treatment Period|Lack of Efficacy|0
1310031|NCT00119678|4261292|P1|Open-label Treatment Period|Lack of Efficacy|9
1310032|NCT00119678|4261291|P2|Open-label Treatment Period|Adverse Event|0
1310033|NCT00119678|4261292|P1|Open-label Treatment Period|Adverse Event|3
1310034|NCT00119678|4261291|P2|Open-label Treatment Period|Death|0
1310035|NCT00119678|4261292|P1|Open-label Treatment Period|Death|1
1310036|NCT00119678|4261291|P2|Double-blind Treatment Period|Site closed due to non-compliance|2
1310037|NCT00119678|4261292|P1|Double-blind Treatment Period|Site closed due to non-compliance|3
1310038|NCT00119678|4261291|P2|Double-blind Treatment Period|Not treated|2
1310039|NCT00119678|4261292|P1|Double-blind Treatment Period|Not treated|1
1310040|NCT00119678|4261291|P2|Double-blind Treatment Period|Pregnancy|2
1310041|NCT00119678|4261292|P1|Double-blind Treatment Period|Pregnancy|0
1310042|NCT00119678|4261291|P2|Double-blind Treatment Period|Poor/Non-compliance|0
1310043|NCT00119678|4261292|P1|Double-blind Treatment Period|Poor/Non-compliance|3
1310044|NCT00119678|4261291|P2|Double-blind Treatment Period|Participants not meeting study criteria|1
1310045|NCT00119678|4261292|P1|Double-blind Treatment Period|Participants not meeting study criteria|0
1310046|NCT00119678|4261291|P2|Double-blind Treatment Period|Participant withdrew consent|4
1310047|NCT00119678|4261292|P1|Double-blind Treatment Period|Participant withdrew consent|4
1310048|NCT00119678|4261291|P2|Double-blind Treatment Period|Lost to Follow-up|2
1310049|NCT00119678|4261292|P1|Double-blind Treatment Period|Lost to Follow-up|1
1310050|NCT00119678|4261291|P2|Double-blind Treatment Period|Lack of Efficacy|12
1310051|NCT00119678|4261292|P1|Double-blind Treatment Period|Lack of Efficacy|21
1310052|NCT00119678|4261291|P2|Double-blind Treatment Period|Adverse Event|1
1310053|NCT00119678|4261292|P1|Double-blind Treatment Period|Adverse Event|7
1310054|NCT00119678|4261291|P2|Double-blind Treatment Period|Death|0
1310055|NCT00119678|4261292|P1|Double-blind Treatment Period|Death|1
1310056|NCT00119405|4261338|P1|Overall Study|Withdrawal by Subject|1
1310057|NCT00119379|4261352|P2|Overall Study|Adverse Event|1
1310058|NCT00119379|4261353|P1|Overall Study|Adverse Event|4
1310059|NCT00119262|4261371|P2|Overall Study|others|5
1310060|NCT00119262|4261372|P1|Overall Study|others|0
1310061|NCT00119262|4261371|P2|Overall Study|ineligble|2
1310062|NCT00119262|4261372|P1|Overall Study|ineligble|1
1310063|NCT00119262|4261371|P2|Overall Study|other disease|2
1310064|NCT00119262|4261372|P1|Overall Study|other disease|0
1310065|NCT00119262|4261371|P2|Overall Study|Adverse Event|35
1310066|NCT00119262|4261372|P1|Overall Study|Adverse Event|33
1310067|NCT00119262|4261371|P2|Overall Study|Withdrawal by Subject|11
1310068|NCT00119262|4261372|P1|Overall Study|Withdrawal by Subject|12
1310069|NCT00119262|4261371|P2|Overall Study|Lack of Efficacy|3
1310070|NCT00119262|4261372|P1|Overall Study|Lack of Efficacy|0
1310071|NCT00119015|4261409|P3|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
1310072|NCT00119015|4261410|P2|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
1310073|NCT00119015|4261411|P1|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48
1310074|NCT00118911|4261427|P2|Overall Study|Withdrawal by Subject|5
1310075|NCT00118911|4261428|P1|Overall Study|Withdrawal by Subject|2
1310076|NCT00118898|4261440|P4|Overall Study|Not able to get to clinic|40
1310077|NCT00118898|4261441|P3|Overall Study|Not able to get to clinic|31
1310078|NCT00118898|4261442|P2|Overall Study|Not able to get to clinic|43
1310079|NCT00118898|4261443|P1|Overall Study|Not able to get to clinic|34
1310080|NCT00118898|4261440|P4|Overall Study|Not compliant with requirements|11
1310081|NCT00118898|4261441|P3|Overall Study|Not compliant with requirements|11
1310082|NCT00118898|4261442|P2|Overall Study|Not compliant with requirements|13
1310083|NCT00118898|4261443|P1|Overall Study|Not compliant with requirements|11
1310084|NCT00118898|4261440|P4|Overall Study|Severe debilitation|4
1310085|NCT00118898|4261441|P3|Overall Study|Severe debilitation|6
1310086|NCT00118898|4261442|P2|Overall Study|Severe debilitation|4
1310087|NCT00118898|4261443|P1|Overall Study|Severe debilitation|1
1310088|NCT00118898|4261440|P4|Overall Study|Site Closure|37
1310089|NCT00118898|4261441|P3|Overall Study|Site Closure|28
1310090|NCT00118898|4261442|P2|Overall Study|Site Closure|31
1310091|NCT00118898|4261443|P1|Overall Study|Site Closure|33
1310092|NCT00118898|4261440|P4|Overall Study|Withdrawal by Subject|8
1310093|NCT00118898|4261441|P3|Overall Study|Withdrawal by Subject|8
1310094|NCT00118898|4261442|P2|Overall Study|Withdrawal by Subject|5
1310095|NCT00118898|4261443|P1|Overall Study|Withdrawal by Subject|10
1310096|NCT00118898|4261440|P4|Overall Study|Lost to Follow-up|33
1310097|NCT00118898|4261441|P3|Overall Study|Lost to Follow-up|33
1310098|NCT00118898|4261442|P2|Overall Study|Lost to Follow-up|34
1310099|NCT00118898|4261443|P1|Overall Study|Lost to Follow-up|26
1310100|NCT00118898|4261440|P4|Overall Study|Death|8
1310101|NCT00118898|4261441|P3|Overall Study|Death|6
1310102|NCT00118898|4261442|P2|Overall Study|Death|11
1310103|NCT00118898|4261443|P1|Overall Study|Death|6
1310104|NCT00118703|4261569|P2|Overall Study|Lost to Follow-up|2
1310105|NCT00118703|4261570|P1|Overall Study|Lost to Follow-up|1
1310106|NCT00118703|4261569|P2|Overall Study|Withdrawal by Subject|5
1310107|NCT00118703|4261570|P1|Overall Study|Withdrawal by Subject|2
1310108|NCT00118703|4261569|P2|Overall Study|Participant took two different treatment|1
1310109|NCT00118703|4261570|P1|Overall Study|Participant took two different treatment|0
1310110|NCT00118703|4261569|P2|Overall Study|Adverse Event|1
1310111|NCT00118703|4261570|P1|Overall Study|Adverse Event|1
1310112|NCT00118703|4261569|P2|Overall Study|Protocol Violation|0
1310113|NCT00118703|4261570|P1|Overall Study|Protocol Violation|1
1310114|NCT00118482|4261667|P2|Overall Study|Withdrawal by Subject|22
1310115|NCT00118482|4261668|P1|Overall Study|Withdrawal by Subject|23
1310116|NCT00118482|4261667|P2|Overall Study|Lost to Follow-up|7
1310117|NCT00118482|4261668|P1|Overall Study|Lost to Follow-up|7
1310118|NCT00118430|4261679|P3|Overall Study|Lost to Follow-up|28
1310119|NCT00118430|4261680|P2|Overall Study|Lost to Follow-up|22
1310120|NCT00118430|4261681|P1|Overall Study|Lost to Follow-up|15
1310121|NCT00118430|4261679|P3|Overall Study|Withdrawal by Subject|0
1310122|NCT00118430|4261680|P2|Overall Study|Withdrawal by Subject|2
1310123|NCT00118430|4261681|P1|Overall Study|Withdrawal by Subject|6
1310124|NCT00118417|4261696|P2|Phase II (Weeks 6 to 12)|Remission|2
1310125|NCT00118417|4261697|P1|Phase II (Weeks 6 to 12)|Remission|1
1310126|NCT00118417|4261696|P2|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
1310127|NCT00118417|4261697|P1|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
1310128|NCT00118417|4261696|P2|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0
1310129|NCT00118417|4261697|P1|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4
1310130|NCT00118417|4261696|P2|Phase I (Weeks 0 to 6)|Lost to Follow-up|0
1310131|NCT00118417|4261697|P1|Phase I (Weeks 0 to 6)|Lost to Follow-up|6
1310132|NCT00118417|4261696|P2|Phase I (Weeks 0 to 6)|Remission|0
1310133|NCT00118417|4261697|P1|Phase I (Weeks 0 to 6)|Remission|8
1310134|NCT00118287|4261841|P1|Overall Study|Muscle pain|1
1310135|NCT00118287|4261841|P1|Overall Study|Intracranial haemorrhage|1
1310136|NCT00118157|4261861|P1|Overall Study|Withdrawal by Subject|2
1310137|NCT00118157|4261861|P1|Overall Study|Death|8
1310138|NCT00118157|4261861|P1|Overall Study|Adverse Event|2
1310139|NCT00118092|4261879|P1|Overall Study|Protocol Violation|1
1310140|NCT00118092|4261879|P1|Overall Study|Withdrawal by Subject|1
1310141|NCT00118040|4261897|P3|Overall Study|Other|1
1310142|NCT00118040|4261898|P2|Overall Study|Other|0
1310143|NCT00118040|4261899|P1|Overall Study|Other|0
1310144|NCT00118040|4261897|P3|Overall Study|Non-Compliant Participant|2
1310145|NCT00118040|4261898|P2|Overall Study|Non-Compliant Participant|1
1310146|NCT00118040|4261899|P1|Overall Study|Non-Compliant Participant|1
1310147|NCT00118040|4261897|P3|Overall Study|Medical Contraindication|1
1310148|NCT00118040|4261898|P2|Overall Study|Medical Contraindication|0
1310149|NCT00118040|4261899|P1|Overall Study|Medical Contraindication|0
1310150|NCT00118040|4261897|P3|Overall Study|Withdrawal by Subject|2
1310151|NCT00118040|4261898|P2|Overall Study|Withdrawal by Subject|0
1310152|NCT00118040|4261899|P1|Overall Study|Withdrawal by Subject|0
1310153|NCT00118040|4261897|P3|Overall Study|Adverse Event|0
1310154|NCT00118040|4261898|P2|Overall Study|Adverse Event|1
1310155|NCT00118040|4261899|P1|Overall Study|Adverse Event|0
1310156|NCT00117988|4261960|P1|Overall Study|Adverse Event|1
1310157|NCT00117988|4261960|P1|Overall Study|Death|3
1310158|NCT00117949|4261983|P4|Overall Study|Hepatic abnormalities|1
1310159|NCT00117949|4261984|P3|Overall Study|Hepatic abnormalities|0
1310160|NCT00117949|4261985|P2|Overall Study|Hepatic abnormalities|1
1310161|NCT00117949|4261986|P1|Overall Study|Hepatic abnormalities|0
1310162|NCT00117949|4261983|P4|Overall Study|PSA reduction <=50%|4
1310163|NCT00117949|4261984|P3|Overall Study|PSA reduction <=50%|2
1310164|NCT00117949|4261985|P2|Overall Study|PSA reduction <=50%|2
1310165|NCT00117949|4261986|P1|Overall Study|PSA reduction <=50%|0
1310166|NCT00117949|4261983|P4|Overall Study|PSA increase >=10ng/mL|0
1310167|NCT00117949|4261984|P3|Overall Study|PSA increase >=10ng/mL|1
1310168|NCT00117949|4261985|P2|Overall Study|PSA increase >=10ng/mL|1
1310169|NCT00117949|4261986|P1|Overall Study|PSA increase >=10ng/mL|0
1310170|NCT00117949|4261983|P4|Overall Study|Prostate-specific antigen increase >=25%|2
1310171|NCT00117949|4261984|P3|Overall Study|Prostate-specific antigen increase >=25%|1
1310172|NCT00117949|4261985|P2|Overall Study|Prostate-specific antigen increase >=25%|1
1310173|NCT00117949|4261986|P1|Overall Study|Prostate-specific antigen increase >=25%|0
1310174|NCT00117949|4261983|P4|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
1310175|NCT00117949|4261984|P3|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
1310176|NCT00117949|4261985|P2|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
1310177|NCT00117949|4261986|P1|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
1310178|NCT00117949|4261983|P4|Overall Study|Testosterone >1.0 ng/mL|15
1310179|NCT00117949|4261984|P3|Overall Study|Testosterone >1.0 ng/mL|17
1310180|NCT00117949|4261985|P2|Overall Study|Testosterone >1.0 ng/mL|18
1310181|NCT00117949|4261986|P1|Overall Study|Testosterone >1.0 ng/mL|10
1310182|NCT00117845|4262020|P1|Overall Study|stopped treatment/drug supplyinterrupted|1
1310183|NCT00117793|4262038|P1|Overall Study|Withdrawal by Subject|12
1310184|NCT00117676|4262061|P2|Open-label Period: Weeks 433 - 480|Withdrew Consent|1
1310185|NCT00117676|4262062|P1|Open-label Period: Weeks 433 - 480|Withdrew Consent|0
1310186|NCT00117676|4262061|P2|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
1310187|NCT00117676|4262062|P1|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
1310188|NCT00117676|4262061|P2|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0
1310189|NCT00117676|4262062|P1|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1
1310190|NCT00117676|4262061|P2|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1
1310191|NCT00117676|4262062|P1|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0
1310192|NCT00117676|4262061|P2|Open-label Period: Weeks 385 - 432|Investigator’s Discretion|1
1310193|NCT00117676|4262062|P1|Open-label Period: Weeks 385 - 432|Investigator’s Discretion|0
1310194|NCT00117676|4262061|P2|Open-label Period: Weeks 337 - 384|Withdrew Consent|1
1310195|NCT00117676|4262062|P1|Open-label Period: Weeks 337 - 384|Withdrew Consent|2
1310196|NCT00117676|4262061|P2|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0
1310197|NCT00117676|4262062|P1|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1
1310198|NCT00117676|4262061|P2|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1
1310199|NCT00117676|4262062|P1|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3
1310200|NCT00117676|4262061|P2|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
1310201|NCT00117676|4262062|P1|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
1310202|NCT00117676|4262061|P2|Open-label Period: Weeks 289 - 336|Withdrew Consent|1
1310203|NCT00117676|4262062|P1|Open-label Period: Weeks 289 - 336|Withdrew Consent|0
1310204|NCT00117676|4262061|P2|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
1310205|NCT00117676|4262062|P1|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
1310206|NCT00117676|4262061|P2|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4
1310207|NCT00117676|4262062|P1|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7
1310208|NCT00117676|4262061|P2|Open-label Period: Weeks 241 - 288|Withdrew Consent|1
1310209|NCT00117676|4262062|P1|Open-label Period: Weeks 241 - 288|Withdrew Consent|5
1310210|NCT00117676|4262061|P2|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
1310211|NCT00117676|4262062|P1|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1
1310212|NCT00117676|4262061|P2|Open-label Period: Weeks 241 - 288|Protocol Violation|0
1310213|NCT00117676|4262062|P1|Open-label Period: Weeks 241 - 288|Protocol Violation|2
1310214|NCT00117676|4262061|P2|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1
1310215|NCT00117676|4262062|P1|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2
1310216|NCT00117676|4262061|P2|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1
1310217|NCT00117676|4262062|P1|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0
1310218|NCT00117676|4262061|P2|Open-label Period: Weeks 193 - 240|Withdrew Consent|1
1310219|NCT00117676|4262062|P1|Open-label Period: Weeks 193 - 240|Withdrew Consent|4
1310220|NCT00117676|4262061|P2|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0
1310221|NCT00117676|4262062|P1|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
1310222|NCT00117676|4262061|P2|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1
1310223|NCT00117676|4262062|P1|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0
1310224|NCT00117676|4262061|P2|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
1310225|NCT00117676|4262062|P1|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
1310226|NCT00117676|4262061|P2|Open-label Period: Weeks 145 - 192|Withdrew Consent|2
1310227|NCT00117676|4262062|P1|Open-label Period: Weeks 145 - 192|Withdrew Consent|5
1310228|NCT00117676|4262061|P2|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1
1310229|NCT00117676|4262062|P1|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3
1310230|NCT00117676|4262061|P2|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0
1310231|NCT00117676|4262062|P1|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2
1310232|NCT00117676|4262061|P2|Open-label Period: Weeks 97 - 144|Withdrew Consent|0
1310233|NCT00117676|4262062|P1|Open-label Period: Weeks 97 - 144|Withdrew Consent|1
1310234|NCT00117676|4262061|P2|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0
1310235|NCT00117676|4262062|P1|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1
1310236|NCT00117676|4262061|P2|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1
1310237|NCT00117676|4262062|P1|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4
1310238|NCT00117676|4262061|P2|Open-label Period: Weeks 49 - 96|Withdrew Consent|1
1310239|NCT00117676|4262062|P1|Open-label Period: Weeks 49 - 96|Withdrew Consent|5
1310240|NCT00117676|4262061|P2|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
1310241|NCT00117676|4262062|P1|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3
1310242|NCT00117676|4262061|P2|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0
1310243|NCT00117676|4262062|P1|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2
1310244|NCT00117676|4262061|P2|Double-blind Period Through Week 48|Withdrew Consent|1
1310245|NCT00117676|4262062|P1|Double-blind Period Through Week 48|Withdrew Consent|0
1310246|NCT00117676|4262061|P2|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2
1310247|NCT00117676|4262062|P1|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5
1310248|NCT00117676|4262061|P2|Double-blind Period Through Week 48|Protocol Violation|1
1310249|NCT00117676|4262062|P1|Double-blind Period Through Week 48|Protocol Violation|0
1310250|NCT00117676|4262061|P2|Double-blind Period Through Week 48|Lost to Follow-up|0
1310251|NCT00117676|4262062|P1|Double-blind Period Through Week 48|Lost to Follow-up|1
1310252|NCT00117676|4262061|P2|Double-blind Period Through Week 48|Randomized but Not Treated|3
1310253|NCT00117676|4262062|P1|Double-blind Period Through Week 48|Randomized but Not Treated|4
1310254|NCT00117637|4262151|P2|Second Intervention (Period 2)|reason not reported|0
1310255|NCT00117637|4262152|P1|Second Intervention (Period 2)|reason not reported|1
1310256|NCT00117637|4262151|P2|Second Intervention (Period 2)|non compliant with study medication|1
1310257|NCT00117637|4262152|P1|Second Intervention (Period 2)|non compliant with study medication|1
1310258|NCT00117637|4262151|P2|Second Intervention (Period 2)|study terminated by the sponsor|9
1310259|NCT00117637|4262152|P1|Second Intervention (Period 2)|study terminated by the sponsor|2
1310260|NCT00117637|4262151|P2|Second Intervention (Period 2)|Withdrawal by Subject|3
1310261|NCT00117637|4262152|P1|Second Intervention (Period 2)|Withdrawal by Subject|4
1310262|NCT00117637|4262151|P2|Second Intervention (Period 2)|Protocol Violation|0
1310263|NCT00117637|4262152|P1|Second Intervention (Period 2)|Protocol Violation|1
1310264|NCT00117637|4262151|P2|Second Intervention (Period 2)|Lost to Follow-up|0
1310265|NCT00117637|4262152|P1|Second Intervention (Period 2)|Lost to Follow-up|1
1310266|NCT00117637|4262151|P2|Second Intervention (Period 2)|Adverse Event|9
1310267|NCT00117637|4262152|P1|Second Intervention (Period 2)|Adverse Event|0
1310268|NCT00117637|4262151|P2|First Intervention (Period 1)|reason not reported|1
1310269|NCT00117637|4262152|P1|First Intervention (Period 1)|reason not reported|0
1310270|NCT00117637|4262151|P2|First Intervention (Period 1)|investig. decision, not protocol driven|1
1310271|NCT00117637|4262152|P1|First Intervention (Period 1)|investig. decision, not protocol driven|0
1310272|NCT00117637|4262151|P2|First Intervention (Period 1)|protocol driven decision point|0
1310273|NCT00117637|4262152|P1|First Intervention (Period 1)|protocol driven decision point|1
1310274|NCT00117637|4262151|P2|First Intervention (Period 1)|study terminated by the sponsor|1
1310275|NCT00117637|4262152|P1|First Intervention (Period 1)|study terminated by the sponsor|3
1310276|NCT00117637|4262151|P2|First Intervention (Period 1)|Withdrawal by Subject|4
1310277|NCT00117637|4262152|P1|First Intervention (Period 1)|Withdrawal by Subject|2
1310278|NCT00117637|4262151|P2|First Intervention (Period 1)|Protocol Violation|0
1310279|NCT00117637|4262152|P1|First Intervention (Period 1)|Protocol Violation|1
1310280|NCT00117637|4262151|P2|First Intervention (Period 1)|Lost to Follow-up|2
1310281|NCT00117637|4262152|P1|First Intervention (Period 1)|Lost to Follow-up|0
1310282|NCT00117637|4262151|P2|First Intervention (Period 1)|Adverse Event|16
1310283|NCT00117637|4262152|P1|First Intervention (Period 1)|Adverse Event|11
1310284|NCT00117598|4262227|P5|After Treament Cross Over|Other|2
1310285|NCT00117598|4262228|P4|After Treament Cross Over|Other|1
1310286|NCT00117598|4262229|P3|After Treament Cross Over|Other|0
1310287|NCT00117598|4262230|P2|After Treament Cross Over|Other|0
1310288|NCT00117598|4262231|P1|After Treament Cross Over|Other|0
1310289|NCT00117598|4262227|P5|After Treament Cross Over|Withdrawal by Subject|0
1310290|NCT00117598|4262228|P4|After Treament Cross Over|Withdrawal by Subject|1
1310291|NCT00117598|4262229|P3|After Treament Cross Over|Withdrawal by Subject|0
1310292|NCT00117598|4262230|P2|After Treament Cross Over|Withdrawal by Subject|0
1310293|NCT00117598|4262231|P1|After Treament Cross Over|Withdrawal by Subject|0
1310294|NCT00117598|4262227|P5|After Treament Cross Over|Death|2
1310295|NCT00117598|4262228|P4|After Treament Cross Over|Death|1
1310296|NCT00117598|4262229|P3|After Treament Cross Over|Death|0
1310297|NCT00117598|4262230|P2|After Treament Cross Over|Death|0
1310298|NCT00117598|4262231|P1|After Treament Cross Over|Death|0
1310299|NCT00117598|4262227|P5|Prior to Treatment Cross Over|Other|0
1310300|NCT00117598|4262228|P4|Prior to Treatment Cross Over|Other|0
1310301|NCT00117598|4262229|P3|Prior to Treatment Cross Over|Other|9
1310302|NCT00117598|4262230|P2|Prior to Treatment Cross Over|Other|9
1310303|NCT00117598|4262231|P1|Prior to Treatment Cross Over|Other|15
1310304|NCT00117598|4262227|P5|Prior to Treatment Cross Over|Withdrawal by Subject|0
1310305|NCT00117598|4262228|P4|Prior to Treatment Cross Over|Withdrawal by Subject|0
1310306|NCT00117598|4262229|P3|Prior to Treatment Cross Over|Withdrawal by Subject|4
1310307|NCT00117598|4262230|P2|Prior to Treatment Cross Over|Withdrawal by Subject|1
1310308|NCT00117598|4262231|P1|Prior to Treatment Cross Over|Withdrawal by Subject|2
1310309|NCT00117598|4262227|P5|Prior to Treatment Cross Over|Lost to Follow-up|0
1310310|NCT00117598|4262228|P4|Prior to Treatment Cross Over|Lost to Follow-up|0
1310311|NCT00117598|4262229|P3|Prior to Treatment Cross Over|Lost to Follow-up|2
1310312|NCT00117598|4262230|P2|Prior to Treatment Cross Over|Lost to Follow-up|2
1310313|NCT00117598|4262231|P1|Prior to Treatment Cross Over|Lost to Follow-up|0
1310314|NCT00117598|4262227|P5|Prior to Treatment Cross Over|Death|0
1310315|NCT00117598|4262228|P4|Prior to Treatment Cross Over|Death|0
1310316|NCT00117598|4262229|P3|Prior to Treatment Cross Over|Death|37
1310317|NCT00117598|4262230|P2|Prior to Treatment Cross Over|Death|41
1310318|NCT00117598|4262231|P1|Prior to Treatment Cross Over|Death|40
1310319|NCT00117572|4262265|P2|Overall Study|Protocol Violation|0
1310320|NCT00117572|4262266|P1|Overall Study|Protocol Violation|1
1310321|NCT00117572|4262265|P2|Overall Study|Withdrawal by Subject|3
1310322|NCT00117572|4262266|P1|Overall Study|Withdrawal by Subject|3
1310323|NCT00117572|4262265|P2|Overall Study|Site withdrew before starting treatment|3
1310324|NCT00117572|4262266|P1|Overall Study|Site withdrew before starting treatment|2
1310325|NCT00117338|4262307|P2|Overall Study|Lack of Efficacy|1
1310326|NCT00117338|4262308|P1|Overall Study|Lack of Efficacy|0
1310327|NCT00117338|4262307|P2|Overall Study|Did not meet Inclusion Criteria|0
1310328|NCT00117338|4262308|P1|Overall Study|Did not meet Inclusion Criteria|1
1310329|NCT00117338|4262307|P2|Overall Study|Withdrawal by Subject|0
1310330|NCT00117338|4262308|P1|Overall Study|Withdrawal by Subject|1
1310331|NCT00117338|4262307|P2|Overall Study|Protocol Violation|2
1310332|NCT00117338|4262308|P1|Overall Study|Protocol Violation|3
1310333|NCT00117338|4262307|P2|Overall Study|Adverse Event|1
1310334|NCT00117338|4262308|P1|Overall Study|Adverse Event|0
1310335|NCT00117325|4262328|P2|Overall Study|Admisnitrative|0
1310336|NCT00117325|4262329|P1|Overall Study|Admisnitrative|1
1310337|NCT00117325|4262328|P2|Overall Study|Early termination|1
1310338|NCT00117325|4262329|P1|Overall Study|Early termination|1
1310339|NCT00117325|4262328|P2|Overall Study|Use of prohibited medicine|2
1310340|NCT00117325|4262329|P1|Overall Study|Use of prohibited medicine|1
1310341|NCT00117325|4262328|P2|Overall Study|Lack of Efficacy|0
1310342|NCT00117325|4262329|P1|Overall Study|Lack of Efficacy|1
1310343|NCT00117325|4262328|P2|Overall Study|Withdrawal by Subject|2
1310344|NCT00117325|4262329|P1|Overall Study|Withdrawal by Subject|3
1310345|NCT00117325|4262328|P2|Overall Study|Protocol Violation|3
1310346|NCT00117325|4262329|P1|Overall Study|Protocol Violation|2
1310347|NCT00117325|4262328|P2|Overall Study|Lost to Follow-up|1
1310348|NCT00117325|4262329|P1|Overall Study|Lost to Follow-up|1
1310349|NCT00117325|4262328|P2|Overall Study|Adverse Event|3
1310350|NCT00117325|4262329|P1|Overall Study|Adverse Event|3
1310351|NCT00117312|4262361|P4|Overall Study|Withdrawal by Subject|0
1310352|NCT00117312|4262362|P3|Overall Study|Withdrawal by Subject|0
1310353|NCT00117312|4262363|P2|Overall Study|Withdrawal by Subject|2
1310354|NCT00117312|4262364|P1|Overall Study|Withdrawal by Subject|0
1310355|NCT00117312|4262361|P4|Overall Study|Hepatic abnormality|1
1310356|NCT00117312|4262362|P3|Overall Study|Hepatic abnormality|0
1310357|NCT00117312|4262363|P2|Overall Study|Hepatic abnormality|1
1310358|NCT00117312|4262364|P1|Overall Study|Hepatic abnormality|0
1310359|NCT00117312|4262361|P4|Overall Study|PSA increase >= 10ng/mL|0
1310360|NCT00117312|4262362|P3|Overall Study|PSA increase >= 10ng/mL|1
1310361|NCT00117312|4262363|P2|Overall Study|PSA increase >= 10ng/mL|1
1310362|NCT00117312|4262364|P1|Overall Study|PSA increase >= 10ng/mL|0
1310363|NCT00117312|4262361|P4|Overall Study|PSA decrease <=50%|4
1310364|NCT00117312|4262362|P3|Overall Study|PSA decrease <=50%|2
1310365|NCT00117312|4262363|P2|Overall Study|PSA decrease <=50%|2
1310366|NCT00117312|4262364|P1|Overall Study|PSA decrease <=50%|0
1310367|NCT00117312|4262361|P4|Overall Study|Protocol Violation|0
1310368|NCT00117312|4262362|P3|Overall Study|Protocol Violation|3
1310369|NCT00117312|4262363|P2|Overall Study|Protocol Violation|1
1310370|NCT00117312|4262364|P1|Overall Study|Protocol Violation|0
1310371|NCT00117312|4262361|P4|Overall Study|Adverse Event|0
1310372|NCT00117312|4262362|P3|Overall Study|Adverse Event|0
1310373|NCT00117312|4262363|P2|Overall Study|Adverse Event|2
1310374|NCT00117312|4262364|P1|Overall Study|Adverse Event|0
1310375|NCT00117312|4262361|P4|Overall Study|Patient choice|1
1310376|NCT00117312|4262362|P3|Overall Study|Patient choice|2
1310377|NCT00117312|4262363|P2|Overall Study|Patient choice|0
1310378|NCT00117312|4262364|P1|Overall Study|Patient choice|0
1310379|NCT00117312|4262361|P4|Overall Study|Not specified|1
1310380|NCT00117312|4262362|P3|Overall Study|Not specified|3
1310381|NCT00117312|4262363|P2|Overall Study|Not specified|1
1310382|NCT00117312|4262364|P1|Overall Study|Not specified|0
1310383|NCT00117312|4262361|P4|Overall Study|Prostate-specific antigen increase >=25%|3
1310384|NCT00117312|4262362|P3|Overall Study|Prostate-specific antigen increase >=25%|5
1310385|NCT00117312|4262363|P2|Overall Study|Prostate-specific antigen increase >=25%|1
1310386|NCT00117312|4262364|P1|Overall Study|Prostate-specific antigen increase >=25%|0
1310387|NCT00117312|4262361|P4|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
1310388|NCT00117312|4262362|P3|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
1310389|NCT00117312|4262363|P2|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
1310390|NCT00117312|4262364|P1|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
1310391|NCT00117312|4262361|P4|Overall Study|Testosterone >1.0 ng/mL|9
1310392|NCT00117312|4262362|P3|Overall Study|Testosterone >1.0 ng/mL|5
1310393|NCT00117312|4262363|P2|Overall Study|Testosterone >1.0 ng/mL|9
1310394|NCT00117312|4262364|P1|Overall Study|Testosterone >1.0 ng/mL|9
1310395|NCT00117286|4262380|P2|Overall Study|Research site closing|2
1310396|NCT00117286|4262381|P1|Overall Study|Research site closing|0
1310397|NCT00117286|4262380|P2|Overall Study|Lack of Efficacy|1
1310398|NCT00117286|4262381|P1|Overall Study|Lack of Efficacy|2
1310399|NCT00117286|4262380|P2|Overall Study|Physician Decision|7
1310400|NCT00117286|4262381|P1|Overall Study|Physician Decision|3
1310401|NCT00117286|4262380|P2|Overall Study|Withdrawal by Subject|2
1310402|NCT00117286|4262381|P1|Overall Study|Withdrawal by Subject|6
1310403|NCT00117286|4262380|P2|Overall Study|Protocol Violation|3
1310404|NCT00117286|4262381|P1|Overall Study|Protocol Violation|3
1310405|NCT00117286|4262380|P2|Overall Study|Lost to Follow-up|0
1310406|NCT00117286|4262381|P1|Overall Study|Lost to Follow-up|2
1310407|NCT00117286|4262380|P2|Overall Study|Adverse Event|6
1310408|NCT00117286|4262381|P1|Overall Study|Adverse Event|12
1310409|NCT00117156|4262389|P1|Overall Study|Trt for Pre-Exist Second Primary|1
1310410|NCT00117156|4262389|P1|Overall Study|Physician Decision|1
1310411|NCT00117156|4262389|P1|Overall Study|Adverse Event|9
1310412|NCT00116844|4262408|P2|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
1310413|NCT00116844|4262409|P1|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
1310414|NCT00116844|4262408|P2|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1
1310415|NCT00116844|4262409|P1|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0
1310416|NCT00116844|4262408|P2|Period 1: Treatment Period 2 (60 Days)|Other|2
1310417|NCT00116844|4262409|P1|Period 1: Treatment Period 2 (60 Days)|Other|0
1310418|NCT00116844|4262408|P2|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1
1310419|NCT00116844|4262409|P1|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2
1310420|NCT00116844|4262408|P2|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0
1310421|NCT00116844|4262409|P1|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1
1310422|NCT00116844|4262408|P2|Period 1: Treatment Period 1 (60 Days)|Other|1
1310423|NCT00116844|4262409|P1|Period 1: Treatment Period 1 (60 Days)|Other|1
1310424|NCT00116844|4262408|P2|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0
1310425|NCT00116844|4262409|P1|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5
1310426|NCT00116844|4262408|P2|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1
1310427|NCT00116844|4262409|P1|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0
1310428|NCT00116844|4262408|P2|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
1310429|NCT00116844|4262409|P1|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
1310430|NCT00116831|4262427|P2|Overall Study|Missing data for participant|0
1310431|NCT00116831|4262428|P1|Overall Study|Missing data for participant|1
1310432|NCT00116831|4262427|P2|Overall Study|Insufficient therapeutic effect|1
1310433|NCT00116831|4262428|P1|Overall Study|Insufficient therapeutic effect|0
1310434|NCT00116831|4262427|P2|Overall Study|Withdrawal by Subject|32
1310435|NCT00116831|4262428|P1|Overall Study|Withdrawal by Subject|32
1310436|NCT00116831|4262427|P2|Overall Study|Withdrawn investigational product|0
1310437|NCT00116831|4262428|P1|Overall Study|Withdrawn investigational product|1
1310438|NCT00116831|4262427|P2|Overall Study|Low haemoglobin on screening|0
1310439|NCT00116831|4262428|P1|Overall Study|Low haemoglobin on screening|1
1310440|NCT00116831|4262427|P2|Overall Study|Hypoglycaemic events|0
1310441|NCT00116831|4262428|P1|Overall Study|Hypoglycaemic events|1
1310442|NCT00116831|4262427|P2|Overall Study|Protocol Violation|6
1310443|NCT00116831|4262428|P1|Overall Study|Protocol Violation|3
1310444|NCT00116831|4262427|P2|Overall Study|Lost to Follow-up|6
1310445|NCT00116831|4262428|P1|Overall Study|Lost to Follow-up|8
1310446|NCT00116831|4262427|P2|Overall Study|Baseline IVUS determined unevaluable|11
1310447|NCT00116831|4262428|P1|Overall Study|Baseline IVUS determined unevaluable|12
1310448|NCT00116831|4262427|P2|Overall Study|Adverse Event|16
1310449|NCT00116831|4262428|P1|Overall Study|Adverse Event|14
1310450|NCT00116805|4262506|P2|Open-label Period Weeks 433 - 480|Withdrew Consent|0
1310451|NCT00116805|4262507|P1|Open-label Period Weeks 433 - 480|Withdrew Consent|3
1310452|NCT00116805|4262506|P2|Open-label Period Weeks 433 - 480|Investigator’s Discretion|0
1310453|NCT00116805|4262507|P1|Open-label Period Weeks 433 - 480|Investigator’s Discretion|1
1310454|NCT00116805|4262506|P2|Open-label Period Weeks 385 - 432|Withdrew Consent|0
1310455|NCT00116805|4262507|P1|Open-label Period Weeks 385 - 432|Withdrew Consent|1
1310456|NCT00116805|4262506|P2|Open-label Period Weeks 385 - 432|Investigator’s Discretion|0
1310457|NCT00116805|4262507|P1|Open-label Period Weeks 385 - 432|Investigator’s Discretion|1
1310458|NCT00116805|4262506|P2|Open-label Period Weeks 337 - 384|Withdrew Consent|1
1310459|NCT00116805|4262507|P1|Open-label Period Weeks 337 - 384|Withdrew Consent|3
1310460|NCT00116805|4262506|P2|Open-label Period Weeks 337 - 384|Protocol Violation|0
1310461|NCT00116805|4262507|P1|Open-label Period Weeks 337 - 384|Protocol Violation|1
1310462|NCT00116805|4262506|P2|Open-label Period Weeks 337 - 384|Lost to Follow-up|0
1310463|NCT00116805|4262507|P1|Open-label Period Weeks 337 - 384|Lost to Follow-up|2
1310464|NCT00116805|4262506|P2|Open-label Period Weeks 337 - 384|Investigator's Discretion|0
1310465|NCT00116805|4262507|P1|Open-label Period Weeks 337 - 384|Investigator's Discretion|1
1310466|NCT00116805|4262506|P2|Open-label Period Weeks 337 - 384|Completed Study|0
1310467|NCT00116805|4262507|P1|Open-label Period Weeks 337 - 384|Completed Study|1
1310468|NCT00116805|4262506|P2|Open-label Period Weeks 289 - 336|Withdrew Consent|0
1310469|NCT00116805|4262507|P1|Open-label Period Weeks 289 - 336|Withdrew Consent|2
1310470|NCT00116805|4262506|P2|Open-label Period Weeks 289 - 336|Study Site Discontinued|1
1310471|NCT00116805|4262507|P1|Open-label Period Weeks 289 - 336|Study Site Discontinued|0
1310472|NCT00116805|4262506|P2|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1
1310473|NCT00116805|4262507|P1|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0
1310474|NCT00116805|4262506|P2|Open-label Period Weeks 289 - 336|Protocol Violation|1
1310475|NCT00116805|4262507|P1|Open-label Period Weeks 289 - 336|Protocol Violation|0
1310476|NCT00116805|4262506|P2|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
1310477|NCT00116805|4262507|P1|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
1310478|NCT00116805|4262506|P2|Open-label Period Weeks 289 - 336|Investigator's Discretion|2
1310479|NCT00116805|4262507|P1|Open-label Period Weeks 289 - 336|Investigator's Discretion|3
1310480|NCT00116805|4262506|P2|Open-label Period Weeks 289 - 336|Completed Study|1
1310481|NCT00116805|4262507|P1|Open-label Period Weeks 289 - 336|Completed Study|0
1310482|NCT00116805|4262506|P2|Open-label Period Weeks 241 - 288|Withdrew Consent|0
1310483|NCT00116805|4262507|P1|Open-label Period Weeks 241 - 288|Withdrew Consent|4
1310484|NCT00116805|4262506|P2|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
1310485|NCT00116805|4262507|P1|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2
1310486|NCT00116805|4262506|P2|Open-label Period Weeks 193 - 240|Withdrew Consent|1
1310487|NCT00116805|4262507|P1|Open-label Period Weeks 193 - 240|Withdrew Consent|7
1310488|NCT00116805|4262506|P2|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
1310489|NCT00116805|4262507|P1|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
1310490|NCT00116805|4262506|P2|Open-label Period Weeks 193 - 240|Lost to Follow-up|0
1310491|NCT00116805|4262507|P1|Open-label Period Weeks 193 - 240|Lost to Follow-up|3
1310492|NCT00116805|4262506|P2|Open-label Period Weeks 193 - 240|Investigator's Discretion|0
1310493|NCT00116805|4262507|P1|Open-label Period Weeks 193 - 240|Investigator's Discretion|1
1310494|NCT00116805|4262506|P2|Open-label Period Weeks 193 - 240|Completed Study|1
1310495|NCT00116805|4262507|P1|Open-label Period Weeks 193 - 240|Completed Study|0
1310496|NCT00116805|4262506|P2|Open-label Period Weeks 145 - 192|Withdrew Consent|2
1310497|NCT00116805|4262507|P1|Open-label Period Weeks 145 - 192|Withdrew Consent|3
1310498|NCT00116805|4262506|P2|Open-label Period Weeks 145 - 192|Seroconversion|1
1310499|NCT00116805|4262507|P1|Open-label Period Weeks 145 - 192|Seroconversion|0
1310500|NCT00116805|4262506|P2|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1
1310501|NCT00116805|4262507|P1|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0
1310502|NCT00116805|4262506|P2|Open-label Period Weeks 145 - 192|Protocol Violation|0
1310503|NCT00116805|4262507|P1|Open-label Period Weeks 145 - 192|Protocol Violation|1
1310504|NCT00116805|4262506|P2|Open-label Period Weeks 145 - 192|Lost to Follow-up|1
1310505|NCT00116805|4262507|P1|Open-label Period Weeks 145 - 192|Lost to Follow-up|3
1310506|NCT00116805|4262506|P2|Open-label Period Weeks 145 - 192|Investigator's Discretion|0
1310507|NCT00116805|4262507|P1|Open-label Period Weeks 145 - 192|Investigator's Discretion|2
1310508|NCT00116805|4262506|P2|Open-label Period Weeks 145 - 192|Completed Study|1
1310509|NCT00116805|4262507|P1|Open-label Period Weeks 145 - 192|Completed Study|1
1310510|NCT00116805|4262506|P2|Open-label Period Weeks 97 - 144|Withdrew Consent|3
1310511|NCT00116805|4262507|P1|Open-label Period Weeks 97 - 144|Withdrew Consent|1
1310512|NCT00116805|4262506|P2|Open-label Period Weeks 97 - 144|Seroconversion|3
1310513|NCT00116805|4262507|P1|Open-label Period Weeks 97 - 144|Seroconversion|2
1310514|NCT00116805|4262506|P2|Open-label Period Weeks 97 - 144|Protocol Violation|1
1310515|NCT00116805|4262507|P1|Open-label Period Weeks 97 - 144|Protocol Violation|0
1310516|NCT00116805|4262506|P2|Open-label Period Weeks 97 - 144|Lost to Follow-up|2
1310517|NCT00116805|4262507|P1|Open-label Period Weeks 97 - 144|Lost to Follow-up|5
1310518|NCT00116805|4262506|P2|Open-label Period Weeks 97 - 144|Investigator's Discretion|0
1310519|NCT00116805|4262507|P1|Open-label Period Weeks 97 - 144|Investigator's Discretion|2
1310520|NCT00116805|4262506|P2|Open-label Period Weeks 97 - 144|Completed Study|0
1310521|NCT00116805|4262507|P1|Open-label Period Weeks 97 - 144|Completed Study|1
1310522|NCT00116805|4262506|P2|Open-label Period Weeks 49 - 96|Withdrew Consent|1
1310523|NCT00116805|4262507|P1|Open-label Period Weeks 49 - 96|Withdrew Consent|2
1310524|NCT00116805|4262506|P2|Open-label Period Weeks 49 - 96|Seroconversion|0
1310525|NCT00116805|4262507|P1|Open-label Period Weeks 49 - 96|Seroconversion|2
1310526|NCT00116805|4262506|P2|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0
1310527|NCT00116805|4262507|P1|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
1310528|NCT00116805|4262506|P2|Open-label Period Weeks 49 - 96|Protocol Violation|0
1310529|NCT00116805|4262507|P1|Open-label Period Weeks 49 - 96|Protocol Violation|2
1310530|NCT00116805|4262506|P2|Open-label Period Weeks 49 - 96|Lost to Follow-up|0
1310531|NCT00116805|4262507|P1|Open-label Period Weeks 49 - 96|Lost to Follow-up|2
1310532|NCT00116805|4262506|P2|Open-label Period Weeks 49 - 96|Investigator's Discretion|0
1310533|NCT00116805|4262507|P1|Open-label Period Weeks 49 - 96|Investigator's Discretion|1
1310534|NCT00116805|4262506|P2|Double-blind Period Through Week 48|Withdrew Consent|2
1310535|NCT00116805|4262507|P1|Double-blind Period Through Week 48|Withdrew Consent|4
1310536|NCT00116805|4262506|P2|Double-blind Period Through Week 48|Protocol Violation|1
1310537|NCT00116805|4262507|P1|Double-blind Period Through Week 48|Protocol Violation|1
1310538|NCT00116805|4262506|P2|Double-blind Period Through Week 48|Lost to Follow-up|2
1310539|NCT00116805|4262507|P1|Double-blind Period Through Week 48|Lost to Follow-up|6
1310540|NCT00116779|4262600|P2|Overall Study|Elevated PSA levels|2
1310541|NCT00116779|4262601|P1|Overall Study|Elevated PSA levels|2
1310542|NCT00116779|4262600|P2|Overall Study|Physician Decision|1
1310543|NCT00116779|4262601|P1|Overall Study|Physician Decision|3
1310544|NCT00116779|4262600|P2|Overall Study|Inadequate testosterone suppression|9
1310545|NCT00116779|4262601|P1|Overall Study|Inadequate testosterone suppression|7
1310546|NCT00116779|4262600|P2|Overall Study|Withdrawal by Subject|1
1310547|NCT00116779|4262601|P1|Overall Study|Withdrawal by Subject|4
1310548|NCT00116779|4262600|P2|Overall Study|Protocol Violation|4
1310549|NCT00116779|4262601|P1|Overall Study|Protocol Violation|1
1310550|NCT00116779|4262600|P2|Overall Study|Adverse Event|2
1310551|NCT00116779|4262601|P1|Overall Study|Adverse Event|4
1310552|NCT00116753|4262634|P3|Overall Study|Dosing Error|0
1310553|NCT00116753|4262635|P2|Overall Study|Dosing Error|1
1310554|NCT00116753|4262636|P1|Overall Study|Dosing Error|0
1310555|NCT00116753|4262634|P3|Overall Study|Progressive Parkinson's Disease|0
1310556|NCT00116753|4262635|P2|Overall Study|Progressive Parkinson's Disease|0
1310557|NCT00116753|4262636|P1|Overall Study|Progressive Parkinson's Disease|1
1310558|NCT00116753|4262634|P3|Overall Study|Abnormal Echocardiogram|1
1310559|NCT00116753|4262635|P2|Overall Study|Abnormal Echocardiogram|0
1310560|NCT00116753|4262636|P1|Overall Study|Abnormal Echocardiogram|0
1310561|NCT00116753|4262634|P3|Overall Study|Disease Progression|3
1310562|NCT00116753|4262635|P2|Overall Study|Disease Progression|4
1310563|NCT00116753|4262636|P1|Overall Study|Disease Progression|3
1310564|NCT00116753|4262634|P3|Overall Study|Did not Fulfil Eligibility Criteria|3
1310565|NCT00116753|4262635|P2|Overall Study|Did not Fulfil Eligibility Criteria|1
1310566|NCT00116753|4262636|P1|Overall Study|Did not Fulfil Eligibility Criteria|1
1310567|NCT00116753|4262634|P3|Overall Study|Protocol Violation|1
1310568|NCT00116753|4262635|P2|Overall Study|Protocol Violation|0
1310569|NCT00116753|4262636|P1|Overall Study|Protocol Violation|0
1310570|NCT00116753|4262634|P3|Overall Study|Lost to Follow-up|1
1310571|NCT00116753|4262635|P2|Overall Study|Lost to Follow-up|2
1310572|NCT00116753|4262636|P1|Overall Study|Lost to Follow-up|0
1310573|NCT00116753|4262634|P3|Overall Study|Withdrawal by Subject|8
1310574|NCT00116753|4262635|P2|Overall Study|Withdrawal by Subject|12
1310575|NCT00116753|4262636|P1|Overall Study|Withdrawal by Subject|11
1310576|NCT00116753|4262634|P3|Overall Study|Adverse Event|7
1310577|NCT00116753|4262635|P2|Overall Study|Adverse Event|10
1310578|NCT00116753|4262636|P1|Overall Study|Adverse Event|16
1310579|NCT00116688|4262658|P2|Overall Study|Other|0
1310580|NCT00116688|4262659|P1|Overall Study|Other|11
1310581|NCT00116688|4262658|P2|Overall Study|Pregnancy|0
1310582|NCT00116688|4262659|P1|Overall Study|Pregnancy|1
1310583|NCT00116688|4262658|P2|Overall Study|Protocol-specified criteria|0
1310584|NCT00116688|4262659|P1|Overall Study|Protocol-specified criteria|3
1310585|NCT00116688|4262658|P2|Overall Study|Death|0
1310586|NCT00116688|4262659|P1|Overall Study|Death|15
1310587|NCT00116688|4262658|P2|Overall Study|Lost to Follow-up|0
1310588|NCT00116688|4262659|P1|Overall Study|Lost to Follow-up|3
1310589|NCT00116688|4262658|P2|Overall Study|Physician Decision|0
1310590|NCT00116688|4262659|P1|Overall Study|Physician Decision|7
1310591|NCT00116688|4262658|P2|Overall Study|Requirement for alternative therapy|1
1310592|NCT00116688|4262659|P1|Overall Study|Requirement for alternative therapy|11
1310593|NCT00116688|4262658|P2|Overall Study|Withdrawal by Subject|2
1310594|NCT00116688|4262659|P1|Overall Study|Withdrawal by Subject|26
1310595|NCT00116688|4262658|P2|Overall Study|Adverse Event|0
1310596|NCT00116688|4262659|P1|Overall Study|Adverse Event|11
1310597|NCT00116688|4262658|P2|Overall Study|Noncompliance|1
1310598|NCT00116688|4262659|P1|Overall Study|Noncompliance|3
1310599|NCT00116688|4262658|P2|Overall Study|Protocol deviation|0
1310600|NCT00116688|4262659|P1|Overall Study|Protocol deviation|1
1310601|NCT00116649|4262674|P1|Overall Study|Protocol Specified|7
1310602|NCT00116649|4262674|P1|Overall Study|Various Reasons|18
1310603|NCT00116649|4262674|P1|Overall Study|Local Skin Reaction|9
1310604|NCT00116649|4262674|P1|Overall Study|Withdrawal by Subject|68
1310605|NCT00116649|4262674|P1|Overall Study|Lost to Follow-up|32
1310606|NCT00116649|4262674|P1|Overall Study|Lack of Efficacy|1
1310607|NCT00116649|4262674|P1|Overall Study|Adverse Event|20
1310608|NCT00116428|4262681|P2|Overall Study|Did not meet inclusion criteria|0
1310609|NCT00116428|4262682|P1|Overall Study|Did not meet inclusion criteria|1
1310610|NCT00116428|4262681|P2|Overall Study|Withdrawal by Subject|5
1310611|NCT00116428|4262682|P1|Overall Study|Withdrawal by Subject|2
1310612|NCT00116272|4262700|P2|Overall Study|Lost to Follow-up|6
1310613|NCT00116272|4262701|P1|Overall Study|Lost to Follow-up|11
1310614|NCT00116168|4262770|P4|Overall Study|Lost to Follow-up|0
1310615|NCT00116168|4262771|P3|Overall Study|Lost to Follow-up|0
1310616|NCT00116168|4262772|P2|Overall Study|Lost to Follow-up|5
1310617|NCT00116168|4262773|P1|Overall Study|Lost to Follow-up|6
1310618|NCT00115934|4262837|P2|Overall Study|Did not receive intervention|2
1310619|NCT00115934|4262838|P1|Overall Study|Did not receive intervention|3
1310620|NCT00115934|4262837|P2|Overall Study|Lost to Follow-up|0
1310621|NCT00115934|4262838|P1|Overall Study|Lost to Follow-up|1
1310622|NCT00115804|4262887|P1|Overall Study|Adverse Event|2
1310623|NCT00115765|4262902|P4|Overall Study|Not specified|2
1310624|NCT00115765|4262903|P3|Overall Study|Not specified|9
1310625|NCT00115765|4262904|P2|Overall Study|Not specified|12
1310626|NCT00115765|4262905|P1|Overall Study|Not specified|6
1310627|NCT00115765|4262902|P4|Overall Study|Lost to Follow-up|1
1310628|NCT00115765|4262903|P3|Overall Study|Lost to Follow-up|18
1310629|NCT00115765|4262904|P2|Overall Study|Lost to Follow-up|20
1310630|NCT00115765|4262905|P1|Overall Study|Lost to Follow-up|3
1310631|NCT00115765|4262902|P4|Overall Study|Physician Decision|13
1310632|NCT00115765|4262903|P3|Overall Study|Physician Decision|18
1310633|NCT00115765|4262904|P2|Overall Study|Physician Decision|15
1310634|NCT00115765|4262905|P1|Overall Study|Physician Decision|4
1310635|NCT00115765|4262902|P4|Overall Study|Withdrawal by Subject|15
1310636|NCT00115765|4262903|P3|Overall Study|Withdrawal by Subject|76
1310637|NCT00115765|4262904|P2|Overall Study|Withdrawal by Subject|53
1310638|NCT00115765|4262905|P1|Overall Study|Withdrawal by Subject|22
1310639|NCT00115739|4262943|P1|Overall Study|Lost to Follow-up|3
1310640|NCT00115349|4262952|P2|Overall Study|Study closed due to low enrollment.|9
1310641|NCT00115349|4262953|P1|Overall Study|Study closed due to low enrollment.|11
1310642|NCT00115063|4262974|P2|Overall Study|Death|0
1310643|NCT00115063|4262975|P1|Overall Study|Death|1
1310644|NCT00115063|4262974|P2|Overall Study|Lost to Follow-up|104
1310645|NCT00115063|4262975|P1|Overall Study|Lost to Follow-up|98
1310646|NCT00114972|4262993|P2|Overall Study|Lost to Follow-up|5
1310647|NCT00114972|4262994|P1|Overall Study|Lost to Follow-up|8
1310648|NCT00114972|4262993|P2|Overall Study|Withdrawal by Subject|7
1310649|NCT00114972|4262994|P1|Overall Study|Withdrawal by Subject|40
1310650|NCT00114959|4263014|P1|Overall Study|Death|1
1310651|NCT00114959|4263014|P1|Overall Study|Physician Decision|1
1310652|NCT00114959|4263014|P1|Overall Study|Lack of Efficacy|6
1310653|NCT00114777|4263024|P3|Long-Term Extension to Month 84|Not Specified|2
1310654|NCT00114777|4263025|P2|Long-Term Extension to Month 84|Not Specified|0
1310655|NCT00114777|4263026|P1|Long-Term Extension to Month 84|Not Specified|2
1310656|NCT00114777|4263024|P3|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1
1310657|NCT00114777|4263025|P2|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
1310658|NCT00114777|4263026|P1|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
1310659|NCT00114777|4263024|P3|Long-Term Extension to Month 84|Lost to Follow-up|2
1310660|NCT00114777|4263025|P2|Long-Term Extension to Month 84|Lost to Follow-up|0
1310661|NCT00114777|4263026|P1|Long-Term Extension to Month 84|Lost to Follow-up|0
1310662|NCT00114777|4263024|P3|Long-Term Extension to Month 84|Withdrawal by Subject|6
1310663|NCT00114777|4263025|P2|Long-Term Extension to Month 84|Withdrawal by Subject|1
1310664|NCT00114777|4263026|P1|Long-Term Extension to Month 84|Withdrawal by Subject|2
1310665|NCT00114777|4263024|P3|Long-Term Extension to Month 84|Adverse Event|7
1310666|NCT00114777|4263025|P2|Long-Term Extension to Month 84|Adverse Event|14
1310667|NCT00114777|4263026|P1|Long-Term Extension to Month 84|Adverse Event|15
1310668|NCT00114777|4263024|P3|Long-Term Extension to Month 84|Poor or Non-Compliance|3
1310669|NCT00114777|4263025|P2|Long-Term Extension to Month 84|Poor or Non-Compliance|1
1310670|NCT00114777|4263026|P1|Long-Term Extension to Month 84|Poor or Non-Compliance|1
1310671|NCT00114777|4263024|P3|Long-Term Extension to Month 84|Lack of Efficacy|1
1310672|NCT00114777|4263025|P2|Long-Term Extension to Month 84|Lack of Efficacy|0
1310673|NCT00114777|4263026|P1|Long-Term Extension to Month 84|Lack of Efficacy|1
1310674|NCT00114777|4263024|P3|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
1310675|NCT00114777|4263025|P2|Long-Term Extension to Month 84|No Longer Met Study Criteria|0
1310676|NCT00114777|4263026|P1|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
1310677|NCT00114777|4263024|P3|Long-Term Extension to Month 84|Death|7
1310678|NCT00114777|4263025|P2|Long-Term Extension to Month 84|Death|13
1310679|NCT00114777|4263026|P1|Long-Term Extension to Month 84|Death|8
1310680|NCT00114777|4263024|P3|Randomization to Month 36|Not Specified|12
1310681|NCT00114777|4263025|P2|Randomization to Month 36|Not Specified|3
1310682|NCT00114777|4263026|P1|Randomization to Month 36|Not Specified|9
1310683|NCT00114777|4263024|P3|Randomization to Month 36|Withdrawal by Subject|5
1310684|NCT00114777|4263025|P2|Randomization to Month 36|Withdrawal by Subject|4
1310685|NCT00114777|4263026|P1|Randomization to Month 36|Withdrawal by Subject|3
1310686|NCT00114777|4263024|P3|Randomization to Month 36|Adverse Event|44
1310687|NCT00114777|4263025|P2|Randomization to Month 36|Adverse Event|35
1310688|NCT00114777|4263026|P1|Randomization to Month 36|Adverse Event|34
1310689|NCT00114777|4263024|P3|Randomization to Month 36|Poor or Non-Compliance|1
1310690|NCT00114777|4263025|P2|Randomization to Month 36|Poor or Non-Compliance|0
1310691|NCT00114777|4263026|P1|Randomization to Month 36|Poor or Non-Compliance|0
1310692|NCT00114777|4263024|P3|Randomization to Month 36|Lack of Efficacy|17
1310693|NCT00114777|4263025|P2|Randomization to Month 36|Lack of Efficacy|15
1310694|NCT00114777|4263026|P1|Randomization to Month 36|Lack of Efficacy|19
1310695|NCT00114777|4263024|P3|Randomization to Month 36|No Longer Met Study Criteria|2
1310696|NCT00114777|4263025|P2|Randomization to Month 36|No Longer Met Study Criteria|0
1310697|NCT00114777|4263026|P1|Randomization to Month 36|No Longer Met Study Criteria|0
1310698|NCT00114777|4263024|P3|Randomization to Month 36|Death|3
1310699|NCT00114777|4263025|P2|Randomization to Month 36|Death|4
1310700|NCT00114777|4263026|P1|Randomization to Month 36|Death|10
1310701|NCT00114738|4263100|P3|Screening for Randomization|Other|0
1310702|NCT00114738|4263101|P2|Screening for Randomization|Other|0
1310703|NCT00114738|4263102|P1|Screening for Randomization|Other|1
1310704|NCT00114738|4263100|P3|Screening for Randomization|CNS Hemorrhage|0
1310705|NCT00114738|4263101|P2|Screening for Randomization|CNS Hemorrhage|0
1310706|NCT00114738|4263102|P1|Screening for Randomization|CNS Hemorrhage|1
1310707|NCT00114738|4263100|P3|Screening for Randomization|Progressive disease|0
1310708|NCT00114738|4263101|P2|Screening for Randomization|Progressive disease|0
1310709|NCT00114738|4263102|P1|Screening for Randomization|Progressive disease|2
1310710|NCT00114738|4263100|P3|Screening for Randomization|Neuropathy|0
1310711|NCT00114738|4263101|P2|Screening for Randomization|Neuropathy|0
1310712|NCT00114738|4263102|P1|Screening for Randomization|Neuropathy|17
1310713|NCT00114738|4263100|P3|Bortezomib Then Bortezomib + Induction|Progressive Disease|0
1310714|NCT00114738|4263101|P2|Bortezomib Then Bortezomib + Induction|Progressive Disease|0
1310715|NCT00114738|4263102|P1|Bortezomib Then Bortezomib + Induction|Progressive Disease|1
1310716|NCT00114738|4263100|P3|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0
1310717|NCT00114738|4263101|P2|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0
1310718|NCT00114738|4263102|P1|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1
1310719|NCT00114634|4263115|P1|Overall Study|failure to return forms|3
1310720|NCT00114530|4263131|P2|Overall Study|Ineligible|0
1310721|NCT00114530|4263132|P1|Overall Study|Ineligible|1
1310722|NCT00114530|4263131|P2|Overall Study|Subject decision after endpoint failure|1
1310723|NCT00114530|4263132|P1|Overall Study|Subject decision after endpoint failure|0
1310724|NCT00114530|4263131|P2|Overall Study|Breast Cancer|0
1310725|NCT00114530|4263132|P1|Overall Study|Breast Cancer|1
1310726|NCT00114530|4263131|P2|Overall Study|Withdrawal by Subject|6
1310727|NCT00114530|4263132|P1|Overall Study|Withdrawal by Subject|2
1310728|NCT00114530|4263131|P2|Overall Study|Physician Decision|1
1310729|NCT00114530|4263132|P1|Overall Study|Physician Decision|1
1310730|NCT00114530|4263131|P2|Overall Study|Lost to Follow-up|1
1310731|NCT00114530|4263132|P1|Overall Study|Lost to Follow-up|1
1310732|NCT00114530|4263131|P2|Overall Study|Death|11
1310733|NCT00114530|4263132|P1|Overall Study|Death|3
1310734|NCT00114244|4263269|P2|Overall Study|Withdrawal by Subject|2
1310735|NCT00114244|4263270|P1|Overall Study|Withdrawal by Subject|0
1310736|NCT00114244|4263269|P2|Overall Study|Adverse Event|5
1310737|NCT00114244|4263270|P1|Overall Study|Adverse Event|2
1310738|NCT00114231|4263282|P2|Overall Study|Biopsy done after registration|0
1310739|NCT00114231|4263283|P1|Overall Study|Biopsy done after registration|1
1310740|NCT00114231|4263282|P2|Overall Study|No Absolute Neutrophil Count|0
1310741|NCT00114231|4263283|P1|Overall Study|No Absolute Neutrophil Count|2
1310742|NCT00114231|4263282|P2|Overall Study|Tumor fixed on digital exam|1
1310743|NCT00114231|4263283|P1|Overall Study|Tumor fixed on digital exam|0
1310744|NCT00114231|4263282|P2|Overall Study|Tumor size > 4cm|0
1310745|NCT00114231|4263283|P1|Overall Study|Tumor size > 4cm|1
1310746|NCT00114231|4263282|P2|Overall Study|Low creatinine clearance|1
1310747|NCT00114231|4263283|P1|Overall Study|Low creatinine clearance|0
1310748|NCT00114231|4263282|P2|Overall Study|No adenocarcinoma|0
1310749|NCT00114231|4263283|P1|Overall Study|No adenocarcinoma|1
1310750|NCT00114231|4263282|P2|Overall Study|Suspected metastatic disease|0
1310751|NCT00114231|4263283|P1|Overall Study|Suspected metastatic disease|1
1310752|NCT00114231|4263282|P2|Overall Study|QARC requirement not met|0
1310753|NCT00114231|4263283|P1|Overall Study|QARC requirement not met|1
1310754|NCT00114231|4263282|P2|Overall Study|No consent|0
1310755|NCT00114231|4263283|P1|Overall Study|No consent|2
1310756|NCT00114218|4263292|P1|Overall Study|Never Treated|1
1310757|NCT00114218|4263292|P1|Overall Study|Wrong Primary|1
1310758|NCT00114218|4263292|P1|Overall Study|Wrong Cell Type|2
1310759|NCT00114166|4263299|P2|Overall Study|Wrong primary|1
1310760|NCT00114166|4263300|P1|Overall Study|Wrong primary|0
1310761|NCT00114140|4263310|P1|Overall Study|Protocol Violation|7
1310762|NCT00114127|4263324|P2|Overall Study|Withdrawal by Subject|3
1310763|NCT00114127|4263325|P1|Overall Study|Withdrawal by Subject|1
1310764|NCT00114127|4263324|P2|Overall Study|Lost to Follow-up|0
1310765|NCT00114127|4263325|P1|Overall Study|Lost to Follow-up|1
1310766|NCT00114127|4263324|P2|Overall Study|Adverse Event|1
1310767|NCT00114127|4263325|P1|Overall Study|Adverse Event|2
1310768|NCT00113919|4263348|P1|Overall Study|Death|6
1310769|NCT00113919|4263348|P1|Overall Study|Physician Decision|8
1310770|NCT00113841|4263416|P2|Overall Study|Non-compliant|0
1310771|NCT00113841|4263417|P1|Overall Study|Non-compliant|1
1310772|NCT00113841|4263416|P2|Overall Study|Disease progression|2
1310773|NCT00113841|4263417|P1|Overall Study|Disease progression|0
1310774|NCT00113763|4263425|P2|Overall Study|Ongoing|0
1310775|NCT00113763|4263426|P1|Overall Study|Ongoing|1
1310776|NCT00113763|4263425|P2|Overall Study|Non-compliance|0
1310777|NCT00113763|4263426|P1|Overall Study|Non-compliance|1
1310778|NCT00113763|4263425|P2|Overall Study|Not specified|6
1310779|NCT00113763|4263426|P1|Overall Study|Not specified|27
1310780|NCT00113763|4263425|P2|Overall Study|Withdrawal by Subject|4
1310781|NCT00113763|4263426|P1|Overall Study|Withdrawal by Subject|1
1310782|NCT00113763|4263425|P2|Overall Study|Lost to Follow-up|0
1310783|NCT00113763|4263426|P1|Overall Study|Lost to Follow-up|10
1310784|NCT00113763|4263425|P2|Overall Study|Disease Progression|14
1310785|NCT00113763|4263426|P1|Overall Study|Disease Progression|28
1310786|NCT00113763|4263425|P2|Overall Study|Adverse Event|2
1310787|NCT00113763|4263426|P1|Overall Study|Adverse Event|5
1310788|NCT00113607|4263452|P2|Overall Study|Other|32
1310789|NCT00113607|4263453|P1|Overall Study|Other|43
1310790|NCT00113607|4263452|P2|Overall Study|Complete Response (Confirmed)|24
1310791|NCT00113607|4263453|P1|Overall Study|Complete Response (Confirmed)|14
1310792|NCT00113607|4263452|P2|Overall Study|Disease Progression|142
1310793|NCT00113607|4263453|P1|Overall Study|Disease Progression|180
1310794|NCT00113607|4263452|P2|Overall Study|Lost to Follow-up|2
1310795|NCT00113607|4263453|P1|Overall Study|Lost to Follow-up|0
1310796|NCT00113607|4263452|P2|Overall Study|Withdrawal by Subject|58
1310797|NCT00113607|4263453|P1|Overall Study|Withdrawal by Subject|50
1310798|NCT00113607|4263452|P2|Overall Study|Death|8
1310799|NCT00113607|4263453|P1|Overall Study|Death|8
1310800|NCT00113607|4263452|P2|Overall Study|Adverse Event|71
1310801|NCT00113607|4263453|P1|Overall Study|Adverse Event|40
1310802|NCT00113568|4263467|P1|Overall Study|Other|112
1310803|NCT00113568|4263467|P1|Overall Study|Withdrawal by Subject|117
1310804|NCT00113568|4263467|P1|Overall Study|Protocol Violation|32
1310805|NCT00113568|4263467|P1|Overall Study|Lost to Follow-up|156
1310806|NCT00113568|4263467|P1|Overall Study|Lack of Efficacy|30
1310807|NCT00113568|4263467|P1|Overall Study|Death|1
1310808|NCT00113568|4263467|P1|Overall Study|Adverse Event|97
1310809|NCT00113555|4263479|P1|Overall Study|Lost to Follow-up|8
1310810|NCT00113555|4263479|P1|Overall Study|Missed Followup|4
1310811|NCT00113555|4263479|P1|Overall Study|Death|1
1310812|NCT00113555|4263479|P1|Overall Study|Permanently Explanted|7
1310813|NCT00113555|4263479|P1|Overall Study|Baseline Failure|59
1310814|NCT00113529|4263489|P1|Overall Study|Withdrawal by Subject|4
1310815|NCT00113529|4263489|P1|Overall Study|Decision of sponsor|6
1310816|NCT00113529|4263489|P1|Overall Study|Lack of Efficacy|20
1310817|NCT00113529|4263489|P1|Overall Study|Adverse Event|4
1310818|NCT00113516|4263522|P2|Part 2|Ongoing|1
1310819|NCT00113516|4263523|P1|Part 2|Ongoing|0
1310820|NCT00113516|4263522|P2|Part 2|Laboratory Abnormality|1
1310821|NCT00113516|4263523|P1|Part 2|Laboratory Abnormality|0
1310822|NCT00113516|4263522|P2|Part 2|Other|3
1310823|NCT00113516|4263523|P1|Part 2|Other|0
1310824|NCT00113516|4263522|P2|Part 2|Withdrawal by Subject|3
1310825|NCT00113516|4263523|P1|Part 2|Withdrawal by Subject|0
1310826|NCT00113516|4263522|P2|Part 2|Lack of Efficacy|37
1310827|NCT00113516|4263523|P1|Part 2|Lack of Efficacy|0
1310828|NCT00113516|4263522|P2|Part 2|Death|5
1310829|NCT00113516|4263523|P1|Part 2|Death|0
1310830|NCT00113516|4263522|P2|Part 2|Adverse Event|16
1310831|NCT00113516|4263523|P1|Part 2|Adverse Event|0
1310832|NCT00113516|4263522|P2|Part 1|Missing|0
1310833|NCT00113516|4263523|P1|Part 1|Missing|65
1310834|NCT00113516|4263522|P2|Part 1|Ongoing|0
1310835|NCT00113516|4263523|P1|Part 1|Ongoing|1
1310836|NCT00113516|4263522|P2|Part 1|Laboratory Abnormality|0
1310837|NCT00113516|4263523|P1|Part 1|Laboratory Abnormality|1
1310838|NCT00113516|4263522|P2|Part 1|Did Not Meet Entrance Criteria|0
1310839|NCT00113516|4263523|P1|Part 1|Did Not Meet Entrance Criteria|1
1310840|NCT00113516|4263522|P2|Part 1|Lack of Efficacy|0
1310841|NCT00113516|4263523|P1|Part 1|Lack of Efficacy|2
1310842|NCT00113516|4263522|P2|Part 1|Withdrawal by Subject|0
1310843|NCT00113516|4263523|P1|Part 1|Withdrawal by Subject|2
1310844|NCT00113516|4263522|P2|Part 1|Other|0
1310845|NCT00113516|4263523|P1|Part 1|Other|3
1310846|NCT00113516|4263522|P2|Part 1|Death|0
1310847|NCT00113516|4263523|P1|Part 1|Death|3
1310848|NCT00113516|4263522|P2|Part 1|Adverse Event|0
1310849|NCT00113516|4263523|P1|Part 1|Adverse Event|6
1310850|NCT00113490|4263566|P2|Overall Study|Lost to Follow-up|0
1310851|NCT00113490|4263567|P1|Overall Study|Lost to Follow-up|1
1310852|NCT00113490|4263566|P2|Overall Study|Withdrawal by Subject|3
1310853|NCT00113490|4263567|P1|Overall Study|Withdrawal by Subject|1
1310854|NCT00113399|4263600|P2|Overall Study|Other|1
1310855|NCT00113399|4263601|P1|Overall Study|Other|0
1310856|NCT00113399|4263600|P2|Overall Study|Complete Response|1
1310857|NCT00113399|4263601|P1|Overall Study|Complete Response|0
1310858|NCT00113399|4263600|P2|Overall Study|Withdrawal by Subject|2
1310859|NCT00113399|4263601|P1|Overall Study|Withdrawal by Subject|1
1310860|NCT00113399|4263600|P2|Overall Study|Death|1
1310861|NCT00113399|4263601|P1|Overall Study|Death|1
1310862|NCT00113386|4263609|P2|Overall Study|Unknown - Lost to Follow-Up|1
1310863|NCT00113386|4263610|P1|Overall Study|Unknown - Lost to Follow-Up|2
1310864|NCT00113386|4263609|P2|Overall Study|Ineligible|2
1310865|NCT00113386|4263610|P1|Overall Study|Ineligible|1
1310866|NCT00113386|4263609|P2|Overall Study|Toxicity|0
1310867|NCT00113386|4263610|P1|Overall Study|Toxicity|3
1310868|NCT00113386|4263609|P2|Overall Study|Physician Decision|1
1310869|NCT00113386|4263610|P1|Overall Study|Physician Decision|0
1310870|NCT00113386|4263609|P2|Overall Study|Withdrawal by Subject|0
1310871|NCT00113386|4263610|P1|Overall Study|Withdrawal by Subject|1
1310872|NCT00113373|4263616|P1|Overall Study|Never Treated|1
1310873|NCT00113373|4263616|P1|Overall Study|Ineligible: second primary|1
1310874|NCT00113373|4263616|P1|Overall Study|Ineligible: wrong primary|1
1310875|NCT00113360|4263631|P1|Overall Study|Did not meet eligibility criteria|3
1310876|NCT00113360|4263631|P1|Overall Study|Subject required surgery|1
1310877|NCT00113360|4263631|P1|Overall Study|Adverse Event|3
1310878|NCT00113295|4263645|P2|Overall Study|Unrelated Medical Illness|0
1310879|NCT00113295|4263646|P1|Overall Study|Unrelated Medical Illness|1
1310880|NCT00113295|4263645|P2|Overall Study|Adverse Event|1
1310881|NCT00113295|4263646|P1|Overall Study|Adverse Event|4
1310882|NCT00113269|4263665|P4|Overall Study|Unable to return for follow up|0
1310883|NCT00113269|4263666|P3|Overall Study|Unable to return for follow up|0
1310884|NCT00113269|4263667|P2|Overall Study|Unable to return for follow up|1
1310885|NCT00113269|4263668|P1|Overall Study|Unable to return for follow up|2
1310886|NCT00113269|4263665|P4|Overall Study|Did not meet eligibility criteria|1
1310887|NCT00113269|4263666|P3|Overall Study|Did not meet eligibility criteria|0
1310888|NCT00113269|4263667|P2|Overall Study|Did not meet eligibility criteria|0
1310889|NCT00113269|4263668|P1|Overall Study|Did not meet eligibility criteria|1
1310890|NCT00113269|4263665|P4|Overall Study|Withdrew consent, Prednisone initiated|1
1310891|NCT00113269|4263666|P3|Overall Study|Withdrew consent, Prednisone initiated|0
1310892|NCT00113269|4263667|P2|Overall Study|Withdrew consent, Prednisone initiated|0
1310893|NCT00113269|4263668|P1|Overall Study|Withdrew consent, Prednisone initiated|0
1310894|NCT00113269|4263665|P4|Overall Study|Received pancreas transplant|2
1310895|NCT00113269|4263666|P3|Overall Study|Received pancreas transplant|0
1310896|NCT00113269|4263667|P2|Overall Study|Received pancreas transplant|0
1310897|NCT00113269|4263668|P1|Overall Study|Received pancreas transplant|0
1310898|NCT00113269|4263665|P4|Overall Study|Moved|3
1310899|NCT00113269|4263666|P3|Overall Study|Moved|0
1310900|NCT00113269|4263667|P2|Overall Study|Moved|1
1310901|NCT00113269|4263668|P1|Overall Study|Moved|0
1310902|NCT00113269|4263665|P4|Overall Study|Discontinued due to rejection|0
1310903|NCT00113269|4263666|P3|Overall Study|Discontinued due to rejection|1
1310904|NCT00113269|4263667|P2|Overall Study|Discontinued due to rejection|0
1310905|NCT00113269|4263668|P1|Overall Study|Discontinued due to rejection|0
1310906|NCT00113269|4263665|P4|Overall Study|Sponsor elected to discontinue patient|1
1310907|NCT00113269|4263666|P3|Overall Study|Sponsor elected to discontinue patient|0
1310908|NCT00113269|4263667|P2|Overall Study|Sponsor elected to discontinue patient|0
1310909|NCT00113269|4263668|P1|Overall Study|Sponsor elected to discontinue patient|1
1310910|NCT00113269|4263665|P4|Overall Study|Lost to Follow-up|3
1310911|NCT00113269|4263666|P3|Overall Study|Lost to Follow-up|6
1310912|NCT00113269|4263667|P2|Overall Study|Lost to Follow-up|3
1310913|NCT00113269|4263668|P1|Overall Study|Lost to Follow-up|2
1310914|NCT00113269|4263665|P4|Overall Study|Protocol Violation|2
1310915|NCT00113269|4263666|P3|Overall Study|Protocol Violation|4
1310916|NCT00113269|4263667|P2|Overall Study|Protocol Violation|0
1310917|NCT00113269|4263668|P1|Overall Study|Protocol Violation|1
1310918|NCT00113269|4263665|P4|Overall Study|Graft loss|9
1310919|NCT00113269|4263666|P3|Overall Study|Graft loss|4
1310920|NCT00113269|4263667|P2|Overall Study|Graft loss|6
1310921|NCT00113269|4263668|P1|Overall Study|Graft loss|6
1310922|NCT00113269|4263665|P4|Overall Study|Withdrawal by Subject|2
1310923|NCT00113269|4263666|P3|Overall Study|Withdrawal by Subject|4
1310924|NCT00113269|4263667|P2|Overall Study|Withdrawal by Subject|3
1310925|NCT00113269|4263668|P1|Overall Study|Withdrawal by Subject|4
1310926|NCT00113269|4263665|P4|Overall Study|Adverse Event|7
1310927|NCT00113269|4263666|P3|Overall Study|Adverse Event|11
1310928|NCT00113269|4263667|P2|Overall Study|Adverse Event|7
1310929|NCT00113269|4263668|P1|Overall Study|Adverse Event|2
1310930|NCT00113269|4263665|P4|Overall Study|Did not meet eligibility – pre-treatment|2
1310931|NCT00113269|4263666|P3|Overall Study|Did not meet eligibility – pre-treatment|0
1310932|NCT00113269|4263667|P2|Overall Study|Did not meet eligibility – pre-treatment|0
1310933|NCT00113269|4263668|P1|Overall Study|Did not meet eligibility – pre-treatment|0
1310934|NCT00113269|4263665|P4|Overall Study|Death in operating room|1
1310935|NCT00113269|4263666|P3|Overall Study|Death in operating room|0
1310936|NCT00113269|4263667|P2|Overall Study|Death in operating room|0
1310937|NCT00113269|4263668|P1|Overall Study|Death in operating room|0
1310938|NCT00113269|4263665|P4|Overall Study|Early graft loss, technical|0
1310939|NCT00113269|4263666|P3|Overall Study|Early graft loss, technical|2
1310940|NCT00113269|4263667|P2|Overall Study|Early graft loss, technical|0
1310941|NCT00113269|4263668|P1|Overall Study|Early graft loss, technical|0
1310942|NCT00113269|4263665|P4|Overall Study|Not transplanted, recipient issues|4
1310943|NCT00113269|4263666|P3|Overall Study|Not transplanted, recipient issues|7
1310944|NCT00113269|4263667|P2|Overall Study|Not transplanted, recipient issues|1
1310945|NCT00113269|4263668|P1|Overall Study|Not transplanted, recipient issues|2
1310946|NCT00113269|4263665|P4|Overall Study|Not transplanted, donor issues|2
1310947|NCT00113269|4263666|P3|Overall Study|Not transplanted, donor issues|2
1310948|NCT00113269|4263667|P2|Overall Study|Not transplanted, donor issues|0
1310949|NCT00113269|4263668|P1|Overall Study|Not transplanted, donor issues|4
1310950|NCT00113087|4263728|P2|Overall Study|Family or MD withdrew subject|5
1310951|NCT00113087|4263729|P1|Overall Study|Family or MD withdrew subject|10
1310952|NCT00113087|4263728|P2|Overall Study|Death or Transplant|16
1310953|NCT00113087|4263729|P1|Overall Study|Death or Transplant|14
1310954|NCT00112957|4263800|P1|Overall Study|Physician Decision|1
1310955|NCT00112957|4263800|P1|Overall Study|Progressive disease|18
1310956|NCT00112905|4263840|P1|Overall Study|performance status was deteiorating|1
1310957|NCT00112905|4263840|P1|Overall Study|Alternative treatment|1
1310958|NCT00112905|4263840|P1|Overall Study|Ineligibility|5
1310959|NCT00112905|4263840|P1|Overall Study|Death|1
1310960|NCT00112905|4263840|P1|Overall Study|Adverse Event|4
1310961|NCT00112866|4263849|P2|Overall Study|did not start treatment post-op|2
1310962|NCT00112866|4263850|P1|Overall Study|did not start treatment post-op|1
1310963|NCT00112866|4263849|P2|Overall Study|Protocol Violation|0
1310964|NCT00112866|4263850|P1|Overall Study|Protocol Violation|1
1310965|NCT00112840|4263872|P3|Overall Study|Protocol Violation|5
1310966|NCT00112840|4263873|P2|Overall Study|Protocol Violation|0
1310967|NCT00112840|4263874|P1|Overall Study|Protocol Violation|0
1310968|NCT00112840|4263872|P3|Overall Study|Withdrawal by Subject|1
1310969|NCT00112840|4263873|P2|Overall Study|Withdrawal by Subject|0
1310970|NCT00112840|4263874|P1|Overall Study|Withdrawal by Subject|1
1310971|NCT00112840|4263872|P3|Overall Study|Physician Decision|0
1310972|NCT00112840|4263873|P2|Overall Study|Physician Decision|0
1310973|NCT00112840|4263874|P1|Overall Study|Physician Decision|1
1310974|NCT00112736|4263893|P2|Overall Study|1 pt never had had RX due rapid decline|0
1310975|NCT00112736|4263894|P1|Overall Study|1 pt never had had RX due rapid decline|1
1310976|NCT00112489|4263951|P1|Overall Study|Ineligible|7
1310977|NCT00112489|4263951|P1|Overall Study|Patient never treated|2
1310978|NCT00112489|4263951|P1|Overall Study|Other, Not Specified|9
1310979|NCT00112489|4263951|P1|Overall Study|Death|2
1310980|NCT00112489|4263951|P1|Overall Study|Adverse Event|12
1310981|NCT00112489|4263951|P1|Overall Study|Refused further treatment|8
1310982|NCT00112463|4263961|P1|Overall Study|Never started treatment|2
1310983|NCT00112463|4263961|P1|Overall Study|Withdrawal by Subject|2
1310984|NCT00112463|4263961|P1|Overall Study|Toxicity|3
1310985|NCT00112463|4263961|P1|Overall Study|Second Primary|1
1310986|NCT00112463|4263961|P1|Overall Study|Progression|30
1310987|NCT00112463|4263961|P1|Overall Study|Physician Decision|1
1310988|NCT00112437|4263973|P26|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3
1310989|NCT00112437|4263974|P25|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1310990|NCT00112437|4263975|P24|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6
1310991|NCT00112437|4263976|P23|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4
1310992|NCT00112437|4263977|P22|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1310993|NCT00112437|4263978|P21|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1310994|NCT00112437|4263979|P20|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1310995|NCT00112437|4263980|P19|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1310996|NCT00112437|4263981|P18|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1310997|NCT00112437|4263982|P17|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1310998|NCT00112437|4263983|P16|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1310999|NCT00112437|4263984|P15|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1311000|NCT00112437|4263985|P14|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1311001|NCT00112437|4263986|P13|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1311002|NCT00112437|4263987|P12|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1311003|NCT00112437|4263988|P11|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1311004|NCT00112437|4263989|P10|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1311005|NCT00112437|4263990|P9|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1311006|NCT00112437|4263991|P8|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1311007|NCT00112437|4263992|P7|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1311008|NCT00112437|4263993|P6|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1311009|NCT00112437|4263994|P5|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1311010|NCT00112437|4263995|P4|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1311011|NCT00112437|4263996|P3|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1311012|NCT00112437|4263997|P2|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1311013|NCT00112437|4263998|P1|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1311014|NCT00112437|4263973|P26|Years 6-10 (60-Month Extension)|Physician Decision|0
1311015|NCT00112437|4263974|P25|Years 6-10 (60-Month Extension)|Physician Decision|0
1311016|NCT00112437|4263975|P24|Years 6-10 (60-Month Extension)|Physician Decision|2
1311017|NCT00112437|4263976|P23|Years 6-10 (60-Month Extension)|Physician Decision|0
1311018|NCT00112437|4263977|P22|Years 6-10 (60-Month Extension)|Physician Decision|0
1311019|NCT00112437|4263978|P21|Years 6-10 (60-Month Extension)|Physician Decision|0
1311020|NCT00112437|4263979|P20|Years 6-10 (60-Month Extension)|Physician Decision|0
1311021|NCT00112437|4263980|P19|Years 6-10 (60-Month Extension)|Physician Decision|0
1311022|NCT00112437|4263981|P18|Years 6-10 (60-Month Extension)|Physician Decision|0
1311023|NCT00112437|4263982|P17|Years 6-10 (60-Month Extension)|Physician Decision|0
1311024|NCT00112437|4263983|P16|Years 6-10 (60-Month Extension)|Physician Decision|0
1311025|NCT00112437|4263984|P15|Years 6-10 (60-Month Extension)|Physician Decision|0
1311026|NCT00112437|4263985|P14|Years 6-10 (60-Month Extension)|Physician Decision|0
1311027|NCT00112437|4263986|P13|Years 6-10 (60-Month Extension)|Physician Decision|0
1311028|NCT00112437|4263987|P12|Years 6-10 (60-Month Extension)|Physician Decision|0
1311029|NCT00112437|4263988|P11|Years 6-10 (60-Month Extension)|Physician Decision|0
1311030|NCT00112437|4263989|P10|Years 6-10 (60-Month Extension)|Physician Decision|0
1311031|NCT00112437|4263990|P9|Years 6-10 (60-Month Extension)|Physician Decision|0
1311032|NCT00112437|4263991|P8|Years 6-10 (60-Month Extension)|Physician Decision|0
1311033|NCT00112437|4263992|P7|Years 6-10 (60-Month Extension)|Physician Decision|0
1311034|NCT00112437|4263993|P6|Years 6-10 (60-Month Extension)|Physician Decision|0
1311035|NCT00112437|4263994|P5|Years 6-10 (60-Month Extension)|Physician Decision|0
1311036|NCT00112437|4263995|P4|Years 6-10 (60-Month Extension)|Physician Decision|0
1311037|NCT00112437|4263996|P3|Years 6-10 (60-Month Extension)|Physician Decision|0
1311038|NCT00112437|4263997|P2|Years 6-10 (60-Month Extension)|Physician Decision|0
1311039|NCT00112437|4263998|P1|Years 6-10 (60-Month Extension)|Physician Decision|0
1311040|NCT00112437|4263973|P26|Years 6-10 (60-Month Extension)|Other|0
1311041|NCT00112437|4263974|P25|Years 6-10 (60-Month Extension)|Other|1
1311042|NCT00112437|4263975|P24|Years 6-10 (60-Month Extension)|Other|0
1311043|NCT00112437|4263976|P23|Years 6-10 (60-Month Extension)|Other|0
1311044|NCT00112437|4263977|P22|Years 6-10 (60-Month Extension)|Other|0
1311045|NCT00112437|4263978|P21|Years 6-10 (60-Month Extension)|Other|0
1311046|NCT00112437|4263979|P20|Years 6-10 (60-Month Extension)|Other|0
1311047|NCT00112437|4263980|P19|Years 6-10 (60-Month Extension)|Other|0
1311048|NCT00112437|4263981|P18|Years 6-10 (60-Month Extension)|Other|0
1311049|NCT00112437|4263982|P17|Years 6-10 (60-Month Extension)|Other|0
1311050|NCT00112437|4263983|P16|Years 6-10 (60-Month Extension)|Other|0
1311051|NCT00112437|4263984|P15|Years 6-10 (60-Month Extension)|Other|0
1311052|NCT00112437|4263985|P14|Years 6-10 (60-Month Extension)|Other|0
1311053|NCT00112437|4263986|P13|Years 6-10 (60-Month Extension)|Other|0
1311054|NCT00112437|4263987|P12|Years 6-10 (60-Month Extension)|Other|0
1311055|NCT00112437|4263988|P11|Years 6-10 (60-Month Extension)|Other|0
1311056|NCT00112437|4263989|P10|Years 6-10 (60-Month Extension)|Other|0
1311057|NCT00112437|4263990|P9|Years 6-10 (60-Month Extension)|Other|0
1311058|NCT00112437|4263991|P8|Years 6-10 (60-Month Extension)|Other|0
1311059|NCT00112437|4263992|P7|Years 6-10 (60-Month Extension)|Other|0
1311060|NCT00112437|4263993|P6|Years 6-10 (60-Month Extension)|Other|0
1311061|NCT00112437|4263994|P5|Years 6-10 (60-Month Extension)|Other|0
1311062|NCT00112437|4263995|P4|Years 6-10 (60-Month Extension)|Other|0
1311063|NCT00112437|4263996|P3|Years 6-10 (60-Month Extension)|Other|0
1311064|NCT00112437|4263997|P2|Years 6-10 (60-Month Extension)|Other|0
1311065|NCT00112437|4263998|P1|Years 6-10 (60-Month Extension)|Other|0
1311066|NCT00112437|4263973|P26|Years 6-10 (60-Month Extension)|Lost to Follow-up|1
1311067|NCT00112437|4263974|P25|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1311068|NCT00112437|4263975|P24|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1311069|NCT00112437|4263976|P23|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1311070|NCT00112437|4263977|P22|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1311071|NCT00112437|4263978|P21|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1311072|NCT00112437|4263979|P20|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1311073|NCT00112437|4263980|P19|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1311074|NCT00112437|4263981|P18|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1311075|NCT00112437|4263982|P17|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1311076|NCT00112437|4263983|P16|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1311077|NCT00112437|4263984|P15|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1311078|NCT00112437|4263985|P14|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1311079|NCT00112437|4263986|P13|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1311080|NCT00112437|4263987|P12|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1311081|NCT00112437|4263988|P11|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1311082|NCT00112437|4263989|P10|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1311083|NCT00112437|4263990|P9|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1311084|NCT00112437|4263991|P8|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1311085|NCT00112437|4263992|P7|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1311086|NCT00112437|4263993|P6|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1311087|NCT00112437|4263994|P5|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1311088|NCT00112437|4263995|P4|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1311089|NCT00112437|4263996|P3|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1311090|NCT00112437|4263997|P2|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1311091|NCT00112437|4263998|P1|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1311092|NCT00112437|4263973|P26|Years 6-10 (60-Month Extension)|Death|0
1311093|NCT00112437|4263974|P25|Years 6-10 (60-Month Extension)|Death|0
1311094|NCT00112437|4263975|P24|Years 6-10 (60-Month Extension)|Death|2
1311095|NCT00112437|4263976|P23|Years 6-10 (60-Month Extension)|Death|0
1311096|NCT00112437|4263977|P22|Years 6-10 (60-Month Extension)|Death|0
1311097|NCT00112437|4263978|P21|Years 6-10 (60-Month Extension)|Death|0
1311098|NCT00112437|4263979|P20|Years 6-10 (60-Month Extension)|Death|0
1311099|NCT00112437|4263980|P19|Years 6-10 (60-Month Extension)|Death|0
1311100|NCT00112437|4263981|P18|Years 6-10 (60-Month Extension)|Death|0
1311101|NCT00112437|4263982|P17|Years 6-10 (60-Month Extension)|Death|0
1311102|NCT00112437|4263983|P16|Years 6-10 (60-Month Extension)|Death|0
1311103|NCT00112437|4263984|P15|Years 6-10 (60-Month Extension)|Death|0
1311104|NCT00112437|4263985|P14|Years 6-10 (60-Month Extension)|Death|0
1311105|NCT00112437|4263986|P13|Years 6-10 (60-Month Extension)|Death|0
1311106|NCT00112437|4263987|P12|Years 6-10 (60-Month Extension)|Death|0
1311107|NCT00112437|4263988|P11|Years 6-10 (60-Month Extension)|Death|0
1311108|NCT00112437|4263989|P10|Years 6-10 (60-Month Extension)|Death|0
1311109|NCT00112437|4263990|P9|Years 6-10 (60-Month Extension)|Death|0
1311110|NCT00112437|4263991|P8|Years 6-10 (60-Month Extension)|Death|0
1311111|NCT00112437|4263992|P7|Years 6-10 (60-Month Extension)|Death|0
1311112|NCT00112437|4263993|P6|Years 6-10 (60-Month Extension)|Death|0
1311113|NCT00112437|4263994|P5|Years 6-10 (60-Month Extension)|Death|0
1311114|NCT00112437|4263995|P4|Years 6-10 (60-Month Extension)|Death|0
1311115|NCT00112437|4263996|P3|Years 6-10 (60-Month Extension)|Death|0
1311116|NCT00112437|4263997|P2|Years 6-10 (60-Month Extension)|Death|0
1311117|NCT00112437|4263998|P1|Years 6-10 (60-Month Extension)|Death|0
1311118|NCT00112437|4263973|P26|Years 6-10 (60-Month Extension)|Adverse Event|1
1311119|NCT00112437|4263974|P25|Years 6-10 (60-Month Extension)|Adverse Event|0
1311120|NCT00112437|4263975|P24|Years 6-10 (60-Month Extension)|Adverse Event|2
1311121|NCT00112437|4263976|P23|Years 6-10 (60-Month Extension)|Adverse Event|1
1311122|NCT00112437|4263977|P22|Years 6-10 (60-Month Extension)|Adverse Event|0
1311123|NCT00112437|4263978|P21|Years 6-10 (60-Month Extension)|Adverse Event|0
1311124|NCT00112437|4263979|P20|Years 6-10 (60-Month Extension)|Adverse Event|0
1311125|NCT00112437|4263980|P19|Years 6-10 (60-Month Extension)|Adverse Event|0
1311126|NCT00112437|4263981|P18|Years 6-10 (60-Month Extension)|Adverse Event|0
1311127|NCT00112437|4263982|P17|Years 6-10 (60-Month Extension)|Adverse Event|0
1311128|NCT00112437|4263983|P16|Years 6-10 (60-Month Extension)|Adverse Event|0
1311129|NCT00112437|4263984|P15|Years 6-10 (60-Month Extension)|Adverse Event|0
1311130|NCT00112437|4263985|P14|Years 6-10 (60-Month Extension)|Adverse Event|0
1311131|NCT00112437|4263986|P13|Years 6-10 (60-Month Extension)|Adverse Event|0
1311132|NCT00112437|4263987|P12|Years 6-10 (60-Month Extension)|Adverse Event|0
1311133|NCT00112437|4263988|P11|Years 6-10 (60-Month Extension)|Adverse Event|0
1311134|NCT00112437|4263989|P10|Years 6-10 (60-Month Extension)|Adverse Event|0
1311135|NCT00112437|4263990|P9|Years 6-10 (60-Month Extension)|Adverse Event|0
1311136|NCT00112437|4263991|P8|Years 6-10 (60-Month Extension)|Adverse Event|0
1311137|NCT00112437|4263992|P7|Years 6-10 (60-Month Extension)|Adverse Event|0
1311138|NCT00112437|4263993|P6|Years 6-10 (60-Month Extension)|Adverse Event|0
1311139|NCT00112437|4263994|P5|Years 6-10 (60-Month Extension)|Adverse Event|0
1311140|NCT00112437|4263995|P4|Years 6-10 (60-Month Extension)|Adverse Event|0
1311141|NCT00112437|4263996|P3|Years 6-10 (60-Month Extension)|Adverse Event|0
1311142|NCT00112437|4263997|P2|Years 6-10 (60-Month Extension)|Adverse Event|0
1311143|NCT00112437|4263998|P1|Years 6-10 (60-Month Extension)|Adverse Event|0
1311144|NCT00112437|4263973|P26|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1311145|NCT00112437|4263974|P25|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1311146|NCT00112437|4263975|P24|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1311147|NCT00112437|4263976|P23|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1311148|NCT00112437|4263977|P22|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2
1311149|NCT00112437|4263978|P21|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1
1311150|NCT00112437|4263979|P20|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1311151|NCT00112437|4263980|P19|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1311152|NCT00112437|4263981|P18|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1311153|NCT00112437|4263982|P17|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1311154|NCT00112437|4263983|P16|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1311155|NCT00112437|4263984|P15|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1311156|NCT00112437|4263985|P14|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1311157|NCT00112437|4263986|P13|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1311158|NCT00112437|4263987|P12|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1311159|NCT00112437|4263988|P11|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1311160|NCT00112437|4263989|P10|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1311161|NCT00112437|4263990|P9|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1311162|NCT00112437|4263991|P8|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1311163|NCT00112437|4263992|P7|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1311164|NCT00112437|4263993|P6|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1311165|NCT00112437|4263994|P5|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1311166|NCT00112437|4263995|P4|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1311167|NCT00112437|4263996|P3|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1311168|NCT00112437|4263997|P2|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1311169|NCT00112437|4263998|P1|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1311170|NCT00112437|4263973|P26|Years 4-5 (24-Month Extension)|Participant moved|0
1311171|NCT00112437|4263974|P25|Years 4-5 (24-Month Extension)|Participant moved|0
1311172|NCT00112437|4263975|P24|Years 4-5 (24-Month Extension)|Participant moved|0
1311173|NCT00112437|4263976|P23|Years 4-5 (24-Month Extension)|Participant moved|0
1311174|NCT00112437|4263977|P22|Years 4-5 (24-Month Extension)|Participant moved|1
1311175|NCT00112437|4263978|P21|Years 4-5 (24-Month Extension)|Participant moved|0
1311176|NCT00112437|4263979|P20|Years 4-5 (24-Month Extension)|Participant moved|0
1311177|NCT00112437|4263980|P19|Years 4-5 (24-Month Extension)|Participant moved|0
1311178|NCT00112437|4263981|P18|Years 4-5 (24-Month Extension)|Participant moved|0
1311179|NCT00112437|4263982|P17|Years 4-5 (24-Month Extension)|Participant moved|0
1311180|NCT00112437|4263983|P16|Years 4-5 (24-Month Extension)|Participant moved|0
1311181|NCT00112437|4263984|P15|Years 4-5 (24-Month Extension)|Participant moved|0
1311182|NCT00112437|4263985|P14|Years 4-5 (24-Month Extension)|Participant moved|0
1311183|NCT00112437|4263986|P13|Years 4-5 (24-Month Extension)|Participant moved|0
1311184|NCT00112437|4263987|P12|Years 4-5 (24-Month Extension)|Participant moved|0
1311185|NCT00112437|4263988|P11|Years 4-5 (24-Month Extension)|Participant moved|0
1311186|NCT00112437|4263989|P10|Years 4-5 (24-Month Extension)|Participant moved|0
1311187|NCT00112437|4263990|P9|Years 4-5 (24-Month Extension)|Participant moved|0
1311188|NCT00112437|4263991|P8|Years 4-5 (24-Month Extension)|Participant moved|0
1311189|NCT00112437|4263992|P7|Years 4-5 (24-Month Extension)|Participant moved|0
1311190|NCT00112437|4263993|P6|Years 4-5 (24-Month Extension)|Participant moved|0
1311191|NCT00112437|4263994|P5|Years 4-5 (24-Month Extension)|Participant moved|0
1311192|NCT00112437|4263995|P4|Years 4-5 (24-Month Extension)|Participant moved|0
1311193|NCT00112437|4263996|P3|Years 4-5 (24-Month Extension)|Participant moved|0
1311194|NCT00112437|4263997|P2|Years 4-5 (24-Month Extension)|Participant moved|0
1311195|NCT00112437|4263998|P1|Years 4-5 (24-Month Extension)|Participant moved|0
1311196|NCT00112437|4263973|P26|Years 4-5 (24-Month Extension)|Adverse Event|0
1311197|NCT00112437|4263974|P25|Years 4-5 (24-Month Extension)|Adverse Event|0
1311198|NCT00112437|4263975|P24|Years 4-5 (24-Month Extension)|Adverse Event|0
1311199|NCT00112437|4263976|P23|Years 4-5 (24-Month Extension)|Adverse Event|0
1311200|NCT00112437|4263977|P22|Years 4-5 (24-Month Extension)|Adverse Event|4
1311201|NCT00112437|4263978|P21|Years 4-5 (24-Month Extension)|Adverse Event|0
1311202|NCT00112437|4263979|P20|Years 4-5 (24-Month Extension)|Adverse Event|0
1311203|NCT00112437|4263980|P19|Years 4-5 (24-Month Extension)|Adverse Event|0
1311204|NCT00112437|4263981|P18|Years 4-5 (24-Month Extension)|Adverse Event|0
1311205|NCT00112437|4263982|P17|Years 4-5 (24-Month Extension)|Adverse Event|0
1311206|NCT00112437|4263983|P16|Years 4-5 (24-Month Extension)|Adverse Event|0
1311207|NCT00112437|4263984|P15|Years 4-5 (24-Month Extension)|Adverse Event|0
1311208|NCT00112437|4263985|P14|Years 4-5 (24-Month Extension)|Adverse Event|0
1311209|NCT00112437|4263986|P13|Years 4-5 (24-Month Extension)|Adverse Event|0
1311210|NCT00112437|4263987|P12|Years 4-5 (24-Month Extension)|Adverse Event|0
1311211|NCT00112437|4263988|P11|Years 4-5 (24-Month Extension)|Adverse Event|0
1311212|NCT00112437|4263989|P10|Years 4-5 (24-Month Extension)|Adverse Event|0
1311213|NCT00112437|4263990|P9|Years 4-5 (24-Month Extension)|Adverse Event|0
1311214|NCT00112437|4263991|P8|Years 4-5 (24-Month Extension)|Adverse Event|0
1311215|NCT00112437|4263992|P7|Years 4-5 (24-Month Extension)|Adverse Event|0
1311216|NCT00112437|4263993|P6|Years 4-5 (24-Month Extension)|Adverse Event|0
1311217|NCT00112437|4263994|P5|Years 4-5 (24-Month Extension)|Adverse Event|0
1311218|NCT00112437|4263995|P4|Years 4-5 (24-Month Extension)|Adverse Event|0
1311219|NCT00112437|4263996|P3|Years 4-5 (24-Month Extension)|Adverse Event|0
1311220|NCT00112437|4263997|P2|Years 4-5 (24-Month Extension)|Adverse Event|0
1311221|NCT00112437|4263998|P1|Years 4-5 (24-Month Extension)|Adverse Event|0
1311222|NCT00112437|4263973|P26|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1311223|NCT00112437|4263974|P25|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1311224|NCT00112437|4263975|P24|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1311225|NCT00112437|4263976|P23|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1311226|NCT00112437|4263977|P22|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1311227|NCT00112437|4263978|P21|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1
1311228|NCT00112437|4263979|P20|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1311229|NCT00112437|4263980|P19|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1311230|NCT00112437|4263981|P18|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1311231|NCT00112437|4263982|P17|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1311232|NCT00112437|4263983|P16|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1311233|NCT00112437|4263984|P15|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1311234|NCT00112437|4263985|P14|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1311235|NCT00112437|4263986|P13|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1311236|NCT00112437|4263987|P12|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1311237|NCT00112437|4263988|P11|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1311238|NCT00112437|4263989|P10|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1311239|NCT00112437|4263990|P9|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1311240|NCT00112437|4263991|P8|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1311241|NCT00112437|4263992|P7|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1311242|NCT00112437|4263993|P6|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1311243|NCT00112437|4263994|P5|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1311244|NCT00112437|4263995|P4|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1311245|NCT00112437|4263996|P3|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1311246|NCT00112437|4263997|P2|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1311247|NCT00112437|4263998|P1|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1311248|NCT00112437|4263973|P26|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1311249|NCT00112437|4263974|P25|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1311250|NCT00112437|4263975|P24|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1311251|NCT00112437|4263976|P23|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1311252|NCT00112437|4263977|P22|Years 4-5 (24-Month Extension)|Lack of Efficacy|1
1311253|NCT00112437|4263978|P21|Years 4-5 (24-Month Extension)|Lack of Efficacy|2
1311254|NCT00112437|4263979|P20|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1311255|NCT00112437|4263980|P19|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1311256|NCT00112437|4263981|P18|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1311257|NCT00112437|4263982|P17|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1311258|NCT00112437|4263983|P16|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1311259|NCT00112437|4263984|P15|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1311260|NCT00112437|4263985|P14|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1311261|NCT00112437|4263986|P13|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1311262|NCT00112437|4263987|P12|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1311263|NCT00112437|4263988|P11|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1311264|NCT00112437|4263989|P10|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1311265|NCT00112437|4263990|P9|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1311266|NCT00112437|4263991|P8|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1311267|NCT00112437|4263992|P7|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1311268|NCT00112437|4263993|P6|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1311269|NCT00112437|4263994|P5|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1311270|NCT00112437|4263995|P4|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1311271|NCT00112437|4263996|P3|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1311272|NCT00112437|4263997|P2|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1311273|NCT00112437|4263998|P1|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1311274|NCT00112437|4263973|P26|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1311275|NCT00112437|4263974|P25|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1311276|NCT00112437|4263975|P24|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1311277|NCT00112437|4263976|P23|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1311278|NCT00112437|4263977|P22|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1311279|NCT00112437|4263978|P21|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1311280|NCT00112437|4263979|P20|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1311281|NCT00112437|4263980|P19|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1311282|NCT00112437|4263981|P18|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1311283|NCT00112437|4263982|P17|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1311284|NCT00112437|4263983|P16|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1311285|NCT00112437|4263984|P15|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1311286|NCT00112437|4263985|P14|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1311287|NCT00112437|4263986|P13|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1311288|NCT00112437|4263987|P12|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
1311289|NCT00112437|4263988|P11|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
1311290|NCT00112437|4263989|P10|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1311291|NCT00112437|4263990|P9|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1311292|NCT00112437|4263991|P8|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1311293|NCT00112437|4263992|P7|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1311294|NCT00112437|4263993|P6|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1311295|NCT00112437|4263994|P5|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1311296|NCT00112437|4263995|P4|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1311297|NCT00112437|4263996|P3|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1311298|NCT00112437|4263997|P2|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1311299|NCT00112437|4263998|P1|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1311300|NCT00112437|4263973|P26|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1311301|NCT00112437|4263974|P25|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1311302|NCT00112437|4263975|P24|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1311303|NCT00112437|4263976|P23|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1311304|NCT00112437|4263977|P22|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1311305|NCT00112437|4263978|P21|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1311306|NCT00112437|4263979|P20|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1311307|NCT00112437|4263980|P19|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1311308|NCT00112437|4263981|P18|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1311309|NCT00112437|4263982|P17|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1311310|NCT00112437|4263983|P16|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1311311|NCT00112437|4263984|P15|Year 3 (12-Month Extension)|Withdrawal by Subject|1
1311312|NCT00112437|4263985|P14|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1311313|NCT00112437|4263986|P13|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1311314|NCT00112437|4263987|P12|Year 3 (12-Month Extension)|Withdrawal by Subject|3
1311315|NCT00112437|4263988|P11|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1311316|NCT00112437|4263989|P10|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1311317|NCT00112437|4263990|P9|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1311318|NCT00112437|4263991|P8|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1311319|NCT00112437|4263992|P7|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1311320|NCT00112437|4263993|P6|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1311321|NCT00112437|4263994|P5|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1311322|NCT00112437|4263995|P4|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1311323|NCT00112437|4263996|P3|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1311324|NCT00112437|4263997|P2|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1311325|NCT00112437|4263998|P1|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1311326|NCT00112437|4263973|P26|Year 3 (12-Month Extension)|Protocol Violation|0
1311327|NCT00112437|4263974|P25|Year 3 (12-Month Extension)|Protocol Violation|0
1311328|NCT00112437|4263975|P24|Year 3 (12-Month Extension)|Protocol Violation|0
1311329|NCT00112437|4263976|P23|Year 3 (12-Month Extension)|Protocol Violation|0
1311330|NCT00112437|4263977|P22|Year 3 (12-Month Extension)|Protocol Violation|0
1311331|NCT00112437|4263978|P21|Year 3 (12-Month Extension)|Protocol Violation|0
1311332|NCT00112437|4263979|P20|Year 3 (12-Month Extension)|Protocol Violation|0
1311333|NCT00112437|4263980|P19|Year 3 (12-Month Extension)|Protocol Violation|0
1311334|NCT00112437|4263981|P18|Year 3 (12-Month Extension)|Protocol Violation|0
1311335|NCT00112437|4263982|P17|Year 3 (12-Month Extension)|Protocol Violation|0
1311336|NCT00112437|4263983|P16|Year 3 (12-Month Extension)|Protocol Violation|1
1311337|NCT00112437|4263984|P15|Year 3 (12-Month Extension)|Protocol Violation|0
1311338|NCT00112437|4263985|P14|Year 3 (12-Month Extension)|Protocol Violation|0
1311339|NCT00112437|4263986|P13|Year 3 (12-Month Extension)|Protocol Violation|0
1311340|NCT00112437|4263987|P12|Year 3 (12-Month Extension)|Protocol Violation|0
1311341|NCT00112437|4263988|P11|Year 3 (12-Month Extension)|Protocol Violation|0
1311342|NCT00112437|4263989|P10|Year 3 (12-Month Extension)|Protocol Violation|0
1311343|NCT00112437|4263990|P9|Year 3 (12-Month Extension)|Protocol Violation|0
1311344|NCT00112437|4263991|P8|Year 3 (12-Month Extension)|Protocol Violation|0
1311345|NCT00112437|4263992|P7|Year 3 (12-Month Extension)|Protocol Violation|0
1311346|NCT00112437|4263993|P6|Year 3 (12-Month Extension)|Protocol Violation|0
1311347|NCT00112437|4263994|P5|Year 3 (12-Month Extension)|Protocol Violation|0
1311348|NCT00112437|4263995|P4|Year 3 (12-Month Extension)|Protocol Violation|0
1311349|NCT00112437|4263996|P3|Year 3 (12-Month Extension)|Protocol Violation|0
1311350|NCT00112437|4263997|P2|Year 3 (12-Month Extension)|Protocol Violation|0
1311351|NCT00112437|4263998|P1|Year 3 (12-Month Extension)|Protocol Violation|0
1311352|NCT00112437|4263973|P26|Year 3 (12-Month Extension)|Lost to Follow-up|0
1311353|NCT00112437|4263974|P25|Year 3 (12-Month Extension)|Lost to Follow-up|0
1311354|NCT00112437|4263975|P24|Year 3 (12-Month Extension)|Lost to Follow-up|0
1311355|NCT00112437|4263976|P23|Year 3 (12-Month Extension)|Lost to Follow-up|0
1311356|NCT00112437|4263977|P22|Year 3 (12-Month Extension)|Lost to Follow-up|0
1311357|NCT00112437|4263978|P21|Year 3 (12-Month Extension)|Lost to Follow-up|0
1311358|NCT00112437|4263979|P20|Year 3 (12-Month Extension)|Lost to Follow-up|0
1311359|NCT00112437|4263980|P19|Year 3 (12-Month Extension)|Lost to Follow-up|0
1311360|NCT00112437|4263981|P18|Year 3 (12-Month Extension)|Lost to Follow-up|0
1311361|NCT00112437|4263982|P17|Year 3 (12-Month Extension)|Lost to Follow-up|0
1311362|NCT00112437|4263983|P16|Year 3 (12-Month Extension)|Lost to Follow-up|1
1311363|NCT00112437|4263984|P15|Year 3 (12-Month Extension)|Lost to Follow-up|0
1311364|NCT00112437|4263985|P14|Year 3 (12-Month Extension)|Lost to Follow-up|0
1311365|NCT00112437|4263986|P13|Year 3 (12-Month Extension)|Lost to Follow-up|0
1311366|NCT00112437|4263987|P12|Year 3 (12-Month Extension)|Lost to Follow-up|0
1311367|NCT00112437|4263988|P11|Year 3 (12-Month Extension)|Lost to Follow-up|0
1311368|NCT00112437|4263989|P10|Year 3 (12-Month Extension)|Lost to Follow-up|0
1311369|NCT00112437|4263990|P9|Year 3 (12-Month Extension)|Lost to Follow-up|0
1311370|NCT00112437|4263991|P8|Year 3 (12-Month Extension)|Lost to Follow-up|0
1311371|NCT00112437|4263992|P7|Year 3 (12-Month Extension)|Lost to Follow-up|0
1311372|NCT00112437|4263993|P6|Year 3 (12-Month Extension)|Lost to Follow-up|0
1311373|NCT00112437|4263994|P5|Year 3 (12-Month Extension)|Lost to Follow-up|0
1311374|NCT00112437|4263995|P4|Year 3 (12-Month Extension)|Lost to Follow-up|0
1311375|NCT00112437|4263996|P3|Year 3 (12-Month Extension)|Lost to Follow-up|0
1311376|NCT00112437|4263997|P2|Year 3 (12-Month Extension)|Lost to Follow-up|0
1311377|NCT00112437|4263998|P1|Year 3 (12-Month Extension)|Lost to Follow-up|0
1311378|NCT00112437|4263973|P26|Year 3 (12-Month Extension)|Lack of Efficacy|0
1311379|NCT00112437|4263974|P25|Year 3 (12-Month Extension)|Lack of Efficacy|0
1311380|NCT00112437|4263975|P24|Year 3 (12-Month Extension)|Lack of Efficacy|0
1311381|NCT00112437|4263976|P23|Year 3 (12-Month Extension)|Lack of Efficacy|0
1311382|NCT00112437|4263977|P22|Year 3 (12-Month Extension)|Lack of Efficacy|0
1311383|NCT00112437|4263978|P21|Year 3 (12-Month Extension)|Lack of Efficacy|0
1311384|NCT00112437|4263979|P20|Year 3 (12-Month Extension)|Lack of Efficacy|0
1311385|NCT00112437|4263980|P19|Year 3 (12-Month Extension)|Lack of Efficacy|2
1311386|NCT00112437|4263981|P18|Year 3 (12-Month Extension)|Lack of Efficacy|0
1311387|NCT00112437|4263982|P17|Year 3 (12-Month Extension)|Lack of Efficacy|0
1311388|NCT00112437|4263983|P16|Year 3 (12-Month Extension)|Lack of Efficacy|1
1311389|NCT00112437|4263984|P15|Year 3 (12-Month Extension)|Lack of Efficacy|0
1311390|NCT00112437|4263985|P14|Year 3 (12-Month Extension)|Lack of Efficacy|1
1311391|NCT00112437|4263986|P13|Year 3 (12-Month Extension)|Lack of Efficacy|0
1311392|NCT00112437|4263987|P12|Year 3 (12-Month Extension)|Lack of Efficacy|1
1311393|NCT00112437|4263988|P11|Year 3 (12-Month Extension)|Lack of Efficacy|0
1311394|NCT00112437|4263989|P10|Year 3 (12-Month Extension)|Lack of Efficacy|0
1311395|NCT00112437|4263990|P9|Year 3 (12-Month Extension)|Lack of Efficacy|0
1311396|NCT00112437|4263991|P8|Year 3 (12-Month Extension)|Lack of Efficacy|0
1311397|NCT00112437|4263992|P7|Year 3 (12-Month Extension)|Lack of Efficacy|0
1311398|NCT00112437|4263993|P6|Year 3 (12-Month Extension)|Lack of Efficacy|0
1311399|NCT00112437|4263994|P5|Year 3 (12-Month Extension)|Lack of Efficacy|0
1311400|NCT00112437|4263995|P4|Year 3 (12-Month Extension)|Lack of Efficacy|0
1311401|NCT00112437|4263996|P3|Year 3 (12-Month Extension)|Lack of Efficacy|0
1311402|NCT00112437|4263997|P2|Year 3 (12-Month Extension)|Lack of Efficacy|0
1311403|NCT00112437|4263998|P1|Year 3 (12-Month Extension)|Lack of Efficacy|0
1311404|NCT00112437|4263973|P26|Year 3 (12-Month Extension)|Adverse Event|0
1311405|NCT00112437|4263974|P25|Year 3 (12-Month Extension)|Adverse Event|0
1311406|NCT00112437|4263975|P24|Year 3 (12-Month Extension)|Adverse Event|0
1311407|NCT00112437|4263976|P23|Year 3 (12-Month Extension)|Adverse Event|0
1311408|NCT00112437|4263977|P22|Year 3 (12-Month Extension)|Adverse Event|0
1311409|NCT00112437|4263978|P21|Year 3 (12-Month Extension)|Adverse Event|0
1311410|NCT00112437|4263979|P20|Year 3 (12-Month Extension)|Adverse Event|1
1311411|NCT00112437|4263980|P19|Year 3 (12-Month Extension)|Adverse Event|0
1311412|NCT00112437|4263981|P18|Year 3 (12-Month Extension)|Adverse Event|1
1311413|NCT00112437|4263982|P17|Year 3 (12-Month Extension)|Adverse Event|3
1311414|NCT00112437|4263983|P16|Year 3 (12-Month Extension)|Adverse Event|1
1311415|NCT00112437|4263984|P15|Year 3 (12-Month Extension)|Adverse Event|0
1311416|NCT00112437|4263985|P14|Year 3 (12-Month Extension)|Adverse Event|0
1311417|NCT00112437|4263986|P13|Year 3 (12-Month Extension)|Adverse Event|0
1311418|NCT00112437|4263987|P12|Year 3 (12-Month Extension)|Adverse Event|0
1311419|NCT00112437|4263988|P11|Year 3 (12-Month Extension)|Adverse Event|1
1311420|NCT00112437|4263989|P10|Year 3 (12-Month Extension)|Adverse Event|0
1311421|NCT00112437|4263990|P9|Year 3 (12-Month Extension)|Adverse Event|0
1311422|NCT00112437|4263991|P8|Year 3 (12-Month Extension)|Adverse Event|0
1311423|NCT00112437|4263992|P7|Year 3 (12-Month Extension)|Adverse Event|0
1311424|NCT00112437|4263993|P6|Year 3 (12-Month Extension)|Adverse Event|0
1311425|NCT00112437|4263994|P5|Year 3 (12-Month Extension)|Adverse Event|0
1311426|NCT00112437|4263995|P4|Year 3 (12-Month Extension)|Adverse Event|0
1311427|NCT00112437|4263996|P3|Year 3 (12-Month Extension)|Adverse Event|0
1311428|NCT00112437|4263997|P2|Year 3 (12-Month Extension)|Adverse Event|0
1311429|NCT00112437|4263998|P1|Year 3 (12-Month Extension)|Adverse Event|0
1311430|NCT00112437|4263973|P26|Year 2 (12-Month Extension)|Moved|0
1311431|NCT00112437|4263974|P25|Year 2 (12-Month Extension)|Moved|0
1311432|NCT00112437|4263975|P24|Year 2 (12-Month Extension)|Moved|0
1311433|NCT00112437|4263976|P23|Year 2 (12-Month Extension)|Moved|0
1311434|NCT00112437|4263977|P22|Year 2 (12-Month Extension)|Moved|0
1311435|NCT00112437|4263978|P21|Year 2 (12-Month Extension)|Moved|0
1311436|NCT00112437|4263979|P20|Year 2 (12-Month Extension)|Moved|0
1311437|NCT00112437|4263980|P19|Year 2 (12-Month Extension)|Moved|0
1311438|NCT00112437|4263981|P18|Year 2 (12-Month Extension)|Moved|0
1311439|NCT00112437|4263982|P17|Year 2 (12-Month Extension)|Moved|0
1311440|NCT00112437|4263983|P16|Year 2 (12-Month Extension)|Moved|0
1311441|NCT00112437|4263984|P15|Year 2 (12-Month Extension)|Moved|0
1311442|NCT00112437|4263985|P14|Year 2 (12-Month Extension)|Moved|0
1311443|NCT00112437|4263986|P13|Year 2 (12-Month Extension)|Moved|0
1311444|NCT00112437|4263987|P12|Year 2 (12-Month Extension)|Moved|0
1311445|NCT00112437|4263988|P11|Year 2 (12-Month Extension)|Moved|0
1311446|NCT00112437|4263989|P10|Year 2 (12-Month Extension)|Moved|1
1311447|NCT00112437|4263990|P9|Year 2 (12-Month Extension)|Moved|0
1311448|NCT00112437|4263991|P8|Year 2 (12-Month Extension)|Moved|0
1311449|NCT00112437|4263992|P7|Year 2 (12-Month Extension)|Moved|0
1311450|NCT00112437|4263993|P6|Year 2 (12-Month Extension)|Moved|0
1311451|NCT00112437|4263994|P5|Year 2 (12-Month Extension)|Moved|0
1311452|NCT00112437|4263995|P4|Year 2 (12-Month Extension)|Moved|0
1311453|NCT00112437|4263996|P3|Year 2 (12-Month Extension)|Moved|0
1311454|NCT00112437|4263997|P2|Year 2 (12-Month Extension)|Moved|0
1311455|NCT00112437|4263998|P1|Year 2 (12-Month Extension)|Moved|0
1311456|NCT00112437|4263973|P26|Year 2 (12-Month Extension)|patient was out of windows|0
1311457|NCT00112437|4263974|P25|Year 2 (12-Month Extension)|patient was out of windows|0
1311458|NCT00112437|4263975|P24|Year 2 (12-Month Extension)|patient was out of windows|0
1311459|NCT00112437|4263976|P23|Year 2 (12-Month Extension)|patient was out of windows|0
1311460|NCT00112437|4263977|P22|Year 2 (12-Month Extension)|patient was out of windows|0
1311461|NCT00112437|4263978|P21|Year 2 (12-Month Extension)|patient was out of windows|0
1311462|NCT00112437|4263979|P20|Year 2 (12-Month Extension)|patient was out of windows|0
1311463|NCT00112437|4263980|P19|Year 2 (12-Month Extension)|patient was out of windows|0
1311464|NCT00112437|4263981|P18|Year 2 (12-Month Extension)|patient was out of windows|0
1311465|NCT00112437|4263982|P17|Year 2 (12-Month Extension)|patient was out of windows|0
1311466|NCT00112437|4263983|P16|Year 2 (12-Month Extension)|patient was out of windows|0
1311467|NCT00112437|4263984|P15|Year 2 (12-Month Extension)|patient was out of windows|0
1311468|NCT00112437|4263985|P14|Year 2 (12-Month Extension)|patient was out of windows|0
1311469|NCT00112437|4263986|P13|Year 2 (12-Month Extension)|patient was out of windows|0
1311470|NCT00112437|4263987|P12|Year 2 (12-Month Extension)|patient was out of windows|0
1311471|NCT00112437|4263988|P11|Year 2 (12-Month Extension)|patient was out of windows|0
1311472|NCT00112437|4263989|P10|Year 2 (12-Month Extension)|patient was out of windows|1
1311473|NCT00112437|4263990|P9|Year 2 (12-Month Extension)|patient was out of windows|0
1311474|NCT00112437|4263991|P8|Year 2 (12-Month Extension)|patient was out of windows|0
1311475|NCT00112437|4263992|P7|Year 2 (12-Month Extension)|patient was out of windows|0
1311476|NCT00112437|4263993|P6|Year 2 (12-Month Extension)|patient was out of windows|0
1311477|NCT00112437|4263994|P5|Year 2 (12-Month Extension)|patient was out of windows|0
1311478|NCT00112437|4263995|P4|Year 2 (12-Month Extension)|patient was out of windows|0
1311479|NCT00112437|4263996|P3|Year 2 (12-Month Extension)|patient was out of windows|0
1311480|NCT00112437|4263997|P2|Year 2 (12-Month Extension)|patient was out of windows|0
1311481|NCT00112437|4263998|P1|Year 2 (12-Month Extension)|patient was out of windows|0
1311482|NCT00112437|4263973|P26|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1311483|NCT00112437|4263974|P25|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1311484|NCT00112437|4263975|P24|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1311485|NCT00112437|4263976|P23|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1311486|NCT00112437|4263977|P22|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1311487|NCT00112437|4263978|P21|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1311708|NCT00112437|4263991|P8|Year 1 (12-Month Base Study)|moved|0
1311488|NCT00112437|4263979|P20|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1311489|NCT00112437|4263980|P19|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1311490|NCT00112437|4263981|P18|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1311491|NCT00112437|4263982|P17|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1311492|NCT00112437|4263983|P16|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1311493|NCT00112437|4263984|P15|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1311494|NCT00112437|4263985|P14|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1311495|NCT00112437|4263986|P13|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1311496|NCT00112437|4263987|P12|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1311497|NCT00112437|4263988|P11|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1311498|NCT00112437|4263989|P10|Year 2 (12-Month Extension)|Patient stopped taking medication|1
1311499|NCT00112437|4263990|P9|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1311500|NCT00112437|4263991|P8|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1311501|NCT00112437|4263992|P7|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1311502|NCT00112437|4263993|P6|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1311503|NCT00112437|4263994|P5|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1311504|NCT00112437|4263995|P4|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1311505|NCT00112437|4263996|P3|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1311506|NCT00112437|4263997|P2|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1311507|NCT00112437|4263998|P1|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1311508|NCT00112437|4263973|P26|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1311509|NCT00112437|4263974|P25|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1311510|NCT00112437|4263975|P24|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1311511|NCT00112437|4263976|P23|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1311512|NCT00112437|4263977|P22|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1311513|NCT00112437|4263978|P21|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1311514|NCT00112437|4263979|P20|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1311515|NCT00112437|4263980|P19|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1311516|NCT00112437|4263981|P18|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1311517|NCT00112437|4263982|P17|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1311518|NCT00112437|4263983|P16|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1311519|NCT00112437|4263984|P15|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1311520|NCT00112437|4263985|P14|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1311521|NCT00112437|4263986|P13|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1311522|NCT00112437|4263987|P12|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1311523|NCT00112437|4263988|P11|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1311524|NCT00112437|4263989|P10|Year 2 (12-Month Extension)|Withdrawal by Subject|1
1311525|NCT00112437|4263990|P9|Year 2 (12-Month Extension)|Withdrawal by Subject|4
1311526|NCT00112437|4263991|P8|Year 2 (12-Month Extension)|Withdrawal by Subject|2
1311527|NCT00112437|4263992|P7|Year 2 (12-Month Extension)|Withdrawal by Subject|1
1311528|NCT00112437|4263993|P6|Year 2 (12-Month Extension)|Withdrawal by Subject|1
1311529|NCT00112437|4263994|P5|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1311530|NCT00112437|4263995|P4|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1311531|NCT00112437|4263996|P3|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1311532|NCT00112437|4263997|P2|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1311533|NCT00112437|4263998|P1|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1311534|NCT00112437|4263973|P26|Year 2 (12-Month Extension)|Protocol Violation|0
1311535|NCT00112437|4263974|P25|Year 2 (12-Month Extension)|Protocol Violation|0
1311536|NCT00112437|4263975|P24|Year 2 (12-Month Extension)|Protocol Violation|0
1311537|NCT00112437|4263976|P23|Year 2 (12-Month Extension)|Protocol Violation|0
1311538|NCT00112437|4263977|P22|Year 2 (12-Month Extension)|Protocol Violation|0
1311539|NCT00112437|4263978|P21|Year 2 (12-Month Extension)|Protocol Violation|0
1311540|NCT00112437|4263979|P20|Year 2 (12-Month Extension)|Protocol Violation|0
1311541|NCT00112437|4263980|P19|Year 2 (12-Month Extension)|Protocol Violation|0
1311542|NCT00112437|4263981|P18|Year 2 (12-Month Extension)|Protocol Violation|0
1311543|NCT00112437|4263982|P17|Year 2 (12-Month Extension)|Protocol Violation|0
1311544|NCT00112437|4263983|P16|Year 2 (12-Month Extension)|Protocol Violation|0
1311545|NCT00112437|4263984|P15|Year 2 (12-Month Extension)|Protocol Violation|0
1311546|NCT00112437|4263985|P14|Year 2 (12-Month Extension)|Protocol Violation|0
1311547|NCT00112437|4263986|P13|Year 2 (12-Month Extension)|Protocol Violation|0
1311548|NCT00112437|4263987|P12|Year 2 (12-Month Extension)|Protocol Violation|0
1311549|NCT00112437|4263988|P11|Year 2 (12-Month Extension)|Protocol Violation|0
1311550|NCT00112437|4263989|P10|Year 2 (12-Month Extension)|Protocol Violation|0
1311551|NCT00112437|4263990|P9|Year 2 (12-Month Extension)|Protocol Violation|1
1311552|NCT00112437|4263991|P8|Year 2 (12-Month Extension)|Protocol Violation|0
1311553|NCT00112437|4263992|P7|Year 2 (12-Month Extension)|Protocol Violation|0
1311554|NCT00112437|4263993|P6|Year 2 (12-Month Extension)|Protocol Violation|0
1311555|NCT00112437|4263994|P5|Year 2 (12-Month Extension)|Protocol Violation|0
1311556|NCT00112437|4263995|P4|Year 2 (12-Month Extension)|Protocol Violation|0
1311557|NCT00112437|4263996|P3|Year 2 (12-Month Extension)|Protocol Violation|0
1311558|NCT00112437|4263997|P2|Year 2 (12-Month Extension)|Protocol Violation|0
1311559|NCT00112437|4263998|P1|Year 2 (12-Month Extension)|Protocol Violation|0
1311560|NCT00112437|4263973|P26|Year 2 (12-Month Extension)|Lost to Follow-up|0
1311561|NCT00112437|4263974|P25|Year 2 (12-Month Extension)|Lost to Follow-up|0
1311562|NCT00112437|4263975|P24|Year 2 (12-Month Extension)|Lost to Follow-up|0
1311563|NCT00112437|4263976|P23|Year 2 (12-Month Extension)|Lost to Follow-up|0
1311564|NCT00112437|4263977|P22|Year 2 (12-Month Extension)|Lost to Follow-up|0
1311565|NCT00112437|4263978|P21|Year 2 (12-Month Extension)|Lost to Follow-up|0
1311566|NCT00112437|4263979|P20|Year 2 (12-Month Extension)|Lost to Follow-up|0
1311567|NCT00112437|4263980|P19|Year 2 (12-Month Extension)|Lost to Follow-up|0
1311568|NCT00112437|4263981|P18|Year 2 (12-Month Extension)|Lost to Follow-up|0
1311569|NCT00112437|4263982|P17|Year 2 (12-Month Extension)|Lost to Follow-up|0
1311570|NCT00112437|4263983|P16|Year 2 (12-Month Extension)|Lost to Follow-up|0
1311571|NCT00112437|4263984|P15|Year 2 (12-Month Extension)|Lost to Follow-up|0
1311572|NCT00112437|4263985|P14|Year 2 (12-Month Extension)|Lost to Follow-up|0
1311573|NCT00112437|4263986|P13|Year 2 (12-Month Extension)|Lost to Follow-up|0
1311574|NCT00112437|4263987|P12|Year 2 (12-Month Extension)|Lost to Follow-up|0
1311575|NCT00112437|4263988|P11|Year 2 (12-Month Extension)|Lost to Follow-up|0
1311576|NCT00112437|4263989|P10|Year 2 (12-Month Extension)|Lost to Follow-up|0
1311577|NCT00112437|4263990|P9|Year 2 (12-Month Extension)|Lost to Follow-up|1
1311578|NCT00112437|4263991|P8|Year 2 (12-Month Extension)|Lost to Follow-up|0
1311579|NCT00112437|4263992|P7|Year 2 (12-Month Extension)|Lost to Follow-up|0
1311580|NCT00112437|4263993|P6|Year 2 (12-Month Extension)|Lost to Follow-up|0
1311581|NCT00112437|4263994|P5|Year 2 (12-Month Extension)|Lost to Follow-up|0
1311582|NCT00112437|4263995|P4|Year 2 (12-Month Extension)|Lost to Follow-up|0
1311583|NCT00112437|4263996|P3|Year 2 (12-Month Extension)|Lost to Follow-up|0
1311584|NCT00112437|4263997|P2|Year 2 (12-Month Extension)|Lost to Follow-up|0
1311585|NCT00112437|4263998|P1|Year 2 (12-Month Extension)|Lost to Follow-up|0
1311586|NCT00112437|4263973|P26|Year 2 (12-Month Extension)|Lack of Efficacy|0
1311587|NCT00112437|4263974|P25|Year 2 (12-Month Extension)|Lack of Efficacy|0
1311588|NCT00112437|4263975|P24|Year 2 (12-Month Extension)|Lack of Efficacy|0
1311589|NCT00112437|4263976|P23|Year 2 (12-Month Extension)|Lack of Efficacy|0
1311590|NCT00112437|4263977|P22|Year 2 (12-Month Extension)|Lack of Efficacy|0
1311591|NCT00112437|4263978|P21|Year 2 (12-Month Extension)|Lack of Efficacy|0
1311592|NCT00112437|4263979|P20|Year 2 (12-Month Extension)|Lack of Efficacy|0
1311593|NCT00112437|4263980|P19|Year 2 (12-Month Extension)|Lack of Efficacy|0
1311594|NCT00112437|4263981|P18|Year 2 (12-Month Extension)|Lack of Efficacy|0
1311595|NCT00112437|4263982|P17|Year 2 (12-Month Extension)|Lack of Efficacy|0
1311596|NCT00112437|4263983|P16|Year 2 (12-Month Extension)|Lack of Efficacy|0
1311597|NCT00112437|4263984|P15|Year 2 (12-Month Extension)|Lack of Efficacy|0
1311598|NCT00112437|4263985|P14|Year 2 (12-Month Extension)|Lack of Efficacy|0
1311599|NCT00112437|4263986|P13|Year 2 (12-Month Extension)|Lack of Efficacy|0
1311600|NCT00112437|4263987|P12|Year 2 (12-Month Extension)|Lack of Efficacy|0
1311601|NCT00112437|4263988|P11|Year 2 (12-Month Extension)|Lack of Efficacy|0
1311602|NCT00112437|4263989|P10|Year 2 (12-Month Extension)|Lack of Efficacy|2
1311603|NCT00112437|4263990|P9|Year 2 (12-Month Extension)|Lack of Efficacy|0
1311604|NCT00112437|4263991|P8|Year 2 (12-Month Extension)|Lack of Efficacy|0
1311605|NCT00112437|4263992|P7|Year 2 (12-Month Extension)|Lack of Efficacy|6
1311606|NCT00112437|4263993|P6|Year 2 (12-Month Extension)|Lack of Efficacy|1
1311607|NCT00112437|4263994|P5|Year 2 (12-Month Extension)|Lack of Efficacy|0
1311608|NCT00112437|4263995|P4|Year 2 (12-Month Extension)|Lack of Efficacy|0
1311609|NCT00112437|4263996|P3|Year 2 (12-Month Extension)|Lack of Efficacy|0
1311610|NCT00112437|4263997|P2|Year 2 (12-Month Extension)|Lack of Efficacy|0
1311611|NCT00112437|4263998|P1|Year 2 (12-Month Extension)|Lack of Efficacy|0
1311612|NCT00112437|4263973|P26|Year 2 (12-Month Extension)|Adverse Event|0
1311613|NCT00112437|4263974|P25|Year 2 (12-Month Extension)|Adverse Event|0
1311614|NCT00112437|4263975|P24|Year 2 (12-Month Extension)|Adverse Event|0
1311615|NCT00112437|4263976|P23|Year 2 (12-Month Extension)|Adverse Event|0
1311616|NCT00112437|4263977|P22|Year 2 (12-Month Extension)|Adverse Event|0
1311617|NCT00112437|4263978|P21|Year 2 (12-Month Extension)|Adverse Event|0
1311618|NCT00112437|4263979|P20|Year 2 (12-Month Extension)|Adverse Event|0
1311619|NCT00112437|4263980|P19|Year 2 (12-Month Extension)|Adverse Event|0
1311620|NCT00112437|4263981|P18|Year 2 (12-Month Extension)|Adverse Event|0
1311621|NCT00112437|4263982|P17|Year 2 (12-Month Extension)|Adverse Event|0
1311622|NCT00112437|4263983|P16|Year 2 (12-Month Extension)|Adverse Event|0
1311623|NCT00112437|4263984|P15|Year 2 (12-Month Extension)|Adverse Event|0
1311624|NCT00112437|4263985|P14|Year 2 (12-Month Extension)|Adverse Event|0
1311625|NCT00112437|4263986|P13|Year 2 (12-Month Extension)|Adverse Event|0
1311626|NCT00112437|4263987|P12|Year 2 (12-Month Extension)|Adverse Event|0
1311627|NCT00112437|4263988|P11|Year 2 (12-Month Extension)|Adverse Event|0
1311628|NCT00112437|4263989|P10|Year 2 (12-Month Extension)|Adverse Event|7
1311629|NCT00112437|4263990|P9|Year 2 (12-Month Extension)|Adverse Event|1
1311630|NCT00112437|4263991|P8|Year 2 (12-Month Extension)|Adverse Event|6
1311631|NCT00112437|4263992|P7|Year 2 (12-Month Extension)|Adverse Event|2
1311632|NCT00112437|4263993|P6|Year 2 (12-Month Extension)|Adverse Event|1
1311633|NCT00112437|4263994|P5|Year 2 (12-Month Extension)|Adverse Event|0
1311634|NCT00112437|4263995|P4|Year 2 (12-Month Extension)|Adverse Event|0
1311635|NCT00112437|4263996|P3|Year 2 (12-Month Extension)|Adverse Event|0
1311636|NCT00112437|4263997|P2|Year 2 (12-Month Extension)|Adverse Event|0
1311637|NCT00112437|4263998|P1|Year 2 (12-Month Extension)|Adverse Event|0
1311638|NCT00112437|4263973|P26|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1311639|NCT00112437|4263974|P25|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1311640|NCT00112437|4263975|P24|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1311641|NCT00112437|4263976|P23|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1311642|NCT00112437|4263977|P22|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1311643|NCT00112437|4263978|P21|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1311644|NCT00112437|4263979|P20|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1311645|NCT00112437|4263980|P19|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1311646|NCT00112437|4263981|P18|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1311647|NCT00112437|4263982|P17|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1311648|NCT00112437|4263983|P16|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1311649|NCT00112437|4263984|P15|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1311650|NCT00112437|4263985|P14|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1311651|NCT00112437|4263986|P13|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1311652|NCT00112437|4263987|P12|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1311653|NCT00112437|4263988|P11|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1311654|NCT00112437|4263989|P10|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1311655|NCT00112437|4263990|P9|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1311656|NCT00112437|4263991|P8|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1311657|NCT00112437|4263992|P7|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1311658|NCT00112437|4263993|P6|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1311659|NCT00112437|4263994|P5|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1
1311660|NCT00112437|4263995|P4|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1311661|NCT00112437|4263996|P3|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1311662|NCT00112437|4263997|P2|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1311663|NCT00112437|4263998|P1|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1311664|NCT00112437|4263973|P26|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1311665|NCT00112437|4263974|P25|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1311666|NCT00112437|4263975|P24|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1311667|NCT00112437|4263976|P23|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1311668|NCT00112437|4263977|P22|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1311669|NCT00112437|4263978|P21|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1311670|NCT00112437|4263979|P20|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1311671|NCT00112437|4263980|P19|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1311672|NCT00112437|4263981|P18|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1311673|NCT00112437|4263982|P17|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1311674|NCT00112437|4263983|P16|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1311675|NCT00112437|4263984|P15|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1311676|NCT00112437|4263985|P14|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1311677|NCT00112437|4263986|P13|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1311678|NCT00112437|4263987|P12|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1311679|NCT00112437|4263988|P11|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1311680|NCT00112437|4263989|P10|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1311681|NCT00112437|4263990|P9|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1311682|NCT00112437|4263991|P8|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1311683|NCT00112437|4263992|P7|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1311684|NCT00112437|4263993|P6|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1311685|NCT00112437|4263994|P5|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1311686|NCT00112437|4263995|P4|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2
1311687|NCT00112437|4263996|P3|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1311688|NCT00112437|4263997|P2|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1311689|NCT00112437|4263998|P1|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1311690|NCT00112437|4263973|P26|Year 1 (12-Month Base Study)|moved|0
1311691|NCT00112437|4263974|P25|Year 1 (12-Month Base Study)|moved|0
1311692|NCT00112437|4263975|P24|Year 1 (12-Month Base Study)|moved|0
1311693|NCT00112437|4263976|P23|Year 1 (12-Month Base Study)|moved|0
1311694|NCT00112437|4263977|P22|Year 1 (12-Month Base Study)|moved|0
1311695|NCT00112437|4263978|P21|Year 1 (12-Month Base Study)|moved|0
1311696|NCT00112437|4263979|P20|Year 1 (12-Month Base Study)|moved|0
1311697|NCT00112437|4263980|P19|Year 1 (12-Month Base Study)|moved|0
1311698|NCT00112437|4263981|P18|Year 1 (12-Month Base Study)|moved|0
1311699|NCT00112437|4263982|P17|Year 1 (12-Month Base Study)|moved|0
1311700|NCT00112437|4263983|P16|Year 1 (12-Month Base Study)|moved|0
1311701|NCT00112437|4263984|P15|Year 1 (12-Month Base Study)|moved|0
1311702|NCT00112437|4263985|P14|Year 1 (12-Month Base Study)|moved|0
1311703|NCT00112437|4263986|P13|Year 1 (12-Month Base Study)|moved|0
1311704|NCT00112437|4263987|P12|Year 1 (12-Month Base Study)|moved|0
1311705|NCT00112437|4263988|P11|Year 1 (12-Month Base Study)|moved|0
1311706|NCT00112437|4263989|P10|Year 1 (12-Month Base Study)|moved|0
1311707|NCT00112437|4263990|P9|Year 1 (12-Month Base Study)|moved|0
1311709|NCT00112437|4263992|P7|Year 1 (12-Month Base Study)|moved|0
1311710|NCT00112437|4263993|P6|Year 1 (12-Month Base Study)|moved|0
1311711|NCT00112437|4263994|P5|Year 1 (12-Month Base Study)|moved|0
1311712|NCT00112437|4263995|P4|Year 1 (12-Month Base Study)|moved|0
1311713|NCT00112437|4263996|P3|Year 1 (12-Month Base Study)|moved|1
1311714|NCT00112437|4263997|P2|Year 1 (12-Month Base Study)|moved|1
1311715|NCT00112437|4263998|P1|Year 1 (12-Month Base Study)|moved|0
1311716|NCT00112437|4263973|P26|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1311717|NCT00112437|4263974|P25|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1311718|NCT00112437|4263975|P24|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1311719|NCT00112437|4263976|P23|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1311720|NCT00112437|4263977|P22|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1311721|NCT00112437|4263978|P21|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1311722|NCT00112437|4263979|P20|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1311723|NCT00112437|4263980|P19|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1311724|NCT00112437|4263981|P18|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1311725|NCT00112437|4263982|P17|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1311726|NCT00112437|4263983|P16|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1311727|NCT00112437|4263984|P15|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1311728|NCT00112437|4263985|P14|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1311729|NCT00112437|4263986|P13|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1311730|NCT00112437|4263987|P12|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1311731|NCT00112437|4263988|P11|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1311732|NCT00112437|4263989|P10|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1311733|NCT00112437|4263990|P9|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1311734|NCT00112437|4263991|P8|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1311735|NCT00112437|4263992|P7|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1311736|NCT00112437|4263993|P6|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1311737|NCT00112437|4263994|P5|Year 1 (12-Month Base Study)|Withdrawal by Subject|7
1311738|NCT00112437|4263995|P4|Year 1 (12-Month Base Study)|Withdrawal by Subject|1
1311739|NCT00112437|4263996|P3|Year 1 (12-Month Base Study)|Withdrawal by Subject|2
1311740|NCT00112437|4263997|P2|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
1311741|NCT00112437|4263998|P1|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
1311742|NCT00112437|4263973|P26|Year 1 (12-Month Base Study)|Protocol Violation|0
1311743|NCT00112437|4263974|P25|Year 1 (12-Month Base Study)|Protocol Violation|0
1311744|NCT00112437|4263975|P24|Year 1 (12-Month Base Study)|Protocol Violation|0
1311745|NCT00112437|4263976|P23|Year 1 (12-Month Base Study)|Protocol Violation|0
1311746|NCT00112437|4263977|P22|Year 1 (12-Month Base Study)|Protocol Violation|0
1311747|NCT00112437|4263978|P21|Year 1 (12-Month Base Study)|Protocol Violation|0
1311748|NCT00112437|4263979|P20|Year 1 (12-Month Base Study)|Protocol Violation|0
1311749|NCT00112437|4263980|P19|Year 1 (12-Month Base Study)|Protocol Violation|0
1311750|NCT00112437|4263981|P18|Year 1 (12-Month Base Study)|Protocol Violation|0
1311751|NCT00112437|4263982|P17|Year 1 (12-Month Base Study)|Protocol Violation|0
1311752|NCT00112437|4263983|P16|Year 1 (12-Month Base Study)|Protocol Violation|0
1311753|NCT00112437|4263984|P15|Year 1 (12-Month Base Study)|Protocol Violation|0
1311754|NCT00112437|4263985|P14|Year 1 (12-Month Base Study)|Protocol Violation|0
1311755|NCT00112437|4263986|P13|Year 1 (12-Month Base Study)|Protocol Violation|0
1311756|NCT00112437|4263987|P12|Year 1 (12-Month Base Study)|Protocol Violation|0
1311757|NCT00112437|4263988|P11|Year 1 (12-Month Base Study)|Protocol Violation|0
1311758|NCT00112437|4263989|P10|Year 1 (12-Month Base Study)|Protocol Violation|0
1311759|NCT00112437|4263990|P9|Year 1 (12-Month Base Study)|Protocol Violation|0
1311760|NCT00112437|4263991|P8|Year 1 (12-Month Base Study)|Protocol Violation|0
1311761|NCT00112437|4263992|P7|Year 1 (12-Month Base Study)|Protocol Violation|0
1311762|NCT00112437|4263993|P6|Year 1 (12-Month Base Study)|Protocol Violation|0
1311763|NCT00112437|4263994|P5|Year 1 (12-Month Base Study)|Protocol Violation|1
1311764|NCT00112437|4263995|P4|Year 1 (12-Month Base Study)|Protocol Violation|1
1311765|NCT00112437|4263996|P3|Year 1 (12-Month Base Study)|Protocol Violation|3
1311766|NCT00112437|4263997|P2|Year 1 (12-Month Base Study)|Protocol Violation|0
1311767|NCT00112437|4263998|P1|Year 1 (12-Month Base Study)|Protocol Violation|1
1311768|NCT00112437|4263973|P26|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1311769|NCT00112437|4263974|P25|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1311770|NCT00112437|4263975|P24|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1311771|NCT00112437|4263976|P23|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1311772|NCT00112437|4263977|P22|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1311773|NCT00112437|4263978|P21|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1311774|NCT00112437|4263979|P20|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1311775|NCT00112437|4263980|P19|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1311776|NCT00112437|4263981|P18|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1311777|NCT00112437|4263982|P17|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1311778|NCT00112437|4263983|P16|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1311779|NCT00112437|4263984|P15|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1311780|NCT00112437|4263985|P14|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1311781|NCT00112437|4263986|P13|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1311782|NCT00112437|4263987|P12|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1311783|NCT00112437|4263988|P11|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1311784|NCT00112437|4263989|P10|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1311785|NCT00112437|4263990|P9|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1311786|NCT00112437|4263991|P8|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1311787|NCT00112437|4263992|P7|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1311788|NCT00112437|4263993|P6|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1311789|NCT00112437|4263994|P5|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1311790|NCT00112437|4263995|P4|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1311791|NCT00112437|4263996|P3|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1311792|NCT00112437|4263997|P2|Year 1 (12-Month Base Study)|Lost to Follow-up|1
1311793|NCT00112437|4263998|P1|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1311794|NCT00112437|4263973|P26|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1311795|NCT00112437|4263974|P25|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1311796|NCT00112437|4263975|P24|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1311797|NCT00112437|4263976|P23|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1311798|NCT00112437|4263977|P22|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1311799|NCT00112437|4263978|P21|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1311800|NCT00112437|4263979|P20|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1311801|NCT00112437|4263980|P19|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1311802|NCT00112437|4263981|P18|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1311803|NCT00112437|4263982|P17|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1311804|NCT00112437|4263983|P16|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1311805|NCT00112437|4263984|P15|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1311806|NCT00112437|4263985|P14|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1311807|NCT00112437|4263986|P13|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1311808|NCT00112437|4263987|P12|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1311809|NCT00112437|4263988|P11|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1311810|NCT00112437|4263989|P10|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1311811|NCT00112437|4263990|P9|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1311812|NCT00112437|4263991|P8|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1311813|NCT00112437|4263992|P7|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1311814|NCT00112437|4263993|P6|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1311815|NCT00112437|4263994|P5|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1311816|NCT00112437|4263995|P4|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1311817|NCT00112437|4263996|P3|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1311818|NCT00112437|4263997|P2|Year 1 (12-Month Base Study)|Lack of Efficacy|1
1311819|NCT00112437|4263998|P1|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1311820|NCT00112437|4263973|P26|Year 1 (12-Month Base Study)|Adverse Event|0
1311821|NCT00112437|4263974|P25|Year 1 (12-Month Base Study)|Adverse Event|0
1311822|NCT00112437|4263975|P24|Year 1 (12-Month Base Study)|Adverse Event|0
1311823|NCT00112437|4263976|P23|Year 1 (12-Month Base Study)|Adverse Event|0
1311824|NCT00112437|4263977|P22|Year 1 (12-Month Base Study)|Adverse Event|0
1311825|NCT00112437|4263978|P21|Year 1 (12-Month Base Study)|Adverse Event|0
1311826|NCT00112437|4263979|P20|Year 1 (12-Month Base Study)|Adverse Event|0
1311827|NCT00112437|4263980|P19|Year 1 (12-Month Base Study)|Adverse Event|0
1311828|NCT00112437|4263981|P18|Year 1 (12-Month Base Study)|Adverse Event|0
1311829|NCT00112437|4263982|P17|Year 1 (12-Month Base Study)|Adverse Event|0
1311830|NCT00112437|4263983|P16|Year 1 (12-Month Base Study)|Adverse Event|0
1311831|NCT00112437|4263984|P15|Year 1 (12-Month Base Study)|Adverse Event|0
1311832|NCT00112437|4263985|P14|Year 1 (12-Month Base Study)|Adverse Event|0
1311833|NCT00112437|4263986|P13|Year 1 (12-Month Base Study)|Adverse Event|0
1311834|NCT00112437|4263987|P12|Year 1 (12-Month Base Study)|Adverse Event|0
1311835|NCT00112437|4263988|P11|Year 1 (12-Month Base Study)|Adverse Event|0
1311836|NCT00112437|4263989|P10|Year 1 (12-Month Base Study)|Adverse Event|0
1311837|NCT00112437|4263990|P9|Year 1 (12-Month Base Study)|Adverse Event|0
1311838|NCT00112437|4263991|P8|Year 1 (12-Month Base Study)|Adverse Event|0
1311839|NCT00112437|4263992|P7|Year 1 (12-Month Base Study)|Adverse Event|0
1311840|NCT00112437|4263993|P6|Year 1 (12-Month Base Study)|Adverse Event|0
1311841|NCT00112437|4263994|P5|Year 1 (12-Month Base Study)|Adverse Event|3
1311842|NCT00112437|4263995|P4|Year 1 (12-Month Base Study)|Adverse Event|4
1311843|NCT00112437|4263996|P3|Year 1 (12-Month Base Study)|Adverse Event|6
1311844|NCT00112437|4263997|P2|Year 1 (12-Month Base Study)|Adverse Event|10
1311845|NCT00112437|4263998|P1|Year 1 (12-Month Base Study)|Adverse Event|9
1311846|NCT00112385|4264278|P2|Overall Study|Withdrawal by Subject|1
1311847|NCT00112385|4264279|P1|Overall Study|Withdrawal by Subject|0
1311848|NCT00112385|4264278|P2|Overall Study|Lost to Follow-up|0
1311849|NCT00112385|4264279|P1|Overall Study|Lost to Follow-up|1
1311850|NCT00112359|4264369|P2|Overall Study|Other|0
1311851|NCT00112359|4264370|P1|Overall Study|Other|3
1311852|NCT00112359|4264369|P2|Overall Study|Personal/administrative|1
1311853|NCT00112359|4264370|P1|Overall Study|Personal/administrative|1
1311854|NCT00112359|4264369|P2|Overall Study|Lost to Follow-up|1
1311855|NCT00112359|4264370|P1|Overall Study|Lost to Follow-up|0
1311856|NCT00112359|4264369|P2|Overall Study|Related adverse event|3
1311857|NCT00112359|4264370|P1|Overall Study|Related adverse event|5
1311858|NCT00112359|4264369|P2|Overall Study|Trial drug intolerance (adverse event)|0
1311859|NCT00112359|4264370|P1|Overall Study|Trial drug intolerance (adverse event)|2
1311860|NCT00112359|4264369|P2|Overall Study|Unrelated adverse event|8
1311861|NCT00112359|4264370|P1|Overall Study|Unrelated adverse event|16
1311862|NCT00112294|4264396|P2|Overall Study|Still on study|0
1311863|NCT00112294|4264397|P1|Overall Study|Still on study|5
1311864|NCT00112047|4264620|P2|Atripla Phase|Not specified|1
1311865|NCT00112047|4264621|P1|Atripla Phase|Not specified|3
1311866|NCT00112047|4264620|P2|Atripla Phase|Non-compliance|0
1311867|NCT00112047|4264621|P1|Atripla Phase|Non-compliance|1
1311868|NCT00112047|4264620|P2|Atripla Phase|Sub-optimal virological response|1
1311869|NCT00112047|4264621|P1|Atripla Phase|Sub-optimal virological response|0
1311870|NCT00112047|4264620|P2|Atripla Phase|Withdrew consent|7
1311871|NCT00112047|4264621|P1|Atripla Phase|Withdrew consent|7
1311872|NCT00112047|4264620|P2|Atripla Phase|Death|2
1311873|NCT00112047|4264621|P1|Atripla Phase|Death|0
1311874|NCT00112047|4264620|P2|Atripla Phase|Pregnancy|1
1311875|NCT00112047|4264621|P1|Atripla Phase|Pregnancy|0
1311876|NCT00112047|4264620|P2|Atripla Phase|Lost to Follow-up|7
1311877|NCT00112047|4264621|P1|Atripla Phase|Lost to Follow-up|5
1311878|NCT00112047|4264620|P2|Atripla Phase|Adverse Event|1
1311879|NCT00112047|4264621|P1|Atripla Phase|Adverse Event|2
1311880|NCT00112047|4264620|P2|Randomized Phase|High Hepatitis B DNA|1
1311881|NCT00112047|4264621|P1|Randomized Phase|High Hepatitis B DNA|0
1311882|NCT00112047|4264620|P2|Randomized Phase|Baseline NNRTI resistance mutations|0
1311883|NCT00112047|4264621|P1|Randomized Phase|Baseline NNRTI resistance mutations|4
1311884|NCT00112047|4264620|P2|Randomized Phase|Moved out of State|1
1311885|NCT00112047|4264621|P1|Randomized Phase|Moved out of State|0
1311886|NCT00112047|4264620|P2|Randomized Phase|Incarceration|2
1311887|NCT00112047|4264621|P1|Randomized Phase|Incarceration|3
1311888|NCT00112047|4264620|P2|Randomized Phase|Inability to swallow pills|1
1311889|NCT00112047|4264621|P1|Randomized Phase|Inability to swallow pills|0
1311890|NCT00112047|4264620|P2|Randomized Phase|Hepatitis C treatment contraindicated|1
1311891|NCT00112047|4264621|P1|Randomized Phase|Hepatitis C treatment contraindicated|0
1311892|NCT00112047|4264620|P2|Randomized Phase|Death|3
1311893|NCT00112047|4264621|P1|Randomized Phase|Death|1
1311894|NCT00112047|4264620|P2|Randomized Phase|Pregnancy|1
1311895|NCT00112047|4264621|P1|Randomized Phase|Pregnancy|3
1311896|NCT00112047|4264620|P2|Randomized Phase|Protocol Violation|0
1311897|NCT00112047|4264621|P1|Randomized Phase|Protocol Violation|2
1311898|NCT00112047|4264620|P2|Randomized Phase|Noncompliance|4
1311899|NCT00112047|4264621|P1|Randomized Phase|Noncompliance|8
1311900|NCT00112047|4264620|P2|Randomized Phase|Sub-optimal virological response|13
1311901|NCT00112047|4264621|P1|Randomized Phase|Sub-optimal virological response|3
1311902|NCT00112047|4264620|P2|Randomized Phase|Withrawal of consent|18
1311903|NCT00112047|4264621|P1|Randomized Phase|Withrawal of consent|10
1311904|NCT00112047|4264620|P2|Randomized Phase|Adverse Event|10
1311905|NCT00112047|4264621|P1|Randomized Phase|Adverse Event|10
1311906|NCT00112047|4264620|P2|Randomized Phase|Lost to Follow-up|33
1311907|NCT00112047|4264621|P1|Randomized Phase|Lost to Follow-up|26
1311908|NCT00111917|4264721|P2|Overall Study|Withdrawal by Subject|1
1311909|NCT00111917|4264722|P1|Overall Study|Withdrawal by Subject|1
1311910|NCT00111839|4264737|P3|Overall Study|Randomized but Not Treated|2
1311911|NCT00111839|4264738|P2|Overall Study|Randomized but Not Treated|0
1311912|NCT00111839|4264739|P1|Overall Study|Randomized but Not Treated|0
1311913|NCT00111839|4264737|P3|Overall Study|Other|3
1311914|NCT00111839|4264738|P2|Overall Study|Other|3
1311915|NCT00111839|4264739|P1|Overall Study|Other|6
1311916|NCT00111839|4264737|P3|Overall Study|Logistical Constraint|0
1311917|NCT00111839|4264738|P2|Overall Study|Logistical Constraint|0
1311918|NCT00111839|4264739|P1|Overall Study|Logistical Constraint|1
1311919|NCT00111839|4264737|P3|Overall Study|Lost to Follow-up|0
1311920|NCT00111839|4264738|P2|Overall Study|Lost to Follow-up|0
1311921|NCT00111839|4264739|P1|Overall Study|Lost to Follow-up|1
1311922|NCT00111839|4264737|P3|Overall Study|Withdrawal by Subject|2
1311923|NCT00111839|4264738|P2|Overall Study|Withdrawal by Subject|2
1311924|NCT00111839|4264739|P1|Overall Study|Withdrawal by Subject|2
1311925|NCT00111839|4264737|P3|Overall Study|Death|6
1311926|NCT00111839|4264738|P2|Overall Study|Death|1
1311927|NCT00111839|4264739|P1|Overall Study|Death|1
1311928|NCT00111839|4264737|P3|Overall Study|Protocol Violation|2
1311929|NCT00111839|4264738|P2|Overall Study|Protocol Violation|4
1311930|NCT00111839|4264739|P1|Overall Study|Protocol Violation|2
1311931|NCT00111839|4264737|P3|Overall Study|Adverse Event|1
1311932|NCT00111839|4264738|P2|Overall Study|Adverse Event|3
1311933|NCT00111839|4264739|P1|Overall Study|Adverse Event|5
1311934|NCT00111839|4264737|P3|Overall Study|Disease Progression|33
1311935|NCT00111839|4264738|P2|Overall Study|Disease Progression|33
1311936|NCT00111839|4264739|P1|Overall Study|Disease Progression|30
1311937|NCT00111813|4264759|P6|Overall Study|Not specified|0
1311938|NCT00111813|4264760|P5|Overall Study|Not specified|0
1311939|NCT00111813|4264761|P4|Overall Study|Not specified|0
1311940|NCT00111813|4264762|P3|Overall Study|Not specified|1
1311941|NCT00111813|4264763|P2|Overall Study|Not specified|0
1311942|NCT00111813|4264764|P1|Overall Study|Not specified|0
1311943|NCT00111813|4264759|P6|Overall Study|Lack of Efficacy|1
1311944|NCT00111813|4264760|P5|Overall Study|Lack of Efficacy|0
1311945|NCT00111813|4264761|P4|Overall Study|Lack of Efficacy|0
1311946|NCT00111813|4264762|P3|Overall Study|Lack of Efficacy|0
1311947|NCT00111813|4264763|P2|Overall Study|Lack of Efficacy|0
1311948|NCT00111813|4264764|P1|Overall Study|Lack of Efficacy|0
1311949|NCT00111813|4264759|P6|Overall Study|Progressive disease|3
1311950|NCT00111813|4264760|P5|Overall Study|Progressive disease|4
1311951|NCT00111813|4264761|P4|Overall Study|Progressive disease|3
1311952|NCT00111813|4264762|P3|Overall Study|Progressive disease|5
1311953|NCT00111813|4264763|P2|Overall Study|Progressive disease|1
1311954|NCT00111813|4264764|P1|Overall Study|Progressive disease|2
1311955|NCT00111813|4264759|P6|Overall Study|Adverse Event|2
1311956|NCT00111813|4264760|P5|Overall Study|Adverse Event|2
1311957|NCT00111813|4264761|P4|Overall Study|Adverse Event|2
1311958|NCT00111813|4264762|P3|Overall Study|Adverse Event|4
1311959|NCT00111813|4264763|P2|Overall Study|Adverse Event|2
1311960|NCT00111813|4264764|P1|Overall Study|Adverse Event|1
1311961|NCT00111800|4264803|P6|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
1311962|NCT00111800|4264804|P5|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
1311963|NCT00111800|4264805|P4|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
1311964|NCT00111800|4264806|P3|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1
1311965|NCT00111800|4264807|P2|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
1311966|NCT00111800|4264808|P1|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
1311967|NCT00111800|4264803|P6|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
1311968|NCT00111800|4264804|P5|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
1311969|NCT00111800|4264805|P4|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
1311970|NCT00111800|4264806|P3|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1
1311971|NCT00111800|4264807|P2|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
1311972|NCT00111800|4264808|P1|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
1311973|NCT00111800|4264803|P6|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
1311974|NCT00111800|4264804|P5|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
1311975|NCT00111800|4264805|P4|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
1311976|NCT00111800|4264806|P3|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
1311977|NCT00111800|4264807|P2|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1
1311978|NCT00111800|4264808|P1|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
1311979|NCT00111800|4264803|P6|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
1311980|NCT00111800|4264804|P5|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
1311981|NCT00111800|4264805|P4|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
1311982|NCT00111800|4264806|P3|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0
1311983|NCT00111800|4264807|P2|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
1311984|NCT00111800|4264808|P1|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
1311985|NCT00111800|4264803|P6|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
1311986|NCT00111800|4264804|P5|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
1311987|NCT00111800|4264805|P4|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
1311988|NCT00111800|4264806|P3|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
1311989|NCT00111800|4264807|P2|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
1311990|NCT00111800|4264808|P1|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
1311991|NCT00111800|4264803|P6|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
1311992|NCT00111800|4264804|P5|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3
1311993|NCT00111800|4264805|P4|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
1311994|NCT00111800|4264806|P3|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
1311995|NCT00111800|4264807|P2|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
1311996|NCT00111800|4264808|P1|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
1311997|NCT00111800|4264803|P6|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
1311998|NCT00111800|4264804|P5|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
1311999|NCT00111800|4264805|P4|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
1312000|NCT00111800|4264806|P3|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
1312001|NCT00111800|4264807|P2|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
1312002|NCT00111800|4264808|P1|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
1312003|NCT00111800|4264803|P6|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
1312004|NCT00111800|4264804|P5|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
1312005|NCT00111800|4264805|P4|Period 2: Extension Phase (12 Weeks)|Adverse Event|3
1312006|NCT00111800|4264806|P3|Period 2: Extension Phase (12 Weeks)|Adverse Event|1
1312007|NCT00111800|4264807|P2|Period 2: Extension Phase (12 Weeks)|Adverse Event|2
1312008|NCT00111800|4264808|P1|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
1312009|NCT00111800|4264803|P6|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1
1312010|NCT00111800|4264804|P5|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
1312011|NCT00111800|4264805|P4|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
1312012|NCT00111800|4264806|P3|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
1312013|NCT00111800|4264807|P2|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
1312014|NCT00111800|4264808|P1|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
1312015|NCT00111800|4264803|P6|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
1312016|NCT00111800|4264804|P5|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1
1312017|NCT00111800|4264805|P4|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
1312018|NCT00111800|4264806|P3|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
1312019|NCT00111800|4264807|P2|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
1312020|NCT00111800|4264808|P1|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
1312021|NCT00111800|4264803|P6|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
1312022|NCT00111800|4264804|P5|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1
1312023|NCT00111800|4264805|P4|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
1312024|NCT00111800|4264806|P3|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
1312025|NCT00111800|4264807|P2|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
1312026|NCT00111800|4264808|P1|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
1312027|NCT00111800|4264803|P6|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
1312028|NCT00111800|4264804|P5|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
1312029|NCT00111800|4264805|P4|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1
1312030|NCT00111800|4264806|P3|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
1312031|NCT00111800|4264807|P2|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
1312032|NCT00111800|4264808|P1|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
1312033|NCT00111800|4264803|P6|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
1312034|NCT00111800|4264804|P5|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
1312035|NCT00111800|4264805|P4|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1
1312036|NCT00111800|4264806|P3|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
1312037|NCT00111800|4264807|P2|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
1312038|NCT00111800|4264808|P1|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
1312039|NCT00111800|4264803|P6|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
1312040|NCT00111800|4264804|P5|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
1312041|NCT00111800|4264805|P4|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
1312042|NCT00111800|4264806|P3|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
1312043|NCT00111800|4264807|P2|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1
1312044|NCT00111800|4264808|P1|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
1312045|NCT00111800|4264803|P6|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
1312046|NCT00111800|4264804|P5|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
1312047|NCT00111800|4264805|P4|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
1312048|NCT00111800|4264806|P3|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
1312049|NCT00111800|4264807|P2|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1
1312050|NCT00111800|4264808|P1|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
1312051|NCT00111800|4264803|P6|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
1312052|NCT00111800|4264804|P5|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
1312053|NCT00111800|4264805|P4|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
1312054|NCT00111800|4264806|P3|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
1312055|NCT00111800|4264807|P2|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1
1312056|NCT00111800|4264808|P1|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
1312057|NCT00111800|4264803|P6|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
1312058|NCT00111800|4264804|P5|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
1312059|NCT00111800|4264805|P4|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
1312060|NCT00111800|4264806|P3|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
1312061|NCT00111800|4264807|P2|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1
1312062|NCT00111800|4264808|P1|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
1312063|NCT00111800|4264803|P6|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
1312064|NCT00111800|4264804|P5|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
1312065|NCT00111800|4264805|P4|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
1312066|NCT00111800|4264806|P3|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
1312067|NCT00111800|4264807|P2|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
1312068|NCT00111800|4264808|P1|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1
1312069|NCT00111800|4264803|P6|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
1312070|NCT00111800|4264804|P5|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
1312071|NCT00111800|4264805|P4|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
1312072|NCT00111800|4264806|P3|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
1312073|NCT00111800|4264807|P2|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
1312074|NCT00111800|4264808|P1|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
1312075|NCT00111800|4264803|P6|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
1312076|NCT00111800|4264804|P5|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
1312077|NCT00111800|4264805|P4|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
1312078|NCT00111800|4264806|P3|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
1312079|NCT00111800|4264807|P2|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
1312080|NCT00111800|4264808|P1|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
1312081|NCT00111800|4264803|P6|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
1312082|NCT00111800|4264804|P5|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
1312083|NCT00111800|4264805|P4|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
1312084|NCT00111800|4264806|P3|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
1312085|NCT00111800|4264807|P2|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
1312086|NCT00111800|4264808|P1|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
1312087|NCT00111800|4264803|P6|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
1312088|NCT00111800|4264804|P5|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
1312089|NCT00111800|4264805|P4|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1
1312090|NCT00111800|4264806|P3|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
1312091|NCT00111800|4264807|P2|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
1312092|NCT00111800|4264808|P1|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3
1312093|NCT00111800|4264803|P6|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1
1312094|NCT00111800|4264804|P5|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
1312095|NCT00111800|4264805|P4|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
1312096|NCT00111800|4264806|P3|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3
1312097|NCT00111800|4264807|P2|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
1312098|NCT00111800|4264808|P1|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
1312099|NCT00111800|4264803|P6|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
1312100|NCT00111800|4264804|P5|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
1312101|NCT00111800|4264805|P4|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
1312102|NCT00111800|4264806|P3|Period 1: Main Phase (12 Weeks)|Protocol Violation|4
1312103|NCT00111800|4264807|P2|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
1312104|NCT00111800|4264808|P1|Period 1: Main Phase (12 Weeks)|Protocol Violation|0
1312105|NCT00111800|4264803|P6|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
1312106|NCT00111800|4264804|P5|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
1312107|NCT00111800|4264805|P4|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
1312108|NCT00111800|4264806|P3|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
1312109|NCT00111800|4264807|P2|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
1312110|NCT00111800|4264808|P1|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1
1312111|NCT00111800|4264803|P6|Period 1: Main Phase (12 Weeks)|Adverse Event|0
1312112|NCT00111800|4264804|P5|Period 1: Main Phase (12 Weeks)|Adverse Event|1
1312113|NCT00111800|4264805|P4|Period 1: Main Phase (12 Weeks)|Adverse Event|0
1312114|NCT00111800|4264806|P3|Period 1: Main Phase (12 Weeks)|Adverse Event|0
1312115|NCT00111800|4264807|P2|Period 1: Main Phase (12 Weeks)|Adverse Event|4
1312116|NCT00111800|4264808|P1|Period 1: Main Phase (12 Weeks)|Adverse Event|5
1312117|NCT00111761|4264978|P2|Part 2|Other|0
1312118|NCT00111761|4264979|P1|Part 2|Other|1
1312119|NCT00111761|4264978|P2|Part 2|Protocol-specified criteria|0
1312120|NCT00111761|4264979|P1|Part 2|Protocol-specified criteria|1
1312121|NCT00111761|4264978|P2|Part 2|Disease progression|0
1312122|NCT00111761|4264979|P1|Part 2|Disease progression|3
1312123|NCT00111761|4264978|P2|Part 2|Death|0
1312124|NCT00111761|4264979|P1|Part 2|Death|1
1312125|NCT00111761|4264978|P2|Part 2|Physician Decision|0
1312126|NCT00111761|4264979|P1|Part 2|Physician Decision|1
1312127|NCT00111761|4264978|P2|Part 2|Adverse Event|0
1312128|NCT00111761|4264979|P1|Part 2|Adverse Event|1
1312129|NCT00111761|4264978|P2|Part 1|Withdrawal by Subject|1
1312130|NCT00111761|4264979|P1|Part 1|Withdrawal by Subject|0
1312131|NCT00111761|4264978|P2|Part 1|Other|1
1312132|NCT00111761|4264979|P1|Part 1|Other|0
1312133|NCT00111761|4264978|P2|Part 1|Death|2
1312134|NCT00111761|4264979|P1|Part 1|Death|0
1312135|NCT00111761|4264978|P2|Part 1|Physician Decision|1
1312136|NCT00111761|4264979|P1|Part 1|Physician Decision|0
1312137|NCT00111241|4265008|P2|Overall Study|Adverse Event|0
1312138|NCT00111241|4265009|P1|Overall Study|Adverse Event|1
1312139|NCT00111241|4265008|P2|Overall Study|Protocol Violation|8
1312140|NCT00111241|4265009|P1|Overall Study|Protocol Violation|9
1312141|NCT00111241|4265008|P2|Overall Study|Withdrawal by Subject|0
1312142|NCT00111241|4265009|P1|Overall Study|Withdrawal by Subject|4
1312143|NCT00111241|4265008|P2|Overall Study|Lost to Follow-up|0
1312144|NCT00111241|4265009|P1|Overall Study|Lost to Follow-up|1
1312145|NCT00111007|4265019|P2|Long Term Follow-up|Missing|3
1312146|NCT00111007|4265020|P1|Long Term Follow-up|Missing|10
1312147|NCT00111007|4265019|P2|Long Term Follow-up|Disease progression/recurrence/relapse|1
1312148|NCT00111007|4265020|P1|Long Term Follow-up|Disease progression/recurrence/relapse|2
1312149|NCT00111007|4265019|P2|Long Term Follow-up|Withdrawal by Subject|1
1312150|NCT00111007|4265020|P1|Long Term Follow-up|Withdrawal by Subject|0
1312151|NCT00111007|4265019|P2|Long Term Follow-up|Lost to Follow-up|1
1312152|NCT00111007|4265020|P1|Long Term Follow-up|Lost to Follow-up|1
1312153|NCT00111007|4265019|P2|Long Term Follow-up|Death|39
1312154|NCT00111007|4265020|P1|Long Term Follow-up|Death|34
1312155|NCT00111007|4265019|P2|Active Follow-up|Disease progression/recurrence/relapse|2
1312156|NCT00111007|4265020|P1|Active Follow-up|Disease progression/recurrence/relapse|3
1312157|NCT00111007|4265019|P2|Active Follow-up|Death|0
1312158|NCT00111007|4265020|P1|Active Follow-up|Death|2
1312159|NCT00111007|4265019|P2|Active Follow-up|Adverse Event|0
1312160|NCT00111007|4265020|P1|Active Follow-up|Adverse Event|1
1312161|NCT00111007|4265019|P2|Double-blind (DB) Treatment|Primary reason with other category|1
1312162|NCT00111007|4265020|P1|Double-blind (DB) Treatment|Primary reason with other category|0
1312163|NCT00111007|4265019|P2|Double-blind (DB) Treatment|Radiological and symptomatic progression|93
1312164|NCT00111007|4265020|P1|Double-blind (DB) Treatment|Radiological and symptomatic progression|83
1312165|NCT00111007|4265019|P2|Double-blind (DB) Treatment|Progression by clinical judgement|2
1312166|NCT00111007|4265020|P1|Double-blind (DB) Treatment|Progression by clinical judgement|0
1312167|NCT00111007|4265019|P2|Double-blind (DB) Treatment|Relapse|0
1312168|NCT00111007|4265020|P1|Double-blind (DB) Treatment|Relapse|1
1312169|NCT00111007|4265019|P2|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0
1312170|NCT00111007|4265020|P1|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1
1312171|NCT00111007|4265019|P2|Double-blind (DB) Treatment|Withdrawal by Subject|8
1312172|NCT00111007|4265020|P1|Double-blind (DB) Treatment|Withdrawal by Subject|6
1312173|NCT00111007|4265019|P2|Double-blind (DB) Treatment|Protocol Violation|1
1312174|NCT00111007|4265020|P1|Double-blind (DB) Treatment|Protocol Violation|0
1312175|NCT00111007|4265019|P2|Double-blind (DB) Treatment|Death|2
1312176|NCT00111007|4265020|P1|Double-blind (DB) Treatment|Death|5
1312177|NCT00111007|4265019|P2|Double-blind (DB) Treatment|Adverse Event|4
1312178|NCT00111007|4265020|P1|Double-blind (DB) Treatment|Adverse Event|12
1312179|NCT00110994|4265036|P2|Long Term Follow-up|Death|17
1312180|NCT00110994|4265037|P1|Long Term Follow-up|Death|19
1312181|NCT00110994|4265036|P2|Active Follow-up|Other reasons|2
1312182|NCT00110994|4265037|P1|Active Follow-up|Other reasons|0
1312183|NCT00110994|4265036|P2|Active Follow-up|Disease progression/recurrence/replace|0
1312184|NCT00110994|4265037|P1|Active Follow-up|Disease progression/recurrence/replace|1
1312185|NCT00110994|4265036|P2|Double-blind (DB) Treatment|other reasons|3
1312186|NCT00110994|4265037|P1|Double-blind (DB) Treatment|other reasons|2
1312187|NCT00110994|4265036|P2|Double-blind (DB) Treatment|Radiological and symptomatic progression|41
1312188|NCT00110994|4265037|P1|Double-blind (DB) Treatment|Radiological and symptomatic progression|34
1312189|NCT00110994|4265036|P2|Double-blind (DB) Treatment|Progression by clinical judgement|1
1312190|NCT00110994|4265037|P1|Double-blind (DB) Treatment|Progression by clinical judgement|2
1312191|NCT00110994|4265036|P2|Double-blind (DB) Treatment|Withdrawal by Subject|2
1312192|NCT00110994|4265037|P1|Double-blind (DB) Treatment|Withdrawal by Subject|0
1312193|NCT00110994|4265036|P2|Double-blind (DB) Treatment|Death|0
1312194|NCT00110994|4265037|P1|Double-blind (DB) Treatment|Death|1
1312195|NCT00110994|4265036|P2|Double-blind (DB) Treatment|Adverse Event|0
1312196|NCT00110994|4265037|P1|Double-blind (DB) Treatment|Adverse Event|3
1312197|NCT00110890|4265063|P2|Overall Study|Did not enter follow-up phase|4
1312198|NCT00110890|4265064|P1|Overall Study|Did not enter follow-up phase|10
1312199|NCT00110890|4265063|P2|Overall Study|Parathyroidectomy|1
1312200|NCT00110890|4265064|P1|Overall Study|Parathyroidectomy|0
1312201|NCT00110890|4265063|P2|Overall Study|Disease progression|1
1312202|NCT00110890|4265064|P1|Overall Study|Disease progression|0
1312203|NCT00110890|4265063|P2|Overall Study|Requirement for alternative therapy|1
1312204|NCT00110890|4265064|P1|Overall Study|Requirement for alternative therapy|0
1312205|NCT00110890|4265063|P2|Overall Study|Ineligibility determined|0
1312206|NCT00110890|4265064|P1|Overall Study|Ineligibility determined|3
1312207|NCT00110890|4265063|P2|Overall Study|Other|23
1312208|NCT00110890|4265064|P1|Overall Study|Other|34
1312209|NCT00110890|4265063|P2|Overall Study|Invest. Product Commercially Available|110
1312210|NCT00110890|4265064|P1|Overall Study|Invest. Product Commercially Available|217
1312211|NCT00110890|4265063|P2|Overall Study|Kidney Transplant|12
1312212|NCT00110890|4265064|P1|Overall Study|Kidney Transplant|16
1312213|NCT00110890|4265063|P2|Overall Study|Noncompliance|0
1312214|NCT00110890|4265064|P1|Overall Study|Noncompliance|10
1312215|NCT00110890|4265063|P2|Overall Study|Protocol Deviation|0
1312216|NCT00110890|4265064|P1|Overall Study|Protocol Deviation|1
1312217|NCT00110890|4265063|P2|Overall Study|Withdrawal by Subject|5
1312218|NCT00110890|4265064|P1|Overall Study|Withdrawal by Subject|17
1312219|NCT00110890|4265063|P2|Overall Study|Physician Decision|5
1312220|NCT00110890|4265064|P1|Overall Study|Physician Decision|4
1312221|NCT00110890|4265063|P2|Overall Study|Lost to Follow-up|1
1312222|NCT00110890|4265064|P1|Overall Study|Lost to Follow-up|3
1312223|NCT00110890|4265063|P2|Overall Study|Death|9
1312224|NCT00110890|4265064|P1|Overall Study|Death|16
1312225|NCT00110890|4265063|P2|Overall Study|Adverse Event|7
1312226|NCT00110890|4265064|P1|Overall Study|Adverse Event|30
1312227|NCT00110812|4265081|P3|Extended Follow-up|Lost to Follow-up|1
1312228|NCT00110812|4265082|P2|Extended Follow-up|Lost to Follow-up|3
1312229|NCT00110812|4265083|P1|Extended Follow-up|Lost to Follow-up|1
1312230|NCT00110812|4265081|P3|Extended Follow-up|Withdrawal by Subject|0
1312231|NCT00110812|4265082|P2|Extended Follow-up|Withdrawal by Subject|1
1312232|NCT00110812|4265083|P1|Extended Follow-up|Withdrawal by Subject|0
1312233|NCT00110812|4265081|P3|Extended Follow-up|Death|3
1312234|NCT00110812|4265082|P2|Extended Follow-up|Death|0
1312235|NCT00110812|4265083|P1|Extended Follow-up|Death|1
1312236|NCT00110812|4265081|P3|Main Study|Lost to Follow-up|10
1312237|NCT00110812|4265082|P2|Main Study|Lost to Follow-up|11
1312238|NCT00110812|4265083|P1|Main Study|Lost to Follow-up|8
1312239|NCT00110812|4265081|P3|Main Study|Withdrawal by Subject|1
1312240|NCT00110812|4265082|P2|Main Study|Withdrawal by Subject|0
1312241|NCT00110812|4265083|P1|Main Study|Withdrawal by Subject|0
1312242|NCT00110812|4265081|P3|Main Study|Death|2
1312243|NCT00110812|4265082|P2|Main Study|Death|0
1312244|NCT00110812|4265083|P1|Main Study|Death|0
1312245|NCT00110617|4265128|P2|Overall Study|Did not receive study drug|12
1312246|NCT00110617|4265129|P1|Overall Study|Did not receive study drug|0
1312247|NCT00110617|4265128|P2|Overall Study|Death|1
1312248|NCT00110617|4265129|P1|Overall Study|Death|1
1312249|NCT00110617|4265128|P2|Overall Study|Administrative problems|5
1312250|NCT00110617|4265129|P1|Overall Study|Administrative problems|6
1312251|NCT00110617|4265128|P2|Overall Study|Lost to Follow-up|1
1312252|NCT00110617|4265129|P1|Overall Study|Lost to Follow-up|9
1312253|NCT00110617|4265128|P2|Overall Study|Withdrawal by Subject|4
1312254|NCT00110617|4265129|P1|Overall Study|Withdrawal by Subject|10
1312255|NCT00110617|4265128|P2|Overall Study|Protocol Violation|0
1312256|NCT00110617|4265129|P1|Overall Study|Protocol Violation|5
1312257|NCT00110617|4265128|P2|Overall Study|Patient no longer requires study drug|0
1312258|NCT00110617|4265129|P1|Overall Study|Patient no longer requires study drug|1
1312259|NCT00110617|4265128|P2|Overall Study|Lack of Efficacy|0
1312260|NCT00110617|4265129|P1|Overall Study|Lack of Efficacy|1
1312261|NCT00110617|4265128|P2|Overall Study|Abnormal Laboratory Value|2
1312262|NCT00110617|4265129|P1|Overall Study|Abnormal Laboratory Value|4
1312263|NCT00110617|4265128|P2|Overall Study|Adverse Event|4
1312264|NCT00110617|4265129|P1|Overall Study|Adverse Event|2
1312265|NCT00110396|4265246|P1|Overall Study|Patient is to be administered copaxone|1
1312266|NCT00110396|4265246|P1|Overall Study|The patient has refused to visit site|1
1312267|NCT00110396|4265246|P1|Overall Study|The patient has refused|2
1312268|NCT00110396|4265246|P1|Overall Study|Patient refused to come back|1
1312269|NCT00110396|4265246|P1|Overall Study|Protocol Violation|2
1312270|NCT00110396|4265246|P1|Overall Study|Pregnancy (Protocol violation)|2
1312271|NCT00110396|4265246|P1|Overall Study|Pregnancy|1
1312272|NCT00110396|4265246|P1|Overall Study|Participation in MS vaccine study|1
1312273|NCT00110396|4265246|P1|Overall Study|Patient's decision|1
1312274|NCT00110396|4265246|P1|Overall Study|Patient will|1
1312275|NCT00110396|4265246|P1|Overall Study|Patient refused to participate|1
1312276|NCT00110396|4265246|P1|Overall Study|Patient refused to continue|1
1312277|NCT00110396|4265246|P1|Overall Study|Patient non-compliance|1
1312278|NCT00110396|4265246|P1|Overall Study|Decided not to continue treatment|1
1312279|NCT00110396|4265246|P1|Overall Study|Lack of Efficacy|1
1312280|NCT00110396|4265246|P1|Overall Study|Initiated mitoxantrone therapy|1
1312281|NCT00110396|4265246|P1|Overall Study|Administration of plasmapheresis|1
1312282|NCT00110396|4265246|P1|Overall Study|Lost to Follow-up|1
1312283|NCT00110396|4265246|P1|Overall Study|Adverse Event|15
1312284|NCT00110357|4265254|P2|Overall Study|Withdrawal by Subject|1
1312285|NCT00110357|4265255|P1|Overall Study|Withdrawal by Subject|3
1312286|NCT00110357|4265254|P2|Overall Study|Study Drug Toxicity|3
1312287|NCT00110357|4265255|P1|Overall Study|Study Drug Toxicity|1
1312288|NCT00110357|4265254|P2|Overall Study|Study Closure|0
1312289|NCT00110357|4265255|P1|Overall Study|Study Closure|1
1312290|NCT00110357|4265254|P2|Overall Study|Disease progression/relapse|15
1312291|NCT00110357|4265255|P1|Overall Study|Disease progression/relapse|20
1312292|NCT00110357|4265254|P2|Overall Study|Deterioration without progression|0
1312293|NCT00110357|4265255|P1|Overall Study|Deterioration without progression|2
1312294|NCT00110305|4265343|P2|Overall Study|Other|2
1312295|NCT00110305|4265344|P1|Overall Study|Other|8
1312296|NCT00110305|4265343|P2|Overall Study|Lost to Follow-up|3
1312297|NCT00110305|4265344|P1|Overall Study|Lost to Follow-up|20
1312298|NCT00110305|4265343|P2|Overall Study|Withdrawal by Subject|7
1312299|NCT00110305|4265344|P1|Overall Study|Withdrawal by Subject|7
1312300|NCT00110305|4265343|P2|Overall Study|Protocol Violation|1
1312301|NCT00110305|4265344|P1|Overall Study|Protocol Violation|0
1312302|NCT00110305|4265343|P2|Overall Study|Subject Reached A Virologic Endpoint|3
1312303|NCT00110305|4265344|P1|Overall Study|Subject Reached A Virologic Endpoint|21
1312304|NCT00110305|4265343|P2|Overall Study|Subject Ineligible To Continue The Trial|1
1312305|NCT00110305|4265344|P1|Overall Study|Subject Ineligible To Continue The Trial|2
1312306|NCT00110305|4265343|P2|Overall Study|Subject Non-Compliant|2
1312307|NCT00110305|4265344|P1|Overall Study|Subject Non-Compliant|9
1312308|NCT00110305|4265343|P2|Overall Study|Sponsors Decision|0
1312309|NCT00110305|4265344|P1|Overall Study|Sponsors Decision|1
1312310|NCT00110305|4265343|P2|Overall Study|Adverse Event|13
1312311|NCT00110305|4265344|P1|Overall Study|Adverse Event|46
1312312|NCT00110214|4265397|P2|Overall Study|Other (not specified)|75
1312313|NCT00110214|4265398|P1|Overall Study|Other (not specified)|61
1312314|NCT00110214|4265397|P2|Overall Study|Refused further treatment|65
1312315|NCT00110214|4265398|P1|Overall Study|Refused further treatment|52
1312316|NCT00110214|4265397|P2|Overall Study|Adverse Event|192
1312317|NCT00110214|4265398|P1|Overall Study|Adverse Event|115
1312318|NCT00110214|4265397|P2|Overall Study|Disease progression or death|151
1312319|NCT00110214|4265398|P1|Overall Study|Disease progression or death|260
1312320|NCT00110214|4265397|P2|Overall Study|Never started treatment|20
1312321|NCT00110214|4265398|P1|Overall Study|Never started treatment|21
1312322|NCT00110149|4265410|P1|Overall Study|Physician Decision|3
1312323|NCT00110084|4265424|P1|Overall Study|Other|2
1312324|NCT00110084|4265424|P1|Overall Study|Intercurrent Illness|1
1312325|NCT00110084|4265424|P1|Overall Study|Alternate Therapy|5
1312326|NCT00110084|4265424|P1|Overall Study|Patient Refusal|10
1312327|NCT00110084|4265424|P1|Overall Study|Death|1
1312328|NCT00110084|4265424|P1|Overall Study|Adverse Event|9
1312329|NCT00110019|4265433|P2|Overall Study|other reasons|30
1312330|NCT00110019|4265434|P1|Overall Study|other reasons|22
1312331|NCT00110019|4265433|P2|Overall Study|Not start protocol therapy|16
1312332|NCT00110019|4265434|P1|Overall Study|Not start protocol therapy|17
1312333|NCT00110019|4265433|P2|Overall Study|symptom deterioration|16
1312334|NCT00110019|4265434|P1|Overall Study|symptom deterioration|13
1312335|NCT00110019|4265433|P2|Overall Study|complicating disease|1
1312336|NCT00110019|4265434|P1|Overall Study|complicating disease|1
1312337|NCT00110019|4265433|P2|Overall Study|alternative therapy|1
1312338|NCT00110019|4265434|P1|Overall Study|alternative therapy|5
1312339|NCT00110019|4265433|P2|Overall Study|Withdrawal by Subject|9
1312340|NCT00110019|4265434|P1|Overall Study|Withdrawal by Subject|21
1312341|NCT00110019|4265433|P2|Overall Study|Death|15
1312342|NCT00110019|4265434|P1|Overall Study|Death|13
1312343|NCT00110019|4265433|P2|Overall Study|Adverse Event|40
1312344|NCT00110019|4265434|P1|Overall Study|Adverse Event|61
1312345|NCT00110019|4265433|P2|Overall Study|Lack of Efficacy|285
1312346|NCT00110019|4265434|P1|Overall Study|Lack of Efficacy|253
1312347|NCT00109967|4265446|P2|Overall Study|Death|2
1312348|NCT00109967|4265447|P1|Overall Study|Death|0
1312349|NCT00109967|4265446|P2|Overall Study|Physician Decision|3
1312350|NCT00109967|4265447|P1|Overall Study|Physician Decision|1
1312351|NCT00109967|4265446|P2|Overall Study|Withdrawal by Subject|0
1312352|NCT00109967|4265447|P1|Overall Study|Withdrawal by Subject|5
1312353|NCT00109967|4265446|P2|Overall Study|Adverse Event|1
1312354|NCT00109967|4265447|P1|Overall Study|Adverse Event|12
1312355|NCT00109967|4265446|P2|Overall Study|Cancel Prior to Treatment|0
1312356|NCT00109967|4265447|P1|Overall Study|Cancel Prior to Treatment|2
1312357|NCT00109928|4265461|P1|Overall Study|not eligible|1
1312358|NCT00109928|4265461|P1|Overall Study|not protocol specified|2
1312359|NCT00109928|4265461|P1|Overall Study|Death|2
1312360|NCT00109928|4265461|P1|Overall Study|Progression|6
1312361|NCT00109928|4265461|P1|Overall Study|Adverse Event|2
1312362|NCT00109850|4265478|P1|Overall Study|Ineligible|1
1312363|NCT00109850|4265478|P1|Overall Study|Death|2
1312364|NCT00109850|4265478|P1|Overall Study|Adverse Event|1
1312365|NCT00109837|4265485|P1|Overall Study|Ineligible|1
1312366|NCT00109837|4265485|P1|Overall Study|Not treated|1
1312367|NCT00109837|4265485|P1|Overall Study|BCR/ABL+ or Ph+|17
1312368|NCT00109837|4265485|P1|Overall Study|Death|1
1312369|NCT00109837|4265485|P1|Overall Study|Refusal unrelated to adverse effects|1
1312370|NCT00109837|4265485|P1|Overall Study|Adverse Event|2
1312371|NCT00109772|4265495|P2|Open-label Extension|not specified|10
1312372|NCT00109772|4265496|P1|Open-label Extension|not specified|4
1312373|NCT00109772|4265495|P2|Open-label Extension|Protocol Violation|2
1312374|NCT00109772|4265496|P1|Open-label Extension|Protocol Violation|2
1312375|NCT00109772|4265495|P2|Open-label Extension|Death|1
1312376|NCT00109772|4265496|P1|Open-label Extension|Death|0
1312377|NCT00109772|4265495|P2|Open-label Extension|Lost to Follow-up|0
1312378|NCT00109772|4265496|P1|Open-label Extension|Lost to Follow-up|1
1312379|NCT00109772|4265495|P2|Open-label Extension|Withdrawal by Subject|6
1312380|NCT00109772|4265496|P1|Open-label Extension|Withdrawal by Subject|9
1312381|NCT00109772|4265495|P2|Open-label Extension|Lack of Efficacy|11
1312382|NCT00109772|4265496|P1|Open-label Extension|Lack of Efficacy|19
1312383|NCT00109772|4265495|P2|Open-label Extension|Adverse Event|19
1312384|NCT00109772|4265496|P1|Open-label Extension|Adverse Event|10
1312385|NCT00109772|4265495|P2|Double-blind Treatment|Withdrew prior to treatment|1
1312386|NCT00109772|4265496|P1|Double-blind Treatment|Withdrew prior to treatment|3
1312387|NCT00109772|4265495|P2|Double-blind Treatment|not specified|4
1312388|NCT00109772|4265496|P1|Double-blind Treatment|not specified|0
1312389|NCT00109772|4265495|P2|Double-blind Treatment|Protocol Violation|1
1312390|NCT00109772|4265496|P1|Double-blind Treatment|Protocol Violation|0
1312391|NCT00109772|4265495|P2|Double-blind Treatment|Lost to Follow-up|3
1312392|NCT00109772|4265496|P1|Double-blind Treatment|Lost to Follow-up|2
1312393|NCT00109772|4265495|P2|Double-blind Treatment|Withdrawal by Subject|1
1312394|NCT00109772|4265496|P1|Double-blind Treatment|Withdrawal by Subject|2
1312395|NCT00109772|4265495|P2|Double-blind Treatment|Lack of Efficacy|0
1312396|NCT00109772|4265496|P1|Double-blind Treatment|Lack of Efficacy|1
1312397|NCT00109772|4265495|P2|Double-blind Treatment|Adverse Event|5
1312398|NCT00109772|4265496|P1|Double-blind Treatment|Adverse Event|14
1312399|NCT00109733|4265536|P2|Overall Study|Could not commit time for study|1
1312400|NCT00109733|4265537|P1|Overall Study|Could not commit time for study|1
1312401|NCT00109733|4265536|P2|Overall Study|Non-compliant|1
1312402|NCT00109733|4265537|P1|Overall Study|Non-compliant|0
1312403|NCT00109733|4265536|P2|Overall Study|Stopped taking study drug|1
1312404|NCT00109733|4265537|P1|Overall Study|Stopped taking study drug|1
1312405|NCT00109733|4265536|P2|Overall Study|Protocol Violation|1
1312406|NCT00109733|4265537|P1|Overall Study|Protocol Violation|0
1312407|NCT00109590|4265554|P3|Overall Study|Never Started Treatment|3
1312408|NCT00109590|4265555|P2|Overall Study|Never Started Treatment|2
1312409|NCT00109590|4265556|P1|Overall Study|Never Started Treatment|1
1312410|NCT00109590|4265554|P3|Overall Study|Lost to Follow-up|1
1312411|NCT00109590|4265555|P2|Overall Study|Lost to Follow-up|0
1312412|NCT00109590|4265556|P1|Overall Study|Lost to Follow-up|1
1312413|NCT00109577|4265598|P2|Overall Study|Withdrawal by Subject|3
1312414|NCT00109577|4265599|P1|Overall Study|Withdrawal by Subject|3
1312415|NCT00109343|4265630|P3|Overall Study|Other|1
1312416|NCT00109343|4265631|P2|Overall Study|Other|2
1312417|NCT00109343|4265632|P1|Overall Study|Other|5
1312418|NCT00109343|4265630|P3|Overall Study|Subject Moved|1
1312419|NCT00109343|4265631|P2|Overall Study|Subject Moved|2
1312420|NCT00109343|4265632|P1|Overall Study|Subject Moved|6
1312421|NCT00109343|4265630|P3|Overall Study|Withdrawal by Subject|10
1312422|NCT00109343|4265631|P2|Overall Study|Withdrawal by Subject|11
1312423|NCT00109343|4265632|P1|Overall Study|Withdrawal by Subject|15
1312424|NCT00109343|4265630|P3|Overall Study|Protocol Violation|2
1312425|NCT00109343|4265631|P2|Overall Study|Protocol Violation|2
1312426|NCT00109343|4265632|P1|Overall Study|Protocol Violation|1
1312427|NCT00109343|4265630|P3|Overall Study|Lost to Follow-up|14
1312428|NCT00109343|4265631|P2|Overall Study|Lost to Follow-up|20
1312429|NCT00109343|4265632|P1|Overall Study|Lost to Follow-up|35
1312430|NCT00109343|4265630|P3|Overall Study|Lack of Efficacy|0
1312431|NCT00109343|4265631|P2|Overall Study|Lack of Efficacy|0
1312432|NCT00109343|4265632|P1|Overall Study|Lack of Efficacy|1
1312433|NCT00109343|4265630|P3|Overall Study|Adverse Event|2
1312434|NCT00109343|4265631|P2|Overall Study|Adverse Event|0
1312435|NCT00109343|4265632|P1|Overall Study|Adverse Event|1
1312436|NCT00109031|4265677|P4|Overall Study|Protocol Violation|0
1312437|NCT00109031|4265678|P3|Overall Study|Protocol Violation|1
1312438|NCT00109031|4265679|P2|Overall Study|Protocol Violation|0
1312439|NCT00109031|4265680|P1|Overall Study|Protocol Violation|0
1312440|NCT00109031|4265677|P4|Overall Study|Physician Decision|0
1312441|NCT00109031|4265678|P3|Overall Study|Physician Decision|0
1312442|NCT00109031|4265679|P2|Overall Study|Physician Decision|1
1312443|NCT00109031|4265680|P1|Overall Study|Physician Decision|0
1312444|NCT00109031|4265677|P4|Overall Study|Withdrawal by Subject|0
1312445|NCT00109031|4265678|P3|Overall Study|Withdrawal by Subject|0
1312446|NCT00109031|4265679|P2|Overall Study|Withdrawal by Subject|1
1312447|NCT00109031|4265680|P1|Overall Study|Withdrawal by Subject|0
1312448|NCT00109031|4265677|P4|Overall Study|Adverse Event|0
1312449|NCT00109031|4265678|P3|Overall Study|Adverse Event|1
1312450|NCT00109031|4265679|P2|Overall Study|Adverse Event|0
1312451|NCT00109031|4265680|P1|Overall Study|Adverse Event|0
1312452|NCT00108953|4265731|P2|Follow-up|Study terminated by sponsor|6
1312453|NCT00108953|4265732|P1|Follow-up|Study terminated by sponsor|10
1312454|NCT00108953|4265731|P2|Follow-up|Lost to Follow-up|1
1312455|NCT00108953|4265732|P1|Follow-up|Lost to Follow-up|1
1312456|NCT00108953|4265731|P2|Follow-up|Death|26
1312457|NCT00108953|4265732|P1|Follow-up|Death|18
1312458|NCT00108862|4265754|P2|Overall Study|Lost to Follow-up|19
1312459|NCT00108862|4265755|P1|Overall Study|Lost to Follow-up|27
1312460|NCT00108862|4265754|P2|Overall Study|Withdrawal by Subject|6
1312461|NCT00108862|4265755|P1|Overall Study|Withdrawal by Subject|10
1312462|NCT00108862|4265754|P2|Overall Study|Death|37
1312463|NCT00108862|4265755|P1|Overall Study|Death|31
1312464|NCT00108732|4265783|P1|Step 2 (Androgen Ablation and Vaccine)|Other|1
1312465|NCT00108732|4265783|P1|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1
1312466|NCT00108732|4265783|P1|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3
1312467|NCT00108732|4265783|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1
1312468|NCT00108732|4265783|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10
1312469|NCT00108732|4265783|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2
1312470|NCT00108732|4265783|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1
1312471|NCT00108628|4265792|P2|Overall Study|Death|0
1312472|NCT00108628|4265793|P1|Overall Study|Death|1
1312473|NCT00108628|4265792|P2|Overall Study|Lack of Efficacy|1
1312474|NCT00108628|4265793|P1|Overall Study|Lack of Efficacy|2
1312475|NCT00108628|4265792|P2|Overall Study|Withdrawal by Subject|9
1312476|NCT00108628|4265793|P1|Overall Study|Withdrawal by Subject|17
1312477|NCT00108485|4265843|P2|Overall Study|Lost to Follow-up|2
1312478|NCT00108485|4265844|P1|Overall Study|Lost to Follow-up|0
1312479|NCT00108485|4265843|P2|Overall Study|Withdrawal by Subject|0
1312480|NCT00108485|4265844|P1|Overall Study|Withdrawal by Subject|3
1312481|NCT00108433|4265852|P2|Overall Study|Other|14
1312482|NCT00108433|4265853|P1|Overall Study|Other|14
1312483|NCT00108433|4265852|P2|Overall Study|Adverse Event|1
1312484|NCT00108433|4265853|P1|Overall Study|Adverse Event|3
1312485|NCT00108433|4265852|P2|Overall Study|Death|0
1312486|NCT00108433|4265853|P1|Overall Study|Death|3
1312487|NCT00108433|4265852|P2|Overall Study|Lack of Efficacy|2
1312488|NCT00108433|4265853|P1|Overall Study|Lack of Efficacy|1
1312489|NCT00108355|4265869|P2|Overall Study|Loculated ascites, limiting paracentesis|1
1312490|NCT00108355|4265870|P1|Overall Study|Loculated ascites, limiting paracentesis|1
1312491|NCT00108355|4265869|P2|Overall Study|Peritonitis at index paracentesis|1
1312492|NCT00108355|4265870|P1|Overall Study|Peritonitis at index paracentesis|1
1312493|NCT00108160|4265919|P2|Overall Study|Protocol Violation|5
1312494|NCT00108160|4265920|P1|Overall Study|Protocol Violation|9
1312495|NCT00108160|4265919|P2|Overall Study|Withdrawal by Subject|2
1312496|NCT00108160|4265920|P1|Overall Study|Withdrawal by Subject|4
1312497|NCT00108160|4265919|P2|Overall Study|Death|2
1312498|NCT00108160|4265920|P1|Overall Study|Death|1
1312499|NCT00108160|4265919|P2|Overall Study|Lost to Follow-up|12
1312500|NCT00108160|4265920|P1|Overall Study|Lost to Follow-up|25
1312501|NCT00108082|4265933|P3|Overall Study|Blood Pressure Not Controlled|0
1312502|NCT00108082|4265934|P2|Overall Study|Blood Pressure Not Controlled|0
1312503|NCT00108082|4265935|P1|Overall Study|Blood Pressure Not Controlled|1
1312504|NCT00108082|4265933|P3|Overall Study|Investigator Not at Site|0
1312505|NCT00108082|4265934|P2|Overall Study|Investigator Not at Site|0
1312506|NCT00108082|4265935|P1|Overall Study|Investigator Not at Site|1
1312507|NCT00108082|4265933|P3|Overall Study|Subject Left Site Location|0
1312508|NCT00108082|4265934|P2|Overall Study|Subject Left Site Location|0
1312509|NCT00108082|4265935|P1|Overall Study|Subject Left Site Location|1
1312510|NCT00108082|4265933|P3|Overall Study|Study Medication Not Tapered|0
1312511|NCT00108082|4265934|P2|Overall Study|Study Medication Not Tapered|1
1312512|NCT00108082|4265935|P1|Overall Study|Study Medication Not Tapered|0
1312513|NCT00108082|4265933|P3|Overall Study|Protocol Amendment|0
1312514|NCT00108082|4265934|P2|Overall Study|Protocol Amendment|1
1312515|NCT00108082|4265935|P1|Overall Study|Protocol Amendment|0
1312516|NCT00108082|4265933|P3|Overall Study|Site Closed Study|0
1312517|NCT00108082|4265934|P2|Overall Study|Site Closed Study|2
1312518|NCT00108082|4265935|P1|Overall Study|Site Closed Study|0
1312519|NCT00108082|4265933|P3|Overall Study|Stopped Study Medication|1
1312520|NCT00108082|4265934|P2|Overall Study|Stopped Study Medication|0
1312521|NCT00108082|4265935|P1|Overall Study|Stopped Study Medication|0
1312522|NCT00108082|4265933|P3|Overall Study|Non-compliance|2
1312523|NCT00108082|4265934|P2|Overall Study|Non-compliance|0
1312524|NCT00108082|4265935|P1|Overall Study|Non-compliance|1
1312525|NCT00108082|4265933|P3|Overall Study|Incorrectly Randomized|2
1312526|NCT00108082|4265934|P2|Overall Study|Incorrectly Randomized|0
1312527|NCT00108082|4265935|P1|Overall Study|Incorrectly Randomized|0
1312528|NCT00108082|4265933|P3|Overall Study|Woman of Child-bearing Potential|2
1312529|NCT00108082|4265934|P2|Overall Study|Woman of Child-bearing Potential|0
1312530|NCT00108082|4265935|P1|Overall Study|Woman of Child-bearing Potential|2
1312531|NCT00108082|4265933|P3|Overall Study|Amendment 4: > Month 12|5
1312532|NCT00108082|4265934|P2|Overall Study|Amendment 4: > Month 12|7
1312533|NCT00108082|4265935|P1|Overall Study|Amendment 4: > Month 12|5
1312534|NCT00108082|4265933|P3|Overall Study|Lack of Efficacy|2
1312535|NCT00108082|4265934|P2|Overall Study|Lack of Efficacy|1
1312536|NCT00108082|4265935|P1|Overall Study|Lack of Efficacy|3
1312537|NCT00108082|4265933|P3|Overall Study|Protocol Violation|0
1312538|NCT00108082|4265934|P2|Overall Study|Protocol Violation|2
1312539|NCT00108082|4265935|P1|Overall Study|Protocol Violation|1
1312540|NCT00108082|4265933|P3|Overall Study|Consent Withdrawn|5
1312541|NCT00108082|4265934|P2|Overall Study|Consent Withdrawn|3
1312542|NCT00108082|4265935|P1|Overall Study|Consent Withdrawn|3
1312543|NCT00108082|4265933|P3|Overall Study|Lost to Follow-up|7
1312544|NCT00108082|4265934|P2|Overall Study|Lost to Follow-up|3
1312545|NCT00108082|4265935|P1|Overall Study|Lost to Follow-up|6
1312546|NCT00108082|4265933|P3|Overall Study|Adverse Event|17
1312547|NCT00108082|4265934|P2|Overall Study|Adverse Event|12
1312548|NCT00108082|4265935|P1|Overall Study|Adverse Event|14
1312549|NCT00108069|4265984|P2|Overall Study|Progessive disease|11
1312550|NCT00108069|4265985|P1|Overall Study|Progessive disease|27
1312551|NCT00108069|4265984|P2|Overall Study|Death|0
1312552|NCT00108069|4265985|P1|Overall Study|Death|1
1312553|NCT00108069|4265984|P2|Overall Study|Withdrawal by Subject|0
1312554|NCT00108069|4265985|P1|Overall Study|Withdrawal by Subject|1
1312555|NCT00108069|4265984|P2|Overall Study|Adverse Event|1
1312556|NCT00108069|4265985|P1|Overall Study|Adverse Event|1
1312557|NCT00108069|4265984|P2|Overall Study|Never rec'd study drug|1
1312558|NCT00108069|4265985|P1|Overall Study|Never rec'd study drug|0
1312559|NCT00107991|4265999|P1|18-Week Post Treatment Assessment|Adverse Event|2
1312560|NCT00107991|4265999|P1|12 Week Treatment Period|Incarcerated|1
1312561|NCT00107991|4265999|P1|12 Week Treatment Period|Protocol Violation|1
1312562|NCT00107991|4265999|P1|12 Week Treatment Period|Adverse Event|1
1312563|NCT00107991|4265999|P1|12 Week Treatment Period|Lack of Efficacy|2
1312564|NCT00107991|4265999|P1|Eligibility Assessment|hx of alcohol abuse in past 12 months|1
1312565|NCT00107991|4265999|P1|Eligibility Assessment|chronic uncontrolled asthma|1
1312566|NCT00107991|4265999|P1|Eligibility Assessment|Ongoing treatment with antibiotics|1
1312567|NCT00107991|4265999|P1|Eligibility Assessment|Abnormal labs|2
1312568|NCT00107991|4265999|P1|Eligibility Assessment|Positive purified protein derivative|4
1312569|NCT00107991|4265999|P1|Eligibility Assessment|Unwilling to participate|7
1312570|NCT00107991|4265999|P1|Eligibility Assessment|Disease not severe enough|7
1312571|NCT00107978|4266009|P2|Overall Study|Other|4
1312572|NCT00107978|4266010|P1|Overall Study|Other|5
1312573|NCT00107978|4266009|P2|Overall Study|Protocol Violation|1
1312574|NCT00107978|4266010|P1|Overall Study|Protocol Violation|0
1312575|NCT00107978|4266009|P2|Overall Study|Withdrawal by Subject|9
1312576|NCT00107978|4266010|P1|Overall Study|Withdrawal by Subject|4
1312577|NCT00107978|4266009|P2|Overall Study|Lost to Follow-up|28
1312578|NCT00107978|4266010|P1|Overall Study|Lost to Follow-up|20
1312579|NCT00107978|4266009|P2|Overall Study|Death|3
1312580|NCT00107978|4266010|P1|Overall Study|Death|3
1312581|NCT00107978|4266009|P2|Overall Study|Adverse Event|5
1312582|NCT00107978|4266010|P1|Overall Study|Adverse Event|1
1312583|NCT00107952|4266018|P2|Overall Study|Never received study treatment|6
1312584|NCT00107952|4266019|P1|Overall Study|Never received study treatment|9
1312585|NCT00107952|4266018|P2|Overall Study|Other|5
1312586|NCT00107952|4266019|P1|Overall Study|Other|2
1312587|NCT00107952|4266018|P2|Overall Study|Withdrawal by Subject|6
1312588|NCT00107952|4266019|P1|Overall Study|Withdrawal by Subject|9
1312589|NCT00107952|4266018|P2|Overall Study|Lost to Follow-up|3
1312590|NCT00107952|4266019|P1|Overall Study|Lost to Follow-up|0
1312591|NCT00107952|4266018|P2|Overall Study|Death|61
1312592|NCT00107952|4266019|P1|Overall Study|Death|75
1312593|NCT00107900|4266031|P6|Overall Study|Administrative Reasons|0
1312594|NCT00107900|4266032|P5|Overall Study|Administrative Reasons|2
1312595|NCT00107900|4266033|P4|Overall Study|Administrative Reasons|2
1312596|NCT00107900|4266034|P3|Overall Study|Administrative Reasons|2
1312597|NCT00107900|4266035|P2|Overall Study|Administrative Reasons|0
1312598|NCT00107900|4266036|P1|Overall Study|Administrative Reasons|1
1312599|NCT00107900|4266031|P6|Overall Study|Withdrawal by Subject|1
1312600|NCT00107900|4266032|P5|Overall Study|Withdrawal by Subject|1
1312601|NCT00107900|4266033|P4|Overall Study|Withdrawal by Subject|0
1312602|NCT00107900|4266034|P3|Overall Study|Withdrawal by Subject|5
1312603|NCT00107900|4266035|P2|Overall Study|Withdrawal by Subject|0
1312604|NCT00107900|4266036|P1|Overall Study|Withdrawal by Subject|1
1312605|NCT00107900|4266031|P6|Overall Study|Protocol Violation|0
1312606|NCT00107900|4266032|P5|Overall Study|Protocol Violation|7
1312607|NCT00107900|4266033|P4|Overall Study|Protocol Violation|5
1312608|NCT00107900|4266034|P3|Overall Study|Protocol Violation|5
1312609|NCT00107900|4266035|P2|Overall Study|Protocol Violation|0
1312610|NCT00107900|4266036|P1|Overall Study|Protocol Violation|1
1312611|NCT00107900|4266031|P6|Overall Study|Lost to Follow-up|5
1312612|NCT00107900|4266032|P5|Overall Study|Lost to Follow-up|5
1312613|NCT00107900|4266033|P4|Overall Study|Lost to Follow-up|2
1312614|NCT00107900|4266034|P3|Overall Study|Lost to Follow-up|3
1312615|NCT00107900|4266035|P2|Overall Study|Lost to Follow-up|1
1312616|NCT00107900|4266036|P1|Overall Study|Lost to Follow-up|4
1312617|NCT00107900|4266031|P6|Overall Study|Death|0
1312618|NCT00107900|4266032|P5|Overall Study|Death|1
1312619|NCT00107900|4266033|P4|Overall Study|Death|0
1312620|NCT00107900|4266034|P3|Overall Study|Death|0
1312621|NCT00107900|4266035|P2|Overall Study|Death|0
1312622|NCT00107900|4266036|P1|Overall Study|Death|0
1312623|NCT00107900|4266031|P6|Overall Study|Adverse Event|3
1312624|NCT00107900|4266032|P5|Overall Study|Adverse Event|5
1312625|NCT00107900|4266033|P4|Overall Study|Adverse Event|3
1312626|NCT00107900|4266034|P3|Overall Study|Adverse Event|10
1312627|NCT00107900|4266035|P2|Overall Study|Adverse Event|2
1312628|NCT00107900|4266036|P1|Overall Study|Adverse Event|3
1312629|NCT00107783|4266070|P2|Overall Study|Second hip replacement|1
1312630|NCT00107783|4266071|P1|Overall Study|Second hip replacement|1
1312631|NCT00107783|4266070|P2|Overall Study|Withdrawal by Subject|0
1312632|NCT00107783|4266071|P1|Overall Study|Withdrawal by Subject|2
1312633|NCT00107783|4266070|P2|Overall Study|Death|1
1312634|NCT00107783|4266071|P1|Overall Study|Death|0
1312635|NCT00107783|4266070|P2|Overall Study|Adverse Event|2
1312636|NCT00107783|4266071|P1|Overall Study|Adverse Event|0
1312637|NCT00107653|4266106|P2|Overall Study|Administrative Reasons|3
1312638|NCT00107653|4266107|P1|Overall Study|Administrative Reasons|3
1312639|NCT00107653|4266106|P2|Overall Study|Lost to Follow-up|5
1312640|NCT00107653|4266107|P1|Overall Study|Lost to Follow-up|13
1312641|NCT00107653|4266106|P2|Overall Study|Withdrawal by Subject|13
1312642|NCT00107653|4266107|P1|Overall Study|Withdrawal by Subject|12
1312643|NCT00107653|4266106|P2|Overall Study|Protocol Violation|0
1312644|NCT00107653|4266107|P1|Overall Study|Protocol Violation|1
1312645|NCT00107653|4266106|P2|Overall Study|Violation of Selection Criteria at Entry|1
1312646|NCT00107653|4266107|P1|Overall Study|Violation of Selection Criteria at Entry|1
1312647|NCT00107653|4266106|P2|Overall Study|Insufficient Therapeutic Response|11
1312648|NCT00107653|4266107|P1|Overall Study|Insufficient Therapeutic Response|25
1312649|NCT00107653|4266106|P2|Overall Study|Adverse Event|43
1312650|NCT00107653|4266107|P1|Overall Study|Adverse Event|24
1312651|NCT00107614|4266153|P1|Overall Study|Death|2
1312652|NCT00107614|4266153|P1|Overall Study|Physician Decision|10
1312653|NCT00107380|4266184|P1|Overall Study|Ineligible|2
1312654|NCT00107380|4266184|P1|Overall Study|Other - not protocol specified|7
1312655|NCT00107380|4266184|P1|Overall Study|Death|3
1312656|NCT00107380|4266184|P1|Overall Study|Progression/relapse|4
1312657|NCT00107380|4266184|P1|Overall Study|Refusal Unrelated to Adverse Event|7
1312658|NCT00107380|4266184|P1|Overall Study|Adverse Event|7
1312659|NCT00107315|4266190|P1|Overall Study|Withdrawal by Subject|2
1312660|NCT00107315|4266190|P1|Overall Study|Adverse Event|4
1312661|NCT00107315|4266190|P1|Overall Study|Disease Progression|9
1312662|NCT00107276|4266197|P1|Overall Study|Ineligible|16
1312663|NCT00107276|4266197|P1|Overall Study|Death|1
1312664|NCT00107276|4266197|P1|Overall Study|Patient refusal|1
1312665|NCT00107276|4266197|P1|Overall Study|M.D. decision|2
1312666|NCT00107276|4266197|P1|Overall Study|Adverse Event|6
1312667|NCT00107276|4266197|P1|Overall Study|Progression|46
1312668|NCT00107198|4266203|P1|Overall Study|Ineligible|5
1312669|NCT00107198|4266203|P1|Overall Study|Withdrawal by Subject|6
1312670|NCT00107198|4266203|P1|Overall Study|Protocol Violation|1
1312671|NCT00107198|4266203|P1|Overall Study|Lost to Follow-up|12
1312672|NCT00107198|4266203|P1|Overall Study|Lack of Efficacy|28
1312673|NCT00107172|4266213|P2|Overall Study|Other Reason|3
1312674|NCT00107172|4266214|P1|Overall Study|Other Reason|4
1312675|NCT00107172|4266213|P2|Overall Study|Death|2
1312676|NCT00107172|4266214|P1|Overall Study|Death|0
1312677|NCT00107172|4266213|P2|Overall Study|Withdrawal by Subject|0
1312678|NCT00107172|4266214|P1|Overall Study|Withdrawal by Subject|1
1312679|NCT00107120|4266244|P2|Overall Study|death of parent|1
1312680|NCT00107120|4266245|P1|Overall Study|death of parent|0
1312681|NCT00107120|4266244|P2|Overall Study|moving away from site|1
1312682|NCT00107120|4266245|P1|Overall Study|moving away from site|1
1312683|NCT00107120|4266244|P2|Overall Study|Pregnancy|1
1312684|NCT00107120|4266245|P1|Overall Study|Pregnancy|0
1312685|NCT00107120|4266244|P2|Overall Study|Lost to Follow-up|6
1312686|NCT00107120|4266245|P1|Overall Study|Lost to Follow-up|8
1312687|NCT00107120|4266244|P2|Overall Study|Withdrawal by Subject|9
1312688|NCT00107120|4266245|P1|Overall Study|Withdrawal by Subject|8
1312689|NCT00107120|4266244|P2|Overall Study|Protocol Violation|0
1312690|NCT00107120|4266245|P1|Overall Study|Protocol Violation|3
1312691|NCT00107120|4266244|P2|Overall Study|Lack of Efficacy|5
1312692|NCT00107120|4266245|P1|Overall Study|Lack of Efficacy|5
1312693|NCT00107120|4266244|P2|Overall Study|Adverse Event|1
1312694|NCT00107120|4266245|P1|Overall Study|Adverse Event|4
1312695|NCT00107042|4266257|P2|Overall Study|Disallowed medications|2
1312696|NCT00107042|4266258|P1|Overall Study|Disallowed medications|0
1312697|NCT00107042|4266257|P2|Overall Study|vaccinated outside window|1
1312698|NCT00107042|4266258|P1|Overall Study|vaccinated outside window|1
1312699|NCT00107042|4266257|P2|Overall Study|Inadvertent enrollment|1
1312700|NCT00107042|4266258|P1|Overall Study|Inadvertent enrollment|0
1312701|NCT00107042|4266257|P2|Overall Study|Pregnancy|1
1312702|NCT00107042|4266258|P1|Overall Study|Pregnancy|1
1312703|NCT00107042|4266257|P2|Overall Study|Moved out of area|3
1312704|NCT00107042|4266258|P1|Overall Study|Moved out of area|5
1312705|NCT00107042|4266257|P2|Overall Study|Withdrawal by Subject|1
1312706|NCT00107042|4266258|P1|Overall Study|Withdrawal by Subject|6
1312707|NCT00107042|4266257|P2|Overall Study|Lost to Follow-up|7
1312708|NCT00107042|4266258|P1|Overall Study|Lost to Follow-up|9
1312709|NCT00106964|4266324|P3|Overall Study|Required disallowed medication|0
1312710|NCT00106964|4266325|P2|Overall Study|Required disallowed medication|1
1312711|NCT00106964|4266326|P1|Overall Study|Required disallowed medication|0
1312712|NCT00106964|4266324|P3|Overall Study|Did not meet eligibility criteria|2
1312713|NCT00106964|4266325|P2|Overall Study|Did not meet eligibility criteria|2
1312714|NCT00106964|4266326|P1|Overall Study|Did not meet eligibility criteria|0
1312715|NCT00106964|4266324|P3|Overall Study|Failure to adhere|0
1312716|NCT00106964|4266325|P2|Overall Study|Failure to adhere|0
1312717|NCT00106964|4266326|P1|Overall Study|Failure to adhere|2
1312718|NCT00106964|4266324|P3|Overall Study|Site Funding Terminated|1
1312719|NCT00106964|4266325|P2|Overall Study|Site Funding Terminated|1
1312720|NCT00106964|4266326|P1|Overall Study|Site Funding Terminated|0
1312721|NCT00106964|4266324|P3|Overall Study|Incarceration|0
1312722|NCT00106964|4266325|P2|Overall Study|Incarceration|1
1312723|NCT00106964|4266326|P1|Overall Study|Incarceration|0
1312724|NCT00106964|4266324|P3|Overall Study|Death|0
1312725|NCT00106964|4266325|P2|Overall Study|Death|1
1312726|NCT00106964|4266326|P1|Overall Study|Death|1
1312727|NCT00106964|4266324|P3|Overall Study|Pregnancy|2
1312728|NCT00106964|4266325|P2|Overall Study|Pregnancy|3
1312729|NCT00106964|4266326|P1|Overall Study|Pregnancy|2
1312730|NCT00106964|4266324|P3|Overall Study|Lost to Follow-up|2
1312731|NCT00106964|4266325|P2|Overall Study|Lost to Follow-up|6
1312732|NCT00106964|4266326|P1|Overall Study|Lost to Follow-up|8
1312733|NCT00106704|4266421|P2|Overall Study|Laboratory test|1
1312734|NCT00106704|4266422|P1|Overall Study|Laboratory test|1
1312735|NCT00106704|4266421|P2|Overall Study|Unable to re-enter US|0
1312736|NCT00106704|4266422|P1|Overall Study|Unable to re-enter US|1
1312737|NCT00106704|4266421|P2|Overall Study|Patient Received Glycemic Medication|41
1312738|NCT00106704|4266422|P1|Overall Study|Patient Received Glycemic Medication|22
1312739|NCT00106704|4266421|P2|Overall Study|Planned major surgery|0
1312740|NCT00106704|4266422|P1|Overall Study|Planned major surgery|1
1312741|NCT00106704|4266421|P2|Overall Study|Site terminated|1
1312742|NCT00106704|4266422|P1|Overall Study|Site terminated|0
1312743|NCT00106704|4266421|P2|Overall Study|Patient moved|0
1312744|NCT00106704|4266422|P1|Overall Study|Patient moved|1
1312745|NCT00106704|4266421|P2|Overall Study|Withdrawal by Subject|21
1312746|NCT00106704|4266422|P1|Overall Study|Withdrawal by Subject|14
1312747|NCT00106704|4266421|P2|Overall Study|Protocol Violation|7
1312748|NCT00106704|4266422|P1|Overall Study|Protocol Violation|4
1312749|NCT00106704|4266421|P2|Overall Study|Pregnancy|0
1312750|NCT00106704|4266422|P1|Overall Study|Pregnancy|1
1312751|NCT00106704|4266421|P2|Overall Study|Lost to Follow-up|3
1312752|NCT00106704|4266422|P1|Overall Study|Lost to Follow-up|7
1312753|NCT00106704|4266421|P2|Overall Study|Lack of Efficacy|69
1312754|NCT00106704|4266422|P1|Overall Study|Lack of Efficacy|67
1312755|NCT00106704|4266421|P2|Overall Study|Death|1
1312756|NCT00106704|4266422|P1|Overall Study|Death|2
1312757|NCT00106704|4266421|P2|Overall Study|Adverse Event|7
1312758|NCT00106704|4266422|P1|Overall Study|Adverse Event|10
1312759|NCT00106639|4266433|P3|Overall Study|Participant defaulted|1
1312760|NCT00106639|4266434|P2|Overall Study|Participant defaulted|1
1312761|NCT00106639|4266435|P1|Overall Study|Participant defaulted|0
1312762|NCT00106639|4266433|P3|Overall Study|Withdrawal by Subject|0
1312763|NCT00106639|4266434|P2|Overall Study|Withdrawal by Subject|1
1312764|NCT00106639|4266435|P1|Overall Study|Withdrawal by Subject|0
1312765|NCT00106639|4266433|P3|Overall Study|Protocol Violation|0
1312766|NCT00106639|4266434|P2|Overall Study|Protocol Violation|1
1312767|NCT00106639|4266435|P1|Overall Study|Protocol Violation|0
1312768|NCT00106639|4266433|P3|Overall Study|Adverse Event|1
1312769|NCT00106639|4266434|P2|Overall Study|Adverse Event|4
1312770|NCT00106639|4266435|P1|Overall Study|Adverse Event|3
1312771|NCT00106626|4266562|P4|Overall Study|> 14 day delay in therapy start|0
1312772|NCT00106626|4266563|P3|Overall Study|> 14 day delay in therapy start|0
1312773|NCT00106626|4266564|P2|Overall Study|> 14 day delay in therapy start|1
1312774|NCT00106626|4266565|P1|Overall Study|> 14 day delay in therapy start|0
1312775|NCT00106626|4266562|P4|Overall Study|Received radiation on new therapy|0
1312776|NCT00106626|4266563|P3|Overall Study|Received radiation on new therapy|0
1312777|NCT00106626|4266564|P2|Overall Study|Received radiation on new therapy|0
1312778|NCT00106626|4266565|P1|Overall Study|Received radiation on new therapy|1
1312779|NCT00106626|4266562|P4|Overall Study|Progressive Disease|10
1312780|NCT00106626|4266563|P3|Overall Study|Progressive Disease|9
1312781|NCT00106626|4266564|P2|Overall Study|Progressive Disease|1
1312782|NCT00106626|4266565|P1|Overall Study|Progressive Disease|4
1312783|NCT00106626|4266562|P4|Overall Study|Adverse Event|3
1312784|NCT00106626|4266563|P3|Overall Study|Adverse Event|3
1312785|NCT00106626|4266564|P2|Overall Study|Adverse Event|4
1312786|NCT00106626|4266565|P1|Overall Study|Adverse Event|5
1312787|NCT00106353|4266910|P7|Part 2|Physician Decision|0
1312788|NCT00106353|4266911|P6|Part 2|Physician Decision|1
1312789|NCT00106353|4266912|P5|Part 2|Physician Decision|0
1312790|NCT00106353|4266913|P4|Part 2|Physician Decision|0
1312791|NCT00106353|4266914|P3|Part 2|Physician Decision|0
1312792|NCT00106353|4266915|P2|Part 2|Physician Decision|0
1312793|NCT00106353|4266916|P1|Part 2|Physician Decision|0
1312794|NCT00106353|4266910|P7|Part 2|Withdrawal by Subject|0
1312795|NCT00106353|4266911|P6|Part 2|Withdrawal by Subject|0
1312796|NCT00106353|4266912|P5|Part 2|Withdrawal by Subject|1
1312797|NCT00106353|4266913|P4|Part 2|Withdrawal by Subject|0
1312798|NCT00106353|4266914|P3|Part 2|Withdrawal by Subject|0
1312799|NCT00106353|4266915|P2|Part 2|Withdrawal by Subject|0
1312800|NCT00106353|4266916|P1|Part 2|Withdrawal by Subject|0
1312801|NCT00106353|4266910|P7|Part 2|Other|1
1312802|NCT00106353|4266911|P6|Part 2|Other|1
1312803|NCT00106353|4266912|P5|Part 2|Other|1
1312804|NCT00106353|4266913|P4|Part 2|Other|0
1312805|NCT00106353|4266914|P3|Part 2|Other|0
1312806|NCT00106353|4266915|P2|Part 2|Other|0
1312807|NCT00106353|4266916|P1|Part 2|Other|0
1312808|NCT00106353|4266910|P7|Part 2|Adverse Event|1
1312809|NCT00106353|4266911|P6|Part 2|Adverse Event|2
1312810|NCT00106353|4266912|P5|Part 2|Adverse Event|0
1312811|NCT00106353|4266913|P4|Part 2|Adverse Event|0
1312812|NCT00106353|4266914|P3|Part 2|Adverse Event|0
1312813|NCT00106353|4266915|P2|Part 2|Adverse Event|0
1312814|NCT00106353|4266916|P1|Part 2|Adverse Event|0
1312815|NCT00106353|4266910|P7|Part 2|Symptomatic deterioration|0
1312816|NCT00106353|4266911|P6|Part 2|Symptomatic deterioration|0
1312817|NCT00106353|4266912|P5|Part 2|Symptomatic deterioration|3
1312818|NCT00106353|4266913|P4|Part 2|Symptomatic deterioration|0
1312819|NCT00106353|4266914|P3|Part 2|Symptomatic deterioration|0
1312820|NCT00106353|4266915|P2|Part 2|Symptomatic deterioration|0
1312821|NCT00106353|4266916|P1|Part 2|Symptomatic deterioration|0
1312822|NCT00106353|4266910|P7|Part 2|Death|1
1312823|NCT00106353|4266911|P6|Part 2|Death|0
1312824|NCT00106353|4266912|P5|Part 2|Death|3
1312825|NCT00106353|4266913|P4|Part 2|Death|0
1312826|NCT00106353|4266914|P3|Part 2|Death|0
1312827|NCT00106353|4266915|P2|Part 2|Death|0
1312828|NCT00106353|4266916|P1|Part 2|Death|0
1312829|NCT00106353|4266910|P7|Part 2|Disease progression|13
1312830|NCT00106353|4266911|P6|Part 2|Disease progression|14
1312831|NCT00106353|4266912|P5|Part 2|Disease progression|8
1312832|NCT00106353|4266913|P4|Part 2|Disease progression|0
1312833|NCT00106353|4266914|P3|Part 2|Disease progression|0
1312834|NCT00106353|4266915|P2|Part 2|Disease progression|0
1312835|NCT00106353|4266916|P1|Part 2|Disease progression|0
1312836|NCT00106353|4266910|P7|Part 1|Adverse Event|0
1312837|NCT00106353|4266911|P6|Part 1|Adverse Event|0
1312838|NCT00106353|4266912|P5|Part 1|Adverse Event|0
1312839|NCT00106353|4266913|P4|Part 1|Adverse Event|1
1312840|NCT00106353|4266914|P3|Part 1|Adverse Event|0
1312841|NCT00106353|4266915|P2|Part 1|Adverse Event|0
1312842|NCT00106353|4266916|P1|Part 1|Adverse Event|0
1312843|NCT00106353|4266910|P7|Part 1|Entered follow-up phase|0
1312844|NCT00106353|4266911|P6|Part 1|Entered follow-up phase|0
1312845|NCT00106353|4266912|P5|Part 1|Entered follow-up phase|0
1312846|NCT00106353|4266913|P4|Part 1|Entered follow-up phase|1
1312847|NCT00106353|4266914|P3|Part 1|Entered follow-up phase|0
1312848|NCT00106353|4266915|P2|Part 1|Entered follow-up phase|1
1312849|NCT00106353|4266916|P1|Part 1|Entered follow-up phase|1
1312850|NCT00106353|4266910|P7|Part 1|Symptomatic deterioration|0
1312851|NCT00106353|4266911|P6|Part 1|Symptomatic deterioration|0
1312852|NCT00106353|4266912|P5|Part 1|Symptomatic deterioration|0
1312853|NCT00106353|4266913|P4|Part 1|Symptomatic deterioration|0
1312854|NCT00106353|4266914|P3|Part 1|Symptomatic deterioration|1
1312855|NCT00106353|4266915|P2|Part 1|Symptomatic deterioration|0
1312856|NCT00106353|4266916|P1|Part 1|Symptomatic deterioration|0
1312857|NCT00106353|4266910|P7|Part 1|Withdrawal by Subject|0
1312858|NCT00106353|4266911|P6|Part 1|Withdrawal by Subject|0
1312859|NCT00106353|4266912|P5|Part 1|Withdrawal by Subject|0
1312860|NCT00106353|4266913|P4|Part 1|Withdrawal by Subject|2
1312861|NCT00106353|4266914|P3|Part 1|Withdrawal by Subject|1
1312862|NCT00106353|4266915|P2|Part 1|Withdrawal by Subject|0
1312863|NCT00106353|4266916|P1|Part 1|Withdrawal by Subject|0
1312864|NCT00106353|4266910|P7|Part 1|Disease progression|0
1312865|NCT00106353|4266911|P6|Part 1|Disease progression|0
1312866|NCT00106353|4266912|P5|Part 1|Disease progression|0
1312867|NCT00106353|4266913|P4|Part 1|Disease progression|3
1312868|NCT00106353|4266914|P3|Part 1|Disease progression|1
1312869|NCT00106353|4266915|P2|Part 1|Disease progression|4
1312870|NCT00106353|4266916|P1|Part 1|Disease progression|3
1312871|NCT00106249|4267043|P2|Overall Study|Lost to Follow-up|2
1312872|NCT00106249|4267044|P1|Overall Study|Lost to Follow-up|3
1312873|NCT00106184|4267056|P2|Overall Study|Withdrawal by Subject|2
1312874|NCT00106184|4267057|P1|Overall Study|Withdrawal by Subject|3
1312875|NCT00106080|4267099|P2|Overall Study|Withdrew/Loss to follow-up|27
1312876|NCT00106080|4267100|P1|Overall Study|Withdrew/Loss to follow-up|43
1312877|NCT00106028|4267110|P2|Overall Study|Lost to Follow-up|1
1312878|NCT00106028|4267111|P1|Overall Study|Lost to Follow-up|0
1312879|NCT00106028|4267110|P2|Overall Study|Withdrawal by Subject|8
1312880|NCT00106028|4267111|P1|Overall Study|Withdrawal by Subject|2
1312881|NCT00106028|4267110|P2|Overall Study|Protocol Violation|1
1312882|NCT00106028|4267111|P1|Overall Study|Protocol Violation|1
1312883|NCT00106028|4267110|P2|Overall Study|Adverse Event|2
1312884|NCT00106028|4267111|P1|Overall Study|Adverse Event|3
1312885|NCT00106002|4267205|P1|Overall Study|Ineligible after Registration|1
1312886|NCT00106002|4267205|P1|Overall Study|Did not take any study drug|1
1312887|NCT00105989|4267213|P2|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
1312888|NCT00105989|4267214|P1|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
1312889|NCT00105989|4267213|P2|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43
1312890|NCT00105989|4267214|P1|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14
1312891|NCT00105989|4267213|P2|Maintenance - Double-Blind:Week 34-86|Death|0
1312892|NCT00105989|4267214|P1|Maintenance - Double-Blind:Week 34-86|Death|0
1312893|NCT00105989|4267213|P2|Maintenance - Double-Blind:Week 34-86|Physician Decision|1
1312894|NCT00105989|4267214|P1|Maintenance - Double-Blind:Week 34-86|Physician Decision|4
1312895|NCT00105989|4267213|P2|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0
1312896|NCT00105989|4267214|P1|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4
1312897|NCT00105989|4267213|P2|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4
1312898|NCT00105989|4267214|P1|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5
1312899|NCT00105989|4267213|P2|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
1312900|NCT00105989|4267214|P1|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
1312901|NCT00105989|4267213|P2|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
1312902|NCT00105989|4267214|P1|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
1312903|NCT00105989|4267213|P2|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18
1312904|NCT00105989|4267214|P1|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17
1312905|NCT00105989|4267213|P2|Maintenance - Double-Blind:Week 34-86|Adverse Event|3
1312906|NCT00105989|4267214|P1|Maintenance - Double-Blind:Week 34-86|Adverse Event|6
1312907|NCT00105989|4267213|P2|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
1312908|NCT00105989|4267214|P1|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
1312909|NCT00105989|4267213|P2|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0
1312910|NCT00105989|4267214|P1|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2
1312911|NCT00105989|4267213|P2|Continuation - Open Label:Week 10-34|Death|0
1312912|NCT00105989|4267214|P1|Continuation - Open Label:Week 10-34|Death|0
1312913|NCT00105989|4267213|P2|Continuation - Open Label:Week 10-34|Physician Decision|0
1312914|NCT00105989|4267214|P1|Continuation - Open Label:Week 10-34|Physician Decision|3
1312915|NCT00105989|4267213|P2|Continuation - Open Label:Week 10-34|Lost to Follow-up|0
1312916|NCT00105989|4267214|P1|Continuation - Open Label:Week 10-34|Lost to Follow-up|9
1312917|NCT00105989|4267213|P2|Continuation - Open Label:Week 10-34|Protocol Violation|0
1312918|NCT00105989|4267214|P1|Continuation - Open Label:Week 10-34|Protocol Violation|5
1312919|NCT00105989|4267213|P2|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0
1312920|NCT00105989|4267214|P1|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16
1312921|NCT00105989|4267213|P2|Continuation - Open Label:Week 10-34|Lack of Efficacy|0
1312922|NCT00105989|4267214|P1|Continuation - Open Label:Week 10-34|Lack of Efficacy|15
1312923|NCT00105989|4267213|P2|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0
1312924|NCT00105989|4267214|P1|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50
1312925|NCT00105989|4267213|P2|Continuation - Open Label:Week 10-34|Adverse Event|0
1312926|NCT00105989|4267214|P1|Continuation - Open Label:Week 10-34|Adverse Event|25
1312927|NCT00105989|4267213|P2|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
1312928|NCT00105989|4267214|P1|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
1312929|NCT00105989|4267213|P2|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
1312930|NCT00105989|4267214|P1|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
1312931|NCT00105989|4267213|P2|Acute - Open Label: Week 0-10|Death|0
1312932|NCT00105989|4267214|P1|Acute - Open Label: Week 0-10|Death|1
1312933|NCT00105989|4267213|P2|Acute - Open Label: Week 0-10|Physician Decision|0
1312934|NCT00105989|4267214|P1|Acute - Open Label: Week 0-10|Physician Decision|0
1312935|NCT00105989|4267213|P2|Acute - Open Label: Week 0-10|Lost to Follow-up|0
1312936|NCT00105989|4267214|P1|Acute - Open Label: Week 0-10|Lost to Follow-up|4
1312937|NCT00105989|4267213|P2|Acute - Open Label: Week 0-10|Protocol Violation|0
1312938|NCT00105989|4267214|P1|Acute - Open Label: Week 0-10|Protocol Violation|8
1312939|NCT00105989|4267213|P2|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0
1312940|NCT00105989|4267214|P1|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14
1312941|NCT00105989|4267213|P2|Acute - Open Label: Week 0-10|Lack of Efficacy|0
1312942|NCT00105989|4267214|P1|Acute - Open Label: Week 0-10|Lack of Efficacy|17
1312943|NCT00105989|4267213|P2|Acute - Open Label: Week 0-10|Withdrawal by Subject|0
1312944|NCT00105989|4267214|P1|Acute - Open Label: Week 0-10|Withdrawal by Subject|24
1312945|NCT00105989|4267213|P2|Acute - Open Label: Week 0-10|Adverse Event|0
1312946|NCT00105989|4267214|P1|Acute - Open Label: Week 0-10|Adverse Event|33
1312947|NCT00105586|4267330|P2|Overall Study|Physician Decision|13
1312948|NCT00105586|4267331|P1|Overall Study|Physician Decision|13
1312949|NCT00105586|4267330|P2|Overall Study|Adverse Event|3
1312950|NCT00105586|4267331|P1|Overall Study|Adverse Event|4
1312951|NCT00105560|4267339|P1|Overall Study|Lost to Follow-up|1
1312952|NCT00105534|4267361|P2|Overall Study|Other Reason|2
1312953|NCT00105534|4267362|P1|Overall Study|Other Reason|0
1312954|NCT00105534|4267361|P2|Overall Study|Treatment unmasked|0
1312955|NCT00105534|4267362|P1|Overall Study|Treatment unmasked|1
1312956|NCT00105534|4267361|P2|Overall Study|Lack of Efficacy|15
1312957|NCT00105534|4267362|P1|Overall Study|Lack of Efficacy|7
1312958|NCT00105534|4267361|P2|Overall Study|Lost to Follow-up|1
1312959|NCT00105534|4267362|P1|Overall Study|Lost to Follow-up|5
1312960|NCT00105534|4267361|P2|Overall Study|Withdrawal by Subject|6
1312961|NCT00105534|4267362|P1|Overall Study|Withdrawal by Subject|6
1312962|NCT00105534|4267361|P2|Overall Study|Protocol Violation|4
1312963|NCT00105534|4267362|P1|Overall Study|Protocol Violation|1
1312964|NCT00105534|4267361|P2|Overall Study|Adverse Event|5
1312965|NCT00105534|4267362|P1|Overall Study|Adverse Event|2
1312966|NCT00105521|4267374|P4|Overall Study|Lost to Follow-up|0
1312967|NCT00105521|4267375|P3|Overall Study|Lost to Follow-up|0
1312968|NCT00105521|4267376|P2|Overall Study|Lost to Follow-up|1
1312969|NCT00105521|4267377|P1|Overall Study|Lost to Follow-up|0
1312970|NCT00105521|4267374|P4|Overall Study|Protocol Violation|4
1312971|NCT00105521|4267375|P3|Overall Study|Protocol Violation|4
1312972|NCT00105521|4267376|P2|Overall Study|Protocol Violation|5
1312973|NCT00105521|4267377|P1|Overall Study|Protocol Violation|3
1312974|NCT00105521|4267374|P4|Overall Study|Lack of Efficacy|1
1312975|NCT00105521|4267375|P3|Overall Study|Lack of Efficacy|0
1312976|NCT00105521|4267376|P2|Overall Study|Lack of Efficacy|0
1312977|NCT00105521|4267377|P1|Overall Study|Lack of Efficacy|0
1312978|NCT00105521|4267374|P4|Overall Study|Withdrawal by Subject|4
1312979|NCT00105521|4267375|P3|Overall Study|Withdrawal by Subject|1
1312980|NCT00105521|4267376|P2|Overall Study|Withdrawal by Subject|0
1312981|NCT00105521|4267377|P1|Overall Study|Withdrawal by Subject|1
1312982|NCT00105521|4267374|P4|Overall Study|Adverse Event|8
1312983|NCT00105521|4267375|P3|Overall Study|Adverse Event|10
1312984|NCT00105521|4267376|P2|Overall Study|Adverse Event|4
1312985|NCT00105521|4267377|P1|Overall Study|Adverse Event|10
1312986|NCT00105521|4267374|P4|Overall Study|Other|0
1312987|NCT00105521|4267375|P3|Overall Study|Other|2
1312988|NCT00105521|4267376|P2|Overall Study|Other|1
1312989|NCT00105521|4267377|P1|Overall Study|Other|1
1312990|NCT00105508|4267401|P2|Overall Study|Other|9
1312991|NCT00105508|4267402|P1|Overall Study|Other|8
1312992|NCT00105508|4267401|P2|Overall Study|Protocol Violation|2
1312993|NCT00105508|4267402|P1|Overall Study|Protocol Violation|1
1312994|NCT00105508|4267401|P2|Overall Study|Lost to Follow-up|0
1312995|NCT00105508|4267402|P1|Overall Study|Lost to Follow-up|3
1312996|NCT00105508|4267401|P2|Overall Study|Withdrawal by Subject|6
1312997|NCT00105508|4267402|P1|Overall Study|Withdrawal by Subject|10
1312998|NCT00105508|4267401|P2|Overall Study|Insufficient Efficacy|0
1312999|NCT00105508|4267402|P1|Overall Study|Insufficient Efficacy|1
1313000|NCT00105508|4267401|P2|Overall Study|Adverse Event|19
1313001|NCT00105508|4267402|P1|Overall Study|Adverse Event|16
1313002|NCT00105508|4267401|P2|Overall Study|Prephase Dropout|0
1313003|NCT00105508|4267402|P1|Overall Study|Prephase Dropout|1
1313004|NCT00105482|4267416|P2|Overall Study|Withdrawn by PI|1
1313005|NCT00105482|4267417|P1|Overall Study|Withdrawn by PI|1
1313006|NCT00105482|4267416|P2|Overall Study|Scheduling Conflict|3
1313007|NCT00105482|4267417|P1|Overall Study|Scheduling Conflict|2
1313008|NCT00105482|4267416|P2|Overall Study|Lost Interest|32
1313009|NCT00105482|4267417|P1|Overall Study|Lost Interest|29
1313010|NCT00105482|4267416|P2|Overall Study|Withdrawal by Subject|1
1313011|NCT00105482|4267417|P1|Overall Study|Withdrawal by Subject|0
1313012|NCT00105482|4267416|P2|Overall Study|Lost to Follow-up|17
1313013|NCT00105482|4267417|P1|Overall Study|Lost to Follow-up|26
1313014|NCT00105482|4267416|P2|Overall Study|Adverse Event|1
1313015|NCT00105482|4267417|P1|Overall Study|Adverse Event|1
1313016|NCT00105469|4267433|P2|Overall Study|Other Reason|0
1313017|NCT00105469|4267434|P1|Overall Study|Other Reason|4
1313018|NCT00105469|4267433|P2|Overall Study|Lack of Efficacy|0
1313019|NCT00105469|4267434|P1|Overall Study|Lack of Efficacy|2
1313020|NCT00105469|4267433|P2|Overall Study|Lost to Follow-up|0
1313021|NCT00105469|4267434|P1|Overall Study|Lost to Follow-up|1
1313022|NCT00105469|4267433|P2|Overall Study|Withdrawal by Subject|3
1313023|NCT00105469|4267434|P1|Overall Study|Withdrawal by Subject|2
1313024|NCT00105469|4267433|P2|Overall Study|Protocol Violation|0
1313025|NCT00105469|4267434|P1|Overall Study|Protocol Violation|4
1313026|NCT00105469|4267433|P2|Overall Study|Adverse Event|8
1313027|NCT00105469|4267434|P1|Overall Study|Adverse Event|9
1313028|NCT00105443|4267444|P4|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11
1313029|NCT00105443|4267445|P3|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
1313030|NCT00105443|4267446|P2|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23
1313031|NCT00105443|4267447|P1|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
1313032|NCT00105443|4267444|P4|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
1313033|NCT00105443|4267445|P3|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
1313034|NCT00105443|4267446|P2|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
1313035|NCT00105443|4267447|P1|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
1313036|NCT00105443|4267444|P4|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1
1313037|NCT00105443|4267445|P3|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
1313038|NCT00105443|4267446|P2|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
1313039|NCT00105443|4267447|P1|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
1313040|NCT00105443|4267444|P4|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
1313041|NCT00105443|4267445|P3|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
1313042|NCT00105443|4267446|P2|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
1313117|NCT00105196|4267487|P2|Overall Study|Lost to Follow-up|2
1313043|NCT00105443|4267447|P1|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1
1313044|NCT00105443|4267444|P4|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
1313045|NCT00105443|4267445|P3|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1
1313046|NCT00105443|4267446|P2|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
1313047|NCT00105443|4267447|P1|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
1313048|NCT00105443|4267444|P4|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
1313049|NCT00105443|4267445|P3|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1
1313050|NCT00105443|4267446|P2|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
1313051|NCT00105443|4267447|P1|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6
1313052|NCT00105443|4267444|P4|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
1313053|NCT00105443|4267445|P3|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
1313054|NCT00105443|4267446|P2|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
1313055|NCT00105443|4267447|P1|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
1313056|NCT00105443|4267444|P4|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5
1313057|NCT00105443|4267445|P3|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
1313058|NCT00105443|4267446|P2|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2
1313059|NCT00105443|4267447|P1|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
1313060|NCT00105443|4267444|P4|Follow-up and/or Open Label Nexavar|Protocol Violation|0
1313061|NCT00105443|4267445|P3|Follow-up and/or Open Label Nexavar|Protocol Violation|0
1313062|NCT00105443|4267446|P2|Follow-up and/or Open Label Nexavar|Protocol Violation|2
1313063|NCT00105443|4267447|P1|Follow-up and/or Open Label Nexavar|Protocol Violation|0
1313064|NCT00105443|4267444|P4|Follow-up and/or Open Label Nexavar|Physician Decision|0
1313065|NCT00105443|4267445|P3|Follow-up and/or Open Label Nexavar|Physician Decision|1
1313066|NCT00105443|4267446|P2|Follow-up and/or Open Label Nexavar|Physician Decision|0
1313067|NCT00105443|4267447|P1|Follow-up and/or Open Label Nexavar|Physician Decision|1
1313068|NCT00105443|4267444|P4|Follow-up and/or Open Label Nexavar|Adverse Event|16
1313069|NCT00105443|4267445|P3|Follow-up and/or Open Label Nexavar|Adverse Event|0
1313070|NCT00105443|4267446|P2|Follow-up and/or Open Label Nexavar|Adverse Event|14
1313071|NCT00105443|4267447|P1|Follow-up and/or Open Label Nexavar|Adverse Event|0
1313072|NCT00105443|4267444|P4|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4
1313073|NCT00105443|4267445|P3|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13
1313074|NCT00105443|4267446|P2|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3
1313075|NCT00105443|4267447|P1|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24
1313076|NCT00105443|4267444|P4|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
1313077|NCT00105443|4267445|P3|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10
1313078|NCT00105443|4267446|P2|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
1313079|NCT00105443|4267447|P1|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14
1313080|NCT00105443|4267444|P4|Follow-up and/or Open Label Nexavar|Death|4
1313081|NCT00105443|4267445|P3|Follow-up and/or Open Label Nexavar|Death|219
1313082|NCT00105443|4267446|P2|Follow-up and/or Open Label Nexavar|Death|7
1313083|NCT00105443|4267447|P1|Follow-up and/or Open Label Nexavar|Death|180
1313084|NCT00105443|4267444|P4|Double-Blind Treatment|Radiological and symptomatic progression|0
1313085|NCT00105443|4267445|P3|Double-Blind Treatment|Radiological and symptomatic progression|1
1313086|NCT00105443|4267446|P2|Double-Blind Treatment|Radiological and symptomatic progression|0
1313087|NCT00105443|4267447|P1|Double-Blind Treatment|Radiological and symptomatic progression|4
1313088|NCT00105443|4267444|P4|Double-Blind Treatment|Physician Decision|0
1313089|NCT00105443|4267445|P3|Double-Blind Treatment|Physician Decision|2
1313090|NCT00105443|4267446|P2|Double-Blind Treatment|Physician Decision|0
1313091|NCT00105443|4267447|P1|Double-Blind Treatment|Physician Decision|1
1313092|NCT00105443|4267444|P4|Double-Blind Treatment|Withdrawal by Subject|0
1313093|NCT00105443|4267445|P3|Double-Blind Treatment|Withdrawal by Subject|7
1313094|NCT00105443|4267446|P2|Double-Blind Treatment|Withdrawal by Subject|0
1313095|NCT00105443|4267447|P1|Double-Blind Treatment|Withdrawal by Subject|8
1313096|NCT00105443|4267444|P4|Double-Blind Treatment|Lost to Follow-up|0
1313097|NCT00105443|4267445|P3|Double-Blind Treatment|Lost to Follow-up|1
1313098|NCT00105443|4267446|P2|Double-Blind Treatment|Lost to Follow-up|0
1313099|NCT00105443|4267447|P1|Double-Blind Treatment|Lost to Follow-up|0
1313100|NCT00105443|4267444|P4|Double-Blind Treatment|Adverse Event|0
1313101|NCT00105443|4267445|P3|Double-Blind Treatment|Adverse Event|0
1313102|NCT00105443|4267446|P2|Double-Blind Treatment|Adverse Event|0
1313103|NCT00105443|4267447|P1|Double-Blind Treatment|Adverse Event|1
1313104|NCT00105235|4267474|P1|Overall Study|Withdrawal by Subject|2
1313105|NCT00105235|4267474|P1|Overall Study|Physician Decision|1
1313106|NCT00105235|4267474|P1|Overall Study|Death|4
1313107|NCT00105196|4267487|P2|Overall Study|Subject became unblinded|1
1313108|NCT00105196|4267488|P1|Overall Study|Subject became unblinded|0
1313109|NCT00105196|4267487|P2|Overall Study|marijuana use|1
1313110|NCT00105196|4267488|P1|Overall Study|marijuana use|0
1313111|NCT00105196|4267487|P2|Overall Study|pending surgery|1
1313112|NCT00105196|4267488|P1|Overall Study|pending surgery|0
1313113|NCT00105196|4267487|P2|Overall Study|Protocol Violation|2
1313114|NCT00105196|4267488|P1|Overall Study|Protocol Violation|5
1313115|NCT00105196|4267487|P2|Overall Study|Poor/noncompliance|4
1313116|NCT00105196|4267488|P1|Overall Study|Poor/noncompliance|3
1313118|NCT00105196|4267488|P1|Overall Study|Lost to Follow-up|3
1313119|NCT00105196|4267487|P2|Overall Study|Withdrawal by Subject|6
1313120|NCT00105196|4267488|P1|Overall Study|Withdrawal by Subject|6
1313121|NCT00105196|4267487|P2|Overall Study|Adverse Event|3
1313122|NCT00105196|4267488|P1|Overall Study|Adverse Event|11
1313123|NCT00105196|4267487|P2|Overall Study|Lack of Efficacy|3
1313124|NCT00105196|4267488|P1|Overall Study|Lack of Efficacy|2
1313125|NCT00105183|4267511|P3|Overall Study|Other reason|0
1313126|NCT00105183|4267512|P2|Overall Study|Other reason|2
1313127|NCT00105183|4267513|P1|Overall Study|Other reason|1
1313128|NCT00105183|4267511|P3|Overall Study|Lost to Follow-up|1
1313129|NCT00105183|4267512|P2|Overall Study|Lost to Follow-up|1
1313130|NCT00105183|4267513|P1|Overall Study|Lost to Follow-up|0
1313131|NCT00105183|4267511|P3|Overall Study|Physician Decision|3
1313132|NCT00105183|4267512|P2|Overall Study|Physician Decision|2
1313133|NCT00105183|4267513|P1|Overall Study|Physician Decision|1
1313134|NCT00105183|4267511|P3|Overall Study|Withdrawal by Subject|4
1313135|NCT00105183|4267512|P2|Overall Study|Withdrawal by Subject|1
1313136|NCT00105183|4267513|P1|Overall Study|Withdrawal by Subject|1
1313137|NCT00105183|4267511|P3|Overall Study|Death|15
1313138|NCT00105183|4267512|P2|Overall Study|Death|13
1313139|NCT00105183|4267513|P1|Overall Study|Death|19
1313140|NCT00105157|4267549|P4|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
1313141|NCT00105157|4267550|P3|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
1313142|NCT00105157|4267551|P2|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0
1313143|NCT00105157|4267552|P1|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
1313144|NCT00105157|4267549|P4|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5
1313145|NCT00105157|4267550|P3|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
1313146|NCT00105157|4267551|P2|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
1313147|NCT00105157|4267552|P1|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
1313148|NCT00105157|4267549|P4|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
1313149|NCT00105157|4267550|P3|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
1313150|NCT00105157|4267551|P2|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
1313151|NCT00105157|4267552|P1|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
1313152|NCT00105157|4267549|P4|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10
1313153|NCT00105157|4267550|P3|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5
1313154|NCT00105157|4267551|P2|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6
1313155|NCT00105157|4267552|P1|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7
1313156|NCT00105157|4267549|P4|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1
1313157|NCT00105157|4267550|P3|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
1313158|NCT00105157|4267551|P2|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
1313159|NCT00105157|4267552|P1|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
1313160|NCT00105157|4267549|P4|Open-Label Continuation of DB|Patient moved/site stopped trial|0
1313161|NCT00105157|4267550|P3|Open-Label Continuation of DB|Patient moved/site stopped trial|2
1313162|NCT00105157|4267551|P2|Open-Label Continuation of DB|Patient moved/site stopped trial|3
1313163|NCT00105157|4267552|P1|Open-Label Continuation of DB|Patient moved/site stopped trial|1
1313164|NCT00105157|4267549|P4|Open-Label Continuation of DB|Patient did not continue in extension|0
1313165|NCT00105157|4267550|P3|Open-Label Continuation of DB|Patient did not continue in extension|0
1313166|NCT00105157|4267551|P2|Open-Label Continuation of DB|Patient did not continue in extension|0
1313167|NCT00105157|4267552|P1|Open-Label Continuation of DB|Patient did not continue in extension|1
1313168|NCT00105157|4267549|P4|Open-Label Continuation of DB|Withdrawal by Subject|0
1313169|NCT00105157|4267550|P3|Open-Label Continuation of DB|Withdrawal by Subject|3
1313170|NCT00105157|4267551|P2|Open-Label Continuation of DB|Withdrawal by Subject|1
1313171|NCT00105157|4267552|P1|Open-Label Continuation of DB|Withdrawal by Subject|0
1313172|NCT00105157|4267549|P4|Open-Label Continuation of DB|Lost to Follow-up|0
1313173|NCT00105157|4267550|P3|Open-Label Continuation of DB|Lost to Follow-up|1
1313174|NCT00105157|4267551|P2|Open-Label Continuation of DB|Lost to Follow-up|1
1313175|NCT00105157|4267552|P1|Open-Label Continuation of DB|Lost to Follow-up|1
1313176|NCT00105157|4267549|P4|Open-Label Continuation of DB|Lack of Efficacy|1
1313177|NCT00105157|4267550|P3|Open-Label Continuation of DB|Lack of Efficacy|3
1313178|NCT00105157|4267551|P2|Open-Label Continuation of DB|Lack of Efficacy|4
1313179|NCT00105157|4267552|P1|Open-Label Continuation of DB|Lack of Efficacy|1
1313180|NCT00105157|4267549|P4|Open-Label Continuation of DB|Adverse Event|0
1313181|NCT00105157|4267550|P3|Open-Label Continuation of DB|Adverse Event|0
1313182|NCT00105157|4267551|P2|Open-Label Continuation of DB|Adverse Event|1
1313183|NCT00105157|4267552|P1|Open-Label Continuation of DB|Adverse Event|3
1313184|NCT00105157|4267549|P4|Double-Blind (DB)|Lack of Efficacy|38
1313185|NCT00105157|4267550|P3|Double-Blind (DB)|Lack of Efficacy|11
1313186|NCT00105157|4267551|P2|Double-Blind (DB)|Lack of Efficacy|14
1313187|NCT00105157|4267552|P1|Double-Blind (DB)|Lack of Efficacy|11
1313188|NCT00105157|4267549|P4|Double-Blind (DB)|Adverse Event|1
1313189|NCT00105157|4267550|P3|Double-Blind (DB)|Adverse Event|1
1313190|NCT00105157|4267551|P2|Double-Blind (DB)|Adverse Event|0
1313191|NCT00105157|4267552|P1|Double-Blind (DB)|Adverse Event|2
1313192|NCT00105157|4267549|P4|Double-Blind (DB)|Never Treated|0
1313193|NCT00105157|4267550|P3|Double-Blind (DB)|Never Treated|0
1313194|NCT00105157|4267551|P2|Double-Blind (DB)|Never Treated|0
1313195|NCT00105157|4267552|P1|Double-Blind (DB)|Never Treated|1
1313196|NCT00105079|4267746|P2|Overall Study|not specified|1
1313197|NCT00105079|4267747|P1|Overall Study|not specified|3
1313198|NCT00105079|4267746|P2|Overall Study|Protocol Violation|0
1313199|NCT00105079|4267747|P1|Overall Study|Protocol Violation|1
1313200|NCT00105079|4267746|P2|Overall Study|Violation of selection criteria at entry|2
1313201|NCT00105079|4267747|P1|Overall Study|Violation of selection criteria at entry|0
1313202|NCT00105079|4267746|P2|Overall Study|Refused treatment|4
1313203|NCT00105079|4267747|P1|Overall Study|Refused treatment|6
1313204|NCT00105079|4267746|P2|Overall Study|Lack of Efficacy|3
1313205|NCT00105079|4267747|P1|Overall Study|Lack of Efficacy|9
1313206|NCT00105079|4267746|P2|Overall Study|Lost to Follow-up|12
1313207|NCT00105079|4267747|P1|Overall Study|Lost to Follow-up|12
1313208|NCT00105079|4267746|P2|Overall Study|Death|1
1313209|NCT00105079|4267747|P1|Overall Study|Death|3
1313210|NCT00105079|4267746|P2|Overall Study|Adverse Event|12
1313211|NCT00105079|4267747|P1|Overall Study|Adverse Event|5
1313212|NCT00105066|4267765|P2|Overall Study|Adverse Event|5
1313213|NCT00105066|4267766|P1|Overall Study|Adverse Event|2
1313214|NCT00104884|4267844|P1|Overall Study|Disease progression|4
1313215|NCT00104871|4267848|P1|Overall Study|Not evaluable|1
1313216|NCT00104728|4267854|P1|Overall Study|screen failures|19
1313217|NCT00104650|4267862|P3|Follow-up Period|Other|0
1313218|NCT00104650|4267863|P2|Follow-up Period|Other|1
1313219|NCT00104650|4267864|P1|Follow-up Period|Other|0
1313220|NCT00104650|4267862|P3|Follow-up Period|Lost to Follow-up|2
1313221|NCT00104650|4267863|P2|Follow-up Period|Lost to Follow-up|1
1313222|NCT00104650|4267864|P1|Follow-up Period|Lost to Follow-up|0
1313223|NCT00104650|4267862|P3|Follow-up Period|Disease progression|0
1313224|NCT00104650|4267863|P2|Follow-up Period|Disease progression|1
1313225|NCT00104650|4267864|P1|Follow-up Period|Disease progression|3
1313226|NCT00104650|4267862|P3|Follow-up Period|Death|4
1313227|NCT00104650|4267863|P2|Follow-up Period|Death|6
1313228|NCT00104650|4267864|P1|Follow-up Period|Death|6
1313229|NCT00104650|4267862|P3|Follow-up Period|Withdrawal by Subject|3
1313230|NCT00104650|4267863|P2|Follow-up Period|Withdrawal by Subject|3
1313231|NCT00104650|4267864|P1|Follow-up Period|Withdrawal by Subject|0
1313232|NCT00104650|4267862|P3|Follow-up Period|Adverse Event|1
1313233|NCT00104650|4267863|P2|Follow-up Period|Adverse Event|0
1313234|NCT00104650|4267864|P1|Follow-up Period|Adverse Event|1
1313235|NCT00104650|4267862|P3|Follow-up Period|Physician Decision|0
1313236|NCT00104650|4267863|P2|Follow-up Period|Physician Decision|1
1313237|NCT00104650|4267864|P1|Follow-up Period|Physician Decision|1
1313238|NCT00104650|4267862|P3|Treatment Period (25 Weeks)|Protocol deviation|0
1313239|NCT00104650|4267863|P2|Treatment Period (25 Weeks)|Protocol deviation|1
1313240|NCT00104650|4267864|P1|Treatment Period (25 Weeks)|Protocol deviation|0
1313241|NCT00104650|4267862|P3|Treatment Period (25 Weeks)|Other|0
1313242|NCT00104650|4267863|P2|Treatment Period (25 Weeks)|Other|0
1313243|NCT00104650|4267864|P1|Treatment Period (25 Weeks)|Other|1
1313244|NCT00104650|4267862|P3|Treatment Period (25 Weeks)|Ineligibility determined|0
1313245|NCT00104650|4267863|P2|Treatment Period (25 Weeks)|Ineligibility determined|1
1313246|NCT00104650|4267864|P1|Treatment Period (25 Weeks)|Ineligibility determined|0
1313247|NCT00104650|4267862|P3|Treatment Period (25 Weeks)|Disease progression|2
1313248|NCT00104650|4267863|P2|Treatment Period (25 Weeks)|Disease progression|3
1313249|NCT00104650|4267864|P1|Treatment Period (25 Weeks)|Disease progression|2
1313250|NCT00104650|4267862|P3|Treatment Period (25 Weeks)|Death|6
1313251|NCT00104650|4267863|P2|Treatment Period (25 Weeks)|Death|5
1313252|NCT00104650|4267864|P1|Treatment Period (25 Weeks)|Death|7
1313253|NCT00104650|4267862|P3|Treatment Period (25 Weeks)|Withdrawal by Subject|1
1313254|NCT00104650|4267863|P2|Treatment Period (25 Weeks)|Withdrawal by Subject|1
1313255|NCT00104650|4267864|P1|Treatment Period (25 Weeks)|Withdrawal by Subject|2
1313256|NCT00104650|4267862|P3|Treatment Period (25 Weeks)|Physician Decision|1
1313257|NCT00104650|4267863|P2|Treatment Period (25 Weeks)|Physician Decision|0
1313258|NCT00104650|4267864|P1|Treatment Period (25 Weeks)|Physician Decision|0
1313259|NCT00104637|4267896|P2|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0
1313260|NCT00104637|4267897|P1|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1
1313261|NCT00104572|4267926|P3|Overall Study|Withdrawal by Subject|0
1313262|NCT00104572|4267927|P2|Overall Study|Withdrawal by Subject|3
1313263|NCT00104572|4267928|P1|Overall Study|Withdrawal by Subject|3
1313264|NCT00104520|4267947|P2|Overall Study|Other|5
1313265|NCT00104520|4267948|P1|Overall Study|Other|1
1313266|NCT00104520|4267947|P2|Overall Study|Personal/administrative|1
1313267|NCT00104520|4267948|P1|Overall Study|Personal/administrative|1
1313268|NCT00104520|4267947|P2|Overall Study|Noncompliance|2
1313269|NCT00104520|4267948|P1|Overall Study|Noncompliance|0
1313270|NCT00104520|4267947|P2|Overall Study|Lost to Follow-up|0
1313271|NCT00104520|4267948|P1|Overall Study|Lost to Follow-up|1
1313272|NCT00104520|4267947|P2|Overall Study|Related adverse event|15
1313273|NCT00104520|4267948|P1|Overall Study|Related adverse event|13
1313274|NCT00104520|4267947|P2|Overall Study|Study drug intolerance|1
1313275|NCT00104520|4267948|P1|Overall Study|Study drug intolerance|0
1313276|NCT00104520|4267947|P2|Overall Study|Unrelated adverse event|47
1313277|NCT00104520|4267948|P1|Overall Study|Unrelated adverse event|34
1313278|NCT00104416|4267968|P5|Continuation Phase|Non-compliance|1
1313279|NCT00104416|4267969|P4|Continuation Phase|Non-compliance|0
1313280|NCT00104416|4267970|P3|Continuation Phase|Non-compliance|0
1313281|NCT00104416|4267971|P2|Continuation Phase|Non-compliance|0
1313282|NCT00104416|4267972|P1|Continuation Phase|Non-compliance|0
1313283|NCT00104416|4267968|P5|Continuation Phase|Pregnancy|0
1313284|NCT00104416|4267969|P4|Continuation Phase|Pregnancy|1
1313285|NCT00104416|4267970|P3|Continuation Phase|Pregnancy|1
1313286|NCT00104416|4267971|P2|Continuation Phase|Pregnancy|0
1313287|NCT00104416|4267972|P1|Continuation Phase|Pregnancy|0
1313288|NCT00104416|4267968|P5|Continuation Phase|Withdrawal by Subject|1
1313289|NCT00104416|4267969|P4|Continuation Phase|Withdrawal by Subject|1
1313290|NCT00104416|4267970|P3|Continuation Phase|Withdrawal by Subject|2
1313291|NCT00104416|4267971|P2|Continuation Phase|Withdrawal by Subject|0
1313292|NCT00104416|4267972|P1|Continuation Phase|Withdrawal by Subject|0
1313293|NCT00104416|4267968|P5|Continuation Phase|Lost to Follow-up|1
1313294|NCT00104416|4267969|P4|Continuation Phase|Lost to Follow-up|0
1313295|NCT00104416|4267970|P3|Continuation Phase|Lost to Follow-up|1
1313296|NCT00104416|4267971|P2|Continuation Phase|Lost to Follow-up|0
1313297|NCT00104416|4267972|P1|Continuation Phase|Lost to Follow-up|0
1313298|NCT00104416|4267968|P5|Continuation Phase|Adverse Event|2
1313299|NCT00104416|4267969|P4|Continuation Phase|Adverse Event|0
1313300|NCT00104416|4267970|P3|Continuation Phase|Adverse Event|2
1313301|NCT00104416|4267971|P2|Continuation Phase|Adverse Event|0
1313302|NCT00104416|4267972|P1|Continuation Phase|Adverse Event|0
1313303|NCT00104416|4267968|P5|Double-Blind Phase|Participant Did Not Take Drug|0
1313304|NCT00104416|4267969|P4|Double-Blind Phase|Participant Did Not Take Drug|0
1313305|NCT00104416|4267970|P3|Double-Blind Phase|Participant Did Not Take Drug|0
1313306|NCT00104416|4267971|P2|Double-Blind Phase|Participant Did Not Take Drug|4
1313307|NCT00104416|4267972|P1|Double-Blind Phase|Participant Did Not Take Drug|3
1313308|NCT00104416|4267968|P5|Double-Blind Phase|Pregnancy|0
1313309|NCT00104416|4267969|P4|Double-Blind Phase|Pregnancy|0
1313310|NCT00104416|4267970|P3|Double-Blind Phase|Pregnancy|0
1313311|NCT00104416|4267971|P2|Double-Blind Phase|Pregnancy|0
1313312|NCT00104416|4267972|P1|Double-Blind Phase|Pregnancy|1
1313313|NCT00104416|4267968|P5|Double-Blind Phase|Withdrawal by Subject|0
1313314|NCT00104416|4267969|P4|Double-Blind Phase|Withdrawal by Subject|0
1313315|NCT00104416|4267970|P3|Double-Blind Phase|Withdrawal by Subject|0
1313316|NCT00104416|4267971|P2|Double-Blind Phase|Withdrawal by Subject|3
1313317|NCT00104416|4267972|P1|Double-Blind Phase|Withdrawal by Subject|2
1313318|NCT00104416|4267968|P5|Double-Blind Phase|Protocol Violation|0
1313319|NCT00104416|4267969|P4|Double-Blind Phase|Protocol Violation|0
1313320|NCT00104416|4267970|P3|Double-Blind Phase|Protocol Violation|0
1313321|NCT00104416|4267971|P2|Double-Blind Phase|Protocol Violation|1
1313322|NCT00104416|4267972|P1|Double-Blind Phase|Protocol Violation|0
1313323|NCT00104416|4267968|P5|Double-Blind Phase|Lost to Follow-up|0
1313324|NCT00104416|4267969|P4|Double-Blind Phase|Lost to Follow-up|0
1313325|NCT00104416|4267970|P3|Double-Blind Phase|Lost to Follow-up|0
1313326|NCT00104416|4267971|P2|Double-Blind Phase|Lost to Follow-up|1
1313327|NCT00104416|4267972|P1|Double-Blind Phase|Lost to Follow-up|0
1313328|NCT00104416|4267968|P5|Double-Blind Phase|Adverse Event|0
1313329|NCT00104416|4267969|P4|Double-Blind Phase|Adverse Event|0
1313330|NCT00104416|4267970|P3|Double-Blind Phase|Adverse Event|0
1313331|NCT00104416|4267971|P2|Double-Blind Phase|Adverse Event|1
1313332|NCT00104416|4267972|P1|Double-Blind Phase|Adverse Event|2
1313333|NCT00104299|4268017|P2|Overall Study|To have renal transplant|0
1313334|NCT00104299|4268018|P1|Overall Study|To have renal transplant|1
1313335|NCT00104299|4268017|P2|Overall Study|Physician Decision|1
1313336|NCT00104299|4268018|P1|Overall Study|Physician Decision|1
1313337|NCT00104299|4268017|P2|Overall Study|Withdrawal by Subject|6
1313338|NCT00104299|4268018|P1|Overall Study|Withdrawal by Subject|2
1313339|NCT00104299|4268017|P2|Overall Study|Death|2
1313340|NCT00104299|4268018|P1|Overall Study|Death|2
1313341|NCT00104299|4268017|P2|Overall Study|Adverse Event|1
1313342|NCT00104299|4268018|P1|Overall Study|Adverse Event|3
1313343|NCT00104247|4268040|P2|Overall Study|Noncompliant with dosing|1
1313344|NCT00104247|4268041|P1|Overall Study|Noncompliant with dosing|0
1313345|NCT00104247|4268040|P2|Overall Study|Withdrawal by Subject|0
1313346|NCT00104247|4268041|P1|Overall Study|Withdrawal by Subject|1
1313347|NCT00104104|4268060|P2|Overall Study|Death|6
1313348|NCT00104104|4268061|P1|Overall Study|Death|9
1313349|NCT00104104|4268060|P2|Overall Study|Administrative problems|13
1313350|NCT00104104|4268061|P1|Overall Study|Administrative problems|12
1313351|NCT00104104|4268060|P2|Overall Study|Lost to Follow-up|7
1313352|NCT00104104|4268061|P1|Overall Study|Lost to Follow-up|3
1313353|NCT00104104|4268060|P2|Overall Study|Withdrawal by Subject|15
1313354|NCT00104104|4268061|P1|Overall Study|Withdrawal by Subject|11
1313355|NCT00104104|4268060|P2|Overall Study|Protocol Violation|2
1313356|NCT00104104|4268061|P1|Overall Study|Protocol Violation|5
1313357|NCT00104104|4268060|P2|Overall Study|Condition no longer requires study drug|4
1313358|NCT00104104|4268061|P1|Overall Study|Condition no longer requires study drug|7
1313359|NCT00104104|4268060|P2|Overall Study|Lack of Efficacy|3
1313360|NCT00104104|4268061|P1|Overall Study|Lack of Efficacy|0
1313361|NCT00104104|4268060|P2|Overall Study|Abnormal laboratory value(s)|14
1313362|NCT00104104|4268061|P1|Overall Study|Abnormal laboratory value(s)|20
1313363|NCT00104104|4268060|P2|Overall Study|Adverse Event|8
1313364|NCT00104104|4268061|P1|Overall Study|Adverse Event|8
1313365|NCT00104052|4268075|P1|Overall Study|Discontinuation unrelated to treatment|2
1313366|NCT00104052|4268075|P1|Overall Study|Lack of Efficacy|26
1313367|NCT00104052|4268075|P1|Overall Study|Adverse Event|1
1313368|NCT00103857|4268086|P7|50-Week Extension Study|reason unspecified|0
1313369|NCT00103857|4268087|P6|50-Week Extension Study|reason unspecified|0
1313370|NCT00103857|4268088|P5|50-Week Extension Study|reason unspecified|1
1313371|NCT00103857|4268089|P4|50-Week Extension Study|reason unspecified|0
1313372|NCT00103857|4268090|P3|50-Week Extension Study|reason unspecified|0
1313373|NCT00103857|4268091|P2|50-Week Extension Study|reason unspecified|0
1313374|NCT00103857|4268092|P1|50-Week Extension Study|reason unspecified|0
1313375|NCT00103857|4268086|P7|50-Week Extension Study|patient scheduled for elective surgery|0
1313376|NCT00103857|4268087|P6|50-Week Extension Study|patient scheduled for elective surgery|0
1313377|NCT00103857|4268088|P5|50-Week Extension Study|patient scheduled for elective surgery|0
1313378|NCT00103857|4268089|P4|50-Week Extension Study|patient scheduled for elective surgery|0
1313379|NCT00103857|4268090|P3|50-Week Extension Study|patient scheduled for elective surgery|1
1313380|NCT00103857|4268091|P2|50-Week Extension Study|patient scheduled for elective surgery|0
1313381|NCT00103857|4268092|P1|50-Week Extension Study|patient scheduled for elective surgery|0
1313382|NCT00103857|4268086|P7|50-Week Extension Study|patient moved|0
1313383|NCT00103857|4268087|P6|50-Week Extension Study|patient moved|0
1313384|NCT00103857|4268088|P5|50-Week Extension Study|patient moved|0
1313385|NCT00103857|4268089|P4|50-Week Extension Study|patient moved|2
1313386|NCT00103857|4268090|P3|50-Week Extension Study|patient moved|1
1313387|NCT00103857|4268091|P2|50-Week Extension Study|patient moved|0
1313388|NCT00103857|4268092|P1|50-Week Extension Study|patient moved|0
1313389|NCT00103857|4268086|P7|50-Week Extension Study|non-compliance with study procedures|0
1313390|NCT00103857|4268087|P6|50-Week Extension Study|non-compliance with study procedures|0
1313391|NCT00103857|4268088|P5|50-Week Extension Study|non-compliance with study procedures|1
1313392|NCT00103857|4268089|P4|50-Week Extension Study|non-compliance with study procedures|1
1313393|NCT00103857|4268090|P3|50-Week Extension Study|non-compliance with study procedures|0
1313394|NCT00103857|4268091|P2|50-Week Extension Study|non-compliance with study procedures|0
1313395|NCT00103857|4268092|P1|50-Week Extension Study|non-compliance with study procedures|1
1313396|NCT00103857|4268086|P7|50-Week Extension Study|protocol discontinuation criteria|0
1313397|NCT00103857|4268087|P6|50-Week Extension Study|protocol discontinuation criteria|3
1313398|NCT00103857|4268088|P5|50-Week Extension Study|protocol discontinuation criteria|3
1313399|NCT00103857|4268089|P4|50-Week Extension Study|protocol discontinuation criteria|2
1313400|NCT00103857|4268090|P3|50-Week Extension Study|protocol discontinuation criteria|3
1313401|NCT00103857|4268091|P2|50-Week Extension Study|protocol discontinuation criteria|2
1313402|NCT00103857|4268092|P1|50-Week Extension Study|protocol discontinuation criteria|2
1313403|NCT00103857|4268086|P7|50-Week Extension Study|Withdrawal by Subject|0
1313404|NCT00103857|4268087|P6|50-Week Extension Study|Withdrawal by Subject|3
1313405|NCT00103857|4268088|P5|50-Week Extension Study|Withdrawal by Subject|3
1313406|NCT00103857|4268089|P4|50-Week Extension Study|Withdrawal by Subject|8
1313407|NCT00103857|4268090|P3|50-Week Extension Study|Withdrawal by Subject|2
1313408|NCT00103857|4268091|P2|50-Week Extension Study|Withdrawal by Subject|5
1313409|NCT00103857|4268092|P1|50-Week Extension Study|Withdrawal by Subject|2
1313410|NCT00103857|4268086|P7|50-Week Extension Study|Protocol Violation|0
1313411|NCT00103857|4268087|P6|50-Week Extension Study|Protocol Violation|1
1313412|NCT00103857|4268088|P5|50-Week Extension Study|Protocol Violation|0
1313413|NCT00103857|4268089|P4|50-Week Extension Study|Protocol Violation|2
1313414|NCT00103857|4268090|P3|50-Week Extension Study|Protocol Violation|1
1313415|NCT00103857|4268091|P2|50-Week Extension Study|Protocol Violation|1
1313416|NCT00103857|4268092|P1|50-Week Extension Study|Protocol Violation|1
1313417|NCT00103857|4268086|P7|50-Week Extension Study|Pregnancy|0
1313418|NCT00103857|4268087|P6|50-Week Extension Study|Pregnancy|0
1313419|NCT00103857|4268088|P5|50-Week Extension Study|Pregnancy|1
1313420|NCT00103857|4268089|P4|50-Week Extension Study|Pregnancy|0
1313421|NCT00103857|4268090|P3|50-Week Extension Study|Pregnancy|1
1313422|NCT00103857|4268091|P2|50-Week Extension Study|Pregnancy|0
1313423|NCT00103857|4268092|P1|50-Week Extension Study|Pregnancy|0
1313424|NCT00103857|4268086|P7|50-Week Extension Study|Physician Decision|0
1313425|NCT00103857|4268087|P6|50-Week Extension Study|Physician Decision|0
1313426|NCT00103857|4268088|P5|50-Week Extension Study|Physician Decision|0
1313427|NCT00103857|4268089|P4|50-Week Extension Study|Physician Decision|0
1313428|NCT00103857|4268090|P3|50-Week Extension Study|Physician Decision|1
1313429|NCT00103857|4268091|P2|50-Week Extension Study|Physician Decision|1
1313430|NCT00103857|4268092|P1|50-Week Extension Study|Physician Decision|0
1313431|NCT00103857|4268086|P7|50-Week Extension Study|Lost to Follow-up|0
1313432|NCT00103857|4268087|P6|50-Week Extension Study|Lost to Follow-up|3
1313433|NCT00103857|4268088|P5|50-Week Extension Study|Lost to Follow-up|3
1313434|NCT00103857|4268089|P4|50-Week Extension Study|Lost to Follow-up|4
1313435|NCT00103857|4268090|P3|50-Week Extension Study|Lost to Follow-up|1
1313436|NCT00103857|4268091|P2|50-Week Extension Study|Lost to Follow-up|0
1313437|NCT00103857|4268092|P1|50-Week Extension Study|Lost to Follow-up|4
1313438|NCT00103857|4268086|P7|50-Week Extension Study|Lack of Efficacy|0
1313439|NCT00103857|4268087|P6|50-Week Extension Study|Lack of Efficacy|8
1313440|NCT00103857|4268088|P5|50-Week Extension Study|Lack of Efficacy|8
1313441|NCT00103857|4268089|P4|50-Week Extension Study|Lack of Efficacy|16
1313442|NCT00103857|4268090|P3|50-Week Extension Study|Lack of Efficacy|13
1313443|NCT00103857|4268091|P2|50-Week Extension Study|Lack of Efficacy|15
1313444|NCT00103857|4268092|P1|50-Week Extension Study|Lack of Efficacy|26
1313445|NCT00103857|4268086|P7|50-Week Extension Study|Death|0
1313446|NCT00103857|4268087|P6|50-Week Extension Study|Death|1
1313447|NCT00103857|4268088|P5|50-Week Extension Study|Death|0
1313448|NCT00103857|4268089|P4|50-Week Extension Study|Death|1
1313449|NCT00103857|4268090|P3|50-Week Extension Study|Death|0
1313450|NCT00103857|4268091|P2|50-Week Extension Study|Death|0
1313451|NCT00103857|4268092|P1|50-Week Extension Study|Death|0
1313452|NCT00103857|4268086|P7|50-Week Extension Study|Adverse Event|0
1313453|NCT00103857|4268087|P6|50-Week Extension Study|Adverse Event|1
1313454|NCT00103857|4268088|P5|50-Week Extension Study|Adverse Event|1
1313455|NCT00103857|4268089|P4|50-Week Extension Study|Adverse Event|0
1313456|NCT00103857|4268090|P3|50-Week Extension Study|Adverse Event|2
1313457|NCT00103857|4268091|P2|50-Week Extension Study|Adverse Event|3
1313458|NCT00103857|4268092|P1|50-Week Extension Study|Adverse Event|2
1313459|NCT00103857|4268086|P7|54-Week Base Study|patient intolerance to rescue therapy|0
1313460|NCT00103857|4268087|P6|54-Week Base Study|patient intolerance to rescue therapy|0
1313461|NCT00103857|4268088|P5|54-Week Base Study|patient intolerance to rescue therapy|0
1313462|NCT00103857|4268089|P4|54-Week Base Study|patient intolerance to rescue therapy|0
1313463|NCT00103857|4268090|P3|54-Week Base Study|patient intolerance to rescue therapy|0
1313464|NCT00103857|4268091|P2|54-Week Base Study|patient intolerance to rescue therapy|0
1313465|NCT00103857|4268092|P1|54-Week Base Study|patient intolerance to rescue therapy|1
1313466|NCT00103857|4268086|P7|54-Week Base Study|site error|0
1313467|NCT00103857|4268087|P6|54-Week Base Study|site error|1
1313468|NCT00103857|4268088|P5|54-Week Base Study|site error|0
1313469|NCT00103857|4268089|P4|54-Week Base Study|site error|0
1313470|NCT00103857|4268090|P3|54-Week Base Study|site error|0
1313471|NCT00103857|4268091|P2|54-Week Base Study|site error|0
1313472|NCT00103857|4268092|P1|54-Week Base Study|site error|0
1313473|NCT00103857|4268086|P7|54-Week Base Study|laboratory reporting error|0
1313474|NCT00103857|4268087|P6|54-Week Base Study|laboratory reporting error|0
1313475|NCT00103857|4268088|P5|54-Week Base Study|laboratory reporting error|1
1313476|NCT00103857|4268089|P4|54-Week Base Study|laboratory reporting error|0
1313477|NCT00103857|4268090|P3|54-Week Base Study|laboratory reporting error|0
1313478|NCT00103857|4268091|P2|54-Week Base Study|laboratory reporting error|0
1313479|NCT00103857|4268092|P1|54-Week Base Study|laboratory reporting error|0
1313480|NCT00103857|4268086|P7|54-Week Base Study|patient incarcerated|0
1313481|NCT00103857|4268087|P6|54-Week Base Study|patient incarcerated|1
1313482|NCT00103857|4268088|P5|54-Week Base Study|patient incarcerated|1
1313483|NCT00103857|4268089|P4|54-Week Base Study|patient incarcerated|0
1313484|NCT00103857|4268090|P3|54-Week Base Study|patient incarcerated|0
1313485|NCT00103857|4268091|P2|54-Week Base Study|patient incarcerated|0
1313486|NCT00103857|4268092|P1|54-Week Base Study|patient incarcerated|0
1313487|NCT00103857|4268086|P7|54-Week Base Study|non-compliance with study procedures|0
1313488|NCT00103857|4268087|P6|54-Week Base Study|non-compliance with study procedures|2
1313489|NCT00103857|4268088|P5|54-Week Base Study|non-compliance with study procedures|0
1313490|NCT00103857|4268089|P4|54-Week Base Study|non-compliance with study procedures|0
1313491|NCT00103857|4268090|P3|54-Week Base Study|non-compliance with study procedures|0
1313492|NCT00103857|4268091|P2|54-Week Base Study|non-compliance with study procedures|2
1313493|NCT00103857|4268092|P1|54-Week Base Study|non-compliance with study procedures|1
1313494|NCT00103857|4268086|P7|54-Week Base Study|patient moved|0
1313495|NCT00103857|4268087|P6|54-Week Base Study|patient moved|1
1313496|NCT00103857|4268088|P5|54-Week Base Study|patient moved|3
1313497|NCT00103857|4268089|P4|54-Week Base Study|patient moved|2
1313498|NCT00103857|4268090|P3|54-Week Base Study|patient moved|1
1313499|NCT00103857|4268091|P2|54-Week Base Study|patient moved|1
1313500|NCT00103857|4268092|P1|54-Week Base Study|patient moved|0
1313501|NCT00103857|4268086|P7|54-Week Base Study|protocol discontinuation criteria|5
1313502|NCT00103857|4268087|P6|54-Week Base Study|protocol discontinuation criteria|3
1313503|NCT00103857|4268088|P5|54-Week Base Study|protocol discontinuation criteria|5
1313504|NCT00103857|4268089|P4|54-Week Base Study|protocol discontinuation criteria|6
1313505|NCT00103857|4268090|P3|54-Week Base Study|protocol discontinuation criteria|2
1313506|NCT00103857|4268091|P2|54-Week Base Study|protocol discontinuation criteria|5
1313507|NCT00103857|4268092|P1|54-Week Base Study|protocol discontinuation criteria|2
1313508|NCT00103857|4268086|P7|54-Week Base Study|Withdrawal by Subject|4
1313509|NCT00103857|4268087|P6|54-Week Base Study|Withdrawal by Subject|15
1313510|NCT00103857|4268088|P5|54-Week Base Study|Withdrawal by Subject|10
1313511|NCT00103857|4268089|P4|54-Week Base Study|Withdrawal by Subject|15
1313512|NCT00103857|4268090|P3|54-Week Base Study|Withdrawal by Subject|16
1313513|NCT00103857|4268091|P2|54-Week Base Study|Withdrawal by Subject|16
1313514|NCT00103857|4268092|P1|54-Week Base Study|Withdrawal by Subject|17
1313515|NCT00103857|4268086|P7|54-Week Base Study|Protocol Violation|3
1313516|NCT00103857|4268087|P6|54-Week Base Study|Protocol Violation|3
1313517|NCT00103857|4268088|P5|54-Week Base Study|Protocol Violation|0
1313518|NCT00103857|4268089|P4|54-Week Base Study|Protocol Violation|4
1313519|NCT00103857|4268090|P3|54-Week Base Study|Protocol Violation|2
1313520|NCT00103857|4268091|P2|54-Week Base Study|Protocol Violation|4
1313521|NCT00103857|4268092|P1|54-Week Base Study|Protocol Violation|6
1313522|NCT00103857|4268086|P7|54-Week Base Study|Pregnancy|1
1313523|NCT00103857|4268087|P6|54-Week Base Study|Pregnancy|0
1313524|NCT00103857|4268088|P5|54-Week Base Study|Pregnancy|1
1313525|NCT00103857|4268089|P4|54-Week Base Study|Pregnancy|0
1313526|NCT00103857|4268090|P3|54-Week Base Study|Pregnancy|0
1313527|NCT00103857|4268091|P2|54-Week Base Study|Pregnancy|0
1313528|NCT00103857|4268092|P1|54-Week Base Study|Pregnancy|1
1313529|NCT00103857|4268086|P7|54-Week Base Study|Physician Decision|0
1313530|NCT00103857|4268087|P6|54-Week Base Study|Physician Decision|0
1313531|NCT00103857|4268088|P5|54-Week Base Study|Physician Decision|1
1313532|NCT00103857|4268089|P4|54-Week Base Study|Physician Decision|0
1313533|NCT00103857|4268090|P3|54-Week Base Study|Physician Decision|0
1313534|NCT00103857|4268091|P2|54-Week Base Study|Physician Decision|1
1313535|NCT00103857|4268092|P1|54-Week Base Study|Physician Decision|1
1313536|NCT00103857|4268086|P7|54-Week Base Study|Lost to Follow-up|3
1313537|NCT00103857|4268087|P6|54-Week Base Study|Lost to Follow-up|9
1313538|NCT00103857|4268088|P5|54-Week Base Study|Lost to Follow-up|10
1313539|NCT00103857|4268089|P4|54-Week Base Study|Lost to Follow-up|5
1313540|NCT00103857|4268090|P3|54-Week Base Study|Lost to Follow-up|7
1313541|NCT00103857|4268091|P2|54-Week Base Study|Lost to Follow-up|4
1313542|NCT00103857|4268092|P1|54-Week Base Study|Lost to Follow-up|5
1313543|NCT00103857|4268086|P7|54-Week Base Study|Lack of Efficacy|19
1313544|NCT00103857|4268087|P6|54-Week Base Study|Lack of Efficacy|14
1313545|NCT00103857|4268088|P5|54-Week Base Study|Lack of Efficacy|3
1313546|NCT00103857|4268089|P4|54-Week Base Study|Lack of Efficacy|4
1313547|NCT00103857|4268090|P3|54-Week Base Study|Lack of Efficacy|8
1313548|NCT00103857|4268091|P2|54-Week Base Study|Lack of Efficacy|14
1313549|NCT00103857|4268092|P1|54-Week Base Study|Lack of Efficacy|11
1313550|NCT00103857|4268086|P7|54-Week Base Study|Death|0
1313551|NCT00103857|4268087|P6|54-Week Base Study|Death|1
1313552|NCT00103857|4268088|P5|54-Week Base Study|Death|1
1313553|NCT00103857|4268089|P4|54-Week Base Study|Death|0
1313554|NCT00103857|4268090|P3|54-Week Base Study|Death|0
1313555|NCT00103857|4268091|P2|54-Week Base Study|Death|0
1313556|NCT00103857|4268092|P1|54-Week Base Study|Death|0
1313557|NCT00103857|4268086|P7|54-Week Base Study|Adverse Event|3
1313558|NCT00103857|4268087|P6|54-Week Base Study|Adverse Event|11
1313559|NCT00103857|4268088|P5|54-Week Base Study|Adverse Event|5
1313560|NCT00103857|4268089|P4|54-Week Base Study|Adverse Event|6
1313561|NCT00103857|4268090|P3|54-Week Base Study|Adverse Event|11
1313562|NCT00103857|4268091|P2|54-Week Base Study|Adverse Event|9
1313563|NCT00103857|4268092|P1|54-Week Base Study|Adverse Event|12
1313564|NCT00103740|4268191|P2|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9
1313565|NCT00103740|4268192|P1|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30
1313566|NCT00103740|4268191|P2|Period 2 - Extended Observation Period|Death|2
1313567|NCT00103740|4268192|P1|Period 2 - Extended Observation Period|Death|6
1313568|NCT00103740|4268191|P2|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6
1313569|NCT00103740|4268192|P1|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5
1313570|NCT00103740|4268191|P2|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13
1313571|NCT00103740|4268192|P1|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21
1313572|NCT00103740|4268191|P2|Period 2 - Extended Observation Period|Lost to Follow-up|6
1313573|NCT00103740|4268192|P1|Period 2 - Extended Observation Period|Lost to Follow-up|7
1313574|NCT00103740|4268191|P2|Period 1 - Core|Patient withdrew consent|2
1313575|NCT00103740|4268192|P1|Period 1 - Core|Patient withdrew consent|3
1313576|NCT00103740|4268191|P2|Period 1 - Core|Protocol Violation|2
1313577|NCT00103740|4268192|P1|Period 1 - Core|Protocol Violation|3
1313578|NCT00103740|4268191|P2|Period 1 - Core|Adverse Event|0
1313579|NCT00103740|4268192|P1|Period 1 - Core|Adverse Event|1
1313580|NCT00103662|4268220|P2|Overall Study|Intercurrent illness|0
1313581|NCT00103662|4268221|P1|Overall Study|Intercurrent illness|1
1313582|NCT00103662|4268220|P2|Overall Study|Failed mobilization|4
1313583|NCT00103662|4268221|P1|Overall Study|Failed mobilization|0
1313584|NCT00103662|4268220|P2|Overall Study|Other|9
1313585|NCT00103662|4268221|P1|Overall Study|Other|6
1313586|NCT00103662|4268220|P2|Overall Study|Lost to Follow-up|1
1313587|NCT00103662|4268221|P1|Overall Study|Lost to Follow-up|0
1313588|NCT00103662|4268220|P2|Overall Study|Elective Withdrawal|5
1313589|NCT00103662|4268221|P1|Overall Study|Elective Withdrawal|5
1313590|NCT00103662|4268220|P2|Overall Study|Death|7
1313591|NCT00103662|4268221|P1|Overall Study|Death|7
1313592|NCT00103662|4268220|P2|Overall Study|Entered Rescue Procedure|7
1313593|NCT00103662|4268221|P1|Overall Study|Entered Rescue Procedure|0
1313594|NCT00103610|4268247|P2|Overall Study|Noncompliance|1
1313595|NCT00103610|4268248|P1|Overall Study|Noncompliance|0
1313596|NCT00103610|4268247|P2|Overall Study|Failed mobilization|5
1313597|NCT00103610|4268248|P1|Overall Study|Failed mobilization|1
1313598|NCT00103610|4268247|P2|Overall Study|Other|7
1313599|NCT00103610|4268248|P1|Overall Study|Other|2
1313600|NCT00103610|4268247|P2|Overall Study|Adverse Event|2
1313601|NCT00103610|4268248|P1|Overall Study|Adverse Event|2
1313602|NCT00103610|4268247|P2|Overall Study|Lost to Follow-up|1
1313603|NCT00103610|4268248|P1|Overall Study|Lost to Follow-up|3
1313604|NCT00103610|4268247|P2|Overall Study|Elective Withdrawal|0
1313605|NCT00103610|4268248|P1|Overall Study|Elective Withdrawal|4
1313606|NCT00103610|4268247|P2|Overall Study|Death|12
1313607|NCT00103610|4268248|P1|Overall Study|Death|16
1313608|NCT00103610|4268247|P2|Overall Study|Entered Rescue Procedure|52
1313609|NCT00103610|4268248|P1|Overall Study|Entered Rescue Procedure|10
1313610|NCT00103506|4268272|P2|Overall Study|Withdrawal by Subject|21
1313611|NCT00103506|4268273|P1|Overall Study|Withdrawal by Subject|18
1313612|NCT00103506|4268272|P2|Overall Study|Lost to Follow-up|13
1313613|NCT00103506|4268273|P1|Overall Study|Lost to Follow-up|13
1313614|NCT00103506|4268272|P2|Overall Study|Death|253
1313615|NCT00103506|4268273|P1|Overall Study|Death|257
1313616|NCT00103506|4268272|P2|Overall Study|Study closed by sponsor|37
1313617|NCT00103506|4268273|P1|Overall Study|Study closed by sponsor|34
1313618|NCT00103311|4268304|P2|Overall Study|Adverse Event|0
1313619|NCT00103311|4268305|P1|Overall Study|Adverse Event|1
1313620|NCT00103311|4268304|P2|Overall Study|Withdrawal by Subject|1
1313621|NCT00103311|4268305|P1|Overall Study|Withdrawal by Subject|2
1313622|NCT00103311|4268304|P2|Overall Study|Lost to Follow-up|0
1313623|NCT00103311|4268305|P1|Overall Study|Lost to Follow-up|1
1313624|NCT00103285|4268315|P8|Response Assignment|Other|53
1313625|NCT00103285|4268316|P7|Response Assignment|Other|11
1313626|NCT00103285|4268317|P6|Response Assignment|Other|17
1313627|NCT00103285|4268318|P5|Response Assignment|Other|37
1313628|NCT00103285|4268319|P4|Response Assignment|Other|38
1313629|NCT00103285|4268320|P3|Response Assignment|Other|48
1313630|NCT00103285|4268321|P2|Response Assignment|Other|30
1313631|NCT00103285|4268322|P1|Response Assignment|Other|0
1313632|NCT00103285|4268315|P8|Response Assignment|Refusal|10
1313633|NCT00103285|4268316|P7|Response Assignment|Refusal|30
1313634|NCT00103285|4268317|P6|Response Assignment|Refusal|15
1313635|NCT00103285|4268318|P5|Response Assignment|Refusal|25
1313636|NCT00103285|4268319|P4|Response Assignment|Refusal|3
1313637|NCT00103285|4268320|P3|Response Assignment|Refusal|5
1313638|NCT00103285|4268321|P2|Response Assignment|Refusal|53
1313639|NCT00103285|4268322|P1|Response Assignment|Refusal|0
1313640|NCT00103285|4268315|P8|Response Assignment|Ineligible|5
1313641|NCT00103285|4268316|P7|Response Assignment|Ineligible|1
1313642|NCT00103285|4268317|P6|Response Assignment|Ineligible|3
1313643|NCT00103285|4268318|P5|Response Assignment|Ineligible|0
1313644|NCT00103285|4268319|P4|Response Assignment|Ineligible|2
1313645|NCT00103285|4268320|P3|Response Assignment|Ineligible|6
1313646|NCT00103285|4268321|P2|Response Assignment|Ineligible|8
1313647|NCT00103285|4268322|P1|Response Assignment|Ineligible|0
1313648|NCT00103285|4268315|P8|Response Assignment|Withdrawal by Subject|2
1313649|NCT00103285|4268316|P7|Response Assignment|Withdrawal by Subject|0
1313650|NCT00103285|4268317|P6|Response Assignment|Withdrawal by Subject|2
1313651|NCT00103285|4268318|P5|Response Assignment|Withdrawal by Subject|2
1313652|NCT00103285|4268319|P4|Response Assignment|Withdrawal by Subject|1
1313653|NCT00103285|4268320|P3|Response Assignment|Withdrawal by Subject|1
1313654|NCT00103285|4268321|P2|Response Assignment|Withdrawal by Subject|4
1313655|NCT00103285|4268322|P1|Response Assignment|Withdrawal by Subject|0
1313656|NCT00103285|4268315|P8|Response Assignment|Protocol Violation|0
1313657|NCT00103285|4268316|P7|Response Assignment|Protocol Violation|0
1313658|NCT00103285|4268317|P6|Response Assignment|Protocol Violation|0
1313659|NCT00103285|4268318|P5|Response Assignment|Protocol Violation|0
1313660|NCT00103285|4268319|P4|Response Assignment|Protocol Violation|0
1313661|NCT00103285|4268320|P3|Response Assignment|Protocol Violation|0
1313662|NCT00103285|4268321|P2|Response Assignment|Protocol Violation|2
1313663|NCT00103285|4268322|P1|Response Assignment|Protocol Violation|0
1313664|NCT00103285|4268315|P8|Response Assignment|Physician Decision|35
1313665|NCT00103285|4268316|P7|Response Assignment|Physician Decision|4
1313666|NCT00103285|4268317|P6|Response Assignment|Physician Decision|7
1313667|NCT00103285|4268318|P5|Response Assignment|Physician Decision|13
1313668|NCT00103285|4268319|P4|Response Assignment|Physician Decision|9
1313669|NCT00103285|4268320|P3|Response Assignment|Physician Decision|14
1313670|NCT00103285|4268321|P2|Response Assignment|Physician Decision|13
1313671|NCT00103285|4268322|P1|Response Assignment|Physician Decision|0
1313672|NCT00103285|4268315|P8|Response Assignment|Lost to Follow-up|5
1313673|NCT00103285|4268316|P7|Response Assignment|Lost to Follow-up|2
1313674|NCT00103285|4268317|P6|Response Assignment|Lost to Follow-up|2
1313675|NCT00103285|4268318|P5|Response Assignment|Lost to Follow-up|1
1313676|NCT00103285|4268319|P4|Response Assignment|Lost to Follow-up|5
1313677|NCT00103285|4268320|P3|Response Assignment|Lost to Follow-up|5
1313678|NCT00103285|4268321|P2|Response Assignment|Lost to Follow-up|9
1313679|NCT00103285|4268322|P1|Response Assignment|Lost to Follow-up|0
1313680|NCT00103285|4268315|P8|Response Assignment|Death|8
1313681|NCT00103285|4268316|P7|Response Assignment|Death|0
1313682|NCT00103285|4268317|P6|Response Assignment|Death|1
1313683|NCT00103285|4268318|P5|Response Assignment|Death|3
1313684|NCT00103285|4268319|P4|Response Assignment|Death|2
1313685|NCT00103285|4268320|P3|Response Assignment|Death|2
1313686|NCT00103285|4268321|P2|Response Assignment|Death|5
1313687|NCT00103285|4268322|P1|Response Assignment|Death|0
1313688|NCT00103285|4268315|P8|Response Assignment|Adverse Event|2
1313689|NCT00103285|4268316|P7|Response Assignment|Adverse Event|1
1313690|NCT00103285|4268317|P6|Response Assignment|Adverse Event|1
1313691|NCT00103285|4268318|P5|Response Assignment|Adverse Event|3
1313692|NCT00103285|4268319|P4|Response Assignment|Adverse Event|2
1313693|NCT00103285|4268320|P3|Response Assignment|Adverse Event|3
1313694|NCT00103285|4268321|P2|Response Assignment|Adverse Event|8
1313695|NCT00103285|4268322|P1|Response Assignment|Adverse Event|0
1313696|NCT00103285|4268315|P8|Induction|Other|0
1313697|NCT00103285|4268316|P7|Induction|Other|0
1313698|NCT00103285|4268317|P6|Induction|Other|0
1313699|NCT00103285|4268318|P5|Induction|Other|0
1313700|NCT00103285|4268319|P4|Induction|Other|0
1313701|NCT00103285|4268320|P3|Induction|Other|0
1313702|NCT00103285|4268321|P2|Induction|Other|0
1313703|NCT00103285|4268322|P1|Induction|Other|258
1313704|NCT00103285|4268315|P8|Induction|Refusal|0
1313705|NCT00103285|4268316|P7|Induction|Refusal|0
1313706|NCT00103285|4268317|P6|Induction|Refusal|0
1313707|NCT00103285|4268318|P5|Induction|Refusal|0
1313708|NCT00103285|4268319|P4|Induction|Refusal|0
1313709|NCT00103285|4268320|P3|Induction|Refusal|0
1313710|NCT00103285|4268321|P2|Induction|Refusal|0
1313711|NCT00103285|4268322|P1|Induction|Refusal|906
1313712|NCT00103285|4268315|P8|Induction|Ineligible|0
1313713|NCT00103285|4268316|P7|Induction|Ineligible|0
1313714|NCT00103285|4268317|P6|Induction|Ineligible|0
1313715|NCT00103285|4268318|P5|Induction|Ineligible|0
1313716|NCT00103285|4268319|P4|Induction|Ineligible|0
1313717|NCT00103285|4268320|P3|Induction|Ineligible|0
1313718|NCT00103285|4268321|P2|Induction|Ineligible|0
1313719|NCT00103285|4268322|P1|Induction|Ineligible|43
1313720|NCT00103285|4268315|P8|Induction|Withdrawal by Subject|0
1313721|NCT00103285|4268316|P7|Induction|Withdrawal by Subject|0
1313722|NCT00103285|4268317|P6|Induction|Withdrawal by Subject|0
1313723|NCT00103285|4268318|P5|Induction|Withdrawal by Subject|0
1313724|NCT00103285|4268319|P4|Induction|Withdrawal by Subject|0
1313725|NCT00103285|4268320|P3|Induction|Withdrawal by Subject|0
1313726|NCT00103285|4268321|P2|Induction|Withdrawal by Subject|0
1313727|NCT00103285|4268322|P1|Induction|Withdrawal by Subject|1
1313728|NCT00103285|4268315|P8|Induction|Physician Decision|0
1313729|NCT00103285|4268316|P7|Induction|Physician Decision|0
1313730|NCT00103285|4268317|P6|Induction|Physician Decision|0
1313731|NCT00103285|4268318|P5|Induction|Physician Decision|0
1313732|NCT00103285|4268319|P4|Induction|Physician Decision|0
1313733|NCT00103285|4268320|P3|Induction|Physician Decision|0
1313734|NCT00103285|4268321|P2|Induction|Physician Decision|0
1313735|NCT00103285|4268322|P1|Induction|Physician Decision|103
1313736|NCT00103285|4268315|P8|Induction|Death|0
1313737|NCT00103285|4268316|P7|Induction|Death|0
1313738|NCT00103285|4268317|P6|Induction|Death|0
1313739|NCT00103285|4268318|P5|Induction|Death|0
1313740|NCT00103285|4268319|P4|Induction|Death|0
1313741|NCT00103285|4268320|P3|Induction|Death|0
1313742|NCT00103285|4268321|P2|Induction|Death|0
1313743|NCT00103285|4268322|P1|Induction|Death|24
1313744|NCT00103285|4268315|P8|Induction|Adverse Event|0
1313745|NCT00103285|4268316|P7|Induction|Adverse Event|0
1313746|NCT00103285|4268317|P6|Induction|Adverse Event|0
1313747|NCT00103285|4268318|P5|Induction|Adverse Event|0
1313748|NCT00103285|4268319|P4|Induction|Adverse Event|0
1313749|NCT00103285|4268320|P3|Induction|Adverse Event|0
1313750|NCT00103285|4268321|P2|Induction|Adverse Event|0
1313751|NCT00103285|4268322|P1|Induction|Adverse Event|14
1313752|NCT00103259|4268351|P2|Overall Study|ineligible/no protocol therapy|6
1313753|NCT00103259|4268352|P1|Overall Study|ineligible/no protocol therapy|4
1313754|NCT00103259|4268351|P2|Overall Study|other (reasons were not specified)|1
1313755|NCT00103259|4268352|P1|Overall Study|other (reasons were not specified)|2
1313756|NCT00103259|4268351|P2|Overall Study|alternative therapy|0
1313757|NCT00103259|4268352|P1|Overall Study|alternative therapy|1
1313758|NCT00103259|4268351|P2|Overall Study|Withdrawal by Subject|3
1313759|NCT00103259|4268352|P1|Overall Study|Withdrawal by Subject|2
1313760|NCT00103259|4268351|P2|Overall Study|Death|2
1313761|NCT00103259|4268352|P1|Overall Study|Death|3
1313762|NCT00103207|4268364|P1|Overall Study|Diagnosis of BAC not confirmed|27
1313763|NCT00103207|4268364|P1|Overall Study|Ineligible|4
1313764|NCT00103207|4268364|P1|Overall Study|Other complicating disease|1
1313765|NCT00103207|4268364|P1|Overall Study|Withdrawal by Subject|2
1313766|NCT00103207|4268364|P1|Overall Study|Death|1
1313767|NCT00103207|4268364|P1|Overall Study|Adverse Event|3
1313768|NCT00103142|4268383|P2|Overall Study|Progression of disease|1
1313769|NCT00103142|4268384|P1|Overall Study|Progression of disease|2
1313770|NCT00103142|4268383|P2|Overall Study|Adverse Event|0
1313771|NCT00103142|4268384|P1|Overall Study|Adverse Event|1
1313772|NCT00103012|4268400|P3|Overall Study|Subject non-compliant with medications|1
1313773|NCT00103012|4268401|P2|Overall Study|Subject non-compliant with medications|0
1313774|NCT00103012|4268402|P1|Overall Study|Subject non-compliant with medications|0
1313775|NCT00103012|4268400|P3|Overall Study|Adverse Event|1
1313776|NCT00103012|4268401|P2|Overall Study|Adverse Event|0
1313777|NCT00103012|4268402|P1|Overall Study|Adverse Event|0
1313778|NCT00103012|4268400|P3|Overall Study|Pregnancy|0
1313779|NCT00103012|4268401|P2|Overall Study|Pregnancy|0
1313780|NCT00103012|4268402|P1|Overall Study|Pregnancy|1
1313781|NCT00103012|4268400|P3|Overall Study|Withdrawal by Subject|2
1313782|NCT00103012|4268401|P2|Overall Study|Withdrawal by Subject|1
1313783|NCT00103012|4268402|P1|Overall Study|Withdrawal by Subject|2
1313784|NCT00102960|4268413|P3|Overall Study|Withdrawal by Subject|1
1313785|NCT00102960|4268414|P2|Overall Study|Withdrawal by Subject|0
1313786|NCT00102960|4268415|P1|Overall Study|Withdrawal by Subject|1
1313787|NCT00102960|4268413|P3|Overall Study|Lost to Follow-up|16
1313788|NCT00102960|4268414|P2|Overall Study|Lost to Follow-up|12
1313789|NCT00102960|4268415|P1|Overall Study|Lost to Follow-up|6
1313790|NCT00102960|4268413|P3|Overall Study|Death|11
1313791|NCT00102960|4268414|P2|Overall Study|Death|11
1313792|NCT00102960|4268415|P1|Overall Study|Death|23
1313793|NCT00102804|4268464|P2|Overall Study|Alive, Receiving Treatment|2
1313794|NCT00102804|4268465|P1|Overall Study|Alive, Receiving Treatment|7
1313795|NCT00102804|4268464|P2|Overall Study|Sponsor Decision|0
1313796|NCT00102804|4268465|P1|Overall Study|Sponsor Decision|1
1313797|NCT00102804|4268464|P2|Overall Study|Satisfactory Response|0
1313798|NCT00102804|4268465|P1|Overall Study|Satisfactory Response|2
1313799|NCT00102804|4268464|P2|Overall Study|Protocol Violation|1
1313800|NCT00102804|4268465|P1|Overall Study|Protocol Violation|2
1313801|NCT00102804|4268464|P2|Overall Study|Lost to Follow-up|1
1313802|NCT00102804|4268465|P1|Overall Study|Lost to Follow-up|4
1313803|NCT00102804|4268464|P2|Overall Study|Enrollment Criteria Not Met|0
1313804|NCT00102804|4268465|P1|Overall Study|Enrollment Criteria Not Met|6
1313805|NCT00102804|4268464|P2|Overall Study|Death|6
1313806|NCT00102804|4268465|P1|Overall Study|Death|5
1313807|NCT00102804|4268464|P2|Overall Study|Physician Decision|6
1313808|NCT00102804|4268465|P1|Overall Study|Physician Decision|24
1313809|NCT00102804|4268464|P2|Overall Study|Adverse Event|3
1313810|NCT00102804|4268465|P1|Overall Study|Adverse Event|37
1313811|NCT00102804|4268464|P2|Overall Study|Withdrawal by Subject|7
1313812|NCT00102804|4268465|P1|Overall Study|Withdrawal by Subject|46
1313813|NCT00102804|4268464|P2|Overall Study|Progressive Disease (PD)|196
1313814|NCT00102804|4268465|P1|Overall Study|Progressive Disease (PD)|307
1313815|NCT00102687|4268486|P5|Maintenance Period|Death|1
1313816|NCT00102687|4268487|P4|Maintenance Period|Death|1
1313817|NCT00102687|4268488|P3|Maintenance Period|Death|0
1313818|NCT00102687|4268489|P2|Maintenance Period|Death|0
1313819|NCT00102687|4268490|P1|Maintenance Period|Death|0
1313820|NCT00102687|4268486|P5|Maintenance Period|Failed Treatment (relapse,disease prog)|4
1313821|NCT00102687|4268487|P4|Maintenance Period|Failed Treatment (relapse,disease prog)|3
1313822|NCT00102687|4268488|P3|Maintenance Period|Failed Treatment (relapse,disease prog)|1
1313823|NCT00102687|4268489|P2|Maintenance Period|Failed Treatment (relapse,disease prog)|1
1313824|NCT00102687|4268490|P1|Maintenance Period|Failed Treatment (relapse,disease prog)|1
1313825|NCT00102687|4268486|P5|Maintenance Period|Sponsor decision|0
1313826|NCT00102687|4268487|P4|Maintenance Period|Sponsor decision|0
1313827|NCT00102687|4268488|P3|Maintenance Period|Sponsor decision|0
1313828|NCT00102687|4268489|P2|Maintenance Period|Sponsor decision|0
1313829|NCT00102687|4268490|P1|Maintenance Period|Sponsor decision|0
1313830|NCT00102687|4268486|P5|Maintenance Period|Physician Decision|4
1313831|NCT00102687|4268487|P4|Maintenance Period|Physician Decision|0
1313832|NCT00102687|4268488|P3|Maintenance Period|Physician Decision|3
1313833|NCT00102687|4268489|P2|Maintenance Period|Physician Decision|2
1313834|NCT00102687|4268490|P1|Maintenance Period|Physician Decision|1
1313835|NCT00102687|4268486|P5|Maintenance Period|Protocol Violation|0
1313836|NCT00102687|4268487|P4|Maintenance Period|Protocol Violation|0
1313837|NCT00102687|4268488|P3|Maintenance Period|Protocol Violation|0
1313838|NCT00102687|4268489|P2|Maintenance Period|Protocol Violation|0
1313839|NCT00102687|4268490|P1|Maintenance Period|Protocol Violation|0
1313840|NCT00102687|4268486|P5|Maintenance Period|Transformation to AML (blast > 30%)|0
1313841|NCT00102687|4268487|P4|Maintenance Period|Transformation to AML (blast > 30%)|2
1313842|NCT00102687|4268488|P3|Maintenance Period|Transformation to AML (blast > 30%)|0
1313843|NCT00102687|4268489|P2|Maintenance Period|Transformation to AML (blast > 30%)|1
1313844|NCT00102687|4268490|P1|Maintenance Period|Transformation to AML (blast > 30%)|0
1313845|NCT00102687|4268486|P5|Maintenance Period|Adverse Event|3
1313846|NCT00102687|4268487|P4|Maintenance Period|Adverse Event|1
1313847|NCT00102687|4268488|P3|Maintenance Period|Adverse Event|0
1313848|NCT00102687|4268489|P2|Maintenance Period|Adverse Event|0
1313849|NCT00102687|4268490|P1|Maintenance Period|Adverse Event|1
1313850|NCT00102687|4268486|P5|Maintenance Period|Withdrawal by Subject|1
1313851|NCT00102687|4268487|P4|Maintenance Period|Withdrawal by Subject|3
1313852|NCT00102687|4268488|P3|Maintenance Period|Withdrawal by Subject|2
1313853|NCT00102687|4268489|P2|Maintenance Period|Withdrawal by Subject|0
1313854|NCT00102687|4268490|P1|Maintenance Period|Withdrawal by Subject|4
1313855|NCT00102687|4268486|P5|Initial Period|Death|0
1313856|NCT00102687|4268487|P4|Initial Period|Death|0
1313857|NCT00102687|4268488|P3|Initial Period|Death|1
1313858|NCT00102687|4268489|P2|Initial Period|Death|1
1313859|NCT00102687|4268490|P1|Initial Period|Death|1
1313860|NCT00102687|4268486|P5|Initial Period|Failed Treatments (relapse,disease prog)|0
1313861|NCT00102687|4268487|P4|Initial Period|Failed Treatments (relapse,disease prog)|0
1313862|NCT00102687|4268488|P3|Initial Period|Failed Treatments (relapse,disease prog)|2
1313863|NCT00102687|4268489|P2|Initial Period|Failed Treatments (relapse,disease prog)|4
1313864|NCT00102687|4268490|P1|Initial Period|Failed Treatments (relapse,disease prog)|4
1313865|NCT00102687|4268486|P5|Initial Period|Sponsor's decision|0
1313866|NCT00102687|4268487|P4|Initial Period|Sponsor's decision|0
1313867|NCT00102687|4268488|P3|Initial Period|Sponsor's decision|1
1313868|NCT00102687|4268489|P2|Initial Period|Sponsor's decision|1
1313869|NCT00102687|4268490|P1|Initial Period|Sponsor's decision|0
1313870|NCT00102687|4268486|P5|Initial Period|Physician Decision|0
1313871|NCT00102687|4268487|P4|Initial Period|Physician Decision|0
1313872|NCT00102687|4268488|P3|Initial Period|Physician Decision|6
1313873|NCT00102687|4268489|P2|Initial Period|Physician Decision|9
1313874|NCT00102687|4268490|P1|Initial Period|Physician Decision|2
1313875|NCT00102687|4268486|P5|Initial Period|Protocol Violation|0
1313876|NCT00102687|4268487|P4|Initial Period|Protocol Violation|0
1313877|NCT00102687|4268488|P3|Initial Period|Protocol Violation|2
1313878|NCT00102687|4268489|P2|Initial Period|Protocol Violation|0
1313879|NCT00102687|4268490|P1|Initial Period|Protocol Violation|0
1313880|NCT00102687|4268486|P5|Initial Period|Transformation to AML (blast > 30%)|0
1313881|NCT00102687|4268487|P4|Initial Period|Transformation to AML (blast > 30%)|0
1313882|NCT00102687|4268488|P3|Initial Period|Transformation to AML (blast > 30%)|0
1313883|NCT00102687|4268489|P2|Initial Period|Transformation to AML (blast > 30%)|3
1313884|NCT00102687|4268490|P1|Initial Period|Transformation to AML (blast > 30%)|1
1313885|NCT00102687|4268486|P5|Initial Period|Adverse Event|0
1313886|NCT00102687|4268487|P4|Initial Period|Adverse Event|0
1313887|NCT00102687|4268488|P3|Initial Period|Adverse Event|9
1313888|NCT00102687|4268489|P2|Initial Period|Adverse Event|7
1313889|NCT00102687|4268490|P1|Initial Period|Adverse Event|4
1313890|NCT00102687|4268486|P5|Initial Period|Withdrawal by Subject|0
1313891|NCT00102687|4268487|P4|Initial Period|Withdrawal by Subject|0
1313892|NCT00102687|4268488|P3|Initial Period|Withdrawal by Subject|5
1313893|NCT00102687|4268489|P2|Initial Period|Withdrawal by Subject|3
1313894|NCT00102687|4268490|P1|Initial Period|Withdrawal by Subject|6
1313895|NCT00102596|4268554|P2|Part A|Adverse Event|0
1313896|NCT00102596|4268555|P1|Part A|Adverse Event|1
1313897|NCT00102596|4268554|P2|Part A|Screen failures|0
1313898|NCT00102596|4268555|P1|Part A|Screen failures|6
1313899|NCT00102531|4268566|P2|Overall Study|Physician Decision|1
1313900|NCT00102531|4268567|P1|Overall Study|Physician Decision|0
1313901|NCT00102531|4268566|P2|Overall Study|Disease Progression|9
1313902|NCT00102531|4268567|P1|Overall Study|Disease Progression|5
1313903|NCT00102531|4268566|P2|Overall Study|Adverse Event|1
1313904|NCT00102531|4268567|P1|Overall Study|Adverse Event|0
1313905|NCT00102440|4268582|P3|Overall Study|Protocol Violation|1
1313906|NCT00102440|4268583|P2|Overall Study|Protocol Violation|2
1313907|NCT00102440|4268584|P1|Overall Study|Protocol Violation|7
1313908|NCT00102440|4268582|P3|Overall Study|Other|14
1313909|NCT00102440|4268583|P2|Overall Study|Other|14
1313910|NCT00102440|4268584|P1|Overall Study|Other|11
1313911|NCT00102440|4268582|P3|Overall Study|Personal Reason(s)|13
1313912|NCT00102440|4268583|P2|Overall Study|Personal Reason(s)|13
1313913|NCT00102440|4268584|P1|Overall Study|Personal Reason(s)|19
1313914|NCT00102440|4268582|P3|Overall Study|Gout Flare|9
1313915|NCT00102440|4268583|P2|Overall Study|Gout Flare|28
1313916|NCT00102440|4268584|P1|Overall Study|Gout Flare|10
1313917|NCT00102440|4268582|P3|Overall Study|Adverse Event|8
1313918|NCT00102440|4268583|P2|Overall Study|Adverse Event|23
1313919|NCT00102440|4268584|P1|Overall Study|Adverse Event|16
1313920|NCT00102440|4268582|P3|Overall Study|Lost to Follow-up|21
1313921|NCT00102440|4268583|P2|Overall Study|Lost to Follow-up|18
1313922|NCT00102440|4268584|P1|Overall Study|Lost to Follow-up|25
1313923|NCT00102063|4268634|P3|Overall Study|Protocol Violation|1
1313924|NCT00102063|4268635|P2|Overall Study|Protocol Violation|1
1313925|NCT00102063|4268636|P1|Overall Study|Protocol Violation|0
1313926|NCT00102063|4268634|P3|Overall Study|Lost to Follow-up|1
1313927|NCT00102063|4268635|P2|Overall Study|Lost to Follow-up|0
1313928|NCT00102063|4268636|P1|Overall Study|Lost to Follow-up|0
1313929|NCT00102063|4268634|P3|Overall Study|Withdrawal by Subject|5
1313930|NCT00102063|4268635|P2|Overall Study|Withdrawal by Subject|12
1313931|NCT00102063|4268636|P1|Overall Study|Withdrawal by Subject|4
1313932|NCT00102063|4268634|P3|Overall Study|Adverse Event|2
1313933|NCT00102063|4268635|P2|Overall Study|Adverse Event|4
1313934|NCT00102063|4268636|P1|Overall Study|Adverse Event|7
1313935|NCT00102063|4268634|P3|Overall Study|Lack of Efficacy|1
1313936|NCT00102063|4268635|P2|Overall Study|Lack of Efficacy|1
1313937|NCT00102063|4268636|P1|Overall Study|Lack of Efficacy|5
1313938|NCT00101907|4268694|P6|Overall Study|Withdrawal by Subject|0
1313939|NCT00101907|4268695|P5|Overall Study|Withdrawal by Subject|1
1313940|NCT00101907|4268696|P4|Overall Study|Withdrawal by Subject|0
1313941|NCT00101907|4268697|P3|Overall Study|Withdrawal by Subject|1
1313942|NCT00101907|4268698|P2|Overall Study|Withdrawal by Subject|0
1313943|NCT00101907|4268699|P1|Overall Study|Withdrawal by Subject|1
1313944|NCT00101907|4268694|P6|Overall Study|Physician Decision|0
1313945|NCT00101907|4268695|P5|Overall Study|Physician Decision|1
1313946|NCT00101907|4268696|P4|Overall Study|Physician Decision|1
1313947|NCT00101907|4268697|P3|Overall Study|Physician Decision|0
1313948|NCT00101907|4268698|P2|Overall Study|Physician Decision|0
1313949|NCT00101907|4268699|P1|Overall Study|Physician Decision|0
1313950|NCT00101907|4268694|P6|Overall Study|Death|0
1313951|NCT00101907|4268695|P5|Overall Study|Death|3
1313952|NCT00101907|4268696|P4|Overall Study|Death|0
1313953|NCT00101907|4268697|P3|Overall Study|Death|0
1313954|NCT00101907|4268698|P2|Overall Study|Death|1
1313955|NCT00101907|4268699|P1|Overall Study|Death|0
1313956|NCT00101907|4268694|P6|Overall Study|Adverse Event|0
1313957|NCT00101907|4268695|P5|Overall Study|Adverse Event|0
1313958|NCT00101907|4268696|P4|Overall Study|Adverse Event|0
1313959|NCT00101907|4268697|P3|Overall Study|Adverse Event|0
1313960|NCT00101907|4268698|P2|Overall Study|Adverse Event|0
1313961|NCT00101907|4268699|P1|Overall Study|Adverse Event|1
1313962|NCT00101868|4268741|P2|Overall Study|Lost to Follow-up|13
1313963|NCT00101868|4268742|P1|Overall Study|Lost to Follow-up|8
1313964|NCT00101868|4268741|P2|Overall Study|Protocol Violation|0
1313965|NCT00101868|4268742|P1|Overall Study|Protocol Violation|3
1313966|NCT00101868|4268741|P2|Overall Study|Withdrawal by Subject|9
1313967|NCT00101868|4268742|P1|Overall Study|Withdrawal by Subject|8
1313968|NCT00101868|4268741|P2|Overall Study|Death|10
1313969|NCT00101868|4268742|P1|Overall Study|Death|10
1313970|NCT00101686|4268812|P10|Overall Study|Withdrawal by Subject|9
1313971|NCT00101686|4268813|P9|Overall Study|Withdrawal by Subject|8
1313972|NCT00101686|4268814|P8|Overall Study|Withdrawal by Subject|7
1313973|NCT00101686|4268815|P7|Overall Study|Withdrawal by Subject|7
1313974|NCT00101686|4268816|P6|Overall Study|Withdrawal by Subject|7
1313975|NCT00101686|4268817|P5|Overall Study|Withdrawal by Subject|8
1313976|NCT00101686|4268818|P4|Overall Study|Withdrawal by Subject|8
1313977|NCT00101686|4268819|P3|Overall Study|Withdrawal by Subject|6
1313978|NCT00101686|4268820|P2|Overall Study|Withdrawal by Subject|8
1313979|NCT00101686|4268821|P1|Overall Study|Withdrawal by Subject|9
1313980|NCT00101686|4268812|P10|Overall Study|Other|3
1313981|NCT00101686|4268813|P9|Overall Study|Other|3
1313982|NCT00101686|4268814|P8|Overall Study|Other|5
1313983|NCT00101686|4268815|P7|Overall Study|Other|1
1313984|NCT00101686|4268816|P6|Overall Study|Other|12
1313985|NCT00101686|4268817|P5|Overall Study|Other|2
1313986|NCT00101686|4268818|P4|Overall Study|Other|6
1313987|NCT00101686|4268819|P3|Overall Study|Other|1
1313988|NCT00101686|4268820|P2|Overall Study|Other|4
1313989|NCT00101686|4268821|P1|Overall Study|Other|1
1313990|NCT00101686|4268812|P10|Overall Study|Physician Decision|1
1313991|NCT00101686|4268813|P9|Overall Study|Physician Decision|1
1313992|NCT00101686|4268814|P8|Overall Study|Physician Decision|5
1313993|NCT00101686|4268815|P7|Overall Study|Physician Decision|5
1313994|NCT00101686|4268816|P6|Overall Study|Physician Decision|9
1313995|NCT00101686|4268817|P5|Overall Study|Physician Decision|8
1313996|NCT00101686|4268818|P4|Overall Study|Physician Decision|7
1313997|NCT00101686|4268819|P3|Overall Study|Physician Decision|6
1313998|NCT00101686|4268820|P2|Overall Study|Physician Decision|13
1313999|NCT00101686|4268821|P1|Overall Study|Physician Decision|10
1314000|NCT00101686|4268812|P10|Overall Study|intercurrent non-cancer related illness|1
1314001|NCT00101686|4268813|P9|Overall Study|intercurrent non-cancer related illness|1
1314002|NCT00101686|4268814|P8|Overall Study|intercurrent non-cancer related illness|0
1314003|NCT00101686|4268815|P7|Overall Study|intercurrent non-cancer related illness|1
1314004|NCT00101686|4268816|P6|Overall Study|intercurrent non-cancer related illness|3
1314005|NCT00101686|4268817|P5|Overall Study|intercurrent non-cancer related illness|1
1314006|NCT00101686|4268818|P4|Overall Study|intercurrent non-cancer related illness|0
1314007|NCT00101686|4268819|P3|Overall Study|intercurrent non-cancer related illness|2
1314008|NCT00101686|4268820|P2|Overall Study|intercurrent non-cancer related illness|0
1314009|NCT00101686|4268821|P1|Overall Study|intercurrent non-cancer related illness|0
1314010|NCT00101686|4268812|P10|Overall Study|Randomized but did not receive treament|1
1314011|NCT00101686|4268813|P9|Overall Study|Randomized but did not receive treament|0
1314012|NCT00101686|4268814|P8|Overall Study|Randomized but did not receive treament|1
1314013|NCT00101686|4268815|P7|Overall Study|Randomized but did not receive treament|0
1314014|NCT00101686|4268816|P6|Overall Study|Randomized but did not receive treament|2
1314015|NCT00101686|4268817|P5|Overall Study|Randomized but did not receive treament|2
1314016|NCT00101686|4268818|P4|Overall Study|Randomized but did not receive treament|2
1314017|NCT00101686|4268819|P3|Overall Study|Randomized but did not receive treament|2
1314018|NCT00101686|4268820|P2|Overall Study|Randomized but did not receive treament|6
1314019|NCT00101686|4268821|P1|Overall Study|Randomized but did not receive treament|1
1314020|NCT00101686|4268812|P10|Overall Study|unacceptable toxicity|4
1314021|NCT00101686|4268813|P9|Overall Study|unacceptable toxicity|1
1314022|NCT00101686|4268814|P8|Overall Study|unacceptable toxicity|2
1314023|NCT00101686|4268815|P7|Overall Study|unacceptable toxicity|4
1314024|NCT00101686|4268816|P6|Overall Study|unacceptable toxicity|10
1314025|NCT00101686|4268817|P5|Overall Study|unacceptable toxicity|16
1314026|NCT00101686|4268818|P4|Overall Study|unacceptable toxicity|6
1314027|NCT00101686|4268819|P3|Overall Study|unacceptable toxicity|10
1314028|NCT00101686|4268820|P2|Overall Study|unacceptable toxicity|9
1314029|NCT00101686|4268821|P1|Overall Study|unacceptable toxicity|3
1314030|NCT00101686|4268812|P10|Overall Study|>3 week delay treatment due toxicity|0
1314031|NCT00101686|4268813|P9|Overall Study|>3 week delay treatment due toxicity|3
1314032|NCT00101686|4268814|P8|Overall Study|>3 week delay treatment due toxicity|1
1314033|NCT00101686|4268815|P7|Overall Study|>3 week delay treatment due toxicity|2
1314034|NCT00101686|4268816|P6|Overall Study|>3 week delay treatment due toxicity|3
1314035|NCT00101686|4268817|P5|Overall Study|>3 week delay treatment due toxicity|7
1314036|NCT00101686|4268818|P4|Overall Study|>3 week delay treatment due toxicity|2
1314037|NCT00101686|4268819|P3|Overall Study|>3 week delay treatment due toxicity|1
1314038|NCT00101686|4268820|P2|Overall Study|>3 week delay treatment due toxicity|2
1314039|NCT00101686|4268821|P1|Overall Study|>3 week delay treatment due toxicity|6
1314040|NCT00101686|4268812|P10|Overall Study|initiation other anti-cancer treatment|3
1314041|NCT00101686|4268813|P9|Overall Study|initiation other anti-cancer treatment|3
1314042|NCT00101686|4268814|P8|Overall Study|initiation other anti-cancer treatment|2
1314043|NCT00101686|4268815|P7|Overall Study|initiation other anti-cancer treatment|2
1314044|NCT00101686|4268816|P6|Overall Study|initiation other anti-cancer treatment|1
1314045|NCT00101686|4268817|P5|Overall Study|initiation other anti-cancer treatment|1
1314046|NCT00101686|4268818|P4|Overall Study|initiation other anti-cancer treatment|3
1314047|NCT00101686|4268819|P3|Overall Study|initiation other anti-cancer treatment|4
1314048|NCT00101686|4268820|P2|Overall Study|initiation other anti-cancer treatment|3
1314049|NCT00101686|4268821|P1|Overall Study|initiation other anti-cancer treatment|4
1314050|NCT00101686|4268812|P10|Overall Study|Progressive Disease|8
1314051|NCT00101686|4268813|P9|Overall Study|Progressive Disease|10
1314052|NCT00101686|4268814|P8|Overall Study|Progressive Disease|7
1314053|NCT00101686|4268815|P7|Overall Study|Progressive Disease|5
1314054|NCT00101686|4268816|P6|Overall Study|Progressive Disease|25
1314055|NCT00101686|4268817|P5|Overall Study|Progressive Disease|28
1314056|NCT00101686|4268818|P4|Overall Study|Progressive Disease|38
1314057|NCT00101686|4268819|P3|Overall Study|Progressive Disease|37
1314058|NCT00101686|4268820|P2|Overall Study|Progressive Disease|28
1314059|NCT00101686|4268821|P1|Overall Study|Progressive Disease|37
1314060|NCT00101582|4268938|P2|Overall Study|Other|1
1314061|NCT00101582|4268939|P1|Overall Study|Other|0
1314062|NCT00101582|4268938|P2|Overall Study|Death|5
1314063|NCT00101582|4268939|P1|Overall Study|Death|3
1314064|NCT00101582|4268938|P2|Overall Study|Physician Decision|0
1314065|NCT00101582|4268939|P1|Overall Study|Physician Decision|1
1314066|NCT00101582|4268938|P2|Overall Study|Withdrawal by Subject|4
1314067|NCT00101582|4268939|P1|Overall Study|Withdrawal by Subject|6
1314068|NCT00101582|4268938|P2|Overall Study|Adverse Event|4
1314069|NCT00101582|4268939|P1|Overall Study|Adverse Event|1
1314070|NCT00101582|4268938|P2|Overall Study|Ineligibility determined|1
1314071|NCT00101582|4268939|P1|Overall Study|Ineligibility determined|0
1314072|NCT00101452|4268962|P3|Overall Study|Other|12
1314073|NCT00101452|4268963|P2|Overall Study|Other|16
1314074|NCT00101452|4268964|P1|Overall Study|Other|15
1314075|NCT00101452|4268962|P3|Overall Study|Protocol Violation|3
1314076|NCT00101452|4268963|P2|Overall Study|Protocol Violation|1
1314077|NCT00101452|4268964|P1|Overall Study|Protocol Violation|2
1314078|NCT00101452|4268962|P3|Overall Study|Physician Decision|2
1314079|NCT00101452|4268963|P2|Overall Study|Physician Decision|3
1314080|NCT00101452|4268964|P1|Overall Study|Physician Decision|0
1314081|NCT00101452|4268962|P3|Overall Study|Baseline Fail|2
1314082|NCT00101452|4268963|P2|Overall Study|Baseline Fail|1
1314083|NCT00101452|4268964|P1|Overall Study|Baseline Fail|2
1314084|NCT00101452|4268962|P3|Overall Study|Withdrawal by Subject|9
1314085|NCT00101452|4268963|P2|Overall Study|Withdrawal by Subject|14
1314086|NCT00101452|4268964|P1|Overall Study|Withdrawal by Subject|10
1314087|NCT00101452|4268962|P3|Overall Study|Lost to Follow-up|14
1314088|NCT00101452|4268963|P2|Overall Study|Lost to Follow-up|8
1314089|NCT00101452|4268964|P1|Overall Study|Lost to Follow-up|13
1314090|NCT00101452|4268962|P3|Overall Study|Adverse Event|1
1314091|NCT00101452|4268963|P2|Overall Study|Adverse Event|0
1314092|NCT00101452|4268964|P1|Overall Study|Adverse Event|2
1314093|NCT00101439|4268978|P2|Period 2|Withdrawal by Subject|2
1314094|NCT00101439|4268979|P1|Period 2|Withdrawal by Subject|0
1314095|NCT00101400|4268995|P1|Survival Follow-Up|Alive|7
1314096|NCT00101283|4269015|P2|Overall Study|Prostate Cancer Recurrence|1
1314097|NCT00101283|4269016|P1|Overall Study|Prostate Cancer Recurrence|0
1314098|NCT00101283|4269015|P2|Overall Study|Insurance Refusal|1
1314099|NCT00101283|4269016|P1|Overall Study|Insurance Refusal|0
1314100|NCT00101283|4269015|P2|Overall Study|Withdrawal by Subject|1
1314101|NCT00101283|4269016|P1|Overall Study|Withdrawal by Subject|0
1314102|NCT00101192|4269026|P1|Overall Study|Inevaluable|1
1314103|NCT00101192|4269026|P1|Overall Study|Ineligible|6
1314104|NCT00101166|4269030|P1|Overall Study|progressive disease|10
1314105|NCT00101101|4269038|P1|Overall Study|never received vaccine|20
1314106|NCT00100932|4269061|P2|Overall Study|Not specified|2
1314107|NCT00100932|4269062|P1|Overall Study|Not specified|5
1314108|NCT00100932|4269061|P2|Overall Study|Physician Decision|5
1314109|NCT00100932|4269062|P1|Overall Study|Physician Decision|7
1314110|NCT00100932|4269061|P2|Overall Study|Progressive Disease|18
1314111|NCT00100932|4269062|P1|Overall Study|Progressive Disease|44
1314112|NCT00100932|4269061|P2|Overall Study|Withdrawal by Subject|0
1314113|NCT00100932|4269062|P1|Overall Study|Withdrawal by Subject|6
1314114|NCT00100932|4269061|P2|Overall Study|Adverse Event|2
1314115|NCT00100932|4269062|P1|Overall Study|Adverse Event|11
1314116|NCT00100828|4269077|P1|Overall Study|Physician Decision|6
1314117|NCT00100815|4269081|P1|Overall Study|not specified|3
1314118|NCT00100815|4269081|P1|Overall Study|Death|4
1314119|NCT00100815|4269081|P1|Overall Study|Adverse Event|18
1314120|NCT00100815|4269081|P1|Overall Study|Progression|24
1314121|NCT00100802|4269089|P1|Overall Study|Ineligible|12
1314122|NCT00100802|4269089|P1|Overall Study|Withdrawal by Subject|5
1314123|NCT00100802|4269089|P1|Overall Study|Protocol Violation|1
1314124|NCT00100802|4269089|P1|Overall Study|Physician Decision|5
1314125|NCT00100802|4269089|P1|Overall Study|Lack of Efficacy|47
1314126|NCT00100802|4269089|P1|Overall Study|Death|1
1314127|NCT00100802|4269089|P1|Overall Study|Adverse Event|9
1314128|NCT00100789|4269094|P1|Overall Study|Never received treatment|1
1314129|NCT00100789|4269094|P1|Overall Study|Ineligible|3
1314130|NCT00100789|4269094|P1|Overall Study|Not protocol specified|5
1314131|NCT00100789|4269094|P1|Overall Study|Death|2
1314132|NCT00100789|4269094|P1|Overall Study|Progression/relapse|42
1314133|NCT00100789|4269094|P1|Overall Study|Withdrawal by Subject|1
1314134|NCT00100789|4269094|P1|Overall Study|Adverse Event|10
1314135|NCT00100178|4269171|P3|Overall Study|Physician Decision|3
1314136|NCT00100178|4269172|P2|Overall Study|Physician Decision|1
1314137|NCT00100178|4269173|P1|Overall Study|Physician Decision|6
1314138|NCT00100178|4269171|P3|Overall Study|Withdrawal by Subject|1
1314139|NCT00100178|4269172|P2|Overall Study|Withdrawal by Subject|1
1314140|NCT00100178|4269173|P1|Overall Study|Withdrawal by Subject|1
1314141|NCT00100178|4269171|P3|Overall Study|Adverse Event|1
1314142|NCT00100178|4269172|P2|Overall Study|Adverse Event|2
1314143|NCT00100178|4269173|P1|Overall Study|Adverse Event|2
1314144|NCT00100178|4269171|P3|Overall Study|Lost to Follow-up|5
1314145|NCT00100178|4269172|P2|Overall Study|Lost to Follow-up|6
1314146|NCT00100178|4269173|P1|Overall Study|Lost to Follow-up|0
1314147|NCT00100048|4269186|P6|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
1314148|NCT00100048|4269187|P5|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
1314149|NCT00100048|4269188|P4|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1
1314150|NCT00100048|4269189|P3|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
1314151|NCT00100048|4269190|P2|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
1314152|NCT00100048|4269191|P1|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
1314153|NCT00100048|4269186|P6|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
1314154|NCT00100048|4269187|P5|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
1314155|NCT00100048|4269188|P4|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
1314156|NCT00100048|4269189|P3|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
1314157|NCT00100048|4269190|P2|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
1314158|NCT00100048|4269191|P1|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
1314159|NCT00100048|4269186|P6|Cohort I & II-Combination Therapy Phase|Other Reason|0
1314160|NCT00100048|4269187|P5|Cohort I & II-Combination Therapy Phase|Other Reason|0
1314161|NCT00100048|4269188|P4|Cohort I & II-Combination Therapy Phase|Other Reason|2
1314162|NCT00100048|4269189|P3|Cohort I & II-Combination Therapy Phase|Other Reason|4
1314163|NCT00100048|4269190|P2|Cohort I & II-Combination Therapy Phase|Other Reason|1
1314164|NCT00100048|4269191|P1|Cohort I & II-Combination Therapy Phase|Other Reason|7
1314165|NCT00100048|4269186|P6|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4
1314166|NCT00100048|4269187|P5|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0
1314167|NCT00100048|4269188|P4|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5
1314168|NCT00100048|4269189|P3|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
1314169|NCT00100048|4269190|P2|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
1314170|NCT00100048|4269191|P1|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1
1314171|NCT00100048|4269186|P6|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
1314172|NCT00100048|4269187|P5|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0
1314173|NCT00100048|4269188|P4|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
1314174|NCT00100048|4269189|P3|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
1314175|NCT00100048|4269190|P2|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1
1314176|NCT00100048|4269191|P1|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
1314177|NCT00100048|4269186|P6|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2
1314178|NCT00100048|4269187|P5|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
1314179|NCT00100048|4269188|P4|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
1314180|NCT00100048|4269189|P3|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
1314181|NCT00100048|4269190|P2|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3
1314182|NCT00100048|4269191|P1|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1
1314183|NCT00100048|4269186|P6|Cohort I & II-Combination Therapy Phase|Adverse Event|1
1314184|NCT00100048|4269187|P5|Cohort I & II-Combination Therapy Phase|Adverse Event|0
1314185|NCT00100048|4269188|P4|Cohort I & II-Combination Therapy Phase|Adverse Event|0
1314186|NCT00100048|4269189|P3|Cohort I & II-Combination Therapy Phase|Adverse Event|2
1314187|NCT00100048|4269190|P2|Cohort I & II-Combination Therapy Phase|Adverse Event|1
1314188|NCT00100048|4269191|P1|Cohort I & II-Combination Therapy Phase|Adverse Event|0
1314189|NCT00100048|4269186|P6|Cohort I & II-Combination Therapy Phase|Never Treated|1
1314190|NCT00100048|4269187|P5|Cohort I & II-Combination Therapy Phase|Never Treated|0
1314191|NCT00100048|4269188|P4|Cohort I & II-Combination Therapy Phase|Never Treated|0
1314192|NCT00100048|4269189|P3|Cohort I & II-Combination Therapy Phase|Never Treated|0
1314193|NCT00100048|4269190|P2|Cohort I & II-Combination Therapy Phase|Never Treated|0
1314194|NCT00100048|4269191|P1|Cohort I & II-Combination Therapy Phase|Never Treated|2
1314195|NCT00099983|4269300|P2|Overall Study|Other issue|0
1314196|NCT00099983|4269301|P1|Overall Study|Other issue|1
1314197|NCT00099983|4269300|P2|Overall Study|Intolerant of burden of visits|1
1314198|NCT00099983|4269301|P1|Overall Study|Intolerant of burden of visits|0
1314199|NCT00099983|4269300|P2|Overall Study|Incarcerated|1
1314200|NCT00099983|4269301|P1|Overall Study|Incarcerated|0
1314201|NCT00099983|4269300|P2|Overall Study|Other psychiatric problem|0
1314202|NCT00099983|4269301|P1|Overall Study|Other psychiatric problem|1
1314203|NCT00099983|4269300|P2|Overall Study|Moved|0
1314204|NCT00099983|4269301|P1|Overall Study|Moved|1
1314205|NCT00099983|4269300|P2|Overall Study|Unable to return for appointments|1
1314206|NCT00099983|4269301|P1|Overall Study|Unable to return for appointments|1
1314207|NCT00099983|4269300|P2|Overall Study|Lack of Efficacy|1
1314208|NCT00099983|4269301|P1|Overall Study|Lack of Efficacy|0
1314209|NCT00099983|4269300|P2|Overall Study|Adverse Event|1
1314210|NCT00099983|4269301|P1|Overall Study|Adverse Event|1
1314211|NCT00099983|4269300|P2|Overall Study|Withdrawal by Subject|2
1314212|NCT00099983|4269301|P1|Overall Study|Withdrawal by Subject|3
1314213|NCT00099983|4269300|P2|Overall Study|Missing Source Documents|15
1314214|NCT00099983|4269301|P1|Overall Study|Missing Source Documents|14
1314215|NCT00099983|4269300|P2|Overall Study|Lost to Follow-up|3
1314216|NCT00099983|4269301|P1|Overall Study|Lost to Follow-up|2
1314217|NCT00099632|4269313|P6|Overall Study|Protocol Violation|1
1314218|NCT00099632|4269314|P5|Overall Study|Protocol Violation|0
1314219|NCT00099632|4269315|P4|Overall Study|Protocol Violation|0
1314220|NCT00099632|4269316|P3|Overall Study|Protocol Violation|0
1314221|NCT00099632|4269317|P2|Overall Study|Protocol Violation|0
1314222|NCT00099632|4269318|P1|Overall Study|Protocol Violation|0
1314223|NCT00099632|4269313|P6|Overall Study|Withdrawal by Subject|1
1314224|NCT00099632|4269314|P5|Overall Study|Withdrawal by Subject|0
1314225|NCT00099632|4269315|P4|Overall Study|Withdrawal by Subject|0
1314226|NCT00099632|4269316|P3|Overall Study|Withdrawal by Subject|0
1314227|NCT00099632|4269317|P2|Overall Study|Withdrawal by Subject|1
1314228|NCT00099632|4269318|P1|Overall Study|Withdrawal by Subject|0
1314229|NCT00099632|4269313|P6|Overall Study|Lost to Follow-up|0
1314230|NCT00099632|4269314|P5|Overall Study|Lost to Follow-up|1
1314231|NCT00099632|4269315|P4|Overall Study|Lost to Follow-up|1
1314232|NCT00099632|4269316|P3|Overall Study|Lost to Follow-up|3
1314233|NCT00099632|4269317|P2|Overall Study|Lost to Follow-up|0
1314234|NCT00099632|4269318|P1|Overall Study|Lost to Follow-up|1
1314235|NCT00099437|4269358|P2|Overall Study|Ongoing in FU but not on treatment|45
1314236|NCT00099437|4269359|P1|Overall Study|Ongoing in FU but not on treatment|37
1314237|NCT00099437|4269358|P2|Overall Study|Withdrawal by Subject|10
1314238|NCT00099437|4269359|P1|Overall Study|Withdrawal by Subject|6
1314239|NCT00099437|4269358|P2|Overall Study|Death|261
1314240|NCT00099437|4269359|P1|Overall Study|Death|293
1314241|NCT00099437|4269358|P2|Overall Study|Lost to Follow-up|33
1314242|NCT00099437|4269359|P1|Overall Study|Lost to Follow-up|30
1314243|NCT00099359|4269382|P3|Overall Study|moved out of area|4
1314244|NCT00099359|4269383|P2|Overall Study|moved out of area|7
1314245|NCT00099359|4269384|P1|Overall Study|moved out of area|9
1314246|NCT00099359|4269382|P3|Overall Study|Lost to Follow-up|24
1314247|NCT00099359|4269383|P2|Overall Study|Lost to Follow-up|24
1314248|NCT00099359|4269384|P1|Overall Study|Lost to Follow-up|15
1314249|NCT00099359|4269382|P3|Overall Study|Withdrawal by Subject|23
1314250|NCT00099359|4269383|P2|Overall Study|Withdrawal by Subject|19
1314251|NCT00099359|4269384|P1|Overall Study|Withdrawal by Subject|19
1314252|NCT00099359|4269382|P3|Overall Study|Death|17
1314253|NCT00099359|4269383|P2|Overall Study|Death|15
1314254|NCT00099359|4269384|P1|Overall Study|Death|11
1314255|NCT00099268|4269407|P2|Overall Study|Death|1
1314256|NCT00099268|4269408|P1|Overall Study|Death|3
1314257|NCT00099268|4269407|P2|Overall Study|Administrative problems|4
1314258|NCT00099268|4269408|P1|Overall Study|Administrative problems|4
1314259|NCT00099268|4269407|P2|Overall Study|Lack of Efficacy|18
1314260|NCT00099268|4269408|P1|Overall Study|Lack of Efficacy|5
1314261|NCT00099268|4269407|P2|Overall Study|Lost to Follow-up|4
1314262|NCT00099268|4269408|P1|Overall Study|Lost to Follow-up|6
1314263|NCT00099268|4269407|P2|Overall Study|Protocol Violation|8
1314264|NCT00099268|4269408|P1|Overall Study|Protocol Violation|9
1314265|NCT00099268|4269407|P2|Overall Study|Adverse Event|19
1314266|NCT00099268|4269408|P1|Overall Study|Adverse Event|19
1314267|NCT00099268|4269407|P2|Overall Study|Withdrawal by Subject|28
1314268|NCT00099268|4269408|P1|Overall Study|Withdrawal by Subject|46
1314269|NCT00098865|4269448|P1|Overall Study|Alternative Therapy|1
1314270|NCT00098865|4269448|P1|Overall Study|Adverse Event|2
1314271|NCT00098865|4269448|P1|Overall Study|Progressive Disease|6
1314272|NCT00098839|4269456|P2|Overall Study|Ineligible|0
1314273|NCT00098839|4269457|P1|Overall Study|Ineligible|2
1314274|NCT00098839|4269456|P2|Overall Study|M2/M3 marrow on Day 15 of Block 2|11
1314275|NCT00098839|4269457|P1|Overall Study|M2/M3 marrow on Day 15 of Block 2|10
1314276|NCT00098839|4269456|P2|Overall Study|Relapse|3
1314277|NCT00098839|4269457|P1|Overall Study|Relapse|6
1314278|NCT00098839|4269456|P2|Overall Study|Refusal of further protocol therapy|1
1314279|NCT00098839|4269457|P1|Overall Study|Refusal of further protocol therapy|3
1314280|NCT00098839|4269456|P2|Overall Study|Withdrawal by Subject|0
1314281|NCT00098839|4269457|P1|Overall Study|Withdrawal by Subject|1
1314282|NCT00098839|4269456|P2|Overall Study|Physician Decision|14
1314283|NCT00098839|4269457|P1|Overall Study|Physician Decision|4
1314284|NCT00098839|4269456|P2|Overall Study|Death|2
1314285|NCT00098839|4269457|P1|Overall Study|Death|1
1314286|NCT00098839|4269456|P2|Overall Study|Adverse Event|2
1314287|NCT00098839|4269457|P1|Overall Study|Adverse Event|5
1314288|NCT00098813|4269468|P1|Overall Study|Reversal of RAI resistance|1
1314289|NCT00098813|4269468|P1|Overall Study|Other complicating disease|1
1314290|NCT00098813|4269468|P1|Overall Study|Progression of Disease|1
1314291|NCT00098813|4269468|P1|Overall Study|Withdrawal by Subject|7
1314292|NCT00098813|4269468|P1|Overall Study|Protocol Violation|1
1314293|NCT00098813|4269468|P1|Overall Study|Death|8
1314294|NCT00098787|4269475|P3|Overall Study|Other|9
1314295|NCT00098787|4269476|P2|Overall Study|Other|6
1314296|NCT00098787|4269477|P1|Overall Study|Other|7
1314297|NCT00098787|4269475|P3|Overall Study|Alternative therapy|13
1314298|NCT00098787|4269476|P2|Overall Study|Alternative therapy|13
1314299|NCT00098787|4269477|P1|Overall Study|Alternative therapy|8
1314300|NCT00098787|4269475|P3|Overall Study|Withdrawal by Subject|6
1314301|NCT00098787|4269476|P2|Overall Study|Withdrawal by Subject|12
1314302|NCT00098787|4269477|P1|Overall Study|Withdrawal by Subject|4
1314303|NCT00098787|4269475|P3|Overall Study|Death|0
1314304|NCT00098787|4269476|P2|Overall Study|Death|1
1314305|NCT00098787|4269477|P1|Overall Study|Death|6
1314306|NCT00098787|4269475|P3|Overall Study|Adverse Event|8
1314307|NCT00098787|4269476|P2|Overall Study|Adverse Event|17
1314308|NCT00098787|4269477|P1|Overall Study|Adverse Event|8
1314309|NCT00098787|4269475|P3|Overall Study|Disease progression|23
1314310|NCT00098787|4269476|P2|Overall Study|Disease progression|17
1314311|NCT00098787|4269477|P1|Overall Study|Disease progression|28
1314312|NCT00098787|4269475|P3|Overall Study|Ineligible|3
1314313|NCT00098787|4269476|P2|Overall Study|Ineligible|7
1314314|NCT00098787|4269477|P1|Overall Study|Ineligible|9
1314315|NCT00098787|4269475|P3|Overall Study|Never started treatment|1
1314316|NCT00098787|4269476|P2|Overall Study|Never started treatment|2
1314317|NCT00098787|4269477|P1|Overall Study|Never started treatment|3
1314318|NCT00098774|4269491|P1|Overall Study|Physician Decision|2
1314319|NCT00098774|4269491|P1|Overall Study|Failed (to respond) during induction|4
1314320|NCT00098774|4269491|P1|Overall Study|Withdrawal by Subject|1
1314321|NCT00098774|4269491|P1|Overall Study|Disease Progression|9
1314322|NCT00098774|4269491|P1|Overall Study|Adverse Event|2
1314323|NCT00098748|4269501|P3|Continued on Open-Label Treatment|Withdrawal by Subject|0
1314324|NCT00098748|4269502|P2|Continued on Open-Label Treatment|Withdrawal by Subject|4
1314325|NCT00098748|4269503|P1|Continued on Open-Label Treatment|Withdrawal by Subject|0
1314326|NCT00098748|4269501|P3|Continued on Open-Label Treatment|Lost to Follow-up|0
1314327|NCT00098748|4269502|P2|Continued on Open-Label Treatment|Lost to Follow-up|1
1314328|NCT00098748|4269503|P1|Continued on Open-Label Treatment|Lost to Follow-up|1
1314329|NCT00098748|4269501|P3|Continued on Open-Label Treatment|Other reason includes protocol violation|0
1314330|NCT00098748|4269502|P2|Continued on Open-Label Treatment|Other reason includes protocol violation|7
1314331|NCT00098748|4269503|P1|Continued on Open-Label Treatment|Other reason includes protocol violation|6
1314332|NCT00098748|4269501|P3|Continued on Open-Label Treatment|Lack of Efficacy|0
1314333|NCT00098748|4269502|P2|Continued on Open-Label Treatment|Lack of Efficacy|2
1314334|NCT00098748|4269503|P1|Continued on Open-Label Treatment|Lack of Efficacy|1
1314335|NCT00098748|4269501|P3|Continued on Open-Label Treatment|Adverse Event|0
1314336|NCT00098748|4269502|P2|Continued on Open-Label Treatment|Adverse Event|1
1314337|NCT00098748|4269503|P1|Continued on Open-Label Treatment|Adverse Event|0
1314338|NCT00098748|4269501|P3|Received Study Treatment|Subject defaulted|4
1314339|NCT00098748|4269502|P2|Received Study Treatment|Subject defaulted|4
1314340|NCT00098748|4269503|P1|Received Study Treatment|Subject defaulted|3
1314341|NCT00098748|4269501|P3|Received Study Treatment|Other|6
1314342|NCT00098748|4269502|P2|Received Study Treatment|Other|2
1314343|NCT00098748|4269503|P1|Received Study Treatment|Other|2
1314344|NCT00098748|4269501|P3|Received Study Treatment|Lack of Efficacy|27
1314345|NCT00098748|4269502|P2|Received Study Treatment|Lack of Efficacy|27
1314346|NCT00098748|4269503|P1|Received Study Treatment|Lack of Efficacy|40
1314347|NCT00098748|4269501|P3|Received Study Treatment|Adverse Event|5
1314348|NCT00098748|4269502|P2|Received Study Treatment|Adverse Event|2
1314349|NCT00098748|4269503|P1|Received Study Treatment|Adverse Event|1
1314350|NCT00098748|4269501|P3|Received Study Treatment|Death|2
1314351|NCT00098748|4269502|P2|Received Study Treatment|Death|1
1314352|NCT00098748|4269503|P1|Received Study Treatment|Death|2
1314353|NCT00098748|4269501|P3|Assigned to Study Treatment|Randomized, but not treated|2
1314354|NCT00098748|4269502|P2|Assigned to Study Treatment|Randomized, but not treated|2
1314355|NCT00098748|4269503|P1|Assigned to Study Treatment|Randomized, but not treated|0
1314356|NCT00098722|4269559|P7|Observation Phase|Other|10
1314357|NCT00098722|4269560|P6|Observation Phase|Other|21
1314358|NCT00098722|4269561|P5|Observation Phase|Other|0
1314359|NCT00098722|4269562|P4|Observation Phase|Other|0
1314360|NCT00098722|4269563|P3|Observation Phase|Other|0
1314361|NCT00098722|4269564|P2|Observation Phase|Other|0
1314362|NCT00098722|4269565|P1|Observation Phase|Other|0
1314363|NCT00098722|4269559|P7|Observation Phase|Participant defaulted|4
1314364|NCT00098722|4269560|P6|Observation Phase|Participant defaulted|17
1314365|NCT00098722|4269561|P5|Observation Phase|Participant defaulted|0
1314366|NCT00098722|4269562|P4|Observation Phase|Participant defaulted|0
1314367|NCT00098722|4269563|P3|Observation Phase|Participant defaulted|0
1314368|NCT00098722|4269564|P2|Observation Phase|Participant defaulted|0
1314369|NCT00098722|4269565|P1|Observation Phase|Participant defaulted|0
1314370|NCT00098722|4269559|P7|Observation Phase|Lack of Efficacy|0
1314371|NCT00098722|4269560|P6|Observation Phase|Lack of Efficacy|2
1314372|NCT00098722|4269561|P5|Observation Phase|Lack of Efficacy|0
1314373|NCT00098722|4269562|P4|Observation Phase|Lack of Efficacy|0
1314374|NCT00098722|4269563|P3|Observation Phase|Lack of Efficacy|0
1314375|NCT00098722|4269564|P2|Observation Phase|Lack of Efficacy|0
1314376|NCT00098722|4269565|P1|Observation Phase|Lack of Efficacy|0
1314377|NCT00098722|4269559|P7|Observation Phase|Death|3
1314378|NCT00098722|4269560|P6|Observation Phase|Death|5
1314379|NCT00098722|4269561|P5|Observation Phase|Death|0
1314380|NCT00098722|4269562|P4|Observation Phase|Death|0
1314381|NCT00098722|4269563|P3|Observation Phase|Death|0
1314382|NCT00098722|4269564|P2|Observation Phase|Death|0
1314383|NCT00098722|4269565|P1|Observation Phase|Death|0
1314384|NCT00098722|4269559|P7|Open Label Phase|Other|0
1314385|NCT00098722|4269560|P6|Open Label Phase|Other|0
1314386|NCT00098722|4269561|P5|Open Label Phase|Other|0
1314387|NCT00098722|4269562|P4|Open Label Phase|Other|18
1314388|NCT00098722|4269563|P3|Open Label Phase|Other|0
1314389|NCT00098722|4269564|P2|Open Label Phase|Other|0
1314390|NCT00098722|4269565|P1|Open Label Phase|Other|0
1314391|NCT00098722|4269559|P7|Open Label Phase|Ongoing at cut-off date|0
1314392|NCT00098722|4269560|P6|Open Label Phase|Ongoing at cut-off date|0
1314393|NCT00098722|4269561|P5|Open Label Phase|Ongoing at cut-off date|50
1314394|NCT00098722|4269562|P4|Open Label Phase|Ongoing at cut-off date|220
1314395|NCT00098722|4269563|P3|Open Label Phase|Ongoing at cut-off date|0
1314396|NCT00098722|4269564|P2|Open Label Phase|Ongoing at cut-off date|0
1314397|NCT00098722|4269565|P1|Open Label Phase|Ongoing at cut-off date|0
1314398|NCT00098722|4269559|P7|Open Label Phase|Participant defaulted|0
1314399|NCT00098722|4269560|P6|Open Label Phase|Participant defaulted|0
1314400|NCT00098722|4269561|P5|Open Label Phase|Participant defaulted|0
1314401|NCT00098722|4269562|P4|Open Label Phase|Participant defaulted|18
1314402|NCT00098722|4269563|P3|Open Label Phase|Participant defaulted|0
1314403|NCT00098722|4269564|P2|Open Label Phase|Participant defaulted|0
1314404|NCT00098722|4269565|P1|Open Label Phase|Participant defaulted|0
1314405|NCT00098722|4269559|P7|Open Label Phase|Pregnancy|0
1314406|NCT00098722|4269560|P6|Open Label Phase|Pregnancy|0
1314407|NCT00098722|4269561|P5|Open Label Phase|Pregnancy|0
1314408|NCT00098722|4269562|P4|Open Label Phase|Pregnancy|1
1314409|NCT00098722|4269563|P3|Open Label Phase|Pregnancy|0
1314410|NCT00098722|4269564|P2|Open Label Phase|Pregnancy|0
1314411|NCT00098722|4269565|P1|Open Label Phase|Pregnancy|0
1314412|NCT00098722|4269559|P7|Open Label Phase|Lack of Efficacy|0
1314413|NCT00098722|4269560|P6|Open Label Phase|Lack of Efficacy|0
1314414|NCT00098722|4269561|P5|Open Label Phase|Lack of Efficacy|0
1314415|NCT00098722|4269562|P4|Open Label Phase|Lack of Efficacy|8
1314416|NCT00098722|4269563|P3|Open Label Phase|Lack of Efficacy|0
1314417|NCT00098722|4269564|P2|Open Label Phase|Lack of Efficacy|0
1314418|NCT00098722|4269565|P1|Open Label Phase|Lack of Efficacy|0
1314419|NCT00098722|4269559|P7|Open Label Phase|Death|0
1314420|NCT00098722|4269560|P6|Open Label Phase|Death|0
1314421|NCT00098722|4269561|P5|Open Label Phase|Death|0
1314422|NCT00098722|4269562|P4|Open Label Phase|Death|2
1314423|NCT00098722|4269563|P3|Open Label Phase|Death|0
1314424|NCT00098722|4269564|P2|Open Label Phase|Death|0
1314425|NCT00098722|4269565|P1|Open Label Phase|Death|0
1314426|NCT00098722|4269559|P7|Open Label Phase|Adverse Event|0
1314427|NCT00098722|4269560|P6|Open Label Phase|Adverse Event|0
1314428|NCT00098722|4269561|P5|Open Label Phase|Adverse Event|0
1314429|NCT00098722|4269562|P4|Open Label Phase|Adverse Event|5
1314430|NCT00098722|4269563|P3|Open Label Phase|Adverse Event|0
1314431|NCT00098722|4269564|P2|Open Label Phase|Adverse Event|0
1314432|NCT00098722|4269565|P1|Open Label Phase|Adverse Event|0
1314433|NCT00098722|4269559|P7|Double Blind Phase|Other|0
1314434|NCT00098722|4269560|P6|Double Blind Phase|Other|0
1314435|NCT00098722|4269561|P5|Double Blind Phase|Other|0
1314436|NCT00098722|4269562|P4|Double Blind Phase|Other|0
1314437|NCT00098722|4269563|P3|Double Blind Phase|Other|7
1314438|NCT00098722|4269564|P2|Double Blind Phase|Other|8
1314439|NCT00098722|4269565|P1|Double Blind Phase|Other|7
1314440|NCT00098722|4269559|P7|Double Blind Phase|Ongoing at cut-off date|0
1314441|NCT00098722|4269560|P6|Double Blind Phase|Ongoing at cut-off date|0
1314442|NCT00098722|4269561|P5|Double Blind Phase|Ongoing at cut-off date|0
1314443|NCT00098722|4269562|P4|Double Blind Phase|Ongoing at cut-off date|0
1314444|NCT00098722|4269563|P3|Double Blind Phase|Ongoing at cut-off date|57
1314445|NCT00098722|4269564|P2|Double Blind Phase|Ongoing at cut-off date|137
1314446|NCT00098722|4269565|P1|Double Blind Phase|Ongoing at cut-off date|128
1314447|NCT00098722|4269559|P7|Double Blind Phase|Randomized, not treated|0
1314448|NCT00098722|4269560|P6|Double Blind Phase|Randomized, not treated|0
1314449|NCT00098722|4269561|P5|Double Blind Phase|Randomized, not treated|0
1314450|NCT00098722|4269562|P4|Double Blind Phase|Randomized, not treated|0
1314451|NCT00098722|4269563|P3|Double Blind Phase|Randomized, not treated|3
1314452|NCT00098722|4269564|P2|Double Blind Phase|Randomized, not treated|3
1314453|NCT00098722|4269565|P1|Double Blind Phase|Randomized, not treated|4
1314454|NCT00098722|4269559|P7|Double Blind Phase|Pregnancy|0
1314455|NCT00098722|4269560|P6|Double Blind Phase|Pregnancy|0
1314456|NCT00098722|4269561|P5|Double Blind Phase|Pregnancy|0
1314457|NCT00098722|4269562|P4|Double Blind Phase|Pregnancy|0
1314458|NCT00098722|4269563|P3|Double Blind Phase|Pregnancy|0
1314459|NCT00098722|4269564|P2|Double Blind Phase|Pregnancy|0
1314460|NCT00098722|4269565|P1|Double Blind Phase|Pregnancy|1
1314461|NCT00098722|4269559|P7|Double Blind Phase|Participant defaulted|0
1314462|NCT00098722|4269560|P6|Double Blind Phase|Participant defaulted|0
1314463|NCT00098722|4269561|P5|Double Blind Phase|Participant defaulted|0
1314464|NCT00098722|4269562|P4|Double Blind Phase|Participant defaulted|0
1314465|NCT00098722|4269563|P3|Double Blind Phase|Participant defaulted|9
1314466|NCT00098722|4269564|P2|Double Blind Phase|Participant defaulted|11
1314467|NCT00098722|4269565|P1|Double Blind Phase|Participant defaulted|16
1314468|NCT00098722|4269559|P7|Double Blind Phase|Lack of Efficacy|0
1314469|NCT00098722|4269560|P6|Double Blind Phase|Lack of Efficacy|0
1314470|NCT00098722|4269561|P5|Double Blind Phase|Lack of Efficacy|0
1314471|NCT00098722|4269562|P4|Double Blind Phase|Lack of Efficacy|0
1314472|NCT00098722|4269563|P3|Double Blind Phase|Lack of Efficacy|15
1314473|NCT00098722|4269564|P2|Double Blind Phase|Lack of Efficacy|23
1314474|NCT00098722|4269565|P1|Double Blind Phase|Lack of Efficacy|21
1314475|NCT00098722|4269559|P7|Double Blind Phase|Death|0
1314476|NCT00098722|4269560|P6|Double Blind Phase|Death|0
1314477|NCT00098722|4269561|P5|Double Blind Phase|Death|0
1314478|NCT00098722|4269562|P4|Double Blind Phase|Death|0
1314479|NCT00098722|4269563|P3|Double Blind Phase|Death|0
1314480|NCT00098722|4269564|P2|Double Blind Phase|Death|5
1314481|NCT00098722|4269565|P1|Double Blind Phase|Death|2
1314482|NCT00098722|4269559|P7|Double Blind Phase|Adverse Event|0
1314483|NCT00098722|4269560|P6|Double Blind Phase|Adverse Event|0
1314484|NCT00098722|4269561|P5|Double Blind Phase|Adverse Event|0
1314485|NCT00098722|4269562|P4|Double Blind Phase|Adverse Event|0
1314486|NCT00098722|4269563|P3|Double Blind Phase|Adverse Event|3
1314487|NCT00098722|4269564|P2|Double Blind Phase|Adverse Event|7
1314488|NCT00098722|4269565|P1|Double Blind Phase|Adverse Event|7
1314489|NCT00098475|4269639|P4|Step 2|Never started treatment|0
1314490|NCT00098475|4269640|P3|Step 2|Never started treatment|0
1314491|NCT00098475|4269641|P2|Step 2|Never started treatment|1
1314492|NCT00098475|4269642|P1|Step 2|Never started treatment|1
1314493|NCT00098475|4269639|P4|Step 2|Alternative therapy|0
1314494|NCT00098475|4269640|P3|Step 2|Alternative therapy|0
1314495|NCT00098475|4269641|P2|Step 2|Alternative therapy|2
1314496|NCT00098475|4269642|P1|Step 2|Alternative therapy|1
1314497|NCT00098475|4269639|P4|Step 2|Physician Decision|0
1314498|NCT00098475|4269640|P3|Step 2|Physician Decision|0
1314499|NCT00098475|4269641|P2|Step 2|Physician Decision|1
1314500|NCT00098475|4269642|P1|Step 2|Physician Decision|0
1314501|NCT00098475|4269639|P4|Step 2|Withdrawal by Subject|0
1314502|NCT00098475|4269640|P3|Step 2|Withdrawal by Subject|0
1314503|NCT00098475|4269641|P2|Step 2|Withdrawal by Subject|2
1314504|NCT00098475|4269642|P1|Step 2|Withdrawal by Subject|0
1314505|NCT00098475|4269639|P4|Step 2|Adverse Event|0
1314506|NCT00098475|4269640|P3|Step 2|Adverse Event|0
1314507|NCT00098475|4269641|P2|Step 2|Adverse Event|0
1314508|NCT00098475|4269642|P1|Step 2|Adverse Event|2
1314509|NCT00098475|4269639|P4|Step 2|Disease progression|0
1314510|NCT00098475|4269640|P3|Step 2|Disease progression|0
1314511|NCT00098475|4269641|P2|Step 2|Disease progression|4
1314512|NCT00098475|4269642|P1|Step 2|Disease progression|1
1314513|NCT00098475|4269639|P4|Step 1|Not documented|0
1314514|NCT00098475|4269640|P3|Step 1|Not documented|0
1314515|NCT00098475|4269641|P2|Step 1|Not documented|1
1314516|NCT00098475|4269642|P1|Step 1|Not documented|0
1314517|NCT00098475|4269639|P4|Step 1|Patient fell with fracture|0
1314518|NCT00098475|4269640|P3|Step 1|Patient fell with fracture|0
1314519|NCT00098475|4269641|P2|Step 1|Patient fell with fracture|0
1314520|NCT00098475|4269642|P1|Step 1|Patient fell with fracture|1
1314521|NCT00098475|4269639|P4|Step 1|Misinterpretation of lab data|0
1314522|NCT00098475|4269640|P3|Step 1|Misinterpretation of lab data|0
1314523|NCT00098475|4269641|P2|Step 1|Misinterpretation of lab data|1
1314524|NCT00098475|4269642|P1|Step 1|Misinterpretation of lab data|0
1314525|NCT00098475|4269639|P4|Step 1|Criteria to continue treatment not met|0
1314526|NCT00098475|4269640|P3|Step 1|Criteria to continue treatment not met|0
1314527|NCT00098475|4269641|P2|Step 1|Criteria to continue treatment not met|1
1314528|NCT00098475|4269642|P1|Step 1|Criteria to continue treatment not met|0
1314529|NCT00098475|4269639|P4|Step 1|Referred to other physicians|0
1314530|NCT00098475|4269640|P3|Step 1|Referred to other physicians|0
1314531|NCT00098475|4269641|P2|Step 1|Referred to other physicians|1
1314532|NCT00098475|4269642|P1|Step 1|Referred to other physicians|0
1314533|NCT00098475|4269639|P4|Step 1|Rising paraprotein|0
1314534|NCT00098475|4269640|P3|Step 1|Rising paraprotein|0
1314535|NCT00098475|4269641|P2|Step 1|Rising paraprotein|1
1314536|NCT00098475|4269642|P1|Step 1|Rising paraprotein|0
1314537|NCT00098475|4269639|P4|Step 1|Insurance issue|0
1314538|NCT00098475|4269640|P3|Step 1|Insurance issue|0
1314539|NCT00098475|4269641|P2|Step 1|Insurance issue|1
1314540|NCT00098475|4269642|P1|Step 1|Insurance issue|0
1314541|NCT00098475|4269639|P4|Step 1|Declining performance status|0
1314542|NCT00098475|4269640|P3|Step 1|Declining performance status|0
1314543|NCT00098475|4269641|P2|Step 1|Declining performance status|1
1314544|NCT00098475|4269642|P1|Step 1|Declining performance status|0
1314545|NCT00098475|4269639|P4|Step 1|Off treatment for > specified timeframe|0
1314546|NCT00098475|4269640|P3|Step 1|Off treatment for > specified timeframe|0
1314547|NCT00098475|4269641|P2|Step 1|Off treatment for > specified timeframe|1
1314548|NCT00098475|4269642|P1|Step 1|Off treatment for > specified timeframe|1
1314549|NCT00098475|4269639|P4|Step 1|Incorrect disease assessment|0
1314550|NCT00098475|4269640|P3|Step 1|Incorrect disease assessment|0
1314551|NCT00098475|4269641|P2|Step 1|Incorrect disease assessment|0
1314552|NCT00098475|4269642|P1|Step 1|Incorrect disease assessment|2
1314553|NCT00098475|4269639|P4|Step 1|Both patient and physician's decision|0
1314554|NCT00098475|4269640|P3|Step 1|Both patient and physician's decision|0
1314555|NCT00098475|4269641|P2|Step 1|Both patient and physician's decision|1
1314556|NCT00098475|4269642|P1|Step 1|Both patient and physician's decision|2
1314557|NCT00098475|4269639|P4|Step 1|Cannot comply due to other tx|0
1314558|NCT00098475|4269640|P3|Step 1|Cannot comply due to other tx|0
1314559|NCT00098475|4269641|P2|Step 1|Cannot comply due to other tx|1
1314560|NCT00098475|4269642|P1|Step 1|Cannot comply due to other tx|0
1314561|NCT00098475|4269639|P4|Step 1|Complications|0
1314562|NCT00098475|4269640|P3|Step 1|Complications|0
1314563|NCT00098475|4269641|P2|Step 1|Complications|0
1314564|NCT00098475|4269642|P1|Step 1|Complications|1
1314565|NCT00098475|4269639|P4|Step 1|Knee surgery|0
1314566|NCT00098475|4269640|P3|Step 1|Knee surgery|0
1314567|NCT00098475|4269641|P2|Step 1|Knee surgery|0
1314568|NCT00098475|4269642|P1|Step 1|Knee surgery|1
1314569|NCT00098475|4269639|P4|Step 1|Still on treatment as of this analysis|0
1314570|NCT00098475|4269640|P3|Step 1|Still on treatment as of this analysis|0
1314571|NCT00098475|4269641|P2|Step 1|Still on treatment as of this analysis|27
1314572|NCT00098475|4269642|P1|Step 1|Still on treatment as of this analysis|14
1314573|NCT00098475|4269639|P4|Step 1|Never started treatment|0
1314574|NCT00098475|4269640|P3|Step 1|Never started treatment|0
1314575|NCT00098475|4269641|P2|Step 1|Never started treatment|2
1314576|NCT00098475|4269642|P1|Step 1|Never started treatment|0
1314577|NCT00098475|4269639|P4|Step 1|Other disease|0
1314578|NCT00098475|4269640|P3|Step 1|Other disease|1
1314579|NCT00098475|4269641|P2|Step 1|Other disease|1
1314580|NCT00098475|4269642|P1|Step 1|Other disease|2
1314581|NCT00098475|4269639|P4|Step 1|Alternative therapy|0
1314582|NCT00098475|4269640|P3|Step 1|Alternative therapy|1
1314583|NCT00098475|4269641|P2|Step 1|Alternative therapy|43
1314584|NCT00098475|4269642|P1|Step 1|Alternative therapy|31
1314585|NCT00098475|4269639|P4|Step 1|Physician Decision|0
1314586|NCT00098475|4269640|P3|Step 1|Physician Decision|0
1314587|NCT00098475|4269641|P2|Step 1|Physician Decision|2
1314588|NCT00098475|4269642|P1|Step 1|Physician Decision|5
1314589|NCT00098475|4269639|P4|Step 1|Withdrawal by Subject|0
1314590|NCT00098475|4269640|P3|Step 1|Withdrawal by Subject|0
1314591|NCT00098475|4269641|P2|Step 1|Withdrawal by Subject|11
1314592|NCT00098475|4269642|P1|Step 1|Withdrawal by Subject|14
1314593|NCT00098475|4269639|P4|Step 1|Death|1
1314594|NCT00098475|4269640|P3|Step 1|Death|0
1314595|NCT00098475|4269641|P2|Step 1|Death|5
1314596|NCT00098475|4269642|P1|Step 1|Death|8
1314597|NCT00098475|4269639|P4|Step 1|Adverse Event|1
1314598|NCT00098475|4269640|P3|Step 1|Adverse Event|0
1314599|NCT00098475|4269641|P2|Step 1|Adverse Event|37
1314600|NCT00098475|4269642|P1|Step 1|Adverse Event|56
1314601|NCT00098475|4269639|P4|Step 1|Progressive disease|1
1314602|NCT00098475|4269640|P3|Step 1|Progressive disease|2
1314603|NCT00098475|4269641|P2|Step 1|Progressive disease|35
1314604|NCT00098475|4269642|P1|Step 1|Progressive disease|33
1314605|NCT00098345|4269679|P1|Overall Study|progression|4
1314606|NCT00098345|4269679|P1|Overall Study|Withdrawal by Subject|2
1314607|NCT00098345|4269679|P1|Overall Study|Adverse Event|7
1314608|NCT00098306|4269692|P7|Observational Phase|Un-specified|4
1314609|NCT00098306|4269693|P6|Observational Phase|Un-specified|7
1314610|NCT00098306|4269694|P5|Observational Phase|Un-specified|0
1314611|NCT00098306|4269695|P4|Observational Phase|Un-specified|0
1314612|NCT00098306|4269696|P3|Observational Phase|Un-specified|0
1314613|NCT00098306|4269697|P2|Observational Phase|Un-specified|0
1314614|NCT00098306|4269698|P1|Observational Phase|Un-specified|0
1314615|NCT00098306|4269692|P7|Observational Phase|Participant defaulted|18
1314616|NCT00098306|4269693|P6|Observational Phase|Participant defaulted|34
1314617|NCT00098306|4269694|P5|Observational Phase|Participant defaulted|0
1314618|NCT00098306|4269695|P4|Observational Phase|Participant defaulted|0
1314619|NCT00098306|4269696|P3|Observational Phase|Participant defaulted|0
1314620|NCT00098306|4269697|P2|Observational Phase|Participant defaulted|0
1314621|NCT00098306|4269698|P1|Observational Phase|Participant defaulted|0
1314622|NCT00098306|4269692|P7|Observational Phase|Death|4
1314623|NCT00098306|4269693|P6|Observational Phase|Death|5
1314624|NCT00098306|4269694|P5|Observational Phase|Death|0
1314625|NCT00098306|4269695|P4|Observational Phase|Death|0
1314626|NCT00098306|4269696|P3|Observational Phase|Death|0
1314627|NCT00098306|4269697|P2|Observational Phase|Death|0
1314628|NCT00098306|4269698|P1|Observational Phase|Death|0
1314629|NCT00098306|4269692|P7|Open Label|Ongoing at cut-off date|0
1314630|NCT00098306|4269693|P6|Open Label|Ongoing at cut-off date|0
1314631|NCT00098306|4269694|P5|Open Label|Ongoing at cut-off date|62
1314632|NCT00098306|4269695|P4|Open Label|Ongoing at cut-off date|269
1314633|NCT00098306|4269696|P3|Open Label|Ongoing at cut-off date|0
1314634|NCT00098306|4269697|P2|Open Label|Ongoing at cut-off date|0
1314635|NCT00098306|4269698|P1|Open Label|Ongoing at cut-off date|0
1314636|NCT00098306|4269692|P7|Open Label|Un-specified|0
1314637|NCT00098306|4269693|P6|Open Label|Un-specified|0
1314638|NCT00098306|4269694|P5|Open Label|Un-specified|0
1314639|NCT00098306|4269695|P4|Open Label|Un-specified|15
1314640|NCT00098306|4269696|P3|Open Label|Un-specified|0
1314641|NCT00098306|4269697|P2|Open Label|Un-specified|0
1314642|NCT00098306|4269698|P1|Open Label|Un-specified|0
1314643|NCT00098306|4269692|P7|Open Label|Participant defaulted|0
1314644|NCT00098306|4269693|P6|Open Label|Participant defaulted|0
1314645|NCT00098306|4269694|P5|Open Label|Participant defaulted|0
1314646|NCT00098306|4269695|P4|Open Label|Participant defaulted|24
1314647|NCT00098306|4269696|P3|Open Label|Participant defaulted|0
1314648|NCT00098306|4269697|P2|Open Label|Participant defaulted|0
1314649|NCT00098306|4269698|P1|Open Label|Participant defaulted|0
1314650|NCT00098306|4269692|P7|Open Label|Death|0
1314651|NCT00098306|4269693|P6|Open Label|Death|0
1314652|NCT00098306|4269694|P5|Open Label|Death|0
1314653|NCT00098306|4269695|P4|Open Label|Death|4
1314654|NCT00098306|4269696|P3|Open Label|Death|0
1314655|NCT00098306|4269697|P2|Open Label|Death|0
1314656|NCT00098306|4269698|P1|Open Label|Death|0
1314657|NCT00098306|4269692|P7|Open Label|Adverse Event|0
1314658|NCT00098306|4269693|P6|Open Label|Adverse Event|0
1314659|NCT00098306|4269694|P5|Open Label|Adverse Event|0
1314660|NCT00098306|4269695|P4|Open Label|Adverse Event|2
1314661|NCT00098306|4269696|P3|Open Label|Adverse Event|0
1314662|NCT00098306|4269697|P2|Open Label|Adverse Event|0
1314663|NCT00098306|4269698|P1|Open Label|Adverse Event|0
1314664|NCT00098306|4269692|P7|Open Label|Lack of Efficacy|0
1314665|NCT00098306|4269693|P6|Open Label|Lack of Efficacy|0
1314666|NCT00098306|4269694|P5|Open Label|Lack of Efficacy|0
1314667|NCT00098306|4269695|P4|Open Label|Lack of Efficacy|13
1314668|NCT00098306|4269696|P3|Open Label|Lack of Efficacy|0
1314669|NCT00098306|4269697|P2|Open Label|Lack of Efficacy|0
1314670|NCT00098306|4269698|P1|Open Label|Lack of Efficacy|0
1314671|NCT00098306|4269692|P7|Double Blind|Un-specified|0
1314672|NCT00098306|4269693|P6|Double Blind|Un-specified|0
1314673|NCT00098306|4269694|P5|Double Blind|Un-specified|0
1314674|NCT00098306|4269695|P4|Double Blind|Un-specified|0
1314675|NCT00098306|4269696|P3|Double Blind|Un-specified|11
1314676|NCT00098306|4269697|P2|Double Blind|Un-specified|3
1314677|NCT00098306|4269698|P1|Double Blind|Un-specified|7
1314678|NCT00098306|4269692|P7|Double Blind|Participant defaulted|0
1314679|NCT00098306|4269693|P6|Double Blind|Participant defaulted|0
1314680|NCT00098306|4269694|P5|Double Blind|Participant defaulted|0
1314681|NCT00098306|4269695|P4|Double Blind|Participant defaulted|0
1314682|NCT00098306|4269696|P3|Double Blind|Participant defaulted|11
1314683|NCT00098306|4269697|P2|Double Blind|Participant defaulted|18
1314684|NCT00098306|4269698|P1|Double Blind|Participant defaulted|19
1314685|NCT00098306|4269692|P7|Double Blind|Death|0
1314686|NCT00098306|4269693|P6|Double Blind|Death|0
1314687|NCT00098306|4269694|P5|Double Blind|Death|0
1314688|NCT00098306|4269695|P4|Double Blind|Death|0
1314689|NCT00098306|4269696|P3|Double Blind|Death|1
1314690|NCT00098306|4269697|P2|Double Blind|Death|4
1314691|NCT00098306|4269698|P1|Double Blind|Death|1
1314692|NCT00098306|4269692|P7|Double Blind|Lack of Efficacy|0
1314693|NCT00098306|4269693|P6|Double Blind|Lack of Efficacy|0
1314694|NCT00098306|4269694|P5|Double Blind|Lack of Efficacy|0
1314695|NCT00098306|4269695|P4|Double Blind|Lack of Efficacy|0
1314696|NCT00098306|4269696|P3|Double Blind|Lack of Efficacy|17
1314697|NCT00098306|4269697|P2|Double Blind|Lack of Efficacy|34
1314698|NCT00098306|4269698|P1|Double Blind|Lack of Efficacy|43
1314699|NCT00098306|4269692|P7|Double Blind|Adverse Event|0
1314700|NCT00098306|4269693|P6|Double Blind|Adverse Event|0
1314701|NCT00098306|4269694|P5|Double Blind|Adverse Event|0
1314702|NCT00098306|4269695|P4|Double Blind|Adverse Event|0
1314703|NCT00098306|4269696|P3|Double Blind|Adverse Event|6
1314704|NCT00098306|4269697|P2|Double Blind|Adverse Event|10
1314705|NCT00098306|4269698|P1|Double Blind|Adverse Event|11
1314706|NCT00098306|4269692|P7|Double Blind|Ongoing at cut-off date|0
1314707|NCT00098306|4269693|P6|Double Blind|Ongoing at cut-off date|0
1314708|NCT00098306|4269694|P5|Double Blind|Ongoing at cut-off date|0
1314709|NCT00098306|4269695|P4|Double Blind|Ongoing at cut-off date|0
1314710|NCT00098306|4269696|P3|Double Blind|Ongoing at cut-off date|72
1314711|NCT00098306|4269697|P2|Double Blind|Ongoing at cut-off date|166
1314712|NCT00098306|4269698|P1|Double Blind|Ongoing at cut-off date|151
1314713|NCT00098306|4269692|P7|Double Blind|Randomized, not treated|0
1314714|NCT00098306|4269693|P6|Double Blind|Randomized, not treated|0
1314715|NCT00098306|4269694|P5|Double Blind|Randomized, not treated|0
1314716|NCT00098306|4269695|P4|Double Blind|Randomized, not treated|0
1314717|NCT00098306|4269696|P3|Double Blind|Randomized, not treated|2
1314718|NCT00098306|4269697|P2|Double Blind|Randomized, not treated|5
1314719|NCT00098306|4269698|P1|Double Blind|Randomized, not treated|9
1314720|NCT00098293|4269764|P5|Supplemental Phase (SP)|Other|22
1314721|NCT00098293|4269765|P4|Supplemental Phase (SP)|Other|0
1314722|NCT00098293|4269766|P3|Supplemental Phase (SP)|Other|0
1314723|NCT00098293|4269767|P2|Supplemental Phase (SP)|Other|0
1314724|NCT00098293|4269768|P1|Supplemental Phase (SP)|Other|0
1314725|NCT00098293|4269764|P5|Supplemental Phase (SP)|Withdrawal by Subject|8
1314726|NCT00098293|4269765|P4|Supplemental Phase (SP)|Withdrawal by Subject|0
1314727|NCT00098293|4269766|P3|Supplemental Phase (SP)|Withdrawal by Subject|0
1314728|NCT00098293|4269767|P2|Supplemental Phase (SP)|Withdrawal by Subject|0
1314729|NCT00098293|4269768|P1|Supplemental Phase (SP)|Withdrawal by Subject|0
1314730|NCT00098293|4269764|P5|Supplemental Phase (SP)|Lost to Follow-up|2
1314731|NCT00098293|4269765|P4|Supplemental Phase (SP)|Lost to Follow-up|0
1314732|NCT00098293|4269766|P3|Supplemental Phase (SP)|Lost to Follow-up|0
1314733|NCT00098293|4269767|P2|Supplemental Phase (SP)|Lost to Follow-up|0
1314734|NCT00098293|4269768|P1|Supplemental Phase (SP)|Lost to Follow-up|0
1314735|NCT00098293|4269764|P5|Supplemental Phase (SP)|Death|1
1314736|NCT00098293|4269765|P4|Supplemental Phase (SP)|Death|0
1314737|NCT00098293|4269766|P3|Supplemental Phase (SP)|Death|0
1314738|NCT00098293|4269767|P2|Supplemental Phase (SP)|Death|0
1314739|NCT00098293|4269768|P1|Supplemental Phase (SP)|Death|0
1314740|NCT00098293|4269764|P5|Open-label (OL) Phase|Death|0
1314741|NCT00098293|4269765|P4|Open-label (OL) Phase|Death|0
1314742|NCT00098293|4269766|P3|Open-label (OL) Phase|Death|3
1314743|NCT00098293|4269767|P2|Open-label (OL) Phase|Death|2
1314744|NCT00098293|4269768|P1|Open-label (OL) Phase|Death|0
1314745|NCT00098293|4269764|P5|Open-label (OL) Phase|Participant Defaulted|0
1314746|NCT00098293|4269765|P4|Open-label (OL) Phase|Participant Defaulted|20
1314747|NCT00098293|4269766|P3|Open-label (OL) Phase|Participant Defaulted|16
1314748|NCT00098293|4269767|P2|Open-label (OL) Phase|Participant Defaulted|6
1314749|NCT00098293|4269768|P1|Open-label (OL) Phase|Participant Defaulted|0
1314750|NCT00098293|4269764|P5|Open-label (OL) Phase|Protocol Violation|0
1314751|NCT00098293|4269765|P4|Open-label (OL) Phase|Protocol Violation|16
1314752|NCT00098293|4269766|P3|Open-label (OL) Phase|Protocol Violation|13
1314753|NCT00098293|4269767|P2|Open-label (OL) Phase|Protocol Violation|6
1314754|NCT00098293|4269768|P1|Open-label (OL) Phase|Protocol Violation|0
1314755|NCT00098293|4269764|P5|Open-label (OL) Phase|Pregnancy|0
1314756|NCT00098293|4269765|P4|Open-label (OL) Phase|Pregnancy|3
1314757|NCT00098293|4269766|P3|Open-label (OL) Phase|Pregnancy|0
1314758|NCT00098293|4269767|P2|Open-label (OL) Phase|Pregnancy|1
1314759|NCT00098293|4269768|P1|Open-label (OL) Phase|Pregnancy|0
1314760|NCT00098293|4269764|P5|Open-label (OL) Phase|Lack of Efficacy|0
1314761|NCT00098293|4269765|P4|Open-label (OL) Phase|Lack of Efficacy|20
1314762|NCT00098293|4269766|P3|Open-label (OL) Phase|Lack of Efficacy|2
1314763|NCT00098293|4269767|P2|Open-label (OL) Phase|Lack of Efficacy|7
1314764|NCT00098293|4269768|P1|Open-label (OL) Phase|Lack of Efficacy|0
1314765|NCT00098293|4269764|P5|Open-label (OL) Phase|Adverse Event|0
1314766|NCT00098293|4269765|P4|Open-label (OL) Phase|Adverse Event|6
1314767|NCT00098293|4269766|P3|Open-label (OL) Phase|Adverse Event|7
1314768|NCT00098293|4269767|P2|Open-label (OL) Phase|Adverse Event|3
1314769|NCT00098293|4269768|P1|Open-label (OL) Phase|Adverse Event|0
1314770|NCT00098293|4269764|P5|Between DB and OL Phase|Did Not Enter Open-label Phase|0
1314771|NCT00098293|4269765|P4|Between DB and OL Phase|Did Not Enter Open-label Phase|0
1314772|NCT00098293|4269766|P3|Between DB and OL Phase|Did Not Enter Open-label Phase|3
1314773|NCT00098293|4269767|P2|Between DB and OL Phase|Did Not Enter Open-label Phase|0
1314774|NCT00098293|4269768|P1|Between DB and OL Phase|Did Not Enter Open-label Phase|0
1314775|NCT00098293|4269764|P5|Double-blind (DB) Phase|Terminated by sponsor|0
1314776|NCT00098293|4269765|P4|Double-blind (DB) Phase|Terminated by sponsor|0
1314777|NCT00098293|4269766|P3|Double-blind (DB) Phase|Terminated by sponsor|0
1314778|NCT00098293|4269767|P2|Double-blind (DB) Phase|Terminated by sponsor|0
1314779|NCT00098293|4269768|P1|Double-blind (DB) Phase|Terminated by sponsor|135
1314780|NCT00098293|4269764|P5|Double-blind (DB) Phase|Protocol Violation|0
1314781|NCT00098293|4269765|P4|Double-blind (DB) Phase|Protocol Violation|0
1314782|NCT00098293|4269766|P3|Double-blind (DB) Phase|Protocol Violation|22
1314783|NCT00098293|4269767|P2|Double-blind (DB) Phase|Protocol Violation|18
1314784|NCT00098293|4269768|P1|Double-blind (DB) Phase|Protocol Violation|2
1314785|NCT00098293|4269764|P5|Double-blind (DB) Phase|Randomized, Not Treated|0
1314786|NCT00098293|4269765|P4|Double-blind (DB) Phase|Randomized, Not Treated|0
1314787|NCT00098293|4269766|P3|Double-blind (DB) Phase|Randomized, Not Treated|11
1314788|NCT00098293|4269767|P2|Double-blind (DB) Phase|Randomized, Not Treated|8
1314789|NCT00098293|4269768|P1|Double-blind (DB) Phase|Randomized, Not Treated|3
1314790|NCT00098293|4269764|P5|Double-blind (DB) Phase|Death|0
1314791|NCT00098293|4269765|P4|Double-blind (DB) Phase|Death|0
1314792|NCT00098293|4269766|P3|Double-blind (DB) Phase|Death|2
1314793|NCT00098293|4269767|P2|Double-blind (DB) Phase|Death|2
1314794|NCT00098293|4269768|P1|Double-blind (DB) Phase|Death|1
1314795|NCT00098293|4269764|P5|Double-blind (DB) Phase|Lack of Efficacy|0
1314796|NCT00098293|4269765|P4|Double-blind (DB) Phase|Lack of Efficacy|0
1314797|NCT00098293|4269766|P3|Double-blind (DB) Phase|Lack of Efficacy|30
1314798|NCT00098293|4269767|P2|Double-blind (DB) Phase|Lack of Efficacy|64
1314799|NCT00098293|4269768|P1|Double-blind (DB) Phase|Lack of Efficacy|11
1314800|NCT00098293|4269764|P5|Double-blind (DB) Phase|Participant Defaulted|0
1314801|NCT00098293|4269765|P4|Double-blind (DB) Phase|Participant Defaulted|0
1314802|NCT00098293|4269766|P3|Double-blind (DB) Phase|Participant Defaulted|36
1314803|NCT00098293|4269767|P2|Double-blind (DB) Phase|Participant Defaulted|40
1314804|NCT00098293|4269768|P1|Double-blind (DB) Phase|Participant Defaulted|11
1314805|NCT00098293|4269764|P5|Double-blind (DB) Phase|Pregnancy|0
1314806|NCT00098293|4269765|P4|Double-blind (DB) Phase|Pregnancy|0
1314807|NCT00098293|4269766|P3|Double-blind (DB) Phase|Pregnancy|9
1314808|NCT00098293|4269767|P2|Double-blind (DB) Phase|Pregnancy|7
1314809|NCT00098293|4269768|P1|Double-blind (DB) Phase|Pregnancy|0
1314810|NCT00098293|4269764|P5|Double-blind (DB) Phase|Adverse Event|0
1314811|NCT00098293|4269765|P4|Double-blind (DB) Phase|Adverse Event|0
1314812|NCT00098293|4269766|P3|Double-blind (DB) Phase|Adverse Event|60
1314813|NCT00098293|4269767|P2|Double-blind (DB) Phase|Adverse Event|27
1314814|NCT00098293|4269768|P1|Double-blind (DB) Phase|Adverse Event|14
1314815|NCT00098254|4269821|P1|Overall Study|Death|1
1314816|NCT00098254|4269821|P1|Overall Study|Adverse Event|2
1314817|NCT00098020|4269887|P1|Overall Study|Low epidermal growth factor receptor|1
1314818|NCT00098020|4269887|P1|Overall Study|Low urine PCR|1
1314819|NCT00098020|4269887|P1|Overall Study|elevated liver enzymes|1
1314820|NCT00098020|4269887|P1|Overall Study|Lost to Follow-up|1
1314821|NCT00098020|4269887|P1|Overall Study|Adverse Event|2
1314822|NCT00097981|4269894|P2|Overall Study|Other|13
1314823|NCT00097981|4269895|P1|Overall Study|Other|19
1314824|NCT00097981|4269894|P2|Overall Study|Transplant planned|27
1314825|NCT00097981|4269895|P1|Overall Study|Transplant planned|28
1314826|NCT00097981|4269894|P2|Overall Study|Disease Progression|2
1314827|NCT00097981|4269895|P1|Overall Study|Disease Progression|8
1314828|NCT00097981|4269894|P2|Overall Study|Physician Decision|1
1314829|NCT00097981|4269895|P1|Overall Study|Physician Decision|7
1314830|NCT00097981|4269894|P2|Overall Study|Death|4
1314831|NCT00097981|4269895|P1|Overall Study|Death|2
1314832|NCT00097981|4269894|P2|Overall Study|Protocol Violation|1
1314833|NCT00097981|4269895|P1|Overall Study|Protocol Violation|1
1314834|NCT00097981|4269894|P2|Overall Study|Withdrawal by Subject|8
1314835|NCT00097981|4269895|P1|Overall Study|Withdrawal by Subject|10
1314836|NCT00097981|4269894|P2|Overall Study|Adverse Event|44
1314837|NCT00097981|4269895|P1|Overall Study|Adverse Event|31
1314838|NCT00097786|4269917|P4|Overall Study|lost to follow-up for all-cause death|310
1314928|NCT00097539|4270044|P3|Overall Study|Withdrawal by Subject|346
1314839|NCT00097786|4269918|P3|Overall Study|lost to follow-up for all-cause death|313
1314840|NCT00097786|4269919|P2|Overall Study|lost to follow-up for all-cause death|292
1314841|NCT00097786|4269920|P1|Overall Study|lost to follow-up for all-cause death|296
1314842|NCT00097773|4269942|P4|Overall Study|Other|0
1314843|NCT00097773|4269943|P3|Overall Study|Other|2
1314844|NCT00097773|4269944|P2|Overall Study|Other|0
1314845|NCT00097773|4269945|P1|Overall Study|Other|1
1314846|NCT00097773|4269942|P4|Overall Study|Adverse Event|0
1314847|NCT00097773|4269943|P3|Overall Study|Adverse Event|0
1314848|NCT00097773|4269944|P2|Overall Study|Adverse Event|1
1314849|NCT00097773|4269945|P1|Overall Study|Adverse Event|0
1314850|NCT00097773|4269942|P4|Overall Study|Withdrawal by Subject|1
1314851|NCT00097773|4269943|P3|Overall Study|Withdrawal by Subject|3
1314852|NCT00097773|4269944|P2|Overall Study|Withdrawal by Subject|3
1314853|NCT00097773|4269945|P1|Overall Study|Withdrawal by Subject|3
1314854|NCT00097773|4269942|P4|Overall Study|Physician Decision|1
1314855|NCT00097773|4269943|P3|Overall Study|Physician Decision|3
1314856|NCT00097773|4269944|P2|Overall Study|Physician Decision|2
1314857|NCT00097773|4269945|P1|Overall Study|Physician Decision|2
1314858|NCT00097773|4269942|P4|Overall Study|Lost to Follow-up|1
1314859|NCT00097773|4269943|P3|Overall Study|Lost to Follow-up|0
1314860|NCT00097773|4269944|P2|Overall Study|Lost to Follow-up|2
1314861|NCT00097773|4269945|P1|Overall Study|Lost to Follow-up|2
1314862|NCT00097721|4269965|P2|Overall Study|Reason not given|1
1314863|NCT00097721|4269966|P1|Overall Study|Reason not given|1
1314864|NCT00097721|4269965|P2|Overall Study|Physician Decision|3
1314865|NCT00097721|4269966|P1|Overall Study|Physician Decision|1
1314866|NCT00097721|4269965|P2|Overall Study|Progressive Disease|27
1314867|NCT00097721|4269966|P1|Overall Study|Progressive Disease|55
1314868|NCT00097721|4269965|P2|Overall Study|Withdrawal by Subject|1
1314869|NCT00097721|4269966|P1|Overall Study|Withdrawal by Subject|6
1314870|NCT00097721|4269965|P2|Overall Study|Adverse Event|1
1314871|NCT00097721|4269966|P1|Overall Study|Adverse Event|8
1314872|NCT00097591|4270016|P2|Overall Study|Other|3
1314873|NCT00097591|4270017|P1|Overall Study|Other|0
1314874|NCT00097591|4270016|P2|Overall Study|Lost to follow up|10
1314875|NCT00097591|4270017|P1|Overall Study|Lost to follow up|6
1314876|NCT00097591|4270016|P2|Overall Study|Unable to attend termination visit|51
1314877|NCT00097591|4270017|P1|Overall Study|Unable to attend termination visit|53
1314878|NCT00097591|4270016|P2|Overall Study|Less than 6 months on study drug|7
1314879|NCT00097591|4270017|P1|Overall Study|Less than 6 months on study drug|9
1314880|NCT00097591|4270016|P2|Overall Study|Withdrawal of consent|323
1314881|NCT00097591|4270017|P1|Overall Study|Withdrawal of consent|342
1314882|NCT00097539|4270040|P7|Overall Study|Reason not Specified|2
1314883|NCT00097539|4270041|P6|Overall Study|Reason not Specified|40
1314884|NCT00097539|4270042|P5|Overall Study|Reason not Specified|11
1314885|NCT00097539|4270043|P4|Overall Study|Reason not Specified|21
1314886|NCT00097539|4270044|P3|Overall Study|Reason not Specified|53
1314887|NCT00097539|4270045|P2|Overall Study|Reason not Specified|49
1314888|NCT00097539|4270046|P1|Overall Study|Reason not Specified|111
1314889|NCT00097539|4270040|P7|Overall Study|Reasons Other Than Above|34
1314890|NCT00097539|4270041|P6|Overall Study|Reasons Other Than Above|1244
1314891|NCT00097539|4270042|P5|Overall Study|Reasons Other Than Above|361
1314892|NCT00097539|4270043|P4|Overall Study|Reasons Other Than Above|692
1314893|NCT00097539|4270044|P3|Overall Study|Reasons Other Than Above|1757
1314894|NCT00097539|4270045|P2|Overall Study|Reasons Other Than Above|1382
1314895|NCT00097539|4270046|P1|Overall Study|Reasons Other Than Above|3602
1314896|NCT00097539|4270040|P7|Overall Study|Death|0
1314897|NCT00097539|4270041|P6|Overall Study|Death|3
1314898|NCT00097539|4270042|P5|Overall Study|Death|1
1314899|NCT00097539|4270043|P4|Overall Study|Death|0
1314900|NCT00097539|4270044|P3|Overall Study|Death|0
1314901|NCT00097539|4270045|P2|Overall Study|Death|7
1314902|NCT00097539|4270046|P1|Overall Study|Death|2
1314903|NCT00097539|4270040|P7|Overall Study|Adverse Event|1
1314904|NCT00097539|4270041|P6|Overall Study|Adverse Event|59
1314905|NCT00097539|4270042|P5|Overall Study|Adverse Event|30
1314906|NCT00097539|4270043|P4|Overall Study|Adverse Event|27
1314907|NCT00097539|4270044|P3|Overall Study|Adverse Event|37
1314908|NCT00097539|4270045|P2|Overall Study|Adverse Event|133
1314909|NCT00097539|4270046|P1|Overall Study|Adverse Event|78
1314910|NCT00097539|4270040|P7|Overall Study|Lack of Efficacy|5
1314911|NCT00097539|4270041|P6|Overall Study|Lack of Efficacy|228
1314912|NCT00097539|4270042|P5|Overall Study|Lack of Efficacy|45
1314913|NCT00097539|4270043|P4|Overall Study|Lack of Efficacy|105
1314914|NCT00097539|4270044|P3|Overall Study|Lack of Efficacy|202
1314915|NCT00097539|4270045|P2|Overall Study|Lack of Efficacy|122
1314916|NCT00097539|4270046|P1|Overall Study|Lack of Efficacy|249
1314917|NCT00097539|4270040|P7|Overall Study|Participant Non-compliant|18
1314918|NCT00097539|4270041|P6|Overall Study|Participant Non-compliant|543
1314919|NCT00097539|4270042|P5|Overall Study|Participant Non-compliant|136
1314920|NCT00097539|4270043|P4|Overall Study|Participant Non-compliant|353
1314921|NCT00097539|4270044|P3|Overall Study|Participant Non-compliant|1067
1314922|NCT00097539|4270045|P2|Overall Study|Participant Non-compliant|567
1314923|NCT00097539|4270046|P1|Overall Study|Participant Non-compliant|2140
1314924|NCT00097539|4270040|P7|Overall Study|Withdrawal by Subject|3
1314925|NCT00097539|4270041|P6|Overall Study|Withdrawal by Subject|229
1314926|NCT00097539|4270042|P5|Overall Study|Withdrawal by Subject|68
1314927|NCT00097539|4270043|P4|Overall Study|Withdrawal by Subject|217
1314929|NCT00097539|4270045|P2|Overall Study|Withdrawal by Subject|323
1314930|NCT00097539|4270046|P1|Overall Study|Withdrawal by Subject|925
1314931|NCT00097539|4270040|P7|Overall Study|Status Unknown (Or no final evaluation)|108
1314932|NCT00097539|4270041|P6|Overall Study|Status Unknown (Or no final evaluation)|3546
1314933|NCT00097539|4270042|P5|Overall Study|Status Unknown (Or no final evaluation)|1106
1314934|NCT00097539|4270043|P4|Overall Study|Status Unknown (Or no final evaluation)|2170
1314935|NCT00097539|4270044|P3|Overall Study|Status Unknown (Or no final evaluation)|5646
1314936|NCT00097539|4270045|P2|Overall Study|Status Unknown (Or no final evaluation)|3948
1314937|NCT00097539|4270046|P1|Overall Study|Status Unknown (Or no final evaluation)|11959
1314938|NCT00097500|4270092|P2|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2
1314939|NCT00097500|4270093|P1|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3
1314940|NCT00097500|4270092|P2|Off-drug Period (Week 52 to Week 64)|Physician Decision|1
1314941|NCT00097500|4270093|P1|Off-drug Period (Week 52 to Week 64)|Physician Decision|0
1314942|NCT00097500|4270092|P2|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1
1314943|NCT00097500|4270093|P1|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2
1314944|NCT00097500|4270092|P2|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1
1314945|NCT00097500|4270093|P1|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0
1314946|NCT00097500|4270092|P2|On-drug Period (Week 0 to Week 52)|Physician Decision|1
1314947|NCT00097500|4270093|P1|On-drug Period (Week 0 to Week 52)|Physician Decision|0
1314948|NCT00097500|4270092|P2|On-drug Period (Week 0 to Week 52)|Adverse Event|0
1314949|NCT00097500|4270093|P1|On-drug Period (Week 0 to Week 52)|Adverse Event|5
1314950|NCT00097500|4270092|P2|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
1314951|NCT00097500|4270093|P1|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
1314952|NCT00097370|4270124|P1|Stage 3|Lost to Follow-up|1
1314953|NCT00097370|4270124|P1|Stage 3|Sponsor Terminated Study|52
1314954|NCT00097370|4270124|P1|Stage 3|Lack of Efficacy|1
1314955|NCT00097370|4270124|P1|Stage 3|Withdrawal by Subject|3
1314956|NCT00097370|4270124|P1|Stage 3|Adverse Event|2
1314957|NCT00097370|4270124|P1|Stage 2|Lost to Follow-up|1
1314958|NCT00097370|4270124|P1|Stage 2|Sponsor Terminated Study|2
1314959|NCT00097370|4270124|P1|Stage 2|Pregnancy|1
1314960|NCT00097370|4270124|P1|Stage 2|Lack of Efficacy|3
1314961|NCT00097370|4270124|P1|Stage 2|Withdrawal by Subject|1
1314962|NCT00097370|4270124|P1|Stage 2|Adverse Event|5
1314963|NCT00097370|4270124|P1|Stage 1|Lack of Efficacy|2
1314964|NCT00097370|4270124|P1|Stage 1|Withdrawal by Subject|1
1314965|NCT00097370|4270124|P1|Stage 1|Adverse Event|3
1314966|NCT00096993|4270158|P2|Overall Study|Other unspecified|1
1314967|NCT00096993|4270159|P1|Overall Study|Other unspecified|1
1314968|NCT00096993|4270158|P2|Overall Study|Non-compliance|1
1314969|NCT00096993|4270159|P1|Overall Study|Non-compliance|0
1314970|NCT00096993|4270158|P2|Overall Study|Physician Decision|1
1314971|NCT00096993|4270159|P1|Overall Study|Physician Decision|2
1314972|NCT00096993|4270158|P2|Overall Study|Subject's decision|1
1314973|NCT00096993|4270159|P1|Overall Study|Subject's decision|3
1314974|NCT00096993|4270158|P2|Overall Study|Adverse Event|8
1314975|NCT00096993|4270159|P1|Overall Study|Adverse Event|2
1314976|NCT00096993|4270158|P2|Overall Study|Disease progression|53
1314977|NCT00096993|4270159|P1|Overall Study|Disease progression|56
1314978|NCT00096993|4270158|P2|Overall Study|Death|0
1314979|NCT00096993|4270159|P1|Overall Study|Death|1
1314980|NCT00096954|4270175|P2|Overall Study|Lost to Follow-up|5
1314981|NCT00096954|4270176|P1|Overall Study|Lost to Follow-up|8
1314982|NCT00096954|4270175|P2|Overall Study|Non-compliance|3
1314983|NCT00096954|4270176|P1|Overall Study|Non-compliance|0
1314984|NCT00096954|4270175|P2|Overall Study|Initiation of immunotherapy|0
1314985|NCT00096954|4270176|P1|Overall Study|Initiation of immunotherapy|1
1314986|NCT00096954|4270175|P2|Overall Study|Pregnancy|1
1314987|NCT00096954|4270176|P1|Overall Study|Pregnancy|1
1314988|NCT00096954|4270175|P2|Overall Study|Sponsors Decision|1
1314989|NCT00096954|4270176|P1|Overall Study|Sponsors Decision|1
1314990|NCT00096954|4270175|P2|Overall Study|Physician Decision|1
1314991|NCT00096954|4270176|P1|Overall Study|Physician Decision|1
1314992|NCT00096954|4270175|P2|Overall Study|Withdrawal by Subject|8
1314993|NCT00096954|4270176|P1|Overall Study|Withdrawal by Subject|9
1314994|NCT00096954|4270175|P2|Overall Study|Adverse Event|1
1314995|NCT00096954|4270176|P1|Overall Study|Adverse Event|3
1314996|NCT00096941|4270188|P1|Overall Study|disease progression|3
1314997|NCT00096785|4270195|P2|Overall Study|Relocated|0
1314998|NCT00096785|4270196|P1|Overall Study|Relocated|1
1314999|NCT00096785|4270195|P2|Overall Study|Withdrawal by Subject|1
1315000|NCT00096785|4270196|P1|Overall Study|Withdrawal by Subject|0
1315001|NCT00096785|4270195|P2|Overall Study|Lost to Follow-up|0
1315002|NCT00096785|4270196|P1|Overall Study|Lost to Follow-up|1
1315003|NCT00096538|4270225|P1|Overall Study|Withdrawal by Subject|1
1315004|NCT00096486|4270233|P4|Overall Study|Not Treated|1
1315005|NCT00096486|4270234|P3|Overall Study|Not Treated|1
1315006|NCT00096486|4270235|P2|Overall Study|Not Treated|0
1315007|NCT00096486|4270236|P1|Overall Study|Not Treated|0
1315008|NCT00096486|4270233|P4|Overall Study|Withdrawal by Subject|1
1315009|NCT00096486|4270234|P3|Overall Study|Withdrawal by Subject|1
1315010|NCT00096486|4270235|P2|Overall Study|Withdrawal by Subject|0
1315011|NCT00096486|4270236|P1|Overall Study|Withdrawal by Subject|0
1315012|NCT00096447|4270255|P1|Overall Study|Never treated|1
1315013|NCT00096382|4270271|P2|Overall Study|Death during treatment|0
1315014|NCT00096382|4270272|P1|Overall Study|Death during treatment|1
1315015|NCT00096382|4270271|P2|Overall Study|Not treated|0
1315016|NCT00096382|4270272|P1|Overall Study|Not treated|1
1315017|NCT00096356|4270282|P2|Overall Study|multiple reasons|18
1315018|NCT00096356|4270283|P1|Overall Study|multiple reasons|10
1315019|NCT00096356|4270282|P2|Overall Study|Lack of Efficacy|0
1315020|NCT00096356|4270283|P1|Overall Study|Lack of Efficacy|1
1315021|NCT00096356|4270282|P2|Overall Study|Withdrawal by Subject|23
1315022|NCT00096356|4270283|P1|Overall Study|Withdrawal by Subject|17
1315023|NCT00096356|4270282|P2|Overall Study|Physician Decision|3
1315024|NCT00096356|4270283|P1|Overall Study|Physician Decision|5
1315025|NCT00096356|4270282|P2|Overall Study|Adverse Event|9
1315026|NCT00096356|4270283|P1|Overall Study|Adverse Event|11
1315027|NCT00096278|4270295|P2|Overall Study|Patient not at risk for primary endpoint|2
1315028|NCT00096278|4270296|P1|Overall Study|Patient not at risk for primary endpoint|3
1315029|NCT00096278|4270295|P2|Overall Study|No follow-up data|18
1315030|NCT00096278|4270296|P1|Overall Study|No follow-up data|15
1315031|NCT00096265|4270315|P3|Overall Study|Ineligible|0
1315032|NCT00096265|4270316|P2|Overall Study|Ineligible|0
1315033|NCT00096265|4270317|P1|Overall Study|Ineligible|1
1315034|NCT00096226|4270343|P1|Overall Study|Surgery but inadequate nodal sampling|1
1315035|NCT00096226|4270343|P1|Overall Study|Surgical restaging not performed|13
1315036|NCT00096226|4270343|P1|Overall Study|Protocol treatment not started|1
1315037|NCT00096226|4270343|P1|Overall Study|Ineligible|2
1315038|NCT00096200|4270350|P3|Overall Study|Ineligible pathology|0
1315039|NCT00096200|4270351|P2|Overall Study|Ineligible pathology|1
1315040|NCT00096200|4270352|P1|Overall Study|Ineligible pathology|0
1315041|NCT00096200|4270350|P3|Overall Study|Withdrawal by Subject|0
1315042|NCT00096200|4270351|P2|Overall Study|Withdrawal by Subject|2
1315043|NCT00096200|4270352|P1|Overall Study|Withdrawal by Subject|1
1315044|NCT00096200|4270350|P3|Overall Study|Adverse Event|0
1315045|NCT00096200|4270351|P2|Overall Study|Adverse Event|4
1315046|NCT00096200|4270352|P1|Overall Study|Adverse Event|0
1315047|NCT00096174|4270366|P1|Overall Study|other reason|8
1315048|NCT00096174|4270366|P1|Overall Study|Ineligible|6
1315049|NCT00096174|4270366|P1|Overall Study|Not started protocol therapy|3
1315050|NCT00096174|4270366|P1|Overall Study|Withdrawal by Subject|15
1315051|NCT00096174|4270366|P1|Overall Study|Death|6
1315052|NCT00096174|4270366|P1|Overall Study|Adverse Event|15
1315053|NCT00096174|4270366|P1|Overall Study|Lack of Efficacy|9
1315054|NCT00096135|4270411|P2|Overall Study|Ineligible|0
1315055|NCT00096135|4270412|P1|Overall Study|Ineligible|2
1315056|NCT00096135|4270411|P2|Overall Study|Other, specify|3
1315057|NCT00096135|4270412|P1|Overall Study|Other, specify|15
1315058|NCT00096135|4270411|P2|Overall Study|Progressive disease, Marrow,CNS, Relapse|7
1315059|NCT00096135|4270412|P1|Overall Study|Progressive disease, Marrow,CNS, Relapse|22
1315060|NCT00096135|4270411|P2|Overall Study|Refusal of further protocol therapy|1
1315061|NCT00096135|4270412|P1|Overall Study|Refusal of further protocol therapy|4
1315062|NCT00096135|4270411|P2|Overall Study|Physician Decision|4
1315063|NCT00096135|4270412|P1|Overall Study|Physician Decision|20
1315064|NCT00096044|4270428|P1|Overall Study|Disease Progression|4
1315065|NCT00096044|4270428|P1|Overall Study|Adverse Event|21
1315066|NCT00096044|4270428|P1|Overall Study|Withdrawal by Subject|9
1315067|NCT00096031|4270437|P1|Overall Study|Not protocol specified|5
1315068|NCT00096031|4270437|P1|Overall Study|Ineligible|8
1315069|NCT00096031|4270437|P1|Overall Study|Withdrawal by Subject|1
1315070|NCT00096031|4270437|P1|Overall Study|Death|4
1315071|NCT00096031|4270437|P1|Overall Study|Lack of Efficacy|42
1315072|NCT00096031|4270437|P1|Overall Study|Adverse Event|3
1315073|NCT00096018|4270445|P2|Overall Study|Miscellaneous|1
1315074|NCT00096018|4270446|P1|Overall Study|Miscellaneous|2
1315075|NCT00096018|4270445|P2|Overall Study|Withdrawal by Subject|2
1315076|NCT00096018|4270446|P1|Overall Study|Withdrawal by Subject|0
1315077|NCT00096018|4270445|P2|Overall Study|Death|1
1315078|NCT00096018|4270446|P1|Overall Study|Death|0
1315079|NCT00096018|4270445|P2|Overall Study|Adverse Event|5
1315080|NCT00096018|4270446|P1|Overall Study|Adverse Event|0
1315081|NCT00096018|4270445|P2|Overall Study|Miscellaneous (not treated)|2
1315082|NCT00096018|4270446|P1|Overall Study|Miscellaneous (not treated)|0
1315083|NCT00096018|4270445|P2|Overall Study|Became Ineligible (not treated)|3
1315084|NCT00096018|4270446|P1|Overall Study|Became Ineligible (not treated)|0
1315085|NCT00095979|4270454|P1|Overall Study|Ineligible: Second primary cancer site|2
1315086|NCT00095940|4270472|P9|Lapatinib Continuation/Phase II|Adverse Event|0
1315087|NCT00095940|4270473|P8|Lapatinib Continuation/Phase II|Adverse Event|1
1315088|NCT00095940|4270474|P7|Lapatinib Continuation/Phase II|Adverse Event|0
1315089|NCT00095940|4270475|P6|Lapatinib Continuation/Phase II|Adverse Event|0
1315090|NCT00095940|4270476|P5|Lapatinib Continuation/Phase II|Adverse Event|0
1315091|NCT00095940|4270477|P4|Lapatinib Continuation/Phase II|Adverse Event|0
1315092|NCT00095940|4270478|P3|Lapatinib Continuation/Phase II|Adverse Event|0
1315093|NCT00095940|4270479|P2|Lapatinib Continuation/Phase II|Adverse Event|0
1315094|NCT00095940|4270480|P1|Lapatinib Continuation/Phase II|Adverse Event|0
1315095|NCT00095940|4270472|P9|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
1315096|NCT00095940|4270473|P8|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
1315097|NCT00095940|4270474|P7|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
1315098|NCT00095940|4270475|P6|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
1315099|NCT00095940|4270476|P5|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
1315505|NCT00094835|4271655|P1|Overall Study|Withdrawal by Subject|0
1315100|NCT00095940|4270477|P4|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
1315101|NCT00095940|4270478|P3|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
1315102|NCT00095940|4270479|P2|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
1315103|NCT00095940|4270480|P1|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
1315104|NCT00095940|4270472|P9|Lapatinib Continuation/Phase II|Disease Progression|12
1315105|NCT00095940|4270473|P8|Lapatinib Continuation/Phase II|Disease Progression|1
1315106|NCT00095940|4270474|P7|Lapatinib Continuation/Phase II|Disease Progression|2
1315107|NCT00095940|4270475|P6|Lapatinib Continuation/Phase II|Disease Progression|13
1315108|NCT00095940|4270476|P5|Lapatinib Continuation/Phase II|Disease Progression|0
1315109|NCT00095940|4270477|P4|Lapatinib Continuation/Phase II|Disease Progression|0
1315110|NCT00095940|4270478|P3|Lapatinib Continuation/Phase II|Disease Progression|15
1315111|NCT00095940|4270479|P2|Lapatinib Continuation/Phase II|Disease Progression|1
1315112|NCT00095940|4270480|P1|Lapatinib Continuation/Phase II|Disease Progression|1
1315113|NCT00095836|4270513|P1|Overall Study|Death|2
1315114|NCT00095836|4270513|P1|Overall Study|Adverse Event|1
1315115|NCT00095836|4270513|P1|Overall Study|Lost to Follow-up|1
1315116|NCT00095628|4270543|P1|Overall Study|Disease progression prior to treatment|1
1315117|NCT00095576|4270554|P2|Overall Study|Subject moved|36
1315118|NCT00095576|4270555|P1|Overall Study|Subject moved|30
1315119|NCT00095576|4270554|P2|Overall Study|Site terminated|67
1315120|NCT00095576|4270555|P1|Overall Study|Site terminated|75
1315121|NCT00095576|4270554|P2|Overall Study|Option to switch to a rollover study|1099
1315122|NCT00095576|4270555|P1|Overall Study|Option to switch to a rollover study|1097
1315123|NCT00095576|4270554|P2|Overall Study|Withdrawal by Subject|47
1315124|NCT00095576|4270555|P1|Overall Study|Withdrawal by Subject|34
1315125|NCT00095576|4270554|P2|Overall Study|Protocol Violation|0
1315126|NCT00095576|4270555|P1|Overall Study|Protocol Violation|1
1315127|NCT00095576|4270554|P2|Overall Study|Lost to Follow-up|229
1315128|NCT00095576|4270555|P1|Overall Study|Lost to Follow-up|233
1315129|NCT00095576|4270554|P2|Overall Study|Adverse Event|3
1315130|NCT00095576|4270555|P1|Overall Study|Adverse Event|5
1315131|NCT00095498|4270579|P3|Overall Study|Requirement for alternative therapy|2
1315132|NCT00095498|4270580|P2|Overall Study|Requirement for alternative therapy|0
1315133|NCT00095498|4270581|P1|Overall Study|Requirement for alternative therapy|1
1315134|NCT00095498|4270579|P3|Overall Study|Protocol Violation|1
1315135|NCT00095498|4270580|P2|Overall Study|Protocol Violation|0
1315136|NCT00095498|4270581|P1|Overall Study|Protocol Violation|0
1315137|NCT00095498|4270579|P3|Overall Study|Other|6
1315138|NCT00095498|4270580|P2|Overall Study|Other|7
1315139|NCT00095498|4270581|P1|Overall Study|Other|6
1315140|NCT00095498|4270579|P3|Overall Study|Noncompliance|1
1315141|NCT00095498|4270580|P2|Overall Study|Noncompliance|0
1315142|NCT00095498|4270581|P1|Overall Study|Noncompliance|1
1315143|NCT00095498|4270579|P3|Overall Study|Lost to Follow-up|2
1315144|NCT00095498|4270580|P2|Overall Study|Lost to Follow-up|1
1315145|NCT00095498|4270581|P1|Overall Study|Lost to Follow-up|1
1315146|NCT00095498|4270579|P3|Overall Study|Ineligibility determined|2
1315147|NCT00095498|4270580|P2|Overall Study|Ineligibility determined|0
1315148|NCT00095498|4270581|P1|Overall Study|Ineligibility determined|3
1315149|NCT00095498|4270579|P3|Overall Study|Disease progression|1
1315150|NCT00095498|4270580|P2|Overall Study|Disease progression|1
1315151|NCT00095498|4270581|P1|Overall Study|Disease progression|0
1315152|NCT00095498|4270579|P3|Overall Study|Withdrawal by Subject|15
1315153|NCT00095498|4270580|P2|Overall Study|Withdrawal by Subject|16
1315154|NCT00095498|4270581|P1|Overall Study|Withdrawal by Subject|15
1315155|NCT00095498|4270579|P3|Overall Study|Adverse Event|1
1315156|NCT00095498|4270580|P2|Overall Study|Adverse Event|0
1315157|NCT00095498|4270581|P1|Overall Study|Adverse Event|1
1315158|NCT00095498|4270579|P3|Overall Study|Physician Decision|8
1315159|NCT00095498|4270580|P2|Overall Study|Physician Decision|10
1315160|NCT00095498|4270581|P1|Overall Study|Physician Decision|9
1315161|NCT00095303|4271008|P2|Follow Up Study|Lost to Follow-up|58
1315162|NCT00095303|4271009|P1|Follow Up Study|Lost to Follow-up|59
1315163|NCT00095303|4271008|P2|Main Study|Lost to Follow-up|87
1315164|NCT00095303|4271009|P1|Main Study|Lost to Follow-up|91
1315165|NCT00095238|4271077|P2|Overall Study|Other Reasons|88
1315166|NCT00095238|4271078|P1|Overall Study|Other Reasons|87
1315167|NCT00095238|4271077|P2|Overall Study|Missing|0
1315168|NCT00095238|4271078|P1|Overall Study|Missing|1
1315169|NCT00095238|4271077|P2|Overall Study|Study terminated by sponsor|1
1315170|NCT00095238|4271078|P1|Overall Study|Study terminated by sponsor|0
1315171|NCT00095238|4271077|P2|Overall Study|No longer met study criteria|5
1315172|NCT00095238|4271078|P1|Overall Study|No longer met study criteria|4
1315173|NCT00095238|4271077|P2|Overall Study|Noncompliance|45
1315174|NCT00095238|4271078|P1|Overall Study|Noncompliance|44
1315175|NCT00095238|4271077|P2|Overall Study|Lost to Follow-up|24
1315176|NCT00095238|4271078|P1|Overall Study|Lost to Follow-up|19
1315177|NCT00095238|4271077|P2|Overall Study|Death|170
1315178|NCT00095238|4271078|P1|Overall Study|Death|154
1315179|NCT00095238|4271077|P2|Overall Study|Subject Withdrew Consent|223
1315180|NCT00095238|4271078|P1|Overall Study|Subject Withdrew Consent|208
1315181|NCT00095238|4271077|P2|Overall Study|Adverse Event|287
1315182|NCT00095238|4271078|P1|Overall Study|Adverse Event|331
1315183|NCT00095238|4271077|P2|Overall Study|Lack of Efficacy|9
1315184|NCT00095238|4271078|P1|Overall Study|Lack of Efficacy|9
1315185|NCT00095212|4271140|P2|Overall Study|Withdrawal by Subject|3
1315186|NCT00095212|4271141|P1|Overall Study|Withdrawal by Subject|1
1315187|NCT00095199|4271171|P4|Overall Study|Data inadvertently lost by site|0
1315188|NCT00095199|4271172|P3|Overall Study|Data inadvertently lost by site|0
1315189|NCT00095199|4271173|P2|Overall Study|Data inadvertently lost by site|0
1315190|NCT00095199|4271174|P1|Overall Study|Data inadvertently lost by site|1
1315191|NCT00095199|4271171|P4|Overall Study|Primary tumor removed in other surgery|0
1315192|NCT00095199|4271172|P3|Overall Study|Primary tumor removed in other surgery|0
1315193|NCT00095199|4271173|P2|Overall Study|Primary tumor removed in other surgery|1
1315194|NCT00095199|4271174|P1|Overall Study|Primary tumor removed in other surgery|0
1315195|NCT00095199|4271171|P4|Overall Study|Started radiotherapy regimen|0
1315196|NCT00095199|4271172|P3|Overall Study|Started radiotherapy regimen|0
1315197|NCT00095199|4271173|P2|Overall Study|Started radiotherapy regimen|1
1315198|NCT00095199|4271174|P1|Overall Study|Started radiotherapy regimen|0
1315199|NCT00095199|4271171|P4|Overall Study|Started Palliative Radiotherapy|0
1315200|NCT00095199|4271172|P3|Overall Study|Started Palliative Radiotherapy|0
1315201|NCT00095199|4271173|P2|Overall Study|Started Palliative Radiotherapy|0
1315202|NCT00095199|4271174|P1|Overall Study|Started Palliative Radiotherapy|1
1315203|NCT00095199|4271171|P4|Overall Study|Not eligible|1
1315204|NCT00095199|4271172|P3|Overall Study|Not eligible|0
1315205|NCT00095199|4271173|P2|Overall Study|Not eligible|7
1315206|NCT00095199|4271174|P1|Overall Study|Not eligible|1
1315207|NCT00095199|4271171|P4|Overall Study|Physician Decision|1
1315208|NCT00095199|4271172|P3|Overall Study|Physician Decision|1
1315209|NCT00095199|4271173|P2|Overall Study|Physician Decision|6
1315210|NCT00095199|4271174|P1|Overall Study|Physician Decision|5
1315211|NCT00095199|4271171|P4|Overall Study|Surgery needed could not start in 7 days|0
1315212|NCT00095199|4271172|P3|Overall Study|Surgery needed could not start in 7 days|1
1315213|NCT00095199|4271173|P2|Overall Study|Surgery needed could not start in 7 days|0
1315214|NCT00095199|4271174|P1|Overall Study|Surgery needed could not start in 7 days|0
1315215|NCT00095199|4271171|P4|Overall Study|Liver function test results elevated|1
1315216|NCT00095199|4271172|P3|Overall Study|Liver function test results elevated|1
1315217|NCT00095199|4271173|P2|Overall Study|Liver function test results elevated|0
1315218|NCT00095199|4271174|P1|Overall Study|Liver function test results elevated|0
1315219|NCT00095199|4271171|P4|Overall Study|Protocol Violation|0
1315220|NCT00095199|4271172|P3|Overall Study|Protocol Violation|2
1315221|NCT00095199|4271173|P2|Overall Study|Protocol Violation|4
1315222|NCT00095199|4271174|P1|Overall Study|Protocol Violation|4
1315223|NCT00095199|4271171|P4|Overall Study|Withdrawal by Subject|22
1315224|NCT00095199|4271172|P3|Overall Study|Withdrawal by Subject|13
1315225|NCT00095199|4271173|P2|Overall Study|Withdrawal by Subject|16
1315226|NCT00095199|4271174|P1|Overall Study|Withdrawal by Subject|21
1315227|NCT00095199|4271171|P4|Overall Study|Death|9
1315228|NCT00095199|4271172|P3|Overall Study|Death|11
1315229|NCT00095199|4271173|P2|Overall Study|Death|6
1315230|NCT00095199|4271174|P1|Overall Study|Death|10
1315231|NCT00095199|4271171|P4|Overall Study|Progressive disease|98
1315232|NCT00095199|4271172|P3|Overall Study|Progressive disease|105
1315233|NCT00095199|4271173|P2|Overall Study|Progressive disease|179
1315234|NCT00095199|4271174|P1|Overall Study|Progressive disease|213
1315235|NCT00095199|4271171|P4|Overall Study|Adverse Event|11
1315236|NCT00095199|4271172|P3|Overall Study|Adverse Event|26
1315237|NCT00095199|4271173|P2|Overall Study|Adverse Event|22
1315238|NCT00095199|4271174|P1|Overall Study|Adverse Event|40
1315239|NCT00095173|4271212|P6|Open-Label Extension Phase (Period C)|Not Specified|8
1315240|NCT00095173|4271213|P5|Open-Label Extension Phase (Period C)|Not Specified|6
1315241|NCT00095173|4271214|P4|Open-Label Extension Phase (Period C)|Not Specified|4
1315242|NCT00095173|4271215|P3|Open-Label Extension Phase (Period C)|Not Specified|0
1315243|NCT00095173|4271216|P2|Open-Label Extension Phase (Period C)|Not Specified|0
1315244|NCT00095173|4271217|P1|Open-Label Extension Phase (Period C)|Not Specified|0
1315245|NCT00095173|4271212|P6|Open-Label Extension Phase (Period C)|Pregnancy|3
1315246|NCT00095173|4271213|P5|Open-Label Extension Phase (Period C)|Pregnancy|2
1315247|NCT00095173|4271214|P4|Open-Label Extension Phase (Period C)|Pregnancy|1
1315248|NCT00095173|4271215|P3|Open-Label Extension Phase (Period C)|Pregnancy|0
1315249|NCT00095173|4271216|P2|Open-Label Extension Phase (Period C)|Pregnancy|0
1315250|NCT00095173|4271217|P1|Open-Label Extension Phase (Period C)|Pregnancy|0
1315251|NCT00095173|4271212|P6|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
1315252|NCT00095173|4271213|P5|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
1315253|NCT00095173|4271214|P4|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
1315254|NCT00095173|4271215|P3|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
1315255|NCT00095173|4271216|P2|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
1315256|NCT00095173|4271217|P1|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
1315257|NCT00095173|4271212|P6|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
1315258|NCT00095173|4271213|P5|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
1315259|NCT00095173|4271214|P4|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
1315260|NCT00095173|4271215|P3|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
1315261|NCT00095173|4271216|P2|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
1315262|NCT00095173|4271217|P1|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
1315263|NCT00095173|4271212|P6|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
1315264|NCT00095173|4271213|P5|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6
1315265|NCT00095173|4271214|P4|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4
1315266|NCT00095173|4271215|P3|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
1315267|NCT00095173|4271216|P2|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
1315268|NCT00095173|4271217|P1|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
1315269|NCT00095173|4271212|P6|Open-Label Extension Phase (Period C)|Lost to Follow-up|6
1315270|NCT00095173|4271213|P5|Open-Label Extension Phase (Period C)|Lost to Follow-up|5
1315271|NCT00095173|4271214|P4|Open-Label Extension Phase (Period C)|Lost to Follow-up|2
1315272|NCT00095173|4271215|P3|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
1315273|NCT00095173|4271216|P2|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
1315274|NCT00095173|4271217|P1|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
1315275|NCT00095173|4271212|P6|Open-Label Extension Phase (Period C)|Lack of Efficacy|8
1315276|NCT00095173|4271213|P5|Open-Label Extension Phase (Period C)|Lack of Efficacy|5
1315277|NCT00095173|4271214|P4|Open-Label Extension Phase (Period C)|Lack of Efficacy|11
1315278|NCT00095173|4271215|P3|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
1315279|NCT00095173|4271216|P2|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
1315280|NCT00095173|4271217|P1|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
1315281|NCT00095173|4271212|P6|Open-Label Extension Phase (Period C)|Adverse Event|3
1315282|NCT00095173|4271213|P5|Open-Label Extension Phase (Period C)|Adverse Event|2
1315283|NCT00095173|4271214|P4|Open-Label Extension Phase (Period C)|Adverse Event|1
1315284|NCT00095173|4271215|P3|Open-Label Extension Phase (Period C)|Adverse Event|0
1315285|NCT00095173|4271216|P2|Open-Label Extension Phase (Period C)|Adverse Event|0
1315286|NCT00095173|4271217|P1|Open-Label Extension Phase (Period C)|Adverse Event|0
1315287|NCT00095173|4271212|P6|Open-Label Extension Phase (Period C)|Death|1
1315288|NCT00095173|4271213|P5|Open-Label Extension Phase (Period C)|Death|0
1315289|NCT00095173|4271214|P4|Open-Label Extension Phase (Period C)|Death|0
1315290|NCT00095173|4271215|P3|Open-Label Extension Phase (Period C)|Death|0
1315291|NCT00095173|4271216|P2|Open-Label Extension Phase (Period C)|Death|0
1315292|NCT00095173|4271217|P1|Open-Label Extension Phase (Period C)|Death|0
1315293|NCT00095173|4271212|P6|Double-Blind Phase (Period B)|Withdrawal by Subject|0
1315294|NCT00095173|4271213|P5|Double-Blind Phase (Period B)|Withdrawal by Subject|0
1315295|NCT00095173|4271214|P4|Double-Blind Phase (Period B)|Withdrawal by Subject|0
1315296|NCT00095173|4271215|P3|Double-Blind Phase (Period B)|Withdrawal by Subject|0
1315297|NCT00095173|4271216|P2|Double-Blind Phase (Period B)|Withdrawal by Subject|1
1315298|NCT00095173|4271217|P1|Double-Blind Phase (Period B)|Withdrawal by Subject|0
1315299|NCT00095173|4271212|P6|Double-Blind Phase (Period B)|Lack of Efficacy|0
1315300|NCT00095173|4271213|P5|Double-Blind Phase (Period B)|Lack of Efficacy|0
1315301|NCT00095173|4271214|P4|Double-Blind Phase (Period B)|Lack of Efficacy|0
1315302|NCT00095173|4271215|P3|Double-Blind Phase (Period B)|Lack of Efficacy|31
1315303|NCT00095173|4271216|P2|Double-Blind Phase (Period B)|Lack of Efficacy|10
1315304|NCT00095173|4271217|P1|Double-Blind Phase (Period B)|Lack of Efficacy|0
1315305|NCT00095173|4271212|P6|Open-Label Lead-In Phase (Period A)|Not specified|0
1315306|NCT00095173|4271213|P5|Open-Label Lead-In Phase (Period A)|Not specified|0
1315307|NCT00095173|4271214|P4|Open-Label Lead-In Phase (Period A)|Not specified|0
1315308|NCT00095173|4271215|P3|Open-Label Lead-In Phase (Period A)|Not specified|0
1315309|NCT00095173|4271216|P2|Open-Label Lead-In Phase (Period A)|Not specified|0
1315310|NCT00095173|4271217|P1|Open-Label Lead-In Phase (Period A)|Not specified|1
1315311|NCT00095173|4271212|P6|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
1315312|NCT00095173|4271213|P5|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
1315313|NCT00095173|4271214|P4|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
1315314|NCT00095173|4271215|P3|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
1315315|NCT00095173|4271216|P2|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
1315316|NCT00095173|4271217|P1|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1
1315317|NCT00095173|4271212|P6|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
1315318|NCT00095173|4271213|P5|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
1315319|NCT00095173|4271214|P4|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
1315320|NCT00095173|4271215|P3|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
1315321|NCT00095173|4271216|P2|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
1315322|NCT00095173|4271217|P1|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17
1315323|NCT00095173|4271212|P6|Open-Label Lead-In Phase (Period A)|Adverse Event|0
1315324|NCT00095173|4271213|P5|Open-Label Lead-In Phase (Period A)|Adverse Event|0
1315325|NCT00095173|4271214|P4|Open-Label Lead-In Phase (Period A)|Adverse Event|0
1315326|NCT00095173|4271215|P3|Open-Label Lead-In Phase (Period A)|Adverse Event|0
1315327|NCT00095173|4271216|P2|Open-Label Lead-In Phase (Period A)|Adverse Event|0
1315328|NCT00095173|4271217|P1|Open-Label Lead-In Phase (Period A)|Adverse Event|1
1315329|NCT00095147|4271255|P5|Long-term Extension Period|Leaving country|1
1315330|NCT00095147|4271256|P4|Long-term Extension Period|Leaving country|0
1315331|NCT00095147|4271257|P3|Long-term Extension Period|Leaving country|0
1315332|NCT00095147|4271258|P2|Long-term Extension Period|Leaving country|0
1315333|NCT00095147|4271259|P1|Long-term Extension Period|Leaving country|0
1315334|NCT00095147|4271255|P5|Long-term Extension Period|Participant chose to use Revellex|1
1315335|NCT00095147|4271256|P4|Long-term Extension Period|Participant chose to use Revellex|0
1315336|NCT00095147|4271257|P3|Long-term Extension Period|Participant chose to use Revellex|0
1315337|NCT00095147|4271258|P2|Long-term Extension Period|Participant chose to use Revellex|0
1315338|NCT00095147|4271259|P1|Long-term Extension Period|Participant chose to use Revellex|0
1315339|NCT00095147|4271255|P5|Long-term Extension Period|No longer meets study criteria|1
1315340|NCT00095147|4271256|P4|Long-term Extension Period|No longer meets study criteria|0
1315341|NCT00095147|4271257|P3|Long-term Extension Period|No longer meets study criteria|0
1315342|NCT00095147|4271258|P2|Long-term Extension Period|No longer meets study criteria|0
1315343|NCT00095147|4271259|P1|Long-term Extension Period|No longer meets study criteria|0
1315344|NCT00095147|4271255|P5|Long-term Extension Period|Pregnancy|1
1315345|NCT00095147|4271256|P4|Long-term Extension Period|Pregnancy|0
1315346|NCT00095147|4271257|P3|Long-term Extension Period|Pregnancy|0
1315347|NCT00095147|4271258|P2|Long-term Extension Period|Pregnancy|0
1315348|NCT00095147|4271259|P1|Long-term Extension Period|Pregnancy|0
1315349|NCT00095147|4271255|P5|Long-term Extension Period|Withdrawal of consent|12
1315350|NCT00095147|4271256|P4|Long-term Extension Period|Withdrawal of consent|0
1315351|NCT00095147|4271257|P3|Long-term Extension Period|Withdrawal of consent|0
1315352|NCT00095147|4271258|P2|Long-term Extension Period|Withdrawal of consent|0
1315353|NCT00095147|4271259|P1|Long-term Extension Period|Withdrawal of consent|0
1315354|NCT00095147|4271255|P5|Long-term Extension Period|Lost to Follow-up|6
1315355|NCT00095147|4271256|P4|Long-term Extension Period|Lost to Follow-up|0
1315356|NCT00095147|4271257|P3|Long-term Extension Period|Lost to Follow-up|0
1315357|NCT00095147|4271258|P2|Long-term Extension Period|Lost to Follow-up|0
1315358|NCT00095147|4271259|P1|Long-term Extension Period|Lost to Follow-up|0
1315359|NCT00095147|4271255|P5|Long-term Extension Period|Lack of Efficacy|9
1315360|NCT00095147|4271256|P4|Long-term Extension Period|Lack of Efficacy|0
1315361|NCT00095147|4271257|P3|Long-term Extension Period|Lack of Efficacy|0
1315362|NCT00095147|4271258|P2|Long-term Extension Period|Lack of Efficacy|0
1315363|NCT00095147|4271259|P1|Long-term Extension Period|Lack of Efficacy|0
1315364|NCT00095147|4271255|P5|Long-term Extension Period|Adverse Event|11
1315365|NCT00095147|4271256|P4|Long-term Extension Period|Adverse Event|0
1315366|NCT00095147|4271257|P3|Long-term Extension Period|Adverse Event|0
1315367|NCT00095147|4271258|P2|Long-term Extension Period|Adverse Event|0
1315368|NCT00095147|4271259|P1|Long-term Extension Period|Adverse Event|0
1315369|NCT00095147|4271255|P5|Long-term Extension Period|Death|3
1315370|NCT00095147|4271256|P4|Long-term Extension Period|Death|0
1315371|NCT00095147|4271257|P3|Long-term Extension Period|Death|0
1315372|NCT00095147|4271258|P2|Long-term Extension Period|Death|0
1315373|NCT00095147|4271259|P1|Long-term Extension Period|Death|0
1315374|NCT00095147|4271255|P5|Double-blind Period 2 (Days 198-365)|Participant relocation|0
1315375|NCT00095147|4271256|P4|Double-blind Period 2 (Days 198-365)|Participant relocation|1
1315376|NCT00095147|4271257|P3|Double-blind Period 2 (Days 198-365)|Participant relocation|0
1315377|NCT00095147|4271258|P2|Double-blind Period 2 (Days 198-365)|Participant relocation|0
1315378|NCT00095147|4271259|P1|Double-blind Period 2 (Days 198-365)|Participant relocation|1
1315379|NCT00095147|4271255|P5|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
1315380|NCT00095147|4271256|P4|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
1315381|NCT00095147|4271257|P3|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
1315382|NCT00095147|4271258|P2|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2
1315383|NCT00095147|4271259|P1|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3
1315384|NCT00095147|4271255|P5|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
1315385|NCT00095147|4271256|P4|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1
1315386|NCT00095147|4271257|P3|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
1315387|NCT00095147|4271258|P2|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4
1315388|NCT00095147|4271259|P1|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2
1315389|NCT00095147|4271255|P5|Double-blind Period 2 (Days 198-365)|Adverse Event|0
1315390|NCT00095147|4271256|P4|Double-blind Period 2 (Days 198-365)|Adverse Event|0
1315391|NCT00095147|4271257|P3|Double-blind Period 2 (Days 198-365)|Adverse Event|0
1315392|NCT00095147|4271258|P2|Double-blind Period 2 (Days 198-365)|Adverse Event|4
1315393|NCT00095147|4271259|P1|Double-blind Period 2 (Days 198-365)|Adverse Event|2
1315394|NCT00095147|4271255|P5|Double-blind Period 2 (Days 198-365)|Death|0
1315395|NCT00095147|4271256|P4|Double-blind Period 2 (Days 198-365)|Death|1
1315396|NCT00095147|4271257|P3|Double-blind Period 2 (Days 198-365)|Death|0
1315397|NCT00095147|4271258|P2|Double-blind Period 2 (Days 198-365)|Death|1
1315398|NCT00095147|4271259|P1|Double-blind Period 2 (Days 198-365)|Death|0
1315399|NCT00095147|4271255|P5|Double-blind Period 1 (Days 1-197)|Pregnancy|0
1315400|NCT00095147|4271256|P4|Double-blind Period 1 (Days 1-197)|Pregnancy|0
1315401|NCT00095147|4271257|P3|Double-blind Period 1 (Days 1-197)|Pregnancy|0
1315402|NCT00095147|4271258|P2|Double-blind Period 1 (Days 1-197)|Pregnancy|1
1315403|NCT00095147|4271259|P1|Double-blind Period 1 (Days 1-197)|Pregnancy|1
1315404|NCT00095147|4271255|P5|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
1315405|NCT00095147|4271256|P4|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
1315406|NCT00095147|4271257|P3|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
1315407|NCT00095147|4271258|P2|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
1315408|NCT00095147|4271259|P1|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
1315409|NCT00095147|4271255|P5|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
1315410|NCT00095147|4271256|P4|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
1315411|NCT00095147|4271257|P3|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
1315412|NCT00095147|4271258|P2|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
1315413|NCT00095147|4271259|P1|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
1315414|NCT00095147|4271255|P5|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
1315415|NCT00095147|4271256|P4|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
1315416|NCT00095147|4271257|P3|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1
1315417|NCT00095147|4271258|P2|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
1315418|NCT00095147|4271259|P1|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
1315419|NCT00095147|4271255|P5|Double-blind Period 1 (Days 1-197)|Adverse Event|0
1315420|NCT00095147|4271256|P4|Double-blind Period 1 (Days 1-197)|Adverse Event|0
1315421|NCT00095147|4271257|P3|Double-blind Period 1 (Days 1-197)|Adverse Event|1
1315422|NCT00095147|4271258|P2|Double-blind Period 1 (Days 1-197)|Adverse Event|8
1315423|NCT00095147|4271259|P1|Double-blind Period 1 (Days 1-197)|Adverse Event|2
1315424|NCT00095147|4271255|P5|Double-blind Period 1 (Days 1-197)|Death|0
1315425|NCT00095147|4271256|P4|Double-blind Period 1 (Days 1-197)|Death|0
1315426|NCT00095147|4271257|P3|Double-blind Period 1 (Days 1-197)|Death|0
1315427|NCT00095147|4271258|P2|Double-blind Period 1 (Days 1-197)|Death|0
1315428|NCT00095147|4271259|P1|Double-blind Period 1 (Days 1-197)|Death|1
1315429|NCT00095121|4271454|P2|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0
1315430|NCT00095121|4271455|P1|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2
1315431|NCT00095121|4271454|P2|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0
1315432|NCT00095121|4271455|P1|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1
1315433|NCT00095056|4271501|P2|Phase B (Weeks 12-54)|Protocol Violation|1
1315434|NCT00095056|4271502|P1|Phase B (Weeks 12-54)|Protocol Violation|0
1315435|NCT00095056|4271501|P2|Phase B (Weeks 12-54)|Protocol specific criteria|0
1315436|NCT00095056|4271502|P1|Phase B (Weeks 12-54)|Protocol specific criteria|1
1315437|NCT00095056|4271501|P2|Phase B (Weeks 12-54)|Death|1
1315438|NCT00095056|4271502|P1|Phase B (Weeks 12-54)|Death|3
1315439|NCT00095056|4271501|P2|Phase B (Weeks 12-54)|Patient Moved|0
1315440|NCT00095056|4271502|P1|Phase B (Weeks 12-54)|Patient Moved|1
1315441|NCT00095056|4271501|P2|Phase B (Weeks 12-54)|Withdrawal by Subject|1
1315442|NCT00095056|4271502|P1|Phase B (Weeks 12-54)|Withdrawal by Subject|2
1315443|NCT00095056|4271501|P2|Phase B (Weeks 12-54)|Lost to Follow-up|0
1315444|NCT00095056|4271502|P1|Phase B (Weeks 12-54)|Lost to Follow-up|1
1315445|NCT00095056|4271501|P2|Phase B (Weeks 12-54)|Adverse Event|2
1315446|NCT00095056|4271502|P1|Phase B (Weeks 12-54)|Adverse Event|2
1315447|NCT00095056|4271501|P2|Phase A (Weeks 0-12)|Protocol specific criteria|0
1315448|NCT00095056|4271502|P1|Phase A (Weeks 0-12)|Protocol specific criteria|2
1315449|NCT00095056|4271501|P2|Phase A (Weeks 0-12)|Death|0
1315450|NCT00095056|4271502|P1|Phase A (Weeks 0-12)|Death|1
1315451|NCT00095056|4271501|P2|Phase A (Weeks 0-12)|Withdrawal by Subject|0
1315452|NCT00095056|4271502|P1|Phase A (Weeks 0-12)|Withdrawal by Subject|3
1315453|NCT00095056|4271501|P2|Phase A (Weeks 0-12)|Adverse Event|1
1315454|NCT00095056|4271502|P1|Phase A (Weeks 0-12)|Adverse Event|1
1315455|NCT00094887|4271612|P2|Overall Study|Physician Decision|2
1315456|NCT00094887|4271613|P1|Overall Study|Physician Decision|2
1315457|NCT00094887|4271612|P2|Overall Study|Family emergency, Subject noncompliance|4
1315458|NCT00094887|4271613|P1|Overall Study|Family emergency, Subject noncompliance|3
1315459|NCT00094861|4271621|P2|Overall Study|Other|0
1315460|NCT00094861|4271622|P1|Overall Study|Other|3
1315461|NCT00094861|4271621|P2|Overall Study|Death|2
1315462|NCT00094861|4271622|P1|Overall Study|Death|4
1315463|NCT00094861|4271621|P2|Overall Study|Lost to Follow-up|1
1315464|NCT00094861|4271622|P1|Overall Study|Lost to Follow-up|0
1315465|NCT00094861|4271621|P2|Overall Study|Physician Decision|1
1315466|NCT00094861|4271622|P1|Overall Study|Physician Decision|1
1315467|NCT00094861|4271621|P2|Overall Study|Withdrawal by Subject|3
1315468|NCT00094861|4271622|P1|Overall Study|Withdrawal by Subject|5
1315469|NCT00094861|4271621|P2|Overall Study|Adverse Event|2
1315470|NCT00094861|4271622|P1|Overall Study|Adverse Event|5
1315471|NCT00094835|4271649|P7|Overall Study|Other|0
1315472|NCT00094835|4271650|P6|Overall Study|Other|0
1315473|NCT00094835|4271651|P5|Overall Study|Other|0
1315474|NCT00094835|4271652|P4|Overall Study|Other|1
1315475|NCT00094835|4271653|P3|Overall Study|Other|1
1315476|NCT00094835|4271654|P2|Overall Study|Other|1
1315477|NCT00094835|4271655|P1|Overall Study|Other|1
1315478|NCT00094835|4271649|P7|Overall Study|Non-compliance|1
1315479|NCT00094835|4271650|P6|Overall Study|Non-compliance|2
1315480|NCT00094835|4271651|P5|Overall Study|Non-compliance|2
1315481|NCT00094835|4271652|P4|Overall Study|Non-compliance|0
1315482|NCT00094835|4271653|P3|Overall Study|Non-compliance|2
1315483|NCT00094835|4271654|P2|Overall Study|Non-compliance|2
1315484|NCT00094835|4271655|P1|Overall Study|Non-compliance|1
1315485|NCT00094835|4271649|P7|Overall Study|Death|0
1315486|NCT00094835|4271650|P6|Overall Study|Death|0
1315487|NCT00094835|4271651|P5|Overall Study|Death|1
1315488|NCT00094835|4271652|P4|Overall Study|Death|0
1315489|NCT00094835|4271653|P3|Overall Study|Death|0
1315490|NCT00094835|4271654|P2|Overall Study|Death|0
1315491|NCT00094835|4271655|P1|Overall Study|Death|1
1315492|NCT00094835|4271649|P7|Overall Study|Lost to Follow-up|0
1315493|NCT00094835|4271650|P6|Overall Study|Lost to Follow-up|0
1315494|NCT00094835|4271651|P5|Overall Study|Lost to Follow-up|1
1315495|NCT00094835|4271652|P4|Overall Study|Lost to Follow-up|0
1315496|NCT00094835|4271653|P3|Overall Study|Lost to Follow-up|0
1315497|NCT00094835|4271654|P2|Overall Study|Lost to Follow-up|0
1315498|NCT00094835|4271655|P1|Overall Study|Lost to Follow-up|0
1315499|NCT00094835|4271649|P7|Overall Study|Withdrawal by Subject|1
1315500|NCT00094835|4271650|P6|Overall Study|Withdrawal by Subject|0
1315501|NCT00094835|4271651|P5|Overall Study|Withdrawal by Subject|0
1315502|NCT00094835|4271652|P4|Overall Study|Withdrawal by Subject|0
1315503|NCT00094835|4271653|P3|Overall Study|Withdrawal by Subject|0
1315504|NCT00094835|4271654|P2|Overall Study|Withdrawal by Subject|0
1315506|NCT00094835|4271649|P7|Overall Study|Physician Decision|0
1315507|NCT00094835|4271650|P6|Overall Study|Physician Decision|1
1315508|NCT00094835|4271651|P5|Overall Study|Physician Decision|0
1315509|NCT00094835|4271652|P4|Overall Study|Physician Decision|0
1315510|NCT00094835|4271653|P3|Overall Study|Physician Decision|0
1315511|NCT00094835|4271654|P2|Overall Study|Physician Decision|0
1315512|NCT00094835|4271655|P1|Overall Study|Physician Decision|1
1315513|NCT00094809|4271733|P2|Overall Study|Other|1
1315514|NCT00094809|4271734|P1|Overall Study|Other|1
1315515|NCT00094809|4271733|P2|Overall Study|Study drug not received|8
1315516|NCT00094809|4271734|P1|Overall Study|Study drug not received|2
1315517|NCT00094809|4271733|P2|Overall Study|Informed consent signed after treatment|0
1315518|NCT00094809|4271734|P1|Overall Study|Informed consent signed after treatment|1
1315519|NCT00094809|4271733|P2|Overall Study|Other|4
1315520|NCT00094809|4271734|P1|Overall Study|Other|2
1315521|NCT00094809|4271733|P2|Overall Study|Protocol-specified criteria|1
1315522|NCT00094809|4271734|P1|Overall Study|Protocol-specified criteria|1
1315523|NCT00094809|4271733|P2|Overall Study|Death|25
1315524|NCT00094809|4271734|P1|Overall Study|Death|19
1315525|NCT00094809|4271733|P2|Overall Study|Lost to Follow-up|6
1315526|NCT00094809|4271734|P1|Overall Study|Lost to Follow-up|6
1315527|NCT00094809|4271733|P2|Overall Study|Physician Decision|5
1315528|NCT00094809|4271734|P1|Overall Study|Physician Decision|3
1315529|NCT00094809|4271733|P2|Overall Study|Disease progression|3
1315530|NCT00094809|4271734|P1|Overall Study|Disease progression|3
1315531|NCT00094809|4271733|P2|Overall Study|Withdrawal by Subject|9
1315532|NCT00094809|4271734|P1|Overall Study|Withdrawal by Subject|8
1315533|NCT00094809|4271733|P2|Overall Study|Adverse Event|1
1315534|NCT00094809|4271734|P1|Overall Study|Adverse Event|3
1315535|NCT00094809|4271733|P2|Overall Study|Noncompliance|0
1315536|NCT00094809|4271734|P1|Overall Study|Noncompliance|1
1315537|NCT00094809|4271733|P2|Overall Study|Protocol deviation|2
1315538|NCT00094809|4271734|P1|Overall Study|Protocol deviation|2
1315539|NCT00094770|4271760|P2|Year 2 (Week 0 to Week 104)|Other|23
1315540|NCT00094770|4271761|P1|Year 2 (Week 0 to Week 104)|Other|15
1315541|NCT00094770|4271760|P2|Year 2 (Week 0 to Week 104)|Site Terminated|2
1315542|NCT00094770|4271761|P1|Year 2 (Week 0 to Week 104)|Site Terminated|2
1315543|NCT00094770|4271760|P2|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38
1315544|NCT00094770|4271761|P1|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28
1315545|NCT00094770|4271760|P2|Year 2 (Week 0 to Week 104)|Patient Moved|2
1315546|NCT00094770|4271761|P1|Year 2 (Week 0 to Week 104)|Patient Moved|6
1315547|NCT00094770|4271760|P2|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30
1315548|NCT00094770|4271761|P1|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29
1315549|NCT00094770|4271760|P2|Year 2 (Week 0 to Week 104)|Protocol Violation|12
1315550|NCT00094770|4271761|P1|Year 2 (Week 0 to Week 104)|Protocol Violation|13
1315551|NCT00094770|4271760|P2|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15
1315552|NCT00094770|4271761|P1|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25
1315553|NCT00094770|4271760|P2|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162
1315554|NCT00094770|4271761|P1|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180
1315555|NCT00094770|4271760|P2|Year 2 (Week 0 to Week 104)|Adverse Event|36
1315556|NCT00094770|4271761|P1|Year 2 (Week 0 to Week 104)|Adverse Event|35
1315557|NCT00094770|4271760|P2|Year 1 ( Week 0 to Week 52)|Other|11
1315558|NCT00094770|4271761|P1|Year 1 ( Week 0 to Week 52)|Other|10
1315559|NCT00094770|4271760|P2|Year 1 ( Week 0 to Week 52)|Site Terminated|2
1315560|NCT00094770|4271761|P1|Year 1 ( Week 0 to Week 52)|Site Terminated|2
1315561|NCT00094770|4271760|P2|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28
1315562|NCT00094770|4271761|P1|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25
1315563|NCT00094770|4271760|P2|Year 1 ( Week 0 to Week 52)|Patient Moved|2
1315564|NCT00094770|4271761|P1|Year 1 ( Week 0 to Week 52)|Patient Moved|6
1315565|NCT00094770|4271760|P2|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25
1315566|NCT00094770|4271761|P1|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19
1315567|NCT00094770|4271760|P2|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
1315568|NCT00094770|4271761|P1|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
1315569|NCT00094770|4271760|P2|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10
1315570|NCT00094770|4271761|P1|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19
1315571|NCT00094770|4271760|P2|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58
1315572|NCT00094770|4271761|P1|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86
1315573|NCT00094770|4271760|P2|Year 1 ( Week 0 to Week 52)|Adverse Event|26
1315574|NCT00094770|4271761|P1|Year 1 ( Week 0 to Week 52)|Adverse Event|25
1315575|NCT00094757|4271792|P3|Overall Study|Protocol specified discontinuation|0
1315576|NCT00094757|4271793|P2|Overall Study|Protocol specified discontinuation|3
1315577|NCT00094757|4271794|P1|Overall Study|Protocol specified discontinuation|1
1315578|NCT00094757|4271792|P3|Overall Study|Other|1
1315579|NCT00094757|4271793|P2|Overall Study|Other|3
1315580|NCT00094757|4271794|P1|Overall Study|Other|3
1315581|NCT00094757|4271792|P3|Overall Study|Withdrawal by Subject|5
1315582|NCT00094757|4271793|P2|Overall Study|Withdrawal by Subject|21
1315583|NCT00094757|4271794|P1|Overall Study|Withdrawal by Subject|14
1315584|NCT00094757|4271792|P3|Overall Study|Protocol Violation|3
1315585|NCT00094757|4271793|P2|Overall Study|Protocol Violation|5
1315586|NCT00094757|4271794|P1|Overall Study|Protocol Violation|8
1315587|NCT00094757|4271792|P3|Overall Study|Patient Moved|1
1315588|NCT00094757|4271793|P2|Overall Study|Patient Moved|1
1315589|NCT00094757|4271794|P1|Overall Study|Patient Moved|2
1315590|NCT00094757|4271792|P3|Overall Study|Lost to Follow-up|6
1315591|NCT00094757|4271793|P2|Overall Study|Lost to Follow-up|5
1315592|NCT00094757|4271794|P1|Overall Study|Lost to Follow-up|3
1315593|NCT00094757|4271792|P3|Overall Study|Lack of Efficacy|8
1315594|NCT00094757|4271793|P2|Overall Study|Lack of Efficacy|15
1315595|NCT00094757|4271794|P1|Overall Study|Lack of Efficacy|11
1315596|NCT00094757|4271792|P3|Overall Study|Adverse Event|6
1315597|NCT00094757|4271793|P2|Overall Study|Adverse Event|9
1315598|NCT00094757|4271794|P1|Overall Study|Adverse Event|11
1315599|NCT00094653|4271814|P3|Overall Study|Protocol Violation|1
1315600|NCT00094653|4271815|P2|Overall Study|Protocol Violation|0
1315601|NCT00094653|4271816|P1|Overall Study|Protocol Violation|0
1315602|NCT00094653|4271814|P3|Overall Study|Lost to Follow-up|1
1315603|NCT00094653|4271815|P2|Overall Study|Lost to Follow-up|2
1315604|NCT00094653|4271816|P1|Overall Study|Lost to Follow-up|3
1315605|NCT00094653|4271814|P3|Overall Study|Not specified|2
1315606|NCT00094653|4271815|P2|Overall Study|Not specified|2
1315607|NCT00094653|4271816|P1|Overall Study|Not specified|2
1315608|NCT00094653|4271814|P3|Overall Study|Subject Withdrew Consent|3
1315609|NCT00094653|4271815|P2|Overall Study|Subject Withdrew Consent|2
1315610|NCT00094653|4271816|P1|Overall Study|Subject Withdrew Consent|10
1315611|NCT00094653|4271814|P3|Overall Study|Death|119
1315612|NCT00094653|4271815|P2|Overall Study|Death|100
1315613|NCT00094653|4271816|P1|Overall Study|Death|306
1315614|NCT00094575|4271879|P2|Overall Study|Death|146
1315615|NCT00094575|4271880|P1|Overall Study|Death|146
1315616|NCT00094536|4271900|P1|Treatment and Follow-up|Unable to attend visits|1
1315617|NCT00094536|4271900|P1|Treatment and Follow-up|Subject non-compliance|9
1315618|NCT00094536|4271900|P1|Treatment and Follow-up|Withdrawal by Subject|1
1315619|NCT00094536|4271900|P1|Treatment and Follow-up|Lost to Follow-up|7
1315620|NCT00094536|4271900|P1|Treatment and Follow-up|Lack of Efficacy|9
1315621|NCT00094536|4271900|P1|Treatment and Follow-up|Adverse Event|4
1315622|NCT00094536|4271900|P1|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24
1315623|NCT00094458|4271924|P6|OLE: Open-Label Extension|Patient decision|0
1315624|NCT00094458|4271925|P5|OLE: Open-Label Extension|Patient decision|1
1315625|NCT00094458|4271926|P4|OLE: Open-Label Extension|Patient decision|0
1315626|NCT00094458|4271927|P3|OLE: Open-Label Extension|Patient decision|0
1315627|NCT00094458|4271928|P2|OLE: Open-Label Extension|Patient decision|0
1315628|NCT00094458|4271929|P1|OLE: Open-Label Extension|Patient decision|0
1315629|NCT00094458|4271924|P6|OLE: Open-Label Extension|Inadequate therapeutic effect|0
1315630|NCT00094458|4271925|P5|OLE: Open-Label Extension|Inadequate therapeutic effect|1
1315631|NCT00094458|4271926|P4|OLE: Open-Label Extension|Inadequate therapeutic effect|1
1315632|NCT00094458|4271927|P3|OLE: Open-Label Extension|Inadequate therapeutic effect|0
1315633|NCT00094458|4271928|P2|OLE: Open-Label Extension|Inadequate therapeutic effect|0
1315634|NCT00094458|4271929|P1|OLE: Open-Label Extension|Inadequate therapeutic effect|0
1315635|NCT00094458|4271924|P6|OLE: Open-Label Extension|Adverse Event|4
1315636|NCT00094458|4271925|P5|OLE: Open-Label Extension|Adverse Event|3
1315637|NCT00094458|4271926|P4|OLE: Open-Label Extension|Adverse Event|0
1315638|NCT00094458|4271927|P3|OLE: Open-Label Extension|Adverse Event|0
1315639|NCT00094458|4271928|P2|OLE: Open-Label Extension|Adverse Event|0
1315640|NCT00094458|4271929|P1|OLE: Open-Label Extension|Adverse Event|0
1315641|NCT00094458|4271924|P6|Study Extension: Week 30 Through Week 50|Other|0
1315642|NCT00094458|4271925|P5|Study Extension: Week 30 Through Week 50|Other|0
1315643|NCT00094458|4271926|P4|Study Extension: Week 30 Through Week 50|Other|0
1315644|NCT00094458|4271927|P3|Study Extension: Week 30 Through Week 50|Other|3
1315645|NCT00094458|4271928|P2|Study Extension: Week 30 Through Week 50|Other|2
1315646|NCT00094458|4271929|P1|Study Extension: Week 30 Through Week 50|Other|1
1315647|NCT00094458|4271924|P6|Study Extension: Week 30 Through Week 50|Adverse Event|0
1315648|NCT00094458|4271925|P5|Study Extension: Week 30 Through Week 50|Adverse Event|0
1315649|NCT00094458|4271926|P4|Study Extension: Week 30 Through Week 50|Adverse Event|0
1315650|NCT00094458|4271927|P3|Study Extension: Week 30 Through Week 50|Adverse Event|7
1315651|NCT00094458|4271928|P2|Study Extension: Week 30 Through Week 50|Adverse Event|9
1315652|NCT00094458|4271929|P1|Study Extension: Week 30 Through Week 50|Adverse Event|3
1315653|NCT00094458|4271924|P6|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
1315654|NCT00094458|4271925|P5|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
1315655|NCT00094458|4271926|P4|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
1315656|NCT00094458|4271927|P3|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4
1315657|NCT00094458|4271928|P2|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
1315658|NCT00094458|4271929|P1|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2
1315659|NCT00094458|4271924|P6|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
1315660|NCT00094458|4271925|P5|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
1315661|NCT00094458|4271926|P4|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
1315662|NCT00094458|4271927|P3|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4
1315663|NCT00094458|4271928|P2|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1
1315664|NCT00094458|4271929|P1|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2
1315665|NCT00094458|4271924|P6|Main Study: Through Week 30|Other|0
1315666|NCT00094458|4271925|P5|Main Study: Through Week 30|Other|0
1315667|NCT00094458|4271926|P4|Main Study: Through Week 30|Other|0
1315668|NCT00094458|4271927|P3|Main Study: Through Week 30|Other|9
1315669|NCT00094458|4271928|P2|Main Study: Through Week 30|Other|16
1315670|NCT00094458|4271929|P1|Main Study: Through Week 30|Other|19
1315671|NCT00094458|4271924|P6|Main Study: Through Week 30|Death|0
1315672|NCT00094458|4271925|P5|Main Study: Through Week 30|Death|0
1315673|NCT00094458|4271926|P4|Main Study: Through Week 30|Death|0
1315674|NCT00094458|4271927|P3|Main Study: Through Week 30|Death|0
1315675|NCT00094458|4271928|P2|Main Study: Through Week 30|Death|0
1315676|NCT00094458|4271929|P1|Main Study: Through Week 30|Death|1
1315677|NCT00094458|4271924|P6|Main Study: Through Week 30|Adverse Event|0
1315678|NCT00094458|4271925|P5|Main Study: Through Week 30|Adverse Event|0
1315679|NCT00094458|4271926|P4|Main Study: Through Week 30|Adverse Event|0
1315680|NCT00094458|4271927|P3|Main Study: Through Week 30|Adverse Event|28
1315681|NCT00094458|4271928|P2|Main Study: Through Week 30|Adverse Event|20
1315682|NCT00094458|4271929|P1|Main Study: Through Week 30|Adverse Event|38
1315683|NCT00094458|4271924|P6|Main Study: Through Week 30|Withdrawal by Subject|0
1315684|NCT00094458|4271925|P5|Main Study: Through Week 30|Withdrawal by Subject|0
1315685|NCT00094458|4271926|P4|Main Study: Through Week 30|Withdrawal by Subject|0
1315686|NCT00094458|4271927|P3|Main Study: Through Week 30|Withdrawal by Subject|7
1315687|NCT00094458|4271928|P2|Main Study: Through Week 30|Withdrawal by Subject|9
1315688|NCT00094458|4271929|P1|Main Study: Through Week 30|Withdrawal by Subject|18
1315689|NCT00094458|4271924|P6|Main Study: Through Week 30|Lost to Follow-up|0
1315690|NCT00094458|4271925|P5|Main Study: Through Week 30|Lost to Follow-up|0
1315691|NCT00094458|4271926|P4|Main Study: Through Week 30|Lost to Follow-up|0
1315692|NCT00094458|4271927|P3|Main Study: Through Week 30|Lost to Follow-up|2
1315693|NCT00094458|4271928|P2|Main Study: Through Week 30|Lost to Follow-up|5
1315694|NCT00094458|4271929|P1|Main Study: Through Week 30|Lost to Follow-up|5
1315695|NCT00094458|4271924|P6|Main Study: Through Week 30|Eligibility criteria not met|0
1315696|NCT00094458|4271925|P5|Main Study: Through Week 30|Eligibility criteria not met|0
1315697|NCT00094458|4271926|P4|Main Study: Through Week 30|Eligibility criteria not met|0
1315698|NCT00094458|4271927|P3|Main Study: Through Week 30|Eligibility criteria not met|2
1315699|NCT00094458|4271928|P2|Main Study: Through Week 30|Eligibility criteria not met|8
1315700|NCT00094458|4271929|P1|Main Study: Through Week 30|Eligibility criteria not met|3
1315701|NCT00094328|4271967|P1|Overall Study|Lost to Follow-up|1
1315702|NCT00094302|4271981|P2|Overall Study|Death|246
1315703|NCT00094302|4271982|P1|Overall Study|Death|266
1315704|NCT00094302|4271981|P2|Overall Study|Withdrawal by Subject|111
1315705|NCT00094302|4271982|P1|Overall Study|Withdrawal by Subject|103
1315706|NCT00094302|4271981|P2|Overall Study|Physician Decision|8
1315707|NCT00094302|4271982|P1|Overall Study|Physician Decision|5
1315708|NCT00094302|4271981|P2|Overall Study|Lost to Follow-up|41
1315709|NCT00094302|4271982|P1|Overall Study|Lost to Follow-up|43
1315710|NCT00094172|4272038|P2|Overall Study|Started other MS therapy due to disease|0
1315711|NCT00094172|4272039|P1|Overall Study|Started other MS therapy due to disease|1
1315712|NCT00094172|4272038|P2|Overall Study|Primary endpoint met.|0
1315713|NCT00094172|4272039|P1|Overall Study|Primary endpoint met.|1
1315714|NCT00094172|4272038|P2|Overall Study|Withdrawal by Subject|5
1315715|NCT00094172|4272039|P1|Overall Study|Withdrawal by Subject|10
1315716|NCT00094172|4272038|P2|Overall Study|Protocol Violation|1
1315717|NCT00094172|4272039|P1|Overall Study|Protocol Violation|0
1315718|NCT00094172|4272038|P2|Overall Study|Lost to Follow-up|0
1315719|NCT00094172|4272039|P1|Overall Study|Lost to Follow-up|2
1315720|NCT00094172|4272038|P2|Overall Study|Adverse Event|1
1315721|NCT00094172|4272039|P1|Overall Study|Adverse Event|0
1315722|NCT00094107|4272049|P1|Overall Study|Withdrawal due to Disease Progression|1
1315723|NCT00094107|4272049|P1|Overall Study|Adverse Event|3
1315724|NCT00094107|4272049|P1|Overall Study|Death|5
1315725|NCT00094107|4272049|P1|Overall Study|Lack of Efficacy|23
1315726|NCT00094094|4272058|P1|Overall Study|Adverse Event|7
1315727|NCT00094094|4272058|P1|Overall Study|Lack of Efficacy|23
1315728|NCT00094094|4272058|P1|Overall Study|Death|2
1315729|NCT00094055|4272067|P1|Overall Study|Withdrawal by Subject|9
1315730|NCT00094055|4272067|P1|Overall Study|roll-over to another study|14
1315731|NCT00094055|4272067|P1|Overall Study|clinical progression|1
1315732|NCT00094055|4272067|P1|Overall Study|progressive disease|2
1315733|NCT00094055|4272067|P1|Overall Study|Lost to Follow-up|2
1315734|NCT00094055|4272067|P1|Overall Study|Lack of Efficacy|17
1315735|NCT00094055|4272067|P1|Overall Study|Death|4
1315736|NCT00094055|4272067|P1|Overall Study|Adverse Event|11
1315737|NCT00093808|4272087|P1|Overall Study|Protocol Violation|1
1315738|NCT00093808|4272087|P1|Overall Study|Cancel participation before receiving tx|1
1315739|NCT00093795|4272097|P3|Overall Study|No follow up data|17
1315740|NCT00093795|4272098|P2|Overall Study|No follow up data|16
1315741|NCT00093795|4272099|P1|Overall Study|No follow up data|20
1315742|NCT00093496|4272144|P2|Overall Study|Protocol Violation|3
1315743|NCT00093496|4272145|P1|Overall Study|Protocol Violation|1
1315744|NCT00093470|4272158|P2|Overall Study|ANC < 1000 on day 1 of cycle 1|0
1315745|NCT00093470|4272159|P1|Overall Study|ANC < 1000 on day 1 of cycle 1|1
1315746|NCT00093470|4272158|P2|Overall Study|Never started treatment|0
1315747|NCT00093470|4272159|P1|Overall Study|Never started treatment|1
1315748|NCT00093470|4272158|P2|Overall Study|Physician Decision|0
1315749|NCT00093470|4272159|P1|Overall Study|Physician Decision|2
1315750|NCT00093470|4272158|P2|Overall Study|Other complicating disease|0
1315751|NCT00093470|4272159|P1|Overall Study|Other complicating disease|3
1315752|NCT00093470|4272158|P2|Overall Study|Alternative therapy|0
1315753|NCT00093470|4272159|P1|Overall Study|Alternative therapy|2
1315754|NCT00093470|4272158|P2|Overall Study|Withdrawal by Subject|0
1315755|NCT00093470|4272159|P1|Overall Study|Withdrawal by Subject|8
1315756|NCT00093470|4272158|P2|Overall Study|Death|0
1315757|NCT00093470|4272159|P1|Overall Study|Death|2
1315758|NCT00093470|4272158|P2|Overall Study|Adverse Event|0
1315759|NCT00093470|4272159|P1|Overall Study|Adverse Event|15
1315760|NCT00093470|4272158|P2|Overall Study|Disease progression|0
1315761|NCT00093470|4272159|P1|Overall Study|Disease progression|39
1315762|NCT00093145|4272173|P1|Overall Study|Other|1
1315763|NCT00093145|4272173|P1|Overall Study|Withdrawal by Subject|9
1315764|NCT00093145|4272173|P1|Overall Study|Physician Decision|5
1315765|NCT00093145|4272173|P1|Overall Study|Unacceptable Toxicity Only|2
1315766|NCT00093015|4272215|P2|Overall Study|Death|385
1315767|NCT00093015|4272216|P1|Overall Study|Death|375
1315768|NCT00093015|4272215|P2|Overall Study|Lost to Follow-up|108
1315769|NCT00093015|4272216|P1|Overall Study|Lost to Follow-up|96
1315770|NCT00093015|4272215|P2|Overall Study|Withdrawal by Subject|171
1315771|NCT00093015|4272216|P1|Overall Study|Withdrawal by Subject|194
1315772|NCT00092677|4272244|P2|Overall Study|Adminstrative|9
1315773|NCT00092677|4272245|P1|Overall Study|Adminstrative|5
1315774|NCT00092677|4272244|P2|Overall Study|Lost to Follow-up|2
1315775|NCT00092677|4272245|P1|Overall Study|Lost to Follow-up|0
1315776|NCT00092547|4272289|P3|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
1315777|NCT00092547|4272290|P2|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
1315778|NCT00092547|4272291|P1|Long-term Follow-up (Month 42 Visit)|Adverse Event|1
1315779|NCT00092547|4272289|P3|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7
1315780|NCT00092547|4272290|P2|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0
1315781|NCT00092547|4272291|P1|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14
1315782|NCT00092547|4272289|P3|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9
1315783|NCT00092547|4272290|P2|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0
1315784|NCT00092547|4272291|P1|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6
1315785|NCT00092547|4272289|P3|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
1315786|NCT00092547|4272290|P2|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
1315787|NCT00092547|4272291|P1|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3
1315788|NCT00092547|4272289|P3|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
1315789|NCT00092547|4272290|P2|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
1315790|NCT00092547|4272291|P1|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1
1315791|NCT00092547|4272289|P3|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
1315792|NCT00092547|4272290|P2|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
1315793|NCT00092547|4272291|P1|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2
1315794|NCT00092547|4272289|P3|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0
1315795|NCT00092547|4272290|P2|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3
1315796|NCT00092547|4272291|P1|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1
1315797|NCT00092547|4272289|P3|Base Follow-up Phase (Month 18 to 30)|Subject moved|0
1315798|NCT00092547|4272290|P2|Base Follow-up Phase (Month 18 to 30)|Subject moved|2
1315799|NCT00092547|4272291|P1|Base Follow-up Phase (Month 18 to 30)|Subject moved|4
1315800|NCT00092547|4272289|P3|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
1315801|NCT00092547|4272290|P2|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
1315802|NCT00092547|4272291|P1|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1
1315803|NCT00092547|4272289|P3|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
1315804|NCT00092547|4272290|P2|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
1315805|NCT00092547|4272291|P1|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1
1315806|NCT00092547|4272289|P3|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0
1315807|NCT00092547|4272290|P2|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7
1315808|NCT00092547|4272291|P1|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13
1315809|NCT00092547|4272289|P3|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0
1315810|NCT00092547|4272290|P2|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2
1315811|NCT00092547|4272291|P1|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4
1315812|NCT00092547|4272289|P3|Base Follow-up Phase (Month 7 to 18)|Subject moved|0
1315813|NCT00092547|4272290|P2|Base Follow-up Phase (Month 7 to 18)|Subject moved|5
1315814|NCT00092547|4272291|P1|Base Follow-up Phase (Month 7 to 18)|Subject moved|1
1315815|NCT00092547|4272289|P3|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0
1315816|NCT00092547|4272290|P2|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3
1315817|NCT00092547|4272291|P1|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5
1315818|NCT00092547|4272289|P3|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
1315819|NCT00092547|4272290|P2|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1
1315820|NCT00092547|4272291|P1|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
1315821|NCT00092547|4272289|P3|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
1315822|NCT00092547|4272290|P2|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1
1315823|NCT00092547|4272291|P1|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
1315824|NCT00092547|4272289|P3|Base Vaccine Phase (Day 1 to Month 7)|Moved|0
1315825|NCT00092547|4272290|P2|Base Vaccine Phase (Day 1 to Month 7)|Moved|1
1315826|NCT00092547|4272291|P1|Base Vaccine Phase (Day 1 to Month 7)|Moved|3
1315827|NCT00092547|4272289|P3|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0
1315828|NCT00092547|4272290|P2|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21
1315829|NCT00092547|4272291|P1|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28
1315830|NCT00092547|4272289|P3|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0
1315831|NCT00092547|4272290|P2|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7
1315832|NCT00092547|4272291|P1|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18
1315833|NCT00092547|4272289|P3|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0
1315834|NCT00092547|4272290|P2|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1
1315835|NCT00092547|4272291|P1|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4
1315836|NCT00092547|4272289|P3|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0
1315837|NCT00092547|4272290|P2|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1
1315838|NCT00092547|4272291|P1|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5
1315839|NCT00092534|4272335|P3|Extension Study|Protocol Deviation|15
1315840|NCT00092534|4272336|P2|Extension Study|Protocol Deviation|0
1315841|NCT00092534|4272337|P1|Extension Study|Protocol Deviation|0
1315842|NCT00092534|4272335|P3|Extension Study|Study Ended|29
1315843|NCT00092534|4272336|P2|Extension Study|Study Ended|0
1315844|NCT00092534|4272337|P1|Extension Study|Study Ended|0
1315845|NCT00092534|4272335|P3|Extension Study|Site Closed|21
1315846|NCT00092534|4272336|P2|Extension Study|Site Closed|0
1315847|NCT00092534|4272337|P1|Extension Study|Site Closed|0
1315848|NCT00092534|4272335|P3|Extension Study|Travel|2
1315849|NCT00092534|4272336|P2|Extension Study|Travel|0
1315850|NCT00092534|4272337|P1|Extension Study|Travel|0
1315851|NCT00092534|4272335|P3|Extension Study|Moved|6
1315852|NCT00092534|4272336|P2|Extension Study|Moved|0
1315853|NCT00092534|4272337|P1|Extension Study|Moved|0
1315854|NCT00092534|4272335|P3|Extension Study|Withdrawal by Subject|18
1315855|NCT00092534|4272336|P2|Extension Study|Withdrawal by Subject|0
1315856|NCT00092534|4272337|P1|Extension Study|Withdrawal by Subject|0
1315857|NCT00092534|4272335|P3|Extension Study|Pregnancy|12
1315858|NCT00092534|4272336|P2|Extension Study|Pregnancy|0
1315859|NCT00092534|4272337|P1|Extension Study|Pregnancy|0
1315860|NCT00092534|4272335|P3|Extension Study|Physician Decision|1
1315861|NCT00092534|4272336|P2|Extension Study|Physician Decision|0
1315862|NCT00092534|4272337|P1|Extension Study|Physician Decision|0
1315863|NCT00092534|4272335|P3|Extension Study|Lost to Follow-up|41
1315864|NCT00092534|4272336|P2|Extension Study|Lost to Follow-up|0
1315865|NCT00092534|4272337|P1|Extension Study|Lost to Follow-up|0
1315866|NCT00092534|4272335|P3|Base Study Follow Up Period|Subjects in extension|0
1315867|NCT00092534|4272336|P2|Base Study Follow Up Period|Subjects in extension|371
1315868|NCT00092534|4272337|P1|Base Study Follow Up Period|Subjects in extension|15
1315869|NCT00092534|4272335|P3|Base Study Follow Up Period|Subjects continuing|0
1315870|NCT00092534|4272336|P2|Base Study Follow Up Period|Subjects continuing|31
1315871|NCT00092534|4272337|P1|Base Study Follow Up Period|Subjects continuing|27
1315872|NCT00092534|4272335|P3|Base Study Follow Up Period|Site Closed|0
1315873|NCT00092534|4272336|P2|Base Study Follow Up Period|Site Closed|2
1315874|NCT00092534|4272337|P1|Base Study Follow Up Period|Site Closed|0
1315875|NCT00092534|4272335|P3|Base Study Follow Up Period|Travel|0
1315876|NCT00092534|4272336|P2|Base Study Follow Up Period|Travel|7
1315877|NCT00092534|4272337|P1|Base Study Follow Up Period|Travel|10
1315878|NCT00092534|4272335|P3|Base Study Follow Up Period|Moved|0
1315879|NCT00092534|4272336|P2|Base Study Follow Up Period|Moved|58
1315880|NCT00092534|4272337|P1|Base Study Follow Up Period|Moved|62
1315881|NCT00092534|4272335|P3|Base Study Follow Up Period|Withdrawal by Subject|0
1315882|NCT00092534|4272336|P2|Base Study Follow Up Period|Withdrawal by Subject|62
1315883|NCT00092534|4272337|P1|Base Study Follow Up Period|Withdrawal by Subject|71
1315884|NCT00092534|4272335|P3|Base Study Follow Up Period|Protocol Violation|0
1315885|NCT00092534|4272336|P2|Base Study Follow Up Period|Protocol Violation|2
1315886|NCT00092534|4272337|P1|Base Study Follow Up Period|Protocol Violation|1
1315887|NCT00092534|4272335|P3|Base Study Follow Up Period|Pregnancy|0
1315888|NCT00092534|4272336|P2|Base Study Follow Up Period|Pregnancy|10
1315889|NCT00092534|4272337|P1|Base Study Follow Up Period|Pregnancy|6
1315890|NCT00092534|4272335|P3|Base Study Follow Up Period|Lost to Follow-up|0
1315891|NCT00092534|4272336|P2|Base Study Follow Up Period|Lost to Follow-up|146
1315892|NCT00092534|4272337|P1|Base Study Follow Up Period|Lost to Follow-up|120
1315893|NCT00092534|4272335|P3|Base Study Follow Up Period|Death|0
1315894|NCT00092534|4272336|P2|Base Study Follow Up Period|Death|1
1315895|NCT00092534|4272337|P1|Base Study Follow Up Period|Death|2
1315896|NCT00092534|4272335|P3|Base Study Follow Up Period|Adverse Event|0
1315897|NCT00092534|4272336|P2|Base Study Follow Up Period|Adverse Event|4
1315898|NCT00092534|4272337|P1|Base Study Follow Up Period|Adverse Event|2
1315899|NCT00092534|4272335|P3|Base Study Vaccination Period|Site Closed|0
1315900|NCT00092534|4272336|P2|Base Study Vaccination Period|Site Closed|1
1315901|NCT00092534|4272337|P1|Base Study Vaccination Period|Site Closed|0
1315902|NCT00092534|4272335|P3|Base Study Vaccination Period|Travel|0
1315903|NCT00092534|4272336|P2|Base Study Vaccination Period|Travel|0
1315904|NCT00092534|4272337|P1|Base Study Vaccination Period|Travel|1
1315905|NCT00092534|4272335|P3|Base Study Vaccination Period|New Medical History (Not AEs)|0
1315906|NCT00092534|4272336|P2|Base Study Vaccination Period|New Medical History (Not AEs)|0
1315907|NCT00092534|4272337|P1|Base Study Vaccination Period|New Medical History (Not AEs)|5
1315908|NCT00092534|4272335|P3|Base Study Vaccination Period|Moved|0
1315909|NCT00092534|4272336|P2|Base Study Vaccination Period|Moved|12
1315910|NCT00092534|4272337|P1|Base Study Vaccination Period|Moved|14
1315911|NCT00092534|4272335|P3|Base Study Vaccination Period|Withdrawal by Subject|0
1315912|NCT00092534|4272336|P2|Base Study Vaccination Period|Withdrawal by Subject|58
1315913|NCT00092534|4272337|P1|Base Study Vaccination Period|Withdrawal by Subject|85
1315914|NCT00092534|4272335|P3|Base Study Vaccination Period|Protocol Violation|0
1315915|NCT00092534|4272336|P2|Base Study Vaccination Period|Protocol Violation|1
1315916|NCT00092534|4272337|P1|Base Study Vaccination Period|Protocol Violation|2
1315917|NCT00092534|4272335|P3|Base Study Vaccination Period|Pregnancy|0
1315918|NCT00092534|4272336|P2|Base Study Vaccination Period|Pregnancy|7
1315919|NCT00092534|4272337|P1|Base Study Vaccination Period|Pregnancy|9
1315920|NCT00092534|4272335|P3|Base Study Vaccination Period|Physician Decision|0
1315921|NCT00092534|4272336|P2|Base Study Vaccination Period|Physician Decision|0
1315922|NCT00092534|4272337|P1|Base Study Vaccination Period|Physician Decision|1
1315923|NCT00092534|4272335|P3|Base Study Vaccination Period|Lost to Follow-up|0
1315924|NCT00092534|4272336|P2|Base Study Vaccination Period|Lost to Follow-up|37
1315925|NCT00092534|4272337|P1|Base Study Vaccination Period|Lost to Follow-up|41
1315926|NCT00092534|4272335|P3|Base Study Vaccination Period|Death|0
1315927|NCT00092534|4272336|P2|Base Study Vaccination Period|Death|4
1315928|NCT00092534|4272337|P1|Base Study Vaccination Period|Death|5
1315929|NCT00092534|4272335|P3|Base Study Vaccination Period|Adverse Event|0
1315930|NCT00092534|4272336|P2|Base Study Vaccination Period|Adverse Event|1
1315931|NCT00092534|4272337|P1|Base Study Vaccination Period|Adverse Event|3
1315932|NCT00092534|4272335|P3|Base Study Vaccination Period|Randomized not Vaccinated|0
1315933|NCT00092534|4272336|P2|Base Study Vaccination Period|Randomized not Vaccinated|5
1315934|NCT00092534|4272337|P1|Base Study Vaccination Period|Randomized not Vaccinated|5
1315935|NCT00092521|4272355|P4|Extension Study (Group 4)|Unable/unwilling to return|25
1315936|NCT00092521|4272356|P3|Extension Study (Group 4)|Unable/unwilling to return|0
1315937|NCT00092521|4272357|P2|Extension Study (Group 4)|Unable/unwilling to return|0
1315938|NCT00092521|4272358|P1|Extension Study (Group 4)|Unable/unwilling to return|0
1315939|NCT00092521|4272355|P4|Extension Study (Group 4)|Site Terminated|4
1315940|NCT00092521|4272356|P3|Extension Study (Group 4)|Site Terminated|0
1315941|NCT00092521|4272357|P2|Extension Study (Group 4)|Site Terminated|0
1315942|NCT00092521|4272358|P1|Extension Study (Group 4)|Site Terminated|0
1315943|NCT00092521|4272355|P4|Extension Study (Group 4)|Moved|16
1315944|NCT00092521|4272356|P3|Extension Study (Group 4)|Moved|0
1315945|NCT00092521|4272357|P2|Extension Study (Group 4)|Moved|0
1315946|NCT00092521|4272358|P1|Extension Study (Group 4)|Moved|0
1315947|NCT00092521|4272355|P4|Extension Study (Group 4)|Withdrawal by Subject|46
1315948|NCT00092521|4272356|P3|Extension Study (Group 4)|Withdrawal by Subject|0
1315949|NCT00092521|4272357|P2|Extension Study (Group 4)|Withdrawal by Subject|0
1315950|NCT00092521|4272358|P1|Extension Study (Group 4)|Withdrawal by Subject|0
1315951|NCT00092521|4272355|P4|Extension Study (Group 4)|Protocol Violation|2
1315952|NCT00092521|4272356|P3|Extension Study (Group 4)|Protocol Violation|0
1315953|NCT00092521|4272357|P2|Extension Study (Group 4)|Protocol Violation|0
1315954|NCT00092521|4272358|P1|Extension Study (Group 4)|Protocol Violation|0
1315955|NCT00092521|4272355|P4|Extension Study (Group 4)|Pregnancy|4
1315956|NCT00092521|4272356|P3|Extension Study (Group 4)|Pregnancy|0
1315957|NCT00092521|4272357|P2|Extension Study (Group 4)|Pregnancy|0
1315958|NCT00092521|4272358|P1|Extension Study (Group 4)|Pregnancy|0
1315959|NCT00092521|4272355|P4|Extension Study (Group 4)|Lost to Follow-up|87
1315960|NCT00092521|4272356|P3|Extension Study (Group 4)|Lost to Follow-up|0
1315961|NCT00092521|4272357|P2|Extension Study (Group 4)|Lost to Follow-up|0
1315962|NCT00092521|4272358|P1|Extension Study (Group 4)|Lost to Follow-up|0
1315963|NCT00092521|4272355|P4|Extension Study (Group 4)|Adverse Event|2
1315964|NCT00092521|4272356|P3|Extension Study (Group 4)|Adverse Event|0
1315965|NCT00092521|4272357|P2|Extension Study (Group 4)|Adverse Event|0
1315966|NCT00092521|4272358|P1|Extension Study (Group 4)|Adverse Event|0
1315967|NCT00092521|4272355|P4|Extension Study (Group 4)|Excluded ineligible for extension|23
1315968|NCT00092521|4272356|P3|Extension Study (Group 4)|Excluded ineligible for extension|0
1315969|NCT00092521|4272357|P2|Extension Study (Group 4)|Excluded ineligible for extension|0
1315970|NCT00092521|4272358|P1|Extension Study (Group 4)|Excluded ineligible for extension|0
1315971|NCT00092521|4272355|P4|Follow-Up (After Month 7)|Visits Compressed|0
1315972|NCT00092521|4272356|P3|Follow-Up (After Month 7)|Visits Compressed|5
1315973|NCT00092521|4272357|P2|Follow-Up (After Month 7)|Visits Compressed|0
1315974|NCT00092521|4272358|P1|Follow-Up (After Month 7)|Visits Compressed|5
1315975|NCT00092521|4272355|P4|Follow-Up (After Month 7)|Travel|0
1315976|NCT00092521|4272356|P3|Follow-Up (After Month 7)|Travel|0
1315977|NCT00092521|4272357|P2|Follow-Up (After Month 7)|Travel|0
1315978|NCT00092521|4272358|P1|Follow-Up (After Month 7)|Travel|2
1315979|NCT00092521|4272355|P4|Follow-Up (After Month 7)|Site Terminated|0
1315980|NCT00092521|4272356|P3|Follow-Up (After Month 7)|Site Terminated|3
1315981|NCT00092521|4272357|P2|Follow-Up (After Month 7)|Site Terminated|0
1315982|NCT00092521|4272358|P1|Follow-Up (After Month 7)|Site Terminated|3
1315983|NCT00092521|4272355|P4|Follow-Up (After Month 7)|Moved|0
1315984|NCT00092521|4272356|P3|Follow-Up (After Month 7)|Moved|28
1315985|NCT00092521|4272357|P2|Follow-Up (After Month 7)|Moved|2
1315986|NCT00092521|4272358|P1|Follow-Up (After Month 7)|Moved|32
1315987|NCT00092521|4272355|P4|Follow-Up (After Month 7)|Withdrawal by Subject|0
1315988|NCT00092521|4272356|P3|Follow-Up (After Month 7)|Withdrawal by Subject|51
1315989|NCT00092521|4272357|P2|Follow-Up (After Month 7)|Withdrawal by Subject|6
1315990|NCT00092521|4272358|P1|Follow-Up (After Month 7)|Withdrawal by Subject|40
1315991|NCT00092521|4272355|P4|Follow-Up (After Month 7)|Protocol Violation|0
1315992|NCT00092521|4272356|P3|Follow-Up (After Month 7)|Protocol Violation|5
1315993|NCT00092521|4272357|P2|Follow-Up (After Month 7)|Protocol Violation|1
1315994|NCT00092521|4272358|P1|Follow-Up (After Month 7)|Protocol Violation|1
1315995|NCT00092521|4272355|P4|Follow-Up (After Month 7)|Lost to Follow-up|0
1315996|NCT00092521|4272356|P3|Follow-Up (After Month 7)|Lost to Follow-up|108
1315997|NCT00092521|4272357|P2|Follow-Up (After Month 7)|Lost to Follow-up|14
1315998|NCT00092521|4272358|P1|Follow-Up (After Month 7)|Lost to Follow-up|113
1315999|NCT00092521|4272355|P4|Follow-Up (After Month 7)|Death|0
1316000|NCT00092521|4272356|P3|Follow-Up (After Month 7)|Death|1
1316001|NCT00092521|4272357|P2|Follow-Up (After Month 7)|Death|0
1316002|NCT00092521|4272358|P1|Follow-Up (After Month 7)|Death|2
1316003|NCT00092521|4272355|P4|Follow-Up (After Month 7)|Adverse Event|0
1316004|NCT00092521|4272356|P3|Follow-Up (After Month 7)|Adverse Event|0
1316005|NCT00092521|4272357|P2|Follow-Up (After Month 7)|Adverse Event|0
1316006|NCT00092521|4272358|P1|Follow-Up (After Month 7)|Adverse Event|1
1316007|NCT00092521|4272355|P4|Follow-Up (After Month 7)|Subjects in Extension|0
1316008|NCT00092521|4272356|P3|Follow-Up (After Month 7)|Subjects in Extension|412
1316009|NCT00092521|4272357|P2|Follow-Up (After Month 7)|Subjects in Extension|109
1316010|NCT00092521|4272358|P1|Follow-Up (After Month 7)|Subjects in Extension|13
1316011|NCT00092521|4272355|P4|Follow-Up (After Month 7)|Subjects Continuing|0
1316012|NCT00092521|4272356|P3|Follow-Up (After Month 7)|Subjects Continuing|35
1316013|NCT00092521|4272357|P2|Follow-Up (After Month 7)|Subjects Continuing|4
1316014|NCT00092521|4272358|P1|Follow-Up (After Month 7)|Subjects Continuing|34
1316015|NCT00092521|4272355|P4|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
1316016|NCT00092521|4272356|P3|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
1316017|NCT00092521|4272357|P2|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
1316018|NCT00092521|4272358|P1|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2
1316019|NCT00092521|4272355|P4|Vaccination (Day 1 Through Month 7)|Unblinded|0
1316020|NCT00092521|4272356|P3|Vaccination (Day 1 Through Month 7)|Unblinded|0
1316021|NCT00092521|4272357|P2|Vaccination (Day 1 Through Month 7)|Unblinded|0
1316022|NCT00092521|4272358|P1|Vaccination (Day 1 Through Month 7)|Unblinded|2
1316023|NCT00092521|4272355|P4|Vaccination (Day 1 Through Month 7)|Moved|0
1316024|NCT00092521|4272356|P3|Vaccination (Day 1 Through Month 7)|Moved|18
1316025|NCT00092521|4272357|P2|Vaccination (Day 1 Through Month 7)|Moved|1
1316026|NCT00092521|4272358|P1|Vaccination (Day 1 Through Month 7)|Moved|14
1316027|NCT00092521|4272355|P4|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0
1316028|NCT00092521|4272356|P3|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62
1316029|NCT00092521|4272357|P2|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7
1316030|NCT00092521|4272358|P1|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59
1316031|NCT00092521|4272355|P4|Vaccination (Day 1 Through Month 7)|Pregnancy|0
1316032|NCT00092521|4272356|P3|Vaccination (Day 1 Through Month 7)|Pregnancy|7
1316033|NCT00092521|4272357|P2|Vaccination (Day 1 Through Month 7)|Pregnancy|0
1316034|NCT00092521|4272358|P1|Vaccination (Day 1 Through Month 7)|Pregnancy|5
1316035|NCT00092521|4272355|P4|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0
1316036|NCT00092521|4272356|P3|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44
1316037|NCT00092521|4272357|P2|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6
1316038|NCT00092521|4272358|P1|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51
1316039|NCT00092521|4272355|P4|Vaccination (Day 1 Through Month 7)|Death|0
1316040|NCT00092521|4272356|P3|Vaccination (Day 1 Through Month 7)|Death|1
1316041|NCT00092521|4272357|P2|Vaccination (Day 1 Through Month 7)|Death|0
1316042|NCT00092521|4272358|P1|Vaccination (Day 1 Through Month 7)|Death|0
1316043|NCT00092521|4272355|P4|Vaccination (Day 1 Through Month 7)|Adverse Event|0
1316044|NCT00092521|4272356|P3|Vaccination (Day 1 Through Month 7)|Adverse Event|7
1316045|NCT00092521|4272357|P2|Vaccination (Day 1 Through Month 7)|Adverse Event|0
1316046|NCT00092521|4272358|P1|Vaccination (Day 1 Through Month 7)|Adverse Event|1
1316047|NCT00092521|4272355|P4|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
1316048|NCT00092521|4272356|P3|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7
1316049|NCT00092521|4272357|P2|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
1316050|NCT00092521|4272358|P1|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6
1316051|NCT00092495|4272372|P5|Base Study Follow-up Period|Withdrawal by Subject|0
1316052|NCT00092495|4272373|P4|Base Study Follow-up Period|Withdrawal by Subject|0
1316053|NCT00092495|4272374|P3|Base Study Follow-up Period|Withdrawal by Subject|0
1316054|NCT00092495|4272375|P2|Base Study Follow-up Period|Withdrawal by Subject|0
1316055|NCT00092495|4272376|P1|Base Study Follow-up Period|Withdrawal by Subject|2
1316056|NCT00092495|4272372|P5|Base Study Follow-up Period|Lost to Follow-up|0
1316057|NCT00092495|4272373|P4|Base Study Follow-up Period|Lost to Follow-up|12
1316058|NCT00092495|4272374|P3|Base Study Follow-up Period|Lost to Follow-up|3
1316059|NCT00092495|4272375|P2|Base Study Follow-up Period|Lost to Follow-up|3
1316060|NCT00092495|4272376|P1|Base Study Follow-up Period|Lost to Follow-up|1
1316061|NCT00092495|4272372|P5|Base Study Follow-up Period|Extended|0
1316062|NCT00092495|4272373|P4|Base Study Follow-up Period|Extended|2
1316063|NCT00092495|4272374|P3|Base Study Follow-up Period|Extended|1
1316064|NCT00092495|4272375|P2|Base Study Follow-up Period|Extended|0
1316065|NCT00092495|4272376|P1|Base Study Follow-up Period|Extended|0
1316066|NCT00092495|4272372|P5|Base Study Vaccination Period|Withdrawal by Subject|0
1316067|NCT00092495|4272373|P4|Base Study Vaccination Period|Withdrawal by Subject|25
1316068|NCT00092495|4272374|P3|Base Study Vaccination Period|Withdrawal by Subject|14
1316069|NCT00092495|4272375|P2|Base Study Vaccination Period|Withdrawal by Subject|10
1316070|NCT00092495|4272376|P1|Base Study Vaccination Period|Withdrawal by Subject|9
1316071|NCT00092495|4272372|P5|Base Study Vaccination Period|Protocol Violation|0
1316072|NCT00092495|4272373|P4|Base Study Vaccination Period|Protocol Violation|0
1316073|NCT00092495|4272374|P3|Base Study Vaccination Period|Protocol Violation|0
1316074|NCT00092495|4272375|P2|Base Study Vaccination Period|Protocol Violation|0
1316075|NCT00092495|4272376|P1|Base Study Vaccination Period|Protocol Violation|1
1316076|NCT00092495|4272372|P5|Base Study Vaccination Period|Parent Withdrew Consent|0
1316077|NCT00092495|4272373|P4|Base Study Vaccination Period|Parent Withdrew Consent|5
1316078|NCT00092495|4272374|P3|Base Study Vaccination Period|Parent Withdrew Consent|1
1316079|NCT00092495|4272375|P2|Base Study Vaccination Period|Parent Withdrew Consent|1
1316080|NCT00092495|4272376|P1|Base Study Vaccination Period|Parent Withdrew Consent|1
1316081|NCT00092495|4272372|P5|Base Study Vaccination Period|Pregnancy|0
1316082|NCT00092495|4272373|P4|Base Study Vaccination Period|Pregnancy|0
1316083|NCT00092495|4272374|P3|Base Study Vaccination Period|Pregnancy|0
1316084|NCT00092495|4272375|P2|Base Study Vaccination Period|Pregnancy|0
1316085|NCT00092495|4272376|P1|Base Study Vaccination Period|Pregnancy|2
1316086|NCT00092495|4272372|P5|Base Study Vaccination Period|Other|0
1316087|NCT00092495|4272373|P4|Base Study Vaccination Period|Other|2
1316088|NCT00092495|4272374|P3|Base Study Vaccination Period|Other|0
1316089|NCT00092495|4272375|P2|Base Study Vaccination Period|Other|1
1316090|NCT00092495|4272376|P1|Base Study Vaccination Period|Other|1
1316091|NCT00092495|4272372|P5|Base Study Vaccination Period|Moved|0
1316092|NCT00092495|4272373|P4|Base Study Vaccination Period|Moved|2
1316093|NCT00092495|4272374|P3|Base Study Vaccination Period|Moved|2
1316094|NCT00092495|4272375|P2|Base Study Vaccination Period|Moved|1
1316095|NCT00092495|4272376|P1|Base Study Vaccination Period|Moved|3
1316096|NCT00092495|4272372|P5|Base Study Vaccination Period|Lost to Follow-up|0
1316097|NCT00092495|4272373|P4|Base Study Vaccination Period|Lost to Follow-up|36
1316098|NCT00092495|4272374|P3|Base Study Vaccination Period|Lost to Follow-up|11
1316099|NCT00092495|4272375|P2|Base Study Vaccination Period|Lost to Follow-up|6
1316100|NCT00092495|4272376|P1|Base Study Vaccination Period|Lost to Follow-up|16
1316101|NCT00092495|4272372|P5|Base Study Vaccination Period|Adverse Event|0
1316102|NCT00092495|4272373|P4|Base Study Vaccination Period|Adverse Event|3
1316103|NCT00092495|4272374|P3|Base Study Vaccination Period|Adverse Event|0
1316104|NCT00092495|4272375|P2|Base Study Vaccination Period|Adverse Event|0
1316105|NCT00092495|4272376|P1|Base Study Vaccination Period|Adverse Event|1
1316106|NCT00092495|4272372|P5|Base Study Vaccination Period|*Pregnancy|0
1316107|NCT00092495|4272373|P4|Base Study Vaccination Period|*Pregnancy|7
1316108|NCT00092495|4272374|P3|Base Study Vaccination Period|*Pregnancy|5
1316109|NCT00092495|4272375|P2|Base Study Vaccination Period|*Pregnancy|2
1316110|NCT00092495|4272376|P1|Base Study Vaccination Period|*Pregnancy|0
1316111|NCT00092495|4272372|P5|Base Study Vaccination Period|*Other reasons|0
1316112|NCT00092495|4272373|P4|Base Study Vaccination Period|*Other reasons|1
1316113|NCT00092495|4272374|P3|Base Study Vaccination Period|*Other reasons|0
1316114|NCT00092495|4272375|P2|Base Study Vaccination Period|*Other reasons|0
1316115|NCT00092495|4272376|P1|Base Study Vaccination Period|*Other reasons|1
1316116|NCT00092495|4272372|P5|Base Study Vaccination Period|*Clinical AE|0
1316117|NCT00092495|4272373|P4|Base Study Vaccination Period|*Clinical AE|2
1316118|NCT00092495|4272374|P3|Base Study Vaccination Period|*Clinical AE|1
1316119|NCT00092495|4272375|P2|Base Study Vaccination Period|*Clinical AE|0
1316120|NCT00092495|4272376|P1|Base Study Vaccination Period|*Clinical AE|1
1316121|NCT00092495|4272372|P5|Base Study Vaccination Period|Extended|0
1316122|NCT00092495|4272373|P4|Base Study Vaccination Period|Extended|1
1316123|NCT00092495|4272374|P3|Base Study Vaccination Period|Extended|0
1316124|NCT00092495|4272375|P2|Base Study Vaccination Period|Extended|0
1316125|NCT00092495|4272376|P1|Base Study Vaccination Period|Extended|0
1316126|NCT00092495|4272372|P5|Base Study Vaccination Period|Randomized Not Vaccinated|0
1316127|NCT00092495|4272373|P4|Base Study Vaccination Period|Randomized Not Vaccinated|4
1316128|NCT00092495|4272374|P3|Base Study Vaccination Period|Randomized Not Vaccinated|0
1316129|NCT00092495|4272375|P2|Base Study Vaccination Period|Randomized Not Vaccinated|1
1316130|NCT00092495|4272376|P1|Base Study Vaccination Period|Randomized Not Vaccinated|1
1316131|NCT00092456|4272442|P4|Overall Study|Not Specified|0
1316132|NCT00092456|4272443|P3|Overall Study|Not Specified|3
1316133|NCT00092456|4272444|P2|Overall Study|Not Specified|2
1316134|NCT00092456|4272445|P1|Overall Study|Not Specified|4
1316135|NCT00092456|4272442|P4|Overall Study|Moved|1
1316136|NCT00092456|4272443|P3|Overall Study|Moved|0
1316137|NCT00092456|4272444|P2|Overall Study|Moved|1
1316138|NCT00092456|4272445|P1|Overall Study|Moved|1
1316139|NCT00092456|4272442|P4|Overall Study|Withdrawal by Subject|6
1316140|NCT00092456|4272443|P3|Overall Study|Withdrawal by Subject|16
1316141|NCT00092456|4272444|P2|Overall Study|Withdrawal by Subject|5
1316142|NCT00092456|4272445|P1|Overall Study|Withdrawal by Subject|13
1316143|NCT00092456|4272442|P4|Overall Study|Protocol Violation|6
1316144|NCT00092456|4272443|P3|Overall Study|Protocol Violation|8
1316145|NCT00092456|4272444|P2|Overall Study|Protocol Violation|7
1316146|NCT00092456|4272445|P1|Overall Study|Protocol Violation|5
1316147|NCT00092456|4272442|P4|Overall Study|Lost to Follow-up|2
1316148|NCT00092456|4272443|P3|Overall Study|Lost to Follow-up|1
1316149|NCT00092456|4272444|P2|Overall Study|Lost to Follow-up|2
1316150|NCT00092456|4272445|P1|Overall Study|Lost to Follow-up|2
1316151|NCT00092456|4272442|P4|Overall Study|Adverse Event|1
1316152|NCT00092456|4272443|P3|Overall Study|Adverse Event|1
1316153|NCT00092456|4272444|P2|Overall Study|Adverse Event|0
1316154|NCT00092456|4272445|P1|Overall Study|Adverse Event|0
1316155|NCT00092443|4272493|P2|Overall Study|Not Specified|13
1316156|NCT00092443|4272494|P1|Overall Study|Not Specified|17
1316157|NCT00092443|4272493|P2|Overall Study|Moved|5
1316158|NCT00092443|4272494|P1|Overall Study|Moved|5
1316159|NCT00092443|4272493|P2|Overall Study|Withdrawal by Subject|11
1316160|NCT00092443|4272494|P1|Overall Study|Withdrawal by Subject|9
1316161|NCT00092443|4272493|P2|Overall Study|Protocol Violation|9
1316162|NCT00092443|4272494|P1|Overall Study|Protocol Violation|11
1316163|NCT00092443|4272493|P2|Overall Study|Lost to Follow-up|3
1316164|NCT00092443|4272494|P1|Overall Study|Lost to Follow-up|7
1316165|NCT00092443|4272493|P2|Overall Study|Adverse Event|13
1316166|NCT00092443|4272494|P1|Overall Study|Adverse Event|9
1316167|NCT00092417|4272512|P2|Overall Study|Not Specified|0
1316168|NCT00092417|4272513|P1|Overall Study|Not Specified|1
1316169|NCT00092417|4272512|P2|Overall Study|Withdrawal by Subject|1
1316170|NCT00092417|4272513|P1|Overall Study|Withdrawal by Subject|2
1316171|NCT00092417|4272512|P2|Overall Study|Lost to Follow-up|0
1316172|NCT00092417|4272513|P1|Overall Study|Lost to Follow-up|2
1316173|NCT00092131|4272527|P2|Treatment Period II|Adverse Event|1
1316174|NCT00092131|4272528|P1|Treatment Period II|Adverse Event|0
1316175|NCT00092131|4272527|P2|Treatment Period I|Adverse Event|0
1316176|NCT00092131|4272528|P1|Treatment Period I|Adverse Event|1
1316177|NCT00092118|4272558|P2|Overall Study|Not Specified|5
1316178|NCT00092118|4272559|P1|Overall Study|Not Specified|6
1316179|NCT00092118|4272558|P2|Overall Study|Withdrawal by Subject|10
1316180|NCT00092118|4272559|P1|Overall Study|Withdrawal by Subject|4
1316181|NCT00092118|4272558|P2|Overall Study|Protocol Violation|25
1316182|NCT00092118|4272559|P1|Overall Study|Protocol Violation|23
1316183|NCT00092118|4272558|P2|Overall Study|Lost to Follow-up|3
1316184|NCT00092118|4272559|P1|Overall Study|Lost to Follow-up|4
1316185|NCT00092118|4272558|P2|Overall Study|Lack of Efficacy|14
1316186|NCT00092118|4272559|P1|Overall Study|Lack of Efficacy|12
1316187|NCT00092118|4272558|P2|Overall Study|Adverse Event|32
1316188|NCT00092118|4272559|P1|Overall Study|Adverse Event|35
1316189|NCT00091949|4272593|P2|Overall Study|Lost to Follow-up|41
1316190|NCT00091949|4272594|P1|Overall Study|Lost to Follow-up|58
1316191|NCT00091949|4272593|P2|Overall Study|Withdrawal by Subject|110
1316192|NCT00091949|4272594|P1|Overall Study|Withdrawal by Subject|117
1316193|NCT00091832|4272618|P6|Overall Study|Protocol Violation|1
1316194|NCT00091832|4272619|P5|Overall Study|Protocol Violation|0
1316195|NCT00091832|4272620|P4|Overall Study|Protocol Violation|0
1316196|NCT00091832|4272621|P3|Overall Study|Protocol Violation|1
1316197|NCT00091832|4272622|P2|Overall Study|Protocol Violation|0
1316198|NCT00091832|4272623|P1|Overall Study|Protocol Violation|0
1316199|NCT00091832|4272618|P6|Overall Study|Other|0
1316200|NCT00091832|4272619|P5|Overall Study|Other|0
1316201|NCT00091832|4272620|P4|Overall Study|Other|0
1316202|NCT00091832|4272621|P3|Overall Study|Other|2
1316203|NCT00091832|4272622|P2|Overall Study|Other|1
1316204|NCT00091832|4272623|P1|Overall Study|Other|0
1316205|NCT00091832|4272618|P6|Overall Study|Noncompliance|0
1316206|NCT00091832|4272619|P5|Overall Study|Noncompliance|0
1316207|NCT00091832|4272620|P4|Overall Study|Noncompliance|0
1316208|NCT00091832|4272621|P3|Overall Study|Noncompliance|0
1316209|NCT00091832|4272622|P2|Overall Study|Noncompliance|1
1316210|NCT00091832|4272623|P1|Overall Study|Noncompliance|0
1316211|NCT00091832|4272618|P6|Overall Study|Lost to Follow-up|1
1316212|NCT00091832|4272619|P5|Overall Study|Lost to Follow-up|2
1316213|NCT00091832|4272620|P4|Overall Study|Lost to Follow-up|3
1316214|NCT00091832|4272621|P3|Overall Study|Lost to Follow-up|3
1316215|NCT00091832|4272622|P2|Overall Study|Lost to Follow-up|0
1316216|NCT00091832|4272623|P1|Overall Study|Lost to Follow-up|1
1316217|NCT00091832|4272618|P6|Overall Study|Ineligibility Determined|0
1316218|NCT00091832|4272619|P5|Overall Study|Ineligibility Determined|1
1316219|NCT00091832|4272620|P4|Overall Study|Ineligibility Determined|0
1316220|NCT00091832|4272621|P3|Overall Study|Ineligibility Determined|1
1316221|NCT00091832|4272622|P2|Overall Study|Ineligibility Determined|0
1316222|NCT00091832|4272623|P1|Overall Study|Ineligibility Determined|0
1316223|NCT00091832|4272618|P6|Overall Study|Disease Progression|2
1316224|NCT00091832|4272619|P5|Overall Study|Disease Progression|1
1316225|NCT00091832|4272620|P4|Overall Study|Disease Progression|1
1316226|NCT00091832|4272621|P3|Overall Study|Disease Progression|0
1316227|NCT00091832|4272622|P2|Overall Study|Disease Progression|0
1316228|NCT00091832|4272623|P1|Overall Study|Disease Progression|2
1316229|NCT00091832|4272618|P6|Overall Study|Death|6
1316230|NCT00091832|4272619|P5|Overall Study|Death|5
1316231|NCT00091832|4272620|P4|Overall Study|Death|8
1316232|NCT00091832|4272621|P3|Overall Study|Death|5
1316233|NCT00091832|4272622|P2|Overall Study|Death|4
1316234|NCT00091832|4272623|P1|Overall Study|Death|6
1316235|NCT00091832|4272618|P6|Overall Study|Withdrawal by Subject|1
1316236|NCT00091832|4272619|P5|Overall Study|Withdrawal by Subject|3
1316237|NCT00091832|4272620|P4|Overall Study|Withdrawal by Subject|1
1316238|NCT00091832|4272621|P3|Overall Study|Withdrawal by Subject|0
1316239|NCT00091832|4272622|P2|Overall Study|Withdrawal by Subject|5
1316240|NCT00091832|4272623|P1|Overall Study|Withdrawal by Subject|4
1316241|NCT00091832|4272618|P6|Overall Study|Adverse Event|0
1316242|NCT00091832|4272619|P5|Overall Study|Adverse Event|3
1316243|NCT00091832|4272620|P4|Overall Study|Adverse Event|1
1316244|NCT00091832|4272621|P3|Overall Study|Adverse Event|0
1316245|NCT00091832|4272622|P2|Overall Study|Adverse Event|0
1316246|NCT00091832|4272623|P1|Overall Study|Adverse Event|0
1316247|NCT00091832|4272618|P6|Overall Study|Physician Decision|0
1316248|NCT00091832|4272619|P5|Overall Study|Physician Decision|0
1316249|NCT00091832|4272620|P4|Overall Study|Physician Decision|0
1316250|NCT00091832|4272621|P3|Overall Study|Physician Decision|0
1316251|NCT00091832|4272622|P2|Overall Study|Physician Decision|0
1316252|NCT00091832|4272623|P1|Overall Study|Physician Decision|1
1316253|NCT00091819|4272741|P2|Overall Study|Never received study treatment|4
1316254|NCT00091819|4272742|P1|Overall Study|Never received study treatment|3
1316255|NCT00091819|4272741|P2|Overall Study|Other|3
1316256|NCT00091819|4272742|P1|Overall Study|Other|2
1316257|NCT00091819|4272741|P2|Overall Study|Protocol Violation|2
1316258|NCT00091819|4272742|P1|Overall Study|Protocol Violation|1
1316259|NCT00091819|4272741|P2|Overall Study|Withdrawal by Subject|8
1316260|NCT00091819|4272742|P1|Overall Study|Withdrawal by Subject|5
1316261|NCT00091819|4272741|P2|Overall Study|Lost to Follow-up|23
1316262|NCT00091819|4272742|P1|Overall Study|Lost to Follow-up|26
1316263|NCT00091819|4272741|P2|Overall Study|Death|5
1316264|NCT00091819|4272742|P1|Overall Study|Death|4
1316265|NCT00091819|4272741|P2|Overall Study|Adverse Event|1
1316266|NCT00091819|4272742|P1|Overall Study|Adverse Event|1
1316267|NCT00091793|4272750|P2|Overall Study|Other|0
1316268|NCT00091793|4272751|P1|Overall Study|Other|2
1316269|NCT00091793|4272750|P2|Overall Study|Noncompliance|0
1316270|NCT00091793|4272751|P1|Overall Study|Noncompliance|2
1316271|NCT00091793|4272750|P2|Overall Study|Lost to Follow-up|5
1316272|NCT00091793|4272751|P1|Overall Study|Lost to Follow-up|7
1316273|NCT00091793|4272750|P2|Overall Study|Ineligibility determined|0
1316274|NCT00091793|4272751|P1|Overall Study|Ineligibility determined|2
1316275|NCT00091793|4272750|P2|Overall Study|Withdrawal by Subject|15
1316276|NCT00091793|4272751|P1|Overall Study|Withdrawal by Subject|10
1316277|NCT00091793|4272750|P2|Overall Study|Adverse Event|2
1316278|NCT00091793|4272751|P1|Overall Study|Adverse Event|1
1316279|NCT00091572|4272775|P2|Overall Study|Toxicity (Related AE)|9
1316280|NCT00091572|4272776|P1|Overall Study|Toxicity (Related AE)|53
1316281|NCT00091572|4272775|P2|Overall Study|Major Protocol Violation|0
1316282|NCT00091572|4272776|P1|Overall Study|Major Protocol Violation|2
1316283|NCT00091572|4272775|P2|Overall Study|Ongoing (still on treatment)|12
1316284|NCT00091572|4272776|P1|Overall Study|Ongoing (still on treatment)|8
1316285|NCT00091572|4272775|P2|Overall Study|Other Reason|13
1316286|NCT00091572|4272776|P1|Overall Study|Other Reason|6
1316287|NCT00091572|4272775|P2|Overall Study|Medical Decision unrelated toxicity/PD|22
1316288|NCT00091572|4272776|P1|Overall Study|Medical Decision unrelated toxicity/PD|10
1316289|NCT00091572|4272775|P2|Overall Study|Death not due to malignancy/toxicity|3
1316290|NCT00091572|4272776|P1|Overall Study|Death not due to malignancy/toxicity|1
1316291|NCT00091572|4272775|P2|Overall Study|Subject's Refusal unrelated to toxicity|22
1316292|NCT00091572|4272776|P1|Overall Study|Subject's Refusal unrelated to toxicity|14
1316293|NCT00091572|4272775|P2|Overall Study|Lost to Follow-up|1
1316294|NCT00091572|4272776|P1|Overall Study|Lost to Follow-up|1
1316295|NCT00091442|4272807|P2|Overall Study|Not Specified|6
1316296|NCT00091442|4272808|P1|Overall Study|Not Specified|2
1316297|NCT00091442|4272807|P2|Overall Study|Lost to Follow-up|3
1316298|NCT00091442|4272808|P1|Overall Study|Lost to Follow-up|1
1316299|NCT00091442|4272807|P2|Overall Study|Death|7
1316300|NCT00091442|4272808|P1|Overall Study|Death|9
1316301|NCT00091442|4272807|P2|Overall Study|2cycles therapy beyond Complete response|16
1316302|NCT00091442|4272808|P1|Overall Study|2cycles therapy beyond Complete response|9
1316303|NCT00091442|4272807|P2|Overall Study|Adverse Event|48
1316304|NCT00091442|4272808|P1|Overall Study|Adverse Event|29
1316305|NCT00091442|4272807|P2|Overall Study|Withdrawal by Subject|46
1316306|NCT00091442|4272808|P1|Overall Study|Withdrawal by Subject|38
1316307|NCT00091442|4272807|P2|Overall Study|Physician Decision|58
1316308|NCT00091442|4272808|P1|Overall Study|Physician Decision|61
1316309|NCT00091442|4272807|P2|Overall Study|Progressive Disease|189
1316310|NCT00091442|4272808|P1|Overall Study|Progressive Disease|220
1316311|NCT00091390|4272818|P1|Overall Study|Protocol Violation|2
1316312|NCT00091390|4272818|P1|Overall Study|Withdrawal by Subject|2
1316313|NCT00091169|4272836|P2|Overall Study|Not start protocol therapy|17
1316314|NCT00091169|4272837|P1|Overall Study|Not start protocol therapy|26
1316315|NCT00091169|4272836|P2|Overall Study|Other|4
1316316|NCT00091169|4272837|P1|Overall Study|Other|3
1316317|NCT00091169|4272836|P2|Overall Study|Withdrawal by Subject|13
1316318|NCT00091169|4272837|P1|Overall Study|Withdrawal by Subject|10
1316319|NCT00091169|4272836|P2|Overall Study|Death|1
1316320|NCT00091169|4272837|P1|Overall Study|Death|4
1316321|NCT00091169|4272836|P2|Overall Study|Adverse Event|17
1316322|NCT00091169|4272837|P1|Overall Study|Adverse Event|11
1316323|NCT00091169|4272836|P2|Overall Study|Disease progression|1
1316324|NCT00091169|4272837|P1|Overall Study|Disease progression|3
1316325|NCT00091026|4272855|P2|Overall Study|Unknown-never received treatment|1
1316326|NCT00091026|4272856|P1|Overall Study|Unknown-never received treatment|0
1316327|NCT00091026|4272855|P2|Overall Study|Patient withdrew and never received trea|2
1316328|NCT00091026|4272856|P1|Overall Study|Patient withdrew and never received trea|0
1316329|NCT00091026|4272855|P2|Overall Study|Patient deemed non eligible-never receiv|0
1316330|NCT00091026|4272856|P1|Overall Study|Patient deemed non eligible-never receiv|1
1316331|NCT00090987|4272866|P1|Overall Study|Incarcerated|1
1316332|NCT00090987|4272866|P1|Overall Study|Non-compliance|4
1316333|NCT00090987|4272866|P1|Overall Study|alternative therapy|1
1316334|NCT00090987|4272866|P1|Overall Study|Withdrawal by Subject|3
1316335|NCT00090987|4272866|P1|Overall Study|Lack of Efficacy|7
1316336|NCT00090987|4272866|P1|Overall Study|Adverse Event|5
1316337|NCT00090857|4272879|P2|Overall Study|Adverse Event|2
1316338|NCT00090857|4272880|P1|Overall Study|Adverse Event|2
1316339|NCT00090857|4272879|P2|Overall Study|Withdrawal by Subject|0
1316340|NCT00090857|4272880|P1|Overall Study|Withdrawal by Subject|2
1316341|NCT00090857|4272879|P2|Overall Study|Lost to Follow-up|1
1316342|NCT00090857|4272880|P1|Overall Study|Lost to Follow-up|0
1316343|NCT00090779|4272919|P2|Step 3|Off extended study due to study closure|3
1316344|NCT00090779|4272920|P1|Step 3|Off extended study due to study closure|4
1316345|NCT00090779|4272919|P2|Step 3|Initiation of ART and off extended study|2
1316346|NCT00090779|4272920|P1|Step 3|Initiation of ART and off extended study|3
1316347|NCT00090779|4272919|P2|Step 2|Non-compliance to study requirements|1
1316348|NCT00090779|4272920|P1|Step 2|Non-compliance to study requirements|0
1316349|NCT00090779|4272919|P2|Step 2|Subject relocated|1
1316350|NCT00090779|4272920|P1|Step 2|Subject relocated|0
1316351|NCT00090779|4272919|P2|Step 2|Off study per study closure|16
1316352|NCT00090779|4272920|P1|Step 2|Off study per study closure|6
1316353|NCT00090779|4272919|P2|Step 1|Subject relocated|8
1316354|NCT00090779|4272920|P1|Step 1|Subject relocated|2
1316355|NCT00090779|4272919|P2|Step 1|Non-compliance to study requirements|1
1316356|NCT00090779|4272920|P1|Step 1|Non-compliance to study requirements|0
1316357|NCT00090779|4272919|P2|Step 1|Pregnancy|0
1316358|NCT00090779|4272920|P1|Step 1|Pregnancy|1
1316359|NCT00090779|4272919|P2|Step 1|Physician Decision|0
1316360|NCT00090779|4272920|P1|Step 1|Physician Decision|1
1316361|NCT00090779|4272919|P2|Step 1|Death|2
1316362|NCT00090779|4272920|P1|Step 1|Death|0
1316363|NCT00090779|4272919|P2|Step 1|Lost to Follow-up|2
1316364|NCT00090779|4272920|P1|Step 1|Lost to Follow-up|3
1316365|NCT00090779|4272919|P2|Step 1|Withdrawal by Subject|2
1316366|NCT00090779|4272920|P1|Step 1|Withdrawal by Subject|4
1316367|NCT00090766|4272944|P3|Overall Study|Lost to Follow-up|2
1316368|NCT00090766|4272945|P2|Overall Study|Lost to Follow-up|0
1316369|NCT00090766|4272946|P1|Overall Study|Lost to Follow-up|2
1316370|NCT00090766|4272944|P3|Overall Study|Admin|0
1316371|NCT00090766|4272945|P2|Overall Study|Admin|2
1316372|NCT00090766|4272946|P1|Overall Study|Admin|0
1316373|NCT00090766|4272944|P3|Overall Study|Death|0
1316374|NCT00090766|4272945|P2|Overall Study|Death|0
1316375|NCT00090766|4272946|P1|Overall Study|Death|1
1316376|NCT00090766|4272944|P3|Overall Study|Nephrectomy Planned|1
1316377|NCT00090766|4272945|P2|Overall Study|Nephrectomy Planned|0
1316378|NCT00090766|4272946|P1|Overall Study|Nephrectomy Planned|0
1316379|NCT00090753|4272988|P2|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43
1316380|NCT00090753|4272989|P1|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65
1316381|NCT00090753|4272988|P2|Extended Treatment Period|Mircera Commercialization|93
1316382|NCT00090753|4272989|P1|Extended Treatment Period|Mircera Commercialization|188
1316383|NCT00090753|4272988|P2|Extended Treatment Period|Renal Transplant|12
1316384|NCT00090753|4272989|P1|Extended Treatment Period|Renal Transplant|15
1316385|NCT00090753|4272988|P2|Extended Treatment Period|Lost to Follow-up|1
1316386|NCT00090753|4272989|P1|Extended Treatment Period|Lost to Follow-up|3
1316387|NCT00090753|4272988|P2|Extended Treatment Period|Refused Treatment|12
1316388|NCT00090753|4272989|P1|Extended Treatment Period|Refused Treatment|18
1316389|NCT00090753|4272988|P2|Extended Treatment Period|Lack of Efficacy|0
1316390|NCT00090753|4272989|P1|Extended Treatment Period|Lack of Efficacy|1
1316391|NCT00090753|4272988|P2|Extended Treatment Period|Death|30
1316392|NCT00090753|4272989|P1|Extended Treatment Period|Death|58
1316393|NCT00090753|4272988|P2|Extended Treatment Period|Adverse Event|0
1316394|NCT00090753|4272989|P1|Extended Treatment Period|Adverse Event|11
1316395|NCT00090753|4272988|P2|First Treatment Period|Other Unrelated to Safety and Efficacy|28
1316396|NCT00090753|4272989|P1|First Treatment Period|Other Unrelated to Safety and Efficacy|39
1316397|NCT00090753|4272988|P2|First Treatment Period|Mircera Commercialization|0
1316398|NCT00090753|4272989|P1|First Treatment Period|Mircera Commercialization|1
1316399|NCT00090753|4272988|P2|First Treatment Period|Renal Transplant|50
1316400|NCT00090753|4272989|P1|First Treatment Period|Renal Transplant|70
1316401|NCT00090753|4272988|P2|First Treatment Period|Lost to Follow-up|4
1316402|NCT00090753|4272989|P1|First Treatment Period|Lost to Follow-up|4
1316403|NCT00090753|4272988|P2|First Treatment Period|Refused Treatment|25
1316404|NCT00090753|4272989|P1|First Treatment Period|Refused Treatment|32
1316405|NCT00090753|4272988|P2|First Treatment Period|Lack of Efficacy|1
1316406|NCT00090753|4272989|P1|First Treatment Period|Lack of Efficacy|2
1316407|NCT00090753|4272988|P2|First Treatment Period|Death|62
1316408|NCT00090753|4272989|P1|First Treatment Period|Death|88
1316409|NCT00090753|4272988|P2|First Treatment Period|Adverse Event|8
1316410|NCT00090753|4272989|P1|First Treatment Period|Adverse Event|20
1316411|NCT00090610|4272999|P2|Overall Study|Withdrawal by Subject|1
1316412|NCT00090610|4273000|P1|Overall Study|Withdrawal by Subject|1
1316413|NCT00090584|4273016|P2|Baseline to 8 Months|Lost to Follow-up|41
1316414|NCT00090584|4273017|P1|Baseline to 8 Months|Lost to Follow-up|44
1316415|NCT00090584|4273016|P2|Baseline to 10 Weeks|Lost to Follow-up|12
1316416|NCT00090584|4273017|P1|Baseline to 10 Weeks|Lost to Follow-up|15
1316417|NCT00090519|4273049|P2|Overall Study|Sponsor Decision|1
1316418|NCT00090519|4273050|P1|Overall Study|Sponsor Decision|3
1316419|NCT00090519|4273049|P2|Overall Study|Physician Decision|3
1316420|NCT00090519|4273050|P1|Overall Study|Physician Decision|2
1316421|NCT00090519|4273049|P2|Overall Study|Withdrawal by Subject|29
1316422|NCT00090519|4273050|P1|Overall Study|Withdrawal by Subject|28
1316423|NCT00090519|4273049|P2|Overall Study|Lost to Follow-up|29
1316424|NCT00090519|4273050|P1|Overall Study|Lost to Follow-up|26
1316425|NCT00090519|4273049|P2|Overall Study|Death|9
1316426|NCT00090519|4273050|P1|Overall Study|Death|9
1316427|NCT00090519|4273049|P2|Overall Study|Adverse Event|4
1316428|NCT00090519|4273050|P1|Overall Study|Adverse Event|5
1316429|NCT00090493|4273074|P1|Overall Study|Physician Decision|2
1316430|NCT00090363|4273081|P3|Overall Study|Continuing on study off treatment|16
1316431|NCT00090363|4273082|P2|Overall Study|Continuing on study off treatment|13
1316432|NCT00090363|4273083|P1|Overall Study|Continuing on study off treatment|14
1316433|NCT00090363|4273081|P3|Overall Study|Reasons not specified|1
1316434|NCT00090363|4273082|P2|Overall Study|Reasons not specified|1
1316435|NCT00090363|4273083|P1|Overall Study|Reasons not specified|2
1316436|NCT00090363|4273081|P3|Overall Study|Consent expired|9
1316437|NCT00090363|4273082|P2|Overall Study|Consent expired|10
1316438|NCT00090363|4273083|P1|Overall Study|Consent expired|7
1316439|NCT00090363|4273081|P3|Overall Study|Eligibility criteria not fulfilled|1
1316440|NCT00090363|4273082|P2|Overall Study|Eligibility criteria not fulfilled|0
1316441|NCT00090363|4273083|P1|Overall Study|Eligibility criteria not fulfilled|0
1316442|NCT00090363|4273081|P3|Overall Study|Study-specific discontinuation criteria|62
1316443|NCT00090363|4273082|P2|Overall Study|Study-specific discontinuation criteria|74
1316444|NCT00090363|4273083|P1|Overall Study|Study-specific discontinuation criteria|75
1316445|NCT00090363|4273081|P3|Overall Study|Withdrawal by Subject|6
1316446|NCT00090363|4273082|P2|Overall Study|Withdrawal by Subject|7
1316447|NCT00090363|4273083|P1|Overall Study|Withdrawal by Subject|7
1316448|NCT00090363|4273081|P3|Overall Study|Lost to Follow-up|1
1316449|NCT00090363|4273082|P2|Overall Study|Lost to Follow-up|2
1316450|NCT00090363|4273083|P1|Overall Study|Lost to Follow-up|1
1316451|NCT00090545|4273105|P2|Overall Study|Adverse Event|2
1316452|NCT00090545|4273106|P1|Overall Study|Adverse Event|0
1316453|NCT00090545|4273105|P2|Overall Study|Death|1
1316454|NCT00090545|4273106|P1|Overall Study|Death|0
1316455|NCT00090545|4273105|P2|Overall Study|Refused further treatment|4
1316456|NCT00090545|4273106|P1|Overall Study|Refused further treatment|1
1316457|NCT00090545|4273105|P2|Overall Study|Disease progression on study|17
1316458|NCT00090545|4273106|P1|Overall Study|Disease progression on study|21
1316459|NCT00090285|4273126|P6|Long-term Follow-up (EXT2)|Physician Decision|5
1316460|NCT00090285|4273127|P5|Long-term Follow-up (EXT2)|Physician Decision|6
1316461|NCT00090285|4273128|P4|Long-term Follow-up (EXT2)|Physician Decision|0
1316462|NCT00090285|4273129|P3|Long-term Follow-up (EXT2)|Physician Decision|0
1316463|NCT00090285|4273130|P2|Long-term Follow-up (EXT2)|Physician Decision|0
1316464|NCT00090285|4273131|P1|Long-term Follow-up (EXT2)|Physician Decision|0
1316465|NCT00090285|4273126|P6|Long-term Follow-up (EXT2)|Withdrawal by Subject|53
1316466|NCT00090285|4273127|P5|Long-term Follow-up (EXT2)|Withdrawal by Subject|60
1316467|NCT00090285|4273128|P4|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1316468|NCT00090285|4273129|P3|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1316469|NCT00090285|4273130|P2|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1316470|NCT00090285|4273131|P1|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1316471|NCT00090285|4273126|P6|Long-term Follow-up (EXT2)|Lost to Follow-up|143
1316472|NCT00090285|4273127|P5|Long-term Follow-up (EXT2)|Lost to Follow-up|156
1316473|NCT00090285|4273128|P4|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1316474|NCT00090285|4273129|P3|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1316475|NCT00090285|4273130|P2|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1316476|NCT00090285|4273131|P1|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1316477|NCT00090285|4273126|P6|Long-term Follow-up (EXT2)|Adverse Event|2
1316478|NCT00090285|4273127|P5|Long-term Follow-up (EXT2)|Adverse Event|5
1316479|NCT00090285|4273128|P4|Long-term Follow-up (EXT2)|Adverse Event|0
1316480|NCT00090285|4273129|P3|Long-term Follow-up (EXT2)|Adverse Event|0
1316481|NCT00090285|4273130|P2|Long-term Follow-up (EXT2)|Adverse Event|0
1316482|NCT00090285|4273131|P1|Long-term Follow-up (EXT2)|Adverse Event|0
1316483|NCT00090285|4273126|P6|Extension 1|Moved|0
1316484|NCT00090285|4273127|P5|Extension 1|Moved|0
1316485|NCT00090285|4273128|P4|Extension 1|Moved|0
1316486|NCT00090285|4273129|P3|Extension 1|Moved|3
1316487|NCT00090285|4273130|P2|Extension 1|Moved|0
1316488|NCT00090285|4273131|P1|Extension 1|Moved|0
1316489|NCT00090285|4273126|P6|Extension 1|Other|0
1316490|NCT00090285|4273127|P5|Extension 1|Other|0
1316491|NCT00090285|4273128|P4|Extension 1|Other|0
1316492|NCT00090285|4273129|P3|Extension 1|Other|4
1316493|NCT00090285|4273130|P2|Extension 1|Other|0
1316494|NCT00090285|4273131|P1|Extension 1|Other|0
1316495|NCT00090285|4273126|P6|Extension 1|Withdrawal by Subject|0
1316496|NCT00090285|4273127|P5|Extension 1|Withdrawal by Subject|0
1316497|NCT00090285|4273128|P4|Extension 1|Withdrawal by Subject|1
1316498|NCT00090285|4273129|P3|Extension 1|Withdrawal by Subject|13
1316499|NCT00090285|4273130|P2|Extension 1|Withdrawal by Subject|0
1316500|NCT00090285|4273131|P1|Extension 1|Withdrawal by Subject|0
1316501|NCT00090285|4273126|P6|Extension 1|Lost to Follow-up|0
1316502|NCT00090285|4273127|P5|Extension 1|Lost to Follow-up|0
1316503|NCT00090285|4273128|P4|Extension 1|Lost to Follow-up|0
1316504|NCT00090285|4273129|P3|Extension 1|Lost to Follow-up|35
1316505|NCT00090285|4273130|P2|Extension 1|Lost to Follow-up|0
1316506|NCT00090285|4273131|P1|Extension 1|Lost to Follow-up|0
1316507|NCT00090285|4273126|P6|Extension 1|Adverse Event|0
1316508|NCT00090285|4273127|P5|Extension 1|Adverse Event|0
1316509|NCT00090285|4273128|P4|Extension 1|Adverse Event|0
1316510|NCT00090285|4273129|P3|Extension 1|Adverse Event|2
1316511|NCT00090285|4273130|P2|Extension 1|Adverse Event|0
1316512|NCT00090285|4273131|P1|Extension 1|Adverse Event|0
1316513|NCT00090285|4273126|P6|Base Study Follow-up Period|Subject Incarcerated|0
1316514|NCT00090285|4273127|P5|Base Study Follow-up Period|Subject Incarcerated|0
1316515|NCT00090285|4273128|P4|Base Study Follow-up Period|Subject Incarcerated|0
1316516|NCT00090285|4273129|P3|Base Study Follow-up Period|Subject Incarcerated|0
1316517|NCT00090285|4273130|P2|Base Study Follow-up Period|Subject Incarcerated|2
1316518|NCT00090285|4273131|P1|Base Study Follow-up Period|Subject Incarcerated|0
1316519|NCT00090285|4273126|P6|Base Study Follow-up Period|Uncooperative|0
1316520|NCT00090285|4273127|P5|Base Study Follow-up Period|Uncooperative|0
1316521|NCT00090285|4273128|P4|Base Study Follow-up Period|Uncooperative|0
1316522|NCT00090285|4273129|P3|Base Study Follow-up Period|Uncooperative|0
1316523|NCT00090285|4273130|P2|Base Study Follow-up Period|Uncooperative|4
1316524|NCT00090285|4273131|P1|Base Study Follow-up Period|Uncooperative|3
1316525|NCT00090285|4273126|P6|Base Study Follow-up Period|Protocol Violation|0
1316526|NCT00090285|4273127|P5|Base Study Follow-up Period|Protocol Violation|0
1316527|NCT00090285|4273128|P4|Base Study Follow-up Period|Protocol Violation|0
1316528|NCT00090285|4273129|P3|Base Study Follow-up Period|Protocol Violation|0
1316529|NCT00090285|4273130|P2|Base Study Follow-up Period|Protocol Violation|0
1316530|NCT00090285|4273131|P1|Base Study Follow-up Period|Protocol Violation|1
1316531|NCT00090285|4273126|P6|Base Study Follow-up Period|Other|0
1316532|NCT00090285|4273127|P5|Base Study Follow-up Period|Other|0
1316533|NCT00090285|4273128|P4|Base Study Follow-up Period|Other|0
1316534|NCT00090285|4273129|P3|Base Study Follow-up Period|Other|0
1316535|NCT00090285|4273130|P2|Base Study Follow-up Period|Other|0
1316536|NCT00090285|4273131|P1|Base Study Follow-up Period|Other|2
1316537|NCT00090285|4273126|P6|Base Study Follow-up Period|Moved|0
1316538|NCT00090285|4273127|P5|Base Study Follow-up Period|Moved|0
1316539|NCT00090285|4273128|P4|Base Study Follow-up Period|Moved|0
1316540|NCT00090285|4273129|P3|Base Study Follow-up Period|Moved|0
1316541|NCT00090285|4273130|P2|Base Study Follow-up Period|Moved|36
1316542|NCT00090285|4273131|P1|Base Study Follow-up Period|Moved|41
1316543|NCT00090285|4273126|P6|Base Study Follow-up Period|Withdrawal by Subject|0
1316544|NCT00090285|4273127|P5|Base Study Follow-up Period|Withdrawal by Subject|0
1316545|NCT00090285|4273128|P4|Base Study Follow-up Period|Withdrawal by Subject|0
1316546|NCT00090285|4273129|P3|Base Study Follow-up Period|Withdrawal by Subject|0
1316547|NCT00090285|4273130|P2|Base Study Follow-up Period|Withdrawal by Subject|64
1316548|NCT00090285|4273131|P1|Base Study Follow-up Period|Withdrawal by Subject|53
1316549|NCT00090285|4273126|P6|Base Study Follow-up Period|Lost to Follow-up|0
1316550|NCT00090285|4273127|P5|Base Study Follow-up Period|Lost to Follow-up|0
1316551|NCT00090285|4273128|P4|Base Study Follow-up Period|Lost to Follow-up|0
1316552|NCT00090285|4273129|P3|Base Study Follow-up Period|Lost to Follow-up|0
1316553|NCT00090285|4273130|P2|Base Study Follow-up Period|Lost to Follow-up|226
1316554|NCT00090285|4273131|P1|Base Study Follow-up Period|Lost to Follow-up|232
1316555|NCT00090285|4273126|P6|Base Study Follow-up Period|Adverse Event|0
1316556|NCT00090285|4273127|P5|Base Study Follow-up Period|Adverse Event|0
1316557|NCT00090285|4273128|P4|Base Study Follow-up Period|Adverse Event|0
1316558|NCT00090285|4273129|P3|Base Study Follow-up Period|Adverse Event|0
1316559|NCT00090285|4273130|P2|Base Study Follow-up Period|Adverse Event|10
1316560|NCT00090285|4273131|P1|Base Study Follow-up Period|Adverse Event|3
1316561|NCT00090285|4273126|P6|Base Study Vaccination Period|HIV positive|0
1316562|NCT00090285|4273127|P5|Base Study Vaccination Period|HIV positive|0
1316563|NCT00090285|4273128|P4|Base Study Vaccination Period|HIV positive|0
1316564|NCT00090285|4273129|P3|Base Study Vaccination Period|HIV positive|0
1316565|NCT00090285|4273130|P2|Base Study Vaccination Period|HIV positive|1
1316566|NCT00090285|4273131|P1|Base Study Vaccination Period|HIV positive|1
1316567|NCT00090285|4273126|P6|Base Study Vaccination Period|Subject Incarcerated|0
1316568|NCT00090285|4273127|P5|Base Study Vaccination Period|Subject Incarcerated|0
1316569|NCT00090285|4273128|P4|Base Study Vaccination Period|Subject Incarcerated|0
1316570|NCT00090285|4273129|P3|Base Study Vaccination Period|Subject Incarcerated|0
1316571|NCT00090285|4273130|P2|Base Study Vaccination Period|Subject Incarcerated|2
1316572|NCT00090285|4273131|P1|Base Study Vaccination Period|Subject Incarcerated|2
1316573|NCT00090285|4273126|P6|Base Study Vaccination Period|Other|0
1316574|NCT00090285|4273127|P5|Base Study Vaccination Period|Other|0
1316575|NCT00090285|4273128|P4|Base Study Vaccination Period|Other|0
1316576|NCT00090285|4273129|P3|Base Study Vaccination Period|Other|0
1316577|NCT00090285|4273130|P2|Base Study Vaccination Period|Other|2
1316578|NCT00090285|4273131|P1|Base Study Vaccination Period|Other|2
1316579|NCT00090285|4273126|P6|Base Study Vaccination Period|Site Terminated|0
1316580|NCT00090285|4273127|P5|Base Study Vaccination Period|Site Terminated|0
1316581|NCT00090285|4273128|P4|Base Study Vaccination Period|Site Terminated|0
1316582|NCT00090285|4273129|P3|Base Study Vaccination Period|Site Terminated|0
1316583|NCT00090285|4273130|P2|Base Study Vaccination Period|Site Terminated|0
1316584|NCT00090285|4273131|P1|Base Study Vaccination Period|Site Terminated|1
1316585|NCT00090285|4273126|P6|Base Study Vaccination Period|Moved|0
1316586|NCT00090285|4273127|P5|Base Study Vaccination Period|Moved|0
1316587|NCT00090285|4273128|P4|Base Study Vaccination Period|Moved|0
1316588|NCT00090285|4273129|P3|Base Study Vaccination Period|Moved|0
1316589|NCT00090285|4273130|P2|Base Study Vaccination Period|Moved|21
1316590|NCT00090285|4273131|P1|Base Study Vaccination Period|Moved|20
1316591|NCT00090285|4273126|P6|Base Study Vaccination Period|Uncooperative|0
1316592|NCT00090285|4273127|P5|Base Study Vaccination Period|Uncooperative|0
1316593|NCT00090285|4273128|P4|Base Study Vaccination Period|Uncooperative|0
1316594|NCT00090285|4273129|P3|Base Study Vaccination Period|Uncooperative|0
1316595|NCT00090285|4273130|P2|Base Study Vaccination Period|Uncooperative|2
1316596|NCT00090285|4273131|P1|Base Study Vaccination Period|Uncooperative|2
1316597|NCT00090285|4273126|P6|Base Study Vaccination Period|Withdrawal by Subject|0
1316598|NCT00090285|4273127|P5|Base Study Vaccination Period|Withdrawal by Subject|0
1316599|NCT00090285|4273128|P4|Base Study Vaccination Period|Withdrawal by Subject|0
1316600|NCT00090285|4273129|P3|Base Study Vaccination Period|Withdrawal by Subject|0
1316601|NCT00090285|4273130|P2|Base Study Vaccination Period|Withdrawal by Subject|69
1316602|NCT00090285|4273131|P1|Base Study Vaccination Period|Withdrawal by Subject|64
1316603|NCT00090285|4273126|P6|Base Study Vaccination Period|Protocol Violation|0
1316604|NCT00090285|4273127|P5|Base Study Vaccination Period|Protocol Violation|0
1316605|NCT00090285|4273128|P4|Base Study Vaccination Period|Protocol Violation|0
1316606|NCT00090285|4273129|P3|Base Study Vaccination Period|Protocol Violation|0
1316607|NCT00090285|4273130|P2|Base Study Vaccination Period|Protocol Violation|3
1316608|NCT00090285|4273131|P1|Base Study Vaccination Period|Protocol Violation|2
1316609|NCT00090285|4273126|P6|Base Study Vaccination Period|Lost to Follow-up|0
1316610|NCT00090285|4273127|P5|Base Study Vaccination Period|Lost to Follow-up|0
1316611|NCT00090285|4273128|P4|Base Study Vaccination Period|Lost to Follow-up|0
1316612|NCT00090285|4273129|P3|Base Study Vaccination Period|Lost to Follow-up|0
1316613|NCT00090285|4273130|P2|Base Study Vaccination Period|Lost to Follow-up|112
1316614|NCT00090285|4273131|P1|Base Study Vaccination Period|Lost to Follow-up|111
1316615|NCT00090285|4273126|P6|Base Study Vaccination Period|Adverse Event|0
1316616|NCT00090285|4273127|P5|Base Study Vaccination Period|Adverse Event|0
1316617|NCT00090285|4273128|P4|Base Study Vaccination Period|Adverse Event|0
1316618|NCT00090285|4273129|P3|Base Study Vaccination Period|Adverse Event|0
1316619|NCT00090285|4273130|P2|Base Study Vaccination Period|Adverse Event|4
1316620|NCT00090285|4273131|P1|Base Study Vaccination Period|Adverse Event|2
1316621|NCT00090285|4273126|P6|Base Study Vaccination Period|Randomized Not Vaccinated|0
1316622|NCT00090285|4273127|P5|Base Study Vaccination Period|Randomized Not Vaccinated|0
1316623|NCT00090285|4273128|P4|Base Study Vaccination Period|Randomized Not Vaccinated|0
1316624|NCT00090285|4273129|P3|Base Study Vaccination Period|Randomized Not Vaccinated|0
1316625|NCT00090285|4273130|P2|Base Study Vaccination Period|Randomized Not Vaccinated|3
1316626|NCT00090285|4273131|P1|Base Study Vaccination Period|Randomized Not Vaccinated|7
1316627|NCT00090259|4273168|P2|Overall Study|Investigator site closed|7
1316628|NCT00090259|4273169|P1|Overall Study|Investigator site closed|11
1316629|NCT00090259|4273168|P2|Overall Study|Withdrawal by Subject|15
1316630|NCT00090259|4273169|P1|Overall Study|Withdrawal by Subject|21
1316631|NCT00090259|4273168|P2|Overall Study|Lost to Follow-up|26
1316632|NCT00090259|4273169|P1|Overall Study|Lost to Follow-up|30
1316633|NCT00090233|4273185|P2|Overall Study|Data not available at data cut-off point|1563
1316634|NCT00090233|4273186|P1|Overall Study|Data not available at data cut-off point|1552
1316635|NCT00090233|4273185|P2|Overall Study|Not Specified|1160
1316636|NCT00090233|4273186|P1|Overall Study|Not Specified|1211
1316637|NCT00090233|4273185|P2|Overall Study|Moved|189
1316638|NCT00090233|4273186|P1|Overall Study|Moved|203
1316639|NCT00090233|4273185|P2|Overall Study|Withdrawal by Subject|211
1316640|NCT00090233|4273186|P1|Overall Study|Withdrawal by Subject|182
1316641|NCT00090233|4273185|P2|Overall Study|Protocol Violation|1022
1316642|NCT00090233|4273186|P1|Overall Study|Protocol Violation|960
1316643|NCT00090233|4273185|P2|Overall Study|Lost to Follow-up|95
1316644|NCT00090233|4273186|P1|Overall Study|Lost to Follow-up|68
1316645|NCT00090233|4273185|P2|Overall Study|Adverse Event|198
1316646|NCT00090233|4273186|P1|Overall Study|Adverse Event|214
1316647|NCT00090233|4273185|P2|Overall Study|Randomized Not Vaccinated (Visit 1)|627
1316648|NCT00090233|4273186|P1|Overall Study|Randomized Not Vaccinated (Visit 1)|609
1316649|NCT00090220|4273210|P6|Long-term Follow-up (EXT2)|Other|0
1316650|NCT00090220|4273211|P5|Long-term Follow-up (EXT2)|Other|1
1316651|NCT00090220|4273212|P4|Long-term Follow-up (EXT2)|Other|0
1316652|NCT00090220|4273213|P3|Long-term Follow-up (EXT2)|Other|0
1316653|NCT00090220|4273214|P2|Long-term Follow-up (EXT2)|Other|0
1316654|NCT00090220|4273215|P1|Long-term Follow-up (EXT2)|Other|0
1316655|NCT00090220|4273210|P6|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
1316656|NCT00090220|4273211|P5|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
1316657|NCT00090220|4273212|P4|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1316658|NCT00090220|4273213|P3|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1316659|NCT00090220|4273214|P2|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1316660|NCT00090220|4273215|P1|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1316661|NCT00090220|4273210|P6|Long-term Follow-up (EXT2)|Death|1
1316662|NCT00090220|4273211|P5|Long-term Follow-up (EXT2)|Death|1
1316663|NCT00090220|4273212|P4|Long-term Follow-up (EXT2)|Death|0
1316664|NCT00090220|4273213|P3|Long-term Follow-up (EXT2)|Death|0
1316665|NCT00090220|4273214|P2|Long-term Follow-up (EXT2)|Death|0
1316666|NCT00090220|4273215|P1|Long-term Follow-up (EXT2)|Death|0
1316667|NCT00090220|4273210|P6|Long-term Follow-up (EXT2)|Lost to Follow-up|23
1316668|NCT00090220|4273211|P5|Long-term Follow-up (EXT2)|Lost to Follow-up|38
1316669|NCT00090220|4273212|P4|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1316670|NCT00090220|4273213|P3|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1316671|NCT00090220|4273214|P2|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1316672|NCT00090220|4273215|P1|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1316673|NCT00090220|4273210|P6|Extension 1 (EXT1)|Other reason|0
1316674|NCT00090220|4273211|P5|Extension 1 (EXT1)|Other reason|0
1316675|NCT00090220|4273212|P4|Extension 1 (EXT1)|Other reason|0
1316676|NCT00090220|4273213|P3|Extension 1 (EXT1)|Other reason|2
1316677|NCT00090220|4273214|P2|Extension 1 (EXT1)|Other reason|0
1316678|NCT00090220|4273215|P1|Extension 1 (EXT1)|Other reason|0
1316679|NCT00090220|4273210|P6|Extension 1 (EXT1)|Protocol Violation|0
1316680|NCT00090220|4273211|P5|Extension 1 (EXT1)|Protocol Violation|0
1316681|NCT00090220|4273212|P4|Extension 1 (EXT1)|Protocol Violation|1
1316682|NCT00090220|4273213|P3|Extension 1 (EXT1)|Protocol Violation|0
1316683|NCT00090220|4273214|P2|Extension 1 (EXT1)|Protocol Violation|0
1316684|NCT00090220|4273215|P1|Extension 1 (EXT1)|Protocol Violation|0
1316685|NCT00090220|4273210|P6|Extension 1 (EXT1)|Withdrawal by Subject|0
1316686|NCT00090220|4273211|P5|Extension 1 (EXT1)|Withdrawal by Subject|0
1316687|NCT00090220|4273212|P4|Extension 1 (EXT1)|Withdrawal by Subject|0
1316688|NCT00090220|4273213|P3|Extension 1 (EXT1)|Withdrawal by Subject|25
1316689|NCT00090220|4273214|P2|Extension 1 (EXT1)|Withdrawal by Subject|0
1316690|NCT00090220|4273215|P1|Extension 1 (EXT1)|Withdrawal by Subject|0
1316691|NCT00090220|4273210|P6|Extension 1 (EXT1)|Moved|0
1316692|NCT00090220|4273211|P5|Extension 1 (EXT1)|Moved|0
1316693|NCT00090220|4273212|P4|Extension 1 (EXT1)|Moved|1
1316694|NCT00090220|4273213|P3|Extension 1 (EXT1)|Moved|2
1316695|NCT00090220|4273214|P2|Extension 1 (EXT1)|Moved|0
1316696|NCT00090220|4273215|P1|Extension 1 (EXT1)|Moved|0
1316697|NCT00090220|4273210|P6|Extension 1 (EXT1)|Lost to Follow-up|0
1316698|NCT00090220|4273211|P5|Extension 1 (EXT1)|Lost to Follow-up|0
1316699|NCT00090220|4273212|P4|Extension 1 (EXT1)|Lost to Follow-up|0
1316700|NCT00090220|4273213|P3|Extension 1 (EXT1)|Lost to Follow-up|22
1316701|NCT00090220|4273214|P2|Extension 1 (EXT1)|Lost to Follow-up|0
1316702|NCT00090220|4273215|P1|Extension 1 (EXT1)|Lost to Follow-up|0
1316703|NCT00090220|4273210|P6|Extension 1 (EXT1)|Adverse Event|0
1316704|NCT00090220|4273211|P5|Extension 1 (EXT1)|Adverse Event|0
1316705|NCT00090220|4273212|P4|Extension 1 (EXT1)|Adverse Event|0
1316706|NCT00090220|4273213|P3|Extension 1 (EXT1)|Adverse Event|4
1316707|NCT00090220|4273214|P2|Extension 1 (EXT1)|Adverse Event|0
1316708|NCT00090220|4273215|P1|Extension 1 (EXT1)|Adverse Event|0
1316709|NCT00090220|4273210|P6|Base Study Follow-up Period|Other|0
1316710|NCT00090220|4273211|P5|Base Study Follow-up Period|Other|0
1316711|NCT00090220|4273212|P4|Base Study Follow-up Period|Other|0
1316712|NCT00090220|4273213|P3|Base Study Follow-up Period|Other|0
1316713|NCT00090220|4273214|P2|Base Study Follow-up Period|Other|21
1316714|NCT00090220|4273215|P1|Base Study Follow-up Period|Other|19
1316715|NCT00090220|4273210|P6|Base Study Follow-up Period|Patient Moved|0
1316716|NCT00090220|4273211|P5|Base Study Follow-up Period|Patient Moved|0
1316717|NCT00090220|4273212|P4|Base Study Follow-up Period|Patient Moved|0
1316718|NCT00090220|4273213|P3|Base Study Follow-up Period|Patient Moved|0
1316719|NCT00090220|4273214|P2|Base Study Follow-up Period|Patient Moved|28
1316720|NCT00090220|4273215|P1|Base Study Follow-up Period|Patient Moved|20
1316721|NCT00090220|4273210|P6|Base Study Follow-up Period|Withdrawal by Subject|0
1316722|NCT00090220|4273211|P5|Base Study Follow-up Period|Withdrawal by Subject|0
1316723|NCT00090220|4273212|P4|Base Study Follow-up Period|Withdrawal by Subject|0
1316724|NCT00090220|4273213|P3|Base Study Follow-up Period|Withdrawal by Subject|0
1316725|NCT00090220|4273214|P2|Base Study Follow-up Period|Withdrawal by Subject|36
1316726|NCT00090220|4273215|P1|Base Study Follow-up Period|Withdrawal by Subject|27
1316727|NCT00090220|4273210|P6|Base Study Follow-up Period|Lost to Follow-up|0
1316728|NCT00090220|4273211|P5|Base Study Follow-up Period|Lost to Follow-up|0
1316729|NCT00090220|4273212|P4|Base Study Follow-up Period|Lost to Follow-up|0
1316730|NCT00090220|4273213|P3|Base Study Follow-up Period|Lost to Follow-up|0
1316731|NCT00090220|4273214|P2|Base Study Follow-up Period|Lost to Follow-up|78
1316732|NCT00090220|4273215|P1|Base Study Follow-up Period|Lost to Follow-up|88
1316733|NCT00090220|4273210|P6|Base Study Follow-up Period|Adverse Event|0
1316734|NCT00090220|4273211|P5|Base Study Follow-up Period|Adverse Event|0
1316735|NCT00090220|4273212|P4|Base Study Follow-up Period|Adverse Event|0
1316736|NCT00090220|4273213|P3|Base Study Follow-up Period|Adverse Event|0
1316737|NCT00090220|4273214|P2|Base Study Follow-up Period|Adverse Event|1
1316738|NCT00090220|4273215|P1|Base Study Follow-up Period|Adverse Event|6
1316739|NCT00090220|4273210|P6|Base Study Vaccination Period|Other|0
1316740|NCT00090220|4273211|P5|Base Study Vaccination Period|Other|0
1316741|NCT00090220|4273212|P4|Base Study Vaccination Period|Other|0
1316742|NCT00090220|4273213|P3|Base Study Vaccination Period|Other|0
1316743|NCT00090220|4273214|P2|Base Study Vaccination Period|Other|4
1316744|NCT00090220|4273215|P1|Base Study Vaccination Period|Other|4
1316745|NCT00090220|4273210|P6|Base Study Vaccination Period|Patient Moved|0
1316746|NCT00090220|4273211|P5|Base Study Vaccination Period|Patient Moved|0
1316747|NCT00090220|4273212|P4|Base Study Vaccination Period|Patient Moved|0
1316748|NCT00090220|4273213|P3|Base Study Vaccination Period|Patient Moved|0
1316749|NCT00090220|4273214|P2|Base Study Vaccination Period|Patient Moved|2
1316750|NCT00090220|4273215|P1|Base Study Vaccination Period|Patient Moved|6
1316751|NCT00090220|4273210|P6|Base Study Vaccination Period|Withdrawal by Subject|0
1316752|NCT00090220|4273211|P5|Base Study Vaccination Period|Withdrawal by Subject|0
1316753|NCT00090220|4273212|P4|Base Study Vaccination Period|Withdrawal by Subject|0
1316754|NCT00090220|4273213|P3|Base Study Vaccination Period|Withdrawal by Subject|0
1316755|NCT00090220|4273214|P2|Base Study Vaccination Period|Withdrawal by Subject|27
1316756|NCT00090220|4273215|P1|Base Study Vaccination Period|Withdrawal by Subject|23
1316757|NCT00090220|4273210|P6|Base Study Vaccination Period|Lost to Follow-up|0
1316758|NCT00090220|4273211|P5|Base Study Vaccination Period|Lost to Follow-up|0
1316759|NCT00090220|4273212|P4|Base Study Vaccination Period|Lost to Follow-up|0
1316760|NCT00090220|4273213|P3|Base Study Vaccination Period|Lost to Follow-up|0
1316761|NCT00090220|4273214|P2|Base Study Vaccination Period|Lost to Follow-up|28
1316762|NCT00090220|4273215|P1|Base Study Vaccination Period|Lost to Follow-up|24
1316763|NCT00090220|4273210|P6|Base Study Vaccination Period|Adverse Event|0
1316764|NCT00090220|4273211|P5|Base Study Vaccination Period|Adverse Event|0
1316765|NCT00090220|4273212|P4|Base Study Vaccination Period|Adverse Event|0
1316766|NCT00090220|4273213|P3|Base Study Vaccination Period|Adverse Event|0
1316767|NCT00090220|4273214|P2|Base Study Vaccination Period|Adverse Event|1
1316768|NCT00090220|4273215|P1|Base Study Vaccination Period|Adverse Event|6
1316769|NCT00090220|4273210|P6|Base Study Vaccination Period|Randomized not Vaccinated|0
1316770|NCT00090220|4273211|P5|Base Study Vaccination Period|Randomized not Vaccinated|0
1316771|NCT00090220|4273212|P4|Base Study Vaccination Period|Randomized not Vaccinated|0
1316772|NCT00090220|4273213|P3|Base Study Vaccination Period|Randomized not Vaccinated|0
1316773|NCT00090220|4273214|P2|Base Study Vaccination Period|Randomized not Vaccinated|1
1316774|NCT00090220|4273215|P1|Base Study Vaccination Period|Randomized not Vaccinated|1
1316775|NCT00090402|4273310|P3|Overall Study|stopped taking study medication|1
1316776|NCT00090402|4273311|P2|Overall Study|stopped taking study medication|0
1316777|NCT00090402|4273312|P1|Overall Study|stopped taking study medication|1
1316778|NCT00090402|4273310|P3|Overall Study|subject moved|0
1316779|NCT00090402|4273311|P2|Overall Study|subject moved|1
1316780|NCT00090402|4273312|P1|Overall Study|subject moved|0
1316781|NCT00090402|4273310|P3|Overall Study|Death|0
1316782|NCT00090402|4273311|P2|Overall Study|Death|1
1316783|NCT00090402|4273312|P1|Overall Study|Death|1
1316784|NCT00090142|4273326|P2|Treatment Period II|Not Specified|0
1316785|NCT00090142|4273327|P1|Treatment Period II|Not Specified|1
1316786|NCT00090142|4273326|P2|Treatment Period I|Not Specified|1
1316787|NCT00090142|4273327|P1|Treatment Period I|Not Specified|0
1316788|NCT00090142|4273326|P2|Treatment Period I|Withdrawal by Subject|0
1316789|NCT00090142|4273327|P1|Treatment Period I|Withdrawal by Subject|2
1316790|NCT00090142|4273326|P2|Treatment Period I|Protocol Violation|0
1316791|NCT00090142|4273327|P1|Treatment Period I|Protocol Violation|2
1316792|NCT00090142|4273326|P2|Treatment Period I|Lost to Follow-up|2
1316793|NCT00090142|4273327|P1|Treatment Period I|Lost to Follow-up|1
1316794|NCT00090103|4273358|P3|16-Week Safety Follow-up Period|Other|0
1316795|NCT00090103|4273359|P2|16-Week Safety Follow-up Period|Other|1
1316796|NCT00090103|4273360|P1|16-Week Safety Follow-up Period|Other|0
1316797|NCT00090103|4273358|P3|16-Week Safety Follow-up Period|Jailed|0
1316798|NCT00090103|4273359|P2|16-Week Safety Follow-up Period|Jailed|1
1316799|NCT00090103|4273360|P1|16-Week Safety Follow-up Period|Jailed|0
1316800|NCT00090103|4273358|P3|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
1316801|NCT00090103|4273359|P2|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1
1316802|NCT00090103|4273360|P1|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
1316803|NCT00090103|4273358|P3|16-Week Safety Follow-up Period|Depression|0
1316804|NCT00090103|4273359|P2|16-Week Safety Follow-up Period|Depression|1
1316805|NCT00090103|4273360|P1|16-Week Safety Follow-up Period|Depression|0
1316806|NCT00090103|4273358|P3|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3
1316807|NCT00090103|4273359|P2|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2
1316808|NCT00090103|4273360|P1|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0
1316809|NCT00090103|4273358|P3|16-Week Safety Follow-up Period|Scheduling Issues|4
1316810|NCT00090103|4273359|P2|16-Week Safety Follow-up Period|Scheduling Issues|2
1316811|NCT00090103|4273360|P1|16-Week Safety Follow-up Period|Scheduling Issues|0
1316812|NCT00090103|4273358|P3|16-Week Safety Follow-up Period|Back Pain|0
1316813|NCT00090103|4273359|P2|16-Week Safety Follow-up Period|Back Pain|1
1316814|NCT00090103|4273360|P1|16-Week Safety Follow-up Period|Back Pain|0
1316815|NCT00090103|4273358|P3|16-Week Safety Follow-up Period|Angina Pectoris|0
1316816|NCT00090103|4273359|P2|16-Week Safety Follow-up Period|Angina Pectoris|1
1316817|NCT00090103|4273360|P1|16-Week Safety Follow-up Period|Angina Pectoris|0
1316818|NCT00090103|4273358|P3|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3
1316819|NCT00090103|4273359|P2|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2
1316820|NCT00090103|4273360|P1|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0
1316821|NCT00090103|4273358|P3|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4
1316822|NCT00090103|4273359|P2|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5
1316823|NCT00090103|4273360|P1|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0
1316824|NCT00090103|4273358|P3|16-Week Safety Follow-up Period|Gyneomastia|0
1316825|NCT00090103|4273359|P2|16-Week Safety Follow-up Period|Gyneomastia|0
1316826|NCT00090103|4273360|P1|16-Week Safety Follow-up Period|Gyneomastia|1
1316827|NCT00090103|4273358|P3|16-Week Safety Follow-up Period|Death|1
1316828|NCT00090103|4273359|P2|16-Week Safety Follow-up Period|Death|0
1316829|NCT00090103|4273360|P1|16-Week Safety Follow-up Period|Death|1
1316830|NCT00090103|4273358|P3|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6
1316831|NCT00090103|4273359|P2|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3
1316832|NCT00090103|4273360|P1|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1
1316833|NCT00090103|4273358|P3|16-Week Safety Follow-up Period|Enrollment Error|2
1316834|NCT00090103|4273359|P2|16-Week Safety Follow-up Period|Enrollment Error|0
1316835|NCT00090103|4273360|P1|16-Week Safety Follow-up Period|Enrollment Error|1
1316836|NCT00090103|4273358|P3|16-Week Safety Follow-up Period|Loss of Libido|0
1316837|NCT00090103|4273359|P2|16-Week Safety Follow-up Period|Loss of Libido|0
1316838|NCT00090103|4273360|P1|16-Week Safety Follow-up Period|Loss of Libido|1
1316839|NCT00090103|4273358|P3|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13
1316840|NCT00090103|4273359|P2|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5
1316841|NCT00090103|4273360|P1|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1
1316842|NCT00090103|4273358|P3|16-Week Safety Follow-up Period|Alcohol Dependent|1
1316843|NCT00090103|4273359|P2|16-Week Safety Follow-up Period|Alcohol Dependent|0
1316844|NCT00090103|4273360|P1|16-Week Safety Follow-up Period|Alcohol Dependent|1
1316845|NCT00090103|4273358|P3|16-Week Safety Follow-up Period|Prohibited Medication|5
1316846|NCT00090103|4273359|P2|16-Week Safety Follow-up Period|Prohibited Medication|3
1316847|NCT00090103|4273360|P1|16-Week Safety Follow-up Period|Prohibited Medication|2
1316848|NCT00090103|4273358|P3|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
1316849|NCT00090103|4273359|P2|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1
1316850|NCT00090103|4273360|P1|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
1316851|NCT00090103|4273358|P3|16-Week Safety Follow-up Period|Participant relocated|1
1316852|NCT00090103|4273359|P2|16-Week Safety Follow-up Period|Participant relocated|3
1316853|NCT00090103|4273360|P1|16-Week Safety Follow-up Period|Participant relocated|2
1316854|NCT00090103|4273358|P3|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
1316855|NCT00090103|4273359|P2|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
1316856|NCT00090103|4273360|P1|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3
1316857|NCT00090103|4273358|P3|16-Week Safety Follow-up Period|Loss of Contact|2
1316858|NCT00090103|4273359|P2|16-Week Safety Follow-up Period|Loss of Contact|0
1316859|NCT00090103|4273360|P1|16-Week Safety Follow-up Period|Loss of Contact|4
1316860|NCT00090103|4273358|P3|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4
1316861|NCT00090103|4273359|P2|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6
1316862|NCT00090103|4273360|P1|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8
1316863|NCT00090103|4273358|P3|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4
1316864|NCT00090103|4273359|P2|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5
1316865|NCT00090103|4273360|P1|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8
1316866|NCT00090103|4273358|P3|16-Week Safety Follow-up Period|Protocol Violation|17
1316867|NCT00090103|4273359|P2|16-Week Safety Follow-up Period|Protocol Violation|18
1316868|NCT00090103|4273360|P1|16-Week Safety Follow-up Period|Protocol Violation|18
1316869|NCT00090103|4273358|P3|16-Week Safety Follow-up Period|Lost to Follow-up|111
1316870|NCT00090103|4273359|P2|16-Week Safety Follow-up Period|Lost to Follow-up|97
1316871|NCT00090103|4273360|P1|16-Week Safety Follow-up Period|Lost to Follow-up|101
1316872|NCT00090103|4273358|P3|16-Week Safety Follow-up Period|Withdrawal by Subject|229
1316873|NCT00090103|4273359|P2|16-Week Safety Follow-up Period|Withdrawal by Subject|212
1316874|NCT00090103|4273360|P1|16-Week Safety Follow-up Period|Withdrawal by Subject|185
1316875|NCT00090103|4273358|P3|16-Week Safety Follow-up Period|Adverse Event|44
1316876|NCT00090103|4273359|P2|16-Week Safety Follow-up Period|Adverse Event|39
1316877|NCT00090103|4273360|P1|16-Week Safety Follow-up Period|Adverse Event|34
1316878|NCT00090103|4273358|P3|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
1316879|NCT00090103|4273359|P2|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1
1316880|NCT00090103|4273360|P1|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
1316881|NCT00090103|4273358|P3|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1
1316882|NCT00090103|4273359|P2|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
1316883|NCT00090103|4273360|P1|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
1316884|NCT00090103|4273358|P3|Four-Year Double-Blind Treatment Period|Enrollment Error|2
1316885|NCT00090103|4273359|P2|Four-Year Double-Blind Treatment Period|Enrollment Error|0
1316886|NCT00090103|4273360|P1|Four-Year Double-Blind Treatment Period|Enrollment Error|0
1316887|NCT00090103|4273358|P3|Four-Year Double-Blind Treatment Period|Investigator Decision|3
1316888|NCT00090103|4273359|P2|Four-Year Double-Blind Treatment Period|Investigator Decision|1
1316889|NCT00090103|4273360|P1|Four-Year Double-Blind Treatment Period|Investigator Decision|0
1316890|NCT00090103|4273358|P3|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
1316891|NCT00090103|4273359|P2|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1
1316892|NCT00090103|4273360|P1|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
1316893|NCT00090103|4273358|P3|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
1316894|NCT00090103|4273359|P2|Four-Year Double-Blind Treatment Period|Scheduling Issues|1
1316895|NCT00090103|4273360|P1|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
1316896|NCT00090103|4273358|P3|Four-Year Double-Blind Treatment Period|Back Pain|0
1316897|NCT00090103|4273359|P2|Four-Year Double-Blind Treatment Period|Back Pain|1
1316898|NCT00090103|4273360|P1|Four-Year Double-Blind Treatment Period|Back Pain|0
1316899|NCT00090103|4273358|P3|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
1316900|NCT00090103|4273359|P2|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1
1316901|NCT00090103|4273360|P1|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
1316902|NCT00090103|4273358|P3|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
1316903|NCT00090103|4273359|P2|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2
1316904|NCT00090103|4273360|P1|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
1316905|NCT00090103|4273358|P3|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
1316906|NCT00090103|4273359|P2|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
1316907|NCT00090103|4273360|P1|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0
1316908|NCT00090103|4273358|P3|Four-Year Double-Blind Treatment Period|Loss of Contact|0
1316909|NCT00090103|4273359|P2|Four-Year Double-Blind Treatment Period|Loss of Contact|1
1316910|NCT00090103|4273360|P1|Four-Year Double-Blind Treatment Period|Loss of Contact|0
1316911|NCT00090103|4273358|P3|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
1316912|NCT00090103|4273359|P2|Four-Year Double-Blind Treatment Period|Angina Pectoris|2
1316913|NCT00090103|4273360|P1|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
1316914|NCT00090103|4273358|P3|Four-Year Double-Blind Treatment Period|Loss of Libido|0
1316915|NCT00090103|4273359|P2|Four-Year Double-Blind Treatment Period|Loss of Libido|0
1316916|NCT00090103|4273360|P1|Four-Year Double-Blind Treatment Period|Loss of Libido|1
1316917|NCT00090103|4273358|P3|Four-Year Double-Blind Treatment Period|Financial Problems|0
1316918|NCT00090103|4273359|P2|Four-Year Double-Blind Treatment Period|Financial Problems|0
1316919|NCT00090103|4273360|P1|Four-Year Double-Blind Treatment Period|Financial Problems|1
1316920|NCT00090103|4273358|P3|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5
1316921|NCT00090103|4273359|P2|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0
1316922|NCT00090103|4273360|P1|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1
1316923|NCT00090103|4273358|P3|Four-Year Double-Blind Treatment Period|No Improvement|0
1316924|NCT00090103|4273359|P2|Four-Year Double-Blind Treatment Period|No Improvement|0
1316925|NCT00090103|4273360|P1|Four-Year Double-Blind Treatment Period|No Improvement|1
1316926|NCT00090103|4273358|P3|Four-Year Double-Blind Treatment Period|Screen Failure|0
1316927|NCT00090103|4273359|P2|Four-Year Double-Blind Treatment Period|Screen Failure|0
1316928|NCT00090103|4273360|P1|Four-Year Double-Blind Treatment Period|Screen Failure|1
1316929|NCT00090103|4273358|P3|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
1316930|NCT00090103|4273359|P2|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
1316931|NCT00090103|4273360|P1|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1
1316932|NCT00090103|4273358|P3|Four-Year Double-Blind Treatment Period|Investigator Departure|0
1316933|NCT00090103|4273359|P2|Four-Year Double-Blind Treatment Period|Investigator Departure|0
1316934|NCT00090103|4273360|P1|Four-Year Double-Blind Treatment Period|Investigator Departure|2
1316935|NCT00090103|4273358|P3|Four-Year Double-Blind Treatment Period|Prohibited Medication|8
1316936|NCT00090103|4273359|P2|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
1316937|NCT00090103|4273360|P1|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
1316938|NCT00090103|4273358|P3|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6
1316939|NCT00090103|4273359|P2|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3
1316940|NCT00090103|4273360|P1|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2
1316941|NCT00090103|4273358|P3|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4
1316942|NCT00090103|4273359|P2|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0
1316943|NCT00090103|4273360|P1|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2
1316944|NCT00090103|4273358|P3|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19
1316945|NCT00090103|4273359|P2|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7
1316946|NCT00090103|4273360|P1|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3
1316947|NCT00090103|4273358|P3|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7
1316948|NCT00090103|4273359|P2|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4
1316949|NCT00090103|4273360|P1|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6
1316950|NCT00090103|4273358|P3|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4
1316951|NCT00090103|4273359|P2|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
1316952|NCT00090103|4273360|P1|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
1316953|NCT00090103|4273358|P3|Four-Year Double-Blind Treatment Period|Participant Relocated|8
1316954|NCT00090103|4273359|P2|Four-Year Double-Blind Treatment Period|Participant Relocated|2
1316955|NCT00090103|4273360|P1|Four-Year Double-Blind Treatment Period|Participant Relocated|7
1316956|NCT00090103|4273358|P3|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104
1316957|NCT00090103|4273359|P2|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71
1316958|NCT00090103|4273360|P1|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53
1316959|NCT00090103|4273358|P3|Four-Year Double-Blind Treatment Period|Protocol Violation|34
1316960|NCT00090103|4273359|P2|Four-Year Double-Blind Treatment Period|Protocol Violation|29
1316961|NCT00090103|4273360|P1|Four-Year Double-Blind Treatment Period|Protocol Violation|29
1316962|NCT00090103|4273358|P3|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58
1316963|NCT00090103|4273359|P2|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48
1316964|NCT00090103|4273360|P1|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53
1316965|NCT00090103|4273358|P3|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148
1316966|NCT00090103|4273359|P2|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160
1316967|NCT00090103|4273360|P1|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114
1316968|NCT00090103|4273358|P3|Four-Year Double-Blind Treatment Period|Adverse Event|210
1316969|NCT00090103|4273359|P2|Four-Year Double-Blind Treatment Period|Adverse Event|185
1316970|NCT00090103|4273360|P1|Four-Year Double-Blind Treatment Period|Adverse Event|211
1316971|NCT00089999|4273526|P2|Overall Study|Skin Nodule Over Right Mastectomy|1
1316972|NCT00089999|4273527|P1|Overall Study|Skin Nodule Over Right Mastectomy|0
1316973|NCT00089999|4273526|P2|Overall Study|Patient Underwent Surgery|0
1316974|NCT00089999|4273527|P1|Overall Study|Patient Underwent Surgery|2
1316975|NCT00089999|4273526|P2|Overall Study|Physician Decision|2
1316976|NCT00089999|4273527|P1|Overall Study|Physician Decision|2
1316977|NCT00089999|4273526|P2|Overall Study|Clinical Progression|2
1316978|NCT00089999|4273527|P1|Overall Study|Clinical Progression|1
1316979|NCT00089999|4273526|P2|Overall Study|Poor General Condition|0
1316980|NCT00089999|4273527|P1|Overall Study|Poor General Condition|1
1316981|NCT00089999|4273526|P2|Overall Study|Death|3
1316982|NCT00089999|4273527|P1|Overall Study|Death|3
1316983|NCT00089999|4273526|P2|Overall Study|Symptomatic Progression of Cancer|5
1316984|NCT00089999|4273527|P1|Overall Study|Symptomatic Progression of Cancer|2
1316985|NCT00089999|4273526|P2|Overall Study|Radiological Progression of Cancer|44
1316986|NCT00089999|4273527|P1|Overall Study|Radiological Progression of Cancer|52
1316987|NCT00089999|4273526|P2|Overall Study|Lost to Follow-up|1
1316988|NCT00089999|4273527|P1|Overall Study|Lost to Follow-up|2
1316989|NCT00089999|4273526|P2|Overall Study|Withdrawal by Subject|4
1316990|NCT00089999|4273527|P1|Overall Study|Withdrawal by Subject|0
1316991|NCT00089999|4273526|P2|Overall Study|Adverse Event|7
1316992|NCT00089999|4273527|P1|Overall Study|Adverse Event|4
1316993|NCT00089986|4273550|P3|Overall Study|Withdrawal by Subject|2
1316994|NCT00089986|4273551|P2|Overall Study|Withdrawal by Subject|6
1316995|NCT00089986|4273552|P1|Overall Study|Withdrawal by Subject|3
1316996|NCT00089986|4273550|P3|Overall Study|Do not resuscitate (DNR)|1
1316997|NCT00089986|4273551|P2|Overall Study|Do not resuscitate (DNR)|0
1316998|NCT00089986|4273552|P1|Overall Study|Do not resuscitate (DNR)|0
1316999|NCT00089986|4273550|P3|Overall Study|Family decision|0
1317000|NCT00089986|4273551|P2|Overall Study|Family decision|1
1317001|NCT00089986|4273552|P1|Overall Study|Family decision|0
1317002|NCT00089986|4273550|P3|Overall Study|Enrollment in another study|0
1317003|NCT00089986|4273551|P2|Overall Study|Enrollment in another study|1
1317004|NCT00089986|4273552|P1|Overall Study|Enrollment in another study|0
1317005|NCT00089986|4273550|P3|Overall Study|Investigator decision to withdrew|0
1317006|NCT00089986|4273551|P2|Overall Study|Investigator decision to withdrew|1
1317007|NCT00089986|4273552|P1|Overall Study|Investigator decision to withdrew|0
1317008|NCT00089986|4273550|P3|Overall Study|Hemohlobin stopping rule|0
1317009|NCT00089986|4273551|P2|Overall Study|Hemohlobin stopping rule|1
1317010|NCT00089986|4273552|P1|Overall Study|Hemohlobin stopping rule|0
1317011|NCT00089986|4273550|P3|Overall Study|Subject withdrew but agreed follow up|0
1317012|NCT00089986|4273551|P2|Overall Study|Subject withdrew but agreed follow up|2
1317013|NCT00089986|4273552|P1|Overall Study|Subject withdrew but agreed follow up|1
1317014|NCT00089986|4273550|P3|Overall Study|Patient transferred to another hospital|0
1317015|NCT00089986|4273551|P2|Overall Study|Patient transferred to another hospital|1
1317016|NCT00089986|4273552|P1|Overall Study|Patient transferred to another hospital|2
1317017|NCT00089986|4273550|P3|Overall Study|Protocol Violation|0
1317018|NCT00089986|4273551|P2|Overall Study|Protocol Violation|1
1317019|NCT00089986|4273552|P1|Overall Study|Protocol Violation|0
1317020|NCT00089986|4273550|P3|Overall Study|Lost to Follow-up|1
1317021|NCT00089986|4273551|P2|Overall Study|Lost to Follow-up|1
1317022|NCT00089986|4273552|P1|Overall Study|Lost to Follow-up|3
1317023|NCT00089986|4273550|P3|Overall Study|Adverse Event|6
1317024|NCT00089986|4273551|P2|Overall Study|Adverse Event|9
1317025|NCT00089986|4273552|P1|Overall Study|Adverse Event|6
1317026|NCT00089973|4273569|P1|Overall Study|Death|1
1317027|NCT00089973|4273569|P1|Overall Study|Disease progression|45
1317028|NCT00089973|4273569|P1|Overall Study|Withdrawal by Subject|1
1317029|NCT00089973|4273569|P1|Overall Study|Adverse Event|3
1317030|NCT00089895|4273584|P2|Overall Study|Missing|2
1317031|NCT00089895|4273585|P1|Overall Study|Missing|4
1317032|NCT00089895|4273584|P2|Overall Study|Not otherwise specified|8
1317033|NCT00089895|4273585|P1|Overall Study|Not otherwise specified|4
1317034|NCT00089895|4273584|P2|Overall Study|Exclusion criteria met|6
1317035|NCT00089895|4273585|P1|Overall Study|Exclusion criteria met|6
1317036|NCT00089895|4273584|P2|Overall Study|Physician Decision|7
1317037|NCT00089895|4273585|P1|Overall Study|Physician Decision|3
1317038|NCT00089895|4273584|P2|Overall Study|Bleeding|2
1317039|NCT00089895|4273585|P1|Overall Study|Bleeding|0
1317040|NCT00089895|4273584|P2|Overall Study|Surgery|1
1317041|NCT00089895|4273585|P1|Overall Study|Surgery|0
1317042|NCT00089895|4273584|P2|Overall Study|Technical reason|2
1317043|NCT00089895|4273585|P1|Overall Study|Technical reason|7
1317044|NCT00089895|4273584|P2|Overall Study|Consent Withdrawn|14
1317045|NCT00089895|4273585|P1|Overall Study|Consent Withdrawn|11
1317046|NCT00089843|4273597|P4|Overall Study|Physician Decision|1
1317047|NCT00089843|4273598|P3|Overall Study|Physician Decision|0
1317048|NCT00089843|4273599|P2|Overall Study|Physician Decision|0
1317049|NCT00089843|4273600|P1|Overall Study|Physician Decision|1
1317050|NCT00089843|4273597|P4|Overall Study|Withdrawal by Subject|6
1317051|NCT00089843|4273598|P3|Overall Study|Withdrawal by Subject|5
1317052|NCT00089843|4273599|P2|Overall Study|Withdrawal by Subject|4
1317053|NCT00089843|4273600|P1|Overall Study|Withdrawal by Subject|1
1317054|NCT00089791|4273612|P2|Overall Study|Requirement for alternative therapy|4
1317055|NCT00089791|4273613|P1|Overall Study|Requirement for alternative therapy|7
1317056|NCT00089791|4273612|P2|Overall Study|Protocol deviation|10
1317057|NCT00089791|4273613|P1|Overall Study|Protocol deviation|12
1317058|NCT00089791|4273612|P2|Overall Study|Other|32
1317059|NCT00089791|4273613|P1|Overall Study|Other|20
1317060|NCT00089791|4273612|P2|Overall Study|Noncompliance|13
1317061|NCT00089791|4273613|P1|Overall Study|Noncompliance|17
1317062|NCT00089791|4273612|P2|Overall Study|Lost to Follow-up|57
1317063|NCT00089791|4273613|P1|Overall Study|Lost to Follow-up|57
1317064|NCT00089791|4273612|P2|Overall Study|Ineligibility determined|9
1317065|NCT00089791|4273613|P1|Overall Study|Ineligibility determined|12
1317066|NCT00089791|4273612|P2|Overall Study|Disease progression|3
1317067|NCT00089791|4273613|P1|Overall Study|Disease progression|7
1317068|NCT00089791|4273612|P2|Overall Study|Death|62
1317069|NCT00089791|4273613|P1|Overall Study|Death|78
1317070|NCT00089791|4273612|P2|Overall Study|Withdrawal by Subject|344
1317071|NCT00089791|4273613|P1|Overall Study|Withdrawal by Subject|403
1317072|NCT00089791|4273612|P2|Overall Study|Adverse Event|93
1317073|NCT00089791|4273613|P1|Overall Study|Adverse Event|81
1317074|NCT00089791|4273612|P2|Overall Study|Physician Decision|3
1317075|NCT00089791|4273613|P1|Overall Study|Physician Decision|6
1317076|NCT00089778|4273647|P3|Overall Study|Protocol Violation|1
1317077|NCT00089778|4273648|P2|Overall Study|Protocol Violation|0
1317078|NCT00089778|4273649|P1|Overall Study|Protocol Violation|0
1317079|NCT00089674|4273662|P2|Overall Study|Requirement for alternative therapy|4
1317080|NCT00089674|4273663|P1|Overall Study|Requirement for alternative therapy|14
1317081|NCT00089674|4273662|P2|Overall Study|Other|9
1317082|NCT00089674|4273663|P1|Overall Study|Other|5
1317083|NCT00089674|4273662|P2|Overall Study|Noncompliance|3
1317084|NCT00089674|4273663|P1|Overall Study|Noncompliance|7
1317085|NCT00089674|4273662|P2|Overall Study|Lost to Follow-up|17
1317086|NCT00089674|4273663|P1|Overall Study|Lost to Follow-up|21
1317087|NCT00089674|4273662|P2|Overall Study|Ineligibility determined|10
1317088|NCT00089674|4273663|P1|Overall Study|Ineligibility determined|8
1317089|NCT00089674|4273662|P2|Overall Study|Disease progression|23
1317090|NCT00089674|4273663|P1|Overall Study|Disease progression|21
1317091|NCT00089674|4273662|P2|Overall Study|Death|43
1317092|NCT00089674|4273663|P1|Overall Study|Death|43
1317093|NCT00089674|4273662|P2|Overall Study|Withdrawal by Subject|127
1317094|NCT00089674|4273663|P1|Overall Study|Withdrawal by Subject|143
1317095|NCT00089674|4273662|P2|Overall Study|Adverse Event|29
1317096|NCT00089674|4273663|P1|Overall Study|Adverse Event|23
1317097|NCT00089674|4273662|P2|Overall Study|Physician Decision|2
1317098|NCT00089674|4273663|P1|Overall Study|Physician Decision|4
1317099|NCT00089661|4273689|P2|Overall Study|Other|1
1317100|NCT00089661|4273690|P1|Overall Study|Other|2
1317101|NCT00089661|4273689|P2|Overall Study|Noncompliance|4
1317102|NCT00089661|4273690|P1|Overall Study|Noncompliance|2
1317103|NCT00089661|4273689|P2|Overall Study|Ineligibility determined|4
1317104|NCT00089661|4273690|P1|Overall Study|Ineligibility determined|4
1317105|NCT00089661|4273689|P2|Overall Study|Disease progression|3
1317106|NCT00089661|4273690|P1|Overall Study|Disease progression|1
1317107|NCT00089661|4273689|P2|Overall Study|Withdrawal by Subject|9
1317108|NCT00089661|4273690|P1|Overall Study|Withdrawal by Subject|11
1317109|NCT00089661|4273689|P2|Overall Study|Lost to Follow-up|3
1317110|NCT00089661|4273690|P1|Overall Study|Lost to Follow-up|0
1317111|NCT00089661|4273689|P2|Overall Study|Death|0
1317112|NCT00089661|4273690|P1|Overall Study|Death|1
1317113|NCT00089661|4273689|P2|Overall Study|Adverse Event|2
1317114|NCT00089661|4273690|P1|Overall Study|Adverse Event|0
1317115|NCT00089648|4273706|P1|Overall Study|Lack of Efficacy|33
1317116|NCT00089648|4273706|P1|Overall Study|Withdrawal by Subject|1
1317117|NCT00089648|4273706|P1|Overall Study|Adverse Event|7
1317118|NCT00089635|4273722|P1|Overall Study|Not specified|2
1317119|NCT00089635|4273722|P1|Overall Study|Ineligibility determined|1
1317120|NCT00089635|4273722|P1|Overall Study|Withdrawal by Subject|6
1317121|NCT00089635|4273722|P1|Overall Study|Lost to Follow-up|3
1317122|NCT00089635|4273722|P1|Overall Study|Disease Progression|12
1317123|NCT00089635|4273722|P1|Overall Study|Death|17
1317124|NCT00089635|4273722|P1|Overall Study|Adverse Event|2
1317125|NCT00089583|4273736|P2|Overall Study|Participant Incarcerated|1
1317126|NCT00089583|4273737|P1|Overall Study|Participant Incarcerated|0
1317127|NCT00089583|4273736|P2|Overall Study|Necessity to Use Prohibited Drug|0
1317128|NCT00089583|4273737|P1|Overall Study|Necessity to Use Prohibited Drug|1
1317129|NCT00089583|4273736|P2|Overall Study|Start of Disallowed Medication|1
1317130|NCT00089583|4273737|P1|Overall Study|Start of Disallowed Medication|0
1317131|NCT00089583|4273736|P2|Overall Study|Principal Investigator Decision|10
1317132|NCT00089583|4273737|P1|Overall Study|Principal Investigator Decision|0
1317133|NCT00089583|4273736|P2|Overall Study|Protocol Violation|3
1317134|NCT00089583|4273737|P1|Overall Study|Protocol Violation|0
1317135|NCT00089583|4273736|P2|Overall Study|Reason Not Provided|1
1317136|NCT00089583|4273737|P1|Overall Study|Reason Not Provided|0
1317137|NCT00089583|4273736|P2|Overall Study|Participant Management Criteria Met|1
1317138|NCT00089583|4273737|P1|Overall Study|Participant Management Criteria Met|0
1317139|NCT00089583|4273736|P2|Overall Study|Poor Medical Compliance/Adherence Issues|3
1317140|NCT00089583|4273737|P1|Overall Study|Poor Medical Compliance/Adherence Issues|0
1317141|NCT00089583|4273736|P2|Overall Study|Non-Compliance|4
1317142|NCT00089583|4273737|P1|Overall Study|Non-Compliance|0
1317143|NCT00089583|4273736|P2|Overall Study|Participant Refused Study Medication|2
1317144|NCT00089583|4273737|P1|Overall Study|Participant Refused Study Medication|0
1317145|NCT00089583|4273736|P2|Overall Study|Participant (Par) Didn't Take Medication|0
1317146|NCT00089583|4273737|P1|Overall Study|Participant (Par) Didn't Take Medication|1
1317147|NCT00089583|4273736|P2|Overall Study|Withdrawal by Subject|4
1317148|NCT00089583|4273737|P1|Overall Study|Withdrawal by Subject|0
1317149|NCT00089583|4273736|P2|Overall Study|Insufficient Viral Load Response|5
1317150|NCT00089583|4273737|P1|Overall Study|Insufficient Viral Load Response|5
1317151|NCT00089583|4273736|P2|Overall Study|Adverse Event|3
1317152|NCT00089583|4273737|P1|Overall Study|Adverse Event|0
1317153|NCT00089609|4273831|P2|Overall Study|Withdrawal by Subject|1
1317154|NCT00089609|4273832|P1|Overall Study|Withdrawal by Subject|3
1317155|NCT00089544|4273851|P2|Overall Study|Ineligible|0
1317156|NCT00089544|4273852|P1|Overall Study|Ineligible|1
1317157|NCT00089505|4273866|P4|Overall Study|Protocol Violation|0
1317158|NCT00089505|4273867|P3|Overall Study|Protocol Violation|1
1317159|NCT00089505|4273868|P2|Overall Study|Protocol Violation|0
1317160|NCT00089505|4273869|P1|Overall Study|Protocol Violation|0
1317161|NCT00089505|4273866|P4|Overall Study|Physician Decision|0
1317162|NCT00089505|4273867|P3|Overall Study|Physician Decision|0
1317163|NCT00089505|4273868|P2|Overall Study|Physician Decision|0
1317164|NCT00089505|4273869|P1|Overall Study|Physician Decision|1
1317165|NCT00089505|4273866|P4|Overall Study|Lost to Follow-up|7
1317166|NCT00089505|4273867|P3|Overall Study|Lost to Follow-up|9
1317167|NCT00089505|4273868|P2|Overall Study|Lost to Follow-up|1
1317168|NCT00089505|4273869|P1|Overall Study|Lost to Follow-up|1
1317169|NCT00089505|4273866|P4|Overall Study|Withdrawal by Subject|6
1317170|NCT00089505|4273867|P3|Overall Study|Withdrawal by Subject|6
1317171|NCT00089505|4273868|P2|Overall Study|Withdrawal by Subject|0
1317172|NCT00089505|4273869|P1|Overall Study|Withdrawal by Subject|3
1317173|NCT00089505|4273866|P4|Overall Study|Death|8
1317174|NCT00089505|4273867|P3|Overall Study|Death|5
1317175|NCT00089505|4273868|P2|Overall Study|Death|1
1317176|NCT00089505|4273869|P1|Overall Study|Death|4
1317177|NCT00089479|4273913|P2|Overall Study|Lost to Follow-up|107
1317178|NCT00089479|4273914|P1|Overall Study|Lost to Follow-up|137
1317179|NCT00089479|4273913|P2|Overall Study|Withdrawal by Subject|107
1317180|NCT00089479|4273914|P1|Overall Study|Withdrawal by Subject|86
1317181|NCT00089479|4273913|P2|Overall Study|Death|75
1317182|NCT00089479|4273914|P1|Overall Study|Death|108
1317183|NCT00089297|4273957|P1|Overall Study|Non-compliance|1
1317184|NCT00089297|4273957|P1|Overall Study|IRB approval not ready|1
1317185|NCT00089297|4273957|P1|Overall Study|Secondary malignancy|1
1317186|NCT00089297|4273957|P1|Overall Study|Ineligible|11
1317187|NCT00089297|4273957|P1|Overall Study|Disease progression|2
1317188|NCT00089297|4273957|P1|Overall Study|Withdrawal by Subject|12
1317189|NCT00089297|4273957|P1|Overall Study|Death|1
1317190|NCT00089297|4273957|P1|Overall Study|Adverse Event|9
1317191|NCT00089141|4273966|P2|Overall Study|Termination of trial|24
1317192|NCT00089141|4273967|P1|Overall Study|Termination of trial|18
1317193|NCT00089076|4274003|P1|Overall Study|Progression|7
1317194|NCT00089076|4274003|P1|Overall Study|Withdrawal by Subject|2
1317195|NCT00089076|4274003|P1|Overall Study|Alternate Therapy|1
1317196|NCT00088907|4274055|P2|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0
1317197|NCT00088907|4274056|P1|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5
1317198|NCT00088907|4274055|P2|Single Gefitinib Treatment (Step 2)|unknown/not specify|0
1317199|NCT00088907|4274056|P1|Single Gefitinib Treatment (Step 2)|unknown/not specify|2
1317200|NCT00088907|4274055|P2|Single Gefitinib Treatment (Step 2)|Death|0
1317201|NCT00088907|4274056|P1|Single Gefitinib Treatment (Step 2)|Death|1
1317202|NCT00088907|4274055|P2|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0
1317203|NCT00088907|4274056|P1|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16
1317204|NCT00088907|4274055|P2|Randomized Study (Step 1)|ineligible or not start protocol therapy|12
1317205|NCT00088907|4274056|P1|Randomized Study (Step 1)|ineligible or not start protocol therapy|19
1317206|NCT00088907|4274055|P2|Randomized Study (Step 1)|unknown/not specify|13
1317207|NCT00088907|4274056|P1|Randomized Study (Step 1)|unknown/not specify|24
1317208|NCT00088907|4274055|P2|Randomized Study (Step 1)|complicating disease|1
1317209|NCT00088907|4274056|P1|Randomized Study (Step 1)|complicating disease|3
1317210|NCT00088907|4274055|P2|Randomized Study (Step 1)|Withdrawal by Subject|15
1317211|NCT00088907|4274056|P1|Randomized Study (Step 1)|Withdrawal by Subject|10
1317212|NCT00088907|4274055|P2|Randomized Study (Step 1)|Death|12
1317213|NCT00088907|4274056|P1|Randomized Study (Step 1)|Death|11
1317214|NCT00088907|4274055|P2|Randomized Study (Step 1)|Adverse Event|19
1317215|NCT00088907|4274056|P1|Randomized Study (Step 1)|Adverse Event|14
1317216|NCT00088907|4274055|P2|Randomized Study (Step 1)|Lack of Efficacy|62
1317217|NCT00088907|4274056|P1|Randomized Study (Step 1)|Lack of Efficacy|55
1317218|NCT00088881|4274067|P1|Step 2 - Zevalin™ Radioimmunotherapy|Other|3
1317219|NCT00088881|4274067|P1|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8
1317220|NCT00088881|4274067|P1|Step 1 - R-CHOP|Insurance company refused to cover|1
1317221|NCT00088881|4274067|P1|Step 1 - R-CHOP|Physician Decision|1
1317222|NCT00088881|4274067|P1|Step 1 - R-CHOP|Withdrawal by Subject|2
1317223|NCT00088881|4274067|P1|Step 1 - R-CHOP|Adverse Event|1
1317224|NCT00088881|4274067|P1|Step 1 - R-CHOP|Patient ineligible|9
1317225|NCT00088829|4274076|P1|Overall Study|PI left institution and study was close|22
1317226|NCT00088595|4274118|P1|Overall Study|New Cancer Therapy|2
1317227|NCT00088595|4274118|P1|Overall Study|Ongoing (After Core)|7
1317228|NCT00088595|4274118|P1|Overall Study|Withdrawal by Subject|8
1317229|NCT00088595|4274118|P1|Overall Study|Adverse Event|11
1317230|NCT00088530|4274136|P2|Overall Study|Patient never treated|0
1317231|NCT00088530|4274137|P1|Overall Study|Patient never treated|1
1317232|NCT00088530|4274136|P2|Overall Study|Sponsor decision|1
1317233|NCT00088530|4274137|P1|Overall Study|Sponsor decision|0
1317234|NCT00088530|4274136|P2|Overall Study|Physician Decision|0
1317235|NCT00088530|4274137|P1|Overall Study|Physician Decision|2
1317236|NCT00088530|4274136|P2|Overall Study|Lost to Follow-up|0
1317237|NCT00088530|4274137|P1|Overall Study|Lost to Follow-up|2
1317238|NCT00088530|4274136|P2|Overall Study|Withdrawal by Subject|5
1317239|NCT00088530|4274137|P1|Overall Study|Withdrawal by Subject|2
1317240|NCT00088530|4274136|P2|Overall Study|Adverse Event|9
1317241|NCT00088530|4274137|P1|Overall Study|Adverse Event|15
1317242|NCT00088530|4274136|P2|Overall Study|Progressive/Relapsed Disease|39
1317243|NCT00088530|4274137|P1|Overall Study|Progressive/Relapsed Disease|28
1317244|NCT00088465|4274149|P1|Overall Study|Death|11
1317245|NCT00088465|4274149|P1|Overall Study|Protocol Violation|17
1317246|NCT00088465|4274149|P1|Overall Study|Lack of Efficacy|27
1317247|NCT00088465|4274149|P1|Overall Study|Sponsor Decision|37
1317248|NCT00088465|4274149|P1|Overall Study|Physician Decision|45
1317249|NCT00088465|4274149|P1|Overall Study|Lost to Follow-up|57
1317250|NCT00088465|4274149|P1|Overall Study|Adverse Event|77
1317251|NCT00088465|4274149|P1|Overall Study|Withdrawal by Subject|290
1317252|NCT00088374|4274172|P1|Overall Study|patient received <1 cycle only of 17AAG|1
1317253|NCT00088374|4274172|P1|Overall Study|patient did not receive any 17AAG|1
1317254|NCT00088166|4274192|P2|Overall Study|Withdrawal by Subject|5
1317255|NCT00088166|4274193|P1|Overall Study|Withdrawal by Subject|5
1317256|NCT00088166|4274192|P2|Overall Study|Patient deterioration|39
1317257|NCT00088166|4274193|P1|Overall Study|Patient deterioration|29
1317258|NCT00088166|4274192|P2|Overall Study|Protocol Violation|5
1317259|NCT00088166|4274193|P1|Overall Study|Protocol Violation|1
1317260|NCT00088166|4274192|P2|Overall Study|Physician Decision|1
1317261|NCT00088166|4274193|P1|Overall Study|Physician Decision|4
1317262|NCT00088166|4274192|P2|Overall Study|Lost to Follow-up|1
1317263|NCT00088166|4274193|P1|Overall Study|Lost to Follow-up|0
1317264|NCT00088166|4274192|P2|Overall Study|Death|1
1317265|NCT00088166|4274193|P1|Overall Study|Death|3
1317266|NCT00088166|4274192|P2|Overall Study|Adverse Event|9
1317267|NCT00088166|4274193|P1|Overall Study|Adverse Event|11
1317268|NCT00088153|4274217|P2|Overall Study|Lost to Follow-up|12
1317269|NCT00088153|4274218|P1|Overall Study|Lost to Follow-up|11
1317270|NCT00088153|4274217|P2|Overall Study|Withdrawal by Subject|10
1317271|NCT00088153|4274218|P1|Overall Study|Withdrawal by Subject|10
1317272|NCT00088153|4274217|P2|Overall Study|Physician Decision|3
1317273|NCT00088153|4274218|P1|Overall Study|Physician Decision|3
1317274|NCT00087698|4274228|P1|Overall Study|Protocol Violation|1
1317275|NCT00087698|4274228|P1|Overall Study|Death from Study Drug Toxicity|2
1317276|NCT00087698|4274228|P1|Overall Study|Death from Study Disease|2
1317277|NCT00087698|4274228|P1|Overall Study|Clinical Relapse|1
1317278|NCT00087698|4274228|P1|Overall Study|Protocol Entry Criteria Not Met|2
1317279|NCT00087698|4274228|P1|Overall Study|Lack of Efficacy, Physician Perception|3
1317280|NCT00087698|4274228|P1|Overall Study|Withdrawal by Subject|4
1317281|NCT00087698|4274228|P1|Overall Study|Adverse Event|4
1317282|NCT00087698|4274228|P1|Overall Study|Death from Other Causes|3
1317283|NCT00087698|4274228|P1|Overall Study|Lack of Efficacy, Progressive Disease|14
1317284|NCT00087685|4274237|P1|Overall Study|Withdrawal by Subject|3
1317285|NCT00087685|4274237|P1|Overall Study|Progressive Disease|5
1317286|NCT00087685|4274237|P1|Overall Study|Non-Compliance|1
1317287|NCT00087685|4274237|P1|Overall Study|Adverse Event|5
1317288|NCT00087646|4274250|P4|Overall Study|Violation of Selection Criteria at Entry|1
1317289|NCT00087646|4274251|P3|Overall Study|Violation of Selection Criteria at Entry|0
1317290|NCT00087646|4274252|P2|Overall Study|Violation of Selection Criteria at Entry|0
1317291|NCT00087646|4274253|P1|Overall Study|Violation of Selection Criteria at Entry|1
1317292|NCT00087646|4274250|P4|Overall Study|Other Protocol Violation|0
1317293|NCT00087646|4274251|P3|Overall Study|Other Protocol Violation|0
1317294|NCT00087646|4274252|P2|Overall Study|Other Protocol Violation|1
1317295|NCT00087646|4274253|P1|Overall Study|Other Protocol Violation|3
1317296|NCT00087646|4274250|P4|Overall Study|Administrative/Other|2
1317297|NCT00087646|4274251|P3|Overall Study|Administrative/Other|1
1317298|NCT00087646|4274252|P2|Overall Study|Administrative/Other|1
1317299|NCT00087646|4274253|P1|Overall Study|Administrative/Other|6
1317300|NCT00087646|4274250|P4|Overall Study|Failure to Return|3
1317301|NCT00087646|4274251|P3|Overall Study|Failure to Return|2
1317302|NCT00087646|4274252|P2|Overall Study|Failure to Return|2
1317303|NCT00087646|4274253|P1|Overall Study|Failure to Return|5
1317304|NCT00087646|4274250|P4|Overall Study|Refused Treatment/Did Not Cooperate|5
1317305|NCT00087646|4274251|P3|Overall Study|Refused Treatment/Did Not Cooperate|4
1317306|NCT00087646|4274252|P2|Overall Study|Refused Treatment/Did Not Cooperate|6
1317307|NCT00087646|4274253|P1|Overall Study|Refused Treatment/Did Not Cooperate|13
1317308|NCT00087646|4274250|P4|Overall Study|Insufficient therapeutic response|51
1317309|NCT00087646|4274251|P3|Overall Study|Insufficient therapeutic response|38
1317310|NCT00087646|4274252|P2|Overall Study|Insufficient therapeutic response|24
1317311|NCT00087646|4274253|P1|Overall Study|Insufficient therapeutic response|64
1317312|NCT00087646|4274250|P4|Overall Study|Withdrawal by Subject|2
1317313|NCT00087646|4274251|P3|Overall Study|Withdrawal by Subject|2
1317314|NCT00087646|4274252|P2|Overall Study|Withdrawal by Subject|1
1317315|NCT00087646|4274253|P1|Overall Study|Withdrawal by Subject|6
1317316|NCT00087646|4274250|P4|Overall Study|Death|0
1317317|NCT00087646|4274251|P3|Overall Study|Death|0
1317318|NCT00087646|4274252|P2|Overall Study|Death|1
1317319|NCT00087646|4274253|P1|Overall Study|Death|0
1317320|NCT00087646|4274250|P4|Overall Study|Adverse Event|20
1317321|NCT00087646|4274251|P3|Overall Study|Adverse Event|18
1317322|NCT00087646|4274252|P2|Overall Study|Adverse Event|6
1317323|NCT00087646|4274253|P1|Overall Study|Adverse Event|37
1317324|NCT00087607|4274292|P2|Overall Study|Violation of Selection Criteria at Entry|1
1317325|NCT00087607|4274293|P1|Overall Study|Violation of Selection Criteria at Entry|0
1317326|NCT00087607|4274292|P2|Overall Study|Other Protocol Violation|2
1317327|NCT00087607|4274293|P1|Overall Study|Other Protocol Violation|5
1317328|NCT00087607|4274292|P2|Overall Study|Refused Treatment|7
1317329|NCT00087607|4274293|P1|Overall Study|Refused Treatment|5
1317330|NCT00087607|4274292|P2|Overall Study|Administrative|12
1317331|NCT00087607|4274293|P1|Overall Study|Administrative|12
1317332|NCT00087607|4274292|P2|Overall Study|Withdrew Consent|16
1317333|NCT00087607|4274293|P1|Overall Study|Withdrew Consent|12
1317334|NCT00087607|4274292|P2|Overall Study|Failure to return|17
1317335|NCT00087607|4274293|P1|Overall Study|Failure to return|21
1317336|NCT00087607|4274292|P2|Overall Study|Insufficient Therapeutic Response|42
1317337|NCT00087607|4274293|P1|Overall Study|Insufficient Therapeutic Response|53
1317338|NCT00087607|4274292|P2|Overall Study|Death|1
1317339|NCT00087607|4274293|P1|Overall Study|Death|0
1317340|NCT00087607|4274292|P2|Overall Study|Adverse Event|24
1317341|NCT00087607|4274293|P1|Overall Study|Adverse Event|14
1317342|NCT00087594|4274333|P2|Overall Study|Lack of Efficacy|5
1317343|NCT00087594|4274334|P1|Overall Study|Lack of Efficacy|2
1317344|NCT00087594|4274333|P2|Overall Study|Withdrawal by Subject|2
1317345|NCT00087594|4274334|P1|Overall Study|Withdrawal by Subject|4
1317346|NCT00087594|4274333|P2|Overall Study|Lost to Follow-up|2
1317347|NCT00087594|4274334|P1|Overall Study|Lost to Follow-up|0
1317348|NCT00087594|4274333|P2|Overall Study|Adverse Event|3
1317349|NCT00087594|4274334|P1|Overall Study|Adverse Event|2
1317350|NCT00087568|4274368|P2|Overall Study|Lack of Efficacy|1
1317351|NCT00087568|4274369|P1|Overall Study|Lack of Efficacy|24
1317352|NCT00087568|4274368|P2|Overall Study|Lost to Follow-up|0
1317353|NCT00087568|4274369|P1|Overall Study|Lost to Follow-up|1
1317354|NCT00087568|4274368|P2|Overall Study|Withdrawal by Subject|1
1317355|NCT00087568|4274369|P1|Overall Study|Withdrawal by Subject|1
1317356|NCT00087568|4274368|P2|Overall Study|Adverse Event|0
1317357|NCT00087568|4274369|P1|Overall Study|Adverse Event|4
1317358|NCT00087555|4274396|P3|Overall Study|Patient wanted to go back on Med|0
1317359|NCT00087555|4274397|P2|Overall Study|Patient wanted to go back on Med|0
1317360|NCT00087555|4274398|P1|Overall Study|Patient wanted to go back on Med|1
1317361|NCT00087555|4274396|P3|Overall Study|Chronic Migraine Headaches (Med History)|0
1317362|NCT00087555|4274397|P2|Overall Study|Chronic Migraine Headaches (Med History)|0
1317363|NCT00087555|4274398|P1|Overall Study|Chronic Migraine Headaches (Med History)|1
1317364|NCT00087555|4274396|P3|Overall Study|Non Compliance|1
1317365|NCT00087555|4274397|P2|Overall Study|Non Compliance|0
1317366|NCT00087555|4274398|P1|Overall Study|Non Compliance|0
1317367|NCT00087555|4274396|P3|Overall Study|Lack of Efficacy|1
1317368|NCT00087555|4274397|P2|Overall Study|Lack of Efficacy|0
1317369|NCT00087555|4274398|P1|Overall Study|Lack of Efficacy|2
1317370|NCT00087555|4274396|P3|Overall Study|Withdrawal by Subject|1
1317371|NCT00087555|4274397|P2|Overall Study|Withdrawal by Subject|2
1317372|NCT00087555|4274398|P1|Overall Study|Withdrawal by Subject|3
1317373|NCT00087555|4274396|P3|Overall Study|Pregnancy|1
1317374|NCT00087555|4274397|P2|Overall Study|Pregnancy|1
1317375|NCT00087555|4274398|P1|Overall Study|Pregnancy|0
1317376|NCT00087555|4274396|P3|Overall Study|Screen Failure|0
1317377|NCT00087555|4274397|P2|Overall Study|Screen Failure|1
1317378|NCT00087555|4274398|P1|Overall Study|Screen Failure|1
1317379|NCT00087555|4274396|P3|Overall Study|Protocol Violation|2
1317380|NCT00087555|4274397|P2|Overall Study|Protocol Violation|0
1317381|NCT00087555|4274398|P1|Overall Study|Protocol Violation|0
1317382|NCT00087555|4274396|P3|Overall Study|Non - Compliance|0
1317383|NCT00087555|4274397|P2|Overall Study|Non - Compliance|0
1317384|NCT00087555|4274398|P1|Overall Study|Non - Compliance|1
1317385|NCT00087555|4274396|P3|Overall Study|Lost to Follow-up|1
1317386|NCT00087555|4274397|P2|Overall Study|Lost to Follow-up|1
1317387|NCT00087555|4274398|P1|Overall Study|Lost to Follow-up|0
1317388|NCT00087555|4274396|P3|Overall Study|Adverse Event|14
1317389|NCT00087555|4274397|P2|Overall Study|Adverse Event|6
1317390|NCT00087555|4274398|P1|Overall Study|Adverse Event|3
1317391|NCT00087529|4274408|P2|Overall Study|Did Not Continue to Safety Follow-Up|5
1317392|NCT00087529|4274409|P1|Overall Study|Did Not Continue to Safety Follow-Up|5
1317393|NCT00087529|4274408|P2|Overall Study|Disease Progression|4
1317394|NCT00087529|4274409|P1|Overall Study|Disease Progression|5
1317395|NCT00087529|4274408|P2|Overall Study|Participant Noncompliance|1
1317396|NCT00087529|4274409|P1|Overall Study|Participant Noncompliance|0
1317397|NCT00087529|4274408|P2|Overall Study|Initiation of Excluded Therapy|1
1317398|NCT00087529|4274409|P1|Overall Study|Initiation of Excluded Therapy|0
1317399|NCT00087529|4274408|P2|Overall Study|Physician Decision|8
1317400|NCT00087529|4274409|P1|Overall Study|Physician Decision|4
1317401|NCT00087529|4274408|P2|Overall Study|Participant Decision|37
1317402|NCT00087529|4274409|P1|Overall Study|Participant Decision|14
1317403|NCT00087529|4274408|P2|Overall Study|Lost to Follow-up|3
1317404|NCT00087529|4274409|P1|Overall Study|Lost to Follow-up|2
1317405|NCT00087529|4274408|P2|Overall Study|Pregnancy|1
1317406|NCT00087529|4274409|P1|Overall Study|Pregnancy|0
1317407|NCT00087529|4274408|P2|Overall Study|Adverse Event|8
1317408|NCT00087529|4274409|P1|Overall Study|Adverse Event|0
1317409|NCT00087529|4274408|P2|Overall Study|Death|0
1317410|NCT00087529|4274409|P1|Overall Study|Death|1
1317411|NCT00087516|4274424|P4|Overall Study|Other|0
1317412|NCT00087516|4274425|P3|Overall Study|Other|1
1317413|NCT00087516|4274426|P2|Overall Study|Other|0
1317414|NCT00087516|4274427|P1|Overall Study|Other|0
1317415|NCT00087516|4274424|P4|Overall Study|Recommendation of Primary Care Physician|1
1317416|NCT00087516|4274425|P3|Overall Study|Recommendation of Primary Care Physician|0
1317417|NCT00087516|4274426|P2|Overall Study|Recommendation of Primary Care Physician|0
1317418|NCT00087516|4274427|P1|Overall Study|Recommendation of Primary Care Physician|0
1317419|NCT00087516|4274424|P4|Overall Study|Patient was non-compliant|0
1317420|NCT00087516|4274425|P3|Overall Study|Patient was non-compliant|0
1317421|NCT00087516|4274426|P2|Overall Study|Patient was non-compliant|1
1317422|NCT00087516|4274427|P1|Overall Study|Patient was non-compliant|3
1317423|NCT00087516|4274424|P4|Overall Study|Patient moved|0
1317424|NCT00087516|4274425|P3|Overall Study|Patient moved|1
1317425|NCT00087516|4274426|P2|Overall Study|Patient moved|2
1317426|NCT00087516|4274427|P1|Overall Study|Patient moved|3
1317427|NCT00087516|4274424|P4|Overall Study|Protocol specified discontinuation|26
1317428|NCT00087516|4274425|P3|Overall Study|Protocol specified discontinuation|33
1317429|NCT00087516|4274426|P2|Overall Study|Protocol specified discontinuation|33
1317430|NCT00087516|4274427|P1|Overall Study|Protocol specified discontinuation|35
1317431|NCT00087516|4274424|P4|Overall Study|Site terminated|0
1317432|NCT00087516|4274425|P3|Overall Study|Site terminated|1
1317433|NCT00087516|4274426|P2|Overall Study|Site terminated|2
1317434|NCT00087516|4274427|P1|Overall Study|Site terminated|0
1317435|NCT00087516|4274424|P4|Overall Study|Withdrawal by Subject|12
1317436|NCT00087516|4274425|P3|Overall Study|Withdrawal by Subject|11
1317437|NCT00087516|4274426|P2|Overall Study|Withdrawal by Subject|27
1317438|NCT00087516|4274427|P1|Overall Study|Withdrawal by Subject|16
1317439|NCT00087516|4274424|P4|Overall Study|Protocol Violation|6
1317440|NCT00087516|4274425|P3|Overall Study|Protocol Violation|3
1317441|NCT00087516|4274426|P2|Overall Study|Protocol Violation|8
1317442|NCT00087516|4274427|P1|Overall Study|Protocol Violation|4
1317443|NCT00087516|4274424|P4|Overall Study|Lost to Follow-up|5
1317444|NCT00087516|4274425|P3|Overall Study|Lost to Follow-up|5
1317445|NCT00087516|4274426|P2|Overall Study|Lost to Follow-up|6
1317446|NCT00087516|4274427|P1|Overall Study|Lost to Follow-up|8
1317447|NCT00087516|4274424|P4|Overall Study|Lack of Efficacy|29
1317448|NCT00087516|4274425|P3|Overall Study|Lack of Efficacy|39
1317449|NCT00087516|4274426|P2|Overall Study|Lack of Efficacy|80
1317450|NCT00087516|4274427|P1|Overall Study|Lack of Efficacy|82
1317451|NCT00087516|4274424|P4|Overall Study|Adverse Event|6
1317452|NCT00087516|4274425|P3|Overall Study|Adverse Event|3
1317453|NCT00087516|4274426|P2|Overall Study|Adverse Event|10
1317454|NCT00087516|4274427|P1|Overall Study|Adverse Event|10
1317455|NCT00087490|4274456|P2|Overall Study|Randomized but not treated|18
1317456|NCT00087490|4274457|P1|Overall Study|Randomized but not treated|7
1317457|NCT00087490|4274456|P2|Overall Study|Lost to Follow-Up/participant withdrawal|36
1317458|NCT00087490|4274457|P1|Overall Study|Lost to Follow-Up/participant withdrawal|28
1317459|NCT00087490|4274456|P2|Overall Study|Protocol Violation or (/) Unspecified|201
1317460|NCT00087490|4274457|P1|Overall Study|Protocol Violation or (/) Unspecified|214
1317461|NCT00087490|4274456|P2|Overall Study|Lack of Efficacy|2
1317462|NCT00087490|4274457|P1|Overall Study|Lack of Efficacy|0
1317463|NCT00087490|4274456|P2|Overall Study|Adverse Event|8
1317464|NCT00087490|4274457|P1|Overall Study|Adverse Event|3
1317465|NCT00087490|4274456|P2|Overall Study|Death|4
1317466|NCT00087490|4274457|P1|Overall Study|Death|6
1317467|NCT00087438|4274491|P1|Overall Study|Ineligible / No protocol treatment|4
1317468|NCT00087152|4274495|P1|Overall Study|Ineligible|6
1317469|NCT00087139|4274504|P3|Overall Study|Extradural disease|1
1317470|NCT00087139|4274505|P2|Overall Study|Extradural disease|0
1317471|NCT00087139|4274506|P1|Overall Study|Extradural disease|0
1317472|NCT00087139|4274504|P3|Overall Study|Response achieved|0
1317473|NCT00087139|4274505|P2|Overall Study|Response achieved|1
1317474|NCT00087139|4274506|P1|Overall Study|Response achieved|0
1317475|NCT00087139|4274504|P3|Overall Study|Use of coumadin|0
1317476|NCT00087139|4274505|P2|Overall Study|Use of coumadin|0
1317477|NCT00087139|4274506|P1|Overall Study|Use of coumadin|1
1317478|NCT00087139|4274504|P3|Overall Study|Symptomatic deterioration|3
1317479|NCT00087139|4274505|P2|Overall Study|Symptomatic deterioration|1
1317480|NCT00087139|4274506|P1|Overall Study|Symptomatic deterioration|1
1317481|NCT00087139|4274504|P3|Overall Study|Ineligible|4
1317482|NCT00087139|4274505|P2|Overall Study|Ineligible|7
1317483|NCT00087139|4274506|P1|Overall Study|Ineligible|4
1317484|NCT00087139|4274504|P3|Overall Study|Disease progression|12
1317485|NCT00087139|4274505|P2|Overall Study|Disease progression|19
1317486|NCT00087139|4274506|P1|Overall Study|Disease progression|9
1317487|NCT00087139|4274504|P3|Overall Study|Physician Decision|1
1317488|NCT00087139|4274505|P2|Overall Study|Physician Decision|1
1317489|NCT00087139|4274506|P1|Overall Study|Physician Decision|1
1317490|NCT00087139|4274504|P3|Overall Study|Withdrawal by Subject|2
1317491|NCT00087139|4274505|P2|Overall Study|Withdrawal by Subject|2
1317492|NCT00087139|4274506|P1|Overall Study|Withdrawal by Subject|3
1317493|NCT00087139|4274504|P3|Overall Study|Death|0
1317494|NCT00087139|4274505|P2|Overall Study|Death|1
1317495|NCT00087139|4274506|P1|Overall Study|Death|2
1317496|NCT00087139|4274504|P3|Overall Study|Adverse Event|13
1317497|NCT00087139|4274505|P2|Overall Study|Adverse Event|17
1317498|NCT00087139|4274506|P1|Overall Study|Adverse Event|18
1317499|NCT00086996|4274537|P1|Overall Study|not eligible|5
1317500|NCT00086996|4274537|P1|Overall Study|not specified|6
1317501|NCT00086996|4274537|P1|Overall Study|Withdrawal by Subject|13
1317502|NCT00086996|4274537|P1|Overall Study|progression/relapse|7
1317503|NCT00086996|4274537|P1|Overall Study|Death|4
1317504|NCT00086996|4274537|P1|Overall Study|Adverse Event|29
1317505|NCT00086684|4274559|P3|Overall Study|Not specified|3
1317506|NCT00086684|4274560|P2|Overall Study|Not specified|2
1317507|NCT00086684|4274561|P1|Overall Study|Not specified|4
1317508|NCT00086684|4274559|P3|Overall Study|WITHDRAWAL OF CONSENT|5
1317509|NCT00086684|4274560|P2|Overall Study|WITHDRAWAL OF CONSENT|7
1317510|NCT00086684|4274561|P1|Overall Study|WITHDRAWAL OF CONSENT|5
1317511|NCT00086684|4274559|P3|Overall Study|STUDY TERMINATED BY SPONSOR|0
1317512|NCT00086684|4274560|P2|Overall Study|STUDY TERMINATED BY SPONSOR|1
1317513|NCT00086684|4274561|P1|Overall Study|STUDY TERMINATED BY SPONSOR|0
1317514|NCT00086684|4274559|P3|Overall Study|NONCOMPLIANCE|6
1317515|NCT00086684|4274560|P2|Overall Study|NONCOMPLIANCE|7
1317516|NCT00086684|4274561|P1|Overall Study|NONCOMPLIANCE|5
1317517|NCT00086684|4274559|P3|Overall Study|Withdrawal by Subject|10
1317518|NCT00086684|4274560|P2|Overall Study|Withdrawal by Subject|4
1317519|NCT00086684|4274561|P1|Overall Study|Withdrawal by Subject|0
1317520|NCT00086684|4274559|P3|Overall Study|Protocol Violation|0
1317521|NCT00086684|4274560|P2|Overall Study|Protocol Violation|3
1317522|NCT00086684|4274561|P1|Overall Study|Protocol Violation|8
1317523|NCT00086684|4274559|P3|Overall Study|Lost to Follow-up|10
1317524|NCT00086684|4274560|P2|Overall Study|Lost to Follow-up|8
1317525|NCT00086684|4274561|P1|Overall Study|Lost to Follow-up|15
1317526|NCT00086684|4274559|P3|Overall Study|Lack of Efficacy|5
1317527|NCT00086684|4274560|P2|Overall Study|Lack of Efficacy|6
1317528|NCT00086684|4274561|P1|Overall Study|Lack of Efficacy|6
1317529|NCT00086684|4274559|P3|Overall Study|Adverse Event|14
1317530|NCT00086684|4274560|P2|Overall Study|Adverse Event|17
1317531|NCT00086684|4274561|P1|Overall Study|Adverse Event|12
1317532|NCT00086619|4274574|P2|Overall Study|Protocol Violation|1
1317533|NCT00086619|4274575|P1|Overall Study|Protocol Violation|1
1317534|NCT00086619|4274574|P2|Overall Study|Adverse Event|10
1317535|NCT00086619|4274575|P1|Overall Study|Adverse Event|8
1317536|NCT00086619|4274574|P2|Overall Study|Withdrawal by Subject|6
1317537|NCT00086619|4274575|P1|Overall Study|Withdrawal by Subject|6
1317538|NCT00086580|4274585|P2|Observation Period|Not specified|7
1317539|NCT00086580|4274586|P1|Observation Period|Not specified|8
1317540|NCT00086580|4274585|P2|Observation Period|Death|55
1317541|NCT00086580|4274586|P1|Observation Period|Death|33
1317542|NCT00086580|4274585|P2|Observation Period|Withdrawal by Subject|2
1317543|NCT00086580|4274586|P1|Observation Period|Withdrawal by Subject|4
1317544|NCT00086580|4274585|P2|Observation Period|Unable to comply with protocol|1
1317545|NCT00086580|4274586|P1|Observation Period|Unable to comply with protocol|1
1317546|NCT00086580|4274585|P2|Follow-up Period|Not specified|6
1317547|NCT00086580|4274586|P1|Follow-up Period|Not specified|7
1317548|NCT00086580|4274585|P2|Follow-up Period|Death|7
1317549|NCT00086580|4274586|P1|Follow-up Period|Death|13
1317550|NCT00086580|4274585|P2|Follow-up Period|AE - not related|0
1317551|NCT00086580|4274586|P1|Follow-up Period|AE - not related|1
1317552|NCT00086580|4274585|P2|Follow-up Period|Physician Decision|1
1317553|NCT00086580|4274586|P1|Follow-up Period|Physician Decision|0
1317554|NCT00086580|4274585|P2|Follow-up Period|Withdrawal by Subject|6
1317555|NCT00086580|4274586|P1|Follow-up Period|Withdrawal by Subject|6
1317556|NCT00086580|4274585|P2|Follow-up Period|Unable to comply with protocol|0
1317557|NCT00086580|4274586|P1|Follow-up Period|Unable to comply with protocol|5
1317558|NCT00086580|4274585|P2|Follow-up Period|Disease progression|99
1317559|NCT00086580|4274586|P1|Follow-up Period|Disease progression|72
1317560|NCT00086580|4274585|P2|Treatment Period|Not specified|3
1317561|NCT00086580|4274586|P1|Treatment Period|Not specified|5
1317562|NCT00086580|4274585|P2|Treatment Period|Death|7
1317563|NCT00086580|4274586|P1|Treatment Period|Death|5
1317564|NCT00086580|4274585|P2|Treatment Period|Anemia or thrombocytopenia|4
1317565|NCT00086580|4274586|P1|Treatment Period|Anemia or thrombocytopenia|1
1317566|NCT00086580|4274585|P2|Treatment Period|Toxicity - treatment related|15
1317567|NCT00086580|4274586|P1|Treatment Period|Toxicity - treatment related|15
1317568|NCT00086580|4274585|P2|Treatment Period|AE - not treatment related|7
1317569|NCT00086580|4274586|P1|Treatment Period|AE - not treatment related|7
1317570|NCT00086580|4274585|P2|Treatment Period|Physician Decision|7
1317571|NCT00086580|4274586|P1|Treatment Period|Physician Decision|13
1317572|NCT00086580|4274585|P2|Treatment Period|Withdrawal by Subject|8
1317573|NCT00086580|4274586|P1|Treatment Period|Withdrawal by Subject|7
1317574|NCT00086580|4274585|P2|Treatment Period|Unable to comply with protocol|1
1317575|NCT00086580|4274586|P1|Treatment Period|Unable to comply with protocol|3
1317576|NCT00086580|4274585|P2|Treatment Period|Disease progression|8
1317577|NCT00086580|4274586|P1|Treatment Period|Disease progression|9
1317578|NCT00086411|4274634|P4|Overall Study|Lost to Follow-up|12
1317579|NCT00086411|4274635|P3|Overall Study|Lost to Follow-up|13
1317580|NCT00086411|4274636|P2|Overall Study|Lost to Follow-up|11
1317581|NCT00086411|4274637|P1|Overall Study|Lost to Follow-up|11
1317582|NCT00086385|4274651|P4|Overall Study|Death|1
1317583|NCT00086385|4274652|P3|Overall Study|Death|1
1317584|NCT00086385|4274653|P2|Overall Study|Death|2
1317585|NCT00086385|4274654|P1|Overall Study|Death|2
1317586|NCT00086515|4274666|P2|Phase B (Weeks 24-104)|Discontinued in error|0
1317587|NCT00086515|4274667|P1|Phase B (Weeks 24-104)|Discontinued in error|1
1317588|NCT00086515|4274666|P2|Phase B (Weeks 24-104)|Personal Circumstance|0
1317589|NCT00086515|4274667|P1|Phase B (Weeks 24-104)|Personal Circumstance|1
1317590|NCT00086515|4274666|P2|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1
1317591|NCT00086515|4274667|P1|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0
1317592|NCT00086515|4274666|P2|Phase B (Weeks 24-104)|Patient Died|1
1317593|NCT00086515|4274667|P1|Phase B (Weeks 24-104)|Patient Died|3
1317594|NCT00086515|4274666|P2|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10
1317595|NCT00086515|4274667|P1|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36
1317596|NCT00086515|4274666|P2|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3
1317597|NCT00086515|4274667|P1|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5
1317598|NCT00086515|4274666|P2|Phase B (Weeks 24-104)|Patient Moved|2
1317599|NCT00086515|4274667|P1|Phase B (Weeks 24-104)|Patient Moved|2
1317600|NCT00086515|4274666|P2|Phase B (Weeks 24-104)|Withdrawal by Subject|5
1317601|NCT00086515|4274667|P1|Phase B (Weeks 24-104)|Withdrawal by Subject|15
1317602|NCT00086515|4274666|P2|Phase B (Weeks 24-104)|Protocol Violation|0
1317603|NCT00086515|4274667|P1|Phase B (Weeks 24-104)|Protocol Violation|1
1317604|NCT00086515|4274666|P2|Phase B (Weeks 24-104)|Physician Decision|0
1317605|NCT00086515|4274667|P1|Phase B (Weeks 24-104)|Physician Decision|3
1317606|NCT00086515|4274666|P2|Phase B (Weeks 24-104)|Lost to Follow-up|4
1317607|NCT00086515|4274667|P1|Phase B (Weeks 24-104)|Lost to Follow-up|13
1317608|NCT00086515|4274666|P2|Phase B (Weeks 24-104)|Lack of Efficacy|19
1317609|NCT00086515|4274667|P1|Phase B (Weeks 24-104)|Lack of Efficacy|94
1317610|NCT00086515|4274666|P2|Phase B (Weeks 24-104)|Adverse Event|10
1317611|NCT00086515|4274667|P1|Phase B (Weeks 24-104)|Adverse Event|16
1317612|NCT00086515|4274666|P2|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0
1317613|NCT00086515|4274667|P1|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1
1317614|NCT00086515|4274666|P2|Phase A to Phase B Transition Period|Poor compliance|0
1317615|NCT00086515|4274667|P1|Phase A to Phase B Transition Period|Poor compliance|1
1317616|NCT00086515|4274666|P2|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
1317617|NCT00086515|4274667|P1|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
1317618|NCT00086515|4274666|P2|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23
1317619|NCT00086515|4274667|P1|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16
1317620|NCT00086515|4274666|P2|Phase A to Phase B Transition Period|Protocol Violation|1
1317621|NCT00086515|4274667|P1|Phase A to Phase B Transition Period|Protocol Violation|0
1317622|NCT00086515|4274666|P2|Phase A to Phase B Transition Period|Withdrawal by Subject|0
1317623|NCT00086515|4274667|P1|Phase A to Phase B Transition Period|Withdrawal by Subject|1
1317624|NCT00086515|4274666|P2|Phase A to Phase B Transition Period|Lack of Efficacy|2
1317625|NCT00086515|4274667|P1|Phase A to Phase B Transition Period|Lack of Efficacy|2
1317626|NCT00086515|4274666|P2|Phase A to Phase B Transition Period|Adverse Event|1
1317627|NCT00086515|4274667|P1|Phase A to Phase B Transition Period|Adverse Event|2
1317628|NCT00086515|4274666|P2|Phase A (Weeks 0-24)|Personal Circumstance|0
1317629|NCT00086515|4274667|P1|Phase A (Weeks 0-24)|Personal Circumstance|1
1317630|NCT00086515|4274666|P2|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1
1317631|NCT00086515|4274667|P1|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0
1317632|NCT00086515|4274666|P2|Phase A (Weeks 0-24)|Poor compliance|0
1317633|NCT00086515|4274667|P1|Phase A (Weeks 0-24)|Poor compliance|1
1317634|NCT00086515|4274666|P2|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3
1317635|NCT00086515|4274667|P1|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4
1317636|NCT00086515|4274666|P2|Phase A (Weeks 0-24)|Patient Moved|3
1317637|NCT00086515|4274667|P1|Phase A (Weeks 0-24)|Patient Moved|2
1317638|NCT00086515|4274666|P2|Phase A (Weeks 0-24)|Withdrawal by Subject|10
1317639|NCT00086515|4274667|P1|Phase A (Weeks 0-24)|Withdrawal by Subject|10
1317640|NCT00086515|4274666|P2|Phase A (Weeks 0-24)|Protocol Violation|1
1317641|NCT00086515|4274667|P1|Phase A (Weeks 0-24)|Protocol Violation|3
1317642|NCT00086515|4274666|P2|Phase A (Weeks 0-24)|Lost to Follow-up|5
1317643|NCT00086515|4274667|P1|Phase A (Weeks 0-24)|Lost to Follow-up|4
1317644|NCT00086515|4274666|P2|Phase A (Weeks 0-24)|Lack of Efficacy|13
1317645|NCT00086515|4274667|P1|Phase A (Weeks 0-24)|Lack of Efficacy|7
1317646|NCT00086515|4274666|P2|Phase A (Weeks 0-24)|Adverse Event|9
1317647|NCT00086515|4274667|P1|Phase A (Weeks 0-24)|Adverse Event|17
1317648|NCT00086502|4274679|P2|Overall Study|Patient Accidentally Unblinded|0
1317649|NCT00086502|4274680|P1|Overall Study|Patient Accidentally Unblinded|1
1317650|NCT00086502|4274679|P2|Overall Study|Protocol Discontinuation Criteria|3
1317651|NCT00086502|4274680|P1|Overall Study|Protocol Discontinuation Criteria|1
1317652|NCT00086502|4274679|P2|Overall Study|Patient Moved|1
1317653|NCT00086502|4274680|P1|Overall Study|Patient Moved|1
1317654|NCT00086502|4274679|P2|Overall Study|Withdrawal by Subject|6
1317655|NCT00086502|4274680|P1|Overall Study|Withdrawal by Subject|5
1317656|NCT00086502|4274679|P2|Overall Study|Protocol Violation|3
1317657|NCT00086502|4274680|P1|Overall Study|Protocol Violation|3
1317658|NCT00086502|4274679|P2|Overall Study|Pregnancy|1
1317659|NCT00086502|4274680|P1|Overall Study|Pregnancy|0
1317660|NCT00086502|4274679|P2|Overall Study|Physician Decision|1
1317661|NCT00086502|4274680|P1|Overall Study|Physician Decision|1
1317662|NCT00086502|4274679|P2|Overall Study|Lost to Follow-up|1
1317663|NCT00086502|4274680|P1|Overall Study|Lost to Follow-up|3
1317664|NCT00086502|4274679|P2|Overall Study|Lack of Efficacy|2
1317665|NCT00086502|4274680|P1|Overall Study|Lack of Efficacy|0
1317666|NCT00086502|4274679|P2|Overall Study|Adverse Event|2
1317667|NCT00086502|4274680|P1|Overall Study|Adverse Event|11
1317668|NCT00086346|4274705|P2|Patients Dosed With Test Article|Lack of Efficacy|0
1317669|NCT00086346|4274706|P1|Patients Dosed With Test Article|Lack of Efficacy|11
1317670|NCT00086346|4274705|P2|Patients Dosed With Test Article|Protocol Violation|3
1317671|NCT00086346|4274706|P1|Patients Dosed With Test Article|Protocol Violation|11
1317672|NCT00086346|4274705|P2|Patients Dosed With Test Article|Withdrawal by Subject|3
1317673|NCT00086346|4274706|P1|Patients Dosed With Test Article|Withdrawal by Subject|16
1317674|NCT00086346|4274705|P2|Patients Dosed With Test Article|Nonmedical event|3
1317675|NCT00086346|4274706|P1|Patients Dosed With Test Article|Nonmedical event|7
1317676|NCT00086346|4274705|P2|Patients Dosed With Test Article|Lost to Follow-up|3
1317677|NCT00086346|4274706|P1|Patients Dosed With Test Article|Lost to Follow-up|1
1317678|NCT00086346|4274705|P2|Patients Dosed With Test Article|Adverse Event|11
1317679|NCT00086346|4274706|P1|Patients Dosed With Test Article|Adverse Event|94
1317680|NCT00086346|4274705|P2|Randomization|Did not receive test article|4
1317681|NCT00086346|4274706|P1|Randomization|Did not receive test article|4
1317682|NCT00086281|4274733|P15|Phase 2|Adverse Event|0
1317683|NCT00086281|4274734|P14|Phase 2|Adverse Event|1
1317684|NCT00086281|4274735|P13|Phase 2|Adverse Event|1
1317685|NCT00086281|4274736|P12|Phase 2|Adverse Event|0
1317686|NCT00086281|4274737|P11|Phase 2|Adverse Event|0
1317687|NCT00086281|4274738|P10|Phase 2|Adverse Event|0
1317688|NCT00086281|4274739|P9|Phase 2|Adverse Event|0
1317689|NCT00086281|4274740|P8|Phase 2|Adverse Event|0
1317690|NCT00086281|4274741|P7|Phase 2|Adverse Event|0
1317691|NCT00086281|4274742|P6|Phase 2|Adverse Event|0
1317692|NCT00086281|4274743|P5|Phase 2|Adverse Event|0
1317693|NCT00086281|4274744|P4|Phase 2|Adverse Event|0
1317694|NCT00086281|4274745|P3|Phase 2|Adverse Event|0
1317695|NCT00086281|4274746|P2|Phase 2|Adverse Event|0
1317696|NCT00086281|4274747|P1|Phase 2|Adverse Event|0
1317697|NCT00086281|4274733|P15|Phase 1|Serious Adverse Event|1
1317698|NCT00086281|4274734|P14|Phase 1|Serious Adverse Event|0
1317699|NCT00086281|4274735|P13|Phase 1|Serious Adverse Event|0
1317700|NCT00086281|4274736|P12|Phase 1|Serious Adverse Event|0
1317701|NCT00086281|4274737|P11|Phase 1|Serious Adverse Event|0
1317702|NCT00086281|4274738|P10|Phase 1|Serious Adverse Event|0
1317703|NCT00086281|4274739|P9|Phase 1|Serious Adverse Event|0
1317704|NCT00086281|4274740|P8|Phase 1|Serious Adverse Event|0
1317705|NCT00086281|4274741|P7|Phase 1|Serious Adverse Event|0
1317706|NCT00086281|4274742|P6|Phase 1|Serious Adverse Event|0
1317707|NCT00086281|4274743|P5|Phase 1|Serious Adverse Event|0
1317708|NCT00086281|4274744|P4|Phase 1|Serious Adverse Event|0
1317709|NCT00086281|4274745|P3|Phase 1|Serious Adverse Event|0
1317710|NCT00086281|4274746|P2|Phase 1|Serious Adverse Event|0
1317711|NCT00086281|4274747|P1|Phase 1|Serious Adverse Event|0
1317712|NCT00086281|4274733|P15|Phase 1|Protocol Violation|0
1317713|NCT00086281|4274734|P14|Phase 1|Protocol Violation|0
1317714|NCT00086281|4274735|P13|Phase 1|Protocol Violation|0
1317715|NCT00086281|4274736|P12|Phase 1|Protocol Violation|0
1317716|NCT00086281|4274737|P11|Phase 1|Protocol Violation|1
1317717|NCT00086281|4274738|P10|Phase 1|Protocol Violation|0
1317718|NCT00086281|4274739|P9|Phase 1|Protocol Violation|0
1317719|NCT00086281|4274740|P8|Phase 1|Protocol Violation|0
1317720|NCT00086281|4274741|P7|Phase 1|Protocol Violation|0
1317721|NCT00086281|4274742|P6|Phase 1|Protocol Violation|0
1317722|NCT00086281|4274743|P5|Phase 1|Protocol Violation|0
1317723|NCT00086281|4274744|P4|Phase 1|Protocol Violation|0
1317724|NCT00086281|4274745|P3|Phase 1|Protocol Violation|0
1317725|NCT00086281|4274746|P2|Phase 1|Protocol Violation|0
1317726|NCT00086281|4274747|P1|Phase 1|Protocol Violation|0
1317727|NCT00086281|4274733|P15|Phase 1|Adverse Event|2
1317728|NCT00086281|4274734|P14|Phase 1|Adverse Event|1
1317729|NCT00086281|4274735|P13|Phase 1|Adverse Event|1
1317730|NCT00086281|4274736|P12|Phase 1|Adverse Event|1
1317731|NCT00086281|4274737|P11|Phase 1|Adverse Event|2
1317732|NCT00086281|4274738|P10|Phase 1|Adverse Event|1
1317733|NCT00086281|4274739|P9|Phase 1|Adverse Event|0
1317734|NCT00086281|4274740|P8|Phase 1|Adverse Event|0
1317735|NCT00086281|4274741|P7|Phase 1|Adverse Event|0
1317736|NCT00086281|4274742|P6|Phase 1|Adverse Event|0
1317737|NCT00086281|4274743|P5|Phase 1|Adverse Event|0
1317738|NCT00086281|4274744|P4|Phase 1|Adverse Event|0
1317739|NCT00086281|4274745|P3|Phase 1|Adverse Event|0
1317740|NCT00086281|4274746|P2|Phase 1|Adverse Event|0
1317741|NCT00086281|4274747|P1|Phase 1|Adverse Event|0
1317742|NCT00086307|4274760|P3|Overall Study|Withdrawal by Subject|2
1317743|NCT00086307|4274761|P2|Overall Study|Withdrawal by Subject|0
1317744|NCT00086307|4274762|P1|Overall Study|Withdrawal by Subject|0
1317745|NCT00086307|4274760|P3|Overall Study|Fatigue and difficulty falling asleep|1
1317746|NCT00086307|4274761|P2|Overall Study|Fatigue and difficulty falling asleep|0
1317747|NCT00086307|4274762|P1|Overall Study|Fatigue and difficulty falling asleep|0
1317748|NCT00086307|4274760|P3|Overall Study|Suicidal ideation|1
1317749|NCT00086307|4274761|P2|Overall Study|Suicidal ideation|0
1317750|NCT00086307|4274762|P1|Overall Study|Suicidal ideation|0
1317751|NCT00086307|4274760|P3|Overall Study|Constipation and sleepiness|1
1317752|NCT00086307|4274761|P2|Overall Study|Constipation and sleepiness|0
1317753|NCT00086307|4274762|P1|Overall Study|Constipation and sleepiness|0
1317754|NCT00086307|4274760|P3|Overall Study|Nausea and headaches|1
1317755|NCT00086307|4274761|P2|Overall Study|Nausea and headaches|0
1317756|NCT00086307|4274762|P1|Overall Study|Nausea and headaches|0
1317757|NCT00086307|4274760|P3|Overall Study|Shortness of breath and muscle spasms|0
1317758|NCT00086307|4274761|P2|Overall Study|Shortness of breath and muscle spasms|0
1317759|NCT00086307|4274762|P1|Overall Study|Shortness of breath and muscle spasms|1
1317760|NCT00086307|4274760|P3|Overall Study|Lack of Efficacy|2
1317761|NCT00086307|4274761|P2|Overall Study|Lack of Efficacy|1
1317762|NCT00086307|4274762|P1|Overall Study|Lack of Efficacy|1
1317763|NCT00086190|4274773|P3|Overall Study|Worsening depression|2
1317764|NCT00086190|4274774|P2|Overall Study|Worsening depression|0
1317765|NCT00086190|4274775|P1|Overall Study|Worsening depression|0
1317766|NCT00086190|4274773|P3|Overall Study|Moved|0
1317767|NCT00086190|4274774|P2|Overall Study|Moved|0
1317768|NCT00086190|4274775|P1|Overall Study|Moved|1
1317769|NCT00086190|4274773|P3|Overall Study|Protocol Violation|0
1317770|NCT00086190|4274774|P2|Overall Study|Protocol Violation|0
1317771|NCT00086190|4274775|P1|Overall Study|Protocol Violation|1
1317772|NCT00086190|4274773|P3|Overall Study|Withdrawal by Subject|2
1317773|NCT00086190|4274774|P2|Overall Study|Withdrawal by Subject|2
1317774|NCT00086190|4274775|P1|Overall Study|Withdrawal by Subject|0
1317775|NCT00086190|4274773|P3|Overall Study|Adverse Event|2
1317776|NCT00086190|4274774|P2|Overall Study|Adverse Event|2
1317777|NCT00086190|4274775|P1|Overall Study|Adverse Event|6
1317778|NCT00086047|4274844|P2|Overall Study|Physician Decision|1
1317779|NCT00086047|4274845|P1|Overall Study|Physician Decision|0
1317780|NCT00086047|4274844|P2|Overall Study|Lost to Follow-up|6
1317781|NCT00086047|4274845|P1|Overall Study|Lost to Follow-up|7
1317782|NCT00085917|4274853|P2|Overall Study|Adverse Event|3
1317783|NCT00085917|4274854|P1|Overall Study|Adverse Event|4
1317784|NCT00085735|4274883|P6|Overall Study|Pt transferred to inst w/out study open|0
1317785|NCT00085735|4274884|P5|Overall Study|Pt transferred to inst w/out study open|0
1317786|NCT00085735|4274885|P4|Overall Study|Pt transferred to inst w/out study open|0
1317787|NCT00085735|4274886|P3|Overall Study|Pt transferred to inst w/out study open|0
1317788|NCT00085735|4274887|P2|Overall Study|Pt transferred to inst w/out study open|0
1317789|NCT00085735|4274888|P1|Overall Study|Pt transferred to inst w/out study open|1
1317790|NCT00085735|4274883|P6|Overall Study|Reason not documented|0
1317791|NCT00085735|4274884|P5|Overall Study|Reason not documented|1
1317792|NCT00085735|4274885|P4|Overall Study|Reason not documented|0
1317793|NCT00085735|4274886|P3|Overall Study|Reason not documented|1
1317794|NCT00085735|4274887|P2|Overall Study|Reason not documented|0
1317795|NCT00085735|4274888|P1|Overall Study|Reason not documented|1
1317796|NCT00085735|4274883|P6|Overall Study|Excess residual disease|4
1317797|NCT00085735|4274884|P5|Overall Study|Excess residual disease|1
1317798|NCT00085735|4274885|P4|Overall Study|Excess residual disease|1
1317799|NCT00085735|4274886|P3|Overall Study|Excess residual disease|1
1317800|NCT00085735|4274887|P2|Overall Study|Excess residual disease|2
1317801|NCT00085735|4274888|P1|Overall Study|Excess residual disease|2
1317802|NCT00085735|4274883|P6|Overall Study|Patient ineligible|8
1317803|NCT00085735|4274884|P5|Overall Study|Patient ineligible|17
1317804|NCT00085735|4274885|P4|Overall Study|Patient ineligible|7
1317805|NCT00085735|4274886|P3|Overall Study|Patient ineligible|3
1317806|NCT00085735|4274887|P2|Overall Study|Patient ineligible|0
1317807|NCT00085735|4274888|P1|Overall Study|Patient ineligible|1
1317808|NCT00085735|4274883|P6|Overall Study|Withdrawal by Subject|8
1317809|NCT00085735|4274884|P5|Overall Study|Withdrawal by Subject|7
1317810|NCT00085735|4274885|P4|Overall Study|Withdrawal by Subject|5
1317811|NCT00085735|4274886|P3|Overall Study|Withdrawal by Subject|4
1317812|NCT00085735|4274887|P2|Overall Study|Withdrawal by Subject|0
1317813|NCT00085735|4274888|P1|Overall Study|Withdrawal by Subject|1
1317814|NCT00085735|4274883|P6|Overall Study|Protocol Violation|0
1317815|NCT00085735|4274884|P5|Overall Study|Protocol Violation|0
1317816|NCT00085735|4274885|P4|Overall Study|Protocol Violation|0
1317817|NCT00085735|4274886|P3|Overall Study|Protocol Violation|0
1317818|NCT00085735|4274887|P2|Overall Study|Protocol Violation|0
1317819|NCT00085735|4274888|P1|Overall Study|Protocol Violation|1
1317820|NCT00085735|4274883|P6|Overall Study|Physician Decision|8
1317821|NCT00085735|4274884|P5|Overall Study|Physician Decision|11
1317822|NCT00085735|4274885|P4|Overall Study|Physician Decision|3
1317823|NCT00085735|4274886|P3|Overall Study|Physician Decision|2
1317824|NCT00085735|4274887|P2|Overall Study|Physician Decision|3
1317825|NCT00085735|4274888|P1|Overall Study|Physician Decision|2
1317826|NCT00085735|4274883|P6|Overall Study|Lost to Follow-up|0
1317827|NCT00085735|4274884|P5|Overall Study|Lost to Follow-up|1
1317828|NCT00085735|4274885|P4|Overall Study|Lost to Follow-up|0
1317829|NCT00085735|4274886|P3|Overall Study|Lost to Follow-up|0
1317830|NCT00085735|4274887|P2|Overall Study|Lost to Follow-up|1
1317831|NCT00085735|4274888|P1|Overall Study|Lost to Follow-up|0
1317832|NCT00085735|4274883|P6|Overall Study|Lack of Efficacy|3
1317833|NCT00085735|4274884|P5|Overall Study|Lack of Efficacy|4
1317834|NCT00085735|4274885|P4|Overall Study|Lack of Efficacy|3
1317835|NCT00085735|4274886|P3|Overall Study|Lack of Efficacy|6
1317836|NCT00085735|4274887|P2|Overall Study|Lack of Efficacy|4
1317837|NCT00085735|4274888|P1|Overall Study|Lack of Efficacy|2
1317838|NCT00085735|4274883|P6|Overall Study|Adverse Event|0
1317839|NCT00085735|4274884|P5|Overall Study|Adverse Event|0
1317840|NCT00085735|4274885|P4|Overall Study|Adverse Event|0
1317841|NCT00085735|4274886|P3|Overall Study|Adverse Event|0
1317842|NCT00085735|4274887|P2|Overall Study|Adverse Event|0
1317843|NCT00085735|4274888|P1|Overall Study|Adverse Event|1
1317844|NCT00085709|4274916|P2|Overall Study|Withdrawal by Subject|1
1317845|NCT00085709|4274917|P1|Overall Study|Withdrawal by Subject|2
1317846|NCT00085709|4274916|P2|Overall Study|Not eligible|19
1317847|NCT00085709|4274917|P1|Overall Study|Not eligible|19
1317848|NCT00085709|4274916|P2|Overall Study|Not protocol specified|22
1317849|NCT00085709|4274917|P1|Overall Study|Not protocol specified|12
1317850|NCT00085709|4274916|P2|Overall Study|Progression|4
1317851|NCT00085709|4274917|P1|Overall Study|Progression|3
1317852|NCT00085709|4274916|P2|Overall Study|Refusal unrelated to adverse events|2
1317853|NCT00085709|4274917|P1|Overall Study|Refusal unrelated to adverse events|1
1317854|NCT00085709|4274916|P2|Overall Study|Death|2
1317855|NCT00085709|4274917|P1|Overall Study|Death|8
1317856|NCT00085709|4274916|P2|Overall Study|Adverse Event|0
1317857|NCT00085709|4274917|P1|Overall Study|Adverse Event|8
1317858|NCT00085644|4274933|P3|Open-Label Period|Personal reason|4
1317859|NCT00085644|4274934|P2|Open-Label Period|Personal reason|0
1317860|NCT00085644|4274935|P1|Open-Label Period|Personal reason|0
1317861|NCT00085644|4274933|P3|Open-Label Period|Protocol Violation|4
1317862|NCT00085644|4274934|P2|Open-Label Period|Protocol Violation|0
1317863|NCT00085644|4274935|P1|Open-Label Period|Protocol Violation|0
1317864|NCT00085644|4274933|P3|Open-Label Period|Contemplating pregnancy|3
1317865|NCT00085644|4274934|P2|Open-Label Period|Contemplating pregnancy|0
1317866|NCT00085644|4274935|P1|Open-Label Period|Contemplating pregnancy|0
1317867|NCT00085644|4274933|P3|Open-Label Period|Pregnancy|3
1317868|NCT00085644|4274934|P2|Open-Label Period|Pregnancy|0
1317869|NCT00085644|4274935|P1|Open-Label Period|Pregnancy|0
1317870|NCT00085644|4274933|P3|Open-Label Period|Lack of Efficacy|15
1317871|NCT00085644|4274934|P2|Open-Label Period|Lack of Efficacy|0
1317872|NCT00085644|4274935|P1|Open-Label Period|Lack of Efficacy|0
1317873|NCT00085644|4274933|P3|Open-Label Period|Lost to Follow-up|13
1317874|NCT00085644|4274934|P2|Open-Label Period|Lost to Follow-up|0
1317875|NCT00085644|4274935|P1|Open-Label Period|Lost to Follow-up|0
1317876|NCT00085644|4274933|P3|Open-Label Period|Withdrawal by Subject|29
1317877|NCT00085644|4274934|P2|Open-Label Period|Withdrawal by Subject|0
1317878|NCT00085644|4274935|P1|Open-Label Period|Withdrawal by Subject|0
1317879|NCT00085644|4274933|P3|Open-Label Period|Adverse Event|38
1317880|NCT00085644|4274934|P2|Open-Label Period|Adverse Event|0
1317881|NCT00085644|4274935|P1|Open-Label Period|Adverse Event|0
1317882|NCT00085644|4274933|P3|Double-Blind Period|Undiagnosed pre-existing condition|0
1317883|NCT00085644|4274934|P2|Double-Blind Period|Undiagnosed pre-existing condition|1
1317884|NCT00085644|4274935|P1|Double-Blind Period|Undiagnosed pre-existing condition|0
1317885|NCT00085644|4274933|P3|Double-Blind Period|Contemplating pregnancy|0
1317886|NCT00085644|4274934|P2|Double-Blind Period|Contemplating pregnancy|0
1317887|NCT00085644|4274935|P1|Double-Blind Period|Contemplating pregnancy|1
1317888|NCT00085644|4274933|P3|Double-Blind Period|Lack/loss of efficacy|0
1317889|NCT00085644|4274934|P2|Double-Blind Period|Lack/loss of efficacy|2
1317890|NCT00085644|4274935|P1|Double-Blind Period|Lack/loss of efficacy|2
1317891|NCT00085644|4274933|P3|Double-Blind Period|Lost to Follow-up|0
1317892|NCT00085644|4274934|P2|Double-Blind Period|Lost to Follow-up|1
1317893|NCT00085644|4274935|P1|Double-Blind Period|Lost to Follow-up|2
1317894|NCT00085644|4274933|P3|Double-Blind Period|Withdrawal by Subject|0
1317895|NCT00085644|4274934|P2|Double-Blind Period|Withdrawal by Subject|0
1317896|NCT00085644|4274935|P1|Double-Blind Period|Withdrawal by Subject|3
1317897|NCT00085644|4274933|P3|Double-Blind Period|Adverse Event|0
1317898|NCT00085644|4274934|P2|Double-Blind Period|Adverse Event|2
1317899|NCT00085644|4274935|P1|Double-Blind Period|Adverse Event|5
1317900|NCT00085631|4274976|P3|Overall Study|Missing Data|7
1317901|NCT00085631|4274977|P2|Overall Study|Missing Data|11
1317902|NCT00085631|4274978|P1|Overall Study|Missing Data|4
1317903|NCT00085566|4274988|P3|Overall Study|Clinical progression|1
1317904|NCT00085566|4274989|P2|Overall Study|Clinical progression|0
1317905|NCT00085566|4274990|P1|Overall Study|Clinical progression|0
1317906|NCT00085566|4274988|P3|Overall Study|Patient Not treated|3
1317907|NCT00085566|4274989|P2|Overall Study|Patient Not treated|0
1317908|NCT00085566|4274990|P1|Overall Study|Patient Not treated|0
1317909|NCT00085566|4274988|P3|Overall Study|Adverse Event|10
1317910|NCT00085566|4274989|P2|Overall Study|Adverse Event|0
1317911|NCT00085566|4274990|P1|Overall Study|Adverse Event|0
1317912|NCT00085540|4275000|P2|Overall Study|Protocol Violation|1
1317913|NCT00085540|4275001|P1|Overall Study|Protocol Violation|0
1317914|NCT00085540|4275000|P2|Overall Study|Withdrawal by Subject|1
1317915|NCT00085540|4275001|P1|Overall Study|Withdrawal by Subject|0
1317916|NCT00085423|4275013|P1|Overall Study|screen failure|1
1317917|NCT00085423|4275013|P1|Overall Study|Withdrawal by Subject|1
1317918|NCT00085202|4275064|P2|Overall Study|Progressive disease|11
1317919|NCT00085202|4275065|P1|Overall Study|Progressive disease|1
1317920|NCT00085202|4275064|P2|Overall Study|Physician Decision|1
1317921|NCT00085202|4275065|P1|Overall Study|Physician Decision|4
1317922|NCT00085202|4275064|P2|Overall Study|Withdrawal by Subject|1
1317923|NCT00085202|4275065|P1|Overall Study|Withdrawal by Subject|2
1317924|NCT00085202|4275064|P2|Overall Study|Non-specified|5
1317925|NCT00085202|4275065|P1|Overall Study|Non-specified|3
1317926|NCT00085202|4275064|P2|Overall Study|Excessive toxicity|5
1317927|NCT00085202|4275065|P1|Overall Study|Excessive toxicity|6
1317928|NCT00085202|4275064|P2|Overall Study|Bone involvement confirmed by bone scan|1
1317929|NCT00085202|4275065|P1|Overall Study|Bone involvement confirmed by bone scan|0
1317930|NCT00085202|4275064|P2|Overall Study|Still on therapy|0
1317931|NCT00085202|4275065|P1|Overall Study|Still on therapy|2
1317932|NCT00085098|4275086|P2|Overall Study|Ineligible|1
1317933|NCT00085098|4275087|P1|Overall Study|Ineligible|1
1317934|NCT00085098|4275086|P2|Overall Study|Withdrawal by Subject|1
1317935|NCT00085098|4275087|P1|Overall Study|Withdrawal by Subject|0
1317936|NCT00084864|4275101|P4|Overall Study|Adverse Event|0
1317937|NCT00084864|4275102|P3|Overall Study|Adverse Event|0
1317938|NCT00084864|4275103|P2|Overall Study|Adverse Event|0
1317939|NCT00084864|4275104|P1|Overall Study|Adverse Event|1
1317940|NCT00084838|4275130|P1|Overall Study|Ineligible|4
1317941|NCT00084838|4275130|P1|Overall Study|Pt Non-Compliance|1
1317942|NCT00084838|4275130|P1|Overall Study|Progressive Disease|4
1317943|NCT00084838|4275130|P1|Overall Study|Withdrawal by Subject|1
1317944|NCT00084838|4275130|P1|Overall Study|Adverse Event|2
1317945|NCT00084838|4275130|P1|Overall Study|Death|1
1317946|NCT00084747|4275152|P1|Overall Study|Withdrawal by Subject|2
1317947|NCT00084747|4275152|P1|Overall Study|Death|3
1317948|NCT00084747|4275152|P1|Overall Study|Relapsed|8
1317949|NCT00084682|4275157|P1|Overall Study|Withdrawal by Subject|1
1317950|NCT00084617|4275161|P1|Overall Study|Protocol Violation|1
1317951|NCT00084617|4275161|P1|Overall Study|Lack of Efficacy|1
1317952|NCT00084617|4275161|P1|Overall Study|Withdrawal by Subject|7
1317953|NCT00084487|4275167|P1|Overall Study|Death|1
1317954|NCT00084318|4275211|P2|Overall Study|No protocol treatment|0
1317955|NCT00084318|4275212|P1|Overall Study|No protocol treatment|2
1317956|NCT00084318|4275211|P2|Overall Study|Protocol Violation|11
1317957|NCT00084318|4275212|P1|Overall Study|Protocol Violation|15
1317958|NCT00084318|4275211|P2|Overall Study|Withdrawal by Subject|2
1317959|NCT00084318|4275212|P1|Overall Study|Withdrawal by Subject|5
1317960|NCT00084266|4275232|P2|Overall Study|Randomized not treated|20
1317961|NCT00084266|4275233|P1|Overall Study|Randomized not treated|21
1317962|NCT00084266|4275232|P2|Overall Study|Other|344
1317963|NCT00084266|4275233|P1|Overall Study|Other|360
1317964|NCT00084266|4275232|P2|Overall Study|Participant not willing to participate|8
1317965|NCT00084266|4275233|P1|Overall Study|Participant not willing to participate|3
1317966|NCT00084266|4275232|P2|Overall Study|Lost to Follow-up|3
1317967|NCT00084266|4275233|P1|Overall Study|Lost to Follow-up|5
1317968|NCT00084266|4275232|P2|Overall Study|Lack of Efficacy|4
1317969|NCT00084266|4275233|P1|Overall Study|Lack of Efficacy|2
1317970|NCT00084266|4275232|P2|Overall Study|Adverse Event|5
1317971|NCT00084266|4275233|P1|Overall Study|Adverse Event|8
1317972|NCT00084266|4275232|P2|Overall Study|Death|39
1317973|NCT00084266|4275233|P1|Overall Study|Death|42
1317974|NCT00084136|4275291|P3|NRTI Comparison|Not reason above|0
1317975|NCT00084136|4275292|P2|NRTI Comparison|Not reason above|0
1317976|NCT00084136|4275293|P1|NRTI Comparison|Not reason above|1
1317977|NCT00084136|4275291|P3|NRTI Comparison|Clinic site closed|14
1317978|NCT00084136|4275292|P2|NRTI Comparison|Clinic site closed|0
1317979|NCT00084136|4275293|P1|NRTI Comparison|Clinic site closed|12
1317980|NCT00084136|4275291|P3|NRTI Comparison|Withdrawal by Subject|38
1317981|NCT00084136|4275292|P2|NRTI Comparison|Withdrawal by Subject|0
1317982|NCT00084136|4275293|P1|NRTI Comparison|Withdrawal by Subject|54
1317983|NCT00084136|4275291|P3|NRTI Comparison|Lost to Follow-up|12
1317984|NCT00084136|4275292|P2|NRTI Comparison|Lost to Follow-up|0
1317985|NCT00084136|4275293|P1|NRTI Comparison|Lost to Follow-up|14
1317986|NCT00084136|4275291|P3|NRTI Comparison|Death|18
1317987|NCT00084136|4275292|P2|NRTI Comparison|Death|0
1317988|NCT00084136|4275293|P1|NRTI Comparison|Death|20
1317989|NCT00084136|4275291|P3|PI Comparison|Clinic site closed|0
1317990|NCT00084136|4275292|P2|PI Comparison|Clinic site closed|0
1317991|NCT00084136|4275293|P1|PI Comparison|Clinic site closed|1
1317992|NCT00084136|4275291|P3|PI Comparison|Withdrawal by Subject|0
1317993|NCT00084136|4275292|P2|PI Comparison|Withdrawal by Subject|30
1317994|NCT00084136|4275293|P1|PI Comparison|Withdrawal by Subject|33
1317995|NCT00084136|4275291|P3|PI Comparison|Lost to Follow-up|0
1317996|NCT00084136|4275292|P2|PI Comparison|Lost to Follow-up|8
1317997|NCT00084136|4275293|P1|PI Comparison|Lost to Follow-up|11
1317998|NCT00084136|4275291|P3|PI Comparison|Death|0
1317999|NCT00084136|4275292|P2|PI Comparison|Death|9
1318000|NCT00084136|4275293|P1|PI Comparison|Death|10
1318001|NCT00084084|4275352|P1|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1
1318002|NCT00084084|4275352|P1|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1
1318003|NCT00083915|4275362|P2|Overall Study|Insurance issues|1
1318004|NCT00083915|4275363|P1|Overall Study|Insurance issues|1
1318005|NCT00083915|4275362|P2|Overall Study|No response|1
1318006|NCT00083915|4275363|P1|Overall Study|No response|3
1318007|NCT00083915|4275362|P2|Overall Study|Failure to collect|0
1318008|NCT00083915|4275363|P1|Overall Study|Failure to collect|3
1318009|NCT00083915|4275362|P2|Overall Study|disease progression|23
1318010|NCT00083915|4275363|P1|Overall Study|disease progression|18
1318011|NCT00083915|4275362|P2|Overall Study|Withdrawal by Subject|3
1318012|NCT00083915|4275363|P1|Overall Study|Withdrawal by Subject|8
1318013|NCT00083915|4275362|P2|Overall Study|Physician Decision|6
1318014|NCT00083915|4275363|P1|Overall Study|Physician Decision|11
1318015|NCT00083915|4275362|P2|Overall Study|Death|3
1318016|NCT00083915|4275363|P1|Overall Study|Death|6
1318017|NCT00083889|4275371|P2|Overall Study|Crossover to SU011248|25
1318018|NCT00083889|4275372|P1|Overall Study|Crossover to SU011248|0
1318019|NCT00083889|4275371|P2|Overall Study|Completed on marketed sunitinub|0
1318020|NCT00083889|4275372|P1|Overall Study|Completed on marketed sunitinub|3
1318021|NCT00083889|4275371|P2|Overall Study|Randomized: did not take study drug|15
1318022|NCT00083889|4275372|P1|Overall Study|Randomized: did not take study drug|0
1318023|NCT00083889|4275371|P2|Overall Study|Decision of sponsor|4
1318024|NCT00083889|4275372|P1|Overall Study|Decision of sponsor|32
1318025|NCT00083889|4275371|P2|Overall Study|Lack of Efficacy|219
1318026|NCT00083889|4275372|P1|Overall Study|Lack of Efficacy|240
1318027|NCT00083889|4275371|P2|Overall Study|Withdrawal by Subject|24
1318028|NCT00083889|4275372|P1|Overall Study|Withdrawal by Subject|22
1318029|NCT00083889|4275371|P2|Overall Study|Protocol Violation|2
1318030|NCT00083889|4275372|P1|Overall Study|Protocol Violation|2
1318031|NCT00083889|4275371|P2|Overall Study|Adverse Event|86
1318032|NCT00083889|4275372|P1|Overall Study|Adverse Event|76
1318033|NCT00083759|4275430|P2|Overall Study|Other|13
1318034|NCT00083759|4275431|P1|Overall Study|Other|14
1318035|NCT00083759|4275430|P2|Overall Study|Sponsor's Discretion|29
1318036|NCT00083759|4275431|P1|Overall Study|Sponsor's Discretion|28
1318037|NCT00083759|4275430|P2|Overall Study|Non-Compliance|0
1318038|NCT00083759|4275431|P1|Overall Study|Non-Compliance|1
1318039|NCT00083759|4275430|P2|Overall Study|Subject Withdrew Consent|2
1318040|NCT00083759|4275431|P1|Overall Study|Subject Withdrew Consent|2
1318041|NCT00083759|4275430|P2|Overall Study|Inadequate Therapeutic Response|35
1318042|NCT00083759|4275431|P1|Overall Study|Inadequate Therapeutic Response|32
1318043|NCT00083759|4275430|P2|Overall Study|Death|1
1318044|NCT00083759|4275431|P1|Overall Study|Death|1
1318045|NCT00083759|4275430|P2|Overall Study|Lost to Follow-up|0
1318046|NCT00083759|4275431|P1|Overall Study|Lost to Follow-up|1
1318047|NCT00083759|4275430|P2|Overall Study|Adverse Event|3
1318048|NCT00083759|4275431|P1|Overall Study|Adverse Event|5
1318049|NCT00083616|4275449|P1|Overall Study|Other|6
1318050|NCT00083616|4275449|P1|Overall Study|Non-compliance|1
1318051|NCT00083616|4275449|P1|Overall Study|Ineligibility determined|2
1318052|NCT00083616|4275449|P1|Overall Study|Withdrawal by Subject|3
1318053|NCT00083616|4275449|P1|Overall Study|Physician Decision|2
1318054|NCT00083616|4275449|P1|Overall Study|Lost to Follow-up|1
1318055|NCT00083616|4275449|P1|Overall Study|Disease Progression|16
1318056|NCT00082888|4275474|P1|Overall Study|Still receiving treatment|4
1318057|NCT00082888|4275474|P1|Overall Study|Other Medical Problems|2
1318058|NCT00082888|4275474|P1|Overall Study|Alternate Treatment|1
1318059|NCT00082888|4275474|P1|Overall Study|Withdrawal by Subject|9
1318060|NCT00082888|4275474|P1|Overall Study|Adverse Event|4
1318061|NCT00082888|4275474|P1|Overall Study|Death|2
1318062|NCT00082810|4275478|P1|Overall Study|Withdrawal by Subject|4
1318063|NCT00082810|4275478|P1|Overall Study|Progressive disease|24
1318064|NCT00082810|4275478|P1|Overall Study|Adverse Event|3
1318065|NCT00082758|4275489|P3|Overall Study|Protocol Violation|0
1318066|NCT00082758|4275490|P2|Overall Study|Protocol Violation|1
1318067|NCT00082758|4275491|P1|Overall Study|Protocol Violation|0
1318068|NCT00082758|4275489|P3|Overall Study|Withdrawal by Subject|0
1318069|NCT00082758|4275490|P2|Overall Study|Withdrawal by Subject|0
1318070|NCT00082758|4275491|P1|Overall Study|Withdrawal by Subject|3
1318071|NCT00082758|4275489|P3|Overall Study|Physician Decision|0
1318072|NCT00082758|4275490|P2|Overall Study|Physician Decision|1
1318073|NCT00082758|4275491|P1|Overall Study|Physician Decision|0
1318074|NCT00082758|4275489|P3|Overall Study|Lack of Efficacy|0
1318075|NCT00082758|4275490|P2|Overall Study|Lack of Efficacy|13
1318076|NCT00082758|4275491|P1|Overall Study|Lack of Efficacy|12
1318077|NCT00082758|4275489|P3|Overall Study|Adverse Event|0
1318078|NCT00082758|4275490|P2|Overall Study|Adverse Event|2
1318079|NCT00082758|4275491|P1|Overall Study|Adverse Event|0
1318080|NCT00083226|4275511|P1|Overall Study|ineligible or not receiving treatment|4
1318081|NCT00083226|4275511|P1|Overall Study|Other|2
1318082|NCT00083226|4275511|P1|Overall Study|Withdrawal by Subject|4
1318083|NCT00083226|4275511|P1|Overall Study|Death|4
1318084|NCT00083226|4275511|P1|Overall Study|Adverse Event|9
1318085|NCT00083226|4275511|P1|Overall Study|Lack of Efficacy|19
1318086|NCT00082628|4275555|P5|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17
1318087|NCT00082628|4275556|P4|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15
1318088|NCT00082628|4275557|P3|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15
1318089|NCT00082628|4275558|P2|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0
1318090|NCT00082628|4275559|P1|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0
1318091|NCT00082628|4275555|P5|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
1318092|NCT00082628|4275556|P4|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1
1318093|NCT00082628|4275557|P3|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
1318094|NCT00082628|4275558|P2|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
1318095|NCT00082628|4275559|P1|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
1318096|NCT00082628|4275555|P5|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1
1318097|NCT00082628|4275556|P4|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
1318098|NCT00082628|4275557|P3|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
1318099|NCT00082628|4275558|P2|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
1318100|NCT00082628|4275559|P1|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
1318101|NCT00082628|4275555|P5|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
1318102|NCT00082628|4275556|P4|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
1318103|NCT00082628|4275557|P3|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
1318104|NCT00082628|4275558|P2|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15
1318105|NCT00082628|4275559|P1|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1
1318106|NCT00082628|4275555|P5|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
1318107|NCT00082628|4275556|P4|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
1318108|NCT00082628|4275557|P3|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
1318109|NCT00082628|4275558|P2|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43
1318110|NCT00082628|4275559|P1|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5
1318111|NCT00082628|4275555|P5|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
1318112|NCT00082628|4275556|P4|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
1318113|NCT00082628|4275557|P3|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
1318114|NCT00082628|4275558|P2|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1
1318115|NCT00082628|4275559|P1|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2
1318116|NCT00082628|4275555|P5|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
1318117|NCT00082628|4275556|P4|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
1318118|NCT00082628|4275557|P3|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
1318119|NCT00082628|4275558|P2|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1
1318120|NCT00082628|4275559|P1|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
1318121|NCT00082433|4275579|P2|Overall Study|Impending surgery|1
1318122|NCT00082433|4275580|P1|Overall Study|Impending surgery|0
1318123|NCT00082433|4275579|P2|Overall Study|New primary cancer|0
1318124|NCT00082433|4275580|P1|Overall Study|New primary cancer|1
1318125|NCT00082433|4275579|P2|Overall Study|Noncompliance|1
1318126|NCT00082433|4275580|P1|Overall Study|Noncompliance|2
1318127|NCT00082433|4275579|P2|Overall Study|Ineligible|1
1318128|NCT00082433|4275580|P1|Overall Study|Ineligible|2
1318129|NCT00082433|4275579|P2|Overall Study|Not Treated|11
1318130|NCT00082433|4275580|P1|Overall Study|Not Treated|12
1318131|NCT00082433|4275579|P2|Overall Study|Still On Treatment|1
1318132|NCT00082433|4275580|P1|Overall Study|Still On Treatment|2
1318133|NCT00082433|4275579|P2|Overall Study|Withdrawal by Subject|30
1318134|NCT00082433|4275580|P1|Overall Study|Withdrawal by Subject|55
1318135|NCT00082433|4275579|P2|Overall Study|Study Drug Toxicity|66
1318136|NCT00082433|4275580|P1|Overall Study|Study Drug Toxicity|179
1318137|NCT00082433|4275579|P2|Overall Study|Lost to Follow-up|2
1318138|NCT00082433|4275580|P1|Overall Study|Lost to Follow-up|1
1318139|NCT00082433|4275579|P2|Overall Study|Physician Decision|61
1318140|NCT00082433|4275580|P1|Overall Study|Physician Decision|50
1318141|NCT00082433|4275579|P2|Overall Study|Disease Progression/Relapse|388
1318142|NCT00082433|4275580|P1|Overall Study|Disease Progression/Relapse|270
1318143|NCT00082433|4275579|P2|Overall Study|Death|18
1318144|NCT00082433|4275580|P1|Overall Study|Death|8
1318145|NCT00082433|4275579|P2|Overall Study|Adverse Event|17
1318146|NCT00082433|4275580|P1|Overall Study|Adverse Event|12
1318147|NCT00082381|4275600|P2|Overall Study|Loss of Glucose Control|0
1318148|NCT00082381|4275601|P1|Overall Study|Loss of Glucose Control|4
1318149|NCT00082381|4275600|P2|Overall Study|Protocol Violation|11
1318150|NCT00082381|4275601|P1|Overall Study|Protocol Violation|10
1318151|NCT00082381|4275600|P2|Overall Study|Physician Decision|2
1318152|NCT00082381|4275601|P1|Overall Study|Physician Decision|1
1318153|NCT00082381|4275600|P2|Overall Study|Patient Decision|4
1318154|NCT00082381|4275601|P1|Overall Study|Patient Decision|8
1318155|NCT00082381|4275600|P2|Overall Study|Lost to Follow-up|7
1318156|NCT00082381|4275601|P1|Overall Study|Lost to Follow-up|5
1318157|NCT00082381|4275600|P2|Overall Study|Adverse Event|2
1318158|NCT00082381|4275601|P1|Overall Study|Adverse Event|27
1318159|NCT00082407|4275621|P2|Overall Study|Lost to Follow-up|3
1318160|NCT00082407|4275622|P1|Overall Study|Lost to Follow-up|0
1318161|NCT00082407|4275621|P2|Overall Study|Death|1
1318162|NCT00082407|4275622|P1|Overall Study|Death|2
1318163|NCT00082407|4275621|P2|Overall Study|Loss of Glucose Control|2
1318164|NCT00082407|4275622|P1|Overall Study|Loss of Glucose Control|2
1318165|NCT00082407|4275621|P2|Overall Study|Physician Decision|3
1318166|NCT00082407|4275622|P1|Overall Study|Physician Decision|5
1318167|NCT00082407|4275621|P2|Overall Study|Patient Decision|6
1318168|NCT00082407|4275622|P1|Overall Study|Patient Decision|13
1318169|NCT00082407|4275621|P2|Overall Study|Protocol Violation|12
1318170|NCT00082407|4275622|P1|Overall Study|Protocol Violation|14
1318171|NCT00082407|4275621|P2|Overall Study|Adverse Event|0
1318172|NCT00082407|4275622|P1|Overall Study|Adverse Event|20
1318173|NCT00082368|4275640|P1|Overall Study|Not treated-pt had poor IV access|1
1318174|NCT00082355|4275645|P1|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28
1318175|NCT00082355|4275645|P1|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1
1318176|NCT00082355|4275645|P1|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1
1318177|NCT00082173|4275679|P2|Overall Study|Culture negative or resistant at baselin|6
1318178|NCT00082173|4275680|P1|Overall Study|Culture negative or resistant at baselin|5
1318179|NCT00082173|4275679|P2|Overall Study|Adverse Event|0
1318180|NCT00082173|4275680|P1|Overall Study|Adverse Event|1
1318181|NCT00082173|4275679|P2|Overall Study|Lost to Follow-up|0
1318182|NCT00082173|4275680|P1|Overall Study|Lost to Follow-up|1
1318183|NCT00082173|4275679|P2|Overall Study|Withdrawal by Subject|5
1318184|NCT00082173|4275680|P1|Overall Study|Withdrawal by Subject|3
1318185|NCT00081770|4275720|P3|Overall Study|Not Specified|8
1318186|NCT00081770|4275721|P2|Overall Study|Not Specified|7
1318187|NCT00081770|4275722|P1|Overall Study|Not Specified|2
1318188|NCT00081770|4275720|P3|Overall Study|Administrative|1
1318189|NCT00081770|4275721|P2|Overall Study|Administrative|0
1318190|NCT00081770|4275722|P1|Overall Study|Administrative|1
1318191|NCT00081770|4275720|P3|Overall Study|Did not meet protocol eligibility|3
1318192|NCT00081770|4275721|P2|Overall Study|Did not meet protocol eligibility|0
1318193|NCT00081770|4275722|P1|Overall Study|Did not meet protocol eligibility|2
1318194|NCT00081770|4275720|P3|Overall Study|Withdrawal by Subject|42
1318195|NCT00081770|4275721|P2|Overall Study|Withdrawal by Subject|40
1318196|NCT00081770|4275722|P1|Overall Study|Withdrawal by Subject|45
1318197|NCT00081770|4275720|P3|Overall Study|Protocol Violation|10
1318198|NCT00081770|4275721|P2|Overall Study|Protocol Violation|10
1318199|NCT00081770|4275722|P1|Overall Study|Protocol Violation|15
1318200|NCT00081770|4275720|P3|Overall Study|Lost to Follow-up|45
1318201|NCT00081770|4275721|P2|Overall Study|Lost to Follow-up|34
1318202|NCT00081770|4275722|P1|Overall Study|Lost to Follow-up|45
1318203|NCT00081770|4275720|P3|Overall Study|Lack of Efficacy|211
1318204|NCT00081770|4275721|P2|Overall Study|Lack of Efficacy|357
1318205|NCT00081770|4275722|P1|Overall Study|Lack of Efficacy|262
1318206|NCT00081770|4275720|P3|Overall Study|Adverse Event|136
1318207|NCT00081770|4275721|P2|Overall Study|Adverse Event|98
1318208|NCT00081770|4275722|P1|Overall Study|Adverse Event|130
1318209|NCT00081731|4275741|P2|Overall Study|scientific integrity issue|8
1318210|NCT00081731|4275742|P1|Overall Study|scientific integrity issue|8
1318211|NCT00081653|4275762|P2|Overall Study|Loss of bone mass|2
1318212|NCT00081653|4275763|P1|Overall Study|Loss of bone mass|0
1318213|NCT00081653|4275762|P2|Overall Study|Participant leaving country|0
1318214|NCT00081653|4275763|P1|Overall Study|Participant leaving country|1
1318215|NCT00081653|4275762|P2|Overall Study|Bone loss|0
1318216|NCT00081653|4275763|P1|Overall Study|Bone loss|2
1318217|NCT00081653|4275762|P2|Overall Study|Low bone mineral density|0
1318218|NCT00081653|4275763|P1|Overall Study|Low bone mineral density|1
1318219|NCT00081653|4275762|P2|Overall Study|Refused Treatment|14
1318220|NCT00081653|4275763|P1|Overall Study|Refused Treatment|18
1318221|NCT00081653|4275762|P2|Overall Study|Lost to Follow-up|4
1318222|NCT00081653|4275763|P1|Overall Study|Lost to Follow-up|2
1318223|NCT00081653|4275762|P2|Overall Study|Adverse Event|17
1318224|NCT00081653|4275763|P1|Overall Study|Adverse Event|23
1318225|NCT00081497|4275781|P2|Overall Study|Non-compliance|1
1318226|NCT00081497|4275782|P1|Overall Study|Non-compliance|0
1318227|NCT00081497|4275781|P2|Overall Study|Withdrawal by Subject|0
1318228|NCT00081497|4275782|P1|Overall Study|Withdrawal by Subject|1
1318229|NCT00081497|4275781|P2|Overall Study|Death|1
1318230|NCT00081497|4275782|P1|Overall Study|Death|0
1318231|NCT00081497|4275781|P2|Overall Study|Adverse Event|0
1318232|NCT00081497|4275782|P1|Overall Study|Adverse Event|2
1318233|NCT00081458|4275800|P3|Overall Study|Randomized but not dosed|1
1318234|NCT00081458|4275801|P2|Overall Study|Randomized but not dosed|0
1318235|NCT00081458|4275802|P1|Overall Study|Randomized but not dosed|0
1318236|NCT00081458|4275800|P3|Overall Study|Withdrawal by Subject|1
1318237|NCT00081458|4275801|P2|Overall Study|Withdrawal by Subject|3
1318238|NCT00081458|4275802|P1|Overall Study|Withdrawal by Subject|0
1318239|NCT00081458|4275800|P3|Overall Study|Adverse Event|2
1318240|NCT00081458|4275801|P2|Overall Study|Adverse Event|5
1318241|NCT00081458|4275802|P1|Overall Study|Adverse Event|1
1318242|NCT00081289|4275858|P2|Overall Study|Ineligible / no protocol treatment|4
1318243|NCT00081289|4275859|P1|Overall Study|Ineligible / no protocol treatment|3
1318244|NCT00081289|4275858|P2|Overall Study|Accrued prior to chemotherapy amendment|17
1318245|NCT00081289|4275859|P1|Overall Study|Accrued prior to chemotherapy amendment|18
1318246|NCT00081263|4275867|P2|Overall Study|Inadequate data|10
1318247|NCT00081263|4275868|P1|Overall Study|Inadequate data|5
1318248|NCT00081263|4275867|P2|Overall Study|Never treated|5
1318249|NCT00081263|4275868|P1|Overall Study|Never treated|4
1318250|NCT00081263|4275867|P2|Overall Study|Inadequate pathology|1
1318251|NCT00081263|4275868|P1|Overall Study|Inadequate pathology|0
1318252|NCT00081263|4275867|P2|Overall Study|improper pre-protocol therapy|1
1318253|NCT00081263|4275868|P1|Overall Study|improper pre-protocol therapy|0
1318254|NCT00081263|4275867|P2|Overall Study|wrong cell type|5
1318255|NCT00081263|4275868|P1|Overall Study|wrong cell type|7
1318256|NCT00081263|4275867|P2|Overall Study|clerical error|0
1318257|NCT00081263|4275868|P1|Overall Study|clerical error|1
1318258|NCT00081159|4275878|P2|Overall Study|Lost to Follow-up|1
1318259|NCT00081159|4275879|P1|Overall Study|Lost to Follow-up|2
1318260|NCT00081159|4275878|P2|Overall Study|Myelosuppression prior to treatment|1
1318261|NCT00081159|4275879|P1|Overall Study|Myelosuppression prior to treatment|0
1318262|NCT00081159|4275878|P2|Overall Study|Withdrawal by Subject|3
1318263|NCT00081159|4275879|P1|Overall Study|Withdrawal by Subject|0
1318264|NCT00080938|4275889|P1|Overall Study|Ineligible|4
1318265|NCT00080938|4275889|P1|Overall Study|Not started protocol therapy|1
1318266|NCT00080938|4275889|P1|Overall Study|other disease|1
1318267|NCT00080938|4275889|P1|Overall Study|Lack of Efficacy|7
1318268|NCT00080938|4275889|P1|Overall Study|Death|2
1318269|NCT00080938|4275889|P1|Overall Study|Withdrawal by Subject|6
1318270|NCT00080938|4275889|P1|Overall Study|Adverse Event|3
1318271|NCT00080899|4275905|P1|Overall Study|Adverse Event|1
1318272|NCT00080483|4275917|P2|Overall Study|Physician Decision|1
1318273|NCT00080483|4275918|P1|Overall Study|Physician Decision|1
1318274|NCT00080483|4275917|P2|Overall Study|Lost to Follow-up|1
1318275|NCT00080483|4275918|P1|Overall Study|Lost to Follow-up|1
1318276|NCT00002525|4275926|P2|Overall Study|Never start protocol therapy|0
1318277|NCT00002525|4275927|P1|Overall Study|Never start protocol therapy|8
1318278|NCT00002525|4275926|P2|Overall Study|Other|0
1318279|NCT00002525|4275927|P1|Overall Study|Other|26
1318280|NCT00002525|4275926|P2|Overall Study|Error|0
1318281|NCT00002525|4275927|P1|Overall Study|Error|6
1318282|NCT00002525|4275926|P2|Overall Study|Duke's A, B1, D disease|0
1318283|NCT00002525|4275927|P1|Overall Study|Duke's A, B1, D disease|92
1318284|NCT00002525|4275926|P2|Overall Study|Other complicating disease|0
1318285|NCT00002525|4275927|P1|Overall Study|Other complicating disease|1
1318286|NCT00002525|4275926|P2|Overall Study|Start non-protocol therapy|0
1318287|NCT00002525|4275927|P1|Overall Study|Start non-protocol therapy|1
1318288|NCT00002525|4275926|P2|Overall Study|Withdrawal by Subject|0
1318289|NCT00002525|4275927|P1|Overall Study|Withdrawal by Subject|11
1318290|NCT00002525|4275926|P2|Overall Study|Death|0
1318291|NCT00002525|4275927|P1|Overall Study|Death|5
1318292|NCT00002525|4275926|P2|Overall Study|Adverse Event|0
1318293|NCT00002525|4275927|P1|Overall Study|Adverse Event|36
1318294|NCT00080301|4275954|P2|Overall Study|Still on Treatment as of CSR date|1
1318295|NCT00080301|4275955|P1|Overall Study|Still on Treatment as of CSR date|0
1318296|NCT00080301|4275954|P2|Overall Study|Randomized but Never Treated|10
1318297|NCT00080301|4275955|P1|Overall Study|Randomized but Never Treated|5
1318298|NCT00080288|4275975|P2|Overall Study|Miscellaneous|11
1318299|NCT00080288|4275976|P1|Overall Study|Miscellaneous|11
1318300|NCT00080288|4275975|P2|Overall Study|Withdrawal by Subject|16
1318301|NCT00080288|4275976|P1|Overall Study|Withdrawal by Subject|3
1318302|NCT00080288|4275975|P2|Overall Study|Physician Decision|2
1318303|NCT00080288|4275976|P1|Overall Study|Physician Decision|6
1318304|NCT00080288|4275975|P2|Overall Study|Lost to Follow-up|5
1318305|NCT00080288|4275976|P1|Overall Study|Lost to Follow-up|3
1318306|NCT00080288|4275975|P2|Overall Study|Adverse Event|4
1318307|NCT00080288|4275976|P1|Overall Study|Adverse Event|7
1318308|NCT00080223|4275984|P1|Overall Study|Physician Decision|1
1318309|NCT00080223|4275984|P1|Overall Study|Participant unwilling to continue|2
1318310|NCT00080223|4275984|P1|Overall Study|Non-compliance With Study Treatment|7
1318311|NCT00080223|4275984|P1|Overall Study|Lung Transplantation|9
1318312|NCT00080223|4275984|P1|Overall Study|Withdrawal by Subject|13
1318313|NCT00080223|4275984|P1|Overall Study|Death|21
1318314|NCT00080223|4275984|P1|Overall Study|Adverse Event|23
1318315|NCT00002540|4275994|P2|Overall Study|Refused Screen (Prostate Screening)|2433
1318316|NCT00002540|4275995|P1|Overall Study|Refused Screen (Prostate Screening)|0
1318317|NCT00002540|4275994|P2|Overall Study|Refused ASU (Control)|0
1318318|NCT00002540|4275995|P1|Overall Study|Refused ASU (Control)|597
1318319|NCT00002540|4275994|P2|Overall Study|Died Before ASU (Control)|0
1318320|NCT00002540|4275995|P1|Overall Study|Died Before ASU (Control)|202
1318321|NCT00002540|4275994|P2|Overall Study|Died Before Randomization|6
1318322|NCT00002540|4275995|P1|Overall Study|Died Before Randomization|2
1318323|NCT00002540|4275994|P2|Overall Study|Cancer Before Rand. (Prostate Screening)|25
1318324|NCT00002540|4275995|P1|Overall Study|Cancer Before Rand. (Prostate Screening)|0
1318325|NCT00080119|4276025|P4|Overall Study|Lost to Follow-up|14
1318326|NCT00080119|4276026|P3|Overall Study|Lost to Follow-up|19
1318327|NCT00080119|4276027|P2|Overall Study|Lost to Follow-up|19
1318328|NCT00080119|4276028|P1|Overall Study|Lost to Follow-up|16
1318329|NCT00080119|4276025|P4|Overall Study|Unwilling to adhere to study requirement|1
1318330|NCT00080119|4276026|P3|Overall Study|Unwilling to adhere to study requirement|5
1318331|NCT00080119|4276027|P2|Overall Study|Unwilling to adhere to study requirement|2
1318332|NCT00080119|4276028|P1|Overall Study|Unwilling to adhere to study requirement|3
1318333|NCT00080119|4276025|P4|Overall Study|Consent withdrawn|6
1318334|NCT00080119|4276026|P3|Overall Study|Consent withdrawn|4
1318335|NCT00080119|4276027|P2|Overall Study|Consent withdrawn|17
1318336|NCT00080119|4276028|P1|Overall Study|Consent withdrawn|13
1318337|NCT00080119|4276025|P4|Overall Study|Unable to get to clinic|1
1318338|NCT00080119|4276026|P3|Overall Study|Unable to get to clinic|7
1318339|NCT00080119|4276027|P2|Overall Study|Unable to get to clinic|24
1318340|NCT00080119|4276028|P1|Overall Study|Unable to get to clinic|24
1318341|NCT00080119|4276025|P4|Overall Study|Discontinued because of study closure|141
1318342|NCT00080119|4276026|P3|Overall Study|Discontinued because of study closure|130
1318343|NCT00080119|4276027|P2|Overall Study|Discontinued because of study closure|0
1318344|NCT00080119|4276028|P1|Overall Study|Discontinued because of study closure|0
1318345|NCT00079937|4276062|P2|Overall Study|Administrative problems|11
1318346|NCT00079937|4276063|P1|Overall Study|Administrative problems|22
1318347|NCT00079937|4276062|P2|Overall Study|Lost to Follow-up|5
1318348|NCT00079937|4276063|P1|Overall Study|Lost to Follow-up|12
1318349|NCT00079937|4276062|P2|Overall Study|Withdrawal by Subject|7
1318350|NCT00079937|4276063|P1|Overall Study|Withdrawal by Subject|21
1318351|NCT00079937|4276062|P2|Overall Study|Protocol Violation|6
1318352|NCT00079937|4276063|P1|Overall Study|Protocol Violation|8
1318353|NCT00079937|4276062|P2|Overall Study|Subject no longer requires study drug|0
1318354|NCT00079937|4276063|P1|Overall Study|Subject no longer requires study drug|3
1318355|NCT00079937|4276062|P2|Overall Study|Unsatisfactory therapeutic effect|2
1318356|NCT00079937|4276063|P1|Overall Study|Unsatisfactory therapeutic effect|1
1318357|NCT00079937|4276062|P2|Overall Study|Adverse Event|1
1318358|NCT00079937|4276063|P1|Overall Study|Adverse Event|2
1318359|NCT00009737|4276081|P2|Overall Study|Administrative/Other Reasons|1
1318360|NCT00009737|4276082|P1|Overall Study|Administrative/Other Reasons|7
1318361|NCT00009737|4276081|P2|Overall Study|Lost to Follow-up|1
1318362|NCT00009737|4276082|P1|Overall Study|Lost to Follow-up|1
1318363|NCT00009737|4276081|P2|Overall Study|Refused Treatment|16
1318364|NCT00009737|4276082|P1|Overall Study|Refused Treatment|15
1318365|NCT00009737|4276081|P2|Overall Study|Other Protocol Violation|0
1318366|NCT00009737|4276082|P1|Overall Study|Other Protocol Violation|1
1318367|NCT00009737|4276081|P2|Overall Study|Violation of Selection Criteria at Entry|9
1318368|NCT00009737|4276082|P1|Overall Study|Violation of Selection Criteria at Entry|13
1318369|NCT00009737|4276081|P2|Overall Study|Lack of Efficacy|15
1318370|NCT00009737|4276082|P1|Overall Study|Lack of Efficacy|17
1318371|NCT00009737|4276081|P2|Overall Study|Death|6
1318372|NCT00009737|4276082|P1|Overall Study|Death|4
1318373|NCT00009737|4276081|P2|Overall Study|Adverse Event|75
1318374|NCT00009737|4276082|P1|Overall Study|Adverse Event|112
1318375|NCT00079781|4276101|P3|Follow-up Period|Death|1
1318376|NCT00079781|4276102|P2|Follow-up Period|Death|0
1318377|NCT00079781|4276103|P1|Follow-up Period|Death|0
1318378|NCT00079781|4276101|P3|Follow-up Period|Lost to Follow-up|0
1318379|NCT00079781|4276102|P2|Follow-up Period|Lost to Follow-up|0
1318380|NCT00079781|4276103|P1|Follow-up Period|Lost to Follow-up|1
1318381|NCT00079781|4276101|P3|Follow-up Period|Withdrawal by Subject|1
1318382|NCT00079781|4276102|P2|Follow-up Period|Withdrawal by Subject|0
1318383|NCT00079781|4276103|P1|Follow-up Period|Withdrawal by Subject|3
1318384|NCT00079781|4276101|P3|Pre-implant Period|Did not meet I/E criteria|1
1318385|NCT00079781|4276102|P2|Pre-implant Period|Did not meet I/E criteria|1
1318386|NCT00079781|4276103|P1|Pre-implant Period|Did not meet I/E criteria|1
1318387|NCT00079781|4276101|P3|Pre-implant Period|Withdrawal by Subject|0
1318388|NCT00079781|4276102|P2|Pre-implant Period|Withdrawal by Subject|0
1318389|NCT00079781|4276103|P1|Pre-implant Period|Withdrawal by Subject|2
1318390|NCT00079677|4276112|P2|Overall Study|Miscellaneous|0
1318391|NCT00079677|4276113|P1|Overall Study|Miscellaneous|2
1318392|NCT00079677|4276112|P2|Overall Study|Withdrawal by Subject|3
1318393|NCT00079677|4276113|P1|Overall Study|Withdrawal by Subject|5
1318394|NCT00079677|4276112|P2|Overall Study|Protocol Violation|3
1318395|NCT00079677|4276113|P1|Overall Study|Protocol Violation|2
1318396|NCT00079677|4276112|P2|Overall Study|Physician Decision|0
1318397|NCT00079677|4276113|P1|Overall Study|Physician Decision|3
1318398|NCT00079677|4276112|P2|Overall Study|Lost to Follow-up|2
1318399|NCT00079677|4276113|P1|Overall Study|Lost to Follow-up|2
1318400|NCT00079677|4276112|P2|Overall Study|Lack of Efficacy|0
1318401|NCT00079677|4276113|P1|Overall Study|Lack of Efficacy|1
1318402|NCT00079677|4276112|P2|Overall Study|Adverse Event|6
1318403|NCT00079677|4276113|P1|Overall Study|Adverse Event|5
1318404|NCT00079417|4276129|P1|Overall Study|Ineligible|7
1318405|NCT00079417|4276129|P1|Overall Study|Physician Decision|2
1318406|NCT00079391|4276137|P1|Overall Study|Withdrawal by Subject|1
1318407|NCT00079339|4276149|P3|Overall Study|Disease progression|2
1318408|NCT00079339|4276150|P2|Overall Study|Disease progression|28
1318409|NCT00079339|4276151|P1|Overall Study|Disease progression|3
1318410|NCT00079339|4276149|P3|Overall Study|Withdrawal by Subject|1
1318411|NCT00079339|4276150|P2|Overall Study|Withdrawal by Subject|4
1318412|NCT00079339|4276151|P1|Overall Study|Withdrawal by Subject|0
1318413|NCT00079339|4276149|P3|Overall Study|Non-compliance|1
1318414|NCT00079339|4276150|P2|Overall Study|Non-compliance|0
1318415|NCT00079339|4276151|P1|Overall Study|Non-compliance|0
1318416|NCT00079339|4276149|P3|Overall Study|Death|0
1318417|NCT00079339|4276150|P2|Overall Study|Death|0
1318418|NCT00079339|4276151|P1|Overall Study|Death|1
1318419|NCT00079339|4276149|P3|Overall Study|Adverse Event|2
1318420|NCT00079339|4276150|P2|Overall Study|Adverse Event|7
1318421|NCT00079339|4276151|P1|Overall Study|Adverse Event|1
1318422|NCT00079274|4276182|P7|Overall Study|Not Specified|0
1318423|NCT00079274|4276183|P6|Overall Study|Not Specified|2
1318424|NCT00079274|4276184|P5|Overall Study|Not Specified|1
1318425|NCT00079274|4276185|P4|Overall Study|Not Specified|55
1318426|NCT00079274|4276186|P3|Overall Study|Not Specified|5
1318427|NCT00079274|4276187|P2|Overall Study|Not Specified|7
1318428|NCT00079274|4276188|P1|Overall Study|Not Specified|43
1318429|NCT00079274|4276182|P7|Overall Study|Cytogenetic resistance|0
1318430|NCT00079274|4276183|P6|Overall Study|Cytogenetic resistance|0
1318431|NCT00079274|4276184|P5|Overall Study|Cytogenetic resistance|0
1318432|NCT00079274|4276185|P4|Overall Study|Cytogenetic resistance|2
1318433|NCT00079274|4276186|P3|Overall Study|Cytogenetic resistance|0
1318434|NCT00079274|4276187|P2|Overall Study|Cytogenetic resistance|0
1318435|NCT00079274|4276188|P1|Overall Study|Cytogenetic resistance|0
1318436|NCT00079274|4276182|P7|Overall Study|Death|0
1318437|NCT00079274|4276183|P6|Overall Study|Death|0
1318438|NCT00079274|4276184|P5|Overall Study|Death|0
1318439|NCT00079274|4276185|P4|Overall Study|Death|15
1318440|NCT00079274|4276186|P3|Overall Study|Death|1
1318441|NCT00079274|4276187|P2|Overall Study|Death|0
1318442|NCT00079274|4276188|P1|Overall Study|Death|4
1318443|NCT00079274|4276182|P7|Overall Study|Other Medical Problems|0
1318444|NCT00079274|4276183|P6|Overall Study|Other Medical Problems|0
1318445|NCT00079274|4276184|P5|Overall Study|Other Medical Problems|0
1318446|NCT00079274|4276185|P4|Overall Study|Other Medical Problems|7
1318447|NCT00079274|4276186|P3|Overall Study|Other Medical Problems|0
1318448|NCT00079274|4276187|P2|Overall Study|Other Medical Problems|1
1318449|NCT00079274|4276188|P1|Overall Study|Other Medical Problems|6
1318450|NCT00079274|4276182|P7|Overall Study|Alternate Treatment|0
1318451|NCT00079274|4276183|P6|Overall Study|Alternate Treatment|0
1318452|NCT00079274|4276184|P5|Overall Study|Alternate Treatment|0
1318453|NCT00079274|4276185|P4|Overall Study|Alternate Treatment|3
1318454|NCT00079274|4276186|P3|Overall Study|Alternate Treatment|0
1318455|NCT00079274|4276187|P2|Overall Study|Alternate Treatment|1
1318456|NCT00079274|4276188|P1|Overall Study|Alternate Treatment|6
1318457|NCT00079274|4276182|P7|Overall Study|Recurrence|0
1318458|NCT00079274|4276183|P6|Overall Study|Recurrence|2
1318459|NCT00079274|4276184|P5|Overall Study|Recurrence|0
1318460|NCT00079274|4276185|P4|Overall Study|Recurrence|15
1318461|NCT00079274|4276186|P3|Overall Study|Recurrence|1
1318462|NCT00079274|4276187|P2|Overall Study|Recurrence|0
1318463|NCT00079274|4276188|P1|Overall Study|Recurrence|21
1318464|NCT00079274|4276182|P7|Overall Study|Adverse Event|0
1318465|NCT00079274|4276183|P6|Overall Study|Adverse Event|8
1318466|NCT00079274|4276184|P5|Overall Study|Adverse Event|7
1318467|NCT00079274|4276185|P4|Overall Study|Adverse Event|184
1318468|NCT00079274|4276186|P3|Overall Study|Adverse Event|8
1318469|NCT00079274|4276187|P2|Overall Study|Adverse Event|8
1318470|NCT00079274|4276188|P1|Overall Study|Adverse Event|130
1318471|NCT00079274|4276182|P7|Overall Study|Withdrawal by Subject|0
1318472|NCT00079274|4276183|P6|Overall Study|Withdrawal by Subject|8
1318473|NCT00079274|4276184|P5|Overall Study|Withdrawal by Subject|7
1318474|NCT00079274|4276185|P4|Overall Study|Withdrawal by Subject|163
1318475|NCT00079274|4276186|P3|Overall Study|Withdrawal by Subject|12
1318476|NCT00079274|4276187|P2|Overall Study|Withdrawal by Subject|10
1318477|NCT00079274|4276188|P1|Overall Study|Withdrawal by Subject|111
1318478|NCT00079183|4276209|P1|Overall Study|Specimen collection non-compliance|1
1318479|NCT00079183|4276209|P1|Overall Study|Study medication non-compliance|2
1318480|NCT00079183|4276209|P1|Overall Study|Withdrawal by Subject|4
1318481|NCT00079040|4276224|P1|Overall Study|Ineligible|1
1318482|NCT00079040|4276224|P1|Overall Study|Withdrew before treatment|1
1318483|NCT00078949|4276247|P4|Maintenance|No treated|3
1318484|NCT00078949|4276248|P3|Maintenance|No treated|3
1318485|NCT00078949|4276249|P2|Maintenance|No treated|0
1318486|NCT00078949|4276250|P1|Maintenance|No treated|0
1318487|NCT00078949|4276247|P4|Salvage|No treated|0
1318488|NCT00078949|4276248|P3|Salvage|No treated|0
1318489|NCT00078949|4276249|P2|Salvage|No treated|5
1318490|NCT00078949|4276250|P1|Salvage|No treated|4
1318491|NCT00078767|4276264|P2|Overall Study|Withdrawal by Subject|1
1318492|NCT00078767|4276265|P1|Overall Study|Withdrawal by Subject|1
1318493|NCT00005947|4276312|P2|Overall Study|Site Closure|0
1318494|NCT00005947|4276313|P1|Overall Study|Site Closure|1
1318495|NCT00005947|4276312|P2|Overall Study|Patient Refused to Continue|1
1318496|NCT00005947|4276313|P1|Overall Study|Patient Refused to Continue|2
1318497|NCT00005947|4276312|P2|Overall Study|Death|40
1318498|NCT00005947|4276313|P1|Overall Study|Death|54
1318499|NCT00002597|4276349|P2|Overall Study|Withdrawal by Subject|6
1318500|NCT00002597|4276350|P1|Overall Study|Withdrawal by Subject|7
1318501|NCT00002597|4276349|P2|Overall Study|Protocol Violation|17
1318502|NCT00002597|4276350|P1|Overall Study|Protocol Violation|19
1318503|NCT00078377|4276375|P3|Overall Study|Miscellaneous|1
1318504|NCT00078377|4276376|P2|Overall Study|Miscellaneous|6
1318505|NCT00078377|4276377|P1|Overall Study|Miscellaneous|2
1318506|NCT00078377|4276375|P3|Overall Study|Withdrawal by Subject|4
1318507|NCT00078377|4276376|P2|Overall Study|Withdrawal by Subject|4
1318508|NCT00078377|4276377|P1|Overall Study|Withdrawal by Subject|3
1318509|NCT00078377|4276375|P3|Overall Study|Physician Decision|0
1318510|NCT00078377|4276376|P2|Overall Study|Physician Decision|0
1318511|NCT00078377|4276377|P1|Overall Study|Physician Decision|2
1318512|NCT00078377|4276375|P3|Overall Study|Lost to Follow-up|1
1318513|NCT00078377|4276376|P2|Overall Study|Lost to Follow-up|1
1318514|NCT00078377|4276377|P1|Overall Study|Lost to Follow-up|0
1318515|NCT00078377|4276375|P3|Overall Study|Lack of Efficacy|2
1318516|NCT00078377|4276376|P2|Overall Study|Lack of Efficacy|0
1318517|NCT00078377|4276377|P1|Overall Study|Lack of Efficacy|2
1318518|NCT00078377|4276375|P3|Overall Study|Adverse Event|1
1318519|NCT00078377|4276376|P2|Overall Study|Adverse Event|5
1318520|NCT00078377|4276377|P1|Overall Study|Adverse Event|2
1318521|NCT00078338|4276392|P2|Overall Study|Subjects randomized, but not treated|3
1318522|NCT00078338|4276393|P1|Overall Study|Subjects randomized, but not treated|3
1318523|NCT00078338|4276392|P2|Overall Study|Other|16
1318524|NCT00078338|4276393|P1|Overall Study|Other|28
1318525|NCT00078338|4276392|P2|Overall Study|Disease Progression|7
1318526|NCT00078338|4276393|P1|Overall Study|Disease Progression|4
1318527|NCT00078338|4276392|P2|Overall Study|Protocol Violation|2
1318528|NCT00078338|4276393|P1|Overall Study|Protocol Violation|2
1318529|NCT00078338|4276392|P2|Overall Study|Lost to Follow-up|2
1318530|NCT00078338|4276393|P1|Overall Study|Lost to Follow-up|17
1318531|NCT00078338|4276392|P2|Overall Study|Adverse Event|24
1318532|NCT00078338|4276393|P1|Overall Study|Adverse Event|31
1318533|NCT00078325|4276486|P3|Overall Study|Miscellaneous|1
1318534|NCT00078325|4276487|P2|Overall Study|Miscellaneous|1
1318535|NCT00078325|4276488|P1|Overall Study|Miscellaneous|1
1318536|NCT00078325|4276486|P3|Overall Study|Physician Decision|1
1318537|NCT00078325|4276487|P2|Overall Study|Physician Decision|0
1318538|NCT00078325|4276488|P1|Overall Study|Physician Decision|2
1318539|NCT00078325|4276486|P3|Overall Study|Lost to Follow-up|1
1318540|NCT00078325|4276487|P2|Overall Study|Lost to Follow-up|1
1318541|NCT00078325|4276488|P1|Overall Study|Lost to Follow-up|0
1318542|NCT00078325|4276486|P3|Overall Study|Withdrawal by Subject|3
1318543|NCT00078325|4276487|P2|Overall Study|Withdrawal by Subject|5
1318544|NCT00078325|4276488|P1|Overall Study|Withdrawal by Subject|1
1318545|NCT00078325|4276486|P3|Overall Study|Protocol Violation|0
1318546|NCT00078325|4276487|P2|Overall Study|Protocol Violation|2
1318547|NCT00078325|4276488|P1|Overall Study|Protocol Violation|2
1318548|NCT00078325|4276486|P3|Overall Study|Adverse Event|5
1318549|NCT00078325|4276487|P2|Overall Study|Adverse Event|10
1318550|NCT00078325|4276488|P1|Overall Study|Adverse Event|15
1318551|NCT00078312|4276499|P1|Overall Study|Miscellaneous|33
1318552|NCT00078312|4276499|P1|Overall Study|Withdrawal by Subject|33
1318553|NCT00078312|4276499|P1|Overall Study|Protocol Violation|3
1318554|NCT00078312|4276499|P1|Overall Study|Physician Decision|9
1318555|NCT00078312|4276499|P1|Overall Study|Lost to Follow-up|41
1318556|NCT00078312|4276499|P1|Overall Study|Lack of Efficacy|15
1318557|NCT00078312|4276499|P1|Overall Study|Adverse Event|43
1318558|NCT00077974|4276514|P1|Overall Study|Decision of Sponsor|2
1318559|NCT00077974|4276514|P1|Overall Study|Lack of Efficacy|76
1318560|NCT00077974|4276514|P1|Overall Study|Withdrawal by Subject|3
1318561|NCT00077974|4276514|P1|Overall Study|Protocol Violation|1
1318562|NCT00077974|4276514|P1|Overall Study|Adverse Event|22
1318563|NCT00077857|4276531|P2|Overall Study|Other|13
1318564|NCT00077857|4276532|P1|Overall Study|Other|15
1318565|NCT00077857|4276531|P2|Overall Study|Failure to return|5
1318566|NCT00077857|4276532|P1|Overall Study|Failure to return|5
1318567|NCT00077857|4276531|P2|Overall Study|Refused treatment|21
1318568|NCT00077857|4276532|P1|Overall Study|Refused treatment|29
1318569|NCT00077857|4276531|P2|Overall Study|Other protocol violation|1
1318570|NCT00077857|4276532|P1|Overall Study|Other protocol violation|0
1318571|NCT00077857|4276531|P2|Overall Study|Violation of selection criteria at entry|1
1318572|NCT00077857|4276532|P1|Overall Study|Violation of selection criteria at entry|3
1318573|NCT00077857|4276531|P2|Overall Study|Insufficient therapeutic response|128
1318574|NCT00077857|4276532|P1|Overall Study|Insufficient therapeutic response|112
1318575|NCT00077857|4276531|P2|Overall Study|Death|3
1318576|NCT00077857|4276532|P1|Overall Study|Death|7
1318577|NCT00077857|4276531|P2|Overall Study|Adverse Event|32
1318578|NCT00077857|4276532|P1|Overall Study|Adverse Event|30
1318579|NCT00077766|4276552|P2|Overall Study|Participants Vacation|1
1318580|NCT00077766|4276553|P1|Overall Study|Participants Vacation|2
1318581|NCT00077766|4276552|P2|Overall Study|Stop Dialysis|1
1318582|NCT00077766|4276553|P1|Overall Study|Stop Dialysis|0
1318583|NCT00077766|4276552|P2|Overall Study|Started Nocturnal Dialysis|1
1318584|NCT00077766|4276553|P1|Overall Study|Started Nocturnal Dialysis|0
1318585|NCT00077766|4276552|P2|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1
1318586|NCT00077766|4276553|P1|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0
1318587|NCT00077766|4276552|P2|Overall Study|Dialysis|1
1318588|NCT00077766|4276553|P1|Overall Study|Dialysis|0
1318589|NCT00077766|4276552|P2|Overall Study|Dialysis Discontinued|0
1318590|NCT00077766|4276553|P1|Overall Study|Dialysis Discontinued|1
1318591|NCT00077766|4276552|P2|Overall Study|Participant's decision|0
1318592|NCT00077766|4276553|P1|Overall Study|Participant's decision|1
1318593|NCT00077766|4276552|P2|Overall Study|Investigators Discretion|0
1318594|NCT00077766|4276553|P1|Overall Study|Investigators Discretion|1
1318595|NCT00077766|4276552|P2|Overall Study|Transplantation|1
1318596|NCT00077766|4276553|P1|Overall Study|Transplantation|5
1318597|NCT00077766|4276552|P2|Overall Study|Kidney Transplantation|5
1318598|NCT00077766|4276553|P1|Overall Study|Kidney Transplantation|9
1318599|NCT00077766|4276552|P2|Overall Study|Protocol Violation|0
1318600|NCT00077766|4276553|P1|Overall Study|Protocol Violation|1
1318601|NCT00077766|4276552|P2|Overall Study|Lost to Follow-up|0
1318602|NCT00077766|4276553|P1|Overall Study|Lost to Follow-up|2
1318603|NCT00077766|4276552|P2|Overall Study|Death|10
1318604|NCT00077766|4276553|P1|Overall Study|Death|12
1318605|NCT00077766|4276552|P2|Overall Study|Withdrawal by Subject|3
1318606|NCT00077766|4276553|P1|Overall Study|Withdrawal by Subject|4
1318607|NCT00077766|4276552|P2|Overall Study|Adverse Event|1
1318608|NCT00077766|4276553|P1|Overall Study|Adverse Event|1
1318609|NCT00077675|4276578|P2|Overall Study|Never received study treatment|3
1318610|NCT00077675|4276579|P1|Overall Study|Never received study treatment|3
1318611|NCT00077675|4276578|P2|Overall Study|Other|1
1318612|NCT00077675|4276579|P1|Overall Study|Other|0
1318613|NCT00077675|4276578|P2|Overall Study|Withdrawal by Subject|0
1318614|NCT00077675|4276579|P1|Overall Study|Withdrawal by Subject|1
1318615|NCT00077675|4276578|P2|Overall Study|Lost to Follow-up|3
1318616|NCT00077675|4276579|P1|Overall Study|Lost to Follow-up|6
1318617|NCT00077675|4276578|P2|Overall Study|Adverse Event|2
1318618|NCT00077675|4276579|P1|Overall Study|Adverse Event|1
1318619|NCT00077649|4276589|P4|Overall Study|Randomized but never dosed|0
1318620|NCT00077649|4276590|P3|Overall Study|Randomized but never dosed|0
1318621|NCT00077649|4276591|P2|Overall Study|Randomized but never dosed|0
1318622|NCT00077649|4276592|P1|Overall Study|Randomized but never dosed|1
1318623|NCT00077649|4276589|P4|Overall Study|Abnormality of Laboratory Test|2
1318624|NCT00077649|4276590|P3|Overall Study|Abnormality of Laboratory Test|1
1318625|NCT00077649|4276591|P2|Overall Study|Abnormality of Laboratory Test|2
1318626|NCT00077649|4276592|P1|Overall Study|Abnormality of Laboratory Test|1
1318627|NCT00077649|4276589|P4|Overall Study|Lost to Follow-up|2
1318628|NCT00077649|4276590|P3|Overall Study|Lost to Follow-up|3
1318629|NCT00077649|4276591|P2|Overall Study|Lost to Follow-up|2
1318630|NCT00077649|4276592|P1|Overall Study|Lost to Follow-up|2
1318631|NCT00077649|4276589|P4|Overall Study|Withdrawal by Subject|2
1318632|NCT00077649|4276590|P3|Overall Study|Withdrawal by Subject|1
1318633|NCT00077649|4276591|P2|Overall Study|Withdrawal by Subject|1
1318634|NCT00077649|4276592|P1|Overall Study|Withdrawal by Subject|0
1318635|NCT00077649|4276589|P4|Overall Study|Lack of Efficacy|2
1318636|NCT00077649|4276590|P3|Overall Study|Lack of Efficacy|3
1318637|NCT00077649|4276591|P2|Overall Study|Lack of Efficacy|3
1318638|NCT00077649|4276592|P1|Overall Study|Lack of Efficacy|5
1318639|NCT00077649|4276589|P4|Overall Study|Adverse Event|9
1318640|NCT00077649|4276590|P3|Overall Study|Adverse Event|7
1318641|NCT00077649|4276591|P2|Overall Study|Adverse Event|1
1318642|NCT00077649|4276592|P1|Overall Study|Adverse Event|5
1318643|NCT00077636|4276640|P2|Overall Study|Abnormality Of Laboratory Test|2
1318644|NCT00077636|4276641|P1|Overall Study|Abnormality Of Laboratory Test|3
1318645|NCT00077636|4276640|P2|Overall Study|Lost to Follow-up|18
1318646|NCT00077636|4276641|P1|Overall Study|Lost to Follow-up|10
1318647|NCT00077636|4276640|P2|Overall Study|Protocol Violation|2
1318648|NCT00077636|4276641|P1|Overall Study|Protocol Violation|0
1318649|NCT00077636|4276640|P2|Overall Study|Adverse Event|34
1318650|NCT00077636|4276641|P1|Overall Study|Adverse Event|17
1318651|NCT00077636|4276640|P2|Overall Study|Withdrawal by Subject|2
1318652|NCT00077636|4276641|P1|Overall Study|Withdrawal by Subject|2
1318653|NCT00077636|4276640|P2|Overall Study|Admin|3
1318654|NCT00077636|4276641|P1|Overall Study|Admin|3
1318655|NCT00077636|4276640|P2|Overall Study|Refused Treatment|31
1318656|NCT00077636|4276641|P1|Overall Study|Refused Treatment|9
1318657|NCT00077623|4276662|P3|Overall Study|Failure to return|0
1318658|NCT00077623|4276663|P2|Overall Study|Failure to return|0
1318659|NCT00077623|4276664|P1|Overall Study|Failure to return|1
1318660|NCT00077623|4276662|P3|Overall Study|Death|11
1318661|NCT00077623|4276663|P2|Overall Study|Death|18
1318662|NCT00077623|4276664|P1|Overall Study|Death|12
1318663|NCT00077623|4276662|P3|Overall Study|Insufficient therapeutic response|0
1318664|NCT00077623|4276663|P2|Overall Study|Insufficient therapeutic response|0
1318665|NCT00077623|4276664|P1|Overall Study|Insufficient therapeutic response|2
1318666|NCT00077623|4276662|P3|Overall Study|Other-Non safety reason|19
1318667|NCT00077623|4276663|P2|Overall Study|Other-Non safety reason|15
1318668|NCT00077623|4276664|P1|Overall Study|Other-Non safety reason|18
1318669|NCT00077623|4276662|P3|Overall Study|Withdrawal by Subject|1
1318670|NCT00077623|4276663|P2|Overall Study|Withdrawal by Subject|10
1318671|NCT00077623|4276664|P1|Overall Study|Withdrawal by Subject|2
1318672|NCT00077623|4276662|P3|Overall Study|Adverse Event|1
1318673|NCT00077623|4276663|P2|Overall Study|Adverse Event|0
1318674|NCT00077623|4276664|P1|Overall Study|Adverse Event|1
1318675|NCT00077610|4276699|P3|Overall Study|Sponsors decision to withdraw|1
1318676|NCT00077610|4276700|P2|Overall Study|Sponsors decision to withdraw|0
1318677|NCT00077610|4276701|P1|Overall Study|Sponsors decision to withdraw|0
1318678|NCT00077610|4276699|P3|Overall Study|Financial issues|0
1318679|NCT00077610|4276700|P2|Overall Study|Financial issues|1
1318680|NCT00077610|4276701|P1|Overall Study|Financial issues|0
1318681|NCT00077610|4276699|P3|Overall Study|Relocation|5
1318682|NCT00077610|4276700|P2|Overall Study|Relocation|8
1318683|NCT00077610|4276701|P1|Overall Study|Relocation|0
1318684|NCT00077610|4276699|P3|Overall Study|Change in dialysis modality|0
1318685|NCT00077610|4276700|P2|Overall Study|Change in dialysis modality|0
1318686|NCT00077610|4276701|P1|Overall Study|Change in dialysis modality|1
1318687|NCT00077610|4276699|P3|Overall Study|Transfer to other center for surgery|0
1318688|NCT00077610|4276700|P2|Overall Study|Transfer to other center for surgery|0
1318689|NCT00077610|4276701|P1|Overall Study|Transfer to other center for surgery|1
1318690|NCT00077610|4276699|P3|Overall Study|Transfer to satellite unit|0
1318691|NCT00077610|4276700|P2|Overall Study|Transfer to satellite unit|0
1318692|NCT00077610|4276701|P1|Overall Study|Transfer to satellite unit|1
1318693|NCT00077610|4276699|P3|Overall Study|Transferred to nursing home|1
1318694|NCT00077610|4276700|P2|Overall Study|Transferred to nursing home|0
1318695|NCT00077610|4276701|P1|Overall Study|Transferred to nursing home|0
1318696|NCT00077610|4276699|P3|Overall Study|Transferred to other unit|1
1318697|NCT00077610|4276700|P2|Overall Study|Transferred to other unit|0
1318698|NCT00077610|4276701|P1|Overall Study|Transferred to other unit|0
1318699|NCT00077610|4276699|P3|Overall Study|Given Epogen in hospital|0
1318700|NCT00077610|4276700|P2|Overall Study|Given Epogen in hospital|0
1318701|NCT00077610|4276701|P1|Overall Study|Given Epogen in hospital|1
1318702|NCT00077610|4276699|P3|Overall Study|Worsening of health condition|0
1318703|NCT00077610|4276700|P2|Overall Study|Worsening of health condition|1
1318704|NCT00077610|4276701|P1|Overall Study|Worsening of health condition|1
1318705|NCT00077610|4276699|P3|Overall Study|Principal Investigator's decision|1
1318706|NCT00077610|4276700|P2|Overall Study|Principal Investigator's decision|0
1318707|NCT00077610|4276701|P1|Overall Study|Principal Investigator's decision|1
1318708|NCT00077610|4276699|P3|Overall Study|Multiple blood transfusions|1
1318709|NCT00077610|4276700|P2|Overall Study|Multiple blood transfusions|0
1318710|NCT00077610|4276701|P1|Overall Study|Multiple blood transfusions|0
1318711|NCT00077610|4276699|P3|Overall Study|Insufficient Therapeutic Response|0
1318712|NCT00077610|4276700|P2|Overall Study|Insufficient Therapeutic Response|0
1318713|NCT00077610|4276701|P1|Overall Study|Insufficient Therapeutic Response|1
1318714|NCT00077610|4276699|P3|Overall Study|Withdrew from dialysis care|3
1318715|NCT00077610|4276700|P2|Overall Study|Withdrew from dialysis care|0
1318716|NCT00077610|4276701|P1|Overall Study|Withdrew from dialysis care|5
1318717|NCT00077610|4276699|P3|Overall Study|Renal transplant|11
1318718|NCT00077610|4276700|P2|Overall Study|Renal transplant|15
1318719|NCT00077610|4276701|P1|Overall Study|Renal transplant|12
1318720|NCT00077610|4276699|P3|Overall Study|Death|13
1318721|NCT00077610|4276700|P2|Overall Study|Death|13
1318722|NCT00077610|4276701|P1|Overall Study|Death|17
1318723|NCT00077610|4276699|P3|Overall Study|Withdrawal by Subject|6
1318724|NCT00077610|4276700|P2|Overall Study|Withdrawal by Subject|10
1318725|NCT00077610|4276701|P1|Overall Study|Withdrawal by Subject|4
1318726|NCT00077610|4276699|P3|Overall Study|Lost to Follow-up|2
1318727|NCT00077610|4276700|P2|Overall Study|Lost to Follow-up|1
1318728|NCT00077610|4276701|P1|Overall Study|Lost to Follow-up|0
1318729|NCT00077610|4276699|P3|Overall Study|Adverse Event|1
1318730|NCT00077610|4276700|P2|Overall Study|Adverse Event|7
1318731|NCT00077610|4276701|P1|Overall Study|Adverse Event|9
1318732|NCT00077376|4276730|P1|Overall Study|Insurance ran out|1
1318733|NCT00077376|4276730|P1|Overall Study|Surgery|1
1318734|NCT00077376|4276730|P1|Overall Study|Symptomatic deterioration|1
1318735|NCT00077376|4276730|P1|Overall Study|Still on treatment|1
1318736|NCT00077376|4276730|P1|Overall Study|Complicating disease|1
1318737|NCT00077376|4276730|P1|Overall Study|Alternative therapy|5
1318738|NCT00077376|4276730|P1|Overall Study|Physician Decision|1
1318739|NCT00077376|4276730|P1|Overall Study|Death|1
1318740|NCT00077376|4276730|P1|Overall Study|Withdrawal by Subject|2
1318741|NCT00077376|4276730|P1|Overall Study|Adverse Event|8
1318742|NCT00077207|4276741|P1|Overall Study|Ineligible|1
1318743|NCT00077207|4276741|P1|Overall Study|Withdrawal by Subject|6
1318744|NCT00077207|4276741|P1|Overall Study|Physician Decision|6
1318745|NCT00077207|4276741|P1|Overall Study|Lack of Efficacy|12
1318746|NCT00077207|4276741|P1|Overall Study|Adverse Event|5
1318747|NCT00077064|4276753|P2|Overall Study|Patient refusal|2
1318748|NCT00077064|4276754|P1|Overall Study|Patient refusal|0
1318749|NCT00077064|4276753|P2|Overall Study|Adverse Event|4
1318750|NCT00077064|4276754|P1|Overall Study|Adverse Event|0
1318751|NCT00076999|4276770|P5|Overall Study|Other reason (not specified)|13
1318752|NCT00076999|4276771|P4|Overall Study|Other reason (not specified)|1
1318753|NCT00076999|4276772|P3|Overall Study|Other reason (not specified)|4
1318754|NCT00076999|4276773|P2|Overall Study|Other reason (not specified)|8
1318755|NCT00076999|4276774|P1|Overall Study|Other reason (not specified)|8
1318756|NCT00076999|4276770|P5|Overall Study|Withdrawal by Subject|1
1318757|NCT00076999|4276771|P4|Overall Study|Withdrawal by Subject|0
1318758|NCT00076999|4276772|P3|Overall Study|Withdrawal by Subject|3
1318759|NCT00076999|4276773|P2|Overall Study|Withdrawal by Subject|4
1318760|NCT00076999|4276774|P1|Overall Study|Withdrawal by Subject|0
1318761|NCT00076999|4276770|P5|Overall Study|Lost to Follow-up|0
1318762|NCT00076999|4276771|P4|Overall Study|Lost to Follow-up|0
1318763|NCT00076999|4276772|P3|Overall Study|Lost to Follow-up|0
1318764|NCT00076999|4276773|P2|Overall Study|Lost to Follow-up|1
1318765|NCT00076999|4276774|P1|Overall Study|Lost to Follow-up|2
1318766|NCT00076999|4276770|P5|Overall Study|Protocol Violation|9
1318767|NCT00076999|4276771|P4|Overall Study|Protocol Violation|0
1318768|NCT00076999|4276772|P3|Overall Study|Protocol Violation|4
1318769|NCT00076999|4276773|P2|Overall Study|Protocol Violation|3
1318770|NCT00076999|4276774|P1|Overall Study|Protocol Violation|0
1318771|NCT00076999|4276770|P5|Overall Study|Adverse Event|2
1318772|NCT00076999|4276771|P4|Overall Study|Adverse Event|0
1318773|NCT00076999|4276772|P3|Overall Study|Adverse Event|6
1318774|NCT00076999|4276773|P2|Overall Study|Adverse Event|8
1318775|NCT00076999|4276774|P1|Overall Study|Adverse Event|2
1318776|NCT00003222|4276893|P2|Overall Study|Physician Decision|1
1318777|NCT00003222|4276894|P1|Overall Study|Physician Decision|0
1318778|NCT00076804|4276906|P2|Overall Study|Early study Closure|32
1318779|NCT00076804|4276907|P1|Overall Study|Early study Closure|32
1318780|NCT00076804|4276906|P2|Overall Study|Withdrawal by Subject|8
1318781|NCT00076804|4276907|P1|Overall Study|Withdrawal by Subject|10
1318782|NCT00076804|4276906|P2|Overall Study|Lost to Follow-up|9
1318783|NCT00076804|4276907|P1|Overall Study|Lost to Follow-up|9
1318784|NCT00076804|4276906|P2|Overall Study|Death|20
1318785|NCT00076804|4276907|P1|Overall Study|Death|9
1318786|NCT00076752|4276919|P1|Overall Study|Withdrawal per PI, PI put study on hold|1
1318787|NCT00076752|4276919|P1|Overall Study|Death|2
1318788|NCT00076570|4276965|P2|Overall Study|Drug intolerance|8
1318789|NCT00076570|4276966|P1|Overall Study|Drug intolerance|8
1318790|NCT00003298|4276974|P1|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2
1318791|NCT00003298|4276974|P1|Step 2 (Adjuvant Therapy)|Excessive complication|1
1318792|NCT00003298|4276974|P1|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1
1318793|NCT00003298|4276974|P1|Step 2 (Adjuvant Therapy)|Death|1
1318794|NCT00003298|4276974|P1|Step 2 (Adjuvant Therapy)|Ineligible|1
1318795|NCT00003298|4276974|P1|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3
1318796|NCT00003298|4276974|P1|Re-register to Step 2 After Surgery|Reason unknown|1
1318797|NCT00003298|4276974|P1|Re-register to Step 2 After Surgery|Other complications|2
1318798|NCT00003298|4276974|P1|Re-register to Step 2 After Surgery|Positive margins|5
1318799|NCT00003298|4276974|P1|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7
1318800|NCT00003298|4276974|P1|Surgery|Unevaluable and off study|2
1318801|NCT00003298|4276974|P1|Surgery|Progression before surgery|2
1318802|NCT00003298|4276974|P1|Surgery|Unresectable at surgery|3
1318803|NCT00003298|4276974|P1|Step 1 (Neoadjuvant Therapy)|Adverse Event|3
1318804|NCT00003298|4276974|P1|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1
1318805|NCT00076336|4276984|P2|Overall Study|Treatment failure|5
1318806|NCT00076336|4276985|P1|Overall Study|Treatment failure|4
1318807|NCT00076336|4276984|P2|Overall Study|Virologic Breakthrough|16
1318808|NCT00076336|4276985|P1|Overall Study|Virologic Breakthrough|14
1318809|NCT00076336|4276984|P2|Overall Study|Liver Transplantation|3
1318810|NCT00076336|4276985|P1|Overall Study|Liver Transplantation|3
1318811|NCT00076336|4276984|P2|Overall Study|Patient, Investigator, Sponsor request|6
1318812|NCT00076336|4276985|P1|Overall Study|Patient, Investigator, Sponsor request|8
1318813|NCT00076336|4276984|P2|Overall Study|Creatinine Clearance < 30 or Dialysis|1
1318814|NCT00076336|4276985|P1|Overall Study|Creatinine Clearance < 30 or Dialysis|0
1318815|NCT00076336|4276984|P2|Overall Study|Non-Compliance|0
1318816|NCT00076336|4276985|P1|Overall Study|Non-Compliance|2
1318817|NCT00076336|4276984|P2|Overall Study|Lost to Follow-up|4
1318818|NCT00076336|4276985|P1|Overall Study|Lost to Follow-up|4
1318819|NCT00076336|4276984|P2|Overall Study|Adverse Event|4
1318820|NCT00076336|4276985|P1|Overall Study|Adverse Event|4
1318821|NCT00076336|4276984|P2|Overall Study|Death|17
1318822|NCT00076336|4276985|P1|Overall Study|Death|13
1318823|NCT00076102|4277038|P1|Overall Study|refusal of further therapy|2
1318824|NCT00076102|4277038|P1|Overall Study|plexiform neurofibroma surgery|1
1318825|NCT00076102|4277038|P1|Overall Study|Progression in pre-existing brain tumor|1
1318826|NCT00076102|4277038|P1|Overall Study|Clinical progression|1
1318827|NCT00076024|4277066|P4|Phase 2, Open-label|Other|2
1318828|NCT00076024|4277067|P3|Phase 2, Open-label|Other|0
1318829|NCT00076024|4277068|P2|Phase 2, Open-label|Other|0
1318830|NCT00076024|4277069|P1|Phase 2, Open-label|Other|0
1318831|NCT00076024|4277066|P4|Phase 2, Open-label|Withdrawal by Subject|1
1318832|NCT00076024|4277067|P3|Phase 2, Open-label|Withdrawal by Subject|0
1318833|NCT00076024|4277068|P2|Phase 2, Open-label|Withdrawal by Subject|0
1318834|NCT00076024|4277069|P1|Phase 2, Open-label|Withdrawal by Subject|0
1318835|NCT00076024|4277066|P4|Phase 2, Open-label|Lack of Efficacy|11
1318836|NCT00076024|4277067|P3|Phase 2, Open-label|Lack of Efficacy|0
1318837|NCT00076024|4277068|P2|Phase 2, Open-label|Lack of Efficacy|0
1318838|NCT00076024|4277069|P1|Phase 2, Open-label|Lack of Efficacy|0
1318839|NCT00076024|4277066|P4|Phase 2, Open-label|Adverse Event|2
1318840|NCT00076024|4277067|P3|Phase 2, Open-label|Adverse Event|0
1318841|NCT00076024|4277068|P2|Phase 2, Open-label|Adverse Event|0
1318842|NCT00076024|4277069|P1|Phase 2, Open-label|Adverse Event|0
1318843|NCT00076024|4277066|P4|Phase 2, Double-blind|Randomized but not treated|0
1318844|NCT00076024|4277067|P3|Phase 2, Double-blind|Randomized but not treated|0
1318845|NCT00076024|4277068|P2|Phase 2, Double-blind|Randomized but not treated|1
1318846|NCT00076024|4277069|P1|Phase 2, Double-blind|Randomized but not treated|0
1318847|NCT00076024|4277066|P4|Phase 2, Double-blind|Un-specified|0
1318848|NCT00076024|4277067|P3|Phase 2, Double-blind|Un-specified|6
1318849|NCT00076024|4277068|P2|Phase 2, Double-blind|Un-specified|14
1318850|NCT00076024|4277069|P1|Phase 2, Double-blind|Un-specified|0
1318851|NCT00076024|4277066|P4|Phase 2, Double-blind|Adverse Event|0
1318852|NCT00076024|4277067|P3|Phase 2, Double-blind|Adverse Event|6
1318853|NCT00076024|4277068|P2|Phase 2, Double-blind|Adverse Event|25
1318854|NCT00076024|4277069|P1|Phase 2, Double-blind|Adverse Event|0
1318855|NCT00076024|4277066|P4|Phase 2, Double-blind|Withdrawal by Subject|0
1318856|NCT00076024|4277067|P3|Phase 2, Double-blind|Withdrawal by Subject|4
1318857|NCT00076024|4277068|P2|Phase 2, Double-blind|Withdrawal by Subject|13
1318858|NCT00076024|4277069|P1|Phase 2, Double-blind|Withdrawal by Subject|0
1318859|NCT00076024|4277066|P4|Phase 2, Double-blind|Lack of Efficacy|0
1318860|NCT00076024|4277067|P3|Phase 2, Double-blind|Lack of Efficacy|40
1318861|NCT00076024|4277068|P2|Phase 2, Double-blind|Lack of Efficacy|59
1318862|NCT00076024|4277069|P1|Phase 2, Double-blind|Lack of Efficacy|0
1318863|NCT00076024|4277066|P4|Phase 1, Lead-in|Clinical progression|0
1318864|NCT00076024|4277067|P3|Phase 1, Lead-in|Clinical progression|0
1318865|NCT00076024|4277068|P2|Phase 1, Lead-in|Clinical progression|0
1318866|NCT00076024|4277069|P1|Phase 1, Lead-in|Clinical progression|1
1318867|NCT00076024|4277066|P4|Phase 1, Lead-in|Adverse Event|0
1318868|NCT00076024|4277067|P3|Phase 1, Lead-in|Adverse Event|0
1318869|NCT00076024|4277068|P2|Phase 1, Lead-in|Adverse Event|0
1318870|NCT00076024|4277069|P1|Phase 1, Lead-in|Adverse Event|1
1318871|NCT00076024|4277066|P4|Phase 1, Lead-in|Lack of Efficacy|0
1318872|NCT00076024|4277067|P3|Phase 1, Lead-in|Lack of Efficacy|0
1318873|NCT00076024|4277068|P2|Phase 1, Lead-in|Lack of Efficacy|0
1318874|NCT00076024|4277069|P1|Phase 1, Lead-in|Lack of Efficacy|4
1318875|NCT00076011|4277083|P1|Overall Study|Ongoing|1
1318876|NCT00076011|4277083|P1|Overall Study|Other|11
1318877|NCT00076011|4277083|P1|Overall Study|Study terminated by sponsor|3
1318878|NCT00076011|4277083|P1|Overall Study|Withdrawal by Subject|1
1318879|NCT00076011|4277083|P1|Overall Study|Lack of Efficacy|25
1318880|NCT00076011|4277083|P1|Overall Study|Adverse Event|10
1318881|NCT00076011|4277083|P1|Overall Study|Death|1
1318882|NCT00075946|4277095|P5|Overall Study|Other|0
1318883|NCT00075946|4277096|P4|Overall Study|Other|2
1318884|NCT00075946|4277097|P3|Overall Study|Other|0
1318885|NCT00075946|4277098|P2|Overall Study|Other|13
1318886|NCT00075946|4277099|P1|Overall Study|Other|5
1318887|NCT00075946|4277095|P5|Overall Study|Time to progression less than 6 months|0
1318888|NCT00075946|4277096|P4|Overall Study|Time to progression less than 6 months|3
1318889|NCT00075946|4277097|P3|Overall Study|Time to progression less than 6 months|8
1318890|NCT00075946|4277098|P2|Overall Study|Time to progression less than 6 months|30
1318891|NCT00075946|4277099|P1|Overall Study|Time to progression less than 6 months|15
1318892|NCT00075946|4277095|P5|Overall Study|No response to retreatment|0
1318893|NCT00075946|4277096|P4|Overall Study|No response to retreatment|0
1318894|NCT00075946|4277097|P3|Overall Study|No response to retreatment|2
1318895|NCT00075946|4277098|P2|Overall Study|No response to retreatment|0
1318896|NCT00075946|4277099|P1|Overall Study|No response to retreatment|23
1318897|NCT00075946|4277095|P5|Overall Study|Other complicating disease|0
1318898|NCT00075946|4277096|P4|Overall Study|Other complicating disease|4
1318899|NCT00075946|4277097|P3|Overall Study|Other complicating disease|1
1318900|NCT00075946|4277098|P2|Overall Study|Other complicating disease|13
1318901|NCT00075946|4277099|P1|Overall Study|Other complicating disease|7
1318902|NCT00075946|4277095|P5|Overall Study|Alternative therapy|0
1318903|NCT00075946|4277096|P4|Overall Study|Alternative therapy|0
1318904|NCT00075946|4277097|P3|Overall Study|Alternative therapy|5
1318905|NCT00075946|4277098|P2|Overall Study|Alternative therapy|2
1318906|NCT00075946|4277099|P1|Overall Study|Alternative therapy|16
1318907|NCT00075946|4277095|P5|Overall Study|Withdrawal by Subject|0
1318908|NCT00075946|4277096|P4|Overall Study|Withdrawal by Subject|9
1318909|NCT00075946|4277097|P3|Overall Study|Withdrawal by Subject|4
1318910|NCT00075946|4277098|P2|Overall Study|Withdrawal by Subject|58
1318911|NCT00075946|4277099|P1|Overall Study|Withdrawal by Subject|23
1318912|NCT00075946|4277095|P5|Overall Study|Death|0
1318913|NCT00075946|4277096|P4|Overall Study|Death|0
1318914|NCT00075946|4277097|P3|Overall Study|Death|0
1318915|NCT00075946|4277098|P2|Overall Study|Death|1
1318916|NCT00075946|4277099|P1|Overall Study|Death|0
1318917|NCT00075946|4277095|P5|Overall Study|Adverse Event|0
1318918|NCT00075946|4277096|P4|Overall Study|Adverse Event|2
1318919|NCT00075946|4277097|P3|Overall Study|Adverse Event|0
1318920|NCT00075946|4277098|P2|Overall Study|Adverse Event|10
1318921|NCT00075946|4277099|P1|Overall Study|Adverse Event|2
1318922|NCT00075946|4277095|P5|Overall Study|Still on treatment at time of analysis|0
1318923|NCT00075946|4277096|P4|Overall Study|Still on treatment at time of analysis|9
1318924|NCT00075946|4277097|P3|Overall Study|Still on treatment at time of analysis|3
1318925|NCT00075946|4277098|P2|Overall Study|Still on treatment at time of analysis|19
1318926|NCT00075946|4277099|P1|Overall Study|Still on treatment at time of analysis|52
1318927|NCT00075946|4277095|P5|Overall Study|Incorrectly randomized (no response)|0
1318928|NCT00075946|4277096|P4|Overall Study|Incorrectly randomized (no response)|1
1318929|NCT00075946|4277097|P3|Overall Study|Incorrectly randomized (no response)|5
1318930|NCT00075946|4277098|P2|Overall Study|Incorrectly randomized (no response)|5
1318931|NCT00075946|4277099|P1|Overall Study|Incorrectly randomized (no response)|5
1318932|NCT00075946|4277095|P5|Overall Study|Did not achieve response after induction|182
1318933|NCT00075946|4277096|P4|Overall Study|Did not achieve response after induction|0
1318934|NCT00075946|4277097|P3|Overall Study|Did not achieve response after induction|0
1318935|NCT00075946|4277098|P2|Overall Study|Did not achieve response after induction|0
1318936|NCT00075946|4277099|P1|Overall Study|Did not achieve response after induction|0
1318937|NCT00075946|4277095|P5|Overall Study|Path ineligible: undetermined histology|6
1318938|NCT00075946|4277096|P4|Overall Study|Path ineligible: undetermined histology|0
1318939|NCT00075946|4277097|P3|Overall Study|Path ineligible: undetermined histology|0
1318940|NCT00075946|4277098|P2|Overall Study|Path ineligible: undetermined histology|0
1318941|NCT00075946|4277099|P1|Overall Study|Path ineligible: undetermined histology|0
1318942|NCT00075881|4277114|P1|Overall Study|never start protocol therapy|1
1318943|NCT00075881|4277114|P1|Overall Study|Ineligible|1
1318944|NCT00075881|4277114|P1|Overall Study|missing data|2
1318945|NCT00075881|4277114|P1|Overall Study|other|4
1318946|NCT00075881|4277114|P1|Overall Study|other complicating disease|3
1318947|NCT00075881|4277114|P1|Overall Study|Protocol Violation|4
1318948|NCT00075881|4277114|P1|Overall Study|Withdrawal by Subject|2
1318949|NCT00075881|4277114|P1|Overall Study|Death|1
1318950|NCT00075881|4277114|P1|Overall Study|Adverse Event|7
1318951|NCT00075881|4277114|P1|Overall Study|Lack of Efficacy|18
1318952|NCT00075816|4277158|P2|Overall Study|Did not undergo transplantation|11
1318953|NCT00075816|4277159|P1|Overall Study|Did not undergo transplantation|14
1318954|NCT00075764|4277228|P2|Overall Study|Under review|1
1318955|NCT00075764|4277229|P1|Overall Study|Under review|0
1318956|NCT00075764|4277228|P2|Overall Study|Not protocol specified|19
1318957|NCT00075764|4277229|P1|Overall Study|Not protocol specified|27
1318958|NCT00075764|4277228|P2|Overall Study|Delinquent|2
1318959|NCT00075764|4277229|P1|Overall Study|Delinquent|4
1318960|NCT00075764|4277228|P2|Overall Study|Still on treatment|15
1318961|NCT00075764|4277229|P1|Overall Study|Still on treatment|8
1318962|NCT00075764|4277228|P2|Overall Study|Progression|274
1318963|NCT00075764|4277229|P1|Overall Study|Progression|269
1318964|NCT00075764|4277228|P2|Overall Study|Withdrawal by Subject|18
1318965|NCT00075764|4277229|P1|Overall Study|Withdrawal by Subject|28
1318966|NCT00075764|4277228|P2|Overall Study|Death|8
1318967|NCT00075764|4277229|P1|Overall Study|Death|4
1318968|NCT00075764|4277228|P2|Overall Study|Adverse Event|12
1318969|NCT00075764|4277229|P1|Overall Study|Adverse Event|5
1318970|NCT00075725|4277253|P12|Overall Study|Pt incarcerated|0
1318971|NCT00075725|4277254|P11|Overall Study|Pt incarcerated|0
1318972|NCT00075725|4277255|P10|Overall Study|Pt incarcerated|0
1318973|NCT00075725|4277256|P9|Overall Study|Pt incarcerated|0
1318974|NCT00075725|4277257|P8|Overall Study|Pt incarcerated|1
1318975|NCT00075725|4277258|P7|Overall Study|Pt incarcerated|0
1318976|NCT00075725|4277259|P6|Overall Study|Pt incarcerated|0
1318977|NCT00075725|4277260|P5|Overall Study|Pt incarcerated|0
1318978|NCT00075725|4277261|P4|Overall Study|Pt incarcerated|0
1318979|NCT00075725|4277262|P3|Overall Study|Pt incarcerated|0
1318980|NCT00075725|4277263|P2|Overall Study|Pt incarcerated|0
1318981|NCT00075725|4277264|P1|Overall Study|Pt incarcerated|0
1318982|NCT00075725|4277253|P12|Overall Study|Pt care terminated due to pt behavior|0
1318983|NCT00075725|4277254|P11|Overall Study|Pt care terminated due to pt behavior|0
1318984|NCT00075725|4277255|P10|Overall Study|Pt care terminated due to pt behavior|0
1318985|NCT00075725|4277256|P9|Overall Study|Pt care terminated due to pt behavior|0
1318986|NCT00075725|4277257|P8|Overall Study|Pt care terminated due to pt behavior|1
1318987|NCT00075725|4277258|P7|Overall Study|Pt care terminated due to pt behavior|0
1318988|NCT00075725|4277259|P6|Overall Study|Pt care terminated due to pt behavior|0
1318989|NCT00075725|4277260|P5|Overall Study|Pt care terminated due to pt behavior|0
1318990|NCT00075725|4277261|P4|Overall Study|Pt care terminated due to pt behavior|0
1318991|NCT00075725|4277262|P3|Overall Study|Pt care terminated due to pt behavior|0
1318992|NCT00075725|4277263|P2|Overall Study|Pt care terminated due to pt behavior|0
1318993|NCT00075725|4277264|P1|Overall Study|Pt care terminated due to pt behavior|0
1318994|NCT00075725|4277253|P12|Overall Study|Other complications|0
1318995|NCT00075725|4277254|P11|Overall Study|Other complications|0
1318996|NCT00075725|4277255|P10|Overall Study|Other complications|0
1318997|NCT00075725|4277256|P9|Overall Study|Other complications|0
1318998|NCT00075725|4277257|P8|Overall Study|Other complications|0
1318999|NCT00075725|4277258|P7|Overall Study|Other complications|0
1319000|NCT00075725|4277259|P6|Overall Study|Other complications|1
1319001|NCT00075725|4277260|P5|Overall Study|Other complications|0
1319002|NCT00075725|4277261|P4|Overall Study|Other complications|0
1319003|NCT00075725|4277262|P3|Overall Study|Other complications|0
1319004|NCT00075725|4277263|P2|Overall Study|Other complications|0
1319005|NCT00075725|4277264|P1|Overall Study|Other complications|0
1319006|NCT00075725|4277253|P12|Overall Study|Study Closure|0
1319007|NCT00075725|4277254|P11|Overall Study|Study Closure|0
1319008|NCT00075725|4277255|P10|Overall Study|Study Closure|0
1319009|NCT00075725|4277256|P9|Overall Study|Study Closure|0
1319010|NCT00075725|4277257|P8|Overall Study|Study Closure|1
1319011|NCT00075725|4277258|P7|Overall Study|Study Closure|0
1319012|NCT00075725|4277259|P6|Overall Study|Study Closure|3
1319013|NCT00075725|4277260|P5|Overall Study|Study Closure|1
1319014|NCT00075725|4277261|P4|Overall Study|Study Closure|0
1319015|NCT00075725|4277262|P3|Overall Study|Study Closure|0
1319016|NCT00075725|4277263|P2|Overall Study|Study Closure|0
1319017|NCT00075725|4277264|P1|Overall Study|Study Closure|1
1319018|NCT00075725|4277253|P12|Overall Study|Institution Terminated|0
1319019|NCT00075725|4277254|P11|Overall Study|Institution Terminated|0
1319020|NCT00075725|4277255|P10|Overall Study|Institution Terminated|0
1319021|NCT00075725|4277256|P9|Overall Study|Institution Terminated|0
1319022|NCT00075725|4277257|P8|Overall Study|Institution Terminated|3
1319023|NCT00075725|4277258|P7|Overall Study|Institution Terminated|0
1319024|NCT00075725|4277259|P6|Overall Study|Institution Terminated|0
1319025|NCT00075725|4277260|P5|Overall Study|Institution Terminated|1
1319026|NCT00075725|4277261|P4|Overall Study|Institution Terminated|0
1319027|NCT00075725|4277262|P3|Overall Study|Institution Terminated|0
1319028|NCT00075725|4277263|P2|Overall Study|Institution Terminated|0
1319029|NCT00075725|4277264|P1|Overall Study|Institution Terminated|0
1319030|NCT00075725|4277253|P12|Overall Study|Pt relocated|0
1319031|NCT00075725|4277254|P11|Overall Study|Pt relocated|0
1319032|NCT00075725|4277255|P10|Overall Study|Pt relocated|0
1319033|NCT00075725|4277256|P9|Overall Study|Pt relocated|1
1319034|NCT00075725|4277257|P8|Overall Study|Pt relocated|2
1319035|NCT00075725|4277258|P7|Overall Study|Pt relocated|1
1319036|NCT00075725|4277259|P6|Overall Study|Pt relocated|1
1319037|NCT00075725|4277260|P5|Overall Study|Pt relocated|0
1319038|NCT00075725|4277261|P4|Overall Study|Pt relocated|2
1319039|NCT00075725|4277262|P3|Overall Study|Pt relocated|0
1319040|NCT00075725|4277263|P2|Overall Study|Pt relocated|0
1319041|NCT00075725|4277264|P1|Overall Study|Pt relocated|0
1319042|NCT00075725|4277253|P12|Overall Study|Pt received additional steroids|0
1319043|NCT00075725|4277254|P11|Overall Study|Pt received additional steroids|0
1319044|NCT00075725|4277255|P10|Overall Study|Pt received additional steroids|0
1319045|NCT00075725|4277256|P9|Overall Study|Pt received additional steroids|0
1319046|NCT00075725|4277257|P8|Overall Study|Pt received additional steroids|0
1319047|NCT00075725|4277258|P7|Overall Study|Pt received additional steroids|0
1319048|NCT00075725|4277259|P6|Overall Study|Pt received additional steroids|0
1319049|NCT00075725|4277260|P5|Overall Study|Pt received additional steroids|0
1319050|NCT00075725|4277261|P4|Overall Study|Pt received additional steroids|1
1319051|NCT00075725|4277262|P3|Overall Study|Pt received additional steroids|0
1319052|NCT00075725|4277263|P2|Overall Study|Pt received additional steroids|0
1319053|NCT00075725|4277264|P1|Overall Study|Pt received additional steroids|0
1319054|NCT00075725|4277253|P12|Overall Study|Pt went to transplant|0
1319055|NCT00075725|4277254|P11|Overall Study|Pt went to transplant|0
1319056|NCT00075725|4277255|P10|Overall Study|Pt went to transplant|0
1319057|NCT00075725|4277256|P9|Overall Study|Pt went to transplant|0
1319058|NCT00075725|4277257|P8|Overall Study|Pt went to transplant|0
1319059|NCT00075725|4277258|P7|Overall Study|Pt went to transplant|0
1319060|NCT00075725|4277259|P6|Overall Study|Pt went to transplant|1
1319061|NCT00075725|4277260|P5|Overall Study|Pt went to transplant|0
1319062|NCT00075725|4277261|P4|Overall Study|Pt went to transplant|1
1319063|NCT00075725|4277262|P3|Overall Study|Pt went to transplant|0
1319064|NCT00075725|4277263|P2|Overall Study|Pt went to transplant|0
1319065|NCT00075725|4277264|P1|Overall Study|Pt went to transplant|0
1319066|NCT00075725|4277253|P12|Overall Study|specimen(s) not submitted|0
1319067|NCT00075725|4277254|P11|Overall Study|specimen(s) not submitted|0
1319068|NCT00075725|4277255|P10|Overall Study|specimen(s) not submitted|0
1319069|NCT00075725|4277256|P9|Overall Study|specimen(s) not submitted|0
1319070|NCT00075725|4277257|P8|Overall Study|specimen(s) not submitted|0
1319071|NCT00075725|4277258|P7|Overall Study|specimen(s) not submitted|0
1319072|NCT00075725|4277259|P6|Overall Study|specimen(s) not submitted|0
1319073|NCT00075725|4277260|P5|Overall Study|specimen(s) not submitted|0
1319074|NCT00075725|4277261|P4|Overall Study|specimen(s) not submitted|0
1319075|NCT00075725|4277262|P3|Overall Study|specimen(s) not submitted|2
1319076|NCT00075725|4277263|P2|Overall Study|specimen(s) not submitted|0
1319077|NCT00075725|4277264|P1|Overall Study|specimen(s) not submitted|0
1319078|NCT00075725|4277253|P12|Overall Study|Unsuccessful institutional transfer|0
1319079|NCT00075725|4277254|P11|Overall Study|Unsuccessful institutional transfer|0
1319080|NCT00075725|4277255|P10|Overall Study|Unsuccessful institutional transfer|1
1319081|NCT00075725|4277256|P9|Overall Study|Unsuccessful institutional transfer|0
1319082|NCT00075725|4277257|P8|Overall Study|Unsuccessful institutional transfer|0
1319083|NCT00075725|4277258|P7|Overall Study|Unsuccessful institutional transfer|0
1319084|NCT00075725|4277259|P6|Overall Study|Unsuccessful institutional transfer|0
1319085|NCT00075725|4277260|P5|Overall Study|Unsuccessful institutional transfer|0
1319086|NCT00075725|4277261|P4|Overall Study|Unsuccessful institutional transfer|0
1319087|NCT00075725|4277262|P3|Overall Study|Unsuccessful institutional transfer|2
1319088|NCT00075725|4277263|P2|Overall Study|Unsuccessful institutional transfer|0
1319089|NCT00075725|4277264|P1|Overall Study|Unsuccessful institutional transfer|0
1319090|NCT00075725|4277253|P12|Overall Study|Clinic chart lost unable to recreate|0
1319091|NCT00075725|4277254|P11|Overall Study|Clinic chart lost unable to recreate|0
1319092|NCT00075725|4277255|P10|Overall Study|Clinic chart lost unable to recreate|0
1319093|NCT00075725|4277256|P9|Overall Study|Clinic chart lost unable to recreate|0
1319094|NCT00075725|4277257|P8|Overall Study|Clinic chart lost unable to recreate|0
1319095|NCT00075725|4277258|P7|Overall Study|Clinic chart lost unable to recreate|0
1319096|NCT00075725|4277259|P6|Overall Study|Clinic chart lost unable to recreate|0
1319097|NCT00075725|4277260|P5|Overall Study|Clinic chart lost unable to recreate|0
1319098|NCT00075725|4277261|P4|Overall Study|Clinic chart lost unable to recreate|0
1319099|NCT00075725|4277262|P3|Overall Study|Clinic chart lost unable to recreate|1
1319100|NCT00075725|4277263|P2|Overall Study|Clinic chart lost unable to recreate|0
1319101|NCT00075725|4277264|P1|Overall Study|Clinic chart lost unable to recreate|0
1319102|NCT00075725|4277253|P12|Overall Study|Pt trying to find a BM donor|0
1319103|NCT00075725|4277254|P11|Overall Study|Pt trying to find a BM donor|0
1319104|NCT00075725|4277255|P10|Overall Study|Pt trying to find a BM donor|0
1319105|NCT00075725|4277256|P9|Overall Study|Pt trying to find a BM donor|0
1319106|NCT00075725|4277257|P8|Overall Study|Pt trying to find a BM donor|0
1319107|NCT00075725|4277258|P7|Overall Study|Pt trying to find a BM donor|0
1319108|NCT00075725|4277259|P6|Overall Study|Pt trying to find a BM donor|0
1319109|NCT00075725|4277260|P5|Overall Study|Pt trying to find a BM donor|0
1319110|NCT00075725|4277261|P4|Overall Study|Pt trying to find a BM donor|0
1319111|NCT00075725|4277262|P3|Overall Study|Pt trying to find a BM donor|0
1319112|NCT00075725|4277263|P2|Overall Study|Pt trying to find a BM donor|1
1319113|NCT00075725|4277264|P1|Overall Study|Pt trying to find a BM donor|0
1319114|NCT00075725|4277253|P12|Overall Study|Other|3
1319115|NCT00075725|4277254|P11|Overall Study|Other|0
1319116|NCT00075725|4277255|P10|Overall Study|Other|1
1319117|NCT00075725|4277256|P9|Overall Study|Other|2
1319118|NCT00075725|4277257|P8|Overall Study|Other|9
1319119|NCT00075725|4277258|P7|Overall Study|Other|2
1319120|NCT00075725|4277259|P6|Overall Study|Other|4
1319121|NCT00075725|4277260|P5|Overall Study|Other|1
1319122|NCT00075725|4277261|P4|Overall Study|Other|1
1319123|NCT00075725|4277262|P3|Overall Study|Other|1
1319124|NCT00075725|4277263|P2|Overall Study|Other|2
1319125|NCT00075725|4277264|P1|Overall Study|Other|4
1319126|NCT00075725|4277253|P12|Overall Study|Inevaluable|0
1319127|NCT00075725|4277254|P11|Overall Study|Inevaluable|1
1319128|NCT00075725|4277255|P10|Overall Study|Inevaluable|0
1319129|NCT00075725|4277256|P9|Overall Study|Inevaluable|2
1319130|NCT00075725|4277257|P8|Overall Study|Inevaluable|11
1319131|NCT00075725|4277258|P7|Overall Study|Inevaluable|1
1319132|NCT00075725|4277259|P6|Overall Study|Inevaluable|9
1319133|NCT00075725|4277260|P5|Overall Study|Inevaluable|2
1319134|NCT00075725|4277261|P4|Overall Study|Inevaluable|2
1319135|NCT00075725|4277262|P3|Overall Study|Inevaluable|4
1319136|NCT00075725|4277263|P2|Overall Study|Inevaluable|1
1319137|NCT00075725|4277264|P1|Overall Study|Inevaluable|1
1319138|NCT00075725|4277253|P12|Overall Study|Pt has very high risk ALL characteristic|3
1319139|NCT00075725|4277254|P11|Overall Study|Pt has very high risk ALL characteristic|0
1319140|NCT00075725|4277255|P10|Overall Study|Pt has very high risk ALL characteristic|1
1319141|NCT00075725|4277256|P9|Overall Study|Pt has very high risk ALL characteristic|29
1319142|NCT00075725|4277257|P8|Overall Study|Pt has very high risk ALL characteristic|74
1319143|NCT00075725|4277258|P7|Overall Study|Pt has very high risk ALL characteristic|23
1319144|NCT00075725|4277259|P6|Overall Study|Pt has very high risk ALL characteristic|75
1319145|NCT00075725|4277260|P5|Overall Study|Pt has very high risk ALL characteristic|11
1319146|NCT00075725|4277261|P4|Overall Study|Pt has very high risk ALL characteristic|18
1319147|NCT00075725|4277262|P3|Overall Study|Pt has very high risk ALL characteristic|26
1319148|NCT00075725|4277263|P2|Overall Study|Pt has very high risk ALL characteristic|11
1319149|NCT00075725|4277264|P1|Overall Study|Pt has very high risk ALL characteristic|15
1319150|NCT00075725|4277253|P12|Overall Study|MRD positive after extended ind|0
1319151|NCT00075725|4277254|P11|Overall Study|MRD positive after extended ind|0
1319152|NCT00075725|4277255|P10|Overall Study|MRD positive after extended ind|0
1319153|NCT00075725|4277256|P9|Overall Study|MRD positive after extended ind|0
1319154|NCT00075725|4277257|P8|Overall Study|MRD positive after extended ind|1
1319155|NCT00075725|4277258|P7|Overall Study|MRD positive after extended ind|0
1319156|NCT00075725|4277259|P6|Overall Study|MRD positive after extended ind|2
1319157|NCT00075725|4277260|P5|Overall Study|MRD positive after extended ind|1
1319158|NCT00075725|4277261|P4|Overall Study|MRD positive after extended ind|0
1319159|NCT00075725|4277262|P3|Overall Study|MRD positive after extended ind|1
1319160|NCT00075725|4277263|P2|Overall Study|MRD positive after extended ind|1
1319161|NCT00075725|4277264|P1|Overall Study|MRD positive after extended ind|0
1319162|NCT00075725|4277253|P12|Overall Study|Insurance issues|0
1319163|NCT00075725|4277254|P11|Overall Study|Insurance issues|0
1319164|NCT00075725|4277255|P10|Overall Study|Insurance issues|0
1319165|NCT00075725|4277256|P9|Overall Study|Insurance issues|0
1319166|NCT00075725|4277257|P8|Overall Study|Insurance issues|1
1319167|NCT00075725|4277258|P7|Overall Study|Insurance issues|0
1319168|NCT00075725|4277259|P6|Overall Study|Insurance issues|1
1319169|NCT00075725|4277260|P5|Overall Study|Insurance issues|1
1319170|NCT00075725|4277261|P4|Overall Study|Insurance issues|1
1319171|NCT00075725|4277262|P3|Overall Study|Insurance issues|0
1319172|NCT00075725|4277263|P2|Overall Study|Insurance issues|1
1319173|NCT00075725|4277264|P1|Overall Study|Insurance issues|0
1319174|NCT00075725|4277253|P12|Overall Study|Pt age out of range for treatment|0
1319175|NCT00075725|4277254|P11|Overall Study|Pt age out of range for treatment|0
1319176|NCT00075725|4277255|P10|Overall Study|Pt age out of range for treatment|0
1319177|NCT00075725|4277256|P9|Overall Study|Pt age out of range for treatment|0
1319178|NCT00075725|4277257|P8|Overall Study|Pt age out of range for treatment|1
1319179|NCT00075725|4277258|P7|Overall Study|Pt age out of range for treatment|0
1319180|NCT00075725|4277259|P6|Overall Study|Pt age out of range for treatment|1
1319181|NCT00075725|4277260|P5|Overall Study|Pt age out of range for treatment|0
1319182|NCT00075725|4277261|P4|Overall Study|Pt age out of range for treatment|0
1319183|NCT00075725|4277262|P3|Overall Study|Pt age out of range for treatment|0
1319184|NCT00075725|4277263|P2|Overall Study|Pt age out of range for treatment|1
1319185|NCT00075725|4277264|P1|Overall Study|Pt age out of range for treatment|0
1319186|NCT00075725|4277253|P12|Overall Study|Pt non compliant with therapy|0
1319187|NCT00075725|4277254|P11|Overall Study|Pt non compliant with therapy|0
1319188|NCT00075725|4277255|P10|Overall Study|Pt non compliant with therapy|0
1319189|NCT00075725|4277256|P9|Overall Study|Pt non compliant with therapy|3
1319190|NCT00075725|4277257|P8|Overall Study|Pt non compliant with therapy|5
1319191|NCT00075725|4277258|P7|Overall Study|Pt non compliant with therapy|2
1319192|NCT00075725|4277259|P6|Overall Study|Pt non compliant with therapy|14
1319193|NCT00075725|4277260|P5|Overall Study|Pt non compliant with therapy|2
1319194|NCT00075725|4277261|P4|Overall Study|Pt non compliant with therapy|0
1319195|NCT00075725|4277262|P3|Overall Study|Pt non compliant with therapy|1
1319196|NCT00075725|4277263|P2|Overall Study|Pt non compliant with therapy|1
1319197|NCT00075725|4277264|P1|Overall Study|Pt non compliant with therapy|2
1319198|NCT00075725|4277253|P12|Overall Study|Pt/Guardian refused RT therapy|0
1319199|NCT00075725|4277254|P11|Overall Study|Pt/Guardian refused RT therapy|0
1319200|NCT00075725|4277255|P10|Overall Study|Pt/Guardian refused RT therapy|0
1319201|NCT00075725|4277256|P9|Overall Study|Pt/Guardian refused RT therapy|0
1319202|NCT00075725|4277257|P8|Overall Study|Pt/Guardian refused RT therapy|0
1319203|NCT00075725|4277258|P7|Overall Study|Pt/Guardian refused RT therapy|0
1319204|NCT00075725|4277259|P6|Overall Study|Pt/Guardian refused RT therapy|0
1319205|NCT00075725|4277260|P5|Overall Study|Pt/Guardian refused RT therapy|1
1319206|NCT00075725|4277261|P4|Overall Study|Pt/Guardian refused RT therapy|2
1319207|NCT00075725|4277262|P3|Overall Study|Pt/Guardian refused RT therapy|1
1319208|NCT00075725|4277263|P2|Overall Study|Pt/Guardian refused RT therapy|0
1319209|NCT00075725|4277264|P1|Overall Study|Pt/Guardian refused RT therapy|1
1319210|NCT00075725|4277253|P12|Overall Study|Ineligible or wrong diagnosis|4
1319211|NCT00075725|4277254|P11|Overall Study|Ineligible or wrong diagnosis|2
1319212|NCT00075725|4277255|P10|Overall Study|Ineligible or wrong diagnosis|1
1319213|NCT00075725|4277256|P9|Overall Study|Ineligible or wrong diagnosis|10
1319214|NCT00075725|4277257|P8|Overall Study|Ineligible or wrong diagnosis|9
1319215|NCT00075725|4277258|P7|Overall Study|Ineligible or wrong diagnosis|6
1319216|NCT00075725|4277259|P6|Overall Study|Ineligible or wrong diagnosis|17
1319217|NCT00075725|4277260|P5|Overall Study|Ineligible or wrong diagnosis|3
1319218|NCT00075725|4277261|P4|Overall Study|Ineligible or wrong diagnosis|10
1319219|NCT00075725|4277262|P3|Overall Study|Ineligible or wrong diagnosis|3
1319220|NCT00075725|4277263|P2|Overall Study|Ineligible or wrong diagnosis|3
1319221|NCT00075725|4277264|P1|Overall Study|Ineligible or wrong diagnosis|8
1319222|NCT00075725|4277253|P12|Overall Study|Patient off treatment|0
1319223|NCT00075725|4277254|P11|Overall Study|Patient off treatment|0
1319224|NCT00075725|4277255|P10|Overall Study|Patient off treatment|0
1319225|NCT00075725|4277256|P9|Overall Study|Patient off treatment|1
1319226|NCT00075725|4277257|P8|Overall Study|Patient off treatment|2
1319227|NCT00075725|4277258|P7|Overall Study|Patient off treatment|0
1319228|NCT00075725|4277259|P6|Overall Study|Patient off treatment|0
1319229|NCT00075725|4277260|P5|Overall Study|Patient off treatment|1
1319230|NCT00075725|4277261|P4|Overall Study|Patient off treatment|2
1319231|NCT00075725|4277262|P3|Overall Study|Patient off treatment|1
1319232|NCT00075725|4277263|P2|Overall Study|Patient off treatment|0
1319233|NCT00075725|4277264|P1|Overall Study|Patient off treatment|0
1319234|NCT00075725|4277253|P12|Overall Study|Disease Progression, all other reasons|5
1319235|NCT00075725|4277254|P11|Overall Study|Disease Progression, all other reasons|0
1319236|NCT00075725|4277255|P10|Overall Study|Disease Progression, all other reasons|4
1319237|NCT00075725|4277256|P9|Overall Study|Disease Progression, all other reasons|21
1319238|NCT00075725|4277257|P8|Overall Study|Disease Progression, all other reasons|46
1319239|NCT00075725|4277258|P7|Overall Study|Disease Progression, all other reasons|20
1319240|NCT00075725|4277259|P6|Overall Study|Disease Progression, all other reasons|59
1319241|NCT00075725|4277260|P5|Overall Study|Disease Progression, all other reasons|21
1319242|NCT00075725|4277261|P4|Overall Study|Disease Progression, all other reasons|6
1319243|NCT00075725|4277262|P3|Overall Study|Disease Progression, all other reasons|33
1319244|NCT00075725|4277263|P2|Overall Study|Disease Progression, all other reasons|5
1319245|NCT00075725|4277264|P1|Overall Study|Disease Progression, all other reasons|17
1319246|NCT00075725|4277253|P12|Overall Study|Withdrawal by Subject|0
1319247|NCT00075725|4277254|P11|Overall Study|Withdrawal by Subject|0
1319248|NCT00075725|4277255|P10|Overall Study|Withdrawal by Subject|2
1319249|NCT00075725|4277256|P9|Overall Study|Withdrawal by Subject|10
1319250|NCT00075725|4277257|P8|Overall Study|Withdrawal by Subject|31
1319251|NCT00075725|4277258|P7|Overall Study|Withdrawal by Subject|7
1319252|NCT00075725|4277259|P6|Overall Study|Withdrawal by Subject|27
1319253|NCT00075725|4277260|P5|Overall Study|Withdrawal by Subject|6
1319254|NCT00075725|4277261|P4|Overall Study|Withdrawal by Subject|10
1319255|NCT00075725|4277262|P3|Overall Study|Withdrawal by Subject|6
1319256|NCT00075725|4277263|P2|Overall Study|Withdrawal by Subject|3
1319257|NCT00075725|4277264|P1|Overall Study|Withdrawal by Subject|12
1319258|NCT00075725|4277253|P12|Overall Study|Protocol Violation|1
1319259|NCT00075725|4277254|P11|Overall Study|Protocol Violation|0
1319260|NCT00075725|4277255|P10|Overall Study|Protocol Violation|0
1319261|NCT00075725|4277256|P9|Overall Study|Protocol Violation|3
1319262|NCT00075725|4277257|P8|Overall Study|Protocol Violation|2
1319263|NCT00075725|4277258|P7|Overall Study|Protocol Violation|1
1319264|NCT00075725|4277259|P6|Overall Study|Protocol Violation|2
1319265|NCT00075725|4277260|P5|Overall Study|Protocol Violation|3
1319266|NCT00075725|4277261|P4|Overall Study|Protocol Violation|3
1319267|NCT00075725|4277262|P3|Overall Study|Protocol Violation|0
1319268|NCT00075725|4277263|P2|Overall Study|Protocol Violation|1
1319269|NCT00075725|4277264|P1|Overall Study|Protocol Violation|1
1319270|NCT00075725|4277253|P12|Overall Study|Pregnancy|0
1319271|NCT00075725|4277254|P11|Overall Study|Pregnancy|0
1319272|NCT00075725|4277255|P10|Overall Study|Pregnancy|0
1319273|NCT00075725|4277256|P9|Overall Study|Pregnancy|0
1319274|NCT00075725|4277257|P8|Overall Study|Pregnancy|1
1319275|NCT00075725|4277258|P7|Overall Study|Pregnancy|0
1319276|NCT00075725|4277259|P6|Overall Study|Pregnancy|1
1319277|NCT00075725|4277260|P5|Overall Study|Pregnancy|0
1319278|NCT00075725|4277261|P4|Overall Study|Pregnancy|0
1319279|NCT00075725|4277262|P3|Overall Study|Pregnancy|0
1319280|NCT00075725|4277263|P2|Overall Study|Pregnancy|0
1319281|NCT00075725|4277264|P1|Overall Study|Pregnancy|0
1319282|NCT00075725|4277253|P12|Overall Study|Physician Decision|0
1319283|NCT00075725|4277254|P11|Overall Study|Physician Decision|1
1319284|NCT00075725|4277255|P10|Overall Study|Physician Decision|0
1319285|NCT00075725|4277256|P9|Overall Study|Physician Decision|5
1319286|NCT00075725|4277257|P8|Overall Study|Physician Decision|17
1319287|NCT00075725|4277258|P7|Overall Study|Physician Decision|3
1319288|NCT00075725|4277259|P6|Overall Study|Physician Decision|19
1319289|NCT00075725|4277260|P5|Overall Study|Physician Decision|4
1319290|NCT00075725|4277261|P4|Overall Study|Physician Decision|8
1319291|NCT00075725|4277262|P3|Overall Study|Physician Decision|5
1319292|NCT00075725|4277263|P2|Overall Study|Physician Decision|6
1319293|NCT00075725|4277264|P1|Overall Study|Physician Decision|2
1319294|NCT00075725|4277253|P12|Overall Study|Lost to Follow-up|0
1319295|NCT00075725|4277254|P11|Overall Study|Lost to Follow-up|0
1319296|NCT00075725|4277255|P10|Overall Study|Lost to Follow-up|0
1319297|NCT00075725|4277256|P9|Overall Study|Lost to Follow-up|1
1319298|NCT00075725|4277257|P8|Overall Study|Lost to Follow-up|4
1319299|NCT00075725|4277258|P7|Overall Study|Lost to Follow-up|2
1319300|NCT00075725|4277259|P6|Overall Study|Lost to Follow-up|13
1319301|NCT00075725|4277260|P5|Overall Study|Lost to Follow-up|0
1319302|NCT00075725|4277261|P4|Overall Study|Lost to Follow-up|1
1319303|NCT00075725|4277262|P3|Overall Study|Lost to Follow-up|4
1319304|NCT00075725|4277263|P2|Overall Study|Lost to Follow-up|1
1319305|NCT00075725|4277264|P1|Overall Study|Lost to Follow-up|1
1319306|NCT00075725|4277253|P12|Overall Study|Death|0
1319307|NCT00075725|4277254|P11|Overall Study|Death|3
1319308|NCT00075725|4277255|P10|Overall Study|Death|4
1319309|NCT00075725|4277256|P9|Overall Study|Death|14
1319310|NCT00075725|4277257|P8|Overall Study|Death|22
1319311|NCT00075725|4277258|P7|Overall Study|Death|4
1319312|NCT00075725|4277259|P6|Overall Study|Death|25
1319313|NCT00075725|4277260|P5|Overall Study|Death|3
1319314|NCT00075725|4277261|P4|Overall Study|Death|2
1319315|NCT00075725|4277262|P3|Overall Study|Death|10
1319316|NCT00075725|4277263|P2|Overall Study|Death|5
1319317|NCT00075725|4277264|P1|Overall Study|Death|3
1319318|NCT00075725|4277253|P12|Overall Study|Adverse Event|2
1319319|NCT00075725|4277254|P11|Overall Study|Adverse Event|2
1319320|NCT00075725|4277255|P10|Overall Study|Adverse Event|4
1319321|NCT00075725|4277256|P9|Overall Study|Adverse Event|15
1319322|NCT00075725|4277257|P8|Overall Study|Adverse Event|51
1319323|NCT00075725|4277258|P7|Overall Study|Adverse Event|3
1319324|NCT00075725|4277259|P6|Overall Study|Adverse Event|38
1319325|NCT00075725|4277260|P5|Overall Study|Adverse Event|4
1319326|NCT00075725|4277261|P4|Overall Study|Adverse Event|8
1319327|NCT00075725|4277262|P3|Overall Study|Adverse Event|20
1319328|NCT00075725|4277263|P2|Overall Study|Adverse Event|6
1319329|NCT00075725|4277264|P1|Overall Study|Adverse Event|6
1319330|NCT00075582|4277361|P2|Overall Study|Ineligible for study|16
1319331|NCT00075582|4277362|P1|Overall Study|Ineligible for study|36
1319332|NCT00075582|4277361|P2|Overall Study|Withdrawal by Subject|2
1319333|NCT00075582|4277362|P1|Overall Study|Withdrawal by Subject|2
1319334|NCT00075582|4277361|P2|Overall Study|Physician Decision|8
1319335|NCT00075582|4277362|P1|Overall Study|Physician Decision|5
1319336|NCT00075582|4277361|P2|Overall Study|Lack of Efficacy|8
1319337|NCT00075582|4277362|P1|Overall Study|Lack of Efficacy|4
1319338|NCT00075582|4277361|P2|Overall Study|Adverse Event|1
1319339|NCT00075582|4277362|P1|Overall Study|Adverse Event|3
1319340|NCT00075504|4277372|P2|Overall Study|Withdrawal by Subject|7
1319341|NCT00075504|4277373|P1|Overall Study|Withdrawal by Subject|9
1319342|NCT00075478|4277385|P2|Overall Study|Physician Decision|1
1319343|NCT00075478|4277386|P1|Overall Study|Physician Decision|0
1319344|NCT00075478|4277385|P2|Overall Study|not eligible|0
1319345|NCT00075478|4277386|P1|Overall Study|not eligible|1
1319346|NCT00075400|4277406|P1|Overall Study|Never treated|2
1319347|NCT00075400|4277406|P1|Overall Study|Ineligible: wrong primary|1
1319348|NCT00075270|4277427|P2|Overall Study|Missing|13
1319349|NCT00075270|4277428|P1|Overall Study|Missing|26
1319350|NCT00075270|4277427|P2|Overall Study|Other/Unknown|5
1319351|NCT00075270|4277428|P1|Overall Study|Other/Unknown|9
1319352|NCT00075270|4277427|P2|Overall Study|Death|215
1319353|NCT00075270|4277428|P1|Overall Study|Death|198
1319354|NCT00075270|4277427|P2|Overall Study|Protocol Violation|2
1319355|NCT00075270|4277428|P1|Overall Study|Protocol Violation|0
1319356|NCT00075270|4277427|P2|Overall Study|Lost to Follow-up|28
1319357|NCT00075270|4277428|P1|Overall Study|Lost to Follow-up|25
1319358|NCT00075270|4277427|P2|Overall Study|Withdrawal by Subject|21
1319359|NCT00075270|4277428|P1|Overall Study|Withdrawal by Subject|28
1319360|NCT00075218|4277474|P3|Open-Label Treatment|enrolled in a separate continuation|9
1319361|NCT00075218|4277475|P2|Open-Label Treatment|enrolled in a separate continuation|0
1319362|NCT00075218|4277476|P1|Open-Label Treatment|enrolled in a separate continuation|0
1319363|NCT00075218|4277474|P3|Open-Label Treatment|Protocol Violation|1
1319364|NCT00075218|4277475|P2|Open-Label Treatment|Protocol Violation|0
1319365|NCT00075218|4277476|P1|Open-Label Treatment|Protocol Violation|0
1319366|NCT00075218|4277474|P3|Open-Label Treatment|Decision of Sponsor|8
1319367|NCT00075218|4277475|P2|Open-Label Treatment|Decision of Sponsor|0
1319368|NCT00075218|4277476|P1|Open-Label Treatment|Decision of Sponsor|0
1319369|NCT00075218|4277474|P3|Open-Label Treatment|Withdrawal by Subject|12
1319370|NCT00075218|4277475|P2|Open-Label Treatment|Withdrawal by Subject|0
1319371|NCT00075218|4277476|P1|Open-Label Treatment|Withdrawal by Subject|0
1319372|NCT00075218|4277474|P3|Open-Label Treatment|Adverse Event|51
1319373|NCT00075218|4277475|P2|Open-Label Treatment|Adverse Event|0
1319374|NCT00075218|4277476|P1|Open-Label Treatment|Adverse Event|0
1319375|NCT00075218|4277474|P3|Open-Label Treatment|Lack of Efficacy|174
1319376|NCT00075218|4277475|P2|Open-Label Treatment|Lack of Efficacy|0
1319377|NCT00075218|4277476|P1|Open-Label Treatment|Lack of Efficacy|0
1319378|NCT00075218|4277474|P3|Double-Blind Treatment|No study medication taken|0
1319379|NCT00075218|4277475|P2|Double-Blind Treatment|No study medication taken|0
1319380|NCT00075218|4277476|P1|Double-Blind Treatment|No study medication taken|2
1319381|NCT00075218|4277474|P3|Double-Blind Treatment|Decision of Sponsor|0
1319382|NCT00075218|4277475|P2|Double-Blind Treatment|Decision of Sponsor|1
1319383|NCT00075218|4277476|P1|Double-Blind Treatment|Decision of Sponsor|0
1319384|NCT00075218|4277474|P3|Double-Blind Treatment|Lack of Efficacy|0
1319385|NCT00075218|4277475|P2|Double-Blind Treatment|Lack of Efficacy|6
1319386|NCT00075218|4277476|P1|Double-Blind Treatment|Lack of Efficacy|58
1319387|NCT00075218|4277474|P3|Double-Blind Treatment|Lost to Follow-up|0
1319388|NCT00075218|4277475|P2|Double-Blind Treatment|Lost to Follow-up|0
1319389|NCT00075218|4277476|P1|Double-Blind Treatment|Lost to Follow-up|1
1319390|NCT00075218|4277474|P3|Double-Blind Treatment|Withdrawal by Subject|0
1319391|NCT00075218|4277475|P2|Double-Blind Treatment|Withdrawal by Subject|4
1319392|NCT00075218|4277476|P1|Double-Blind Treatment|Withdrawal by Subject|7
1319393|NCT00075218|4277474|P3|Double-Blind Treatment|Adverse Event|0
1319394|NCT00075218|4277475|P2|Double-Blind Treatment|Adverse Event|4
1319395|NCT00075218|4277476|P1|Double-Blind Treatment|Adverse Event|23
1319396|NCT00075023|4277525|P2|Pilot Study|Withdrawal by Subject|0
1319397|NCT00075023|4277526|P1|Pilot Study|Withdrawal by Subject|1
1319398|NCT00075023|4277525|P2|Pilot Study|Physician Decision|2
1319399|NCT00075023|4277526|P1|Pilot Study|Physician Decision|1
1319400|NCT00074984|4277535|P2|Overall Study|Patient Withdrawn Per Protocol|3
1319401|NCT00074984|4277536|P1|Overall Study|Patient Withdrawn Per Protocol|0
1319402|NCT00074984|4277535|P2|Overall Study|Withdrawal by Subject|3
1319403|NCT00074984|4277536|P1|Overall Study|Withdrawal by Subject|2
1319404|NCT00074984|4277535|P2|Overall Study|Death|2
1319405|NCT00074984|4277536|P1|Overall Study|Death|1
1319406|NCT00074958|4277551|P1|Overall Study|Adverse Event|1
1319407|NCT00074711|4277592|P2|Overall Study|Participant stopped study drug|6
1319408|NCT00074711|4277593|P1|Overall Study|Participant stopped study drug|4
1319409|NCT00074711|4277592|P2|Overall Study|Lost to Follow-up|8
1319410|NCT00074711|4277593|P1|Overall Study|Lost to Follow-up|10
1319411|NCT00074711|4277592|P2|Overall Study|Withdrawal by Subject|1
1319412|NCT00074711|4277593|P1|Overall Study|Withdrawal by Subject|1
1319413|NCT00074581|4277611|P2|Overall Study|Other|19
1319414|NCT00074581|4277612|P1|Overall Study|Other|14
1319415|NCT00074581|4277611|P2|Overall Study|Ended relationship w. index participant|106
1319416|NCT00074581|4277612|P1|Overall Study|Ended relationship w. index participant|117
1319417|NCT00074581|4277611|P2|Overall Study|Lost to Follow-up|11
1319418|NCT00074581|4277612|P1|Overall Study|Lost to Follow-up|16
1319419|NCT00074581|4277611|P2|Overall Study|Were withdrawn by investigator|2
1319420|NCT00074581|4277612|P1|Overall Study|Were withdrawn by investigator|5
1319421|NCT00074581|4277611|P2|Overall Study|Relocated|9
1319422|NCT00074581|4277612|P1|Overall Study|Relocated|14
1319423|NCT00074581|4277611|P2|Overall Study|Unable to adhere to visit schedule|14
1319424|NCT00074581|4277612|P1|Overall Study|Unable to adhere to visit schedule|13
1319425|NCT00074581|4277611|P2|Overall Study|Withdrawal by Subject|49
1319426|NCT00074581|4277612|P1|Overall Study|Withdrawal by Subject|50
1319427|NCT00074581|4277611|P2|Overall Study|Death|16
1319428|NCT00074581|4277612|P1|Overall Study|Death|15
1319429|NCT00074490|4277625|P6|Overall Study|Progressive malignancy|0
1319430|NCT00074490|4277626|P5|Overall Study|Progressive malignancy|3
1319431|NCT00074490|4277627|P4|Overall Study|Progressive malignancy|0
1319432|NCT00074490|4277628|P3|Overall Study|Progressive malignancy|0
1319433|NCT00074490|4277629|P2|Overall Study|Progressive malignancy|7
1319434|NCT00074490|4277630|P1|Overall Study|Progressive malignancy|0
1319435|NCT00074412|4277664|P2|Overall Study|Lost to Follow-up|58
1319436|NCT00074412|4277665|P1|Overall Study|Lost to Follow-up|52
1319437|NCT00074412|4277664|P2|Overall Study|Death|26
1319438|NCT00074412|4277665|P1|Overall Study|Death|30
1319439|NCT00074152|4277713|P2|Overall Study|Lack of Efficacy|24
1319440|NCT00074152|4277714|P1|Overall Study|Lack of Efficacy|34
1319441|NCT00074152|4277713|P2|Overall Study|Death|9
1319442|NCT00074152|4277714|P1|Overall Study|Death|21
1319443|NCT00073983|4277731|P1|Overall Study|not evaluable|1
1319444|NCT00073918|4277752|P1|Overall Study|Eligibility requirement not met-low CD20|1
1319445|NCT00073918|4277752|P1|Overall Study|Rapid disease progression|2
1319446|NCT00073918|4277752|P1|Overall Study|Eligibility requirement not met - HAMA+|1
1319447|NCT00073749|4277766|P7|Overall Study|Other|0
1319448|NCT00073749|4277767|P6|Overall Study|Other|2
1319449|NCT00073749|4277768|P5|Overall Study|Other|0
1319450|NCT00073749|4277769|P4|Overall Study|Other|0
1319451|NCT00073749|4277770|P3|Overall Study|Other|0
1319452|NCT00073749|4277771|P2|Overall Study|Other|0
1319453|NCT00073749|4277772|P1|Overall Study|Other|0
1319454|NCT00073749|4277766|P7|Overall Study|Lost to Follow-up|2
1319455|NCT00073749|4277767|P6|Overall Study|Lost to Follow-up|0
1319456|NCT00073749|4277768|P5|Overall Study|Lost to Follow-up|0
1319457|NCT00073749|4277769|P4|Overall Study|Lost to Follow-up|0
1319458|NCT00073749|4277770|P3|Overall Study|Lost to Follow-up|0
1319459|NCT00073749|4277771|P2|Overall Study|Lost to Follow-up|0
1319460|NCT00073749|4277772|P1|Overall Study|Lost to Follow-up|0
1319461|NCT00073749|4277766|P7|Overall Study|Discontinuation of Study by Sponsor|4
1319462|NCT00073749|4277767|P6|Overall Study|Discontinuation of Study by Sponsor|0
1319463|NCT00073749|4277768|P5|Overall Study|Discontinuation of Study by Sponsor|0
1319464|NCT00073749|4277769|P4|Overall Study|Discontinuation of Study by Sponsor|0
1319465|NCT00073749|4277770|P3|Overall Study|Discontinuation of Study by Sponsor|0
1319466|NCT00073749|4277771|P2|Overall Study|Discontinuation of Study by Sponsor|0
1319467|NCT00073749|4277772|P1|Overall Study|Discontinuation of Study by Sponsor|0
1319468|NCT00073749|4277766|P7|Overall Study|Withdrawal by Subject|2
1319469|NCT00073749|4277767|P6|Overall Study|Withdrawal by Subject|0
1319470|NCT00073749|4277768|P5|Overall Study|Withdrawal by Subject|1
1319471|NCT00073749|4277769|P4|Overall Study|Withdrawal by Subject|0
1319472|NCT00073749|4277770|P3|Overall Study|Withdrawal by Subject|0
1319473|NCT00073749|4277771|P2|Overall Study|Withdrawal by Subject|1
1319474|NCT00073749|4277772|P1|Overall Study|Withdrawal by Subject|0
1319475|NCT00073749|4277766|P7|Overall Study|Physician Decision|0
1319476|NCT00073749|4277767|P6|Overall Study|Physician Decision|2
1319477|NCT00073749|4277768|P5|Overall Study|Physician Decision|0
1319478|NCT00073749|4277769|P4|Overall Study|Physician Decision|0
1319479|NCT00073749|4277770|P3|Overall Study|Physician Decision|1
1319480|NCT00073749|4277771|P2|Overall Study|Physician Decision|0
1319481|NCT00073749|4277772|P1|Overall Study|Physician Decision|0
1319482|NCT00073749|4277766|P7|Overall Study|Adverse Event|0
1319483|NCT00073749|4277767|P6|Overall Study|Adverse Event|1
1319484|NCT00073749|4277768|P5|Overall Study|Adverse Event|2
1319485|NCT00073749|4277769|P4|Overall Study|Adverse Event|4
1319486|NCT00073749|4277770|P3|Overall Study|Adverse Event|6
1319487|NCT00073749|4277771|P2|Overall Study|Adverse Event|3
1319488|NCT00073749|4277772|P1|Overall Study|Adverse Event|0
1319489|NCT00073749|4277766|P7|Overall Study|Death|29
1319490|NCT00073749|4277767|P6|Overall Study|Death|0
1319491|NCT00073749|4277768|P5|Overall Study|Death|0
1319492|NCT00073749|4277769|P4|Overall Study|Death|0
1319493|NCT00073749|4277770|P3|Overall Study|Death|1
1319494|NCT00073749|4277771|P2|Overall Study|Death|1
1319495|NCT00073749|4277772|P1|Overall Study|Death|0
1319496|NCT00073749|4277766|P7|Overall Study|Disease Progression|3
1319497|NCT00073749|4277767|P6|Overall Study|Disease Progression|1
1319498|NCT00073749|4277768|P5|Overall Study|Disease Progression|3
1319499|NCT00073749|4277769|P4|Overall Study|Disease Progression|2
1319500|NCT00073749|4277770|P3|Overall Study|Disease Progression|3
1319501|NCT00073749|4277771|P2|Overall Study|Disease Progression|0
1319502|NCT00073749|4277772|P1|Overall Study|Disease Progression|2
1319503|NCT00073528|4277803|P2|Overall Study|Ongoing|344
1319504|NCT00073528|4277804|P1|Overall Study|Ongoing|349
1319505|NCT00073528|4277803|P2|Overall Study|Non-compliance|1
1319506|NCT00073528|4277804|P1|Overall Study|Non-compliance|0
1319507|NCT00073528|4277803|P2|Overall Study|Enrolled in Error|1
1319508|NCT00073528|4277804|P1|Overall Study|Enrolled in Error|0
1319509|NCT00073528|4277803|P2|Overall Study|Participant Was Unblinded|1
1319510|NCT00073528|4277804|P1|Overall Study|Participant Was Unblinded|0
1319511|NCT00073528|4277803|P2|Overall Study|Progressive Disease|1
1319512|NCT00073528|4277804|P1|Overall Study|Progressive Disease|0
1319513|NCT00073528|4277803|P2|Overall Study|Randomized in Error; Not Treated|0
1319514|NCT00073528|4277804|P1|Overall Study|Randomized in Error; Not Treated|2
1319515|NCT00073528|4277803|P2|Overall Study|Mastectomy Intervention|0
1319516|NCT00073528|4277804|P1|Overall Study|Mastectomy Intervention|1
1319517|NCT00073528|4277803|P2|Overall Study|Death|238
1319518|NCT00073528|4277804|P1|Overall Study|Death|229
1319519|NCT00073528|4277803|P2|Overall Study|Protocol Violation|5
1319520|NCT00073528|4277804|P1|Overall Study|Protocol Violation|3
1319521|NCT00073528|4277803|P2|Overall Study|Lost to Follow-up|22
1319522|NCT00073528|4277804|P1|Overall Study|Lost to Follow-up|26
1319523|NCT00073528|4277803|P2|Overall Study|Withdrawal by Subject|29
1319524|NCT00073528|4277804|P1|Overall Study|Withdrawal by Subject|34
1319525|NCT00073307|4277893|P3|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83
1319526|NCT00073307|4277894|P2|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0
1319527|NCT00073307|4277895|P1|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35
1319528|NCT00073307|4277893|P3|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9
1319529|NCT00073307|4277894|P2|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0
1319530|NCT00073307|4277895|P1|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19
1319531|NCT00073307|4277893|P3|Open Label-Sorafenib Only [30Jun2008]|Missing|1
1319532|NCT00073307|4277894|P2|Open Label-Sorafenib Only [30Jun2008]|Missing|0
1319533|NCT00073307|4277895|P1|Open Label-Sorafenib Only [30Jun2008]|Missing|3
1319534|NCT00073307|4277893|P3|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3
1319535|NCT00073307|4277894|P2|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
1319536|NCT00073307|4277895|P1|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
1319537|NCT00073307|4277893|P3|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
1319538|NCT00073307|4277894|P2|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0
1319539|NCT00073307|4277895|P1|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
1319540|NCT00073307|4277893|P3|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
1319541|NCT00073307|4277894|P2|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0
1319542|NCT00073307|4277895|P1|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
1319543|NCT00073307|4277893|P3|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28
1319544|NCT00073307|4277894|P2|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0
1319783|NCT00071032|4278372|P1|Overall Study|Missing Primary Outcome|0
1319545|NCT00073307|4277895|P1|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37
1319546|NCT00073307|4277893|P3|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9
1319547|NCT00073307|4277894|P2|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0
1319548|NCT00073307|4277895|P1|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19
1319549|NCT00073307|4277893|P3|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
1319550|NCT00073307|4277894|P2|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0
1319551|NCT00073307|4277895|P1|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
1319552|NCT00073307|4277893|P3|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19
1319553|NCT00073307|4277894|P2|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0
1319554|NCT00073307|4277895|P1|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17
1319555|NCT00073307|4277893|P3|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
1319556|NCT00073307|4277894|P2|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1
1319557|NCT00073307|4277895|P1|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
1319558|NCT00073307|4277893|P3|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0
1319559|NCT00073307|4277894|P2|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114
1319560|NCT00073307|4277895|P1|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165
1319561|NCT00073307|4277893|P3|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
1319562|NCT00073307|4277894|P2|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1
1319563|NCT00073307|4277895|P1|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
1319564|NCT00073307|4277893|P3|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
1319565|NCT00073307|4277894|P2|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
1319566|NCT00073307|4277895|P1|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1
1319567|NCT00073307|4277893|P3|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0
1319568|NCT00073307|4277894|P2|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2
1319569|NCT00073307|4277895|P1|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1
1319570|NCT00073307|4277893|P3|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0
1319571|NCT00073307|4277894|P2|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
1319572|NCT00073307|4277895|P1|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
1319573|NCT00073307|4277893|P3|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0
1319574|NCT00073307|4277894|P2|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11
1319575|NCT00073307|4277895|P1|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6
1319576|NCT00073307|4277893|P3|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0
1319577|NCT00073307|4277894|P2|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6
1319578|NCT00073307|4277895|P1|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1
1319579|NCT00073307|4277893|P3|Double-Blind (DB, as of ~31May2005)|Adverse Event|0
1319580|NCT00073307|4277894|P2|Double-Blind (DB, as of ~31May2005)|Adverse Event|17
1319581|NCT00073307|4277895|P1|Double-Blind (DB, as of ~31May2005)|Adverse Event|22
1319582|NCT00073021|4277926|P2|Overall Study|Lack of Efficacy|5
1319583|NCT00073021|4277927|P1|Overall Study|Lack of Efficacy|11
1319584|NCT00073021|4277926|P2|Overall Study|Physician Decision|1
1319585|NCT00073021|4277927|P1|Overall Study|Physician Decision|3
1319586|NCT00073021|4277926|P2|Overall Study|Withdrawal by Subject|5
1319587|NCT00073021|4277927|P1|Overall Study|Withdrawal by Subject|6
1319588|NCT00073021|4277926|P2|Overall Study|Adverse Event|4
1319589|NCT00073021|4277927|P1|Overall Study|Adverse Event|4
1319590|NCT00073021|4277926|P2|Overall Study|Protocol Violation|1
1319591|NCT00073021|4277927|P1|Overall Study|Protocol Violation|2
1319592|NCT00073008|4277957|P2|Overall Study|"Other selected on Case Report Form"|5
1319593|NCT00073008|4277958|P1|Overall Study|"Other selected on Case Report Form"|7
1319594|NCT00073008|4277957|P2|Overall Study|Death|47
1319595|NCT00073008|4277958|P1|Overall Study|Death|46
1319596|NCT00073008|4277957|P2|Overall Study|Lost to Follow-up|3
1319597|NCT00073008|4277958|P1|Overall Study|Lost to Follow-up|1
1319598|NCT00073008|4277957|P2|Overall Study|Withdrawal by Subject|2
1319599|NCT00073008|4277958|P1|Overall Study|Withdrawal by Subject|2
1319600|NCT00073008|4277957|P2|Overall Study|Missing|6
1319601|NCT00073008|4277958|P1|Overall Study|Missing|6
1319602|NCT00072475|4277997|P1|Overall Study|Patient/Investigator Decision|4
1319603|NCT00072475|4277997|P1|Overall Study|Withdrawal by Subject|46
1319604|NCT00072475|4277997|P1|Overall Study|Death|3
1319605|NCT00072475|4277997|P1|Overall Study|Adverse Event|44
1319606|NCT00072384|4278012|P1|Overall Study|Ineligible|8
1319607|NCT00072384|4278012|P1|Overall Study|Physician Decision|1
1319608|NCT00072293|4278025|P2|Overall Study|Withdrawal by Subject|1
1319609|NCT00072293|4278026|P1|Overall Study|Withdrawal by Subject|0
1319610|NCT00072293|4278025|P2|Overall Study|Lost to Follow-up|1
1319611|NCT00072293|4278026|P1|Overall Study|Lost to Follow-up|1
1319612|NCT00072280|4278038|P2|Follow-up|Early termination of study|2
1319613|NCT00072280|4278039|P1|Follow-up|Early termination of study|2
1319614|NCT00072280|4278038|P2|Treatment|Found ineligible|2
1319615|NCT00072280|4278039|P1|Treatment|Found ineligible|1
1319616|NCT00072189|4278044|P1|Overall Study|Withdrawal by Subject|1
1319617|NCT00072176|4278052|P2|Overall Study|Protocol Violation|1
1319618|NCT00072176|4278053|P1|Overall Study|Protocol Violation|0
1319619|NCT00072176|4278052|P2|Overall Study|Withdrawal by Subject|0
1319620|NCT00072176|4278053|P1|Overall Study|Withdrawal by Subject|1
1319621|NCT00071981|4278065|P4|Overall Study|others (not specified in the study)|0
1319622|NCT00071981|4278066|P3|Overall Study|others (not specified in the study)|2
1319623|NCT00071981|4278067|P2|Overall Study|others (not specified in the study)|2
1319624|NCT00071981|4278068|P1|Overall Study|others (not specified in the study)|0
1319625|NCT00071981|4278065|P4|Overall Study|No protocol therapy|0
1319626|NCT00071981|4278066|P3|Overall Study|No protocol therapy|1
1319627|NCT00071981|4278067|P2|Overall Study|No protocol therapy|5
1319628|NCT00071981|4278068|P1|Overall Study|No protocol therapy|2
1319629|NCT00071981|4278065|P4|Overall Study|Withdrawal by Subject|0
1319630|NCT00071981|4278066|P3|Overall Study|Withdrawal by Subject|0
1319631|NCT00071981|4278067|P2|Overall Study|Withdrawal by Subject|1
1319632|NCT00071981|4278068|P1|Overall Study|Withdrawal by Subject|3
1319633|NCT00071981|4278065|P4|Overall Study|Death|1
1319634|NCT00071981|4278066|P3|Overall Study|Death|1
1319635|NCT00071981|4278067|P2|Overall Study|Death|0
1319636|NCT00071981|4278068|P1|Overall Study|Death|0
1319637|NCT00071981|4278065|P4|Overall Study|Adverse Event|1
1319638|NCT00071981|4278066|P3|Overall Study|Adverse Event|3
1319639|NCT00071981|4278067|P2|Overall Study|Adverse Event|4
1319640|NCT00071981|4278068|P1|Overall Study|Adverse Event|4
1319641|NCT00071981|4278065|P4|Overall Study|Lack of Efficacy|43
1319642|NCT00071981|4278066|P3|Overall Study|Lack of Efficacy|30
1319643|NCT00071981|4278067|P2|Overall Study|Lack of Efficacy|29
1319644|NCT00071981|4278068|P1|Overall Study|Lack of Efficacy|37
1319645|NCT00071812|4278111|P4|24-Week Open-Label Extension Period|Lack of Compliance|2
1319646|NCT00071812|4278112|P3|24-Week Open-Label Extension Period|Lack of Compliance|1
1319647|NCT00071812|4278113|P2|24-Week Open-Label Extension Period|Lack of Compliance|0
1319648|NCT00071812|4278114|P1|24-Week Open-Label Extension Period|Lack of Compliance|0
1319649|NCT00071812|4278111|P4|24-Week Open-Label Extension Period|Withdrawal by Subject|12
1319650|NCT00071812|4278112|P3|24-Week Open-Label Extension Period|Withdrawal by Subject|0
1319651|NCT00071812|4278113|P2|24-Week Open-Label Extension Period|Withdrawal by Subject|0
1319652|NCT00071812|4278114|P1|24-Week Open-Label Extension Period|Withdrawal by Subject|0
1319653|NCT00071812|4278111|P4|24-Week Open-Label Extension Period|Lost to Follow-up|2
1319654|NCT00071812|4278112|P3|24-Week Open-Label Extension Period|Lost to Follow-up|0
1319655|NCT00071812|4278113|P2|24-Week Open-Label Extension Period|Lost to Follow-up|0
1319656|NCT00071812|4278114|P1|24-Week Open-Label Extension Period|Lost to Follow-up|0
1319657|NCT00071812|4278111|P4|24-Week Open-Label Extension Period|Lack of Efficacy|17
1319658|NCT00071812|4278112|P3|24-Week Open-Label Extension Period|Lack of Efficacy|0
1319659|NCT00071812|4278113|P2|24-Week Open-Label Extension Period|Lack of Efficacy|0
1319660|NCT00071812|4278114|P1|24-Week Open-Label Extension Period|Lack of Efficacy|0
1319661|NCT00071812|4278111|P4|24-Week Open-Label Extension Period|Adverse Event|7
1319662|NCT00071812|4278112|P3|24-Week Open-Label Extension Period|Adverse Event|0
1319663|NCT00071812|4278113|P2|24-Week Open-Label Extension Period|Adverse Event|0
1319664|NCT00071812|4278114|P1|24-Week Open-Label Extension Period|Adverse Event|0
1319665|NCT00071812|4278111|P4|24-Week Double-Blind Period|Protocol Violation|1
1319666|NCT00071812|4278112|P3|24-Week Double-Blind Period|Protocol Violation|0
1319667|NCT00071812|4278113|P2|24-Week Double-Blind Period|Protocol Violation|0
1319668|NCT00071812|4278114|P1|24-Week Double-Blind Period|Protocol Violation|0
1319669|NCT00071812|4278111|P4|24-Week Double-Blind Period|Withdrawal by Subject|5
1319670|NCT00071812|4278112|P3|24-Week Double-Blind Period|Withdrawal by Subject|1
1319671|NCT00071812|4278113|P2|24-Week Double-Blind Period|Withdrawal by Subject|1
1319672|NCT00071812|4278114|P1|24-Week Double-Blind Period|Withdrawal by Subject|5
1319673|NCT00071812|4278111|P4|24-Week Double-Blind Period|Lost to Follow-up|0
1319674|NCT00071812|4278112|P3|24-Week Double-Blind Period|Lost to Follow-up|1
1319675|NCT00071812|4278113|P2|24-Week Double-Blind Period|Lost to Follow-up|1
1319676|NCT00071812|4278114|P1|24-Week Double-Blind Period|Lost to Follow-up|0
1319677|NCT00071812|4278111|P4|24-Week Double-Blind Period|Lack of Efficacy|1
1319678|NCT00071812|4278112|P3|24-Week Double-Blind Period|Lack of Efficacy|2
1319679|NCT00071812|4278113|P2|24-Week Double-Blind Period|Lack of Efficacy|1
1319680|NCT00071812|4278114|P1|24-Week Double-Blind Period|Lack of Efficacy|3
1319681|NCT00071812|4278111|P4|24-Week Double-Blind Period|Adverse Event|4
1319682|NCT00071812|4278112|P3|24-Week Double-Blind Period|Adverse Event|4
1319683|NCT00071812|4278113|P2|24-Week Double-Blind Period|Adverse Event|3
1319684|NCT00071812|4278114|P1|24-Week Double-Blind Period|Adverse Event|2
1319685|NCT00071799|4278156|P2|Overall Study|Not Documented|2
1319686|NCT00071799|4278157|P1|Overall Study|Not Documented|0
1319687|NCT00071799|4278156|P2|Overall Study|Different Central+Local Pathology Review|1
1319688|NCT00071799|4278157|P1|Overall Study|Different Central+Local Pathology Review|0
1319689|NCT00071799|4278156|P2|Overall Study|Disease Progression|20
1319690|NCT00071799|4278157|P1|Overall Study|Disease Progression|23
1319691|NCT00071799|4278156|P2|Overall Study|Lack of Efficacy|18
1319692|NCT00071799|4278157|P1|Overall Study|Lack of Efficacy|11
1319693|NCT00071799|4278156|P2|Overall Study|Physician Decision|2
1319694|NCT00071799|4278157|P1|Overall Study|Physician Decision|0
1319695|NCT00071799|4278156|P2|Overall Study|Withdrawal by Subject|37
1319696|NCT00071799|4278157|P1|Overall Study|Withdrawal by Subject|15
1319697|NCT00071799|4278156|P2|Overall Study|Lost to Follow-up|1
1319698|NCT00071799|4278157|P1|Overall Study|Lost to Follow-up|1
1319699|NCT00071799|4278156|P2|Overall Study|Protocol Violation|7
1319700|NCT00071799|4278157|P1|Overall Study|Protocol Violation|1
1319701|NCT00071799|4278156|P2|Overall Study|Adverse Event|10
1319702|NCT00071799|4278157|P1|Overall Study|Adverse Event|19
1319703|NCT00071760|4278210|P1|Overall Study|Ongoing|25
1319704|NCT00071760|4278210|P1|Overall Study|Study Team Rec./Resistance|1
1319705|NCT00071760|4278210|P1|Overall Study|Investigator's Recommendation (Rec.)|4
1319706|NCT00071760|4278210|P1|Overall Study|Relocation|1
1319707|NCT00071760|4278210|P1|Overall Study|Unavailability of RTV|8
1319708|NCT00071760|4278210|P1|Overall Study|Pulmonary Tuberculosis|1
1319709|NCT00071760|4278210|P1|Overall Study|Insufficient Viral Load Response|3
1319710|NCT00071760|4278210|P1|Overall Study|Withdrawal by Subject|3
1319711|NCT00071760|4278210|P1|Overall Study|Protocol Violation|1
1319712|NCT00071760|4278210|P1|Overall Study|Lost to Follow-up|4
1319713|NCT00071760|4278210|P1|Overall Study|Adverse Event|3
1319714|NCT00071513|4278290|P2|Follow-up Assessment|Withdrawal by Subject|6
1319715|NCT00071513|4278291|P1|Follow-up Assessment|Withdrawal by Subject|6
1319716|NCT00071513|4278290|P2|Intervention Component|Withdrawal by Subject|3
1319717|NCT00071513|4278291|P1|Intervention Component|Withdrawal by Subject|2
1319718|NCT00071487|4278303|P4|24-Week Open-Label Extension Period|Lack of Compliance|2
1319719|NCT00071487|4278304|P3|24-Week Open-Label Extension Period|Lack of Compliance|0
1319720|NCT00071487|4278305|P2|24-Week Open-Label Extension Period|Lack of Compliance|0
1319721|NCT00071487|4278306|P1|24-Week Open-Label Extension Period|Lack of Compliance|0
1319722|NCT00071487|4278303|P4|24-Week Open-Label Extension Period|Lost to Follow-up|2
1319723|NCT00071487|4278304|P3|24-Week Open-Label Extension Period|Lost to Follow-up|0
1319724|NCT00071487|4278305|P2|24-Week Open-Label Extension Period|Lost to Follow-up|0
1319725|NCT00071487|4278306|P1|24-Week Open-Label Extension Period|Lost to Follow-up|0
1319726|NCT00071487|4278303|P4|24-Week Open-Label Extension Period|Pregnancy|1
1319727|NCT00071487|4278304|P3|24-Week Open-Label Extension Period|Pregnancy|0
1319728|NCT00071487|4278305|P2|24-Week Open-Label Extension Period|Pregnancy|0
1319729|NCT00071487|4278306|P1|24-Week Open-Label Extension Period|Pregnancy|0
1319730|NCT00071487|4278303|P4|24-Week Open-Label Extension Period|Withdrawal by Subject|9
1319731|NCT00071487|4278304|P3|24-Week Open-Label Extension Period|Withdrawal by Subject|0
1319732|NCT00071487|4278305|P2|24-Week Open-Label Extension Period|Withdrawal by Subject|0
1319733|NCT00071487|4278306|P1|24-Week Open-Label Extension Period|Withdrawal by Subject|0
1319734|NCT00071487|4278303|P4|24-Week Open-Label Extension Period|Lack of Efficacy|3
1319735|NCT00071487|4278304|P3|24-Week Open-Label Extension Period|Lack of Efficacy|0
1319736|NCT00071487|4278305|P2|24-Week Open-Label Extension Period|Lack of Efficacy|0
1319737|NCT00071487|4278306|P1|24-Week Open-Label Extension Period|Lack of Efficacy|0
1319738|NCT00071487|4278303|P4|24-Week Open-Label Extension Period|Adverse Event|6
1319739|NCT00071487|4278304|P3|24-Week Open-Label Extension Period|Adverse Event|1
1319740|NCT00071487|4278305|P2|24-Week Open-Label Extension Period|Adverse Event|0
1319741|NCT00071487|4278306|P1|24-Week Open-Label Extension Period|Adverse Event|0
1319742|NCT00071487|4278303|P4|52-Week Double-Blind Period|Lack of Compliance|3
1319743|NCT00071487|4278304|P3|52-Week Double-Blind Period|Lack of Compliance|3
1319744|NCT00071487|4278305|P2|52-Week Double-Blind Period|Lack of Compliance|3
1319745|NCT00071487|4278306|P1|52-Week Double-Blind Period|Lack of Compliance|6
1319746|NCT00071487|4278303|P4|52-Week Double-Blind Period|Death|0
1319747|NCT00071487|4278304|P3|52-Week Double-Blind Period|Death|0
1319748|NCT00071487|4278305|P2|52-Week Double-Blind Period|Death|1
1319749|NCT00071487|4278306|P1|52-Week Double-Blind Period|Death|0
1319750|NCT00071487|4278303|P4|52-Week Double-Blind Period|Protocol Violation|0
1319751|NCT00071487|4278304|P3|52-Week Double-Blind Period|Protocol Violation|1
1319752|NCT00071487|4278305|P2|52-Week Double-Blind Period|Protocol Violation|1
1319753|NCT00071487|4278306|P1|52-Week Double-Blind Period|Protocol Violation|0
1319754|NCT00071487|4278303|P4|52-Week Double-Blind Period|Pregnancy|0
1319755|NCT00071487|4278304|P3|52-Week Double-Blind Period|Pregnancy|0
1319756|NCT00071487|4278305|P2|52-Week Double-Blind Period|Pregnancy|1
1319757|NCT00071487|4278306|P1|52-Week Double-Blind Period|Pregnancy|0
1319758|NCT00071487|4278303|P4|52-Week Double-Blind Period|Lost to Follow-up|2
1319759|NCT00071487|4278304|P3|52-Week Double-Blind Period|Lost to Follow-up|2
1319760|NCT00071487|4278305|P2|52-Week Double-Blind Period|Lost to Follow-up|0
1319761|NCT00071487|4278306|P1|52-Week Double-Blind Period|Lost to Follow-up|0
1319762|NCT00071487|4278303|P4|52-Week Double-Blind Period|Physician Decision|0
1319763|NCT00071487|4278304|P3|52-Week Double-Blind Period|Physician Decision|0
1319764|NCT00071487|4278305|P2|52-Week Double-Blind Period|Physician Decision|0
1319765|NCT00071487|4278306|P1|52-Week Double-Blind Period|Physician Decision|1
1319766|NCT00071487|4278303|P4|52-Week Double-Blind Period|Withdrawal by Subject|7
1319767|NCT00071487|4278304|P3|52-Week Double-Blind Period|Withdrawal by Subject|7
1319768|NCT00071487|4278305|P2|52-Week Double-Blind Period|Withdrawal by Subject|11
1319769|NCT00071487|4278306|P1|52-Week Double-Blind Period|Withdrawal by Subject|7
1319770|NCT00071487|4278303|P4|52-Week Double-Blind Period|Lack of Efficacy|1
1319771|NCT00071487|4278304|P3|52-Week Double-Blind Period|Lack of Efficacy|0
1319772|NCT00071487|4278305|P2|52-Week Double-Blind Period|Lack of Efficacy|2
1319773|NCT00071487|4278306|P1|52-Week Double-Blind Period|Lack of Efficacy|1
1319774|NCT00071487|4278303|P4|52-Week Double-Blind Period|Adverse Event|8
1319775|NCT00071487|4278304|P3|52-Week Double-Blind Period|Adverse Event|4
1319776|NCT00071487|4278305|P2|52-Week Double-Blind Period|Adverse Event|8
1319777|NCT00071487|4278306|P1|52-Week Double-Blind Period|Adverse Event|5
1319778|NCT00071396|4278350|P1|Overall Study|Physician Decision|2
1319779|NCT00071396|4278350|P1|Overall Study|Withdrawal by Subject|1
1319780|NCT00071110|4278356|P2|Overall Study|Protocol Violation|4
1319781|NCT00071110|4278357|P1|Overall Study|Protocol Violation|0
1319782|NCT00071032|4278371|P2|Overall Study|Missing Primary Outcome|1
1319784|NCT00071032|4278371|P2|Overall Study|Withdrawal by Subject|6
1319785|NCT00071032|4278372|P1|Overall Study|Withdrawal by Subject|8
1319786|NCT00071032|4278371|P2|Overall Study|Lost to Follow-up|1
1319787|NCT00071032|4278372|P1|Overall Study|Lost to Follow-up|1
1319788|NCT00071006|4278380|P1|Overall Study|Other|3
1319789|NCT00071006|4278380|P1|Overall Study|Withdrawal by Subject|1
1319790|NCT00071006|4278380|P1|Overall Study|Adverse Event|1
1319791|NCT00071006|4278380|P1|Overall Study|Lack of Efficacy|7
1319792|NCT00070941|4278393|P3|Overall Study|Adverse Event|4
1319793|NCT00070941|4278394|P2|Overall Study|Adverse Event|8
1319794|NCT00070941|4278395|P1|Overall Study|Adverse Event|10
1319795|NCT00071058|4278403|P1|Overall Study|brain tumor-removed from study|1
1319796|NCT00003907|4278410|P2|Overall Study|ineligible or not treated|2
1319797|NCT00003907|4278411|P1|Overall Study|ineligible or not treated|2
1319798|NCT00003907|4278410|P2|Overall Study|Not specified|3
1319799|NCT00003907|4278411|P1|Overall Study|Not specified|1
1319800|NCT00003907|4278410|P2|Overall Study|Complicating disease|0
1319801|NCT00003907|4278411|P1|Overall Study|Complicating disease|1
1319802|NCT00003907|4278410|P2|Overall Study|Progressive disease|4
1319803|NCT00003907|4278411|P1|Overall Study|Progressive disease|4
1319804|NCT00003907|4278410|P2|Overall Study|Withdrawal by Subject|3
1319805|NCT00003907|4278411|P1|Overall Study|Withdrawal by Subject|1
1319806|NCT00003907|4278410|P2|Overall Study|Death|0
1319807|NCT00003907|4278411|P1|Overall Study|Death|2
1319808|NCT00003907|4278410|P2|Overall Study|Adverse Event|11
1319809|NCT00003907|4278411|P1|Overall Study|Adverse Event|2
1319810|NCT00070564|4278427|P6|Overall Study|Not reported|0
1319811|NCT00070564|4278428|P5|Overall Study|Not reported|1
1319812|NCT00070564|4278429|P4|Overall Study|Not reported|0
1319813|NCT00070564|4278430|P3|Overall Study|Not reported|0
1319814|NCT00070564|4278431|P2|Overall Study|Not reported|0
1319815|NCT00070564|4278432|P1|Overall Study|Not reported|0
1319816|NCT00070564|4278427|P6|Overall Study|Withdrawal by Subject|8
1319817|NCT00070564|4278428|P5|Overall Study|Withdrawal by Subject|8
1319818|NCT00070564|4278429|P4|Overall Study|Withdrawal by Subject|30
1319819|NCT00070564|4278430|P3|Overall Study|Withdrawal by Subject|23
1319820|NCT00070564|4278431|P2|Overall Study|Withdrawal by Subject|37
1319821|NCT00070564|4278432|P1|Overall Study|Withdrawal by Subject|26
1319822|NCT00070564|4278427|P6|Overall Study|Other, not protocol specified|7
1319823|NCT00070564|4278428|P5|Overall Study|Other, not protocol specified|6
1319824|NCT00070564|4278429|P4|Overall Study|Other, not protocol specified|19
1319825|NCT00070564|4278430|P3|Overall Study|Other, not protocol specified|14
1319826|NCT00070564|4278431|P2|Overall Study|Other, not protocol specified|15
1319827|NCT00070564|4278432|P1|Overall Study|Other, not protocol specified|17
1319828|NCT00070564|4278427|P6|Overall Study|Death|1
1319829|NCT00070564|4278428|P5|Overall Study|Death|0
1319830|NCT00070564|4278429|P4|Overall Study|Death|3
1319831|NCT00070564|4278430|P3|Overall Study|Death|5
1319832|NCT00070564|4278431|P2|Overall Study|Death|1
1319833|NCT00070564|4278432|P1|Overall Study|Death|4
1319834|NCT00070564|4278427|P6|Overall Study|Adverse Event|36
1319835|NCT00070564|4278428|P5|Overall Study|Adverse Event|63
1319836|NCT00070564|4278429|P4|Overall Study|Adverse Event|108
1319837|NCT00070564|4278430|P3|Overall Study|Adverse Event|120
1319838|NCT00070564|4278431|P2|Overall Study|Adverse Event|142
1319839|NCT00070564|4278432|P1|Overall Study|Adverse Event|150
1319840|NCT00070564|4278427|P6|Overall Study|Delinquent|0
1319841|NCT00070564|4278428|P5|Overall Study|Delinquent|0
1319842|NCT00070564|4278429|P4|Overall Study|Delinquent|0
1319843|NCT00070564|4278430|P3|Overall Study|Delinquent|2
1319844|NCT00070564|4278431|P2|Overall Study|Delinquent|4
1319845|NCT00070564|4278432|P1|Overall Study|Delinquent|1
1319846|NCT00070564|4278427|P6|Overall Study|Progression|0
1319847|NCT00070564|4278428|P5|Overall Study|Progression|1
1319848|NCT00070564|4278429|P4|Overall Study|Progression|7
1319849|NCT00070564|4278430|P3|Overall Study|Progression|7
1319850|NCT00070564|4278431|P2|Overall Study|Progression|4
1319851|NCT00070564|4278432|P1|Overall Study|Progression|2
1319852|NCT00070499|4278486|P4|Overall Study|Not eligible|2
1319853|NCT00070499|4278487|P3|Overall Study|Not eligible|3
1319854|NCT00070499|4278488|P2|Overall Study|Not eligible|5
1319855|NCT00070499|4278489|P1|Overall Study|Not eligible|2
1319856|NCT00070499|4278486|P4|Overall Study|Did not start treatment|2
1319857|NCT00070499|4278487|P3|Overall Study|Did not start treatment|0
1319858|NCT00070499|4278488|P2|Overall Study|Did not start treatment|0
1319859|NCT00070499|4278489|P1|Overall Study|Did not start treatment|1
1319860|NCT00070499|4278486|P4|Overall Study|Still on protocol treatment|57
1319861|NCT00070499|4278487|P3|Overall Study|Still on protocol treatment|79
1319862|NCT00070499|4278488|P2|Overall Study|Still on protocol treatment|4
1319863|NCT00070499|4278489|P1|Overall Study|Still on protocol treatment|10
1319864|NCT00070499|4278486|P4|Overall Study|Other - not protocol specified|20
1319865|NCT00070499|4278487|P3|Overall Study|Other - not protocol specified|12
1319866|NCT00070499|4278488|P2|Overall Study|Other - not protocol specified|3
1319867|NCT00070499|4278489|P1|Overall Study|Other - not protocol specified|7
1319868|NCT00070499|4278486|P4|Overall Study|Death|2
1319869|NCT00070499|4278487|P3|Overall Study|Death|1
1319870|NCT00070499|4278488|P2|Overall Study|Death|1
1319871|NCT00070499|4278489|P1|Overall Study|Death|1
1319872|NCT00070499|4278486|P4|Overall Study|Progression/relapse|4
1319873|NCT00070499|4278487|P3|Overall Study|Progression/relapse|1
1319874|NCT00070499|4278488|P2|Overall Study|Progression/relapse|2
1319875|NCT00070499|4278489|P1|Overall Study|Progression/relapse|4
1319876|NCT00070499|4278486|P4|Overall Study|Refusal unrelated to adverse effects|8
1319877|NCT00070499|4278487|P3|Overall Study|Refusal unrelated to adverse effects|5
1319878|NCT00070499|4278488|P2|Overall Study|Refusal unrelated to adverse effects|5
1319879|NCT00070499|4278489|P1|Overall Study|Refusal unrelated to adverse effects|7
1319880|NCT00070499|4278486|P4|Overall Study|Adverse Event|15
1319881|NCT00070499|4278487|P3|Overall Study|Adverse Event|19
1319882|NCT00070499|4278488|P2|Overall Study|Adverse Event|6
1319883|NCT00070499|4278489|P1|Overall Study|Adverse Event|6
1319884|NCT00070317|4278515|P1|Overall Study|Ineligible-Inadequate pathology|6
1319885|NCT00070317|4278515|P1|Overall Study|Ineligible-Improper prior treatment|2
1319886|NCT00070317|4278515|P1|Overall Study|Ineligible required test not done|1
1319887|NCT00070317|4278515|P1|Overall Study|Ineligible Wrong Cell type/primary/stage|3
1319888|NCT00070317|4278515|P1|Overall Study|Inevaluable (Never Treated)|1
1319889|NCT00070291|4278520|P1|Step 2|Adverse Event|1
1319890|NCT00070291|4278520|P1|Step 1|Adverse Event|1
1319891|NCT00070291|4278520|P1|Step 1|Withdrawal by Subject|1
1319892|NCT00070109|4278536|P5|Overall Study|removed from prot thpy prior to chemo|0
1319893|NCT00070109|4278537|P4|Overall Study|removed from prot thpy prior to chemo|1
1319894|NCT00070109|4278538|P3|Overall Study|removed from prot thpy prior to chemo|0
1319895|NCT00070109|4278539|P2|Overall Study|removed from prot thpy prior to chemo|0
1319896|NCT00070109|4278540|P1|Overall Study|removed from prot thpy prior to chemo|0
1319897|NCT00070109|4278536|P5|Overall Study|Adverse Event|2
1319898|NCT00070109|4278537|P4|Overall Study|Adverse Event|4
1319899|NCT00070109|4278538|P3|Overall Study|Adverse Event|2
1319900|NCT00070109|4278539|P2|Overall Study|Adverse Event|0
1319901|NCT00070109|4278540|P1|Overall Study|Adverse Event|0
1319902|NCT00070109|4278536|P5|Overall Study|Withdrawal by Subject|0
1319903|NCT00070109|4278537|P4|Overall Study|Withdrawal by Subject|0
1319904|NCT00070109|4278538|P3|Overall Study|Withdrawal by Subject|1
1319905|NCT00070109|4278539|P2|Overall Study|Withdrawal by Subject|1
1319906|NCT00070109|4278540|P1|Overall Study|Withdrawal by Subject|0
1319907|NCT00070109|4278536|P5|Overall Study|Physician Decision|0
1319908|NCT00070109|4278537|P4|Overall Study|Physician Decision|0
1319909|NCT00070109|4278538|P3|Overall Study|Physician Decision|0
1319910|NCT00070109|4278539|P2|Overall Study|Physician Decision|0
1319911|NCT00070109|4278540|P1|Overall Study|Physician Decision|1
1319912|NCT00070109|4278536|P5|Overall Study|Lack of Efficacy|5
1319913|NCT00070109|4278537|P4|Overall Study|Lack of Efficacy|15
1319914|NCT00070109|4278538|P3|Overall Study|Lack of Efficacy|5
1319915|NCT00070109|4278539|P2|Overall Study|Lack of Efficacy|4
1319916|NCT00070109|4278540|P1|Overall Study|Lack of Efficacy|6
1319917|NCT00070109|4278536|P5|Overall Study|Death|1
1319918|NCT00070109|4278537|P4|Overall Study|Death|0
1319919|NCT00070109|4278538|P3|Overall Study|Death|0
1319920|NCT00070109|4278539|P2|Overall Study|Death|1
1319921|NCT00070109|4278540|P1|Overall Study|Death|1
1319922|NCT00070018|4278568|P1|Overall Study|Withdrawal by Subject|1
1319923|NCT00070018|4278568|P1|Overall Study|Lack of Efficacy|1
1319924|NCT00070018|4278568|P1|Overall Study|Adverse Event|2
1319925|NCT00069953|4278572|P1|Overall Study|Protocol Violation|2
1319926|NCT00069784|4278578|P2|Overall Study|Other|0
1319927|NCT00069784|4278579|P1|Overall Study|Other|17
1319928|NCT00069784|4278578|P2|Overall Study|Withdrawal by Subject|0
1319929|NCT00069784|4278579|P1|Overall Study|Withdrawal by Subject|1090
1319930|NCT00069784|4278578|P2|Overall Study|Adverse Event|0
1319931|NCT00069784|4278579|P1|Overall Study|Adverse Event|105
1319932|NCT00069823|4278599|P2|Overall Study|Did not have follow-up diary cards|3
1319933|NCT00069823|4278600|P1|Overall Study|Did not have follow-up diary cards|6
1319934|NCT00069641|4278643|P3|Overall Study|Death|1
1319935|NCT00069641|4278644|P2|Overall Study|Death|0
1319936|NCT00069641|4278645|P1|Overall Study|Death|1
1319937|NCT00069277|4278670|P1|Overall Study|Physician Decision|2
1319938|NCT00069277|4278670|P1|Overall Study|Progressive Disease|15
1319939|NCT00069277|4278670|P1|Overall Study|Withdrawal by Subject|1
1319940|NCT00069277|4278670|P1|Overall Study|Adverse Event|3
1319941|NCT00069264|4278674|P1|Overall Study|Discon Therapy|3
1319942|NCT00069264|4278674|P1|Overall Study|Withdrawal by Subject|3
1319943|NCT00069264|4278674|P1|Overall Study|Progressive Disease|23
1319944|NCT00069264|4278674|P1|Overall Study|Adverse Event|3
1319945|NCT00069238|4278702|P3|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2
1319946|NCT00069238|4278703|P2|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
1319947|NCT00069238|4278704|P1|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
1319948|NCT00069238|4278702|P3|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
1319949|NCT00069238|4278703|P2|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2
1319950|NCT00069238|4278704|P1|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
1319951|NCT00069238|4278702|P3|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
1319952|NCT00069238|4278703|P2|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
1319953|NCT00069238|4278704|P1|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9
1319954|NCT00069121|4278712|P2|Overall Study|Lost to Follow-up|57
1319955|NCT00069121|4278713|P1|Overall Study|Lost to Follow-up|57
1319956|NCT00069121|4278712|P2|Overall Study|Withdrawal by Subject|22
1319957|NCT00069121|4278713|P1|Overall Study|Withdrawal by Subject|20
1319958|NCT00069121|4278712|P2|Overall Study|Death|197
1319959|NCT00069121|4278713|P1|Overall Study|Death|225
1319960|NCT00069108|4278735|P2|Overall Study|Refused treatment|10
1319961|NCT00069108|4278736|P1|Overall Study|Refused treatment|5
1319962|NCT00069108|4278735|P2|Overall Study|Violation criteria|4
1319963|NCT00069108|4278736|P1|Overall Study|Violation criteria|1
1319964|NCT00069108|4278735|P2|Overall Study|Insufficient therapy|144
1319965|NCT00069108|4278736|P1|Overall Study|Insufficient therapy|117
1319966|NCT00069108|4278735|P2|Overall Study|Administration|4
1319967|NCT00069108|4278736|P1|Overall Study|Administration|15
1319968|NCT00069108|4278735|P2|Overall Study|Death|6
1319969|NCT00069108|4278736|P1|Overall Study|Death|6
1319970|NCT00069108|4278735|P2|Overall Study|Adverse Event|42
1319971|NCT00069108|4278736|P1|Overall Study|Adverse Event|64
1319972|NCT00069108|4278735|P2|Overall Study|Withdrawal by Subject|9
1319973|NCT00069108|4278736|P1|Overall Study|Withdrawal by Subject|5
1319974|NCT00069095|4278768|P6|Follow-up Phase|Death|101
1319975|NCT00069095|4278769|P5|Follow-up Phase|Death|92
1319976|NCT00069095|4278770|P4|Follow-up Phase|Death|112
1319977|NCT00069095|4278771|P3|Follow-up Phase|Death|120
1319978|NCT00069095|4278772|P2|Follow-up Phase|Death|206
1319979|NCT00069095|4278773|P1|Follow-up Phase|Death|174
1319980|NCT00069095|4278768|P6|Post-study Treatment Phase|Investigator decision|1
1319981|NCT00069095|4278769|P5|Post-study Treatment Phase|Investigator decision|0
1319982|NCT00069095|4278770|P4|Post-study Treatment Phase|Investigator decision|0
1319983|NCT00069095|4278771|P3|Post-study Treatment Phase|Investigator decision|0
1319984|NCT00069095|4278772|P2|Post-study Treatment Phase|Investigator decision|0
1319985|NCT00069095|4278773|P1|Post-study Treatment Phase|Investigator decision|0
1319986|NCT00069095|4278768|P6|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
1319987|NCT00069095|4278769|P5|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1
1319988|NCT00069095|4278770|P4|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
1319989|NCT00069095|4278771|P3|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
1319990|NCT00069095|4278772|P2|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
1319991|NCT00069095|4278773|P1|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
1319992|NCT00069095|4278768|P6|Post-study Treatment Phase|Participant/Physician decision to stop|0
1319993|NCT00069095|4278769|P5|Post-study Treatment Phase|Participant/Physician decision to stop|1
1319994|NCT00069095|4278770|P4|Post-study Treatment Phase|Participant/Physician decision to stop|0
1319995|NCT00069095|4278771|P3|Post-study Treatment Phase|Participant/Physician decision to stop|0
1319996|NCT00069095|4278772|P2|Post-study Treatment Phase|Participant/Physician decision to stop|0
1319997|NCT00069095|4278773|P1|Post-study Treatment Phase|Participant/Physician decision to stop|0
1319998|NCT00069095|4278768|P6|Post-study Treatment Phase|Participant had progressive disease|0
1319999|NCT00069095|4278769|P5|Post-study Treatment Phase|Participant had progressive disease|1
1320000|NCT00069095|4278770|P4|Post-study Treatment Phase|Participant had progressive disease|0
1320001|NCT00069095|4278771|P3|Post-study Treatment Phase|Participant had progressive disease|0
1320002|NCT00069095|4278772|P2|Post-study Treatment Phase|Participant had progressive disease|0
1320003|NCT00069095|4278773|P1|Post-study Treatment Phase|Participant had progressive disease|0
1320004|NCT00069095|4278768|P6|Post-study Treatment Phase|Death|0
1320005|NCT00069095|4278769|P5|Post-study Treatment Phase|Death|1
1320006|NCT00069095|4278770|P4|Post-study Treatment Phase|Death|0
1320007|NCT00069095|4278771|P3|Post-study Treatment Phase|Death|0
1320008|NCT00069095|4278772|P2|Post-study Treatment Phase|Death|0
1320009|NCT00069095|4278773|P1|Post-study Treatment Phase|Death|0
1320010|NCT00069095|4278768|P6|Post-study Treatment Phase|Surgery|0
1320011|NCT00069095|4278769|P5|Post-study Treatment Phase|Surgery|1
1320012|NCT00069095|4278770|P4|Post-study Treatment Phase|Surgery|1
1320013|NCT00069095|4278771|P3|Post-study Treatment Phase|Surgery|0
1320014|NCT00069095|4278772|P2|Post-study Treatment Phase|Surgery|0
1320015|NCT00069095|4278773|P1|Post-study Treatment Phase|Surgery|0
1320016|NCT00069095|4278768|P6|Post-study Treatment Phase|Participant completed treatment|0
1320017|NCT00069095|4278769|P5|Post-study Treatment Phase|Participant completed treatment|0
1320018|NCT00069095|4278770|P4|Post-study Treatment Phase|Participant completed treatment|1
1320019|NCT00069095|4278771|P3|Post-study Treatment Phase|Participant completed treatment|0
1320020|NCT00069095|4278772|P2|Post-study Treatment Phase|Participant completed treatment|0
1320021|NCT00069095|4278773|P1|Post-study Treatment Phase|Participant completed treatment|0
1320022|NCT00069095|4278768|P6|Post-study Treatment Phase|Participant wanted break from treatment|0
1320023|NCT00069095|4278769|P5|Post-study Treatment Phase|Participant wanted break from treatment|0
1320024|NCT00069095|4278770|P4|Post-study Treatment Phase|Participant wanted break from treatment|1
1320025|NCT00069095|4278771|P3|Post-study Treatment Phase|Participant wanted break from treatment|0
1320026|NCT00069095|4278772|P2|Post-study Treatment Phase|Participant wanted break from treatment|0
1320027|NCT00069095|4278773|P1|Post-study Treatment Phase|Participant wanted break from treatment|0
1320028|NCT00069095|4278768|P6|Post-study Treatment Phase|Participant will start new treatment|0
1320029|NCT00069095|4278769|P5|Post-study Treatment Phase|Participant will start new treatment|0
1320030|NCT00069095|4278770|P4|Post-study Treatment Phase|Participant will start new treatment|0
1320031|NCT00069095|4278771|P3|Post-study Treatment Phase|Participant will start new treatment|1
1320032|NCT00069095|4278772|P2|Post-study Treatment Phase|Participant will start new treatment|0
1320033|NCT00069095|4278773|P1|Post-study Treatment Phase|Participant will start new treatment|0
1320034|NCT00069095|4278768|P6|Post-study Treatment Phase|Participant withdrew consent|0
1320035|NCT00069095|4278769|P5|Post-study Treatment Phase|Participant withdrew consent|0
1320036|NCT00069095|4278770|P4|Post-study Treatment Phase|Participant withdrew consent|0
1320037|NCT00069095|4278771|P3|Post-study Treatment Phase|Participant withdrew consent|1
1320038|NCT00069095|4278772|P2|Post-study Treatment Phase|Participant withdrew consent|0
1320198|NCT00068692|4278878|P8|Step 2: Randomization|Adverse Event|4
1320039|NCT00069095|4278773|P1|Post-study Treatment Phase|Participant withdrew consent|0
1320040|NCT00069095|4278768|P6|Post-study Treatment Phase|Investigator decision (enough treatment)|0
1320041|NCT00069095|4278769|P5|Post-study Treatment Phase|Investigator decision (enough treatment)|1
1320042|NCT00069095|4278770|P4|Post-study Treatment Phase|Investigator decision (enough treatment)|0
1320043|NCT00069095|4278771|P3|Post-study Treatment Phase|Investigator decision (enough treatment)|1
1320044|NCT00069095|4278772|P2|Post-study Treatment Phase|Investigator decision (enough treatment)|1
1320045|NCT00069095|4278773|P1|Post-study Treatment Phase|Investigator decision (enough treatment)|0
1320046|NCT00069095|4278768|P6|Post-study Treatment Phase|More than 21 days delay between cycles|0
1320047|NCT00069095|4278769|P5|Post-study Treatment Phase|More than 21 days delay between cycles|0
1320048|NCT00069095|4278770|P4|Post-study Treatment Phase|More than 21 days delay between cycles|0
1320049|NCT00069095|4278771|P3|Post-study Treatment Phase|More than 21 days delay between cycles|0
1320050|NCT00069095|4278772|P2|Post-study Treatment Phase|More than 21 days delay between cycles|1
1320051|NCT00069095|4278773|P1|Post-study Treatment Phase|More than 21 days delay between cycles|0
1320052|NCT00069095|4278768|P6|Post-study Treatment Phase|Participant had complete response|0
1320053|NCT00069095|4278769|P5|Post-study Treatment Phase|Participant had complete response|0
1320054|NCT00069095|4278770|P4|Post-study Treatment Phase|Participant had complete response|0
1320055|NCT00069095|4278771|P3|Post-study Treatment Phase|Participant had complete response|0
1320056|NCT00069095|4278772|P2|Post-study Treatment Phase|Participant had complete response|1
1320057|NCT00069095|4278773|P1|Post-study Treatment Phase|Participant had complete response|1
1320058|NCT00069095|4278768|P6|Post-study Treatment Phase|Participant refusal/Admin reasons|1
1320059|NCT00069095|4278769|P5|Post-study Treatment Phase|Participant refusal/Admin reasons|0
1320060|NCT00069095|4278770|P4|Post-study Treatment Phase|Participant refusal/Admin reasons|0
1320061|NCT00069095|4278771|P3|Post-study Treatment Phase|Participant refusal/Admin reasons|0
1320062|NCT00069095|4278772|P2|Post-study Treatment Phase|Participant refusal/Admin reasons|0
1320063|NCT00069095|4278773|P1|Post-study Treatment Phase|Participant refusal/Admin reasons|1
1320064|NCT00069095|4278768|P6|Post-study Treatment Phase|Insufficient therapeutic response|9
1320065|NCT00069095|4278769|P5|Post-study Treatment Phase|Insufficient therapeutic response|7
1320066|NCT00069095|4278770|P4|Post-study Treatment Phase|Insufficient therapeutic response|6
1320067|NCT00069095|4278771|P3|Post-study Treatment Phase|Insufficient therapeutic response|5
1320068|NCT00069095|4278772|P2|Post-study Treatment Phase|Insufficient therapeutic response|4
1320069|NCT00069095|4278773|P1|Post-study Treatment Phase|Insufficient therapeutic response|1
1320070|NCT00069095|4278768|P6|Post-study Treatment Phase|Eligible for surgery|0
1320071|NCT00069095|4278769|P5|Post-study Treatment Phase|Eligible for surgery|0
1320072|NCT00069095|4278770|P4|Post-study Treatment Phase|Eligible for surgery|0
1320073|NCT00069095|4278771|P3|Post-study Treatment Phase|Eligible for surgery|0
1320074|NCT00069095|4278772|P2|Post-study Treatment Phase|Eligible for surgery|0
1320075|NCT00069095|4278773|P1|Post-study Treatment Phase|Eligible for surgery|2
1320076|NCT00069095|4278768|P6|Post-study Treatment Phase|Adverse Event|1
1320077|NCT00069095|4278769|P5|Post-study Treatment Phase|Adverse Event|5
1320078|NCT00069095|4278770|P4|Post-study Treatment Phase|Adverse Event|0
1320079|NCT00069095|4278771|P3|Post-study Treatment Phase|Adverse Event|1
1320080|NCT00069095|4278772|P2|Post-study Treatment Phase|Adverse Event|3
1320081|NCT00069095|4278773|P1|Post-study Treatment Phase|Adverse Event|2
1320082|NCT00069095|4278768|P6|Post-study Treatment Phase|Missing reason|17
1320083|NCT00069095|4278769|P5|Post-study Treatment Phase|Missing reason|18
1320084|NCT00069095|4278770|P4|Post-study Treatment Phase|Missing reason|8
1320085|NCT00069095|4278771|P3|Post-study Treatment Phase|Missing reason|12
1320086|NCT00069095|4278772|P2|Post-study Treatment Phase|Missing reason|3
1320087|NCT00069095|4278773|P1|Post-study Treatment Phase|Missing reason|1
1320088|NCT00069095|4278768|P6|Primary Treatment Phase|Violation criteria|5
1320089|NCT00069095|4278769|P5|Primary Treatment Phase|Violation criteria|1
1320090|NCT00069095|4278770|P4|Primary Treatment Phase|Violation criteria|3
1320091|NCT00069095|4278771|P3|Primary Treatment Phase|Violation criteria|4
1320092|NCT00069095|4278772|P2|Primary Treatment Phase|Violation criteria|2
1320093|NCT00069095|4278773|P1|Primary Treatment Phase|Violation criteria|0
1320094|NCT00069095|4278768|P6|Primary Treatment Phase|Other Violation|1
1320095|NCT00069095|4278769|P5|Primary Treatment Phase|Other Violation|0
1320096|NCT00069095|4278770|P4|Primary Treatment Phase|Other Violation|1
1320097|NCT00069095|4278771|P3|Primary Treatment Phase|Other Violation|1
1320098|NCT00069095|4278772|P2|Primary Treatment Phase|Other Violation|1
1320099|NCT00069095|4278773|P1|Primary Treatment Phase|Other Violation|0
1320100|NCT00069095|4278768|P6|Primary Treatment Phase|Withdrew|9
1320101|NCT00069095|4278769|P5|Primary Treatment Phase|Withdrew|4
1320102|NCT00069095|4278770|P4|Primary Treatment Phase|Withdrew|2
1320103|NCT00069095|4278771|P3|Primary Treatment Phase|Withdrew|8
1320104|NCT00069095|4278772|P2|Primary Treatment Phase|Withdrew|3
1320105|NCT00069095|4278773|P1|Primary Treatment Phase|Withdrew|2
1320106|NCT00069095|4278768|P6|Primary Treatment Phase|Refused treatment|27
1320107|NCT00069095|4278769|P5|Primary Treatment Phase|Refused treatment|24
1320108|NCT00069095|4278770|P4|Primary Treatment Phase|Refused treatment|31
1320109|NCT00069095|4278771|P3|Primary Treatment Phase|Refused treatment|17
1320110|NCT00069095|4278772|P2|Primary Treatment Phase|Refused treatment|26
1320111|NCT00069095|4278773|P1|Primary Treatment Phase|Refused treatment|15
1320112|NCT00069095|4278768|P6|Primary Treatment Phase|Insufficient Therapeutic Response|102
1320113|NCT00069095|4278769|P5|Primary Treatment Phase|Insufficient Therapeutic Response|101
1320114|NCT00069095|4278770|P4|Primary Treatment Phase|Insufficient Therapeutic Response|154
1320115|NCT00069095|4278771|P3|Primary Treatment Phase|Insufficient Therapeutic Response|175
1320116|NCT00069095|4278772|P2|Primary Treatment Phase|Insufficient Therapeutic Response|127
1320117|NCT00069095|4278773|P1|Primary Treatment Phase|Insufficient Therapeutic Response|131
1320118|NCT00069095|4278768|P6|Primary Treatment Phase|Failure to return|2
1320119|NCT00069095|4278769|P5|Primary Treatment Phase|Failure to return|0
1320120|NCT00069095|4278770|P4|Primary Treatment Phase|Failure to return|0
1320121|NCT00069095|4278771|P3|Primary Treatment Phase|Failure to return|0
1320122|NCT00069095|4278772|P2|Primary Treatment Phase|Failure to return|5
1320123|NCT00069095|4278773|P1|Primary Treatment Phase|Failure to return|5
1320124|NCT00069095|4278768|P6|Primary Treatment Phase|Death|8
1320125|NCT00069095|4278769|P5|Primary Treatment Phase|Death|8
1320126|NCT00069095|4278770|P4|Primary Treatment Phase|Death|5
1320127|NCT00069095|4278771|P3|Primary Treatment Phase|Death|2
1320128|NCT00069095|4278772|P2|Primary Treatment Phase|Death|8
1320129|NCT00069095|4278773|P1|Primary Treatment Phase|Death|14
1320130|NCT00069095|4278768|P6|Primary Treatment Phase|Adverse Event|101
1320131|NCT00069095|4278769|P5|Primary Treatment Phase|Adverse Event|109
1320132|NCT00069095|4278770|P4|Primary Treatment Phase|Adverse Event|72
1320133|NCT00069095|4278771|P3|Primary Treatment Phase|Adverse Event|71
1320134|NCT00069095|4278772|P2|Primary Treatment Phase|Adverse Event|92
1320135|NCT00069095|4278773|P1|Primary Treatment Phase|Adverse Event|99
1320136|NCT00069095|4278768|P6|Primary Treatment Phase|Admin/Other|42
1320137|NCT00069095|4278769|P5|Primary Treatment Phase|Admin/Other|48
1320138|NCT00069095|4278770|P4|Primary Treatment Phase|Admin/Other|45
1320139|NCT00069095|4278771|P3|Primary Treatment Phase|Admin/Other|31
1320140|NCT00069095|4278772|P2|Primary Treatment Phase|Admin/Other|38
1320141|NCT00069095|4278773|P1|Primary Treatment Phase|Admin/Other|29
1320142|NCT00069095|4278768|P6|Primary Treatment Phase|Ongoing|4
1320143|NCT00069095|4278769|P5|Primary Treatment Phase|Ongoing|7
1320144|NCT00069095|4278770|P4|Primary Treatment Phase|Ongoing|7
1320145|NCT00069095|4278771|P3|Primary Treatment Phase|Ongoing|5
1320146|NCT00069095|4278772|P2|Primary Treatment Phase|Ongoing|0
1320147|NCT00069095|4278773|P1|Primary Treatment Phase|Ongoing|0
1320148|NCT00068822|4278843|P2|First Randomized Intervention|Lost to Follow-up|2
1320149|NCT00068822|4278844|P1|First Randomized Intervention|Lost to Follow-up|1
1320150|NCT00068692|4278878|P8|Step 2: Randomization|never start protocol therapy|0
1320151|NCT00068692|4278879|P7|Step 2: Randomization|never start protocol therapy|0
1320152|NCT00068692|4278880|P6|Step 2: Randomization|never start protocol therapy|0
1320153|NCT00068692|4278881|P5|Step 2: Randomization|never start protocol therapy|1
1320154|NCT00068692|4278882|P4|Step 2: Randomization|never start protocol therapy|0
1320155|NCT00068692|4278883|P3|Step 2: Randomization|never start protocol therapy|1
1320156|NCT00068692|4278884|P2|Step 2: Randomization|never start protocol therapy|0
1320157|NCT00068692|4278885|P1|Step 2: Randomization|never start protocol therapy|0
1320158|NCT00068692|4278878|P8|Step 2: Randomization|Other|0
1320159|NCT00068692|4278879|P7|Step 2: Randomization|Other|0
1320160|NCT00068692|4278880|P6|Step 2: Randomization|Other|1
1320161|NCT00068692|4278881|P5|Step 2: Randomization|Other|0
1320162|NCT00068692|4278882|P4|Step 2: Randomization|Other|1
1320163|NCT00068692|4278883|P3|Step 2: Randomization|Other|0
1320164|NCT00068692|4278884|P2|Step 2: Randomization|Other|0
1320165|NCT00068692|4278885|P1|Step 2: Randomization|Other|0
1320166|NCT00068692|4278878|P8|Step 2: Randomization|Physician Decision|0
1320167|NCT00068692|4278879|P7|Step 2: Randomization|Physician Decision|0
1320168|NCT00068692|4278880|P6|Step 2: Randomization|Physician Decision|0
1320169|NCT00068692|4278881|P5|Step 2: Randomization|Physician Decision|1
1320170|NCT00068692|4278882|P4|Step 2: Randomization|Physician Decision|1
1320171|NCT00068692|4278883|P3|Step 2: Randomization|Physician Decision|0
1320172|NCT00068692|4278884|P2|Step 2: Randomization|Physician Decision|0
1320173|NCT00068692|4278885|P1|Step 2: Randomization|Physician Decision|0
1320174|NCT00068692|4278878|P8|Step 2: Randomization|alternative therapy|0
1320175|NCT00068692|4278879|P7|Step 2: Randomization|alternative therapy|0
1320176|NCT00068692|4278880|P6|Step 2: Randomization|alternative therapy|0
1320177|NCT00068692|4278881|P5|Step 2: Randomization|alternative therapy|1
1320178|NCT00068692|4278882|P4|Step 2: Randomization|alternative therapy|1
1320179|NCT00068692|4278883|P3|Step 2: Randomization|alternative therapy|0
1320180|NCT00068692|4278884|P2|Step 2: Randomization|alternative therapy|0
1320181|NCT00068692|4278885|P1|Step 2: Randomization|alternative therapy|0
1320182|NCT00068692|4278878|P8|Step 2: Randomization|Withdrawal by Subject|3
1320183|NCT00068692|4278879|P7|Step 2: Randomization|Withdrawal by Subject|0
1320184|NCT00068692|4278880|P6|Step 2: Randomization|Withdrawal by Subject|2
1320185|NCT00068692|4278881|P5|Step 2: Randomization|Withdrawal by Subject|3
1320186|NCT00068692|4278882|P4|Step 2: Randomization|Withdrawal by Subject|6
1320187|NCT00068692|4278883|P3|Step 2: Randomization|Withdrawal by Subject|4
1320188|NCT00068692|4278884|P2|Step 2: Randomization|Withdrawal by Subject|0
1320189|NCT00068692|4278885|P1|Step 2: Randomization|Withdrawal by Subject|0
1320190|NCT00068692|4278878|P8|Step 2: Randomization|Death|1
1320191|NCT00068692|4278879|P7|Step 2: Randomization|Death|0
1320192|NCT00068692|4278880|P6|Step 2: Randomization|Death|0
1320193|NCT00068692|4278881|P5|Step 2: Randomization|Death|1
1320194|NCT00068692|4278882|P4|Step 2: Randomization|Death|0
1320195|NCT00068692|4278883|P3|Step 2: Randomization|Death|0
1320196|NCT00068692|4278884|P2|Step 2: Randomization|Death|0
1320197|NCT00068692|4278885|P1|Step 2: Randomization|Death|0
1320199|NCT00068692|4278879|P7|Step 2: Randomization|Adverse Event|4
1320200|NCT00068692|4278880|P6|Step 2: Randomization|Adverse Event|3
1320201|NCT00068692|4278881|P5|Step 2: Randomization|Adverse Event|2
1320202|NCT00068692|4278882|P4|Step 2: Randomization|Adverse Event|2
1320203|NCT00068692|4278883|P3|Step 2: Randomization|Adverse Event|4
1320204|NCT00068692|4278884|P2|Step 2: Randomization|Adverse Event|0
1320205|NCT00068692|4278885|P1|Step 2: Randomization|Adverse Event|0
1320206|NCT00068692|4278878|P8|Step 2: Randomization|Disesae progression/replase|0
1320207|NCT00068692|4278879|P7|Step 2: Randomization|Disesae progression/replase|0
1320208|NCT00068692|4278880|P6|Step 2: Randomization|Disesae progression/replase|0
1320209|NCT00068692|4278881|P5|Step 2: Randomization|Disesae progression/replase|0
1320210|NCT00068692|4278882|P4|Step 2: Randomization|Disesae progression/replase|1
1320211|NCT00068692|4278883|P3|Step 2: Randomization|Disesae progression/replase|1
1320212|NCT00068692|4278884|P2|Step 2: Randomization|Disesae progression/replase|0
1320213|NCT00068692|4278885|P1|Step 2: Randomization|Disesae progression/replase|0
1320214|NCT00068692|4278878|P8|Step 1: Registration|Registered but not randomized|0
1320215|NCT00068692|4278879|P7|Step 1: Registration|Registered but not randomized|0
1320216|NCT00068692|4278880|P6|Step 1: Registration|Registered but not randomized|0
1320217|NCT00068692|4278881|P5|Step 1: Registration|Registered but not randomized|0
1320218|NCT00068692|4278882|P4|Step 1: Registration|Registered but not randomized|0
1320219|NCT00068692|4278883|P3|Step 1: Registration|Registered but not randomized|0
1320220|NCT00068692|4278884|P2|Step 1: Registration|Registered but not randomized|1
1320221|NCT00068692|4278885|P1|Step 1: Registration|Registered but not randomized|0
1320222|NCT00068692|4278878|P8|Step 1: Registration|Not start protocol therapy|0
1320223|NCT00068692|4278879|P7|Step 1: Registration|Not start protocol therapy|0
1320224|NCT00068692|4278880|P6|Step 1: Registration|Not start protocol therapy|0
1320225|NCT00068692|4278881|P5|Step 1: Registration|Not start protocol therapy|0
1320226|NCT00068692|4278882|P4|Step 1: Registration|Not start protocol therapy|0
1320227|NCT00068692|4278883|P3|Step 1: Registration|Not start protocol therapy|0
1320228|NCT00068692|4278884|P2|Step 1: Registration|Not start protocol therapy|0
1320229|NCT00068692|4278885|P1|Step 1: Registration|Not start protocol therapy|3
1320230|NCT00068692|4278878|P8|Step 1: Registration|Not specified|0
1320231|NCT00068692|4278879|P7|Step 1: Registration|Not specified|0
1320232|NCT00068692|4278880|P6|Step 1: Registration|Not specified|0
1320233|NCT00068692|4278881|P5|Step 1: Registration|Not specified|0
1320234|NCT00068692|4278882|P4|Step 1: Registration|Not specified|0
1320235|NCT00068692|4278883|P3|Step 1: Registration|Not specified|0
1320236|NCT00068692|4278884|P2|Step 1: Registration|Not specified|0
1320237|NCT00068692|4278885|P1|Step 1: Registration|Not specified|2
1320238|NCT00068692|4278878|P8|Step 1: Registration|Not eligible|0
1320239|NCT00068692|4278879|P7|Step 1: Registration|Not eligible|0
1320240|NCT00068692|4278880|P6|Step 1: Registration|Not eligible|0
1320241|NCT00068692|4278881|P5|Step 1: Registration|Not eligible|0
1320242|NCT00068692|4278882|P4|Step 1: Registration|Not eligible|0
1320243|NCT00068692|4278883|P3|Step 1: Registration|Not eligible|0
1320244|NCT00068692|4278884|P2|Step 1: Registration|Not eligible|0
1320245|NCT00068692|4278885|P1|Step 1: Registration|Not eligible|6
1320246|NCT00068692|4278878|P8|Step 1: Registration|Protocol Violation|0
1320247|NCT00068692|4278879|P7|Step 1: Registration|Protocol Violation|0
1320248|NCT00068692|4278880|P6|Step 1: Registration|Protocol Violation|0
1320249|NCT00068692|4278881|P5|Step 1: Registration|Protocol Violation|0
1320250|NCT00068692|4278882|P4|Step 1: Registration|Protocol Violation|0
1320251|NCT00068692|4278883|P3|Step 1: Registration|Protocol Violation|0
1320252|NCT00068692|4278884|P2|Step 1: Registration|Protocol Violation|0
1320253|NCT00068692|4278885|P1|Step 1: Registration|Protocol Violation|1
1320254|NCT00068692|4278878|P8|Step 1: Registration|Complicating disease|0
1320255|NCT00068692|4278879|P7|Step 1: Registration|Complicating disease|0
1320256|NCT00068692|4278880|P6|Step 1: Registration|Complicating disease|0
1320257|NCT00068692|4278881|P5|Step 1: Registration|Complicating disease|0
1320258|NCT00068692|4278882|P4|Step 1: Registration|Complicating disease|0
1320259|NCT00068692|4278883|P3|Step 1: Registration|Complicating disease|0
1320260|NCT00068692|4278884|P2|Step 1: Registration|Complicating disease|0
1320261|NCT00068692|4278885|P1|Step 1: Registration|Complicating disease|2
1320262|NCT00068692|4278878|P8|Step 1: Registration|Alternative therapy|0
1320263|NCT00068692|4278879|P7|Step 1: Registration|Alternative therapy|0
1320264|NCT00068692|4278880|P6|Step 1: Registration|Alternative therapy|0
1320265|NCT00068692|4278881|P5|Step 1: Registration|Alternative therapy|0
1320266|NCT00068692|4278882|P4|Step 1: Registration|Alternative therapy|0
1320267|NCT00068692|4278883|P3|Step 1: Registration|Alternative therapy|0
1320268|NCT00068692|4278884|P2|Step 1: Registration|Alternative therapy|0
1320269|NCT00068692|4278885|P1|Step 1: Registration|Alternative therapy|2
1320270|NCT00068692|4278878|P8|Step 1: Registration|Withdrawal by Subject|0
1320271|NCT00068692|4278879|P7|Step 1: Registration|Withdrawal by Subject|0
1320272|NCT00068692|4278880|P6|Step 1: Registration|Withdrawal by Subject|0
1320273|NCT00068692|4278881|P5|Step 1: Registration|Withdrawal by Subject|0
1320274|NCT00068692|4278882|P4|Step 1: Registration|Withdrawal by Subject|0
1320275|NCT00068692|4278883|P3|Step 1: Registration|Withdrawal by Subject|0
1320276|NCT00068692|4278884|P2|Step 1: Registration|Withdrawal by Subject|0
1320277|NCT00068692|4278885|P1|Step 1: Registration|Withdrawal by Subject|11
1320278|NCT00068692|4278878|P8|Step 1: Registration|Death|0
1320279|NCT00068692|4278879|P7|Step 1: Registration|Death|0
1320280|NCT00068692|4278880|P6|Step 1: Registration|Death|0
1320281|NCT00068692|4278881|P5|Step 1: Registration|Death|0
1320282|NCT00068692|4278882|P4|Step 1: Registration|Death|0
1320283|NCT00068692|4278883|P3|Step 1: Registration|Death|0
1320284|NCT00068692|4278884|P2|Step 1: Registration|Death|0
1320285|NCT00068692|4278885|P1|Step 1: Registration|Death|1
1320286|NCT00068692|4278878|P8|Step 1: Registration|Adverse Event|0
1320287|NCT00068692|4278879|P7|Step 1: Registration|Adverse Event|0
1320288|NCT00068692|4278880|P6|Step 1: Registration|Adverse Event|0
1320289|NCT00068692|4278881|P5|Step 1: Registration|Adverse Event|0
1320290|NCT00068692|4278882|P4|Step 1: Registration|Adverse Event|0
1320291|NCT00068692|4278883|P3|Step 1: Registration|Adverse Event|0
1320292|NCT00068692|4278884|P2|Step 1: Registration|Adverse Event|0
1320293|NCT00068692|4278885|P1|Step 1: Registration|Adverse Event|7
1320294|NCT00068692|4278878|P8|Step 1: Registration|Disese progression/relapse|0
1320295|NCT00068692|4278879|P7|Step 1: Registration|Disese progression/relapse|0
1320296|NCT00068692|4278880|P6|Step 1: Registration|Disese progression/relapse|0
1320297|NCT00068692|4278881|P5|Step 1: Registration|Disese progression/relapse|0
1320298|NCT00068692|4278882|P4|Step 1: Registration|Disese progression/relapse|0
1320299|NCT00068692|4278883|P3|Step 1: Registration|Disese progression/relapse|0
1320300|NCT00068692|4278884|P2|Step 1: Registration|Disese progression/relapse|0
1320301|NCT00068692|4278885|P1|Step 1: Registration|Disese progression/relapse|5
1320302|NCT00068601|4278908|P2|Overall Study|Missing primary outcome data|34
1320303|NCT00068601|4278909|P1|Overall Study|Missing primary outcome data|30
1320304|NCT00068601|4278908|P2|Overall Study|Lost to Follow-up|2
1320305|NCT00068601|4278909|P1|Overall Study|Lost to Follow-up|3
1320306|NCT00068601|4278908|P2|Overall Study|Death|3
1320307|NCT00068601|4278909|P1|Overall Study|Death|11
1320308|NCT00068601|4278908|P2|Overall Study|Not evaluable: hysterectomy/oophorectomy|4
1320309|NCT00068601|4278909|P1|Overall Study|Not evaluable: hysterectomy/oophorectomy|2
1320310|NCT00068601|4278908|P2|Overall Study|Not evaluable: withdrew consent|4
1320311|NCT00068601|4278909|P1|Overall Study|Not evaluable: withdrew consent|5
1320312|NCT00068601|4278908|P2|Overall Study|Ineligible|13
1320313|NCT00068601|4278909|P1|Overall Study|Ineligible|11
1320314|NCT00068588|4278922|P3|Overall Study|Poor KPS|1
1320315|NCT00068588|4278923|P2|Overall Study|Poor KPS|0
1320316|NCT00068588|4278924|P1|Overall Study|Poor KPS|0
1320317|NCT00068588|4278922|P3|Overall Study|Withdrawal by Subject|1
1320318|NCT00068588|4278923|P2|Overall Study|Withdrawal by Subject|0
1320319|NCT00068588|4278924|P1|Overall Study|Withdrawal by Subject|0
1320320|NCT00068588|4278922|P3|Overall Study|Adverse Event|2
1320321|NCT00068588|4278923|P2|Overall Study|Adverse Event|0
1320322|NCT00068588|4278924|P1|Overall Study|Adverse Event|0
1320323|NCT00068445|4278940|P2|Treatment|Other (Specifics not available)|5
1320324|NCT00068445|4278941|P1|Treatment|Other (Specifics not available)|9
1320325|NCT00068445|4278940|P2|Treatment|Adverse Event|1
1320326|NCT00068445|4278941|P1|Treatment|Adverse Event|7
1320327|NCT00068445|4278940|P2|Treatment|Refused Further Treatment|10
1320328|NCT00068445|4278941|P1|Treatment|Refused Further Treatment|13
1320329|NCT00068445|4278940|P2|Randomization|Ineligible|1
1320330|NCT00068445|4278941|P1|Randomization|Ineligible|1
1320331|NCT00068445|4278940|P2|Randomization|Cancel|3
1320332|NCT00068445|4278941|P1|Randomization|Cancel|1
1320333|NCT00068419|4278965|P1|Overall Study|Ineligible|11
1320334|NCT00068419|4278965|P1|Overall Study|Withdrawal by Subject|14
1320335|NCT00068419|4278965|P1|Overall Study|Physician Decision|7
1320336|NCT00068419|4278965|P1|Overall Study|Lost to Follow-up|1
1320337|NCT00068419|4278965|P1|Overall Study|Lack of Efficacy|24
1320338|NCT00068419|4278965|P1|Overall Study|Adverse Event|3
1320339|NCT00068406|4278969|P1|Overall Study|Ineligible-Inadequate Pathology|2
1320340|NCT00068406|4278969|P1|Overall Study|Ineligible-improper pre-protocol treatm|1
1320341|NCT00068393|4278974|P1|Overall Study|Quality of life worsening|1
1320342|NCT00068393|4278974|P1|Overall Study|Alternative treatment|1
1320343|NCT00068393|4278974|P1|Overall Study|Withdrawal by Subject|3
1320344|NCT00068393|4278974|P1|Overall Study|Death|3
1320345|NCT00068393|4278974|P1|Overall Study|Adverse Event|2
1320346|NCT00068380|4278980|P1|Overall Study|Adverse Event|2
1320347|NCT00068380|4278980|P1|Overall Study|Withdrawal by Subject|3
1320348|NCT00068250|4279024|P4|Phase I: Dose Level 2|Protocol Violation|0
1320349|NCT00068250|4279025|P3|Phase I: Dose Level 2|Protocol Violation|0
1320350|NCT00068250|4279026|P2|Phase I: Dose Level 2|Protocol Violation|1
1320351|NCT00068250|4279027|P1|Phase I: Dose Level 2|Protocol Violation|0
1320352|NCT00068237|4279037|P1|Overall Study|No protocol treatment received|2
1320353|NCT00068237|4279037|P1|Overall Study|Ineligible|3
1320354|NCT00068107|4279041|P1|Overall Study|Withdrawal by Subject|1
1320355|NCT00068107|4279041|P1|Overall Study|Death|2
1320356|NCT00068107|4279041|P1|Overall Study|end-stage renal disease|6
1320357|NCT00067990|4279054|P2|Overall Study|Withdrawal by Subject|12
1320358|NCT00067990|4279055|P1|Overall Study|Withdrawal by Subject|4
1320359|NCT00067990|4279054|P2|Overall Study|ESRD, Non IF/TA|3
1320360|NCT00067990|4279055|P1|Overall Study|ESRD, Non IF/TA|1
1320361|NCT00067990|4279054|P2|Overall Study|Death|7
1320362|NCT00067990|4279055|P1|Overall Study|Death|5
1320363|NCT00067470|4279078|P2|Overall Study|Withdrawal by Subject|1
1320364|NCT00067470|4279079|P1|Overall Study|Withdrawal by Subject|0
1320365|NCT00066807|4279142|P2|Overall Study|Study was terminated early|15
1320366|NCT00066807|4279143|P1|Overall Study|Study was terminated early|14
1320367|NCT00066742|4279168|P1|Consolidation Chemotherapy|Ineligible|2
1320368|NCT00066742|4279168|P1|Consolidation Chemotherapy|not protocol specified|1
1320369|NCT00066742|4279168|P1|Induction Chemoradiotherapy|Ineligible|3
1320370|NCT00066742|4279168|P1|Induction Chemoradiotherapy|not protocol specified|2
1320371|NCT00066742|4279168|P1|Induction Chemoradiotherapy|Withdrawal by Subject|2
1320372|NCT00066742|4279168|P1|Induction Chemoradiotherapy|Adverse Event|21
1320373|NCT00066742|4279168|P1|Induction Chemoradiotherapy|Did not receive any protocol treatment|1
1320374|NCT00066703|4279177|P2|Overall Study|Treatment ongoing|311
1320375|NCT00066703|4279178|P1|Overall Study|Treatment ongoing|346
1320376|NCT00066703|4279177|P2|Overall Study|Withdrawal by Subject|63
1320377|NCT00066703|4279178|P1|Overall Study|Withdrawal by Subject|38
1320378|NCT00066703|4279177|P2|Overall Study|Lost to Follow-up|28
1320379|NCT00066703|4279178|P1|Overall Study|Lost to Follow-up|31
1320380|NCT00066703|4279177|P2|Overall Study|Lack of Efficacy|69
1320381|NCT00066703|4279178|P1|Overall Study|Lack of Efficacy|114
1320382|NCT00066703|4279177|P2|Overall Study|Death|0
1320383|NCT00066703|4279178|P1|Overall Study|Death|3
1320384|NCT00066703|4279177|P2|Overall Study|Adverse Event|111
1320385|NCT00066703|4279178|P1|Overall Study|Adverse Event|80
1320386|NCT00066690|4279191|P3|Overall Study|Treatment Ongoing|282
1320387|NCT00066690|4279192|P2|Overall Study|Treatment Ongoing|278
1320388|NCT00066690|4279193|P1|Overall Study|Treatment Ongoing|246
1320389|NCT00066690|4279191|P3|Overall Study|Withdrawal by Subject|49
1320390|NCT00066690|4279192|P2|Overall Study|Withdrawal by Subject|55
1320391|NCT00066690|4279193|P1|Overall Study|Withdrawal by Subject|50
1320392|NCT00066690|4279191|P3|Overall Study|Lost to Follow-up|29
1320393|NCT00066690|4279192|P2|Overall Study|Lost to Follow-up|21
1320394|NCT00066690|4279193|P1|Overall Study|Lost to Follow-up|40
1320395|NCT00066690|4279191|P3|Overall Study|Lack of Efficacy|76
1320396|NCT00066690|4279192|P2|Overall Study|Lack of Efficacy|110
1320397|NCT00066690|4279193|P1|Overall Study|Lack of Efficacy|114
1320398|NCT00066690|4279191|P3|Overall Study|Death|2
1320399|NCT00066690|4279192|P2|Overall Study|Death|0
1320400|NCT00066690|4279193|P1|Overall Study|Death|3
1320401|NCT00066690|4279191|P3|Overall Study|Adverse Event|126
1320402|NCT00066690|4279192|P2|Overall Study|Adverse Event|58
1320403|NCT00066690|4279193|P1|Overall Study|Adverse Event|145
1320404|NCT00066573|4279209|P2|Overall Study|Did not received protocol treatment|28
1320405|NCT00066573|4279210|P1|Overall Study|Did not received protocol treatment|28
1320406|NCT00066469|4279222|P1|Overall Study|ineligible|1
1320407|NCT00066469|4279222|P1|Overall Study|Withdrawal by Subject|1
1320408|NCT00066469|4279222|P1|Overall Study|Physician Decision|1
1320409|NCT00066469|4279222|P1|Overall Study|Lost to Follow-up|1
1320410|NCT00066469|4279222|P1|Overall Study|Lack of Efficacy|9
1320411|NCT00066469|4279222|P1|Overall Study|Death|3
1320412|NCT00066365|4279228|P2|Overall Study|Ineligible|2
1320413|NCT00066365|4279229|P1|Overall Study|Ineligible|4
1320414|NCT00066365|4279228|P2|Overall Study|No viable tumor after 1 cycle of therapy|0
1320415|NCT00066365|4279229|P1|Overall Study|No viable tumor after 1 cycle of therapy|2
1320416|NCT00066365|4279228|P2|Overall Study|Physician Decision|0
1320417|NCT00066365|4279229|P1|Overall Study|Physician Decision|1
1320418|NCT00066365|4279228|P2|Overall Study|Lack of Efficacy|12
1320419|NCT00066365|4279229|P1|Overall Study|Lack of Efficacy|15
1320420|NCT00066365|4279228|P2|Overall Study|Adverse Event|0
1320421|NCT00066365|4279229|P1|Overall Study|Adverse Event|1
1320422|NCT00066222|4279257|P1|Overall Study|No protocol treatment received|1
1320423|NCT00066170|4279270|P4|Overall Study|Other|0
1320424|NCT00066170|4279271|P3|Overall Study|Other|2
1320425|NCT00066170|4279272|P2|Overall Study|Other|5
1320426|NCT00066170|4279273|P1|Overall Study|Other|1
1320427|NCT00066170|4279270|P4|Overall Study|Protocol Violation|0
1320428|NCT00066170|4279271|P3|Overall Study|Protocol Violation|0
1320429|NCT00066170|4279272|P2|Overall Study|Protocol Violation|0
1320430|NCT00066170|4279273|P1|Overall Study|Protocol Violation|3
1320431|NCT00066170|4279270|P4|Overall Study|Non-Compliance with Trial Medicine|1
1320432|NCT00066170|4279271|P3|Overall Study|Non-Compliance with Trial Medicine|0
1320433|NCT00066170|4279272|P2|Overall Study|Non-Compliance with Trial Medicine|0
1320434|NCT00066170|4279273|P1|Overall Study|Non-Compliance with Trial Medicine|1
1320435|NCT00066170|4279270|P4|Overall Study|Lost to Follow-up|0
1320436|NCT00066170|4279271|P3|Overall Study|Lost to Follow-up|0
1320437|NCT00066170|4279272|P2|Overall Study|Lost to Follow-up|1
1320438|NCT00066170|4279273|P1|Overall Study|Lost to Follow-up|0
1320439|NCT00066170|4279270|P4|Overall Study|Serious Adverse Event|1
1320440|NCT00066170|4279271|P3|Overall Study|Serious Adverse Event|1
1320441|NCT00066170|4279272|P2|Overall Study|Serious Adverse Event|0
1320442|NCT00066170|4279273|P1|Overall Study|Serious Adverse Event|0
1320443|NCT00066170|4279270|P4|Overall Study|Adverse Event|7
1320444|NCT00066170|4279271|P3|Overall Study|Adverse Event|1
1320445|NCT00066170|4279272|P2|Overall Study|Adverse Event|4
1320446|NCT00066170|4279273|P1|Overall Study|Adverse Event|2
1320447|NCT00066066|4279286|P6|Overall Study|Lost to Follow-up|5
1320448|NCT00066066|4279287|P5|Overall Study|Lost to Follow-up|3
1320449|NCT00066066|4279288|P4|Overall Study|Lost to Follow-up|4
1320450|NCT00066066|4279289|P3|Overall Study|Lost to Follow-up|7
1320451|NCT00066066|4279290|P2|Overall Study|Lost to Follow-up|4
1320452|NCT00066066|4279291|P1|Overall Study|Lost to Follow-up|6
1320453|NCT00065507|4279369|P2|Overall Study|Subject No Longer Meets Study Criteria|0
1320454|NCT00065507|4279370|P1|Overall Study|Subject No Longer Meets Study Criteria|1
1320455|NCT00065507|4279369|P2|Overall Study|Subject Withdrew Consent|1
1320456|NCT00065507|4279370|P1|Overall Study|Subject Withdrew Consent|2
1320457|NCT00065507|4279369|P2|Overall Study|Lost to Follow-up|0
1320458|NCT00065507|4279370|P1|Overall Study|Lost to Follow-up|3
1320459|NCT00065507|4279369|P2|Overall Study|Poor/Non-compliance|2
1320460|NCT00065507|4279370|P1|Overall Study|Poor/Non-compliance|3
1320461|NCT00065507|4279369|P2|Overall Study|Lack of Efficacy|6
1320462|NCT00065507|4279370|P1|Overall Study|Lack of Efficacy|0
1320463|NCT00065507|4279369|P2|Overall Study|Adverse Event|3
1320464|NCT00065507|4279370|P1|Overall Study|Adverse Event|4
1320465|NCT00065507|4279369|P2|Overall Study|Death|17
1320466|NCT00065507|4279370|P1|Overall Study|Death|16
1320467|NCT00065468|4279435|P3|Overall Study|Other|18
1320468|NCT00065468|4279436|P2|Overall Study|Other|24
1320469|NCT00065468|4279437|P1|Overall Study|Other|14
1320470|NCT00065468|4279435|P3|Overall Study|Disease progression|1
1320471|NCT00065468|4279436|P2|Overall Study|Disease progression|0
1320472|NCT00065468|4279437|P1|Overall Study|Disease progression|0
1320473|NCT00065468|4279435|P3|Overall Study|Discontinuation of study by Sponsor|13
1320474|NCT00065468|4279436|P2|Overall Study|Discontinuation of study by Sponsor|9
1320475|NCT00065468|4279437|P1|Overall Study|Discontinuation of study by Sponsor|13
1320476|NCT00065468|4279435|P3|Overall Study|Lost to Follow-up|2
1320477|NCT00065468|4279436|P2|Overall Study|Lost to Follow-up|3
1320478|NCT00065468|4279437|P1|Overall Study|Lost to Follow-up|5
1320479|NCT00065468|4279435|P3|Overall Study|Withdrawal by Subject|5
1320480|NCT00065468|4279436|P2|Overall Study|Withdrawal by Subject|4
1320481|NCT00065468|4279437|P1|Overall Study|Withdrawal by Subject|3
1320482|NCT00065468|4279435|P3|Overall Study|Death|171
1320483|NCT00065468|4279436|P2|Overall Study|Death|169
1320484|NCT00065468|4279437|P1|Overall Study|Death|172
1320485|NCT00065442|4279468|P2|Overall Study|Withdrawal by Subject|9
1320486|NCT00065442|4279469|P1|Overall Study|Withdrawal by Subject|3
1320487|NCT00065442|4279468|P2|Overall Study|Death|210
1320488|NCT00065442|4279469|P1|Overall Study|Death|121
1320489|NCT00065442|4279468|P2|Overall Study|Lost to Follow-up|1
1320490|NCT00065442|4279469|P1|Overall Study|Lost to Follow-up|1
1320491|NCT00065429|4279484|P7|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
1320492|NCT00065429|4279485|P6|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
1320493|NCT00065429|4279486|P5|Phase II - Apr 2003 - Aug 2008|Adverse Event|2
1320494|NCT00065429|4279487|P4|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
1320495|NCT00065429|4279488|P3|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
1320496|NCT00065429|4279489|P2|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
1320497|NCT00065429|4279490|P1|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
1320498|NCT00065429|4279484|P7|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
1320499|NCT00065429|4279485|P6|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
1320500|NCT00065429|4279486|P5|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4
1320501|NCT00065429|4279487|P4|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
1320502|NCT00065429|4279488|P3|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
1320503|NCT00065429|4279489|P2|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
1320504|NCT00065429|4279490|P1|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
1320505|NCT00065429|4279484|P7|Phase I - May 2001 - Oct 2002|Adverse Event|2
1320506|NCT00065429|4279485|P6|Phase I - May 2001 - Oct 2002|Adverse Event|1
1320507|NCT00065429|4279486|P5|Phase I - May 2001 - Oct 2002|Adverse Event|0
1320508|NCT00065429|4279487|P4|Phase I - May 2001 - Oct 2002|Adverse Event|1
1320509|NCT00065429|4279488|P3|Phase I - May 2001 - Oct 2002|Adverse Event|0
1320510|NCT00065429|4279489|P2|Phase I - May 2001 - Oct 2002|Adverse Event|0
1320511|NCT00065429|4279490|P1|Phase I - May 2001 - Oct 2002|Adverse Event|0
1320512|NCT00065429|4279484|P7|Phase I - May 2001 - Oct 2002|Death|0
1320513|NCT00065429|4279485|P6|Phase I - May 2001 - Oct 2002|Death|0
1320514|NCT00065429|4279486|P5|Phase I - May 2001 - Oct 2002|Death|1
1320515|NCT00065429|4279487|P4|Phase I - May 2001 - Oct 2002|Death|0
1320516|NCT00065429|4279488|P3|Phase I - May 2001 - Oct 2002|Death|0
1320517|NCT00065429|4279489|P2|Phase I - May 2001 - Oct 2002|Death|0
1320518|NCT00065429|4279490|P1|Phase I - May 2001 - Oct 2002|Death|0
1320519|NCT00065429|4279484|P7|Phase I - May 2001 - Oct 2002|Physician Decision|0
1320520|NCT00065429|4279485|P6|Phase I - May 2001 - Oct 2002|Physician Decision|0
1320521|NCT00065429|4279486|P5|Phase I - May 2001 - Oct 2002|Physician Decision|0
1320522|NCT00065429|4279487|P4|Phase I - May 2001 - Oct 2002|Physician Decision|0
1320523|NCT00065429|4279488|P3|Phase I - May 2001 - Oct 2002|Physician Decision|0
1320524|NCT00065429|4279489|P2|Phase I - May 2001 - Oct 2002|Physician Decision|0
1320525|NCT00065429|4279490|P1|Phase I - May 2001 - Oct 2002|Physician Decision|1
1320526|NCT00065429|4279484|P7|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
1320527|NCT00065429|4279485|P6|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
1320528|NCT00065429|4279486|P5|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
1320529|NCT00065429|4279487|P4|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
1320530|NCT00065429|4279488|P3|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1
1320531|NCT00065429|4279489|P2|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
1320532|NCT00065429|4279490|P1|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
1320533|NCT00065429|4279484|P7|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
1320534|NCT00065429|4279485|P6|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1
1320535|NCT00065429|4279486|P5|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
1320536|NCT00065429|4279487|P4|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
1320537|NCT00065429|4279488|P3|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
1320538|NCT00065429|4279489|P2|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
1320539|NCT00065429|4279490|P1|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
1320540|NCT00065260|4279504|P2|Overall Study|Death|1
1320541|NCT00065260|4279505|P1|Overall Study|Death|0
1320542|NCT00065156|4279511|P1|Overall Study|Secondary Malign Disease|1
1320543|NCT00065156|4279511|P1|Overall Study|Loss of Response|1
1320544|NCT00065156|4279511|P1|Overall Study|Non-Compliance|2
1320545|NCT00065156|4279511|P1|Overall Study|Investigator Decision|2
1320546|NCT00065156|4279511|P1|Overall Study|Disease Progression|7
1320547|NCT00065156|4279511|P1|Overall Study|Study Closed by Sponsor|2
1320548|NCT00065156|4279511|P1|Overall Study|Death|11
1320549|NCT00065156|4279511|P1|Overall Study|Lost to Follow-up|1
1320550|NCT00065156|4279511|P1|Overall Study|Withdrawal by Subject|8
1320551|NCT00065156|4279511|P1|Overall Study|Lack of Efficacy|52
1320552|NCT00065156|4279511|P1|Overall Study|Adverse Event|37
1320553|NCT00065065|4279528|P2|Overall Study|Other|2
1320554|NCT00065065|4279529|P1|Overall Study|Other|2
1320555|NCT00065065|4279528|P2|Overall Study|Lack of Efficacy|11
1320556|NCT00065065|4279529|P1|Overall Study|Lack of Efficacy|4
1320557|NCT00065065|4279528|P2|Overall Study|Withdrawal by Subject|5
1320558|NCT00065065|4279529|P1|Overall Study|Withdrawal by Subject|1
1320559|NCT00065065|4279528|P2|Overall Study|Adverse Event|2
1320560|NCT00065065|4279529|P1|Overall Study|Adverse Event|3
1320561|NCT00003895|4279541|P2|Overall Study|Withdrawal by Subject|3
1320562|NCT00003895|4279542|P1|Overall Study|Withdrawal by Subject|0
1320563|NCT00003895|4279541|P2|Overall Study|Patient Vacation|0
1320564|NCT00003895|4279542|P1|Overall Study|Patient Vacation|2
1320565|NCT00003895|4279541|P2|Overall Study|Lack of Efficacy|1
1320566|NCT00003895|4279542|P1|Overall Study|Lack of Efficacy|1
1320567|NCT00003895|4279541|P2|Overall Study|Adverse Event|0
1320568|NCT00003895|4279542|P1|Overall Study|Adverse Event|4
1320569|NCT00064987|4279550|P2|Overall Study|Physician Decision|0
1320570|NCT00064987|4279551|P1|Overall Study|Physician Decision|3
1320571|NCT00064753|4279582|P2|Overall Study|Lost to Follow-up|235
1320572|NCT00064753|4279583|P1|Overall Study|Lost to Follow-up|225
1320573|NCT00064753|4279582|P2|Overall Study|Withdrawal by Subject|171
1320574|NCT00064753|4279583|P1|Overall Study|Withdrawal by Subject|198
1320575|NCT00064753|4279582|P2|Overall Study|Death|242
1320576|NCT00064753|4279583|P1|Overall Study|Death|251
1320577|NCT00064792|4279613|P2|Overall Study|Adverse Event|0
1320578|NCT00064792|4279614|P1|Overall Study|Adverse Event|3
1320579|NCT00064792|4279613|P2|Overall Study|Withdrawal by Subject|0
1320580|NCT00064792|4279614|P1|Overall Study|Withdrawal by Subject|2
1320581|NCT00064701|4279625|P3|Clinical Continuation Phase|Patient opted out|1
1320582|NCT00064701|4279626|P2|Clinical Continuation Phase|Patient opted out|0
1320583|NCT00064701|4279627|P1|Clinical Continuation Phase|Patient opted out|0
1320584|NCT00064701|4279625|P3|Clinical Continuation Phase|Incorrect study drug dispensed|0
1320585|NCT00064701|4279626|P2|Clinical Continuation Phase|Incorrect study drug dispensed|1
1320586|NCT00064701|4279627|P1|Clinical Continuation Phase|Incorrect study drug dispensed|0
1320587|NCT00064701|4279625|P3|Clinical Continuation Phase|Discharged to nursing home|0
1320588|NCT00064701|4279626|P2|Clinical Continuation Phase|Discharged to nursing home|1
1320589|NCT00064701|4279627|P1|Clinical Continuation Phase|Discharged to nursing home|0
1320590|NCT00064701|4279625|P3|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
1320591|NCT00064701|4279626|P2|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1
1320592|NCT00064701|4279627|P1|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
1320593|NCT00064701|4279625|P3|Clinical Continuation Phase|Pancreas transplant|0
1320594|NCT00064701|4279626|P2|Clinical Continuation Phase|Pancreas transplant|0
1320595|NCT00064701|4279627|P1|Clinical Continuation Phase|Pancreas transplant|1
1320596|NCT00064701|4279625|P3|Clinical Continuation Phase|Unable to return to site for study visit|1
1320597|NCT00064701|4279626|P2|Clinical Continuation Phase|Unable to return to site for study visit|0
1320598|NCT00064701|4279627|P1|Clinical Continuation Phase|Unable to return to site for study visit|1
1320599|NCT00064701|4279625|P3|Clinical Continuation Phase|Physician Decision|0
1320600|NCT00064701|4279626|P2|Clinical Continuation Phase|Physician Decision|3
1320601|NCT00064701|4279627|P1|Clinical Continuation Phase|Physician Decision|1
1320602|NCT00064701|4279625|P3|Clinical Continuation Phase|Immunosuppressive treatment crossover|6
1320603|NCT00064701|4279626|P2|Clinical Continuation Phase|Immunosuppressive treatment crossover|3
1320604|NCT00064701|4279627|P1|Clinical Continuation Phase|Immunosuppressive treatment crossover|0
1320605|NCT00064701|4279625|P3|Clinical Continuation Phase|Sponsor discontinued study|79
1320606|NCT00064701|4279626|P2|Clinical Continuation Phase|Sponsor discontinued study|129
1320607|NCT00064701|4279627|P1|Clinical Continuation Phase|Sponsor discontinued study|113
1320608|NCT00064701|4279625|P3|Clinical Continuation Phase|Rejection|2
1320609|NCT00064701|4279626|P2|Clinical Continuation Phase|Rejection|2
1320610|NCT00064701|4279627|P1|Clinical Continuation Phase|Rejection|1
1320611|NCT00064701|4279625|P3|Clinical Continuation Phase|Graft Failure|2
1320612|NCT00064701|4279626|P2|Clinical Continuation Phase|Graft Failure|5
1320613|NCT00064701|4279627|P1|Clinical Continuation Phase|Graft Failure|5
1320614|NCT00064701|4279625|P3|Clinical Continuation Phase|Lost to Follow-up|6
1320615|NCT00064701|4279626|P2|Clinical Continuation Phase|Lost to Follow-up|3
1320616|NCT00064701|4279627|P1|Clinical Continuation Phase|Lost to Follow-up|6
1320617|NCT00064701|4279625|P3|Clinical Continuation Phase|Withdrawal by Subject|22
1320618|NCT00064701|4279626|P2|Clinical Continuation Phase|Withdrawal by Subject|3
1320619|NCT00064701|4279627|P1|Clinical Continuation Phase|Withdrawal by Subject|22
1320620|NCT00064701|4279625|P3|Clinical Continuation Phase|Non-compliance|7
1320621|NCT00064701|4279626|P2|Clinical Continuation Phase|Non-compliance|6
1320622|NCT00064701|4279627|P1|Clinical Continuation Phase|Non-compliance|8
1320623|NCT00064701|4279625|P3|Clinical Continuation Phase|Adverse Event|14
1320624|NCT00064701|4279626|P2|Clinical Continuation Phase|Adverse Event|21
1320625|NCT00064701|4279627|P1|Clinical Continuation Phase|Adverse Event|12
1320626|NCT00064701|4279625|P3|One Year Post-transplant|Pancreas transplant|1
1320627|NCT00064701|4279626|P2|One Year Post-transplant|Pancreas transplant|0
1320628|NCT00064701|4279627|P1|One Year Post-transplant|Pancreas transplant|0
1320629|NCT00064701|4279625|P3|One Year Post-transplant|Poor absorption|0
1320630|NCT00064701|4279626|P2|One Year Post-transplant|Poor absorption|1
1320631|NCT00064701|4279627|P1|One Year Post-transplant|Poor absorption|0
1320632|NCT00064701|4279625|P3|One Year Post-transplant|Crossover secondary to possible toxicity|0
1320633|NCT00064701|4279626|P2|One Year Post-transplant|Crossover secondary to possible toxicity|1
1320634|NCT00064701|4279627|P1|One Year Post-transplant|Crossover secondary to possible toxicity|0
1320635|NCT00064701|4279625|P3|One Year Post-transplant|Incorrect study drug dispensed|0
1320636|NCT00064701|4279626|P2|One Year Post-transplant|Incorrect study drug dispensed|1
1320637|NCT00064701|4279627|P1|One Year Post-transplant|Incorrect study drug dispensed|0
1320638|NCT00064701|4279625|P3|One Year Post-transplant|Acute tubular necrosis|0
1320639|NCT00064701|4279626|P2|One Year Post-transplant|Acute tubular necrosis|0
1320640|NCT00064701|4279627|P1|One Year Post-transplant|Acute tubular necrosis|1
1320641|NCT00064701|4279625|P3|One Year Post-transplant|Converted to rapamycin|0
1320642|NCT00064701|4279626|P2|One Year Post-transplant|Converted to rapamycin|0
1320643|NCT00064701|4279627|P1|One Year Post-transplant|Converted to rapamycin|1
1320644|NCT00064701|4279625|P3|One Year Post-transplant|Lost to Follow-up|0
1320645|NCT00064701|4279626|P2|One Year Post-transplant|Lost to Follow-up|0
1320646|NCT00064701|4279627|P1|One Year Post-transplant|Lost to Follow-up|1
1320647|NCT00064701|4279625|P3|One Year Post-transplant|Withdrawal by Subject|1
1320648|NCT00064701|4279626|P2|One Year Post-transplant|Withdrawal by Subject|4
1320649|NCT00064701|4279627|P1|One Year Post-transplant|Withdrawal by Subject|0
1320650|NCT00064701|4279625|P3|One Year Post-transplant|Graft Failure|1
1320651|NCT00064701|4279626|P2|One Year Post-transplant|Graft Failure|2
1320652|NCT00064701|4279627|P1|One Year Post-transplant|Graft Failure|3
1320653|NCT00064701|4279625|P3|One Year Post-transplant|Non-compliance|5
1320654|NCT00064701|4279626|P2|One Year Post-transplant|Non-compliance|2
1320655|NCT00064701|4279627|P1|One Year Post-transplant|Non-compliance|4
1320656|NCT00064701|4279625|P3|One Year Post-transplant|Rejection|16
1320657|NCT00064701|4279626|P2|One Year Post-transplant|Rejection|1
1320658|NCT00064701|4279627|P1|One Year Post-transplant|Rejection|0
1320659|NCT00064701|4279625|P3|One Year Post-transplant|Adverse Event|37
1320660|NCT00064701|4279626|P2|One Year Post-transplant|Adverse Event|19
1320661|NCT00064701|4279627|P1|One Year Post-transplant|Adverse Event|23
1320662|NCT00064701|4279625|P3|One Year Post-transplant|Did not receive study drug|11
1320663|NCT00064701|4279626|P2|One Year Post-transplant|Did not receive study drug|12
1320664|NCT00064701|4279627|P1|One Year Post-transplant|Did not receive study drug|7
1320665|NCT00064662|4279679|P2|Overall Study|Administratively withdrawn|2
1320666|NCT00064662|4279680|P1|Overall Study|Administratively withdrawn|2
1320667|NCT00064662|4279679|P2|Overall Study|Withdrawal by Subject|14
1320668|NCT00064662|4279680|P1|Overall Study|Withdrawal by Subject|14
1320669|NCT00064662|4279679|P2|Overall Study|Lost to Follow-up|44
1320670|NCT00064662|4279680|P1|Overall Study|Lost to Follow-up|57
1320671|NCT00064662|4279679|P2|Overall Study|Death|1
1320672|NCT00064662|4279680|P1|Overall Study|Death|1
1320673|NCT00064350|4279691|P3|Cross-Over|Other|0
1320674|NCT00064350|4279692|P2|Cross-Over|Other|2
1320675|NCT00064350|4279693|P1|Cross-Over|Other|0
1320676|NCT00064350|4279691|P3|Cross-Over|Ineligible or never started treatment|0
1320677|NCT00064350|4279692|P2|Cross-Over|Ineligible or never started treatment|6
1320678|NCT00064350|4279693|P1|Cross-Over|Ineligible or never started treatment|3
1320679|NCT00064350|4279691|P3|Cross-Over|Withdrawal by Subject|0
1320680|NCT00064350|4279692|P2|Cross-Over|Withdrawal by Subject|2
1320681|NCT00064350|4279693|P1|Cross-Over|Withdrawal by Subject|2
1320682|NCT00064350|4279691|P3|Cross-Over|Death|0
1320683|NCT00064350|4279692|P2|Cross-Over|Death|3
1320684|NCT00064350|4279693|P1|Cross-Over|Death|1
1320685|NCT00064350|4279691|P3|Cross-Over|Adverse Event|0
1320686|NCT00064350|4279692|P2|Cross-Over|Adverse Event|1
1320687|NCT00064350|4279693|P1|Cross-Over|Adverse Event|0
1320688|NCT00064350|4279691|P3|Randomization|Other|0
1320689|NCT00064350|4279692|P2|Randomization|Other|0
1320690|NCT00064350|4279693|P1|Randomization|Other|5
1320691|NCT00064350|4279691|P3|Randomization|Ineligible or never started treatment|0
1320692|NCT00064350|4279692|P2|Randomization|Ineligible or never started treatment|15
1320693|NCT00064350|4279693|P1|Randomization|Ineligible or never started treatment|9
1320694|NCT00064350|4279691|P3|Randomization|Withdrawal by Subject|0
1320695|NCT00064350|4279692|P2|Randomization|Withdrawal by Subject|0
1320696|NCT00064350|4279693|P1|Randomization|Withdrawal by Subject|1
1320697|NCT00064350|4279691|P3|Randomization|Death|0
1320698|NCT00064350|4279692|P2|Randomization|Death|0
1320699|NCT00064350|4279693|P1|Randomization|Death|3
1320700|NCT00064350|4279691|P3|Randomization|Adverse Event|0
1320701|NCT00064350|4279692|P2|Randomization|Adverse Event|3
1320702|NCT00064350|4279693|P1|Randomization|Adverse Event|8
1320703|NCT00064350|4279691|P3|Induction Treatment|Other|13
1320704|NCT00064350|4279692|P2|Induction Treatment|Other|0
1320705|NCT00064350|4279693|P1|Induction Treatment|Other|0
1320706|NCT00064350|4279691|P3|Induction Treatment|Ineligible or never started treatment|34
1320707|NCT00064350|4279692|P2|Induction Treatment|Ineligible or never started treatment|6
1320708|NCT00064350|4279693|P1|Induction Treatment|Ineligible or never started treatment|3
1320709|NCT00064350|4279691|P3|Induction Treatment|Withdrawal by Subject|21
1320710|NCT00064350|4279692|P2|Induction Treatment|Withdrawal by Subject|0
1320711|NCT00064350|4279693|P1|Induction Treatment|Withdrawal by Subject|0
1320712|NCT00064350|4279691|P3|Induction Treatment|Death|9
1320713|NCT00064350|4279692|P2|Induction Treatment|Death|0
1320714|NCT00064350|4279693|P1|Induction Treatment|Death|0
1320715|NCT00064350|4279691|P3|Induction Treatment|Adverse Event|49
1320716|NCT00064350|4279692|P2|Induction Treatment|Adverse Event|2
1320717|NCT00064350|4279693|P1|Induction Treatment|Adverse Event|0
1320718|NCT00064350|4279691|P3|Induction Treatment|Disease Progression|110
1320719|NCT00064350|4279692|P2|Induction Treatment|Disease Progression|1
1320720|NCT00064350|4279693|P1|Induction Treatment|Disease Progression|5
1320721|NCT00064337|4279708|P1|Maintenance|Death|1
1320722|NCT00064337|4279708|P1|Maintenance|Not protocol-specified|2
1320723|NCT00064337|4279708|P1|Maintenance|On treatment at time of analysis|2
1320724|NCT00064337|4279708|P1|Maintenance|Progression|2
1320725|NCT00064337|4279708|P1|Maintenance|Adverse Event|3
1320726|NCT00064337|4279708|P1|Transplant|Progression|2
1320727|NCT00064337|4279708|P1|Transplant|Patient Refusal|2
1320728|NCT00064337|4279708|P1|Transplant|Death|3
1320729|NCT00064337|4279708|P1|Transplant|Not protocol-specified|5
1320730|NCT00064337|4279708|P1|Transplant|Adverse Event|9
1320731|NCT00064337|4279708|P1|PBSCC or Induction/PBSCC|Death|2
1320732|NCT00064337|4279708|P1|PBSCC or Induction/PBSCC|Patient Refusal|2
1320733|NCT00064337|4279708|P1|PBSCC or Induction/PBSCC|Progression|3
1320734|NCT00064337|4279708|P1|PBSCC or Induction/PBSCC|Adverse Event|6
1320735|NCT00064337|4279708|P1|PBSCC or Induction/PBSCC|Not protocol-specified|7
1320736|NCT00064298|4279717|P2|Overall Study|Disease Progression|1
1320737|NCT00064298|4279718|P1|Overall Study|Disease Progression|2
1320738|NCT00064298|4279717|P2|Overall Study|Death|1
1320739|NCT00064298|4279718|P1|Overall Study|Death|0
1320740|NCT00064298|4279717|P2|Overall Study|Lost to Follow-up|2
1320741|NCT00064298|4279718|P1|Overall Study|Lost to Follow-up|2
1320742|NCT00064298|4279717|P2|Overall Study|Withdrawal by Subject|1
1320743|NCT00064298|4279718|P1|Overall Study|Withdrawal by Subject|2
1320744|NCT00064259|4279726|P4|Overall Study|Adverse Event|1
1320745|NCT00064259|4279727|P3|Overall Study|Adverse Event|0
1320746|NCT00064259|4279728|P2|Overall Study|Adverse Event|0
1320747|NCT00064259|4279729|P1|Overall Study|Adverse Event|1
1320748|NCT00064077|4279737|P4|Overall Study|Other reasons|2
1320749|NCT00064077|4279738|P3|Overall Study|Other reasons|1
1320750|NCT00064077|4279739|P2|Overall Study|Other reasons|2
1320751|NCT00064077|4279740|P1|Overall Study|Other reasons|2
1320752|NCT00064077|4279737|P4|Overall Study|No tumor|0
1320753|NCT00064077|4279738|P3|Overall Study|No tumor|1
1320754|NCT00064077|4279739|P2|Overall Study|No tumor|0
1320755|NCT00064077|4279740|P1|Overall Study|No tumor|0
1320756|NCT00064077|4279737|P4|Overall Study|No surgery|0
1320757|NCT00064077|4279738|P3|Overall Study|No surgery|1
1320758|NCT00064077|4279739|P2|Overall Study|No surgery|0
1320759|NCT00064077|4279740|P1|Overall Study|No surgery|0
1320760|NCT00064077|4279737|P4|Overall Study|Pathology|4
1320761|NCT00064077|4279738|P3|Overall Study|Pathology|3
1320762|NCT00064077|4279739|P2|Overall Study|Pathology|7
1320763|NCT00064077|4279740|P1|Overall Study|Pathology|10
1320764|NCT00064077|4279737|P4|Overall Study|Poor risk|1
1320765|NCT00064077|4279738|P3|Overall Study|Poor risk|1
1320766|NCT00064077|4279739|P2|Overall Study|Poor risk|0
1320767|NCT00064077|4279740|P1|Overall Study|Poor risk|2
1320768|NCT00064077|4279737|P4|Overall Study|Improper prior treatment|0
1320769|NCT00064077|4279738|P3|Overall Study|Improper prior treatment|0
1320770|NCT00064077|4279739|P2|Overall Study|Improper prior treatment|0
1320771|NCT00064077|4279740|P1|Overall Study|Improper prior treatment|1
1320772|NCT00064025|4279784|P1|Overall Study|Inevaluable|3
1320773|NCT00064025|4279784|P1|Overall Study|Ineligible|4
1320774|NCT00063999|4279793|P2|Overall Study|Ineligible|24
1320775|NCT00063999|4279794|P1|Overall Study|Ineligible|44
1320776|NCT00063999|4279793|P2|Overall Study|Withdrawal by Subject|0
1320777|NCT00063999|4279794|P1|Overall Study|Withdrawal by Subject|1
1320778|NCT00063986|4279810|P1|Overall Study|Intra-operatively ineligible|4
1320779|NCT00063986|4279810|P1|Overall Study|Ineligible|1
1320780|NCT00063986|4279810|P1|Overall Study|Withdrawal by Subject|1
1320781|NCT00063934|4279822|P1|Overall Study|Ineligible|1
1320782|NCT00063258|4279927|P2|Overall Study|Lack of Efficacy|0
1320783|NCT00063258|4279928|P1|Overall Study|Lack of Efficacy|2
1320784|NCT00063258|4279927|P2|Overall Study|Physician Decision|0
1320785|NCT00063258|4279928|P1|Overall Study|Physician Decision|2
1320786|NCT00063154|4279934|P1|Overall Study|Did not receive treatment|8
1320787|NCT00063154|4279934|P1|Overall Study|Reason unspecified|1
1320788|NCT00063154|4279934|P1|Overall Study|Death|3
1320789|NCT00063154|4279934|P1|Overall Study|Physician Decision|10
1320790|NCT00063154|4279934|P1|Overall Study|Adverse Event|2
1320791|NCT00063154|4279934|P1|Overall Study|Disease progression|27
1320792|NCT00062751|4279960|P5|Overall Study|Death|0
1320793|NCT00062751|4279961|P4|Overall Study|Death|0
1320794|NCT00062751|4279962|P3|Overall Study|Death|1
1320795|NCT00062751|4279963|P2|Overall Study|Death|0
1320796|NCT00062751|4279964|P1|Overall Study|Death|1
1320797|NCT00062751|4279960|P5|Overall Study|Symptomatic deterioration|1
1320798|NCT00062751|4279961|P4|Overall Study|Symptomatic deterioration|0
1320799|NCT00062751|4279962|P3|Overall Study|Symptomatic deterioration|0
1320800|NCT00062751|4279963|P2|Overall Study|Symptomatic deterioration|1
1320801|NCT00062751|4279964|P1|Overall Study|Symptomatic deterioration|1
1320802|NCT00062751|4279960|P5|Overall Study|Withdrawal by Subject|0
1320803|NCT00062751|4279961|P4|Overall Study|Withdrawal by Subject|1
1320804|NCT00062751|4279962|P3|Overall Study|Withdrawal by Subject|2
1320805|NCT00062751|4279963|P2|Overall Study|Withdrawal by Subject|2
1320806|NCT00062751|4279964|P1|Overall Study|Withdrawal by Subject|1
1320807|NCT00062751|4279960|P5|Overall Study|Other|1
1320808|NCT00062751|4279961|P4|Overall Study|Other|0
1320809|NCT00062751|4279962|P3|Overall Study|Other|1
1320810|NCT00062751|4279963|P2|Overall Study|Other|3
1320811|NCT00062751|4279964|P1|Overall Study|Other|2
1320812|NCT00062751|4279960|P5|Overall Study|Adverse Event|2
1320813|NCT00062751|4279961|P4|Overall Study|Adverse Event|2
1320814|NCT00062751|4279962|P3|Overall Study|Adverse Event|2
1320815|NCT00062751|4279963|P2|Overall Study|Adverse Event|7
1320816|NCT00062751|4279964|P1|Overall Study|Adverse Event|4
1320817|NCT00062751|4279960|P5|Overall Study|Disease progression|2
1320818|NCT00062751|4279961|P4|Overall Study|Disease progression|2
1320819|NCT00062751|4279962|P3|Overall Study|Disease progression|24
1320820|NCT00062751|4279963|P2|Overall Study|Disease progression|17
1320821|NCT00062751|4279964|P1|Overall Study|Disease progression|24
1320822|NCT00062647|4280050|P2|Overall Study|Never received study treatment|1
1320823|NCT00062647|4280051|P1|Overall Study|Never received study treatment|1
1320824|NCT00062647|4280050|P2|Overall Study|Other|4
1320825|NCT00062647|4280051|P1|Overall Study|Other|4
1320826|NCT00062647|4280050|P2|Overall Study|Failed continuation criteria|2
1320827|NCT00062647|4280051|P1|Overall Study|Failed continuation criteria|4
1320828|NCT00062647|4280050|P2|Overall Study|Lost to Follow-up|2
1320829|NCT00062647|4280051|P1|Overall Study|Lost to Follow-up|1
1320830|NCT00062647|4280050|P2|Overall Study|Protocol Violation|0
1320831|NCT00062647|4280051|P1|Overall Study|Protocol Violation|1
1320832|NCT00062647|4280050|P2|Overall Study|Withdrawal by Subject|1
1320833|NCT00062647|4280051|P1|Overall Study|Withdrawal by Subject|2
1320834|NCT00062647|4280050|P2|Overall Study|Adverse Event|1
1320835|NCT00062647|4280051|P1|Overall Study|Adverse Event|1
1320836|NCT00062647|4280050|P2|Overall Study|Death|2
1320837|NCT00062647|4280051|P1|Overall Study|Death|2
1320838|NCT00062439|4280057|P1|Consolidation Chemotherapy|Adverse Event|2
1320839|NCT00062439|4280057|P1|Surgery|Adverse Event|2
1320840|NCT00062439|4280057|P1|Surgery|Death|1
1320841|NCT00062439|4280057|P1|Surgery|Physician Decision|4
1320842|NCT00062439|4280057|P1|Post Chemoradiation Assessment|Not eligible to continue to surgery|4
1320843|NCT00062439|4280057|P1|Post Chemoradiation Assessment|Physician Decision|1
1320844|NCT00062439|4280057|P1|Post Chemoradiation Assessment|Withdrawal by Subject|1
1320845|NCT00062439|4280057|P1|Post Chemoradiation Assessment|Disease progression|2
1320846|NCT00062439|4280057|P1|Post Chemoradiation Assessment|Death|1
1320847|NCT00062439|4280057|P1|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3
1320848|NCT00062439|4280057|P1|Induction Chemotherapy + Radiotherapy|Adverse Event|3
1320849|NCT00062439|4280057|P1|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1
1320850|NCT00062439|4280057|P1|Induction Chemotherapy + Radiotherapy|Ineligible|1
1320851|NCT00062374|4280069|P1|Overall Study|Not treated|12
1320852|NCT00062166|4280074|P1|Overall Study|Withdrawal by Subject|6
1320853|NCT00062010|4280082|P1|Overall Study|Ineligible|3
1320854|NCT00061945|4280090|P2|Course IV: Alemtuzumab|Early exits|15
1320855|NCT00061945|4280091|P1|Course IV: Alemtuzumab|Early exits|6
1320856|NCT00061945|4280090|P2|Course IV: Alemtuzumab|Declined Alemtuzumab|1
1320857|NCT00061945|4280091|P1|Course IV: Alemtuzumab|Declined Alemtuzumab|1
1320858|NCT00061945|4280090|P2|Registration Through Course 3|Early discontinuation during course I-IV|90
1320859|NCT00061945|4280091|P1|Registration Through Course 3|Early discontinuation during course I-IV|76
1320860|NCT00061945|4280090|P2|Registration Through Course 3|Not Alemtuzumab Eligible|25
1320861|NCT00061945|4280091|P1|Registration Through Course 3|Not Alemtuzumab Eligible|18
1320862|NCT00061932|4280101|P2|Overall Study|Withdrawal by Subject|4
1320863|NCT00061932|4280102|P1|Overall Study|Withdrawal by Subject|13
1320864|NCT00061633|4280115|P2|Overall Study|Never received study treatment|2
1320865|NCT00061633|4280116|P1|Overall Study|Never received study treatment|0
1320866|NCT00061633|4280115|P2|Overall Study|Other|1
1320867|NCT00061633|4280116|P1|Overall Study|Other|1
1320868|NCT00061633|4280115|P2|Overall Study|Lost to Follow-up|4
1320869|NCT00061633|4280116|P1|Overall Study|Lost to Follow-up|1
1320870|NCT00061633|4280115|P2|Overall Study|Withdrawal by Subject|2
1320871|NCT00061633|4280116|P1|Overall Study|Withdrawal by Subject|2
1320872|NCT00061633|4280115|P2|Overall Study|Adverse Event|2
1320873|NCT00061633|4280116|P1|Overall Study|Adverse Event|1
1320874|NCT00061048|4280141|P1|Overall Study|disease progression|20
1320875|NCT00061048|4280141|P1|Overall Study|Adverse Event|2
1320876|NCT00060944|4280151|P2|Overall Study|randomized but not treated|4
1320877|NCT00060944|4280152|P1|Overall Study|randomized but not treated|6
1320878|NCT00060944|4280151|P2|Overall Study|Not specified|4
1320879|NCT00060944|4280152|P1|Overall Study|Not specified|2
1320880|NCT00060944|4280151|P2|Overall Study|Treatment Switch|13
1320881|NCT00060944|4280152|P1|Overall Study|Treatment Switch|0
1320882|NCT00060944|4280151|P2|Overall Study|Subject Ineligible To Continue|1
1320883|NCT00060944|4280152|P1|Overall Study|Subject Ineligible To Continue|2
1320884|NCT00060944|4280151|P2|Overall Study|Lost to Follow-up|0
1320885|NCT00060944|4280152|P1|Overall Study|Lost to Follow-up|1
1320886|NCT00060944|4280151|P2|Overall Study|Disease Progression|94
1320887|NCT00060944|4280152|P1|Overall Study|Disease Progression|93
1320888|NCT00060944|4280151|P2|Overall Study|Withdrawal by Subject|5
1320889|NCT00060944|4280152|P1|Overall Study|Withdrawal by Subject|18
1320890|NCT00060944|4280151|P2|Overall Study|Death|3
1320891|NCT00060944|4280152|P1|Overall Study|Death|2
1320892|NCT00060944|4280151|P2|Overall Study|Adverse Event|10
1320893|NCT00060944|4280152|P1|Overall Study|Adverse Event|12
1320894|NCT00060840|4280168|P2|Overall Study|Other|0
1320895|NCT00060840|4280169|P1|Overall Study|Other|1
1320896|NCT00060840|4280168|P2|Overall Study|Physician Decision|0
1320897|NCT00060840|4280169|P1|Overall Study|Physician Decision|1
1320898|NCT00060840|4280168|P2|Overall Study|Subinvestigator unavailable|1
1320899|NCT00060840|4280169|P1|Overall Study|Subinvestigator unavailable|0
1320900|NCT00060840|4280168|P2|Overall Study|Withdrawal by Subject|1
1320901|NCT00060840|4280169|P1|Overall Study|Withdrawal by Subject|0
1320902|NCT00060840|4280168|P2|Overall Study|Death|1
1320903|NCT00060840|4280169|P1|Overall Study|Death|0
1320904|NCT00060840|4280168|P2|Overall Study|Change in surgical plan|6
1320905|NCT00060840|4280169|P1|Overall Study|Change in surgical plan|2
1320906|NCT00059839|4280222|P2|Overall Study|Ineligible|3
1320907|NCT00059839|4280223|P1|Overall Study|Ineligible|1
1320908|NCT00059839|4280222|P2|Overall Study|Withdrawal by Subject|6
1320909|NCT00059839|4280223|P1|Overall Study|Withdrawal by Subject|1
1320910|NCT00059839|4280222|P2|Overall Study|Physician Decision|2
1320911|NCT00059839|4280223|P1|Overall Study|Physician Decision|1
1320912|NCT00059839|4280222|P2|Overall Study|Lost to Follow-up|0
1320913|NCT00059839|4280223|P1|Overall Study|Lost to Follow-up|2
1320914|NCT00059839|4280222|P2|Overall Study|Lack of Efficacy|5
1320915|NCT00059839|4280223|P1|Overall Study|Lack of Efficacy|6
1320916|NCT00059839|4280222|P2|Overall Study|Death|1
1320917|NCT00059839|4280223|P1|Overall Study|Death|1
1320918|NCT00059787|4280229|P1|Overall Study|Other|4
1320919|NCT00059787|4280229|P1|Overall Study|ineligible|1
1320920|NCT00059787|4280229|P1|Overall Study|disease progression|2
1320921|NCT00059787|4280229|P1|Overall Study|Adverse Event|13
1320922|NCT00059332|4280280|P2|Overall Study|Lost to Follow-up|1
1320923|NCT00059332|4280281|P1|Overall Study|Lost to Follow-up|1
1320924|NCT00059332|4280280|P2|Overall Study|Withdrawal by Subject|1
1320925|NCT00059332|4280281|P1|Overall Study|Withdrawal by Subject|2
1320926|NCT00059215|4280307|P4|Overall Study|Physician Decision|1
1320927|NCT00059215|4280308|P3|Overall Study|Physician Decision|1
1320928|NCT00059215|4280309|P2|Overall Study|Physician Decision|2
1320929|NCT00059215|4280310|P1|Overall Study|Physician Decision|1
1320930|NCT00059215|4280307|P4|Overall Study|Protocol entry criteria not met|2
1320931|NCT00059215|4280308|P3|Overall Study|Protocol entry criteria not met|0
1320932|NCT00059215|4280309|P2|Overall Study|Protocol entry criteria not met|1
1320933|NCT00059215|4280310|P1|Overall Study|Protocol entry criteria not met|1
1320934|NCT00059215|4280307|P4|Overall Study|Protocol Violation|0
1320935|NCT00059215|4280308|P3|Overall Study|Protocol Violation|1
1320936|NCT00059215|4280309|P2|Overall Study|Protocol Violation|0
1320937|NCT00059215|4280310|P1|Overall Study|Protocol Violation|1
1320938|NCT00059215|4280307|P4|Overall Study|Withdrawal by Subject|3
1320939|NCT00059215|4280308|P3|Overall Study|Withdrawal by Subject|1
1320940|NCT00059215|4280309|P2|Overall Study|Withdrawal by Subject|4
1320941|NCT00059215|4280310|P1|Overall Study|Withdrawal by Subject|4
1320942|NCT00059215|4280307|P4|Overall Study|Lost to Follow-up|0
1320943|NCT00059215|4280308|P3|Overall Study|Lost to Follow-up|0
1320944|NCT00059215|4280309|P2|Overall Study|Lost to Follow-up|2
1320945|NCT00059215|4280310|P1|Overall Study|Lost to Follow-up|1
1320946|NCT00059215|4280307|P4|Overall Study|Death|0
1320947|NCT00059215|4280308|P3|Overall Study|Death|3
1320948|NCT00059215|4280309|P2|Overall Study|Death|0
1320949|NCT00059215|4280310|P1|Overall Study|Death|0
1320950|NCT00059215|4280307|P4|Overall Study|Adverse Event|9
1320951|NCT00059215|4280308|P3|Overall Study|Adverse Event|9
1320952|NCT00059215|4280309|P2|Overall Study|Adverse Event|5
1320953|NCT00059215|4280310|P1|Overall Study|Adverse Event|5
1320954|NCT00058825|4280347|P1|Overall Study|Death|3
1320955|NCT00058825|4280347|P1|Overall Study|Graft Failure|5
1320956|NCT00058825|4280347|P1|Overall Study|Progressive Disease|5
1320957|NCT00058825|4280347|P1|Overall Study|Relapse|9
1320958|NCT00058552|4280363|P2|Overall Study|Clinical disease progression|4
1320959|NCT00058552|4280364|P1|Overall Study|Clinical disease progression|0
1320960|NCT00058552|4280363|P2|Overall Study|Physician Decision|5
1320961|NCT00058552|4280364|P1|Overall Study|Physician Decision|2
1320962|NCT00058552|4280363|P2|Overall Study|Withdrawal by Subject|5
1320963|NCT00058552|4280364|P1|Overall Study|Withdrawal by Subject|3
1320964|NCT00058552|4280363|P2|Overall Study|Adverse Event|2
1320965|NCT00058552|4280364|P1|Overall Study|Adverse Event|4
1320966|NCT00058552|4280363|P2|Overall Study|Disease progression|44
1320967|NCT00058552|4280364|P1|Overall Study|Disease progression|52
1320968|NCT00058552|4280363|P2|Overall Study|Died prior to receiving treatment|2
1320969|NCT00058552|4280364|P1|Overall Study|Died prior to receiving treatment|4
1320970|NCT00058539|4280382|P1|Overall Study|Death|1
1320971|NCT00058539|4280382|P1|Overall Study|Physician Decision|9
1320972|NCT00058539|4280382|P1|Overall Study|Withdrawal by Subject|5
1320973|NCT00058539|4280382|P1|Overall Study|Adverse Event|3
1320974|NCT00058539|4280382|P1|Overall Study|Disease progression|24
1320975|NCT00058214|4280409|P1|Overall Study|Adverse Event|1
1320976|NCT00058123|4280414|P1|Overall Study|Received >3 prior treatments|1
1320977|NCT00058123|4280414|P1|Overall Study|Wrong histology|9
1320978|NCT00058058|4280421|P1|Overall Study|Poor positioning, illness,pain|3
1320979|NCT00058058|4280421|P1|Overall Study|technical issues|6
1320980|NCT00058058|4280421|P1|Overall Study|Claustrophobic|5
1320981|NCT00058058|4280421|P1|Overall Study|Ineligible|20
1320982|NCT00058058|4280421|P1|Overall Study|Withdrawal by Subject|4
1320983|NCT00057954|4280446|P1|Overall Study|Disease progression|1
1320984|NCT00057954|4280446|P1|Overall Study|Death|1
1320985|NCT00057941|4280454|P2|Overall Study|Ineligible|5
1320986|NCT00057941|4280455|P1|Overall Study|Ineligible|2
1320987|NCT00057941|4280454|P2|Overall Study|insurance, symptomatic deterioration|3
1320988|NCT00057941|4280455|P1|Overall Study|insurance, symptomatic deterioration|1
1320989|NCT00057941|4280454|P2|Overall Study|still on treatment|1
1320990|NCT00057941|4280455|P1|Overall Study|still on treatment|3
1320991|NCT00057941|4280454|P2|Overall Study|Withdrawal by Subject|1
1320992|NCT00057941|4280455|P1|Overall Study|Withdrawal by Subject|6
1320993|NCT00057941|4280454|P2|Overall Study|Lack of Efficacy|53
1320994|NCT00057941|4280455|P1|Overall Study|Lack of Efficacy|54
1320995|NCT00057941|4280454|P2|Overall Study|Adverse Event|9
1320996|NCT00057941|4280455|P1|Overall Study|Adverse Event|7
1320997|NCT00057941|4280454|P2|Overall Study|Death|2
1320998|NCT00057941|4280455|P1|Overall Study|Death|1
1320999|NCT00057876|4280463|P2|Overall Study|other complicating disease|0
1321000|NCT00057876|4280464|P1|Overall Study|other complicating disease|1
1321001|NCT00057876|4280463|P2|Overall Study|other reason|2
1321002|NCT00057876|4280464|P1|Overall Study|other reason|2
1321003|NCT00057876|4280463|P2|Overall Study|Ineligible|2
1321004|NCT00057876|4280464|P1|Overall Study|Ineligible|1
1321005|NCT00057876|4280463|P2|Overall Study|Lack of Efficacy|8
1321006|NCT00057876|4280464|P1|Overall Study|Lack of Efficacy|10
1321007|NCT00057876|4280463|P2|Overall Study|Withdrawal by Subject|6
1321008|NCT00057876|4280464|P1|Overall Study|Withdrawal by Subject|5
1321009|NCT00057876|4280463|P2|Overall Study|Death|1
1321010|NCT00057876|4280464|P1|Overall Study|Death|2
1321011|NCT00057876|4280463|P2|Overall Study|Adverse Event|8
1321012|NCT00057876|4280464|P1|Overall Study|Adverse Event|8
1321013|NCT00057863|4280474|P1|Overall Study|Withdrawal by Subject|2
1321014|NCT00057863|4280474|P1|Overall Study|Death|1
1321015|NCT00057837|4280483|P2|Overall Study|Never started treatment|1
1321016|NCT00057837|4280484|P1|Overall Study|Never started treatment|1
1321017|NCT00057837|4280483|P2|Overall Study|Ineligible|3
1321018|NCT00057837|4280484|P1|Overall Study|Ineligible|3
1321019|NCT00057837|4280483|P2|Overall Study|Physician Decision|0
1321020|NCT00057837|4280484|P1|Overall Study|Physician Decision|1
1321021|NCT00057837|4280483|P2|Overall Study|Other complicating disease|1
1321022|NCT00057837|4280484|P1|Overall Study|Other complicating disease|2
1321023|NCT00057837|4280483|P2|Overall Study|Alternative therapy|1
1321024|NCT00057837|4280484|P1|Overall Study|Alternative therapy|0
1321025|NCT00057837|4280483|P2|Overall Study|Withdrawal by Subject|3
1321026|NCT00057837|4280484|P1|Overall Study|Withdrawal by Subject|5
1321027|NCT00057837|4280483|P2|Overall Study|Death|4
1321028|NCT00057837|4280484|P1|Overall Study|Death|5
1321029|NCT00057837|4280483|P2|Overall Study|Adverse Event|12
1321030|NCT00057837|4280484|P1|Overall Study|Adverse Event|2
1321031|NCT00057837|4280483|P2|Overall Study|Progression/relapse|14
1321032|NCT00057837|4280484|P1|Overall Study|Progression/relapse|12
1321033|NCT00057811|4280496|P2|Overall Study|Inevaluable|2
1321034|NCT00057811|4280497|P1|Overall Study|Inevaluable|1
1321035|NCT00057811|4280496|P2|Overall Study|Ineligible|2
1321036|NCT00057811|4280497|P1|Overall Study|Ineligible|4
1321037|NCT00057811|4280496|P2|Overall Study|Withdrawal by Subject|4
1321038|NCT00057811|4280497|P1|Overall Study|Withdrawal by Subject|3
1321039|NCT00057811|4280496|P2|Overall Study|Physician Decision|0
1321040|NCT00057811|4280497|P1|Overall Study|Physician Decision|1
1321041|NCT00057811|4280496|P2|Overall Study|Lack of Efficacy|4
1321042|NCT00057811|4280497|P1|Overall Study|Lack of Efficacy|1
1321043|NCT00057746|4280516|P3|Overall Study|Withdrawal by Subject|1
1321044|NCT00057746|4280517|P2|Overall Study|Withdrawal by Subject|0
1321045|NCT00057746|4280518|P1|Overall Study|Withdrawal by Subject|0
1321046|NCT00023673|4280529|P4|Overall Study|Patient withdrew consent|1
1321047|NCT00023673|4280530|P3|Overall Study|Patient withdrew consent|0
1321048|NCT00023673|4280531|P2|Overall Study|Patient withdrew consent|0
1321049|NCT00023673|4280532|P1|Overall Study|Patient withdrew consent|0
1321050|NCT00023673|4280529|P4|Overall Study|Ineligible / no protocol treatment|1
1321051|NCT00023673|4280530|P3|Overall Study|Ineligible / no protocol treatment|0
1321052|NCT00023673|4280531|P2|Overall Study|Ineligible / no protocol treatment|0
1321053|NCT00023673|4280532|P1|Overall Study|Ineligible / no protocol treatment|0
1321054|NCT00057330|4280596|P2|Overall Study|Other|206
1321055|NCT00057330|4280597|P1|Overall Study|Other|260
1321056|NCT00057330|4280596|P2|Overall Study|Physician Decision|0
1321057|NCT00057330|4280597|P1|Overall Study|Physician Decision|1
1321058|NCT00057330|4280596|P2|Overall Study|Lost to Follow-up|617
1321059|NCT00057330|4280597|P1|Overall Study|Lost to Follow-up|745
1321060|NCT00057330|4280596|P2|Overall Study|Withdrawal by Subject|84
1321061|NCT00057330|4280597|P1|Overall Study|Withdrawal by Subject|115
1321062|NCT00057330|4280596|P2|Overall Study|Protocol Violation|1
1321063|NCT00057330|4280597|P1|Overall Study|Protocol Violation|1
1321064|NCT00057330|4280596|P2|Overall Study|Death|0
1321065|NCT00057330|4280597|P1|Overall Study|Death|1
1321066|NCT00057330|4280596|P2|Overall Study|Adverse Event|12
1321067|NCT00057330|4280597|P1|Overall Study|Adverse Event|9
1321068|NCT00056862|4280627|P2|Overall Study|Protocol Violation|0
1321069|NCT00056862|4280628|P1|Overall Study|Protocol Violation|1
1321070|NCT00056407|4280686|P2|Overall Study|Missing|34
1321071|NCT00056407|4280687|P1|Overall Study|Missing|25
1321072|NCT00056407|4280686|P2|Overall Study|"Listed as Other on Case Report Form"|60
1321073|NCT00056407|4280687|P1|Overall Study|"Listed as Other on Case Report Form"|98
1321074|NCT00056407|4280686|P2|Overall Study|Diagnosed with Prostate Cancer|166
1321075|NCT00056407|4280687|P1|Overall Study|Diagnosed with Prostate Cancer|202
1321076|NCT00056407|4280686|P2|Overall Study|Protocol Violation|95
1321077|NCT00056407|4280687|P1|Overall Study|Protocol Violation|104
1321078|NCT00056407|4280686|P2|Overall Study|Lost to Follow-up|113
1321079|NCT00056407|4280687|P1|Overall Study|Lost to Follow-up|123
1321080|NCT00056407|4280686|P2|Overall Study|Withdrawal by Subject|361
1321081|NCT00056407|4280687|P1|Overall Study|Withdrawal by Subject|377
1321082|NCT00056407|4280686|P2|Overall Study|Adverse Event|364
1321083|NCT00056407|4280687|P1|Overall Study|Adverse Event|282
1321084|NCT00056316|4280745|P2|Overall Study|Death/NH placement of pt|1
1321085|NCT00056316|4280746|P1|Overall Study|Death/NH placement of pt|1
1321086|NCT00056316|4280745|P2|Overall Study|Withdrawal by Subject|2
1321087|NCT00056316|4280746|P1|Overall Study|Withdrawal by Subject|2
1321088|NCT00056160|4280760|P2|Final Follow-up|Adverse Event|0
1321089|NCT00056160|4280761|P1|Final Follow-up|Adverse Event|1
1321090|NCT00056160|4280760|P2|Final Follow-up|Transferred into RevAssist Program|0
1321091|NCT00056160|4280761|P1|Final Follow-up|Transferred into RevAssist Program|2
1321092|NCT00056160|4280760|P2|Final Follow-up|Transferred into expanded access study.|0
1321093|NCT00056160|4280761|P1|Final Follow-up|Transferred into expanded access study.|3
1321094|NCT00056160|4280760|P2|Extended Follow-up Cutoff (23 Jul 2008)|Not specified|0
1321095|NCT00056160|4280761|P1|Extended Follow-up Cutoff (23 Jul 2008)|Not specified|21
1321096|NCT00056160|4280760|P2|Extended Follow-up Cutoff (23 Jul 2008)|Death|0
1321097|NCT00056160|4280761|P1|Extended Follow-up Cutoff (23 Jul 2008)|Death|5
1321098|NCT00056160|4280760|P2|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0
1321099|NCT00056160|4280761|P1|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11
1321100|NCT00056160|4280760|P2|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0
1321101|NCT00056160|4280761|P1|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3
1321102|NCT00056160|4280760|P2|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0
1321103|NCT00056160|4280761|P1|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87
1321104|NCT00056160|4280760|P2|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0
1321105|NCT00056160|4280761|P1|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44
1321106|NCT00056160|4280760|P2|Up to Unblinding (07 Jun 2005)|Not specified|7
1321107|NCT00056160|4280761|P1|Up to Unblinding (07 Jun 2005)|Not specified|8
1321108|NCT00056160|4280760|P2|Up to Unblinding (07 Jun 2005)|Death|1
1321109|NCT00056160|4280761|P1|Up to Unblinding (07 Jun 2005)|Death|2
1321110|NCT00056160|4280760|P2|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
1321111|NCT00056160|4280761|P1|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
1321112|NCT00056160|4280760|P2|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5
1321113|NCT00056160|4280761|P1|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3
1321114|NCT00056160|4280760|P2|Up to Unblinding (07 Jun 2005)|Progression of disease|124
1321115|NCT00056160|4280761|P1|Up to Unblinding (07 Jun 2005)|Progression of disease|57
1321116|NCT00056160|4280760|P2|Up to Unblinding (07 Jun 2005)|Adverse Event|18
1321117|NCT00056160|4280761|P1|Up to Unblinding (07 Jun 2005)|Adverse Event|35
1321118|NCT00055601|4280784|P2|Overall Study|No protocol treatment received|1
1321119|NCT00055601|4280785|P1|Overall Study|No protocol treatment received|1
1321120|NCT00055601|4280784|P2|Overall Study|Protocol Violation|1
1321121|NCT00055601|4280785|P1|Overall Study|Protocol Violation|1
1321122|NCT00055497|4280799|P4|Overall Study|Other|11
1321123|NCT00055497|4280800|P3|Overall Study|Other|0
1321124|NCT00055497|4280801|P2|Overall Study|Other|0
1321125|NCT00055497|4280802|P1|Overall Study|Other|0
1321126|NCT00055497|4280799|P4|Overall Study|Administrative Reasons|1
1321127|NCT00055497|4280800|P3|Overall Study|Administrative Reasons|0
1321128|NCT00055497|4280801|P2|Overall Study|Administrative Reasons|0
1321129|NCT00055497|4280802|P1|Overall Study|Administrative Reasons|0
1321130|NCT00055497|4280799|P4|Overall Study|Lack of Efficacy|27
1321131|NCT00055497|4280800|P3|Overall Study|Lack of Efficacy|0
1321132|NCT00055497|4280801|P2|Overall Study|Lack of Efficacy|0
1321133|NCT00055497|4280802|P1|Overall Study|Lack of Efficacy|1
1321134|NCT00055497|4280799|P4|Overall Study|Protocol Violation|3
1321135|NCT00055497|4280800|P3|Overall Study|Protocol Violation|0
1321136|NCT00055497|4280801|P2|Overall Study|Protocol Violation|0
1321137|NCT00055497|4280802|P1|Overall Study|Protocol Violation|0
1321138|NCT00055497|4280799|P4|Overall Study|Lost to Follow-up|5
1321139|NCT00055497|4280800|P3|Overall Study|Lost to Follow-up|0
1321140|NCT00055497|4280801|P2|Overall Study|Lost to Follow-up|1
1321141|NCT00055497|4280802|P1|Overall Study|Lost to Follow-up|0
1321142|NCT00055497|4280799|P4|Overall Study|Withdrawal by Subject|15
1321143|NCT00055497|4280800|P3|Overall Study|Withdrawal by Subject|1
1321144|NCT00055497|4280801|P2|Overall Study|Withdrawal by Subject|1
1321145|NCT00055497|4280802|P1|Overall Study|Withdrawal by Subject|3
1321146|NCT00055497|4280799|P4|Overall Study|Adverse Event|28
1321147|NCT00055497|4280800|P3|Overall Study|Adverse Event|1
1321148|NCT00055497|4280801|P2|Overall Study|Adverse Event|1
1321149|NCT00055497|4280802|P1|Overall Study|Adverse Event|1
1321150|NCT00055471|4280847|P3|Period 1: Dose Escalation Period|Disease progression|0
1321151|NCT00055471|4280848|P2|Period 1: Dose Escalation Period|Disease progression|1
1321152|NCT00055471|4280849|P1|Period 1: Dose Escalation Period|Disease progression|0
1321153|NCT00055471|4280847|P3|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1
1321154|NCT00055471|4280848|P2|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
1321155|NCT00055471|4280849|P1|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
1321156|NCT00055471|4280847|P3|Period 1: Dose Escalation Period|Adverse Event|2
1321157|NCT00055471|4280848|P2|Period 1: Dose Escalation Period|Adverse Event|1
1321158|NCT00055471|4280849|P1|Period 1: Dose Escalation Period|Adverse Event|0
1321159|NCT00054717|4280904|P2|Overall Study|Other reason not defined above|217
1321160|NCT00054717|4280905|P1|Overall Study|Other reason not defined above|117
1321161|NCT00054717|4280904|P2|Overall Study|Withdrawal by Subject|20
1321162|NCT00054717|4280905|P1|Overall Study|Withdrawal by Subject|32
1321163|NCT00054717|4280904|P2|Overall Study|Lost to Follow-up|13
1321164|NCT00054717|4280905|P1|Overall Study|Lost to Follow-up|23
1321165|NCT00054717|4280904|P2|Overall Study|Protocol Violation|19
1321166|NCT00054717|4280905|P1|Overall Study|Protocol Violation|18
1321167|NCT00054717|4280904|P2|Overall Study|Adverse Event|22
1321168|NCT00054717|4280905|P1|Overall Study|Adverse Event|70
1321169|NCT00054717|4280904|P2|Overall Study|Randomized but not treated|8
1321170|NCT00054717|4280905|P1|Overall Study|Randomized but not treated|2
1321171|NCT00054704|4281093|P2|Overall Study|Lost to Follow-up|0
1321172|NCT00054704|4281094|P1|Overall Study|Lost to Follow-up|1
1321173|NCT00054704|4281093|P2|Overall Study|Adverse Event|2
1321174|NCT00054704|4281094|P1|Overall Study|Adverse Event|3
1321175|NCT00054704|4281093|P2|Overall Study|Lack of Efficacy|3
1321176|NCT00054704|4281094|P1|Overall Study|Lack of Efficacy|1
1321177|NCT00054691|4281100|P1|Overall Study|Noncompliant|1
1321178|NCT00054691|4281100|P1|Overall Study|Unmeasurable Disease|2
1321179|NCT00054639|4281114|P1|Overall Study|Physician Decision|1
1321180|NCT00054639|4281114|P1|Overall Study|Lack of Efficacy|1
1321181|NCT00054327|4281147|P6|Overall Study|Engraftment failure|0
1321182|NCT00054327|4281148|P5|Overall Study|Engraftment failure|0
1321183|NCT00054327|4281149|P4|Overall Study|Engraftment failure|0
1321184|NCT00054327|4281150|P3|Overall Study|Engraftment failure|0
1321185|NCT00054327|4281151|P2|Overall Study|Engraftment failure|0
1321186|NCT00054327|4281152|P1|Overall Study|Engraftment failure|1
1321187|NCT00054275|4281190|P1|Overall Study|Physician Decision|1
1321188|NCT00054275|4281190|P1|Overall Study|Progressive disease in cycle 1|1
1321189|NCT00054275|4281190|P1|Overall Study|Adverse Event|5
1321190|NCT00054275|4281190|P1|Overall Study|Withdrawal by Subject|4
1321191|NCT00054132|4281196|P1|Overall Study|Not Treated|1
1321192|NCT00053898|4281215|P2|Overall Study|Follow-up from telephone contact only|1
1321193|NCT00053898|4281216|P1|Overall Study|Follow-up from telephone contact only|5
1321194|NCT00053898|4281215|P2|Overall Study|No follow-up data from any source|12
1321195|NCT00053898|4281216|P1|Overall Study|No follow-up data from any source|9
1321196|NCT00053846|4281242|P2|Overall Study|Pills too large|1
1321197|NCT00053846|4281243|P1|Overall Study|Pills too large|0
1321198|NCT00053846|4281242|P2|Overall Study|Quit due to side effects|3
1321199|NCT00053846|4281243|P1|Overall Study|Quit due to side effects|1
1321200|NCT00053846|4281242|P2|Overall Study|Did not return data|2
1321201|NCT00053846|4281243|P1|Overall Study|Did not return data|1
1321202|NCT00053846|4281242|P2|Overall Study|Became ineligible|1
1321203|NCT00053846|4281243|P1|Overall Study|Became ineligible|3
1321204|NCT00053846|4281242|P2|Overall Study|Expired|0
1321205|NCT00053846|4281243|P1|Overall Study|Expired|5
1321206|NCT00053846|4281242|P2|Overall Study|Became too ill|7
1321207|NCT00053846|4281243|P1|Overall Study|Became too ill|8
1321208|NCT00053846|4281242|P2|Overall Study|Changed mind|13
1321209|NCT00053846|4281243|P1|Overall Study|Changed mind|8
1321210|NCT00053417|4281402|P4|Overall Study|Lost to Follow-up|0
1321211|NCT00053417|4281403|P3|Overall Study|Lost to Follow-up|0
1321212|NCT00053417|4281404|P2|Overall Study|Lost to Follow-up|1
1321213|NCT00053417|4281405|P1|Overall Study|Lost to Follow-up|1
1321214|NCT00053417|4281402|P4|Overall Study|Withdrawal by Subject|0
1321215|NCT00053417|4281403|P3|Overall Study|Withdrawal by Subject|0
1321216|NCT00053417|4281404|P2|Overall Study|Withdrawal by Subject|1
1321217|NCT00053417|4281405|P1|Overall Study|Withdrawal by Subject|0
1321218|NCT00053417|4281402|P4|Overall Study|Non-Compliance|1
1321219|NCT00053417|4281403|P3|Overall Study|Non-Compliance|0
1321220|NCT00053417|4281404|P2|Overall Study|Non-Compliance|0
1321221|NCT00053417|4281405|P1|Overall Study|Non-Compliance|0
1321222|NCT00053417|4281402|P4|Overall Study|Adverse Event|5
1321223|NCT00053417|4281403|P3|Overall Study|Adverse Event|1
1321224|NCT00053417|4281404|P2|Overall Study|Adverse Event|0
1321225|NCT00053417|4281405|P1|Overall Study|Adverse Event|1
1321226|NCT00053365|4281415|P1|Overall Study|Never treated|4
1321227|NCT00053365|4281415|P1|Overall Study|Platinum-sensitive interval >12 months|1
1321228|NCT00053365|4281415|P1|Overall Study|Incorrect cell type|1
1321229|NCT00053352|4281424|P2|Overall Study|Disease at new site|0
1321230|NCT00053352|4281425|P1|Overall Study|Disease at new site|1
1321231|NCT00053352|4281424|P2|Overall Study|Ineligible|8
1321232|NCT00053352|4281425|P1|Overall Study|Ineligible|8
1321233|NCT00053352|4281424|P2|Overall Study|Withdrawal by Subject|0
1321234|NCT00053352|4281425|P1|Overall Study|Withdrawal by Subject|1
1321235|NCT00053352|4281424|P2|Overall Study|Physician Decision|1
1321236|NCT00053352|4281425|P1|Overall Study|Physician Decision|11
1321237|NCT00053352|4281424|P2|Overall Study|Lost to Follow-up|1
1321238|NCT00053352|4281425|P1|Overall Study|Lost to Follow-up|0
1321239|NCT00003830|4281441|P2|Overall Study|Sentinel node positive patients|793
1321240|NCT00003830|4281442|P1|Overall Study|Sentinel node positive patients|829
1321241|NCT00003830|4281441|P2|Overall Study|No follow up data|0
1321242|NCT00003830|4281442|P1|Overall Study|No follow up data|3
1321243|NCT00052962|4281468|P2|Overall Study|Not randomized/not evaluable|0
1321244|NCT00052962|4281469|P1|Overall Study|Not randomized/not evaluable|1
1321245|NCT00052962|4281468|P2|Overall Study|Not evaluable|2
1321246|NCT00052962|4281469|P1|Overall Study|Not evaluable|0
1321247|NCT00052715|4281488|P1|Overall Study|wrong histology|1
1321248|NCT00049543|4281504|P2|Overall Study|still on treatment|9
1321249|NCT00049543|4281505|P1|Overall Study|still on treatment|2
1321250|NCT00049530|4281515|P1|Overall Study|ineligible|3
1321251|NCT00049530|4281515|P1|Overall Study|symptomatic deterioration|1
1321252|NCT00049530|4281515|P1|Overall Study|Death|1
1321253|NCT00049530|4281515|P1|Overall Study|Adverse Event|2
1321254|NCT00049530|4281515|P1|Overall Study|Lack of Efficacy|25
1321255|NCT00049517|4281524|P6|Conditioning/Transplant|Reasons not reported|5
1321256|NCT00049517|4281525|P5|Conditioning/Transplant|Reasons not reported|5
1321257|NCT00049517|4281526|P4|Conditioning/Transplant|Reasons not reported|15
1321258|NCT00049517|4281527|P3|Conditioning/Transplant|Reasons not reported|18
1321259|NCT00049517|4281528|P2|Conditioning/Transplant|Reasons not reported|31
1321260|NCT00049517|4281529|P1|Conditioning/Transplant|Reasons not reported|25
1321261|NCT00049517|4281524|P6|Conditioning/Transplant|Other complicating disease|1
1321262|NCT00049517|4281525|P5|Conditioning/Transplant|Other complicating disease|0
1321263|NCT00049517|4281526|P4|Conditioning/Transplant|Other complicating disease|4
1321264|NCT00049517|4281527|P3|Conditioning/Transplant|Other complicating disease|0
1321265|NCT00049517|4281528|P2|Conditioning/Transplant|Other complicating disease|0
1321266|NCT00049517|4281529|P1|Conditioning/Transplant|Other complicating disease|2
1321267|NCT00049517|4281524|P6|Conditioning/Transplant|Alternative therapy|0
1321268|NCT00049517|4281525|P5|Conditioning/Transplant|Alternative therapy|1
1321269|NCT00049517|4281526|P4|Conditioning/Transplant|Alternative therapy|1
1321270|NCT00049517|4281527|P3|Conditioning/Transplant|Alternative therapy|2
1321271|NCT00049517|4281528|P2|Conditioning/Transplant|Alternative therapy|4
1321272|NCT00049517|4281529|P1|Conditioning/Transplant|Alternative therapy|4
1321273|NCT00049517|4281524|P6|Conditioning/Transplant|Withdrawal by Subject|0
1321274|NCT00049517|4281525|P5|Conditioning/Transplant|Withdrawal by Subject|0
1321275|NCT00049517|4281526|P4|Conditioning/Transplant|Withdrawal by Subject|7
1321276|NCT00049517|4281527|P3|Conditioning/Transplant|Withdrawal by Subject|4
1321277|NCT00049517|4281528|P2|Conditioning/Transplant|Withdrawal by Subject|8
1321278|NCT00049517|4281529|P1|Conditioning/Transplant|Withdrawal by Subject|4
1321279|NCT00049517|4281524|P6|Conditioning/Transplant|Death|0
1321280|NCT00049517|4281525|P5|Conditioning/Transplant|Death|0
1321281|NCT00049517|4281526|P4|Conditioning/Transplant|Death|2
1321282|NCT00049517|4281527|P3|Conditioning/Transplant|Death|0
1321283|NCT00049517|4281528|P2|Conditioning/Transplant|Death|0
1321284|NCT00049517|4281529|P1|Conditioning/Transplant|Death|1
1321285|NCT00049517|4281524|P6|Conditioning/Transplant|Adverse Event|0
1321286|NCT00049517|4281525|P5|Conditioning/Transplant|Adverse Event|0
1321287|NCT00049517|4281526|P4|Conditioning/Transplant|Adverse Event|8
1321288|NCT00049517|4281527|P3|Conditioning/Transplant|Adverse Event|4
1321289|NCT00049517|4281528|P2|Conditioning/Transplant|Adverse Event|1
1321290|NCT00049517|4281529|P1|Conditioning/Transplant|Adverse Event|2
1321291|NCT00049517|4281524|P6|Conditioning/Transplant|Disease progression|0
1321292|NCT00049517|4281525|P5|Conditioning/Transplant|Disease progression|0
1321293|NCT00049517|4281526|P4|Conditioning/Transplant|Disease progression|6
1321294|NCT00049517|4281527|P3|Conditioning/Transplant|Disease progression|10
1321295|NCT00049517|4281528|P2|Conditioning/Transplant|Disease progression|6
1321296|NCT00049517|4281529|P1|Conditioning/Transplant|Disease progression|14
1321297|NCT00049517|4281524|P6|Induction|Reasons not reported|25
1321298|NCT00049517|4281525|P5|Induction|Reasons not reported|22
1321299|NCT00049517|4281526|P4|Induction|Reasons not reported|0
1321300|NCT00049517|4281527|P3|Induction|Reasons not reported|0
1321301|NCT00049517|4281528|P2|Induction|Reasons not reported|0
1321302|NCT00049517|4281529|P1|Induction|Reasons not reported|0
1321303|NCT00049517|4281524|P6|Induction|Other complicating disease|0
1321304|NCT00049517|4281525|P5|Induction|Other complicating disease|3
1321305|NCT00049517|4281526|P4|Induction|Other complicating disease|0
1321306|NCT00049517|4281527|P3|Induction|Other complicating disease|0
1321307|NCT00049517|4281528|P2|Induction|Other complicating disease|0
1321308|NCT00049517|4281529|P1|Induction|Other complicating disease|0
1321309|NCT00049517|4281524|P6|Induction|Alternative therapy|2
1321310|NCT00049517|4281525|P5|Induction|Alternative therapy|2
1321311|NCT00049517|4281526|P4|Induction|Alternative therapy|0
1321312|NCT00049517|4281527|P3|Induction|Alternative therapy|0
1321313|NCT00049517|4281528|P2|Induction|Alternative therapy|0
1321314|NCT00049517|4281529|P1|Induction|Alternative therapy|0
1321315|NCT00049517|4281524|P6|Induction|Withdrawal by Subject|3
1321316|NCT00049517|4281525|P5|Induction|Withdrawal by Subject|1
1321317|NCT00049517|4281526|P4|Induction|Withdrawal by Subject|0
1321318|NCT00049517|4281527|P3|Induction|Withdrawal by Subject|0
1321319|NCT00049517|4281528|P2|Induction|Withdrawal by Subject|0
1321320|NCT00049517|4281529|P1|Induction|Withdrawal by Subject|0
1321321|NCT00049517|4281524|P6|Induction|Death|6
1321322|NCT00049517|4281525|P5|Induction|Death|9
1321323|NCT00049517|4281526|P4|Induction|Death|0
1321324|NCT00049517|4281527|P3|Induction|Death|0
1321325|NCT00049517|4281528|P2|Induction|Death|0
1321326|NCT00049517|4281529|P1|Induction|Death|0
1321327|NCT00049517|4281524|P6|Induction|Adverse Event|7
1321328|NCT00049517|4281525|P5|Induction|Adverse Event|5
1321329|NCT00049517|4281526|P4|Induction|Adverse Event|0
1321330|NCT00049517|4281527|P3|Induction|Adverse Event|0
1321331|NCT00049517|4281528|P2|Induction|Adverse Event|0
1321332|NCT00049517|4281529|P1|Induction|Adverse Event|0
1321333|NCT00049517|4281524|P6|Induction|Disease progression|11
1321334|NCT00049517|4281525|P5|Induction|Disease progression|18
1321335|NCT00049517|4281526|P4|Induction|Disease progression|0
1321336|NCT00049517|4281527|P3|Induction|Disease progression|0
1321337|NCT00049517|4281528|P2|Induction|Disease progression|0
1321338|NCT00049517|4281529|P1|Induction|Disease progression|0
1321339|NCT00049322|4281547|P2|Overall Study|refused angio|3
1321340|NCT00049322|4281548|P1|Overall Study|refused angio|0
1321341|NCT00049322|4281547|P2|Overall Study|Adverse Event|0
1321342|NCT00049322|4281548|P1|Overall Study|Adverse Event|1
1321343|NCT00049322|4281547|P2|Overall Study|disease burden|3
1321344|NCT00049322|4281548|P1|Overall Study|disease burden|0
1321345|NCT00049257|4281560|P1|Follow-up Period for Survival Status|Lost to Follow-up|4
1321346|NCT00049257|4281560|P1|Carboplatin, Paclitaxel|Death|2
1321347|NCT00049257|4281560|P1|Carboplatin, Paclitaxel|Lost to Follow-up|1
1321348|NCT00049257|4281560|P1|Carboplatin, Paclitaxel|Withdrawal by Subject|10
1321349|NCT00049127|4281572|P5|Overall Study|Withdrawal by Subject|0
1321350|NCT00049127|4281573|P4|Overall Study|Withdrawal by Subject|0
1321351|NCT00049127|4281574|P3|Overall Study|Withdrawal by Subject|1
1321352|NCT00049127|4281575|P2|Overall Study|Withdrawal by Subject|0
1321353|NCT00049127|4281576|P1|Overall Study|Withdrawal by Subject|0
1321354|NCT00048997|4281614|P2|Overall Study|Withdrawal by Subject|1
1321355|NCT00048997|4281615|P1|Overall Study|Withdrawal by Subject|6
1321356|NCT00048997|4281614|P2|Overall Study|Protocol Violation|2
1321357|NCT00048997|4281615|P1|Overall Study|Protocol Violation|7
1321358|NCT00047385|4281638|P2|Overall Study|Eligible for screening but had no screen|492
1321359|NCT00047385|4281639|P1|Overall Study|Eligible for screening but had no screen|260
1321360|NCT00047385|4281638|P2|Overall Study|Lung Cancer diagnosed before screening|3
1321361|NCT00047385|4281639|P1|Overall Study|Lung Cancer diagnosed before screening|5
1321362|NCT00047385|4281638|P2|Overall Study|Death before any screening|5
1321363|NCT00047385|4281639|P1|Overall Study|Death before any screening|2
1321364|NCT00047320|4281657|P1|Overall Study|Ineligible|2
1321365|NCT00047320|4281657|P1|Overall Study|Withdrawal by Subject|9
1321366|NCT00047320|4281657|P1|Overall Study|Physician Decision|8
1321367|NCT00047320|4281657|P1|Overall Study|Lost to Follow-up|1
1321368|NCT00047320|4281657|P1|Overall Study|Lack of Efficacy|8
1321369|NCT00047008|4281668|P2|Overall Study|Ineligible|8
1321370|NCT00047008|4281669|P1|Overall Study|Ineligible|9
1321371|NCT00047008|4281668|P2|Overall Study|Withdrawn consent|3
1321372|NCT00047008|4281669|P1|Overall Study|Withdrawn consent|2
1321373|NCT00046930|4281677|P2|Overall Study|Ineligible|4
1321374|NCT00046930|4281678|P1|Overall Study|Ineligible|12
1321375|NCT00046891|4281693|P2|Overall Study|Adverse Event|5
1321376|NCT00046891|4281694|P1|Overall Study|Adverse Event|5
1321377|NCT00046891|4281693|P2|Overall Study|Withdrawal by Subject|15
1321378|NCT00046891|4281694|P1|Overall Study|Withdrawal by Subject|18
1321379|NCT00046891|4281693|P2|Overall Study|Ineligible|1
1321380|NCT00046891|4281694|P1|Overall Study|Ineligible|1
1321381|NCT00046891|4281693|P2|Overall Study|Cancels|9
1321382|NCT00046891|4281694|P1|Overall Study|Cancels|5
1321383|NCT00046839|4281714|P2|Overall Study|Withdrawal of consent|0
1321384|NCT00046839|4281715|P1|Overall Study|Withdrawal of consent|1
1321385|NCT00046839|4281714|P2|Overall Study|Ineligible / No protocol treatment|2
1321386|NCT00046839|4281715|P1|Overall Study|Ineligible / No protocol treatment|0
1321387|NCT00045734|4281722|P1|Overall Study|Protocol Violation|1
1321388|NCT00045708|4281737|P3|Phase 1|early progressive disease|0
1321389|NCT00045708|4281738|P2|Phase 1|early progressive disease|1
1321390|NCT00045708|4281739|P1|Phase 1|early progressive disease|0
1321391|NCT00045630|4281764|P1|Overall Study|Ineligible|2
1321392|NCT00045630|4281764|P1|Overall Study|Death|1
1321393|NCT00045630|4281764|P1|Overall Study|Progression/relapse|1
1321394|NCT00045630|4281764|P1|Overall Study|Refusal unrelated to adverse event|1
1321395|NCT00045630|4281764|P1|Overall Study|Adverse Event|1
1321396|NCT00045305|4281783|P1|Overall Study|site error|2
1321397|NCT00045305|4281783|P1|Overall Study|Death|3
1321398|NCT00045305|4281783|P1|Overall Study|Adverse Event|3
1321399|NCT00045305|4281783|P1|Overall Study|Lack of Efficacy|6
1321400|NCT00045162|4281794|P2|Overall Study|Not specified|16
1321401|NCT00045162|4281795|P1|Overall Study|Not specified|21
1321402|NCT00045162|4281794|P2|Overall Study|Withdrawal by Subject|3
1321403|NCT00045162|4281795|P1|Overall Study|Withdrawal by Subject|5
1321404|NCT00045162|4281794|P2|Overall Study|Death|10
1321405|NCT00045162|4281795|P1|Overall Study|Death|10
1321406|NCT00045162|4281794|P2|Overall Study|Lack of Efficacy|29
1321407|NCT00045162|4281795|P1|Overall Study|Lack of Efficacy|32
1321408|NCT00045162|4281794|P2|Overall Study|Adverse Event|50
1321409|NCT00045162|4281795|P1|Overall Study|Adverse Event|55
1321410|NCT00045162|4281794|P2|Overall Study|Not treated|2
1321411|NCT00045162|4281795|P1|Overall Study|Not treated|7
1321412|NCT00045162|4281794|P2|Overall Study|Ineligible|8
1321413|NCT00045162|4281795|P1|Overall Study|Ineligible|12
1321414|NCT00045110|4281810|P3|100mg Phase 1 Dose Escalalation|ineligible histology|1
1321415|NCT00045110|4281811|P2|100mg Phase 1 Dose Escalalation|ineligible histology|0
1321416|NCT00045110|4281812|P1|100mg Phase 1 Dose Escalalation|ineligible histology|0
1321417|NCT00045110|4281810|P3|100mg Phase 1 Dose Escalalation|prior treatment history|0
1321418|NCT00045110|4281811|P2|100mg Phase 1 Dose Escalalation|prior treatment history|4
1321419|NCT00045110|4281812|P1|100mg Phase 1 Dose Escalalation|prior treatment history|0
1321420|NCT00045110|4281810|P3|100mg Phase 1 Dose Escalalation|did not initiate treatment|1
1321421|NCT00045110|4281811|P2|100mg Phase 1 Dose Escalalation|did not initiate treatment|2
1321422|NCT00045110|4281812|P1|100mg Phase 1 Dose Escalalation|did not initiate treatment|0
1321423|NCT00045032|4281861|P3|Overall Study|Not Specified|105
1321424|NCT00045032|4281862|P2|Overall Study|Not Specified|84
1321425|NCT00045032|4281863|P1|Overall Study|Not Specified|93
1321426|NCT00045032|4281861|P3|Overall Study|Failure to Return|61
1321427|NCT00045032|4281862|P2|Overall Study|Failure to Return|62
1321428|NCT00045032|4281863|P1|Overall Study|Failure to Return|57
1321429|NCT00045032|4281861|P3|Overall Study|Refused/Did Not Cooperate/Withdrew|84
1321430|NCT00045032|4281862|P2|Overall Study|Refused/Did Not Cooperate/Withdrew|93
1321431|NCT00045032|4281863|P1|Overall Study|Refused/Did Not Cooperate/Withdrew|142
1321432|NCT00045032|4281861|P3|Overall Study|Other Protocol Violation|1
1321433|NCT00045032|4281862|P2|Overall Study|Other Protocol Violation|0
1321434|NCT00045032|4281863|P1|Overall Study|Other Protocol Violation|2
1321435|NCT00045032|4281861|P3|Overall Study|Violation of Selection Criteria at Entry|6
1321436|NCT00045032|4281862|P2|Overall Study|Violation of Selection Criteria at Entry|6
1321437|NCT00045032|4281863|P1|Overall Study|Violation of Selection Criteria at Entry|3
1321438|NCT00045032|4281861|P3|Overall Study|Insufficient Therapeutic Response|445
1321439|NCT00045032|4281862|P2|Overall Study|Insufficient Therapeutic Response|437
1321440|NCT00045032|4281863|P1|Overall Study|Insufficient Therapeutic Response|542
1321441|NCT00045032|4281861|P3|Overall Study|Death|17
1321442|NCT00045032|4281862|P2|Overall Study|Death|24
1321443|NCT00045032|4281863|P1|Overall Study|Death|22
1321444|NCT00045032|4281861|P3|Overall Study|Adverse Event/Intercurrent Illness|7
1321445|NCT00045032|4281862|P2|Overall Study|Adverse Event/Intercurrent Illness|2
1321446|NCT00045032|4281863|P1|Overall Study|Adverse Event/Intercurrent Illness|2
1321447|NCT00042991|4281997|P7|Overall Study|Alternative Therapy|0
1321448|NCT00042991|4281998|P6|Overall Study|Alternative Therapy|0
1321449|NCT00042991|4281999|P5|Overall Study|Alternative Therapy|1
1321450|NCT00042991|4282000|P4|Overall Study|Alternative Therapy|0
1321451|NCT00042991|4282001|P3|Overall Study|Alternative Therapy|0
1321452|NCT00042991|4282002|P2|Overall Study|Alternative Therapy|0
1321453|NCT00042991|4282003|P1|Overall Study|Alternative Therapy|0
1321454|NCT00042991|4281997|P7|Overall Study|Disease Progression|2
1321455|NCT00042991|4281998|P6|Overall Study|Disease Progression|4
1321456|NCT00042991|4281999|P5|Overall Study|Disease Progression|1
1321457|NCT00042991|4282000|P4|Overall Study|Disease Progression|2
1321458|NCT00042991|4282001|P3|Overall Study|Disease Progression|2
1321459|NCT00042991|4282002|P2|Overall Study|Disease Progression|29
1321460|NCT00042991|4282003|P1|Overall Study|Disease Progression|5
1321461|NCT00042991|4281997|P7|Overall Study|Withdrawal by Subject|0
1321462|NCT00042991|4281998|P6|Overall Study|Withdrawal by Subject|0
1321463|NCT00042991|4281999|P5|Overall Study|Withdrawal by Subject|1
1321464|NCT00042991|4282000|P4|Overall Study|Withdrawal by Subject|0
1321465|NCT00042991|4282001|P3|Overall Study|Withdrawal by Subject|2
1321466|NCT00042991|4282002|P2|Overall Study|Withdrawal by Subject|7
1321467|NCT00042991|4282003|P1|Overall Study|Withdrawal by Subject|0
1321468|NCT00042991|4281997|P7|Overall Study|Adverse Event|0
1321469|NCT00042991|4281998|P6|Overall Study|Adverse Event|1
1321470|NCT00042991|4281999|P5|Overall Study|Adverse Event|0
1321471|NCT00042991|4282000|P4|Overall Study|Adverse Event|0
1321472|NCT00042991|4282001|P3|Overall Study|Adverse Event|2
1321473|NCT00042991|4282002|P2|Overall Study|Adverse Event|4
1321474|NCT00042991|4282003|P1|Overall Study|Adverse Event|1
1321475|NCT00042939|4282046|P2|Overall Study|Did not start treatment|1
1321476|NCT00042939|4282047|P1|Overall Study|Did not start treatment|2
1321477|NCT00042939|4282046|P2|Overall Study|Treatment break > 4 weeks|1
1321478|NCT00042939|4282047|P1|Overall Study|Treatment break > 4 weeks|0
1321479|NCT00042939|4282046|P2|Overall Study|Still on treatment|0
1321480|NCT00042939|4282047|P1|Overall Study|Still on treatment|1
1321481|NCT00042939|4282046|P2|Overall Study|Patient non-compliance|0
1321482|NCT00042939|4282047|P1|Overall Study|Patient non-compliance|1
1321483|NCT00042939|4282046|P2|Overall Study|Rising ca 19-9|0
1321484|NCT00042939|4282047|P1|Overall Study|Rising ca 19-9|1
1321485|NCT00042939|4282046|P2|Overall Study|QOL diminished|0
1321486|NCT00042939|4282047|P1|Overall Study|QOL diminished|1
1321487|NCT00042939|4282046|P2|Overall Study|Deterioration of health|4
1321488|NCT00042939|4282047|P1|Overall Study|Deterioration of health|3
1321489|NCT00042939|4282046|P2|Overall Study|Ineligible|2
1321490|NCT00042939|4282047|P1|Overall Study|Ineligible|2
1321491|NCT00042939|4282046|P2|Overall Study|Other disease|0
1321492|NCT00042939|4282047|P1|Overall Study|Other disease|1
1321493|NCT00042939|4282046|P2|Overall Study|Withdrawal by Subject|4
1321494|NCT00042939|4282047|P1|Overall Study|Withdrawal by Subject|3
1321495|NCT00042939|4282046|P2|Overall Study|Death|2
1321496|NCT00042939|4282047|P1|Overall Study|Death|3
1321497|NCT00042939|4282046|P2|Overall Study|Adverse Event|7
1321498|NCT00042939|4282047|P1|Overall Study|Adverse Event|6
1321499|NCT00041132|4282061|P1|Overall Study|Physician Decision|2
1321500|NCT00041132|4282061|P1|Overall Study|Withdrawal by Subject|1
1321501|NCT00041132|4282061|P1|Overall Study|Not Eligible|7
1321502|NCT00041132|4282061|P1|Overall Study|Death|1
1321503|NCT00041132|4282061|P1|Overall Study|Adverse Event|19
1321504|NCT00041080|4282096|P2|Overall Study|Ineligible|0
1321505|NCT00041080|4282097|P1|Overall Study|Ineligible|1
1321506|NCT00041080|4282096|P2|Overall Study|Did not start therapy|1
1321507|NCT00041080|4282097|P1|Overall Study|Did not start therapy|1
1321508|NCT00041080|4282096|P2|Overall Study|Concommitant Illness/Other|2
1321509|NCT00041080|4282097|P1|Overall Study|Concommitant Illness/Other|1
1321510|NCT00041080|4282096|P2|Overall Study|Withdrawal by Subject|6
1321511|NCT00041080|4282097|P1|Overall Study|Withdrawal by Subject|6
1321512|NCT00041080|4282096|P2|Overall Study|Adverse Event|1
1321513|NCT00041080|4282097|P1|Overall Study|Adverse Event|21
1321514|NCT00041067|4282103|P1|Overall Study|Ineligible|2
1321515|NCT00041067|4282103|P1|Overall Study|Other reasons|23
1321516|NCT00041067|4282103|P1|Overall Study|Patient refusal|12
1321517|NCT00041067|4282103|P1|Overall Study|Progression|19
1321518|NCT00041067|4282103|P1|Overall Study|Adverse Event|20
1321519|NCT00040742|4282170|P4|Overall Study|Other medical|5
1321520|NCT00040742|4282171|P3|Overall Study|Other medical|5
1321521|NCT00040742|4282172|P2|Overall Study|Other medical|5
1321522|NCT00040742|4282173|P1|Overall Study|Other medical|7
1321523|NCT00040742|4282170|P4|Overall Study|Incomplete Forms|5
1321524|NCT00040742|4282171|P3|Overall Study|Incomplete Forms|4
1321525|NCT00040742|4282172|P2|Overall Study|Incomplete Forms|10
1321526|NCT00040742|4282173|P1|Overall Study|Incomplete Forms|6
1321527|NCT00040742|4282170|P4|Overall Study|Chemotoxicity|2
1321528|NCT00040742|4282171|P3|Overall Study|Chemotoxicity|5
1321529|NCT00040742|4282172|P2|Overall Study|Chemotoxicity|3
1321530|NCT00040742|4282173|P1|Overall Study|Chemotoxicity|4
1321531|NCT00040742|4282170|P4|Overall Study|Withdrawal by Subject|13
1321532|NCT00040742|4282171|P3|Overall Study|Withdrawal by Subject|10
1321533|NCT00040742|4282172|P2|Overall Study|Withdrawal by Subject|15
1321534|NCT00040742|4282173|P1|Overall Study|Withdrawal by Subject|7
1321535|NCT00040742|4282170|P4|Overall Study|Adverse Event|9
1321536|NCT00040742|4282171|P3|Overall Study|Adverse Event|21
1321537|NCT00040742|4282172|P2|Overall Study|Adverse Event|16
1321538|NCT00040742|4282173|P1|Overall Study|Adverse Event|15
1321539|NCT00040742|4282170|P4|Overall Study|Death|0
1321540|NCT00040742|4282171|P3|Overall Study|Death|1
1321541|NCT00040742|4282172|P2|Overall Study|Death|0
1321542|NCT00040742|4282173|P1|Overall Study|Death|0
1321543|NCT00039377|4282187|P4|Initial Registration|Withdrawal by Subject|0
1321544|NCT00039377|4282188|P3|Initial Registration|Withdrawal by Subject|0
1321545|NCT00039377|4282189|P2|Initial Registration|Withdrawal by Subject|0
1321546|NCT00039377|4282190|P1|Initial Registration|Withdrawal by Subject|3
1321547|NCT00039377|4282187|P4|Initial Registration|Received non-protocol therapy|0
1321548|NCT00039377|4282188|P3|Initial Registration|Received non-protocol therapy|0
1321549|NCT00039377|4282189|P2|Initial Registration|Received non-protocol therapy|0
1321550|NCT00039377|4282190|P1|Initial Registration|Received non-protocol therapy|11
1321551|NCT00039377|4282187|P4|Initial Registration|Relapsed|0
1321552|NCT00039377|4282188|P3|Initial Registration|Relapsed|0
1321553|NCT00039377|4282189|P2|Initial Registration|Relapsed|0
1321554|NCT00039377|4282190|P1|Initial Registration|Relapsed|6
1321555|NCT00039377|4282187|P4|Initial Registration|Adverse Event|0
1321556|NCT00039377|4282188|P3|Initial Registration|Adverse Event|0
1321557|NCT00039377|4282189|P2|Initial Registration|Adverse Event|0
1321558|NCT00039377|4282190|P1|Initial Registration|Adverse Event|2
1321559|NCT00039130|4282206|P1|Overall Study|Physician Decision|3
1321560|NCT00039130|4282206|P1|Overall Study|Subsequent treatment|2
1321561|NCT00039130|4282206|P1|Overall Study|Progression|2
1321562|NCT00039130|4282206|P1|Overall Study|Withdrawal by Subject|3
1321563|NCT00039130|4282206|P1|Overall Study|Death|9
1321564|NCT00039130|4282206|P1|Overall Study|Adverse Event|11
1321565|NCT00033657|4282222|P2|Adjuvant Chemotherapy|Other|2
1321566|NCT00033657|4282223|P1|Adjuvant Chemotherapy|Other|0
1321567|NCT00033657|4282222|P2|Adjuvant Chemotherapy|alternative therapy|0
1321568|NCT00033657|4282223|P1|Adjuvant Chemotherapy|alternative therapy|1
1321569|NCT00033657|4282222|P2|Adjuvant Chemotherapy|Withdrawal by Subject|3
1321570|NCT00033657|4282223|P1|Adjuvant Chemotherapy|Withdrawal by Subject|5
1321571|NCT00033657|4282222|P2|Adjuvant Chemotherapy|Death|1
1321572|NCT00033657|4282223|P1|Adjuvant Chemotherapy|Death|2
1321573|NCT00033657|4282222|P2|Adjuvant Chemotherapy|Adverse Event|10
1321574|NCT00033657|4282223|P1|Adjuvant Chemotherapy|Adverse Event|7
1321575|NCT00033657|4282222|P2|Adjuvant Chemotherapy|Lack of Efficacy|1
1321576|NCT00033657|4282223|P1|Adjuvant Chemotherapy|Lack of Efficacy|3
1321577|NCT00033657|4282222|P2|Surgical Resection|not complete resection|3
1321578|NCT00033657|4282223|P1|Surgical Resection|not complete resection|0
1321579|NCT00033657|4282222|P2|Neoadjuvant Chemotherapy|Not started protocol therapy|1
1321580|NCT00033657|4282223|P1|Neoadjuvant Chemotherapy|Not started protocol therapy|3
1321581|NCT00033657|4282222|P2|Neoadjuvant Chemotherapy|Ineligible|4
1321582|NCT00033657|4282223|P1|Neoadjuvant Chemotherapy|Ineligible|8
1321583|NCT00033657|4282222|P2|Neoadjuvant Chemotherapy|other complicating disease|1
1321584|NCT00033657|4282223|P1|Neoadjuvant Chemotherapy|other complicating disease|0
1321585|NCT00033657|4282222|P2|Neoadjuvant Chemotherapy|Withdrawal by Subject|0
1321586|NCT00033657|4282223|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
1321587|NCT00033657|4282222|P2|Neoadjuvant Chemotherapy|Death|1
1321588|NCT00033657|4282223|P1|Neoadjuvant Chemotherapy|Death|1
1321589|NCT00033657|4282222|P2|Neoadjuvant Chemotherapy|Adverse Event|2
1321590|NCT00033657|4282223|P1|Neoadjuvant Chemotherapy|Adverse Event|0
1321591|NCT00033657|4282222|P2|Neoadjuvant Chemotherapy|Lack of Efficacy|2
1321592|NCT00033657|4282223|P1|Neoadjuvant Chemotherapy|Lack of Efficacy|1
1321593|NCT00033631|4282237|P2|Overall Study|Withdrawal by Subject|4
1321594|NCT00033631|4282238|P1|Overall Study|Withdrawal by Subject|4
1321595|NCT00033631|4282237|P2|Overall Study|Protocol Violation|11
1321596|NCT00033631|4282238|P1|Overall Study|Protocol Violation|14
1321597|NCT00033540|4282256|P1|Overall Study|Never received treatment|2
1321598|NCT00033540|4282256|P1|Overall Study|Ineligible|3
1321599|NCT00033540|4282256|P1|Overall Study|Not specified|5
1321600|NCT00033540|4282256|P1|Overall Study|Withdrawal by Subject|6
1321601|NCT00033540|4282256|P1|Overall Study|Progression|26
1321602|NCT00033540|4282256|P1|Overall Study|Death|1
1321603|NCT00033540|4282256|P1|Overall Study|Adverse Event|14
1321604|NCT00033514|4282266|P2|Overall Study|Withdrawal by Subject|3
1321605|NCT00033514|4282267|P1|Overall Study|Withdrawal by Subject|0
1321606|NCT00033514|4282266|P2|Overall Study|Lost to Follow-up|1
1321607|NCT00033514|4282267|P1|Overall Study|Lost to Follow-up|1
1321608|NCT00033371|4282277|P2|Overall Study|Disease Progression|1
1321609|NCT00033371|4282278|P1|Overall Study|Disease Progression|0
1321610|NCT00033371|4282277|P2|Overall Study|Withdrawal by Subject|3
1321611|NCT00033371|4282278|P1|Overall Study|Withdrawal by Subject|3
1321612|NCT00033371|4282277|P2|Overall Study|Lost to Follow-up|1
1321613|NCT00033371|4282278|P1|Overall Study|Lost to Follow-up|2
1321614|NCT00033371|4282277|P2|Overall Study|Adverse Event|5
1321615|NCT00033371|4282278|P1|Overall Study|Adverse Event|1
1321616|NCT00033293|4282286|P2|Overall Study|Treatment refused|6
1321617|NCT00033293|4282287|P1|Overall Study|Treatment refused|0
1321618|NCT00033293|4282286|P2|Overall Study|Could not be weaned from steroid therapy|1
1321619|NCT00033293|4282287|P1|Overall Study|Could not be weaned from steroid therapy|1
1321620|NCT00033293|4282286|P2|Overall Study|Withdrawal by Subject|0
1321621|NCT00033293|4282287|P1|Overall Study|Withdrawal by Subject|1
1321622|NCT00033293|4282286|P2|Overall Study|Physician Decision|1
1321623|NCT00033293|4282287|P1|Overall Study|Physician Decision|3
1321624|NCT00033293|4282286|P2|Overall Study|Lost to Follow-up|1
1321625|NCT00033293|4282287|P1|Overall Study|Lost to Follow-up|0
1321626|NCT00033293|4282286|P2|Overall Study|Lack of Efficacy|8
1321627|NCT00033293|4282287|P1|Overall Study|Lack of Efficacy|5
1321628|NCT00033293|4282286|P2|Overall Study|Death|1
1321629|NCT00033293|4282287|P1|Overall Study|Death|0
1321630|NCT00031694|4282305|P1|Overall Study|Withdrawal by Subject|5
1321631|NCT00031694|4282305|P1|Overall Study|Death|2
1321632|NCT00031694|4282305|P1|Overall Study|Adverse Event|12
1321633|NCT00030901|4282311|P3|Randomization|Ineligible|14
1321634|NCT00030901|4282312|P2|Randomization|Ineligible|15
1321635|NCT00030901|4282313|P1|Randomization|Ineligible|0
1321636|NCT00030901|4282311|P3|Randomization|Other|33
1321637|NCT00030901|4282312|P2|Randomization|Other|36
1321638|NCT00030901|4282313|P1|Randomization|Other|0
1321639|NCT00030901|4282311|P3|Randomization|Death|3
1321640|NCT00030901|4282312|P2|Randomization|Death|1
1321641|NCT00030901|4282313|P1|Randomization|Death|0
1321642|NCT00030901|4282311|P3|Randomization|Progression/Relapse|21
1321643|NCT00030901|4282312|P2|Randomization|Progression/Relapse|22
1321644|NCT00030901|4282313|P1|Randomization|Progression/Relapse|0
1321645|NCT00030901|4282311|P3|Randomization|Refusal Unrelated to Adverse Event|10
1321646|NCT00030901|4282312|P2|Randomization|Refusal Unrelated to Adverse Event|16
1321647|NCT00030901|4282313|P1|Randomization|Refusal Unrelated to Adverse Event|0
1321648|NCT00030901|4282311|P3|Randomization|Adverse Event|7
1321649|NCT00030901|4282312|P2|Randomization|Adverse Event|11
1321650|NCT00030901|4282313|P1|Randomization|Adverse Event|0
1321651|NCT00030901|4282311|P3|Initial Registration|Ineligible|0
1321652|NCT00030901|4282312|P2|Initial Registration|Ineligible|0
1321653|NCT00030901|4282313|P1|Initial Registration|Ineligible|167
1321654|NCT00030823|4282321|P1|Overall Study|Withdrawal by Subject|1
1321655|NCT00028769|4282329|P1|Overall Study|Not Analyzable|1
1321656|NCT00028769|4282329|P1|Overall Study|Ineligible|5
1321657|NCT00028769|4282329|P1|Overall Study|Other - Not Protocol Specified|1
1321658|NCT00028769|4282329|P1|Overall Study|Progression or Death|31
1321659|NCT00028769|4282329|P1|Overall Study|Refusal Unrelated to Adverse Events|1
1321660|NCT00028769|4282329|P1|Overall Study|Adverse Event|2
1321661|NCT00028002|4282335|P1|Overall Study|Ineligible|8
1321662|NCT00028002|4282335|P1|Overall Study|Withdrawal by Subject|3
1321663|NCT00027846|4282345|P3|Overall Study|Neuraxis dissemination during/after ther|5
1321664|NCT00027846|4282346|P2|Overall Study|Neuraxis dissemination during/after ther|2
1321665|NCT00027846|4282347|P1|Overall Study|Neuraxis dissemination during/after ther|0
1321666|NCT00027846|4282345|P3|Overall Study|Entry into another COG therapeutic study|2
1321667|NCT00027846|4282346|P2|Overall Study|Entry into another COG therapeutic study|5
1321668|NCT00027846|4282347|P1|Overall Study|Entry into another COG therapeutic study|0
1321669|NCT00027846|4282345|P3|Overall Study|Ineligible for study|14
1321670|NCT00027846|4282346|P2|Overall Study|Ineligible for study|6
1321671|NCT00027846|4282347|P1|Overall Study|Ineligible for study|2
1321672|NCT00027846|4282345|P3|Overall Study|Withdrawal by Subject|7
1321673|NCT00027846|4282346|P2|Overall Study|Withdrawal by Subject|14
1321674|NCT00027846|4282347|P1|Overall Study|Withdrawal by Subject|0
1321675|NCT00027846|4282345|P3|Overall Study|Lost to Follow-up|9
1321676|NCT00027846|4282346|P2|Overall Study|Lost to Follow-up|41
1321677|NCT00027846|4282347|P1|Overall Study|Lost to Follow-up|0
1321678|NCT00027560|4282365|P1|Overall Study|Withdrawal by Subject|1
1321679|NCT00026494|4282378|P4|Overall Study|Clinical progression|0
1321680|NCT00026494|4282379|P3|Overall Study|Clinical progression|3
1321681|NCT00026494|4282380|P2|Overall Study|Clinical progression|0
1321682|NCT00026494|4282381|P1|Overall Study|Clinical progression|0
1321683|NCT00026494|4282378|P4|Overall Study|Patient not treated|0
1321684|NCT00026494|4282379|P3|Overall Study|Patient not treated|2
1321685|NCT00026494|4282380|P2|Overall Study|Patient not treated|0
1321686|NCT00026494|4282381|P1|Overall Study|Patient not treated|0
1321687|NCT00026494|4282378|P4|Overall Study|Patient non-compliance|0
1321688|NCT00026494|4282379|P3|Overall Study|Patient non-compliance|0
1321689|NCT00026494|4282380|P2|Overall Study|Patient non-compliance|0
1321690|NCT00026494|4282381|P1|Overall Study|Patient non-compliance|1
1321691|NCT00026494|4282378|P4|Overall Study|Withdrawal by Subject|0
1321692|NCT00026494|4282379|P3|Overall Study|Withdrawal by Subject|1
1321693|NCT00026494|4282380|P2|Overall Study|Withdrawal by Subject|0
1321694|NCT00026494|4282381|P1|Overall Study|Withdrawal by Subject|1
1321695|NCT00026312|4282393|P2|Overall Study|Refusal by patient/parent/guardian|59
1321696|NCT00026312|4282394|P1|Overall Study|Refusal by patient/parent/guardian|8
1321697|NCT00026312|4282393|P2|Overall Study|Entry onto another COG study|1
1321698|NCT00026312|4282394|P1|Overall Study|Entry onto another COG study|0
1321699|NCT00026312|4282393|P2|Overall Study|Ineligible|5
1321700|NCT00026312|4282394|P1|Overall Study|Ineligible|4
1321701|NCT00026312|4282393|P2|Overall Study|Withdrawal by Subject|6
1321702|NCT00026312|4282394|P1|Overall Study|Withdrawal by Subject|1
1321703|NCT00026312|4282393|P2|Overall Study|Protocol Violation|3
1321704|NCT00026312|4282394|P1|Overall Study|Protocol Violation|0
1321705|NCT00026312|4282393|P2|Overall Study|Physician Decision|37
1321706|NCT00026312|4282394|P1|Overall Study|Physician Decision|1
1321707|NCT00026312|4282393|P2|Overall Study|Lost to Follow-up|5
1321708|NCT00026312|4282394|P1|Overall Study|Lost to Follow-up|0
1321709|NCT00026312|4282393|P2|Overall Study|Lack of Efficacy|114
1321710|NCT00026312|4282394|P1|Overall Study|Lack of Efficacy|19
1321711|NCT00026312|4282393|P2|Overall Study|Death|7
1321712|NCT00026312|4282394|P1|Overall Study|Death|1
1321713|NCT00026312|4282393|P2|Overall Study|Adverse Event|32
1321714|NCT00026312|4282394|P1|Overall Study|Adverse Event|0
1321715|NCT00026208|4282433|P2|Overall Study|Complications of auto accident|0
1321716|NCT00026208|4282434|P1|Overall Study|Complications of auto accident|1
1321717|NCT00025662|4282452|P1|Overall Study|Technical failure of manipulation|1
1321718|NCT00025662|4282452|P1|Overall Study|Withdrawal by Subject|2
1321719|NCT00025506|4282460|P1|Overall Study|Never Treated|2
1321720|NCT00025506|4282460|P1|Overall Study|Ineligible: inadequate pathology|2
1321721|NCT00025506|4282460|P1|Overall Study|Ineligible: wrong cell type|5
1321722|NCT00025506|4282460|P1|Overall Study|Ineligible: clerical error|1
1321723|NCT00025259|4282481|P7|Overall Study|Adverse Event|0
1321724|NCT00025259|4282482|P6|Overall Study|Adverse Event|0
1321725|NCT00025259|4282483|P5|Overall Study|Adverse Event|0
1321726|NCT00025259|4282484|P4|Overall Study|Adverse Event|0
1321727|NCT00025259|4282485|P3|Overall Study|Adverse Event|0
1321728|NCT00025259|4282486|P2|Overall Study|Adverse Event|0
1321729|NCT00025259|4282487|P1|Overall Study|Adverse Event|1
1321730|NCT00025259|4282481|P7|Overall Study|Randomization error|2
1321731|NCT00025259|4282482|P6|Overall Study|Randomization error|7
1321732|NCT00025259|4282483|P5|Overall Study|Randomization error|1
1321733|NCT00025259|4282484|P4|Overall Study|Randomization error|0
1321734|NCT00025259|4282485|P3|Overall Study|Randomization error|0
1321735|NCT00025259|4282486|P2|Overall Study|Randomization error|0
1321736|NCT00025259|4282487|P1|Overall Study|Randomization error|1
1321737|NCT00025259|4282481|P7|Overall Study|Ineligible|1
1321738|NCT00025259|4282482|P6|Overall Study|Ineligible|0
1321739|NCT00025259|4282483|P5|Overall Study|Ineligible|6
1321740|NCT00025259|4282484|P4|Overall Study|Ineligible|0
1321741|NCT00025259|4282485|P3|Overall Study|Ineligible|0
1321742|NCT00025259|4282486|P2|Overall Study|Ineligible|1
1321743|NCT00025259|4282487|P1|Overall Study|Ineligible|14
1321744|NCT00025259|4282481|P7|Overall Study|Withdrawal by Subject|3
1321745|NCT00025259|4282482|P6|Overall Study|Withdrawal by Subject|8
1321746|NCT00025259|4282483|P5|Overall Study|Withdrawal by Subject|11
1321747|NCT00025259|4282484|P4|Overall Study|Withdrawal by Subject|14
1321748|NCT00025259|4282485|P3|Overall Study|Withdrawal by Subject|6
1321749|NCT00025259|4282486|P2|Overall Study|Withdrawal by Subject|27
1321750|NCT00025259|4282487|P1|Overall Study|Withdrawal by Subject|9
1321751|NCT00025259|4282481|P7|Overall Study|Protocol Violation|3
1321752|NCT00025259|4282482|P6|Overall Study|Protocol Violation|1
1321753|NCT00025259|4282483|P5|Overall Study|Protocol Violation|2
1321754|NCT00025259|4282484|P4|Overall Study|Protocol Violation|1
1321755|NCT00025259|4282485|P3|Overall Study|Protocol Violation|2
1321756|NCT00025259|4282486|P2|Overall Study|Protocol Violation|2
1321757|NCT00025259|4282487|P1|Overall Study|Protocol Violation|3
1321758|NCT00025259|4282481|P7|Overall Study|Physician Decision|1
1321759|NCT00025259|4282482|P6|Overall Study|Physician Decision|2
1321760|NCT00025259|4282483|P5|Overall Study|Physician Decision|4
1321761|NCT00025259|4282484|P4|Overall Study|Physician Decision|5
1321762|NCT00025259|4282485|P3|Overall Study|Physician Decision|0
1321763|NCT00025259|4282486|P2|Overall Study|Physician Decision|1
1321764|NCT00025259|4282487|P1|Overall Study|Physician Decision|12
1321765|NCT00025259|4282481|P7|Overall Study|Lost to Follow-up|1
1321766|NCT00025259|4282482|P6|Overall Study|Lost to Follow-up|3
1321767|NCT00025259|4282483|P5|Overall Study|Lost to Follow-up|1
1321768|NCT00025259|4282484|P4|Overall Study|Lost to Follow-up|13
1321769|NCT00025259|4282485|P3|Overall Study|Lost to Follow-up|13
1321770|NCT00025259|4282486|P2|Overall Study|Lost to Follow-up|9
1321771|NCT00025259|4282487|P1|Overall Study|Lost to Follow-up|2
1321772|NCT00025259|4282481|P7|Overall Study|Lack of Efficacy|38
1321773|NCT00025259|4282482|P6|Overall Study|Lack of Efficacy|30
1321774|NCT00025259|4282483|P5|Overall Study|Lack of Efficacy|11
1321775|NCT00025259|4282484|P4|Overall Study|Lack of Efficacy|78
1321776|NCT00025259|4282485|P3|Overall Study|Lack of Efficacy|60
1321777|NCT00025259|4282486|P2|Overall Study|Lack of Efficacy|46
1321778|NCT00025259|4282487|P1|Overall Study|Lack of Efficacy|2
1321779|NCT00025259|4282481|P7|Overall Study|Death|2
1321780|NCT00025259|4282482|P6|Overall Study|Death|1
1321781|NCT00025259|4282483|P5|Overall Study|Death|0
1321782|NCT00025259|4282484|P4|Overall Study|Death|3
1321783|NCT00025259|4282485|P3|Overall Study|Death|0
1321784|NCT00025259|4282486|P2|Overall Study|Death|3
1321785|NCT00025259|4282487|P1|Overall Study|Death|1
1321786|NCT00025233|4282523|P1|Overall Study|Never treated|1
1321787|NCT00025233|4282523|P1|Overall Study|Ineligible: improper prior treatment|1
1321788|NCT00025233|4282523|P1|Overall Study|Ineligible: wrong primary|1
1321789|NCT00025233|4282523|P1|Overall Study|Ineligible: wrong cell type|1
1321790|NCT00025155|4282538|P1|Overall Study|Ineligible: Second primary cancer site|1
1321791|NCT00025155|4282538|P1|Overall Study|Ineligible: Wrong primary cancer site|1
1321792|NCT00024258|4282549|P1|Overall Study|Disease Progression|8
1321793|NCT00024258|4282549|P1|Overall Study|Withdrawal by Subject|1
1321794|NCT00024167|4282556|P2|Overall Study|Death|47
1321795|NCT00024167|4282557|P1|Overall Study|Death|53
1321796|NCT00023764|4282581|P1|Overall Study|delay in obtaining staging images|1
1321797|NCT00023764|4282581|P1|Overall Study|patient received other treatment|1
1321798|NCT00023764|4282581|P1|Overall Study|Progression of disease|6
1321799|NCT00023764|4282581|P1|Overall Study|Withdrawal by Subject|1
1321800|NCT00023764|4282581|P1|Overall Study|Adverse Event|4
1321801|NCT00023764|4282581|P1|Overall Study|Other|1
1321802|NCT00023712|4282588|P2|Overall Study|Never treated|1
1321803|NCT00023712|4282589|P1|Overall Study|Never treated|1
1321804|NCT00023712|4282588|P2|Overall Study|Not platinum sensitive|0
1321805|NCT00023712|4282589|P1|Overall Study|Not platinum sensitive|1
1321806|NCT00022698|4282613|P2|Overall Study|Administrative /other|7
1321807|NCT00022698|4282614|P1|Overall Study|Administrative /other|1
1321808|NCT00022698|4282613|P2|Overall Study|Insufficient therapeutic response|14
1321809|NCT00022698|4282614|P1|Overall Study|Insufficient therapeutic response|2
1321810|NCT00022698|4282613|P2|Overall Study|Refused treatment|2
1321811|NCT00022698|4282614|P1|Overall Study|Refused treatment|0
1321812|NCT00022698|4282613|P2|Overall Study|Failure to return|1
1321813|NCT00022698|4282614|P1|Overall Study|Failure to return|0
1321814|NCT00022698|4282613|P2|Overall Study|Death|2
1321815|NCT00022698|4282614|P1|Overall Study|Death|0
1321816|NCT00022698|4282613|P2|Overall Study|Adverse Event|9
1321817|NCT00022698|4282614|P1|Overall Study|Adverse Event|5
1321818|NCT00022672|4282639|P2|Extension Phase|Other|1
1321819|NCT00022672|4282640|P1|Extension Phase|Other|1
1321820|NCT00022672|4282639|P2|Extension Phase|Refused Treatment|2
1321821|NCT00022672|4282640|P1|Extension Phase|Refused Treatment|0
1321822|NCT00022672|4282639|P2|Extension Phase|Insufficient Therapeutic Response|44
1321823|NCT00022672|4282640|P1|Extension Phase|Insufficient Therapeutic Response|1
1321824|NCT00022672|4282639|P2|Extension Phase|Death|1
1321825|NCT00022672|4282640|P1|Extension Phase|Death|0
1321826|NCT00022672|4282639|P2|Extension Phase|Adverse Event|3
1321827|NCT00022672|4282640|P1|Extension Phase|Adverse Event|1
1321828|NCT00022672|4282639|P2|Main Phase: 24 Months|Other|0
1321829|NCT00022672|4282640|P1|Main Phase: 24 Months|Other|1
1321830|NCT00022672|4282639|P2|Main Phase: 24 Months|Failure to Return|1
1321831|NCT00022672|4282640|P1|Main Phase: 24 Months|Failure to Return|1
1321832|NCT00022672|4282639|P2|Main Phase: 24 Months|Refused Treatment|4
1321833|NCT00022672|4282640|P1|Main Phase: 24 Months|Refused Treatment|3
1321834|NCT00022672|4282639|P2|Main Phase: 24 Months|Other Protocol Violation|0
1321835|NCT00022672|4282640|P1|Main Phase: 24 Months|Other Protocol Violation|1
1321836|NCT00022672|4282639|P2|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1
1321837|NCT00022672|4282640|P1|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0
1321838|NCT00022672|4282639|P2|Main Phase: 24 Months|Insufficient Therapeutic Response|91
1321839|NCT00022672|4282640|P1|Main Phase: 24 Months|Insufficient Therapeutic Response|75
1321840|NCT00022672|4282639|P2|Main Phase: 24 Months|Death|3
1321841|NCT00022672|4282640|P1|Main Phase: 24 Months|Death|0
1321842|NCT00022672|4282639|P2|Main Phase: 24 Months|Adverse Event|0
1321843|NCT00022672|4282640|P1|Main Phase: 24 Months|Adverse Event|6
1321844|NCT00022659|4282673|P1|Overall Study|Never treated|1
1321845|NCT00022659|4282673|P1|Overall Study|Ineligible: wrong primary|1
1321846|NCT00022633|4282686|P2|Overall Study|Ineligible|0
1321847|NCT00022633|4282687|P1|Overall Study|Ineligible|4
1321848|NCT00022633|4282686|P2|Overall Study|Other - not protocol specified|2
1321849|NCT00022633|4282687|P1|Overall Study|Other - not protocol specified|3
1321850|NCT00022633|4282686|P2|Overall Study|Death|0
1321851|NCT00022633|4282687|P1|Overall Study|Death|4
1321852|NCT00022633|4282686|P2|Overall Study|Progression/relapse|2
1321853|NCT00022633|4282687|P1|Overall Study|Progression/relapse|9
1321854|NCT00022633|4282686|P2|Overall Study|Refusal unrelated to adverse event|0
1321855|NCT00022633|4282687|P1|Overall Study|Refusal unrelated to adverse event|1
1321856|NCT00022633|4282686|P2|Overall Study|Adverse Event|1
1321857|NCT00022633|4282687|P1|Overall Study|Adverse Event|11
1321858|NCT00022516|4282700|P2|Overall Study|Incomplete documentation|27
1321859|NCT00022516|4282701|P1|Overall Study|Incomplete documentation|0
1321860|NCT00022516|4282700|P2|Overall Study|Withdrawal by Subject|113
1321861|NCT00022516|4282701|P1|Overall Study|Withdrawal by Subject|2
1321862|NCT00022516|4282700|P2|Overall Study|Protocol Violation|3
1321863|NCT00022516|4282701|P1|Overall Study|Protocol Violation|1
1321864|NCT00022516|4282700|P2|Overall Study|Physician Decision|1
1321865|NCT00022516|4282701|P1|Overall Study|Physician Decision|0
1321866|NCT00022516|4282700|P2|Overall Study|Lack of Efficacy|27
1321867|NCT00022516|4282701|P1|Overall Study|Lack of Efficacy|0
1321868|NCT00022516|4282700|P2|Overall Study|Adverse Event|59
1321869|NCT00022516|4282701|P1|Overall Study|Adverse Event|0
1321870|NCT00021255|4282720|P3|Overall Study|Randomized but not treated|18
1321871|NCT00021255|4282721|P2|Overall Study|Randomized but not treated|2
1321872|NCT00021255|4282722|P1|Overall Study|Randomized but not treated|28
1321873|NCT00021255|4282720|P3|Overall Study|Missing|13
1321874|NCT00021255|4282721|P2|Overall Study|Missing|27
1321875|NCT00021255|4282722|P1|Overall Study|Missing|0
1321876|NCT00021255|4282720|P3|Overall Study|Other than specified above|19
1321877|NCT00021255|4282721|P2|Overall Study|Other than specified above|38
1321878|NCT00021255|4282722|P1|Overall Study|Other than specified above|0
1321879|NCT00021255|4282720|P3|Overall Study|Protocol Violation|0
1321880|NCT00021255|4282721|P2|Overall Study|Protocol Violation|2
1321881|NCT00021255|4282722|P1|Overall Study|Protocol Violation|0
1321882|NCT00021255|4282720|P3|Overall Study|Adverse Event|18
1321883|NCT00021255|4282721|P2|Overall Study|Adverse Event|30
1321884|NCT00021255|4282722|P1|Overall Study|Adverse Event|46
1321885|NCT00021255|4282720|P3|Overall Study|Herceptin toxicity|6
1321886|NCT00021255|4282721|P2|Overall Study|Herceptin toxicity|22
1321887|NCT00021255|4282722|P1|Overall Study|Herceptin toxicity|0
1321888|NCT00021255|4282720|P3|Overall Study|Cardiac toxicity|32
1321889|NCT00021255|4282721|P2|Overall Study|Cardiac toxicity|61
1321890|NCT00021255|4282722|P1|Overall Study|Cardiac toxicity|0
1321891|NCT00021255|4282720|P3|Overall Study|Lost to Follow-up|3
1321892|NCT00021255|4282721|P2|Overall Study|Lost to Follow-up|2
1321893|NCT00021255|4282722|P1|Overall Study|Lost to Follow-up|0
1321894|NCT00021255|4282720|P3|Overall Study|Withdrawal by Subject|26
1321895|NCT00021255|4282721|P2|Overall Study|Withdrawal by Subject|64
1321896|NCT00021255|4282722|P1|Overall Study|Withdrawal by Subject|41
1321897|NCT00021255|4282720|P3|Overall Study|Second primary malignancy|1
1321898|NCT00021255|4282721|P2|Overall Study|Second primary malignancy|4
1321899|NCT00021255|4282722|P1|Overall Study|Second primary malignancy|0
1321900|NCT00021255|4282720|P3|Overall Study|Breast cancer relapse|11
1321901|NCT00021255|4282721|P2|Overall Study|Breast cancer relapse|18
1321902|NCT00021255|4282722|P1|Overall Study|Breast cancer relapse|5
1321903|NCT00021255|4282720|P3|Overall Study|Death|2
1321904|NCT00021255|4282721|P2|Overall Study|Death|0
1321905|NCT00021255|4282722|P1|Overall Study|Death|1
1321906|NCT00021229|4282739|P3|Overall Study|Punctate hemmorrhage post RT|0
1321907|NCT00021229|4282740|P2|Overall Study|Punctate hemmorrhage post RT|0
1321908|NCT00021229|4282741|P1|Overall Study|Punctate hemmorrhage post RT|2
1321909|NCT00021229|4282739|P3|Overall Study|Physician Decision|1
1321910|NCT00021229|4282740|P2|Overall Study|Physician Decision|0
1321911|NCT00021229|4282741|P1|Overall Study|Physician Decision|0
1321912|NCT00021229|4282739|P3|Overall Study|Protocol Violation|0
1321913|NCT00021229|4282740|P2|Overall Study|Protocol Violation|1
1321914|NCT00021229|4282741|P1|Overall Study|Protocol Violation|1
1321915|NCT00021229|4282739|P3|Overall Study|Progressive Disease|12
1321916|NCT00021229|4282740|P2|Overall Study|Progressive Disease|19
1321917|NCT00021229|4282741|P1|Overall Study|Progressive Disease|15
1321918|NCT00021229|4282739|P3|Overall Study|Withdrawal by Subject|1
1321919|NCT00021229|4282740|P2|Overall Study|Withdrawal by Subject|7
1321920|NCT00021229|4282741|P1|Overall Study|Withdrawal by Subject|7
1321921|NCT00021229|4282739|P3|Overall Study|Death|0
1321922|NCT00021229|4282740|P2|Overall Study|Death|1
1321923|NCT00021229|4282741|P1|Overall Study|Death|0
1321924|NCT00021229|4282739|P3|Overall Study|Adverse Event|2
1321925|NCT00021229|4282740|P2|Overall Study|Adverse Event|5
1321926|NCT00021229|4282741|P1|Overall Study|Adverse Event|10
1321927|NCT00019604|4282796|P1|Overall Study|Details for other not available|4
1321928|NCT00019604|4282796|P1|Overall Study|Unable to evaluate|1
1321929|NCT00019604|4282796|P1|Overall Study|Too much disease|1
1321930|NCT00019604|4282796|P1|Overall Study|Pt going to immunotherapy study|1
1321931|NCT00019604|4282796|P1|Overall Study|Started new chemo regimen|1
1321932|NCT00019604|4282796|P1|Overall Study|Resectable disease|1
1321933|NCT00019604|4282796|P1|Overall Study|Non compliant|1
1321934|NCT00019604|4282796|P1|Overall Study|Non compliant on systemic CH|1
1321935|NCT00019604|4282796|P1|Overall Study|Move to a different study|1
1321936|NCT00019604|4282796|P1|Overall Study|Going to have liver transplant|1
1321937|NCT00019604|4282796|P1|Overall Study|Carcinoid tumor, not treatable|1
1321938|NCT00019604|4282796|P1|Overall Study|Refused treatment|1
1321939|NCT00019604|4282796|P1|Overall Study|Progressive disease|23
1321940|NCT00019604|4282796|P1|Overall Study|Death|1
1321941|NCT00016354|4282819|P8|Overall Study|Lack of Efficacy|1
1321942|NCT00016354|4282820|P7|Overall Study|Lack of Efficacy|0
1321943|NCT00016354|4282821|P6|Overall Study|Lack of Efficacy|0
1321944|NCT00016354|4282822|P5|Overall Study|Lack of Efficacy|0
1321945|NCT00016354|4282823|P4|Overall Study|Lack of Efficacy|0
1321946|NCT00016354|4282824|P3|Overall Study|Lack of Efficacy|0
1321947|NCT00016354|4282825|P2|Overall Study|Lack of Efficacy|0
1321948|NCT00016354|4282826|P1|Overall Study|Lack of Efficacy|0
1321949|NCT00014495|4282840|P4|Overall Study|Clinical deterioration|1
1321950|NCT00014495|4282841|P3|Overall Study|Clinical deterioration|0
1321951|NCT00014495|4282842|P2|Overall Study|Clinical deterioration|0
1321952|NCT00014495|4282843|P1|Overall Study|Clinical deterioration|0
1321953|NCT00014495|4282840|P4|Overall Study|Death|0
1321954|NCT00014495|4282841|P3|Overall Study|Death|1
1321955|NCT00014495|4282842|P2|Overall Study|Death|0
1321956|NCT00014495|4282843|P1|Overall Study|Death|0
1321957|NCT00012012|4282893|P2|Overall Study|Withdrawal by Subject|2
1321958|NCT00012012|4282894|P1|Overall Study|Withdrawal by Subject|0
1321959|NCT00012012|4282893|P2|Overall Study|Protocol Violation|1
1321960|NCT00012012|4282894|P1|Overall Study|Protocol Violation|1
1321961|NCT00010257|4282923|P2|Overall Study|Withdrawal by Subject|0
1321962|NCT00010257|4282924|P1|Overall Study|Withdrawal by Subject|1
1321963|NCT00009945|4282934|P2|Overall Study|no follow up data|5
1321964|NCT00009945|4282935|P1|Overall Study|no follow up data|7
1321965|NCT00008385|4282951|P2|Overall Study|Not start protocol therapy|175
1321966|NCT00008385|4282952|P1|Overall Study|Not start protocol therapy|44
1321967|NCT00008385|4282951|P2|Overall Study|Not specified|212
1321968|NCT00008385|4282952|P1|Overall Study|Not specified|105
1321969|NCT00008385|4282951|P2|Overall Study|Maximum dose reached|2
1321970|NCT00008385|4282952|P1|Overall Study|Maximum dose reached|0
1321971|NCT00008385|4282951|P2|Overall Study|Other complicating disease|30
1321972|NCT00008385|4282952|P1|Overall Study|Other complicating disease|17
1321973|NCT00008385|4282951|P2|Overall Study|Start non-protocol therapy|1
1321974|NCT00008385|4282952|P1|Overall Study|Start non-protocol therapy|3
1321975|NCT00008385|4282951|P2|Overall Study|Withdrawal by Subject|157
1321976|NCT00008385|4282952|P1|Overall Study|Withdrawal by Subject|67
1321977|NCT00008385|4282951|P2|Overall Study|Death|18
1321978|NCT00008385|4282952|P1|Overall Study|Death|12
1321979|NCT00008385|4282951|P2|Overall Study|Adverse Event|20
1321980|NCT00008385|4282952|P1|Overall Study|Adverse Event|8
1321981|NCT00008385|4282951|P2|Overall Study|Progressive disease|117
1321982|NCT00008385|4282952|P1|Overall Study|Progressive disease|52
1321983|NCT00008385|4282951|P2|Overall Study|Off treatment reasons not reported|70
1321984|NCT00008385|4282952|P1|Overall Study|Off treatment reasons not reported|79
1321985|NCT00008138|4282962|P1|Post-Cytoreduction Chemotherapy|not protocol specified|1
1321986|NCT00008138|4282962|P1|Post-Cytoreduction Chemotherapy|Progression|1
1321987|NCT00008138|4282962|P1|Post-Cytoreduction Chemotherapy|Adverse Event|6
1321988|NCT00008138|4282962|P1|Interval Debulking|Withdrawal by Subject|2
1321989|NCT00008138|4282962|P1|Neoadjuvant Chemotherapy|not protocol specified|8
1321990|NCT00008138|4282962|P1|Neoadjuvant Chemotherapy|Lack of Efficacy|6
1321991|NCT00008138|4282962|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|3
1321992|NCT00008138|4282962|P1|Neoadjuvant Chemotherapy|Adverse Event|3
1321993|NCT00006916|4282968|P1|Overall Study|Complication of device insertion|1
1321994|NCT00006916|4282968|P1|Overall Study|Device not inserted|4
1321995|NCT00006903|4282974|P3|Overall Study|Ineligible|2
1321996|NCT00006903|4282975|P2|Overall Study|Ineligible|1
1321997|NCT00006903|4282976|P1|Overall Study|Ineligible|10
1321998|NCT00006903|4282974|P3|Overall Study|Patient never treated|1
1321999|NCT00006903|4282975|P2|Overall Study|Patient never treated|0
1322000|NCT00006903|4282976|P1|Overall Study|Patient never treated|0
1322001|NCT00006903|4282974|P3|Overall Study|Death|0
1322002|NCT00006903|4282975|P2|Overall Study|Death|1
1322003|NCT00006903|4282976|P1|Overall Study|Death|0
1322004|NCT00006903|4282974|P3|Overall Study|Adverse Event|1
1322005|NCT00006903|4282975|P2|Overall Study|Adverse Event|0
1322006|NCT00006903|4282976|P1|Overall Study|Adverse Event|0
1322007|NCT00006903|4282974|P3|Overall Study|Refused further treatment|1
1322008|NCT00006903|4282975|P2|Overall Study|Refused further treatment|2
1322009|NCT00006903|4282976|P1|Overall Study|Refused further treatment|0
1322010|NCT00006903|4282974|P3|Overall Study|Still receiving treatment|1
1322011|NCT00006903|4282975|P2|Overall Study|Still receiving treatment|0
1322012|NCT00006903|4282976|P1|Overall Study|Still receiving treatment|0
1322013|NCT00006721|4282989|P3|Overall Study|Eligible but no Treatment Received|0
1322014|NCT00006721|4282990|P2|Overall Study|Eligible but no Treatment Received|0
1322015|NCT00006721|4282991|P1|Overall Study|Eligible but no Treatment Received|1
1322016|NCT00006721|4282989|P3|Overall Study|Ineligible|10
1322017|NCT00006721|4282990|P2|Overall Study|Ineligible|12
1322018|NCT00006721|4282991|P1|Overall Study|Ineligible|2
1322019|NCT00006721|4282989|P3|Overall Study|Other - Not Protocol Specified|7
1322020|NCT00006721|4282990|P2|Overall Study|Other - Not Protocol Specified|7
1322021|NCT00006721|4282991|P1|Overall Study|Other - Not Protocol Specified|0
1322022|NCT00006721|4282989|P3|Overall Study|Death|2
1322023|NCT00006721|4282990|P2|Overall Study|Death|1
1322024|NCT00006721|4282991|P1|Overall Study|Death|0
1322025|NCT00006721|4282989|P3|Overall Study|Progression/Relapse|2
1322026|NCT00006721|4282990|P2|Overall Study|Progression/Relapse|1
1322027|NCT00006721|4282991|P1|Overall Study|Progression/Relapse|0
1322028|NCT00006721|4282989|P3|Overall Study|Refusal Unrelated to Adverse Event|8
1322029|NCT00006721|4282990|P2|Overall Study|Refusal Unrelated to Adverse Event|0
1322030|NCT00006721|4282991|P1|Overall Study|Refusal Unrelated to Adverse Event|1
1322031|NCT00006721|4282989|P3|Overall Study|Adverse Event|4
1322032|NCT00006721|4282990|P2|Overall Study|Adverse Event|4
1322033|NCT00006721|4282991|P1|Overall Study|Adverse Event|0
1322034|NCT00006478|4283009|P1|Overall Study|Physician Decision|6
1322035|NCT00006478|4283009|P1|Overall Study|Vaccine could not be produced|1
1322036|NCT00006392|4283020|P4|Overall Study|Poor data/ppt mgmt, regulatory problems|155
1322037|NCT00006392|4283021|P3|Overall Study|Poor data/ppt mgmt, regulatory problems|155
1322038|NCT00006392|4283022|P2|Overall Study|Poor data/ppt mgmt, regulatory problems|155
1322039|NCT00006392|4283023|P1|Overall Study|Poor data/ppt mgmt, regulatory problems|156
1322040|NCT00006392|4283020|P4|Overall Study|Ineligible|5
1322041|NCT00006392|4283021|P3|Overall Study|Ineligible|5
1322042|NCT00006392|4283022|P2|Overall Study|Ineligible|3
1322043|NCT00006392|4283023|P1|Overall Study|Ineligible|11
1322044|NCT00006389|4283053|P1|Overall Study|Adverse Event|1
1322045|NCT00006237|4283070|P2|Overall Study|Not protocol specified|5
1322046|NCT00006237|4283071|P1|Overall Study|Not protocol specified|14
1322047|NCT00006237|4283070|P2|Overall Study|Withdrawal by Subject|1
1322048|NCT00006237|4283071|P1|Overall Study|Withdrawal by Subject|0
1322049|NCT00006237|4283070|P2|Overall Study|Not eligible|20
1322050|NCT00006237|4283071|P1|Overall Study|Not eligible|9
1322051|NCT00006237|4283070|P2|Overall Study|Progression/relapse|2
1322052|NCT00006237|4283071|P1|Overall Study|Progression/relapse|54
1322053|NCT00006237|4283070|P2|Overall Study|Refusal unrelated to adverse effects|4
1322054|NCT00006237|4283071|P1|Overall Study|Refusal unrelated to adverse effects|8
1322055|NCT00006237|4283070|P2|Overall Study|Death|0
1322056|NCT00006237|4283071|P1|Overall Study|Death|1
1322057|NCT00006237|4283070|P2|Overall Study|Adverse Event|29
1322058|NCT00006237|4283071|P1|Overall Study|Adverse Event|39
1322059|NCT00006011|4283108|P3|Overall Study|Ineligible|9
1322060|NCT00006011|4283109|P2|Overall Study|Ineligible|16
1322061|NCT00006011|4283110|P1|Overall Study|Ineligible|18
1322062|NCT00006011|4283108|P3|Overall Study|Not specified|5
1322063|NCT00006011|4283109|P2|Overall Study|Not specified|2
1322064|NCT00006011|4283110|P1|Overall Study|Not specified|4
1322065|NCT00006011|4283108|P3|Overall Study|Death|2
1322066|NCT00006011|4283109|P2|Overall Study|Death|1
1322067|NCT00006011|4283110|P1|Overall Study|Death|0
1322068|NCT00006011|4283108|P3|Overall Study|Adverse Event|5
1322069|NCT00006011|4283109|P2|Overall Study|Adverse Event|39
1322070|NCT00006011|4283110|P1|Overall Study|Adverse Event|15
1322071|NCT00006011|4283108|P3|Overall Study|Refused further treatment|26
1322072|NCT00006011|4283109|P2|Overall Study|Refused further treatment|13
1322073|NCT00006011|4283110|P1|Overall Study|Refused further treatment|15
1322074|NCT00006011|4283108|P3|Overall Study|Disease progression|26
1322075|NCT00006011|4283109|P2|Overall Study|Disease progression|6
1322076|NCT00006011|4283110|P1|Overall Study|Disease progression|13
1322077|NCT00005957|4283118|P2|Overall Study|Crossover to the other arm|19
1322078|NCT00005957|4283119|P1|Overall Study|Crossover to the other arm|5
1322079|NCT00005957|4283118|P2|Overall Study|No treated|9
1322080|NCT00005957|4283119|P1|Overall Study|No treated|3
1322081|NCT00005879|4283129|P2|Overall Study|Withdrawal by Subject|10
1322082|NCT00005879|4283130|P1|Overall Study|Withdrawal by Subject|8
1322083|NCT00005047|4283153|P4|Overall Study|Lack of Efficacy|0
1322084|NCT00005047|4283154|P3|Overall Study|Lack of Efficacy|0
1322085|NCT00005047|4283155|P2|Overall Study|Lack of Efficacy|0
1322086|NCT00005047|4283156|P1|Overall Study|Lack of Efficacy|1
1322087|NCT00005047|4283153|P4|Overall Study|Lost to Follow-up|0
1322088|NCT00005047|4283154|P3|Overall Study|Lost to Follow-up|0
1322089|NCT00005047|4283155|P2|Overall Study|Lost to Follow-up|0
1322090|NCT00005047|4283156|P1|Overall Study|Lost to Follow-up|1
1322091|NCT00005047|4283153|P4|Overall Study|Adverse Event|0
1322092|NCT00005047|4283154|P3|Overall Study|Adverse Event|0
1322093|NCT00005047|4283155|P2|Overall Study|Adverse Event|0
1322094|NCT00005047|4283156|P1|Overall Study|Adverse Event|5
1322095|NCT00005047|4283153|P4|Overall Study|Withdrawal by Subject|0
1322096|NCT00005047|4283154|P3|Overall Study|Withdrawal by Subject|0
1322097|NCT00005047|4283155|P2|Overall Study|Withdrawal by Subject|0
1322098|NCT00005047|4283156|P1|Overall Study|Withdrawal by Subject|12
1322099|NCT00005044|4283172|P2|Overall Study|No protocol treatment|1
1322100|NCT00005044|4283173|P1|Overall Study|No protocol treatment|0
1322101|NCT00005044|4283172|P2|Overall Study|Withdrawal by Subject|5
1322102|NCT00005044|4283173|P1|Overall Study|Withdrawal by Subject|1
1322103|NCT00005044|4283172|P2|Overall Study|Protocol Violation|46
1322104|NCT00005044|4283173|P1|Overall Study|Protocol Violation|37
1322105|NCT00004888|4283193|P2|Overall Study|Toxic death|0
1322106|NCT00004888|4283194|P1|Overall Study|Toxic death|1
1322107|NCT00004888|4283193|P2|Overall Study|Death without progressive disease|1
1322108|NCT00004888|4283194|P1|Overall Study|Death without progressive disease|0
1322109|NCT00004888|4283193|P2|Overall Study|Progressive Disease|9
1322110|NCT00004888|4283194|P1|Overall Study|Progressive Disease|4
1322111|NCT00004888|4283193|P2|Overall Study|Physician Decision|1
1322112|NCT00004888|4283194|P1|Overall Study|Physician Decision|1
1322113|NCT00004888|4283193|P2|Overall Study|Withdrawal by Subject|3
1322114|NCT00004888|4283194|P1|Overall Study|Withdrawal by Subject|0
1322115|NCT00004888|4283193|P2|Overall Study|Adverse Event|10
1322116|NCT00004888|4283194|P1|Overall Study|Adverse Event|5
1322117|NCT00004859|4283212|P2|Overall Study|Not specified|21
1322118|NCT00004859|4283213|P1|Overall Study|Not specified|13
1322119|NCT00004859|4283212|P2|Overall Study|missing data|11
1322120|NCT00004859|4283213|P1|Overall Study|missing data|14
1322121|NCT00004859|4283212|P2|Overall Study|error|1
1322122|NCT00004859|4283213|P1|Overall Study|error|3
1322123|NCT00004859|4283212|P2|Overall Study|other disease|3
1322124|NCT00004859|4283213|P1|Overall Study|other disease|0
1322125|NCT00004859|4283212|P2|Overall Study|Protocol Violation|2
1322126|NCT00004859|4283213|P1|Overall Study|Protocol Violation|2
1322127|NCT00004859|4283212|P2|Overall Study|Withdrawal by Subject|33
1322128|NCT00004859|4283213|P1|Overall Study|Withdrawal by Subject|7
1322129|NCT00004859|4283212|P2|Overall Study|Death|5
1322130|NCT00004859|4283213|P1|Overall Study|Death|5
1322131|NCT00004859|4283212|P2|Overall Study|Adverse Event|93
1322132|NCT00004859|4283213|P1|Overall Study|Adverse Event|31
1322133|NCT00004859|4283212|P2|Overall Study|Lack of Efficacy|113
1322134|NCT00004859|4283213|P1|Overall Study|Lack of Efficacy|43
1322135|NCT00004259|4283227|P4|Overall Study|Withdrawal by Subject|0
1322136|NCT00004259|4283228|P3|Overall Study|Withdrawal by Subject|0
1322137|NCT00004259|4283229|P2|Overall Study|Withdrawal by Subject|2
1322138|NCT00004259|4283230|P1|Overall Study|Withdrawal by Subject|0
1322139|NCT00004259|4283227|P4|Overall Study|Protocol Violation|0
1322140|NCT00004259|4283228|P3|Overall Study|Protocol Violation|0
1322141|NCT00004259|4283229|P2|Overall Study|Protocol Violation|2
1322142|NCT00004259|4283230|P1|Overall Study|Protocol Violation|1
1322143|NCT00004228|4283251|P7|Overall Study|ineligible|5
1322144|NCT00004228|4283252|P6|Overall Study|ineligible|2
1322145|NCT00004228|4283253|P5|Overall Study|ineligible|1
1322146|NCT00004228|4283254|P4|Overall Study|ineligible|1
1322147|NCT00004228|4283255|P3|Overall Study|ineligible|4
1322148|NCT00004228|4283256|P2|Overall Study|ineligible|2
1322149|NCT00004228|4283257|P1|Overall Study|ineligible|4
1322150|NCT00004228|4283251|P7|Overall Study|Other|0
1322151|NCT00004228|4283252|P6|Overall Study|Other|0
1322152|NCT00004228|4283253|P5|Overall Study|Other|0
1322153|NCT00004228|4283254|P4|Overall Study|Other|0
1322154|NCT00004228|4283255|P3|Overall Study|Other|1
1322155|NCT00004228|4283256|P2|Overall Study|Other|0
1322156|NCT00004228|4283257|P1|Overall Study|Other|0
1322157|NCT00004228|4283251|P7|Overall Study|Withdrawal by Subject|2
1322158|NCT00004228|4283252|P6|Overall Study|Withdrawal by Subject|1
1322159|NCT00004228|4283253|P5|Overall Study|Withdrawal by Subject|2
1322160|NCT00004228|4283254|P4|Overall Study|Withdrawal by Subject|0
1322161|NCT00004228|4283255|P3|Overall Study|Withdrawal by Subject|1
1322162|NCT00004228|4283256|P2|Overall Study|Withdrawal by Subject|0
1322163|NCT00004228|4283257|P1|Overall Study|Withdrawal by Subject|3
1322164|NCT00004228|4283251|P7|Overall Study|Protocol Violation|0
1322165|NCT00004228|4283252|P6|Overall Study|Protocol Violation|2
1322166|NCT00004228|4283253|P5|Overall Study|Protocol Violation|1
1322167|NCT00004228|4283254|P4|Overall Study|Protocol Violation|1
1322168|NCT00004228|4283255|P3|Overall Study|Protocol Violation|2
1322169|NCT00004228|4283256|P2|Overall Study|Protocol Violation|5
1322170|NCT00004228|4283257|P1|Overall Study|Protocol Violation|0
1322171|NCT00004228|4283251|P7|Overall Study|Physician Decision|1
1322172|NCT00004228|4283252|P6|Overall Study|Physician Decision|1
1322173|NCT00004228|4283253|P5|Overall Study|Physician Decision|1
1322174|NCT00004228|4283254|P4|Overall Study|Physician Decision|2
1322175|NCT00004228|4283255|P3|Overall Study|Physician Decision|3
1322176|NCT00004228|4283256|P2|Overall Study|Physician Decision|0
1322177|NCT00004228|4283257|P1|Overall Study|Physician Decision|1
1322178|NCT00004228|4283251|P7|Overall Study|Lost to Follow-up|0
1322179|NCT00004228|4283252|P6|Overall Study|Lost to Follow-up|0
1322180|NCT00004228|4283253|P5|Overall Study|Lost to Follow-up|0
1322181|NCT00004228|4283254|P4|Overall Study|Lost to Follow-up|0
1322182|NCT00004228|4283255|P3|Overall Study|Lost to Follow-up|1
1322183|NCT00004228|4283256|P2|Overall Study|Lost to Follow-up|0
1322184|NCT00004228|4283257|P1|Overall Study|Lost to Follow-up|0
1322185|NCT00004228|4283251|P7|Overall Study|Lack of Efficacy|4
1322186|NCT00004228|4283252|P6|Overall Study|Lack of Efficacy|8
1322187|NCT00004228|4283253|P5|Overall Study|Lack of Efficacy|9
1322188|NCT00004228|4283254|P4|Overall Study|Lack of Efficacy|3
1322189|NCT00004228|4283255|P3|Overall Study|Lack of Efficacy|5
1322190|NCT00004228|4283256|P2|Overall Study|Lack of Efficacy|6
1322191|NCT00004228|4283257|P1|Overall Study|Lack of Efficacy|1
1322192|NCT00004228|4283251|P7|Overall Study|Death|0
1322193|NCT00004228|4283252|P6|Overall Study|Death|0
1322194|NCT00004228|4283253|P5|Overall Study|Death|1
1322195|NCT00004228|4283254|P4|Overall Study|Death|0
1322196|NCT00004228|4283255|P3|Overall Study|Death|2
1322197|NCT00004228|4283256|P2|Overall Study|Death|1
1322198|NCT00004228|4283257|P1|Overall Study|Death|0
1322199|NCT00004228|4283251|P7|Overall Study|Adverse Event|0
1322200|NCT00004228|4283252|P6|Overall Study|Adverse Event|0
1322201|NCT00004228|4283253|P5|Overall Study|Adverse Event|1
1322202|NCT00004228|4283254|P4|Overall Study|Adverse Event|0
1322203|NCT00004228|4283255|P3|Overall Study|Adverse Event|0
1322204|NCT00004228|4283256|P2|Overall Study|Adverse Event|1
1322205|NCT00004228|4283257|P1|Overall Study|Adverse Event|0
1322206|NCT00004124|4283291|P2|Overall Study|Received no protocol therapy|20
1322207|NCT00004124|4283292|P1|Overall Study|Received no protocol therapy|12
1322208|NCT00003901|4283340|P1|Overall Study|Medical problems|6
1322209|NCT00003901|4283340|P1|Overall Study|Chest X-Ray not done prior registration|1
1322210|NCT00003901|4283340|P1|Overall Study|CT Scan not within protocol requirement|2
1322211|NCT00003901|4283340|P1|Overall Study|Ineligible|6
1322212|NCT00003901|4283340|P1|Overall Study|Withdrawal by Subject|1
1322213|NCT00003901|4283340|P1|Overall Study|Adverse Event|1
1322214|NCT00003896|4283351|P1|Overall Study|ineligible|5
1322215|NCT00003896|4283351|P1|Overall Study|not protocol specified|3
1322216|NCT00003896|4283351|P1|Overall Study|Death|3
1322217|NCT00003896|4283351|P1|Overall Study|Lack of Efficacy|1
1322218|NCT00003896|4283351|P1|Overall Study|Withdrawal by Subject|1
1322219|NCT00003896|4283351|P1|Overall Study|Adverse Event|16
1322220|NCT00003875|4283357|P1|Overall Study|Screen Failed|1
1322221|NCT00003869|4283366|P2|Overall Study|Alternative treatmnt, medical problems|4
1322222|NCT00003869|4283367|P1|Overall Study|Alternative treatmnt, medical problems|5
1322223|NCT00003869|4283366|P2|Overall Study|Death|2
1322224|NCT00003869|4283367|P1|Overall Study|Death|1
1322225|NCT00003869|4283366|P2|Overall Study|Withdrawal by Subject|3
1322226|NCT00003869|4283367|P1|Overall Study|Withdrawal by Subject|21
1322227|NCT00003869|4283366|P2|Overall Study|Adverse Event|3
1322228|NCT00003869|4283367|P1|Overall Study|Adverse Event|14
1322229|NCT00003782|4283393|P3|Overall Study|No follow up data|26
1322230|NCT00003782|4283394|P2|Overall Study|No follow up data|31
1322231|NCT00003782|4283395|P1|Overall Study|No follow up data|30
1322232|NCT00003702|4283405|P2|Overall Study|Inadequate documentation of disease|3
1322233|NCT00003702|4283406|P1|Overall Study|Inadequate documentation of disease|1
1322234|NCT00003702|4283405|P2|Overall Study|WHO score > 6|1
1322235|NCT00003702|4283406|P1|Overall Study|WHO score > 6|2
1322236|NCT00003702|4283405|P2|Overall Study|Did not meet criteria for persistence|5
1322237|NCT00003702|4283406|P1|Overall Study|Did not meet criteria for persistence|8
1322238|NCT00003702|4283405|P2|Overall Study|Ineligible cell types|2
1322239|NCT00003702|4283406|P1|Overall Study|Ineligible cell types|2
1322240|NCT00003659|4283415|P1|Overall Study|Withdrawal by Subject|3
1322241|NCT00003641|4283423|P2|Overall Study|Never started interferon|12
1322242|NCT00003641|4283424|P1|Overall Study|Never started interferon|567
1322243|NCT00003641|4283423|P2|Overall Study|Should not receive interferon therapy|0
1322244|NCT00003641|4283424|P1|Overall Study|Should not receive interferon therapy|2
1322245|NCT00003641|4283423|P2|Overall Study|Unknown/missing|22
1322246|NCT00003641|4283424|P1|Overall Study|Unknown/missing|0
1322247|NCT00003641|4283423|P2|Overall Study|Disease progression|2
1322248|NCT00003641|4283424|P1|Overall Study|Disease progression|0
1322249|NCT00003641|4283423|P2|Overall Study|Adverse Event|38
1322250|NCT00003641|4283424|P1|Overall Study|Adverse Event|0
1322251|NCT00003641|4283423|P2|Overall Study|Withdrawal by Subject|100
1322252|NCT00003641|4283424|P1|Overall Study|Withdrawal by Subject|0
1322253|NCT00003631|4283435|P3|Overall Study|Evaluable for toxicity only|2
1322254|NCT00003631|4283436|P2|Overall Study|Evaluable for toxicity only|0
1322255|NCT00003631|4283437|P1|Overall Study|Evaluable for toxicity only|0
1322256|NCT00003631|4283435|P3|Overall Study|Death|1
1322257|NCT00003631|4283436|P2|Overall Study|Death|0
1322258|NCT00003631|4283437|P1|Overall Study|Death|0
1322259|NCT00003631|4283435|P3|Overall Study|Adverse Event|5
1322260|NCT00003631|4283436|P2|Overall Study|Adverse Event|1
1322261|NCT00003631|4283437|P1|Overall Study|Adverse Event|1
1322262|NCT00003631|4283435|P3|Overall Study|Protocol Violation|0
1322263|NCT00003631|4283436|P2|Overall Study|Protocol Violation|0
1322264|NCT00003631|4283437|P1|Overall Study|Protocol Violation|1
1322265|NCT00003631|4283435|P3|Overall Study|Patient not treated|1
1322266|NCT00003631|4283436|P2|Overall Study|Patient not treated|0
1322267|NCT00003631|4283437|P1|Overall Study|Patient not treated|1
1322268|NCT00003590|4283445|P1|Overall Study|Physician Decision|1
1322269|NCT00003590|4283445|P1|Overall Study|Death|1
1322270|NCT00003590|4283445|P1|Overall Study|Lack of Efficacy|11
1322271|NCT00003590|4283445|P1|Overall Study|Withdrawal by Subject|1
1322272|NCT00003590|4283445|P1|Overall Study|Adverse Event|7
1322273|NCT00003590|4283445|P1|Overall Study|Ineligible Patient|1
1322274|NCT00003537|4283450|P1|Overall Study|Not evalauable|1
1322275|NCT00003535|4283455|P1|Overall Study|Not evaluable|5
1322276|NCT00003483|4283460|P1|Overall Study|Not evaluable|1
1322277|NCT00003479|4283465|P1|Overall Study|Not evaluable|3
1322278|NCT00003477|4283470|P1|Overall Study|Not evalauable|4
1322279|NCT00003476|4283475|P1|Overall Study|Not evaluable|1
1322280|NCT00003475|4283480|P1|Overall Study|Not evaluable|13
1322281|NCT00003474|4283485|P1|Overall Study|Not Evaluable|14
1322282|NCT00003473|4283490|P1|Overall Study|Three patients were not evaluable.|3
1322283|NCT00003472|4283495|P1|Overall Study|Not evaluable|3
1322284|NCT00003471|4283500|P1|Overall Study|Not evaluable|4
1322285|NCT00003470|4283505|P1|Overall Study|Not evaluable|6
1322286|NCT00003458|4283530|P1|Overall Study|Not evaluable|4
1322287|NCT00003457|4283535|P1|Overall Study|Not evaluable|9
1322288|NCT00003456|4283540|P1|Overall Study|Not evaluable|8
1322289|NCT00003389|4283552|P2|Overall Study|Ineligible|27
1322290|NCT00003389|4283553|P1|Overall Study|Ineligible|33
1322291|NCT00003389|4283552|P2|Overall Study|Off-treatment reason missing|21
1322292|NCT00003389|4283553|P1|Overall Study|Off-treatment reason missing|31
1322293|NCT00003389|4283552|P2|Overall Study|Complicating disease|0
1322294|NCT00003389|4283553|P1|Overall Study|Complicating disease|1
1322295|NCT00003389|4283552|P2|Overall Study|Alternative therapy|1
1322296|NCT00003389|4283553|P1|Overall Study|Alternative therapy|2
1322297|NCT00003389|4283552|P2|Overall Study|Withdrawal by Subject|5
1322298|NCT00003389|4283553|P1|Overall Study|Withdrawal by Subject|12
1322299|NCT00003389|4283552|P2|Overall Study|Death|3
1322300|NCT00003389|4283553|P1|Overall Study|Death|0
1322301|NCT00003389|4283552|P2|Overall Study|Adverse Event|2
1322302|NCT00003389|4283553|P1|Overall Study|Adverse Event|13
1322303|NCT00003389|4283552|P2|Overall Study|Disease progression|1
1322304|NCT00003389|4283553|P1|Overall Study|Disease progression|6
1322305|NCT00003377|4283568|P5|Period II|Ureteral stent complications|1
1322306|NCT00003377|4283569|P4|Period II|Ureteral stent complications|0
1322307|NCT00003377|4283570|P3|Period II|Ureteral stent complications|0
1322308|NCT00003377|4283571|P2|Period II|Ureteral stent complications|0
1322309|NCT00003377|4283572|P1|Period II|Ureteral stent complications|0
1322310|NCT00003377|4283568|P5|Period I|Dose Limiting Toxicity(DLT)|0
1322311|NCT00003377|4283569|P4|Period I|Dose Limiting Toxicity(DLT)|1
1322312|NCT00003377|4283570|P3|Period I|Dose Limiting Toxicity(DLT)|1
1322313|NCT00003377|4283571|P2|Period I|Dose Limiting Toxicity(DLT)|0
1322314|NCT00003377|4283572|P1|Period I|Dose Limiting Toxicity(DLT)|0
1322315|NCT00003199|4283586|P1|Overall Study|Screen fail|15
1322316|NCT00003199|4283586|P1|Overall Study|Lack of insurance clearance|2
1322317|NCT00003199|4283586|P1|Overall Study|Refused Post-Transplant Immunotherapy|5
1322318|NCT00003138|4283594|P2|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7
1322319|NCT00003138|4283595|P1|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6
1322320|NCT00003138|4283594|P2|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1
1322321|NCT00003138|4283595|P1|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0
1322322|NCT00003138|4283594|P2|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19
1322323|NCT00003138|4283595|P1|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12
1322324|NCT00003138|4283594|P2|Step 2 (Cross Over)|Reasons off treatment not documented|0
1322325|NCT00003138|4283595|P1|Step 2 (Cross Over)|Reasons off treatment not documented|26
1322326|NCT00003138|4283594|P2|Step 1|Never started treatment|0
1322327|NCT00003138|4283595|P1|Step 1|Never started treatment|1
1322328|NCT00003138|4283594|P2|Step 1|Reasons off treatment not documented|57
1322329|NCT00003138|4283595|P1|Step 1|Reasons off treatment not documented|60
1322330|NCT00002931|4283612|P1|Overall Study|rapidly progressing disease during|2
1322331|NCT00002874|4283620|P2|Overall Study|Protocol Violation|34
1322332|NCT00002874|4283621|P1|Overall Study|Protocol Violation|44
1322333|NCT00002874|4283620|P2|Overall Study|Withdrawal by Subject|1
1322334|NCT00002874|4283621|P1|Overall Study|Withdrawal by Subject|1
1322335|NCT00002850|4283646|P3|Overall Study|Withdrawal by Subject|0
1322336|NCT00002850|4283647|P2|Overall Study|Withdrawal by Subject|1
1322337|NCT00002850|4283648|P1|Overall Study|Withdrawal by Subject|0
1322338|NCT00002850|4283646|P3|Overall Study|Protocol Violation|1
1322339|NCT00002850|4283647|P2|Overall Study|Protocol Violation|0
1322340|NCT00002850|4283648|P1|Overall Study|Protocol Violation|1
1322341|NCT00002850|4283646|P3|Overall Study|Death|3
1322342|NCT00002850|4283647|P2|Overall Study|Death|1
1322343|NCT00002850|4283648|P1|Overall Study|Death|4
1322344|NCT00002842|4283656|P1|Overall Study|ineligible for surgical resection|27
1322345|NCT00002766|4283662|P2|Overall Study|Protocol Violation|0
1322346|NCT00002766|4283663|P1|Overall Study|Protocol Violation|1
1322347|NCT00002766|4283662|P2|Overall Study|Adverse Event|1
1322348|NCT00002766|4283663|P1|Overall Study|Adverse Event|1
1322349|NCT00002766|4283662|P2|Overall Study|Patient Not Treated|2
1322350|NCT00002766|4283663|P1|Overall Study|Patient Not Treated|1
1322351|NCT00002766|4283662|P2|Overall Study|Withdrawal by Subject|1
1322352|NCT00002766|4283663|P1|Overall Study|Withdrawal by Subject|0
1322353|NCT00002651|4283671|P3|Consolidation and Randomization|not eligible|112
1322354|NCT00002651|4283672|P2|Consolidation and Randomization|not eligible|102
1322355|NCT00002651|4283673|P1|Consolidation and Randomization|not eligible|0
1322356|NCT00002651|4283671|P3|Consolidation and Randomization|not specified|313
1322357|NCT00002651|4283672|P2|Consolidation and Randomization|not specified|314
1322358|NCT00002651|4283673|P1|Consolidation and Randomization|not specified|0
1322359|NCT00002651|4283671|P3|Consolidation and Randomization|Death|48
1322360|NCT00002651|4283672|P2|Consolidation and Randomization|Death|38
1322361|NCT00002651|4283673|P1|Consolidation and Randomization|Death|0
1322362|NCT00002651|4283671|P3|Consolidation and Randomization|Progression/relapse|298
1322363|NCT00002651|4283672|P2|Consolidation and Randomization|Progression/relapse|295
1322364|NCT00002651|4283673|P1|Consolidation and Randomization|Progression/relapse|0
1322365|NCT00002651|4283671|P3|Consolidation and Randomization|Refusal unrelated to adverse event|75
1322366|NCT00002651|4283672|P2|Consolidation and Randomization|Refusal unrelated to adverse event|53
1322367|NCT00002651|4283673|P1|Consolidation and Randomization|Refusal unrelated to adverse event|0
1322368|NCT00002651|4283671|P3|Consolidation and Randomization|Adverse Event|14
1322369|NCT00002651|4283672|P2|Consolidation and Randomization|Adverse Event|36
1322370|NCT00002651|4283673|P1|Consolidation and Randomization|Adverse Event|0
1322371|NCT00002651|4283671|P3|Induction|not eligible|0
1322372|NCT00002651|4283672|P2|Induction|not eligible|0
1322373|NCT00002651|4283673|P1|Induction|not eligible|90
1322374|NCT00002651|4283671|P3|Induction|not specified|0
1322375|NCT00002651|4283672|P2|Induction|not specified|0
1322376|NCT00002651|4283673|P1|Induction|not specified|823
1322377|NCT00002651|4283671|P3|Induction|Death|0
1322378|NCT00002651|4283672|P2|Induction|Death|0
1322379|NCT00002651|4283673|P1|Induction|Death|62
1322380|NCT00002651|4283671|P3|Induction|Progression/relapse|0
1322381|NCT00002651|4283672|P2|Induction|Progression/relapse|0
1322382|NCT00002651|4283673|P1|Induction|Progression/relapse|274
1322383|NCT00002651|4283671|P3|Induction|Refusal unrelated to adverse event|0
1322384|NCT00002651|4283672|P2|Induction|Refusal unrelated to adverse event|0
1322385|NCT00002651|4283673|P1|Induction|Refusal unrelated to adverse event|50
1322386|NCT00002651|4283671|P3|Induction|Adverse Event|0
1322387|NCT00002651|4283672|P2|Induction|Adverse Event|0
1322388|NCT00002651|4283673|P1|Induction|Adverse Event|44
1322389|NCT00002558|4283691|P2|Overall Study|Withdrawal by Subject|1
1322390|NCT00002558|4283692|P1|Overall Study|Withdrawal by Subject|0
1322391|NCT00051636|4283717|P2|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12
1322392|NCT00051636|4283718|P1|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40
1322393|NCT00051636|4283717|P2|Period 2- Extended Observation Period|Death|5
1322394|NCT00051636|4283718|P1|Period 2- Extended Observation Period|Death|4
1322395|NCT00051636|4283717|P2|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2
1322396|NCT00051636|4283718|P1|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9
1322397|NCT00051636|4283717|P2|Period 2- Extended Observation Period|withdrew for nonclinical reason|7
1322398|NCT00051636|4283718|P1|Period 2- Extended Observation Period|withdrew for nonclinical reason|12
1322399|NCT00051636|4283717|P2|Period 2- Extended Observation Period|Lost to Follow-up|4
1322400|NCT00051636|4283718|P1|Period 2- Extended Observation Period|Lost to Follow-up|5
1322401|NCT00051636|4283717|P2|Period 1 - Core|Lost to Follow-up|2
1322402|NCT00051636|4283718|P1|Period 1 - Core|Lost to Follow-up|0
1322403|NCT00051636|4283717|P2|Period 1 - Core|Withdrawal by Subject|2
1322404|NCT00051636|4283718|P1|Period 1 - Core|Withdrawal by Subject|1
1322405|NCT00051636|4283717|P2|Period 1 - Core|Protocol Violation|0
1322406|NCT00051636|4283718|P1|Period 1 - Core|Protocol Violation|1
1322407|NCT00051636|4283717|P2|Period 1 - Core|Adverse Event|2
1322408|NCT00051636|4283718|P1|Period 1 - Core|Adverse Event|2
1322409|NCT00051558|4283746|P2|Overall Study|Physician Decision|0
1322410|NCT00051558|4283747|P1|Overall Study|Physician Decision|5
1322411|NCT00051558|4283746|P2|Overall Study|Significant Lab Value|0
1322412|NCT00051558|4283747|P1|Overall Study|Significant Lab Value|2
1322413|NCT00051558|4283746|P2|Overall Study|Other|1
1322414|NCT00051558|4283747|P1|Overall Study|Other|2
1322415|NCT00051558|4283746|P2|Overall Study|Sponsor Decision|1
1322416|NCT00051558|4283747|P1|Overall Study|Sponsor Decision|6
1322417|NCT00051558|4283746|P2|Overall Study|Protocol Entry Criteria Unmet|2
1322418|NCT00051558|4283747|P1|Overall Study|Protocol Entry Criteria Unmet|1
1322419|NCT00051558|4283746|P2|Overall Study|Protocol Violation|4
1322420|NCT00051558|4283747|P1|Overall Study|Protocol Violation|3
1322421|NCT00051558|4283746|P2|Overall Study|Lost to Follow-up|13
1322422|NCT00051558|4283747|P1|Overall Study|Lost to Follow-up|4
1322423|NCT00051558|4283746|P2|Overall Study|Death|15
1322424|NCT00051558|4283747|P1|Overall Study|Death|9
1322425|NCT00051558|4283746|P2|Overall Study|Withdrawal by Subject|42
1322426|NCT00051558|4283747|P1|Overall Study|Withdrawal by Subject|29
1322427|NCT00051558|4283746|P2|Overall Study|Adverse Event|18
1322428|NCT00051558|4283747|P1|Overall Study|Adverse Event|30
1322429|NCT00051363|4283783|P2|Overall Study|Excluded Pre-Randomization|5
1322430|NCT00051363|4283784|P1|Overall Study|Excluded Pre-Randomization|2
1322431|NCT00051363|4283783|P2|Overall Study|Death|2
1322432|NCT00051363|4283784|P1|Overall Study|Death|2
1322433|NCT00051363|4283783|P2|Overall Study|Disqualified Post-Rand for Any Reason|11
1322434|NCT00051363|4283784|P1|Overall Study|Disqualified Post-Rand for Any Reason|9
1322435|NCT00051363|4283783|P2|Overall Study|Dropped Post-Rand for Any Reason|126
1322436|NCT00051363|4283784|P1|Overall Study|Dropped Post-Rand for Any Reason|102
1322437|NCT00051025|4283824|P2|Overall Study|Death|1
1322438|NCT00051025|4283825|P1|Overall Study|Death|0
1322439|NCT00051025|4283824|P2|Overall Study|Withdrawal by Subject|1
1322440|NCT00051025|4283825|P1|Overall Study|Withdrawal by Subject|0
1322441|NCT00051025|4283824|P2|Overall Study|Adverse Event|1
1322442|NCT00051025|4283825|P1|Overall Study|Adverse Event|1
1322443|NCT00051025|4283824|P2|Overall Study|Progressive Disease|1
1322444|NCT00051025|4283825|P1|Overall Study|Progressive Disease|1
1322445|NCT00050960|4283839|P2|Overall Study|Death|15
1322446|NCT00050960|4283840|P1|Overall Study|Death|13
1322447|NCT00050960|4283839|P2|Overall Study|Non-compliance|1
1322448|NCT00050960|4283840|P1|Overall Study|Non-compliance|3
1322449|NCT00050960|4283839|P2|Overall Study|Administrative|46
1322450|NCT00050960|4283840|P1|Overall Study|Administrative|31
1322451|NCT00050960|4283839|P2|Overall Study|Withdrawal by Subject|18
1322452|NCT00050960|4283840|P1|Overall Study|Withdrawal by Subject|23
1322453|NCT00050960|4283839|P2|Overall Study|Lost to Follow-up|1
1322454|NCT00050960|4283840|P1|Overall Study|Lost to Follow-up|0
1322455|NCT00050960|4283839|P2|Overall Study|Adverse Event|61
1322456|NCT00050960|4283840|P1|Overall Study|Adverse Event|62
1322457|NCT00050960|4283839|P2|Overall Study|Complete Response|2
1322458|NCT00050960|4283840|P1|Overall Study|Complete Response|0
1322459|NCT00050960|4283839|P2|Overall Study|Partial Response|19
1322460|NCT00050960|4283840|P1|Overall Study|Partial Response|14
1322461|NCT00050960|4283839|P2|Overall Study|Stable Disease|48
1322462|NCT00050960|4283840|P1|Overall Study|Stable Disease|19
1322463|NCT00050960|4283839|P2|Overall Study|Progressive Disease|93
1322464|NCT00050960|4283840|P1|Overall Study|Progressive Disease|137
1322465|NCT00050778|4283849|P3|Overall Study|Familial and personal reasons|0
1322466|NCT00050778|4283850|P2|Overall Study|Familial and personal reasons|0
1322467|NCT00050778|4283851|P1|Overall Study|Familial and personal reasons|1
1322468|NCT00050778|4283849|P3|Overall Study|Randomized but not treated|2
1322469|NCT00050778|4283850|P2|Overall Study|Randomized but not treated|5
1322470|NCT00050778|4283851|P1|Overall Study|Randomized but not treated|4
1322471|NCT00050778|4283849|P3|Overall Study|Withdrawal by Subject|4
1322472|NCT00050778|4283850|P2|Overall Study|Withdrawal by Subject|8
1322473|NCT00050778|4283851|P1|Overall Study|Withdrawal by Subject|6
1322474|NCT00050778|4283849|P3|Overall Study|Protocol Violation|1
1322475|NCT00050778|4283850|P2|Overall Study|Protocol Violation|0
1322476|NCT00050778|4283851|P1|Overall Study|Protocol Violation|2
1322477|NCT00050778|4283849|P3|Overall Study|Physician Decision|2
1322478|NCT00050778|4283850|P2|Overall Study|Physician Decision|0
1322479|NCT00050778|4283851|P1|Overall Study|Physician Decision|3
1322480|NCT00050778|4283849|P3|Overall Study|Lost to Follow-up|4
1322481|NCT00050778|4283850|P2|Overall Study|Lost to Follow-up|2
1322482|NCT00050778|4283851|P1|Overall Study|Lost to Follow-up|0
1322483|NCT00050778|4283849|P3|Overall Study|Lack of Efficacy|2
1322484|NCT00050778|4283850|P2|Overall Study|Lack of Efficacy|2
1322485|NCT00050778|4283851|P1|Overall Study|Lack of Efficacy|16
1322486|NCT00050778|4283849|P3|Overall Study|Death|1
1322487|NCT00050778|4283850|P2|Overall Study|Death|1
1322488|NCT00050778|4283851|P1|Overall Study|Death|0
1322489|NCT00050778|4283849|P3|Overall Study|Adverse Event|2
1322490|NCT00050778|4283850|P2|Overall Study|Adverse Event|3
1322491|NCT00050778|4283851|P1|Overall Study|Adverse Event|13
1322492|NCT00050622|4283877|P1|Overall Study|Adverse Event|1
1322493|NCT00050167|4283915|P2|Overall Study|not eligible not invasive|1
1322494|NCT00050167|4283916|P1|Overall Study|not eligible not invasive|1
1322495|NCT00050011|4283949|P2|Overall Study|Unknown - Reason is missing|2
1322496|NCT00050011|4283950|P1|Overall Study|Unknown - Reason is missing|0
1322497|NCT00050011|4283949|P2|Overall Study|Death|4
1322498|NCT00050011|4283950|P1|Overall Study|Death|7
1322499|NCT00050011|4283949|P2|Overall Study|Administrative problems|6
1322500|NCT00050011|4283950|P1|Overall Study|Administrative problems|10
1322501|NCT00050011|4283949|P2|Overall Study|Lost to Follow-up|9
1322502|NCT00050011|4283950|P1|Overall Study|Lost to Follow-up|7
1322503|NCT00050011|4283949|P2|Overall Study|Withdrawal by Subject|26
1322504|NCT00050011|4283950|P1|Overall Study|Withdrawal by Subject|34
1322505|NCT00050011|4283949|P2|Overall Study|Protocol Violation|10
1322506|NCT00050011|4283950|P1|Overall Study|Protocol Violation|4
1322507|NCT00050011|4283949|P2|Overall Study|Participant condition no longer required|0
1322508|NCT00050011|4283950|P1|Overall Study|Participant condition no longer required|1
1322509|NCT00050011|4283949|P2|Overall Study|Lack of Efficacy|21
1322510|NCT00050011|4283950|P1|Overall Study|Lack of Efficacy|16
1322511|NCT00050011|4283949|P2|Overall Study|Abnormal test procedure results|1
1322512|NCT00050011|4283950|P1|Overall Study|Abnormal test procedure results|0
1322513|NCT00050011|4283949|P2|Overall Study|Abnormal laboratory value(s)|1
1322514|NCT00050011|4283950|P1|Overall Study|Abnormal laboratory value(s)|1
1322515|NCT00050011|4283949|P2|Overall Study|Adverse Event|46
1322516|NCT00050011|4283950|P1|Overall Study|Adverse Event|41
1322517|NCT00049842|4283972|P2|Follow-up Phase|Not specified|4
1322518|NCT00049842|4283973|P1|Follow-up Phase|Not specified|1
1322519|NCT00049842|4283972|P2|Follow-up Phase|Adverse Event|1
1322520|NCT00049842|4283973|P1|Follow-up Phase|Adverse Event|6
1322521|NCT00049842|4283972|P2|Treatment Phase|Did not meet protocol eligibility|1
1322522|NCT00049842|4283973|P1|Treatment Phase|Did not meet protocol eligibility|0
1322523|NCT00049842|4283972|P2|Treatment Phase|Administrative|3
1322524|NCT00049842|4283973|P1|Treatment Phase|Administrative|0
1322525|NCT00049842|4283972|P2|Treatment Phase|Lost to Follow-up|8
1322526|NCT00049842|4283973|P1|Treatment Phase|Lost to Follow-up|4
1322527|NCT00049842|4283972|P2|Treatment Phase|Non-compliance with protocol|8
1322528|NCT00049842|4283973|P1|Treatment Phase|Non-compliance with protocol|7
1322529|NCT00049842|4283972|P2|Treatment Phase|Withdrawal by Subject|46
1322530|NCT00049842|4283973|P1|Treatment Phase|Withdrawal by Subject|35
1322531|NCT00049842|4283972|P2|Treatment Phase|Adverse Event|12
1322532|NCT00049842|4283973|P1|Treatment Phase|Adverse Event|47
1322533|NCT00048932|4283991|P3|Open Label Period (OL)|Participant Surgery|1
1322534|NCT00048932|4283992|P2|Open Label Period (OL)|Participant Surgery|0
1322535|NCT00048932|4283993|P1|Open Label Period (OL)|Participant Surgery|0
1322536|NCT00048932|4283991|P3|Open Label Period (OL)|Site Not Participating in Open Label|9
1322537|NCT00048932|4283992|P2|Open Label Period (OL)|Site Not Participating in Open Label|0
1322538|NCT00048932|4283993|P1|Open Label Period (OL)|Site Not Participating in Open Label|0
1322539|NCT00048932|4283991|P3|Open Label Period (OL)|Site Staff Issues|2
1322540|NCT00048932|4283992|P2|Open Label Period (OL)|Site Staff Issues|0
1322541|NCT00048932|4283993|P1|Open Label Period (OL)|Site Staff Issues|0
1322542|NCT00048932|4283991|P3|Open Label Period (OL)|Investigator Decision|4
1322543|NCT00048932|4283992|P2|Open Label Period (OL)|Investigator Decision|0
1322544|NCT00048932|4283993|P1|Open Label Period (OL)|Investigator Decision|0
1322545|NCT00048932|4283991|P3|Open Label Period (OL)|Medication Lost Efficacy|1
1322546|NCT00048932|4283992|P2|Open Label Period (OL)|Medication Lost Efficacy|0
1322547|NCT00048932|4283993|P1|Open Label Period (OL)|Medication Lost Efficacy|0
1322548|NCT00048932|4283991|P3|Open Label Period (OL)|Participant Missed Consecutive Doses|5
1322549|NCT00048932|4283992|P2|Open Label Period (OL)|Participant Missed Consecutive Doses|0
1322550|NCT00048932|4283993|P1|Open Label Period (OL)|Participant Missed Consecutive Doses|0
1322551|NCT00048932|4283991|P3|Open Label Period (OL)|Participant Desires Pregnancy|2
1322552|NCT00048932|4283992|P2|Open Label Period (OL)|Participant Desires Pregnancy|0
1322553|NCT00048932|4283993|P1|Open Label Period (OL)|Participant Desires Pregnancy|0
1322554|NCT00048932|4283991|P3|Open Label Period (OL)|Participant Received Wrong Medication|1
1322555|NCT00048932|4283992|P2|Open Label Period (OL)|Participant Received Wrong Medication|0
1322556|NCT00048932|4283993|P1|Open Label Period (OL)|Participant Received Wrong Medication|0
1322557|NCT00048932|4283991|P3|Open Label Period (OL)|Patient Decision|4
1322558|NCT00048932|4283992|P2|Open Label Period (OL)|Patient Decision|0
1322559|NCT00048932|4283993|P1|Open Label Period (OL)|Patient Decision|0
1322560|NCT00048932|4283991|P3|Open Label Period (OL)|Difficult IV Access with Participant|1
1322561|NCT00048932|4283992|P2|Open Label Period (OL)|Difficult IV Access with Participant|0
1322562|NCT00048932|4283993|P1|Open Label Period (OL)|Difficult IV Access with Participant|0
1322563|NCT00048932|4283991|P3|Open Label Period (OL)|Trial Terminated|1
1322564|NCT00048932|4283992|P2|Open Label Period (OL)|Trial Terminated|0
1322565|NCT00048932|4283993|P1|Open Label Period (OL)|Trial Terminated|0
1322566|NCT00048932|4283991|P3|Open Label Period (OL)|Site Closure|3
1322567|NCT00048932|4283992|P2|Open Label Period (OL)|Site Closure|0
1322568|NCT00048932|4283993|P1|Open Label Period (OL)|Site Closure|0
1322569|NCT00048932|4283991|P3|Open Label Period (OL)|Investigator Dosing the Trial|1
1322570|NCT00048932|4283992|P2|Open Label Period (OL)|Investigator Dosing the Trial|0
1322571|NCT00048932|4283993|P1|Open Label Period (OL)|Investigator Dosing the Trial|0
1322572|NCT00048932|4283991|P3|Open Label Period (OL)|Participant Relocated|6
1322573|NCT00048932|4283992|P2|Open Label Period (OL)|Participant Relocated|0
1322574|NCT00048932|4283993|P1|Open Label Period (OL)|Participant Relocated|0
1322575|NCT00048932|4283991|P3|Open Label Period (OL)|Participant Transportation Issues|1
1322576|NCT00048932|4283992|P2|Open Label Period (OL)|Participant Transportation Issues|0
1322577|NCT00048932|4283993|P1|Open Label Period (OL)|Participant Transportation Issues|0
1322578|NCT00048932|4283991|P3|Open Label Period (OL)|Investigator Retiring|2
1322579|NCT00048932|4283992|P2|Open Label Period (OL)|Investigator Retiring|0
1322580|NCT00048932|4283993|P1|Open Label Period (OL)|Investigator Retiring|0
1322581|NCT00048932|4283991|P3|Open Label Period (OL)|Administrative Reason By Sponsor|20
1322582|NCT00048932|4283992|P2|Open Label Period (OL)|Administrative Reason By Sponsor|0
1322583|NCT00048932|4283993|P1|Open Label Period (OL)|Administrative Reason By Sponsor|0
1322584|NCT00048932|4283991|P3|Open Label Period (OL)|Pregnancy|6
1322585|NCT00048932|4283992|P2|Open Label Period (OL)|Pregnancy|0
1322586|NCT00048932|4283993|P1|Open Label Period (OL)|Pregnancy|0
1322587|NCT00048932|4283991|P3|Open Label Period (OL)|Poor/Non-Compliance|13
1322588|NCT00048932|4283992|P2|Open Label Period (OL)|Poor/Non-Compliance|0
1322589|NCT00048932|4283993|P1|Open Label Period (OL)|Poor/Non-Compliance|0
1322590|NCT00048932|4283991|P3|Open Label Period (OL)|No Longer Meets Study Criteria|5
1322591|NCT00048932|4283992|P2|Open Label Period (OL)|No Longer Meets Study Criteria|0
1322592|NCT00048932|4283993|P1|Open Label Period (OL)|No Longer Meets Study Criteria|0
1322593|NCT00048932|4283991|P3|Open Label Period (OL)|Withdrawal by Subject|117
1322594|NCT00048932|4283992|P2|Open Label Period (OL)|Withdrawal by Subject|0
1322595|NCT00048932|4283993|P1|Open Label Period (OL)|Withdrawal by Subject|0
1322596|NCT00048932|4283991|P3|Open Label Period (OL)|Lost to Follow-up|27
1322597|NCT00048932|4283992|P2|Open Label Period (OL)|Lost to Follow-up|0
1322598|NCT00048932|4283993|P1|Open Label Period (OL)|Lost to Follow-up|0
1322599|NCT00048932|4283991|P3|Open Label Period (OL)|Lack of Efficacy|81
1322600|NCT00048932|4283992|P2|Open Label Period (OL)|Lack of Efficacy|0
1322601|NCT00048932|4283993|P1|Open Label Period (OL)|Lack of Efficacy|0
1322602|NCT00048932|4283991|P3|Open Label Period (OL)|Adverse Event|103
1322603|NCT00048932|4283992|P2|Open Label Period (OL)|Adverse Event|0
1322604|NCT00048932|4283993|P1|Open Label Period (OL)|Adverse Event|0
1322605|NCT00048932|4283991|P3|Open Label Period (OL)|Death|25
1322606|NCT00048932|4283992|P2|Open Label Period (OL)|Death|0
1322607|NCT00048932|4283993|P1|Open Label Period (OL)|Death|0
1322608|NCT00048932|4283991|P3|Double Blind Period (DB)|Poor/Non-Compliance|0
1322609|NCT00048932|4283992|P2|Double Blind Period (DB)|Poor/Non-Compliance|4
1322610|NCT00048932|4283993|P1|Double Blind Period (DB)|Poor/Non-Compliance|2
1322611|NCT00048932|4283991|P3|Double Blind Period (DB)|Withdrawal by Subject|0
1322612|NCT00048932|4283992|P2|Double Blind Period (DB)|Withdrawal by Subject|10
1322613|NCT00048932|4283993|P1|Double Blind Period (DB)|Withdrawal by Subject|24
1322614|NCT00048932|4283991|P3|Double Blind Period (DB)|No Longer Meets Study Criteria|0
1322615|NCT00048932|4283992|P2|Double Blind Period (DB)|No Longer Meets Study Criteria|2
1322616|NCT00048932|4283993|P1|Double Blind Period (DB)|No Longer Meets Study Criteria|8
1322617|NCT00048932|4283991|P3|Double Blind Period (DB)|Pregnancy|0
1322618|NCT00048932|4283992|P2|Double Blind Period (DB)|Pregnancy|0
1322619|NCT00048932|4283993|P1|Double Blind Period (DB)|Pregnancy|1
1322620|NCT00048932|4283991|P3|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
1322621|NCT00048932|4283992|P2|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
1322622|NCT00048932|4283993|P1|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1
1322623|NCT00048932|4283991|P3|Double Blind Period (DB)|Uncontrolled hypertension|0
1322624|NCT00048932|4283992|P2|Double Blind Period (DB)|Uncontrolled hypertension|1
1322625|NCT00048932|4283993|P1|Double Blind Period (DB)|Uncontrolled hypertension|0
1322626|NCT00048932|4283991|P3|Double Blind Period (DB)|Relocation|0
1322627|NCT00048932|4283992|P2|Double Blind Period (DB)|Relocation|0
1322628|NCT00048932|4283993|P1|Double Blind Period (DB)|Relocation|1
1322629|NCT00048932|4283991|P3|Double Blind Period (DB)|Lost to Follow-up|0
1322630|NCT00048932|4283992|P2|Double Blind Period (DB)|Lost to Follow-up|4
1322631|NCT00048932|4283993|P1|Double Blind Period (DB)|Lost to Follow-up|3
1322632|NCT00048932|4283991|P3|Double Blind Period (DB)|Lack of Efficacy|0
1322633|NCT00048932|4283992|P2|Double Blind Period (DB)|Lack of Efficacy|44
1322634|NCT00048932|4283993|P1|Double Blind Period (DB)|Lack of Efficacy|26
1322635|NCT00048932|4283991|P3|Double Blind Period (DB)|Death|0
1322636|NCT00048932|4283992|P2|Double Blind Period (DB)|Death|3
1322637|NCT00048932|4283993|P1|Double Blind Period (DB)|Death|5
1322638|NCT00048932|4283991|P3|Double Blind Period (DB)|Adverse Event|0
1322639|NCT00048932|4283992|P2|Double Blind Period (DB)|Adverse Event|19
1322640|NCT00048932|4283993|P1|Double Blind Period (DB)|Adverse Event|51
1322641|NCT00048932|4283991|P3|Double Blind Period (DB)|Administrative Reason By Sponsor|0
1322642|NCT00048932|4283992|P2|Double Blind Period (DB)|Administrative Reason By Sponsor|0
1322643|NCT00048932|4283993|P1|Double Blind Period (DB)|Administrative Reason By Sponsor|1
1322644|NCT00048581|4284035|P3|Open-Label Period|Study Ended By Sponsor|1
1322645|NCT00048581|4284036|P2|Open-Label Period|Study Ended By Sponsor|0
1322646|NCT00048581|4284037|P1|Open-Label Period|Study Ended By Sponsor|0
1322647|NCT00048581|4284035|P3|Open-Label Period|Primary Investigator Retired|2
1322648|NCT00048581|4284036|P2|Open-Label Period|Primary Investigator Retired|0
1322649|NCT00048581|4284037|P1|Open-Label Period|Primary Investigator Retired|0
1322650|NCT00048581|4284035|P3|Open-Label Period|Problem With Transportation To Site|1
1322651|NCT00048581|4284036|P2|Open-Label Period|Problem With Transportation To Site|0
1322652|NCT00048581|4284037|P1|Open-Label Period|Problem With Transportation To Site|0
1322653|NCT00048581|4284035|P3|Open-Label Period|Continue ABA With Primary Rheumatologist|3
1322654|NCT00048581|4284036|P2|Open-Label Period|Continue ABA With Primary Rheumatologist|0
1322655|NCT00048581|4284037|P1|Open-Label Period|Continue ABA With Primary Rheumatologist|0
1322656|NCT00048581|4284035|P3|Open-Label Period|Study Site Closure|2
1322657|NCT00048581|4284036|P2|Open-Label Period|Study Site Closure|0
1322658|NCT00048581|4284037|P1|Open-Label Period|Study Site Closure|0
1322659|NCT00048581|4284035|P3|Open-Label Period|Pregnancy|7
1322660|NCT00048581|4284036|P2|Open-Label Period|Pregnancy|0
1322661|NCT00048581|4284037|P1|Open-Label Period|Pregnancy|0
1322662|NCT00048581|4284035|P3|Open-Label Period|Poor/Non-compliance|5
1322663|NCT00048581|4284036|P2|Open-Label Period|Poor/Non-compliance|0
1322664|NCT00048581|4284037|P1|Open-Label Period|Poor/Non-compliance|0
1322665|NCT00048581|4284035|P3|Open-Label Period|No Longer Meets Study Criteria|2
1322666|NCT00048581|4284036|P2|Open-Label Period|No Longer Meets Study Criteria|0
1322667|NCT00048581|4284037|P1|Open-Label Period|No Longer Meets Study Criteria|0
1322668|NCT00048581|4284035|P3|Open-Label Period|Withdrawal by Subject|20
1322669|NCT00048581|4284036|P2|Open-Label Period|Withdrawal by Subject|0
1322670|NCT00048581|4284037|P1|Open-Label Period|Withdrawal by Subject|0
1322671|NCT00048581|4284035|P3|Open-Label Period|Lost to Follow-up|14
1322672|NCT00048581|4284036|P2|Open-Label Period|Lost to Follow-up|0
1322673|NCT00048581|4284037|P1|Open-Label Period|Lost to Follow-up|0
1322674|NCT00048581|4284035|P3|Open-Label Period|Lack of Efficacy|69
1322675|NCT00048581|4284036|P2|Open-Label Period|Lack of Efficacy|0
1322676|NCT00048581|4284037|P1|Open-Label Period|Lack of Efficacy|0
1322677|NCT00048581|4284035|P3|Open-Label Period|Adverse Event|37
1322678|NCT00048581|4284036|P2|Open-Label Period|Adverse Event|0
1322679|NCT00048581|4284037|P1|Open-Label Period|Adverse Event|0
1322680|NCT00048581|4284035|P3|Open-Label Period|Death|4
1322681|NCT00048581|4284036|P2|Open-Label Period|Death|0
1322682|NCT00048581|4284037|P1|Open-Label Period|Death|0
1322683|NCT00048581|4284035|P3|Double-Blind Period|Investigator Decision|0
1322684|NCT00048581|4284036|P2|Double-Blind Period|Investigator Decision|0
1322685|NCT00048581|4284037|P1|Double-Blind Period|Investigator Decision|1
1322686|NCT00048581|4284035|P3|Double-Blind Period|Participant Has History of Lymphopenia|0
1322687|NCT00048581|4284036|P2|Double-Blind Period|Participant Has History of Lymphopenia|0
1322688|NCT00048581|4284037|P1|Double-Blind Period|Participant Has History of Lymphopenia|1
1322689|NCT00048581|4284035|P3|Double-Blind Period|Withdrawal by Subject|0
1322690|NCT00048581|4284036|P2|Double-Blind Period|Withdrawal by Subject|2
1322691|NCT00048581|4284037|P1|Double-Blind Period|Withdrawal by Subject|5
1322692|NCT00048581|4284035|P3|Double-Blind Period|Lost to Follow-up|0
1322693|NCT00048581|4284036|P2|Double-Blind Period|Lost to Follow-up|0
1322694|NCT00048581|4284037|P1|Double-Blind Period|Lost to Follow-up|5
1322695|NCT00048581|4284035|P3|Double-Blind Period|Lack of Efficacy|0
1322696|NCT00048581|4284036|P2|Double-Blind Period|Lack of Efficacy|27
1322697|NCT00048581|4284037|P1|Double-Blind Period|Lack of Efficacy|14
1322698|NCT00048581|4284035|P3|Double-Blind Period|Adverse Event|0
1322699|NCT00048581|4284036|P2|Double-Blind Period|Adverse Event|5
1322700|NCT00048581|4284037|P1|Double-Blind Period|Adverse Event|9
1322701|NCT00048568|4284204|P3|Open-Label Period|Lost to Follow-up|7
1322702|NCT00048568|4284205|P2|Open-Label Period|Lost to Follow-up|0
1322703|NCT00048568|4284206|P1|Open-Label Period|Lost to Follow-up|0
1322704|NCT00048568|4284204|P3|Open-Label Period|Unknown Reasons|25
1322705|NCT00048568|4284205|P2|Open-Label Period|Unknown Reasons|0
1322706|NCT00048568|4284206|P1|Open-Label Period|Unknown Reasons|0
1322707|NCT00048568|4284204|P3|Open-Label Period|Administrative Decision By Sponsor|1
1322708|NCT00048568|4284205|P2|Open-Label Period|Administrative Decision By Sponsor|0
1322709|NCT00048568|4284206|P1|Open-Label Period|Administrative Decision By Sponsor|0
1322710|NCT00048568|4284204|P3|Open-Label Period|No Longer Met Study Criteria|2
1322711|NCT00048568|4284205|P2|Open-Label Period|No Longer Met Study Criteria|0
1322942|NCT00048074|4284640|P2|Overall Study|Withdrawal by Subject|30
1322712|NCT00048568|4284206|P1|Open-Label Period|No Longer Met Study Criteria|0
1322713|NCT00048568|4284204|P3|Open-Label Period|Pregnancy|5
1322714|NCT00048568|4284205|P2|Open-Label Period|Pregnancy|0
1322715|NCT00048568|4284206|P1|Open-Label Period|Pregnancy|0
1322716|NCT00048568|4284204|P3|Open-Label Period|Withdrawal by Subject|26
1322717|NCT00048568|4284205|P2|Open-Label Period|Withdrawal by Subject|0
1322718|NCT00048568|4284206|P1|Open-Label Period|Withdrawal by Subject|0
1322719|NCT00048568|4284204|P3|Open-Label Period|Lack of Efficacy|32
1322720|NCT00048568|4284205|P2|Open-Label Period|Lack of Efficacy|0
1322721|NCT00048568|4284206|P1|Open-Label Period|Lack of Efficacy|0
1322722|NCT00048568|4284204|P3|Open-Label Period|Adverse Event|49
1322723|NCT00048568|4284205|P2|Open-Label Period|Adverse Event|0
1322724|NCT00048568|4284206|P1|Open-Label Period|Adverse Event|0
1322725|NCT00048568|4284204|P3|Open-Label Period|Death|13
1322726|NCT00048568|4284205|P2|Open-Label Period|Death|0
1322727|NCT00048568|4284206|P1|Open-Label Period|Death|0
1322728|NCT00048568|4284204|P3|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0
1322729|NCT00048568|4284205|P2|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
1322730|NCT00048568|4284206|P1|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
1322731|NCT00048568|4284204|P3|Double-Blind Period Days 170 to 365|Pregnancy|0
1322732|NCT00048568|4284205|P2|Double-Blind Period Days 170 to 365|Pregnancy|0
1322733|NCT00048568|4284206|P1|Double-Blind Period Days 170 to 365|Pregnancy|2
1322734|NCT00048568|4284204|P3|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
1322735|NCT00048568|4284205|P2|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1
1322736|NCT00048568|4284206|P1|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
1322737|NCT00048568|4284204|P3|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0
1322738|NCT00048568|4284205|P2|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1
1322739|NCT00048568|4284206|P1|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3
1322740|NCT00048568|4284204|P3|Double-Blind Period Days 170 to 365|Lack of Efficacy|0
1322741|NCT00048568|4284205|P2|Double-Blind Period Days 170 to 365|Lack of Efficacy|7
1322742|NCT00048568|4284206|P1|Double-Blind Period Days 170 to 365|Lack of Efficacy|2
1322743|NCT00048568|4284204|P3|Double-Blind Period Days 170 to 365|Adverse Event|0
1322744|NCT00048568|4284205|P2|Double-Blind Period Days 170 to 365|Adverse Event|1
1322745|NCT00048568|4284206|P1|Double-Blind Period Days 170 to 365|Adverse Event|7
1322746|NCT00048568|4284204|P3|Double-Blind Period Days 170 to 365|Death|0
1322747|NCT00048568|4284205|P2|Double-Blind Period Days 170 to 365|Death|1
1322748|NCT00048568|4284206|P1|Double-Blind Period Days 170 to 365|Death|1
1322749|NCT00048568|4284204|P3|Double-Blind Period Days 1 to 169|Unknown Reasons|0
1322750|NCT00048568|4284205|P2|Double-Blind Period Days 1 to 169|Unknown Reasons|4
1322751|NCT00048568|4284206|P1|Double-Blind Period Days 1 to 169|Unknown Reasons|2
1322752|NCT00048568|4284204|P3|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0
1322753|NCT00048568|4284205|P2|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4
1322754|NCT00048568|4284206|P1|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7
1322755|NCT00048568|4284204|P3|Double-Blind Period Days 1 to 169|Lost to Follow-up|0
1322756|NCT00048568|4284205|P2|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
1322757|NCT00048568|4284206|P1|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
1322758|NCT00048568|4284204|P3|Double-Blind Period Days 1 to 169|Lack of Efficacy|0
1322759|NCT00048568|4284205|P2|Double-Blind Period Days 1 to 169|Lack of Efficacy|33
1322760|NCT00048568|4284206|P1|Double-Blind Period Days 1 to 169|Lack of Efficacy|11
1322761|NCT00048568|4284204|P3|Double-Blind Period Days 1 to 169|Adverse Event|0
1322762|NCT00048568|4284205|P2|Double-Blind Period Days 1 to 169|Adverse Event|3
1322763|NCT00048568|4284206|P1|Double-Blind Period Days 1 to 169|Adverse Event|11
1322764|NCT00048724|4284511|P2|Overall Study|Administrative|1
1322765|NCT00048724|4284512|P1|Overall Study|Administrative|1
1322766|NCT00048724|4284511|P2|Overall Study|Did Not Meet Protocol Eligibility|2
1322767|NCT00048724|4284512|P1|Overall Study|Did Not Meet Protocol Eligibility|2
1322768|NCT00048724|4284511|P2|Overall Study|Noncompliance With Protocol|12
1322769|NCT00048724|4284512|P1|Overall Study|Noncompliance With Protocol|4
1322770|NCT00048724|4284511|P2|Overall Study|Protocol-defined Clinical Event|32
1322771|NCT00048724|4284512|P1|Overall Study|Protocol-defined Clinical Event|17
1322772|NCT00048724|4284511|P2|Overall Study|Lost to Follow-up|5
1322773|NCT00048724|4284512|P1|Overall Study|Lost to Follow-up|5
1322774|NCT00048724|4284511|P2|Overall Study|Withdrawal by Subject|54
1322775|NCT00048724|4284512|P1|Overall Study|Withdrawal by Subject|34
1322776|NCT00048724|4284511|P2|Overall Study|Adverse Event|12
1322777|NCT00048724|4284512|P1|Overall Study|Adverse Event|53
1322778|NCT00048542|4284524|P8|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8
1322779|NCT00048542|4284525|P7|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5
1322780|NCT00048542|4284526|P6|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
1322781|NCT00048542|4284527|P5|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
1322782|NCT00048542|4284528|P4|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
1322783|NCT00048542|4284529|P3|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
1322784|NCT00048542|4284530|P2|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
1322785|NCT00048542|4284531|P1|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
1322786|NCT00048542|4284524|P8|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1
1322787|NCT00048542|4284525|P7|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2
1322788|NCT00048542|4284526|P6|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
1322943|NCT00048074|4284641|P1|Overall Study|Withdrawal by Subject|28
1322789|NCT00048542|4284527|P5|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
1322790|NCT00048542|4284528|P4|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
1322791|NCT00048542|4284529|P3|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
1322792|NCT00048542|4284530|P2|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
1322793|NCT00048542|4284531|P1|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
1322794|NCT00048542|4284524|P8|Open-Label Extension Fixed Dose Phase|Adverse Event|2
1322795|NCT00048542|4284525|P7|Open-Label Extension Fixed Dose Phase|Adverse Event|2
1322796|NCT00048542|4284526|P6|Open-Label Extension Fixed Dose Phase|Adverse Event|0
1322797|NCT00048542|4284527|P5|Open-Label Extension Fixed Dose Phase|Adverse Event|0
1322798|NCT00048542|4284528|P4|Open-Label Extension Fixed Dose Phase|Adverse Event|0
1322799|NCT00048542|4284529|P3|Open-Label Extension Fixed Dose Phase|Adverse Event|0
1322800|NCT00048542|4284530|P2|Open-Label Extension Fixed Dose Phase|Adverse Event|0
1322801|NCT00048542|4284531|P1|Open-Label Extension Fixed Dose Phase|Adverse Event|0
1322802|NCT00048542|4284524|P8|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7
1322803|NCT00048542|4284525|P7|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6
1322804|NCT00048542|4284526|P6|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
1322805|NCT00048542|4284527|P5|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
1322806|NCT00048542|4284528|P4|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
1322807|NCT00048542|4284529|P3|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
1322808|NCT00048542|4284530|P2|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
1322809|NCT00048542|4284531|P1|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
1322810|NCT00048542|4284524|P8|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
1322811|NCT00048542|4284525|P7|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
1322812|NCT00048542|4284526|P6|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
1322813|NCT00048542|4284527|P5|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
1322814|NCT00048542|4284528|P4|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
1322815|NCT00048542|4284529|P3|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
1322816|NCT00048542|4284530|P2|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
1322817|NCT00048542|4284531|P1|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
1322818|NCT00048542|4284524|P8|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3
1322819|NCT00048542|4284525|P7|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6
1322820|NCT00048542|4284526|P6|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
1322821|NCT00048542|4284527|P5|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
1322822|NCT00048542|4284528|P4|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
1322823|NCT00048542|4284529|P3|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
1322824|NCT00048542|4284530|P2|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
1322825|NCT00048542|4284531|P1|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
1322826|NCT00048542|4284524|P8|Open-Label Extension BSA Phase|Lack of Efficacy|0
1322827|NCT00048542|4284525|P7|Open-Label Extension BSA Phase|Lack of Efficacy|0
1322828|NCT00048542|4284526|P6|Open-Label Extension BSA Phase|Lack of Efficacy|1
1322829|NCT00048542|4284527|P5|Open-Label Extension BSA Phase|Lack of Efficacy|3
1322830|NCT00048542|4284528|P4|Open-Label Extension BSA Phase|Lack of Efficacy|0
1322831|NCT00048542|4284529|P3|Open-Label Extension BSA Phase|Lack of Efficacy|0
1322832|NCT00048542|4284530|P2|Open-Label Extension BSA Phase|Lack of Efficacy|0
1322833|NCT00048542|4284531|P1|Open-Label Extension BSA Phase|Lack of Efficacy|0
1322834|NCT00048542|4284524|P8|Open-Label Extension BSA Phase|Adverse Event|0
1322835|NCT00048542|4284525|P7|Open-Label Extension BSA Phase|Adverse Event|0
1322836|NCT00048542|4284526|P6|Open-Label Extension BSA Phase|Adverse Event|1
1322837|NCT00048542|4284527|P5|Open-Label Extension BSA Phase|Adverse Event|1
1322838|NCT00048542|4284528|P4|Open-Label Extension BSA Phase|Adverse Event|0
1322839|NCT00048542|4284529|P3|Open-Label Extension BSA Phase|Adverse Event|0
1322840|NCT00048542|4284530|P2|Open-Label Extension BSA Phase|Adverse Event|0
1322841|NCT00048542|4284531|P1|Open-Label Extension BSA Phase|Adverse Event|0
1322842|NCT00048542|4284524|P8|Open-Label Extension BSA Phase|Sponsor request or decision|0
1322843|NCT00048542|4284525|P7|Open-Label Extension BSA Phase|Sponsor request or decision|0
1322844|NCT00048542|4284526|P6|Open-Label Extension BSA Phase|Sponsor request or decision|1
1322845|NCT00048542|4284527|P5|Open-Label Extension BSA Phase|Sponsor request or decision|5
1322846|NCT00048542|4284528|P4|Open-Label Extension BSA Phase|Sponsor request or decision|0
1322847|NCT00048542|4284529|P3|Open-Label Extension BSA Phase|Sponsor request or decision|0
1322848|NCT00048542|4284530|P2|Open-Label Extension BSA Phase|Sponsor request or decision|0
1322849|NCT00048542|4284531|P1|Open-Label Extension BSA Phase|Sponsor request or decision|0
1322850|NCT00048542|4284524|P8|Open-Label Extension BSA Phase|Protocol Violation|0
1322851|NCT00048542|4284525|P7|Open-Label Extension BSA Phase|Protocol Violation|0
1322852|NCT00048542|4284526|P6|Open-Label Extension BSA Phase|Protocol Violation|1
1322853|NCT00048542|4284527|P5|Open-Label Extension BSA Phase|Protocol Violation|0
1322854|NCT00048542|4284528|P4|Open-Label Extension BSA Phase|Protocol Violation|0
1322855|NCT00048542|4284529|P3|Open-Label Extension BSA Phase|Protocol Violation|0
1322856|NCT00048542|4284530|P2|Open-Label Extension BSA Phase|Protocol Violation|0
1322857|NCT00048542|4284531|P1|Open-Label Extension BSA Phase|Protocol Violation|0
1322858|NCT00048542|4284524|P8|Open-Label Extension BSA Phase|Withdrawal by Subject|0
1322859|NCT00048542|4284525|P7|Open-Label Extension BSA Phase|Withdrawal by Subject|0
1322860|NCT00048542|4284526|P6|Open-Label Extension BSA Phase|Withdrawal by Subject|6
1322861|NCT00048542|4284527|P5|Open-Label Extension BSA Phase|Withdrawal by Subject|3
1322862|NCT00048542|4284528|P4|Open-Label Extension BSA Phase|Withdrawal by Subject|0
1322863|NCT00048542|4284529|P3|Open-Label Extension BSA Phase|Withdrawal by Subject|0
1322864|NCT00048542|4284530|P2|Open-Label Extension BSA Phase|Withdrawal by Subject|0
1322865|NCT00048542|4284531|P1|Open-Label Extension BSA Phase|Withdrawal by Subject|0
1322866|NCT00048542|4284524|P8|Double-Blind Phase|Randomized in error|0
1322867|NCT00048542|4284525|P7|Double-Blind Phase|Randomized in error|0
1322868|NCT00048542|4284526|P6|Double-Blind Phase|Randomized in error|0
1322869|NCT00048542|4284527|P5|Double-Blind Phase|Randomized in error|0
1322870|NCT00048542|4284528|P4|Double-Blind Phase|Randomized in error|0
1322871|NCT00048542|4284529|P3|Double-Blind Phase|Randomized in error|0
1322872|NCT00048542|4284530|P2|Double-Blind Phase|Randomized in error|0
1322873|NCT00048542|4284531|P1|Double-Blind Phase|Randomized in error|1
1322874|NCT00048542|4284524|P8|Double-Blind Phase|Sponsor request or decision|0
1322875|NCT00048542|4284525|P7|Double-Blind Phase|Sponsor request or decision|0
1322876|NCT00048542|4284526|P6|Double-Blind Phase|Sponsor request or decision|0
1322877|NCT00048542|4284527|P5|Double-Blind Phase|Sponsor request or decision|0
1322878|NCT00048542|4284528|P4|Double-Blind Phase|Sponsor request or decision|0
1322879|NCT00048542|4284529|P3|Double-Blind Phase|Sponsor request or decision|0
1322880|NCT00048542|4284530|P2|Double-Blind Phase|Sponsor request or decision|0
1322881|NCT00048542|4284531|P1|Double-Blind Phase|Sponsor request or decision|2
1322882|NCT00048542|4284524|P8|Double-Blind Phase|Protocol Violation|0
1322883|NCT00048542|4284525|P7|Double-Blind Phase|Protocol Violation|0
1322884|NCT00048542|4284526|P6|Double-Blind Phase|Protocol Violation|0
1322885|NCT00048542|4284527|P5|Double-Blind Phase|Protocol Violation|0
1322886|NCT00048542|4284528|P4|Double-Blind Phase|Protocol Violation|0
1322887|NCT00048542|4284529|P3|Double-Blind Phase|Protocol Violation|1
1322888|NCT00048542|4284530|P2|Double-Blind Phase|Protocol Violation|0
1322889|NCT00048542|4284531|P1|Double-Blind Phase|Protocol Violation|0
1322890|NCT00048542|4284524|P8|Double-Blind Phase|Withdrawal by Subject|0
1322891|NCT00048542|4284525|P7|Double-Blind Phase|Withdrawal by Subject|0
1322892|NCT00048542|4284526|P6|Double-Blind Phase|Withdrawal by Subject|0
1322893|NCT00048542|4284527|P5|Double-Blind Phase|Withdrawal by Subject|0
1322894|NCT00048542|4284528|P4|Double-Blind Phase|Withdrawal by Subject|0
1322895|NCT00048542|4284529|P3|Double-Blind Phase|Withdrawal by Subject|0
1322896|NCT00048542|4284530|P2|Double-Blind Phase|Withdrawal by Subject|1
1322897|NCT00048542|4284531|P1|Double-Blind Phase|Withdrawal by Subject|0
1322898|NCT00048347|4284597|P1|Overall Study|Screen failure|2
1322899|NCT00048165|4284603|P2|Completed 12 Months Study|Did not co-operate/Withdrew|0
1322900|NCT00048165|4284604|P1|Completed 12 Months Study|Did not co-operate/Withdrew|1
1322901|NCT00048165|4284603|P2|Completed 12 Months Study|Death|1
1322902|NCT00048165|4284604|P1|Completed 12 Months Study|Death|2
1322903|NCT00048165|4284603|P2|Completed 12 Months Study|Administration/Other|2
1322904|NCT00048165|4284604|P1|Completed 12 Months Study|Administration/Other|0
1322905|NCT00048165|4284603|P2|Completed 6 Months Study|Did not receive study drug|6
1322906|NCT00048165|4284604|P1|Completed 6 Months Study|Did not receive study drug|6
1322907|NCT00048165|4284603|P2|Completed 6 Months Study|Violation criteria|2
1322908|NCT00048165|4284604|P1|Completed 6 Months Study|Violation criteria|0
1322909|NCT00048165|4284603|P2|Completed 6 Months Study|Refused treatment|5
1322910|NCT00048165|4284604|P1|Completed 6 Months Study|Refused treatment|5
1322911|NCT00048165|4284603|P2|Completed 6 Months Study|Other violation|6
1322912|NCT00048165|4284604|P1|Completed 6 Months Study|Other violation|4
1322913|NCT00048165|4284603|P2|Completed 6 Months Study|Insufficient therapy|4
1322914|NCT00048165|4284604|P1|Completed 6 Months Study|Insufficient therapy|1
1322915|NCT00048165|4284603|P2|Completed 6 Months Study|Death|6
1322916|NCT00048165|4284604|P1|Completed 6 Months Study|Death|12
1322917|NCT00048165|4284603|P2|Completed 6 Months Study|Adverse event/intermittent illness|11
1322918|NCT00048165|4284604|P1|Completed 6 Months Study|Adverse event/intermittent illness|14
1322919|NCT00048165|4284603|P2|Completed 6 Months Study|Abnormality of laboratory test|0
1322920|NCT00048165|4284604|P1|Completed 6 Months Study|Abnormality of laboratory test|1
1322921|NCT00048165|4284603|P2|Completed 6 Months Study|Administration/Other|8
1322922|NCT00048165|4284604|P1|Completed 6 Months Study|Administration/Other|8
1322923|NCT00048074|4284639|P3|Overall Study|Social reasons|0
1322924|NCT00048074|4284640|P2|Overall Study|Social reasons|0
1322925|NCT00048074|4284641|P1|Overall Study|Social reasons|1
1322926|NCT00048074|4284639|P3|Overall Study|Out of station|1
1322927|NCT00048074|4284640|P2|Overall Study|Out of station|1
1322928|NCT00048074|4284641|P1|Overall Study|Out of station|0
1322929|NCT00048074|4284639|P3|Overall Study|Poor compliance|0
1322930|NCT00048074|4284640|P2|Overall Study|Poor compliance|1
1322931|NCT00048074|4284641|P1|Overall Study|Poor compliance|0
1322932|NCT00048074|4284639|P3|Overall Study|Husband ill|0
1322933|NCT00048074|4284640|P2|Overall Study|Husband ill|1
1322934|NCT00048074|4284641|P1|Overall Study|Husband ill|0
1322935|NCT00048074|4284639|P3|Overall Study|Study participation was terminated|0
1322936|NCT00048074|4284640|P2|Overall Study|Study participation was terminated|1
1322937|NCT00048074|4284641|P1|Overall Study|Study participation was terminated|0
1322938|NCT00048074|4284639|P3|Overall Study|Protocol Violation|0
1322939|NCT00048074|4284640|P2|Overall Study|Protocol Violation|3
1322940|NCT00048074|4284641|P1|Overall Study|Protocol Violation|1
1322941|NCT00048074|4284639|P3|Overall Study|Withdrawal by Subject|35
1322944|NCT00048074|4284639|P3|Overall Study|Lost to Follow-up|6
1322945|NCT00048074|4284640|P2|Overall Study|Lost to Follow-up|6
1322946|NCT00048074|4284641|P1|Overall Study|Lost to Follow-up|2
1322947|NCT00048074|4284639|P3|Overall Study|Death|2
1322948|NCT00048074|4284640|P2|Overall Study|Death|3
1322949|NCT00048074|4284641|P1|Overall Study|Death|3
1322950|NCT00048074|4284639|P3|Overall Study|Adverse Event|53
1322951|NCT00048074|4284640|P2|Overall Study|Adverse Event|41
1322952|NCT00048074|4284641|P1|Overall Study|Adverse Event|46
1322953|NCT00048061|4284698|P4|Overall Study|Early improvement|0
1322954|NCT00048061|4284699|P3|Overall Study|Early improvement|3
1322955|NCT00048061|4284700|P2|Overall Study|Early improvement|5
1322956|NCT00048061|4284701|P1|Overall Study|Early improvement|6
1322957|NCT00048061|4284698|P4|Overall Study|Did not follow-up|5
1322958|NCT00048061|4284699|P3|Overall Study|Did not follow-up|4
1322959|NCT00048061|4284700|P2|Overall Study|Did not follow-up|5
1322960|NCT00048061|4284701|P1|Overall Study|Did not follow-up|5
1322961|NCT00048061|4284698|P4|Overall Study|Withdrawal by Subject|32
1322962|NCT00048061|4284699|P3|Overall Study|Withdrawal by Subject|29
1322963|NCT00048061|4284700|P2|Overall Study|Withdrawal by Subject|29
1322964|NCT00048061|4284701|P1|Overall Study|Withdrawal by Subject|20
1322965|NCT00048061|4284698|P4|Overall Study|Lost to Follow-up|5
1322966|NCT00048061|4284699|P3|Overall Study|Lost to Follow-up|4
1322967|NCT00048061|4284700|P2|Overall Study|Lost to Follow-up|2
1322968|NCT00048061|4284701|P1|Overall Study|Lost to Follow-up|3
1322969|NCT00048061|4284698|P4|Overall Study|Adverse Event|37
1322970|NCT00048061|4284699|P3|Overall Study|Adverse Event|44
1322971|NCT00048061|4284700|P2|Overall Study|Adverse Event|32
1322972|NCT00048061|4284701|P1|Overall Study|Adverse Event|41
1322973|NCT00048048|4284780|P12|Extension Year 2|Early withdrawals|2
1322974|NCT00048048|4284781|P11|Extension Year 2|Early withdrawals|4
1322975|NCT00048048|4284782|P10|Extension Year 2|Early withdrawals|0
1322976|NCT00048048|4284783|P9|Extension Year 2|Early withdrawals|0
1322977|NCT00048048|4284784|P8|Extension Year 2|Early withdrawals|0
1322978|NCT00048048|4284785|P7|Extension Year 2|Early withdrawals|0
1322979|NCT00048048|4284786|P6|Extension Year 2|Early withdrawals|0
1322980|NCT00048048|4284787|P5|Extension Year 2|Early withdrawals|0
1322981|NCT00048048|4284788|P4|Extension Year 2|Early withdrawals|0
1322982|NCT00048048|4284789|P3|Extension Year 2|Early withdrawals|0
1322983|NCT00048048|4284790|P2|Extension Year 2|Early withdrawals|0
1322984|NCT00048048|4284791|P1|Extension Year 2|Early withdrawals|0
1322985|NCT00048048|4284780|P12|Extension Year 1|Early withdrawals|4
1322986|NCT00048048|4284781|P11|Extension Year 1|Early withdrawals|2
1322987|NCT00048048|4284782|P10|Extension Year 1|Early withdrawals|2
1322988|NCT00048048|4284783|P9|Extension Year 1|Early withdrawals|0
1322989|NCT00048048|4284784|P8|Extension Year 1|Early withdrawals|0
1322990|NCT00048048|4284785|P7|Extension Year 1|Early withdrawals|0
1322991|NCT00048048|4284786|P6|Extension Year 1|Early withdrawals|0
1322992|NCT00048048|4284787|P5|Extension Year 1|Early withdrawals|0
1322993|NCT00048048|4284788|P4|Extension Year 1|Early withdrawals|0
1322994|NCT00048048|4284789|P3|Extension Year 1|Early withdrawals|0
1322995|NCT00048048|4284790|P2|Extension Year 1|Early withdrawals|0
1322996|NCT00048048|4284791|P1|Extension Year 1|Early withdrawals|0
1322997|NCT00048048|4284780|P12|Core Treatment|Adverse Event|0
1322998|NCT00048048|4284781|P11|Core Treatment|Adverse Event|0
1322999|NCT00048048|4284782|P10|Core Treatment|Adverse Event|0
1323000|NCT00048048|4284783|P9|Core Treatment|Adverse Event|0
1323001|NCT00048048|4284784|P8|Core Treatment|Adverse Event|1
1323002|NCT00048048|4284785|P7|Core Treatment|Adverse Event|0
1323003|NCT00048048|4284786|P6|Core Treatment|Adverse Event|0
1323004|NCT00048048|4284787|P5|Core Treatment|Adverse Event|0
1323005|NCT00048048|4284788|P4|Core Treatment|Adverse Event|0
1323006|NCT00048048|4284789|P3|Core Treatment|Adverse Event|0
1323007|NCT00048048|4284790|P2|Core Treatment|Adverse Event|0
1323008|NCT00048048|4284791|P1|Core Treatment|Adverse Event|0
1323009|NCT00048048|4284780|P12|Core Treatment|Withdrawal by Subject|0
1323010|NCT00048048|4284781|P11|Core Treatment|Withdrawal by Subject|0
1323011|NCT00048048|4284782|P10|Core Treatment|Withdrawal by Subject|0
1323012|NCT00048048|4284783|P9|Core Treatment|Withdrawal by Subject|0
1323013|NCT00048048|4284784|P8|Core Treatment|Withdrawal by Subject|0
1323014|NCT00048048|4284785|P7|Core Treatment|Withdrawal by Subject|0
1323015|NCT00048048|4284786|P6|Core Treatment|Withdrawal by Subject|0
1323016|NCT00048048|4284787|P5|Core Treatment|Withdrawal by Subject|0
1323017|NCT00048048|4284788|P4|Core Treatment|Withdrawal by Subject|0
1323018|NCT00048048|4284789|P3|Core Treatment|Withdrawal by Subject|1
1323019|NCT00048048|4284790|P2|Core Treatment|Withdrawal by Subject|0
1323020|NCT00048048|4284791|P1|Core Treatment|Withdrawal by Subject|0
1323021|NCT00048035|4284847|P8|Extension Year 2|Early Withdrawals|3
1323022|NCT00048035|4284848|P7|Extension Year 2|Early Withdrawals|3
1323023|NCT00048035|4284849|P6|Extension Year 2|Early Withdrawals|0
1323024|NCT00048035|4284850|P5|Extension Year 2|Early Withdrawals|0
1323025|NCT00048035|4284851|P4|Extension Year 2|Early Withdrawals|0
1323026|NCT00048035|4284852|P3|Extension Year 2|Early Withdrawals|0
1323027|NCT00048035|4284853|P2|Extension Year 2|Early Withdrawals|0
1323028|NCT00048035|4284854|P1|Extension Year 2|Early Withdrawals|0
1323029|NCT00048035|4284847|P8|Extension Year 1|Early Withdrawals|11
1323030|NCT00048035|4284848|P7|Extension Year 1|Early Withdrawals|11
1323031|NCT00048035|4284849|P6|Extension Year 1|Early Withdrawals|0
1323032|NCT00048035|4284850|P5|Extension Year 1|Early Withdrawals|0
1323033|NCT00048035|4284851|P4|Extension Year 1|Early Withdrawals|0
1323034|NCT00048035|4284852|P3|Extension Year 1|Early Withdrawals|0
1323035|NCT00048035|4284853|P2|Extension Year 1|Early Withdrawals|0
1323036|NCT00048035|4284854|P1|Extension Year 1|Early Withdrawals|0
1323037|NCT00048035|4284847|P8|Core Period|Early Withdrawals|0
1323038|NCT00048035|4284848|P7|Core Period|Early Withdrawals|0
1323039|NCT00048035|4284849|P6|Core Period|Early Withdrawals|1
1323040|NCT00048035|4284850|P5|Core Period|Early Withdrawals|1
1323041|NCT00048035|4284851|P4|Core Period|Early Withdrawals|1
1323042|NCT00048035|4284852|P3|Core Period|Early Withdrawals|1
1323043|NCT00048035|4284853|P2|Core Period|Early Withdrawals|2
1323044|NCT00048035|4284854|P1|Core Period|Early Withdrawals|4
1323045|NCT00047879|4284892|P2|Overall Study|Progressive disease|3
1323046|NCT00047879|4284893|P1|Overall Study|Progressive disease|4
1323047|NCT00047463|4284929|P2|Overall Study|Withdrawal by Subject|3
1323048|NCT00047463|4284930|P1|Overall Study|Withdrawal by Subject|0
1323049|NCT00045942|4285047|P9|PKC412A2104E2|Death|0
1323050|NCT00045942|4285048|P8|PKC412A2104E2|Death|0
1323051|NCT00045942|4285049|P7|PKC412A2104E2|Death|2
1323052|NCT00045942|4285050|P6|PKC412A2104E2|Death|1
1323053|NCT00045942|4285051|P5|PKC412A2104E2|Death|0
1323054|NCT00045942|4285052|P4|PKC412A2104E2|Death|0
1323055|NCT00045942|4285053|P3|PKC412A2104E2|Death|0
1323056|NCT00045942|4285054|P2|PKC412A2104E2|Death|0
1323057|NCT00045942|4285055|P1|PKC412A2104E2|Death|0
1323058|NCT00045942|4285047|P9|PKC412A2104E2|Adverse Event|0
1323059|NCT00045942|4285048|P8|PKC412A2104E2|Adverse Event|1
1323060|NCT00045942|4285049|P7|PKC412A2104E2|Adverse Event|3
1323061|NCT00045942|4285050|P6|PKC412A2104E2|Adverse Event|4
1323062|NCT00045942|4285051|P5|PKC412A2104E2|Adverse Event|0
1323063|NCT00045942|4285052|P4|PKC412A2104E2|Adverse Event|0
1323064|NCT00045942|4285053|P3|PKC412A2104E2|Adverse Event|0
1323065|NCT00045942|4285054|P2|PKC412A2104E2|Adverse Event|0
1323066|NCT00045942|4285055|P1|PKC412A2104E2|Adverse Event|0
1323067|NCT00045942|4285047|P9|PKC412A2104E2|Lack of Efficacy|6
1323068|NCT00045942|4285048|P8|PKC412A2104E2|Lack of Efficacy|2
1323069|NCT00045942|4285049|P7|PKC412A2104E2|Lack of Efficacy|2
1323070|NCT00045942|4285050|P6|PKC412A2104E2|Lack of Efficacy|3
1323071|NCT00045942|4285051|P5|PKC412A2104E2|Lack of Efficacy|0
1323072|NCT00045942|4285052|P4|PKC412A2104E2|Lack of Efficacy|0
1323073|NCT00045942|4285053|P3|PKC412A2104E2|Lack of Efficacy|0
1323074|NCT00045942|4285054|P2|PKC412A2104E2|Lack of Efficacy|0
1323075|NCT00045942|4285055|P1|PKC412A2104E2|Lack of Efficacy|0
1323076|NCT00045942|4285047|P9|PKC412A2104E2|Withdrawal by Subject|0
1323077|NCT00045942|4285048|P8|PKC412A2104E2|Withdrawal by Subject|1
1323078|NCT00045942|4285049|P7|PKC412A2104E2|Withdrawal by Subject|0
1323079|NCT00045942|4285050|P6|PKC412A2104E2|Withdrawal by Subject|1
1323080|NCT00045942|4285051|P5|PKC412A2104E2|Withdrawal by Subject|0
1323081|NCT00045942|4285052|P4|PKC412A2104E2|Withdrawal by Subject|0
1323082|NCT00045942|4285053|P3|PKC412A2104E2|Withdrawal by Subject|0
1323083|NCT00045942|4285054|P2|PKC412A2104E2|Withdrawal by Subject|0
1323084|NCT00045942|4285055|P1|PKC412A2104E2|Withdrawal by Subject|0
1323085|NCT00045942|4285047|P9|PKC412A2104E2|Lost to Follow-up|0
1323086|NCT00045942|4285048|P8|PKC412A2104E2|Lost to Follow-up|3
1323087|NCT00045942|4285049|P7|PKC412A2104E2|Lost to Follow-up|0
1323088|NCT00045942|4285050|P6|PKC412A2104E2|Lost to Follow-up|0
1323089|NCT00045942|4285051|P5|PKC412A2104E2|Lost to Follow-up|0
1323090|NCT00045942|4285052|P4|PKC412A2104E2|Lost to Follow-up|0
1323091|NCT00045942|4285053|P3|PKC412A2104E2|Lost to Follow-up|0
1323092|NCT00045942|4285054|P2|PKC412A2104E2|Lost to Follow-up|0
1323093|NCT00045942|4285055|P1|PKC412A2104E2|Lost to Follow-up|0
1323094|NCT00045942|4285047|P9|PKC412A2104E1|Enrolled into PKC412A2104E2|0
1323095|NCT00045942|4285048|P8|PKC412A2104E1|Enrolled into PKC412A2104E2|0
1323096|NCT00045942|4285049|P7|PKC412A2104E1|Enrolled into PKC412A2104E2|0
1323097|NCT00045942|4285050|P6|PKC412A2104E1|Enrolled into PKC412A2104E2|0
1323098|NCT00045942|4285051|P5|PKC412A2104E1|Enrolled into PKC412A2104E2|0
1323099|NCT00045942|4285052|P4|PKC412A2104E1|Enrolled into PKC412A2104E2|1
1323100|NCT00045942|4285053|P3|PKC412A2104E1|Enrolled into PKC412A2104E2|1
1323101|NCT00045942|4285054|P2|PKC412A2104E1|Enrolled into PKC412A2104E2|0
1323102|NCT00045942|4285055|P1|PKC412A2104E1|Enrolled into PKC412A2104E2|0
1323103|NCT00045942|4285047|P9|PKC412A2104E1|Death|0
1323104|NCT00045942|4285048|P8|PKC412A2104E1|Death|0
1323105|NCT00045942|4285049|P7|PKC412A2104E1|Death|0
1323106|NCT00045942|4285050|P6|PKC412A2104E1|Death|0
1323107|NCT00045942|4285051|P5|PKC412A2104E1|Death|1
1323108|NCT00045942|4285052|P4|PKC412A2104E1|Death|1
1323109|NCT00045942|4285053|P3|PKC412A2104E1|Death|1
1323110|NCT00045942|4285054|P2|PKC412A2104E1|Death|4
1323111|NCT00045942|4285055|P1|PKC412A2104E1|Death|0
1323112|NCT00045942|4285047|P9|PKC412A2104E1|Adverse Event|0
1323113|NCT00045942|4285048|P8|PKC412A2104E1|Adverse Event|0
1323114|NCT00045942|4285049|P7|PKC412A2104E1|Adverse Event|0
1323115|NCT00045942|4285050|P6|PKC412A2104E1|Adverse Event|0
1323116|NCT00045942|4285051|P5|PKC412A2104E1|Adverse Event|6
1323117|NCT00045942|4285052|P4|PKC412A2104E1|Adverse Event|3
1323118|NCT00045942|4285053|P3|PKC412A2104E1|Adverse Event|1
1323119|NCT00045942|4285054|P2|PKC412A2104E1|Adverse Event|1
1323120|NCT00045942|4285055|P1|PKC412A2104E1|Adverse Event|0
1323121|NCT00045942|4285047|P9|PKC412A2104E1|Abnormal laboratory value|0
1323122|NCT00045942|4285048|P8|PKC412A2104E1|Abnormal laboratory value|0
1323123|NCT00045942|4285049|P7|PKC412A2104E1|Abnormal laboratory value|0
1323124|NCT00045942|4285050|P6|PKC412A2104E1|Abnormal laboratory value|0
1323125|NCT00045942|4285051|P5|PKC412A2104E1|Abnormal laboratory value|0
1323126|NCT00045942|4285052|P4|PKC412A2104E1|Abnormal laboratory value|0
1323127|NCT00045942|4285053|P3|PKC412A2104E1|Abnormal laboratory value|0
1323128|NCT00045942|4285054|P2|PKC412A2104E1|Abnormal laboratory value|1
1323129|NCT00045942|4285055|P1|PKC412A2104E1|Abnormal laboratory value|0
1323130|NCT00045942|4285047|P9|PKC412A2104E1|Lack of Efficacy|0
1323131|NCT00045942|4285048|P8|PKC412A2104E1|Lack of Efficacy|0
1323132|NCT00045942|4285049|P7|PKC412A2104E1|Lack of Efficacy|0
1323133|NCT00045942|4285050|P6|PKC412A2104E1|Lack of Efficacy|0
1323134|NCT00045942|4285051|P5|PKC412A2104E1|Lack of Efficacy|17
1323135|NCT00045942|4285052|P4|PKC412A2104E1|Lack of Efficacy|23
1323136|NCT00045942|4285053|P3|PKC412A2104E1|Lack of Efficacy|11
1323137|NCT00045942|4285054|P2|PKC412A2104E1|Lack of Efficacy|11
1323138|NCT00045942|4285055|P1|PKC412A2104E1|Lack of Efficacy|0
1323139|NCT00045942|4285047|P9|PKC412A2104E1|Condition no longer requires study drug|0
1323140|NCT00045942|4285048|P8|PKC412A2104E1|Condition no longer requires study drug|0
1323141|NCT00045942|4285049|P7|PKC412A2104E1|Condition no longer requires study drug|0
1323142|NCT00045942|4285050|P6|PKC412A2104E1|Condition no longer requires study drug|0
1323143|NCT00045942|4285051|P5|PKC412A2104E1|Condition no longer requires study drug|1
1323144|NCT00045942|4285052|P4|PKC412A2104E1|Condition no longer requires study drug|0
1323145|NCT00045942|4285053|P3|PKC412A2104E1|Condition no longer requires study drug|1
1323146|NCT00045942|4285054|P2|PKC412A2104E1|Condition no longer requires study drug|1
1323147|NCT00045942|4285055|P1|PKC412A2104E1|Condition no longer requires study drug|0
1323148|NCT00045942|4285047|P9|PKC412A2104E1|Withdrawal by Subject|0
1323149|NCT00045942|4285048|P8|PKC412A2104E1|Withdrawal by Subject|0
1323150|NCT00045942|4285049|P7|PKC412A2104E1|Withdrawal by Subject|0
1323151|NCT00045942|4285050|P6|PKC412A2104E1|Withdrawal by Subject|0
1323152|NCT00045942|4285051|P5|PKC412A2104E1|Withdrawal by Subject|2
1323153|NCT00045942|4285052|P4|PKC412A2104E1|Withdrawal by Subject|5
1323154|NCT00045942|4285053|P3|PKC412A2104E1|Withdrawal by Subject|2
1323155|NCT00045942|4285054|P2|PKC412A2104E1|Withdrawal by Subject|0
1323156|NCT00045942|4285055|P1|PKC412A2104E1|Withdrawal by Subject|0
1323157|NCT00045942|4285047|P9|PKC412A2104 (Core)|Death|0
1323158|NCT00045942|4285048|P8|PKC412A2104 (Core)|Death|0
1323159|NCT00045942|4285049|P7|PKC412A2104 (Core)|Death|0
1323160|NCT00045942|4285050|P6|PKC412A2104 (Core)|Death|0
1323161|NCT00045942|4285051|P5|PKC412A2104 (Core)|Death|0
1323162|NCT00045942|4285052|P4|PKC412A2104 (Core)|Death|0
1323163|NCT00045942|4285053|P3|PKC412A2104 (Core)|Death|0
1323164|NCT00045942|4285054|P2|PKC412A2104 (Core)|Death|0
1323165|NCT00045942|4285055|P1|PKC412A2104 (Core)|Death|1
1323166|NCT00045942|4285047|P9|PKC412A2104 (Core)|Lack of Efficacy|0
1323167|NCT00045942|4285048|P8|PKC412A2104 (Core)|Lack of Efficacy|0
1323168|NCT00045942|4285049|P7|PKC412A2104 (Core)|Lack of Efficacy|0
1323169|NCT00045942|4285050|P6|PKC412A2104 (Core)|Lack of Efficacy|0
1323170|NCT00045942|4285051|P5|PKC412A2104 (Core)|Lack of Efficacy|0
1323171|NCT00045942|4285052|P4|PKC412A2104 (Core)|Lack of Efficacy|0
1323172|NCT00045942|4285053|P3|PKC412A2104 (Core)|Lack of Efficacy|0
1323173|NCT00045942|4285054|P2|PKC412A2104 (Core)|Lack of Efficacy|0
1323174|NCT00045942|4285055|P1|PKC412A2104 (Core)|Lack of Efficacy|13
1323175|NCT00045942|4285047|P9|PKC412A2104 (Core)|Adverse Event|0
1323176|NCT00045942|4285048|P8|PKC412A2104 (Core)|Adverse Event|0
1323177|NCT00045942|4285049|P7|PKC412A2104 (Core)|Adverse Event|0
1323178|NCT00045942|4285050|P6|PKC412A2104 (Core)|Adverse Event|0
1323179|NCT00045942|4285051|P5|PKC412A2104 (Core)|Adverse Event|0
1323180|NCT00045942|4285052|P4|PKC412A2104 (Core)|Adverse Event|0
1323181|NCT00045942|4285053|P3|PKC412A2104 (Core)|Adverse Event|0
1323182|NCT00045942|4285054|P2|PKC412A2104 (Core)|Adverse Event|0
1323183|NCT00045942|4285055|P1|PKC412A2104 (Core)|Adverse Event|5
1323184|NCT00045942|4285047|P9|PKC412A2104 (Core)|Withdrawal by Subject|0
1323185|NCT00045942|4285048|P8|PKC412A2104 (Core)|Withdrawal by Subject|0
1323186|NCT00045942|4285049|P7|PKC412A2104 (Core)|Withdrawal by Subject|0
1323187|NCT00045942|4285050|P6|PKC412A2104 (Core)|Withdrawal by Subject|0
1323188|NCT00045942|4285051|P5|PKC412A2104 (Core)|Withdrawal by Subject|0
1323189|NCT00045942|4285052|P4|PKC412A2104 (Core)|Withdrawal by Subject|0
1323190|NCT00045942|4285053|P3|PKC412A2104 (Core)|Withdrawal by Subject|0
1323191|NCT00045942|4285054|P2|PKC412A2104 (Core)|Withdrawal by Subject|0
1323192|NCT00045942|4285055|P1|PKC412A2104 (Core)|Withdrawal by Subject|1
1323193|NCT00044512|4285144|P1|Follow Up|Lost to Follow-up|2
1323194|NCT00044213|4285159|P4|Overall Study|Lost to Follow-up|4
1323195|NCT00044213|4285160|P3|Overall Study|Lost to Follow-up|5
1323196|NCT00044213|4285161|P2|Overall Study|Lost to Follow-up|5
1323197|NCT00044213|4285162|P1|Overall Study|Lost to Follow-up|8
1323198|NCT00044213|4285159|P4|Overall Study|Death|49
1323199|NCT00044213|4285160|P3|Overall Study|Death|42
1323200|NCT00044213|4285161|P2|Overall Study|Death|42
1323201|NCT00044213|4285162|P1|Overall Study|Death|42
1323202|NCT00044213|4285159|P4|Overall Study|Withdrawal by Subject|83
1323203|NCT00044213|4285160|P3|Overall Study|Withdrawal by Subject|91
1323204|NCT00044213|4285161|P2|Overall Study|Withdrawal by Subject|65
1323205|NCT00044213|4285162|P1|Overall Study|Withdrawal by Subject|50
1323206|NCT00044083|4285227|P2|Second Intervention (One Week) Patients|Withdrawal by Subject|1
1323207|NCT00044083|4285228|P1|Second Intervention (One Week) Patients|Withdrawal by Subject|0
1323208|NCT00044083|4285227|P2|First Intervention (One Week) Patients|Used illegal drug|0
1323209|NCT00044083|4285228|P1|First Intervention (One Week) Patients|Used illegal drug|1
1323210|NCT00044083|4285227|P2|First Intervention (One Week) Patients|Not follow directions|2
1323211|NCT00044083|4285228|P1|First Intervention (One Week) Patients|Not follow directions|0
1323212|NCT00044083|4285227|P2|First Intervention (One Week)- HV's|Drank while on protocol|1
1323213|NCT00044083|4285228|P1|First Intervention (One Week)- HV's|Drank while on protocol|0
1323214|NCT00044083|4285227|P2|First Intervention (One Week)- HV's|Abnormal MRI|1
1323215|NCT00044083|4285228|P1|First Intervention (One Week)- HV's|Abnormal MRI|0
1323216|NCT00044083|4285227|P2|First Intervention (One Week)- HV's|Used illegal drugs|0
1323217|NCT00044083|4285228|P1|First Intervention (One Week)- HV's|Used illegal drugs|1
1323218|NCT00044083|4285227|P2|First Intervention (One Week)- HV's|Pregnancy|0
1323219|NCT00044083|4285228|P1|First Intervention (One Week)- HV's|Pregnancy|1
1323220|NCT00044083|4285227|P2|First Intervention (One Week)- HV's|Withdrawal by Subject|3
1323221|NCT00044083|4285228|P1|First Intervention (One Week)- HV's|Withdrawal by Subject|5
1323222|NCT00044083|4285227|P2|First Intervention (One Week)- HV's|Not follow directions|2
1323223|NCT00044083|4285228|P1|First Intervention (One Week)- HV's|Not follow directions|2
1323224|NCT00044083|4285227|P2|First Intervention (One Week)- HV's|Adverse Event|0
1323225|NCT00044083|4285228|P1|First Intervention (One Week)- HV's|Adverse Event|1
1323226|NCT00043979|4285266|P3|Period 1|recipient with progressive disease|3
1323227|NCT00043979|4285267|P2|Period 1|recipient with progressive disease|4
1323228|NCT00043979|4285268|P1|Period 1|recipient with progressive disease|7
1323229|NCT00043550|4285289|P3|Overall Study|Withdrawal by Subject|20
1323230|NCT00043550|4285290|P2|Overall Study|Withdrawal by Subject|12
1323231|NCT00043550|4285291|P1|Overall Study|Withdrawal by Subject|22
1323232|NCT00043186|4285308|P9|Overall Study|Other|0
1323233|NCT00043186|4285309|P8|Overall Study|Other|0
1323234|NCT00043186|4285310|P7|Overall Study|Other|0
1323235|NCT00043186|4285311|P6|Overall Study|Other|0
1323236|NCT00043186|4285312|P5|Overall Study|Other|0
1323237|NCT00043186|4285313|P4|Overall Study|Other|1
1323238|NCT00043186|4285314|P3|Overall Study|Other|1
1323239|NCT00043186|4285315|P2|Overall Study|Other|0
1323240|NCT00043186|4285316|P1|Overall Study|Other|0
1323241|NCT00043186|4285308|P9|Overall Study|Noncompliance|0
1323242|NCT00043186|4285309|P8|Overall Study|Noncompliance|0
1323243|NCT00043186|4285310|P7|Overall Study|Noncompliance|0
1323244|NCT00043186|4285311|P6|Overall Study|Noncompliance|0
1323245|NCT00043186|4285312|P5|Overall Study|Noncompliance|0
1323246|NCT00043186|4285313|P4|Overall Study|Noncompliance|1
1323247|NCT00043186|4285314|P3|Overall Study|Noncompliance|1
1323248|NCT00043186|4285315|P2|Overall Study|Noncompliance|0
1323249|NCT00043186|4285316|P1|Overall Study|Noncompliance|0
1323250|NCT00043186|4285308|P9|Overall Study|Lost to Follow-up|2
1323251|NCT00043186|4285309|P8|Overall Study|Lost to Follow-up|1
1323252|NCT00043186|4285310|P7|Overall Study|Lost to Follow-up|1
1323253|NCT00043186|4285311|P6|Overall Study|Lost to Follow-up|1
1323254|NCT00043186|4285312|P5|Overall Study|Lost to Follow-up|1
1323255|NCT00043186|4285313|P4|Overall Study|Lost to Follow-up|1
1323256|NCT00043186|4285314|P3|Overall Study|Lost to Follow-up|1
1323257|NCT00043186|4285315|P2|Overall Study|Lost to Follow-up|5
1323258|NCT00043186|4285316|P1|Overall Study|Lost to Follow-up|3
1323259|NCT00043186|4285308|P9|Overall Study|Ineligibility determined|1
1323260|NCT00043186|4285309|P8|Overall Study|Ineligibility determined|0
1323261|NCT00043186|4285310|P7|Overall Study|Ineligibility determined|0
1323262|NCT00043186|4285311|P6|Overall Study|Ineligibility determined|0
1323263|NCT00043186|4285312|P5|Overall Study|Ineligibility determined|0
1323264|NCT00043186|4285313|P4|Overall Study|Ineligibility determined|0
1323265|NCT00043186|4285314|P3|Overall Study|Ineligibility determined|0
1323266|NCT00043186|4285315|P2|Overall Study|Ineligibility determined|0
1323267|NCT00043186|4285316|P1|Overall Study|Ineligibility determined|0
1323268|NCT00043186|4285308|P9|Overall Study|Disease progression|0
1323269|NCT00043186|4285309|P8|Overall Study|Disease progression|4
1323270|NCT00043186|4285310|P7|Overall Study|Disease progression|0
1323271|NCT00043186|4285311|P6|Overall Study|Disease progression|0
1323272|NCT00043186|4285312|P5|Overall Study|Disease progression|0
1323273|NCT00043186|4285313|P4|Overall Study|Disease progression|3
1323274|NCT00043186|4285314|P3|Overall Study|Disease progression|0
1323275|NCT00043186|4285315|P2|Overall Study|Disease progression|0
1323276|NCT00043186|4285316|P1|Overall Study|Disease progression|1
1323277|NCT00043186|4285308|P9|Overall Study|Death|0
1323278|NCT00043186|4285309|P8|Overall Study|Death|0
1323279|NCT00043186|4285310|P7|Overall Study|Death|2
1323280|NCT00043186|4285311|P6|Overall Study|Death|0
1323281|NCT00043186|4285312|P5|Overall Study|Death|0
1323282|NCT00043186|4285313|P4|Overall Study|Death|0
1323283|NCT00043186|4285314|P3|Overall Study|Death|1
1323284|NCT00043186|4285315|P2|Overall Study|Death|0
1323285|NCT00043186|4285316|P1|Overall Study|Death|0
1323286|NCT00043186|4285308|P9|Overall Study|Withdrawal by Subject|10
1323287|NCT00043186|4285309|P8|Overall Study|Withdrawal by Subject|9
1323288|NCT00043186|4285310|P7|Overall Study|Withdrawal by Subject|12
1323289|NCT00043186|4285311|P6|Overall Study|Withdrawal by Subject|6
1323290|NCT00043186|4285312|P5|Overall Study|Withdrawal by Subject|14
1323291|NCT00043186|4285313|P4|Overall Study|Withdrawal by Subject|13
1323292|NCT00043186|4285314|P3|Overall Study|Withdrawal by Subject|11
1323293|NCT00043186|4285315|P2|Overall Study|Withdrawal by Subject|8
1323294|NCT00043186|4285316|P1|Overall Study|Withdrawal by Subject|11
1323295|NCT00043186|4285308|P9|Overall Study|Adverse Event|3
1323296|NCT00043186|4285309|P8|Overall Study|Adverse Event|1
1323297|NCT00043186|4285310|P7|Overall Study|Adverse Event|2
1323298|NCT00043186|4285311|P6|Overall Study|Adverse Event|1
1323299|NCT00043186|4285312|P5|Overall Study|Adverse Event|2
1323300|NCT00043186|4285313|P4|Overall Study|Adverse Event|3
1323301|NCT00043186|4285314|P3|Overall Study|Adverse Event|2
1323302|NCT00043186|4285315|P2|Overall Study|Adverse Event|2
1323303|NCT00043186|4285316|P1|Overall Study|Adverse Event|2
1323304|NCT00043186|4285308|P9|Overall Study|Physician Decision|1
1323305|NCT00043186|4285309|P8|Overall Study|Physician Decision|1
1323306|NCT00043186|4285310|P7|Overall Study|Physician Decision|0
1323307|NCT00043186|4285311|P6|Overall Study|Physician Decision|0
1323308|NCT00043186|4285312|P5|Overall Study|Physician Decision|1
1323309|NCT00043186|4285313|P4|Overall Study|Physician Decision|0
1323310|NCT00043186|4285314|P3|Overall Study|Physician Decision|3
1323311|NCT00043186|4285315|P2|Overall Study|Physician Decision|0
1323312|NCT00043186|4285316|P1|Overall Study|Physician Decision|0
1323313|NCT00042432|4285644|P2|Overall Study|Other|0
1323314|NCT00042432|4285645|P1|Overall Study|Other|2
1323315|NCT00042432|4285644|P2|Overall Study|Initiation of maintenance dialysis|1
1323316|NCT00042432|4285645|P1|Overall Study|Initiation of maintenance dialysis|1
1323317|NCT00042432|4285644|P2|Overall Study|Ineligibility determined|0
1323318|NCT00042432|4285645|P1|Overall Study|Ineligibility determined|1
1323319|NCT00042432|4285644|P2|Overall Study|Death|2
1323320|NCT00042432|4285645|P1|Overall Study|Death|0
1323321|NCT00042432|4285644|P2|Overall Study|Withdrawal by Subject|3
1323322|NCT00042432|4285645|P1|Overall Study|Withdrawal by Subject|1
1323323|NCT00042432|4285644|P2|Overall Study|Adverse Event|1
1323324|NCT00042432|4285645|P1|Overall Study|Adverse Event|4
1323325|NCT00041756|4285698|P5|Overall Study|Data Monitoring Committee Recommendation|21
1323326|NCT00041756|4285699|P4|Overall Study|Data Monitoring Committee Recommendation|0
1323327|NCT00041756|4285700|P3|Overall Study|Data Monitoring Committee Recommendation|0
1323328|NCT00041756|4285701|P2|Overall Study|Data Monitoring Committee Recommendation|0
1323329|NCT00041756|4285702|P1|Overall Study|Data Monitoring Committee Recommendation|0
1323330|NCT00041756|4285698|P5|Overall Study|Unable to meet protocol criteria|1
1323331|NCT00041756|4285699|P4|Overall Study|Unable to meet protocol criteria|0
1323332|NCT00041756|4285700|P3|Overall Study|Unable to meet protocol criteria|1
1323333|NCT00041756|4285701|P2|Overall Study|Unable to meet protocol criteria|0
1323334|NCT00041756|4285702|P1|Overall Study|Unable to meet protocol criteria|0
1323335|NCT00041756|4285698|P5|Overall Study|Lost to Follow-up|0
1323336|NCT00041756|4285699|P4|Overall Study|Lost to Follow-up|1
1323337|NCT00041756|4285700|P3|Overall Study|Lost to Follow-up|0
1323338|NCT00041756|4285701|P2|Overall Study|Lost to Follow-up|1
1323339|NCT00041756|4285702|P1|Overall Study|Lost to Follow-up|0
1323340|NCT00041756|4285698|P5|Overall Study|Withdrawal by Subject|3
1323341|NCT00041756|4285699|P4|Overall Study|Withdrawal by Subject|2
1323342|NCT00041756|4285700|P3|Overall Study|Withdrawal by Subject|4
1323343|NCT00041756|4285701|P2|Overall Study|Withdrawal by Subject|3
1323344|NCT00041756|4285702|P1|Overall Study|Withdrawal by Subject|3
1323345|NCT00041756|4285698|P5|Overall Study|Protocol Violation|1
1323346|NCT00041756|4285699|P4|Overall Study|Protocol Violation|2
1323347|NCT00041756|4285700|P3|Overall Study|Protocol Violation|2
1323348|NCT00041756|4285701|P2|Overall Study|Protocol Violation|1
1323349|NCT00041756|4285702|P1|Overall Study|Protocol Violation|1
1323350|NCT00041756|4285698|P5|Overall Study|Adverse Event|34
1323351|NCT00041756|4285699|P4|Overall Study|Adverse Event|11
1323352|NCT00041756|4285700|P3|Overall Study|Adverse Event|6
1323353|NCT00041756|4285701|P2|Overall Study|Adverse Event|10
1323354|NCT00041756|4285702|P1|Overall Study|Adverse Event|4
1323355|NCT00041470|4285730|P1|Overall Study|Loss of Funding|38
1323356|NCT00040664|4285735|P4|Overall Study|Non-viability of oral suspension|0
1323357|NCT00040664|4285736|P3|Overall Study|Non-viability of oral suspension|1
1323358|NCT00040664|4285737|P2|Overall Study|Non-viability of oral suspension|0
1323359|NCT00040664|4285738|P1|Overall Study|Non-viability of oral suspension|1
1323360|NCT00040664|4285735|P4|Overall Study|Change of formulation|0
1323361|NCT00040664|4285736|P3|Overall Study|Change of formulation|0
1323362|NCT00040664|4285737|P2|Overall Study|Change of formulation|2
1323363|NCT00040664|4285738|P1|Overall Study|Change of formulation|2
1323364|NCT00040664|4285735|P4|Overall Study|Pharmacokinetic target not achieved|1
1323365|NCT00040664|4285736|P3|Overall Study|Pharmacokinetic target not achieved|0
1323366|NCT00040664|4285737|P2|Overall Study|Pharmacokinetic target not achieved|1
1323367|NCT00040664|4285738|P1|Overall Study|Pharmacokinetic target not achieved|2
1323368|NCT00040664|4285735|P4|Overall Study|Poor taste|0
1323369|NCT00040664|4285736|P3|Overall Study|Poor taste|2
1323370|NCT00040664|4285737|P2|Overall Study|Poor taste|0
1323371|NCT00040664|4285738|P1|Overall Study|Poor taste|2
1323372|NCT00040664|4285735|P4|Overall Study|Medication adherence/compliance problems|5
1323373|NCT00040664|4285736|P3|Overall Study|Medication adherence/compliance problems|1
1323374|NCT00040664|4285737|P2|Overall Study|Medication adherence/compliance problems|2
1323375|NCT00040664|4285738|P1|Overall Study|Medication adherence/compliance problems|8
1323376|NCT00040664|4285735|P4|Overall Study|Pregnancy|3
1323377|NCT00040664|4285736|P3|Overall Study|Pregnancy|0
1323378|NCT00040664|4285737|P2|Overall Study|Pregnancy|0
1323379|NCT00040664|4285738|P1|Overall Study|Pregnancy|3
1323380|NCT00040664|4285735|P4|Overall Study|Withdrawal by Subject|4
1323381|NCT00040664|4285736|P3|Overall Study|Withdrawal by Subject|3
1323382|NCT00040664|4285737|P2|Overall Study|Withdrawal by Subject|0
1323383|NCT00040664|4285738|P1|Overall Study|Withdrawal by Subject|7
1323384|NCT00040664|4285735|P4|Overall Study|Protocol Violation|1
1323385|NCT00040664|4285736|P3|Overall Study|Protocol Violation|0
1323386|NCT00040664|4285737|P2|Overall Study|Protocol Violation|1
1323387|NCT00040664|4285738|P1|Overall Study|Protocol Violation|2
1323388|NCT00040664|4285735|P4|Overall Study|Lost to Follow-up|2
1323389|NCT00040664|4285736|P3|Overall Study|Lost to Follow-up|0
1323390|NCT00040664|4285737|P2|Overall Study|Lost to Follow-up|2
1323391|NCT00040664|4285738|P1|Overall Study|Lost to Follow-up|4
1323392|NCT00040664|4285735|P4|Overall Study|Insufficient CD4 response|0
1323393|NCT00040664|4285736|P3|Overall Study|Insufficient CD4 response|1
1323394|NCT00040664|4285737|P2|Overall Study|Insufficient CD4 response|0
1323395|NCT00040664|4285738|P1|Overall Study|Insufficient CD4 response|1
1323396|NCT00040664|4285735|P4|Overall Study|Lack of Efficacy|4
1323397|NCT00040664|4285736|P3|Overall Study|Lack of Efficacy|3
1323398|NCT00040664|4285737|P2|Overall Study|Lack of Efficacy|2
1323399|NCT00040664|4285738|P1|Overall Study|Lack of Efficacy|9
1323400|NCT00040664|4285735|P4|Overall Study|Adverse Event|7
1323401|NCT00040664|4285736|P3|Overall Study|Adverse Event|2
1323402|NCT00040664|4285737|P2|Overall Study|Adverse Event|3
1323403|NCT00040664|4285738|P1|Overall Study|Adverse Event|12
1323404|NCT00040365|4285804|P1|Overall Study|Lost to Follow-up|3
1323405|NCT00040365|4285804|P1|Overall Study|Progressive disease|7
1323406|NCT00040365|4285804|P1|Overall Study|Death|1
1323407|NCT00039871|4285813|P1|Overall Study|Never entered follow-up|7
1323408|NCT00039871|4285813|P1|Overall Study|Discontinued at Week 12 per protocol|1061
1323409|NCT00039871|4285813|P1|Overall Study|Administrative|1
1323410|NCT00039871|4285813|P1|Overall Study|Did not meet eligibility criteria|11
1323411|NCT00039871|4285813|P1|Overall Study|Withdrawal by Subject|97
1323412|NCT00039871|4285813|P1|Overall Study|Protocol Violation|24
1323413|NCT00039871|4285813|P1|Overall Study|Lost to Follow-up|18
1323414|NCT00039871|4285813|P1|Overall Study|Adverse Event|165
1323415|NCT00039741|4285823|P4|Overall Study|Missed final visit|2
1323416|NCT00039741|4285824|P3|Overall Study|Missed final visit|2
1323417|NCT00039741|4285825|P2|Overall Study|Missed final visit|1
1323418|NCT00039741|4285826|P1|Overall Study|Missed final visit|2
1323419|NCT00039741|4285823|P4|Overall Study|Withdrew consent|1
1323420|NCT00039741|4285824|P3|Overall Study|Withdrew consent|0
1323421|NCT00039741|4285825|P2|Overall Study|Withdrew consent|5
1323422|NCT00039741|4285826|P1|Overall Study|Withdrew consent|0
1323423|NCT00039741|4285823|P4|Overall Study|Non-compliance with protocol|0
1323424|NCT00039741|4285824|P3|Overall Study|Non-compliance with protocol|1
1323425|NCT00039741|4285825|P2|Overall Study|Non-compliance with protocol|0
1323426|NCT00039741|4285826|P1|Overall Study|Non-compliance with protocol|1
1323427|NCT00039741|4285823|P4|Overall Study|Moved|6
1323428|NCT00039741|4285824|P3|Overall Study|Moved|3
1323429|NCT00039741|4285825|P2|Overall Study|Moved|2
1323430|NCT00039741|4285826|P1|Overall Study|Moved|3
1323431|NCT00039741|4285823|P4|Overall Study|Not able to get to clinic|3
1323432|NCT00039741|4285824|P3|Overall Study|Not able to get to clinic|0
1323433|NCT00039741|4285825|P2|Overall Study|Not able to get to clinic|2
1323434|NCT00039741|4285826|P1|Overall Study|Not able to get to clinic|5
1323435|NCT00039741|4285823|P4|Overall Study|Confounding medical condition|0
1323436|NCT00039741|4285824|P3|Overall Study|Confounding medical condition|0
1323437|NCT00039741|4285825|P2|Overall Study|Confounding medical condition|0
1323438|NCT00039741|4285826|P1|Overall Study|Confounding medical condition|1
1323439|NCT00039741|4285823|P4|Overall Study|Lost to Follow-up|2
1323440|NCT00039741|4285824|P3|Overall Study|Lost to Follow-up|5
1323441|NCT00039741|4285825|P2|Overall Study|Lost to Follow-up|1
1323442|NCT00039741|4285826|P1|Overall Study|Lost to Follow-up|3
1323443|NCT00039741|4285823|P4|Overall Study|Death|0
1323444|NCT00039741|4285824|P3|Overall Study|Death|0
1323445|NCT00039741|4285825|P2|Overall Study|Death|1
1323446|NCT00039741|4285826|P1|Overall Study|Death|0
1323447|NCT00038948|4285870|P2|Overall Study|Lack of Efficacy|6
1323448|NCT00038948|4285871|P1|Overall Study|Lack of Efficacy|3
1323449|NCT00038948|4285870|P2|Overall Study|Protocol Violation|7
1323450|NCT00038948|4285871|P1|Overall Study|Protocol Violation|3
1323451|NCT00038948|4285870|P2|Overall Study|Withdrawal by Subject|10
1323452|NCT00038948|4285871|P1|Overall Study|Withdrawal by Subject|23
1323453|NCT00038948|4285870|P2|Overall Study|Nonmedical event|7
1323454|NCT00038948|4285871|P1|Overall Study|Nonmedical event|5
1323455|NCT00038948|4285870|P2|Overall Study|Lost to Follow-up|4
1323456|NCT00038948|4285871|P1|Overall Study|Lost to Follow-up|4
1323457|NCT00038948|4285870|P2|Overall Study|Adverse Event|43
1323458|NCT00038948|4285871|P1|Overall Study|Adverse Event|131
1323459|NCT00038649|4285903|P1|Overall Study|Adverse Event|9
1323460|NCT00038467|4285916|P2|Overall Study|Other|28
1323461|NCT00038467|4285917|P1|Overall Study|Other|26
1323462|NCT00038467|4285916|P2|Overall Study|Randomized, but not treated|35
1323463|NCT00038467|4285917|P1|Overall Study|Randomized, but not treated|31
1323464|NCT00038467|4285916|P2|Overall Study|Recurrence|179
1323465|NCT00038467|4285917|P1|Overall Study|Recurrence|109
1323466|NCT00038467|4285916|P2|Overall Study|Lost to Follow-up|10
1323467|NCT00038467|4285917|P1|Overall Study|Lost to Follow-up|15
1323468|NCT00038467|4285916|P2|Overall Study|Death|16
1323469|NCT00038467|4285917|P1|Overall Study|Death|22
1323470|NCT00038467|4285916|P2|Overall Study|Protocol Violation|22
1323471|NCT00038467|4285917|P1|Overall Study|Protocol Violation|19
1323472|NCT00038467|4285916|P2|Overall Study|Withdrawal by Subject|107
1323473|NCT00038467|4285917|P1|Overall Study|Withdrawal by Subject|150
1323474|NCT00038467|4285916|P2|Overall Study|Adverse Event|145
1323475|NCT00038467|4285917|P1|Overall Study|Adverse Event|170
1323476|NCT00038103|4285979|P2|Overall Study|Randomized/never treated|0
1323477|NCT00038103|4285980|P1|Overall Study|Randomized/never treated|2
1323478|NCT00038103|4285979|P2|Overall Study|Sponsor Decision|1
1323479|NCT00038103|4285980|P1|Overall Study|Sponsor Decision|0
1323480|NCT00038103|4285979|P2|Overall Study|Protocol Violation|2
1323481|NCT00038103|4285980|P1|Overall Study|Protocol Violation|0
1323482|NCT00038103|4285979|P2|Overall Study|Lost to Follow-up|3
1323483|NCT00038103|4285980|P1|Overall Study|Lost to Follow-up|0
1323484|NCT00038103|4285979|P2|Overall Study|Withdrawal by Subject|3
1323485|NCT00038103|4285980|P1|Overall Study|Withdrawal by Subject|0
1323486|NCT00038103|4285979|P2|Overall Study|Lack of Efficacy|41
1323487|NCT00038103|4285980|P1|Overall Study|Lack of Efficacy|48
1323488|NCT00038103|4285979|P2|Overall Study|Adverse Event|6
1323489|NCT00038103|4285980|P1|Overall Study|Adverse Event|5
1323490|NCT00037830|4286003|P3|Overall Study|Unrelated Medical Problem|0
1323491|NCT00037830|4286004|P2|Overall Study|Unrelated Medical Problem|0
1323492|NCT00037830|4286005|P1|Overall Study|Unrelated Medical Problem|2
1323493|NCT00037830|4286003|P3|Overall Study|Protocol Violation|0
1323494|NCT00037830|4286004|P2|Overall Study|Protocol Violation|2
1323495|NCT00037830|4286005|P1|Overall Study|Protocol Violation|2
1323496|NCT00037830|4286003|P3|Overall Study|Withdrawal by Subject|1
1323497|NCT00037830|4286004|P2|Overall Study|Withdrawal by Subject|5
1323498|NCT00037830|4286005|P1|Overall Study|Withdrawal by Subject|4
1323499|NCT00037830|4286003|P3|Overall Study|Adverse Event|0
1323500|NCT00037830|4286004|P2|Overall Study|Adverse Event|0
1323501|NCT00037830|4286005|P1|Overall Study|Adverse Event|2
1323502|NCT00036270|4286037|P2|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750
1323503|NCT00036270|4286038|P1|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0
1323504|NCT00036270|4286037|P2|Study Treatment to 5 Year Report|Too early switch|103
1323505|NCT00036270|4286038|P1|Study Treatment to 5 Year Report|Too early switch|0
1323506|NCT00036270|4286037|P2|Study Treatment to 5 Year Report|Intercurrent illness|29
1323507|NCT00036270|4286038|P1|Study Treatment to 5 Year Report|Intercurrent illness|17
1323508|NCT00036270|4286037|P2|Study Treatment to 5 Year Report|Protocol Violation|91
1323509|NCT00036270|4286038|P1|Study Treatment to 5 Year Report|Protocol Violation|23
1323510|NCT00036270|4286037|P2|Study Treatment to 5 Year Report|Randomized but not treated|54
1323511|NCT00036270|4286038|P1|Study Treatment to 5 Year Report|Randomized but not treated|46
1323512|NCT00036270|4286037|P2|Study Treatment to 5 Year Report|Treatment refusal|208
1323513|NCT00036270|4286038|P1|Study Treatment to 5 Year Report|Treatment refusal|113
1323514|NCT00036270|4286037|P2|Study Treatment to 5 Year Report|Other|288
1323515|NCT00036270|4286038|P1|Study Treatment to 5 Year Report|Other|277
1323516|NCT00036270|4286037|P2|Study Treatment to 5 Year Report|Adverse Event|782
1323517|NCT00036270|4286038|P1|Study Treatment to 5 Year Report|Adverse Event|501
1323518|NCT00036270|4286037|P2|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447
1323519|NCT00036270|4286038|P1|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507
1323520|NCT00036270|4286037|P2|Study Treatment to 5 Year Report|Ongoing|736
1323521|NCT00036270|4286038|P1|Study Treatment to 5 Year Report|Ongoing|1081
1323522|NCT00036270|4286037|P2|Randomized to Study Treatment|Withdrawal by Subject|7
1323523|NCT00036270|4286038|P1|Randomized to Study Treatment|Withdrawal by Subject|6
1323524|NCT00035932|4286057|P3|Overall Study|Lack of Efficacy|28
1323525|NCT00035932|4286058|P2|Overall Study|Lack of Efficacy|33
1323526|NCT00035932|4286059|P1|Overall Study|Lack of Efficacy|33
1323527|NCT00035932|4286057|P3|Overall Study|Study Termination by Sponsor|0
1323528|NCT00035932|4286058|P2|Overall Study|Study Termination by Sponsor|0
1323529|NCT00035932|4286059|P1|Overall Study|Study Termination by Sponsor|1
1323530|NCT00035932|4286057|P3|Overall Study|Withdrawal by Subject|0
1323531|NCT00035932|4286058|P2|Overall Study|Withdrawal by Subject|5
1323532|NCT00035932|4286059|P1|Overall Study|Withdrawal by Subject|1
1323533|NCT00035932|4286057|P3|Overall Study|Protocol Violation While on Study|2
1323534|NCT00035932|4286058|P2|Overall Study|Protocol Violation While on Study|1
1323535|NCT00035932|4286059|P1|Overall Study|Protocol Violation While on Study|0
1323536|NCT00035932|4286057|P3|Overall Study|Noncompliance|6
1323537|NCT00035932|4286058|P2|Overall Study|Noncompliance|7
1323538|NCT00035932|4286059|P1|Overall Study|Noncompliance|6
1323539|NCT00035932|4286057|P3|Overall Study|Lost to Follow-up|3
1323540|NCT00035932|4286058|P2|Overall Study|Lost to Follow-up|4
1323541|NCT00035932|4286059|P1|Overall Study|Lost to Follow-up|4
1323542|NCT00035932|4286057|P3|Overall Study|Disease Progression / Relapse|0
1323543|NCT00035932|4286058|P2|Overall Study|Disease Progression / Relapse|1
1323544|NCT00035932|4286059|P1|Overall Study|Disease Progression / Relapse|1
1323545|NCT00035932|4286057|P3|Overall Study|Death|1
1323546|NCT00035932|4286058|P2|Overall Study|Death|0
1323547|NCT00035932|4286059|P1|Overall Study|Death|0
1323548|NCT00035932|4286057|P3|Overall Study|Adverse Event|9
1323549|NCT00035932|4286058|P2|Overall Study|Adverse Event|9
1323550|NCT00035932|4286059|P1|Overall Study|Adverse Event|10
1323551|NCT00035815|4286185|P2|Overall Study|Withdrawal by Subject|11
1323552|NCT00035815|4286186|P1|Overall Study|Withdrawal by Subject|17
1323553|NCT00035555|4286199|P3|Overall Study|Received cyclosporin in error|1
1323554|NCT00035555|4286200|P2|Overall Study|Received cyclosporin in error|0
1323555|NCT00035555|4286201|P1|Overall Study|Received cyclosporin in error|0
1323556|NCT00035555|4286199|P3|Overall Study|Investigator deemed not a good candidate|1
1323557|NCT00035555|4286200|P2|Overall Study|Investigator deemed not a good candidate|0
1323558|NCT00035555|4286201|P1|Overall Study|Investigator deemed not a good candidate|0
1323559|NCT00035555|4286199|P3|Overall Study|Withdrawal by Subject|2
1323560|NCT00035555|4286200|P2|Overall Study|Withdrawal by Subject|0
1323561|NCT00035555|4286201|P1|Overall Study|Withdrawal by Subject|2
1323562|NCT00035555|4286199|P3|Overall Study|Treatment failure/lack of efficacy|3
1323563|NCT00035555|4286200|P2|Overall Study|Treatment failure/lack of efficacy|5
1323564|NCT00035555|4286201|P1|Overall Study|Treatment failure/lack of efficacy|7
1323565|NCT00035555|4286199|P3|Overall Study|Prohibited medication|0
1323566|NCT00035555|4286200|P2|Overall Study|Prohibited medication|1
1323567|NCT00035555|4286201|P1|Overall Study|Prohibited medication|1
1323568|NCT00035555|4286199|P3|Overall Study|Noncompliance|1
1323569|NCT00035555|4286200|P2|Overall Study|Noncompliance|1
1323570|NCT00035555|4286201|P1|Overall Study|Noncompliance|0
1323571|NCT00035555|4286199|P3|Overall Study|Lost to Follow-up|1
1323572|NCT00035555|4286200|P2|Overall Study|Lost to Follow-up|0
1323573|NCT00035555|4286201|P1|Overall Study|Lost to Follow-up|0
1323574|NCT00035555|4286199|P3|Overall Study|Death|2
1323575|NCT00035555|4286200|P2|Overall Study|Death|0
1323576|NCT00035555|4286201|P1|Overall Study|Death|0
1323577|NCT00035555|4286199|P3|Overall Study|Allograft loss|2
1323578|NCT00035555|4286200|P2|Overall Study|Allograft loss|1
1323579|NCT00035555|4286201|P1|Overall Study|Allograft loss|1
1323580|NCT00035555|4286199|P3|Overall Study|Adverse Event|9
1323581|NCT00035555|4286200|P2|Overall Study|Adverse Event|8
1323582|NCT00035555|4286201|P1|Overall Study|Adverse Event|5
1323583|NCT00032487|4286285|P2|Overall Study|Had other reason|12
1323584|NCT00032487|4286286|P1|Overall Study|Had other reason|12
1323585|NCT00032487|4286285|P2|Overall Study|Lost to Follow-up|58
1323586|NCT00032487|4286286|P1|Overall Study|Lost to Follow-up|57
1323587|NCT00032487|4286285|P2|Overall Study|Adverse Event|7
1323588|NCT00032487|4286286|P1|Overall Study|Adverse Event|3
1323589|NCT00032487|4286285|P2|Overall Study|Withdrawal by Subject|43
1323590|NCT00032487|4286286|P1|Overall Study|Withdrawal by Subject|67
1323591|NCT00031551|4286296|P2|Overall Study|Withdrew due to chemotherapy effects|0
1323592|NCT00031551|4286297|P1|Overall Study|Withdrew due to chemotherapy effects|2
1323593|NCT00031486|4286309|P2|Overall Study|Other|1
1323594|NCT00031486|4286310|P1|Overall Study|Other|1
1323595|NCT00031486|4286309|P2|Overall Study|Did not meet eligibility requirement|1
1323596|NCT00031486|4286310|P1|Overall Study|Did not meet eligibility requirement|2
1323597|NCT00031486|4286309|P2|Overall Study|Non-compliant|4
1323598|NCT00031486|4286310|P1|Overall Study|Non-compliant|0
1323599|NCT00031486|4286309|P2|Overall Study|Death|3
1323600|NCT00031486|4286310|P1|Overall Study|Death|0
1323601|NCT00031486|4286309|P2|Overall Study|Withdrawal by Subject|2
1323602|NCT00031486|4286310|P1|Overall Study|Withdrawal by Subject|3
1323603|NCT00031486|4286309|P2|Overall Study|Lost to Follow-up|1
1323604|NCT00031486|4286310|P1|Overall Study|Lost to Follow-up|0
1323605|NCT00031486|4286309|P2|Overall Study|Adverse Event|0
1323606|NCT00031486|4286310|P1|Overall Study|Adverse Event|1
1323607|NCT00031460|4286336|P2|Overall Study|Confirmed unevaluable|1
1323608|NCT00031460|4286337|P1|Overall Study|Confirmed unevaluable|0
1323609|NCT00031460|4286336|P2|Overall Study|Disruption of blinded drug supply|0
1323610|NCT00031460|4286337|P1|Overall Study|Disruption of blinded drug supply|2
1323611|NCT00031460|4286336|P2|Overall Study|Reactivation of Disease|9
1323612|NCT00031460|4286337|P1|Overall Study|Reactivation of Disease|5
1323613|NCT00031460|4286336|P2|Overall Study|Death|1
1323614|NCT00031460|4286337|P1|Overall Study|Death|0
1323615|NCT00031460|4286336|P2|Overall Study|Non-Compliant|1
1323616|NCT00031460|4286337|P1|Overall Study|Non-Compliant|1
1323617|NCT00031460|4286336|P2|Overall Study|Withdrawal by Subject|1
1323618|NCT00031460|4286337|P1|Overall Study|Withdrawal by Subject|1
1323619|NCT00031460|4286336|P2|Overall Study|Lost to Follow-up|1
1323620|NCT00031460|4286337|P1|Overall Study|Lost to Follow-up|0
1323621|NCT00031447|4286351|P2|Overall Study|Disruption of blinded study drug supply|4
1323622|NCT00031447|4286352|P1|Overall Study|Disruption of blinded study drug supply|7
1323623|NCT00031447|4286351|P2|Overall Study|Re-activation of Disease|1
1323624|NCT00031447|4286352|P1|Overall Study|Re-activation of Disease|2
1323625|NCT00031447|4286351|P2|Overall Study|Non-compliant|1
1323626|NCT00031447|4286352|P1|Overall Study|Non-compliant|1
1323627|NCT00031447|4286351|P2|Overall Study|Lost to Follow-up|1
1323628|NCT00031447|4286352|P1|Overall Study|Lost to Follow-up|0
1323629|NCT00029146|4286427|P2|Overall Study|Lost to Follow-up|1
1323630|NCT00029146|4286428|P1|Overall Study|Lost to Follow-up|2
1323631|NCT00027378|4286479|P2|Overall Study|Physician Decision|3
1323632|NCT00027378|4286480|P1|Overall Study|Physician Decision|0
1323633|NCT00027027|4286493|P5|Overall Study|Withdrawal by Subject|1
1323634|NCT00027027|4286494|P4|Overall Study|Withdrawal by Subject|0
1323635|NCT00027027|4286495|P3|Overall Study|Withdrawal by Subject|0
1323636|NCT00027027|4286496|P2|Overall Study|Withdrawal by Subject|0
1323637|NCT00027027|4286497|P1|Overall Study|Withdrawal by Subject|0
1323638|NCT00027027|4286493|P5|Overall Study|Physician Decision Due To PD|5
1323639|NCT00027027|4286494|P4|Overall Study|Physician Decision Due To PD|3
1323640|NCT00027027|4286495|P3|Overall Study|Physician Decision Due To PD|2
1323641|NCT00027027|4286496|P2|Overall Study|Physician Decision Due To PD|3
1323642|NCT00027027|4286497|P1|Overall Study|Physician Decision Due To PD|2
1323643|NCT00027027|4286493|P5|Overall Study|PD Requiring Surgery|0
1323644|NCT00027027|4286494|P4|Overall Study|PD Requiring Surgery|0
1323645|NCT00027027|4286495|P3|Overall Study|PD Requiring Surgery|1
1323646|NCT00027027|4286496|P2|Overall Study|PD Requiring Surgery|0
1323647|NCT00027027|4286497|P1|Overall Study|PD Requiring Surgery|0
1323648|NCT00027027|4286493|P5|Overall Study|Clinical Symptoms Progression not PD|0
1323649|NCT00027027|4286494|P4|Overall Study|Clinical Symptoms Progression not PD|0
1323650|NCT00027027|4286495|P3|Overall Study|Clinical Symptoms Progression not PD|0
1323651|NCT00027027|4286496|P2|Overall Study|Clinical Symptoms Progression not PD|0
1323652|NCT00027027|4286497|P1|Overall Study|Clinical Symptoms Progression not PD|1
1323653|NCT00027027|4286493|P5|Overall Study|Admitted for Signs of PD|1
1323654|NCT00027027|4286494|P4|Overall Study|Admitted for Signs of PD|0
1323655|NCT00027027|4286495|P3|Overall Study|Admitted for Signs of PD|0
1323656|NCT00027027|4286496|P2|Overall Study|Admitted for Signs of PD|0
1323657|NCT00027027|4286497|P1|Overall Study|Admitted for Signs of PD|0
1323658|NCT00027027|4286493|P5|Overall Study|Adverse Event|1
1323659|NCT00027027|4286494|P4|Overall Study|Adverse Event|0
1323660|NCT00027027|4286495|P3|Overall Study|Adverse Event|1
1323661|NCT00027027|4286496|P2|Overall Study|Adverse Event|0
1323662|NCT00027027|4286497|P1|Overall Study|Adverse Event|0
1323663|NCT00025883|4286544|P1|Overall Study|didn't reach 6 months of Metreleptin|10
1323664|NCT00025883|4286544|P1|Overall Study|Adverse Event|1
1323665|NCT00025883|4286544|P1|Overall Study|Death|1
1323666|NCT00025883|4286544|P1|Overall Study|no baseline data|1
1323667|NCT00025883|4286544|P1|Overall Study|had atypical progeriod lipodystrophy|4
1323668|NCT00023595|4286556|P5|10 Year Follow up|Lost to Follow-up|0
1323669|NCT00023595|4286557|P4|10 Year Follow up|Lost to Follow-up|0
1323670|NCT00023595|4286558|P3|10 Year Follow up|Lost to Follow-up|3
1323671|NCT00023595|4286559|P2|10 Year Follow up|Lost to Follow-up|10
1323672|NCT00023595|4286560|P1|10 Year Follow up|Lost to Follow-up|12
1323673|NCT00023595|4286556|P5|5 Year Follow up|Lost to Follow-up|3
1323674|NCT00023595|4286557|P4|5 Year Follow up|Lost to Follow-up|7
1323675|NCT00023595|4286558|P3|5 Year Follow up|Lost to Follow-up|1
1323676|NCT00023595|4286559|P2|5 Year Follow up|Lost to Follow-up|2
1323677|NCT00023595|4286560|P1|5 Year Follow up|Lost to Follow-up|2
1323678|NCT00023452|4286771|P2|Overall Study|Other|69
1323679|NCT00023452|4286772|P1|Overall Study|Other|204
1323680|NCT00023452|4286771|P2|Overall Study|Pregnant|20
1323681|NCT00023452|4286772|P1|Overall Study|Pregnant|53
1323682|NCT00023452|4286771|P2|Overall Study|Refused Treatment (continued follow-up)|224
1323683|NCT00023452|4286772|P1|Overall Study|Refused Treatment (continued follow-up)|225
1323684|NCT00023452|4286771|P2|Overall Study|Physician Decision|21
1323685|NCT00023452|4286772|P1|Overall Study|Physician Decision|49
1323686|NCT00023452|4286771|P2|Overall Study|Lost to Follow-up|60
1323687|NCT00023452|4286772|P1|Overall Study|Lost to Follow-up|293
1323688|NCT00023452|4286771|P2|Overall Study|Adverse Event|196
1323689|NCT00023452|4286772|P1|Overall Study|Adverse Event|139
1323690|NCT00023452|4286771|P2|Overall Study|Withdrawal by Subject|54
1323691|NCT00023452|4286772|P1|Overall Study|Withdrawal by Subject|66
1323692|NCT00023452|4286771|P2|Overall Study|Death|0
1323693|NCT00023452|4286772|P1|Overall Study|Death|2
1323694|NCT00023452|4286771|P2|Overall Study|Out of Window|69
1323695|NCT00023452|4286772|P1|Overall Study|Out of Window|129
1323696|NCT00023452|4286771|P2|Overall Study|Ineligible for Study|159
1323697|NCT00023452|4286772|P1|Overall Study|Ineligible for Study|163
1323698|NCT00023322|4286796|P1|Overall Study|Lost to Follow-up|1
1323699|NCT00022763|4286820|P2|Overall Study|Admin|2
1323700|NCT00022763|4286821|P1|Overall Study|Admin|3
1323701|NCT00022763|4286820|P2|Overall Study|Insufficient Therapy|0
1323702|NCT00022763|4286821|P1|Overall Study|Insufficient Therapy|1
1323703|NCT00022763|4286820|P2|Overall Study|Withdrawal by Subject|7
1323704|NCT00022763|4286821|P1|Overall Study|Withdrawal by Subject|4
1323705|NCT00022763|4286820|P2|Overall Study|Lost to Follow-up|3
1323706|NCT00022763|4286821|P1|Overall Study|Lost to Follow-up|0
1323707|NCT00022763|4286820|P2|Overall Study|Death|1
1323708|NCT00022763|4286821|P1|Overall Study|Death|0
1323709|NCT00022763|4286820|P2|Overall Study|Injection Site Reactions|2
1323710|NCT00022763|4286821|P1|Overall Study|Injection Site Reactions|0
1323711|NCT00022763|4286820|P2|Overall Study|Adverse Event|2
1323712|NCT00022763|4286821|P1|Overall Study|Adverse Event|1
1323713|NCT00014911|4286863|P1|Overall Study|Immunosuppression-related Side Effects|1
1323714|NCT00014911|4286863|P1|Overall Study|Unknown Reasons|2
1323715|NCT00014911|4286863|P1|Overall Study|Withdrawal by Subject|6
1323716|NCT00014911|4286863|P1|Overall Study|Lost to Follow-up|1
1323717|NCT00014911|4286863|P1|Overall Study|Adverse Event|1
1323718|NCT00006604|4286879|P17|Overall Study|Other Reason|0
1323719|NCT00006604|4286880|P16|Overall Study|Other Reason|0
1323720|NCT00006604|4286881|P15|Overall Study|Other Reason|0
1323721|NCT00006604|4286882|P14|Overall Study|Other Reason|0
1323722|NCT00006604|4286883|P13|Overall Study|Other Reason|0
1323723|NCT00006604|4286884|P12|Overall Study|Other Reason|0
1323724|NCT00006604|4286885|P11|Overall Study|Other Reason|0
1323725|NCT00006604|4286886|P10|Overall Study|Other Reason|1
1323726|NCT00006604|4286887|P9|Overall Study|Other Reason|0
1323727|NCT00006604|4286888|P8|Overall Study|Other Reason|0
1323728|NCT00006604|4286889|P7|Overall Study|Other Reason|0
1323729|NCT00006604|4286890|P6|Overall Study|Other Reason|1
1323730|NCT00006604|4286891|P5|Overall Study|Other Reason|0
1323731|NCT00006604|4286892|P4|Overall Study|Other Reason|0
1323732|NCT00006604|4286893|P3|Overall Study|Other Reason|0
1323733|NCT00006604|4286894|P2|Overall Study|Other Reason|0
1323734|NCT00006604|4286895|P1|Overall Study|Other Reason|0
1323735|NCT00006604|4286879|P17|Overall Study|Lost to Follow-up|3
1323736|NCT00006604|4286880|P16|Overall Study|Lost to Follow-up|1
1323737|NCT00006604|4286881|P15|Overall Study|Lost to Follow-up|0
1323738|NCT00006604|4286882|P14|Overall Study|Lost to Follow-up|0
1323739|NCT00006604|4286883|P13|Overall Study|Lost to Follow-up|0
1323740|NCT00006604|4286884|P12|Overall Study|Lost to Follow-up|0
1323741|NCT00006604|4286885|P11|Overall Study|Lost to Follow-up|0
1323742|NCT00006604|4286886|P10|Overall Study|Lost to Follow-up|2
1323743|NCT00006604|4286887|P9|Overall Study|Lost to Follow-up|0
1323744|NCT00006604|4286888|P8|Overall Study|Lost to Follow-up|1
1323745|NCT00006604|4286889|P7|Overall Study|Lost to Follow-up|0
1323746|NCT00006604|4286890|P6|Overall Study|Lost to Follow-up|0
1323747|NCT00006604|4286891|P5|Overall Study|Lost to Follow-up|0
1323748|NCT00006604|4286892|P4|Overall Study|Lost to Follow-up|0
1323749|NCT00006604|4286893|P3|Overall Study|Lost to Follow-up|0
1323750|NCT00006604|4286894|P2|Overall Study|Lost to Follow-up|0
1323751|NCT00006604|4286895|P1|Overall Study|Lost to Follow-up|0
1323752|NCT00006604|4286879|P17|Overall Study|Subj/parent not willing to adhere to req|4
1323753|NCT00006604|4286880|P16|Overall Study|Subj/parent not willing to adhere to req|3
1323754|NCT00006604|4286881|P15|Overall Study|Subj/parent not willing to adhere to req|3
1323755|NCT00006604|4286882|P14|Overall Study|Subj/parent not willing to adhere to req|2
1323756|NCT00006604|4286883|P13|Overall Study|Subj/parent not willing to adhere to req|0
1323757|NCT00006604|4286884|P12|Overall Study|Subj/parent not willing to adhere to req|0
1323758|NCT00006604|4286885|P11|Overall Study|Subj/parent not willing to adhere to req|3
1323759|NCT00006604|4286886|P10|Overall Study|Subj/parent not willing to adhere to req|6
1323760|NCT00006604|4286887|P9|Overall Study|Subj/parent not willing to adhere to req|0
1323761|NCT00006604|4286888|P8|Overall Study|Subj/parent not willing to adhere to req|1
1323762|NCT00006604|4286889|P7|Overall Study|Subj/parent not willing to adhere to req|3
1323763|NCT00006604|4286890|P6|Overall Study|Subj/parent not willing to adhere to req|0
1323764|NCT00006604|4286891|P5|Overall Study|Subj/parent not willing to adhere to req|0
1323765|NCT00006604|4286892|P4|Overall Study|Subj/parent not willing to adhere to req|3
1323766|NCT00006604|4286893|P3|Overall Study|Subj/parent not willing to adhere to req|1
1323767|NCT00006604|4286894|P2|Overall Study|Subj/parent not willing to adhere to req|0
1323768|NCT00006604|4286895|P1|Overall Study|Subj/parent not willing to adhere to req|0
1323769|NCT00006604|4286879|P17|Overall Study|Withdrawal by Subject|1
1323770|NCT00006604|4286880|P16|Overall Study|Withdrawal by Subject|0
1323771|NCT00006604|4286881|P15|Overall Study|Withdrawal by Subject|1
1323772|NCT00006604|4286882|P14|Overall Study|Withdrawal by Subject|2
1323773|NCT00006604|4286883|P13|Overall Study|Withdrawal by Subject|1
1323774|NCT00006604|4286884|P12|Overall Study|Withdrawal by Subject|0
1323775|NCT00006604|4286885|P11|Overall Study|Withdrawal by Subject|2
1323776|NCT00006604|4286886|P10|Overall Study|Withdrawal by Subject|3
1323777|NCT00006604|4286887|P9|Overall Study|Withdrawal by Subject|1
1323778|NCT00006604|4286888|P8|Overall Study|Withdrawal by Subject|0
1323779|NCT00006604|4286889|P7|Overall Study|Withdrawal by Subject|2
1323780|NCT00006604|4286890|P6|Overall Study|Withdrawal by Subject|2
1323781|NCT00006604|4286891|P5|Overall Study|Withdrawal by Subject|1
1323782|NCT00006604|4286892|P4|Overall Study|Withdrawal by Subject|0
1323783|NCT00006604|4286893|P3|Overall Study|Withdrawal by Subject|2
1323784|NCT00006604|4286894|P2|Overall Study|Withdrawal by Subject|0
1323785|NCT00006604|4286895|P1|Overall Study|Withdrawal by Subject|1
1323786|NCT00006604|4286879|P17|Overall Study|Site closing|1
1323787|NCT00006604|4286880|P16|Overall Study|Site closing|0
1323788|NCT00006604|4286881|P15|Overall Study|Site closing|0
1323789|NCT00006604|4286882|P14|Overall Study|Site closing|1
1323790|NCT00006604|4286883|P13|Overall Study|Site closing|1
1323791|NCT00006604|4286884|P12|Overall Study|Site closing|1
1323792|NCT00006604|4286885|P11|Overall Study|Site closing|0
1323793|NCT00006604|4286886|P10|Overall Study|Site closing|0
1323794|NCT00006604|4286887|P9|Overall Study|Site closing|0
1323795|NCT00006604|4286888|P8|Overall Study|Site closing|1
1323796|NCT00006604|4286889|P7|Overall Study|Site closing|0
1323797|NCT00006604|4286890|P6|Overall Study|Site closing|0
1323798|NCT00006604|4286891|P5|Overall Study|Site closing|0
1323799|NCT00006604|4286892|P4|Overall Study|Site closing|1
1323800|NCT00006604|4286893|P3|Overall Study|Site closing|1
1323801|NCT00006604|4286894|P2|Overall Study|Site closing|0
1323802|NCT00006604|4286895|P1|Overall Study|Site closing|0
1323803|NCT00006604|4286879|P17|Overall Study|Subj/Parent not able to get to clinic|0
1323804|NCT00006604|4286880|P16|Overall Study|Subj/Parent not able to get to clinic|0
1323805|NCT00006604|4286881|P15|Overall Study|Subj/Parent not able to get to clinic|3
1323806|NCT00006604|4286882|P14|Overall Study|Subj/Parent not able to get to clinic|1
1323807|NCT00006604|4286883|P13|Overall Study|Subj/Parent not able to get to clinic|1
1323808|NCT00006604|4286884|P12|Overall Study|Subj/Parent not able to get to clinic|1
1323809|NCT00006604|4286885|P11|Overall Study|Subj/Parent not able to get to clinic|2
1323810|NCT00006604|4286886|P10|Overall Study|Subj/Parent not able to get to clinic|1
1323811|NCT00006604|4286887|P9|Overall Study|Subj/Parent not able to get to clinic|0
1323812|NCT00006604|4286888|P8|Overall Study|Subj/Parent not able to get to clinic|0
1323813|NCT00006604|4286889|P7|Overall Study|Subj/Parent not able to get to clinic|1
1323814|NCT00006604|4286890|P6|Overall Study|Subj/Parent not able to get to clinic|0
1323815|NCT00006604|4286891|P5|Overall Study|Subj/Parent not able to get to clinic|1
1323816|NCT00006604|4286892|P4|Overall Study|Subj/Parent not able to get to clinic|1
1323817|NCT00006604|4286893|P3|Overall Study|Subj/Parent not able to get to clinic|0
1323818|NCT00006604|4286894|P2|Overall Study|Subj/Parent not able to get to clinic|0
1323819|NCT00006604|4286895|P1|Overall Study|Subj/Parent not able to get to clinic|0
1323820|NCT00006604|4286879|P17|Overall Study|Severe debilitation, unable to continue|0
1323821|NCT00006604|4286880|P16|Overall Study|Severe debilitation, unable to continue|0
1323822|NCT00006604|4286881|P15|Overall Study|Severe debilitation, unable to continue|2
1323823|NCT00006604|4286882|P14|Overall Study|Severe debilitation, unable to continue|0
1323824|NCT00006604|4286883|P13|Overall Study|Severe debilitation, unable to continue|1
1323825|NCT00006604|4286884|P12|Overall Study|Severe debilitation, unable to continue|2
1323826|NCT00006604|4286885|P11|Overall Study|Severe debilitation, unable to continue|0
1323827|NCT00006604|4286886|P10|Overall Study|Severe debilitation, unable to continue|5
1323828|NCT00006604|4286887|P9|Overall Study|Severe debilitation, unable to continue|0
1323829|NCT00006604|4286888|P8|Overall Study|Severe debilitation, unable to continue|0
1323830|NCT00006604|4286889|P7|Overall Study|Severe debilitation, unable to continue|3
1323831|NCT00006604|4286890|P6|Overall Study|Severe debilitation, unable to continue|0
1323832|NCT00006604|4286891|P5|Overall Study|Severe debilitation, unable to continue|0
1323833|NCT00006604|4286892|P4|Overall Study|Severe debilitation, unable to continue|0
1323834|NCT00006604|4286893|P3|Overall Study|Severe debilitation, unable to continue|0
1323835|NCT00006604|4286894|P2|Overall Study|Severe debilitation, unable to continue|0
1323836|NCT00006604|4286895|P1|Overall Study|Severe debilitation, unable to continue|0
1323837|NCT00006604|4286879|P17|Overall Study|Death|0
1323838|NCT00006604|4286880|P16|Overall Study|Death|0
1323839|NCT00006604|4286881|P15|Overall Study|Death|0
1323840|NCT00006604|4286882|P14|Overall Study|Death|0
1323841|NCT00006604|4286883|P13|Overall Study|Death|0
1323842|NCT00006604|4286884|P12|Overall Study|Death|1
1323843|NCT00006604|4286885|P11|Overall Study|Death|1
1323844|NCT00006604|4286886|P10|Overall Study|Death|1
1323845|NCT00006604|4286887|P9|Overall Study|Death|0
1323846|NCT00006604|4286888|P8|Overall Study|Death|0
1323847|NCT00006604|4286889|P7|Overall Study|Death|0
1323848|NCT00006604|4286890|P6|Overall Study|Death|0
1323849|NCT00006604|4286891|P5|Overall Study|Death|0
1323850|NCT00006604|4286892|P4|Overall Study|Death|0
1323851|NCT00006604|4286893|P3|Overall Study|Death|0
1323852|NCT00006604|4286894|P2|Overall Study|Death|0
1323853|NCT00006604|4286895|P1|Overall Study|Death|0
1323854|NCT00006604|4286879|P17|Overall Study|Randomization entry error-no RX, no FU|0
1323855|NCT00006604|4286880|P16|Overall Study|Randomization entry error-no RX, no FU|0
1323856|NCT00006604|4286881|P15|Overall Study|Randomization entry error-no RX, no FU|0
1323857|NCT00006604|4286882|P14|Overall Study|Randomization entry error-no RX, no FU|0
1323858|NCT00006604|4286883|P13|Overall Study|Randomization entry error-no RX, no FU|0
1323859|NCT00006604|4286884|P12|Overall Study|Randomization entry error-no RX, no FU|1
1323860|NCT00006604|4286885|P11|Overall Study|Randomization entry error-no RX, no FU|0
1323861|NCT00006604|4286886|P10|Overall Study|Randomization entry error-no RX, no FU|0
1323862|NCT00006604|4286887|P9|Overall Study|Randomization entry error-no RX, no FU|0
1323863|NCT00006604|4286888|P8|Overall Study|Randomization entry error-no RX, no FU|0
1323864|NCT00006604|4286889|P7|Overall Study|Randomization entry error-no RX, no FU|0
1323865|NCT00006604|4286890|P6|Overall Study|Randomization entry error-no RX, no FU|0
1323866|NCT00006604|4286891|P5|Overall Study|Randomization entry error-no RX, no FU|0
1323867|NCT00006604|4286892|P4|Overall Study|Randomization entry error-no RX, no FU|0
1323868|NCT00006604|4286893|P3|Overall Study|Randomization entry error-no RX, no FU|0
1323869|NCT00006604|4286894|P2|Overall Study|Randomization entry error-no RX, no FU|0
1323870|NCT00006604|4286895|P1|Overall Study|Randomization entry error-no RX, no FU|0
1323871|NCT00006604|4286879|P17|Overall Study|Met study objective - no further FU|0
1323872|NCT00006604|4286880|P16|Overall Study|Met study objective - no further FU|1
1323873|NCT00006604|4286881|P15|Overall Study|Met study objective - no further FU|1
1323874|NCT00006604|4286882|P14|Overall Study|Met study objective - no further FU|0
1323875|NCT00006604|4286883|P13|Overall Study|Met study objective - no further FU|0
1323876|NCT00006604|4286884|P12|Overall Study|Met study objective - no further FU|0
1323877|NCT00006604|4286885|P11|Overall Study|Met study objective - no further FU|0
1323878|NCT00006604|4286886|P10|Overall Study|Met study objective - no further FU|0
1323879|NCT00006604|4286887|P9|Overall Study|Met study objective - no further FU|0
1323880|NCT00006604|4286888|P8|Overall Study|Met study objective - no further FU|0
1323881|NCT00006604|4286889|P7|Overall Study|Met study objective - no further FU|0
1323882|NCT00006604|4286890|P6|Overall Study|Met study objective - no further FU|0
1323883|NCT00006604|4286891|P5|Overall Study|Met study objective - no further FU|0
1323884|NCT00006604|4286892|P4|Overall Study|Met study objective - no further FU|0
1323885|NCT00006604|4286893|P3|Overall Study|Met study objective - no further FU|0
1323886|NCT00006604|4286894|P2|Overall Study|Met study objective - no further FU|0
1323887|NCT00006604|4286895|P1|Overall Study|Met study objective - no further FU|1
1323888|NCT00004978|4287011|P2|Overall Study|site closure - not in analysis cohort|20
1323889|NCT00004978|4287012|P1|Overall Study|site closure - not in analysis cohort|19
1323890|NCT00004978|4287011|P2|Overall Study|Withdrawal by Subject|26
1323891|NCT00004978|4287012|P1|Overall Study|Withdrawal by Subject|17
1323892|NCT00004978|4287011|P2|Overall Study|Lost to Follow-up|108
1323893|NCT00004978|4287012|P1|Overall Study|Lost to Follow-up|101
1323894|NCT00004978|4287011|P2|Overall Study|Death|116
1323895|NCT00004978|4287012|P1|Overall Study|Death|107
1323896|NCT00021541|4287038|P2|Period 2-crossover|Pts that did not progress|3
1323897|NCT00021541|4287039|P1|Period 2-crossover|Pts that did not progress|2
1323898|NCT00021541|4287038|P2|Period 2-crossover|non-adherence|0
1323899|NCT00021541|4287039|P1|Period 2-crossover|non-adherence|1
1323900|NCT00021541|4287038|P2|Period 2-crossover|Adverse Event|2
1323901|NCT00021541|4287039|P1|Period 2-crossover|Adverse Event|2
1323902|NCT00021541|4287038|P2|Period 2-crossover|Withdrawal by Subject|4
1323903|NCT00021541|4287039|P1|Period 2-crossover|Withdrawal by Subject|3
1323904|NCT00021541|4287038|P2|Period 2-crossover|refused phase B|2
1323905|NCT00021541|4287039|P1|Period 2-crossover|refused phase B|2
1323906|NCT00021541|4287038|P2|Period 1-First Treatment|Ineligible|2
1323907|NCT00021541|4287039|P1|Period 1-First Treatment|Ineligible|0
1323908|NCT00021541|4287038|P2|Period 1-First Treatment|Pts that did not progress|2
1323909|NCT00021541|4287039|P1|Period 1-First Treatment|Pts that did not progress|2
1323910|NCT00021541|4287038|P2|Period 1-First Treatment|Death|0
1323911|NCT00021541|4287039|P1|Period 1-First Treatment|Death|1
1323912|NCT00021541|4287038|P2|Period 1-First Treatment|non-adherence|0
1323913|NCT00021541|4287039|P1|Period 1-First Treatment|non-adherence|3
1323914|NCT00021541|4287038|P2|Period 1-First Treatment|Adverse Event|1
1323915|NCT00021541|4287039|P1|Period 1-First Treatment|Adverse Event|2
1323916|NCT00021541|4287038|P2|Period 1-First Treatment|Withdrawal by Subject|3
1323917|NCT00021541|4287039|P1|Period 1-First Treatment|Withdrawal by Subject|3
1323918|NCT00015457|4287053|P2|Second Intervention|Withdrawal by Subject|0
1323919|NCT00015457|4287054|P1|Second Intervention|Withdrawal by Subject|1
1323920|NCT00015457|4287053|P2|First Intervention|Lack of Efficacy|1
1323921|NCT00015457|4287054|P1|First Intervention|Lack of Efficacy|0
1323922|NCT00015457|4287053|P2|First Intervention|Adverse Event|2
1323923|NCT00015457|4287054|P1|First Intervention|Adverse Event|0
1323924|NCT00013611|4287064|P2|Overall Study|Lost to Follow-up|100
1323925|NCT00013611|4287065|P1|Overall Study|Lost to Follow-up|91
1323926|NCT00010803|4287083|P2|Overall Study|Withdrawal by Subject|98
1323927|NCT00010803|4287084|P1|Overall Study|Withdrawal by Subject|97
1323928|NCT00007475|4287111|P4|Overall Study|Adverse Event|0
1323929|NCT00007475|4287112|P3|Overall Study|Adverse Event|0
1323930|NCT00007475|4287113|P2|Overall Study|Adverse Event|0
1323931|NCT00007475|4287114|P1|Overall Study|Adverse Event|3
1323932|NCT00007475|4287111|P4|Overall Study|Withdrawal by Subject|0
1323933|NCT00007475|4287112|P3|Overall Study|Withdrawal by Subject|0
1323934|NCT00007475|4287113|P2|Overall Study|Withdrawal by Subject|0
1323935|NCT00007475|4287114|P1|Overall Study|Withdrawal by Subject|1
1323936|NCT00007345|4287136|P2|Overall Study|Death on study|1
1323937|NCT00007345|4287137|P1|Overall Study|Death on study|1
1323938|NCT00007345|4287136|P2|Overall Study|Intercurrent illness|0
1323939|NCT00007345|4287137|P1|Overall Study|Intercurrent illness|1
1323940|NCT00007345|4287136|P2|Overall Study|Switched to alternative treatment|3
1323941|NCT00007345|4287137|P1|Overall Study|Switched to alternative treatment|0
1323942|NCT00007345|4287136|P2|Overall Study|Refused further treatment|7
1323943|NCT00007345|4287137|P1|Overall Study|Refused further treatment|0
1323944|NCT00006489|4287159|P4|Overall Study|Death|1
1323945|NCT00006489|4287160|P3|Overall Study|Death|0
1323946|NCT00006489|4287161|P2|Overall Study|Death|0
1323947|NCT00006489|4287162|P1|Overall Study|Death|0
1323948|NCT00006489|4287159|P4|Overall Study|Scheduling Conflict|1
1323949|NCT00006489|4287160|P3|Overall Study|Scheduling Conflict|2
1323950|NCT00006489|4287161|P2|Overall Study|Scheduling Conflict|3
1323951|NCT00006489|4287162|P1|Overall Study|Scheduling Conflict|0
1323952|NCT00006489|4287159|P4|Overall Study|Withdrawal by Subject|6
1323953|NCT00006489|4287160|P3|Overall Study|Withdrawal by Subject|9
1323954|NCT00006489|4287161|P2|Overall Study|Withdrawal by Subject|9
1323955|NCT00006489|4287162|P1|Overall Study|Withdrawal by Subject|10
1323956|NCT00006489|4287159|P4|Overall Study|Adverse Event|3
1323957|NCT00006489|4287160|P3|Overall Study|Adverse Event|4
1323958|NCT00006489|4287161|P2|Overall Study|Adverse Event|2
1323959|NCT00006489|4287162|P1|Overall Study|Adverse Event|3
1323960|NCT00006409|4287186|P6|Post-3 Year Intervention|Protocol Violation|62
1323961|NCT00006409|4287187|P5|Post-3 Year Intervention|Protocol Violation|62
1323962|NCT00006409|4287188|P4|Post-3 Year Intervention|Protocol Violation|0
1323963|NCT00006409|4287189|P3|Post-3 Year Intervention|Protocol Violation|0
1323964|NCT00006409|4287190|P2|Post-3 Year Intervention|Protocol Violation|0
1323965|NCT00006409|4287191|P1|Post-3 Year Intervention|Protocol Violation|0
1323966|NCT00006409|4287186|P6|Post-2 Year Intervention|Protocol Violation|0
1323967|NCT00006409|4287187|P5|Post-2 Year Intervention|Protocol Violation|0
1323968|NCT00006409|4287188|P4|Post-2 Year Intervention|Protocol Violation|168
1323969|NCT00006409|4287189|P3|Post-2 Year Intervention|Protocol Violation|251
1323970|NCT00006409|4287190|P2|Post-2 Year Intervention|Protocol Violation|0
1323971|NCT00006409|4287191|P1|Post-2 Year Intervention|Protocol Violation|0
1323972|NCT00006409|4287186|P6|Baseline|Protocol Violation|0
1323973|NCT00006409|4287187|P5|Baseline|Protocol Violation|0
1323974|NCT00006409|4287188|P4|Baseline|Protocol Violation|0
1323975|NCT00006409|4287189|P3|Baseline|Protocol Violation|0
1323976|NCT00006409|4287190|P2|Baseline|Protocol Violation|70
1323977|NCT00006409|4287191|P1|Baseline|Protocol Violation|48
1323978|NCT00006305|4287215|P4|Overall Study|Withdrawal by Subject|14
1323979|NCT00006305|4287216|P3|Overall Study|Withdrawal by Subject|15
1323980|NCT00006305|4287217|P2|Overall Study|Withdrawal by Subject|10
1323981|NCT00006305|4287218|P1|Overall Study|Withdrawal by Subject|17
1323982|NCT00006289|4287234|P2|Second Intervention (5 Weeks)|Protocol Violation|1
1323983|NCT00006289|4287235|P1|Second Intervention (5 Weeks)|Protocol Violation|1
1323984|NCT00006289|4287234|P2|First Intervention (5 Weeks)|Adverse Event|0
1323985|NCT00006289|4287235|P1|First Intervention (5 Weeks)|Adverse Event|1
1323986|NCT00006184|4287253|P2|Overall Study|Death|0
1323987|NCT00006184|4287254|P1|Overall Study|Death|1
1323988|NCT00006164|4287305|P2|Overall Study|Withdrew or lost to follow-up|81
1323989|NCT00006164|4287306|P1|Overall Study|Withdrew or lost to follow-up|70
1323990|NCT00005937|4287349|P1|Overall Study|Lack of Efficacy|5
1323991|NCT00005908|4287353|P2|Overall Study|Withdrawal by Subject|0
1323992|NCT00005908|4287354|P1|Overall Study|Withdrawal by Subject|1
1323993|NCT00005906|4287363|P1|Overall Study|Lack of Efficacy|3
1323994|NCT00004980|4287407|P2|Overall Study|Physician Decision|1
1323995|NCT00004980|4287408|P1|Overall Study|Physician Decision|0
1323996|NCT00004980|4287407|P2|Overall Study|memory difficulties|1
1323997|NCT00004980|4287408|P1|Overall Study|memory difficulties|1
1323998|NCT00004980|4287407|P2|Overall Study|Withdrawal by Subject|0
1323999|NCT00004980|4287408|P1|Overall Study|Withdrawal by Subject|1
1324000|NCT00004732|4287422|P2|Overall Study|Lost to Follow-up|47
1324001|NCT00004732|4287423|P1|Overall Study|Lost to Follow-up|33
1324002|NCT00004732|4287422|P2|Overall Study|Withdrawal by Subject|64
1324003|NCT00004732|4287423|P1|Overall Study|Withdrawal by Subject|36
1324004|NCT00004635|4287433|P2|Period Two|discrepancy in data entry|1
1324005|NCT00004635|4287434|P1|Period Two|discrepancy in data entry|0
1324006|NCT00004635|4287433|P2|Period Two|Lost to Follow-up|0
1324007|NCT00004635|4287434|P1|Period Two|Lost to Follow-up|1
1324008|NCT00004635|4287433|P2|Period Two|secondary malignancy|1
1324009|NCT00004635|4287434|P1|Period Two|secondary malignancy|1
1324010|NCT00004635|4287433|P2|Period Two|travel issues|1
1324011|NCT00004635|4287434|P1|Period Two|travel issues|0
1324012|NCT00004635|4287433|P2|Period Two|health problem|1
1324013|NCT00004635|4287434|P1|Period Two|health problem|1
1324014|NCT00004635|4287433|P2|Period Two|refused|2
1324015|NCT00004635|4287434|P1|Period Two|refused|0
1324016|NCT00004635|4287433|P2|Period Two|Adverse Event|0
1324017|NCT00004635|4287434|P1|Period Two|Adverse Event|1
1324018|NCT00004635|4287433|P2|Period Two|progression|3
1324019|NCT00004635|4287434|P1|Period Two|progression|2
1324020|NCT00004635|4287433|P2|Period One|discrepancy in data entry|1
1324021|NCT00004635|4287434|P1|Period One|discrepancy in data entry|0
1324022|NCT00004635|4287433|P2|Period One|health problem|1
1324023|NCT00004635|4287434|P1|Period One|health problem|0
1324024|NCT00004635|4287433|P2|Period One|progressed|2
1324025|NCT00004635|4287434|P1|Period One|progressed|0
1324026|NCT00004635|4287433|P2|Period One|second malignancy|0
1324027|NCT00004635|4287434|P1|Period One|second malignancy|1
1324028|NCT00004635|4287433|P2|Period One|PSA did not go <5 ng/mL|0
1324029|NCT00004635|4287434|P1|Period One|PSA did not go <5 ng/mL|1
1324030|NCT00004635|4287433|P2|Period One|Protocol Violation|0
1324031|NCT00004635|4287434|P1|Period One|Protocol Violation|1
1324032|NCT00004635|4287433|P2|Period One|Withdrawal by Subject|1
1324033|NCT00004635|4287434|P1|Period One|Withdrawal by Subject|1
1324034|NCT00004635|4287433|P2|Period One|refused|1
1324035|NCT00004635|4287434|P1|Period One|refused|2
1324036|NCT00004563|4287446|P2|Overall Study|Death|3
1324037|NCT00004563|4287447|P1|Overall Study|Death|2
1324038|NCT00004563|4287446|P2|Overall Study|Lack of Efficacy|5
1324039|NCT00004563|4287447|P1|Overall Study|Lack of Efficacy|3
1324040|NCT00004563|4287446|P2|Overall Study|Withdrawal by Subject|16
1324041|NCT00004563|4287447|P1|Overall Study|Withdrawal by Subject|20
1324042|NCT00004562|4287459|P2|Overall Study|Lost to Follow-up|91
1324043|NCT00004562|4287460|P1|Overall Study|Lost to Follow-up|102
1324044|NCT00001962|4287501|P1|Overall Study|Adverse Event|1
1324045|NCT00001962|4287501|P1|Overall Study|Lost to Follow-up|2
1324046|NCT00001962|4287501|P1|Overall Study|Death|1
1324047|NCT00001962|4287501|P1|Overall Study|Lack of Accrual|6
1324048|NCT00001962|4287501|P1|Overall Study|Lack of Efficacy|18
1324049|NCT00001959|4287505|P1|Overall Study|non-compliance|1
1324050|NCT00001959|4287505|P1|Overall Study|disabling sedation|1
1324051|NCT00001959|4287505|P1|Overall Study|newly diagnosed colon cancer|1
1324052|NCT00001941|4287511|P5|Overall Study|not treated- rapidly progressing disease|1
1324053|NCT00001941|4287512|P4|Overall Study|not treated- rapidly progressing disease|0
1324054|NCT00001941|4287513|P3|Overall Study|not treated- rapidly progressing disease|0
1324055|NCT00001941|4287514|P2|Overall Study|not treated- rapidly progressing disease|0
1324056|NCT00001941|4287515|P1|Overall Study|not treated- rapidly progressing disease|0
1324057|NCT00001832|4287547|P15|Treatment Period|Not treated|0
1324058|NCT00001832|4287548|P14|Treatment Period|Not treated|0
1324059|NCT00001832|4287549|P13|Treatment Period|Not treated|0
1324060|NCT00001832|4287550|P12|Treatment Period|Not treated|0
1324061|NCT00001832|4287551|P11|Treatment Period|Not treated|0
1324062|NCT00001832|4287552|P10|Treatment Period|Not treated|0
1324063|NCT00001832|4287553|P9|Treatment Period|Not treated|0
1324064|NCT00001832|4287554|P8|Treatment Period|Not treated|1
1324065|NCT00001832|4287555|P7|Treatment Period|Not treated|0
1324066|NCT00001832|4287556|P6|Treatment Period|Not treated|0
1324067|NCT00001832|4287557|P5|Treatment Period|Not treated|0
1324068|NCT00001832|4287558|P4|Treatment Period|Not treated|0
1324069|NCT00001832|4287559|P3|Treatment Period|Not treated|0
1324070|NCT00001832|4287560|P2|Treatment Period|Not treated|0
1324071|NCT00001832|4287561|P1|Treatment Period|Not treated|0
1324072|NCT00001832|4287547|P15|Treatment Period|Death during treatment|0
1324073|NCT00001832|4287548|P14|Treatment Period|Death during treatment|0
1324074|NCT00001832|4287549|P13|Treatment Period|Death during treatment|0
1324075|NCT00001832|4287550|P12|Treatment Period|Death during treatment|0
1324076|NCT00001832|4287551|P11|Treatment Period|Death during treatment|0
1324077|NCT00001832|4287552|P10|Treatment Period|Death during treatment|0
1324078|NCT00001832|4287553|P9|Treatment Period|Death during treatment|0
1324079|NCT00001832|4287554|P8|Treatment Period|Death during treatment|0
1324080|NCT00001832|4287555|P7|Treatment Period|Death during treatment|0
1324081|NCT00001832|4287556|P6|Treatment Period|Death during treatment|1
1324082|NCT00001832|4287557|P5|Treatment Period|Death during treatment|0
1324083|NCT00001832|4287558|P4|Treatment Period|Death during treatment|0
1324084|NCT00001832|4287559|P3|Treatment Period|Death during treatment|0
1324085|NCT00001832|4287560|P2|Treatment Period|Death during treatment|0
1324086|NCT00001832|4287561|P1|Treatment Period|Death during treatment|0
1324087|NCT00001832|4287547|P15|Apheresis Period|not able to manufacture treatment cells|0
1324088|NCT00001832|4287548|P14|Apheresis Period|not able to manufacture treatment cells|0
1324089|NCT00001832|4287549|P13|Apheresis Period|not able to manufacture treatment cells|0
1324090|NCT00001832|4287550|P12|Apheresis Period|not able to manufacture treatment cells|0
1324091|NCT00001832|4287551|P11|Apheresis Period|not able to manufacture treatment cells|0
1324092|NCT00001832|4287552|P10|Apheresis Period|not able to manufacture treatment cells|0
1324093|NCT00001832|4287553|P9|Apheresis Period|not able to manufacture treatment cells|0
1324094|NCT00001832|4287554|P8|Apheresis Period|not able to manufacture treatment cells|0
1324095|NCT00001832|4287555|P7|Apheresis Period|not able to manufacture treatment cells|0
1324096|NCT00001832|4287556|P6|Apheresis Period|not able to manufacture treatment cells|0
1324097|NCT00001832|4287557|P5|Apheresis Period|not able to manufacture treatment cells|0
1324098|NCT00001832|4287558|P4|Apheresis Period|not able to manufacture treatment cells|0
1324099|NCT00001832|4287559|P3|Apheresis Period|not able to manufacture treatment cells|0
1324100|NCT00001832|4287560|P2|Apheresis Period|not able to manufacture treatment cells|0
1324101|NCT00001832|4287561|P1|Apheresis Period|not able to manufacture treatment cells|60
1324102|NCT00001723|4287607|P2|Overall Study|medication intolerance|2
1324103|NCT00001723|4287608|P1|Overall Study|medication intolerance|1
1324104|NCT00001723|4287607|P2|Overall Study|Lost to Follow-up|2
1324105|NCT00001723|4287608|P1|Overall Study|Lost to Follow-up|2
1324106|NCT00001723|4287607|P2|Overall Study|Lack of family interest|5
1324107|NCT00001723|4287608|P1|Overall Study|Lack of family interest|4
1324108|NCT00001723|4287607|P2|Overall Study|Lack of Efficacy|7
1324109|NCT00001723|4287608|P1|Overall Study|Lack of Efficacy|6
1324110|NCT00001703|4287624|P1|Overall Study|recurrent disease|2
1324111|NCT00001703|4287624|P1|Overall Study|No evidence of disease|1
1324112|NCT00001703|4287624|P1|Overall Study|progressed disease|2
1324113|NCT00001596|4287662|P2|Overall Study|Adverse Event|0
1324114|NCT00001596|4287663|P1|Overall Study|Adverse Event|1
1324115|NCT00001596|4287662|P2|Overall Study|Study Termination|9
1324116|NCT00001596|4287663|P1|Overall Study|Study Termination|12
1324117|NCT00001596|4287662|P2|Overall Study|Withdrawal by Subject|1
1324118|NCT00001596|4287663|P1|Overall Study|Withdrawal by Subject|3
1324119|NCT00001596|4287662|P2|Overall Study|Death|0
1324120|NCT00001596|4287663|P1|Overall Study|Death|1
1324121|NCT00001575|4287694|P1|Overall Study|Withdrawn/deaths|23
1324122|NCT00001575|4287694|P1|Overall Study|Screening failures-Ph I portion|22
1324123|NCT00001566|4287700|P1|Overall Study|unable to complete initial apheresis|1
1324124|NCT00001566|4287700|P1|Overall Study|Lost to Follow-up|1
1324125|NCT00001566|4287700|P1|Overall Study|Death|13
1324126|NCT00001566|4287700|P1|Overall Study|stopped after C3 due to symptomatic PD|1
1324127|NCT00001566|4287700|P1|Overall Study|patients' choice to discontinue protocol|3
1324128|NCT00001262|4287736|P3|Overall Study|Withdrawal by Subject|0
1324129|NCT00001262|4287737|P2|Overall Study|Withdrawal by Subject|3
1324130|NCT00001262|4287738|P1|Overall Study|Withdrawal by Subject|0
1324131|NCT00001262|4287736|P3|Overall Study|Death|0
1324132|NCT00001262|4287737|P2|Overall Study|Death|11
1324133|NCT00001262|4287738|P1|Overall Study|Death|10
1324134|NCT00001213|4287764|P1|Overall Study|Death|18
1324135|NCT00000378|4287775|P2|Overall Study|Lack of Efficacy|14
1324136|NCT00000378|4287776|P1|Overall Study|Lack of Efficacy|16
1324137|NCT00000620|4287793|P8|Overall Study|missed closeout visit|16
1324138|NCT00000620|4287794|P7|Overall Study|missed closeout visit|13
1324139|NCT00000620|4287795|P6|Overall Study|missed closeout visit|28
1324140|NCT00000620|4287796|P5|Overall Study|missed closeout visit|26
1324141|NCT00000620|4287797|P4|Overall Study|missed closeout visit|11
1324142|NCT00000620|4287798|P3|Overall Study|missed closeout visit|16
1324143|NCT00000620|4287799|P2|Overall Study|missed closeout visit|28
1324144|NCT00000620|4287800|P1|Overall Study|missed closeout visit|22
1324145|NCT00000620|4287793|P8|Overall Study|Withdrawal by Subject|21
1324146|NCT00000620|4287794|P7|Overall Study|Withdrawal by Subject|32
1324147|NCT00000620|4287795|P6|Overall Study|Withdrawal by Subject|32
1324148|NCT00000620|4287796|P5|Overall Study|Withdrawal by Subject|30
1324149|NCT00000620|4287797|P4|Overall Study|Withdrawal by Subject|27
1324150|NCT00000620|4287798|P3|Overall Study|Withdrawal by Subject|28
1324151|NCT00000620|4287799|P2|Overall Study|Withdrawal by Subject|27
1324152|NCT00000620|4287800|P1|Overall Study|Withdrawal by Subject|40
1324153|NCT00000620|4287793|P8|Overall Study|Lost to Follow-up|14
1324154|NCT00000620|4287794|P7|Overall Study|Lost to Follow-up|13
1324155|NCT00000620|4287795|P6|Overall Study|Lost to Follow-up|15
1324156|NCT00000620|4287796|P5|Overall Study|Lost to Follow-up|15
1324157|NCT00000620|4287797|P4|Overall Study|Lost to Follow-up|14
1324158|NCT00000620|4287798|P3|Overall Study|Lost to Follow-up|14
1324159|NCT00000620|4287799|P2|Overall Study|Lost to Follow-up|14
1324160|NCT00000620|4287800|P1|Overall Study|Lost to Follow-up|14
1324161|NCT00000620|4287793|P8|Overall Study|Death|95
1324162|NCT00000620|4287794|P7|Overall Study|Death|91
1324163|NCT00000620|4287795|P6|Overall Study|Death|77
1324164|NCT00000620|4287796|P5|Overall Study|Death|64
1324165|NCT00000620|4287797|P4|Overall Study|Death|126
1324166|NCT00000620|4287798|P3|Overall Study|Death|112
1324167|NCT00000620|4287799|P2|Overall Study|Death|67
1324168|NCT00000620|4287800|P1|Overall Study|Death|86
1324169|NCT00004412|4287884|P3|Randomized Period|Moved to Crossover Period|0
1324170|NCT00004412|4287885|P2|Randomized Period|Moved to Crossover Period|0
1324171|NCT00004412|4287886|P1|Randomized Period|Moved to Crossover Period|3
1324172|NCT00000135|4287927|P2|Overall Study|Death|14
1324173|NCT00000135|4287928|P1|Overall Study|Death|27
